{"text_format":"3","workbook":"xlsx","n_sheets":3,"sheets":["YO-A","YO-F","YO-P"],"read":"whole","date_system":"1900"}

{"sheet":"YO-A","index":0,"n_rows":20175,"n_cols":24,"rows_kept":2250,"cut":true,"bounds":{"rows_first":1000,"rows_last":250,"rows_between":1000,"halvings":1}}
["seqnames","start","end","width","geneId","transcriptId","distanceToTSS","geneName","Description","GO","KEGG","score","blockCount","blockSizes","blockStarts","lg.p","lg.fdr","fold_enrichment","annotation","geneChr","geneStart","geneEnd","geneLength","geneStrand"]
["chr1",956124,956392,269,"ENSBGRG00000000004","ENSBGRT00000000007",119,"VGLL3","vestigial like family member 3 [Source:HGNC Symbol;Acc:HGNC:24327]","GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":0.011,"d":"0.01"},1,"269,",0,-1.95,-1.18,8.91,"5' UTR",1,956005,1012265,56261,1]
["chr1",956600,969814,13215,"ENSBGRG00000000004","ENSBGRT00000000007",595,"VGLL3","vestigial like family member 3 [Source:HGNC Symbol;Acc:HGNC:24327]","GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":7.9e-23,"d":"0.00"},2,"14,166,","0,13049",{"v":-22.1,"d":"-22.10"},{"v":-21.2,"d":"-21.20"},{"v":20.8,"d":"20.80"},"Exon (ENSBGRT00000000007/ENSBGRG00000000004, exon 1 of 5)",1,956005,1012265,56261,1]
["chr1",982761,1011729,28969,"ENSBGRG00000000004","ENSBGRT00000000007",26756,"VGLL3","vestigial like family member 3 [Source:HGNC Symbol;Acc:HGNC:24327]","GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":4e-42,"d":"0.00"},2,"27,301,","0,28668",{"v":-41.4,"d":"-41.40"},{"v":-40.3,"d":"-40.30"},6.13,"3' UTR",1,956005,1012265,56261,1]
["chr1",14233227,14233527,301,"ENSBGRG00000000023","ENSBGRT00000000034",20889,"RBM11","RNA binding motif protein 11 [Source:HGNC Symbol;Acc:HGNC:9897]","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008266(poly(U) RNA binding);GO:0016607(nuclear speck);GO:0034599(cellular response to oxidative stress);GO:0042803(protein homodimerization activity)","NA",{"v":2e-13,"d":"0.00"},1,"301,",0,{"v":-12.7,"d":"-12.70"},{"v":-11.9,"d":"-11.90"},3.48,"3' UTR",1,14212338,14234545,22208,1]
["chr1",16172664,16186530,13867,"ENSBGRG00000000031","ENSBGRT00000000048",156596,"USP25","ubiquitin specific peptidase 25 [Source:HGNC Symbol;Acc:HGNC:12624]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032183(SUMO binding);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0051117(ATPase binding);GO:0070536(protein K63-linked deubiquitination);GO:0071108(protein K48-linked deubiquitination);GO:1904293(negative regulation of ERAD pathway)","04657(IL-17 signaling pathway)",{"v":3.4E-5,"d":"0.00"},5,"4,79,80,124,11,","0,1827,5407,9620,13856",-4.47,-3.81,1.56,"Exon (ENSBGRT00000000048/ENSBGRG00000000031, exon 21 of 26)",1,16016068,16187193,171126,1]
["chr1",16186709,16187193,485,"ENSBGRG00000000031","ENSBGRT00000000048",170641,"USP25","ubiquitin specific peptidase 25 [Source:HGNC Symbol;Acc:HGNC:12624]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032183(SUMO binding);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0051117(ATPase binding);GO:0070536(protein K63-linked deubiquitination);GO:0071108(protein K48-linked deubiquitination);GO:1904293(negative regulation of ERAD pathway)","04657(IL-17 signaling pathway)",{"v":3.2e-39,"d":"0.00"},2,"7,173,","0,312",{"v":-38.5,"d":"-38.50"},{"v":-37.4,"d":"-37.40"},2.06,"Exon (ENSBGRT00000000048/ENSBGRG00000000031, exon 25 of 26)",1,16016068,16187193,171126,1]
["chr1",16667823,16704457,36635,"ENSBGRG00000000034","ENSBGRT00000000062",0,"ENSBGRG00000000034","NA","NA","NA",{"v":0.00039,"d":"0.00"},4,"12,197,50,72,","0,12256,35973,36563",-3.41,-2.79,8.42,"Exon (ENSBGRT00000000057/ENSBGRG00000000034, exon 2 of 2)",1,16680079,16751435,71357,1]
["chr1",18868344,18868581,238,"ENSBGRG00000000043","ENSBGRT00000000075",22997,"CHODL","chondrolectin [Source:HGNC Symbol;Acc:HGNC:17807]","GO:0005737(cytoplasm);GO:0010975(regulation of neuron projection development);GO:0048471(perinuclear region of cytoplasm)","NA",{"v":2.5e-45,"d":"0.00"},1,"238,",0,{"v":-44.6,"d":"-44.60"},{"v":-43.4,"d":"-43.40"},5.03,"3' UTR",1,18845347,18869739,24393,1]
["chr1",22428117,22449705,21589,"ENSBGRG00000000047","ENSBGRT00000000080",537085,"NCAM2","neural cell adhesion molecule 2 [Source:HGNC Symbol;Acc:HGNC:7657]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0016020(membrane);GO:0016604(nuclear body);GO:0030424(axon);GO:0042802(identical protein binding)","04514(Cell adhesion molecules (CAMs));05020(Prion diseases)",{"v":0.00093,"d":"0.00"},2,"41,80,","0,21509",-3.03,-2.43,2.05,"Exon (ENSBGRT00000000080/ENSBGRG00000000047, exon 14 of 18)",1,21891032,22492928,601897,1]
["chr1",27544221,27546263,2043,"ENSBGRG00000000061","ENSBGRT00000000101",19189,"GABPA","GA binding protein transcription factor subunit alpha [Source:HGNC Symbol;Acc:HGNC:4071]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0001825(blastocyst formation);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0010628(positive regulation of gene expression);GO:0033613(activating transcription factor binding);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045653(negative regulation of megakaryocyte differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1903351(cellular response to dopamine);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.0021,"d":"0.00"},2,"71,109,","0,1934",-2.67,-2.09,1.79,"Exon (ENSBGRT00000000101/ENSBGRG00000000061, exon 5 of 10)",1,27525032,27568278,43247,1]
["chr1",27555100,27567979,12880,"ENSBGRG00000000061","ENSBGRT00000000101",30068,"GABPA","GA binding protein transcription factor subunit alpha [Source:HGNC Symbol;Acc:HGNC:4071]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0001825(blastocyst formation);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0010628(positive regulation of gene expression);GO:0033613(activating transcription factor binding);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045653(negative regulation of megakaryocyte differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1903351(cellular response to dopamine);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1E-107,"d":"0.00"},3,"35,193,281,","0,5890,12599",-107,-105,5.26,"3' UTR",1,27525032,27568278,43247,1]
["chr1",28926276,28927863,1588,"ENSBGRG00000000070","ENSBGRT00000000122",88,"ENSBGRG00000000070","NA","NA","NA",0.01,2,"13,312,","0,1276",-1.99,-1.46,3.71,"Exon (ENSBGRT00000000122/ENSBGRG00000000070, exon 1 of 2)",1,28926188,28928863,2676,1]
["chr1",31433180,31434509,1330,"ENSBGRG00000000077","ENSBGRT00000000134",12884,"USP16","ubiquitin specific peptidase 16 [Source:HGNC Symbol;Acc:HGNC:12614]","GO:0000278(mitotic cell cycle);GO:0003713(transcription coactivator activity);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008270(zinc ion binding);GO:0010468(regulation of gene expression);GO:0016578(histone deubiquitination);GO:0016579(protein deubiquitination);GO:0035522(monoubiquitinated histone H2A deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042393(histone binding);GO:0043130(ubiquitin binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045901(positive regulation of translational elongation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051289(protein homotetramerization);GO:0051726(regulation of cell cycle);GO:0070537(histone H2A K63-linked deubiquitination)","NA",{"v":1.9e-08,"d":"0.00"},2,"36,114,","0,1216",-7.72,-6.97,1.49,"Exon (ENSBGRT00000000134/ENSBGRG00000000077, exon 5 of 18)",1,31420296,31451387,31092,1]
["chr1",31440744,31450480,9737,"ENSBGRG00000000077","ENSBGRT00000000134",20448,"USP16","ubiquitin specific peptidase 16 [Source:HGNC Symbol;Acc:HGNC:12614]","GO:0000278(mitotic cell cycle);GO:0003713(transcription coactivator activity);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008270(zinc ion binding);GO:0010468(regulation of gene expression);GO:0016578(histone deubiquitination);GO:0016579(protein deubiquitination);GO:0035522(monoubiquitinated histone H2A deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042393(histone binding);GO:0043130(ubiquitin binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045901(positive regulation of translational elongation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051289(protein homotetramerization);GO:0051726(regulation of cell cycle);GO:0070537(histone H2A K63-linked deubiquitination)","NA",{"v":1e-198,"d":"0.00"},5,"10,177,664,95,11,","0,1866,4900,6615,9726",-198,-196,4.84,"Exon (ENSBGRT00000000134/ENSBGRG00000000077, exon 12 of 18)",1,31420296,31451387,31092,1]
["chr1",31783463,31783671,209,"ENSBGRG00000000080","ENSBGRT00000000142",0,"BACH1","BTB domain and CNC homolog 1 [Source:HGNC Symbol;Acc:HGNC:935]","GO:0000083(regulation of transcription involved in G1/S transition of mitotic cell cycle);GO:0000117(regulation of transcription involved in G2/M transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0006355(regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061418(regulation of transcription from RNA polymerase II promoter in response to hypoxia)","NA",{"v":3e-05,"d":"0.00"},1,"209,",0,-4.52,-3.86,3.96,"5' UTR",1,31783463,31799779,16317,1]
["chr1",31787358,31799779,12422,"ENSBGRG00000000080","ENSBGRT00000000142",3895,"BACH1","BTB domain and CNC homolog 1 [Source:HGNC Symbol;Acc:HGNC:935]","GO:0000083(regulation of transcription involved in G1/S transition of mitotic cell cycle);GO:0000117(regulation of transcription involved in G2/M transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0006355(regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061418(regulation of transcription from RNA polymerase II promoter in response to hypoxia)","NA",{"v":1E-58,"d":"0.00"},3,"1335,207,447,","0,2936,11975",-58,{"v":-56.8,"d":"-56.80"},7.05,"Exon (ENSBGRT00000000142/ENSBGRG00000000080, exon 2 of 4)",1,31783463,31799779,16317,1]
["chr1",35470778,35470837,60,"ENSBGRG00000000119","ENSBGRT00000000189",145063,"HUNK","hormonally up-regulated Neu-associated kinase [Source:HGNC Symbol;Acc:HGNC:13326]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA",{"v":0.0072,"d":"0.01"},1,"60,",0,-2.14,{"v":-1.6,"d":"-1.60"},2.18,"Exon (ENSBGRT00000000189/ENSBGRG00000000119, exon 12 of 12)",1,35325715,35471104,145390,1]
["chr1",35471045,35471104,60,"ENSBGRG00000000119","ENSBGRT00000000189",145330,"HUNK","hormonally up-regulated Neu-associated kinase [Source:HGNC Symbol;Acc:HGNC:13326]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA",{"v":0.018,"d":"0.02"},1,"60,",0,-1.74,-1.22,3.96,"Exon (ENSBGRT00000000189/ENSBGRG00000000119, exon 12 of 12)",1,35325715,35471104,145390,1]
["chr1",36059638,36100084,40447,"ENSBGRG00000000123","ENSBGRT00000000199",107985,"EVA1C","eva-1 homolog C [Source:HGNC Symbol;Acc:HGNC:13239]","GO:0005576(extracellular region);GO:0008201(heparin binding);GO:0030246(carbohydrate binding)","03420(Nucleotide excision repair);00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":1E-136,"d":"0.00"},4,"52,587,221,122,","0,14111,37386,40325",-136,-134,9.91,"3' UTR",1,35951653,36074335,122683,1]
["chr1",36819634,36826279,6646,"ENSBGRG00000000131","ENSBGRT00000000219",33339,"ENSBGRG00000000131","NA","GO:0005515(protein binding)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04217(Necroptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04380(Osteoclast differentiation);05200(Pathways in cancer);05162(Measles);05164(Influenza A);05160(Hepatitis C);05168(Herpes simplex infection);05167(Kaposi sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection)",{"v":9.99999999999998e-217,"d":"0.00"},2,"84,1025,","0,5621",-216,-214,{"v":12.2,"d":"12.20"},"3' UTR",1,36786295,36825265,38971,1]
["chr1",36826339,36826549,211,"ENSBGRG00000000131","ENSBGRT00000000218",40044,"ENSBGRG00000000131","NA","GO:0005515(protein binding)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04217(Necroptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04380(Osteoclast differentiation);05200(Pathways in cancer);05162(Measles);05164(Influenza A);05160(Hepatitis C);05168(Herpes simplex infection);05167(Kaposi sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection)",{"v":1.3e-21,"d":"0.00"},1,"211,",0,{"v":-20.9,"d":"-20.90"},{"v":-19.9,"d":"-19.90"},1.93,"3' UTR",1,36786295,36826818,40524,1]
["chr1",36857290,36863430,6141,"ENSBGRG00000000132","ENSBGRT00000000220",28218,"IL10RB","interleukin 10 receptor subunit beta [Source:HGNC Symbol;Acc:HGNC:5965]","GO:0005515(protein binding);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);05152(Tuberculosis);05163(Human cytomegalovirus infection);05169(Epstein-Barr virus infection);05145(Toxoplasmosis)",{"v":2e-15,"d":"0.00"},4,"8,147,12,12,","0,5966,6116,6129",{"v":-14.7,"d":"-14.70"},{"v":-13.8,"d":"-13.80"},2.59,"Exon (ENSBGRT00000000220/ENSBGRG00000000132, exon 6 of 9)",1,36829072,36863430,34359,1]
["chr1",36965831,36967325,1495,"ENSBGRG00000000133","ENSBGRT00000000221",28695,"IFNAR1","interferon alpha and beta receptor subunit 1 [Source:HGNC Symbol;Acc:HGNC:5432]","GO:0004904(interferon receptor activity);GO:0004905(type I interferon receptor activity);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0060337(type I interferon signaling pathway)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04217(Necroptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04380(Osteoclast differentiation);05200(Pathways in cancer);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05168(Herpes simplex infection);05167(Kaposi sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection)",{"v":1e-189,"d":"0.00"},2,"27,240,","0,1255",-189,-187,4.64,"Exon (ENSBGRT00000000221/ENSBGRG00000000133, exon 11 of 11)",1,36937136,36967325,30190,1]
["chr1",37061456,37065571,4116,"ENSBGRG00000000134","ENSBGRT00000000223",28654,"IFNGR2","interferon gamma receptor 2 [Source:HGNC Symbol;Acc:HGNC:5440]","GO:0005515(protein binding)","04630(Jak-STAT signaling pathway);04066(HIF-1 signaling pathway);04060(Cytokine-cytokine receptor interaction);04217(Necroptosis);04650(Natural killer cell mediated cytotoxicity);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04380(Osteoclast differentiation);05200(Pathways in cancer);05321(Inflammatiory bowel disease (IBD));05132(Salmonella infection);05152(Tuberculosis);05162(Measles);05164(Influenza A);05168(Herpes simplex infection);05145(Toxoplasmosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis))",{"v":1e-124,"d":"0.00"},2,"8,231,","0,3885",-124,-122,3.49,"Exon (ENSBGRT00000000223/ENSBGRG00000000134, exon 6 of 7)",1,37032802,37065571,32770,1]
["chr1",37196629,37202065,5437,"ENSBGRG00000000139","ENSBGRT00000000232",0,"SON","SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183]","GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0043484(regulation of RNA splicing);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:0050733(RS domain binding);GO:0051726(regulation of cell cycle)","NA",{"v":2.8e-08,"d":"0.00"},3,"47,164,30,","0,4627,5407",-7.55,{"v":-6.8,"d":"-6.80"},9.91,"Exon (ENSBGRT00000000229/ENSBGRG00000000139, exon 1 of 12)",1,37201256,37212679,11424,1]
["chr1",37202337,37204225,1889,"ENSBGRG00000000140","ENSBGRT00000000233",0,"ENSBGRG00000000140","NA","NA","NA",{"v":1E-135,"d":"0.00"},1,"1889,",0,-135,-133,7.15,"Exon (ENSBGRT00000000232/ENSBGRG00000000139, exon 3 of 8)",1,37203211,37203274,64,1]
["chr1",37204345,37204465,121,"ENSBGRG00000000139","ENSBGRT00000000229",7746,"SON","SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183]","GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0043484(regulation of RNA splicing);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:0050733(RS domain binding);GO:0051726(regulation of cell cycle)","NA",{"v":1.1e-08,"d":"0.00"},1,"121,",0,-7.95,-7.19,2.26,"Exon (ENSBGRT00000000232/ENSBGRG00000000139, exon 3 of 8)",1,37196599,37229433,32835,1]
["chr1",37205403,37205463,61,"ENSBGRG00000000139","ENSBGRT00000000229",8804,"SON","SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183]","GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0043484(regulation of RNA splicing);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:0050733(RS domain binding);GO:0051726(regulation of cell cycle)","NA",{"v":1.4E-5,"d":"0.00"},1,"61,",0,-4.84,-4.17,1.69,"Exon (ENSBGRT00000000232/ENSBGRG00000000139, exon 4 of 8)",1,37196599,37229433,32835,1]
["chr1",37205762,37207980,2219,"ENSBGRG00000000139","ENSBGRT00000000229",9163,"SON","SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183]","GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0043484(regulation of RNA splicing);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:0050733(RS domain binding);GO:0051726(regulation of cell cycle)","NA",0,1,"2219,",0,-411,"-Inf",{"v":12.7,"d":"12.70"},"Exon (ENSBGRT00000000232/ENSBGRG00000000139, exon 4 of 8)",1,37196599,37229433,32835,1]
["chr1",37411696,37450855,39160,"ENSBGRG00000000143","ENSBGRT00000000245",49613,"ITSN1","intersectin 1 [Source:HGNC Symbol;Acc:HGNC:6183]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005905(clathrin-coated pit);GO:0007264(small GTPase mediated signal transduction);GO:0019209(kinase activator activity);GO:0030027(lamellipodium);GO:0030139(endocytic vesicle);GO:0034613(cellular protein localization);GO:0035556(intracellular signal transduction);GO:0043524(negative regulation of neuron apoptotic process);GO:0044305(calyx of Held);GO:0048488(synaptic vesicle endocytosis);GO:0051897(positive regulation of protein kinase B signaling);GO:0060090(molecular adaptor activity);GO:0070064(proline-rich region binding);GO:0098833(presynaptic endocytic zone)","NA",{"v":2.5e-55,"d":"0.00"},7,"240,150,141,88,140,128,192,","0,3001,3236,11542,11752,34662,38968",{"v":-54.6,"d":"-54.60"},{"v":-53.3,"d":"-53.30"},{"v":3.2,"d":"3.20"},"Exon (ENSBGRT00000000245/ENSBGRG00000000143, exon 11 of 22)",1,37362083,37468747,106665,1]
["chr1",37787567,37858026,70460,"ENSBGRG00000000146","ENSBGRT00000000249",29,"MRPS6","mitochondrial ribosomal protein S6 [Source:HGNC Symbol;Acc:HGNC:14051]","GO:0003735(structural constituent of ribosome);GO:0005739(mitochondrion);GO:0005763(mitochondrial small ribosomal subunit);GO:0005840(ribosome);GO:0006412(translation);GO:0019843(rRNA binding)","03010(Ribosome)",{"v":2.5e-19,"d":"0.00"},3,"16,140,190,","0,52730,70270",{"v":-18.6,"d":"-18.60"},{"v":-17.7,"d":"-17.70"},{"v":1.7,"d":"1.70"},"Exon (ENSBGRT00000000249/ENSBGRG00000000146, exon 1 of 3)",1,37787538,37858026,70489,1]
["chr1",38671826,38672421,596,"ENSBGRG00000000161","ENSBGRT00000000266",327,"HTR1F","5-hydroxytryptamine receptor 1F [Source:HGNC Symbol;Acc:HGNC:5292]","GO:0004930(G protein-coupled receptor activity);GO:0004993(G protein-coupled serotonin receptor activity);GO:0005887(integral component of plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0051378(serotonin binding)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04726(Serotonergic synapse);04742(Taste transduction)",{"v":0.011,"d":"0.01"},1,"596,",0,-1.95,-1.18,8.91,"Exon (ENSBGRT00000000266/ENSBGRG00000000161, exon 1 of 1)",1,38671499,38672599,1101,1]
["chr1",38733050,38733288,239,"ENSBGRG00000000164","ENSBGRT00000000269",92699,"CGGBP1","CGG triplet repeat binding protein 1 [Source:HGNC Symbol;Acc:HGNC:1888]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0042802(identical protein binding);GO:0090579(dsDNA loop formation);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.00072,"d":"0.00"},1,"239,",0,-3.14,-2.54,4.95,"5' UTR",1,38729830,38825987,96158,2]
["chr1",38733437,38760993,27557,"ENSBGRG00000000164","ENSBGRT00000000269",64994,"CGGBP1","CGG triplet repeat binding protein 1 [Source:HGNC Symbol;Acc:HGNC:1888]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0042802(identical protein binding);GO:0090579(dsDNA loop formation);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1.1E-5,"d":"0.00"},2,"283,46,","0,27511",-4.94,-4.26,{"v":19.8,"d":"19.80"},"5' UTR",1,38729830,38825987,96158,2]
["chr1",38824326,38825905,1580,"ENSBGRG00000000164","ENSBGRT00000000269",82,"CGGBP1","CGG triplet repeat binding protein 1 [Source:HGNC Symbol;Acc:HGNC:1888]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0042802(identical protein binding);GO:0090579(dsDNA loop formation);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1.6E-51,"d":"0.00"},1,"1580,",0,{"v":-50.8,"d":"-50.80"},{"v":-49.5,"d":"-49.50"},7.21,"Exon (ENSBGRT00000000273/ENSBGRG00000000166, exon 8 of 9)",1,38729830,38825987,96158,2]
["chr1",38848443,38849189,747,"ENSBGRG00000000178","ENSBGRT00000000285",12585,"C3orf38","chromosome 3 open reading frame 38 [Source:HGNC Symbol;Acc:HGNC:28384]","GO:0005634(nucleus);GO:0043065(positive regulation of apoptotic process)","NA",{"v":1E-108,"d":"0.00"},1,"747,",0,-108,-106,115,"3' UTR",1,38835858,38850353,14496,1]
["chr1",38849666,38850323,658,"ENSBGRG00000000178","ENSBGRT00000000285",13808,"C3orf38","chromosome 3 open reading frame 38 [Source:HGNC Symbol;Acc:HGNC:28384]","GO:0005634(nucleus);GO:0043065(positive regulation of apoptotic process)","NA",{"v":1E-179,"d":"0.00"},1,"658,",0,-179,-177,{"v":13.5,"d":"13.50"},"3' UTR",1,38835858,38850353,14496,1]
["chr1",41218481,41228215,9735,"ENSBGRG00000000594","ENSBGRT00000001136",64686,"ARL13B","ADP ribosylation factor like GTPase 13B [Source:HGNC Symbol;Acc:HGNC:25419]","GO:0001947(heart looping);GO:0005525(GTP binding);GO:0005929(cilium);GO:0005930(axoneme);GO:0007224(smoothened signaling pathway);GO:0007368(determination of left/right symmetry);GO:0009953(dorsal/ventral pattern formation);GO:0021532(neural tube patterning);GO:0021830(interneuron migration from the subpallium to the cortex);GO:0021943(formation of radial glial scaffolds);GO:0031514(motile cilium);GO:0060170(ciliary membrane);GO:0060271(cilium assembly);GO:0070986(left/right axis specification);GO:1905515(non-motile cilium assembly)","NA",{"v":6.3E-29,"d":"0.00"},5,"36,115,70,223,90,","0,3462,4368,6744,9645",{"v":-28.2,"d":"-28.20"},{"v":-27.1,"d":"-27.10"},3.96,"Exon (ENSBGRT00000001136/ENSBGRG00000000594, exon 5 of 10)",1,41153795,41238379,84585,1]
["chr1",41229673,41238053,8381,"ENSBGRG00000000594","ENSBGRT00000001136",75878,"ARL13B","ADP ribosylation factor like GTPase 13B [Source:HGNC Symbol;Acc:HGNC:25419]","GO:0001947(heart looping);GO:0005525(GTP binding);GO:0005929(cilium);GO:0005930(axoneme);GO:0007224(smoothened signaling pathway);GO:0007368(determination of left/right symmetry);GO:0009953(dorsal/ventral pattern formation);GO:0021532(neural tube patterning);GO:0021830(interneuron migration from the subpallium to the cortex);GO:0021943(formation of radial glial scaffolds);GO:0031514(motile cilium);GO:0060170(ciliary membrane);GO:0060271(cilium assembly);GO:0070986(left/right axis specification);GO:1905515(non-motile cilium assembly)","NA",{"v":5e-77,"d":"0.00"},2,"66,527,","0,7854",{"v":-76.3,"d":"-76.30"},{"v":-74.9,"d":"-74.90"},6.08,"3' UTR",1,41153795,41238379,84585,1]
["chr1",41256097,41310473,54377,"ENSBGRG00000000728","ENSBGRT00000001293",10414,"NSUN3","NOP2/Sun RNA methyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:26208]","GO:0002127(tRNA wobble base cytosine methylation);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0008168(methyltransferase activity);GO:0016428(tRNA (cytosine-5-)-methyltransferase activity);GO:0070129(regulation of mitochondrial translation)","NA",{"v":6.3e-37,"d":"0.00"},4,"279,155,122,374,","0,9227,10161,54003",{"v":-36.2,"d":"-36.20"},{"v":-35.1,"d":"-35.10"},{"v":5.8,"d":"5.80"},"3' UTR",1,41245683,41310952,65270,1]
["chr1",45201231,45201378,148,"ENSBGRG00000000838","ENSBGRT00000001515",36866,"ARL6","ADP ribosylation factor like GTPase 6 [Source:HGNC Symbol;Acc:HGNC:13210]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005929(cilium);GO:0007420(brain development);GO:0008589(regulation of smoothened signaling pathway);GO:0010842(retina layer formation);GO:0016020(membrane);GO:0016055(Wnt signaling pathway);GO:0045444(fat cell differentiation);GO:0060271(cilium assembly);GO:0061512(protein localization to cilium);GO:0097499(protein localization to non-motile cilium);GO:1903445(protein transport from ciliary membrane to plasma membrane)","NA",{"v":2.3E-3,"d":"0.00"},1,"148,",0,-2.64,-2.06,2.04,"3' UTR",1,45164365,45201378,37014,1]
["chr1",45167400,45167460,61,"ENSBGRG00000000838","ENSBGRT00000001555",3035,"ARL6","ADP ribosylation factor like GTPase 6 [Source:HGNC Symbol;Acc:HGNC:13210]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005929(cilium);GO:0007420(brain development);GO:0008589(regulation of smoothened signaling pathway);GO:0010842(retina layer formation);GO:0016020(membrane);GO:0016055(Wnt signaling pathway);GO:0045444(fat cell differentiation);GO:0060271(cilium assembly);GO:0061512(protein localization to cilium);GO:0097499(protein localization to non-motile cilium);GO:1903445(protein transport from ciliary membrane to plasma membrane)","NA",{"v":0.0058,"d":"0.01"},1,"61,",0,-2.24,-1.69,1.58,"Exon (ENSBGRT00000001568/ENSBGRG00000000859, exon 2 of 2)",1,45164365,45185528,21164,1]
["chr1",45281730,45281820,91,"ENSBGRG00000000874","ENSBGRT00000001593",56591,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":0.0078,"d":"0.01"},1,"91,",0,-2.11,-1.57,3.17,"Exon (ENSBGRT00000001593/ENSBGRG00000000874, exon 4 of 23)",1,45225139,45364143,139005,1]
["chr1",45282599,45282778,180,"ENSBGRG00000000874","ENSBGRT00000001593",57460,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":0.00052,"d":"0.00"},1,"180,",0,-3.28,-2.68,{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000001593/ENSBGRG00000000874, exon 4 of 23)",1,45225139,45364143,139005,1]
["chr1",45285092,45285272,181,"ENSBGRG00000000874","ENSBGRT00000001593",59953,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":0.0016,"d":"0.00"},1,"181,",0,{"v":-2.8,"d":"-2.80"},-2.21,2.97,"Exon (ENSBGRT00000001593/ENSBGRG00000000874, exon 5 of 23)",1,45225139,45364143,139005,1]
["chr1",45285391,45286380,990,"ENSBGRG00000000874","ENSBGRT00000001593",60252,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":4e-21,"d":"0.00"},1,"990,",0,{"v":-20.4,"d":"-20.40"},{"v":-19.4,"d":"-19.40"},6.23,"Exon (ENSBGRT00000001593/ENSBGRG00000000874, exon 5 of 23)",1,45225139,45364143,139005,1]
["chr1",45286709,45287487,779,"ENSBGRG00000000874","ENSBGRT00000001593",61570,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":6.3e-11,"d":"0.00"},1,"779,",0,{"v":-10.2,"d":"-10.20"},-9.42,3.83,"Exon (ENSBGRT00000001593/ENSBGRG00000000874, exon 5 of 23)",1,45225139,45364143,139005,1]
["chr1",45362694,45363754,1061,"ENSBGRG00000000874","ENSBGRT00000001593",137555,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":4e-38,"d":"0.00"},2,"80,191,","0,870",{"v":-37.4,"d":"-37.40"},{"v":-36.3,"d":"-36.30"},2.43,"3' UTR",1,45225139,45364143,139005,1]
["chr1",46377211,46377660,450,"ENSBGRG00000002273","ENSBGRT00000004300",96161,"ST3GAL6","ST3 beta-galactoside alpha-2,3-sialyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:18080]","GO:0006486(protein glycosylation);GO:0008373(sialyltransferase activity)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":8.9e-09,"d":"0.00"},1,"450,",0,-8.05,-7.29,4.46,"3' UTR",1,46281050,46377660,96611,1]
["chr1",47195552,47196118,567,"ENSBGRG00000002573","ENSBGRT00000004822",44748,"ENSBGRG00000002573","NA","NA","NA",0.02,1,"567,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"3' UTR",1,47150804,47196624,45821,1]
["chr1",47196297,47196535,239,"ENSBGRG00000002573","ENSBGRT00000004822",45493,"ENSBGRG00000002573","NA","NA","NA",0.02,1,"239,",0,{"v":-1.7,"d":"-1.70"},-1.19,6.93,"3' UTR",1,47150804,47196624,45821,1]
["chr1",47441407,47441736,330,"ENSBGRG00000002584","ENSBGRT00000004837",63104,"COL8A1","collagen type VIII alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2215]","GO:0005515(protein binding);GO:0010811(positive regulation of cell-substrate adhesion);GO:0035987(endodermal cell differentiation);GO:0048593(camera-type eye morphogenesis);GO:0050673(epithelial cell proliferation)","04974(Protein digestion and absorption)",{"v":0.00019,"d":"0.00"},1,"330,",0,-3.71,-3.08,2.07,"Exon (ENSBGRT00000004837/ENSBGRG00000002584, exon 3 of 3)",1,47378303,47443264,64962,1]
["chr1",47442126,47442395,270,"ENSBGRG00000002584","ENSBGRT00000004837",63823,"COL8A1","collagen type VIII alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2215]","GO:0005515(protein binding);GO:0010811(positive regulation of cell-substrate adhesion);GO:0035987(endodermal cell differentiation);GO:0048593(camera-type eye morphogenesis);GO:0050673(epithelial cell proliferation)","04974(Protein digestion and absorption)",{"v":3.1e-05,"d":"0.00"},1,"270,",0,-4.51,-3.85,2.56,"Exon (ENSBGRT00000004837/ENSBGRG00000002584, exon 3 of 3)",1,47378303,47443264,64962,1]
["chr1",47442545,47443264,720,"ENSBGRG00000002584","ENSBGRT00000004837",64242,"COL8A1","collagen type VIII alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2215]","GO:0005515(protein binding);GO:0010811(positive regulation of cell-substrate adhesion);GO:0035987(endodermal cell differentiation);GO:0048593(camera-type eye morphogenesis);GO:0050673(epithelial cell proliferation)","04974(Protein digestion and absorption)",{"v":1.6e-67,"d":"0.00"},1,"720,",0,{"v":-66.8,"d":"-66.80"},{"v":-65.5,"d":"-65.50"},8.07,"Exon (ENSBGRT00000004837/ENSBGRG00000002584, exon 3 of 3)",1,47378303,47443264,64962,1]
["chr1",48166010,48166070,61,"ENSBGRG00000003008","ENSBGRT00000005631",8846,"ENSBGRG00000003008","NA","NA","04742(Taste transduction)",{"v":0.046,"d":"0.05"},1,"61,",0,-1.34,{"v":-0.855,"d":"-0.86"},1.72,"Exon (ENSBGRT00000005631/ENSBGRG00000003008, exon 2 of 2)",1,48157164,48167439,10276,1]
["chr1",48167438,48171621,4184,"ENSBGRG00000003008","ENSBGRT00000005631",10274,"ENSBGRG00000003008","NA","NA","04742(Taste transduction)",{"v":3.1E-4,"d":"0.00"},2,"2,237,","0,3947",-3.51,-2.89,2.26,"3' UTR",1,48157164,48167439,10276,1]
["chr1",49544595,49549586,4992,"ENSBGRG00000003698","ENSBGRT00000006864",819,"TRMT10C","tRNA methyltransferase 10C, mitochondrial RNase P subunit [Source:HGNC Symbol;Acc:HGNC:26022]","GO:0000049(tRNA binding);GO:0000964(mitochondrial RNA 5'-end processing);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008033(tRNA processing);GO:0009019(tRNA (guanine-N1-)-methyltransferase activity);GO:0016429(tRNA (adenine-N1-)-methyltransferase activity);GO:0042802(identical protein binding);GO:0061953(mRNA (adenine-N1-)-methyltransferase activity);GO:0070131(positive regulation of mitochondrial translation);GO:0080009(mRNA methylation);GO:0090646(mitochondrial tRNA processing);GO:0097745(mitochondrial tRNA 5'-end processing);GO:1990180(mitochondrial tRNA 3'-end processing)","NA",{"v":2.3E-6,"d":"0.00"},2,"35,591,","0,4401",-5.63,-4.93,3.85,"5' UTR",1,49543776,49573670,29895,1]
["chr1",49549646,49550003,358,"ENSBGRG00000003698","ENSBGRT00000006864",5870,"TRMT10C","tRNA methyltransferase 10C, mitochondrial RNase P subunit [Source:HGNC Symbol;Acc:HGNC:26022]","GO:0000049(tRNA binding);GO:0000964(mitochondrial RNA 5'-end processing);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008033(tRNA processing);GO:0009019(tRNA (guanine-N1-)-methyltransferase activity);GO:0016429(tRNA (adenine-N1-)-methyltransferase activity);GO:0042802(identical protein binding);GO:0061953(mRNA (adenine-N1-)-methyltransferase activity);GO:0070131(positive regulation of mitochondrial translation);GO:0080009(mRNA methylation);GO:0090646(mitochondrial tRNA processing);GO:0097745(mitochondrial tRNA 5'-end processing);GO:1990180(mitochondrial tRNA 3'-end processing)","NA",{"v":6.9e-08,"d":"0.00"},1,"358,",0,-7.16,-6.43,3.27,"Exon (ENSBGRT00000006882/ENSBGRG00000003698, exon 3 of 3)",1,49543776,49573670,29895,1]
["chr1",49572450,49573670,1221,"ENSBGRG00000003698","ENSBGRT00000006864",28674,"TRMT10C","tRNA methyltransferase 10C, mitochondrial RNase P subunit [Source:HGNC Symbol;Acc:HGNC:26022]","GO:0000049(tRNA binding);GO:0000964(mitochondrial RNA 5'-end processing);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008033(tRNA processing);GO:0009019(tRNA (guanine-N1-)-methyltransferase activity);GO:0016429(tRNA (adenine-N1-)-methyltransferase activity);GO:0042802(identical protein binding);GO:0061953(mRNA (adenine-N1-)-methyltransferase activity);GO:0070131(positive regulation of mitochondrial translation);GO:0080009(mRNA methylation);GO:0090646(mitochondrial tRNA processing);GO:0097745(mitochondrial tRNA 5'-end processing);GO:1990180(mitochondrial tRNA 3'-end processing)","NA",{"v":1E-173,"d":"0.00"},1,"1221,",0,-173,-171,8,"Exon (ENSBGRT00000006864/ENSBGRG00000003698, exon 3 of 3)",1,49543776,49573670,29895,1]
["chr1",49584716,49589881,5166,"ENSBGRG00000003722","ENSBGRT00000006931",0,"PCNP","PEST proteolytic signal containing nuclear protein [Source:HGNC Symbol;Acc:HGNC:30023]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016567(protein ubiquitination);GO:0016604(nuclear body);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process)","NA",{"v":3.2e-38,"d":"0.00"},2,"64,86,","0,5080",{"v":-37.5,"d":"-37.50"},{"v":-36.4,"d":"-36.40"},2.23,"Exon (ENSBGRT00000006931/ENSBGRG00000003722, exon 1 of 5)",1,49584716,49597829,13114,1]
["chr1",49680308,49689453,9146,"ENSBGRG00000003937","ENSBGRT00000007567",13109,"CEP97","centrosomal protein 97 [Source:HGNC Symbol;Acc:HGNC:26244]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0005829(cytosol);GO:0032991(protein-containing complex);GO:0034451(centriolar satellite);GO:1901673(regulation of mitotic spindle assembly);GO:1902018(negative regulation of cilium assembly)","NA",{"v":6.3e-16,"d":"0.00"},5,"202,209,149,76,169,","0,2574,2815,7257,8977",{"v":-15.2,"d":"-15.20"},{"v":-14.3,"d":"-14.30"},{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000007567/ENSBGRG00000003937, exon 9 of 13)",1,49667199,49689989,22791,1]
["chr1",49689542,49689721,180,"ENSBGRG00000003937","ENSBGRT00000007567",22343,"CEP97","centrosomal protein 97 [Source:HGNC Symbol;Acc:HGNC:26244]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0005829(cytosol);GO:0032991(protein-containing complex);GO:0034451(centriolar satellite);GO:1901673(regulation of mitotic spindle assembly);GO:1902018(negative regulation of cilium assembly)","NA",{"v":0.00042,"d":"0.00"},1,"180,",0,-3.38,-2.77,1.95,"Exon (ENSBGRT00000007567/ENSBGRG00000003937, exon 13 of 13)",1,49667199,49689989,22791,1]
["chr1",49742263,49742772,510,"ENSBGRG00000004124","ENSBGRT00000007643",32309,"NXPE3","neurexophilin and PC-esterase domain family member 3 [Source:HGNC Symbol;Acc:HGNC:28238]","NA","04068(FoxO signaling pathway)",{"v":2e-96,"d":"0.00"},1,"510,",0,{"v":-95.7,"d":"-95.70"},{"v":-94.2,"d":"-94.20"},6.21,"Exon (ENSBGRT00000007643/ENSBGRG00000004124, exon 3 of 6)",1,49709954,49766563,56610,1]
["chr1",49762771,49766563,3793,"ENSBGRG00000004124","ENSBGRT00000007643",52817,"NXPE3","neurexophilin and PC-esterase domain family member 3 [Source:HGNC Symbol;Acc:HGNC:28238]","NA","04068(FoxO signaling pathway)",{"v":1E-204,"d":"0.00"},2,"19,551,","0,3242",-204,-202,5.09,"Exon (ENSBGRT00000007643/ENSBGRG00000004124, exon 5 of 6)",1,49709954,49766563,56610,1]
["chr1",53899912,53900300,389,"ENSBGRG00000004469","ENSBGRT00000008260",0,"ALCAM","activated leukocyte cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:400]","GO:0001772(immunological synapse);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007411(axon guidance);GO:0008045(motor neuron axon guidance);GO:0009897(external side of plasma membrane);GO:0030424(axon);GO:0031226(intrinsic component of plasma membrane);GO:0042101(T cell receptor complex);GO:0042802(identical protein binding);GO:0043025(neuronal cell body)","04514(Cell adhesion molecules (CAMs))",{"v":2.5e-14,"d":"0.00"},1,"389,",0,{"v":-13.6,"d":"-13.60"},{"v":-12.7,"d":"-12.70"},4.86,"5' UTR",1,53899912,54146464,246553,1]
["chr1",54125214,54145957,20744,"ENSBGRG00000004469","ENSBGRT00000008260",225302,"ALCAM","activated leukocyte cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:400]","GO:0001772(immunological synapse);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007411(axon guidance);GO:0008045(motor neuron axon guidance);GO:0009897(external side of plasma membrane);GO:0030424(axon);GO:0031226(intrinsic component of plasma membrane);GO:0042101(T cell receptor complex);GO:0042802(identical protein binding);GO:0043025(neuronal cell body)","04514(Cell adhesion molecules (CAMs))",{"v":1.3e-46,"d":"0.00"},3,"52,116,161,","0,18917,20583",{"v":-45.9,"d":"-45.90"},{"v":-44.8,"d":"-44.80"},4.52,"3' UTR",1,53899912,54146464,246553,1]
["chr1",56594439,56594529,91,"ENSBGRG00000005097","ENSBGRT00000009549",281694,"BBX","BBX high mobility group box domain containing [Source:HGNC Symbol;Acc:HGNC:14422]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0060348(bone development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":7.9e-28,"d":"0.00"},1,"91,",0,{"v":-27.1,"d":"-27.10"},-26,3.52,"Exon (ENSBGRT00000009549/ENSBGRG00000005097, exon 10 of 16)",1,56312745,56624479,311735,1]
["chr1",56594589,56596394,1806,"ENSBGRG00000005097","ENSBGRT00000009549",281844,"BBX","BBX high mobility group box domain containing [Source:HGNC Symbol;Acc:HGNC:14422]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0060348(bone development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":3.2e-62,"d":"0.00"},2,"777,32,","0,1774",{"v":-61.5,"d":"-61.50"},{"v":-60.3,"d":"-60.30"},5.82,"Exon (ENSBGRT00000009549/ENSBGRG00000005097, exon 10 of 16)",1,56312745,56624479,311735,1]
["chr1",56628951,56629041,91,"ENSBGRG00000005097","ENSBGRT00000009514",316206,"BBX","BBX high mobility group box domain containing [Source:HGNC Symbol;Acc:HGNC:14422]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0060348(bone development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.029,"d":"0.03"},1,"91,",0,-1.54,-1.04,1.43,"3' UTR",1,56312745,56629969,317225,1]
["chr1",56974848,56975145,298,"ENSBGRG00000005454","ENSBGRT00000010045",50202,"CD47","CD47 molecule [Source:HGNC Symbol;Acc:HGNC:1682]","GO:0005887(integral component of plasma membrane);GO:0008228(opsonization);GO:0008284(positive regulation of cell population proliferation);GO:0009617(response to bacterium);GO:0009986(cell surface);GO:0022409(positive regulation of cell-cell adhesion);GO:0032649(regulation of interferon-gamma production);GO:0032653(regulation of interleukin-10 production);GO:0032655(regulation of interleukin-12 production);GO:0032675(regulation of interleukin-6 production);GO:0032680(regulation of tumor necrosis factor production);GO:0045428(regulation of nitric oxide biosynthetic process);GO:0050729(positive regulation of inflammatory response);GO:0050766(positive regulation of phagocytosis);GO:0050870(positive regulation of T cell activation);GO:0070053(thrombospondin receptor activity);GO:0070062(extracellular exosome);GO:0071349(cellular response to interleukin-12);GO:0098632(cell-cell adhesion mediator activity)","04512(ECM-receptor interaction)",{"v":0.011,"d":"0.01"},1,"298,",0,-1.95,-1.18,8.91,"Exon (ENSBGRT00000010425/ENSBGRG00000005662, exon 1 of 1)",1,56949662,57025347,75686,2]
["chr1",57253433,57257224,3792,"ENSBGRG00000005718","ENSBGRT00000010544",4857,"ENSBGRG00000005718","NA","NA","NA",{"v":5.4e-09,"d":"0.00"},2,"5,856,","0,2936",-8.27,-7.51,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000010544/ENSBGRG00000005718, exon 3 of 3)",1,57248576,57253437,4862,1]
["chr1",57693451,57695223,1773,"ENSBGRG00000006159","ENSBGRT00000011460",58026,"DZIP3","DAZ interacting zinc finger protein 3 [Source:HGNC Symbol;Acc:HGNC:30938]","GO:0000209(protein polyubiquitination);GO:0003723(RNA binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005737(cytoplasm);GO:0019902(phosphatase binding);GO:0031593(polyubiquitin modification-dependent protein binding);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":2.8E-3,"d":"0.00"},2,"48,73,","0,1700",-2.56,-1.99,2.07,"Exon (ENSBGRT00000011460/ENSBGRG00000006159, exon 12 of 30)",1,57635425,57753008,117584,1]
["chr1",57695760,57725147,29388,"ENSBGRG00000006159","ENSBGRT00000011460",60335,"DZIP3","DAZ interacting zinc finger protein 3 [Source:HGNC Symbol;Acc:HGNC:30938]","GO:0000209(protein polyubiquitination);GO:0003723(RNA binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005737(cytoplasm);GO:0019902(phosphatase binding);GO:0031593(polyubiquitin modification-dependent protein binding);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":3.2e-16,"d":"0.00"},6,"9,33,170,45,26,165,","0,1856,2902,3865,24530,29223",{"v":-15.5,"d":"-15.50"},{"v":-14.6,"d":"-14.60"},3.19,"Exon (ENSBGRT00000011460/ENSBGRG00000006159, exon 13 of 30)",1,57635425,57753008,117584,1]
["chr1",57926304,57926452,149,"ENSBGRG00000006345","ENSBGRT00000011688",80828,"ENSBGRG00000006345","NA","NA","04146(Peroxisome)",{"v":0.0013,"d":"0.00"},1,"149,",0,-2.87,-2.28,4.16,"Exon (ENSBGRT00000011688/ENSBGRG00000006345, exon 7 of 7)",1,57845476,57926452,80977,1]
["chr1",60480791,60492354,11564,"ENSBGRG00000000168","ENSBGRT00000000293",77033,"NECTIN3","nectin cell adhesion molecule 3 [Source:HGNC Symbol;Acc:HGNC:17664]","GO:0002089(lens morphogenesis in camera-type eye);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007286(spermatid development);GO:0009566(fertilization);GO:0042803(protein homodimerization activity);GO:0043296(apical junction complex);GO:0044291(cell-cell contact zone);GO:0050839(cell adhesion molecule binding);GO:0060042(retina morphogenesis in camera-type eye);GO:0061951(establishment of protein localization to plasma membrane);GO:0098609(cell-cell adhesion);GO:0098686(hippocampal mossy fiber to CA3 synapse);GO:0099061(integral component of postsynaptic density membrane);GO:1902414(protein localization to cell junction)","04514(Cell adhesion molecules (CAMs));04520(Adherens junction)",{"v":2.5e-98,"d":"0.00"},2,"540,117,","0,11447",{"v":-97.6,"d":"-97.60"},-96,5.25,"Exon (ENSBGRT00000000293/ENSBGRG00000000168, exon 7 of 7)",1,60403758,60481330,77573,1]
["chr1",60853655,60855827,2173,"ENSBGRG00000000198","ENSBGRT00000000319",868,"CD96","CD96 molecule [Source:HGNC Symbol;Acc:HGNC:16892]","GO:0002534(cytokine production involved in inflammatory response);GO:0002728(negative regulation of natural killer cell cytokine production);GO:0005737(cytoplasm);GO:0007160(cell-matrix adhesion);GO:0032496(response to lipopolysaccharide);GO:0032689(negative regulation of interferon-gamma production)","NA",{"v":1.8E-3,"d":"0.00"},2,"10,231,","0,1942",-2.74,-2.16,{"v":3.4,"d":"3.40"},"Exon (ENSBGRT00000000319/ENSBGRG00000000198, exon 1 of 14)",1,60852787,60961654,108868,1]
["chr1",61366912,61366972,61,"ENSBGRG00000000410","ENSBGRT00000000700",14907,"TAGLN3","transgelin 3 [Source:HGNC Symbol;Acc:HGNC:29868]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005515(protein binding);GO:0005634(nucleus)","NA",{"v":0.011,"d":"0.01"},1,"61,",0,-1.97,-1.44,3.22,"3' UTR",1,61352005,61366972,14968,1]
["chr1",61730266,61733869,3604,"ENSBGRG00000000619","ENSBGRT00000001124",4022,"ENSBGRG00000000619","NA","GO:0043031(negative regulation of macrophage activation);GO:0050776(regulation of immune response)","NA",{"v":1e-17,"d":"0.00"},2,"8,319,","0,3285",-17,{"v":-16.1,"d":"-16.10"},1.98,"5' UTR",1,61726244,61737301,11058,1]
["chr1",61982854,61986266,3413,"ENSBGRG00000000743","ENSBGRT00000001353",16760,"SLC35A5","solute carrier family 35 member A5 [Source:HGNC Symbol;Acc:HGNC:20792]","GO:0000139(Golgi membrane);GO:0015165(pyrimidine nucleotide-sugar transmembrane transporter activity);GO:0016021(integral component of membrane);GO:0090481(pyrimidine nucleotide-sugar transmembrane transport)","NA",{"v":1e-102,"d":"0.00"},2,"667,69,","0,3344",-102,-100,6.45,"Exon (ENSBGRT00000001353/ENSBGRG00000000743, exon 5 of 6)",1,61966094,61983491,17398,1]
["chr1",63048071,63048726,656,"ENSBGRG00000001237","ENSBGRT00000002472",112456,"SIDT1","SID1 transmembrane family member 1 [Source:HGNC Symbol;Acc:HGNC:25967]","GO:0015485(cholesterol binding);GO:0016021(integral component of membrane);GO:0033227(dsRNA transport);GO:0051033(RNA transmembrane transporter activity)","NA",{"v":3.3E-3,"d":"0.00"},1,"656,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"3' UTR",1,62935615,63048786,113172,1]
["chr1",63364446,63368890,4445,"ENSBGRG00000001529","ENSBGRT00000002923",101069,"GRAMD1C","GRAM domain containing 1C [Source:HGNC Symbol;Acc:HGNC:25252]","NA","NA",{"v":4E-14,"d":"0.00"},2,"49,252,","0,4193",{"v":-13.4,"d":"-13.40"},{"v":-12.5,"d":"-12.50"},3.32,"3' UTR",1,63263377,63371109,107733,1]
["chr1",63377462,63378031,570,"ENSBGRG00000001676","ENSBGRT00000003112",4840,"ZDHHC23","zinc finger DHHC-type containing 23 [Source:HGNC Symbol;Acc:HGNC:28654]","GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0072659(protein localization to plasma membrane)","NA",{"v":4.2e-08,"d":"0.00"},1,"570,",0,-7.38,-6.63,8.91,"Exon (ENSBGRT00000003112/ENSBGRG00000001676, exon 2 of 4)",1,63372622,63386515,13894,1]
["chr1",63384251,63384641,391,"ENSBGRG00000001676","ENSBGRT00000003112",11629,"ZDHHC23","zinc finger DHHC-type containing 23 [Source:HGNC Symbol;Acc:HGNC:28654]","GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0072659(protein localization to plasma membrane)","NA",{"v":0.00022,"d":"0.00"},1,"391,",0,-3.66,-3.04,8.91,"3' UTR",1,63372622,63386515,13894,1]
["chr1",63532576,63532755,180,"ENSBGRG00000001757","ENSBGRT00000003277",22417,"QTRT2","queuine tRNA-ribosyltransferase accessory subunit 2 [Source:HGNC Symbol;Acc:HGNC:25771]","GO:0006400(tRNA modification);GO:0008479(queuine tRNA-ribosyltransferase activity);GO:0016763(transferase activity, transferring pentosyl groups);GO:0032991(protein-containing complex);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0101030(tRNA-guanine transglycosylation)","NA",{"v":2e-18,"d":"0.00"},1,"180,",0,{"v":-17.7,"d":"-17.70"},{"v":-16.8,"d":"-16.80"},5.55,"Exon (ENSBGRT00000003277/ENSBGRG00000001757, exon 8 of 8)",1,63510159,63532755,22597,1]
["chr1",69494849,69496669,1821,"ENSBGRG00000002180","ENSBGRT00000004097",132891,"ARHGAP31","Rho GTPase activating protein 31 [Source:HGNC Symbol;Acc:HGNC:29216]","GO:0005096(GTPase activator activity);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0017124(SH3 domain binding);GO:0030027(lamellipodium)","NA",{"v":9.99999999999998e-290,"d":"0.00"},1,"1821,",0,-289,-286,5.14,"Exon (ENSBGRT00000004097/ENSBGRG00000002180, exon 12 of 12)",1,69361958,69496669,134712,1]
["chr1",69572574,69574114,1541,"ENSBGRG00000002270","ENSBGRT00000004229",25296,"POGLUT1","protein O-glucosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:22954]","GO:0001756(somitogenesis);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0005829(cytosol);GO:0006493(protein O-linked glycosylation);GO:0008593(regulation of Notch signaling pathway);GO:0010470(regulation of gastrulation);GO:0018242(protein O-linked glycosylation via serine);GO:0035251(UDP-glucosyltransferase activity);GO:0035252(UDP-xylosyltransferase activity);GO:0045747(positive regulation of Notch signaling pathway);GO:0046527(glucosyltransferase activity);GO:0048318(axial mesoderm development);GO:0048339(paraxial mesoderm development);GO:0060537(muscle tissue development);GO:0072358(cardiovascular system development)","00514(Other types of O-glycan biosynthesis)",{"v":3.2e-39,"d":"0.00"},3,"24,57,157,","0,742,1384",{"v":-38.5,"d":"-38.50"},{"v":-37.4,"d":"-37.40"},4.48,"Exon (ENSBGRT00000004229/ENSBGRG00000002270, exon 9 of 11)",1,69547278,69574114,26837,1]
["chr1",69594767,69600588,5822,"ENSBGRG00000002286","ENSBGRT00000004256",13502,"TIMMDC1","translocase of inner mitochondrial membrane domain containing 1 [Source:HGNC Symbol;Acc:HGNC:1321]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","NA",{"v":1e-170,"d":"0.00"},3,"64,111,151,","0,3352,5671",-170,-169,{"v":12.9,"d":"12.90"},"Exon (ENSBGRT00000004256/ENSBGRG00000002286, exon 5 of 7)",1,69581265,69600588,19324,1]
["chr1",69648427,69651195,2769,"ENSBGRG00000002318","ENSBGRT00000004323",5870,"ADPRH","ADP-ribosylarginine hydrolase [Source:HGNC Symbol;Acc:HGNC:269]","GO:0000287(magnesium ion binding);GO:0003875(ADP-ribosylarginine hydrolase activity);GO:0006464(cellular protein modification process);GO:0030955(potassium ion binding);GO:0051725(protein de-ADP-ribosylation)","NA",{"v":3.2e-14,"d":"0.00"},2,"189,109,","0,2660",{"v":-13.5,"d":"-13.50"},{"v":-12.6,"d":"-12.60"},{"v":3.1,"d":"3.10"},"Exon (ENSBGRT00000004323/ENSBGRG00000002318, exon 3 of 4)",1,69642557,69651492,8936,1]
["chr1",69876080,69876140,61,"ENSBGRG00000002380","ENSBGRT00000004499",103455,"ENSBGRG00000002380","NA","NA","03320(PPAR signaling pathway)",{"v":0.039,"d":"0.04"},1,"61,",0,-1.41,{"v":-0.918,"d":"-0.92"},1.64,"Exon (ENSBGRT00000004499/ENSBGRG00000002380, exon 17 of 18)",1,69772625,69879153,106529,1]
["chr1",70868388,70900552,32165,"ENSBGRG00000002869","ENSBGRT00000005369",0,"SNORA70","Small nucleolar RNA SNORA70 [Source:RFAM;Acc:RF00156]","NA","NA",{"v":5e-43,"d":"0.00"},5,"26,478,202,242,425,","0,4633,20734,26925,31740",{"v":-42.3,"d":"-42.30"},{"v":-41.1,"d":"-41.10"},4.51,"5' UTR",1,70878443,70878575,133,2]
["chr1",71606264,71606502,239,"ENSBGRG00000003263","ENSBGRT00000006059",13598,"FBXO40","F-box protein 40 [Source:HGNC Symbol;Acc:HGNC:29816]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0042692(muscle cell differentiation);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":3.3E-3,"d":"0.00"},1,"239,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000006059/ENSBGRG00000003263, exon 4 of 5)",1,71592666,71611010,18345,1]
["chr1",71607663,71607872,210,"ENSBGRG00000003263","ENSBGRT00000006059",14997,"FBXO40","F-box protein 40 [Source:HGNC Symbol;Acc:HGNC:29816]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0042692(muscle cell differentiation);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":0.00052,"d":"0.00"},1,"210,",0,-3.28,-2.68,{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000006059/ENSBGRG00000003263, exon 4 of 5)",1,71592666,71611010,18345,1]
["chr1",71607931,71607991,61,"ENSBGRG00000003263","ENSBGRT00000006059",15265,"FBXO40","F-box protein 40 [Source:HGNC Symbol;Acc:HGNC:29816]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0042692(muscle cell differentiation);GO:0061630(ubiquitin protein ligase activity)","NA",0.03,1,"61,",0,-1.52,-1.03,3.63,"Exon (ENSBGRT00000006059/ENSBGRG00000003263, exon 4 of 5)",1,71592666,71611010,18345,1]
["chr1",71847796,71870302,22507,"ENSBGRG00000004433","ENSBGRT00000008141",37914,"EAF2","ELL associated factor 2 [Source:HGNC Symbol;Acc:HGNC:23115]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008023(transcription elongation factor complex);GO:0030308(negative regulation of cell growth);GO:0032783(super elongation complex);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060770(negative regulation of epithelial cell proliferation involved in prostate gland development)","NA",{"v":2.3E-3,"d":"0.00"},2,"223,47,","0,22460",-2.63,-2.06,5.94,"Exon (ENSBGRT00000008141/ENSBGRG00000004433, exon 5 of 6)",1,71809882,71870302,60421,1]
["chr1",72334241,72334329,89,"ENSBGRG00000005022","ENSBGRT00000009269",295,"FAM162A","family with sequence similarity 162 member A [Source:HGNC Symbol;Acc:HGNC:17865]","GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0051402(neuron apoptotic process);GO:0071456(cellular response to hypoxia);GO:0090200(positive regulation of release of cytochrome c from mitochondria)","NA",{"v":6.9e-08,"d":"0.00"},1,"89,",0,-7.16,-6.43,3.63,"5' UTR",1,72333946,72380713,46768,1]
["chr1",72363249,72380713,17465,"ENSBGRG00000007133","ENSBGRT00000013146",0,"ENSBGRG00000007133","NA","NA","NA",{"v":4e-38,"d":"0.00"},3,"64,109,93,","0,14788,17372",{"v":-37.4,"d":"-37.40"},{"v":-36.3,"d":"-36.30"},2.69,"Exon (ENSBGRT00000009269/ENSBGRG00000005022, exon 3 of 5)",1,72378575,72379673,1099,1]
["chr1",72522750,72532212,9463,"ENSBGRG00000007487","ENSBGRT00000013756",3449,"ENSBGRG00000007487","NA","GO:0007219(Notch signaling pathway);GO:0016567(protein ubiquitination)","04330(Notch signaling pathway)",{"v":3.6E-9,"d":"0.00"},2,"186,170,","0,9293",-8.44,-7.67,2.46,"Exon (ENSBGRT00000013756/ENSBGRG00000007487, exon 2 of 4)",1,72519301,72533190,13890,1]
["chr1",72572401,72574290,1890,"ENSBGRG00000007559","ENSBGRT00000013829",19364,"PARP14","poly(ADP-ribose) polymerase family member 14 [Source:HGNC Symbol;Acc:HGNC:29232]","GO:0003676(nucleic acid binding);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006471(protein ADP-ribosylation);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042532(negative regulation of tyrosine phosphorylation of STAT protein);GO:0060336(negative regulation of interferon-gamma-mediated signaling pathway);GO:0140289(protein mono-ADP-ribosylation);GO:1902216(positive regulation of interleukin-4-mediated signaling pathway);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":2.5e-26,"d":"0.00"},1,"1890,",0,{"v":-25.6,"d":"-25.60"},{"v":-24.6,"d":"-24.60"},8.72,"Exon (ENSBGRT00000013829/ENSBGRG00000007559, exon 6 of 17)",1,72553037,72602132,49096,1]
["chr1",72591682,72591772,91,"ENSBGRG00000007559","ENSBGRT00000013829",38645,"PARP14","poly(ADP-ribose) polymerase family member 14 [Source:HGNC Symbol;Acc:HGNC:29232]","GO:0003676(nucleic acid binding);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006471(protein ADP-ribosylation);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042532(negative regulation of tyrosine phosphorylation of STAT protein);GO:0060336(negative regulation of interferon-gamma-mediated signaling pathway);GO:0140289(protein mono-ADP-ribosylation);GO:1902216(positive regulation of interleukin-4-mediated signaling pathway);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":2E-3,"d":"0.00"},1,"91,",0,{"v":-2.7,"d":"-2.70"},-2.12,{"v":2.2,"d":"2.20"},"Exon (ENSBGRT00000013829/ENSBGRG00000007559, exon 14 of 17)",1,72553037,72602132,49096,1]
["chr1",72591862,72592252,391,"ENSBGRG00000007559","ENSBGRT00000013829",38825,"PARP14","poly(ADP-ribose) polymerase family member 14 [Source:HGNC Symbol;Acc:HGNC:29232]","GO:0003676(nucleic acid binding);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006471(protein ADP-ribosylation);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042532(negative regulation of tyrosine phosphorylation of STAT protein);GO:0060336(negative regulation of interferon-gamma-mediated signaling pathway);GO:0140289(protein mono-ADP-ribosylation);GO:1902216(positive regulation of interleukin-4-mediated signaling pathway);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":1e-15,"d":"0.00"},1,"391,",0,-15,{"v":-14.1,"d":"-14.10"},4.95,"Exon (ENSBGRT00000013829/ENSBGRG00000007559, exon 14 of 17)",1,72553037,72602132,49096,1]
["chr1",72602042,72602132,91,"ENSBGRG00000007559","ENSBGRT00000013829",49005,"PARP14","poly(ADP-ribose) polymerase family member 14 [Source:HGNC Symbol;Acc:HGNC:29232]","GO:0003676(nucleic acid binding);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006471(protein ADP-ribosylation);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042532(negative regulation of tyrosine phosphorylation of STAT protein);GO:0060336(negative regulation of interferon-gamma-mediated signaling pathway);GO:0140289(protein mono-ADP-ribosylation);GO:1902216(positive regulation of interleukin-4-mediated signaling pathway);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":4.7e-05,"d":"0.00"},1,"91,",0,-4.33,-3.68,1.93,"Exon (ENSBGRT00000013829/ENSBGRG00000007559, exon 17 of 17)",1,72553037,72602132,49096,1]
["chr1",73207604,73262133,54530,"ENSBGRG00000008128","ENSBGRT00000014875",14867,"SEC22A","SEC22 homolog A, vesicle trafficking protein [Source:HGNC Symbol;Acc:HGNC:20260]","NA","NA",{"v":5e-41,"d":"0.00"},4,"1,116,66,201,","0,29204,43938,54329",{"v":-40.3,"d":"-40.30"},{"v":-39.2,"d":"-39.20"},{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000014875/ENSBGRG00000008128, exon 3 of 6)",1,73192737,73262133,69397,1]
["chr1",74865846,74880553,14708,"ENSBGRG00000009282","ENSBGRT00000019256",621628,"KALRN","kalirin RhoGEF kinase [Source:HGNC Symbol;Acc:HGNC:4814]","GO:0004672(protein kinase activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0035023(regulation of Rho protein signal transduction)","NA",{"v":0.0005,"d":"0.00"},3,"82,96,32,","0,5846,14676",{"v":-3.3,"d":"-3.30"},-2.69,2.48,"Exon (ENSBGRT00000019256/ENSBGRG00000009282, exon 36 of 60)",1,74244218,74952619,708402,1]
["chr1",74951031,74951240,210,"ENSBGRG00000009282","ENSBGRT00000019256",706813,"KALRN","kalirin RhoGEF kinase [Source:HGNC Symbol;Acc:HGNC:4814]","GO:0004672(protein kinase activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0035023(regulation of Rho protein signal transduction)","NA",{"v":2.5e-05,"d":"0.00"},1,"210,",0,-4.61,-3.94,4.75,"Exon (ENSBGRT00000019256/ENSBGRG00000009282, exon 60 of 60)",1,74244218,74952619,708402,1]
["chr1",74951360,74951900,541,"ENSBGRG00000009282","ENSBGRT00000019256",707142,"KALRN","kalirin RhoGEF kinase [Source:HGNC Symbol;Acc:HGNC:4814]","GO:0004672(protein kinase activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0035023(regulation of Rho protein signal transduction)","NA",{"v":7.9e-11,"d":"0.00"},1,"541,",0,{"v":-10.1,"d":"-10.10"},-9.28,7.53,"3' UTR",1,74244218,74952619,708402,1]
["chr1",74979248,74981571,2324,"ENSBGRG00000010943","ENSBGRT00000020152",18897,"UMPS","uridine monophosphate synthetase [Source:HGNC Symbol;Acc:HGNC:12563]","GO:0003824(catalytic activity);GO:0004588(orotate phosphoribosyltransferase activity);GO:0004590(orotidine-5'-phosphate decarboxylase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006207('de novo' pyrimidine nucleobase biosynthetic process);GO:0006221(pyrimidine nucleotide biosynthetic process);GO:0006222(UMP biosynthetic process);GO:0009116(nucleoside metabolic process);GO:0044205('de novo' UMP biosynthetic process)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)",{"v":2.5e-62,"d":"0.00"},2,"40,440,","0,1884",{"v":-61.6,"d":"-61.60"},{"v":-60.4,"d":"-60.40"},{"v":5.2,"d":"5.20"},"Exon (ENSBGRT00000020152/ENSBGRG00000010943, exon 2 of 6)",1,74960351,74993190,32840,1]
["chr1",74983337,75015605,32269,"ENSBGRG00000010943","ENSBGRT00000020152",22986,"UMPS","uridine monophosphate synthetase [Source:HGNC Symbol;Acc:HGNC:12563]","GO:0003824(catalytic activity);GO:0004588(orotate phosphoribosyltransferase activity);GO:0004590(orotidine-5'-phosphate decarboxylase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006207('de novo' pyrimidine nucleobase biosynthetic process);GO:0006221(pyrimidine nucleotide biosynthetic process);GO:0006222(UMP biosynthetic process);GO:0009116(nucleoside metabolic process);GO:0044205('de novo' UMP biosynthetic process)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)",0,4,"20,115,44,541,","0,1806,9810,31728",-335,"-Inf",{"v":9.1,"d":"9.10"},"3' UTR",1,74960351,74993190,32840,1]
["chr1",76137892,76140136,2245,"ENSBGRG00000013579","ENSBGRT00000025031",6959,"IQCG","IQ motif containing G [Source:HGNC Symbol;Acc:HGNC:25251]","GO:0002177(manchette);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007286(spermatid development);GO:0007288(sperm axoneme assembly);GO:0030544(Hsp70 protein binding);GO:0031514(motile cilium);GO:0036126(sperm flagellum)","NA",{"v":0.012,"d":"0.01"},2,"19,42,","0,2203",-1.93,-1.41,2.06,"Exon (ENSBGRT00000025031/ENSBGRG00000013579, exon 3 of 10)",1,76130933,76171918,40986,1]
["chr1",76156183,76158740,2558,"ENSBGRG00000013579","ENSBGRT00000025031",25250,"IQCG","IQ motif containing G [Source:HGNC Symbol;Acc:HGNC:25251]","GO:0002177(manchette);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007286(spermatid development);GO:0007288(sperm axoneme assembly);GO:0030544(Hsp70 protein binding);GO:0031514(motile cilium);GO:0036126(sperm flagellum)","NA",{"v":3.1E-6,"d":"0.00"},2,"92,59,","0,2499",-5.51,-4.82,2.81,"Exon (ENSBGRT00000025031/ENSBGRG00000013579, exon 6 of 10)",1,76130933,76171918,40986,1]
["chr1",76372707,76376712,4006,"ENSBGRG00000015738","ENSBGRT00000029671",27843,"RUBCN","rubicon autophagy regulator [Source:HGNC Symbol;Acc:HGNC:28991]","GO:0005654(nucleoplasm);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005829(cytosol);GO:0010507(negative regulation of autophagy);GO:0043231(intracellular membrane-bounded organelle);GO:0043553(negative regulation of phosphatidylinositol 3-kinase activity);GO:0045806(negative regulation of endocytosis);GO:1901097(negative regulation of autophagosome maturation)","04140(Autophagy - animal)",{"v":1E-13,"d":"0.00"},3,"484,45,8,","0,1867,3998",-13,{"v":-12.2,"d":"-12.20"},3.48,"Exon (ENSBGRT00000029671/ENSBGRG00000015738, exon 7 of 22)",1,76344864,76398227,53364,1]
["chr1",76397792,76398227,436,"ENSBGRG00000015738","ENSBGRT00000029671",52928,"RUBCN","rubicon autophagy regulator [Source:HGNC Symbol;Acc:HGNC:28991]","GO:0005654(nucleoplasm);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005829(cytosol);GO:0010507(negative regulation of autophagy);GO:0043231(intracellular membrane-bounded organelle);GO:0043553(negative regulation of phosphatidylinositol 3-kinase activity);GO:0045806(negative regulation of endocytosis);GO:1901097(negative regulation of autophagosome maturation)","04140(Autophagy - animal)",{"v":7.9e-19,"d":"0.00"},2,"30,179,","0,257",{"v":-18.1,"d":"-18.10"},{"v":-17.2,"d":"-17.20"},3.37,"3' UTR",1,76344864,76398227,53364,1]
["chr1",76439934,76440113,180,"ENSBGRG00000016657","ENSBGRT00000030608",9220,"ENSBGRG00000016657","NA","GO:0048012(hepatocyte growth factor receptor signaling pathway)","NA",{"v":0.0068,"d":"0.01"},1,"180,",0,-2.17,-1.63,8.91,"Exon (ENSBGRT00000030608/ENSBGRG00000016657, exon 2 of 3)",1,76430714,76444543,13830,1]
["chr1",77161926,77172230,10305,"ENSBGRG00000018893","ENSBGRT00000034636",291,"FBXO45","F-box protein 45 [Source:HGNC Symbol;Acc:HGNC:29148]","GO:0001764(neuron migration);GO:0005515(protein binding);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0014069(postsynaptic density);GO:0016567(protein ubiquitination);GO:0021799(cerebral cortex radially oriented cell migration);GO:0021800(cerebral cortex tangential migration);GO:0021957(corticospinal tract morphogenesis);GO:0021960(anterior commissure morphogenesis);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0045202(synapse);GO:0060384(innervation);GO:0060386(synapse assembly involved in innervation);GO:0098793(presynapse);GO:0098978(glutamatergic synapse)","NA",{"v":3.5e-10,"d":"0.00"},3,"12,357,186,","0,5276,10119",-9.46,-8.67,3.96,"Exon (ENSBGRT00000034636/ENSBGRG00000018893, exon 1 of 3)",1,77161635,77172230,10596,1]
["chr1",77254846,77255894,1049,"ENSBGRG00000018922","ENSBGRT00000034677",30484,"NRROS","negative regulator of reactive oxygen species [Source:HGNC Symbol;Acc:HGNC:24613]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0006801(superoxide metabolic process);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0009986(cell surface);GO:0014005(microglia development);GO:0035583(sequestering of TGFbeta in extracellular matrix);GO:0036364(transforming growth factor beta1 activation);GO:0050431(transforming growth factor beta binding)","NA",{"v":3.2e-15,"d":"0.00"},1,"1049,",0,{"v":-14.5,"d":"-14.50"},{"v":-13.6,"d":"-13.60"},9.57,"Exon (ENSBGRT00000034677/ENSBGRG00000018922, exon 3 of 5)",1,77224362,77259784,35423,1]
["chr1",77256254,77256583,330,"ENSBGRG00000018922","ENSBGRT00000034677",31892,"NRROS","negative regulator of reactive oxygen species [Source:HGNC Symbol;Acc:HGNC:24613]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0006801(superoxide metabolic process);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0009986(cell surface);GO:0014005(microglia development);GO:0035583(sequestering of TGFbeta in extracellular matrix);GO:0036364(transforming growth factor beta1 activation);GO:0050431(transforming growth factor beta binding)","NA",{"v":0.011,"d":"0.01"},1,"330,",0,-1.95,-1.18,8.91,"Exon (ENSBGRT00000034677/ENSBGRG00000018922, exon 3 of 5)",1,77224362,77259784,35423,1]
["chr1",77411186,77411730,545,"ENSBGRG00000019104","ENSBGRT00000035087",92663,"PAK2","p21 (RAC1) activated kinase 2 [Source:HGNC Symbol;Acc:HGNC:8591]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0014069(postsynaptic density);GO:0016310(phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0030296(protein tyrosine kinase activator activity);GO:0031267(small GTPase binding);GO:0034333(adherens junction assembly);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0048365(Rac GTPase binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051493(regulation of cytoskeleton organization);GO:0051497(negative regulation of stress fiber assembly);GO:0060996(dendritic spine development);GO:0070830(bicellular tight junction assembly);GO:0071407(cellular response to organic cyclic compound);GO:0098978(glutamatergic synapse);GO:0150105(protein localization to cell-cell junction);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04660(T cell receptor signaling pathway);04360(Axon guidance);05211(Renal cell carcinoma)",{"v":0.00052,"d":"0.00"},2,"5,56,","0,489",-3.28,-2.67,1.32,"Exon (ENSBGRT00000035087/ENSBGRG00000019104, exon 10 of 16)",1,77318523,77430765,112243,1]
["chr1",77430194,77582245,152052,"ENSBGRG00000019330","ENSBGRT00000035552",0,"SENP5","SUMO specific peptidase 5 [Source:HGNC Symbol;Acc:HGNC:28407]","GO:0005730(nucleolus);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity);GO:0016926(protein desumoylation);GO:0019783(ubiquitin-like protein-specific protease activity)","NA",{"v":2e-44,"d":"0.00"},3,"32,87,300,","0,485,151752",{"v":-43.7,"d":"-43.70"},{"v":-42.6,"d":"-42.60"},3.66,"5' UTR",1,77448331,77495396,47066,1]
["chr1",77448479,77464463,15985,"ENSBGRG00000019104","ENSBGRT00000035256",61928,"PAK2","p21 (RAC1) activated kinase 2 [Source:HGNC Symbol;Acc:HGNC:8591]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0014069(postsynaptic density);GO:0016310(phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0030296(protein tyrosine kinase activator activity);GO:0031267(small GTPase binding);GO:0034333(adherens junction assembly);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0048365(Rac GTPase binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051493(regulation of cytoskeleton organization);GO:0051497(negative regulation of stress fiber assembly);GO:0060996(dendritic spine development);GO:0070830(bicellular tight junction assembly);GO:0071407(cellular response to organic cyclic compound);GO:0098978(glutamatergic synapse);GO:0150105(protein localization to cell-cell junction);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04660(T cell receptor signaling pathway);04360(Axon guidance);05211(Renal cell carcinoma)",{"v":1.6E-49,"d":"0.00"},2,"22,1524,","0,14461",{"v":-48.8,"d":"-48.80"},{"v":-47.6,"d":"-47.60"},7.25,"5' UTR",1,77386551,77583260,196710,1]
["chr1",77495337,77495396,60,"ENSBGRG00000019104","ENSBGRT00000035256",108786,"PAK2","p21 (RAC1) activated kinase 2 [Source:HGNC Symbol;Acc:HGNC:8591]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0014069(postsynaptic density);GO:0016310(phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0030296(protein tyrosine kinase activator activity);GO:0031267(small GTPase binding);GO:0034333(adherens junction assembly);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0048365(Rac GTPase binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051493(regulation of cytoskeleton organization);GO:0051497(negative regulation of stress fiber assembly);GO:0060996(dendritic spine development);GO:0070830(bicellular tight junction assembly);GO:0071407(cellular response to organic cyclic compound);GO:0098978(glutamatergic synapse);GO:0150105(protein localization to cell-cell junction);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04660(T cell receptor signaling pathway);04360(Axon guidance);05211(Renal cell carcinoma)",{"v":0.039,"d":"0.04"},1,"60,",0,-1.41,{"v":-0.921,"d":"-0.92"},{"v":1.9,"d":"1.90"},"Exon (ENSBGRT00000035552/ENSBGRG00000019330, exon 10 of 10)",1,77386551,77583260,196710,1]
["chr1",78244582,78244731,150,"ENSBGRG00000022918","ENSBGRT00000042322",743,"APOD","apolipoprotein D [Source:HGNC Symbol;Acc:HGNC:612]","GO:0000302(response to reactive oxygen species);GO:0005615(extracellular space);GO:0006006(glucose metabolic process);GO:0006629(lipid metabolic process);GO:0006869(lipid transport);GO:0007568(aging);GO:0008289(lipid binding);GO:0010642(negative regulation of platelet-derived growth factor receptor signaling pathway);GO:0015485(cholesterol binding);GO:0042308(negative regulation of protein import into nucleus);GO:0048471(perinuclear region of cytoplasm);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0051895(negative regulation of focal adhesion assembly);GO:0060588(negative regulation of lipoprotein lipid oxidation);GO:0071638(negative regulation of monocyte chemotactic protein-1 production);GO:1900016(negative regulation of cytokine production involved in inflammatory response);GO:2000098(negative regulation of smooth muscle cell-matrix adhesion);GO:2000405(negative regulation of T cell migration)","NA",{"v":2.5e-40,"d":"0.00"},1,"150,",0,{"v":-39.6,"d":"-39.60"},{"v":-38.5,"d":"-38.50"},3.57,"5' UTR",1,78243839,78259182,15344,1]
["chr1",78258706,78259182,477,"ENSBGRG00000022918","ENSBGRT00000042322",14867,"APOD","apolipoprotein D [Source:HGNC Symbol;Acc:HGNC:612]","GO:0000302(response to reactive oxygen species);GO:0005615(extracellular space);GO:0006006(glucose metabolic process);GO:0006629(lipid metabolic process);GO:0006869(lipid transport);GO:0007568(aging);GO:0008289(lipid binding);GO:0010642(negative regulation of platelet-derived growth factor receptor signaling pathway);GO:0015485(cholesterol binding);GO:0042308(negative regulation of protein import into nucleus);GO:0048471(perinuclear region of cytoplasm);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0051895(negative regulation of focal adhesion assembly);GO:0060588(negative regulation of lipoprotein lipid oxidation);GO:0071638(negative regulation of monocyte chemotactic protein-1 production);GO:1900016(negative regulation of cytokine production involved in inflammatory response);GO:2000098(negative regulation of smooth muscle cell-matrix adhesion);GO:2000405(negative regulation of T cell migration)","NA",0,1,"477,",0,-4240,"-Inf",2.38,"3' UTR",1,78243839,78259182,15344,1]
["chr1",78304065,78310793,6729,"ENSBGRG00000022948","ENSBGRT00000042439",13521,"ENSBGRG00000022948","NA","GO:0004864(protein phosphatase inhibitor activity);GO:0009966(regulation of signal transduction);GO:0043666(regulation of phosphoprotein phosphatase activity)","NA",{"v":6.3e-60,"d":"0.00"},4,"8,101,168,23,","0,554,4964,6706",{"v":-59.2,"d":"-59.20"},{"v":-57.9,"d":"-57.90"},3.06,"Exon (ENSBGRT00000042439/ENSBGRG00000022948, exon 3 of 6)",1,78290544,78311452,20909,1]
["chr1",78529425,78529574,150,"ENSBGRG00000023053","ENSBGRT00000042554",185862,"ACAP2","ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 [Source:HGNC Symbol;Acc:HGNC:16469]","GO:0001726(ruffle);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0017137(Rab GTPase binding);GO:0030029(actin filament-based process);GO:0080025(phosphatidylinositol-3,5-bisphosphate binding)","04144(Endocytosis)",{"v":0.00013,"d":"0.00"},1,"150,",0,-3.88,-3.25,2.21,"3' UTR",1,78343563,78530171,186609,1]
["chr1",78652537,78737916,85380,"ENSBGRG00000023443","ENSBGRT00000043289",113850,"XXYLT1","xyloside xylosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:26639]","GO:0000287(magnesium ion binding);GO:0016266(O-glycan processing);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030145(manganese ion binding);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0035252(UDP-xylosyltransferase activity)","NA",{"v":3.2e-76,"d":"0.00"},2,"59,508,","0,84872",{"v":-75.5,"d":"-75.50"},{"v":-74.1,"d":"-74.10"},6.84,"3' UTR",1,78538687,78737916,199230,1]
["chr1",79181835,79188043,6209,"ENSBGRG00000023529","ENSBGRT00000043425",10824,"LSG1","large 60S subunit nuclear export GTPase 1 [Source:HGNC Symbol;Acc:HGNC:25652]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0015030(Cajal body);GO:0016604(nuclear body);GO:0051168(nuclear export)","03008(Ribosome biogenesis in eukaryotes)",{"v":9.99999999999998e-239,"d":"0.00"},3,"159,387,54,","0,5322,6155",-238,-236,4.69,"Exon (ENSBGRT00000043425/ENSBGRG00000023529, exon 7 of 14)",1,79171011,79197825,26815,1]
["chr1",79194352,79196326,1975,"ENSBGRG00000023529","ENSBGRT00000043425",23341,"LSG1","large 60S subunit nuclear export GTPase 1 [Source:HGNC Symbol;Acc:HGNC:25652]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0015030(Cajal body);GO:0016604(nuclear body);GO:0051168(nuclear export)","03008(Ribosome biogenesis in eukaryotes)",{"v":1E-173,"d":"0.00"},2,"61,390,","0,1585",-173,-171,4.15,"3' UTR",1,79171011,79197825,26815,1]
["chr1",79257100,79257189,90,"ENSBGRG00000023581","ENSBGRT00000043526",51989,"TMEM44","transmembrane protein 44 [Source:HGNC Symbol;Acc:HGNC:25120]","NA","NA",{"v":0.00014,"d":"0.00"},1,"90,",0,-3.85,-3.21,2.61,"Exon (ENSBGRT00000043526/ENSBGRG00000023581, exon 11 of 11)",1,79205111,79257189,52079,1]
["chr1",79529301,79529810,510,"ENSBGRG00000024371","ENSBGRT00000044979",1137,"CPN2","carboxypeptidase N subunit 2 [Source:HGNC Symbol;Acc:HGNC:2313]","GO:0005515(protein binding)","NA",{"v":0.036,"d":"0.04"},1,"510,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000044979/ENSBGRG00000024371, exon 1 of 1)",1,79528164,79529810,1647,1]
["chr1",81078777,81099537,20761,"ENSBGRG00000000376","ENSBGRT00000000612",103088,"MB21D2","Mab-21 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30438]","GO:0044877(protein-containing complex binding)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer);05226(Gastric cancer);05218(Melanoma);05224(Breast cancer)",{"v":2.5e-69,"d":"0.00"},2,"38,1265,","0,19496",{"v":-68.6,"d":"-68.60"},{"v":-67.2,"d":"-67.20"},8.54,"Exon (ENSBGRT00000000612/ENSBGRG00000000376, exon 2 of 3)",1,80975689,81099537,123849,1]
["chr1",81847189,81847830,642,"ENSBGRG00000000418","ENSBGRT00000000706",674175,"FGF12","fibroblast growth factor 12 [Source:HGNC Symbol;Acc:HGNC:3668]","GO:0005634(nucleus);GO:0007268(chemical synaptic transmission);GO:0008083(growth factor activity);GO:0008344(adult locomotory behavior);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0010765(positive regulation of sodium ion transport);GO:0050905(neuromuscular process);GO:0098908(regulation of neuronal action potential);GO:1905150(regulation of voltage-gated sodium channel activity)","NA",{"v":2e-10,"d":"0.00"},2,"147,119,","0,523",{"v":-9.7,"d":"-9.70"},-8.91,{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000000706/ENSBGRG00000000418, exon 5 of 5)",1,81173014,81847830,674817,1]
["chr1",83037011,83037101,91,"ENSBGRG00000000645","ENSBGRT00000001164",122507,"GMNC","geminin coiled-coil domain containing [Source:HGNC Symbol;Acc:HGNC:40049]","GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0006260(DNA replication);GO:0006270(DNA replication initiation);GO:0060271(cilium assembly)","NA",0.02,1,"91,",0,{"v":-1.7,"d":"-1.70"},-1.19,6.93,"Exon (ENSBGRT00000001164/ENSBGRG00000000645, exon 5 of 5)",1,82914504,83039134,124631,1]
["chr1",83681236,83681325,90,"ENSBGRG00000000800","ENSBGRT00000001454",17670,"CLDN1","claudin 1 [Source:HGNC Symbol;Acc:HGNC:2032]","GO:0005198(structural molecule activity);GO:0005923(bicellular tight junction);GO:0016021(integral component of membrane)","04514(Cell adhesion molecules (CAMs));04530(Tight junction);04670(Leukocyte transendothelial migration);05160(Hepatitis C)",{"v":6.3e-11,"d":"0.00"},1,"90,",0,{"v":-10.2,"d":"-10.20"},-9.36,2.86,"3' UTR",1,83663566,83682216,18651,1]
["chr1",87060434,87060643,210,"ENSBGRG00000001306","ENSBGRT00000002546",69812,"MASP1","mannan binding lectin serine peptidase 1 [Source:HGNC Symbol;Acc:HGNC:6901]","GO:0001867(complement activation, lectin pathway);GO:0004252(serine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0042803(protein homodimerization activity);GO:0048306(calcium-dependent protein binding)","04610(Complement and coagulation cascades);05150(Staphylococcus aureus infection)",{"v":0.00046,"d":"0.00"},1,"210,",0,-3.34,-2.72,{"v":11.9,"d":"11.90"},"3' UTR",1,86990622,87061841,71220,1]
["chr1",87060973,87061152,180,"ENSBGRG00000001306","ENSBGRT00000002546",70351,"MASP1","mannan binding lectin serine peptidase 1 [Source:HGNC Symbol;Acc:HGNC:6901]","GO:0001867(complement activation, lectin pathway);GO:0004252(serine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0042803(protein homodimerization activity);GO:0048306(calcium-dependent protein binding)","04610(Complement and coagulation cascades);05150(Staphylococcus aureus infection)",{"v":8.5e-06,"d":"0.00"},1,"180,",0,-5.07,-4.39,9.91,"3' UTR",1,86990622,87061841,71220,1]
["chr1",87061661,87061841,181,"ENSBGRG00000001306","ENSBGRT00000002546",71039,"MASP1","mannan binding lectin serine peptidase 1 [Source:HGNC Symbol;Acc:HGNC:6901]","GO:0001867(complement activation, lectin pathway);GO:0004252(serine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0042803(protein homodimerization activity);GO:0048306(calcium-dependent protein binding)","04610(Complement and coagulation cascades);05150(Staphylococcus aureus infection)",0.02,1,"181,",0,{"v":-1.7,"d":"-1.70"},-1.19,6.93,"3' UTR",1,86990622,87061841,71220,1]
["chr1",87739422,87748207,8786,"ENSBGRG00000001905","ENSBGRT00000003558",13542,"TBCCD1","TBCC domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25546]","GO:0000902(cell morphogenesis);GO:0008360(regulation of cell shape);GO:0030334(regulation of cell migration);GO:0031616(spindle pole centrosome);GO:0051661(maintenance of centrosome location);GO:0051684(maintenance of Golgi location)","NA",{"v":7.9e-31,"d":"0.00"},4,"215,187,498,52,","0,1988,2308,8734",{"v":-30.1,"d":"-30.10"},{"v":-29.1,"d":"-29.10"},3.32,"Exon (ENSBGRT00000003558/ENSBGRG00000001905, exon 4 of 8)",1,87725880,87753459,27580,1]
["chr1",88320795,88320855,61,"ENSBGRG00000002337","ENSBGRT00000004376",57433,"ETV5","ETS variant transcription factor 5 [Source:HGNC Symbol;Acc:HGNC:3494]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007274(neuromuscular synaptic transmission);GO:0007626(locomotory behavior);GO:0034599(cellular response to oxidative stress);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050807(regulation of synapse organization);GO:0060762(regulation of branching involved in mammary gland duct morphogenesis);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:1990837(sequence-specific double-stranded DNA binding)","05202(Transcriptional misregulation in cancers);05215(Prostate cancer)",{"v":0.026,"d":"0.03"},1,"61,",0,-1.59,-1.09,3.22,"3' UTR",1,88263362,88321482,58121,1]
["chr1",88439348,88445563,6216,"ENSBGRG00000002443","ENSBGRT00000004586",15240,"TRA2B","transformer 2 beta homolog [Source:HGNC Symbol;Acc:HGNC:10781]","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005637(nuclear inner membrane);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0019904(protein domain specific binding);GO:0021796(cerebral cortex regionalization);GO:0032991(protein-containing complex);GO:0036002(pre-mRNA binding);GO:0042802(identical protein binding);GO:0043484(regulation of RNA splicing);GO:0048026(positive regulation of mRNA splicing, via spliceosome);GO:0071333(cellular response to glucose stimulus);GO:1990403(embryonic brain development)","03040(Spliceosome)",{"v":3.2e-65,"d":"0.00"},6,"18,116,84,60,74,64,","0,3070,3492,4784,5615,6152",{"v":-64.5,"d":"-64.50"},{"v":-63.2,"d":"-63.20"},1.88,"3' UTR",1,88424108,88445919,21812,1]
["chr1",89112911,89124716,11806,"ENSBGRG00000002913","ENSBGRT00000005461",44226,"EHHADH","enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase [Source:HGNC Symbol;Acc:HGNC:3247]","GO:0003824(catalytic activity);GO:0003857(3-hydroxyacyl-CoA dehydrogenase activity);GO:0004300(enoyl-CoA hydratase activity);GO:0005777(peroxisome);GO:0006631(fatty acid metabolic process);GO:0006635(fatty acid beta-oxidation);GO:0016491(oxidoreductase activity);GO:0016509(long-chain-3-hydroxyacyl-CoA dehydrogenase activity);GO:0019899(enzyme binding);GO:0055114(oxidation-reduction process)","00640(Propanoate metabolism);00650(Butanoate metabolism);00071(Fatty acid degradation);00280(Valine, leucine and isoleucine degradation);00310(Lysine degradation);00380(Tryptophan metabolism);00410(beta-Alanine metabolism);04146(Peroxisome);03320(PPAR signaling pathway)",{"v":2E-3,"d":"0.00"},2,"99,21,","0,11785",-2.69,-2.12,3.22,"Exon (ENSBGRT00000005461/ENSBGRG00000002913, exon 6 of 7)",1,89068685,89126235,57551,1]
["chr1",89124806,89125223,418,"ENSBGRG00000002913","ENSBGRT00000005461",56121,"EHHADH","enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase [Source:HGNC Symbol;Acc:HGNC:3247]","GO:0003824(catalytic activity);GO:0003857(3-hydroxyacyl-CoA dehydrogenase activity);GO:0004300(enoyl-CoA hydratase activity);GO:0005777(peroxisome);GO:0006631(fatty acid metabolic process);GO:0006635(fatty acid beta-oxidation);GO:0016491(oxidoreductase activity);GO:0016509(long-chain-3-hydroxyacyl-CoA dehydrogenase activity);GO:0019899(enzyme binding);GO:0055114(oxidation-reduction process)","00640(Propanoate metabolism);00650(Butanoate metabolism);00071(Fatty acid degradation);00280(Valine, leucine and isoleucine degradation);00310(Lysine degradation);00380(Tryptophan metabolism);00410(beta-Alanine metabolism);04146(Peroxisome);03320(PPAR signaling pathway)",{"v":6.3e-08,"d":"0.00"},1,"418,",0,{"v":-7.2,"d":"-7.20"},-6.46,5.06,"Exon (ENSBGRT00000005461/ENSBGRG00000002913, exon 7 of 7)",1,89068685,89126235,57551,1]
["chr1",89319090,89319650,561,"ENSBGRG00000002933","ENSBGRT00000005514",135382,"C3orf70","chromosome 3 open reading frame 70 [Source:HGNC Symbol;Acc:HGNC:33731]","NA","NA",{"v":4e-43,"d":"0.00"},2,"7,486,","0,75",{"v":-42.4,"d":"-42.40"},{"v":-41.3,"d":"-41.30"},{"v":6.6,"d":"6.60"},"Exon (ENSBGRT00000005514/ENSBGRG00000002933, exon 2 of 3)",1,89183708,89319650,135943,1]
["chr1",90153281,90153674,394,"ENSBGRG00000003222","ENSBGRT00000006041",4689,"THPO","thrombopoietin [Source:HGNC Symbol;Acc:HGNC:11795]","GO:0001934(positive regulation of protein phosphorylation);GO:0005125(cytokine activity);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0030099(myeloid cell differentiation);GO:0035855(megakaryocyte development);GO:0038163(thrombopoietin-mediated signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0045654(positive regulation of megakaryocyte differentiation);GO:0051897(positive regulation of protein kinase B signaling);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0097696(receptor signaling pathway via STAT);GO:1902035(positive regulation of hematopoietic stem cell proliferation)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage)",{"v":5.8E-4,"d":"0.00"},2,"131,47,","0,347",-3.24,-2.63,3.47,"Exon (ENSBGRT00000006041/ENSBGRG00000003222, exon 4 of 6)",1,90148592,90154208,5617,1]
["chr1",90153792,90154293,502,"ENSBGRG00000003222","ENSBGRT00000006041",5200,"THPO","thrombopoietin [Source:HGNC Symbol;Acc:HGNC:11795]","GO:0001934(positive regulation of protein phosphorylation);GO:0005125(cytokine activity);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0030099(myeloid cell differentiation);GO:0035855(megakaryocyte development);GO:0038163(thrombopoietin-mediated signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0045654(positive regulation of megakaryocyte differentiation);GO:0051897(positive regulation of protein kinase B signaling);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0097696(receptor signaling pathway via STAT);GO:1902035(positive regulation of hematopoietic stem cell proliferation)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage)",{"v":5e-33,"d":"0.00"},1,"502,",0,{"v":-32.3,"d":"-32.30"},{"v":-31.2,"d":"-31.20"},4.39,"Exon (ENSBGRT00000006041/ENSBGRG00000003222, exon 6 of 6)",1,90148592,90154208,5617,1]
["chr1",90217517,90217665,149,"ENSBGRG00000000165","ENSBGRT00000000270",1660,"ENSBGRG00000000165","NA","NA","NA",{"v":0.036,"d":"0.04"},1,"149,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000000270/ENSBGRG00000000165, exon 1 of 1)",1,90215857,90217665,1809,1]
["chr1",90265770,90265830,61,"ENSBGRG00000000240","ENSBGRT00000000382",0,"CAMK2N2","calcium/calmodulin dependent protein kinase II inhibitor 2 [Source:HGNC Symbol;Acc:HGNC:24197]","GO:0004860(protein kinase inhibitor activity);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0008427(calcium-dependent protein kinase inhibitor activity)","NA",0.02,1,"61,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000000382/ENSBGRG00000000240, exon 1 of 2)",1,90265770,90266906,1137,1]
["chr1",90281578,90281817,240,"ENSBGRG00000000258","ENSBGRT00000000412",6263,"ALG3","ALG3 alpha-1,3- mannosyltransferase [Source:HGNC Symbol;Acc:HGNC:23056]","GO:0000030(mannosyltransferase activity);GO:0000033(alpha-1,3-mannosyltransferase activity);GO:0005789(endoplasmic reticulum membrane);GO:0030176(integral component of endoplasmic reticulum membrane)","00510(N-Glycan biosynthesis)",{"v":6.3e-61,"d":"0.00"},1,"240,",0,{"v":-60.2,"d":"-60.20"},{"v":-58.9,"d":"-58.90"},5.43,"3' UTR",1,90275315,90281817,6503,1]
["chr1",90529764,90535252,5489,"ENSBGRG00000001081","ENSBGRT00000002343",36929,"ABCC5","ATP binding cassette subfamily C member 5 [Source:HGNC Symbol;Acc:HGNC:56]","GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0008514(organic anion transmembrane transporter activity);GO:0015562(efflux transmembrane transporter activity);GO:0015711(organic anion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0016887(ATPase activity);GO:0042626(ATPase-coupled transmembrane transporter activity);GO:0042908(xenobiotic transport);GO:0042910(xenobiotic transmembrane transporter activity);GO:0055085(transmembrane transport);GO:0140115(export across plasma membrane)","02010(ABC transporters);01523(Antifolate resistance)",{"v":6.3e-24,"d":"0.00"},2,"39,321,","0,5168",{"v":-23.2,"d":"-23.20"},{"v":-22.2,"d":"-22.20"},2.02,"Exon (ENSBGRT00000002343/ENSBGRG00000001081, exon 10 of 30)",1,90492835,90584540,91706,1]
["chr1",90697985,90698654,670,"ENSBGRG00000001403","ENSBGRT00000002559",5977,"MAP6D1","MAP6 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25753]","GO:0000226(microtubule cytoskeleton organization);GO:0005516(calmodulin binding);GO:0005798(Golgi-associated vesicle);GO:0005801(cis-Golgi network);GO:0005874(microtubule);GO:0007026(negative regulation of microtubule depolymerization);GO:0008017(microtubule binding);GO:0018009(N-terminal peptidyl-L-cysteine N-palmitoylation)","NA",{"v":3.1E-6,"d":"0.00"},2,"93,81,","0,589",-5.51,-4.82,1.84,"Exon (ENSBGRT00000002559/ENSBGRG00000001403, exon 2 of 3)",1,90692008,90698654,6647,1]
["chr1",90950654,90995431,44778,"ENSBGRG00000001459","ENSBGRT00000002678",0,"KLHL6","kelch like family member 6 [Source:HGNC Symbol;Acc:HGNC:18653]","GO:0002467(germinal center formation);GO:0005515(protein binding);GO:0009617(response to bacterium);GO:0050853(B cell receptor signaling pathway)","NA",{"v":0.0062,"d":"0.01"},3,"293,166,400,","0,27681,44378",-2.21,-1.67,9.91,"Exon (ENSBGRT00000002678/ENSBGRG00000001459, exon 1 of 7)",1,90950654,91012078,61425,1]
["chr1",91011841,91012078,238,"ENSBGRG00000001459","ENSBGRT00000002678",61187,"KLHL6","kelch like family member 6 [Source:HGNC Symbol;Acc:HGNC:18653]","GO:0002467(germinal center formation);GO:0005515(protein binding);GO:0009617(response to bacterium);GO:0050853(B cell receptor signaling pathway)","NA",{"v":3.3E-3,"d":"0.00"},1,"238,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000002678/ENSBGRG00000001459, exon 7 of 7)",1,90950654,91012078,61425,1]
["chr1",91370076,91382258,12183,"ENSBGRG00000001692","ENSBGRT00000003155",8265,"ENSBGRG00000001692","NA","GO:0016020(membrane)","04142(Lysosome)",{"v":0.048,"d":"0.05"},3,"16,58,16,","0,10656,12167",-1.32,{"v":-0.839,"d":"-0.84"},{"v":3.3,"d":"3.30"},"Exon (ENSBGRT00000003155/ENSBGRG00000001692, exon 3 of 6)",1,91361811,91385624,23814,1]
["chr1",91385107,91385462,356,"ENSBGRG00000001692","ENSBGRT00000003155",23296,"ENSBGRG00000001692","NA","GO:0016020(membrane)","04142(Lysosome)",{"v":0.036,"d":"0.04"},1,"356,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"3' UTR",1,91361811,91385624,23814,1]
["chr1",91472531,91472650,120,"ENSBGRG00000001725","ENSBGRT00000003225",66968,"MCCC1","methylcrotonoyl-CoA carboxylase 1 [Source:HGNC Symbol;Acc:HGNC:6936]","GO:0004485(methylcrotonoyl-CoA carboxylase activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0046872(metal ion binding);GO:1905202(methylcrotonoyl-CoA carboxylase complex)","00280(Valine, leucine and isoleucine degradation)",{"v":3.6e-08,"d":"0.00"},1,"120,",0,-7.44,-6.69,1.83,"Exon (ENSBGRT00000003225/ENSBGRG00000001725, exon 19 of 19)",1,91405563,91472650,67088,1]
["chr1",91515848,91517589,1742,"ENSBGRG00000001763","ENSBGRT00000003247",12561,"DCUN1D1","defective in cullin neddylation 1 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:18184]","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:2000436(positive regulation of protein neddylation)","NA",{"v":7.9E-39,"d":"0.00"},3,"19,217,91,","0,247,1651",{"v":-38.1,"d":"-38.10"},-37,2.86,"5' UTR",1,91503287,91535656,32370,1]
["chr1",91534245,91535203,959,"ENSBGRG00000001763","ENSBGRT00000003247",30958,"DCUN1D1","defective in cullin neddylation 1 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:18184]","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:2000436(positive regulation of protein neddylation)","NA",{"v":1E-56,"d":"0.00"},2,"27,270,","0,689",-56,{"v":-54.7,"d":"-54.70"},5.54,"3' UTR",1,91503287,91535656,32370,1]
["chr1",91535647,91536405,759,"ENSBGRG00000001763","ENSBGRT00000003247",32360,"DCUN1D1","defective in cullin neddylation 1 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:18184]","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:2000436(positive regulation of protein neddylation)","NA",{"v":0.00026,"d":"0.00"},2,"10,80,","0,679",-3.58,-2.95,3.05,"3' UTR",1,91503287,91535656,32370,1]
["chr1",93715790,93717996,2207,"ENSBGRG00000001844","ENSBGRT00000003468",2982,"DNAJC19","DnaJ heat shock protein family (Hsp40) member C19 [Source:HGNC Symbol;Acc:HGNC:30528]","GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0007601(visual perception);GO:0032991(protein-containing complex);GO:0048806(genitalia development)","NA",{"v":1e-31,"d":"0.00"},3,"10,71,147,","0,667,2060",-31,-30,1.92,"3' UTR",1,93712808,93717996,5189,1]
["chr1",94038027,94040598,2572,"ENSBGRG00000002146","ENSBGRT00000004291",16033,"CCDC39","coiled-coil domain containing 39 [Source:HGNC Symbol;Acc:HGNC:25244]","GO:0001947(heart looping);GO:0003341(cilium movement);GO:0003356(regulation of cilium beat frequency);GO:0005829(cytosol);GO:0005929(cilium);GO:0005930(axoneme);GO:0007368(determination of left/right symmetry);GO:0007507(heart development);GO:0030317(flagellated sperm motility);GO:0030324(lung development);GO:0035469(determination of pancreatic left/right asymmetry);GO:0036159(inner dynein arm assembly);GO:0044458(motile cilium assembly);GO:0060285(cilium-dependent cell motility);GO:0060287(epithelial cilium movement involved in determination of left/right asymmetry);GO:0070286(axonemal dynein complex assembly);GO:0071907(determination of digestive tract left/right asymmetry);GO:0071910(determination of liver left/right asymmetry)","00514(Other types of O-glycan biosynthesis)",{"v":0.018,"d":"0.02"},2,"50,11,","0,2561",-1.74,-1.22,4.95,"Exon (ENSBGRT00000004291/ENSBGRG00000002146, exon 6 of 14)",1,94021994,94064542,42549,1]
["chr1",94750620,94750979,360,"ENSBGRG00000002451","ENSBGRT00000005250",0,"ENSBGRG00000002451","NA","GO:0005515(protein binding)","04146(Peroxisome)",{"v":0.011,"d":"0.01"},1,"360,",0,-1.95,-1.18,8.91,"5' UTR",1,94750975,95071839,320865,1]
["chr1",94922715,94937949,15235,"ENSBGRG00000002451","ENSBGRT00000005183",172244,"ENSBGRG00000002451","NA","GO:0005515(protein binding)","04146(Peroxisome)",0.03,4,"43,195,124,27,","0,12438,14122,15208",-1.52,-1.03,3.96,"Exon (ENSBGRT00000005183/ENSBGRG00000002451, exon 3 of 14)",1,94750471,95071839,321369,1]
["chr1",95071660,95071839,180,"ENSBGRG00000002451","ENSBGRT00000005183",321189,"ENSBGRG00000002451","NA","GO:0005515(protein binding)","04146(Peroxisome)",{"v":1.2E-4,"d":"0.00"},1,"180,",0,-3.92,-3.28,9.41,"Exon (ENSBGRT00000005183/ENSBGRG00000002451, exon 14 of 14)",1,94750471,95071839,321369,1]
["chr1",95276299,95288327,12029,"ENSBGRG00000003051","ENSBGRT00000005733",2981,"MRPL47","mitochondrial ribosomal protein L47 [Source:HGNC Symbol;Acc:HGNC:16652]","GO:0003735(structural constituent of ribosome);GO:0005739(mitochondrion);GO:0005761(mitochondrial ribosome);GO:0005762(mitochondrial large ribosomal subunit);GO:0006412(translation)","NA",{"v":1.6e-20,"d":"0.00"},4,"129,61,97,11,","0,657,5519,12018",{"v":-19.8,"d":"-19.80"},{"v":-18.9,"d":"-18.90"},2.88,"Exon (ENSBGRT00000005733/ENSBGRG00000003051, exon 2 of 7)",1,95273318,95293187,19870,1]
["chr1",95492073,95492162,90,"ENSBGRG00000003113","ENSBGRT00000005796",33713,"GNB4","G protein subunit beta 4 [Source:HGNC Symbol;Acc:HGNC:20731]","GO:0005515(protein binding);GO:0007165(signal transduction)","04014(Ras signaling pathway);04371(Apelin signaling pathway);04151(PI3K-Akt signaling pathway);04062(Chemokine signaling pathway);04926(Relaxin signaling pathway);04724(Glutamatergic synapse);04727(GABAergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);04713(Circadian entrainment);05200(Pathways in cancer);05032(Morphine addiction);05034(Alcoholism);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":1.9e-05,"d":"0.00"},1,"90,",0,-4.71,-4.04,2.74,"3' UTR",1,95458360,95492162,33803,1]
["chr1",95659583,95664125,4543,"ENSBGRG00000003201","ENSBGRT00000005942",13181,"ENSBGRG00000003201","NA","GO:0006813(potassium ion transport);GO:0015269(calcium-activated potassium channel activity);GO:0016020(membrane)","04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04270(Vascular smooth muscle contraction)",{"v":0.049,"d":"0.05"},3,"28,27,36,","0,4479,4507",-1.31,{"v":-0.831,"d":"-0.83"},2.31,"Exon (ENSBGRT00000005942/ENSBGRG00000003201, exon 4 of 6)",1,95646402,95664125,17724,1]
["chr1",95839358,95898892,59535,"ENSBGRG00000003264","ENSBGRT00000006063",30156,"ZMAT3","zinc finger matrin-type 3 [Source:HGNC Symbol;Acc:HGNC:29983]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0008270(zinc ion binding)","04115(p53 signaling pathway)",{"v":0.018,"d":"0.02"},2,"77,159,","0,59376",-1.74,-1.22,7.92,"3' UTR",1,95809202,95899364,90163,1]
["chr1",103105834,103106606,773,"ENSBGRG00000003789","ENSBGRT00000007073",64852,"NCEH1","neutral cholesterol ester hydrolase 1 [Source:HGNC Symbol;Acc:HGNC:29260]","GO:0006470(protein dephosphorylation);GO:0006805(xenobiotic metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0017171(serine hydrolase activity);GO:0042301(phosphate ion binding);GO:0046485(ether lipid metabolic process);GO:0052689(carboxylic ester hydrolase activity);GO:0060395(SMAD protein signal transduction)","04927(Cortisol synthesis and secretion);04976(Bile secretion);04979(Cholesterol metabolism);04934(Cushing syndrome)",{"v":3.2e-23,"d":"0.00"},1,"773,",0,{"v":-22.5,"d":"-22.50"},{"v":-21.5,"d":"-21.50"},7.18,"3' UTR",1,103040982,103107171,66190,1]
["chr1",103235643,103252449,16807,"ENSBGRG00000003840","ENSBGRT00000007132",89,"TNFSF10","TNF superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:11925]","GO:0005164(tumor necrosis factor receptor binding);GO:0005515(protein binding);GO:0006955(immune response);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0032813(tumor necrosis factor receptor superfamily binding);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045569(TRAIL binding);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway)","04068(FoxO signaling pathway);04060(Cytokine-cytokine receptor interaction);04210(Apoptosis);04217(Necroptosis);04650(Natural killer cell mediated cytotoxicity);05162(Measles);05164(Influenza A)",{"v":6.3e-89,"d":"0.00"},5,"40,138,43,102,452,","0,7893,9954,14347,16355",{"v":-88.2,"d":"-88.20"},{"v":-86.7,"d":"-86.70"},11,"Exon (ENSBGRT00000007132/ENSBGRG00000003840, exon 1 of 5)",1,103235554,103252449,16896,1]
["chr1",103285461,103285905,445,"ENSBGRG00000003884","ENSBGRT00000007161",1118,"GHSR","growth hormone secretagogue receptor [Source:HGNC Symbol;Acc:HGNC:4267]","GO:0001616(growth hormone secretagogue receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008154(actin polymerization or depolymerization);GO:0008343(adult feeding behavior);GO:0009725(response to hormone);GO:0009755(hormone-mediated signaling pathway);GO:0009986(cell surface);GO:0016021(integral component of membrane);GO:0016520(growth hormone-releasing hormone receptor activity);GO:0030252(growth hormone secretion);GO:0032094(response to food);GO:0032100(positive regulation of appetite);GO:0032691(negative regulation of interleukin-1 beta production);GO:0032715(negative regulation of interleukin-6 production);GO:0032869(cellular response to insulin stimulus);GO:0040018(positive regulation of multicellular organism growth);GO:0042536(negative regulation of tumor necrosis factor biosynthetic process);GO:0043005(neuron projection);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045121(membrane raft);GO:0046697(decidualization);GO:0050728(negative regulation of inflammatory response);GO:0051963(regulation of synapse assembly)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction)",{"v":3.3E-3,"d":"0.00"},1,"445,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"5' UTR",1,103284343,103288766,4424,1]
["chr1",103288529,103288766,238,"ENSBGRG00000003884","ENSBGRT00000007161",4186,"GHSR","growth hormone secretagogue receptor [Source:HGNC Symbol;Acc:HGNC:4267]","GO:0001616(growth hormone secretagogue receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008154(actin polymerization or depolymerization);GO:0008343(adult feeding behavior);GO:0009725(response to hormone);GO:0009755(hormone-mediated signaling pathway);GO:0009986(cell surface);GO:0016021(integral component of membrane);GO:0016520(growth hormone-releasing hormone receptor activity);GO:0030252(growth hormone secretion);GO:0032094(response to food);GO:0032100(positive regulation of appetite);GO:0032691(negative regulation of interleukin-1 beta production);GO:0032715(negative regulation of interleukin-6 production);GO:0032869(cellular response to insulin stimulus);GO:0040018(positive regulation of multicellular organism growth);GO:0042536(negative regulation of tumor necrosis factor biosynthetic process);GO:0043005(neuron projection);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045121(membrane raft);GO:0046697(decidualization);GO:0050728(negative regulation of inflammatory response);GO:0051963(regulation of synapse assembly)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction)",{"v":0.036,"d":"0.04"},1,"238,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000007161/ENSBGRG00000003884, exon 4 of 4)",1,103284343,103288766,4424,1]
["chr1",104230525,104309051,78527,"ENSBGRG00000004430","ENSBGRT00000008272",119368,"PLD1","phospholipase D1 [Source:HGNC Symbol;Acc:HGNC:9067]","GO:0003824(catalytic activity);GO:0004630(phospholipase D activity);GO:0005768(endosome);GO:0005794(Golgi apparatus);GO:0006654(phosphatidic acid biosynthetic process);GO:0016324(apical plasma membrane);GO:0030139(endocytic vesicle);GO:0032534(regulation of microvillus assembly);GO:0035091(phosphatidylinositol binding);GO:0045727(positive regulation of translation);GO:0048017(inositol lipid-mediated signaling);GO:0098693(regulation of synaptic vesicle cycle);GO:0098981(cholinergic synapse)","00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism);04014(Ras signaling pathway);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04144(Endocytosis);04666(Fc gamma R-mediated phagocytosis);04912(GnRH signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);04724(Glutamatergic synapse);05231(Choline metabolism in cancer)",{"v":1e-159,"d":"0.00"},4,"66,118,386,30,","0,10046,13409,78497",-159,-158,8.27,"3' UTR",1,104111157,104244319,133163,1]
["chr1",104711258,104744973,33716,"ENSBGRG00000004855","ENSBGRT00000012818",339372,"TNIK","TRAF2 and NCK interacting kinase [Source:HGNC Symbol;Acc:HGNC:30765]","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0007010(cytoskeleton organization);GO:0007256(activation of JNKK activity);GO:0016324(apical plasma membrane);GO:0030033(microvillus assembly);GO:0031532(actin cytoskeleton reorganization);GO:0035556(intracellular signal transduction);GO:0046777(protein autophosphorylation);GO:0048814(regulation of dendrite morphogenesis);GO:0072659(protein localization to plasma membrane)","NA",{"v":2.4e-05,"d":"0.00"},5,"99,67,205,111,56,","0,5034,8556,32577,33660",-4.62,-3.95,2.38,"Exon (ENSBGRT00000012818/ENSBGRG00000004855, exon 10 of 34)",1,104371886,104828624,456739,1]
["chr1",104825764,104828445,2682,"ENSBGRG00000004855","ENSBGRT00000012818",453878,"TNIK","TRAF2 and NCK interacting kinase [Source:HGNC Symbol;Acc:HGNC:30765]","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0007010(cytoskeleton organization);GO:0007256(activation of JNKK activity);GO:0016324(apical plasma membrane);GO:0030033(microvillus assembly);GO:0031532(actin cytoskeleton reorganization);GO:0035556(intracellular signal transduction);GO:0046777(protein autophosphorylation);GO:0048814(regulation of dendrite morphogenesis);GO:0072659(protein localization to plasma membrane)","NA",{"v":2e-69,"d":"0.00"},2,"105,433,","0,2249",{"v":-68.7,"d":"-68.70"},{"v":-67.4,"d":"-67.40"},4.18,"3' UTR",1,104371886,104828624,456739,1]
["chr1",104991210,104993326,2117,"ENSBGRG00000007513","ENSBGRT00000013895",2153,"ENSBGRG00000007513","NA","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)",{"v":1.3E-23,"d":"0.00"},2,"26,145,","0,1972",{"v":-22.9,"d":"-22.90"},{"v":-21.9,"d":"-21.90"},1.69,"Exon (ENSBGRT00000013895/ENSBGRG00000007513, exon 3 of 4)",1,104989057,104993326,4270,1]
["chr1",105743287,105750308,7022,"ENSBGRG00000006509","ENSBGRT00000012457",72871,"PHC3","polyhomeotic homolog 3 [Source:HGNC Symbol;Acc:HGNC:15682]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008270(zinc ion binding);GO:0031519(PcG protein complex);GO:0035102(PRC1 complex)","NA",{"v":3.3E-3,"d":"0.00"},3,"115,232,43,","0,206,6979",-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000012457/ENSBGRG00000006509, exon 12 of 13)",1,105670416,105743562,73147,1]
["chr1",105750398,105750548,151,"ENSBGRG00000006509","ENSBGRT00000012422",79982,"PHC3","polyhomeotic homolog 3 [Source:HGNC Symbol;Acc:HGNC:15682]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008270(zinc ion binding);GO:0031519(PcG protein complex);GO:0035102(PRC1 complex)","NA",{"v":0.0017,"d":"0.00"},1,"151,",0,-2.77,-2.18,{"v":2.7,"d":"2.70"},"3' UTR",1,105670416,105752882,82467,1]
["chr1",106132619,106133307,689,"ENSBGRG00000007581","ENSBGRT00000013870",2003,"ACTRT3","actin related protein T3 [Source:HGNC Symbol;Acc:HGNC:24022]","GO:0001673(male germ cell nucleus)","NA",{"v":5e-44,"d":"0.00"},1,"689,",0,{"v":-43.3,"d":"-43.30"},{"v":-42.2,"d":"-42.20"},{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000013870/ENSBGRG00000007581, exon 2 of 2)",1,106130616,106133785,3170,1]
["chr1",106901768,106902036,269,"ENSBGRG00000007660","ENSBGRT00000015098",675385,"MECOM","MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498]","GO:0000118(histone deacetylase complex);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0043069(negative regulation of programmed cell death);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0051726(regulation of cell cycle)","04010(MAPK signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)",{"v":1.7E-8,"d":"0.00"},1,"269,",0,-7.77,-7.01,{"v":29.7,"d":"29.70"},"Exon (ENSBGRT00000015098/ENSBGRG00000007660, exon 8 of 19)",1,106226383,106941820,715438,1]
["chr1",106902096,106902364,269,"ENSBGRG00000007660","ENSBGRT00000015098",675713,"MECOM","MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498]","GO:0000118(histone deacetylase complex);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0043069(negative regulation of programmed cell death);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0051726(regulation of cell cycle)","04010(MAPK signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)",{"v":8.5E-9,"d":"0.00"},1,"269,",0,-8.07,-7.31,6.11,"Exon (ENSBGRT00000015098/ENSBGRG00000007660, exon 8 of 19)",1,106226383,106941820,715438,1]
["chr1",106904921,106905040,120,"ENSBGRG00000007660","ENSBGRT00000015098",678538,"MECOM","MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498]","GO:0000118(histone deacetylase complex);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0043069(negative regulation of programmed cell death);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0051726(regulation of cell cycle)","04010(MAPK signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)",{"v":2.3E-5,"d":"0.00"},1,"120,",0,-4.64,-3.97,1.92,"Exon (ENSBGRT00000015098/ENSBGRG00000007660, exon 10 of 19)",1,106226383,106941820,715438,1]
["chr1",106905249,106922690,17442,"ENSBGRG00000007660","ENSBGRT00000015098",678866,"MECOM","MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498]","GO:0000118(histone deacetylase complex);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0043069(negative regulation of programmed cell death);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0051726(regulation of cell cycle)","04010(MAPK signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)",{"v":1.2e-06,"d":"0.00"},4,"65,88,27,30,","0,3461,9251,17412",-5.92,-5.21,8.42,"Exon (ENSBGRT00000015098/ENSBGRG00000007660, exon 10 of 19)",1,106226383,106941820,715438,1]
["chr1",106931365,106936805,5441,"ENSBGRG00000007660","ENSBGRT00000015098",704982,"MECOM","MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498]","GO:0000118(histone deacetylase complex);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0043069(negative regulation of programmed cell death);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0051726(regulation of cell cycle)","04010(MAPK signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)",{"v":7.9e-10,"d":"0.00"},3,"12,237,110,","0,4271,5331",{"v":-9.1,"d":"-9.10"},-8.32,2,"Exon (ENSBGRT00000015098/ENSBGRG00000007660, exon 16 of 19)",1,106226383,106941820,715438,1]
["chr1",106936865,106941820,4956,"ENSBGRG00000007660","ENSBGRT00000015098",710482,"MECOM","MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498]","GO:0000118(histone deacetylase complex);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0043069(negative regulation of programmed cell death);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0051726(regulation of cell cycle)","04010(MAPK signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)",{"v":1.6E-12,"d":"0.00"},2,"15,135,","0,4821",{"v":-11.8,"d":"-11.80"},-11,3.17,"Exon (ENSBGRT00000015098/ENSBGRG00000007660, exon 18 of 19)",1,106226383,106941820,715438,1]
["chr1",108051801,108051949,149,"ENSBGRG00000008924","ENSBGRT00000016330",89,"GOLIM4","golgi integral membrane protein 4 [Source:HGNC Symbol;Acc:HGNC:15448]","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0016021(integral component of membrane)","NA",{"v":3.5e-06,"d":"0.00"},1,"149,",0,-5.46,-4.76,2.39,"5' UTR",1,108051712,108144188,92477,1]
["chr1",108114933,108115554,622,"ENSBGRG00000008924","ENSBGRT00000016330",63221,"GOLIM4","golgi integral membrane protein 4 [Source:HGNC Symbol;Acc:HGNC:15448]","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0016021(integral component of membrane)","NA",{"v":4e-11,"d":"0.00"},2,"82,8,","0,614",{"v":-10.4,"d":"-10.40"},-9.64,1.33,"Exon (ENSBGRT00000016330/ENSBGRG00000008924, exon 6 of 16)",1,108051712,108144188,92477,1]
["chr1",108124535,108144188,19654,"ENSBGRG00000008924","ENSBGRT00000016330",72823,"GOLIM4","golgi integral membrane protein 4 [Source:HGNC Symbol;Acc:HGNC:15448]","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0016021(integral component of membrane)","NA",0,8,"209,254,83,110,168,69,81,243,","0,2314,4213,6324,9103,10498,19027,19411",-420,"-Inf",5.05,"3' UTR",1,108051712,108144188,92477,1]
["chr1",108755568,108762670,7103,"ENSBGRG00000009583","ENSBGRT00000017703",183605,"WDR49","WD repeat domain 49 [Source:HGNC Symbol;Acc:HGNC:26587]","GO:0005515(protein binding);GO:0005615(extracellular space)","05146(Amoebiasis)",{"v":0.034,"d":"0.03"},2,"23,127,","0,6976",-1.47,{"v":-0.977,"d":"-0.98"},4.95,"Exon (ENSBGRT00000017703/ENSBGRG00000009583, exon 17 of 23)",1,108571963,108789917,217955,1]
["chr1",108856312,108871463,15152,"ENSBGRG00000009753","ENSBGRT00000018113",89,"ZBBX","zinc finger B-box domain containing [Source:HGNC Symbol;Acc:HGNC:26245]","GO:0008270(zinc ion binding)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);05168(Herpes simplex infection)",{"v":0.0013,"d":"0.00"},4,"19,106,114,1,","0,2087,10137,15151",{"v":-2.9,"d":"-2.90"},-2.31,{"v":10.9,"d":"10.90"},"5' UTR",1,108856223,108978875,122653,1]
["chr1",110439208,110439416,209,"ENSBGRG00000009941","ENSBGRT00000018328",7168,"BCHE","butyrylcholinesterase [Source:HGNC Symbol;Acc:HGNC:983]","GO:0003990(acetylcholinesterase activity);GO:0004104(cholinesterase activity);GO:0005641(nuclear envelope lumen);GO:0005783(endoplasmic reticulum);GO:0042802(identical protein binding)","NA",{"v":6.3E-22,"d":"0.00"},1,"209,",0,{"v":-21.2,"d":"-21.20"},{"v":-20.3,"d":"-20.30"},7.46,"Exon (ENSBGRT00000018328/ENSBGRG00000009941, exon 2 of 3)",1,110432040,110444513,12474,1]
["chr1",110439864,110440102,239,"ENSBGRG00000009941","ENSBGRT00000018328",7824,"BCHE","butyrylcholinesterase [Source:HGNC Symbol;Acc:HGNC:983]","GO:0003990(acetylcholinesterase activity);GO:0004104(cholinesterase activity);GO:0005641(nuclear envelope lumen);GO:0005783(endoplasmic reticulum);GO:0042802(identical protein binding)","NA",{"v":5e-29,"d":"0.00"},1,"239,",0,{"v":-28.3,"d":"-28.30"},{"v":-27.3,"d":"-27.30"},4.86,"Exon (ENSBGRT00000018328/ENSBGRG00000009941, exon 2 of 3)",1,110432040,110444513,12474,1]
["chr1",110440221,110440341,121,"ENSBGRG00000009941","ENSBGRT00000018328",8181,"BCHE","butyrylcholinesterase [Source:HGNC Symbol;Acc:HGNC:983]","GO:0003990(acetylcholinesterase activity);GO:0004104(cholinesterase activity);GO:0005641(nuclear envelope lumen);GO:0005783(endoplasmic reticulum);GO:0042802(identical protein binding)","NA",{"v":1.3E-22,"d":"0.00"},1,"121,",0,{"v":-21.9,"d":"-21.90"},-21,4.48,"Exon (ENSBGRT00000018328/ENSBGRG00000009941, exon 2 of 3)",1,110432040,110444513,12474,1]
["chr1",114327454,114328383,930,"ENSBGRG00000010725","ENSBGRT00000019611",425,"KNSTRN","kinetochore localized astrin (SPAG5) binding protein [Source:HGNC Symbol;Acc:HGNC:30767]","GO:0000070(mitotic sister chromatid segregation);GO:0000226(microtubule cytoskeleton organization);GO:0000776(kinetochore);GO:0001726(ruffle);GO:0005886(plasma membrane);GO:0007051(spindle organization);GO:0007059(chromosome segregation);GO:0016477(cell migration);GO:0034451(centriolar satellite);GO:0035371(microtubule plus-end);GO:0042803(protein homodimerization activity);GO:0051010(microtubule plus-end binding);GO:0051988(regulation of attachment of spindle microtubules to kinetochore);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0072686(mitotic spindle)","NA",{"v":1E-182,"d":"0.00"},1,"930,",0,-182,-180,6.91,"3' UTR",1,114327029,114328383,1355,1]
["chr1",116362643,116363331,689,"ENSBGRG00000011942","ENSBGRT00000021973",30,"KPNA4","karyopherin subunit alpha 4 [Source:HGNC Symbol;Acc:HGNC:6397]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006606(protein import into nucleus);GO:0031965(nuclear membrane);GO:0042025(host cell nucleus);GO:0042542(response to hydrogen peroxide);GO:0061608(nuclear import signal receptor activity)","NA",{"v":1.6e-39,"d":"0.00"},1,"689,",0,{"v":-38.8,"d":"-38.80"},{"v":-37.6,"d":"-37.60"},{"v":16.8,"d":"16.80"},"5' UTR",1,116362613,116430347,67735,1]
["chr1",116430581,116431209,629,"ENSBGRG00000011942","ENSBGRT00000021838",67968,"KPNA4","karyopherin subunit alpha 4 [Source:HGNC Symbol;Acc:HGNC:6397]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006606(protein import into nucleus);GO:0031965(nuclear membrane);GO:0042025(host cell nucleus);GO:0042542(response to hydrogen peroxide);GO:0061608(nuclear import signal receptor activity)","NA",{"v":3.2e-17,"d":"0.00"},1,"629,",0,{"v":-16.5,"d":"-16.50"},{"v":-15.6,"d":"-15.60"},3.34,"3' UTR",1,116362613,116431299,68687,1]
["chr1",116493094,116494184,1091,"ENSBGRG00000012188","ENSBGRT00000022273",0,"TRIM59","tripartite motif containing 59 [Source:HGNC Symbol;Acc:HGNC:30834]","GO:0005783(endoplasmic reticulum);GO:0008270(zinc ion binding);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045087(innate immune response);GO:0046597(negative regulation of viral entry into host cell);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":7.9e-52,"d":"0.00"},1,"1091,",0,{"v":-51.1,"d":"-51.10"},{"v":-49.9,"d":"-49.90"},8.45,"Exon (ENSBGRT00000022273/ENSBGRG00000012188, exon 1 of 1)",1,116493094,116494302,1209,1]
["chr1",116913631,116913690,60,"ENSBGRG00000013199","ENSBGRT00000024227",37883,"ENSBGRG00000013199","NA","GO:0005515(protein binding);GO:0007165(signal transduction)","04621(NOD-like receptor signaling pathway)",{"v":0.00015,"d":"0.00"},1,"60,",0,-3.83,{"v":-3.2,"d":"-3.20"},{"v":15.8,"d":"15.80"},"Exon (ENSBGRT00000024227/ENSBGRG00000013199, exon 15 of 16)",1,116875748,116917778,42031,1]
["chr1",116914914,116919533,4620,"ENSBGRG00000013199","ENSBGRT00000024227",39166,"ENSBGRG00000013199","NA","GO:0005515(protein binding);GO:0007165(signal transduction)","04621(NOD-like receptor signaling pathway)",{"v":2E-55,"d":"0.00"},3,"23,344,20,","0,2521,4600",{"v":-54.7,"d":"-54.70"},{"v":-53.5,"d":"-53.50"},6.57,"Exon (ENSBGRT00000024227/ENSBGRG00000013199, exon 16 of 16)",1,116875748,116917778,42031,1]
["chr1",118461036,118461246,211,"ENSBGRG00000014425","ENSBGRT00000026472",60,"RARRES1","retinoic acid receptor responder 1 [Source:HGNC Symbol;Acc:HGNC:9867]","GO:0008285(negative regulation of cell population proliferation)","NA",0.03,1,"211,",0,-1.52,-1.03,5.94,"5' UTR",1,118460976,118507949,46974,1]
["chr1",119117333,119122827,5495,"ENSBGRG00000015647","ENSBGRT00000028951",2931,"SHOX2","short stature homeobox 2 [Source:HGNC Symbol;Acc:HGNC:10854]","GO:0001649(osteoblast differentiation);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002062(chondrocyte differentiation);GO:0002063(chondrocyte development);GO:0003170(heart valve development);GO:0003209(cardiac atrium morphogenesis);GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0030326(embryonic limb morphogenesis);GO:0032330(regulation of chondrocyte differentiation);GO:0035115(embryonic forelimb morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045880(positive regulation of smoothened signaling pathway);GO:0048557(embryonic digestive tract morphogenesis);GO:0048598(embryonic morphogenesis);GO:0048743(positive regulation of skeletal muscle fiber development);GO:0050772(positive regulation of axonogenesis);GO:0060272(embryonic skeletal joint morphogenesis);GO:0060351(cartilage development involved in endochondral bone morphogenesis);GO:0060415(muscle tissue morphogenesis);GO:2000172(regulation of branching morphogenesis of a nerve)","NA",0.02,5,"120,209,58,89,151,","0,530,3124,3497,5344",-1.69,{"v":-0.941,"d":"-0.94"},7.92,"5' UTR",1,119114402,119123330,8929,1]
["chr1",119125778,119125867,90,"ENSBGRG00000015647","ENSBGRT00000029281",9334,"SHOX2","short stature homeobox 2 [Source:HGNC Symbol;Acc:HGNC:10854]","GO:0001649(osteoblast differentiation);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002062(chondrocyte differentiation);GO:0002063(chondrocyte development);GO:0003170(heart valve development);GO:0003209(cardiac atrium morphogenesis);GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0030326(embryonic limb morphogenesis);GO:0032330(regulation of chondrocyte differentiation);GO:0035115(embryonic forelimb morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045880(positive regulation of smoothened signaling pathway);GO:0048557(embryonic digestive tract morphogenesis);GO:0048598(embryonic morphogenesis);GO:0048743(positive regulation of skeletal muscle fiber development);GO:0050772(positive regulation of axonogenesis);GO:0060272(embryonic skeletal joint morphogenesis);GO:0060351(cartilage development involved in endochondral bone morphogenesis);GO:0060415(muscle tissue morphogenesis);GO:2000172(regulation of branching morphogenesis of a nerve)","NA",{"v":0.0039,"d":"0.00"},1,"90,",0,-2.41,-1.85,9.91,"3' UTR",1,119116444,119125867,9424,1]
["chr1",120219420,120219689,270,"ENSBGRG00000016437","ENSBGRT00000030425",180,"CCNL1","cyclin L1 [Source:HGNC Symbol;Acc:HGNC:20569]","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006396(RNA processing);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0042025(host cell nucleus)","NA",{"v":1.8e-06,"d":"0.00"},1,"270,",0,-5.74,-5.04,1.85,"5' UTR",1,120219240,120231613,12374,1]
["chr1",120230560,120231923,1364,"ENSBGRG00000016437","ENSBGRT00000030425",11320,"CCNL1","cyclin L1 [Source:HGNC Symbol;Acc:HGNC:20569]","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006396(RNA processing);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0042025(host cell nucleus)","NA",0,2,"90,659,","0,705",-501,"-Inf",4.82,"3' UTR",1,120219240,120231613,12374,1]
["chr1",120958914,120958974,61,"ENSBGRG00000016835","ENSBGRT00000031276",11172,"SSR3","signal sequence receptor subunit 3 [Source:HGNC Symbol;Acc:HGNC:11325]","GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0016021(integral component of membrane)","04141(Protein processing in endoplasmic reticulum)",{"v":6.3e-20,"d":"0.00"},1,"61,",0,{"v":-19.2,"d":"-19.20"},{"v":-18.3,"d":"-18.30"},1.52,"3' UTR",1,120947742,120959375,11634,1]
["chr1",121728797,121731277,2481,"ENSBGRG00000007522","ENSBGRT00000013766",0,"ENSBGRG00000007522","NA","NA","NA",{"v":1.8E-3,"d":"0.00"},2,"266,5,","0,2476",-2.74,-2.16,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000013766/ENSBGRG00000007522, exon 1 of 2)",1,121728797,121732356,3560,1]
["chr1",121731726,121731906,181,"ENSBGRG00000007522","ENSBGRT00000013766",2929,"ENSBGRG00000007522","NA","NA","NA",{"v":0.00071,"d":"0.00"},1,"181,",0,-3.15,-2.55,7.92,"Exon (ENSBGRT00000013766/ENSBGRG00000007522, exon 2 of 2)",1,121728797,121732356,3560,1]
["chr1",121732206,121732356,151,"ENSBGRG00000007522","ENSBGRT00000013766",3409,"ENSBGRG00000007522","NA","NA","NA",{"v":0.041,"d":"0.04"},1,"151,",0,-1.39,{"v":-0.9,"d":"-0.90"},2.97,"Exon (ENSBGRT00000013766/ENSBGRG00000007522, exon 2 of 2)",1,121728797,121732356,3560,1]
["chr1",121763197,121763963,767,"ENSBGRG00000007545","ENSBGRT00000013909",0,"ENSBGRG00000007545","NA","GO:0008521(acetyl-CoA transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","00604(Glycosphingolipid biosynthesis - ganglio series)",{"v":1e-82,"d":"0.00"},1,"767,",0,-82,{"v":-80.6,"d":"-80.60"},12,"Exon (ENSBGRT00000013909/ENSBGRG00000007545, exon 1 of 6)",1,121763197,121783645,20449,1]
["chr1",121838469,121842518,4050,"ENSBGRG00000007709","ENSBGRT00000014152",26778,"C3orf33","chromosome 3 open reading frame 33 [Source:HGNC Symbol;Acc:HGNC:26434]","GO:0005615(extracellular space);GO:0051090(regulation of DNA-binding transcription factor activity);GO:0070373(negative regulation of ERK1 and ERK2 cascade)","03010(Ribosome)",{"v":5e-19,"d":"0.00"},2,"13,402,","0,3648",{"v":-18.3,"d":"-18.30"},{"v":-17.3,"d":"-17.30"},5.52,"Exon (ENSBGRT00000014152/ENSBGRG00000007709, exon 4 of 5)",1,121811691,121842518,30828,1]
["chr1",123404079,123409968,5890,"ENSBGRG00000010375","ENSBGRT00000020703",0,"DHX36","DEAH-box helicase 36 [Source:HGNC Symbol;Acc:HGNC:14410]","GO:0000287(magnesium ion binding);GO:0000781(chromosome, telomeric region);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001503(ossification);GO:0002151(G-quadruplex RNA binding);GO:0002735(positive regulation of myeloid dendritic cell cytokine production);GO:0003676(nucleic acid binding);GO:0003678(DNA helicase activity);GO:0003697(single-stranded DNA binding);GO:0003723(RNA binding);GO:0003724(RNA helicase activity);GO:0003725(double-stranded RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006359(regulation of transcription by RNA polymerase III);GO:0007283(spermatogenesis);GO:0008094(DNA-dependent ATPase activity);GO:0009615(response to virus);GO:0010494(cytoplasmic stress granule);GO:0010501(RNA secondary structure unwinding);GO:0016607(nuclear speck);GO:0017148(negative regulation of translation);GO:0031442(positive regulation of mRNA 3'-end processing);GO:0032206(positive regulation of telomere maintenance);GO:0032727(positive regulation of interferon-alpha production);GO:0034605(cellular response to heat);GO:0034644(cellular response to UV);GO:0035925(mRNA 3'-UTR AU-rich region binding);GO:0042826(histone deacetylase binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043330(response to exogenous dsRNA);GO:0043488(regulation of mRNA stability);GO:0044806(G-quadruplex DNA unwinding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045995(regulation of embryonic development);GO:0048027(mRNA 5'-UTR binding);GO:0051880(G-quadruplex DNA binding);GO:0051891(positive regulation of cardioblast differentiation);GO:0060261(positive regulation of transcription initiation from RNA polymerase II promoter);GO:0061158(3'-UTR-mediated mRNA destabilization);GO:0070034(telomerase RNA binding);GO:0090669(telomerase RNA stabilization);GO:1900153(positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:1901534(positive regulation of hematopoietic progenitor cell differentiation);GO:1902064(regulation of transcription from RNA polymerase II promoter involved in spermatogenesis);GO:1903843(cellular response to arsenite ion);GO:1904358(positive regulation of telomere maintenance via telomere lengthening);GO:2000767(positive regulation of cytoplasmic translation)","03018(RNA degradation)",{"v":1.1e-10,"d":"0.00"},3,"252,73,4,","0,4376,5886",-9.95,-9.15,3.74,"5' UTR",1,123404079,123451711,47633,1]
["chr1",123451030,123451711,682,"ENSBGRG00000010375","ENSBGRT00000020703",46951,"DHX36","DEAH-box helicase 36 [Source:HGNC Symbol;Acc:HGNC:14410]","GO:0000287(magnesium ion binding);GO:0000781(chromosome, telomeric region);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001503(ossification);GO:0002151(G-quadruplex RNA binding);GO:0002735(positive regulation of myeloid dendritic cell cytokine production);GO:0003676(nucleic acid binding);GO:0003678(DNA helicase activity);GO:0003697(single-stranded DNA binding);GO:0003723(RNA binding);GO:0003724(RNA helicase activity);GO:0003725(double-stranded RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006359(regulation of transcription by RNA polymerase III);GO:0007283(spermatogenesis);GO:0008094(DNA-dependent ATPase activity);GO:0009615(response to virus);GO:0010494(cytoplasmic stress granule);GO:0010501(RNA secondary structure unwinding);GO:0016607(nuclear speck);GO:0017148(negative regulation of translation);GO:0031442(positive regulation of mRNA 3'-end processing);GO:0032206(positive regulation of telomere maintenance);GO:0032727(positive regulation of interferon-alpha production);GO:0034605(cellular response to heat);GO:0034644(cellular response to UV);GO:0035925(mRNA 3'-UTR AU-rich region binding);GO:0042826(histone deacetylase binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043330(response to exogenous dsRNA);GO:0043488(regulation of mRNA stability);GO:0044806(G-quadruplex DNA unwinding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045995(regulation of embryonic development);GO:0048027(mRNA 5'-UTR binding);GO:0051880(G-quadruplex DNA binding);GO:0051891(positive regulation of cardioblast differentiation);GO:0060261(positive regulation of transcription initiation from RNA polymerase II promoter);GO:0061158(3'-UTR-mediated mRNA destabilization);GO:0070034(telomerase RNA binding);GO:0090669(telomerase RNA stabilization);GO:1900153(positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:1901534(positive regulation of hematopoietic progenitor cell differentiation);GO:1902064(regulation of transcription from RNA polymerase II promoter involved in spermatogenesis);GO:1903843(cellular response to arsenite ion);GO:1904358(positive regulation of telomere maintenance via telomere lengthening);GO:2000767(positive regulation of cytoplasmic translation)","03018(RNA degradation)",{"v":2e-98,"d":"0.00"},2,"92,296,","0,386",{"v":-97.7,"d":"-97.70"},{"v":-96.2,"d":"-96.20"},3.44,"3' UTR",1,123404079,123451711,47633,1]
["chr1",126995719,126998676,2958,"ENSBGRG00000013927","ENSBGRT00000025582",5666,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":2.1e-08,"d":"0.00"},2,"115,215,","0,2743",-7.67,-6.92,{"v":3.8,"d":"3.80"},"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 4 of 8)",1,126990053,127017625,27573,1]
["chr1",127005641,127006149,509,"ENSBGRG00000013927","ENSBGRT00000025582",15588,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":7.9e-22,"d":"0.00"},1,"509,",0,{"v":-21.1,"d":"-21.10"},{"v":-20.2,"d":"-20.20"},9.33,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127006628,127007226,599,"ENSBGRG00000013927","ENSBGRT00000025582",16575,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":6.3e-23,"d":"0.00"},1,"599,",0,{"v":-22.2,"d":"-22.20"},{"v":-21.3,"d":"-21.30"},3.52,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127007615,127008274,660,"ENSBGRG00000013927","ENSBGRT00000025582",17562,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":5e-22,"d":"0.00"},1,"660,",0,{"v":-21.3,"d":"-21.30"},{"v":-20.4,"d":"-20.40"},3.29,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127008633,127017266,8634,"ENSBGRG00000013927","ENSBGRT00000025582",18580,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":1e-151,"d":"0.00"},3,"724,898,1550,","0,1181,7084",-151,-149,9.66,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127017356,127017625,270,"ENSBGRG00000013927","ENSBGRT00000025582",27303,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":1E-142,"d":"0.00"},1,"270,",0,-142,-140,4.76,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 8 of 8)",1,126990053,127017625,27573,1]
["chr1",127116373,127117017,645,"ENSBGRG00000014050","ENSBGRT00000025921",288295,"MED12L","mediator complex subunit 12L [Source:HGNC Symbol;Acc:HGNC:16050]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008013(beta-catenin binding);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)",{"v":1.8E-3,"d":"0.00"},1,"645,",0,-2.74,-2.16,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000026299/ENSBGRG00000014296, exon 1 of 3)",1,127021523,127405312,383790,2]
["chr1",127117190,127117634,445,"ENSBGRG00000014050","ENSBGRT00000025921",287678,"MED12L","mediator complex subunit 12L [Source:HGNC Symbol;Acc:HGNC:16050]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008013(beta-catenin binding);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)",{"v":0.011,"d":"0.01"},2,"75,131,","0,314",-1.95,-1.18,8.91,"Exon (ENSBGRT00000026299/ENSBGRG00000014296, exon 2 of 3)",1,127021523,127405312,383790,2]
["chr1",127128132,127128544,413,"ENSBGRG00000014050","ENSBGRT00000025921",276768,"MED12L","mediator complex subunit 12L [Source:HGNC Symbol;Acc:HGNC:16050]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008013(beta-catenin binding);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)",{"v":1.2E-4,"d":"0.00"},1,"413,",0,-3.92,-3.28,{"v":12.9,"d":"12.90"},"Exon (ENSBGRT00000026344/ENSBGRG00000014357, exon 1 of 1)",1,127021523,127405312,383790,2]
["chr1",127258794,127259063,270,"ENSBGRG00000014050","ENSBGRT00000025921",146249,"MED12L","mediator complex subunit 12L [Source:HGNC Symbol;Acc:HGNC:16050]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008013(beta-catenin binding);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)",{"v":3.2e-11,"d":"0.00"},1,"270,",0,{"v":-10.5,"d":"-10.50"},-9.66,{"v":12.2,"d":"12.20"},"Exon (ENSBGRT00000026452/ENSBGRG00000014410, exon 1 of 1)",1,127021523,127405312,383790,2]
["chr1",127277013,127277252,240,"ENSBGRG00000014050","ENSBGRT00000025921",128060,"MED12L","mediator complex subunit 12L [Source:HGNC Symbol;Acc:HGNC:16050]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008013(beta-catenin binding);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)",{"v":1.6E-7,"d":"0.00"},1,"240,",0,-6.79,-6.06,{"v":5.2,"d":"5.20"},"Exon (ENSBGRT00000026488/ENSBGRG00000014427, exon 1 of 1)",1,127021523,127405312,383790,2]
["chr1",127277312,127277702,391,"ENSBGRG00000014050","ENSBGRT00000025921",127610,"MED12L","mediator complex subunit 12L [Source:HGNC Symbol;Acc:HGNC:16050]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008013(beta-catenin binding);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)",{"v":2.5e-17,"d":"0.00"},1,"391,",0,{"v":-16.6,"d":"-16.60"},{"v":-15.7,"d":"-15.70"},7.33,"Exon (ENSBGRT00000026488/ENSBGRG00000014427, exon 1 of 1)",1,127021523,127405312,383790,2]
["chr1",127794513,127814911,20399,"ENSBGRG00000014649","ENSBGRT00000026999",372,"SIAH2","siah E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:10858]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007275(multicellular organism development);GO:0008270(zinc ion binding);GO:0042025(host cell nucleus);GO:0042752(regulation of circadian rhythm);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0044257(cellular protein catabolic process);GO:0061630(ubiquitin protein ligase activity);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","NA",{"v":9.99999999999999e-258,"d":"0.00"},2,"61,558,","0,19841",-257,-255,{"v":11.4,"d":"11.40"},"Exon (ENSBGRT00000026999/ENSBGRG00000014649, exon 3 of 4)",1,127794141,127814911,20771,1]
["chr1",128055349,128056648,1300,"ENSBGRG00000015147","ENSBGRT00000027867",365,"SERP1","stress associated endoplasmic reticulum protein 1 [Source:HGNC Symbol;Acc:HGNC:10759]","GO:0001501(skeletal system development);GO:0005783(endoplasmic reticulum);GO:0005881(cytoplasmic microtubule);GO:0006006(glucose metabolic process);GO:0009791(post-embryonic development);GO:0010259(multicellular organism aging);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0032024(positive regulation of insulin secretion);GO:0045727(positive regulation of translation);GO:0046622(positive regulation of organ growth);GO:0048644(muscle organ morphogenesis);GO:0060124(positive regulation of growth hormone secretion)","NA",{"v":5.5e-07,"d":"0.00"},2,"74,41,","0,1259",-6.26,-5.54,{"v":1.4,"d":"1.40"},"Exon (ENSBGRT00000027867/ENSBGRG00000015147, exon 2 of 3)",1,128054984,128056648,1665,1]
["chr1",128731815,128734562,2748,"ENSBGRG00000015699","ENSBGRT00000029261",2291,"PFN2","profilin 2 [Source:HGNC Symbol;Acc:HGNC:8882]","GO:0003779(actin binding);GO:0003785(actin monomer binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0010633(negative regulation of epithelial cell migration);GO:0016887(ATPase activity);GO:0030036(actin cytoskeleton organization);GO:0030833(regulation of actin filament polymerization);GO:0030837(negative regulation of actin filament polymerization);GO:0030838(positive regulation of actin filament polymerization);GO:0032233(positive regulation of actin filament bundle assembly);GO:0032781(positive regulation of ATPase activity);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0050821(protein stabilization);GO:0051496(positive regulation of stress fiber assembly);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:1900028(negative regulation of ruffle assembly);GO:2000300(regulation of synaptic vesicle exocytosis)","04015(Rap1 signaling pathway);04810(Regulation of actin cytoskeleton);05132(Salmonella infection)",{"v":2e-21,"d":"0.00"},2,"152,51,","0,2697",{"v":-20.7,"d":"-20.70"},{"v":-19.8,"d":"-19.80"},1.42,"Exon (ENSBGRT00000029261/ENSBGRG00000015699, exon 2 of 3)",1,128729524,128734609,5086,1]
["chr1",128905815,128918303,12489,"ENSBGRG00000016179","ENSBGRT00000029741",11788,"ANKUB1","ankyrin repeat and ubiquitin domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29642]","GO:0005515(protein binding)","NA",{"v":0.036,"d":"0.04"},3,"65,115,475,","0,7934,12014",-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000029741/ENSBGRG00000016179, exon 3 of 6)",1,128894027,128924733,30707,1]
["chr1",128918362,128924733,6372,"ENSBGRG00000016179","ENSBGRT00000029741",24335,"ANKUB1","ankyrin repeat and ubiquitin domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29642]","GO:0005515(protein binding)","NA",{"v":0.00028,"d":"0.00"},2,"406,130,","0,6242",-3.56,-2.94,{"v":14.9,"d":"14.90"},"Exon (ENSBGRT00000029741/ENSBGRG00000016179, exon 5 of 6)",1,128894027,128924733,30707,1]
["chr1",129395316,129395521,206,"ENSBGRG00000016631","ENSBGRT00000030570",0,"TM4SF1","transmembrane 4 L six family member 1 [Source:HGNC Symbol;Acc:HGNC:11853]","GO:0005887(integral component of plasma membrane);GO:0016021(integral component of membrane)","00430(Taurine and hypotaurine metabolism);00480(Glutathione metabolism)",{"v":3.2e-81,"d":"0.00"},1,"206,",0,{"v":-80.5,"d":"-80.50"},{"v":-79.1,"d":"-79.10"},4.65,"5' UTR",1,129395316,129400764,5449,1]
["chr1",129610192,129619841,9650,"ENSBGRG00000017021","ENSBGRT00000031232",35069,"HPS3","HPS3 biogenesis of lysosomal organelles complex 2 subunit 1 [Source:HGNC Symbol;Acc:HGNC:15597]","GO:0005737(cytoplasm);GO:0006996(organelle organization);GO:0031084(BLOC-2 complex);GO:0043473(pigmentation)","NA",{"v":9.1e-05,"d":"0.00"},2,"16,75,","0,9575",-4.04,{"v":-3.4,"d":"-3.40"},2.66,"3' UTR",1,129520908,129654910,134003,2]
["chr1",129704117,129710016,5900,"ENSBGRG00000018610","ENSBGRT00000034314",20902,"HLTF","helicase like transcription factor [Source:HGNC Symbol;Acc:HGNC:11099]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008094(DNA-dependent ATPase activity);GO:0008270(zinc ion binding);GO:0016818(hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides);GO:0031625(ubiquitin protein ligase binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":0.0081,"d":"0.01"},2,"17,44,","0,5856",-2.09,-1.55,1.58,"Exon (ENSBGRT00000034314/ENSBGRG00000018610, exon 8 of 24)",1,129683215,129747320,64106,1]
["chr1",130305572,130305838,267,"ENSBGRG00000019617","ENSBGRT00000036032",1638,"ENSBGRG00000019617","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.036,"d":"0.04"},1,"267,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"3' UTR",1,130303934,130306429,2496,1]
["chr1",133096469,133096617,149,"ENSBGRG00000020343","ENSBGRT00000037397",0,"ENSBGRG00000020343","NA","GO:0017121(plasma membrane phospholipid scrambling);GO:0017128(phospholipid scramblase activity)","NA",{"v":0.0012,"d":"0.00"},1,"149,",0,-2.91,-2.32,4.95,"5' UTR",1,133096469,133141212,44744,1]
["chr1",133096706,133096795,90,"ENSBGRG00000020343","ENSBGRT00000037397",237,"ENSBGRG00000020343","NA","GO:0017121(plasma membrane phospholipid scrambling);GO:0017128(phospholipid scramblase activity)","NA",{"v":2.6e-06,"d":"0.00"},1,"90,",0,-5.58,-4.88,2.21,"5' UTR",1,133096469,133141212,44744,1]
["chr1",133331414,133331533,120,"ENSBGRG00000020444","ENSBGRT00000037757",133352,"PLOD2","procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 [Source:HGNC Symbol;Acc:HGNC:9082]","GO:0001666(response to hypoxia);GO:0005506(iron ion binding);GO:0008475(procollagen-lysine 5-dioxygenase activity);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0017185(peptidyl-lysine hydroxylation);GO:0031418(L-ascorbic acid binding);GO:0046947(hydroxylysine biosynthetic process);GO:0055114(oxidation-reduction process)","00310(Lysine degradation)",{"v":7.9e-62,"d":"0.00"},1,"120,",0,{"v":-61.1,"d":"-61.10"},{"v":-59.8,"d":"-59.80"},2.11,"3' UTR",1,133198062,133332306,134245,1]
["chr1",136867244,136869878,2635,"ENSBGRG00000000195","ENSBGRT00000000322",736788,"SLC9A9","solute carrier family 9 member A9 [Source:HGNC Symbol;Acc:HGNC:20653]","GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0006885(regulation of pH);GO:0015299(solute:proton antiporter activity);GO:0015385(sodium:proton antiporter activity);GO:0016021(integral component of membrane);GO:0055037(recycling endosome);GO:0055085(transmembrane transport)","NA",{"v":4e-45,"d":"0.00"},4,"30,90,3,117,","0,2419,2513,2518",{"v":-44.4,"d":"-44.40"},{"v":-43.3,"d":"-43.30"},5.24,"Exon (ENSBGRT00000000322/ENSBGRG00000000195, exon 15 of 18)",1,136130456,136869878,739423,1]
["chr1",137741817,137741937,121,"ENSBGRG00000000428","ENSBGRT00000001119",22411,"ATR","ATR serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:882]","GO:0000077(DNA damage checkpoint);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0006974(cellular response to DNA damage stimulus);GO:0008156(negative regulation of DNA replication);GO:0016301(kinase activity);GO:0016605(PML body);GO:0018105(peptidyl-serine phosphorylation);GO:0032405(MutLalpha complex binding);GO:0032407(MutSalpha complex binding);GO:0034644(cellular response to UV);GO:0043517(positive regulation of DNA damage response, signal transduction by p53 class mediator);GO:0046777(protein autophosphorylation);GO:0070198(protein localization to chromosome, telomeric region);GO:0071480(cellular response to gamma radiation);GO:0090399(replicative senescence);GO:0097694(establishment of RNA localization to telomere);GO:1904884(positive regulation of telomerase catalytic core complex assembly)","03460(Fanconi anemia pathway);04110(Cell cycle);04115(p53 signaling pathway);04218(Cellular senescence);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":0.004,"d":"0.00"},1,"121,",0,{"v":-2.4,"d":"-2.40"},-1.84,4.95,"Exon (ENSBGRT00000001119/ENSBGRG00000000428, exon 4 of 47)",1,137719406,137847000,127595,1]
["chr1",137846850,137846910,61,"ENSBGRG00000000428","ENSBGRT00000001119",127444,"ATR","ATR serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:882]","GO:0000077(DNA damage checkpoint);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0006974(cellular response to DNA damage stimulus);GO:0008156(negative regulation of DNA replication);GO:0016301(kinase activity);GO:0016605(PML body);GO:0018105(peptidyl-serine phosphorylation);GO:0032405(MutLalpha complex binding);GO:0032407(MutSalpha complex binding);GO:0034644(cellular response to UV);GO:0043517(positive regulation of DNA damage response, signal transduction by p53 class mediator);GO:0046777(protein autophosphorylation);GO:0070198(protein localization to chromosome, telomeric region);GO:0071480(cellular response to gamma radiation);GO:0090399(replicative senescence);GO:0097694(establishment of RNA localization to telomere);GO:1904884(positive regulation of telomerase catalytic core complex assembly)","03460(Fanconi anemia pathway);04110(Cell cycle);04115(p53 signaling pathway);04218(Cellular senescence);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":0.00093,"d":"0.00"},1,"61,",0,-3.03,-2.43,1.56,"3' UTR",1,137719406,137847000,127595,1]
["chr1",138011188,138023129,11942,"ENSBGRG00000000970","ENSBGRT00000001804",0,"GK5","glycerol kinase 5 [Source:HGNC Symbol;Acc:HGNC:28635]","GO:0005975(carbohydrate metabolic process);GO:0016773(phosphotransferase activity, alcohol group as acceptor)","NA",0.02,2,"147,3,","0,11939",-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000001804/ENSBGRG00000000970, exon 1 of 17)",1,138011188,138099742,88555,1]
["chr1",141095434,141110463,15030,"ENSBGRG00000001428","ENSBGRT00000002725",52365,"NMNAT3","nicotinamide nucleotide adenylyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:20989]","GO:0000309(nicotinamide-nucleotide adenylyltransferase activity);GO:0002138(retinoic acid biosynthetic process);GO:0003824(catalytic activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006776(vitamin A metabolic process);GO:0008289(lipid binding);GO:0009058(biosynthetic process);GO:0009435(NAD biosynthetic process);GO:0009611(response to wounding);GO:0016779(nucleotidyltransferase activity)","00760(Nicotinate and nicotinamide metabolism)",{"v":1.8E-3,"d":"0.00"},6,"10,83,26,18,41,3,","0,6425,8055,8085,8105,15027",-2.74,-2.16,{"v":11.9,"d":"11.90"},"5' UTR",1,141043069,141110470,67402,1]
["chr1",141111063,141111303,241,"ENSBGRG00000001428","ENSBGRT00000002698",67994,"NMNAT3","nicotinamide nucleotide adenylyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:20989]","GO:0000309(nicotinamide-nucleotide adenylyltransferase activity);GO:0002138(retinoic acid biosynthetic process);GO:0003824(catalytic activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006776(vitamin A metabolic process);GO:0008289(lipid binding);GO:0009058(biosynthetic process);GO:0009435(NAD biosynthetic process);GO:0009611(response to wounding);GO:0016779(nucleotidyltransferase activity)","00760(Nicotinate and nicotinamide metabolism)",{"v":3.3e-08,"d":"0.00"},1,"241,",0,-7.48,-6.73,9.41,"3' UTR",1,141043069,141111660,68592,1]
["chr1",141138420,141140123,1704,"ENSBGRG00000001428","ENSBGRT00000002664",95351,"NMNAT3","nicotinamide nucleotide adenylyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:20989]","GO:0000309(nicotinamide-nucleotide adenylyltransferase activity);GO:0002138(retinoic acid biosynthetic process);GO:0003824(catalytic activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006776(vitamin A metabolic process);GO:0008289(lipid binding);GO:0009058(biosynthetic process);GO:0009435(NAD biosynthetic process);GO:0009611(response to wounding);GO:0016779(nucleotidyltransferase activity)","00760(Nicotinate and nicotinamide metabolism)",{"v":9.99999999999998e-288,"d":"0.00"},3,"231,179,130,","0,721,1574",-287,-285,3.31,"5' UTR",1,141043069,141140215,97147,1]
["chr1",141709611,141710049,439,"ENSBGRG00000001602","ENSBGRT00000002969",797,"ENSBGRG00000001602","NA","NA","NA",0.02,1,"439,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000002969/ENSBGRG00000001602, exon 2 of 2)",1,141708814,141710107,1294,1]
["chr1",141845929,141846078,150,"ENSBGRG00000001637","ENSBGRT00000003031",0,"FOXL2","forkhead box L2 [Source:HGNC Symbol;Acc:HGNC:1092]","GO:0001541(ovarian follicle development);GO:0002074(extraocular skeletal muscle development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006309(apoptotic DNA fragmentation);GO:0006355(regulation of transcription, DNA-templated);GO:0031624(ubiquitin conjugating enzyme binding);GO:0043028(cysteine-type endopeptidase regulator activity involved in apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045171(intercellular bridge);GO:0045892(negative regulation of transcription, DNA-templated);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1E-56,"d":"0.00"},1,"150,",0,-56,{"v":-54.7,"d":"-54.70"},{"v":10.5,"d":"10.50"},"Exon (ENSBGRT00000003031/ENSBGRG00000001637, exon 1 of 1)",1,141845929,141847062,1134,1]
["chr1",141846197,141846615,419,"ENSBGRG00000001637","ENSBGRT00000003031",268,"FOXL2","forkhead box L2 [Source:HGNC Symbol;Acc:HGNC:1092]","GO:0001541(ovarian follicle development);GO:0002074(extraocular skeletal muscle development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006309(apoptotic DNA fragmentation);GO:0006355(regulation of transcription, DNA-templated);GO:0031624(ubiquitin conjugating enzyme binding);GO:0043028(cysteine-type endopeptidase regulator activity involved in apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045171(intercellular bridge);GO:0045892(negative regulation of transcription, DNA-templated);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":9.99999999999999e-262,"d":"0.00"},1,"419,",0,-261,-258,9.31,"Exon (ENSBGRT00000003031/ENSBGRG00000001637, exon 1 of 1)",1,141845929,141847062,1134,1]
["chr1",142164065,142165695,1631,"ENSBGRG00000001650","ENSBGRT00000003055",192565,"PIK3CB","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [Source:HGNC Symbol;Acc:HGNC:8976]","GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0016301(kinase activity);GO:0035004(phosphatidylinositol 3-kinase activity);GO:0046854(phosphatidylinositol phosphorylation);GO:0048015(phosphatidylinositol-mediated signaling)","00562(Inositol phosphate metabolism);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04630(Jak-STAT signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04218(Cellular senescence);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04670(Leukocyte transendothelial migration);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04919(Thyroid hormone signaling pathway);04973(Carbohydrate digestion and absorption);04960(Aldosterone-regulated sodium reabsorption);04725(Cholinergic synapse);04722(Neurotrophin signaling pathway);04750(Inflammatory mediator regulation of TRP channels);04360(Axon guidance);04380(Osteoclast differentiation);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05205(Proteoglycans in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05100(Bacterial invasion of epithelial cells);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05146(Amoebiasis);05142(Chagas disease (American trypanosomiasis));01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":1.6e-30,"d":"0.00"},3,"58,133,138,","0,1005,1493",{"v":-29.8,"d":"-29.80"},{"v":-28.8,"d":"-28.80"},6.41,"Exon (ENSBGRT00000003055/ENSBGRG00000001650, exon 22 of 24)",1,141971500,142165695,194196,1]
["chr1",142236569,142236628,60,"ENSBGRG00000001714","ENSBGRT00000003315",16596,"CEP70","centrosomal protein 70 [Source:HGNC Symbol;Acc:HGNC:29972]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0042802(identical protein binding);GO:0043015(gamma-tubulin binding);GO:0060271(cilium assembly);GO:0070507(regulation of microtubule cytoskeleton organization)","NA",{"v":0.00018,"d":"0.00"},1,"60,",0,-3.74,-3.11,1.81,"Exon (ENSBGRT00000003315/ENSBGRG00000001714, exon 5 of 17)",1,142219973,142304509,84537,1]
["chr1",142274839,142275042,204,"ENSBGRG00000001714","ENSBGRT00000003315",54866,"CEP70","centrosomal protein 70 [Source:HGNC Symbol;Acc:HGNC:29972]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0042802(identical protein binding);GO:0043015(gamma-tubulin binding);GO:0060271(cilium assembly);GO:0070507(regulation of microtubule cytoskeleton organization)","NA",{"v":0.0032,"d":"0.00"},1,"204,",0,{"v":-2.5,"d":"-2.50"},-1.93,3.71,"Exon (ENSBGRT00000003438/ENSBGRG00000001833, exon 2 of 2)",1,142219973,142304509,84537,1]
["chr1",142697954,142698133,180,"ENSBGRG00000002171","ENSBGRT00000004059",119,"DBR1","debranching RNA lariats 1 [Source:HGNC Symbol;Acc:HGNC:15594]","GO:0000375(RNA splicing, via transesterification reactions);GO:0000398(mRNA splicing, via spliceosome);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0008419(RNA lariat debranching enzyme activity);GO:0016787(hydrolase activity);GO:0016788(hydrolase activity, acting on ester bonds)","NA",{"v":1.1E-4,"d":"0.00"},1,"180,",0,-3.96,-3.33,6.93,"5' UTR",1,142697835,142711265,13431,1]
["chr1",142710019,142711265,1247,"ENSBGRG00000002171","ENSBGRT00000004059",12184,"DBR1","debranching RNA lariats 1 [Source:HGNC Symbol;Acc:HGNC:15594]","GO:0000375(RNA splicing, via transesterification reactions);GO:0000398(mRNA splicing, via spliceosome);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0008419(RNA lariat debranching enzyme activity);GO:0016787(hydrolase activity);GO:0016788(hydrolase activity, acting on ester bonds)","NA",{"v":1E-146,"d":"0.00"},2,"81,694,","0,553",-146,-144,{"v":11.1,"d":"11.10"},"Exon (ENSBGRT00000004059/ENSBGRG00000002171, exon 7 of 8)",1,142697835,142711265,13431,1]
["chr1",142775998,142776206,209,"ENSBGRG00000002235","ENSBGRT00000004170",0,"ENSBGRG00000002235","NA","NA","NA",{"v":0.00083,"d":"0.00"},1,"209,",0,-3.08,-2.48,6.93,"Exon (ENSBGRT00000004166/ENSBGRG00000002235, exon 2 of 4)",1,142776196,142799044,22849,1]
["chr1",142797946,142798213,268,"ENSBGRG00000002235","ENSBGRT00000004166",23372,"ENSBGRG00000002235","NA","NA","NA",{"v":2.2e-07,"d":"0.00"},1,"268,",0,-6.65,-5.93,9.91,"Exon (ENSBGRT00000004166/ENSBGRG00000002235, exon 4 of 4)",1,142774574,142797997,23424,1]
["chr1",142799154,142801559,2406,"ENSBGRG00000002249","ENSBGRT00000004193",89,"DZIP1L","DAZ interacting zinc finger protein 1 like [Source:HGNC Symbol;Acc:HGNC:26551]","GO:0003676(nucleic acid binding);GO:0005814(centriole);GO:0005930(axoneme);GO:0007224(smoothened signaling pathway);GO:0021532(neural tube patterning);GO:0032880(regulation of protein localization);GO:0033365(protein localization to organelle);GO:0033504(floor plate development);GO:0036064(ciliary basal body);GO:0060271(cilium assembly);GO:0061512(protein localization to cilium);GO:1905349(ciliary transition zone assembly)","NA",{"v":6.3E-7,"d":"0.00"},2,"325,34,","0,2372",{"v":-6.2,"d":"-6.20"},-5.48,4.62,"Exon (ENSBGRT00000004193/ENSBGRG00000002249, exon 1 of 15)",1,142799065,142837705,38641,1]
["chr1",142808255,142817715,9461,"ENSBGRG00000002249","ENSBGRT00000004193",9190,"DZIP1L","DAZ interacting zinc finger protein 1 like [Source:HGNC Symbol;Acc:HGNC:26551]","GO:0003676(nucleic acid binding);GO:0005814(centriole);GO:0005930(axoneme);GO:0007224(smoothened signaling pathway);GO:0021532(neural tube patterning);GO:0032880(regulation of protein localization);GO:0033365(protein localization to organelle);GO:0033504(floor plate development);GO:0036064(ciliary basal body);GO:0060271(cilium assembly);GO:0061512(protein localization to cilium);GO:1905349(ciliary transition zone assembly)","NA",{"v":3.7e-05,"d":"0.00"},3,"127,129,43,","0,4208,9418",-4.43,-3.78,1.94,"Exon (ENSBGRT00000004193/ENSBGRG00000002249, exon 4 of 15)",1,142799065,142837705,38641,1]
["chr1",142837586,142837705,120,"ENSBGRG00000002249","ENSBGRT00000004193",38521,"DZIP1L","DAZ interacting zinc finger protein 1 like [Source:HGNC Symbol;Acc:HGNC:26551]","GO:0003676(nucleic acid binding);GO:0005814(centriole);GO:0005930(axoneme);GO:0007224(smoothened signaling pathway);GO:0021532(neural tube patterning);GO:0032880(regulation of protein localization);GO:0033365(protein localization to organelle);GO:0033504(floor plate development);GO:0036064(ciliary basal body);GO:0060271(cilium assembly);GO:0061512(protein localization to cilium);GO:1905349(ciliary transition zone assembly)","NA",{"v":7.8e-05,"d":"0.00"},1,"120,",0,-4.11,-3.46,2.19,"3' UTR",1,142799065,142837705,38641,1]
["chr1",144860564,144862643,2080,"ENSBGRG00000002516","ENSBGRT00000005249",361256,"STAG1","stromal antigen 1 [Source:HGNC Symbol;Acc:HGNC:11354]","GO:0000785(chromatin);GO:0003682(chromatin binding);GO:0005654(nucleoplasm);GO:0008278(cohesin complex);GO:0016363(nuclear matrix);GO:0016604(nuclear body);GO:0090307(mitotic spindle assembly);GO:0097431(mitotic spindle pole)","04110(Cell cycle)",{"v":6.3e-11,"d":"0.00"},3,"16,81,24,","0,1888,2056",{"v":-10.2,"d":"-10.20"},{"v":-9.4,"d":"-9.40"},2.49,"Exon (ENSBGRT00000005249/ENSBGRG00000002516, exon 31 of 33)",1,144499308,144862643,363336,1]
["chr1",145034789,145067748,32960,"ENSBGRG00000003049","ENSBGRT00000005705",0,"MSL2","MSL complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:25544]","GO:0043984(histone H4-K16 acetylation);GO:0061630(ubiquitin protein ligase activity);GO:0072487(MSL complex)","NA",{"v":9.99999999999998e-248,"d":"0.00"},2,"387,1592,","0,31368",-247,-245,{"v":11.9,"d":"11.90"},"5' UTR",1,145034789,145067748,32960,1]
["chr1",146963462,146968437,4976,"ENSBGRG00000003311","ENSBGRT00000006157",266,"ANAPC13","anaphase promoting complex subunit 13 [Source:HGNC Symbol;Acc:HGNC:24540]","GO:0005680(anaphase-promoting complex);GO:0070979(protein K11-linked ubiquitination)","04120(Ubiquitin mediated proteolysis);04110(Cell cycle);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation)",{"v":7.9e-50,"d":"0.00"},3,"92,131,222,","0,221,4754",{"v":-49.1,"d":"-49.10"},{"v":-47.9,"d":"-47.90"},{"v":2.9,"d":"2.90"},"5' UTR",1,146963196,146969444,6249,1]
["chr1",147090559,147091008,450,"ENSBGRG00000003321","ENSBGRT00000006180",180,"AMOTL2","angiomotin like 2 [Source:HGNC Symbol;Acc:HGNC:17812]","GO:0005923(bicellular tight junction);GO:0016324(apical plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0042802(identical protein binding)","04530(Tight junction)",{"v":0.00071,"d":"0.00"},1,"450,",0,-3.15,-2.55,7.92,"Exon (ENSBGRT00000006180/ENSBGRG00000003321, exon 1 of 10)",1,147090379,147107653,17275,1]
["chr1",147103553,147103643,91,"ENSBGRG00000003321","ENSBGRT00000006180",13174,"AMOTL2","angiomotin like 2 [Source:HGNC Symbol;Acc:HGNC:17812]","GO:0005923(bicellular tight junction);GO:0016324(apical plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0042802(identical protein binding)","04530(Tight junction)",{"v":1E-22,"d":"0.00"},1,"91,",0,-22,{"v":-21.1,"d":"-21.10"},1.74,"Exon (ENSBGRT00000006180/ENSBGRG00000003321, exon 6 of 10)",1,147090379,147107653,17275,1]
["chr1",147106626,147107653,1028,"ENSBGRG00000003321","ENSBGRT00000006180",16247,"AMOTL2","angiomotin like 2 [Source:HGNC Symbol;Acc:HGNC:17812]","GO:0005923(bicellular tight junction);GO:0016324(apical plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0042802(identical protein binding)","04530(Tight junction)",{"v":1e-109,"d":"0.00"},2,"151,150,","0,878",-109,-107,2.37,"3' UTR",1,147090379,147107653,17275,1]
["chr1",147350276,147352262,1987,"ENSBGRG00000003356","ENSBGRT00000006334",118638,"RYK","receptor like tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:10481]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004888(transmembrane signaling receptor activity);GO:0005109(frizzled binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007409(axonogenesis);GO:0007411(axon guidance);GO:0016020(membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0022038(corpus callosum development);GO:0030182(neuron differentiation);GO:0031175(neuron projection development);GO:0036518(chemorepulsion of dopaminergic neuron axon);GO:0042813(Wnt-activated receptor activity);GO:0043410(positive regulation of MAPK cascade);GO:0048705(skeletal system morphogenesis);GO:0048843(negative regulation of axon extension involved in axon guidance);GO:0050919(negative chemotaxis);GO:0071679(commissural neuron axon guidance);GO:1904938(planar cell polarity pathway involved in axon guidance);GO:1904948(midbrain dopaminergic neuron differentiation)","04360(Axon guidance)",{"v":9.99999999999998e-275,"d":"0.00"},2,"49,430,","0,1557",-274,-272,5.44,"3' UTR",1,147231638,147352262,120625,1]
["chr1",149088399,149090351,1953,"ENSBGRG00000006292","ENSBGRT00000011810",298,"ENSBGRG00000006292","NA","GO:0001822(kidney development);GO:0005515(protein binding);GO:0006629(lipid metabolic process);GO:0007163(establishment or maintenance of cell polarity);GO:0007368(determination of left/right symmetry);GO:0030198(extracellular matrix organization);GO:0032092(positive regulation of protein binding);GO:0048496(maintenance of animal organ identity);GO:0060271(cilium assembly);GO:0060993(kidney morphogenesis);GO:0097543(ciliary inversin compartment);GO:0097546(ciliary base);GO:1905515(non-motile cilium assembly)","NA",0.01,2,"98,52,","0,1901",-1.99,-1.46,2.11,"Exon (ENSBGRT00000011810/ENSBGRG00000006292, exon 1 of 28)",1,149088101,149147923,59823,1]
["chr1",149146665,149147923,1259,"ENSBGRG00000006292","ENSBGRT00000011810",58564,"ENSBGRG00000006292","NA","GO:0001822(kidney development);GO:0005515(protein binding);GO:0006629(lipid metabolic process);GO:0007163(establishment or maintenance of cell polarity);GO:0007368(determination of left/right symmetry);GO:0030198(extracellular matrix organization);GO:0032092(positive regulation of protein binding);GO:0048496(maintenance of animal organ identity);GO:0060271(cilium assembly);GO:0060993(kidney morphogenesis);GO:0097543(ciliary inversin compartment);GO:0097546(ciliary base);GO:1905515(non-motile cilium assembly)","NA",{"v":3.2e-60,"d":"0.00"},2,"88,181,","0,1078",{"v":-59.5,"d":"-59.50"},{"v":-58.2,"d":"-58.20"},4.14,"Exon (ENSBGRT00000011810/ENSBGRG00000006292, exon 27 of 28)",1,149088101,149147923,59823,1]
["chr1",150872606,150873313,708,"ENSBGRG00000007836","ENSBGRT00000014532",60914,"MRPL3","mitochondrial ribosomal protein L3 [Source:HGNC Symbol;Acc:HGNC:10379]","GO:0003735(structural constituent of ribosome);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)",{"v":6.3e-71,"d":"0.00"},2,"110,131,","0,577",{"v":-70.2,"d":"-70.20"},{"v":-68.8,"d":"-68.80"},1.68,"3' UTR",1,150811692,150872715,61024,1]
["chr1",151301158,151301631,474,"ENSBGRG00000008357","ENSBGRT00000015300",647,"ASTE1","asteroid homolog 1 [Source:HGNC Symbol;Acc:HGNC:25021]","GO:0004518(nuclease activity);GO:0006281(DNA repair)","NA",{"v":2.2e-05,"d":"0.00"},2,"30,300,","0,174",-4.66,-4,5.74,"5' UTR",1,151300511,151316894,16384,1]
["chr1",151301691,151302527,837,"ENSBGRG00000008357","ENSBGRT00000015300",1180,"ASTE1","asteroid homolog 1 [Source:HGNC Symbol;Acc:HGNC:25021]","GO:0004518(nuclease activity);GO:0006281(DNA repair)","NA",{"v":8.1e-09,"d":"0.00"},1,"837,",0,-8.09,-7.33,3.58,"Exon (ENSBGRT00000015300/ENSBGRG00000008357, exon 3 of 6)",1,151300511,151316894,16384,1]
["chr1",151302587,151310355,7769,"ENSBGRG00000008357","ENSBGRT00000015300",2076,"ASTE1","asteroid homolog 1 [Source:HGNC Symbol;Acc:HGNC:25021]","GO:0004518(nuclease activity);GO:0006281(DNA repair)","NA",{"v":2E-3,"d":"0.00"},2,"68,23,","0,7746",-2.69,-2.12,2.64,"Exon (ENSBGRT00000015300/ENSBGRG00000008357, exon 3 of 6)",1,151300511,151316894,16384,1]
["chr1",151316636,151316845,210,"ENSBGRG00000008357","ENSBGRT00000015300",16125,"ASTE1","asteroid homolog 1 [Source:HGNC Symbol;Acc:HGNC:25021]","GO:0004518(nuclease activity);GO:0006281(DNA repair)","NA",{"v":1.9E-6,"d":"0.00"},1,"210,",0,-5.71,-5.01,4.14,"Exon (ENSBGRT00000015300/ENSBGRG00000008357, exon 6 of 6)",1,151300511,151316894,16384,1]
["chr1",152065179,152065417,239,"ENSBGRG00000011752","ENSBGRT00000021424",0,"ENSBGRG00000011752","NA","NA","NA",{"v":1e-16,"d":"0.00"},1,"239,",0,-16,{"v":-15.1,"d":"-15.10"},7.92,"5' UTR",1,152065179,152144752,79574,1]
["chr1",152111008,152138516,27509,"ENSBGRG00000011808","ENSBGRT00000021511",0,"U6","U6 spliceosomal RNA [Source:RFAM;Acc:RF00026]","NA","NA",{"v":9.99999999999998e-244,"d":"0.00"},4,"14,93,30,102,","0,866,22451,27407",-243,-241,{"v":2.2,"d":"2.20"},"Exon (ENSBGRT00000021424/ENSBGRG00000011752, exon 4 of 8)",1,152116016,152116122,107,2]
["chr1",154223050,154223200,151,"ENSBGRG00000013059","ENSBGRT00000024379",122370,"BACE2","beta-secretase 2 [Source:HGNC Symbol;Acc:HGNC:934]","GO:0004190(aspartic-type endopeptidase activity);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0006509(membrane protein ectodomain proteolysis);GO:0016021(integral component of membrane);GO:0042593(glucose homeostasis);GO:0042985(negative regulation of amyloid precursor protein biosynthetic process)","05010(Alzheimer disease)",{"v":1.6E-12,"d":"0.00"},1,"151,",0,{"v":-11.8,"d":"-11.80"},-11,2.14,"3' UTR",1,154100680,154223200,122521,1]
["chr1",154478874,154484051,5178,"ENSBGRG00000014066","ENSBGRT00000026227",87971,"MX1","MX dynamin like GTPase 1 [Source:HGNC Symbol;Acc:HGNC:7532]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0009615(response to virus);GO:0031965(nuclear membrane);GO:0042802(identical protein binding);GO:0045071(negative regulation of viral genome replication);GO:0048471(perinuclear region of cytoplasm);GO:0051607(defense response to virus)","05162(Measles);05164(Influenza A);05165(Human papillomavirus infection)",{"v":4e-31,"d":"0.00"},2,"137,643,","0,4535",{"v":-30.4,"d":"-30.40"},{"v":-29.3,"d":"-29.30"},3.17,"3' UTR",1,154390903,154484561,93659,1]
["chr1",155460105,155460404,300,"ENSBGRG00000017210","ENSBGRT00000032093",71241,"ABCG1","ATP binding cassette subfamily G member 1 [Source:HGNC Symbol;Acc:HGNC:73]","GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0008203(cholesterol metabolic process);GO:0009897(external side of plasma membrane);GO:0010033(response to organic substance);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0019534(toxin transmembrane transporter activity);GO:0032367(intracellular cholesterol transport);GO:0033344(cholesterol efflux);GO:0033700(phospholipid efflux);GO:0033993(response to lipid);GO:0034041(ATPase-coupled sterol transmembrane transporter activity);GO:0034436(glycoprotein transport);GO:0042632(cholesterol homeostasis);GO:0042803(protein homodimerization activity);GO:0042987(amyloid precursor protein catabolic process);GO:0043531(ADP binding);GO:0046982(protein heterodimerization activity);GO:0050714(positive regulation of protein secretion);GO:0055085(transmembrane transport);GO:0055091(phospholipid homeostasis);GO:0090554(phosphatidylcholine floppase activity);GO:0120020(cholesterol transfer activity);GO:0140328(floppase activity);GO:1902004(positive regulation of amyloid-beta formation)","02010(ABC transporters)",{"v":0.0003,"d":"0.00"},1,"300,",0,-3.52,{"v":-2.9,"d":"-2.90"},6.93,"3' UTR",1,155388864,155460897,72034,1]
["chr1",155461301,155461511,211,"ENSBGRG00000017210","ENSBGRT00000031952",72437,"ABCG1","ATP binding cassette subfamily G member 1 [Source:HGNC Symbol;Acc:HGNC:73]","GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0008203(cholesterol metabolic process);GO:0009897(external side of plasma membrane);GO:0010033(response to organic substance);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0019534(toxin transmembrane transporter activity);GO:0032367(intracellular cholesterol transport);GO:0033344(cholesterol efflux);GO:0033700(phospholipid efflux);GO:0033993(response to lipid);GO:0034041(ATPase-coupled sterol transmembrane transporter activity);GO:0034436(glycoprotein transport);GO:0042632(cholesterol homeostasis);GO:0042803(protein homodimerization activity);GO:0042987(amyloid precursor protein catabolic process);GO:0043531(ADP binding);GO:0046982(protein heterodimerization activity);GO:0050714(positive regulation of protein secretion);GO:0055085(transmembrane transport);GO:0055091(phospholipid homeostasis);GO:0090554(phosphatidylcholine floppase activity);GO:0120020(cholesterol transfer activity);GO:0140328(floppase activity);GO:1902004(positive regulation of amyloid-beta formation)","02010(ABC transporters)",{"v":2e-31,"d":"0.00"},1,"211,",0,{"v":-30.7,"d":"-30.70"},{"v":-29.7,"d":"-29.70"},6.93,"Exon (ENSBGRT00000031952/ENSBGRG00000017210, exon 16 of 16)",1,155388864,155461511,72648,1]
["chr1",155669050,155671028,1979,"ENSBGRG00000018065","ENSBGRT00000033793",43496,"UBASH3A","ubiquitin associated and SH3 domain containing A [Source:HGNC Symbol;Acc:HGNC:12462]","GO:0001817(regulation of cytokine production);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0050860(negative regulation of T cell receptor signaling pathway)","NA",{"v":1.5e-08,"d":"0.00"},2,"86,451,","0,1528",-7.83,-7.08,8.67,"3' UTR",1,155625554,155670641,45088,1]
["chr1",156025590,156028197,2608,"ENSBGRG00000019109","ENSBGRT00000036113",120251,"PDE9A","phosphodiesterase 9A [Source:HGNC Symbol;Acc:HGNC:8795]","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0010613(positive regulation of cardiac muscle hypertrophy);GO:0042383(sarcolemma);GO:0046068(cGMP metabolic process);GO:0046069(cGMP catabolic process);GO:0047555(3',5'-cyclic-GMP phosphodiesterase activity)","00230(Purine metabolism)",{"v":1.6e-19,"d":"0.00"},2,"63,206,","0,2402",{"v":-18.8,"d":"-18.80"},{"v":-17.8,"d":"-17.80"},2.72,"3' UTR",1,155905339,156029002,123664,1]
["chr1",156127993,156133282,5290,"ENSBGRG00000019941","ENSBGRT00000036739",4672,"ENSBGRG00000019941","NA","GO:0005739(mitochondrion);GO:0005747(mitochondrial respiratory chain complex I)","00190(Oxidative phosphorylation);04723(Retrograde endocannabinoid signaling);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":1E-73,"d":"0.00"},2,"30,926,","0,4364",-73,{"v":-71.7,"d":"-71.70"},4.39,"Exon (ENSBGRT00000036693/ENSBGRG00000019941, exon 3 of 4)",1,156123321,156135753,12433,1]
["chr1",156213650,156213829,180,"ENSBGRG00000020052","ENSBGRT00000037075",23688,"PKNOX1","PBX/knotted 1 homeobox 1 [Source:HGNC Symbol;Acc:HGNC:9022]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001525(angiogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0030097(hemopoiesis);GO:0030217(T cell differentiation);GO:0030218(erythrocyte differentiation);GO:0043010(camera-type eye development);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.00071,"d":"0.00"},1,"180,",0,-3.15,-2.55,{"v":4.7,"d":"4.70"},"3' UTR",1,156189962,156213774,23813,1]
["chr1",156214097,156214216,120,"ENSBGRG00000020052","ENSBGRT00000036977",24135,"PKNOX1","PBX/knotted 1 homeobox 1 [Source:HGNC Symbol;Acc:HGNC:9022]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001525(angiogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0030097(hemopoiesis);GO:0030217(T cell differentiation);GO:0030218(erythrocyte differentiation);GO:0043010(camera-type eye development);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.0026,"d":"0.00"},1,"120,",0,-2.58,-2.01,1.49,"3' UTR",1,156189962,156214377,24416,1]
["chr1",156812991,156813080,90,"ENSBGRG00000021030","ENSBGRT00000038887",388,"RRP1B","ribosomal RNA processing 1B [Source:HGNC Symbol;Acc:HGNC:23818]","GO:0001652(granular component);GO:0003713(transcription coactivator activity);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0010923(negative regulation of phosphatase activity);GO:0030688(preribosome, small subunit precursor);GO:0043065(positive regulation of apoptotic process);GO:0043923(positive regulation by host of viral transcription);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0098586(cellular response to virus)","NA",{"v":0.048,"d":"0.05"},1,"90,",0,-1.32,{"v":-0.839,"d":"-0.84"},3.47,"5' UTR",1,156812603,156838207,25605,1]
["chr1",156813170,156813378,209,"ENSBGRG00000021030","ENSBGRT00000038887",567,"RRP1B","ribosomal RNA processing 1B [Source:HGNC Symbol;Acc:HGNC:23818]","GO:0001652(granular component);GO:0003713(transcription coactivator activity);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0010923(negative regulation of phosphatase activity);GO:0030688(preribosome, small subunit precursor);GO:0043065(positive regulation of apoptotic process);GO:0043923(positive regulation by host of viral transcription);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0098586(cellular response to virus)","NA",{"v":0.0068,"d":"0.01"},1,"209,",0,-2.17,-1.62,6.93,"5' UTR",1,156812603,156838207,25605,1]
["chr1",156833633,156837924,4292,"ENSBGRG00000021030","ENSBGRT00000038887",21030,"RRP1B","ribosomal RNA processing 1B [Source:HGNC Symbol;Acc:HGNC:23818]","GO:0001652(granular component);GO:0003713(transcription coactivator activity);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0010923(negative regulation of phosphatase activity);GO:0030688(preribosome, small subunit precursor);GO:0043065(positive regulation of apoptotic process);GO:0043923(positive regulation by host of viral transcription);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0098586(cellular response to virus)","NA",{"v":1e-63,"d":"0.00"},4,"647,54,147,227,","0,1024,2756,4065",-63,{"v":-61.7,"d":"-61.70"},5.74,"Exon (ENSBGRT00000038887/ENSBGRG00000021030, exon 13 of 16)",1,156812603,156838207,25605,1]
["chr1",156838192,156838545,354,"ENSBGRG00000021030","ENSBGRT00000038887",25589,"RRP1B","ribosomal RNA processing 1B [Source:HGNC Symbol;Acc:HGNC:23818]","GO:0001652(granular component);GO:0003713(transcription coactivator activity);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0010923(negative regulation of phosphatase activity);GO:0030688(preribosome, small subunit precursor);GO:0043065(positive regulation of apoptotic process);GO:0043923(positive regulation by host of viral transcription);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0098586(cellular response to virus)","NA",{"v":1.7E-6,"d":"0.00"},2,"16,194,","0,160",-5.78,-5.08,2.48,"Exon (ENSBGRT00000038887/ENSBGRG00000021030, exon 16 of 16)",1,156812603,156838207,25605,1]
["chr1",156893154,156893737,584,"ENSBGRG00000021296","ENSBGRT00000039593",19916,"PDXK","pyridoxal kinase [Source:HGNC Symbol;Acc:HGNC:8819]","GO:0000287(magnesium ion binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0008270(zinc ion binding);GO:0008478(pyridoxal kinase activity);GO:0009443(pyridoxal 5'-phosphate salvage);GO:0030170(pyridoxal phosphate binding);GO:0030955(potassium ion binding);GO:0031402(sodium ion binding);GO:0031403(lithium ion binding);GO:0042803(protein homodimerization activity)","00750(Vitamin B6 metabolism)",0.02,2,"36,55,","0,529",-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000039593/ENSBGRG00000021296, exon 4 of 13)",1,156873238,156902763,29526,1]
["chr1",156973163,156973744,582,"ENSBGRG00000021680","ENSBGRT00000040134",14070,"RRP1","ribosomal RNA processing 1 [Source:HGNC Symbol;Acc:HGNC:18785]","GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0030688(preribosome, small subunit precursor)","NA",{"v":6.3e-91,"d":"0.00"},2,"5,233,","0,349",{"v":-90.2,"d":"-90.20"},{"v":-88.8,"d":"-88.80"},5.26,"Exon (ENSBGRT00000040134/ENSBGRG00000021680, exon 12 of 12)",1,156959093,156973167,14075,1]
["chr1",157144077,157144376,300,"ENSBGRG00000021804","ENSBGRT00000040329",67231,"AGPAT3","1-acylglycerol-3-phosphate O-acyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:326]","GO:0003841(1-acylglycerol-3-phosphate O-acyltransferase activity);GO:0005635(nuclear envelope);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0016746(transferase activity, transferring acyl groups);GO:0042171(lysophosphatidic acid acyltransferase activity)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04072(Phospholipase D signaling pathway)",{"v":0.036,"d":"0.04"},1,"300,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"3' UTR",1,157076846,157144740,67895,1]
["chr1",157151094,157151709,616,"ENSBGRG00000021804","ENSBGRT00000040296",74248,"AGPAT3","1-acylglycerol-3-phosphate O-acyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:326]","GO:0003841(1-acylglycerol-3-phosphate O-acyltransferase activity);GO:0005635(nuclear envelope);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0016746(transferase activity, transferring acyl groups);GO:0042171(lysophosphatidic acid acyltransferase activity)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04072(Phospholipase D signaling pathway)",{"v":1E-168,"d":"0.00"},2,"42,258,","0,358",-168,-166,5.73,"3' UTR",1,157076846,157151135,74290,1]
["chr1",157152138,157155183,3046,"ENSBGRG00000021874","ENSBGRT00000040382",0,"ENSBGRG00000021874","NA","NA","NA",{"v":2.1E-10,"d":"0.00"},2,"349,99,","0,2947",-9.68,-8.89,3.41,"Exon (ENSBGRT00000040382/ENSBGRG00000021874, exon 1 of 2)",1,157152138,157157182,5045,1]
["chr1",157156556,157157182,627,"ENSBGRG00000021874","ENSBGRT00000040382",4418,"ENSBGRG00000021874","NA","NA","NA",{"v":1.6e-68,"d":"0.00"},1,"627,",0,{"v":-67.8,"d":"-67.80"},{"v":-66.5,"d":"-66.50"},6.05,"Exon (ENSBGRT00000040382/ENSBGRG00000021874, exon 2 of 2)",1,157152138,157157182,5045,1]
["chr1",157272692,157272752,61,"ENSBGRG00000021882","ENSBGRT00000040707",83492,"TRAPPC10","trafficking protein particle complex 10 [Source:HGNC Symbol;Acc:HGNC:11868]","GO:0030008(TRAPP complex)","NA",{"v":3.8E-3,"d":"0.00"},1,"61,",0,-2.42,-1.86,1.73,"Exon (ENSBGRT00000040707/ENSBGRG00000021882, exon 23 of 23)",1,157189200,157272842,83643,1]
["chr1",157291158,157292085,928,"ENSBGRG00000022101","ENSBGRT00000040822",14123,"ENSBGRG00000022101","NA","GO:0005515(protein binding)","03008(Ribosome biogenesis in eukaryotes)",{"v":1E-117,"d":"0.00"},1,"928,",0,-117,-115,{"v":11.8,"d":"11.80"},"3' UTR",1,157277035,157292085,15051,1]
["chr1",157306070,157306742,673,"ENSBGRG00000022271","ENSBGRT00000041105",12046,"ENSBGRG00000022271","NA","NA","NA",{"v":7.9e-17,"d":"0.00"},2,"20,129,","0,544",{"v":-16.1,"d":"-16.10"},{"v":-15.2,"d":"-15.20"},1.97,"Exon (ENSBGRT00000041105/ENSBGRG00000022271, exon 5 of 6)",1,157294024,157306742,12719,1]
["chr1",157459384,157459654,271,"ENSBGRG00000022599","ENSBGRT00000042067",0,"AIRE","autoimmune regulator [Source:HGNC Symbol;Acc:HGNC:360]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0002458(peripheral T cell tolerance induction);GO:0002509(central tolerance induction to self antigen);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006959(humoral immune response);GO:0008270(zinc ion binding);GO:0016604(nuclear body);GO:0032602(chemokine production);GO:0042393(histone binding);GO:0042802(identical protein binding);GO:0045060(negative thymic T cell selection);GO:0045182(translation regulator activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0097536(thymus epithelium morphogenesis);GO:2000410(regulation of thymocyte migration)","04120(Ubiquitin mediated proteolysis);05340(Primary immunodeficiency)",0.02,1,"271,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"5' UTR",1,157459606,157472198,12593,1]
["chr1",157619189,157619903,715,"ENSBGRG00000023411","ENSBGRT00000043239",59,"LRRC3","leucine rich repeat containing 3 [Source:HGNC Symbol;Acc:HGNC:14965]","GO:0005515(protein binding)","NA",{"v":1.6e-32,"d":"0.00"},1,"715,",0,{"v":-31.8,"d":"-31.80"},{"v":-30.7,"d":"-30.70"},3.09,"Exon (ENSBGRT00000043239/ENSBGRG00000023411, exon 1 of 1)",1,157619130,157619903,774,1]
["chr1",158066498,158068512,2015,"ENSBGRG00000000257","ENSBGRT00000000403",23472,"FAM207A","family with sequence similarity 207 member A [Source:HGNC Symbol;Acc:HGNC:15811]","GO:0000462(maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0005730(nucleolus);GO:0030686(90S preribosome);GO:0030688(preribosome, small subunit precursor)","NA",{"v":1.6e-06,"d":"0.00"},2,"27,124,","0,1891",-5.79,-5.09,2.18,"Exon (ENSBGRT00000000403/ENSBGRG00000000257, exon 5 of 6)",1,158043026,158068512,25487,1]
["chr1",158272886,158276696,3811,"ENSBGRG00000000280","ENSBGRT00000000448",35509,"ADARB1","adenosine deaminase RNA specific B1 [Source:HGNC Symbol;Acc:HGNC:226]","GO:0003723(RNA binding);GO:0004000(adenosine deaminase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006382(adenosine to inosine editing);GO:0006396(RNA processing);GO:0007274(neuromuscular synaptic transmission);GO:0008285(negative regulation of cell population proliferation);GO:0021610(facial nerve morphogenesis);GO:0021618(hypoglossal nerve morphogenesis);GO:0021965(spinal cord ventral commissure morphogenesis);GO:0030336(negative regulation of cell migration);GO:0035264(multicellular organism growth);GO:0044387(negative regulation of protein kinase activity by regulation of protein phosphorylation);GO:0045070(positive regulation of viral genome replication);GO:0050884(neuromuscular process controlling posture);GO:0051726(regulation of cell cycle);GO:0060384(innervation);GO:0060415(muscle tissue morphogenesis);GO:0061744(motor behavior);GO:0097049(motor neuron apoptotic process)","NA",{"v":0.00098,"d":"0.00"},3,"1,39,81,","0,164,3730",-3.01,-2.42,{"v":2.1,"d":"2.10"},"Exon (ENSBGRT00000000448/ENSBGRG00000000280, exon 3 of 12)",1,158237377,158319534,82158,1]
["chr1",158276935,158277474,540,"ENSBGRG00000000280","ENSBGRT00000000448",39558,"ADARB1","adenosine deaminase RNA specific B1 [Source:HGNC Symbol;Acc:HGNC:226]","GO:0003723(RNA binding);GO:0004000(adenosine deaminase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006382(adenosine to inosine editing);GO:0006396(RNA processing);GO:0007274(neuromuscular synaptic transmission);GO:0008285(negative regulation of cell population proliferation);GO:0021610(facial nerve morphogenesis);GO:0021618(hypoglossal nerve morphogenesis);GO:0021965(spinal cord ventral commissure morphogenesis);GO:0030336(negative regulation of cell migration);GO:0035264(multicellular organism growth);GO:0044387(negative regulation of protein kinase activity by regulation of protein phosphorylation);GO:0045070(positive regulation of viral genome replication);GO:0050884(neuromuscular process controlling posture);GO:0051726(regulation of cell cycle);GO:0060384(innervation);GO:0060415(muscle tissue morphogenesis);GO:0061744(motor behavior);GO:0097049(motor neuron apoptotic process)","NA",{"v":7.9e-14,"d":"0.00"},1,"540,",0,{"v":-13.1,"d":"-13.10"},{"v":-12.3,"d":"-12.30"},4.32,"Exon (ENSBGRT00000000448/ENSBGRG00000000280, exon 5 of 12)",1,158237377,158319534,82158,1]
["chr1",158543875,158544024,150,"ENSBGRG00000000371","ENSBGRT00000000602",459,"ENSBGRG00000000371","NA","NA","NA",{"v":2.8E-5,"d":"0.00"},1,"150,",0,-4.56,{"v":-3.9,"d":"-3.90"},3.35,"Exon (ENSBGRT00000001044/ENSBGRG00000000404, exon 1 of 50)",1,158539605,158544483,4879,2]
["chr1",158544084,158544359,276,"ENSBGRG00000000371","ENSBGRT00000000602",124,"ENSBGRG00000000371","NA","NA","NA",{"v":0.00026,"d":"0.00"},4,"2,63,6,139,","0,65,130,137",-3.58,-2.96,3.96,"Exon (ENSBGRT00000001044/ENSBGRG00000000404, exon 1 of 50)",1,158539605,158544483,4879,2]
["chr1",158544496,158544645,150,"ENSBGRG00000000404","ENSBGRT00000001044",890,"ENSBGRG00000000404","NA","NA","04974(Protein digestion and absorption)",{"v":3.8E-3,"d":"0.00"},1,"150,",0,-2.42,-1.86,2.97,"Exon (ENSBGRT00000001044/ENSBGRG00000000404, exon 6 of 50)",1,158543606,158602983,59378,1]
["chr1",158544765,158544914,150,"ENSBGRG00000000404","ENSBGRT00000001044",1159,"ENSBGRG00000000404","NA","NA","04974(Protein digestion and absorption)",{"v":0.018,"d":"0.02"},1,"150,",0,-1.74,-1.22,3.96,"Exon (ENSBGRT00000001044/ENSBGRG00000000404, exon 6 of 50)",1,158543606,158602983,59378,1]
["chr1",158545063,158558050,12988,"ENSBGRG00000000404","ENSBGRT00000001044",1457,"ENSBGRG00000000404","NA","NA","04974(Protein digestion and absorption)",{"v":1.7e-09,"d":"0.00"},2,"14,167,","0,12821",-8.78,-8,2.03,"Exon (ENSBGRT00000001044/ENSBGRG00000000404, exon 6 of 50)",1,158543606,158602983,59378,1]
["chr1",158584559,158596368,11810,"ENSBGRG00000000404","ENSBGRT00000001044",40953,"ENSBGRG00000000404","NA","NA","04974(Protein digestion and absorption)",0,20,"6,63,27,36,72,36,90,30,27,63,51,21,27,54,75,69,43,63,44,60,","0,351,1592,2373,2771,3150,3478,4012,4117,4332,4626,4679,5482,5731,6075,7830,8472,9003,11442,11750",-653,"-Inf",3.82,"Exon (ENSBGRT00000001044/ENSBGRG00000000404, exon 22 of 50)",1,158543606,158602983,59378,1]
["chr1",158601847,158602983,1137,"ENSBGRG00000000404","ENSBGRT00000001044",58241,"ENSBGRG00000000404","NA","NA","04974(Protein digestion and absorption)",0,2,"56,214,","0,923",-443,"-Inf",2.98,"Exon (ENSBGRT00000001044/ENSBGRG00000000404, exon 49 of 50)",1,158543606,158602983,59378,1]
["chr1",158648961,158649260,300,"ENSBGRG00000000644","ENSBGRT00000001161",150,"ENSBGRG00000000644","NA","NA","NA",{"v":1.5E-5,"d":"0.00"},1,"300,",0,-4.82,-4.15,{"v":14.9,"d":"14.90"},"Exon (ENSBGRT00000001161/ENSBGRG00000000644, exon 1 of 1)",1,158648811,158650517,1707,1]
["chr1",158649888,158649948,61,"ENSBGRG00000000644","ENSBGRT00000001161",1077,"ENSBGRG00000000644","NA","NA","NA",{"v":0.026,"d":"0.03"},1,"61,",0,-1.59,-1.09,3.22,"Exon (ENSBGRT00000001161/ENSBGRG00000000644, exon 1 of 1)",1,158648811,158650517,1707,1]
["chr1",158650098,158650517,420,"ENSBGRG00000000644","ENSBGRT00000001161",1287,"ENSBGRG00000000644","NA","NA","NA",{"v":3.2e-06,"d":"0.00"},1,"420,",0,{"v":-5.5,"d":"-5.50"},-4.81,{"v":12.4,"d":"12.40"},"Exon (ENSBGRT00000001161/ENSBGRG00000000644, exon 1 of 1)",1,158648811,158650517,1707,1]
["chr1",158988743,158989012,270,"ENSBGRG00000000669","ENSBGRT00000001367",63990,"PCBP3","poly(rC) binding protein 3 [Source:HGNC Symbol;Acc:HGNC:8651]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003690(double-stranded DNA binding);GO:0003723(RNA binding);GO:1990829(C-rich single-stranded DNA binding)","NA",{"v":7.2e-06,"d":"0.00"},1,"270,",0,-5.14,-4.45,{"v":15.8,"d":"15.80"},"3' UTR",1,158924753,158989012,64260,1]
["chr1",159041979,159042069,91,"ENSBGRG00000000813","ENSBGRT00000001486",599,"COL6A1","collagen type VI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2211]","GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0035987(endodermal cell differentiation);GO:0042383(sarcolemma);GO:0048407(platelet-derived growth factor binding);GO:0071230(cellular response to amino acid stimulus)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":2.2e-07,"d":"0.00"},1,"91,",0,-6.65,-5.92,3.08,"5' UTR",1,159041380,159063428,22049,1]
["chr1",159046418,159055899,9482,"ENSBGRG00000000813","ENSBGRT00000001486",5038,"COL6A1","collagen type VI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2211]","GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0035987(endodermal cell differentiation);GO:0042383(sarcolemma);GO:0048407(platelet-derived growth factor binding);GO:0071230(cellular response to amino acid stimulus)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",0,14,"31,54,45,27,27,45,54,63,63,54,36,63,63,6,","0,818,2110,2252,2448,2567,2932,3185,4010,4162,4299,4524,5854,9476",-1080,"-Inf",{"v":2.4,"d":"2.40"},"Exon (ENSBGRT00000001486/ENSBGRG00000000813, exon 8 of 38)",1,159041380,159063428,22049,1]
["chr1",159060364,159063428,3065,"ENSBGRG00000000813","ENSBGRT00000001486",18984,"COL6A1","collagen type VI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2211]","GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0035987(endodermal cell differentiation);GO:0042383(sarcolemma);GO:0048407(platelet-derived growth factor binding);GO:0071230(cellular response to amino acid stimulus)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",0,4,"37,30,16,607,","0,1608,1761,2458",-793,"-Inf",3.43,"Exon (ENSBGRT00000001486/ENSBGRG00000000813, exon 35 of 38)",1,159041380,159063428,22049,1]
["chr1",159213009,159220322,7314,"ENSBGRG00000000863","ENSBGRT00000001699",1885,"COL6A2","collagen type VI alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2212]","GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0042383(sarcolemma)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",0,16,"19,54,45,27,27,45,54,63,63,90,63,63,63,63,51,17,","0,1275,1414,1751,2007,2132,2736,3190,4270,4617,5314,5964,6237,6666,7002,7297",-806,"-Inf",3.29,"Exon (ENSBGRT00000001699/ENSBGRG00000000863, exon 4 of 28)",1,159211124,159225575,14452,1]
["chr1",159222453,159229313,6861,"ENSBGRG00000000863","ENSBGRT00000001699",11329,"COL6A2","collagen type VI alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2212]","GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0042383(sarcolemma)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",0,4,"36,26,296,360,","0,3097,3437,6501",-448,"-Inf",3.46,"Exon (ENSBGRT00000001699/ENSBGRG00000000863, exon 27 of 28)",1,159211124,159225575,14452,1]
["chr1",159387153,159387359,207,"ENSBGRG00000001586","ENSBGRT00000002974",440,"ENSBGRG00000001586","NA","GO:0004222(metalloendopeptidase activity);GO:0006364(rRNA processing)","00514(Other types of O-glycan biosynthesis)",{"v":1.1E-4,"d":"0.00"},1,"207,",0,-3.96,-3.33,1.67,"Exon (ENSBGRT00000002974/ENSBGRG00000001586, exon 1 of 3)",1,159386713,159390293,3581,1]
["chr1",159688389,159691247,2859,"ENSBGRG00000001765","ENSBGRT00000004313",134358,"DIP2A","disco interacting protein 2 homolog A [Source:HGNC Symbol;Acc:HGNC:17217]","GO:0003824(catalytic activity);GO:0009986(cell surface);GO:0010629(negative regulation of gene expression);GO:0042981(regulation of apoptotic process)","04512(ECM-receptor interaction);04510(Focal adhesion)",{"v":7.9e-15,"d":"0.00"},2,"17,253,","0,2606",{"v":-14.1,"d":"-14.10"},{"v":-13.3,"d":"-13.30"},2.83,"Exon (ENSBGRT00000004313/ENSBGRG00000001765, exon 38 of 39)",1,159554031,159691247,137217,1]
["chr1",159801076,159801552,477,"ENSBGRG00000002397","ENSBGRT00000004492",47445,"PRMT2","protein arginine methyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:5186]","GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008168(methyltransferase activity);GO:0016274(protein-arginine N-methyltransferase activity);GO:0016571(histone methylation);GO:0018216(peptidyl-arginine methylation);GO:0030331(estrogen receptor binding);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0033142(progesterone receptor binding);GO:0042054(histone methyltransferase activity);GO:0042803(protein homodimerization activity);GO:0042974(retinoic acid receptor binding);GO:0042975(peroxisome proliferator activated receptor binding);GO:0043065(positive regulation of apoptotic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046966(thyroid hormone receptor binding);GO:0050681(androgen receptor binding);GO:0060765(regulation of androgen receptor signaling pathway)","NA",{"v":1e-30,"d":"0.00"},1,"477,",0,-30,{"v":-28.9,"d":"-28.90"},2.31,"3' UTR",1,159753631,159801552,47922,1]
["chr1",160015957,160017708,1752,"ENSBGRG00000002483","ENSBGRT00000004767",30,"FBXO25","F-box protein 25 [Source:HGNC Symbol;Acc:HGNC:13596]","GO:0005515(protein binding);GO:0005634(nucleus)","04068(FoxO signaling pathway)",{"v":2.3e-07,"d":"0.00"},2,"111,97,","0,1655",-6.64,-5.92,1.68,"5' UTR",1,160015927,160032841,16915,1]
["chr1",160019772,160023395,3624,"ENSBGRG00000002483","ENSBGRT00000004767",3845,"FBXO25","F-box protein 25 [Source:HGNC Symbol;Acc:HGNC:13596]","GO:0005515(protein binding);GO:0005634(nucleus)","04068(FoxO signaling pathway)",{"v":0.039,"d":"0.04"},2,"1,59,","0,3565",-1.41,{"v":-0.921,"d":"-0.92"},{"v":1.8,"d":"1.80"},"Exon (ENSBGRT00000004767/ENSBGRG00000002483, exon 4 of 9)",1,160015927,160032841,16915,1]
["chr1",160041067,160041334,268,"ENSBGRG00000002483","ENSBGRT00000004668",25140,"FBXO25","F-box protein 25 [Source:HGNC Symbol;Acc:HGNC:13596]","GO:0005515(protein binding);GO:0005634(nucleus)","04068(FoxO signaling pathway)",{"v":2.4E-9,"d":"0.00"},1,"268,",0,-8.62,-7.85,2.17,"3' UTR",1,160015927,160041690,25764,1]
["chr1",160041393,160041690,298,"ENSBGRG00000002483","ENSBGRT00000004668",25466,"FBXO25","F-box protein 25 [Source:HGNC Symbol;Acc:HGNC:13596]","GO:0005515(protein binding);GO:0005634(nucleus)","04068(FoxO signaling pathway)",{"v":1.2e-06,"d":"0.00"},1,"298,",0,-5.91,-5.21,2.16,"3' UTR",1,160015927,160041690,25764,1]
["chr1",161996560,161997188,629,"ENSBGRG00000002778","ENSBGRT00000005203",6218,"CBR1","carbonyl reductase 1 [Source:HGNC Symbol;Acc:HGNC:1548]","GO:0004090(carbonyl reductase (NADPH) activity);GO:0016491(oxidoreductase activity);GO:0016655(oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor);GO:0017144(drug metabolic process);GO:0030855(epithelial cell differentiation);GO:0042373(vitamin K metabolic process);GO:0055114(oxidation-reduction process)","00590(Arachidonic acid metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00790(Folate biosynthesis);05204(Chemical carcinogenesis)",{"v":9.99999999999998e-274,"d":"0.00"},1,"629,",0,-273,-271,5.96,"3' UTR",1,161990342,161997190,6849,1]
["chr1",162073639,162084276,10638,"ENSBGRG00000002778","ENSBGRT00000005189",83297,"CBR1","carbonyl reductase 1 [Source:HGNC Symbol;Acc:HGNC:1548]","GO:0004090(carbonyl reductase (NADPH) activity);GO:0016491(oxidoreductase activity);GO:0016655(oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor);GO:0017144(drug metabolic process);GO:0030855(epithelial cell differentiation);GO:0042373(vitamin K metabolic process);GO:0055114(oxidation-reduction process)","00590(Arachidonic acid metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00790(Folate biosynthesis);05204(Chemical carcinogenesis)",{"v":9.99999999999998e-226,"d":"0.00"},3,"23,108,498,","0,1858,10140",-225,-223,8.16,"3' UTR",1,161990342,162084276,93935,1]
["chr1",162168951,162169161,211,"ENSBGRG00000002831","ENSBGRT00000005352",66824,"DOP1B","DOP1 leucine zipper like protein B [Source:HGNC Symbol;Acc:HGNC:1291]","GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","04144(Endocytosis)",{"v":0.0013,"d":"0.00"},1,"211,",0,{"v":-2.9,"d":"-2.90"},-2.31,7.43,"5' UTR",1,162102127,162248714,146588,1]
["chr1",162195193,162195913,721,"ENSBGRG00000002831","ENSBGRT00000005352",93066,"DOP1B","DOP1 leucine zipper like protein B [Source:HGNC Symbol;Acc:HGNC:1291]","GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","04144(Endocytosis)",{"v":8.9e-09,"d":"0.00"},1,"721,",0,-8.05,-7.29,{"v":30.7,"d":"30.70"},"Exon (ENSBGRT00000005352/ENSBGRG00000002831, exon 20 of 38)",1,162102127,162248714,146588,1]
["chr1",162197163,162197223,61,"ENSBGRG00000002831","ENSBGRT00000005352",95036,"DOP1B","DOP1 leucine zipper like protein B [Source:HGNC Symbol;Acc:HGNC:1291]","GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","04144(Endocytosis)",{"v":6.2E-4,"d":"0.00"},1,"61,",0,-3.21,-2.61,2.89,"Exon (ENSBGRT00000005352/ENSBGRG00000002831, exon 21 of 38)",1,162102127,162248714,146588,1]
["chr1",162244609,162245148,540,"ENSBGRG00000002831","ENSBGRT00000005352",142482,"DOP1B","DOP1 leucine zipper like protein B [Source:HGNC Symbol;Acc:HGNC:1291]","GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","04144(Endocytosis)",{"v":1E-22,"d":"0.00"},1,"540,",0,-22,-21,4.66,"3' UTR",1,162102127,162248714,146588,1]
["chr1",162246676,162247036,361,"ENSBGRG00000002831","ENSBGRT00000005352",144549,"DOP1B","DOP1 leucine zipper like protein B [Source:HGNC Symbol;Acc:HGNC:1291]","GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","04144(Endocytosis)",{"v":1.8e-08,"d":"0.00"},1,"361,",0,-7.74,-6.98,{"v":20.8,"d":"20.80"},"3' UTR",1,162102127,162248714,146588,1]
["chr1",162300342,162300907,566,"ENSBGRG00000002919","ENSBGRT00000005650",21527,"MORC3","MORC family CW-type zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:23572]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation);GO:0007569(cell aging);GO:0008270(zinc ion binding);GO:0009791(post-embryonic development);GO:0016605(PML body);GO:0018105(peptidyl-serine phosphorylation);GO:0048147(negative regulation of fibroblast proliferation);GO:0050821(protein stabilization);GO:0051457(maintenance of protein location in nucleus)","NA",{"v":1.3E-99,"d":"0.00"},1,"566,",0,{"v":-98.9,"d":"-98.90"},{"v":-97.4,"d":"-97.40"},7.82,"Exon (ENSBGRT00000005650/ENSBGRG00000002919, exon 13 of 14)",1,162278815,162302351,23537,1]
["chr1",162301920,162308674,6755,"ENSBGRG00000002919","ENSBGRT00000005650",23105,"MORC3","MORC family CW-type zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:23572]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation);GO:0007569(cell aging);GO:0008270(zinc ion binding);GO:0009791(post-embryonic development);GO:0016605(PML body);GO:0018105(peptidyl-serine phosphorylation);GO:0048147(negative regulation of fibroblast proliferation);GO:0050821(protein stabilization);GO:0051457(maintenance of protein location in nucleus)","NA",{"v":2.5e-19,"d":"0.00"},3,"432,158,95,","0,3614,6660",{"v":-18.6,"d":"-18.60"},{"v":-17.7,"d":"-17.70"},2.66,"Exon (ENSBGRT00000005650/ENSBGRG00000002919, exon 14 of 14)",1,162278815,162302351,23537,1]
["chr1",162358688,162360221,1534,"ENSBGRG00000003046","ENSBGRT00000005732",35761,"CHAF1B","chromatin assembly factor 1 subunit B [Source:HGNC Symbol;Acc:HGNC:1911]","GO:0000790(nuclear chromatin);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006335(DNA replication-dependent nucleosome assembly);GO:0031497(chromatin assembly);GO:0032991(protein-containing complex);GO:0033186(CAF-1 complex)","NA",{"v":2.5e-22,"d":"0.00"},2,"16,641,","0,893",{"v":-21.6,"d":"-21.60"},{"v":-20.7,"d":"-20.70"},{"v":10.5,"d":"10.50"},"3' UTR",1,162322927,162359678,36752,1]
["chr1",162360281,162360340,60,"ENSBGRG00000003046","ENSBGRT00000005703",37354,"CHAF1B","chromatin assembly factor 1 subunit B [Source:HGNC Symbol;Acc:HGNC:1911]","GO:0000790(nuclear chromatin);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006335(DNA replication-dependent nucleosome assembly);GO:0031497(chromatin assembly);GO:0032991(protein-containing complex);GO:0033186(CAF-1 complex)","NA",{"v":0.0021,"d":"0.00"},1,"60,",0,-2.68,{"v":-2.1,"d":"-2.10"},2.48,"3' UTR",1,162322927,162360969,38043,1]
["chr1",163026918,163030706,3789,"ENSBGRG00000003171","ENSBGRT00000005903",6778,"RIPPLY3","ripply transcriptional repressor 3 [Source:HGNC Symbol;Acc:HGNC:3047]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0007507(heart development);GO:0008285(negative regulation of cell population proliferation);GO:0060037(pharyngeal system development)","NA",{"v":3.3E-3,"d":"0.00"},2,"31,60,","0,3729",-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000005903/ENSBGRG00000003171, exon 3 of 6)",1,163020140,163030947,10808,1]
["chr1",163169448,163173572,4125,"ENSBGRG00000003246","ENSBGRT00000006013",34768,"ENSBGRG00000003246","NA","GO:0005515(protein binding)","NA",{"v":2e-33,"d":"0.00"},4,"131,338,9,3,","0,3773,4112,4122",{"v":-32.7,"d":"-32.70"},{"v":-31.6,"d":"-31.60"},3.36,"Exon (ENSBGRT00000006013/ENSBGRG00000003246, exon 15 of 18)",1,163134680,163173572,38893,1]
["chr1",163188512,163189376,865,"ENSBGRG00000003250","ENSBGRT00000006023",0,"ENSBGRG00000003250","NA","NA","NA",{"v":1.6e-83,"d":"0.00"},1,"865,",0,{"v":-82.8,"d":"-82.80"},{"v":-81.4,"d":"-81.40"},3.36,"5' UTR",1,163188512,163228771,40260,1]
["chr1",163193371,163207303,13933,"ENSBGRG00000003250","ENSBGRT00000006023",4859,"ENSBGRG00000003250","NA","NA","NA",{"v":6.3e-85,"d":"0.00"},4,"122,140,69,87,","0,10609,13068,13846",{"v":-84.2,"d":"-84.20"},{"v":-82.8,"d":"-82.80"},2.26,"5' UTR",1,163188512,163228771,40260,1]
["chr1",163522803,163534794,11992,"ENSBGRG00000003329","ENSBGRT00000006258",89545,"DYRK1A","dual specificity tyrosine phosphorylation regulated kinase 1A [Source:HGNC Symbol;Acc:HGNC:3091]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0007623(circadian rhythm);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030424(axon);GO:0030425(dendrite);GO:0031115(negative regulation of microtubule polymerization);GO:0033120(positive regulation of RNA splicing);GO:0034205(amyloid-beta formation);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0042802(identical protein binding);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0043621(protein self-association);GO:0046777(protein autophosphorylation);GO:0048025(negative regulation of mRNA splicing, via spliceosome);GO:0048156(tau protein binding);GO:0090312(positive regulation of protein deacetylation);GO:1990904(ribonucleoprotein complex)","NA",0,2,"69,621,","0,11371",-370,"-Inf",8.16,"Exon (ENSBGRT00000006258/ENSBGRG00000003329, exon 10 of 10)",1,163433258,163534217,100960,1]
["chr1",165249676,165251415,1740,"ENSBGRG00000003739","ENSBGRT00000006960",18920,"ETS2","ETS proto-oncogene 2, transcription factor [Source:HGNC Symbol;Acc:HGNC:3489]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0019904(protein domain specific binding);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:1990837(sequence-specific double-stranded DNA binding)","04014(Ras signaling pathway);05166(HTLV-I infection)",{"v":1e-143,"d":"0.00"},2,"96,501,","0,1239",-143,-141,8.46,"3' UTR",1,165230756,165251974,21219,1]
["chr1",165612299,165623812,11514,"ENSBGRG00000003866","ENSBGRT00000007146",90,"PIK3R4","phosphoinositide-3-kinase regulatory subunit 4 [Source:HGNC Symbol;Acc:HGNC:8982]","GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005770(late endosome);GO:0006468(protein phosphorylation);GO:0015630(microtubule cytoskeleton);GO:0032465(regulation of cytokinesis);GO:0032801(receptor catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity)","04371(Apelin signaling pathway);04140(Autophagy - animal);04136(Autophagy - other eukaryotes)",{"v":1E-107,"d":"0.00"},3,"694,134,516,","0,8893,10998",-107,-106,5.64,"Exon (ENSBGRT00000007146/ENSBGRG00000003866, exon 1 of 19)",1,165612209,165698664,86456,1]
["chr1",165698276,165698485,210,"ENSBGRG00000003866","ENSBGRT00000007146",86067,"PIK3R4","phosphoinositide-3-kinase regulatory subunit 4 [Source:HGNC Symbol;Acc:HGNC:8982]","GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005770(late endosome);GO:0006468(protein phosphorylation);GO:0015630(microtubule cytoskeleton);GO:0032465(regulation of cytokinesis);GO:0032801(receptor catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity)","04371(Apelin signaling pathway);04140(Autophagy - animal);04136(Autophagy - other eukaryotes)",{"v":4e-12,"d":"0.00"},1,"210,",0,{"v":-11.4,"d":"-11.40"},{"v":-10.5,"d":"-10.50"},1.77,"3' UTR",1,165612209,165698664,86456,1]
["chr1",166479961,166480710,750,"ENSBGRG00000004003","ENSBGRT00000007541",56466,"CAPN7","calpain 7 [Source:HGNC Symbol;Acc:HGNC:1484]","GO:0004175(endopeptidase activity);GO:0004198(calcium-dependent cysteine-type endopeptidase activity);GO:0006508(proteolysis);GO:0010634(positive regulation of epithelial cell migration);GO:0090541(MIT domain binding);GO:0097264(self proteolysis)","NA",{"v":1E-176,"d":"0.00"},2,"89,568,","0,182",-176,-174,6.65,"3' UTR",1,166423495,166480710,57216,1]
["chr1",166684703,166689301,4599,"ENSBGRG00000004328","ENSBGRT00000007994",7201,"EAF1","ELL associated factor 1 [Source:HGNC Symbol;Acc:HGNC:20907]","GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008023(transcription elongation factor complex);GO:0016604(nuclear body);GO:0032783(super elongation complex);GO:0043231(intracellular membrane-bounded organelle);GO:0045171(intercellular bridge)","NA",{"v":7.9e-26,"d":"0.00"},3,"74,225,210,","0,1686,4389",{"v":-25.1,"d":"-25.10"},{"v":-24.1,"d":"-24.10"},2.23,"3' UTR",1,166677502,166690138,12637,1]
["chr1",166689510,166689809,300,"ENSBGRG00000004328","ENSBGRT00000007994",12008,"EAF1","ELL associated factor 1 [Source:HGNC Symbol;Acc:HGNC:20907]","GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008023(transcription elongation factor complex);GO:0016604(nuclear body);GO:0032783(super elongation complex);GO:0043231(intracellular membrane-bounded organelle);GO:0045171(intercellular bridge)","NA",{"v":1.6E-34,"d":"0.00"},1,"300,",0,{"v":-33.8,"d":"-33.80"},{"v":-32.8,"d":"-32.80"},1.73,"3' UTR",1,166677502,166690138,12637,1]
["chr1",166912165,166912225,61,"ENSBGRG00000005423","ENSBGRT00000010036",6382,"ENSBGRG00000005423","NA","GO:0006807(nitrogen compound metabolic process)","00780(Biotin metabolism);04977(Vitamin digestion and absorption)",{"v":4e-13,"d":"0.00"},1,"61,",0,{"v":-12.4,"d":"-12.40"},{"v":-11.6,"d":"-11.60"},{"v":9.2,"d":"9.20"},"Exon (ENSBGRT00000010036/ENSBGRG00000005423, exon 4 of 4)",1,166905783,166912225,6443,1]
["chr1",167478731,167478909,179,"ENSBGRG00000005716","ENSBGRT00000010545",0,"GALNT15","polypeptide N-acetylgalactosaminyltransferase 15 [Source:HGNC Symbol;Acc:HGNC:21531]","GO:0030133(transport vesicle)","00512(Mucin type O-glycan biosynthesis)",{"v":0.00039,"d":"0.00"},1,"179,",0,-3.41,-2.79,{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000010545/ENSBGRG00000005716, exon 1 of 11)",1,167478731,167528054,49324,1]
["chr1",167635390,167636721,1332,"ENSBGRG00000005867","ENSBGRT00000010807",57144,"OXNAD1","oxidoreductase NAD binding domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25128]","GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00520(Amino sugar and nucleotide sugar metabolism)",{"v":1e-192,"d":"0.00"},2,"102,556,","0,776",-192,-190,{"v":11.7,"d":"11.70"},"3' UTR",1,167578246,167636721,58476,1]
["chr1",168438020,168439009,990,"ENSBGRG00000000215","ENSBGRT00000000343",139452,"PLCL2","phospholipase C like 2 [Source:HGNC Symbol;Acc:HGNC:9064]","GO:0002322(B cell proliferation involved in immune response);GO:0002337(B-1a B cell differentiation);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0050859(negative regulation of B cell receptor signaling pathway);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","NA",{"v":1E-134,"d":"0.00"},1,"990,",0,-134,-132,6.09,"Exon (ENSBGRT00000000343/ENSBGRG00000000215, exon 3 of 7)",1,168298568,168542235,243668,1]
["chr1",168439399,168443201,3803,"ENSBGRG00000000215","ENSBGRT00000000343",140831,"PLCL2","phospholipase C like 2 [Source:HGNC Symbol;Acc:HGNC:9064]","GO:0002322(B cell proliferation involved in immune response);GO:0002337(B-1a B cell differentiation);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0050859(negative regulation of B cell receptor signaling pathway);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","NA",{"v":1e-231,"d":"0.00"},2,"1045,126,","0,3677",-231,-229,7.84,"Exon (ENSBGRT00000000343/ENSBGRG00000000215, exon 3 of 7)",1,168298568,168542235,243668,1]
["chr1",168541845,168542235,391,"ENSBGRG00000000215","ENSBGRT00000000343",243277,"PLCL2","phospholipase C like 2 [Source:HGNC Symbol;Acc:HGNC:9064]","GO:0002322(B cell proliferation involved in immune response);GO:0002337(B-1a B cell differentiation);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0050859(negative regulation of B cell receptor signaling pathway);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","NA",{"v":9.99999999999998e-218,"d":"0.00"},1,"391,",0,-217,-215,4.45,"3' UTR",1,168298568,168542235,243668,1]
["chr1",171282255,171354074,71820,"ENSBGRG00000001743","ENSBGRT00000003223",245576,"KCNH8","potassium voltage-gated channel subfamily H member 8 [Source:HGNC Symbol;Acc:HGNC:18864]","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0016020(membrane);GO:0055085(transmembrane transport)","NA",0.02,3,"104,128,67,","0,66095,71753",-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000003223/ENSBGRG00000001743, exon 3 of 16)",1,171036679,171586895,550217,1]
["chr1",171996226,171999521,3296,"ENSBGRG00000001791","ENSBGRT00000003323",0,"RAB5A","RAB5A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9783]","GO:0001726(ruffle);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0010008(endosome membrane);GO:0015629(actin cytoskeleton);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0030139(endocytic vesicle);GO:0032009(early phagosome);GO:0036465(synaptic vesicle recycling);GO:0036477(somatodendritic compartment);GO:0039694(viral RNA genome replication);GO:0043195(terminal bouton);GO:0045022(early endosome to late endosome transport);GO:0045121(membrane raft);GO:0045335(phagocytic vesicle);GO:0045921(positive regulation of exocytosis);GO:0051036(regulation of endosome size);GO:0051489(regulation of filopodium assembly);GO:0098559(cytoplasmic side of early endosome membrane);GO:0150093(amyloid-beta clearance by transcytosis);GO:2000286(receptor internalization involved in canonical Wnt signaling pathway);GO:2000300(regulation of synaptic vesicle exocytosis)","04014(Ras signaling pathway);04144(Endocytosis);04145(Phagosome);04962(Vasopressin-regulated water reabsorption);05014(Amyotrophic lateral sclerosis (ALS));05152(Tuberculosis);05146(Amoebiasis)",{"v":4e-75,"d":"0.00"},2,"84,244,","0,3052",{"v":-74.4,"d":"-74.40"},-73,5.22,"5' UTR",1,171996226,172032562,36337,1]
["chr1",172032413,172032473,61,"ENSBGRG00000001791","ENSBGRT00000003323",36187,"RAB5A","RAB5A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9783]","GO:0001726(ruffle);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0010008(endosome membrane);GO:0015629(actin cytoskeleton);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0030139(endocytic vesicle);GO:0032009(early phagosome);GO:0036465(synaptic vesicle recycling);GO:0036477(somatodendritic compartment);GO:0039694(viral RNA genome replication);GO:0043195(terminal bouton);GO:0045022(early endosome to late endosome transport);GO:0045121(membrane raft);GO:0045335(phagocytic vesicle);GO:0045921(positive regulation of exocytosis);GO:0051036(regulation of endosome size);GO:0051489(regulation of filopodium assembly);GO:0098559(cytoplasmic side of early endosome membrane);GO:0150093(amyloid-beta clearance by transcytosis);GO:2000286(receptor internalization involved in canonical Wnt signaling pathway);GO:2000300(regulation of synaptic vesicle exocytosis)","04014(Ras signaling pathway);04144(Endocytosis);04145(Phagosome);04962(Vasopressin-regulated water reabsorption);05014(Amyotrophic lateral sclerosis (ALS));05152(Tuberculosis);05146(Amoebiasis)",{"v":0.0027,"d":"0.00"},1,"61,",0,-2.57,-2,1.44,"Exon (ENSBGRT00000003323/ENSBGRG00000001791, exon 7 of 7)",1,171996226,172032562,36337,1]
["chr1",172194743,172200571,5829,"ENSBGRG00000001845","ENSBGRT00000003653",112031,"KAT2B","lysine acetyltransferase 2B [Source:HGNC Symbol;Acc:HGNC:8638]","GO:0000123(histone acetyltransferase complex);GO:0000776(kinetochore);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003682(chromatin binding);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0004468(lysine N-acetyltransferase activity, acting on acetyl phosphate as donor);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0005813(centrosome);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-templated);GO:0006473(protein acetylation);GO:0008080(N-acetyltransferase activity);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0010835(regulation of protein ADP-ribosylation);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0018076(N-terminal peptidyl-lysine acetylation);GO:0018393(internal peptidyl-lysine acetylation);GO:0018394(peptidyl-lysine acetylation);GO:0019901(protein kinase binding);GO:0031672(A band);GO:0031674(I band);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0042641(actomyosin);GO:0042826(histone deacetylase binding);GO:0043966(histone H3 acetylation);GO:0043970(histone H3-K9 acetylation);GO:0045722(positive regulation of gluconeogenesis);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046600(negative regulation of centriole replication);GO:0061733(peptide-lysine-N-acetyltransferase activity);GO:2000233(negative regulation of rRNA processing)","04330(Notch signaling pathway);04919(Thyroid hormone signaling pathway);05203(Viral carcinogenesis);05166(HTLV-I infection)",{"v":1e-147,"d":"0.00"},3,"160,85,296,","0,1403,5533",-147,-145,3.77,"3' UTR",1,172082712,172194902,112191,1]
["chr1",172201834,172202781,948,"ENSBGRG00000001845","ENSBGRT00000003463",119122,"KAT2B","lysine acetyltransferase 2B [Source:HGNC Symbol;Acc:HGNC:8638]","GO:0000123(histone acetyltransferase complex);GO:0000776(kinetochore);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003682(chromatin binding);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0004468(lysine N-acetyltransferase activity, acting on acetyl phosphate as donor);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0005813(centrosome);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-templated);GO:0006473(protein acetylation);GO:0008080(N-acetyltransferase activity);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0010835(regulation of protein ADP-ribosylation);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0018076(N-terminal peptidyl-lysine acetylation);GO:0018393(internal peptidyl-lysine acetylation);GO:0018394(peptidyl-lysine acetylation);GO:0019901(protein kinase binding);GO:0031672(A band);GO:0031674(I band);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0042641(actomyosin);GO:0042826(histone deacetylase binding);GO:0043966(histone H3 acetylation);GO:0043970(histone H3-K9 acetylation);GO:0045722(positive regulation of gluconeogenesis);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046600(negative regulation of centriole replication);GO:0061733(peptide-lysine-N-acetyltransferase activity);GO:2000233(negative regulation of rRNA processing)","04330(Notch signaling pathway);04919(Thyroid hormone signaling pathway);05203(Viral carcinogenesis);05166(HTLV-I infection)",0,2,"396,55,","0,893",-379,"-Inf",5.42,"3' UTR",1,172082712,172202229,119518,1]
["chr1",7552912,7553117,206,"ENSBGRG00000000013","ENSBGRT00000000018",949,"ENSBGRG00000000013","NA","GO:0003755(peptidyl-prolyl cis-trans isomerase activity)","NA",{"v":0.00072,"d":"0.00"},1,"206,",0,-3.14,-2.54,1.98,"Exon (ENSBGRT00000000018/ENSBGRG00000000013, exon 2 of 2)",1,7552707,7554066,1360,2]
["chr1",11912833,11914915,2083,"ENSBGRG00000000017","ENSBGRT00000000026",203078,"ROBO2","roundabout guidance receptor 2 [Source:HGNC Symbol;Acc:HGNC:10250]","GO:0001657(ureteric bud development);GO:0005515(protein binding);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007420(brain development);GO:0009986(cell surface);GO:0032870(cellular response to hormone stimulus);GO:0042802(identical protein binding);GO:0050772(positive regulation of axonogenesis);GO:0050925(negative regulation of negative chemotaxis);GO:0061364(apoptotic process involved in luteolysis)","04360(Axon guidance)",{"v":7.9e-36,"d":"0.00"},2,"171,158,","0,1925",{"v":-35.1,"d":"-35.10"},-34,1.82,"3' UTR",1,11912833,12117993,205161,2]
["chr1",12556198,12631150,74953,"ENSBGRG00000000017","ENSBGRT00000000024",0,"ROBO2","roundabout guidance receptor 2 [Source:HGNC Symbol;Acc:HGNC:10250]","GO:0001657(ureteric bud development);GO:0005515(protein binding);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007420(brain development);GO:0009986(cell surface);GO:0032870(cellular response to hormone stimulus);GO:0042802(identical protein binding);GO:0050772(positive regulation of axonogenesis);GO:0050925(negative regulation of negative chemotaxis);GO:0061364(apoptotic process involved in luteolysis)","04360(Axon guidance)",{"v":2E-3,"d":"0.00"},2,"119,61,","0,74892",-2.69,-2.11,{"v":2.1,"d":"2.10"},"Exon (ENSBGRT00000000024/ENSBGRG00000000017, exon 1 of 27)",1,11912833,12631150,718318,2]
["chr1",14189068,14189393,326,"ENSBGRG00000000021","ENSBGRT00000000031",14571,"LIPI","lipase I [Source:HGNC Symbol;Acc:HGNC:18821]","GO:0004620(phospholipase activity);GO:0006629(lipid metabolic process);GO:0008201(heparin binding);GO:0016042(lipid catabolic process);GO:0052689(carboxylic ester hydrolase activity)","NA",{"v":2.8E-3,"d":"0.00"},1,"326,",0,-2.55,-1.98,8.91,"Exon (ENSBGRT00000000031/ENSBGRG00000000021, exon 2 of 10)",1,14126671,14203964,77294,2]
["chr1",14404460,14406279,1820,"ENSBGRG00000000025","ENSBGRT00000000038",8636,"HSPA13","heat shock protein family A (Hsp70) member 13 [Source:HGNC Symbol;Acc:HGNC:11375]","NA","NA",0,2,"764,121,","0,1699",-332,"-Inf",30,"3' UTR",1,14404460,14414915,10456,2]
["chr1",15063990,15065778,1789,"ENSBGRG00000000027","ENSBGRT00000000044",1490,"NRIP1","nuclear receptor interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:8001]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001543(ovarian follicle rupture);GO:0001650(fibrillar center);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005102(signaling receptor binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0016607(nuclear speck);GO:0019915(lipid storage);GO:0030331(estrogen receptor binding);GO:0030728(ovulation);GO:0032922(circadian regulation of gene expression);GO:0035257(nuclear hormone receptor binding);GO:0035259(glucocorticoid receptor binding);GO:0042826(histone deacetylase binding);GO:0042974(retinoic acid receptor binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046965(retinoid X receptor binding);GO:0071392(cellular response to estradiol stimulus)","NA",{"v":1E-187,"d":"0.00"},1,"1789,",0,-187,-185,{"v":10.6,"d":"10.60"},"Exon (ENSBGRT00000000044/ENSBGRG00000000027, exon 1 of 1)",1,15063990,15067268,3279,2]
["chr1",15066225,15067238,1014,"ENSBGRG00000000027","ENSBGRT00000000044",30,"NRIP1","nuclear receptor interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:8001]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001543(ovarian follicle rupture);GO:0001650(fibrillar center);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005102(signaling receptor binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0016607(nuclear speck);GO:0019915(lipid storage);GO:0030331(estrogen receptor binding);GO:0030728(ovulation);GO:0032922(circadian regulation of gene expression);GO:0035257(nuclear hormone receptor binding);GO:0035259(glucocorticoid receptor binding);GO:0042826(histone deacetylase binding);GO:0042974(retinoic acid receptor binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046965(retinoid X receptor binding);GO:0071392(cellular response to estradiol stimulus)","NA",{"v":4e-77,"d":"0.00"},1,"1014,",0,{"v":-76.4,"d":"-76.40"},-75,7.92,"Exon (ENSBGRT00000000044/ENSBGRG00000000027, exon 1 of 1)",1,15063990,15067268,3279,2]
["chr1",18279608,18309181,29574,"ENSBGRG00000000042","ENSBGRT00000000073",2862,"C21orf91","chromosome 21 open reading frame 91 [Source:HGNC Symbol;Acc:HGNC:16459]","GO:0021895(cerebral cortex neuron differentiation);GO:0060999(positive regulation of dendritic spine development)","NA",{"v":5e-44,"d":"0.00"},5,"134,2,63,537,36,","0,135,2193,4220,29538",{"v":-43.3,"d":"-43.30"},{"v":-42.2,"d":"-42.20"},5.85,"Exon (ENSBGRT00000000073/ENSBGRG00000000042, exon 2 of 5)",1,18279578,18312043,32466,2]
["chr1",18923555,18925190,1636,"ENSBGRG00000000044","ENSBGRT00000000077",102781,"TMPRSS15","transmembrane serine protease 15 [Source:HGNC Symbol;Acc:HGNC:9490]","GO:0004252(serine-type endopeptidase activity);GO:0005044(scavenger receptor activity);GO:0005515(protein binding);GO:0006508(proteolysis);GO:0016020(membrane)","NA",0.02,2,"77,13,","0,1623",{"v":-1.7,"d":"-1.70"},-1.19,6.93,"Exon (ENSBGRT00000000077/ENSBGRG00000000044, exon 17 of 25)",1,18871985,19027971,155987,2]
["chr1",26557557,26557806,250,"ENSBGRG00000000055","ENSBGRT00000000088",0,"ENSBGRG00000000055","NA","GO:0042254(ribosome biogenesis)","NA",{"v":0.0068,"d":"0.01"},2,"8,123,","0,127",-2.17,-1.62,5.94,"Exon (ENSBGRT00000000088/ENSBGRG00000000055, exon 1 of 2)",1,26557505,26557806,302,2]
["chr1",27353737,27353796,60,"ENSBGRG00000000058","ENSBGRT00000000092",15669,"MRPL39","mitochondrial ribosomal protein L39 [Source:HGNC Symbol;Acc:HGNC:14027]","GO:0000166(nucleotide binding);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit)","NA",{"v":0.0037,"d":"0.00"},1,"60,",0,-2.43,-1.87,1.31,"3' UTR",1,27342662,27369465,26804,2]
["chr1",27511939,27512722,784,"ENSBGRG00000000060","ENSBGRT00000000098",8591,"ENSBGRG00000000060","NA","GO:0000276(mitochondrial proton-transporting ATP synthase complex, coupling factor F(o));GO:0015078(proton transmembrane transporter activity);GO:0015986(ATP synthesis coupled proton transport)","00190(Oxidative phosphorylation);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)",{"v":0.0013,"d":"0.00"},2,"127,54,","0,730",{"v":-2.9,"d":"-2.90"},-2.31,1.82,"3' UTR",1,27511939,27521313,9375,2]
["chr1",27698287,27698496,210,"ENSBGRG00000000062","ENSBGRT00000000103",347382,"APP","amyloid beta precursor protein [Source:HGNC Symbol;Acc:HGNC:620]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001774(microglial cell activation);GO:0001934(positive regulation of protein phosphorylation);GO:0001967(suckling behavior);GO:0002265(astrocyte activation involved in immune response);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005102(signaling receptor binding);GO:0005615(extracellular space);GO:0005641(nuclear envelope lumen);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0005798(Golgi-associated vesicle);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006378(mRNA polyadenylation);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0006878(cellular copper ion homeostasis);GO:0006897(endocytosis);GO:0006979(response to oxidative stress);GO:0007176(regulation of epidermal growth factor-activated receptor activity);GO:0007399(nervous system development);GO:0007409(axonogenesis);GO:0007611(learning or memory);GO:0007612(learning);GO:0007617(mating behavior);GO:0007626(locomotory behavior);GO:0008021(synaptic vesicle);GO:0008088(axo-dendritic transport);GO:0008201(heparin binding);GO:0008203(cholesterol metabolic process);GO:0008285(negative regulation of cell population proliferation);GO:0008344(adult locomotory behavior);GO:0008542(visual learning);GO:0009986(cell surface);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010800(positive regulation of peptidyl-threonine phosphorylation);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0014005(microglia development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016199(axon midline choice point recognition);GO:0016322(neuron remodeling);GO:0016358(dendrite development);GO:0019899(enzyme binding);GO:0030134(COPII-coated ER to Golgi transport vesicle);GO:0030198(extracellular matrix organization);GO:0030424(axon);GO:0030546(signaling receptor activator activity);GO:0030900(forebrain development);GO:0031175(neuron projection development);GO:0031410(cytoplasmic vesicle);GO:0031594(neuromuscular junction);GO:0032092(positive regulation of protein binding);GO:0032640(tumor necrosis factor production);GO:0032731(positive regulation of interleukin-1 beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0035235(ionotropic glutamate receptor signaling pathway);GO:0035253(ciliary rootlet);GO:0040014(regulation of multicellular organism growth);GO:0042327(positive regulation of phosphorylation);GO:0042535(positive regulation of tumor necrosis factor biosynthetic process);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043197(dendritic spine);GO:0043198(dendritic shaft);GO:0043235(receptor complex);GO:0043393(regulation of protein binding);GO:0045080(positive regulation of chemokine biosynthetic process);GO:0045121(membrane raft);GO:0045177(apical part of cell);GO:0045202(synapse);GO:0045665(negative regulation of neuron differentiation);GO:0045821(positive regulation of glycolytic process);GO:0045931(positive regulation of mitotic cell cycle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046330(positive regulation of JNK cascade);GO:0046914(transition metal ion binding);GO:0048143(astrocyte activation);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048669(collateral sprouting in absence of injury);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:0050803(regulation of synapse structure or activity);GO:0050808(synapse organization);GO:0050885(neuromuscular process controlling balance);GO:0050890(cognition);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051124(synaptic growth at neuromuscular junction);GO:0051233(spindle midzone);GO:0051247(positive regulation of protein metabolic process);GO:0051402(neuron apoptotic process);GO:0051425(PTB domain binding);GO:0051563(smooth endoplasmic reticulum calcium ion homeostasis);GO:0055037(recycling endosome);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0090647(modulation of age-related behavioral decline);GO:0098815(modulation of excitatory postsynaptic potential);GO:0150003(regulation of spontaneous synaptic transmission);GO:1900272(negative regulation of long-term synaptic potentiation);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1902004(positive regulation of amyloid-beta formation);GO:1904646(cellular response to amyloid-beta);GO:1905606(regulation of presynapse assembly);GO:1905908(positive regulation of amyloid fibril formation);GO:1990000(amyloid fibril formation);GO:1990535(neuron projection maintenance);GO:2000406(positive regulation of T cell migration)","04726(Serotonergic synapse);05010(Alzheimer disease)",{"v":1e-163,"d":"0.00"},1,"210,",0,-163,-161,3.35,"3' UTR",1,27698287,28045878,347592,2]
["chr1",27857877,27900203,42327,"ENSBGRG00000000064","ENSBGRT00000000111",0,"ENSBGRG00000000064","NA","NA","NA",{"v":9.99999999999998e-226,"d":"0.00"},2,"144,66,","0,42261",-225,-223,1.58,"Exon (ENSBGRT00000000111/ENSBGRG00000000064, exon 1 of 1)",1,27860863,27861963,1101,1]
["chr1",28286617,28287154,538,"ENSBGRG00000000067","ENSBGRT00000000114",160209,"ENSBGRG00000000067","NA","NA","NA",{"v":6E-9,"d":"0.00"},1,"538,",0,-8.22,-7.46,{"v":29.7,"d":"29.70"},"3' UTR",1,28282365,28447363,164999,2]
["chr1",28287303,28287423,121,"ENSBGRG00000000067","ENSBGRT00000000114",159940,"ENSBGRG00000000067","NA","NA","NA",{"v":0.011,"d":"0.01"},1,"121,",0,-1.95,{"v":-1.4,"d":"-1.40"},8.91,"3' UTR",1,28282365,28447363,164999,2]
["chr1",28287631,28288096,466,"ENSBGRG00000000067","ENSBGRT00000000114",159267,"ENSBGRG00000000067","NA","NA","NA",{"v":0.012,"d":"0.01"},2,"230,40,","0,426",-1.93,{"v":-1.4,"d":"-1.40"},7.92,"3' UTR",1,28282365,28447363,164999,2]
["chr1",28288931,28289339,409,"ENSBGRG00000000067","ENSBGRT00000000114",158024,"ENSBGRG00000000067","NA","NA","NA",0.02,2,"212,117,","0,292",-1.69,{"v":-0.941,"d":"-0.94"},7.92,"3' UTR",1,28282365,28447363,164999,2]
["chr1",28754591,28755461,871,"ENSBGRG00000000068","ENSBGRT00000000120",7225,"ADAMTS1","ADAM metallopeptidase with thrombospondin type 1 motif 1 [Source:HGNC Symbol;Acc:HGNC:217]","GO:0001542(ovulation from ovarian follicle);GO:0001822(kidney development);GO:0004222(metalloendopeptidase activity);GO:0005604(basement membrane);GO:0006508(proteolysis);GO:0008201(heparin binding);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016525(negative regulation of angiogenesis);GO:0031012(extracellular matrix);GO:0031410(cytoplasmic vesicle);GO:0060347(heart trabecula formation);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration)","NA",0,1,"871,",0,-1270,"-Inf",5.44,"3' UTR",1,28754201,28762686,8486,2]
["chr1",28761756,28762686,931,"ENSBGRG00000000068","ENSBGRT00000000120",0,"ADAMTS1","ADAM metallopeptidase with thrombospondin type 1 motif 1 [Source:HGNC Symbol;Acc:HGNC:217]","GO:0001542(ovulation from ovarian follicle);GO:0001822(kidney development);GO:0004222(metalloendopeptidase activity);GO:0005604(basement membrane);GO:0006508(proteolysis);GO:0008201(heparin binding);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016525(negative regulation of angiogenesis);GO:0031012(extracellular matrix);GO:0031410(cytoplasmic vesicle);GO:0060347(heart trabecula formation);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration)","NA",{"v":1.3e-91,"d":"0.00"},1,"931,",0,{"v":-90.9,"d":"-90.90"},{"v":-89.4,"d":"-89.40"},3.64,"5' UTR",1,28754201,28762686,8486,2]
["chr1",28867875,28868621,747,"ENSBGRG00000000069","ENSBGRT00000000121",57389,"ADAMTS5","ADAM metallopeptidase with thrombospondin type 1 motif 5 [Source:HGNC Symbol;Acc:HGNC:221]","GO:0004222(metalloendopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008201(heparin binding);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0042742(defense response to bacterium);GO:0050840(extracellular matrix binding);GO:0062023(collagen-containing extracellular matrix);GO:0120163(negative regulation of cold-induced thermogenesis)","NA",{"v":5e-12,"d":"0.00"},1,"747,",0,{"v":-11.3,"d":"-11.30"},{"v":-10.5,"d":"-10.50"},7.26,"3' UTR",1,28866712,28926010,59299,2]
["chr1",28925069,28925519,451,"ENSBGRG00000000069","ENSBGRT00000000121",491,"ADAMTS5","ADAM metallopeptidase with thrombospondin type 1 motif 5 [Source:HGNC Symbol;Acc:HGNC:221]","GO:0004222(metalloendopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008201(heparin binding);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0042742(defense response to bacterium);GO:0050840(extracellular matrix binding);GO:0062023(collagen-containing extracellular matrix);GO:0120163(negative regulation of cold-induced thermogenesis)","NA",{"v":0.0013,"d":"0.00"},2,"380,39,","0,412",{"v":-2.9,"d":"-2.90"},-2.31,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000000121/ENSBGRG00000000069, exon 2 of 10)",1,28866712,28926010,59299,2]
["chr1",31363479,31363778,300,"ENSBGRG00000000075","ENSBGRT00000000131",25625,"LTN1","listerin E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:13082]","GO:0004842(ubiquitin-protein transferase activity);GO:0008270(zinc ion binding);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:1990112(RQC complex);GO:1990116(ribosome-associated ubiquitin-dependent protein catabolic process)","00260(Glycine, serine and threonine metabolism);00270(Cysteine and methionine metabolism);00450(Selenocompound metabolism)",{"v":1.4E-8,"d":"0.00"},1,"300,",0,-7.85,{"v":-7.1,"d":"-7.10"},7.13,"Exon (ENSBGRT00000000131/ENSBGRG00000000075, exon 10 of 30)",1,31319321,31389403,70083,2]
["chr1",31403553,31405901,2349,"ENSBGRG00000000076","ENSBGRT00000000133",9213,"RWDD2B","RWD domain containing 2B [Source:HGNC Symbol;Acc:HGNC:1302]","GO:0005515(protein binding)","NA",{"v":6.3e-31,"d":"0.00"},2,"267,173,","0,2176",{"v":-30.2,"d":"-30.20"},{"v":-29.2,"d":"-29.20"},{"v":3.2,"d":"3.20"},"3' UTR",1,31403553,31415114,11562,2]
["chr1",32083417,32084873,1457,"ENSBGRG00000000082","ENSBGRT00000000145",164513,"GRIK1","glutamate ionotropic receptor kainate type subunit 1 [Source:HGNC Symbol;Acc:HGNC:4579]","GO:0004970(ionotropic glutamate receptor activity);GO:0005216(ion channel activity);GO:0006811(ion transport);GO:0015276(ligand-gated ion channel activity);GO:0016020(membrane);GO:0038023(signaling receptor activity)","04080(Neuroactive ligand-receptor interaction);04724(Glutamatergic synapse)",{"v":0.011,"d":"0.01"},2,"111,39,","0,1418",-1.95,-1.18,8.91,"Exon (ENSBGRT00000000145/ENSBGRG00000000082, exon 14 of 16)",1,32063270,32249386,186117,2]
["chr1",34418281,34418401,121,"ENSBGRG00000000112","ENSBGRT00000000179",54727,"TIAM1","TIAM Rac1 associated GEF 1 [Source:HGNC Symbol;Acc:HGNC:11805]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007160(cell-matrix adhesion);GO:0007165(signal transduction);GO:0008284(positive regulation of cell population proliferation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0016477(cell migration);GO:0016601(Rac protein signal transduction);GO:0019900(kinase binding);GO:0030335(positive regulation of cell migration);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032092(positive regulation of protein binding);GO:0034622(cellular protein-containing complex assembly);GO:0035556(intracellular signal transduction);GO:0044291(cell-cell contact zone);GO:0090630(activation of GTPase activity)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04530(Tight junction);04810(Regulation of actin cytoskeleton);04062(Chemokine signaling pathway);05205(Proteoglycans in cancer)",{"v":1.2E-4,"d":"0.00"},1,"121,",0,-3.92,-3.28,2.58,"Exon (ENSBGRT00000000179/ENSBGRG00000000112, exon 13 of 14)",1,34418102,34473128,55027,2]
["chr1",34598549,34599087,539,"ENSBGRG00000000112","ENSBGRT00000000180",20775,"TIAM1","TIAM Rac1 associated GEF 1 [Source:HGNC Symbol;Acc:HGNC:11805]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007160(cell-matrix adhesion);GO:0007165(signal transduction);GO:0008284(positive regulation of cell population proliferation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0016477(cell migration);GO:0016601(Rac protein signal transduction);GO:0019900(kinase binding);GO:0030335(positive regulation of cell migration);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032092(positive regulation of protein binding);GO:0034622(cellular protein-containing complex assembly);GO:0035556(intracellular signal transduction);GO:0044291(cell-cell contact zone);GO:0090630(activation of GTPase activity)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04530(Tight junction);04810(Regulation of actin cytoskeleton);04062(Chemokine signaling pathway);05205(Proteoglycans in cancer)",{"v":7.2e-06,"d":"0.00"},1,"539,",0,-5.14,-4.45,{"v":16.8,"d":"16.80"},"Exon (ENSBGRT00000000180/ENSBGRG00000000112, exon 3 of 27)",1,34418116,34619862,201747,2]
["chr1",34611492,34619653,8162,"ENSBGRG00000000112","ENSBGRT00000000180",209,"TIAM1","TIAM Rac1 associated GEF 1 [Source:HGNC Symbol;Acc:HGNC:11805]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007160(cell-matrix adhesion);GO:0007165(signal transduction);GO:0008284(positive regulation of cell population proliferation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0016477(cell migration);GO:0016601(Rac protein signal transduction);GO:0019900(kinase binding);GO:0030335(positive regulation of cell migration);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032092(positive regulation of protein binding);GO:0034622(cellular protein-containing complex assembly);GO:0035556(intracellular signal transduction);GO:0044291(cell-cell contact zone);GO:0090630(activation of GTPase activity)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04530(Tight junction);04810(Regulation of actin cytoskeleton);04062(Chemokine signaling pathway);05205(Proteoglycans in cancer)",{"v":0.00098,"d":"0.00"},2,"88,92,","0,8070",-3.01,-2.42,{"v":12.9,"d":"12.90"},"5' UTR",1,34418116,34619862,201747,2]
["chr1",35101017,35101739,723,"ENSBGRG00000000118","ENSBGRT00000000187",65393,"SCAF4","SR-related CTD associated factor 4 [Source:HGNC Symbol;Acc:HGNC:19304]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:1990269(RNA polymerase II C-terminal domain phosphoserine binding);GO:2000805(negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled)","NA",{"v":9.99999999999999e-237,"d":"0.00"},2,"3,717,","0,6",-236,-234,5.26,"Exon (ENSBGRT00000000187/ENSBGRG00000000118, exon 20 of 21)",1,35101017,35167132,66116,2]
["chr1",35783651,35800928,17278,"ENSBGRG00000000120","ENSBGRT00000000190",263,"MIS18A","MIS18 kinetochore protein A [Source:HGNC Symbol;Acc:HGNC:1286]","GO:0000775(chromosome, centromeric region);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0007059(chromosome segregation);GO:0034080(CENP-A containing nucleosome assembly);GO:0042802(identical protein binding);GO:0044030(regulation of DNA methylation)","NA",{"v":1.6e-05,"d":"0.00"},4,"3,123,67,304,","0,3988,10936,16974",{"v":-4.8,"d":"-4.80"},-4.13,3.33,"Exon (ENSBGRT00000000190/ENSBGRG00000000120, exon 1 of 5)",1,35781819,35801191,19373,2]
["chr1",35837881,35838210,330,"ENSBGRG00000000122","ENSBGRT00000000196",84401,"URB1","URB1 ribosome biogenesis homolog [Source:HGNC Symbol;Acc:HGNC:17344]","GO:0001650(fibrillar center);GO:0005730(nucleolus)","NA",{"v":0.0022,"d":"0.00"},1,"330,",0,-2.65,-2.08,6.93,"Exon (ENSBGRT00000000196/ENSBGRG00000000122, exon 35 of 36)",1,35836490,35922611,86122,2]
["chr1",36123216,36135586,12371,"ENSBGRG00000000124","ENSBGRT00000000203",58,"ENSBGRG00000000124","cilia and flagella associated protein 298 [Source:HGNC Symbol;Acc:HGNC:1301]","GO:0003352(regulation of cilium movement)","NA",{"v":3.2e-80,"d":"0.00"},9,"161,96,33,33,138,159,68,168,264,","0,450,1994,2029,2064,3509,7897,9663,12107",{"v":-79.5,"d":"-79.50"},{"v":-78.1,"d":"-78.10"},2.49,"5' UTR",1,36123216,36135644,12429,2]
["chr1",36144896,36145195,300,"ENSBGRG00000000125","ENSBGRT00000000209",81551,"SYNJ1","synaptojanin 1 [Source:HGNC Symbol;Acc:HGNC:11503]","GO:0003676(nucleic acid binding);GO:0034595(phosphatidylinositol phosphate 5-phosphatase activity);GO:0042578(phosphoric ester hydrolase activity);GO:0046856(phosphatidylinositol dephosphorylation);GO:0048488(synaptic vesicle endocytosis)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":1.3E-23,"d":"0.00"},1,"300,",0,{"v":-22.9,"d":"-22.90"},{"v":-21.9,"d":"-21.90"},6.48,"Exon (ENSBGRT00000000209/ENSBGRG00000000125, exon 27 of 27)",1,36144896,36226746,81851,2]
["chr1",36145284,36145404,121,"ENSBGRG00000000125","ENSBGRT00000000209",81342,"SYNJ1","synaptojanin 1 [Source:HGNC Symbol;Acc:HGNC:11503]","GO:0003676(nucleic acid binding);GO:0034595(phosphatidylinositol phosphate 5-phosphatase activity);GO:0042578(phosphoric ester hydrolase activity);GO:0046856(phosphatidylinositol dephosphorylation);GO:0048488(synaptic vesicle endocytosis)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":1.8e-08,"d":"0.00"},1,"121,",0,-7.75,-7,3.17,"Exon (ENSBGRT00000000209/ENSBGRG00000000125, exon 27 of 27)",1,36144896,36226746,81851,2]
["chr1",36290539,36290598,60,"ENSBGRG00000000127","ENSBGRT00000000213",0,"PAXBP1","PAX3 and PAX7 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:13579]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0014842(regulation of skeletal muscle satellite cell proliferation);GO:0031062(positive regulation of histone methylation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2000288(positive regulation of myoblast proliferation)","NA",{"v":0.049,"d":"0.05"},1,"60,",0,-1.31,{"v":-0.831,"d":"-0.83"},2.26,"Exon (ENSBGRT00000000213/ENSBGRG00000000127, exon 1 of 18)",1,36258968,36290598,31631,2]
["chr1",37145166,37146308,1143,"ENSBGRG00000000137","ENSBGRT00000000227",0,"DNAJC28","DnaJ heat shock protein family (Hsp40) member C28 [Source:HGNC Symbol;Acc:HGNC:1297]","NA","NA",{"v":7.9e-29,"d":"0.00"},1,"1143,",0,{"v":-28.1,"d":"-28.10"},{"v":-27.1,"d":"-27.10"},6.93,"Exon (ENSBGRT00000000227/ENSBGRG00000000137, exon 1 of 1)",1,37145166,37146308,1143,2]
["chr1",37168370,37168661,292,"ENSBGRG00000000138","ENSBGRT00000000228",27364,"GART","phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase [Source:HGNC Symbol;Acc:HGNC:4163]","GO:0004637(phosphoribosylamine-glycine ligase activity);GO:0004641(phosphoribosylformylglycinamidine cyclo-ligase activity);GO:0004644(phosphoribosylglycinamide formyltransferase activity);GO:0005524(ATP binding);GO:0006189('de novo' IMP biosynthetic process);GO:0009058(biosynthetic process);GO:0009113(purine nucleobase biosynthetic process);GO:0016742(hydroxymethyl-, formyl- and related transferase activity);GO:0046872(metal ion binding)","00230(Purine metabolism);00670(One carbon pool by folate);01523(Antifolate resistance)",{"v":2e-18,"d":"0.00"},2,"162,48,","0,244",{"v":-17.7,"d":"-17.70"},{"v":-16.8,"d":"-16.80"},{"v":2.1,"d":"2.10"},"Exon (ENSBGRT00000000228/ENSBGRG00000000138, exon 21 of 22)",1,37168340,37196025,27686,2]
["chr1",37184110,37190824,6715,"ENSBGRG00000000138","ENSBGRT00000000228",5201,"GART","phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase [Source:HGNC Symbol;Acc:HGNC:4163]","GO:0004637(phosphoribosylamine-glycine ligase activity);GO:0004641(phosphoribosylformylglycinamidine cyclo-ligase activity);GO:0004644(phosphoribosylglycinamide formyltransferase activity);GO:0005524(ATP binding);GO:0006189('de novo' IMP biosynthetic process);GO:0009058(biosynthetic process);GO:0009113(purine nucleobase biosynthetic process);GO:0016742(hydroxymethyl-, formyl- and related transferase activity);GO:0046872(metal ion binding)","00230(Purine metabolism);00670(One carbon pool by folate);01523(Antifolate resistance)",{"v":2E-14,"d":"0.00"},5,"13,126,69,112,9,","0,1089,1719,2757,6706",{"v":-13.7,"d":"-13.70"},{"v":-12.8,"d":"-12.80"},2.28,"Exon (ENSBGRT00000000228/ENSBGRG00000000138, exon 4 of 22)",1,37168340,37196025,27686,2]
["chr1",37231775,37233016,1242,"ENSBGRG00000000141","ENSBGRT00000000234",9858,"DONSON","downstream neighbor of SON [Source:HGNC Symbol;Acc:HGNC:2993]","GO:0000077(DNA damage checkpoint);GO:0005634(nucleus);GO:0005657(replication fork);GO:0006260(DNA replication);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0030894(replisome);GO:0048478(replication fork protection)","NA",{"v":5.4E-8,"d":"0.00"},2,"199,130,","0,1112",-7.27,-6.53,1.65,"3' UTR",1,37231178,37242874,11697,2]
["chr1",37241680,37242068,389,"ENSBGRG00000000141","ENSBGRT00000000234",806,"DONSON","downstream neighbor of SON [Source:HGNC Symbol;Acc:HGNC:2993]","GO:0000077(DNA damage checkpoint);GO:0005634(nucleus);GO:0005657(replication fork);GO:0006260(DNA replication);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0030894(replisome);GO:0048478(replication fork protection)","NA",{"v":6.9e-07,"d":"0.00"},1,"389,",0,-6.16,-5.45,9.91,"5' UTR",1,37231178,37242874,11697,2]
["chr1",37242187,37242874,688,"ENSBGRG00000000141","ENSBGRT00000000234",0,"DONSON","downstream neighbor of SON [Source:HGNC Symbol;Acc:HGNC:2993]","GO:0000077(DNA damage checkpoint);GO:0005634(nucleus);GO:0005657(replication fork);GO:0006260(DNA replication);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0030894(replisome);GO:0048478(replication fork protection)","NA",{"v":1e-104,"d":"0.00"},1,"688,",0,-104,-103,4.72,"5' UTR",1,37231178,37242874,11697,2]
["chr1",38225926,38226370,445,"ENSBGRG00000000151","ENSBGRT00000000254",6033,"ENSBGRG00000000151","NA","NA","NA",0.02,1,"445,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"3' UTR",1,38225837,38232403,6567,2]
["chr1",38226518,38226873,356,"ENSBGRG00000000151","ENSBGRT00000000254",5530,"ENSBGRG00000000151","NA","NA","NA",{"v":0.011,"d":"0.01"},1,"356,",0,-1.95,-1.18,8.91,"3' UTR",1,38225837,38232403,6567,2]
["chr1",38262094,38262486,393,"ENSBGRG00000000153","ENSBGRT00000000256",0,"ENSBGRG00000000153","NA","GO:0002070(epithelial cell maturation);GO:0005249(voltage-gated potassium channel activity);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0015459(potassium channel regulator activity);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0060047(heart contraction);GO:0086091(regulation of heart rate by cardiac conduction)","04261(Adrenergic signaling in cardiomyocytes)",{"v":3.2e-19,"d":"0.00"},1,"393,",0,{"v":-18.5,"d":"-18.50"},{"v":-17.6,"d":"-17.60"},7.92,"Exon (ENSBGRT00000000256/ENSBGRG00000000153, exon 1 of 1)",1,38262094,38262486,393,2]
["chr1",38315662,38315898,237,"ENSBGRG00000000154","ENSBGRT00000000259",11303,"RCAN1","regulator of calcineurin 1 [Source:HGNC Symbol;Acc:HGNC:3040]","GO:0002931(response to ischemia);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006979(response to oxidative stress);GO:0007614(short-term memory);GO:0019722(calcium-mediated signaling);GO:0031987(locomotion involved in locomotory behavior);GO:0033173(calcineurin-NFAT signaling cascade);GO:0043666(regulation of phosphoprotein phosphatase activity);GO:0048741(skeletal muscle fiber development)","04921(Oxytocin signaling pathway);04919(Thyroid hormone signaling pathway);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":1.3E-39,"d":"0.00"},1,"237,",0,{"v":-38.9,"d":"-38.90"},{"v":-37.8,"d":"-37.80"},3.74,"3' UTR",1,38314924,38327201,12278,2]
["chr1",38729830,38730308,479,"ENSBGRG00000000164","ENSBGRT00000000269",95679,"CGGBP1","CGG triplet repeat binding protein 1 [Source:HGNC Symbol;Acc:HGNC:1888]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0042802(identical protein binding);GO:0090579(dsDNA loop formation);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1e-192,"d":"0.00"},1,"479,",0,-192,-190,{"v":4.6,"d":"4.60"},"Exon (ENSBGRT00000000269/ENSBGRG00000000164, exon 4 of 4)",1,38729830,38825987,96158,2]
["chr1",45362625,45365584,2960,"ENSBGRG00000000874","ENSBGRT00000001593",137486,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":5e-32,"d":"0.00"},2,"237,271,","0,2689",{"v":-31.3,"d":"-31.30"},{"v":-30.2,"d":"-30.20"},{"v":2.8,"d":"2.80"},"3' UTR",1,45225139,45364143,139005,1]
["chr1",45390072,45400991,10920,"ENSBGRG00000000955","ENSBGRT00000001762",0,"RIOX2","ribosomal oxygenase 2 [Source:HGNC Symbol;Acc:HGNC:19441]","GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0042802(identical protein binding)","NA",{"v":4e-17,"d":"0.00"},3,"7,469,2,","0,6385,10918",{"v":-16.4,"d":"-16.40"},{"v":-15.5,"d":"-15.50"},3.03,"5' UTR",1,45361838,45400991,39154,2]
["chr1",46067984,46068133,150,"ENSBGRG00000002153","ENSBGRT00000004039",59,"CLDND1","claudin domain containing 1 [Source:HGNC Symbol;Acc:HGNC:1322]","GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane)","NA",{"v":4.3e-05,"d":"0.00"},1,"150,",0,-4.37,-3.71,2.97,"Exon (ENSBGRT00000004039/ENSBGRG00000002153, exon 1 of 6)",1,46060763,46068192,7430,2]
["chr1",46143851,46144327,477,"ENSBGRG00000002215","ENSBGRT00000004158",0,"ENSBGRG00000002215","coproporphyrinogen oxidase [Source:HGNC Symbol;Acc:HGNC:2321]","GO:0004109(coproporphyrinogen oxidase activity);GO:0005212(structural constituent of eye lens);GO:0005739(mitochondrion);GO:0006779(porphyrin-containing compound biosynthetic process);GO:0006783(heme biosynthetic process);GO:0016020(membrane);GO:0055114(oxidation-reduction process)","00860(Porphyrin and chlorophyll metabolism)",{"v":4.4e-07,"d":"0.00"},1,"477,",0,-6.36,-5.64,4.95,"Exon (ENSBGRT00000004158/ENSBGRG00000002215, exon 1 of 7)",1,46129945,46144327,14383,2]
["chr1",46381779,46382226,448,"ENSBGRG00000002387","ENSBGRT00000004632",87022,"DCBLD2","discoidin, CUB and LCCL domain containing 2 [Source:HGNC Symbol;Acc:HGNC:24627]","GO:0005887(integral component of plasma membrane);GO:0009986(cell surface);GO:0030308(negative regulation of cell growth);GO:0042060(wound healing)","NA",{"v":1.6e-37,"d":"0.00"},1,"448,",0,{"v":-36.8,"d":"-36.80"},{"v":-35.7,"d":"-35.70"},4.04,"3' UTR",1,46380795,46469248,88454,2]
["chr1",47469769,47481339,11571,"ENSBGRG00000002590","ENSBGRT00000004850",112005,"FILIP1L","filamin A interacting protein 1 like [Source:HGNC Symbol;Acc:HGNC:24589]","NA","NA",{"v":0.011,"d":"0.01"},2,"73,108,","0,11463",-1.95,-1.42,6.93,"3' UTR",1,47458229,47593344,135116,2]
["chr1",47488219,47488639,421,"ENSBGRG00000002590","ENSBGRT00000004850",104705,"FILIP1L","filamin A interacting protein 1 like [Source:HGNC Symbol;Acc:HGNC:24589]","NA","NA",{"v":1e-17,"d":"0.00"},1,"421,",0,-17,{"v":-16.1,"d":"-16.10"},4.95,"Exon (ENSBGRT00000004850/ENSBGRG00000002590, exon 5 of 7)",1,47458229,47593344,135116,2]
["chr1",47489149,47489209,61,"ENSBGRG00000002590","ENSBGRT00000004850",104135,"FILIP1L","filamin A interacting protein 1 like [Source:HGNC Symbol;Acc:HGNC:24589]","NA","NA",{"v":1e-11,"d":"0.00"},1,"61,",0,-11,{"v":-10.2,"d":"-10.20"},1.44,"Exon (ENSBGRT00000004850/ENSBGRG00000002590, exon 5 of 7)",1,47458229,47593344,135116,2]
["chr1",47489509,47581733,92225,"ENSBGRG00000002590","ENSBGRT00000004850",11611,"FILIP1L","filamin A interacting protein 1 like [Source:HGNC Symbol;Acc:HGNC:24589]","NA","NA",{"v":9.99999999999999e-227,"d":"0.00"},3,"1047,437,46,","0,1505,92179",-226,-224,6.37,"Exon (ENSBGRT00000004850/ENSBGRG00000002590, exon 3 of 7)",1,47458229,47593344,135116,2]
["chr1",48088685,48089014,330,"ENSBGRG00000002944","ENSBGRT00000005529",38049,"TOMM70","translocase of outer mitochondrial membrane 70 [Source:HGNC Symbol;Acc:HGNC:11985]","GO:0005515(protein binding);GO:0005739(mitochondrion)","NA",{"v":3.2e-20,"d":"0.00"},1,"330,",0,{"v":-19.5,"d":"-19.50"},{"v":-18.6,"d":"-18.60"},2.09,"3' UTR",1,48088685,48127063,38379,2]
["chr1",48126913,48127063,151,"ENSBGRG00000002944","ENSBGRT00000005529",0,"TOMM70","translocase of outer mitochondrial membrane 70 [Source:HGNC Symbol;Acc:HGNC:11985]","GO:0005515(protein binding);GO:0005739(mitochondrion)","NA",{"v":7.9e-15,"d":"0.00"},1,"151,",0,{"v":-14.1,"d":"-14.10"},{"v":-13.3,"d":"-13.30"},3.28,"Exon (ENSBGRT00000005529/ENSBGRG00000002944, exon 1 of 12)",1,48088685,48127063,38379,2]
["chr1",49292342,49295215,2874,"ENSBGRG00000003382","ENSBGRT00000006328",86428,"IMPG2","interphotoreceptor matrix proteoglycan 2 [Source:HGNC Symbol;Acc:HGNC:18362]","GO:0005201(extracellular matrix structural constituent);GO:0005540(hyaluronic acid binding);GO:0007601(visual perception);GO:0008201(heparin binding);GO:0033165(interphotoreceptor matrix);GO:0043235(receptor complex)","NA",{"v":0.011,"d":"0.01"},2,"13,48,","0,2826",-1.95,-1.42,4.95,"Exon (ENSBGRT00000006328/ENSBGRG00000003382, exon 19 of 20)",1,49292342,49381643,89302,2]
["chr1",49314368,49314488,121,"ENSBGRG00000003382","ENSBGRT00000006328",67155,"IMPG2","interphotoreceptor matrix proteoglycan 2 [Source:HGNC Symbol;Acc:HGNC:18362]","GO:0005201(extracellular matrix structural constituent);GO:0005540(hyaluronic acid binding);GO:0007601(visual perception);GO:0008201(heparin binding);GO:0033165(interphotoreceptor matrix);GO:0043235(receptor complex)","NA",{"v":0.0013,"d":"0.00"},1,"121,",0,{"v":-2.9,"d":"-2.90"},-2.31,{"v":3.8,"d":"3.80"},"Exon (ENSBGRT00000006328/ENSBGRG00000003382, exon 14 of 20)",1,49292342,49381643,89302,2]
["chr1",49314547,49314786,240,"ENSBGRG00000003382","ENSBGRT00000006328",66857,"IMPG2","interphotoreceptor matrix proteoglycan 2 [Source:HGNC Symbol;Acc:HGNC:18362]","GO:0005201(extracellular matrix structural constituent);GO:0005540(hyaluronic acid binding);GO:0007601(visual perception);GO:0008201(heparin binding);GO:0033165(interphotoreceptor matrix);GO:0043235(receptor complex)","NA",{"v":1.4E-5,"d":"0.00"},1,"240,",0,-4.84,-4.17,4.81,"Exon (ENSBGRT00000006328/ENSBGRG00000003382, exon 14 of 20)",1,49292342,49381643,89302,2]
["chr1",49314995,49315144,150,"ENSBGRG00000003382","ENSBGRT00000006328",66499,"IMPG2","interphotoreceptor matrix proteoglycan 2 [Source:HGNC Symbol;Acc:HGNC:18362]","GO:0005201(extracellular matrix structural constituent);GO:0005540(hyaluronic acid binding);GO:0007601(visual perception);GO:0008201(heparin binding);GO:0033165(interphotoreceptor matrix);GO:0043235(receptor complex)","NA",{"v":0.00087,"d":"0.00"},1,"150,",0,-3.06,-2.46,{"v":2.2,"d":"2.20"},"Exon (ENSBGRT00000006328/ENSBGRG00000003382, exon 14 of 20)",1,49292342,49381643,89302,2]
["chr1",49502116,49543327,41212,"ENSBGRG00000003455","ENSBGRT00000006822",0,"SENP7","SUMO specific peptidase 7 [Source:HGNC Symbol;Acc:HGNC:30402]","GO:0005634(nucleus);GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity)","NA",{"v":5.9e-06,"d":"0.00"},4,"4,96,53,86,","0,10729,16458,41126",-5.23,-4.54,3.07,"5' UTR",1,49384551,49512931,128381,2]
["chr1",49611692,49612844,1153,"ENSBGRG00000003762","ENSBGRT00000006964",29193,"ZBTB11","zinc finger and BTB domain containing 11 [Source:HGNC Symbol;Acc:HGNC:16740]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm)","NA",{"v":1E-125,"d":"0.00"},2,"518,49,","0,1104",-125,-123,6.29,"Exon (ENSBGRT00000006964/ENSBGRG00000003762, exon 10 of 11)",1,49611692,49642037,30346,2]
["chr1",49621321,49629717,8397,"ENSBGRG00000003762","ENSBGRT00000006964",12320,"ZBTB11","zinc finger and BTB domain containing 11 [Source:HGNC Symbol;Acc:HGNC:16740]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm)","NA",{"v":2.5e-44,"d":"0.00"},3,"172,839,63,","0,376,8334",{"v":-43.6,"d":"-43.60"},{"v":-42.5,"d":"-42.50"},5.94,"Exon (ENSBGRT00000006964/ENSBGRG00000003762, exon 3 of 11)",1,49611692,49642037,30346,2]
["chr1",49630859,49642037,11179,"ENSBGRG00000003762","ENSBGRT00000006964",0,"ZBTB11","zinc finger and BTB domain containing 11 [Source:HGNC Symbol;Acc:HGNC:16740]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm)","NA",{"v":8.5e-06,"d":"0.00"},2,"78,310,","0,10869",-5.07,-4.39,2.97,"Exon (ENSBGRT00000006964/ENSBGRG00000003762, exon 1 of 11)",1,49611692,49642037,30346,2]
["chr1",49646404,49647147,744,"ENSBGRG00000003803","ENSBGRT00000007147",7841,"RPL24","ribosomal protein L24 [Source:HGNC Symbol;Acc:HGNC:10325]","GO:0000027(ribosomal large subunit assembly);GO:0002181(cytoplasmic translation);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006412(translation);GO:0007093(mitotic cell cycle checkpoint);GO:0010458(exit from mitosis);GO:0021554(optic nerve development);GO:0022625(cytosolic large ribosomal subunit);GO:0031290(retinal ganglion cell axon guidance);GO:0042788(polysomal ribosome);GO:0060041(retina development in camera-type eye)","03010(Ribosome)",{"v":5e-13,"d":"0.00"},3,"81,10,56,","0,677,688",{"v":-12.3,"d":"-12.30"},{"v":-11.5,"d":"-11.50"},1.74,"Exon (ENSBGRT00000007147/ENSBGRG00000003803, exon 5 of 6)",1,49646404,49654988,8585,2]
["chr1",49649422,49654988,5567,"ENSBGRG00000003803","ENSBGRT00000007147",0,"RPL24","ribosomal protein L24 [Source:HGNC Symbol;Acc:HGNC:10325]","GO:0000027(ribosomal large subunit assembly);GO:0002181(cytoplasmic translation);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006412(translation);GO:0007093(mitotic cell cycle checkpoint);GO:0010458(exit from mitosis);GO:0021554(optic nerve development);GO:0022625(cytosolic large ribosomal subunit);GO:0031290(retinal ganglion cell axon guidance);GO:0042788(polysomal ribosome);GO:0060041(retina development in camera-type eye)","03010(Ribosome)",{"v":7.9e-79,"d":"0.00"},4,"43,111,76,5,","0,4730,5355,5562",{"v":-78.1,"d":"-78.10"},{"v":-76.7,"d":"-76.70"},2.65,"Exon (ENSBGRT00000007147/ENSBGRG00000003803, exon 1 of 6)",1,49646404,49654988,8585,2]
["chr1",54264345,54277254,12910,"ENSBGRG00000004626","ENSBGRT00000008595",228549,"CBLB","Cbl proto-oncogene B [Source:HGNC Symbol;Acc:HGNC:1542]","GO:0001784(phosphotyrosine residue binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005509(calcium ion binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0007166(cell surface receptor signaling pathway);GO:0023051(regulation of signaling)","04120(Ubiquitin mediated proteolysis);04012(ErbB signaling pathway);04144(Endocytosis);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04910(Insulin signaling pathway);05162(Measles)",{"v":1E-107,"d":"0.00"},2,"510,61,","0,12849",-107,-106,7.53,"3' UTR",1,54263595,54505803,242209,2]
["chr1",57134045,57139624,5580,"ENSBGRG00000005675","ENSBGRT00000010496",71540,"IFT57","intraflagellar transport 57 [Source:HGNC Symbol;Acc:HGNC:17367]","GO:0001843(neural tube closure);GO:0001947(heart looping);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005929(cilium);GO:0005930(axoneme);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0007224(smoothened signaling pathway);GO:0030992(intraciliary transport particle B);GO:0032391(photoreceptor connecting cilium);GO:0036064(ciliary basal body);GO:0042981(regulation of apoptotic process);GO:0044292(dendrite terminus);GO:0044458(motile cilium assembly);GO:0050680(negative regulation of epithelial cell proliferation);GO:0060972(left/right pattern formation);GO:1905515(non-motile cilium assembly)","05016(Huntington disease)",{"v":4e-98,"d":"0.00"},4,"209,67,63,110,","0,1256,4093,5470",{"v":-97.4,"d":"-97.40"},{"v":-95.8,"d":"-95.80"},2.72,"3' UTR",1,57133866,57211164,77299,2]
["chr1",57210537,57210657,121,"ENSBGRG00000005675","ENSBGRT00000010496",507,"IFT57","intraflagellar transport 57 [Source:HGNC Symbol;Acc:HGNC:17367]","GO:0001843(neural tube closure);GO:0001947(heart looping);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005929(cilium);GO:0005930(axoneme);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0007224(smoothened signaling pathway);GO:0030992(intraciliary transport particle B);GO:0032391(photoreceptor connecting cilium);GO:0036064(ciliary basal body);GO:0042981(regulation of apoptotic process);GO:0044292(dendrite terminus);GO:0044458(motile cilium assembly);GO:0050680(negative regulation of epithelial cell proliferation);GO:0060972(left/right pattern formation);GO:1905515(non-motile cilium assembly)","05016(Huntington disease)",{"v":5.8e-06,"d":"0.00"},1,"121,",0,-5.24,-4.55,{"v":2.1,"d":"2.10"},"5' UTR",1,57133866,57211164,77299,2]
["chr1",57588184,57591882,3699,"ENSBGRG00000005873","ENSBGRT00000011198",25523,"CIP2A","cell proliferation regulating inhibitor of protein phosphatase 2A [Source:HGNC Symbol;Acc:HGNC:29302]","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007283(spermatogenesis);GO:0042803(protein homodimerization activity);GO:2000179(positive regulation of neural precursor cell proliferation)","NA",{"v":7.9e-16,"d":"0.00"},4,"103,83,114,57,","0,1054,1377,3642",{"v":-15.1,"d":"-15.10"},{"v":-14.2,"d":"-14.20"},3.06,"Exon (ENSBGRT00000011198/ENSBGRG00000005873, exon 17 of 21)",1,57586764,57617405,30642,2]
["chr1",57591942,57594517,2576,"ENSBGRG00000005873","ENSBGRT00000011198",22888,"CIP2A","cell proliferation regulating inhibitor of protein phosphatase 2A [Source:HGNC Symbol;Acc:HGNC:29302]","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007283(spermatogenesis);GO:0042803(protein homodimerization activity);GO:2000179(positive regulation of neural precursor cell proliferation)","NA",{"v":0.015,"d":"0.02"},2,"81,38,","0,2538",-1.81,-1.29,4.95,"Exon (ENSBGRT00000011198/ENSBGRG00000005873, exon 16 of 21)",1,57586764,57617405,30642,2]
["chr1",61927801,61953177,25377,"ENSBGRG00000000674","ENSBGRT00000001264",11324,"ATG3","autophagy related 3 [Source:HGNC Symbol;Acc:HGNC:20962]","GO:0000045(autophagosome assembly);GO:0000153(cytoplasmic ubiquitin ligase complex);GO:0005829(cytosol);GO:0006464(cellular protein modification process);GO:0016236(macroautophagy);GO:0016567(protein ubiquitination);GO:0019776(Atg8 ligase activity);GO:0019777(Atg12 transferase activity);GO:0019787(ubiquitin-like protein transferase activity);GO:0019899(enzyme binding);GO:0043653(mitochondrial fragmentation involved in apoptotic process);GO:0050765(negative regulation of phagocytosis);GO:1902017(regulation of cilium assembly)","04140(Autophagy - animal);04136(Autophagy - other eukaryotes);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":7.9e-24,"d":"0.00"},5,"3,82,50,108,26,","0,4005,6160,8896,25351",{"v":-23.1,"d":"-23.10"},{"v":-22.1,"d":"-22.10"},1.91,"Exon (ENSBGRT00000001264/ENSBGRG00000000674, exon 4 of 12)",1,61922447,61964501,42055,2]
["chr1",62002763,62002912,150,"ENSBGRG00000000776","ENSBGRT00000001429",35966,"CCDC80","coiled-coil domain containing 80 [Source:HGNC Symbol;Acc:HGNC:30649]","GO:0001968(fibronectin binding);GO:0005539(glycosaminoglycan binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0008201(heparin binding);GO:0009617(response to bacterium);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)","NA",{"v":2e-26,"d":"0.00"},1,"150,",0,{"v":-25.7,"d":"-25.70"},{"v":-24.7,"d":"-24.70"},2.17,"Exon (ENSBGRT00000001429/ENSBGRG00000000776, exon 8 of 8)",1,62002733,62038878,36146,2]
["chr1",62036998,62037684,687,"ENSBGRG00000000776","ENSBGRT00000001429",1194,"CCDC80","coiled-coil domain containing 80 [Source:HGNC Symbol;Acc:HGNC:30649]","GO:0001968(fibronectin binding);GO:0005539(glycosaminoglycan binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0008201(heparin binding);GO:0009617(response to bacterium);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)","NA",0,1,"687,",0,-467,"-Inf",{"v":3.8,"d":"3.80"},"Exon (ENSBGRT00000001429/ENSBGRG00000000776, exon 2 of 8)",1,62002733,62038878,36146,2]
["chr1",62037922,62038848,927,"ENSBGRG00000000776","ENSBGRT00000001429",30,"CCDC80","coiled-coil domain containing 80 [Source:HGNC Symbol;Acc:HGNC:30649]","GO:0001968(fibronectin binding);GO:0005539(glycosaminoglycan binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0008201(heparin binding);GO:0009617(response to bacterium);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)","NA",{"v":3.2e-57,"d":"0.00"},2,"793,132,","0,795",{"v":-56.5,"d":"-56.50"},{"v":-55.2,"d":"-55.20"},{"v":5.7,"d":"5.70"},"Exon (ENSBGRT00000001429/ENSBGRG00000000776, exon 1 of 8)",1,62002733,62038878,36146,2]
["chr1",62039677,62113777,74101,"ENSBGRG00000000776","ENSBGRT00000001411",0,"CCDC80","coiled-coil domain containing 80 [Source:HGNC Symbol;Acc:HGNC:30649]","GO:0001968(fibronectin binding);GO:0005539(glycosaminoglycan binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0008201(heparin binding);GO:0009617(response to bacterium);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)","NA",{"v":3.2e-61,"d":"0.00"},2,"378,40,","0,74061",{"v":-60.5,"d":"-60.50"},{"v":-59.2,"d":"-59.20"},4.41,"Exon (ENSBGRT00000001411/ENSBGRG00000000776, exon 1 of 9)",1,62002733,62113777,111045,2]
["chr1",62371978,62375423,3446,"ENSBGRG00000000866","ENSBGRT00000001624",18200,"GTPBP8","GTP binding protein 8 (putative) [Source:HGNC Symbol;Acc:HGNC:25007]","GO:0005525(GTP binding);GO:0005739(mitochondrion)","04146(Peroxisome)",{"v":1e-114,"d":"0.00"},2,"541,117,","0,3329",-114,-112,5.25,"3' UTR",1,62353778,62374443,20666,1]
["chr1",62378380,62378500,121,"ENSBGRG00000000919","ENSBGRT00000001714",8542,"NEPRO","nucleolus and neural progenitor protein [Source:HGNC Symbol;Acc:HGNC:24496]","GO:0005634(nucleus);GO:0005730(nucleolus);GO:0045665(negative regulation of neuron differentiation);GO:0045747(positive regulation of Notch signaling pathway)","NA",{"v":9.1E-4,"d":"0.00"},1,"121,",0,-3.04,-2.45,{"v":1.7,"d":"1.70"},"Exon (ENSBGRT00000001714/ENSBGRG00000000919, exon 6 of 9)",1,62371888,62387042,15155,2]
["chr1",62453369,62453517,149,"ENSBGRG00000000959","ENSBGRT00000001749",0,"ENSBGRG00000000959","NA","GO:0004298(threonine-type endopeptidase activity);GO:0005839(proteasome core complex);GO:0019773(proteasome core complex, alpha-subunit complex);GO:0051603(proteolysis involved in cellular protein catabolic process)","03050(Proteasome)",{"v":3.3E-3,"d":"0.00"},1,"149,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000001749/ENSBGRG00000000959, exon 1 of 2)",1,62452480,62453517,1038,2]
["chr1",62731418,62731508,91,"ENSBGRG00000001051","ENSBGRT00000001942",106333,"CFAP44","cilia and flagella associated protein 44 [Source:HGNC Symbol;Acc:HGNC:25631]","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0007288(sperm axoneme assembly);GO:0008233(peptidase activity);GO:0030317(flagellated sperm motility)","NA",{"v":6.6e-05,"d":"0.00"},1,"91,",0,-4.18,-3.53,9.91,"5' UTR",1,62711066,62837841,126776,2]
["chr1",62848034,62848154,121,"ENSBGRG00000001108","ENSBGRT00000002134",59086,"ENSBGRG00000001108","NA","GO:0090307(mitotic spindle assembly)","NA",{"v":3.1E-6,"d":"0.00"},1,"121,",0,-5.51,-4.82,1.83,"3' UTR",1,62847974,62907240,59267,2]
["chr1",63067912,63067972,61,"ENSBGRG00000001394","ENSBGRT00000002549",20257,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":0.017,"d":"0.02"},1,"61,",0,-1.78,-1.27,1.64,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 5 of 5)",1,63067523,63088229,20707,2]
["chr1",63068271,63068331,61,"ENSBGRG00000001394","ENSBGRT00000002549",19898,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":3.6e-07,"d":"0.00"},1,"61,",0,-6.44,-5.72,3.28,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 5 of 5)",1,63067523,63088229,20707,2]
["chr1",63069288,63069617,330,"ENSBGRG00000001394","ENSBGRT00000002549",18612,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":0.00046,"d":"0.00"},1,"330,",0,-3.34,-2.73,{"v":3.1,"d":"3.10"},"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 5 of 5)",1,63067523,63088229,20707,2]
["chr1",63072378,63072617,240,"ENSBGRG00000001394","ENSBGRT00000002549",15612,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":1.1e-06,"d":"0.00"},1,"240,",0,-5.97,-5.26,4.51,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 4 of 5)",1,63067523,63088229,20707,2]
["chr1",63073245,63074576,1332,"ENSBGRG00000001394","ENSBGRT00000002549",13653,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":0.0062,"d":"0.01"},2,"76,613,","0,719",-2.21,-1.67,9.91,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 3 of 5)",1,63067523,63088229,20707,2]
["chr1",63074905,63074995,91,"ENSBGRG00000001394","ENSBGRT00000002549",13234,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":0.00017,"d":"0.00"},1,"91,",0,-3.77,-3.14,{"v":5.7,"d":"5.70"},"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 3 of 5)",1,63067523,63088229,20707,2]
["chr1",63079121,63088229,9109,"ENSBGRG00000001394","ENSBGRT00000002549",0,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":3.3E-3,"d":"0.00"},2,"34,117,","0,8992",-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 1 of 5)",1,63067523,63088229,20707,2]
["chr1",63136585,63137830,1246,"ENSBGRG00000001410","ENSBGRT00000002646",30089,"ENSBGRG00000001410","NA","GO:0008080(N-acetyltransferase activity)","NA",{"v":4.5e-07,"d":"0.00"},3,"148,67,25,","0,848,1221",-6.35,-5.63,1.57,"Exon (ENSBGRT00000002646/ENSBGRG00000001410, exon 3 of 5)",1,63136555,63167919,31365,2]
["chr1",63392720,63406053,13334,"ENSBGRG00000001705","ENSBGRT00000003162",96998,"CCDC191","coiled-coil domain containing 191 [Source:HGNC Symbol;Acc:HGNC:29272]","NA","NA",{"v":0.00098,"d":"0.00"},2,"252,48,","0,13286",-3.01,-2.42,{"v":12.9,"d":"12.90"},"3' UTR",1,63392571,63503051,110481,2]
["chr1",63458494,63481105,22612,"ENSBGRG00000001705","ENSBGRT00000003162",21946,"CCDC191","coiled-coil domain containing 191 [Source:HGNC Symbol;Acc:HGNC:29272]","NA","NA",{"v":4.3e-10,"d":"0.00"},3,"15,151,134,","0,19331,22478",-9.37,-8.58,4.49,"Exon (ENSBGRT00000003162/ENSBGRG00000001705, exon 6 of 17)",1,63392571,63503051,110481,2]
["chr1",63774174,63774323,150,"ENSBGRG00000001895","ENSBGRT00000003570",51020,"ZBTB20","zinc finger and BTB domain containing 20 [Source:HGNC Symbol;Acc:HGNC:13503]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010629(negative regulation of gene expression);GO:0032728(positive regulation of interferon-beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0045821(positive regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046889(positive regulation of lipid biosynthetic process);GO:0055088(lipid homeostasis);GO:0071333(cellular response to glucose stimulus)","NA",{"v":0.012,"d":"0.01"},1,"150,",0,-1.93,{"v":-1.4,"d":"-1.40"},7.92,"3' UTR",1,63774174,63825343,51170,2]
["chr1",63774473,63774562,90,"ENSBGRG00000001895","ENSBGRT00000003570",50781,"ZBTB20","zinc finger and BTB domain containing 20 [Source:HGNC Symbol;Acc:HGNC:13503]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010629(negative regulation of gene expression);GO:0032728(positive regulation of interferon-beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0045821(positive regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046889(positive regulation of lipid biosynthetic process);GO:0055088(lipid homeostasis);GO:0071333(cellular response to glucose stimulus)","NA",{"v":0.012,"d":"0.01"},1,"90,",0,-1.93,{"v":-1.4,"d":"-1.40"},6.93,"3' UTR",1,63774174,63825343,51170,2]
["chr1",63775279,63788115,12837,"ENSBGRG00000001895","ENSBGRT00000003570",37228,"ZBTB20","zinc finger and BTB domain containing 20 [Source:HGNC Symbol;Acc:HGNC:13503]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010629(negative regulation of gene expression);GO:0032728(positive regulation of interferon-beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0045821(positive regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046889(positive regulation of lipid biosynthetic process);GO:0055088(lipid homeostasis);GO:0071333(cellular response to glucose stimulus)","NA",{"v":3.3E-3,"d":"0.00"},2,"161,49,","0,12788",-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000003570/ENSBGRG00000001895, exon 3 of 4)",1,63774174,63825343,51170,2]
["chr1",63789189,63789309,121,"ENSBGRG00000001895","ENSBGRT00000003570",36034,"ZBTB20","zinc finger and BTB domain containing 20 [Source:HGNC Symbol;Acc:HGNC:13503]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010629(negative regulation of gene expression);GO:0032728(positive regulation of interferon-beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0045821(positive regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046889(positive regulation of lipid biosynthetic process);GO:0055088(lipid homeostasis);GO:0071333(cellular response to glucose stimulus)","NA",{"v":1.8E-3,"d":"0.00"},1,"121,",0,-2.74,-2.16,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000003570/ENSBGRG00000001895, exon 3 of 4)",1,63774174,63825343,51170,2]
["chr1",65439906,65476794,36889,"ENSBGRG00000001944","ENSBGRT00000003701",735596,"LSAMP","limbic system associated membrane protein [Source:HGNC Symbol;Acc:HGNC:6705]","GO:0005829(cytosol)","NA",{"v":1.4E-3,"d":"0.00"},4,"69,33,36,39,","0,5636,26183,36850",-2.86,-2.28,2.85,"Exon (ENSBGRT00000003701/ENSBGRG00000001944, exon 6 of 9)",1,65439877,66212390,772514,2]
["chr1",68572314,68572492,179,"ENSBGRG00000002008","ENSBGRT00000003754",0,"ENSBGRG00000002008","NA","GO:0005787(signal peptidase complex);GO:0006465(signal peptide processing);GO:0008233(peptidase activity);GO:0016021(integral component of membrane)","03060(Protein export)",{"v":0.005,"d":"0.01"},1,"179,",0,{"v":-2.3,"d":"-2.30"},-1.75,4.95,"Exon (ENSBGRT00000003754/ENSBGRG00000002008, exon 1 of 2)",1,68571675,68572492,818,2]
["chr1",69295492,69299919,4428,"ENSBGRG00000002166","ENSBGRT00000004041",28961,"B4GALT4","beta-1,4-galactosyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:927]","GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0016757(transferase activity, transferring glycosyl groups)","00533(Glycosaminoglycan biosynthesis - keratan sulfate);00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":1.3e-66,"d":"0.00"},3,"133,105,27,","0,1890,4401",{"v":-65.9,"d":"-65.90"},{"v":-64.6,"d":"-64.60"},4.51,"Exon (ENSBGRT00000004041/ENSBGRG00000002166, exon 6 of 8)",1,69295492,69328880,33389,2]
["chr1",69314506,69328851,14346,"ENSBGRG00000002166","ENSBGRT00000004041",29,"B4GALT4","beta-1,4-galactosyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:927]","GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0016757(transferase activity, transferring glycosyl groups)","00533(Glycosaminoglycan biosynthesis - keratan sulfate);00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":1E-176,"d":"0.00"},3,"323,69,49,","0,11403,14297",-176,-174,4.66,"5' UTR",1,69295492,69328880,33389,2]
["chr1",69515816,69516055,240,"ENSBGRG00000002229","ENSBGRT00000004156",23958,"TMEM39A","transmembrane protein 39A [Source:HGNC Symbol;Acc:HGNC:25600]","GO:0005789(endoplasmic reticulum membrane);GO:0045070(positive regulation of viral genome replication);GO:1901097(negative regulation of autophagosome maturation);GO:1902902(negative regulation of autophagosome assembly)","NA",{"v":3.2e-15,"d":"0.00"},1,"240,",0,{"v":-14.5,"d":"-14.50"},{"v":-13.6,"d":"-13.60"},1.58,"Exon (ENSBGRT00000004156/ENSBGRG00000002229, exon 5 of 9)",1,69508987,69540013,31027,2]
["chr1",69621066,69621126,61,"ENSBGRG00000002311","ENSBGRT00000004303",12593,"CD80","CD80 molecule [Source:HGNC Symbol;Acc:HGNC:1700]","GO:0015026(coreceptor activity);GO:0031295(T cell costimulation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0098636(protein complex involved in cell adhesion)","04514(Cell adhesion molecules (CAMs));04620(Toll-like receptor signaling pathway);04672(Intestinal immune network for IgA production);05322(Systemic lupus erythematosus);05323(Rheumatoid arthritis);05320(Autoimmune thyroid disease);05330(Allograft rejection);05332(Graft-versus-host disease);05416(Viral myocarditis);04940(Type I diabetes mellitus)",0.01,1,"61,",0,-1.99,-1.46,3.71,"Exon (ENSBGRT00000004303/ENSBGRG00000002311, exon 3 of 4)",1,69614777,69633719,18943,2]
["chr1",69718677,69727836,9160,"ENSBGRG00000002360","ENSBGRT00000004400",5420,"POPDC2","popeye domain containing 2 [Source:HGNC Symbol;Acc:HGNC:17648]","GO:0016020(membrane);GO:0042383(sarcolemma)","04530(Tight junction)",{"v":0.011,"d":"0.01"},2,"48,100,","0,9060",-1.95,-1.18,8.91,"Exon (ENSBGRT00000004400/ENSBGRG00000002360, exon 2 of 4)",1,69712531,69733256,20726,2]
["chr1",69750054,69752045,1992,"ENSBGRG00000002369","ENSBGRT00000004421",0,"COX17","cytochrome c oxidase copper chaperone COX17 [Source:HGNC Symbol;Acc:HGNC:2264]","GO:0005507(copper ion binding);GO:0005737(cytoplasm);GO:0005758(mitochondrial intermembrane space);GO:0006825(copper ion transport);GO:0008284(positive regulation of cell population proliferation);GO:0016531(copper chaperone activity);GO:0033617(mitochondrial respiratory chain complex IV assembly);GO:1903136(cuprous ion binding);GO:1904960(positive regulation of cytochrome-c oxidase activity)","00190(Oxidative phosphorylation);04714(Thermogenesis)",{"v":1e-101,"d":"0.00"},2,"85,107,","0,1885",-101,{"v":-99.1,"d":"-99.10"},2.67,"Exon (ENSBGRT00000004421/ENSBGRG00000002369, exon 1 of 2)",1,69750054,69752045,1992,2]
["chr1",70208846,70225970,17125,"ENSBGRG00000002466","ENSBGRT00000004695",0,"GSK3B","glycogen synthase kinase 3 beta [Source:HGNC Symbol;Acc:HGNC:4617]","GO:0001085(RNA polymerase II transcription factor binding);GO:0001837(epithelial to mesenchymal transition);GO:0001954(positive regulation of cell-matrix adhesion);GO:0002020(protease binding);GO:0002039(p53 binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005886(plasma membrane);GO:0005977(glycogen metabolic process);GO:0006468(protein phosphorylation);GO:0006983(ER overload response);GO:0008013(beta-catenin binding);GO:0010822(positive regulation of mitochondrion organization);GO:0016301(kinase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0019901(protein kinase binding);GO:0021766(hippocampus development);GO:0030877(beta-catenin destruction complex);GO:0031175(neuron projection development);GO:0031333(negative regulation of protein-containing complex assembly);GO:0031334(positive regulation of protein-containing complex assembly);GO:0031625(ubiquitin protein ligase binding);GO:0032091(negative regulation of protein binding);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032886(regulation of microtubule-based process);GO:0034236(protein kinase A catalytic subunit binding);GO:0034452(dynactin binding);GO:0035556(intracellular signal transduction);GO:0043066(negative regulation of apoptotic process);GO:0043547(positive regulation of GTPase activity);GO:0046777(protein autophosphorylation);GO:0046827(positive regulation of protein export from nucleus);GO:0050321(tau-protein kinase activity);GO:0051059(NF-kappaB binding);GO:0070885(negative regulation of calcineurin-NFAT signaling cascade);GO:0071109(superior temporal gyrus development);GO:0098978(glutamatergic synapse);GO:0150101(regulation of microtubule anchoring at centrosome);GO:1901215(negative regulation of neuron death);GO:1901216(positive regulation of neuron death);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1904781(positive regulation of protein localization to centrosome);GO:2000300(regulation of synaptic vesicle exocytosis)","04012(ErbB signaling pathway);04310(Wnt signaling pathway);04340(Hedgehog signaling pathway);04390(Hippo signaling pathway);04151(PI3K-Akt signaling pathway);04150(mTOR signaling pathway);04110(Cell cycle);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04660(T cell receptor signaling pathway);04657(IL-17 signaling pathway);04662(B cell receptor signaling pathway);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04917(Prolactin signaling pathway);04919(Thyroid hormone signaling pathway);04916(Melanogenesis);04728(Dopaminergic synapse);04722(Neurotrophin signaling pathway);04360(Axon guidance);05200(Pathways in cancer);05210(Colorectal cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05010(Alzheimer disease);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04934(Cushing syndrome);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);01521(EGFR tyrosine kinase inhibitor resistance)",{"v":4.3E-3,"d":"0.00"},2,"62,58,","0,17067",-2.37,-1.81,1.87,"5' UTR",1,69993406,70208907,215502,2]
["chr1",70318716,70332309,13594,"ENSBGRG00000002541","ENSBGRT00000004762",75135,"GPR156","G protein-coupled receptor 156 [Source:HGNC Symbol;Acc:HGNC:20844]","GO:0004930(G protein-coupled receptor activity);GO:0004965(G protein-coupled GABA receptor activity);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","04080(Neuroactive ligand-receptor interaction)",{"v":1.1E-5,"d":"0.00"},2,"782,53,","0,13541",-4.97,-4.29,{"v":11.4,"d":"11.40"},"Exon (ENSBGRT00000004762/ENSBGRG00000002541, exon 8 of 10)",1,70318179,70407444,89266,2]
["chr1",70474763,70474882,120,"ENSBGRG00000002589","ENSBGRT00000004869",17655,"LRRC58","leucine rich repeat containing 58 [Source:HGNC Symbol;Acc:HGNC:26968]","GO:0005515(protein binding)","NA",{"v":6.6E-4,"d":"0.00"},1,"120,",0,-3.18,-2.58,4.95,"3' UTR",1,70474763,70492537,17775,2]
["chr1",70478441,70478500,60,"ENSBGRG00000002589","ENSBGRT00000004869",14037,"LRRC58","leucine rich repeat containing 58 [Source:HGNC Symbol;Acc:HGNC:26968]","GO:0005515(protein binding)","NA",{"v":0.012,"d":"0.01"},1,"60,",0,-1.91,-1.38,1.85,"Exon (ENSBGRT00000004869/ENSBGRG00000002589, exon 3 of 4)",1,70474763,70492537,17775,2]
["chr1",70492211,70492329,119,"ENSBGRG00000002589","ENSBGRT00000004869",208,"LRRC58","leucine rich repeat containing 58 [Source:HGNC Symbol;Acc:HGNC:26968]","GO:0005515(protein binding)","NA",0.04,1,"119,",0,{"v":-1.4,"d":"-1.40"},-0.91,2.97,"Exon (ENSBGRT00000004869/ENSBGRG00000002589, exon 1 of 4)",1,70474763,70492537,17775,2]
["chr1",70492478,70492537,60,"ENSBGRG00000002589","ENSBGRT00000004869",0,"LRRC58","leucine rich repeat containing 58 [Source:HGNC Symbol;Acc:HGNC:26968]","GO:0005515(protein binding)","NA",{"v":0.034,"d":"0.03"},1,"60,",0,-1.47,{"v":-0.977,"d":"-0.98"},4.95,"Exon (ENSBGRT00000004869/ENSBGRG00000002589, exon 1 of 4)",1,70474763,70492537,17775,2]
["chr1",70538857,70539006,150,"ENSBGRG00000002621","ENSBGRT00000005027",63043,"FSTL1","follistatin like 1 [Source:HGNC Symbol;Acc:HGNC:3972]","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0042594(response to starvation)","04512(ECM-receptor interaction)",{"v":1.3E-11,"d":"0.00"},1,"150,",0,{"v":-10.9,"d":"-10.90"},{"v":-10.1,"d":"-10.10"},{"v":1.8,"d":"1.80"},"3' UTR",1,70538857,70602049,63193,2]
["chr1",70760525,70768786,8262,"ENSBGRG00000002735","ENSBGRT00000005168",38368,"HGD","homogentisate 1,2-dioxygenase [Source:HGNC Symbol;Acc:HGNC:4892]","GO:0004411(homogentisate 1,2-dioxygenase activity);GO:0006520(cellular amino acid metabolic process);GO:0006559(L-phenylalanine catabolic process);GO:0006570(tyrosine metabolic process);GO:0042802(identical protein binding);GO:0055114(oxidation-reduction process)","00350(Tyrosine metabolism)",0.02,3,"150,182,57,","0,2630,8205",-1.69,{"v":-0.977,"d":"-0.98"},7.92,"Exon (ENSBGRT00000005168/ENSBGRG00000002735, exon 12 of 14)",1,70760525,70807154,46630,2]
["chr1",70860664,70868128,7465,"ENSBGRG00000002799","ENSBGRT00000005290",0,"RABL3","RAB, member of RAS oncogene family like 3 [Source:HGNC Symbol;Acc:HGNC:18072]","GO:0001779(natural killer cell differentiation);GO:0005525(GTP binding);GO:0030183(B cell differentiation);GO:0033077(T cell differentiation in thymus);GO:0042803(protein homodimerization activity);GO:0046578(regulation of Ras protein signal transduction);GO:0050821(protein stabilization);GO:1903059(regulation of protein lipidation)","NA",{"v":0.011,"d":"0.01"},2,"14,46,","0,7419",-1.95,-1.18,8.91,"5' UTR",1,70816851,70868128,51278,2]
["chr1",71479711,71480460,750,"ENSBGRG00000002979","ENSBGRT00000005814",61803,"POLQ","DNA polymerase theta [Source:HGNC Symbol;Acc:HGNC:9186]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005524(ATP binding);GO:0006260(DNA replication);GO:0006261(DNA-dependent DNA replication);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006302(double-strand break repair);GO:0006974(cellular response to DNA damage stimulus);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0017116(single-stranded DNA helicase activity);GO:0051260(protein homooligomerization);GO:0051575(5'-deoxyribose-5-phosphate lyase activity);GO:0097681(double-strand break repair via alternative nonhomologous end joining);GO:2000042(negative regulation of double-strand break repair via homologous recombination)","NA",{"v":0.016,"d":"0.02"},1,"750,",0,-1.79,-1.27,6.93,"Exon (ENSBGRT00000005814/ENSBGRG00000002979, exon 16 of 29)",1,71412021,71542263,130243,2]
["chr1",71480730,71481330,601,"ENSBGRG00000002979","ENSBGRT00000005814",60933,"POLQ","DNA polymerase theta [Source:HGNC Symbol;Acc:HGNC:9186]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005524(ATP binding);GO:0006260(DNA replication);GO:0006261(DNA-dependent DNA replication);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006302(double-strand break repair);GO:0006974(cellular response to DNA damage stimulus);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0017116(single-stranded DNA helicase activity);GO:0051260(protein homooligomerization);GO:0051575(5'-deoxyribose-5-phosphate lyase activity);GO:0097681(double-strand break repair via alternative nonhomologous end joining);GO:2000042(negative regulation of double-strand break repair via homologous recombination)","NA",{"v":1.8E-3,"d":"0.00"},1,"601,",0,-2.74,-2.16,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000005814/ENSBGRG00000002979, exon 16 of 29)",1,71412021,71542263,130243,2]
["chr1",71620055,71620756,702,"ENSBGRG00000003280","ENSBGRT00000006163",30758,"HCLS1","hematopoietic cell-specific Lyn substrate 1 [Source:HGNC Symbol;Acc:HGNC:4844]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001085(RNA polymerase II transcription factor binding);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0008284(positive regulation of cell population proliferation);GO:0009725(response to hormone);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0017124(SH3 domain binding);GO:0019901(protein kinase binding);GO:0030041(actin filament polymerization);GO:0030218(erythrocyte differentiation);GO:0030833(regulation of actin filament polymerization);GO:0030854(positive regulation of granulocyte differentiation);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0042307(positive regulation of protein import into nucleus);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0044877(protein-containing complex binding);GO:0045651(positive regulation of macrophage differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051897(positive regulation of protein kinase B signaling);GO:0071345(cellular response to cytokine stimulus);GO:2000107(negative regulation of leukocyte apoptotic process)","04530(Tight junction);05205(Proteoglycans in cancer);05100(Bacterial invasion of epithelial cells)",{"v":1.4E-3,"d":"0.00"},2,"60,31,","0,671",-2.84,-2.25,1.81,"Exon (ENSBGRT00000006163/ENSBGRG00000003280, exon 7 of 13)",1,71617464,71651514,34051,2]
["chr1",71681231,71693273,12043,"ENSBGRG00000003446","ENSBGRT00000007938",36246,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":1e-131,"d":"0.00"},3,"10,1912,1192,","0,8088,10851",-131,-130,7.13,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 14 of 23)",1,71662324,71729519,67196,2]
["chr1",71693602,71693991,390,"ENSBGRG00000003446","ENSBGRT00000007938",35528,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":7.9e-23,"d":"0.00"},1,"390,",0,{"v":-22.1,"d":"-22.10"},{"v":-21.2,"d":"-21.20"},3.41,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 14 of 23)",1,71662324,71729519,67196,2]
["chr1",71694590,71694680,91,"ENSBGRG00000003446","ENSBGRT00000007938",34839,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",0.02,1,"91,",0,{"v":-1.7,"d":"-1.70"},-1.19,4.95,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 14 of 23)",1,71662324,71729519,67196,2]
["chr1",71695099,71695368,270,"ENSBGRG00000003446","ENSBGRT00000007938",34151,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":6.3e-20,"d":"0.00"},1,"270,",0,{"v":-19.2,"d":"-19.20"},{"v":-18.3,"d":"-18.30"},4.82,"Exon (ENSBGRT00000007525/ENSBGRG00000003446, exon 13 of 22)",1,71662324,71729519,67196,2]
["chr1",71695727,71695787,61,"ENSBGRG00000003446","ENSBGRT00000007938",33732,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":0.00042,"d":"0.00"},1,"61,",0,-3.38,-2.77,3.68,"Exon (ENSBGRT00000007525/ENSBGRG00000003446, exon 13 of 22)",1,71662324,71729519,67196,2]
["chr1",71776628,71778477,1850,"ENSBGRG00000004390","ENSBGRT00000008070",31384,"IQCB1","IQ motif containing B1 [Source:HGNC Symbol;Acc:HGNC:28949]","GO:0001750(photoreceptor outer segment);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0015630(microtubule cytoskeleton);GO:0019899(enzyme binding);GO:0032391(photoreceptor connecting cilium);GO:0045171(intercellular bridge);GO:0045494(photoreceptor cell maintenance);GO:0048496(maintenance of animal organ identity);GO:0060271(cilium assembly);GO:0072686(mitotic spindle)","NA",{"v":5.8e-08,"d":"0.00"},2,"100,139,","0,1711",-7.24,{"v":-6.5,"d":"-6.50"},1.73,"Exon (ENSBGRT00000008070/ENSBGRG00000004390, exon 10 of 16)",1,71762461,71809861,47401,2]
["chr1",72384145,72385137,993,"ENSBGRG00000007190","ENSBGRT00000013200",0,"WDR5B","WD repeat domain 5B [Source:HGNC Symbol;Acc:HGNC:17826]","GO:0005515(protein binding)","04934(Cushing syndrome)",{"v":5e-47,"d":"0.00"},1,"993,",0,{"v":-46.3,"d":"-46.30"},{"v":-45.2,"d":"-45.20"},{"v":15.6,"d":"15.60"},"Exon (ENSBGRT00000013200/ENSBGRG00000007190, exon 1 of 1)",1,72384145,72385137,993,2]
["chr1",72485132,72485311,180,"ENSBGRG00000007330","ENSBGRT00000013561",33487,"PARP9","poly(ADP-ribose) polymerase family member 9 [Source:HGNC Symbol;Acc:HGNC:24118]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002230(positive regulation of defense response to virus by host);GO:0003714(transcription corepressor activity);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0004857(enzyme inhibitor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006302(double-strand break repair);GO:0006471(protein ADP-ribosylation);GO:0010608(posttranscriptional regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0032991(protein-containing complex);GO:0035563(positive regulation of chromatin binding);GO:0042393(histone binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0043086(negative regulation of catalytic activity);GO:0044389(ubiquitin-like protein ligase binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060330(regulation of response to interferon-gamma);GO:0060335(positive regulation of interferon-gamma-mediated signaling pathway);GO:0072570(ADP-D-ribose binding);GO:0090734(site of DNA damage);GO:0097677(STAT family protein binding);GO:1900182(positive regulation of protein localization to nucleus);GO:2001034(positive regulation of double-strand break repair via nonhomologous end joining)","NA",{"v":1.4E-5,"d":"0.00"},1,"180,",0,-4.84,-4.17,1.42,"Exon (ENSBGRT00000013561/ENSBGRG00000007330, exon 11 of 11)",1,72485102,72518798,33697,2]
["chr1",72492093,72495891,3799,"ENSBGRG00000007330","ENSBGRT00000013561",22907,"PARP9","poly(ADP-ribose) polymerase family member 9 [Source:HGNC Symbol;Acc:HGNC:24118]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002230(positive regulation of defense response to virus by host);GO:0003714(transcription corepressor activity);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0004857(enzyme inhibitor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006302(double-strand break repair);GO:0006471(protein ADP-ribosylation);GO:0010608(posttranscriptional regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0032991(protein-containing complex);GO:0035563(positive regulation of chromatin binding);GO:0042393(histone binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0043086(negative regulation of catalytic activity);GO:0044389(ubiquitin-like protein ligase binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060330(regulation of response to interferon-gamma);GO:0060335(positive regulation of interferon-gamma-mediated signaling pathway);GO:0072570(ADP-D-ribose binding);GO:0090734(site of DNA damage);GO:0097677(STAT family protein binding);GO:1900182(positive regulation of protein localization to nucleus);GO:2001034(positive regulation of double-strand break repair via nonhomologous end joining)","NA",{"v":2e-33,"d":"0.00"},2,"86,333,","0,3466",{"v":-32.7,"d":"-32.70"},{"v":-31.6,"d":"-31.60"},2.53,"Exon (ENSBGRT00000013561/ENSBGRG00000007330, exon 8 of 11)",1,72485102,72518798,33697,2]
["chr1",72508232,72508978,747,"ENSBGRG00000007330","ENSBGRT00000013561",9820,"PARP9","poly(ADP-ribose) polymerase family member 9 [Source:HGNC Symbol;Acc:HGNC:24118]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002230(positive regulation of defense response to virus by host);GO:0003714(transcription corepressor activity);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0004857(enzyme inhibitor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006302(double-strand break repair);GO:0006471(protein ADP-ribosylation);GO:0010608(posttranscriptional regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0032991(protein-containing complex);GO:0035563(positive regulation of chromatin binding);GO:0042393(histone binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0043086(negative regulation of catalytic activity);GO:0044389(ubiquitin-like protein ligase binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060330(regulation of response to interferon-gamma);GO:0060335(positive regulation of interferon-gamma-mediated signaling pathway);GO:0072570(ADP-D-ribose binding);GO:0090734(site of DNA damage);GO:0097677(STAT family protein binding);GO:1900182(positive regulation of protein localization to nucleus);GO:2001034(positive regulation of double-strand break repair via nonhomologous end joining)","NA",{"v":1e-130,"d":"0.00"},1,"747,",0,-130,-128,5.62,"Exon (ENSBGRT00000013561/ENSBGRG00000007330, exon 4 of 11)",1,72485102,72518798,33697,2]
["chr1",72611836,72612340,505,"ENSBGRG00000007624","ENSBGRT00000013952",63314,"HSPBAP1","HSPB1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16389]","NA","NA",{"v":1e-159,"d":"0.00"},1,"505,",0,-159,-157,{"v":11.2,"d":"11.20"},"Exon (ENSBGRT00000013952/ENSBGRG00000007624, exon 8 of 8)",1,72611836,72675654,63819,2]
["chr1",73486522,73486761,240,"ENSBGRG00000008188","ENSBGRT00000015332",1968,"ADCY5","adenylate cyclase 5 [Source:HGNC Symbol;Acc:HGNC:236]","GO:0001973(G protein-coupled adenosine receptor signaling pathway);GO:0004016(adenylate cyclase activity);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0006171(cAMP biosynthetic process);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007191(adenylate cyclase-activating dopamine receptor signaling pathway);GO:0007195(adenylate cyclase-inhibiting dopamine receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007626(locomotory behavior);GO:0008179(adenylate cyclase binding);GO:0009190(cyclic nucleotide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016849(phosphorus-oxygen lyase activity);GO:0035556(intracellular signal transduction);GO:0045111(intermediate filament cytoskeleton);GO:0050885(neuromuscular process controlling balance);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0097110(scaffold protein binding);GO:1904322(cellular response to forskolin)","00230(Purine metabolism);04015(Rap1 signaling pathway);04371(Apelin signaling pathway);04072(Phospholipase D signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04114(Oocyte meiosis);04540(Gap junction);04611(Platelet activation);04062(Chemokine signaling pathway);04911(Insulin secretion);04923(Regulation of lipolysis in adipocyte);04912(GnRH signaling pathway);04913(Ovarian Steroidogenesis);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04918(Thyroid hormone synthesis);04928(Parathyroid hormone synthesis, secretion and action);04916(Melanogenesis);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);04724(Glutamatergic synapse);04727(GABAergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);04750(Inflammatory mediator regulation of TRP channels);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);04713(Circadian entrainment);04714(Thermogenesis);05200(Pathways in cancer);05012(Parkinson disease);05030(Cocaine addiction);05031(Amphetamine addiction);05032(Morphine addiction);05034(Alcoholism);05414(Dilated cardiomyopathy (DCM));04934(Cushing syndrome);05166(HTLV-I infection);05163(Human cytomegalovirus infection);01522(Endocrine resistance)",{"v":0.00026,"d":"0.00"},1,"240,",0,-3.58,-2.96,7.92,"Exon (ENSBGRT00000015332/ENSBGRG00000008188, exon 2 of 24)",1,73298495,73488729,190235,2]
["chr1",73486821,73488729,1909,"ENSBGRG00000008188","ENSBGRT00000015332",0,"ADCY5","adenylate cyclase 5 [Source:HGNC Symbol;Acc:HGNC:236]","GO:0001973(G protein-coupled adenosine receptor signaling pathway);GO:0004016(adenylate cyclase activity);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0006171(cAMP biosynthetic process);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007191(adenylate cyclase-activating dopamine receptor signaling pathway);GO:0007195(adenylate cyclase-inhibiting dopamine receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007626(locomotory behavior);GO:0008179(adenylate cyclase binding);GO:0009190(cyclic nucleotide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016849(phosphorus-oxygen lyase activity);GO:0035556(intracellular signal transduction);GO:0045111(intermediate filament cytoskeleton);GO:0050885(neuromuscular process controlling balance);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0097110(scaffold protein binding);GO:1904322(cellular response to forskolin)","00230(Purine metabolism);04015(Rap1 signaling pathway);04371(Apelin signaling pathway);04072(Phospholipase D signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04114(Oocyte meiosis);04540(Gap junction);04611(Platelet activation);04062(Chemokine signaling pathway);04911(Insulin secretion);04923(Regulation of lipolysis in adipocyte);04912(GnRH signaling pathway);04913(Ovarian Steroidogenesis);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04918(Thyroid hormone synthesis);04928(Parathyroid hormone synthesis, secretion and action);04916(Melanogenesis);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);04724(Glutamatergic synapse);04727(GABAergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);04750(Inflammatory mediator regulation of TRP channels);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);04713(Circadian entrainment);04714(Thermogenesis);05200(Pathways in cancer);05012(Parkinson disease);05030(Cocaine addiction);05031(Amphetamine addiction);05032(Morphine addiction);05034(Alcoholism);05414(Dilated cardiomyopathy (DCM));04934(Cushing syndrome);05166(HTLV-I infection);05163(Human cytomegalovirus infection);01522(Endocrine resistance)",{"v":6.2e-08,"d":"0.00"},2,"320,11,","0,1898",-7.21,-6.47,8.91,"Exon (ENSBGRT00000015332/ENSBGRG00000008188, exon 1 of 24)",1,73298495,73488729,190235,2]
["chr1",73636312,73636432,121,"ENSBGRG00000008479","ENSBGRT00000015416",238,"HACD2","3-hydroxyacyl-CoA dehydratase 2 [Source:HGNC Symbol;Acc:HGNC:9640]","GO:0005783(endoplasmic reticulum);GO:0018812(3-hydroxyacyl-CoA dehydratase activity);GO:0019899(enzyme binding);GO:0030148(sphingolipid biosynthetic process);GO:0030497(fatty acid elongation);GO:0042761(very long-chain fatty acid biosynthetic process)","00062(Fatty acid elongation);01040(Biosynthesis of unsaturated fatty acids)",{"v":2.4e-07,"d":"0.00"},1,"121,",0,-6.62,-5.89,8.42,"Exon (ENSBGRT00000015416/ENSBGRG00000008479, exon 1 of 7)",1,73542390,73636670,94281,2]
["chr1",73758976,73776377,17402,"ENSBGRG00000008571","ENSBGRT00000015698",216372,"MYLK","myosin light chain kinase [Source:HGNC Symbol;Acc:HGNC:7590]","GO:0001725(stress fiber);GO:0004672(protein kinase activity);GO:0004687(myosin light chain kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0015629(actin cytoskeleton);GO:0030027(lamellipodium);GO:0030335(positive regulation of cell migration);GO:0032060(bleb assembly);GO:0032154(cleavage furrow);GO:0051928(positive regulation of calcium ion transport);GO:0060414(aorta smooth muscle tissue morphogenesis);GO:0071476(cellular hypotonic response);GO:0090303(positive regulation of wound healing)","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04921(Oxytocin signaling pathway);04270(Vascular smooth muscle contraction);04971(Gastric acid secretion)",0,6,"23,357,374,261,72,54,","0,9451,10348,10806,11497,17348",-449,"-Inf",3.44,"Exon (ENSBGRT00000015698/ENSBGRG00000008571, exon 16 of 37)",1,73669379,73992749,323371,2]
["chr1",74023077,74029180,6104,"ENSBGRG00000008926","ENSBGRT00000016521",35786,"CCDC14","coiled-coil domain containing 14 [Source:HGNC Symbol;Acc:HGNC:25766]","GO:0005813(centrosome);GO:0034451(centriolar satellite);GO:0071539(protein localization to centrosome)","NA",{"v":1e-200,"d":"0.00"},4,"603,316,133,170,","0,605,5729,5934",-200,-198,9.27,"Exon (ENSBGRT00000016521/ENSBGRG00000008926, exon 11 of 14)",1,74023077,74064966,41890,2]
["chr1",74044708,74046064,1357,"ENSBGRG00000008926","ENSBGRT00000016521",18902,"CCDC14","coiled-coil domain containing 14 [Source:HGNC Symbol;Acc:HGNC:25766]","GO:0005813(centrosome);GO:0034451(centriolar satellite);GO:0071539(protein localization to centrosome)","NA",{"v":1.6e-26,"d":"0.00"},2,"453,24,","0,1333",{"v":-25.8,"d":"-25.80"},{"v":-24.8,"d":"-24.80"},3.65,"Exon (ENSBGRT00000016521/ENSBGRG00000008926, exon 7 of 14)",1,74023077,74064966,41890,2]
["chr1",75032033,75040386,8354,"ENSBGRG00000011141","ENSBGRT00000020371",132646,"ITGB5","integrin subunit beta 5 [Source:HGNC Symbol;Acc:HGNC:6160]","GO:0007160(cell-matrix adhesion);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0034684(integrin alphav-beta5 complex);GO:0035987(endodermal cell differentiation);GO:0038023(signaling receptor activity);GO:0043149(stress fiber assembly);GO:0043235(receptor complex);GO:0090136(epithelial cell-cell adhesion)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04145(Phagosome);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);05205(Proteoglycans in cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection)",0,4,"9,508,167,93,","0,5818,6954,8261",-511,"-Inf",6.72,"3' UTR",1,75031197,75173032,141836,2]
["chr1",75040996,75041265,270,"ENSBGRG00000011141","ENSBGRT00000020371",131767,"ITGB5","integrin subunit beta 5 [Source:HGNC Symbol;Acc:HGNC:6160]","GO:0007160(cell-matrix adhesion);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0034684(integrin alphav-beta5 complex);GO:0035987(endodermal cell differentiation);GO:0038023(signaling receptor activity);GO:0043149(stress fiber assembly);GO:0043235(receptor complex);GO:0090136(epithelial cell-cell adhesion)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04145(Phagosome);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);05205(Proteoglycans in cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection)",{"v":5.8e-09,"d":"0.00"},1,"270,",0,-8.24,-7.48,2.54,"3' UTR",1,75031197,75173032,141836,2]
["chr1",75072163,75090910,18748,"ENSBGRG00000011141","ENSBGRT00000020371",82122,"ITGB5","integrin subunit beta 5 [Source:HGNC Symbol;Acc:HGNC:6160]","GO:0007160(cell-matrix adhesion);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0034684(integrin alphav-beta5 complex);GO:0035987(endodermal cell differentiation);GO:0038023(signaling receptor activity);GO:0043149(stress fiber assembly);GO:0043235(receptor complex);GO:0090136(epithelial cell-cell adhesion)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04145(Phagosome);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);05205(Proteoglycans in cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection)",{"v":6.3e-92,"d":"0.00"},3,"289,135,25,","0,11936,18723",{"v":-91.2,"d":"-91.20"},{"v":-89.7,"d":"-89.70"},2.91,"Exon (ENSBGRT00000020371/ENSBGRG00000011141, exon 9 of 12)",1,75031197,75173032,141836,2]
["chr1",75172674,75173002,329,"ENSBGRG00000011141","ENSBGRT00000020371",30,"ITGB5","integrin subunit beta 5 [Source:HGNC Symbol;Acc:HGNC:6160]","GO:0007160(cell-matrix adhesion);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0034684(integrin alphav-beta5 complex);GO:0035987(endodermal cell differentiation);GO:0038023(signaling receptor activity);GO:0043149(stress fiber assembly);GO:0043235(receptor complex);GO:0090136(epithelial cell-cell adhesion)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04145(Phagosome);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);05205(Proteoglycans in cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection)",{"v":1.6E-45,"d":"0.00"},1,"329,",0,{"v":-44.8,"d":"-44.80"},{"v":-43.7,"d":"-43.70"},7.53,"5' UTR",1,75031197,75173032,141836,2]
["chr1",75291837,75296564,4728,"ENSBGRG00000011820","ENSBGRT00000021576",58355,"ENSBGRG00000011820","NA","GO:0005509(calcium ion binding);GO:0007043(cell-cell junction assembly);GO:0007507(heart development)","NA",{"v":1e-148,"d":"0.00"},2,"1150,194,","0,4534",-148,-146,{"v":11.6,"d":"11.60"},"3' UTR",1,75291837,75354919,63083,2]
["chr1",75335424,75335543,120,"ENSBGRG00000011820","ENSBGRT00000021576",19376,"ENSBGRG00000011820","NA","GO:0005509(calcium ion binding);GO:0007043(cell-cell junction assembly);GO:0007507(heart development)","NA",{"v":5e-40,"d":"0.00"},1,"120,",0,{"v":-39.3,"d":"-39.30"},{"v":-38.2,"d":"-38.20"},{"v":2.7,"d":"2.70"},"Exon (ENSBGRT00000021576/ENSBGRG00000011820, exon 6 of 16)",1,75291837,75354919,63083,2]
["chr1",75343736,75343915,180,"ENSBGRG00000011820","ENSBGRT00000021576",11004,"ENSBGRG00000011820","NA","GO:0005509(calcium ion binding);GO:0007043(cell-cell junction assembly);GO:0007507(heart development)","NA",{"v":5E-15,"d":"0.00"},1,"180,",0,{"v":-14.3,"d":"-14.30"},{"v":-13.4,"d":"-13.40"},2.22,"5' UTR",1,75291837,75354919,63083,2]
["chr1",75402508,75402686,179,"ENSBGRG00000011908","ENSBGRT00000022020",148786,"SLC12A8","solute carrier family 12 member 8 [Source:HGNC Symbol;Acc:HGNC:15595]","GO:0016020(membrane);GO:0055085(transmembrane transport)","NA",{"v":0.00017,"d":"0.00"},1,"179,",0,-3.77,-3.14,5.94,"3' UTR",1,75402508,75551472,148965,2]
["chr1",75582760,75584778,2019,"ENSBGRG00000012130","ENSBGRT00000022245",106510,"ZNF148","zinc finger protein 148 [Source:HGNC Symbol;Acc:HGNC:12933]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0007276(gamete generation);GO:0010629(negative regulation of gene expression);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":1e-163,"d":"0.00"},2,"1599,97,","0,1922",-163,-161,6.23,"Exon (ENSBGRT00000022245/ENSBGRG00000012130, exon 7 of 8)",1,75582760,75691288,108529,2]
["chr1",75638594,75666745,28152,"ENSBGRG00000012130","ENSBGRT00000022245",24543,"ZNF148","zinc finger protein 148 [Source:HGNC Symbol;Acc:HGNC:12933]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0007276(gamete generation);GO:0010629(negative regulation of gene expression);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":3.2e-29,"d":"0.00"},2,"89,298,","0,27854",{"v":-28.5,"d":"-28.50"},{"v":-27.5,"d":"-27.50"},4.14,"Exon (ENSBGRT00000022245/ENSBGRG00000012130, exon 3 of 8)",1,75582760,75691288,108529,2]
["chr1",75783452,75798575,15124,"ENSBGRG00000012306","ENSBGRT00000022539",63680,"SNX4","sorting nexin 4 [Source:HGNC Symbol;Acc:HGNC:11175]","GO:0005154(epidermal growth factor receptor binding);GO:0005158(insulin receptor binding);GO:0005737(cytoplasm);GO:0005868(cytoplasmic dynein complex);GO:0005886(plasma membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0031201(SNARE complex);GO:0031901(early endosome membrane);GO:0032456(endocytic recycling);GO:0032991(protein-containing complex);GO:0035091(phosphatidylinositol binding);GO:1903595(positive regulation of histamine secretion by mast cell);GO:1990459(transferrin receptor binding);GO:1990460(leptin receptor binding)","04144(Endocytosis)",{"v":0.0068,"d":"0.01"},2,"81,10,","0,15114",-2.17,-1.62,5.94,"3' UTR",1,75782493,75862255,79763,2]
["chr1",75808481,75809612,1132,"ENSBGRG00000012306","ENSBGRT00000022539",52643,"SNX4","sorting nexin 4 [Source:HGNC Symbol;Acc:HGNC:11175]","GO:0005154(epidermal growth factor receptor binding);GO:0005158(insulin receptor binding);GO:0005737(cytoplasm);GO:0005868(cytoplasmic dynein complex);GO:0005886(plasma membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0031201(SNARE complex);GO:0031901(early endosome membrane);GO:0032456(endocytic recycling);GO:0032991(protein-containing complex);GO:0035091(phosphatidylinositol binding);GO:1903595(positive regulation of histamine secretion by mast cell);GO:1990459(transferrin receptor binding);GO:1990460(leptin receptor binding)","04144(Endocytosis)",{"v":4.3e-06,"d":"0.00"},2,"49,12,","0,1120",-5.37,-4.68,1.36,"Exon (ENSBGRT00000022539/ENSBGRG00000012306, exon 12 of 14)",1,75782493,75862255,79763,2]
["chr1",75882857,75899702,16846,"ENSBGRG00000012716","ENSBGRT00000023302",82967,"OSBPL11","oxysterol binding protein like 11 [Source:HGNC Symbol;Acc:HGNC:16397]","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0010890(positive regulation of sequestering of triglyceride);GO:0045444(fat cell differentiation)","NA",{"v":1e-112,"d":"0.00"},3,"691,154,115,","0,9728,16731",-112,-111,8.55,"3' UTR",1,75882857,75982669,99813,2]
["chr1",75914872,75915081,210,"ENSBGRG00000012716","ENSBGRT00000023302",67588,"OSBPL11","oxysterol binding protein like 11 [Source:HGNC Symbol;Acc:HGNC:16397]","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0010890(positive regulation of sequestering of triglyceride);GO:0045444(fat cell differentiation)","NA",{"v":0.012,"d":"0.01"},1,"210,",0,-1.92,-1.39,1.81,"Exon (ENSBGRT00000023302/ENSBGRG00000012716, exon 10 of 14)",1,75882857,75982669,99813,2]
["chr1",76174625,76174685,61,"ENSBGRG00000013795","ENSBGRT00000026551",116299,"LRCH3","leucine rich repeats and calponin homology domain containing 3 [Source:HGNC Symbol;Acc:HGNC:28637]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0032185(septin cytoskeleton organization)","NA",{"v":0.013,"d":"0.01"},1,"61,",0,-1.87,-1.34,1.35,"3' UTR",1,76174565,76290984,116420,2]
["chr1",76177133,76189345,12213,"ENSBGRG00000013795","ENSBGRT00000026551",101639,"LRCH3","leucine rich repeats and calponin homology domain containing 3 [Source:HGNC Symbol;Acc:HGNC:28637]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0032185(septin cytoskeleton organization)","NA",{"v":5e-46,"d":"0.00"},3,"266,78,16,","0,8132,12197",{"v":-45.3,"d":"-45.30"},{"v":-44.1,"d":"-44.10"},2.35,"3' UTR",1,76174565,76290984,116420,2]
["chr1",76599655,76601446,1792,"ENSBGRG00000017484","ENSBGRT00000032522",25840,"TNK2","tyrosine kinase non receptor 2 [Source:HGNC Symbol;Acc:HGNC:19297]","GO:0004672(protein kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0016310(phosphorylation)","NA",{"v":1e-30,"d":"0.00"},2,"403,77,","0,1715",-30,-29,2.63,"Exon (ENSBGRT00000032522/ENSBGRG00000017484, exon 13 of 17)",1,76595235,76627286,32052,2]
["chr1",76618420,76632191,13772,"ENSBGRG00000017484","ENSBGRT00000032522",0,"TNK2","tyrosine kinase non receptor 2 [Source:HGNC Symbol;Acc:HGNC:19297]","GO:0004672(protein kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0016310(phosphorylation)","NA",{"v":4e-21,"d":"0.00"},4,"34,181,78,38,","0,2153,8789,13734",{"v":-20.4,"d":"-20.40"},{"v":-19.5,"d":"-19.50"},3.31,"5' UTR",1,76595235,76627286,32052,2]
["chr1",76632251,76646117,13867,"ENSBGRG00000017484","ENSBGRT00000032392",0,"TNK2","tyrosine kinase non receptor 2 [Source:HGNC Symbol;Acc:HGNC:19297]","GO:0004672(protein kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0016310(phosphorylation)","NA",{"v":1e-69,"d":"0.00"},2,"42,378,","0,13489",-69,{"v":-67.7,"d":"-67.70"},{"v":32.4,"d":"32.40"},"5' UTR",1,76595235,76646117,50883,2]
["chr1",76646138,76647125,988,"ENSBGRG00000017823","ENSBGRT00000032649",209,"ENSBGRG00000017823","NA","NA","NA",{"v":6.3e-62,"d":"0.00"},1,"988,",0,{"v":-61.2,"d":"-61.20"},{"v":-59.9,"d":"-59.90"},{"v":53.5,"d":"53.50"},"Exon (ENSBGRT00000032649/ENSBGRG00000017823, exon 1 of 1)",1,76646138,76647334,1197,2]
["chr1",76978624,76980912,2289,"ENSBGRG00000018000","ENSBGRT00000033156",55885,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":4e-57,"d":"0.00"},3,"395,80,392,","0,1701,1897",{"v":-56.4,"d":"-56.40"},{"v":-55.1,"d":"-55.10"},{"v":3.9,"d":"3.90"},"3' UTR",1,76787597,77036797,249201,2]
["chr1",76857590,76868161,10572,"ENSBGRG00000018000","ENSBGRT00000033156",168636,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":1.1e-10,"d":"0.00"},3,"30,187,48,","0,9458,10524",-9.96,-9.16,3.96,"Exon (ENSBGRT00000033712/ENSBGRG00000018377, exon 7 of 8)",1,76787597,77036797,249201,2]
["chr1",76946171,76946378,208,"ENSBGRG00000018000","ENSBGRT00000033156",90419,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":2.3E-5,"d":"0.00"},1,"208,",0,-4.64,-3.98,1.85,"Exon (ENSBGRT00000034129/ENSBGRG00000018600, exon 1 of 5)",1,76787597,77036797,249201,2]
["chr1",76946437,76946525,89,"ENSBGRG00000018000","ENSBGRT00000033156",90272,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":3.3E-3,"d":"0.00"},1,"89,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000034129/ENSBGRG00000018600, exon 1 of 5)",1,76787597,77036797,249201,2]
["chr1",76946584,76946702,119,"ENSBGRG00000018600","ENSBGRT00000034129",0,"ENSBGRG00000018600","NA","NA","NA",0.04,1,"119,",0,{"v":-1.4,"d":"-1.40"},-0.91,2.97,"Exon (ENSBGRT00000034129/ENSBGRG00000018600, exon 1 of 5)",1,76918942,76946702,27761,2]
["chr1",76950052,76950202,151,"ENSBGRG00000018000","ENSBGRT00000033156",86595,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":5.6e-05,"d":"0.00"},1,"151,",0,-4.25,{"v":-3.6,"d":"-3.60"},{"v":2.7,"d":"2.70"},"3' UTR",1,76787597,77036797,249201,2]
["chr1",76950561,76951011,451,"ENSBGRG00000018000","ENSBGRT00000033156",85786,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",0.02,1,"451,",0,-1.69,{"v":-0.977,"d":"-0.98"},7.92,"3' UTR",1,76787597,77036797,249201,2]
["chr1",76951221,76951491,271,"ENSBGRG00000018000","ENSBGRT00000033156",85306,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":1.8E-3,"d":"0.00"},1,"271,",0,-2.74,-2.16,{"v":11.9,"d":"11.90"},"3' UTR",1,76787597,77036797,249201,2]
["chr1",77072182,77095313,23132,"ENSBGRG00000018793","ENSBGRT00000034429",0,"ENSBGRG00000018793","NA","NA","NA",{"v":1E-174,"d":"0.00"},6,"1299,82,122,180,77,157,","0,4534,6629,9280,16946,22975",-174,-172,8.59,"Exon (ENSBGRT00000034429/ENSBGRG00000018793, exon 1 of 1)",1,77086383,77087993,1611,1]
["chr1",77146813,77152319,5507,"ENSBGRG00000018865","ENSBGRT00000034606",0,"WDR53","WD repeat domain 53 [Source:HGNC Symbol;Acc:HGNC:28786]","GO:0005515(protein binding)","NA",{"v":6.3e-96,"d":"0.00"},2,"597,496,","0,5011",{"v":-95.2,"d":"-95.20"},{"v":-93.7,"d":"-93.70"},{"v":33.7,"d":"33.70"},"5' UTR",1,77146813,77152319,5507,2]
["chr1",77302430,77303637,1208,"ENSBGRG00000018942","ENSBGRT00000034720",59,"CEP19","centrosomal protein 19 [Source:HGNC Symbol;Acc:HGNC:28209]","GO:0000922(spindle pole);GO:0005813(centrosome);GO:0005814(centriole);GO:0005929(cilium);GO:0034454(microtubule anchoring at centrosome);GO:0036064(ciliary basal body);GO:0060271(cilium assembly);GO:0097712(vesicle targeting, trans-Golgi to periciliary membrane compartment)","NA",{"v":1e-103,"d":"0.00"},2,"362,141,","0,1067",-103,-101,11,"5' UTR",1,77302430,77303696,1267,2]
["chr1",77505812,77506022,211,"ENSBGRG00000019513","ENSBGRT00000035963",0,"NCBP2","nuclear cap binding protein subunit 2 [Source:HGNC Symbol;Acc:HGNC:7659]","GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0000339(RNA cap binding);GO:0000340(RNA 7-methylguanosine cap binding);GO:0003676(nucleic acid binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005845(mRNA cap binding complex);GO:0005846(nuclear cap binding complex);GO:0006446(regulation of translational initiation);GO:0017069(snRNA binding);GO:0031442(positive regulation of mRNA 3'-end processing);GO:0034518(RNA cap binding complex);GO:0045292(mRNA cis splicing, via spliceosome);GO:0098789(pre-mRNA cleavage required for polyadenylation)","03040(Spliceosome);03013(RNA transport);03015(mRNA surveillance pathway)",{"v":1.1E-5,"d":"0.00"},1,"211,",0,-4.95,-4.27,3.96,"5' UTR",1,77499029,77506022,6994,2]
["chr1",77511801,77511920,120,"ENSBGRG00000019104","ENSBGRT00000035256",125250,"PAK2","p21 (RAC1) activated kinase 2 [Source:HGNC Symbol;Acc:HGNC:8591]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0014069(postsynaptic density);GO:0016310(phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0030296(protein tyrosine kinase activator activity);GO:0031267(small GTPase binding);GO:0034333(adherens junction assembly);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0048365(Rac GTPase binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051493(regulation of cytoskeleton organization);GO:0051497(negative regulation of stress fiber assembly);GO:0060996(dendritic spine development);GO:0070830(bicellular tight junction assembly);GO:0071407(cellular response to organic cyclic compound);GO:0098978(glutamatergic synapse);GO:0150105(protein localization to cell-cell junction);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04660(T cell receptor signaling pathway);04360(Axon guidance);05211(Renal cell carcinoma)",0.02,1,"120,",0,-1.69,-1.18,1.68,"Exon (ENSBGRT00000036186/ENSBGRG00000019688, exon 2 of 2)",1,77386551,77583260,196710,1]
["chr1",77512395,77512573,179,"ENSBGRG00000019104","ENSBGRT00000035256",125844,"PAK2","p21 (RAC1) activated kinase 2 [Source:HGNC Symbol;Acc:HGNC:8591]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0014069(postsynaptic density);GO:0016310(phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0030296(protein tyrosine kinase activator activity);GO:0031267(small GTPase binding);GO:0034333(adherens junction assembly);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0048365(Rac GTPase binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051493(regulation of cytoskeleton organization);GO:0051497(negative regulation of stress fiber assembly);GO:0060996(dendritic spine development);GO:0070830(bicellular tight junction assembly);GO:0071407(cellular response to organic cyclic compound);GO:0098978(glutamatergic synapse);GO:0150105(protein localization to cell-cell junction);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04660(T cell receptor signaling pathway);04360(Axon guidance);05211(Renal cell carcinoma)",{"v":0.0017,"d":"0.00"},1,"179,",0,-2.76,-2.18,2.17,"Exon (ENSBGRT00000036186/ENSBGRG00000019688, exon 2 of 2)",1,77386551,77583260,196710,1]
["chr1",77512633,77512870,238,"ENSBGRG00000019104","ENSBGRT00000035256",126082,"PAK2","p21 (RAC1) activated kinase 2 [Source:HGNC Symbol;Acc:HGNC:8591]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0014069(postsynaptic density);GO:0016310(phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0030296(protein tyrosine kinase activator activity);GO:0031267(small GTPase binding);GO:0034333(adherens junction assembly);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0048365(Rac GTPase binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051493(regulation of cytoskeleton organization);GO:0051497(negative regulation of stress fiber assembly);GO:0060996(dendritic spine development);GO:0070830(bicellular tight junction assembly);GO:0071407(cellular response to organic cyclic compound);GO:0098978(glutamatergic synapse);GO:0150105(protein localization to cell-cell junction);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04660(T cell receptor signaling pathway);04360(Axon guidance);05211(Renal cell carcinoma)",{"v":4.7e-05,"d":"0.00"},1,"238,",0,-4.33,-3.67,3.38,"Exon (ENSBGRT00000036186/ENSBGRG00000019688, exon 2 of 2)",1,77386551,77583260,196710,1]
["chr1",77645429,77662596,17168,"ENSBGRG00000020056","ENSBGRT00000041592",250165,"DLG1","discs large MAGUK scaffold protein 1 [Source:HGNC Symbol;Acc:HGNC:2900]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001657(ureteric bud development);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001771(immunological synapse formation);GO:0001772(immunological synapse);GO:0001935(endothelial cell proliferation);GO:0002088(lens development in camera-type eye);GO:0002369(T cell cytokine production);GO:0005515(protein binding);GO:0005604(basement membrane);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005923(bicellular tight junction);GO:0007015(actin filament organization);GO:0008022(protein C-terminus binding);GO:0008104(protein localization);GO:0008284(positive regulation of cell population proliferation);GO:0008360(regulation of cell shape);GO:0009898(cytoplasmic side of plasma membrane);GO:0014069(postsynaptic density);GO:0015459(potassium channel regulator activity);GO:0016323(basolateral plasma membrane);GO:0016328(lateral plasma membrane);GO:0019900(kinase binding);GO:0019901(protein kinase binding);GO:0019902(phosphatase binding);GO:0030054(cell junction);GO:0030432(peristalsis);GO:0030838(positive regulation of actin filament polymerization);GO:0030866(cortical actin cytoskeleton organization);GO:0030953(astral microtubule organization);GO:0031253(cell projection membrane);GO:0031434(mitogen-activated protein kinase kinase binding);GO:0031579(membrane raft organization);GO:0031594(neuromuscular junction);GO:0031641(regulation of myelination);GO:0032147(activation of protein kinase activity);GO:0033268(node of Ranvier);GO:0034629(cellular protein-containing complex localization);GO:0035748(myelin sheath abaxonal region);GO:0042110(T cell activation);GO:0042130(negative regulation of T cell proliferation);GO:0042391(regulation of membrane potential);GO:0042982(amyloid precursor protein metabolic process);GO:0043219(lateral loop);GO:0043268(positive regulation of potassium ion transport);GO:0043622(cortical microtubule organization);GO:0044325(ion channel binding);GO:0045121(membrane raft);GO:0045202(synapse);GO:0045930(negative regulation of mitotic cell cycle);GO:0048471(perinuclear region of cytoplasm);GO:0048608(reproductive structure development);GO:0048704(embryonic skeletal system morphogenesis);GO:0048729(tissue morphogenesis);GO:0048745(smooth muscle tissue development);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051660(establishment of centrosome localization);GO:0051898(negative regulation of protein kinase B signaling);GO:0060022(hard palate development);GO:0060090(molecular adaptor activity);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0070830(bicellular tight junction assembly);GO:0072659(protein localization to plasma membrane);GO:0097016(L27 domain binding);GO:0097025(MPP7-DLG1-LIN7 complex);GO:0097060(synaptic membrane);GO:0098609(cell-cell adhesion);GO:0098911(regulation of ventricular cardiac muscle cell action potential);GO:0098919(structural constituent of postsynaptic density);GO:0098978(glutamatergic synapse);GO:0099645(neurotransmitter receptor localization to postsynaptic specialization membrane);GO:1902473(regulation of protein localization to synapse);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1903286(regulation of potassium ion import);GO:1903753(negative regulation of p38MAPK cascade);GO:1903760(regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization);GO:1903764(regulation of potassium ion export across plasma membrane)","04390(Hippo signaling pathway);04530(Tight junction);04660(T cell receptor signaling pathway);05203(Viral carcinogenesis);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":3.1E-6,"d":"0.00"},5,"38,102,51,42,37,","0,5667,6877,9613,17131",-5.51,-4.82,1.54,"Exon (ENSBGRT00000041592/ENSBGRG00000020056, exon 18 of 25)",1,77624902,77912761,287860,2]
["chr1",78123285,78123524,240,"ENSBGRG00000022869","ENSBGRT00000042238",32407,"BDH1","3-hydroxybutyrate dehydrogenase 1 [Source:HGNC Symbol;Acc:HGNC:1027]","GO:0003858(3-hydroxybutyrate dehydrogenase activity);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0016491(oxidoreductase activity)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies)",{"v":1.3E-11,"d":"0.00"},1,"240,",0,{"v":-10.9,"d":"-10.90"},-10,{"v":4.5,"d":"4.50"},"Exon (ENSBGRT00000042238/ENSBGRG00000022869, exon 7 of 7)",1,78122628,78155931,33304,2]
["chr1",79155100,79156371,1272,"ENSBGRG00000023485","ENSBGRT00000043328",0,"FAM43A","family with sequence similarity 43 member A [Source:HGNC Symbol;Acc:HGNC:26888]","GO:0005515(protein binding)","NA",{"v":9.99999999999998e-234,"d":"0.00"},1,"1272,",0,-233,-230,{"v":22.1,"d":"22.10"},"Exon (ENSBGRT00000043328/ENSBGRG00000023485, exon 1 of 1)",1,79155100,79156371,1272,2]
["chr1",79729389,79729747,359,"ENSBGRG00000024386","ENSBGRT00000045011",2855,"HES1","hes family bHLH transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:5192]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001085(RNA polymerase II transcription factor binding);GO:0001217(DNA-binding transcription repressor activity);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0001889(liver development);GO:0003143(embryonic heart tube morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0003266(regulation of secondary heart field cardioblast proliferation);GO:0003281(ventricular septum development);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007155(cell adhesion);GO:0007219(Notch signaling pathway);GO:0007224(smoothened signaling pathway);GO:0007389(pattern specification process);GO:0008284(positive regulation of cell population proliferation);GO:0016477(cell migration);GO:0021537(telencephalon development);GO:0021555(midbrain-hindbrain boundary morphogenesis);GO:0021557(oculomotor nerve development);GO:0021558(trochlear nerve development);GO:0021575(hindbrain morphogenesis);GO:0021915(neural tube development);GO:0021983(pituitary gland development);GO:0021984(adenohypophysis development);GO:0030324(lung development);GO:0030513(positive regulation of BMP signaling pathway);GO:0030901(midbrain development);GO:0031016(pancreas development);GO:0032991(protein-containing complex);GO:0035019(somatic stem cell population maintenance);GO:0035909(aorta morphogenesis);GO:0035910(ascending aorta morphogenesis);GO:0042102(positive regulation of T cell proliferation);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0043388(positive regulation of DNA binding);GO:0043398(HLH domain binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045165(cell fate commitment);GO:0045596(negative regulation of cell differentiation);GO:0045598(regulation of fat cell differentiation);GO:0045608(negative regulation of inner ear auditory receptor cell differentiation);GO:0045665(negative regulation of neuron differentiation);GO:0045747(positive regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045977(positive regulation of mitotic cell cycle, embryonic);GO:0046331(lateral inhibition);GO:0046425(regulation of receptor signaling pathway via JAK-STAT);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT);GO:0046983(protein dimerization activity);GO:0048469(cell maturation);GO:0048505(regulation of timing of cell differentiation);GO:0048538(thymus development);GO:0048667(cell morphogenesis involved in neuron differentiation);GO:0048711(positive regulation of astrocyte differentiation);GO:0048715(negative regulation of oligodendrocyte differentiation);GO:0048844(artery morphogenesis);GO:0050678(regulation of epithelial cell proliferation);GO:0050767(regulation of neurogenesis);GO:0051087(chaperone binding);GO:0060122(inner ear receptor cell stereocilium organization);GO:0060164(regulation of timing of neuron differentiation);GO:0060253(negative regulation of glial cell proliferation);GO:0060412(ventricular septum morphogenesis);GO:0060675(ureteric bud morphogenesis);GO:0060716(labyrinthine layer blood vessel development);GO:0061009(common bile duct development);GO:0061106(negative regulation of stomach neuroendocrine cell differentiation);GO:0061309(cardiac neural crest cell development involved in outflow tract morphogenesis);GO:0061626(pharyngeal arch artery morphogenesis);GO:0065003(protein-containing complex assembly);GO:0070888(E-box binding);GO:0071820(N-box binding);GO:0072012(glomerulus vasculature development);GO:0072049(comma-shaped body morphogenesis);GO:0072050(S-shaped body morphogenesis);GO:0072141(renal interstitial fibroblast development);GO:0072282(metanephric nephron tubule morphogenesis);GO:0090102(cochlea development);GO:0090162(establishment of epithelial cell polarity);GO:0097084(vascular smooth muscle cell development);GO:0097150(neuronal stem cell population maintenance);GO:1905934(negative regulation of cell fate determination);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000227(negative regulation of pancreatic A cell differentiation);GO:2000737(negative regulation of stem cell differentiation);GO:2000974(negative regulation of pro-B cell differentiation);GO:2000981(negative regulation of inner ear receptor cell differentiation)","03460(Fanconi anemia pathway);04330(Notch signaling pathway);05200(Pathways in cancer);05224(Breast cancer);04950(Maturity onset diabetes of the young);05165(Human papillomavirus infection)",{"v":3.2e-31,"d":"0.00"},1,"359,",0,{"v":-30.5,"d":"-30.50"},{"v":-29.5,"d":"-29.50"},8.79,"Exon (ENSBGRT00000045011/ENSBGRG00000024386, exon 5 of 5)",1,79729389,79732602,3214,2]
["chr1",79730755,79731053,299,"ENSBGRG00000024386","ENSBGRT00000045011",1549,"HES1","hes family bHLH transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:5192]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001085(RNA polymerase II transcription factor binding);GO:0001217(DNA-binding transcription repressor activity);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0001889(liver development);GO:0003143(embryonic heart tube morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0003266(regulation of secondary heart field cardioblast proliferation);GO:0003281(ventricular septum development);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007155(cell adhesion);GO:0007219(Notch signaling pathway);GO:0007224(smoothened signaling pathway);GO:0007389(pattern specification process);GO:0008284(positive regulation of cell population proliferation);GO:0016477(cell migration);GO:0021537(telencephalon development);GO:0021555(midbrain-hindbrain boundary morphogenesis);GO:0021557(oculomotor nerve development);GO:0021558(trochlear nerve development);GO:0021575(hindbrain morphogenesis);GO:0021915(neural tube development);GO:0021983(pituitary gland development);GO:0021984(adenohypophysis development);GO:0030324(lung development);GO:0030513(positive regulation of BMP signaling pathway);GO:0030901(midbrain development);GO:0031016(pancreas development);GO:0032991(protein-containing complex);GO:0035019(somatic stem cell population maintenance);GO:0035909(aorta morphogenesis);GO:0035910(ascending aorta morphogenesis);GO:0042102(positive regulation of T cell proliferation);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0043388(positive regulation of DNA binding);GO:0043398(HLH domain binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045165(cell fate commitment);GO:0045596(negative regulation of cell differentiation);GO:0045598(regulation of fat cell differentiation);GO:0045608(negative regulation of inner ear auditory receptor cell differentiation);GO:0045665(negative regulation of neuron differentiation);GO:0045747(positive regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045977(positive regulation of mitotic cell cycle, embryonic);GO:0046331(lateral inhibition);GO:0046425(regulation of receptor signaling pathway via JAK-STAT);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT);GO:0046983(protein dimerization activity);GO:0048469(cell maturation);GO:0048505(regulation of timing of cell differentiation);GO:0048538(thymus development);GO:0048667(cell morphogenesis involved in neuron differentiation);GO:0048711(positive regulation of astrocyte differentiation);GO:0048715(negative regulation of oligodendrocyte differentiation);GO:0048844(artery morphogenesis);GO:0050678(regulation of epithelial cell proliferation);GO:0050767(regulation of neurogenesis);GO:0051087(chaperone binding);GO:0060122(inner ear receptor cell stereocilium organization);GO:0060164(regulation of timing of neuron differentiation);GO:0060253(negative regulation of glial cell proliferation);GO:0060412(ventricular septum morphogenesis);GO:0060675(ureteric bud morphogenesis);GO:0060716(labyrinthine layer blood vessel development);GO:0061009(common bile duct development);GO:0061106(negative regulation of stomach neuroendocrine cell differentiation);GO:0061309(cardiac neural crest cell development involved in outflow tract morphogenesis);GO:0061626(pharyngeal arch artery morphogenesis);GO:0065003(protein-containing complex assembly);GO:0070888(E-box binding);GO:0071820(N-box binding);GO:0072012(glomerulus vasculature development);GO:0072049(comma-shaped body morphogenesis);GO:0072050(S-shaped body morphogenesis);GO:0072141(renal interstitial fibroblast development);GO:0072282(metanephric nephron tubule morphogenesis);GO:0090102(cochlea development);GO:0090162(establishment of epithelial cell polarity);GO:0097084(vascular smooth muscle cell development);GO:0097150(neuronal stem cell population maintenance);GO:1905934(negative regulation of cell fate determination);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000227(negative regulation of pancreatic A cell differentiation);GO:2000737(negative regulation of stem cell differentiation);GO:2000974(negative regulation of pro-B cell differentiation);GO:2000981(negative regulation of inner ear receptor cell differentiation)","03460(Fanconi anemia pathway);04330(Notch signaling pathway);05200(Pathways in cancer);05224(Breast cancer);04950(Maturity onset diabetes of the young);05165(Human papillomavirus infection)",{"v":0.012,"d":"0.01"},1,"299,",0,-1.92,-1.39,5.94,"Exon (ENSBGRT00000045031/ENSBGRG00000024386, exon 4 of 4)",1,79729389,79732602,3214,2]
["chr1",79732283,79732602,320,"ENSBGRG00000024386","ENSBGRT00000045011",0,"HES1","hes family bHLH transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:5192]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001085(RNA polymerase II transcription factor binding);GO:0001217(DNA-binding transcription repressor activity);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0001889(liver development);GO:0003143(embryonic heart tube morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0003266(regulation of secondary heart field cardioblast proliferation);GO:0003281(ventricular septum development);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007155(cell adhesion);GO:0007219(Notch signaling pathway);GO:0007224(smoothened signaling pathway);GO:0007389(pattern specification process);GO:0008284(positive regulation of cell population proliferation);GO:0016477(cell migration);GO:0021537(telencephalon development);GO:0021555(midbrain-hindbrain boundary morphogenesis);GO:0021557(oculomotor nerve development);GO:0021558(trochlear nerve development);GO:0021575(hindbrain morphogenesis);GO:0021915(neural tube development);GO:0021983(pituitary gland development);GO:0021984(adenohypophysis development);GO:0030324(lung development);GO:0030513(positive regulation of BMP signaling pathway);GO:0030901(midbrain development);GO:0031016(pancreas development);GO:0032991(protein-containing complex);GO:0035019(somatic stem cell population maintenance);GO:0035909(aorta morphogenesis);GO:0035910(ascending aorta morphogenesis);GO:0042102(positive regulation of T cell proliferation);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0043388(positive regulation of DNA binding);GO:0043398(HLH domain binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045165(cell fate commitment);GO:0045596(negative regulation of cell differentiation);GO:0045598(regulation of fat cell differentiation);GO:0045608(negative regulation of inner ear auditory receptor cell differentiation);GO:0045665(negative regulation of neuron differentiation);GO:0045747(positive regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045977(positive regulation of mitotic cell cycle, embryonic);GO:0046331(lateral inhibition);GO:0046425(regulation of receptor signaling pathway via JAK-STAT);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT);GO:0046983(protein dimerization activity);GO:0048469(cell maturation);GO:0048505(regulation of timing of cell differentiation);GO:0048538(thymus development);GO:0048667(cell morphogenesis involved in neuron differentiation);GO:0048711(positive regulation of astrocyte differentiation);GO:0048715(negative regulation of oligodendrocyte differentiation);GO:0048844(artery morphogenesis);GO:0050678(regulation of epithelial cell proliferation);GO:0050767(regulation of neurogenesis);GO:0051087(chaperone binding);GO:0060122(inner ear receptor cell stereocilium organization);GO:0060164(regulation of timing of neuron differentiation);GO:0060253(negative regulation of glial cell proliferation);GO:0060412(ventricular septum morphogenesis);GO:0060675(ureteric bud morphogenesis);GO:0060716(labyrinthine layer blood vessel development);GO:0061009(common bile duct development);GO:0061106(negative regulation of stomach neuroendocrine cell differentiation);GO:0061309(cardiac neural crest cell development involved in outflow tract morphogenesis);GO:0061626(pharyngeal arch artery morphogenesis);GO:0065003(protein-containing complex assembly);GO:0070888(E-box binding);GO:0071820(N-box binding);GO:0072012(glomerulus vasculature development);GO:0072049(comma-shaped body morphogenesis);GO:0072050(S-shaped body morphogenesis);GO:0072141(renal interstitial fibroblast development);GO:0072282(metanephric nephron tubule morphogenesis);GO:0090102(cochlea development);GO:0090162(establishment of epithelial cell polarity);GO:0097084(vascular smooth muscle cell development);GO:0097150(neuronal stem cell population maintenance);GO:1905934(negative regulation of cell fate determination);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000227(negative regulation of pancreatic A cell differentiation);GO:2000737(negative regulation of stem cell differentiation);GO:2000974(negative regulation of pro-B cell differentiation);GO:2000981(negative regulation of inner ear receptor cell differentiation)","03460(Fanconi anemia pathway);04330(Notch signaling pathway);05200(Pathways in cancer);05224(Breast cancer);04950(Maturity onset diabetes of the young);05165(Human papillomavirus infection)",{"v":4.1e-08,"d":"0.00"},2,"72,108,","0,212",-7.39,-6.64,2.22,"Exon (ENSBGRT00000045011/ENSBGRG00000024386, exon 1 of 5)",1,79729389,79732602,3214,2]
["chr1",82551724,82566823,15100,"ENSBGRG00000000499","ENSBGRT00000000962",60187,"CCDC50","coiled-coil domain containing 50 [Source:HGNC Symbol;Acc:HGNC:18111]","GO:0005829(cytosol);GO:0007605(sensory perception of sound);GO:0031625(ubiquitin protein ligase binding)","NA",{"v":4e-16,"d":"0.00"},3,"33,116,472,","0,5458,14628",{"v":-15.4,"d":"-15.40"},{"v":-14.5,"d":"-14.50"},{"v":4.2,"d":"4.20"},"Exon (ENSBGRT00000000962/ENSBGRG00000000499, exon 6 of 12)",1,82541012,82627010,85999,2]
["chr1",85583876,85584115,240,"ENSBGRG00000001121","ENSBGRT00000002076",353794,"LPP","LIM domain containing preferred translocation partner in lipoma [Source:HGNC Symbol;Acc:HGNC:6679]","GO:0005829(cytosol);GO:0005925(focal adhesion)","04621(NOD-like receptor signaling pathway)",{"v":0.00013,"d":"0.00"},1,"240,",0,-3.87,-3.24,2.97,"Exon (ENSBGRT00000002076/ENSBGRG00000001121, exon 6 of 11)",1,85249182,85937909,688728,2]
["chr1",86888754,86903265,14512,"ENSBGRG00000001272","ENSBGRT00000002315",781,"ENSBGRG00000001272","NA","NA","NA",{"v":3.2e-29,"d":"0.00"},3,"394,193,9,","0,2996,14503",{"v":-28.5,"d":"-28.50"},{"v":-27.5,"d":"-27.50"},5.31,"5' UTR",1,86887264,86904046,16783,2]
["chr1",87243967,87244562,596,"ENSBGRG00000001507","ENSBGRT00000002763",0,"RTP1","receptor transporter protein 1 [Source:HGNC Symbol;Acc:HGNC:28580]","GO:0009986(cell surface);GO:0031849(olfactory receptor binding);GO:0051205(protein insertion into membrane)","00510(N-Glycan biosynthesis);00514(Other types of O-glycan biosynthesis)",{"v":1.6E-90,"d":"0.00"},1,"596,",0,{"v":-89.8,"d":"-89.80"},{"v":-88.3,"d":"-88.30"},5.62,"5' UTR",1,87073783,87244562,170780,2]
["chr1",87201946,87202095,150,"ENSBGRG00000001507","ENSBGRT00000002763",42467,"RTP1","receptor transporter protein 1 [Source:HGNC Symbol;Acc:HGNC:28580]","GO:0009986(cell surface);GO:0031849(olfactory receptor binding);GO:0051205(protein insertion into membrane)","00510(N-Glycan biosynthesis);00514(Other types of O-glycan biosynthesis)",{"v":2.6e-05,"d":"0.00"},1,"150,",0,-4.58,-3.91,{"v":1.7,"d":"1.70"},"Exon (ENSBGRT00000002838/ENSBGRG00000001521, exon 5 of 5)",1,87073783,87244562,170780,2]
["chr1",87243938,87244562,625,"ENSBGRG00000001507","ENSBGRT00000002763",0,"RTP1","receptor transporter protein 1 [Source:HGNC Symbol;Acc:HGNC:28580]","GO:0009986(cell surface);GO:0031849(olfactory receptor binding);GO:0051205(protein insertion into membrane)","00510(N-Glycan biosynthesis);00514(Other types of O-glycan biosynthesis)",{"v":1.3e-89,"d":"0.00"},1,"625,",0,{"v":-88.9,"d":"-88.90"},{"v":-87.4,"d":"-87.40"},5.57,"5' UTR",1,87073783,87244562,170780,2]
["chr1",87430632,87449976,19345,"ENSBGRG00000001590","ENSBGRT00000002959",2640,"ENSBGRG00000001590","NA","GO:0005515(protein binding)","04152(AMPK signaling pathway);04920(Adipocytokine signaling pathway);03320(PPAR signaling pathway);04211(Longevity regulating pathway - mammal);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":0.012,"d":"0.01"},2,"2,119,","0,19226",-1.92,-1.39,2.97,"3' UTR",1,87430394,87452616,22223,2]
["chr1",87505785,87505994,210,"ENSBGRG00000001653","ENSBGRT00000003091",5774,"ENSBGRG00000001653","NA","GO:0003676(nucleic acid binding);GO:0005524(ATP binding)","03013(RNA transport)",{"v":3.2E-78,"d":"0.00"},1,"210,",0,{"v":-77.5,"d":"-77.50"},{"v":-76.2,"d":"-76.20"},1.58,"3' UTR",1,87505785,87511768,5984,2]
["chr1",87506204,87507539,1336,"ENSBGRG00000001653","ENSBGRT00000003091",4229,"ENSBGRG00000001653","NA","GO:0003676(nucleic acid binding);GO:0005524(ATP binding)","03013(RNA transport)",{"v":7.9e-20,"d":"0.00"},3,"76,10,5,","0,887,1331",{"v":-19.1,"d":"-19.10"},{"v":-18.2,"d":"-18.20"},1.17,"Exon (ENSBGRT00000003091/ENSBGRG00000001653, exon 10 of 11)",1,87505785,87511768,5984,2]
["chr1",87706645,87707278,634,"ENSBGRG00000001887","ENSBGRT00000003524",18245,"ENSBGRG00000001887","NA","GO:0005102(signaling receptor binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006457(protein folding);GO:0016556(mRNA modification);GO:0050768(negative regulation of neurogenesis);GO:0051082(unfolded protein binding)","04141(Protein processing in endoplasmic reticulum)",{"v":4e-38,"d":"0.00"},2,"47,131,","0,503",{"v":-37.4,"d":"-37.40"},{"v":-36.3,"d":"-36.30"},2.48,"Exon (ENSBGRT00000003524/ENSBGRG00000001887, exon 9 of 10)",1,87706586,87725523,18938,2]
["chr1",87725110,87725523,414,"ENSBGRG00000001887","ENSBGRT00000003524",0,"ENSBGRG00000001887","NA","GO:0005102(signaling receptor binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006457(protein folding);GO:0016556(mRNA modification);GO:0050768(negative regulation of neurogenesis);GO:0051082(unfolded protein binding)","04141(Protein processing in endoplasmic reticulum)",{"v":1.6e-30,"d":"0.00"},1,"414,",0,{"v":-29.8,"d":"-29.80"},{"v":-28.8,"d":"-28.80"},{"v":8.8,"d":"8.80"},"5' UTR",1,87706586,87725523,18938,2]
["chr1",88771778,88773811,2034,"ENSBGRG00000002680","ENSBGRT00000005016",17498,"SENP2","SUMO specific peptidase 2 [Source:HGNC Symbol;Acc:HGNC:23116]","GO:0005643(nuclear pore);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0007507(heart development);GO:0008234(cysteine-type peptidase activity);GO:0016604(nuclear body);GO:0016605(PML body);GO:0016926(protein desumoylation);GO:0031397(negative regulation of protein ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0031648(protein destabilization);GO:0032875(regulation of DNA endoreduplication);GO:0035562(negative regulation of chromatin binding);GO:0045444(fat cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060707(trophoblast giant cell differentiation);GO:0060711(labyrinthine layer development);GO:0060712(spongiotrophoblast layer development);GO:0070139(SUMO-specific endopeptidase activity);GO:0070140(SUMO-specific isopeptidase activity);GO:2000045(regulation of G1/S transition of mitotic cell cycle)","03013(RNA transport);04310(Wnt signaling pathway)",{"v":2E-14,"d":"0.00"},2,"87,4,","0,2030",{"v":-13.7,"d":"-13.70"},{"v":-12.8,"d":"-12.80"},1.57,"Exon (ENSBGRT00000005016/ENSBGRG00000002680, exon 10 of 17)",1,88755640,88791309,35670,2]
["chr1",88777647,88779552,1906,"ENSBGRG00000002680","ENSBGRT00000005016",11757,"SENP2","SUMO specific peptidase 2 [Source:HGNC Symbol;Acc:HGNC:23116]","GO:0005643(nuclear pore);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0007507(heart development);GO:0008234(cysteine-type peptidase activity);GO:0016604(nuclear body);GO:0016605(PML body);GO:0016926(protein desumoylation);GO:0031397(negative regulation of protein ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0031648(protein destabilization);GO:0032875(regulation of DNA endoreduplication);GO:0035562(negative regulation of chromatin binding);GO:0045444(fat cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060707(trophoblast giant cell differentiation);GO:0060711(labyrinthine layer development);GO:0060712(spongiotrophoblast layer development);GO:0070139(SUMO-specific endopeptidase activity);GO:0070140(SUMO-specific isopeptidase activity);GO:2000045(regulation of G1/S transition of mitotic cell cycle)","03013(RNA transport);04310(Wnt signaling pathway)",{"v":0.0004,"d":"0.00"},2,"43,48,","0,1858",{"v":-3.4,"d":"-3.40"},-2.79,1.25,"Exon (ENSBGRT00000005016/ENSBGRG00000002680, exon 6 of 17)",1,88755640,88791309,35670,2]
["chr1",88889707,88889767,61,"ENSBGRG00000002802","ENSBGRT00000005394",51467,"MAP3K13","mitogen-activated protein kinase kinase kinase 13 [Source:HGNC Symbol;Acc:HGNC:6852]","GO:0000186(activation of MAPKK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004706(JUN kinase kinase kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007254(JNK cascade);GO:0007256(activation of JNKK activity);GO:0007257(activation of JUN kinase activity);GO:0014042(positive regulation of neuron maturation);GO:0016020(membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0045773(positive regulation of axon extension);GO:0046777(protein autophosphorylation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0106137(IkappaB kinase complex binding);GO:0150012(positive regulation of neuron projection arborization);GO:1905492(positive regulation of branching morphogenesis of a nerve)","04010(MAPK signaling pathway)",{"v":0.034,"d":"0.03"},1,"61,",0,-1.47,{"v":-0.977,"d":"-0.98"},4.46,"Exon (ENSBGRT00000005394/ENSBGRG00000002802, exon 13 of 13)",1,88889707,88941234,51528,2]
["chr1",88897923,88898372,450,"ENSBGRG00000002802","ENSBGRT00000005394",42862,"MAP3K13","mitogen-activated protein kinase kinase kinase 13 [Source:HGNC Symbol;Acc:HGNC:6852]","GO:0000186(activation of MAPKK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004706(JUN kinase kinase kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007254(JNK cascade);GO:0007256(activation of JNKK activity);GO:0007257(activation of JUN kinase activity);GO:0014042(positive regulation of neuron maturation);GO:0016020(membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0045773(positive regulation of axon extension);GO:0046777(protein autophosphorylation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0106137(IkappaB kinase complex binding);GO:0150012(positive regulation of neuron projection arborization);GO:1905492(positive regulation of branching morphogenesis of a nerve)","04010(MAPK signaling pathway)",{"v":2.1e-09,"d":"0.00"},1,"450,",0,-8.68,-7.91,{"v":4.2,"d":"4.20"},"Exon (ENSBGRT00000005394/ENSBGRG00000002802, exon 10 of 13)",1,88889707,88941234,51528,2]
["chr1",88928823,88941182,12360,"ENSBGRG00000002802","ENSBGRT00000005394",52,"MAP3K13","mitogen-activated protein kinase kinase kinase 13 [Source:HGNC Symbol;Acc:HGNC:6852]","GO:0000186(activation of MAPKK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004706(JUN kinase kinase kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007254(JNK cascade);GO:0007256(activation of JNKK activity);GO:0007257(activation of JUN kinase activity);GO:0014042(positive regulation of neuron maturation);GO:0016020(membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0045773(positive regulation of axon extension);GO:0046777(protein autophosphorylation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0106137(IkappaB kinase complex binding);GO:0150012(positive regulation of neuron projection arborization);GO:1905492(positive regulation of branching morphogenesis of a nerve)","04010(MAPK signaling pathway)",{"v":4.1e-07,"d":"0.00"},2,"151,508,","0,11852",-6.39,-5.67,5.32,"5' UTR",1,88889707,88941234,51528,2]
["chr1",89333686,89372546,38861,"ENSBGRG00000002973","ENSBGRT00000005605",274544,"VPS8","VPS8 subunit of CORVET complex [Source:HGNC Symbol;Acc:HGNC:29122]","GO:0005515(protein binding);GO:0005769(early endosome);GO:0033263(CORVET complex);GO:0034058(endosomal vesicle fusion)","NA",{"v":4e-11,"d":"0.00"},4,"18,129,81,13,","0,20,3013,38848",{"v":-10.4,"d":"-10.40"},{"v":-9.6,"d":"-9.60"},{"v":4.7,"d":"4.70"},"Exon (ENSBGRT00000005605/ENSBGRG00000002973, exon 45 of 48)",1,89333686,89647090,313405,2]
["chr1",89647000,89647090,91,"ENSBGRG00000002973","ENSBGRT00000005605",0,"VPS8","VPS8 subunit of CORVET complex [Source:HGNC Symbol;Acc:HGNC:29122]","GO:0005515(protein binding);GO:0005769(early endosome);GO:0033263(CORVET complex);GO:0034058(endosomal vesicle fusion)","NA",{"v":0.011,"d":"0.01"},1,"91,",0,-1.94,-1.41,1.82,"5' UTR",1,89333686,89647090,313405,2]
["chr1",90158231,90159356,1126,"ENSBGRG00000003267","ENSBGRT00000006071",2906,"POLR2H","RNA polymerase II subunit H [Source:HGNC Symbol;Acc:HGNC:9195]","GO:0003697(single-stranded DNA binding);GO:0005634(nucleus);GO:0005665(RNA polymerase II, core complex);GO:0006351(transcription, DNA-templated);GO:0006366(transcription by RNA polymerase II);GO:0032993(protein-DNA complex)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway);05016(Huntington disease);05169(Epstein-Barr virus infection)",{"v":1.1e-09,"d":"0.00"},2,"118,52,","0,1074",-8.94,-8.16,1.54,"Exon (ENSBGRT00000006071/ENSBGRG00000003267, exon 4 of 5)",1,90158231,90162262,4032,2]
["chr1",90182590,90182768,179,"ENSBGRG00000003599","ENSBGRT00000006707",6376,"FAM131A","family with sequence similarity 131 member A [Source:HGNC Symbol;Acc:HGNC:28308]","NA","03013(RNA transport);05416(Viral myocarditis)",{"v":0.0022,"d":"0.00"},1,"179,",0,-2.65,-2.07,1.82,"3' UTR",1,90182232,90189144,6913,2]
["chr1",90183126,90185530,2405,"ENSBGRG00000003599","ENSBGRT00000006707",3614,"FAM131A","family with sequence similarity 131 member A [Source:HGNC Symbol;Acc:HGNC:28308]","NA","03013(RNA transport);05416(Viral myocarditis)",{"v":1.6e-26,"d":"0.00"},3,"582,117,47,","0,2077,2358",{"v":-25.8,"d":"-25.80"},{"v":-24.8,"d":"-24.80"},4.57,"3' UTR",1,90182232,90189144,6913,2]
["chr1",90192428,90195624,3197,"ENSBGRG00000003743","ENSBGRT00000009257",20212,"EIF4G1","eukaryotic translation initiation factor 4 gamma 1 [Source:HGNC Symbol;Acc:HGNC:3296]","GO:0001662(behavioral fear response);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005844(polysome);GO:0006412(translation);GO:0006446(regulation of translational initiation);GO:0008135(translation factor activity, RNA binding);GO:0008190(eukaryotic initiation factor 4E binding);GO:0010507(negative regulation of autophagy);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0010942(positive regulation of cell death);GO:0016281(eukaryotic translation initiation factor 4F complex);GO:0030307(positive regulation of cell growth);GO:0031669(cellular response to nutrient levels);GO:0032270(positive regulation of cellular protein metabolic process);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034645(cellular macromolecule biosynthetic process);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042802(identical protein binding);GO:0045666(positive regulation of neuron differentiation);GO:0097009(energy homeostasis);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1905537(positive regulation of eukaryotic translation initiation factor 4F complex assembly);GO:1905606(regulation of presynapse assembly);GO:1905612(positive regulation of mRNA cap binding);GO:1905618(positive regulation of miRNA mediated inhibition of translation);GO:1905696(regulation of polysome binding)","03013(RNA transport);05416(Viral myocarditis)",0,2,"353,66,","0,3131",-530,"-Inf",{"v":18.2,"d":"18.20"},"3' UTR",1,90192428,90215836,23409,2]
["chr1",90199861,90199921,61,"ENSBGRG00000003743","ENSBGRT00000009257",15915,"EIF4G1","eukaryotic translation initiation factor 4 gamma 1 [Source:HGNC Symbol;Acc:HGNC:3296]","GO:0001662(behavioral fear response);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005844(polysome);GO:0006412(translation);GO:0006446(regulation of translational initiation);GO:0008135(translation factor activity, RNA binding);GO:0008190(eukaryotic initiation factor 4E binding);GO:0010507(negative regulation of autophagy);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0010942(positive regulation of cell death);GO:0016281(eukaryotic translation initiation factor 4F complex);GO:0030307(positive regulation of cell growth);GO:0031669(cellular response to nutrient levels);GO:0032270(positive regulation of cellular protein metabolic process);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034645(cellular macromolecule biosynthetic process);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042802(identical protein binding);GO:0045666(positive regulation of neuron differentiation);GO:0097009(energy homeostasis);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1905537(positive regulation of eukaryotic translation initiation factor 4F complex assembly);GO:1905606(regulation of presynapse assembly);GO:1905612(positive regulation of mRNA cap binding);GO:1905618(positive regulation of miRNA mediated inhibition of translation);GO:1905696(regulation of polysome binding)","03013(RNA transport);05416(Viral myocarditis)",{"v":5.4e-05,"d":"0.00"},1,"61,",0,-4.27,-3.62,2.45,"Exon (ENSBGRT00000009257/ENSBGRG00000003743, exon 26 of 36)",1,90192428,90215836,23409,2]
["chr1",90206683,90209145,2463,"ENSBGRG00000003743","ENSBGRT00000009257",6691,"EIF4G1","eukaryotic translation initiation factor 4 gamma 1 [Source:HGNC Symbol;Acc:HGNC:3296]","GO:0001662(behavioral fear response);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005844(polysome);GO:0006412(translation);GO:0006446(regulation of translational initiation);GO:0008135(translation factor activity, RNA binding);GO:0008190(eukaryotic initiation factor 4E binding);GO:0010507(negative regulation of autophagy);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0010942(positive regulation of cell death);GO:0016281(eukaryotic translation initiation factor 4F complex);GO:0030307(positive regulation of cell growth);GO:0031669(cellular response to nutrient levels);GO:0032270(positive regulation of cellular protein metabolic process);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034645(cellular macromolecule biosynthetic process);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042802(identical protein binding);GO:0045666(positive regulation of neuron differentiation);GO:0097009(energy homeostasis);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1905537(positive regulation of eukaryotic translation initiation factor 4F complex assembly);GO:1905606(regulation of presynapse assembly);GO:1905612(positive regulation of mRNA cap binding);GO:1905618(positive regulation of miRNA mediated inhibition of translation);GO:1905696(regulation of polysome binding)","03013(RNA transport);05416(Viral myocarditis)",{"v":9.99999999999998e-263,"d":"0.00"},4,"118,89,424,177,","0,210,1818,2286",-262,-260,{"v":4.7,"d":"4.70"},"Exon (ENSBGRT00000009257/ENSBGRG00000003743, exon 10 of 36)",1,90192428,90215836,23409,2]
["chr1",90230570,90230690,121,"ENSBGRG00000000173","ENSBGRT00000000288",0,"PSMD2","proteasome 26S subunit, non-ATPase 2 [Source:HGNC Symbol;Acc:HGNC:9559]","GO:0000502(proteasome complex);GO:0005838(proteasome regulatory particle);GO:0022624(proteasome accessory complex);GO:0030234(enzyme regulator activity);GO:0042176(regulation of protein catabolic process)","03050(Proteasome);05169(Epstein-Barr virus infection)",{"v":3.2E-34,"d":"0.00"},1,"121,",0,{"v":-33.5,"d":"-33.50"},{"v":-32.5,"d":"-32.50"},2.11,"Exon (ENSBGRT00000000288/ENSBGRG00000000173, exon 1 of 21)",1,90221538,90230690,9153,2]
["chr1",90268456,90268545,90,"ENSBGRG00000000248","ENSBGRT00000000391",5961,"EEF1AKMT4","EEF1A lysine methyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:53611]","GO:0008168(methyltransferase activity);GO:0016279(protein-lysine N-methyltransferase activity)","NA",{"v":1.1E-5,"d":"0.00"},1,"90,",0,-4.97,-4.29,{"v":11.4,"d":"11.40"},"Exon (ENSBGRT00000000391/ENSBGRG00000000248, exon 3 of 3)",1,90268456,90274506,6051,2]
["chr1",90282470,90282825,356,"ENSBGRG00000000570","ENSBGRT00000000995",0,"MIR1224","microRNA 1224 [Source:HGNC Symbol;Acc:HGNC:33923]","NA","NA",{"v":0.036,"d":"0.04"},2,"250,20,","0,336",-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000000872/ENSBGRG00000000310, exon 17 of 18)",1,90282720,90282805,86,2]
["chr1",90314125,90314709,585,"ENSBGRG00000000581","ENSBGRT00000001191",6954,"ABCF3","ATP binding cassette subfamily F member 3 [Source:HGNC Symbol;Acc:HGNC:72]","GO:0005524(ATP binding);GO:0016887(ATPase activity)","NA",{"v":1e-30,"d":"0.00"},3,"159,88,113,","0,247,472",-30,-29,4.14,"Exon (ENSBGRT00000001191/ENSBGRG00000000581, exon 20 of 22)",1,90314125,90321663,7539,2]
["chr1",90338446,90338979,534,"ENSBGRG00000000862","ENSBGRT00000001629",8899,"DVL3","dishevelled segment polarity protein 3 [Source:HGNC Symbol;Acc:HGNC:3087]","GO:0000790(nuclear chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0002020(protease binding);GO:0005102(signaling receptor binding);GO:0005109(frizzled binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0008013(beta-catenin binding);GO:0016055(Wnt signaling pathway);GO:0035556(intracellular signal transduction);GO:0035567(non-canonical Wnt signaling pathway);GO:0043507(positive regulation of JUN kinase activity);GO:0043547(positive regulation of GTPase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048365(Rac GTPase binding);GO:0050821(protein stabilization);GO:0060070(canonical Wnt signaling pathway);GO:0060071(Wnt signaling pathway, planar cell polarity pathway);GO:1903827(regulation of cellular protein localization)","04310(Wnt signaling pathway);04330(Notch signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":2e-47,"d":"0.00"},2,"383,64,","0,470",{"v":-46.7,"d":"-46.70"},{"v":-45.6,"d":"-45.60"},2.09,"Exon (ENSBGRT00000001629/ENSBGRG00000000862, exon 12 of 14)",1,90337559,90347878,10320,2]
["chr1",90363090,90363856,767,"ENSBGRG00000000921","ENSBGRT00000001753",9719,"EIF2B5","eukaryotic translation initiation factor 2B subunit epsilon [Source:HGNC Symbol;Acc:HGNC:3261]","GO:0001541(ovarian follicle development);GO:0003743(translation initiation factor activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005851(eukaryotic translation initiation factor 2B complex);GO:0006413(translational initiation);GO:0009408(response to heat);GO:0014002(astrocyte development);GO:0014003(oligodendrocyte development);GO:0034976(response to endoplasmic reticulum stress);GO:0042552(myelination);GO:0048708(astrocyte differentiation);GO:0050852(T cell receptor signaling pathway)","03013(RNA transport)",{"v":1E-175,"d":"0.00"},2,"537,64,","0,703",-175,-173,3.96,"3' UTR",1,90362131,90373575,11445,2]
["chr1",90373515,90373575,61,"ENSBGRG00000000921","ENSBGRT00000001753",0,"EIF2B5","eukaryotic translation initiation factor 2B subunit epsilon [Source:HGNC Symbol;Acc:HGNC:3261]","GO:0001541(ovarian follicle development);GO:0003743(translation initiation factor activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005851(eukaryotic translation initiation factor 2B complex);GO:0006413(translational initiation);GO:0009408(response to heat);GO:0014002(astrocyte development);GO:0014003(oligodendrocyte development);GO:0034976(response to endoplasmic reticulum stress);GO:0042552(myelination);GO:0048708(astrocyte differentiation);GO:0050852(T cell receptor signaling pathway)","03013(RNA transport)",{"v":2.5e-11,"d":"0.00"},1,"61,",0,{"v":-10.6,"d":"-10.60"},-9.83,{"v":30.7,"d":"30.70"},"Exon (ENSBGRT00000001753/ENSBGRG00000000921, exon 1 of 17)",1,90362131,90373575,11445,2]
["chr1",90704488,90707646,3159,"ENSBGRG00000001414","ENSBGRT00000002587",85824,"YEATS2","YEATS domain containing 2 [Source:HGNC Symbol;Acc:HGNC:25489]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005634(nucleus);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0006355(regulation of transcription, DNA-templated);GO:0017025(TBP-class protein binding);GO:0042393(histone binding);GO:0043966(histone H3 acetylation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0072686(mitotic spindle);GO:0140030(modification-dependent protein binding)","NA",{"v":7.9e-54,"d":"0.00"},4,"109,74,75,131,","0,1377,2097,3028",{"v":-53.1,"d":"-53.10"},{"v":-51.9,"d":"-51.90"},3.91,"Exon (ENSBGRT00000002587/ENSBGRG00000001414, exon 29 of 32)",1,90704488,90793470,88983,2]
["chr1",90850073,90855906,5834,"ENSBGRG00000001442","ENSBGRT00000002647",19185,"KLHL24","kelch like family member 24 [Source:HGNC Symbol;Acc:HGNC:25947]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005912(adherens junction);GO:0016567(protein ubiquitination);GO:0030057(desmosome);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0045109(intermediate filament organization);GO:0051865(protein autoubiquitination);GO:2000312(regulation of kainate selective glutamate receptor activity)","NA",{"v":1E-13,"d":"0.00"},2,"171,36,","0,5798",-13,{"v":-12.2,"d":"-12.20"},2.41,"Exon (ENSBGRT00000002647/ENSBGRG00000001442, exon 5 of 6)",1,90850043,90875091,25049,2]
["chr1",90863484,90875091,11608,"ENSBGRG00000001442","ENSBGRT00000002647",0,"KLHL24","kelch like family member 24 [Source:HGNC Symbol;Acc:HGNC:25947]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005912(adherens junction);GO:0016567(protein ubiquitination);GO:0030057(desmosome);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0045109(intermediate filament organization);GO:0051865(protein autoubiquitination);GO:2000312(regulation of kainate selective glutamate receptor activity)","NA",{"v":5e-13,"d":"0.00"},2,"26,920,","0,10688",{"v":-12.3,"d":"-12.30"},{"v":-11.5,"d":"-11.50"},5.41,"Exon (ENSBGRT00000002647/ENSBGRG00000001442, exon 1 of 6)",1,90850043,90875091,25049,2]
["chr1",91244388,91245533,1146,"ENSBGRG00000001683","ENSBGRT00000003117",0,"B3GNT5","UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:15684]","GO:0006486(protein glycosylation);GO:0007417(central nervous system development);GO:0008457(beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity);GO:0016020(membrane)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":7.9e-90,"d":"0.00"},1,"1146,",0,{"v":-89.1,"d":"-89.10"},{"v":-87.6,"d":"-87.60"},6.05,"Exon (ENSBGRT00000003117/ENSBGRG00000001683, exon 1 of 1)",1,91244388,91245533,1146,2]
["chr1",91577731,91596674,18944,"ENSBGRG00000001781","ENSBGRT00000003296",108977,"ATP11B","ATPase phospholipid transporting 11B (putative) [Source:HGNC Symbol;Acc:HGNC:13553]","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0005524(ATP binding);GO:0005783(endoplasmic reticulum);GO:0015914(phospholipid transport);GO:0016021(integral component of membrane);GO:0055037(recycling endosome);GO:0140326(ATPase-coupled intramembrane lipid transporter activity)","NA",{"v":0.0048,"d":"0.00"},2,"34,26,","0,18918",-2.32,-1.77,1.52,"Exon (ENSBGRT00000003296/ENSBGRG00000001781, exon 28 of 30)",1,91572601,91705651,133051,2]
["chr1",93724525,93724854,330,"ENSBGRG00000001900","ENSBGRT00000003792",83248,"FXR1","FMR1 autosomal homolog 1 [Source:HGNC Symbol;Acc:HGNC:4023]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005844(polysome);GO:0006417(regulation of translation);GO:0007517(muscle organ development);GO:0030424(axon);GO:0030425(dendrite);GO:0033592(RNA strand annealing activity);GO:0035770(ribonucleoprotein granule);GO:0042803(protein homodimerization activity);GO:0043034(costamere);GO:0043197(dendritic spine);GO:0046982(protein heterodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:2000637(positive regulation of gene silencing by miRNA)","03013(RNA transport)",{"v":5e-19,"d":"0.00"},1,"330,",0,{"v":-18.3,"d":"-18.30"},{"v":-17.4,"d":"-17.40"},2.11,"3' UTR",1,93724375,93808102,83728,2]
["chr1",93724973,93726192,1220,"ENSBGRG00000001900","ENSBGRT00000003792",81910,"FXR1","FMR1 autosomal homolog 1 [Source:HGNC Symbol;Acc:HGNC:4023]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005844(polysome);GO:0006417(regulation of translation);GO:0007517(muscle organ development);GO:0030424(axon);GO:0030425(dendrite);GO:0033592(RNA strand annealing activity);GO:0035770(ribonucleoprotein granule);GO:0042803(protein homodimerization activity);GO:0043034(costamere);GO:0043197(dendritic spine);GO:0046982(protein heterodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:2000637(positive regulation of gene silencing by miRNA)","03013(RNA transport)",{"v":1E-153,"d":"0.00"},2,"474,6,","0,1214",-153,-152,3.35,"3' UTR",1,93724375,93808102,83728,2]
["chr1",93738553,93751742,13190,"ENSBGRG00000001900","ENSBGRT00000003792",56360,"FXR1","FMR1 autosomal homolog 1 [Source:HGNC Symbol;Acc:HGNC:4023]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005844(polysome);GO:0006417(regulation of translation);GO:0007517(muscle organ development);GO:0030424(axon);GO:0030425(dendrite);GO:0033592(RNA strand annealing activity);GO:0035770(ribonucleoprotein granule);GO:0042803(protein homodimerization activity);GO:0043034(costamere);GO:0043197(dendritic spine);GO:0046982(protein heterodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:2000637(positive regulation of gene silencing by miRNA)","03013(RNA transport)",{"v":1.6e-16,"d":"0.00"},4,"38,87,110,5,","0,1974,9368,13185",{"v":-15.8,"d":"-15.80"},-15,1.44,"Exon (ENSBGRT00000003792/ENSBGRG00000001900, exon 9 of 18)",1,93724375,93808102,83728,2]
["chr1",94086763,94087595,833,"ENSBGRG00000002327","ENSBGRT00000004463",8124,"TTC14","tetratricopeptide repeat domain 14 [Source:HGNC Symbol;Acc:HGNC:24697]","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","04140(Autophagy - animal);04136(Autophagy - other eukaryotes)",{"v":1e-231,"d":"0.00"},1,"833,",0,-231,-229,4.05,"3' UTR",1,94086763,94095719,8957,2]
["chr1",95093948,95095059,1112,"ENSBGRG00000002861","ENSBGRT00000005365",138172,"USP13","ubiquitin specific peptidase 13 [Source:HGNC Symbol;Acc:HGNC:12611]","GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0006355(regulation of transcription, DNA-templated);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008270(zinc ion binding);GO:0008283(cell population proliferation);GO:0010506(regulation of autophagy);GO:0016579(protein deubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0035523(protein K29-linked deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0043130(ubiquitin binding);GO:0044313(protein K6-linked deubiquitination);GO:0044389(ubiquitin-like protein ligase binding);GO:0050821(protein stabilization);GO:0051087(chaperone binding);GO:0070536(protein K63-linked deubiquitination);GO:0070628(proteasome binding);GO:1904288(BAT3 complex binding);GO:1904294(positive regulation of ERAD pathway);GO:1904378(maintenance of unfolded protein involved in ERAD pathway);GO:1990380(Lys48-specific deubiquitinase activity)","NA",{"v":0.00055,"d":"0.00"},2,"126,174,","0,938",-3.26,-2.66,3.37,"3' UTR",1,95093948,95233231,139284,2]
["chr1",95499425,95505203,5779,"ENSBGRG00000003185","ENSBGRT00000005915",0,"ENSBGRG00000003185","NA","NA","NA",{"v":2.5e-19,"d":"0.00"},2,"232,66,","0,5713",{"v":-18.6,"d":"-18.60"},{"v":-17.7,"d":"-17.70"},1.95,"3' UTR",1,95501189,95502547,1359,1]
["chr1",95663651,95671604,7954,"ENSBGRG00000003201","ENSBGRT00000005942",17249,"ENSBGRG00000003201","NA","GO:0006813(potassium ion transport);GO:0015269(calcium-activated potassium channel activity);GO:0016020(membrane)","04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04270(Vascular smooth muscle contraction)",{"v":1E-119,"d":"0.00"},3,"22,441,75,","0,6648,7879",-119,-118,8.27,"3' UTR",1,95646402,95664125,17724,1]
["chr1",95700410,95716007,15598,"ENSBGRG00000003231","ENSBGRT00000005988",0,"PIK3CA","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [Source:HGNC Symbol;Acc:HGNC:8975]","GO:0001889(liver development);GO:0001932(regulation of protein phosphorylation);GO:0005942(phosphatidylinositol 3-kinase complex);GO:0005943(phosphatidylinositol 3-kinase complex, class IA);GO:0006006(glucose metabolic process);GO:0010468(regulation of gene expression);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0016301(kinase activity);GO:0016303(1-phosphatidylinositol-3-kinase activity);GO:0016310(phosphorylation);GO:0030027(lamellipodium);GO:0030295(protein kinase activator activity);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0035004(phosphatidylinositol 3-kinase activity);GO:0040014(regulation of multicellular organism growth);GO:0043457(regulation of cellular respiration);GO:0043491(protein kinase B signaling);GO:0043524(negative regulation of neuron apoptotic process);GO:0043560(insulin receptor substrate binding);GO:0044029(hypomethylation of CpG island);GO:0046854(phosphatidylinositol phosphorylation);GO:0048015(phosphatidylinositol-mediated signaling);GO:0060612(adipose tissue development);GO:0071333(cellular response to glucose stimulus);GO:0097009(energy homeostasis);GO:2000270(negative regulation of fibroblast apoptotic process);GO:2000653(regulation of genetic imprinting);GO:2000811(negative regulation of anoikis)","00562(Inositol phosphate metabolism);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04630(Jak-STAT signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04218(Cellular senescence);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04670(Leukocyte transendothelial migration);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04919(Thyroid hormone signaling pathway);04973(Carbohydrate digestion and absorption);04960(Aldosterone-regulated sodium reabsorption);04725(Cholinergic synapse);04722(Neurotrophin signaling pathway);04750(Inflammatory mediator regulation of TRP channels);04360(Axon guidance);04380(Osteoclast differentiation);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05205(Proteoglycans in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05100(Bacterial invasion of epithelial cells);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05146(Amoebiasis);05142(Chagas disease (American trypanosomiasis));01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":2.5e-26,"d":"0.00"},2,"344,15,","0,15583",{"v":-25.6,"d":"-25.60"},{"v":-24.6,"d":"-24.60"},5.38,"5' UTR",1,95663621,95700753,37133,2]
["chr1",95973894,95974013,120,"ENSBGRG00000003278","ENSBGRT00000006089",37808,"ENSBGRG00000003278","NA","GO:0006813(potassium ion transport);GO:0015269(calcium-activated potassium channel activity);GO:0016020(membrane)","04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04270(Vascular smooth muscle contraction)",0.02,1,"120,",0,{"v":-1.7,"d":"-1.70"},-1.19,5.94,"Exon (ENSBGRT00000006089/ENSBGRG00000003278, exon 4 of 4)",1,95973894,96011821,37928,2]
["chr1",100563622,100564041,420,"ENSBGRG00000003433","ENSBGRT00000006383",239,"ENSBGRG00000003433","NA","NA","NA",{"v":0.036,"d":"0.04"},1,"420,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000006383/ENSBGRG00000003433, exon 1 of 1)",1,100562904,100564280,1377,2]
["chr1",101229243,101229332,90,"ENSBGRG00000003457","ENSBGRT00000006436",812882,"NLGN1","neuroligin 1 [Source:HGNC Symbol;Acc:HGNC:14291]","GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007158(neuron cell-cell adhesion);GO:0007399(nervous system development);GO:0007416(synapse assembly);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010841(positive regulation of circadian sleep/wake cycle, wakefulness);GO:0016020(membrane);GO:0016080(synaptic vesicle targeting);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0030165(PDZ domain binding);GO:0031175(neuron projection development);GO:0035418(protein localization to synapse);GO:0042043(neurexin family protein binding);GO:0043235(receptor complex);GO:0045184(establishment of protein localization);GO:0045202(synapse);GO:0045664(regulation of neuron differentiation);GO:0048789(cytoskeletal matrix organization at active zone);GO:0050804(modulation of chemical synaptic transmission);GO:0050808(synapse organization);GO:0051965(positive regulation of synapse assembly);GO:0060076(excitatory synapse);GO:0060999(positive regulation of dendritic spine development);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0072553(terminal button organization);GO:0097091(synaptic vesicle clustering);GO:0097104(postsynaptic membrane assembly);GO:0097105(presynaptic membrane assembly);GO:0097110(scaffold protein binding);GO:0097113(AMPA glutamate receptor clustering);GO:0097115(neurexin clustering involved in presynaptic membrane assembly);GO:0097119(postsynaptic density protein 95 clustering);GO:0097120(receptor localization to synapse);GO:0099560(synaptic membrane adhesion);GO:1900244(positive regulation of synaptic vesicle endocytosis);GO:1904861(excitatory synapse assembly);GO:2000302(positive regulation of synaptic vesicle exocytosis);GO:2000310(regulation of NMDA receptor activity);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000809(positive regulation of synaptic vesicle clustering)","04514(Cell adhesion molecules (CAMs))",{"v":0.015,"d":"0.02"},1,"90,",0,-1.83,-1.31,2.69,"Exon (ENSBGRT00000006436/ENSBGRG00000003457, exon 5 of 5)",1,101229243,102042214,812972,2]
["chr1",101229600,101229719,120,"ENSBGRG00000003457","ENSBGRT00000006436",812495,"NLGN1","neuroligin 1 [Source:HGNC Symbol;Acc:HGNC:14291]","GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007158(neuron cell-cell adhesion);GO:0007399(nervous system development);GO:0007416(synapse assembly);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010841(positive regulation of circadian sleep/wake cycle, wakefulness);GO:0016020(membrane);GO:0016080(synaptic vesicle targeting);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0030165(PDZ domain binding);GO:0031175(neuron projection development);GO:0035418(protein localization to synapse);GO:0042043(neurexin family protein binding);GO:0043235(receptor complex);GO:0045184(establishment of protein localization);GO:0045202(synapse);GO:0045664(regulation of neuron differentiation);GO:0048789(cytoskeletal matrix organization at active zone);GO:0050804(modulation of chemical synaptic transmission);GO:0050808(synapse organization);GO:0051965(positive regulation of synapse assembly);GO:0060076(excitatory synapse);GO:0060999(positive regulation of dendritic spine development);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0072553(terminal button organization);GO:0097091(synaptic vesicle clustering);GO:0097104(postsynaptic membrane assembly);GO:0097105(presynaptic membrane assembly);GO:0097110(scaffold protein binding);GO:0097113(AMPA glutamate receptor clustering);GO:0097115(neurexin clustering involved in presynaptic membrane assembly);GO:0097119(postsynaptic density protein 95 clustering);GO:0097120(receptor localization to synapse);GO:0099560(synaptic membrane adhesion);GO:1900244(positive regulation of synaptic vesicle endocytosis);GO:1904861(excitatory synapse assembly);GO:2000302(positive regulation of synaptic vesicle exocytosis);GO:2000310(regulation of NMDA receptor activity);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000809(positive regulation of synaptic vesicle clustering)","04514(Cell adhesion molecules (CAMs))",{"v":0.00059,"d":"0.00"},1,"120,",0,-3.23,-2.62,3.68,"Exon (ENSBGRT00000006436/ENSBGRG00000003457, exon 5 of 5)",1,101229243,102042214,812972,2]
["chr1",101229809,101231040,1232,"ENSBGRG00000003457","ENSBGRT00000006436",811174,"NLGN1","neuroligin 1 [Source:HGNC Symbol;Acc:HGNC:14291]","GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007158(neuron cell-cell adhesion);GO:0007399(nervous system development);GO:0007416(synapse assembly);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010841(positive regulation of circadian sleep/wake cycle, wakefulness);GO:0016020(membrane);GO:0016080(synaptic vesicle targeting);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0030165(PDZ domain binding);GO:0031175(neuron projection development);GO:0035418(protein localization to synapse);GO:0042043(neurexin family protein binding);GO:0043235(receptor complex);GO:0045184(establishment of protein localization);GO:0045202(synapse);GO:0045664(regulation of neuron differentiation);GO:0048789(cytoskeletal matrix organization at active zone);GO:0050804(modulation of chemical synaptic transmission);GO:0050808(synapse organization);GO:0051965(positive regulation of synapse assembly);GO:0060076(excitatory synapse);GO:0060999(positive regulation of dendritic spine development);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0072553(terminal button organization);GO:0097091(synaptic vesicle clustering);GO:0097104(postsynaptic membrane assembly);GO:0097105(presynaptic membrane assembly);GO:0097110(scaffold protein binding);GO:0097113(AMPA glutamate receptor clustering);GO:0097115(neurexin clustering involved in presynaptic membrane assembly);GO:0097119(postsynaptic density protein 95 clustering);GO:0097120(receptor localization to synapse);GO:0099560(synaptic membrane adhesion);GO:1900244(positive regulation of synaptic vesicle endocytosis);GO:1904861(excitatory synapse assembly);GO:2000302(positive regulation of synaptic vesicle exocytosis);GO:2000310(regulation of NMDA receptor activity);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000809(positive regulation of synaptic vesicle clustering)","04514(Cell adhesion molecules (CAMs))",{"v":3.9e-05,"d":"0.00"},2,"257,160,","0,1072",-4.41,-3.75,6.93,"Exon (ENSBGRT00000006436/ENSBGRG00000003457, exon 4 of 5)",1,101229243,102042214,812972,2]
["chr1",101794885,102041857,246973,"ENSBGRG00000003487","ENSBGRT00000006471",0,"ENSBGRG00000003487","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.0062,"d":"0.01"},2,"103,136,","0,246837",-2.21,-1.67,9.91,"Exon (ENSBGRT00000006471/ENSBGRG00000003487, exon 1 of 1)",1,101927584,101928585,1002,1]
["chr1",102929238,102929298,61,"ENSBGRG00000003533","ENSBGRT00000006726",52508,"ECT2","epithelial cell transforming 2 [Source:HGNC Symbol;Acc:HGNC:3155]","GO:0000281(mitotic cytokinesis);GO:0000902(cell morphogenesis);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0005923(bicellular tight junction);GO:0016604(nuclear body);GO:0017048(Rho GTPase binding);GO:0030496(midbody);GO:0032147(activation of protein kinase activity);GO:0032154(cleavage furrow);GO:0032467(positive regulation of cytokinesis);GO:0035556(intracellular signal transduction);GO:0042307(positive regulation of protein import into nucleus);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0043547(positive regulation of GTPase activity);GO:0045666(positive regulation of neuron differentiation);GO:0045859(regulation of protein kinase activity);GO:0051260(protein homooligomerization);GO:0051988(regulation of attachment of spindle microtubules to kinetochore);GO:0070301(cellular response to hydrogen peroxide);GO:0070830(bicellular tight junction assembly);GO:0071277(cellular response to calcium ion);GO:0071479(cellular response to ionizing radiation);GO:0072686(mitotic spindle);GO:0090630(activation of GTPase activity);GO:0097149(centralspindlin complex);GO:2000431(regulation of cytokinesis, actomyosin contractile ring assembly)","NA",{"v":0.024,"d":"0.02"},1,"61,",0,-1.62,-1.11,1.86,"Exon (ENSBGRT00000006726/ENSBGRG00000003533, exon 22 of 24)",1,102923935,102981806,57872,2]
["chr1",103749417,103749802,386,"ENSBGRG00000004384","ENSBGRT00000008058",240,"ENSBGRG00000004384","NA","NA","04146(Peroxisome)",{"v":0.0068,"d":"0.01"},1,"386,",0,-2.17,-1.62,8.91,"Exon (ENSBGRT00000008058/ENSBGRG00000004384, exon 2 of 2)",1,103749387,103750042,656,2]
["chr1",105493927,105495486,1560,"ENSBGRG00000006204","ENSBGRT00000011461",18203,"SKIL","SKI like proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10897]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001825(blastocyst formation);GO:0002260(lymphocyte homeostasis);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032991(protein-containing complex);GO:0045596(negative regulation of cell differentiation);GO:0046332(SMAD binding);GO:0070306(lens fiber cell differentiation);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902231(positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":7.9e-23,"d":"0.00"},3,"159,225,216,","0,829,1344",{"v":-22.1,"d":"-22.10"},{"v":-21.1,"d":"-21.10"},5.94,"Exon (ENSBGRT00000011461/ENSBGRG00000006204, exon 4 of 6)",1,105493927,105513689,19763,2]
["chr1",105500801,105512372,11572,"ENSBGRG00000006204","ENSBGRT00000011461",1317,"SKIL","SKI like proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10897]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001825(blastocyst formation);GO:0002260(lymphocyte homeostasis);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032991(protein-containing complex);GO:0045596(negative regulation of cell differentiation);GO:0046332(SMAD binding);GO:0070306(lens fiber cell differentiation);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902231(positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":1.6e-17,"d":"0.00"},2,"29,451,","0,11121",{"v":-16.8,"d":"-16.80"},{"v":-15.9,"d":"-15.90"},5.89,"Exon (ENSBGRT00000011461/ENSBGRG00000006204, exon 1 of 6)",1,105493927,105513689,19763,2]
["chr1",105512552,105512671,120,"ENSBGRG00000006204","ENSBGRT00000011461",1018,"SKIL","SKI like proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10897]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001825(blastocyst formation);GO:0002260(lymphocyte homeostasis);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032991(protein-containing complex);GO:0045596(negative regulation of cell differentiation);GO:0046332(SMAD binding);GO:0070306(lens fiber cell differentiation);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902231(positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":1.4e-06,"d":"0.00"},1,"120,",0,-5.86,-5.16,{"v":2.2,"d":"2.20"},"Exon (ENSBGRT00000011461/ENSBGRG00000006204, exon 1 of 6)",1,105493927,105513689,19763,2]
["chr1",105512761,105513509,749,"ENSBGRG00000006204","ENSBGRT00000011461",180,"SKIL","SKI like proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10897]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001825(blastocyst formation);GO:0002260(lymphocyte homeostasis);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032991(protein-containing complex);GO:0045596(negative regulation of cell differentiation);GO:0046332(SMAD binding);GO:0070306(lens fiber cell differentiation);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902231(positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":1.1e-07,"d":"0.00"},1,"749,",0,-6.95,-6.22,3.42,"5' UTR",1,105493927,105513689,19763,2]
["chr1",105560608,105560697,90,"ENSBGRG00000006256","ENSBGRT00000011845",71118,"PRKCI","protein kinase C iota [Source:HGNC Symbol;Acc:HGNC:9404]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004697(protein kinase C activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005543(phospholipid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007015(actin filament organization);GO:0007163(establishment or maintenance of cell polarity);GO:0010976(positive regulation of neuron projection development);GO:0015630(microtubule cytoskeleton);GO:0016324(apical plasma membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0032869(cellular response to insulin stimulus);GO:0034351(negative regulation of glial cell apoptotic process);GO:0035089(establishment of apical/basal cell polarity);GO:0035556(intracellular signal transduction);GO:0042462(eye photoreceptor cell development);GO:0043220(Schmidt-Lanterman incisure);GO:0043524(negative regulation of neuron apoptotic process);GO:0045171(intercellular bridge);GO:0045177(apical part of cell);GO:0045216(cell-cell junction organization);GO:0046326(positive regulation of glucose import);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0060252(positive regulation of glial cell proliferation);GO:1903078(positive regulation of protein localization to plasma membrane);GO:2000353(positive regulation of endothelial cell apoptotic process)","04015(Rap1 signaling pathway);04390(Hippo signaling pathway);04144(Endocytosis);04530(Tight junction);04611(Platelet activation);04910(Insulin signaling pathway);05165(Human papillomavirus infection)",{"v":0.00045,"d":"0.00"},1,"90,",0,-3.35,-2.74,1.71,"3' UTR",1,105560488,105631815,71328,2]
["chr1",105876694,105901039,24346,"ENSBGRG00000006891","ENSBGRT00000012758",1197,"SEC62","SEC62 homolog, preprotein translocation factor [Source:HGNC Symbol;Acc:HGNC:11846]","GO:0006620(posttranslational protein targeting to endoplasmic reticulum membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0031204(posttranslational protein targeting to membrane, translocation)","03060(Protein export);04141(Protein processing in endoplasmic reticulum)",0,7,"608,120,61,93,93,205,69,","0,5650,7604,15615,16839,17177,24277",-1540,"-Inf",8.68,"3' UTR",1,105876456,105902236,25781,2]
["chr1",106110113,106113003,2891,"ENSBGRG00000007490","ENSBGRT00000013746",13307,"MYNN","myoneurin [Source:HGNC Symbol;Acc:HGNC:14955]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:1990830(cellular response to leukemia inhibitory factor)","NA",{"v":4e-72,"d":"0.00"},3,"263,87,8,","0,1920,2883",{"v":-71.4,"d":"-71.40"},-70,8.63,"Exon (ENSBGRT00000013746/ENSBGRG00000007490, exon 6 of 8)",1,106110113,106126310,16198,2]
["chr1",106119013,106119785,773,"ENSBGRG00000007490","ENSBGRT00000013746",6525,"MYNN","myoneurin [Source:HGNC Symbol;Acc:HGNC:14955]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:1990830(cellular response to leukemia inhibitory factor)","NA",{"v":1e-149,"d":"0.00"},1,"773,",0,-149,-147,{"v":9.6,"d":"9.60"},"Exon (ENSBGRT00000013746/ENSBGRG00000007490, exon 3 of 8)",1,106110113,106126310,16198,2]
["chr1",106125812,106126132,321,"ENSBGRG00000007490","ENSBGRT00000013746",178,"MYNN","myoneurin [Source:HGNC Symbol;Acc:HGNC:14955]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:1990830(cellular response to leukemia inhibitory factor)","NA",{"v":7.9e-15,"d":"0.00"},2,"138,42,","0,279",{"v":-14.1,"d":"-14.10"},{"v":-13.2,"d":"-13.20"},{"v":2.5,"d":"2.50"},"5' UTR",1,106110113,106126310,16198,2]
["chr1",107149563,107149682,120,"ENSBGRG00000008768","ENSBGRT00000016031",270063,"ENSBGRG00000008768","NA","GO:0005509(calcium ion binding)","NA",{"v":2.5e-22,"d":"0.00"},1,"120,",0,{"v":-21.6,"d":"-21.60"},{"v":-20.6,"d":"-20.60"},4.88,"3' UTR",1,107149563,107419745,270183,2]
["chr1",108420388,108476320,55933,"ENSBGRG00000009344","ENSBGRT00000017143",712,"SERPINI1","serpin family I member 1 [Source:HGNC Symbol;Acc:HGNC:8943]","GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005615(extracellular space);GO:0034774(secretory granule lumen);GO:0043025(neuronal cell body);GO:0060205(cytoplasmic vesicle lumen)","NA",{"v":0.014,"d":"0.01"},2,"52,126,","0,55807",-1.85,-1.33,3.96,"5' UTR",1,108387032,108477032,90001,2]
["chr1",116150447,116150625,179,"ENSBGRG00000011599","ENSBGRT00000021389",0,"PPM1L","protein phosphatase, Mg2+/Mn2+ dependent 1L [Source:HGNC Symbol;Acc:HGNC:16381]","GO:0000165(MAPK cascade);GO:0003824(catalytic activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0007178(transmembrane receptor protein serine/threonine kinase signaling pathway);GO:0043169(cation binding)","NA",{"v":0.004,"d":"0.00"},1,"179,",0,{"v":-2.4,"d":"-2.40"},-1.84,5.94,"Exon (ENSBGRT00000021389/ENSBGRG00000011599, exon 1 of 5)",1,115791281,116150625,359345,2]
["chr1",116497457,116497636,180,"ENSBGRG00000012219","ENSBGRT00000023058",34941,"SMC4","structural maintenance of chromosomes 4 [Source:HGNC Symbol;Acc:HGNC:14013]","GO:0000775(chromosome, centromeric region);GO:0000796(condensin complex);GO:0000797(condensin core heterodimer);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005694(chromosome);GO:0005829(cytosol);GO:0007076(mitotic chromosome condensation);GO:0010032(meiotic chromosome condensation);GO:0016607(nuclear speck);GO:0045132(meiotic chromosome segregation);GO:0051276(chromosome organization);GO:0051383(kinetochore organization)","NA",{"v":1e-06,"d":"0.00"},1,"180,",0,-5.99,-5.28,2.53,"3' UTR",1,116497307,116532577,35271,2]
["chr1",116514232,116517551,3320,"ENSBGRG00000012219","ENSBGRT00000023058",15026,"SMC4","structural maintenance of chromosomes 4 [Source:HGNC Symbol;Acc:HGNC:14013]","GO:0000775(chromosome, centromeric region);GO:0000796(condensin complex);GO:0000797(condensin core heterodimer);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005694(chromosome);GO:0005829(cytosol);GO:0007076(mitotic chromosome condensation);GO:0010032(meiotic chromosome condensation);GO:0016607(nuclear speck);GO:0045132(meiotic chromosome segregation);GO:0051276(chromosome organization);GO:0051383(kinetochore organization)","NA",{"v":1.6e-36,"d":"0.00"},3,"76,165,120,","0,1386,3200",{"v":-35.8,"d":"-35.80"},{"v":-34.7,"d":"-34.70"},6.71,"Exon (ENSBGRT00000023058/ENSBGRG00000012219, exon 9 of 24)",1,116497307,116532577,35271,2]
["chr1",117042745,117051144,8400,"ENSBGRG00000013519","ENSBGRT00000025025",64310,"ENSBGRG00000013519","NA","NA","03420(Nucleotide excision repair)",0.02,2,"345,286,","0,8114",-1.69,{"v":-0.941,"d":"-0.94"},7.92,"3' UTR",1,117042715,117115454,72740,2]
["chr1",117115397,117793968,678572,"ENSBGRG00000013519","ENSBGRT00000025025",0,"ENSBGRG00000013519","NA","NA","03420(Nucleotide excision repair)",{"v":7.9E-75,"d":"0.00"},4,"58,78,849,66,","0,5304,109933,678506",{"v":-74.1,"d":"-74.10"},{"v":-72.7,"d":"-72.70"},{"v":11.3,"d":"11.30"},"5' UTR",1,117042715,117115454,72740,2]
["chr1",118512012,118512409,398,"ENSBGRG00000014469","ENSBGRT00000027086",57336,"GFM1","G elongation factor mitochondrial 1 [Source:HGNC Symbol;Acc:HGNC:13780]","GO:0003746(translation elongation factor activity);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0006414(translational elongation);GO:0070125(mitochondrial translational elongation)","NA",{"v":5e-20,"d":"0.00"},2,"236,4,","0,394",{"v":-19.3,"d":"-19.30"},{"v":-18.4,"d":"-18.40"},3.37,"3' UTR",1,118512012,118569745,57734,2]
["chr1",118857154,119094752,237599,"ENSBGRG00000015425","ENSBGRT00000028375",19029,"RSRC1","arginine and serine rich coiled-coil 1 [Source:HGNC Symbol;Acc:HGNC:24152]","GO:0000380(alternative mRNA splicing, via spliceosome);GO:0000398(mRNA splicing, via spliceosome);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0006913(nucleocytoplasmic transport);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0046677(response to antibiotic)","NA",{"v":7.9e-22,"d":"0.00"},4,"21,37,174,93,","0,51395,134699,237506",{"v":-21.1,"d":"-21.10"},{"v":-20.1,"d":"-20.10"},2.14,"Exon (ENSBGRT00000028375/ENSBGRG00000015425, exon 3 of 11)",1,118642582,119113781,471200,2]
["chr1",119095221,119113634,18414,"ENSBGRG00000015425","ENSBGRT00000028610",0,"RSRC1","arginine and serine rich coiled-coil 1 [Source:HGNC Symbol;Acc:HGNC:24152]","GO:0000380(alternative mRNA splicing, via spliceosome);GO:0000398(mRNA splicing, via spliceosome);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0006913(nucleocytoplasmic transport);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0046677(response to antibiotic)","NA",{"v":0.0032,"d":"0.00"},2,"90,88,","0,18326",{"v":-2.5,"d":"-2.50"},-1.93,1.66,"5' UTR",1,118823392,119095310,271919,2]
["chr1",120364691,120385523,20833,"ENSBGRG00000016645","ENSBGRT00000030590",198362,"ENSBGRG00000016645","NA","NA","NA",{"v":4e-11,"d":"0.00"},2,"621,249,","0,20584",{"v":-10.4,"d":"-10.40"},-9.63,5.53,"3' UTR",1,120363852,120583885,220034,2]
["chr1",120748660,120749995,1336,"ENSBGRG00000016750","ENSBGRT00000030776",26570,"TIPARP","TCDD inducible poly(ADP-ribose) polymerase [Source:HGNC Symbol;Acc:HGNC:23696]","GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001570(vasculogenesis);GO:0001822(kidney development);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005634(nucleus);GO:0006471(protein ADP-ribosylation);GO:0006807(nitrogen compound metabolic process);GO:0008209(androgen metabolic process);GO:0008210(estrogen metabolic process);GO:0008585(female gonad development);GO:0009791(post-embryonic development);GO:0010629(negative regulation of gene expression);GO:0030097(hemopoiesis);GO:0045732(positive regulation of protein catabolic process);GO:0046872(metal ion binding);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048705(skeletal system morphogenesis);GO:0048745(smooth muscle tissue development);GO:0060021(roof of mouth development);GO:0060325(face morphogenesis);GO:0070213(protein auto-ADP-ribosylation);GO:0071407(cellular response to organic cyclic compound);GO:0140289(protein mono-ADP-ribosylation);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":0,"d":"0.00"},2,"388,270,","0,1066",-309,-306,5.93,"Exon (ENSBGRT00000030776/ENSBGRG00000016750, exon 5 of 6)",1,120748600,120776565,27966,2]
["chr1",120755819,120774152,18334,"ENSBGRG00000016750","ENSBGRT00000030776",2413,"TIPARP","TCDD inducible poly(ADP-ribose) polymerase [Source:HGNC Symbol;Acc:HGNC:23696]","GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001570(vasculogenesis);GO:0001822(kidney development);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005634(nucleus);GO:0006471(protein ADP-ribosylation);GO:0006807(nitrogen compound metabolic process);GO:0008209(androgen metabolic process);GO:0008210(estrogen metabolic process);GO:0008585(female gonad development);GO:0009791(post-embryonic development);GO:0010629(negative regulation of gene expression);GO:0030097(hemopoiesis);GO:0045732(positive regulation of protein catabolic process);GO:0046872(metal ion binding);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048705(skeletal system morphogenesis);GO:0048745(smooth muscle tissue development);GO:0060021(roof of mouth development);GO:0060325(face morphogenesis);GO:0070213(protein auto-ADP-ribosylation);GO:0071407(cellular response to organic cyclic compound);GO:0140289(protein mono-ADP-ribosylation);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":9.99999999999999e-219,"d":"0.00"},3,"24,169,913,","0,1332,17421",-218,-216,{"v":5.7,"d":"5.70"},"Exon (ENSBGRT00000030776/ENSBGRG00000016750, exon 2 of 6)",1,120748600,120776565,27966,2]
["chr1",121476593,121476743,151,"ENSBGRG00000017121","ENSBGRT00000031990",0,"KCNAB1","potassium voltage-gated channel subfamily A member regulatory beta subunit 1 [Source:HGNC Symbol;Acc:HGNC:6228]","GO:0005249(voltage-gated potassium channel activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006813(potassium ion transport);GO:0007611(learning or memory);GO:0008076(voltage-gated potassium channel complex);GO:0015459(potassium channel regulator activity);GO:0016021(integral component of membrane);GO:0019904(protein domain specific binding);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0034705(potassium channel complex);GO:0055085(transmembrane transport);GO:0070402(NADPH binding);GO:1901016(regulation of potassium ion transmembrane transporter activity);GO:1901379(regulation of potassium ion transmembrane transport);GO:1903817(negative regulation of voltage-gated potassium channel activity)","NA",{"v":0.048,"d":"0.05"},1,"151,",0,-1.32,{"v":-0.839,"d":"-0.84"},3.96,"Exon (ENSBGRT00000031990/ENSBGRG00000017121, exon 1 of 14)",1,120972424,121476743,504320,2]
["chr1",122591201,122591321,121,"ENSBGRG00000009643","ENSBGRT00000017725",478,"MME","membrane metalloendopeptidase [Source:HGNC Symbol;Acc:HGNC:7154]","GO:0001786(phosphatidylserine binding);GO:0001822(kidney development);GO:0004175(endopeptidase activity);GO:0004222(metalloendopeptidase activity);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0005903(brush border);GO:0006508(proteolysis);GO:0007568(aging);GO:0007611(learning or memory);GO:0008021(synaptic vesicle);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008238(exopeptidase activity);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0019233(sensory perception of pain);GO:0030424(axon);GO:0030425(dendrite);GO:0031410(cytoplasmic vesicle);GO:0042803(protein homodimerization activity);GO:0043025(neuronal cell body);GO:0044306(neuron projection terminus);GO:0045121(membrane raft);GO:0045202(synapse);GO:0046449(creatinine metabolic process);GO:0050435(amyloid-beta metabolic process);GO:0050769(positive regulation of neurogenesis);GO:0061837(neuropeptide processing);GO:0071345(cellular response to cytokine stimulus);GO:0071492(cellular response to UV-A);GO:0071493(cellular response to UV-B);GO:0090399(replicative senescence);GO:0097242(amyloid-beta clearance);GO:0098793(presynapse);GO:0150094(amyloid-beta clearance by cellular catabolic process);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1901612(cardiolipin binding)","04640(Hematopoietic cell lineage);04614(Renin-angiotensin system);04974(Protein digestion and absorption);05010(Alzheimer disease)",{"v":0.034,"d":"0.03"},1,"121,",0,-1.47,{"v":-0.977,"d":"-0.98"},5.94,"5' UTR",1,122462847,122591799,128953,2]
["chr1",122690067,122690156,90,"ENSBGRG00000010202","ENSBGRT00000018705",297,"ENSBGRG00000010202","NA","GO:0006506(GPI anchor biosynthetic process);GO:0017176(phosphatidylinositol N-acetylglucosaminyltransferase activity)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":0.036,"d":"0.04"},1,"90,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000018705/ENSBGRG00000010202, exon 1 of 1)",1,122690067,122690453,387,2]
["chr1",123471270,123471389,120,"ENSBGRG00000011886","ENSBGRT00000021733",154423,"ARHGEF26","Rho guanine nucleotide exchange factor 26 [Source:HGNC Symbol;Acc:HGNC:24490]","GO:0001886(endothelial cell morphogenesis);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0097178(ruffle assembly)","05100(Bacterial invasion of epithelial cells)",{"v":0.011,"d":"0.01"},1,"120,",0,-1.94,-1.41,1.82,"3' UTR",1,123470614,123625812,155199,2]
["chr1",123624767,123625095,329,"ENSBGRG00000011886","ENSBGRT00000021733",717,"ARHGEF26","Rho guanine nucleotide exchange factor 26 [Source:HGNC Symbol;Acc:HGNC:24490]","GO:0001886(endothelial cell morphogenesis);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0097178(ruffle assembly)","05100(Bacterial invasion of epithelial cells)",{"v":1.3E-7,"d":"0.00"},1,"329,",0,-6.87,-6.14,2.87,"Exon (ENSBGRT00000021733/ENSBGRG00000011886, exon 1 of 13)",1,123470614,123625812,155199,2]
["chr1",123625214,123625541,328,"ENSBGRG00000011886","ENSBGRT00000021733",271,"ARHGEF26","Rho guanine nucleotide exchange factor 26 [Source:HGNC Symbol;Acc:HGNC:24490]","GO:0001886(endothelial cell morphogenesis);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0097178(ruffle assembly)","05100(Bacterial invasion of epithelial cells)",{"v":3.2e-11,"d":"0.00"},1,"328,",0,{"v":-10.5,"d":"-10.50"},-9.65,3.28,"Exon (ENSBGRT00000021733/ENSBGRG00000011886, exon 1 of 13)",1,123470614,123625812,155199,2]
["chr1",125149261,125149940,680,"ENSBGRG00000012398","ENSBGRT00000022700",1655,"P2RY1","purinergic receptor P2Y1 [Source:HGNC Symbol;Acc:HGNC:8539]","GO:0001621(G protein-coupled ADP receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005929(cilium);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007200(phospholipase C-activating G protein-coupled receptor signaling pathway);GO:0008360(regulation of cell shape);GO:0016021(integral component of membrane);GO:0030168(platelet activation);GO:0043270(positive regulation of ion transport);GO:0045028(G protein-coupled purinergic nucleotide receptor activity);GO:0071407(cellular response to organic cyclic compound);GO:0071415(cellular response to purine-containing compound);GO:0090075(relaxation of muscle)","04015(Rap1 signaling pathway);04080(Neuroactive ligand-receptor interaction);04611(Platelet activation);04742(Taste transduction)",{"v":4E-95,"d":"0.00"},2,"435,243,","0,437",{"v":-94.4,"d":"-94.40"},{"v":-92.9,"d":"-92.90"},8.32,"Exon (ENSBGRT00000022700/ENSBGRG00000012398, exon 2 of 3)",1,125149261,125151595,2335,2]
["chr1",125151271,125151595,325,"ENSBGRG00000012398","ENSBGRT00000022700",0,"P2RY1","purinergic receptor P2Y1 [Source:HGNC Symbol;Acc:HGNC:8539]","GO:0001621(G protein-coupled ADP receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005929(cilium);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007200(phospholipase C-activating G protein-coupled receptor signaling pathway);GO:0008360(regulation of cell shape);GO:0016021(integral component of membrane);GO:0030168(platelet activation);GO:0043270(positive regulation of ion transport);GO:0045028(G protein-coupled purinergic nucleotide receptor activity);GO:0071407(cellular response to organic cyclic compound);GO:0071415(cellular response to purine-containing compound);GO:0090075(relaxation of muscle)","04015(Rap1 signaling pathway);04080(Neuroactive ligand-receptor interaction);04611(Platelet activation);04742(Taste transduction)",{"v":1.3e-05,"d":"0.00"},1,"325,",0,-4.88,-4.21,7.43,"Exon (ENSBGRT00000022700/ENSBGRG00000012398, exon 1 of 3)",1,125149261,125151595,2335,2]
["chr1",125754014,125754522,509,"ENSBGRG00000012526","ENSBGRT00000023959",389,"MBNL1","muscleblind like splicing regulator 1 [Source:HGNC Symbol;Acc:HGNC:6923]","GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008380(RNA splicing);GO:0010494(cytoplasmic stress granule);GO:0043484(regulation of RNA splicing);GO:0046872(metal ion binding)","NA",{"v":5e-25,"d":"0.00"},1,"509,",0,{"v":-24.3,"d":"-24.30"},{"v":-23.3,"d":"-23.30"},2.94,"5' UTR",1,125576565,125754911,178347,2]
["chr1",126263987,126271363,7377,"ENSBGRG00000013608","ENSBGRT00000024913",236,"SUCNR1","succinate receptor 1 [Source:HGNC Symbol;Acc:HGNC:4542]","GO:0002001(renin secretion into blood stream);GO:0002281(macrophage activation involved in immune response);GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0032611(interleukin-1 beta production);GO:0038023(signaling receptor activity);GO:0042593(glucose homeostasis);GO:0050729(positive regulation of inflammatory response);GO:0050921(positive regulation of chemotaxis);GO:0051592(response to calcium ion);GO:0060177(regulation of angiotensin metabolic process)","04024(cAMP signaling pathway)",{"v":1.4E-8,"d":"0.00"},2,"418,83,","0,7294",-7.84,-7.08,6.44,"5' UTR",1,126263457,126271599,8143,2]
["chr1",126363844,126364173,330,"ENSBGRG00000013712","ENSBGRT00000025133",18078,"ENSBGRG00000013712","NA","GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0052689(carboxylic ester hydrolase activity)","NA",{"v":0.011,"d":"0.01"},1,"330,",0,-1.95,-1.18,8.91,"Exon (ENSBGRT00000025133/ENSBGRG00000013712, exon 5 of 5)",1,126363456,126382251,18796,2]
["chr1",126669577,126669846,270,"ENSBGRG00000013878","ENSBGRT00000025477",239,"C1GALT1C1","C1GALT1 specific chaperone 1 [Source:HGNC Symbol;Acc:HGNC:24338]","GO:0006493(protein O-linked glycosylation)","00512(Mucin type O-glycan biosynthesis)",{"v":5e-49,"d":"0.00"},1,"270,",0,{"v":-48.3,"d":"-48.30"},{"v":-47.1,"d":"-47.10"},{"v":11.6,"d":"11.60"},"Exon (ENSBGRT00000025477/ENSBGRG00000013878, exon 1 of 1)",1,126669129,126670085,957,2]
["chr1",127060892,127063293,2402,"ENSBGRG00000014050","ENSBGRT00000025921",342019,"MED12L","mediator complex subunit 12L [Source:HGNC Symbol;Acc:HGNC:16050]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008013(beta-catenin binding);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)",{"v":0.011,"d":"0.01"},2,"24,66,","0,2336",-1.95,{"v":-1.4,"d":"-1.40"},8.91,"Exon (ENSBGRT00000025921/ENSBGRG00000014050, exon 34 of 43)",1,127021523,127405312,383790,2]
["chr1",128009984,128025592,15609,"ENSBGRG00000014873","ENSBGRT00000027440",29246,"EIF2A","eukaryotic translation initiation factor 2A [Source:HGNC Symbol;Acc:HGNC:3254]","GO:0000049(tRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005850(eukaryotic translation initiation factor 2 complex);GO:0006412(translation);GO:0006413(translational initiation);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0009967(positive regulation of signal transduction);GO:0032933(SREBP signaling pathway);GO:0042255(ribosome assembly);GO:0043022(ribosome binding)","NA",{"v":2.5e-47,"d":"0.00"},5,"66,66,129,114,12,","0,3199,3945,10633,15597",{"v":-46.6,"d":"-46.60"},{"v":-45.4,"d":"-45.40"},1.54,"Exon (ENSBGRT00000027440/ENSBGRG00000014873, exon 10 of 14)",1,128009984,128054838,44855,2]
["chr1",128025859,128029233,3375,"ENSBGRG00000014873","ENSBGRT00000027440",25605,"EIF2A","eukaryotic translation initiation factor 2A [Source:HGNC Symbol;Acc:HGNC:3254]","GO:0000049(tRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005850(eukaryotic translation initiation factor 2 complex);GO:0006412(translation);GO:0006413(translational initiation);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0009967(positive regulation of signal transduction);GO:0032933(SREBP signaling pathway);GO:0042255(ribosome assembly);GO:0043022(ribosome binding)","NA",0,3,"294,117,6,","0,3049,3369",-327,"-Inf",6.11,"Exon (ENSBGRT00000027440/ENSBGRG00000014873, exon 8 of 14)",1,128009984,128054838,44855,2]
["chr1",128054452,128054808,357,"ENSBGRG00000014873","ENSBGRT00000027440",30,"EIF2A","eukaryotic translation initiation factor 2A [Source:HGNC Symbol;Acc:HGNC:3254]","GO:0000049(tRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005850(eukaryotic translation initiation factor 2 complex);GO:0006412(translation);GO:0006413(translational initiation);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0009967(positive regulation of signal transduction);GO:0032933(SREBP signaling pathway);GO:0042255(ribosome assembly);GO:0043022(ribosome binding)","NA",{"v":3.2e-12,"d":"0.00"},1,"357,",0,{"v":-11.5,"d":"-11.50"},{"v":-10.6,"d":"-10.60"},4.95,"5' UTR",1,128009984,128054838,44855,2]
["chr1",128139346,128174976,35631,"ENSBGRG00000015241","ENSBGRT00000028693",0,"TSC22D2","TSC22 domain family member 2 [Source:HGNC Symbol;Acc:HGNC:29095]","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006970(response to osmotic stress)","NA",{"v":1E-191,"d":"0.00"},4,"261,52,26,48,","0,1202,1923,35583",-191,-189,4.83,"Exon (ENSBGRT00000028693/ENSBGRG00000015241, exon 1 of 3)",1,128139346,128141294,1949,2]
["chr1",128188872,128189852,981,"ENSBGRG00000015241","ENSBGRT00000028386",0,"TSC22D2","TSC22 domain family member 2 [Source:HGNC Symbol;Acc:HGNC:29095]","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006970(response to osmotic stress)","NA",{"v":1.6E-27,"d":"0.00"},1,"981,",0,{"v":-26.8,"d":"-26.80"},{"v":-25.8,"d":"-25.80"},7.51,"Exon (ENSBGRT00000028386/ENSBGRG00000015241, exon 1 of 5)",1,128139346,128189852,50507,2]
["chr1",128740096,128779213,39118,"ENSBGRG00000015971","ENSBGRT00000029509",95733,"RNF13","ring finger protein 13 [Source:HGNC Symbol;Acc:HGNC:10057]","GO:0004842(ubiquitin-protein transferase activity);GO:0005654(nucleoplasm);GO:0005765(lysosomal membrane);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0008432(JUN kinase binding);GO:0031902(late endosome membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0070304(positive regulation of stress-activated protein kinase signaling cascade)","NA",{"v":4e-17,"d":"0.00"},3,"392,81,2,","0,634,39116",{"v":-16.4,"d":"-16.40"},{"v":-15.5,"d":"-15.50"},{"v":1.8,"d":"1.80"},"3' UTR",1,128739386,128874946,135561,2]
["chr1",129611976,129616359,4384,"ENSBGRG00000017021","ENSBGRT00000031232",38551,"HPS3","HPS3 biogenesis of lysosomal organelles complex 2 subunit 1 [Source:HGNC Symbol;Acc:HGNC:15597]","GO:0005737(cytoplasm);GO:0006996(organelle organization);GO:0031084(BLOC-2 complex);GO:0043473(pigmentation)","NA",{"v":2.5e-31,"d":"0.00"},2,"553,137,","0,4247",{"v":-30.6,"d":"-30.60"},{"v":-29.5,"d":"-29.50"},3.73,"3' UTR",1,129520908,129654910,134003,2]
["chr1",129644476,129644536,61,"ENSBGRG00000017021","ENSBGRT00000031232",10374,"HPS3","HPS3 biogenesis of lysosomal organelles complex 2 subunit 1 [Source:HGNC Symbol;Acc:HGNC:15597]","GO:0005737(cytoplasm);GO:0006996(organelle organization);GO:0031084(BLOC-2 complex);GO:0043473(pigmentation)","NA",{"v":0.0046,"d":"0.00"},1,"61,",0,-2.34,-1.79,{"v":1.6,"d":"1.60"},"Exon (ENSBGRT00000031232/ENSBGRG00000017021, exon 2 of 17)",1,129520908,129654910,134003,2]
["chr1",129644596,129644656,61,"ENSBGRG00000017021","ENSBGRT00000031232",10254,"HPS3","HPS3 biogenesis of lysosomal organelles complex 2 subunit 1 [Source:HGNC Symbol;Acc:HGNC:15597]","GO:0005737(cytoplasm);GO:0006996(organelle organization);GO:0031084(BLOC-2 complex);GO:0043473(pigmentation)","NA",{"v":0.0005,"d":"0.00"},1,"61,",0,{"v":-3.3,"d":"-3.30"},{"v":-2.7,"d":"-2.70"},1.87,"Exon (ENSBGRT00000031232/ENSBGRG00000017021, exon 2 of 17)",1,129520908,129654910,134003,2]
["chr1",129644746,129644806,61,"ENSBGRG00000017021","ENSBGRT00000031232",10104,"HPS3","HPS3 biogenesis of lysosomal organelles complex 2 subunit 1 [Source:HGNC Symbol;Acc:HGNC:15597]","GO:0005737(cytoplasm);GO:0006996(organelle organization);GO:0031084(BLOC-2 complex);GO:0043473(pigmentation)","NA",{"v":0.013,"d":"0.01"},1,"61,",0,{"v":-1.9,"d":"-1.90"},-1.37,{"v":1.6,"d":"1.60"},"Exon (ENSBGRT00000031232/ENSBGRG00000017021, exon 2 of 17)",1,129520908,129654910,134003,2]
["chr1",129770552,129770672,121,"ENSBGRG00000019043","ENSBGRT00000035004",44231,"GYG1","glycogenin 1 [Source:HGNC Symbol;Acc:HGNC:4699]","GO:0005978(glycogen biosynthetic process);GO:0008466(glycogenin glucosyltransferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030145(manganese ion binding);GO:0042803(protein homodimerization activity);GO:0102751(UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity)","00500(Starch and sucrose metabolism)",{"v":0.0056,"d":"0.01"},1,"121,",0,-2.25,{"v":-1.7,"d":"-1.70"},3.57,"3' UTR",1,129769236,129814903,45668,2]
["chr1",130125929,130126345,417,"ENSBGRG00000019592","ENSBGRT00000036014",1958,"AGTR1","angiotensin II receptor type 1 [Source:HGNC Symbol;Acc:HGNC:336]","GO:0004930(G protein-coupled receptor activity);GO:0004945(angiotensin type II receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0019229(regulation of vasoconstriction)","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04072(Phospholipase D signaling pathway);04022(cGMP - PKG signaling pathway);04080(Neuroactive ligand-receptor interaction);04924(Renin secretion);04614(Renin-angiotensin system);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);05200(Pathways in cancer);04933(AGE-RAGE signaling pathway in diabetic complications);04934(Cushing syndrome)",{"v":7.9e-24,"d":"0.00"},1,"417,",0,{"v":-23.1,"d":"-23.10"},{"v":-22.1,"d":"-22.10"},3.76,"Exon (ENSBGRT00000036014/ENSBGRG00000019592, exon 3 of 3)",1,130125929,130128303,2375,2]
["chr1",130126762,130128303,1542,"ENSBGRG00000019592","ENSBGRT00000036014",0,"AGTR1","angiotensin II receptor type 1 [Source:HGNC Symbol;Acc:HGNC:336]","GO:0004930(G protein-coupled receptor activity);GO:0004945(angiotensin type II receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0019229(regulation of vasoconstriction)","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04072(Phospholipase D signaling pathway);04022(cGMP - PKG signaling pathway);04080(Neuroactive ligand-receptor interaction);04924(Renin secretion);04614(Renin-angiotensin system);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);05200(Pathways in cancer);04933(AGE-RAGE signaling pathway in diabetic complications);04934(Cushing syndrome)",{"v":3.2e-16,"d":"0.00"},3,"259,29,40,","0,264,1502",{"v":-15.5,"d":"-15.50"},{"v":-14.6,"d":"-14.60"},4.23,"Exon (ENSBGRT00000036014/ENSBGRG00000019592, exon 1 of 3)",1,130125929,130128303,2375,2]
["chr1",135940345,135959999,19655,"ENSBGRG00000000180","ENSBGRT00000000286",568,"DIPK2A","divergent protein kinase domain 2A [Source:HGNC Symbol;Acc:HGNC:28490]","GO:0000139(Golgi membrane);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0030126(COPI vesicle coat);GO:0030137(COPI-coated vesicle);GO:0034392(negative regulation of smooth muscle cell apoptotic process);GO:0060038(cardiac muscle cell proliferation);GO:1900020(positive regulation of protein kinase C activity)","NA",{"v":5E-42,"d":"0.00"},3,"563,304,89,","0,3265,19566",{"v":-41.3,"d":"-41.30"},{"v":-40.1,"d":"-40.10"},{"v":13.9,"d":"13.90"},"3' UTR",1,135939807,135960567,20761,2]
["chr1",135960388,135960567,180,"ENSBGRG00000000180","ENSBGRT00000000286",0,"DIPK2A","divergent protein kinase domain 2A [Source:HGNC Symbol;Acc:HGNC:28490]","GO:0000139(Golgi membrane);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0030126(COPI vesicle coat);GO:0030137(COPI-coated vesicle);GO:0034392(negative regulation of smooth muscle cell apoptotic process);GO:0060038(cardiac muscle cell proliferation);GO:1900020(positive regulation of protein kinase C activity)","NA",{"v":0.00098,"d":"0.00"},1,"180,",0,-3.01,-2.42,{"v":12.9,"d":"12.90"},"Exon (ENSBGRT00000000286/ENSBGRG00000000180, exon 1 of 3)",1,135939807,135960567,20761,2]
["chr1",137060027,137062776,2750,"ENSBGRG00000000218","ENSBGRT00000000347",0,"CHST2","carbohydrate sulfotransferase 2 [Source:HGNC Symbol;Acc:HGNC:1970]","GO:0000139(Golgi membrane);GO:0001517(N-acetylglucosamine 6-O-sulfotransferase activity);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006044(N-acetylglucosamine metabolic process);GO:0006790(sulfur compound metabolic process);GO:0008146(sulfotransferase activity)","00533(Glycosaminoglycan biosynthesis - keratan sulfate)",{"v":1E-127,"d":"0.00"},3,"159,1165,254,","0,736,2496",-127,-125,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000000347/ENSBGRG00000000218, exon 1 of 3)",1,137060027,137062776,2750,2]
["chr1",137136681,137151574,14894,"ENSBGRG00000000223","ENSBGRT00000000356",40317,"U2SURP","U2 snRNP associated SURP domain containing [Source:HGNC Symbol;Acc:HGNC:30855]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006396(RNA processing)","03040(Spliceosome)",{"v":5e-97,"d":"0.00"},6,"79,177,119,111,160,9,","0,2067,3473,6104,10888,14885",{"v":-96.3,"d":"-96.30"},{"v":-94.8,"d":"-94.80"},4.22,"Exon (ENSBGRT00000000356/ENSBGRG00000000223, exon 23 of 28)",1,137136621,137191891,55271,2]
["chr1",137481771,137483152,1382,"ENSBGRG00000000286","ENSBGRT00000000536",67309,"TRPC1","transient receptor potential cation channel subfamily C member 1 [Source:HGNC Symbol;Acc:HGNC:12333]","GO:0005102(signaling receptor binding);GO:0005216(ion channel activity);GO:0005262(calcium channel activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042438(melanin biosynthetic process);GO:0043235(receptor complex);GO:0051117(ATPase binding);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0051480(regulation of cytosolic calcium ion concentration);GO:0051592(response to calcium ion);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport);GO:0070679(inositol 1,4,5 trisphosphate binding)","04972(Pancreatic secretion);04724(Glutamatergic synapse);04726(Serotonergic synapse);04360(Axon guidance)",{"v":2e-56,"d":"0.00"},2,"228,131,","0,1251",{"v":-55.7,"d":"-55.70"},{"v":-54.4,"d":"-54.40"},{"v":16.3,"d":"16.30"},"Exon (ENSBGRT00000000536/ENSBGRG00000000286, exon 12 of 13)",1,137481771,137550461,68691,2]
["chr1",138554497,138560974,6478,"ENSBGRG00000001134","ENSBGRT00000002094",0,"RNF7","ring finger protein 7 [Source:HGNC Symbol;Acc:HGNC:10070]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0031466(Cul5-RING ubiquitin ligase complex);GO:0045116(protein neddylation);GO:0061663(NEDD8 ligase activity);GO:0097602(cullin family protein binding)","04120(Ubiquitin mediated proteolysis)",{"v":7.9e-22,"d":"0.00"},3,"119,48,175,","0,2797,6303",{"v":-21.1,"d":"-21.10"},{"v":-20.1,"d":"-20.10"},2.62,"Exon (ENSBGRT00000002094/ENSBGRG00000001134, exon 1 of 3)",1,138554497,138560974,6478,2]
["chr1",138894957,138899557,4601,"ENSBGRG00000001246","ENSBGRT00000002273",48121,"ZBTB38","zinc finger and BTB domain containing 38 [Source:HGNC Symbol;Acc:HGNC:26636]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006275(regulation of DNA replication);GO:0006974(cellular response to DNA damage stimulus);GO:0008327(methyl-CpG binding);GO:0042803(protein homodimerization activity);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":1e-160,"d":"0.00"},2,"44,2532,","0,2069",-160,-159,6.48,"Exon (ENSBGRT00000002273/ENSBGRG00000001246, exon 2 of 3)",1,138894957,138947678,52722,2]
["chr1",138899827,138900366,540,"ENSBGRG00000001246","ENSBGRT00000002273",47312,"ZBTB38","zinc finger and BTB domain containing 38 [Source:HGNC Symbol;Acc:HGNC:26636]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006275(regulation of DNA replication);GO:0006974(cellular response to DNA damage stimulus);GO:0008327(methyl-CpG binding);GO:0042803(protein homodimerization activity);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":1.3e-29,"d":"0.00"},1,"540,",0,{"v":-28.9,"d":"-28.90"},{"v":-27.9,"d":"-27.90"},4.48,"Exon (ENSBGRT00000002273/ENSBGRG00000001246, exon 2 of 3)",1,138894957,138947678,52722,2]
["chr1",139076748,139082837,6090,"ENSBGRG00000001263","ENSBGRT00000002318",34518,"PXYLP1","2-phosphoxylose phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:26303]","GO:0005794(Golgi apparatus);GO:0006024(glycosaminoglycan biosynthetic process);GO:0010909(positive regulation of heparan sulfate proteoglycan biosynthetic process);GO:0016791(phosphatase activity);GO:0050650(chondroitin sulfate proteoglycan biosynthetic process)","NA",{"v":1.6e-97,"d":"0.00"},2,"879,129,","0,5961",{"v":-96.8,"d":"-96.80"},{"v":-95.3,"d":"-95.30"},{"v":10.6,"d":"10.60"},"Exon (ENSBGRT00000002318/ENSBGRG00000001263, exon 4 of 5)",1,139076689,139117355,40667,2]
["chr1",139329068,139329425,358,"ENSBGRG00000001297","ENSBGRT00000002384",0,"SPSB4","splA/ryanodine receptor domain and SOCS box containing 4 [Source:HGNC Symbol;Acc:HGNC:30630]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0035556(intracellular signal transduction);GO:0042752(regulation of circadian rhythm);GO:1902916(positive regulation of protein polyubiquitination);GO:1990756(ubiquitin ligase-substrate adaptor activity)","NA",0.02,1,"358,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"5' UTR",1,139245929,139329425,83497,2]
["chr1",139446585,139448246,1662,"ENSBGRG00000001317","ENSBGRT00000002419",36102,"SLC25A36","solute carrier family 25 member 36 [Source:HGNC Symbol;Acc:HGNC:25554]","GO:0000002(mitochondrial genome maintenance);GO:0005347(ATP transmembrane transporter activity);GO:0005739(mitochondrion);GO:0006864(pyrimidine nucleotide transport);GO:0007005(mitochondrion organization);GO:0015218(pyrimidine nucleotide transmembrane transporter activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055085(transmembrane transport)","NA",{"v":5e-86,"d":"0.00"},2,"194,252,","0,1410",{"v":-85.3,"d":"-85.30"},{"v":-83.8,"d":"-83.80"},{"v":5.2,"d":"5.20"},"Exon (ENSBGRT00000002419/ENSBGRG00000001317, exon 6 of 7)",1,139446585,139484348,37764,2]
["chr1",139483814,139483992,179,"ENSBGRG00000001317","ENSBGRT00000002419",356,"SLC25A36","solute carrier family 25 member 36 [Source:HGNC Symbol;Acc:HGNC:25554]","GO:0000002(mitochondrial genome maintenance);GO:0005347(ATP transmembrane transporter activity);GO:0005739(mitochondrion);GO:0006864(pyrimidine nucleotide transport);GO:0007005(mitochondrion organization);GO:0015218(pyrimidine nucleotide transmembrane transporter activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055085(transmembrane transport)","NA",0.01,1,"179,",0,-1.99,-1.46,3.71,"5' UTR",1,139446585,139484348,37764,2]
["chr1",139859052,139859141,90,"ENSBGRG00000001375","ENSBGRT00000002548",803265,"CLSTN2","calsyntenin 2 [Source:HGNC Symbol;Acc:HGNC:17448]","GO:0005509(calcium ion binding);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0009986(cell surface);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0045211(postsynaptic membrane);GO:0050806(positive regulation of synaptic transmission);GO:0051965(positive regulation of synapse assembly);GO:0098978(glutamatergic synapse);GO:0099061(integral component of postsynaptic density membrane)","NA",{"v":0.0039,"d":"0.00"},1,"90,",0,-2.41,-1.85,9.91,"Exon (ENSBGRT00000002548/ENSBGRG00000001375, exon 17 of 17)",1,139859022,140662406,803385,2]
["chr1",142184509,142194905,10397,"ENSBGRG00000001673","ENSBGRT00000003109",1454,"FAIM","Fas apoptotic inhibitory molecule [Source:HGNC Symbol;Acc:HGNC:18703]","GO:0043066(negative regulation of apoptotic process)","NA",{"v":6.3E-29,"d":"0.00"},5,"8,142,50,229,45,","0,19,4868,9771,10352",{"v":-28.2,"d":"-28.20"},{"v":-27.1,"d":"-27.10"},3.47,"Exon (ENSBGRT00000003109/ENSBGRG00000001673, exon 2 of 6)",1,142184509,142196359,11851,2]
["chr1",142318829,142325657,6829,"ENSBGRG00000001860","ENSBGRT00000003487",51404,"ESYT3","extended synaptotagmin 3 [Source:HGNC Symbol;Acc:HGNC:24295]","GO:0005887(integral component of plasma membrane);GO:0006869(lipid transport);GO:0008289(lipid binding);GO:0031227(intrinsic component of endoplasmic reticulum membrane);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0044232(organelle membrane contact site);GO:0061817(endoplasmic reticulum-plasma membrane tethering);GO:0140268(endoplasmic reticulum-plasma membrane contact site)","NA",{"v":0.036,"d":"0.04"},4,"101,132,99,176,","0,5241,5873,6653",-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000003487/ENSBGRG00000001860, exon 18 of 23)",1,142317578,142377061,59484,2]
["chr1",142426358,142429370,3013,"ENSBGRG00000001941","ENSBGRT00000003635",82960,"MRAS","muscle RAS oncogene homolog [Source:HGNC Symbol;Acc:HGNC:7227]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0007265(Ras protein signal transduction);GO:0016020(membrane);GO:0030742(GTP-dependent protein binding);GO:1990830(cellular response to leukemia inhibitory factor)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04371(Apelin signaling pathway);04072(Phospholipase D signaling pathway);04140(Autophagy - animal);04137(Mitophagy - animal);04218(Cellular senescence);04810(Regulation of actin cytoskeleton);04625(C-type lectin receptor signaling pathway);05205(Proteoglycans in cancer);05166(HTLV-I infection)",{"v":6.3e-40,"d":"0.00"},2,"725,53,","0,2960",{"v":-39.2,"d":"-39.20"},{"v":-38.1,"d":"-38.10"},3.05,"3' UTR",1,142426358,142512330,85973,2]
["chr1",142511553,142511613,61,"ENSBGRG00000001941","ENSBGRT00000003635",717,"MRAS","muscle RAS oncogene homolog [Source:HGNC Symbol;Acc:HGNC:7227]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0007265(Ras protein signal transduction);GO:0016020(membrane);GO:0030742(GTP-dependent protein binding);GO:1990830(cellular response to leukemia inhibitory factor)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04371(Apelin signaling pathway);04072(Phospholipase D signaling pathway);04140(Autophagy - animal);04137(Mitophagy - animal);04218(Cellular senescence);04810(Regulation of actin cytoskeleton);04625(C-type lectin receptor signaling pathway);05205(Proteoglycans in cancer);05166(HTLV-I infection)",0.01,1,"61,",0,-1.99,-1.46,3.71,"5' UTR",1,142426358,142512330,85973,2]
["chr1",142512151,142512330,180,"ENSBGRG00000001941","ENSBGRT00000003635",0,"MRAS","muscle RAS oncogene homolog [Source:HGNC Symbol;Acc:HGNC:7227]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0007265(Ras protein signal transduction);GO:0016020(membrane);GO:0030742(GTP-dependent protein binding);GO:1990830(cellular response to leukemia inhibitory factor)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04371(Apelin signaling pathway);04072(Phospholipase D signaling pathway);04140(Autophagy - animal);04137(Mitophagy - animal);04218(Cellular senescence);04810(Regulation of actin cytoskeleton);04625(C-type lectin receptor signaling pathway);05205(Proteoglycans in cancer);05166(HTLV-I infection)",{"v":6.3E-3,"d":"0.01"},1,"180,",0,{"v":-2.2,"d":"-2.20"},-1.66,4.29,"5' UTR",1,142426358,142512330,85973,2]
["chr1",142567061,142579707,12647,"ENSBGRG00000002029","ENSBGRT00000003769",105970,"ARMC8","armadillo repeat containing 8 [Source:HGNC Symbol;Acc:HGNC:24999]","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm)","NA",{"v":2E-51,"d":"0.00"},5,"170,94,518,73,11,","0,6639,7426,8075,12636",{"v":-50.7,"d":"-50.70"},{"v":-49.5,"d":"-49.50"},{"v":10.9,"d":"10.90"},"3' UTR",1,142567061,142685677,118617,2]
["chr1",144046569,144047462,894,"ENSBGRG00000002412","ENSBGRT00000004515",41989,"NCK1","NCK adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:7664]","GO:0000164(protein phosphatase type 1 complex);GO:0004860(protein kinase inhibitor activity);GO:0005070(SH3/SH2 adaptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005840(ribosome);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006930(substrate-dependent cell migration, cell extension);GO:0007015(actin filament organization);GO:0010976(positive regulation of neuron projection development);GO:0012506(vesicle membrane);GO:0016477(cell migration);GO:0019904(protein domain specific binding);GO:0030032(lamellipodium assembly);GO:0030334(regulation of cell migration);GO:0030674(protein-macromolecule adaptor activity);GO:0030838(positive regulation of actin filament polymerization);GO:0030971(receptor tyrosine kinase binding);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042102(positive regulation of T cell proliferation);GO:0042110(T cell activation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0051707(response to other organism);GO:0060548(negative regulation of cell death);GO:0070262(peptidyl-serine dephosphorylation);GO:0071074(eukaryotic initiation factor eIF2 binding);GO:1902237(positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway);GO:1903676(positive regulation of cap-dependent translational initiation);GO:1903679(positive regulation of cap-independent translational initiation);GO:1903898(negative regulation of PERK-mediated unfolded protein response);GO:1903912(negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation);GO:1990441(negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04012(ErbB signaling pathway);04660(T cell receptor signaling pathway);04360(Axon guidance)",{"v":6.3e-30,"d":"0.00"},1,"894,",0,{"v":-29.2,"d":"-29.20"},{"v":-28.2,"d":"-28.20"},5.36,"3' UTR",1,144046569,144089451,42883,2]
["chr1",144103292,144125538,22247,"ENSBGRG00000002412","ENSBGRT00000004487",0,"NCK1","NCK adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:7664]","GO:0000164(protein phosphatase type 1 complex);GO:0004860(protein kinase inhibitor activity);GO:0005070(SH3/SH2 adaptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005840(ribosome);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006930(substrate-dependent cell migration, cell extension);GO:0007015(actin filament organization);GO:0010976(positive regulation of neuron projection development);GO:0012506(vesicle membrane);GO:0016477(cell migration);GO:0019904(protein domain specific binding);GO:0030032(lamellipodium assembly);GO:0030334(regulation of cell migration);GO:0030674(protein-macromolecule adaptor activity);GO:0030838(positive regulation of actin filament polymerization);GO:0030971(receptor tyrosine kinase binding);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042102(positive regulation of T cell proliferation);GO:0042110(T cell activation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0051707(response to other organism);GO:0060548(negative regulation of cell death);GO:0070262(peptidyl-serine dephosphorylation);GO:0071074(eukaryotic initiation factor eIF2 binding);GO:1902237(positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway);GO:1903676(positive regulation of cap-dependent translational initiation);GO:1903679(positive regulation of cap-independent translational initiation);GO:1903898(negative regulation of PERK-mediated unfolded protein response);GO:1903912(negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation);GO:1990441(negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04012(ErbB signaling pathway);04660(T cell receptor signaling pathway);04360(Axon guidance)",0,4,"290,713,34,244,","0,2178,15728,22003",-338,"-Inf",4.03,"5' UTR",1,144046569,144125538,78970,2]
["chr1",144197183,144197565,383,"ENSBGRG00000002474","ENSBGRT00000004609",441,"SLC35G2","solute carrier family 35 member G2 [Source:HGNC Symbol;Acc:HGNC:28480]","GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":2.3E-3,"d":"0.00"},1,"383,",0,-2.63,-2.06,4.46,"Exon (ENSBGRT00000004609/ENSBGRG00000002474, exon 1 of 1)",1,144196771,144198006,1236,2]
["chr1",145034111,145034350,240,"ENSBGRG00000003035","ENSBGRT00000005672",418,"ENSBGRG00000003035","NA","NA","NA",{"v":9.1e-07,"d":"0.00"},1,"240,",0,-6.04,-5.33,{"v":13.4,"d":"13.40"},"Exon (ENSBGRT00000005672/ENSBGRG00000003035, exon 1 of 2)",1,145029635,145034768,5134,2]
["chr1",145034410,145034768,359,"ENSBGRG00000003035","ENSBGRT00000005672",0,"ENSBGRG00000003035","NA","NA","NA",{"v":0.0044,"d":"0.00"},1,"359,",0,-2.36,{"v":-1.8,"d":"-1.80"},3.96,"Exon (ENSBGRT00000005672/ENSBGRG00000003035, exon 1 of 2)",1,145029635,145034768,5134,2]
["chr1",145255664,145256261,598,"ENSBGRG00000003074","ENSBGRT00000005767",19974,"PPP2R3A","protein phosphatase 2 regulatory subunit B''alpha [Source:HGNC Symbol;Acc:HGNC:9307]","GO:0000159(protein phosphatase type 2A complex);GO:0005509(calcium ion binding)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);05165(Human papillomavirus infection)",{"v":1e-05,"d":"0.00"},1,"598,",0,-4.99,-4.31,2.83,"Exon (ENSBGRT00000005767/ENSBGRG00000003074, exon 2 of 14)",1,145073358,145276235,202878,2]
["chr1",145256708,145257543,836,"ENSBGRG00000003074","ENSBGRT00000005767",18692,"PPP2R3A","protein phosphatase 2 regulatory subunit B''alpha [Source:HGNC Symbol;Acc:HGNC:9307]","GO:0000159(protein phosphatase type 2A complex);GO:0005509(calcium ion binding)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);05165(Human papillomavirus infection)",{"v":1.6E-11,"d":"0.00"},1,"836,",0,{"v":-10.8,"d":"-10.80"},-9.98,4.43,"5' UTR",1,145073358,145276235,202878,2]
["chr1",146134879,146138962,4084,"ENSBGRG00000003150","ENSBGRT00000005871",508040,"ENSBGRG00000003150","EPH receptor B1 [Source:HGNC Symbol;Acc:HGNC:3392]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0016021(integral component of membrane)","04360(Axon guidance)",{"v":3.2e-23,"d":"0.00"},2,"661,89,","0,3995",{"v":-22.5,"d":"-22.50"},{"v":-21.5,"d":"-21.50"},{"v":5.3,"d":"5.30"},"3' UTR",1,146134490,146647002,512513,2]
["chr1",146471438,146471707,270,"ENSBGRG00000003150","ENSBGRT00000005871",175295,"ENSBGRG00000003150","EPH receptor B1 [Source:HGNC Symbol;Acc:HGNC:3392]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0016021(integral component of membrane)","04360(Axon guidance)",{"v":2.6E-7,"d":"0.00"},1,"270,",0,-6.59,-5.86,7.33,"Exon (ENSBGRT00000005871/ENSBGRG00000003150, exon 3 of 17)",1,146134490,146647002,512513,2]
["chr1",146646822,146646912,91,"ENSBGRG00000003150","ENSBGRT00000005871",90,"ENSBGRG00000003150","EPH receptor B1 [Source:HGNC Symbol;Acc:HGNC:3392]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0016021(integral component of membrane)","04360(Axon guidance)",{"v":0.017,"d":"0.02"},1,"91,",0,-1.77,-1.25,2.05,"5' UTR",1,146134490,146647002,512513,2]
["chr1",146882524,146886543,4020,"ENSBGRG00000003279","ENSBGRT00000006099",65399,"CEP63","centrosomal protein 63 [Source:HGNC Symbol;Acc:HGNC:25815]","GO:0005813(centrosome);GO:0007099(centriole replication)","NA",{"v":0.00081,"d":"0.00"},2,"159,80,","0,3940",-3.09,-2.49,1.75,"Exon (ENSBGRT00000006099/ENSBGRG00000003279, exon 13 of 14)",1,146882524,146951942,69419,2]
["chr1",146900450,146900510,61,"ENSBGRG00000003279","ENSBGRT00000006099",51432,"CEP63","centrosomal protein 63 [Source:HGNC Symbol;Acc:HGNC:25815]","GO:0005813(centrosome);GO:0007099(centriole replication)","NA",{"v":0.0081,"d":"0.01"},1,"61,",0,-2.09,-1.55,1.53,"Exon (ENSBGRT00000006099/ENSBGRG00000003279, exon 8 of 14)",1,146882524,146951942,69419,2]
["chr1",146932171,146933745,1575,"ENSBGRG00000003279","ENSBGRT00000006099",18197,"CEP63","centrosomal protein 63 [Source:HGNC Symbol;Acc:HGNC:25815]","GO:0005813(centrosome);GO:0007099(centriole replication)","NA",{"v":4e-08,"d":"0.00"},2,"104,46,","0,1529",{"v":-7.4,"d":"-7.40"},-6.65,2.22,"Exon (ENSBGRT00000006099/ENSBGRG00000003279, exon 3 of 14)",1,146882524,146951942,69419,2]
["chr1",147712998,147713057,60,"ENSBGRG00000003560","ENSBGRT00000006635",42804,"SRPRB","SRP receptor subunit beta [Source:HGNC Symbol;Acc:HGNC:24085]","GO:0005737(cytoplasm);GO:0005881(cytoplasmic microtubule);GO:0016020(membrane)","03060(Protein export)",{"v":0.0013,"d":"0.00"},1,"60,",0,-2.87,-2.28,1.36,"Exon (ENSBGRT00000006635/ENSBGRG00000003560, exon 7 of 7)",1,147711866,147755861,43996,2]
["chr1",148053661,148055115,1455,"ENSBGRG00000004386","ENSBGRT00000008114",10745,"ENSBGRG00000004386","NA","NA","NA",{"v":2e-42,"d":"0.00"},2,"151,147,","0,1308",{"v":-41.7,"d":"-41.70"},{"v":-40.6,"d":"-40.60"},2.45,"Exon (ENSBGRT00000008114/ENSBGRG00000004386, exon 4 of 5)",1,148053661,148065860,12200,2]
["chr1",148065622,148065860,239,"ENSBGRG00000004386","ENSBGRT00000008114",0,"ENSBGRG00000004386","NA","NA","NA",{"v":4e-25,"d":"0.00"},1,"239,",0,{"v":-24.4,"d":"-24.40"},{"v":-23.4,"d":"-23.40"},{"v":6.3,"d":"6.30"},"Exon (ENSBGRT00000008114/ENSBGRG00000004386, exon 1 of 5)",1,148053661,148065860,12200,2]
["chr1",148248209,148248447,239,"ENSBGRG00000006213","ENSBGRT00000011528",174320,"TMEM108","transmembrane protein 108 [Source:HGNC Symbol;Acc:HGNC:28451]","GO:0005769(early endosome);GO:0006898(receptor-mediated endocytosis);GO:0008090(retrograde axonal transport);GO:0010008(endosome membrane);GO:0014069(postsynaptic density);GO:0021542(dentate gyrus development);GO:0030424(axon);GO:0031175(neuron projection development);GO:0036477(somatodendritic compartment);GO:0051388(positive regulation of neurotrophin TRK receptor signaling pathway);GO:0097106(postsynaptic density organization);GO:0097484(dendrite extension);GO:0098815(modulation of excitatory postsynaptic potential);GO:1990416(cellular response to brain-derived neurotrophic factor stimulus)","NA",{"v":0.036,"d":"0.04"},1,"239,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000011493/ENSBGRG00000006213, exon 4 of 6)",1,148233498,148422767,189270,2]
["chr1",148248596,148248774,179,"ENSBGRG00000006213","ENSBGRT00000011528",173993,"TMEM108","transmembrane protein 108 [Source:HGNC Symbol;Acc:HGNC:28451]","GO:0005769(early endosome);GO:0006898(receptor-mediated endocytosis);GO:0008090(retrograde axonal transport);GO:0010008(endosome membrane);GO:0014069(postsynaptic density);GO:0021542(dentate gyrus development);GO:0030424(axon);GO:0031175(neuron projection development);GO:0036477(somatodendritic compartment);GO:0051388(positive regulation of neurotrophin TRK receptor signaling pathway);GO:0097106(postsynaptic density organization);GO:0097484(dendrite extension);GO:0098815(modulation of excitatory postsynaptic potential);GO:1990416(cellular response to brain-derived neurotrophic factor stimulus)","NA",0.02,1,"179,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000011493/ENSBGRG00000006213, exon 4 of 6)",1,148233498,148422767,189270,2]
["chr1",149153317,149154190,874,"ENSBGRG00000006457","ENSBGRT00000012028",34231,"UBA5","ubiquitin like modifier activating enzyme 5 [Source:HGNC Symbol;Acc:HGNC:23230]","GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0008641(ubiquitin-like modifier activating enzyme activity);GO:0030218(erythrocyte differentiation);GO:0030219(megakaryocyte differentiation);GO:0033146(regulation of intracellular estrogen receptor signaling pathway);GO:0034976(response to endoplasmic reticulum stress);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0050905(neuromuscular process);GO:0061709(reticulophagy);GO:0071566(UFM1 activating enzyme activity);GO:0071569(protein ufmylation);GO:1990592(protein K69-linked ufmylation)","NA",{"v":1.3e-26,"d":"0.00"},3,"57,107,44,","0,572,830",{"v":-25.9,"d":"-25.90"},{"v":-24.9,"d":"-24.90"},4.24,"Exon (ENSBGRT00000012028/ENSBGRG00000006457, exon 10 of 12)",1,149152963,149188421,35459,2]
["chr1",150988836,150989374,539,"ENSBGRG00000008026","ENSBGRT00000014683",2490,"NUDT16","nudix hydrolase 16 [Source:HGNC Symbol;Acc:HGNC:26442]","GO:0000287(magnesium ion binding);GO:0003729(mRNA binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006382(adenosine to inosine editing);GO:0006402(mRNA catabolic process);GO:0008235(metalloexopeptidase activity);GO:0008284(positive regulation of cell population proliferation);GO:0016077(snoRNA catabolic process);GO:0016787(hydrolase activity);GO:0030145(manganese ion binding);GO:0030515(snoRNA binding);GO:0031404(chloride ion binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0046709(IDP catabolic process);GO:0050072(m7G(5')pppN diphosphatase activity);GO:0050897(cobalt ion binding);GO:0090068(positive regulation of cell cycle process);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic);GO:0098519(nucleotide phosphatase activity, acting on free nucleotides);GO:1901639(XDP catabolic process);GO:1901640(XTP binding);GO:1901641(ITP binding);GO:1990174(phosphodiesterase decapping endonuclease activity);GO:2000781(positive regulation of double-strand break repair)","00230(Purine metabolism);03018(RNA degradation)",{"v":6.3e-18,"d":"0.00"},1,"539,",0,{"v":-17.2,"d":"-17.20"},{"v":-16.3,"d":"-16.30"},{"v":22.8,"d":"22.80"},"3' UTR",1,150988836,150991864,3029,2]
["chr1",150990241,150991864,1624,"ENSBGRG00000008026","ENSBGRT00000014683",0,"NUDT16","nudix hydrolase 16 [Source:HGNC Symbol;Acc:HGNC:26442]","GO:0000287(magnesium ion binding);GO:0003729(mRNA binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006382(adenosine to inosine editing);GO:0006402(mRNA catabolic process);GO:0008235(metalloexopeptidase activity);GO:0008284(positive regulation of cell population proliferation);GO:0016077(snoRNA catabolic process);GO:0016787(hydrolase activity);GO:0030145(manganese ion binding);GO:0030515(snoRNA binding);GO:0031404(chloride ion binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0046709(IDP catabolic process);GO:0050072(m7G(5')pppN diphosphatase activity);GO:0050897(cobalt ion binding);GO:0090068(positive regulation of cell cycle process);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic);GO:0098519(nucleotide phosphatase activity, acting on free nucleotides);GO:1901639(XDP catabolic process);GO:1901640(XTP binding);GO:1901641(ITP binding);GO:1990174(phosphodiesterase decapping endonuclease activity);GO:2000781(positive regulation of double-strand break repair)","00230(Purine metabolism);03018(RNA degradation)",{"v":1E-172,"d":"0.00"},3,"400,270,138,","0,1112,1486",-172,-170,5.91,"3' UTR",1,150988836,150991864,3029,2]
["chr1",151006871,151059633,52763,"ENSBGRG00000008332","ENSBGRT00000015164",0,"U6","U6 spliceosomal RNA [Source:RFAM;Acc:RF00026]","NA","NA",{"v":2.9E-4,"d":"0.00"},2,"292,36,","0,52727",-3.54,-2.92,5.45,"Exon (ENSBGRT00000015164/ENSBGRG00000008332, exon 1 of 1)",1,151028273,151028379,107,1]
["chr1",151312740,151337690,24951,"ENSBGRG00000008357","ENSBGRT00000015300",12229,"ASTE1","asteroid homolog 1 [Source:HGNC Symbol;Acc:HGNC:25021]","GO:0004518(nuclease activity);GO:0006281(DNA repair)","NA",0,3,"7,564,57,","0,23978,24894",-337,"-Inf",5.12,"3' UTR",1,151300511,151316894,16384,1]
["chr1",151505776,151505925,150,"ENSBGRG00000008500","ENSBGRT00000015560",119,"ATP2C1","ATPase secretory pathway Ca2+ transporting 1 [Source:HGNC Symbol;Acc:HGNC:13211]","GO:0000139(Golgi membrane);GO:0000166(nucleotide binding);GO:0005388(calcium transmembrane transporter activity, phosphorylative mechanism);GO:0005524(ATP binding);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0006816(calcium ion transport);GO:0006874(cellular calcium ion homeostasis);GO:0008544(epidermis development);GO:0016021(integral component of membrane);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0031532(actin cytoskeleton reorganization);GO:0032468(Golgi calcium ion homeostasis);GO:0032472(Golgi calcium ion transport);GO:0070588(calcium ion transmembrane transport)","NA",{"v":0.022,"d":"0.02"},1,"150,",0,-1.66,-1.15,3.22,"5' UTR",1,151312651,151506044,193394,2]
["chr1",151735549,151750064,14516,"ENSBGRG00000009216","ENSBGRT00000017073",0,"BRWD1","bromodomain and WD repeat domain containing 1 [Source:HGNC Symbol;Acc:HGNC:12760]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0043248(proteasome assembly)","NA",{"v":1e-126,"d":"0.00"},4,"100,134,392,65,","0,1433,4909,14451",-126,-124,{"v":10.1,"d":"10.10"},"3' UTR",1,151722680,151737115,14436,2]
["chr1",151750333,151753510,3178,"ENSBGRG00000009216","ENSBGRT00000018882",112068,"BRWD1","bromodomain and WD repeat domain containing 1 [Source:HGNC Symbol;Acc:HGNC:12760]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0043248(proteasome assembly)","NA",{"v":1e-163,"d":"0.00"},2,"1432,789,","0,2389",-163,-161,{"v":7.7,"d":"7.70"},"3' UTR",1,151735566,151865578,130013,2]
["chr1",151922053,151946694,24642,"ENSBGRG00000011188","ENSBGRT00000020815",0,"ENSBGRG00000011188","NA","GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)","00310(Lysine degradation);05168(Herpes simplex infection)",{"v":0.00017,"d":"0.00"},4,"70,24,39,491,","0,342,377,24151",-3.77,-3.14,{"v":14.9,"d":"14.90"},"5' UTR",1,151916078,151922122,6045,2]
["chr1",151996470,151996560,91,"ENSBGRG00000011685","ENSBGRT00000021279",32568,"LCA5L","lebercilin LCA5 like [Source:HGNC Symbol;Acc:HGNC:1255]","NA","NA",{"v":0.004,"d":"0.00"},1,"91,",0,{"v":-2.4,"d":"-2.40"},-1.84,5.94,"Exon (ENSBGRT00000021279/ENSBGRG00000011685, exon 9 of 9)",1,151994913,152029128,34216,2]
["chr1",154840692,154841230,539,"ENSBGRG00000014918","ENSBGRT00000027447",26995,"RIPK4","receptor interacting serine/threonine kinase 4 [Source:HGNC Symbol;Acc:HGNC:496]","GO:0002009(morphogenesis of an epithelium);GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0051092(positive regulation of NF-kappaB transcription factor activity)","NA",{"v":2.2e-05,"d":"0.00"},1,"539,",0,-4.66,-4,{"v":18.8,"d":"18.80"},"Exon (ENSBGRT00000027447/ENSBGRG00000014918, exon 8 of 8)",1,154840453,154868225,27773,2]
["chr1",154841589,154843471,1883,"ENSBGRG00000014918","ENSBGRT00000027447",24754,"RIPK4","receptor interacting serine/threonine kinase 4 [Source:HGNC Symbol;Acc:HGNC:496]","GO:0002009(morphogenesis of an epithelium);GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0051092(positive regulation of NF-kappaB transcription factor activity)","NA",{"v":1.2E-4,"d":"0.00"},2,"24,156,","0,1727",-3.92,-3.28,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000027447/ENSBGRG00000014918, exon 7 of 8)",1,154840453,154868225,27773,2]
["chr1",154899528,154900275,748,"ENSBGRG00000014984","ENSBGRT00000028691",57106,"PRDM15","PR/SET domain 15 [Source:HGNC Symbol;Acc:HGNC:13999]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0043409(negative regulation of MAPK cascade);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1990841(promoter-specific chromatin binding);GO:2000035(regulation of stem cell division)","NA",{"v":3.2e-11,"d":"0.00"},1,"748,",0,{"v":-10.5,"d":"-10.50"},-9.67,{"v":14.4,"d":"14.40"},"3' UTR",1,154898543,154957381,58839,2]
["chr1",154900334,154900514,181,"ENSBGRG00000014984","ENSBGRT00000028691",56867,"PRDM15","PR/SET domain 15 [Source:HGNC Symbol;Acc:HGNC:13999]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0043409(negative regulation of MAPK cascade);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1990841(promoter-specific chromatin binding);GO:2000035(regulation of stem cell division)","NA",{"v":2.8E-5,"d":"0.00"},1,"181,",0,-4.56,{"v":-3.9,"d":"-3.90"},2.18,"3' UTR",1,154898543,154957381,58839,2]
["chr1",154986722,154997279,10558,"ENSBGRG00000015751","ENSBGRT00000029333",64636,"C2CD2","C2 calcium dependent domain containing 2 [Source:HGNC Symbol;Acc:HGNC:1266]","NA","NA",{"v":1e-11,"d":"0.00"},3,"90,131,284,","0,1373,10274",-11,{"v":-10.2,"d":"-10.20"},4.68,"Exon (ENSBGRT00000029333/ENSBGRG00000015751, exon 14 of 16)",1,154986722,155061915,75194,2]
["chr1",155098245,155098512,268,"ENSBGRG00000016033","ENSBGRT00000029461",3571,"ZBTB21","zinc finger and BTB domain containing 21 [Source:HGNC Symbol;Acc:HGNC:13083]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008327(methyl-CpG binding);GO:0031208(POZ domain binding)","NA",{"v":7.9e-16,"d":"0.00"},1,"268,",0,{"v":-15.1,"d":"-15.10"},{"v":-14.2,"d":"-14.20"},4.56,"Exon (ENSBGRT00000029461/ENSBGRG00000016033, exon 2 of 2)",1,155098245,155102083,3839,2]
["chr1",155098780,155099047,268,"ENSBGRG00000016033","ENSBGRT00000029461",3036,"ZBTB21","zinc finger and BTB domain containing 21 [Source:HGNC Symbol;Acc:HGNC:13083]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008327(methyl-CpG binding);GO:0031208(POZ domain binding)","NA",{"v":4.8E-8,"d":"0.00"},1,"268,",0,-7.32,-6.57,3.01,"Exon (ENSBGRT00000029461/ENSBGRG00000016033, exon 2 of 2)",1,155098245,155102083,3839,2]
["chr1",155100538,155100776,239,"ENSBGRG00000016033","ENSBGRT00000029461",1307,"ZBTB21","zinc finger and BTB domain containing 21 [Source:HGNC Symbol;Acc:HGNC:13083]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008327(methyl-CpG binding);GO:0031208(POZ domain binding)","NA",{"v":5.4E-8,"d":"0.00"},1,"239,",0,-7.27,-6.52,5.39,"Exon (ENSBGRT00000029461/ENSBGRG00000016033, exon 1 of 2)",1,155098245,155102083,3839,2]
["chr1",155100954,155101964,1011,"ENSBGRG00000016033","ENSBGRT00000029461",119,"ZBTB21","zinc finger and BTB domain containing 21 [Source:HGNC Symbol;Acc:HGNC:13083]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008327(methyl-CpG binding);GO:0031208(POZ domain binding)","NA",{"v":6.3E-22,"d":"0.00"},1,"1011,",0,{"v":-21.2,"d":"-21.20"},{"v":-20.2,"d":"-20.20"},{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000029461/ENSBGRG00000016033, exon 1 of 2)",1,155098245,155102083,3839,2]
["chr1",155710426,155710911,486,"ENSBGRG00000018504","ENSBGRT00000034220",864,"RSPH1","radial spoke head component 1 [Source:HGNC Symbol;Acc:HGNC:12371]","GO:0000794(condensed nuclear chromosome);GO:0001520(outer dense fiber);GO:0005737(cytoplasm);GO:0007286(spermatid development);GO:0031514(motile cilium);GO:0035082(axoneme assembly);GO:0036126(sperm flagellum);GO:0072687(meiotic spindle)","NA",{"v":0.011,"d":"0.01"},2,"53,97,","0,389",-1.95,-1.18,8.91,"5' UTR",1,155696969,155711775,14807,2]
["chr1",156089395,156089454,60,"ENSBGRG00000019836","ENSBGRT00000036514",20854,"WDR4","WD repeat domain 4 [Source:HGNC Symbol;Acc:HGNC:12756]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006400(tRNA modification);GO:0008176(tRNA (guanine-N7-)-methyltransferase activity);GO:0036265(RNA (guanine-N7)-methylation);GO:0043527(tRNA methyltransferase complex)","NA",{"v":0.0044,"d":"0.00"},1,"60,",0,-2.36,{"v":-1.8,"d":"-1.80"},2.33,"Exon (ENSBGRT00000036514/ENSBGRG00000019836, exon 11 of 11)",1,156089395,156110308,20914,2]
["chr1",156089513,156090206,694,"ENSBGRG00000019836","ENSBGRT00000036514",20102,"WDR4","WD repeat domain 4 [Source:HGNC Symbol;Acc:HGNC:12756]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006400(tRNA modification);GO:0008176(tRNA (guanine-N7-)-methyltransferase activity);GO:0036265(RNA (guanine-N7)-methylation);GO:0043527(tRNA methyltransferase complex)","NA",{"v":0.00016,"d":"0.00"},2,"79,10,","0,684",{"v":-3.8,"d":"-3.80"},-3.17,2.03,"Exon (ENSBGRT00000036514/ENSBGRG00000019836, exon 10 of 11)",1,156089395,156110308,20914,2]
["chr1",156281271,156283386,2116,"ENSBGRG00000020541","ENSBGRT00000037949",10654,"ENSBGRG00000020541","NA","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0016607(nuclear speck);GO:0046872(metal ion binding);GO:0050733(RS domain binding);GO:0089701(U2AF)","03040(Spliceosome);05131(Shigellosis)",{"v":3.2E-54,"d":"0.00"},4,"139,93,134,11,","0,1300,1474,2105",{"v":-53.5,"d":"-53.50"},{"v":-52.3,"d":"-52.30"},5.11,"Exon (ENSBGRT00000037949/ENSBGRG00000020541, exon 5 of 8)",1,156281271,156294040,12770,2]
["chr1",156565091,156565939,849,"ENSBGRG00000020700","ENSBGRT00000038146",8775,"ENSBGRG00000020700","NA","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007346(regulation of mitotic cell cycle);GO:0008140(cAMP response element binding protein binding);GO:0010830(regulation of myotube differentiation);GO:0010868(negative regulation of triglyceride biosynthetic process);GO:0019901(protein kinase binding);GO:0032792(negative regulation of CREB transcription factor activity);GO:0035556(intracellular signal transduction);GO:0042826(histone deacetylase binding);GO:0043153(entrainment of circadian clock by photoperiod);GO:0043276(anoikis);GO:0045595(regulation of cell differentiation);GO:0045721(negative regulation of gluconeogenesis);GO:0055007(cardiac muscle cell differentiation)","04922(Glucagon signaling pathway)",{"v":1.6e-61,"d":"0.00"},2,"367,80,","0,769",{"v":-60.8,"d":"-60.80"},{"v":-59.5,"d":"-59.50"},6.93,"Exon (ENSBGRT00000038146/ENSBGRG00000020700, exon 12 of 13)",1,156565091,156574714,9624,2]
["chr1",157380234,157380323,90,"ENSBGRG00000022351","ENSBGRT00000041263",620,"ENSBGRG00000022351","NA","NA","NA",{"v":0.018,"d":"0.02"},1,"90,",0,-1.74,-1.22,2.97,"Exon (ENSBGRT00000041263/ENSBGRG00000022351, exon 1 of 1)",1,157379909,157380943,1035,2]
["chr1",157380707,157380884,178,"ENSBGRG00000022351","ENSBGRT00000041263",59,"ENSBGRG00000022351","NA","NA","NA",{"v":2.3E-3,"d":"0.00"},1,"178,",0,-2.63,-2.06,4.46,"Exon (ENSBGRT00000041263/ENSBGRG00000022351, exon 1 of 1)",1,157379909,157380943,1035,2]
["chr1",157386146,157387582,1437,"ENSBGRG00000022358","ENSBGRT00000041289",8751,"ENSBGRG00000022358","NA","NA","04514(Cell adhesion molecules (CAMs));04672(Intestinal immune network for IgA production)",{"v":2.5e-12,"d":"0.00"},3,"103,36,155,","0,314,1282",{"v":-11.6,"d":"-11.60"},{"v":-10.7,"d":"-10.70"},{"v":2.8,"d":"2.80"},"Exon (ENSBGRT00000041289/ENSBGRG00000022358, exon 5 of 7)",1,157386058,157396333,10276,2]
["chr1",157520293,157520352,60,"ENSBGRG00000023037","ENSBGRT00000042499",11331,"CFAP410","cilia and flagella associated protein 410 [Source:HGNC Symbol;Acc:HGNC:1260]","GO:0001750(photoreceptor outer segment);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007010(cytoskeleton organization);GO:0007224(smoothened signaling pathway);GO:0008360(regulation of cell shape);GO:0032391(photoreceptor connecting cilium);GO:0036064(ciliary basal body);GO:0042769(DNA damage response, detection of DNA damage);GO:0043231(intracellular membrane-bounded organelle);GO:0060271(cilium assembly);GO:0097733(photoreceptor cell cilium)","NA",{"v":0.0062,"d":"0.01"},1,"60,",0,-2.21,-1.66,2.58,"3' UTR",1,157520175,157531683,11509,2]
["chr1",157881484,157884878,3395,"ENSBGRG00000000181","ENSBGRT00000000292",24551,"UBE2G2","ubiquitin conjugating enzyme E2 G2 [Source:HGNC Symbol;Acc:HGNC:12483]","GO:0004842(ubiquitin-protein transferase activity);GO:0005783(endoplasmic reticulum);GO:0005811(lipid droplet);GO:0005829(cytosol);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0035458(cellular response to interferon-beta);GO:0042802(identical protein binding);GO:0044257(cellular protein catabolic process);GO:0061631(ubiquitin conjugating enzyme activity);GO:0070936(protein K48-linked ubiquitination);GO:1904153(negative regulation of retrograde protein transport, ER to cytosol)","04141(Protein processing in endoplasmic reticulum);04120(Ubiquitin mediated proteolysis);05012(Parkinson disease)",{"v":1.6e-14,"d":"0.00"},2,"232,4,","0,3391",{"v":-13.8,"d":"-13.80"},{"v":-12.9,"d":"-12.90"},1.66,"3' UTR",1,157881015,157909429,28415,2]
["chr1",157913278,157914738,1461,"ENSBGRG00000000186","ENSBGRT00000000302",6816,"ENSBGRG00000000186","NA","GO:0005515(protein binding)","03013(RNA transport);05418(Fluid shear stress and atherosclerosis)",{"v":4e-21,"d":"0.00"},3,"21,112,70,","0,23,1391",{"v":-20.4,"d":"-20.40"},{"v":-19.5,"d":"-19.50"},2.89,"Exon (ENSBGRT00000000302/ENSBGRG00000000186, exon 3 of 5)",1,157913278,157921554,8277,2]
["chr1",157991075,157991375,301,"ENSBGRG00000000208","ENSBGRT00000000333",18266,"ITGB2","integrin subunit beta 2 [Source:HGNC Symbol;Acc:HGNC:6155]","GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007159(leukocyte cell-cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0019901(protein kinase binding);GO:0030369(ICAM-3 receptor activity);GO:0030593(neutrophil chemotaxis);GO:0031072(heat shock protein binding);GO:0032930(positive regulation of superoxide anion generation);GO:0034113(heterotypic cell-cell adhesion);GO:0034687(integrin alphaL-beta2 complex);GO:0035987(endodermal cell differentiation);GO:0038023(signaling receptor activity);GO:0043113(receptor clustering);GO:0043235(receptor complex);GO:0043315(positive regulation of neutrophil degranulation);GO:0044853(plasma membrane raft);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:0050839(cell adhesion molecule binding);GO:0099568(cytoplasmic region);GO:1990266(neutrophil migration)","04015(Rap1 signaling pathway);04390(Hippo signaling pathway);04514(Cell adhesion molecules (CAMs));04145(Phagosome);04810(Regulation of actin cytoskeleton);04610(Complement and coagulation cascades);04650(Natural killer cell mediated cytotoxicity);04670(Leukocyte transendothelial migration);05323(Rheumatoid arthritis);05416(Viral myocarditis);05133(Pertussis);05134(Legionellosis);05150(Staphylococcus aureus infection);05152(Tuberculosis);05166(HTLV-I infection);05146(Amoebiasis);05144(Malaria);05140(Leishmaniasis)",{"v":4e-26,"d":"0.00"},1,"301,",0,{"v":-25.4,"d":"-25.40"},{"v":-24.4,"d":"-24.40"},3.14,"3' UTR",1,157991075,158009641,18567,2]
["chr1",158363908,158365838,1931,"ENSBGRG00000000326","ENSBGRT00000000568",13649,"POFUT2","protein O-fucosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:14683]","GO:0001707(mesoderm formation);GO:0005794(Golgi apparatus);GO:0008417(fucosyltransferase activity);GO:0010468(regulation of gene expression);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0036065(fucosylation);GO:0036066(protein O-linked fucosylation);GO:0046922(peptide-O-fucosyltransferase activity);GO:0051046(regulation of secretion);GO:1903334(positive regulation of protein folding)","00514(Other types of O-glycan biosynthesis)",0,3,"824,124,32,","0,1471,1899",-436,"-Inf",{"v":25.8,"d":"25.80"},"3' UTR",1,158363670,158379487,15818,2]
["chr1",158541781,158542049,269,"ENSBGRG00000000371","ENSBGRT00000000602",2434,"ENSBGRG00000000371","NA","NA","NA",{"v":0.011,"d":"0.01"},1,"269,",0,-1.95,-1.18,8.91,"Exon (ENSBGRT00000000602/ENSBGRG00000000371, exon 2 of 2)",1,158539605,158544483,4879,2]
["chr1",158543390,158543539,150,"ENSBGRG00000000371","ENSBGRT00000000602",944,"ENSBGRG00000000371","NA","NA","NA",{"v":0.036,"d":"0.04"},1,"150,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000000602/ENSBGRG00000000371, exon 2 of 2)",1,158539605,158544483,4879,2]
["chr1",158543867,158544245,379,"ENSBGRG00000000371","ENSBGRT00000000602",238,"ENSBGRG00000000371","NA","NA","NA",{"v":0.00019,"d":"0.00"},2,"96,25,","0,354",-3.71,-3.08,3.24,"Exon (ENSBGRT00000001044/ENSBGRG00000000404, exon 1 of 50)",1,158539605,158544483,4879,2]
["chr1",158608239,158608746,508,"ENSBGRG00000000631","ENSBGRT00000001126",26660,"SLC19A1","solute carrier family 19 member 1 [Source:HGNC Symbol;Acc:HGNC:10937]","GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0008517(folic acid transmembrane transporter activity);GO:0008518(folate:anion antiporter activity);GO:0015350(methotrexate transmembrane transporter activity);GO:0015884(folic acid transport);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0051180(vitamin transport);GO:0051958(methotrexate transport);GO:0061507(cyclic-GMP-AMP binding);GO:0090482(vitamin transmembrane transporter activity);GO:0098838(folate transmembrane transport);GO:0140360(cyclic-GMP-AMP transmembrane transporter activity);GO:0140361(cyclic-GMP-AMP transmembrane import across plasma membrane);GO:1904447(folate import across plasma membrane)","04977(Vitamin digestion and absorption);01523(Antifolate resistance)",{"v":6.3E-21,"d":"0.00"},1,"508,",0,{"v":-20.2,"d":"-20.20"},{"v":-19.2,"d":"-19.20"},7.85,"3' UTR",1,158607612,158635406,27795,2]
["chr1",158627074,158627612,539,"ENSBGRG00000000631","ENSBGRT00000001126",7794,"SLC19A1","solute carrier family 19 member 1 [Source:HGNC Symbol;Acc:HGNC:10937]","GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0008517(folic acid transmembrane transporter activity);GO:0008518(folate:anion antiporter activity);GO:0015350(methotrexate transmembrane transporter activity);GO:0015884(folic acid transport);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0051180(vitamin transport);GO:0051958(methotrexate transport);GO:0061507(cyclic-GMP-AMP binding);GO:0090482(vitamin transmembrane transporter activity);GO:0098838(folate transmembrane transport);GO:0140360(cyclic-GMP-AMP transmembrane transporter activity);GO:0140361(cyclic-GMP-AMP transmembrane import across plasma membrane);GO:1904447(folate import across plasma membrane)","04977(Vitamin digestion and absorption);01523(Antifolate resistance)",{"v":2e-06,"d":"0.00"},1,"539,",0,{"v":-5.7,"d":"-5.70"},-5,4.62,"Exon (ENSBGRT00000001126/ENSBGRG00000000631, exon 3 of 6)",1,158607612,158635406,27795,2]
["chr1",158632632,158632692,61,"ENSBGRG00000000631","ENSBGRT00000001126",2714,"SLC19A1","solute carrier family 19 member 1 [Source:HGNC Symbol;Acc:HGNC:10937]","GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0008517(folic acid transmembrane transporter activity);GO:0008518(folate:anion antiporter activity);GO:0015350(methotrexate transmembrane transporter activity);GO:0015884(folic acid transport);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0051180(vitamin transport);GO:0051958(methotrexate transport);GO:0061507(cyclic-GMP-AMP binding);GO:0090482(vitamin transmembrane transporter activity);GO:0098838(folate transmembrane transport);GO:0140360(cyclic-GMP-AMP transmembrane transporter activity);GO:0140361(cyclic-GMP-AMP transmembrane import across plasma membrane);GO:1904447(folate import across plasma membrane)","04977(Vitamin digestion and absorption);01523(Antifolate resistance)",{"v":0.0068,"d":"0.01"},1,"61,",0,-2.17,-1.62,8.91,"5' UTR",1,158607612,158635406,27795,2]
["chr1",159300503,159301712,1210,"ENSBGRG00000001100","ENSBGRT00000002608",29221,"LSS","lanosterol synthase [Source:HGNC Symbol;Acc:HGNC:6708]","GO:0000250(lanosterol synthase activity);GO:0005789(endoplasmic reticulum membrane);GO:0005811(lipid droplet);GO:0006694(steroid biosynthetic process);GO:0006695(cholesterol biosynthetic process);GO:0016104(triterpenoid biosynthetic process);GO:0016866(intramolecular transferase activity);GO:0031647(regulation of protein stability);GO:0042300(beta-amyrin synthase activity)","00100(Steroid biosynthesis)",{"v":0.034,"d":"0.03"},3,"26,79,15,","0,421,1195",-1.47,{"v":-0.978,"d":"-0.98"},2.41,"Exon (ENSBGRT00000002608/ENSBGRG00000001100, exon 21 of 23)",1,159299969,159330933,30965,2]
["chr1",159342672,159345899,3228,"ENSBGRG00000001560","ENSBGRT00000002896",39954,"MCM3AP","minichromosome maintenance complex component 3 associated protein [Source:HGNC Symbol;Acc:HGNC:6946]","GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0010484(H3 histone acetyltransferase activity);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0031965(nuclear membrane);GO:0034728(nucleosome organization);GO:0042393(histone binding);GO:0044615(nuclear pore nuclear basket);GO:0070390(transcription export complex 2)","NA",{"v":1E-141,"d":"0.00"},3,"297,151,61,","0,1187,3167",-141,-139,{"v":3.3,"d":"3.30"},"3' UTR",1,159342672,159385853,43182,2]
["chr1",159384268,159385853,1586,"ENSBGRG00000001560","ENSBGRT00000002896",0,"MCM3AP","minichromosome maintenance complex component 3 associated protein [Source:HGNC Symbol;Acc:HGNC:6946]","GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0010484(H3 histone acetyltransferase activity);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0031965(nuclear membrane);GO:0034728(nucleosome organization);GO:0042393(histone binding);GO:0044615(nuclear pore nuclear basket);GO:0070390(transcription export complex 2)","NA",{"v":1e-103,"d":"0.00"},2,"25,1320,","0,266",-103,-101,4.68,"5' UTR",1,159342672,159385853,43182,2]
["chr1",159725058,159728323,3266,"ENSBGRG00000002365","ENSBGRT00000004417",0,"S100B","S100 calcium binding protein B [Source:HGNC Symbol;Acc:HGNC:10500]","GO:0001726(ruffle);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007611(learning or memory);GO:0007613(memory);GO:0008270(zinc ion binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043025(neuronal cell body);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043231(intracellular membrane-bounded organelle);GO:0044548(S100 protein binding);GO:0046872(metal ion binding);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048306(calcium-dependent protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0050786(RAGE receptor binding)","NA",{"v":1.6e-75,"d":"0.00"},2,"319,138,","0,3128",{"v":-74.8,"d":"-74.80"},{"v":-73.5,"d":"-73.50"},2.78,"3' UTR",1,159725058,159728323,3266,2]
["chr1",160047755,160047935,181,"ENSBGRG00000002585","ENSBGRT00000004839",57978,"ENSBGRG00000002585","NA","GO:0007283(spermatogenesis)","NA",{"v":0.00051,"d":"0.00"},1,"181,",0,-3.29,-2.69,1.75,"3' UTR",1,160047695,160105913,58219,2]
["chr1",160048175,160048265,91,"ENSBGRG00000002585","ENSBGRT00000004839",57648,"ENSBGRG00000002585","NA","GO:0007283(spermatogenesis)","NA",{"v":0.0013,"d":"0.00"},1,"91,",0,-2.87,-2.28,1.67,"3' UTR",1,160047695,160105913,58219,2]
["chr1",160049884,160105223,55340,"ENSBGRG00000002585","ENSBGRT00000004839",690,"ENSBGRG00000002585","NA","GO:0007283(spermatogenesis)","NA",{"v":4E-51,"d":"0.00"},3,"355,104,412,","0,1669,54928",{"v":-50.4,"d":"-50.40"},{"v":-49.2,"d":"-49.20"},9.41,"5' UTR",1,160047695,160105913,58219,2]
["chr1",160455349,160455409,61,"ENSBGRG00000002635","ENSBGRT00000004955",304408,"RUNX1","RUNX family transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:10471]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0030097(hemopoiesis);GO:0030854(positive regulation of granulocyte differentiation);GO:0032743(positive regulation of interleukin-2 production);GO:0043231(intracellular membrane-bounded organelle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","04530(Tight junction);04659(Th17 cell differentiation);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia)",{"v":0.016,"d":"0.02"},1,"61,",0,{"v":-1.8,"d":"-1.80"},-1.28,4.95,"Exon (ENSBGRT00000004955/ENSBGRG00000002635, exon 9 of 9)",1,160455349,160759817,304469,2]
["chr1",160565238,160571145,5908,"ENSBGRG00000002635","ENSBGRT00000005041",0,"RUNX1","RUNX family transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:10471]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0030097(hemopoiesis);GO:0030854(positive regulation of granulocyte differentiation);GO:0032743(positive regulation of interleukin-2 production);GO:0043231(intracellular membrane-bounded organelle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","04530(Tight junction);04659(Th17 cell differentiation);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia)",{"v":0.0062,"d":"0.01"},2,"28,32,","0,5876",-2.21,-1.66,2.64,"Exon (ENSBGRT00000004955/ENSBGRG00000002635, exon 3 of 9)",1,160494383,160565265,70883,2]
["chr1",162749101,162751297,2197,"ENSBGRG00000003161","ENSBGRT00000005882",218454,"HLCS","holocarboxylase synthetase [Source:HGNC Symbol;Acc:HGNC:4976]","GO:0004077(biotin-[acetyl-CoA-carboxylase] ligase activity);GO:0006464(cellular protein modification process)","00780(Biotin metabolism)",{"v":6.3e-42,"d":"0.00"},2,"320,40,","0,2157",{"v":-41.2,"d":"-41.20"},-40,{"v":13.1,"d":"13.10"},"3' UTR",1,162747427,162969751,222325,2]
["chr1",162949983,162950641,659,"ENSBGRG00000003161","ENSBGRT00000005882",19110,"HLCS","holocarboxylase synthetase [Source:HGNC Symbol;Acc:HGNC:4976]","GO:0004077(biotin-[acetyl-CoA-carboxylase] ligase activity);GO:0006464(cellular protein modification process)","00780(Biotin metabolism)",{"v":1.6E-18,"d":"0.00"},1,"659,",0,{"v":-17.8,"d":"-17.80"},{"v":-16.9,"d":"-16.90"},9.91,"Exon (ENSBGRT00000005882/ENSBGRG00000003161, exon 3 of 10)",1,162747427,162969751,222325,2]
["chr1",163074841,163074964,124,"ENSBGRG00000003202","ENSBGRT00000005950",13323,"ENSBGRG00000003202","NA","GO:0006506(GPI anchor biosynthetic process);GO:0017176(phosphatidylinositol N-acetylglucosaminyltransferase activity)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":1.4e-10,"d":"0.00"},2,"18,103,","0,21",-9.84,-9.05,2.51,"Exon (ENSBGRT00000005950/ENSBGRG00000003202, exon 4 of 5)",1,163074841,163088287,13447,2]
["chr1",163258383,163260534,2152,"ENSBGRG00000003274","ENSBGRT00000006170",37405,"VPS26C","VPS26 endosomal protein sorting factor C [Source:HGNC Symbol;Acc:HGNC:3044]","GO:0006886(intracellular protein transport);GO:0032456(endocytic recycling);GO:1990126(retrograde transport, endosome to plasma membrane)","NA",{"v":8.1e-06,"d":"0.00"},2,"53,38,","0,2114",-5.09,-4.41,2.48,"Exon (ENSBGRT00000006170/ENSBGRG00000003274, exon 6 of 7)",1,163258353,163297939,39587,2]
["chr1",163378385,163378887,503,"ENSBGRG00000003325","ENSBGRT00000006192",1240,"ENSBGRG00000003325","NA","NA","NA",{"v":1.2e-06,"d":"0.00"},1,"503,",0,-5.92,-5.21,8.58,"Exon (ENSBGRT00000006192/ENSBGRG00000003325, exon 1 of 1)",1,163378385,163380127,1743,2]
["chr1",164665696,164666024,329,"ENSBGRG00000003442","ENSBGRT00000006832",87435,"ERG","ETS transcription factor ERG [Source:HGNC Symbol;Acc:HGNC:3446]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0006355(regulation of transcription, DNA-templated);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990904(ribonucleoprotein complex)","05202(Transcriptional misregulation in cancers);05215(Prostate cancer)",{"v":6e-08,"d":"0.00"},1,"329,",0,-7.22,-6.48,{"v":11.9,"d":"11.90"},"3' UTR",1,164665696,164753459,87764,2]
["chr1",164666620,164680436,13817,"ENSBGRG00000003442","ENSBGRT00000006832",73023,"ERG","ETS transcription factor ERG [Source:HGNC Symbol;Acc:HGNC:3446]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0006355(regulation of transcription, DNA-templated);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990904(ribonucleoprotein complex)","05202(Transcriptional misregulation in cancers);05215(Prostate cancer)",{"v":1E-194,"d":"0.00"},2,"1928,11,","0,13806",-194,-192,18,"3' UTR",1,164665696,164753459,87764,2]
["chr1",165702980,165703100,121,"ENSBGRG00000003893","ENSBGRT00000007197",125876,"COL6A6","collagen type VI alpha 6 chain [Source:HGNC Symbol;Acc:HGNC:27023]","GO:0031012(extracellular matrix)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":1.2E-4,"d":"0.00"},1,"121,",0,-3.92,-3.28,9.41,"Exon (ENSBGRT00000007197/ENSBGRG00000003893, exon 36 of 36)",1,165702980,165828976,125997,2]
["chr1",165717591,165717800,210,"ENSBGRG00000003893","ENSBGRT00000007197",111176,"COL6A6","collagen type VI alpha 6 chain [Source:HGNC Symbol;Acc:HGNC:27023]","GO:0031012(extracellular matrix)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":1.4e-09,"d":"0.00"},1,"210,",0,-8.85,-8.07,9.11,"Exon (ENSBGRT00000007197/ENSBGRG00000003893, exon 34 of 36)",1,165702980,165828976,125997,2]
["chr1",165795285,165804733,9449,"ENSBGRG00000003893","ENSBGRT00000007197",24243,"COL6A6","collagen type VI alpha 6 chain [Source:HGNC Symbol;Acc:HGNC:27023]","GO:0031012(extracellular matrix)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":0.0013,"d":"0.00"},4,"34,155,79,1,","0,4008,9285,9448",{"v":-2.9,"d":"-2.90"},-2.31,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000007197/ENSBGRG00000003893, exon 8 of 36)",1,165702980,165828976,125997,2]
["chr1",165824637,165826487,1851,"ENSBGRG00000003893","ENSBGRT00000007197",2489,"COL6A6","collagen type VI alpha 6 chain [Source:HGNC Symbol;Acc:HGNC:27023]","GO:0031012(extracellular matrix)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":0.0062,"d":"0.01"},2,"62,507,","0,1344",-2.21,-1.67,9.91,"Exon (ENSBGRT00000007197/ENSBGRG00000003893, exon 2 of 36)",1,165702980,165828976,125997,2]
["chr1",165979659,165980471,813,"ENSBGRG00000003956","ENSBGRT00000007296",74606,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":2e-28,"d":"0.00"},2,"182,88,","0,725",{"v":-27.7,"d":"-27.70"},{"v":-26.7,"d":"-26.70"},4.27,"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 34 of 41)",1,165937093,166055077,117985,2]
["chr1",166002453,166005386,2934,"ENSBGRG00000003956","ENSBGRT00000007296",49691,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":5e-11,"d":"0.00"},3,"5,63,53,","0,1811,2881",{"v":-10.3,"d":"-10.30"},-9.45,3.82,"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 22 of 41)",1,165937093,166055077,117985,2]
["chr1",166017553,166017613,61,"ENSBGRG00000003956","ENSBGRT00000007296",37464,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":4.7e-10,"d":"0.00"},1,"61,",0,-9.33,-8.55,3.03,"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 13 of 41)",1,165937093,166055077,117985,2]
["chr1",166029200,166032643,3444,"ENSBGRG00000003956","ENSBGRT00000007296",22434,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":1.6E-11,"d":"0.00"},2,"523,317,","0,3127",{"v":-10.8,"d":"-10.80"},-10,{"v":34.7,"d":"34.70"},"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 6 of 41)",1,165937093,166055077,117985,2]
["chr1",166036759,166036849,91,"ENSBGRG00000003956","ENSBGRT00000007296",18228,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":5.6e-05,"d":"0.00"},1,"91,",0,-4.25,{"v":-3.6,"d":"-3.60"},3.66,"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 5 of 41)",1,165937093,166055077,117985,2]
["chr1",166036909,166048275,11367,"ENSBGRG00000003956","ENSBGRT00000007296",6802,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":2e-13,"d":"0.00"},3,"156,561,92,","0,4639,11275",{"v":-12.7,"d":"-12.70"},{"v":-11.9,"d":"-11.90"},4.55,"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 3 of 41)",1,165937093,166055077,117985,2]
["chr1",166048664,166048784,121,"ENSBGRG00000003956","ENSBGRT00000007296",6293,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":0.0025,"d":"0.00"},1,"121,",0,-2.61,-2.03,{"v":3.1,"d":"3.10"},"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 3 of 41)",1,165937093,166055077,117985,2]
["chr1",166053167,166053256,90,"ENSBGRG00000003956","ENSBGRT00000007296",1821,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":0.0068,"d":"0.01"},1,"90,",0,-2.17,-1.62,5.94,"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 2 of 41)",1,165937093,166055077,117985,2]
["chr1",166482451,166482808,358,"ENSBGRG00000004132","ENSBGRT00000007669",55466,"SH3BP5","SH3 domain binding protein 5 [Source:HGNC Symbol;Acc:HGNC:10827]","GO:0004860(protein kinase inhibitor activity);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0030659(cytoplasmic vesicle membrane);GO:0035556(intracellular signal transduction)","NA",{"v":2e-96,"d":"0.00"},1,"358,",0,{"v":-95.7,"d":"-95.70"},{"v":-94.2,"d":"-94.20"},8.23,"3' UTR",1,166482451,166538274,55824,2]
["chr1",166483194,166483920,727,"ENSBGRG00000004132","ENSBGRT00000007669",54354,"SH3BP5","SH3 domain binding protein 5 [Source:HGNC Symbol;Acc:HGNC:10827]","GO:0004860(protein kinase inhibitor activity);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0030659(cytoplasmic vesicle membrane);GO:0035556(intracellular signal transduction)","NA",{"v":3.2E-94,"d":"0.00"},2,"320,38,","0,689",{"v":-93.5,"d":"-93.50"},-92,{"v":2.9,"d":"2.90"},"3' UTR",1,166482451,166538274,55824,2]
["chr1",166538158,166575363,37206,"ENSBGRG00000004132","ENSBGRT00000007669",0,"SH3BP5","SH3 domain binding protein 5 [Source:HGNC Symbol;Acc:HGNC:10827]","GO:0004860(protein kinase inhibitor activity);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0030659(cytoplasmic vesicle membrane);GO:0035556(intracellular signal transduction)","NA",{"v":4e-17,"d":"0.00"},2,"117,181,","0,37025",{"v":-16.4,"d":"-16.40"},{"v":-15.5,"d":"-15.50"},3.37,"Exon (ENSBGRT00000007669/ENSBGRG00000004132, exon 1 of 7)",1,166482451,166538274,55824,2]
["chr1",166654533,166654739,207,"ENSBGRG00000004234","ENSBGRT00000007937",21445,"METTL6","methyltransferase like 6 [Source:HGNC Symbol;Acc:HGNC:28343]","GO:0019899(enzyme binding);GO:0030488(tRNA methylation);GO:0052735(tRNA (cytosine-3-)-methyltransferase activity)","NA",{"v":5E-15,"d":"0.00"},1,"207,",0,{"v":-14.3,"d":"-14.30"},{"v":-13.4,"d":"-13.40"},1.83,"3' UTR",1,166654474,166676184,21711,2]
["chr1",166674099,166676340,2242,"ENSBGRG00000004234","ENSBGRT00000007937",0,"METTL6","methyltransferase like 6 [Source:HGNC Symbol;Acc:HGNC:28343]","GO:0019899(enzyme binding);GO:0030488(tRNA methylation);GO:0052735(tRNA (cytosine-3-)-methyltransferase activity)","NA",{"v":1E-136,"d":"0.00"},3,"5,57,381,","0,1250,1861",-136,-135,7.53,"5' UTR",1,166654474,166676184,21711,2]
["chr1",166708334,166708962,629,"ENSBGRG00000004392","ENSBGRT00000008338",45467,"COLQ","collagen like tail subunit of asymmetric acetylcholinesterase [Source:HGNC Symbol;Acc:HGNC:2226]","GO:0005886(plasma membrane);GO:0008582(regulation of synaptic growth at neuromuscular junction);GO:0030054(cell junction);GO:0031594(neuromuscular junction);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090150(establishment of protein localization to membrane)","04146(Peroxisome)",{"v":1.6E-13,"d":"0.00"},1,"629,",0,{"v":-12.8,"d":"-12.80"},{"v":-11.9,"d":"-11.90"},{"v":12.1,"d":"12.10"},"3' UTR",1,166708334,166754429,46096,2]
["chr1",166709052,166712288,3237,"ENSBGRG00000004392","ENSBGRT00000008338",42141,"COLQ","collagen like tail subunit of asymmetric acetylcholinesterase [Source:HGNC Symbol;Acc:HGNC:2226]","GO:0005886(plasma membrane);GO:0008582(regulation of synaptic growth at neuromuscular junction);GO:0030054(cell junction);GO:0031594(neuromuscular junction);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090150(establishment of protein localization to membrane)","04146(Peroxisome)",{"v":2.5e-39,"d":"0.00"},2,"686,63,","0,3174",{"v":-38.6,"d":"-38.60"},{"v":-37.4,"d":"-37.40"},{"v":8.6,"d":"8.60"},"3' UTR",1,166708334,166754429,46096,2]
["chr1",166951121,166960530,9410,"ENSBGRG00000005474","ENSBGRT00000010449",123914,"ANKRD28","ankyrin repeat domain 28 [Source:HGNC Symbol;Acc:HGNC:29024]","GO:0005515(protein binding)","NA",{"v":1E-196,"d":"0.00"},4,"662,92,83,2,","0,7831,8871,9408",-196,-194,4.62,"3' UTR",1,166951121,167084444,133324,2]
["chr1",167573368,167577875,4508,"ENSBGRG00000005826","ENSBGRT00000010754",59,"DPH3","diphthamide biosynthesis 3 [Source:HGNC Symbol;Acc:HGNC:27717]","NA","NA",0,3,"970,75,262,","0,3196,4246",-331,"-Inf",8.01,"3' UTR",1,167573309,167577934,4626,2]
["chr1",167658598,167714444,55847,"ENSBGRG00000005969","ENSBGRT00000011001",186291,"ENSBGRG00000005969","raftlin, lipid raft linker 1 [Source:HGNC Symbol;Acc:HGNC:30278]","NA","NA",{"v":1.3E-84,"d":"0.00"},4,"376,82,104,8,","0,9898,10921,55839",{"v":-83.9,"d":"-83.90"},{"v":-82.5,"d":"-82.50"},4.94,"3' UTR",1,167657699,167900735,243037,2]
["chr1",168218285,168218524,240,"ENSBGRG00000000188","ENSBGRT00000000303",10362,"ENSBGRG00000000188","NA","NA","NA",{"v":4.8E-8,"d":"0.00"},1,"240,",0,-7.32,-6.57,3.96,"Exon (ENSBGRT00000000304/ENSBGRG00000000188, exon 3 of 3)",1,168207158,168228886,21729,2]
["chr1",168219151,168219838,688,"ENSBGRG00000000188","ENSBGRT00000000303",9048,"ENSBGRG00000000188","NA","NA","NA",{"v":4E-35,"d":"0.00"},1,"688,",0,{"v":-34.4,"d":"-34.40"},{"v":-33.3,"d":"-33.30"},5.44,"Exon (ENSBGRT00000000304/ENSBGRG00000000188, exon 3 of 3)",1,168207158,168228886,21729,2]
["chr1",168220555,168220645,91,"ENSBGRG00000000188","ENSBGRT00000000303",8241,"ENSBGRG00000000188","NA","NA","NA",{"v":0.00051,"d":"0.00"},1,"91,",0,-3.29,-2.68,{"v":1.8,"d":"1.80"},"Exon (ENSBGRT00000000304/ENSBGRG00000000188, exon 3 of 3)",1,168207158,168228886,21729,2]
["chr1",168220735,168220854,120,"ENSBGRG00000000188","ENSBGRT00000000303",8032,"ENSBGRG00000000188","NA","NA","NA",{"v":0.00078,"d":"0.00"},1,"120,",0,-3.11,-2.51,1.66,"Exon (ENSBGRT00000000304/ENSBGRG00000000188, exon 3 of 3)",1,168207158,168228886,21729,2]
["chr1",168220914,168227147,6234,"ENSBGRG00000000188","ENSBGRT00000000303",1739,"ENSBGRG00000000188","NA","NA","NA",{"v":0.0093,"d":"0.01"},2,"57,34,","0,6200",-2.03,-1.49,1.46,"Exon (ENSBGRT00000000304/ENSBGRG00000000188, exon 3 of 3)",1,168207158,168228886,21729,2]
["chr1",168227655,168227834,180,"ENSBGRG00000000188","ENSBGRT00000000303",1052,"ENSBGRG00000000188","NA","NA","NA",{"v":5.8E-5,"d":"0.00"},1,"180,",0,-4.24,-3.59,6.44,"Exon (ENSBGRT00000000307/ENSBGRG00000000188, exon 2 of 2)",1,168207158,168228886,21729,2]
["chr1",168228162,168228222,61,"ENSBGRG00000000188","ENSBGRT00000000303",664,"ENSBGRG00000000188","NA","NA","NA",{"v":0.015,"d":"0.02"},1,"61,",0,-1.83,-1.31,2.15,"Exon (ENSBGRT00000000307/ENSBGRG00000000188, exon 2 of 2)",1,168207158,168228886,21729,2]
["chr1",168228431,168228670,240,"ENSBGRG00000000188","ENSBGRT00000000303",216,"ENSBGRG00000000188","NA","NA","NA",{"v":0.0068,"d":"0.01"},1,"240,",0,-2.17,-1.63,7.92,"Exon (ENSBGRT00000000307/ENSBGRG00000000188, exon 2 of 2)",1,168207158,168228886,21729,2]
["chr1",168244141,168245730,1590,"ENSBGRG00000000188","ENSBGRT00000000304",179,"ENSBGRG00000000188","NA","NA","NA",0.02,3,"52,69,299,","0,1091,1291",{"v":-1.7,"d":"-1.70"},-1.19,6.93,"Exon (ENSBGRT00000000304/ENSBGRG00000000188, exon 1 of 3)",1,168218103,168245909,27807,2]
["chr1",168245849,168245909,61,"ENSBGRG00000000188","ENSBGRT00000000304",0,"ENSBGRG00000000188","NA","NA","NA",{"v":0.034,"d":"0.03"},1,"61,",0,-1.47,{"v":-0.977,"d":"-0.98"},5.94,"Exon (ENSBGRT00000000304/ENSBGRG00000000188, exon 1 of 3)",1,168218103,168245909,27807,2]
["chr1",168538166,168538341,176,"ENSBGRG00000000215","ENSBGRT00000000343",239598,"PLCL2","phospholipase C like 2 [Source:HGNC Symbol;Acc:HGNC:9064]","GO:0002322(B cell proliferation involved in immune response);GO:0002337(B-1a B cell differentiation);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0050859(negative regulation of B cell receptor signaling pathway);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","NA",{"v":7.9e-21,"d":"0.00"},1,"176,",0,{"v":-20.1,"d":"-20.10"},{"v":-19.1,"d":"-19.10"},2.31,"Exon (ENSBGRT00000000372/ENSBGRG00000000231, exon 1 of 1)",1,168298568,168542235,243668,1]
["chr1",168544478,168544627,150,"ENSBGRG00000000433","ENSBGRT00000003068",315140,"TBC1D5","TBC1 domain family member 5 [Source:HGNC Symbol;Acc:HGNC:19166]","GO:0002092(positive regulation of receptor internalization);GO:0005776(autophagosome);GO:0005794(Golgi apparatus);GO:0006914(autophagy);GO:0010008(endosome membrane);GO:0016236(macroautophagy);GO:0030122(AP-2 adaptor complex);GO:0030904(retromer complex);GO:0035612(AP-2 adaptor complex binding);GO:0042147(retrograde transport, endosome to Golgi);GO:0042594(response to starvation);GO:0043231(intracellular membrane-bounded organelle);GO:0044877(protein-containing complex binding);GO:1905394(retromer complex binding);GO:1990316(Atg1/ULK1 kinase complex)","NA",{"v":0.00068,"d":"0.00"},1,"150,",0,-3.17,-2.56,2.12,"Exon (ENSBGRT00000003068/ENSBGRG00000000433, exon 19 of 19)",1,168544388,168859767,315380,2]
["chr1",172033606,172033874,269,"ENSBGRG00000001807","ENSBGRT00000003363",18415,"ENSBGRG00000001807","NA","NA","NA",{"v":1.1E-5,"d":"0.00"},1,"269,",0,-4.95,-4.27,6.19,"Exon (ENSBGRT00000003363/ENSBGRG00000001807, exon 4 of 7)",1,172032010,172052289,20280,2]
["chr1",172049027,172049116,90,"ENSBGRG00000001807","ENSBGRT00000003363",3173,"ENSBGRG00000001807","NA","NA","NA",{"v":1E-3,"d":"0.00"},1,"90,",0,-2.98,-2.39,2.72,"Exon (ENSBGRT00000003363/ENSBGRG00000001807, exon 3 of 7)",1,172032010,172052289,20280,2]
["chr1",172049178,172049446,269,"ENSBGRG00000001807","ENSBGRT00000003363",2843,"ENSBGRG00000001807","NA","NA","NA",{"v":1.1E-5,"d":"0.00"},1,"269,",0,-4.97,-4.29,{"v":16.8,"d":"16.80"},"Exon (ENSBGRT00000003363/ENSBGRG00000001807, exon 2 of 7)",1,172032010,172052289,20280,2]
["chr1",172049566,172050073,508,"ENSBGRG00000001807","ENSBGRT00000003363",2216,"ENSBGRG00000001807","NA","NA","NA",{"v":4.6e-07,"d":"0.00"},1,"508,",0,-6.34,-5.62,7.92,"Exon (ENSBGRT00000003363/ENSBGRG00000001807, exon 2 of 7)",1,172032010,172052289,20280,2]
["chr1",172233013,172233190,178,"ENSBGRG00000001982","ENSBGRT00000003698",8743,"SGO1","shugoshin 1 [Source:HGNC Symbol;Acc:HGNC:25088]","GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000779(condensed chromosome, centromeric region);GO:0000922(spindle pole);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0007059(chromosome segregation);GO:0008608(attachment of spindle microtubules to kinetochore);GO:0010457(centriole-centriole cohesion);GO:0016604(nuclear body);GO:0019900(kinase binding);GO:0045132(meiotic chromosome segregation);GO:0071962(mitotic sister chromatid cohesion, centromeric)","04114(Oocyte meiosis)",{"v":5e-27,"d":"0.00"},1,"178,",0,{"v":-26.3,"d":"-26.30"},{"v":-25.3,"d":"-25.30"},3.83,"Exon (ENSBGRT00000003698/ENSBGRG00000001982, exon 6 of 8)",1,172223733,172241933,18201,2]
["chr1",172233279,172233368,90,"ENSBGRG00000001982","ENSBGRT00000003698",8565,"SGO1","shugoshin 1 [Source:HGNC Symbol;Acc:HGNC:25088]","GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000779(condensed chromosome, centromeric region);GO:0000922(spindle pole);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0007059(chromosome segregation);GO:0008608(attachment of spindle microtubules to kinetochore);GO:0010457(centriole-centriole cohesion);GO:0016604(nuclear body);GO:0019900(kinase binding);GO:0045132(meiotic chromosome segregation);GO:0071962(mitotic sister chromatid cohesion, centromeric)","04114(Oocyte meiosis)",{"v":3.2e-26,"d":"0.00"},1,"90,",0,{"v":-25.5,"d":"-25.50"},{"v":-24.5,"d":"-24.50"},4.01,"Exon (ENSBGRT00000003698/ENSBGRG00000001982, exon 6 of 8)",1,172223733,172241933,18201,2]
["chr1",172325928,172326344,417,"ENSBGRG00000002023","ENSBGRT00000003804",3357,"ZNF596","zinc finger protein 596 [Source:HGNC Symbol;Acc:HGNC:27268]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.6e-80,"d":"0.00"},1,"417,",0,{"v":-79.8,"d":"-79.80"},{"v":-78.4,"d":"-78.40"},7.76,"3' UTR",1,172325928,172329701,3774,2]
["chr1",172326761,172329634,2874,"ENSBGRG00000002023","ENSBGRT00000003804",67,"ZNF596","zinc finger protein 596 [Source:HGNC Symbol;Acc:HGNC:27268]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":7.9e-88,"d":"0.00"},3,"1460,92,84,","0,1932,2790",{"v":-87.1,"d":"-87.10"},{"v":-85.6,"d":"-85.60"},9.58,"3' UTR",1,172325928,172329701,3774,2]
["chr2",72482,75031,2550,"ENSBGRG00000002052","ENSBGRT00000003828",0,"SRARP","steroid receptor associated and regulated protein [Source:HGNC Symbol;Acc:HGNC:28339]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0030331(estrogen receptor binding);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway)","NA",{"v":0.012,"d":"0.01"},2,"76,276,","0,2274",-1.93,{"v":-1.4,"d":"-1.40"},7.92,"Exon (ENSBGRT00000003828/ENSBGRG00000002052, exon 1 of 2)",2,72482,75177,2696,1]
["chr2",99195,100714,1520,"ENSBGRG00000002080","ENSBGRT00000004033",3223,"ENSBGRG00000002080","NA","GO:0005247(voltage-gated chloride channel activity);GO:0006821(chloride transport);GO:0016020(membrane);GO:0055085(transmembrane transport)","04966(Collecting duct acid secretion)",{"v":1.8E-3,"d":"0.00"},4,"115,140,78,25,","0,902,1324,1495",-2.74,-2.16,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000004033/ENSBGRG00000002080, exon 4 of 18)",2,95972,109372,13401,1]
["chr2",443432,467346,23915,"ENSBGRG00000002351","ENSBGRT00000004398",0,"SZRD1","SUZ RNA binding domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30232]","NA","NA",{"v":1E-51,"d":"0.00"},3,"51,50,129,","0,22189,23786",-51,{"v":-49.8,"d":"-49.80"},2.94,"Exon (ENSBGRT00000004398/ENSBGRG00000002351, exon 1 of 4)",2,443432,468550,25119,1]
["chr2",541004,542197,1194,"ENSBGRG00000002425","ENSBGRT00000004547",12437,"NECAP2","NECAP endocytosis associated 2 [Source:HGNC Symbol;Acc:HGNC:25528]","GO:0006897(endocytosis);GO:0016020(membrane);GO:0030125(clathrin vesicle coat)","NA",{"v":1E-180,"d":"0.00"},2,"71,317,","0,877",-180,-178,2.96,"Exon (ENSBGRT00000004547/ENSBGRG00000002425, exon 5 of 6)",2,528567,541929,13363,1]
["chr2",557326,565346,8021,"ENSBGRG00000002459","ENSBGRT00000004709",0,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":7.1e-07,"d":"0.00"},9,"42,115,2,144,186,84,62,166,7,","0,587,1317,1321,6663,6932,7088,7226,8014",-6.15,-5.44,3.96,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 1 of 38)",2,557326,608335,51010,1]
["chr2",565406,569701,4296,"ENSBGRG00000002459","ENSBGRT00000004709",8080,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":0.00016,"d":"0.00"},2,"41,140,","0,4156",{"v":-3.8,"d":"-3.80"},-3.17,2.27,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 9 of 38)",2,557326,608335,51010,1]
["chr2",572641,572731,91,"ENSBGRG00000002459","ENSBGRT00000004709",15315,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":0.042,"d":"0.04"},1,"91,",0,-1.38,{"v":-0.893,"d":"-0.89"},1.47,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 14 of 38)",2,557326,608335,51010,1]
["chr2",576855,580756,3902,"ENSBGRG00000002459","ENSBGRT00000004709",19529,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":2e-36,"d":"0.00"},6,"10,147,231,194,128,69,","0,610,1454,2382,2764,3833",{"v":-35.7,"d":"-35.70"},{"v":-34.6,"d":"-34.60"},4.69,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 16 of 38)",2,557326,608335,51010,1]
["chr2",580816,582852,2037,"ENSBGRG00000002459","ENSBGRT00000004709",23490,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":1.4E-3,"d":"0.00"},2,"42,138,","0,1899",-2.85,-2.27,7.92,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 21 of 38)",2,557326,608335,51010,1]
["chr2",584579,591129,6551,"ENSBGRG00000002459","ENSBGRT00000004709",27253,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":4E-50,"d":"0.00"},6,"58,144,239,160,168,338,","0,491,1543,2275,4837,6213",{"v":-49.4,"d":"-49.40"},{"v":-48.2,"d":"-48.20"},5.62,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 23 of 38)",2,557326,608335,51010,1]
["chr2",599220,608335,9116,"ENSBGRG00000002459","ENSBGRT00000004709",41894,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":1E-62,"d":"0.00"},10,"5,121,164,216,225,150,201,132,165,87,","0,219,512,2623,3747,4339,4756,5235,8196,9029",-62,{"v":-60.7,"d":"-60.70"},3.94,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 29 of 38)",2,557326,608335,51010,1]
["chr2",929045,929255,211,"ENSBGRG00000002860","ENSBGRT00000005521",52286,"PADI1","peptidyl arginine deiminase 1 [Source:HGNC Symbol;Acc:HGNC:18367]","GO:0004668(protein-arginine deiminase activity);GO:0005509(calcium ion binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0018101(protein citrullination)","NA",{"v":0.036,"d":"0.04"},1,"211,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"3' UTR",2,876759,930119,53361,1]
["chr2",929853,930003,151,"ENSBGRG00000002860","ENSBGRT00000005521",53094,"PADI1","peptidyl arginine deiminase 1 [Source:HGNC Symbol;Acc:HGNC:18367]","GO:0004668(protein-arginine deiminase activity);GO:0005509(calcium ion binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0018101(protein citrullination)","NA",{"v":0.0022,"d":"0.00"},1,"151,",0,-2.65,-2.08,6.93,"3' UTR",2,876759,930119,53361,1]
["chr2",1358419,1360334,1916,"ENSBGRG00000003200","ENSBGRT00000005955",196349,"ARHGEF10L","Rho guanine nucleotide exchange factor 10 like [Source:HGNC Symbol;Acc:HGNC:25540]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0032933(SREBP signaling pathway);GO:0051496(positive regulation of stress fiber assembly)","NA",{"v":1.5E-3,"d":"0.00"},2,"75,16,","0,1900",-2.81,-2.23,1.76,"Exon (ENSBGRT00000005955/ENSBGRG00000003200, exon 27 of 28)",2,1162070,1361440,199371,1]
["chr2",1360424,1361440,1017,"ENSBGRG00000003200","ENSBGRT00000005955",198354,"ARHGEF10L","Rho guanine nucleotide exchange factor 10 like [Source:HGNC Symbol;Acc:HGNC:25540]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0032933(SREBP signaling pathway);GO:0051496(positive regulation of stress fiber assembly)","NA",{"v":1.3E-74,"d":"0.00"},1,"1017,",0,{"v":-73.9,"d":"-73.90"},{"v":-72.5,"d":"-72.50"},4.87,"3' UTR",2,1162070,1361440,199371,1]
["chr2",1521032,1521330,299,"ENSBGRG00000003302","ENSBGRT00000006148",90799,"ACTL8","actin like 8 [Source:HGNC Symbol;Acc:HGNC:24018]","GO:0030855(epithelial cell differentiation)","NA",{"v":0.012,"d":"0.01"},1,"299,",0,-1.93,{"v":-1.4,"d":"-1.40"},6.93,"Exon (ENSBGRT00000006148/ENSBGRG00000003302, exon 3 of 3)",2,1430233,1522224,91992,1]
["chr2",2288601,2288928,328,"ENSBGRG00000003326","ENSBGRT00000006207",297,"KLHDC7A","kelch domain containing 7A [Source:HGNC Symbol;Acc:HGNC:26791]","GO:0005515(protein binding)","NA",{"v":7.1E-8,"d":"0.00"},1,"328,",0,-7.15,-6.41,{"v":26.7,"d":"26.70"},"Exon (ENSBGRT00000006207/ENSBGRG00000003326, exon 1 of 4)",2,2288304,2291102,2799,1]
["chr2",2289196,2289314,119,"ENSBGRG00000003326","ENSBGRT00000006207",892,"KLHDC7A","kelch domain containing 7A [Source:HGNC Symbol;Acc:HGNC:26791]","GO:0005515(protein binding)","NA",{"v":0.022,"d":"0.02"},1,"119,",0,-1.66,-1.15,3.96,"Exon (ENSBGRT00000006207/ENSBGRG00000003326, exon 1 of 4)",2,2288304,2291102,2799,1]
["chr2",2289648,2290454,807,"ENSBGRG00000003326","ENSBGRT00000006207",1344,"KLHDC7A","kelch domain containing 7A [Source:HGNC Symbol;Acc:HGNC:26791]","GO:0005515(protein binding)","NA",{"v":0.00052,"d":"0.00"},2,"114,659,","0,148",-3.28,-2.68,{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000006207/ENSBGRG00000003326, exon 2 of 4)",2,2288304,2291102,2799,1]
["chr2",3201505,3201802,298,"ENSBGRG00000004243","ENSBGRT00000007876",149,"MRTO4","MRT4 homolog, ribosome maturation factor [Source:HGNC Symbol;Acc:HGNC:18477]","GO:0000027(ribosomal large subunit assembly);GO:0042254(ribosome biogenesis)","NA",{"v":6.5e-10,"d":"0.00"},1,"298,",0,-9.19,-8.41,3.31,"5' UTR",2,3201356,3207104,5749,1]
["chr2",3206303,3207104,802,"ENSBGRG00000004243","ENSBGRT00000007876",4947,"MRTO4","MRT4 homolog, ribosome maturation factor [Source:HGNC Symbol;Acc:HGNC:18477]","GO:0000027(ribosomal large subunit assembly);GO:0042254(ribosome biogenesis)","NA",{"v":9.99999999999998e-264,"d":"0.00"},2,"5,679,","0,123",-263,-260,5.09,"3' UTR",2,3201356,3207104,5749,1]
["chr2",3620627,3620716,90,"ENSBGRG00000004678","ENSBGRT00000008632",1803,"ENSBGRG00000004678","NA","NA","NA",{"v":0.013,"d":"0.01"},1,"90,",0,-1.88,-1.35,1.76,"Exon (ENSBGRT00000008632/ENSBGRG00000004678, exon 1 of 1)",2,3618824,3620716,1893,1]
["chr2",3630661,3630780,120,"ENSBGRG00000004686","ENSBGRT00000008650",59,"NBL1","NBL1, DAN family BMP antagonist [Source:HGNC Symbol;Acc:HGNC:7650]","GO:0005615(extracellular space);GO:0007399(nervous system development);GO:0016015(morphogen activity);GO:0030514(negative regulation of BMP signaling pathway);GO:0035582(sequestering of BMP in extracellular matrix);GO:0036122(BMP binding);GO:0038098(sequestering of BMP from receptor via BMP binding);GO:0042802(identical protein binding);GO:0045666(positive regulation of neuron differentiation);GO:0048263(determination of dorsal identity);GO:0048812(neuron projection morphogenesis);GO:0090027(negative regulation of monocyte chemotaxis)","04350(TGF-beta signaling pathway)",0.01,1,"120,",0,-1.98,-1.44,{"v":1.3,"d":"1.30"},"5' UTR",2,3630602,3632537,1936,1]
["chr2",3632299,3632537,239,"ENSBGRG00000004686","ENSBGRT00000008650",1697,"NBL1","NBL1, DAN family BMP antagonist [Source:HGNC Symbol;Acc:HGNC:7650]","GO:0005615(extracellular space);GO:0007399(nervous system development);GO:0016015(morphogen activity);GO:0030514(negative regulation of BMP signaling pathway);GO:0035582(sequestering of BMP in extracellular matrix);GO:0036122(BMP binding);GO:0038098(sequestering of BMP from receptor via BMP binding);GO:0042802(identical protein binding);GO:0045666(positive regulation of neuron differentiation);GO:0048263(determination of dorsal identity);GO:0048812(neuron projection morphogenesis);GO:0090027(negative regulation of monocyte chemotaxis)","04350(TGF-beta signaling pathway)",0,1,"239,",0,-811,"-Inf",7.53,"Exon (ENSBGRT00000008650/ENSBGRG00000004686, exon 3 of 3)",2,3630602,3632537,1936,1]
["chr2",3660472,3660710,239,"ENSBGRG00000004712","ENSBGRT00000008718",14155,"ENSBGRG00000004712","NA","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","04020(Calcium signaling pathway);04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04726(Serotonergic synapse)",{"v":0.0013,"d":"0.00"},1,"239,",0,{"v":-2.9,"d":"-2.90"},-2.31,2.48,"Exon (ENSBGRT00000008718/ENSBGRG00000004712, exon 3 of 3)",2,3646317,3660829,14513,1]
["chr2",3913362,3913629,268,"ENSBGRG00000004823","ENSBGRT00000008922",31743,"OTUD3","OTU deubiquitinase 3 [Source:HGNC Symbol;Acc:HGNC:29038]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005737(cytoplasm);GO:0035871(protein K11-linked deubiquitination);GO:0044313(protein K6-linked deubiquitination);GO:0050821(protein stabilization);GO:0051898(negative regulation of protein kinase B signaling);GO:0071108(protein K48-linked deubiquitination);GO:1990167(protein K27-linked deubiquitination)","NA",{"v":1.3e-21,"d":"0.00"},1,"268,",0,{"v":-20.9,"d":"-20.90"},{"v":-19.9,"d":"-19.90"},3.03,"3' UTR",2,3881619,3914488,32870,1]
["chr2",4664089,4664472,384,"ENSBGRG00000005472","ENSBGRT00000010075",59,"ENSBGRG00000005472","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.00052,"d":"0.00"},1,"384,",0,-3.28,-2.68,{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000010075/ENSBGRG00000005472, exon 1 of 1)",2,4664030,4665268,1239,1]
["chr2",4664649,4664796,148,"ENSBGRG00000005472","ENSBGRT00000010075",619,"ENSBGRG00000005472","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.036,"d":"0.04"},1,"148,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000010075/ENSBGRG00000005472, exon 1 of 1)",2,4664030,4665268,1239,1]
["chr2",4702394,4702453,60,"ENSBGRG00000005498","ENSBGRT00000010126",0,"FAM43B","family with sequence similarity 43 member B [Source:HGNC Symbol;Acc:HGNC:31791]","GO:0005515(protein binding)","03008(Ribosome biogenesis in eukaryotes)",{"v":0.0078,"d":"0.01"},1,"60,",0,-2.11,-1.57,3.14,"Exon (ENSBGRT00000010126/ENSBGRG00000005498, exon 1 of 2)",2,4702394,4704961,2568,1]
["chr2",4702631,4702839,209,"ENSBGRG00000005484","ENSBGRT00000010098",838,"ENSBGRG00000005484","NA","NA","03008(Ribosome biogenesis in eukaryotes)",{"v":0.005,"d":"0.01"},1,"209,",0,{"v":-2.3,"d":"-2.30"},-1.75,4.95,"Exon (ENSBGRT00000010126/ENSBGRG00000005498, exon 1 of 2)",2,4700968,4703677,2710,2]
["chr2",4767929,4768229,301,"ENSBGRG00000000172","ENSBGRT00000000277",23219,"ENSBGRG00000000172","NA","GO:0003824(catalytic activity);GO:0004126(cytidine deaminase activity);GO:0008270(zinc ion binding);GO:0009972(cytidine deamination);GO:0016787(hydrolase activity)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)",{"v":5e-11,"d":"0.00"},1,"301,",0,{"v":-10.3,"d":"-10.30"},-9.52,6.93,"3' UTR",2,4744710,4768797,24088,1]
["chr2",4806560,4808179,1620,"ENSBGRG00000000185","ENSBGRT00000000301",21397,"PINK1","PTEN induced kinase 1 [Source:HGNC Symbol;Acc:HGNC:14581]","GO:0000287(magnesium ion binding);GO:0000422(autophagy of mitochondrion);GO:0000785(chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0002020(protease binding);GO:0002082(regulation of oxidative phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006979(response to oxidative stress);GO:0007005(mitochondrion organization);GO:0010310(regulation of hydrogen peroxide metabolic process);GO:0010629(negative regulation of gene expression);GO:0010821(regulation of mitochondrion organization);GO:0010857(calcium-dependent protein kinase activity);GO:0016020(membrane);GO:0016239(positive regulation of macroautophagy);GO:0016242(negative regulation of macroautophagy);GO:0016301(kinase activity);GO:0016567(protein ubiquitination);GO:0018105(peptidyl-serine phosphorylation);GO:0022904(respiratory electron transport chain);GO:0030424(axon);GO:0031307(integral component of mitochondrial outer membrane);GO:0031396(regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032226(positive regulation of synaptic transmission, dopaminergic);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033603(positive regulation of dopamine secretion);GO:0033605(positive regulation of catecholamine secretion);GO:0034599(cellular response to oxidative stress);GO:0035307(positive regulation of protein dephosphorylation);GO:0035556(intracellular signal transduction);GO:0036289(peptidyl-serine autophosphorylation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043254(regulation of protein-containing complex assembly);GO:0043422(protein kinase B binding);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0044297(cell body);GO:0044877(protein-containing complex binding);GO:0045727(positive regulation of translation);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055131(C3HC4-type RING finger domain binding);GO:0071456(cellular response to hypoxia);GO:0072655(establishment of protein localization to mitochondrion);GO:0072656(maintenance of protein location in mitochondrion);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0090258(negative regulation of mitochondrial fission);GO:0097237(cellular response to toxic substance);GO:0097449(astrocyte projection);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization);GO:0099074(mitochondrion to lysosome transport);GO:1900407(regulation of cellular response to oxidative stress);GO:1901727(positive regulation of histone deacetylase activity);GO:1902902(negative regulation of autophagosome assembly);GO:1902958(positive regulation of mitochondrial electron transport, NADH to ubiquinone);GO:1903147(negative regulation of autophagy of mitochondrion);GO:1903202(negative regulation of oxidative stress-induced cell death);GO:1903214(regulation of protein targeting to mitochondrion);GO:1903298(negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway);GO:1903384(negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway);GO:1903751(negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:1903852(positive regulation of cristae formation);GO:1904841(TORC2 complex binding);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04137(Mitophagy - animal);05012(Parkinson disease)",{"v":1e-163,"d":"0.00"},2,"180,480,","0,1140",-163,-162,5.25,"3' UTR",2,4785163,4810601,25439,1]
["chr2",4808598,4809197,600,"ENSBGRG00000000185","ENSBGRT00000000301",23435,"PINK1","PTEN induced kinase 1 [Source:HGNC Symbol;Acc:HGNC:14581]","GO:0000287(magnesium ion binding);GO:0000422(autophagy of mitochondrion);GO:0000785(chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0002020(protease binding);GO:0002082(regulation of oxidative phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006979(response to oxidative stress);GO:0007005(mitochondrion organization);GO:0010310(regulation of hydrogen peroxide metabolic process);GO:0010629(negative regulation of gene expression);GO:0010821(regulation of mitochondrion organization);GO:0010857(calcium-dependent protein kinase activity);GO:0016020(membrane);GO:0016239(positive regulation of macroautophagy);GO:0016242(negative regulation of macroautophagy);GO:0016301(kinase activity);GO:0016567(protein ubiquitination);GO:0018105(peptidyl-serine phosphorylation);GO:0022904(respiratory electron transport chain);GO:0030424(axon);GO:0031307(integral component of mitochondrial outer membrane);GO:0031396(regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032226(positive regulation of synaptic transmission, dopaminergic);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033603(positive regulation of dopamine secretion);GO:0033605(positive regulation of catecholamine secretion);GO:0034599(cellular response to oxidative stress);GO:0035307(positive regulation of protein dephosphorylation);GO:0035556(intracellular signal transduction);GO:0036289(peptidyl-serine autophosphorylation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043254(regulation of protein-containing complex assembly);GO:0043422(protein kinase B binding);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0044297(cell body);GO:0044877(protein-containing complex binding);GO:0045727(positive regulation of translation);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055131(C3HC4-type RING finger domain binding);GO:0071456(cellular response to hypoxia);GO:0072655(establishment of protein localization to mitochondrion);GO:0072656(maintenance of protein location in mitochondrion);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0090258(negative regulation of mitochondrial fission);GO:0097237(cellular response to toxic substance);GO:0097449(astrocyte projection);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization);GO:0099074(mitochondrion to lysosome transport);GO:1900407(regulation of cellular response to oxidative stress);GO:1901727(positive regulation of histone deacetylase activity);GO:1902902(negative regulation of autophagosome assembly);GO:1902958(positive regulation of mitochondrial electron transport, NADH to ubiquinone);GO:1903147(negative regulation of autophagy of mitochondrion);GO:1903202(negative regulation of oxidative stress-induced cell death);GO:1903214(regulation of protein targeting to mitochondrion);GO:1903298(negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway);GO:1903384(negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway);GO:1903751(negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:1903852(positive regulation of cristae formation);GO:1904841(TORC2 complex binding);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04137(Mitophagy - animal);05012(Parkinson disease)",0,1,"600,",0,-368,"-Inf",5.88,"3' UTR",2,4785163,4810601,25439,1]
["chr2",4809407,4809736,330,"ENSBGRG00000000185","ENSBGRT00000000301",24244,"PINK1","PTEN induced kinase 1 [Source:HGNC Symbol;Acc:HGNC:14581]","GO:0000287(magnesium ion binding);GO:0000422(autophagy of mitochondrion);GO:0000785(chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0002020(protease binding);GO:0002082(regulation of oxidative phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006979(response to oxidative stress);GO:0007005(mitochondrion organization);GO:0010310(regulation of hydrogen peroxide metabolic process);GO:0010629(negative regulation of gene expression);GO:0010821(regulation of mitochondrion organization);GO:0010857(calcium-dependent protein kinase activity);GO:0016020(membrane);GO:0016239(positive regulation of macroautophagy);GO:0016242(negative regulation of macroautophagy);GO:0016301(kinase activity);GO:0016567(protein ubiquitination);GO:0018105(peptidyl-serine phosphorylation);GO:0022904(respiratory electron transport chain);GO:0030424(axon);GO:0031307(integral component of mitochondrial outer membrane);GO:0031396(regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032226(positive regulation of synaptic transmission, dopaminergic);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033603(positive regulation of dopamine secretion);GO:0033605(positive regulation of catecholamine secretion);GO:0034599(cellular response to oxidative stress);GO:0035307(positive regulation of protein dephosphorylation);GO:0035556(intracellular signal transduction);GO:0036289(peptidyl-serine autophosphorylation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043254(regulation of protein-containing complex assembly);GO:0043422(protein kinase B binding);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0044297(cell body);GO:0044877(protein-containing complex binding);GO:0045727(positive regulation of translation);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055131(C3HC4-type RING finger domain binding);GO:0071456(cellular response to hypoxia);GO:0072655(establishment of protein localization to mitochondrion);GO:0072656(maintenance of protein location in mitochondrion);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0090258(negative regulation of mitochondrial fission);GO:0097237(cellular response to toxic substance);GO:0097449(astrocyte projection);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization);GO:0099074(mitochondrion to lysosome transport);GO:1900407(regulation of cellular response to oxidative stress);GO:1901727(positive regulation of histone deacetylase activity);GO:1902902(negative regulation of autophagosome assembly);GO:1902958(positive regulation of mitochondrial electron transport, NADH to ubiquinone);GO:1903147(negative regulation of autophagy of mitochondrion);GO:1903202(negative regulation of oxidative stress-induced cell death);GO:1903214(regulation of protein targeting to mitochondrion);GO:1903298(negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway);GO:1903384(negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway);GO:1903751(negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:1903852(positive regulation of cristae formation);GO:1904841(TORC2 complex binding);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04137(Mitophagy - animal);05012(Parkinson disease)",{"v":1E-182,"d":"0.00"},1,"330,",0,-182,-180,2.63,"3' UTR",2,4785163,4810601,25439,1]
["chr2",4810485,4905870,95386,"ENSBGRG00000000203","ENSBGRT00000000344",0,"DDOST","dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit [Source:HGNC Symbol;Acc:HGNC:2728]","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006487(protein N-linked glycosylation);GO:0008047(enzyme activator activity);GO:0008250(oligosaccharyltransferase complex);GO:0018279(protein N-linked glycosylation via asparagine);GO:0031647(regulation of protein stability);GO:0034097(response to cytokine);GO:0042110(T cell activation);GO:0043231(intracellular membrane-bounded organelle)","00510(N-Glycan biosynthesis);04141(Protein processing in endoplasmic reticulum)",{"v":0.00085,"d":"0.00"},2,"117,63,","0,95323",-3.07,-2.48,2.61,"5' UTR",2,4809446,4812458,3013,2]
["chr2",5708704,5708854,151,"ENSBGRG00000000875","ENSBGRT00000001606",41872,"ALPL","alkaline phosphatase, biomineralization associated [Source:HGNC Symbol;Acc:HGNC:438]","GO:0001958(endochondral ossification);GO:0003006(developmental process involved in reproduction);GO:0003824(catalytic activity);GO:0004035(alkaline phosphatase activity);GO:0005886(plasma membrane);GO:0016462(pyrophosphatase activity);GO:0016791(phosphatase activity);GO:0031012(extracellular matrix);GO:0033280(response to vitamin D);GO:0046677(response to antibiotic);GO:0065010(extracellular membrane-bounded organelle);GO:0071407(cellular response to organic cyclic compound)","00730(Thiamine metabolism);00790(Folate biosynthesis)",{"v":0.00013,"d":"0.00"},1,"151,",0,{"v":-3.9,"d":"-3.90"},-3.27,2.15,"3' UTR",2,5666832,5709093,42262,1]
["chr2",6149957,6150500,544,"ENSBGRG00000003260","ENSBGRT00000006046",0,"ENSBGRG00000003260","NA","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",0,2,"389,93,","0,451",-614,"-Inf",3.17,"5' UTR",2,6149957,6150500,544,1]
["chr2",6199436,6199884,449,"ENSBGRG00000003268","ENSBGRT00000006062",90,"ENSBGRG00000003268","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.0013,"d":"0.00"},1,"449,",0,{"v":-2.9,"d":"-2.90"},-2.31,4.95,"Exon (ENSBGRT00000006062/ENSBGRG00000003268, exon 1 of 1)",2,6199346,6200452,1107,1]
["chr2",6199944,6200452,509,"ENSBGRG00000003268","ENSBGRT00000006062",598,"ENSBGRG00000003268","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.00022,"d":"0.00"},1,"509,",0,-3.66,-3.04,8.91,"Exon (ENSBGRT00000006062/ENSBGRG00000003268, exon 1 of 1)",2,6199346,6200452,1107,1]
["chr2",6199436,6199884,449,"ENSBGRG00000003268","ENSBGRT00000006062",90,"ENSBGRG00000003268","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.0013,"d":"0.00"},1,"449,",0,{"v":-2.9,"d":"-2.90"},-2.31,4.95,"Exon (ENSBGRT00000006062/ENSBGRG00000003268, exon 1 of 1)",2,6199346,6200452,1107,1]
["chr2",6199944,6200452,509,"ENSBGRG00000003268","ENSBGRT00000006062",598,"ENSBGRG00000003268","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.00022,"d":"0.00"},1,"509,",0,-3.66,-3.04,8.91,"Exon (ENSBGRT00000006062/ENSBGRG00000003268, exon 1 of 1)",2,6199346,6200452,1107,1]
["chr2",6670534,6682279,11746,"ENSBGRG00000003315","ENSBGRT00000006176",0,"ZBTB40","zinc finger and BTB domain containing 40 [Source:HGNC Symbol;Acc:HGNC:29045]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus)","NA",{"v":7.9e-49,"d":"0.00"},2,"51,518,","0,11228",{"v":-48.1,"d":"-48.10"},{"v":-46.9,"d":"-46.90"},4.16,"5' UTR",2,6670534,6726689,56156,1]
["chr2",6708521,6709215,695,"ENSBGRG00000003315","ENSBGRT00000006176",37987,"ZBTB40","zinc finger and BTB domain containing 40 [Source:HGNC Symbol;Acc:HGNC:29045]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus)","NA",{"v":2.5e-24,"d":"0.00"},2,"38,352,","0,343",{"v":-23.6,"d":"-23.60"},{"v":-22.6,"d":"-22.60"},2.68,"Exon (ENSBGRT00000006176/ENSBGRG00000003315, exon 10 of 18)",2,6670534,6726689,56156,1]
["chr2",6723475,6726689,3215,"ENSBGRG00000003315","ENSBGRT00000006176",52941,"ZBTB40","zinc finger and BTB domain containing 40 [Source:HGNC Symbol;Acc:HGNC:29045]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus)","NA",{"v":7.9e-53,"d":"0.00"},2,"88,212,","0,3003",{"v":-52.1,"d":"-52.10"},{"v":-50.9,"d":"-50.90"},3,"3' UTR",2,6670534,6726689,56156,1]
["chr2",6847001,6850217,3217,"ENSBGRG00000003422","ENSBGRT00000006360",89,"C1QA","complement C1q A chain [Source:HGNC Symbol;Acc:HGNC:1241]","GO:0001774(microglial cell activation);GO:0005515(protein binding);GO:0006958(complement activation, classical pathway);GO:0007568(aging);GO:0016322(neuron remodeling);GO:0045202(synapse);GO:0048143(astrocyte activation);GO:0050808(synapse organization);GO:0098794(postsynapse);GO:0098883(synapse pruning);GO:0150062(complement-mediated synapse pruning);GO:0150064(vertebrate eye-specific patterning);GO:1901216(positive regulation of neuron death)","04610(Complement and coagulation cascades);05322(Systemic lupus erythematosus);05020(Prion diseases);05133(Pertussis);05150(Staphylococcus aureus infection);05142(Chagas disease (American trypanosomiasis))",{"v":1.6E-12,"d":"0.00"},3,"33,170,35,","0,1987,3182",{"v":-11.8,"d":"-11.80"},-11,6.11,"5' UTR",2,6846912,6850959,4048,1]
["chr2",6859272,6859481,210,"ENSBGRG00000003430","ENSBGRT00000006373",3797,"C1QC","complement C1q C chain [Source:HGNC Symbol;Acc:HGNC:1245]","GO:0005515(protein binding);GO:0030853(negative regulation of granulocyte differentiation);GO:0045202(synapse);GO:0045650(negative regulation of macrophage differentiation);GO:0098794(postsynapse);GO:0098883(synapse pruning)","04610(Complement and coagulation cascades);05322(Systemic lupus erythematosus);05020(Prion diseases);05133(Pertussis);05150(Staphylococcus aureus infection);05142(Chagas disease (American trypanosomiasis))",{"v":1.6E-57,"d":"0.00"},1,"210,",0,{"v":-56.8,"d":"-56.80"},{"v":-55.5,"d":"-55.50"},3.08,"Exon (ENSBGRT00000006373/ENSBGRG00000003430, exon 3 of 3)",2,6855475,6860494,5020,1]
["chr2",6860976,6863595,2620,"ENSBGRG00000003435","ENSBGRT00000006390",239,"ENSBGRG00000003435","NA","GO:0003676(nucleic acid binding);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus)","NA",{"v":1.2E-4,"d":"0.00"},2,"1071,362,","0,2258",-3.92,-3.28,{"v":10.9,"d":"10.90"},"5' UTR",2,6860737,6864013,3277,1]
["chr2",7016814,7021629,4816,"ENSBGRG00000003473","ENSBGRT00000006575",85295,"EPHB2","EPH receptor B2 [Source:HGNC Symbol;Acc:HGNC:3393]","GO:0000902(cell morphogenesis);GO:0001525(angiogenesis);GO:0001540(amyloid-beta binding);GO:0001655(urogenital system development);GO:0001933(negative regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0007611(learning or memory);GO:0007612(learning);GO:0008046(axon guidance receptor activity);GO:0009887(animal organ morphogenesis);GO:0016021(integral component of membrane);GO:0016310(phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021631(optic nerve morphogenesis);GO:0021952(central nervous system projection neuron axonogenesis);GO:0022038(corpus callosum development);GO:0030193(regulation of blood coagulation);GO:0030424(axon);GO:0030425(dendrite);GO:0031290(retinal ganglion cell axon guidance);GO:0031915(positive regulation of synaptic plasticity);GO:0038023(signaling receptor activity);GO:0042472(inner ear morphogenesis);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0044877(protein-containing complex binding);GO:0046580(negative regulation of Ras protein signal transduction);GO:0048013(ephrin receptor signaling pathway);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048170(positive regulation of long-term neuronal synaptic plasticity);GO:0048593(camera-type eye morphogenesis);GO:0050770(regulation of axonogenesis);GO:0050771(negative regulation of axonogenesis);GO:0050878(regulation of body fluid levels);GO:0051389(inactivation of MAPKK activity);GO:0051965(positive regulation of synapse assembly);GO:0060021(roof of mouth development);GO:0060996(dendritic spine development);GO:0060997(dendritic spine morphogenesis);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0071679(commissural neuron axon guidance);GO:0099557(trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission);GO:0106028(neuron projection retraction);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1904782(negative regulation of NMDA glutamate receptor activity);GO:1904783(positive regulation of NMDA glutamate receptor activity)","04360(Axon guidance)",{"v":3.2e-14,"d":"0.00"},2,"36,382,","0,4434",{"v":-13.5,"d":"-13.50"},{"v":-12.6,"d":"-12.60"},{"v":3.6,"d":"3.60"},"Exon (ENSBGRT00000006575/ENSBGRG00000003473, exon 2 of 16)",2,6931519,7187286,255768,1]
["chr2",7185465,7186808,1344,"ENSBGRG00000003473","ENSBGRT00000006575",253946,"EPHB2","EPH receptor B2 [Source:HGNC Symbol;Acc:HGNC:3393]","GO:0000902(cell morphogenesis);GO:0001525(angiogenesis);GO:0001540(amyloid-beta binding);GO:0001655(urogenital system development);GO:0001933(negative regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0007611(learning or memory);GO:0007612(learning);GO:0008046(axon guidance receptor activity);GO:0009887(animal organ morphogenesis);GO:0016021(integral component of membrane);GO:0016310(phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021631(optic nerve morphogenesis);GO:0021952(central nervous system projection neuron axonogenesis);GO:0022038(corpus callosum development);GO:0030193(regulation of blood coagulation);GO:0030424(axon);GO:0030425(dendrite);GO:0031290(retinal ganglion cell axon guidance);GO:0031915(positive regulation of synaptic plasticity);GO:0038023(signaling receptor activity);GO:0042472(inner ear morphogenesis);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0044877(protein-containing complex binding);GO:0046580(negative regulation of Ras protein signal transduction);GO:0048013(ephrin receptor signaling pathway);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048170(positive regulation of long-term neuronal synaptic plasticity);GO:0048593(camera-type eye morphogenesis);GO:0050770(regulation of axonogenesis);GO:0050771(negative regulation of axonogenesis);GO:0050878(regulation of body fluid levels);GO:0051389(inactivation of MAPKK activity);GO:0051965(positive regulation of synapse assembly);GO:0060021(roof of mouth development);GO:0060996(dendritic spine development);GO:0060997(dendritic spine morphogenesis);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0071679(commissural neuron axon guidance);GO:0099557(trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission);GO:0106028(neuron projection retraction);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1904782(negative regulation of NMDA glutamate receptor activity);GO:1904783(positive regulation of NMDA glutamate receptor activity)","04360(Axon guidance)",{"v":2e-84,"d":"0.00"},1,"1344,",0,{"v":-83.7,"d":"-83.70"},{"v":-82.2,"d":"-82.20"},7.59,"3' UTR",2,6931519,7187286,255768,1]
["chr2",7259703,7260060,358,"ENSBGRG00000003651","ENSBGRT00000006863",30,"KDM1A","lysine demethylase 1A [Source:HGNC Symbol;Acc:HGNC:29079]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000784(nuclear chromosome, telomeric region);GO:0000790(nuclear chromatin);GO:0002039(p53 binding);GO:0002052(positive regulation of neuroblast proliferation);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006482(protein demethylation);GO:0008134(transcription factor binding);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0016491(oxidoreductase activity);GO:0019899(enzyme binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0032091(negative regulation of protein binding);GO:0032451(demethylase activity);GO:0032452(histone demethylase activity);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0032454(histone demethylase activity (H3-K9 specific));GO:0032991(protein-containing complex);GO:0033169(histone H3-K9 demethylation);GO:0033184(positive regulation of histone ubiquitination);GO:0034644(cellular response to UV);GO:0034648(histone demethylase activity (H3-dimethyl-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0043426(MRF binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050660(flavin adenine dinucleotide binding);GO:0050681(androgen receptor binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0055114(oxidation-reduction process);GO:0061752(telomeric repeat-containing RNA binding);GO:0071480(cellular response to gamma radiation);GO:1902166(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:1903827(regulation of cellular protein localization);GO:1990391(DNA repair complex)","04714(Thermogenesis)",{"v":5.6e-05,"d":"0.00"},1,"358,",0,-4.25,{"v":-3.6,"d":"-3.60"},6.93,"5' UTR",2,7259673,7335143,75471,1]
["chr2",7334756,7335143,388,"ENSBGRG00000003651","ENSBGRT00000006863",75083,"KDM1A","lysine demethylase 1A [Source:HGNC Symbol;Acc:HGNC:29079]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000784(nuclear chromosome, telomeric region);GO:0000790(nuclear chromatin);GO:0002039(p53 binding);GO:0002052(positive regulation of neuroblast proliferation);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006482(protein demethylation);GO:0008134(transcription factor binding);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0016491(oxidoreductase activity);GO:0019899(enzyme binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0032091(negative regulation of protein binding);GO:0032451(demethylase activity);GO:0032452(histone demethylase activity);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0032454(histone demethylase activity (H3-K9 specific));GO:0032991(protein-containing complex);GO:0033169(histone H3-K9 demethylation);GO:0033184(positive regulation of histone ubiquitination);GO:0034644(cellular response to UV);GO:0034648(histone demethylase activity (H3-dimethyl-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0043426(MRF binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050660(flavin adenine dinucleotide binding);GO:0050681(androgen receptor binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0055114(oxidation-reduction process);GO:0061752(telomeric repeat-containing RNA binding);GO:0071480(cellular response to gamma radiation);GO:1902166(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:1903827(regulation of cellular protein localization);GO:1990391(DNA repair complex)","04714(Thermogenesis)",0,1,"388,",0,-415,"-Inf",6.23,"3' UTR",2,7259673,7335143,75471,1]
["chr2",7990370,7990793,424,"ENSBGRG00000004602","ENSBGRT00000008569",4017,"ENSBGRG00000004602","elongin A [Source:HGNC Symbol;Acc:HGNC:11620]","GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005840(ribosome);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006412(translation);GO:0070449(elongin complex)","03010(Ribosome)",0,2,"92,88,","0,336",-356,"-Inf",{"v":1.8,"d":"1.80"},"Exon (ENSBGRT00000008569/ENSBGRG00000004602, exon 5 of 8)",2,7986353,8041684,55332,1]
["chr2",7990882,8031797,40916,"ENSBGRG00000004602","ENSBGRT00000008781",0,"ENSBGRG00000004602","elongin A [Source:HGNC Symbol;Acc:HGNC:11620]","GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005840(ribosome);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006412(translation);GO:0070449(elongin complex)","03010(Ribosome)",{"v":2.5e-10,"d":"0.00"},2,"82,9,","0,40907",{"v":-9.6,"d":"-9.60"},-8.81,2.01,"3' UTR",2,8031789,8048703,16915,1]
["chr2",8031916,8040668,8753,"ENSBGRG00000004602","ENSBGRT00000008569",45563,"ENSBGRG00000004602","elongin A [Source:HGNC Symbol;Acc:HGNC:11620]","GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005840(ribosome);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006412(translation);GO:0070449(elongin complex)","03010(Ribosome)",{"v":4E-14,"d":"0.00"},4,"26,57,107,139,","0,6803,7839,8614",{"v":-13.4,"d":"-13.40"},{"v":-12.5,"d":"-12.50"},1.62,"Exon (ENSBGRT00000008569/ENSBGRG00000004602, exon 6 of 8)",2,7986353,8041684,55332,1]
["chr2",8040937,8041503,567,"ENSBGRG00000004602","ENSBGRT00000008569",54584,"ENSBGRG00000004602","elongin A [Source:HGNC Symbol;Acc:HGNC:11620]","GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005840(ribosome);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006412(translation);GO:0070449(elongin complex)","03010(Ribosome)",{"v":3.2e-17,"d":"0.00"},1,"567,",0,{"v":-16.5,"d":"-16.50"},{"v":-15.6,"d":"-15.60"},3.21,"3' UTR",2,7986353,8041684,55332,1]
["chr2",8041593,8042517,925,"ENSBGRG00000004602","ENSBGRT00000008569",55240,"ENSBGRG00000004602","elongin A [Source:HGNC Symbol;Acc:HGNC:11620]","GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005840(ribosome);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006412(translation);GO:0070449(elongin complex)","03010(Ribosome)",{"v":2.5e-84,"d":"0.00"},1,"925,",0,{"v":-83.6,"d":"-83.60"},{"v":-82.2,"d":"-82.20"},4.08,"3' UTR",2,7986353,8041684,55332,1]
["chr2",8280282,8281321,1040,"ENSBGRG00000005315","ENSBGRT00000009833",0,"ENSBGRG00000005315","NA","NA","NA",{"v":1.3E-33,"d":"0.00"},2,"167,4,","0,1036",{"v":-32.9,"d":"-32.90"},{"v":-31.8,"d":"-31.80"},1.88,"Exon (ENSBGRT00000009833/ENSBGRG00000005315, exon 1 of 2)",2,8280282,8281321,1040,1]
["chr2",8281336,8284144,2809,"ENSBGRG00000005344","ENSBGRT00000009878",0,"PNRC2","proline rich nuclear receptor coactivator 2 [Source:HGNC Symbol;Acc:HGNC:23158]","GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0000932(P-body);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus)","NA",{"v":9e-303,"d":"0.00"},2,"299,124,","0,2685",-302,-300,3.65,"Exon (ENSBGRT00000009878/ENSBGRG00000005344, exon 1 of 2)",2,8281336,8284144,2809,1]
["chr2",8720069,8720457,389,"ENSBGRG00000006200","ENSBGRT00000011619",39894,"GRHL3","grainyhead like transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:25839]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001736(establishment of planar polarity);GO:0001843(neural tube closure);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007389(pattern specification process);GO:0007398(ectoderm development);GO:0007417(central nervous system development);GO:0008544(epidermis development);GO:0010628(positive regulation of gene expression);GO:0031490(chromatin DNA binding);GO:0032956(regulation of actin cytoskeleton organization);GO:0042060(wound healing);GO:0043547(positive regulation of GTPase activity);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061029(eyelid development in camera-type eye);GO:0061436(establishment of skin barrier);GO:0090103(cochlea morphogenesis);GO:0090179(planar cell polarity pathway involved in neural tube closure)","NA",{"v":3.3E-3,"d":"0.00"},1,"389,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"3' UTR",2,8680175,8720666,40492,1]
["chr2",8854651,8855066,416,"ENSBGRG00000006640","ENSBGRT00000012269",50028,"NIPAL3","NIPA like domain containing 3 [Source:HGNC Symbol;Acc:HGNC:25233]","GO:0015095(magnesium ion transmembrane transporter activity);GO:0015693(magnesium ion transport);GO:0016021(integral component of membrane)","NA",{"v":3.2e-59,"d":"0.00"},1,"416,",0,{"v":-58.5,"d":"-58.50"},{"v":-57.2,"d":"-57.20"},5.48,"3' UTR",2,8804623,8855066,50444,1]
["chr2",8892737,8892826,90,"ENSBGRG00000006726","ENSBGRT00000012551",118,"RCAN3","RCAN family member 3 [Source:HGNC Symbol;Acc:HGNC:3042]","GO:0003676(nucleic acid binding);GO:0019722(calcium-mediated signaling);GO:0019902(phosphatase binding);GO:0031013(troponin I binding)","NA",0.02,1,"90,",0,{"v":-1.7,"d":"-1.70"},-1.19,1.79,"Exon (ENSBGRT00000012551/ENSBGRG00000006726, exon 1 of 3)",2,8892619,8916870,24252,1]
["chr2",8916768,8917035,268,"ENSBGRG00000006726","ENSBGRT00000012551",24149,"RCAN3","RCAN family member 3 [Source:HGNC Symbol;Acc:HGNC:3042]","GO:0003676(nucleic acid binding);GO:0019722(calcium-mediated signaling);GO:0019902(phosphatase binding);GO:0031013(troponin I binding)","NA",{"v":1.8e-06,"d":"0.00"},1,"268,",0,-5.74,-5.04,8.91,"3' UTR",2,8892619,8916870,24252,1]
["chr2",8917903,8918288,386,"ENSBGRG00000006726","ENSBGRT00000012445",25284,"RCAN3","RCAN family member 3 [Source:HGNC Symbol;Acc:HGNC:3042]","GO:0003676(nucleic acid binding);GO:0019722(calcium-mediated signaling);GO:0019902(phosphatase binding);GO:0031013(troponin I binding)","NA",{"v":5e-13,"d":"0.00"},1,"386,",0,{"v":-12.3,"d":"-12.30"},{"v":-11.5,"d":"-11.50"},6.93,"3' UTR",2,8892619,8918377,25759,1]
["chr2",8942857,8942975,119,"ENSBGRG00000006848","ENSBGRT00000012635",4037,"ENSBGRG00000006848","NA","GO:0005887(integral component of plasma membrane);GO:0019911(structural constituent of myelin sheath);GO:0031641(regulation of myelination);GO:0033270(paranode region of axon);GO:0043220(Schmidt-Lanterman incisure)","NA",{"v":0.0013,"d":"0.00"},1,"119,",0,{"v":-2.9,"d":"-2.90"},-2.31,2.48,"5' UTR",2,8938820,8992425,53606,1]
["chr2",9033101,9036106,3006,"ENSBGRG00000006897","ENSBGRT00000013165",0,"ENSBGRG00000006897","NA","GO:0006397(mRNA processing)","03013(RNA transport);03015(mRNA surveillance pathway)",{"v":6.6e-06,"d":"0.00"},3,"21,90,9,","0,2597,2997",-5.18,{"v":-4.5,"d":"-4.50"},1.63,"Exon (ENSBGRT00000013165/ENSBGRG00000006897, exon 1 of 20)",2,9033101,9064317,31217,1]
["chr2",9063640,9064317,678,"ENSBGRG00000006897","ENSBGRT00000013165",30539,"ENSBGRG00000006897","NA","GO:0006397(mRNA processing)","03013(RNA transport);03015(mRNA surveillance pathway)",{"v":1e-106,"d":"0.00"},2,"194,105,","0,573",-106,-105,1.95,"Exon (ENSBGRT00000013165/ENSBGRG00000006897, exon 19 of 20)",2,9033101,9064317,31217,1]
["chr2",9216079,9216258,180,"ENSBGRG00000007301","ENSBGRT00000013449",81163,"CLIC4","chloride intracellular channel 4 [Source:HGNC Symbol;Acc:HGNC:13518]","GO:0001525(angiogenesis);GO:0001886(endothelial cell morphogenesis);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0005911(cell-cell junction);GO:0007035(vacuolar acidification);GO:0009566(fertilization);GO:0009986(cell surface);GO:0015630(microtubule cytoskeleton);GO:0016363(nuclear matrix);GO:0030216(keratinocyte differentiation);GO:0030336(negative regulation of cell migration);GO:0030496(midbody);GO:0035264(multicellular organism growth);GO:0045177(apical part of cell);GO:0048471(perinuclear region of cytoplasm);GO:0048754(branching morphogenesis of an epithelial tube);GO:0061299(retina vasculature morphogenesis in camera-type eye);GO:0071277(cellular response to calcium ion)","NA",{"v":3.2e-85,"d":"0.00"},1,"180,",0,{"v":-84.5,"d":"-84.50"},{"v":-83.1,"d":"-83.10"},1.75,"3' UTR",2,9134916,9217534,82619,1]
["chr2",9813101,9842970,29870,"ENSBGRG00000007916","ENSBGRT00000014465",26273,"MACO1","macoilin 1 [Source:HGNC Symbol;Acc:HGNC:25572]","GO:0005634(nucleus);GO:0007420(brain development);GO:0023041(neuronal signal transduction);GO:0030424(axon);GO:0030867(rough endoplasmic reticulum membrane);GO:0031965(nuclear membrane);GO:0043005(neuron projection);GO:0044306(neuron projection terminus);GO:0045202(synapse)","NA",{"v":1E-141,"d":"0.00"},4,"27,179,502,71,","0,2419,3802,29799",-141,-140,6.59,"Exon (ENSBGRT00000014465/ENSBGRG00000007916, exon 4 of 11)",2,9786828,9864715,77888,1]
["chr2",9843029,9864715,21687,"ENSBGRG00000007916","ENSBGRT00000014465",56201,"MACO1","macoilin 1 [Source:HGNC Symbol;Acc:HGNC:25572]","GO:0005634(nucleus);GO:0007420(brain development);GO:0023041(neuronal signal transduction);GO:0030424(axon);GO:0030867(rough endoplasmic reticulum membrane);GO:0031965(nuclear membrane);GO:0043005(neuron projection);GO:0044306(neuron projection terminus);GO:0045202(synapse)","NA",0,5,"30,183,121,175,718,","0,5135,7489,15780,20969",-327,"-Inf",5.52,"3' UTR",2,9786828,9864715,77888,1]
["chr2",9931676,9932351,676,"ENSBGRG00000008061","ENSBGRT00000014977",27983,"LDLRAP1","low density lipoprotein receptor adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:18640]","GO:0001540(amyloid-beta binding);GO:0001784(phosphotyrosine residue binding);GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005883(neurofilament);GO:0006898(receptor-mediated endocytosis);GO:0009898(cytoplasmic side of plasma membrane);GO:0009925(basal plasma membrane);GO:0030159(receptor signaling complex adaptor activity);GO:0030276(clathrin binding);GO:0031623(receptor internalization);GO:0034383(low-density lipoprotein particle clearance);GO:0035591(signaling adaptor activity);GO:0035612(AP-2 adaptor complex binding);GO:0035650(AP-1 adaptor complex binding);GO:0042632(cholesterol homeostasis);GO:0042982(amyloid precursor protein metabolic process);GO:0043393(regulation of protein binding);GO:0048260(positive regulation of receptor-mediated endocytosis);GO:0050750(low-density lipoprotein particle receptor binding);GO:0055037(recycling endosome);GO:0071345(cellular response to cytokine stimulus);GO:0090118(receptor-mediated endocytosis involved in cholesterol transport);GO:1903076(regulation of protein localization to plasma membrane);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1905581(positive regulation of low-density lipoprotein particle clearance);GO:1905602(positive regulation of receptor-mediated endocytosis involved in cholesterol transport)","04144(Endocytosis);04979(Cholesterol metabolism)",{"v":5e-06,"d":"0.00"},2,"3,145,","0,531",{"v":-5.3,"d":"-5.30"},-4.61,2.67,"Exon (ENSBGRT00000014977/ENSBGRG00000008061, exon 10 of 10)",2,9903693,9931678,27986,1]
["chr2",9976093,10053072,76980,"ENSBGRG00000008298","ENSBGRT00000015315",0,"MAN1C1","mannosidase alpha class 1C member 1 [Source:HGNC Symbol;Acc:HGNC:19080]","GO:0003824(catalytic activity);GO:0004571(mannosyl-oligosaccharide 1,2-alpha-mannosidase activity);GO:0005509(calcium ion binding);GO:0016020(membrane)","00510(N-Glycan biosynthesis);04141(Protein processing in endoplasmic reticulum)",{"v":3.2E-49,"d":"0.00"},2,"540,29,","0,76951",{"v":-48.5,"d":"-48.50"},{"v":-47.3,"d":"-47.30"},4.17,"Exon (ENSBGRT00000015315/ENSBGRG00000008298, exon 1 of 12)",2,9976093,10160758,184666,1]
["chr2",10159188,10160429,1242,"ENSBGRG00000008298","ENSBGRT00000015315",183095,"MAN1C1","mannosidase alpha class 1C member 1 [Source:HGNC Symbol;Acc:HGNC:19080]","GO:0003824(catalytic activity);GO:0004571(mannosyl-oligosaccharide 1,2-alpha-mannosidase activity);GO:0005509(calcium ion binding);GO:0016020(membrane)","00510(N-Glycan biosynthesis);04141(Protein processing in endoplasmic reticulum)",{"v":1.6E-34,"d":"0.00"},2,"72,436,","0,806",{"v":-33.8,"d":"-33.80"},{"v":-32.7,"d":"-32.70"},3,"3' UTR",2,9976093,10160758,184666,1]
["chr2",10163258,10164401,1144,"ENSBGRG00000008460","ENSBGRT00000015377",502,"ENSBGRG00000008460","NA","NA","NA",0.02,2,"136,43,","0,1101",{"v":-1.7,"d":"-1.70"},-1.19,2.31,"Exon (ENSBGRT00000015377/ENSBGRG00000008460, exon 1 of 2)",2,10162756,10165317,2562,1]
["chr2",10186199,10186437,239,"ENSBGRG00000008512","ENSBGRT00000015467",0,"ENSBGRG00000008512","NA","NA","NA",{"v":2.4E-9,"d":"0.00"},1,"239,",0,-8.62,-7.85,{"v":32.7,"d":"32.70"},"5' UTR",2,10186199,10201579,15381,1]
["chr2",10186556,10186675,120,"ENSBGRG00000008512","ENSBGRT00000015467",357,"ENSBGRG00000008512","NA","NA","NA",{"v":4.7E-7,"d":"0.00"},1,"120,",0,-6.33,-5.61,2.82,"5' UTR",2,10186199,10201579,15381,1]
["chr2",10220167,10227433,7267,"ENSBGRG00000008577","ENSBGRT00000015711",6224,"MTFR1L","mitochondrial fission regulator 1 like [Source:HGNC Symbol;Acc:HGNC:28836]","NA","NA",{"v":9.99999999999998e-244,"d":"0.00"},2,"164,946,","0,6321",-243,-241,5.45,"3' UTR",2,10213943,10226794,12852,1]
["chr2",10425837,10426255,419,"ENSBGRG00000008937","ENSBGRT00000016357",30,"EXTL1","exostosin like glycosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:3515]","GO:0006486(protein glycosylation);GO:0016021(integral component of membrane);GO:0016757(transferase activity, transferring glycosyl groups)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)",{"v":2.9E-4,"d":"0.00"},1,"419,",0,-3.54,-2.92,6.27,"Exon (ENSBGRT00000016357/ENSBGRG00000008937, exon 1 of 12)",2,10425807,10446156,20350,1]
["chr2",10445917,10446156,240,"ENSBGRG00000008937","ENSBGRT00000016357",20110,"EXTL1","exostosin like glycosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:3515]","GO:0006486(protein glycosylation);GO:0016021(integral component of membrane);GO:0016757(transferase activity, transferring glycosyl groups)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)",{"v":7.2e-05,"d":"0.00"},1,"240,",0,-4.14,-3.49,{"v":3.3,"d":"3.30"},"3' UTR",2,10425807,10446156,20350,1]
["chr2",10537685,10542590,4906,"ENSBGRG00000005649","ENSBGRT00000010410",30,"PDIK1L","PDLIM1 interacting kinase 1 like [Source:HGNC Symbol;Acc:HGNC:18981]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation)","NA",{"v":1.6E-90,"d":"0.00"},2,"272,741,","0,4165",{"v":-89.8,"d":"-89.80"},{"v":-88.3,"d":"-88.30"},{"v":13.4,"d":"13.40"},"Exon (ENSBGRT00000010410/ENSBGRG00000005649, exon 1 of 2)",2,10537655,10542590,4936,1]
["chr2",10575872,10576423,552,"ENSBGRG00000005660","ENSBGRT00000010438",29,"FAM110D","family with sequence similarity 110 member D [Source:HGNC Symbol;Acc:HGNC:25860]","NA","NA",{"v":2.2e-09,"d":"0.00"},1,"552,",0,-8.66,-7.88,{"v":6.6,"d":"6.60"},"Exon (ENSBGRT00000010438/ENSBGRG00000005660, exon 1 of 1)",2,10575843,10576655,813,1]
["chr2",10583368,10584000,633,"ENSBGRG00000005708","ENSBGRT00000010559",87,"ZNF593","zinc finger protein 593 [Source:HGNC Symbol;Acc:HGNC:30943]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0008270(zinc ion binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1903026(negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding)","NA",{"v":1e-138,"d":"0.00"},3,"113,63,142,","0,335,491",-138,-136,5.57,"Exon (ENSBGRT00000010559/ENSBGRG00000005708, exon 1 of 3)",2,10583281,10584000,720,1]
["chr2",10605802,10606160,359,"ENSBGRG00000005760","ENSBGRT00000010660",13268,"CNKSR1","connector enhancer of kinase suppressor of Ras 1 [Source:HGNC Symbol;Acc:HGNC:19700]","GO:0005515(protein binding);GO:0005938(cell cortex);GO:0007265(Ras protein signal transduction);GO:0007266(Rho protein signal transduction);GO:0030674(protein-macromolecule adaptor activity)","NA",{"v":1.1e-07,"d":"0.00"},1,"359,",0,-6.96,-6.23,3.33,"5' UTR",2,10592534,10606160,13627,1]
["chr2",10605815,10606145,331,"ENSBGRG00000005760","ENSBGRT00000010660",13281,"CNKSR1","connector enhancer of kinase suppressor of Ras 1 [Source:HGNC Symbol;Acc:HGNC:19700]","GO:0005515(protein binding);GO:0005938(cell cortex);GO:0007265(Ras protein signal transduction);GO:0007266(Rho protein signal transduction);GO:0030674(protein-macromolecule adaptor activity)","NA",{"v":9.3e-08,"d":"0.00"},1,"331,",0,-7.03,{"v":-6.3,"d":"-6.30"},3.33,"5' UTR",2,10592534,10606160,13627,1]
["chr2",10664746,10665074,329,"ENSBGRG00000006005","ENSBGRT00000011174",18213,"CEP85","centrosomal protein 85 [Source:HGNC Symbol;Acc:HGNC:25309]","GO:0000242(pericentriolar material);GO:0000922(spindle pole);GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006469(negative regulation of protein kinase activity);GO:0046602(regulation of mitotic centrosome separation)","NA",{"v":0.00051,"d":"0.00"},1,"329,",0,-3.29,-2.68,2.59,"Exon (ENSBGRT00000011174/ENSBGRG00000006005, exon 4 of 14)",2,10646533,10689918,43386,1]
["chr2",10689619,10689679,61,"ENSBGRG00000006005","ENSBGRT00000011174",43086,"CEP85","centrosomal protein 85 [Source:HGNC Symbol;Acc:HGNC:25309]","GO:0000242(pericentriolar material);GO:0000922(spindle pole);GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006469(negative regulation of protein kinase activity);GO:0046602(regulation of mitotic centrosome separation)","NA",{"v":1.8E-3,"d":"0.00"},1,"61,",0,-2.75,-2.17,2.44,"3' UTR",2,10646533,10689918,43386,1]
["chr2",10689739,10689828,90,"ENSBGRG00000006005","ENSBGRT00000011174",43206,"CEP85","centrosomal protein 85 [Source:HGNC Symbol;Acc:HGNC:25309]","GO:0000242(pericentriolar material);GO:0000922(spindle pole);GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006469(negative regulation of protein kinase activity);GO:0046602(regulation of mitotic centrosome separation)","NA",{"v":5.5e-08,"d":"0.00"},1,"90,",0,-7.26,-6.52,2.87,"3' UTR",2,10646533,10689918,43386,1]
["chr2",10879271,10879510,240,"ENSBGRG00000006684","ENSBGRT00000012397",39652,"DHDDS","dehydrodolichyl diphosphate synthase subunit [Source:HGNC Symbol;Acc:HGNC:20603]","GO:0002094(polyprenyltransferase activity);GO:0006489(dolichyl diphosphate biosynthetic process);GO:0016765(transferase activity, transferring alkyl or aryl (other than methyl) groups);GO:0045547(dehydrodolichyl diphosphate synthase activity);GO:1904423(dehydrodolichyl diphosphate synthase complex)","00900(Terpenoid backbone biosynthesis)",{"v":4.2e-09,"d":"0.00"},1,"240,",0,-8.38,-7.61,2.26,"3' UTR",2,10839619,10880469,40851,1]
["chr2",10882850,10883560,711,"ENSBGRG00000006878","ENSBGRT00000012750",0,"ENSBGRG00000006878","high mobility group nucleosomal binding domain 2 [Source:HGNC Symbol;Acc:HGNC:4986]","GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)","NA",{"v":6.3e-13,"d":"0.00"},2,"15,164,","0,547",{"v":-12.2,"d":"-12.20"},{"v":-11.4,"d":"-11.40"},2.49,"5' UTR",2,10882850,10885225,2376,1]
["chr2",10883708,10885143,1436,"ENSBGRG00000006878","ENSBGRT00000012750",858,"ENSBGRG00000006878","high mobility group nucleosomal binding domain 2 [Source:HGNC Symbol;Acc:HGNC:4986]","GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)","NA",0,5,"39,45,30,51,221,","0,178,417,773,1215",-523,"-Inf",{"v":2.4,"d":"2.40"},"5' UTR",2,10882850,10885225,2376,1]
["chr2",10939640,10939730,91,"ENSBGRG00000007015","ENSBGRT00000013869",90,"RPS6KA1","ribosomal protein S6 kinase A1 [Source:HGNC Symbol;Acc:HGNC:10430]","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0035556(intracellular signal transduction);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2000491(positive regulation of hepatic stellate cell activation)","04010(MAPK signaling pathway);04150(mTOR signaling pathway);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04714(Thermogenesis);04931(Insulin resistance)",{"v":0.048,"d":"0.05"},1,"91,",0,-1.32,{"v":-0.839,"d":"-0.84"},3.47,"5' UTR",2,10939550,10981930,42381,1]
["chr2",10980628,10981571,944,"ENSBGRG00000007015","ENSBGRT00000013869",41078,"RPS6KA1","ribosomal protein S6 kinase A1 [Source:HGNC Symbol;Acc:HGNC:10430]","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0035556(intracellular signal transduction);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2000491(positive regulation of hepatic stellate cell activation)","04010(MAPK signaling pathway);04150(mTOR signaling pathway);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04714(Thermogenesis);04931(Insulin resistance)",{"v":6.3e-63,"d":"0.00"},2,"5,594,","0,350",{"v":-62.2,"d":"-62.20"},{"v":-60.9,"d":"-60.90"},5.48,"3' UTR",2,10939550,10981930,42381,1]
["chr2",11087382,11088519,1138,"ENSBGRG00000008144","ENSBGRT00000015489",0,"ARID1A","AT-rich interaction domain 1A [Source:HGNC Symbol;Acc:HGNC:11110]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0001704(formation of primary germ layer);GO:0001843(neural tube closure);GO:0003205(cardiac chamber development);GO:0003408(optic cup formation involved in camera-type eye development);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0007369(gastrulation);GO:0007566(embryo implantation);GO:0016514(SWI/SNF complex);GO:0016922(nuclear receptor binding);GO:0019827(stem cell population maintenance);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030900(forebrain development);GO:0031491(nucleosome binding);GO:0035060(brahma complex);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043044(ATP-dependent chromatin remodeling);GO:0045893(positive regulation of transcription, DNA-templated);GO:0055007(cardiac muscle cell differentiation);GO:0060674(placenta blood vessel development);GO:0070829(heterochromatin maintenance);GO:0071564(npBAF complex);GO:0071565(nBAF complex);GO:1901998(toxin transport)","04714(Thermogenesis);05225(Hepatocellular carcinoma)",{"v":3.2e-36,"d":"0.00"},1,"1138,",0,{"v":-35.5,"d":"-35.50"},{"v":-34.4,"d":"-34.40"},8.54,"Exon (ENSBGRT00000015489/ENSBGRG00000008144, exon 1 of 20)",2,11087382,11161143,73762,1]
["chr2",11156277,11156606,330,"ENSBGRG00000008144","ENSBGRT00000015489",68895,"ARID1A","AT-rich interaction domain 1A [Source:HGNC Symbol;Acc:HGNC:11110]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0001704(formation of primary germ layer);GO:0001843(neural tube closure);GO:0003205(cardiac chamber development);GO:0003408(optic cup formation involved in camera-type eye development);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0007369(gastrulation);GO:0007566(embryo implantation);GO:0016514(SWI/SNF complex);GO:0016922(nuclear receptor binding);GO:0019827(stem cell population maintenance);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030900(forebrain development);GO:0031491(nucleosome binding);GO:0035060(brahma complex);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043044(ATP-dependent chromatin remodeling);GO:0045893(positive regulation of transcription, DNA-templated);GO:0055007(cardiac muscle cell differentiation);GO:0060674(placenta blood vessel development);GO:0070829(heterochromatin maintenance);GO:0071564(npBAF complex);GO:0071565(nBAF complex);GO:1901998(toxin transport)","04714(Thermogenesis);05225(Hepatocellular carcinoma)",{"v":3.9e-08,"d":"0.00"},1,"330,",0,-7.41,-6.67,1.34,"Exon (ENSBGRT00000015489/ENSBGRG00000008144, exon 18 of 20)",2,11087382,11161143,73762,1]
["chr2",11157251,11161083,3833,"ENSBGRG00000008144","ENSBGRT00000015489",69869,"ARID1A","AT-rich interaction domain 1A [Source:HGNC Symbol;Acc:HGNC:11110]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0001704(formation of primary germ layer);GO:0001843(neural tube closure);GO:0003205(cardiac chamber development);GO:0003408(optic cup formation involved in camera-type eye development);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0007369(gastrulation);GO:0007566(embryo implantation);GO:0016514(SWI/SNF complex);GO:0016922(nuclear receptor binding);GO:0019827(stem cell population maintenance);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030900(forebrain development);GO:0031491(nucleosome binding);GO:0035060(brahma complex);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043044(ATP-dependent chromatin remodeling);GO:0045893(positive regulation of transcription, DNA-templated);GO:0055007(cardiac muscle cell differentiation);GO:0060674(placenta blood vessel development);GO:0070829(heterochromatin maintenance);GO:0071564(npBAF complex);GO:0071565(nBAF complex);GO:1901998(toxin transport)","04714(Thermogenesis);05225(Hepatocellular carcinoma)",0,2,"68,2028,","0,1805",-516,"-Inf",7.83,"3' UTR",2,11087382,11161143,73762,1]
["chr2",11172792,11179066,6275,"ENSBGRG00000008647","ENSBGRT00000015787",0,"PIGV","phosphatidylinositol glycan anchor biosynthesis class V [Source:HGNC Symbol;Acc:HGNC:26031]","GO:0004584(dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity);GO:0006506(GPI anchor biosynthetic process)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":1.9E-3,"d":"0.00"},3,"1,135,220,","0,2886,6055",-2.72,-2.14,2.12,"5' UTR",2,11175678,11182889,7212,1]
["chr2",11179480,11182889,3410,"ENSBGRG00000008647","ENSBGRT00000015744",6777,"PIGV","phosphatidylinositol glycan anchor biosynthesis class V [Source:HGNC Symbol;Acc:HGNC:26031]","GO:0004584(dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity);GO:0006506(GPI anchor biosynthetic process)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":2.5e-43,"d":"0.00"},2,"489,282,","0,3128",{"v":-42.6,"d":"-42.60"},{"v":-41.4,"d":"-41.40"},7.86,"Exon (ENSBGRT00000015744/ENSBGRG00000008647, exon 3 of 4)",2,11172703,11182889,10187,1]
["chr2",11230376,11230555,180,"ENSBGRG00000008689","ENSBGRT00000015860",28663,"ZDHHC18","zinc finger DHHC-type containing 18 [Source:HGNC Symbol;Acc:HGNC:20712]","GO:0005794(Golgi apparatus);GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0034613(cellular protein localization)","NA",{"v":2e-09,"d":"0.00"},1,"180,",0,-8.69,-7.92,{"v":3.8,"d":"3.80"},"3' UTR",2,11201713,11235736,34024,1]
["chr2",11301748,11311955,10208,"ENSBGRG00000008953","ENSBGRT00000016406",0,"ENSBGRG00000008953","NA","NA","04976(Bile secretion)",{"v":1e-106,"d":"0.00"},3,"81,78,170,","0,2398,10038",-106,-105,2.63,"5' UTR",2,11281988,11302217,20230,2]
["chr2",11312552,11313859,1308,"ENSBGRG00000008992","ENSBGRT00000016453",10804,"NUDC","nuclear distribution C, dynein complex regulator [Source:HGNC Symbol;Acc:HGNC:8045]","GO:0005737(cytoplasm);GO:0005829(cytosol)","NA",{"v":1E-142,"d":"0.00"},4,"224,66,117,12,","0,313,1106,1296",-142,-140,2.43,"Exon (ENSBGRT00000016453/ENSBGRG00000008992, exon 3 of 9)",2,11301748,11318286,16539,1]
["chr2",11317241,11317540,300,"ENSBGRG00000008992","ENSBGRT00000016453",15493,"NUDC","nuclear distribution C, dynein complex regulator [Source:HGNC Symbol;Acc:HGNC:8045]","GO:0005737(cytoplasm);GO:0005829(cytosol)","NA",{"v":6.3e-99,"d":"0.00"},1,"300,",0,{"v":-98.2,"d":"-98.20"},{"v":-96.7,"d":"-96.70"},2.78,"3' UTR",2,11301748,11318286,16539,1]
["chr2",11366840,11366990,151,"ENSBGRG00000009143","ENSBGRT00000016780",120,"ENSBGRG00000009143","NA","NA","NA",0.02,1,"151,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000016780/ENSBGRG00000009143, exon 1 of 2)",2,11366720,11367417,698,1]
["chr2",11666980,11669179,2200,"ENSBGRG00000009375","ENSBGRT00000017454",61306,"WDTC1","WD and tetratricopeptide repeats 1 [Source:HGNC Symbol;Acc:HGNC:29175]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001701(in utero embryonic development);GO:0004857(enzyme inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006006(glucose metabolic process);GO:0008361(regulation of cell size);GO:0032869(cellular response to insulin stimulus);GO:0035264(multicellular organism growth);GO:0042393(histone binding);GO:0042826(histone deacetylase binding);GO:0045717(negative regulation of fatty acid biosynthetic process);GO:0055082(cellular chemical homeostasis)","NA",{"v":1e-198,"d":"0.00"},2,"266,601,","0,1599",-198,-196,{"v":20.8,"d":"20.80"},"3' UTR",2,11605674,11667245,61572,1]
["chr2",11697255,11697583,329,"ENSBGRG00000009602","ENSBGRT00000017687",12581,"ENSBGRG00000009602","NA","NA","03040(Spliceosome)",{"v":1.6e-20,"d":"0.00"},1,"329,",0,{"v":-19.8,"d":"-19.80"},{"v":-18.9,"d":"-18.90"},4.62,"3' UTR",2,11684674,11698866,14193,1]
["chr2",11698120,11698866,747,"ENSBGRG00000009602","ENSBGRT00000017687",13446,"ENSBGRG00000009602","NA","NA","03040(Spliceosome)",0,1,"747,",0,-437,"-Inf",9.72,"3' UTR",2,11684674,11698866,14193,1]
["chr2",12059668,12061131,1464,"ENSBGRG00000012076","ENSBGRT00000022553",180,"FAM76A","family with sequence similarity 76 member A [Source:HGNC Symbol;Acc:HGNC:28530]","GO:0005654(nucleoplasm)","04150(mTOR signaling pathway);04115(p53 signaling pathway)",{"v":0.00019,"d":"0.00"},2,"151,29,","0,1435",-3.73,{"v":-3.1,"d":"-3.10"},2.41,"5' UTR",2,12059488,12091300,31813,1]
["chr2",12174518,12182617,8100,"ENSBGRG00000012519","ENSBGRT00000022916",10948,"PPP1R8","protein phosphatase 1 regulatory subunit 8 [Source:HGNC Symbol;Acc:HGNC:9296]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008283(cell population proliferation);GO:0016607(nuclear speck);GO:0019888(protein phosphatase regulator activity)","NA",{"v":9.99999999999998e-212,"d":"0.00"},4,"23,145,65,354,","0,1557,6451,7746",-211,-209,4.32,"Exon (ENSBGRT00000022916/ENSBGRG00000012519, exon 4 of 7)",2,12163570,12182617,19048,1]
["chr2",12236236,12236326,91,"ENSBGRG00000012596","ENSBGRT00000023174",9242,"THEMIS2","thymocyte selection associated family member 2 [Source:HGNC Symbol;Acc:HGNC:16839]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0050852(T cell receptor signaling pathway)","NA",0.02,1,"91,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000023174/ENSBGRG00000012596, exon 4 of 6)",2,12226994,12240040,13047,1]
["chr2",12238574,12239980,1407,"ENSBGRG00000012596","ENSBGRT00000023174",11580,"THEMIS2","thymocyte selection associated family member 2 [Source:HGNC Symbol;Acc:HGNC:16839]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0050852(T cell receptor signaling pathway)","NA",{"v":6.2e-07,"d":"0.00"},2,"800,69,","0,1338",-6.21,-5.49,8.17,"Exon (ENSBGRT00000023174/ENSBGRG00000012596, exon 5 of 6)",2,12226994,12240040,13047,1]
["chr2",12321774,12322012,239,"ENSBGRG00000012884","ENSBGRT00000023818",35323,"SMPDL3B","sphingomyelin phosphodiesterase acid like 3B [Source:HGNC Symbol;Acc:HGNC:21416]","GO:0004767(sphingomyelin phosphodiesterase activity);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0006685(sphingomyelin catabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0008270(zinc ion binding);GO:0016787(hydrolase activity);GO:0034122(negative regulation of toll-like receptor signaling pathway);GO:0046466(membrane lipid catabolic process);GO:0050728(negative regulation of inflammatory response)","NA",{"v":1.2e-07,"d":"0.00"},1,"239,",0,-6.91,-6.18,{"v":26.7,"d":"26.70"},"3' UTR",2,12286451,12322071,35621,1]
["chr2",12328596,12329044,449,"ENSBGRG00000013224","ENSBGRT00000024225",5964,"XKR8","XK related 8 [Source:HGNC Symbol;Acc:HGNC:25508]","GO:0005886(plasma membrane);GO:0016021(integral component of membrane);GO:0043652(engulfment of apoptotic cell);GO:0070782(phosphatidylserine exposure on apoptotic cell surface)","NA",{"v":3.2e-06,"d":"0.00"},1,"449,",0,{"v":-5.5,"d":"-5.50"},{"v":-4.8,"d":"-4.80"},4.13,"3' UTR",2,12322632,12330237,7606,1]
["chr2",12602208,12611995,9788,"ENSBGRG00000013915","ENSBGRT00000025661",0,"ATP5IF1","ATP synthase inhibitory factor subunit 1 [Source:HGNC Symbol;Acc:HGNC:871]","GO:0001937(negative regulation of endothelial cell proliferation);GO:0005739(mitochondrion);GO:0006783(heme biosynthetic process);GO:0009986(cell surface);GO:0019899(enzyme binding);GO:0030218(erythrocyte differentiation);GO:0032780(negative regulation of ATPase activity);GO:0042030(ATPase inhibitor activity);GO:0043532(angiostatin binding);GO:0051117(ATPase binding);GO:0051346(negative regulation of hydrolase activity);GO:0051882(mitochondrial depolarization);GO:0072593(reactive oxygen species metabolic process);GO:0140260(mitochondrial proton-transporting ATP synthase complex binding);GO:1901030(positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway);GO:1903052(positive regulation of proteolysis involved in cellular protein catabolic process);GO:1903214(regulation of protein targeting to mitochondrion);GO:1903578(regulation of ATP metabolic process);GO:1904925(positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization)","NA",0,6,"87,92,34,151,8,47,","0,189,1901,1974,9719,9741",-326,"-Inf",2.13,"Exon (ENSBGRT00000025661/ENSBGRG00000013915, exon 1 of 3)",2,12602208,12604142,1935,1]
["chr2",12635748,12636968,1221,"ENSBGRG00000014010","ENSBGRT00000025896",17277,"SESN2","sestrin 2 [Source:HGNC Symbol;Acc:HGNC:20746]","GO:0001932(regulation of protein phosphorylation);GO:0005092(GDP-dissociation inhibitor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006111(regulation of gluconeogenesis);GO:0006635(fatty acid beta-oxidation);GO:0007005(mitochondrion organization);GO:0009749(response to glucose);GO:0016239(positive regulation of macroautophagy);GO:0016684(oxidoreductase activity, acting on peroxide as acceptor);GO:0030308(negative regulation of cell growth);GO:0030330(DNA damage response, signal transduction by p53 class mediator);GO:0031588(nucleotide-activated protein kinase complex);GO:0031932(TORC2 complex);GO:0032042(mitochondrial DNA metabolic process);GO:0032542(sulfiredoxin activity);GO:0032868(response to insulin);GO:0034198(cellular response to amino acid starvation);GO:0034599(cellular response to oxidative stress);GO:0036091(positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress);GO:0042149(cellular response to glucose starvation);GO:0042593(glucose homeostasis);GO:0043491(protein kinase B signaling);GO:0046323(glucose import);GO:0061700(GATOR2 complex);GO:0070328(triglyceride homeostasis);GO:0070728(leucine binding);GO:0071230(cellular response to amino acid stimulus);GO:0071233(cellular response to leucine);GO:0072593(reactive oxygen species metabolic process);GO:0098869(cellular oxidant detoxification);GO:1900182(positive regulation of protein localization to nucleus);GO:1901031(regulation of response to reactive oxygen species);GO:1902010(negative regulation of translation in response to endoplasmic reticulum stress);GO:1904262(negative regulation of TORC1 signaling);GO:1904504(positive regulation of lipophagy);GO:1990253(cellular response to leucine starvation);GO:1990316(Atg1/ULK1 kinase complex);GO:2000479(regulation of cAMP-dependent protein kinase activity)","04150(mTOR signaling pathway);04115(p53 signaling pathway);04211(Longevity regulating pathway - mammal)",{"v":1E-73,"d":"0.00"},2,"67,560,","0,661",-73,{"v":-71.6,"d":"-71.60"},9.26,"3' UTR",2,12618471,12638249,19779,1]
["chr2",12637951,12638160,210,"ENSBGRG00000014010","ENSBGRT00000025896",19480,"SESN2","sestrin 2 [Source:HGNC Symbol;Acc:HGNC:20746]","GO:0001932(regulation of protein phosphorylation);GO:0005092(GDP-dissociation inhibitor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006111(regulation of gluconeogenesis);GO:0006635(fatty acid beta-oxidation);GO:0007005(mitochondrion organization);GO:0009749(response to glucose);GO:0016239(positive regulation of macroautophagy);GO:0016684(oxidoreductase activity, acting on peroxide as acceptor);GO:0030308(negative regulation of cell growth);GO:0030330(DNA damage response, signal transduction by p53 class mediator);GO:0031588(nucleotide-activated protein kinase complex);GO:0031932(TORC2 complex);GO:0032042(mitochondrial DNA metabolic process);GO:0032542(sulfiredoxin activity);GO:0032868(response to insulin);GO:0034198(cellular response to amino acid starvation);GO:0034599(cellular response to oxidative stress);GO:0036091(positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress);GO:0042149(cellular response to glucose starvation);GO:0042593(glucose homeostasis);GO:0043491(protein kinase B signaling);GO:0046323(glucose import);GO:0061700(GATOR2 complex);GO:0070328(triglyceride homeostasis);GO:0070728(leucine binding);GO:0071230(cellular response to amino acid stimulus);GO:0071233(cellular response to leucine);GO:0072593(reactive oxygen species metabolic process);GO:0098869(cellular oxidant detoxification);GO:1900182(positive regulation of protein localization to nucleus);GO:1901031(regulation of response to reactive oxygen species);GO:1902010(negative regulation of translation in response to endoplasmic reticulum stress);GO:1904262(negative regulation of TORC1 signaling);GO:1904504(positive regulation of lipophagy);GO:1990253(cellular response to leucine starvation);GO:1990316(Atg1/ULK1 kinase complex);GO:2000479(regulation of cAMP-dependent protein kinase activity)","04150(mTOR signaling pathway);04115(p53 signaling pathway);04211(Longevity regulating pathway - mammal)",{"v":2.6e-06,"d":"0.00"},1,"210,",0,-5.59,{"v":-4.9,"d":"-4.90"},{"v":1.9,"d":"1.90"},"3' UTR",2,12618471,12638249,19779,1]
["chr2",12687326,12691565,4240,"ENSBGRG00000014253","ENSBGRT00000026198",29,"MED18","mediator complex subunit 18 [Source:HGNC Symbol;Acc:HGNC:25944]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016592(mediator complex)","NA",{"v":1E-84,"d":"0.00"},2,"115,554,","0,3686",-84,{"v":-82.6,"d":"-82.60"},7.41,"5' UTR",2,12687297,12691565,4269,1]
["chr2",12838195,12847801,9607,"ENSBGRG00000014359","ENSBGRT00000026775",104257,"PHACTR4","phosphatase and actin regulator 4 [Source:HGNC Symbol;Acc:HGNC:25793]","GO:0001755(neural crest cell migration);GO:0001843(neural tube closure);GO:0003779(actin binding);GO:0007266(Rho protein signal transduction);GO:0008157(protein phosphatase 1 binding);GO:0019888(protein phosphatase regulator activity);GO:0030027(lamellipodium);GO:0030036(actin cytoskeleton organization);GO:0043085(positive regulation of catalytic activity);GO:0048484(enteric nervous system development);GO:0051726(regulation of cell cycle);GO:0061386(closure of optic fissure);GO:0072542(protein phosphatase activator activity);GO:2001045(negative regulation of integrin-mediated signaling pathway)","NA",{"v":6.3E-3,"d":"0.01"},2,"82,9,","0,9598",{"v":-2.2,"d":"-2.20"},-1.65,1.18,"Exon (ENSBGRT00000026775/ENSBGRG00000014359, exon 11 of 15)",2,12733938,12850465,116528,1]
["chr2",12896727,12897132,406,"ENSBGRG00000014760","ENSBGRT00000027270",5576,"RCC1","regulator of chromosome condensation 1 [Source:HGNC Symbol;Acc:HGNC:1913]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000785(chromatin);GO:0000790(nuclear chromatin);GO:0000794(condensed nuclear chromosome);GO:0003682(chromatin binding);GO:0005087(Ran guanyl-nucleotide exchange factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0007052(mitotic spindle organization);GO:0007059(chromosome segregation);GO:0007088(regulation of mitotic nuclear division);GO:0008536(Ran GTPase binding);GO:0031491(nucleosome binding);GO:0031492(nucleosomal DNA binding);GO:0031965(nuclear membrane);GO:0032991(protein-containing complex);GO:0042393(histone binding);GO:0043199(sulfate binding);GO:0046982(protein heterodimerization activity);GO:0051225(spindle assembly)","NA",0.02,2,"40,21,","0,385",{"v":-1.7,"d":"-1.70"},-1.19,4.95,"Exon (ENSBGRT00000027270/ENSBGRG00000014760, exon 8 of 10)",2,12891151,12899924,8774,1]
["chr2",12897192,12901000,3809,"ENSBGRG00000014760","ENSBGRT00000027270",6041,"RCC1","regulator of chromosome condensation 1 [Source:HGNC Symbol;Acc:HGNC:1913]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000785(chromatin);GO:0000790(nuclear chromatin);GO:0000794(condensed nuclear chromosome);GO:0003682(chromatin binding);GO:0005087(Ran guanyl-nucleotide exchange factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0007052(mitotic spindle organization);GO:0007059(chromosome segregation);GO:0007088(regulation of mitotic nuclear division);GO:0008536(Ran GTPase binding);GO:0031491(nucleosome binding);GO:0031492(nucleosomal DNA binding);GO:0031965(nuclear membrane);GO:0032991(protein-containing complex);GO:0042393(histone binding);GO:0043199(sulfate binding);GO:0046982(protein heterodimerization activity);GO:0051225(spindle assembly)","NA",{"v":2.5e-26,"d":"0.00"},3,"73,179,47,","0,2554,3762",{"v":-25.6,"d":"-25.60"},{"v":-24.6,"d":"-24.60"},4.16,"3' UTR",2,12891151,12899924,8774,1]
["chr2",12923789,12931126,7338,"ENSBGRG00000014936","ENSBGRT00000027663",18038,"TRNAU1AP","tRNA selenocysteine 1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:30813]","GO:0001514(selenocysteine incorporation);GO:0003676(nucleic acid binding);GO:0005634(nucleus)","NA",{"v":1e-237,"d":"0.00"},3,"98,34,403,","0,300,6935",-237,-235,7.57,"3' UTR",2,12905751,12931126,25376,1]
["chr2",12946350,12946824,475,"ENSBGRG00000015211","ENSBGRT00000027982",3707,"RAB42","RAB42, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:28702]","GO:0003924(GTPase activity);GO:0005525(GTP binding)","NA",{"v":7.9e-07,"d":"0.00"},1,"475,",0,{"v":-6.1,"d":"-6.10"},-5.39,9.57,"3' UTR",2,12942643,12947802,5160,1]
["chr2",12946943,12947091,149,"ENSBGRG00000015211","ENSBGRT00000027982",4300,"RAB42","RAB42, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:28702]","GO:0003924(GTPase activity);GO:0005525(GTP binding)","NA",0.02,1,"149,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"3' UTR",2,12942643,12947802,5160,1]
["chr2",13045169,13045767,599,"ENSBGRG00000015362","ENSBGRT00000028340",31102,"GMEB1","glucocorticoid modulatory element binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4370]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0042802(identical protein binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051008(Hsp27 protein binding);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1E-134,"d":"0.00"},1,"599,",0,-134,-132,6.36,"Exon (ENSBGRT00000028340/ENSBGRG00000015362, exon 9 of 9)",2,13014067,13045767,31701,1]
["chr2",13071793,13073167,1375,"ENSBGRG00000015573","ENSBGRT00000028695",988,"YTHDF2","YTH N6-methyladenosine RNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:31675]","GO:0000932(P-body);GO:0001556(oocyte maturation);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006402(mRNA catabolic process);GO:0034451(centriolar satellite);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0043488(regulation of mRNA stability);GO:0050767(regulation of neurogenesis);GO:0060339(negative regulation of type I interferon-mediated signaling pathway);GO:0061157(mRNA destabilization);GO:0071425(hematopoietic stem cell proliferation);GO:1902036(regulation of hematopoietic stem cell differentiation);GO:1903538(regulation of meiotic cell cycle process involved in oocyte maturation);GO:1903679(positive regulation of cap-independent translational initiation);GO:1990247(N6-methyladenosine-containing RNA binding)","NA",{"v":1e-307,"d":"0.00"},3,"130,15,1111,","0,198,264",-307,-305,{"v":14.9,"d":"14.90"},"Exon (ENSBGRT00000028695/ENSBGRG00000015573, exon 2 of 4)",2,13070805,13073167,2363,1]
["chr2",13310166,13315203,5038,"ENSBGRG00000016000","ENSBGRT00000039943",119,"EPB41","erythrocyte membrane protein band 4.1 [Source:HGNC Symbol;Acc:HGNC:3377]","GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005545(1-phosphatidylinositol binding);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0008022(protein C-terminus binding);GO:0008092(cytoskeletal protein binding);GO:0008360(regulation of cell shape);GO:0016020(membrane);GO:0016323(basolateral plasma membrane);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030863(cortical cytoskeleton);GO:0030866(cortical actin cytoskeleton organization);GO:0032092(positive regulation of protein binding);GO:0032991(protein-containing complex);GO:0045171(intercellular bridge);GO:0047485(protein N-terminus binding);GO:0051219(phosphoprotein binding);GO:0051924(regulation of calcium ion transport);GO:0072686(mitotic spindle);GO:0099738(cell cortex region);GO:1904478(regulation of intestinal absorption);GO:1904778(positive regulation of protein localization to cell cortex)","NA",{"v":5e-23,"d":"0.00"},2,"352,97,","0,4941",{"v":-22.3,"d":"-22.30"},{"v":-21.4,"d":"-21.40"},2.91,"5' UTR",2,13310047,13386697,76651,1]
["chr2",13426333,13426662,330,"ENSBGRG00000016000","ENSBGRT00000038654",116286,"EPB41","erythrocyte membrane protein band 4.1 [Source:HGNC Symbol;Acc:HGNC:3377]","GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005545(1-phosphatidylinositol binding);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0008022(protein C-terminus binding);GO:0008092(cytoskeletal protein binding);GO:0008360(regulation of cell shape);GO:0016020(membrane);GO:0016323(basolateral plasma membrane);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030863(cortical cytoskeleton);GO:0030866(cortical actin cytoskeleton organization);GO:0032092(positive regulation of protein binding);GO:0032991(protein-containing complex);GO:0045171(intercellular bridge);GO:0047485(protein N-terminus binding);GO:0051219(phosphoprotein binding);GO:0051924(regulation of calcium ion transport);GO:0072686(mitotic spindle);GO:0099738(cell cortex region);GO:1904478(regulation of intestinal absorption);GO:1904778(positive regulation of protein localization to cell cortex)","NA",{"v":7.1e-07,"d":"0.00"},1,"330,",0,-6.15,-5.44,4.46,"3' UTR",2,13310047,13427319,117273,1]
["chr2",15814436,15830518,16083,"ENSBGRG00000007511","ENSBGRT00000014094",29567,"ENSBGRG00000007511","NA","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding)","03040(Spliceosome)",0,3,"24,146,305,","0,1996,15778",-334,"-Inf",4.49,"3' UTR",2,15784869,15830236,45368,1]
["chr2",15989708,15989917,210,"ENSBGRG00000008317","ENSBGRT00000015230",0,"TINAGL1","tubulointerstitial nephritis antigen like 1 [Source:HGNC Symbol;Acc:HGNC:19168]","GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity);GO:0043236(laminin binding)","04142(Lysosome);04140(Autophagy - animal);04210(Apoptosis);04621(NOD-like receptor signaling pathway)",{"v":0.00071,"d":"0.00"},1,"210,",0,-3.15,-2.55,{"v":12.9,"d":"12.90"},"5' UTR",2,15989708,16000083,10376,1]
["chr2",16524072,16524252,181,"ENSBGRG00000010825","ENSBGRT00000019888",23172,"KHDRBS1","KH RNA binding domain containing, signal transduction associated 1 [Source:HGNC Symbol;Acc:HGNC:18116]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","NA",{"v":2.5E-15,"d":"0.00"},1,"181,",0,{"v":-14.6,"d":"-14.60"},{"v":-13.7,"d":"-13.70"},1.42,"Exon (ENSBGRT00000019888/ENSBGRG00000010825, exon 6 of 9)",2,16500900,16528007,27108,1]
["chr2",16548736,16551904,3169,"ENSBGRG00000011031","ENSBGRT00000020164",149,"TMEM39B","transmembrane protein 39B [Source:HGNC Symbol;Acc:HGNC:25510]","NA","NA",{"v":0.0025,"d":"0.00"},2,"147,4,","0,3165",{"v":-2.6,"d":"-2.60"},-2.03,3.96,"5' UTR",2,16548587,16573300,24714,1]
["chr2",16570371,16570700,330,"ENSBGRG00000011031","ENSBGRT00000020164",21784,"TMEM39B","transmembrane protein 39B [Source:HGNC Symbol;Acc:HGNC:25510]","NA","NA",{"v":3.2E-91,"d":"0.00"},1,"330,",0,{"v":-90.5,"d":"-90.50"},{"v":-89.1,"d":"-89.10"},{"v":11.4,"d":"11.40"},"3' UTR",2,16548587,16573300,24714,1]
["chr2",16574205,16621175,46971,"ENSBGRG00000011110","ENSBGRT00000020631",0,"KPNA6","karyopherin subunit alpha 6 [Source:HGNC Symbol;Acc:HGNC:6399]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006606(protein import into nucleus);GO:0019079(viral genome replication);GO:0030682(mitigation of host defenses by symbiont);GO:0042025(host cell nucleus);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060135(maternal process involved in female pregnancy);GO:0061608(nuclear import signal receptor activity);GO:0075506(entry of viral genome into host nucleus through nuclear pore complex via importin);GO:1900017(positive regulation of cytokine production involved in inflammatory response);GO:1903902(positive regulation of viral life cycle)","NA",{"v":1.6e-16,"d":"0.00"},3,"4,134,72,","0,45916,46899",{"v":-15.8,"d":"-15.80"},{"v":-14.9,"d":"-14.90"},4.08,"Exon (ENSBGRT00000020631/ENSBGRG00000011110, exon 1 of 14)",2,16574205,16635700,61496,1]
["chr2",16635521,16635700,180,"ENSBGRG00000011110","ENSBGRT00000020631",61316,"KPNA6","karyopherin subunit alpha 6 [Source:HGNC Symbol;Acc:HGNC:6399]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006606(protein import into nucleus);GO:0019079(viral genome replication);GO:0030682(mitigation of host defenses by symbiont);GO:0042025(host cell nucleus);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060135(maternal process involved in female pregnancy);GO:0061608(nuclear import signal receptor activity);GO:0075506(entry of viral genome into host nucleus through nuclear pore complex via importin);GO:1900017(positive regulation of cytokine production involved in inflammatory response);GO:1903902(positive regulation of viral life cycle)","NA",{"v":6.2e-09,"d":"0.00"},1,"180,",0,-8.21,-7.45,1.51,"Exon (ENSBGRT00000020631/ENSBGRG00000011110, exon 14 of 14)",2,16574205,16635700,61496,1]
["chr2",16647336,16648427,1092,"ENSBGRG00000011469","ENSBGRT00000020916",0,"TXLNA","taxilin alpha [Source:HGNC Symbol;Acc:HGNC:30685]","GO:0005737(cytoplasm);GO:0019905(syntaxin binding);GO:0042113(B cell activation)","NA",{"v":1.3E-22,"d":"0.00"},2,"210,27,","0,1065",{"v":-21.9,"d":"-21.90"},{"v":-20.9,"d":"-20.90"},2.71,"5' UTR",2,16647336,16658711,11376,1]
["chr2",16656321,16658711,2391,"ENSBGRG00000011469","ENSBGRT00000020916",8985,"TXLNA","taxilin alpha [Source:HGNC Symbol;Acc:HGNC:30685]","GO:0005737(cytoplasm);GO:0019905(syntaxin binding);GO:0042113(B cell activation)","NA",{"v":1e-286,"d":"0.00"},6,"34,75,93,96,168,126,","0,291,878,1269,2064,2265",-286,-284,4.67,"Exon (ENSBGRT00000020916/ENSBGRG00000011469, exon 6 of 11)",2,16647336,16658711,11376,1]
["chr2",16668854,16668913,60,"ENSBGRG00000011550","ENSBGRT00000021085",2678,"CCDC28B","coiled-coil domain containing 28B [Source:HGNC Symbol;Acc:HGNC:28163]","GO:0005813(centrosome);GO:0060271(cilium assembly)","03013(RNA transport)",{"v":0.00015,"d":"0.00"},1,"60,",0,-3.81,-3.17,1.34,"Exon (ENSBGRT00000021085/ENSBGRG00000011550, exon 3 of 4)",2,16666176,16669372,3197,1]
["chr2",16669128,16670158,1031,"ENSBGRG00000011550","ENSBGRT00000021085",2952,"CCDC28B","coiled-coil domain containing 28B [Source:HGNC Symbol;Acc:HGNC:28163]","GO:0005813(centrosome);GO:0060271(cilium assembly)","03013(RNA transport)",{"v":3.2e-99,"d":"0.00"},3,"245,23,55,","0,379,976",{"v":-98.5,"d":"-98.50"},-97,3.82,"Exon (ENSBGRT00000021085/ENSBGRG00000011550, exon 4 of 4)",2,16666176,16669372,3197,1]
["chr2",16670590,16671218,629,"ENSBGRG00000011655","ENSBGRT00000021216",0,"IQCC","IQ motif containing C [Source:HGNC Symbol;Acc:HGNC:25545]","GO:0005515(protein binding)","NA",{"v":5.8E-4,"d":"0.00"},2,"42,19,","0,610",-3.24,-2.63,1.89,"Exon (ENSBGRT00000021216/ENSBGRG00000011655, exon 1 of 5)",2,16670590,16673114,2525,1]
["chr2",16671337,16671636,300,"ENSBGRG00000011655","ENSBGRT00000021216",747,"IQCC","IQ motif containing C [Source:HGNC Symbol;Acc:HGNC:25545]","GO:0005515(protein binding)","NA",{"v":0.00059,"d":"0.00"},2,"7,84,","0,216",-3.23,-2.62,1.31,"Exon (ENSBGRT00000021216/ENSBGRG00000011655, exon 2 of 5)",2,16670590,16673114,2525,1]
["chr2",16672067,16673114,1048,"ENSBGRG00000011655","ENSBGRT00000021216",1477,"IQCC","IQ motif containing C [Source:HGNC Symbol;Acc:HGNC:25545]","GO:0005515(protein binding)","NA",{"v":1E-168,"d":"0.00"},2,"91,837,","0,211",-168,-166,4.53,"Exon (ENSBGRT00000021216/ENSBGRG00000011655, exon 4 of 5)",2,16670590,16673114,2525,1]
["chr2",16680042,16680131,90,"ENSBGRG00000011717","ENSBGRT00000021441",6252,"DCDC2B","doublecortin domain containing 2B [Source:HGNC Symbol;Acc:HGNC:32576]","GO:0035556(intracellular signal transduction)","NA",{"v":3.2e-08,"d":"0.00"},1,"90,",0,-7.49,-6.75,3.04,"Exon (ENSBGRT00000021441/ENSBGRG00000011717, exon 7 of 7)",2,16673790,16680131,6342,1]
["chr2",16694940,16695186,247,"ENSBGRG00000011926","ENSBGRT00000022021",8517,"EIF3I","eukaryotic translation initiation factor 3 subunit I [Source:HGNC Symbol;Acc:HGNC:3272]","GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005852(eukaryotic translation initiation factor 3 complex);GO:0006413(translational initiation);GO:0071541(eukaryotic translation initiation factor 3 complex, eIF3m)","03013(RNA transport)",{"v":5e-21,"d":"0.00"},2,"38,82,","0,165",{"v":-20.3,"d":"-20.30"},{"v":-19.3,"d":"-19.30"},1.37,"Exon (ENSBGRT00000022021/ENSBGRG00000011926, exon 9 of 10)",2,16686423,16695186,8764,1]
["chr2",16775094,16775214,121,"ENSBGRG00000012575","ENSBGRT00000023223",33426,"HDAC1","histone deacetylase 1 [Source:HGNC Symbol;Acc:HGNC:4852]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000785(chromatin);GO:0000790(nuclear chromatin);GO:0000792(heterochromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0001046(core promoter sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0002039(p53 binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003714(transcription corepressor activity);GO:0004407(histone deacetylase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005829(cytosol);GO:0006346(methylation-dependent chromatin silencing);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006476(protein deacetylation);GO:0007492(endoderm development);GO:0007623(circadian rhythm);GO:0008134(transcription factor binding);GO:0008284(positive regulation of cell population proliferation);GO:0009913(epidermal cell differentiation);GO:0010629(negative regulation of gene expression);GO:0010870(positive regulation of receptor biosynthetic process);GO:0016575(histone deacetylation);GO:0016580(Sin3 complex);GO:0016581(NuRD complex);GO:0017053(transcriptional repressor complex);GO:0019213(deacetylase activity);GO:0019899(enzyme binding);GO:0021766(hippocampus development);GO:0030182(neuron differentiation);GO:0032922(circadian regulation of gene expression);GO:0032991(protein-containing complex);GO:0033558(protein deacetylase activity);GO:0033613(activating transcription factor binding);GO:0035851(Krueppel-associated box domain binding);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042733(embryonic digit morphogenesis);GO:0042826(histone deacetylase binding);GO:0043025(neuronal cell body);GO:0043066(negative regulation of apoptotic process);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043922(negative regulation by host of viral transcription);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0047485(protein N-terminus binding);GO:0048714(positive regulation of oligodendrocyte differentiation);GO:0051059(NF-kappaB binding);GO:0052548(regulation of endopeptidase activity);GO:0060766(negative regulation of androgen receptor signaling pathway);GO:0060789(hair follicle placode formation);GO:0061029(eyelid development in camera-type eye);GO:0061198(fungiform papilla formation);GO:0070491(repressing transcription factor binding);GO:0070888(E-box binding);GO:0070932(histone H3 deacetylation);GO:0070933(histone H4 deacetylation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:1990841(promoter-specific chromatin binding);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04330(Notch signaling pathway);04110(Cell cycle);04919(Thyroid hormone signaling pathway);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05203(Viral carcinogenesis);05220(Chronic myeloid leukemia);05016(Huntington disease);05034(Alcoholism);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection)",{"v":2.8e-08,"d":"0.00"},1,"121,",0,-7.56,-6.82,1.31,"Exon (ENSBGRT00000023223/ENSBGRG00000012575, exon 12 of 12)",2,16741668,16776560,34893,1]
["chr2",16807927,16808106,180,"ENSBGRG00000012978","ENSBGRT00000023708",950,"TSSK3","testis specific serine kinase 3 [Source:HGNC Symbol;Acc:HGNC:15473]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007283(spermatogenesis)","NA",{"v":3.9e-06,"d":"0.00"},1,"180,",0,-5.41,-4.72,3.08,"Exon (ENSBGRT00000023708/ENSBGRG00000012978, exon 2 of 2)",2,16806977,16808494,1518,1]
["chr2",16892443,16892801,359,"ENSBGRG00000013452","ENSBGRT00000024686",16330,"ENSBGRG00000013452","NA","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","NA",{"v":1.7E-6,"d":"0.00"},1,"359,",0,-5.78,-5.08,{"v":22.8,"d":"22.80"},"3' UTR",2,16876113,16893725,17613,1]
["chr2",16975342,17008178,32837,"ENSBGRG00000013499","ENSBGRT00000024773",0,"ZBTB8A","zinc finger and BTB domain containing 8A [Source:HGNC Symbol;Acc:HGNC:24172]","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","NA",{"v":7.1e-07,"d":"0.00"},2,"101,822,","0,32015",-6.15,-5.44,4.95,"5' UTR",2,16975342,17016616,41275,1]
["chr2",17016289,17016616,328,"ENSBGRG00000013499","ENSBGRT00000024773",40947,"ZBTB8A","zinc finger and BTB domain containing 8A [Source:HGNC Symbol;Acc:HGNC:24172]","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","NA",{"v":4e-15,"d":"0.00"},1,"328,",0,{"v":-14.4,"d":"-14.40"},{"v":-13.5,"d":"-13.50"},4.28,"Exon (ENSBGRT00000024773/ENSBGRG00000013499, exon 4 of 4)",2,16975342,17016616,41275,1]
["chr2",17174561,17175787,1227,"ENSBGRG00000014294","ENSBGRT00000026257",7055,"ENSBGRG00000014294","NA","NA","NA",{"v":1E-125,"d":"0.00"},2,"654,87,","0,1140",-125,-124,5.63,"Exon (ENSBGRT00000026257/ENSBGRG00000014294, exon 5 of 6)",2,17167506,17175662,8157,1]
["chr2",17217707,17226628,8922,"ENSBGRG00000014391","ENSBGRT00000026442",0,"YARS1","tyrosyl-tRNA synthetase 1 [Source:HGNC Symbol;Acc:HGNC:12840]","GO:0000049(tRNA binding);GO:0000166(nucleotide binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004831(tyrosine-tRNA ligase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006418(tRNA aminoacylation for protein translation);GO:0006437(tyrosyl-tRNA aminoacylation);GO:0016604(nuclear body)","00970(Aminoacyl-tRNA biosynthesis)",{"v":1E-100,"d":"0.00"},3,"32,117,709,","0,7381,8213",-100,{"v":-98.6,"d":"-98.60"},3.37,"5' UTR",2,17179541,17217708,38168,2]
["chr2",17521797,17521983,187,"ENSBGRG00000016701","ENSBGRT00000030692",39584,"AZIN2","antizyme inhibitor 2 [Source:HGNC Symbol;Acc:HGNC:29957]","GO:0003824(catalytic activity);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005801(cis-Golgi network);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0006591(ornithine metabolic process);GO:0006596(polyamine biosynthetic process);GO:0030133(transport vesicle);GO:0030424(axon);GO:0030425(dendrite);GO:0031410(cytoplasmic vesicle);GO:0033116(endoplasmic reticulum-Golgi intermediate compartment membrane);GO:0042177(negative regulation of protein catabolic process);GO:0042978(ornithine decarboxylase activator activity);GO:0043085(positive regulation of catalytic activity);GO:0043204(perikaryon);GO:0048471(perinuclear region of cytoplasm);GO:0098629(trans-Golgi network membrane organization);GO:1902269(positive regulation of polyamine transmembrane transport);GO:1990005(granular vesicle)","00330(Arginine and proline metabolism)",{"v":0.0017,"d":"0.00"},2,"15,105,","0,82",-2.78,-2.19,2.33,"Exon (ENSBGRT00000030692/ENSBGRG00000016701, exon 11 of 12)",2,17482213,17521983,39771,1]
["chr2",17696129,17696425,297,"ENSBGRG00000016893","ENSBGRT00000031124",27974,"ZNF362","zinc finger protein 362 [Source:HGNC Symbol;Acc:HGNC:18079]","GO:0003676(nucleic acid binding)","NA",{"v":2e-68,"d":"0.00"},1,"297,",0,{"v":-67.7,"d":"-67.70"},{"v":-66.4,"d":"-66.40"},{"v":3.6,"d":"3.60"},"3' UTR",2,17668155,17696425,28271,1]
["chr2",18811103,18811283,181,"ENSBGRG00000020792","ENSBGRT00000038420",74246,"PDE6D","phosphodiesterase 6D [Source:HGNC Symbol;Acc:HGNC:8788]","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0005095(GTPase inhibitor activity);GO:0005829(cytosol);GO:0017137(Rab GTPase binding);GO:0031410(cytoplasmic vesicle);GO:0050953(sensory perception of light stimulus)","00230(Purine metabolism)",{"v":0.00056,"d":"0.00"},1,"181,",0,-3.25,-2.64,1.46,"3' UTR",2,18736857,18813531,76675,1]
["chr2",18811583,18811853,271,"ENSBGRG00000020792","ENSBGRT00000038420",74726,"PDE6D","phosphodiesterase 6D [Source:HGNC Symbol;Acc:HGNC:8788]","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0005095(GTPase inhibitor activity);GO:0005829(cytosol);GO:0017137(Rab GTPase binding);GO:0031410(cytoplasmic vesicle);GO:0050953(sensory perception of light stimulus)","00230(Purine metabolism)",{"v":3.3E-3,"d":"0.00"},1,"271,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"3' UTR",2,18736857,18813531,76675,1]
["chr2",18812932,18813231,300,"ENSBGRG00000020792","ENSBGRT00000038420",76075,"PDE6D","phosphodiesterase 6D [Source:HGNC Symbol;Acc:HGNC:8788]","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0005095(GTPase inhibitor activity);GO:0005829(cytosol);GO:0017137(Rab GTPase binding);GO:0031410(cytoplasmic vesicle);GO:0050953(sensory perception of light stimulus)","00230(Purine metabolism)",{"v":3.3E-4,"d":"0.00"},1,"300,",0,-3.48,-2.86,4.62,"3' UTR",2,18736857,18813531,76675,1]
["chr2",18813291,18813531,241,"ENSBGRG00000020792","ENSBGRT00000038420",76434,"PDE6D","phosphodiesterase 6D [Source:HGNC Symbol;Acc:HGNC:8788]","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0005095(GTPase inhibitor activity);GO:0005829(cytosol);GO:0017137(Rab GTPase binding);GO:0031410(cytoplasmic vesicle);GO:0050953(sensory perception of light stimulus)","00230(Purine metabolism)",{"v":1.1E-5,"d":"0.00"},1,"241,",0,-4.97,{"v":-4.3,"d":"-4.30"},3.54,"3' UTR",2,18736857,18813531,76675,1]
["chr2",18990455,18990573,119,"ENSBGRG00000021016","ENSBGRT00000038766",9565,"NMUR1","neuromedin U receptor 1 [Source:HGNC Symbol;Acc:HGNC:4518]","GO:0001607(neuromedin U receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0006816(calcium ion transport);GO:0006821(chloride transport);GO:0006939(smooth muscle contraction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007200(phospholipase C-activating G protein-coupled receptor signaling pathway);GO:0007202(activation of phospholipase C activity);GO:0007218(neuropeptide signaling pathway);GO:0008188(neuropeptide receptor activity);GO:0016021(integral component of membrane);GO:0019722(calcium-mediated signaling);GO:0042924(neuromedin U binding);GO:0048016(inositol phosphate-mediated signaling)","04080(Neuroactive ligand-receptor interaction)",0.02,1,"119,",0,{"v":-1.7,"d":"-1.70"},-1.19,7.92,"Exon (ENSBGRT00000038766/ENSBGRG00000021016, exon 3 of 3)",2,18980890,18990573,9684,1]
["chr2",19052037,19054202,2166,"ENSBGRG00000021225","ENSBGRT00000039156",0,"SNORD82","Small nucleolar RNA SNORD82 [Source:RFAM;Acc:RF00158]","NA","NA",0,6,"288,101,29,216,87,110,","0,947,1066,1471,1786,2056",-2310,"-Inf",3.88,"Exon (ENSBGRT00000039057/ENSBGRG00000021053, exon 3 of 16)",2,19053950,19054019,70,1]
["chr2",19058253,19059111,859,"ENSBGRG00000021242","ENSBGRT00000039183",0,"SNORA75","Small nucleolar RNA SNORA75 [Source:RFAM;Acc:RF00072]","NA","NA",0,3,"85,224,77,","0,390,782",-849,"-Inf",4.31,"Exon (ENSBGRT00000039057/ENSBGRG00000021053, exon 14 of 16)",2,19058374,19058507,134,1]
["chr2",19435780,19436200,421,"ENSBGRG00000022636","ENSBGRT00000042287",47254,"PSMD1","proteasome 26S subunit, non-ATPase 1 [Source:HGNC Symbol;Acc:HGNC:9554]","GO:0000502(proteasome complex);GO:0022624(proteasome accessory complex);GO:0030234(enzyme regulator activity);GO:0031625(ubiquitin protein ligase binding);GO:0042176(regulation of protein catabolic process)","03050(Proteasome);05169(Epstein-Barr virus infection)",{"v":0.00052,"d":"0.00"},1,"421,",0,-3.28,-2.68,{"v":13.9,"d":"13.90"},"5' UTR",2,19391883,19483454,91572,2]
["chr2",19449188,19449428,241,"ENSBGRG00000022636","ENSBGRT00000042287",34026,"PSMD1","proteasome 26S subunit, non-ATPase 1 [Source:HGNC Symbol;Acc:HGNC:9554]","GO:0000502(proteasome complex);GO:0022624(proteasome accessory complex);GO:0030234(enzyme regulator activity);GO:0031625(ubiquitin protein ligase binding);GO:0042176(regulation of protein catabolic process)","03050(Proteasome);05169(Epstein-Barr virus infection)",{"v":1.4E-5,"d":"0.00"},1,"241,",0,-4.84,-4.17,5.12,"Exon (ENSBGRT00000042454/ENSBGRG00000022997, exon 3 of 3)",2,19391883,19483454,91572,2]
["chr2",19449668,19449848,181,"ENSBGRG00000022636","ENSBGRT00000042287",33606,"PSMD1","proteasome 26S subunit, non-ATPase 1 [Source:HGNC Symbol;Acc:HGNC:9554]","GO:0000502(proteasome complex);GO:0022624(proteasome accessory complex);GO:0030234(enzyme regulator activity);GO:0031625(ubiquitin protein ligase binding);GO:0042176(regulation of protein catabolic process)","03050(Proteasome);05169(Epstein-Barr virus infection)",{"v":2.6e-06,"d":"0.00"},1,"181,",0,-5.58,-4.89,{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000042454/ENSBGRG00000022997, exon 3 of 3)",2,19391883,19483454,91572,2]
["chr2",20193090,20202927,9838,"ENSBGRG00000008249","ENSBGRT00000015508",16426,"ENSBGRG00000008249","NA","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus)","05203(Viral carcinogenesis);05168(Herpes simplex infection)",{"v":1.3E-24,"d":"0.00"},4,"1,78,129,121,","0,4193,7313,9717",{"v":-23.9,"d":"-23.90"},{"v":-22.9,"d":"-22.90"},3.06,"Exon (ENSBGRT00000015508/ENSBGRG00000008249, exon 4 of 14)",2,20176664,20223862,47199,1]
["chr2",20223226,20223315,90,"ENSBGRG00000008249","ENSBGRT00000015508",46562,"ENSBGRG00000008249","NA","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus)","05203(Viral carcinogenesis);05168(Herpes simplex infection)",{"v":6.6E-3,"d":"0.01"},1,"90,",0,-2.18,-1.64,1.55,"3' UTR",2,20176664,20223862,47199,1]
["chr2",20327238,20327417,180,"ENSBGRG00000008685","ENSBGRT00000015822",12224,"SLC16A14","solute carrier family 16 member 14 [Source:HGNC Symbol;Acc:HGNC:26417]","GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",0.02,1,"180,",0,{"v":-1.7,"d":"-1.70"},-1.19,4.95,"5' UTR",2,20315014,20353842,38829,1]
["chr2",20340991,20341556,566,"ENSBGRG00000008685","ENSBGRT00000015822",25977,"SLC16A14","solute carrier family 16 member 14 [Source:HGNC Symbol;Acc:HGNC:26417]","GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":1.3e-21,"d":"0.00"},1,"566,",0,{"v":-20.9,"d":"-20.90"},{"v":-19.9,"d":"-19.90"},7.46,"Exon (ENSBGRT00000015822/ENSBGRG00000008685, exon 5 of 6)",2,20315014,20353842,38829,1]
["chr2",20551342,20551791,450,"ENSBGRG00000008829","ENSBGRT00000016758",43501,"TRIP12","thyroid hormone receptor interactor 12 [Source:HGNC Symbol;Acc:HGNC:12306]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005654(nucleoplasm);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008270(zinc ion binding);GO:0016607(nuclear speck);GO:0045995(regulation of embryonic development);GO:0046966(thyroid hormone receptor binding);GO:0061630(ubiquitin protein ligase activity);GO:1901315(negative regulation of histone H2A K63-linked ubiquitination);GO:2000780(negative regulation of double-strand break repair)","04120(Ubiquitin mediated proteolysis)",{"v":7.9e-95,"d":"0.00"},1,"450,",0,{"v":-94.1,"d":"-94.10"},{"v":-92.6,"d":"-92.60"},4.57,"Exon (ENSBGRT00000016758/ENSBGRG00000008829, exon 4 of 43)",2,20507841,20653726,145886,1]
["chr2",20551851,20552031,181,"ENSBGRG00000008829","ENSBGRT00000016758",44010,"TRIP12","thyroid hormone receptor interactor 12 [Source:HGNC Symbol;Acc:HGNC:12306]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005654(nucleoplasm);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008270(zinc ion binding);GO:0016607(nuclear speck);GO:0045995(regulation of embryonic development);GO:0046966(thyroid hormone receptor binding);GO:0061630(ubiquitin protein ligase activity);GO:1901315(negative regulation of histone H2A K63-linked ubiquitination);GO:2000780(negative regulation of double-strand break repair)","04120(Ubiquitin mediated proteolysis)",{"v":4e-16,"d":"0.00"},1,"181,",0,{"v":-15.4,"d":"-15.40"},{"v":-14.5,"d":"-14.50"},2.04,"Exon (ENSBGRT00000016758/ENSBGRG00000008829, exon 4 of 43)",2,20507841,20653726,145886,1]
["chr2",20651689,20653726,2038,"ENSBGRG00000008829","ENSBGRT00000016758",143848,"TRIP12","thyroid hormone receptor interactor 12 [Source:HGNC Symbol;Acc:HGNC:12306]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005654(nucleoplasm);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008270(zinc ion binding);GO:0016607(nuclear speck);GO:0045995(regulation of embryonic development);GO:0046966(thyroid hormone receptor binding);GO:0061630(ubiquitin protein ligase activity);GO:1901315(negative regulation of histone H2A K63-linked ubiquitination);GO:2000780(negative regulation of double-strand break repair)","04120(Ubiquitin mediated proteolysis)",{"v":1e-158,"d":"0.00"},3,"37,104,549,","0,485,1489",-158,-156,2.81,"3' UTR",2,20507841,20653726,145886,1]
["chr2",21539209,21539472,264,"ENSBGRG00000009672","ENSBGRT00000017766",290828,"PID1","phosphotyrosine interaction domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26084]","GO:0001933(negative regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0010628(positive regulation of gene expression);GO:0042127(regulation of cell population proliferation);GO:0044320(cellular response to leptin stimulus);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046325(negative regulation of glucose import);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0051881(regulation of mitochondrial membrane potential);GO:0070346(positive regulation of fat cell proliferation);GO:0070584(mitochondrion morphogenesis);GO:0071345(cellular response to cytokine stimulus);GO:0071354(cellular response to interleukin-6);GO:0071356(cellular response to tumor necrosis factor);GO:0071398(cellular response to fatty acid);GO:1903077(negative regulation of protein localization to plasma membrane);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000379(positive regulation of reactive oxygen species metabolic process);GO:2001170(negative regulation of ATP biosynthetic process);GO:2001171(positive regulation of ATP biosynthetic process)","NA",{"v":1e-199,"d":"0.00"},1,"264,",0,-199,-197,5.97,"3' UTR",2,21248381,21539472,291092,1]
["chr2",22514765,22515095,331,"ENSBGRG00000009780","ENSBGRT00000018002",167176,"SPHKAP","SPHK1 interactor, AKAP domain containing [Source:HGNC Symbol;Acc:HGNC:30619]","GO:0051018(protein kinase A binding)","NA",{"v":0.004,"d":"0.00"},1,"331,",0,{"v":-2.4,"d":"-2.40"},-1.84,4.95,"Exon (ENSBGRT00000018002/ENSBGRG00000009780, exon 8 of 13)",2,22347589,22552581,204993,1]
["chr2",22515933,22517340,1408,"ENSBGRG00000009780","ENSBGRT00000018002",168344,"SPHKAP","SPHK1 interactor, AKAP domain containing [Source:HGNC Symbol;Acc:HGNC:30619]","GO:0051018(protein kinase A binding)","NA",{"v":2.8E-5,"d":"0.00"},1,"1408,",0,-4.56,{"v":-3.9,"d":"-3.90"},{"v":17.8,"d":"17.80"},"Exon (ENSBGRT00000018002/ENSBGRG00000009780, exon 8 of 13)",2,22347589,22552581,204993,1]
["chr2",22517400,22517490,91,"ENSBGRG00000009780","ENSBGRT00000018002",169811,"SPHKAP","SPHK1 interactor, AKAP domain containing [Source:HGNC Symbol;Acc:HGNC:30619]","GO:0051018(protein kinase A binding)","NA",{"v":1.8E-3,"d":"0.00"},1,"91,",0,-2.75,-2.17,2.44,"Exon (ENSBGRT00000018002/ENSBGRG00000009780, exon 8 of 13)",2,22347589,22552581,204993,1]
["chr2",22836903,22837293,391,"ENSBGRG00000010183","ENSBGRT00000018690",4155,"ENSBGRG00000010183","solute carrier family 19 member 3 [Source:HGNC Symbol;Acc:HGNC:16266]","GO:0016021(integral component of membrane);GO:0051180(vitamin transport);GO:0090482(vitamin transmembrane transporter activity)","04977(Vitamin digestion and absorption)",{"v":0.00068,"d":"0.00"},1,"391,",0,-3.17,-2.57,2.81,"Exon (ENSBGRT00000018690/ENSBGRG00000010183, exon 2 of 5)",2,22832748,22842587,9840,1]
["chr2",22841718,22842167,450,"ENSBGRG00000010183","ENSBGRT00000018690",8970,"ENSBGRG00000010183","solute carrier family 19 member 3 [Source:HGNC Symbol;Acc:HGNC:16266]","GO:0016021(integral component of membrane);GO:0051180(vitamin transport);GO:0090482(vitamin transmembrane transporter activity)","04977(Vitamin digestion and absorption)",{"v":4e-17,"d":"0.00"},1,"450,",0,{"v":-16.4,"d":"-16.40"},{"v":-15.5,"d":"-15.50"},3.75,"3' UTR",2,22832748,22842587,9840,1]
["chr2",23489182,23489242,61,"ENSBGRG00000012460","ENSBGRT00000023562",81561,"COL4A4","collagen type IV alpha 4 chain [Source:HGNC Symbol;Acc:HGNC:2206]","GO:0005201(extracellular matrix structural constituent);GO:0005581(collagen trimer);GO:0005587(collagen type IV trimer);GO:0005604(basement membrane);GO:0032836(glomerular basement membrane development)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04926(Relaxin signaling pathway);04974(Protein digestion and absorption);05200(Pathways in cancer);05222(Small cell lung cancer);04933(AGE-RAGE signaling pathway in diabetic complications);05165(Human papillomavirus infection);05146(Amoebiasis)",{"v":0.019,"d":"0.02"},1,"61,",0,-1.72,-1.21,4.95,"Exon (ENSBGRT00000023562/ENSBGRG00000012460, exon 25 of 48)",2,23407621,23557635,150015,1]
["chr2",23556295,23557635,1341,"ENSBGRG00000012460","ENSBGRT00000023562",148674,"COL4A4","collagen type IV alpha 4 chain [Source:HGNC Symbol;Acc:HGNC:2206]","GO:0005201(extracellular matrix structural constituent);GO:0005581(collagen trimer);GO:0005587(collagen type IV trimer);GO:0005604(basement membrane);GO:0032836(glomerular basement membrane development)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04926(Relaxin signaling pathway);04974(Protein digestion and absorption);05200(Pathways in cancer);05222(Small cell lung cancer);04933(AGE-RAGE signaling pathway in diabetic complications);05165(Human papillomavirus infection);05146(Amoebiasis)",{"v":0,"d":"0.00"},2,"6,264,","0,1077",-308,-305,3.23,"3' UTR",2,23407621,23557635,150015,1]
["chr2",23757667,23758446,780,"ENSBGRG00000013185","ENSBGRT00000024094",0,"IRS1","insulin receptor substrate 1 [Source:HGNC Symbol;Acc:HGNC:6125]","GO:0001784(phosphotyrosine residue binding);GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0008286(insulin receptor signaling pathway);GO:0010907(positive regulation of glucose metabolic process);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0030159(receptor signaling complex adaptor activity);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0032868(response to insulin);GO:0032869(cellular response to insulin stimulus);GO:0043548(phosphatidylinositol 3-kinase binding);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0046326(positive regulation of glucose import);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0046676(negative regulation of insulin secretion);GO:0048009(insulin-like growth factor receptor signaling pathway)","04068(FoxO signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04960(Aldosterone-regulated sodium reabsorption);04722(Neurotrophin signaling pathway);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05206(MicroRNAs in cancer);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance)",{"v":1E-61,"d":"0.00"},1,"780,",0,-61,{"v":-59.7,"d":"-59.70"},11,"Exon (ENSBGRT00000024094/ENSBGRG00000013185, exon 1 of 1)",2,23757667,23761380,3714,1]
["chr2",23759374,23761380,2007,"ENSBGRG00000013185","ENSBGRT00000024094",1707,"IRS1","insulin receptor substrate 1 [Source:HGNC Symbol;Acc:HGNC:6125]","GO:0001784(phosphotyrosine residue binding);GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0008286(insulin receptor signaling pathway);GO:0010907(positive regulation of glucose metabolic process);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0030159(receptor signaling complex adaptor activity);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0032868(response to insulin);GO:0032869(cellular response to insulin stimulus);GO:0043548(phosphatidylinositol 3-kinase binding);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0046326(positive regulation of glucose import);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0046676(negative regulation of insulin secretion);GO:0048009(insulin-like growth factor receptor signaling pathway)","04068(FoxO signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04960(Aldosterone-regulated sodium reabsorption);04722(Neurotrophin signaling pathway);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05206(MicroRNAs in cancer);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance)",{"v":1e-148,"d":"0.00"},1,"2007,",0,-148,-146,6.95,"Exon (ENSBGRT00000024094/ENSBGRG00000013185, exon 1 of 1)",2,23757667,23761380,3714,1]
["chr2",26377376,26381357,3982,"ENSBGRG00000015353","ENSBGRT00000028229",111458,"CUL3","cullin 3 [Source:HGNC Symbol;Acc:HGNC:2553]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000209(protein polyubiquitination);GO:0000278(mitotic cell cycle);GO:0000902(cell morphogenesis);GO:0000922(spindle pole);GO:0001701(in utero embryonic development);GO:0001831(trophectodermal cellular morphogenesis);GO:0004842(ubiquitin-protein transferase activity);GO:0005112(Notch binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005827(polar microtubule);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006513(protein monoubiquitination);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007080(mitotic metaphase plate congression);GO:0007229(integrin-mediated signaling pathway);GO:0007369(gastrulation);GO:0016055(Wnt signaling pathway);GO:0016477(cell migration);GO:0016567(protein ubiquitination);GO:0017145(stem cell division);GO:0030332(cyclin binding);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0031208(POZ domain binding);GO:0031398(positive regulation of protein ubiquitination);GO:0031461(cullin-RING ubiquitin ligase complex);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0031625(ubiquitin protein ligase binding);GO:0031648(protein destabilization);GO:0032467(positive regulation of cytokinesis);GO:0035024(negative regulation of Rho protein signal transduction);GO:0036126(sperm flagellum);GO:0040016(embryonic cleavage);GO:0043149(stress fiber assembly);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0044346(fibroblast apoptotic process);GO:0045842(positive regulation of mitotic metaphase/anaphase transition);GO:0048208(COPII vesicle coating);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0071630(nuclear protein quality control by the ubiquitin-proteasome system);GO:0072576(liver morphogenesis);GO:0072686(mitotic spindle);GO:1901992(positive regulation of mitotic cell cycle phase transition)","04120(Ubiquitin mediated proteolysis);04340(Hedgehog signaling pathway)",{"v":5e-22,"d":"0.00"},2,"48,192,","0,3790",{"v":-21.3,"d":"-21.30"},{"v":-20.3,"d":"-20.30"},2.73,"Exon (ENSBGRT00000028229/ENSBGRG00000015353, exon 14 of 15)",2,26265918,26381464,115547,1]
["chr2",26383528,26383647,120,"ENSBGRG00000015353","ENSBGRT00000028184",117610,"CUL3","cullin 3 [Source:HGNC Symbol;Acc:HGNC:2553]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000209(protein polyubiquitination);GO:0000278(mitotic cell cycle);GO:0000902(cell morphogenesis);GO:0000922(spindle pole);GO:0001701(in utero embryonic development);GO:0001831(trophectodermal cellular morphogenesis);GO:0004842(ubiquitin-protein transferase activity);GO:0005112(Notch binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005827(polar microtubule);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006513(protein monoubiquitination);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007080(mitotic metaphase plate congression);GO:0007229(integrin-mediated signaling pathway);GO:0007369(gastrulation);GO:0016055(Wnt signaling pathway);GO:0016477(cell migration);GO:0016567(protein ubiquitination);GO:0017145(stem cell division);GO:0030332(cyclin binding);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0031208(POZ domain binding);GO:0031398(positive regulation of protein ubiquitination);GO:0031461(cullin-RING ubiquitin ligase complex);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0031625(ubiquitin protein ligase binding);GO:0031648(protein destabilization);GO:0032467(positive regulation of cytokinesis);GO:0035024(negative regulation of Rho protein signal transduction);GO:0036126(sperm flagellum);GO:0040016(embryonic cleavage);GO:0043149(stress fiber assembly);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0044346(fibroblast apoptotic process);GO:0045842(positive regulation of mitotic metaphase/anaphase transition);GO:0048208(COPII vesicle coating);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0071630(nuclear protein quality control by the ubiquitin-proteasome system);GO:0072576(liver morphogenesis);GO:0072686(mitotic spindle);GO:1901992(positive regulation of mitotic cell cycle phase transition)","04120(Ubiquitin mediated proteolysis);04340(Hedgehog signaling pathway)",{"v":7.9e-37,"d":"0.00"},1,"120,",0,{"v":-36.1,"d":"-36.10"},-35,4.95,"3' UTR",2,26265918,26383647,117730,1]
["chr2",26479628,26479924,297,"ENSBGRG00000015631","ENSBGRT00000028720",16094,"FAM124B","family with sequence similarity 124 member B [Source:HGNC Symbol;Acc:HGNC:26224]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","NA",{"v":0.0013,"d":"0.00"},2,"23,187,","0,110",-2.87,-2.28,4.16,"Exon (ENSBGRT00000028720/ENSBGRG00000015631, exon 2 of 4)",2,26463534,26490951,27418,1]
["chr2",26480462,26490562,10101,"ENSBGRG00000015631","ENSBGRT00000028720",16928,"FAM124B","family with sequence similarity 124 member B [Source:HGNC Symbol;Acc:HGNC:26224]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","NA",{"v":2.6E-7,"d":"0.00"},2,"64,265,","0,9836",-6.59,-5.86,7.33,"Exon (ENSBGRT00000028720/ENSBGRG00000015631, exon 3 of 4)",2,26463534,26490951,27418,1]
["chr2",26490652,26490951,300,"ENSBGRG00000015631","ENSBGRT00000028720",27118,"FAM124B","family with sequence similarity 124 member B [Source:HGNC Symbol;Acc:HGNC:26224]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","NA",{"v":6.3E-10,"d":"0.00"},1,"300,",0,{"v":-9.2,"d":"-9.20"},-8.42,{"v":12.9,"d":"12.90"},"Exon (ENSBGRT00000028720/ENSBGRG00000015631, exon 4 of 4)",2,26463534,26490951,27418,1]
["chr2",26850824,26850914,91,"ENSBGRG00000015709","ENSBGRT00000029181",598,"SERPINE2","serpin family E member 2 [Source:HGNC Symbol;Acc:HGNC:8951]","GO:0005615(extracellular space)","NA",0.02,1,"91,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"5' UTR",2,26850226,26914532,64307,1]
["chr2",27007996,27010043,2048,"ENSBGRG00000016123","ENSBGRT00000029885",54915,"ENSBGRG00000016123","WD repeat and FYVE domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20451]","GO:0005515(protein binding);GO:0005769(early endosome);GO:0034141(positive regulation of toll-like receptor 3 signaling pathway);GO:0034145(positive regulation of toll-like receptor 4 signaling pathway);GO:0046872(metal ion binding)","04144(Endocytosis);04145(Phagosome)",{"v":1e-138,"d":"0.00"},2,"11,1002,","0,1046",-138,-137,{"v":3.9,"d":"3.90"},"3' UTR",2,26953081,27010101,57021,1]
["chr2",29609205,29617794,8590,"ENSBGRG00000017734","ENSBGRT00000033254",0,"EPHA4","EPH receptor A4 [Source:HGNC Symbol;Acc:HGNC:3388]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005004(GPI-linked ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007628(adult walking behavior);GO:0008045(motor neuron axon guidance);GO:0010977(negative regulation of neuron projection development);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021957(corticospinal tract morphogenesis);GO:0030424(axon);GO:0030425(dendrite);GO:0031901(early endosome membrane);GO:0034332(adherens junction organization);GO:0042731(PH domain binding);GO:0042802(identical protein binding);GO:0043087(regulation of GTPase activity);GO:0043507(positive regulation of JUN kinase activity);GO:0046777(protein autophosphorylation);GO:0048013(ephrin receptor signaling pathway);GO:0048681(negative regulation of axon regeneration);GO:0048710(regulation of astrocyte differentiation);GO:0050770(regulation of axonogenesis);GO:0050821(protein stabilization);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0072178(nephric duct morphogenesis);GO:0090102(cochlea development);GO:0097155(fasciculation of sensory neuron axon);GO:0097156(fasciculation of motor neuron axon);GO:0097161(DH domain binding);GO:0097485(neuron projection guidance);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099056(integral component of presynaptic membrane);GO:0106030(neuron projection fasciculation);GO:1900272(negative regulation of long-term synaptic potentiation);GO:1902004(positive regulation of amyloid-beta formation);GO:1902961(positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process);GO:1903051(negative regulation of proteolysis involved in cellular protein catabolic process);GO:1904646(cellular response to amyloid-beta);GO:1905244(regulation of modification of synaptic structure);GO:1990782(protein tyrosine kinase binding);GO:2001108(positive regulation of Rho guanyl-nucleotide exchange factor activity)","04360(Axon guidance)",{"v":1.6e-14,"d":"0.00"},4,"158,68,72,241,","0,4151,7729,8349",{"v":-13.8,"d":"-13.80"},-13,{"v":22.8,"d":"22.80"},"5' UTR",2,29616934,29784566,167633,1]
["chr2",32030748,32031017,270,"ENSBGRG00000018601","ENSBGRT00000035228",0,"OBSL1","obscurin like cytoskeletal adaptor 1 [Source:HGNC Symbol;Acc:HGNC:29092]","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0007030(Golgi organization);GO:0007088(regulation of mitotic nuclear division);GO:0034067(protein localization to Golgi apparatus);GO:0048471(perinuclear region of cytoplasm);GO:0050775(positive regulation of dendrite morphogenesis);GO:1990393(3M complex)","NA",{"v":0.00024,"d":"0.00"},1,"270,",0,-3.62,-2.99,4.56,"Exon (ENSBGRT00000035228/ENSBGRG00000018601, exon 1 of 24)",2,32030748,32055462,24715,1]
["chr2",32031077,32032013,937,"ENSBGRG00000018601","ENSBGRT00000035228",329,"OBSL1","obscurin like cytoskeletal adaptor 1 [Source:HGNC Symbol;Acc:HGNC:29092]","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0007030(Golgi organization);GO:0007088(regulation of mitotic nuclear division);GO:0034067(protein localization to Golgi apparatus);GO:0048471(perinuclear region of cytoplasm);GO:0050775(positive regulation of dendrite morphogenesis);GO:1990393(3M complex)","NA",{"v":4e-11,"d":"0.00"},2,"40,560,","0,377",{"v":-10.4,"d":"-10.40"},-9.57,{"v":22.8,"d":"22.80"},"Exon (ENSBGRT00000035228/ENSBGRG00000018601, exon 1 of 24)",2,32030748,32055462,24715,1]
["chr2",32050634,32051816,1183,"ENSBGRG00000018601","ENSBGRT00000035228",19886,"OBSL1","obscurin like cytoskeletal adaptor 1 [Source:HGNC Symbol;Acc:HGNC:29092]","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0007030(Golgi organization);GO:0007088(regulation of mitotic nuclear division);GO:0034067(protein localization to Golgi apparatus);GO:0048471(perinuclear region of cytoplasm);GO:0050775(positive regulation of dendrite morphogenesis);GO:1990393(3M complex)","NA",{"v":3.2e-06,"d":"0.00"},2,"26,154,","0,1029",{"v":-5.5,"d":"-5.50"},{"v":-4.8,"d":"-4.80"},2.23,"Exon (ENSBGRT00000035228/ENSBGRG00000018601, exon 15 of 24)",2,32030748,32055462,24715,1]
["chr2",32065283,32066977,1695,"ENSBGRG00000019378","ENSBGRT00000035619",2999,"CHPF","chondroitin polymerizing factor [Source:HGNC Symbol;Acc:HGNC:24291]","GO:0008376(acetylgalactosaminyltransferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030206(chondroitin sulfate biosynthetic process);GO:0032580(Golgi cisterna membrane);GO:0047238(glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity);GO:0050510(N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)",0,2,"24,1260,","0,435",-526,"-Inf",6.46,"Exon (ENSBGRT00000035619/ENSBGRG00000019378, exon 3 of 4)",2,32062284,32066977,4694,1]
["chr2",32392332,32392840,509,"ENSBGRG00000021241","ENSBGRT00000039476",19343,"ENSBGRG00000021241","NA","GO:0003924(GTPase activity);GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0004565(beta-galactosidase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005525(GTP binding);GO:0005874(microtubule);GO:0005975(carbohydrate metabolic process);GO:0007017(microtubule-based process)","04145(Phagosome);04210(Apoptosis);04530(Tight junction);04540(Gap junction);05130(Pathogenic Escherichia coli infection)",{"v":3.2E-91,"d":"0.00"},1,"509,",0,{"v":-90.5,"d":"-90.50"},-89,3.25,"3' UTR",2,32372989,32392537,19549,1]
["chr2",32400433,32400493,61,"ENSBGRG00000021721","ENSBGRT00000040136",392,"ANKZF1","ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1 [Source:HGNC Symbol;Acc:HGNC:25527]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0070301(cellular response to hydrogen peroxide)","NA",{"v":0.013,"d":"0.01"},1,"61,",0,-1.87,-1.34,1.77,"5' UTR",2,32392647,32400885,8239,2]
["chr2",32408922,32409192,271,"ENSBGRG00000021811","ENSBGRT00000040355",9088,"ENSBGRG00000021811","autophagy related 9A [Source:HGNC Symbol;Acc:HGNC:22408]","GO:0006914(autophagy)","04140(Autophagy - animal);04136(Autophagy - other eukaryotes);04137(Mitophagy - animal)",{"v":2.5e-29,"d":"0.00"},1,"271,",0,{"v":-28.6,"d":"-28.60"},{"v":-27.6,"d":"-27.60"},1.75,"3' UTR",2,32399834,32409910,10077,1]
["chr2",32409700,32409910,211,"ENSBGRG00000021811","ENSBGRT00000040355",9866,"ENSBGRG00000021811","autophagy related 9A [Source:HGNC Symbol;Acc:HGNC:22408]","GO:0006914(autophagy)","04140(Autophagy - animal);04136(Autophagy - other eukaryotes);04137(Mitophagy - animal)",{"v":3.8e-05,"d":"0.00"},1,"211,",0,-4.42,-3.77,1.88,"3' UTR",2,32399834,32409910,10077,1]
["chr2",32418909,32418972,64,"ENSBGRG00000021927","ENSBGRT00000040923",7276,"ABCB6","ATP binding cassette subfamily B member 6 (Langereis blood group) [Source:HGNC Symbol;Acc:HGNC:47]","GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005740(mitochondrial envelope);GO:0005741(mitochondrial outer membrane);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006779(porphyrin-containing compound biosynthetic process);GO:0007420(brain development);GO:0015439(ATPase-coupled heme transmembrane transporter activity);GO:0015562(efflux transmembrane transporter activity);GO:0015886(heme transport);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0020037(heme binding);GO:0031307(integral component of mitochondrial outer membrane);GO:0042626(ATPase-coupled transmembrane transporter activity);GO:0043588(skin development);GO:0055085(transmembrane transport)","02010(ABC transporters)",{"v":6e-06,"d":"0.00"},2,"58,3,","0,61",-5.22,-4.54,2.41,"Exon (ENSBGRT00000040923/ENSBGRG00000021927, exon 19 of 20)",2,32411633,32418972,7340,1]
["chr2",32576535,32576864,330,"ENSBGRG00000000275","ENSBGRT00000000562",111401,"ENSBGRG00000000275","NA","GO:0005634(nucleus);GO:0006302(double-strand break repair);GO:0016020(membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","03450(Non-homologous end-joining)",{"v":0.00022,"d":"0.00"},1,"330,",0,-3.66,-3.04,{"v":14.9,"d":"14.90"},"3' UTR",2,32465134,32579212,114079,1]
["chr2",32578852,32579122,271,"ENSBGRG00000000275","ENSBGRT00000000562",113718,"ENSBGRG00000000275","NA","GO:0005634(nucleus);GO:0006302(double-strand break repair);GO:0016020(membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","03450(Non-homologous end-joining)",{"v":4.9E-9,"d":"0.00"},1,"271,",0,-8.31,-7.54,2.14,"3' UTR",2,32465134,32579212,114079,1]
["chr2",32599991,32600318,328,"ENSBGRG00000000478","ENSBGRT00000000835",5085,"IHH","Indian hedgehog signaling molecule [Source:HGNC Symbol;Acc:HGNC:5956]","GO:0001501(skeletal system development);GO:0001503(ossification);GO:0001569(branching involved in blood vessel morphogenesis);GO:0001649(osteoblast differentiation);GO:0001701(in utero embryonic development);GO:0001708(cell fate specification);GO:0001763(morphogenesis of a branching structure);GO:0001944(vasculature development);GO:0001947(heart looping);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0003382(epithelial cell morphogenesis);GO:0003406(retinal pigment epithelium development);GO:0003413(chondrocyte differentiation involved in endochondral bone morphogenesis);GO:0005113(patched binding);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0006029(proteoglycan metabolic process);GO:0007224(smoothened signaling pathway);GO:0007267(cell-cell signaling);GO:0007275(multicellular organism development);GO:0007389(pattern specification process);GO:0008284(positive regulation of cell population proliferation);GO:0009880(embryonic pattern specification);GO:0016539(intein-mediated protein splicing);GO:0016540(protein autoprocessing);GO:0030154(cell differentiation);GO:0030704(vitelline membrane formation);GO:0031012(extracellular matrix);GO:0031016(pancreas development);GO:0032967(positive regulation of collagen biosynthetic process);GO:0033085(negative regulation of T cell differentiation in thymus);GO:0033088(negative regulation of immature T cell proliferation in thymus);GO:0033089(positive regulation of T cell differentiation in thymus);GO:0035264(multicellular organism growth);GO:0035988(chondrocyte proliferation);GO:0040008(regulation of growth);GO:0042733(embryonic digit morphogenesis);GO:0043010(camera-type eye development);GO:0045453(bone resorption);GO:0045596(negative regulation of cell differentiation);GO:0045880(positive regulation of smoothened signaling pathway);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046638(positive regulation of alpha-beta T cell differentiation);GO:0046639(negative regulation of alpha-beta T cell differentiation);GO:0048074(negative regulation of eye pigmentation);GO:0048469(cell maturation);GO:0048557(embryonic digestive tract morphogenesis);GO:0048596(embryonic camera-type eye morphogenesis);GO:0048666(neuron development);GO:0048745(smooth muscle tissue development);GO:0051216(cartilage development);GO:0060220(camera-type eye photoreceptor cell fate commitment);GO:0060323(head morphogenesis);GO:0061053(somite development);GO:0072498(embryonic skeletal joint development);GO:0090136(epithelial cell-cell adhesion)","04340(Hedgehog signaling pathway);05205(Proteoglycans in cancer)",{"v":2e-13,"d":"0.00"},1,"328,",0,{"v":-12.7,"d":"-12.70"},{"v":-11.9,"d":"-11.90"},{"v":25.3,"d":"25.30"},"3' UTR",2,32594906,32601030,6125,1]
["chr2",33034709,33035625,917,"ENSBGRG00000001002","ENSBGRT00000001866",7926,"RNF25","ring finger protein 25 [Source:HGNC Symbol;Acc:HGNC:14662]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0016567(protein ubiquitination);GO:0051059(NF-kappaB binding);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0061630(ubiquitin protein ligase activity)","NA",0,2,"59,655,","0,262",-480,"-Inf",9.48,"3' UTR",2,33026783,33035625,8843,1]
["chr2",33045779,33045989,211,"ENSBGRG00000001065","ENSBGRT00000001984",0,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":4.6e-08,"d":"0.00"},1,"211,",0,-7.34,{"v":-6.6,"d":"-6.60"},1.74,"5' UTR",2,33045779,33061179,15401,1]
["chr2",33052277,33052606,330,"ENSBGRG00000001065","ENSBGRT00000001984",6498,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":3.2e-14,"d":"0.00"},1,"330,",0,{"v":-13.5,"d":"-13.50"},{"v":-12.7,"d":"-12.70"},2.65,"Exon (ENSBGRT00000001984/ENSBGRG00000001065, exon 4 of 8)",2,33045779,33061179,15401,1]
["chr2",33056474,33057522,1049,"ENSBGRG00000001065","ENSBGRT00000001984",10695,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":1E-119,"d":"0.00"},1,"1049,",0,-119,-117,{"v":11.7,"d":"11.70"},"Exon (ENSBGRT00000001984/ENSBGRG00000001065, exon 6 of 8)",2,33045779,33061179,15401,1]
["chr2",33057671,33058539,869,"ENSBGRG00000001065","ENSBGRT00000001984",11892,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":3.2e-28,"d":"0.00"},1,"869,",0,{"v":-27.5,"d":"-27.50"},{"v":-26.5,"d":"-26.50"},5.94,"Exon (ENSBGRT00000001984/ENSBGRG00000001065, exon 6 of 8)",2,33045779,33061179,15401,1]
["chr2",33058659,33058809,151,"ENSBGRG00000001065","ENSBGRT00000001984",12880,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":0.0068,"d":"0.01"},1,"151,",0,-2.17,-1.62,6.93,"Exon (ENSBGRT00000001984/ENSBGRG00000001065, exon 6 of 8)",2,33045779,33061179,15401,1]
["chr2",33059018,33060679,1662,"ENSBGRG00000001065","ENSBGRT00000001984",13239,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":1e-133,"d":"0.00"},2,"852,47,","0,1615",-133,-131,9.91,"Exon (ENSBGRT00000001984/ENSBGRG00000001065, exon 6 of 8)",2,33045779,33061179,15401,1]
["chr2",33062394,33062604,211,"ENSBGRG00000001065","ENSBGRT00000001957",16615,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":1e-144,"d":"0.00"},1,"211,",0,-144,-143,5.48,"Exon (ENSBGRT00000001957/ENSBGRG00000001065, exon 8 of 8)",2,33045779,33062604,16826,1]
["chr2",33133038,33133247,210,"ENSBGRG00000001130","ENSBGRT00000002085",0,"CNOT9","CCR4-NOT transcription complex subunit 9 [Source:HGNC Symbol;Acc:HGNC:10445]","GO:0000932(P-body);GO:0005154(epidermal growth factor receptor binding);GO:0006402(mRNA catabolic process);GO:0019221(cytokine-mediated signaling pathway);GO:0019900(kinase binding);GO:0019904(protein domain specific binding);GO:0030014(CCR4-NOT complex);GO:0032991(protein-containing complex);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033147(negative regulation of intracellular estrogen receptor signaling pathway);GO:0042803(protein homodimerization activity);GO:0045742(positive regulation of epidermal growth factor receptor signaling pathway);GO:2000327(positive regulation of nuclear receptor transcription coactivator activity)","03018(RNA degradation)",0.01,1,"210,",0,-1.99,-1.46,4.95,"5' UTR",2,33100868,33133170,32303,2]
["chr2",33221568,33221748,181,"ENSBGRG00000001165","ENSBGRT00000002206",88590,"USP37","ubiquitin specific peptidase 37 [Source:HGNC Symbol;Acc:HGNC:20063]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0006275(regulation of DNA replication);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0019901(protein kinase binding);GO:0035871(protein K11-linked deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0071108(protein K48-linked deubiquitination)","NA",{"v":3.3e-05,"d":"0.00"},1,"181,",0,-4.48,-3.82,7.92,"Exon (ENSBGRT00000002257/ENSBGRG00000001165, exon 25 of 26)",2,33132978,33222832,89855,1]
["chr2",33403125,33403185,61,"ENSBGRG00000001618","ENSBGRT00000003054",0,"PNKD","PNKD metallo-beta-lactamase domain containing [Source:HGNC Symbol;Acc:HGNC:9153]","GO:0004416(hydroxyacylglutathione hydrolase activity);GO:0005739(mitochondrion);GO:0016020(membrane);GO:0019243(methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione);GO:0032225(regulation of synaptic transmission, dopaminergic);GO:0042053(regulation of dopamine metabolic process);GO:0046929(negative regulation of neurotransmitter secretion);GO:0050884(neuromuscular process controlling posture)","00620(Pyruvate metabolism);04144(Endocytosis);04810(Regulation of actin cytoskeleton);05132(Salmonella infection)",{"v":0.003,"d":"0.00"},1,"61,",0,-2.52,-1.95,1.24,"5' UTR",2,33400265,33403181,2917,2]
["chr2",33403245,33405243,1999,"ENSBGRG00000001618","ENSBGRT00000003004",0,"PNKD","PNKD metallo-beta-lactamase domain containing [Source:HGNC Symbol;Acc:HGNC:9153]","GO:0004416(hydroxyacylglutathione hydrolase activity);GO:0005739(mitochondrion);GO:0016020(membrane);GO:0019243(methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione);GO:0032225(regulation of synaptic transmission, dopaminergic);GO:0042053(regulation of dopamine metabolic process);GO:0046929(negative regulation of neurotransmitter secretion);GO:0050884(neuromuscular process controlling posture)","00620(Pyruvate metabolism);04144(Endocytosis);04810(Regulation of actin cytoskeleton);05132(Salmonella infection)",{"v":6.3E-21,"d":"0.00"},4,"78,153,120,9,","0,560,1355,1990",{"v":-20.2,"d":"-20.20"},{"v":-19.3,"d":"-19.30"},1.68,"5' UTR",2,33316633,33403696,87064,2]
["chr2",33788990,33789619,630,"ENSBGRG00000001914","ENSBGRT00000003950",196768,"TNS1","tensin 1 [Source:HGNC Symbol;Acc:HGNC:11973]","GO:0005515(protein binding);GO:0005925(focal adhesion);GO:0007044(cell-substrate junction assembly);GO:0010761(fibroblast migration);GO:0030055(cell-substrate junction);GO:0035556(intracellular signal transduction)","NA",{"v":1E-205,"d":"0.00"},1,"630,",0,-205,-203,{"v":5.8,"d":"5.80"},"Exon (ENSBGRT00000003950/ENSBGRG00000001914, exon 19 of 35)",2,33592222,33840431,248210,1]
["chr2",33838632,33839382,751,"ENSBGRG00000001914","ENSBGRT00000003950",246410,"TNS1","tensin 1 [Source:HGNC Symbol;Acc:HGNC:11973]","GO:0005515(protein binding);GO:0005925(focal adhesion);GO:0007044(cell-substrate junction assembly);GO:0010761(fibroblast migration);GO:0030055(cell-substrate junction);GO:0035556(intracellular signal transduction)","NA",0,1,"751,",0,-2390,"-Inf",{"v":10.1,"d":"10.10"},"3' UTR",2,33592222,33840431,248210,1]
["chr2",35237179,35237448,270,"ENSBGRG00000002228","ENSBGRT00000004148",26179,"IGFBP5","insulin like growth factor binding protein 5 [Source:HGNC Symbol;Acc:HGNC:5474]","GO:0001558(regulation of cell growth);GO:0001649(osteoblast differentiation);GO:0001968(fibronectin binding);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0007565(female pregnancy);GO:0014912(negative regulation of smooth muscle cell migration);GO:0017148(negative regulation of translation);GO:0030336(negative regulation of cell migration);GO:0031069(hair follicle morphogenesis);GO:0031994(insulin-like growth factor I binding);GO:0040008(regulation of growth);GO:0042567(insulin-like growth factor ternary complex);GO:0042593(glucose homeostasis);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0043569(negative regulation of insulin-like growth factor receptor signaling pathway);GO:0044342(type B pancreatic cell proliferation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045926(negative regulation of growth);GO:0048286(lung alveolus development);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0051146(striated muscle cell differentiation);GO:0051897(positive regulation of protein kinase B signaling);GO:0060056(mammary gland involution);GO:0071320(cellular response to cAMP);GO:0071407(cellular response to organic cyclic compound);GO:1901862(negative regulation of muscle tissue development);GO:1904205(negative regulation of skeletal muscle hypertrophy);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration)","04115(p53 signaling pathway);04218(Cellular senescence);05202(Transcriptional misregulation in cancers)",0,1,"270,",0,-537,"-Inf",2.67,"3' UTR",2,35211000,35238586,27587,1]
["chr2",35238496,35238586,91,"ENSBGRG00000002228","ENSBGRT00000004148",27496,"IGFBP5","insulin like growth factor binding protein 5 [Source:HGNC Symbol;Acc:HGNC:5474]","GO:0001558(regulation of cell growth);GO:0001649(osteoblast differentiation);GO:0001968(fibronectin binding);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0007565(female pregnancy);GO:0014912(negative regulation of smooth muscle cell migration);GO:0017148(negative regulation of translation);GO:0030336(negative regulation of cell migration);GO:0031069(hair follicle morphogenesis);GO:0031994(insulin-like growth factor I binding);GO:0040008(regulation of growth);GO:0042567(insulin-like growth factor ternary complex);GO:0042593(glucose homeostasis);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0043569(negative regulation of insulin-like growth factor receptor signaling pathway);GO:0044342(type B pancreatic cell proliferation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045926(negative regulation of growth);GO:0048286(lung alveolus development);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0051146(striated muscle cell differentiation);GO:0051897(positive regulation of protein kinase B signaling);GO:0060056(mammary gland involution);GO:0071320(cellular response to cAMP);GO:0071407(cellular response to organic cyclic compound);GO:1901862(negative regulation of muscle tissue development);GO:1904205(negative regulation of skeletal muscle hypertrophy);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration)","04115(p53 signaling pathway);04218(Cellular senescence);05202(Transcriptional misregulation in cancers)",{"v":1e-115,"d":"0.00"},1,"91,",0,-115,-113,2.05,"3' UTR",2,35211000,35238586,27587,1]
["chr2",37274994,37275233,240,"ENSBGRG00000003261","ENSBGRT00000006470",33430,"BARD1","BRCA1 associated RING domain 1 [Source:HGNC Symbol;Acc:HGNC:952]","GO:0003723(RNA binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016607(nuclear speck);GO:0031436(BRCA1-BARD1 complex);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0042325(regulation of phosphorylation);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046826(negative regulation of protein export from nucleus);GO:0046982(protein heterodimerization activity);GO:0070531(BRCA1-A complex);GO:0085020(protein K6-linked ubiquitination)","03440(Homologous recombination)",{"v":1.5E-5,"d":"0.00"},1,"240,",0,-4.82,-4.14,2.97,"Exon (ENSBGRT00000006415/ENSBGRG00000003261, exon 4 of 11)",2,37241564,37290279,48716,1]
["chr2",37275592,37275832,241,"ENSBGRG00000003261","ENSBGRT00000006470",34028,"BARD1","BRCA1 associated RING domain 1 [Source:HGNC Symbol;Acc:HGNC:952]","GO:0003723(RNA binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016607(nuclear speck);GO:0031436(BRCA1-BARD1 complex);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0042325(regulation of phosphorylation);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046826(negative regulation of protein export from nucleus);GO:0046982(protein heterodimerization activity);GO:0070531(BRCA1-A complex);GO:0085020(protein K6-linked ubiquitination)","03440(Homologous recombination)",{"v":3.2e-08,"d":"0.00"},1,"241,",0,{"v":-7.5,"d":"-7.50"},-6.75,3.89,"Exon (ENSBGRT00000006415/ENSBGRG00000003261, exon 4 of 11)",2,37241564,37290279,48716,1]
["chr2",42577021,42578130,1110,"ENSBGRG00000004930","ENSBGRT00000009081",929,"KANSL1L","KAT8 regulatory NSL complex subunit 1 like [Source:HGNC Symbol;Acc:HGNC:26310]","GO:0000123(histone acetyltransferase complex)","NA",{"v":1e-101,"d":"0.00"},1,"1110,",0,-101,{"v":-99.2,"d":"-99.20"},{"v":8.2,"d":"8.20"},"5' UTR",2,42576092,42685209,109118,1]
["chr2",42685029,42685209,181,"ENSBGRG00000004930","ENSBGRT00000009081",108937,"KANSL1L","KAT8 regulatory NSL complex subunit 1 like [Source:HGNC Symbol;Acc:HGNC:26310]","GO:0000123(histone acetyltransferase complex)","NA",{"v":1e-39,"d":"0.00"},1,"181,",0,-39,{"v":-37.9,"d":"-37.90"},2.48,"Exon (ENSBGRT00000009081/ENSBGRG00000004930, exon 14 of 14)",2,42576092,42685209,109118,1]
["chr2",44134992,44136205,1214,"ENSBGRG00000006637","ENSBGRT00000012224",689,"IDH1","isocitrate dehydrogenase (NADP(+)) 1 [Source:HGNC Symbol;Acc:HGNC:5382]","GO:0000287(magnesium ion binding);GO:0004448(isocitrate dehydrogenase activity);GO:0004450(isocitrate dehydrogenase (NADP+) activity);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005777(peroxisome);GO:0005829(cytosol);GO:0006102(isocitrate metabolic process);GO:0006103(2-oxoglutarate metabolic process);GO:0006749(glutathione metabolic process);GO:0006979(response to oxidative stress);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0051287(NAD binding);GO:0055114(oxidation-reduction process);GO:0060696(regulation of phospholipid catabolic process);GO:0071071(regulation of phospholipid biosynthetic process)","00020(Citrate cycle (TCA cycle));00480(Glutathione metabolism);04146(Peroxisome)",{"v":6.3e-15,"d":"0.00"},2,"218,23,","0,1191",{"v":-14.2,"d":"-14.20"},{"v":-13.3,"d":"-13.30"},{"v":2.1,"d":"2.10"},"5' UTR",2,44134303,44155217,20915,1]
["chr2",44400164,44400940,777,"ENSBGRG00000006928","ENSBGRT00000012867",0,"PLEKHM3","pleckstrin homology domain containing M3 [Source:HGNC Symbol;Acc:HGNC:34006]","GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0045445(myoblast differentiation)","04140(Autophagy - animal)",{"v":1E-13,"d":"0.00"},1,"777,",0,-13,{"v":-12.1,"d":"-12.10"},{"v":12.9,"d":"12.90"},"5' UTR",2,44400164,44605470,205307,1]
["chr2",44423548,44423697,150,"ENSBGRG00000006928","ENSBGRT00000012867",23384,"PLEKHM3","pleckstrin homology domain containing M3 [Source:HGNC Symbol;Acc:HGNC:34006]","GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0045445(myoblast differentiation)","04140(Autophagy - animal)",{"v":0.00018,"d":"0.00"},1,"150,",0,-3.75,-3.12,2.84,"Exon (ENSBGRT00000012867/ENSBGRG00000006928, exon 2 of 7)",2,44400164,44605470,205307,1]
["chr2",44423756,44423816,61,"ENSBGRG00000006928","ENSBGRT00000012867",23592,"PLEKHM3","pleckstrin homology domain containing M3 [Source:HGNC Symbol;Acc:HGNC:34006]","GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0045445(myoblast differentiation)","04140(Autophagy - animal)",{"v":0.00037,"d":"0.00"},1,"61,",0,-3.43,-2.81,2.34,"Exon (ENSBGRT00000012867/ENSBGRG00000006928, exon 2 of 7)",2,44400164,44605470,205307,1]
["chr2",44423876,44424264,389,"ENSBGRG00000006928","ENSBGRT00000012867",23712,"PLEKHM3","pleckstrin homology domain containing M3 [Source:HGNC Symbol;Acc:HGNC:34006]","GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0045445(myoblast differentiation)","04140(Autophagy - animal)",{"v":1e-06,"d":"0.00"},1,"389,",0,-5.98,-5.27,2.97,"Exon (ENSBGRT00000012867/ENSBGRG00000006928, exon 2 of 7)",2,44400164,44605470,205307,1]
["chr2",44683720,44684703,984,"ENSBGRG00000007062","ENSBGRT00000012964",774,"FZD5","frizzled class receptor 5 [Source:HGNC Symbol;Acc:HGNC:4043]","GO:0000578(embryonic axis specification);GO:0001525(angiogenesis);GO:0001540(amyloid-beta binding);GO:0001944(vasculature development);GO:0002726(positive regulation of T cell cytokine production);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005923(bicellular tight junction);GO:0007166(cell surface receptor signaling pathway);GO:0008285(negative regulation of cell population proliferation);GO:0008595(anterior/posterior axis specification, embryo);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0019901(protein kinase binding);GO:0031076(embryonic camera-type eye development);GO:0031077(post-embryonic camera-type eye development);GO:0031625(ubiquitin protein ligase binding);GO:0032729(positive regulation of interferon-gamma production);GO:0032731(positive regulation of interleukin-1 beta production);GO:0033077(T cell differentiation in thymus);GO:0042813(Wnt-activated receptor activity);GO:0043507(positive regulation of JUN kinase activity);GO:0044877(protein-containing complex binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048469(cell maturation);GO:0048471(perinuclear region of cytoplasm);GO:0048596(embryonic camera-type eye morphogenesis);GO:0060061(Spemann organizer formation);GO:0060070(canonical Wnt signaling pathway);GO:0060561(apoptotic process involved in morphogenesis);GO:0060670(branching involved in labyrinthine layer morphogenesis);GO:0060715(syncytiotrophoblast cell differentiation involved in labyrinthine layer development);GO:0060716(labyrinthine layer blood vessel development);GO:0060718(chorionic trophoblast cell differentiation);GO:0071219(cellular response to molecule of bacterial origin);GO:1901382(regulation of chorionic trophoblast cell proliferation);GO:1904469(positive regulation of tumor necrosis factor secretion);GO:2000810(regulation of bicellular tight junction assembly)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":1.1e-10,"d":"0.00"},1,"984,",0,-9.96,-9.16,{"v":23.8,"d":"23.80"},"Exon (ENSBGRT00000012964/ENSBGRG00000007062, exon 1 of 1)",2,44682946,44684703,1758,1]
["chr2",44828812,44829022,211,"ENSBGRG00000007457","ENSBGRT00000013789",0,"METTL21A","methyltransferase like 21A [Source:HGNC Symbol;Acc:HGNC:30476]","NA","NA",{"v":0.036,"d":"0.04"},1,"211,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"5' UTR",2,44828812,44839885,11074,1]
["chr2",44831754,44857076,25323,"ENSBGRG00000007457","ENSBGRT00000013789",2942,"METTL21A","methyltransferase like 21A [Source:HGNC Symbol;Acc:HGNC:30476]","NA","NA",{"v":5E-36,"d":"0.00"},6,"99,398,21,14,62,6,","0,7734,8867,25004,25254,25317",{"v":-35.3,"d":"-35.30"},{"v":-34.2,"d":"-34.20"},4.08,"3' UTR",2,44828812,44839885,11074,1]
["chr2",45327207,45438648,111442,"ENSBGRG00000007842","ENSBGRT00000014355",0,"KLF7","Kruppel like factor 7 [Source:HGNC Symbol;Acc:HGNC:6350]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0007409(axonogenesis);GO:0007411(axon guidance);GO:0042593(glucose homeostasis);GO:0045604(regulation of epidermal cell differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048813(dendrite morphogenesis);GO:0061179(negative regulation of insulin secretion involved in cellular response to glucose stimulus);GO:1904178(negative regulation of adipose tissue development)","NA",{"v":1.3E-87,"d":"0.00"},6,"119,240,51,631,128,536,","0,335,35106,45493,102964,110906",{"v":-86.9,"d":"-86.90"},{"v":-85.4,"d":"-85.40"},7.29,"5' UTR",2,45327207,45430298,103092,1]
["chr2",45792303,45792723,421,"ENSBGRG00000008141","ENSBGRT00000015061",13824,"MDH1B","malate dehydrogenase 1B [Source:HGNC Symbol;Acc:HGNC:17836]","GO:0003824(catalytic activity);GO:0005975(carbohydrate metabolic process);GO:0006108(malate metabolic process);GO:0016615(malate dehydrogenase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0055114(oxidation-reduction process)","00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);00630(Glyoxylate and dicarboxylate metabolism);00270(Cysteine and methionine metabolism)",{"v":2.5e-11,"d":"0.00"},1,"421,",0,{"v":-10.6,"d":"-10.60"},-9.76,8.75,"Exon (ENSBGRT00000015061/ENSBGRG00000008141, exon 6 of 12)",2,45778479,45816282,37804,1]
["chr2",45811363,45814723,3361,"ENSBGRG00000008141","ENSBGRT00000015061",32884,"MDH1B","malate dehydrogenase 1B [Source:HGNC Symbol;Acc:HGNC:17836]","GO:0003824(catalytic activity);GO:0005975(carbohydrate metabolic process);GO:0006108(malate metabolic process);GO:0016615(malate dehydrogenase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0055114(oxidation-reduction process)","00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);00630(Glyoxylate and dicarboxylate metabolism);00270(Cysteine and methionine metabolism)",{"v":0.00079,"d":"0.00"},2,"36,175,","0,3186",{"v":-3.1,"d":"-3.10"},{"v":-2.5,"d":"-2.50"},5.94,"3' UTR",2,45778479,45816282,37804,1]
["chr2",45815413,45815773,361,"ENSBGRG00000008141","ENSBGRT00000015061",36934,"MDH1B","malate dehydrogenase 1B [Source:HGNC Symbol;Acc:HGNC:17836]","GO:0003824(catalytic activity);GO:0005975(carbohydrate metabolic process);GO:0006108(malate metabolic process);GO:0016615(malate dehydrogenase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0055114(oxidation-reduction process)","00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);00630(Glyoxylate and dicarboxylate metabolism);00270(Cysteine and methionine metabolism)",{"v":3.5e-09,"d":"0.00"},1,"361,",0,-8.45,-7.68,{"v":12.9,"d":"12.90"},"3' UTR",2,45778479,45816282,37804,1]
["chr2",45816043,45816163,121,"ENSBGRG00000008141","ENSBGRT00000015061",37564,"MDH1B","malate dehydrogenase 1B [Source:HGNC Symbol;Acc:HGNC:17836]","GO:0003824(catalytic activity);GO:0005975(carbohydrate metabolic process);GO:0006108(malate metabolic process);GO:0016615(malate dehydrogenase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0055114(oxidation-reduction process)","00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);00630(Glyoxylate and dicarboxylate metabolism);00270(Cysteine and methionine metabolism)",{"v":0.036,"d":"0.04"},1,"121,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"3' UTR",2,45778479,45816282,37804,1]
["chr2",46393941,46394090,150,"ENSBGRG00000009401","ENSBGRT00000017240",54185,"GPR1","G protein-coupled receptor 1 [Source:HGNC Symbol;Acc:HGNC:4463]","GO:0004930(G protein-coupled receptor activity);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":0.036,"d":"0.04"},1,"150,",0,-1.44,{"v":-0.839,"d":"-0.84"},6.93,"3' UTR",2,46339756,46394982,55227,1]
["chr2",46443017,46443076,60,"ENSBGRG00000009516","ENSBGRT00000018047",29421,"NDUFS1","NADH:ubiquinone oxidoreductase core subunit S1 [Source:HGNC Symbol;Acc:HGNC:7707]","GO:0005739(mitochondrion);GO:0005747(mitochondrial respiratory chain complex I);GO:0005758(mitochondrial intermembrane space);GO:0008137(NADH dehydrogenase (ubiquinone) activity);GO:0008637(apoptotic mitochondrial changes);GO:0009055(electron transfer activity);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0016651(oxidoreductase activity, acting on NAD(P)H);GO:0042773(ATP synthesis coupled electron transport);GO:0045333(cellular respiration);GO:0046034(ATP metabolic process);GO:0051536(iron-sulfur cluster binding);GO:0051881(regulation of mitochondrial membrane potential);GO:0055114(oxidation-reduction process);GO:0072593(reactive oxygen species metabolic process)","00190(Oxidative phosphorylation);04723(Retrograde endocannabinoid signaling);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":0.003,"d":"0.00"},1,"60,",0,-2.53,-1.96,2.56,"3' UTR",2,46413596,46443076,29481,1]
["chr2",46483177,46483895,719,"ENSBGRG00000009960","ENSBGRT00000018260",0,"INO80D","INO80 complex subunit D [Source:HGNC Symbol;Acc:HGNC:25997]","NA","NA",{"v":1E-168,"d":"0.00"},1,"719,",0,-168,-166,6.11,"5' UTR",2,46483177,46550212,67036,1]
["chr2",46512101,46512251,151,"ENSBGRG00000009960","ENSBGRT00000018260",28924,"INO80D","INO80 complex subunit D [Source:HGNC Symbol;Acc:HGNC:25997]","NA","NA",{"v":0.036,"d":"0.04"},1,"151,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000018260/ENSBGRG00000009960, exon 4 of 11)",2,46483177,46550212,67036,1]
["chr2",46546959,46548896,1938,"ENSBGRG00000009960","ENSBGRT00000018260",63782,"INO80D","INO80 complex subunit D [Source:HGNC Symbol;Acc:HGNC:25997]","NA","NA",{"v":1E-4,"d":"0.00"},2,"87,423,","0,1515",-4,-3.36,{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000018260/ENSBGRG00000009960, exon 10 of 11)",2,46483177,46550212,67036,1]
["chr2",46548956,46549015,60,"ENSBGRG00000009960","ENSBGRT00000018260",65779,"INO80D","INO80 complex subunit D [Source:HGNC Symbol;Acc:HGNC:25997]","NA","NA",{"v":0.011,"d":"0.01"},1,"60,",0,-1.97,-1.44,2.21,"Exon (ENSBGRT00000018260/ENSBGRG00000009960, exon 11 of 11)",2,46483177,46550212,67036,1]
["chr2",46549105,46549165,61,"ENSBGRG00000009960","ENSBGRT00000018260",65928,"INO80D","INO80 complex subunit D [Source:HGNC Symbol;Acc:HGNC:25997]","NA","NA",{"v":0.014,"d":"0.01"},1,"61,",0,-1.85,-1.33,3.96,"Exon (ENSBGRT00000018260/ENSBGRG00000009960, exon 11 of 11)",2,46483177,46550212,67036,1]
["chr2",49474332,49505117,30786,"ENSBGRG00000012733","ENSBGRT00000026863",5299,"ENSBGRG00000012733","NA","GO:0007165(signal transduction)","04015(Rap1 signaling pathway);04611(Platelet activation)",{"v":0.0069,"d":"0.01"},4,"255,81,75,67,","0,13415,20009,30719",-2.16,-1.61,2.97,"Exon (ENSBGRT00000026863/ENSBGRG00000012733, exon 3 of 15)",2,49469033,49529390,60358,1]
["chr2",50496125,50496302,178,"ENSBGRG00000017875","ENSBGRT00000032854",562,"ENSBGRG00000017875","NA","GO:0005515(protein binding)","03013(RNA transport);05418(Fluid shear stress and atherosclerosis)",{"v":1.3e-29,"d":"0.00"},1,"178,",0,{"v":-28.9,"d":"-28.90"},{"v":-27.9,"d":"-27.90"},6.38,"Exon (ENSBGRT00000032854/ENSBGRG00000017875, exon 1 of 5)",2,50495563,50523507,27945,1]
["chr2",50565023,50565082,60,"ENSBGRG00000017875","ENSBGRT00000032785",69460,"ENSBGRG00000017875","NA","GO:0005515(protein binding)","03013(RNA transport);05418(Fluid shear stress and atherosclerosis)",{"v":1.3E-18,"d":"0.00"},1,"60,",0,{"v":-17.9,"d":"-17.90"},-17,2,"Exon (ENSBGRT00000032785/ENSBGRG00000017875, exon 5 of 5)",2,50495563,50565374,69812,1]
["chr2",51024309,51028341,4033,"ENSBGRG00000018345","ENSBGRT00000033582",1471,"ALS2","alsin Rho guanine nucleotide exchange factor ALS2 [Source:HGNC Symbol;Acc:HGNC:443]","GO:0001662(behavioral fear response);GO:0001726(ruffle);GO:0001881(receptor recycling);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006979(response to oxidative stress);GO:0007032(endosome organization);GO:0007041(lysosomal transport);GO:0007528(neuromuscular junction development);GO:0007626(locomotory behavior);GO:0008104(protein localization);GO:0014069(postsynaptic density);GO:0016050(vesicle organization);GO:0016197(endosomal transport);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0030027(lamellipodium);GO:0030425(dendrite);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031982(vesicle);GO:0032991(protein-containing complex);GO:0035249(synaptic transmission, glutamatergic);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043087(regulation of GTPase activity);GO:0043197(dendritic spine);GO:0043539(protein serine/threonine kinase activator activity);GO:0043547(positive regulation of GTPase activity);GO:0045860(positive regulation of protein kinase activity);GO:0048365(Rac GTPase binding);GO:0048812(neuron projection morphogenesis);GO:0051036(regulation of endosome size);GO:0051260(protein homooligomerization)","05014(Amyotrophic lateral sclerosis (ALS))",{"v":2E-16,"d":"0.00"},2,"52,398,","0,3635",{"v":-15.7,"d":"-15.70"},{"v":-14.8,"d":"-14.80"},4.91,"Exon (ENSBGRT00000033582/ENSBGRG00000018345, exon 2 of 33)",2,51022838,51085939,63102,1]
["chr2",56311231,56312903,1673,"ENSBGRG00000000882","ENSBGRT00000001831",73655,"PGAP1","post-GPI attachment to proteins inositol deacylase 1 [Source:HGNC Symbol;Acc:HGNC:25712]","GO:0007605(sensory perception of sound);GO:0009880(embryonic pattern specification);GO:0009948(anterior/posterior axis specification);GO:0016788(hydrolase activity, acting on ester bonds);GO:0021871(forebrain regionalization);GO:0060322(head development)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":0.036,"d":"0.04"},2,"86,94,","0,1579",-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000001831/ENSBGRG00000000882, exon 24 of 26)",2,56237576,56314065,76490,1]
["chr2",57124203,57124532,330,"ENSBGRG00000001329","ENSBGRT00000002440",17389,"STK17B","serine/threonine kinase 17b [Source:HGNC Symbol;Acc:HGNC:11396]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006468(protein phosphorylation);GO:0035556(intracellular signal transduction);GO:2000271(positive regulation of fibroblast apoptotic process)","NA",{"v":3.2e-11,"d":"0.00"},1,"330,",0,{"v":-10.5,"d":"-10.50"},-9.71,2.79,"3' UTR",2,57106814,57124712,17899,1]
["chr2",81896159,81918153,21995,"ENSBGRG00000000816","ENSBGRT00000001594",115420,"RAB3GAP1","RAB3 GTPase activating protein catalytic subunit 1 [Source:HGNC Symbol;Acc:HGNC:17063]","GO:0005096(GTPase activator activity);GO:0005794(Golgi apparatus);GO:0005811(lipid droplet);GO:0007420(brain development);GO:0010628(positive regulation of gene expression);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0021854(hypothalamus development);GO:0032991(protein-containing complex);GO:0034389(lipid droplet organization);GO:0043010(camera-type eye development);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0060079(excitatory postsynaptic potential);GO:0060325(face morphogenesis);GO:0061646(positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization);GO:0071782(endoplasmic reticulum tubular network);GO:0097051(establishment of protein localization to endoplasmic reticulum membrane);GO:1903061(positive regulation of protein lipidation);GO:1903233(regulation of calcium ion-dependent exocytosis of neurotransmitter);GO:1903373(positive regulation of endoplasmic reticulum tubular network organization);GO:2000786(positive regulation of autophagosome assembly)","NA",{"v":1E-107,"d":"0.00"},5,"44,103,21,237,163,","0,2704,5271,6112,21832",-107,-106,4.83,"3' UTR",2,81780739,81902507,121769,1]
["chr2",107173714,107189809,16096,"ENSBGRG00000008625","ENSBGRT00000015811",1164,"GALNT5","polypeptide N-acetylgalactosaminyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:4127]","GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity)","00512(Mucin type O-glycan biosynthesis)",{"v":0.011,"d":"0.01"},2,"290,69,","0,16027",-1.95,-1.18,8.91,"Exon (ENSBGRT00000015811/ENSBGRG00000008625, exon 1 of 10)",2,107172550,107219516,46967,1]
["chr2",118977899,118978820,922,"ENSBGRG00000023526","ENSBGRT00000043417",59,"B3GALT1","beta-1,3-galactosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:916]","GO:0000139(Golgi membrane);GO:0006486(protein glycosylation);GO:0006682(galactosylceramide biosynthetic process);GO:0008499(UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity);GO:0009312(oligosaccharide biosynthetic process);GO:0016020(membrane);GO:0030259(lipid glycosylation)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":2e-11,"d":"0.00"},1,"922,",0,{"v":-10.7,"d":"-10.70"},{"v":-9.9,"d":"-9.90"},6.93,"Exon (ENSBGRT00000043417/ENSBGRG00000023526, exon 1 of 1)",2,118977840,118978820,981,1]
["chr2",123686015,123686075,61,"ENSBGRG00000010970","ENSBGRT00000020286",95250,"ITGA6","integrin subunit alpha 6 [Source:HGNC Symbol;Acc:HGNC:6142]","GO:0005604(basement membrane);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007160(cell-matrix adhesion);GO:0008305(integrin complex);GO:0009897(external side of plasma membrane);GO:0009925(basal plasma membrane);GO:0009986(cell surface);GO:0010668(ectodermal cell differentiation);GO:0010976(positive regulation of neuron projection development);GO:0016323(basolateral plasma membrane);GO:0022409(positive regulation of cell-cell adhesion);GO:0030056(hemidesmosome);GO:0030335(positive regulation of cell migration);GO:0031589(cell-substrate adhesion);GO:0031668(cellular response to extracellular stimulus);GO:0031994(insulin-like growth factor I binding);GO:0035878(nail development);GO:0038132(neuregulin binding);GO:0042327(positive regulation of phosphorylation);GO:0042475(odontogenesis of dentin-containing tooth);GO:0043065(positive regulation of apoptotic process);GO:0043547(positive regulation of GTPase activity);GO:0043589(skin morphogenesis);GO:0045178(basal part of cell);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046847(filopodium assembly);GO:0050873(brown fat cell differentiation);GO:0050900(leukocyte migration);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04514(Cell adhesion molecules (CAMs));04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04640(Hematopoietic cell lineage);05200(Pathways in cancer);05222(Small cell lung cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection);05145(Toxoplasmosis)",{"v":2e-15,"d":"0.00"},1,"61,",0,{"v":-14.7,"d":"-14.70"},{"v":-13.8,"d":"-13.80"},{"v":3.7,"d":"3.70"},"Exon (ENSBGRT00000020286/ENSBGRG00000010970, exon 25 of 25)",2,123590765,123686614,95850,1]
["chr2",133013937,133014146,210,"ENSBGRG00000001286","ENSBGRT00000002353",98049,"UBE2E3","ubiquitin conjugating enzyme E2 E3 [Source:HGNC Symbol;Acc:HGNC:12479]","GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0061631(ubiquitin conjugating enzyme activity);GO:0070534(protein K63-linked ubiquitination);GO:0070936(protein K48-linked ubiquitination);GO:0070979(protein K11-linked ubiquitination)","04120(Ubiquitin mediated proteolysis)",{"v":4e-81,"d":"0.00"},1,"210,",0,{"v":-80.4,"d":"-80.40"},-79,2.47,"3' UTR",2,132915888,133013951,98064,1]
["chr2",143681302,143681722,421,"ENSBGRG00000000481","ENSBGRT00000000839",41734,"INPP1","inositol polyphosphate-1-phosphatase [Source:HGNC Symbol;Acc:HGNC:6071]","GO:0046854(phosphatidylinositol phosphorylation);GO:0046855(inositol phosphate dephosphorylation)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":1E-107,"d":"0.00"},1,"421,",0,-107,-105,6.23,"Exon (ENSBGRT00000000839/ENSBGRG00000000481, exon 6 of 6)",2,143639568,143681722,42155,1]
["chr2",143994761,144008889,14129,"ENSBGRG00000000603","ENSBGRT00000001072",30313,"NAB1","NGFI-A binding protein 1 [Source:HGNC Symbol;Acc:HGNC:7626]","GO:0001958(endochondral ossification);GO:0003712(transcription coregulator activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0014037(Schwann cell differentiation);GO:0042552(myelination);GO:0045682(regulation of epidermis development);GO:0045892(negative regulation of transcription, DNA-templated)","04146(Peroxisome)",{"v":1.5e-07,"d":"0.00"},4,"80,52,90,47,","0,2638,12326,14082",-6.83,{"v":-6.1,"d":"-6.10"},2.43,"Exon (ENSBGRT00000001072/ENSBGRG00000000603, exon 3 of 7)",2,143964448,144013147,48700,1]
["chr2",609926,610075,150,"ENSBGRG00000002548","ENSBGRT00000004815",3711,"MFAP2","microfibril associated protein 2 [Source:HGNC Symbol;Acc:HGNC:7033]","GO:0001527(microfibril);GO:0048048(embryonic eye morphogenesis);GO:0048050(post-embryonic eye morphogenesis)","NA",{"v":3E-9,"d":"0.00"},1,"150,",0,-8.53,-7.76,1.73,"3' UTR",2,609270,613786,4517,2]
["chr2",4828371,4829027,657,"ENSBGRG00000000185","ENSBGRT00000000296",43208,"PINK1","PTEN induced kinase 1 [Source:HGNC Symbol;Acc:HGNC:14581]","GO:0000287(magnesium ion binding);GO:0000422(autophagy of mitochondrion);GO:0000785(chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0002020(protease binding);GO:0002082(regulation of oxidative phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006979(response to oxidative stress);GO:0007005(mitochondrion organization);GO:0010310(regulation of hydrogen peroxide metabolic process);GO:0010629(negative regulation of gene expression);GO:0010821(regulation of mitochondrion organization);GO:0010857(calcium-dependent protein kinase activity);GO:0016020(membrane);GO:0016239(positive regulation of macroautophagy);GO:0016242(negative regulation of macroautophagy);GO:0016301(kinase activity);GO:0016567(protein ubiquitination);GO:0018105(peptidyl-serine phosphorylation);GO:0022904(respiratory electron transport chain);GO:0030424(axon);GO:0031307(integral component of mitochondrial outer membrane);GO:0031396(regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032226(positive regulation of synaptic transmission, dopaminergic);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033603(positive regulation of dopamine secretion);GO:0033605(positive regulation of catecholamine secretion);GO:0034599(cellular response to oxidative stress);GO:0035307(positive regulation of protein dephosphorylation);GO:0035556(intracellular signal transduction);GO:0036289(peptidyl-serine autophosphorylation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043254(regulation of protein-containing complex assembly);GO:0043422(protein kinase B binding);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0044297(cell body);GO:0044877(protein-containing complex binding);GO:0045727(positive regulation of translation);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055131(C3HC4-type RING finger domain binding);GO:0071456(cellular response to hypoxia);GO:0072655(establishment of protein localization to mitochondrion);GO:0072656(maintenance of protein location in mitochondrion);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0090258(negative regulation of mitochondrial fission);GO:0097237(cellular response to toxic substance);GO:0097449(astrocyte projection);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization);GO:0099074(mitochondrion to lysosome transport);GO:1900407(regulation of cellular response to oxidative stress);GO:1901727(positive regulation of histone deacetylase activity);GO:1902902(negative regulation of autophagosome assembly);GO:1902958(positive regulation of mitochondrial electron transport, NADH to ubiquinone);GO:1903147(negative regulation of autophagy of mitochondrion);GO:1903202(negative regulation of oxidative stress-induced cell death);GO:1903214(regulation of protein targeting to mitochondrion);GO:1903298(negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway);GO:1903384(negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway);GO:1903751(negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:1903852(positive regulation of cristae formation);GO:1904841(TORC2 complex binding);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04137(Mitophagy - animal);05012(Parkinson disease)",{"v":4e-25,"d":"0.00"},1,"657,",0,{"v":-24.4,"d":"-24.40"},{"v":-23.5,"d":"-23.50"},6.48,"3' UTR",2,4785163,4907008,121846,1]
["chr2",7607911,7608708,798,"ENSBGRG00000003976","ENSBGRT00000007422",29088,"HNRNPR","heterogeneous nuclear ribonucleoprotein R [Source:HGNC Symbol;Acc:HGNC:5047]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0071013(catalytic step 2 spliceosome);GO:1990904(ribonucleoprotein complex)","NA",0,2,"613,68,","0,730",-887,"-Inf",5.94,"Exon (ENSBGRT00000007422/ENSBGRG00000003976, exon 9 of 10)",2,7607911,7637796,29886,2]
["chr2",10292994,10329388,36395,"ENSBGRG00000008727","ENSBGRT00000015897",734,"ENSBGRG00000008727","NA","GO:0031110(regulation of microtubule polymerization or depolymerization)","04010(MAPK signaling pathway);05206(MicroRNAs in cancer)",{"v":1e-188,"d":"0.00"},5,"43,192,173,73,48,","0,453,2566,3242,36347",-188,-186,2.66,"5' UTR",2,10292965,10330122,37158,2]
["chr2",11272336,11272662,327,"ENSBGRG00000008880","ENSBGRT00000016256",89,"GPATCH3","G-patch domain containing 3 [Source:HGNC Symbol;Acc:HGNC:25720]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0032480(negative regulation of type I interferon production);GO:0039536(negative regulation of RIG-I signaling pathway);GO:0045893(positive regulation of transcription, DNA-templated)","NA",{"v":0.0032,"d":"0.00"},1,"327,",0,{"v":-2.5,"d":"-2.50"},-1.93,6.93,"Exon (ENSBGRT00000016256/ENSBGRG00000008880, exon 1 of 7)",2,11263821,11272751,8931,2]
["chr2",16090111,16099013,8903,"ENSBGRG00000008612","ENSBGRT00000016454",53178,"COL16A1","collagen type XVI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2193]","GO:0005178(integrin binding);GO:0007155(cell adhesion);GO:0033622(integrin activation);GO:0033627(cell adhesion mediated by integrin);GO:0051894(positive regulation of focal adhesion assembly);GO:0071230(cellular response to amino acid stimulus)","04974(Protein digestion and absorption)",0,10,"203,78,177,67,189,45,36,90,51,51,","0,946,1196,2083,2511,3574,4182,5686,6075,8852",-446,"-Inf",2.55,"Exon (ENSBGRT00000016454/ENSBGRG00000008612, exon 61 of 70)",2,16090111,16152191,62081,2]
["chr2",17343298,17345184,1887,"ENSBGRG00000015458","ENSBGRT00000029183",24938,"RNF19B","ring finger protein 19B [Source:HGNC Symbol;Acc:HGNC:26886]","GO:0004842(ubiquitin-protein transferase activity);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0016567(protein ubiquitination);GO:0043130(ubiquitin binding);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":1e-162,"d":"0.00"},3,"834,22,73,","0,862,1814",-162,-161,5.09,"3' UTR",2,17343298,17370122,26825,2]
["chr2",20107956,20123365,15410,"ENSBGRG00000008056","ENSBGRT00000014693",51391,"ENSBGRG00000008056","NA","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016604(nuclear body)","05203(Viral carcinogenesis);05168(Herpes simplex infection)",{"v":1.6e-06,"d":"0.00"},4,"82,57,86,15,","0,1826,14325,15395",-5.79,-5.09,2.13,"Exon (ENSBGRT00000014693/ENSBGRG00000008056, exon 14 of 27)",2,20088883,20174756,85874,2]
["chr2",31992822,31993833,1012,"ENSBGRG00000018330","ENSBGRT00000033536",15151,"STK11IP","serine/threonine kinase 11 interacting protein [Source:HGNC Symbol;Acc:HGNC:19184]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008104(protein localization);GO:0019901(protein kinase binding)","NA",{"v":7.4e-09,"d":"0.00"},2,"150,148,","0,864",-8.13,-7.37,3.79,"Exon (ENSBGRT00000033536/ENSBGRG00000018330, exon 23 of 24)",2,31992822,32008984,16163,2]
["chr2",32771404,32771761,358,"ENSBGRG00000000672","ENSBGRT00000001209",13719,"WNT10A","Wnt family member 10A [Source:HGNC Symbol;Acc:HGNC:13829]","GO:0001942(hair follicle development);GO:0005102(signaling receptor binding);GO:0005576(extracellular region);GO:0007275(multicellular organism development);GO:0010628(positive regulation of gene expression);GO:0014033(neural crest cell differentiation);GO:0016055(Wnt signaling pathway);GO:0031069(hair follicle morphogenesis);GO:0042476(odontogenesis);GO:0042487(regulation of odontogenesis of dentin-containing tooth);GO:0043586(tongue development);GO:0043588(skin development);GO:0048018(receptor ligand activity);GO:0048730(epidermis morphogenesis);GO:0048733(sebaceous gland development);GO:0060070(canonical Wnt signaling pathway);GO:0071560(cellular response to transforming growth factor beta stimulus)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":0.011,"d":"0.01"},1,"358,",0,-1.95,-1.18,8.91,"3' UTR",2,32771404,32785480,14077,2]
["chr2",33063359,33064288,930,"ENSBGRG00000001098","ENSBGRT00000002047",26023,"PLCD4","phospholipase C delta 4 [Source:HGNC Symbol;Acc:HGNC:9062]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0004629(phospholipase C activity);GO:0005509(calcium ion binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007340(acrosome reaction);GO:0008081(phosphoric diester hydrolase activity);GO:0031965(nuclear membrane);GO:0035556(intracellular signal transduction);GO:0046488(phosphatidylinositol metabolic process)","00562(Inositol phosphate metabolism);04020(Calcium signaling pathway);04070(Phosphatidylinositol signaling system);04919(Thyroid hormone signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications)",{"v":2.5E-56,"d":"0.00"},1,"930,",0,{"v":-55.6,"d":"-55.60"},{"v":-54.3,"d":"-54.30"},{"v":14.9,"d":"14.90"},"3' UTR",2,33063359,33090311,26953,2]
["chr2",43034747,43035076,330,"ENSBGRG00000005995","ENSBGRT00000011130",125605,"MAP2","microtubule associated protein 2 [Source:HGNC Symbol;Acc:HGNC:6839]","GO:0000226(microtubule cytoskeleton organization);GO:0001578(microtubule bundle formation);GO:0002162(dystroglycan binding);GO:0005737(cytoplasm);GO:0007409(axonogenesis);GO:0008017(microtubule binding);GO:0014069(postsynaptic density);GO:0015631(tubulin binding);GO:0016358(dendrite development);GO:0021954(central nervous system neuron development);GO:0030010(establishment of cell polarity);GO:0030425(dendrite);GO:0030517(negative regulation of axon extension);GO:0031175(neuron projection development);GO:0034399(nuclear periphery);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0043194(axon initial segment);GO:0043198(dendritic shaft);GO:0043203(axon hillock);GO:0044297(cell body);GO:0048813(dendrite morphogenesis);GO:0071310(cellular response to organic substance);GO:0097442(CA3 pyramidal cell dendrite);GO:1903827(regulation of cellular protein localization);GO:1990769(proximal neuron projection)","NA",{"v":0.00049,"d":"0.00"},1,"330,",0,-3.31,{"v":-2.7,"d":"-2.70"},{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000011130/ENSBGRG00000005995, exon 6 of 14)",2,43000576,43160681,160106,2]
["chr2",50720810,50720899,90,"ENSBGRG00000018191","ENSBGRT00000033257",30,"FZD7","frizzled class receptor 7 [Source:HGNC Symbol;Acc:HGNC:4045]","GO:0004888(transmembrane signaling receptor activity);GO:0005109(frizzled binding);GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0007166(cell surface receptor signaling pathway);GO:0010812(negative regulation of cell-substrate adhesion);GO:0014834(skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0019827(stem cell population maintenance);GO:0030165(PDZ domain binding);GO:0033077(T cell differentiation in thymus);GO:0034446(substrate adhesion-dependent cell spreading);GO:0035567(non-canonical Wnt signaling pathway);GO:0038031(non-canonical Wnt signaling pathway via JNK cascade);GO:0042327(positive regulation of phosphorylation);GO:0042666(negative regulation of ectodermal cell fate specification);GO:0042813(Wnt-activated receptor activity);GO:0043231(intracellular membrane-bounded organelle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0048103(somatic stem cell division);GO:0055038(recycling endosome membrane);GO:0060054(positive regulation of epithelial cell proliferation involved in wound healing);GO:0060070(canonical Wnt signaling pathway);GO:0060231(mesenchymal to epithelial transition);GO:0060828(regulation of canonical Wnt signaling pathway);GO:2000726(negative regulation of cardiac muscle cell differentiation)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":0.0017,"d":"0.00"},1,"90,",0,-2.76,-2.18,1.57,"Exon (ENSBGRT00000033257/ENSBGRG00000018191, exon 1 of 1)",2,50719205,50720929,1725,2]
["chr2",55683884,55684034,151,"ENSBGRG00000000566","ENSBGRT00000001014",16734,"COQ10B","coenzyme Q10B [Source:HGNC Symbol;Acc:HGNC:25819]","NA","NA",{"v":1.2e-07,"d":"0.00"},1,"151,",0,-6.91,-6.18,1.98,"3' UTR",2,55683854,55700768,16915,2]
["chr2",71831664,71836958,5295,"ENSBGRG00000002915","ENSBGRT00000005452",652,"TMEM37","transmembrane protein 37 [Source:HGNC Symbol;Acc:HGNC:18216]","GO:0005244(voltage-gated ion channel activity);GO:0005262(calcium channel activity);GO:0016021(integral component of membrane)","NA",{"v":1e-18,"d":"0.00"},2,"128,139,","0,5156",-18,{"v":-17.1,"d":"-17.10"},8.91,"5' UTR",2,71830805,71837610,6806,2]
["chr2",87879727,87909587,29861,"ENSBGRG00000001782","ENSBGRT00000007179",1098932,"LRP1B","LDL receptor related protein 1B [Source:HGNC Symbol;Acc:HGNC:6693]","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0043235(receptor complex)","NA",{"v":0.036,"d":"0.04"},3,"78,224,29,","0,1510,29832",-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000007179/ENSBGRG00000001782, exon 74 of 87)",2,87727149,89008519,1281371,2]
["chr2",107315759,107315998,240,"ENSBGRG00000008859","ENSBGRT00000016320",28744,"CYTIP","cytohesin 1 interacting protein [Source:HGNC Symbol;Acc:HGNC:9506]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005938(cell cortex);GO:0030155(regulation of cell adhesion)","NA",{"v":1.1e-08,"d":"0.00"},1,"240,",0,-7.95,-7.19,{"v":16.8,"d":"16.80"},"Exon (ENSBGRT00000016320/ENSBGRG00000008859, exon 8 of 8)",2,107314950,107344742,29793,2]
["chr2",109514762,109518317,3556,"ENSBGRG00000010962","ENSBGRT00000020067",252507,"BAZ2B","bromodomain adjacent to zinc finger domain 2B [Source:HGNC Symbol;Acc:HGNC:963]","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0042025(host cell nucleus)","NA",{"v":0.018,"d":"0.02"},2,"53,7,","0,3549",-1.74,-1.22,2.81,"Exon (ENSBGRT00000020067/ENSBGRG00000010962, exon 11 of 37)",2,109407784,109770824,363041,2]
["chr2",117258385,117258445,61,"ENSBGRG00000023014","ENSBGRT00000042575",88785,"SCN7A","sodium voltage-gated channel alpha subunit 7 [Source:HGNC Symbol;Acc:HGNC:10594]","GO:0001518(voltage-gated sodium channel complex);GO:0005216(ion channel activity);GO:0005248(voltage-gated sodium channel activity);GO:0005261(cation channel activity);GO:0005272(sodium channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0006936(muscle contraction);GO:0009617(response to bacterium);GO:0016020(membrane);GO:0055078(sodium ion homeostasis);GO:0055085(transmembrane transport);GO:0097386(glial cell projection)","04261(Adrenergic signaling in cardiomyocytes)",{"v":1.4E-5,"d":"0.00"},1,"61,",0,-4.86,-4.19,5.28,"Exon (ENSBGRT00000042575/ENSBGRG00000023014, exon 25 of 25)",2,117257608,117347230,89623,2]
["chr2",125632038,125632307,270,"ENSBGRG00000014271","ENSBGRT00000026269",37625,"SCRN3","secernin 3 [Source:HGNC Symbol;Acc:HGNC:30382]","GO:0006508(proteolysis);GO:0016805(dipeptidase activity)","NA",{"v":2e-10,"d":"0.00"},1,"270,",0,{"v":-9.7,"d":"-9.70"},{"v":-8.9,"d":"-8.90"},2.18,"3' UTR",2,125594413,125665083,70671,1]
["chr2",135113604,135114235,632,"ENSBGRG00000002408","ENSBGRT00000004484",30,"FRZB","frizzled related protein [Source:HGNC Symbol;Acc:HGNC:3959]","GO:0005515(protein binding);GO:0008285(negative regulation of cell population proliferation);GO:0010721(negative regulation of cell development);GO:0014033(neural crest cell differentiation);GO:0017147(Wnt-protein binding);GO:0030178(negative regulation of Wnt signaling pathway);GO:0030308(negative regulation of cell growth);GO:0042472(inner ear morphogenesis);GO:0043065(positive regulation of apoptotic process);GO:0045600(positive regulation of fat cell differentiation);GO:0060029(convergent extension involved in organogenesis);GO:0061037(negative regulation of cartilage development);GO:0061053(somite development);GO:0070367(negative regulation of hepatocyte differentiation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090103(cochlea morphogenesis)","04310(Wnt signaling pathway)",{"v":7.8e-09,"d":"0.00"},2,"175,34,","0,598",-8.11,-7.35,{"v":1.6,"d":"1.60"},"5' UTR",2,135077998,135114265,36268,2]
["chr2",144953095,144953362,268,"ENSBGRG00000003286","ENSBGRT00000006104",592,"ENSBGRG00000003286","NA","NA","NA",{"v":2.3e-07,"d":"0.00"},1,"268,",0,-6.63,{"v":-5.9,"d":"-5.90"},{"v":25.8,"d":"25.80"},"Exon (ENSBGRT00000006104/ENSBGRG00000003286, exon 1 of 1)",2,144952236,144953954,1719,2]
["chr2",149146702,149147027,326,"ENSBGRG00000005572","ENSBGRT00000010293",48671,"NIPA1","NIPA magnesium transporter 1 [Source:HGNC Symbol;Acc:HGNC:17043]","GO:0005769(early endosome);GO:0005886(plasma membrane);GO:0015095(magnesium ion transmembrane transporter activity);GO:0015693(magnesium ion transport);GO:0016021(integral component of membrane)","NA",{"v":7.2E-9,"d":"0.00"},1,"326,",0,-8.14,-7.38,5.45,"Exon (ENSBGRT00000010293/ENSBGRG00000005572, exon 5 of 5)",2,149146702,149195698,48997,2]
["chr3",1769395,1769722,328,"ENSBGRG00000018334","ENSBGRT00000033774",30,"MTX1","metaxin 1 [Source:HGNC Symbol;Acc:HGNC:7504]","GO:0001401(SAM complex)","NA",{"v":4.2e-05,"d":"0.00"},1,"328,",0,-4.38,-3.73,{"v":17.8,"d":"17.80"},"Exon (ENSBGRT00000033774/ENSBGRG00000018334, exon 1 of 8)",3,1769365,1774216,4852,1]
["chr3",2692414,2692653,240,"ENSBGRG00000023097","ENSBGRT00000042668",18507,"SLC25A44","solute carrier family 25 member 44 [Source:HGNC Symbol;Acc:HGNC:29036]","GO:0005347(ATP transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":1E-175,"d":"0.00"},1,"240,",0,-175,-173,5.22,"3' UTR",3,2673907,2692653,18747,1]
["chr3",7424114,7425233,1120,"ENSBGRG00000012802","ENSBGRT00000023431",180,"DUSP23","dual specificity phosphatase 23 [Source:HGNC Symbol;Acc:HGNC:21480]","GO:0004725(protein tyrosine phosphatase activity);GO:0005654(nucleoplasm);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity)","NA",{"v":7.9e-40,"d":"0.00"},2,"89,421,","0,699",{"v":-39.1,"d":"-39.10"},-38,6.83,"3' UTR",3,7423934,7425233,1300,1]
["chr3",8085320,8085469,150,"ENSBGRG00000017046","ENSBGRT00000031296",15155,"NCSTN","nicastrin [Source:HGNC Symbol;Acc:HGNC:17091]","GO:0002262(myeloid cell homeostasis);GO:0004175(endopeptidase activity);GO:0005764(lysosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006509(membrane protein ectodomain proteolysis);GO:0007212(dopamine receptor signaling pathway);GO:0007215(glutamate receptor signaling pathway);GO:0007611(learning or memory);GO:0008021(synaptic vesicle);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016485(protein processing);GO:0022010(central nervous system myelination);GO:0030534(adult behavior);GO:0032991(protein-containing complex);GO:0034205(amyloid-beta formation);GO:0042098(T cell proliferation);GO:0042982(amyloid precursor protein metabolic process);GO:0042983(amyloid precursor protein biosynthetic process);GO:0042986(positive regulation of amyloid precursor protein biosynthetic process);GO:0043085(positive regulation of catalytic activity);GO:0050435(amyloid-beta metabolic process);GO:0050673(epithelial cell proliferation);GO:0051117(ATPase binding);GO:0051402(neuron apoptotic process);GO:0070765(gamma-secretase complex);GO:0070851(growth factor receptor binding);GO:0070997(neuron death);GO:0071277(cellular response to calcium ion);GO:1900271(regulation of long-term synaptic potentiation);GO:1990926(short-term synaptic potentiation)","04330(Notch signaling pathway);05010(Alzheimer disease)",{"v":7.6e-05,"d":"0.00"},1,"150,",0,-4.12,-3.47,1.46,"3' UTR",3,8070165,8086964,16800,1]
["chr3",10020398,10020636,239,"ENSBGRG00000002089","ENSBGRT00000003902",254480,"ATF6","activating transcription factor 6 [Source:HGNC Symbol;Acc:HGNC:791]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001654(eye development);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0006355(regulation of transcription, DNA-templated);GO:0007601(visual perception);GO:0016020(membrane);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0035497(cAMP response element binding);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:1903893(positive regulation of ATF6-mediated unfolded protein response);GO:1990440(positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress);GO:1990837(sequence-specific double-stranded DNA binding)","04141(Protein processing in endoplasmic reticulum);05010(Alzheimer disease)",{"v":2e-42,"d":"0.00"},1,"239,",0,{"v":-41.7,"d":"-41.70"},{"v":-40.6,"d":"-40.60"},6.65,"3' UTR",3,9765918,10020636,254719,1]
["chr3",18066810,18075261,8452,"ENSBGRG00000010060","ENSBGRT00000018686",146488,"TIPRL","TOR signaling pathway regulator [Source:HGNC Symbol;Acc:HGNC:30231]","GO:0000077(DNA damage checkpoint);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0032515(negative regulation of phosphoprotein phosphatase activity);GO:0043666(regulation of phosphoprotein phosphatase activity)","NA",{"v":1.3E-75,"d":"0.00"},6,"10,82,36,59,30,621,","0,1495,3952,4075,6004,7831",{"v":-74.9,"d":"-74.90"},{"v":-73.5,"d":"-73.50"},5.27,"3' UTR",3,17920322,18066819,146498,1]
["chr3",20758993,20761505,2513,"ENSBGRG00000000272","ENSBGRT00000000438",0,"C1orf54","chromosome 1 open reading frame 54 [Source:HGNC Symbol;Acc:HGNC:26258]","NA","NA",{"v":7.9e-15,"d":"0.00"},5,"46,84,8,48,84,","0,1256,1955,1965,2429",{"v":-14.1,"d":"-14.10"},{"v":-13.2,"d":"-13.20"},{"v":3.6,"d":"3.60"},"Exon (ENSBGRT00000000438/ENSBGRG00000000272, exon 1 of 6)",3,20758993,20766289,7297,1]
["chr3",21536400,21537974,1575,"ENSBGRG00000001610","ENSBGRT00000003019",20266,"GABPB2","GA binding protein transcription factor subunit beta 2 [Source:HGNC Symbol;Acc:HGNC:28441]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":4e-11,"d":"0.00"},2,"535,300,","0,1275",{"v":-10.4,"d":"-10.40"},-9.57,6.93,"3' UTR",3,21516134,21536934,20801,1]
["chr3",22036312,22039994,3683,"ENSBGRG00000002259","ENSBGRT00000004261",10111,"ENSBGRG00000002259","NA","GO:0003774(motor activity);GO:0016459(myosin complex)","04530(Tight junction)",{"v":1.6E-13,"d":"0.00"},5,"33,70,90,128,8,","0,176,349,2113,3675",{"v":-12.8,"d":"-12.80"},-12,2.66,"Exon (ENSBGRT00000004261/ENSBGRG00000002259, exon 3 of 20)",3,22026201,22052913,26713,1]
["chr3",38165142,38165202,61,"ENSBGRG00000001080","ENSBGRT00000001994",83048,"ELAPOR1","KIAA1324 [Source:HGNC Symbol;Acc:HGNC:29618]","GO:0000045(autophagosome assembly);GO:0005764(lysosome);GO:0005770(late endosome);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0009267(cellular response to starvation);GO:0044090(positive regulation of vacuole organization);GO:2000786(positive regulation of autophagosome assembly)","00970(Aminoacyl-tRNA biosynthesis)",{"v":1.5E-5,"d":"0.00"},1,"61,",0,-4.82,-4.15,8.25,"3' UTR",3,38082094,38165322,83229,1]
["chr3",38217354,38217504,151,"ENSBGRG00000001203","ENSBGRT00000002276",3215,"CELSR2","cadherin EGF LAG seven-pass G-type receptor 2 [Source:HGNC Symbol;Acc:HGNC:3231]","GO:0001764(neuron migration);GO:0003341(cilium movement);GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0021591(ventricular system development);GO:0021999(neural plate anterior/posterior regionalization);GO:0032880(regulation of protein localization);GO:0033326(cerebrospinal fluid secretion);GO:0060271(cilium assembly)","NA",{"v":5.5e-07,"d":"0.00"},1,"151,",0,-6.26,-5.54,6.27,"Exon (ENSBGRT00000002276/ENSBGRG00000001203, exon 3 of 36)",3,38214139,38240461,26323,1]
["chr3",39308066,39308396,331,"ENSBGRG00000002862","ENSBGRT00000005487",17251,"KCNC4","potassium voltage-gated channel subfamily C member 4 [Source:HGNC Symbol;Acc:HGNC:6236]","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005515(protein binding);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031594(neuromuscular junction);GO:0043679(axon terminus);GO:0046928(regulation of neurotransmitter secretion);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport)","NA",{"v":9.8e-08,"d":"0.00"},1,"331,",0,-7.01,-6.27,4.95,"Exon (ENSBGRT00000005487/ENSBGRG00000002862, exon 2 of 4)",3,39290815,39315462,24648,1]
["chr3",43136128,43144651,8524,"ENSBGRG00000004622","ENSBGRT00000008924",197221,"MAGI3","membrane associated guanylate kinase, WW and PDZ domain containing 3 [Source:HGNC Symbol;Acc:HGNC:29647]","GO:0005515(protein binding);GO:0005911(cell-cell junction);GO:0007165(signal transduction);GO:0030054(cell junction);GO:0046328(regulation of JNK cascade);GO:0060090(molecular adaptor activity)","04015(Rap1 signaling pathway)",{"v":0.006,"d":"0.01"},2,"16,75,","0,8449",-2.22,-1.67,1.65,"Exon (ENSBGRT00000008924/ENSBGRG00000004622, exon 4 of 21)",3,42938907,43230612,291706,1]
["chr3",50788813,50789682,870,"ENSBGRG00000013976","ENSBGRT00000027364",123887,"PDE4DIP","phosphodiesterase 4D interacting protein [Source:HGNC Symbol;Acc:HGNC:15580]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0060090(molecular adaptor activity);GO:1903358(regulation of Golgi organization)","NA",{"v":1.3e-26,"d":"0.00"},1,"870,",0,{"v":-25.9,"d":"-25.90"},{"v":-24.9,"d":"-24.90"},4.62,"Exon (ENSBGRT00000029511/ENSBGRG00000013976, exon 1 of 21)",3,50664926,50820460,155535,1]
["chr3",59032065,59033069,1005,"ENSBGRG00000002846","ENSBGRT00000005315",123395,"GBP2","guanylate binding protein 2 [Source:HGNC Symbol;Acc:HGNC:4183]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0015629(actin cytoskeleton);GO:0034504(protein localization to nucleus);GO:0042803(protein homodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0071346(cellular response to interferon-gamma);GO:0071347(cellular response to interleukin-1);GO:0071356(cellular response to tumor necrosis factor)","04621(NOD-like receptor signaling pathway)",{"v":9.8e-08,"d":"0.00"},2,"15,105,","0,900",-7.01,-6.27,4.95,"3' UTR",3,58908670,59033069,124400,1]
["chr3",63564095,63564363,269,"ENSBGRG00000000411","ENSBGRT00000000750",989,"C1orf52","chromosome 1 open reading frame 52 [Source:HGNC Symbol;Acc:HGNC:24871]","GO:0005654(nucleoplasm)","NA",{"v":1e-30,"d":"0.00"},1,"269,",0,-30,-29,3.32,"3' UTR",3,63563106,63566258,3153,1]
["chr3",84329436,84338941,9506,"ENSBGRG00000009099","ENSBGRT00000016846",4758,"SERBP1","SERPINE1 mRNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:17860]","GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0030578(PML body organization);GO:0032183(SUMO binding)","NA",0,6,"96,90,120,178,174,300,","0,208,878,3512,7224,9206",-562,"-Inf",2.68,"3' UTR",3,84324678,84340048,15371,1]
["chr3",97410529,97410885,357,"ENSBGRG00000000652","ENSBGRT00000001174",0,"ENSBGRG00000000652","NA","GO:0001568(blood vessel development);GO:0001702(gastrulation with mouth forming second);GO:0001933(negative regulation of protein phosphorylation);GO:0005178(integrin binding);GO:0005886(plasma membrane);GO:0006644(phospholipid metabolic process);GO:0007155(cell adhesion);GO:0008195(phosphatidate phosphatase activity);GO:0030111(regulation of Wnt signaling pathway);GO:0042392(sphingosine-1-phosphate phosphatase activity);GO:0042577(lipid phosphatase activity);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050821(protein stabilization);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060020(Bergmann glial cell differentiation);GO:0060070(canonical Wnt signaling pathway);GO:0098609(cell-cell adhesion);GO:1902068(regulation of sphingolipid mediated signaling pathway)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism);00600(Sphingolipid metabolism);04072(Phospholipase D signaling pathway);04666(Fc gamma R-mediated phagocytosis);04975(Fat digestion and absorption);05231(Choline metabolism in cancer)",{"v":2e-86,"d":"0.00"},1,"357,",0,{"v":-85.7,"d":"-85.70"},{"v":-84.3,"d":"-84.30"},6.99,"5' UTR",3,97410529,97516547,106019,1]
["chr3",99715821,99715970,150,"ENSBGRG00000001202","ENSBGRT00000002235",60758,"ENSBGRG00000001202","NA","NA","NA",{"v":1.8E-3,"d":"0.00"},1,"150,",0,-2.75,-2.16,2.64,"Exon (ENSBGRT00000002235/ENSBGRG00000001202, exon 8 of 10)",3,99655063,99716442,61380,1]
["chr3",102275973,102276301,329,"ENSBGRG00000003617","ENSBGRT00000006739",718,"ENSBGRG00000003617","NA","NA","NA",{"v":0.036,"d":"0.04"},1,"329,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000006739/ENSBGRG00000003617, exon 2 of 2)",3,102275255,102279169,3915,1]
["chr3",107855987,107856434,448,"ENSBGRG00000000873","ENSBGRT00000001583",12820,"TAL1","TAL bHLH transcription factor 1, erythroid differentiation factor [Source:HGNC Symbol;Acc:HGNC:11556]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001085(RNA polymerase II transcription factor binding);GO:0001525(angiogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007626(locomotory behavior);GO:0019899(enzyme binding);GO:0021527(spinal cord association neuron differentiation);GO:0030097(hemopoiesis);GO:0030099(myeloid cell differentiation);GO:0030182(neuron differentiation);GO:0030218(erythrocyte differentiation);GO:0030219(megakaryocyte differentiation);GO:0030220(platelet formation);GO:0030221(basophil differentiation);GO:0031334(positive regulation of protein-containing complex assembly);GO:0032991(protein-containing complex);GO:0033193(Lsd1/2 complex);GO:0035162(embryonic hemopoiesis);GO:0035855(megakaryocyte development);GO:0042127(regulation of cell population proliferation);GO:0042826(histone deacetylase binding);GO:0043249(erythrocyte maturation);GO:0045165(cell fate commitment);GO:0045637(regulation of myeloid cell differentiation);GO:0045648(positive regulation of erythrocyte differentiation);GO:0045799(positive regulation of chromatin assembly or disassembly);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045931(positive regulation of mitotic cell cycle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0048699(generation of neurons);GO:0051781(positive regulation of cell division);GO:0060018(astrocyte fate commitment);GO:0060216(definitive hemopoiesis);GO:0060217(hemangioblast cell differentiation);GO:0060218(hematopoietic stem cell differentiation);GO:0060375(regulation of mast cell differentiation);GO:0070888(E-box binding);GO:2000036(regulation of stem cell population maintenance)","NA",{"v":5e-16,"d":"0.00"},1,"448,",0,{"v":-15.3,"d":"-15.30"},{"v":-14.4,"d":"-14.40"},{"v":15.2,"d":"15.20"},"Exon (ENSBGRT00000001583/ENSBGRG00000000873, exon 5 of 5)",3,107843167,107856434,13268,1]
["chr3",110050945,110051094,150,"ENSBGRG00000003153","ENSBGRT00000005930",160594,"ZSWIM5","zinc finger SWIM-type containing 5 [Source:HGNC Symbol;Acc:HGNC:29299]","GO:0008270(zinc ion binding)","00510(N-Glycan biosynthesis)",0.04,1,"150,",0,{"v":-1.4,"d":"-1.40"},-0.91,{"v":3.3,"d":"3.30"},"Exon (ENSBGRT00000005930/ENSBGRG00000003153, exon 15 of 15)",3,109890351,110053427,163077,1]
["chr3",114049219,114049399,181,"ENSBGRG00000014136","ENSBGRT00000026233",1199,"HIVEP3","HIVEP zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:13561]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0035914(skeletal muscle cell differentiation);GO:0045893(positive regulation of transcription, DNA-templated)","NA",{"v":0.014,"d":"0.01"},1,"181,",0,-1.85,-1.33,3.17,"Exon (ENSBGRT00000026233/ENSBGRG00000014136, exon 1 of 7)",3,114048020,114110747,62728,1]
["chr3",117955103,117960354,5252,"ENSBGRG00000005837","ENSBGRT00000010783",41344,"MTF1","metal regulatory transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:7428]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-templated);GO:0006979(response to oxidative stress);GO:0035035(histone acetyltransferase binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046686(response to cadmium ion);GO:0071294(cellular response to zinc ion);GO:1990079(cartilage homeostasis);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":4e-36,"d":"0.00"},3,"19,64,457,","0,3555,4795",{"v":-35.4,"d":"-35.40"},{"v":-34.3,"d":"-34.30"},4.72,"Exon (ENSBGRT00000010783/ENSBGRG00000005837, exon 10 of 11)",3,117913759,117960354,46596,1]
["chr3",119832818,119833830,1013,"ENSBGRG00000009153","ENSBGRT00000016781",22586,"COL8A2","collagen type VIII alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2216]","GO:0005515(protein binding);GO:0048593(camera-type eye morphogenesis);GO:0050673(epithelial cell proliferation)","04974(Protein digestion and absorption)",{"v":2.5e-43,"d":"0.00"},1,"1013,",0,{"v":-42.6,"d":"-42.60"},{"v":-41.5,"d":"-41.50"},{"v":31.7,"d":"31.70"},"Exon (ENSBGRT00000016781/ENSBGRG00000009153, exon 4 of 4)",3,119810232,119834277,24046,1]
["chr3",121099686,121100347,662,"ENSBGRG00000007485","ENSBGRT00000013697",4887,"ENSBGRG00000007485","NA","NA","NA",{"v":9.99999999999998e-288,"d":"0.00"},3,"59,118,301,","0,162,361",-287,-285,6.97,"3' UTR",3,121094799,121100347,5549,1]
["chr3",123081712,123091446,9735,"ENSBGRG00000009551","ENSBGRT00000017564",98606,"GIGYF2","GRB10 interacting GYF protein 2 [Source:HGNC Symbol;Acc:HGNC:11960]","GO:0005515(protein binding);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0010494(cytoplasmic stress granule);GO:0016441(posttranscriptional gene silencing);GO:0017148(negative regulation of translation);GO:0032991(protein-containing complex);GO:0043204(perikaryon);GO:0048009(insulin-like growth factor receptor signaling pathway);GO:0061157(mRNA destabilization);GO:0070064(proline-rich region binding);GO:1990635(proximal dendrite)","NA",{"v":1e-145,"d":"0.00"},4,"39,162,159,151,","0,1880,3367,9584",-145,-143,{"v":3.2,"d":"3.20"},"Exon (ENSBGRT00000017564/ENSBGRG00000009551, exon 19 of 29)",3,122983106,123117353,134248,1]
["chr3",128710824,128712259,1436,"ENSBGRG00000021383","ENSBGRT00000039449",25383,"ESPNL","espin like [Source:HGNC Symbol;Acc:HGNC:27937]","GO:0005515(protein binding);GO:0007605(sensory perception of sound);GO:0032426(stereocilium tip);GO:0051015(actin filament binding)","NA",{"v":1.6e-29,"d":"0.00"},1,"1436,",0,{"v":-28.8,"d":"-28.80"},{"v":-27.8,"d":"-27.80"},{"v":10.6,"d":"10.60"},"Exon (ENSBGRT00000039449/ENSBGRG00000021383, exon 9 of 9)",3,128685441,128712259,26819,1]
["chr3",131427466,131432009,4544,"ENSBGRG00000000737","ENSBGRT00000001404",22796,"ENSBGRG00000000737","NA","NA","NA",{"v":0.00018,"d":"0.00"},2,"123,118,","0,4426",-3.75,-3.12,2.37,"Exon (ENSBGRT00000001404/ENSBGRG00000000737, exon 11 of 23)",3,131404670,131453392,48723,1]
["chr3",958455,958603,149,"ENSBGRG00000008191","ENSBGRT00000015058",16198,"SHE","Src homology 2 domain containing E [Source:HGNC Symbol;Acc:HGNC:27004]","NA","04020(Calcium signaling pathway);04080(Neuroactive ligand-receptor interaction);04810(Regulation of actin cytoskeleton)",{"v":0.0024,"d":"0.00"},1,"149,",0,-2.62,-2.05,{"v":2.7,"d":"2.70"},"Exon (ENSBGRT00000015058/ENSBGRG00000008191, exon 4 of 6)",3,955556,974801,19246,2]
["chr3",2053589,2053679,91,"ENSBGRG00000020526","ENSBGRT00000037795",32930,"ASH1L","ASH1 like histone lysine methyltransferase [Source:HGNC Symbol;Acc:HGNC:19088]","GO:0001501(skeletal system development);GO:0002674(negative regulation of acute inflammatory response);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0007338(single fertilization);GO:0009791(post-embryonic development);GO:0010468(regulation of gene expression);GO:0018024(histone-lysine N-methyltransferase activity);GO:0030317(flagellated sperm motility);GO:0032635(interleukin-6 production);GO:0042800(histone methyltransferase activity (H3-K4 specific));GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043409(negative regulation of MAPK cascade);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046697(decidualization);GO:0046974(histone methyltransferase activity (H3-K9 specific));GO:0046975(histone methyltransferase activity (H3-K36 specific));GO:0048733(sebaceous gland development);GO:0050728(negative regulation of inflammatory response);GO:0051568(histone H3-K4 methylation);GO:0061038(uterus morphogenesis);GO:0097676(histone H3-K36 dimethylation);GO:1903699(tarsal gland development);GO:1903709(uterine gland development)","00310(Lysine degradation)",{"v":0.0012,"d":"0.00"},1,"91,",0,-2.92,-2.33,2.16,"Exon (ENSBGRT00000037795/ENSBGRG00000020526, exon 2 of 27)",3,1903275,2086609,183335,2]
["chr3",3281752,3282137,386,"ENSBGRG00000006648","ENSBGRT00000012297",91,"HDGF","heparin binding growth factor [Source:HGNC Symbol;Acc:HGNC:4856]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001222(transcription corepressor binding);GO:0003714(transcription corepressor activity);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0009987(cellular process);GO:0017053(transcriptional repressor complex);GO:0098761(cellular response to interleukin-7)","NA",{"v":0.00098,"d":"0.00"},1,"386,",0,-3.01,-2.42,{"v":12.9,"d":"12.90"},"5' UTR",3,3271917,3282228,10312,2]
["chr3",8798764,8798823,60,"ENSBGRG00000000537","ENSBGRT00000000955",1098,"ENSBGRG00000000537","NA","GO:0003723(RNA binding);GO:0005515(protein binding)","03013(RNA transport)",{"v":0.0087,"d":"0.01"},1,"60,",0,-2.06,-1.53,{"v":1.8,"d":"1.80"},"Exon (ENSBGRT00000000955/ENSBGRG00000000537, exon 2 of 4)",3,8798298,8799921,1624,2]
["chr3",11188258,11188347,90,"ENSBGRG00000002667","ENSBGRT00000004995",0,"CCDC190","coiled-coil domain containing 190 [Source:HGNC Symbol;Acc:HGNC:28736]","NA","NA",{"v":1e-05,"d":"0.00"},1,"90,",0,-4.99,-4.31,2.37,"5' UTR",3,11182162,11188347,6186,2]
["chr3",17735630,17801163,65534,"ENSBGRG00000009999","ENSBGRT00000018340",0,"ENSBGRG00000009999","NA","NA","NA",{"v":1.3e-21,"d":"0.00"},3,"134,266,111,","0,61997,65423",{"v":-20.9,"d":"-20.90"},{"v":-19.9,"d":"-19.90"},4.92,"3' UTR",3,17792285,17792593,309,2]
["chr3",20552434,20553635,1202,"ENSBGRG00000016913","ENSBGRT00000031030",0,"ENSBGRG00000016913","NA","NA","NA",{"v":4e-40,"d":"0.00"},2,"287,103,","0,1099",{"v":-39.4,"d":"-39.40"},{"v":-38.3,"d":"-38.30"},{"v":6.6,"d":"6.60"},"Exon (ENSBGRT00000031030/ENSBGRG00000016913, exon 1 of 2)",3,20550786,20553635,2850,2]
["chr3",21929837,21931904,2068,"ENSBGRG00000002163","ENSBGRT00000004132",27330,"POGZ","pogo transposable element derived with ZNF domain [Source:HGNC Symbol;Acc:HGNC:18801]","GO:0000790(nuclear chromatin);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007064(mitotic sister chromatid cohesion);GO:0051382(kinetochore assembly)","NA",0,1,"2068,",0,-413,"-Inf",{"v":29.7,"d":"29.70"},"Exon (ENSBGRT00000004132/ENSBGRG00000002163, exon 17 of 17)",3,21929837,21959234,29398,2]
["chr3",22899410,22899499,90,"ENSBGRG00000003087","ENSBGRT00000005777",0,"ENSBGRG00000003087","NA","GO:0001533(cornified envelope);GO:0005198(structural molecule activity)","NA",{"v":0.0039,"d":"0.00"},1,"90,",0,-2.41,-1.85,7.92,"Exon (ENSBGRT00000005777/ENSBGRG00000003087, exon 1 of 6)",3,22894472,22899499,5028,2]
["chr3",38465275,38466549,1275,"ENSBGRG00000001535","ENSBGRT00000002829",207,"AMIGO1","adhesion molecule with Ig like domain 1 [Source:HGNC Symbol;Acc:HGNC:20824]","GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007413(axonal fasciculation);GO:0008076(voltage-gated potassium channel complex);GO:0015459(potassium channel regulator activity);GO:0030425(dendrite);GO:0032809(neuronal cell body membrane);GO:0042552(myelination);GO:0051965(positive regulation of synapse assembly);GO:1901381(positive regulation of potassium ion transmembrane transport)","NA",{"v":1.6e-74,"d":"0.00"},1,"1275,",0,{"v":-73.8,"d":"-73.80"},{"v":-72.4,"d":"-72.40"},{"v":14.9,"d":"14.90"},"Exon (ENSBGRT00000002829/ENSBGRG00000001535, exon 1 of 1)",3,38465275,38466756,1482,2]
["chr3",42319219,42319488,270,"ENSBGRG00000004446","ENSBGRT00000008188",159501,"SLC16A1","solute carrier family 16 member 1 [Source:HGNC Symbol;Acc:HGNC:10922]","GO:0005887(integral component of plasma membrane);GO:0008028(monocarboxylic acid transmembrane transporter activity);GO:0015129(lactate transmembrane transporter activity);GO:0015718(monocarboxylic acid transport);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":1.8E-3,"d":"0.00"},1,"270,",0,-2.74,-2.16,{"v":11.9,"d":"11.90"},"3' UTR",3,42318443,42478989,160547,2]
["chr3",44453252,44461844,8593,"ENSBGRG00000006823","ENSBGRT00000012620",0,"ENSBGRG00000006823","NA","GO:0003676(nucleic acid binding)","NA",{"v":3.2e-36,"d":"0.00"},2,"49,397,","0,8196",{"v":-35.5,"d":"-35.50"},{"v":-34.4,"d":"-34.40"},1.74,"5' UTR",3,44431328,44461844,30517,2]
["chr3",49906009,49909419,3411,"ENSBGRG00000012446","ENSBGRT00000022763",0,"ZNF697","zinc finger protein 697 [Source:HGNC Symbol;Acc:HGNC:32034]","GO:0003676(nucleic acid binding)","NA",{"v":3.2e-58,"d":"0.00"},2,"439,281,","0,3130",{"v":-57.5,"d":"-57.50"},{"v":-56.2,"d":"-56.20"},6.96,"5' UTR",3,49905043,49909419,4377,2]
["chr3",58039454,58042643,3190,"ENSBGRG00000002454","ENSBGRT00000004578",329,"LRRC8D","leucine rich repeat containing 8 VRAC subunit D [Source:HGNC Symbol;Acc:HGNC:16992]","GO:0005225(volume-sensitive anion channel activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0015734(taurine transport);GO:0015810(aspartate transmembrane transport);GO:0034702(ion channel complex);GO:0071470(cellular response to osmotic stress);GO:0098656(anion transmembrane transport)","NA",{"v":8.99999999999999e-295,"d":"0.00"},2,"2351,404,","0,2786",-294,-291,{"v":11.8,"d":"11.80"},"3' UTR",3,58039394,58042972,3579,2]
["chr3",67559741,67566459,6719,"ENSBGRG00000001750","ENSBGRT00000003295",270192,"ADGRL2","adhesion G protein-coupled receptor L2 [Source:HGNC Symbol;Acc:HGNC:18582]","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030246(carbohydrate binding)","NA",{"v":1e-121,"d":"0.00"},3,"695,12,73,","0,1589,6646",-121,-119,6.53,"Exon (ENSBGRT00000003295/ENSBGRG00000001750, exon 5 of 23)",3,67507768,67836651,328884,2]
["chr3",73101777,73129884,28108,"ENSBGRG00000003196","ENSBGRT00000005932",198175,"ST6GALNAC5","ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:19342]","GO:0006486(protein glycosylation);GO:0008373(sialyltransferase activity)","00604(Glycosphingolipid biosynthesis - ganglio series)",{"v":1.8E-3,"d":"0.00"},3,"202,108,48,","0,19250,28060",-2.74,-2.16,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000005932/ENSBGRG00000003196, exon 4 of 6)",3,73101747,73328059,226313,2]
["chr3",85480712,85480951,240,"ENSBGRG00000012087","ENSBGRT00000022837",20972,"PDE4B","phosphodiesterase 4B [Source:HGNC Symbol;Acc:HGNC:8781]","GO:0000930(gamma-tubulin complex);GO:0001780(neutrophil homeostasis);GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0004115(3',5'-cyclic-AMP phosphodiesterase activity);GO:0005813(centrosome);GO:0005829(cytosol);GO:0007165(signal transduction);GO:0008021(synaptic vesicle);GO:0008081(phosphoric diester hydrolase activity);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0030552(cAMP binding);GO:0030593(neutrophil chemotaxis);GO:0032729(positive regulation of interferon-gamma production);GO:0032743(positive regulation of interleukin-2 production);GO:0035690(cellular response to drug);GO:0043015(gamma-tubulin binding);GO:0043197(dendritic spine);GO:0050852(T cell receptor signaling pathway);GO:0050900(leukocyte migration);GO:0060076(excitatory synapse);GO:0071222(cellular response to lipopolysaccharide);GO:0071944(cell periphery)","00230(Purine metabolism);04024(cAMP signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);05032(Morphine addiction)",{"v":4.2e-05,"d":"0.00"},1,"240,",0,-4.38,-3.73,{"v":17.8,"d":"17.80"},"3' UTR",3,85480324,85501923,21600,2]
["chr3",99571947,99572006,60,"ENSBGRG00000001022","ENSBGRT00000001879",0,"TTC4","tetratricopeptide repeat domain 4 [Source:HGNC Symbol;Acc:HGNC:12394]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0045087(innate immune response);GO:0051607(defense response to virus)","NA",{"v":1.2E-5,"d":"0.00"},1,"60,",0,-4.92,-4.24,1.94,"Exon (ENSBGRT00000001879/ENSBGRG00000001022, exon 1 of 11)",3,99545958,99572006,26049,2]
["chr3",103445609,103492174,46566,"ENSBGRG00000007453","ENSBGRT00000013658",0,"ENSBGRG00000007453","ring finger protein 11 [Source:HGNC Symbol;Acc:HGNC:10056]","NA","NA",0,3,"172,170,146,","0,1339,46420",-554,"-Inf",{"v":11.8,"d":"11.80"},"5' UTR",3,103445609,103492174,46566,2]
["chr3",108674336,108675215,880,"ENSBGRG00000001974","ENSBGRT00000003697",24496,"NSUN4","NOP2/Sun RNA methyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:31802]","GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit);GO:0008168(methyltransferase activity);GO:0031167(rRNA methylation);GO:0042256(mature ribosome assembly);GO:0070131(positive regulation of mitochondrial translation);GO:0070181(small ribosomal subunit rRNA binding)","NA",{"v":1.7e-09,"d":"0.00"},2,"277,23,","0,857",-8.77,-8,5.94,"Exon (ENSBGRT00000003697/ENSBGRG00000001974, exon 5 of 6)",3,108674336,108699711,25376,2]
["chr3",111232840,111235451,2612,"ENSBGRG00000007939","ENSBGRT00000014872",0,"IPO13","importin 13 [Source:HGNC Symbol;Acc:HGNC:16853]","GO:0006606(protein import into nucleus);GO:0006886(intracellular protein transport);GO:0008536(Ran GTPase binding)","NA",{"v":2E-55,"d":"0.00"},2,"721,84,","0,2528",{"v":-54.7,"d":"-54.70"},{"v":-53.4,"d":"-53.40"},6.26,"Exon (ENSBGRT00000014872/ENSBGRG00000007939, exon 1 of 19)",3,111212029,111235451,23423,2]
["chr3",112893342,112894170,829,"ENSBGRG00000012821","ENSBGRT00000023466",125651,"ENSBGRG00000012821","NA","NA","NA",{"v":6.3e-25,"d":"0.00"},1,"829,",0,{"v":-24.2,"d":"-24.20"},{"v":-23.2,"d":"-23.20"},{"v":11.8,"d":"11.80"},"Exon (ENSBGRT00000023696/ENSBGRG00000012949, exon 3 of 3)",3,112874537,113019821,145285,2]
["chr3",115274737,115275217,481,"ENSBGRG00000017070","ENSBGRT00000031317",0,"ENSBGRG00000017070","NA","NA","NA",{"v":0.00028,"d":"0.00"},1,"481,",0,-3.56,-2.94,{"v":14.9,"d":"14.90"},"Exon (ENSBGRT00000031317/ENSBGRG00000017070, exon 1 of 1)",3,115274108,115275217,1110,2]
["chr3",115489758,115489878,121,"ENSBGRG00000000230","ENSBGRT00000000369",0,"TMCO2","transmembrane and coiled-coil domains 2 [Source:HGNC Symbol;Acc:HGNC:23312]","NA","NA",{"v":0.0013,"d":"0.00"},1,"121,",0,{"v":-2.9,"d":"-2.90"},-2.31,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000000369/ENSBGRG00000000230, exon 1 of 3)",3,115487394,115489878,2485,2]
["chr3",116307935,116310917,2983,"ENSBGRG00000005001","ENSBGRT00000009267",0,"ENSBGRG00000005001","NA","NA","NA",{"v":2e-49,"d":"0.00"},3,"662,136,1745,","0,664,1238",{"v":-48.7,"d":"-48.70"},{"v":-47.5,"d":"-47.50"},{"v":8.1,"d":"8.10"},"Exon (ENSBGRT00000009267/ENSBGRG00000005001, exon 1 of 9)",3,116304872,116310917,6046,2]
["chr3",120527286,120540248,12963,"ENSBGRG00000011314","ENSBGRT00000020630",164403,"ZMYM4","zinc finger MYM-type containing 4 [Source:HGNC Symbol;Acc:HGNC:13055]","GO:0007010(cytoskeleton organization);GO:0008270(zinc ion binding);GO:0022604(regulation of cell morphogenesis)","NA",{"v":1E-150,"d":"0.00"},3,"208,130,21,","0,1049,12942",-150,-148,7.56,"Exon (ENSBGRT00000020630/ENSBGRG00000011314, exon 28 of 30)",3,120527286,120704651,177366,2]
["chr3",127983972,128024707,40736,"ENSBGRG00000017439","ENSBGRT00000035744",0,"ENSBGRG00000017439","NA","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",0,5,"222,585,36,118,475,","0,3691,10464,19106,40261",-446,"-Inf",{"v":24.8,"d":"24.80"},"5' UTR",3,127953157,127994471,41315,2]
["chr3",132041922,132042944,1023,"ENSBGRG00000001869","ENSBGRT00000003483",7324,"DTYMK","deoxythymidylate kinase [Source:HGNC Symbol;Acc:HGNC:3061]","GO:0004798(thymidylate kinase activity);GO:0005524(ATP binding);GO:0006233(dTDP biosynthetic process);GO:0009165(nucleotide biosynthetic process);GO:0071363(cellular response to growth factor stimulus)","00240(Pyrimidine metabolism)",{"v":3.3E-3,"d":"0.00"},2,"21,99,","0,924",-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000003483/ENSBGRG00000001869, exon 4 of 5)",3,132038597,132050268,11672,2]
["chr4",7267647,7267827,181,"ENSBGRG00000012528","ENSBGRT00000022900",103193,"ENSBGRG00000012528","NA","GO:0006511(ubiquitin-dependent protein catabolic process);GO:0031461(cullin-RING ubiquitin ligase complex);GO:0031625(ubiquitin protein ligase binding)","04141(Protein processing in endoplasmic reticulum);04120(Ubiquitin mediated proteolysis);04310(Wnt signaling pathway);04340(Hedgehog signaling pathway);04350(TGF-beta signaling pathway);04110(Cell cycle);04114(Oocyte meiosis);04710(Circadian rhythm);05200(Pathways in cancer);05168(Herpes simplex infection)",{"v":4.7e-08,"d":"0.00"},1,"181,",0,-7.33,-6.59,9.16,"3' UTR",4,7164454,7268379,103926,1]
["chr4",8184218,8184634,417,"ENSBGRG00000018284","ENSBGRT00000033420",21089,"ENSBGRG00000018284","NA","GO:0003676(nucleic acid binding)","NA",{"v":1.6E-11,"d":"0.00"},1,"417,",0,{"v":-10.8,"d":"-10.80"},-10,{"v":13.5,"d":"13.50"},"3' UTR",4,8163129,8184477,21349,1]
["chr4",9029549,9030813,1265,"ENSBGRG00000006836","ENSBGRT00000012734",1606,"CHPF2","chondroitin polymerizing factor 2 [Source:HGNC Symbol;Acc:HGNC:29270]","GO:0008376(acetylgalactosaminyltransferase activity);GO:0032580(Golgi cisterna membrane)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)",{"v":3.2e-37,"d":"0.00"},2,"488,80,","0,1185",{"v":-36.5,"d":"-36.50"},{"v":-35.4,"d":"-35.40"},{"v":8.5,"d":"8.50"},"Exon (ENSBGRT00000012734/ENSBGRG00000006836, exon 3 of 6)",4,9027943,9033358,5416,1]
["chr4",10212979,10213484,506,"ENSBGRG00000008514","ENSBGRT00000015466",921,"CCT8L2","chaperonin containing TCP1 subunit 8 like 2 [Source:HGNC Symbol;Acc:HGNC:15553]","GO:0005524(ATP binding)","NA",0.02,1,"506,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000015466/ENSBGRG00000008514, exon 1 of 1)",4,10212058,10213662,1605,1]
["chr4",17487522,17488030,509,"ENSBGRG00000000595","ENSBGRT00000001064",99121,"DENND2A","DENN domain containing 2A [Source:HGNC Symbol;Acc:HGNC:22212]","GO:0015629(actin cytoskeleton);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0042147(retrograde transport, endosome to Golgi)","NA",{"v":1.3e-68,"d":"0.00"},1,"509,",0,{"v":-67.9,"d":"-67.90"},{"v":-66.6,"d":"-66.60"},3.27,"3' UTR",4,17388401,17488328,99928,1]
["chr4",20720279,20720547,269,"ENSBGRG00000003344","ENSBGRT00000006245",446,"PTN","pleiotrophin [Source:HGNC Symbol;Acc:HGNC:9630]","GO:0001503(ossification);GO:0002232(leukocyte chemotaxis involved in inflammatory response);GO:0002690(positive regulation of leukocyte chemotaxis);GO:0004864(protein phosphatase inhibitor activity);GO:0005178(integrin binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005783(endoplasmic reticulum);GO:0007229(integrin-mediated signaling pathway);GO:0007406(negative regulation of neuroblast proliferation);GO:0007612(learning);GO:0007613(memory);GO:0008083(growth factor activity);GO:0008201(heparin binding);GO:0008284(positive regulation of cell population proliferation);GO:0010996(response to auditory stimulus);GO:0019901(protein kinase binding);GO:0030282(bone mineralization);GO:0030501(positive regulation of bone mineralization);GO:0031641(regulation of myelination);GO:0032991(protein-containing complex);GO:0035374(chondroitin sulfate binding);GO:0042246(tissue regeneration);GO:0043113(receptor clustering);GO:0043932(ossification involved in bone remodeling);GO:0044849(estrous cycle);GO:0045597(positive regulation of cell differentiation);GO:0046697(decidualization);GO:0048167(regulation of synaptic plasticity);GO:0048477(oogenesis);GO:0048714(positive regulation of oligodendrocyte differentiation);GO:0140059(dendrite arborization);GO:1900006(positive regulation of dendrite development);GO:1900272(negative regulation of long-term synaptic potentiation);GO:1903706(regulation of hemopoiesis);GO:2000036(regulation of stem cell population maintenance);GO:2000347(positive regulation of hepatocyte proliferation);GO:2000738(positive regulation of stem cell differentiation)","NA",0,1,"269,",0,-507,"-Inf",3.75,"5' UTR",4,20719833,20838833,119001,1]
["chr4",29589488,29590260,773,"ENSBGRG00000010458","ENSBGRT00000020629",723,"KCP","kielin cysteine rich BMP regulator [Source:HGNC Symbol;Acc:HGNC:17585]","GO:0002244(hematopoietic progenitor cell differentiation);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0030513(positive regulation of BMP signaling pathway)","NA",{"v":0.0068,"d":"0.01"},2,"139,101,","0,672",-2.17,-1.62,5.94,"Exon (ENSBGRT00000020629/ENSBGRG00000010458, exon 2 of 31)",4,29588765,29618828,30064,1]
["chr4",33834509,33854998,20490,"ENSBGRG00000024165","ENSBGRT00000044630",1221,"GPR37","G protein-coupled receptor 37 [Source:HGNC Symbol;Acc:HGNC:4494]","GO:0000151(ubiquitin ligase complex);GO:0004930(G protein-coupled receptor activity);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0007218(neuropeptide signaling pathway);GO:0008188(neuropeptide receptor activity);GO:0008528(G protein-coupled peptide receptor activity);GO:0009986(cell surface);GO:0016021(integral component of membrane);GO:0030544(Hsp70 protein binding);GO:0031072(heat shock protein binding);GO:0031625(ubiquitin protein ligase binding);GO:0031987(locomotion involved in locomotory behavior);GO:0036505(prosaposin receptor activity);GO:0042277(peptide binding);GO:0042416(dopamine biosynthetic process);GO:0042923(neuropeptide binding);GO:0043235(receptor complex);GO:0043410(positive regulation of MAPK cascade);GO:0045964(positive regulation of dopamine metabolic process);GO:1903206(negative regulation of hydrogen peroxide-induced cell death)","05012(Parkinson disease)",{"v":6.3e-12,"d":"0.00"},2,"255,819,","0,19671",{"v":-11.2,"d":"-11.20"},{"v":-10.4,"d":"-10.40"},{"v":14.5,"d":"14.50"},"Exon (ENSBGRT00000044630/ENSBGRG00000024165, exon 1 of 2)",4,33833288,33854998,21711,1]
["chr4",46871004,46871154,151,"ENSBGRG00000011094","ENSBGRT00000020222",1468,"AEBP1","AE binding protein 1 [Source:HGNC Symbol;Acc:HGNC:303]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0004181(metallocarboxypeptidase activity);GO:0005518(collagen binding);GO:0006508(proteolysis);GO:0008270(zinc ion binding);GO:1904026(regulation of collagen fibril organization)","NA",{"v":0.00032,"d":"0.00"},1,"151,",0,-3.49,-2.88,1.65,"5' UTR",4,46869536,46881556,12021,1]
["chr4",55090115,55090534,420,"ENSBGRG00000001498","ENSBGRT00000002744",1346,"NFE2L3","nuclear factor, erythroid 2 like 3 [Source:HGNC Symbol;Acc:HGNC:7783]","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II)","NA",{"v":1.2E-4,"d":"0.00"},1,"420,",0,-3.92,-3.28,{"v":14.9,"d":"14.90"},"Exon (ENSBGRT00000002744/ENSBGRG00000001498, exon 1 of 4)",4,55088769,55131116,42348,1]
["chr4",59951938,59952176,239,"ENSBGRG00000003951","ENSBGRT00000007328",14663,"ENSBGRG00000003951","NA","GO:0003094(glomerular filtration);GO:0005372(water transmembrane transporter activity);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0005903(brush border);GO:0006813(potassium ion transport);GO:0006833(water transport);GO:0009925(basal plasma membrane);GO:0015079(potassium ion transmembrane transporter activity);GO:0015267(channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0019233(sensory perception of pain);GO:0020003(symbiont-containing vacuole);GO:0021670(lateral ventricle development);GO:0030104(water homeostasis);GO:0030335(positive regulation of cell migration);GO:0030424(axon);GO:0032940(secretion by cell);GO:0033363(secretory granule organization);GO:0042060(wound healing);GO:0044241(lipid digestion);GO:0046875(ephrin receptor binding);GO:0048593(camera-type eye morphogenesis);GO:0051458(corticotropin secretion);GO:0055085(transmembrane transport);GO:0070062(extracellular exosome);GO:0070295(renal water absorption);GO:0072220(metanephric descending thin limb development);GO:0072230(metanephric proximal straight tubule development);GO:0072232(metanephric proximal convoluted tubule segment 2 development);GO:0072239(metanephric glomerulus vasculature development);GO:0085018(maintenance of symbiont-containing vacuole by host)","04924(Renin secretion);04976(Bile secretion);04964(Proximal tubule bicarbonate reclamation)",{"v":1e-109,"d":"0.00"},1,"239,",0,-109,-107,4.34,"3' UTR",4,59937275,59952176,14902,1]
["chr4",61815818,61818638,2821,"ENSBGRG00000005437","ENSBGRT00000010054",7186,"ENSBGRG00000005437","NA","NA","NA",0.02,3,"248,96,15,","0,2434,2806",-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000010054/ENSBGRG00000005437, exon 3 of 3)",4,61808632,61816065,7434,1]
["chr4",74885176,74922306,37131,"ENSBGRG00000002134","ENSBGRT00000004012",2723,"CAV1","caveolin 1 [Source:HGNC Symbol;Acc:HGNC:1527]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000139(Golgi membrane);GO:0000188(inactivation of MAPK activity);GO:0001525(angiogenesis);GO:0001570(vasculogenesis);GO:0001666(response to hypoxia);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001960(negative regulation of cytokine-mediated signaling pathway);GO:0002026(regulation of the force of heart contraction);GO:0002080(acrosomal membrane);GO:0002095(caveolar macromolecular signaling complex);GO:0002931(response to ischemia);GO:0003057(regulation of the force of heart contraction by chemical signal);GO:0005102(signaling receptor binding);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0005925(focal adhesion);GO:0005929(cilium);GO:0005938(cell cortex);GO:0006641(triglyceride metabolic process);GO:0006816(calcium ion transport);GO:0006874(cellular calcium ion homeostasis);GO:0006940(regulation of smooth muscle contraction);GO:0007519(skeletal muscle tissue development);GO:0007595(lactation);GO:0008104(protein localization);GO:0008285(negative regulation of cell population proliferation);GO:0009617(response to bacterium);GO:0009968(negative regulation of signal transduction);GO:0010524(positive regulation of calcium ion transport into cytosol);GO:0010608(posttranscriptional regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0010875(positive regulation of cholesterol efflux);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016504(peptidase activator activity);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0019217(regulation of fatty acid metabolic process);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0019915(lipid storage);GO:0030193(regulation of blood coagulation);GO:0030335(positive regulation of cell migration);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030674(protein-macromolecule adaptor activity);GO:0030857(negative regulation of epithelial cell differentiation);GO:0030879(mammary gland development);GO:0031295(T cell costimulation);GO:0031397(negative regulation of protein ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0031410(cytoplasmic vesicle);GO:0031623(receptor internalization);GO:0032091(negative regulation of protein binding);GO:0032092(positive regulation of protein binding);GO:0032570(response to progesterone);GO:0032991(protein-containing complex);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033484(nitric oxide homeostasis);GO:0034141(positive regulation of toll-like receptor 3 signaling pathway);GO:0038016(insulin receptor internalization);GO:0042310(vasoconstriction);GO:0042532(negative regulation of tyrosine phosphorylation of STAT protein);GO:0042632(cholesterol homeostasis);GO:0042802(identical protein binding);GO:0043085(positive regulation of catalytic activity);GO:0043407(negative regulation of MAP kinase activity);GO:0043409(negative regulation of MAPK cascade);GO:0043627(response to estrogen);GO:0044325(ion channel binding);GO:0044877(protein-containing complex binding);GO:0045019(negative regulation of nitric oxide biosynthetic process);GO:0045121(membrane raft);GO:0045907(positive regulation of vasoconstriction);GO:0046426(negative regulation of receptor signaling pathway via JAK-STAT);GO:0046982(protein heterodimerization activity);GO:0048365(Rac GTPase binding);GO:0048471(perinuclear region of cytoplasm);GO:0048550(negative regulation of pinocytosis);GO:0050998(nitric-oxide synthase binding);GO:0051001(negative regulation of nitric-oxide synthase activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051117(ATPase binding);GO:0051480(regulation of cytosolic calcium ion concentration);GO:0051592(response to calcium ion);GO:0051899(membrane depolarization);GO:0052547(regulation of peptidase activity);GO:0055074(calcium ion homeostasis);GO:0060056(mammary gland involution);GO:0060090(molecular adaptor activity);GO:0060355(positive regulation of cell adhesion molecule production);GO:0060546(negative regulation of necroptotic process);GO:0061099(negative regulation of protein tyrosine kinase activity);GO:0070320(inward rectifier potassium channel inhibitor activity);GO:0070836(caveola assembly);GO:0071360(cellular response to exogenous dsRNA);GO:0071375(cellular response to peptide hormone stimulus);GO:0071455(cellular response to hyperoxia);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:0071711(basement membrane organization);GO:0072584(caveolin-mediated endocytosis);GO:0086091(regulation of heart rate by cardiac conduction);GO:0086098(angiotensin-activated signaling pathway involved in heart process);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0097190(apoptotic signaling pathway);GO:0098903(regulation of membrane repolarization during action potential);GO:0098911(regulation of ventricular cardiac muscle cell action potential);GO:0120162(positive regulation of cold-induced thermogenesis);GO:1900027(regulation of ruffle assembly);GO:1900085(negative regulation of peptidyl-tyrosine autophosphorylation);GO:1901380(negative regulation of potassium ion transmembrane transport);GO:1901844(regulation of cell communication by electrical coupling involved in cardiac conduction);GO:1903071(positive regulation of ER-associated ubiquitin-dependent protein catabolic process);GO:1903598(positive regulation of gap junction assembly);GO:1903609(negative regulation of inward rectifier potassium channel activity);GO:2000286(receptor internalization involved in canonical Wnt signaling pathway);GO:2000535(regulation of entry of bacterium into host cell);GO:2000811(negative regulation of anoikis);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","04144(Endocytosis);04510(Focal adhesion);05205(Proteoglycans in cancer);05418(Fluid shear stress and atherosclerosis);05416(Viral myocarditis);05100(Bacterial invasion of epithelial cells)",{"v":3.2e-85,"d":"0.00"},2,"134,137,","0,36994",{"v":-84.5,"d":"-84.50"},-83,1.99,"5' UTR",4,74882453,74922511,40059,1]
["chr4",80618579,80620262,1684,"ENSBGRG00000008616","ENSBGRT00000016094",16894,"EFCAB10","EF-hand calcium binding domain 10 [Source:HGNC Symbol;Acc:HGNC:34531]","GO:0005509(calcium ion binding)","NA",{"v":1.7E-5,"d":"0.00"},3,"36,67,46,","0,1469,1638",-4.78,-4.11,2.15,"Exon (ENSBGRT00000016094/ENSBGRG00000008616, exon 3 of 3)",4,80601685,80618614,16930,1]
["chr4",96932453,96932692,240,"ENSBGRG00000000895","ENSBGRT00000001636",298,"RAPGEF5","Rap guanine nucleotide exchange factor 5 [Source:HGNC Symbol;Acc:HGNC:16862]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005654(nucleoplasm);GO:0007264(small GTPase mediated signal transduction);GO:0016604(nuclear body)","04014(Ras signaling pathway);04015(Rap1 signaling pathway)",{"v":6.6E-4,"d":"0.00"},1,"240,",0,-3.18,-2.58,{"v":4.7,"d":"4.70"},"5' UTR",4,96932155,97004727,72573,1]
["chr4",109503707,109507020,3314,"ENSBGRG00000003304","ENSBGRT00000006412",509249,"THSD7A","thrombospondin type 1 domain containing 7A [Source:HGNC Symbol;Acc:HGNC:22207]","GO:0005886(plasma membrane)","04310(Wnt signaling pathway)",{"v":0.00023,"d":"0.00"},3,"8,88,85,","0,2451,3229",-3.63,-3.01,{"v":5.2,"d":"5.20"},"Exon (ENSBGRT00000006412/ENSBGRG00000003304, exon 26 of 28)",4,108994458,109507020,512563,1]
["chr4",901043,901223,181,"ENSBGRG00000007491","ENSBGRT00000013739",8654,"EPHB6","EPH receptor B6 [Source:HGNC Symbol;Acc:HGNC:3396]","GO:0001806(type IV hypersensitivity);GO:0002456(T cell mediated immunity);GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0009986(cell surface);GO:0032092(positive regulation of protein binding);GO:0050663(cytokine secretion);GO:0050798(activated T cell proliferation);GO:2000525(positive regulation of T cell costimulation)","04360(Axon guidance)",{"v":0.028,"d":"0.03"},1,"181,",0,-1.56,-1.06,2.72,"3' UTR",4,892389,901588,9200,1]
["chr4",7453255,7483132,29878,"ENSBGRG00000014204","ENSBGRT00000026078",0,"Y_RNA","Y RNA [Source:RFAM;Acc:RF00019]","NA","NA",0,2,"23,485,","0,29393",-1920,"-Inf",{"v":15.4,"d":"15.40"},"3' UTR",4,7458278,7458379,102,1]
["chr4",8958709,8958947,239,"ENSBGRG00000006572","ENSBGRT00000012154",13589,"ASB10","ankyrin repeat and SOCS box containing 10 [Source:HGNC Symbol;Acc:HGNC:17185]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0035556(intracellular signal transduction)","NA",{"v":6e-08,"d":"0.00"},1,"239,",0,-7.22,-6.48,{"v":15.4,"d":"15.40"},"3' UTR",4,8958709,8972536,13828,2]
["chr4",9927433,9929067,1635,"ENSBGRG00000008413","ENSBGRT00000015316",274979,"KMT2C","lysine methyltransferase 2C [Source:HGNC Symbol;Acc:HGNC:13726]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0035097(histone methyltransferase complex);GO:0042054(histone methyltransferase activity);GO:0042800(histone methyltransferase activity (H3-K4 specific));GO:0044666(MLL3/4 complex);GO:0097692(histone H3-K4 monomethylation)","00310(Lysine degradation)",{"v":1e-133,"d":"0.00"},2,"792,18,","0,1617",-133,-131,7.01,"Exon (ENSBGRT00000015316/ENSBGRG00000008413, exon 54 of 62)",4,9919287,10204046,284760,2]
["chr4",16216948,16222298,5351,"ENSBGRG00000016274","ENSBGRT00000029865",7085,"SSBP1","single stranded DNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:11317]","GO:0003682(chromatin binding);GO:0003697(single-stranded DNA binding);GO:0005739(mitochondrion);GO:0006260(DNA replication);GO:0006268(DNA unwinding involved in DNA replication);GO:0042645(mitochondrial nucleoid);GO:0051096(positive regulation of helicase activity);GO:0070584(mitochondrion morphogenesis);GO:1905776(positive regulation of DNA helicase activity)","03030(DNA replication);03430(Mismatch repair);03440(Homologous recombination)",{"v":4e-45,"d":"0.00"},3,"151,89,29,","0,3675,5322",{"v":-44.4,"d":"-44.40"},{"v":-43.3,"d":"-43.30"},2.45,"3' UTR",4,16216531,16229383,12853,2]
["chr4",23985624,23985984,361,"ENSBGRG00000004512","ENSBGRT00000008371",81367,"ENSBGRG00000004512","NA","GO:0005515(protein binding)","00230(Purine metabolism)",{"v":0.0062,"d":"0.01"},1,"361,",0,-2.21,-1.67,9.91,"Exon (ENSBGRT00000008430/ENSBGRG00000004512, exon 16 of 16)",4,23954831,24067351,112521,2]
["chr4",29765416,29771048,5633,"ENSBGRG00000022337","ENSBGRT00000041788",0,"CALU","calumenin [Source:HGNC Symbol;Acc:HGNC:1458]","GO:0005509(calcium ion binding);GO:0005783(endoplasmic reticulum)","04621(NOD-like receptor signaling pathway)",{"v":2e-44,"d":"0.00"},4,"160,194,232,13,","0,233,5216,5620",{"v":-43.7,"d":"-43.70"},{"v":-42.5,"d":"-42.50"},1.87,"5' UTR",4,29755417,29770863,15447,2]
["chr4",40711447,40714805,3359,"ENSBGRG00000007313","ENSBGRT00000013488",4713,"ENSBGRG00000007313","NA","GO:0000398(mRNA splicing, via spliceosome);GO:0005688(U6 snRNP);GO:0046540(U4/U6 x U5 tri-snRNP complex)","03040(Spliceosome);03018(RNA degradation)",{"v":3.2e-22,"d":"0.00"},2,"123,87,","0,3272",{"v":-21.5,"d":"-21.50"},{"v":-20.5,"d":"-20.50"},2.01,"3' UTR",4,40667565,40719518,51954,2]
["chr4",47134212,47134301,90,"ENSBGRG00000013980","ENSBGRT00000025777",81089,"NUDCD3","NudC domain containing 3 [Source:HGNC Symbol;Acc:HGNC:22208]","GO:0005868(cytoplasmic dynein complex);GO:0060271(cilium assembly);GO:1905793(protein localization to pericentriolar material)","NA",{"v":0.0087,"d":"0.01"},1,"90,",0,-2.06,-1.52,1.51,"3' UTR",4,47133499,47215390,81892,2]
["chr4",49864542,49871474,6933,"ENSBGRG00000020411","ENSBGRT00000037572",0,"ENSBGRG00000020411","NA","GO:0005525(GTP binding)","NA",{"v":1.9E-6,"d":"0.00"},3,"11,194,33,","0,3744,6900",-5.72,-5.02,2.26,"5' UTR",4,49842903,49871474,28572,2]
["chr4",56077388,56077595,208,"ENSBGRG00000002039","ENSBGRT00000003794",2911,"HOXA6","homeobox A6 [Source:HGNC Symbol;Acc:HGNC:5107]","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0009952(anterior/posterior pattern specification);GO:0016607(nuclear speck);GO:0043565(sequence-specific DNA binding);GO:0048704(embryonic skeletal system morphogenesis);GO:0048706(embryonic skeletal system development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.0068,"d":"0.01"},1,"208,",0,-2.17,-1.62,6.93,"3' UTR",4,56076914,56080506,3593,2]
["chr4",63870526,63898100,27575,"ENSBGRG00000007950","ENSBGRT00000015030",0,"DPY19L2","dpy-19 like 2 [Source:HGNC Symbol;Acc:HGNC:19414]","GO:0005637(nuclear inner membrane);GO:0007286(spermatid development);GO:0016021(integral component of membrane)","NA",{"v":0.012,"d":"0.01"},5,"87,138,88,25,382,","0,14233,21093,23041,27193",-1.93,{"v":-1.4,"d":"-1.40"},5.45,"Exon (ENSBGRT00000015030/ENSBGRG00000007950, exon 1 of 22)",4,63796782,63898100,101319,2]
["chr4",77165469,77167743,2275,"ENSBGRG00000004974","ENSBGRT00000009155",37763,"EPDR1","ependymin related 1 [Source:HGNC Symbol;Acc:HGNC:17572]","GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0007160(cell-matrix adhesion)","NA",{"v":6.6e-05,"d":"0.00"},3,"7,197,6,","0,974,2269",-4.18,-3.53,{"v":14.9,"d":"14.90"},"Exon (ENSBGRT00000009155/ENSBGRG00000004974, exon 2 of 3)",4,77164633,77205506,40874,2]
["chr4",78302841,78320783,17943,"ENSBGRG00000006083","ENSBGRT00000011209",71347,"SLC26A4","solute carrier family 26 member 4 [Source:HGNC Symbol;Acc:HGNC:8818]","GO:0006885(regulation of pH);GO:0008271(secondary active sulfate transmembrane transporter activity);GO:0008272(sulfate transport);GO:0015116(sulfate transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0031526(brush border membrane);GO:0032880(regulation of protein localization);GO:0055085(transmembrane transport);GO:0070062(extracellular exosome);GO:0098656(anion transmembrane transport)","04918(Thyroid hormone synthesis)",{"v":7.2e-08,"d":"0.00"},2,"415,63,","0,17880",-7.14,{"v":-6.4,"d":"-6.40"},8.42,"3' UTR",4,78302064,78392130,90067,2]
["chr4",83226414,83228153,1740,"ENSBGRG00000011795","ENSBGRT00000023906",91420,"FBXL13","F-box and leucine rich repeat protein 13 [Source:HGNC Symbol;Acc:HGNC:21658]","GO:0005515(protein binding)","NA",{"v":1e-57,"d":"0.00"},3,"6,374,127,","0,128,1613",-57,{"v":-55.7,"d":"-55.70"},7.92,"3' UTR",4,83134994,83360516,225523,1]
["chr4",91553494,91553791,298,"ENSBGRG00000022242","ENSBGRT00000041364",316568,"SEMA3A","semaphorin 3A [Source:HGNC Symbol;Acc:HGNC:10723]","GO:0001764(neuron migration);GO:0002027(regulation of heart rate);GO:0005515(protein binding);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0008045(motor neuron axon guidance);GO:0010633(negative regulation of epithelial cell migration);GO:0010977(negative regulation of neuron projection development);GO:0021612(facial nerve structural organization);GO:0021637(trigeminal nerve structural organization);GO:0021675(nerve development);GO:0021772(olfactory bulb development);GO:0021785(branchiomotor neuron axon guidance);GO:0021828(gonadotrophin-releasing hormone neuronal migration to the hypothalamus);GO:0030215(semaphorin receptor binding);GO:0030517(negative regulation of axon extension);GO:0036486(ventral trunk neural crest cell migration);GO:0038191(neuropilin binding);GO:0045499(chemorepellent activity);GO:0048813(dendrite morphogenesis);GO:0048841(regulation of axon extension involved in axon guidance);GO:0048843(negative regulation of axon extension involved in axon guidance);GO:0048846(axon extension involved in axon guidance);GO:0050919(negative chemotaxis);GO:0060385(axonogenesis involved in innervation);GO:0060666(dichotomous subdivision of terminal units involved in salivary gland branching);GO:0061549(sympathetic ganglion development);GO:0061551(trigeminal ganglion development);GO:0071526(semaphorin-plexin signaling pathway);GO:0097490(sympathetic neuron projection extension);GO:0097491(sympathetic neuron projection guidance);GO:0150020(basal dendrite arborization);GO:1901166(neural crest cell migration involved in autonomic nervous system development);GO:1902285(semaphorin-plexin signaling pathway involved in neuron projection guidance);GO:1902287(semaphorin-plexin signaling pathway involved in axon guidance);GO:1903045(neural crest cell migration involved in sympathetic nervous system development);GO:1903375(facioacoustic ganglion development);GO:2000020(positive regulation of male gonad development);GO:2001224(positive regulation of neuron migration)","04360(Axon guidance)",{"v":1.3E-14,"d":"0.00"},1,"298,",0,{"v":-13.9,"d":"-13.90"},{"v":-13.1,"d":"-13.10"},5.09,"Exon (ENSBGRT00000041364/ENSBGRG00000022242, exon 18 of 18)",4,91553494,91870359,316866,2]
["chr4",110000372,110000492,121,"ENSBGRG00000003530","ENSBGRT00000006570",0,"PHF14","PHD finger protein 14 [Source:HGNC Symbol;Acc:HGNC:22203]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005634(nucleus);GO:0008285(negative regulation of cell population proliferation);GO:0048286(lung alveolus development);GO:0072201(negative regulation of mesenchymal cell proliferation);GO:2000584(negative regulation of platelet-derived growth factor receptor-alpha signaling pathway);GO:2000791(negative regulation of mesenchymal cell proliferation involved in lung development)","04080(Neuroactive ligand-receptor interaction);04727(GABAergic synapse);04723(Retrograde endocannabinoid signaling);04742(Taste transduction);05032(Morphine addiction);05033(Nicotine addiction)",{"v":0.0068,"d":"0.01"},1,"121,",0,-2.17,-1.62,5.94,"5' UTR",4,109741837,110000492,258656,2]
["chr4",120167688,120172137,4450,"ENSBGRG00000017280","ENSBGRT00000031726",0,"RBM48","RNA binding motif protein 48 [Source:HGNC Symbol;Acc:HGNC:21785]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm)","NA",{"v":1e-60,"d":"0.00"},6,"2,40,602,146,191,111,","0,30,78,1993,3637,4339",-60,{"v":-58.7,"d":"-58.70"},4.23,"Exon (ENSBGRT00000031726/ENSBGRG00000017280, exon 1 of 5)",4,120165887,120172137,6251,2]
["chr4",125059682,125059771,90,"ENSBGRG00000021949","ENSBGRT00000040959",87074,"DDC","dopa decarboxylase [Source:HGNC Symbol;Acc:HGNC:2719]","GO:0003824(catalytic activity);GO:0004058(aromatic-L-amino-acid decarboxylase activity);GO:0005737(cytoplasm);GO:0006520(cellular amino acid metabolic process);GO:0009636(response to toxic substance);GO:0016831(carboxy-lyase activity);GO:0019752(carboxylic acid metabolic process);GO:0019899(enzyme binding);GO:0030170(pyridoxal phosphate binding);GO:0036468(L-dopa decarboxylase activity)","00350(Tyrosine metabolism);00360(Phenylalanine metabolism);00380(Tryptophan metabolism);04728(Dopaminergic synapse);04726(Serotonergic synapse);05030(Cocaine addiction);05031(Amphetamine addiction);05034(Alcoholism)",{"v":0.034,"d":"0.03"},1,"90,",0,-1.47,{"v":-0.977,"d":"-0.98"},4.46,"3' UTR",4,125059652,125146845,87194,2]
["chr5",4996245,4996334,90,"ENSBGRG00000000791","ENSBGRT00000001426",552,"ENSBGRG00000000791","NA","NA","NA",{"v":0.00046,"d":"0.00"},1,"90,",0,-3.34,-2.72,{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000001426/ENSBGRG00000000791, exon 2 of 2)",5,4995693,4996453,761,1]
["chr5",12094399,12094668,270,"ENSBGRG00000002854","ENSBGRT00000005415",213480,"PLEKHA5","pleckstrin homology domain containing A5 [Source:HGNC Symbol;Acc:HGNC:30036]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0010314(phosphatidylinositol-5-phosphate binding);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0061458(reproductive system development);GO:0070273(phosphatidylinositol-4-phosphate binding);GO:0080025(phosphatidylinositol-3,5-bisphosphate binding)","NA",{"v":1.4e-06,"d":"0.00"},1,"270,",0,-5.86,-5.16,1.49,"Exon (ENSBGRT00000005415/ENSBGRG00000002854, exon 12 of 32)",5,11880919,12172221,291303,1]
["chr5",14203234,14203474,241,"ENSBGRG00000003299","ENSBGRT00000006197",32521,"PYROXD1","pyridine nucleotide-disulphide oxidoreductase domain 1 [Source:HGNC Symbol;Acc:HGNC:26162]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016491(oxidoreductase activity);GO:0030017(sarcomere);GO:0034599(cellular response to oxidative stress);GO:0055114(oxidation-reduction process)","NA",{"v":2.3e-10,"d":"0.00"},1,"241,",0,-9.64,-8.84,3.07,"3' UTR",5,14170713,14203474,32762,1]
["chr5",25990561,25990770,210,"ENSBGRG00000004628","ENSBGRT00000008520",179,"RESF1","retroelement silencing factor 1 [Source:HGNC Symbol;Acc:HGNC:25559]","NA","NA",{"v":5.5e-07,"d":"0.00"},1,"210,",0,-6.26,-5.54,6.93,"Exon (ENSBGRT00000008520/ENSBGRG00000004628, exon 1 of 1)",5,25990382,25995223,4842,1]
["chr5",28329553,28330775,1223,"ENSBGRG00000006310","ENSBGRT00000011630",1252,"ELFN2","extracellular leucine rich repeat and fibronectin type III domain containing 2 [Source:HGNC Symbol;Acc:HGNC:29396]","GO:0005515(protein binding);GO:0010923(negative regulation of phosphatase activity)","NA",{"v":5.9e-06,"d":"0.00"},1,"1223,",0,-5.23,-4.55,{"v":16.8,"d":"16.80"},"Exon (ENSBGRT00000011630/ENSBGRG00000006310, exon 1 of 1)",5,28328301,28330775,2475,1]
["chr5",33573823,33574392,570,"ENSBGRG00000013813","ENSBGRT00000025417",15849,"RTCB","RNA 2',3'-cyclic phosphate and 5'-OH ligase [Source:HGNC Symbol;Acc:HGNC:26935]","GO:0001701(in utero embryonic development);GO:0001890(placenta development);GO:0003972(RNA ligase (ATP) activity);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0006388(tRNA splicing, via endonucleolytic cleavage and ligation);GO:0006396(RNA processing);GO:0008452(RNA ligase activity);GO:0017166(vinculin binding);GO:0043231(intracellular membrane-bounded organelle);GO:0072669(tRNA-splicing ligase complex)","NA",{"v":4.9e-07,"d":"0.00"},2,"7,53,","0,517",-6.31,-5.59,{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000025417/ENSBGRG00000013813, exon 10 of 11)",5,33557974,33576969,18996,1]
["chr5",37617926,37617988,63,"ENSBGRG00000020334","ENSBGRT00000037582",72131,"NT5DC3","5'-nucleotidase domain containing 3 [Source:HGNC Symbol;Acc:HGNC:30826]","GO:0043235(receptor complex)","00230(Purine metabolism);00240(Pyrimidine metabolism);00760(Nicotinate and nicotinamide metabolism)",{"v":0.023,"d":"0.02"},2,"36,25,","0,38",-1.64,-1.13,2.55,"Exon (ENSBGRT00000037582/ENSBGRG00000020334, exon 14 of 15)",5,37545795,37618167,72373,1]
["chr5",47478335,47478680,346,"ENSBGRG00000000464","ENSBGRT00000000869",17663,"DGKA","diacylglycerol kinase alpha [Source:HGNC Symbol;Acc:HGNC:2849]","GO:0003951(NAD+ kinase activity);GO:0004143(diacylglycerol kinase activity);GO:0005509(calcium ion binding);GO:0005543(phospholipid binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006654(phosphatidic acid biosynthetic process);GO:0007165(signal transduction);GO:0007205(protein kinase C-activating G protein-coupled receptor signaling pathway);GO:0008289(lipid binding);GO:0016301(kinase activity);GO:0035556(intracellular signal transduction);GO:0046339(diacylglycerol metabolic process);GO:0046486(glycerolipid metabolic process);GO:0046834(lipid phosphorylation)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);05231(Choline metabolism in cancer)",{"v":6.3E-5,"d":"0.00"},2,"96,84,","0,262",{"v":-4.2,"d":"-4.20"},-3.55,1.58,"Exon (ENSBGRT00000000869/ENSBGRG00000000464, exon 22 of 22)",5,47460672,47478430,17759,1]
["chr5",48787612,48787848,237,"ENSBGRG00000005113","ENSBGRT00000009415",10779,"NXPH4","neurexophilin 4 [Source:HGNC Symbol;Acc:HGNC:8078]","NA","00630(Glyoxylate and dicarboxylate metabolism);00260(Glycine, serine and threonine metabolism);00670(One carbon pool by folate)",0.02,1,"237,",0,{"v":-1.7,"d":"-1.70"},-1.19,5.94,"Exon (ENSBGRT00000009415/ENSBGRG00000005113, exon 2 of 2)",5,48776833,48788262,11430,1]
["chr5",49186809,49187150,342,"ENSBGRG00000009681","ENSBGRT00000019191",8325,"ENSBGRG00000009681","NA","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0035023(regulation of Rho protein signal transduction)","NA",{"v":2.4e-07,"d":"0.00"},2,"5,56,","0,286",-6.62,-5.89,1.52,"Exon (ENSBGRT00000019191/ENSBGRG00000009681, exon 14 of 16)",5,49178484,49187717,9234,1]
["chr5",55737455,55743387,5933,"ENSBGRG00000015661","ENSBGRT00000028806",23804,"RXYLT1","ribitol xylosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:13530]","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0035269(protein O-linked mannosylation);GO:0120053(ribitol beta-1,4-xylosyltransferase activity)","00515(Mannose type O-glycan biosyntheis)",{"v":1e-152,"d":"0.00"},2,"60,418,","0,5515",-152,-150,8.84,"Exon (ENSBGRT00000028806/ENSBGRG00000015661, exon 5 of 6)",5,55713651,55743387,29737,1]
["chr5",62296264,62298395,2132,"ENSBGRG00000007705","ENSBGRT00000014237",4984,"FRS2","fibroblast growth factor receptor substrate 2 [Source:HGNC Symbol;Acc:HGNC:16971]","GO:0000187(activation of MAPK activity);GO:0001702(gastrulation with mouth forming second);GO:0001759(organ induction);GO:0002088(lens development in camera-type eye);GO:0003281(ventricular septum development);GO:0005068(transmembrane receptor protein tyrosine kinase adaptor activity);GO:0005104(fibroblast growth factor receptor binding);GO:0005168(neurotrophin TRKA receptor binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007405(neuroblast proliferation);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0008595(anterior/posterior axis specification, embryo);GO:0030900(forebrain development);GO:0042981(regulation of apoptotic process);GO:0046619(optic placode formation involved in camera-type eye formation);GO:0050678(regulation of epithelial cell proliferation);GO:0060527(prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis);GO:0070307(lens fiber cell development);GO:0070372(regulation of ERK1 and ERK2 cascade);GO:2000726(negative regulation of cardiac muscle cell differentiation)","04722(Neurotrophin signaling pathway);04714(Thermogenesis);05205(Proteoglycans in cancer)",{"v":3.2e-82,"d":"0.00"},2,"69,951,","0,1181",{"v":-81.5,"d":"-81.50"},{"v":-80.1,"d":"-80.10"},7.61,"Exon (ENSBGRT00000014237/ENSBGRG00000007705, exon 5 of 6)",5,62291280,62298395,7116,1]
["chr5",74803216,74803692,477,"ENSBGRG00000023644","ENSBGRT00000043713",9583,"SLC48A1","solute carrier family 48 member 1 [Source:HGNC Symbol;Acc:HGNC:26035]","GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0010008(endosome membrane);GO:0015232(heme transporter activity);GO:0015886(heme transport);GO:0020037(heme binding)","NA",{"v":5e-16,"d":"0.00"},1,"477,",0,{"v":-15.3,"d":"-15.30"},{"v":-14.4,"d":"-14.40"},3.19,"3' UTR",5,74793633,74804287,10655,1]
["chr5",79437588,79437917,330,"ENSBGRG00000005468","ENSBGRT00000010157",207624,"SCN8A","sodium voltage-gated channel alpha subunit 8 [Source:HGNC Symbol;Acc:HGNC:10596]","GO:0001518(voltage-gated sodium channel complex);GO:0005216(ion channel activity);GO:0005248(voltage-gated sodium channel activity);GO:0005261(cation channel activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0016020(membrane);GO:0030054(cell junction);GO:0055085(transmembrane transport)","NA",{"v":3.5e-05,"d":"0.00"},1,"330,",0,-4.45,-3.79,4.29,"Exon (ENSBGRT00000010157/ENSBGRG00000005468, exon 27 of 27)",5,79229964,79437917,207954,1]
["chr5",80933405,80933613,209,"ENSBGRG00000002968","ENSBGRT00000005615",10111,"MYG1","chromosome 12 open reading frame 10 [Source:HGNC Symbol;Acc:HGNC:17590]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0035641(locomotory exploration behavior)","03030(DNA replication);03420(Nucleotide excision repair);03430(Mismatch repair)",{"v":6.3E-29,"d":"0.00"},1,"209,",0,{"v":-28.2,"d":"-28.20"},{"v":-27.1,"d":"-27.10"},3.85,"3' UTR",5,80923294,80934118,10825,1]
["chr5",83034371,83034789,419,"ENSBGRG00000000973","ENSBGRT00000001926",7133,"FGD6","FYVE, RhoGEF and PH domain containing 6 [Source:HGNC Symbol;Acc:HGNC:21740]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0043087(regulation of GTPase activity);GO:0046872(metal ion binding)","NA",{"v":2.8e-10,"d":"0.00"},1,"419,",0,-9.55,-8.76,4.01,"Exon (ENSBGRT00000001926/ENSBGRG00000000973, exon 2 of 21)",5,83027238,83134906,107669,1]
["chr5",88958400,88968433,10034,"ENSBGRG00000002414","ENSBGRT00000004607",65210,"ATP2B1","ATPase plasma membrane Ca2+ transporting 1 [Source:HGNC Symbol;Acc:HGNC:814]","GO:0000166(nucleotide binding);GO:0001772(immunological synapse);GO:0001818(negative regulation of cytokine production);GO:0003056(regulation of vascular smooth muscle contraction);GO:0005388(calcium transmembrane transporter activity, phosphorylative mechanism);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006874(cellular calcium ion homeostasis);GO:0008217(regulation of blood pressure);GO:0015085(calcium ion transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016887(ATPase activity);GO:0030501(positive regulation of bone mineralization);GO:0051480(regulation of cytosolic calcium ion concentration);GO:0051481(negative regulation of cytosolic calcium ion concentration);GO:0051928(positive regulation of calcium ion transport);GO:0070588(calcium ion transmembrane transport);GO:1900076(regulation of cellular response to insulin stimulus);GO:1990034(calcium ion export across plasma membrane)","04020(Calcium signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04925(Aldosterone synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04970(Salivary secretion);04972(Pancreatic secretion)",0,3,"51,87,668,","0,439,9366",-689,"-Inf",5.71,"3' UTR",5,88893190,88968433,75244,1]
["chr5",100002945,100029099,26155,"ENSBGRG00000006560","ENSBGRT00000013395",153533,"PPP1R12A","protein phosphatase 1 regulatory subunit 12A [Source:HGNC Symbol;Acc:HGNC:7618]","GO:0000278(mitotic cell cycle);GO:0000776(kinetochore);GO:0004857(enzyme inhibitor activity);GO:0005515(protein binding);GO:0005730(nucleolus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006470(protein dephosphorylation);GO:0007098(centrosome cycle);GO:0007165(signal transduction);GO:0015629(actin cytoskeleton);GO:0019208(phosphatase regulator activity);GO:0019901(protein kinase binding);GO:0030018(Z disc);GO:0030155(regulation of cell adhesion);GO:0031672(A band);GO:0035507(regulation of myosin-light-chain-phosphatase activity);GO:0035508(positive regulation of myosin-light-chain-phosphatase activity);GO:0035690(cellular response to drug);GO:0043086(negative regulation of catalytic activity);GO:0043292(contractile fiber);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046822(regulation of nucleocytoplasmic transport);GO:0071889(14-3-3 protein binding);GO:0072357(PTW/PP1 phosphatase complex)","04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04921(Oxytocin signaling pathway);04270(Vascular smooth muscle contraction);05205(Proteoglycans in cancer)",{"v":1e-189,"d":"0.00"},8,"121,66,17,136,105,72,51,87,","0,3195,10033,11290,13705,20558,23502,26068",-189,-187,4.62,"Exon (ENSBGRT00000013395/ENSBGRG00000006560, exon 18 of 23)",5,99849412,100023574,174163,1]
["chr5",103874442,103875540,1099,"ENSBGRG00000010078","ENSBGRT00000018541",0,"BBS10","Bardet-Biedl syndrome 10 [Source:HGNC Symbol;Acc:HGNC:26291]","GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0005524(ATP binding);GO:0043254(regulation of protein-containing complex assembly);GO:0045494(photoreceptor cell maintenance);GO:0051131(chaperone-mediated protein complex assembly);GO:1905515(non-motile cilium assembly)","NA",{"v":0.00079,"d":"0.00"},2,"75,105,","0,994",{"v":-3.1,"d":"-3.10"},{"v":-2.5,"d":"-2.50"},9.91,"5' UTR",5,103875436,103878270,2835,1]
["chr5",110741174,110741263,90,"ENSBGRG00000000386","ENSBGRT00000000636",4026,"MLF2","myeloid leukemia factor 2 [Source:HGNC Symbol;Acc:HGNC:7126]","GO:0005634(nucleus)","05202(Transcriptional misregulation in cancers)",{"v":4e-07,"d":"0.00"},1,"90,",0,{"v":-6.4,"d":"-6.40"},-5.68,1.24,"3' UTR",5,110737148,110741293,4146,1]
["chr5",114398459,114398638,180,"ENSBGRG00000013846","ENSBGRT00000025654",11909,"FOXM1","forkhead box M1 [Source:HGNC Symbol;Acc:HGNC:3818]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006978(DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator);GO:0008284(positive regulation of cell population proliferation);GO:0019901(protein kinase binding);GO:0032873(negative regulation of stress-activated MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046578(regulation of Ras protein signal transduction);GO:0071156(regulation of cell cycle arrest);GO:0090344(negative regulation of cell aging);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000781(positive regulation of double-strand break repair)","04218(Cellular senescence)",{"v":1e-12,"d":"0.00"},1,"180,",0,-12,{"v":-11.2,"d":"-11.20"},8.91,"Exon (ENSBGRT00000025654/ENSBGRG00000013846, exon 9 of 9)",5,114386550,114398638,12089,1]
["chr5",115841984,115842313,330,"ENSBGRG00000019557","ENSBGRT00000035997",25367,"WNT5B","Wnt family member 5B [Source:HGNC Symbol;Acc:HGNC:16265]","GO:0002062(chondrocyte differentiation);GO:0005102(signaling receptor binding);GO:0005576(extracellular region);GO:0007275(multicellular organism development);GO:0009986(cell surface);GO:0016055(Wnt signaling pathway);GO:0030335(positive regulation of cell migration);GO:0031012(extracellular matrix);GO:0045600(positive regulation of fat cell differentiation);GO:0090090(negative regulation of canonical Wnt signaling pathway)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);04360(Axon guidance);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":0.034,"d":"0.03"},1,"330,",0,-1.47,{"v":-0.977,"d":"-0.98"},4.95,"Exon (ENSBGRT00000035948/ENSBGRG00000019557, exon 5 of 5)",5,115816617,115842888,26272,1]
["chr5",117429442,117438097,8656,"ENSBGRG00000001162","ENSBGRT00000002135",861,"PDXP","pyridoxal phosphatase [Source:HGNC Symbol;Acc:HGNC:30259]","GO:0000287(magnesium ion binding);GO:0004721(phosphoprotein phosphatase activity);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006470(protein dephosphorylation);GO:0007088(regulation of mitotic nuclear division);GO:0015629(actin cytoskeleton);GO:0016791(phosphatase activity);GO:0030027(lamellipodium);GO:0030496(midbody);GO:0030836(positive regulation of actin filament depolymerization);GO:0031072(heat shock protein binding);GO:0031247(actin rod assembly);GO:0032154(cleavage furrow);GO:0032361(pyridoxal phosphate catabolic process);GO:0032465(regulation of cytokinesis);GO:0032587(ruffle membrane);GO:0033883(pyridoxal phosphatase activity);GO:0042803(protein homodimerization activity);GO:0070938(contractile ring);GO:0071318(cellular response to ATP)","00750(Vitamin B6 metabolism)",{"v":6.3E-21,"d":"0.00"},2,"224,460,","0,8196",{"v":-20.2,"d":"-20.20"},{"v":-19.3,"d":"-19.30"},6.93,"3' UTR",5,117428581,117438364,9784,1]
["chr5",118383448,118384984,1537,"ENSBGRG00000002734","ENSBGRT00000005129",940,"TOMM22","translocase of outer mitochondrial membrane 22 [Source:HGNC Symbol;Acc:HGNC:18002]","GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005742(mitochondrial outer membrane translocase complex);GO:0006886(intracellular protein transport);GO:0016021(integral component of membrane);GO:0045040(protein insertion into mitochondrial outer membrane)","NA",{"v":2E-12,"d":"0.00"},2,"67,75,","0,1462",{"v":-11.7,"d":"-11.70"},{"v":-10.9,"d":"-10.90"},2.76,"Exon (ENSBGRT00000005129/ENSBGRG00000002734, exon 3 of 4)",5,118382508,118384984,2477,1]
["chr5",120699566,120699938,373,"ENSBGRG00000006401","ENSBGRT00000012064",63451,"EP300","E1A binding protein p300 [Source:HGNC Symbol;Acc:HGNC:3373]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000123(histone acetyltransferase complex);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001666(response to hypoxia);GO:0001756(somitogenesis);GO:0001966(thigmotaxis);GO:0002039(p53 binding);GO:0002209(behavioral defense response);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003684(damaged DNA binding);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0004468(lysine N-acetyltransferase activity, acting on acetyl phosphate as donor);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005829(cytosol);GO:0006110(regulation of glycolytic process);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006473(protein acetylation);GO:0006475(internal protein amino acid acetylation);GO:0006915(apoptotic process);GO:0006990(positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response);GO:0007507(heart development);GO:0007519(skeletal muscle tissue development);GO:0007611(learning or memory);GO:0007623(circadian rhythm);GO:0008013(beta-catenin binding);GO:0008022(protein C-terminus binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0009887(animal organ morphogenesis);GO:0010628(positive regulation of gene expression);GO:0010742(macrophage derived foam cell differentiation);GO:0010821(regulation of mitochondrion organization);GO:0010976(positive regulation of neuron projection development);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0016746(transferase activity, transferring acyl groups);GO:0018076(N-terminal peptidyl-lysine acetylation);GO:0018393(internal peptidyl-lysine acetylation);GO:0018394(peptidyl-lysine acetylation);GO:0030183(B cell differentiation);GO:0030220(platelet formation);GO:0030324(lung development);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0031333(negative regulation of protein-containing complex assembly);GO:0031490(chromatin DNA binding);GO:0031648(protein destabilization);GO:0032092(positive regulation of protein binding);GO:0032991(protein-containing complex);GO:0033613(activating transcription factor binding);GO:0034644(cellular response to UV);GO:0035257(nuclear hormone receptor binding);GO:0035264(multicellular organism growth);GO:0035855(megakaryocyte development);GO:0036268(swimming);GO:0042025(host cell nucleus);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0043627(response to estrogen);GO:0043923(positive regulation by host of viral transcription);GO:0043967(histone H4 acetylation);GO:0043969(histone H2B acetylation);GO:0045444(fat cell differentiation);GO:0045721(negative regulation of gluconeogenesis);GO:0045815(positive regulation of gene expression, epigenetic);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050681(androgen receptor binding);GO:0050821(protein stabilization);GO:0051059(NF-kappaB binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060325(face morphogenesis);GO:0060765(regulation of androgen receptor signaling pathway);GO:0061733(peptide-lysine-N-acetyltransferase activity);GO:0061920(protein propionyltransferase activity);GO:0061921(peptidyl-lysine propionylation);GO:0090043(regulation of tubulin deacetylation);GO:0097157(pre-mRNA intronic binding);GO:0097677(STAT family protein binding);GO:0140065(peptide butyryltransferase activity);GO:0140066(peptidyl-lysine crotonylation);GO:0140067(peptidyl-lysine butyrylation);GO:0140068(histone crotonyltransferase activity);GO:0140069(histone butyryltransferase activity);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1905636(positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding)","04310(Wnt signaling pathway);04330(Notch signaling pathway);04350(TGF-beta signaling pathway);04630(Jak-STAT signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04024(cAMP signaling pathway);04110(Cell cycle);04520(Adherens junction);04922(Glucagon signaling pathway);04919(Thyroid hormone signaling pathway);04916(Melanogenesis);04720(Long-term potentiation);05200(Pathways in cancer);05206(MicroRNAs in cancer);05203(Viral carcinogenesis);05211(Renal cell carcinoma);05215(Prostate cancer);05016(Huntington disease);05152(Tuberculosis);05166(HTLV-I infection);05164(Influenza A);05161(Hepatitis B);05168(Herpes simplex infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection)",{"v":0.0042,"d":"0.00"},2,"8,112,","0,261",-2.38,-1.83,1.87,"Exon (ENSBGRT00000012064/ENSBGRG00000006401, exon 30 of 32)",5,120636115,120703924,67810,1]
["chr5",121993614,121994360,747,"ENSBGRG00000012024","ENSBGRT00000022251",22541,"SERHL2","serine hydrolase like 2 [Source:HGNC Symbol;Acc:HGNC:29446]","GO:0031410(cytoplasmic vesicle)","NA",{"v":1e-101,"d":"0.00"},1,"747,",0,-101,{"v":-99.2,"d":"-99.20"},{"v":12.4,"d":"12.40"},"3' UTR",5,121971073,121994360,23288,1]
["chr5",124450577,124450814,238,"ENSBGRG00000018554","ENSBGRT00000034015",18488,"NUP50","nucleoporin 50 [Source:HGNC Symbol;Acc:HGNC:8065]","GO:0005643(nuclear pore);GO:0005654(nucleoplasm);GO:0031965(nuclear membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0046907(intracellular transport)","03013(RNA transport)",{"v":7.9e-43,"d":"0.00"},1,"238,",0,{"v":-42.1,"d":"-42.10"},-41,{"v":4.6,"d":"4.60"},"3' UTR",5,124432089,124450814,18726,1]
["chr5",128779173,128782307,3135,"ENSBGRG00000002056","ENSBGRT00000003822",390,"ENSBGRG00000002056","NA","NA","NA",{"v":1.4E-8,"d":"0.00"},2,"158,143,","0,2992",-7.85,{"v":-7.1,"d":"-7.10"},9.91,"Exon (ENSBGRT00000003822/ENSBGRG00000002056, exon 1 of 2)",5,128778783,128783517,4735,1]
["chr5",129646432,129646581,150,"ENSBGRG00000005496","ENSBGRT00000011046",43940,"ENSBGRG00000005496","NA","NA","04724(Glutamatergic synapse)",{"v":3e-06,"d":"0.00"},1,"150,",0,-5.53,-4.83,1.47,"Exon (ENSBGRT00000011046/ENSBGRG00000005496, exon 25 of 27)",5,129602492,129657291,54800,1]
["chr5",2837339,2837399,61,"ENSBGRG00000021591","ENSBGRT00000040010",15197,"ENSBGRG00000021591","NA","GO:0005634(nucleus);GO:0008380(RNA splicing);GO:0035145(exon-exon junction complex)","03040(Spliceosome);03013(RNA transport);03015(mRNA surveillance pathway);04145(Phagosome);03320(PPAR signaling pathway)",{"v":0.018,"d":"0.02"},1,"61,",0,-1.74,-1.22,2.81,"3' UTR",5,2837219,2852596,15378,2]
["chr5",7179165,7179255,91,"ENSBGRG00000001570","ENSBGRT00000002912",8749,"ENSBGRG00000001570","NA","GO:0006396(RNA processing)","03040(Spliceosome)",{"v":3.4e-06,"d":"0.00"},1,"91,",0,-5.47,-4.78,1.25,"Exon (ENSBGRT00000002912/ENSBGRG00000001570, exon 8 of 12)",5,7173633,7188004,14372,2]
["chr5",18458442,18462591,4150,"ENSBGRG00000001323","ENSBGRT00000002637",18901,"CASC1","cancer susceptibility 1 [Source:HGNC Symbol;Acc:HGNC:29599]","NA","NA",{"v":2.1e-06,"d":"0.00"},3,"30,92,27,","0,2385,4123",-5.68,-4.98,2.48,"Exon (ENSBGRT00000002637/ENSBGRG00000001323, exon 3 of 16)",5,18384663,18481492,96830,2]
["chr5",28404785,28405411,627,"ENSBGRG00000006329","ENSBGRT00000011713",33440,"CYTH4","cytohesin 4 [Source:HGNC Symbol;Acc:HGNC:9505]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005886(plasma membrane);GO:0032012(regulation of ARF protein signal transduction)","04072(Phospholipase D signaling pathway);04144(Endocytosis)",{"v":7.9e-18,"d":"0.00"},1,"627,",0,{"v":-17.1,"d":"-17.10"},{"v":-16.2,"d":"-16.20"},{"v":7.2,"d":"7.20"},"3' UTR",5,28394324,28438851,44528,2]
["chr5",33671504,33674789,3286,"ENSBGRG00000014122","ENSBGRT00000026245",59,"PWP1","PWP1 homolog, endonuclein [Source:HGNC Symbol;Acc:HGNC:17015]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0033140(negative regulation of peptidyl-serine phosphorylation of STAT protein);GO:0034773(histone H4-K20 trimethylation);GO:1901838(positive regulation of transcription of nucleolar large rRNA by RNA polymerase I);GO:1990889(H4K20me3 modified histone binding);GO:2000738(positive regulation of stem cell differentiation)","NA",{"v":2.5E-51,"d":"0.00"},3,"166,59,13,","0,303,3273",{"v":-50.6,"d":"-50.60"},{"v":-49.4,"d":"-49.40"},1.99,"Exon (ENSBGRT00000026245/ENSBGRG00000014122, exon 1 of 15)",5,33654968,33674848,19881,2]
["chr5",34875438,34882663,7226,"ENSBGRG00000016356","ENSBGRT00000029998",128080,"POLR3B","RNA polymerase III subunit B [Source:HGNC Symbol;Acc:HGNC:30348]","GO:0003677(DNA binding);GO:0003899(DNA-directed 5'-3' RNA polymerase activity);GO:0005666(RNA polymerase III complex);GO:0006351(transcription, DNA-templated);GO:0032549(ribonucleoside binding);GO:0032728(positive regulation of interferon-beta production);GO:0045089(positive regulation of innate immune response)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway);05169(Epstein-Barr virus infection)",{"v":0.00087,"d":"0.00"},2,"19,191,","0,7035",-3.06,-2.46,2.55,"3' UTR",5,34875438,35010743,135306,2]
["chr5",40903552,40903908,357,"ENSBGRG00000003088","ENSBGRT00000005770",19783,"GAS2L3","growth arrest specific 2 like 3 [Source:HGNC Symbol;Acc:HGNC:27475]","GO:0000226(microtubule cytoskeleton organization);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005856(cytoskeleton);GO:0008017(microtubule binding);GO:0015629(actin cytoskeleton);GO:0015630(microtubule cytoskeleton);GO:0030036(actin cytoskeleton organization)","NA",{"v":3.2e-16,"d":"0.00"},1,"357,",0,{"v":-15.5,"d":"-15.50"},{"v":-14.6,"d":"-14.60"},4.42,"Exon (ENSBGRT00000005770/ENSBGRG00000003088, exon 8 of 8)",5,40902989,40923691,20703,2]
["chr5",47428248,47429954,1707,"ENSBGRG00000000440","ENSBGRT00000000748",25,"PYM1","PYM homolog 1, exon junction complex associated factor [Source:HGNC Symbol;Acc:HGNC:30258]","GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0030054(cell junction);GO:0035145(exon-exon junction complex);GO:0043022(ribosome binding);GO:0045727(positive regulation of translation);GO:1903259(exon-exon junction complex disassembly)","03013(RNA transport);03015(mRNA surveillance pathway)",{"v":1e-130,"d":"0.00"},2,"965,181,","0,1526",-130,-128,6.71,"3' UTR",5,47428248,47429979,1732,2]
["chr5",48557247,48557306,60,"ENSBGRG00000003965","ENSBGRT00000007309",6658,"ENSBGRG00000003965","NA","GO:0007217(tachykinin receptor signaling pathway)","04080(Neuroactive ligand-receptor interaction)",{"v":1.3e-08,"d":"0.00"},1,"60,",0,{"v":-7.9,"d":"-7.90"},-7.15,3.32,"3' UTR",5,48557247,48563964,6718,2]
["chr5",54789366,54952337,162972,"ENSBGRG00000015365","ENSBGRT00000028226",690,"PPM1H","protein phosphatase, Mg2+/Mn2+ dependent 1H [Source:HGNC Symbol;Acc:HGNC:18583]","GO:0003824(catalytic activity);GO:0004721(phosphoprotein phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006470(protein dephosphorylation);GO:0042802(identical protein binding)","NA",{"v":0.012,"d":"0.01"},3,"75,166,59,","0,41718,162913",-1.93,{"v":-1.4,"d":"-1.40"},5.45,"Exon (ENSBGRT00000028226/ENSBGRG00000015365, exon 1 of 10)",5,54605084,54953027,347944,2]
["chr5",68361325,68366415,5091,"ENSBGRG00000018534","ENSBGRT00000034049",0,"ZCRB1","zinc finger CCHC-type and RNA binding motif containing 1 [Source:HGNC Symbol;Acc:HGNC:29620]","GO:0003676(nucleic acid binding);GO:0005689(U12-type spliceosomal complex);GO:0008270(zinc ion binding)","NA",{"v":3.2e-05,"d":"0.00"},2,"3,86,","0,5005",{"v":-4.5,"d":"-4.50"},-3.84,2.13,"5' UTR",5,68348987,68361327,12341,2]
["chr5",75216391,75217188,798,"ENSBGRG00000025109","ENSBGRT00000046418",3455,"ASB8","ankyrin repeat and SOCS box containing 8 [Source:HGNC Symbol;Acc:HGNC:17183]","GO:0005515(protein binding);GO:0035556(intracellular signal transduction)","NA",{"v":9.99999999999999e-294,"d":"0.00"},2,"664,27,","0,771",-293,-291,8.24,"3' UTR",5,75216391,75220643,4253,2]
["chr5",77254981,77255130,150,"ENSBGRG00000001837","ENSBGRT00000003465",8939,"FAM186B","family with sequence similarity 186 member B [Source:HGNC Symbol;Acc:HGNC:25296]","GO:0032991(protein-containing complex)","NA",{"v":0.00042,"d":"0.00"},1,"150,",0,-3.38,-2.77,3.59,"Exon (ENSBGRT00000003465/ENSBGRG00000001837, exon 6 of 10)",5,77247479,77264069,16591,2]
["chr5",79452237,79452386,150,"ENSBGRG00000000309","ENSBGRT00000000483",1403,"FIGNL2","fidgetin like 2 [Source:HGNC Symbol;Acc:HGNC:13287]","GO:0005524(ATP binding)","NA",{"v":0.0068,"d":"0.01"},1,"150,",0,-2.17,-1.62,7.92,"Exon (ENSBGRT00000000483/ENSBGRG00000000309, exon 1 of 2)",5,79451385,79453789,2405,2]
["chr5",82017574,82017933,360,"ENSBGRG00000004167","ENSBGRT00000007700",2901,"NFE2","nuclear factor, erythroid 2 [Source:HGNC Symbol;Acc:HGNC:7780]","GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0032993(protein-DNA complex);GO:0047485(protein N-terminus binding);GO:0050699(WW domain binding);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.00098,"d":"0.00"},1,"360,",0,-3.01,-2.42,{"v":12.9,"d":"12.90"},"3' UTR",5,82016708,82020834,4127,2]
["chr5",82745315,82769525,24211,"ENSBGRG00000000711","ENSBGRT00000001651",0,"METAP2","methionyl aminopeptidase 2 [Source:HGNC Symbol;Acc:HGNC:16672]","GO:0004177(aminopeptidase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0008235(metalloexopeptidase activity);GO:0016485(protein processing);GO:0018206(peptidyl-methionine modification);GO:0031365(N-terminal protein amino acid modification)","NA",{"v":1E-168,"d":"0.00"},6,"50,103,66,108,151,86,","0,6322,10585,19354,22861,24125",-168,-166,3.96,"Exon (ENSBGRT00000001651/ENSBGRG00000000711, exon 1 of 11)",5,82736959,82768326,31368,2]
["chr5",105820696,105820989,294,"ENSBGRG00000011433","ENSBGRT00000020861",0,"ATXN7L3B","ataxin 7 like 3B [Source:HGNC Symbol;Acc:HGNC:37931]","GO:0005737(cytoplasm);GO:0010468(regulation of gene expression)","NA",{"v":1e-74,"d":"0.00"},1,"294,",0,-74,{"v":-72.6,"d":"-72.60"},4.95,"Exon (ENSBGRT00000020861/ENSBGRG00000011433, exon 1 of 1)",5,105820696,105820989,294,2]
["chr5",110756598,110757017,420,"ENSBGRG00000000407","ENSBGRT00000000675",0,"ENSBGRG00000000407","NA","NA","03010(Ribosome)",{"v":6.6e-09,"d":"0.00"},1,"420,",0,-8.18,-7.41,{"v":3.8,"d":"3.80"},"Exon (ENSBGRT00000000675/ENSBGRG00000000407, exon 1 of 1)",5,110756478,110757017,540,2]
["chr5",116641760,116642749,990,"ENSBGRG00000000511","ENSBGRT00000000918",579,"ENSBGRG00000000511","NA","NA","NA",{"v":0.0062,"d":"0.01"},3,"622,3,362,","0,623,628",-2.21,-1.67,9.91,"Exon (ENSBGRT00000000918/ENSBGRG00000000511, exon 13 of 17)",5,116641575,116643328,1754,2]
["chr5",118235784,118235904,121,"ENSBGRG00000002557","ENSBGRT00000004885",0,"DDX17","DEAD-box helicase 17 [Source:HGNC Symbol;Acc:HGNC:2740]","GO:0003676(nucleic acid binding);GO:0005524(ATP binding)","NA",{"v":1e-29,"d":"0.00"},1,"121,",0,-29,-28,1.98,"Exon (ENSBGRT00000004885/ENSBGRG00000002557, exon 1 of 13)",5,118218387,118235904,17518,2]
["chr5",120440070,120451786,11717,"ENSBGRG00000006165","ENSBGRT00000011399",0,"ST13","ST13 Hsp70 interacting protein [Source:HGNC Symbol;Acc:HGNC:11343]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0009617(response to bacterium);GO:0046983(protein dimerization activity)","NA",{"v":9.99999999999998E-281,"d":"0.00"},5,"46,71,76,58,110,","0,3139,6195,7581,11607",-280,-277,1.96,"Exon (ENSBGRT00000011399/ENSBGRG00000006165, exon 1 of 12)",5,120429306,120451786,22481,2]
["chr5",122034333,122034392,60,"ENSBGRG00000012803","ENSBGRT00000023643",13811,"CYB5R3","cytochrome b5 reductase 3 [Source:HGNC Symbol;Acc:HGNC:2873]","GO:0005783(endoplasmic reticulum);GO:0005811(lipid droplet);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00520(Amino sugar and nucleotide sugar metabolism)",{"v":4e-85,"d":"0.00"},1,"60,",0,{"v":-84.4,"d":"-84.40"},{"v":-82.9,"d":"-82.90"},1.83,"3' UTR",5,122034005,122048203,14199,2]
["chr5",125192503,125192713,211,"ENSBGRG00000001139","ENSBGRT00000002122",32741,"WNT7B","Wnt family member 7B [Source:HGNC Symbol;Acc:HGNC:12787]","GO:0005102(signaling receptor binding);GO:0005576(extracellular region);GO:0007275(multicellular organism development);GO:0016055(Wnt signaling pathway);GO:0021871(forebrain regionalization);GO:0030182(neuron differentiation);GO:0048018(receptor ligand activity);GO:0048144(fibroblast proliferation);GO:0060070(canonical Wnt signaling pathway);GO:0061180(mammary gland epithelium development);GO:0071300(cellular response to retinoic acid);GO:0072089(stem cell proliferation)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",0.02,1,"211,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"3' UTR",5,125192473,125225454,32982,2]
["chr5",125604862,125605192,331,"ENSBGRG00000001235","ENSBGRT00000002279",4804,"ENSBGRG00000001235","NA","NA","NA",{"v":0.011,"d":"0.01"},2,"242,58,","0,273",-1.95,-1.18,8.91,"Exon (ENSBGRT00000002279/ENSBGRG00000001235, exon 7 of 10)",5,125603688,125609996,6309,2]
["chr5",129169705,129172977,3273,"ENSBGRG00000002564","ENSBGRT00000005022",21286,"ENSBGRG00000002564","NA","NA","NA",{"v":1e-152,"d":"0.00"},7,"826,107,76,139,116,89,57,","0,877,1200,1600,2848,3045,3216",-152,-151,8.11,"Exon (ENSBGRT00000005022/ENSBGRG00000002564, exon 11 of 26)",5,129167401,129194263,26863,2]
["chr6",355725,355995,271,"ENSBGRG00000006253","ENSBGRT00000011527",58681,"KIAA0232","KIAA0232 [Source:HGNC Symbol;Acc:HGNC:28992]","NA","NA",{"v":1e-24,"d":"0.00"},1,"271,",0,-24,-23,{"v":2.9,"d":"2.90"},"3' UTR",6,297044,357761,60718,1]
["chr6",3456060,3457690,1631,"ENSBGRG00000015105","ENSBGRT00000027826",29533,"TNIP2","TNFAIP3 interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:19118]","GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0019901(protein kinase binding);GO:0023035(CD40 signaling pathway);GO:0031593(polyubiquitin modification-dependent protein binding);GO:0034134(toll-like receptor 2 signaling pathway);GO:0034138(toll-like receptor 3 signaling pathway);GO:0034162(toll-like receptor 9 signaling pathway);GO:0043032(positive regulation of macrophage activation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050821(protein stabilization);GO:0050871(positive regulation of B cell activation);GO:0070498(interleukin-1-mediated signaling pathway);GO:0070530(K63-linked polyubiquitin modification-dependent protein binding);GO:0071222(cellular response to lipopolysaccharide);GO:2000352(negative regulation of endothelial cell apoptotic process)","NA",{"v":1e-132,"d":"0.00"},3,"43,120,617,","0,476,1014",-132,-130,8.01,"3' UTR",6,3426527,3457690,31164,1]
["chr6",5070493,5071208,716,"ENSBGRG00000019777","ENSBGRT00000036695",13302,"DGKQ","diacylglycerol kinase theta [Source:HGNC Symbol;Acc:HGNC:2856]","GO:0003951(NAD+ kinase activity);GO:0004143(diacylglycerol kinase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0006111(regulation of gluconeogenesis);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006654(phosphatidic acid biosynthetic process);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007205(protein kinase C-activating G protein-coupled receptor signaling pathway);GO:0008277(regulation of G protein-coupled receptor signaling pathway);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0012506(vesicle membrane);GO:0016301(kinase activity);GO:0016607(nuclear speck);GO:0018105(peptidyl-serine phosphorylation);GO:0019900(kinase binding);GO:0019933(cAMP-mediated signaling);GO:0030297(transmembrane receptor protein tyrosine kinase activator activity);GO:0033198(response to ATP);GO:0033613(activating transcription factor binding);GO:0035556(intracellular signal transduction);GO:0043274(phospholipase binding);GO:0046339(diacylglycerol metabolic process);GO:0046486(glycerolipid metabolic process);GO:0046834(lipid phosphorylation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051591(response to cAMP);GO:0070493(thrombin-activated receptor signaling pathway);GO:0070528(protein kinase C signaling);GO:0090181(regulation of cholesterol metabolic process);GO:1903432(regulation of TORC1 signaling);GO:2000064(regulation of cortisol biosynthetic process);GO:2000182(regulation of progesterone biosynthetic process)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);05231(Choline metabolism in cancer)",{"v":9.99999999999999e-251,"d":"0.00"},1,"716,",0,-250,-248,{"v":10.1,"d":"10.10"},"3' UTR",6,5057191,5071208,14018,1]
["chr6",14506791,14520006,13216,"ENSBGRG00000010047","ENSBGRT00000018417",3517,"ZBTB49","zinc finger and BTB domain containing 49 [Source:HGNC Symbol;Acc:HGNC:19883]","GO:0001223(transcription coactivator binding);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007050(cell cycle arrest);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0015630(microtubule cytoskeleton);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","04110(Cell cycle);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05222(Small cell lung cancer)",{"v":5e-47,"d":"0.00"},4,"1066,47,74,31,","0,4451,11380,13185",{"v":-46.3,"d":"-46.30"},{"v":-45.1,"d":"-45.10"},5.04,"Exon (ENSBGRT00000018417/ENSBGRG00000010047, exon 2 of 7)",6,14503274,14525641,22368,1]
["chr6",20242824,20243003,180,"ENSBGRG00000018444","ENSBGRT00000037739",68032,"WDFY3","WD repeat and FYVE domain containing 3 [Source:HGNC Symbol;Acc:HGNC:20751]","GO:0003831(beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity);GO:0005515(protein binding);GO:0005545(1-phosphatidylinositol binding);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005776(autophagosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0016234(inclusion body);GO:0016605(PML body);GO:0019898(extrinsic component of membrane);GO:0034274(Atg12-Atg5-Atg16 complex);GO:0035973(aggrephagy);GO:0046872(metal ion binding);GO:0097635(extrinsic component of autophagosome membrane)","NA",{"v":3.8E-6,"d":"0.00"},1,"180,",0,-5.42,-4.73,2.23,"Exon (ENSBGRT00000037739/ENSBGRG00000018444, exon 11 of 69)",6,20174792,20400183,225392,1]
["chr6",28956897,29002275,45379,"ENSBGRG00000013500","ENSBGRT00000025132",0,"SEPTIN11","septin 11 [Source:HGNC Symbol;Acc:HGNC:25589]","GO:0001725(stress fiber);GO:0005525(GTP binding);GO:0031105(septin complex)","05100(Bacterial invasion of epithelial cells)",{"v":7.4e-07,"d":"0.00"},2,"163,75,","0,45304",-6.13,-5.42,4.56,"5' UTR",6,28827875,28957075,129201,2]
["chr6",29811162,29811221,60,"ENSBGRG00000014836","ENSBGRT00000027300",35849,"NUP54","nucleoporin 54 [Source:HGNC Symbol;Acc:HGNC:17359]","GO:0005643(nuclear pore)","03013(RNA transport)",{"v":0.0078,"d":"0.01"},1,"60,",0,-2.11,-1.57,1.38,"Exon (ENSBGRT00000027300/ENSBGRG00000014836, exon 12 of 12)",6,29775313,29811221,35909,1]
["chr6",35085664,35085723,60,"ENSBGRG00000026393","ENSBGRT00000048856",43835,"GRSF1","G-rich RNA sequence binding factor 1 [Source:HGNC Symbol;Acc:HGNC:4610]","GO:0000962(positive regulation of mitochondrial RNA catabolic process);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005739(mitochondrion);GO:0006396(RNA processing);GO:0009952(anterior/posterior pattern specification);GO:0016331(morphogenesis of embryonic epithelium);GO:0035770(ribonucleoprotein granule);GO:0042645(mitochondrial nucleoid)","NA",{"v":0.048,"d":"0.05"},1,"60,",0,-1.32,{"v":-0.839,"d":"-0.84"},{"v":3.3,"d":"3.30"},"Exon (ENSBGRT00000048863/ENSBGRG00000026393, exon 2 of 9)",6,35041829,35099257,57429,1]
["chr6",54810705,54810884,180,"ENSBGRG00000000416","ENSBGRT00000000695",21126,"LRRC66","leucine rich repeat containing 66 [Source:HGNC Symbol;Acc:HGNC:34299]","GO:0005515(protein binding)","NA",{"v":0.005,"d":"0.01"},1,"180,",0,{"v":-2.3,"d":"-2.30"},-1.75,3.96,"Exon (ENSBGRT00000000695/ENSBGRG00000000416, exon 4 of 5)",6,54789579,54812052,22474,1]
["chr6",56500282,56503323,3042,"ENSBGRG00000001280","ENSBGRT00000002533",306438,"CORIN","corin, serine peptidase [Source:HGNC Symbol;Acc:HGNC:19012]","GO:0003050(regulation of systemic arterial blood pressure by atrial natriuretic peptide);GO:0004175(endopeptidase activity);GO:0004252(serine-type endopeptidase activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0007565(female pregnancy);GO:0008217(regulation of blood pressure);GO:0009986(cell surface);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0016486(peptide hormone processing);GO:0016604(nuclear body);GO:0035813(regulation of renal sodium excretion)","NA",{"v":0.0022,"d":"0.00"},3,"21,50,19,","0,2819,3023",-2.65,-2.08,6.93,"Exon (ENSBGRT00000002533/ENSBGRG00000001280, exon 17 of 22)",6,56193844,56534683,340840,1]
["chr6",65570924,65571369,446,"ENSBGRG00000004282","ENSBGRT00000007904",2956,"TLR10","toll like receptor 10 [Source:HGNC Symbol;Acc:HGNC:15634]","GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0007165(signal transduction);GO:0016021(integral component of membrane);GO:0034166(toll-like receptor 10 signaling pathway);GO:0042802(identical protein binding);GO:0045087(innate immune response);GO:0050707(regulation of cytokine secretion);GO:0050729(positive regulation of inflammatory response)","NA",{"v":7.9e-16,"d":"0.00"},1,"446,",0,{"v":-15.1,"d":"-15.10"},{"v":-14.2,"d":"-14.20"},{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000007904/ENSBGRG00000004282, exon 3 of 3)",6,65567968,65571369,3402,1]
["chr6",88949961,88950366,406,"ENSBGRG00000020518","ENSBGRT00000037773",66494,"PKD2","polycystin 2, transient receptor potential cation channel [Source:HGNC Symbol;Acc:HGNC:9009]","GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001822(kidney development);GO:0001889(liver development);GO:0001892(embryonic placenta development);GO:0001947(heart looping);GO:0002133(polycystin complex);GO:0003127(detection of nodal flow);GO:0005102(signaling receptor binding);GO:0005244(voltage-gated ion channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0005248(voltage-gated sodium channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005261(cation channel activity);GO:0005262(calcium channel activity);GO:0005267(potassium channel activity);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005911(cell-cell junction);GO:0005929(cilium);GO:0006816(calcium ion transport);GO:0006874(cellular calcium ion homeostasis);GO:0007050(cell cycle arrest);GO:0007259(receptor signaling pathway via JAK-STAT);GO:0007368(determination of left/right symmetry);GO:0007507(heart development);GO:0008092(cytoskeletal protein binding);GO:0009925(basal plasma membrane);GO:0010628(positive regulation of gene expression);GO:0015267(channel activity);GO:0015271(outward rectifier potassium channel activity);GO:0016020(membrane);GO:0021510(spinal cord development);GO:0021915(neural tube development);GO:0022843(voltage-gated cation channel activity);GO:0030027(lamellipodium);GO:0031514(motile cilium);GO:0031587(positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity);GO:0031941(filamentous actin);GO:0034703(cation channel complex);GO:0035502(metanephric part of ureteric bud development);GO:0035725(sodium ion transmembrane transport);GO:0035904(aorta development);GO:0036064(ciliary basal body);GO:0042127(regulation of cell population proliferation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042805(actinin binding);GO:0042994(cytoplasmic sequestering of transcription factor);GO:0043398(HLH domain binding);GO:0044325(ion channel binding);GO:0044782(cilium organization);GO:0045180(basal cortex);GO:0045429(positive regulation of nitric oxide biosynthetic process);GO:0045737(positive regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048763(calcium-induced calcium release activity);GO:0050982(detection of mechanical stimulus);GO:0051117(ATPase binding);GO:0051209(release of sequestered calcium ion into cytosol);GO:0051219(phosphoprotein binding);GO:0051262(protein tetramerization);GO:0051289(protein homotetramerization);GO:0051290(protein heterotetramerization);GO:0060170(ciliary membrane);GO:0060315(negative regulation of ryanodine-sensitive calcium-release channel activity);GO:0060674(placenta blood vessel development);GO:0061333(renal tubule morphogenesis);GO:0061441(renal artery morphogenesis);GO:0070588(calcium ion transmembrane transport);GO:0071158(positive regulation of cell cycle arrest);GO:0071277(cellular response to calcium ion);GO:0071320(cellular response to cAMP);GO:0071458(integral component of cytoplasmic side of endoplasmic reticulum membrane);GO:0071464(cellular response to hydrostatic pressure);GO:0071470(cellular response to osmotic stress);GO:0071498(cellular response to fluid shear stress);GO:0071556(integral component of lumenal side of endoplasmic reticulum membrane);GO:0071805(potassium ion transmembrane transport);GO:0071910(determination of liver left/right asymmetry);GO:0072075(metanephric mesenchyme development);GO:0072164(mesonephric tubule development);GO:0072177(mesonephric duct development);GO:0072208(metanephric smooth muscle tissue development);GO:0072214(metanephric cortex development);GO:0072218(metanephric ascending thin limb development);GO:0072219(metanephric cortical collecting duct development);GO:0072235(metanephric distal tubule development);GO:0072284(metanephric S-shaped body morphogenesis);GO:0072686(mitotic spindle);GO:0090279(regulation of calcium ion import);GO:0097730(non-motile cilium);GO:0098662(inorganic cation transmembrane transport);GO:0198738(cell-cell signaling by wnt);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","NA",{"v":0.0051,"d":"0.01"},2,"2,59,","0,347",-2.29,-1.74,1.63,"Exon (ENSBGRT00000037773/ENSBGRG00000020518, exon 16 of 16)",6,88883467,88950544,67078,1]
["chr6",104596269,104598090,1822,"ENSBGRG00000003138","ENSBGRT00000005878",77463,"NFKB1","nuclear factor kappa B subunit 1 [Source:HGNC Symbol;Acc:HGNC:7794]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001818(negative regulation of cytokine production);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007165(signal transduction);GO:0008134(transcription factor binding);GO:0010629(negative regulation of gene expression);GO:0010956(negative regulation of calcidiol 1-monooxygenase activity);GO:0032695(negative regulation of interleukin-12 production);GO:0035994(response to muscle stretch);GO:0042025(host cell nucleus);GO:0042802(identical protein binding);GO:0042805(actinin binding);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050728(negative regulation of inflammatory response);GO:0071222(cellular response to lipopolysaccharide);GO:0071260(cellular response to mechanical stimulus);GO:0071316(cellular response to nicotine);GO:0071347(cellular response to interleukin-1);GO:0071354(cellular response to interleukin-6);GO:0071356(cellular response to tumor necrosis factor);GO:0071359(cellular response to dsRNA);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1900127(positive regulation of hyaluronan biosynthetic process);GO:1904385(cellular response to angiotensin);GO:2000630(positive regulation of miRNA metabolic process)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04151(PI3K-Akt signaling pathway);04210(Apoptosis);04218(Cellular senescence);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04657(IL-17 signaling pathway);04662(B cell receptor signaling pathway);04062(Chemokine signaling pathway);04920(Adipocytokine signaling pathway);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04722(Neurotrophin signaling pathway);04380(Osteoclast differentiation);04211(Longevity regulating pathway - mammal);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05206(MicroRNAs in cancer);05203(Viral carcinogenesis);05212(Pancreatic cancer);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05215(Prostate cancer);05222(Small cell lung cancer);05321(Inflammatiory bowel disease (IBD));05030(Cocaine addiction);05418(Fluid shear stress and atherosclerosis);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05132(Salmonella infection);05133(Pertussis);05134(Legionellosis);05152(Tuberculosis);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05168(Herpes simplex infection);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05146(Amoebiasis);05145(Toxoplasmosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));01523(Antifolate resistance)",{"v":6.8e-09,"d":"0.00"},2,"137,13,","0,1809",-8.17,{"v":-7.4,"d":"-7.40"},1.84,"Exon (ENSBGRT00000005878/ENSBGRG00000003138, exon 11 of 23)",6,104518806,104621771,102966,1]
["chr6",111496200,111512598,16399,"ENSBGRG00000001484","ENSBGRT00000002733",239,"SEC24B","SEC24 homolog B, COPII coat complex component [Source:HGNC Symbol;Acc:HGNC:10704]","GO:0001843(neural tube closure);GO:0002093(auditory receptor cell morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0008270(zinc ion binding);GO:0021747(cochlear nucleus development);GO:0030127(COPII vesicle coat);GO:0035909(aorta morphogenesis);GO:0060088(auditory receptor cell stereocilium organization);GO:0060425(lung morphogenesis);GO:0060463(lung lobe morphogenesis);GO:0060982(coronary artery morphogenesis);GO:0061156(pulmonary artery morphogenesis);GO:0072358(cardiovascular system development);GO:0090110(COPII-coated vesicle cargo loading);GO:0090178(regulation of establishment of planar polarity involved in neural tube closure);GO:1901301(regulation of cargo loading into COPII-coated vesicle)","04141(Protein processing in endoplasmic reticulum)",{"v":3.3E-4,"d":"0.00"},2,"503,6,","0,16393",-3.48,-2.86,5.94,"5' UTR",6,111495961,111582946,86986,1]
["chr6",111858475,111858919,445,"ENSBGRG00000001886","ENSBGRT00000003526",20132,"RRH","retinal pigment epithelium-derived rhodopsin homolog [Source:HGNC Symbol;Acc:HGNC:10450]","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007601(visual perception);GO:0016021(integral component of membrane)","NA",{"v":8.5e-06,"d":"0.00"},1,"445,",0,-5.07,-4.39,8.58,"3' UTR",6,111838343,111858919,20577,1]
["chr6",121970896,121971104,209,"ENSBGRG00000004790","ENSBGRT00000008842",185750,"SYNPO2","synaptopodin 2 [Source:HGNC Symbol;Acc:HGNC:17732]","GO:0001725(stress fiber);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0015629(actin cytoskeleton);GO:0030018(Z disc);GO:0031005(filamin binding);GO:0043231(intracellular membrane-bounded organelle);GO:0051393(alpha-actinin binding)","04530(Tight junction)",{"v":1e-159,"d":"0.00"},1,"209,",0,-159,-158,2.53,"Exon (ENSBGRT00000008842/ENSBGRG00000004790, exon 4 of 5)",6,121785146,121971883,186738,1]
["chr6",2969267,2969477,211,"ENSBGRG00000008977","ENSBGRT00000024681",126118,"HTT","huntingtin [Source:HGNC Symbol;Acc:HGNC:4851]","GO:0000132(establishment of mitotic spindle orientation);GO:0002039(p53 binding);GO:0005522(profilin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005776(autophagosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005814(centriole);GO:0005829(cytosol);GO:0006890(retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum);GO:0007030(Golgi organization);GO:0016234(inclusion body);GO:0019900(kinase binding);GO:0030424(axon);GO:0030425(dendrite);GO:0030659(cytoplasmic vesicle membrane);GO:0031072(heat shock protein binding);GO:0031587(positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity);GO:0031648(protein destabilization);GO:0032991(protein-containing complex);GO:0034452(dynactin binding);GO:0042297(vocal learning);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0043666(regulation of phosphoprotein phosphatase activity);GO:0044325(ion channel binding);GO:0045505(dynein intermediate chain binding);GO:0045724(positive regulation of cilium assembly);GO:0047496(vesicle transport along microtubule);GO:0048471(perinuclear region of cytoplasm);GO:0048487(beta-tubulin binding);GO:0099524(postsynaptic cytosol);GO:1903599(positive regulation of autophagy of mitochondrion);GO:1904504(positive regulation of lipophagy);GO:1905289(regulation of CAMKK-AMPK signaling cascade);GO:1905337(positive regulation of aggrephagy);GO:2000479(regulation of cAMP-dependent protein kinase activity);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","05016(Huntington disease)",{"v":1.5E-5,"d":"0.00"},1,"211,",0,-4.82,-4.14,2.97,"3' UTR",6,2968458,3095595,127138,2]
["chr6",4393850,4395304,1455,"ENSBGRG00000017804","ENSBGRT00000032622",3545,"TACC3","transforming acidic coiled-coil containing protein 3 [Source:HGNC Symbol;Acc:HGNC:11524]","GO:0005829(cytosol);GO:0007052(mitotic spindle organization);GO:0007091(metaphase/anaphase transition of mitotic cell cycle);GO:0034451(centriolar satellite);GO:0043231(intracellular membrane-bounded organelle);GO:0060236(regulation of mitotic spindle organization);GO:0072686(mitotic spindle);GO:1902850(microtubule cytoskeleton organization involved in mitosis)","03013(RNA transport)",{"v":1e-105,"d":"0.00"},3,"31,67,765,","0,162,690",-105,-104,{"v":10.5,"d":"10.50"},"Exon (ENSBGRT00000032622/ENSBGRG00000017804, exon 4 of 16)",6,4388851,4398849,9999,2]
["chr6",14474783,14478700,3918,"ENSBGRG00000009901","ENSBGRT00000018229",12848,"LYAR","Ly1 antibody reactive [Source:HGNC Symbol;Acc:HGNC:26021]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001750(photoreceptor outer segment);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0042802(identical protein binding);GO:0048821(erythrocyte development);GO:0050766(positive regulation of phagocytosis)","NA",{"v":4.8E-8,"d":"0.00"},3,"75,86,139,","0,608,3779",-7.32,-6.58,1.75,"3' UTR",6,14474723,14491548,16826,2]
["chr6",21648202,21657239,9038,"ENSBGRG00000020797","ENSBGRT00000038304",66078,"ENSBGRG00000020797","glycerol-3-phosphate acyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:28157]","GO:0016746(transferase activity, transferring acyl groups)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism)",{"v":3.2E-13,"d":"0.00"},2,"100,19,","0,9019",{"v":-12.5,"d":"-12.50"},{"v":-11.6,"d":"-11.60"},2.67,"Exon (ENSBGRT00000038304/ENSBGRG00000020797, exon 12 of 13)",6,21648202,21723317,75116,2]
["chr6",29124938,29125297,360,"ENSBGRG00000014140","ENSBGRT00000025948",28553,"SHROOM3","shroom family member 3 [Source:HGNC Symbol;Acc:HGNC:30422]","GO:0000902(cell morphogenesis);GO:0001843(neural tube closure);GO:0002064(epithelial cell development);GO:0003779(actin binding);GO:0051015(actin filament binding)","NA",{"v":6.3e-20,"d":"0.00"},1,"360,",0,{"v":-19.2,"d":"-19.20"},{"v":-18.2,"d":"-18.20"},3.22,"Exon (ENSBGRT00000025948/ENSBGRG00000014140, exon 5 of 8)",6,29105333,29153850,48518,2]
["chr6",29146768,29153850,7083,"ENSBGRG00000014140","ENSBGRT00000025948",0,"SHROOM3","shroom family member 3 [Source:HGNC Symbol;Acc:HGNC:30422]","GO:0000902(cell morphogenesis);GO:0001843(neural tube closure);GO:0002064(epithelial cell development);GO:0003779(actin binding);GO:0051015(actin filament binding)","NA",{"v":0.0021,"d":"0.00"},2,"229,132,","0,6951",-2.67,-2.09,{"v":3.1,"d":"3.10"},"5' UTR",6,29105333,29153850,48518,2]
["chr6",50398182,50399148,967,"ENSBGRG00000021740","ENSBGRT00000040516",31597,"SRP72","signal recognition particle 72 [Source:HGNC Symbol;Acc:HGNC:11303]","GO:0005047(signal recognition particle binding);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005786(signal recognition particle, endoplasmic reticulum targeting);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0008312(7S RNA binding);GO:0030911(TPR domain binding);GO:0042493(response to drug);GO:0043022(ribosome binding);GO:0048500(signal recognition particle)","03060(Protein export)",{"v":7.9e-21,"d":"0.00"},2,"178,90,","0,877",{"v":-20.1,"d":"-20.10"},{"v":-19.2,"d":"-19.20"},1.77,"Exon (ENSBGRT00000040516/ENSBGRG00000021740, exon 18 of 19)",6,50398182,50430745,32564,2]
["chr6",54063116,54066574,3459,"ENSBGRG00000025282","ENSBGRT00000046748",1052,"RASL11B","RAS like family 11 member B [Source:HGNC Symbol;Acc:HGNC:23804]","GO:0003924(GTPase activity);GO:0005160(transforming growth factor beta receptor binding);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway)","NA",0,3,"1388,77,54,","0,2177,3405",-335,"-Inf",5.45,"3' UTR",6,54063056,54067626,4571,2]
["chr6",64395824,64399078,3255,"ENSBGRG00000002859","ENSBGRT00000005363",7312,"N4BP2","NEDD4 binding protein 2 [Source:HGNC Symbol;Acc:HGNC:29851]","GO:0004519(endonuclease activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0046404(ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity)","NA",0.02,2,"10,51,","0,3204",{"v":-1.7,"d":"-1.70"},-1.19,4.95,"Exon (ENSBGRT00000005363/ENSBGRG00000002859, exon 5 of 19)",6,64348642,64406390,57749,2]
["chr6",78881279,78881547,269,"ENSBGRG00000011453","ENSBGRT00000021219",37,"ENSBGRG00000011453","NA","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II)","04330(Notch signaling pathway);04658(Th1 and Th2 cell differentiation);05203(Viral carcinogenesis);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection)",{"v":6E-9,"d":"0.00"},1,"269,",0,-8.22,-7.46,{"v":17.3,"d":"17.30"},"5' UTR",6,78763817,78881584,117768,2]
["chr6",89610300,89613760,3461,"ENSBGRG00000021778","ENSBGRT00000041837",105348,"FAM13A","family with sequence similarity 13 member A [Source:HGNC Symbol;Acc:HGNC:19367]","GO:0007165(signal transduction)","NA",{"v":1e-131,"d":"0.00"},2,"1008,98,","0,3363",-131,-129,9.67,"3' UTR",6,89610181,89719108,108928,2]
["chr6",104914787,104916123,1337,"ENSBGRG00000003476","ENSBGRT00000006485",47767,"SLC9B1","solute carrier family 9 member B1 [Source:HGNC Symbol;Acc:HGNC:24244]","GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0015299(solute:proton antiporter activity);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","00561(Glycerolipid metabolism);04742(Taste transduction)",{"v":0.003,"d":"0.00"},2,"77,14,","0,1323",-2.52,-1.95,2.29,"Exon (ENSBGRT00000006485/ENSBGRG00000003476, exon 10 of 12)",6,104875270,104963890,88621,2]
["chr6",112643071,112643220,150,"ENSBGRG00000002238","ENSBGRT00000004216",5455,"PITX2","paired like homeodomain 2 [Source:HGNC Symbol;Acc:HGNC:9005]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008134(transcription factor binding);GO:0035993(deltoid tuberosity development);GO:0042476(odontogenesis);GO:0043010(camera-type eye development);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061072(iris morphogenesis);GO:1990837(sequence-specific double-stranded DNA binding)","04350(TGF-beta signaling pathway)",{"v":0.036,"d":"0.04"},1,"150,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"3' UTR",6,112642892,112648675,5784,2]
["chr6",114667260,114667827,568,"ENSBGRG00000002512","ENSBGRT00000004702",8802,"ZGRF1","zinc finger GRF-type containing 1 [Source:HGNC Symbol;Acc:HGNC:25654]","GO:0008270(zinc ion binding)","03013(RNA transport);03015(mRNA surveillance pathway)",{"v":0.00024,"d":"0.00"},1,"568,",0,-3.62,-2.99,3.96,"Exon (ENSBGRT00000004702/ENSBGRG00000002512, exon 5 of 27)",6,114622290,114676629,54340,2]
["chr6",126581548,126662678,81131,"ENSBGRG00000005585","ENSBGRT00000010305",0,"ENSBGRG00000005585","NA","NA","NA",0.02,3,"299,148,2,","0,10004,81129",-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000010305/ENSBGRG00000005585, exon 1 of 1)",6,126635360,126636571,1212,1]
["chr7",5444897,5445319,423,"ENSBGRG00000013440","ENSBGRT00000024659",14906,"CHMP7","charged multivesicular body protein 7 [Source:HGNC Symbol;Acc:HGNC:28439]","GO:0000785(chromatin);GO:0000815(ESCRT III complex);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006997(nucleus organization);GO:0007034(vacuolar transport);GO:0007080(mitotic metaphase plate congression);GO:0010458(exit from mitosis);GO:0031468(nuclear envelope reassembly);GO:0045324(late endosome to vacuole transport);GO:0061952(midbody abscission);GO:0071168(protein localization to chromatin)","04144(Endocytosis);04217(Necroptosis)",{"v":4e-13,"d":"0.00"},2,"24,186,","0,237",{"v":-12.4,"d":"-12.40"},{"v":-11.6,"d":"-11.60"},1.79,"3' UTR",7,5429991,5446186,16196,1]
["chr7",11329382,11329963,582,"ENSBGRG00000002243","ENSBGRT00000004178",8779,"NUDT2","nudix hydrolase 2 [Source:HGNC Symbol;Acc:HGNC:8049]","GO:0008796(bis(5'-nucleosyl)-tetraphosphatase activity);GO:0016787(hydrolase activity)","00230(Purine metabolism);00240(Pyrimidine metabolism)",{"v":1E-156,"d":"0.00"},2,"38,317,","0,265",-156,-154,5.85,"Exon (ENSBGRT00000004178/ENSBGRG00000002243, exon 3 of 3)",7,11320603,11329963,9361,1]
["chr7",17828162,17828861,700,"ENSBGRG00000009137","ENSBGRT00000016738",0,"MIR3074","microRNA 3074 [Source:HGNC Symbol;Acc:HGNC:38268]","NA","NA",{"v":0.0032,"d":"0.00"},2,"21,70,","0,630",{"v":-2.5,"d":"-2.50"},-1.93,1.33,"3' UTR",7,17828158,17828242,85,2]
["chr7",22395023,22402123,7101,"ENSBGRG00000016738","ENSBGRT00000030969",0,"SPTLC1","serine palmitoyltransferase long chain base subunit 1 [Source:HGNC Symbol;Acc:HGNC:11277]","GO:0003824(catalytic activity);GO:0004758(serine C-palmitoyltransferase activity);GO:0005783(endoplasmic reticulum);GO:0009058(biosynthetic process);GO:0017059(serine C-palmitoyltransferase complex);GO:0030148(sphingolipid biosynthetic process);GO:0030170(pyridoxal phosphate binding);GO:0035339(SPOTS complex);GO:0046513(ceramide biosynthetic process);GO:1904504(positive regulation of lipophagy)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway)",0.01,3,"57,108,45,","0,2869,7056",-1.99,-1.46,{"v":3.3,"d":"3.30"},"Exon (ENSBGRT00000030969/ENSBGRG00000016738, exon 1 of 15)",7,22395023,22466105,71083,1]
["chr7",28495554,28496003,450,"ENSBGRG00000000693","ENSBGRT00000001239",25318,"RNF20","ring finger protein 20 [Source:HGNC Symbol;Acc:HGNC:10062]","GO:0000151(ubiquitin ligase complex);GO:0000209(protein polyubiquitination);GO:0002039(p53 binding);GO:0003682(chromatin binding);GO:0003713(transcription coactivator activity);GO:0003730(mRNA 3'-UTR binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0010390(histone monoubiquitination);GO:0016574(histone ubiquitination);GO:0030336(negative regulation of cell migration);GO:0031062(positive regulation of histone methylation);GO:0031625(ubiquitin protein ligase binding);GO:0033503(HULC complex);GO:0033523(histone H2B ubiquitination);GO:0042393(histone binding);GO:0042802(identical protein binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:1900364(negative regulation of mRNA polyadenylation);GO:2001168(positive regulation of histone H2B ubiquitination)","NA",{"v":1e-164,"d":"0.00"},1,"450,",0,-164,-162,3.05,"3' UTR",7,28470236,28496632,26397,1]
["chr7",40097900,40098020,121,"ENSBGRG00000005067","ENSBGRT00000009406",58655,"KIAA1958","KIAA1958 [Source:HGNC Symbol;Acc:HGNC:23427]","NA","NA",{"v":6.3E-3,"d":"0.01"},1,"121,",0,{"v":-2.2,"d":"-2.20"},-1.66,3.96,"3' UTR",7,40039245,40098070,58826,1]
["chr7",50319235,50320042,808,"ENSBGRG00000013932","ENSBGRT00000025711",4640,"ENSBGRG00000013932","NA","GO:0010309(acireductone dioxygenase [iron(II)-requiring] activity);GO:0016491(oxidoreductase activity);GO:0019509(L-methionine salvage from methylthioadenosine);GO:0055114(oxidation-reduction process)","00270(Cysteine and methionine metabolism)",{"v":0.0039,"d":"0.00"},2,"2,88,","0,720",-2.41,-1.85,6.44,"Exon (ENSBGRT00000025711/ENSBGRG00000013932, exon 3 of 3)",7,50314595,50320758,6164,1]
["chr7",52997556,53002765,5210,"ENSBGRG00000000372","ENSBGRT00000000603",89383,"ALG2","ALG2 alpha-1,3/1,6-mannosyltransferase [Source:HGNC Symbol;Acc:HGNC:23159]","GO:0000033(alpha-1,3-mannosyltransferase activity);GO:0004378(GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006486(protein glycosylation);GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0033577(protein glycosylation in endoplasmic reticulum);GO:0046982(protein heterodimerization activity);GO:0047485(protein N-terminus binding);GO:0048306(calcium-dependent protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0051592(response to calcium ion)","00510(N-Glycan biosynthesis)",{"v":7.9e-34,"d":"0.00"},3,"78,149,280,","0,4112,4930",{"v":-33.1,"d":"-33.10"},-32,4.39,"3' UTR",7,52980602,53092148,111547,2]
["chr7",56459235,56459354,120,"ENSBGRG00000001654","ENSBGRT00000003067",359,"EXOSC3","exosome component 3 [Source:HGNC Symbol;Acc:HGNC:17944]","GO:0000176(nuclear exosome (RNase complex));GO:0000177(cytoplasmic exosome (RNase complex));GO:0000178(exosome (RNase complex));GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006364(rRNA processing);GO:0035327(transcriptionally active chromatin);GO:0043928(exonucleolytic catabolism of deadenylated mRNA);GO:0045006(DNA deamination);GO:0045190(isotype switching);GO:0045830(positive regulation of isotype switching);GO:0071034(CUT catabolic process)","03018(RNA degradation)",{"v":7.9e-07,"d":"0.00"},1,"120,",0,{"v":-6.1,"d":"-6.10"},-5.39,2.76,"5' UTR",7,56458876,56464299,5424,1]
["chr7",57961237,57961627,391,"ENSBGRG00000003060","ENSBGRT00000005761",33349,"GNE","glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase [Source:HGNC Symbol;Acc:HGNC:23657]","GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0006047(UDP-N-acetylglucosamine metabolic process)","00520(Amino sugar and nucleotide sugar metabolism)",{"v":2.5e-48,"d":"0.00"},1,"391,",0,{"v":-47.6,"d":"-47.60"},{"v":-46.4,"d":"-46.40"},4.37,"Exon (ENSBGRT00000005761/ENSBGRG00000003060, exon 3 of 12)",7,57927888,57988865,60978,1]
["chr7",66501752,66501812,61,"ENSBGRG00000019111","ENSBGRT00000035554",326585,"PRUNE2","prune homolog 2 with BCH domain [Source:HGNC Symbol;Acc:HGNC:25209]","GO:0005737(cytoplasm);GO:0016462(pyrophosphatase activity)","NA",0.02,1,"61,",0,{"v":-1.7,"d":"-1.70"},-1.19,6.93,"Exon (ENSBGRT00000035554/ENSBGRG00000019111, exon 8 of 12)",7,66175167,66571920,396754,1]
["chr7",73251035,73280055,29021,"ENSBGRG00000000307","ENSBGRT00000000482",470,"KLF9","Kruppel like factor 9 [Source:HGNC Symbol;Acc:HGNC:1123]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007623(circadian rhythm);GO:0010839(negative regulation of keratinocyte proliferation);GO:0071387(cellular response to cortisol stimulus);GO:0097067(cellular response to thyroid hormone stimulus)","NA",{"v":2.5e-34,"d":"0.00"},2,"35,230,","0,28791",{"v":-33.6,"d":"-33.60"},{"v":-32.5,"d":"-32.50"},2.13,"Exon (ENSBGRT00000000482/ENSBGRG00000000307, exon 1 of 2)",7,73250565,73280055,29491,1]
["chr7",80866528,80866677,150,"ENSBGRG00000005812","ENSBGRT00000010902",72383,"RCL1","RNA terminal phosphate cyclase like 1 [Source:HGNC Symbol;Acc:HGNC:17687]","GO:0000447(endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0000480(endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0003824(catalytic activity);GO:0005730(nucleolus);GO:0006396(RNA processing);GO:0042254(ribosome biogenesis)","03008(Ribosome biogenesis in eukaryotes)",{"v":1.2e-07,"d":"0.00"},1,"150,",0,-6.92,-6.19,2.46,"3' UTR",7,80794145,80867685,73541,1]
["chr7",94591714,94592421,708,"ENSBGRG00000001209","ENSBGRT00000002312",127366,"CNTLN","centlein [Source:HGNC Symbol;Acc:HGNC:23432]","GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0010457(centriole-centriole cohesion);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0030674(protein-macromolecule adaptor activity);GO:0033365(protein localization to organelle)","NA",{"v":0.014,"d":"0.01"},2,"72,19,","0,689",-1.86,-1.34,1.65,"Exon (ENSBGRT00000002312/ENSBGRG00000001209, exon 4 of 26)",7,94464348,94845554,381207,1]
["chr7",113181236,113194413,13178,"ENSBGRG00000002025","ENSBGRT00000003766",36837,"EXTL3","exostosin like glycosyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:3518]","GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0016021(integral component of membrane);GO:0016757(transferase activity, transferring glycosyl groups)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)",{"v":1e-113,"d":"0.00"},2,"803,127,","0,13051",-113,-111,{"v":15.4,"d":"15.40"},"Exon (ENSBGRT00000003766/ENSBGRG00000002025, exon 3 of 7)",7,113144399,113218398,74000,1]
["chr7",117940749,117941043,295,"ENSBGRG00000012036","ENSBGRT00000021977",0,"ENSBGRG00000012036","NA","NA","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":0.011,"d":"0.01"},1,"295,",0,-1.95,-1.19,8.91,"Exon (ENSBGRT00000021977/ENSBGRG00000012036, exon 1 of 1)",7,117940749,117941807,1059,1]
["chr7",3888005,3889119,1115,"ENSBGRG00000006183","ENSBGRT00000011389",22348,"GFRA2","GDNF family receptor alpha 2 [Source:HGNC Symbol;Acc:HGNC:4244]","GO:0038023(signaling receptor activity)","NA",{"v":1E-3,"d":"0.00"},2,"14,47,","0,1068",-2.98,-2.38,2.28,"5' UTR",7,3656813,3911467,254655,2]
["chr7",9150012,9150160,149,"ENSBGRG00000000490","ENSBGRT00000000854",857,"PNMA2","PNMA family member 2 [Source:HGNC Symbol;Acc:HGNC:9159]","NA","NA",{"v":0.0012,"d":"0.00"},1,"149,",0,-2.93,-2.34,2.51,"Exon (ENSBGRT00000000854/ENSBGRG00000000490, exon 1 of 1)",7,9149923,9151017,1095,2]
["chr7",9838832,9840637,1806,"ENSBGRG00000000766","ENSBGRT00000001392",13740,"TRIM35","tripartite motif containing 35 [Source:HGNC Symbol;Acc:HGNC:16285]","GO:0005515(protein binding);GO:0008270(zinc ion binding);GO:0043065(positive regulation of apoptotic process);GO:0045087(innate immune response);GO:0045930(negative regulation of mitotic cell cycle);GO:1902187(negative regulation of viral release from host cell)","NA",{"v":2e-10,"d":"0.00"},2,"263,7,","0,1799",-9.69,{"v":-8.9,"d":"-8.90"},3.52,"Exon (ENSBGRT00000001392/ENSBGRG00000000766, exon 5 of 6)",7,9837517,9854377,16861,2]
["chr7",11640831,11641005,175,"ENSBGRG00000002714","ENSBGRT00000005091",448,"ENSBGRG00000002714","NA","NA","NA",{"v":3.3E-3,"d":"0.00"},1,"175,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000005091/ENSBGRG00000002714, exon 2 of 2)",7,11640658,11641453,796,2]
["chr7",15424028,15439996,15969,"ENSBGRG00000005567","ENSBGRT00000010674",44526,"ENSBGRG00000005567","NA","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding);GO:0016779(nucleotidyltransferase activity)","NA",{"v":1.3E-75,"d":"0.00"},3,"38,326,27,","0,13231,15942",{"v":-74.9,"d":"-74.90"},{"v":-73.5,"d":"-73.50"},5.24,"Exon (ENSBGRT00000010674/ENSBGRG00000005567, exon 24 of 26)",7,15423998,15484522,60525,2]
["chr7",20351531,20353296,1766,"ENSBGRG00000012947","ENSBGRT00000023772",8781,"NOL8","nucleolar protein 8 [Source:HGNC Symbol;Acc:HGNC:23387]","GO:0003676(nucleic acid binding);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:1902570(protein localization to nucleolus)","NA",{"v":6.3e-85,"d":"0.00"},1,"1766,",0,{"v":-84.2,"d":"-84.20"},{"v":-82.8,"d":"-82.80"},6.56,"Exon (ENSBGRT00000023772/ENSBGRG00000012947, exon 7 of 17)",7,20332862,20362077,29216,2]
["chr7",28382773,28388249,5477,"ENSBGRG00000000599","ENSBGRT00000001086",1587,"ENSBGRG00000000599","NA","GO:0003824(catalytic activity);GO:0004332(fructose-bisphosphate aldolase activity);GO:0006096(glycolytic process)","00010(Glycolysis / Gluconeogenesis);00030(Pentose phosphate pathway);00051(Fructose and mannose metabolism)",{"v":6.3e-36,"d":"0.00"},2,"49,400,","0,5077",{"v":-35.2,"d":"-35.20"},{"v":-34.1,"d":"-34.10"},5.47,"Exon (ENSBGRT00000001086/ENSBGRG00000000599, exon 1 of 9)",7,28331910,28389836,57927,2]
["chr7",40751980,40752127,148,"ENSBGRG00000005646","ENSBGRT00000010419",0,"CDC26","cell division cycle 26 [Source:HGNC Symbol;Acc:HGNC:17839]","GO:0005680(anaphase-promoting complex);GO:0030071(regulation of mitotic metaphase/anaphase transition);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0070979(protein K11-linked ubiquitination)","04120(Ubiquitin mediated proteolysis);04110(Cell cycle);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation);05166(HTLV-I infection)",{"v":0.0026,"d":"0.00"},1,"148,",0,-2.59,-2.02,4.46,"5' UTR",7,40746710,40752127,5418,2]
["chr7",47657648,47657738,91,"ENSBGRG00000010303","ENSBGRT00000018899",222987,"BRINP1","BMP/retinoic acid inducible neural specific 1 [Source:HGNC Symbol;Acc:HGNC:2687]","GO:0001662(behavioral fear response);GO:0005737(cytoplasm);GO:0007614(short-term memory);GO:0008219(cell death);GO:0035176(social behavior);GO:0035640(exploration behavior);GO:0042711(maternal behavior);GO:0045666(positive regulation of neuron differentiation);GO:0045786(negative regulation of cell cycle);GO:0045930(negative regulation of mitotic cell cycle);GO:0050768(negative regulation of neurogenesis);GO:0071300(cellular response to retinoic acid);GO:0071625(vocalization behavior)","NA",{"v":4.7e-05,"d":"0.00"},1,"91,",0,-4.33,-3.67,3.38,"Exon (ENSBGRT00000018899/ENSBGRG00000010303, exon 9 of 9)",7,47657618,47880725,223108,2]
["chr7",49232885,49232974,90,"ENSBGRG00000010366","ENSBGRT00000019049",60,"CDK5RAP2","CDK5 regulatory subunit associated protein 2 [Source:HGNC Symbol;Acc:HGNC:18672]","GO:0000132(establishment of mitotic spindle orientation);GO:0000226(microtubule cytoskeleton organization);GO:0000242(pericentriolar material);GO:0000922(spindle pole);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0001578(microtubule bundle formation);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005874(microtubule);GO:0007059(chromosome segregation);GO:0007098(centrosome cycle);GO:0007099(centriole replication);GO:0007420(brain development);GO:0008017(microtubule binding);GO:0008274(gamma-tubulin ring complex);GO:0015631(tubulin binding);GO:0019901(protein kinase binding);GO:0022008(neurogenesis);GO:0030054(cell junction);GO:0031023(microtubule organizing center organization);GO:0031116(positive regulation of microtubule polymerization);GO:0035371(microtubule plus-end);GO:0043015(gamma-tubulin binding);GO:0045665(negative regulation of neuron differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046600(negative regulation of centriole replication);GO:0048471(perinuclear region of cytoplasm);GO:0090266(regulation of mitotic cell cycle spindle assembly checkpoint);GO:0097431(mitotic spindle pole)","NA",{"v":3.2e-06,"d":"0.00"},1,"90,",0,{"v":-5.5,"d":"-5.50"},-4.81,{"v":21.8,"d":"21.80"},"5' UTR",7,49021643,49233034,211392,2]
["chr7",55387954,55388044,91,"ENSBGRG00000001251","ENSBGRT00000002295",509,"NCBP1","nuclear cap binding protein subunit 1 [Source:HGNC Symbol;Acc:HGNC:7658]","GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0000245(spliceosomal complex assembly);GO:0000339(RNA cap binding);GO:0000340(RNA 7-methylguanosine cap binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005845(mRNA cap binding complex);GO:0005846(nuclear cap binding complex);GO:0006370(7-methylguanosine mRNA capping);GO:0006401(RNA catabolic process);GO:0006406(mRNA export from nucleus);GO:0006446(regulation of translational initiation);GO:0016070(RNA metabolic process);GO:0030307(positive regulation of cell growth);GO:0031442(positive regulation of mRNA 3'-end processing);GO:0034518(RNA cap binding complex);GO:0045292(mRNA cis splicing, via spliceosome);GO:0048026(positive regulation of mRNA splicing, via spliceosome);GO:0051028(mRNA transport);GO:0098789(pre-mRNA cleavage required for polyadenylation);GO:1905216(positive regulation of RNA binding);GO:1990904(ribonucleoprotein complex)","03040(Spliceosome);03013(RNA transport);03015(mRNA surveillance pathway)",{"v":0.032,"d":"0.03"},1,"91,",0,-1.49,{"v":-0.991,"d":"-0.99"},{"v":2.2,"d":"2.20"},"5' UTR",7,55348421,55388553,40133,2]
["chr7",58781935,58782448,514,"ENSBGRG00000006379","ENSBGRT00000011952",14384,"RUSC2","RUN and SH3 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:23625]","GO:0005515(protein binding);GO:0017137(Rab GTPase binding);GO:0031410(cytoplasmic vesicle)","04142(Lysosome)",{"v":1e-16,"d":"0.00"},2,"357,122,","0,392",-16,{"v":-15.1,"d":"-15.10"},3.46,"Exon (ENSBGRT00000011952/ENSBGRG00000006379, exon 12 of 14)",7,58781315,58796832,15518,2]
["chr7",68718058,68730576,12519,"ENSBGRG00000021739","ENSBGRT00000040453",13383,"RORB","RAR related orphan receptor B [Source:HGNC Symbol;Acc:HGNC:10259]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0042025(host cell nucleus);GO:0042462(eye photoreceptor cell development);GO:0042752(regulation of circadian rhythm);GO:0043565(sequence-specific DNA binding);GO:0045668(negative regulation of osteoblast differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046548(retinal rod cell development);GO:0046549(retinal cone cell development);GO:1990837(sequence-specific double-stranded DNA binding)","04710(Circadian rhythm)",{"v":0.034,"d":"0.03"},3,"132,142,51,","0,7229,12468",-1.47,{"v":-0.977,"d":"-0.98"},6.93,"Exon (ENSBGRT00000040453/ENSBGRG00000021739, exon 2 of 10)",7,68677663,68743959,66297,2]
["chr7",75741960,75743525,1566,"ENSBGRG00000002972","ENSBGRT00000006219",11737,"ENSBGRG00000002972","NA","NA","NA",{"v":2.5e-29,"d":"0.00"},2,"330,119,","0,1447",{"v":-28.6,"d":"-28.60"},{"v":-27.6,"d":"-27.60"},5.85,"3' UTR",7,75741960,75755262,13303,2]
["chr7",84469321,84470824,1504,"ENSBGRG00000007730","ENSBGRT00000014379",298198,"PTPRD","protein tyrosine phosphatase receptor type D [Source:HGNC Symbol;Acc:HGNC:9668]","GO:0004725(protein tyrosine phosphatase activity);GO:0005515(protein binding);GO:0006470(protein dephosphorylation);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0098978(glutamatergic synapse);GO:0099545(trans-synaptic signaling by trans-synaptic complex);GO:0099560(synaptic membrane adhesion);GO:1905606(regulation of presynapse assembly)","NA",{"v":1.4E-5,"d":"0.00"},3,"8,98,134,","0,836,1370",-4.84,-4.17,3.24,"Exon (ENSBGRT00000014379/ENSBGRG00000007730, exon 17 of 35)",7,84285973,84769022,483050,2]
["chr7",91579104,91579164,61,"ENSBGRG00000000469","ENSBGRT00000001114",0,"NFIB","nuclear factor I B [Source:HGNC Symbol;Acc:HGNC:7785]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001650(fibrillar center);GO:0002062(chondrocyte differentiation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007420(brain development);GO:0008285(negative regulation of cell population proliferation);GO:0009617(response to bacterium);GO:0010001(glial cell differentiation);GO:0021740(principal sensory nucleus of trigeminal nerve development);GO:0021960(anterior commissure morphogenesis);GO:0030324(lung development);GO:0030900(forebrain development);GO:0030902(hindbrain development);GO:0044300(cerebellar mossy fiber);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060486(club cell differentiation);GO:0060509(type I pneumocyte differentiation);GO:0060510(type II pneumocyte differentiation);GO:0060662(salivary gland cavitation);GO:0060689(cell differentiation involved in salivary gland development);GO:0061141(lung ciliated cell differentiation);GO:0071679(commissural neuron axon guidance);GO:1902894(negative regulation of pri-miRNA transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000791(negative regulation of mesenchymal cell proliferation involved in lung development);GO:2000795(negative regulation of epithelial cell proliferation involved in lung morphogenesis)","NA",{"v":0.012,"d":"0.01"},1,"61,",0,-1.93,-1.41,2.04,"5' UTR",7,91312504,91579164,266661,2]
["chr7",97956320,97971116,14797,"ENSBGRG00000002074","ENSBGRT00000003895",286755,"MLLT3","MLLT3 super elongation complex subunit [Source:HGNC Symbol;Acc:HGNC:7136]","GO:0003682(chromatin binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0007379(segment specification);GO:0008023(transcription elongation factor complex);GO:0009952(anterior/posterior pattern specification);GO:0042393(histone binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060218(hematopoietic stem cell differentiation);GO:0070577(lysine-acetylated histone binding);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0140030(modification-dependent protein binding);GO:1902275(regulation of chromatin organization);GO:2000035(regulation of stem cell division);GO:2000096(positive regulation of Wnt signaling pathway, planar cell polarity pathway)","05202(Transcriptional misregulation in cancers)",{"v":1.3e-78,"d":"0.00"},4,"271,72,72,32,","0,8233,9450,14765",{"v":-77.9,"d":"-77.90"},{"v":-76.5,"d":"-76.50"},5.56,"3' UTR",7,97956320,98257871,301552,2]
["chr7",105830670,105830969,300,"ENSBGRG00000001111","ENSBGRT00000002056",36936,"C9orf72","C9orf72-SMCR8 complex subunit [Source:HGNC Symbol;Acc:HGNC:28337]","GO:0000932(P-body);GO:0001933(negative regulation of protein phosphorylation);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005776(autophagosome);GO:0006897(endocytosis);GO:0006914(autophagy);GO:0010494(cytoplasmic stress granule);GO:0010506(regulation of autophagy);GO:0016239(positive regulation of macroautophagy);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0032045(guanyl-nucleotide exchange factor complex);GO:0034063(stress granule assembly);GO:0044295(axonal growth cone);GO:0044304(main axon);GO:0048675(axon extension);GO:0110053(regulation of actin filament organization);GO:1903432(regulation of TORC1 signaling);GO:1990316(Atg1/ULK1 kinase complex);GO:2000785(regulation of autophagosome assembly)","NA",{"v":0.036,"d":"0.04"},1,"300,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"3' UTR",7,105828572,105867905,39334,2]
["chr7",113757215,113827465,70251,"ENSBGRG00000002206","ENSBGRT00000004129",19768,"ENSBGRG00000002206","NA","GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0072383(plus-end-directed vesicle transport along microtubule)","NA",{"v":0.0021,"d":"0.00"},3,"33,13,45,","0,7726,70206",-2.68,{"v":-2.1,"d":"-2.10"},2.48,"Exon (ENSBGRT00000004129/ENSBGRG00000002206, exon 2 of 19)",7,113707321,113847233,139913,2]
["chr8",2905131,2905431,301,"ENSBGRG00000011095","ENSBGRT00000020260",8007,"ENSBGRG00000011095","NA","GO:0007165(signal transduction)","04015(Rap1 signaling pathway);04390(Hippo signaling pathway);04144(Endocytosis);04530(Tight junction);04611(Platelet activation);04910(Insulin signaling pathway);05165(Human papillomavirus infection)",{"v":1.3e-12,"d":"0.00"},1,"301,",0,{"v":-11.9,"d":"-11.90"},{"v":-11.1,"d":"-11.10"},7.37,"Exon (ENSBGRT00000020260/ENSBGRG00000011095, exon 6 of 6)",8,2897124,2905581,8458,1]
["chr8",4028809,4029125,317,"ENSBGRG00000017208","ENSBGRT00000043731",101968,"MYO9B","myosin IXB [Source:HGNC Symbol;Acc:HGNC:7609]","GO:0000146(microfilament motor activity);GO:0003774(motor activity);GO:0003779(actin binding);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005884(actin filament);GO:0005938(cell cortex);GO:0007165(signal transduction);GO:0007266(Rho protein signal transduction);GO:0016459(myosin complex);GO:0016887(ATPase activity);GO:0017048(Rho GTPase binding);GO:0030048(actin filament-based movement);GO:0035023(regulation of Rho protein signal transduction);GO:0035385(Roundabout signaling pathway);GO:0035556(intracellular signal transduction);GO:0043531(ADP binding);GO:0048471(perinuclear region of cytoplasm);GO:0048495(Roundabout binding)","NA",{"v":4e-25,"d":"0.00"},2,"9,261,","0,56",{"v":-24.4,"d":"-24.40"},{"v":-23.5,"d":"-23.50"},2.88,"Exon (ENSBGRT00000043731/ENSBGRG00000017208, exon 39 of 40)",8,3926841,4029125,102285,1]
["chr8",4766928,4774987,8060,"ENSBGRG00000026081","ENSBGRT00000048234",0,"CCDC124","coiled-coil domain containing 124 [Source:HGNC Symbol;Acc:HGNC:25171]","GO:0005829(cytosol);GO:0005886(plasma membrane)","NA",{"v":1e-120,"d":"0.00"},5,"83,90,190,115,267,","0,963,6840,7550,7793",-120,-118,3.46,"5' UTR",8,4766928,4775166,8239,1]
["chr8",6446837,6446897,61,"ENSBGRG00000001969","ENSBGRT00000003670",725,"ENSBGRG00000001969","NA","NA","NA",{"v":4e-15,"d":"0.00"},1,"61,",0,{"v":-14.4,"d":"-14.40"},{"v":-13.5,"d":"-13.50"},1.78,"Exon (ENSBGRT00000003670/ENSBGRG00000001969, exon 2 of 2)",8,6446112,6451687,5576,1]
["chr8",7659030,7664318,5289,"ENSBGRG00000003221","ENSBGRT00000006224",179509,"ENSBGRG00000003221","NA","NA","NA",{"v":1.8E-3,"d":"0.00"},2,"184,206,","0,5083",-2.74,-2.16,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000006224/ENSBGRG00000003221, exon 52 of 123)",8,7479521,7742779,263259,1]
["chr8",7998371,8014612,16242,"ENSBGRG00000003460","ENSBGRT00000006433",2820,"ZNF454","zinc finger protein 454 [Source:HGNC Symbol;Acc:HGNC:21200]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":7.9e-51,"d":"0.00"},2,"41,1334,","0,14908",{"v":-50.1,"d":"-50.10"},{"v":-48.9,"d":"-48.90"},5.94,"Exon (ENSBGRT00000006433/ENSBGRG00000003460, exon 3 of 4)",8,7995551,8014612,19062,1]
["chr8",11583284,11583912,629,"ENSBGRG00000006558","ENSBGRT00000012083",29040,"MAST1","microtubule associated serine/threonine kinase 1 [Source:HGNC Symbol;Acc:HGNC:19034]","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007010(cytoskeleton organization);GO:0007420(brain development);GO:0008017(microtubule binding);GO:0016020(membrane);GO:0035556(intracellular signal transduction);GO:0043005(neuron projection);GO:0043025(neuronal cell body)","NA",{"v":2.9E-4,"d":"0.00"},1,"629,",0,-3.54,-2.92,6.93,"Exon (ENSBGRT00000012083/ENSBGRG00000006558, exon 27 of 27)",8,11554244,11584540,30297,1]
["chr8",12650419,12650859,441,"ENSBGRG00000022053","ENSBGRT00000041884",20883,"CC2D1A","coiled-coil and C2 domain containing 1A [Source:HGNC Symbol;Acc:HGNC:30237]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001650(fibrillar center);GO:0005829(cytosol);GO:0005886(plasma membrane)","NA",{"v":3.2E-13,"d":"0.00"},2,"5,355,","0,86",{"v":-12.5,"d":"-12.50"},{"v":-11.6,"d":"-11.60"},1.93,"3' UTR",8,12629536,12651013,21478,1]
["chr8",15130744,15131782,1039,"ENSBGRG00000002625","ENSBGRT00000004926",31243,"ENSBGRG00000002625","NA","GO:0016020(membrane);GO:0098609(cell-cell adhesion)","04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04514(Cell adhesion molecules (CAMs));04650(Natural killer cell mediated cytotoxicity);04670(Leukocyte transendothelial migration);05323(Rheumatoid arthritis);05418(Fluid shear stress and atherosclerosis);05416(Viral myocarditis);04933(AGE-RAGE signaling pathway in diabetic complications);05150(Staphylococcus aureus infection);05166(HTLV-I infection);05164(Influenza A);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05144(Malaria);05143(African trypanosomiasis)",0,2,"227,730,","0,309",-565,"-Inf",4.64,"3' UTR",8,15099501,15132440,32940,1]
["chr8",16538695,16539235,541,"ENSBGRG00000014085","ENSBGRT00000026035",10063,"ENSBGRG00000014085","zinc finger protein 558 [Source:HGNC Symbol;Acc:HGNC:26422]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":0.0026,"d":"0.00"},2,"48,12,","0,529",-2.59,-2.02,1.69,"Exon (ENSBGRT00000026035/ENSBGRG00000014085, exon 4 of 6)",8,16528632,16540575,11944,1]
["chr8",17258630,17259827,1198,"ENSBGRG00000019640","ENSBGRT00000036183",19398,"EVI5L","ecotropic viral integration site 5 like [Source:HGNC Symbol;Acc:HGNC:30464]","GO:0005096(GTPase activator activity);GO:0017137(Rab GTPase binding);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:1902018(negative regulation of cilium assembly)","NA",{"v":7.9e-29,"d":"0.00"},5,"152,147,96,96,287,","0,238,463,642,911",{"v":-28.1,"d":"-28.10"},{"v":-27.1,"d":"-27.10"},{"v":12.9,"d":"12.90"},"3' UTR",8,17239232,17261471,22240,1]
["chr8",17794806,17808397,13592,"ENSBGRG00000025188","ENSBGRT00000046616",25684,"HNRNPM","heterogeneous nuclear ribonucleoprotein M [Source:HGNC Symbol;Acc:HGNC:5046]","GO:0000380(alternative mRNA splicing, via spliceosome);GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0016363(nuclear matrix);GO:0019904(protein domain specific binding);GO:0042382(paraspeckles);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)",0,6,"36,102,45,78,54,583,","0,2250,3766,4271,10988,13009",-610,"-Inf",6.41,"Exon (ENSBGRT00000046616/ENSBGRG00000025188, exon 8 of 13)",8,17769122,17808869,39748,1]
["chr8",19348818,19348997,180,"ENSBGRG00000001255","ENSBGRT00000002289",30,"ENSBGRG00000001255","NA","GO:0006486(protein glycosylation);GO:0008417(fucosyltransferase activity);GO:0016020(membrane)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":3.3E-3,"d":"0.00"},1,"180,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000002289/ENSBGRG00000001255, exon 1 of 1)",8,19348788,19349891,1104,1]
["chr8",19449330,19449509,180,"ENSBGRG00000001424","ENSBGRT00000002674",6644,"LONP1","lon peptidase 1, mitochondrial [Source:HGNC Symbol;Acc:HGNC:9479]","GO:0001018(mitochondrial promoter sequence-specific DNA binding);GO:0001666(response to hypoxia);GO:0003727(single-stranded RNA binding);GO:0004176(ATP-dependent peptidase activity);GO:0004252(serine-type endopeptidase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006515(protein quality control for misfolded or incompletely synthesized proteins);GO:0007005(mitochondrion organization);GO:0016887(ATPase activity);GO:0030163(protein catabolic process);GO:0034599(cellular response to oxidative stress);GO:0042645(mitochondrial nucleoid);GO:0042802(identical protein binding);GO:0043531(ADP binding);GO:0043565(sequence-specific DNA binding);GO:0051603(proteolysis involved in cellular protein catabolic process);GO:0051880(G-quadruplex DNA binding);GO:0070182(DNA polymerase binding);GO:0070407(oxidation-dependent protein catabolic process)","NA",{"v":6.3e-17,"d":"0.00"},1,"180,",0,{"v":-16.2,"d":"-16.20"},{"v":-15.3,"d":"-15.30"},1.89,"Exon (ENSBGRT00000002674/ENSBGRG00000001424, exon 4 of 18)",8,19442686,19463297,20612,1]
["chr8",20590357,20591458,1102,"ENSBGRG00000014367","ENSBGRT00000026384",35442,"SEMA6B","semaphorin 6B [Source:HGNC Symbol;Acc:HGNC:10739]","GO:0005515(protein binding);GO:0030215(semaphorin receptor binding)","04360(Axon guidance)",{"v":1e-11,"d":"0.00"},3,"43,59,494,","0,174,608",-11,{"v":-10.2,"d":"-10.20"},7.43,"Exon (ENSBGRT00000026384/ENSBGRG00000014367, exon 15 of 17)",8,20554915,20591875,36961,1]
["chr8",21117097,21117545,449,"ENSBGRG00000018816","ENSBGRT00000034860",10555,"EEF2","eukaryotic translation elongation factor 2 [Source:HGNC Symbol;Acc:HGNC:3214]","GO:0002244(hematopoietic progenitor cell differentiation);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005844(polysome);GO:0005886(plasma membrane);GO:0006414(translational elongation);GO:0016235(aggresome);GO:0019901(protein kinase binding);GO:0045727(positive regulation of translation);GO:1990904(ribonucleoprotein complex)","04152(AMPK signaling pathway);04921(Oxytocin signaling pathway)",0,1,"449,",0,-6980,"-Inf",5.01,"3' UTR",8,21106542,21117373,10832,1]
["chr8",22706662,22706811,150,"ENSBGRG00000001703","ENSBGRT00000003170",10768,"JSRP1","junctional sarcoplasmic reticulum protein 1 [Source:HGNC Symbol;Acc:HGNC:24963]","GO:0003009(skeletal muscle contraction)","03040(Spliceosome)",{"v":1.7e-10,"d":"0.00"},1,"150,",0,-9.77,-8.97,1.63,"Exon (ENSBGRT00000003309/ENSBGRG00000001773, exon 8 of 8)",8,22700399,22717579,17181,2]
["chr8",28752276,28753420,1145,"ENSBGRG00000008873","ENSBGRT00000016261",24723,"ENSBGRG00000008873","NA","NA","00620(Pyruvate metabolism);00630(Glyoxylate and dicarboxylate metabolism);00640(Propanoate metabolism);00650(Butanoate metabolism);00071(Fatty acid degradation);00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);00310(Lysine degradation);00380(Tryptophan metabolism);00900(Terpenoid backbone biosynthesis)",{"v":2e-06,"d":"0.00"},2,"41,439,","0,706",-5.69,-4.99,3.32,"3' UTR",8,28727553,28753570,26018,1]
["chr8",42270435,42272141,1707,"ENSBGRG00000010517","ENSBGRT00000019275",4206,"TMED9","transmembrane p24 trafficking protein 9 [Source:HGNC Symbol;Acc:HGNC:24878]","GO:0005783(endoplasmic reticulum);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0007030(Golgi organization);GO:0008021(synaptic vesicle);GO:0010638(positive regulation of organelle organization);GO:0019905(syntaxin binding);GO:0048205(COPI coating of Golgi vesicle)","NA",0,2,"71,671,","0,1036",-812,"-Inf",5.17,"3' UTR",8,42266229,42272319,6091,1]
["chr8",46702102,46702191,90,"ENSBGRG00000005465","ENSBGRT00000010056",7942,"ENSBGRG00000005465","NA","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007411(axon guidance)","NA",{"v":5e-57,"d":"0.00"},1,"90,",0,{"v":-56.3,"d":"-56.30"},-55,1.37,"3' UTR",8,46694160,46702191,8032,1]
["chr8",47261293,47261729,437,"ENSBGRG00000014414","ENSBGRT00000026469",776,"MIDN","midnolin [Source:HGNC Symbol;Acc:HGNC:16298]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol)","NA",{"v":2e-33,"d":"0.00"},2,"104,136,","0,301",{"v":-32.7,"d":"-32.70"},{"v":-31.6,"d":"-31.60"},4.88,"5' UTR",8,47260517,47269385,8869,1]
["chr8",48133430,48133490,61,"ENSBGRG00000000468","ENSBGRT00000000828",120,"ENSBGRG00000000468","NA","GO:0008121(ubiquinol-cytochrome-c reductase activity)","00190(Oxidative phosphorylation);04260(Cardiac muscle contraction);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":0.048,"d":"0.05"},1,"61,",0,-1.32,{"v":-0.839,"d":"-0.84"},{"v":3.3,"d":"3.30"},"5' UTR",8,48133310,48134517,1208,1]
["chr8",50240285,50240610,326,"ENSBGRG00000001937","ENSBGRT00000003611",7010,"TXNDC15","thioredoxin domain containing 15 [Source:HGNC Symbol;Acc:HGNC:20652]","GO:0005929(cilium);GO:0045454(cell redox homeostasis);GO:0045880(positive regulation of smoothened signaling pathway);GO:0060271(cilium assembly)","NA",{"v":2.5E-79,"d":"0.00"},1,"326,",0,{"v":-78.6,"d":"-78.60"},{"v":-77.2,"d":"-77.20"},3.17,"Exon (ENSBGRT00000003611/ENSBGRG00000001937, exon 2 of 5)",8,50233275,50249244,15970,1]
["chr8",55413985,55418592,4608,"ENSBGRG00000012544","ENSBGRT00000023002",388,"PSD2","pleckstrin and Sec7 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:19092]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0030425(dendrite);GO:0032012(regulation of ARF protein signal transduction);GO:0032154(cleavage furrow);GO:0032587(ruffle membrane);GO:0043025(neuronal cell body);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse)","04144(Endocytosis)",{"v":0.036,"d":"0.04"},2,"146,64,","0,4544",-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000023002/ENSBGRG00000012544, exon 1 of 13)",8,55413597,55461473,47877,1]
["chr8",56223594,56224876,1283,"ENSBGRG00000016704","ENSBGRT00000030696",0,"EIF4EBP3","eukaryotic translation initiation factor 4E binding protein 3 [Source:HGNC Symbol;Acc:HGNC:3290]","GO:0008190(eukaryotic initiation factor 4E binding);GO:0045947(negative regulation of translational initiation)","03013(RNA transport)",{"v":6.3E-5,"d":"0.00"},3,"76,27,92,","0,86,1191",{"v":-4.2,"d":"-4.20"},-3.55,6.93,"Exon (ENSBGRT00000030696/ENSBGRG00000016704, exon 1 of 4)",8,56223594,56225146,1553,1]
["chr8",56474073,56475032,960,"ENSBGRG00000021397","ENSBGRT00000040029",55706,"PCDHAC2","protocadherin alpha subfamily C, 2 [Source:HGNC Symbol;Acc:HGNC:8677]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007399(nervous system development);GO:0016020(membrane)","NA",{"v":1.2E-4,"d":"0.00"},1,"960,",0,-3.92,-3.28,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000040237/ENSBGRG00000021397, exon 1 of 4)",8,56418367,56648556,230190,1]
["chr8",56868540,56870203,1664,"ENSBGRG00000023237","ENSBGRT00000043025",0,"ENSBGRG00000023237","NA","NA","NA",{"v":2.5e-20,"d":"0.00"},1,"1664,",0,{"v":-19.6,"d":"-19.60"},{"v":-18.6,"d":"-18.60"},7.23,"Exon (ENSBGRT00000043025/ENSBGRG00000023237, exon 1 of 8)",8,56868540,56870934,2395,1]
["chr8",56999831,56999921,91,"ENSBGRG00000024033","ENSBGRT00000045398",450,"PCDHGA4","protocadherin gamma subfamily A, 4 [Source:HGNC Symbol;Acc:HGNC:8702]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane)","NA",{"v":0.018,"d":"0.02"},1,"91,",0,-1.74,-1.23,1.83,"Exon (ENSBGRT00000045398/ENSBGRG00000024033, exon 1 of 4)",8,56999381,57207978,208598,1]
["chr8",57181351,57181741,391,"ENSBGRG00000024033","ENSBGRT00000045398",181970,"PCDHGA4","protocadherin gamma subfamily A, 4 [Source:HGNC Symbol;Acc:HGNC:8702]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane)","NA",{"v":0.012,"d":"0.01"},1,"391,",0,-1.93,{"v":-1.4,"d":"-1.40"},5.45,"Exon (ENSBGRT00000045607/ENSBGRG00000024033, exon 1 of 4)",8,56999381,57207978,208598,1]
["chr8",57694867,57695163,297,"ENSBGRG00000025636","ENSBGRT00000047431",15303,"DELE1","DAP3 binding cell death enhancer 1 [Source:HGNC Symbol;Acc:HGNC:28969]","GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0043281(regulation of cysteine-type endopeptidase activity involved in apoptotic process)","NA",0,1,"297,",0,-381,"-Inf",6.95,"Exon (ENSBGRT00000047431/ENSBGRG00000025636, exon 12 of 12)",8,57679564,57695163,15600,1]
["chr8",66325881,66330236,4356,"ENSBGRG00000018960","ENSBGRT00000034825",2674,"GRPEL2","GrpE like 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:21060]","GO:0000774(adenyl-nucleotide exchange factor activity);GO:0005739(mitochondrion);GO:0006457(protein folding);GO:0042803(protein homodimerization activity);GO:0051082(unfolded protein binding);GO:0051087(chaperone binding)","NA",{"v":1e-113,"d":"0.00"},3,"2,82,365,","0,1092,3991",-113,-112,9.43,"Exon (ENSBGRT00000034825/ENSBGRG00000018960, exon 2 of 3)",8,66323207,66330009,6803,1]
["chr8",66822699,66826281,3583,"ENSBGRG00000019954","ENSBGRT00000036732",125499,"PPARGC1B","PPARG coactivator 1 beta [Source:HGNC Symbol;Acc:HGNC:30022]","GO:0001503(ossification);GO:0003676(nucleic acid binding);GO:0003712(transcription coregulator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006390(mitochondrial transcription);GO:0007015(actin filament organization);GO:0008134(transcription factor binding);GO:0010694(positive regulation of alkaline phosphatase activity);GO:0016592(mediator complex);GO:0030331(estrogen receptor binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0034614(cellular response to reactive oxygen species);GO:0042327(positive regulation of phosphorylation);GO:0045672(positive regulation of osteoclast differentiation);GO:0045780(positive regulation of bone resorption);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050682(AF-2 domain binding);GO:0060346(bone trabecula formation);GO:0120162(positive regulation of cold-induced thermogenesis)","04931(Insulin resistance)",{"v":0.049,"d":"0.05"},2,"104,46,","0,3537",-1.31,{"v":-0.831,"d":"-0.83"},2.58,"Exon (ENSBGRT00000036732/ENSBGRG00000019954, exon 12 of 14)",8,66697200,66827633,130434,1]
["chr8",67793672,67794002,331,"ENSBGRG00000022770","ENSBGRT00000042088",11035,"SYNPO","synaptopodin [Source:HGNC Symbol;Acc:HGNC:30672]","GO:0003779(actin binding);GO:0005829(cytosol);GO:0008542(visual learning);GO:0015629(actin cytoskeleton);GO:0032233(positive regulation of actin filament bundle assembly);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0097444(spine apparatus);GO:0098886(modification of dendritic spine);GO:0098978(glutamatergic synapse);GO:0099588(positive regulation of postsynaptic cytosolic calcium concentration);GO:1905355(spine apparatus assembly)","04530(Tight junction)",{"v":1e-178,"d":"0.00"},1,"331,",0,-178,-176,3.36,"3' UTR",8,67782637,67794002,11366,1]
["chr8",75236724,75237134,411,"ENSBGRG00000015077","ENSBGRT00000027720",1969,"NIPAL4","NIPA like domain containing 4 [Source:HGNC Symbol;Acc:HGNC:28018]","GO:0015095(magnesium ion transmembrane transporter activity);GO:0015693(magnesium ion transport);GO:0016021(integral component of membrane)","NA",{"v":6.3e-27,"d":"0.00"},1,"411,",0,{"v":-26.2,"d":"-26.20"},{"v":-25.2,"d":"-25.20"},3.57,"Exon (ENSBGRT00000027720/ENSBGRG00000015077, exon 2 of 2)",8,75234755,75237134,2380,1]
["chr8",90489456,90502149,12694,"ENSBGRG00000002672","ENSBGRT00000005008",0,"XRCC4","X-ray repair cross complementing 4 [Source:HGNC Symbol;Acc:HGNC:12831]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005958(DNA-dependent protein kinase-DNA ligase 4 complex);GO:0006302(double-strand break repair);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0006310(DNA recombination);GO:0008022(protein C-terminus binding);GO:0010165(response to X-ray);GO:0032807(DNA ligase IV complex);GO:0042802(identical protein binding);GO:0051103(DNA ligation involved in DNA repair);GO:0051351(positive regulation of ligase activity);GO:0070419(nonhomologous end joining complex)","03450(Non-homologous end-joining)",{"v":6.6E-4,"d":"0.00"},2,"149,147,","0,12547",-3.18,-2.58,2.07,"5' UTR",8,90489456,90768200,278745,1]
["chr8",103506767,103507367,601,"ENSBGRG00000010931","ENSBGRT00000019942",719,"GPR150","G protein-coupled receptor 150 [Source:HGNC Symbol;Acc:HGNC:23628]","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","NA",{"v":0.00015,"d":"0.00"},1,"601,",0,-3.83,{"v":-3.2,"d":"-3.20"},{"v":15.8,"d":"15.80"},"Exon (ENSBGRT00000019942/ENSBGRG00000010931, exon 1 of 1)",8,103506048,103507367,1320,1]
["chr8",111556599,111557222,624,"ENSBGRG00000019769","ENSBGRT00000036341",0,"MACIR","chromosome 5 open reading frame 30 [Source:HGNC Symbol;Acc:HGNC:25052]","GO:0005737(cytoplasm);GO:0010764(negative regulation of fibroblast migration);GO:0035869(ciliary transition zone);GO:0050728(negative regulation of inflammatory response);GO:1900016(negative regulation of cytokine production involved in inflammatory response)","NA",{"v":1e-103,"d":"0.00"},1,"624,",0,-103,-102,9.44,"Exon (ENSBGRT00000036341/ENSBGRG00000019769, exon 1 of 1)",8,111556599,111557222,624,1]
["chr8",1878892,1883751,4860,"ENSBGRG00000022240","ENSBGRT00000041710",0,"ENSBGRG00000022240","NA","GO:0003676(nucleic acid binding)","NA",{"v":0.0068,"d":"0.01"},2,"76,104,","0,4756",-2.17,-1.63,4.62,"Exon (ENSBGRT00000041710/ENSBGRG00000022240, exon 1 of 8)",8,1868367,1878967,10601,2]
["chr8",4154726,4164882,10157,"ENSBGRG00000025077","ENSBGRT00000046366",325,"PLVAP","plasmalemma vesicle associated protein [Source:HGNC Symbol;Acc:HGNC:13635]","GO:0000165(MAPK cascade);GO:0002693(positive regulation of cellular extravasation);GO:0005901(caveola);GO:0009986(cell surface);GO:0033209(tumor necrosis factor-mediated signaling pathway)","NA",{"v":1.3e-08,"d":"0.00"},3,"332,97,44,","0,451,10113",-7.87,-7.12,4.95,"Exon (ENSBGRT00000046366/ENSBGRG00000025077, exon 1 of 6)",8,4145406,4165207,19802,2]
["chr8",4884529,4884948,420,"ENSBGRG00000026103","ENSBGRT00000048311",17502,"IL12RB1","interleukin 12 receptor subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:5971]","GO:0002230(positive regulation of defense response to virus by host);GO:0002827(positive regulation of T-helper 1 type immune response);GO:0005143(interleukin-12 receptor binding);GO:0005515(protein binding);GO:0032729(positive regulation of interferon-gamma production);GO:0042019(interleukin-23 binding);GO:0042020(interleukin-23 receptor activity);GO:0042022(interleukin-12 receptor complex);GO:0042104(positive regulation of activated T cell proliferation);GO:0071346(cellular response to interferon-gamma);GO:0072536(interleukin-23 receptor complex)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);05200(Pathways in cancer);05321(Inflammatiory bowel disease (IBD))",{"v":5.5e-07,"d":"0.00"},1,"420,",0,-6.26,-5.54,8.91,"3' UTR",8,4884529,4902450,17922,2]
["chr8",5986030,5986772,743,"ENSBGRG00000001227","ENSBGRT00000002251",32643,"SUGP2","SURP and G-patch domain containing 2 [Source:HGNC Symbol;Acc:HGNC:18641]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0006396(RNA processing);GO:0016604(nuclear body)","NA",{"v":5.9e-07,"d":"0.00"},2,"26,94,","0,649",-6.23,-5.51,{"v":1.5,"d":"1.50"},"Exon (ENSBGRT00000002251/ENSBGRG00000001227, exon 9 of 11)",8,5984736,6019415,34680,2]
["chr8",6833958,6834787,830,"ENSBGRG00000002925","ENSBGRT00000005483",4900,"JMJD4","jumonji domain containing 4 [Source:HGNC Symbol;Acc:HGNC:25724]","GO:0005737(cytoplasm);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0018126(protein hydroxylation);GO:0045905(positive regulation of translational termination)","NA",{"v":1.6e-25,"d":"0.00"},2,"253,134,","0,696",{"v":-24.8,"d":"-24.80"},{"v":-23.8,"d":"-23.80"},3.49,"Exon (ENSBGRT00000005483/ENSBGRG00000002925, exon 5 of 6)",8,6833780,6839687,5908,2]
["chr8",10132432,10132492,61,"ENSBGRG00000006109","ENSBGRT00000011428",25152,"FLT4","fms related tyrosine kinase 4 [Source:HGNC Symbol;Acc:HGNC:3767]","GO:0001934(positive regulation of protein phosphorylation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001946(lymphangiogenesis);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005021(vascular endothelial growth factor-activated receptor activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0010575(positive regulation of vascular endothelial growth factor production);GO:0010595(positive regulation of endothelial cell migration);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019838(growth factor binding);GO:0019903(protein phosphatase binding);GO:0035924(cellular response to vascular endothelial growth factor stimulus);GO:0036328(VEGF-C-activated receptor activity);GO:0038084(vascular endothelial growth factor signaling pathway);GO:0042803(protein homodimerization activity);GO:0043066(negative regulation of apoptotic process);GO:0043235(receptor complex);GO:0043410(positive regulation of MAPK cascade);GO:0046330(positive regulation of JNK cascade);GO:0046777(protein autophosphorylation);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0090037(positive regulation of protein kinase C signaling)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);05200(Pathways in cancer);05224(Breast cancer)",{"v":0.00036,"d":"0.00"},1,"61,",0,-3.44,-2.82,2.76,"3' UTR",8,10113864,10157644,43781,2]
["chr8",12629253,12629579,327,"ENSBGRG00000022053","ENSBGRT00000041884",0,"CC2D1A","coiled-coil and C2 domain containing 1A [Source:HGNC Symbol;Acc:HGNC:30237]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001650(fibrillar center);GO:0005829(cytosol);GO:0005886(plasma membrane)","NA",{"v":1.1e-10,"d":"0.00"},1,"327,",0,-9.94,-9.15,3.11,"5' UTR",8,12629536,12651013,21478,1]
["chr8",14387963,14389009,1047,"ENSBGRG00000001399","ENSBGRT00000002572",1608,"ZNF699","zinc finger protein 699 [Source:HGNC Symbol;Acc:HGNC:24750]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.3E-36,"d":"0.00"},1,"1047,",0,{"v":-35.9,"d":"-35.90"},{"v":-34.8,"d":"-34.80"},9.56,"Exon (ENSBGRT00000002572/ENSBGRG00000001399, exon 2 of 2)",8,14387963,14390617,2655,2]
["chr8",15173901,15174413,513,"ENSBGRG00000002843","ENSBGRT00000005366",397,"ENSBGRG00000002843","NA","GO:0003676(nucleic acid binding)","04514(Cell adhesion molecules (CAMs))",{"v":1E-27,"d":"0.00"},3,"9,188,224,","0,12,289",-27,-26,3.76,"5' UTR",8,15159574,15174810,15237,2]
["chr8",16293560,16293917,358,"ENSBGRG00000012601","ENSBGRT00000023082",0,"ENSBGRG00000012601","NA","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0008321(Ral guanyl-nucleotide exchange factor activity);GO:0043547(positive regulation of GTPase activity)","NA",{"v":1.1e-06,"d":"0.00"},1,"358,",0,-5.94,-5.23,{"v":11.4,"d":"11.40"},"5' UTR",8,16277290,16293917,16628,2]
["chr8",16371066,16372308,1243,"ENSBGRG00000013329","ENSBGRT00000024485",0,"ZNF653","zinc finger protein 653 [Source:HGNC Symbol;Acc:HGNC:25196]","GO:0003676(nucleic acid binding);GO:0003714(transcription corepressor activity);GO:0008134(transcription factor binding);GO:0050682(AF-2 domain binding);GO:1900116(extracellular negative regulation of signal transduction);GO:1903507(negative regulation of nucleic acid-templated transcription)","04010(MAPK signaling pathway)",{"v":2e-24,"d":"0.00"},3,"355,106,46,","0,931,1197",{"v":-23.7,"d":"-23.70"},{"v":-22.7,"d":"-22.70"},3.96,"5' UTR",8,16352388,16372102,19715,2]
["chr8",17665571,17666780,1210,"ENSBGRG00000025061","ENSBGRT00000046338",412,"KANK3","KN motif and ankyrin repeat domains 3 [Source:HGNC Symbol;Acc:HGNC:24796]","GO:0005515(protein binding)","03015(mRNA surveillance pathway);04114(Oocyte meiosis);04218(Cellular senescence);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04910(Insulin signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);05168(Herpes simplex infection)",{"v":6.3e-37,"d":"0.00"},2,"85,1047,","0,163",{"v":-36.2,"d":"-36.20"},{"v":-35.1,"d":"-35.10"},7.81,"Exon (ENSBGRT00000046338/ENSBGRG00000025061, exon 1 of 11)",8,17658305,17667192,8888,2]
["chr8",20164308,20164368,61,"ENSBGRG00000013371","ENSBGRT00000024658",37671,"UHRF1","ubiquitin like with PHD and ring finger domains 1 [Source:HGNC Symbol;Acc:HGNC:12556]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000792(heterochromatin);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005657(replication fork);GO:0005720(nuclear heterochromatin);GO:0010216(maintenance of DNA methylation);GO:0010390(histone monoubiquitination);GO:0016363(nuclear matrix);GO:0031493(nucleosomal histone binding);GO:0035064(methylated histone binding);GO:0042802(identical protein binding);GO:0044729(hemi-methylated DNA-binding);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":1.6e-16,"d":"0.00"},1,"61,",0,{"v":-15.8,"d":"-15.80"},{"v":-14.9,"d":"-14.90"},6.06,"3' UTR",8,20163472,20202039,38568,2]
["chr8",20881315,20882362,1048,"ENSBGRG00000017470","ENSBGRT00000032433",16149,"ANKRD24","ankyrin repeat domain 24 [Source:HGNC Symbol;Acc:HGNC:29424]","GO:0005515(protein binding)","NA",{"v":2.5E-15,"d":"0.00"},2,"97,915,","0,133",{"v":-14.6,"d":"-14.60"},{"v":-13.8,"d":"-13.80"},{"v":11.7,"d":"11.70"},"Exon (ENSBGRT00000032433/ENSBGRG00000017470, exon 16 of 21)",8,20874137,20898511,24375,2]
["chr8",21902045,21902995,951,"ENSBGRG00000000769","ENSBGRT00000001401",16267,"GNA11","G protein subunit alpha 11 [Source:HGNC Symbol;Acc:HGNC:4379]","GO:0001501(skeletal system development);GO:0001508(action potential);GO:0001664(G protein-coupled receptor binding);GO:0003924(GTPase activity);GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007507(heart development);GO:0019001(guanyl nucleotide binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0045634(regulation of melanocyte differentiation);GO:0048066(developmental pigmentation);GO:0060158(phospholipase C-activating dopamine receptor signaling pathway);GO:0071467(cellular response to pH)","04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04540(Gap junction);04911(Insulin secretion);04912(GnRH signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04270(Vascular smooth muscle contraction);04725(Cholinergic synapse);04730(Long-term depression);05200(Pathways in cancer);04934(Cushing syndrome);05163(Human cytomegalovirus infection);05146(Amoebiasis);05142(Chagas disease (American trypanosomiasis))",{"v":1.3e-69,"d":"0.00"},1,"951,",0,{"v":-68.9,"d":"-68.90"},{"v":-67.5,"d":"-67.50"},6.49,"3' UTR",8,21901837,21919262,17426,2]
["chr8",25546465,25547030,566,"ENSBGRG00000006040","ENSBGRT00000011154",324976,"CHSY3","chondroitin sulfate synthase 3 [Source:HGNC Symbol;Acc:HGNC:24293]","GO:0008376(acetylgalactosaminyltransferase activity);GO:0032580(Golgi cisterna membrane)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)",{"v":4E-52,"d":"0.00"},1,"566,",0,{"v":-51.4,"d":"-51.40"},{"v":-50.1,"d":"-50.10"},7.73,"Exon (ENSBGRT00000011154/ENSBGRG00000006040, exon 4 of 4)",8,25546465,25872006,325542,2]
["chr8",33045592,33045917,326,"ENSBGRG00000010168","ENSBGRT00000018668",199172,"SNX24","sorting nexin 24 [Source:HGNC Symbol;Acc:HGNC:21533]","GO:0010314(phosphatidylinositol-5-phosphate binding);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0035091(phosphatidylinositol binding);GO:0070273(phosphatidylinositol-4-phosphate binding)","NA",{"v":4e-37,"d":"0.00"},1,"326,",0,{"v":-36.4,"d":"-36.40"},{"v":-35.3,"d":"-35.30"},3.12,"3' UTR",8,33041690,33245089,203400,2]
["chr8",40830498,40830920,423,"ENSBGRG00000014324","ENSBGRT00000026325",17054,"ARL10","ADP ribosylation factor like GTPase 10 [Source:HGNC Symbol;Acc:HGNC:22042]","GO:0005525(GTP binding)","NA",{"v":2e-11,"d":"0.00"},2,"64,267,","0,156",{"v":-10.7,"d":"-10.70"},{"v":-9.9,"d":"-9.90"},4.95,"5' UTR",8,40813444,40831037,17594,1]
["chr8",41487562,41487921,360,"ENSBGRG00000015772","ENSBGRT00000029416",611,"UIMC1","ubiquitin interaction motif containing 1 [Source:HGNC Symbol;Acc:HGNC:30298]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006302(double-strand break repair);GO:0010212(response to ionizing radiation);GO:0016604(nuclear body);GO:0042393(histone binding);GO:0045739(positive regulation of DNA repair);GO:0045892(negative regulation of transcription, DNA-templated);GO:0070530(K63-linked polyubiquitin modification-dependent protein binding);GO:0070531(BRCA1-A complex);GO:0070537(histone H2A K63-linked deubiquitination);GO:0072425(signal transduction involved in G2 DNA damage checkpoint)","03440(Homologous recombination)",{"v":1.7E-5,"d":"0.00"},1,"360,",0,-4.76,-4.09,1.98,"Exon (ENSBGRT00000029176/ENSBGRG00000015772, exon 7 of 16)",8,41407044,41488532,81489,2]
["chr8",43024357,43047132,22776,"ENSBGRG00000012549","ENSBGRT00000023055",0,"ZNF354A","zinc finger protein 354A [Source:HGNC Symbol;Acc:HGNC:11628]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.6E-84,"d":"0.00"},4,"730,96,127,33,","0,17038,18076,22743",{"v":-83.8,"d":"-83.80"},{"v":-82.4,"d":"-82.40"},3.73,"Exon (ENSBGRT00000023055/ENSBGRG00000012549, exon 1 of 4)",8,43023522,43047132,23611,2]
["chr8",46733907,46733997,91,"ENSBGRG00000005610","ENSBGRT00000010381",10285,"POLRMT","RNA polymerase mitochondrial [Source:HGNC Symbol;Acc:HGNC:9200]","GO:0003677(DNA binding);GO:0003899(DNA-directed 5'-3' RNA polymerase activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006351(transcription, DNA-templated);GO:0006390(mitochondrial transcription);GO:0032991(protein-containing complex);GO:0042645(mitochondrial nucleoid);GO:0043565(sequence-specific DNA binding)","NA",{"v":0.00013,"d":"0.00"},1,"91,",0,{"v":-3.9,"d":"-3.90"},-3.27,2.01,"Exon (ENSBGRT00000010381/ENSBGRG00000005610, exon 10 of 21)",8,46730202,46744282,14081,2]
["chr8",48094101,48094371,271,"ENSBGRG00000000396","ENSBGRT00000000661",8695,"SHROOM1","shroom family member 1 [Source:HGNC Symbol;Acc:HGNC:24084]","GO:0000902(cell morphogenesis);GO:0045159(myosin II binding);GO:0051015(actin filament binding);GO:0051017(actin filament bundle assembly)","NA",{"v":1.5E-10,"d":"0.00"},1,"271,",0,-9.83,-9.04,5.26,"Exon (ENSBGRT00000000661/ENSBGRG00000000396, exon 6 of 9)",8,48092851,48103066,10216,2]
["chr8",53688993,53696285,7293,"ENSBGRG00000002960","ENSBGRT00000005576",56222,"FAM13B","family with sequence similarity 13 member B [Source:HGNC Symbol;Acc:HGNC:1335]","GO:0007165(signal transduction)","NA",{"v":5e-18,"d":"0.00"},5,"1,230,82,130,34,","0,2285,4130,6569,7259",{"v":-17.3,"d":"-17.30"},{"v":-16.4,"d":"-16.40"},2.71,"Exon (ENSBGRT00000005576/ENSBGRG00000002960, exon 12 of 21)",8,53682969,53752507,69539,2]
["chr8",56772477,56789878,17402,"ENSBGRG00000022767","ENSBGRT00000042032",0,"ENSBGRG00000022767","NA","NA","NA",{"v":0.011,"d":"0.01"},2,"105,37,","0,17365",-1.95,-1.42,4.29,"Exon (ENSBGRT00000042196/ENSBGRG00000022804, exon 1 of 4)",8,56772421,56789878,17458,2]
["chr8",58385567,58393206,7640,"ENSBGRG00000010951","ENSBGRT00000020016",91524,"ENSBGRG00000010951","NA","GO:0005104(fibroblast growth factor receptor binding);GO:0005576(extracellular region);GO:0008083(growth factor activity);GO:0008543(fibroblast growth factor receptor signaling pathway)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04390(Hippo signaling pathway);04151(PI3K-Akt signaling pathway);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer);05226(Gastric cancer);05218(Melanoma);05224(Breast cancer)",{"v":3.2e-17,"d":"0.00"},2,"165,15,","0,7625",{"v":-16.5,"d":"-16.50"},{"v":-15.6,"d":"-15.60"},3.55,"Exon (ENSBGRT00000020016/ENSBGRG00000010951, exon 5 of 5)",8,58385537,58484730,99194,2]
["chr8",65951908,65952088,181,"ENSBGRG00000018333","ENSBGRT00000033602",37160,"SH3TC2","SH3 domain and tetratricopeptide repeats 2 [Source:HGNC Symbol;Acc:HGNC:29427]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0022011(myelination in peripheral nervous system);GO:0031410(cytoplasmic vesicle);GO:0032287(peripheral nervous system myelin maintenance);GO:0033157(regulation of intracellular protein transport);GO:1901184(regulation of ERBB signaling pathway)","NA",{"v":0.0012,"d":"0.00"},1,"181,",0,-2.93,-2.34,2.34,"Exon (ENSBGRT00000033602/ENSBGRG00000018333, exon 10 of 17)",8,65862815,65989248,126434,2]
["chr8",66361605,66361903,299,"ENSBGRG00000019180","ENSBGRT00000035219",7847,"IL17B","interleukin 17B [Source:HGNC Symbol;Acc:HGNC:5982]","GO:0005125(cytokine activity);GO:0005576(extracellular region);GO:0006954(inflammatory response);GO:1900017(positive regulation of cytokine production involved in inflammatory response)","04060(Cytokine-cytokine receptor interaction);04657(IL-17 signaling pathway)",{"v":1.1e-06,"d":"0.00"},1,"299,",0,-5.94,-5.23,5.08,"5' UTR",8,66355423,66369750,14328,2]
["chr8",68158094,68161257,3164,"ENSBGRG00000006833","ENSBGRT00000012702",53608,"ANXA6","annexin A6 [Source:HGNC Symbol;Acc:HGNC:544]","GO:0005509(calcium ion binding);GO:0005525(GTP binding);GO:0005544(calcium-dependent phospholipid binding);GO:0005765(lysosomal membrane);GO:0006816(calcium ion transport);GO:0006937(regulation of muscle contraction);GO:0008289(lipid binding);GO:0015276(ligand-gated ion channel activity);GO:0015485(cholesterol binding);GO:0031902(late endosome membrane);GO:0034220(ion transmembrane transport);GO:0042802(identical protein binding);GO:0048306(calcium-dependent protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0051560(mitochondrial calcium ion homeostasis);GO:0097190(apoptotic signaling pathway)","NA",0,2,"330,30,","0,3134",-987,"-Inf",{"v":33.7,"d":"33.70"},"3' UTR",8,68158094,68214865,56772,2]
["chr8",78086229,78086467,239,"ENSBGRG00000017485","ENSBGRT00000032144",1049,"PWWP2A","PWWP domain containing 2A [Source:HGNC Symbol;Acc:HGNC:29406]","GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0042025(host cell nucleus);GO:0042393(histone binding)","04068(FoxO signaling pathway)",{"v":1.8E-3,"d":"0.00"},1,"239,",0,-2.75,-2.17,4.95,"Exon (ENSBGRT00000032144/ENSBGRG00000017485, exon 1 of 4)",8,78053226,78087516,34291,2]
["chr8",98043780,98059232,15453,"ENSBGRG00000005546","ENSBGRT00000010323",73,"CETN3","centrin 3 [Source:HGNC Symbol;Acc:HGNC:1868]","GO:0005509(calcium ion binding);GO:0005813(centrosome);GO:0005814(centriole);GO:0008017(microtubule binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0032391(photoreceptor connecting cilium);GO:0035869(ciliary transition zone);GO:0036064(ciliary basal body)","NA",{"v":1.3e-50,"d":"0.00"},5,"82,192,54,126,116,","0,5108,13334,13413,15337",{"v":-49.9,"d":"-49.90"},{"v":-48.6,"d":"-48.60"},2.15,"3' UTR",8,98043450,98059305,15856,2]
["chr8",104904505,104904595,91,"ENSBGRG00000014665","ENSBGRT00000027004",4405,"ERAP1","endoplasmic reticulum aminopeptidase 1 [Source:HGNC Symbol;Acc:HGNC:18173]","GO:0004177(aminopeptidase activity);GO:0005138(interleukin-6 receptor binding);GO:0005576(extracellular region);GO:0005789(endoplasmic reticulum membrane);GO:0006508(proteolysis);GO:0006509(membrane protein ectodomain proteolysis);GO:0008217(regulation of blood pressure);GO:0008235(metalloexopeptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0019885(antigen processing and presentation of endogenous peptide antigen via MHC class I);GO:0070006(metalloaminopeptidase activity)","NA",{"v":0.0006,"d":"0.00"},1,"91,",0,-3.22,-2.61,1.77,"Exon (ENSBGRT00000027004/ENSBGRG00000014665, exon 2 of 19)",8,104808253,104909000,100748,2]
["chr9",1292389,1294108,1720,"ENSBGRG00000013821","ENSBGRT00000025346",38006,"PTGS1","prostaglandin-endoperoxide synthase 1 [Source:HGNC Symbol;Acc:HGNC:9604]","GO:0001516(prostaglandin biosynthetic process);GO:0004601(peroxidase activity);GO:0004666(prostaglandin-endoperoxide synthase activity);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006954(inflammatory response);GO:0006979(response to oxidative stress);GO:0008217(regulation of blood pressure);GO:0019371(cyclooxygenase pathway);GO:0020037(heme binding);GO:0043231(intracellular membrane-bounded organelle);GO:0055114(oxidation-reduction process)","00590(Arachidonic acid metabolism);04611(Platelet activation);04923(Regulation of lipolysis in adipocyte);04726(Serotonergic synapse)",{"v":1E-3,"d":"0.00"},2,"63,58,","0,1662",-2.98,-2.39,2.21,"Exon (ENSBGRT00000025346/ENSBGRG00000013821, exon 10 of 11)",9,1254383,1294406,40024,1]
["chr9",6784794,6785121,328,"ENSBGRG00000004637","ENSBGRT00000008605",10465,"SLC2A8","solute carrier family 2 member 8 [Source:HGNC Symbol;Acc:HGNC:13812]","GO:0001666(response to hypoxia);GO:0005353(fructose transmembrane transporter activity);GO:0005355(glucose transmembrane transporter activity);GO:0005536(glucose binding);GO:0005887(integral component of plasma membrane);GO:0008286(insulin receptor signaling pathway);GO:0015755(fructose transmembrane transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0033300(dehydroascorbic acid transmembrane transporter activity);GO:0055085(transmembrane transport);GO:0070837(dehydroascorbic acid transport);GO:1904659(glucose transmembrane transport)","NA",{"v":2.5e-29,"d":"0.00"},1,"328,",0,{"v":-28.6,"d":"-28.60"},{"v":-27.5,"d":"-27.50"},{"v":5.4,"d":"5.40"},"3' UTR",9,6774329,6785121,10793,1]
["chr9",7887425,7887741,317,"ENSBGRG00000012175","ENSBGRT00000024467",15596,"SPTAN1","spectrin alpha, non-erythrocytic 1 [Source:HGNC Symbol;Acc:HGNC:11273]","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0015630(microtubule cytoskeleton);GO:0043231(intracellular membrane-bounded organelle)","04210(Apoptosis)",{"v":7.9e-23,"d":"0.00"},2,"74,77,","0,240",{"v":-22.1,"d":"-22.10"},{"v":-21.1,"d":"-21.10"},1.58,"Exon (ENSBGRT00000024467/ENSBGRG00000012175, exon 6 of 53)",9,7871829,7933919,62091,1]
["chr9",10043567,10044196,630,"ENSBGRG00000009365","ENSBGRT00000017180",330,"ABL1","ABL proto-oncogene 1, non-receptor tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:76]","GO:0000287(magnesium ion binding);GO:0000400(four-way junction DNA binding);GO:0000405(bubble DNA binding);GO:0001784(phosphotyrosine residue binding);GO:0001843(neural tube closure);GO:0001922(B-1 B cell homeostasis);GO:0001934(positive regulation of protein phosphorylation);GO:0002322(B cell proliferation involved in immune response);GO:0002333(transitional one stage B cell differentiation);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005080(protein kinase C binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006909(phagocytosis);GO:0006974(cellular response to DNA damage stimulus);GO:0006975(DNA damage induced protein phosphorylation);GO:0006979(response to oxidative stress);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007229(integrin-mediated signaling pathway);GO:0008022(protein C-terminus binding);GO:0009791(post-embryonic development);GO:0010595(positive regulation of endothelial cell migration);GO:0015629(actin cytoskeleton);GO:0016301(kinase activity);GO:0016604(nuclear body);GO:0017124(SH3 domain binding);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019904(protein domain specific binding);GO:0019905(syntaxin binding);GO:0021587(cerebellum morphogenesis);GO:0022408(negative regulation of cell-cell adhesion);GO:0030035(microspike assembly);GO:0030036(actin cytoskeleton organization);GO:0030145(manganese ion binding);GO:0030182(neuron differentiation);GO:0030514(negative regulation of BMP signaling pathway);GO:0030516(regulation of axon extension);GO:0031113(regulation of microtubule polymerization);GO:0031252(cell leading edge);GO:0032489(regulation of Cdc42 protein signal transduction);GO:0032729(positive regulation of interferon-gamma production);GO:0032743(positive regulation of interleukin-2 production);GO:0032956(regulation of actin cytoskeleton organization);GO:0032991(protein-containing complex);GO:0033690(positive regulation of osteoblast proliferation);GO:0034446(substrate adhesion-dependent cell spreading);GO:0035791(platelet-derived growth factor receptor-beta signaling pathway);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0038189(neuropilin signaling pathway);GO:0038191(neuropilin binding);GO:0042100(B cell proliferation);GO:0042127(regulation of cell population proliferation);GO:0042169(SH2 domain binding);GO:0042770(signal transduction in response to DNA damage);GO:0043065(positive regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043542(endothelial cell migration);GO:0045184(establishment of protein localization);GO:0045580(regulation of T cell differentiation);GO:0045930(negative regulation of mitotic cell cycle);GO:0045931(positive regulation of mitotic cell cycle);GO:0046632(alpha-beta T cell differentiation);GO:0046777(protein autophosphorylation);GO:0046875(ephrin receptor binding);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048471(perinuclear region of cytoplasm);GO:0048536(spleen development);GO:0048538(thymus development);GO:0048668(collateral sprouting);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050798(activated T cell proliferation);GO:0050852(T cell receptor signaling pathway);GO:0050853(B cell receptor signaling pathway);GO:0050885(neuromuscular process controlling balance);GO:0051015(actin filament binding);GO:0051019(mitogen-activated protein kinase binding);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0051353(positive regulation of oxidoreductase activity);GO:0051444(negative regulation of ubiquitin-protein transferase activity);GO:0051496(positive regulation of stress fiber assembly);GO:0051726(regulation of cell cycle);GO:0051894(positive regulation of focal adhesion assembly);GO:0060020(Bergmann glial cell differentiation);GO:0060563(neuroepithelial cell differentiation);GO:0070064(proline-rich region binding);GO:0070301(cellular response to hydrogen peroxide);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071103(DNA conformation change);GO:0071222(cellular response to lipopolysaccharide);GO:0071901(negative regulation of protein serine/threonine kinase activity);GO:0072358(cardiovascular system development);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis);GO:0090135(actin filament branching);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading);GO:1900272(negative regulation of long-term synaptic potentiation);GO:1900275(negative regulation of phospholipase C activity);GO:1901216(positive regulation of neuron death);GO:1903053(regulation of extracellular matrix organization);GO:1904528(positive regulation of microtubule binding);GO:1904531(positive regulation of actin filament binding);GO:1905244(regulation of modification of synaptic structure);GO:1905555(positive regulation blood vessel branching);GO:1990051(activation of protein kinase C activity);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000096(positive regulation of Wnt signaling pathway, planar cell polarity pathway);GO:2000251(positive regulation of actin cytoskeleton reorganization);GO:2000352(negative regulation of endothelial cell apoptotic process);GO:2000772(regulation of cellular senescence);GO:2000773(negative regulation of cellular senescence);GO:2001020(regulation of response to DNA damage stimulus)","04014(Ras signaling pathway);04012(ErbB signaling pathway);04110(Cell cycle);04722(Neurotrophin signaling pathway);04360(Axon guidance);05200(Pathways in cancer);05206(MicroRNAs in cancer);05220(Chronic myeloid leukemia);05416(Viral myocarditis)",{"v":4e-18,"d":"0.00"},1,"630,",0,{"v":-17.4,"d":"-17.40"},{"v":-16.5,"d":"-16.50"},8.82,"5' UTR",9,10043237,10197760,154524,1]
["chr9",12801272,12801704,433,"ENSBGRG00000019473","ENSBGRT00000044736",91812,"KCNT1","potassium sodium-activated channel subfamily T member 1 [Source:HGNC Symbol;Acc:HGNC:18865]","GO:0006813(potassium ion transport);GO:0016020(membrane)","NA",{"v":0.011,"d":"0.01"},2,"28,272,","0,161",-1.95,-1.42,4.29,"3' UTR",9,12709460,12801704,92245,1]
["chr9",13632728,13632995,268,"ENSBGRG00000025875","ENSBGRT00000047840",10518,"ENSBGRG00000025875","NA","GO:0005509(calcium ion binding);GO:0005515(protein binding)","04330(Notch signaling pathway)",{"v":1e-184,"d":"0.00"},1,"268,",0,-184,-182,3.08,"3' UTR",9,13622210,13632995,10786,1]
["chr9",15182520,15182669,150,"ENSBGRG00000005255","ENSBGRT00000011080",170811,"COL5A1","collagen type V alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2209]","GO:0001568(blood vessel development);GO:0003007(heart morphogenesis);GO:0005201(extracellular matrix structural constituent);GO:0005581(collagen trimer);GO:0005588(collagen type V trimer);GO:0005604(basement membrane);GO:0007155(cell adhesion);GO:0008201(heparin binding);GO:0016477(cell migration);GO:0030199(collagen fibril organization);GO:0031012(extracellular matrix);GO:0032964(collagen biosynthetic process);GO:0035313(wound healing, spreading of epidermal cells);GO:0035989(tendon development);GO:0043394(proteoglycan binding);GO:0043588(skin development);GO:0045112(integrin biosynthetic process);GO:0048407(platelet-derived growth factor binding);GO:0048592(eye morphogenesis);GO:0051128(regulation of cellular component organization);GO:0062023(collagen-containing extracellular matrix);GO:0097435(supramolecular fiber organization);GO:1903225(negative regulation of endodermal cell differentiation)","04974(Protein digestion and absorption)",{"v":1.3e-19,"d":"0.00"},1,"150,",0,{"v":-18.9,"d":"-18.90"},{"v":-17.9,"d":"-17.90"},1.28,"3' UTR",9,15011709,15184165,172457,1]
["chr9",15796784,15798005,1222,"ENSBGRG00000007028","ENSBGRT00000012934",0,"PHPT1","phosphohistidine phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:30033]","GO:0005829(cytosol);GO:0006470(protein dephosphorylation);GO:0019855(calcium channel inhibitor activity);GO:0035971(peptidyl-histidine dephosphorylation);GO:0044325(ion channel binding);GO:0050860(negative regulation of T cell receptor signaling pathway);GO:0051350(negative regulation of lyase activity);GO:0101006(protein histidine phosphatase activity);GO:2000147(positive regulation of cell motility);GO:2000249(regulation of actin cytoskeleton reorganization);GO:2000984(negative regulation of ATP citrate synthase activity)","NA",0,3,"160,125,93,","0,522,1129",-573,"-Inf",4.91,"Exon (ENSBGRT00000012934/ENSBGRG00000007028, exon 1 of 3)",9,15796784,15798005,1222,1]
["chr9",16204148,16205070,923,"ENSBGRG00000011560","ENSBGRT00000021028",0,"TOR4A","torsin family 4 member A [Source:HGNC Symbol;Acc:HGNC:25981]","GO:0005524(ATP binding)","NA",{"v":2.5e-13,"d":"0.00"},1,"923,",0,{"v":-12.6,"d":"-12.60"},{"v":-11.8,"d":"-11.80"},{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000021028/ENSBGRG00000011560, exon 1 of 1)",9,16204148,16205368,1221,1]
["chr9",20173490,20174059,570,"ENSBGRG00000026799","ENSBGRT00000049693",808,"CNNM4","cyclin and CBS domain divalent metal cation transport mediator 4 [Source:HGNC Symbol;Acc:HGNC:105]","GO:0010960(magnesium ion homeostasis);GO:0015081(sodium ion transmembrane transporter activity);GO:0015095(magnesium ion transmembrane transporter activity);GO:0015693(magnesium ion transport);GO:0016323(basolateral plasma membrane);GO:0032991(protein-containing complex);GO:0055065(metal ion homeostasis);GO:0070166(enamel mineralization)","NA",{"v":7.9e-35,"d":"0.00"},1,"570,",0,{"v":-34.1,"d":"-34.10"},-33,4.79,"Exon (ENSBGRT00000049693/ENSBGRG00000026799, exon 1 of 8)",9,20172682,20215984,43303,1]
["chr9",24933895,24935602,1708,"ENSBGRG00000004895","ENSBGRT00000009047",40711,"IL1R1","interleukin 1 receptor type 1 [Source:HGNC Symbol;Acc:HGNC:5993]","GO:0002020(protease binding);GO:0004908(interleukin-1 receptor activity);GO:0004909(interleukin-1, type I, activating receptor activity);GO:0005161(platelet-derived growth factor receptor binding);GO:0005515(protein binding);GO:0007165(signal transduction);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0019966(interleukin-1 binding);GO:0032729(positive regulation of interferon-gamma production);GO:0050727(regulation of inflammatory response);GO:0070498(interleukin-1-mediated signaling pathway);GO:0070555(response to interleukin-1);GO:2000391(positive regulation of neutrophil extravasation);GO:2000556(positive regulation of T-helper 1 cell cytokine production);GO:2000661(positive regulation of interleukin-1-mediated signaling pathway)","04010(MAPK signaling pathway);04064(NF-kappa B signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage);04659(Th17 cell differentiation);04750(Inflammatory mediator regulation of TRP channels);04380(Osteoclast differentiation);05418(Fluid shear stress and atherosclerosis);05166(HTLV-I infection);05163(Human cytomegalovirus infection);05146(Amoebiasis)",{"v":1e-122,"d":"0.00"},2,"92,779,","0,929",-122,-120,6.85,"3' UTR",9,24893184,24936951,43768,1]
["chr9",28611502,28612093,592,"ENSBGRG00000007799","ENSBGRT00000014316",1784,"ENSBGRG00000007799","NA","NA","NA",{"v":1.2E-4,"d":"0.00"},3,"12,148,47,","0,68,545",-3.92,-3.28,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000014316/ENSBGRG00000007799, exon 4 of 7)",9,28609718,28612431,2714,1]
["chr9",30991102,30991578,477,"ENSBGRG00000014352","ENSBGRT00000026330",59,"ENSBGRG00000014352","NA","NA","NA",{"v":4.2e-05,"d":"0.00"},1,"477,",0,-4.38,-3.73,{"v":17.8,"d":"17.80"},"Exon (ENSBGRT00000026330/ENSBGRG00000014352, exon 1 of 1)",9,30991043,30992113,1071,1]
["chr9",33900392,33900688,297,"ENSBGRG00000007493","ENSBGRT00000013703",0,"ENSBGRG00000007493","NA","NA","NA",{"v":2.5e-06,"d":"0.00"},1,"297,",0,-5.61,-4.92,9.41,"Exon (ENSBGRT00000013703/ENSBGRG00000007493, exon 1 of 1)",9,33900392,33901840,1449,1]
["chr9",40595783,40596142,360,"ENSBGRG00000017412","ENSBGRT00000031898",0,"ENSBGRG00000017412","NA","GO:0005515(protein binding)","04120(Ubiquitin mediated proteolysis);04144(Endocytosis)",{"v":6E-9,"d":"0.00"},1,"360,",0,-8.22,-7.46,{"v":19.8,"d":"19.80"},"Exon (ENSBGRT00000031898/ENSBGRG00000017412, exon 1 of 1)",9,40595783,40597549,1767,1]
["chr9",48800702,48801001,300,"ENSBGRG00000006817","ENSBGRT00000012573",3469,"ENSBGRG00000006817","NA","NA","NA",{"v":0.0062,"d":"0.01"},1,"300,",0,-2.21,-1.67,9.91,"Exon (ENSBGRT00000012573/ENSBGRG00000006817, exon 2 of 2)",9,48797233,48803659,6427,1]
["chr9",65432330,65467092,34763,"ENSBGRG00000007532","ENSBGRT00000013782",89,"PEX13","peroxisomal biogenesis factor 13 [Source:HGNC Symbol;Acc:HGNC:8855]","GO:0001561(fatty acid alpha-oxidation);GO:0001764(neuron migration);GO:0001967(suckling behavior);GO:0005515(protein binding);GO:0005777(peroxisome);GO:0005778(peroxisomal membrane);GO:0005779(integral component of peroxisomal membrane);GO:0007626(locomotory behavior);GO:0016021(integral component of membrane);GO:0016560(protein import into peroxisome matrix, docking);GO:0021795(cerebral cortex cell migration);GO:0043231(intracellular membrane-bounded organelle);GO:0060152(microtubule-based peroxisome localization)","04146(Peroxisome)",{"v":1E-52,"d":"0.00"},4,"3,695,126,299,","0,27373,32001,34464",-52,{"v":-50.8,"d":"-50.80"},5.82,"Exon (ENSBGRT00000013782/ENSBGRG00000007532, exon 1 of 4)",9,65432241,65467092,34852,1]
["chr9",70130685,70130863,179,"ENSBGRG00000018104","ENSBGRT00000033133",29998,"KRCC1","lysine rich coiled-coil 1 [Source:HGNC Symbol;Acc:HGNC:28039]","NA","NA",{"v":7.6e-09,"d":"0.00"},1,"179,",0,-8.12,-7.36,2.01,"3' UTR",9,70100687,70131012,30326,1]
["chr9",86849460,86850144,685,"ENSBGRG00000011713","ENSBGRT00000021347",29897,"SLC1A4","solute carrier family 1 member 4 [Source:HGNC Symbol;Acc:HGNC:10942]","GO:0005254(chloride channel activity);GO:0005813(centrosome);GO:0005882(intermediate filament);GO:0005886(plasma membrane);GO:0015175(neutral amino acid transmembrane transporter activity);GO:0015180(L-alanine transmembrane transporter activity);GO:0015183(L-aspartate transmembrane transporter activity);GO:0015184(L-cystine transmembrane transporter activity);GO:0015193(L-proline transmembrane transporter activity);GO:0015194(L-serine transmembrane transporter activity);GO:0015195(L-threonine transmembrane transporter activity);GO:0015293(symporter activity);GO:0015808(L-alanine transport);GO:0015811(L-cystine transport);GO:0015824(proline transport);GO:0015825(L-serine transport);GO:0015826(threonine transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034589(hydroxyproline transport);GO:0034590(L-hydroxyproline transmembrane transporter activity);GO:0050890(cognition);GO:0140009(L-aspartate import across plasma membrane);GO:1903812(L-serine import across plasma membrane);GO:1904273(L-alanine import across plasma membrane)","NA",{"v":4e-62,"d":"0.00"},1,"685,",0,{"v":-61.4,"d":"-61.40"},{"v":-60.1,"d":"-60.10"},7.96,"3' UTR",9,86819563,86850560,30998,1]
["chr9",92627551,92629082,1532,"ENSBGRG00000005537","ENSBGRT00000010214",13430,"PCYOX1","prenylcysteine oxidase 1 [Source:HGNC Symbol;Acc:HGNC:20588]","GO:0001735(prenylcysteine oxidase activity);GO:0005764(lysosome);GO:0016670(oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor);GO:0030327(prenylated protein catabolic process);GO:0030328(prenylcysteine catabolic process);GO:0034361(very-low-density lipoprotein particle);GO:0055114(oxidation-reduction process)","00900(Terpenoid backbone biosynthesis)",{"v":9.99999999999998e-273,"d":"0.00"},2,"151,659,","0,873",-272,-270,5.49,"Exon (ENSBGRT00000010214/ENSBGRG00000005537, exon 5 of 6)",9,92614121,92629082,14962,1]
["chr9",96813012,96813999,988,"ENSBGRG00000009718","ENSBGRT00000017922",13533,"GTF3C2","general transcription factor IIIC subunit 2 [Source:HGNC Symbol;Acc:HGNC:4665]","GO:0000127(transcription factor TFIIIC complex);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006383(transcription by RNA polymerase III)","NA",{"v":9.99999999999999e-245,"d":"0.00"},1,"988,",0,-244,-241,4.36,"3' UTR",9,96799479,96814178,14700,1]
["chr9",98629229,98629288,60,"ENSBGRG00000014178","ENSBGRT00000026626",232225,"DTNB","dystrobrevin beta [Source:HGNC Symbol;Acc:HGNC:3058]","GO:0008270(zinc ion binding)","NA",{"v":0.00015,"d":"0.00"},1,"60,",0,-3.82,-3.19,8.91,"3' UTR",9,98397004,98632489,235486,1]
["chr9",99053617,99056216,2600,"ENSBGRG00000016424","ENSBGRT00000030422",32035,"DNAJC27","DnaJ heat shock protein family (Hsp40) member C27 [Source:HGNC Symbol;Acc:HGNC:30290]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0043410(positive regulation of MAPK cascade);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071701(regulation of MAPK export from nucleus)","NA",{"v":0.0029,"d":"0.00"},2,"15,133,","0,2467",-2.54,-1.97,1.94,"Exon (ENSBGRT00000030422/ENSBGRG00000016424, exon 6 of 6)",9,99021582,99056089,34508,1]
["chr9",104125061,104125330,270,"ENSBGRG00000020733","ENSBGRT00000038170",37769,"MATN3","matrilin 3 [Source:HGNC Symbol;Acc:HGNC:6909]","GO:0005509(calcium ion binding);GO:0016021(integral component of membrane);GO:0031012(extracellular matrix);GO:0051216(cartilage development)","04142(Lysosome)",{"v":0.016,"d":"0.02"},1,"270,",0,-1.79,-1.27,4.95,"Exon (ENSBGRT00000038170/ENSBGRG00000020733, exon 3 of 8)",9,104087292,104140519,53228,1]
["chr9",114763825,114766896,3072,"ENSBGRG00000014129","ENSBGRT00000026180",109222,"MBOAT2","membrane bound O-acyltransferase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:25193]","NA","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism)",{"v":4E-35,"d":"0.00"},2,"18,221,","0,2851",{"v":-34.4,"d":"-34.40"},{"v":-33.3,"d":"-33.30"},2.29,"Exon (ENSBGRT00000026180/ENSBGRG00000014129, exon 12 of 13)",9,114654603,114767639,113037,1]
["chr9",2704468,2705154,687,"ENSBGRG00000017060","ENSBGRT00000031775",599754,"DENND1A","DENN domain containing 1A [Source:HGNC Symbol;Acc:HGNC:29324]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006897(endocytosis);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017124(SH3 domain binding);GO:0017137(Rab GTPase binding);GO:0030136(clathrin-coated vesicle);GO:0030425(dendrite);GO:0030665(clathrin-coated vesicle membrane);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0032456(endocytic recycling);GO:0032483(regulation of Rab protein signal transduction);GO:0043025(neuronal cell body);GO:0043231(intracellular membrane-bounded organelle);GO:0043547(positive regulation of GTPase activity);GO:0045202(synapse);GO:0048488(synaptic vesicle endocytosis);GO:1901981(phosphatidylinositol phosphate binding)","NA",{"v":1.6E-15,"d":"0.00"},1,"687,",0,{"v":-14.8,"d":"-14.80"},-14,2.14,"Exon (ENSBGRT00000031775/ENSBGRG00000017060, exon 22 of 22)",9,2704408,3304908,600501,2]
["chr9",7169341,7170088,748,"ENSBGRG00000006641","ENSBGRT00000012774",11695,"FPGS","folylpolyglutamate synthase [Source:HGNC Symbol;Acc:HGNC:3824]","GO:0004326(tetrahydrofolylpolyglutamate synthase activity);GO:0005524(ATP binding);GO:0006536(glutamate metabolic process);GO:0006760(folic acid-containing compound metabolic process);GO:0009058(biosynthetic process);GO:0009396(folic acid-containing compound biosynthetic process);GO:0016874(ligase activity);GO:0046901(tetrahydrofolylpolyglutamate biosynthetic process)","00790(Folate biosynthesis);01523(Antifolate resistance)",0,1,"748,",0,-732,"-Inf",3.91,"3' UTR",9,7157646,7183990,26345,1]
["chr9",7602343,7602742,400,"ENSBGRG00000009764","ENSBGRT00000018281",17718,"ENSBGRG00000009764","NA","GO:0005794(Golgi apparatus)","NA",{"v":7.9e-21,"d":"0.00"},3,"88,103,19,","0,185,381",{"v":-20.1,"d":"-20.10"},{"v":-19.1,"d":"-19.10"},{"v":1.4,"d":"1.40"},"Exon (ENSBGRT00000018281/ENSBGRG00000009764, exon 24 of 28)",9,7601797,7620460,18664,2]
["chr9",8934810,8936061,1252,"ENSBGRG00000018789","ENSBGRT00000034714",4747,"ASB6","ankyrin repeat and SOCS box containing 6 [Source:HGNC Symbol;Acc:HGNC:17181]","GO:0005515(protein binding);GO:0035556(intracellular signal transduction)","NA",{"v":1E-172,"d":"0.00"},1,"1252,",0,-172,-170,13,"3' UTR",9,8934601,8940808,6208,2]
["chr9",10851280,10853199,1920,"ENSBGRG00000013023","ENSBGRT00000025399",69356,"RAPGEF1","Rap guanine nucleotide exchange factor 1 [Source:HGNC Symbol;Acc:HGNC:4568]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0007264(small GTPase mediated signal transduction);GO:0010976(positive regulation of neuron projection development);GO:0017034(Rap guanyl-nucleotide exchange factor activity);GO:0032486(Rap protein signal transduction);GO:0038180(nerve growth factor signaling pathway);GO:0043231(intracellular membrane-bounded organelle);GO:0043547(positive regulation of GTPase activity);GO:0061028(establishment of endothelial barrier);GO:0071320(cellular response to cAMP);GO:1901888(regulation of cell junction assembly);GO:1990090(cellular response to nerve growth factor stimulus)","04015(Rap1 signaling pathway);04510(Focal adhesion);04910(Insulin signaling pathway);04722(Neurotrophin signaling pathway);05211(Renal cell carcinoma)",{"v":1E-119,"d":"0.00"},3,"605,129,13,","0,769,1907",-119,-118,8.49,"3' UTR",9,10849911,10922555,72645,2]
["chr9",13162296,13165258,2963,"ENSBGRG00000024893","ENSBGRT00000045975",21577,"QSOX2","quiescin sulfhydryl oxidase 2 [Source:HGNC Symbol;Acc:HGNC:30249]","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0016971(flavin-linked sulfhydryl oxidase activity);GO:0016972(thiol oxidase activity);GO:0045454(cell redox homeostasis);GO:0055114(oxidation-reduction process)","NA",{"v":1e-154,"d":"0.00"},2,"1089,137,","0,2826",-154,-152,7.13,"3' UTR",9,13161251,13186835,25585,2]
["chr9",13738897,13739225,329,"ENSBGRG00000025935","ENSBGRT00000047963",43547,"ENSBGRG00000025935","NA","GO:0005975(carbohydrate metabolic process);GO:0016020(membrane);GO:0016758(transferase activity, transferring hexosyl groups)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":0.00015,"d":"0.00"},1,"329,",0,-3.83,{"v":-3.2,"d":"-3.20"},{"v":15.8,"d":"15.80"},"Exon (ENSBGRT00000047963/ENSBGRG00000025935, exon 8 of 8)",9,13737733,13782772,45040,2]
["chr9",14475639,14480232,4594,"ENSBGRG00000004936","ENSBGRT00000009084",11841,"BRD3","bromodomain containing 3 [Source:HGNC Symbol;Acc:HGNC:1104]","GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0006357(regulation of transcription by RNA polymerase II);GO:0070577(lysine-acetylated histone binding)","NA",{"v":1e-29,"d":"0.00"},2,"53,218,","0,4376",-29,-28,3.83,"Exon (ENSBGRT00000009084/ENSBGRG00000004936, exon 8 of 11)",9,14466823,14492073,25251,2]
["chr9",16251026,16251284,259,"ENSBGRG00000011590","ENSBGRT00000021102",86,"NRARP","NOTCH regulated ankyrin repeat protein [Source:HGNC Symbol;Acc:HGNC:33843]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001569(branching involved in blood vessel morphogenesis);GO:0001938(positive regulation of endothelial cell proliferation);GO:0002040(sprouting angiogenesis);GO:0002043(blood vessel endothelial cell proliferation involved in sprouting angiogenesis);GO:0005515(protein binding);GO:0007219(Notch signaling pathway);GO:0022407(regulation of cell-cell adhesion);GO:0032525(somite rostral/caudal axis specification);GO:0045581(negative regulation of T cell differentiation);GO:0045746(negative regulation of Notch signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1902367(negative regulation of Notch signaling pathway involved in somitogenesis)","NA",{"v":4e-21,"d":"0.00"},1,"259,",0,{"v":-20.4,"d":"-20.40"},{"v":-19.5,"d":"-19.50"},3.76,"Exon (ENSBGRT00000021102/ENSBGRG00000011590, exon 1 of 1)",9,16251026,16251370,345,2]
["chr9",17331134,17331461,328,"ENSBGRG00000026744","ENSBGRT00000049602",47704,"FBLN7","fibulin 7 [Source:HGNC Symbol;Acc:HGNC:26740]","GO:0005509(calcium ion binding)","NA",{"v":4e-17,"d":"0.00"},1,"328,",0,{"v":-16.4,"d":"-16.40"},{"v":-15.5,"d":"-15.50"},2.34,"3' UTR",9,17331045,17379165,48121,2]
["chr9",21954840,21969604,14765,"ENSBGRG00000026829","ENSBGRT00000049763",0,"MITD1","microtubule interacting and trafficking domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25207]","GO:0000281(mitotic cytokinesis);GO:0019898(extrinsic component of membrane);GO:0019904(protein domain specific binding);GO:0030496(midbody);GO:0032091(negative regulation of protein binding);GO:0035091(phosphatidylinositol binding);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle);GO:0061952(midbody abscission)","03050(Proteasome)",{"v":4e-39,"d":"0.00"},3,"46,102,151,","0,2318,14614",{"v":-38.4,"d":"-38.40"},{"v":-37.2,"d":"-37.20"},4.14,"Exon (ENSBGRT00000049763/ENSBGRG00000026829, exon 1 of 7)",9,21952568,21969604,17037,2]
["chr9",28042414,28053736,11323,"ENSBGRG00000006151","ENSBGRT00000011327",0,"U6","U6 spliceosomal RNA [Source:RFAM;Acc:RF00026]","NA","NA",{"v":2.5e-68,"d":"0.00"},4,"14,42,85,339,","0,9253,10324,10984",{"v":-67.6,"d":"-67.60"},{"v":-66.3,"d":"-66.30"},4.29,"5' UTR",9,28050099,28050204,106,1]
["chr9",28563495,28563792,298,"ENSBGRG00000007333","ENSBGRT00000013523",1754,"ENSBGRG00000007333","NA","GO:0006338(chromatin remodeling);GO:0031011(Ino80 complex)","NA",{"v":1.3e-52,"d":"0.00"},1,"298,",0,{"v":-51.9,"d":"-51.90"},{"v":-50.7,"d":"-50.70"},3.85,"Exon (ENSBGRT00000013523/ENSBGRG00000007333, exon 5 of 5)",9,28563495,28565546,2052,2]
["chr9",29392004,29395014,3011,"ENSBGRG00000011405","ENSBGRT00000021699",154295,"ALMS1","ALMS1 centrosome and basal body associated protein [Source:HGNC Symbol;Acc:HGNC:428]","GO:0005813(centrosome);GO:0005814(centriole);GO:0016197(endosomal transport);GO:0051492(regulation of stress fiber assembly)","NA",{"v":9.99999999999998e-217,"d":"0.00"},2,"1121,20,","0,2991",-216,-214,4.71,"Exon (ENSBGRT00000021699/ENSBGRG00000011405, exon 11 of 18)",9,29352180,29549309,197130,2]
["chr9",35225338,35226115,778,"ENSBGRG00000009878","ENSBGRT00000018306",16131,"FAM98A","family with sequence similarity 98 member A [Source:HGNC Symbol;Acc:HGNC:24520]","GO:0006479(protein methylation);GO:0008276(protein methyltransferase activity);GO:0008284(positive regulation of cell population proliferation);GO:0010628(positive regulation of gene expression);GO:0032418(lysosome localization);GO:1900029(positive regulation of ruffle assembly)","NA",{"v":9.99999999999998e-229,"d":"0.00"},2,"666,22,","0,756",-228,-226,123,"Exon (ENSBGRT00000018306/ENSBGRG00000009878, exon 7 of 8)",9,35225338,35242246,16909,2]
["chr9",40847828,40850211,2384,"ENSBGRG00000017905","ENSBGRT00000033675",94938,"SOS1","SOS Ras/Rac guanine nucleotide exchange factor 1 [Source:HGNC Symbol;Acc:HGNC:11187]","GO:0000786(nucleosome);GO:0001782(B cell homeostasis);GO:0001942(hair follicle development);GO:0002260(lymphocyte homeostasis);GO:0003007(heart morphogenesis);GO:0003209(cardiac atrium morphogenesis);GO:0003344(pericardium morphogenesis);GO:0003677(DNA binding);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005088(Ras guanyl-nucleotide exchange factor activity);GO:0005737(cytoplasm);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007264(small GTPase mediated signal transduction);GO:0007296(vitellogenesis);GO:0033081(regulation of T cell differentiation in thymus);GO:0035264(multicellular organism growth);GO:0042129(regulation of T cell proliferation);GO:0046982(protein heterodimerization activity);GO:0048514(blood vessel morphogenesis);GO:0060021(roof of mouth development);GO:0061029(eyelid development in camera-type eye);GO:0061384(heart trabecula morphogenesis);GO:1904693(midbrain morphogenesis);GO:2000973(regulation of pro-B cell differentiation)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04630(Jak-STAT signaling pathway);04068(FoxO signaling pathway);04072(Phospholipase D signaling pathway);04151(PI3K-Akt signaling pathway);04150(mTOR signaling pathway);04510(Focal adhesion);04540(Gap junction);04810(Regulation of actin cytoskeleton);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04722(Neurotrophin signaling pathway);04714(Thermogenesis);05200(Pathways in cancer);05231(Choline metabolism in cancer);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05210(Colorectal cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05223(Non-small cell lung cancer);05034(Alcoholism);05160(Hepatitis C);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance)",{"v":1.6e-38,"d":"0.00"},3,"310,190,128,","0,1271,2256",{"v":-37.8,"d":"-37.80"},{"v":-36.7,"d":"-36.70"},6.44,"Exon (ENSBGRT00000033675/ENSBGRG00000017905, exon 9 of 25)",9,40803302,40945149,141848,2]
["chr9",49535167,49535406,240,"ENSBGRG00000007812","ENSBGRT00000014459",9517,"ENSBGRG00000007812","NA","GO:0005509(calcium ion binding)","NA",{"v":5e-18,"d":"0.00"},1,"240,",0,{"v":-17.3,"d":"-17.30"},{"v":-16.4,"d":"-16.40"},2.63,"3' UTR",9,49535107,49544923,9817,2]
["chr9",59312607,59321581,8975,"ENSBGRG00000018551","ENSBGRT00000034030",45017,"PPP4R3B","protein phosphatase 4 regulatory subunit 3B [Source:HGNC Symbol;Acc:HGNC:29267]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0006470(protein dephosphorylation);GO:0016607(nuclear speck);GO:0030289(protein phosphatase 4 complex);GO:0045722(positive regulation of gluconeogenesis)","04922(Glucagon signaling pathway)",{"v":1e-115,"d":"0.00"},4,"459,203,185,19,","0,6762,8392,8956",-115,-114,2.72,"3' UTR",9,59311891,59366598,54708,2]
["chr9",66615150,66615300,151,"ENSBGRG00000010965","ENSBGRT00000020005",12605,"GCC2","GRIP and coiled-coil domain containing 2 [Source:HGNC Symbol;Acc:HGNC:23218]","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0006622(protein targeting to lysosome);GO:0031023(microtubule organizing center organization);GO:0034067(protein localization to Golgi apparatus);GO:0034453(microtubule anchoring);GO:0034499(late endosome to Golgi transport);GO:0042147(retrograde transport, endosome to Golgi);GO:0042802(identical protein binding);GO:0070861(regulation of protein exit from endoplasmic reticulum);GO:0071955(recycling endosome to Golgi transport);GO:0090161(Golgi ribbon formation)","NA",{"v":1.7E-5,"d":"0.00"},1,"151,",0,-4.77,{"v":-4.1,"d":"-4.10"},2.35,"Exon (ENSBGRT00000020005/ENSBGRG00000010965, exon 6 of 23)",9,66590195,66627905,37711,2]
["chr9",69973334,69973514,181,"ENSBGRG00000017501","ENSBGRT00000032100",18333,"THNSL2","threonine synthase like 2 [Source:HGNC Symbol;Acc:HGNC:25602]","GO:0009071(serine family amino acid catabolic process);GO:0016311(dephosphorylation);GO:0030170(pyridoxal phosphate binding);GO:0046360(2-oxobutyrate biosynthetic process);GO:0070905(serine binding)","NA",{"v":1.2e-07,"d":"0.00"},1,"181,",0,-6.93,-6.19,{"v":2.1,"d":"2.10"},"3' UTR",9,69971581,69991847,20267,2]
["chr9",71397497,71398212,716,"ENSBGRG00000004693","ENSBGRT00000008649",0,"ATOH8","atonal bHLH transcription factor 8 [Source:HGNC Symbol;Acc:HGNC:24126]","GO:0001704(formation of primary germ layer);GO:0001937(negative regulation of endothelial cell proliferation);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0010595(positive regulation of endothelial cell migration);GO:0010629(negative regulation of gene expression);GO:0030154(cell differentiation);GO:0033613(activating transcription factor binding);GO:0035148(tube formation);GO:0045603(positive regulation of endothelial cell differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046983(protein dimerization activity);GO:0051450(myoblast proliferation);GO:0060395(SMAD protein signal transduction);GO:0070888(E-box binding);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II)","NA",{"v":5e-29,"d":"0.00"},1,"716,",0,{"v":-28.3,"d":"-28.30"},{"v":-27.3,"d":"-27.30"},5.61,"Exon (ENSBGRT00000008649/ENSBGRG00000004693, exon 1 of 3)",9,71346756,71398212,51457,2]
["chr9",85667929,85677476,9548,"ENSBGRG00000010687","ENSBGRT00000019676",69485,"VPS54","VPS54 subunit of GARP complex [Source:HGNC Symbol;Acc:HGNC:18652]","GO:0000938(GARP complex);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0007041(lysosomal transport);GO:0040008(regulation of growth);GO:0042147(retrograde transport, endosome to Golgi);GO:0048471(perinuclear region of cytoplasm);GO:0048873(homeostasis of number of cells within a tissue);GO:0050881(musculoskeletal movement);GO:0060052(neurofilament cytoskeleton organization)","NA",{"v":4e-08,"d":"0.00"},3,"193,95,43,","0,6866,9505",{"v":-7.4,"d":"-7.40"},-6.66,2.03,"3' UTR",9,85665576,85746961,81386,2]
["chr9",93899169,93899737,569,"ENSBGRG00000006202","ENSBGRT00000011441",1650,"YPEL5","yippee like 5 [Source:HGNC Symbol;Acc:HGNC:18329]","GO:0000151(ubiquitin ligase complex)","NA",{"v":1.3E-74,"d":"0.00"},1,"569,",0,{"v":-73.9,"d":"-73.90"},{"v":-72.5,"d":"-72.50"},2.26,"3' UTR",9,93882815,93901387,18573,2]
["chr9",97058511,97058894,384,"ENSBGRG00000011857","ENSBGRT00000021663",14031,"KHK","ketohexokinase [Source:HGNC Symbol;Acc:HGNC:6315]","GO:0004454(ketohexokinase activity);GO:0005737(cytoplasm);GO:0006000(fructose metabolic process);GO:0016773(phosphotransferase activity, alcohol group as acceptor)","00051(Fructose and mannose metabolism)",{"v":1.7E-8,"d":"0.00"},2,"287,11,","0,373",-7.77,-7.02,2.76,"3' UTR",9,97057263,97072925,15663,2]
["chr9",99279526,99280272,747,"ENSBGRG00000017177","ENSBGRT00000032628",46415,"NCOA1","nuclear receptor coactivator 1 [Source:HGNC Symbol;Acc:HGNC:7668]","GO:0000435(positive regulation of transcription from RNA polymerase II promoter by galactose);GO:0000790(nuclear chromatin);GO:0002155(regulation of thyroid hormone mediated signaling pathway);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0016922(nuclear receptor binding);GO:0017162(aryl hydrocarbon receptor binding);GO:0019899(enzyme binding);GO:0030331(estrogen receptor binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0032991(protein-containing complex);GO:0035257(nuclear hormone receptor binding);GO:0043065(positive regulation of apoptotic process);GO:0043967(histone H4 acetylation);GO:0045666(positive regulation of neuron differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0047485(protein N-terminus binding);GO:0060713(labyrinthine layer morphogenesis);GO:1904017(cellular response to Thyroglobulin triiodothyronine);GO:2001038(regulation of cellular response to drug);GO:2001141(regulation of RNA biosynthetic process)","04915(Estrogen signaling pathway);04919(Thyroid hormone signaling pathway);05200(Pathways in cancer);05224(Breast cancer)",{"v":6.3e-39,"d":"0.00"},1,"747,",0,{"v":-38.2,"d":"-38.20"},-37,3.69,"Exon (ENSBGRT00000032628/ENSBGRG00000017177, exon 9 of 19)",9,99223493,99326687,103195,2]
["chr9",113734776,113737174,2399,"ENSBGRG00000011215","ENSBGRT00000020573",1502,"KLF11","Kruppel like factor 11 [Source:HGNC Symbol;Acc:HGNC:11811]","GO:0000083(regulation of transcription involved in G1/S transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0008285(negative regulation of cell population proliferation);GO:0016604(nuclear body);GO:0043065(positive regulation of apoptotic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1E-172,"d":"0.00"},2,"814,44,","0,2355",-172,-170,3.88,"Exon (ENSBGRT00000020573/ENSBGRG00000011215, exon 2 of 4)",9,113729036,113738676,9641,2]
["chr10",249896,250225,330,"ENSBGRG00000017268","ENSBGRT00000031662",0,"LATS1","large tumor suppressor kinase 1 [Source:HGNC Symbol;Acc:HGNC:6514]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0000287(magnesium ion binding);GO:0000819(sister chromatid segregation);GO:0000922(spindle pole);GO:0001827(inner cell mass cell fate commitment);GO:0001828(inner cell mass cellular morphogenesis);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0009755(hormone-mediated signaling pathway);GO:0019901(protein kinase binding);GO:0030216(keratinocyte differentiation);GO:0030331(estrogen receptor binding);GO:0030833(regulation of actin filament polymerization);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033146(regulation of intracellular estrogen receptor signaling pathway);GO:0034613(cellular protein localization);GO:0035329(hippo signaling);GO:0043254(regulation of protein-containing complex assembly);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0051220(cytoplasmic sequestering of protein);GO:0060644(mammary gland epithelial cell differentiation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:2000058(regulation of ubiquitin-dependent protein catabolic process)","04390(Hippo signaling pathway);04392(Hippo signaling pathway - multiple species)",{"v":1.9e-09,"d":"0.00"},1,"330,",0,-8.71,-7.94,6.93,"5' UTR",10,249896,273566,23671,1]
["chr10",10930978,10931677,700,"ENSBGRG00000023646","ENSBGRT00000043674",116,"CITED2","Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 [Source:HGNC Symbol;Acc:HGNC:1987]","GO:0000790(nuclear chromatin);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001568(blood vessel development);GO:0001570(vasculogenesis);GO:0001701(in utero embryonic development);GO:0001829(trophectodermal cell differentiation);GO:0001841(neural tube formation);GO:0001843(neural tube closure);GO:0001889(liver development);GO:0001892(embryonic placenta development);GO:0001944(vasculature development);GO:0001947(heart looping);GO:0002089(lens morphogenesis in camera-type eye);GO:0002244(hematopoietic progenitor cell differentiation);GO:0002521(leukocyte differentiation);GO:0003151(outflow tract morphogenesis);GO:0003156(regulation of animal organ formation);GO:0003197(endocardial cushion development);GO:0003281(ventricular septum development);GO:0003682(chromatin binding);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007368(determination of left/right symmetry);GO:0007417(central nervous system development);GO:0007422(peripheral nervous system development);GO:0007507(heart development);GO:0007530(sex determination);GO:0008584(male gonad development);GO:0021602(cranial nerve morphogenesis);GO:0022409(positive regulation of cell-cell adhesion);GO:0030325(adrenal gland development);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0030851(granulocyte differentiation);GO:0035802(adrenal cortex formation);GO:0035914(skeletal muscle cell differentiation);GO:0043066(negative regulation of apoptotic process);GO:0045787(positive regulation of cell cycle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046332(SMAD binding);GO:0046697(decidualization);GO:0048536(spleen development);GO:0048538(thymus development);GO:0048596(embryonic camera-type eye morphogenesis);GO:0048821(erythrocyte development);GO:0060136(embryonic process involved in female pregnancy);GO:0060349(bone morphogenesis);GO:0060411(cardiac septum morphogenesis);GO:0060412(ventricular septum morphogenesis);GO:0060971(embryonic heart tube left/right pattern formation);GO:0061156(pulmonary artery morphogenesis);GO:0061308(cardiac neural crest cell development involved in heart development);GO:0061371(determination of heart left/right asymmetry);GO:0070986(left/right axis specification);GO:1900164(nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry);GO:2000020(positive regulation of male gonad development)","04137(Mitophagy - animal)",0,1,"700,",0,-1440,"-Inf",3.42,"Exon (ENSBGRT00000043674/ENSBGRG00000023646, exon 1 of 1)",10,10930862,10931677,816,1]
["chr10",15265357,15265687,331,"ENSBGRG00000017504","ENSBGRT00000032958",22678,"HBS1L","HBS1 like translational GTPase [Source:HGNC Symbol;Acc:HGNC:4834]","GO:0003924(GTPase activity);GO:0005525(GTP binding)","03015(mRNA surveillance pathway);05134(Legionellosis)",{"v":3.4E-5,"d":"0.00"},1,"331,",0,-4.47,-3.81,2.41,"Exon (ENSBGRT00000032958/ENSBGRG00000017504, exon 5 of 5)",10,15242679,15266568,23890,1]
["chr10",26488105,26488195,91,"ENSBGRG00000021935","ENSBGRT00000040568",0,"ZNF292","zinc finger protein 292 [Source:HGNC Symbol;Acc:HGNC:18410]","GO:0003676(nucleic acid binding)","NA",{"v":0.034,"d":"0.03"},1,"91,",0,-1.47,{"v":-0.977,"d":"-0.98"},6.93,"Exon (ENSBGRT00000040568/ENSBGRG00000021935, exon 1 of 8)",10,26488105,26589198,101094,1]
["chr10",26659604,26659783,180,"ENSBGRG00000022024","ENSBGRT00000040726",18149,"SMIM8","small integral membrane protein 8 [Source:HGNC Symbol;Acc:HGNC:21401]","NA","02010(ABC transporters)",{"v":3e-05,"d":"0.00"},1,"180,",0,-4.52,-3.86,5.45,"3' UTR",10,26641455,26660444,18990,1]
["chr10",29149914,29157048,7135,"ENSBGRG00000026240","ENSBGRT00000048536",1128,"GJA10","gap junction protein alpha 10 [Source:HGNC Symbol;Acc:HGNC:16995]","GO:0005243(gap junction channel activity);GO:0005921(gap junction);GO:0005922(connexin complex);GO:0007154(cell communication);GO:0007276(gamete generation);GO:0007416(synapse assembly);GO:0009416(response to light stimulus);GO:0050908(detection of light stimulus involved in visual perception)","NA",{"v":1.6e-06,"d":"0.00"},2,"318,9,","0,7126",-5.79,-5.08,6.54,"Exon (ENSBGRT00000048536/ENSBGRG00000026240, exon 1 of 2)",10,29148786,29157078,8293,1]
["chr10",48080458,48080666,209,"ENSBGRG00000006478","ENSBGRT00000011937",746,"ENSBGRG00000006478","NA","NA","NA",{"v":2.3E-3,"d":"0.00"},1,"209,",0,-2.63,-2.06,4.46,"Exon (ENSBGRT00000011937/ENSBGRG00000006478, exon 1 of 2)",10,48079712,48081561,1850,1]
["chr10",55147213,55148719,1507,"ENSBGRG00000013546","ENSBGRT00000024883",1548,"MARCKS","myristoylated alanine rich protein kinase C substrate [Source:HGNC Symbol;Acc:HGNC:6759]","GO:0005080(protein kinase C binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005938(cell cortex);GO:0016020(membrane);GO:0032432(actin filament bundle);GO:0042585(germinal vesicle);GO:0042802(identical protein binding);GO:0051015(actin filament binding);GO:0051017(actin filament bundle assembly);GO:0051764(actin crosslink formation)","04666(Fc gamma R-mediated phagocytosis);05206(MicroRNAs in cancer)",{"v":9.99999999999998e-276,"d":"0.00"},2,"30,1104,","0,403",-275,-273,{"v":4.4,"d":"4.40"},"5' UTR",10,55145665,55149285,3621,1]
["chr10",67391808,67417967,26160,"ENSBGRG00000012960","ENSBGRT00000023802",61115,"NCOA7","nuclear receptor coactivator 7 [Source:HGNC Symbol;Acc:HGNC:21081]","GO:0030374(nuclear receptor transcription coactivator activity);GO:0035257(nuclear hormone receptor binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1900408(negative regulation of cellular response to oxidative stress);GO:1902083(negative regulation of peptidyl-cysteine S-nitrosylation);GO:1903204(negative regulation of oxidative stress-induced neuron death)","03018(RNA degradation)",{"v":0.00018,"d":"0.00"},2,"80,41,","0,26119",-3.75,-3.12,1.85,"Exon (ENSBGRT00000023802/ENSBGRG00000012960, exon 3 of 16)",10,67330693,67479811,149119,1]
["chr10",79166831,79166951,121,"ENSBGRG00000006189","ENSBGRT00000013439",34818,"COL12A1","collagen type XII alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2188]","GO:0005515(protein binding);GO:0035987(endodermal cell differentiation)","04974(Protein digestion and absorption)",{"v":1e-120,"d":"0.00"},1,"121,",0,-120,-118,2.47,"Exon (ENSBGRT00000013439/ENSBGRG00000006189, exon 13 of 65)",10,79132013,79257374,125362,1]
["chr10",96162199,96162286,88,"ENSBGRG00000008656","ENSBGRT00000015748",17793,"ENSBGRG00000008656","NA","NA","NA",{"v":0.00015,"d":"0.00"},1,"88,",0,-3.81,-3.18,2.45,"Exon (ENSBGRT00000015748/ENSBGRG00000008656, exon 3 of 3)",10,96144406,96162489,18084,1]
["chr10",106132943,106135426,2484,"ENSBGRG00000026663","ENSBGRT00000049423",43509,"SERAC1","serine active site containing 1 [Source:HGNC Symbol;Acc:HGNC:21061]","GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0032367(intracellular cholesterol transport);GO:0036148(phosphatidylglycerol acyl-chain remodeling);GO:0044233(mitochondria-associated endoplasmic reticulum membrane)","00190(Oxidative phosphorylation)",{"v":3.2e-65,"d":"0.00"},2,"139,701,","0,1783",{"v":-64.5,"d":"-64.50"},{"v":-63.2,"d":"-63.20"},{"v":13.4,"d":"13.40"},"3' UTR",10,106089434,106135597,46164,1]
["chr10",110386547,110396287,9741,"ENSBGRG00000004304","ENSBGRT00000007942",92170,"ENSBGRG00000004304","interaction protein for cytohesin exchange factors 1 [Source:HGNC Symbol;Acc:HGNC:21204]","NA","NA",{"v":0.00039,"d":"0.00"},2,"32,88,","0,9653",-3.41,-2.79,8.42,"Exon (ENSBGRT00000007942/ENSBGRG00000004304, exon 8 of 11)",10,110294377,110425717,131341,1]
["chr10",6272858,6273318,461,"ENSBGRG00000021729","ENSBGRT00000040278",17180,"ENSBGRG00000021729","NA","GO:0042274(ribosomal small subunit biogenesis)","NA",{"v":1e-121,"d":"0.00"},2,"205,124,","0,337",-121,-119,{"v":4.1,"d":"4.10"},"3' UTR",10,6272858,6290498,17641,2]
["chr10",18738206,18738884,679,"ENSBGRG00000021648","ENSBGRT00000040498",49055,"ENPP1","ectonucleotide pyrophosphatase/phosphodiesterase 1 [Source:HGNC Symbol;Acc:HGNC:3356]","GO:0003676(nucleic acid binding);GO:0003824(catalytic activity);GO:0004527(exonuclease activity);GO:0004528(phosphodiesterase I activity);GO:0004551(nucleotide diphosphatase activity);GO:0005044(scavenger receptor activity);GO:0005158(insulin receptor binding);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0006091(generation of precursor metabolites and energy);GO:0006796(phosphate-containing compound metabolic process);GO:0006955(immune response);GO:0009143(nucleoside triphosphate catabolic process);GO:0009986(cell surface);GO:0016787(hydrolase activity);GO:0030247(polysaccharide binding);GO:0030308(negative regulation of cell growth);GO:0030318(melanocyte differentiation);GO:0030505(inorganic diphosphate transport);GO:0030643(cellular phosphate ion homeostasis);GO:0030730(sequestering of triglyceride);GO:0031953(negative regulation of protein autophosphorylation);GO:0032869(cellular response to insulin stimulus);GO:0042803(protein homodimerization activity);GO:0045599(negative regulation of fat cell differentiation);GO:0045719(negative regulation of glycogen biosynthetic process);GO:0046325(negative regulation of glucose import);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046872(metal ion binding);GO:0047429(nucleoside-triphosphate diphosphatase activity);GO:0050427(3'-phosphoadenosine 5'-phosphosulfate metabolic process);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0106177(cyclic-GMP-AMP hydrolase activity)","00500(Starch and sucrose metabolism);00230(Purine metabolism);00240(Pyrimidine metabolism);00740(Riboflavin metabolism);00760(Nicotinate and nicotinamide metabolism);00770(Pantothenate and CoA biosynthesis)",{"v":0.00016,"d":"0.00"},2,"34,26,","0,653",-3.79,-3.15,1.68,"Exon (ENSBGRT00000040498/ENSBGRG00000021648, exon 24 of 25)",10,18735408,18787939,52532,2]
["chr10",27687107,27687519,413,"ENSBGRG00000023109","ENSBGRT00000042649",0,"ENSBGRG00000023109","NA","GO:0008270(zinc ion binding)","NA",0.02,1,"413,",0,{"v":-1.7,"d":"-1.70"},-1.19,6.93,"Exon (ENSBGRT00000042649/ENSBGRG00000023109, exon 1 of 2)",10,27686002,27687519,1518,2]
["chr10",37054093,37054603,511,"ENSBGRG00000026414","ENSBGRT00000048881",749,"GPR63","G protein-coupled receptor 63 [Source:HGNC Symbol;Acc:HGNC:13302]","GO:0004930(G protein-coupled receptor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0043235(receptor complex)","NA",{"v":1.6e-14,"d":"0.00"},1,"511,",0,{"v":-13.8,"d":"-13.80"},{"v":-12.9,"d":"-12.90"},7.43,"Exon (ENSBGRT00000048881/ENSBGRG00000026414, exon 1 of 1)",10,37054093,37055352,1260,2]
["chr10",48431532,48431801,270,"ENSBGRG00000006508","ENSBGRT00000011996",0,"PDSS2","decaprenyl diphosphate synthase subunit 2 [Source:HGNC Symbol;Acc:HGNC:23041]","GO:0000010(trans-hexaprenyltranstransferase activity);GO:0005829(cytosol);GO:0006744(ubiquinone biosynthetic process);GO:0008299(isoprenoid biosynthetic process);GO:0046982(protein heterodimerization activity);GO:0050347(trans-octaprenyltranstransferase activity);GO:0050878(regulation of body fluid levels);GO:1990234(transferase complex)","00900(Terpenoid backbone biosynthesis)",{"v":0.00045,"d":"0.00"},1,"270,",0,-3.35,-2.74,2.83,"5' UTR",10,48143185,48431801,288617,2]
["chr10",52370937,52375582,4646,"ENSBGRG00000011672","ENSBGRT00000021948",120853,"REV3L","REV3 like, DNA directed polymerase zeta catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9968]","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005730(nucleolus);GO:0006281(DNA repair);GO:0016035(zeta DNA polymerase complex);GO:0019985(translesion synthesis)","03460(Fanconi anemia pathway);01524(Platinum drug resistance)",{"v":1.6e-83,"d":"0.00"},2,"877,82,","0,4564",{"v":-82.8,"d":"-82.80"},{"v":-81.3,"d":"-81.30"},6.62,"Exon (ENSBGRT00000021948/ENSBGRG00000011672, exon 13 of 32)",10,52296447,52496435,199989,2]
["chr10",58833908,58855379,21472,"ENSBGRG00000007399","ENSBGRT00000013660",3515,"ENSBGRG00000007399","golgi associated PDZ and coiled-coil motif containing [Source:HGNC Symbol;Acc:HGNC:17643]","GO:0005109(frizzled binding);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0007289(spermatid nucleus differentiation);GO:0008022(protein C-terminus binding);GO:0030695(GTPase regulator activity);GO:0042803(protein homodimerization activity);GO:0043004(cytoplasmic sequestering of CFTR protein);GO:0045202(synapse)","03010(Ribosome)",{"v":2E-16,"d":"0.00"},2,"93,414,","0,21058",{"v":-15.7,"d":"-15.70"},{"v":-14.8,"d":"-14.80"},4.37,"5' UTR",10,58813385,58858894,45510,2]
["chr10",59957281,59968843,11563,"ENSBGRG00000008532","ENSBGRT00000015528",89319,"MCM9","minichromosome maintenance 9 homologous recombination repair factor [Source:HGNC Symbol;Acc:HGNC:21484]","GO:0000724(double-strand break repair via homologous recombination);GO:0003677(DNA binding);GO:0003678(DNA helicase activity);GO:0003682(chromatin binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006270(DNA replication initiation);GO:0006974(cellular response to DNA damage stimulus);GO:0007276(gamete generation);GO:0007292(female gamete generation);GO:0019899(enzyme binding);GO:0032406(MutLbeta complex binding);GO:0032407(MutSalpha complex binding);GO:0032408(MutSbeta complex binding);GO:0032508(DNA duplex unwinding);GO:0036298(recombinational interstrand cross-link repair);GO:0044877(protein-containing complex binding);GO:0070716(mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication);GO:0071168(protein localization to chromatin);GO:0097362(MCM8-MCM9 complex)","NA",{"v":2.5e-61,"d":"0.00"},3,"29,1462,2,","0,5564,11561",{"v":-60.6,"d":"-60.60"},{"v":-59.3,"d":"-59.30"},{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000015528/ENSBGRG00000008532, exon 11 of 14)",10,59931238,60058162,126925,2]
["chr10",70012096,70015057,2962,"ENSBGRG00000015553","ENSBGRT00000028614",59147,"DOP1A","DOP1 leucine zipper like protein A [Source:HGNC Symbol;Acc:HGNC:21194]","GO:0006895(Golgi to endosome transport)","04144(Endocytosis)",{"v":7.6e-10,"d":"0.00"},2,"588,71,","0,2891",-9.12,-8.34,4.62,"Exon (ENSBGRT00000028614/ENSBGRG00000015553, exon 19 of 41)",10,69977602,70074204,96603,2]
["chr10",95390426,95391674,1249,"ENSBGRG00000023577","ENSBGRT00000043561",75495,"FAM120B","family with sequence similarity 120B [Source:HGNC Symbol;Acc:HGNC:21109]","GO:0005634(nucleus);GO:0035357(peroxisome proliferator activated receptor signaling pathway);GO:0045444(fat cell differentiation)","NA",{"v":0.048,"d":"0.05"},3,"71,52,27,","0,237,1222",-1.32,{"v":-0.841,"d":"-0.84"},{"v":1.9,"d":"1.90"},"3' UTR",10,95355992,95467169,111178,2]
["chr10",97842402,97842848,447,"ENSBGRG00000012482","ENSBGRT00000022908",32917,"CCR6","C-C motif chemokine receptor 6 [Source:HGNC Symbol;Acc:HGNC:1607]","GO:0004930(G protein-coupled receptor activity);GO:0004950(chemokine receptor activity);GO:0006935(chemotaxis);GO:0006955(immune response);GO:0007186(G protein-coupled receptor signaling pathway);GO:0009986(cell surface);GO:0016021(integral component of membrane);GO:0016493(C-C chemokine receptor activity);GO:0019722(calcium-mediated signaling);GO:0019957(C-C chemokine binding);GO:0036126(sperm flagellum);GO:0060326(cell chemotaxis);GO:0060474(positive regulation of flagellated sperm motility involved in capacitation);GO:0097225(sperm midpiece);GO:0097228(sperm principal piece);GO:0097524(sperm plasma membrane)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway)",{"v":0.0011,"d":"0.00"},1,"447,",0,-2.97,-2.38,3.22,"3' UTR",10,97842134,97875765,33632,2]
["chr10",106541120,106542137,1018,"ENSBGRG00000026696","ENSBGRT00000049490",333563,"ZDHHC14","zinc finger DHHC-type containing 14 [Source:HGNC Symbol;Acc:HGNC:20341]","GO:0005783(endoplasmic reticulum);GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation)","NA",{"v":9.99999999999998e-234,"d":"0.00"},1,"1018,",0,-233,-231,{"v":13.3,"d":"13.30"},"3' UTR",10,106541120,106875700,334581,2]
["chr10",113175426,113175935,510,"ENSBGRG00000006364","ENSBGRT00000011783",123597,"AKAP12","A-kinase anchoring protein 12 [Source:HGNC Symbol;Acc:HGNC:370]","GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006605(protein targeting);GO:0007165(signal transduction);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0008179(adenylate cyclase binding);GO:0010738(regulation of protein kinase A signaling);GO:0010739(positive regulation of protein kinase A signaling);GO:0050804(modulation of chemical synaptic transmission);GO:0051018(protein kinase A binding);GO:0090036(regulation of protein kinase C signaling);GO:0098685(Schaffer collateral - CA1 synapse)","NA",{"v":3.2e-62,"d":"0.00"},1,"510,",0,{"v":-61.5,"d":"-61.50"},{"v":-60.2,"d":"-60.20"},2.37,"Exon (ENSBGRT00000011783/ENSBGRG00000006364, exon 3 of 4)",10,113170760,113299532,128773,2]
["chr11",2408429,2408646,218,"ENSBGRG00000016448","ENSBGRT00000030828",384,"ENSBGRG00000016448","NA","GO:0003676(nucleic acid binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0009898(cytoplasmic side of plasma membrane);GO:0016567(protein ubiquitination);GO:0023035(CD40 signaling pathway);GO:0035631(CD40 receptor complex);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0060546(negative regulation of necroptotic process);GO:0071797(LUBAC complex)","04217(Necroptosis);04621(NOD-like receptor signaling pathway)",{"v":0.022,"d":"0.02"},2,"41,49,","0,169",-1.66,-1.15,2.97,"Exon (ENSBGRT00000030828/ENSBGRG00000016448, exon 2 of 21)",11,2408045,2422640,14596,1]
["chr11",2690239,2692578,2340,"ENSBGRG00000020512","ENSBGRT00000037741",11801,"NYNRIN","NYN domain and retroviral integrase containing [Source:HGNC Symbol;Acc:HGNC:20165]","GO:0003676(nucleic acid binding);GO:0015074(DNA integration)","NA",{"v":7.9e-84,"d":"0.00"},3,"188,937,494,","0,304,1846",{"v":-83.1,"d":"-83.10"},{"v":-81.7,"d":"-81.70"},{"v":5.6,"d":"5.60"},"5' UTR",11,2678438,2703545,25108,1]
["chr11",3416156,3416694,539,"ENSBGRG00000010576","ENSBGRT00000019405",49311,"HCN4","hyperpolarization activated cyclic nucleotide gated potassium channel 4 [Source:HGNC Symbol;Acc:HGNC:16882]","GO:0002027(regulation of heart rate);GO:0003254(regulation of membrane depolarization);GO:0005216(ion channel activity);GO:0005222(intracellular cAMP-activated cation channel activity);GO:0005248(voltage-gated sodium channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006812(cation transport);GO:0006813(potassium ion transport);GO:0006814(sodium ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030552(cAMP binding);GO:0031226(intrinsic component of plasma membrane);GO:0035725(sodium ion transmembrane transport);GO:0042391(regulation of membrane potential);GO:0042802(identical protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0055085(transmembrane transport);GO:0055117(regulation of cardiac muscle contraction);GO:0071320(cellular response to cAMP);GO:0071321(cellular response to cGMP);GO:0071805(potassium ion transmembrane transport);GO:0086015(SA node cell action potential);GO:0086041(voltage-gated potassium channel activity involved in SA node cell action potential depolarization);GO:0086046(membrane depolarization during SA node cell action potential);GO:0086091(regulation of heart rate by cardiac conduction);GO:0098719(sodium ion import across plasma membrane);GO:0098855(HCN channel complex);GO:0098909(regulation of cardiac muscle cell action potential involved in regulation of contraction);GO:1990573(potassium ion import across plasma membrane)","04024(cAMP signaling pathway);04742(Taste transduction)",{"v":7.6e-08,"d":"0.00"},1,"539,",0,-7.12,-6.39,{"v":26.7,"d":"26.70"},"Exon (ENSBGRT00000019405/ENSBGRG00000010576, exon 8 of 8)",11,3366845,3417529,50685,1]
["chr11",8401353,8402622,1270,"ENSBGRG00000021463","ENSBGRT00000039614",40182,"ENSBGRG00000021463","NA","GO:0005515(protein binding);GO:0005634(nucleus);GO:0016363(nuclear matrix)","NA",{"v":1e-11,"d":"0.00"},2,"41,139,","0,1131",-11,{"v":-10.2,"d":"-10.20"},5.64,"Exon (ENSBGRT00000039614/ENSBGRG00000021463, exon 5 of 5)",11,8361171,8405245,44075,1]
["chr11",12434009,12436268,2260,"ENSBGRG00000025646","ENSBGRT00000047411",10302,"PDCD7","programmed cell death 7 [Source:HGNC Symbol;Acc:HGNC:8767]","GO:0005689(U12-type spliceosomal complex)","NA",{"v":1e-32,"d":"0.00"},3,"115,88,124,","0,376,2136",-32,{"v":-30.9,"d":"-30.90"},2.61,"Exon (ENSBGRT00000047411/ENSBGRG00000025646, exon 3 of 5)",11,12423707,12436268,12562,1]
["chr11",15236592,15262026,25435,"ENSBGRG00000005875","ENSBGRT00000010827",477,"LHFPL2","LHFPL tetraspan subfamily member 2 [Source:HGNC Symbol;Acc:HGNC:6588]","GO:0046545(development of primary female sexual characteristics);GO:0046546(development of primary male sexual characteristics);GO:1905516(positive regulation of fertilization)","NA",{"v":1e-132,"d":"0.00"},2,"134,971,","0,24464",-132,-131,6.08,"3' UTR",11,15236115,15262026,25912,1]
["chr11",20867622,20876331,8710,"ENSBGRG00000013314","ENSBGRT00000024415",59,"ENSBGRG00000013314","transmembrane p24 trafficking protein 7 [Source:HGNC Symbol;Acc:HGNC:24253]","NA","NA",{"v":6.3e-77,"d":"0.00"},4,"136,246,87,118,","0,4958,8503,8592",{"v":-76.2,"d":"-76.20"},{"v":-74.8,"d":"-74.80"},2.25,"Exon (ENSBGRT00000024415/ENSBGRG00000013314, exon 1 of 4)",11,20867563,20876360,8798,1]
["chr11",32809885,32811060,1176,"ENSBGRG00000025007","ENSBGRT00000047740",108203,"HERC1","HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 [Source:HGNC Symbol;Acc:HGNC:4867]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0010507(negative regulation of autophagy);GO:0021702(cerebellar Purkinje cell differentiation);GO:0031175(neuron projection development);GO:0050885(neuromuscular process controlling balance)","04120(Ubiquitin mediated proteolysis)",{"v":1e-18,"d":"0.00"},2,"493,17,","0,1159",-18,{"v":-17.1,"d":"-17.10"},4.95,"Exon (ENSBGRT00000047740/ENSBGRG00000025007, exon 38 of 80)",11,32701682,32881578,179897,1]
["chr11",38377629,38377749,121,"ENSBGRG00000009659","ENSBGRT00000017788",16690,"RNF111","ring finger protein 111 [Source:HGNC Symbol;Acc:HGNC:17384]","GO:0000209(protein polyubiquitination);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007389(pattern specification process);GO:0016567(protein ubiquitination);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0030579(ubiquitin-dependent SMAD protein catabolic process);GO:0031398(positive regulation of protein ubiquitination);GO:0032184(SUMO polymer binding);GO:0032991(protein-containing complex);GO:0045893(positive regulation of transcription, DNA-templated);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":2E-12,"d":"0.00"},1,"121,",0,{"v":-11.7,"d":"-11.70"},{"v":-10.9,"d":"-10.90"},{"v":1.8,"d":"1.80"},"Exon (ENSBGRT00000017933/ENSBGRG00000009782, exon 2 of 2)",11,38288388,38394439,106052,2]
["chr11",38768306,38770404,2099,"ENSBGRG00000010308","ENSBGRT00000019041",136883,"ADAM10","ADAM metallopeptidase domain 10 [Source:HGNC Symbol;Acc:HGNC:188]","GO:0001701(in utero embryonic development);GO:0004175(endopeptidase activity);GO:0004222(metalloendopeptidase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005798(Golgi-associated vesicle);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006508(proteolysis);GO:0006509(membrane protein ectodomain proteolysis);GO:0007162(negative regulation of cell adhesion);GO:0007219(Notch signaling pathway);GO:0008237(metallopeptidase activity);GO:0008284(positive regulation of cell population proliferation);GO:0008593(regulation of Notch signaling pathway);GO:0009986(cell surface);GO:0010820(positive regulation of T cell chemotaxis);GO:0014069(postsynaptic density);GO:0016485(protein processing);GO:0019901(protein kinase binding);GO:0030307(positive regulation of cell growth);GO:0030335(positive regulation of cell migration);GO:0034332(adherens junction organization);GO:0034612(response to tumor necrosis factor);GO:0042117(monocyte activation);GO:0042803(protein homodimerization activity);GO:0042987(amyloid precursor protein catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0046930(pore complex);GO:0046931(pore complex assembly);GO:0051088(PMA-inducible membrane protein ectodomain proteolysis);GO:0051089(constitutive protein ectodomain proteolysis);GO:0090102(cochlea development);GO:0097038(perinuclear endoplasmic reticulum);GO:0097060(synaptic membrane);GO:0097197(tetraspanin-enriched microdomain);GO:0098696(regulation of neurotransmitter receptor localization to postsynaptic specialization membrane);GO:0098978(glutamatergic synapse);GO:0099173(postsynapse organization);GO:1901342(regulation of vasculature development);GO:1901998(toxin transport);GO:1902945(metalloendopeptidase activity involved in amyloid precursor protein catabolic process)","05010(Alzheimer disease);05120(Epithelial cell signaling in Helicobacter pylori infection)",{"v":0.00019,"d":"0.00"},2,"16,44,","0,2055",-3.72,-3.09,1.53,"Exon (ENSBGRT00000018936/ENSBGRG00000010308, exon 11 of 16)",11,38631423,38785515,154093,1]
["chr11",45701695,45706884,5190,"ENSBGRG00000017940","ENSBGRT00000037391",151902,"MYO5A","myosin VA [Source:HGNC Symbol;Acc:HGNC:7602]","GO:0000146(microfilament motor activity);GO:0001726(ruffle);GO:0001750(photoreceptor outer segment);GO:0003774(motor activity);GO:0003779(actin binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005777(peroxisome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005882(intermediate filament);GO:0005884(actin filament);GO:0006582(melanin metabolic process);GO:0006887(exocytosis);GO:0006892(post-Golgi vesicle-mediated transport);GO:0007268(chemical synaptic transmission);GO:0007601(visual perception);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0016459(myosin complex);GO:0016461(unconventional myosin complex);GO:0017137(Rab GTPase binding);GO:0030048(actin filament-based movement);GO:0030050(vesicle transport along actin filament);GO:0030073(insulin secretion);GO:0030141(secretory granule);GO:0030318(melanocyte differentiation);GO:0031585(regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity);GO:0031982(vesicle);GO:0031987(locomotion involved in locomotory behavior);GO:0032252(secretory granule localization);GO:0032400(melanosome localization);GO:0032402(melanosome transport);GO:0032433(filopodium tip);GO:0032593(insulin-responsive compartment);GO:0032869(cellular response to insulin stimulus);GO:0035371(microtubule plus-end);GO:0042438(melanin biosynthetic process);GO:0042470(melanosome);GO:0042476(odontogenesis);GO:0042552(myelination);GO:0042641(actomyosin);GO:0042759(long-chain fatty acid biosynthetic process);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0043473(pigmentation);GO:0048066(developmental pigmentation);GO:0048820(hair follicle maturation);GO:0050808(synapse organization);GO:0051015(actin filament binding);GO:0051643(endoplasmic reticulum localization);GO:0055037(recycling endosome);GO:0072659(protein localization to plasma membrane);GO:0097718(disordered domain specific binding);GO:0098978(glutamatergic synapse);GO:0099089(establishment of endoplasmic reticulum localization to postsynapse);GO:0099566(regulation of postsynaptic cytosolic calcium ion concentration)","NA",{"v":8.5e-05,"d":"0.00"},3,"180,94,27,","0,2953,5163",-4.07,-3.43,2.43,"Exon (ENSBGRT00000037391/ENSBGRG00000017940, exon 22 of 41)",11,45549793,45756954,207162,1]
["chr11",49483093,49491344,8252,"ENSBGRG00000015031","ENSBGRT00000027737",68036,"CEP152","centrosomal protein 152 [Source:HGNC Symbol;Acc:HGNC:29298]","GO:0000242(pericentriolar material);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0007099(centriole replication);GO:0019901(protein kinase binding);GO:0051298(centrosome duplication);GO:0098535(de novo centriole assembly involved in multi-ciliated epithelial cell differentiation);GO:0098536(deuterosome)","NA",{"v":2.1e-05,"d":"0.00"},3,"43,132,336,","0,3476,7916",-4.68,-4.02,3.69,"Exon (ENSBGRT00000027737/ENSBGRG00000015031, exon 18 of 29)",11,49415057,49521216,106160,1]
["chr11",55828738,55828798,61,"ENSBGRG00000023839","ENSBGRT00000044149",225225,"SAMD4A","sterile alpha motif domain containing 4A [Source:HGNC Symbol;Acc:HGNC:23023]","GO:0001650(fibrillar center);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0017148(negative regulation of translation);GO:0030054(cell junction);GO:0030371(translation repressor activity);GO:0043488(regulation of mRNA stability);GO:0045202(synapse);GO:0045727(positive regulation of translation)","NA",{"v":3.3E-3,"d":"0.00"},1,"61,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000044149/ENSBGRG00000023839, exon 9 of 9)",11,55603513,55828842,225330,1]
["chr11",59538167,59550471,12305,"ENSBGRG00000006268","ENSBGRT00000011564",37454,"ARID4A","AT-rich interaction domain 4A [Source:HGNC Symbol;Acc:HGNC:9885]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006349(regulation of gene expression by genetic imprinting);GO:0007283(spermatogenesis);GO:0017053(transcriptional repressor complex);GO:0034773(histone H4-K20 trimethylation);GO:0036124(histone H3-K9 trimethylation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048821(erythrocyte development);GO:0080182(histone H3-K4 trimethylation);GO:0097368(establishment of Sertoli cell barrier)","NA",{"v":1.3e-66,"d":"0.00"},4,"189,251,198,21,","0,4824,7528,12284",{"v":-65.9,"d":"-65.90"},{"v":-64.6,"d":"-64.60"},4.06,"Exon (ENSBGRT00000011564/ENSBGRG00000006268, exon 15 of 24)",11,59500713,59567882,67170,1]
["chr11",61956962,61957351,390,"ENSBGRG00000008661","ENSBGRT00000015759",3266,"ENSBGRG00000008661","NA","NA","NA",{"v":1.2e-07,"d":"0.00"},1,"390,",0,-6.91,-6.18,{"v":26.7,"d":"26.70"},"Exon (ENSBGRT00000015759/ENSBGRG00000008661, exon 2 of 2)",11,61953696,61960259,6564,1]
["chr11",68911941,68912000,60,"ENSBGRG00000005372","ENSBGRT00000009946",716,"MPP5","membrane palmitoylated protein 5 [Source:HGNC Symbol;Acc:HGNC:18669]","GO:0002011(morphogenesis of an epithelial sheet);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0007009(plasma membrane organization);GO:0019904(protein domain specific binding);GO:0032287(peripheral nervous system myelin maintenance);GO:0032991(protein-containing complex);GO:0035749(myelin sheath adaxonal region);GO:0035750(protein localization to myelin sheath abaxonal region);GO:0043219(lateral loop);GO:0043220(Schmidt-Lanterman incisure);GO:0070830(bicellular tight junction assembly);GO:0090162(establishment of epithelial cell polarity)","04390(Hippo signaling pathway);04530(Tight junction);05165(Human papillomavirus infection)",{"v":0.018,"d":"0.02"},1,"60,",0,-1.74,-1.22,4.95,"5' UTR",11,68911225,68991603,80379,1]
["chr11",72162418,72172906,10489,"ENSBGRG00000008784","ENSBGRT00000016124",1091,"COX16","cytochrome c oxidase assembly factor COX16 [Source:HGNC Symbol;Acc:HGNC:20213]","GO:0031305(integral component of mitochondrial inner membrane);GO:0031966(mitochondrial membrane);GO:0033617(mitochondrial respiratory chain complex IV assembly)","04714(Thermogenesis)",{"v":3.2e-06,"d":"0.00"},3,"161,72,37,","0,5876,10452",-5.49,{"v":-4.8,"d":"-4.80"},{"v":2.3,"d":"2.30"},"5' UTR",11,72161327,72176729,15403,1]
["chr11",73438824,73439890,1067,"ENSBGRG00000010469","ENSBGRT00000019216",206349,"SIPA1L1","signal induced proliferation associated 1 like 1 [Source:HGNC Symbol;Acc:HGNC:20284]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0031532(actin cytoskeleton reorganization);GO:0043087(regulation of GTPase activity);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0048814(regulation of dendrite morphogenesis);GO:0050770(regulation of axonogenesis);GO:0051056(regulation of small GTPase mediated signal transduction)","04015(Rap1 signaling pathway)",{"v":1.3E-15,"d":"0.00"},2,"308,143,","0,924",{"v":-14.9,"d":"-14.90"},-14,{"v":1.7,"d":"1.70"},"Exon (ENSBGRT00000019216/ENSBGRG00000010469, exon 9 of 22)",11,73232475,73519900,287426,1]
["chr11",75946955,76052821,105867,"ENSBGRG00000006226","ENSBGRT00000011567",13553,"LIN52","lin-52 DREAM MuvB core complex component [Source:HGNC Symbol;Acc:HGNC:19856]","GO:0006351(transcription, DNA-templated);GO:0070176(DRM complex)","04218(Cellular senescence)",{"v":6.6e-05,"d":"0.00"},3,"9,35,255,","0,4897,105612",-4.18,-3.53,1.75,"3' UTR",11,75933402,75951886,18485,1]
["chr11",77935317,77987136,51820,"ENSBGRG00000010136","ENSBGRT00000018924",0,"IFT43","intraflagellar transport 43 [Source:HGNC Symbol;Acc:HGNC:29669]","GO:0005929(cilium);GO:0015630(microtubule cytoskeleton);GO:0030991(intraciliary transport particle A);GO:0034451(centriolar satellite);GO:0035721(intraciliary retrograde transport);GO:0060271(cilium assembly)","NA",{"v":4.6e-07,"d":"0.00"},3,"54,93,60,","0,2923,51760",-6.34,-5.62,1.48,"Exon (ENSBGRT00000018924/ENSBGRG00000010136, exon 1 of 5)",11,77935317,78023599,88283,1]
["chr11",92162493,92162553,61,"ENSBGRG00000004424","ENSBGRT00000008241",179,"SPATA7","spermatogenesis associated 7 [Source:HGNC Symbol;Acc:HGNC:20423]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005930(axoneme);GO:0015630(microtubule cytoskeleton);GO:0036064(ciliary basal body)","NA",{"v":0.0068,"d":"0.01"},1,"61,",0,-2.17,-1.62,5.94,"5' UTR",11,92162314,92202839,40526,1]
["chr11",1372157,1372304,148,"ENSBGRG00000004439","ENSBGRT00000009297",0,"PRMT5","protein arginine methyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:10894]","GO:0000387(spliceosomal snRNP assembly);GO:0002039(p53 binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006353(DNA-templated transcription, termination);GO:0006479(protein methylation);GO:0008168(methyltransferase activity);GO:0008327(methyl-CpG binding);GO:0016274(protein-arginine N-methyltransferase activity);GO:0018216(peptidyl-arginine methylation);GO:0034709(methylosome);GO:0035097(histone methyltransferase complex);GO:0035243(protein-arginine omega-N symmetric methyltransferase activity);GO:0035246(peptidyl-arginine N-methylation);GO:0042118(endothelial cell activation);GO:0042802(identical protein binding);GO:0043021(ribonucleoprotein complex binding);GO:0044020(histone methyltransferase activity (H4-R3 specific));GO:0046982(protein heterodimerization activity);GO:0090161(Golgi ribbon formation);GO:1904992(positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway)","03013(RNA transport)",{"v":1.1e-06,"d":"0.00"},2,"11,110,","0,38",-5.94,-5.23,3.82,"Exon (ENSBGRT00000009297/ENSBGRG00000004439, exon 1 of 17)",11,1365011,1372167,7157,2]
["chr11",1927758,1928237,480,"ENSBGRG00000010123","ENSBGRT00000019429",50439,"NGDN","neuroguidin [Source:HGNC Symbol;Acc:HGNC:20271]","GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005739(mitochondrion)","NA",{"v":8.9e-09,"d":"0.00"},1,"480,",0,-8.05,-7.29,4.29,"3' UTR",11,1877319,1932569,55251,1]
["chr11",2603828,2604739,912,"ENSBGRG00000019981","ENSBGRT00000036738",3320,"RIPK3","receptor interacting serine/threonine kinase 3 [Source:HGNC Symbol;Acc:HGNC:10021]","GO:0001914(regulation of T cell mediated cytotoxicity);GO:0002819(regulation of adaptive immune response);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004704(NF-kappaB-inducing kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0010922(positive regulation of phosphatase activity);GO:0010940(positive regulation of necrotic cell death);GO:0032147(activation of protein kinase activity);GO:0032649(regulation of interferon-gamma production);GO:0032991(protein-containing complex);GO:0033077(T cell differentiation in thymus);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043029(T cell homeostasis);GO:0044877(protein-containing complex binding);GO:0046006(regulation of activated T cell proliferation);GO:0046777(protein autophosphorylation);GO:0048535(lymph node development);GO:0048536(spleen development);GO:0048538(thymus development);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051351(positive regulation of ligase activity);GO:0051353(positive regulation of oxidoreductase activity);GO:0051607(defense response to virus);GO:0060545(positive regulation of necroptotic process);GO:0070235(regulation of activation-induced cell death of T cells);GO:0070266(necroptotic process);GO:0070301(cellular response to hydrogen peroxide);GO:0097300(programmed necrotic cell death);GO:0097527(necroptotic signaling pathway);GO:0097528(execution phase of necroptosis);GO:1990000(amyloid fibril formation);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000379(positive regulation of reactive oxygen species metabolic process);GO:2000452(regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","04668(TNF signaling pathway);04217(Necroptosis);04621(NOD-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway)",{"v":4e-53,"d":"0.00"},3,"21,197,52,","0,25,860",{"v":-52.4,"d":"-52.40"},{"v":-51.2,"d":"-51.20"},{"v":8.7,"d":"8.70"},"Exon (ENSBGRT00000036738/ENSBGRG00000019981, exon 10 of 12)",11,2603828,2608059,4232,2]
["chr11",10215427,10219593,4167,"ENSBGRG00000023965","ENSBGRT00000044275",129733,"SMAD3","SMAD family member 3 [Source:HGNC Symbol;Acc:HGNC:6769]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001223(transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0001649(osteoblast differentiation);GO:0001657(ureteric bud development);GO:0001666(response to hypoxia);GO:0001701(in utero embryonic development);GO:0001707(mesoderm formation);GO:0001756(somitogenesis);GO:0001889(liver development);GO:0001947(heart looping);GO:0002076(osteoblast development);GO:0002520(immune system development);GO:0003682(chromatin binding);GO:0003690(double-stranded DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005160(transforming growth factor beta receptor binding);GO:0005515(protein binding);GO:0005518(collagen binding);GO:0005634(nucleus);GO:0005637(nuclear inner membrane);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006955(immune response);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007183(SMAD protein complex assembly);GO:0007369(gastrulation);GO:0007492(endoderm development);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0009880(embryonic pattern specification);GO:0010628(positive regulation of gene expression);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0016202(regulation of striated muscle tissue development);GO:0017015(regulation of transforming growth factor beta receptor signaling pathway);GO:0017151(DEAD/H-box RNA helicase binding);GO:0019901(protein kinase binding);GO:0019902(phosphatase binding);GO:0030308(negative regulation of cell growth);GO:0030878(thyroid gland development);GO:0031490(chromatin DNA binding);GO:0031625(ubiquitin protein ligase binding);GO:0031962(mineralocorticoid receptor binding);GO:0032332(positive regulation of chondrocyte differentiation);GO:0032909(regulation of transforming growth factor beta2 production);GO:0032924(activin receptor signaling pathway);GO:0033689(negative regulation of osteoblast proliferation);GO:0035259(glucocorticoid receptor binding);GO:0038092(nodal signaling pathway);GO:0042110(T cell activation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043130(ubiquitin binding);GO:0043235(receptor complex);GO:0043425(bHLH transcription factor binding);GO:0043565(sequence-specific DNA binding);GO:0045216(cell-cell junction organization);GO:0045429(positive regulation of nitric oxide biosynthetic process);GO:0045599(negative regulation of fat cell differentiation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045930(negative regulation of mitotic cell cycle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048340(paraxial mesoderm morphogenesis);GO:0048589(developmental growth);GO:0048617(embryonic foregut morphogenesis);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0050678(regulation of epithelial cell proliferation);GO:0050728(negative regulation of inflammatory response);GO:0050776(regulation of immune response);GO:0051098(regulation of binding);GO:0051481(negative regulation of cytosolic calcium ion concentration);GO:0060039(pericardium development);GO:0060395(SMAD protein signal transduction);GO:0061045(negative regulation of wound healing);GO:0070306(lens fiber cell differentiation);GO:0070410(co-SMAD binding);GO:0070412(R-SMAD binding);GO:0071141(SMAD protein complex);GO:0071144(heteromeric SMAD protein complex);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:0097191(extrinsic apoptotic signaling pathway);GO:1901203(positive regulation of extracellular matrix assembly);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II)","04350(TGF-beta signaling pathway);04390(Hippo signaling pathway);04371(Apelin signaling pathway);04068(FoxO signaling pathway);04144(Endocytosis);04110(Cell cycle);04218(Cellular senescence);04520(Adherens junction);04550(Signaling pathways regulating pluripotency of stem cells);04659(Th17 cell differentiation);04926(Relaxin signaling pathway);05200(Pathways in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05321(Inflammatiory bowel disease (IBD));04933(AGE-RAGE signaling pathway in diabetic complications);05166(HTLV-I infection);05142(Chagas disease (American trypanosomiasis))",{"v":1e-20,"d":"0.00"},2,"159,19,","0,4148",-20,{"v":-19.1,"d":"-19.10"},2.41,"Exon (ENSBGRT00000044275/ENSBGRG00000023965, exon 9 of 10)",11,10215427,10349326,133900,2]
["chr11",17003006,17003365,360,"ENSBGRG00000007892","ENSBGRT00000014400",19707,"F2R","coagulation factor II thrombin receptor [Source:HGNC Symbol;Acc:HGNC:3537]","GO:0001965(G-protein alpha-subunit binding);GO:0002248(connective tissue replacement involved in inflammatory response wound healing);GO:0004930(G protein-coupled receptor activity);GO:0005102(signaling receptor binding);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006954(inflammatory response);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007200(phospholipase C-activating G protein-coupled receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007596(blood coagulation);GO:0008285(negative regulation of cell population proliferation);GO:0009611(response to wounding);GO:0009986(cell surface);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0015057(thrombin-activated receptor activity);GO:0016021(integral component of membrane);GO:0030168(platelet activation);GO:0030193(regulation of blood coagulation);GO:0030194(positive regulation of blood coagulation);GO:0030335(positive regulation of cell migration);GO:0031094(platelet dense tubular network);GO:0031681(G-protein beta-subunit binding);GO:0032496(response to lipopolysaccharide);GO:0032651(regulation of interleukin-1 beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0032967(positive regulation of collagen biosynthetic process);GO:0035025(positive regulation of Rho protein signal transduction);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0045217(cell-cell junction maintenance);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045907(positive regulation of vasoconstriction);GO:0048873(homeostasis of number of cells within a tissue);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070493(thrombin-activated receptor signaling pathway);GO:0099553(trans-synaptic signaling by endocannabinoid, modulating synaptic transmission);GO:1900134(negative regulation of renin secretion into blood stream)","04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04072(Phospholipase D signaling pathway);04024(cAMP signaling pathway);04151(PI3K-Akt signaling pathway);04080(Neuroactive ligand-receptor interaction);04810(Regulation of actin cytoskeleton);04610(Complement and coagulation cascades);04611(Platelet activation);05200(Pathways in cancer)",{"v":6.3e-79,"d":"0.00"},1,"360,",0,{"v":-78.2,"d":"-78.20"},{"v":-76.8,"d":"-76.80"},6.49,"Exon (ENSBGRT00000014400/ENSBGRG00000007892, exon 2 of 2)",11,17003006,17023072,20067,2]
["chr11",23221601,23304179,82579,"ENSBGRG00000012240","ENSBGRT00000022534",0,"NREP","neuronal regeneration related protein [Source:HGNC Symbol;Acc:HGNC:16834]","NA","NA",{"v":1.3E-59,"d":"0.00"},6,"33,126,78,114,69,112,","0,45576,51687,70452,81107,82467",{"v":-58.9,"d":"-58.90"},{"v":-57.6,"d":"-57.60"},3.12,"5' UTR",11,23267177,23292166,24990,2]
["chr11",29807906,29809358,1453,"ENSBGRG00000019999","ENSBGRT00000039713",69760,"NIN","ninein [Source:HGNC Symbol;Acc:HGNC:14906]","GO:0000242(pericentriolar material);GO:0000922(spindle pole);GO:0005509(calcium ion binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005813(centrosome);GO:0005814(centriole);GO:0005881(cytoplasmic microtubule);GO:0005886(plasma membrane);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0019900(kinase binding);GO:0021540(corpus callosum morphogenesis);GO:0021957(corticospinal tract morphogenesis);GO:0030424(axon);GO:0030425(dendrite);GO:0031116(positive regulation of microtubule polymerization);GO:0034454(microtubule anchoring at centrosome);GO:0036449(microtubule minus-end);GO:0044295(axonal growth cone);GO:0045177(apical part of cell);GO:0048668(collateral sprouting);GO:0050772(positive regulation of axonogenesis);GO:0051642(centrosome localization);GO:0072686(mitotic spindle);GO:0090222(centrosome-templated microtubule nucleation);GO:0097431(mitotic spindle pole);GO:0097539(ciliary transition fiber);GO:0120103(centriolar subdistal appendage)","NA",{"v":0.0011,"d":"0.00"},2,"64,117,","0,1336",-2.94,-2.35,5.61,"Exon (ENSBGRT00000039713/ENSBGRG00000019999, exon 18 of 31)",11,29777842,29879118,101277,2]
["chr11",31580793,31581032,240,"ENSBGRG00000023055","ENSBGRT00000042610",22515,"ENSBGRG00000023055","NA","NA","NA",{"v":2.3E-5,"d":"0.00"},1,"240,",0,-4.63,-3.97,6.93,"3' UTR",11,31580763,31603547,22785,2]
["chr11",33859849,33866320,6472,"ENSBGRG00000004335","ENSBGRT00000008396",226439,"TLN2","talin 2 [Source:HGNC Symbol;Acc:HGNC:15447]","GO:0001726(ruffle);GO:0003779(actin binding);GO:0005200(structural constituent of cytoskeleton);GO:0005856(cytoskeleton);GO:0005925(focal adhesion);GO:0007016(cytoskeletal anchoring at plasma membrane);GO:0007155(cell adhesion);GO:0051015(actin filament binding)","04015(Rap1 signaling pathway);04510(Focal adhesion);04611(Platelet activation);05166(HTLV-I infection)",{"v":7.9e-28,"d":"0.00"},3,"857,126,6,","0,2666,6466",{"v":-27.1,"d":"-27.10"},{"v":-26.1,"d":"-26.10"},8.48,"3' UTR",11,33859819,34092759,232941,2]
["chr11",42391732,42392478,747,"ENSBGRG00000016245","ENSBGRT00000030195",21819,"CCPG1","cell cycle progression 1 [Source:HGNC Symbol;Acc:HGNC:24227]","GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0045787(positive regulation of cell cycle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2001106(regulation of Rho guanyl-nucleotide exchange factor activity)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":1e-162,"d":"0.00"},2,"371,48,","0,699",-162,-160,8.56,"3' UTR",11,42369913,42391752,21840,1]
["chr11",49342556,49343131,576,"ENSBGRG00000014994","ENSBGRT00000027584",0,"ENSBGRG00000014994","NA","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005634(nucleus);GO:0035065(regulation of histone acetylation);GO:0045595(regulation of cell differentiation)","04014(Ras signaling pathway);04012(ErbB signaling pathway);04072(Phospholipase D signaling pathway);04510(Focal adhesion);04650(Natural killer cell mediated cytotoxicity);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04722(Neurotrophin signaling pathway);05206(MicroRNAs in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05220(Chronic myeloid leukemia);05224(Breast cancer);05034(Alcoholism);05100(Bacterial invasion of epithelial cells);01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance)",{"v":1.3E-87,"d":"0.00"},1,"576,",0,{"v":-86.9,"d":"-86.90"},{"v":-85.4,"d":"-85.40"},{"v":2.4,"d":"2.40"},"Exon (ENSBGRT00000027584/ENSBGRG00000014994, exon 1 of 1)",11,49342556,49343131,576,2]
["chr11",58432021,58433115,1095,"ENSBGRG00000005408","ENSBGRT00000010356",51033,"EXOC5","exocyst complex component 5 [Source:HGNC Symbol;Acc:HGNC:10696]","GO:0000145(exocyst);GO:0005737(cytoplasm);GO:0006887(exocytosis);GO:0017160(Ral GTPase binding);GO:0047485(protein N-terminus binding);GO:0072659(protein localization to plasma membrane)","NA",{"v":1E-182,"d":"0.00"},2,"468,10,","0,1085",-182,-180,{"v":7.2,"d":"7.20"},"3' UTR",11,58432021,58484148,52128,2]
["chr11",66000296,66006179,5884,"ENSBGRG00000012917","ENSBGRT00000023849",14507,"ENSBGRG00000012917","NA","NA","NA",{"v":1.1E-5,"d":"0.00"},3,"71,94,105,","0,1906,5779",-4.97,-4.29,{"v":11.4,"d":"11.40"},"Exon (ENSBGRT00000023849/ENSBGRG00000012917, exon 3 of 9)",11,65987624,66020686,33063,2]
["chr11",70598889,70599009,121,"ENSBGRG00000006595","ENSBGRT00000012699",116083,"ACTN1","actinin alpha 1 [Source:HGNC Symbol;Acc:HGNC:163]","GO:0001725(stress fiber);GO:0001726(ruffle);GO:0003725(double-stranded RNA binding);GO:0005178(integrin binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005884(actin filament);GO:0005903(brush border);GO:0005911(cell-cell junction);GO:0005916(fascia adherens);GO:0005925(focal adhesion);GO:0007015(actin filament organization);GO:0017166(vinculin binding);GO:0030017(sarcomere);GO:0030018(Z disc);GO:0030220(platelet formation);GO:0030374(nuclear receptor transcription coactivator activity);GO:0036344(platelet morphogenesis);GO:0042803(protein homodimerization activity);GO:0042995(cell projection);GO:0044325(ion channel binding);GO:0048041(focal adhesion assembly);GO:0051015(actin filament binding);GO:0051017(actin filament bundle assembly);GO:0051271(negative regulation of cellular component movement);GO:0051639(actin filament network formation);GO:0051764(actin crosslink formation);GO:0098978(glutamatergic synapse);GO:0099186(structural constituent of postsynapse)","04510(Focal adhesion);04520(Adherens junction);04530(Tight junction);04810(Regulation of actin cytoskeleton);04670(Leukocyte transendothelial migration);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus);05146(Amoebiasis)",{"v":2.5e-35,"d":"0.00"},1,"121,",0,{"v":-34.6,"d":"-34.60"},{"v":-33.5,"d":"-33.50"},1.91,"3' UTR",11,70598259,70715092,116834,2]
["chr11",74524617,74527657,3041,"ENSBGRG00000013900","ENSBGRT00000026124",125953,"DPF3","double PHD fingers 3 [Source:HGNC Symbol;Acc:HGNC:17427]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0007399(nervous system development);GO:0008270(zinc ion binding);GO:0071565(nBAF complex)","04714(Thermogenesis);05225(Hepatocellular carcinoma)",{"v":0.028,"d":"0.03"},2,"174,6,","0,3035",-1.56,-1.06,3.96,"Exon (ENSBGRT00000026124/ENSBGRG00000013900, exon 8 of 11)",11,74453536,74653610,200075,2]
["chr11",75397657,75397717,61,"ENSBGRG00000017051","ENSBGRT00000031289",6322,"ENSBGRG00000017051","NA","NA","NA",{"v":0.0035,"d":"0.00"},1,"61,",0,-2.45,-1.89,2.61,"Exon (ENSBGRT00000031289/ENSBGRG00000017051, exon 2 of 7)",11,75383563,75404039,20477,2]
["chr11",76910682,76911219,538,"ENSBGRG00000008456","ENSBGRT00000016007",2626,"MLH3","mutL homolog 3 [Source:HGNC Symbol;Acc:HGNC:7128]","GO:0000793(condensed chromosome);GO:0000794(condensed nuclear chromosome);GO:0000795(synaptonemal complex);GO:0001673(male germ cell nucleus);GO:0003682(chromatin binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005712(chiasma);GO:0006298(mismatch repair);GO:0006974(cellular response to DNA damage stimulus);GO:0007130(synaptonemal complex assembly);GO:0007140(male meiotic nuclear division);GO:0007144(female meiosis I);GO:0008104(protein localization);GO:0016887(ATPase activity);GO:0019237(centromeric DNA binding);GO:0030983(mismatched DNA binding);GO:0032300(mismatch repair complex)","03430(Mismatch repair)",{"v":5.4e-09,"d":"0.00"},1,"538,",0,-8.27,{"v":-7.5,"d":"-7.50"},{"v":19.8,"d":"19.80"},"Exon (ENSBGRT00000016007/ENSBGRG00000008456, exon 1 of 13)",11,76888345,76913845,25501,2]
["chr11",83021637,83021697,61,"ENSBGRG00000016490","ENSBGRT00000030346",529173,"CEP128","centrosomal protein 128 [Source:HGNC Symbol;Acc:HGNC:20359]","GO:0000922(spindle pole);GO:0005814(centriole);GO:0008104(protein localization);GO:0120103(centriolar subdistal appendage)","NA",{"v":0.028,"d":"0.03"},1,"61,",0,-1.56,-1.06,2.58,"3' UTR",11,83021637,83550870,529234,2]
["chr11",94179486,94179725,240,"ENSBGRG00000006341","ENSBGRT00000011844",48470,"NRDE2","NRDE-2, necessary for RNA interference, domain containing [Source:HGNC Symbol;Acc:HGNC:20186]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006396(RNA processing);GO:0016607(nuclear speck);GO:0046833(positive regulation of RNA export from nucleus);GO:1902369(negative regulation of RNA catabolic process)","NA",{"v":0.0017,"d":"0.00"},1,"240,",0,-2.76,-2.18,{"v":1.9,"d":"1.90"},"Exon (ENSBGRT00000011844/ENSBGRG00000006341, exon 10 of 14)",11,94170222,94228195,57974,2]
["chr12",1546055,1546561,507,"ENSBGRG00000012795","ENSBGRT00000024108",133794,"USP6NL","USP6 N-terminal like [Source:HGNC Symbol;Acc:HGNC:16858]","GO:0005096(GTPase activator activity);GO:0005886(plasma membrane);GO:0007030(Golgi organization);GO:0017137(Rab GTPase binding);GO:0019068(virion assembly);GO:0031410(cytoplasmic vesicle);GO:0035526(retrograde transport, plasma membrane to Golgi);GO:0043547(positive regulation of GTPase activity);GO:0048227(plasma membrane to endosome transport);GO:1903358(regulation of Golgi organization)","NA",{"v":1e-163,"d":"0.00"},1,"507,",0,-163,-161,6.15,"Exon (ENSBGRT00000024108/ENSBGRG00000012795, exon 18 of 18)",12,1412261,1546561,134301,1]
["chr12",14383374,14383646,273,"ENSBGRG00000024587","ENSBGRT00000045369",0,"ENSBGRG00000024587","NA","NA","NA",{"v":0.00098,"d":"0.00"},4,"96,141,18,12,","0,98,241,261",-3.01,-2.42,{"v":12.9,"d":"12.90"},"Exon (ENSBGRT00000045519/ENSBGRG00000024605, exon 7 of 18)",12,14360651,14383576,22926,2]
["chr12",23084570,23084781,212,"ENSBGRG00000019868","ENSBGRT00000037409",121019,"ENSBGRG00000019868","NA","NA","04145(Phagosome);05152(Tuberculosis)",{"v":5.5e-07,"d":"0.00"},2,"198,12,","0,200",-6.26,-5.55,6.11,"Exon (ENSBGRT00000037409/ENSBGRG00000019868, exon 61 of 62)",12,22963551,23084781,121231,1]
["chr12",26364356,26364627,272,"ENSBGRG00000024822","ENSBGRT00000045891",0,"ENSBGRG00000024822","NA","NA","04010(MAPK signaling pathway);04668(TNF signaling pathway);04620(Toll-like receptor signaling pathway);04660(T cell receptor signaling pathway)",{"v":2e-34,"d":"0.00"},2,"21,249,","0,23",{"v":-33.7,"d":"-33.70"},{"v":-32.6,"d":"-32.60"},5.24,"Exon (ENSBGRT00000045891/ENSBGRG00000024822, exon 1 of 15)",12,26364356,26387920,23565,1]
["chr12",31046953,31047219,267,"ENSBGRG00000005893","ENSBGRT00000010931",20508,"NAA20","N(alpha)-acetyltransferase 20, NatB catalytic subunit [Source:HGNC Symbol;Acc:HGNC:15908]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008080(N-acetyltransferase activity)","NA",{"v":5e-14,"d":"0.00"},1,"267,",0,{"v":-13.3,"d":"-13.30"},{"v":-12.4,"d":"-12.40"},{"v":1.5,"d":"1.50"},"3' UTR",12,31026445,31047868,21424,1]
["chr12",35107924,35108787,864,"ENSBGRG00000010624","ENSBGRT00000019533",9051,"TUBAL3","tubulin alpha like 3 [Source:HGNC Symbol;Acc:HGNC:23534]","GO:0003924(GTPase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005525(GTP binding);GO:0005874(microtubule);GO:0007017(microtubule-based process)","04145(Phagosome);04210(Apoptosis);04530(Tight junction);04540(Gap junction)",{"v":7.8e-05,"d":"0.00"},1,"864,",0,-4.11,-3.46,{"v":16.8,"d":"16.80"},"3' UTR",12,35098873,35108787,9915,1]
["chr12",44095099,44096584,1486,"ENSBGRG00000009336","ENSBGRT00000018377",1457,"ADAM33","ADAM metallopeptidase domain 33 [Source:HGNC Symbol;Acc:HGNC:15478]","GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity)","NA",{"v":7.1e-06,"d":"0.00"},2,"69,52,","0,1434",-5.15,-4.47,{"v":1.3,"d":"1.30"},"Exon (ENSBGRT00000018377/ENSBGRG00000009336, exon 4 of 15)",12,44093642,44099913,6272,1]
["chr12",46746908,46747172,265,"ENSBGRG00000013547","ENSBGRT00000024827",1903,"ZNF512B","zinc finger protein 512B [Source:HGNC Symbol;Acc:HGNC:29212]","GO:0003676(nucleic acid binding)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)",{"v":6.3E-5,"d":"0.00"},2,"134,17,","0,248",{"v":-4.2,"d":"-4.20"},-3.55,1.43,"Exon (ENSBGRT00000024827/ENSBGRG00000013547, exon 5 of 15)",12,46745005,46753606,8602,1]
["chr12",47286782,47288127,1346,"ENSBGRG00000019459","ENSBGRT00000035791",0,"ENSBGRG00000019459","NA","NA","NA",{"v":6.3e-88,"d":"0.00"},2,"877,431,","0,915",{"v":-87.2,"d":"-87.20"},{"v":-85.8,"d":"-85.80"},8.76,"Exon (ENSBGRT00000035791/ENSBGRG00000019459, exon 1 of 2)",12,47286782,47288394,1613,1]
["chr12",54242626,54243105,480,"ENSBGRG00000013625","ENSBGRT00000024962",5804,"SRXN1","sulfiredoxin 1 [Source:HGNC Symbol;Acc:HGNC:16132]","GO:0005829(cytosol);GO:0006979(response to oxidative stress);GO:0016667(oxidoreductase activity, acting on a sulfur group of donors);GO:0032542(sulfiredoxin activity);GO:0055114(oxidation-reduction process)","NA",{"v":6.3e-47,"d":"0.00"},1,"480,",0,{"v":-46.2,"d":"-46.20"},{"v":-45.1,"d":"-45.10"},7.22,"3' UTR",12,54236822,54243055,6234,1]
["chr12",57249680,57249979,300,"ENSBGRG00000006122","ENSBGRT00000011316",160594,"CBFA2T2","CBFA2/RUNX1 partner transcriptional co-repressor 2 [Source:HGNC Symbol;Acc:HGNC:1536]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0010976(positive regulation of neuron projection development);GO:0030855(epithelial cell differentiation);GO:0045746(negative regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0060575(intestinal epithelial cell differentiation)","05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05221(Acute myeloid leukemia)",{"v":3.2e-32,"d":"0.00"},1,"300,",0,{"v":-31.5,"d":"-31.50"},{"v":-30.4,"d":"-30.40"},3.94,"Exon (ENSBGRT00000011316/ENSBGRG00000006122, exon 11 of 11)",12,57089086,57249979,160894,1]
["chr12",58991493,58991552,60,"ENSBGRG00000010097","ENSBGRT00000018579",0,"ENSBGRG00000010097","NA","NA","04350(TGF-beta signaling pathway);04390(Hippo signaling pathway);04060(Cytokine-cytokine receptor interaction)",{"v":0.012,"d":"0.01"},1,"60,",0,-1.93,{"v":-1.4,"d":"-1.40"},5.45,"Exon (ENSBGRT00000018579/ENSBGRG00000010097, exon 1 of 5)",12,58991493,58992244,752,1]
["chr12",59179162,59180112,951,"ENSBGRG00000011566","ENSBGRT00000021338",2638,"SPAG4","sperm associated antigen 4 [Source:HGNC Symbol;Acc:HGNC:11214]","NA","NA",{"v":0.011,"d":"0.01"},3,"50,116,75,","0,195,876",-1.95,-1.18,8.91,"Exon (ENSBGRT00000021338/ENSBGRG00000011566, exon 8 of 14)",12,59176524,59181059,4536,1]
["chr12",61350948,61351156,209,"ENSBGRG00000005781","ENSBGRT00000010718",172961,"CTNNBL1","catenin beta like 1 [Source:HGNC Symbol;Acc:HGNC:15879]","GO:0000974(Prp19 complex);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0005813(centrosome);GO:0005829(cytosol);GO:0016445(somatic diversification of immunoglobulins);GO:0019899(enzyme binding);GO:0043065(positive regulation of apoptotic process)","03040(Spliceosome)",{"v":2.5e-21,"d":"0.00"},1,"209,",0,{"v":-20.6,"d":"-20.60"},{"v":-19.7,"d":"-19.70"},4.46,"3' UTR",12,61177987,61352018,174032,1]
["chr12",70191369,70191429,61,"ENSBGRG00000018891","ENSBGRT00000034656",13,"ACOT8","acyl-CoA thioesterase 8 [Source:HGNC Symbol;Acc:HGNC:15919]","GO:0005777(peroxisome);GO:0005782(peroxisomal matrix);GO:0006637(acyl-CoA metabolic process);GO:0016290(palmitoyl-CoA hydrolase activity);GO:0016559(peroxisome fission);GO:0043649(dicarboxylic acid catabolic process);GO:0045225(negative regulation of CD4 biosynthetic process);GO:0047617(acyl-CoA hydrolase activity);GO:0052815(medium-chain acyl-CoA hydrolase activity)","00120(Primary bile acid biosynthesis);04146(Peroxisome)",{"v":0.0049,"d":"0.00"},1,"61,",0,-2.31,-1.76,2.75,"5' UTR",12,70171527,70191442,19916,2]
["chr12",75111420,75111597,178,"ENSBGRG00000005144","ENSBGRT00000009453",0,"MOCS3","molybdenum cofactor synthesis 3 [Source:HGNC Symbol;Acc:HGNC:15765]","GO:0002098(tRNA wobble uridine modification);GO:0002143(tRNA wobble position uridine thiolation);GO:0004792(thiosulfate sulfurtransferase activity);GO:0005829(cytosol);GO:0006777(Mo-molybdopterin cofactor biosynthetic process);GO:0008641(ubiquitin-like modifier activating enzyme activity);GO:0016779(nucleotidyltransferase activity);GO:0016783(sulfurtransferase activity);GO:0018192(enzyme active site formation via cysteine modification to L-cysteine persulfide);GO:0034227(tRNA thio-modification);GO:0042292(URM1 activating enzyme activity)","04122(Sulfur relay system)",{"v":3.3E-4,"d":"0.00"},1,"178,",0,-3.48,-2.86,3.76,"5' UTR",12,75111420,75114026,2607,1]
["chr12",84068741,84068800,60,"ENSBGRG00000009325","ENSBGRT00000017101",67527,"ESF1","ESF1 nucleolar pre-rRNA processing protein homolog [Source:HGNC Symbol;Acc:HGNC:15898]","GO:0005634(nucleus);GO:0006364(rRNA processing)","00450(Selenocompound metabolism);00970(Aminoacyl-tRNA biosynthesis)",{"v":0.0051,"d":"0.01"},1,"60,",0,-2.29,-1.74,1.44,"Exon (ENSBGRT00000017101/ENSBGRG00000009325, exon 13 of 13)",12,84001214,84068830,67617,1]
["chr12",7113080,7113321,242,"ENSBGRG00000013550","ENSBGRT00000025557",59,"ACBD5","acyl-CoA binding domain containing 5 [Source:HGNC Symbol;Acc:HGNC:23338]","GO:0000062(fatty-acyl-CoA binding);GO:0005654(nucleoplasm);GO:0005777(peroxisome);GO:0030242(autophagy of peroxisome)","00071(Fatty acid degradation);04146(Peroxisome)",{"v":0.029,"d":"0.03"},2,"15,46,","0,196",-1.54,-1.04,1.77,"5' UTR",12,7091447,7113380,21934,2]
["chr12",18344797,18348912,4116,"ENSBGRG00000012432","ENSBGRT00000022717",0,"ENSBGRG00000012432","NA","NA","NA",{"v":1.6E-13,"d":"0.00"},2,"137,71,","0,4045",{"v":-12.8,"d":"-12.80"},{"v":-11.9,"d":"-11.90"},3.23,"Exon (ENSBGRT00000022717/ENSBGRG00000012432, exon 1 of 2)",12,18345092,18372005,26914,1]
["chr12",19976961,19977648,688,"ENSBGRG00000013835","ENSBGRT00000025394",3902,"ENSBGRG00000013835","NA","NA","03040(Spliceosome);04141(Protein processing in endoplasmic reticulum);04144(Endocytosis)",{"v":3.2E-34,"d":"0.00"},1,"688,",0,{"v":-33.5,"d":"-33.50"},{"v":-32.5,"d":"-32.50"},4.47,"Exon (ENSBGRT00000025586/ENSBGRG00000013933, exon 2 of 2)",12,19973059,20001162,28104,1]
["chr12",28227113,28227173,61,"ENSBGRG00000003701","ENSBGRT00000007167",28028,"ENSBGRG00000003701","NA","NA","NA",{"v":1.6E-7,"d":"0.00"},2,"15,44,","0,17",{"v":-6.8,"d":"-6.80"},-6.07,3.05,"Exon (ENSBGRT00000007167/ENSBGRG00000003701, exon 13 of 15)",12,28227024,28255201,28178,2]
["chr12",33583895,33587307,3413,"ENSBGRG00000006986","ENSBGRT00000012884",30,"CD93","CD93 molecule [Source:HGNC Symbol;Acc:HGNC:15855]","GO:0001849(complement component C1q complex binding);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0009986(cell surface);GO:0031410(cytoplasmic vesicle);GO:0098609(cell-cell adhesion)","NA",{"v":7.9e-83,"d":"0.00"},4,"25,216,715,958,","0,264,1066,2455",{"v":-82.1,"d":"-82.10"},{"v":-80.7,"d":"-80.70"},7.38,"Exon (ENSBGRT00000012884/ENSBGRG00000006986, exon 1 of 4)",12,33583895,33587337,3443,2]
["chr12",40507323,40507502,180,"ENSBGRG00000007152","ENSBGRT00000013118",60,"LRRN4","leucine rich repeat neuronal 4 [Source:HGNC Symbol;Acc:HGNC:16208]","GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0007616(long-term memory);GO:0008542(visual learning)","NA",{"v":0.036,"d":"0.04"},1,"180,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000013118/ENSBGRG00000007152, exon 1 of 4)",12,40490194,40507562,17369,2]
["chr12",45203980,45204193,214,"ENSBGRG00000014361","ENSBGRT00000026379",10782,"IDH3B","isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta [Source:HGNC Symbol;Acc:HGNC:5385]","GO:0000287(magnesium ion binding);GO:0004449(isocitrate dehydrogenase (NAD+) activity);GO:0005739(mitochondrion);GO:0006099(tricarboxylic acid cycle);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0051287(NAD binding);GO:0055114(oxidation-reduction process)","00020(Citrate cycle (TCA cycle))",{"v":1.3e-05,"d":"0.00"},2,"14,46,","0,168",-4.89,-4.21,2,"5' UTR",12,45193198,45249312,56115,1]
["chr12",46816917,46817788,872,"ENSBGRG00000014398","ENSBGRT00000026670",15767,"TPD52L2","TPD52 like 2 [Source:HGNC Symbol;Acc:HGNC:12007]","GO:0003824(catalytic activity)","NA",{"v":2e-28,"d":"0.00"},2,"365,22,","0,850",{"v":-27.7,"d":"-27.70"},{"v":-26.7,"d":"-26.70"},1.62,"3' UTR",12,46815729,46833555,17827,2]
["chr12",51129156,51129215,60,"ENSBGRG00000008119","ENSBGRT00000015198",18289,"NPEPL1","aminopeptidase like 1 [Source:HGNC Symbol;Acc:HGNC:16244]","GO:0004177(aminopeptidase activity);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0008235(metalloexopeptidase activity);GO:0019538(protein metabolic process);GO:0030145(manganese ion binding)","NA",{"v":0.044,"d":"0.04"},1,"60,",0,-1.36,{"v":-0.879,"d":"-0.88"},1.23,"3' UTR",12,51128679,51147504,18826,2]
["chr12",55216958,55217378,421,"ENSBGRG00000016346","ENSBGRT00000029965",1962,"ENSBGRG00000016346","NA","GO:0042981(regulation of apoptotic process)","04014(Ras signaling pathway);04630(Jak-STAT signaling pathway);04064(NF-kappa B signaling pathway);04151(PI3K-Akt signaling pathway);04140(Autophagy - animal);04137(Mitophagy - animal);04210(Apoptosis);04215(Apoptosis - multiple species);04115(p53 signaling pathway);04621(NOD-like receptor signaling pathway);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05220(Chronic myeloid leukemia);05222(Small cell lung cancer);05014(Amyotrophic lateral sclerosis (ALS));05166(HTLV-I infection);05145(Toxoplasmosis);01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance)",{"v":2.2e-09,"d":"0.00"},1,"421,",0,-8.66,-7.88,9.91,"3' UTR",12,55216569,55219340,2772,2]
["chr12",55445205,55449672,4468,"ENSBGRG00000016804","ENSBGRT00000030915",2439,"PDRG1","p53 and DNA damage regulated 1 [Source:HGNC Symbol;Acc:HGNC:16119]","GO:0006457(protein folding);GO:0016272(prefoldin complex);GO:0051082(unfolded protein binding)","NA",{"v":1E-187,"d":"0.00"},4,"572,81,75,21,","0,1147,3313,4447",-187,-185,{"v":13.1,"d":"13.10"},"3' UTR",12,55445205,55452111,6907,2]
["chr12",58327547,58328384,838,"ENSBGRG00000007972","ENSBGRT00000014615",61290,"NCOA6","nuclear receptor coactivator 6 [Source:HGNC Symbol;Acc:HGNC:15936]","GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006352(DNA-templated transcription, initiation);GO:0006974(cellular response to DNA damage stimulus);GO:0019899(enzyme binding);GO:0030099(myeloid cell differentiation);GO:0030374(nuclear receptor transcription coactivator activity);GO:0035097(histone methyltransferase complex);GO:0043231(intracellular membrane-bounded organelle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046966(thyroid hormone receptor binding)","NA",{"v":4e-53,"d":"0.00"},1,"838,",0,{"v":-52.4,"d":"-52.40"},{"v":-51.2,"d":"-51.20"},2.53,"Exon (ENSBGRT00000014615/ENSBGRG00000007972, exon 11 of 15)",12,58302634,58389674,87041,2]
["chr12",61641356,61642911,1556,"ENSBGRG00000005996","ENSBGRT00000011113",12719,"TGM2","transglutaminase 2 [Source:HGNC Symbol;Acc:HGNC:11778]","GO:0003810(protein-glutamine gamma-glutamyltransferase activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0018149(peptide cross-linking);GO:0031226(intrinsic component of plasma membrane);GO:0032471(negative regulation of endoplasmic reticulum calcium ion concentration);GO:0043065(positive regulation of apoptotic process);GO:0043277(apoptotic cell clearance);GO:0045785(positive regulation of cell adhesion);GO:0051561(positive regulation of mitochondrial calcium ion concentration);GO:0060445(branching involved in salivary gland morphogenesis);GO:0060662(salivary gland cavitation)","05016(Huntington disease)",{"v":1.3E-11,"d":"0.00"},2,"169,11,","0,1545",{"v":-10.9,"d":"-10.90"},{"v":-10.1,"d":"-10.10"},1.17,"Exon (ENSBGRT00000011113/ENSBGRG00000005996, exon 6 of 11)",12,61628148,61655630,27483,2]
["chr12",70171527,70174512,2986,"ENSBGRG00000018891","ENSBGRT00000034744",16776,"ACOT8","acyl-CoA thioesterase 8 [Source:HGNC Symbol;Acc:HGNC:15919]","GO:0005777(peroxisome);GO:0005782(peroxisomal matrix);GO:0006637(acyl-CoA metabolic process);GO:0016290(palmitoyl-CoA hydrolase activity);GO:0016559(peroxisome fission);GO:0043649(dicarboxylic acid catabolic process);GO:0045225(negative regulation of CD4 biosynthetic process);GO:0047617(acyl-CoA hydrolase activity);GO:0052815(medium-chain acyl-CoA hydrolase activity)","00120(Primary bile acid biosynthesis);04146(Peroxisome)",{"v":1e-207,"d":"0.00"},3,"257,60,102,","0,2113,2884",-207,-205,5.38,"3' UTR",12,70171527,70191288,19762,2]
["chr12",73229314,73257781,28468,"ENSBGRG00000025224","ENSBGRT00000046766",10626,"STAU1","staufen double-stranded RNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:11370]","GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0030425(dendrite);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0044297(cell body);GO:0045070(positive regulation of viral genome replication);GO:0046726(positive regulation by virus of viral protein levels in host cell)","NA",{"v":1.4e-07,"d":"0.00"},3,"139,99,62,","0,13045,28406",-6.84,-6.11,1.78,"Exon (ENSBGRT00000046766/ENSBGRG00000025224, exon 3 of 12)",12,73221033,73268407,47375,2]
["chr12",77041630,77041929,300,"ENSBGRG00000005809","ENSBGRT00000010730",0,"ENSBGRG00000005809","NA","NA","NA",{"v":1.8e-06,"d":"0.00"},1,"300,",0,-5.74,-5.04,{"v":20.8,"d":"20.80"},"Exon (ENSBGRT00000010730/ENSBGRG00000005809, exon 1 of 2)",12,77038861,77041832,2972,2]
["chr12",86194466,86194526,61,"ENSBGRG00000009832","ENSBGRT00000018107",5898,"BTBD3","BTB domain containing 3 [Source:HGNC Symbol;Acc:HGNC:15854]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0021987(cerebral cortex development);GO:0042802(identical protein binding);GO:0048813(dendrite morphogenesis)","NA",{"v":1.1E-4,"d":"0.00"},1,"61,",0,-3.94,-3.31,{"v":1.4,"d":"1.40"},"3' UTR",12,86193567,86200424,6858,2]
["chr13",1975192,1976225,1034,"ENSBGRG00000005543","ENSBGRT00000010213",352,"ENSBGRG00000005543","NA","NA","NA",{"v":7.9e-51,"d":"0.00"},2,"496,474,","0,560",{"v":-50.1,"d":"-50.10"},{"v":-48.9,"d":"-48.90"},{"v":27.7,"d":"27.70"},"Exon (ENSBGRT00000010213/ENSBGRG00000005543, exon 1 of 2)",13,1974840,1976225,1386,1]
["chr13",4876110,4876229,120,"ENSBGRG00000014742","ENSBGRT00000027142",17787,"VPS26B","VPS26, retromer complex component B [Source:HGNC Symbol;Acc:HGNC:28119]","GO:0006886(intracellular protein transport)","04144(Endocytosis)",{"v":2e-07,"d":"0.00"},1,"120,",0,{"v":-6.7,"d":"-6.70"},-5.97,1.74,"Exon (ENSBGRT00000027142/ENSBGRG00000014742, exon 7 of 7)",13,4858323,4877301,18979,1]
["chr13",9853948,9892793,38846,"ENSBGRG00000011464","ENSBGRT00000021038",196340,"METTL15","methyltransferase like 15 [Source:HGNC Symbol;Acc:HGNC:26606]","GO:0008168(methyltransferase activity)","NA",{"v":1e-11,"d":"0.00"},3,"169,44,532,","0,35967,38314",-11,{"v":-10.1,"d":"-10.10"},7.04,"3' UTR",13,9657608,9889958,232351,1]
["chr13",13369274,13441248,71975,"ENSBGRG00000012396","ENSBGRT00000022688",119,"DNAJC24","DnaJ heat shock protein family (Hsp40) member C24 [Source:HGNC Symbol;Acc:HGNC:26979]","GO:0001671(ATPase activator activity);GO:0008198(ferrous iron binding);GO:0008270(zinc ion binding);GO:0032781(positive regulation of ATPase activity)","NA",{"v":2.6E-7,"d":"0.00"},4,"62,113,139,44,","0,927,59608,71931",-6.58,-5.86,2.27,"Exon (ENSBGRT00000022688/ENSBGRG00000012396, exon 1 of 5)",13,13369155,13449820,80666,1]
["chr13",17339925,17472200,132276,"ENSBGRG00000020517","ENSBGRT00000039435",88083,"CD44","CD44 molecule (Indian blood group) [Source:HGNC Symbol;Acc:HGNC:1681]","GO:0004896(cytokine receptor activity);GO:0005540(hyaluronic acid binding);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0009986(cell surface);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0016477(cell migration);GO:0030214(hyaluronan catabolic process);GO:0031258(lamellipodium membrane);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034116(positive regulation of heterotypic cell-cell adhesion);GO:0035692(macrophage migration inhibitory factor receptor complex);GO:0042110(T cell activation);GO:0042995(cell projection);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0044319(wound healing, spreading of cells);GO:0044344(cellular response to fibroblast growth factor stimulus);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051216(cartilage development);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070487(monocyte aggregation);GO:1900625(positive regulation of monocyte aggregation);GO:1902166(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:2000392(regulation of lamellipodium morphogenesis)","04512(ECM-receptor interaction);04640(Hematopoietic cell lineage);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05169(Epstein-Barr virus infection)",{"v":1e-178,"d":"0.00"},3,"31,249,79,","0,9666,132197",-178,-176,2.61,"3' UTR",13,17251842,17349839,97998,1]
["chr13",27942346,27989210,46865,"ENSBGRG00000008834","ENSBGRT00000016181",48765,"PRDM11","PR/SET domain 11 [Source:HGNC Symbol;Acc:HGNC:13996]","GO:0005515(protein binding)","00310(Lysine degradation)",{"v":6.3e-26,"d":"0.00"},5,"67,68,422,560,114,","0,28736,33306,36745,46751",{"v":-25.2,"d":"-25.20"},{"v":-24.2,"d":"-24.20"},8.72,"Exon (ENSBGRT00000016181/ENSBGRG00000008834, exon 4 of 7)",13,27893581,27979650,86070,1]
["chr13",32725669,32725818,150,"ENSBGRG00000003748","ENSBGRT00000006935",30,"PGM2L1","phosphoglucomutase 2 like 1 [Source:HGNC Symbol;Acc:HGNC:20898]","GO:0005975(carbohydrate metabolic process);GO:0016868(intramolecular transferase activity, phosphotransferases);GO:0047933(glucose-1,6-bisphosphate synthase activity);GO:0071704(organic substance metabolic process)","00500(Starch and sucrose metabolism)",0.02,1,"150,",0,{"v":-1.7,"d":"-1.70"},-1.19,6.93,"5' UTR",13,32725639,32785560,59922,1]
["chr13",35078292,35082358,4067,"ENSBGRG00000009339","ENSBGRT00000017443",53380,"NUMA1","nuclear mitotic apparatus protein 1 [Source:HGNC Symbol;Acc:HGNC:8059]","GO:0000132(establishment of mitotic spindle orientation);GO:0000139(Golgi membrane);GO:0000922(spindle pole);GO:0001578(microtubule bundle formation);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005876(spindle microtubule);GO:0005938(cell cortex);GO:0008017(microtubule binding);GO:0008022(protein C-terminus binding);GO:0015631(tubulin binding);GO:0016363(nuclear matrix);GO:0019897(extrinsic component of plasma membrane);GO:0019904(protein domain specific binding);GO:0030513(positive regulation of BMP signaling pathway);GO:0030953(astral microtubule organization);GO:0031116(positive regulation of microtubule polymerization);GO:0031616(spindle pole centrosome);GO:0032388(positive regulation of intracellular transport);GO:0032991(protein-containing complex);GO:0035091(phosphatidylinositol binding);GO:0035371(microtubule plus-end);GO:0036449(microtubule minus-end);GO:0044877(protein-containing complex binding);GO:0045618(positive regulation of keratinocyte differentiation);GO:0051010(microtubule plus-end binding);GO:0051011(microtubule minus-end binding);GO:0051798(positive regulation of hair follicle development);GO:0051984(positive regulation of chromosome segregation);GO:0055028(cortical microtubule);GO:0055048(anastral spindle assembly);GO:0060236(regulation of mitotic spindle organization);GO:0061673(mitotic spindle astral microtubule);GO:0070840(dynein complex binding);GO:0072686(mitotic spindle);GO:0090235(regulation of metaphase plate congression);GO:0097427(microtubule bundle);GO:0097431(mitotic spindle pole);GO:0097575(lateral cell cortex);GO:0097718(disordered domain specific binding);GO:0099738(cell cortex region);GO:1902365(positive regulation of protein localization to spindle pole body);GO:1902846(positive regulation of mitotic spindle elongation);GO:1904778(positive regulation of protein localization to cell cortex);GO:1905720(cytoplasmic microtubule bundle);GO:1905820(positive regulation of chromosome separation);GO:1905832(positive regulation of spindle assembly);GO:1990023(mitotic spindle midzone)","NA",{"v":9.99999999999999e-198,"d":"0.00"},5,"448,42,69,117,133,","0,895,2348,3735,3934",-197,-196,2.33,"Exon (ENSBGRT00000017443/ENSBGRG00000009339, exon 17 of 28)",13,35024912,35090096,65185,1]
["chr13",39741723,39742237,515,"ENSBGRG00000005243","ENSBGRT00000009704",13274,"ZNF215","zinc finger protein 215 [Source:HGNC Symbol;Acc:HGNC:13007]","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":3.3E-3,"d":"0.00"},2,"291,185,","0,330",-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000009704/ENSBGRG00000005243, exon 4 of 5)",13,39728449,39742237,13789,1]
["chr13",43538440,43538529,90,"ENSBGRG00000004160","ENSBGRT00000007690",119,"ADM","adrenomedullin [Source:HGNC Symbol;Acc:HGNC:259]","GO:0001570(vasculogenesis);GO:0001843(neural tube closure);GO:0002031(G protein-coupled receptor internalization);GO:0003073(regulation of systemic arterial blood pressure);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007507(heart development);GO:0008284(positive regulation of cell population proliferation);GO:0010460(positive regulation of heart rate);GO:0031623(receptor internalization);GO:0031700(adrenomedullin receptor binding);GO:0035809(regulation of urine volume);GO:0043116(negative regulation of vascular permeability);GO:0045766(positive regulation of angiogenesis);GO:0045906(negative regulation of vasoconstriction);GO:0048589(developmental growth);GO:0060670(branching involved in labyrinthine layer morphogenesis);GO:0060712(spongiotrophoblast layer development);GO:0097084(vascular smooth muscle cell development);GO:0097647(amylin receptor signaling pathway);GO:1990410(adrenomedullin receptor signaling pathway);GO:2001214(positive regulation of vasculogenesis)","04270(Vascular smooth muscle contraction)",0.02,1,"90,",0,{"v":-1.7,"d":"-1.70"},-1.19,4.95,"5' UTR",13,43538321,43541675,3355,1]
["chr13",47178902,47179411,510,"ENSBGRG00000006818","ENSBGRT00000012575",1384,"ENSBGRG00000006818","NA","NA","NA",{"v":1.6e-14,"d":"0.00"},1,"510,",0,{"v":-13.8,"d":"-13.80"},{"v":-12.9,"d":"-12.90"},2.76,"3' UTR",13,47177518,47179441,1924,1]
["chr13",48521566,48523249,1684,"ENSBGRG00000007548","ENSBGRT00000014287",175475,"PDE3B","phosphodiesterase 3B [Source:HGNC Symbol;Acc:HGNC:8779]","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0007162(negative regulation of cell adhesion);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0016020(membrane);GO:0016525(negative regulation of angiogenesis);GO:0032045(guanyl-nucleotide exchange factor complex);GO:0050995(negative regulation of lipid catabolic process)","00230(Purine metabolism);04371(Apelin signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04923(Regulation of lipolysis in adipocyte);04914(Progesterone-mediated oocyte maturation);04924(Renin secretion);05032(Morphine addiction)",{"v":2.5e-47,"d":"0.00"},2,"15,466,","0,1218",{"v":-46.6,"d":"-46.60"},{"v":-45.4,"d":"-45.40"},6.19,"3' UTR",13,48346091,48523998,177908,1]
["chr13",57537051,57537628,578,"ENSBGRG00000015232","ENSBGRT00000027949",726,"C1QTNF5","C1q and TNF related 5 [Source:HGNC Symbol;Acc:HGNC:14344]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0005923(bicellular tight junction);GO:0009306(protein secretion);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0016328(lateral plasma membrane);GO:0030133(transport vesicle);GO:0032991(protein-containing complex);GO:0042802(identical protein binding);GO:0042995(cell projection);GO:0048839(inner ear development)","04152(AMPK signaling pathway);04920(Adipocytokine signaling pathway);03320(PPAR signaling pathway);04211(Longevity regulating pathway - mammal);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":1.8E-3,"d":"0.00"},2,"227,12,","0,566",-2.74,-2.16,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000027949/ENSBGRG00000015232, exon 2 of 3)",13,57536325,57538520,2196,1]
["chr13",59813028,59814091,1064,"ENSBGRG00000025271","ENSBGRT00000046740",32086,"PCSK7","proprotein convertase subtilisin/kexin type 7 [Source:HGNC Symbol;Acc:HGNC:8748]","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0016485(protein processing);GO:0030173(integral component of Golgi membrane)","NA",{"v":1e-143,"d":"0.00"},2,"10,797,","0,267",-143,-142,7.64,"3' UTR",13,59780942,59814659,33718,1]
["chr13",70660554,70660823,270,"ENSBGRG00000013750","ENSBGRT00000025423",119897,"EXPH5","exophilin 5 [Source:HGNC Symbol;Acc:HGNC:30578]","GO:0003334(keratinocyte development);GO:0005768(endosome);GO:0006886(intracellular protein transport);GO:0017137(Rab GTPase binding);GO:0045921(positive regulation of exocytosis);GO:0050714(positive regulation of protein secretion);GO:0071985(multivesicular body sorting pathway)","NA",{"v":0.0062,"d":"0.01"},1,"270,",0,-2.21,-1.67,9.91,"Exon (ENSBGRT00000025423/ENSBGRG00000013750, exon 7 of 7)",13,70540657,70660823,120167,1]
["chr13",74798892,74800961,2070,"ENSBGRG00000012542","ENSBGRT00000023936",39711,"CEP57","centrosomal protein 57 [Source:HGNC Symbol;Acc:HGNC:30794]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005874(microtubule);GO:0007286(spermatid development);GO:0008017(microtubule binding);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0017134(fibroblast growth factor binding);GO:0034453(microtubule anchoring);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043015(gamma-tubulin binding);GO:0051260(protein homooligomerization)","NA",{"v":2.5e-95,"d":"0.00"},3,"46,145,200,","0,596,1870",{"v":-94.6,"d":"-94.60"},{"v":-93.1,"d":"-93.10"},2.91,"Exon (ENSBGRT00000023936/ENSBGRG00000012542, exon 9 of 11)",13,74759181,74801470,42290,1]
["chr13",1686984,1709860,22877,"ENSBGRG00000004747","ENSBGRT00000008771",2422,"TNKS1BP1","tankyrase 1 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:19081]","GO:0005634(nucleus);GO:0005720(nuclear heterochromatin);GO:0005737(cytoplasm);GO:0005912(adherens junction);GO:0006302(double-strand break repair);GO:0010800(positive regulation of peptidyl-threonine phosphorylation);GO:0019899(enzyme binding);GO:0030014(CCR4-NOT complex);GO:0031954(positive regulation of protein autophosphorylation);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0044877(protein-containing complex binding);GO:0071479(cellular response to ionizing radiation);GO:0071532(ankyrin repeat binding)","NA",0,7,"84,713,1305,1137,521,74,355,","0,6902,8183,12225,14008,21024,22522",-912,"-Inf",{"v":50.5,"d":"50.50"},"Exon (ENSBGRT00000008771/ENSBGRG00000004747, exon 3 of 13)",13,1685158,1712282,27125,2]
["chr13",3758270,3758684,415,"ENSBGRG00000011869","ENSBGRT00000021789",9,"ENSBGRG00000011869","NA","GO:0004930(G protein-coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","04740(Olfactory transduction)",0.02,2,"191,14,","0,401",-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000021789/ENSBGRG00000011869, exon 1 of 3)",13,3757531,3758693,1163,2]
["chr13",11793087,11793413,327,"ENSBGRG00000011603","ENSBGRT00000021117",828,"KCNA4","potassium voltage-gated channel subfamily A member 4 [Source:HGNC Symbol;Acc:HGNC:6222]","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030955(potassium ion binding);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport);GO:0071805(potassium ion transmembrane transport)","04927(Cortisol synthesis and secretion);04934(Cushing syndrome)",{"v":4.6e-09,"d":"0.00"},1,"327,",0,-8.34,-7.57,{"v":31.7,"d":"31.70"},"Exon (ENSBGRT00000021117/ENSBGRG00000011603, exon 1 of 1)",13,11792259,11794241,1983,2]
["chr13",15129043,15153359,24317,"ENSBGRG00000017836","ENSBGRT00000032966",0,"CSTF3","cleavage stimulation factor subunit 3 [Source:HGNC Symbol;Acc:HGNC:2485]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006396(RNA processing);GO:0006397(mRNA processing)","03015(mRNA surveillance pathway)",{"v":4e-11,"d":"0.00"},3,"22,102,27,","0,144,24290",{"v":-10.4,"d":"-10.40"},-9.64,3.09,"Exon (ENSBGRT00000032966/ENSBGRG00000017836, exon 1 of 22)",13,15072209,15153359,81151,2]
["chr13",29437583,29438691,1109,"ENSBGRG00000012979","ENSBGRT00000023793",4003,"AMBRA1","autophagy and beclin 1 regulator 1 [Source:HGNC Symbol;Acc:HGNC:25990]","GO:0000045(autophagosome assembly);GO:0000422(autophagy of mitochondrion);GO:0000423(mitophagy);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005930(axoneme);GO:0006914(autophagy);GO:0008285(negative regulation of cell population proliferation);GO:0021915(neural tube development);GO:0031625(ubiquitin protein ligase binding);GO:0043524(negative regulation of neuron apoptotic process);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0045335(phagocytic vesicle);GO:0051020(GTPase binding);GO:0098780(response to mitochondrial depolarisation)","04140(Autophagy - animal);04137(Mitophagy - animal)",{"v":3.2e-48,"d":"0.00"},1,"1109,",0,{"v":-47.5,"d":"-47.50"},{"v":-46.3,"d":"-46.30"},6.01,"Exon (ENSBGRT00000023793/ENSBGRG00000012979, exon 6 of 18)",13,29273494,29442694,169201,2]
["chr13",32162359,32176374,14016,"ENSBGRG00000024225","ENSBGRT00000044739",120,"NEU3","neuraminidase 3 [Source:HGNC Symbol;Acc:HGNC:7760]","GO:0004308(exo-alpha-sialidase activity);GO:0005886(plasma membrane);GO:0005975(carbohydrate metabolic process);GO:0006689(ganglioside catabolic process);GO:0009313(oligosaccharide catabolic process);GO:0016997(alpha-sialidase activity)","00600(Sphingolipid metabolism);00511(Other glycan degradation)",{"v":3.2e-57,"d":"0.00"},3,"1549,212,4,","0,8557,14012",{"v":-56.5,"d":"-56.50"},{"v":-55.3,"d":"-55.30"},9.91,"3' UTR",13,32161881,32176494,14614,2]
["chr13",35432740,35432999,260,"ENSBGRG00000011947","ENSBGRT00000021818",230,"RHOG","ras homolog family member G [Source:HGNC Symbol;Acc:HGNC:672]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007264(small GTPase mediated signal transduction);GO:0007266(Rho protein signal transduction);GO:0016601(Rac protein signal transduction);GO:0030036(actin cytoskeleton organization);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060326(cell chemotaxis);GO:0090630(activation of GTPase activity);GO:1900027(regulation of ruffle assembly);GO:1903078(positive regulation of protein localization to plasma membrane)","05132(Salmonella infection);05100(Bacterial invasion of epithelial cells)",{"v":2.5e-18,"d":"0.00"},1,"260,",0,{"v":-17.6,"d":"-17.60"},{"v":-16.6,"d":"-16.60"},2.33,"Exon (ENSBGRT00000021818/ENSBGRG00000011947, exon 1 of 1)",13,35432654,35433229,576,2]
["chr13",39102063,39105340,3278,"ENSBGRG00000004714","ENSBGRT00000009014",23309,"ENSBGRG00000004714","NA","NA","04392(Hippo signaling pathway - multiple species)",{"v":9.99999999999998e-260,"d":"0.00"},2,"1863,741,","0,2537",-259,-257,{"v":11.5,"d":"11.50"},"Exon (ENSBGRT00000009014/ENSBGRG00000004714, exon 25 of 26)",13,39102063,39128649,26587,2]
["chr13",43871582,43879630,8049,"ENSBGRG00000004494","ENSBGRT00000008920",131044,"IRAG1","murine retrovirus integration site 1 homolog [Source:HGNC Symbol;Acc:HGNC:7237]","NA","04022(cGMP - PKG signaling pathway);04270(Vascular smooth muscle contraction)",{"v":1e-114,"d":"0.00"},3,"244,135,67,","0,6519,7982",-114,-112,3.43,"Exon (ENSBGRT00000008920/ENSBGRG00000004494, exon 20 of 22)",13,43871582,44010674,139093,2]
["chr13",51650691,51651259,569,"ENSBGRG00000009694","ENSBGRT00000017823",0,"KCNJ11","potassium inwardly rectifying channel subfamily J member 11 [Source:HGNC Symbol;Acc:HGNC:6257]","GO:0005242(inward rectifier potassium channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005886(plasma membrane);GO:0006006(glucose metabolic process);GO:0006813(potassium ion transport);GO:0008282(inward rectifying potassium channel);GO:0015272(ATP-activated inward rectifier potassium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030506(ankyrin binding);GO:0033198(response to ATP);GO:0042391(regulation of membrane potential);GO:0042493(response to drug);GO:0044325(ion channel binding);GO:0046676(negative regulation of insulin secretion);GO:0050796(regulation of insulin secretion);GO:0050877(nervous system process);GO:0071805(potassium ion transmembrane transport)","04911(Insulin secretion);04930(Type II diabetes mellitus)",{"v":5.1e-06,"d":"0.00"},1,"569,",0,-5.29,{"v":-4.6,"d":"-4.60"},{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000017823/ENSBGRG00000009694, exon 1 of 2)",13,51649554,51651259,1706,2]
["chr13",56371263,56371651,389,"ENSBGRG00000013401","ENSBGRT00000024869",28402,"POU2F3","POU class 2 homeobox 3 [Source:HGNC Symbol;Acc:HGNC:19864]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0016604(nuclear body);GO:0043565(sequence-specific DNA binding);GO:0043922(negative regulation by host of viral transcription);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.00015,"d":"0.00"},1,"389,",0,-3.83,{"v":-3.2,"d":"-3.20"},{"v":15.8,"d":"15.80"},"3' UTR",13,56370457,56400053,29597,2]
["chr13",57585624,57587269,1646,"ENSBGRG00000015641","ENSBGRT00000029469",92701,"CBL","Cbl proto-oncogene [Source:HGNC Symbol;Acc:HGNC:1541]","GO:0001784(phosphotyrosine residue binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007166(cell surface receptor signaling pathway);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016600(flotillin complex);GO:0017124(SH3 domain binding);GO:0023051(regulation of signaling);GO:0032487(regulation of Rap protein signal transduction);GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway);GO:0043066(negative regulation of apoptotic process);GO:0046875(ephrin receptor binding);GO:0048260(positive regulation of receptor-mediated endocytosis);GO:2000583(regulation of platelet-derived growth factor receptor-alpha signaling pathway)","04120(Ubiquitin mediated proteolysis);04012(ErbB signaling pathway);04144(Endocytosis);04910(Insulin signaling pathway);05200(Pathways in cancer);05205(Proteoglycans in cancer);05220(Chronic myeloid leukemia);05100(Bacterial invasion of epithelial cells)",{"v":1E-10,"d":"0.00"},2,"653,6,","0,1640",-10,-9.23,3.52,"3' UTR",13,57584996,57679970,94975,2]
["chr13",58362839,58364637,1799,"ENSBGRG00000021523","ENSBGRT00000040709",31795,"ENSBGRG00000021523","NA","NA","00310(Lysine degradation);05202(Transcriptional misregulation in cancers);04934(Cushing syndrome)",{"v":2.5e-48,"d":"0.00"},2,"988,152,","0,1647",{"v":-47.6,"d":"-47.60"},{"v":-46.4,"d":"-46.40"},3.99,"Exon (ENSBGRT00000040709/ENSBGRG00000021523, exon 30 of 41)",13,58345665,58396432,50768,2]
["chr13",59736887,59772879,35993,"ENSBGRG00000025266","ENSBGRT00000046699",0,"ENSBGRG00000025266","NA","NA","NA",{"v":6.3e-63,"d":"0.00"},6,"72,97,140,141,60,87,","0,275,28553,31750,35133,35906",{"v":-62.2,"d":"-62.20"},{"v":-60.9,"d":"-60.90"},2.56,"Exon (ENSBGRT00000046699/ENSBGRG00000025266, exon 1 of 1)",13,59749821,59749958,138,1]
["chr13",66114393,66116114,1722,"ENSBGRG00000009255","ENSBGRT00000017106",32409,"DIXDC1","DIX domain containing 1 [Source:HGNC Symbol;Acc:HGNC:23695]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0016055(Wnt signaling pathway);GO:0019904(protein domain specific binding);GO:0021795(cerebral cortex cell migration);GO:0021799(cerebral cortex radially oriented cell migration);GO:0021846(cell proliferation in forebrain);GO:0021869(forebrain ventricular zone progenitor cell division);GO:0030177(positive regulation of Wnt signaling pathway);GO:0032956(regulation of actin cytoskeleton organization);GO:0043015(gamma-tubulin binding);GO:0045665(negative regulation of neuron differentiation);GO:0060070(canonical Wnt signaling pathway);GO:0070507(regulation of microtubule cytoskeleton organization)","04310(Wnt signaling pathway);04330(Notch signaling pathway);04150(mTOR signaling pathway);04916(Melanogenesis)",{"v":1.8e-06,"d":"0.00"},2,"51,10,","0,1712",-5.74,-5.04,2.13,"Exon (ENSBGRT00000017106/ENSBGRG00000009255, exon 15 of 16)",13,66114363,66148523,34161,2]
["chr13",75127455,75127574,120,"ENSBGRG00000013332","ENSBGRT00000024618",110,"MAML2","mastermind like transcriptional coactivator 2 [Source:HGNC Symbol;Acc:HGNC:16259]","GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0007219(Notch signaling pathway);GO:0016607(nuclear speck);GO:0045944(positive regulation of transcription by RNA polymerase II)","04330(Notch signaling pathway);04658(Th1 and Th2 cell differentiation);05165(Human papillomavirus infection)",{"v":0.034,"d":"0.03"},1,"120,",0,-1.47,{"v":-0.977,"d":"-0.98"},4.46,"Exon (ENSBGRT00000024618/ENSBGRG00000013332, exon 1 of 5)",13,74978710,75127684,148975,2]
["chr14",13112179,13113602,1424,"ENSBGRG00000004811","ENSBGRT00000008859",76418,"KCTD3","potassium channel tetramerization domain containing 3 [Source:HGNC Symbol;Acc:HGNC:21305]","GO:0005515(protein binding);GO:0051260(protein homooligomerization)","NA",{"v":1E-194,"d":"0.00"},3,"12,133,541,","0,97,883",-194,-192,5.11,"Exon (ENSBGRT00000008859/ENSBGRG00000004811, exon 16 of 18)",14,13035761,13113632,77872,1]
["chr14",21248555,21248703,149,"ENSBGRG00000008569","ENSBGRT00000015720",59,"BROX","BRO1 domain and CAAX motif containing [Source:HGNC Symbol;Acc:HGNC:26512]","NA","NA",{"v":0.023,"d":"0.02"},1,"149,",0,-1.64,-1.13,2.55,"5' UTR",14,21248496,21269470,20975,1]
["chr14",25417180,25417959,780,"ENSBGRG00000005906","ENSBGRT00000010897",24767,"COQ8A","coenzyme Q8A [Source:HGNC Symbol;Acc:HGNC:16812]","GO:0005739(mitochondrion);GO:0006744(ubiquinone biosynthetic process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0043531(ADP binding)","NA",{"v":0.0021,"d":"0.00"},2,"125,472,","0,308",-2.67,-2.09,9.91,"3' UTR",14,25392413,25418019,25607,1]
["chr14",26358838,26362324,3487,"ENSBGRG00000006812","ENSBGRT00000012714",18043,"TFB2M","transcription factor B2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:18559]","GO:0000154(rRNA modification);GO:0000179(rRNA (adenine-N6,N6-)-dimethyltransferase activity);GO:0003712(transcription coregulator activity);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006355(regulation of transcription, DNA-templated);GO:0006390(mitochondrial transcription);GO:0006391(transcription initiation from mitochondrial promoter);GO:0008649(rRNA methyltransferase activity);GO:0031167(rRNA methylation);GO:0034246(mitochondrial sequence-specific DNA-binding transcription factor activity);GO:0042645(mitochondrial nucleoid)","NA",{"v":5E-36,"d":"0.00"},2,"119,212,","0,3275",{"v":-35.3,"d":"-35.30"},{"v":-34.3,"d":"-34.30"},7.92,"3' UTR",14,26340795,26362846,22052,1]
["chr14",33774144,33775197,1054,"ENSBGRG00000004950","ENSBGRT00000009470",51103,"C1orf112","chromosome 1 open reading frame 112 [Source:HGNC Symbol;Acc:HGNC:25565]","NA","NA",{"v":3.2E-51,"d":"0.00"},2,"6,562,","0,492",{"v":-50.5,"d":"-50.50"},{"v":-49.3,"d":"-49.30"},4.46,"3' UTR",14,33723041,33774928,51888,1]
["chr14",36733016,36741211,8196,"ENSBGRG00000007038","ENSBGRT00000012970",1712,"FASLG","Fas ligand [Source:HGNC Symbol;Acc:HGNC:11936]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005164(tumor necrosis factor receptor binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006955(immune response);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016525(negative regulation of angiogenesis);GO:0043065(positive regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0046666(retinal cell programmed cell death);GO:0070062(extracellular exosome);GO:0070231(T cell apoptotic process);GO:0070266(necroptotic process);GO:0097190(apoptotic signaling pathway);GO:0097191(extrinsic apoptotic signaling pathway);GO:0097527(necroptotic signaling pathway);GO:1903514(release of sequestered calcium ion into cytosol by endoplasmic reticulum);GO:2000353(positive regulation of endothelial cell apoptotic process)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04068(FoxO signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04210(Apoptosis);04217(Necroptosis);04650(Natural killer cell mediated cytotoxicity);04722(Neurotrophin signaling pathway);05200(Pathways in cancer);05205(Proteoglycans in cancer);05320(Autoimmune thyroid disease);05330(Allograft rejection);05332(Graft-versus-host disease);04940(Type I diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));05162(Measles);05164(Influenza A);05161(Hepatitis B);05168(Herpes simplex infection);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05142(Chagas disease (American trypanosomiasis));05143(African trypanosomiasis);01524(Platinum drug resistance)",{"v":3.2e-06,"d":"0.00"},4,"33,46,57,428,","0,610,6459,7768",{"v":-5.5,"d":"-5.50"},-4.81,{"v":21.8,"d":"21.80"},"3' UTR",14,36731304,36741803,10500,1]
["chr14",40866859,40867513,655,"ENSBGRG00000013801","ENSBGRT00000025277",82324,"CLSTN1","calsyntenin 1 [Source:HGNC Symbol;Acc:HGNC:17447]","GO:0001540(amyloid-beta binding);GO:0001558(regulation of cell growth);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0009986(cell surface);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019894(kinesin binding);GO:0042988(X11-like protein binding);GO:0045211(postsynaptic membrane);GO:0050806(positive regulation of synaptic transmission);GO:0051965(positive regulation of synapse assembly);GO:0090128(regulation of synapse maturation);GO:0098969(neurotransmitter receptor transport to postsynaptic membrane);GO:0098978(glutamatergic synapse);GO:0099003(vesicle-mediated transport in synapse)","NA",{"v":1E-150,"d":"0.00"},2,"116,274,","0,381",-150,-149,2.04,"3' UTR",14,40784535,40867902,83368,1]
["chr14",44641773,44642129,357,"ENSBGRG00000017258","ENSBGRT00000031651",787,"GPR153","G protein-coupled receptor 153 [Source:HGNC Symbol;Acc:HGNC:23618]","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","NA",{"v":4.6E-6,"d":"0.00"},1,"357,",0,-5.34,-4.65,3.04,"Exon (ENSBGRT00000031651/ENSBGRG00000017258, exon 2 of 5)",14,44640986,44648571,7586,1]
["chr14",49060517,49069179,8663,"ENSBGRG00000024526","ENSBGRT00000045747",0,"ENSBGRG00000024526","NA","GO:0001824(blastocyst development);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006468(protein phosphorylation);GO:0007088(regulation of mitotic nuclear division);GO:2001234(negative regulation of apoptotic signaling pathway)","NA",{"v":5e-20,"d":"0.00"},3,"97,124,50,","0,8415,8613",{"v":-19.3,"d":"-19.30"},{"v":-18.4,"d":"-18.40"},2.05,"5' UTR",14,49069168,49087672,18505,1]
["chr14",49396140,49399466,3327,"ENSBGRG00000014450","ENSBGRT00000026599",268,"SDF4","stromal cell derived factor 4 [Source:HGNC Symbol;Acc:HGNC:24188]","GO:0005509(calcium ion binding);GO:0005770(late endosome);GO:0005794(Golgi apparatus);GO:0005796(Golgi lumen);GO:0045444(fat cell differentiation)","NA",{"v":0.00037,"d":"0.00"},2,"85,35,","0,3292",-3.43,-2.81,1.22,"Exon (ENSBGRT00000026599/ENSBGRG00000014450, exon 1 of 7)",14,49395872,49409550,13679,1]
["chr14",54954955,54955584,630,"ENSBGRG00000004812","ENSBGRT00000008893",12784,"CACYBP","calcyclin binding protein [Source:HGNC Symbol;Acc:HGNC:30423]","GO:0005641(nuclear envelope lumen);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0015631(tubulin binding);GO:0019005(SCF ubiquitin ligase complex);GO:0019904(protein domain specific binding);GO:0030877(beta-catenin destruction complex);GO:0031625(ubiquitin protein ligase binding);GO:0042803(protein homodimerization activity);GO:0044548(S100 protein binding);GO:1990830(cellular response to leukemia inhibitory factor)","04310(Wnt signaling pathway)",{"v":2E-92,"d":"0.00"},2,"18,162,","0,468",{"v":-91.7,"d":"-91.70"},{"v":-90.2,"d":"-90.20"},3.48,"3' UTR",14,54942171,54954972,12802,1]
["chr14",59650270,59650774,505,"ENSBGRG00000008050","ENSBGRT00000014813",33392,"FAM20B","FAM20B glycosaminoglycan xylosylkinase [Source:HGNC Symbol;Acc:HGNC:23017]","GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0016773(phosphotransferase activity, alcohol group as acceptor)","NA",{"v":1.6e-93,"d":"0.00"},1,"505,",0,{"v":-92.8,"d":"-92.80"},{"v":-91.4,"d":"-91.40"},5.55,"3' UTR",14,59616878,59650922,34045,1]
["chr14",60833776,60836700,2925,"ENSBGRG00000010947","ENSBGRT00000019994",51682,"LHX4","LIM homeobox 4 [Source:HGNC Symbol;Acc:HGNC:21734]","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001890(placenta development);GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0008045(motor neuron axon guidance);GO:0008327(methyl-CpG binding);GO:0009887(animal organ morphogenesis);GO:0021526(medial motor column neuron differentiation);GO:0043066(negative regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":4.2e-05,"d":"0.00"},3,"123,172,125,","0,512,2800",-4.38,-3.73,{"v":17.8,"d":"17.80"},"Exon (ENSBGRT00000019994/ENSBGRG00000010947, exon 4 of 6)",14,60782094,60836970,54877,1]
["chr14",66099981,66115122,15142,"ENSBGRG00000016059","ENSBGRT00000029823",2138,"SWT1","SWT1 RNA endoribonuclease homolog [Source:HGNC Symbol;Acc:HGNC:16785]","NA","03015(mRNA surveillance pathway)",{"v":1.6E-15,"d":"0.00"},3,"40,59,706,","0,11815,14436",{"v":-14.8,"d":"-14.80"},{"v":-13.9,"d":"-13.90"},9.91,"Exon (ENSBGRT00000029823/ENSBGRG00000016059, exon 2 of 18)",14,66097843,66209201,111359,1]
["chr14",72248295,72281436,33142,"ENSBGRG00000022090","ENSBGRT00000040791",56254,"LPGAT1","lysophosphatidylglycerol acyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:28985]","GO:0005737(cytoplasm);GO:0016746(transferase activity, transferring acyl groups);GO:0045723(positive regulation of fatty acid biosynthetic process)","00564(Glycerophospholipid metabolism)",{"v":2.5e-73,"d":"0.00"},3,"3,107,519,","0,28191,32623",{"v":-72.6,"d":"-72.60"},{"v":-71.3,"d":"-71.30"},6.12,"3' UTR",14,72192041,72282094,90054,1]
["chr14",76577919,76578008,90,"ENSBGRG00000024571","ENSBGRT00000045356",25733,"ENSBGRG00000024571","CD34 molecule [Source:HGNC Symbol;Acc:HGNC:1662]","GO:0007155(cell adhesion);GO:0016020(membrane)","04514(Cell adhesion molecules (CAMs));04640(Hematopoietic cell lineage)",{"v":0.00018,"d":"0.00"},1,"90,",0,-3.75,-3.12,2.84,"3' UTR",14,76552186,76578008,25823,1]
["chr14",81785674,81785734,61,"ENSBGRG00000025542","ENSBGRT00000047214",54949,"ENSBGRG00000025542","NA","GO:0005544(calcium-dependent phospholipid binding);GO:0007269(neurotransmitter secretion);GO:0008021(synaptic vesicle);GO:0016020(membrane)","NA",{"v":0.00085,"d":"0.00"},1,"61,",0,-3.07,-2.48,2.14,"3' UTR",14,81730725,81785823,55099,1]
["chr14",83786571,83786840,270,"ENSBGRG00000007893","ENSBGRT00000014435",61737,"ATP2B4","ATPase plasma membrane Ca2+ transporting 4 [Source:HGNC Symbol;Acc:HGNC:817]","GO:0000166(nucleotide binding);GO:0005388(calcium transmembrane transporter activity, phosphorylative mechanism);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006874(cellular calcium ion homeostasis);GO:0010629(negative regulation of gene expression);GO:0010751(negative regulation of nitric oxide mediated signal transduction);GO:0014832(urinary bladder smooth muscle contraction);GO:0015085(calcium ion transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016525(negative regulation of angiogenesis);GO:0030018(Z disc);GO:0030315(T-tubule);GO:0030317(flagellated sperm motility);GO:0030346(protein phosphatase 2B binding);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0036126(sperm flagellum);GO:0036487(nitric-oxide synthase inhibitor activity);GO:0042383(sarcolemma);GO:0043537(negative regulation of blood vessel endothelial cell migration);GO:0045019(negative regulation of nitric oxide biosynthetic process);GO:0048306(calcium-dependent protein binding);GO:0050998(nitric-oxide synthase binding);GO:0051001(negative regulation of nitric-oxide synthase activity);GO:0051599(response to hydrostatic pressure);GO:0070588(calcium ion transmembrane transport);GO:0070885(negative regulation of calcineurin-NFAT signaling cascade);GO:0071872(cellular response to epinephrine stimulus);GO:0098736(negative regulation of the force of heart contraction);GO:0140199(negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process);GO:1900082(negative regulation of arginine catabolic process);GO:1901660(calcium ion export);GO:1902548(negative regulation of cellular response to vascular endothelial growth factor stimulus);GO:1902806(regulation of cell cycle G1/S phase transition);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1903243(negative regulation of cardiac muscle hypertrophy in response to stress);GO:1903249(negative regulation of citrulline biosynthetic process);GO:1905145(cellular response to acetylcholine);GO:2000481(positive regulation of cAMP-dependent protein kinase activity)","04020(Calcium signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04925(Aldosterone synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04970(Salivary secretion);04972(Pancreatic secretion)",{"v":9.99999999999998e-290,"d":"0.00"},1,"270,",0,-289,-287,{"v":4.1,"d":"4.10"},"Exon (ENSBGRT00000014435/ENSBGRG00000007893, exon 21 of 21)",14,83724834,83786840,62007,1]
["chr14",86002839,86003076,238,"ENSBGRG00000012903","ENSBGRT00000023580",30,"ENSBGRG00000012903","NA","NA","NA",{"v":0.011,"d":"0.01"},1,"238,",0,-1.95,-1.18,8.91,"Exon (ENSBGRT00000023580/ENSBGRG00000012903, exon 1 of 2)",14,86002809,86024599,21791,1]
["chr14",20134398,20134786,389,"ENSBGRG00000007455","ENSBGRT00000013706",44427,"DUSP10","dual specificity phosphatase 10 [Source:HGNC Symbol;Acc:HGNC:3065]","GO:0000188(inactivation of MAPK activity);GO:0002819(regulation of adaptive immune response);GO:0004725(protein tyrosine phosphatase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0008330(protein tyrosine/threonine phosphatase activity);GO:0008432(JUN kinase binding);GO:0010633(negative regulation of epithelial cell migration);GO:0016311(dephosphorylation);GO:0016607(nuclear speck);GO:0016791(phosphatase activity);GO:0017017(MAP kinase tyrosine/serine/threonine phosphatase activity);GO:0032496(response to lipopolysaccharide);GO:0032873(negative regulation of stress-activated MAPK cascade);GO:0033549(MAP kinase phosphatase activity);GO:0035970(peptidyl-threonine dephosphorylation);GO:0043508(negative regulation of JUN kinase activity);GO:0044387(negative regulation of protein kinase activity by regulation of protein phosphorylation);GO:0045088(regulation of innate immune response);GO:0045591(positive regulation of regulatory T cell differentiation);GO:0046329(negative regulation of JNK cascade);GO:0048273(mitogen-activated protein kinase p38 binding);GO:0048709(oligodendrocyte differentiation);GO:0050680(negative regulation of epithelial cell proliferation);GO:0060266(negative regulation of respiratory burst involved in inflammatory response);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0090335(regulation of brown fat cell differentiation);GO:1903753(negative regulation of p38MAPK cascade);GO:1905042(negative regulation of epithelium regeneration);GO:1990264(peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity)","04010(MAPK signaling pathway)",{"v":1.8E-10,"d":"0.00"},1,"389,",0,-9.74,-8.95,{"v":2.8,"d":"2.80"},"3' UTR",14,20134398,20179213,44816,2]
["chr14",24206263,24208647,2385,"ENSBGRG00000004302","ENSBGRT00000007918",47168,"EPHX1","epoxide hydrolase 1 [Source:HGNC Symbol;Acc:HGNC:3401]","GO:0003824(catalytic activity);GO:0004301(epoxide hydrolase activity);GO:0019369(arachidonic acid metabolic process);GO:0033961(cis-stilbene-oxide hydrolase activity);GO:0097176(epoxide metabolic process)","00980(Metabolism of xenobiotics by cytochrome P450);04976(Bile secretion);05204(Chemical carcinogenesis)",{"v":9.99999999999999e-198,"d":"0.00"},3,"492,63,42,","0,1925,2343",-197,-195,8.63,"3' UTR",14,24159095,24256389,97295,1]
["chr14",24574633,24574813,181,"ENSBGRG00000004916","ENSBGRT00000009037",0,"ACBD3","acyl-CoA binding domain containing 3 [Source:HGNC Symbol;Acc:HGNC:15453]","GO:0000062(fatty-acyl-CoA binding);GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0034237(protein kinase A regulatory subunit binding)","NA",{"v":2.4E-9,"d":"0.00"},1,"181,",0,-8.62,-7.85,2.81,"Exon (ENSBGRT00000009037/ENSBGRG00000004916, exon 1 of 8)",14,24533184,24574813,41630,2]
["chr14",30905996,30906679,684,"ENSBGRG00000011233","ENSBGRT00000020432",951,"BECN2","beclin 2 [Source:HGNC Symbol;Acc:HGNC:38606]","GO:0006914(autophagy);GO:0008333(endosome to lysosome transport);GO:1990172(G protein-coupled receptor catabolic process)","04371(Apelin signaling pathway);04140(Autophagy - animal);04136(Autophagy - other eukaryotes);04137(Mitophagy - animal);04215(Apoptosis - multiple species);05167(Kaposi sarcoma-associated herpesvirus infection)",0.02,1,"684,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000020432/ENSBGRG00000011233, exon 1 of 2)",14,30903243,30907630,4388,2]
["chr14",37474712,37474770,59,"ENSBGRG00000007264","ENSBGRT00000013468",19741,"TNFSF4","TNF superfamily member 4 [Source:HGNC Symbol;Acc:HGNC:11934]","GO:0005125(cytokine activity);GO:0005164(tumor necrosis factor receptor binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0006955(immune response);GO:0009986(cell surface);GO:0016020(membrane);GO:0032700(negative regulation of interleukin-17 production);GO:0032729(positive regulation of interferon-gamma production);GO:0032753(positive regulation of interleukin-4 production);GO:0032755(positive regulation of interleukin-6 production);GO:0050729(positive regulation of inflammatory response);GO:0071222(cellular response to lipopolysaccharide);GO:0071380(cellular response to prostaglandin E stimulus)","04060(Cytokine-cytokine receptor interaction)",{"v":4e-13,"d":"0.00"},1,"59,",0,{"v":-12.4,"d":"-12.40"},{"v":-11.5,"d":"-11.50"},{"v":3.2,"d":"3.20"},"Exon (ENSBGRT00000013468/ENSBGRG00000007264, exon 3 of 3)",14,37474510,37494511,20002,2]
["chr14",41013417,41019881,6465,"ENSBGRG00000011115","ENSBGRT00000020327",29710,"SLC25A33","solute carrier family 25 member 33 [Source:HGNC Symbol;Acc:HGNC:29681]","GO:0000002(mitochondrial genome maintenance);GO:0002082(regulation of oxidative phosphorylation);GO:0006390(mitochondrial transcription);GO:0006864(pyrimidine nucleotide transport);GO:0007005(mitochondrion organization);GO:0008284(positive regulation of cell population proliferation);GO:0015218(pyrimidine nucleotide transmembrane transporter activity);GO:0030307(positive regulation of cell growth);GO:0031930(mitochondria-nucleus signaling pathway);GO:0031966(mitochondrial membrane);GO:0032869(cellular response to insulin stimulus);GO:0034551(mitochondrial respiratory chain complex III assembly);GO:0051881(regulation of mitochondrial membrane potential);GO:0071156(regulation of cell cycle arrest);GO:1903426(regulation of reactive oxygen species biosynthetic process);GO:1990314(cellular response to insulin-like growth factor stimulus);GO:1990519(pyrimidine nucleotide import into mitochondrion)","NA",{"v":1.3E-51,"d":"0.00"},3,"265,281,16,","0,1946,6449",{"v":-50.9,"d":"-50.90"},{"v":-49.6,"d":"-49.60"},4.14,"3' UTR",14,41013417,41049591,36175,2]
["chr14",48592859,48593427,569,"ENSBGRG00000023660","ENSBGRT00000043925",902,"SKI","SKI proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10896]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0006351(transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0008285(negative regulation of cell population proliferation);GO:0010626(negative regulation of Schwann cell proliferation);GO:0014902(myotube differentiation);GO:0016604(nuclear body);GO:0016605(PML body);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030514(negative regulation of BMP signaling pathway);GO:0031625(ubiquitin protein ligase binding);GO:0032926(negative regulation of activin receptor signaling pathway);GO:0032991(protein-containing complex);GO:0042802(identical protein binding);GO:0043388(positive regulation of DNA binding);GO:0045668(negative regulation of osteoblast differentiation);GO:0046332(SMAD binding);GO:0060395(SMAD protein signal transduction);GO:0070491(repressing transcription factor binding)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":3.2e-79,"d":"0.00"},1,"569,",0,{"v":-78.5,"d":"-78.50"},{"v":-77.1,"d":"-77.10"},3.71,"Exon (ENSBGRT00000043925/ENSBGRG00000023660, exon 2 of 8)",14,48534659,48594329,59671,2]
["chr14",49819562,49820940,1379,"ENSBGRG00000017603","ENSBGRT00000033855",90958,"SPEN","spen family transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:17575]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001085(RNA polymerase II transcription factor binding);GO:0003676(nucleic acid binding);GO:0003714(transcription corepressor activity);GO:0005654(nucleoplasm);GO:0017053(transcriptional repressor complex);GO:0045892(negative regulation of transcription, DNA-templated);GO:0050769(positive regulation of neurogenesis)","NA",{"v":3.2e-27,"d":"0.00"},1,"1379,",0,{"v":-26.5,"d":"-26.50"},{"v":-25.5,"d":"-25.50"},3.51,"Exon (ENSBGRT00000033855/ENSBGRG00000017603, exon 13 of 17)",14,49814808,49911898,97091,2]
["chr14",50546806,50546983,178,"ENSBGRG00000020549","ENSBGRT00000037827",61208,"TMEM51","transmembrane protein 51 [Source:HGNC Symbol;Acc:HGNC:25488]","NA","NA",{"v":3.2e-32,"d":"0.00"},1,"178,",0,{"v":-31.5,"d":"-31.50"},{"v":-30.5,"d":"-30.50"},2.84,"5' UTR",14,50542266,50608191,65926,2]
["chr14",56988888,57001405,12518,"ENSBGRG00000005944","ENSBGRT00000011510",405968,"ASTN1","astrotactin 1 [Source:HGNC Symbol;Acc:HGNC:773]","GO:0001764(neuron migration);GO:0005515(protein binding);GO:0005768(endosome);GO:0007158(neuron cell-cell adhesion);GO:0007626(locomotory behavior);GO:0009897(external side of plasma membrane);GO:0016021(integral component of membrane);GO:0016477(cell migration);GO:0098609(cell-cell adhesion)","04145(Phagosome);05132(Salmonella infection)",{"v":5E-56,"d":"0.00"},3,"173,1238,59,","0,4130,12459",{"v":-55.3,"d":"-55.30"},-54,5.67,"3' UTR",14,56988888,57407373,418486,2]
["chr14",59817428,59817878,451,"ENSBGRG00000008350","ENSBGRT00000015664",509,"ABL2","ABL proto-oncogene 2, non-receptor tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:77]","GO:0000287(magnesium ion binding);GO:0001784(phosphotyrosine residue binding);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0010863(positive regulation of phospholipase C activity);GO:0010976(positive regulation of neuron projection development);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030145(manganese ion binding);GO:0051353(positive regulation of oxidoreductase activity);GO:0071300(cellular response to retinoic acid)","04014(Ras signaling pathway);04012(ErbB signaling pathway);05416(Viral myocarditis)",{"v":8.7e-07,"d":"0.00"},1,"451,",0,-6.06,-5.35,{"v":23.8,"d":"23.80"},"5' UTR",14,59703709,59818387,114679,2]
["chr14",64414716,64420737,6022,"ENSBGRG00000013563","ENSBGRT00000024980",0,"ARPC5","actin related protein 2/3 complex subunit 5 [Source:HGNC Symbol;Acc:HGNC:708]","GO:0005200(structural constituent of cytoskeleton);GO:0005885(Arp2/3 protein complex);GO:0015629(actin cytoskeleton);GO:0016477(cell migration);GO:0030027(lamellipodium);GO:0030833(regulation of actin filament polymerization);GO:0034314(Arp2/3 complex-mediated actin nucleation);GO:0051015(actin filament binding)","NA",{"v":1E-173,"d":"0.00"},3,"135,82,143,","0,2400,5879",-173,-171,3.11,"Exon (ENSBGRT00000024980/ENSBGRG00000013563, exon 1 of 4)",14,64401166,64420737,19572,2]
["chr14",69895141,69895528,388,"ENSBGRG00000020065","ENSBGRT00000036897",982,"PROX1","prospero homeobox 1 [Source:HGNC Symbol;Acc:HGNC:9459]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001709(cell fate determination);GO:0001822(kidney development);GO:0001889(liver development);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001945(lymph vessel development);GO:0001946(lymphangiogenesis);GO:0002088(lens development in camera-type eye);GO:0002089(lens morphogenesis in camera-type eye);GO:0002194(hepatocyte cell migration);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007420(brain development);GO:0007623(circadian rhythm);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0010468(regulation of gene expression);GO:0010595(positive regulation of endothelial cell migration);GO:0016922(nuclear receptor binding);GO:0021542(dentate gyrus development);GO:0021707(cerebellar granule cell differentiation);GO:0030240(skeletal muscle thin filament assembly);GO:0030324(lung development);GO:0031016(pancreas development);GO:0042752(regulation of circadian rhythm);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043565(sequence-specific DNA binding);GO:0045071(negative regulation of viral genome replication);GO:0045446(endothelial cell differentiation);GO:0045737(positive regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045787(positive regulation of cell cycle);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046619(optic placode formation involved in camera-type eye formation);GO:0048839(inner ear development);GO:0048845(venous blood vessel morphogenesis);GO:0050692(DNA binding domain binding);GO:0050693(LBD domain binding);GO:0055005(ventricular cardiac myofibril assembly);GO:0055009(atrial cardiac muscle tissue morphogenesis);GO:0055010(ventricular cardiac muscle tissue morphogenesis);GO:0060059(embryonic retina morphogenesis in camera-type eye);GO:0060214(endocardium formation);GO:0060298(positive regulation of sarcomere organization);GO:0060412(ventricular septum morphogenesis);GO:0060414(aorta smooth muscle tissue morphogenesis);GO:0060421(positive regulation of heart growth);GO:0060836(lymphatic endothelial cell differentiation);GO:0060849(regulation of transcription involved in lymphatic endothelial cell fate commitment);GO:0061114(branching involved in pancreas morphogenesis);GO:0070309(lens fiber cell morphogenesis);GO:0070365(hepatocyte differentiation);GO:0070858(negative regulation of bile acid biosynthetic process);GO:0072574(hepatocyte proliferation);GO:0090425(acinar cell differentiation);GO:0097150(neuronal stem cell population maintenance);GO:1901978(positive regulation of cell cycle checkpoint);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000179(positive regulation of neural precursor cell proliferation);GO:2000979(positive regulation of forebrain neuron differentiation)","NA",{"v":1e-05,"d":"0.00"},1,"388,",0,-4.99,-4.31,5.45,"Exon (ENSBGRT00000036897/ENSBGRG00000020065, exon 1 of 4)",14,69846166,69896510,50345,2]
["chr14",74267578,74267847,270,"ENSBGRG00000023209","ENSBGRT00000043012",9446,"UTP25","UTP25 small subunit processor component [Source:HGNC Symbol;Acc:HGNC:28440]","GO:0005634(nucleus);GO:0005730(nucleolus);GO:0030163(protein catabolic process);GO:0031648(protein destabilization)","NA",{"v":6.3e-11,"d":"0.00"},1,"270,",0,{"v":-10.2,"d":"-10.20"},-9.44,{"v":2.6,"d":"2.60"},"Exon (ENSBGRT00000043012/ENSBGRG00000023209, exon 8 of 14)",14,74240986,74277293,36308,2]
["chr14",80818561,80818681,121,"ENSBGRG00000018354","ENSBGRT00000034260",539,"KIF14","kinesin family member 14 [Source:HGNC Symbol;Acc:HGNC:19181]","GO:0001558(regulation of cell growth);GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0007018(microtubule-based movement);GO:0007080(mitotic metaphase plate congression);GO:0008017(microtubule binding);GO:0008284(positive regulation of cell population proliferation);GO:0008574(ATP-dependent microtubule motor activity, plus-end-directed);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0015631(tubulin binding);GO:0016887(ATPase activity);GO:0019901(protein kinase binding);GO:0021685(cerebellar granular layer structural organization);GO:0021693(cerebellar Purkinje cell layer structural organization);GO:0021695(cerebellar cortex development);GO:0021766(hippocampus development);GO:0021772(olfactory bulb development);GO:0021846(cell proliferation in forebrain);GO:0021987(cerebral cortex development);GO:0030155(regulation of cell adhesion);GO:0030165(PDZ domain binding);GO:0030334(regulation of cell migration);GO:0030496(midbody);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0031641(regulation of myelination);GO:0032147(activation of protein kinase activity);GO:0032467(positive regulation of cytokinesis);GO:0032487(regulation of Rap protein signal transduction);GO:0033624(negative regulation of integrin activation);GO:0034446(substrate adhesion-dependent cell spreading);GO:0043066(negative regulation of apoptotic process);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0045184(establishment of protein localization);GO:0051233(spindle midzone);GO:0051301(cell division);GO:0090543(Flemming body);GO:1903429(regulation of cell maturation);GO:2000045(regulation of G1/S transition of mitotic cell cycle)","NA",{"v":0.00083,"d":"0.00"},1,"121,",0,-3.08,-2.48,4.95,"Exon (ENSBGRT00000034260/ENSBGRG00000018354, exon 1 of 29)",14,80758770,80819220,60451,2]
["chr14",84546151,84546509,359,"ENSBGRG00000009666","ENSBGRT00000017764",63578,"PIK3C2B","phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta [Source:HGNC Symbol;Acc:HGNC:8972]","GO:0001727(lipid kinase activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0009267(cellular response to starvation);GO:0016236(macroautophagy);GO:0016301(kinase activity);GO:0030139(endocytic vesicle);GO:0035091(phosphatidylinositol binding);GO:0036092(phosphatidylinositol-3-phosphate biosynthetic process);GO:0043491(protein kinase B signaling);GO:0046854(phosphatidylinositol phosphorylation);GO:0048015(phosphatidylinositol-mediated signaling);GO:1905037(autophagosome organization)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":7.9e-83,"d":"0.00"},1,"359,",0,{"v":-82.1,"d":"-82.10"},{"v":-80.7,"d":"-80.70"},8.02,"3' UTR",14,84546151,84610087,63937,2]
["chr14",86084606,86085075,470,"ENSBGRG00000012944","ENSBGRT00000023675",5836,"ENSBGRG00000012944","NA","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0016192(vesicle-mediated transport);GO:0031982(vesicle)","NA",{"v":0.00048,"d":"0.00"},2,"12,168,","0,302",-3.32,-2.71,7.92,"Exon (ENSBGRT00000023675/ENSBGRG00000012944, exon 3 of 10)",14,86027375,86090911,63537,2]
["chr15",6830513,6871881,41369,"ENSBGRG00000021620","ENSBGRT00000039918",144,"RAP2A","RAP2A, member of RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9861]","GO:0000287(magnesium ion binding);GO:0001934(positive regulation of protein phosphorylation);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0016020(membrane);GO:0019003(GDP binding);GO:0030033(microvillus assembly);GO:0030336(negative regulation of cell migration);GO:0031532(actin cytoskeleton reorganization);GO:0031954(positive regulation of protein autophosphorylation);GO:0032486(Rap protein signal transduction);GO:0034613(cellular protein localization);GO:0035690(cellular response to drug);GO:0045184(establishment of protein localization);GO:0046328(regulation of JNK cascade);GO:0048814(regulation of dendrite morphogenesis);GO:0055037(recycling endosome);GO:0055038(recycling endosome membrane);GO:0072659(protein localization to plasma membrane)","NA",{"v":1e-101,"d":"0.00"},3,"170,121,114,","0,41132,41255",-101,{"v":-99.6,"d":"-99.60"},8.07,"Exon (ENSBGRT00000039918/ENSBGRG00000021620, exon 1 of 3)",15,6830369,6871881,41513,1]
["chr15",9155845,9156263,419,"ENSBGRG00000023354","ENSBGRT00000043128",256753,"CLYBL","citrate lyase beta like [Source:HGNC Symbol;Acc:HGNC:18355]","GO:0000287(magnesium ion binding);GO:0003824(catalytic activity);GO:0004474(malate synthase activity);GO:0047777((S)-citramalyl-CoA lyase activity);GO:0070207(protein homotrimerization);GO:0106064(regulation of cobalamin metabolic process);GO:0106121(positive regulation of cobalamin metabolic process)","NA",{"v":2e-15,"d":"0.00"},1,"419,",0,{"v":-14.7,"d":"-14.70"},{"v":-13.8,"d":"-13.80"},2.71,"3' UTR",15,8899092,9156538,257447,1]
["chr15",18829294,18831641,2348,"ENSBGRG00000008539","ENSBGRT00000015673",8239,"ENSBGRG00000008539","NAD(P)HX dehydratase [Source:HGNC Symbol;Acc:HGNC:25576]","GO:0052855(ADP-dependent NAD(P)H-hydrate dehydratase activity)","NA",{"v":4e-54,"d":"0.00"},3,"44,105,658,","0,124,1690",{"v":-53.4,"d":"-53.40"},{"v":-52.2,"d":"-52.20"},6.02,"3' UTR",15,18821055,18832589,11535,1]
["chr15",25174021,25188839,14819,"ENSBGRG00000019863","ENSBGRT00000036593",67110,"RBM26","RNA binding motif protein 26 [Source:HGNC Symbol;Acc:HGNC:20327]","GO:0003676(nucleic acid binding);GO:0006397(mRNA processing);GO:0046872(metal ion binding)","NA",{"v":1.6e-95,"d":"0.00"},4,"28,87,180,425,","0,3155,12661,14394",{"v":-94.8,"d":"-94.80"},{"v":-93.3,"d":"-93.30"},6.64,"3' UTR",15,25106911,25189138,82228,1]
["chr15",40429076,40430750,1675,"ENSBGRG00000006993","ENSBGRT00000012895",3277,"PCDH9","protocadherin 9 [Source:HGNC Symbol;Acc:HGNC:8661]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane)","NA",{"v":7.1e-09,"d":"0.00"},1,"1675,",0,-8.15,-7.39,6.77,"Exon (ENSBGRT00000012895/ENSBGRG00000006993, exon 2 of 3)",15,40425799,40452190,26392,1]
["chr15",48937019,48942143,5125,"ENSBGRG00000004578","ENSBGRT00000008484",42452,"WASF3","WASP family member 3 [Source:HGNC Symbol;Acc:HGNC:12734]","GO:0003779(actin binding);GO:0005856(cytoskeleton);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0014003(oligodendrocyte development);GO:0030027(lamellipodium);GO:0030032(lamellipodium assembly);GO:0030036(actin cytoskeleton organization);GO:0031643(positive regulation of myelination);GO:0098794(postsynapse)","04520(Adherens junction);04666(Fc gamma R-mediated phagocytosis);05231(Choline metabolism in cancer)",{"v":0.0039,"d":"0.00"},2,"27,154,","0,4971",-2.41,-1.85,1.66,"Exon (ENSBGRT00000008484/ENSBGRG00000004578, exon 6 of 10)",15,48894567,48952135,57569,1]
["chr15",53667138,53674027,6890,"ENSBGRG00000010015","ENSBGRT00000025540",346530,"FRY","FRY microtubule binding protein [Source:HGNC Symbol;Acc:HGNC:20367]","GO:0000902(cell morphogenesis);GO:0004857(enzyme inhibitor activity);GO:1904428(negative regulation of tubulin deacetylation)","03015(mRNA surveillance pathway)",{"v":7.9e-14,"d":"0.00"},3,"93,190,78,","0,2234,6812",{"v":-13.1,"d":"-13.10"},{"v":-12.2,"d":"-12.20"},2.14,"Exon (ENSBGRT00000025540/ENSBGRG00000010015, exon 55 of 62)",15,53320608,53692760,372153,1]
["chr15",58209909,58215664,5756,"ENSBGRG00000021155","ENSBGRT00000039074",0,"EXOSC8","exosome component 8 [Source:HGNC Symbol;Acc:HGNC:17035]","GO:0000178(exosome (RNase complex));GO:0001650(fibrillar center);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006396(RNA processing);GO:0006401(RNA catabolic process);GO:0035925(mRNA 3'-UTR AU-rich region binding);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle)","03018(RNA degradation)",{"v":1.9E-3,"d":"0.00"},5,"17,99,64,74,44,","0,1856,2184,3249,5712",-2.73,-2.15,2.09,"Exon (ENSBGRT00000039074/ENSBGRG00000021155, exon 1 of 11)",15,58209909,58219987,10079,1]
["chr15",64376226,64385694,9469,"ENSBGRG00000018215","ENSBGRT00000033375",31125,"RCBTB1","RCC1 and BTB domain containing protein 1 [Source:HGNC Symbol;Acc:HGNC:18243]","GO:0005515(protein binding);GO:0005737(cytoplasm)","NA",{"v":6.3e-37,"d":"0.00"},3,"47,164,120,","0,8906,9349",{"v":-36.2,"d":"-36.20"},{"v":-35.1,"d":"-35.10"},5.12,"3' UTR",15,64345101,64385754,40654,1]
["chr15",66866206,66934047,67842,"ENSBGRG00000020868","ENSBGRT00000038440",6504,"HTR2A","5-hydroxytryptamine receptor 2A [Source:HGNC Symbol;Acc:HGNC:5293]","GO:0004930(G protein-coupled receptor activity);GO:0004993(G protein-coupled serotonin receptor activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006874(cellular calcium ion homeostasis);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007202(activation of phospholipase C activity);GO:0007210(serotonin receptor signaling pathway);GO:0008144(drug binding);GO:0010513(positive regulation of phosphatidylinositol biosynthetic process);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0016021(integral component of membrane);GO:0033674(positive regulation of kinase activity);GO:0042493(response to drug);GO:0042802(identical protein binding);GO:0044380(protein localization to cytoskeleton);GO:0045600(positive regulation of fat cell differentiation);GO:0045821(positive regulation of glycolytic process);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051209(release of sequestered calcium ion into cytosol);GO:0051378(serotonin binding);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071886(1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding)","04020(Calcium signaling pathway);04080(Neuroactive ligand-receptor interaction);04540(Gap junction);04726(Serotonergic synapse);04750(Inflammatory mediator regulation of TRP channels)",{"v":0.00098,"d":"0.00"},2,"62,206,","0,67636",-3.01,-2.42,{"v":12.9,"d":"12.90"},"Exon (ENSBGRT00000038440/ENSBGRG00000020868, exon 3 of 4)",15,66859702,66934641,74940,1]
["chr15",72895291,72896682,1392,"ENSBGRG00000006036","ENSBGRT00000011119",651,"KBTBD7","kelch repeat and BTB domain containing 7 [Source:HGNC Symbol;Acc:HGNC:25266]","GO:0005515(protein binding)","NA",{"v":1e-123,"d":"0.00"},1,"1392,",0,-123,-121,{"v":13.6,"d":"13.60"},"Exon (ENSBGRT00000011119/ENSBGRG00000006036, exon 1 of 1)",15,72894640,72896682,2043,1]
["chr15",9749450,9750072,623,"ENSBGRG00000023824","ENSBGRT00000044027",31529,"ENSBGRG00000023824","NA","GO:0061929(gamma-glutamylaminecyclotransferase activity)","NA",{"v":4E-41,"d":"0.00"},1,"623,",0,{"v":-40.4,"d":"-40.40"},{"v":-39.2,"d":"-39.20"},5.52,"3' UTR",15,9749420,9781601,32182,2]
["chr15",18751949,18752189,241,"ENSBGRG00000008497","ENSBGRT00000015468",39696,"RAB20","RAB20, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:18260]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005794(Golgi apparatus);GO:0043231(intracellular membrane-bounded organelle);GO:0045335(phagocytic vesicle);GO:0071346(cellular response to interferon-gamma);GO:0090383(phagosome acidification);GO:0090385(phagosome-lysosome fusion)","NA",{"v":0.012,"d":"0.01"},1,"241,",0,-1.93,{"v":-1.4,"d":"-1.40"},6.93,"3' UTR",15,18751589,18791885,40297,2]
["chr15",32877324,32883789,6466,"ENSBGRG00000006206","ENSBGRT00000011658",19604,"BORA","BORA aurora kinase A activator [Source:HGNC Symbol;Acc:HGNC:24724]","GO:0072687(meiotic spindle)","NA",{"v":4e-32,"d":"0.00"},3,"230,132,594,","0,1464,5872",{"v":-31.4,"d":"-31.40"},{"v":-30.4,"d":"-30.40"},5.04,"3' UTR",15,32877234,32903393,26160,2]
["chr15",46979778,46979897,120,"ENSBGRG00000014596","ENSBGRT00000026900",2574,"ENSBGRG00000014596","NA","NA","NA",{"v":0.0021,"d":"0.00"},1,"120,",0,-2.68,{"v":-2.1,"d":"-2.10"},2.48,"Exon (ENSBGRT00000026900/ENSBGRG00000014596, exon 1 of 4)",15,46967575,46982471,14897,2]
["chr15",47386613,47388623,2011,"ENSBGRG00000015156","ENSBGRT00000028030",146,"ENSBGRG00000015156","NA","GO:0005179(hormone activity);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0019395(fatty acid oxidation);GO:0042802(identical protein binding);GO:0045792(negative regulation of cell size);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0097009(energy homeostasis);GO:1900078(positive regulation of cellular response to insulin stimulus)","04920(Adipocytokine signaling pathway);03320(PPAR signaling pathway)",{"v":5e-13,"d":"0.00"},2,"473,155,","0,1856",{"v":-12.3,"d":"-12.30"},{"v":-11.5,"d":"-11.50"},{"v":3.9,"d":"3.90"},"Exon (ENSBGRT00000028030/ENSBGRG00000015156, exon 1 of 2)",15,47382196,47388769,6574,2]
["chr15",52479940,52484109,4170,"ENSBGRG00000007830","ENSBGRT00000015005",21883,"HSPH1","heat shock protein family H (Hsp110) member 1 [Source:HGNC Symbol;Acc:HGNC:16969]","GO:0000774(adenyl-nucleotide exchange factor activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005874(microtubule);GO:0032991(protein-containing complex);GO:0043014(alpha-tubulin binding);GO:0051085(chaperone cofactor-dependent protein refolding)","04141(Protein processing in endoplasmic reticulum)",{"v":6.3e-55,"d":"0.00"},5,"103,120,108,126,53,","0,328,548,2731,4117",{"v":-54.2,"d":"-54.20"},-53,2.97,"Exon (ENSBGRT00000015005/ENSBGRG00000007830, exon 13 of 18)",15,52477604,52505992,28389,2]
["chr15",53934104,53941579,7476,"ENSBGRG00000015604","ENSBGRT00000028971",0,"ENSBGRG00000015604","NA","NA","03440(Homologous recombination);03460(Fanconi anemia pathway)",{"v":1E-169,"d":"0.00"},2,"14,1244,","0,6232",-169,-167,9.42,"Exon (ENSBGRT00000028971/ENSBGRG00000015604, exon 1 of 7)",15,53882516,53941579,59064,2]
["chr15",61367448,61378989,11542,"ENSBGRG00000012666","ENSBGRT00000023190",16238,"MRPS31","mitochondrial ribosomal protein S31 [Source:HGNC Symbol;Acc:HGNC:16632]","GO:0003735(structural constituent of ribosome);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0005763(mitochondrial small ribosomal subunit);GO:0019904(protein domain specific binding)","NA",{"v":2.5e-31,"d":"0.00"},2,"230,40,","0,11502",{"v":-30.6,"d":"-30.60"},{"v":-29.6,"d":"-29.60"},4.36,"Exon (ENSBGRT00000023190/ENSBGRG00000012666, exon 6 of 7)",15,61367448,61395227,27780,2]
["chr15",67012383,67022260,9878,"ENSBGRG00000020993","ENSBGRT00000039426",228341,"LRCH1","leucine rich repeats and calponin homology domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20309]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0034260(negative regulation of GTPase activity);GO:1990869(cellular response to chemokine);GO:2000405(negative regulation of T cell migration)","04510(Focal adhesion);04810(Regulation of actin cytoskeleton)",{"v":3.4E-5,"d":"0.00"},2,"9,52,","0,9826",-4.47,-3.81,1.61,"Exon (ENSBGRT00000039426/ENSBGRG00000020993, exon 19 of 19)",15,67011281,67250601,239321,2]
["chr15",73272356,73272475,120,"ENSBGRG00000006282","ENSBGRT00000011602",44944,"CNMD","chondromodulin [Source:HGNC Symbol;Acc:HGNC:17005]","GO:0016525(negative regulation of angiogenesis)","04080(Neuroactive ligand-receptor interaction)",{"v":5.1E-5,"d":"0.00"},1,"120,",0,-4.29,-3.64,{"v":1.7,"d":"1.70"},"3' UTR",15,73272207,73317419,45213,2]
["chr16",4163361,4163659,299,"ENSBGRG00000011004","ENSBGRT00000020175",0,"ARHGAP10","Rho GTPase activating protein 10 [Source:HGNC Symbol;Acc:HGNC:26099]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0043066(negative regulation of apoptotic process)","05100(Bacterial invasion of epithelial cells)",{"v":0.00079,"d":"0.00"},1,"299,",0,{"v":-3.1,"d":"-3.10"},{"v":-2.5,"d":"-2.50"},6.93,"5' UTR",16,4163361,4577420,414060,1]
["chr16",15397455,15398329,875,"ENSBGRG00000020095","ENSBGRT00000037125",25758,"TMEM192","transmembrane protein 192 [Source:HGNC Symbol;Acc:HGNC:26775]","GO:0005654(nucleoplasm);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0005770(late endosome);GO:0042803(protein homodimerization activity);GO:0048471(perinuclear region of cytoplasm)","NA",{"v":6.3E-48,"d":"0.00"},2,"45,514,","0,361",{"v":-47.2,"d":"-47.20"},-46,{"v":5.7,"d":"5.70"},"3' UTR",16,15371697,15398358,26662,1]
["chr16",20496278,20498942,2665,"ENSBGRG00000003822","ENSBGRT00000007453",74700,"ELF2","E74 like ETS transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:3317]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0003735(structural constituent of ribosome);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005840(ribosome);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006412(translation);GO:0016604(nuclear body);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":9.8e-10,"d":"0.00"},2,"110,69,","0,2596",-9.01,-8.23,1.48,"Exon (ENSBGRT00000007453/ENSBGRG00000003822, exon 9 of 11)",16,20421578,20500460,78883,1]
["chr16",36360691,36389336,28646,"ENSBGRG00000009949","ENSBGRT00000018242",0,"ANKRD50","ankyrin repeat domain 50 [Source:HGNC Symbol;Acc:HGNC:29223]","GO:0005515(protein binding);GO:1990126(retrograde transport, endosome to plasma membrane)","NA",{"v":1.3E-18,"d":"0.00"},3,"950,545,31,","0,1567,28615",{"v":-17.9,"d":"-17.90"},-17,{"v":36.6,"d":"36.60"},"5' UTR",16,36360691,36397135,36445,1]
["chr16",44256944,44258507,1564,"ENSBGRG00000003839","ENSBGRT00000007140",59,"C4orf46","chromosome 4 open reading frame 46 [Source:HGNC Symbol;Acc:HGNC:27320]","NA","NA",{"v":2e-30,"d":"0.00"},2,"129,156,","0,1408",{"v":-29.7,"d":"-29.70"},{"v":-28.7,"d":"-28.70"},3.57,"Exon (ENSBGRT00000007140/ENSBGRG00000003839, exon 2 of 3)",16,44256885,44258507,1623,1]
["chr16",48798022,48802348,4327,"ENSBGRG00000005691","ENSBGRT00000010604",21008,"GOLGA3","golgin A3 [Source:HGNC Symbol;Acc:HGNC:4426]","GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0007283(spermatogenesis);GO:0017119(Golgi transport complex);GO:0090498(extrinsic component of Golgi membrane)","NA",{"v":2e-20,"d":"0.00"},5,"82,162,369,78,239,","0,1704,2105,3227,4088",{"v":-19.7,"d":"-19.70"},{"v":-18.8,"d":"-18.80"},3.06,"Exon (ENSBGRT00000010604/ENSBGRG00000005691, exon 8 of 17)",16,48777014,48806301,29288,1]
["chr16",57473031,57473328,298,"ENSBGRG00000003817","ENSBGRT00000007089",861,"RILPL1","Rab interacting lysosomal protein like 1 [Source:HGNC Symbol;Acc:HGNC:26814]","GO:0003382(epithelial cell morphogenesis);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0046983(protein dimerization activity);GO:1901214(regulation of neuron death);GO:1903445(protein transport from ciliary membrane to plasma membrane)","NA",{"v":2.2e-08,"d":"0.00"},1,"298,",0,-7.66,-6.91,3.19,"5' UTR",16,57472170,57526574,54405,1]
["chr16",58550893,58550985,93,"ENSBGRG00000006328","ENSBGRT00000011818",37085,"CLIP1","CAP-Gly domain containing linker protein 1 [Source:HGNC Symbol;Acc:HGNC:10461]","GO:0001578(microtubule bundle formation);GO:0005635(nuclear envelope);GO:0005813(centrosome);GO:0005874(microtubule);GO:0005881(cytoplasmic microtubule);GO:0008017(microtubule binding);GO:0008270(zinc ion binding);GO:0015630(microtubule cytoskeleton);GO:0015631(tubulin binding);GO:0031116(positive regulation of microtubule polymerization);GO:0035371(microtubule plus-end);GO:0044354(macropinosome);GO:0044861(protein transport into plasma membrane raft);GO:0051010(microtubule plus-end binding)","04150(mTOR signaling pathway)",{"v":0.033,"d":"0.03"},2,"8,83,","0,10",-1.48,{"v":-0.983,"d":"-0.98"},2.97,"Exon (ENSBGRT00000011818/ENSBGRG00000006328, exon 11 of 28)",16,58513808,58611510,97703,1]
["chr16",62985098,63001758,16661,"ENSBGRG00000017791","ENSBGRT00000033472",87087,"TAOK3","TAO kinase 3 [Source:HGNC Symbol;Acc:HGNC:18133]","GO:0000165(MAPK cascade);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0006974(cellular response to DNA damage stimulus);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0016740(transferase activity);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0043507(positive regulation of JUN kinase activity);GO:0046329(negative regulation of JNK cascade);GO:0046330(positive regulation of JNK cascade);GO:0046777(protein autophosphorylation)","04010(MAPK signaling pathway)",{"v":1.6E-59,"d":"0.00"},5,"32,129,204,240,20,","0,2028,6927,15035,16641",{"v":-58.8,"d":"-58.80"},{"v":-57.5,"d":"-57.50"},3.13,"Exon (ENSBGRT00000033472/ENSBGRG00000017791, exon 15 of 20)",16,62898011,63011580,113570,1]
["chr16",65073238,65075556,2319,"ENSBGRG00000013849","ENSBGRT00000026373",291876,"MED13L","mediator complex subunit 13L [Source:HGNC Symbol;Acc:HGNC:22962]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)",{"v":2e-21,"d":"0.00"},4,"32,258,76,54,","0,1002,2187,2265",{"v":-20.7,"d":"-20.70"},{"v":-19.8,"d":"-19.80"},5.45,"Exon (ENSBGRT00000026373/ENSBGRG00000013849, exon 29 of 29)",16,64781362,65074497,293136,1]
["chr16",69574803,69576633,1831,"ENSBGRG00000026352","ENSBGRT00000048751",0,"ENSBGRG00000026352","NA","GO:0005875(microtubule associated complex);GO:0007017(microtubule-based process);GO:0030286(dynein complex)","04962(Vasopressin-regulated water reabsorption)",0,2,"132,138,","0,1693",-687,"-Inf",3.01,"Exon (ENSBGRT00000048751/ENSBGRG00000026352, exon 1 of 2)",16,69574803,69576633,1831,1]
["chr16",72346984,72347044,61,"ENSBGRG00000013651","ENSBGRT00000025015",7874,"ENSBGRG00000013651","NA","NA","04514(Cell adhesion molecules (CAMs))",{"v":2.3e-07,"d":"0.00"},1,"61,",0,-6.63,-5.91,1.87,"Exon (ENSBGRT00000025015/ENSBGRG00000013651, exon 3 of 5)",16,72339110,72477028,137919,1]
["chr16",76088302,76093291,4990,"ENSBGRG00000020129","ENSBGRT00000038482",18235,"EWSR1","EWS RNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:3508]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0042802(identical protein binding)","05202(Transcriptional misregulation in cancers)",{"v":1e-178,"d":"0.00"},4,"12,181,91,14,","0,2044,3843,4976",-178,-176,{"v":11.7,"d":"11.70"},"Exon (ENSBGRT00000038482/ENSBGRG00000020129, exon 7 of 9)",16,76070067,76092235,22169,1]
["chr16",77245137,77245557,421,"ENSBGRG00000024733","ENSBGRT00000045634",5437,"SLC35E4","solute carrier family 35 member E4 [Source:HGNC Symbol;Acc:HGNC:17058]","NA","NA",{"v":3.5e-08,"d":"0.00"},1,"421,",0,-7.46,-6.71,6.77,"Exon (ENSBGRT00000045634/ENSBGRG00000024733, exon 3 of 3)",16,77239700,77245557,5858,1]
["chr16",78036219,78037657,1439,"ENSBGRG00000009211","ENSBGRT00000018221",95901,"SFI1","SFI1 centrin binding protein [Source:HGNC Symbol;Acc:HGNC:29064]","GO:0005813(centrosome);GO:0010923(negative regulation of phosphatase activity);GO:0019902(phosphatase binding)","NA",{"v":6.3e-19,"d":"0.00"},3,"23,112,105,","0,1154,1334",{"v":-18.2,"d":"-18.20"},{"v":-17.3,"d":"-17.30"},3.77,"Exon (ENSBGRT00000018221/ENSBGRG00000009211, exon 30 of 32)",16,77940318,78037657,97340,1]
["chr16",79185209,79185328,120,"ENSBGRG00000023185","ENSBGRT00000042874",16224,"GUCD1","guanylyl cyclase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:14237]","NA","NA",{"v":0.0013,"d":"0.00"},1,"120,",0,{"v":-2.9,"d":"-2.90"},-2.31,9.91,"3' UTR",16,79168985,79186791,17807,1]
["chr16",80004461,80004550,90,"ENSBGRG00000025189","ENSBGRT00000046572",2020,"HIC2","HIC ZBTB transcriptional repressor 2 [Source:HGNC Symbol;Acc:HGNC:18595]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008022(protein C-terminus binding)","NA",{"v":0.022,"d":"0.02"},1,"90,",0,-1.66,-1.15,2.97,"Exon (ENSBGRT00000046572/ENSBGRG00000025189, exon 3 of 3)",16,80002441,80004997,2557,1]
["chr16",80941221,80941460,240,"ENSBGRG00000022686","ENSBGRT00000042056",16331,"DGCR8","DGCR8 microprocessor complex subunit [Source:HGNC Symbol;Acc:HGNC:2847]","GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0004525(ribonuclease III activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0020037(heme binding);GO:0031053(primary miRNA processing);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0046907(intracellular transport);GO:0070877(microprocessor complex);GO:0070878(primary miRNA binding)","05203(Viral carcinogenesis);05166(HTLV-I infection)",{"v":7.1e-09,"d":"0.00"},1,"240,",0,-8.15,-7.39,1.77,"Exon (ENSBGRT00000042056/ENSBGRG00000022686, exon 12 of 13)",16,80924890,80941778,16889,1]
["chr16",5069322,5069829,508,"ENSBGRG00000011166","ENSBGRT00000021297",1005,"NR3C2","nuclear receptor subfamily 3 group C member 2 [Source:HGNC Symbol;Acc:HGNC:7979]","GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0042025(host cell nucleus);GO:0043235(receptor complex);GO:0043565(sequence-specific DNA binding);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1990837(sequence-specific double-stranded DNA binding)","04960(Aldosterone-regulated sodium reabsorption)",{"v":3.2e-08,"d":"0.00"},1,"508,",0,-7.49,-6.74,4.68,"Exon (ENSBGRT00000021297/ENSBGRG00000011166, exon 1 of 8)",16,4589384,5070834,481451,2]
["chr16",15789153,15792475,3323,"ENSBGRG00000020282","ENSBGRT00000037606",30185,"SMARCA5","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 [Source:HGNC Symbol;Acc:HGNC:11101]","GO:0000793(condensed chromosome);GO:0001650(fibrillar center);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006334(nucleosome assembly);GO:0006338(chromatin remodeling);GO:0006352(DNA-templated transcription, initiation);GO:0016584(nucleosome positioning);GO:0016589(NURF complex);GO:0016818(hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides);GO:0016887(ATPase activity);GO:0031213(RSF complex);GO:0031491(nucleosome binding);GO:0042393(histone binding);GO:0043044(ATP-dependent chromatin remodeling);GO:0043596(nuclear replication fork)","NA",{"v":5e-17,"d":"0.00"},3,"5,149,55,","0,196,3268",{"v":-16.3,"d":"-16.30"},{"v":-15.5,"d":"-15.50"},{"v":1.5,"d":"1.50"},"Exon (ENSBGRT00000037606/ENSBGRG00000020282, exon 14 of 24)",16,15780737,15822660,41924,2]
["chr16",20221330,20231383,10054,"ENSBGRG00000022725","ENSBGRT00000042637",53577,"NAA15","N(alpha)-acetyltransferase 15, NatA auxiliary subunit [Source:HGNC Symbol;Acc:HGNC:30782]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006474(N-terminal protein amino acid acetylation);GO:0016407(acetyltransferase activity);GO:0031415(NatA complex);GO:0043022(ribosome binding);GO:0043066(negative regulation of apoptotic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0050821(protein stabilization)","NA",{"v":5e-55,"d":"0.00"},3,"43,194,122,","0,5040,9932",{"v":-54.3,"d":"-54.30"},{"v":-53.1,"d":"-53.10"},3.29,"Exon (ENSBGRT00000042637/ENSBGRG00000022725, exon 14 of 20)",16,20210146,20284960,74815,2]
["chr16",21116632,21116752,121,"ENSBGRG00000004336","ENSBGRT00000007966",25143,"ENSBGRG00000004336","NA","NA","NA",{"v":0.046,"d":"0.05"},1,"121,",0,-1.34,{"v":-0.854,"d":"-0.85"},2.09,"Exon (ENSBGRT00000007993/ENSBGRG00000004343, exon 1 of 1)",16,21091489,21195050,103562,1]
["chr16",35700644,35700854,211,"ENSBGRG00000009618","ENSBGRT00000017642",3868,"FAT4","FAT atypical cadherin 4 [Source:HGNC Symbol;Acc:HGNC:23109]","GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001822(kidney development);GO:0003007(heart morphogenesis);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007009(plasma membrane organization);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007219(Notch signaling pathway);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0016020(membrane);GO:0021987(cerebral cortex development);GO:0022008(neurogenesis);GO:0035329(hippo signaling);GO:0043931(ossification involved in bone maturation);GO:0045177(apical part of cell);GO:0048565(digestive tract development);GO:0060122(inner ear receptor cell stereocilium organization);GO:0072006(nephron development);GO:0072137(condensed mesenchymal cell proliferation);GO:0072307(regulation of metanephric nephron tubule epithelial cell differentiation)","04392(Hippo signaling pathway - multiple species)",{"v":6e-05,"d":"0.00"},1,"211,",0,-4.22,-3.57,3.96,"Exon (ENSBGRT00000017642/ENSBGRG00000009618, exon 1 of 18)",16,35502823,35704722,201900,2]
["chr16",43473206,43477032,3827,"ENSBGRG00000012332","ENSBGRT00000023515",105495,"RAPGEF2","Rap guanine nucleotide exchange factor 2 [Source:HGNC Symbol;Acc:HGNC:16854]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005088(Ras guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005770(late endosome);GO:0005829(cytosol);GO:0005923(bicellular tight junction);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007218(neuropeptide signaling pathway);GO:0007264(small GTPase mediated signal transduction);GO:0008285(negative regulation of cell population proliferation);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0017034(Rap guanyl-nucleotide exchange factor activity);GO:0019933(cAMP-mediated signaling);GO:0030033(microvillus assembly);GO:0030139(endocytic vesicle);GO:0030165(PDZ domain binding);GO:0030552(cAMP binding);GO:0031175(neuron projection development);GO:0031697(beta-1 adrenergic receptor binding);GO:0032486(Rap protein signal transduction);GO:0042127(regulation of cell population proliferation);GO:0043547(positive regulation of GTPase activity);GO:0043950(positive regulation of cAMP-mediated signaling);GO:0045860(positive regulation of protein kinase activity);GO:0048471(perinuclear region of cytoplasm);GO:0050699(WW domain binding);GO:0050774(negative regulation of dendrite morphogenesis);GO:0061028(establishment of endothelial barrier);GO:0070300(phosphatidic acid binding);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071320(cellular response to cAMP);GO:0071321(cellular response to cGMP);GO:0071880(adenylate cyclase-activating adrenergic receptor signaling pathway);GO:0072659(protein localization to plasma membrane);GO:0090557(establishment of endothelial intestinal barrier);GO:1901888(regulation of cell junction assembly);GO:2000481(positive regulation of cAMP-dependent protein kinase activity);GO:2000670(positive regulation of dendritic cell apoptotic process)","04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04530(Tight junction)",{"v":1E-108,"d":"0.00"},2,"273,534,","0,3293",-108,-106,7.99,"Exon (ENSBGRT00000023515/ENSBGRG00000012332, exon 23 of 25)",16,43472054,43582527,110474,2]
["chr16",49830619,49843668,13050,"ENSBGRG00000008209","ENSBGRT00000015047",3804,"SFSWAP","splicing factor SWAP [Source:HGNC Symbol;Acc:HGNC:10790]","GO:0000380(alternative mRNA splicing, via spliceosome);GO:0000395(mRNA 5'-splice site recognition);GO:0003723(RNA binding);GO:0006396(RNA processing)","NA",{"v":2.6e-06,"d":"0.00"},3,"20,86,104,","0,8071,12946",-5.58,-4.88,{"v":1.3,"d":"1.30"},"Exon (ENSBGRT00000015047/ENSBGRG00000008209, exon 3 of 19)",16,49754370,49847472,93103,2]
["chr16",57720101,57722156,2056,"ENSBGRG00000004182","ENSBGRT00000007733",176,"C12orf65","chromosome 12 open reading frame 65 [Source:HGNC Symbol;Acc:HGNC:26784]","GO:0003747(translation release factor activity);GO:0006415(translational termination)","00760(Nicotinate and nicotinamide metabolism)",{"v":6.3e-83,"d":"0.00"},2,"219,106,","0,1950",{"v":-82.2,"d":"-82.20"},{"v":-80.7,"d":"-80.70"},4.35,"Exon (ENSBGRT00000007733/ENSBGRG00000004182, exon 1 of 2)",16,57720101,57722332,2232,2]
["chr16",59359725,59364262,4538,"ENSBGRG00000008846","ENSBGRT00000016338",16891,"RNF34","ring finger protein 34 [Source:HGNC Symbol;Acc:HGNC:17297]","GO:0002039(p53 binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0035872(nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0061630(ubiquitin protein ligase activity);GO:0070417(cellular response to cold);GO:0070936(protein K48-linked ubiquitination);GO:1901797(negative regulation of signal transduction by p53 class mediator);GO:1901981(phosphatidylinositol phosphate binding);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:2000374(regulation of oxygen metabolic process);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","NA",{"v":1e-143,"d":"0.00"},4,"568,202,99,79,","0,2410,2868,4459",-143,-142,8.82,"3' UTR",16,59359341,59381153,21813,2]
["chr16",67612004,67612213,210,"ENSBGRG00000016096","ENSBGRT00000029969",24558,"PLBD2","phospholipase B domain containing 2 [Source:HGNC Symbol;Acc:HGNC:27283]","GO:0004620(phospholipase activity)","NA",{"v":2.5E-15,"d":"0.00"},1,"210,",0,{"v":-14.6,"d":"-14.60"},{"v":-13.8,"d":"-13.80"},1.43,"3' UTR",16,67611109,67636771,25663,2]
["chr16",69219006,69220356,1351,"ENSBGRG00000026176","ENSBGRT00000048422",16567,"RAB35","RAB35, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9774]","GO:0000281(mitotic cytokinesis);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005886(plasma membrane);GO:0005905(clathrin-coated pit);GO:0008104(protein localization);GO:0016197(endosomal transport);GO:0019003(GDP binding);GO:0019882(antigen processing and presentation);GO:0031175(neuron projection development);GO:0031253(cell projection membrane);GO:0032482(Rab protein signal transduction);GO:0036010(protein localization to endosome);GO:0045171(intercellular bridge);GO:0045334(clathrin-coated endocytic vesicle);GO:0048227(plasma membrane to endosome transport)","04144(Endocytosis)",{"v":5e-19,"d":"0.00"},2,"129,82,","0,1269",{"v":-18.3,"d":"-18.30"},{"v":-17.4,"d":"-17.40"},2.19,"Exon (ENSBGRT00000048422/ENSBGRG00000026176, exon 4 of 5)",16,69219006,69236923,17918,2]
["chr16",72114460,72115757,1298,"ENSBGRG00000011316","ENSBGRT00000020628",24165,"PIWIL3","piwi like RNA-mediated gene silencing 3 [Source:HGNC Symbol;Acc:HGNC:18443]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm)","NA",{"v":0.0062,"d":"0.01"},2,"572,54,","0,1244",-2.21,-1.67,9.91,"3' UTR",16,72108744,72139922,31179,2]
["chr16",73553598,73554373,776,"ENSBGRG00000015814","ENSBGRT00000029085",0,"TPST2","tyrosylprotein sulfotransferase 2 [Source:HGNC Symbol;Acc:HGNC:12021]","GO:0005783(endoplasmic reticulum);GO:0006478(peptidyl-tyrosine sulfation);GO:0008476(protein-tyrosine sulfotransferase activity);GO:0042803(protein homodimerization activity)","NA",{"v":6.3e-23,"d":"0.00"},1,"776,",0,{"v":-22.2,"d":"-22.20"},{"v":-21.3,"d":"-21.30"},4.79,"Exon (ENSBGRT00000029085/ENSBGRG00000015814, exon 1 of 5)",16,73536336,73554373,18038,2]
["chr16",76435977,76438614,2638,"ENSBGRG00000022318","ENSBGRT00000041206",8886,"ZMAT5","zinc finger matrin-type 5 [Source:HGNC Symbol;Acc:HGNC:28046]","GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","NA",{"v":2.5e-44,"d":"0.00"},2,"413,156,","0,2482",{"v":-43.6,"d":"-43.60"},{"v":-42.4,"d":"-42.40"},{"v":5.1,"d":"5.10"},"3' UTR",16,76435260,76447500,12241,2]
["chr16",78038691,78038869,179,"ENSBGRG00000010261","ENSBGRT00000018929",32205,"PISD","phosphatidylserine decarboxylase [Source:HGNC Symbol;Acc:HGNC:8999]","GO:0004609(phosphatidylserine decarboxylase activity);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0008654(phospholipid biosynthetic process)","00564(Glycerophospholipid metabolism)",{"v":7.9e-23,"d":"0.00"},1,"179,",0,{"v":-22.1,"d":"-22.10"},{"v":-21.1,"d":"-21.10"},3.65,"Exon (ENSBGRT00000018929/ENSBGRG00000010261, exon 9 of 9)",16,78038691,78071074,32384,2]
["chr16",79279241,79279389,149,"ENSBGRG00000023392","ENSBGRT00000043187",15783,"ADORA2A","adenosine A2a receptor [Source:HGNC Symbol;Acc:HGNC:263]","GO:0001609(G protein-coupled adenosine receptor activity);GO:0001963(synaptic transmission, dopaminergic);GO:0001973(G protein-coupled adenosine receptor signaling pathway);GO:0001975(response to amphetamine);GO:0004930(G protein-coupled receptor activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007626(locomotory behavior);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019899(enzyme binding);GO:0032230(positive regulation of synaptic transmission, GABAergic);GO:0042755(eating behavior);GO:0042802(identical protein binding);GO:0046636(negative regulation of alpha-beta T cell activation);GO:0050728(negative regulation of inflammatory response);GO:0060080(inhibitory postsynaptic potential);GO:2001235(positive regulation of apoptotic signaling pathway)","04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04270(Vascular smooth muscle contraction);05012(Parkinson disease);05034(Alcoholism)",{"v":0.041,"d":"0.04"},1,"149,",0,-1.39,{"v":-0.9,"d":"-0.90"},2.48,"3' UTR",16,79279211,79295172,15962,2]
["chr16",79582090,79582238,149,"ENSBGRG00000024348","ENSBGRT00000044942",33464,"RSPH14","radial spoke head 14 homolog [Source:HGNC Symbol;Acc:HGNC:13437]","GO:0005515(protein binding)","04730(Long-term depression)",{"v":5.2e-06,"d":"0.00"},1,"149,",0,-5.28,-4.59,4.67,"Exon (ENSBGRT00000044942/ENSBGRG00000024348, exon 4 of 7)",16,79548626,79607136,58511,1]
["chr16",80755012,80755162,151,"ENSBGRG00000020901","ENSBGRT00000038484",35203,"GNB1L","G protein subunit beta 1 like [Source:HGNC Symbol;Acc:HGNC:4397]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0035176(social behavior)","NA",{"v":0.031,"d":"0.03"},1,"151,",0,-1.51,-1.01,1.75,"3' UTR",16,80754952,80790365,35414,2]
["chr17",5697045,5701027,3983,"ENSBGRG00000005456","ENSBGRT00000010086",0,"LYSMD4","LysM domain containing 4 [Source:HGNC Symbol;Acc:HGNC:26571]","NA","NA",{"v":6.3e-80,"d":"0.00"},2,"290,1099,","0,2884",{"v":-79.2,"d":"-79.20"},{"v":-77.7,"d":"-77.70"},9.49,"5' UTR",17,5697045,5701027,3983,1]
["chr17",19995577,19995786,210,"ENSBGRG00000012912","ENSBGRT00000023629",10209,"AEN","apoptosis enhancing nuclease [Source:HGNC Symbol;Acc:HGNC:25722]","GO:0003676(nucleic acid binding);GO:0004527(exonuclease activity);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0010212(response to ionizing radiation);GO:0031965(nuclear membrane);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator)","NA",{"v":0.00018,"d":"0.00"},1,"210,",0,-3.75,-3.12,4.95,"3' UTR",17,19985368,19998108,12741,1]
["chr17",20902330,20902689,360,"ENSBGRG00000013726","ENSBGRT00000025195",52708,"ACAN","aggrecan [Source:HGNC Symbol;Acc:HGNC:319]","GO:0001502(cartilage condensation);GO:0002063(chondrocyte development);GO:0005509(calcium ion binding);GO:0005540(hyaluronic acid binding);GO:0005604(basement membrane);GO:0007155(cell adhesion);GO:0007507(heart development);GO:0030166(proteoglycan biosynthetic process);GO:0030199(collagen fibril organization);GO:0031012(extracellular matrix)","NA",{"v":7.9e-07,"d":"0.00"},1,"360,",0,{"v":-6.1,"d":"-6.10"},-5.39,7.43,"Exon (ENSBGRT00000025195/ENSBGRG00000013726, exon 12 of 19)",17,20849622,20930448,80827,1]
["chr17",22402932,22404194,1263,"ENSBGRG00000008060","ENSBGRT00000014896",0,"HDDC3","HD domain containing 3 [Source:HGNC Symbol;Acc:HGNC:30522]","NA","00230(Purine metabolism)",{"v":1E-14,"d":"0.00"},6,"112,216,250,14,14,131,","0,272,594,846,985,1132",-14,{"v":-13.1,"d":"-13.10"},4.62,"Exon (ENSBGRT00000014896/ENSBGRG00000008060, exon 1 of 4)",17,22402932,22403791,860,1]
["chr17",25979507,25979656,150,"ENSBGRG00000017033","ENSBGRT00000031333",72739,"HDGFL3","HDGF like 3 [Source:HGNC Symbol;Acc:HGNC:24937]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007026(negative regulation of microtubule depolymerization);GO:0008017(microtubule binding);GO:0015631(tubulin binding);GO:0031175(neuron projection development);GO:0046785(microtubule polymerization)","04742(Taste transduction)",{"v":0.036,"d":"0.04"},1,"150,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"3' UTR",17,25906768,25982761,75994,1]
["chr17",30385733,30393521,7789,"ENSBGRG00000014717","ENSBGRT00000027782",4547,"TARS3","threonyl-tRNA synthetase 3 [Source:HGNC Symbol;Acc:HGNC:24728]","GO:0000166(nucleotide binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004829(threonine-tRNA ligase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006418(tRNA aminoacylation for protein translation);GO:0006435(threonyl-tRNA aminoacylation);GO:0043039(tRNA aminoacylation)","00970(Aminoacyl-tRNA biosynthesis)",{"v":0.00098,"d":"0.00"},2,"143,37,","0,7752",-3.01,-2.42,1.98,"Exon (ENSBGRT00000027782/ENSBGRG00000014717, exon 3 of 17)",17,30381186,30430766,49581,1]
["chr17",34133633,34144195,10563,"ENSBGRG00000022566","ENSBGRT00000041638",25240,"PSTPIP1","proline-serine-threonine phosphatase interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:9580]","GO:0005515(protein binding);GO:0042802(identical protein binding)","04621(NOD-like receptor signaling pathway)",{"v":0.0081,"d":"0.01"},3,"65,75,39,","0,398,10524",-2.09,-1.55,1.81,"5' UTR",17,34108393,34155622,47230,1]
["chr17",36680192,36680282,91,"ENSBGRG00000004535","ENSBGRT00000008531",27646,"STRA6","stimulated by retinoic acid 6 [Source:HGNC Symbol;Acc:HGNC:30650]","GO:0001568(blood vessel development);GO:0001822(kidney development);GO:0003184(pulmonary valve morphogenesis);GO:0003281(ventricular septum development);GO:0005887(integral component of plasma membrane);GO:0007507(heart development);GO:0007612(learning);GO:0007631(feeding behavior);GO:0030324(lung development);GO:0030325(adrenal gland development);GO:0030540(female genitalia development);GO:0032991(protein-containing complex);GO:0034632(retinol transmembrane transporter activity);GO:0034633(retinol transport);GO:0038023(signaling receptor activity);GO:0042297(vocal learning);GO:0043010(camera-type eye development);GO:0043583(ear development);GO:0043585(nose morphogenesis);GO:0048286(lung alveolus development);GO:0048520(positive regulation of behavior);GO:0048546(digestive tract morphogenesis);GO:0048566(embryonic digestive tract development);GO:0048589(developmental growth);GO:0048745(smooth muscle tissue development);GO:0048844(artery morphogenesis);GO:0050890(cognition);GO:0050905(neuromuscular process);GO:0060322(head development);GO:0060323(head morphogenesis);GO:0060325(face morphogenesis);GO:0060426(lung vasculature development);GO:0060539(diaphragm development);GO:0060900(embryonic camera-type eye formation);GO:0061029(eyelid development in camera-type eye);GO:0061038(uterus morphogenesis);GO:0061143(alveolar primary septum development);GO:0061156(pulmonary artery morphogenesis);GO:0061205(paramesonephric duct development);GO:0097070(ductus arteriosus closure)","NA",{"v":5e-76,"d":"0.00"},1,"91,",0,{"v":-75.3,"d":"-75.30"},{"v":-73.9,"d":"-73.90"},4.32,"3' UTR",17,36652546,36680282,27737,1]
["chr17",46133232,46133531,300,"ENSBGRG00000008525","ENSBGRT00000015525",425131,"AKAP6","A-kinase anchoring protein 6 [Source:HGNC Symbol;Acc:HGNC:376]","GO:0005515(protein binding);GO:0005635(nuclear envelope);GO:0016529(sarcoplasmic reticulum);GO:0031965(nuclear membrane);GO:0034704(calcium channel complex);GO:0044325(ion channel binding);GO:0048471(perinuclear region of cytoplasm);GO:0060306(regulation of membrane repolarization);GO:0071320(cellular response to cAMP);GO:1901381(positive regulation of potassium ion transmembrane transport);GO:1902261(positive regulation of delayed rectifier potassium channel activity)","NA",{"v":7.8e-05,"d":"0.00"},1,"300,",0,-4.11,-3.46,{"v":16.8,"d":"16.80"},"Exon (ENSBGRT00000015525/ENSBGRG00000008525, exon 14 of 15)",17,45708101,46136474,428374,1]
["chr17",48558686,48563319,4634,"ENSBGRG00000010465","ENSBGRT00000019213",0,"PPP2R3C","protein phosphatase 2 regulatory subunit B''gamma [Source:HGNC Symbol;Acc:HGNC:17485]","GO:0001782(B cell homeostasis);GO:0002759(regulation of antimicrobial humoral response);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0032147(activation of protein kinase activity);GO:0035303(regulation of dephosphorylation);GO:0043029(T cell homeostasis);GO:0045579(positive regulation of B cell differentiation);GO:0048536(spleen development);GO:0050864(regulation of B cell activation);GO:0051900(regulation of mitochondrial depolarization)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);05165(Human papillomavirus infection)",{"v":1.6e-75,"d":"0.00"},4,"219,115,1266,18,","0,562,993,4616",{"v":-74.8,"d":"-74.80"},{"v":-73.4,"d":"-73.40"},{"v":14.5,"d":"14.50"},"5' UTR",17,48526802,48558875,32074,2]
["chr17",58932433,58932553,121,"ENSBGRG00000008250","ENSBGRT00000015273",420,"FANCM","FA complementation group M [Source:HGNC Symbol;Acc:HGNC:23168]","GO:0000712(resolution of meiotic recombination intermediates);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0004518(nuclease activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006281(DNA repair);GO:0016787(hydrolase activity);GO:0031297(replication fork processing);GO:0043138(3'-5' DNA helicase activity);GO:0043240(Fanconi anaemia nuclear complex);GO:0071821(FANCM-MHF complex);GO:1902527(positive regulation of protein monoubiquitination)","03460(Fanconi anemia pathway)",{"v":2.3E-3,"d":"0.00"},1,"121,",0,-2.63,-2.05,5.28,"Exon (ENSBGRT00000015273/ENSBGRG00000008250, exon 1 of 5)",17,58932013,58947850,15838,1]
["chr17",59612051,59613548,1498,"ENSBGRG00000013717","ENSBGRT00000025304",26732,"WDR76","WD repeat domain 76 [Source:HGNC Symbol;Acc:HGNC:25773]","GO:0000792(heterochromatin);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus);GO:0019899(enzyme binding);GO:0090734(site of DNA damage)","04120(Ubiquitin mediated proteolysis);03420(Nucleotide excision repair);04115(p53 signaling pathway);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05216(Thyroid cancer);05220(Chronic myeloid leukemia);05217(Basal cell carcinoma);05218(Melanoma);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05161(Hepatitis B)",{"v":0.00014,"d":"0.00"},2,"70,79,","0,1419",-3.86,-3.23,1.74,"Exon (ENSBGRT00000025304/ENSBGRG00000013717, exon 7 of 14)",17,59585319,59640473,55155,1]
["chr17",69950707,69950767,61,"ENSBGRG00000020081","ENSBGRT00000037007",66979,"EML1","EMAP like 1 [Source:HGNC Symbol;Acc:HGNC:3330]","GO:0000226(microtubule cytoskeleton organization);GO:0002244(hematopoietic progenitor cell differentiation);GO:0005515(protein binding);GO:0005829(cytosol);GO:0007052(mitotic spindle organization);GO:0007405(neuroblast proliferation);GO:0007420(brain development);GO:0008017(microtubule binding);GO:0015630(microtubule cytoskeleton);GO:0015631(tubulin binding);GO:0097431(mitotic spindle pole);GO:1990023(mitotic spindle midzone)","NA",0.05,1,"61,",0,{"v":-1.3,"d":"-1.30"},{"v":-0.821,"d":"-0.82"},4.95,"5' UTR",17,69883728,70112111,228384,1]
["chr17",72355481,72355600,120,"ENSBGRG00000011785","ENSBGRT00000022853",165195,"PPP2R5C","protein phosphatase 2 regulatory subunit B'gamma [Source:HGNC Symbol;Acc:HGNC:9311]","GO:0000159(protein phosphatase type 2A complex);GO:0000775(chromosome, centromeric region);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0007165(signal transduction);GO:0008285(negative regulation of cell population proliferation);GO:0019888(protein phosphatase regulator activity);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04114(Oocyte meiosis);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);05165(Human papillomavirus infection)",{"v":5e-14,"d":"0.00"},1,"120,",0,{"v":-13.3,"d":"-13.30"},{"v":-12.4,"d":"-12.40"},1.82,"3' UTR",17,72190286,72355899,165614,1]
["chr17",73704000,73705121,1122,"ENSBGRG00000023240","ENSBGRT00000042948",5308,"EIF5","eukaryotic translation initiation factor 5 [Source:HGNC Symbol;Acc:HGNC:3299]","GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006413(translational initiation);GO:0006446(regulation of translational initiation)","03013(RNA transport)",{"v":1E-117,"d":"0.00"},3,"113,159,119,","0,359,1003",-117,-115,2.12,"Exon (ENSBGRT00000042948/ENSBGRG00000023240, exon 7 of 11)",17,73698692,73706096,7405,1]
["chr17",75353295,75353766,472,"ENSBGRG00000005879","ENSBGRT00000010853",8665,"ENSBGRG00000005879","NA","NA","NA",{"v":1.1e-08,"d":"0.00"},2,"15,165,","0,307",-7.96,{"v":-7.2,"d":"-7.20"},{"v":13.9,"d":"13.90"},"3' UTR",17,75344630,75353309,8680,1]
["chr17",4757194,4806599,49406,"ENSBGRG00000004639","ENSBGRT00000008627",0,"ASB7","ankyrin repeat and SOCS box containing 7 [Source:HGNC Symbol;Acc:HGNC:17182]","GO:0005515(protein binding);GO:0035556(intracellular signal transduction)","NA",{"v":4e-54,"d":"0.00"},6,"280,100,614,269,23,42,","0,630,15649,46569,48568,49364",{"v":-53.4,"d":"-53.40"},{"v":-52.2,"d":"-52.20"},7.92,"5' UTR",17,4757824,4805784,47961,2]
["chr17",9783476,9783925,450,"ENSBGRG00000006400","ENSBGRT00000011809",4020,"NR2F2","nuclear receptor subfamily 2 group F member 2 [Source:HGNC Symbol;Acc:HGNC:7976]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001701(in utero embryonic development);GO:0001764(neuron migration);GO:0001893(maternal placenta development);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001945(lymph vessel development);GO:0001972(retinoic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007519(skeletal muscle tissue development);GO:0008270(zinc ion binding);GO:0009566(fertilization);GO:0009952(anterior/posterior pattern specification);GO:0009956(radial pattern formation);GO:0010596(negative regulation of endothelial cell migration);GO:0030900(forebrain development);GO:0042025(host cell nucleus);GO:0042803(protein homodimerization activity);GO:0043565(sequence-specific DNA binding);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0048514(blood vessel morphogenesis);GO:0060173(limb development);GO:0060674(placenta blood vessel development);GO:0060707(trophoblast giant cell differentiation);GO:0060849(regulation of transcription involved in lymphatic endothelial cell fate commitment)","NA",0,2,"171,243,","0,207",-1500,"-Inf",8.37,"Exon (ENSBGRT00000011809/ENSBGRG00000006400, exon 3 of 4)",17,9783476,9787945,4470,2]
["chr17",19909574,19909903,330,"ENSBGRG00000012708","ENSBGRT00000023399",19595,"ENSBGRG00000012708","NA","NA","04120(Ubiquitin mediated proteolysis)",{"v":5e-32,"d":"0.00"},1,"330,",0,{"v":-31.3,"d":"-31.30"},{"v":-30.3,"d":"-30.30"},2.24,"3' UTR",17,19909544,19929498,19955,2]
["chr17",21639940,21641574,1635,"ENSBGRG00000005580","ENSBGRT00000010312",6195,"KIF7","kinesin family member 7 [Source:HGNC Symbol;Acc:HGNC:30497]","GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005929(cilium);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding)","04340(Hedgehog signaling pathway);05200(Pathways in cancer);05217(Basal cell carcinoma)",{"v":2.5e-22,"d":"0.00"},3,"51,143,136,","0,456,1499",{"v":-21.6,"d":"-21.60"},{"v":-20.6,"d":"-20.60"},2.32,"Exon (ENSBGRT00000010312/ENSBGRG00000005580, exon 6 of 18)",17,21629843,21647769,17927,2]
["chr17",23669388,23671667,2280,"ENSBGRG00000012385","ENSBGRT00000023704",1257,"ENSBGRG00000012385","NA","GO:0003676(nucleic acid binding);GO:0003730(mRNA 3'-UTR binding);GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation);GO:0006417(regulation of translation);GO:0045182(translation regulator activity)","04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation);03010(Ribosome)",0,3,"51,66,3,","0,1330,2277",-849,"-Inf",1.88,"Exon (ENSBGRT00000023704/ENSBGRG00000012385, exon 3 of 5)",17,23669358,23672924,3567,2]
["chr17",28847828,28850465,2638,"ENSBGRG00000008601","ENSBGRT00000015826",29588,"FAN1","FANCD2 and FANCI associated nuclease 1 [Source:HGNC Symbol;Acc:HGNC:29170]","GO:0000724(double-strand break repair via homologous recombination);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0004518(nuclease activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0006289(nucleotide-excision repair);GO:0008409(5'-3' exonuclease activity);GO:0016788(hydrolase activity, acting on ester bonds);GO:0017108(5'-flap endonuclease activity);GO:0033683(nucleotide-excision repair, DNA incision);GO:0036297(interstrand cross-link repair);GO:0045171(intercellular bridge);GO:0070336(flap-structured DNA binding);GO:0140036(ubiquitin-dependent protein binding)","03460(Fanconi anemia pathway)",{"v":1.3e-89,"d":"0.00"},2,"785,138,","0,2500",{"v":-88.9,"d":"-88.90"},{"v":-87.5,"d":"-87.50"},8.38,"3' UTR",17,28818240,28853014,34775,1]
["chr17",32882319,32882408,90,"ENSBGRG00000019896","ENSBGRT00000036556",15227,"CHRNB4","cholinergic receptor nicotinic beta 4 subunit [Source:HGNC Symbol;Acc:HGNC:1964]","GO:0001508(action potential);GO:0004888(transmembrane signaling receptor activity);GO:0005216(ion channel activity);GO:0005230(extracellular ligand-gated ion channel activity);GO:0005892(acetylcholine-gated channel complex);GO:0006811(ion transport);GO:0006939(smooth muscle contraction);GO:0006940(regulation of smooth muscle contraction);GO:0007165(signal transduction);GO:0007626(locomotory behavior);GO:0015464(acetylcholine receptor activity);GO:0016021(integral component of membrane);GO:0022848(acetylcholine-gated cation-selective channel activity);GO:0034220(ion transmembrane transport);GO:0035094(response to nicotine);GO:0035095(behavioral response to nicotine);GO:0042391(regulation of membrane potential);GO:0045211(postsynaptic membrane);GO:0051971(positive regulation of transmission of nerve impulse);GO:0060084(synaptic transmission involved in micturition)","04080(Neuroactive ligand-receptor interaction);04725(Cholinergic synapse)",{"v":0.016,"d":"0.02"},1,"90,",0,-1.79,-1.27,3.47,"Exon (ENSBGRT00000036556/ENSBGRG00000019896, exon 5 of 6)",17,32875159,32897635,22477,2]
["chr17",35570170,35571035,866,"ENSBGRG00000024963","ENSBGRT00000046083",6993,"C15orf39","chromosome 15 open reading frame 39 [Source:HGNC Symbol;Acc:HGNC:24497]","GO:0005829(cytosol)","NA",{"v":1.3e-48,"d":"0.00"},1,"866,",0,{"v":-47.9,"d":"-47.90"},{"v":-46.7,"d":"-46.70"},3.88,"Exon (ENSBGRT00000046083/ENSBGRG00000024963, exon 2 of 3)",17,35566516,35578028,11513,2]
["chr17",36881960,36882049,90,"ENSBGRG00000005233","ENSBGRT00000009649",0,"LOXL1","lysyl oxidase like 1 [Source:HGNC Symbol;Acc:HGNC:6665]","GO:0005507(copper ion binding);GO:0016641(oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor);GO:0055114(oxidation-reduction process)","NA",{"v":0.00046,"d":"0.00"},1,"90,",0,-3.34,-2.73,1.85,"Exon (ENSBGRT00000009649/ENSBGRG00000005233, exon 1 of 7)",17,36855873,36882049,26177,2]
["chr17",44518154,44519144,991,"ENSBGRG00000007751","ENSBGRT00000014266",53642,"HECTD1","HECT domain E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:20157]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0016567(protein ubiquitination);GO:0046872(metal ion binding)","NA",{"v":1.6e-22,"d":"0.00"},2,"52,248,","0,743",{"v":-21.8,"d":"-21.80"},{"v":-20.8,"d":"-20.80"},2.97,"Exon (ENSBGRT00000014266/ENSBGRG00000007751, exon 25 of 43)",17,44490968,44572786,81819,2]
["chr17",59044035,59046928,2894,"ENSBGRG00000008879","ENSBGRT00000016240",597,"MIS18BP1","MIS18 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:20190]","GO:0003677(DNA binding)","NA",{"v":0.036,"d":"0.04"},2,"34,26,","0,2868",-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000016240/ENSBGRG00000008879, exon 1 of 14)",17,59000736,59047525,46790,2]
["chr17",59571604,59580238,8635,"ENSBGRG00000013656","ENSBGRT00000025029",3850,"MFAP1","microfibril associated protein 1 [Source:HGNC Symbol;Acc:HGNC:7032]","GO:0000398(mRNA splicing, via spliceosome);GO:0001527(microfibril);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0071005(U2-type precatalytic spliceosome)","NA",{"v":1E-187,"d":"0.00"},8,"694,90,160,161,109,188,130,33,","0,787,3476,4545,4809,5658,6130,8602",-187,-185,6.05,"3' UTR",17,59571604,59584088,12485,2]
["chr17",60827974,60828330,357,"ENSBGRG00000017027","ENSBGRT00000031373",98321,"FBLN5","fibulin 5 [Source:HGNC Symbol;Acc:HGNC:3602]","GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0008022(protein C-terminus binding);GO:0042803(protein homodimerization activity);GO:0046903(secretion);GO:0048251(elastic fiber assembly);GO:0062023(collagen-containing extracellular matrix)","NA",0,1,"357,",0,-524,"-Inf",6.29,"3' UTR",17,60827974,60926651,98678,2]
["chr17",63213007,63216517,3511,"ENSBGRG00000013664","ENSBGRT00000025354",0,"DDX24","DEAD-box helicase 24 [Source:HGNC Symbol;Acc:HGNC:13266]","GO:0003676(nucleic acid binding);GO:0005524(ATP binding);GO:0005730(nucleolus)","NA",{"v":9.99999999999999e-272,"d":"0.00"},4,"402,154,400,88,","0,724,1945,3423",-271,-269,8.52,"Exon (ENSBGRT00000025354/ENSBGRG00000013664, exon 1 of 8)",17,63203765,63215062,11298,2]
["chr17",69755278,69755635,358,"ENSBGRG00000019695","ENSBGRT00000036300",179,"CCDC85C","coiled-coil domain containing 85C [Source:HGNC Symbol;Acc:HGNC:35459]","GO:0005912(adherens junction);GO:0021987(cerebral cortex development);GO:0043296(apical junction complex)","NA",{"v":4.2e-06,"d":"0.00"},1,"358,",0,-5.38,-4.69,4.29,"Exon (ENSBGRT00000036300/ENSBGRG00000019695, exon 1 of 7)",17,69664064,69755814,91751,2]
["chr17",72724148,72726428,2281,"ENSBGRG00000016232","ENSBGRT00000029766",0,"U5","U5 spliceosomal RNA [Source:RFAM;Acc:RF00020]","NA","NA",{"v":1e-15,"d":"0.00"},2,"61,118,","0,2163",-15,{"v":-14.1,"d":"-14.10"},3.68,"Exon (ENSBGRT00000029766/ENSBGRG00000016232, exon 1 of 1)",17,72725097,72725213,117,1]
["chr17",75522825,75523242,418,"ENSBGRG00000006476","ENSBGRT00000012293",59223,"BRF1","BRF1 RNA polymerase III transcription initiation factor subunit [Source:HGNC Symbol;Acc:HGNC:11551]","GO:0006355(regulation of transcription, DNA-templated);GO:0017025(TBP-class protein binding);GO:0070897(transcription preinitiation complex assembly)","NA",{"v":9.99999999999998e-249,"d":"0.00"},1,"418,",0,-248,-246,{"v":16.1,"d":"16.10"},"3' UTR",17,75522825,75582465,59641,2]
["chr18",3053181,3053241,61,"ENSBGRG00000012697","ENSBGRT00000023312",180876,"MTSS1","MTSS I-BAR domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20443]","GO:0003779(actin binding);GO:0003785(actin monomer binding);GO:0005102(signaling receptor binding);GO:0007009(plasma membrane organization);GO:0015629(actin cytoskeleton);GO:0030036(actin cytoskeleton organization);GO:0042802(identical protein binding)","NA",{"v":3.2e-11,"d":"0.00"},1,"61,",0,{"v":-10.5,"d":"-10.50"},-9.66,1.94,"3' UTR",18,2872305,3054559,182255,1]
["chr18",12347907,12352507,4601,"ENSBGRG00000021817","ENSBGRT00000040476",63996,"PHF20L1","PHD finger protein 20 like 1 [Source:HGNC Symbol;Acc:HGNC:24280]","GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":0.0089,"d":"0.01"},2,"141,130,","0,4471",-2.05,-1.51,8.91,"Exon (ENSBGRT00000040476/ENSBGRG00000021817, exon 14 of 21)",18,12283911,12362391,78481,1]
["chr18",20545183,20545422,240,"ENSBGRG00000005027","ENSBGRT00000009250",10210,"RHPN1","rhophilin Rho GTPase binding protein 1 [Source:HGNC Symbol;Acc:HGNC:19973]","GO:0005515(protein binding);GO:0007165(signal transduction)","NA",{"v":0.00036,"d":"0.00"},1,"240,",0,-3.44,-2.82,2.43,"3' UTR",18,20534973,20547061,12089,1]
["chr18",20829037,20837958,8922,"ENSBGRG00000006055","ENSBGRT00000011258",573,"ENSBGRG00000006055","NA","NA","NA",{"v":5e-38,"d":"0.00"},10,"82,165,192,63,63,140,55,93,109,85,","0,234,466,734,1346,8004,8207,8373,8635,8837",{"v":-37.3,"d":"-37.30"},{"v":-36.1,"d":"-36.10"},6.52,"Exon (ENSBGRT00000011258/ENSBGRG00000006055, exon 2 of 13)",18,20828464,20838563,10100,1]
["chr18",21447580,21449010,1431,"ENSBGRG00000018411","ENSBGRT00000034022",1895,"KIFC2","kinesin family member C2 [Source:HGNC Symbol;Acc:HGNC:29530]","GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding)","NA",{"v":1.6e-21,"d":"0.00"},6,"111,66,129,78,115,8,","0,216,367,1042,1235,1423",{"v":-20.8,"d":"-20.80"},{"v":-19.8,"d":"-19.80"},3.67,"Exon (ENSBGRT00000034022/ENSBGRG00000018411, exon 6 of 19)",18,21445685,21456547,10863,1]
["chr18",26771358,26771538,181,"ENSBGRG00000015785","ENSBGRT00000029091",0,"GDAP1","ganglioside induced differentiation associated protein 1 [Source:HGNC Symbol;Acc:HGNC:15968]","GO:0000266(mitochondrial fission);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006626(protein targeting to mitochondrion);GO:0008053(mitochondrial fusion);GO:0031307(integral component of mitochondrial outer membrane);GO:0032526(response to retinoic acid)","NA",{"v":0.011,"d":"0.01"},1,"181,",0,-1.95,-1.42,4.46,"5' UTR",18,26771358,26788566,17209,1]
["chr18",45516080,45517126,1047,"ENSBGRG00000004707","ENSBGRT00000008675",13741,"SYBU","syntabulin [Source:HGNC Symbol;Acc:HGNC:26011]","GO:0005874(microtubule);GO:0017075(syntaxin-1 binding);GO:0019894(kinesin binding);GO:0031982(vesicle);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":1.2e-06,"d":"0.00"},1,"1047,",0,-5.91,-5.21,{"v":16.8,"d":"16.80"},"Exon (ENSBGRT00000008675/ENSBGRG00000004707, exon 4 of 4)",18,45502339,45517126,14788,1]
["chr18",55494027,55494296,270,"ENSBGRG00000009988","ENSBGRT00000018404",95270,"ANKRD46","ankyrin repeat domain 46 [Source:HGNC Symbol;Acc:HGNC:27229]","GO:0005515(protein binding)","04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04024(cAMP signaling pathway);04210(Apoptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04657(IL-17 signaling pathway);04662(B cell receptor signaling pathway);04062(Chemokine signaling pathway);04920(Adipocytokine signaling pathway);04926(Relaxin signaling pathway);04722(Neurotrophin signaling pathway);04380(Osteoclast differentiation);05200(Pathways in cancer);05203(Viral carcinogenesis);05220(Chronic myeloid leukemia);05215(Prostate cancer);05222(Small cell lung cancer);04931(Insulin resistance);05134(Legionellosis);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05168(Herpes simplex infection);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05145(Toxoplasmosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis))",0.02,1,"270,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"3' UTR",18,55398757,55494384,95628,1]
["chr18",62370790,62371415,626,"ENSBGRG00000008787","ENSBGRT00000016085",59118,"GEM","GTP binding protein overexpressed in skeletal muscle [Source:HGNC Symbol;Acc:HGNC:4234]","GO:0000278(mitotic cell cycle);GO:0000287(magnesium ion binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0007165(signal transduction);GO:0009898(cytoplasmic side of plasma membrane);GO:0016020(membrane);GO:0019003(GDP binding);GO:0030496(midbody);GO:0051233(spindle midzone);GO:0051276(chromosome organization);GO:0051310(metaphase plate congression);GO:0072686(mitotic spindle);GO:1901842(negative regulation of high voltage-gated calcium channel activity)","NA",0,1,"626,",0,-1680,"-Inf",{"v":5.5,"d":"5.50"},"3' UTR",18,62311672,62371980,60309,1]
["chr18",74566660,74618048,51389,"ENSBGRG00000015859","ENSBGRT00000029497",0,"DEPTOR","DEP domain containing MTOR interacting protein [Source:HGNC Symbol;Acc:HGNC:22953]","GO:0005515(protein binding);GO:0006469(negative regulation of protein kinase activity);GO:0032007(negative regulation of TOR signaling);GO:0035556(intracellular signal transduction);GO:0045792(negative regulation of cell size);GO:2001236(regulation of extrinsic apoptotic signaling pathway)","04150(mTOR signaling pathway);04140(Autophagy - animal)",{"v":2.9e-06,"d":"0.00"},3,"191,179,20,","0,50107,51369",-5.54,-4.84,7.92,"Exon (ENSBGRT00000029376/ENSBGRG00000015859, exon 1 of 9)",18,74566762,74749066,182305,1]
["chr18",955119,955296,178,"ENSBGRG00000009732","ENSBGRT00000017852",473,"ENSBGRG00000009732","NA","NA","NA",{"v":2.3E-3,"d":"0.00"},1,"178,",0,-2.63,-2.06,4.46,"Exon (ENSBGRT00000017852/ENSBGRG00000009732, exon 1 of 1)",18,954498,955769,1272,2]
["chr18",12175446,12175505,60,"ENSBGRG00000021441","ENSBGRT00000039641",40809,"LRRC6","leucine rich repeat containing 6 [Source:HGNC Symbol;Acc:HGNC:16725]","GO:0003341(cilium movement);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005929(cilium);GO:0008584(male gonad development);GO:0030317(flagellated sperm motility);GO:0036158(outer dynein arm assembly);GO:0036159(inner dynein arm assembly);GO:0043393(regulation of protein binding);GO:0044458(motile cilium assembly);GO:0060287(epithelial cilium movement involved in determination of left/right asymmetry);GO:0061458(reproductive system development)","NA",{"v":6.2E-4,"d":"0.00"},1,"60,",0,-3.21,-2.61,1.93,"Exon (ENSBGRT00000039641/ENSBGRG00000021441, exon 6 of 12)",18,12140279,12216314,76036,2]
["chr18",18997306,18997723,418,"ENSBGRG00000025134","ENSBGRT00000046457",10207,"GPR20","G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:HGNC:4475]","GO:0004930(G protein-coupled receptor activity);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0043235(receptor complex)","NA",{"v":0.00026,"d":"0.00"},1,"418,",0,-3.58,-2.95,8.91,"Exon (ENSBGRT00000046457/ENSBGRG00000025134, exon 3 of 3)",18,18996086,19007930,11845,2]
["chr18",20890520,20890906,387,"ENSBGRG00000007392","ENSBGRT00000013677",4112,"ENSBGRG00000007392","NA","NA","NA",{"v":3.2e-25,"d":"0.00"},1,"387,",0,{"v":-24.5,"d":"-24.50"},{"v":-23.5,"d":"-23.50"},6.58,"3' UTR",18,20890520,20895018,4499,2]
["chr18",21037284,21038101,818,"ENSBGRG00000010159","ENSBGRT00000018947",2062,"PARP10","poly(ADP-ribose) polymerase family member 10 [Source:HGNC Symbol;Acc:HGNC:25895]","GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0005829(cytosol)","NA",{"v":2E-52,"d":"0.00"},2,"544,86,","0,732",{"v":-51.7,"d":"-51.70"},{"v":-50.5,"d":"-50.50"},4.51,"Exon (ENSBGRT00000018947/ENSBGRG00000010159, exon 7 of 11)",18,21032489,21040163,7675,2]
["chr18",21511763,21513037,1275,"ENSBGRG00000019546","ENSBGRT00000036055",1729,"LRRC24","leucine rich repeat containing 24 [Source:HGNC Symbol;Acc:HGNC:28947]","GO:0005515(protein binding);GO:0051965(positive regulation of synapse assembly)","NA",{"v":2e-34,"d":"0.00"},2,"648,132,","0,1143",{"v":-33.7,"d":"-33.70"},{"v":-32.6,"d":"-32.60"},8.91,"Exon (ENSBGRT00000036055/ENSBGRG00000019546, exon 4 of 5)",18,21511733,21514766,3034,2]
["chr18",32574516,32575084,569,"ENSBGRG00000017930","ENSBGRT00000032916",1936,"HEY1","hes related family bHLH transcription factor with YRPW motif 1 [Source:HGNC Symbol;Acc:HGNC:4880]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001525(angiogenesis);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0007219(Notch signaling pathway);GO:0045746(negative regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046983(protein dimerization activity);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000678(negative regulation of transcription regulatory region DNA binding);GO:2000820(negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation)","05200(Pathways in cancer);05224(Breast cancer);05165(Human papillomavirus infection)",{"v":6.2e-09,"d":"0.00"},1,"569,",0,-8.21,-7.45,{"v":3.5,"d":"3.50"},"Exon (ENSBGRT00000032916/ENSBGRG00000017930, exon 5 of 5)",18,32574516,32577020,2505,2]
["chr18",46791542,46799161,7620,"ENSBGRG00000005080","ENSBGRT00000009361",163876,"EMC2","ER membrane protein complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:28963]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0072546(ER membrane protein complex)","NA",{"v":7.9e-58,"d":"0.00"},3,"20,114,105,","0,538,7515",{"v":-57.1,"d":"-57.10"},{"v":-55.9,"d":"-55.90"},3.96,"Exon (ENSBGRT00000009361/ENSBGRG00000005080, exon 3 of 12)",18,46746523,46963037,216515,2]
["chr18",52015944,52210405,194462,"ENSBGRG00000006606","ENSBGRT00000012697",599,"RIMS2","regulating synaptic membrane exocytosis 2 [Source:HGNC Symbol;Acc:HGNC:17283]","GO:0005515(protein binding);GO:0006886(intracellular protein transport);GO:0006887(exocytosis);GO:0016020(membrane);GO:0017137(Rab GTPase binding);GO:0017157(regulation of exocytosis);GO:0048786(presynaptic active zone);GO:0048791(calcium ion-regulated exocytosis of neurotransmitter);GO:1903861(positive regulation of dendrite extension)","04911(Insulin secretion)",0.02,5,"251,211,87,33,18,","0,58700,77877,78365,194444",-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000012697/ENSBGRG00000006606, exon 1 of 33)",18,51559344,52211004,651661,2]
["chr18",69134122,69134601,480,"ENSBGRG00000013430","ENSBGRT00000025218",103714,"WWP1","WW domain containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:17004]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0061630(ubiquitin protein ligase activity)","04120(Ubiquitin mediated proteolysis);04144(Endocytosis)",{"v":7.9e-87,"d":"0.00"},1,"480,",0,{"v":-86.1,"d":"-86.10"},{"v":-84.6,"d":"-84.60"},3.22,"3' UTR",18,69133972,69238315,104344,2]
["chr18",70371270,70376245,4976,"ENSBGRG00000011071","ENSBGRT00000020168",37313,"LRRCC1","leucine rich repeat and coiled-coil centrosomal protein 1 [Source:HGNC Symbol;Acc:HGNC:29373]","GO:0005515(protein binding);GO:0005813(centrosome)","NA",{"v":1e-163,"d":"0.00"},3,"170,209,129,","0,261,4847",-163,-162,2.68,"3' UTR",18,70356773,70413558,56786,2]
["chr19",5252973,5253183,211,"ENSBGRG00000026479","ENSBGRT00000049028",6413,"SOX9","SRY-box transcription factor 9 [Source:HGNC Symbol;Acc:HGNC:11204]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0001502(cartilage condensation);GO:0001503(ossification);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001708(cell fate specification);GO:0001837(epithelial to mesenchymal transition);GO:0001894(tissue homeostasis);GO:0001934(positive regulation of protein phosphorylation);GO:0001942(hair follicle development);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002062(chondrocyte differentiation);GO:0002063(chondrocyte development);GO:0002683(negative regulation of immune system process);GO:0003170(heart valve development);GO:0003179(heart valve morphogenesis);GO:0003180(aortic valve morphogenesis);GO:0003188(heart valve formation);GO:0003203(endocardial cushion morphogenesis);GO:0003413(chondrocyte differentiation involved in endochondral bone morphogenesis);GO:0003415(chondrocyte hypertrophy);GO:0003430(growth plate cartilage chondrocyte growth);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0006334(nucleosome assembly);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007219(Notch signaling pathway);GO:0007283(spermatogenesis);GO:0007417(central nervous system development);GO:0007507(heart development);GO:0008013(beta-catenin binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0010468(regulation of gene expression);GO:0010564(regulation of cell cycle process);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010634(positive regulation of epithelial cell migration);GO:0014032(neural crest cell development);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0019100(male germ-line sex determination);GO:0019933(cAMP-mediated signaling);GO:0030154(cell differentiation);GO:0030155(regulation of cell adhesion);GO:0030198(extracellular matrix organization);GO:0030238(male sex determination);GO:0030279(negative regulation of ossification);GO:0030502(negative regulation of bone mineralization);GO:0030850(prostate gland development);GO:0030857(negative regulation of epithelial cell differentiation);GO:0030858(positive regulation of epithelial cell differentiation);GO:0030879(mammary gland development);GO:0030903(notochord development);GO:0030916(otic vesicle formation);GO:0031018(endocrine pancreas development);GO:0032331(negative regulation of chondrocyte differentiation);GO:0032332(positive regulation of chondrocyte differentiation);GO:0032808(lacrimal gland development);GO:0032991(protein-containing complex);GO:0034236(protein kinase A catalytic subunit binding);GO:0034504(protein localization to nucleus);GO:0035019(somatic stem cell population maintenance);GO:0035622(intrahepatic bile duct development);GO:0042127(regulation of cell population proliferation);GO:0043066(negative regulation of apoptotic process);GO:0043491(protein kinase B signaling);GO:0043565(sequence-specific DNA binding);GO:0045165(cell fate commitment);GO:0045595(regulation of cell differentiation);GO:0045662(negative regulation of myoblast differentiation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045732(positive regulation of protein catabolic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046322(negative regulation of fatty acid oxidation);GO:0046533(negative regulation of photoreceptor cell differentiation);GO:0048709(oligodendrocyte differentiation);GO:0048873(homeostasis of number of cells within a tissue);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051216(cartilage development);GO:0060008(Sertoli cell differentiation);GO:0060009(Sertoli cell development);GO:0060018(astrocyte fate commitment);GO:0060041(retina development in camera-type eye);GO:0060174(limb bud formation);GO:0060221(retinal rod cell differentiation);GO:0060350(endochondral bone morphogenesis);GO:0060441(epithelial tube branching involved in lung morphogenesis);GO:0060487(lung epithelial cell differentiation);GO:0060512(prostate gland morphogenesis);GO:0060517(epithelial cell proliferation involved in prostatic bud elongation);GO:0060532(bronchus cartilage development);GO:0060534(trachea cartilage development);GO:0060729(intestinal epithelial structure maintenance);GO:0060784(regulation of cell proliferation involved in tissue homeostasis);GO:0061036(positive regulation of cartilage development);GO:0061046(regulation of branching involved in lung morphogenesis);GO:0061138(morphogenesis of a branching epithelium);GO:0061145(lung smooth muscle development);GO:0065003(protein-containing complex assembly);GO:0070168(negative regulation of biomineral tissue development);GO:0070371(ERK1 and ERK2 cascade);GO:0070384(Harderian gland development);GO:0070542(response to fatty acid);GO:0071260(cellular response to mechanical stimulus);GO:0071300(cellular response to retinoic acid);GO:0071347(cellular response to interleukin-1);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0071504(cellular response to heparin);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:0071599(otic vesicle development);GO:0072034(renal vesicle induction);GO:0072170(metanephric tubule development);GO:0072189(ureter development);GO:0072190(ureter urothelium development);GO:0072193(ureter smooth muscle cell differentiation);GO:0072197(ureter morphogenesis);GO:0072289(metanephric nephron tubule formation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090103(cochlea morphogenesis);GO:0090184(positive regulation of kidney development);GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis);GO:0097065(anterior head development);GO:0097157(pre-mRNA intronic binding);GO:0098609(cell-cell adhesion);GO:1901203(positive regulation of extracellular matrix assembly);GO:1902732(positive regulation of chondrocyte proliferation);GO:1902894(negative regulation of pri-miRNA transcription by RNA polymerase II);GO:1904864(negative regulation of beta-catenin-TCF complex assembly);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000020(positive regulation of male gonad development);GO:2000138(positive regulation of cell proliferation involved in heart morphogenesis);GO:2000741(positive regulation of mesenchymal stem cell differentiation);GO:2000794(regulation of epithelial cell proliferation involved in lung morphogenesis);GO:2001054(negative regulation of mesenchymal cell apoptotic process)","04024(cAMP signaling pathway)",{"v":0.00052,"d":"0.00"},1,"211,",0,-3.28,-2.68,{"v":13.9,"d":"13.90"},"3' UTR",19,5246560,5253422,6863,1]
["chr19",7450708,7457442,6735,"ENSBGRG00000012539","ENSBGRT00000022919",56202,"GPRC5C","G protein-coupled receptor class C group 5 member C [Source:HGNC Symbol;Acc:HGNC:13309]","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","NA",{"v":0.00052,"d":"0.00"},4,"139,38,297,120,","0,4049,4516,6615",-3.28,-2.68,{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000023503/ENSBGRG00000012732, exon 4 of 6)",19,7394506,7494428,99923,1]
["chr19",8123433,8137654,14222,"ENSBGRG00000016610","ENSBGRT00000030522",1504,"ARMC7","armadillo repeat containing 7 [Source:HGNC Symbol;Acc:HGNC:26168]","GO:0005515(protein binding)","NA",{"v":0.049,"d":"0.05"},2,"15,46,","0,14176",-1.31,-0.83,1.71,"Exon (ENSBGRT00000030522/ENSBGRG00000016610, exon 2 of 3)",19,8121929,8139201,17273,1]
["chr19",9653580,9653669,90,"ENSBGRG00000011899","ENSBGRT00000021785",33556,"MFSD11","major facilitator superfamily domain containing 11 [Source:HGNC Symbol;Acc:HGNC:25458]","NA","NA",{"v":0.0093,"d":"0.01"},1,"90,",0,-2.03,-1.49,{"v":1.5,"d":"1.50"},"Exon (ENSBGRT00000021785/ENSBGRG00000011899, exon 14 of 14)",19,9620024,9653699,33676,1]
["chr19",12520067,12520243,177,"ENSBGRG00000021182","ENSBGRT00000039088",59,"ENSBGRG00000021182","NA","NA","NA",{"v":1.1e-06,"d":"0.00"},1,"177,",0,-5.95,-5.24,8.91,"Exon (ENSBGRT00000039088/ENSBGRG00000021182, exon 1 of 2)",19,12520008,12524108,4101,1]
["chr19",12760978,12768485,7508,"ENSBGRG00000022237","ENSBGRT00000041146",97749,"SLC26A11","solute carrier family 26 member 11 [Source:HGNC Symbol;Acc:HGNC:14471]","GO:0005654(nucleoplasm);GO:0005765(lysosomal membrane);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0008271(secondary active sulfate transmembrane transporter activity);GO:0008272(sulfate transport);GO:0008509(anion transmembrane transporter activity);GO:0015116(sulfate transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport)","NA",{"v":0.0062,"d":"0.01"},6,"43,105,181,174,138,320,","0,1398,2648,3730,4282,7188",-2.21,-1.67,9.91,"Exon (ENSBGRT00000043517/ENSBGRG00000022479, exon 16 of 69)",19,12663229,12828588,165360,1]
["chr19",13789055,13789364,310,"ENSBGRG00000025318","ENSBGRT00000046815",55028,"BAHCC1","BAH domain and coiled-coil containing 1 [Source:HGNC Symbol;Acc:HGNC:29279]","GO:0003682(chromatin binding)","NA",{"v":6.6e-05,"d":"0.00"},2,"6,205,","0,105",-4.18,-3.53,{"v":2.5,"d":"2.50"},"Exon (ENSBGRT00000046815/ENSBGRG00000025318, exon 19 of 30)",19,13734027,13797669,63643,1]
["chr19",15224267,15224507,241,"ENSBGRG00000006866","ENSBGRT00000012661",11199,"FN3K","fructosamine 3 kinase [Source:HGNC Symbol;Acc:HGNC:24822]","GO:0030387(fructosamine-3-kinase activity);GO:0030389(fructosamine metabolic process);GO:0030855(epithelial cell differentiation);GO:0036525(protein deglycation)","NA",{"v":0.0016,"d":"0.00"},1,"241,",0,-2.79,-2.21,1.62,"Exon (ENSBGRT00000012661/ENSBGRG00000006866, exon 6 of 6)",19,15213068,15224597,11530,1]
["chr19",17044110,17045336,1227,"ENSBGRG00000011837","ENSBGRT00000021575",86485,"ERN1","endoplasmic reticulum to nucleus signaling 1 [Source:HGNC Symbol;Acc:HGNC:3449]","GO:0000287(magnesium ion binding);GO:0001935(endothelial cell proliferation);GO:0004519(endonuclease activity);GO:0004521(endoribonuclease activity);GO:0004540(ribonuclease activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005161(platelet-derived growth factor receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005637(nuclear inner membrane);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006379(mRNA cleavage);GO:0006397(mRNA processing);GO:0006468(protein phosphorylation);GO:0007050(cell cycle arrest);GO:0007257(activation of JUN kinase activity);GO:0019899(enzyme binding);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0030544(Hsp70 protein binding);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0033120(positive regulation of RNA splicing);GO:0034620(cellular response to unfolded protein);GO:0034976(response to endoplasmic reticulum stress);GO:0035924(cellular response to vascular endothelial growth factor stimulus);GO:0036289(peptidyl-serine autophosphorylation);GO:0036498(IRE1-mediated unfolded protein response);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043531(ADP binding);GO:0046777(protein autophosphorylation);GO:0051879(Hsp90 protein binding);GO:0070054(mRNA splicing, via endonucleolytic cleavage and ligation);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress);GO:0071333(cellular response to glucose stimulus);GO:0098787(mRNA cleavage involved in mRNA processing);GO:1900103(positive regulation of endoplasmic reticulum unfolded protein response);GO:1901142(insulin metabolic process);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1990579(peptidyl-serine trans-autophosphorylation);GO:1990597(AIP1-IRE1 complex);GO:1990604(IRE1-TRAF2-ASK1 complex);GO:1990630(IRE1-RACK1-PP2A complex)","04141(Protein processing in endoplasmic reticulum);04140(Autophagy - animal);04210(Apoptosis);05010(Alzheimer disease);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":6.3e-37,"d":"0.00"},3,"21,68,210,","0,455,1017",{"v":-36.2,"d":"-36.20"},{"v":-35.1,"d":"-35.10"},9.19,"Exon (ENSBGRT00000021575/ENSBGRG00000011837, exon 20 of 22)",19,16957625,17045336,87712,1]
["chr19",20421269,20421359,91,"ENSBGRG00000021695","ENSBGRT00000040369",18132,"ENSBGRG00000021695","NA","GO:0005484(SNAP receptor activity);GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016192(vesicle-mediated transport)","04130(SNARE interactions in vesicular transport)",{"v":0.034,"d":"0.03"},1,"91,",0,-1.47,{"v":-0.977,"d":"-0.98"},4.46,"3' UTR",19,20403137,20421896,18760,1]
["chr19",21226610,21227337,728,"ENSBGRG00000024717","ENSBGRT00000045801",35990,"EFTUD2","elongation factor Tu GTP binding domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30858]","GO:0000398(mRNA splicing, via spliceosome);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0015030(Cajal body);GO:0016607(nuclear speck);GO:0043231(intracellular membrane-bounded organelle);GO:0046540(U4/U6 x U5 tri-snRNP complex);GO:0071005(U2-type precatalytic spliceosome);GO:0071007(U2-type catalytic step 2 spliceosome);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)",{"v":4e-26,"d":"0.00"},3,"35,108,96,","0,192,632",{"v":-25.4,"d":"-25.40"},{"v":-24.4,"d":"-24.40"},2.33,"Exon (ENSBGRT00000045801/ENSBGRG00000024717, exon 25 of 27)",19,21190620,21227337,36718,1]
["chr19",21840136,21840701,566,"ENSBGRG00000025857","ENSBGRT00000048140",15453,"UBTF","upstream binding transcription factor [Source:HGNC Symbol;Acc:HGNC:12511]","GO:0001164(RNA polymerase I core promoter sequence-specific DNA binding);GO:0001165(RNA polymerase I cis-regulatory region sequence-specific DNA binding);GO:0001181(RNA polymerase I general transcription initiation factor activity);GO:0001650(fibrillar center);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006360(transcription by RNA polymerase I);GO:0006361(transcription initiation from RNA polymerase I promoter);GO:0097110(scaffold protein binding)","NA",{"v":2E-46,"d":"0.00"},3,"2,144,244,","0,100,322",{"v":-45.7,"d":"-45.70"},{"v":-44.5,"d":"-44.50"},1.94,"3' UTR",19,21824683,21840701,16019,1]
["chr19",23345765,23345824,60,"ENSBGRG00000009321","ENSBGRT00000017219",30,"RETREG3","reticulophagy regulator family member 3 [Source:HGNC Symbol;Acc:HGNC:27258]","GO:0010976(positive regulation of neuron projection development);GO:0032991(protein-containing complex)","03040(Spliceosome)",{"v":0.026,"d":"0.03"},1,"60,",0,-1.58,-1.08,1.58,"Exon (ENSBGRT00000017219/ENSBGRG00000009321, exon 1 of 9)",19,23345735,23365387,19653,1]
["chr19",23838972,23839092,121,"ENSBGRG00000012275","ENSBGRT00000022781",239,"DHX58","DExH-box helicase 58 [Source:HGNC Symbol;Acc:HGNC:29517]","GO:0003677(DNA binding);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0009615(response to virus);GO:0009617(response to bacterium);GO:0016787(hydrolase activity);GO:0032480(negative regulation of type I interferon production);GO:0032481(positive regulation of type I interferon production);GO:0039534(negative regulation of MDA-5 signaling pathway);GO:0039536(negative regulation of RIG-I signaling pathway);GO:0045088(regulation of innate immune response);GO:0045824(negative regulation of innate immune response);GO:1900245(positive regulation of MDA-5 signaling pathway);GO:1900246(positive regulation of RIG-I signaling pathway)","04622(RIG-I-like receptor signaling pathway)",0.04,1,"121,",0,{"v":-1.4,"d":"-1.40"},-0.91,2.97,"5' UTR",19,23838733,23852025,13293,1]
["chr19",25593609,25594150,542,"ENSBGRG00000017101","ENSBGRT00000031637",29066,"TNS4","tensin 4 [Source:HGNC Symbol;Acc:HGNC:24352]","GO:0005515(protein binding);GO:0005925(focal adhesion);GO:0008104(protein localization)","NA",{"v":0.034,"d":"0.03"},2,"23,158,","0,384",-1.47,{"v":-0.977,"d":"-0.98"},4.46,"3' UTR",19,25564543,25593631,29089,1]
["chr19",27229211,27229330,120,"ENSBGRG00000015572","ENSBGRT00000028577",510,"EPOP","elongin BC and polycomb repressive complex 2 associated protein [Source:HGNC Symbol;Acc:HGNC:34493]","GO:0003682(chromatin binding);GO:0006357(regulation of transcription by RNA polymerase II);GO:0035098(ESC/E(Z) complex);GO:0035616(histone H2B conserved C-terminal lysine deubiquitination);GO:0048663(neuron fate commitment);GO:0048863(stem cell differentiation);GO:0070449(elongin complex)","NA",{"v":0.036,"d":"0.04"},1,"120,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000028577/ENSBGRG00000015572, exon 1 of 1)",19,27228701,27229840,1140,1]
["chr19",30532375,30532642,268,"ENSBGRG00000005968","ENSBGRT00000011052",6140,"TMEM92","transmembrane protein 92 [Source:HGNC Symbol;Acc:HGNC:26579]","GO:0005654(nucleoplasm)","NA",{"v":0.034,"d":"0.03"},1,"268,",0,-1.47,{"v":-0.977,"d":"-0.98"},5.94,"3' UTR",19,30526235,30532672,6438,1]
["chr19",30862207,30862357,151,"ENSBGRG00000007753","ENSBGRT00000014200",59741,"CACNA1G","calcium voltage-gated channel subunit alpha1 G [Source:HGNC Symbol;Acc:HGNC:1394]","GO:0001508(action potential);GO:0002027(regulation of heart rate);GO:0005216(ion channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0005261(cation channel activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005891(voltage-gated calcium channel complex);GO:0006811(ion transport);GO:0007268(chemical synaptic transmission);GO:0008332(low voltage-gated calcium channel activity);GO:0010045(response to nickel cation);GO:0016020(membrane);GO:0042391(regulation of membrane potential);GO:0055085(transmembrane transport);GO:0060371(regulation of atrial cardiac muscle cell membrane depolarization);GO:0070509(calcium ion import);GO:0070588(calcium ion transmembrane transport);GO:0086002(cardiac muscle cell action potential involved in contraction);GO:0086015(SA node cell action potential);GO:0086016(AV node cell action potential);GO:0086018(SA node cell to atrial cardiac muscle cell signaling);GO:0086027(AV node cell to bundle of His cell signaling);GO:0086045(membrane depolarization during AV node cell action potential);GO:0086046(membrane depolarization during SA node cell action potential);GO:0086056(voltage-gated calcium channel activity involved in AV node cell action potential);GO:0086059(voltage-gated calcium channel activity involved SA node cell action potential);GO:0086091(regulation of heart rate by cardiac conduction);GO:0097110(scaffold protein binding)","04010(MAPK signaling pathway);04020(Calcium signaling pathway);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04713(Circadian entrainment);04930(Type II diabetes mellitus);04934(Cushing syndrome)",{"v":0.0035,"d":"0.00"},1,"151,",0,-2.46,{"v":-1.9,"d":"-1.90"},2.97,"3' UTR",19,30802466,30862387,59922,1]
["chr19",33096152,33096212,61,"ENSBGRG00000022521","ENSBGRT00000041700",13104,"EPN2","epsin 2 [Source:HGNC Symbol;Acc:HGNC:18639]","GO:0006897(endocytosis);GO:0030128(clathrin coat of endocytic vesicle);GO:0030948(negative regulation of vascular endothelial growth factor receptor signaling pathway);GO:0043231(intracellular membrane-bounded organelle);GO:0045747(positive regulation of Notch signaling pathway);GO:1903671(negative regulation of sprouting angiogenesis)","04144(Endocytosis)",{"v":0.034,"d":"0.03"},1,"61,",0,-1.47,{"v":-0.974,"d":"-0.97"},1.45,"Exon (ENSBGRT00000041700/ENSBGRG00000022521, exon 3 of 9)",19,33083048,33111069,28022,1]
["chr19",34330961,34331380,420,"ENSBGRG00000014506","ENSBGRT00000026778",4497,"ENSBGRG00000014506","NA","GO:0005515(protein binding)","NA",{"v":1.3e-19,"d":"0.00"},2,"229,189,","0,231",{"v":-18.9,"d":"-18.90"},-18,{"v":9.8,"d":"9.80"},"Exon (ENSBGRT00000026778/ENSBGRG00000014506, exon 4 of 5)",19,34326464,34331380,4917,1]
["chr19",38782050,38783210,1161,"ENSBGRG00000026582","ENSBGRT00000049244",232830,"GAS7","growth arrest specific 7 [Source:HGNC Symbol;Acc:HGNC:4169]","GO:0005515(protein binding)","NA",{"v":7.9e-68,"d":"0.00"},2,"89,451,","0,710",{"v":-67.1,"d":"-67.10"},{"v":-65.8,"d":"-65.80"},{"v":22.8,"d":"22.80"},"3' UTR",19,38549220,38782873,233654,1]
["chr19",40233149,40234976,1828,"ENSBGRG00000026738","ENSBGRT00000049583",1627,"HES7","hes family bHLH transcription factor 7 [Source:HGNC Symbol;Acc:HGNC:15977]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001501(skeletal system development);GO:0001756(somitogenesis);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007219(Notch signaling pathway);GO:0036342(post-anal tail morphogenesis);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046983(protein dimerization activity);GO:0048511(rhythmic process);GO:1990837(sequence-specific double-stranded DNA binding)","05165(Human papillomavirus infection)",{"v":0.00049,"d":"0.00"},2,"79,247,","0,1581",-3.31,{"v":-2.7,"d":"-2.70"},5.94,"Exon (ENSBGRT00000049583/ENSBGRG00000026738, exon 3 of 4)",19,40231522,40235477,3956,1]
["chr19",41544305,41544956,652,"ENSBGRG00000025709","ENSBGRT00000047526",629,"GLTPD2","glycolipid transfer protein domain containing 2 [Source:HGNC Symbol;Acc:HGNC:33756]","GO:0005737(cytoplasm);GO:0120009(intermembrane lipid transfer);GO:0120013(lipid transfer activity)","NA",{"v":0.00028,"d":"0.00"},2,"40,514,","0,138",-3.56,-2.94,{"v":14.9,"d":"14.90"},"Exon (ENSBGRT00000047526/ENSBGRG00000025709, exon 3 of 4)",19,41543676,41544956,1281,1]
["chr19",41640600,41640890,291,"ENSBGRG00000026201","ENSBGRT00000048472",3834,"CHRNE","cholinergic receptor nicotinic epsilon subunit [Source:HGNC Symbol;Acc:HGNC:1966]","GO:0004888(transmembrane signaling receptor activity);GO:0005216(ion channel activity);GO:0005230(extracellular ligand-gated ion channel activity);GO:0006811(ion transport);GO:0016021(integral component of membrane);GO:0022848(acetylcholine-gated cation-selective channel activity);GO:0031594(neuromuscular junction);GO:0034220(ion transmembrane transport);GO:0042391(regulation of membrane potential);GO:0045211(postsynaptic membrane);GO:0099060(integral component of postsynaptic specialization membrane)","04080(Neuroactive ligand-receptor interaction)",{"v":0.0062,"d":"0.01"},2,"174,6,","0,285",-2.21,-1.67,9.91,"5' UTR",19,41639679,41644724,5046,2]
["chr19",43301495,43301944,450,"ENSBGRG00000013936","ENSBGRT00000025600",10589,"MYBBP1A","MYB binding protein 1a [Source:HGNC Symbol;Acc:HGNC:7546]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0042149(cellular response to glucose starvation);GO:0043231(intracellular membrane-bounded organelle);GO:0071158(positive regulation of cell cycle arrest);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:2000210(positive regulation of anoikis)","NA",{"v":1.3e-29,"d":"0.00"},3,"37,159,75,","0,115,375",{"v":-28.9,"d":"-28.90"},{"v":-27.9,"d":"-27.90"},2.14,"Exon (ENSBGRT00000025600/ENSBGRG00000013936, exon 16 of 26)",19,43290906,43307199,16294,1]
["chr19",45298678,45299458,781,"ENSBGRG00000024191","ENSBGRT00000045021",0,"TSR1","TSR1 ribosome maturation factor [Source:HGNC Symbol;Acc:HGNC:25542]","GO:0005634(nucleus);GO:0042254(ribosome biogenesis)","NA",{"v":7.9e-11,"d":"0.00"},3,"97,104,68,","0,284,713",{"v":-10.1,"d":"-10.10"},-9.26,3.04,"Exon (ENSBGRT00000045021/ENSBGRG00000024191, exon 1 of 16)",19,45298678,45308140,9463,1]
["chr19",46941441,46941648,208,"ENSBGRG00000015916","ENSBGRT00000029219",5833,"TIMM22","translocase of inner mitochondrial membrane 22 [Source:HGNC Symbol;Acc:HGNC:17317]","GO:0042721(TIM22 mitochondrial import inner membrane insertion complex);GO:0045039(protein insertion into mitochondrial inner membrane)","NA",{"v":0.0017,"d":"0.00"},1,"208,",0,-2.76,-2.18,{"v":1.8,"d":"1.80"},"3' UTR",19,46935608,46942624,7017,1]
["chr19",48706955,48709924,2970,"ENSBGRG00000022098","ENSBGRT00000040936",20960,"PHF12","PHD finger protein 12 [Source:HGNC Symbol;Acc:HGNC:20816]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001222(transcription corepressor binding);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016580(Sin3 complex);GO:0017053(transcriptional repressor complex);GO:0035091(phosphatidylinositol binding);GO:0045892(negative regulation of transcription, DNA-templated)","04120(Ubiquitin mediated proteolysis)",{"v":7.9e-13,"d":"0.00"},2,"22,368,","0,2602",{"v":-12.1,"d":"-12.10"},{"v":-11.2,"d":"-11.20"},3.76,"Exon (ENSBGRT00000040936/ENSBGRG00000022098, exon 3 of 15)",19,48685995,48725500,39506,1]
["chr19",49609690,49611087,1398,"ENSBGRG00000012826","ENSBGRT00000023453",0,"ENSBGRG00000012826","NA","NA","NA",{"v":2.3E-3,"d":"0.00"},2,"55,35,","0,1363",-2.63,-2.05,5.28,"Exon (ENSBGRT00000023453/ENSBGRG00000012826, exon 1 of 3)",19,49609690,49624993,15304,1]
["chr19",52100805,52101101,297,"ENSBGRG00000019780","ENSBGRT00000036329",1821,"TMEM98","transmembrane protein 98 [Source:HGNC Symbol;Acc:HGNC:24529]","GO:0005615(extracellular space);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0010955(negative regulation of protein processing);GO:0031642(negative regulation of myelination);GO:0045063(T-helper 1 cell differentiation);GO:0048715(negative regulation of oligodendrocyte differentiation);GO:0070062(extracellular exosome);GO:1900181(negative regulation of protein localization to nucleus)","04974(Protein digestion and absorption)",{"v":9.1e-07,"d":"0.00"},1,"297,",0,-6.04,-5.33,{"v":13.4,"d":"13.40"},"5' UTR",19,52098984,52114012,15029,1]
["chr19",56445416,56447154,1739,"ENSBGRG00000014792","ENSBGRT00000029709",318073,"ACACA","acetyl-CoA carboxylase alpha [Source:HGNC Symbol;Acc:HGNC:84]","GO:0001650(fibrillar center);GO:0001894(tissue homeostasis);GO:0003989(acetyl-CoA carboxylase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006084(acetyl-CoA metabolic process);GO:0006629(lipid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0015629(actin cytoskeleton);GO:0016874(ligase activity);GO:0019538(protein metabolic process);GO:0042802(identical protein binding);GO:0046872(metal ion binding);GO:0051289(protein homotetramerization);GO:0055088(lipid homeostasis);GO:0071380(cellular response to prostaglandin E stimulus)","00620(Pyruvate metabolism);00640(Propanoate metabolism);00061(Fatty acid biosynthesis);00254(Aflatoxin biosynthesis);04152(AMPK signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway)",{"v":9.99999999999999e-223,"d":"0.00"},1,"1739,",0,-222,-220,{"v":11.6,"d":"11.60"},"3' UTR",19,56127343,56447154,319812,1]
["chr19",60189596,60225154,35559,"ENSBGRG00000022897","ENSBGRT00000042259",0,"MIR301A","microRNA 301a [Source:HGNC Symbol;Acc:HGNC:31622]","NA","NA",{"v":9.99999999999999e-227,"d":"0.00"},4,"69,87,177,278,","0,20766,29760,35281",-226,-224,3.69,"5' UTR",19,60193086,60193170,85,1]
["chr19",61729453,61729572,120,"ENSBGRG00000015169","ENSBGRT00000027870",3274,"SRSF1","serine and arginine rich splicing factor 1 [Source:HGNC Symbol;Acc:HGNC:10780]","GO:0000380(alternative mRNA splicing, via spliceosome);GO:0000395(mRNA 5'-splice site recognition);GO:0001701(in utero embryonic development);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0035145(exon-exon junction complex);GO:0044547(DNA topoisomerase binding);GO:0050733(RS domain binding);GO:0060048(cardiac muscle contraction);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome);04657(IL-17 signaling pathway);05168(Herpes simplex infection)",{"v":6.3e-28,"d":"0.00"},1,"120,",0,{"v":-27.2,"d":"-27.20"},{"v":-26.2,"d":"-26.20"},3.86,"3' UTR",19,61726179,61729572,3394,1]
["chr19",2081803,2084598,2796,"ENSBGRG00000020564","ENSBGRT00000037961",44264,"FAM20A","FAM20A golgi associated secretory pathway pseudokinase [Source:HGNC Symbol;Acc:HGNC:23015]","GO:0001934(positive regulation of protein phosphorylation);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0009617(response to bacterium);GO:0031214(biomineral tissue development);GO:0043539(protein serine/threonine kinase activator activity);GO:0044691(tooth eruption);GO:0055074(calcium ion homeostasis);GO:0070166(enamel mineralization)","NA",{"v":9.99999999999999e-262,"d":"0.00"},4,"265,60,82,71,","0,1414,2173,2725",-261,-259,7.29,"Exon (ENSBGRT00000037961/ENSBGRG00000020564, exon 8 of 11)",19,2081803,2128862,47060,2]
["chr19",8226110,8226558,449,"ENSBGRG00000017506","ENSBGRT00000032218",15822,"GGA3","golgi associated, gamma adaptin ear containing, ARF binding protein 3 [Source:HGNC Symbol;Acc:HGNC:17079]","GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0006886(intracellular protein transport);GO:0016192(vesicle-mediated transport);GO:0030306(ADP-ribosylation factor binding);GO:0031647(regulation of protein stability);GO:0031648(protein destabilization);GO:0034394(protein localization to cell surface);GO:0043001(Golgi to plasma membrane protein transport);GO:0043130(ubiquitin binding);GO:0045732(positive regulation of protein catabolic process);GO:0061462(protein localization to lysosome);GO:1902430(negative regulation of amyloid-beta formation)","04142(Lysosome)",{"v":1.6E-69,"d":"0.00"},1,"449,",0,{"v":-68.8,"d":"-68.80"},{"v":-67.5,"d":"-67.50"},3.28,"3' UTR",19,8226110,8242380,16271,2]
["chr19",8603423,8603573,151,"ENSBGRG00000020596","ENSBGRT00000038331",2437,"RECQL5","RecQ like helicase 5 [Source:HGNC Symbol;Acc:HGNC:9950]","GO:0000278(mitotic cell cycle);GO:0000993(RNA polymerase II complex binding);GO:0003676(nucleic acid binding);GO:0003678(DNA helicase activity);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006310(DNA recombination);GO:0016591(RNA polymerase II, holoenzyme);GO:0034244(negative regulation of transcription elongation from RNA polymerase II promoter);GO:0035690(cellular response to drug);GO:0051304(chromosome separation);GO:0072757(cellular response to camptothecin);GO:1990414(replication-born double-strand break repair via sister chromatid exchange);GO:2000042(negative regulation of double-strand break repair via homologous recombination)","NA",{"v":2.8E-5,"d":"0.00"},1,"151,",0,-4.55,-3.89,2.39,"Exon (ENSBGRT00000038331/ENSBGRG00000020596, exon 3 of 19)",19,8572454,8606010,33557,2]
["chr19",9165987,9175888,9902,"ENSBGRG00000024904","ENSBGRT00000046042",0,"ENSBGRG00000024904","NA","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0030031(cell projection assembly);GO:0030317(flagellated sperm motility);GO:0036126(sperm flagellum);GO:2000059(negative regulation of ubiquitin-dependent protein catabolic process)","NA",{"v":2.2e-09,"d":"0.00"},5,"14,115,98,86,467,","0,6307,6915,8108,9435",-8.66,-7.88,6.31,"Exon (ENSBGRT00000046042/ENSBGRG00000024904, exon 1 of 11)",19,9160710,9167422,6713,2]
["chr19",12272803,12272863,61,"ENSBGRG00000020275","ENSBGRT00000037474",2927,"CBX8","chromobox 8 [Source:HGNC Symbol;Acc:HGNC:15962]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000151(ubiquitin ligase complex);GO:0000790(nuclear chromatin);GO:0000792(heterochromatin);GO:0003727(single-stranded RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016574(histone ubiquitination);GO:0031519(PcG protein complex);GO:0035064(methylated histone binding);GO:0035102(PRC1 complex);GO:0097027(ubiquitin-protein transferase activator activity)","NA",0.01,1,"61,",0,-1.99,-1.46,2.83,"3' UTR",19,12272414,12275790,3377,2]
["chr19",13939481,13944677,5197,"ENSBGRG00000025394","ENSBGRT00000047013",0,"NPLOC4","NPL4 homolog, ubiquitin recognition factor [Source:HGNC Symbol;Acc:HGNC:18261]","GO:0006511(ubiquitin-dependent protein catabolic process);GO:0030970(retrograde protein transport, ER to cytosol);GO:0032480(negative regulation of type I interferon production);GO:0036501(UFD1-NPL4 complex);GO:0039536(negative regulation of RIG-I signaling pathway)","04141(Protein processing in endoplasmic reticulum)",{"v":3.3E-3,"d":"0.00"},3,"11,12,188,","0,69,5009",-2.48,-1.91,{"v":10.9,"d":"10.90"},"5' UTR",19,13923514,13939561,16048,2]
["chr19",14110479,14112291,1813,"ENSBGRG00000003861","ENSBGRT00000007143",176,"ARHGDIA","Rho GDP dissociation inhibitor alpha [Source:HGNC Symbol;Acc:HGNC:678]","GO:0005094(Rho GDP-dissociation inhibitor activity);GO:0005737(cytoplasm)","04962(Vasopressin-regulated water reabsorption);04722(Neurotrophin signaling pathway)",{"v":6.3e-60,"d":"0.00"},2,"213,82,","0,1731",{"v":-59.2,"d":"-59.20"},-58,1.67,"5' UTR",19,14109308,14112467,3160,2]
["chr19",15104735,15105625,891,"ENSBGRG00000006704","ENSBGRT00000012378",28162,"WDR45B","WD repeat domain 45B [Source:HGNC Symbol;Acc:HGNC:25072]","GO:0000045(autophagosome assembly);GO:0000407(phagophore assembly site);GO:0005515(protein binding);GO:0005764(lysosome);GO:0009267(cellular response to starvation);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0062078(TSC1-TSC2 complex binding);GO:0080025(phosphatidylinositol-3,5-bisphosphate binding)","NA",{"v":1.1e-06,"d":"0.00"},1,"891,",0,-5.97,-5.26,{"v":14.9,"d":"14.90"},"3' UTR",19,15104705,15133787,29083,2]
["chr19",17652303,17652843,541,"ENSBGRG00000016558","ENSBGRT00000031326",357424,"TANC2","tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 [Source:HGNC Symbol;Acc:HGNC:30212]","GO:0001701(in utero embryonic development);GO:0005515(protein binding);GO:0043197(dendritic spine)","NA",{"v":2e-57,"d":"0.00"},1,"541,",0,{"v":-56.7,"d":"-56.70"},{"v":-55.4,"d":"-55.40"},5.49,"Exon (ENSBGRT00000031326/ENSBGRG00000016558, exon 26 of 26)",19,17652303,18010267,357965,2]
["chr19",21228963,21229832,870,"ENSBGRG00000024979","ENSBGRT00000046128",0,"HIGD1B","HIG1 hypoxia inducible domain family member 1B [Source:HGNC Symbol;Acc:HGNC:24318]","NA","NA",{"v":3.9e-05,"d":"0.00"},2,"37,202,","0,668",-4.41,-3.75,2.42,"5' UTR",19,21228072,21229781,1710,2]
["chr19",22526599,22526778,180,"ENSBGRG00000005463","ENSBGRT00000010071",8177,"DHX8","DEAH-box helicase 8 [Source:HGNC Symbol;Acc:HGNC:2749]","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0004386(helicase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0042802(identical protein binding);GO:0071007(U2-type catalytic step 2 spliceosome);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)",{"v":4.5e-08,"d":"0.00"},1,"180,",0,-7.35,{"v":-6.6,"d":"-6.60"},1.79,"Exon (ENSBGRT00000010071/ENSBGRG00000005463, exon 6 of 23)",19,22503164,22534955,31792,2]
["chr19",23169235,23169385,151,"ENSBGRG00000007775","ENSBGRT00000014471",18601,"WNK4","WNK lysine deficient protein kinase 4 [Source:HGNC Symbol;Acc:HGNC:14544]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005923(bicellular tight junction);GO:0006468(protein phosphorylation);GO:0006811(ion transport);GO:0006821(chloride transport);GO:0008104(protein localization);GO:0019869(chloride channel inhibitor activity);GO:0050794(regulation of cellular process);GO:0050801(ion homeostasis);GO:0070294(renal sodium ion absorption);GO:0072156(distal tubule morphogenesis);GO:0090188(negative regulation of pancreatic juice secretion)","NA",{"v":2.4e-05,"d":"0.00"},1,"151,",0,-4.62,-3.95,2.27,"Exon (ENSBGRT00000014471/ENSBGRG00000007775, exon 18 of 21)",19,23168011,23187986,19976,2]
["chr19",25626904,25627023,120,"ENSBGRG00000017437","ENSBGRT00000032029",44,"IGFBP4","insulin like growth factor binding protein 4 [Source:HGNC Symbol;Acc:HGNC:5473]","GO:0001558(regulation of cell growth);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0010906(regulation of glucose metabolic process);GO:0040008(regulation of growth);GO:0043410(positive regulation of MAPK cascade);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0044342(type B pancreatic cell proliferation)","04115(p53 signaling pathway);04218(Cellular senescence);05202(Transcriptional misregulation in cancers)",{"v":2.3E-3,"d":"0.00"},1,"120,",0,-2.63,-2.05,5.28,"5' UTR",19,25612484,25627067,14584,2]
["chr19",26489236,26508262,19027,"ENSBGRG00000011539","ENSBGRT00000021628",36244,"CDK12","cyclin dependent kinase 12 [Source:HGNC Symbol;Acc:HGNC:24224]","GO:0002944(cyclin K-CDK12 complex);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation);GO:0008353(RNA polymerase II CTD heptapeptide repeat kinase activity);GO:0016607(nuclear speck);GO:0019901(protein kinase binding);GO:0030332(cyclin binding);GO:0043405(regulation of MAP kinase activity);GO:0046777(protein autophosphorylation);GO:0070816(phosphorylation of RNA polymerase II C-terminal domain);GO:2000737(negative regulation of stem cell differentiation)","NA",{"v":2.5e-72,"d":"0.00"},3,"4,713,2,","0,14416,19025",{"v":-71.6,"d":"-71.60"},{"v":-70.3,"d":"-70.30"},9.27,"Exon (ENSBGRT00000021628/ENSBGRG00000011539, exon 13 of 15)",19,26489236,26544506,55271,2]
["chr19",27197903,27199281,1379,"ENSBGRG00000015018","ENSBGRT00000028224",0,"MLLT6","MLLT6, PHD finger containing [Source:HGNC Symbol;Acc:HGNC:7138]","GO:0003014(renal system process);GO:0007588(excretion);GO:0010765(positive regulation of sodium ion transport);GO:0031491(nucleosome binding);GO:0035811(negative regulation of urine volume);GO:0035812(renal sodium excretion);GO:0036359(renal potassium excretion);GO:0042393(histone binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2001161(negative regulation of histone H3-K79 methylation)","04080(Neuroactive ligand-receptor interaction);04727(GABAergic synapse);04723(Retrograde endocannabinoid signaling);04742(Taste transduction);05032(Morphine addiction);05033(Nicotine addiction)",{"v":0.00052,"d":"0.00"},2,"42,109,","0,1270",-3.28,-2.68,{"v":13.9,"d":"13.90"},"5' UTR",19,27176307,27197944,21638,2]
["chr19",28744452,28746016,1565,"ENSBGRG00000021464","ENSBGRT00000039632",14384,"HOXB3","homeobox B3 [Source:HGNC Symbol;Acc:HGNC:5114]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001525(angiogenesis);GO:0002244(hematopoietic progenitor cell differentiation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0009952(anterior/posterior pattern specification);GO:0021546(rhombomere development);GO:0021615(glossopharyngeal nerve morphogenesis);GO:0030878(thyroid gland development);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048704(embryonic skeletal system morphogenesis);GO:0050767(regulation of neurogenesis);GO:0051216(cartilage development);GO:0060216(definitive hemopoiesis);GO:0060324(face development)","NA",{"v":1.3E-76,"d":"0.00"},2,"536,184,","0,1381",{"v":-75.9,"d":"-75.90"},{"v":-74.6,"d":"-74.60"},6.17,"3' UTR",19,28744182,28760400,16219,2]
["chr19",30208876,30208965,90,"ENSBGRG00000004899","ENSBGRT00000009028",4816,"DLX3","distal-less homeobox 3 [Source:HGNC Symbol;Acc:HGNC:2916]","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001568(blood vessel development);GO:0001890(placenta development);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0042475(odontogenesis of dentin-containing tooth);GO:0043565(sequence-specific DNA binding);GO:0071895(odontoblast differentiation);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.018,"d":"0.02"},1,"90,",0,-1.74,-1.22,3.96,"3' UTR",19,30207512,30213781,6270,2]
["chr19",32630643,32632365,1723,"ENSBGRG00000016030","ENSBGRT00000029693",9776,"ATPAF2","ATP synthase mitochondrial F1 complex assembly factor 2 [Source:HGNC Symbol;Acc:HGNC:18802]","GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0043461(proton-transporting ATP synthase complex assembly)","NA",{"v":2E-19,"d":"0.00"},3,"426,116,82,","0,1146,1641",{"v":-18.7,"d":"-18.70"},{"v":-17.8,"d":"-17.80"},4.99,"3' UTR",19,32629931,32642141,12211,2]
["chr19",33887098,33892213,5116,"ENSBGRG00000011022","ENSBGRT00000021875",95431,"NCOR1","nuclear receptor corepressor 1 [Source:HGNC Symbol;Acc:HGNC:7672]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0003677(DNA binding);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016580(Sin3 complex);GO:0017053(transcriptional repressor complex);GO:0035257(nuclear hormone receptor binding);GO:0042826(histone deacetylase binding);GO:0045820(negative regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045922(negative regulation of fatty acid metabolic process);GO:0046329(negative regulation of JNK cascade);GO:0051225(spindle assembly);GO:0060766(negative regulation of androgen receptor signaling pathway);GO:0072686(mitotic spindle);GO:1903799(negative regulation of production of miRNAs involved in gene silencing by miRNA)","04919(Thyroid hormone signaling pathway);05202(Transcriptional misregulation in cancers);01522(Endocrine resistance)",{"v":1e-184,"d":"0.00"},2,"94,446,","0,4670",-184,-182,3.08,"Exon (ENSBGRT00000021875/ENSBGRG00000011022, exon 34 of 43)",19,33872241,33987644,115404,2]
["chr19",40040845,40043260,2416,"ENSBGRG00000026704","ENSBGRT00000049520",7716,"ARHGEF15","Rho guanine nucleotide exchange factor 15 [Source:HGNC Symbol;Acc:HGNC:15590]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0030425(dendrite);GO:0050790(regulation of catalytic activity);GO:0061299(retina vasculature morphogenesis in camera-type eye);GO:2000297(negative regulation of synapse maturation)","NA",{"v":4e-09,"d":"0.00"},2,"152,88,","0,2328",{"v":-8.4,"d":"-8.40"},-7.63,2.73,"Exon (ENSBGRT00000049520/ENSBGRG00000026704, exon 14 of 15)",19,40040845,40050976,10132,2]
["chr19",40926121,40926745,625,"ENSBGRG00000019375","ENSBGRT00000035576",895,"TMEM102","transmembrane protein 102 [Source:HGNC Symbol;Acc:HGNC:26722]","GO:0007165(signal transduction);GO:0009986(cell surface);GO:0010820(positive regulation of T cell chemotaxis);GO:0032991(protein-containing complex);GO:0034097(response to cytokine);GO:0042981(regulation of apoptotic process);GO:0045785(positive regulation of cell adhesion);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:1901028(regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway);GO:2000406(positive regulation of T cell migration)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer);05226(Gastric cancer);05218(Melanoma);05224(Breast cancer)",{"v":9.5e-07,"d":"0.00"},2,"489,49,","0,576",-6.02,-5.31,6.74,"Exon (ENSBGRT00000035576/ENSBGRG00000019375, exon 1 of 2)",19,40925285,40927640,2356,2]
["chr19",41369999,41370118,120,"ENSBGRG00000024892","ENSBGRT00000046839",0,"ENSBGRG00000024892","NA","GO:0004052(arachidonate 12(S)-lipoxygenase activity);GO:0005506(iron ion binding);GO:0005515(protein binding);GO:0016165(linoleate 13S-lipoxygenase activity);GO:0016702(oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen);GO:0019369(arachidonic acid metabolic process);GO:0019372(lipoxygenase pathway);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","00590(Arachidonic acid metabolism);04726(Serotonergic synapse);04750(Inflammatory mediator regulation of TRP channels);01523(Antifolate resistance)",0.01,1,"120,",0,-1.99,-1.46,8.91,"Exon (ENSBGRT00000046839/ENSBGRG00000024892, exon 1 of 16)",19,41360866,41370118,9253,2]
["chr19",41717839,41717929,91,"ENSBGRG00000026325","ENSBGRT00000048777",4714,"CAMTA2","calmodulin binding transcription activator 2 [Source:HGNC Symbol;Acc:HGNC:18807]","GO:0000785(chromatin);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008134(transcription factor binding);GO:0014898(cardiac muscle hypertrophy in response to stress);GO:0042826(histone deacetylase binding);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":1e-05,"d":"0.00"},1,"91,",0,-4.99,-4.31,1.28,"Exon (ENSBGRT00000048777/ENSBGRG00000026325, exon 8 of 21)",19,41706603,41722643,16041,2]
["chr19",44032313,44032583,271,"ENSBGRG00000020964","ENSBGRT00000038989",58702,"ITGAE","integrin subunit alpha E [Source:HGNC Symbol;Acc:HGNC:6147]","GO:0007155(cell adhesion);GO:0008305(integrin complex);GO:0009897(external side of plasma membrane)","04810(Regulation of actin cytoskeleton)",{"v":0.00098,"d":"0.00"},1,"271,",0,-3.01,-2.42,{"v":2.1,"d":"2.10"},"Exon (ENSBGRT00000039134/ENSBGRG00000021199, exon 2 of 2)",19,43973611,44042031,68421,1]
["chr19",46504913,46505537,625,"ENSBGRG00000014440","ENSBGRT00000027262",136445,"VPS53","VPS53 subunit of GARP complex [Source:HGNC Symbol;Acc:HGNC:25608]","GO:0000938(GARP complex);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0007041(lysosomal transport);GO:0016020(membrane);GO:0032456(endocytic recycling);GO:0042147(retrograde transport, endosome to Golgi);GO:0048471(perinuclear region of cytoplasm);GO:0055037(recycling endosome);GO:1990745(EARP complex)","NA",{"v":3.2e-08,"d":"0.00"},2,"171,8,","0,617",-7.49,-6.75,2.97,"Exon (ENSBGRT00000027262/ENSBGRG00000014440, exon 21 of 22)",19,46504913,46641982,137070,2]
["chr19",48918564,48923957,5394,"ENSBGRG00000023259","ENSBGRT00000043026",0,"SUPT6H","SPT6 homolog, histone chaperone and transcription elongation factor [Source:HGNC Symbol;Acc:HGNC:11470]","GO:0001825(blastocyst formation);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0006139(nucleobase-containing compound metabolic process);GO:0010793(regulation of mRNA export from nucleus);GO:0032968(positive regulation of transcription elongation from RNA polymerase II promoter);GO:0042393(histone binding);GO:0045191(regulation of isotype switching);GO:0050684(regulation of mRNA processing);GO:0051147(regulation of muscle cell differentiation);GO:0061086(negative regulation of histone H3-K27 methylation)","NA",{"v":1e-36,"d":"0.00"},6,"183,85,193,77,159,142,","0,854,3609,4129,4301,5252",-36,{"v":-34.9,"d":"-34.90"},3.26,"5' UTR",19,48894762,48923957,29196,2]
["chr19",54742230,54744314,2085,"ENSBGRG00000021630","ENSBGRT00000039914",0,"ENSBGRG00000021630","NA","NA","NA",{"v":1.6E-11,"d":"0.00"},4,"114,165,71,38,","0,278,1851,2047",{"v":-10.8,"d":"-10.80"},-10,2.24,"Exon (ENSBGRT00000039660/ENSBGRG00000021490, exon 7 of 11)",19,54742395,54742465,71,2]
["chr19",58974178,58974487,310,"ENSBGRG00000019530","ENSBGRT00000036297",57180,"INTS2","integrator complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:29241]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016180(snRNA processing);GO:0032039(integrator complex)","NA",{"v":1.6e-25,"d":"0.00"},2,"170,40,","0,270",{"v":-24.8,"d":"-24.80"},{"v":-23.8,"d":"-23.80"},{"v":16.5,"d":"16.50"},"Exon (ENSBGRT00000036297/ENSBGRG00000019530, exon 24 of 25)",19,58974178,59031667,57490,2]
["chr19",61780232,61780498,267,"ENSBGRG00000015434","ENSBGRT00000028321",796,"ENSBGRG00000015434","NA","NA","NA",{"v":0.011,"d":"0.01"},1,"267,",0,-1.95,-1.18,8.91,"Exon (ENSBGRT00000028321/ENSBGRG00000015434, exon 1 of 1)",19,61780173,61781294,1122,2]
["chr20",3778501,3778560,60,"ENSBGRG00000017291","ENSBGRT00000031684",952,"ENSBGRG00000017291","NA","NA","NA",{"v":0.012,"d":"0.01"},1,"60,",0,-1.93,{"v":-1.4,"d":"-1.40"},5.45,"Exon (ENSBGRT00000031689/ENSBGRG00000017296, exon 1 of 1)",20,3772510,3779512,7003,2]
["chr20",6786402,6788017,1616,"ENSBGRG00000019875","ENSBGRT00000036522",448,"ATXN1L","ataxin 1 like [Source:HGNC Symbol;Acc:HGNC:33279]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0007420(brain development);GO:0007612(learning);GO:0007613(memory);GO:0030198(extracellular matrix organization);GO:0035176(social behavior);GO:0048286(lung alveolus development);GO:1902035(positive regulation of hematopoietic stem cell proliferation)","NA",{"v":1e-144,"d":"0.00"},1,"1616,",0,-144,-143,{"v":11.5,"d":"11.50"},"Exon (ENSBGRT00000036522/ENSBGRG00000019875, exon 1 of 1)",20,6785954,6788017,2064,1]
["chr20",11274290,11313547,39258,"ENSBGRG00000025507","ENSBGRT00000047197",0,"GFOD2","glucose-fructose oxidoreductase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:28159]","GO:0016491(oxidoreductase activity);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)","NA",{"v":1E-117,"d":"0.00"},3,"197,346,1184,","0,28255,38074",-117,-115,{"v":12.9,"d":"12.90"},"5' UTR",20,11302545,11313934,11390,1]
["chr20",11791292,11792472,1181,"ENSBGRG00000026876","ENSBGRT00000049837",3662,"KIAA0895L","KIAA0895 like [Source:HGNC Symbol;Acc:HGNC:34408]","NA","NA",{"v":0.00046,"d":"0.00"},2,"13,165,","0,1016",-3.34,-2.73,3.47,"Exon (ENSBGRT00000049837/ENSBGRG00000026876, exon 6 of 7)",20,11787630,11792472,4843,1]
["chr20",21017723,21018554,832,"ENSBGRG00000012057","ENSBGRT00000022171",10427,"SLC38A7","solute carrier family 38 member 7 [Source:HGNC Symbol;Acc:HGNC:25582]","GO:0005290(L-histidine transmembrane transporter activity);GO:0005313(L-glutamate transmembrane transporter activity);GO:0006814(sodium ion transport);GO:0015179(L-amino acid transmembrane transporter activity);GO:0015180(L-alanine transmembrane transporter activity);GO:0015182(L-asparagine transmembrane transporter activity);GO:0015183(L-aspartate transmembrane transporter activity);GO:0015186(L-glutamine transmembrane transporter activity);GO:0015190(L-leucine transmembrane transporter activity);GO:0015191(L-methionine transmembrane transporter activity);GO:0015194(L-serine transmembrane transporter activity);GO:0030424(axon);GO:0043025(neuronal cell body)","NA",{"v":5e-55,"d":"0.00"},1,"832,",0,{"v":-54.3,"d":"-54.30"},-53,8.25,"3' UTR",20,21007296,21017864,10569,1]
["chr20",22438795,22438941,147,"ENSBGRG00000019331","ENSBGRT00000035646",29505,"PSME3IP1","proteasome activator subunit 3 interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:29856]","GO:0005634(nucleus);GO:0032091(negative regulation of protein binding);GO:1901799(negative regulation of proteasomal protein catabolic process)","NA",{"v":5e-31,"d":"0.00"},1,"147,",0,{"v":-30.3,"d":"-30.30"},{"v":-29.3,"d":"-29.30"},1.93,"Exon (ENSBGRT00000035646/ENSBGRG00000019331, exon 6 of 6)",20,22409290,22438941,29652,1]
["chr20",31832772,31833410,639,"ENSBGRG00000013045","ENSBGRT00000023838",2804,"ENSBGRG00000013045","NA","GO:0005515(protein binding);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007275(multicellular organism development);GO:0008270(zinc ion binding);GO:0042025(host cell nucleus)","04120(Ubiquitin mediated proteolysis);04310(Wnt signaling pathway);04115(p53 signaling pathway)",{"v":8.7e-06,"d":"0.00"},2,"501,88,","0,551",-5.06,-4.38,{"v":12.9,"d":"12.90"},"Exon (ENSBGRT00000024049/ENSBGRG00000013137, exon 1 of 2)",20,31829968,31834556,4589,1]
["chr20",34281317,34281376,60,"ENSBGRG00000026749","ENSBGRT00000049614",2787,"SPATA2L","spermatogenesis associated 2 like [Source:HGNC Symbol;Acc:HGNC:28393]","NA","04217(Necroptosis)",{"v":0.015,"d":"0.02"},1,"60,",0,-1.81,-1.29,2.25,"Exon (ENSBGRT00000049614/ENSBGRG00000026749, exon 2 of 2)",20,34278530,34282173,3644,1]
["chr20",35833532,35834101,570,"ENSBGRG00000012190","ENSBGRT00000022352",32459,"KLHDC4","kelch domain containing 4 [Source:HGNC Symbol;Acc:HGNC:25272]","GO:0005515(protein binding)","05168(Herpes simplex infection)",{"v":5E-36,"d":"0.00"},1,"570,",0,{"v":-35.3,"d":"-35.30"},{"v":-34.2,"d":"-34.20"},9.76,"3' UTR",20,35801073,35836087,35015,1]
["chr20",41012641,41013283,643,"ENSBGRG00000019000","ENSBGRT00000034908",14191,"MPHOSPH6","M-phase phosphoprotein 6 [Source:HGNC Symbol;Acc:HGNC:7214]","GO:0000176(nuclear exosome (RNase complex));GO:0000178(exosome (RNase complex));GO:0000460(maturation of 5.8S rRNA);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol)","03018(RNA degradation)",{"v":5.1e-06,"d":"0.00"},2,"70,140,","0,503",-5.29,{"v":-4.6,"d":"-4.60"},1.57,"3' UTR",20,40998450,41013283,14834,1]
["chr20",47692239,47729062,36824,"ENSBGRG00000012860","ENSBGRT00000023667",0,"CFDP1","craniofacial development protein 1 [Source:HGNC Symbol;Acc:HGNC:1873]","GO:0007155(cell adhesion);GO:0008360(regulation of cell shape);GO:0042127(regulation of cell population proliferation);GO:2000270(negative regulation of fibroblast apoptotic process)","03008(Ribosome biogenesis in eukaryotes)",{"v":5e-26,"d":"0.00"},2,"93,176,","0,36648",{"v":-25.3,"d":"-25.30"},{"v":-24.3,"d":"-24.30"},2.27,"Exon (ENSBGRT00000023505/ENSBGRG00000012860, exon 2 of 7)",20,47728887,47862985,134099,1]
["chr20",48274763,48282810,8048,"ENSBGRG00000014214","ENSBGRT00000026875",82442,"WDR59","WD repeat domain 59 [Source:HGNC Symbol;Acc:HGNC:25706]","GO:0005515(protein binding);GO:0005765(lysosomal membrane);GO:0032008(positive regulation of TOR signaling);GO:0034198(cellular response to amino acid starvation);GO:0061700(GATOR2 complex)","04150(mTOR signaling pathway)",{"v":1e-253,"d":"0.00"},2,"107,794,","0,7254",-253,-251,{"v":14.6,"d":"14.60"},"3' UTR",20,48192321,48282810,90490,1]
["chr20",50967227,50967437,211,"ENSBGRG00000021653","ENSBGRT00000040005",24134,"PRKCG","protein kinase C gamma [Source:HGNC Symbol;Acc:HGNC:9402]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004697(protein kinase C activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0008270(zinc ion binding);GO:0016310(phosphorylation);GO:0031397(negative regulation of protein ubiquitination);GO:0032425(positive regulation of mismatch repair);GO:0035556(intracellular signal transduction);GO:0042177(negative regulation of protein catabolic process)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04310(Wnt signaling pathway);04370(VEGF signaling pathway);04066(HIF-1 signaling pathway);04020(Calcium signaling pathway);04070(Phosphatidylinositol signaling system);04071(Sphingolipid signaling pathway);04150(mTOR signaling pathway);04510(Focal adhesion);04540(Gap junction);04650(Natural killer cell mediated cytotoxicity);04666(Fc gamma R-mediated phagocytosis);04670(Leukocyte transendothelial migration);04911(Insulin secretion);04921(Oxytocin signaling pathway);04918(Thyroid hormone synthesis);04919(Thyroid hormone signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);04916(Melanogenesis);04925(Aldosterone synthesis and secretion);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04960(Aldosterone-regulated sodium reabsorption);04961(Endocrine and other factor-regulated calcium reabsorption);04724(Glutamatergic synapse);04727(GABAergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04720(Long-term potentiation);04730(Long-term depression);04723(Retrograde endocannabinoid signaling);04750(Inflammatory mediator regulation of TRP channels);04713(Circadian entrainment);05200(Pathways in cancer);05231(Choline metabolism in cancer);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05214(Glioma);05223(Non-small cell lung cancer);05031(Amphetamine addiction);05032(Morphine addiction);05161(Hepatitis B);05163(Human cytomegalovirus infection);05146(Amoebiasis);05143(African trypanosomiasis);01521(EGFR tyrosine kinase inhibitor resistance)",{"v":0.016,"d":"0.02"},1,"211,",0,-1.79,-1.27,3.47,"3' UTR",20,50943093,50967437,24345,1]
["chr20",51778849,51779787,939,"ENSBGRG00000014260","ENSBGRT00000026451",22636,"TNNI3","troponin I3, cardiac type [Source:HGNC Symbol;Acc:HGNC:11947]","GO:0001570(vasculogenesis);GO:0001980(regulation of systemic arterial blood pressure by ischemic conditions);GO:0003779(actin binding);GO:0005861(troponin complex);GO:0006874(cellular calcium ion homeostasis);GO:0006937(regulation of muscle contraction);GO:0006941(striated muscle contraction);GO:0007507(heart development);GO:0010882(regulation of cardiac muscle contraction by calcium ion signaling);GO:0019855(calcium channel inhibitor activity);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0030017(sarcomere);GO:0030172(troponin C binding);GO:0031014(troponin T binding);GO:0032780(negative regulation of ATPase activity);GO:0048306(calcium-dependent protein binding);GO:0051015(actin filament binding);GO:0055010(ventricular cardiac muscle tissue morphogenesis);GO:0060047(heart contraction);GO:0060048(cardiac muscle contraction);GO:0097512(cardiac myofibril);GO:1990584(cardiac Troponin complex)","04024(cAMP signaling pathway);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))",{"v":0.034,"d":"0.03"},2,"21,160,","0,779",-1.47,{"v":-0.977,"d":"-0.98"},4.46,"3' UTR",20,51756213,51779673,23461,1]
["chr20",52939986,52940105,120,"ENSBGRG00000021283","ENSBGRT00000039256",11084,"ENSBGRG00000021283","NA","GO:0005515(protein binding)","NA",{"v":1.4E-3,"d":"0.00"},1,"120,",0,-2.85,-2.27,{"v":4.7,"d":"4.70"},"Exon (ENSBGRT00000039256/ENSBGRG00000021283, exon 7 of 12)",20,52928902,52944236,15335,1]
["chr20",54009261,54011140,1880,"ENSBGRG00000014220","ENSBGRT00000026179",0,"ENSBGRG00000014220","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":0.00018,"d":"0.00"},3,"27,135,21,","0,1723,1859",-3.75,-3.12,8.91,"Exon (ENSBGRT00000026179/ENSBGRG00000014220, exon 1 of 3)",20,54009261,54011140,1880,1]
["chr20",54483765,54506994,23230,"ENSBGRG00000015242","ENSBGRT00000027976",77983,"ENSBGRG00000015242","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1e-126,"d":"0.00"},3,"137,127,1349,","0,606,21881",-126,-124,7.11,"3' UTR",20,54405782,54485204,79423,1]
["chr20",55488641,55488849,209,"ENSBGRG00000017986","ENSBGRT00000032917",10368,"ENSBGRG00000017986","NA","NA","NA",{"v":1.8E-5,"d":"0.00"},1,"209,",0,-4.74,-4.07,2.21,"Exon (ENSBGRT00000032917/ENSBGRG00000017986, exon 4 of 4)",20,55478273,55489384,11112,1]
["chr20",56490503,56490800,298,"ENSBGRG00000015904","ENSBGRT00000029198",2758,"ENSBGRG00000015904","NA","GO:0003676(nucleic acid binding)","NA",{"v":2.3E-5,"d":"0.00"},1,"298,",0,-4.63,-3.97,5.12,"Exon (ENSBGRT00000029198/ENSBGRG00000015904, exon 2 of 2)",20,56487745,56491274,3530,1]
["chr20",57313404,57314403,1000,"ENSBGRG00000018294","ENSBGRT00000033450",29,"ENSBGRG00000018294","NA","NA","NA",{"v":0.00028,"d":"0.00"},1,"1000,",0,-3.56,-2.94,{"v":14.9,"d":"14.90"},"Exon (ENSBGRT00000033450/ENSBGRG00000018294, exon 1 of 1)",20,57313375,57314403,1029,1]
["chr20",58037935,58039220,1286,"ENSBGRG00000016408","ENSBGRT00000030117",3813,"KLK15","kallikrein related peptidase 15 [Source:HGNC Symbol;Acc:HGNC:20453]","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis)","NA",{"v":0.00052,"d":"0.00"},3,"42,137,355,","0,167,931",-3.28,-2.68,{"v":13.9,"d":"13.90"},"3' UTR",20,58034122,58040018,5897,1]
["chr20",58824291,58824988,698,"ENSBGRG00000020877","ENSBGRT00000038530",3386,"IL4I1","interleukin 4 induced 1 [Source:HGNC Symbol;Acc:HGNC:19094]","GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00250(Alanine, aspartate and glutamate metabolism);00270(Cysteine and methionine metabolism);00280(Valine, leucine and isoleucine degradation);00350(Tyrosine metabolism);00360(Phenylalanine metabolism);00380(Tryptophan metabolism);00400(Phenylalanine, tyrosine and tryptophan biosynthesis)",{"v":0.0005,"d":"0.00"},2,"87,242,","0,456",{"v":-3.3,"d":"-3.30"},-2.69,5.94,"Exon (ENSBGRT00000038530/ENSBGRG00000020877, exon 6 of 9)",20,58820905,58825710,4806,1]
["chr20",59774280,59777777,3498,"ENSBGRG00000019779","ENSBGRT00000036372",0,"BCAT2","branched chain amino acid transaminase 2 [Source:HGNC Symbol;Acc:HGNC:977]","GO:0003824(catalytic activity);GO:0004084(branched-chain-amino-acid transaminase activity);GO:0005739(mitochondrion);GO:0006549(isoleucine metabolic process);GO:0006550(isoleucine catabolic process);GO:0006551(leucine metabolic process);GO:0006573(valine metabolic process);GO:0009081(branched-chain amino acid metabolic process);GO:0009083(branched-chain amino acid catabolic process);GO:0010817(regulation of hormone levels);GO:1990830(cellular response to leukemia inhibitory factor)","00270(Cysteine and methionine metabolism);00280(Valine, leucine and isoleucine degradation);00290(Valine, leucine and isoleucine biosynthesis);00770(Pantothenate and CoA biosynthesis)",{"v":4.6E-5,"d":"0.00"},2,"24,155,","0,3343",-4.34,-3.68,1.91,"Exon (ENSBGRT00000036372/ENSBGRG00000019779, exon 1 of 11)",20,59774280,59788083,13804,1]
["chr20",60436096,60436335,240,"ENSBGRG00000022291","ENSBGRT00000045342",35194,"LIG1","DNA ligase 1 [Source:HGNC Symbol;Acc:HGNC:6598]","GO:0003677(DNA binding);GO:0003909(DNA ligase activity);GO:0003910(DNA ligase (ATP) activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006310(DNA recombination);GO:0043231(intracellular membrane-bounded organelle);GO:0051103(DNA ligation involved in DNA repair);GO:0071897(DNA biosynthetic process)","03030(DNA replication);03410(Base excision repair);03420(Nucleotide excision repair);03430(Mismatch repair)",{"v":1e-05,"d":"0.00"},1,"240,",0,-4.98,-4.31,2.74,"3' UTR",20,60400902,60436335,35434,1]
["chr20",62289895,62290881,987,"ENSBGRG00000019948","ENSBGRT00000036851",4012,"DMWD","DM1 locus, WD repeat containing [Source:HGNC Symbol;Acc:HGNC:2936]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","03015(mRNA surveillance pathway);04530(Tight junction)",{"v":1e-110,"d":"0.00"},1,"987,",0,-110,-108,9.47,"Exon (ENSBGRT00000036851/ENSBGRG00000019948, exon 3 of 4)",20,62285883,62293359,7477,1]
["chr20",62773084,62777378,4295,"ENSBGRG00000023691","ENSBGRT00000043763",0,"ENSBGRG00000023691","exocyst complex component 3 like 2 [Source:HGNC Symbol;Acc:HGNC:30162]","GO:0000145(exocyst);GO:0006887(exocytosis)","NA",{"v":2.6E-7,"d":"0.00"},2,"66,174,","0,4121",-6.59,-5.86,{"v":13.9,"d":"13.90"},"5' UTR",20,62777205,62795617,18413,1]
["chr20",63844919,63845008,90,"ENSBGRG00000010456","ENSBGRT00000019147",5587,"LYPD5","LY6/PLAUR domain containing 5 [Source:HGNC Symbol;Acc:HGNC:26397]","NA","NA",{"v":0.0022,"d":"0.00"},1,"90,",0,-2.65,-2.08,6.93,"3' UTR",20,63839332,63845008,5677,1]
["chr20",64043072,64045015,1944,"ENSBGRG00000011490","ENSBGRT00000020928",3746,"IRGQ","immunity related GTPase Q [Source:HGNC Symbol;Acc:HGNC:24868]","GO:0005525(GTP binding)","NA",{"v":2.5e-78,"d":"0.00"},2,"476,534,","0,1410",{"v":-77.6,"d":"-77.60"},{"v":-76.2,"d":"-76.20"},9.76,"3' UTR",20,64039326,64045994,6669,1]
["chr20",64808499,64809812,1314,"ENSBGRG00000016716","ENSBGRT00000030651",3708,"ZNF574","zinc finger protein 574 [Source:HGNC Symbol;Acc:HGNC:26166]","GO:0003676(nucleic acid binding)","04080(Neuroactive ligand-receptor interaction)",{"v":1E-108,"d":"0.00"},1,"1314,",0,-108,-106,5.44,"Exon (ENSBGRT00000030651/ENSBGRG00000016716, exon 2 of 2)",20,64804791,64810827,6037,1]
["chr20",65447916,65448214,299,"ENSBGRG00000019201","ENSBGRT00000035261",4852,"EXOSC5","exosome component 5 [Source:HGNC Symbol;Acc:HGNC:24662]","GO:0000178(exosome (RNase complex));GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006401(RNA catabolic process);GO:0035327(transcriptionally active chromatin);GO:0043928(exonucleolytic catabolism of deadenylated mRNA);GO:0045006(DNA deamination);GO:0051607(defense response to virus)","03018(RNA degradation)",{"v":3.2e-41,"d":"0.00"},1,"299,",0,{"v":-40.5,"d":"-40.50"},{"v":-39.3,"d":"-39.30"},4.63,"3' UTR",20,65443064,65448244,5181,1]
["chr20",66703682,66703742,61,"ENSBGRG00000021421","ENSBGRT00000041526",1623,"ENSBGRG00000021421","NA","GO:0005515(protein binding)","NA",{"v":1.4E-3,"d":"0.00"},1,"61,",0,-2.85,-2.27,{"v":4.7,"d":"4.70"},"5' UTR",20,66702059,66742495,40437,1]
["chr20",67666367,67667008,642,"ENSBGRG00000025574","ENSBGRT00000047303",4659,"RINL","Ras and Rab interactor like [Source:HGNC Symbol;Acc:HGNC:24795]","GO:0001726(ruffle);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0006897(endocytosis);GO:0015629(actin cytoskeleton)","NA",{"v":0.034,"d":"0.03"},2,"215,25,","0,617",-1.47,{"v":-0.977,"d":"-0.98"},5.94,"Exon (ENSBGRT00000047303/ENSBGRG00000025574, exon 7 of 12)",20,67661708,67671367,9660,1]
["chr20",68914052,68914202,151,"ENSBGRG00000017410","ENSBGRT00000031879",1555,"ENSBGRG00000017410","NA","GO:0003676(nucleic acid binding)","NA",{"v":0.00022,"d":"0.00"},1,"151,",0,-3.66,-3.04,8.91,"Exon (ENSBGRT00000031879/ENSBGRG00000017410, exon 1 of 1)",20,68912497,68914890,2394,1]
["chr20",69715035,69715093,59,"ENSBGRG00000019287","ENSBGRT00000035530",1133,"POLR2I","RNA polymerase II subunit I [Source:HGNC Symbol;Acc:HGNC:9196]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005665(RNA polymerase II, core complex);GO:0006351(transcription, DNA-templated);GO:0006366(transcription by RNA polymerase II);GO:0006379(mRNA cleavage);GO:0008270(zinc ion binding)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);05016(Huntington disease);05169(Epstein-Barr virus infection)",{"v":1.1E-4,"d":"0.00"},1,"59,",0,-3.94,{"v":-3.3,"d":"-3.30"},1.64,"Exon (ENSBGRT00000035530/ENSBGRG00000019287, exon 6 of 6)",20,69713902,69715093,1192,1]
["chr20",457019,457197,179,"ENSBGRG00000022026","ENSBGRT00000040705",32905,"ENSBGRG00000022026","NA","GO:0008641(ubiquitin-like modifier activating enzyme activity);GO:0016925(protein sumoylation);GO:0019948(SUMO activating enzyme activity)","04120(Ubiquitin mediated proteolysis)",{"v":2.9E-5,"d":"0.00"},1,"179,",0,-4.54,-3.87,1.67,"Exon (ENSBGRT00000040705/ENSBGRG00000022026, exon 17 of 17)",20,457019,490102,33084,2]
["chr20",586003,622925,36923,"ENSBGRG00000010861","ENSBGRT00000019859",568,"GARRE1","KIAA0355 [Source:HGNC Symbol;Acc:HGNC:29016]","GO:0000932(P-body);GO:0016601(Rac protein signal transduction);GO:0048365(Rac GTPase binding);GO:1905762(CCR4-NOT complex binding)","NA",{"v":1.3e-45,"d":"0.00"},3,"60,210,718,","0,5182,36205",{"v":-44.9,"d":"-44.90"},{"v":-43.8,"d":"-43.80"},3.74,"5' UTR",20,565064,623493,58430,2]
["chr20",2704798,2705155,358,"ENSBGRG00000017072","ENSBGRT00000031350",9571,"ZNF507","zinc finger protein 507 [Source:HGNC Symbol;Acc:HGNC:23783]","GO:0003676(nucleic acid binding)","NA",{"v":5e-19,"d":"0.00"},1,"358,",0,{"v":-18.3,"d":"-18.30"},{"v":-17.4,"d":"-17.40"},5.14,"Exon (ENSBGRT00000031350/ENSBGRG00000017072, exon 3 of 8)",20,2672099,2714726,42628,2]
["chr20",6664043,6668519,4477,"ENSBGRG00000019571","ENSBGRT00000035980",90077,"AP1G1","adaptor related protein complex 1 subunit gamma 1 [Source:HGNC Symbol;Acc:HGNC:555]","GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0016192(vesicle-mediated transport);GO:0017137(Rab GTPase binding);GO:0019894(kinesin binding);GO:0030117(membrane coat);GO:0030121(AP-1 adaptor complex);GO:0030136(clathrin-coated vesicle);GO:0030742(GTP-dependent protein binding);GO:0035646(endosome to melanosome transport);GO:0043231(intracellular membrane-bounded organelle);GO:0043323(positive regulation of natural killer cell degranulation);GO:0045954(positive regulation of natural killer cell mediated cytotoxicity);GO:0055037(recycling endosome);GO:0090160(Golgi to lysosome transport)","04142(Lysosome)",{"v":1e-18,"d":"0.00"},3,"102,99,8,","0,1491,4469",-18,{"v":-17.1,"d":"-17.10"},3.33,"Exon (ENSBGRT00000035980/ENSBGRG00000019571, exon 22 of 24)",20,6664043,6758596,94554,2]
["chr20",9562904,9562963,60,"ENSBGRG00000006014","ENSBGRT00000011474",116993,"NFAT5","nuclear factor of activated T cells 5 [Source:HGNC Symbol;Acc:HGNC:7774]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001816(cytokine production);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006366(transcription by RNA polymerase II);GO:0010628(positive regulation of gene expression);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0070884(regulation of calcineurin-NFAT signaling cascade);GO:0071345(cellular response to cytokine stimulus);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1904996(positive regulation of leukocyte adhesion to vascular endothelial cell);GO:1990837(sequence-specific double-stranded DNA binding)","NA",0.01,1,"60,",0,-1.99,-1.46,2.83,"Exon (ENSBGRT00000011474/ENSBGRG00000006014, exon 13 of 14)",20,9559923,9679956,120034,2]
["chr20",10534851,10541159,6309,"ENSBGRG00000014757","ENSBGRT00000027377",21346,"ZFP90","ZFP90 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:23329]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043392(negative regulation of DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated)","NA",{"v":1e-149,"d":"0.00"},3,"700,26,48,","0,729,6261",-149,-147,5.95,"Exon (ENSBGRT00000027377/ENSBGRG00000014757, exon 3 of 4)",20,10533899,10562505,28607,2]
["chr20",11766272,11766332,61,"ENSBGRG00000026869","ENSBGRT00000049825",0,"ELMO3","engulfment and cell motility 3 [Source:HGNC Symbol;Acc:HGNC:17289]","GO:0016477(cell migration)","05100(Bacterial invasion of epithelial cells)",{"v":0.015,"d":"0.02"},1,"61,",0,-1.81,-1.29,2.69,"Exon (ENSBGRT00000049825/ENSBGRG00000026869, exon 1 of 20)",20,11761953,11766332,4380,2]
["chr20",21273002,21273179,178,"ENSBGRG00000014032","ENSBGRT00000025754",4914,"GINS3","GINS complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:25851]","GO:0005654(nucleoplasm)","NA",{"v":5.5e-09,"d":"0.00"},1,"178,",0,-8.26,{"v":-7.5,"d":"-7.50"},5.94,"Exon (ENSBGRT00000025754/ENSBGRG00000014032, exon 3 of 3)",20,21273002,21278093,5092,2]
["chr20",22577111,22578424,1314,"ENSBGRG00000019570","ENSBGRT00000037099",8598,"ENSBGRG00000019570","NA","NA","NA",{"v":1.9e-09,"d":"0.00"},1,"1314,",0,-8.72,-7.95,4.42,"Exon (ENSBGRT00000037099/ENSBGRG00000019570, exon 3 of 40)",20,22519324,22587022,67699,2]
["chr20",26338450,26356377,17928,"ENSBGRG00000025060","ENSBGRT00000046893",51,"CHD9","chromodomain helicase DNA binding protein 9 [Source:HGNC Symbol;Acc:HGNC:25701]","GO:0005515(protein binding);GO:0005524(ATP binding);GO:0016817(hydrolase activity, acting on acid anhydrides)","NA",{"v":4.3e-06,"d":"0.00"},5,"33,147,58,112,281,","0,891,4374,5117,17647",-5.37,-4.68,{"v":19.8,"d":"19.80"},"5' UTR",20,26262564,26356428,93865,2]
["chr20",34043139,34046251,3113,"ENSBGRG00000021282","ENSBGRT00000039960",9022,"GAS8","growth arrest specific 8 [Source:HGNC Symbol;Acc:HGNC:4166]","GO:0005874(microtubule);GO:0005929(cilium);GO:0005930(axoneme);GO:0008017(microtubule binding);GO:0017137(Rab GTPase binding);GO:0031514(motile cilium);GO:0035082(axoneme assembly);GO:0048870(cell motility);GO:0060294(cilium movement involved in cell motility);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":2e-18,"d":"0.00"},4,"24,87,168,17,","0,2161,2568,3096",{"v":-17.7,"d":"-17.70"},{"v":-16.8,"d":"-16.80"},2.67,"Exon (ENSBGRT00000039960/ENSBGRG00000021282, exon 5 of 10)",20,34039200,34055273,16074,2]
["chr20",35286658,35286838,181,"ENSBGRG00000026917","ENSBGRT00000049919",5509,"ENSBGRG00000026917","NA","NA","NA",{"v":5e-20,"d":"0.00"},1,"181,",0,{"v":-19.3,"d":"-19.30"},{"v":-18.4,"d":"-18.40"},{"v":3.5,"d":"3.50"},"Exon (ENSBGRT00000049924/ENSBGRG00000026919, exon 34 of 34)",20,35281149,35333608,52460,1]
["chr20",36842362,36842690,329,"ENSBGRG00000013269","ENSBGRT00000024300",0,"FOXF1","forkhead box F1 [Source:HGNC Symbol;Acc:HGNC:3809]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001568(blood vessel development);GO:0001570(vasculogenesis);GO:0001701(in utero embryonic development);GO:0001756(somitogenesis);GO:0001763(morphogenesis of a branching structure);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0003197(endocardial cushion development);GO:0003214(cardiac left ventricle morphogenesis);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007224(smoothened signaling pathway);GO:0007368(determination of left/right symmetry);GO:0007494(midgut development);GO:0007498(mesoderm development);GO:0007507(heart development);GO:0009887(animal organ morphogenesis);GO:0010811(positive regulation of cell-substrate adhesion);GO:0014822(detection of wounding);GO:0030198(extracellular matrix organization);GO:0030323(respiratory tube development);GO:0030324(lung development);GO:0030335(positive regulation of cell migration);GO:0031016(pancreas development);GO:0043305(negative regulation of mast cell degranulation);GO:0043565(sequence-specific DNA binding);GO:0045198(establishment of epithelial cell apical/basal polarity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048286(lung alveolus development);GO:0048371(lateral mesodermal cell differentiation);GO:0048557(embryonic digestive tract morphogenesis);GO:0048565(digestive tract development);GO:0048566(embryonic digestive tract development);GO:0048613(embryonic ectodermal digestive tract morphogenesis);GO:0048617(embryonic foregut morphogenesis);GO:0050728(negative regulation of inflammatory response);GO:0051145(smooth muscle cell differentiation);GO:0060425(lung morphogenesis);GO:0060426(lung vasculature development);GO:0060438(trachea development);GO:0060441(epithelial tube branching involved in lung morphogenesis);GO:0060461(right lung morphogenesis);GO:0060463(lung lobe morphogenesis);GO:0060841(venous blood vessel development);GO:0061030(epithelial cell differentiation involved in mammary gland alveolus development);GO:0071345(cellular response to cytokine stimulus);GO:0071407(cellular response to organic cyclic compound);GO:0072189(ureter development);GO:0090131(mesenchyme migration);GO:0097070(ductus arteriosus closure);GO:0098609(cell-cell adhesion)","NA",{"v":0.036,"d":"0.04"},1,"329,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"5' UTR",20,36836182,36842690,6509,2]
["chr20",39026202,39027121,920,"ENSBGRG00000016699","ENSBGRT00000030628",23827,"ENSBGRG00000016699","NA","GO:0005515(protein binding);GO:0044458(motile cilium assembly)","NA",{"v":1.8E-3,"d":"0.00"},2,"93,57,","0,863",-2.74,-2.16,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000030628/ENSBGRG00000016699, exon 11 of 12)",20,39025188,39050948,25761,2]
["chr20",48794848,48795226,379,"ENSBGRG00000017323","ENSBGRT00000031814",439,"ENSBGRG00000017323","NA","NA","03018(RNA degradation)",{"v":2.8e-07,"d":"0.00"},1,"379,",0,-6.56,-5.83,4.29,"Exon (ENSBGRT00000031814/ENSBGRG00000017323, exon 2 of 2)",20,48794848,48795665,818,2]
["chr20",51363494,51364025,532,"ENSBGRG00000022526","ENSBGRT00000041573",266,"ZNF524","zinc finger protein 524 [Source:HGNC Symbol;Acc:HGNC:28322]","GO:0003676(nucleic acid binding);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":6.3e-19,"d":"0.00"},1,"532,",0,{"v":-18.2,"d":"-18.20"},{"v":-17.3,"d":"-17.30"},2.67,"Exon (ENSBGRT00000041573/ENSBGRG00000022526, exon 1 of 1)",20,51363494,51364291,798,2]
["chr20",51456553,51458367,1815,"ENSBGRG00000022738","ENSBGRT00000041991",38,"SSC5D","scavenger receptor cysteine rich family member with 5 domains [Source:HGNC Symbol;Acc:HGNC:26641]","GO:0001968(fibronectin binding);GO:0005044(scavenger receptor activity);GO:0005615(extracellular space);GO:0006952(defense response);GO:0016020(membrane);GO:0032677(regulation of interleukin-8 production);GO:0032717(negative regulation of interleukin-8 production);GO:0042494(detection of bacterial lipoprotein);GO:0043236(laminin binding);GO:0050829(defense response to Gram-negative bacterium);GO:0050830(defense response to Gram-positive bacterium);GO:0050840(extracellular matrix binding);GO:0062023(collagen-containing extracellular matrix)","04970(Salivary secretion)",{"v":1.1E-4,"d":"0.00"},4,"76,114,120,437,","0,404,703,1378",-3.97,-3.33,4.46,"Exon (ENSBGRT00000041991/ENSBGRG00000022738, exon 1 of 11)",20,51432722,51458405,25684,2]
["chr20",52444526,52445739,1214,"ENSBGRG00000018449","ENSBGRT00000033842",766,"LENG9","leukocyte receptor cluster member 9 [Source:HGNC Symbol;Acc:HGNC:16306]","GO:0046872(metal ion binding)","04010(MAPK signaling pathway);04012(ErbB signaling pathway);04310(Wnt signaling pathway);04370(VEGF signaling pathway);04020(Calcium signaling pathway);04070(Phosphatidylinositol signaling system);04150(mTOR signaling pathway);04510(Focal adhesion);04540(Gap junction);04916(Melanogenesis);04270(Vascular smooth muscle contraction)",{"v":4e-22,"d":"0.00"},3,"139,713,238,","0,189,976",{"v":-21.4,"d":"-21.40"},{"v":-20.5,"d":"-20.50"},{"v":76.3,"d":"76.30"},"Exon (ENSBGRT00000033842/ENSBGRG00000018449, exon 2 of 4)",20,52444467,52446505,2039,2]
["chr20",53426825,53427184,360,"ENSBGRG00000013422","ENSBGRT00000024576",0,"ENSBGRG00000013422","NA","NA","NA",{"v":5.2e-09,"d":"0.00"},1,"360,",0,-8.28,-7.52,3.96,"3' UTR",20,53426903,53428789,1887,1]
["chr20",54596299,54611415,15117,"ENSBGRG00000015710","ENSBGRT00000028929",726,"ENSBGRG00000015710","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":6.3e-41,"d":"0.00"},2,"39,1786,","0,13331",{"v":-40.2,"d":"-40.20"},-39,{"v":12.9,"d":"12.90"},"Exon (ENSBGRT00000028929/ENSBGRG00000015710, exon 1 of 2)",20,54594415,54612141,17727,2]
["chr20",55498407,55498674,268,"ENSBGRG00000018097","ENSBGRT00000033103",3010,"ENSBGRG00000018097","NA","NA","NA",{"v":6.8E-8,"d":"0.00"},1,"268,",0,-7.17,-6.43,2.49,"Exon (ENSBGRT00000033103/ENSBGRG00000018097, exon 2 of 2)",20,55497486,55501684,4199,2]
["chr20",55980833,55982331,1499,"ENSBGRG00000015081","ENSBGRT00000027746",38570,"ENSBGRG00000015081","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.6e-70,"d":"0.00"},1,"1499,",0,{"v":-69.8,"d":"-69.80"},{"v":-68.4,"d":"-68.40"},7.15,"3' UTR",20,55957155,56020901,63747,2]
["chr20",57143158,57147184,4027,"ENSBGRG00000017457","ENSBGRT00000031986",4877,"ENSBGRG00000017457","zinc finger protein 350 [Source:HGNC Symbol;Acc:HGNC:16656]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":0.00083,"d":"0.00"},3,"36,93,21,","0,3649,4006",-3.08,-2.48,1.98,"Exon (ENSBGRT00000031986/ENSBGRG00000017457, exon 3 of 5)",20,57128457,57152061,23605,2]
["chr20",58200844,58201682,839,"ENSBGRG00000017085","ENSBGRT00000031378",49795,"ENSBGRG00000017085","NA","NA","04724(Glutamatergic synapse)",{"v":6.6e-05,"d":"0.00"},1,"839,",0,-4.18,-3.54,{"v":12.9,"d":"12.90"},"Exon (ENSBGRT00000031378/ENSBGRG00000017085, exon 23 of 27)",20,58151049,58206530,55482,1]
["chr20",59119839,59119958,120,"ENSBGRG00000024220","ENSBGRT00000044747",11657,"RCN3","reticulocalbin 3 [Source:HGNC Symbol;Acc:HGNC:21145]","GO:0005509(calcium ion binding);GO:0005783(endoplasmic reticulum);GO:0009306(protein secretion);GO:0010952(positive regulation of peptidase activity);GO:0015031(protein transport);GO:0032964(collagen biosynthetic process);GO:0036503(ERAD pathway);GO:0043129(surfactant homeostasis);GO:0051896(regulation of protein kinase B signaling);GO:0055091(phospholipid homeostasis);GO:0060428(lung epithelium development)","NA",{"v":4E-41,"d":"0.00"},1,"120,",0,{"v":-40.4,"d":"-40.40"},{"v":-39.2,"d":"-39.20"},2.31,"3' UTR",20,59119839,59131615,11777,2]
["chr20",59663485,59663878,394,"ENSBGRG00000018991","ENSBGRT00000035090",11223,"DHDH","dihydrodiol dehydrogenase [Source:HGNC Symbol;Acc:HGNC:17887]","GO:0016491(oxidoreductase activity)","00040(Pentose and glucuronate interconversions);00980(Metabolism of xenobiotics by cytochrome P450)",{"v":0.0002,"d":"0.00"},2,"100,49,","0,345",{"v":-3.7,"d":"-3.70"},-3.08,{"v":1.8,"d":"1.80"},"Exon (ENSBGRT00000035090/ENSBGRG00000018991, exon 6 of 7)",20,59663426,59675101,11676,2]
["chr20",60747050,60747169,120,"ENSBGRG00000025286","ENSBGRT00000046751",30,"EHD2","EH domain containing 2 [Source:HGNC Symbol;Acc:HGNC:3243]","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006897(endocytosis);GO:0015630(microtubule cytoskeleton);GO:0016020(membrane);GO:0019898(extrinsic component of membrane);GO:0019904(protein domain specific binding);GO:0030036(actin cytoskeleton organization);GO:0030866(cortical actin cytoskeleton organization);GO:0032456(endocytic recycling);GO:0042802(identical protein binding);GO:0045171(intercellular bridge);GO:0048471(perinuclear region of cytoplasm);GO:0055038(recycling endosome membrane);GO:0072659(protein localization to plasma membrane);GO:0097320(plasma membrane tubulation);GO:1901741(positive regulation of myoblast fusion);GO:2001137(positive regulation of endocytic recycling)","04144(Endocytosis)",{"v":0.0012,"d":"0.00"},1,"120,",0,-2.91,-2.32,2.97,"5' UTR",20,60727891,60747199,19309,2]
["chr20",61104667,61104876,210,"ENSBGRG00000014586","ENSBGRT00000026821",208,"ENSBGRG00000014586","NA","NA","NA",{"v":0.00081,"d":"0.00"},1,"210,",0,-3.09,-2.49,3.63,"5' UTR",20,61045216,61105084,59869,2]
["chr20",61967177,61973704,6528,"ENSBGRG00000018431","ENSBGRT00000033801",9474,"PPP5C","protein phosphatase 5 catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9322]","GO:0004721(phosphoprotein phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006470(protein dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0032991(protein-containing complex);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle);GO:0043531(ADP binding);GO:0051879(Hsp90 protein binding);GO:0070262(peptidyl-serine dephosphorylation);GO:0101031(chaperone complex)","04010(MAPK signaling pathway)",{"v":2.7E-6,"d":"0.00"},2,"96,25,","0,6503",-5.57,-4.87,1.45,"Exon (ENSBGRT00000033801/ENSBGRG00000018431, exon 2 of 13)",20,61957416,61983178,25763,2]
["chr20",62984778,62987393,2616,"ENSBGRG00000024145","ENSBGRT00000044599",13546,"CLASRP","CLK4 associating serine/arginine rich protein [Source:HGNC Symbol;Acc:HGNC:17731]","GO:0005654(nucleoplasm)","NA",{"v":2e-38,"d":"0.00"},3,"45,149,76,","0,848,2540",{"v":-37.7,"d":"-37.70"},{"v":-36.6,"d":"-36.60"},2.23,"Exon (ENSBGRT00000044599/ENSBGRG00000024145, exon 5 of 20)",20,62972654,63000939,28286,2]
["chr20",64034927,64038936,4010,"ENSBGRG00000011436","ENSBGRT00000020873",149,"ZNF576","zinc finger protein 576 [Source:HGNC Symbol;Acc:HGNC:28357]","GO:0003676(nucleic acid binding)","NA",0,3,"1390,101,534,","0,3006,3476",-402,"-Inf",8.91,"5' UTR",20,64034897,64039085,4189,2]
["chr20",65552030,65552477,448,"ENSBGRG00000019572","ENSBGRT00000036845",0,"HNRNPUL1","heterogeneous nuclear ribonucleoprotein U like 1 [Source:HGNC Symbol;Acc:HGNC:17011]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006396(RNA processing);GO:0009615(response to virus);GO:0019899(enzyme binding)","05164(Influenza A)",{"v":1E-127,"d":"0.00"},1,"448,",0,-127,-125,6.68,"5' UTR",20,65517622,65552300,34679,2]
["chr20",66644345,66644494,150,"ENSBGRG00000021126","ENSBGRT00000039252",11465,"PSMC4","proteasome 26S subunit, ATPase 4 [Source:HGNC Symbol;Acc:HGNC:9551]","GO:0000502(proteasome complex);GO:0001824(blastocyst development);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0016787(hydrolase activity);GO:0022624(proteasome accessory complex);GO:0030163(protein catabolic process);GO:0036402(proteasome-activating ATPase activity)","03050(Proteasome);05169(Epstein-Barr virus infection)",{"v":2.5E-46,"d":"0.00"},1,"150,",0,{"v":-45.6,"d":"-45.60"},{"v":-44.4,"d":"-44.40"},2.54,"3' UTR",20,66644137,66655959,11823,2]
["chr20",67975230,67975547,318,"ENSBGRG00000026024","ENSBGRT00000049033",83808,"ENSBGRG00000026024","NA","NA","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04921(Oxytocin signaling pathway);04730(Long-term depression);04713(Circadian entrainment)",{"v":3.8E-6,"d":"0.00"},2,"62,59,","0,259",-5.42,-4.73,2.28,"Exon (ENSBGRT00000049033/ENSBGRG00000026024, exon 75 of 106)",20,67920041,68059355,139315,2]
["chr20",68429340,68429985,646,"ENSBGRG00000015384","ENSBGRT00000030524",451,"SIPA1L3","signal induced proliferation associated 1 like 3 [Source:HGNC Symbol;Acc:HGNC:23801]","GO:0001654(eye development);GO:0001725(stress fiber);GO:0002244(hematopoietic progenitor cell differentiation);GO:0003382(epithelial cell morphogenesis);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0007010(cytoskeleton organization);GO:0045177(apical part of cell);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0061689(tricellular tight junction);GO:0090162(establishment of epithelial cell polarity)","04015(Rap1 signaling pathway)",{"v":0.0068,"d":"0.01"},2,"114,36,","0,610",-2.17,-1.63,4.29,"Exon (ENSBGRT00000030524/ENSBGRG00000015384, exon 2 of 25)",20,68315235,68430436,115202,2]
["chr20",69217900,69225328,7429,"ENSBGRG00000018166","ENSBGRT00000033214",3271,"ZNF829","zinc finger protein 829 [Source:HGNC Symbol;Acc:HGNC:34032]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":5e-39,"d":"0.00"},2,"980,30,","0,7399",{"v":-38.3,"d":"-38.30"},{"v":-37.2,"d":"-37.20"},6.07,"Exon (ENSBGRT00000033214/ENSBGRG00000018166, exon 3 of 4)",20,69217900,69228599,10700,2]
["chr20",69943447,69943656,210,"ENSBGRG00000022530","ENSBGRT00000042505",9822,"APLP1","amyloid beta precursor like protein 1 [Source:HGNC Symbol;Acc:HGNC:597]","GO:0005886(plasma membrane);GO:0008201(heparin binding);GO:0016021(integral component of membrane);GO:0031694(alpha-2A adrenergic receptor binding);GO:0031695(alpha-2B adrenergic receptor binding);GO:0031696(alpha-2C adrenergic receptor binding);GO:0042802(identical protein binding);GO:0046914(transition metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0071874(cellular response to norepinephrine stimulus);GO:0106072(negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway)","NA",{"v":7.9E-94,"d":"0.00"},1,"210,",0,{"v":-93.1,"d":"-93.10"},{"v":-91.6,"d":"-91.60"},4.05,"3' UTR",20,69943447,69953478,10032,2]
["chr20",70888402,70888731,330,"ENSBGRG00000018150","ENSBGRT00000034546",22522,"GRAMD1A","GRAM domain containing 1A [Source:HGNC Symbol;Acc:HGNC:29305]","GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0031227(intrinsic component of endoplasmic reticulum membrane);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0044232(organelle membrane contact site)","NA",{"v":6.3e-27,"d":"0.00"},1,"330,",0,{"v":-26.2,"d":"-26.20"},{"v":-25.2,"d":"-25.20"},3.96,"3' UTR",20,70888402,70911253,22852,2]
["chr21",9420212,9420331,120,"ENSBGRG00000022510","ENSBGRT00000041548",29990,"ZNF407","zinc finger protein 407 [Source:HGNC Symbol;Acc:HGNC:19904]","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding)","NA",{"v":0.00052,"d":"0.00"},1,"120,",0,-3.28,-2.67,2.23,"Exon (ENSBGRT00000041548/ENSBGRG00000022510, exon 2 of 9)",21,9390222,9816832,426611,1]
["chr21",13322120,13322327,208,"ENSBGRG00000024626","ENSBGRT00000045492",4229,"ENSBGRG00000024626","NA","GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0051287(NAD binding);GO:0055114(oxidation-reduction process)","00620(Pyruvate metabolism);00630(Glyoxylate and dicarboxylate metabolism);00260(Glycine, serine and threonine metabolism)",{"v":0.00059,"d":"0.00"},1,"208,",0,-3.23,-2.62,{"v":3.4,"d":"3.40"},"Exon (ENSBGRT00000045492/ENSBGRG00000024626, exon 3 of 5)",21,13317891,13326494,8604,1]
["chr21",24180393,24180691,299,"ENSBGRG00000023975","ENSBGRT00000044276",1401,"CDH2","cadherin 2 [Source:HGNC Symbol;Acc:HGNC:1759]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0009966(regulation of signal transduction);GO:0016020(membrane);GO:0098609(cell-cell adhesion)","04514(Cell adhesion molecules (CAMs));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC))",{"v":2E-3,"d":"0.00"},1,"299,",0,{"v":-2.7,"d":"-2.70"},-2.12,6.93,"Exon (ENSBGRT00000044276/ENSBGRG00000023975, exon 1 of 17)",21,24178992,24455597,276606,1]
["chr21",31348769,31359838,11070,"ENSBGRG00000017206","ENSBGRT00000033339",107195,"ROCK1","Rho associated coiled-coil containing protein kinase 1 [Source:HGNC Symbol;Acc:HGNC:10251]","GO:0001726(ruffle);GO:0003383(apical constriction);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007159(leukocyte cell-cell adhesion);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0007266(Rho protein signal transduction);GO:0010494(cytoplasmic stress granule);GO:0010508(positive regulation of autophagy);GO:0010613(positive regulation of cardiac muscle hypertrophy);GO:0010628(positive regulation of gene expression);GO:0016525(negative regulation of angiogenesis);GO:0017048(Rho GTPase binding);GO:0017049(GTP-Rho binding);GO:0018105(peptidyl-serine phosphorylation);GO:0019828(aspartic-type endopeptidase inhibitor activity);GO:0022614(membrane to membrane docking);GO:0030027(lamellipodium);GO:0030036(actin cytoskeleton organization);GO:0030334(regulation of cell migration);GO:0030866(cortical actin cytoskeleton organization);GO:0031175(neuron projection development);GO:0032060(bleb assembly);GO:0032091(negative regulation of protein binding);GO:0032956(regulation of actin cytoskeleton organization);GO:0032970(regulation of actin filament-based process);GO:0035509(negative regulation of myosin-light-chain-phosphatase activity);GO:0035556(intracellular signal transduction);GO:0043410(positive regulation of MAPK cascade);GO:0043524(negative regulation of neuron apoptotic process);GO:0045616(regulation of keratinocyte differentiation);GO:0045664(regulation of neuron differentiation);GO:0050900(leukocyte migration);GO:0050901(leukocyte tethering or rolling);GO:0051451(myoblast migration);GO:0051894(positive regulation of focal adhesion assembly);GO:0061157(mRNA destabilization);GO:0070507(regulation of microtubule cytoskeleton organization);GO:0071559(response to transforming growth factor beta);GO:0072518(Rho-dependent protein serine/threonine kinase activity);GO:0072659(protein localization to plasma membrane);GO:0097746(regulation of blood vessel diameter);GO:0106003(amyloid-beta complex);GO:0110061(regulation of angiotensin-activated signaling pathway);GO:0140058(neuron projection arborization);GO:1900223(positive regulation of amyloid-beta clearance);GO:1900242(regulation of synaptic vesicle endocytosis);GO:1902430(negative regulation of amyloid-beta formation);GO:1902992(negative regulation of amyloid precursor protein catabolic process);GO:1903140(regulation of establishment of endothelial barrier);GO:1903347(negative regulation of bicellular tight junction assembly);GO:1905205(positive regulation of connective tissue replacement);GO:1990776(response to angiotensin)","04350(TGF-beta signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04510(Focal adhesion);04530(Tight junction);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04670(Leukocyte transendothelial migration);04062(Chemokine signaling pathway);04921(Oxytocin signaling pathway);04270(Vascular smooth muscle contraction);04360(Axon guidance);05200(Pathways in cancer);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05132(Salmonella infection);05163(Human cytomegalovirus infection)",{"v":1.6e-56,"d":"0.00"},8,"9,95,166,94,89,67,189,130,","0,1787,4944,6710,7471,9674,10158,10940",{"v":-55.8,"d":"-55.80"},{"v":-54.5,"d":"-54.50"},2.56,"Exon (ENSBGRT00000033339/ENSBGRG00000017206, exon 21 of 27)",21,31241574,31358934,117361,1]
["chr21",38441888,38441948,61,"ENSBGRG00000024894","ENSBGRT00000045949",30,"ANKRD12","ankyrin repeat domain 12 [Source:HGNC Symbol;Acc:HGNC:29135]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol)","NA",0.02,1,"61,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"5' UTR",21,38441858,38510694,68837,1]
["chr21",38541126,38542848,1723,"ENSBGRG00000024927","ENSBGRT00000046029",17469,"TWSG1","twisted gastrulation BMP signaling modulator 1 [Source:HGNC Symbol;Acc:HGNC:12429]","GO:0001503(ossification);GO:0001707(mesoderm formation);GO:0001818(negative regulation of cytokine production);GO:0005615(extracellular space);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007435(salivary gland morphogenesis);GO:0009888(tissue development);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0030097(hemopoiesis);GO:0030154(cell differentiation);GO:0030509(BMP signaling pathway);GO:0030513(positive regulation of BMP signaling pathway);GO:0030514(negative regulation of BMP signaling pathway);GO:0030900(forebrain development);GO:0043010(camera-type eye development);GO:0045668(negative regulation of osteoblast differentiation);GO:0050431(transforming growth factor beta binding);GO:2000515(negative regulation of CD4-positive, alpha-beta T cell activation);GO:2000562(negative regulation of CD4-positive, alpha-beta T cell proliferation)","NA",{"v":9.99999999999999e-198,"d":"0.00"},4,"72,21,24,182,","0,74,96,1541",-197,-195,6.77,"Exon (ENSBGRT00000046029/ENSBGRG00000024927, exon 4 of 6)",21,38523657,38541245,17589,1]
["chr21",40635464,40635554,91,"ENSBGRG00000016812","ENSBGRT00000030885",78311,"LDLRAD4","low density lipoprotein receptor class A domain containing 4 [Source:HGNC Symbol;Acc:HGNC:1224]","GO:0005515(protein binding);GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0010991(negative regulation of SMAD protein complex assembly);GO:0030336(negative regulation of cell migration);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043231(intracellular membrane-bounded organelle);GO:0060394(negative regulation of pathway-restricted SMAD protein phosphorylation);GO:0070412(R-SMAD binding)","NA",{"v":0.0022,"d":"0.00"},1,"91,",0,-2.65,-2.07,1.82,"5' UTR",21,40557153,40697726,140574,1]
["chr21",48425337,48437416,12080,"ENSBGRG00000024517","ENSBGRT00000045260",0,"ELAC1","elaC ribonuclease Z 1 [Source:HGNC Symbol;Acc:HGNC:14197]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016891(endoribonuclease activity, producing 5'-phosphomonoesters);GO:0042779(tRNA 3'-trailer cleavage)","03013(RNA transport)",{"v":9.99999999999998e-244,"d":"0.00"},3,"157,468,467,","0,8417,11613",-243,-241,13,"Exon (ENSBGRT00000045260/ENSBGRG00000024517, exon 1 of 3)",21,48425337,48437416,12080,1]
["chr21",56986544,56987021,478,"ENSBGRG00000014854","ENSBGRT00000027307",137185,"ZNF532","zinc finger protein 532 [Source:HGNC Symbol;Acc:HGNC:30940]","GO:0003676(nucleic acid binding)","NA",{"v":1e-109,"d":"0.00"},1,"478,",0,-109,-107,{"v":3.3,"d":"3.30"},"Exon (ENSBGRT00000027307/ENSBGRG00000014854, exon 10 of 10)",21,56849359,56987021,137663,1]
["chr21",7817212,7818584,1373,"ENSBGRG00000021651","ENSBGRT00000040071",0,"CBLN2","cerebellin 2 precursor [Source:HGNC Symbol;Acc:HGNC:1544]","GO:0005515(protein binding);GO:0005615(extracellular space);GO:0050808(synapse organization);GO:0051965(positive regulation of synapse assembly);GO:0098814(spontaneous synaptic transmission);GO:0098978(glutamatergic synapse);GO:0099558(maintenance of synapse structure);GO:1905606(regulation of presynapse assembly)","NA",{"v":2.8e-07,"d":"0.00"},3,"157,58,54,","0,1081,1319",-6.56,-5.83,{"v":18.8,"d":"18.80"},"5' UTR",21,7811742,7818539,6798,2]
["chr21",16564576,16564815,240,"ENSBGRG00000019835","ENSBGRT00000036519",51521,"ENSBGRG00000019835","NA","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":3.2e-14,"d":"0.00"},1,"240,",0,{"v":-13.5,"d":"-13.50"},{"v":-12.7,"d":"-12.70"},2.01,"Exon (ENSBGRT00000036519/ENSBGRG00000019835, exon 3 of 3)",21,16563559,16616336,52778,2]
["chr21",29531857,29538301,6445,"ENSBGRG00000025900","ENSBGRT00000047893",48926,"RBBP8","RB binding protein 8, endonuclease [Source:HGNC Symbol;Acc:HGNC:9891]","GO:0000014(single-stranded DNA endodeoxyribonuclease activity);GO:0000082(G1/S transition of mitotic cell cycle);GO:0000724(double-strand break repair via homologous recombination);GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0001835(blastocyst hatching);GO:0003684(damaged DNA binding);GO:0003714(transcription corepressor activity);GO:0004519(endonuclease activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006281(DNA repair);GO:0010792(DNA double-strand break processing involved in repair via single-strand annealing);GO:0017053(transcriptional repressor complex);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle)","03440(Homologous recombination)",{"v":7.9e-14,"d":"0.00"},3,"140,115,45,","0,3357,6400",{"v":-13.1,"d":"-13.10"},{"v":-12.3,"d":"-12.30"},1.81,"Exon (ENSBGRT00000047893/ENSBGRG00000025900, exon 12 of 17)",21,29521282,29587227,65946,2]
["chr21",35988090,36022483,34394,"ENSBGRG00000023853","ENSBGRT00000044056",0,"ENSBGRG00000023853","NA","NA","NA",{"v":6.3E-3,"d":"0.01"},2,"5,206,","0,34188",{"v":-2.2,"d":"-2.20"},-1.66,4.62,"Exon (ENSBGRT00000044056/ENSBGRG00000023853, exon 1 of 2)",21,35985184,36022483,37300,2]
["chr21",38650530,38659998,9469,"ENSBGRG00000025046","ENSBGRT00000047902",5679,"PPP4R1","protein phosphatase 4 regulatory subunit 1 [Source:HGNC Symbol;Acc:HGNC:9320]","GO:0005515(protein binding);GO:0007165(signal transduction);GO:0019888(protein phosphatase regulator activity);GO:0030289(protein phosphatase 4 complex);GO:0050790(regulation of catalytic activity)","NA",{"v":7.9e-63,"d":"0.00"},6,"80,442,23,19,13,20,","0,1180,7459,7946,9197,9449",{"v":-62.1,"d":"-62.10"},{"v":-60.8,"d":"-60.80"},6.02,"Exon (ENSBGRT00000047902/ENSBGRG00000025046, exon 7 of 15)",21,38637669,38665677,28009,2]
["chr21",45305638,45306176,539,"ENSBGRG00000022372","ENSBGRT00000041397",121603,"ZBTB7C","zinc finger and BTB domain containing 7C [Source:HGNC Symbol;Acc:HGNC:31700]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0008285(negative regulation of cell population proliferation);GO:0045600(positive regulation of fat cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1903025(regulation of RNA polymerase II regulatory region sequence-specific DNA binding)","NA",{"v":5e-13,"d":"0.00"},1,"539,",0,{"v":-12.3,"d":"-12.30"},{"v":-11.4,"d":"-11.40"},{"v":26.7,"d":"26.70"},"3' UTR",21,45304711,45427779,123069,2]
["chr21",59847336,59847636,301,"ENSBGRG00000016802","ENSBGRT00000031515",82789,"PIGN","phosphatidylinositol glycan anchor biosynthesis class N [Source:HGNC Symbol;Acc:HGNC:8967]","GO:0003824(catalytic activity);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006506(GPI anchor biosynthetic process);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0051377(mannose-ethanolamine phosphotransferase activity)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":2.3E-3,"d":"0.00"},1,"301,",0,-2.63,-2.06,6.93,"3' UTR",21,59825229,59930425,105197,2]
["chr22",1036407,1039708,3302,"ENSBGRG00000010865","ENSBGRT00000020019",0,"ENSBGRG00000010865","NA","NA","NA",{"v":9.1e-05,"d":"0.00"},3,"22,180,213,","0,2491,3089",-4.04,{"v":-3.4,"d":"-3.40"},{"v":3.1,"d":"3.10"},"Exon (ENSBGRT00000019734/ENSBGRG00000010818, exon 6 of 8)",22,1039496,1045539,6044,1]
["chr22",3396306,3396516,211,"ENSBGRG00000019545","ENSBGRT00000036371",569,"SLC6A6","solute carrier family 6 member 6 [Source:HGNC Symbol;Acc:HGNC:11052]","GO:0005328(neurotransmitter:sodium symporter activity);GO:0005368(taurine transmembrane transporter activity);GO:0005369(taurine:sodium symporter activity);GO:0005887(integral component of plasma membrane);GO:0006836(neurotransmitter transport);GO:0015734(taurine transport);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":3.9e-05,"d":"0.00"},1,"211,",0,-4.41,-3.76,8.42,"5' UTR",22,3395737,3490297,94561,1]
["chr22",7530094,7530154,61,"ENSBGRG00000025543","ENSBGRT00000047208",3503,"ENSBGRG00000025543","NA","NA","NA",{"v":1e-06,"d":"0.00"},1,"61,",0,-5.99,-5.28,2.07,"Exon (ENSBGRT00000047208/ENSBGRG00000025543, exon 2 of 2)",22,7526591,7530314,3724,1]
["chr22",8959783,8959871,89,"ENSBGRG00000010403","ENSBGRT00000019085",970,"CCR5","C-C motif chemokine receptor 5 (gene/pseudogene) [Source:HGNC Symbol;Acc:HGNC:1606]","GO:0000165(MAPK cascade);GO:0003779(actin binding);GO:0004930(G protein-coupled receptor activity);GO:0004950(chemokine receptor activity);GO:0005768(endosome);GO:0006816(calcium ion transport);GO:0006935(chemotaxis);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007267(cell-cell signaling);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0014808(release of sequestered calcium ion into cytosol by sarcoplasmic reticulum);GO:0016021(integral component of membrane);GO:0016493(C-C chemokine receptor activity);GO:0019722(calcium-mediated signaling);GO:0019957(C-C chemokine binding);GO:0023052(signaling);GO:0042802(identical protein binding);GO:0070723(response to cholesterol);GO:0071222(cellular response to lipopolysaccharide);GO:0071791(chemokine (C-C motif) ligand 5 binding)","04060(Cytokine-cytokine receptor interaction);04144(Endocytosis);04062(Chemokine signaling pathway);05203(Viral carcinogenesis);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05145(Toxoplasmosis)",{"v":2.3E-3,"d":"0.00"},1,"89,",0,-2.63,-2.06,4.46,"Exon (ENSBGRT00000019085/ENSBGRG00000010403, exon 1 of 1)",22,8958813,8959871,1059,1]
["chr22",9540970,9541179,210,"ENSBGRG00000015116","ENSBGRT00000027871",153865,"KIF9","kinesin family member 9 [Source:HGNC Symbol;Acc:HGNC:16666]","GO:0002102(podosome);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005874(microtubule);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0022617(extracellular matrix disassembly);GO:0031982(vesicle);GO:0042802(identical protein binding);GO:0071801(regulation of podosome assembly);GO:1903008(organelle disassembly)","NA",{"v":0.00059,"d":"0.00"},1,"210,",0,-3.23,-2.62,2.69,"Exon (ENSBGRT00000028591/ENSBGRG00000015579, exon 4 of 4)",22,9503278,9695044,191767,2]
["chr22",11621928,11622084,157,"ENSBGRG00000020826","ENSBGRT00000038372",0,"ENSBGRG00000020826","NA","NA","04512(ECM-receptor interaction);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05416(Viral myocarditis)",{"v":3.2e-47,"d":"0.00"},1,"157,",0,{"v":-46.5,"d":"-46.50"},{"v":-45.3,"d":"-45.30"},6.47,"Exon (ENSBGRT00000038372/ENSBGRG00000020826, exon 1 of 1)",22,11621928,11622084,157,1]
["chr22",12159284,12159464,181,"ENSBGRG00000023542","ENSBGRT00000043461",28825,"SEMA3F","semaphorin 3F [Source:HGNC Symbol;Acc:HGNC:10728]","GO:0001755(neural crest cell migration);GO:0005515(protein binding);GO:0007411(axon guidance);GO:0021612(facial nerve structural organization);GO:0021637(trigeminal nerve structural organization);GO:0021675(nerve development);GO:0021785(branchiomotor neuron axon guidance);GO:0030215(semaphorin receptor binding);GO:0036486(ventral trunk neural crest cell migration);GO:0045499(chemorepellent activity);GO:0048843(negative regulation of axon extension involved in axon guidance);GO:0048846(axon extension involved in axon guidance);GO:0050919(negative chemotaxis);GO:0061549(sympathetic ganglion development);GO:0097490(sympathetic neuron projection extension);GO:0097491(sympathetic neuron projection guidance);GO:0098978(glutamatergic synapse);GO:0099175(regulation of postsynapse organization);GO:1901166(neural crest cell migration involved in autonomic nervous system development);GO:1902285(semaphorin-plexin signaling pathway involved in neuron projection guidance);GO:1902287(semaphorin-plexin signaling pathway involved in axon guidance)","04360(Axon guidance)",{"v":2.5e-39,"d":"0.00"},1,"181,",0,{"v":-38.6,"d":"-38.60"},{"v":-37.4,"d":"-37.40"},3.33,"Exon (ENSBGRT00000043461/ENSBGRG00000023542, exon 20 of 20)",22,12130459,12159464,29006,1]
["chr22",14131951,14170542,38592,"ENSBGRG00000009033","ENSBGRT00000016848",26476,"NISCH","nischarin [Source:HGNC Symbol;Acc:HGNC:18006]","GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0016601(Rac protein signal transduction);GO:0030036(actin cytoskeleton organization);GO:0030336(negative regulation of cell migration);GO:0035091(phosphatidylinositol binding);GO:0042802(identical protein binding)","NA",{"v":9.99999999999999e-266,"d":"0.00"},3,"93,50,786,","0,1248,37806",-265,-263,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000016848/ENSBGRG00000009033, exon 14 of 21)",22,14105475,14177019,71545,1]
["chr22",19748589,19753444,4856,"ENSBGRG00000024830","ENSBGRT00000046597",140533,"SLMAP","sarcolemma associated protein [Source:HGNC Symbol;Acc:HGNC:16643]","GO:0005515(protein binding);GO:0006936(muscle contraction);GO:0072659(protein localization to plasma membrane);GO:1900825(regulation of membrane depolarization during cardiac muscle cell action potential);GO:1902305(regulation of sodium ion transmembrane transport);GO:1905150(regulation of voltage-gated sodium channel activity)","00062(Fatty acid elongation);00140(Steroid hormone biosynthesis);01040(Biosynthesis of unsaturated fatty acids)",{"v":1.3E-35,"d":"0.00"},4,"112,75,321,2,","0,1129,4126,4854",{"v":-34.9,"d":"-34.90"},{"v":-33.8,"d":"-33.80"},2.82,"Exon (ENSBGRT00000046597/ENSBGRG00000024830, exon 17 of 23)",22,19608056,19764618,156563,1]
["chr22",34696818,34697522,705,"ENSBGRG00000021497","ENSBGRT00000039788",0,"EIF4E3","eukaryotic translation initiation factor 4E family member 3 [Source:HGNC Symbol;Acc:HGNC:31837]","GO:0003723(RNA binding);GO:0003743(translation initiation factor activity);GO:0006413(translational initiation)","03013(RNA transport);04150(mTOR signaling pathway)",{"v":3.3E-3,"d":"0.00"},1,"705,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"5' UTR",22,34617767,34697024,79258,2]
["chr22",49041752,49042147,396,"ENSBGRG00000009903","ENSBGRT00000018415",59,"OGG1","8-oxoguanine DNA glycosylase [Source:HGNC Symbol;Acc:HGNC:8125]","GO:0003677(DNA binding);GO:0003684(damaged DNA binding);GO:0003824(catalytic activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006289(nucleotide-excision repair);GO:0006355(regulation of transcription, DNA-templated);GO:0006974(cellular response to DNA damage stimulus);GO:0006979(response to oxidative stress);GO:0008017(microtubule binding);GO:0008534(oxidized purine nucleobase lesion DNA N-glycosylase activity);GO:0009314(response to radiation);GO:0016363(nuclear matrix);GO:0016607(nuclear speck);GO:0032357(oxidized purine DNA binding);GO:0032991(protein-containing complex);GO:0033683(nucleotide-excision repair, DNA incision);GO:0034039(8-oxo-7,8-dihydroguanine DNA N-glycosylase activity);GO:1901291(negative regulation of double-strand break repair via single-strand annealing)","03410(Base excision repair)",{"v":0.00015,"d":"0.00"},2,"78,11,","0,385",-3.83,{"v":-3.2,"d":"-3.20"},1.64,"Exon (ENSBGRT00000018415/ENSBGRG00000009903, exon 1 of 8)",22,49041693,49046757,5065,1]
["chr22",49754694,49757584,2891,"ENSBGRG00000015475","ENSBGRT00000028419",0,"ZNF445","zinc finger protein 445 [Source:HGNC Symbol;Acc:HGNC:21018]","GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0010216(maintenance of DNA methylation);GO:0010385(double-stranded methylated DNA binding);GO:0071517(maintenance of imprinting at mating-type locus);GO:2000653(regulation of genetic imprinting)","NA",{"v":3.7e-10,"d":"0.00"},2,"572,86,","0,2805",-9.43,-8.65,3.57,"5' UTR",22,49754694,49763394,8701,1]
["chr22",52525591,52525741,151,"ENSBGRG00000020150","ENSBGRT00000037645",571081,"ULK4","unc-51 like kinase 4 [Source:HGNC Symbol;Acc:HGNC:15784]","GO:0000226(microtubule cytoskeleton organization);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0010975(regulation of neuron projection development);GO:0043408(regulation of MAPK cascade);GO:0046328(regulation of JNK cascade);GO:0090036(regulation of protein kinase C signaling);GO:1900744(regulation of p38MAPK cascade);GO:2001222(regulation of neuron migration)","NA",{"v":3.3E-3,"d":"0.00"},1,"151,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"3' UTR",22,51954510,52526457,571948,1]
["chr22",59475389,59480337,4949,"ENSBGRG00000022018","ENSBGRT00000040809",67386,"UBP1","upstream binding protein 1 [Source:HGNC Symbol;Acc:HGNC:12507]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001525(angiogenesis);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0032897(negative regulation of viral transcription);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":2E-19,"d":"0.00"},3,"406,96,38,","0,789,4911",{"v":-18.7,"d":"-18.70"},{"v":-17.8,"d":"-17.80"},3.32,"Exon (ENSBGRT00000040809/ENSBGRG00000022018, exon 13 of 13)",22,59408003,59475794,67792,1]
["chr22",1057187,1057336,150,"ENSBGRG00000011063","ENSBGRT00000020338",105122,"ENSBGRG00000011063","NA","NA","00561(Glycerolipid metabolism);04923(Regulation of lipolysis in adipocyte);04723(Retrograde endocannabinoid signaling);04714(Thermogenesis)",{"v":9.5e-08,"d":"0.00"},1,"150,",0,-7.02,-6.29,2.81,"3' UTR",22,1056739,1162458,105720,2]
["chr22",3518072,3518161,90,"ENSBGRG00000020144","ENSBGRT00000038343",50141,"GRIP2","glutamate receptor interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:23841]","GO:0005515(protein binding);GO:0007219(Notch signaling pathway);GO:0014824(artery smooth muscle contraction);GO:0030159(receptor signaling complex adaptor activity);GO:0045777(positive regulation of blood pressure);GO:0098887(neurotransmitter receptor transport, endosome to postsynaptic membrane);GO:0098978(glutamatergic synapse);GO:0099003(vesicle-mediated transport in synapse)","NA",{"v":6e-05,"d":"0.00"},1,"90,",0,-4.22,-3.57,3.85,"3' UTR",22,3517145,3568302,51158,2]
["chr22",7539783,7539873,91,"ENSBGRG00000025573","ENSBGRT00000047287",35070,"ENSBGRG00000025573","NA","GO:0016409(palmitoyltransferase activity)","NA",{"v":1.4E-3,"d":"0.00"},1,"91,",0,-2.86,-2.27,1.46,"3' UTR",22,7539454,7574943,35490,2]
["chr22",9355751,9356315,565,"ENSBGRG00000012967","ENSBGRT00000023919",587,"ENSBGRG00000012967","NA","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis)","NA",{"v":2.2e-05,"d":"0.00"},2,"179,56,","0,509",-4.65,-3.99,4.33,"Exon (ENSBGRT00000023919/ENSBGRG00000012967, exon 2 of 6)",22,9352053,9356902,4850,2]
["chr22",10423261,10423411,151,"ENSBGRG00000019593","ENSBGRT00000036140",30953,"Cdc25A","cell division cycle 25A [Source:HGNC Symbol;Acc:HGNC:1725]","GO:0004725(protein tyrosine phosphatase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006470(protein dephosphorylation);GO:0007049(cell cycle);GO:0009314(response to radiation);GO:0016787(hydrolase activity);GO:0019901(protein kinase binding);GO:0034644(cellular response to UV);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0051087(chaperone binding);GO:0051301(cell division);GO:1902751(positive regulation of cell cycle G2/M phase transition)","04110(Cell cycle);04218(Cellular senescence);04914(Progesterone-mediated oocyte maturation);05206(MicroRNAs in cancer)",{"v":9.1e-07,"d":"0.00"},1,"151,",0,-6.04,-5.33,2.97,"3' UTR",22,10423231,10454364,31134,2]
["chr22",10986119,10986504,386,"ENSBGRG00000023323","ENSBGRT00000043298",3034,"NCKIPSD","NCK interacting protein with SH3 domain [Source:HGNC Symbol;Acc:HGNC:15486]","GO:0005515(protein binding);GO:0008180(COP9 signalosome);GO:0010976(positive regulation of neuron projection development)","NA",{"v":0.00085,"d":"0.00"},2,"52,158,","0,228",-3.07,-2.48,2.58,"Exon (ENSBGRT00000043298/ENSBGRG00000023323, exon 3 of 15)",22,10977858,10989538,11681,2]
["chr22",11783672,11783731,60,"ENSBGRG00000021700","ENSBGRT00000040373",24966,"RNF123","ring finger protein 123 [Source:HGNC Symbol;Acc:HGNC:21148]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0031965(nuclear membrane)","NA",{"v":7.6e-07,"d":"0.00"},1,"60,",0,-6.12,-5.41,2.11,"Exon (ENSBGRT00000040489/ENSBGRG00000021936, exon 1 of 1)",22,11758706,11787904,29199,1]
["chr22",11943491,11944896,1406,"ENSBGRG00000022982","ENSBGRT00000042475",2161,"MON1A","MON1 homolog A, secretory trafficking associated [Source:HGNC Symbol;Acc:HGNC:28207]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0006623(protein targeting to vacuole);GO:0035658(Mon1-Ccz1 complex)","NA",{"v":6.3e-15,"d":"0.00"},2,"10,438,","0,968",{"v":-14.2,"d":"-14.20"},{"v":-13.3,"d":"-13.30"},7.02,"Exon (ENSBGRT00000042475/ENSBGRG00000022982, exon 3 of 6)",22,11941325,11947057,5733,2]
["chr22",13817003,13817122,120,"ENSBGRG00000007329","ENSBGRT00000013467",1383,"ENSBGRG00000007329","NA","GO:0001816(cytokine production);GO:0001932(regulation of protein phosphorylation);GO:0002218(activation of innate immune response);GO:0002237(response to molecule of bacterial origin);GO:0002730(regulation of dendritic cell cytokine production);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005764(lysosome);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0009615(response to virus);GO:0016021(integral component of membrane);GO:0030277(maintenance of gastrointestinal epithelium);GO:0032009(early phagosome);GO:0032640(tumor necrosis factor production);GO:0032715(negative regulation of interleukin-6 production);GO:0032728(positive regulation of interferon-beta production);GO:0032733(positive regulation of interleukin-10 production);GO:0032735(positive regulation of interleukin-12 production);GO:0032741(positive regulation of interleukin-18 production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0034162(toll-like receptor 9 signaling pathway);GO:0034165(positive regulation of toll-like receptor 9 signaling pathway);GO:0036019(endolysosome);GO:0045087(innate immune response);GO:0045335(phagocytic vesicle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050707(regulation of cytokine secretion);GO:0050727(regulation of inflammatory response);GO:0050729(positive regulation of inflammatory response);GO:0050864(regulation of B cell activation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051607(defense response to virus);GO:0051770(positive regulation of nitric-oxide synthase biosynthetic process);GO:1902350(cellular response to chloroquine)","04620(Toll-like receptor signaling pathway);05152(Tuberculosis);05162(Measles);05168(Herpes simplex infection);05144(Malaria);05142(Chagas disease (American trypanosomiasis));05143(African trypanosomiasis)",{"v":0.036,"d":"0.04"},1,"120,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000013467/ENSBGRG00000007329, exon 2 of 3)",22,13814802,13818505,3704,2]
["chr22",14285750,14287432,1683,"ENSBGRG00000010511","ENSBGRT00000027094",96242,"PBRM1","polybromo 1 [Source:HGNC Symbol;Acc:HGNC:30064]","GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006338(chromatin remodeling);GO:0008285(negative regulation of cell population proliferation);GO:0016586(RSC-type complex)","05225(Hepatocellular carcinoma)",{"v":0.00038,"d":"0.00"},3,"29,211,30,","0,659,1653",-3.42,-2.81,1.26,"Exon (ENSBGRT00000027094/ENSBGRG00000010511, exon 24 of 31)",22,14272573,14383674,111102,2]
["chr22",19041395,19042145,751,"ENSBGRG00000023132","ENSBGRT00000042823",64028,"IL17RD","interleukin 17 receptor D [Source:HGNC Symbol;Acc:HGNC:17616]","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0030368(interleukin-17 receptor activity);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway)","NA",{"v":5e-27,"d":"0.00"},3,"192,7,549,","0,194,202",{"v":-26.3,"d":"-26.30"},{"v":-25.3,"d":"-25.30"},7.98,"Exon (ENSBGRT00000042823/ENSBGRG00000023132, exon 12 of 15)",22,19040507,19106173,65667,2]
["chr22",36498367,36498986,620,"ENSBGRG00000022160","ENSBGRT00000040894",147,"ENSBGRG00000022160","NA","NA","NA",{"v":0.012,"d":"0.01"},1,"620,",0,-1.93,{"v":-1.4,"d":"-1.40"},7.92,"Exon (ENSBGRT00000040894/ENSBGRG00000022160, exon 1 of 1)",22,36497895,36499133,1239,2]
["chr22",49630605,49642148,11544,"ENSBGRG00000015163","ENSBGRT00000028031",3756,"ZNF197","zinc finger protein 197 [Source:HGNC Symbol;Acc:HGNC:12988]","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1e-111,"d":"0.00"},4,"5,55,2263,117,","0,1911,1993,11427",-111,-109,8.91,"Exon (ENSBGRT00000028031/ENSBGRG00000015163, exon 4 of 6)",22,49630574,49645904,15331,2]
["chr22",51336552,51377330,40779,"ENSBGRG00000017119","ENSBGRT00000031377",6455,"ACKR2","atypical chemokine receptor 2 [Source:HGNC Symbol;Acc:HGNC:1565]","GO:0004930(G protein-coupled receptor activity);GO:0004950(chemokine receptor activity);GO:0005044(scavenger receptor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006935(chemotaxis);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0016493(C-C chemokine receptor activity);GO:0019957(C-C chemokine binding);GO:0031965(nuclear membrane);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":0.0062,"d":"0.01"},2,"48,252,","0,40527",-2.21,-1.67,9.91,"5' UTR",22,51335416,51383785,48370,2]
["chr22",54713953,54714371,419,"ENSBGRG00000011105","ENSBGRT00000020230",35305,"ENSBGRG00000011105","NA","GO:0003676(nucleic acid binding);GO:0016787(hydrolase activity);GO:0046872(metal ion binding)","NA",{"v":0.0039,"d":"0.00"},1,"419,",0,-2.41,-1.85,8.91,"3' UTR",22,54713326,54749676,36351,2]
["chr22",56098271,56101318,3048,"ENSBGRG00000014964","ENSBGRT00000027944",76142,"TRANK1","tetratricopeptide repeat and ankyrin repeat containing 1 [Source:HGNC Symbol;Acc:HGNC:29011]","GO:0005515(protein binding)","NA",{"v":9.99999999999999e-223,"d":"0.00"},2,"14,1783,","0,1265",-222,-220,6.93,"Exon (ENSBGRT00000027944/ENSBGRG00000014964, exon 23 of 25)",22,56095899,56177460,81562,2]
["chr23",1681049,1681286,238,"ENSBGRG00000013644","ENSBGRT00000025049",15117,"ENSBGRG00000013644","NA","NA","04080(Neuroactive ligand-receptor interaction);04727(GABAergic synapse);04723(Retrograde endocannabinoid signaling);05032(Morphine addiction);05033(Nicotine addiction)",{"v":4e-26,"d":"0.00"},1,"238,",0,{"v":-25.4,"d":"-25.40"},{"v":-24.4,"d":"-24.40"},1.67,"3' UTR",23,1665932,1681790,15859,1]
["chr23",3055178,3056697,1520,"ENSBGRG00000015198","ENSBGRT00000028058",130461,"SH3PXD2B","SH3 and PX domains 2B [Source:HGNC Symbol;Acc:HGNC:29242]","GO:0001501(skeletal system development);GO:0001654(eye development);GO:0005515(protein binding);GO:0006801(superoxide metabolic process);GO:0007507(heart development);GO:0022617(extracellular matrix disassembly);GO:0035091(phosphatidylinositol binding);GO:0060348(bone development);GO:0071800(podosome assembly);GO:0072657(protein localization to membrane)","04145(Phagosome)",{"v":7.9E-91,"d":"0.00"},1,"1520,",0,{"v":-90.1,"d":"-90.10"},{"v":-88.7,"d":"-88.70"},3.89,"3' UTR",23,2924717,3057502,132786,1]
["chr23",7933882,7936581,2700,"ENSBGRG00000022350","ENSBGRT00000041261",0,"ENSBGRG00000022350","NA","NA","NA",{"v":0.00098,"d":"0.00"},3,"18,106,79,","0,2357,2621",-3.01,-2.42,{"v":12.9,"d":"12.90"},"Exon (ENSBGRT00000041279/ENSBGRG00000022360, exon 1 of 3)",23,7932808,7935467,2660,2]
["chr23",22210960,22214449,3490,"ENSBGRG00000018948","ENSBGRT00000035114",132466,"ENSBGRG00000018948","NA","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0007411(axon guidance);GO:0007417(central nervous system development)","NA",{"v":3.2e-14,"d":"0.00"},2,"35,384,","0,3106",{"v":-13.5,"d":"-13.50"},{"v":-12.6,"d":"-12.60"},4.46,"Exon (ENSBGRT00000035114/ENSBGRG00000018948, exon 5 of 32)",23,22078494,22327582,249089,1]
["chr23",43593964,43594278,315,"ENSBGRG00000010199","ENSBGRT00000020339",177664,"RAI14","retinoic acid induced 14 [Source:HGNC Symbol;Acc:HGNC:14873]","GO:0001650(fibrillar center);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol)","NA",{"v":1.6e-33,"d":"0.00"},2,"78,102,","0,213",{"v":-32.8,"d":"-32.80"},{"v":-31.7,"d":"-31.70"},{"v":2.9,"d":"2.90"},"Exon (ENSBGRT00000020339/ENSBGRG00000010199, exon 19 of 19)",23,43416300,43594041,177742,1]
["chr23",47287317,47287407,91,"ENSBGRG00000021685","ENSBGRT00000041117",225814,"EGFLAM","EGF like, fibronectin type III and laminin G domains [Source:HGNC Symbol;Acc:HGNC:26810]","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005539(glycosaminoglycan binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0010811(positive regulation of cell-substrate adhesion);GO:0019800(peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)","04512(ECM-receptor interaction)",{"v":5E-15,"d":"0.00"},1,"91,",0,{"v":-14.3,"d":"-14.30"},{"v":-13.4,"d":"-13.40"},1.55,"Exon (ENSBGRT00000041117/ENSBGRG00000021685, exon 25 of 25)",23,47061503,47287407,225905,1]
["chr23",57905001,57905860,860,"ENSBGRG00000020271","ENSBGRT00000037287",17525,"ITGA1","integrin subunit alpha 1 [Source:HGNC Symbol;Acc:HGNC:6134]","GO:0005925(focal adhesion);GO:0007155(cell adhesion);GO:0007160(cell-matrix adhesion);GO:0008285(negative regulation of cell population proliferation);GO:0008305(integrin complex);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0019903(protein phosphatase binding);GO:0030593(neutrophil chemotaxis);GO:0032516(positive regulation of phosphoprotein phosphatase activity);GO:0034665(integrin alpha1-beta1 complex);GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway);GO:0045123(cellular extravasation);GO:0045178(basal part of cell);GO:0098639(collagen binding involved in cell-matrix adhesion)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04640(Hematopoietic cell lineage);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection)",{"v":1e-240,"d":"0.00"},2,"126,435,","0,425",-240,-238,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000037511/ENSBGRG00000020395, exon 1 of 2)",23,57887476,58084798,197323,1]
["chr23",2200448,2206269,5822,"ENSBGRG00000013853","ENSBGRT00000025583",16076,"BNIP1","BCL2 interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:1082]","GO:0005484(SNAP receptor activity);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006890(retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum);GO:0006915(apoptotic process);GO:0007029(endoplasmic reticulum organization);GO:0016320(endoplasmic reticulum membrane fusion);GO:0031201(SNARE complex);GO:0031966(mitochondrial membrane);GO:0043231(intracellular membrane-bounded organelle)","04130(SNARE interactions in vesicular transport)",{"v":0.00071,"d":"0.00"},2,"75,133,","0,5689",-3.15,-2.55,7.92,"Exon (ENSBGRT00000025583/ENSBGRG00000013853, exon 6 of 6)",23,2199647,2222345,22699,2]
["chr23",2667533,2669102,1570,"ENSBGRG00000015084","ENSBGRT00000027802",44525,"NEURL1B","neuralized E3 ubiquitin protein ligase 1B [Source:HGNC Symbol;Acc:HGNC:35422]","NA","NA",{"v":7.9e-64,"d":"0.00"},2,"749,50,","0,1520",{"v":-63.1,"d":"-63.10"},{"v":-61.8,"d":"-61.80"},5.28,"3' UTR",23,2667533,2713627,46095,2]
["chr23",16193004,16193393,390,"ENSBGRG00000011867","ENSBGRT00000021956",499758,"SEMA5A","semaphorin 5A [Source:HGNC Symbol;Acc:HGNC:10736]","GO:0005515(protein binding);GO:0030215(semaphorin receptor binding)","04360(Axon guidance)",{"v":7.9e-30,"d":"0.00"},1,"390,",0,{"v":-29.1,"d":"-29.10"},-28,5.74,"3' UTR",23,16192914,16693151,500238,2]
["chr23",41270026,41274169,4144,"ENSBGRG00000008494","ENSBGRT00000015686",62240,"MTMR12","myotubularin related protein 12 [Source:HGNC Symbol;Acc:HGNC:18191]","GO:0005737(cytoplasm);GO:0019208(phosphatase regulator activity);GO:1901998(toxin transport)","NA",{"v":1E-108,"d":"0.00"},2,"876,106,","0,4038",-108,-106,7.89,"3' UTR",23,41269877,41336409,66533,2]
["chr23",48115295,48115831,537,"ENSBGRG00000023892","ENSBGRT00000044175",75824,"FYB1","FYN binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4036]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0008289(lipid binding);GO:0015629(actin cytoskeleton);GO:0032991(protein-containing complex);GO:0072659(protein localization to plasma membrane)","04015(Rap1 signaling pathway)",{"v":2.4e-05,"d":"0.00"},1,"537,",0,-4.62,-3.96,5.61,"Exon (ENSBGRT00000044175/ENSBGRG00000023892, exon 2 of 19)",23,48008194,48191655,183462,2]
["chr23",59550431,59550757,327,"ENSBGRG00000020951","ENSBGRT00000038607",119,"ARL15","ADP ribosylation factor like GTPase 15 [Source:HGNC Symbol;Acc:HGNC:25945]","GO:0005525(GTP binding)","NA",{"v":0.00026,"d":"0.00"},1,"327,",0,-3.58,-2.95,7.92,"5' UTR",23,59036898,59550876,513979,2]
["chr24",3047843,3051021,3179,"ENSBGRG00000015165","ENSBGRT00000027906",5249,"TRIM38","tripartite motif containing 38 [Source:HGNC Symbol;Acc:HGNC:10059]","GO:0005515(protein binding);GO:0008270(zinc ion binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0046598(positive regulation of viral entry into host cell);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity)","NA",{"v":7.9e-11,"d":"0.00"},4,"31,231,23,12,","0,1836,3049,3167",{"v":-10.1,"d":"-10.10"},{"v":-9.3,"d":"-9.30"},1.76,"Exon (ENSBGRT00000027906/ENSBGRG00000015165, exon 4 of 8)",24,3042594,3057377,14784,1]
["chr24",4483299,4483596,298,"ENSBGRG00000018866","ENSBGRT00000034624",263,"ZKSCAN8","zinc finger with KRAB and SCAN domains 8 [Source:HGNC Symbol;Acc:HGNC:12983]","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":2e-21,"d":"0.00"},1,"298,",0,{"v":-20.7,"d":"-20.70"},{"v":-19.8,"d":"-19.80"},2.78,"5' UTR",24,4483036,4492544,9509,1]
["chr24",6083164,6083460,297,"ENSBGRG00000018510","ENSBGRT00000033900",1529,"ENSBGRG00000018510","NA","GO:0005515(protein binding);GO:0034612(response to tumor necrosis factor);GO:0070628(proteasome binding)","NA",{"v":5e-40,"d":"0.00"},1,"297,",0,{"v":-39.3,"d":"-39.30"},{"v":-38.2,"d":"-38.20"},7.01,"3' UTR",24,6081635,6083846,2212,1]
["chr24",6640265,6640751,487,"ENSBGRG00000006969","ENSBGRT00000013550",12731,"ABCF1","ATP binding cassette subfamily F member 1 [Source:HGNC Symbol;Acc:HGNC:70]","GO:0005524(ATP binding);GO:0005829(cytosol);GO:0016887(ATPase activity)","NA",{"v":1.3e-63,"d":"0.00"},2,"252,167,","0,320",{"v":-62.9,"d":"-62.90"},{"v":-61.6,"d":"-61.60"},{"v":10.6,"d":"10.60"},"Exon (ENSBGRT00000013550/ENSBGRG00000006969, exon 25 of 25)",24,6627534,6640516,12983,1]
["chr24",7771543,7772204,662,"ENSBGRG00000020707","ENSBGRT00000038450",12490,"SKIV2L","Ski2 like RNA helicase [Source:HGNC Symbol;Acc:HGNC:10898]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003724(RNA helicase activity);GO:0005524(ATP binding);GO:0006401(RNA catabolic process);GO:0055087(Ski complex)","03018(RNA degradation)",{"v":5e-30,"d":"0.00"},3,"46,141,201,","0,225,461",{"v":-29.3,"d":"-29.30"},{"v":-28.3,"d":"-28.30"},2.11,"Exon (ENSBGRT00000038450/ENSBGRG00000020707, exon 27 of 29)",24,7759053,7772204,13152,1]
["chr24",14607845,14608144,300,"ENSBGRG00000024761","ENSBGRT00000045690",71485,"TNFRSF21","TNF receptor superfamily member 21 [Source:HGNC Symbol;Acc:HGNC:13469]","GO:0001783(B cell apoptotic process);GO:0002250(adaptive immune response);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0006915(apoptotic process);GO:0006959(humoral immune response);GO:0007165(signal transduction);GO:0030424(axon);GO:0030889(negative regulation of B cell proliferation);GO:0031226(intrinsic component of plasma membrane);GO:0031642(negative regulation of myelination);GO:0032693(negative regulation of interleukin-10 production);GO:0032696(negative regulation of interleukin-13 production);GO:0032714(negative regulation of interleukin-5 production);GO:0042130(negative regulation of T cell proliferation);GO:0042552(myelination);GO:0048713(regulation of oligodendrocyte differentiation);GO:0050852(T cell receptor signaling pathway);GO:0051402(neuron apoptotic process);GO:0071356(cellular response to tumor necrosis factor);GO:0097252(oligodendrocyte apoptotic process)","04060(Cytokine-cytokine receptor interaction)",{"v":4e-05,"d":"0.00"},1,"300,",0,{"v":-4.4,"d":"-4.40"},-3.75,5.15,"3' UTR",24,14536360,14609175,72816,1]
["chr24",18542529,18549431,6903,"ENSBGRG00000013542","ENSBGRT00000025081",3606,"ZNF318","zinc finger protein 318 [Source:HGNC Symbol;Acc:HGNC:13578]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0042803(protein homodimerization activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated)","NA",{"v":2.8e-10,"d":"0.00"},3,"96,192,72,","0,6577,6831",-9.55,-8.76,3.28,"Exon (ENSBGRT00000025081/ENSBGRG00000013542, exon 3 of 14)",24,18538923,18567517,28595,1]
["chr24",19783150,19783269,120,"ENSBGRG00000022013","ENSBGRT00000040644",2677,"C6orf132","chromosome 6 open reading frame 132 [Source:HGNC Symbol;Acc:HGNC:21288]","NA","NA",{"v":0.0039,"d":"0.00"},1,"120,",0,-2.41,-1.85,6.44,"Exon (ENSBGRT00000040644/ENSBGRG00000022013, exon 1 of 2)",24,19780473,19784342,3870,1]
["chr24",22786747,22790993,4247,"ENSBGRG00000024002","ENSBGRT00000044459",441206,"KIF6","kinesin family member 6 [Source:HGNC Symbol;Acc:HGNC:21202]","GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding)","NA",{"v":0.011,"d":"0.01"},3,"41,136,3,","0,1195,4244",-1.95,-1.18,8.91,"Exon (ENSBGRT00000044459/ENSBGRG00000024002, exon 19 of 24)",24,22345541,22811601,466061,1]
["chr24",27631831,27636374,4544,"ENSBGRG00000018993","ENSBGRT00000035167",4336,"TAF11","TATA-box binding protein associated factor 11 [Source:HGNC Symbol;Acc:HGNC:11544]","GO:0003677(DNA binding);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005669(transcription factor TFIID complex);GO:0005794(Golgi apparatus);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0017025(TBP-class protein binding);GO:0042809(vitamin D receptor binding);GO:0043923(positive regulation by host of viral transcription);GO:0046966(thyroid hormone receptor binding);GO:0046982(protein heterodimerization activity);GO:0047485(protein N-terminus binding)","03022(Basal transcription factors)",{"v":8.99999999999999e-296,"d":"0.00"},7,"139,88,97,26,66,3,678,","0,2672,3090,3423,3451,3518,3866",-295,-293,6.27,"3' UTR",24,27627495,27635351,7857,1]
["chr24",29429113,29430120,1008,"ENSBGRG00000019137","ENSBGRT00000039336",29118,"COL11A2","collagen type XI alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2187]","GO:0001894(tissue homeostasis);GO:0002062(chondrocyte differentiation);GO:0005201(extracellular matrix structural constituent);GO:0005581(collagen trimer);GO:0007605(sensory perception of sound);GO:0030199(collagen fibril organization);GO:0048705(skeletal system morphogenesis)","04974(Protein digestion and absorption)",0.03,5,"23,54,36,54,132,","0,156,510,728,876",-1.52,-1.03,3.63,"Exon (ENSBGRT00000039336/ENSBGRG00000019137, exon 60 of 67)",24,29399995,29432849,32855,1]
["chr24",30513499,30513558,60,"ENSBGRG00000023693","ENSBGRT00000044046",142523,"MLIP","muscular LMNA interacting protein [Source:HGNC Symbol;Acc:HGNC:21355]","NA","NA",{"v":0.0068,"d":"0.01"},1,"60,",0,-2.17,-1.62,5.94,"Exon (ENSBGRT00000044046/ENSBGRG00000023693, exon 3 of 13)",24,30370976,30678330,307355,1]
["chr24",45170084,45172125,2042,"ENSBGRG00000010332","ENSBGRT00000019281",97958,"DTNBP1","dystrobrevin binding protein 1 [Source:HGNC Symbol;Acc:HGNC:17328]","GO:0001956(positive regulation of neurotransmitter secretion);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0006996(organelle organization);GO:0007596(blood coagulation);GO:0008089(anterograde axonal transport);GO:0010628(positive regulation of gene expression);GO:0014059(regulation of dopamine secretion);GO:0014069(postsynaptic density);GO:0015630(microtubule cytoskeleton);GO:0016528(sarcoplasm);GO:0030424(axon);GO:0030426(growth cone);GO:0030496(midbody);GO:0030672(synaptic vesicle membrane);GO:0031083(BLOC-1 complex);GO:0031175(neuron projection development);GO:0031532(actin cytoskeleton reorganization);GO:0032091(negative regulation of protein binding);GO:0042383(sarcolemma);GO:0043005(neuron projection);GO:0043197(dendritic spine);GO:0043506(regulation of JUN kinase activity);GO:0048490(anterograde synaptic vesicle transport);GO:0048812(neuron projection morphogenesis);GO:0048813(dendrite morphogenesis);GO:0060155(platelet dense granule organization);GO:0071901(negative regulation of protein serine/threonine kinase activity)","NA",{"v":1.2E-9,"d":"0.00"},2,"87,92,","0,1950",-8.91,-8.13,{"v":33.7,"d":"33.70"},"Exon (ENSBGRT00000019281/ENSBGRG00000010332, exon 8 of 10)",24,45072126,45182520,110395,1]
["chr24",52771234,52772396,1163,"ENSBGRG00000018745","ENSBGRT00000034309",2382,"ENSBGRG00000018745","NA","NA","NA",{"v":0.00022,"d":"0.00"},1,"1163,",0,-3.66,-3.04,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000034309/ENSBGRG00000018745, exon 1 of 2)",24,52768852,52811663,42812,1]
["chr24",55827097,55830077,2981,"ENSBGRG00000010205","ENSBGRT00000018696",6491,"SERPINB1","serpin family B member 1 [Source:HGNC Symbol;Acc:HGNC:3311]","GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0010951(negative regulation of endopeptidase activity);GO:0030414(peptidase inhibitor activity);GO:0032691(negative regulation of interleukin-1 beta production);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0044342(type B pancreatic cell proliferation)","05146(Amoebiasis)",{"v":2.5e-26,"d":"0.00"},4,"2,143,168,45,","0,1288,1514,2936",{"v":-25.6,"d":"-25.60"},{"v":-24.6,"d":"-24.60"},2.97,"Exon (ENSBGRT00000018696/ENSBGRG00000010205, exon 4 of 7)",24,55820606,55830434,9829,1]
["chr24",3153876,3279617,125742,"ENSBGRG00000016006","ENSBGRT00000029393",0,"H2AC6","H2A clustered histone 6 [Source:HGNC Symbol;Acc:HGNC:4733]","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0008285(negative regulation of cell population proliferation);GO:0046982(protein heterodimerization activity)","04217(Necroptosis);05322(Systemic lupus erythematosus);05034(Alcoholism)",{"v":6.2e-06,"d":"0.00"},2,"35,204,","0,125538",-5.21,-4.53,{"v":17.8,"d":"17.80"},"Exon (ENSBGRT00000029393/ENSBGRG00000016006, exon 1 of 1)",24,3169960,3170352,393,1]
["chr24",6341441,6343620,2180,"ENSBGRG00000020507","ENSBGRT00000037804",118,"TRIM10","tripartite motif containing 10 [Source:HGNC Symbol;Acc:HGNC:10072]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0030218(erythrocyte differentiation);GO:0045087(innate immune response);GO:0046597(negative regulation of viral entry into host cell);GO:0046872(metal ion binding)","NA",{"v":0.00098,"d":"0.00"},2,"73,311,","0,1869",-3.01,-2.42,{"v":12.9,"d":"12.90"},"Exon (ENSBGRT00000037804/ENSBGRG00000020507, exon 1 of 7)",24,6336028,6343738,7711,2]
["chr24",7109154,7109358,205,"ENSBGRG00000010231","ENSBGRT00000020023",6566,"CCHCR1","coiled-coil alpha-helical rod protein 1 [Source:HGNC Symbol;Acc:HGNC:13930]","GO:0005737(cytoplasm);GO:0005814(centriole);GO:0005829(cytosol);GO:0006611(protein export from nucleus);GO:0030154(cell differentiation)","NA",{"v":0.015,"d":"0.02"},2,"44,77,","0,128",-1.83,-1.31,1.58,"Exon (ENSBGRT00000020023/ENSBGRG00000010231, exon 8 of 18)",24,7098909,7115924,17016,2]
["chr24",7551649,7551799,151,"ENSBGRG00000016105","ENSBGRT00000029598",403,"CLIC1","chloride intracellular channel 1 [Source:HGNC Symbol;Acc:HGNC:2062]","GO:0005254(chloride channel activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006821(chloride transport);GO:0045669(positive regulation of osteoblast differentiation);GO:0048471(perinuclear region of cytoplasm);GO:0051726(regulation of cell cycle);GO:0051881(regulation of mitochondrial membrane potential);GO:0070062(extracellular exosome)","NA",0.02,1,"151,",0,{"v":-1.7,"d":"-1.70"},-1.19,6.93,"5' UTR",24,7545147,7552202,7056,2]
["chr24",7887468,7887528,61,"ENSBGRG00000026000","ENSBGRT00000048182",32007,"ENSBGRG00000026000","NA","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);05206(MicroRNAs in cancer);05165(Human papillomavirus infection)",{"v":6.9e-09,"d":"0.00"},1,"61,",0,-8.16,{"v":-7.4,"d":"-7.40"},{"v":2.6,"d":"2.60"},"Exon (ENSBGRT00000048182/ENSBGRG00000026000, exon 18 of 50)",24,7856845,7919535,62691,2]
["chr24",15099048,15099257,210,"ENSBGRG00000024998","ENSBGRT00000046163",9917,"ANKRD66","ankyrin repeat domain 66 [Source:HGNC Symbol;Acc:HGNC:44669]","GO:0005515(protein binding)","NA",{"v":1.8E-3,"d":"0.00"},1,"210,",0,-2.74,-2.16,{"v":11.9,"d":"11.90"},"3' UTR",24,15098928,15109174,10247,2]
["chr24",18380743,18408025,27283,"ENSBGRG00000011470","ENSBGRT00000021629",22459,"XPO5","exportin 5 [Source:HGNC Symbol;Acc:HGNC:17675]","GO:0000049(tRNA binding);GO:0003729(mRNA binding);GO:0005049(nuclear export signal receptor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006611(protein export from nucleus);GO:0006886(intracellular protein transport);GO:0008536(Ran GTPase binding);GO:0016442(RISC complex);GO:0035281(pre-miRNA export from nucleus);GO:0042565(RNA nuclear export complex);GO:0051168(nuclear export);GO:0070883(pre-miRNA binding);GO:1900370(positive regulation of RNA interference);GO:1905172(RISC complex binding)","03013(RNA transport)",{"v":4E-14,"d":"0.00"},3,"2,133,101,","0,26936,27182",{"v":-13.4,"d":"-13.40"},{"v":-12.6,"d":"-12.60"},{"v":2.9,"d":"2.90"},"3' UTR",24,18358284,18405384,47101,1]
["chr24",19703778,19703837,60,"ENSBGRG00000021900","ENSBGRT00000040528",8203,"GUCA1A","guanylate cyclase activator 1A [Source:HGNC Symbol;Acc:HGNC:4678]","GO:0001750(photoreceptor outer segment);GO:0001917(photoreceptor inner segment);GO:0005509(calcium ion binding);GO:0007601(visual perception);GO:0007602(phototransduction);GO:0008048(calcium sensitive guanylate cyclase activator activity);GO:0030249(guanylate cyclase regulator activity);GO:0031282(regulation of guanylate cyclase activity);GO:0120199(cone photoreceptor outer segment)","04744(Phototransduction)",{"v":0.014,"d":"0.01"},1,"60,",0,-1.85,-1.33,3.17,"Exon (ENSBGRT00000040528/ENSBGRG00000021900, exon 5 of 5)",24,19703719,19712040,8322,2]
["chr24",25661293,25661413,121,"ENSBGRG00000011007","ENSBGRT00000020075",2271,"ENSBGRG00000011007","NA","NA","NA",{"v":0.00017,"d":"0.00"},1,"121,",0,-3.77,-3.14,{"v":5.7,"d":"5.70"},"Exon (ENSBGRT00000020085/ENSBGRG00000011007, exon 2 of 2)",24,25658801,25663684,4884,2]
["chr24",28904006,28905529,1524,"ENSBGRG00000021666","ENSBGRT00000040749",78139,"ITPR3","inositol 1,4,5-trisphosphate receptor type 3 [Source:HGNC Symbol;Acc:HGNC:6182]","GO:0005216(ion channel activity);GO:0005220(inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity);GO:0005262(calcium channel activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0007613(memory);GO:0015278(calcium-release channel activity);GO:0016020(membrane);GO:0035091(phosphatidylinositol binding);GO:0043235(receptor complex);GO:0050913(sensory perception of bitter taste);GO:0050916(sensory perception of sweet taste);GO:0050917(sensory perception of umami taste);GO:0051592(response to calcium ion);GO:0055085(transmembrane transport);GO:0060291(long-term synaptic potentiation);GO:0060402(calcium ion transport into cytosol);GO:0070588(calcium ion transmembrane transport);GO:0070679(inositol 1,4,5 trisphosphate binding)","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04070(Phosphatidylinositol signaling system);04022(cGMP - PKG signaling pathway);04114(Oocyte meiosis);04210(Apoptosis);04218(Cellular senescence);04540(Gap junction);04611(Platelet activation);04621(NOD-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04911(Insulin secretion);04922(Glucagon signaling pathway);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04921(Oxytocin signaling pathway);04918(Thyroid hormone synthesis);04928(Parathyroid hormone synthesis, secretion and action);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04724(Glutamatergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04720(Long-term potentiation);04730(Long-term depression);04723(Retrograde endocannabinoid signaling);04742(Taste transduction);04750(Inflammatory mediator regulation of TRP channels);04713(Circadian entrainment);05205(Proteoglycans in cancer);05010(Alzheimer disease);04934(Cushing syndrome);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":5e-85,"d":"0.00"},2,"782,117,","0,1407",{"v":-84.3,"d":"-84.30"},{"v":-82.8,"d":"-82.80"},4.93,"3' UTR",24,28904006,28983668,79663,2]
["chr24",29508975,29509035,61,"ENSBGRG00000021838","ENSBGRT00000040321",716,"ENSBGRG00000021838","NA","NA","NA",{"v":0.015,"d":"0.02"},1,"61,",0,-1.82,{"v":-1.3,"d":"-1.30"},1.98,"Exon (ENSBGRT00000040321/ENSBGRG00000021838, exon 1 of 2)",24,29505814,29509751,3938,2]
["chr24",40006020,40007462,1443,"ENSBGRG00000025903","ENSBGRT00000047887",690189,"CDKAL1","CDK5 regulatory subunit associated protein 1 like 1 [Source:HGNC Symbol;Acc:HGNC:21050]","GO:0003824(catalytic activity);GO:0005783(endoplasmic reticulum);GO:0005791(rough endoplasmic reticulum);GO:0006400(tRNA modification);GO:0016740(transferase activity);GO:0035596(methylthiotransferase activity);GO:0035598(N6-threonylcarbomyladenosine methylthiotransferase activity);GO:0035600(tRNA methylthiolation);GO:0051536(iron-sulfur cluster binding);GO:0051539(4 iron, 4 sulfur cluster binding);GO:1990145(maintenance of translational fidelity)","NA",{"v":1.1e-08,"d":"0.00"},2,"226,281,","0,1162",-7.96,{"v":-7.2,"d":"-7.20"},{"v":15.8,"d":"15.80"},"3' UTR",24,39916068,40697651,781584,2]
["chr24",48351993,48385596,33604,"ENSBGRG00000012906","ENSBGRT00000023622",116567,"HIVEP1","HIVEP zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:4920]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008270(zinc ion binding);GO:0016604(nuclear body);GO:0030509(BMP signaling pathway);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":3.2e-36,"d":"0.00"},5,"1079,494,102,176,66,","0,2634,27930,32649,33538",{"v":-35.5,"d":"-35.50"},{"v":-34.4,"d":"-34.40"},5.33,"5' UTR",24,48351940,48502163,150224,2]
["chr24",52354728,52364130,9403,"ENSBGRG00000016827","ENSBGRT00000030979",124,"SNRNP48","small nuclear ribonucleoprotein U11/U12 subunit 48 [Source:HGNC Symbol;Acc:HGNC:21368]","GO:0005654(nucleoplasm);GO:0005689(U12-type spliceosomal complex);GO:0005829(cytosol)","NA",{"v":2.2e-08,"d":"0.00"},2,"18,163,","0,9240",-7.66,-6.91,2.25,"5' UTR",24,52339451,52364254,24804,2]
["chr24",52385929,52385989,61,"ENSBGRG00000016985","ENSBGRT00000032505",40141,"DSP","desmoplakin [Source:HGNC Symbol;Acc:HGNC:3052]","GO:0001533(cornified envelope);GO:0002934(desmosome organization);GO:0003223(ventricular compact myocardium morphogenesis);GO:0005080(protein kinase C binding);GO:0005515(protein binding);GO:0005856(cytoskeleton);GO:0005882(intermediate filament);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0014704(intercalated disc);GO:0016323(basolateral plasma membrane);GO:0018149(peptide cross-linking);GO:0030054(cell junction);GO:0030057(desmosome);GO:0030216(keratinocyte differentiation);GO:0034332(adherens junction organization);GO:0043588(skin development);GO:0045104(intermediate filament cytoskeleton organization);GO:0045109(intermediate filament organization);GO:0050839(cell adhesion molecule binding);GO:0086073(bundle of His cell-Purkinje myocyte adhesion involved in cell communication);GO:0086091(regulation of heart rate by cardiac conduction);GO:0090136(epithelial cell-cell adhesion);GO:0097110(scaffold protein binding);GO:0098609(cell-cell adhesion);GO:0098911(regulation of ventricular cardiac muscle cell action potential);GO:0150105(protein localization to cell-cell junction)","05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC))",{"v":2E-12,"d":"0.00"},1,"61,",0,{"v":-11.7,"d":"-11.70"},{"v":-10.9,"d":"-10.90"},3.19,"Exon (ENSBGRT00000032505/ENSBGRG00000016985, exon 24 of 27)",24,52374379,52426130,51752,2]
["chr24",55633352,55634898,1547,"ENSBGRG00000009131","ENSBGRT00000016785",10341,"NQO2","N-ribosyldihydronicotinamide:quinone reductase 2 [Source:HGNC Symbol;Acc:HGNC:7856]","GO:0001512(dihydronicotinamide riboside quinone reductase activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0009055(electron transfer activity);GO:0016491(oxidoreductase activity);GO:0016661(oxidoreductase activity, acting on other nitrogenous compounds as donors);GO:0031404(chloride ion binding);GO:0042803(protein homodimerization activity);GO:0055114(oxidation-reduction process);GO:0071949(FAD binding);GO:1904408(melatonin binding);GO:1905594(resveratrol binding)","NA",{"v":1E-35,"d":"0.00"},2,"269,56,","0,1491",-35,{"v":-33.9,"d":"-33.90"},5.03,"3' UTR",24,55633352,55645239,11888,2]
["chr25",11963176,11963898,723,"ENSBGRG00000017867","ENSBGRT00000032804",5212,"IFIT1","interferon induced protein with tetratricopeptide repeats 1 [Source:HGNC Symbol;Acc:HGNC:5407]","GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0009615(response to virus);GO:0019060(intracellular transport of viral protein in host cell);GO:0032091(negative regulation of protein binding);GO:0045070(positive regulation of viral genome replication);GO:0045071(negative regulation of viral genome replication);GO:0050688(regulation of defense response to virus);GO:0051097(negative regulation of helicase activity);GO:0071357(cellular response to type I interferon);GO:0071360(cellular response to exogenous dsRNA)","05160(Hepatitis C);05168(Herpes simplex infection)",{"v":2.5e-26,"d":"0.00"},3,"540,4,170,","0,544,553",{"v":-25.6,"d":"-25.60"},{"v":-24.6,"d":"-24.60"},4.85,"Exon (ENSBGRT00000032804/ENSBGRG00000017867, exon 2 of 4)",25,11957964,11963898,5935,1]
["chr25",16983341,16992025,8685,"ENSBGRG00000024803","ENSBGRT00000045963",275665,"PLCE1","phospholipase C epsilon 1 [Source:HGNC Symbol;Acc:HGNC:17175]","GO:0000187(activation of MAPK activity);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0004629(phospholipase C activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0006651(diacylglycerol biosynthetic process);GO:0007165(signal transduction);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007200(phospholipase C-activating G protein-coupled receptor signaling pathway);GO:0007264(small GTPase mediated signal transduction);GO:0007265(Ras protein signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0008277(regulation of G protein-coupled receptor signaling pathway);GO:0010592(positive regulation of lamellipodium assembly);GO:0017016(Ras GTPase binding);GO:0019899(enzyme binding);GO:0030027(lamellipodium);GO:0032835(glomerulus development);GO:0035556(intracellular signal transduction);GO:0045859(regulation of protein kinase activity);GO:0046578(regulation of Ras protein signal transduction)","00562(Inositol phosphate metabolism);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04070(Phosphatidylinositol signaling system);04024(cAMP signaling pathway);04919(Thyroid hormone signaling pathway);05205(Proteoglycans in cancer);04933(AGE-RAGE signaling pathway in diabetic complications)",{"v":7.8e-10,"d":"0.00"},2,"403,77,","0,8608",-9.11,-8.33,6.11,"Exon (ENSBGRT00000045963/ENSBGRG00000024803, exon 7 of 31)",25,16707676,17063528,355853,1]
["chr25",19627614,19628392,779,"ENSBGRG00000026094","ENSBGRT00000048260",128712,"LCOR","ligand dependent nuclear receptor corepressor [Source:HGNC Symbol;Acc:HGNC:29503]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001226(RNA polymerase II transcription corepressor binding);GO:0003677(DNA binding);GO:0003714(transcription corepressor activity);GO:0005654(nucleoplasm);GO:0030331(estrogen receptor binding);GO:0042826(histone deacetylase binding);GO:0071392(cellular response to estradiol stimulus);GO:1990226(histone methyltransferase binding);GO:1990381(ubiquitin-specific protease binding)","04214(Apoptosis - fly)",{"v":3.2e-12,"d":"0.00"},1,"779,",0,{"v":-11.5,"d":"-11.50"},{"v":-10.7,"d":"-10.70"},5.14,"Exon (ENSBGRT00000048260/ENSBGRG00000026094, exon 7 of 7)",25,19498902,19631592,132691,1]
["chr25",22409159,22410899,1741,"ENSBGRG00000022756","ENSBGRT00000042049",34955,"CUTC","cutC copper transporter [Source:HGNC Symbol;Acc:HGNC:24271]","GO:0005507(copper ion binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0051262(protein tetramerization);GO:0055070(copper ion homeostasis)","NA",{"v":7.9E-91,"d":"0.00"},2,"90,420,","0,1321",{"v":-90.1,"d":"-90.10"},{"v":-88.6,"d":"-88.60"},5.34,"3' UTR",25,22374204,22410989,36786,1]
["chr25",25007234,25007294,61,"ENSBGRG00000026160","ENSBGRT00000048385",122492,"GBF1","golgi brefeldin A resistant guanine nucleotide exchange factor 1 [Source:HGNC Symbol;Acc:HGNC:4181]","GO:0002263(cell activation involved in immune response);GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:0005802(trans-Golgi network);GO:0006890(retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum);GO:0006895(Golgi to endosome transport);GO:0007030(Golgi organization);GO:0007346(regulation of mitotic cell cycle);GO:0030593(neutrophil chemotaxis);GO:0031252(cell leading edge);GO:0032012(regulation of ARF protein signal transduction);GO:0034067(protein localization to Golgi apparatus);GO:0042147(retrograde transport, endosome to Golgi);GO:0048205(COPI coating of Golgi vesicle);GO:0061162(establishment of monopolar cell polarity);GO:0070973(protein localization to endoplasmic reticulum exit site);GO:0080025(phosphatidylinositol-3,5-bisphosphate binding);GO:0090166(Golgi disassembly);GO:0097111(endoplasmic reticulum-Golgi intermediate compartment organization);GO:0098586(cellular response to virus);GO:1903409(reactive oxygen species biosynthetic process);GO:1903420(protein localization to endoplasmic reticulum tubular network);GO:2000008(regulation of protein localization to cell surface)","04144(Endocytosis)",{"v":1.8E-5,"d":"0.00"},1,"61,",0,-4.75,-4.09,3.43,"Exon (ENSBGRT00000048385/ENSBGRG00000026160, exon 38 of 39)",25,24884742,25008098,123357,1]
["chr25",26724972,26725702,731,"ENSBGRG00000010186","ENSBGRT00000019262",35852,"SLK","STE20 like kinase [Source:HGNC Symbol;Acc:HGNC:11088]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0030334(regulation of cell migration);GO:0031122(cytoplasmic microtubule organization);GO:0031252(cell leading edge);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0048471(perinuclear region of cytoplasm);GO:0051893(regulation of focal adhesion assembly)","04114(Oocyte meiosis)",{"v":1.8E-5,"d":"0.00"},2,"37,84,","0,647",-4.75,-4.09,3.43,"Exon (ENSBGRT00000019262/ENSBGRG00000010186, exon 8 of 19)",25,26689120,26748441,59322,1]
["chr25",26996586,26996646,61,"ENSBGRG00000012710","ENSBGRT00000023270",2725,"GSTO1","glutathione S-transferase omega 1 [Source:HGNC Symbol;Acc:HGNC:13312]","GO:0004364(glutathione transferase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0010880(regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum);GO:0016491(oxidoreductase activity);GO:0019852(L-ascorbic acid metabolic process);GO:0042178(xenobiotic catabolic process);GO:0045174(glutathione dehydrogenase (ascorbate) activity);GO:0060315(negative regulation of ryanodine-sensitive calcium-release channel activity);GO:0060316(positive regulation of ryanodine-sensitive calcium-release channel activity);GO:0071243(cellular response to arsenic-containing substance)","00480(Glutathione metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00982(Drug metabolism - cytochrome P450);00983(Drug metabolism - other enzymes);05200(Pathways in cancer);05204(Chemical carcinogenesis);05225(Hepatocellular carcinoma);05418(Fluid shear stress and atherosclerosis);01524(Platinum drug resistance)",{"v":0.018,"d":"0.02"},1,"61,",0,-1.74,-1.23,2.15,"5' UTR",25,26993861,27038306,44446,1]
["chr25",34069367,34069456,90,"ENSBGRG00000018320","ENSBGRT00000033512",89,"ENSBGRG00000018320","NA","NA","NA",{"v":0.036,"d":"0.04"},1,"90,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000033512/ENSBGRG00000018320, exon 1 of 3)",25,34069278,34070809,1532,1]
["chr25",42622714,42623067,354,"ENSBGRG00000019738","ENSBGRT00000036280",29,"NANOS1","nanos C2HC-type zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:23044]","GO:0001558(regulation of cell growth);GO:0001894(tissue homeostasis);GO:0003723(RNA binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0010608(posttranscriptional regulation of gene expression);GO:0010631(epithelial cell migration);GO:0016477(cell migration);GO:0017148(negative regulation of translation);GO:0048471(perinuclear region of cytoplasm);GO:0098749(cerebellar neuron development);GO:1900153(positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay)","NA",{"v":8.1e-06,"d":"0.00"},1,"354,",0,-5.09,-4.41,3.96,"Exon (ENSBGRT00000036280/ENSBGRG00000019738, exon 1 of 1)",25,42622685,42623566,882,1]
["chr25",46555535,46563944,8410,"ENSBGRG00000025341","ENSBGRT00000046875",14567,"ENSBGRG00000025341","NA","NA","NA",{"v":4e-63,"d":"0.00"},3,"305,18,235,","0,462,8175",{"v":-62.4,"d":"-62.40"},{"v":-61.1,"d":"-61.10"},6.18,"Exon (ENSBGRT00000046875/ENSBGRG00000025341, exon 6 of 7)",25,46540968,46556014,15047,1]
["chr25",55985933,55986142,210,"ENSBGRG00000013046","ENSBGRT00000023845",17300,"DPYSL4","dihydropyrimidinase like 4 [Source:HGNC Symbol;Acc:HGNC:3016]","GO:0005737(cytoplasm);GO:0016787(hydrolase activity);GO:0016810(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds);GO:0031005(filamin binding);GO:0070997(neuron death);GO:0097485(neuron projection guidance)","04360(Axon guidance)",{"v":3.8e-10,"d":"0.00"},1,"210,",0,-9.42,-8.63,2.79,"3' UTR",25,55968633,55986530,17898,1]
["chr25",9405266,9405754,489,"ENSBGRG00000019263","ENSBGRT00000035519",171,"SGMS1","sphingomyelin synthase 1 [Source:HGNC Symbol;Acc:HGNC:29799]","GO:0000138(Golgi trans cisterna);GO:0002950(ceramide phosphoethanolamine synthase activity);GO:0005515(protein binding);GO:0006686(sphingomyelin biosynthetic process);GO:0030173(integral component of Golgi membrane);GO:0033188(sphingomyelin synthase activity);GO:0046513(ceramide biosynthetic process);GO:0047493(ceramide cholinephosphotransferase activity)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway)",{"v":1e-29,"d":"0.00"},2,"309,133,","0,356",-29,-28,5.26,"Exon (ENSBGRT00000035519/ENSBGRG00000019263, exon 2 of 7)",25,9362460,9405925,43466,2]
["chr25",19382341,19488089,105749,"ENSBGRG00000026070","ENSBGRT00000048242",0,"PIK3AP1","phosphoinositide-3-kinase adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:30034]","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0034134(toll-like receptor 2 signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0034154(toll-like receptor 7 signaling pathway);GO:0034162(toll-like receptor 9 signaling pathway);GO:0036312(phosphatidylinositol 3-kinase regulatory subunit binding);GO:0042802(identical protein binding);GO:0050727(regulation of inflammatory response)","04151(PI3K-Akt signaling pathway);04662(B cell receptor signaling pathway)",{"v":1e-129,"d":"0.00"},3,"34,13,523,","0,13085,105226",-129,-128,{"v":11.2,"d":"11.20"},"5' UTR",25,19253522,19395438,141917,2]
["chr25",22620872,22621501,630,"ENSBGRG00000023150","ENSBGRT00000043007",10483,"DNMBP","dynamin binding protein [Source:HGNC Symbol;Acc:HGNC:30373]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005911(cell-cell junction);GO:0008360(regulation of cell shape);GO:0035556(intracellular signal transduction)","NA",{"v":1.3E-24,"d":"0.00"},1,"630,",0,{"v":-23.9,"d":"-23.90"},-23,3.86,"5' UTR",25,22531620,22631984,100365,2]
["chr25",23681928,23684866,2939,"ENSBGRG00000025335","ENSBGRT00000046826",12689,"PDZD7","PDZ domain containing 7 [Source:HGNC Symbol;Acc:HGNC:26257]","GO:0002141(stereocilia ankle link);GO:0002142(stereocilia ankle link complex);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005929(cilium);GO:0032420(stereocilium);GO:0042802(identical protein binding);GO:0045184(establishment of protein localization);GO:0050910(detection of mechanical stimulus involved in sensory perception of sound);GO:0060088(auditory receptor cell stereocilium organization);GO:0060117(auditory receptor cell development);GO:1990696(USH2 complex)","NA",{"v":0.034,"d":"0.03"},2,"38,23,","0,2916",-1.47,{"v":-0.977,"d":"-0.98"},4.46,"Exon (ENSBGRT00000046826/ENSBGRG00000025335, exon 8 of 16)",25,23673466,23697555,24090,2]
["chr25",26113042,26113101,60,"ENSBGRG00000009752","ENSBGRT00000017910",3217,"CALHM2","calcium homeostasis modulator family member 2 [Source:HGNC Symbol;Acc:HGNC:23493]","GO:0043065(positive regulation of apoptotic process)","NA",{"v":0.012,"d":"0.01"},1,"60,",0,-1.93,{"v":-1.4,"d":"-1.40"},5.45,"3' UTR",25,26112953,26116318,3366,2]
["chr25",37133727,37134055,329,"ENSBGRG00000024914","ENSBGRT00000045985",4284,"DCLRE1A","DNA cross-link repair 1A [Source:HGNC Symbol;Acc:HGNC:17660]","GO:0001650(fibrillar center);GO:0005654(nucleoplasm);GO:0035312(5'-3' exodeoxyribonuclease activity)","NA",{"v":7.9e-19,"d":"0.00"},1,"329,",0,{"v":-18.1,"d":"-18.10"},{"v":-17.2,"d":"-17.20"},3.35,"Exon (ENSBGRT00000045985/ENSBGRG00000024914, exon 2 of 9)",25,37111348,37138339,26992,2]
["chr25",42310119,42319200,9082,"ENSBGRG00000019540","ENSBGRT00000036097",59970,"CACUL1","CDK2 associated cullin domain 1 [Source:HGNC Symbol;Acc:HGNC:23727]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008284(positive regulation of cell population proliferation);GO:0019901(protein kinase binding);GO:0031625(ubiquitin protein ligase binding);GO:0045860(positive regulation of protein kinase activity)","NA",{"v":1E-78,"d":"0.00"},3,"390,44,70,","0,822,9012",-78,{"v":-76.6,"d":"-76.60"},{"v":10.2,"d":"10.20"},"3' UTR",25,42309468,42379170,69703,2]
["chr25",47438054,47438233,180,"ENSBGRG00000025616","ENSBGRT00000047391",155855,"CPXM2","carboxypeptidase X, M14 family member 2 [Source:HGNC Symbol;Acc:HGNC:26977]","GO:0004181(metallocarboxypeptidase activity);GO:0006508(proteolysis);GO:0008270(zinc ion binding)","NA",{"v":0.0087,"d":"0.01"},1,"180,",0,-2.06,-1.53,{"v":1.8,"d":"1.80"},"Exon (ENSBGRT00000047391/ENSBGRG00000025616, exon 15 of 15)",25,47437994,47594088,156095,2]
["chr25",55987980,55998301,10322,"ENSBGRG00000013147","ENSBGRT00000024101",30916,"STK32C","serine/threonine kinase 32C [Source:HGNC Symbol;Acc:HGNC:21332]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA",{"v":0.0032,"d":"0.00"},3,"97,68,163,","0,1048,10159",{"v":-2.5,"d":"-2.50"},-1.93,3.47,"3' UTR",25,55987950,56029217,41268,2]
["chr26",293055,293113,59,"ENSBGRG00000021118","ENSBGRT00000039045",1359,"SAP25","Sin3A associated protein 25 [Source:HGNC Symbol;Acc:HGNC:41908]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":3.2e-12,"d":"0.00"},1,"59,",0,{"v":-11.5,"d":"-11.50"},{"v":-10.7,"d":"-10.70"},2.73,"Exon (ENSBGRT00000039045/ENSBGRG00000021118, exon 6 of 6)",26,291696,293172,1477,1]
["chr26",882175,883071,897,"ENSBGRG00000020291","ENSBGRT00000037310",0,"ENSBGRG00000020291","NA","NA","04740(Olfactory transduction)",{"v":3.3E-3,"d":"0.00"},1,"897,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000037310/ENSBGRG00000020291, exon 1 of 3)",26,882175,883135,961,1]
["chr26",1271417,1271833,417,"ENSBGRG00000024303","ENSBGRT00000044909",0,"ENSBGRG00000024303","NA","GO:0005515(protein binding);GO:0032543(mitochondrial translation)","NA",{"v":1e-40,"d":"0.00"},1,"417,",0,-40,{"v":-38.9,"d":"-38.90"},{"v":4.5,"d":"4.50"},"Exon (ENSBGRT00000044909/ENSBGRG00000024303, exon 1 of 8)",26,1271417,1282521,11105,1]
["chr26",3126603,3126929,327,"ENSBGRG00000016858","ENSBGRT00000031065",2514,"RBAK","RB associated KRAB zinc finger [Source:HGNC Symbol;Acc:HGNC:17680]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":3.2E-13,"d":"0.00"},1,"327,",0,{"v":-12.5,"d":"-12.50"},{"v":-11.7,"d":"-11.70"},5.15,"Exon (ENSBGRT00000031065/ENSBGRG00000016858, exon 4 of 4)",26,3124089,3127908,3820,1]
["chr26",5720789,5720999,211,"ENSBGRG00000023745","ENSBGRT00000043867",1354,"ENSBGRG00000023745","NA","NA","NA",{"v":2.5e-22,"d":"0.00"},1,"211,",0,{"v":-21.6,"d":"-21.60"},{"v":-20.7,"d":"-20.70"},2.14,"Exon (ENSBGRT00000043867/ENSBGRG00000023745, exon 2 of 2)",26,5719435,5723421,3987,1]
["chr26",7745999,7746178,180,"ENSBGRG00000025556","ENSBGRT00000047246",7423,"ZNHIT1","zinc finger HIT-type containing 1 [Source:HGNC Symbol;Acc:HGNC:21688]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006338(chromatin remodeling);GO:0043486(histone exchange)","NA",{"v":1.9e-05,"d":"0.00"},1,"180,",0,-4.72,-4.06,1.43,"3' UTR",26,7738576,7746357,7782,1]
["chr26",9644760,9645089,330,"ENSBGRG00000010238","ENSBGRT00000018765",18140,"ENSBGRG00000010238","NA","NA","03013(RNA transport)",{"v":3.2e-17,"d":"0.00"},1,"330,",0,{"v":-16.5,"d":"-16.50"},{"v":-15.6,"d":"-15.60"},3.54,"Exon (ENSBGRT00000018765/ENSBGRG00000010238, exon 11 of 13)",26,9626620,9648173,21554,1]
["chr26",16381172,16389877,8706,"ENSBGRG00000024374","ENSBGRT00000045065",13303,"ENSBGRG00000024374","NA","GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0005975(carbohydrate metabolic process)","00040(Pentose and glucuronate interconversions);00531(Glycosaminoglycan degradation);00860(Porphyrin and chlorophyll metabolism);00983(Drug metabolism - other enzymes);04142(Lysosome)",{"v":1.6E-58,"d":"0.00"},2,"149,31,","0,8675",{"v":-57.8,"d":"-57.80"},{"v":-56.6,"d":"-56.60"},3.34,"3' UTR",26,16367869,16381320,13452,1]
["chr26",17716788,17719594,2807,"ENSBGRG00000025756","ENSBGRT00000047619",0,"ENSBGRG00000025756","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":2.5e-87,"d":"0.00"},3,"166,114,887,","0,317,1920",{"v":-86.6,"d":"-86.60"},{"v":-85.2,"d":"-85.20"},9.21,"Exon (ENSBGRT00000047603/ENSBGRG00000025744, exon 1 of 3)",26,17717382,17717948,567,1]
["chr26",18212571,18213458,888,"ENSBGRG00000026292","ENSBGRT00000048655",8262,"TAOK2","TAO kinase 2 [Source:HGNC Symbol;Acc:HGNC:16835]","GO:0000186(activation of MAPKK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006974(cellular response to DNA damage stimulus);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0007409(axonogenesis);GO:0008360(regulation of cell shape);GO:0015629(actin cytoskeleton);GO:0030036(actin cytoskeleton organization);GO:0030424(axon);GO:0031410(cytoplasmic vesicle);GO:0031434(mitogen-activated protein kinase kinase binding);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0032956(regulation of actin cytoskeleton organization);GO:0038191(neuropilin binding);GO:0043005(neuron projection);GO:0043235(receptor complex);GO:0044294(dendritic growth cone);GO:0044295(axonal growth cone);GO:0046330(positive regulation of JNK cascade);GO:0048041(focal adhesion assembly);GO:0051403(stress-activated MAPK cascade);GO:0150019(basal dendrite morphogenesis);GO:0150020(basal dendrite arborization)","04010(MAPK signaling pathway)",{"v":2e-27,"d":"0.00"},3,"228,204,48,","0,314,840",{"v":-26.7,"d":"-26.70"},{"v":-25.6,"d":"-25.60"},1.78,"Exon (ENSBGRT00000048655/ENSBGRG00000026292, exon 13 of 18)",26,18204309,18219806,15498,1]
["chr26",18284208,18284358,151,"ENSBGRG00000026380","ENSBGRT00000048815",569,"ENSBGRG00000026380","NA","NA","NA",{"v":4e-19,"d":"0.00"},1,"151,",0,{"v":-18.4,"d":"-18.40"},{"v":-17.4,"d":"-17.40"},{"v":12.5,"d":"12.50"},"Exon (ENSBGRT00000048815/ENSBGRG00000026380, exon 1 of 1)",26,18283639,18284658,1020,1]
["chr26",19663909,19671810,7902,"ENSBGRG00000017644","ENSBGRT00000033621",87488,"GTF3C1","general transcription factor IIIC subunit 1 [Source:HGNC Symbol;Acc:HGNC:4664]","GO:0000127(transcription factor TFIIIC complex);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:1990904(ribonucleoprotein complex)","NA",{"v":1e-133,"d":"0.00"},6,"68,198,353,52,193,907,","0,817,2304,3330,5860,6995",-133,-131,7.91,"3' UTR",26,19576421,19671667,95247,1]
["chr26",26658851,26659060,210,"ENSBGRG00000025929","ENSBGRT00000048896",225654,"DNAH3","dynein axonemal heavy chain 3 [Source:HGNC Symbol;Acc:HGNC:2949]","GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0007018(microtubule-based movement);GO:0030286(dynein complex)","05016(Huntington disease)",{"v":0.011,"d":"0.01"},1,"210,",0,-1.95,-1.18,8.91,"Exon (ENSBGRT00000048896/ENSBGRG00000025929, exon 54 of 63)",26,26433197,26692444,259248,1]
["chr26",29153101,29153220,120,"ENSBGRG00000022485","ENSBGRT00000041529",20553,"ENSBGRG00000022485","NA","NA","03015(mRNA surveillance pathway)",{"v":0.036,"d":"0.04"},1,"120,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000041529/ENSBGRG00000022485, exon 13 of 13)",26,29132548,29153368,20821,1]
["chr26",36962418,36962627,210,"ENSBGRG00000026595","ENSBGRT00000049255",208,"ENSBGRG00000026595","NA","NA","NA",{"v":0.00028,"d":"0.00"},1,"210,",0,-3.56,-2.94,{"v":14.9,"d":"14.90"},"Exon (ENSBGRT00000049255/ENSBGRG00000026595, exon 1 of 2)",26,36962210,36985612,23403,1]
["chr26",43820215,43820768,554,"ENSBGRG00000014975","ENSBGRT00000027667",0,"NMRAL1","NmrA like redox sensor 1 [Source:HGNC Symbol;Acc:HGNC:24987]","GO:0005654(nucleoplasm);GO:0042802(identical protein binding)","NA",{"v":3.1E-9,"d":"0.00"},3,"95,74,72,","0,260,482",-8.51,-7.74,2.18,"5' UTR",26,43820475,43826860,6386,1]
["chr26",44896055,44896528,474,"ENSBGRG00000023657","ENSBGRT00000043737",8218,"ENSBGRG00000023657","NA","GO:0003676(nucleic acid binding)","NA",{"v":1.6e-17,"d":"0.00"},2,"2,441,","0,33",{"v":-16.8,"d":"-16.80"},{"v":-15.9,"d":"-15.90"},4.36,"Exon (ENSBGRT00000043737/ENSBGRG00000023657, exon 4 of 5)",26,44887837,44896528,8692,1]
["chr26",45959915,45960240,326,"ENSBGRG00000020745","ENSBGRT00000038229",1016,"PGP","phosphoglycolate phosphatase [Source:HGNC Symbol;Acc:HGNC:8909]","GO:0000287(magnesium ion binding);GO:0004725(protein tyrosine phosphatase activity);GO:0006114(glycerol biosynthetic process);GO:0006650(glycerophospholipid metabolic process);GO:0008967(phosphoglycolate phosphatase activity);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0043136(glycerol-3-phosphatase activity);GO:0045721(negative regulation of gluconeogenesis);GO:0098519(nucleotide phosphatase activity, acting on free nucleotides)","00630(Glyoxylate and dicarboxylate metabolism)",{"v":4e-57,"d":"0.00"},1,"326,",0,{"v":-56.4,"d":"-56.40"},{"v":-55.2,"d":"-55.20"},4.57,"3' UTR",26,45958899,45960240,1342,1]
["chr26",46069997,46070476,480,"ENSBGRG00000021346","ENSBGRT00000039806",20546,"ENSBGRG00000021346","NA","NA","NA",{"v":1.3E-13,"d":"0.00"},1,"480,",0,{"v":-12.9,"d":"-12.90"},-12,2.91,"Exon (ENSBGRT00000039806/ENSBGRG00000021346, exon 10 of 52)",26,46049451,46091624,42174,1]
["chr26",46638234,46638384,151,"ENSBGRG00000026360","ENSBGRT00000048789",4440,"PTX4","pentraxin 4 [Source:HGNC Symbol;Acc:HGNC:14171]","NA","NA",{"v":0.036,"d":"0.04"},1,"151,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000048789/ENSBGRG00000026360, exon 5 of 5)",26,46633794,46638384,4591,1]
["chr26",51184,51542,359,"ENSBGRG00000018487","ENSBGRT00000033910",4833,"TRIP6","thyroid hormone receptor interactor 6 [Source:HGNC Symbol;Acc:HGNC:12311]","GO:0005149(interleukin-1 receptor binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0019900(kinase binding);GO:0030335(positive regulation of cell migration);GO:0043009(chordate embryonic development);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04621(NOD-like receptor signaling pathway)",{"v":0.011,"d":"0.01"},1,"359,",0,-1.95,-1.42,5.45,"3' UTR",26,51035,56375,5341,2]
["chr26",265902,266022,121,"ENSBGRG00000020581","ENSBGRT00000038349",10190,"FBXO24","F-box protein 24 [Source:HGNC Symbol;Acc:HGNC:13595]","GO:0005515(protein binding)","NA",{"v":6.2E-4,"d":"0.00"},1,"121,",0,-3.21,-2.61,2.18,"Exon (ENSBGRT00000038349/ENSBGRG00000020581, exon 10 of 11)",26,264905,276212,11308,2]
["chr26",1120312,1128401,8090,"ENSBGRG00000023838","ENSBGRT00000044031",4423,"ZNF655","zinc finger protein 655 [Source:HGNC Symbol;Acc:HGNC:30899]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","NA",{"v":6.3E-74,"d":"0.00"},3,"1391,105,25,","0,1904,8065",{"v":-73.2,"d":"-73.20"},{"v":-71.8,"d":"-71.80"},6.08,"Exon (ENSBGRT00000044031/ENSBGRG00000023838, exon 3 of 4)",26,1120312,1132824,12513,2]
["chr26",3012604,3013399,796,"ENSBGRG00000016677","ENSBGRT00000030580",0,"ENSBGRG00000016677","NA","NA","NA",{"v":4E-35,"d":"0.00"},1,"796,",0,{"v":-34.4,"d":"-34.40"},{"v":-33.3,"d":"-33.30"},6.69,"Exon (ENSBGRT00000030494/ENSBGRG00000016492, exon 14 of 19)",26,3012044,3013399,1356,2]
["chr26",5583336,5586109,2774,"ENSBGRG00000022933","ENSBGRT00000042348",38453,"BRAT1","BRCA1 associated ATM activator 1 [Source:HGNC Symbol;Acc:HGNC:21701]","GO:0001934(positive regulation of protein phosphorylation);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006006(glucose metabolic process);GO:0006915(apoptotic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008283(cell population proliferation);GO:0010212(response to ionizing radiation);GO:0016477(cell migration);GO:0030307(positive regulation of cell growth);GO:0051646(mitochondrion localization)","NA",{"v":0.0003,"d":"0.00"},2,"27,121,","0,2653",-3.52,{"v":-2.9,"d":"-2.90"},4.75,"Exon (ENSBGRT00000042790/ENSBGRG00000023152, exon 5 of 7)",26,5519174,5624562,105389,2]
["chr26",7648381,7648441,61,"ENSBGRG00000025474","ENSBGRT00000047086",958,"VGF","VGF nerve growth factor inducible [Source:HGNC Symbol;Acc:HGNC:12684]","GO:0001541(ovarian follicle development);GO:0002021(response to dietary excess);GO:0005184(neuropeptide hormone activity);GO:0005615(extracellular space);GO:0005794(Golgi apparatus);GO:0006091(generation of precursor metabolites and energy);GO:0009409(response to cold);GO:0019953(sexual reproduction);GO:0030073(insulin secretion);GO:0031410(cytoplasmic vesicle);GO:0032868(response to insulin);GO:0042593(glucose homeostasis);GO:0043231(intracellular membrane-bounded organelle);GO:0051591(response to cAMP)","NA",{"v":2.5e-13,"d":"0.00"},1,"61,",0,{"v":-12.6,"d":"-12.60"},{"v":-11.7,"d":"-11.70"},{"v":17.8,"d":"17.80"},"Exon (ENSBGRT00000047086/ENSBGRG00000025474, exon 1 of 1)",26,7647543,7649399,1857,2]
["chr26",9864312,9864876,565,"ENSBGRG00000011658","ENSBGRT00000021525",3836,"TBL2","transducin beta like 2 [Source:HGNC Symbol;Acc:HGNC:11586]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0019901(protein kinase binding);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0031369(translation initiation factor binding);GO:0042149(cellular response to glucose starvation);GO:0051219(phosphoprotein binding);GO:0071456(cellular response to hypoxia)","NA",{"v":7.9e-18,"d":"0.00"},2,"226,103,","0,462",{"v":-17.1,"d":"-17.10"},{"v":-16.2,"d":"-16.20"},3.18,"Exon (ENSBGRT00000021525/ENSBGRG00000011658, exon 6 of 7)",26,9861748,9868712,6965,2]
["chr26",16285445,16285624,180,"ENSBGRG00000023686","ENSBGRT00000043744",419,"CRCP","CGRP receptor component [Source:HGNC Symbol;Acc:HGNC:17888]","GO:0000166(nucleotide binding);GO:0003824(catalytic activity);GO:0005666(RNA polymerase III complex);GO:0006352(DNA-templated transcription, initiation);GO:0006384(transcription initiation from RNA polymerase III promoter);GO:0030880(RNA polymerase complex);GO:0044237(cellular metabolic process)","NA",{"v":0.00081,"d":"0.00"},1,"180,",0,-3.09,{"v":-2.5,"d":"-2.50"},3.37,"5' UTR",26,16241107,16286043,44937,2]
["chr26",16795587,16796215,629,"ENSBGRG00000018141","ENSBGRT00000033174",1180,"ENSBGRG00000018141","NA","GO:0006457(protein folding);GO:0030218(erythrocyte differentiation);GO:0030492(hemoglobin binding);GO:0050821(protein stabilization)","NA",{"v":2.5e-48,"d":"0.00"},2,"344,30,","0,599",{"v":-47.6,"d":"-47.60"},{"v":-46.4,"d":"-46.40"},5.46,"3' UTR",26,16795558,16797395,1838,2]
["chr26",17296576,17296636,61,"ENSBGRG00000024472","ENSBGRT00000045910",19471,"ENSBGRG00000024472","NA","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0018024(histone-lysine N-methyltransferase activity);GO:0042800(histone methyltransferase activity (H3-K4 specific));GO:0048188(Set1C/COMPASS complex)","00310(Lysine degradation)",{"v":0.035,"d":"0.04"},1,"61,",0,-1.46,{"v":-0.967,"d":"-0.97"},1.53,"Exon (ENSBGRT00000045910/ENSBGRG00000024472, exon 15 of 21)",26,17293056,17316107,23052,2]
["chr26",17644866,17646463,1598,"ENSBGRG00000025628","ENSBGRT00000047471",90,"FBRS","fibrosin [Source:HGNC Symbol;Acc:HGNC:20442]","NA","NA",{"v":4e-40,"d":"0.00"},3,"25,180,363,","0,758,1235",{"v":-39.4,"d":"-39.40"},{"v":-38.3,"d":"-38.30"},5.52,"Exon (ENSBGRT00000047471/ENSBGRG00000025628, exon 1 of 16)",26,17634534,17646553,12020,2]
["chr26",19775914,19776213,300,"ENSBGRG00000018652","ENSBGRT00000034184",40692,"IL4R","interleukin 4 receptor [Source:HGNC Symbol;Acc:HGNC:6015]","GO:0002532(production of molecular mediator involved in inflammatory response);GO:0002639(positive regulation of immunoglobulin production);GO:0004896(cytokine receptor activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016064(immunoglobulin mediated immune response);GO:0034451(centriolar satellite);GO:0042832(defense response to protozoan);GO:0043032(positive regulation of macrophage activation);GO:0043235(receptor complex);GO:0043306(positive regulation of mast cell degranulation);GO:0045626(negative regulation of T-helper 1 cell differentiation);GO:0045630(positive regulation of T-helper 2 cell differentiation);GO:0090197(positive regulation of chemokine secretion);GO:0120162(positive regulation of cold-induced thermogenesis);GO:1901741(positive regulation of myoblast fusion)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);05200(Pathways in cancer);05321(Inflammatiory bowel disease (IBD))",{"v":1E-180,"d":"0.00"},1,"300,",0,-180,-178,3.21,"3' UTR",26,19775644,19816905,41262,2]
["chr26",25467421,25474224,6804,"ENSBGRG00000024497","ENSBGRT00000045281",15329,"SDR42E2","short chain dehydrogenase/reductase family 42E, member 2 [Source:HGNC Symbol;Acc:HGNC:35414]","GO:0003854(3-beta-hydroxy-delta5-steroid dehydrogenase activity);GO:0006694(steroid biosynthetic process);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0055114(oxidation-reduction process)","00100(Steroid biosynthesis)",{"v":2E-12,"d":"0.00"},3,"485,74,11,","0,4699,6793",{"v":-11.7,"d":"-11.70"},{"v":-10.8,"d":"-10.80"},{"v":15.4,"d":"15.40"},"3' UTR",26,25465982,25489553,23572,2]
["chr26",33256371,33257300,930,"ENSBGRG00000026357","ENSBGRT00000048775",37120,"ERCC4","ERCC excision repair 4, endonuclease catalytic subunit [Source:HGNC Symbol;Acc:HGNC:3436]","GO:0000109(nucleotide-excision repair complex);GO:0000110(nucleotide-excision repair factor 1 complex);GO:0000723(telomere maintenance);GO:0000724(double-strand break repair via homologous recombination);GO:0000781(chromosome, telomeric region);GO:0000784(nuclear chromosome, telomeric region);GO:0001094(TFIID-class transcription factor complex binding);GO:0003677(DNA binding);GO:0003684(damaged DNA binding);GO:0003697(single-stranded DNA binding);GO:0004518(nuclease activity);GO:0004520(endodeoxyribonuclease activity);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0006289(nucleotide-excision repair);GO:0006295(nucleotide-excision repair, DNA incision, 3'-to lesion);GO:0006296(nucleotide-excision repair, DNA incision, 5'-to lesion);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0008022(protein C-terminus binding);GO:0009411(response to UV);GO:0009650(UV protection);GO:0010506(regulation of autophagy);GO:0032205(negative regulation of telomere maintenance);GO:0033683(nucleotide-excision repair, DNA incision);GO:0034644(cellular response to UV);GO:0042802(identical protein binding);GO:0047485(protein N-terminus binding);GO:0061819(telomeric DNA-containing double minutes formation);GO:0070522(ERCC4-ERCC1 complex);GO:1904357(negative regulation of telomere maintenance via telomere lengthening);GO:1905765(negative regulation of protection from non-homologous end joining at telomere);GO:1905768(negative regulation of double-stranded telomeric DNA binding);GO:1990599(3' overhang single-stranded DNA endodeoxyribonuclease activity);GO:1990841(promoter-specific chromatin binding)","03420(Nucleotide excision repair);03460(Fanconi anemia pathway)",{"v":1e-143,"d":"0.00"},1,"930,",0,-143,-142,8.84,"3' UTR",26,33256371,33294420,38050,2]
["chr26",36693781,36695159,1379,"ENSBGRG00000026544","ENSBGRT00000049235",264803,"CLEC16A","C-type lectin domain containing 16A [Source:HGNC Symbol;Acc:HGNC:29013]","GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0009267(cellular response to starvation);GO:0031982(vesicle);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0036020(endolysosome membrane);GO:1901097(negative regulation of autophagosome maturation);GO:1901098(positive regulation of autophagosome maturation);GO:1901525(negative regulation of mitophagy);GO:1904263(positive regulation of TORC1 signaling);GO:1904766(negative regulation of macroautophagy by TORC1 signaling)","NA",{"v":1E-53,"d":"0.00"},1,"1379,",0,-53,{"v":-51.7,"d":"-51.70"},8.22,"3' UTR",26,36693691,36959962,266272,2]
["chr26",43831543,43836735,5193,"ENSBGRG00000015126","ENSBGRT00000028647",29626,"DNAJA3","DnaJ heat shock protein family (Hsp40) member A3 [Source:HGNC Symbol;Acc:HGNC:11808]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0005884(actin filament);GO:0006264(mitochondrial DNA replication);GO:0006457(protein folding);GO:0006915(apoptotic process);GO:0006924(activation-induced cell death of T cells);GO:0007005(mitochondrion organization);GO:0007264(small GTPase mediated signal transduction);GO:0007528(neuromuscular junction development);GO:0007569(cell aging);GO:0008285(negative regulation of cell population proliferation);GO:0009408(response to heat);GO:0019897(extrinsic component of plasma membrane);GO:0030695(GTPase regulator activity);GO:0031072(heat shock protein binding);GO:0031594(neuromuscular junction);GO:0033077(T cell differentiation in thymus);GO:0042102(positive regulation of T cell proliferation);GO:0042645(mitochondrial nucleoid);GO:0043069(negative regulation of programmed cell death);GO:0043231(intracellular membrane-bounded organelle);GO:0045211(postsynaptic membrane);GO:0051082(unfolded protein binding)","05203(Viral carcinogenesis)",{"v":1e-106,"d":"0.00"},3,"699,104,31,","0,1253,5162",-106,-104,6.93,"3' UTR",26,43831127,43866361,35235,2]
["chr26",44705906,44709853,3948,"ENSBGRG00000023242","ENSBGRT00000043015",1868,"ZNF174","zinc finger protein 174 [Source:HGNC Symbol;Acc:HGNC:12963]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0015629(actin cytoskeleton);GO:0042803(protein homodimerization activity);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1E-153,"d":"0.00"},4,"640,18,97,11,","0,3770,3838,3937",-153,-152,5.71,"3' UTR",26,44705906,44711721,5816,2]
["chr26",45150768,45151391,624,"ENSBGRG00000024674","ENSBGRT00000045525",0,"CLDN9","claudin 9 [Source:HGNC Symbol;Acc:HGNC:2051]","GO:0001618(virus receptor activity);GO:0005198(structural molecule activity);GO:0005886(plasma membrane);GO:0005923(bicellular tight junction);GO:0016021(integral component of membrane);GO:0030054(cell junction);GO:0043231(intracellular membrane-bounded organelle);GO:0045216(cell-cell junction organization);GO:0120193(tight junction organization)","04514(Cell adhesion molecules (CAMs));04530(Tight junction);04670(Leukocyte transendothelial migration);05160(Hepatitis C)",0.02,1,"624,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000045525/ENSBGRG00000024674, exon 1 of 1)",26,45150738,45151391,654,2]
["chr26",45659869,45660792,924,"ENSBGRG00000015857","ENSBGRT00000029432",0,"ENSBGRG00000015857","NA","GO:0016358(dendrite development);GO:0031175(neuron projection development);GO:0036475(neuron death in response to oxidative stress);GO:0048488(synaptic vesicle endocytosis);GO:0061564(axon development);GO:1902083(negative regulation of peptidyl-cysteine S-nitrosylation);GO:1903204(negative regulation of oxidative stress-induced neuron death)","NA",{"v":3.2e-85,"d":"0.00"},2,"489,434,","0,490",{"v":-84.5,"d":"-84.50"},{"v":-83.1,"d":"-83.10"},{"v":10.4,"d":"10.40"},"Exon (ENSBGRT00000029432/ENSBGRG00000015857, exon 1 of 8)",26,45655406,45660792,5387,2]
["chr26",46505885,46507308,1424,"ENSBGRG00000026195","ENSBGRT00000048568",18332,"CRAMP1","cramped chromatin regulator homolog 1 [Source:HGNC Symbol;Acc:HGNC:14122]","NA","NA",{"v":5e-24,"d":"0.00"},2,"894,63,","0,1361",{"v":-23.3,"d":"-23.30"},{"v":-22.4,"d":"-22.40"},6.77,"Exon (ENSBGRT00000048568/ENSBGRG00000026195, exon 8 of 21)",26,46492413,46525640,33228,2]
["chr26",47320331,47321345,1015,"ENSBGRG00000009158","ENSBGRT00000016789",0,"RHOT2","ras homolog family member T2 [Source:HGNC Symbol;Acc:HGNC:21169]","GO:0003924(GTPase activity);GO:0005509(calcium ion binding);GO:0005525(GTP binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0007005(mitochondrion organization);GO:0019725(cellular homeostasis);GO:0031307(integral component of mitochondrial outer membrane);GO:0047497(mitochondrion transport along microtubule);GO:0097345(mitochondrial outer membrane permeabilization)","04137(Mitophagy - animal)",{"v":0.00026,"d":"0.00"},3,"57,68,85,","0,89,930",-3.58,-2.96,2.38,"5' UTR",26,47313026,47320487,7462,2]
["chr26",47815041,47819342,4302,"ENSBGRG00000014968","ENSBGRT00000027992",39840,"NPRL3","NPR3 like, GATOR1 complex subunit [Source:HGNC Symbol;Acc:HGNC:14124]","GO:0003281(ventricular septum development);GO:0005096(GTPase activator activity);GO:0005765(lysosomal membrane);GO:0032007(negative regulation of TOR signaling);GO:0034198(cellular response to amino acid starvation);GO:0035909(aorta morphogenesis);GO:0048738(cardiac muscle tissue development);GO:0060021(roof of mouth development);GO:1990130(GATOR1 complex)","04150(mTOR signaling pathway)",{"v":1e-149,"d":"0.00"},3,"457,205,47,","0,3082,4255",-149,-147,{"v":12.9,"d":"12.90"},"3' UTR",26,47775201,47815571,40371,1]
["chr27",8607960,8609059,1100,"ENSBGRG00000022389","ENSBGRT00000042286",838754,"RYR2","ryanodine receptor 2 [Source:HGNC Symbol;Acc:HGNC:10484]","GO:0001666(response to hypoxia);GO:0002027(regulation of heart rate);GO:0003143(embryonic heart tube morphogenesis);GO:0003220(left ventricular cardiac muscle tissue morphogenesis);GO:0003300(cardiac muscle hypertrophy);GO:0005216(ion channel activity);GO:0005219(ryanodine-sensitive calcium-release channel activity);GO:0005262(calcium channel activity);GO:0005509(calcium ion binding);GO:0005513(detection of calcium ion);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005790(smooth endoplasmic reticulum);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0006874(cellular calcium ion homeostasis);GO:0010460(positive regulation of heart rate);GO:0010881(regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion);GO:0010882(regulation of cardiac muscle contraction by calcium ion signaling);GO:0014808(release of sequestered calcium ion into cytosol by sarcoplasmic reticulum);GO:0014850(response to muscle activity);GO:0015278(calcium-release channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016529(sarcoplasmic reticulum);GO:0019722(calcium-mediated signaling);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0030017(sarcomere);GO:0030018(Z disc);GO:0031000(response to caffeine);GO:0032991(protein-containing complex);GO:0033017(sarcoplasmic reticulum membrane);GO:0034236(protein kinase A catalytic subunit binding);GO:0034237(protein kinase A regulatory subunit binding);GO:0034704(calcium channel complex);GO:0035584(calcium-mediated signaling using intracellular calcium source);GO:0035994(response to muscle stretch);GO:0042802(identical protein binding);GO:0043621(protein self-association);GO:0043924(suramin binding);GO:0048763(calcium-induced calcium release activity);GO:0051209(release of sequestered calcium ion into cytosol);GO:0051284(positive regulation of sequestering of calcium ion);GO:0051775(response to redox state);GO:0055085(transmembrane transport);GO:0055117(regulation of cardiac muscle contraction);GO:0060048(cardiac muscle contraction);GO:0060401(cytosolic calcium ion transport);GO:0060402(calcium ion transport into cytosol);GO:0070588(calcium ion transmembrane transport);GO:0071313(cellular response to caffeine);GO:0071872(cellular response to epinephrine stimulus);GO:0072599(establishment of protein localization to endoplasmic reticulum);GO:0086005(ventricular cardiac muscle cell action potential);GO:0086029(Purkinje myocyte to ventricular cardiac muscle cell signaling);GO:0097050(type B pancreatic cell apoptotic process);GO:0097159(organic cyclic compound binding);GO:0098735(positive regulation of the force of heart contraction);GO:0098904(regulation of AV node cell action potential);GO:0098907(regulation of SA node cell action potential);GO:0098910(regulation of atrial cardiac muscle cell action potential);GO:0098911(regulation of ventricular cardiac muscle cell action potential);GO:1901896(positive regulation of ATPase-coupled calcium transmembrane transporter activity)","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04911(Insulin secretion);04921(Oxytocin signaling pathway);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04972(Pancreatic secretion);04713(Circadian entrainment);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))",{"v":1.5E-5,"d":"0.00"},2,"246,55,","0,1045",-4.82,-4.15,2.86,"Exon (ENSBGRT00000042286/ENSBGRG00000022389, exon 90 of 105)",27,7769206,8678585,909380,1]
["chr27",17358116,17358326,211,"ENSBGRG00000025826","ENSBGRT00000047739",29259,"ENSBGRG00000025826","zinc finger protein 365 [Source:HGNC Symbol;Acc:HGNC:18194]","GO:0000723(telomere maintenance);GO:0021687(cerebellar molecular layer morphogenesis);GO:0048714(positive regulation of oligodendrocyte differentiation);GO:0060997(dendritic spine morphogenesis);GO:0140059(dendrite arborization)","NA",{"v":2.8E-5,"d":"0.00"},1,"211,",0,-4.56,{"v":-3.9,"d":"-3.90"},2.74,"3' UTR",27,17328857,17358505,29649,1]
["chr27",23901324,23906630,5307,"ENSBGRG00000007475","ENSBGRT00000013691",21234,"SIRT1","sirtuin 1 [Source:HGNC Symbol;Acc:HGNC:14929]","GO:0000012(single strand break repair);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000183(chromatin silencing at rDNA);GO:0000720(pyrimidine dimer repair by nucleotide-excision repair);GO:0000731(DNA synthesis involved in DNA repair);GO:0000785(chromatin);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001525(angiogenesis);GO:0001542(ovulation from ovarian follicle);GO:0001678(cellular glucose homeostasis);GO:0001934(positive regulation of protein phosphorylation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0002039(p53 binding);GO:0002821(positive regulation of adaptive immune response);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0004407(histone deacetylase activity);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005637(nuclear inner membrane);GO:0005654(nucleoplasm);GO:0005677(chromatin silencing complex);GO:0005719(nuclear euchromatin);GO:0005720(nuclear heterochromatin);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006325(chromatin organization);GO:0006476(protein deacetylation);GO:0006642(triglyceride mobilization);GO:0006974(cellular response to DNA damage stimulus);GO:0006979(response to oxidative stress);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007283(spermatogenesis);GO:0007346(regulation of mitotic cell cycle);GO:0007623(circadian rhythm);GO:0008022(protein C-terminus binding);GO:0008134(transcription factor binding);GO:0008284(positive regulation of cell population proliferation);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0009267(cellular response to starvation);GO:0010629(negative regulation of gene expression);GO:0010875(positive regulation of cholesterol efflux);GO:0010883(regulation of lipid storage);GO:0010906(regulation of glucose metabolic process);GO:0010934(macrophage cytokine production);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016239(positive regulation of macroautophagy);GO:0016567(protein ubiquitination);GO:0016575(histone deacetylation);GO:0016605(PML body);GO:0017136(NAD-dependent histone deacetylase activity);GO:0018394(peptidyl-lysine acetylation);GO:0019213(deacetylase activity);GO:0019899(enzyme binding);GO:0019904(protein domain specific binding);GO:0030225(macrophage differentiation);GO:0030308(negative regulation of cell growth);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0031393(negative regulation of prostaglandin biosynthetic process);GO:0031507(heterochromatin assembly);GO:0031648(protein destabilization);GO:0032007(negative regulation of TOR signaling);GO:0032071(regulation of endodeoxyribonuclease activity);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032868(response to insulin);GO:0032922(circadian regulation of gene expression);GO:0033210(leptin-mediated signaling pathway);GO:0033553(rDNA heterochromatin);GO:0033558(protein deacetylase activity);GO:0034391(regulation of smooth muscle cell apoptotic process);GO:0034979(NAD-dependent protein deacetylase activity);GO:0034983(peptidyl-lysine deacetylation);GO:0035098(ESC/E(Z) complex);GO:0035257(nuclear hormone receptor binding);GO:0035356(cellular triglyceride homeostasis);GO:0035358(regulation of peroxisome proliferator activated receptor signaling pathway);GO:0042127(regulation of cell population proliferation);GO:0042326(negative regulation of phosphorylation);GO:0042393(histone binding);GO:0042542(response to hydrogen peroxide);GO:0042595(behavioral response to starvation);GO:0042632(cholesterol homeostasis);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043398(HLH domain binding);GO:0043425(bHLH transcription factor binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0044321(response to leptin);GO:0045348(positive regulation of MHC class II biosynthetic process);GO:0045599(negative regulation of fat cell differentiation);GO:0045722(positive regulation of gluconeogenesis);GO:0045739(positive regulation of DNA repair);GO:0045766(positive regulation of angiogenesis);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0046969(NAD-dependent histone deacetylase activity (H3-K9 specific));GO:0050872(white fat cell differentiation);GO:0051019(mitogen-activated protein kinase binding);GO:0051097(negative regulation of helicase activity);GO:0051152(positive regulation of smooth muscle cell differentiation);GO:0051574(positive regulation of histone H3-K9 methylation);GO:0051898(negative regulation of protein kinase B signaling);GO:0055089(fatty acid homeostasis);GO:0060766(negative regulation of androgen receptor signaling pathway);GO:0070301(cellular response to hydrogen peroxide);GO:0070403(NAD+ binding);GO:0070829(heterochromatin maintenance);GO:0070857(regulation of bile acid biosynthetic process);GO:0070914(UV-damage excision repair);GO:0070932(histone H3 deacetylation);GO:0071356(cellular response to tumor necrosis factor);GO:0071441(negative regulation of histone H3-K14 acetylation);GO:0071456(cellular response to hypoxia);GO:0071479(cellular response to ionizing radiation);GO:0071900(regulation of protein serine/threonine kinase activity);GO:0090335(regulation of brown fat cell differentiation);GO:0090400(stress-induced premature senescence);GO:0106230(protein depropionylation);GO:0106231(protein-propionyllysine depropionylase activity);GO:1900113(negative regulation of histone H3-K9 trimethylation);GO:1901215(negative regulation of neuron death);GO:1901984(negative regulation of protein acetylation);GO:1902166(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:1902176(negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway);GO:1902237(positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway);GO:1904179(positive regulation of adipose tissue development);GO:1990254(keratin filament binding);GO:1990830(cellular response to leukemia inhibitory factor);GO:2000111(positive regulation of macrophage apoptotic process);GO:2000480(negative regulation of cAMP-dependent protein kinase activity);GO:2000481(positive regulation of cAMP-dependent protein kinase activity);GO:2000619(negative regulation of histone H4-K16 acetylation);GO:2000655(negative regulation of cellular response to testosterone stimulus);GO:2000757(negative regulation of peptidyl-lysine acetylation);GO:2000773(negative regulation of cellular senescence);GO:2000774(positive regulation of cellular senescence)","04068(FoxO signaling pathway);04152(AMPK signaling pathway);04218(Cellular senescence);04922(Glucagon signaling pathway);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05206(MicroRNAs in cancer);05031(Amphetamine addiction)",{"v":1E-190,"d":"0.00"},3,"59,564,329,","0,1425,4978",-190,-188,6.22,"Exon (ENSBGRT00000013691/ENSBGRG00000007475, exon 7 of 9)",27,23880090,23906630,26541,1]
["chr27",24817834,24818190,357,"ENSBGRG00000011050","ENSBGRT00000020250",30,"KIFBP","kinesin family binding protein [Source:HGNC Symbol;Acc:HGNC:23419]","GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0006839(mitochondrial transport);GO:0019894(kinesin binding)","NA",{"v":1.6e-73,"d":"0.00"},1,"357,",0,{"v":-72.8,"d":"-72.80"},{"v":-71.5,"d":"-71.50"},4.37,"5' UTR",27,24817804,24877341,59538,1]
["chr27",28092644,28093460,817,"ENSBGRG00000023934","ENSBGRT00000044220",14611,"CHST3","carbohydrate sulfotransferase 3 [Source:HGNC Symbol;Acc:HGNC:1971]","GO:0006790(sulfur compound metabolic process);GO:0008146(sulfotransferase activity);GO:0008459(chondroitin 6-sulfotransferase activity);GO:0030206(chondroitin sulfate biosynthetic process)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)",{"v":7.9e-40,"d":"0.00"},2,"464,315,","0,502",{"v":-39.1,"d":"-39.10"},-38,6.82,"Exon (ENSBGRT00000044220/ENSBGRG00000023934, exon 4 of 5)",27,28078033,28093460,15428,1]
["chr27",40783866,40784854,989,"ENSBGRG00000026406","ENSBGRT00000048878",167616,"CCSER2","coiled-coil serine rich protein 2 [Source:HGNC Symbol;Acc:HGNC:29197]","GO:0001578(microtubule bundle formation);GO:0008017(microtubule binding);GO:0015630(microtubule cytoskeleton)","NA",{"v":1E-179,"d":"0.00"},1,"989,",0,-179,-177,{"v":12.4,"d":"12.40"},"3' UTR",27,40616250,40785064,168815,1]
["chr27",45929353,45929828,476,"ENSBGRG00000012358","ENSBGRT00000022653",0,"PARG","poly(ADP-ribose) glycohydrolase [Source:HGNC Symbol;Acc:HGNC:8605]","GO:0004649(poly(ADP-ribose) glycohydrolase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:1990966(ATP generation from poly-ADP-D-ribose)","NA",{"v":1.6E-13,"d":"0.00"},1,"476,",0,{"v":-12.8,"d":"-12.80"},-12,2.88,"5' UTR",27,45810141,45929676,119536,2]
["chr27",49814414,49819368,4955,"ENSBGRG00000020935","ENSBGRT00000038566",18390,"CCSAP","centriole, cilia and spindle associated protein [Source:HGNC Symbol;Acc:HGNC:29578]","GO:0005813(centrosome);GO:0005814(centriole);GO:0005819(spindle);GO:0005856(cytoskeleton);GO:0005929(cilium);GO:0005930(axoneme);GO:0008017(microtubule binding);GO:0030424(axon);GO:0035869(ciliary transition zone);GO:0036064(ciliary basal body);GO:0061673(mitotic spindle astral microtubule);GO:0072686(mitotic spindle);GO:1901673(regulation of mitotic spindle assembly);GO:1990755(mitotic spindle microtubule depolymerization)","NA",{"v":6.3e-14,"d":"0.00"},2,"88,61,","0,4894",{"v":-13.2,"d":"-13.20"},{"v":-12.4,"d":"-12.40"},{"v":12.2,"d":"12.20"},"Exon (ENSBGRT00000038566/ENSBGRG00000020935, exon 3 of 3)",27,49796024,49814501,18478,1]
["chr27",5726725,5728267,1543,"ENSBGRG00000018139","ENSBGRT00000033250",13818,"TOMM20","translocase of outer mitochondrial membrane 20 [Source:HGNC Symbol;Acc:HGNC:20947]","GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005742(mitochondrial outer membrane translocase complex);GO:0006605(protein targeting);GO:0006626(protein targeting to mitochondrion);GO:0006886(intracellular protein transport);GO:0015450(P-P-bond-hydrolysis-driven protein transmembrane transporter activity);GO:0044233(mitochondria-associated endoplasmic reticulum membrane);GO:0051082(unfolded protein binding)","NA",{"v":2.2e-08,"d":"0.00"},2,"45,102,","0,1441",-7.66,-6.91,3.42,"Exon (ENSBGRT00000033250/ENSBGRG00000018139, exon 4 of 5)",27,5726725,5742085,15361,2]
["chr27",14100420,14100777,358,"ENSBGRG00000025238","ENSBGRT00000046673",117345,"CCDC6","coiled-coil domain containing 6 [Source:HGNC Symbol;Acc:HGNC:18782]","GO:0005829(cytosol);GO:0042802(identical protein binding)","05200(Pathways in cancer);05216(Thyroid cancer)",{"v":2.5e-22,"d":"0.00"},1,"358,",0,{"v":-21.6,"d":"-21.60"},{"v":-20.7,"d":"-20.70"},2.13,"3' UTR",27,14100361,14218122,117762,2]
["chr27",15341463,15341612,150,"ENSBGRG00000025733","ENSBGRT00000047574",56349,"RHOBTB1","Rho related BTB domain containing 1 [Source:HGNC Symbol;Acc:HGNC:18738]","GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0007264(small GTPase mediated signal transduction)","04120(Ubiquitin mediated proteolysis)",{"v":7.9e-14,"d":"0.00"},1,"150,",0,{"v":-13.1,"d":"-13.10"},{"v":-12.2,"d":"-12.20"},1.99,"3' UTR",27,15341254,15397961,56708,2]
["chr27",26095885,26099780,3896,"ENSBGRG00000021766","ENSBGRT00000040185",4201,"TYSND1","trypsin domain containing 1 [Source:HGNC Symbol;Acc:HGNC:28531]","GO:0002020(protease binding);GO:0004252(serine-type endopeptidase activity);GO:0005777(peroxisome);GO:0006508(proteolysis);GO:0016485(protein processing);GO:0031998(regulation of fatty acid beta-oxidation)","NA",{"v":1.6e-28,"d":"0.00"},3,"218,186,46,","0,2658,3850",{"v":-27.8,"d":"-27.80"},{"v":-26.8,"d":"-26.80"},{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000040185/ENSBGRG00000021766, exon 2 of 4)",27,26095885,26103981,8097,2]
["chr27",31519714,31524252,4539,"ENSBGRG00000021005","ENSBGRT00000038687",0,"ZNF503","zinc finger protein 503 [Source:HGNC Symbol;Acc:HGNC:23589]","GO:0003676(nucleic acid binding);GO:0008285(negative regulation of cell population proliferation);GO:0010629(negative regulation of gene expression);GO:0061351(neural precursor cell proliferation);GO:0070315(G1 to G0 transition involved in cell differentiation)","NA",0,3,"948,1401,303,","0,2115,4236",-432,"-Inf",{"v":12.8,"d":"12.80"},"3' UTR",27,31519714,31524252,4539,2]
["chr27",43415505,43416561,1057,"ENSBGRG00000026621","ENSBGRT00000049332",7029,"ENSBGRG00000026621","NA","GO:0019898(extrinsic component of membrane)","NA",{"v":1.1e-07,"d":"0.00"},3,"151,81,8,","0,241,1049",-6.97,-6.23,{"v":10.2,"d":"10.20"},"3' UTR",27,43415505,43423590,8086,2]
["chr27",46586899,46586989,91,"ENSBGRG00000018526","ENSBGRT00000034077",25651,"RASSF4","Ras association domain family member 4 [Source:HGNC Symbol;Acc:HGNC:20793]","GO:0007165(signal transduction)","04392(Hippo signaling pathway - multiple species)",{"v":2.8e-08,"d":"0.00"},1,"91,",0,-7.55,{"v":-6.8,"d":"-6.80"},2.42,"3' UTR",27,46586090,46612640,26551,2]
["chr28",11109842,11112188,2347,"ENSBGRG00000009728","ENSBGRT00000017986",12955,"NR1D2","nuclear receptor subfamily 1 group D member 2 [Source:HGNC Symbol;Acc:HGNC:7963]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0019216(regulation of lipid metabolic process);GO:0042025(host cell nucleus);GO:0042752(regulation of circadian rhythm);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0048384(retinoic acid receptor signaling pathway);GO:0048512(circadian behavior);GO:0050727(regulation of inflammatory response);GO:0050728(negative regulation of inflammatory response);GO:0055088(lipid homeostasis);GO:0097009(energy homeostasis);GO:1990837(sequence-specific double-stranded DNA binding);GO:2001014(regulation of skeletal muscle cell differentiation)","NA",{"v":1e-72,"d":"0.00"},2,"85,485,","0,1862",-72,{"v":-70.6,"d":"-70.60"},4.26,"Exon (ENSBGRT00000017986/ENSBGRG00000009728, exon 5 of 9)",28,11096887,11131054,34168,1]
["chr28",16683624,16683684,61,"ENSBGRG00000008639","ENSBGRT00000015921",689,"PLAT","plasminogen activator, tissue type [Source:HGNC Symbol;Acc:HGNC:9051]","GO:0001666(response to hypoxia);GO:0004252(serine-type endopeptidase activity);GO:0005102(signaling receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0009986(cell surface);GO:0014909(smooth muscle cell migration);GO:0030141(secretory granule);GO:0031639(plasminogen activation);GO:0045177(apical part of cell);GO:0045861(negative regulation of proteolysis);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0051219(phosphoprotein binding);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099183(trans-synaptic signaling by BDNF, modulating synaptic transmission)","04371(Apelin signaling pathway);04610(Complement and coagulation cascades);05202(Transcriptional misregulation in cancers);05215(Prostate cancer);05418(Fluid shear stress and atherosclerosis)",{"v":4e-13,"d":"0.00"},1,"61,",0,{"v":-12.4,"d":"-12.40"},{"v":-11.5,"d":"-11.50"},2.12,"5' UTR",28,16682935,16713213,30279,1]
["chr28",20777183,20778803,1621,"ENSBGRG00000016971","ENSBGRT00000031319",70482,"NSD3","nuclear receptor binding SET domain protein 3 [Source:HGNC Symbol;Acc:HGNC:12767]","GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016571(histone methylation);GO:0018024(histone-lysine N-methyltransferase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:2001255(positive regulation of histone H3-K36 trimethylation)","00310(Lysine degradation)",{"v":1.6e-43,"d":"0.00"},3,"17,205,436,","0,634,1185",{"v":-42.8,"d":"-42.80"},{"v":-41.6,"d":"-41.60"},4.94,"3' UTR",28,20706701,20779609,72909,1]
["chr28",27994229,27994529,301,"ENSBGRG00000024980","ENSBGRT00000046160",5215,"TEX15","testis expressed 15, meiosis and synapsis associated [Source:HGNC Symbol;Acc:HGNC:11738]","GO:0007129(synapsis);GO:0007140(male meiotic nuclear division);GO:0010569(regulation of double-strand break repair via homologous recombination)","03015(mRNA surveillance pathway);04350(TGF-beta signaling pathway);04140(Autophagy - animal);04136(Autophagy - other eukaryotes);04114(Oocyte meiosis);04530(Tight junction);04261(Adrenergic signaling in cardiomyocytes)",{"v":6e-06,"d":"0.00"},1,"301,",0,-5.22,-4.53,{"v":20.8,"d":"20.80"},"Exon (ENSBGRT00000046160/ENSBGRG00000024980, exon 5 of 11)",28,27989014,28002379,13366,1]
["chr28",27995590,27995860,271,"ENSBGRG00000024980","ENSBGRT00000046160",6576,"TEX15","testis expressed 15, meiosis and synapsis associated [Source:HGNC Symbol;Acc:HGNC:11738]","GO:0007129(synapsis);GO:0007140(male meiotic nuclear division);GO:0010569(regulation of double-strand break repair via homologous recombination)","03015(mRNA surveillance pathway);04350(TGF-beta signaling pathway);04140(Autophagy - animal);04136(Autophagy - other eukaryotes);04114(Oocyte meiosis);04530(Tight junction);04261(Adrenergic signaling in cardiomyocytes)",{"v":3.3E-3,"d":"0.00"},1,"271,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000046160/ENSBGRG00000024980, exon 6 of 11)",28,27989014,28002379,13366,1]
["chr28",31957483,32054256,96774,"ENSBGRG00000008770","ENSBGRT00000016020",835,"ENSBGRG00000008770","NA","NA","04514(Cell adhesion molecules (CAMs))",{"v":2e-63,"d":"0.00"},2,"553,163,","0,96611",{"v":-62.7,"d":"-62.70"},{"v":-61.4,"d":"-61.40"},{"v":61.4,"d":"61.40"},"3' UTR",28,31956648,32054703,98056,1]
["chr28",39593687,39593836,150,"ENSBGRG00000015602","ENSBGRT00000029230",113453,"FAT1","FAT atypical cadherin 1 [Source:HGNC Symbol;Acc:HGNC:3595]","GO:0002088(lens development in camera-type eye);GO:0003382(epithelial cell morphogenesis);GO:0003412(establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007015(actin filament organization);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007163(establishment or maintenance of cell polarity);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0030027(lamellipodium);GO:0030054(cell junction);GO:0030175(filopodium);GO:0043010(camera-type eye development);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0048471(perinuclear region of cytoplasm);GO:0048593(camera-type eye morphogenesis);GO:0098609(cell-cell adhesion)","NA",{"v":1.3e-21,"d":"0.00"},1,"150,",0,{"v":-20.9,"d":"-20.90"},{"v":-19.9,"d":"-19.90"},2.45,"Exon (ENSBGRT00000029230/ENSBGRG00000015602, exon 20 of 28)",28,39480234,39608094,127861,1]
["chr28",5571991,5572258,268,"ENSBGRG00000008792","ENSBGRT00000016071",1214,"KBTBD11","kelch repeat and BTB domain containing 11 [Source:HGNC Symbol;Acc:HGNC:29104]","GO:0005515(protein binding)","NA",{"v":3.5e-05,"d":"0.00"},1,"268,",0,-4.45,-3.79,4.39,"Exon (ENSBGRT00000016071/ENSBGRG00000008792, exon 1 of 1)",28,5571547,5573472,1926,2]
["chr28",16566061,16566241,181,"ENSBGRG00000008023","ENSBGRT00000015189",65287,"IKBKB","inhibitor of nuclear factor kappa B kinase subunit beta [Source:HGNC Symbol;Acc:HGNC:5960]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0008384(IkappaB kinase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0030866(cortical actin cytoskeleton organization);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0035509(negative regulation of myosin-light-chain-phosphatase activity);GO:0042325(regulation of phosphorylation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0070498(interleukin-1-mediated signaling pathway);GO:0071356(cellular response to tumor necrosis factor);GO:0072659(protein localization to plasma membrane);GO:0097110(scaffold protein binding);GO:1903140(regulation of establishment of endothelial barrier);GO:1903347(negative regulation of bicellular tight junction assembly);GO:1990459(transferrin receptor binding)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04068(FoxO signaling pathway);04151(PI3K-Akt signaling pathway);04150(mTOR signaling pathway);04210(Apoptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04657(IL-17 signaling pathway);04662(B cell receptor signaling pathway);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04920(Adipocytokine signaling pathway);04722(Neurotrophin signaling pathway);04380(Osteoclast differentiation);05200(Pathways in cancer);05206(MicroRNAs in cancer);05212(Pancreatic cancer);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05215(Prostate cancer);05222(Small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);05166(HTLV-I infection);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05168(Herpes simplex infection);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05145(Toxoplasmosis);05142(Chagas disease (American trypanosomiasis));01523(Antifolate resistance)",{"v":8.1e-05,"d":"0.00"},1,"181,",0,-4.09,-3.44,1.84,"3' UTR",28,16566061,16631528,65468,2]
["chr28",21138125,21138633,509,"ENSBGRG00000019012","ENSBGRT00000034903",3809,"BRF2","BRF2 RNA polymerase III transcription initiation factor subunit [Source:HGNC Symbol;Acc:HGNC:17298]","GO:0000126(transcription factor TFIIIB complex);GO:0001006(RNA polymerase III type 3 promoter sequence-specific DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0006359(regulation of transcription by RNA polymerase III);GO:0034599(cellular response to oxidative stress);GO:0070897(transcription preinitiation complex assembly)","NA",{"v":0.00015,"d":"0.00"},1,"509,",0,-3.82,-3.19,6.93,"3' UTR",28,21134316,21140304,5989,1]
["chr28",21246652,21277560,30909,"ENSBGRG00000019985","ENSBGRT00000036757",0,"ZNF703","zinc finger protein 703 [Source:HGNC Symbol;Acc:HGNC:25883]","GO:0003676(nucleic acid binding);GO:0005783(endoplasmic reticulum);GO:0031625(ubiquitin protein ligase binding)","00051(Fructose and mannose metabolism);00520(Amino sugar and nucleotide sugar metabolism)",{"v":2e-77,"d":"0.00"},2,"570,120,","0,30789",{"v":-76.7,"d":"-76.70"},{"v":-75.3,"d":"-75.30"},6.73,"5' UTR",28,21229055,21247221,18167,2]
["chr28",34596968,34611831,14864,"ENSBGRG00000009456","ENSBGRT00000017370",55583,"MSR1","macrophage scavenger receptor 1 [Source:HGNC Symbol;Acc:HGNC:7376]","GO:0001540(amyloid-beta binding);GO:0005044(scavenger receptor activity);GO:0005886(plasma membrane);GO:0006898(receptor-mediated endocytosis);GO:0006911(phagocytosis, engulfment);GO:0010629(negative regulation of gene expression);GO:0010744(positive regulation of macrophage derived foam cell differentiation);GO:0010886(positive regulation of cholesterol storage);GO:0016020(membrane);GO:0030169(low-density lipoprotein particle binding);GO:0030301(cholesterol transport);GO:0034381(plasma lipoprotein particle clearance);GO:0038024(cargo receptor activity);GO:0042953(lipoprotein transport);GO:0097242(amyloid-beta clearance)","04145(Phagosome)",{"v":0.036,"d":"0.04"},2,"93,27,","0,14837",-1.44,{"v":-0.946,"d":"-0.95"},1.67,"3' UTR",28,34595927,34667414,71488,2]
["chr28",41571411,41591055,19645,"ENSBGRG00000020882","ENSBGRT00000038444",0,"ENSBGRG00000020882","NA","GO:0006357(regulation of transcription by RNA polymerase II)","NA",{"v":1.7E-6,"d":"0.00"},2,"71,75,","0,19570",-5.77,-5.07,{"v":15.8,"d":"15.80"},"3' UTR",28,41576506,41580207,3702,2]
["chr29",654974,655200,227,"ENSBGRG00000022560","ENSBGRT00000041732",2023,"ENSBGRG00000022560","NA","NA","03010(Ribosome)",{"v":1.6E-52,"d":"0.00"},3,"50,35,36,","0,152,191",{"v":-51.8,"d":"-51.80"},{"v":-50.6,"d":"-50.60"},1.62,"Exon (ENSBGRT00000041732/ENSBGRG00000022560, exon 7 of 9)",29,652951,655200,2250,1]
["chr29",3272335,3273139,805,"ENSBGRG00000017928","ENSBGRT00000032957",10591,"DHCR7","7-dehydrocholesterol reductase [Source:HGNC Symbol;Acc:HGNC:2860]","GO:0001568(blood vessel development);GO:0005640(nuclear outer membrane);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006695(cholesterol biosynthetic process);GO:0009791(post-embryonic development);GO:0016020(membrane);GO:0016126(sterol biosynthetic process);GO:0016628(oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor);GO:0030154(cell differentiation);GO:0030324(lung development);GO:0035264(multicellular organism growth);GO:0042127(regulation of cell population proliferation);GO:0047598(7-dehydrocholesterol reductase activity)","00100(Steroid biosynthesis)",{"v":3.3e-05,"d":"0.00"},3,"14,161,35,","0,49,770",-4.48,-3.82,4.09,"Exon (ENSBGRT00000032957/ENSBGRG00000017928, exon 7 of 9)",29,3261744,3273139,11396,1]
["chr29",6689754,6691444,1691,"ENSBGRG00000015718","ENSBGRT00000029106",0,"ENSBGRG00000015718","NA","NA","NA",{"v":1.1E-5,"d":"0.00"},8,"3,45,120,18,160,11,75,18,","0,1226,1275,1399,1419,1583,1596,1673",-4.97,-4.29,{"v":11.4,"d":"11.40"},"Exon (ENSBGRT00000029106/ENSBGRG00000015718, exon 1 of 12)",29,6689754,6691571,1818,1]
["chr29",8315684,8316149,466,"ENSBGRG00000021381","ENSBGRT00000039769",3295,"ENSBGRG00000021381","NA","NA","NA",{"v":2.8e-08,"d":"0.00"},11,"21,12,117,24,57,99,24,78,6,3,6,","0,23,37,156,182,241,341,367,447,455,460",-7.55,{"v":-6.8,"d":"-6.80"},6.08,"Exon (ENSBGRT00000039769/ENSBGRG00000021381, exon 27 of 37)",29,8312389,8316179,3791,1]
["chr29",9044131,9044363,233,"ENSBGRG00000026340","ENSBGRT00000048893",13351,"ENSBGRG00000026340","NA","NA","NA",{"v":0.0068,"d":"0.01"},3,"75,31,45,","0,155,188",-2.17,-1.62,5.94,"Exon (ENSBGRT00000048893/ENSBGRG00000026340, exon 38 of 55)",29,9030780,9046278,15499,1]
["chr29",14105967,14106175,209,"ENSBGRG00000022970","ENSBGRT00000042593",33162,"NFRKB","nuclear factor related to kappaB binding protein [Source:HGNC Symbol;Acc:HGNC:7802]","GO:0002020(protease binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0031011(Ino80 complex)","NA",{"v":1.7E-5,"d":"0.00"},1,"209,",0,-4.78,-4.11,2.67,"3' UTR",29,14072805,14105988,33184,1]
["chr29",21815051,21815380,330,"ENSBGRG00000019029","ENSBGRT00000034894",104929,"CDON","cell adhesion associated, oncogene regulated [Source:HGNC Symbol;Acc:HGNC:17104]","GO:0001708(cell fate specification);GO:0001934(positive regulation of protein phosphorylation);GO:0002088(lens development in camera-type eye);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0007224(smoothened signaling pathway);GO:0007520(myoblast fusion);GO:0009952(anterior/posterior pattern specification);GO:0010172(embryonic body morphogenesis);GO:0014816(skeletal muscle satellite cell differentiation);GO:0021987(cerebral cortex development);GO:0043393(regulation of protein binding);GO:0043410(positive regulation of MAPK cascade);GO:0045663(positive regulation of myoblast differentiation);GO:0045664(regulation of neuron differentiation);GO:0045666(positive regulation of neuron differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048598(embryonic morphogenesis);GO:0048643(positive regulation of skeletal muscle tissue development);GO:0051057(positive regulation of small GTPase mediated signal transduction);GO:0051146(striated muscle cell differentiation);GO:0060059(embryonic retina morphogenesis in camera-type eye);GO:2000179(positive regulation of neural precursor cell proliferation)","04340(Hedgehog signaling pathway)",{"v":1.6e-20,"d":"0.00"},1,"330,",0,{"v":-19.8,"d":"-19.80"},{"v":-18.9,"d":"-18.90"},8.42,"3' UTR",29,21710122,21816158,106037,1]
["chr29",31996109,31996199,91,"ENSBGRG00000021411","ENSBGRT00000039528",20635,"DDIAS","DNA damage induced apoptosis suppressor [Source:HGNC Symbol;Acc:HGNC:26351]","GO:0097752(regulation of DNA stability);GO:1902230(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","NA",{"v":0.00026,"d":"0.00"},1,"91,",0,-3.58,-2.95,{"v":6.6,"d":"6.60"},"Exon (ENSBGRT00000039528/ENSBGRG00000021411, exon 6 of 6)",29,31975474,31998380,22907,1]
["chr29",32261475,32261954,480,"ENSBGRG00000021669","ENSBGRT00000039990",15264,"PCF11","PCF11 cleavage and polyadenylation factor subunit [Source:HGNC Symbol;Acc:HGNC:30097]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","03015(mRNA surveillance pathway)",{"v":1.6e-25,"d":"0.00"},1,"480,",0,{"v":-24.8,"d":"-24.80"},{"v":-23.8,"d":"-23.80"},9.57,"Exon (ENSBGRT00000040098/ENSBGRG00000021705, exon 2 of 2)",29,32246211,32275498,29288,1]
["chr29",44531102,44531634,533,"ENSBGRG00000017172","ENSBGRT00000031829",54387,"CEP295","centrosomal protein 295 [Source:HGNC Symbol;Acc:HGNC:29366]","GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0008017(microtubule binding);GO:0010825(positive regulation of centrosome duplication);GO:1901985(positive regulation of protein acetylation);GO:1903724(positive regulation of centriole elongation);GO:1904951(positive regulation of establishment of protein localization);GO:1990498(mitotic spindle microtubule)","NA",{"v":1e-114,"d":"0.00"},3,"83,100,118,","0,223,415",-114,-113,2.82,"3' UTR",29,44476715,44531634,54920,1]
["chr29",2565394,2565992,599,"ENSBGRG00000014930","ENSBGRT00000027458",3480,"ENSBGRG00000014930","NA","NA","NA",{"v":2.6e-09,"d":"0.00"},1,"599,",0,-8.59,-7.82,9.66,"Exon (ENSBGRT00000027458/ENSBGRG00000014930, exon 2 of 2)",29,2563929,2569472,5544,2]
["chr29",8091706,8091825,120,"ENSBGRG00000018549","ENSBGRT00000033963",1546,"ENSBGRG00000018549","NA","GO:0004869(cysteine-type endopeptidase inhibitor activity)","NA",{"v":0.005,"d":"0.01"},1,"120,",0,{"v":-2.3,"d":"-2.30"},-1.74,2.25,"3' UTR",29,8091646,8093371,1726,2]
["chr29",8470749,8470935,187,"ENSBGRG00000025175","ENSBGRT00000046830",6711,"ENSBGRG00000025175","NA","NA","NA",{"v":7.6e-06,"d":"0.00"},3,"159,21,1,","0,161,186",-5.12,-4.44,1.91,"Exon (ENSBGRT00000046830/ENSBGRG00000025175, exon 30 of 97)",29,8461260,8477646,16387,2]
["chr29",12713140,12713773,634,"ENSBGRG00000020478","ENSBGRT00000037994",12630,"TMEM132A","transmembrane protein 132A [Source:HGNC Symbol;Acc:HGNC:31092]","NA","NA",{"v":1.2E-8,"d":"0.00"},2,"158,52,","0,582",-7.91,-7.16,2.41,"Exon (ENSBGRT00000037994/ENSBGRG00000020478, exon 11 of 13)",29,12712241,12726403,14163,2]
["chr29",21451801,21453841,2041,"ENSBGRG00000018128","ENSBGRT00000033184",16208,"ENSBGRG00000018128","NA","GO:0005515(protein binding);GO:0007165(signal transduction)","04064(NF-kappa B signaling pathway);04620(Toll-like receptor signaling pathway);05133(Pertussis);05152(Tuberculosis);05161(Hepatitis B)",{"v":1.2E-4,"d":"0.00"},2,"20,250,","0,1791",-3.92,-3.28,4.95,"Exon (ENSBGRT00000033184/ENSBGRG00000018128, exon 3 of 4)",29,21451801,21470049,18249,2]
["chr29",26203309,26203369,61,"ENSBGRG00000020232","ENSBGRT00000037343",27544,"ALG8","ALG8 alpha-1,3-glucosyltransferase [Source:HGNC Symbol;Acc:HGNC:23161]","GO:0000033(alpha-1,3-mannosyltransferase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006487(protein N-linked glycosylation);GO:0006490(oligosaccharide-lipid intermediate biosynthetic process);GO:0016758(transferase activity, transferring hexosyl groups);GO:0018279(protein N-linked glycosylation via asparagine);GO:0042283(dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity)","00510(N-Glycan biosynthesis)",{"v":7.9e-11,"d":"0.00"},1,"61,",0,{"v":-10.1,"d":"-10.10"},-9.28,5.28,"Exon (ENSBGRT00000037343/ENSBGRG00000020232, exon 13 of 13)",29,26203309,26230913,27605,2]
["chr29",26845259,26845319,61,"ENSBGRG00000020793","ENSBGRT00000038620",500223,"TENM4","teneurin transmembrane protein 4 [Source:HGNC Symbol;Acc:HGNC:29945]","GO:0001702(gastrulation with mouth forming second);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0016021(integral component of membrane);GO:0031641(regulation of myelination);GO:0031643(positive regulation of myelination);GO:0032289(central nervous system myelin formation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043005(neuron projection);GO:0048666(neuron development);GO:0048714(positive regulation of oligodendrocyte differentiation);GO:0060038(cardiac muscle cell proliferation);GO:0060912(cardiac cell fate specification);GO:2000543(positive regulation of gastrulation)","NA",{"v":0.0085,"d":"0.01"},1,"61,",0,-2.07,-1.54,{"v":1.5,"d":"1.50"},"Exon (ENSBGRT00000038620/ENSBGRG00000020793, exon 32 of 34)",29,26833240,27345542,512303,2]
["chr29",36605938,36606807,870,"ENSBGRG00000025585","ENSBGRT00000047301",4051,"FZD4","frizzled class receptor 4 [Source:HGNC Symbol;Acc:HGNC:4042]","GO:0001540(amyloid-beta binding);GO:0001553(luteinization);GO:0001568(blood vessel development);GO:0001570(vasculogenesis);GO:0004888(transmembrane signaling receptor activity);GO:0004896(cytokine receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007166(cell surface receptor signaling pathway);GO:0007223(Wnt signaling pathway, calcium modulating pathway);GO:0007605(sensory perception of sound);GO:0009986(cell surface);GO:0010812(negative regulation of cell-substrate adhesion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0019955(cytokine binding);GO:0030165(PDZ domain binding);GO:0030425(dendrite);GO:0030947(regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031625(ubiquitin protein ligase binding);GO:0031987(locomotion involved in locomotory behavior);GO:0034446(substrate adhesion-dependent cell spreading);GO:0035426(extracellular matrix-cell signaling);GO:0038023(signaling receptor activity);GO:0042701(progesterone secretion);GO:0042803(protein homodimerization activity);GO:0042813(Wnt-activated receptor activity);GO:0043507(positive regulation of JUN kinase activity);GO:0044877(protein-containing complex binding);GO:0045202(synapse);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046982(protein heterodimerization activity);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060070(canonical Wnt signaling pathway);GO:0061299(retina vasculature morphogenesis in camera-type eye);GO:0061301(cerebellum vasculature morphogenesis);GO:0061304(retinal blood vessel morphogenesis);GO:0098978(glutamatergic synapse);GO:0110135(Norrin signaling pathway);GO:0150012(positive regulation of neuron projection arborization);GO:1990830(cellular response to leukemia inhibitory factor)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":9.99999999999998e-218,"d":"0.00"},1,"870,",0,-217,-215,{"v":14.2,"d":"14.20"},"Exon (ENSBGRT00000047301/ENSBGRG00000025585, exon 2 of 3)",29,36599990,36610858,10869,2]
["X",498103,500396,2294,"ENSBGRG00000020705","ENSBGRT00000038106",108716,"ENSBGRG00000020705","NA","NA","04120(Ubiquitin mediated proteolysis)",{"v":2.5e-25,"d":"0.00"},2,"64,1183,","0,1111",{"v":-24.6,"d":"-24.60"},{"v":-23.6,"d":"-23.60"},4.46,"Exon (ENSBGRT00000038717/ENSBGRG00000020971, exon 1 of 4)",30,488864,609112,120249,2]
["X",10027076,10027304,229,"ENSBGRG00000007748","ENSBGRT00000014222",30006,"XPNPEP2","X-prolyl aminopeptidase 2 [Source:HGNC Symbol;Acc:HGNC:12823]","GO:0016787(hydrolase activity);GO:0070006(metalloaminopeptidase activity);GO:0070062(extracellular exosome)","04974(Protein digestion and absorption)",{"v":2.5e-67,"d":"0.00"},1,"229,",0,{"v":-66.6,"d":"-66.60"},{"v":-65.3,"d":"-65.30"},2.96,"3' UTR",30,10026113,10057310,31198,2]
["X",33579634,33580498,865,"ENSBGRG00000020734","ENSBGRT00000038244",8406,"ENSBGRG00000020734","NA","NA","04742(Taste transduction)",{"v":1e-32,"d":"0.00"},2,"81,306,","0,559",-32,{"v":-30.9,"d":"-30.90"},4.24,"3' UTR",30,33571228,33580352,9125,1]
["X",39988996,39989203,208,"ENSBGRG00000023696","ENSBGRT00000043864",36115,"GDI1","GDP dissociation inhibitor 1 [Source:HGNC Symbol;Acc:HGNC:4226]","GO:0005092(GDP-dissociation inhibitor activity);GO:0005093(Rab GDP-dissociation inhibitor activity);GO:0005737(cytoplasm);GO:0007264(small GTPase mediated signal transduction);GO:0015031(protein transport);GO:0030496(midbody);GO:0090315(negative regulation of protein targeting to membrane)","NA",{"v":1E-35,"d":"0.00"},1,"208,",0,-35,{"v":-33.9,"d":"-33.90"},2.39,"3' UTR",30,39952881,40084960,132080,1]
["X",54370012,54373004,2993,"ENSBGRG00000019010","ENSBGRT00000034875",41693,"ZMAT1","zinc finger matrin-type 1 [Source:HGNC Symbol;Acc:HGNC:29377]","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding)","04115(p53 signaling pathway)",{"v":1.3E-13,"d":"0.00"},2,"69,1719,","0,1274",{"v":-12.9,"d":"-12.90"},{"v":-12.1,"d":"-12.10"},7.23,"3' UTR",30,54328319,54373451,45133,1]
["X",59147844,59170922,23079,"ENSBGRG00000022973","ENSBGRT00000042410",766,"ENSBGRG00000022973","NA","NA","NA",{"v":0.00022,"d":"0.00"},2,"49,11,","0,23068",-3.65,-3.03,{"v":2.3,"d":"2.30"},"5' UTR",30,59147078,59172983,25906,1]
["X",59349506,59350179,674,"ENSBGRG00000023145","ENSBGRT00000042725",0,"ENSBGRG00000023145","NA","NA","NA",{"v":4e-48,"d":"0.00"},2,"31,268,","0,406",{"v":-47.4,"d":"-47.40"},{"v":-46.3,"d":"-46.30"},2.62,"Exon (ENSBGRT00000042760/ENSBGRG00000023158, exon 2 of 2)",30,59348075,59350073,1999,2]
["X",64640180,64643513,3334,"ENSBGRG00000022996","ENSBGRT00000042792",141602,"PAK3","p21 (RAC1) activated kinase 3 [Source:HGNC Symbol;Acc:HGNC:8592]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004708(MAP kinase kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007409(axonogenesis);GO:0016358(dendrite development);GO:0017048(Rho GTPase binding);GO:0030833(regulation of actin filament polymerization);GO:0060996(dendritic spine development);GO:0060997(dendritic spine morphogenesis);GO:0071407(cellular response to organic cyclic compound)","04014(Ras signaling pathway);04012(ErbB signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04660(T cell receptor signaling pathway);04360(Axon guidance);05211(Renal cell carcinoma)",{"v":1.8E-3,"d":"0.00"},2,"99,172,","0,3162",-2.74,-2.16,{"v":11.9,"d":"11.90"},"3' UTR",30,64498578,64643513,144936,1]
["X",83129652,83129922,271,"ENSBGRG00000023991","ENSBGRT00000044295",17318,"RLIM","ring finger protein, LIM domain interacting [Source:HGNC Symbol;Acc:HGNC:13429]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0060816(random inactivation of X chromosome);GO:0061630(ubiquitin protein ligase activity);GO:1900095(regulation of dosage compensation by inactivation of X chromosome)","NA",{"v":5e-18,"d":"0.00"},1,"271,",0,{"v":-17.3,"d":"-17.30"},{"v":-16.3,"d":"-16.30"},2.43,"3' UTR",30,83112334,83130490,18157,1]
["X",92243442,92243709,268,"ENSBGRG00000010242","ENSBGRT00000018762",2001,"ENSBGRG00000010242","NA","NA","NA",{"v":1.8E-3,"d":"0.00"},1,"268,",0,-2.74,-2.16,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000018762/ENSBGRG00000010242, exon 2 of 2)",30,92241441,92244598,3158,1]
["X",94212083,94212463,381,"ENSBGRG00000017760","ENSBGRT00000032705",3979,"FTSJ1","FtsJ RNA 2'-O-methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:13254]","GO:0001510(RNA methylation);GO:0008033(tRNA processing);GO:0008168(methyltransferase activity);GO:0008175(tRNA methyltransferase activity);GO:0032259(methylation)","NA",{"v":5e-11,"d":"0.00"},2,"136,42,","0,339",{"v":-10.3,"d":"-10.30"},-9.52,2.11,"3' UTR",30,94208104,94212217,4114,1]
["X",95074110,95074319,210,"ENSBGRG00000025406","ENSBGRT00000046979",16747,"PPP1R3F","protein phosphatase 1 regulatory subunit 3F [Source:HGNC Symbol;Acc:HGNC:14944]","GO:0005515(protein binding);GO:0005979(regulation of glycogen biosynthetic process);GO:0016020(membrane);GO:0019903(protein phosphatase binding);GO:2000465(regulation of glycogen (starch) synthase activity);GO:2001069(glycogen binding)","04910(Insulin signaling pathway)",{"v":2.2e-05,"d":"0.00"},1,"210,",0,-4.66,-4,{"v":18.8,"d":"18.80"},"3' UTR",30,95057363,95074617,17255,1]
["X",100071357,100071417,61,"ENSBGRG00000026168","ENSBGRT00000048396",480,"MAGED2","MAGE family member D2 [Source:HGNC Symbol;Acc:HGNC:16353]","GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0007565(female pregnancy);GO:0070294(renal sodium ion absorption)","04722(Neurotrophin signaling pathway)",{"v":1.6e-20,"d":"0.00"},1,"61,",0,{"v":-19.8,"d":"-19.80"},{"v":-18.9,"d":"-18.90"},5.94,"5' UTR",30,100070877,100080211,9335,1]
["X",100079281,100079371,91,"ENSBGRG00000026168","ENSBGRT00000048396",8404,"MAGED2","MAGE family member D2 [Source:HGNC Symbol;Acc:HGNC:16353]","GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0007565(female pregnancy);GO:0070294(renal sodium ion absorption)","04722(Neurotrophin signaling pathway)",{"v":7.9e-20,"d":"0.00"},1,"91,",0,{"v":-19.1,"d":"-19.10"},{"v":-18.1,"d":"-18.10"},1.53,"3' UTR",30,100070877,100080211,9335,1]
["X",105020566,105020797,232,"ENSBGRG00000010108","ENSBGRT00000018600",938,"SPIN4","spindlin family member 4 [Source:HGNC Symbol;Acc:HGNC:27040]","GO:0007276(gamete generation);GO:0035064(methylated histone binding)","NA",0.02,2,"21,39,","0,193",{"v":-1.7,"d":"-1.70"},-1.19,4.95,"Exon (ENSBGRT00000018600/ENSBGRG00000010108, exon 3 of 4)",30,105019628,105020797,1170,1]
["X",122812610,122812699,90,"ENSBGRG00000009952","ENSBGRT00000018529",8140,"TAB3","TGF-beta activated kinase 1 (MAP3K7) binding protein 3 [Source:HGNC Symbol;Acc:HGNC:30681]","GO:0005515(protein binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling)","04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04621(NOD-like receptor signaling pathway);04657(IL-17 signaling pathway)",{"v":7.9e-09,"d":"0.00"},1,"90,",0,{"v":-8.1,"d":"-8.10"},-7.34,2.67,"Exon (ENSBGRT00000018529/ENSBGRG00000009952, exon 2 of 6)",30,122804470,122830817,26348,1]
["X",501891,502101,211,"ENSBGRG00000020705","ENSBGRT00000038106",107011,"ENSBGRG00000020705","NA","NA","04120(Ubiquitin mediated proteolysis)",{"v":0.036,"d":"0.04"},1,"211,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"3' UTR",30,488864,609112,120249,2]
["X",4701718,4702769,1052,"ENSBGRG00000023903","ENSBGRT00000044159",10371,"ZNF449","zinc finger protein 449 [Source:HGNC Symbol;Acc:HGNC:21039]","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":4e-85,"d":"0.00"},2,"768,92,","0,960",{"v":-84.4,"d":"-84.40"},{"v":-82.9,"d":"-82.90"},8.28,"Exon (ENSBGRT00000044159/ENSBGRG00000023903, exon 3 of 4)",30,4701599,4713140,11542,2]
["X",10028182,10028602,421,"ENSBGRG00000007748","ENSBGRT00000014222",28708,"XPNPEP2","X-prolyl aminopeptidase 2 [Source:HGNC Symbol;Acc:HGNC:12823]","GO:0016787(hydrolase activity);GO:0070006(metalloaminopeptidase activity);GO:0070062(extracellular exosome)","04974(Protein digestion and absorption)",{"v":1.2E-4,"d":"0.00"},1,"421,",0,-3.92,-3.28,9.41,"3' UTR",30,10026113,10057310,31198,2]
["X",35610220,35610735,516,"ENSBGRG00000023594","ENSBGRT00000043542",83250,"ENSBGRG00000023594","NA","GO:0070072(vacuolar proton-transporting V-type ATPase complex assembly)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":3.5e-06,"d":"0.00"},2,"321,6,","0,510",-5.46,-4.76,7.92,"3' UTR",30,35610220,35693985,83766,2]
["X",39549176,39549475,300,"ENSBGRG00000020974","ENSBGRT00000038690",30644,"L1CAM","L1 cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:6470]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007160(cell-matrix adhesion);GO:0007411(axon guidance);GO:0009986(cell surface);GO:0016477(cell migration);GO:0019904(protein domain specific binding);GO:0030424(axon);GO:0031175(neuron projection development);GO:0043025(neuronal cell body);GO:0050808(synapse organization);GO:0061564(axon development)","04514(Cell adhesion molecules (CAMs));04360(Axon guidance)",{"v":6.8e-09,"d":"0.00"},1,"300,",0,-8.17,{"v":-7.4,"d":"-7.40"},6.93,"3' UTR",30,39549146,39580119,30974,2]
["X",39658758,39658997,240,"ENSBGRG00000021965","ENSBGRT00000042279",18026,"HCFC1","host cell factor C1 [Source:HGNC Symbol;Acc:HGNC:4839]","GO:0000123(histone acetyltransferase complex);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001835(blastocyst hatching);GO:0003682(chromatin binding);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0010628(positive regulation of gene expression);GO:0019046(release from viral latency);GO:0030674(protein-macromolecule adaptor activity);GO:0032991(protein-containing complex);GO:0033613(activating transcription factor binding);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0043254(regulation of protein-containing complex assembly);GO:0043981(histone H4-K5 acetylation);GO:0043982(histone H4-K8 acetylation);GO:0043984(histone H4-K16 acetylation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048188(Set1C/COMPASS complex);GO:0050821(protein stabilization);GO:0070461(SAGA-type complex);GO:0071339(MLL1 complex)","05168(Herpes simplex infection)",{"v":1.6e-14,"d":"0.00"},1,"240,",0,{"v":-13.8,"d":"-13.80"},{"v":-12.9,"d":"-12.90"},1.88,"Exon (ENSBGRT00000042279/ENSBGRG00000021965, exon 19 of 27)",30,39652315,39677023,24709,2]
["X",53318190,53318370,181,"ENSBGRG00000017593","ENSBGRT00000032560",2780,"PCDH19","protocadherin 19 [Source:HGNC Symbol;Acc:HGNC:14270]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007420(brain development);GO:0016020(membrane)","NA",{"v":0.0039,"d":"0.00"},1,"181,",0,-2.41,-1.85,6.44,"Exon (ENSBGRT00000032560/ENSBGRG00000017593, exon 3 of 10)",30,53185886,53321150,135265,2]
["X",55474667,55475916,1250,"ENSBGRG00000021191","ENSBGRT00000039523",0,"CSTF2","cleavage stimulation factor subunit 2 [Source:HGNC Symbol;Acc:HGNC:2484]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0005847(mRNA cleavage and polyadenylation specificity factor complex);GO:0006378(mRNA polyadenylation);GO:0016604(nuclear body);GO:0031124(mRNA 3'-end processing)","03015(mRNA surveillance pathway)",{"v":0.035,"d":"0.04"},2,"63,58,","0,1192",-1.46,{"v":-0.963,"d":"-0.96"},1.57,"Exon (ENSBGRT00000039523/ENSBGRG00000021191, exon 1 of 15)",30,55444286,55475916,31631,2]
["X",69182627,69182864,238,"ENSBGRG00000024233","ENSBGRT00000044759",0,"LRCH2","leucine rich repeats and calponin homology domain containing 2 [Source:HGNC Symbol;Acc:HGNC:29292]","GO:0005515(protein binding)","NA",{"v":2.2e-05,"d":"0.00"},1,"238,",0,-4.66,-4,{"v":18.8,"d":"18.80"},"Exon (ENSBGRT00000044759/ENSBGRG00000024233, exon 1 of 22)",30,69072845,69182864,110020,2]
["X",82052692,82052841,150,"ENSBGRG00000022890","ENSBGRT00000042288",0,"PBDC1","polysaccharide biosynthesis domain containing 1 [Source:HGNC Symbol;Acc:HGNC:28790]","NA","NA",{"v":4.4e-07,"d":"0.00"},2,"30,30,","0,120",-6.36,-5.64,1.86,"Exon (ENSBGRT00000042288/ENSBGRG00000022890, exon 1 of 6)",30,82047916,82052841,4926,2]
["X",85356951,85357190,240,"ENSBGRG00000025208","ENSBGRT00000046693",90564,"NHSL2","NHS like 2 [Source:HGNC Symbol;Acc:HGNC:33737]","NA","NA",{"v":1.9e-05,"d":"0.00"},1,"240,",0,-4.72,-4.05,{"v":2.7,"d":"2.70"},"Exon (ENSBGRT00000046693/ENSBGRG00000025208, exon 2 of 4)",30,85352017,85447754,95738,2]
["X",85357430,85357580,151,"ENSBGRG00000025208","ENSBGRT00000046693",90174,"NHSL2","NHS like 2 [Source:HGNC Symbol;Acc:HGNC:33737]","NA","NA",{"v":1.9E-3,"d":"0.00"},1,"151,",0,-2.73,-2.15,2.87,"Exon (ENSBGRT00000046693/ENSBGRG00000025208, exon 2 of 4)",30,85352017,85447754,95738,2]
["X",85956630,85956839,210,"ENSBGRG00000025338","ENSBGRT00000046871",44695,"OGT","O-linked N-acetylglucosamine (GlcNAc) transferase [Source:HGNC Symbol;Acc:HGNC:8127]","GO:0000123(histone acetyltransferase complex);GO:0005515(protein binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006110(regulation of glycolytic process);GO:0006111(regulation of gluconeogenesis);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006493(protein O-linked glycosylation);GO:0006915(apoptotic process);GO:0016262(protein N-acetylglucosaminyltransferase activity);GO:0016485(protein processing);GO:0016757(transferase activity, transferring glycosyl groups);GO:0017122(protein N-acetylglucosaminyltransferase complex);GO:0031397(negative regulation of protein ubiquitination);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032868(response to insulin);GO:0032922(circadian regulation of gene expression);GO:0032991(protein-containing complex);GO:0035020(regulation of Rac protein signal transduction);GO:0043981(histone H4-K5 acetylation);GO:0043982(histone H4-K8 acetylation);GO:0043984(histone H4-K16 acetylation);GO:0043995(histone acetyltransferase activity (H4-K5 specific));GO:0043996(histone acetyltransferase activity (H4-K8 specific));GO:0045862(positive regulation of proteolysis);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046626(regulation of insulin receptor signaling pathway);GO:0046972(histone acetyltransferase activity (H4-K16 specific));GO:0048015(phosphatidylinositol-mediated signaling);GO:0061087(positive regulation of histone H3-K27 methylation);GO:0080182(histone H3-K4 trimethylation);GO:0097363(protein O-GlcNAc transferase activity);GO:0120162(positive regulation of cold-induced thermogenesis)","00514(Other types of O-glycan biosynthesis);04931(Insulin resistance)",{"v":6.3e-16,"d":"0.00"},1,"210,",0,{"v":-15.2,"d":"-15.20"},{"v":-14.3,"d":"-14.30"},1.98,"3' UTR",30,85956630,86001534,44905,2]
["X",85957527,85965872,8346,"ENSBGRG00000025338","ENSBGRT00000046871",35662,"OGT","O-linked N-acetylglucosamine (GlcNAc) transferase [Source:HGNC Symbol;Acc:HGNC:8127]","GO:0000123(histone acetyltransferase complex);GO:0005515(protein binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006110(regulation of glycolytic process);GO:0006111(regulation of gluconeogenesis);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006493(protein O-linked glycosylation);GO:0006915(apoptotic process);GO:0016262(protein N-acetylglucosaminyltransferase activity);GO:0016485(protein processing);GO:0016757(transferase activity, transferring glycosyl groups);GO:0017122(protein N-acetylglucosaminyltransferase complex);GO:0031397(negative regulation of protein ubiquitination);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032868(response to insulin);GO:0032922(circadian regulation of gene expression);GO:0032991(protein-containing complex);GO:0035020(regulation of Rac protein signal transduction);GO:0043981(histone H4-K5 acetylation);GO:0043982(histone H4-K8 acetylation);GO:0043984(histone H4-K16 acetylation);GO:0043995(histone acetyltransferase activity (H4-K5 specific));GO:0043996(histone acetyltransferase activity (H4-K8 specific));GO:0045862(positive regulation of proteolysis);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046626(regulation of insulin receptor signaling pathway);GO:0046972(histone acetyltransferase activity (H4-K16 specific));GO:0048015(phosphatidylinositol-mediated signaling);GO:0061087(positive regulation of histone H3-K27 methylation);GO:0080182(histone H3-K4 trimethylation);GO:0097363(protein O-GlcNAc transferase activity);GO:0120162(positive regulation of cold-induced thermogenesis)","00514(Other types of O-glycan biosynthesis);04931(Insulin resistance)",0,3,"629,124,85,","0,7893,8261",-1470,"-Inf",5.37,"3' UTR",30,85956630,86001534,44905,2]
["X",86083736,86089417,5682,"ENSBGRG00000025461","ENSBGRT00000047675",82182,"ENSBGRG00000025461","NA","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005669(transcription factor TFIID complex);GO:0006352(DNA-templated transcription, initiation);GO:0006355(regulation of transcription, DNA-templated)","03022(Basal transcription factors)",{"v":2.5e-11,"d":"0.00"},3,"207,146,8,","0,3934,5674",{"v":-10.6,"d":"-10.60"},-9.77,2.81,"Exon (ENSBGRT00000047675/ENSBGRG00000025461, exon 40 of 42)",30,86083736,86171599,87864,2]
["X",86192937,86193349,413,"ENSBGRG00000025796","ENSBGRT00000047691",961,"ENSBGRG00000025796","NA","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007264(small GTPase mediated signal transduction)","05132(Salmonella infection);05100(Bacterial invasion of epithelial cells)",{"v":2E-12,"d":"0.00"},1,"413,",0,{"v":-11.7,"d":"-11.70"},{"v":-10.9,"d":"-10.90"},6.19,"Exon (ENSBGRT00000047691/ENSBGRG00000025796, exon 2 of 2)",30,86192937,86194310,1374,2]
["X",86270831,86271959,1129,"ENSBGRG00000025854","ENSBGRT00000047801",4813,"NONO","non-POU domain containing octamer binding [Source:HGNC Symbol;Acc:HGNC:7871]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001650(fibrillar center);GO:0002218(activation of innate immune response);GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016363(nuclear matrix);GO:0042382(paraspeckles);GO:0042752(regulation of circadian rhythm);GO:0042802(identical protein binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0070888(E-box binding);GO:0090575(RNA polymerase II transcription factor complex);GO:1903377(negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway)","NA",{"v":1E-181,"d":"0.00"},3,"88,85,185,","0,515,944",-181,-179,1.72,"Exon (ENSBGRT00000047801/ENSBGRG00000025854, exon 6 of 11)",30,86268951,86276772,7822,2]
["X",86333812,86333871,60,"ENSBGRG00000025862","ENSBGRT00000047817",736,"GJB1","gap junction protein beta 1 [Source:HGNC Symbol;Acc:HGNC:4283]","GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005921(gap junction);GO:0005922(connexin complex);GO:0007154(cell communication)","NA",{"v":0.011,"d":"0.01"},1,"60,",0,-1.95,-1.18,8.91,"Exon (ENSBGRT00000047817/ENSBGRG00000025862, exon 1 of 1)",30,86333753,86334607,855,2]
["X",86389196,86389614,419,"ENSBGRG00000025879","ENSBGRT00000047843",22589,"NLGN3","neuroligin 3 [Source:HGNC Symbol;Acc:HGNC:14289]","GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007612(learning);GO:0008542(visual learning);GO:0009986(cell surface);GO:0016020(membrane);GO:0030534(adult behavior);GO:0035176(social behavior);GO:0042043(neurexin family protein binding);GO:0045202(synapse);GO:0048709(oligodendrocyte differentiation);GO:0050804(modulation of chemical synaptic transmission);GO:0050808(synapse organization);GO:0051965(positive regulation of synapse assembly);GO:0051966(regulation of synaptic transmission, glutamatergic);GO:0051968(positive regulation of synaptic transmission, glutamatergic);GO:0060076(excitatory synapse);GO:0060079(excitatory postsynaptic potential);GO:0060080(inhibitory postsynaptic potential);GO:0060291(long-term synaptic potentiation);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0071625(vocalization behavior);GO:0090394(negative regulation of excitatory postsynaptic potential);GO:0097104(postsynaptic membrane assembly);GO:0097110(scaffold protein binding);GO:1900271(regulation of long-term synaptic potentiation);GO:2000310(regulation of NMDA receptor activity);GO:2000311(regulation of AMPA receptor activity);GO:2000331(regulation of terminal button organization);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000809(positive regulation of synaptic vesicle clustering);GO:2000969(positive regulation of AMPA receptor activity)","04514(Cell adhesion molecules (CAMs))",{"v":2.5e-08,"d":"0.00"},1,"419,",0,{"v":-7.6,"d":"-7.60"},-6.85,2.49,"Exon (ENSBGRT00000047843/ENSBGRG00000025879, exon 6 of 7)",30,86389104,86412203,23100,2]
["X",86390698,86391356,659,"ENSBGRG00000025879","ENSBGRT00000047843",20847,"NLGN3","neuroligin 3 [Source:HGNC Symbol;Acc:HGNC:14289]","GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007612(learning);GO:0008542(visual learning);GO:0009986(cell surface);GO:0016020(membrane);GO:0030534(adult behavior);GO:0035176(social behavior);GO:0042043(neurexin family protein binding);GO:0045202(synapse);GO:0048709(oligodendrocyte differentiation);GO:0050804(modulation of chemical synaptic transmission);GO:0050808(synapse organization);GO:0051965(positive regulation of synapse assembly);GO:0051966(regulation of synaptic transmission, glutamatergic);GO:0051968(positive regulation of synaptic transmission, glutamatergic);GO:0060076(excitatory synapse);GO:0060079(excitatory postsynaptic potential);GO:0060080(inhibitory postsynaptic potential);GO:0060291(long-term synaptic potentiation);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0071625(vocalization behavior);GO:0090394(negative regulation of excitatory postsynaptic potential);GO:0097104(postsynaptic membrane assembly);GO:0097110(scaffold protein binding);GO:1900271(regulation of long-term synaptic potentiation);GO:2000310(regulation of NMDA receptor activity);GO:2000311(regulation of AMPA receptor activity);GO:2000331(regulation of terminal button organization);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000809(positive regulation of synaptic vesicle clustering);GO:2000969(positive regulation of AMPA receptor activity)","04514(Cell adhesion molecules (CAMs))",{"v":1.2E-8,"d":"0.00"},2,"81,576,","0,83",-7.91,-7.15,5.61,"Exon (ENSBGRT00000047843/ENSBGRG00000025879, exon 4 of 7)",30,86389104,86412203,23100,2]
["X",86461760,86461937,178,"ENSBGRG00000026112","ENSBGRT00000048304",89,"FOXO4","forkhead box O4 [Source:HGNC Symbol;Acc:HGNC:7139]","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0007050(cell cycle arrest);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016525(negative regulation of angiogenesis);GO:0016607(nuclear speck);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048863(stem cell differentiation);GO:0051151(negative regulation of smooth muscle cell differentiation);GO:0070317(negative regulation of G0 to G1 transition);GO:0071158(positive regulation of cell cycle arrest);GO:1990837(sequence-specific double-stranded DNA binding)","04014(Ras signaling pathway);04068(FoxO signaling pathway)",{"v":7.9e-13,"d":"0.00"},1,"178,",0,{"v":-12.1,"d":"-12.10"},{"v":-11.3,"d":"-11.30"},2.15,"Exon (ENSBGRT00000048304/ENSBGRG00000026112, exon 1 of 4)",30,86455596,86462026,6431,2]
["X",86934184,86935662,1479,"ENSBGRG00000007926","ENSBGRT00000014636",52446,"DLG3","discs large MAGUK scaffold protein 3 [Source:HGNC Symbol;Acc:HGNC:2902]","GO:0001736(establishment of planar polarity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005923(bicellular tight junction);GO:0010923(negative regulation of phosphatase activity);GO:0019900(kinase binding);GO:0019902(phosphatase binding);GO:0031625(ubiquitin protein ligase binding);GO:0032281(AMPA glutamate receptor complex);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0098978(glutamatergic synapse);GO:0099072(regulation of postsynaptic membrane neurotransmitter receptor levels)","04390(Hippo signaling pathway);04530(Tight junction);05165(Human papillomavirus infection)",{"v":1.6e-55,"d":"0.00"},2,"391,26,","0,1453",{"v":-54.8,"d":"-54.80"},{"v":-53.5,"d":"-53.50"},5.38,"3' UTR",30,86934154,86988108,53955,2]
["X",86985342,86985431,90,"ENSBGRG00000007926","ENSBGRT00000014636",2677,"DLG3","discs large MAGUK scaffold protein 3 [Source:HGNC Symbol;Acc:HGNC:2902]","GO:0001736(establishment of planar polarity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005923(bicellular tight junction);GO:0010923(negative regulation of phosphatase activity);GO:0019900(kinase binding);GO:0019902(phosphatase binding);GO:0031625(ubiquitin protein ligase binding);GO:0032281(AMPA glutamate receptor complex);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0098978(glutamatergic synapse);GO:0099072(regulation of postsynaptic membrane neurotransmitter receptor levels)","04390(Hippo signaling pathway);04530(Tight junction);05165(Human papillomavirus infection)",{"v":0.0039,"d":"0.00"},1,"90,",0,-2.41,-1.85,9.91,"5' UTR",30,86934154,86988108,53955,2]
["X",87009095,87009424,330,"ENSBGRG00000008136","ENSBGRT00000014886",9714,"GDPD2","glycerophosphodiester phosphodiesterase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:25974]","GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0030027(lamellipodium);GO:0045669(positive regulation of osteoblast differentiation);GO:0090527(actin filament reorganization)","NA",0.02,1,"330,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"3' UTR",30,87008915,87019138,10224,2]
["X",87024747,87024837,91,"ENSBGRG00000008356","ENSBGRT00000015266",138635,"KIF4A","kinesin family member 4A [Source:HGNC Symbol;Acc:HGNC:13339]","GO:0000281(mitotic cytokinesis);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0030496(midbody);GO:0051256(mitotic spindle midzone assembly)","NA",{"v":0.046,"d":"0.05"},1,"91,",0,-1.34,{"v":-0.854,"d":"-0.85"},2.09,"Exon (ENSBGRT00000015266/ENSBGRG00000008356, exon 31 of 32)",30,87024285,87163472,139188,2]
["X",87170628,87171668,1041,"ENSBGRG00000008523","ENSBGRT00000015532",30,"ENSBGRG00000008523","NA","GO:0003924(GTPase activity);GO:0005525(GTP binding)","NA",{"v":2E-19,"d":"0.00"},3,"290,73,21,","0,494,1020",{"v":-18.7,"d":"-18.70"},{"v":-17.7,"d":"-17.70"},9.91,"Exon (ENSBGRT00000015532/ENSBGRG00000008523, exon 1 of 3)",30,87170628,87171698,1071,2]
["X",88067916,88068714,799,"ENSBGRG00000009407","ENSBGRT00000017250",0,"FAM155B","family with sequence similarity 155 member B [Source:HGNC Symbol;Acc:HGNC:30701]","NA","NA",{"v":2.1e-08,"d":"0.00"},1,"799,",0,-7.68,-6.92,{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000017250/ENSBGRG00000009407, exon 1 of 3)",30,88036630,88068714,32085,2]
["X",88447862,88448273,412,"ENSBGRG00000009422","ENSBGRT00000017286",1941,"ENSBGRG00000009422","NA","NA","NA",{"v":5e-59,"d":"0.00"},1,"412,",0,{"v":-58.3,"d":"-58.30"},{"v":-57.1,"d":"-57.10"},8.54,"Exon (ENSBGRT00000017286/ENSBGRG00000009422, exon 2 of 2)",30,88447833,88450214,2382,2]
["X",88458158,88458307,150,"ENSBGRG00000009478","ENSBGRT00000017387",2118,"ENSBGRG00000009478","NA","NA","NA",{"v":0.0042,"d":"0.00"},1,"150,",0,-2.38,-1.82,2.23,"Exon (ENSBGRT00000017387/ENSBGRG00000009478, exon 2 of 2)",30,88457681,88460425,2745,2]
["X",88870140,88870764,625,"ENSBGRG00000009492","ENSBGRT00000017469",14310,"EFNB1","ephrin B1 [Source:HGNC Symbol;Acc:HGNC:3226]","GO:0001755(neural crest cell migration);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007411(axon guidance);GO:0009880(embryonic pattern specification);GO:0016020(membrane);GO:0031295(T cell costimulation);GO:0042102(positive regulation of T cell proliferation);GO:0045121(membrane raft);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway)","04360(Axon guidance)",{"v":6.3e-20,"d":"0.00"},1,"625,",0,{"v":-19.2,"d":"-19.20"},{"v":-18.3,"d":"-18.30"},3.15,"3' UTR",30,88857620,88885074,27455,2]
["X",88996099,88997109,1011,"ENSBGRG00000009592","ENSBGRT00000017580",40398,"STARD8","StAR related lipid transfer domain containing 8 [Source:HGNC Symbol;Acc:HGNC:19161]","GO:0007165(signal transduction);GO:0008289(lipid binding)","NA",{"v":4.8E-10,"d":"0.00"},2,"612,47,","0,964",-9.32,-8.54,4.12,"Exon (ENSBGRT00000017580/ENSBGRG00000009592, exon 5 of 15)",30,88988942,89037507,48566,2]
["X",89161154,89164720,3567,"ENSBGRG00000009673","ENSBGRT00000017856",25820,"YIPF6","Yip1 domain family member 6 [Source:HGNC Symbol;Acc:HGNC:28304]","GO:0000138(Golgi trans cisterna);GO:0005783(endoplasmic reticulum);GO:0005797(Golgi medial cisterna);GO:0005801(cis-Golgi network);GO:0005802(trans-Golgi network);GO:0016020(membrane);GO:0030134(COPII-coated ER to Golgi transport vesicle);GO:0042802(identical protein binding);GO:0060576(intestinal epithelial cell development)","NA",{"v":0.016,"d":"0.02"},2,"92,58,","0,3509",-1.79,-1.27,1.55,"3' UTR",30,89161154,89190540,29387,2]
["X",90470545,90471444,900,"ENSBGRG00000010012","ENSBGRT00000018343",231772,"AR","androgen receptor [Source:HGNC Symbol;Acc:HGNC:644]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001091(RNA polymerase II general transcription initiation factor binding);GO:0001225(RNA polymerase II transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003073(regulation of systemic arterial blood pressure);GO:0003382(epithelial cell morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0004879(nuclear receptor activity);GO:0005102(signaling receptor binding);GO:0005496(steroid binding);GO:0005497(androgen binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0009566(fertilization);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0016607(nuclear speck);GO:0019102(male somatic sex determination);GO:0019899(enzyme binding);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030522(intracellular receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway);GO:0033327(Leydig cell differentiation);GO:0035264(multicellular organism growth);GO:0042025(host cell nucleus);GO:0042327(positive regulation of phosphorylation);GO:0043410(positive regulation of MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045597(positive regulation of cell differentiation);GO:0045720(negative regulation of integrin biosynthetic process);GO:0045726(positive regulation of integrin biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0048608(reproductive structure development);GO:0048638(regulation of developmental growth);GO:0048645(animal organ formation);GO:0048808(male genitalia morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051117(ATPase binding);GO:0060520(activation of prostate induction by androgen receptor signaling pathway);GO:0060571(morphogenesis of an epithelial fold);GO:0060599(lateral sprouting involved in mammary gland duct morphogenesis);GO:0060685(regulation of prostatic bud formation);GO:0060736(prostate gland growth);GO:0060740(prostate gland epithelium morphogenesis);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis);GO:0060749(mammary gland alveolus development);GO:0060769(positive regulation of epithelial cell proliferation involved in prostate gland development);GO:0061458(reproductive system development);GO:0070974(POU domain binding);GO:0071383(cellular response to steroid hormone stimulus);GO:0071391(cellular response to estrogen stimulus);GO:0071394(cellular response to testosterone stimulus);GO:0072520(seminiferous tubule development);GO:1903076(regulation of protein localization to plasma membrane);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04114(Oocyte meiosis);05200(Pathways in cancer);05215(Prostate cancer)",{"v":1e-129,"d":"0.00"},1,"900,",0,-129,-127,8.42,"3' UTR",30,90470545,90703216,232672,2]
["X",90700430,90700999,570,"ENSBGRG00000010012","ENSBGRT00000018343",2217,"AR","androgen receptor [Source:HGNC Symbol;Acc:HGNC:644]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001091(RNA polymerase II general transcription initiation factor binding);GO:0001225(RNA polymerase II transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003073(regulation of systemic arterial blood pressure);GO:0003382(epithelial cell morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0004879(nuclear receptor activity);GO:0005102(signaling receptor binding);GO:0005496(steroid binding);GO:0005497(androgen binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0009566(fertilization);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0016607(nuclear speck);GO:0019102(male somatic sex determination);GO:0019899(enzyme binding);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030522(intracellular receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway);GO:0033327(Leydig cell differentiation);GO:0035264(multicellular organism growth);GO:0042025(host cell nucleus);GO:0042327(positive regulation of phosphorylation);GO:0043410(positive regulation of MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045597(positive regulation of cell differentiation);GO:0045720(negative regulation of integrin biosynthetic process);GO:0045726(positive regulation of integrin biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0048608(reproductive structure development);GO:0048638(regulation of developmental growth);GO:0048645(animal organ formation);GO:0048808(male genitalia morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051117(ATPase binding);GO:0060520(activation of prostate induction by androgen receptor signaling pathway);GO:0060571(morphogenesis of an epithelial fold);GO:0060599(lateral sprouting involved in mammary gland duct morphogenesis);GO:0060685(regulation of prostatic bud formation);GO:0060736(prostate gland growth);GO:0060740(prostate gland epithelium morphogenesis);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis);GO:0060749(mammary gland alveolus development);GO:0060769(positive regulation of epithelial cell proliferation involved in prostate gland development);GO:0061458(reproductive system development);GO:0070974(POU domain binding);GO:0071383(cellular response to steroid hormone stimulus);GO:0071391(cellular response to estrogen stimulus);GO:0071394(cellular response to testosterone stimulus);GO:0072520(seminiferous tubule development);GO:1903076(regulation of protein localization to plasma membrane);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04114(Oocyte meiosis);05200(Pathways in cancer);05215(Prostate cancer)",{"v":2.5e-20,"d":"0.00"},1,"570,",0,{"v":-19.6,"d":"-19.60"},{"v":-18.7,"d":"-18.70"},{"v":11.4,"d":"11.40"},"Exon (ENSBGRT00000018343/ENSBGRG00000010012, exon 1 of 9)",30,90470545,90703216,232672,2]
["X",90701299,90702287,989,"ENSBGRG00000010012","ENSBGRT00000018343",929,"AR","androgen receptor [Source:HGNC Symbol;Acc:HGNC:644]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001091(RNA polymerase II general transcription initiation factor binding);GO:0001225(RNA polymerase II transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003073(regulation of systemic arterial blood pressure);GO:0003382(epithelial cell morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0004879(nuclear receptor activity);GO:0005102(signaling receptor binding);GO:0005496(steroid binding);GO:0005497(androgen binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0009566(fertilization);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0016607(nuclear speck);GO:0019102(male somatic sex determination);GO:0019899(enzyme binding);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030522(intracellular receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway);GO:0033327(Leydig cell differentiation);GO:0035264(multicellular organism growth);GO:0042025(host cell nucleus);GO:0042327(positive regulation of phosphorylation);GO:0043410(positive regulation of MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045597(positive regulation of cell differentiation);GO:0045720(negative regulation of integrin biosynthetic process);GO:0045726(positive regulation of integrin biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0048608(reproductive structure development);GO:0048638(regulation of developmental growth);GO:0048645(animal organ formation);GO:0048808(male genitalia morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051117(ATPase binding);GO:0060520(activation of prostate induction by androgen receptor signaling pathway);GO:0060571(morphogenesis of an epithelial fold);GO:0060599(lateral sprouting involved in mammary gland duct morphogenesis);GO:0060685(regulation of prostatic bud formation);GO:0060736(prostate gland growth);GO:0060740(prostate gland epithelium morphogenesis);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis);GO:0060749(mammary gland alveolus development);GO:0060769(positive regulation of epithelial cell proliferation involved in prostate gland development);GO:0061458(reproductive system development);GO:0070974(POU domain binding);GO:0071383(cellular response to steroid hormone stimulus);GO:0071391(cellular response to estrogen stimulus);GO:0071394(cellular response to testosterone stimulus);GO:0072520(seminiferous tubule development);GO:1903076(regulation of protein localization to plasma membrane);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04114(Oocyte meiosis);05200(Pathways in cancer);05215(Prostate cancer)",{"v":4e-46,"d":"0.00"},1,"989,",0,{"v":-45.4,"d":"-45.40"},{"v":-44.3,"d":"-44.30"},{"v":17.6,"d":"17.60"},"Exon (ENSBGRT00000018343/ENSBGRG00000010012, exon 1 of 9)",30,90470545,90703216,232672,2]
["X",90702407,90702886,480,"ENSBGRG00000010012","ENSBGRT00000018343",330,"AR","androgen receptor [Source:HGNC Symbol;Acc:HGNC:644]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001091(RNA polymerase II general transcription initiation factor binding);GO:0001225(RNA polymerase II transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003073(regulation of systemic arterial blood pressure);GO:0003382(epithelial cell morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0004879(nuclear receptor activity);GO:0005102(signaling receptor binding);GO:0005496(steroid binding);GO:0005497(androgen binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0009566(fertilization);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0016607(nuclear speck);GO:0019102(male somatic sex determination);GO:0019899(enzyme binding);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030522(intracellular receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway);GO:0033327(Leydig cell differentiation);GO:0035264(multicellular organism growth);GO:0042025(host cell nucleus);GO:0042327(positive regulation of phosphorylation);GO:0043410(positive regulation of MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045597(positive regulation of cell differentiation);GO:0045720(negative regulation of integrin biosynthetic process);GO:0045726(positive regulation of integrin biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0048608(reproductive structure development);GO:0048638(regulation of developmental growth);GO:0048645(animal organ formation);GO:0048808(male genitalia morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051117(ATPase binding);GO:0060520(activation of prostate induction by androgen receptor signaling pathway);GO:0060571(morphogenesis of an epithelial fold);GO:0060599(lateral sprouting involved in mammary gland duct morphogenesis);GO:0060685(regulation of prostatic bud formation);GO:0060736(prostate gland growth);GO:0060740(prostate gland epithelium morphogenesis);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis);GO:0060749(mammary gland alveolus development);GO:0060769(positive regulation of epithelial cell proliferation involved in prostate gland development);GO:0061458(reproductive system development);GO:0070974(POU domain binding);GO:0071383(cellular response to steroid hormone stimulus);GO:0071391(cellular response to estrogen stimulus);GO:0071394(cellular response to testosterone stimulus);GO:0072520(seminiferous tubule development);GO:1903076(regulation of protein localization to plasma membrane);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04114(Oocyte meiosis);05200(Pathways in cancer);05215(Prostate cancer)",{"v":2.5e-19,"d":"0.00"},1,"480,",0,{"v":-18.6,"d":"-18.60"},{"v":-17.7,"d":"-17.70"},{"v":20.8,"d":"20.80"},"5' UTR",30,90470545,90703216,232672,2]
["X",90705822,90706239,418,"ENSBGRG00000010049","ENSBGRT00000018401",1791,"ENSBGRG00000010049","NA","NA","NA",{"v":1E-4,"d":"0.00"},1,"418,",0,-4,-3.36,5.94,"Exon (ENSBGRT00000018401/ENSBGRG00000010049, exon 2 of 2)",30,90704840,90708030,3191,2]
["X",92228030,92228475,446,"ENSBGRG00000010181","ENSBGRT00000018656",1816,"ENSBGRG00000010181","NA","NA","NA",{"v":2.3e-08,"d":"0.00"},1,"446,",0,-7.63,-6.88,{"v":14.9,"d":"14.90"},"Exon (ENSBGRT00000018732/ENSBGRG00000010191, exon 3 of 3)",30,92226214,92242297,16084,1]
["X",92430659,92430719,61,"ENSBGRG00000010277","ENSBGRT00000018911",215882,"SLC9A7","solute carrier family 9 member A7 [Source:HGNC Symbol;Acc:HGNC:17123]","GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0006885(regulation of pH);GO:0015299(solute:proton antiporter activity);GO:0015385(sodium:proton antiporter activity);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport)","NA",{"v":0.044,"d":"0.04"},1,"61,",0,-1.36,{"v":-0.873,"d":"-0.87"},1.65,"Exon (ENSBGRT00000018911/ENSBGRG00000010277, exon 19 of 19)",30,92430539,92646601,216063,2]
["X",93135631,93138642,3012,"ENSBGRG00000010871","ENSBGRT00000019905",90,"NDUFB11","NADH:ubiquinone oxidoreductase subunit B11 [Source:HGNC Symbol;Acc:HGNC:20372]","GO:0005747(mitochondrial respiratory chain complex I);GO:0032981(mitochondrial respiratory chain complex I assembly)","00190(Oxidative phosphorylation);04723(Retrograde endocannabinoid signaling);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":2e-59,"d":"0.00"},2,"123,117,","0,2895",{"v":-58.7,"d":"-58.70"},{"v":-57.4,"d":"-57.40"},3.47,"Exon (ENSBGRT00000019905/ENSBGRG00000010871, exon 1 of 4)",30,93102431,93138732,36302,2]
["X",93412120,93413843,1724,"ENSBGRG00000015259","ENSBGRT00000028421",12812,"ZNF41","zinc finger protein 41 [Source:HGNC Symbol;Acc:HGNC:13107]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.3e-29,"d":"0.00"},2,"566,656,","0,1068",{"v":-28.9,"d":"-28.90"},{"v":-27.9,"d":"-27.90"},9.16,"Exon (ENSBGRT00000028421/ENSBGRG00000015259, exon 6 of 7)",30,93412120,93426655,14536,2]
["X",93413962,93414652,691,"ENSBGRG00000015259","ENSBGRT00000028421",12003,"ZNF41","zinc finger protein 41 [Source:HGNC Symbol;Acc:HGNC:13107]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":5e-26,"d":"0.00"},2,"542,114,","0,577",{"v":-25.3,"d":"-25.30"},{"v":-24.3,"d":"-24.30"},{"v":6.8,"d":"6.80"},"Exon (ENSBGRT00000028421/ENSBGRG00000015259, exon 5 of 7)",30,93412120,93426655,14536,2]
["X",93595107,93595166,60,"ENSBGRG00000015712","ENSBGRT00000028844",62210,"SYN1","synapsin I [Source:HGNC Symbol;Acc:HGNC:11494]","GO:0000795(synaptonemal complex);GO:0005524(ATP binding);GO:0005856(cytoskeleton);GO:0007269(neurotransmitter secretion);GO:0008021(synaptic vesicle);GO:0014069(postsynaptic density);GO:0019901(protein kinase binding);GO:0030424(axon);GO:0030672(synaptic vesicle membrane);GO:0042802(identical protein binding);GO:0045202(synapse);GO:0048786(presynaptic active zone);GO:0097091(synaptic vesicle clustering);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098693(regulation of synaptic vesicle cycle);GO:0098793(presynapse);GO:0099504(synaptic vesicle cycle)","NA",{"v":4.3E-3,"d":"0.00"},1,"60,",0,-2.37,-1.81,2.04,"3' UTR",30,93595017,93657376,62360,2]
["X",93664581,93667040,2460,"ENSBGRG00000016091","ENSBGRT00000029558",3965,"CFP","complement factor properdin [Source:HGNC Symbol;Acc:HGNC:8864]","GO:0005615(extracellular space);GO:0006957(complement activation, alternative pathway);GO:0030141(secretory granule)","05168(Herpes simplex infection)",{"v":4e-27,"d":"0.00"},4,"13,240,275,12,","0,851,1488,2448",{"v":-26.4,"d":"-26.40"},{"v":-25.4,"d":"-25.40"},5.76,"3' UTR",30,93664428,93671005,6578,2]
["X",93698483,93698781,299,"ENSBGRG00000016358","ENSBGRT00000030112",9971,"UXT","ubiquitously expressed prefoldin like chaperone [Source:HGNC Symbol;Acc:HGNC:12641]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000226(microtubule cytoskeleton organization);GO:0000930(gamma-tubulin complex);GO:0003682(chromatin binding);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005856(cytoskeleton);GO:0007098(centrosome cycle);GO:0048487(beta-tubulin binding)","NA",0.02,1,"299,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"3' UTR",30,93698483,93708752,10270,2]
["X",93800169,93800466,298,"ENSBGRG00000016563","ENSBGRT00000030360",0,"ENSBGRG00000016563","NA","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","04310(Wnt signaling pathway);04340(Hedgehog signaling pathway);05225(Hepatocellular carcinoma);05226(Gastric cancer);05224(Breast cancer);05165(Human papillomavirus infection)",{"v":4e-16,"d":"0.00"},1,"298,",0,{"v":-15.4,"d":"-15.40"},{"v":-14.5,"d":"-14.50"},2.71,"Exon (ENSBGRT00000030360/ENSBGRG00000016563, exon 1 of 1)",30,93799456,93800466,1011,2]
["X",93934301,93935415,1115,"ENSBGRG00000016643","ENSBGRT00000030538",170,"ENSBGRG00000016643","NA","NA","NA",{"v":0.012,"d":"0.01"},2,"26,32,","0,1083",-1.93,{"v":-1.4,"d":"-1.40"},5.94,"Exon (ENSBGRT00000030538/ENSBGRG00000016643, exon 1 of 2)",30,93934301,93935585,1285,2]
["X",94005337,94007265,1929,"ENSBGRG00000016702","ENSBGRT00000030966",7131,"ZNF182","zinc finger protein 182 [Source:HGNC Symbol;Acc:HGNC:13001]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":3.2e-11,"d":"0.00"},3,"521,338,545,","0,973,1384",{"v":-10.5,"d":"-10.50"},-9.66,9.08,"Exon (ENSBGRT00000030966/ENSBGRG00000016702, exon 5 of 7)",30,94005218,94014396,9179,2]
["X",94026395,94027205,811,"ENSBGRG00000016905","ENSBGRT00000031020",4560,"ENSBGRG00000016905","NA","NA","NA",{"v":2e-05,"d":"0.00"},1,"811,",0,{"v":-4.7,"d":"-4.70"},-4.04,{"v":14.9,"d":"14.90"},"Exon (ENSBGRT00000031020/ENSBGRG00000016905, exon 2 of 2)",30,94026395,94031765,5371,2]
["X",94027535,94027924,390,"ENSBGRG00000016905","ENSBGRT00000031020",3841,"ENSBGRG00000016905","NA","NA","NA",{"v":0.018,"d":"0.02"},1,"390,",0,-1.74,-1.22,4.95,"Exon (ENSBGRT00000031020/ENSBGRG00000016905, exon 2 of 2)",30,94026395,94031765,5371,2]
["X",94028254,94028434,181,"ENSBGRG00000016905","ENSBGRT00000031020",3331,"ENSBGRG00000016905","NA","NA","NA",{"v":0.016,"d":"0.02"},1,"181,",0,-1.79,-1.27,3.47,"Exon (ENSBGRT00000031020/ENSBGRG00000016905, exon 2 of 2)",30,94026395,94031765,5371,2]
["X",94028524,94029214,691,"ENSBGRG00000016905","ENSBGRT00000031020",2551,"ENSBGRG00000016905","NA","NA","NA",{"v":7.1e-05,"d":"0.00"},1,"691,",0,-4.15,{"v":-3.5,"d":"-3.50"},3.57,"Exon (ENSBGRT00000031020/ENSBGRG00000016905, exon 2 of 2)",30,94026395,94031765,5371,2]
["X",94029304,94029994,691,"ENSBGRG00000016905","ENSBGRT00000031020",1771,"ENSBGRG00000016905","NA","NA","NA",{"v":2.5e-10,"d":"0.00"},1,"691,",0,-9.61,-8.82,{"v":10.6,"d":"10.60"},"Exon (ENSBGRT00000031020/ENSBGRG00000016905, exon 2 of 2)",30,94026395,94031765,5371,2]
["X",94171527,94171764,238,"ENSBGRG00000017186","ENSBGRT00000031489",7113,"ENSBGRG00000017186","NA","NA","NA",0.02,1,"238,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"3' UTR",30,94170668,94178877,8210,2]
["X",94196696,94196786,91,"ENSBGRG00000017235","ENSBGRT00000032026",393,"SLC38A5","solute carrier family 38 member 5 [Source:HGNC Symbol;Acc:HGNC:18070]","GO:0005290(L-histidine transmembrane transporter activity);GO:0006868(glutamine transport);GO:0015182(L-asparagine transmembrane transporter activity);GO:0015186(L-glutamine transmembrane transporter activity);GO:0015187(glycine transmembrane transporter activity);GO:0015816(glycine transport);GO:0022858(alanine transmembrane transporter activity);GO:0022889(serine transmembrane transporter activity);GO:0032329(serine transport);GO:0089709(L-histidine transmembrane transport);GO:1903713(asparagine transmembrane transport);GO:1904557(L-alanine transmembrane transport)","04727(GABAergic synapse)",0.02,1,"91,",0,-1.69,{"v":-0.977,"d":"-0.98"},7.92,"5' UTR",30,94188969,94197179,8211,2]
["X",94692134,94692432,299,"ENSBGRG00000018055","ENSBGRT00000033028",238,"TIMM17B","translocase of inner mitochondrial membrane 17B [Source:HGNC Symbol;Acc:HGNC:17310]","GO:0005743(mitochondrial inner membrane);GO:0005744(TIM23 mitochondrial import inner membrane translocase complex);GO:0006886(intracellular protein transport);GO:0015450(P-P-bond-hydrolysis-driven protein transmembrane transporter activity);GO:0031305(integral component of mitochondrial inner membrane)","NA",{"v":2e-30,"d":"0.00"},1,"299,",0,{"v":-29.7,"d":"-29.70"},{"v":-28.6,"d":"-28.60"},104,"5' UTR",30,94684799,94692670,7872,2]
["X",94699441,94699530,90,"ENSBGRG00000018196","ENSBGRT00000033528",7042,"SLC35A2","solute carrier family 35 member A2 [Source:HGNC Symbol;Acc:HGNC:11022]","GO:0000139(Golgi membrane);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0015165(pyrimidine nucleotide-sugar transmembrane transporter activity);GO:0016021(integral component of membrane);GO:0090481(pyrimidine nucleotide-sugar transmembrane transport)","NA",{"v":0.00044,"d":"0.00"},1,"90,",0,-3.36,-2.75,2.22,"3' UTR",30,94697953,94706572,8620,2]
["X",94710538,94710864,327,"ENSBGRG00000018477","ENSBGRT00000033918",6225,"PIM2","Pim-2 proto-oncogene, serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:8987]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0008285(negative regulation of cell population proliferation);GO:0009615(response to virus);GO:0043066(negative regulation of apoptotic process);GO:0050821(protein stabilization)","05200(Pathways in cancer);05221(Acute myeloid leukemia)",{"v":1e-55,"d":"0.00"},1,"327,",0,-55,{"v":-53.8,"d":"-53.80"},{"v":4.4,"d":"4.40"},"3' UTR",30,94710538,94717089,6552,2]
["X",94722745,94723314,570,"ENSBGRG00000018572","ENSBGRT00000034432",33598,"OTUD5","OTU deubiquitinase 5 [Source:HGNC Symbol;Acc:HGNC:25402]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0016579(protein deubiquitination);GO:0032496(response to lipopolysaccharide);GO:0061578(Lys63-specific deubiquitinase activity);GO:0070536(protein K63-linked deubiquitination);GO:0071108(protein K48-linked deubiquitination);GO:0101005(ubiquitinyl hydrolase activity);GO:1990380(Lys48-specific deubiquitinase activity)","04622(RIG-I-like receptor signaling pathway)",{"v":7.9e-70,"d":"0.00"},1,"570,",0,{"v":-69.1,"d":"-69.10"},{"v":-67.8,"d":"-67.80"},6.57,"3' UTR",30,94722745,94756912,34168,2]
["X",94756493,94756792,300,"ENSBGRG00000018572","ENSBGRT00000034432",120,"OTUD5","OTU deubiquitinase 5 [Source:HGNC Symbol;Acc:HGNC:25402]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0016579(protein deubiquitination);GO:0032496(response to lipopolysaccharide);GO:0061578(Lys63-specific deubiquitinase activity);GO:0070536(protein K63-linked deubiquitination);GO:0071108(protein K48-linked deubiquitination);GO:0101005(ubiquitinyl hydrolase activity);GO:1990380(Lys48-specific deubiquitinase activity)","04622(RIG-I-like receptor signaling pathway)",{"v":1.6E-15,"d":"0.00"},1,"300,",0,{"v":-14.8,"d":"-14.80"},-14,3.35,"Exon (ENSBGRT00000034432/ENSBGRG00000018572, exon 1 of 9)",30,94722745,94756912,34168,2]
["X",94762888,94762948,61,"ENSBGRG00000018827","ENSBGRT00000034550",9327,"KCND1","potassium voltage-gated channel subfamily D member 1 [Source:HGNC Symbol;Acc:HGNC:6237]","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005515(protein binding);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport)","NA",{"v":0.019,"d":"0.02"},1,"61,",0,-1.73,-1.21,1.56,"Exon (ENSBGRT00000034550/ENSBGRG00000018827, exon 8 of 8)",30,94762591,94772275,9685,2]
["X",94767433,94771851,4419,"ENSBGRG00000018827","ENSBGRT00000034550",424,"KCND1","potassium voltage-gated channel subfamily D member 1 [Source:HGNC Symbol;Acc:HGNC:6237]","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005515(protein binding);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport)","NA",{"v":5e-25,"d":"0.00"},3,"839,324,57,","0,2145,4362",{"v":-24.3,"d":"-24.30"},{"v":-23.3,"d":"-23.30"},{"v":37.6,"d":"37.60"},"5' UTR",30,94762591,94772275,9685,2]
["X",94776503,94777871,1369,"ENSBGRG00000018956","ENSBGRT00000035769",21189,"GRIPAP1","GRIP1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:18706]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle)","04137(Mitophagy - animal);05202(Transcriptional misregulation in cancers);05211(Renal cell carcinoma)",{"v":1e-44,"d":"0.00"},2,"426,112,","0,1257",-44,{"v":-42.9,"d":"-42.90"},{"v":44.6,"d":"44.60"},"3' UTR",30,94776055,94799060,23006,2]
["X",94785560,94785703,144,"ENSBGRG00000018956","ENSBGRT00000035769",13357,"GRIPAP1","GRIP1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:18706]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle)","04137(Mitophagy - animal);05202(Transcriptional misregulation in cancers);05211(Renal cell carcinoma)",{"v":0.00076,"d":"0.00"},2,"34,26,","0,118",-3.12,-2.52,1.17,"Exon (ENSBGRT00000035769/ENSBGRG00000018956, exon 17 of 25)",30,94776055,94799060,23006,2]
["X",94798419,94798777,359,"ENSBGRG00000018956","ENSBGRT00000035769",283,"GRIPAP1","GRIP1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:18706]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle)","04137(Mitophagy - animal);05202(Transcriptional misregulation in cancers);05211(Renal cell carcinoma)",{"v":0.0068,"d":"0.01"},1,"359,",0,-2.17,-1.62,5.94,"5' UTR",30,94776055,94799060,23006,2]
["X",94815454,94816797,1344,"ENSBGRG00000019914","ENSBGRT00000036791",9124,"TFE3","transcription factor binding to IGHM enhancer 3 [Source:HGNC Symbol;Acc:HGNC:11752]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006959(humoral immune response);GO:0045670(regulation of osteoclast differentiation);GO:0045785(positive regulation of cell adhesion);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:1990837(sequence-specific double-stranded DNA binding)","04137(Mitophagy - animal);05202(Transcriptional misregulation in cancers);05211(Renal cell carcinoma)",{"v":1e-137,"d":"0.00"},2,"567,61,","0,1283",-137,-135,{"v":18.3,"d":"18.30"},"3' UTR",30,94814200,94825921,11722,2]
["X",94865248,94865930,683,"ENSBGRG00000020477","ENSBGRT00000037993",4998,"WDR45","WD repeat domain 45 [Source:HGNC Symbol;Acc:HGNC:28912]","GO:0000045(autophagosome assembly);GO:0000407(phagophore assembly site);GO:0005515(protein binding);GO:0006914(autophagy);GO:0009267(cellular response to starvation);GO:0019901(protein kinase binding);GO:1901981(phosphatidylinositol phosphate binding)","NA",{"v":1.3E-25,"d":"0.00"},2,"208,91,","0,592",{"v":-24.9,"d":"-24.90"},{"v":-23.9,"d":"-23.90"},2.61,"3' UTR",30,94865248,94870928,5681,2]
["X",94868509,94870690,2182,"ENSBGRG00000020477","ENSBGRT00000037993",238,"WDR45","WD repeat domain 45 [Source:HGNC Symbol;Acc:HGNC:28912]","GO:0000045(autophagosome assembly);GO:0000407(phagophore assembly site);GO:0005515(protein binding);GO:0006914(autophagy);GO:0009267(cellular response to starvation);GO:0019901(protein kinase binding);GO:1901981(phosphatidylinositol phosphate binding)","NA",{"v":6.3e-18,"d":"0.00"},3,"57,72,528,","0,186,1654",{"v":-17.2,"d":"-17.20"},{"v":-16.3,"d":"-16.30"},3.96,"5' UTR",30,94865248,94870928,5681,2]
["X",94903917,94907187,3271,"ENSBGRG00000020742","ENSBGRT00000038185",0,"GPKOW","G-patch domain and KOW motifs [Source:HGNC Symbol;Acc:HGNC:30677]","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex)","NA",{"v":3.5e-07,"d":"0.00"},2,"430,106,","0,3165",-6.46,-5.74,9.91,"5' UTR",30,94893427,94907187,13761,2]
["X",94923727,94923905,179,"ENSBGRG00000020888","ENSBGRT00000038457",1499,"ENSBGRG00000020888","NA","NA","NA",{"v":0.015,"d":"0.02"},1,"179,",0,-1.81,-1.29,3.96,"Exon (ENSBGRT00000038465/ENSBGRG00000020888, exon 2 of 2)",30,94921184,94925404,4221,2]
["X",94944885,94945424,540,"ENSBGRG00000021159","ENSBGRT00000039076",10818,"PRICKLE3","prickle planar cell polarity protein 3 [Source:HGNC Symbol;Acc:HGNC:6645]","GO:0008270(zinc ion binding)","04310(Wnt signaling pathway)",{"v":1E-134,"d":"0.00"},1,"540,",0,-134,-132,8.54,"3' UTR",30,94944076,94956242,12167,2]
["X",94958601,94958721,121,"ENSBGRG00000021237","ENSBGRT00000039236",12172,"SYP","synaptophysin [Source:HGNC Symbol;Acc:HGNC:11506]","GO:0008021(synaptic vesicle);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0042169(SH2 domain binding);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043195(terminal bouton);GO:0044306(neuron projection terminus);GO:0045202(synapse);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048488(synaptic vesicle endocytosis);GO:0048786(presynaptic active zone);GO:0060076(excitatory synapse);GO:0071310(cellular response to organic substance)","04122(Sulfur relay system)",{"v":1.8E-3,"d":"0.00"},1,"121,",0,-2.74,-2.16,{"v":11.9,"d":"11.90"},"3' UTR",30,94958242,94970893,12652,2]
["X",94958990,94959439,450,"ENSBGRG00000021237","ENSBGRT00000039236",11454,"SYP","synaptophysin [Source:HGNC Symbol;Acc:HGNC:11506]","GO:0008021(synaptic vesicle);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0042169(SH2 domain binding);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043195(terminal bouton);GO:0044306(neuron projection terminus);GO:0045202(synapse);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048488(synaptic vesicle endocytosis);GO:0048786(presynaptic active zone);GO:0060076(excitatory synapse);GO:0071310(cellular response to organic substance)","04122(Sulfur relay system)",{"v":8.3e-08,"d":"0.00"},1,"450,",0,-7.08,-6.35,{"v":11.4,"d":"11.40"},"3' UTR",30,94958242,94970893,12652,2]
["X",94960576,94960636,61,"ENSBGRG00000021237","ENSBGRT00000039236",10257,"SYP","synaptophysin [Source:HGNC Symbol;Acc:HGNC:11506]","GO:0008021(synaptic vesicle);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0042169(SH2 domain binding);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043195(terminal bouton);GO:0044306(neuron projection terminus);GO:0045202(synapse);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048488(synaptic vesicle endocytosis);GO:0048786(presynaptic active zone);GO:0060076(excitatory synapse);GO:0071310(cellular response to organic substance)","04122(Sulfur relay system)",{"v":0.048,"d":"0.05"},1,"61,",0,-1.32,{"v":-0.839,"d":"-0.84"},{"v":3.3,"d":"3.30"},"3' UTR",30,94958242,94970893,12652,2]
["X",94970135,94970374,240,"ENSBGRG00000021237","ENSBGRT00000039236",519,"SYP","synaptophysin [Source:HGNC Symbol;Acc:HGNC:11506]","GO:0008021(synaptic vesicle);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0042169(SH2 domain binding);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043195(terminal bouton);GO:0044306(neuron projection terminus);GO:0045202(synapse);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048488(synaptic vesicle endocytosis);GO:0048786(presynaptic active zone);GO:0060076(excitatory synapse);GO:0071310(cellular response to organic substance)","04122(Sulfur relay system)",{"v":0.0035,"d":"0.00"},1,"240,",0,-2.45,-1.89,7.92,"5' UTR",30,94958242,94970893,12652,2]
["X",94970434,94970703,270,"ENSBGRG00000021237","ENSBGRT00000039236",190,"SYP","synaptophysin [Source:HGNC Symbol;Acc:HGNC:11506]","GO:0008021(synaptic vesicle);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0042169(SH2 domain binding);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043195(terminal bouton);GO:0044306(neuron projection terminus);GO:0045202(synapse);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048488(synaptic vesicle endocytosis);GO:0048786(presynaptic active zone);GO:0060076(excitatory synapse);GO:0071310(cellular response to organic substance)","04122(Sulfur relay system)",0.02,1,"270,",0,{"v":-1.7,"d":"-1.70"},-1.19,7.92,"5' UTR",30,94958242,94970893,12652,2]
["X",94978064,94978652,589,"ENSBGRG00000021471","ENSBGRT00000045644",32043,"CACNA1F","calcium voltage-gated channel subunit alpha1 F [Source:HGNC Symbol;Acc:HGNC:1393]","GO:0005216(ion channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0005891(voltage-gated calcium channel complex);GO:0006811(ion transport);GO:0007601(visual perception);GO:0008331(high voltage-gated calcium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043029(T cell homeostasis);GO:0050856(regulation of T cell receptor signaling pathway);GO:0050908(detection of light stimulus involved in visual perception);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport)","04010(MAPK signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04912(GnRH signaling pathway);04921(Oxytocin signaling pathway);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04727(GABAergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);05010(Alzheimer disease);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));04934(Cushing syndrome)",{"v":1.2E-4,"d":"0.00"},2,"302,28,","0,561",-3.92,-3.28,9.91,"3' UTR",30,94978064,95010695,32632,2]
["X",95349295,95351665,2371,"ENSBGRG00000025443","ENSBGRT00000047038",0,"ENSBGRG00000025443","NA","NA","NA",{"v":3.2e-16,"d":"0.00"},2,"1086,13,","0,2358",{"v":-15.5,"d":"-15.50"},{"v":-14.6,"d":"-14.60"},7.26,"Exon (ENSBGRT00000047038/ENSBGRG00000025443, exon 1 of 2)",30,95349265,95351665,2401,2]
["X",95747560,95747738,179,"ENSBGRG00000025520","ENSBGRT00000047171",17459,"ENSBGRG00000025520","NA","NA","NA",{"v":1.6e-14,"d":"0.00"},1,"179,",0,{"v":-13.8,"d":"-13.80"},{"v":-12.9,"d":"-12.90"},6.84,"Exon (ENSBGRT00000047171/ENSBGRG00000025520, exon 4 of 5)",30,95746301,95765197,18897,2]
["X",96285654,96286923,1270,"ENSBGRG00000025572","ENSBGRT00000047281",0,"ENSBGRG00000025572","NA","GO:0051015(actin filament binding)","NA",{"v":1.6E-44,"d":"0.00"},2,"246,114,","0,1156",{"v":-43.8,"d":"-43.80"},{"v":-42.6,"d":"-42.60"},3.55,"Exon (ENSBGRT00000047281/ENSBGRG00000025572, exon 1 of 2)",30,96285654,96286923,1270,2]
["X",96991862,96995939,4078,"ENSBGRG00000025627","ENSBGRT00000047379",175,"ENSBGRG00000025627","NA","GO:0016787(hydrolase activity)","NA",{"v":1E-14,"d":"0.00"},2,"1,318,","0,3760",-14,{"v":-13.1,"d":"-13.10"},2.44,"Exon (ENSBGRT00000047379/ENSBGRG00000025627, exon 2 of 3)",30,96991862,96996114,4253,2]
["X",96995998,96996114,117,"ENSBGRG00000025627","ENSBGRT00000047379",0,"ENSBGRG00000025627","NA","GO:0016787(hydrolase activity)","NA",{"v":7.8e-06,"d":"0.00"},1,"117,",0,-5.11,-4.42,2.92,"Exon (ENSBGRT00000047379/ENSBGRG00000025627, exon 1 of 3)",30,96991862,96996114,4253,2]
["X",97231541,97234145,2605,"ENSBGRG00000025638","ENSBGRT00000047400",0,"GSPT2","G1 to S phase transition 2 [Source:HGNC Symbol;Acc:HGNC:4622]","GO:0003924(GTPase activity);GO:0005525(GTP binding)","03015(mRNA surveillance pathway)",{"v":1E-156,"d":"0.00"},3,"895,948,47,","0,932,2558",-156,-154,7.61,"Exon (ENSBGRT00000047400/ENSBGRG00000025638, exon 1 of 3)",30,97231541,97234145,2605,2]
["X",98238710,98240344,1635,"ENSBGRG00000025771","ENSBGRT00000047836",30329,"KDM5C","lysine demethylase 5C [Source:HGNC Symbol;Acc:HGNC:11114]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":1E-168,"d":"0.00"},5,"270,200,79,447,113,","0,378,712,1073,1522",-168,-166,6.59,"Exon (ENSBGRT00000047836/ENSBGRG00000025771, exon 24 of 28)",30,98238620,98270673,32054,2]
["X",98241569,98242576,1008,"ENSBGRG00000025771","ENSBGRT00000047836",28097,"KDM5C","lysine demethylase 5C [Source:HGNC Symbol;Acc:HGNC:11114]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":1E-107,"d":"0.00"},2,"75,345,","0,663",-107,-106,2.47,"Exon (ENSBGRT00000047836/ENSBGRG00000025771, exon 20 of 28)",30,98238620,98270673,32054,2]
["X",98262146,98262462,317,"ENSBGRG00000025771","ENSBGRT00000047836",8211,"KDM5C","lysine demethylase 5C [Source:HGNC Symbol;Acc:HGNC:11114]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":1.9e-08,"d":"0.00"},2,"149,62,","0,255",-7.72,-6.97,1.38,"Exon (ENSBGRT00000047836/ENSBGRG00000025771, exon 6 of 28)",30,98238620,98270673,32054,2]
["X",98296745,98297044,300,"ENSBGRG00000025892","ENSBGRT00000047945",31901,"IQSEC2","IQ motif and Sec7 domain ArfGEF 2 [Source:HGNC Symbol;Acc:HGNC:29059]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0032012(regulation of ARF protein signal transduction);GO:0050804(modulation of chemical synaptic transmission);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098696(regulation of neurotransmitter receptor localization to postsynaptic specialization membrane)","04144(Endocytosis)",{"v":3.8e-10,"d":"0.00"},1,"300,",0,-9.42,-8.63,2.87,"Exon (ENSBGRT00000047945/ENSBGRG00000025892, exon 5 of 16)",30,98283184,98328945,45762,2]
["X",98300043,98312284,12242,"ENSBGRG00000025892","ENSBGRT00000047945",16661,"IQSEC2","IQ motif and Sec7 domain ArfGEF 2 [Source:HGNC Symbol;Acc:HGNC:29059]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0032012(regulation of ARF protein signal transduction);GO:0050804(modulation of chemical synaptic transmission);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098696(regulation of neurotransmitter receptor localization to postsynaptic specialization membrane)","04144(Endocytosis)",{"v":2.9E-5,"d":"0.00"},3,"286,262,22,","0,1139,12220",-4.54,-3.88,2.56,"3' UTR",30,98283184,98328945,45762,2]
["X",98373363,98373902,540,"ENSBGRG00000025892","ENSBGRT00000047926",150,"IQSEC2","IQ motif and Sec7 domain ArfGEF 2 [Source:HGNC Symbol;Acc:HGNC:29059]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0032012(regulation of ARF protein signal transduction);GO:0050804(modulation of chemical synaptic transmission);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098696(regulation of neurotransmitter receptor localization to postsynaptic specialization membrane)","04144(Endocytosis)",{"v":1.1e-06,"d":"0.00"},1,"540,",0,-5.95,-5.24,3.96,"Exon (ENSBGRT00000047926/ENSBGRG00000025892, exon 1 of 16)",30,98283184,98374052,90869,2]
["X",98443684,98444566,883,"ENSBGRG00000025945","ENSBGRT00000048022",38994,"ENSBGRG00000025945","NA","NA","04110(Cell cycle);04114(Oocyte meiosis)",{"v":1E-10,"d":"0.00"},2,"63,147,","0,736",-10,-9.23,2.64,"Exon (ENSBGRT00000048022/ENSBGRG00000025945, exon 24 of 29)",30,98441200,98483560,42361,2]
["X",98455481,98465338,9858,"ENSBGRG00000025945","ENSBGRT00000048022",18222,"ENSBGRG00000025945","NA","NA","04110(Cell cycle);04114(Oocyte meiosis)",{"v":2.5e-35,"d":"0.00"},5,"36,138,142,107,57,","0,1045,5222,9596,9801",{"v":-34.6,"d":"-34.60"},{"v":-33.5,"d":"-33.50"},3.58,"Exon (ENSBGRT00000048022/ENSBGRG00000025945, exon 18 of 29)",30,98441200,98483560,42361,2]
["X",98466936,98467149,214,"ENSBGRG00000025945","ENSBGRT00000048022",16411,"ENSBGRG00000025945","NA","NA","04110(Cell cycle);04114(Oocyte meiosis)",{"v":0.004,"d":"0.00"},2,"101,20,","0,194",{"v":-2.4,"d":"-2.40"},-1.84,1.71,"Exon (ENSBGRT00000048022/ENSBGRG00000025945, exon 14 of 29)",30,98441200,98483560,42361,2]
["X",98467269,98468461,1193,"ENSBGRG00000025945","ENSBGRT00000048022",15099,"ENSBGRG00000025945","NA","NA","04110(Cell cycle);04114(Oocyte meiosis)",{"v":6.3E-22,"d":"0.00"},2,"47,193,","0,1000",{"v":-21.2,"d":"-21.20"},{"v":-20.2,"d":"-20.20"},2.53,"Exon (ENSBGRT00000048022/ENSBGRG00000025945, exon 13 of 29)",30,98441200,98483560,42361,2]
["X",98483380,98483560,181,"ENSBGRG00000025945","ENSBGRT00000048022",0,"ENSBGRG00000025945","NA","NA","04110(Cell cycle);04114(Oocyte meiosis)",{"v":0.012,"d":"0.01"},1,"181,",0,-1.93,{"v":-1.4,"d":"-1.40"},7.92,"Exon (ENSBGRT00000048022/ENSBGRG00000025945, exon 1 of 29)",30,98441200,98483560,42361,2]
["X",98500503,98500562,60,"ENSBGRG00000025993","ENSBGRT00000048085",3906,"HSD17B10","hydroxysteroid 17-beta dehydrogenase 10 [Source:HGNC Symbol;Acc:HGNC:4800]","GO:0000049(tRNA binding);GO:0003857(3-hydroxyacyl-CoA dehydrogenase activity);GO:0005739(mitochondrion);GO:0007005(mitochondrion organization);GO:0030283(testosterone dehydrogenase [NAD(P)] activity);GO:0030678(mitochondrial ribonuclease P complex);GO:0051289(protein homotetramerization);GO:0070901(mitochondrial tRNA methylation);GO:0097745(mitochondrial tRNA 5'-end processing);GO:1990180(mitochondrial tRNA 3'-end processing)","00280(Valine, leucine and isoleucine degradation);05010(Alzheimer disease)",{"v":0.0021,"d":"0.00"},1,"60,",0,-2.68,-2.11,1.44,"Exon (ENSBGRT00000048085/ENSBGRG00000025993, exon 8 of 8)",30,98500503,98504468,3966,2]
["X",98634521,98635674,1154,"ENSBGRG00000026013","ENSBGRT00000048135",154842,"HUWE1","HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:30892]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006284(base-excision repair);GO:0006513(protein monoubiquitination);GO:0010637(negative regulation of mitochondrial fusion);GO:0016574(histone ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0032922(circadian regulation of gene expression);GO:0061630(ubiquitin protein ligase activity);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization)","04120(Ubiquitin mediated proteolysis)",{"v":1e-158,"d":"0.00"},2,"388,93,","0,1061",-158,-156,3.46,"Exon (ENSBGRT00000048135/ENSBGRG00000026013, exon 66 of 85)",30,98616053,98790516,174464,2]
["X",98635944,98636004,61,"ENSBGRG00000026013","ENSBGRT00000048135",154512,"HUWE1","HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:30892]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006284(base-excision repair);GO:0006513(protein monoubiquitination);GO:0010637(negative regulation of mitochondrial fusion);GO:0016574(histone ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0032922(circadian regulation of gene expression);GO:0061630(ubiquitin protein ligase activity);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization)","04120(Ubiquitin mediated proteolysis)",{"v":0.0069,"d":"0.01"},1,"61,",0,-2.16,-1.62,1.18,"Exon (ENSBGRT00000048135/ENSBGRG00000026013, exon 66 of 85)",30,98616053,98790516,174464,2]
["X",98647454,98650229,2776,"ENSBGRG00000026013","ENSBGRT00000048135",140287,"HUWE1","HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:30892]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006284(base-excision repair);GO:0006513(protein monoubiquitination);GO:0010637(negative regulation of mitochondrial fusion);GO:0016574(histone ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0032922(circadian regulation of gene expression);GO:0061630(ubiquitin protein ligase activity);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization)","04120(Ubiquitin mediated proteolysis)",{"v":7.9e-51,"d":"0.00"},5,"25,134,99,76,87,","0,211,933,1860,2689",{"v":-50.1,"d":"-50.10"},{"v":-48.9,"d":"-48.90"},2.02,"Exon (ENSBGRT00000048135/ENSBGRG00000026013, exon 50 of 85)",30,98616053,98790516,174464,2]
["X",98667224,98667603,380,"ENSBGRG00000026013","ENSBGRT00000048135",122913,"HUWE1","HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:30892]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006284(base-excision repair);GO:0006513(protein monoubiquitination);GO:0010637(negative regulation of mitochondrial fusion);GO:0016574(histone ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0032922(circadian regulation of gene expression);GO:0061630(ubiquitin protein ligase activity);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization)","04120(Ubiquitin mediated proteolysis)",{"v":5.1E-5,"d":"0.00"},2,"43,48,","0,332",-4.29,-3.64,1.41,"Exon (ENSBGRT00000048135/ENSBGRG00000026013, exon 40 of 85)",30,98616053,98790516,174464,2]
["X",99438106,99438435,330,"ENSBGRG00000026090","ENSBGRT00000048250",136280,"WNK3","WNK lysine deficient protein kinase 3 [Source:HGNC Symbol;Acc:HGNC:14543]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005912(adherens junction);GO:0005923(bicellular tight junction);GO:0006468(protein phosphorylation);GO:0006884(cell volume homeostasis);GO:0007231(osmosensory signaling pathway);GO:0010765(positive regulation of sodium ion transport);GO:0010800(positive regulation of peptidyl-threonine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0019869(chloride channel inhibitor activity);GO:0032414(positive regulation of ion transmembrane transporter activity);GO:0035633(maintenance of permeability of blood-brain barrier);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0050801(ion homeostasis);GO:0051928(positive regulation of calcium ion transport);GO:0072659(protein localization to plasma membrane);GO:0090188(negative regulation of pancreatic juice secretion);GO:0090279(regulation of calcium ion import);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1904062(regulation of cation transmembrane transport);GO:2000651(positive regulation of sodium ion transmembrane transporter activity)","NA",{"v":0.036,"d":"0.04"},1,"330,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000048250/ENSBGRG00000026090, exon 20 of 23)",30,99395079,99574715,179637,2]
["X",99545290,99574416,29127,"ENSBGRG00000026095","ENSBGRT00000048258",0,"ENSBGRG00000026095","NA","NA","NA",{"v":1.8E-3,"d":"0.00"},2,"34,356,","0,28771",-2.74,-2.16,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000048258/ENSBGRG00000026095, exon 1 of 1)",30,99561201,99561262,62,1]
["X",99574566,99574715,150,"ENSBGRG00000026090","ENSBGRT00000048250",0,"WNK3","WNK lysine deficient protein kinase 3 [Source:HGNC Symbol;Acc:HGNC:14543]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005912(adherens junction);GO:0005923(bicellular tight junction);GO:0006468(protein phosphorylation);GO:0006884(cell volume homeostasis);GO:0007231(osmosensory signaling pathway);GO:0010765(positive regulation of sodium ion transport);GO:0010800(positive regulation of peptidyl-threonine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0019869(chloride channel inhibitor activity);GO:0032414(positive regulation of ion transmembrane transporter activity);GO:0035633(maintenance of permeability of blood-brain barrier);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0050801(ion homeostasis);GO:0051928(positive regulation of calcium ion transport);GO:0072659(protein localization to plasma membrane);GO:0090188(negative regulation of pancreatic juice secretion);GO:0090279(regulation of calcium ion import);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1904062(regulation of cation transmembrane transport);GO:2000651(positive regulation of sodium ion transmembrane transporter activity)","NA",0.02,1,"150,",0,-1.69,-1.03,7.92,"5' UTR",30,99395079,99574715,179637,2]
["X",101982379,101983125,747,"ENSBGRG00000008507","ENSBGRT00000015472",0,"ENSBGRG00000008507","NA","GO:0005634(nucleus);GO:0007276(gamete generation);GO:0051726(regulation of cell cycle)","NA",{"v":7.9e-82,"d":"0.00"},1,"747,",0,{"v":-81.1,"d":"-81.10"},{"v":-79.6,"d":"-79.60"},9.48,"Exon (ENSBGRT00000015472/ENSBGRG00000008507, exon 1 of 1)",30,101982349,101983125,777,2]
["X",102059514,102060290,777,"ENSBGRG00000008521","ENSBGRT00000015499",0,"ENSBGRG00000008521","NA","GO:0005634(nucleus);GO:0007276(gamete generation);GO:0051726(regulation of cell cycle)","NA",{"v":2.5e-21,"d":"0.00"},1,"777,",0,{"v":-20.6,"d":"-20.60"},{"v":-19.7,"d":"-19.70"},9.16,"Exon (ENSBGRT00000015499/ENSBGRG00000008521, exon 1 of 1)",30,102059514,102060290,777,2]
["X",102204316,102205242,927,"ENSBGRG00000008637","ENSBGRT00000015784",158665,"HEPH","hephaestin [Source:HGNC Symbol;Acc:HGNC:4866]","GO:0004322(ferroxidase activity);GO:0005507(copper ion binding);GO:0005886(plasma membrane);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008198(ferrous iron binding);GO:0016323(basolateral plasma membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00860(Porphyrin and chlorophyll metabolism);04978(Mineral absorption)",{"v":1E-78,"d":"0.00"},1,"927,",0,-78,{"v":-76.6,"d":"-76.60"},4.87,"3' UTR",30,102203240,102363907,160668,2]
["X",102352803,102352863,61,"ENSBGRG00000008637","ENSBGRT00000015784",11044,"HEPH","hephaestin [Source:HGNC Symbol;Acc:HGNC:4866]","GO:0004322(ferroxidase activity);GO:0005507(copper ion binding);GO:0005886(plasma membrane);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008198(ferrous iron binding);GO:0016323(basolateral plasma membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00860(Porphyrin and chlorophyll metabolism);04978(Mineral absorption)",{"v":0.036,"d":"0.04"},1,"61,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000015922/ENSBGRG00000008637, exon 5 of 23)",30,102203240,102363907,160668,2]
["X",102363489,102363638,150,"ENSBGRG00000008637","ENSBGRT00000015784",269,"HEPH","hephaestin [Source:HGNC Symbol;Acc:HGNC:4866]","GO:0004322(ferroxidase activity);GO:0005507(copper ion binding);GO:0005886(plasma membrane);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008198(ferrous iron binding);GO:0016323(basolateral plasma membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00860(Porphyrin and chlorophyll metabolism);04978(Mineral absorption)",{"v":0.005,"d":"0.01"},1,"150,",0,{"v":-2.3,"d":"-2.30"},-1.75,2.16,"5' UTR",30,102203240,102363907,160668,2]
["X",102692047,102697783,5737,"ENSBGRG00000009295","ENSBGRT00000017039",75296,"MSN","moesin [Source:HGNC Symbol;Acc:HGNC:7373]","GO:0001771(immunological synapse formation);GO:0001931(uropod);GO:0003725(double-stranded RNA binding);GO:0003779(actin binding);GO:0005102(signaling receptor binding);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0005925(focal adhesion);GO:0007159(leukocyte cell-cell adhesion);GO:0008092(cytoskeletal protein binding);GO:0008360(regulation of cell shape);GO:0008361(regulation of cell size);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0022612(gland morphogenesis);GO:0022614(membrane to membrane docking);GO:0030175(filopodium);GO:0031143(pseudopodium);GO:0042098(T cell proliferation);GO:0045177(apical part of cell);GO:0045198(establishment of epithelial cell apical/basal polarity);GO:0048471(perinuclear region of cytoplasm);GO:0050839(cell adhesion molecule binding);GO:0050900(leukocyte migration);GO:0061028(establishment of endothelial barrier);GO:0070489(T cell aggregation);GO:0071394(cellular response to testosterone stimulus);GO:0071437(invadopodium);GO:0071803(positive regulation of podosome assembly);GO:0071944(cell periphery);GO:0072678(T cell migration);GO:1902115(regulation of organelle assembly);GO:1902966(positive regulation of protein localization to early endosome);GO:1903364(positive regulation of cellular protein catabolic process);GO:2000401(regulation of lymphocyte migration);GO:2000643(positive regulation of early endosome to late endosome transport)","04530(Tight junction);04810(Regulation of actin cytoskeleton);04670(Leukocyte transendothelial migration);05205(Proteoglycans in cancer);05162(Measles)",0,6,"131,93,161,131,84,1,","0,476,1750,2171,4717,5736",-336,"-Inf",2.51,"Exon (ENSBGRT00000017039/ENSBGRG00000009295, exon 9 of 15)",30,102691033,102773079,82047,2]
["X",102998101,102998311,211,"ENSBGRG00000009366","ENSBGRT00000017339",35847,"LAS1L","LAS1 like ribosome biogenesis factor [Source:HGNC Symbol;Acc:HGNC:25726]","GO:0004519(endonuclease activity);GO:0006364(rRNA processing);GO:0071339(MLL1 complex);GO:0090730(Las1 complex)","NA",{"v":0.034,"d":"0.03"},1,"211,",0,-1.47,{"v":-0.977,"d":"-0.98"},6.93,"Exon (ENSBGRT00000017626/ENSBGRG00000009600, exon 6 of 6)",30,102962254,103009072,46819,1]
["X",103055128,103055607,480,"ENSBGRG00000009600","ENSBGRT00000017626",270,"ZC3H12B","zinc finger CCCH-type containing 12B [Source:HGNC Symbol;Acc:HGNC:17407]","GO:0046872(metal ion binding)","NA",{"v":5.2e-10,"d":"0.00"},1,"480,",0,-9.28,{"v":-8.5,"d":"-8.50"},{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000017626/ENSBGRG00000009600, exon 1 of 6)",30,102997742,103055877,58136,2]
["X",103543209,103543928,720,"ENSBGRG00000009685","ENSBGRT00000017749",0,"ENSBGRG00000009685","NA","NA","NA",{"v":7.2e-06,"d":"0.00"},1,"720,",0,-5.14,-4.45,{"v":15.8,"d":"15.80"},"Exon (ENSBGRT00000017749/ENSBGRG00000009685, exon 1 of 1)",30,103542879,103543928,1050,2]
["X",103543209,103543928,720,"ENSBGRG00000009685","ENSBGRT00000017749",0,"ENSBGRG00000009685","NA","NA","NA",{"v":7.2e-06,"d":"0.00"},1,"720,",0,-5.14,-4.45,{"v":15.8,"d":"15.80"},"Exon (ENSBGRT00000017749/ENSBGRG00000009685, exon 1 of 1)",30,103542879,103543928,1050,2]
["X",104155387,104155648,262,"ENSBGRG00000009820","ENSBGRT00000018051",288528,"MTMR8","myotubularin related protein 8 [Source:HGNC Symbol;Acc:HGNC:16825]","GO:0004438(phosphatidylinositol-3-phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0010506(regulation of autophagy);GO:0016311(dephosphorylation);GO:0046856(phosphatidylinositol dephosphorylation);GO:0052629(phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":0.018,"d":"0.02"},1,"262,",0,-1.74,-1.22,3.96,"3' UTR",30,103866859,104181355,314497,1]
["X",104220764,104220854,91,"ENSBGRG00000009910","ENSBGRT00000018180",3667,"ENSBGRG00000009910","NA","NA","NA",{"v":0.034,"d":"0.03"},1,"91,",0,-1.47,{"v":-0.977,"d":"-0.98"},4.95,"Exon (ENSBGRT00000018180/ENSBGRG00000009910, exon 2 of 2)",30,104219176,104224521,5346,2]
["X",105444975,105446148,1174,"ENSBGRG00000010451","ENSBGRT00000019140",0,"ENSBGRG00000010451","NA","NA","NA",{"v":1.3e-47,"d":"0.00"},3,"903,30,107,","0,1001,1067",{"v":-46.9,"d":"-46.90"},{"v":-45.7,"d":"-45.70"},{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000019140/ENSBGRG00000010451, exon 1 of 2)",30,105445752,105447570,1819,1]
["X",105446237,105446614,378,"ENSBGRG00000010334","ENSBGRT00000019096",208,"ENSBGRG00000010334","NA","NA","00340(Histidine metabolism)",{"v":7.1E-8,"d":"0.00"},3,"179,99,19,","0,227,359",-7.15,-6.41,{"v":11.2,"d":"11.20"},"Exon (ENSBGRT00000019140/ENSBGRG00000010451, exon 1 of 2)",30,105444382,105446822,2441,2]
["X",105686695,105716520,29826,"ENSBGRG00000010500","ENSBGRT00000019223",4006,"ENSBGRG00000010500","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1E-150,"d":"0.00"},3,"1403,99,22,","0,29419,29804",-150,-148,9.88,"Exon (ENSBGRT00000019223/ENSBGRG00000010500, exon 3 of 5)",30,105686605,105720526,33922,2]
["X",107043227,107048616,5390,"ENSBGRG00000010653","ENSBGRT00000021643",144877,"ENSBGRG00000010653","lysine demethylase 6A [Source:HGNC Symbol;Acc:HGNC:12637]","GO:0005515(protein binding)","05202(Transcriptional misregulation in cancers)",{"v":1e-94,"d":"0.00"},2,"670,376,","0,5014",-94,{"v":-92.5,"d":"-92.50"},4.08,"Exon (ENSBGRT00000021643/ENSBGRG00000010653, exon 17 of 30)",30,107002280,107193493,191214,2]
["X",108556983,108557521,539,"ENSBGRG00000013578","ENSBGRT00000024960",717,"ENSBGRG00000013578","NA","GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00260(Glycine, serine and threonine metabolism);00330(Arginine and proline metabolism);00340(Histidine metabolism);00350(Tyrosine metabolism);00360(Phenylalanine metabolism);00380(Tryptophan metabolism);00982(Drug metabolism - cytochrome P450);04728(Dopaminergic synapse);04726(Serotonergic synapse);05030(Cocaine addiction);05031(Amphetamine addiction);05034(Alcoholism)",{"v":1.8E-3,"d":"0.00"},1,"539,",0,-2.74,-2.16,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000024960/ENSBGRG00000013578, exon 1 of 16)",30,108441376,108558238,116863,2]
["X",111020891,111021618,728,"ENSBGRG00000015328","ENSBGRT00000033557",12952,"DDX3X","DEAD-box helicase 3 X-linked [Source:HGNC Symbol;Acc:HGNC:2745]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003678(DNA helicase activity);GO:0003723(RNA binding);GO:0003724(RNA helicase activity);GO:0003729(mRNA binding);GO:0003924(GTPase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005852(eukaryotic translation initiation factor 3 complex);GO:0005886(plasma membrane);GO:0006413(translational initiation);GO:0007059(chromosome segregation);GO:0008134(transcription factor binding);GO:0008143(poly(A) binding);GO:0008190(eukaryotic initiation factor 4E binding);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0009615(response to virus);GO:0010494(cytoplasmic stress granule);GO:0010501(RNA secondary structure unwinding);GO:0010628(positive regulation of gene expression);GO:0016055(Wnt signaling pathway);GO:0016887(ATPase activity);GO:0017111(nucleoside-triphosphatase activity);GO:0017148(negative regulation of translation);GO:0022627(cytosolic small ribosomal subunit);GO:0030307(positive regulation of cell growth);GO:0030308(negative regulation of cell growth);GO:0031252(cell leading edge);GO:0031333(negative regulation of protein-containing complex assembly);GO:0031369(translation initiation factor binding);GO:0031954(positive regulation of protein autophosphorylation);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0033592(RNA strand annealing activity);GO:0034063(stress granule assembly);GO:0034157(positive regulation of toll-like receptor 7 signaling pathway);GO:0034161(positive regulation of toll-like receptor 8 signaling pathway);GO:0035556(intracellular signal transduction);GO:0035613(RNA stem-loop binding);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042256(mature ribosome assembly);GO:0043015(gamma-tubulin binding);GO:0043024(ribosomal small subunit binding);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043273(CTPase activity);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043539(protein serine/threonine kinase activator activity);GO:0045070(positive regulation of viral genome replication);GO:0045087(innate immune response);GO:0045727(positive regulation of translation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045948(positive regulation of translational initiation);GO:0048027(mRNA 5'-UTR binding);GO:0055088(lipid homeostasis);GO:0071243(cellular response to arsenic-containing substance);GO:0071470(cellular response to osmotic stress);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0097193(intrinsic apoptotic signaling pathway);GO:0098586(cellular response to virus);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1901223(negative regulation of NIK/NF-kappaB signaling);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1901985(positive regulation of protein acetylation);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902523(positive regulation of protein K63-linked ubiquitination);GO:1903608(protein localization to cytoplasmic stress granule);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04622(RIG-I-like receptor signaling pathway);05203(Viral carcinogenesis);05161(Hepatitis B)",{"v":5e-99,"d":"0.00"},2,"419,119,","0,609",{"v":-98.3,"d":"-98.30"},{"v":-96.8,"d":"-96.80"},1.62,"3' UTR",30,111010406,111034570,24165,2]
["X",111027418,111031746,4329,"ENSBGRG00000015328","ENSBGRT00000033557",2824,"DDX3X","DEAD-box helicase 3 X-linked [Source:HGNC Symbol;Acc:HGNC:2745]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003678(DNA helicase activity);GO:0003723(RNA binding);GO:0003724(RNA helicase activity);GO:0003729(mRNA binding);GO:0003924(GTPase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005852(eukaryotic translation initiation factor 3 complex);GO:0005886(plasma membrane);GO:0006413(translational initiation);GO:0007059(chromosome segregation);GO:0008134(transcription factor binding);GO:0008143(poly(A) binding);GO:0008190(eukaryotic initiation factor 4E binding);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0009615(response to virus);GO:0010494(cytoplasmic stress granule);GO:0010501(RNA secondary structure unwinding);GO:0010628(positive regulation of gene expression);GO:0016055(Wnt signaling pathway);GO:0016887(ATPase activity);GO:0017111(nucleoside-triphosphatase activity);GO:0017148(negative regulation of translation);GO:0022627(cytosolic small ribosomal subunit);GO:0030307(positive regulation of cell growth);GO:0030308(negative regulation of cell growth);GO:0031252(cell leading edge);GO:0031333(negative regulation of protein-containing complex assembly);GO:0031369(translation initiation factor binding);GO:0031954(positive regulation of protein autophosphorylation);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0033592(RNA strand annealing activity);GO:0034063(stress granule assembly);GO:0034157(positive regulation of toll-like receptor 7 signaling pathway);GO:0034161(positive regulation of toll-like receptor 8 signaling pathway);GO:0035556(intracellular signal transduction);GO:0035613(RNA stem-loop binding);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042256(mature ribosome assembly);GO:0043015(gamma-tubulin binding);GO:0043024(ribosomal small subunit binding);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043273(CTPase activity);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043539(protein serine/threonine kinase activator activity);GO:0045070(positive regulation of viral genome replication);GO:0045087(innate immune response);GO:0045727(positive regulation of translation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045948(positive regulation of translational initiation);GO:0048027(mRNA 5'-UTR binding);GO:0055088(lipid homeostasis);GO:0071243(cellular response to arsenic-containing substance);GO:0071470(cellular response to osmotic stress);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0097193(intrinsic apoptotic signaling pathway);GO:0098586(cellular response to virus);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1901223(negative regulation of NIK/NF-kappaB signaling);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1901985(positive regulation of protein acetylation);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902523(positive regulation of protein K63-linked ubiquitination);GO:1903608(protein localization to cytoplasmic stress granule);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04622(RIG-I-like receptor signaling pathway);05203(Viral carcinogenesis);05161(Hepatitis B)",{"v":6.6e-07,"d":"0.00"},3,"88,48,43,","0,2717,4286",-6.18,-5.47,{"v":1.2,"d":"1.20"},"Exon (ENSBGRT00000033557/ENSBGRG00000015328, exon 2 of 17)",30,111010406,111034570,24165,2]
["X",111149253,111152057,2805,"ENSBGRG00000018694","ENSBGRT00000034455",88442,"USP9X","ubiquitin specific peptidase 9 X-linked [Source:HGNC Symbol;Acc:HGNC:12632]","GO:0001764(neuron migration);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0016579(protein deubiquitination);GO:0030426(growth cone);GO:0030509(BMP signaling pathway);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042752(regulation of circadian rhythm);GO:0048675(axon extension);GO:0050821(protein stabilization);GO:0070410(co-SMAD binding);GO:0071947(protein deubiquitination involved in ubiquitin-dependent protein catabolic process);GO:1901537(positive regulation of DNA demethylation);GO:1990380(Lys48-specific deubiquitinase activity)","NA",{"v":6.9E-6,"d":"0.00"},3,"25,110,15,","0,297,2790",-5.16,-4.47,{"v":4.7,"d":"4.70"},"Exon (ENSBGRT00000034455/ENSBGRG00000018694, exon 45 of 47)",30,111149193,111240499,91307,2]
["X",111162575,111165389,2815,"ENSBGRG00000018694","ENSBGRT00000034455",75110,"USP9X","ubiquitin specific peptidase 9 X-linked [Source:HGNC Symbol;Acc:HGNC:12632]","GO:0001764(neuron migration);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0016579(protein deubiquitination);GO:0030426(growth cone);GO:0030509(BMP signaling pathway);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042752(regulation of circadian rhythm);GO:0048675(axon extension);GO:0050821(protein stabilization);GO:0070410(co-SMAD binding);GO:0071947(protein deubiquitination involved in ubiquitin-dependent protein catabolic process);GO:1901537(positive regulation of DNA demethylation);GO:1990380(Lys48-specific deubiquitinase activity)","NA",{"v":9.99999999999998e-249,"d":"0.00"},3,"58,668,23,","0,967,2792",-248,-246,7.11,"Exon (ENSBGRT00000034455/ENSBGRG00000018694, exon 35 of 47)",30,111149193,111240499,91307,2]
["X",111209203,111214211,5009,"ENSBGRG00000018910","ENSBGRT00000034661",0,"ENSBGRG00000018910","NA","GO:0005634(nucleus);GO:0005719(nuclear euchromatin);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":1.2e-06,"d":"0.00"},2,"251,19,","0,4990",-5.92,-5.21,2.97,"Exon (ENSBGRT00000034661/ENSBGRG00000018910, exon 1 of 1)",30,111211695,111212312,618,1]
["X",113671372,113673531,2160,"ENSBGRG00000021050","ENSBGRT00000038802",0,"MID1IP1","MID1 interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:20715]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007026(negative regulation of microtubule depolymerization);GO:0008022(protein C-terminus binding);GO:0015630(microtubule cytoskeleton);GO:0042802(identical protein binding);GO:0045723(positive regulation of fatty acid biosynthetic process);GO:0051258(protein polymerization);GO:0051351(positive regulation of ligase activity)","NA",{"v":9.99999999999998e-280,"d":"0.00"},2,"530,430,","0,1730",-279,-277,9.55,"5' UTR",30,113671372,113673531,2160,2]
["X",115054454,115054574,121,"ENSBGRG00000007179","ENSBGRT00000013630",38342,"CYBB","cytochrome b-245 beta chain [Source:HGNC Symbol;Acc:HGNC:2578]","GO:0005887(integral component of plasma membrane);GO:0006801(superoxide metabolic process);GO:0009055(electron transfer activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016175(superoxide-generating NADPH oxidase activity);GO:0016491(oxidoreductase activity);GO:0020037(heme binding);GO:0042554(superoxide anion generation);GO:0043020(NADPH oxidase complex);GO:0045087(innate immune response);GO:0045730(respiratory burst);GO:0046982(protein heterodimerization activity);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process)","04066(HIF-1 signaling pathway);04145(Phagosome);04216(Ferroptosis);04217(Necroptosis);04621(NOD-like receptor signaling pathway);04670(Leukocyte transendothelial migration);04933(AGE-RAGE signaling pathway in diabetic complications);05140(Leishmaniasis)",{"v":2.8E-3,"d":"0.00"},1,"121,",0,-2.56,-1.99,2.16,"Exon (ENSBGRT00000013515/ENSBGRG00000007179, exon 4 of 16)",30,114965391,115092916,127526,2]
["X",116843805,116849129,5325,"ENSBGRG00000008170","ENSBGRT00000014950",39665,"ENSBGRG00000008170","NA","NA","NA",0.02,3,"59,153,26,","0,707,5299",-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000014950/ENSBGRG00000008170, exon 10 of 18)",30,116831157,116888794,57638,2]
["X",121107835,121108361,527,"ENSBGRG00000008820","ENSBGRT00000016136",0,"ENSBGRG00000008820","NA","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","03040(Spliceosome);05168(Herpes simplex infection)",{"v":0.0068,"d":"0.01"},1,"527,",0,-2.17,-1.62,7.92,"Exon (ENSBGRT00000016136/ENSBGRG00000008820, exon 1 of 1)",30,121107777,121108361,585,2]
["X",130493202,130494162,961,"ENSBGRG00000013130","ENSBGRT00000024173",16033,"ZFX","zinc finger protein X-linked [Source:HGNC Symbol;Acc:HGNC:12869]","GO:0001541(ovarian follicle development);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0009566(fertilization);GO:0009791(post-embryonic development);GO:0035264(multicellular organism growth);GO:0046872(metal ion binding);GO:0048599(oocyte development);GO:0048872(homeostasis of number of cells);GO:0060746(parental behavior)","NA",{"v":7.9e-84,"d":"0.00"},2,"232,218,","0,743",{"v":-83.1,"d":"-83.10"},{"v":-81.6,"d":"-81.60"},6.23,"Exon (ENSBGRT00000024173/ENSBGRG00000013130, exon 7 of 8)",30,130493202,130510195,16994,2]
["X",130494282,130497092,2811,"ENSBGRG00000013130","ENSBGRT00000024173",13103,"ZFX","zinc finger protein X-linked [Source:HGNC Symbol;Acc:HGNC:12869]","GO:0001541(ovarian follicle development);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0009566(fertilization);GO:0009791(post-embryonic development);GO:0035264(multicellular organism growth);GO:0046872(metal ion binding);GO:0048599(oocyte development);GO:0048872(homeostasis of number of cells);GO:0060746(parental behavior)","NA",{"v":1e-101,"d":"0.00"},2,"615,75,","0,2736",-101,{"v":-99.3,"d":"-99.30"},7.18,"Exon (ENSBGRT00000024173/ENSBGRG00000013130, exon 6 of 8)",30,130493202,130510195,16994,2]
["X",130509972,130510195,224,"ENSBGRG00000013130","ENSBGRT00000024173",0,"ZFX","zinc finger protein X-linked [Source:HGNC Symbol;Acc:HGNC:12869]","GO:0001541(ovarian follicle development);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0009566(fertilization);GO:0009791(post-embryonic development);GO:0035264(multicellular organism growth);GO:0046872(metal ion binding);GO:0048599(oocyte development);GO:0048872(homeostasis of number of cells);GO:0060746(parental behavior)","NA",{"v":1.4E-5,"d":"0.00"},2,"94,87,","0,137",-4.86,-4.19,3.51,"Exon (ENSBGRT00000024173/ENSBGRG00000013130, exon 1 of 8)",30,130493202,130510195,16994,2]
["X",130718153,130719206,1054,"ENSBGRG00000007185","ENSBGRT00000013212",22516,"CXorf58","chromosome X open reading frame 58 [Source:HGNC Symbol;Acc:HGNC:26356]","NA","NA",{"v":0.015,"d":"0.02"},2,"17,73,","0,981",-1.81,-1.29,2.69,"Exon (ENSBGRT00000013212/ENSBGRG00000007185, exon 8 of 9)",30,130717621,130741722,24102,2]
["X",131286248,131286907,660,"ENSBGRG00000008455","ENSBGRT00000015371",55346,"PTCHD1","patched domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26392]","GO:0005886(plasma membrane);GO:0007224(smoothened signaling pathway);GO:0007614(short-term memory);GO:0007616(long-term memory);GO:0016021(integral component of membrane);GO:0021794(thalamus development);GO:0035176(social behavior);GO:0045202(synapse);GO:0050890(cognition);GO:0098976(excitatory chemical synaptic transmission);GO:0098977(inhibitory chemical synaptic transmission)","04142(Lysosome)",0.02,1,"660,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000015371/ENSBGRG00000008455, exon 3 of 3)",30,131286098,131342253,56156,2]
["X",133054450,133055904,1455,"ENSBGRG00000009064","ENSBGRT00000016882",50432,"MBTPS2","membrane bound transcription factor peptidase, site 2 [Source:HGNC Symbol;Acc:HGNC:15455]","GO:0004222(metalloendopeptidase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0016020(membrane);GO:0031293(membrane protein intracellular domain proteolysis);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0070977(bone maturation);GO:1990440(positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04141(Protein processing in endoplasmic reticulum)",{"v":1E-35,"d":"0.00"},2,"317,42,","0,1413",-35,-34,4.97,"3' UTR",30,133054450,133106336,51887,2]
["X",133079485,133081230,1746,"ENSBGRG00000009064","ENSBGRT00000016882",25106,"MBTPS2","membrane bound transcription factor peptidase, site 2 [Source:HGNC Symbol;Acc:HGNC:15455]","GO:0004222(metalloendopeptidase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0016020(membrane);GO:0031293(membrane protein intracellular domain proteolysis);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0070977(bone maturation);GO:1990440(positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04141(Protein processing in endoplasmic reticulum)",{"v":6.3E-64,"d":"0.00"},2,"702,446,","0,1300",{"v":-63.2,"d":"-63.20"},{"v":-61.9,"d":"-61.90"},8.94,"Exon (ENSBGRT00000017019/ENSBGRG00000009234, exon 1 of 2)",30,133054450,133106336,51887,2]
["X",133310466,133358746,48281,"ENSBGRG00000009403","ENSBGRT00000017518",259155,"CNKSR2","connector enhancer of kinase suppressor of Ras 2 [Source:HGNC Symbol;Acc:HGNC:19701]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0009966(regulation of signal transduction);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0019901(protein kinase binding);GO:0035556(intracellular signal transduction)","NA",{"v":8.9e-06,"d":"0.00"},3,"144,5,240,","0,7341,48041",-5.05,-4.37,4.58,"Exon (ENSBGRT00000017518/ENSBGRG00000009403, exon 20 of 22)",30,133307182,133617901,310720,2]
["X",135651062,135651716,655,"ENSBGRG00000014128","ENSBGRT00000026657",22284,"PDHA1","pyruvate dehydrogenase E1 alpha 1 subunit [Source:HGNC Symbol;Acc:HGNC:8806]","GO:0004739(pyruvate dehydrogenase (acetyl-transferring) activity);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0006086(acetyl-CoA biosynthetic process from pyruvate);GO:0016624(oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor);GO:0043231(intracellular membrane-bounded organelle);GO:0045254(pyruvate dehydrogenase complex)","00010(Glycolysis / Gluconeogenesis);00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);04066(HIF-1 signaling pathway);04922(Glucagon signaling pathway);05230(Central carbon metabolism in cancer)",{"v":1e-159,"d":"0.00"},1,"655,",0,-159,-157,4.29,"3' UTR",30,135651062,135674000,22939,2]
["Y",1615942,1616211,270,"ENSBGRG00000016666","ENSBGRT00000030700",21838,"ENSBGRG00000016666","NA","NA","NA",0.04,1,"270,",0,{"v":-1.4,"d":"-1.40"},{"v":-0.912,"d":"-0.91"},2.23,"Exon (ENSBGRT00000030731/ENSBGRG00000016756, exon 2 of 2)",31,1612302,1638049,25748,2]
["Y",1626853,1626997,145,"ENSBGRG00000016666","ENSBGRT00000030700",11052,"ENSBGRG00000016666","NA","NA","NA",{"v":3.5e-06,"d":"0.00"},1,"145,",0,-5.46,-4.76,{"v":20.8,"d":"20.80"},"Exon (ENSBGRT00000030765/ENSBGRG00000016770, exon 1 of 1)",31,1612302,1638049,25748,2]
["Y",1945892,1947834,1943,"ENSBGRG00000016807","ENSBGRT00000030832",4560,"ENSBGRG00000016807","NA","NA","NA",{"v":3.3E-3,"d":"0.00"},1,"1943,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000030832/ENSBGRG00000016807, exon 3 of 3)",31,1941332,1947834,6503,1]
["Y",2481402,2482966,1565,"ENSBGRG00000017134","ENSBGRT00000031412",985,"ENSBGRG00000017134","NA","NA","NA",{"v":0.00078,"d":"0.00"},2,"52,218,","0,1347",-3.11,-2.51,4.95,"Exon (ENSBGRT00000031412/ENSBGRG00000017134, exon 1 of 2)",31,2480417,2486697,6281,1]
["Y",2483921,2483981,61,"ENSBGRG00000017134","ENSBGRT00000031412",3504,"ENSBGRG00000017134","NA","NA","NA",{"v":0.021,"d":"0.02"},1,"61,",0,-1.68,-1.17,2.06,"Exon (ENSBGRT00000031412/ENSBGRG00000017134, exon 2 of 2)",31,2480417,2486697,6281,1]
["Y",2484607,2484996,390,"ENSBGRG00000017134","ENSBGRT00000031412",4190,"ENSBGRG00000017134","NA","NA","NA",{"v":0.00018,"d":"0.00"},1,"390,",0,-3.75,-3.12,{"v":5.2,"d":"5.20"},"Exon (ENSBGRT00000031412/ENSBGRG00000017134, exon 2 of 2)",31,2480417,2486697,6281,1]
["Y",3034568,3034657,90,"ENSBGRG00000017194","ENSBGRT00000031547",497,"PNPLA4","patatin like phospholipase domain containing 4 [Source:HGNC Symbol;Acc:HGNC:24887]","GO:0004806(triglyceride lipase activity);GO:0005739(mitochondrion);GO:0006629(lipid metabolic process);GO:0016042(lipid catabolic process);GO:0016787(hydrolase activity);GO:0050253(retinyl-palmitate esterase activity)","00830(Retinol metabolism)",0.03,1,"90,",0,-1.53,-1.03,1.67,"5' UTR",31,3034071,3081145,47075,1]
["Y",3909462,3909612,151,"ENSBGRG00000017714","ENSBGRT00000032531",59597,"ENSBGRG00000017714","NA","GO:0016787(hydrolase activity)","NA",{"v":0.034,"d":"0.03"},1,"151,",0,-1.47,{"v":-0.977,"d":"-0.98"},4.95,"3' UTR",31,3849865,3910386,60522,1]
["Y",5102350,5102559,210,"ENSBGRG00000017805","ENSBGRT00000032748",424625,"ENSBGRG00000017805","NA","GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0016020(membrane);GO:0042043(neurexin family protein binding);GO:0045202(synapse);GO:0050808(synapse organization)","04514(Cell adhesion molecules (CAMs))",{"v":3.2e-06,"d":"0.00"},1,"210,",0,-5.49,{"v":-4.8,"d":"-4.80"},8.91,"3' UTR",31,4677725,5102679,424955,1]
["Y",5102619,5102679,61,"ENSBGRG00000017805","ENSBGRT00000032748",424894,"ENSBGRG00000017805","NA","GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0016020(membrane);GO:0042043(neurexin family protein binding);GO:0045202(synapse);GO:0050808(synapse organization)","04514(Cell adhesion molecules (CAMs))",{"v":1.2E-4,"d":"0.00"},1,"61,",0,-3.92,-3.28,9.41,"3' UTR",31,4677725,5102679,424955,1]
["Y",6968770,6974585,5816,"ENSBGRG00000018435","ENSBGRT00000033769",67791,"ENSBGRG00000018435","NA","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA",{"v":2.5e-16,"d":"0.00"},3,"44,149,404,","0,4262,5412",{"v":-15.6,"d":"-15.60"},{"v":-14.7,"d":"-14.70"},4.18,"3' UTR",31,6900979,6975181,74203,1]
["Y",7147076,7148026,951,"ENSBGRG00000018584","ENSBGRT00000034448",32037,"ENSBGRG00000018584","NA","GO:0016757(transferase activity, transferring glycosyl groups)","00500(Starch and sucrose metabolism)",{"v":4e-26,"d":"0.00"},1,"951,",0,{"v":-25.4,"d":"-25.40"},{"v":-24.4,"d":"-24.40"},5,"3' UTR",31,7122200,7180063,57864,2]
["Y",7526456,7527053,598,"ENSBGRG00000019175","ENSBGRT00000035211",176351,"ENSBGRG00000019175","dehydrogenase/reductase X-linked [Source:HGNC Symbol;Acc:HGNC:18399]","GO:0016491(oxidoreductase activity)","NA",{"v":3.2e-14,"d":"0.00"},1,"598,",0,{"v":-13.5,"d":"-13.50"},{"v":-12.7,"d":"-12.70"},{"v":4.5,"d":"4.50"},"3' UTR",31,7350105,7527273,177169,1]
["Y",7527113,7566509,39397,"ENSBGRG00000019175","ENSBGRT00000035211",177008,"ENSBGRG00000019175","dehydrogenase/reductase X-linked [Source:HGNC Symbol;Acc:HGNC:18399]","GO:0016491(oxidoreductase activity)","NA",{"v":3.8e-05,"d":"0.00"},2,"161,168,","0,39229",-4.42,-3.77,2.76,"3' UTR",31,7350105,7527273,177169,1]
["Y",7566987,7567046,60,"ENSBGRG00000019175","ENSBGRT00000035334",159188,"ENSBGRG00000019175","dehydrogenase/reductase X-linked [Source:HGNC Symbol;Acc:HGNC:18399]","GO:0016491(oxidoreductase activity)","NA",{"v":2.8E-3,"d":"0.00"},1,"60,",0,-2.55,-1.99,3.37,"3' UTR",31,7407799,7567345,159547,1]
["Y",7368972,7370706,1735,"ENSBGRG00000019175","ENSBGRT00000035289",18867,"ENSBGRG00000019175","dehydrogenase/reductase X-linked [Source:HGNC Symbol;Acc:HGNC:18399]","GO:0016491(oxidoreductase activity)","NA",{"v":5E-56,"d":"0.00"},2,"941,792,","0,943",{"v":-55.3,"d":"-55.30"},{"v":-54.1,"d":"-54.10"},{"v":18.5,"d":"18.50"},"Exon (ENSBGRT00000035505/ENSBGRG00000019303, exon 1 of 2)",31,7350105,7480052,129948,1]
["Y",7947575,7947845,271,"ENSBGRG00000007075","ENSBGRT00000013054",20095,"ASMTL","acetylserotonin O-methyltransferase like [Source:HGNC Symbol;Acc:HGNC:751]","GO:0005829(cytosol);GO:0008171(O-methyltransferase activity);GO:0047429(nucleoside-triphosphate diphosphatase activity)","NA",{"v":3.5E-4,"d":"0.00"},1,"271,",0,-3.46,-2.84,1.87,"3' UTR",31,7927480,7948714,21235,1]
["Y",7947935,7947995,61,"ENSBGRG00000007075","ENSBGRT00000013054",20455,"ASMTL","acetylserotonin O-methyltransferase like [Source:HGNC Symbol;Acc:HGNC:751]","GO:0005829(cytosol);GO:0008171(O-methyltransferase activity);GO:0047429(nucleoside-triphosphate diphosphatase activity)","NA",{"v":0.0029,"d":"0.00"},1,"61,",0,-2.54,-1.97,2.13,"3' UTR",31,7927480,7948714,21235,1]
["Y",7948175,7948384,210,"ENSBGRG00000007075","ENSBGRT00000013054",20695,"ASMTL","acetylserotonin O-methyltransferase like [Source:HGNC Symbol;Acc:HGNC:751]","GO:0005829(cytosol);GO:0008171(O-methyltransferase activity);GO:0047429(nucleoside-triphosphate diphosphatase activity)","NA",{"v":8.3e-05,"d":"0.00"},1,"210,",0,-4.08,-3.44,{"v":2.8,"d":"2.80"},"3' UTR",31,7927480,7948714,21235,1]
["Y",7948504,7948654,151,"ENSBGRG00000007075","ENSBGRT00000013054",21024,"ASMTL","acetylserotonin O-methyltransferase like [Source:HGNC Symbol;Acc:HGNC:751]","GO:0005829(cytosol);GO:0008171(O-methyltransferase activity);GO:0047429(nucleoside-triphosphate diphosphatase activity)","NA",{"v":0.023,"d":"0.02"},1,"151,",0,-1.64,-1.13,3.96,"3' UTR",31,7927480,7948714,21235,1]
["Y",8111558,8111916,359,"ENSBGRG00000007417","ENSBGRT00000013700",22687,"CRLF2","cytokine receptor like factor 2 [Source:HGNC Symbol;Acc:HGNC:14281]","GO:0004896(cytokine receptor activity);GO:0005515(protein binding);GO:0008284(positive regulation of cell population proliferation);GO:0019221(cytokine-mediated signaling pathway);GO:0032754(positive regulation of interleukin-5 production);GO:0033005(positive regulation of mast cell activation);GO:1904894(positive regulation of receptor signaling pathway via STAT)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction)",0.02,1,"359,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"3' UTR",31,8088871,8112214,23344,1]
["Y",8706842,8706931,90,"ENSBGRG00000007677","ENSBGRT00000014083",269,"ENSBGRG00000007677","NA","GO:0005509(calcium ion binding)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);05165(Human papillomavirus infection)",{"v":0.004,"d":"0.00"},1,"90,",0,{"v":-2.4,"d":"-2.40"},-1.84,4.95,"5' UTR",31,8706573,8755308,48736,1]
["Y",8754651,8754890,240,"ENSBGRG00000007677","ENSBGRT00000014083",48078,"ENSBGRG00000007677","NA","GO:0005509(calcium ion binding)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);05165(Human papillomavirus infection)",{"v":5.2e-06,"d":"0.00"},1,"240,",0,-5.28,{"v":-4.6,"d":"-4.60"},3.38,"3' UTR",31,8706573,8755308,48736,1]
["Y",8761070,8761189,120,"ENSBGRG00000007868","ENSBGRT00000014695",239,"GTPBP6","GTP binding protein 6 (putative) [Source:HGNC Symbol;Acc:HGNC:30189]","GO:0005525(GTP binding)","00250(Alanine, aspartate and glutamate metabolism)",{"v":0.039,"d":"0.04"},1,"120,",0,-1.41,{"v":-0.918,"d":"-0.92"},1.34,"Exon (ENSBGRT00000014695/ENSBGRG00000007868, exon 1 of 9)",31,8760831,8770231,9401,1]
["Y",8770187,8779813,9627,"ENSBGRG00000007868","ENSBGRT00000014695",9356,"GTPBP6","GTP binding protein 6 (putative) [Source:HGNC Symbol;Acc:HGNC:30189]","GO:0005525(GTP binding)","00250(Alanine, aspartate and glutamate metabolism)",{"v":9.99999999999999e-271,"d":"0.00"},3,"45,1003,148,","0,7856,9479",-270,-267,9.81,"3' UTR",31,8760831,8770231,9401,1]
["Y",9036989,9037287,299,"ENSBGRG00000008199","ENSBGRT00000015012",51844,"WWC3","WWC family member 3 [Source:HGNC Symbol;Acc:HGNC:29237]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005829(cytosol);GO:0019900(kinase binding);GO:0035331(negative regulation of hippo signaling);GO:0046621(negative regulation of organ growth);GO:0060090(molecular adaptor activity)","04390(Hippo signaling pathway);04392(Hippo signaling pathway - multiple species)",{"v":1.2e-07,"d":"0.00"},1,"299,",0,-6.91,-6.18,2.73,"Exon (ENSBGRT00000015012/ENSBGRG00000008199, exon 12 of 24)",31,8985145,9064380,79236,1]
["Y",9145806,9145956,151,"ENSBGRG00000008267","ENSBGRT00000015182",59634,"CLCN4","chloride voltage-gated channel 4 [Source:HGNC Symbol;Acc:HGNC:2022]","GO:0005247(voltage-gated chloride channel activity);GO:0005254(chloride channel activity);GO:0005765(lysosomal membrane);GO:0005789(endoplasmic reticulum membrane);GO:0006821(chloride transport);GO:0010008(endosome membrane);GO:0015297(antiporter activity);GO:0016020(membrane);GO:0055037(recycling endosome);GO:0055085(transmembrane transport)","NA",{"v":0.041,"d":"0.04"},1,"151,",0,-1.39,{"v":-0.9,"d":"-0.90"},5.94,"Exon (ENSBGRT00000015182/ENSBGRG00000008267, exon 10 of 12)",31,9086172,9164412,78241,1]
["Y",9154587,9164412,9826,"ENSBGRG00000008267","ENSBGRT00000015182",68415,"CLCN4","chloride voltage-gated channel 4 [Source:HGNC Symbol;Acc:HGNC:2022]","GO:0005247(voltage-gated chloride channel activity);GO:0005254(chloride channel activity);GO:0005765(lysosomal membrane);GO:0005789(endoplasmic reticulum membrane);GO:0006821(chloride transport);GO:0010008(endosome membrane);GO:0015297(antiporter activity);GO:0016020(membrane);GO:0055037(recycling endosome);GO:0055085(transmembrane transport)","NA",{"v":0.00046,"d":"0.00"},2,"62,178,","0,9648",-3.34,-2.72,7.92,"3' UTR",31,9086172,9164412,78241,1]
["Y",10094974,10123790,28817,"ENSBGRG00000008638","ENSBGRT00000015817",12952,"EGFL6","EGF like domain multiple 6 [Source:HGNC Symbol;Acc:HGNC:3235]","GO:0005178(integrin binding);GO:0005509(calcium ion binding);GO:0010811(positive regulation of cell-substrate adhesion);GO:0016020(membrane)","NA",{"v":0.00052,"d":"0.00"},3,"157,107,62,","0,26372,28755",-3.28,-2.67,3.14,"Exon (ENSBGRT00000015817/ENSBGRG00000008638, exon 3 of 10)",31,10082022,10139772,57751,1]
["Y",10176541,10177425,885,"ENSBGRG00000008725","ENSBGRT00000015941",404,"ENSBGRG00000008725","NA","GO:0005634(nucleus);GO:0006351(transcription, DNA-templated)","NA",{"v":5e-55,"d":"0.00"},3,"562,13,222,","0,597,663",{"v":-54.3,"d":"-54.30"},-53,8.09,"Exon (ENSBGRT00000015941/ENSBGRG00000008725, exon 2 of 4)",31,10176137,10177425,1289,1]
["Y",10202377,10217955,15579,"ENSBGRG00000008752","ENSBGRT00000015974",897,"ENSBGRG00000008752","NA","NA","NA",{"v":3.2e-23,"d":"0.00"},3,"1,139,220,","0,209,15359",{"v":-22.5,"d":"-22.50"},{"v":-21.5,"d":"-21.50"},4.05,"Exon (ENSBGRT00000015974/ENSBGRG00000008752, exon 1 of 3)",31,10201480,10218015,16536,1]
["Y",10222965,10223541,577,"ENSBGRG00000008766","ENSBGRT00000016019",0,"RAB9A","RAB9A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9792]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005764(lysosome);GO:0005770(late endosome);GO:0019003(GDP binding);GO:0030659(cytoplasmic vesicle membrane);GO:0032482(Rab protein signal transduction);GO:0032880(regulation of protein localization);GO:0042470(melanosome);GO:0042802(identical protein binding);GO:0045335(phagocytic vesicle);GO:0045921(positive regulation of exocytosis);GO:0052405(negative regulation by host of symbiont molecular function)","05162(Measles)",{"v":1e-69,"d":"0.00"},1,"577,",0,-69,{"v":-67.7,"d":"-67.70"},5.94,"Exon (ENSBGRT00000016019/ENSBGRG00000008766, exon 1 of 1)",31,10222965,10223570,606,1]
["Y",10273959,10282159,8201,"ENSBGRG00000009522","ENSBGRT00000017475",0,"U6","U6 spliceosomal RNA [Source:RFAM;Acc:RF00026]","NA","NA",{"v":2.8E-3,"d":"0.00"},3,"147,107,15,","0,6284,8186",-2.56,-1.99,2.48,"Exon (ENSBGRT00000017127/ENSBGRG00000008898, exon 8 of 25)",31,10277560,10277666,107,2]
["Y",10301439,10301677,239,"ENSBGRG00000008898","ENSBGRT00000017127",55400,"ENSBGRG00000008898","NA","GO:0005515(protein binding)","NA",{"v":0.00051,"d":"0.00"},1,"239,",0,-3.29,-2.68,2.01,"Exon (ENSBGRT00000017127/ENSBGRG00000008898, exon 17 of 25)",31,10246039,10316103,70065,1]
["Y",10314393,10316103,1711,"ENSBGRG00000008898","ENSBGRT00000017127",68354,"ENSBGRG00000008898","NA","GO:0005515(protein binding)","NA",{"v":3.5e-10,"d":"0.00"},4,"44,159,71,143,","0,529,1226,1568",-9.45,-8.66,2.66,"3' UTR",31,10246039,10316103,70065,1]
["Y",12494973,12498766,3794,"ENSBGRG00000012055","ENSBGRT00000022103",7642,"CA5B","carbonic anhydrase 5B [Source:HGNC Symbol;Acc:HGNC:1378]","GO:0004089(carbonate dehydratase activity);GO:0005739(mitochondrion);GO:0008270(zinc ion binding);GO:0009617(response to bacterium)","00910(Nitrogen metabolism)",{"v":1.3E-35,"d":"0.00"},3,"178,198,104,","0,849,3690",{"v":-34.9,"d":"-34.90"},{"v":-33.9,"d":"-33.90"},3.04,"3' UTR",31,12487331,12495150,7820,1]
["Y",12512411,12527693,15283,"ENSBGRG00000012125","ENSBGRT00000022170",325,"ENSBGRG00000012125","zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 [Source:HGNC Symbol;Acc:HGNC:23019]","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0046872(metal ion binding);GO:0089701(U2AF)","03040(Spliceosome)",{"v":4e-21,"d":"0.00"},7,"59,80,91,109,87,39,98,","0,449,3996,9250,10651,14558,15185",{"v":-20.4,"d":"-20.40"},{"v":-19.5,"d":"-19.50"},2.36,"5' UTR",31,12512086,12538082,25997,1]
["Y",12534913,12538082,3170,"ENSBGRG00000012125","ENSBGRT00000022170",22827,"ENSBGRG00000012125","zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 [Source:HGNC Symbol;Acc:HGNC:23019]","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0046872(metal ion binding);GO:0089701(U2AF)","03040(Spliceosome)",{"v":1e-199,"d":"0.00"},3,"18,458,27,","0,2682,3143",-199,-197,{"v":10.7,"d":"10.70"},"Exon (ENSBGRT00000022170/ENSBGRG00000012125, exon 10 of 12)",31,12512086,12538082,25997,1]
["Y",13565314,13565432,119,"ENSBGRG00000012637","ENSBGRT00000023254",18170,"SYAP1","synapse associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16273]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0030424(axon);GO:0030425(dendrite);GO:0030426(growth cone);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032869(cellular response to insulin stimulus);GO:0036120(cellular response to platelet-derived growth factor stimulus);GO:0038203(TORC2 signaling);GO:0042734(presynaptic membrane);GO:0043204(perikaryon);GO:0045211(postsynaptic membrane);GO:0045600(positive regulation of fat cell differentiation);GO:0048471(perinuclear region of cytoplasm);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:1990314(cellular response to insulin-like growth factor stimulus)","NA",{"v":6.3E-5,"d":"0.00"},1,"119,",0,{"v":-4.2,"d":"-4.20"},-3.55,4.29,"Exon (ENSBGRT00000023254/ENSBGRG00000012637, exon 10 of 10)",31,13547144,13565432,18289,1]
["Y",13611635,13633309,21675,"ENSBGRG00000012780","ENSBGRT00000023592",0,"TXLNG","taxilin gamma [Source:HGNC Symbol;Acc:HGNC:18578]","GO:0005829(cytosol);GO:0008134(transcription factor binding);GO:0010564(regulation of cell cycle process);GO:0019905(syntaxin binding);GO:0030500(regulation of bone mineralization);GO:0031965(nuclear membrane);GO:0033613(activating transcription factor binding);GO:0051726(regulation of cell cycle)","NA",{"v":4.6e-07,"d":"0.00"},2,"102,254,","0,21421",-6.34,-5.62,6.34,"Exon (ENSBGRT00000023592/ENSBGRG00000012780, exon 1 of 10)",31,13611635,13655116,43482,1]
["Y",13642560,13654909,12350,"ENSBGRG00000012780","ENSBGRT00000023592",30925,"TXLNG","taxilin gamma [Source:HGNC Symbol;Acc:HGNC:18578]","GO:0005829(cytosol);GO:0008134(transcription factor binding);GO:0010564(regulation of cell cycle process);GO:0019905(syntaxin binding);GO:0030500(regulation of bone mineralization);GO:0031965(nuclear membrane);GO:0033613(activating transcription factor binding);GO:0051726(regulation of cell cycle)","NA",{"v":5e-37,"d":"0.00"},6,"184,120,75,93,96,84,","0,2693,4430,9691,11314,12266",{"v":-36.3,"d":"-36.30"},{"v":-35.2,"d":"-35.20"},3.62,"Exon (ENSBGRT00000023592/ENSBGRG00000012780, exon 5 of 10)",31,13611635,13655116,43482,1]
["Y",14760340,14760640,301,"ENSBGRG00000014125","ENSBGRT00000026136",400112,"NHS","NHS actin remodeling regulator [Source:HGNC Symbol;Acc:HGNC:7820]","GO:0002088(lens development in camera-type eye);GO:0005794(Golgi apparatus);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030154(cell differentiation)","NA",{"v":2.1e-09,"d":"0.00"},1,"301,",0,-8.68,-7.91,3.19,"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 7 of 11)",31,14360228,14767640,407413,1]
["Y",14760700,14761689,990,"ENSBGRG00000014125","ENSBGRT00000026136",400472,"NHS","NHS actin remodeling regulator [Source:HGNC Symbol;Acc:HGNC:7820]","GO:0002088(lens development in camera-type eye);GO:0005794(Golgi apparatus);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030154(cell differentiation)","NA",{"v":1.6e-19,"d":"0.00"},1,"990,",0,{"v":-18.8,"d":"-18.80"},{"v":-17.9,"d":"-17.90"},5.94,"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 7 of 11)",31,14360228,14767640,407413,1]
["Y",14762997,14763537,541,"ENSBGRG00000014125","ENSBGRT00000026136",402769,"NHS","NHS actin remodeling regulator [Source:HGNC Symbol;Acc:HGNC:7820]","GO:0002088(lens development in camera-type eye);GO:0005794(Golgi apparatus);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030154(cell differentiation)","NA",{"v":3E-9,"d":"0.00"},1,"541,",0,-8.52,-7.75,8.72,"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 9 of 11)",31,14360228,14767640,407413,1]
["Y",14767160,14767640,481,"ENSBGRG00000014125","ENSBGRT00000026136",406932,"NHS","NHS actin remodeling regulator [Source:HGNC Symbol;Acc:HGNC:7820]","GO:0002088(lens development in camera-type eye);GO:0005794(Golgi apparatus);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030154(cell differentiation)","NA",{"v":6.3e-39,"d":"0.00"},1,"481,",0,{"v":-38.2,"d":"-38.20"},{"v":-37.1,"d":"-37.10"},{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 11 of 11)",31,14360228,14767640,407413,1]
["Y",15761578,15762007,430,"ENSBGRG00000014796","ENSBGRT00000028536",32492,"CDKL5","cyclin dependent kinase like 5 [Source:HGNC Symbol;Acc:HGNC:11411]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005813(centrosome);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0036064(ciliary basal body);GO:0046777(protein autophosphorylation);GO:0097542(ciliary tip);GO:1902017(regulation of cilium assembly)","NA",{"v":1.2E-5,"d":"0.00"},2,"105,285,","0,145",-4.91,-4.24,7.92,"Exon (ENSBGRT00000028536/ENSBGRG00000014796, exon 10 of 17)",31,15729086,15786225,57140,1]
["Y",16011689,16014583,2895,"ENSBGRG00000015703","ENSBGRT00000028907",136204,"PPEF1","protein phosphatase with EF-hand domain 1 [Source:HGNC Symbol;Acc:HGNC:9243]","GO:0004721(phosphoprotein phosphatase activity);GO:0005506(iron ion binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0016787(hydrolase activity);GO:0030145(manganese ion binding);GO:0050906(detection of stimulus involved in sensory perception)","NA",{"v":0.011,"d":"0.01"},3,"73,9,9,","0,2876,2886",-1.95,-1.18,8.91,"Exon (ENSBGRT00000028907/ENSBGRG00000015703, exon 16 of 20)",31,15875485,16016049,140565,1]
["Y",16418322,16419836,1515,"ENSBGRG00000016871","ENSBGRT00000031010",8027,"HCCS","holocytochrome c synthase [Source:HGNC Symbol;Acc:HGNC:4837]","GO:0004408(holocytochrome-c synthase activity);GO:0005739(mitochondrion)","00860(Porphyrin and chlorophyll metabolism)",{"v":5e-37,"d":"0.00"},2,"35,353,","0,1162",{"v":-36.3,"d":"-36.30"},{"v":-35.2,"d":"-35.20"},3.92,"3' UTR",31,16410295,16421237,10943,1]
["Y",17182465,17182555,91,"ENSBGRG00000017670","ENSBGRT00000032454",21307,"MSL3","MSL complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:7370]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-templated);GO:0035064(methylated histone binding);GO:0043984(histone H4-K16 acetylation);GO:0046972(histone acetyltransferase activity (H4-K16 specific));GO:0072487(MSL complex)","NA",{"v":0.0022,"d":"0.00"},1,"91,",0,-2.66,-2.08,1.32,"3' UTR",31,17161158,17182674,21517,1]
["Y",18151715,18157609,5895,"ENSBGRG00000018169","ENSBGRT00000034323",836460,"FRMPD4","FERM and PDZ domain containing 4 [Source:HGNC Symbol;Acc:HGNC:29007]","GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005856(cytoskeleton);GO:0032991(protein-containing complex);GO:0043197(dendritic spine);GO:0051835(positive regulation of synapse structural plasticity)","NA",{"v":4.2e-05,"d":"0.00"},2,"87,483,","0,5412",-4.38,-3.73,{"v":17.8,"d":"17.80"},"Exon (ENSBGRT00000034323/ENSBGRG00000018169, exon 14 of 19)",31,17315255,18162769,847515,1]
["Y",18157848,18159430,1583,"ENSBGRG00000018169","ENSBGRT00000034323",842593,"FRMPD4","FERM and PDZ domain containing 4 [Source:HGNC Symbol;Acc:HGNC:29007]","GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005856(cytoskeleton);GO:0032991(protein-containing complex);GO:0043197(dendritic spine);GO:0051835(positive regulation of synapse structural plasticity)","NA",{"v":1.2E-4,"d":"0.00"},2,"347,882,","0,701",-3.92,-3.28,{"v":14.9,"d":"14.90"},"Exon (ENSBGRT00000034323/ENSBGRG00000018169, exon 15 of 19)",31,17315255,18162769,847515,1]
["Y",18161557,18162365,809,"ENSBGRG00000018169","ENSBGRT00000034323",846302,"FRMPD4","FERM and PDZ domain containing 4 [Source:HGNC Symbol;Acc:HGNC:29007]","GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005856(cytoskeleton);GO:0032991(protein-containing complex);GO:0043197(dendritic spine);GO:0051835(positive regulation of synapse structural plasticity)","NA",{"v":1.2E-4,"d":"0.00"},1,"809,",0,-3.92,-3.28,{"v":14.9,"d":"14.90"},"3' UTR",31,17315255,18162769,847515,1]
["Y",18286537,18300754,14218,"ENSBGRG00000019181","ENSBGRT00000035382",0,"TLR7","toll like receptor 7 [Source:HGNC Symbol;Acc:HGNC:15631]","GO:0001932(regulation of protein phosphorylation);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007252(I-kappaB phosphorylation);GO:0016021(integral component of membrane);GO:0032009(early phagosome);GO:0032722(positive regulation of chemokine production);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032729(positive regulation of interferon-gamma production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0034154(toll-like receptor 7 signaling pathway);GO:0035197(siRNA binding);GO:0043235(receptor complex);GO:0051607(defense response to virus);GO:0071260(cellular response to mechanical stimulus);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04620(Toll-like receptor signaling pathway);05162(Measles);05164(Influenza A)",{"v":8.9e-06,"d":"0.00"},3,"37,122,497,","0,13406,13721",-5.05,-4.37,8.91,"5' UTR",31,18299943,18303404,3462,1]
["Y",18301082,18301886,805,"ENSBGRG00000019181","ENSBGRT00000035241",15879,"TLR7","toll like receptor 7 [Source:HGNC Symbol;Acc:HGNC:15631]","GO:0001932(regulation of protein phosphorylation);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007252(I-kappaB phosphorylation);GO:0016021(integral component of membrane);GO:0032009(early phagosome);GO:0032722(positive regulation of chemokine production);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032729(positive regulation of interferon-gamma production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0034154(toll-like receptor 7 signaling pathway);GO:0035197(siRNA binding);GO:0043235(receptor complex);GO:0051607(defense response to virus);GO:0071260(cellular response to mechanical stimulus);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04620(Toll-like receptor signaling pathway);05162(Measles);05164(Influenza A)",{"v":3.7E-7,"d":"0.00"},1,"805,",0,-6.43,-5.71,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000035241/ENSBGRG00000019181, exon 2 of 2)",31,18285203,18303404,18202,1]
["Y",18302213,18302809,597,"ENSBGRG00000019181","ENSBGRT00000035241",17010,"TLR7","toll like receptor 7 [Source:HGNC Symbol;Acc:HGNC:15631]","GO:0001932(regulation of protein phosphorylation);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007252(I-kappaB phosphorylation);GO:0016021(integral component of membrane);GO:0032009(early phagosome);GO:0032722(positive regulation of chemokine production);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032729(positive regulation of interferon-gamma production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0034154(toll-like receptor 7 signaling pathway);GO:0035197(siRNA binding);GO:0043235(receptor complex);GO:0051607(defense response to virus);GO:0071260(cellular response to mechanical stimulus);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04620(Toll-like receptor signaling pathway);05162(Measles);05164(Influenza A)",{"v":1.7e-07,"d":"0.00"},1,"597,",0,-6.77,-6.05,{"v":4.4,"d":"4.40"},"Exon (ENSBGRT00000035241/ENSBGRG00000019181, exon 2 of 2)",31,18285203,18303404,18202,1]
["Y",18302868,18303404,537,"ENSBGRG00000019181","ENSBGRT00000035241",17665,"TLR7","toll like receptor 7 [Source:HGNC Symbol;Acc:HGNC:15631]","GO:0001932(regulation of protein phosphorylation);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007252(I-kappaB phosphorylation);GO:0016021(integral component of membrane);GO:0032009(early phagosome);GO:0032722(positive regulation of chemokine production);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032729(positive regulation of interferon-gamma production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0034154(toll-like receptor 7 signaling pathway);GO:0035197(siRNA binding);GO:0043235(receptor complex);GO:0051607(defense response to virus);GO:0071260(cellular response to mechanical stimulus);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04620(Toll-like receptor signaling pathway);05162(Measles);05164(Influenza A)",{"v":4.1e-10,"d":"0.00"},1,"537,",0,-9.39,{"v":-8.6,"d":"-8.60"},4.25,"Exon (ENSBGRT00000035241/ENSBGRG00000019181, exon 2 of 2)",31,18285203,18303404,18202,1]
["Y",18342865,18343582,718,"ENSBGRG00000019302","ENSBGRT00000035414",60,"ENSBGRG00000019302","NA","NA","04620(Toll-like receptor signaling pathway)",{"v":0.036,"d":"0.04"},2,"363,353,","0,365",-1.44,{"v":-0.839,"d":"-0.84"},6.93,"Exon (ENSBGRT00000035414/ENSBGRG00000019302, exon 1 of 2)",31,18342805,18345905,3101,1]
["Y",18345130,18345399,270,"ENSBGRG00000019302","ENSBGRT00000035414",2325,"ENSBGRG00000019302","NA","NA","04620(Toll-like receptor signaling pathway)",{"v":0.0068,"d":"0.01"},1,"270,",0,-2.17,-1.62,5.94,"Exon (ENSBGRT00000035414/ENSBGRG00000019302, exon 2 of 2)",31,18342805,18345905,3101,1]
["Y",18345488,18345696,209,"ENSBGRG00000019302","ENSBGRT00000035414",2683,"ENSBGRG00000019302","NA","NA","04620(Toll-like receptor signaling pathway)",{"v":0.00022,"d":"0.00"},1,"209,",0,-3.66,-3.04,{"v":13.9,"d":"13.90"},"Exon (ENSBGRT00000035414/ENSBGRG00000019302, exon 2 of 2)",31,18342805,18345905,3101,1]
["Y",18381808,18382363,556,"ENSBGRG00000019310","ENSBGRT00000035484",0,"TMSB4Y","thymosin beta 4 X-linked [Source:HGNC Symbol;Acc:HGNC:11881]","GO:0003785(actin monomer binding);GO:0007015(actin filament organization)","04810(Regulation of actin cytoskeleton)",0,2,"100,35,","0,521",-387,"-Inf",1.67,"Exon (ENSBGRT00000035484/ENSBGRG00000019310, exon 1 of 2)",31,18381808,18382363,556,1]
["Y",1612392,1615711,3320,"ENSBGRG00000016756","ENSBGRT00000030731",0,"ENSBGRG00000016756","NA","NA","NA",{"v":1.9E-3,"d":"0.00"},2,"177,33,","0,3287",-2.73,-2.15,1.76,"Exon (ENSBGRT00000030731/ENSBGRG00000016756, exon 1 of 2)",31,1614161,1616960,2800,1]
["Y",1630607,1630667,61,"ENSBGRG00000016666","ENSBGRT00000030700",7382,"ENSBGRG00000016666","NA","NA","NA",{"v":0.018,"d":"0.02"},1,"61,",0,-1.74,-1.23,2.15,"Exon (ENSBGRT00000030700/ENSBGRG00000016666, exon 8 of 10)",31,1612302,1638049,25748,2]
["Y",2979009,2979279,271,"ENSBGRG00000017179","ENSBGRT00000031473",4121,"ENSBGRG00000017179","NA","NA","NA",0.02,1,"271,",0,-1.69,{"v":-0.977,"d":"-0.98"},7.92,"Exon (ENSBGRT00000031473/ENSBGRG00000017179, exon 2 of 2)",31,2974753,2983400,8648,2]
["Y",2982861,2983010,150,"ENSBGRG00000017179","ENSBGRT00000031473",390,"ENSBGRG00000017179","NA","NA","NA",0.02,1,"150,",0,{"v":-1.7,"d":"-1.70"},-1.19,4.95,"Exon (ENSBGRT00000031473/ENSBGRG00000017179, exon 1 of 2)",31,2974753,2983400,8648,2]
["Y",3653337,3653814,478,"ENSBGRG00000017387","ENSBGRT00000032306",131376,"STS","steroid sulfatase [Source:HGNC Symbol;Acc:HGNC:11425]","GO:0003824(catalytic activity);GO:0008484(sulfuric ester hydrolase activity)","00140(Steroid hormone biosynthesis)",{"v":4.7e-08,"d":"0.00"},1,"478,",0,-7.33,-6.59,{"v":13.4,"d":"13.40"},"3' UTR",31,3653337,3785190,131854,2]
["Y",3690030,3706371,16342,"ENSBGRG00000017387","ENSBGRT00000032306",78819,"STS","steroid sulfatase [Source:HGNC Symbol;Acc:HGNC:11425]","GO:0003824(catalytic activity);GO:0008484(sulfuric ester hydrolase activity)","00140(Steroid hormone biosynthesis)",{"v":0.036,"d":"0.04"},2,"141,9,","0,16333",-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000032306/ENSBGRG00000017387, exon 7 of 9)",31,3653337,3785190,131854,2]
["Y",3751118,3757707,6590,"ENSBGRG00000017387","ENSBGRT00000032306",27483,"STS","steroid sulfatase [Source:HGNC Symbol;Acc:HGNC:11425]","GO:0003824(catalytic activity);GO:0008484(sulfuric ester hydrolase activity)","00140(Steroid hormone biosynthesis)",{"v":0.011,"d":"0.01"},3,"36,123,51,","0,6312,6539",-1.95,-1.18,8.91,"Exon (ENSBGRT00000032306/ENSBGRG00000017387, exon 3 of 9)",31,3653337,3785190,131854,2]
["Y",7122200,7155938,33739,"ENSBGRG00000018981","ENSBGRT00000034786",0,"ENSBGRG00000018981","NA","GO:0003824(catalytic activity);GO:0008484(sulfuric ester hydrolase activity)","NA",{"v":0.0013,"d":"0.00"},2,"170,10,","0,33729",{"v":-2.9,"d":"-2.90"},-2.31,7.43,"5' UTR",31,7141164,7148026,6863,1]
["Y",7190919,7191573,655,"ENSBGRG00000019017","ENSBGRT00000034857",37375,"ENSBGRG00000019017","NA","NA","00500(Starch and sucrose metabolism)",{"v":9.99999999999998e-278,"d":"0.00"},1,"655,",0,-277,-274,{"v":12.1,"d":"12.10"},"3' UTR",31,7190919,7228948,38030,2]
["Y",7191751,7192019,269,"ENSBGRG00000019017","ENSBGRT00000034857",36929,"ENSBGRG00000019017","NA","NA","00500(Starch and sucrose metabolism)",{"v":2E-14,"d":"0.00"},1,"269,",0,{"v":-13.7,"d":"-13.70"},{"v":-12.8,"d":"-12.80"},1.99,"3' UTR",31,7190919,7228948,38030,2]
["Y",7192227,7193941,1715,"ENSBGRG00000019017","ENSBGRT00000034857",35007,"ENSBGRG00000019017","NA","NA","00500(Starch and sucrose metabolism)",{"v":1.3E-64,"d":"0.00"},2,"511,55,","0,1660",{"v":-63.9,"d":"-63.90"},{"v":-62.5,"d":"-62.50"},{"v":7.9,"d":"7.90"},"3' UTR",31,7190919,7228948,38030,2]
["Y",7236432,7242594,6163,"ENSBGRG00000019127","ENSBGRT00000035103",23424,"CD99","CD99 molecule (Xg blood group) [Source:HGNC Symbol;Acc:HGNC:7082]","NA","04514(Cell adhesion molecules (CAMs));04670(Leukocyte transendothelial migration)",0,3,"600,54,4,","0,795,6159",-2040,"-Inf",4.47,"3' UTR",31,7236432,7266018,29587,2]
["Y",7783831,7784245,415,"ENSBGRG00000019382","ENSBGRT00000035601",32102,"ASMT","acetylserotonin O-methyltransferase [Source:HGNC Symbol;Acc:HGNC:750]","GO:0008168(methyltransferase activity);GO:0008171(O-methyltransferase activity);GO:0016740(transferase activity);GO:0017096(acetylserotonin O-methyltransferase activity);GO:0030187(melatonin biosynthetic process);GO:0032259(methylation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity)","00380(Tryptophan metabolism)",{"v":0.00052,"d":"0.00"},1,"415,",0,-3.28,-2.68,{"v":13.9,"d":"13.90"},"3' UTR",31,7783831,7816347,32517,2]
["Y",7830647,7830947,301,"ENSBGRG00000019461","ENSBGRT00000035765",12020,"AKAP17A","A-kinase anchoring protein 17A [Source:HGNC Symbol;Acc:HGNC:18783]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0043484(regulation of RNA splicing);GO:0051018(protein kinase A binding)","NA",{"v":7.2e-06,"d":"0.00"},1,"301,",0,-5.14,-4.45,{"v":6.6,"d":"6.60"},"Exon (ENSBGRT00000035765/ENSBGRG00000019461, exon 7 of 7)",31,7830647,7842967,12321,2]
["Y",7831692,7839133,7442,"ENSBGRG00000019461","ENSBGRT00000035765",3834,"AKAP17A","A-kinase anchoring protein 17A [Source:HGNC Symbol;Acc:HGNC:18783]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0043484(regulation of RNA splicing);GO:0051018(protein kinase A binding)","NA",{"v":1e-106,"d":"0.00"},5,"30,318,241,149,701,","0,90,2563,5884,6741",-106,-104,7.78,"Exon (ENSBGRT00000035765/ENSBGRG00000019461, exon 2 of 7)",31,7830647,7842967,12321,2]
["Y",8020139,8020378,240,"ENSBGRG00000007304","ENSBGRT00000013396",0,"ENSBGRG00000007304","NA","GO:0004896(cytokine receptor activity);GO:0005515(protein binding);GO:0016020(membrane)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage);05200(Pathways in cancer)",{"v":5e-24,"d":"0.00"},1,"240,",0,{"v":-23.3,"d":"-23.30"},{"v":-22.4,"d":"-22.40"},4.42,"5' UTR",31,8002269,8020378,18110,2]
["Y",8774629,8775442,814,"ENSBGRG00000007868","ENSBGRT00000014467",13798,"GTPBP6","GTP binding protein 6 (putative) [Source:HGNC Symbol;Acc:HGNC:30189]","GO:0005525(GTP binding)","00250(Alanine, aspartate and glutamate metabolism)",{"v":0.0003,"d":"0.00"},2,"209,2,","0,812",-3.53,-2.91,1.87,"Exon (ENSBGRT00000014802/ENSBGRG00000008103, exon 7 of 7)",31,8760831,8779045,18215,1]
["Y",8778158,8781541,3384,"ENSBGRG00000007868","ENSBGRT00000014467",17327,"GTPBP6","GTP binding protein 6 (putative) [Source:HGNC Symbol;Acc:HGNC:30189]","GO:0005525(GTP binding)","00250(Alanine, aspartate and glutamate metabolism)",{"v":0.044,"d":"0.04"},2,"48,43,","0,3341",-1.36,{"v":-0.876,"d":"-0.88"},1.43,"3' UTR",31,8760831,8779045,18215,1]
["Y",8785358,8789568,4211,"ENSBGRG00000008103","ENSBGRT00000014802",60,"PLCXD1","phosphatidylinositol specific phospholipase C X domain containing 1 [Source:HGNC Symbol;Acc:HGNC:23148]","GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity)","NA",{"v":0.00023,"d":"0.00"},2,"94,177,","0,4034",-3.63,-3.01,4.95,"5' UTR",31,8774599,8789628,15030,2]
["Y",8939088,8939296,209,"ENSBGRG00000008177","ENSBGRT00000014938",683,"ENSBGRG00000008177","NA","NA","NA",{"v":2.3E-3,"d":"0.00"},1,"209,",0,-2.63,-2.05,6.93,"Exon (ENSBGRT00000014938/ENSBGRG00000008177, exon 1 of 1)",31,8938672,8939979,1308,2]
["Y",9450636,9450904,269,"ENSBGRG00000008397","ENSBGRT00000015543",154269,"MID1","midline 1 [Source:HGNC Symbol;Acc:HGNC:7095]","GO:0005515(protein binding);GO:0005874(microtubule);GO:0005881(cytoplasmic microtubule);GO:0008017(microtubule binding);GO:0008270(zinc ion binding);GO:0019899(enzyme binding);GO:0031625(ubiquitin protein ligase binding);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0035372(protein localization to microtubule);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0051219(phosphoprotein binding)","04120(Ubiquitin mediated proteolysis)",{"v":6.3e-12,"d":"0.00"},1,"269,",0,{"v":-11.2,"d":"-11.20"},{"v":-10.4,"d":"-10.40"},3.53,"Exon (ENSBGRT00000015543/ENSBGRG00000008397, exon 11 of 11)",31,9450636,9605173,154538,2]
["Y",10367524,10503504,135981,"ENSBGRG00000009564","ENSBGRT00000017751",0,"GPM6B","glycoprotein M6B [Source:HGNC Symbol;Acc:HGNC:4461]","GO:0016021(integral component of membrane);GO:0030501(positive regulation of bone mineralization);GO:0032956(regulation of actin cytoskeleton organization);GO:0051893(regulation of focal adhesion assembly);GO:0085029(extracellular matrix assembly)","NA",{"v":0.0016,"d":"0.00"},4,"58,61,7,175,","0,12049,76012,135806",{"v":-2.8,"d":"-2.80"},-2.21,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000017751/ENSBGRG00000009564, exon 1 of 9)",31,10327526,10379633,52108,2]
["Y",10504492,10506543,2052,"ENSBGRG00000009564","ENSBGRT00000017636",0,"GPM6B","glycoprotein M6B [Source:HGNC Symbol;Acc:HGNC:4461]","GO:0016021(integral component of membrane);GO:0030501(positive regulation of bone mineralization);GO:0032956(regulation of actin cytoskeleton organization);GO:0051893(regulation of focal adhesion assembly);GO:0085029(extracellular matrix assembly)","NA",0.02,2,"8,173,","0,1879",-1.69,{"v":-0.977,"d":"-0.98"},7.92,"5' UTR",31,10327526,10504499,176974,2]
["Y",12039315,12039375,61,"ENSBGRG00000010354","ENSBGRT00000019266",31942,"ENSBGRG00000010354","NA","GO:0005515(protein binding);GO:0006506(GPI anchor biosynthetic process);GO:0035556(intracellular signal transduction)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":0.015,"d":"0.02"},1,"61,",0,-1.83,-1.31,2.69,"3' UTR",31,12039315,12071317,32003,2]
["Y",12039435,12039494,60,"ENSBGRG00000010354","ENSBGRT00000019266",31823,"ENSBGRG00000010354","NA","GO:0005515(protein binding);GO:0006506(GPI anchor biosynthetic process);GO:0035556(intracellular signal transduction)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":0.043,"d":"0.04"},1,"60,",0,-1.37,{"v":-0.881,"d":"-0.88"},1.52,"3' UTR",31,12039315,12071317,32003,2]
["Y",12077885,12081342,3458,"ENSBGRG00000010354","ENSBGRT00000019031",1330,"ENSBGRG00000010354","NA","GO:0005515(protein binding);GO:0006506(GPI anchor biosynthetic process);GO:0035556(intracellular signal transduction)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":6.5e-05,"d":"0.00"},2,"243,26,","0,3432",-4.19,-3.55,2.48,"Exon (ENSBGRT00000019031/ENSBGRG00000010354, exon 3 of 11)",31,12039315,12082672,43358,2]
["Y",12086760,12087029,270,"ENSBGRG00000010354","ENSBGRT00000019351",2963,"ENSBGRG00000010354","NA","GO:0005515(protein binding);GO:0006506(GPI anchor biosynthetic process);GO:0035556(intracellular signal transduction)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":1E-4,"d":"0.00"},1,"270,",0,-3.99,-3.35,3.08,"Exon (ENSBGRT00000019351/ENSBGRG00000010354, exon 2 of 13)",31,12040798,12089992,49195,2]
["Y",12087178,12089962,2785,"ENSBGRG00000010354","ENSBGRT00000019827",0,"ENSBGRG00000010354","NA","GO:0005515(protein binding);GO:0006506(GPI anchor biosynthetic process);GO:0035556(intracellular signal transduction)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":1.3e-12,"d":"0.00"},2,"222,78,","0,2707",{"v":-11.9,"d":"-11.90"},-11,6.14,"5' UTR",31,12077205,12087337,10133,2]
["Y",12327709,12332687,4979,"ENSBGRG00000011584","ENSBGRT00000021468",50555,"ACE2","angiotensin I converting enzyme 2 [Source:HGNC Symbol;Acc:HGNC:13557]","GO:0001618(virus receptor activity);GO:0003051(angiotensin-mediated drinking behavior);GO:0003081(regulation of systemic arterial blood pressure by renin-angiotensin);GO:0004175(endopeptidase activity);GO:0004180(carboxypeptidase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0008241(peptidyl-dipeptidase activity);GO:0009986(cell surface);GO:0015827(tryptophan transport);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0022898(regulation of transmembrane transporter activity);GO:0031526(brush border membrane);GO:0032800(receptor biosynthetic process);GO:0046718(viral entry into host cell);GO:0046813(receptor-mediated virion attachment to host cell);GO:0051957(positive regulation of amino acid transport);GO:0060452(positive regulation of cardiac muscle contraction);GO:1903598(positive regulation of gap junction assembly);GO:1903779(regulation of cardiac conduction);GO:1905737(positive regulation of L-proline import across plasma membrane)","04614(Renin-angiotensin system);04974(Protein digestion and absorption)",{"v":7.8e-05,"d":"0.00"},3,"100,288,92,","0,2515,4887",-4.11,-3.46,3.96,"3' UTR",31,12327679,12383242,55564,2]
["Y",12409728,12410024,297,"ENSBGRG00000012004","ENSBGRT00000021940",50379,"ENSBGRG00000012004","NA","NA","NA",{"v":5e-28,"d":"0.00"},1,"297,",0,{"v":-27.3,"d":"-27.30"},{"v":-26.3,"d":"-26.30"},3.03,"3' UTR",31,12409698,12460403,50706,2]
["Y",12410172,12410468,297,"ENSBGRG00000012004","ENSBGRT00000021940",49935,"ENSBGRG00000012004","NA","NA","NA",{"v":3.2E-40,"d":"0.00"},1,"297,",0,{"v":-39.5,"d":"-39.50"},{"v":-38.3,"d":"-38.30"},3.09,"3' UTR",31,12409698,12460403,50706,2]
["Y",13407445,13407535,91,"ENSBGRG00000012368","ENSBGRT00000022646",126265,"CTPS2","CTP synthase 2 [Source:HGNC Symbol;Acc:HGNC:2520]","GO:0003883(CTP synthase activity);GO:0006221(pyrimidine nucleotide biosynthetic process);GO:0006241(CTP biosynthetic process);GO:0042802(identical protein binding)","00240(Pyrimidine metabolism)",{"v":4.3e-07,"d":"0.00"},1,"91,",0,-6.37,-5.65,2.07,"3' UTR",31,13407445,13533800,126356,2]
["Y",14818693,14820596,1904,"ENSBGRG00000014390","ENSBGRT00000026401",79512,"RAI2","retinoic acid induced 2 [Source:HGNC Symbol;Acc:HGNC:9835]","NA","NA",{"v":2e-62,"d":"0.00"},2,"29,778,","0,1126",{"v":-61.7,"d":"-61.70"},{"v":-60.4,"d":"-60.40"},4.56,"Exon (ENSBGRT00000026401/ENSBGRG00000014390, exon 2 of 4)",31,14751100,14900108,149009,2]
["Y",14821223,14821313,91,"ENSBGRG00000014390","ENSBGRT00000026401",78795,"RAI2","retinoic acid induced 2 [Source:HGNC Symbol;Acc:HGNC:9835]","NA","NA",{"v":1.1e-09,"d":"0.00"},1,"91,",0,-8.97,-8.19,1.87,"Exon (ENSBGRT00000026401/ENSBGRG00000014390, exon 2 of 4)",31,14751100,14900108,149009,2]
["Y",15471921,15482445,10525,"ENSBGRG00000014565","ENSBGRT00000026792",0,"SCML2","Scm polycomb group protein like 2 [Source:HGNC Symbol;Acc:HGNC:10581]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0009653(anatomical structure morphogenesis);GO:0031519(PcG protein complex)","NA",{"v":0.0013,"d":"0.00"},3,"65,69,46,","0,8106,10479",{"v":-2.9,"d":"-2.90"},-2.31,7.43,"5' UTR",31,15344211,15482445,138235,2]
["Y",16075614,16076273,660,"ENSBGRG00000015880","ENSBGRT00000029238",105799,"PHKA2","phosphorylase kinase regulatory subunit alpha 2 [Source:HGNC Symbol;Acc:HGNC:8926]","GO:0003824(catalytic activity);GO:0005516(calmodulin binding);GO:0005977(glycogen metabolic process)","04020(Calcium signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway)",{"v":1.3E-43,"d":"0.00"},1,"660,",0,{"v":-42.9,"d":"-42.90"},{"v":-41.8,"d":"-41.80"},6.85,"3' UTR",31,16075134,16182072,106939,2]
["Y",16076839,16077079,241,"ENSBGRG00000015880","ENSBGRT00000029238",104993,"PHKA2","phosphorylase kinase regulatory subunit alpha 2 [Source:HGNC Symbol;Acc:HGNC:8926]","GO:0003824(catalytic activity);GO:0005516(calmodulin binding);GO:0005977(glycogen metabolic process)","04020(Calcium signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway)",{"v":6.6e-05,"d":"0.00"},1,"241,",0,-4.18,-3.53,{"v":13.9,"d":"13.90"},"3' UTR",31,16075134,16182072,106939,2]
["Y",16434641,16440769,6129,"ENSBGRG00000016957","ENSBGRT00000031345",120937,"ARHGAP6","Rho GTPase activating protein 6 [Source:HGNC Symbol;Acc:HGNC:676]","GO:0005096(GTPase activator activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007015(actin filament organization);GO:0007165(signal transduction);GO:0015629(actin cytoskeleton);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0048041(focal adhesion assembly);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly)","NA",{"v":9.99999999999998e-218,"d":"0.00"},3,"672,81,53,","0,3942,6076",-217,-215,{"v":16.2,"d":"16.20"},"3' UTR",31,16434313,16561706,127394,2]
["chr1",61183862,61214506,30645,"ENSBGRG00000000255","ENSBGRT00000000490",90,"PHLDB2","pleckstrin homology like domain family B member 2 [Source:HGNC Symbol;Acc:HGNC:29573]","GO:0000226(microtubule cytoskeleton organization);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0010470(regulation of gastrulation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0031252(cell leading edge);GO:0045111(intermediate filament cytoskeleton);GO:0045180(basal cortex);GO:0045184(establishment of protein localization);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:1903690(negative regulation of wound healing, spreading of epidermal cells);GO:1904261(positive regulation of basement membrane assembly involved in embryonic body morphogenesis)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);04141(Protein processing in endoplasmic reticulum)",{"v":7.9e-37,"d":"0.00"},2,"25,246,","0,30399",{"v":-36.1,"d":"-36.10"},-35,7.06,"5' UTR",1,61183772,61303761,119990,1]
["chr1",61214656,61250114,35459,"ENSBGRG00000000255","ENSBGRT00000000490",30884,"PHLDB2","pleckstrin homology like domain family B member 2 [Source:HGNC Symbol;Acc:HGNC:29573]","GO:0000226(microtubule cytoskeleton organization);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0010470(regulation of gastrulation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0031252(cell leading edge);GO:0045111(intermediate filament cytoskeleton);GO:0045180(basal cortex);GO:0045184(establishment of protein localization);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:1903690(negative regulation of wound healing, spreading of epidermal cells);GO:1904261(positive regulation of basement membrane assembly involved in embryonic body morphogenesis)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);04141(Protein processing in endoplasmic reticulum)",{"v":1e-101,"d":"0.00"},4,"954,384,144,138,","0,22858,33960,35321",-101,{"v":-99.1,"d":"-99.10"},7.28,"Exon (ENSBGRT00000000490/ENSBGRG00000000255, exon 2 of 19)",1,61183772,61303761,119990,1]
["chr1",61306752,61311797,5046,"ENSBGRG00000000255","ENSBGRT00000000416",122980,"PHLDB2","pleckstrin homology like domain family B member 2 [Source:HGNC Symbol;Acc:HGNC:29573]","GO:0000226(microtubule cytoskeleton organization);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0010470(regulation of gastrulation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0031252(cell leading edge);GO:0045111(intermediate filament cytoskeleton);GO:0045180(basal cortex);GO:0045184(establishment of protein localization);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:1903690(negative regulation of wound healing, spreading of epidermal cells);GO:1904261(positive regulation of basement membrane assembly involved in embryonic body morphogenesis)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);04141(Protein processing in endoplasmic reticulum)",{"v":9.99999999999999e-203,"d":"0.00"},3,"134,86,141,","0,4266,4905",-202,-200,2.66,"Exon (ENSBGRT00000000416/ENSBGRG00000000255, exon 16 of 18)",1,61183772,61311797,128026,1]
["chr1",95557314,95558682,1369,"ENSBGRG00000003142","ENSBGRT00000005846",0,"MFN1","mitofusin 1 [Source:HGNC Symbol;Acc:HGNC:18262]","GO:0003676(nucleic acid binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0008053(mitochondrial fusion);GO:0010918(positive regulation of mitochondrial membrane potential);GO:0016021(integral component of membrane);GO:0031307(integral component of mitochondrial outer membrane);GO:0042802(identical protein binding);GO:0046039(GTP metabolic process);GO:0051646(mitochondrion localization);GO:0098799(outer mitochondrial membrane protein complex);GO:1990613(mitochondrial membrane fusion)","04137(Mitophagy - animal);04621(NOD-like receptor signaling pathway)",{"v":1E-173,"d":"0.00"},2,"1154,66,","0,1303",-173,-171,{"v":14.8,"d":"14.80"},"Exon (ENSBGRT00000005846/ENSBGRG00000003142, exon 1 of 18)",1,95499008,95557831,58824,2]
["chr2",135117504,135117714,211,"ENSBGRG00000002427","ENSBGRT00000004514",2197,"ENSBGRG00000002427","NA","NA","NA",{"v":0.034,"d":"0.03"},1,"211,",0,-1.47,{"v":-0.977,"d":"-0.98"},6.93,"Exon (ENSBGRT00000004514/ENSBGRG00000002427, exon 2 of 2)",2,135115736,135119911,4176,2]
["chr2",135117804,135118163,360,"ENSBGRG00000002427","ENSBGRT00000004514",1748,"ENSBGRG00000002427","NA","NA","NA",{"v":2.6e-06,"d":"0.00"},1,"360,",0,-5.58,-4.89,{"v":21.8,"d":"21.80"},"Exon (ENSBGRT00000004514/ENSBGRG00000002427, exon 2 of 2)",2,135115736,135119911,4176,2]
["chr2",135118373,135118433,61,"ENSBGRG00000002427","ENSBGRT00000004514",1478,"ENSBGRG00000002427","NA","NA","NA",{"v":0.0044,"d":"0.00"},1,"61,",0,-2.36,{"v":-1.8,"d":"-1.80"},3.14,"Exon (ENSBGRT00000004514/ENSBGRG00000002427, exon 2 of 2)",2,135115736,135119911,4176,2]
["chr4",101643364,101643872,509,"ENSBGRG00000002148","ENSBGRT00000004007",0,"ENSBGRG00000002148","NA","NA","NA",{"v":3.3E-3,"d":"0.00"},1,"509,",0,-2.48,-1.91,{"v":10.9,"d":"10.90"},"Exon (ENSBGRT00000004007/ENSBGRG00000002148, exon 1 of 2)",4,101579906,101643872,63967,2]
["chr5",81708243,81708951,709,"ENSBGRG00000003819","ENSBGRT00000007091",0,"HOXC9","homeobox C9 [Source:HGNC Symbol;Acc:HGNC:5130]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0009952(anterior/posterior pattern specification);GO:0016235(aggresome);GO:0043565(sequence-specific DNA binding);GO:0048704(embryonic skeletal system morphogenesis);GO:0048706(embryonic skeletal system development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":6.3E-3,"d":"0.01"},2,"269,147,","0,562",{"v":-2.2,"d":"-2.20"},-1.66,3.96,"5' UTR",5,81708805,81720928,12124,1]
["chr5",81718299,81720786,2488,"ENSBGRG00000003819","ENSBGRT00000007074",10145,"HOXC9","homeobox C9 [Source:HGNC Symbol;Acc:HGNC:5130]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0009952(anterior/posterior pattern specification);GO:0016235(aggresome);GO:0043565(sequence-specific DNA binding);GO:0048704(embryonic skeletal system morphogenesis);GO:0048706(embryonic skeletal system development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":5e-11,"d":"0.00"},2,"668,103,","0,2385",{"v":-10.3,"d":"-10.30"},-9.45,5.61,"5' UTR",5,81708154,81720928,12775,1]
["chr5",81720964,81721260,297,"ENSBGRG00000003819","ENSBGRT00000007113",2761,"HOXC9","homeobox C9 [Source:HGNC Symbol;Acc:HGNC:5130]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0009952(anterior/posterior pattern specification);GO:0016235(aggresome);GO:0043565(sequence-specific DNA binding);GO:0048704(embryonic skeletal system morphogenesis);GO:0048706(embryonic skeletal system development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":7.9e-62,"d":"0.00"},1,"297,",0,{"v":-61.1,"d":"-61.10"},{"v":-59.8,"d":"-59.80"},5.14,"3' UTR",5,81718203,81721260,3058,1]
["chr8",7347229,7347349,121,"ENSBGRG00000003078","ENSBGRT00000005739",986,"ENSBGRG00000003078","NA","NA","NA",{"v":7.9e-11,"d":"0.00"},1,"121,",0,{"v":-10.1,"d":"-10.10"},-9.34,{"v":10.1,"d":"10.10"},"Exon (ENSBGRT00000005739/ENSBGRG00000003078, exon 2 of 2)",8,7342239,7348335,6097,2]
["chr9",2658020,2658408,389,"ENSBGRG00000016924","ENSBGRT00000031069",487,"ENSBGRG00000016924","NA","NA","NA",{"v":0.00022,"d":"0.00"},1,"389,",0,-3.66,-3.04,{"v":14.9,"d":"14.90"},"Exon (ENSBGRT00000031069/ENSBGRG00000016924, exon 1 of 2)",9,2657453,2658895,1443,2]
["chr9",7532675,7533033,359,"ENSBGRG00000009047","ENSBGRT00000017212",4425,"ENSBGRG00000009047","NA","NA","NA",0.02,1,"359,",0,-1.69,{"v":-0.941,"d":"-0.94"},7.92,"Exon (ENSBGRT00000017212/ENSBGRG00000009047, exon 3 of 3)",9,7531809,7537458,5650,2]
["chr9",7533093,7533242,150,"ENSBGRG00000009047","ENSBGRT00000017212",4216,"ENSBGRG00000009047","NA","NA","NA",{"v":0.0062,"d":"0.01"},1,"150,",0,-2.21,-1.67,9.91,"Exon (ENSBGRT00000017212/ENSBGRG00000009047, exon 3 of 3)",9,7531809,7537458,5650,2]
["chr11",9069424,9069843,420,"ENSBGRG00000022370","ENSBGRT00000041311",0,"ENSBGRG00000022370","NA","NA","NA",{"v":7.9e-09,"d":"0.00"},1,"420,",0,{"v":-8.1,"d":"-8.10"},-7.34,8.32,"Exon (ENSBGRT00000041311/ENSBGRG00000022370, exon 1 of 2)",11,9066932,9069778,2847,2]
["chr17",71970567,71970627,61,"ENSBGRG00000011625","ENSBGRT00000021160",400,"ENSBGRG00000011625","NA","NA","NA",{"v":0.036,"d":"0.04"},1,"61,",0,-1.44,{"v":-0.712,"d":"-0.71"},6.93,"Exon (ENSBGRT00000021160/ENSBGRG00000011625, exon 1 of 3)",17,71965931,71971027,5097,2]
["chr20",66492813,66494912,2100,"ENSBGRG00000020492","ENSBGRT00000038236",29124,"AKT2","AKT serine/threonine kinase 2 [Source:HGNC Symbol;Acc:HGNC:392]","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006006(glucose metabolic process);GO:0006468(protein phosphorylation);GO:0008284(positive regulation of cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0010748(negative regulation of long-chain fatty acid import across plasma membrane);GO:0010907(positive regulation of glucose metabolic process);GO:0010918(positive regulation of mitochondrial membrane potential);GO:0030335(positive regulation of cell migration);GO:0031340(positive regulation of vesicle fusion);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0032287(peripheral nervous system myelin maintenance);GO:0032587(ruffle membrane);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0046326(positive regulation of glucose import);GO:0065002(intracellular protein transmembrane transport);GO:0071486(cellular response to high light intensity);GO:0072659(protein localization to plasma membrane);GO:0090314(positive regulation of protein targeting to membrane);GO:0090630(activation of GTPase activity);GO:0097473(retinal rod cell apoptotic process);GO:2000147(positive regulation of cell motility)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04371(Apelin signaling pathway);04630(Jak-STAT signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04218(Cellular senescence);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04919(Thyroid hormone signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04973(Carbohydrate digestion and absorption);04725(Cholinergic synapse);04728(Dopaminergic synapse);04722(Neurotrophin signaling pathway);04380(Osteoclast differentiation);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05205(Proteoglycans in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05152(Tuberculosis);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05145(Toxoplasmosis);05142(Chagas disease (American trypanosomiasis));01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":1E-135,"d":"0.00"},2,"18,1116,","0,984",-135,-134,3.05,"3' UTR",20,66463689,66494176,30488,1]
["chr20",66495211,66495330,120,"ENSBGRG00000020492","ENSBGRT00000038161",31522,"AKT2","AKT serine/threonine kinase 2 [Source:HGNC Symbol;Acc:HGNC:392]","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006006(glucose metabolic process);GO:0006468(protein phosphorylation);GO:0008284(positive regulation of cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0010748(negative regulation of long-chain fatty acid import across plasma membrane);GO:0010907(positive regulation of glucose metabolic process);GO:0010918(positive regulation of mitochondrial membrane potential);GO:0030335(positive regulation of cell migration);GO:0031340(positive regulation of vesicle fusion);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0032287(peripheral nervous system myelin maintenance);GO:0032587(ruffle membrane);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0046326(positive regulation of glucose import);GO:0065002(intracellular protein transmembrane transport);GO:0071486(cellular response to high light intensity);GO:0072659(protein localization to plasma membrane);GO:0090314(positive regulation of protein targeting to membrane);GO:0090630(activation of GTPase activity);GO:0097473(retinal rod cell apoptotic process);GO:2000147(positive regulation of cell motility)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04371(Apelin signaling pathway);04630(Jak-STAT signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04218(Cellular senescence);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04919(Thyroid hormone signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04973(Carbohydrate digestion and absorption);04725(Cholinergic synapse);04728(Dopaminergic synapse);04722(Neurotrophin signaling pathway);04380(Osteoclast differentiation);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05205(Proteoglycans in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05152(Tuberculosis);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05145(Toxoplasmosis);05142(Chagas disease (American trypanosomiasis));01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":1.9e-10,"d":"0.00"},1,"120,",0,-9.72,-8.93,2.71,"3' UTR",20,66463689,66495330,31642,1]
["chr20",59646393,59647409,1017,"ENSBGRG00000018680","ENSBGRT00000034477",4605,"BAX","BCL2 associated X, apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:959]","GO:0001541(ovarian follicle development);GO:0001764(neuron migration);GO:0001776(leukocyte homeostasis);GO:0001777(T cell homeostatic proliferation);GO:0001782(B cell homeostasis);GO:0001783(B cell apoptotic process);GO:0001822(kidney development);GO:0001836(release of cytochrome c from mitochondria);GO:0001844(protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:0001974(blood vessel remodeling);GO:0002262(myeloid cell homeostasis);GO:0002352(B cell negative selection);GO:0002358(B cell homeostatic proliferation);GO:0002904(positive regulation of B cell apoptotic process);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005757(mitochondrial permeability transition pore complex);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0006687(glycosphingolipid metabolic process);GO:0006808(regulation of nitrogen utilization);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006974(cellular response to DNA damage stimulus);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0007399(nervous system development);GO:0007548(sex differentiation);GO:0008053(mitochondrial fusion);GO:0008199(ferric iron binding);GO:0008283(cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008289(lipid binding);GO:0008584(male gonad development);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0008635(activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c);GO:0008637(apoptotic mitochondrial changes);GO:0009566(fertilization);GO:0009611(response to wounding);GO:0009636(response to toxic substance);GO:0009651(response to salt stress);GO:0009791(post-embryonic development);GO:0010212(response to ionizing radiation);GO:0010248(establishment or maintenance of transmembrane electrochemical gradient);GO:0010332(response to gamma radiation);GO:0010524(positive regulation of calcium ion transport into cytosol);GO:0010917(negative regulation of mitochondrial membrane potential);GO:0015267(channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021854(hypothalamus development);GO:0021987(cerebral cortex development);GO:0030544(Hsp70 protein binding);GO:0031334(positive regulation of protein-containing complex assembly);GO:0031966(mitochondrial membrane);GO:0032091(negative regulation of protein binding);GO:0032471(negative regulation of endoplasmic reticulum calcium ion concentration);GO:0032976(release of matrix enzymes from mitochondria);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0033599(regulation of mammary gland epithelial cell proliferation);GO:0034644(cellular response to UV);GO:0035108(limb morphogenesis);GO:0035234(ectopic germ cell programmed cell death);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043281(regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0043525(positive regulation of neuron apoptotic process);GO:0043653(mitochondrial fragmentation involved in apoptotic process);GO:0045136(development of secondary sexual characteristics);GO:0046666(retinal cell programmed cell death);GO:0046930(pore complex);GO:0046982(protein heterodimerization activity);GO:0048087(positive regulation of developmental pigmentation);GO:0048147(negative regulation of fibroblast proliferation);GO:0048515(spermatid differentiation);GO:0048597(post-embryonic camera-type eye morphogenesis);GO:0048678(response to axon injury);GO:0048872(homeostasis of number of cells);GO:0048873(homeostasis of number of cells within a tissue);GO:0051087(chaperone binding);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0051402(neuron apoptotic process);GO:0051434(BH3 domain binding);GO:0051726(regulation of cell cycle);GO:0051881(regulation of mitochondrial membrane potential);GO:0060011(Sertoli cell proliferation);GO:0060041(retina development in camera-type eye);GO:0060058(positive regulation of apoptotic process involved in mammary gland involution);GO:0060068(vagina development);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress);GO:0070242(thymocyte apoptotic process);GO:0070584(mitochondrion morphogenesis);GO:0071310(cellular response to organic substance);GO:0071944(cell periphery);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0097136(Bcl-2 family protein complex);GO:0097144(BAX complex);GO:0097145(BAK complex);GO:0097190(apoptotic signaling pathway);GO:0097191(extrinsic apoptotic signaling pathway);GO:0097192(extrinsic apoptotic signaling pathway in absence of ligand);GO:0097193(intrinsic apoptotic signaling pathway);GO:0097296(activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway);GO:1900103(positive regulation of endoplasmic reticulum unfolded protein response);GO:1902108(regulation of mitochondrial membrane permeability involved in apoptotic process);GO:1902110(positive regulation of mitochondrial membrane permeability involved in apoptotic process);GO:1902262(apoptotic process involved in blood vessel morphogenesis);GO:1902263(apoptotic process involved in embryonic digit morphogenesis);GO:1902445(regulation of mitochondrial membrane permeability involved in programmed necrotic cell death);GO:1902512(positive regulation of apoptotic DNA fragmentation);GO:1990117(B cell receptor apoptotic signaling pathway);GO:2001234(negative regulation of apoptotic signaling pathway);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","04216(Ferroptosis);04217(Necroptosis);04978(Mineral absorption);04141(Protein processing in endoplasmic reticulum);04071(Sphingolipid signaling pathway);04210(Apoptosis);04215(Apoptosis - multiple species);04115(p53 signaling pathway);04722(Neurotrophin signaling pathway);04211(Longevity regulating pathway - mammal);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05216(Thyroid cancer);05220(Chronic myeloid leukemia);05217(Basal cell carcinoma);05218(Melanoma);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05014(Amyotrophic lateral sclerosis (ALS));05016(Huntington disease);05020(Prion diseases);04932(Non-alcoholic fatty liver disease (NAFLD));04933(AGE-RAGE signaling pathway in diabetic complications);05152(Tuberculosis);05166(HTLV-I infection);05161(Hepatitis B);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection);01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":1.1E-5,"d":"0.00"},2,"83,98,","0,919",-4.94,-4.26,{"v":19.8,"d":"19.80"},"3' UTR",20,59641685,59652014,10330,2]
["chr25",55950210,55950960,751,"ENSBGRG00000013010","ENSBGRT00000023773",0,"ENSBGRG00000013010","NA","NA","NA",{"v":3.8e-09,"d":"0.00"},1,"751,",0,-8.42,-7.65,{"v":18.8,"d":"18.80"},"Exon (ENSBGRT00000023756/ENSBGRG00000013010, exon 2 of 2)",25,55950210,55967242,17033,1]
["chr25",55964993,55965623,631,"ENSBGRG00000013010","ENSBGRT00000023773",14783,"ENSBGRG00000013010","NA","NA","NA",{"v":3.3e-09,"d":"0.00"},1,"631,",0,-8.48,-7.71,4.65,"Exon (ENSBGRT00000023773/ENSBGRG00000013010, exon 2 of 2)",25,55950210,55967242,17033,1]
["chr25",56530449,56540180,9732,"ENSBGRG00000014069","ENSBGRT00000027055",20394,"ENSBGRG00000014069","NA","GO:0035082(axoneme assembly);GO:0060294(cilium movement involved in cell motility)","NA",{"v":0.011,"d":"0.01"},2,"38,171,","0,9561",-1.95,-1.42,4.29,"Exon (ENSBGRT00000027055/ENSBGRG00000014069, exon 7 of 21)",25,56510246,56560574,50329,2]
["chr26",47737722,47737780,59,"ENSBGRG00000014632","ENSBGRT00000026993",276,"ENSBGRG00000014632","NA","GO:0005506(iron ion binding);GO:0005833(hemoglobin complex);GO:0015671(oxygen transport);GO:0019825(oxygen binding);GO:0020037(heme binding)","05144(Malaria);05143(African trypanosomiasis)",0.04,1,"59,",0,{"v":-1.4,"d":"-1.40"},-0.91,2.97,"Exon (ENSBGRT00000026993/ENSBGRG00000014632, exon 2 of 3)",26,47737327,47738056,730,2]
["chr26",47737839,47738056,218,"ENSBGRG00000014632","ENSBGRT00000026993",0,"ENSBGRG00000014632","NA","GO:0005506(iron ion binding);GO:0005833(hemoglobin complex);GO:0015671(oxygen transport);GO:0019825(oxygen binding);GO:0020037(heme binding)","05144(Malaria);05143(African trypanosomiasis)",{"v":0.0039,"d":"0.00"},2,"22,95,","0,123",-2.41,-1.85,9.91,"Exon (ENSBGRT00000026993/ENSBGRG00000014632, exon 1 of 3)",26,47737327,47738056,730,2]

{"sheet":"YO-F","index":1,"n_rows":19748,"n_cols":24,"rows_kept":2250,"cut":true,"bounds":{"rows_first":1000,"rows_last":250,"rows_between":1000,"halvings":1}}
["seqnames","start","end","width","geneId","transcriptId","distanceToTSS","geneName","Description","GO","KEGG","score","blockCount","blockSizes","blockStarts","lg.p","lg.fdr","fold_enrichment","annotation","geneChr","geneStart","geneEnd","geneLength","geneStrand"]
["chr1",956005,982433,26429,"ENSBGRG00000000004","ENSBGRT00000000007",0,"VGLL3","vestigial like family member 3 [Source:HGNC Symbol;Acc:HGNC:24327]","GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.3E-11,"d":"0.00"},4,"609,286,107,70,","0,13644,26250,26359",{"v":-10.9,"d":"-10.90"},-10,14,"5' UTR",1,956005,1012265,56261,1]
["chr1",982582,1011700,29119,"ENSBGRG00000000004","ENSBGRT00000000007",26577,"VGLL3","vestigial like family member 3 [Source:HGNC Symbol;Acc:HGNC:24327]","GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":2.5e-16,"d":"0.00"},2,"206,272,","0,28847",{"v":-15.6,"d":"-15.60"},{"v":-14.6,"d":"-14.60"},6.28,"3' UTR",1,956005,1012265,56261,1]
["chr1",10383010,10383189,180,"ENSBGRG00000000014","ENSBGRT00000000019",815800,"ROBO1","roundabout guidance receptor 1 [Source:HGNC Symbol;Acc:HGNC:10249]","GO:0002042(cell migration involved in sprouting angiogenesis);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007411(axon guidance);GO:0008046(axon guidance receptor activity);GO:0009986(cell surface);GO:0016199(axon midline choice point recognition);GO:0021836(chemorepulsion involved in postnatal olfactory bulb interneuron migration);GO:0030275(LRR domain binding);GO:0030336(negative regulation of cell migration);GO:0033600(negative regulation of mammary gland epithelial cell proliferation);GO:0035025(positive regulation of Rho protein signal transduction);GO:0035385(Roundabout signaling pathway);GO:0042802(identical protein binding);GO:0043406(positive regulation of MAP kinase activity);GO:0050772(positive regulation of axonogenesis);GO:0050925(negative regulation of negative chemotaxis);GO:0070100(negative regulation of chemokine-mediated signaling pathway);GO:1900748(positive regulation of vascular endothelial growth factor signaling pathway)","04360(Axon guidance)",{"v":0.012,"d":"0.01"},1,"180,",0,-1.92,-1.37,1.91,"Exon (ENSBGRT00000000019/ENSBGRG00000000014, exon 3 of 30)",1,9567210,10778605,1211396,1]
["chr1",14233227,14233527,301,"ENSBGRG00000000023","ENSBGRT00000000034",20889,"RBM11","RNA binding motif protein 11 [Source:HGNC Symbol;Acc:HGNC:9897]","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008266(poly(U) RNA binding);GO:0016607(nuclear speck);GO:0034599(cellular response to oxidative stress);GO:0042803(protein homodimerization activity)","NA",{"v":7.9e-15,"d":"0.00"},1,"301,",0,{"v":-14.1,"d":"-14.10"},{"v":-13.2,"d":"-13.20"},3.46,"3' UTR",1,14212338,14234545,22208,1]
["chr1",16186709,16187193,485,"ENSBGRG00000000031","ENSBGRT00000000048",170641,"USP25","ubiquitin specific peptidase 25 [Source:HGNC Symbol;Acc:HGNC:12624]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032183(SUMO binding);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0051117(ATPase binding);GO:0070536(protein K63-linked deubiquitination);GO:0071108(protein K48-linked deubiquitination);GO:1904293(negative regulation of ERAD pathway)","04657(IL-17 signaling pathway)",{"v":3.2e-18,"d":"0.00"},2,"7,173,","0,312",{"v":-17.5,"d":"-17.50"},{"v":-16.5,"d":"-16.50"},1.79,"Exon (ENSBGRT00000000048/ENSBGRG00000000031, exon 25 of 26)",1,16016068,16187193,171126,1]
["chr1",16703827,16705207,1381,"ENSBGRG00000000034","ENSBGRT00000000056",117330,"ENSBGRG00000000034","NA","NA","NA",{"v":0.019,"d":"0.02"},2,"19,822,","0,559",-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000000056/ENSBGRG00000000034, exon 2 of 2)",1,16586497,16705236,118740,1]
["chr1",18044582,18071143,26562,"ENSBGRG00000000037","ENSBGRT00000000066",46503,"CXADR","CXADR Ig-like cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:2559]","GO:0001669(acrosomal vesicle);GO:0005178(integrin binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0005923(bicellular tight junction);GO:0007005(mitochondrion organization);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007507(heart development);GO:0008013(beta-catenin binding);GO:0008354(germ cell migration);GO:0010669(epithelial structure maintenance);GO:0014704(intercalated disc);GO:0016323(basolateral plasma membrane);GO:0016327(apicolateral plasma membrane);GO:0030054(cell junction);GO:0030165(PDZ domain binding);GO:0030175(filopodium);GO:0030426(growth cone);GO:0030593(neutrophil chemotaxis);GO:0031532(actin cytoskeleton reorganization);GO:0032991(protein-containing complex);GO:0043005(neuron projection);GO:0044297(cell body);GO:0045121(membrane raft);GO:0045216(cell-cell junction organization);GO:0046629(gamma-delta T cell activation);GO:0048739(cardiac muscle fiber development);GO:0050839(cell adhesion molecule binding);GO:0060044(negative regulation of cardiac muscle cell proliferation);GO:0070633(transepithelial transport);GO:0071253(connexin binding);GO:0086067(AV node cell to bundle of His cell communication);GO:0086072(AV node cell-bundle of His cell adhesion involved in cell communication);GO:0098609(cell-cell adhesion);GO:0098904(regulation of AV node cell action potential)","05416(Viral myocarditis)",{"v":0.00021,"d":"0.00"},2,"84,125,","0,26437",-3.68,-3.02,3.57,"3' UTR",1,17998079,18044665,46587,1]
["chr1",18865911,18868581,2671,"ENSBGRG00000000043","ENSBGRT00000000076",20564,"CHODL","chondrolectin [Source:HGNC Symbol;Acc:HGNC:17807]","GO:0005737(cytoplasm);GO:0010975(regulation of neuron projection development);GO:0048471(perinuclear region of cytoplasm)","NA",{"v":8.9e-10,"d":"0.00"},2,"20,248,","0,2423",-9.05,-8.21,5.01,"3' UTR",1,18845347,18865930,20584,1]
["chr1",22428117,22449734,21618,"ENSBGRG00000000047","ENSBGRT00000000080",537085,"NCAM2","neural cell adhesion molecule 2 [Source:HGNC Symbol;Acc:HGNC:7657]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0016020(membrane);GO:0016604(nuclear body);GO:0030424(axon);GO:0042802(identical protein binding)","04514(Cell adhesion molecules (CAMs));05020(Prion diseases)",{"v":0.0047,"d":"0.00"},2,"41,109,","0,21509",-2.33,-1.75,2.39,"Exon (ENSBGRT00000000080/ENSBGRG00000000047, exon 14 of 18)",1,21891032,22492928,601897,1]
["chr1",22487194,22492928,5735,"ENSBGRG00000000047","ENSBGRT00000000080",596162,"NCAM2","neural cell adhesion molecule 2 [Source:HGNC Symbol;Acc:HGNC:7657]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0016020(membrane);GO:0016604(nuclear body);GO:0030424(axon);GO:0042802(identical protein binding)","04514(Cell adhesion molecules (CAMs));05020(Prion diseases)",{"v":1.8E-3,"d":"0.00"},2,"9,112,","0,5623",-2.74,-2.13,4.26,"Exon (ENSBGRT00000000080/ENSBGRG00000000047, exon 17 of 18)",1,21891032,22492928,601897,1]
["chr1",27529677,27534702,5026,"ENSBGRG00000000061","ENSBGRT00000000101",4645,"GABPA","GA binding protein transcription factor subunit alpha [Source:HGNC Symbol;Acc:HGNC:4071]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0001825(blastocyst formation);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0010628(positive regulation of gene expression);GO:0033613(activating transcription factor binding);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045653(negative regulation of megakaryocyte differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1903351(cellular response to dopamine);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.0035,"d":"0.00"},2,"43,107,","0,4919",-2.46,-1.86,{"v":1.9,"d":"1.90"},"Exon (ENSBGRT00000000101/ENSBGRG00000000061, exon 2 of 10)",1,27525032,27568278,43247,1]
["chr1",27539232,27568039,28808,"ENSBGRG00000000061","ENSBGRT00000000101",14200,"GABPA","GA binding protein transcription factor subunit alpha [Source:HGNC Symbol;Acc:HGNC:4071]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0001825(blastocyst formation);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0010628(positive regulation of gene expression);GO:0033613(activating transcription factor binding);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045653(negative regulation of megakaryocyte differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1903351(cellular response to dopamine);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":4E-79,"d":"0.00"},8,"64,246,195,54,141,141,193,341,","0,4814,6923,11132,12096,15762,21758,28467",{"v":-78.4,"d":"-78.40"},{"v":-76.8,"d":"-76.80"},109,"3' UTR",1,27525032,27568278,43247,1]
["chr1",31434419,31434509,91,"ENSBGRG00000000077","ENSBGRT00000000134",14123,"USP16","ubiquitin specific peptidase 16 [Source:HGNC Symbol;Acc:HGNC:12614]","GO:0000278(mitotic cell cycle);GO:0003713(transcription coactivator activity);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008270(zinc ion binding);GO:0010468(regulation of gene expression);GO:0016578(histone deubiquitination);GO:0016579(protein deubiquitination);GO:0035522(monoubiquitinated histone H2A deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042393(histone binding);GO:0043130(ubiquitin binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045901(positive regulation of translational elongation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051289(protein homotetramerization);GO:0051726(regulation of cell cycle);GO:0070537(histone H2A K63-linked deubiquitination)","NA",{"v":0.0022,"d":"0.00"},1,"91,",0,-2.65,-2.04,1.42,"Exon (ENSBGRT00000000134/ENSBGRG00000000077, exon 6 of 18)",1,31420296,31451387,31092,1]
["chr1",31440714,31447434,6721,"ENSBGRG00000000077","ENSBGRT00000000134",20418,"USP16","ubiquitin specific peptidase 16 [Source:HGNC Symbol;Acc:HGNC:12614]","GO:0000278(mitotic cell cycle);GO:0003713(transcription coactivator activity);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008270(zinc ion binding);GO:0010468(regulation of gene expression);GO:0016578(histone deubiquitination);GO:0016579(protein deubiquitination);GO:0035522(monoubiquitinated histone H2A deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042393(histone binding);GO:0043130(ubiquitin binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045901(positive regulation of translational elongation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051289(protein homotetramerization);GO:0051726(regulation of cell cycle);GO:0070537(histone H2A K63-linked deubiquitination)","NA",{"v":1E-119,"d":"0.00"},4,"40,177,664,76,","0,1896,4930,6645",-119,-117,3.73,"Exon (ENSBGRT00000000134/ENSBGRG00000000077, exon 12 of 18)",1,31420296,31451387,31092,1]
["chr1",31783463,31783611,149,"ENSBGRG00000000080","ENSBGRT00000000142",0,"BACH1","BTB domain and CNC homolog 1 [Source:HGNC Symbol;Acc:HGNC:935]","GO:0000083(regulation of transcription involved in G1/S transition of mitotic cell cycle);GO:0000117(regulation of transcription involved in G2/M transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0006355(regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061418(regulation of transcription from RNA polymerase II promoter in response to hypoxia)","NA",{"v":0.019,"d":"0.02"},1,"149,",0,-1.72,-1.19,5.01,"5' UTR",1,31783463,31799779,16317,1]
["chr1",31783671,31790353,6683,"ENSBGRG00000000080","ENSBGRT00000000142",208,"BACH1","BTB domain and CNC homolog 1 [Source:HGNC Symbol;Acc:HGNC:935]","GO:0000083(regulation of transcription involved in G1/S transition of mitotic cell cycle);GO:0000117(regulation of transcription involved in G2/M transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0006355(regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061418(regulation of transcription from RNA polymerase II promoter in response to hypoxia)","NA",{"v":3.2e-16,"d":"0.00"},3,"86,1338,60,","0,3684,6623",{"v":-15.5,"d":"-15.50"},{"v":-14.5,"d":"-14.50"},6.22,"Exon (ENSBGRT00000000142/ENSBGRG00000000080, exon 1 of 4)",1,31783463,31799779,16317,1]
["chr1",31790472,31799779,9308,"ENSBGRG00000000080","ENSBGRT00000000142",7009,"BACH1","BTB domain and CNC homolog 1 [Source:HGNC Symbol;Acc:HGNC:935]","GO:0000083(regulation of transcription involved in G1/S transition of mitotic cell cycle);GO:0000117(regulation of transcription involved in G2/M transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0006355(regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061418(regulation of transcription from RNA polymerase II promoter in response to hypoxia)","NA",{"v":2e-10,"d":"0.00"},2,"29,447,","0,8861",{"v":-9.7,"d":"-9.70"},-8.85,5.44,"Exon (ENSBGRT00000000142/ENSBGRG00000000080, exon 3 of 4)",1,31783463,31799779,16317,1]
["chr1",35470541,35470837,297,"ENSBGRG00000000119","ENSBGRT00000000189",144826,"HUNK","hormonally up-regulated Neu-associated kinase [Source:HGNC Symbol;Acc:HGNC:13326]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA",{"v":0.00026,"d":"0.00"},1,"297,",0,-3.58,-2.92,4.81,"Exon (ENSBGRT00000000189/ENSBGRG00000000119, exon 12 of 12)",1,35325715,35471104,145390,1]
["chr1",35470896,35471104,209,"ENSBGRG00000000119","ENSBGRT00000000189",145181,"HUNK","hormonally up-regulated Neu-associated kinase [Source:HGNC Symbol;Acc:HGNC:13326]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA",{"v":0.0058,"d":"0.01"},1,"209,",0,-2.24,-1.66,10,"Exon (ENSBGRT00000000189/ENSBGRG00000000119, exon 12 of 12)",1,35325715,35471104,145390,1]
["chr1",36059638,36097069,37432,"ENSBGRG00000000123","ENSBGRT00000000199",107985,"EVA1C","eva-1 homolog C [Source:HGNC Symbol;Acc:HGNC:13239]","GO:0005576(extracellular region);GO:0008201(heparin binding);GO:0030246(carbohydrate binding)","03420(Nucleotide excision repair);00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":4e-97,"d":"0.00"},3,"52,587,46,","0,14111,37386",{"v":-96.4,"d":"-96.40"},{"v":-94.7,"d":"-94.70"},{"v":12.8,"d":"12.80"},"3' UTR",1,35951653,36074335,122683,1]
["chr1",36819634,36826668,7035,"ENSBGRG00000000131","ENSBGRT00000000219",33339,"ENSBGRG00000000131","NA","GO:0005515(protein binding)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04217(Necroptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04380(Osteoclast differentiation);05200(Pathways in cancer);05162(Measles);05164(Influenza A);05160(Hepatitis C);05168(Herpes simplex infection);05167(Kaposi sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection)",{"v":1e-130,"d":"0.00"},2,"84,1414,","0,5621",-130,-128,{"v":11.6,"d":"11.60"},"3' UTR",1,36786295,36825265,38971,1]
["chr1",36863337,36863430,94,"ENSBGRG00000000132","ENSBGRT00000000220",34265,"IL10RB","interleukin 10 receptor subunit beta [Source:HGNC Symbol;Acc:HGNC:5965]","GO:0005515(protein binding);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);05152(Tuberculosis);05163(Human cytomegalovirus infection);05169(Epstein-Barr virus infection);05145(Toxoplasmosis)",{"v":5.1E-5,"d":"0.00"},3,"66,12,12,","0,69,82",-4.29,{"v":-3.6,"d":"-3.60"},1.83,"Exon (ENSBGRT00000000220/ENSBGRG00000000132, exon 7 of 9)",1,36829072,36863430,34359,1]
["chr1",36965831,36967325,1495,"ENSBGRG00000000133","ENSBGRT00000000221",28695,"IFNAR1","interferon alpha and beta receptor subunit 1 [Source:HGNC Symbol;Acc:HGNC:5432]","GO:0004904(interferon receptor activity);GO:0004905(type I interferon receptor activity);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0060337(type I interferon signaling pathway)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04217(Necroptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04380(Osteoclast differentiation);05200(Pathways in cancer);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05168(Herpes simplex infection);05167(Kaposi sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection)",{"v":2.5e-94,"d":"0.00"},2,"27,240,","0,1255",{"v":-93.6,"d":"-93.60"},{"v":-91.9,"d":"-91.90"},6.98,"Exon (ENSBGRT00000000221/ENSBGRG00000000133, exon 11 of 11)",1,36937136,36967325,30190,1]
["chr1",37061308,37065571,4264,"ENSBGRG00000000134","ENSBGRT00000000223",28506,"IFNGR2","interferon gamma receptor 2 [Source:HGNC Symbol;Acc:HGNC:5440]","GO:0005515(protein binding)","04630(Jak-STAT signaling pathway);04066(HIF-1 signaling pathway);04060(Cytokine-cytokine receptor interaction);04217(Necroptosis);04650(Natural killer cell mediated cytotoxicity);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04380(Osteoclast differentiation);05200(Pathways in cancer);05321(Inflammatiory bowel disease (IBD));05132(Salmonella infection);05152(Tuberculosis);05162(Measles);05164(Influenza A);05168(Herpes simplex infection);05145(Toxoplasmosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis))",{"v":1e-106,"d":"0.00"},2,"156,231,","0,4033",-106,-105,3.43,"Exon (ENSBGRT00000000223/ENSBGRG00000000134, exon 6 of 7)",1,37032802,37065571,32770,1]
["chr1",37202188,37202967,780,"ENSBGRG00000000139","ENSBGRT00000000229",5589,"SON","SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183]","GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0043484(regulation of RNA splicing);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:0050733(RS domain binding);GO:0051726(regulation of cell cycle)","NA",{"v":1.3e-66,"d":"0.00"},1,"780,",0,{"v":-65.9,"d":"-65.90"},{"v":-64.4,"d":"-64.40"},7.22,"Exon (ENSBGRT00000000232/ENSBGRG00000000139, exon 3 of 8)",1,37196599,37229433,32835,1]
["chr1",37203087,37204255,1169,"ENSBGRG00000000140","ENSBGRT00000000233",0,"ENSBGRG00000000140","NA","NA","NA",{"v":2e-40,"d":"0.00"},1,"1169,",0,{"v":-39.7,"d":"-39.70"},{"v":-38.4,"d":"-38.40"},4.67,"Exon (ENSBGRT00000000232/ENSBGRG00000000139, exon 3 of 8)",1,37203211,37203274,64,1]
["chr1",37204375,37204435,61,"ENSBGRG00000000139","ENSBGRT00000000229",7776,"SON","SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183]","GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0043484(regulation of RNA splicing);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:0050733(RS domain binding);GO:0051726(regulation of cell cycle)","NA",{"v":0.0037,"d":"0.00"},1,"61,",0,-2.43,-1.84,1.74,"Exon (ENSBGRT00000000232/ENSBGRG00000000139, exon 3 of 8)",1,37196599,37229433,32835,1]
["chr1",37205822,37207980,2159,"ENSBGRG00000000139","ENSBGRT00000000229",9223,"SON","SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183]","GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0043484(regulation of RNA splicing);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:0050733(RS domain binding);GO:0051726(regulation of cell cycle)","NA",{"v":1e-220,"d":"0.00"},1,"2159,",0,-220,-217,{"v":14.7,"d":"14.70"},"Exon (ENSBGRT00000000232/ENSBGRG00000000139, exon 4 of 8)",1,37196599,37229433,32835,1]
["chr1",37229468,37229618,151,"ENSBGRG00000000139","ENSBGRT00000000231",28212,"SON","SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183]","GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0043484(regulation of RNA splicing);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:0050733(RS domain binding);GO:0051726(regulation of cell cycle)","NA",{"v":6.9e-09,"d":"0.00"},1,"151,",0,-8.16,-7.35,1.35,"3' UTR",1,37201256,37229585,28330,1]
["chr1",37230247,37230307,61,"ENSBGRG00000000139","ENSBGRT00000000230",28991,"SON","SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183]","GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0043484(regulation of RNA splicing);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:0050733(RS domain binding);GO:0051726(regulation of cell cycle)","NA",{"v":3e-08,"d":"0.00"},1,"61,",0,-7.52,-6.72,1.27,"3' UTR",1,37201256,37230367,29112,1]
["chr1",37407471,37450795,43325,"ENSBGRG00000000143","ENSBGRT00000000245",45388,"ITSN1","intersectin 1 [Source:HGNC Symbol;Acc:HGNC:6183]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005905(clathrin-coated pit);GO:0007264(small GTPase mediated signal transduction);GO:0019209(kinase activator activity);GO:0030027(lamellipodium);GO:0030139(endocytic vesicle);GO:0034613(cellular protein localization);GO:0035556(intracellular signal transduction);GO:0043524(negative regulation of neuron apoptotic process);GO:0044305(calyx of Held);GO:0048488(synaptic vesicle endocytosis);GO:0051897(positive regulation of protein kinase B signaling);GO:0060090(molecular adaptor activity);GO:0070064(proline-rich region binding);GO:0098833(presynaptic endocytic zone)","NA",{"v":3.2e-38,"d":"0.00"},8,"7,263,150,141,88,140,128,132,","0,4202,7226,7461,15767,15977,38887,43193",{"v":-37.5,"d":"-37.50"},{"v":-36.2,"d":"-36.20"},5.25,"Exon (ENSBGRT00000000245/ENSBGRG00000000143, exon 10 of 22)",1,37362083,37468747,106665,1]
["chr1",37787538,37857853,70316,"ENSBGRG00000000146","ENSBGRT00000000249",0,"MRPS6","mitochondrial ribosomal protein S6 [Source:HGNC Symbol;Acc:HGNC:14051]","GO:0003735(structural constituent of ribosome);GO:0005739(mitochondrion);GO:0005763(mitochondrial small ribosomal subunit);GO:0005840(ribosome);GO:0006412(translation);GO:0019843(rRNA binding)","03010(Ribosome)",{"v":3.2e-11,"d":"0.00"},3,"45,140,17,","0,52759,70299",{"v":-10.5,"d":"-10.50"},-9.63,2.25,"Exon (ENSBGRT00000000249/ENSBGRG00000000146, exon 1 of 3)",1,37787538,37858026,70489,1]
["chr1",38188990,38195603,6614,"ENSBGRG00000000149","ENSBGRT00000000252",0,"ENSBGRG00000000149","NA","NA","NA",{"v":7.8e-09,"d":"0.00"},2,"12,165,","0,6449",-8.11,-7.29,2.64,"Exon (ENSBGRT00000000252/ENSBGRG00000000149, exon 1 of 2)",1,38188990,38195603,6614,1]
["chr1",38671499,38672599,1101,"ENSBGRG00000000161","ENSBGRT00000000266",0,"HTR1F","5-hydroxytryptamine receptor 1F [Source:HGNC Symbol;Acc:HGNC:5292]","GO:0004930(G protein-coupled receptor activity);GO:0004993(G protein-coupled serotonin receptor activity);GO:0005887(integral component of plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0051378(serotonin binding)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04726(Serotonergic synapse);04742(Taste transduction)",{"v":0.00013,"d":"0.00"},1,"1101,",0,-3.87,{"v":-3.2,"d":"-3.20"},16,"Exon (ENSBGRT00000000266/ENSBGRG00000000161, exon 1 of 1)",1,38671499,38672599,1101,1]
["chr1",38733020,38733229,210,"ENSBGRG00000000166","ENSBGRT00000000273",0,"ZNF654","zinc finger protein 654 [Source:HGNC Symbol;Acc:HGNC:25612]","GO:0003676(nucleic acid binding)","NA",{"v":0.011,"d":"0.01"},1,"210,",0,-1.94,-1.38,2.51,"5' UTR",1,38733020,38826550,93531,1]
["chr1",38824297,38825041,745,"ENSBGRG00000000164","ENSBGRT00000000269",946,"CGGBP1","CGG triplet repeat binding protein 1 [Source:HGNC Symbol;Acc:HGNC:1888]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0042802(identical protein binding);GO:0090579(dsDNA loop formation);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":8.9e-10,"d":"0.00"},1,"745,",0,-9.05,-8.21,4.92,"Exon (ENSBGRT00000000273/ENSBGRG00000000166, exon 8 of 9)",1,38729830,38825987,96158,2]
["chr1",38825131,38825816,686,"ENSBGRG00000000164","ENSBGRT00000000269",171,"CGGBP1","CGG triplet repeat binding protein 1 [Source:HGNC Symbol;Acc:HGNC:1888]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0042802(identical protein binding);GO:0090579(dsDNA loop formation);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1E-25,"d":"0.00"},1,"686,",0,-25,{"v":-23.9,"d":"-23.90"},4.84,"Exon (ENSBGRT00000000273/ENSBGRG00000000166, exon 8 of 9)",1,38729830,38825987,96158,2]
["chr1",38825905,38826550,646,"ENSBGRG00000000164","ENSBGRT00000000269",0,"CGGBP1","CGG triplet repeat binding protein 1 [Source:HGNC Symbol;Acc:HGNC:1888]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0042802(identical protein binding);GO:0090579(dsDNA loop formation);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.018,"d":"0.02"},2,"53,8,","0,638",-1.75,-1.21,1.68,"5' UTR",1,38729830,38825987,96158,2]
["chr1",38846059,38849428,3370,"ENSBGRG00000000178","ENSBGRT00000000285",10201,"C3orf38","chromosome 3 open reading frame 38 [Source:HGNC Symbol;Acc:HGNC:28384]","GO:0005634(nucleus);GO:0043065(positive regulation of apoptotic process)","NA",{"v":4e-46,"d":"0.00"},2,"185,1070,","0,2300",{"v":-45.4,"d":"-45.40"},{"v":-44.1,"d":"-44.10"},{"v":10.8,"d":"10.80"},"3' UTR",1,38835858,38850353,14496,1]
["chr1",38849726,38850353,628,"ENSBGRG00000000178","ENSBGRT00000000285",13868,"C3orf38","chromosome 3 open reading frame 38 [Source:HGNC Symbol;Acc:HGNC:28384]","GO:0005634(nucleus);GO:0043065(positive regulation of apoptotic process)","NA",{"v":1e-104,"d":"0.00"},1,"628,",0,-104,-102,9.55,"3' UTR",1,38835858,38850353,14496,1]
["chr1",40331513,40331961,449,"ENSBGRG00000000197","ENSBGRT00000000326",456276,"EPHA3","EPH receptor A3 [Source:HGNC Symbol;Acc:HGNC:3387]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005004(GPI-linked ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0010976(positive regulation of neuron projection development);GO:0015629(actin cytoskeleton);GO:0016021(integral component of membrane);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0031965(nuclear membrane);GO:0032956(regulation of actin cytoskeleton organization);GO:0043087(regulation of GTPase activity);GO:0045806(negative regulation of endocytosis);GO:0048013(ephrin receptor signaling pathway);GO:0051893(regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:0071300(cellular response to retinoic acid);GO:1903078(positive regulation of protein localization to plasma membrane)","04360(Axon guidance)",{"v":0.011,"d":"0.01"},1,"449,",0,-1.96,{"v":-1.4,"d":"-1.40"},7.02,"3' UTR",1,39875237,40333962,458726,1]
["chr1",41218422,41228156,9735,"ENSBGRG00000000594","ENSBGRT00000001136",64627,"ARL13B","ADP ribosylation factor like GTPase 13B [Source:HGNC Symbol;Acc:HGNC:25419]","GO:0001947(heart looping);GO:0005525(GTP binding);GO:0005929(cilium);GO:0005930(axoneme);GO:0007224(smoothened signaling pathway);GO:0007368(determination of left/right symmetry);GO:0009953(dorsal/ventral pattern formation);GO:0021532(neural tube patterning);GO:0021830(interneuron migration from the subpallium to the cortex);GO:0021943(formation of radial glial scaffolds);GO:0031514(motile cilium);GO:0060170(ciliary membrane);GO:0060271(cilium assembly);GO:0070986(left/right axis specification);GO:1905515(non-motile cilium assembly)","NA",{"v":1.6E-27,"d":"0.00"},5,"95,115,70,223,31,","0,3521,4427,6803,9704",{"v":-26.8,"d":"-26.80"},{"v":-25.7,"d":"-25.70"},4.62,"Exon (ENSBGRT00000001136/ENSBGRG00000000594, exon 5 of 10)",1,41153795,41238379,84585,1]
["chr1",41229703,41238112,8410,"ENSBGRG00000000594","ENSBGRT00000001136",75908,"ARL13B","ADP ribosylation factor like GTPase 13B [Source:HGNC Symbol;Acc:HGNC:25419]","GO:0001947(heart looping);GO:0005525(GTP binding);GO:0005929(cilium);GO:0005930(axoneme);GO:0007224(smoothened signaling pathway);GO:0007368(determination of left/right symmetry);GO:0009953(dorsal/ventral pattern formation);GO:0021532(neural tube patterning);GO:0021830(interneuron migration from the subpallium to the cortex);GO:0021943(formation of radial glial scaffolds);GO:0031514(motile cilium);GO:0060170(ciliary membrane);GO:0060271(cilium assembly);GO:0070986(left/right axis specification);GO:1905515(non-motile cilium assembly)","NA",{"v":2.5e-68,"d":"0.00"},2,"36,586,","0,7824",{"v":-67.6,"d":"-67.60"},{"v":-66.1,"d":"-66.10"},8.28,"3' UTR",1,41153795,41238379,84585,1]
["chr1",41256276,41265344,9069,"ENSBGRG00000000728","ENSBGRT00000001293",10593,"NSUN3","NOP2/Sun RNA methyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:26208]","GO:0002127(tRNA wobble base cytosine methylation);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0008168(methyltransferase activity);GO:0016428(tRNA (cytosine-5-)-methyltransferase activity);GO:0070129(regulation of mitochondrial translation)","NA",{"v":0.021,"d":"0.02"},2,"100,21,","0,9048",-1.68,-1.15,2.01,"Exon (ENSBGRT00000001293/ENSBGRG00000000728, exon 3 of 6)",1,41245683,41310952,65270,1]
["chr1",41310113,41310413,301,"ENSBGRG00000000728","ENSBGRT00000001293",64430,"NSUN3","NOP2/Sun RNA methyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:26208]","GO:0002127(tRNA wobble base cytosine methylation);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0008168(methyltransferase activity);GO:0016428(tRNA (cytosine-5-)-methyltransferase activity);GO:0070129(regulation of mitochondrial translation)","NA",{"v":7.9e-30,"d":"0.00"},1,"301,",0,{"v":-29.1,"d":"-29.10"},-28,6.08,"3' UTR",1,41245683,41310952,65270,1]
["chr1",44051383,44051532,150,"ENSBGRG00000000760","ENSBGRT00000001431",0,"EPHA6","EPH receptor A6 [Source:HGNC Symbol;Acc:HGNC:19296]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0016021(integral component of membrane)","04360(Axon guidance)",{"v":0.035,"d":"0.04"},1,"150,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000001431/ENSBGRG00000000760, exon 1 of 18)",1,44051383,45144482,1093100,1]
["chr1",44051621,44152596,100976,"ENSBGRG00000000760","ENSBGRT00000001444",0,"EPHA6","EPH receptor A6 [Source:HGNC Symbol;Acc:HGNC:19296]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0016021(integral component of membrane)","04360(Axon guidance)",{"v":6.3E-3,"d":"0.01"},2,"138,42,","0,100934",{"v":-2.2,"d":"-2.20"},-1.62,6.02,"5' UTR",1,44152555,44279730,127176,1]
["chr1",45192027,45201260,9234,"ENSBGRG00000000838","ENSBGRT00000001515",27662,"ARL6","ADP ribosylation factor like GTPase 6 [Source:HGNC Symbol;Acc:HGNC:13210]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005929(cilium);GO:0007420(brain development);GO:0008589(regulation of smoothened signaling pathway);GO:0010842(retina layer formation);GO:0016020(membrane);GO:0016055(Wnt signaling pathway);GO:0045444(fat cell differentiation);GO:0060271(cilium assembly);GO:0061512(protein localization to cilium);GO:0097499(protein localization to non-motile cilium);GO:1903445(protein transport from ciliary membrane to plasma membrane)","NA",{"v":0.017,"d":"0.02"},3,"105,56,76,","0,3937,9158",-1.76,-1.22,2.08,"3' UTR",1,45164365,45201378,37014,1]
["chr1",45167251,45167490,240,"ENSBGRG00000000838","ENSBGRT00000001555",2886,"ARL6","ADP ribosylation factor like GTPase 6 [Source:HGNC Symbol;Acc:HGNC:13210]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005929(cilium);GO:0007420(brain development);GO:0008589(regulation of smoothened signaling pathway);GO:0010842(retina layer formation);GO:0016020(membrane);GO:0016055(Wnt signaling pathway);GO:0045444(fat cell differentiation);GO:0060271(cilium assembly);GO:0061512(protein localization to cilium);GO:0097499(protein localization to non-motile cilium);GO:1903445(protein transport from ciliary membrane to plasma membrane)","NA",{"v":1.8E-3,"d":"0.00"},1,"240,",0,-2.75,-2.14,1.87,"Exon (ENSBGRT00000001568/ENSBGRG00000000859, exon 2 of 2)",1,45164365,45185528,21164,1]
["chr1",45225139,45273160,48022,"ENSBGRG00000000874","ENSBGRT00000001593",0,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":0.00048,"d":"0.00"},4,"149,885,67,307,","0,646,19120,47715",-3.32,-2.67,14,"5' UTR",1,45225139,45364143,139005,1]
["chr1",45273220,45281251,8032,"ENSBGRG00000000874","ENSBGRT00000001593",48081,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":0.038,"d":"0.04"},2,"53,8,","0,8024",-1.42,{"v":-0.915,"d":"-0.92"},3.01,"Exon (ENSBGRT00000001593/ENSBGRG00000000874, exon 3 of 23)",1,45225139,45364143,139005,1]
["chr1",45281311,45281850,540,"ENSBGRG00000000874","ENSBGRT00000001593",56172,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":0.0037,"d":"0.00"},1,"540,",0,-2.43,-1.84,5.52,"Exon (ENSBGRT00000001593/ENSBGRG00000000874, exon 4 of 23)",1,45225139,45364143,139005,1]
["chr1",45282389,45282569,181,"ENSBGRG00000000874","ENSBGRT00000001593",57250,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":0.0011,"d":"0.00"},1,"181,",0,-2.95,-2.32,4.21,"Exon (ENSBGRT00000001593/ENSBGRG00000000874, exon 4 of 23)",1,45225139,45364143,139005,1]
["chr1",45284433,45284583,151,"ENSBGRG00000000874","ENSBGRT00000001593",59294,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":0.0017,"d":"0.00"},1,"151,",0,-2.77,-2.16,12,"Exon (ENSBGRT00000001593/ENSBGRG00000000874, exon 5 of 23)",1,45225139,45364143,139005,1]
["chr1",45285122,45287607,2486,"ENSBGRG00000000874","ENSBGRT00000001593",59983,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":7.9e-10,"d":"0.00"},1,"2486,",0,{"v":-9.1,"d":"-9.10"},-8.27,6.88,"Exon (ENSBGRT00000001593/ENSBGRG00000000874, exon 5 of 23)",1,45225139,45364143,139005,1]
["chr1",45359909,45363844,3936,"ENSBGRG00000000874","ENSBGRT00000001593",134770,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":1e-30,"d":"0.00"},3,"10,160,281,","0,2705,3655",-30,{"v":-28.9,"d":"-28.90"},2.45,"3' UTR",1,45225139,45364143,139005,1]
["chr1",46377241,46377660,420,"ENSBGRG00000002273","ENSBGRT00000004300",96191,"ST3GAL6","ST3 beta-galactoside alpha-2,3-sialyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:18080]","GO:0006486(protein glycosylation);GO:0008373(sialyltransferase activity)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":1.5E-9,"d":"0.00"},1,"420,",0,-8.81,-7.98,8.02,"3' UTR",1,46281050,46377660,96611,1]
["chr1",47150804,47196505,45702,"ENSBGRG00000002573","ENSBGRT00000004822",0,"ENSBGRG00000002573","NA","NA","NA",{"v":0.035,"d":"0.04"},3,"250,151,1624,","0,42550,44078",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"5' UTR",1,47150804,47196624,45821,1]
["chr1",47438505,47441437,2933,"ENSBGRG00000002584","ENSBGRT00000004837",60202,"COL8A1","collagen type VIII alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2215]","GO:0005515(protein binding);GO:0010811(positive regulation of cell-substrate adhesion);GO:0035987(endodermal cell differentiation);GO:0048593(camera-type eye morphogenesis);GO:0050673(epithelial cell proliferation)","04974(Protein digestion and absorption)",{"v":0.0025,"d":"0.00"},2,"68,83,","0,2850",{"v":-2.6,"d":"-2.60"},-2,2.26,"Exon (ENSBGRT00000004837/ENSBGRG00000002584, exon 2 of 3)",1,47378303,47443264,64962,1]
["chr1",47441766,47442335,570,"ENSBGRG00000002584","ENSBGRT00000004837",63463,"COL8A1","collagen type VIII alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2215]","GO:0005515(protein binding);GO:0010811(positive regulation of cell-substrate adhesion);GO:0035987(endodermal cell differentiation);GO:0048593(camera-type eye morphogenesis);GO:0050673(epithelial cell proliferation)","04974(Protein digestion and absorption)",{"v":1.4E-3,"d":"0.00"},1,"570,",0,-2.85,-2.23,3.26,"Exon (ENSBGRT00000004837/ENSBGRG00000002584, exon 3 of 3)",1,47378303,47443264,64962,1]
["chr1",47442575,47443264,690,"ENSBGRG00000002584","ENSBGRT00000004837",64272,"COL8A1","collagen type VIII alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2215]","GO:0005515(protein binding);GO:0010811(positive regulation of cell-substrate adhesion);GO:0035987(endodermal cell differentiation);GO:0048593(camera-type eye morphogenesis);GO:0050673(epithelial cell proliferation)","04974(Protein digestion and absorption)",{"v":1.6E-27,"d":"0.00"},1,"690,",0,{"v":-26.8,"d":"-26.80"},{"v":-25.6,"d":"-25.60"},6.48,"Exon (ENSBGRT00000004837/ENSBGRG00000002584, exon 3 of 3)",1,47378303,47443264,64962,1]
["chr1",47895550,47898253,2704,"ENSBGRG00000002638","ENSBGRT00000005020",437178,"CMSS1","cms1 ribosomal small subunit homolog [Source:HGNC Symbol;Acc:HGNC:28666]","NA","NA",{"v":0.00089,"d":"0.00"},2,"53,155,","0,2549",-3.05,-2.42,2.31,"3' UTR",1,47458372,47898402,440031,1]
["chr1",48044971,48045031,61,"ENSBGRG00000002818","ENSBGRT00000005253",60342,"TBC1D23","TBC1 domain family member 23 [Source:HGNC Symbol;Acc:HGNC:25622]","GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0007420(brain development);GO:0016192(vesicle-mediated transport);GO:0031175(neuron projection development);GO:0031410(cytoplasmic vesicle);GO:0032680(regulation of tumor necrosis factor production);GO:0032755(positive regulation of interleukin-6 production);GO:0042147(retrograde transport, endosome to Golgi);GO:0050727(regulation of inflammatory response);GO:0071203(WASH complex);GO:0099041(vesicle tethering to Golgi);GO:1990403(embryonic brain development)","NA",{"v":7.8e-05,"d":"0.00"},1,"61,",0,-4.11,-3.42,1.52,"Exon (ENSBGRT00000005253/ENSBGRG00000002818, exon 19 of 19)",1,47984629,48045031,60403,1]
["chr1",48052126,48059988,7863,"ENSBGRG00000002889","ENSBGRT00000005414",0,"NIT2","nitrilase family member 2 [Source:HGNC Symbol;Acc:HGNC:29878]","GO:0005813(centrosome);GO:0005829(cytosol);GO:0006107(oxaloacetate metabolic process);GO:0006528(asparagine metabolic process);GO:0006541(glutamine metabolic process);GO:0006807(nitrogen compound metabolic process);GO:0050152(omega-amidase activity)","00250(Alanine, aspartate and glutamate metabolism)",{"v":0.046,"d":"0.05"},4,"28,119,121,54,","0,4950,6575,7809",-1.34,{"v":-0.843,"d":"-0.84"},3.34,"Exon (ENSBGRT00000005414/ENSBGRG00000002889, exon 1 of 10)",1,48052126,48074017,21892,1]
["chr1",48171473,48171621,149,"ENSBGRG00000003008","ENSBGRT00000005657",14270,"ENSBGRG00000003008","NA","NA","04742(Taste transduction)",{"v":0.013,"d":"0.01"},1,"149,",0,-1.88,-1.33,1.82,"3' UTR",1,48157203,48171770,14568,1]
["chr1",49549051,49550033,983,"ENSBGRG00000003698","ENSBGRT00000006864",5275,"TRMT10C","tRNA methyltransferase 10C, mitochondrial RNase P subunit [Source:HGNC Symbol;Acc:HGNC:26022]","GO:0000049(tRNA binding);GO:0000964(mitochondrial RNA 5'-end processing);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008033(tRNA processing);GO:0009019(tRNA (guanine-N1-)-methyltransferase activity);GO:0016429(tRNA (adenine-N1-)-methyltransferase activity);GO:0042802(identical protein binding);GO:0061953(mRNA (adenine-N1-)-methyltransferase activity);GO:0070131(positive regulation of mitochondrial translation);GO:0080009(mRNA methylation);GO:0090646(mitochondrial tRNA processing);GO:0097745(mitochondrial tRNA 5'-end processing);GO:1990180(mitochondrial tRNA 3'-end processing)","NA",{"v":2.7E-8,"d":"0.00"},1,"983,",0,-7.57,-6.77,12,"Exon (ENSBGRT00000006882/ENSBGRG00000003698, exon 3 of 3)",1,49543776,49573670,29895,1]
["chr1",49572390,49573670,1281,"ENSBGRG00000003698","ENSBGRT00000006864",28614,"TRMT10C","tRNA methyltransferase 10C, mitochondrial RNase P subunit [Source:HGNC Symbol;Acc:HGNC:26022]","GO:0000049(tRNA binding);GO:0000964(mitochondrial RNA 5'-end processing);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008033(tRNA processing);GO:0009019(tRNA (guanine-N1-)-methyltransferase activity);GO:0016429(tRNA (adenine-N1-)-methyltransferase activity);GO:0042802(identical protein binding);GO:0061953(mRNA (adenine-N1-)-methyltransferase activity);GO:0070131(positive regulation of mitochondrial translation);GO:0080009(mRNA methylation);GO:0090646(mitochondrial tRNA processing);GO:0097745(mitochondrial tRNA 5'-end processing);GO:1990180(mitochondrial tRNA 3'-end processing)","NA",{"v":1e-121,"d":"0.00"},1,"1281,",0,-121,-119,{"v":10.3,"d":"10.30"},"Exon (ENSBGRT00000006864/ENSBGRG00000003698, exon 3 of 3)",1,49543776,49573670,29895,1]
["chr1",49584716,49589881,5166,"ENSBGRG00000003722","ENSBGRT00000006931",0,"PCNP","PEST proteolytic signal containing nuclear protein [Source:HGNC Symbol;Acc:HGNC:30023]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016567(protein ubiquitination);GO:0016604(nuclear body);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process)","NA",{"v":5e-22,"d":"0.00"},2,"64,86,","0,5080",{"v":-21.3,"d":"-21.30"},{"v":-20.3,"d":"-20.30"},1.85,"Exon (ENSBGRT00000006931/ENSBGRG00000003722, exon 1 of 5)",1,49584716,49597829,13114,1]
["chr1",49679326,49680487,1162,"ENSBGRG00000003937","ENSBGRT00000007567",12127,"CEP97","centrosomal protein 97 [Source:HGNC Symbol;Acc:HGNC:26244]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0005829(cytosol);GO:0032991(protein-containing complex);GO:0034451(centriolar satellite);GO:1901673(regulation of mitotic spindle assembly);GO:1902018(negative regulation of cilium assembly)","NA",{"v":0.0058,"d":"0.01"},2,"110,368,","0,794",-2.24,-1.66,10,"Exon (ENSBGRT00000007567/ENSBGRG00000003937, exon 8 of 13)",1,49667199,49689989,22791,1]
["chr1",49687601,49689483,1883,"ENSBGRG00000003937","ENSBGRT00000007567",20402,"CEP97","centrosomal protein 97 [Source:HGNC Symbol;Acc:HGNC:26244]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0005829(cytosol);GO:0032991(protein-containing complex);GO:0034451(centriolar satellite);GO:1901673(regulation of mitotic spindle assembly);GO:1902018(negative regulation of cilium assembly)","NA",{"v":2.5e-05,"d":"0.00"},2,"40,199,","0,1684",{"v":-4.6,"d":"-4.60"},{"v":-3.9,"d":"-3.90"},3.51,"Exon (ENSBGRT00000007567/ENSBGRG00000003937, exon 12 of 13)",1,49667199,49689989,22791,1]
["chr1",49715735,49742832,27098,"ENSBGRG00000004168","ENSBGRT00000007710",0,"ENSBGRG00000004168","ribosomal protein S27a pseudogene 5 [Source:HGNC Symbol;Acc:HGNC:36867]","GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)",{"v":1.6E-86,"d":"0.00"},2,"62,628,","0,26470",{"v":-85.8,"d":"-85.80"},{"v":-84.2,"d":"-84.20"},6.49,"Exon (ENSBGRT00000007643/ENSBGRG00000004124, exon 2 of 6)",1,49736579,49737330,752,2]
["chr1",49766054,49766563,510,"ENSBGRG00000004124","ENSBGRT00000007643",56100,"NXPE3","neurexophilin and PC-esterase domain family member 3 [Source:HGNC Symbol;Acc:HGNC:28238]","NA","04068(FoxO signaling pathway)",{"v":1e-129,"d":"0.00"},1,"510,",0,-129,-127,4.67,"Exon (ENSBGRT00000007643/ENSBGRG00000004124, exon 6 of 6)",1,49709954,49766563,56610,1]
["chr1",53899912,53900300,389,"ENSBGRG00000004469","ENSBGRT00000008260",0,"ALCAM","activated leukocyte cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:400]","GO:0001772(immunological synapse);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007411(axon guidance);GO:0008045(motor neuron axon guidance);GO:0009897(external side of plasma membrane);GO:0030424(axon);GO:0031226(intrinsic component of plasma membrane);GO:0042101(T cell receptor complex);GO:0042802(identical protein binding);GO:0043025(neuronal cell body)","04514(Cell adhesion molecules (CAMs))",{"v":1.3E-11,"d":"0.00"},1,"389,",0,{"v":-10.9,"d":"-10.90"},-9.98,{"v":32.1,"d":"32.10"},"5' UTR",1,53899912,54146464,246553,1]
["chr1",54122921,54145927,23007,"ENSBGRG00000004469","ENSBGRT00000008260",223009,"ALCAM","activated leukocyte cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:400]","GO:0001772(immunological synapse);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007411(axon guidance);GO:0008045(motor neuron axon guidance);GO:0009897(external side of plasma membrane);GO:0030424(axon);GO:0031226(intrinsic component of plasma membrane);GO:0042101(T cell receptor complex);GO:0042802(identical protein binding);GO:0043025(neuronal cell body)","04514(Cell adhesion molecules (CAMs))",{"v":2.6e-10,"d":"0.00"},5,"44,39,118,116,131,","0,1899,2227,21210,22876",-9.58,-8.73,2.14,"3' UTR",1,53899912,54146464,246553,1]
["chr1",56594439,56596394,1956,"ENSBGRG00000005097","ENSBGRT00000009549",281694,"BBX","BBX high mobility group box domain containing [Source:HGNC Symbol;Acc:HGNC:14422]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0060348(bone development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":4e-16,"d":"0.00"},2,"927,32,","0,1924",{"v":-15.4,"d":"-15.40"},{"v":-14.5,"d":"-14.50"},5.42,"Exon (ENSBGRT00000009549/ENSBGRG00000005097, exon 10 of 16)",1,56312745,56624479,311735,1]
["chr1",56629610,56629789,180,"ENSBGRG00000005097","ENSBGRT00000009514",316865,"BBX","BBX high mobility group box domain containing [Source:HGNC Symbol;Acc:HGNC:14422]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0060348(bone development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1.4E-3,"d":"0.00"},1,"180,",0,-2.85,-2.23,2.14,"3' UTR",1,56312745,56629969,317225,1]
["chr1",57253404,57256957,3554,"ENSBGRG00000005718","ENSBGRT00000010544",4828,"ENSBGRG00000005718","NA","NA","NA",{"v":1.6E-11,"d":"0.00"},2,"34,589,","0,2965",{"v":-10.8,"d":"-10.80"},-9.91,{"v":20.1,"d":"20.10"},"Exon (ENSBGRT00000010544/ENSBGRG00000005718, exon 3 of 3)",1,57248576,57253437,4862,1]
["chr1",57360670,57363199,2530,"ENSBGRG00000005737","ENSBGRT00000010603",38156,"HHLA2","HERV-H LTR-associating 2 [Source:HGNC Symbol;Acc:HGNC:4905]","GO:0001819(positive regulation of cytokine production);GO:0031295(T cell costimulation);GO:0042104(positive regulation of activated T cell proliferation)","04514(Cell adhesion molecules (CAMs))",{"v":0.028,"d":"0.03"},2,"193,77,","0,2453",-1.55,-1.03,6.02,"Exon (ENSBGRT00000010603/ENSBGRG00000005737, exon 6 of 8)",1,57322514,57365365,42852,1]
["chr1",57698739,57725028,26290,"ENSBGRG00000006159","ENSBGRT00000011460",63314,"DZIP3","DAZ interacting zinc finger protein 3 [Source:HGNC Symbol;Acc:HGNC:30938]","GO:0000209(protein polyubiquitination);GO:0003723(RNA binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005737(cytoplasm);GO:0019902(phosphatase binding);GO:0031593(polyubiquitin modification-dependent protein binding);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":0.00015,"d":"0.00"},4,"93,45,26,46,","0,886,21551,26244",-3.81,-3.14,2.01,"Exon (ENSBGRT00000011460/ENSBGRG00000006159, exon 14 of 30)",1,57635425,57753008,117584,1]
["chr1",57752314,57755507,3194,"ENSBGRG00000006159","ENSBGRT00000011460",116889,"DZIP3","DAZ interacting zinc finger protein 3 [Source:HGNC Symbol;Acc:HGNC:30938]","GO:0000209(protein polyubiquitination);GO:0003723(RNA binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005737(cytoplasm);GO:0019902(phosphatase binding);GO:0031593(polyubiquitin modification-dependent protein binding);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":0.048,"d":"0.05"},2,"695,111,","0,3083",-1.32,{"v":-0.827,"d":"-0.83"},3.01,"3' UTR",1,57635425,57753008,117584,1]
["chr1",57917539,57926452,8914,"ENSBGRG00000006345","ENSBGRT00000011688",72063,"ENSBGRG00000006345","NA","NA","04146(Peroxisome)",{"v":0.0032,"d":"0.00"},3,"21,86,279,","0,2124,8635",{"v":-2.5,"d":"-2.50"},-1.91,11,"Exon (ENSBGRT00000011688/ENSBGRG00000006345, exon 5 of 7)",1,57845476,57926452,80977,1]
["chr1",60473582,60495190,21609,"ENSBGRG00000000168","ENSBGRT00000000293",69824,"NECTIN3","nectin cell adhesion molecule 3 [Source:HGNC Symbol;Acc:HGNC:17664]","GO:0002089(lens morphogenesis in camera-type eye);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007286(spermatid development);GO:0009566(fertilization);GO:0042803(protein homodimerization activity);GO:0043296(apical junction complex);GO:0044291(cell-cell contact zone);GO:0050839(cell adhesion molecule binding);GO:0060042(retina morphogenesis in camera-type eye);GO:0061951(establishment of protein localization to plasma membrane);GO:0098609(cell-cell adhesion);GO:0098686(hippocampal mossy fiber to CA3 synapse);GO:0099061(integral component of postsynaptic density membrane);GO:1902414(protein localization to cell junction)","04514(Cell adhesion molecules (CAMs));04520(Adherens junction)",{"v":1.6e-48,"d":"0.00"},4,"48,581,139,8,","0,7168,18656,21601",{"v":-47.8,"d":"-47.80"},{"v":-46.5,"d":"-46.50"},5.92,"Exon (ENSBGRT00000000293/ENSBGRG00000000168, exon 6 of 7)",1,60403758,60481330,77573,1]
["chr1",61366644,61366972,329,"ENSBGRG00000000410","ENSBGRT00000000700",14639,"TAGLN3","transgelin 3 [Source:HGNC Symbol;Acc:HGNC:29868]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005515(protein binding);GO:0005634(nucleus)","NA",{"v":2e-06,"d":"0.00"},1,"329,",0,-5.69,-4.95,10,"3' UTR",1,61352005,61366972,14968,1]
["chr1",61733572,61737091,3520,"ENSBGRG00000000619","ENSBGRT00000001124",7328,"ENSBGRG00000000619","NA","GO:0043031(negative regulation of macrophage activation);GO:0050776(regulation of immune response)","NA",{"v":1.6e-28,"d":"0.00"},2,"300,146,","0,3374",{"v":-27.8,"d":"-27.80"},{"v":-26.7,"d":"-26.70"},2.58,"5' UTR",1,61726244,61737301,11058,1]
["chr1",61982796,61983236,441,"ENSBGRG00000000743","ENSBGRT00000001353",16702,"SLC35A5","solute carrier family 35 member A5 [Source:HGNC Symbol;Acc:HGNC:20792]","GO:0000139(Golgi membrane);GO:0015165(pyrimidine nucleotide-sugar transmembrane transporter activity);GO:0016021(integral component of membrane);GO:0090481(pyrimidine nucleotide-sugar transmembrane transport)","NA",{"v":1.3E-58,"d":"0.00"},1,"441,",0,{"v":-57.9,"d":"-57.90"},{"v":-56.4,"d":"-56.40"},5.38,"Exon (ENSBGRT00000001353/ENSBGRG00000000743, exon 5 of 6)",1,61966094,61983491,17398,1]
["chr1",61983442,61986266,2825,"ENSBGRG00000000743","ENSBGRT00000001353",17348,"SLC35A5","solute carrier family 35 member A5 [Source:HGNC Symbol;Acc:HGNC:20792]","GO:0000139(Golgi membrane);GO:0015165(pyrimidine nucleotide-sugar transmembrane transporter activity);GO:0016021(integral component of membrane);GO:0090481(pyrimidine nucleotide-sugar transmembrane transport)","NA",{"v":4e-19,"d":"0.00"},2,"79,69,","0,2756",{"v":-18.4,"d":"-18.40"},{"v":-17.4,"d":"-17.40"},2.52,"Exon (ENSBGRT00000001353/ENSBGRG00000000743, exon 6 of 6)",1,61966094,61983491,17398,1]
["chr1",63238659,63238809,151,"ENSBGRG00000001479","ENSBGRT00000002719",34956,"ATP6V1A","ATPase H+ transporting V1 subunit A [Source:HGNC Symbol;Acc:HGNC:851]","GO:0005524(ATP binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0006879(cellular iron ion homeostasis);GO:0016324(apical plasma membrane);GO:0033180(proton-transporting V-type ATPase, V1 domain);GO:0036295(cellular response to increased oxygen levels);GO:0046034(ATP metabolic process);GO:0046961(proton-transporting ATPase activity, rotational mechanism);GO:1902600(proton transmembrane transport)","00190(Oxidative phosphorylation);04150(mTOR signaling pathway);04145(Phagosome);04966(Collecting duct acid secretion);04721(Synaptic vesicle cycle);05323(Rheumatoid arthritis);05165(Human papillomavirus infection)",{"v":1.5e-07,"d":"0.00"},1,"151,",0,-6.83,-6.05,2.06,"3' UTR",1,63203703,63238989,35287,1]
["chr1",63363952,63368920,4969,"ENSBGRG00000001529","ENSBGRT00000002923",100575,"GRAMD1C","GRAM domain containing 1C [Source:HGNC Symbol;Acc:HGNC:25252]","NA","NA",{"v":2.8e-09,"d":"0.00"},3,"63,106,282,","0,437,4687",-8.56,-7.73,2.71,"3' UTR",1,63263377,63371109,107733,1]
["chr1",63372622,63377762,5141,"ENSBGRG00000001676","ENSBGRT00000003112",0,"ZDHHC23","zinc finger DHHC-type containing 23 [Source:HGNC Symbol;Acc:HGNC:28654]","GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0072659(protein localization to plasma membrane)","NA",{"v":0.0021,"d":"0.00"},2,"195,316,","0,4825",-2.67,-2.07,6.02,"5' UTR",1,63372622,63386515,13894,1]
["chr1",63377822,63384251,6430,"ENSBGRG00000001676","ENSBGRT00000003112",5200,"ZDHHC23","zinc finger DHHC-type containing 23 [Source:HGNC Symbol;Acc:HGNC:28654]","GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0072659(protein localization to plasma membrane)","NA",{"v":0.0034,"d":"0.00"},4,"336,168,168,18,","0,2951,4221,6412",-2.47,-1.87,7.02,"Exon (ENSBGRT00000003112/ENSBGRG00000001676, exon 2 of 4)",1,63372622,63386515,13894,1]
["chr1",63530505,63532755,2251,"ENSBGRG00000001757","ENSBGRT00000003324",20346,"QTRT2","queuine tRNA-ribosyltransferase accessory subunit 2 [Source:HGNC Symbol;Acc:HGNC:25771]","GO:0006400(tRNA modification);GO:0008479(queuine tRNA-ribosyltransferase activity);GO:0016763(transferase activity, transferring pentosyl groups);GO:0032991(protein-containing complex);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0101030(tRNA-guanine transglycosylation)","NA",{"v":1.2E-10,"d":"0.00"},3,"86,131,232,","0,1670,2019",-9.92,-9.06,3.87,"3' UTR",1,63510159,63532305,22147,1]
["chr1",69251710,69252067,358,"ENSBGRG00000002125","ENSBGRT00000003982",239,"UPK1B","uroplakin 1B [Source:HGNC Symbol;Acc:HGNC:12578]","GO:0009617(response to bacterium);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0030855(epithelial cell differentiation);GO:0120001(apical plasma membrane urothelial plaque)","NA",{"v":0.019,"d":"0.02"},1,"358,",0,-1.72,-1.19,6.02,"5' UTR",1,69251471,69284402,32932,1]
["chr1",69284134,69284283,150,"ENSBGRG00000002125","ENSBGRT00000003982",32663,"UPK1B","uroplakin 1B [Source:HGNC Symbol;Acc:HGNC:12578]","GO:0009617(response to bacterium);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0030855(epithelial cell differentiation);GO:0120001(apical plasma membrane urothelial plaque)","NA",{"v":1.3e-12,"d":"0.00"},1,"150,",0,{"v":-11.9,"d":"-11.90"},-11,2.57,"3' UTR",1,69251471,69284402,32932,1]
["chr1",69495028,69495178,151,"ENSBGRG00000002180","ENSBGRT00000004097",133070,"ARHGAP31","Rho GTPase activating protein 31 [Source:HGNC Symbol;Acc:HGNC:29216]","GO:0005096(GTPase activator activity);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0017124(SH3 domain binding);GO:0030027(lamellipodium)","NA",{"v":1E-119,"d":"0.00"},1,"151,",0,-119,-117,3.16,"Exon (ENSBGRT00000004097/ENSBGRG00000002180, exon 12 of 12)",1,69361958,69496669,134712,1]
["chr1",69495386,69495744,359,"ENSBGRG00000002180","ENSBGRT00000004097",133428,"ARHGAP31","Rho GTPase activating protein 31 [Source:HGNC Symbol;Acc:HGNC:29216]","GO:0005096(GTPase activator activity);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0017124(SH3 domain binding);GO:0030027(lamellipodium)","NA",{"v":1e-140,"d":"0.00"},1,"359,",0,-140,-138,3.27,"Exon (ENSBGRT00000004097/ENSBGRG00000002180, exon 12 of 12)",1,69361958,69496669,134712,1]
["chr1",69496013,69496669,657,"ENSBGRG00000002180","ENSBGRT00000004097",134055,"ARHGAP31","Rho GTPase activating protein 31 [Source:HGNC Symbol;Acc:HGNC:29216]","GO:0005096(GTPase activator activity);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0017124(SH3 domain binding);GO:0030027(lamellipodium)","NA",{"v":1e-121,"d":"0.00"},1,"657,",0,-121,-119,3.13,"Exon (ENSBGRT00000004097/ENSBGRG00000002180, exon 12 of 12)",1,69361958,69496669,134712,1]
["chr1",69572544,69574114,1571,"ENSBGRG00000002270","ENSBGRT00000004229",25266,"POGLUT1","protein O-glucosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:22954]","GO:0001756(somitogenesis);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0005829(cytosol);GO:0006493(protein O-linked glycosylation);GO:0008593(regulation of Notch signaling pathway);GO:0010470(regulation of gastrulation);GO:0018242(protein O-linked glycosylation via serine);GO:0035251(UDP-glucosyltransferase activity);GO:0035252(UDP-xylosyltransferase activity);GO:0045747(positive regulation of Notch signaling pathway);GO:0046527(glucosyltransferase activity);GO:0048318(axial mesoderm development);GO:0048339(paraxial mesoderm development);GO:0060537(muscle tissue development);GO:0072358(cardiovascular system development)","00514(Other types of O-glycan biosynthesis)",{"v":6.3e-44,"d":"0.00"},3,"54,57,157,","0,772,1414",{"v":-43.2,"d":"-43.20"},{"v":-41.9,"d":"-41.90"},7.54,"Exon (ENSBGRT00000004229/ENSBGRG00000002270, exon 9 of 11)",1,69547278,69574114,26837,1]
["chr1",69594767,69600588,5822,"ENSBGRG00000002286","ENSBGRT00000004256",13502,"TIMMDC1","translocase of inner mitochondrial membrane domain containing 1 [Source:HGNC Symbol;Acc:HGNC:1321]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","NA",{"v":1e-109,"d":"0.00"},3,"64,111,151,","0,3352,5671",-109,-107,7.75,"Exon (ENSBGRT00000004256/ENSBGRG00000002286, exon 5 of 7)",1,69581265,69600588,19324,1]
["chr1",69648487,69651314,2828,"ENSBGRG00000002318","ENSBGRT00000004323",5930,"ADPRH","ADP-ribosylarginine hydrolase [Source:HGNC Symbol;Acc:HGNC:269]","GO:0000287(magnesium ion binding);GO:0003875(ADP-ribosylarginine hydrolase activity);GO:0006464(cellular protein modification process);GO:0030955(potassium ion binding);GO:0051725(protein de-ADP-ribosylation)","NA",{"v":2e-15,"d":"0.00"},2,"129,228,","0,2600",{"v":-14.7,"d":"-14.70"},{"v":-13.7,"d":"-13.70"},3.98,"Exon (ENSBGRT00000004323/ENSBGRG00000002318, exon 3 of 4)",1,69642557,69651492,8936,1]
["chr1",69651373,69651492,120,"ENSBGRG00000002318","ENSBGRT00000004323",8816,"ADPRH","ADP-ribosylarginine hydrolase [Source:HGNC Symbol;Acc:HGNC:269]","GO:0000287(magnesium ion binding);GO:0003875(ADP-ribosylarginine hydrolase activity);GO:0006464(cellular protein modification process);GO:0030955(potassium ion binding);GO:0051725(protein de-ADP-ribosylation)","NA",{"v":0.035,"d":"0.04"},1,"120,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000004323/ENSBGRG00000002318, exon 4 of 4)",1,69642557,69651492,8936,1]
["chr1",69818260,69821930,3671,"ENSBGRG00000002380","ENSBGRT00000004499",45635,"ENSBGRG00000002380","NA","NA","03320(PPAR signaling pathway)",{"v":0.038,"d":"0.04"},2,"66,24,","0,3647",-1.42,{"v":-0.915,"d":"-0.92"},3.01,"Exon (ENSBGRT00000004499/ENSBGRG00000002380, exon 8 of 18)",1,69772625,69879153,106529,1]
["chr1",69852455,69876050,23596,"ENSBGRG00000002380","ENSBGRT00000004499",79830,"ENSBGRG00000002380","NA","NA","03320(PPAR signaling pathway)",{"v":0.019,"d":"0.02"},3,"147,92,59,","0,686,23537",-1.71,-1.18,1.78,"Exon (ENSBGRT00000004499/ENSBGRG00000002380, exon 15 of 18)",1,69772625,69879153,106529,1]
["chr1",70742615,70744256,1642,"ENSBGRG00000002707","ENSBGRT00000005070",6076,"ENSBGRG00000002707","NA","GO:0005739(mitochondrion);GO:0008137(NADH dehydrogenase (ubiquinone) activity)","00190(Oxidative phosphorylation);04723(Retrograde endocannabinoid signaling);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":1.4e-06,"d":"0.00"},2,"88,63,","0,1579",-5.86,-5.11,1.31,"Exon (ENSBGRT00000005070/ENSBGRG00000002707, exon 2 of 3)",1,70736539,70744256,7718,1]
["chr1",70867970,70900552,32583,"ENSBGRG00000002799","ENSBGRT00000005290",0,"RABL3","RAB, member of RAS oncogene family like 3 [Source:HGNC Symbol;Acc:HGNC:18072]","GO:0001779(natural killer cell differentiation);GO:0005525(GTP binding);GO:0030183(B cell differentiation);GO:0033077(T cell differentiation in thymus);GO:0042803(protein homodimerization activity);GO:0046578(regulation of Ras protein signal transduction);GO:0050821(protein stabilization);GO:1903059(regulation of protein lipidation)","NA",{"v":3.2e-28,"d":"0.00"},5,"444,478,202,242,425,","0,5051,21152,27343,32158",{"v":-27.5,"d":"-27.50"},{"v":-26.4,"d":"-26.40"},7.52,"5' UTR",1,70816851,70868128,51278,2]
["chr1",72079747,72090287,10541,"ENSBGRG00000004781","ENSBGRT00000008811",63670,"CD86","CD86 molecule [Source:HGNC Symbol;Acc:HGNC:1705]","GO:0070062(extracellular exosome)","04514(Cell adhesion molecules (CAMs));04620(Toll-like receptor signaling pathway);04672(Intestinal immune network for IgA production);05202(Transcriptional misregulation in cancers);05322(Systemic lupus erythematosus);05323(Rheumatoid arthritis);05320(Autoimmune thyroid disease);05330(Allograft rejection);05332(Graft-versus-host disease);05416(Viral myocarditis);04940(Type I diabetes mellitus);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":2.2e-06,"d":"0.00"},3,"67,46,97,","0,8230,10444",-5.65,-4.91,9.36,"Exon (ENSBGRT00000008811/ENSBGRG00000004781, exon 5 of 7)",1,72016077,72090287,74211,1]
["chr1",72334241,72380713,46473,"ENSBGRG00000005048","ENSBGRT00000009281",0,"ENSBGRG00000005048","NA","NA","NA",{"v":6.3E-48,"d":"0.00"},5,"183,126,109,109,93,","0,24811,28963,43796,46380",{"v":-47.2,"d":"-47.20"},{"v":-45.9,"d":"-45.90"},3.59,"5' UTR",1,72359448,72360455,1008,2]
["chr1",72522839,72533190,10352,"ENSBGRG00000007487","ENSBGRT00000013756",3538,"ENSBGRG00000007487","NA","GO:0007219(Notch signaling pathway);GO:0016567(protein ubiquitination)","04330(Notch signaling pathway)",{"v":0.0065,"d":"0.01"},3,"97,218,70,","0,9204,10282",-2.19,-1.62,4.01,"Exon (ENSBGRT00000013756/ENSBGRG00000007487, exon 2 of 4)",1,72519301,72533190,13890,1]
["chr1",72572251,72574290,2040,"ENSBGRG00000007559","ENSBGRT00000013829",19214,"PARP14","poly(ADP-ribose) polymerase family member 14 [Source:HGNC Symbol;Acc:HGNC:29232]","GO:0003676(nucleic acid binding);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006471(protein ADP-ribosylation);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042532(negative regulation of tyrosine phosphorylation of STAT protein);GO:0060336(negative regulation of interferon-gamma-mediated signaling pathway);GO:0140289(protein mono-ADP-ribosylation);GO:1902216(positive regulation of interleukin-4-mediated signaling pathway);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":7.9e-15,"d":"0.00"},1,"2040,",0,{"v":-14.1,"d":"-14.10"},{"v":-13.2,"d":"-13.20"},7.52,"Exon (ENSBGRT00000013829/ENSBGRG00000007559, exon 6 of 17)",1,72553037,72602132,49096,1]
["chr1",72587817,72591802,3986,"ENSBGRG00000007559","ENSBGRT00000013829",34780,"PARP14","poly(ADP-ribose) polymerase family member 14 [Source:HGNC Symbol;Acc:HGNC:29232]","GO:0003676(nucleic acid binding);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006471(protein ADP-ribosylation);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042532(negative regulation of tyrosine phosphorylation of STAT protein);GO:0060336(negative regulation of interferon-gamma-mediated signaling pathway);GO:0140289(protein mono-ADP-ribosylation);GO:1902216(positive regulation of interleukin-4-mediated signaling pathway);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":0.00085,"d":"0.00"},2,"182,149,","0,3837",-3.07,-2.44,2.17,"Exon (ENSBGRT00000013829/ENSBGRG00000007559, exon 13 of 17)",1,72553037,72602132,49096,1]
["chr1",72591892,72594855,2964,"ENSBGRG00000007559","ENSBGRT00000013829",38855,"PARP14","poly(ADP-ribose) polymerase family member 14 [Source:HGNC Symbol;Acc:HGNC:29232]","GO:0003676(nucleic acid binding);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006471(protein ADP-ribosylation);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042532(negative regulation of tyrosine phosphorylation of STAT protein);GO:0060336(negative regulation of interferon-gamma-mediated signaling pathway);GO:0140289(protein mono-ADP-ribosylation);GO:1902216(positive regulation of interleukin-4-mediated signaling pathway);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":1.3e-12,"d":"0.00"},2,"362,29,","0,2935",{"v":-11.9,"d":"-11.90"},-11,5.35,"Exon (ENSBGRT00000013829/ENSBGRG00000007559, exon 14 of 17)",1,72553037,72602132,49096,1]
["chr1",72601952,72602132,181,"ENSBGRG00000007559","ENSBGRT00000013829",48915,"PARP14","poly(ADP-ribose) polymerase family member 14 [Source:HGNC Symbol;Acc:HGNC:29232]","GO:0003676(nucleic acid binding);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006471(protein ADP-ribosylation);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042532(negative regulation of tyrosine phosphorylation of STAT protein);GO:0060336(negative regulation of interferon-gamma-mediated signaling pathway);GO:0140289(protein mono-ADP-ribosylation);GO:1902216(positive regulation of interleukin-4-mediated signaling pathway);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":7.4e-05,"d":"0.00"},1,"181,",0,-4.13,-3.45,1.94,"Exon (ENSBGRT00000013829/ENSBGRG00000007559, exon 17 of 17)",1,72553037,72602132,49096,1]
["chr1",72677197,72677466,270,"ENSBGRG00000007670","ENSBGRT00000014055",0,"SLC49A4","solute carrier family 49 member 4 [Source:HGNC Symbol;Acc:HGNC:16628]","GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":0.032,"d":"0.03"},1,"270,",0,-1.49,{"v":-0.978,"d":"-0.98"},4.51,"Exon (ENSBGRT00000014055/ENSBGRG00000007670, exon 1 of 9)",1,72677197,72771744,94548,1]
["chr1",73192737,73206109,13373,"ENSBGRG00000008128","ENSBGRT00000014875",0,"SEC22A","SEC22 homolog A, vesicle trafficking protein [Source:HGNC Symbol;Acc:HGNC:20260]","NA","NA",{"v":0.00065,"d":"0.00"},2,"201,6,","0,13367",-3.19,-2.55,3.72,"5' UTR",1,73192737,73262133,69397,1]
["chr1",73251543,73262133,10591,"ENSBGRG00000008128","ENSBGRT00000014875",58806,"SEC22A","SEC22 homolog A, vesicle trafficking protein [Source:HGNC Symbol;Acc:HGNC:20260]","NA","NA",{"v":6.3e-18,"d":"0.00"},2,"65,201,","0,10390",{"v":-17.2,"d":"-17.20"},{"v":-16.3,"d":"-16.30"},3.89,"Exon (ENSBGRT00000014875/ENSBGRG00000008128, exon 5 of 6)",1,73192737,73262133,69397,1]
["chr1",74863260,74871700,8441,"ENSBGRG00000009282","ENSBGRT00000019256",619042,"KALRN","kalirin RhoGEF kinase [Source:HGNC Symbol;Acc:HGNC:4814]","GO:0004672(protein kinase activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0035023(regulation of Rho protein signal transduction)","NA",{"v":0.0059,"d":"0.01"},3,"7,105,9,","0,2563,8432",-2.23,-1.66,1.31,"Exon (ENSBGRT00000019256/ENSBGRG00000009282, exon 35 of 60)",1,74244218,74952619,708402,1]
["chr1",74951001,74951150,150,"ENSBGRG00000009282","ENSBGRT00000019256",706783,"KALRN","kalirin RhoGEF kinase [Source:HGNC Symbol;Acc:HGNC:4814]","GO:0004672(protein kinase activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0035023(regulation of Rho protein signal transduction)","NA",{"v":0.00019,"d":"0.00"},1,"150,",0,-3.71,-3.04,9.03,"Exon (ENSBGRT00000019256/ENSBGRG00000009282, exon 60 of 60)",1,74244218,74952619,708402,1]
["chr1",74951510,74951750,241,"ENSBGRG00000009282","ENSBGRT00000019256",707292,"KALRN","kalirin RhoGEF kinase [Source:HGNC Symbol;Acc:HGNC:4814]","GO:0004672(protein kinase activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0035023(regulation of Rho protein signal transduction)","NA",{"v":1E-3,"d":"0.00"},1,"241,",0,-2.99,-2.36,3.58,"3' UTR",1,74244218,74952619,708402,1]
["chr1",74979188,74981601,2414,"ENSBGRG00000010943","ENSBGRT00000020152",18837,"UMPS","uridine monophosphate synthetase [Source:HGNC Symbol;Acc:HGNC:12563]","GO:0003824(catalytic activity);GO:0004588(orotate phosphoribosyltransferase activity);GO:0004590(orotidine-5'-phosphate decarboxylase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006207('de novo' pyrimidine nucleobase biosynthetic process);GO:0006221(pyrimidine nucleotide biosynthetic process);GO:0006222(UMP biosynthetic process);GO:0009116(nucleoside metabolic process);GO:0044205('de novo' UMP biosynthetic process)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)",{"v":2e-29,"d":"0.00"},2,"100,470,","0,1944",{"v":-28.7,"d":"-28.70"},{"v":-27.6,"d":"-27.60"},5.25,"Exon (ENSBGRT00000020152/ENSBGRG00000010943, exon 2 of 6)",1,74960351,74993190,32840,1]
["chr1",74985153,75015605,30453,"ENSBGRG00000010943","ENSBGRT00000020152",24802,"UMPS","uridine monophosphate synthetase [Source:HGNC Symbol;Acc:HGNC:12563]","GO:0003824(catalytic activity);GO:0004588(orotate phosphoribosyltransferase activity);GO:0004590(orotidine-5'-phosphate decarboxylase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006207('de novo' pyrimidine nucleobase biosynthetic process);GO:0006221(pyrimidine nucleotide biosynthetic process);GO:0006222(UMP biosynthetic process);GO:0009116(nucleoside metabolic process);GO:0044205('de novo' UMP biosynthetic process)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)",{"v":1E-203,"d":"0.00"},3,"105,44,541,","0,7994,29912",-203,-201,{"v":11.5,"d":"11.50"},"3' UTR",1,74960351,74993190,32840,1]
["chr1",76156183,76168167,11985,"ENSBGRG00000013579","ENSBGRT00000025031",25250,"IQCG","IQ motif containing G [Source:HGNC Symbol;Acc:HGNC:25251]","GO:0002177(manchette);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007286(spermatid development);GO:0007288(sperm axoneme assembly);GO:0030544(Hsp70 protein binding);GO:0031514(motile cilium);GO:0036126(sperm flagellum)","NA",{"v":0.0046,"d":"0.00"},3,"92,75,14,","0,2499,11971",-2.34,-1.76,3.61,"Exon (ENSBGRT00000025031/ENSBGRG00000013579, exon 6 of 10)",1,76130933,76171918,40986,1]
["chr1",76372677,76374596,1920,"ENSBGRG00000015738","ENSBGRT00000029671",27813,"RUBCN","rubicon autophagy regulator [Source:HGNC Symbol;Acc:HGNC:28991]","GO:0005654(nucleoplasm);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005829(cytosol);GO:0010507(negative regulation of autophagy);GO:0043231(intracellular membrane-bounded organelle);GO:0043553(negative regulation of phosphatidylinositol 3-kinase activity);GO:0045806(negative regulation of endocytosis);GO:1901097(negative regulation of autophagosome maturation)","04140(Autophagy - animal)",{"v":1.6e-19,"d":"0.00"},2,"514,23,","0,1897",{"v":-18.8,"d":"-18.80"},{"v":-17.8,"d":"-17.80"},5.29,"Exon (ENSBGRT00000029671/ENSBGRG00000015738, exon 7 of 22)",1,76344864,76398227,53364,1]
["chr1",76396376,76398227,1852,"ENSBGRG00000015738","ENSBGRT00000029671",51512,"RUBCN","rubicon autophagy regulator [Source:HGNC Symbol;Acc:HGNC:28991]","GO:0005654(nucleoplasm);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005829(cytosol);GO:0010507(negative regulation of autophagy);GO:0043231(intracellular membrane-bounded organelle);GO:0043553(negative regulation of phosphatidylinositol 3-kinase activity);GO:0045806(negative regulation of endocytosis);GO:1901097(negative regulation of autophagosome maturation)","04140(Autophagy - animal)",{"v":1e-12,"d":"0.00"},3,"26,94,179,","0,1352,1673",-12,{"v":-11.1,"d":"-11.10"},2.79,"3' UTR",1,76344864,76398227,53364,1]
["chr1",77167453,77172230,4778,"ENSBGRG00000018893","ENSBGRT00000034636",5818,"FBXO45","F-box protein 45 [Source:HGNC Symbol;Acc:HGNC:29148]","GO:0001764(neuron migration);GO:0005515(protein binding);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0014069(postsynaptic density);GO:0016567(protein ubiquitination);GO:0021799(cerebral cortex radially oriented cell migration);GO:0021800(cerebral cortex tangential migration);GO:0021957(corticospinal tract morphogenesis);GO:0021960(anterior commissure morphogenesis);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0045202(synapse);GO:0060384(innervation);GO:0060386(synapse assembly involved in innervation);GO:0098793(presynapse);GO:0098978(glutamatergic synapse)","NA",{"v":2e-05,"d":"0.00"},2,"106,186,","0,4592",-4.69,-3.98,4.73,"Exon (ENSBGRT00000034636/ENSBGRG00000018893, exon 2 of 3)",1,77161635,77172230,10596,1]
["chr1",77254786,77255355,570,"ENSBGRG00000018922","ENSBGRT00000034677",30424,"NRROS","negative regulator of reactive oxygen species [Source:HGNC Symbol;Acc:HGNC:24613]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0006801(superoxide metabolic process);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0009986(cell surface);GO:0014005(microglia development);GO:0035583(sequestering of TGFbeta in extracellular matrix);GO:0036364(transforming growth factor beta1 activation);GO:0050431(transforming growth factor beta binding)","NA",{"v":1.3e-12,"d":"0.00"},1,"570,",0,{"v":-11.9,"d":"-11.90"},-11,6.27,"Exon (ENSBGRT00000034677/ENSBGRG00000018922, exon 3 of 5)",1,77224362,77259784,35423,1]
["chr1",77255505,77256283,779,"ENSBGRG00000018922","ENSBGRT00000034677",31143,"NRROS","negative regulator of reactive oxygen species [Source:HGNC Symbol;Acc:HGNC:24613]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0006801(superoxide metabolic process);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0009986(cell surface);GO:0014005(microglia development);GO:0035583(sequestering of TGFbeta in extracellular matrix);GO:0036364(transforming growth factor beta1 activation);GO:0050431(transforming growth factor beta binding)","NA",{"v":0.00048,"d":"0.00"},1,"779,",0,-3.32,-2.67,14,"Exon (ENSBGRT00000034677/ENSBGRG00000018922, exon 3 of 5)",1,77224362,77259784,35423,1]
["chr1",77256523,77259784,3262,"ENSBGRG00000018922","ENSBGRT00000034677",32161,"NRROS","negative regulator of reactive oxygen species [Source:HGNC Symbol;Acc:HGNC:24613]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0006801(superoxide metabolic process);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0009986(cell surface);GO:0014005(microglia development);GO:0035583(sequestering of TGFbeta in extracellular matrix);GO:0036364(transforming growth factor beta1 activation);GO:0050431(transforming growth factor beta binding)","NA",{"v":7.6e-05,"d":"0.00"},3,"378,132,90,","0,856,3172",-4.12,-3.43,8.02,"Exon (ENSBGRT00000034677/ENSBGRG00000018922, exon 3 of 5)",1,77224362,77259784,35423,1]
["chr1",77407947,77411700,3754,"ENSBGRG00000019104","ENSBGRT00000035087",89424,"PAK2","p21 (RAC1) activated kinase 2 [Source:HGNC Symbol;Acc:HGNC:8591]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0014069(postsynaptic density);GO:0016310(phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0030296(protein tyrosine kinase activator activity);GO:0031267(small GTPase binding);GO:0034333(adherens junction assembly);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0048365(Rac GTPase binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051493(regulation of cytoskeleton organization);GO:0051497(negative regulation of stress fiber assembly);GO:0060996(dendritic spine development);GO:0070830(bicellular tight junction assembly);GO:0071407(cellular response to organic cyclic compound);GO:0098978(glutamatergic synapse);GO:0150105(protein localization to cell-cell junction);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04660(T cell receptor signaling pathway);04360(Axon guidance);05211(Renal cell carcinoma)",{"v":4.6e-09,"d":"0.00"},4,"71,64,49,26,","0,1457,3195,3728",-8.34,-7.52,1.82,"Exon (ENSBGRT00000035087/ENSBGRG00000019104, exon 8 of 16)",1,77318523,77430765,112243,1]
["chr1",77430164,77582125,151962,"ENSBGRG00000019330","ENSBGRT00000035552",0,"SENP5","SUMO specific peptidase 5 [Source:HGNC Symbol;Acc:HGNC:28407]","GO:0005730(nucleolus);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity);GO:0016926(protein desumoylation);GO:0019783(ubiquitin-like protein-specific protease activity)","NA",{"v":1.6e-35,"d":"0.00"},3,"62,87,180,","0,515,151782",{"v":-34.8,"d":"-34.80"},{"v":-33.6,"d":"-33.60"},3.67,"5' UTR",1,77448331,77495396,47066,1]
["chr1",77448331,77463453,15123,"ENSBGRG00000019330","ENSBGRT00000035552",0,"SENP5","SUMO specific peptidase 5 [Source:HGNC Symbol;Acc:HGNC:28407]","GO:0005730(nucleolus);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity);GO:0016926(protein desumoylation);GO:0019783(ubiquitin-like protein-specific protease activity)","NA",{"v":1E-14,"d":"0.00"},2,"170,514,","0,14609",-14,{"v":-13.1,"d":"-13.10"},8.02,"5' UTR",1,77448331,77495396,47066,1]
["chr1",77463572,77464314,743,"ENSBGRG00000019104","ENSBGRT00000035256",77021,"PAK2","p21 (RAC1) activated kinase 2 [Source:HGNC Symbol;Acc:HGNC:8591]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0014069(postsynaptic density);GO:0016310(phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0030296(protein tyrosine kinase activator activity);GO:0031267(small GTPase binding);GO:0034333(adherens junction assembly);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0048365(Rac GTPase binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051493(regulation of cytoskeleton organization);GO:0051497(negative regulation of stress fiber assembly);GO:0060996(dendritic spine development);GO:0070830(bicellular tight junction assembly);GO:0071407(cellular response to organic cyclic compound);GO:0098978(glutamatergic synapse);GO:0150105(protein localization to cell-cell junction);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04660(T cell receptor signaling pathway);04360(Axon guidance);05211(Renal cell carcinoma)",{"v":6.3e-33,"d":"0.00"},1,"743,",0,{"v":-32.2,"d":"-32.20"},-31,6.91,"Exon (ENSBGRT00000035552/ENSBGRG00000019330, exon 2 of 10)",1,77386551,77583260,196710,1]
["chr1",77489225,77492175,2951,"ENSBGRG00000019104","ENSBGRT00000035256",102674,"PAK2","p21 (RAC1) activated kinase 2 [Source:HGNC Symbol;Acc:HGNC:8591]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0014069(postsynaptic density);GO:0016310(phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0030296(protein tyrosine kinase activator activity);GO:0031267(small GTPase binding);GO:0034333(adherens junction assembly);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0048365(Rac GTPase binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051493(regulation of cytoskeleton organization);GO:0051497(negative regulation of stress fiber assembly);GO:0060996(dendritic spine development);GO:0070830(bicellular tight junction assembly);GO:0071407(cellular response to organic cyclic compound);GO:0098978(glutamatergic synapse);GO:0150105(protein localization to cell-cell junction);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04660(T cell receptor signaling pathway);04360(Axon guidance);05211(Renal cell carcinoma)",0.01,2,"22,38,","0,2913",-1.98,-1.43,2.07,"Exon (ENSBGRT00000035552/ENSBGRG00000019330, exon 7 of 10)",1,77386551,77583260,196710,1]
["chr1",78244642,78248149,3508,"ENSBGRG00000022918","ENSBGRT00000042322",803,"APOD","apolipoprotein D [Source:HGNC Symbol;Acc:HGNC:612]","GO:0000302(response to reactive oxygen species);GO:0005615(extracellular space);GO:0006006(glucose metabolic process);GO:0006629(lipid metabolic process);GO:0006869(lipid transport);GO:0007568(aging);GO:0008289(lipid binding);GO:0010642(negative regulation of platelet-derived growth factor receptor signaling pathway);GO:0015485(cholesterol binding);GO:0042308(negative regulation of protein import into nucleus);GO:0048471(perinuclear region of cytoplasm);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0051895(negative regulation of focal adhesion assembly);GO:0060588(negative regulation of lipoprotein lipid oxidation);GO:0071638(negative regulation of monocyte chemotactic protein-1 production);GO:1900016(negative regulation of cytokine production involved in inflammatory response);GO:2000098(negative regulation of smooth muscle cell-matrix adhesion);GO:2000405(negative regulation of T cell migration)","NA",{"v":4e-40,"d":"0.00"},3,"123,75,70,","0,705,3438",{"v":-39.4,"d":"-39.40"},{"v":-38.2,"d":"-38.20"},2.53,"5' UTR",1,78243839,78259182,15344,1]
["chr1",78258736,78259182,447,"ENSBGRG00000022918","ENSBGRT00000042322",14897,"APOD","apolipoprotein D [Source:HGNC Symbol;Acc:HGNC:612]","GO:0000302(response to reactive oxygen species);GO:0005615(extracellular space);GO:0006006(glucose metabolic process);GO:0006629(lipid metabolic process);GO:0006869(lipid transport);GO:0007568(aging);GO:0008289(lipid binding);GO:0010642(negative regulation of platelet-derived growth factor receptor signaling pathway);GO:0015485(cholesterol binding);GO:0042308(negative regulation of protein import into nucleus);GO:0048471(perinuclear region of cytoplasm);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0051895(negative regulation of focal adhesion assembly);GO:0060588(negative regulation of lipoprotein lipid oxidation);GO:0071638(negative regulation of monocyte chemotactic protein-1 production);GO:1900016(negative regulation of cytokine production involved in inflammatory response);GO:2000098(negative regulation of smooth muscle cell-matrix adhesion);GO:2000405(negative regulation of T cell migration)","NA",0,1,"447,",0,-2210,"-Inf",2.35,"3' UTR",1,78243839,78259182,15344,1]
["chr1",78304640,78309189,4550,"ENSBGRG00000022948","ENSBGRT00000042439",14096,"ENSBGRG00000022948","NA","GO:0004864(protein phosphatase inhibitor activity);GO:0009966(regulation of signal transduction);GO:0043666(regulation of phosphoprotein phosphatase activity)","NA",{"v":5e-25,"d":"0.00"},2,"80,161,","0,4389",{"v":-24.3,"d":"-24.30"},{"v":-23.2,"d":"-23.20"},2.72,"Exon (ENSBGRT00000042439/ENSBGRG00000022948, exon 4 of 6)",1,78290544,78311452,20909,1]
["chr1",78521067,78529574,8508,"ENSBGRG00000023053","ENSBGRT00000042554",177504,"ACAP2","ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 [Source:HGNC Symbol;Acc:HGNC:16469]","GO:0001726(ruffle);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0017137(Rab GTPase binding);GO:0030029(actin filament-based process);GO:0080025(phosphatidylinositol-3,5-bisphosphate binding)","04144(Endocytosis)",{"v":1.1E-5,"d":"0.00"},3,"25,62,332,","0,2196,8176",-4.94,-4.22,3.64,"3' UTR",1,78343563,78530171,186609,1]
["chr1",78737439,78737916,478,"ENSBGRG00000023443","ENSBGRT00000043289",198752,"XXYLT1","xyloside xylosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:26639]","GO:0000287(magnesium ion binding);GO:0016266(O-glycan processing);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030145(manganese ion binding);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0035252(UDP-xylosyltransferase activity)","NA",{"v":3.2e-41,"d":"0.00"},1,"478,",0,{"v":-40.5,"d":"-40.50"},{"v":-39.2,"d":"-39.20"},{"v":6.1,"d":"6.10"},"3' UTR",1,78538687,78737916,199230,1]
["chr1",79181985,79188013,6029,"ENSBGRG00000023529","ENSBGRT00000043425",10974,"LSG1","large 60S subunit nuclear export GTPase 1 [Source:HGNC Symbol;Acc:HGNC:25652]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0015030(Cajal body);GO:0016604(nuclear body);GO:0051168(nuclear export)","03008(Ribosome biogenesis in eukaryotes)",{"v":7.9e-77,"d":"0.00"},3,"9,387,24,","0,5172,6005",{"v":-76.1,"d":"-76.10"},{"v":-74.5,"d":"-74.50"},3.09,"Exon (ENSBGRT00000043425/ENSBGRG00000023529, exon 7 of 14)",1,79171011,79197825,26815,1]
["chr1",79194292,79196416,2125,"ENSBGRG00000023529","ENSBGRT00000043425",23281,"LSG1","large 60S subunit nuclear export GTPase 1 [Source:HGNC Symbol;Acc:HGNC:25652]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0015030(Cajal body);GO:0016604(nuclear body);GO:0051168(nuclear export)","03008(Ribosome biogenesis in eukaryotes)",{"v":1E-179,"d":"0.00"},2,"121,480,","0,1645",-179,-177,5.26,"3' UTR",1,79171011,79197825,26815,1]
["chr1",79255635,79257189,1555,"ENSBGRG00000023581","ENSBGRT00000043666",50524,"TMEM44","transmembrane protein 44 [Source:HGNC Symbol;Acc:HGNC:25120]","NA","NA",{"v":1.2E-5,"d":"0.00"},2,"9,111,","0,1444",-4.92,{"v":-4.2,"d":"-4.20"},4.23,"3' UTR",1,79205111,79255643,50533,1]
["chr1",81078777,81099300,20524,"ENSBGRG00000000376","ENSBGRT00000000612",103088,"MB21D2","Mab-21 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30438]","GO:0044877(protein-containing complex binding)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer);05226(Gastric cancer);05218(Melanoma);05224(Breast cancer)",{"v":5e-33,"d":"0.00"},2,"38,1028,","0,19496",{"v":-32.3,"d":"-32.30"},{"v":-31.1,"d":"-31.10"},10,"Exon (ENSBGRT00000000612/ENSBGRG00000000376, exon 2 of 3)",1,80975689,81099537,123849,1]
["chr1",81099359,81099537,179,"ENSBGRG00000000376","ENSBGRT00000000612",123670,"MB21D2","Mab-21 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30438]","GO:0044877(protein-containing complex binding)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer);05226(Gastric cancer);05218(Melanoma);05224(Breast cancer)",{"v":6.3E-5,"d":"0.00"},1,"179,",0,{"v":-4.2,"d":"-4.20"},-3.52,5.01,"Exon (ENSBGRT00000000612/ENSBGRG00000000376, exon 3 of 3)",1,80975689,81099537,123849,1]
["chr1",83681236,83681295,60,"ENSBGRG00000000800","ENSBGRT00000001454",17670,"CLDN1","claudin 1 [Source:HGNC Symbol;Acc:HGNC:2032]","GO:0005198(structural molecule activity);GO:0005923(bicellular tight junction);GO:0016021(integral component of membrane)","04514(Cell adhesion molecules (CAMs));04530(Tight junction);04670(Leukocyte transendothelial migration);05160(Hepatitis C)",{"v":8.9e-06,"d":"0.00"},1,"60,",0,-5.05,-4.33,2.09,"3' UTR",1,83663566,83682216,18651,1]
["chr1",86527370,86539836,12467,"ENSBGRG00000001245","ENSBGRT00000002272",0,"ENSBGRG00000001245","NA","NA","NA",{"v":4.1e-09,"d":"0.00"},3,"62,39,49,","0,11558,12418",-8.39,-7.57,2.49,"5' UTR",1,86527411,86527518,108,2]
["chr1",86544216,86544544,329,"ENSBGRG00000001201","ENSBGRT00000002196",17055,"BCL6","BCL6 transcription repressor [Source:HGNC Symbol;Acc:HGNC:1001]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000902(cell morphogenesis);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001161(intronic transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001953(negative regulation of cell-matrix adhesion);GO:0002467(germinal center formation);GO:0002829(negative regulation of type 2 immune response);GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005657(replication fork);GO:0005794(Golgi apparatus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006974(cellular response to DNA damage stimulus);GO:0007266(Rho protein signal transduction);GO:0007283(spermatogenesis);GO:0008104(protein localization);GO:0008285(negative regulation of cell population proliferation);GO:0030036(actin cytoskeleton organization);GO:0030183(B cell differentiation);GO:0030308(negative regulation of cell growth);GO:0030890(positive regulation of B cell proliferation);GO:0031065(positive regulation of histone deacetylation);GO:0031490(chromatin DNA binding);GO:0032764(negative regulation of mast cell cytokine production);GO:0035024(negative regulation of Rho protein signal transduction);GO:0042092(type 2 immune response);GO:0042127(regulation of cell population proliferation);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043087(regulation of GTPase activity);GO:0043380(regulation of memory T cell differentiation);GO:0043565(sequence-specific DNA binding);GO:0045591(positive regulation of regulatory T cell differentiation);GO:0045596(negative regulation of cell differentiation);GO:0045629(negative regulation of T-helper 2 cell differentiation);GO:0045666(positive regulation of neuron differentiation);GO:0045746(negative regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0048294(negative regulation of isotype switching to IgE isotypes);GO:0048821(erythrocyte development);GO:0050727(regulation of inflammatory response);GO:0051272(positive regulation of cellular component movement);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000773(negative regulation of cellular senescence)","04068(FoxO signaling pathway);05202(Transcriptional misregulation in cancers)",{"v":6.3e-32,"d":"0.00"},1,"329,",0,{"v":-31.2,"d":"-31.20"},{"v":-30.1,"d":"-30.10"},2.47,"Exon (ENSBGRT00000002196/ENSBGRG00000001201, exon 5 of 10)",1,86527161,86549904,22744,1]
["chr1",87044674,87060913,16240,"ENSBGRG00000001306","ENSBGRT00000002616",54052,"MASP1","mannan binding lectin serine peptidase 1 [Source:HGNC Symbol;Acc:HGNC:6901]","GO:0001867(complement activation, lectin pathway);GO:0004252(serine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0042803(protein homodimerization activity);GO:0048306(calcium-dependent protein binding)","04610(Complement and coagulation cascades);05150(Staphylococcus aureus infection)",{"v":0.032,"d":"0.03"},9,"46,144,138,114,186,68,100,226,536,","0,3617,4336,7540,8537,10500,12897,13456,15704",-1.49,{"v":-0.978,"d":"-0.98"},7.02,"3' UTR",1,86990622,87044719,54098,1]
["chr1",87060973,87061302,330,"ENSBGRG00000001306","ENSBGRT00000002546",70351,"MASP1","mannan binding lectin serine peptidase 1 [Source:HGNC Symbol;Acc:HGNC:6901]","GO:0001867(complement activation, lectin pathway);GO:0004252(serine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0042803(protein homodimerization activity);GO:0048306(calcium-dependent protein binding)","04610(Complement and coagulation cascades);05150(Staphylococcus aureus infection)",{"v":0.011,"d":"0.01"},1,"330,",0,-1.97,-1.14,9.03,"3' UTR",1,86990622,87061841,71220,1]
["chr1",87061542,87061841,300,"ENSBGRG00000001306","ENSBGRT00000002546",70920,"MASP1","mannan binding lectin serine peptidase 1 [Source:HGNC Symbol;Acc:HGNC:6901]","GO:0001867(complement activation, lectin pathway);GO:0004252(serine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0042803(protein homodimerization activity);GO:0048306(calcium-dependent protein binding)","04610(Complement and coagulation cascades);05150(Staphylococcus aureus infection)",{"v":0.019,"d":"0.02"},1,"300,",0,-1.71,{"v":-0.901,"d":"-0.90"},8.02,"3' UTR",1,86990622,87061841,71220,1]
["chr1",87505179,87505443,265,"ENSBGRG00000001625","ENSBGRT00000003018",12868,"RFC4","replication factor C subunit 4 [Source:HGNC Symbol;Acc:HGNC:9972]","GO:0003677(DNA binding);GO:0003689(DNA clamp loader activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005663(DNA replication factor C complex);GO:0006260(DNA replication);GO:0017116(single-stranded DNA helicase activity);GO:0031390(Ctf18 RFC-like complex);GO:0031391(Elg1 RFC-like complex);GO:1900264(positive regulation of DNA-directed DNA polymerase activity)","03030(DNA replication);03420(Nucleotide excision repair);03430(Mismatch repair)",{"v":2E-8,"d":"0.00"},2,"80,96,","0,169",{"v":-7.7,"d":"-7.70"},{"v":-6.9,"d":"-6.90"},3.05,"Exon (ENSBGRT00000003018/ENSBGRG00000001625, exon 10 of 11)",1,87492311,87505443,13133,1]
["chr1",87741803,87748177,6375,"ENSBGRG00000001905","ENSBGRT00000003558",15923,"TBCCD1","TBCC domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25546]","GO:0000902(cell morphogenesis);GO:0008360(regulation of cell shape);GO:0030334(regulation of cell migration);GO:0031616(spindle pole centrosome);GO:0051661(maintenance of centrosome location);GO:0051684(maintenance of Golgi location)","NA",{"v":1.6e-30,"d":"0.00"},2,"425,22,","0,6353",{"v":-29.8,"d":"-29.80"},{"v":-28.6,"d":"-28.60"},4.56,"Exon (ENSBGRT00000003558/ENSBGRG00000001905, exon 6 of 8)",1,87725880,87753459,27580,1]
["chr1",87761977,87762237,261,"ENSBGRG00000001924","ENSBGRT00000003594",6705,"CRYGS","crystallin gamma S [Source:HGNC Symbol;Acc:HGNC:2417]","GO:0002009(morphogenesis of an epithelium);GO:0002088(lens development in camera-type eye);GO:0005212(structural constituent of eye lens)","NA",{"v":0.0013,"d":"0.00"},1,"261,",0,{"v":-2.9,"d":"-2.90"},-2.28,5.68,"3' UTR",1,87755272,87762237,6966,1]
["chr1",88104869,88169945,65077,"ENSBGRG00000001984","ENSBGRT00000003782",100194,"DGKG","diacylglycerol kinase gamma [Source:HGNC Symbol;Acc:HGNC:2853]","GO:0003951(NAD+ kinase activity);GO:0004143(diacylglycerol kinase activity);GO:0005509(calcium ion binding);GO:0005829(cytosol);GO:0006654(phosphatidic acid biosynthetic process);GO:0007165(signal transduction);GO:0007205(protein kinase C-activating G protein-coupled receptor signaling pathway);GO:0008289(lipid binding);GO:0016020(membrane);GO:0016301(kinase activity);GO:0035556(intracellular signal transduction);GO:0046339(diacylglycerol metabolic process);GO:0046486(glycerolipid metabolic process);GO:0046834(lipid phosphorylation);GO:0050773(regulation of dendrite development);GO:0090038(negative regulation of protein kinase C signaling)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);05231(Choline metabolism in cancer)",{"v":0.035,"d":"0.04"},3,"60,91,58,","0,39199,65019",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000003782/ENSBGRG00000001984, exon 19 of 24)",1,88004675,88212421,207747,1]
["chr1",88196080,88212421,16342,"ENSBGRG00000001984","ENSBGRT00000003782",191405,"DGKG","diacylglycerol kinase gamma [Source:HGNC Symbol;Acc:HGNC:2853]","GO:0003951(NAD+ kinase activity);GO:0004143(diacylglycerol kinase activity);GO:0005509(calcium ion binding);GO:0005829(cytosol);GO:0006654(phosphatidic acid biosynthetic process);GO:0007165(signal transduction);GO:0007205(protein kinase C-activating G protein-coupled receptor signaling pathway);GO:0008289(lipid binding);GO:0016020(membrane);GO:0016301(kinase activity);GO:0035556(intracellular signal transduction);GO:0046339(diacylglycerol metabolic process);GO:0046486(glycerolipid metabolic process);GO:0046834(lipid phosphorylation);GO:0050773(regulation of dendrite development);GO:0090038(negative regulation of protein kinase C signaling)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);05231(Choline metabolism in cancer)",{"v":1.5e-07,"d":"0.00"},3,"63,61,235,","0,2404,16107",-6.81,-6.03,5.68,"3' UTR",1,88004675,88212421,207747,1]
["chr1",88439259,88445534,6276,"ENSBGRG00000002443","ENSBGRT00000004586",15151,"TRA2B","transformer 2 beta homolog [Source:HGNC Symbol;Acc:HGNC:10781]","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005637(nuclear inner membrane);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0019904(protein domain specific binding);GO:0021796(cerebral cortex regionalization);GO:0032991(protein-containing complex);GO:0036002(pre-mRNA binding);GO:0042802(identical protein binding);GO:0043484(regulation of RNA splicing);GO:0048026(positive regulation of mRNA splicing, via spliceosome);GO:0071333(cellular response to glucose stimulus);GO:1990403(embryonic brain development)","03040(Spliceosome)",{"v":2.5e-59,"d":"0.00"},6,"107,116,84,60,74,35,","0,3159,3581,4873,5704,6241",{"v":-58.6,"d":"-58.60"},{"v":-57.1,"d":"-57.10"},8.52,"3' UTR",1,88424108,88445919,21812,1]
["chr1",89124746,89125312,567,"ENSBGRG00000002913","ENSBGRT00000005461",56061,"EHHADH","enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase [Source:HGNC Symbol;Acc:HGNC:3247]","GO:0003824(catalytic activity);GO:0003857(3-hydroxyacyl-CoA dehydrogenase activity);GO:0004300(enoyl-CoA hydratase activity);GO:0005777(peroxisome);GO:0006631(fatty acid metabolic process);GO:0006635(fatty acid beta-oxidation);GO:0016491(oxidoreductase activity);GO:0016509(long-chain-3-hydroxyacyl-CoA dehydrogenase activity);GO:0019899(enzyme binding);GO:0055114(oxidation-reduction process)","00640(Propanoate metabolism);00650(Butanoate metabolism);00071(Fatty acid degradation);00280(Valine, leucine and isoleucine degradation);00310(Lysine degradation);00380(Tryptophan metabolism);00410(beta-Alanine metabolism);04146(Peroxisome);03320(PPAR signaling pathway)",{"v":0.0025,"d":"0.00"},1,"567,",0,{"v":-2.6,"d":"-2.60"},-2,2.27,"Exon (ENSBGRT00000005461/ENSBGRG00000002913, exon 7 of 7)",1,89068685,89126235,57551,1]
["chr1",89319061,89319650,590,"ENSBGRG00000002933","ENSBGRT00000005514",135353,"C3orf70","chromosome 3 open reading frame 70 [Source:HGNC Symbol;Acc:HGNC:33731]","NA","NA",{"v":4e-43,"d":"0.00"},2,"36,486,","0,104",{"v":-42.4,"d":"-42.40"},{"v":-41.1,"d":"-41.10"},6.08,"Exon (ENSBGRT00000005514/ENSBGRG00000002933, exon 2 of 3)",1,89183708,89319650,135943,1]
["chr1",90153645,90154293,649,"ENSBGRG00000003222","ENSBGRT00000006041",5053,"THPO","thrombopoietin [Source:HGNC Symbol;Acc:HGNC:11795]","GO:0001934(positive regulation of protein phosphorylation);GO:0005125(cytokine activity);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0030099(myeloid cell differentiation);GO:0035855(megakaryocyte development);GO:0038163(thrombopoietin-mediated signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0045654(positive regulation of megakaryocyte differentiation);GO:0051897(positive regulation of protein kinase B signaling);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0097696(receptor signaling pathway via STAT);GO:1902035(positive regulation of hematopoietic stem cell proliferation)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage)",{"v":1.7E-8,"d":"0.00"},1,"649,",0,-7.78,-6.98,3.31,"Exon (ENSBGRT00000006041/ENSBGRG00000003222, exon 5 of 6)",1,90148592,90154208,5617,1]
["chr1",90215857,90217665,1809,"ENSBGRG00000000165","ENSBGRT00000000270",0,"ENSBGRG00000000165","NA","NA","NA",{"v":0.011,"d":"0.01"},1,"1809,",0,-1.97,-1.14,9.03,"Exon (ENSBGRT00000000270/ENSBGRG00000000165, exon 1 of 1)",1,90215857,90217665,1809,1]
["chr1",90281406,90281817,412,"ENSBGRG00000000258","ENSBGRT00000000412",6091,"ALG3","ALG3 alpha-1,3- mannosyltransferase [Source:HGNC Symbol;Acc:HGNC:23056]","GO:0000030(mannosyltransferase activity);GO:0000033(alpha-1,3-mannosyltransferase activity);GO:0005789(endoplasmic reticulum membrane);GO:0030176(integral component of endoplasmic reticulum membrane)","00510(N-Glycan biosynthesis)",{"v":7.9e-27,"d":"0.00"},2,"20,249,","0,163",{"v":-26.1,"d":"-26.10"},-25,3.99,"3' UTR",1,90275315,90281817,6503,1]
["chr1",90534953,90535252,300,"ENSBGRG00000001081","ENSBGRT00000002343",42118,"ABCC5","ATP binding cassette subfamily C member 5 [Source:HGNC Symbol;Acc:HGNC:56]","GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0008514(organic anion transmembrane transporter activity);GO:0015562(efflux transmembrane transporter activity);GO:0015711(organic anion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0016887(ATPase activity);GO:0042626(ATPase-coupled transmembrane transporter activity);GO:0042908(xenobiotic transport);GO:0042910(xenobiotic transmembrane transporter activity);GO:0055085(transmembrane transport);GO:0140115(export across plasma membrane)","02010(ABC transporters);01523(Antifolate resistance)",{"v":6.3e-18,"d":"0.00"},1,"300,",0,{"v":-17.2,"d":"-17.20"},{"v":-16.2,"d":"-16.20"},2.07,"Exon (ENSBGRT00000002343/ENSBGRG00000001081, exon 11 of 30)",1,90492835,90584540,91706,1]
["chr1",90629449,90641496,12048,"ENSBGRG00000001380","ENSBGRT00000002524",30,"ENSBGRG00000001380","NA","GO:0004175(endopeptidase activity);GO:0004252(serine-type endopeptidase activity);GO:0005743(mitochondrial inner membrane);GO:0006508(proteolysis);GO:0016021(integral component of membrane);GO:0090201(negative regulation of release of cytochrome c from mitochondria);GO:1903146(regulation of autophagy of mitochondrion);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","NA",{"v":1.5E-6,"d":"0.00"},2,"173,123,","0,11925",-5.82,-5.07,2.09,"Exon (ENSBGRT00000002524/ENSBGRG00000001380, exon 1 of 10)",1,90629419,90686992,57574,1]
["chr1",90698013,90698654,642,"ENSBGRG00000001403","ENSBGRT00000002559",6005,"MAP6D1","MAP6 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25753]","GO:0000226(microtubule cytoskeleton organization);GO:0005516(calmodulin binding);GO:0005798(Golgi-associated vesicle);GO:0005801(cis-Golgi network);GO:0005874(microtubule);GO:0007026(negative regulation of microtubule depolymerization);GO:0008017(microtubule binding);GO:0018009(N-terminal peptidyl-L-cysteine N-palmitoylation)","NA",{"v":9.3e-05,"d":"0.00"},2,"65,81,","0,561",-4.03,-3.35,1.94,"Exon (ENSBGRT00000002559/ENSBGRG00000001403, exon 2 of 3)",1,90692008,90698654,6647,1]
["chr1",91348206,91348460,255,"ENSBGRG00000001502","ENSBGRT00000003048",274948,"MCF2L2","MCF.2 cell line derived transforming sequence-like 2 [Source:HGNC Symbol;Acc:HGNC:30319]","GO:0005085(guanyl-nucleotide exchange factor activity)","NA",{"v":0.048,"d":"0.05"},2,"44,136,","0,119",-1.32,{"v":-0.827,"d":"-0.83"},2.61,"Exon (ENSBGRT00000003048/ENSBGRG00000001502, exon 29 of 30)",1,91073258,91348460,275203,1]
["chr1",91472012,91472650,639,"ENSBGRG00000001725","ENSBGRT00000003225",66449,"MCCC1","methylcrotonoyl-CoA carboxylase 1 [Source:HGNC Symbol;Acc:HGNC:6936]","GO:0004485(methylcrotonoyl-CoA carboxylase activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0046872(metal ion binding);GO:1905202(methylcrotonoyl-CoA carboxylase complex)","00280(Valine, leucine and isoleucine degradation)",{"v":0.00019,"d":"0.00"},2,"21,129,","0,510",-3.72,-3.05,1.85,"Exon (ENSBGRT00000003225/ENSBGRG00000001725, exon 18 of 19)",1,91405563,91472650,67088,1]
["chr1",91516106,91517529,1424,"ENSBGRG00000001763","ENSBGRT00000003247",12819,"DCUN1D1","defective in cullin neddylation 1 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:18184]","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:2000436(positive regulation of protein neddylation)","NA",{"v":2.5e-19,"d":"0.00"},2,"206,31,","0,1393",{"v":-18.6,"d":"-18.60"},{"v":-17.6,"d":"-17.60"},2.54,"5' UTR",1,91503287,91535656,32370,1]
["chr1",91534245,91535499,1255,"ENSBGRG00000001763","ENSBGRT00000003247",30958,"DCUN1D1","defective in cullin neddylation 1 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:18184]","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:2000436(positive regulation of protein neddylation)","NA",{"v":2.5e-43,"d":"0.00"},2,"27,566,","0,689",{"v":-42.6,"d":"-42.60"},{"v":-41.3,"d":"-41.30"},9.53,"3' UTR",1,91503287,91535656,32370,1]
["chr1",91535647,91536405,759,"ENSBGRG00000001763","ENSBGRT00000003247",32360,"DCUN1D1","defective in cullin neddylation 1 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:18184]","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:2000436(positive regulation of protein neddylation)","NA",{"v":0.043,"d":"0.04"},2,"10,80,","0,679",-1.37,{"v":-0.866,"d":"-0.87"},2.12,"3' UTR",1,91503287,91535656,32370,1]
["chr1",93715761,93717996,2236,"ENSBGRG00000001844","ENSBGRT00000003468",2953,"DNAJC19","DnaJ heat shock protein family (Hsp40) member C19 [Source:HGNC Symbol;Acc:HGNC:30528]","GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0007601(visual perception);GO:0032991(protein-containing complex);GO:0048806(genitalia development)","NA",{"v":1.6e-56,"d":"0.00"},3,"39,71,147,","0,696,2089",{"v":-55.8,"d":"-55.80"},{"v":-54.3,"d":"-54.30"},3.02,"3' UTR",1,93712808,93717996,5189,1]
["chr1",94043850,94048205,4356,"ENSBGRG00000002146","ENSBGRT00000004291",21856,"CCDC39","coiled-coil domain containing 39 [Source:HGNC Symbol;Acc:HGNC:25244]","GO:0001947(heart looping);GO:0003341(cilium movement);GO:0003356(regulation of cilium beat frequency);GO:0005829(cytosol);GO:0005929(cilium);GO:0005930(axoneme);GO:0007368(determination of left/right symmetry);GO:0007507(heart development);GO:0030317(flagellated sperm motility);GO:0030324(lung development);GO:0035469(determination of pancreatic left/right asymmetry);GO:0036159(inner dynein arm assembly);GO:0044458(motile cilium assembly);GO:0060285(cilium-dependent cell motility);GO:0060287(epithelial cilium movement involved in determination of left/right asymmetry);GO:0070286(axonemal dynein complex assembly);GO:0071907(determination of digestive tract left/right asymmetry);GO:0071910(determination of liver left/right asymmetry)","00514(Other types of O-glycan biosynthesis)",{"v":0.00089,"d":"0.00"},4,"77,133,195,45,","0,397,3288,4311",-3.05,-2.42,13,"Exon (ENSBGRT00000004291/ENSBGRG00000002146, exon 8 of 14)",1,94021994,94064542,42549,1]
["chr1",95277005,95281895,4891,"ENSBGRG00000003051","ENSBGRT00000005733",3687,"MRPL47","mitochondrial ribosomal protein L47 [Source:HGNC Symbol;Acc:HGNC:16652]","GO:0003735(structural constituent of ribosome);GO:0005739(mitochondrion);GO:0005761(mitochondrial ribosome);GO:0005762(mitochondrial large ribosomal subunit);GO:0006412(translation)","NA",{"v":0.024,"d":"0.02"},2,"12,78,","0,4813",-1.62,{"v":-1.1,"d":"-1.10"},1.26,"Exon (ENSBGRT00000005733/ENSBGRG00000003051, exon 3 of 7)",1,95273318,95293187,19870,1]
["chr1",95489452,95492044,2593,"ENSBGRG00000003113","ENSBGRT00000005796",31092,"GNB4","G protein subunit beta 4 [Source:HGNC Symbol;Acc:HGNC:20731]","GO:0005515(protein binding);GO:0007165(signal transduction)","04014(Ras signaling pathway);04371(Apelin signaling pathway);04151(PI3K-Akt signaling pathway);04062(Chemokine signaling pathway);04926(Relaxin signaling pathway);04724(Glutamatergic synapse);04727(GABAergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);04713(Circadian entrainment);05200(Pathways in cancer);05032(Morphine addiction);05034(Alcoholism);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":2.8E-3,"d":"0.00"},2,"8,82,","0,2511",-2.55,-1.95,1.74,"Exon (ENSBGRT00000005796/ENSBGRG00000003113, exon 8 of 9)",1,95458360,95492162,33803,1]
["chr1",97982243,97982586,344,"ENSBGRG00000003307","ENSBGRT00000006155",133281,"TBL1XR1","transducin beta like 1 X-linked receptor 1 [Source:HGNC Symbol;Acc:HGNC:29529]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0008013(beta-catenin binding);GO:0017053(transcriptional repressor complex);GO:0042393(histone binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0047485(protein N-terminus binding);GO:0072686(mitotic spindle);GO:0090263(positive regulation of canonical Wnt signaling pathway)","04310(Wnt signaling pathway)",{"v":0.019,"d":"0.02"},2,"146,5,","0,339",-1.73,-1.19,3.51,"3' UTR",1,97848962,97985064,136103,1]
["chr1",97983177,97983417,241,"ENSBGRG00000003307","ENSBGRT00000006155",134215,"TBL1XR1","transducin beta like 1 X-linked receptor 1 [Source:HGNC Symbol;Acc:HGNC:29529]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0008013(beta-catenin binding);GO:0017053(transcriptional repressor complex);GO:0042393(histone binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0047485(protein N-terminus binding);GO:0072686(mitotic spindle);GO:0090263(positive regulation of canonical Wnt signaling pathway)","04310(Wnt signaling pathway)",{"v":2.5e-05,"d":"0.00"},1,"241,",0,-4.61,{"v":-3.9,"d":"-3.90"},1.82,"3' UTR",1,97848962,97985064,136103,1]
["chr1",102533176,102589231,56056,"ENSBGRG00000003501","ENSBGRT00000006496",26157,"SPATA16","spermatogenesis associated 16 [Source:HGNC Symbol;Acc:HGNC:29935]","GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0007283(spermatogenesis)","NA",{"v":0.0058,"d":"0.01"},2,"504,35,","0,56021",-2.24,-1.66,10,"Exon (ENSBGRT00000006496/ENSBGRG00000003501, exon 2 of 11)",1,102507019,102805978,298960,1]
["chr1",103103836,103106725,2890,"ENSBGRG00000003789","ENSBGRT00000007073",62854,"NCEH1","neutral cholesterol ester hydrolase 1 [Source:HGNC Symbol;Acc:HGNC:29260]","GO:0006470(protein dephosphorylation);GO:0006805(xenobiotic metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0017171(serine hydrolase activity);GO:0042301(phosphate ion binding);GO:0046485(ether lipid metabolic process);GO:0052689(carboxylic ester hydrolase activity);GO:0060395(SMAD protein signal transduction)","04927(Cortisol synthesis and secretion);04976(Bile secretion);04979(Cholesterol metabolism);04934(Cushing syndrome)",{"v":2e-20,"d":"0.00"},2,"19,933,","0,1957",{"v":-19.7,"d":"-19.70"},{"v":-18.6,"d":"-18.60"},{"v":16.5,"d":"16.50"},"3' UTR",1,103040982,103107171,66190,1]
["chr1",103235554,103245628,10075,"ENSBGRG00000003840","ENSBGRT00000007132",0,"TNFSF10","TNF superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:11925]","GO:0005164(tumor necrosis factor receptor binding);GO:0005515(protein binding);GO:0006955(immune response);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0032813(tumor necrosis factor receptor superfamily binding);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045569(TRAIL binding);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway)","04068(FoxO signaling pathway);04060(Cytokine-cytokine receptor interaction);04210(Apoptosis);04217(Necroptosis);04650(Natural killer cell mediated cytotoxicity);05162(Measles);05164(Influenza A)",{"v":0.00052,"d":"0.00"},3,"129,138,32,","0,7982,10043",-3.28,-2.64,2.84,"Exon (ENSBGRT00000007132/ENSBGRG00000003840, exon 1 of 5)",1,103235554,103252449,16896,1]
["chr1",103252003,103252449,447,"ENSBGRG00000003840","ENSBGRT00000007132",16449,"TNFSF10","TNF superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:11925]","GO:0005164(tumor necrosis factor receptor binding);GO:0005515(protein binding);GO:0006955(immune response);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0032813(tumor necrosis factor receptor superfamily binding);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045569(TRAIL binding);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway)","04068(FoxO signaling pathway);04060(Cytokine-cytokine receptor interaction);04210(Apoptosis);04217(Necroptosis);04650(Natural killer cell mediated cytotoxicity);05162(Measles);05164(Influenza A)",{"v":2e-89,"d":"0.00"},1,"447,",0,{"v":-88.7,"d":"-88.70"},-87,{"v":11.7,"d":"11.70"},"Exon (ENSBGRT00000007132/ENSBGRG00000003840, exon 5 of 5)",1,103235554,103252449,16896,1]
["chr1",104230495,104309051,78557,"ENSBGRG00000004430","ENSBGRT00000008272",119338,"PLD1","phospholipase D1 [Source:HGNC Symbol;Acc:HGNC:9067]","GO:0003824(catalytic activity);GO:0004630(phospholipase D activity);GO:0005768(endosome);GO:0005794(Golgi apparatus);GO:0006654(phosphatidic acid biosynthetic process);GO:0016324(apical plasma membrane);GO:0030139(endocytic vesicle);GO:0032534(regulation of microvillus assembly);GO:0035091(phosphatidylinositol binding);GO:0045727(positive regulation of translation);GO:0048017(inositol lipid-mediated signaling);GO:0098693(regulation of synaptic vesicle cycle);GO:0098981(cholinergic synapse)","00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism);04014(Ras signaling pathway);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04144(Endocytosis);04666(Fc gamma R-mediated phagocytosis);04912(GnRH signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);04724(Glutamatergic synapse);05231(Choline metabolism in cancer)",{"v":1E-73,"d":"0.00"},4,"96,118,386,30,","0,10076,13439,78527",-73,{"v":-71.4,"d":"-71.40"},7.97,"3' UTR",1,104111157,104244319,133163,1]
["chr1",104711317,104719946,8630,"ENSBGRG00000004855","ENSBGRT00000012818",339431,"TNIK","TRAF2 and NCK interacting kinase [Source:HGNC Symbol;Acc:HGNC:30765]","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0007010(cytoskeleton organization);GO:0007256(activation of JNKK activity);GO:0016324(apical plasma membrane);GO:0030033(microvillus assembly);GO:0031532(actin cytoskeleton reorganization);GO:0035556(intracellular signal transduction);GO:0046777(protein autophosphorylation);GO:0048814(regulation of dendrite morphogenesis);GO:0072659(protein localization to plasma membrane)","NA",{"v":0.0074,"d":"0.01"},3,"40,67,133,","0,4975,8497",-2.13,-1.57,2.01,"Exon (ENSBGRT00000012818/ENSBGRG00000004855, exon 10 of 34)",1,104371886,104828624,456739,1]
["chr1",104825457,104828415,2959,"ENSBGRG00000004855","ENSBGRT00000012818",453571,"TNIK","TRAF2 and NCK interacting kinase [Source:HGNC Symbol;Acc:HGNC:30765]","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0007010(cytoskeleton organization);GO:0007256(activation of JNKK activity);GO:0016324(apical plasma membrane);GO:0030033(microvillus assembly);GO:0031532(actin cytoskeleton reorganization);GO:0035556(intracellular signal transduction);GO:0046777(protein autophosphorylation);GO:0048814(regulation of dendrite morphogenesis);GO:0072659(protein localization to plasma membrane)","NA",{"v":1.3e-45,"d":"0.00"},3,"24,140,403,","0,272,2556",{"v":-44.9,"d":"-44.90"},{"v":-43.6,"d":"-43.60"},4.43,"3' UTR",1,104371886,104828624,456739,1]
["chr1",104991210,104993326,2117,"ENSBGRG00000007513","ENSBGRT00000013895",2153,"ENSBGRG00000007513","NA","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)",{"v":9.1e-08,"d":"0.00"},2,"26,145,","0,1972",-7.04,-6.25,1.58,"Exon (ENSBGRT00000013895/ENSBGRG00000007513, exon 3 of 4)",1,104989057,104993326,4270,1]
["chr1",105750518,105750697,180,"ENSBGRG00000006509","ENSBGRT00000012422",80102,"PHC3","polyhomeotic homolog 3 [Source:HGNC Symbol;Acc:HGNC:15682]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008270(zinc ion binding);GO:0031519(PcG protein complex);GO:0035102(PRC1 complex)","NA",{"v":0.013,"d":"0.01"},1,"180,",0,-1.88,-1.34,3.21,"3' UTR",1,105670416,105752882,82467,1]
["chr1",106081548,106087701,6154,"ENSBGRG00000007360","ENSBGRT00000013491",0,"LRRC34","leucine rich repeat containing 34 [Source:HGNC Symbol;Acc:HGNC:28408]","GO:0005515(protein binding)","NA",{"v":0.0032,"d":"0.00"},3,"108,376,117,","0,213,6037",{"v":-2.5,"d":"-2.50"},-1.91,11,"5' UTR",1,106081548,106100369,18822,1]
["chr1",106132918,106133785,868,"ENSBGRG00000007581","ENSBGRT00000013870",2302,"ACTRT3","actin related protein T3 [Source:HGNC Symbol;Acc:HGNC:24022]","GO:0001673(male germ cell nucleus)","NA",{"v":1.3E-25,"d":"0.00"},1,"868,",0,{"v":-24.9,"d":"-24.90"},{"v":-23.8,"d":"-23.80"},{"v":7.4,"d":"7.40"},"3' UTR",1,106130616,106133785,3170,1]
["chr1",106901797,106902305,509,"ENSBGRG00000007660","ENSBGRT00000015098",675414,"MECOM","MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498]","GO:0000118(histone deacetylase complex);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0043069(negative regulation of programmed cell death);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0051726(regulation of cell cycle)","04010(MAPK signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)",{"v":0.00076,"d":"0.00"},1,"509,",0,-3.12,-2.49,10,"Exon (ENSBGRT00000015098/ENSBGRG00000007660, exon 8 of 19)",1,106226383,106941820,715438,1]
["chr1",106935684,106936716,1033,"ENSBGRG00000007660","ENSBGRT00000015098",709301,"MECOM","MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498]","GO:0000118(histone deacetylase complex);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0043069(negative regulation of programmed cell death);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0051726(regulation of cell cycle)","04010(MAPK signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)",{"v":1.7E-5,"d":"0.00"},2,"189,21,","0,1012",-4.76,-4.05,1.95,"Exon (ENSBGRT00000015098/ENSBGRG00000007660, exon 17 of 19)",1,106226383,106941820,715438,1]
["chr1",106936865,106941820,4956,"ENSBGRG00000007660","ENSBGRT00000015098",710482,"MECOM","MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498]","GO:0000118(histone deacetylase complex);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0043069(negative regulation of programmed cell death);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0051726(regulation of cell cycle)","04010(MAPK signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)",{"v":6.3e-19,"d":"0.00"},2,"15,135,","0,4821",{"v":-18.2,"d":"-18.20"},{"v":-17.2,"d":"-17.20"},9.25,"Exon (ENSBGRT00000015098/ENSBGRG00000007660, exon 18 of 19)",1,106226383,106941820,715438,1]
["chr1",108051801,108051979,179,"ENSBGRG00000008924","ENSBGRT00000016330",89,"GOLIM4","golgi integral membrane protein 4 [Source:HGNC Symbol;Acc:HGNC:15448]","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0016021(integral component of membrane)","NA",0.01,1,"179,",0,-2,-1.45,2.63,"5' UTR",1,108051712,108144188,92477,1]
["chr1",108103065,108108163,5099,"ENSBGRG00000008924","ENSBGRT00000016330",51353,"GOLIM4","golgi integral membrane protein 4 [Source:HGNC Symbol;Acc:HGNC:15448]","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0016021(integral component of membrane)","NA",{"v":3.6e-06,"d":"0.00"},4,"70,50,54,94,","0,1298,3164,5005",-5.44,{"v":-4.7,"d":"-4.70"},1.45,"Exon (ENSBGRT00000016330/ENSBGRG00000008924, exon 2 of 16)",1,108051712,108144188,92477,1]
["chr1",108124445,108144188,19744,"ENSBGRG00000008924","ENSBGRT00000016330",72733,"GOLIM4","golgi integral membrane protein 4 [Source:HGNC Symbol;Acc:HGNC:15448]","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0016021(integral component of membrane)","NA",{"v":1e-245,"d":"0.00"},8,"299,254,83,110,168,69,81,243,","0,2404,4303,6414,9193,10588,19117,19501",-245,-242,5.08,"3' UTR",1,108051712,108144188,92477,1]
["chr1",108477252,108477551,300,"ENSBGRG00000009426","ENSBGRT00000017468",0,"PDCD10","programmed cell death 10 [Source:HGNC Symbol;Acc:HGNC:8761]","GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0008284(positive regulation of cell population proliferation);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0019901(protein kinase binding);GO:0030335(positive regulation of cell migration);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0036481(intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:0042542(response to hydrogen peroxide);GO:0042803(protein homodimerization activity);GO:0043066(negative regulation of apoptotic process);GO:0043406(positive regulation of MAP kinase activity);GO:0044319(wound healing, spreading of cells);GO:0045747(positive regulation of Notch signaling pathway);GO:0047485(protein N-terminus binding);GO:0050821(protein stabilization);GO:0051683(establishment of Golgi localization);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0090051(negative regulation of cell migration involved in sprouting angiogenesis);GO:0090168(Golgi reassembly);GO:0090316(positive regulation of intracellular protein transport);GO:1903588(negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis);GO:1990830(cellular response to leukemia inhibitory factor)","NA",{"v":0.0058,"d":"0.01"},1,"300,",0,-2.24,-1.66,10,"5' UTR",1,108477252,108529736,52485,1]
["chr1",110439148,110443953,4806,"ENSBGRG00000009941","ENSBGRT00000018328",7108,"BCHE","butyrylcholinesterase [Source:HGNC Symbol;Acc:HGNC:983]","GO:0003990(acetylcholinesterase activity);GO:0004104(cholinesterase activity);GO:0005641(nuclear envelope lumen);GO:0005783(endoplasmic reticulum);GO:0042802(identical protein binding)","NA",{"v":2e-28,"d":"0.00"},2,"1461,120,","0,4686",{"v":-27.7,"d":"-27.70"},{"v":-26.6,"d":"-26.60"},6.44,"Exon (ENSBGRT00000018328/ENSBGRG00000009941, exon 2 of 3)",1,110432040,110444513,12474,1]
["chr1",114327274,114328383,1110,"ENSBGRG00000010725","ENSBGRT00000019611",245,"KNSTRN","kinetochore localized astrin (SPAG5) binding protein [Source:HGNC Symbol;Acc:HGNC:30767]","GO:0000070(mitotic sister chromatid segregation);GO:0000226(microtubule cytoskeleton organization);GO:0000776(kinetochore);GO:0001726(ruffle);GO:0005886(plasma membrane);GO:0007051(spindle organization);GO:0007059(chromosome segregation);GO:0016477(cell migration);GO:0034451(centriolar satellite);GO:0035371(microtubule plus-end);GO:0042803(protein homodimerization activity);GO:0051010(microtubule plus-end binding);GO:0051988(regulation of attachment of spindle microtubules to kinetochore);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0072686(mitotic spindle)","NA",{"v":1e-123,"d":"0.00"},1,"1110,",0,-123,-121,6.67,"3' UTR",1,114327029,114328383,1355,1]
["chr1",116362613,116363927,1315,"ENSBGRG00000011942","ENSBGRT00000021973",0,"KPNA4","karyopherin subunit alpha 4 [Source:HGNC Symbol;Acc:HGNC:6397]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006606(protein import into nucleus);GO:0031965(nuclear membrane);GO:0042025(host cell nucleus);GO:0042542(response to hydrogen peroxide);GO:0061608(nuclear import signal receptor activity)","NA",{"v":1.6e-10,"d":"0.00"},2,"722,27,","0,1288",{"v":-9.8,"d":"-9.80"},-8.94,12,"5' UTR",1,116362613,116430347,67735,1]
["chr1",116430372,116430760,389,"ENSBGRG00000011942","ENSBGRT00000021838",67759,"KPNA4","karyopherin subunit alpha 4 [Source:HGNC Symbol;Acc:HGNC:6397]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006606(protein import into nucleus);GO:0031965(nuclear membrane);GO:0042025(host cell nucleus);GO:0042542(response to hydrogen peroxide);GO:0061608(nuclear import signal receptor activity)","NA",{"v":1.6e-20,"d":"0.00"},1,"389,",0,{"v":-19.8,"d":"-19.80"},{"v":-18.8,"d":"-18.80"},1.96,"3' UTR",1,116362613,116431299,68687,1]
["chr1",116430940,116431179,240,"ENSBGRG00000011942","ENSBGRT00000021838",68327,"KPNA4","karyopherin subunit alpha 4 [Source:HGNC Symbol;Acc:HGNC:6397]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006606(protein import into nucleus);GO:0031965(nuclear membrane);GO:0042025(host cell nucleus);GO:0042542(response to hydrogen peroxide);GO:0061608(nuclear import signal receptor activity)","NA",{"v":2.9e-06,"d":"0.00"},1,"240,",0,-5.54,{"v":-4.8,"d":"-4.80"},2.15,"3' UTR",1,116362613,116431299,68687,1]
["chr1",116493094,116494155,1062,"ENSBGRG00000012188","ENSBGRT00000022273",0,"TRIM59","tripartite motif containing 59 [Source:HGNC Symbol;Acc:HGNC:30834]","GO:0005783(endoplasmic reticulum);GO:0008270(zinc ion binding);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045087(innate immune response);GO:0046597(negative regulation of viral entry into host cell);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":1e-34,"d":"0.00"},1,"1062,",0,-34,{"v":-32.8,"d":"-32.80"},9.03,"Exon (ENSBGRT00000022273/ENSBGRG00000012188, exon 1 of 1)",1,116493094,116494302,1209,1]
["chr1",116917501,116919533,2033,"ENSBGRG00000013199","ENSBGRT00000024227",41753,"ENSBGRG00000013199","NA","GO:0005515(protein binding);GO:0007165(signal transduction)","04621(NOD-like receptor signaling pathway)",{"v":2.5e-34,"d":"0.00"},2,"278,20,","0,2013",{"v":-33.6,"d":"-33.60"},{"v":-32.4,"d":"-32.40"},3.26,"Exon (ENSBGRT00000024227/ENSBGRG00000013199, exon 16 of 16)",1,116875748,116917778,42031,1]
["chr1",118507829,118507949,121,"ENSBGRG00000014425","ENSBGRT00000026472",46853,"RARRES1","retinoic acid receptor responder 1 [Source:HGNC Symbol;Acc:HGNC:9867]","GO:0008285(negative regulation of cell population proliferation)","NA",{"v":6.3e-84,"d":"0.00"},1,"121,",0,{"v":-83.2,"d":"-83.20"},{"v":-81.5,"d":"-81.50"},3.03,"Exon (ENSBGRT00000026472/ENSBGRG00000014425, exon 6 of 6)",1,118460976,118507949,46974,1]
["chr1",119114402,119115058,657,"ENSBGRG00000015647","ENSBGRT00000028951",0,"SHOX2","short stature homeobox 2 [Source:HGNC Symbol;Acc:HGNC:10854]","GO:0001649(osteoblast differentiation);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002062(chondrocyte differentiation);GO:0002063(chondrocyte development);GO:0003170(heart valve development);GO:0003209(cardiac atrium morphogenesis);GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0030326(embryonic limb morphogenesis);GO:0032330(regulation of chondrocyte differentiation);GO:0035115(embryonic forelimb morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045880(positive regulation of smoothened signaling pathway);GO:0048557(embryonic digestive tract morphogenesis);GO:0048598(embryonic morphogenesis);GO:0048743(positive regulation of skeletal muscle fiber development);GO:0050772(positive regulation of axonogenesis);GO:0060272(embryonic skeletal joint morphogenesis);GO:0060351(cartilage development involved in endochondral bone morphogenesis);GO:0060415(muscle tissue morphogenesis);GO:2000172(regulation of branching morphogenesis of a nerve)","NA",{"v":0.039,"d":"0.04"},1,"657,",0,-1.41,{"v":-0.908,"d":"-0.91"},3.01,"5' UTR",1,119114402,119123330,8929,1]
["chr1",119125390,119125450,61,"ENSBGRG00000015647","ENSBGRT00000029224",10748,"SHOX2","short stature homeobox 2 [Source:HGNC Symbol;Acc:HGNC:10854]","GO:0001649(osteoblast differentiation);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002062(chondrocyte differentiation);GO:0002063(chondrocyte development);GO:0003170(heart valve development);GO:0003209(cardiac atrium morphogenesis);GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0030326(embryonic limb morphogenesis);GO:0032330(regulation of chondrocyte differentiation);GO:0035115(embryonic forelimb morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045880(positive regulation of smoothened signaling pathway);GO:0048557(embryonic digestive tract morphogenesis);GO:0048598(embryonic morphogenesis);GO:0048743(positive regulation of skeletal muscle fiber development);GO:0050772(positive regulation of axonogenesis);GO:0060272(embryonic skeletal joint morphogenesis);GO:0060351(cartilage development involved in endochondral bone morphogenesis);GO:0060415(muscle tissue morphogenesis);GO:2000172(regulation of branching morphogenesis of a nerve)","NA",{"v":0.043,"d":"0.04"},1,"61,",0,-1.37,{"v":-0.866,"d":"-0.87"},2.26,"Exon (ENSBGRT00000029224/ENSBGRG00000015647, exon 6 of 6)",1,119114642,119125502,10861,1]
["chr1",119125509,119125569,61,"ENSBGRG00000015647","ENSBGRT00000029281",9065,"SHOX2","short stature homeobox 2 [Source:HGNC Symbol;Acc:HGNC:10854]","GO:0001649(osteoblast differentiation);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002062(chondrocyte differentiation);GO:0002063(chondrocyte development);GO:0003170(heart valve development);GO:0003209(cardiac atrium morphogenesis);GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0030326(embryonic limb morphogenesis);GO:0032330(regulation of chondrocyte differentiation);GO:0035115(embryonic forelimb morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045880(positive regulation of smoothened signaling pathway);GO:0048557(embryonic digestive tract morphogenesis);GO:0048598(embryonic morphogenesis);GO:0048743(positive regulation of skeletal muscle fiber development);GO:0050772(positive regulation of axonogenesis);GO:0060272(embryonic skeletal joint morphogenesis);GO:0060351(cartilage development involved in endochondral bone morphogenesis);GO:0060415(muscle tissue morphogenesis);GO:2000172(regulation of branching morphogenesis of a nerve)","NA",{"v":0.0046,"d":"0.00"},1,"61,",0,-2.34,-1.75,2.55,"3' UTR",1,119116444,119125867,9424,1]
["chr1",119125778,119125867,90,"ENSBGRG00000015647","ENSBGRT00000029281",9334,"SHOX2","short stature homeobox 2 [Source:HGNC Symbol;Acc:HGNC:10854]","GO:0001649(osteoblast differentiation);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002062(chondrocyte differentiation);GO:0002063(chondrocyte development);GO:0003170(heart valve development);GO:0003209(cardiac atrium morphogenesis);GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0030326(embryonic limb morphogenesis);GO:0032330(regulation of chondrocyte differentiation);GO:0035115(embryonic forelimb morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045880(positive regulation of smoothened signaling pathway);GO:0048557(embryonic digestive tract morphogenesis);GO:0048598(embryonic morphogenesis);GO:0048743(positive regulation of skeletal muscle fiber development);GO:0050772(positive regulation of axonogenesis);GO:0060272(embryonic skeletal joint morphogenesis);GO:0060351(cartilage development involved in endochondral bone morphogenesis);GO:0060415(muscle tissue morphogenesis);GO:2000172(regulation of branching morphogenesis of a nerve)","NA",{"v":9.3e-05,"d":"0.00"},1,"90,",0,-4.03,-3.35,{"v":4.3,"d":"4.30"},"3' UTR",1,119116444,119125867,9424,1]
["chr1",119988560,119989344,785,"ENSBGRG00000016007","ENSBGRT00000029736",181320,"VEPH1","ventricular zone expressed PH domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25735]","GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0060392(negative regulation of SMAD protein signal transduction)","NA",{"v":0.0058,"d":"0.01"},2,"7,203,","0,582",-2.24,-1.66,10,"Exon (ENSBGRT00000029736/ENSBGRG00000016007, exon 8 of 13)",1,119807240,120097278,290039,1]
["chr1",120096395,120101829,5435,"ENSBGRG00000016007","ENSBGRT00000029736",289155,"VEPH1","ventricular zone expressed PH domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25735]","GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0060392(negative regulation of SMAD protein signal transduction)","NA",{"v":0.035,"d":"0.04"},2,"884,281,","0,5154",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"3' UTR",1,119807240,120097278,290039,1]
["chr1",120219240,120219360,121,"ENSBGRG00000016437","ENSBGRT00000030425",0,"CCNL1","cyclin L1 [Source:HGNC Symbol;Acc:HGNC:20569]","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006396(RNA processing);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0042025(host cell nucleus)","NA",{"v":0.011,"d":"0.01"},1,"121,",0,-1.96,{"v":-1.4,"d":"-1.40"},7.02,"5' UTR",1,120219240,120231613,12374,1]
["chr1",120219449,120219569,121,"ENSBGRG00000016437","ENSBGRT00000030425",209,"CCNL1","cyclin L1 [Source:HGNC Symbol;Acc:HGNC:20569]","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006396(RNA processing);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0042025(host cell nucleus)","NA",{"v":0.012,"d":"0.01"},1,"121,",0,-1.91,-1.36,1.56,"5' UTR",1,120219240,120231613,12374,1]
["chr1",120230560,120231953,1394,"ENSBGRG00000016437","ENSBGRT00000030425",11320,"CCNL1","cyclin L1 [Source:HGNC Symbol;Acc:HGNC:20569]","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006396(RNA processing);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0042025(host cell nucleus)","NA",{"v":0,"d":"0.00"},2,"90,689,","0,705",-320,-317,4.02,"3' UTR",1,120219240,120231613,12374,1]
["chr1",120958826,120959003,178,"ENSBGRG00000016835","ENSBGRT00000031276",11084,"SSR3","signal sequence receptor subunit 3 [Source:HGNC Symbol;Acc:HGNC:11325]","GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0016021(integral component of membrane)","04141(Protein processing in endoplasmic reticulum)",{"v":2.5e-28,"d":"0.00"},1,"178,",0,{"v":-27.6,"d":"-27.60"},{"v":-26.5,"d":"-26.50"},1.92,"3' UTR",1,120947742,120959375,11634,1]
["chr1",121731726,121732146,421,"ENSBGRG00000007522","ENSBGRT00000013766",2929,"ENSBGRG00000007522","NA","NA","NA",{"v":0.0032,"d":"0.00"},1,"421,",0,{"v":-2.5,"d":"-2.50"},-1.91,11,"Exon (ENSBGRT00000013766/ENSBGRG00000007522, exon 2 of 2)",1,121728797,121732356,3560,1]
["chr1",121763197,121763963,767,"ENSBGRG00000007545","ENSBGRT00000013909",0,"ENSBGRG00000007545","NA","GO:0008521(acetyl-CoA transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","00604(Glycosphingolipid biosynthesis - ganglio series)",{"v":7.9e-41,"d":"0.00"},1,"767,",0,{"v":-40.1,"d":"-40.10"},{"v":-38.9,"d":"-38.90"},{"v":34.1,"d":"34.10"},"Exon (ENSBGRT00000013909/ENSBGRG00000007545, exon 1 of 6)",1,121763197,121783645,20449,1]
["chr1",121838469,121842518,4050,"ENSBGRG00000007709","ENSBGRT00000014152",26778,"C3orf33","chromosome 3 open reading frame 33 [Source:HGNC Symbol;Acc:HGNC:26434]","GO:0005615(extracellular space);GO:0051090(regulation of DNA-binding transcription factor activity);GO:0070373(negative regulation of ERK1 and ERK2 cascade)","03010(Ribosome)",{"v":1.3E-13,"d":"0.00"},2,"13,402,","0,3648",{"v":-12.9,"d":"-12.90"},-12,7.58,"Exon (ENSBGRT00000014152/ENSBGRG00000007709, exon 4 of 5)",1,121811691,121842518,30828,1]
["chr1",122120163,122121102,940,"ENSBGRG00000007957","ENSBGRT00000016392",262028,"PLCH1","phospholipase C eta 1 [Source:HGNC Symbol;Acc:HGNC:29185]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0016020(membrane);GO:0035556(intracellular signal transduction);GO:0043231(intracellular membrane-bounded organelle);GO:0048015(phosphatidylinositol-mediated signaling);GO:0050429(calcium-dependent phospholipase C activity)","00562(Inositol phosphate metabolism)",{"v":0.035,"d":"0.04"},2,"9,620,","0,320",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000016392/ENSBGRG00000007957, exon 25 of 25)",1,121858135,122122554,264420,1]
["chr1",122121162,122121342,181,"ENSBGRG00000007957","ENSBGRT00000016392",263027,"PLCH1","phospholipase C eta 1 [Source:HGNC Symbol;Acc:HGNC:29185]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0016020(membrane);GO:0035556(intracellular signal transduction);GO:0043231(intracellular membrane-bounded organelle);GO:0048015(phosphatidylinositol-mediated signaling);GO:0050429(calcium-dependent phospholipase C activity)","00562(Inositol phosphate metabolism)",{"v":0.028,"d":"0.03"},1,"181,",0,-1.55,-1.03,3.68,"Exon (ENSBGRT00000016392/ENSBGRG00000007957, exon 25 of 25)",1,121858135,122122554,264420,1]
["chr1",122121581,122121761,181,"ENSBGRG00000007957","ENSBGRT00000016392",263446,"PLCH1","phospholipase C eta 1 [Source:HGNC Symbol;Acc:HGNC:29185]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0016020(membrane);GO:0035556(intracellular signal transduction);GO:0043231(intracellular membrane-bounded organelle);GO:0048015(phosphatidylinositol-mediated signaling);GO:0050429(calcium-dependent phospholipase C activity)","00562(Inositol phosphate metabolism)",{"v":0.00089,"d":"0.00"},1,"181,",0,-3.05,-2.42,13,"Exon (ENSBGRT00000016392/ENSBGRG00000007957, exon 25 of 25)",1,121858135,122122554,264420,1]
["chr1",122121940,122122299,360,"ENSBGRG00000007957","ENSBGRT00000016392",263805,"PLCH1","phospholipase C eta 1 [Source:HGNC Symbol;Acc:HGNC:29185]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0016020(membrane);GO:0035556(intracellular signal transduction);GO:0043231(intracellular membrane-bounded organelle);GO:0048015(phosphatidylinositol-mediated signaling);GO:0050429(calcium-dependent phospholipase C activity)","00562(Inositol phosphate metabolism)",{"v":0.032,"d":"0.03"},1,"360,",0,-1.49,{"v":-0.978,"d":"-0.98"},7.02,"Exon (ENSBGRT00000016392/ENSBGRG00000007957, exon 25 of 25)",1,121858135,122122554,264420,1]
["chr1",123404079,123408501,4423,"ENSBGRG00000010375","ENSBGRT00000020703",0,"DHX36","DEAH-box helicase 36 [Source:HGNC Symbol;Acc:HGNC:14410]","GO:0000287(magnesium ion binding);GO:0000781(chromosome, telomeric region);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001503(ossification);GO:0002151(G-quadruplex RNA binding);GO:0002735(positive regulation of myeloid dendritic cell cytokine production);GO:0003676(nucleic acid binding);GO:0003678(DNA helicase activity);GO:0003697(single-stranded DNA binding);GO:0003723(RNA binding);GO:0003724(RNA helicase activity);GO:0003725(double-stranded RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006359(regulation of transcription by RNA polymerase III);GO:0007283(spermatogenesis);GO:0008094(DNA-dependent ATPase activity);GO:0009615(response to virus);GO:0010494(cytoplasmic stress granule);GO:0010501(RNA secondary structure unwinding);GO:0016607(nuclear speck);GO:0017148(negative regulation of translation);GO:0031442(positive regulation of mRNA 3'-end processing);GO:0032206(positive regulation of telomere maintenance);GO:0032727(positive regulation of interferon-alpha production);GO:0034605(cellular response to heat);GO:0034644(cellular response to UV);GO:0035925(mRNA 3'-UTR AU-rich region binding);GO:0042826(histone deacetylase binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043330(response to exogenous dsRNA);GO:0043488(regulation of mRNA stability);GO:0044806(G-quadruplex DNA unwinding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045995(regulation of embryonic development);GO:0048027(mRNA 5'-UTR binding);GO:0051880(G-quadruplex DNA binding);GO:0051891(positive regulation of cardioblast differentiation);GO:0060261(positive regulation of transcription initiation from RNA polymerase II promoter);GO:0061158(3'-UTR-mediated mRNA destabilization);GO:0070034(telomerase RNA binding);GO:0090669(telomerase RNA stabilization);GO:1900153(positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:1901534(positive regulation of hematopoietic progenitor cell differentiation);GO:1902064(regulation of transcription from RNA polymerase II promoter involved in spermatogenesis);GO:1903843(cellular response to arsenite ion);GO:1904358(positive regulation of telomere maintenance via telomere lengthening);GO:2000767(positive regulation of cytoplasmic translation)","03018(RNA degradation)",{"v":1.4E-3,"d":"0.00"},2,"252,47,","0,4376",-2.85,-2.23,5.52,"5' UTR",1,123404079,123451711,47633,1]
["chr1",123451089,123451711,623,"ENSBGRG00000010375","ENSBGRT00000020703",47010,"DHX36","DEAH-box helicase 36 [Source:HGNC Symbol;Acc:HGNC:14410]","GO:0000287(magnesium ion binding);GO:0000781(chromosome, telomeric region);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001503(ossification);GO:0002151(G-quadruplex RNA binding);GO:0002735(positive regulation of myeloid dendritic cell cytokine production);GO:0003676(nucleic acid binding);GO:0003678(DNA helicase activity);GO:0003697(single-stranded DNA binding);GO:0003723(RNA binding);GO:0003724(RNA helicase activity);GO:0003725(double-stranded RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006359(regulation of transcription by RNA polymerase III);GO:0007283(spermatogenesis);GO:0008094(DNA-dependent ATPase activity);GO:0009615(response to virus);GO:0010494(cytoplasmic stress granule);GO:0010501(RNA secondary structure unwinding);GO:0016607(nuclear speck);GO:0017148(negative regulation of translation);GO:0031442(positive regulation of mRNA 3'-end processing);GO:0032206(positive regulation of telomere maintenance);GO:0032727(positive regulation of interferon-alpha production);GO:0034605(cellular response to heat);GO:0034644(cellular response to UV);GO:0035925(mRNA 3'-UTR AU-rich region binding);GO:0042826(histone deacetylase binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043330(response to exogenous dsRNA);GO:0043488(regulation of mRNA stability);GO:0044806(G-quadruplex DNA unwinding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045995(regulation of embryonic development);GO:0048027(mRNA 5'-UTR binding);GO:0051880(G-quadruplex DNA binding);GO:0051891(positive regulation of cardioblast differentiation);GO:0060261(positive regulation of transcription initiation from RNA polymerase II promoter);GO:0061158(3'-UTR-mediated mRNA destabilization);GO:0070034(telomerase RNA binding);GO:0090669(telomerase RNA stabilization);GO:1900153(positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:1901534(positive regulation of hematopoietic progenitor cell differentiation);GO:1902064(regulation of transcription from RNA polymerase II promoter involved in spermatogenesis);GO:1903843(cellular response to arsenite ion);GO:1904358(positive regulation of telomere maintenance via telomere lengthening);GO:2000767(positive regulation of cytoplasmic translation)","03018(RNA degradation)",{"v":1.3e-57,"d":"0.00"},2,"33,296,","0,327",{"v":-56.9,"d":"-56.90"},{"v":-55.4,"d":"-55.40"},3.34,"3' UTR",1,123404079,123451711,47633,1]
["chr1",126998496,127005312,6817,"ENSBGRG00000013927","ENSBGRT00000025582",8443,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":4.3e-05,"d":"0.00"},2,"357,273,","0,6544",-4.37,-3.67,13,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 5 of 8)",1,126990053,127017625,27573,1]
["chr1",127005371,127005431,61,"ENSBGRG00000013927","ENSBGRT00000025582",15318,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":0.035,"d":"0.04"},1,"61,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127005641,127006030,390,"ENSBGRG00000013927","ENSBGRT00000025582",15588,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":3.2e-09,"d":"0.00"},1,"390,",0,-8.49,-7.67,5.62,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127006449,127007226,778,"ENSBGRG00000013927","ENSBGRT00000025582",16396,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":1e-15,"d":"0.00"},1,"778,",0,-15,{"v":-14.1,"d":"-14.10"},5.55,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127007316,127007376,61,"ENSBGRG00000013927","ENSBGRT00000025582",17263,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":0.037,"d":"0.04"},1,"61,",0,-1.43,{"v":-0.919,"d":"-0.92"},1.63,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127007466,127008244,779,"ENSBGRG00000013927","ENSBGRT00000025582",17413,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":4e-20,"d":"0.00"},1,"779,",0,{"v":-19.4,"d":"-19.40"},{"v":-18.3,"d":"-18.30"},3.94,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127008603,127009022,420,"ENSBGRG00000013927","ENSBGRT00000025582",18550,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":1e-12,"d":"0.00"},1,"420,",0,-12,{"v":-11.1,"d":"-11.10"},3.01,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127009111,127017625,8515,"ENSBGRG00000013927","ENSBGRT00000025582",19058,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":1.3E-82,"d":"0.00"},3,"246,898,1909,","0,703,6606",{"v":-81.9,"d":"-81.90"},{"v":-80.3,"d":"-80.30"},9.45,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127116344,127117046,703,"ENSBGRG00000014296","ENSBGRT00000026299",0,"P2RY12","purinergic receptor P2Y12 [Source:HGNC Symbol;Acc:HGNC:18124]","GO:0001609(G protein-coupled adenosine receptor activity);GO:0001621(G protein-coupled ADP receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005886(plasma membrane);GO:0006930(substrate-dependent cell migration, cell extension);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G protein-coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0007596(blood coagulation);GO:0016021(integral component of membrane);GO:0030168(platelet activation);GO:0031224(intrinsic component of membrane);GO:0031253(cell projection membrane);GO:0043270(positive regulation of ion transport);GO:0044298(cell body membrane);GO:0045028(G protein-coupled purinergic nucleotide receptor activity);GO:0070527(platelet aggregation);GO:0071318(cellular response to ATP);GO:0071407(cellular response to organic cyclic compound);GO:0150063(visual system development);GO:1904139(regulation of microglial cell migration)","04611(Platelet activation)",{"v":0.019,"d":"0.02"},1,"703,",0,-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000026299/ENSBGRG00000014296, exon 1 of 3)",1,127116344,127117634,1291,1]
["chr1",127127896,127128897,1002,"ENSBGRG00000014357","ENSBGRT00000026344",0,"P2RY13","purinergic receptor P2Y13 [Source:HGNC Symbol;Acc:HGNC:4537]","GO:0004930(G protein-coupled receptor activity);GO:0005783(endoplasmic reticulum);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007194(negative regulation of adenylate cyclase activity);GO:0016021(integral component of membrane);GO:0045028(G protein-coupled purinergic nucleotide receptor activity);GO:0071407(cellular response to organic cyclic compound)","04080(Neuroactive ligand-receptor interaction)",{"v":0.00048,"d":"0.00"},1,"1002,",0,-3.32,-2.67,14,"Exon (ENSBGRT00000026344/ENSBGRG00000014357, exon 1 of 1)",1,127127896,127128897,1002,1]
["chr1",127258047,127259063,1017,"ENSBGRG00000014410","ENSBGRT00000026452",0,"P2RY14","purinergic receptor P2Y14 [Source:HGNC Symbol;Acc:HGNC:16442]","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0045028(G protein-coupled purinergic nucleotide receptor activity)","04080(Neuroactive ligand-receptor interaction)",{"v":5.1e-06,"d":"0.00"},1,"1017,",0,-5.29,-4.56,12,"Exon (ENSBGRT00000026452/ENSBGRG00000014410, exon 1 of 1)",1,127258047,127259063,1017,1]
["chr1",127277193,127277702,510,"ENSBGRG00000014050","ENSBGRT00000025921",127610,"MED12L","mediator complex subunit 12L [Source:HGNC Symbol;Acc:HGNC:16050]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008013(beta-catenin binding);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)",{"v":1.1e-08,"d":"0.00"},1,"510,",0,-7.97,-7.16,4.92,"Exon (ENSBGRT00000026488/ENSBGRG00000014427, exon 1 of 1)",1,127021523,127405312,383790,2]
["chr1",127794543,127814911,20369,"ENSBGRG00000014649","ENSBGRT00000026999",402,"SIAH2","siah E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:10858]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007275(multicellular organism development);GO:0008270(zinc ion binding);GO:0042025(host cell nucleus);GO:0042752(regulation of circadian rhythm);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0044257(cellular protein catabolic process);GO:0061630(ubiquitin protein ligase activity);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","NA",{"v":9.99999999999998e-239,"d":"0.00"},2,"31,558,","0,19811",-238,-236,9.87,"Exon (ENSBGRT00000026999/ENSBGRG00000014649, exon 3 of 4)",1,127794141,127814911,20771,1]
["chr1",128054984,128056648,1665,"ENSBGRG00000015147","ENSBGRT00000027867",0,"SERP1","stress associated endoplasmic reticulum protein 1 [Source:HGNC Symbol;Acc:HGNC:10759]","GO:0001501(skeletal system development);GO:0005783(endoplasmic reticulum);GO:0005881(cytoplasmic microtubule);GO:0006006(glucose metabolic process);GO:0009791(post-embryonic development);GO:0010259(multicellular organism aging);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0032024(positive regulation of insulin secretion);GO:0045727(positive regulation of translation);GO:0046622(positive regulation of organ growth);GO:0048644(muscle organ morphogenesis);GO:0060124(positive regulation of growth hormone secretion)","NA",{"v":7.9e-12,"d":"0.00"},3,"84,76,41,","0,363,1624",{"v":-11.1,"d":"-11.10"},{"v":-10.2,"d":"-10.20"},2.13,"Exon (ENSBGRT00000027867/ENSBGRG00000015147, exon 1 of 3)",1,128054984,128056648,1665,1]
["chr1",128731902,128734562,2661,"ENSBGRG00000015699","ENSBGRT00000029261",2378,"PFN2","profilin 2 [Source:HGNC Symbol;Acc:HGNC:8882]","GO:0003779(actin binding);GO:0003785(actin monomer binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0010633(negative regulation of epithelial cell migration);GO:0016887(ATPase activity);GO:0030036(actin cytoskeleton organization);GO:0030833(regulation of actin filament polymerization);GO:0030837(negative regulation of actin filament polymerization);GO:0030838(positive regulation of actin filament polymerization);GO:0032233(positive regulation of actin filament bundle assembly);GO:0032781(positive regulation of ATPase activity);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0050821(protein stabilization);GO:0051496(positive regulation of stress fiber assembly);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:1900028(negative regulation of ruffle assembly);GO:2000300(regulation of synaptic vesicle exocytosis)","04015(Rap1 signaling pathway);04810(Regulation of actin cytoskeleton);05132(Salmonella infection)",{"v":4e-15,"d":"0.00"},2,"65,51,","0,2610",{"v":-14.4,"d":"-14.40"},{"v":-13.5,"d":"-13.50"},1.45,"Exon (ENSBGRT00000029261/ENSBGRG00000015699, exon 2 of 3)",1,128729524,128734609,5086,1]
["chr1",129029698,129029758,61,"ENSBGRG00000016273","ENSBGRT00000029940",97242,"WWTR1","WW domain containing transcription regulator 1 [Source:HGNC Symbol;Acc:HGNC:24042]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001649(osteoblast differentiation);GO:0001894(tissue homeostasis);GO:0001933(negative regulation of protein phosphorylation);GO:0003015(heart process);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006469(negative regulation of protein kinase activity);GO:0008284(positive regulation of cell population proliferation);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0016567(protein ubiquitination);GO:0016604(nuclear body);GO:0017145(stem cell division);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0032835(glomerulus development);GO:0035264(multicellular organism growth);GO:0035329(hippo signaling);GO:0042803(protein homodimerization activity);GO:0045599(negative regulation of fat cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048762(mesenchymal cell differentiation);GO:0060271(cilium assembly);GO:0060390(regulation of SMAD protein signal transduction);GO:0060828(regulation of canonical Wnt signaling pathway);GO:0060993(kidney morphogenesis);GO:0072307(regulation of metanephric nephron tubule epithelial cell differentiation);GO:0090090(negative regulation of canonical Wnt signaling pathway)","04390(Hippo signaling pathway);04392(Hippo signaling pathway - multiple species)",{"v":0.0095,"d":"0.01"},1,"61,",0,-2.02,-1.47,5.52,"Exon (ENSBGRT00000030194/ENSBGRG00000016273, exon 1 of 7)",1,128932456,129205193,272738,1]
["chr1",129395316,129395521,206,"ENSBGRG00000016631","ENSBGRT00000030570",0,"TM4SF1","transmembrane 4 L six family member 1 [Source:HGNC Symbol;Acc:HGNC:11853]","GO:0005887(integral component of plasma membrane);GO:0016021(integral component of membrane)","00430(Taurine and hypotaurine metabolism);00480(Glutathione metabolism)",{"v":2e-49,"d":"0.00"},1,"206,",0,{"v":-48.7,"d":"-48.70"},{"v":-47.3,"d":"-47.30"},3.26,"5' UTR",1,129395316,129400764,5449,1]
["chr1",129610163,129619871,9709,"ENSBGRG00000017021","ENSBGRT00000031232",35039,"HPS3","HPS3 biogenesis of lysosomal organelles complex 2 subunit 1 [Source:HGNC Symbol;Acc:HGNC:15597]","GO:0005737(cytoplasm);GO:0006996(organelle organization);GO:0031084(BLOC-2 complex);GO:0043473(pigmentation)","NA",{"v":0.0083,"d":"0.01"},2,"45,105,","0,9604",-2.08,-1.52,3.41,"3' UTR",1,129520908,129654910,134003,2]
["chr1",129748973,129749182,210,"ENSBGRG00000018610","ENSBGRT00000034120",65758,"HLTF","helicase like transcription factor [Source:HGNC Symbol;Acc:HGNC:11099]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008094(DNA-dependent ATPase activity);GO:0008270(zinc ion binding);GO:0016818(hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides);GO:0031625(ubiquitin protein ligase binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":8.3e-07,"d":"0.00"},1,"210,",0,-6.08,-5.33,1.43,"3' UTR",1,129683215,129749272,66058,1]
["chr1",133096528,133096617,90,"ENSBGRG00000020343","ENSBGRT00000037397",59,"ENSBGRG00000020343","NA","GO:0017121(plasma membrane phospholipid scrambling);GO:0017128(phospholipid scramblase activity)","NA",{"v":0.024,"d":"0.02"},1,"90,",0,-1.62,-1.09,4.01,"5' UTR",1,133096469,133141212,44744,1]
["chr1",133331295,133331623,329,"ENSBGRG00000020444","ENSBGRT00000037757",133233,"PLOD2","procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 [Source:HGNC Symbol;Acc:HGNC:9082]","GO:0001666(response to hypoxia);GO:0005506(iron ion binding);GO:0008475(procollagen-lysine 5-dioxygenase activity);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0017185(peptidyl-lysine hydroxylation);GO:0031418(L-ascorbic acid binding);GO:0046947(hydroxylysine biosynthetic process);GO:0055114(oxidation-reduction process)","00310(Lysine degradation)",{"v":5E-53,"d":"0.00"},1,"329,",0,{"v":-52.3,"d":"-52.30"},{"v":-50.9,"d":"-50.90"},2.43,"3' UTR",1,133198062,133332306,134245,1]
["chr1",136153422,136188223,34802,"ENSBGRG00000000195","ENSBGRT00000000322",22966,"SLC9A9","solute carrier family 9 member A9 [Source:HGNC Symbol;Acc:HGNC:20653]","GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0006885(regulation of pH);GO:0015299(solute:proton antiporter activity);GO:0015385(sodium:proton antiporter activity);GO:0016021(integral component of membrane);GO:0055037(recycling endosome);GO:0055085(transmembrane transport)","NA",{"v":0.035,"d":"0.04"},2,"168,72,","0,34730",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000000322/ENSBGRG00000000195, exon 2 of 18)",1,136130456,136869878,739423,1]
["chr1",136869692,136869878,187,"ENSBGRG00000000195","ENSBGRT00000000322",739236,"SLC9A9","solute carrier family 9 member A9 [Source:HGNC Symbol;Acc:HGNC:20653]","GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0006885(regulation of pH);GO:0015299(solute:proton antiporter activity);GO:0015385(sodium:proton antiporter activity);GO:0016021(integral component of membrane);GO:0055037(recycling endosome);GO:0055085(transmembrane transport)","NA",{"v":6.3e-30,"d":"0.00"},3,"61,3,117,","0,65,70",{"v":-29.2,"d":"-29.20"},{"v":-28.1,"d":"-28.10"},6.47,"Exon (ENSBGRT00000000322/ENSBGRG00000000195, exon 16 of 18)",1,136130456,136869878,739423,1]
["chr1",137845286,137846940,1655,"ENSBGRG00000000428","ENSBGRT00000001119",125880,"ATR","ATR serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:882]","GO:0000077(DNA damage checkpoint);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0006974(cellular response to DNA damage stimulus);GO:0008156(negative regulation of DNA replication);GO:0016301(kinase activity);GO:0016605(PML body);GO:0018105(peptidyl-serine phosphorylation);GO:0032405(MutLalpha complex binding);GO:0032407(MutSalpha complex binding);GO:0034644(cellular response to UV);GO:0043517(positive regulation of DNA damage response, signal transduction by p53 class mediator);GO:0046777(protein autophosphorylation);GO:0070198(protein localization to chromosome, telomeric region);GO:0071480(cellular response to gamma radiation);GO:0090399(replicative senescence);GO:0097694(establishment of RNA localization to telomere);GO:1904884(positive regulation of telomerase catalytic core complex assembly)","03460(Fanconi anemia pathway);04110(Cell cycle);04115(p53 signaling pathway);04218(Cellular senescence);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":2.5e-14,"d":"0.00"},2,"98,322,","0,1333",{"v":-13.6,"d":"-13.60"},{"v":-12.7,"d":"-12.70"},2.93,"3' UTR",1,137719406,137847000,127595,1]
["chr1",137857564,137869317,11754,"ENSBGRG00000000705","ENSBGRT00000001705",9312,"XRN1","5'-3' exoribonuclease 1 [Source:HGNC Symbol;Acc:HGNC:30654]","GO:0000956(nuclear-transcribed mRNA catabolic process);GO:0003676(nucleic acid binding);GO:0004527(exonuclease activity);GO:0004534(5'-3' exoribonuclease activity);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0008409(5'-3' exonuclease activity);GO:0016075(rRNA catabolic process);GO:0071028(nuclear mRNA surveillance);GO:0071044(histone mRNA catabolic process)","03008(Ribosome biogenesis in eukaryotes);03018(RNA degradation)",{"v":0.026,"d":"0.03"},7,"129,98,110,111,83,88,159,","0,6565,7804,8003,10115,11426,11595",-1.59,-1.07,4.01,"Exon (ENSBGRT00000001705/ENSBGRG00000000705, exon 2 of 42)",1,137848252,137969665,121414,1]
["chr1",141101909,141110853,8945,"ENSBGRG00000001428","ENSBGRT00000002725",58840,"NMNAT3","nicotinamide nucleotide adenylyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:20989]","GO:0000309(nicotinamide-nucleotide adenylyltransferase activity);GO:0002138(retinoic acid biosynthetic process);GO:0003824(catalytic activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006776(vitamin A metabolic process);GO:0008289(lipid binding);GO:0009058(biosynthetic process);GO:0009435(NAD biosynthetic process);GO:0009611(response to wounding);GO:0016779(nucleotidyltransferase activity)","00760(Nicotinate and nicotinamide metabolism)",{"v":0.0032,"d":"0.00"},5,"33,26,18,41,393,","0,1580,1610,1630,8552",{"v":-2.5,"d":"-2.50"},-1.91,11,"5' UTR",1,141043069,141110470,67402,1]
["chr1",141111003,141121479,10477,"ENSBGRG00000001428","ENSBGRT00000002698",67934,"NMNAT3","nicotinamide nucleotide adenylyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:20989]","GO:0000309(nicotinamide-nucleotide adenylyltransferase activity);GO:0002138(retinoic acid biosynthetic process);GO:0003824(catalytic activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006776(vitamin A metabolic process);GO:0008289(lipid binding);GO:0009058(biosynthetic process);GO:0009435(NAD biosynthetic process);GO:0009611(response to wounding);GO:0016779(nucleotidyltransferase activity)","00760(Nicotinate and nicotinamide metabolism)",{"v":0.0022,"d":"0.00"},2,"658,333,","0,10144",-2.66,-2.06,7.02,"3' UTR",1,141043069,141111660,68592,1]
["chr1",141138450,141140123,1674,"ENSBGRG00000001428","ENSBGRT00000002664",95381,"NMNAT3","nicotinamide nucleotide adenylyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:20989]","GO:0000309(nicotinamide-nucleotide adenylyltransferase activity);GO:0002138(retinoic acid biosynthetic process);GO:0003824(catalytic activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006776(vitamin A metabolic process);GO:0008289(lipid binding);GO:0009058(biosynthetic process);GO:0009435(NAD biosynthetic process);GO:0009611(response to wounding);GO:0016779(nucleotidyltransferase activity)","00760(Nicotinate and nicotinamide metabolism)",{"v":9.99999999999998e-212,"d":"0.00"},3,"201,179,130,","0,691,1544",-211,-208,2.02,"5' UTR",1,141043069,141140215,97147,1]
["chr1",141167650,141170081,2432,"ENSBGRG00000001428","ENSBGRT00000002649",124581,"NMNAT3","nicotinamide nucleotide adenylyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:20989]","GO:0000309(nicotinamide-nucleotide adenylyltransferase activity);GO:0002138(retinoic acid biosynthetic process);GO:0003824(catalytic activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006776(vitamin A metabolic process);GO:0008289(lipid binding);GO:0009058(biosynthetic process);GO:0009435(NAD biosynthetic process);GO:0009611(response to wounding);GO:0016779(nucleotidyltransferase activity)","00760(Nicotinate and nicotinamide metabolism)",{"v":0.0074,"d":"0.01"},2,"10,51,","0,2381",-2.13,-1.57,1.35,"3' UTR",1,141043069,141167659,124591,1]
["chr1",141353544,141353901,358,"ENSBGRG00000001520","ENSBGRT00000002817",35628,"ENSBGRG00000001520","NA","GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0006886(intracellular protein transport);GO:0016192(vesicle-mediated transport);GO:0030117(membrane coat)","NA",{"v":1.4E-8,"d":"0.00"},2,"25,96,","0,262",-7.86,-7.05,1.43,"Exon (ENSBGRT00000002817/ENSBGRG00000001520, exon 21 of 22)",1,141317916,141353901,35986,1]
["chr1",141845929,141846615,687,"ENSBGRG00000001637","ENSBGRT00000003031",0,"FOXL2","forkhead box L2 [Source:HGNC Symbol;Acc:HGNC:1092]","GO:0001541(ovarian follicle development);GO:0002074(extraocular skeletal muscle development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006309(apoptotic DNA fragmentation);GO:0006355(regulation of transcription, DNA-templated);GO:0031624(ubiquitin conjugating enzyme binding);GO:0043028(cysteine-type endopeptidase regulator activity involved in apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045171(intercellular bridge);GO:0045892(negative regulation of transcription, DNA-templated);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":2.5e-99,"d":"0.00"},1,"687,",0,{"v":-98.6,"d":"-98.60"},{"v":-96.8,"d":"-96.80"},{"v":20.1,"d":"20.10"},"Exon (ENSBGRT00000003031/ENSBGRG00000001637, exon 1 of 1)",1,141845929,141847062,1134,1]
["chr1",142164065,142165695,1631,"ENSBGRG00000001650","ENSBGRT00000003055",192565,"PIK3CB","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [Source:HGNC Symbol;Acc:HGNC:8976]","GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0016301(kinase activity);GO:0035004(phosphatidylinositol 3-kinase activity);GO:0046854(phosphatidylinositol phosphorylation);GO:0048015(phosphatidylinositol-mediated signaling)","00562(Inositol phosphate metabolism);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04630(Jak-STAT signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04218(Cellular senescence);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04670(Leukocyte transendothelial migration);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04919(Thyroid hormone signaling pathway);04973(Carbohydrate digestion and absorption);04960(Aldosterone-regulated sodium reabsorption);04725(Cholinergic synapse);04722(Neurotrophin signaling pathway);04750(Inflammatory mediator regulation of TRP channels);04360(Axon guidance);04380(Osteoclast differentiation);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05205(Proteoglycans in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05100(Bacterial invasion of epithelial cells);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05146(Amoebiasis);05142(Chagas disease (American trypanosomiasis));01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":3.2e-15,"d":"0.00"},3,"58,133,138,","0,1005,1493",{"v":-14.5,"d":"-14.50"},{"v":-13.6,"d":"-13.60"},5.21,"Exon (ENSBGRT00000003055/ENSBGRG00000001650, exon 22 of 24)",1,141971500,142165695,194196,1]
["chr1",142236220,142260290,24071,"ENSBGRG00000001714","ENSBGRT00000003315",16247,"CEP70","centrosomal protein 70 [Source:HGNC Symbol;Acc:HGNC:29972]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0042802(identical protein binding);GO:0043015(gamma-tubulin binding);GO:0060271(cilium assembly);GO:0070507(regulation of microtubule cytoskeleton organization)","NA",{"v":0.0051,"d":"0.01"},4,"25,181,170,162,","0,344,23095,23909",-2.29,-1.71,7.02,"Exon (ENSBGRT00000003315/ENSBGRG00000001714, exon 4 of 17)",1,142219973,142304509,84537,1]
["chr1",142277340,142288668,11329,"ENSBGRG00000001714","ENSBGRT00000003315",57367,"CEP70","centrosomal protein 70 [Source:HGNC Symbol;Acc:HGNC:29972]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0042802(identical protein binding);GO:0043015(gamma-tubulin binding);GO:0060271(cilium assembly);GO:0070507(regulation of microtubule cytoskeleton organization)","NA",{"v":0.0025,"d":"0.00"},4,"2,89,75,44,","0,98,1685,11285",-2.61,-2.01,1.75,"Exon (ENSBGRT00000003315/ENSBGRG00000001714, exon 8 of 17)",1,142219973,142304509,84537,1]
["chr1",142273452,142275042,1591,"ENSBGRG00000001833","ENSBGRT00000003438",0,"ENSBGRG00000001833","NA","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)",{"v":0.035,"d":"0.04"},2,"365,217,","0,1374",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000003438/ENSBGRG00000001833, exon 1 of 2)",1,142273452,142275042,1591,1]
["chr1",142698014,142698163,150,"ENSBGRG00000002171","ENSBGRT00000004059",179,"DBR1","debranching RNA lariats 1 [Source:HGNC Symbol;Acc:HGNC:15594]","GO:0000375(RNA splicing, via transesterification reactions);GO:0000398(mRNA splicing, via spliceosome);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0008419(RNA lariat debranching enzyme activity);GO:0016787(hydrolase activity);GO:0016788(hydrolase activity, acting on ester bonds)","NA",{"v":0.049,"d":"0.05"},1,"150,",0,-1.31,{"v":-0.819,"d":"-0.82"},2.01,"5' UTR",1,142697835,142711265,13431,1]
["chr1",142710049,142711265,1217,"ENSBGRG00000002171","ENSBGRT00000004059",12214,"DBR1","debranching RNA lariats 1 [Source:HGNC Symbol;Acc:HGNC:15594]","GO:0000375(RNA splicing, via transesterification reactions);GO:0000398(mRNA splicing, via spliceosome);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0008419(RNA lariat debranching enzyme activity);GO:0016787(hydrolase activity);GO:0016788(hydrolase activity, acting on ester bonds)","NA",{"v":1E-89,"d":"0.00"},2,"51,694,","0,523",-89,{"v":-87.3,"d":"-87.30"},{"v":8.4,"d":"8.40"},"Exon (ENSBGRT00000004059/ENSBGRG00000002171, exon 7 of 8)",1,142697835,142711265,13431,1]
["chr1",142797917,142798095,179,"ENSBGRG00000002235","ENSBGRT00000004166",23343,"ENSBGRG00000002235","NA","NA","NA",{"v":0.0011,"d":"0.00"},1,"179,",0,-2.95,-2.32,5.68,"Exon (ENSBGRT00000004166/ENSBGRG00000002235, exon 4 of 4)",1,142774574,142797997,23424,1]
["chr1",144802273,144802333,61,"ENSBGRG00000002516","ENSBGRT00000005249",302965,"STAG1","stromal antigen 1 [Source:HGNC Symbol;Acc:HGNC:11354]","GO:0000785(chromatin);GO:0003682(chromatin binding);GO:0005654(nucleoplasm);GO:0008278(cohesin complex);GO:0016363(nuclear matrix);GO:0016604(nuclear body);GO:0090307(mitotic spindle assembly);GO:0097431(mitotic spindle pole)","04110(Cell cycle)",{"v":0.024,"d":"0.02"},1,"61,",0,-1.62,-1.09,1.68,"Exon (ENSBGRT00000005249/ENSBGRG00000002516, exon 17 of 33)",1,144499308,144862643,363336,1]
["chr1",144852337,144852487,151,"ENSBGRG00000002516","ENSBGRT00000005249",353029,"STAG1","stromal antigen 1 [Source:HGNC Symbol;Acc:HGNC:11354]","GO:0000785(chromatin);GO:0003682(chromatin binding);GO:0005654(nucleoplasm);GO:0008278(cohesin complex);GO:0016363(nuclear matrix);GO:0016604(nuclear body);GO:0090307(mitotic spindle assembly);GO:0097431(mitotic spindle pole)","04110(Cell cycle)",{"v":2.8E-3,"d":"0.00"},1,"151,",0,-2.55,-1.95,1.45,"Exon (ENSBGRT00000005249/ENSBGRG00000002516, exon 28 of 33)",1,144499308,144862643,363336,1]
["chr1",144860505,144862643,2139,"ENSBGRG00000002516","ENSBGRT00000005249",361197,"STAG1","stromal antigen 1 [Source:HGNC Symbol;Acc:HGNC:11354]","GO:0000785(chromatin);GO:0003682(chromatin binding);GO:0005654(nucleoplasm);GO:0008278(cohesin complex);GO:0016363(nuclear matrix);GO:0016604(nuclear body);GO:0090307(mitotic spindle assembly);GO:0097431(mitotic spindle pole)","04110(Cell cycle)",{"v":1.6E-7,"d":"0.00"},3,"75,81,24,","0,1947,2115",-6.79,-6.01,2.49,"Exon (ENSBGRT00000005249/ENSBGRG00000002516, exon 31 of 33)",1,144499308,144862643,363336,1]
["chr1",145034789,145067748,32960,"ENSBGRG00000003049","ENSBGRT00000005705",0,"MSL2","MSL complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:25544]","GO:0043984(histone H4-K16 acetylation);GO:0061630(ubiquitin protein ligase activity);GO:0072487(MSL complex)","NA",{"v":1e-110,"d":"0.00"},2,"387,1592,","0,31368",-110,-108,9.03,"5' UTR",1,145034789,145067748,32960,1]
["chr1",146963522,146968437,4916,"ENSBGRG00000003311","ENSBGRT00000006157",326,"ANAPC13","anaphase promoting complex subunit 13 [Source:HGNC Symbol;Acc:HGNC:24540]","GO:0005680(anaphase-promoting complex);GO:0070979(protein K11-linked ubiquitination)","04120(Ubiquitin mediated proteolysis);04110(Cell cycle);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation)",{"v":2.5e-55,"d":"0.00"},3,"32,131,222,","0,161,4694",{"v":-54.6,"d":"-54.60"},{"v":-53.1,"d":"-53.10"},2.56,"5' UTR",1,146963196,146969444,6249,1]
["chr1",146968970,146969178,209,"ENSBGRG00000003311","ENSBGRT00000006157",5774,"ANAPC13","anaphase promoting complex subunit 13 [Source:HGNC Symbol;Acc:HGNC:24540]","GO:0005680(anaphase-promoting complex);GO:0070979(protein K11-linked ubiquitination)","04120(Ubiquitin mediated proteolysis);04110(Cell cycle);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation)",{"v":1E-10,"d":"0.00"},1,"209,",0,-10,-9.18,3.36,"3' UTR",1,146963196,146969444,6249,1]
["chr1",147090559,147090739,181,"ENSBGRG00000003321","ENSBGRT00000006180",180,"AMOTL2","angiomotin like 2 [Source:HGNC Symbol;Acc:HGNC:17812]","GO:0005923(bicellular tight junction);GO:0016324(apical plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0042802(identical protein binding)","04530(Tight junction)",{"v":0.024,"d":"0.02"},1,"181,",0,-1.62,-1.09,4.01,"Exon (ENSBGRT00000006180/ENSBGRG00000003321, exon 1 of 10)",1,147090379,147107653,17275,1]
["chr1",147096131,147103793,7663,"ENSBGRG00000003321","ENSBGRT00000006180",5752,"AMOTL2","angiomotin like 2 [Source:HGNC Symbol;Acc:HGNC:17812]","GO:0005923(bicellular tight junction);GO:0016324(apical plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0042802(identical protein binding)","04530(Tight junction)",{"v":5e-16,"d":"0.00"},4,"160,145,93,292,","0,1245,1752,7371",{"v":-15.3,"d":"-15.30"},{"v":-14.4,"d":"-14.40"},2.08,"Exon (ENSBGRT00000006180/ENSBGRG00000003321, exon 3 of 10)",1,147090379,147107653,17275,1]
["chr1",147106626,147107653,1028,"ENSBGRG00000003321","ENSBGRT00000006180",16247,"AMOTL2","angiomotin like 2 [Source:HGNC Symbol;Acc:HGNC:17812]","GO:0005923(bicellular tight junction);GO:0016324(apical plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0042802(identical protein binding)","04530(Tight junction)",{"v":1.6E-44,"d":"0.00"},2,"151,150,","0,878",{"v":-43.8,"d":"-43.80"},{"v":-42.5,"d":"-42.50"},2.06,"3' UTR",1,147090379,147107653,17275,1]
["chr1",147350276,147352262,1987,"ENSBGRG00000003356","ENSBGRT00000006334",118638,"RYK","receptor like tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:10481]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004888(transmembrane signaling receptor activity);GO:0005109(frizzled binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007409(axonogenesis);GO:0007411(axon guidance);GO:0016020(membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0022038(corpus callosum development);GO:0030182(neuron differentiation);GO:0031175(neuron projection development);GO:0036518(chemorepulsion of dopaminergic neuron axon);GO:0042813(Wnt-activated receptor activity);GO:0043410(positive regulation of MAPK cascade);GO:0048705(skeletal system morphogenesis);GO:0048843(negative regulation of axon extension involved in axon guidance);GO:0050919(negative chemotaxis);GO:0071679(commissural neuron axon guidance);GO:1904938(planar cell polarity pathway involved in axon guidance);GO:1904948(midbrain dopaminergic neuron differentiation)","04360(Axon guidance)",{"v":1e-140,"d":"0.00"},2,"49,430,","0,1557",-140,-138,4.03,"3' UTR",1,147231638,147352262,120625,1]
["chr1",147498037,147498217,181,"ENSBGRG00000003496","ENSBGRT00000006498",0,"SLCO2A1","solute carrier organic anion transporter family member 2A1 [Source:HGNC Symbol;Acc:HGNC:10955]","GO:0005515(protein binding);GO:0015132(prostaglandin transmembrane transporter activity);GO:0015732(prostaglandin transport);GO:0016020(membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":0.035,"d":"0.04"},1,"181,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"5' UTR",1,147498037,147596243,98207,1]
["chr1",147594115,147594265,151,"ENSBGRG00000003496","ENSBGRT00000006498",96078,"SLCO2A1","solute carrier organic anion transporter family member 2A1 [Source:HGNC Symbol;Acc:HGNC:10955]","GO:0005515(protein binding);GO:0015132(prostaglandin transmembrane transporter activity);GO:0015732(prostaglandin transport);GO:0016020(membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":4.3e-06,"d":"0.00"},1,"151,",0,-5.37,-4.63,5.16,"3' UTR",1,147498037,147596243,98207,1]
["chr1",147596123,147596243,121,"ENSBGRG00000003496","ENSBGRT00000006498",98086,"SLCO2A1","solute carrier organic anion transporter family member 2A1 [Source:HGNC Symbol;Acc:HGNC:10955]","GO:0005515(protein binding);GO:0015132(prostaglandin transmembrane transporter activity);GO:0015732(prostaglandin transport);GO:0016020(membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":0.012,"d":"0.01"},1,"121,",0,-1.93,-1.38,2.63,"3' UTR",1,147498037,147596243,98207,1]
["chr1",149146665,149147923,1259,"ENSBGRG00000006292","ENSBGRT00000011810",58564,"ENSBGRG00000006292","NA","GO:0001822(kidney development);GO:0005515(protein binding);GO:0006629(lipid metabolic process);GO:0007163(establishment or maintenance of cell polarity);GO:0007368(determination of left/right symmetry);GO:0030198(extracellular matrix organization);GO:0032092(positive regulation of protein binding);GO:0048496(maintenance of animal organ identity);GO:0060271(cilium assembly);GO:0060993(kidney morphogenesis);GO:0097543(ciliary inversin compartment);GO:0097546(ciliary base);GO:1905515(non-motile cilium assembly)","NA",{"v":3.2e-53,"d":"0.00"},2,"88,181,","0,1078",{"v":-52.5,"d":"-52.50"},{"v":-51.1,"d":"-51.10"},4.03,"Exon (ENSBGRT00000011810/ENSBGRG00000006292, exon 27 of 28)",1,149088101,149147923,59823,1]
["chr1",150872576,150873313,738,"ENSBGRG00000007836","ENSBGRT00000014532",60884,"MRPL3","mitochondrial ribosomal protein L3 [Source:HGNC Symbol;Acc:HGNC:10379]","GO:0003735(structural constituent of ribosome);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)",{"v":2.5e-90,"d":"0.00"},2,"140,131,","0,607",{"v":-89.6,"d":"-89.60"},{"v":-87.9,"d":"-87.90"},1.92,"3' UTR",1,150811692,150872715,61024,1]
["chr1",151301362,151301571,210,"ENSBGRG00000008357","ENSBGRT00000015300",851,"ASTE1","asteroid homolog 1 [Source:HGNC Symbol;Acc:HGNC:25021]","GO:0004518(nuclease activity);GO:0006281(DNA repair)","NA",{"v":2E-3,"d":"0.00"},1,"210,",0,-2.69,-2.08,7.02,"5' UTR",1,151300511,151316894,16384,1]
["chr1",151301780,151302527,748,"ENSBGRG00000008357","ENSBGRT00000015300",1269,"ASTE1","asteroid homolog 1 [Source:HGNC Symbol;Acc:HGNC:25021]","GO:0004518(nuclease activity);GO:0006281(DNA repair)","NA",{"v":1.9E-6,"d":"0.00"},1,"748,",0,-5.71,-4.97,4.01,"Exon (ENSBGRT00000015300/ENSBGRG00000008357, exon 3 of 6)",1,151300511,151316894,16384,1]
["chr1",151316756,151317278,523,"ENSBGRG00000008357","ENSBGRT00000015300",16245,"ASTE1","asteroid homolog 1 [Source:HGNC Symbol;Acc:HGNC:25021]","GO:0004518(nuclease activity);GO:0006281(DNA repair)","NA",{"v":0.0081,"d":"0.01"},2,"139,11,","0,512",-2.09,-1.53,2.51,"Exon (ENSBGRT00000015300/ENSBGRG00000008357, exon 6 of 6)",1,151300511,151316894,16384,1]
["chr1",152065268,152075073,9806,"ENSBGRG00000011752","ENSBGRT00000021424",89,"ENSBGRG00000011752","NA","NA","NA",{"v":2.5e-12,"d":"0.00"},2,"266,62,","0,9744",{"v":-11.6,"d":"-11.60"},{"v":-10.7,"d":"-10.70"},4.01,"5' UTR",1,152065179,152144752,79574,1]
["chr1",152087758,152144722,56965,"ENSBGRG00000011808","ENSBGRT00000021511",0,"U6","U6 spliceosomal RNA [Source:RFAM;Acc:RF00026]","NA","NA",{"v":1E-165,"d":"0.00"},6,"28,75,93,30,150,11,","0,23189,24116,45701,50657,56954",-165,-163,2.21,"3' UTR",1,152116016,152116122,107,2]
["chr1",154223080,154223200,121,"ENSBGRG00000013059","ENSBGRT00000024379",122400,"BACE2","beta-secretase 2 [Source:HGNC Symbol;Acc:HGNC:934]","GO:0004190(aspartic-type endopeptidase activity);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0006509(membrane protein ectodomain proteolysis);GO:0016021(integral component of membrane);GO:0042593(glucose homeostasis);GO:0042985(negative regulation of amyloid precursor protein biosynthetic process)","05010(Alzheimer disease)",{"v":6.6e-06,"d":"0.00"},1,"121,",0,-5.18,-4.45,1.94,"3' UTR",1,154100680,154223200,122521,1]
["chr1",154377035,154377125,91,"ENSBGRG00000013649","ENSBGRT00000025542",75184,"FAM3B","family with sequence similarity 3 member B [Source:HGNC Symbol;Acc:HGNC:1253]","GO:0030073(insulin secretion);GO:0042593(glucose homeostasis)","NA",{"v":1.4E-3,"d":"0.00"},1,"91,",0,-2.85,-2.23,3.26,"3' UTR",1,154301851,154377125,75275,1]
["chr1",154403048,154415487,12440,"ENSBGRG00000014066","ENSBGRT00000026346",12145,"MX1","MX dynamin like GTPase 1 [Source:HGNC Symbol;Acc:HGNC:7532]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0009615(response to virus);GO:0031965(nuclear membrane);GO:0042802(identical protein binding);GO:0045071(negative regulation of viral genome replication);GO:0048471(perinuclear region of cytoplasm);GO:0051607(defense response to virus)","05162(Measles);05164(Influenza A);05165(Human papillomavirus infection)",{"v":0.019,"d":"0.02"},3,"115,79,47,","0,7689,12393",-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000026346/ENSBGRG00000014066, exon 7 of 14)",1,154390903,154422639,31737,1]
["chr1",154469812,154470353,542,"ENSBGRG00000014066","ENSBGRT00000026227",78909,"MX1","MX dynamin like GTPase 1 [Source:HGNC Symbol;Acc:HGNC:7532]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0009615(response to virus);GO:0031965(nuclear membrane);GO:0042802(identical protein binding);GO:0045071(negative regulation of viral genome replication);GO:0048471(perinuclear region of cytoplasm);GO:0051607(defense response to virus)","05162(Measles);05164(Influenza A);05165(Human papillomavirus infection)",{"v":0.00076,"d":"0.00"},2,"89,62,","0,480",-3.12,-2.49,1.37,"Exon (ENSBGRT00000026227/ENSBGRG00000014066, exon 11 of 16)",1,154390903,154484561,93659,1]
["chr1",154478904,154484051,5148,"ENSBGRG00000014066","ENSBGRT00000026227",88001,"MX1","MX dynamin like GTPase 1 [Source:HGNC Symbol;Acc:HGNC:7532]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0009615(response to virus);GO:0031965(nuclear membrane);GO:0042802(identical protein binding);GO:0045071(negative regulation of viral genome replication);GO:0048471(perinuclear region of cytoplasm);GO:0051607(defense response to virus)","05162(Measles);05164(Influenza A);05165(Human papillomavirus infection)",{"v":1.3e-46,"d":"0.00"},2,"107,643,","0,4505",{"v":-45.9,"d":"-45.90"},{"v":-44.6,"d":"-44.60"},3.44,"3' UTR",1,154390903,154484561,93659,1]
["chr1",154484411,154484561,151,"ENSBGRG00000014066","ENSBGRT00000026227",93508,"MX1","MX dynamin like GTPase 1 [Source:HGNC Symbol;Acc:HGNC:7532]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0009615(response to virus);GO:0031965(nuclear membrane);GO:0042802(identical protein binding);GO:0045071(negative regulation of viral genome replication);GO:0048471(perinuclear region of cytoplasm);GO:0051607(defense response to virus)","05162(Measles);05164(Influenza A);05165(Human papillomavirus infection)",{"v":0.0032,"d":"0.00"},1,"151,",0,{"v":-2.5,"d":"-2.50"},-1.91,11,"3' UTR",1,154390903,154484561,93659,1]
["chr1",155460225,155460494,270,"ENSBGRG00000017210","ENSBGRT00000032093",71361,"ABCG1","ATP binding cassette subfamily G member 1 [Source:HGNC Symbol;Acc:HGNC:73]","GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0008203(cholesterol metabolic process);GO:0009897(external side of plasma membrane);GO:0010033(response to organic substance);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0019534(toxin transmembrane transporter activity);GO:0032367(intracellular cholesterol transport);GO:0033344(cholesterol efflux);GO:0033700(phospholipid efflux);GO:0033993(response to lipid);GO:0034041(ATPase-coupled sterol transmembrane transporter activity);GO:0034436(glycoprotein transport);GO:0042632(cholesterol homeostasis);GO:0042803(protein homodimerization activity);GO:0042987(amyloid precursor protein catabolic process);GO:0043531(ADP binding);GO:0046982(protein heterodimerization activity);GO:0050714(positive regulation of protein secretion);GO:0055085(transmembrane transport);GO:0055091(phospholipid homeostasis);GO:0090554(phosphatidylcholine floppase activity);GO:0120020(cholesterol transfer activity);GO:0140328(floppase activity);GO:1902004(positive regulation of amyloid-beta formation)","02010(ABC transporters)",{"v":2E-3,"d":"0.00"},1,"270,",0,-2.69,-2.08,10,"3' UTR",1,155388864,155460897,72034,1]
["chr1",155460853,155461511,659,"ENSBGRG00000017210","ENSBGRT00000032093",71989,"ABCG1","ATP binding cassette subfamily G member 1 [Source:HGNC Symbol;Acc:HGNC:73]","GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0008203(cholesterol metabolic process);GO:0009897(external side of plasma membrane);GO:0010033(response to organic substance);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0019534(toxin transmembrane transporter activity);GO:0032367(intracellular cholesterol transport);GO:0033344(cholesterol efflux);GO:0033700(phospholipid efflux);GO:0033993(response to lipid);GO:0034041(ATPase-coupled sterol transmembrane transporter activity);GO:0034436(glycoprotein transport);GO:0042632(cholesterol homeostasis);GO:0042803(protein homodimerization activity);GO:0042987(amyloid precursor protein catabolic process);GO:0043531(ADP binding);GO:0046982(protein heterodimerization activity);GO:0050714(positive regulation of protein secretion);GO:0055085(transmembrane transport);GO:0055091(phospholipid homeostasis);GO:0090554(phosphatidylcholine floppase activity);GO:0120020(cholesterol transfer activity);GO:0140328(floppase activity);GO:1902004(positive regulation of amyloid-beta formation)","02010(ABC transporters)",{"v":0.0004,"d":"0.00"},3,"45,10,216,","0,431,443",{"v":-3.4,"d":"-3.40"},-2.75,{"v":3.1,"d":"3.10"},"3' UTR",1,155388864,155460897,72034,1]
["chr1",155625554,155633463,7910,"ENSBGRG00000018065","ENSBGRT00000033793",0,"UBASH3A","ubiquitin associated and SH3 domain containing A [Source:HGNC Symbol;Acc:HGNC:12462]","GO:0001817(regulation of cytokine production);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0050860(negative regulation of T cell receptor signaling pathway)","NA",{"v":0.019,"d":"0.02"},3,"113,54,102,","0,3359,7808",-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000033793/ENSBGRG00000018065, exon 1 of 12)",1,155625554,155670641,45088,1]
["chr1",155670671,155670790,120,"ENSBGRG00000018065","ENSBGRT00000033558",45117,"UBASH3A","ubiquitin associated and SH3 domain containing A [Source:HGNC Symbol;Acc:HGNC:12462]","GO:0001817(regulation of cytokine production);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0050860(negative regulation of T cell receptor signaling pathway)","NA",{"v":0.014,"d":"0.01"},1,"120,",0,-1.85,{"v":-1.3,"d":"-1.30"},2.72,"3' UTR",1,155625554,155671117,45564,1]
["chr1",155670849,155671058,210,"ENSBGRG00000018065","ENSBGRT00000033558",45295,"UBASH3A","ubiquitin associated and SH3 domain containing A [Source:HGNC Symbol;Acc:HGNC:12462]","GO:0001817(regulation of cytokine production);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0050860(negative regulation of T cell receptor signaling pathway)","NA",{"v":0.00045,"d":"0.00"},1,"210,",0,-3.35,{"v":-2.7,"d":"-2.70"},4.61,"3' UTR",1,155625554,155671117,45564,1]
["chr1",155951476,155985213,33738,"ENSBGRG00000019109","ENSBGRT00000036113",46137,"PDE9A","phosphodiesterase 9A [Source:HGNC Symbol;Acc:HGNC:8795]","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0010613(positive regulation of cardiac muscle hypertrophy);GO:0042383(sarcolemma);GO:0046068(cGMP metabolic process);GO:0046069(cGMP catabolic process);GO:0047555(3',5'-cyclic-GMP phosphodiesterase activity)","00230(Purine metabolism)",{"v":4.3E-3,"d":"0.00"},3,"5,55,61,","0,32756,33677",-2.37,-1.79,1.89,"Exon (ENSBGRT00000036113/ENSBGRG00000019109, exon 4 of 19)",1,155905339,156029002,123664,1]
["chr1",156024096,156028048,3953,"ENSBGRG00000019109","ENSBGRT00000036113",118757,"PDE9A","phosphodiesterase 9A [Source:HGNC Symbol;Acc:HGNC:8795]","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0010613(positive regulation of cardiac muscle hypertrophy);GO:0042383(sarcolemma);GO:0046068(cGMP metabolic process);GO:0046069(cGMP catabolic process);GO:0047555(3',5'-cyclic-GMP phosphodiesterase activity)","00230(Purine metabolism)",{"v":1.6E-27,"d":"0.00"},3,"50,73,57,","0,1484,3896",{"v":-26.8,"d":"-26.80"},{"v":-25.7,"d":"-25.70"},3.19,"3' UTR",1,155905339,156029002,123664,1]
["chr1",156127605,156127754,150,"ENSBGRG00000019941","ENSBGRT00000036739",4284,"ENSBGRG00000019941","NA","GO:0005739(mitochondrion);GO:0005747(mitochondrial respiratory chain complex I)","00190(Oxidative phosphorylation);04723(Retrograde endocannabinoid signaling);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":1.1e-06,"d":"0.00"},1,"150,",0,-5.94,-5.18,{"v":1.8,"d":"1.80"},"5' UTR",1,156123321,156135753,12433,1]
["chr1",156132387,156132715,329,"ENSBGRG00000019941","ENSBGRT00000036739",9066,"ENSBGRG00000019941","NA","GO:0005739(mitochondrion);GO:0005747(mitochondrial respiratory chain complex I)","00190(Oxidative phosphorylation);04723(Retrograde endocannabinoid signaling);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":1e-47,"d":"0.00"},1,"329,",0,-47,{"v":-45.7,"d":"-45.70"},4.09,"Exon (ENSBGRT00000036693/ENSBGRG00000019941, exon 3 of 4)",1,156123321,156135753,12433,1]
["chr1",156132775,156133162,388,"ENSBGRG00000019941","ENSBGRT00000036739",9454,"ENSBGRG00000019941","NA","GO:0005739(mitochondrion);GO:0005747(mitochondrial respiratory chain complex I)","00190(Oxidative phosphorylation);04723(Retrograde endocannabinoid signaling);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":1.3E-13,"d":"0.00"},1,"388,",0,{"v":-12.9,"d":"-12.90"},-12,1.76,"Exon (ENSBGRT00000036693/ENSBGRG00000019941, exon 3 of 4)",1,156123321,156135753,12433,1]
["chr1",156833037,156836404,3368,"ENSBGRG00000021030","ENSBGRT00000038887",20434,"RRP1B","ribosomal RNA processing 1B [Source:HGNC Symbol;Acc:HGNC:23818]","GO:0001652(granular component);GO:0003713(transcription coactivator activity);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0010923(negative regulation of phosphatase activity);GO:0030688(preribosome, small subunit precursor);GO:0043065(positive regulation of apoptotic process);GO:0043923(positive regulation by host of viral transcription);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0098586(cellular response to virus)","NA",{"v":2.5e-49,"d":"0.00"},4,"68,668,54,16,","0,575,1620,3352",{"v":-48.6,"d":"-48.60"},{"v":-47.2,"d":"-47.20"},7.65,"Exon (ENSBGRT00000038887/ENSBGRG00000021030, exon 12 of 16)",1,156812603,156838207,25605,1]
["chr1",156838133,156838545,413,"ENSBGRG00000021030","ENSBGRT00000038887",25530,"RRP1B","ribosomal RNA processing 1B [Source:HGNC Symbol;Acc:HGNC:23818]","GO:0001652(granular component);GO:0003713(transcription coactivator activity);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0010923(negative regulation of phosphatase activity);GO:0030688(preribosome, small subunit precursor);GO:0043065(positive regulation of apoptotic process);GO:0043923(positive regulation by host of viral transcription);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0098586(cellular response to virus)","NA",{"v":0.004,"d":"0.00"},2,"75,194,","0,219",{"v":-2.4,"d":"-2.40"},-1.82,2.56,"Exon (ENSBGRT00000038887/ENSBGRG00000021030, exon 16 of 16)",1,156812603,156838207,25605,1]
["chr1",156972512,156972690,179,"ENSBGRG00000021680","ENSBGRT00000040134",13419,"RRP1","ribosomal RNA processing 1 [Source:HGNC Symbol;Acc:HGNC:18785]","GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0030688(preribosome, small subunit precursor)","NA",{"v":5.9e-09,"d":"0.00"},1,"179,",0,-8.23,-7.42,1.84,"Exon (ENSBGRT00000040134/ENSBGRG00000021680, exon 12 of 12)",1,156959093,156973167,14075,1]
["chr1",156973134,156973744,611,"ENSBGRG00000021680","ENSBGRT00000040134",14041,"RRP1","ribosomal RNA processing 1 [Source:HGNC Symbol;Acc:HGNC:18785]","GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0030688(preribosome, small subunit precursor)","NA",{"v":6.3e-59,"d":"0.00"},2,"34,233,","0,378",{"v":-58.2,"d":"-58.20"},{"v":-56.7,"d":"-56.70"},3.77,"Exon (ENSBGRT00000040134/ENSBGRG00000021680, exon 12 of 12)",1,156959093,156973167,14075,1]
["chr1",157149620,157150796,1177,"ENSBGRG00000021804","ENSBGRT00000040296",72774,"AGPAT3","1-acylglycerol-3-phosphate O-acyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:326]","GO:0003841(1-acylglycerol-3-phosphate O-acyltransferase activity);GO:0005635(nuclear envelope);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0016746(transferase activity, transferring acyl groups);GO:0042171(lysophosphatidic acid acyltransferase activity)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04072(Phospholipase D signaling pathway)",{"v":5e-17,"d":"0.00"},2,"57,124,","0,1053",{"v":-16.3,"d":"-16.30"},{"v":-15.4,"d":"-15.40"},4.72,"Exon (ENSBGRT00000040296/ENSBGRG00000021804, exon 8 of 8)",1,157076846,157151135,74290,1]
["chr1",157150885,157151709,825,"ENSBGRG00000021804","ENSBGRT00000040296",74039,"AGPAT3","1-acylglycerol-3-phosphate O-acyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:326]","GO:0003841(1-acylglycerol-3-phosphate O-acyltransferase activity);GO:0005635(nuclear envelope);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0016746(transferase activity, transferring acyl groups);GO:0042171(lysophosphatidic acid acyltransferase activity)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04072(Phospholipase D signaling pathway)",{"v":2.5e-99,"d":"0.00"},2,"251,258,","0,567",{"v":-98.6,"d":"-98.60"},{"v":-96.8,"d":"-96.80"},6.71,"3' UTR",1,157076846,157151135,74290,1]
["chr1",157152138,157155183,3046,"ENSBGRG00000021874","ENSBGRT00000040382",0,"ENSBGRG00000021874","NA","NA","NA",{"v":1e-17,"d":"0.00"},2,"349,99,","0,2947",-17,{"v":-16.1,"d":"-16.10"},6.08,"Exon (ENSBGRT00000040382/ENSBGRG00000021874, exon 1 of 2)",1,157152138,157157182,5045,1]
["chr1",157155541,157155780,240,"ENSBGRG00000021874","ENSBGRT00000040382",3403,"ENSBGRG00000021874","NA","NA","NA",{"v":0.043,"d":"0.04"},1,"240,",0,-1.37,{"v":-0.866,"d":"-0.87"},2.12,"Exon (ENSBGRT00000040382/ENSBGRG00000021874, exon 2 of 2)",1,157152138,157157182,5045,1]
["chr1",157156645,157157182,538,"ENSBGRG00000021874","ENSBGRT00000040382",4507,"ENSBGRG00000021874","NA","NA","NA",{"v":2e-29,"d":"0.00"},1,"538,",0,{"v":-28.7,"d":"-28.70"},{"v":-27.6,"d":"-27.60"},6.46,"Exon (ENSBGRT00000040382/ENSBGRG00000021874, exon 2 of 2)",1,157152138,157157182,5045,1]
["chr1",157266499,157270230,3732,"ENSBGRG00000021882","ENSBGRT00000040707",77299,"TRAPPC10","trafficking protein particle complex 10 [Source:HGNC Symbol;Acc:HGNC:11868]","GO:0030008(TRAPP complex)","NA",{"v":6.3E-3,"d":"0.01"},2,"19,162,","0,3570",{"v":-2.2,"d":"-2.20"},-1.63,5.01,"Exon (ENSBGRT00000040707/ENSBGRG00000021882, exon 20 of 23)",1,157189200,157272842,83643,1]
["chr1",157281639,157281759,121,"ENSBGRG00000022101","ENSBGRT00000040822",4604,"ENSBGRG00000022101","NA","GO:0005515(protein binding)","03008(Ribosome biogenesis in eukaryotes)",{"v":0.003,"d":"0.00"},1,"121,",0,-2.53,-1.94,4.26,"Exon (ENSBGRT00000040822/ENSBGRG00000022101, exon 6 of 19)",1,157277035,157292085,15051,1]
["chr1",157291217,157292085,869,"ENSBGRG00000022101","ENSBGRT00000040822",14182,"ENSBGRG00000022101","NA","GO:0005515(protein binding)","03008(Ribosome biogenesis in eukaryotes)",{"v":1e-76,"d":"0.00"},1,"869,",0,-76,{"v":-74.4,"d":"-74.40"},{"v":11.6,"d":"11.60"},"3' UTR",1,157277035,157292085,15051,1]
["chr1",157619249,157619814,566,"ENSBGRG00000023411","ENSBGRT00000043239",119,"LRRC3","leucine rich repeat containing 3 [Source:HGNC Symbol;Acc:HGNC:14965]","GO:0005515(protein binding)","NA",{"v":1e-06,"d":"0.00"},1,"566,",0,-6,-5.25,{"v":2.9,"d":"2.90"},"Exon (ENSBGRT00000043239/ENSBGRG00000023411, exon 1 of 1)",1,157619130,157619903,774,1]
["chr1",158272826,158281178,8353,"ENSBGRG00000000280","ENSBGRT00000000448",35449,"ADARB1","adenosine deaminase RNA specific B1 [Source:HGNC Symbol;Acc:HGNC:226]","GO:0003723(RNA binding);GO:0004000(adenosine deaminase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006382(adenosine to inosine editing);GO:0006396(RNA processing);GO:0007274(neuromuscular synaptic transmission);GO:0008285(negative regulation of cell population proliferation);GO:0021610(facial nerve morphogenesis);GO:0021618(hypoglossal nerve morphogenesis);GO:0021965(spinal cord ventral commissure morphogenesis);GO:0030336(negative regulation of cell migration);GO:0035264(multicellular organism growth);GO:0044387(negative regulation of protein kinase activity by regulation of protein phosphorylation);GO:0045070(positive regulation of viral genome replication);GO:0050884(neuromuscular process controlling posture);GO:0051726(regulation of cell cycle);GO:0060384(innervation);GO:0060415(muscle tissue morphogenesis);GO:0061744(motor behavior);GO:0097049(motor neuron apoptotic process)","NA",{"v":6.2e-07,"d":"0.00"},4,"61,39,935,13,","0,224,3790,8340",-6.21,-5.45,5.01,"Exon (ENSBGRT00000000448/ENSBGRG00000000280, exon 3 of 12)",1,158237377,158319534,82158,1]
["chr1",158318726,158318876,151,"ENSBGRG00000000280","ENSBGRT00000000448",81349,"ADARB1","adenosine deaminase RNA specific B1 [Source:HGNC Symbol;Acc:HGNC:226]","GO:0003723(RNA binding);GO:0004000(adenosine deaminase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006382(adenosine to inosine editing);GO:0006396(RNA processing);GO:0007274(neuromuscular synaptic transmission);GO:0008285(negative regulation of cell population proliferation);GO:0021610(facial nerve morphogenesis);GO:0021618(hypoglossal nerve morphogenesis);GO:0021965(spinal cord ventral commissure morphogenesis);GO:0030336(negative regulation of cell migration);GO:0035264(multicellular organism growth);GO:0044387(negative regulation of protein kinase activity by regulation of protein phosphorylation);GO:0045070(positive regulation of viral genome replication);GO:0050884(neuromuscular process controlling posture);GO:0051726(regulation of cell cycle);GO:0060384(innervation);GO:0060415(muscle tissue morphogenesis);GO:0061744(motor behavior);GO:0097049(motor neuron apoptotic process)","NA",{"v":0.011,"d":"0.01"},1,"151,",0,-1.94,-1.39,3.51,"3' UTR",1,158237377,158319534,82158,1]
["chr1",158544496,158558079,13584,"ENSBGRG00000000404","ENSBGRT00000001044",890,"ENSBGRG00000000404","NA","NA","04974(Protein digestion and absorption)",{"v":2.3e-07,"d":"0.00"},2,"581,196,","0,13388",-6.64,-5.87,5.01,"Exon (ENSBGRT00000001044/ENSBGRG00000000404, exon 6 of 50)",1,158543606,158602983,59378,1]
["chr1",158584440,158598486,14047,"ENSBGRG00000000404","ENSBGRT00000001044",40834,"ENSBGRG00000000404","NA","NA","04974(Protein digestion and absorption)",0,21,"125,63,27,36,72,36,90,30,27,63,51,21,27,54,75,69,43,63,44,123,26,","0,470,1711,2492,2890,3269,3597,4131,4236,4451,4745,4798,5601,5850,6194,7949,8591,9122,11561,11869,14021",-558,"-Inf",4.78,"Exon (ENSBGRT00000001044/ENSBGRG00000000404, exon 22 of 50)",1,158543606,158602983,59378,1]
["chr1",158601847,158602983,1137,"ENSBGRG00000000404","ENSBGRT00000001044",58241,"ENSBGRG00000000404","NA","NA","04974(Protein digestion and absorption)",{"v":1e-189,"d":"0.00"},2,"56,214,","0,923",-189,-186,2.28,"Exon (ENSBGRT00000001044/ENSBGRG00000000404, exon 49 of 50)",1,158543606,158602983,59378,1]
["chr1",158648901,158649230,330,"ENSBGRG00000000644","ENSBGRT00000001161",90,"ENSBGRG00000000644","NA","NA","NA",{"v":0.046,"d":"0.05"},1,"330,",0,-1.34,{"v":-0.843,"d":"-0.84"},5.01,"Exon (ENSBGRT00000001161/ENSBGRG00000000644, exon 1 of 1)",1,158648811,158650517,1707,1]
["chr1",158650098,158650517,420,"ENSBGRG00000000644","ENSBGRT00000001161",1287,"ENSBGRG00000000644","NA","NA","NA",{"v":0.00026,"d":"0.00"},1,"420,",0,-3.59,-2.93,15,"Exon (ENSBGRT00000001161/ENSBGRG00000000644, exon 1 of 1)",1,158648811,158650517,1707,1]
["chr1",159041949,159042099,151,"ENSBGRG00000000813","ENSBGRT00000001486",569,"COL6A1","collagen type VI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2211]","GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0035987(endodermal cell differentiation);GO:0042383(sarcolemma);GO:0048407(platelet-derived growth factor binding);GO:0071230(cellular response to amino acid stimulus)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":2.6e-05,"d":"0.00"},1,"151,",0,-4.58,-3.88,2.87,"5' UTR",1,159041380,159063428,22049,1]
["chr1",159046448,159050953,4506,"ENSBGRG00000000813","ENSBGRT00000001486",5068,"COL6A1","collagen type VI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2211]","GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0035987(endodermal cell differentiation);GO:0042383(sarcolemma);GO:0048407(platelet-derived growth factor binding);GO:0071230(cellular response to amino acid stimulus)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",0,12,"1,54,45,27,27,45,54,63,63,54,36,12,","0,788,2080,2222,2418,2537,2902,3155,3980,4132,4269,4494",-528,"-Inf",2.26,"Exon (ENSBGRT00000001486/ENSBGRG00000000813, exon 8 of 38)",1,159041380,159063428,22049,1]
["chr1",159060364,159063428,3065,"ENSBGRG00000000813","ENSBGRT00000001486",18984,"COL6A1","collagen type VI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2211]","GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0035987(endodermal cell differentiation);GO:0042383(sarcolemma);GO:0048407(platelet-derived growth factor binding);GO:0071230(cellular response to amino acid stimulus)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",0,4,"37,30,16,607,","0,1608,1761,2458",-345,"-Inf",2.42,"Exon (ENSBGRT00000001486/ENSBGRG00000000813, exon 35 of 38)",1,159041380,159063428,22049,1]
["chr1",159213009,159220924,7916,"ENSBGRG00000000863","ENSBGRT00000001699",1885,"COL6A2","collagen type VI alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2212]","GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0042383(sarcolemma)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":1E-155,"d":"0.00"},19,"19,54,45,27,27,45,54,63,63,90,63,63,63,63,51,36,63,63,5,","0,1275,1414,1751,2007,2132,2736,3190,4270,4617,5314,5964,6237,6666,7002,7297,7557,7705,7911",-155,-153,1.91,"Exon (ENSBGRT00000001699/ENSBGRG00000000863, exon 4 of 28)",1,159211124,159225575,14452,1]
["chr1",159222202,159229373,7172,"ENSBGRG00000000863","ENSBGRT00000001699",11078,"COL6A2","collagen type VI alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2212]","GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0042383(sarcolemma)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":1e-171,"d":"0.00"},5,"26,40,26,296,420,","0,247,3348,3688,6752",-171,-168,2.78,"Exon (ENSBGRT00000001699/ENSBGRG00000000863, exon 25 of 28)",1,159211124,159225575,14452,1]
["chr1",159387330,159388757,1428,"ENSBGRG00000001586","ENSBGRT00000002974",617,"ENSBGRG00000001586","NA","GO:0004222(metalloendopeptidase activity);GO:0006364(rRNA processing)","00514(Other types of O-glycan biosynthesis)",{"v":1.6E-7,"d":"0.00"},2,"256,9,","0,1419",{"v":-6.8,"d":"-6.80"},-6.02,1.77,"Exon (ENSBGRT00000002974/ENSBGRG00000001586, exon 1 of 3)",1,159386713,159390293,3581,1]
["chr1",159419209,159419412,204,"ENSBGRG00000001685","ENSBGRT00000003122",0,"ENSBGRG00000001685","NA","NA","NA",{"v":0.011,"d":"0.01"},1,"204,",0,-1.96,{"v":-1.4,"d":"-1.40"},5.52,"Exon (ENSBGRT00000003122/ENSBGRG00000001685, exon 1 of 1)",1,159419209,159419412,204,1]
["chr1",159691008,159691157,150,"ENSBGRG00000001765","ENSBGRT00000004313",136977,"DIP2A","disco interacting protein 2 homolog A [Source:HGNC Symbol;Acc:HGNC:17217]","GO:0003824(catalytic activity);GO:0009986(cell surface);GO:0010629(negative regulation of gene expression);GO:0042981(regulation of apoptotic process)","04512(ECM-receptor interaction);04510(Focal adhesion)",{"v":3.5e-07,"d":"0.00"},1,"150,",0,-6.46,-5.69,2.33,"Exon (ENSBGRT00000004313/ENSBGRG00000001765, exon 39 of 39)",1,159554031,159691247,137217,1]
["chr1",159777194,159777283,90,"ENSBGRG00000002397","ENSBGRT00000004550",0,"PRMT2","protein arginine methyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:5186]","GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008168(methyltransferase activity);GO:0016274(protein-arginine N-methyltransferase activity);GO:0016571(histone methylation);GO:0018216(peptidyl-arginine methylation);GO:0030331(estrogen receptor binding);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0033142(progesterone receptor binding);GO:0042054(histone methyltransferase activity);GO:0042803(protein homodimerization activity);GO:0042974(retinoic acid receptor binding);GO:0042975(peroxisome proliferator activated receptor binding);GO:0043065(positive regulation of apoptotic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046966(thyroid hormone receptor binding);GO:0050681(androgen receptor binding);GO:0060765(regulation of androgen receptor signaling pathway)","NA",{"v":0.032,"d":"0.03"},1,"90,",0,{"v":-1.5,"d":"-1.50"},{"v":-0.985,"d":"-0.99"},1.78,"5' UTR",1,159777194,159801552,24359,1]
["chr1",159801076,159801552,477,"ENSBGRG00000002397","ENSBGRT00000004492",47445,"PRMT2","protein arginine methyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:5186]","GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008168(methyltransferase activity);GO:0016274(protein-arginine N-methyltransferase activity);GO:0016571(histone methylation);GO:0018216(peptidyl-arginine methylation);GO:0030331(estrogen receptor binding);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0033142(progesterone receptor binding);GO:0042054(histone methyltransferase activity);GO:0042803(protein homodimerization activity);GO:0042974(retinoic acid receptor binding);GO:0042975(peroxisome proliferator activated receptor binding);GO:0043065(positive regulation of apoptotic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046966(thyroid hormone receptor binding);GO:0050681(androgen receptor binding);GO:0060765(regulation of androgen receptor signaling pathway)","NA",{"v":1e-40,"d":"0.00"},1,"477,",0,-40,{"v":-38.7,"d":"-38.70"},3.22,"3' UTR",1,159753631,159801552,47922,1]
["chr1",160015927,160018535,2609,"ENSBGRG00000002483","ENSBGRT00000004767",0,"FBXO25","F-box protein 25 [Source:HGNC Symbol;Acc:HGNC:13596]","GO:0005515(protein binding);GO:0005634(nucleus)","04068(FoxO signaling pathway)",{"v":8.3e-09,"d":"0.00"},3,"141,121,6,","0,1685,2603",-8.08,-7.27,2.09,"5' UTR",1,160015927,160032841,16915,1]
["chr1",160023395,160027650,4256,"ENSBGRG00000002483","ENSBGRT00000004767",7468,"FBXO25","F-box protein 25 [Source:HGNC Symbol;Acc:HGNC:13596]","GO:0005515(protein binding);GO:0005634(nucleus)","04068(FoxO signaling pathway)",{"v":0.013,"d":"0.01"},3,"35,94,80,","0,2985,4176",-1.88,-1.34,3.34,"Exon (ENSBGRT00000004767/ENSBGRG00000002483, exon 5 of 9)",1,160015927,160032841,16915,1]
["chr1",160041038,160041275,238,"ENSBGRG00000002483","ENSBGRT00000004668",25111,"FBXO25","F-box protein 25 [Source:HGNC Symbol;Acc:HGNC:13596]","GO:0005515(protein binding);GO:0005634(nucleus)","04068(FoxO signaling pathway)",{"v":1.5e-08,"d":"0.00"},1,"238,",0,-7.82,-7.02,{"v":2.3,"d":"2.30"},"3' UTR",1,160015927,160041690,25764,1]
["chr1",160041542,160041690,149,"ENSBGRG00000002483","ENSBGRT00000004668",25615,"FBXO25","F-box protein 25 [Source:HGNC Symbol;Acc:HGNC:13596]","GO:0005515(protein binding);GO:0005634(nucleus)","04068(FoxO signaling pathway)",{"v":1.9e-10,"d":"0.00"},1,"149,",0,-9.71,-8.86,2.46,"3' UTR",1,160015927,160041690,25764,1]
["chr1",161991243,161997188,5946,"ENSBGRG00000002778","ENSBGRT00000005203",901,"CBR1","carbonyl reductase 1 [Source:HGNC Symbol;Acc:HGNC:1548]","GO:0004090(carbonyl reductase (NADPH) activity);GO:0016491(oxidoreductase activity);GO:0016655(oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor);GO:0017144(drug metabolic process);GO:0030855(epithelial cell differentiation);GO:0042373(vitamin K metabolic process);GO:0055114(oxidation-reduction process)","00590(Arachidonic acid metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00790(Folate biosynthesis);05204(Chemical carcinogenesis)",{"v":1E-182,"d":"0.00"},2,"8,681,","0,5265",-182,-179,6.61,"3' UTR",1,161990342,161997190,6849,1]
["chr1",162073579,162084276,10698,"ENSBGRG00000002778","ENSBGRT00000005189",83237,"CBR1","carbonyl reductase 1 [Source:HGNC Symbol;Acc:HGNC:1548]","GO:0004090(carbonyl reductase (NADPH) activity);GO:0016491(oxidoreductase activity);GO:0016655(oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor);GO:0017144(drug metabolic process);GO:0030855(epithelial cell differentiation);GO:0042373(vitamin K metabolic process);GO:0055114(oxidation-reduction process)","00590(Arachidonic acid metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00790(Folate biosynthesis);05204(Chemical carcinogenesis)",{"v":1e-178,"d":"0.00"},3,"83,108,498,","0,1918,10200",-178,-176,{"v":14.5,"d":"14.50"},"3' UTR",1,161990342,162084276,93935,1]
["chr1",162190621,162195313,4693,"ENSBGRG00000002831","ENSBGRT00000005352",88494,"DOP1B","DOP1 leucine zipper like protein B [Source:HGNC Symbol;Acc:HGNC:1291]","GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","04144(Endocytosis)",{"v":0.019,"d":"0.02"},3,"75,76,179,","0,1259,4514",-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000005352/ENSBGRG00000002831, exon 18 of 38)",1,162102127,162248714,146588,1]
["chr1",162195463,162195733,271,"ENSBGRG00000002831","ENSBGRT00000005352",93336,"DOP1B","DOP1 leucine zipper like protein B [Source:HGNC Symbol;Acc:HGNC:1291]","GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","04144(Endocytosis)",{"v":0.035,"d":"0.04"},1,"271,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000005352/ENSBGRG00000002831, exon 20 of 38)",1,162102127,162248714,146588,1]
["chr1",162196893,162197103,211,"ENSBGRG00000002831","ENSBGRT00000005352",94766,"DOP1B","DOP1 leucine zipper like protein B [Source:HGNC Symbol;Acc:HGNC:1291]","GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","04144(Endocytosis)",{"v":0.00019,"d":"0.00"},1,"211,",0,-3.71,-3.04,9.03,"Exon (ENSBGRT00000005352/ENSBGRG00000002831, exon 21 of 38)",1,162102127,162248714,146588,1]
["chr1",162243672,162245148,1477,"ENSBGRG00000002831","ENSBGRT00000005352",141545,"DOP1B","DOP1 leucine zipper like protein B [Source:HGNC Symbol;Acc:HGNC:1291]","GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","04144(Endocytosis)",{"v":1.6e-19,"d":"0.00"},2,"32,568,","0,909",{"v":-18.8,"d":"-18.80"},{"v":-17.8,"d":"-17.80"},5.97,"3' UTR",1,162102127,162248714,146588,1]
["chr1",162246646,162246976,331,"ENSBGRG00000002831","ENSBGRT00000005352",144519,"DOP1B","DOP1 leucine zipper like protein B [Source:HGNC Symbol;Acc:HGNC:1291]","GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","04144(Endocytosis)",{"v":1.9e-05,"d":"0.00"},1,"331,",0,-4.71,-4,{"v":19.1,"d":"19.10"},"3' UTR",1,162102127,162248714,146588,1]
["chr1",162300342,162305637,5296,"ENSBGRG00000002919","ENSBGRT00000005650",21527,"MORC3","MORC family CW-type zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:23572]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation);GO:0007569(cell aging);GO:0008270(zinc ion binding);GO:0009791(post-embryonic development);GO:0016605(PML body);GO:0018105(peptidyl-serine phosphorylation);GO:0048147(negative regulation of fibroblast proliferation);GO:0050821(protein stabilization);GO:0051457(maintenance of protein location in nucleus)","NA",{"v":5e-39,"d":"0.00"},3,"615,560,104,","0,1450,5192",{"v":-38.3,"d":"-38.30"},{"v":-37.1,"d":"-37.10"},{"v":13.4,"d":"13.40"},"Exon (ENSBGRT00000005650/ENSBGRG00000002919, exon 13 of 14)",1,162278815,162302351,23537,1]
["chr1",162358659,162360490,1832,"ENSBGRG00000003046","ENSBGRT00000005732",35732,"CHAF1B","chromatin assembly factor 1 subunit B [Source:HGNC Symbol;Acc:HGNC:1911]","GO:0000790(nuclear chromatin);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006335(DNA replication-dependent nucleosome assembly);GO:0031497(chromatin assembly);GO:0032991(protein-containing complex);GO:0033186(CAF-1 complex)","NA",{"v":2e-11,"d":"0.00"},2,"45,910,","0,922",{"v":-10.7,"d":"-10.70"},-9.84,{"v":13.5,"d":"13.50"},"3' UTR",1,162322927,162359678,36752,1]
["chr1",163030736,163030947,212,"ENSBGRG00000003171","ENSBGRT00000005903",10596,"RIPPLY3","ripply transcriptional repressor 3 [Source:HGNC Symbol;Acc:HGNC:3047]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0007507(heart development);GO:0008285(negative regulation of cell population proliferation);GO:0060037(pharyngeal system development)","NA",{"v":0.00076,"d":"0.00"},3,"44,18,147,","0,46,65",-3.12,-2.49,10,"Exon (ENSBGRT00000005903/ENSBGRG00000003171, exon 4 of 6)",1,163020140,163030947,10808,1]
["chr1",163169538,163173572,4035,"ENSBGRG00000003246","ENSBGRT00000006013",34858,"ENSBGRG00000003246","NA","GO:0005515(protein binding)","NA",{"v":3.2e-12,"d":"0.00"},4,"41,338,9,3,","0,3683,4022,4032",{"v":-11.5,"d":"-11.50"},{"v":-10.7,"d":"-10.70"},2.65,"Exon (ENSBGRT00000006013/ENSBGRG00000003246, exon 15 of 18)",1,163134680,163173572,38893,1]
["chr1",163188512,163189376,865,"ENSBGRG00000003250","ENSBGRT00000006023",0,"ENSBGRG00000003250","NA","NA","NA",{"v":2.5e-62,"d":"0.00"},1,"865,",0,{"v":-61.6,"d":"-61.60"},{"v":-60.2,"d":"-60.20"},2.98,"5' UTR",1,163188512,163228771,40260,1]
["chr1",163193371,163210171,16801,"ENSBGRG00000003250","ENSBGRT00000006023",4859,"ENSBGRG00000003250","NA","NA","NA",{"v":2e-64,"d":"0.00"},5,"122,140,69,97,49,","0,10609,13068,13846,16752",{"v":-63.7,"d":"-63.70"},{"v":-62.2,"d":"-62.20"},2.32,"5' UTR",1,163188512,163228771,40260,1]
["chr1",163226546,163228771,2226,"ENSBGRG00000003250","ENSBGRT00000006023",38034,"ENSBGRG00000003250","NA","NA","NA",{"v":1e-05,"d":"0.00"},2,"45,75,","0,2151",-4.98,-4.26,1.65,"Exon (ENSBGRT00000006023/ENSBGRG00000003250, exon 13 of 14)",1,163188512,163228771,40260,1]
["chr1",163522863,163534794,11932,"ENSBGRG00000003329","ENSBGRT00000006258",89605,"DYRK1A","dual specificity tyrosine phosphorylation regulated kinase 1A [Source:HGNC Symbol;Acc:HGNC:3091]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0007623(circadian rhythm);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030424(axon);GO:0030425(dendrite);GO:0031115(negative regulation of microtubule polymerization);GO:0033120(positive regulation of RNA splicing);GO:0034205(amyloid-beta formation);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0042802(identical protein binding);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0043621(protein self-association);GO:0046777(protein autophosphorylation);GO:0048025(negative regulation of mRNA splicing, via spliceosome);GO:0048156(tau protein binding);GO:0090312(positive regulation of protein deacetylation);GO:1990904(ribonucleoprotein complex)","NA",{"v":1e-188,"d":"0.00"},2,"9,621,","0,11311",-188,-186,{"v":8.2,"d":"8.20"},"Exon (ENSBGRT00000006258/ENSBGRG00000003329, exon 10 of 10)",1,163433258,163534217,100960,1]
["chr1",165248074,165251594,3521,"ENSBGRG00000003739","ENSBGRT00000006960",17318,"ETS2","ETS proto-oncogene 2, transcription factor [Source:HGNC Symbol;Acc:HGNC:3489]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0019904(protein domain specific binding);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:1990837(sequence-specific double-stranded DNA binding)","04014(Ras signaling pathway);05166(HTLV-I infection)",{"v":1e-143,"d":"0.00"},3,"37,119,680,","0,1579,2841",-143,-141,7.88,"3' UTR",1,165230756,165251974,21219,1]
["chr1",165612358,165623872,11515,"ENSBGRG00000003866","ENSBGRT00000007146",149,"PIK3R4","phosphoinositide-3-kinase regulatory subunit 4 [Source:HGNC Symbol;Acc:HGNC:8982]","GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005770(late endosome);GO:0006468(protein phosphorylation);GO:0015630(microtubule cytoskeleton);GO:0032465(regulation of cytokinesis);GO:0032801(receptor catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity)","04371(Apelin signaling pathway);04140(Autophagy - animal);04136(Autophagy - other eukaryotes)",{"v":2e-61,"d":"0.00"},3,"635,134,576,","0,8834,10939",{"v":-60.7,"d":"-60.70"},{"v":-59.2,"d":"-59.20"},7.79,"Exon (ENSBGRT00000007146/ENSBGRG00000003866, exon 1 of 19)",1,165612209,165698664,86456,1]
["chr1",165698276,165698515,240,"ENSBGRG00000003866","ENSBGRT00000007146",86067,"PIK3R4","phosphoinositide-3-kinase regulatory subunit 4 [Source:HGNC Symbol;Acc:HGNC:8982]","GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005770(late endosome);GO:0006468(protein phosphorylation);GO:0015630(microtubule cytoskeleton);GO:0032465(regulation of cytokinesis);GO:0032801(receptor catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity)","04371(Apelin signaling pathway);04140(Autophagy - animal);04136(Autophagy - other eukaryotes)",{"v":1.6e-16,"d":"0.00"},1,"240,",0,{"v":-15.8,"d":"-15.80"},{"v":-14.8,"d":"-14.80"},2.02,"3' UTR",1,165612209,165698664,86456,1]
["chr1",166479990,166480710,721,"ENSBGRG00000004003","ENSBGRT00000007541",56495,"CAPN7","calpain 7 [Source:HGNC Symbol;Acc:HGNC:1484]","GO:0004175(endopeptidase activity);GO:0004198(calcium-dependent cysteine-type endopeptidase activity);GO:0006508(proteolysis);GO:0010634(positive regulation of epithelial cell migration);GO:0090541(MIT domain binding);GO:0097264(self proteolysis)","NA",{"v":7.9e-97,"d":"0.00"},2,"60,568,","0,153",{"v":-96.1,"d":"-96.10"},{"v":-94.4,"d":"-94.40"},4.81,"3' UTR",1,166423495,166480710,57216,1]
["chr1",166681630,166689271,7642,"ENSBGRG00000004328","ENSBGRT00000007994",4128,"EAF1","ELL associated factor 1 [Source:HGNC Symbol;Acc:HGNC:20907]","GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008023(transcription elongation factor complex);GO:0016604(nuclear body);GO:0032783(super elongation complex);GO:0043231(intracellular membrane-bounded organelle);GO:0045171(intercellular bridge)","NA",{"v":6.3e-24,"d":"0.00"},4,"66,188,225,180,","0,2959,4759,7462",{"v":-23.2,"d":"-23.20"},{"v":-22.1,"d":"-22.10"},3.39,"3' UTR",1,166677502,166690138,12637,1]
["chr1",166689510,166689869,360,"ENSBGRG00000004328","ENSBGRT00000007994",12008,"EAF1","ELL associated factor 1 [Source:HGNC Symbol;Acc:HGNC:20907]","GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008023(transcription elongation factor complex);GO:0016604(nuclear body);GO:0032783(super elongation complex);GO:0043231(intracellular membrane-bounded organelle);GO:0045171(intercellular bridge)","NA",{"v":1e-32,"d":"0.00"},1,"360,",0,-32,{"v":-30.9,"d":"-30.90"},2.09,"3' UTR",1,166677502,166690138,12637,1]
["chr1",166905783,166905873,91,"ENSBGRG00000005423","ENSBGRT00000010036",0,"ENSBGRG00000005423","NA","GO:0006807(nitrogen compound metabolic process)","00780(Biotin metabolism);04977(Vitamin digestion and absorption)",{"v":0.0072,"d":"0.01"},1,"91,",0,-2.14,-1.58,3.18,"Exon (ENSBGRT00000010036/ENSBGRG00000005423, exon 1 of 4)",1,166905783,166912225,6443,1]
["chr1",166912128,166912225,98,"ENSBGRG00000005423","ENSBGRT00000010036",6345,"ENSBGRG00000005423","NA","GO:0006807(nitrogen compound metabolic process)","00780(Biotin metabolism);04977(Vitamin digestion and absorption)",{"v":0.0022,"d":"0.00"},2,"19,72,","0,26",-2.65,-2.05,3.81,"Exon (ENSBGRT00000010036/ENSBGRG00000005423, exon 3 of 4)",1,166905783,166912225,6443,1]
["chr1",167478938,167502252,23315,"ENSBGRG00000005716","ENSBGRT00000010545",207,"GALNT15","polypeptide N-acetylgalactosaminyltransferase 15 [Source:HGNC Symbol;Acc:HGNC:21531]","GO:0030133(transport vesicle)","00512(Mucin type O-glycan biosynthesis)",{"v":1e-05,"d":"0.00"},3,"320,75,51,","0,875,23264",-4.99,-4.27,{"v":20.1,"d":"20.10"},"Exon (ENSBGRT00000010545/ENSBGRG00000005716, exon 1 of 11)",1,167478731,167528054,49324,1]
["chr1",167635479,167636721,1243,"ENSBGRG00000005867","ENSBGRT00000010807",57233,"OXNAD1","oxidoreductase NAD binding domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25128]","GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00520(Amino sugar and nucleotide sugar metabolism)",{"v":1e-121,"d":"0.00"},2,"13,556,","0,687",-121,-119,8.11,"3' UTR",1,167578246,167636721,58476,1]
["chr1",168437960,168439069,1110,"ENSBGRG00000000215","ENSBGRT00000000343",139392,"PLCL2","phospholipase C like 2 [Source:HGNC Symbol;Acc:HGNC:9064]","GO:0002322(B cell proliferation involved in immune response);GO:0002337(B-1a B cell differentiation);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0050859(negative regulation of B cell receptor signaling pathway);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","NA",{"v":4e-60,"d":"0.00"},1,"1110,",0,{"v":-59.4,"d":"-59.40"},{"v":-57.9,"d":"-57.90"},9.87,"5' UTR",1,168298568,168542235,243668,1]
["chr1",168439429,168443201,3773,"ENSBGRG00000000215","ENSBGRT00000000343",140861,"PLCL2","phospholipase C like 2 [Source:HGNC Symbol;Acc:HGNC:9064]","GO:0002322(B cell proliferation involved in immune response);GO:0002337(B-1a B cell differentiation);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0050859(negative regulation of B cell receptor signaling pathway);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","NA",{"v":1E-70,"d":"0.00"},2,"1015,126,","0,3647",-70,{"v":-68.4,"d":"-68.40"},5.53,"Exon (ENSBGRT00000000343/ENSBGRG00000000215, exon 3 of 7)",1,168298568,168542235,243668,1]
["chr1",168502715,168542235,39521,"ENSBGRG00000000231","ENSBGRT00000000372",0,"ENSBGRG00000000231","NA","GO:0000062(fatty-acyl-CoA binding)","03320(PPAR signaling pathway)",{"v":1E-141,"d":"0.00"},2,"25,396,","0,39125",-141,-139,5.76,"3' UTR",1,168538166,168538429,264,2]
["chr1",171036679,171586776,550098,"ENSBGRG00000001743","ENSBGRT00000003223",0,"KCNH8","potassium voltage-gated channel subfamily H member 8 [Source:HGNC Symbol;Acc:HGNC:18864]","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0016020(membrane);GO:0055085(transmembrane transport)","NA",{"v":0.019,"d":"0.02"},16,"303,234,132,128,241,158,208,198,200,250,215,39,353,107,77,580,","0,194766,245548,311671,317329,365232,371620,422667,442922,445034,452024,490776,499732,502225,504649,549518",-1.71,{"v":-0.901,"d":"-0.90"},8.02,"5' UTR",1,171036679,171586895,550217,1]
["chr1",171996226,172024089,27864,"ENSBGRG00000001791","ENSBGRT00000003323",0,"RAB5A","RAB5A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9783]","GO:0001726(ruffle);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0010008(endosome membrane);GO:0015629(actin cytoskeleton);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0030139(endocytic vesicle);GO:0032009(early phagosome);GO:0036465(synaptic vesicle recycling);GO:0036477(somatodendritic compartment);GO:0039694(viral RNA genome replication);GO:0043195(terminal bouton);GO:0045022(early endosome to late endosome transport);GO:0045121(membrane raft);GO:0045335(phagocytic vesicle);GO:0045921(positive regulation of exocytosis);GO:0051036(regulation of endosome size);GO:0051489(regulation of filopodium assembly);GO:0098559(cytoplasmic side of early endosome membrane);GO:0150093(amyloid-beta clearance by transcytosis);GO:2000286(receptor internalization involved in canonical Wnt signaling pathway);GO:2000300(regulation of synaptic vesicle exocytosis)","04014(Ras signaling pathway);04144(Endocytosis);04145(Phagosome);04962(Vasopressin-regulated water reabsorption);05014(Amyotrophic lateral sclerosis (ALS));05152(Tuberculosis);05146(Amoebiasis)",{"v":1.6e-42,"d":"0.00"},3,"84,256,18,","0,3052,27846",{"v":-41.8,"d":"-41.80"},{"v":-40.5,"d":"-40.50"},3.41,"5' UTR",1,171996226,172032562,36337,1]
["chr1",172192746,172200601,7856,"ENSBGRG00000001845","ENSBGRT00000003653",110034,"KAT2B","lysine acetyltransferase 2B [Source:HGNC Symbol;Acc:HGNC:8638]","GO:0000123(histone acetyltransferase complex);GO:0000776(kinetochore);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003682(chromatin binding);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0004468(lysine N-acetyltransferase activity, acting on acetyl phosphate as donor);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0005813(centrosome);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-templated);GO:0006473(protein acetylation);GO:0008080(N-acetyltransferase activity);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0010835(regulation of protein ADP-ribosylation);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0018076(N-terminal peptidyl-lysine acetylation);GO:0018393(internal peptidyl-lysine acetylation);GO:0018394(peptidyl-lysine acetylation);GO:0019901(protein kinase binding);GO:0031672(A band);GO:0031674(I band);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0042641(actomyosin);GO:0042826(histone deacetylase binding);GO:0043966(histone H3 acetylation);GO:0043970(histone H3-K9 acetylation);GO:0045722(positive regulation of gluconeogenesis);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046600(negative regulation of centriole replication);GO:0061733(peptide-lysine-N-acetyltransferase activity);GO:2000233(negative regulation of rRNA processing)","04330(Notch signaling pathway);04919(Thyroid hormone signaling pathway);05203(Viral carcinogenesis);05166(HTLV-I infection)",{"v":3.2E-72,"d":"0.00"},6,"68,37,64,170,85,326,","0,1551,1825,1987,3400,7530",{"v":-71.5,"d":"-71.50"},{"v":-69.9,"d":"-69.90"},2.95,"3' UTR",1,172082712,172194902,112191,1]
["chr1",172201834,172202751,918,"ENSBGRG00000001845","ENSBGRT00000003463",119122,"KAT2B","lysine acetyltransferase 2B [Source:HGNC Symbol;Acc:HGNC:8638]","GO:0000123(histone acetyltransferase complex);GO:0000776(kinetochore);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003682(chromatin binding);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0004468(lysine N-acetyltransferase activity, acting on acetyl phosphate as donor);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0005813(centrosome);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-templated);GO:0006473(protein acetylation);GO:0008080(N-acetyltransferase activity);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0010835(regulation of protein ADP-ribosylation);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0018076(N-terminal peptidyl-lysine acetylation);GO:0018393(internal peptidyl-lysine acetylation);GO:0018394(peptidyl-lysine acetylation);GO:0019901(protein kinase binding);GO:0031672(A band);GO:0031674(I band);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0042641(actomyosin);GO:0042826(histone deacetylase binding);GO:0043966(histone H3 acetylation);GO:0043970(histone H3-K9 acetylation);GO:0045722(positive regulation of gluconeogenesis);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046600(negative regulation of centriole replication);GO:0061733(peptide-lysine-N-acetyltransferase activity);GO:2000233(negative regulation of rRNA processing)","04330(Notch signaling pathway);04919(Thyroid hormone signaling pathway);05203(Viral carcinogenesis);05166(HTLV-I infection)",{"v":1e-307,"d":"0.00"},2,"396,25,","0,893",-307,-305,{"v":5.1,"d":"5.10"},"3' UTR",1,172082712,172202229,119518,1]
["chr1",172202931,172203200,270,"ENSBGRG00000001845","ENSBGRT00000003434",120219,"KAT2B","lysine acetyltransferase 2B [Source:HGNC Symbol;Acc:HGNC:8638]","GO:0000123(histone acetyltransferase complex);GO:0000776(kinetochore);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003682(chromatin binding);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0004468(lysine N-acetyltransferase activity, acting on acetyl phosphate as donor);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0005813(centrosome);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-templated);GO:0006473(protein acetylation);GO:0008080(N-acetyltransferase activity);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0010835(regulation of protein ADP-ribosylation);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0018076(N-terminal peptidyl-lysine acetylation);GO:0018393(internal peptidyl-lysine acetylation);GO:0018394(peptidyl-lysine acetylation);GO:0019901(protein kinase binding);GO:0031672(A band);GO:0031674(I band);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0042641(actomyosin);GO:0042826(histone deacetylase binding);GO:0043966(histone H3 acetylation);GO:0043970(histone H3-K9 acetylation);GO:0045722(positive regulation of gluconeogenesis);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046600(negative regulation of centriole replication);GO:0061733(peptide-lysine-N-acetyltransferase activity);GO:2000233(negative regulation of rRNA processing)","04330(Notch signaling pathway);04919(Thyroid hormone signaling pathway);05203(Viral carcinogenesis);05166(HTLV-I infection)",{"v":0.011,"d":"0.01"},1,"270,",0,-1.97,-1.14,9.03,"3' UTR",1,172082712,172203590,120879,1]
["chr1",669675,669825,151,"ENSBGRG00000000003","ENSBGRT00000000004",30,"CHMP2B","charged multivesicular body protein 2B [Source:HGNC Symbol;Acc:HGNC:24537]","GO:0000815(ESCRT III complex);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005770(late endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006997(nucleus organization);GO:0007032(endosome organization);GO:0007034(vacuolar transport);GO:0007080(mitotic metaphase plate congression);GO:0010824(regulation of centrosome duplication);GO:0019904(protein domain specific binding);GO:0039702(viral budding via host ESCRT complex);GO:0050890(cognition);GO:0061952(midbody abscission);GO:0070050(neuron cellular homeostasis);GO:1901673(regulation of mitotic spindle assembly);GO:1902188(positive regulation of viral release from host cell)","04144(Endocytosis);04217(Necroptosis)",{"v":0.0035,"d":"0.00"},1,"151,",0,-2.46,-1.87,{"v":1.6,"d":"1.60"},"Exon (ENSBGRT00000000004/ENSBGRG00000000003, exon 1 of 6)",1,633575,669855,36281,2]
["chr1",1082516,1082725,210,"ENSBGRG00000000005","ENSBGRT00000000008",1194,"ENSBGRG00000000005","NA","NA","NA",{"v":0.035,"d":"0.04"},1,"210,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000000008/ENSBGRG00000000005, exon 1 of 1)",1,1082516,1083919,1404,2]
["chr1",11912833,11914886,2054,"ENSBGRG00000000017","ENSBGRT00000000026",203107,"ROBO2","roundabout guidance receptor 2 [Source:HGNC Symbol;Acc:HGNC:10250]","GO:0001657(ureteric bud development);GO:0005515(protein binding);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007420(brain development);GO:0009986(cell surface);GO:0032870(cellular response to hormone stimulus);GO:0042802(identical protein binding);GO:0050772(positive regulation of axonogenesis);GO:0050925(negative regulation of negative chemotaxis);GO:0061364(apoptotic process involved in luteolysis)","04360(Axon guidance)",{"v":6.3e-47,"d":"0.00"},2,"171,129,","0,1925",{"v":-46.2,"d":"-46.20"},{"v":-44.8,"d":"-44.80"},2.44,"3' UTR",1,11912833,12117993,205161,2]
["chr1",14154371,14212482,58112,"ENSBGRG00000000021","ENSBGRT00000000031",0,"LIPI","lipase I [Source:HGNC Symbol;Acc:HGNC:18821]","GO:0004620(phospholipase activity);GO:0006629(lipid metabolic process);GO:0008201(heparin binding);GO:0016042(lipid catabolic process);GO:0052689(carboxylic ester hydrolase activity)","NA",{"v":0.0032,"d":"0.00"},9,"57,105,168,90,102,109,386,19,31,","0,8172,10006,11359,23321,32276,34676,49575,58081",{"v":-2.5,"d":"-2.50"},-1.91,11,"Exon (ENSBGRT00000000034/ENSBGRG00000000023, exon 1 of 5)",1,14126671,14203964,77294,2]
["chr1",14404460,14406249,1790,"ENSBGRG00000000025","ENSBGRT00000000038",8666,"HSPA13","heat shock protein family A (Hsp70) member 13 [Source:HGNC Symbol;Acc:HGNC:11375]","NA","NA",{"v":9.99999999999999e-198,"d":"0.00"},2,"764,91,","0,1699",-197,-195,{"v":51.4,"d":"51.40"},"3' UTR",1,14404460,14414915,10456,2]
["chr1",14560953,14570704,9752,"ENSBGRG00000000026","ENSBGRT00000000041",27824,"SAMSN1","SAM domain, SH3 domain and nuclear localization signals 1 [Source:HGNC Symbol;Acc:HGNC:10528]","GO:0005515(protein binding)","NA",{"v":0.017,"d":"0.02"},3,"44,150,16,","0,4963,9736",-1.77,-1.23,2.84,"Exon (ENSBGRT00000000041/ENSBGRG00000000026, exon 2 of 8)",1,14535345,14598528,63184,2]
["chr1",14638202,14638322,121,"ENSBGRG00000000026","ENSBGRT00000000040",78643,"SAMSN1","SAM domain, SH3 domain and nuclear localization signals 1 [Source:HGNC Symbol;Acc:HGNC:10528]","GO:0005515(protein binding)","NA",{"v":0.011,"d":"0.01"},1,"121,",0,-1.97,-1.14,9.03,"Exon (ENSBGRT00000000040/ENSBGRG00000000026, exon 9 of 16)",1,14535345,14716965,181621,2]
["chr1",15063990,15065748,1759,"ENSBGRG00000000027","ENSBGRT00000000044",1520,"NRIP1","nuclear receptor interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:8001]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001543(ovarian follicle rupture);GO:0001650(fibrillar center);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005102(signaling receptor binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0016607(nuclear speck);GO:0019915(lipid storage);GO:0030331(estrogen receptor binding);GO:0030728(ovulation);GO:0032922(circadian regulation of gene expression);GO:0035257(nuclear hormone receptor binding);GO:0035259(glucocorticoid receptor binding);GO:0042826(histone deacetylase binding);GO:0042974(retinoic acid receptor binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046965(retinoid X receptor binding);GO:0071392(cellular response to estradiol stimulus)","NA",{"v":7.9e-85,"d":"0.00"},1,"1759,",0,{"v":-84.1,"d":"-84.10"},{"v":-82.4,"d":"-82.40"},{"v":9.6,"d":"9.60"},"Exon (ENSBGRT00000000044/ENSBGRG00000000027, exon 1 of 1)",1,15063990,15067268,3279,2]
["chr1",15066225,15066285,61,"ENSBGRG00000000027","ENSBGRT00000000044",983,"NRIP1","nuclear receptor interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:8001]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001543(ovarian follicle rupture);GO:0001650(fibrillar center);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005102(signaling receptor binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0016607(nuclear speck);GO:0019915(lipid storage);GO:0030331(estrogen receptor binding);GO:0030728(ovulation);GO:0032922(circadian regulation of gene expression);GO:0035257(nuclear hormone receptor binding);GO:0035259(glucocorticoid receptor binding);GO:0042826(histone deacetylase binding);GO:0042974(retinoic acid receptor binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046965(retinoid X receptor binding);GO:0071392(cellular response to estradiol stimulus)","NA",{"v":1e-12,"d":"0.00"},1,"61,",0,-12,{"v":-11.1,"d":"-11.10"},3.08,"Exon (ENSBGRT00000000044/ENSBGRG00000000027, exon 1 of 1)",1,15063990,15067268,3279,2]
["chr1",15066344,15066970,627,"ENSBGRG00000000027","ENSBGRT00000000044",298,"NRIP1","nuclear receptor interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:8001]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001543(ovarian follicle rupture);GO:0001650(fibrillar center);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005102(signaling receptor binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0016607(nuclear speck);GO:0019915(lipid storage);GO:0030331(estrogen receptor binding);GO:0030728(ovulation);GO:0032922(circadian regulation of gene expression);GO:0035257(nuclear hormone receptor binding);GO:0035259(glucocorticoid receptor binding);GO:0042826(histone deacetylase binding);GO:0042974(retinoic acid receptor binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046965(retinoid X receptor binding);GO:0071392(cellular response to estradiol stimulus)","NA",{"v":1e-18,"d":"0.00"},1,"627,",0,-18,-17,4.68,"Exon (ENSBGRT00000000044/ENSBGRG00000000027, exon 1 of 1)",1,15063990,15067268,3279,2]
["chr1",18087150,18087210,61,"ENSBGRG00000000038","ENSBGRT00000000069",0,"BTG3","BTG anti-proliferation factor 3 [Source:HGNC Symbol;Acc:HGNC:1132]","GO:0005737(cytoplasm);GO:0045930(negative regulation of mitotic cell cycle)","03018(RNA degradation)",{"v":0.0036,"d":"0.00"},1,"61,",0,-2.44,-1.85,1.59,"Exon (ENSBGRT00000000069/ENSBGRG00000000038, exon 1 of 5)",1,18071760,18087210,15451,2]
["chr1",18279578,18309151,29574,"ENSBGRG00000000042","ENSBGRT00000000073",2892,"C21orf91","chromosome 21 open reading frame 91 [Source:HGNC Symbol;Acc:HGNC:16459]","GO:0021895(cerebral cortex neuron differentiation);GO:0060999(positive regulation of dendritic spine development)","NA",{"v":2E-16,"d":"0.00"},5,"164,2,63,537,6,","0,165,2223,4250,29568",{"v":-15.7,"d":"-15.70"},{"v":-14.7,"d":"-14.70"},4.21,"Exon (ENSBGRT00000000073/ENSBGRG00000000042, exon 2 of 5)",1,18279578,18312043,32466,2]
["chr1",27346485,27358001,11517,"ENSBGRG00000000058","ENSBGRT00000000092",11464,"MRPL39","mitochondrial ribosomal protein L39 [Source:HGNC Symbol;Acc:HGNC:14027]","GO:0000166(nucleotide binding);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit)","NA",{"v":6.3e-14,"d":"0.00"},5,"26,70,114,48,98,","0,6464,7200,9446,11419",{"v":-13.2,"d":"-13.20"},{"v":-12.3,"d":"-12.30"},2.42,"3' UTR",1,27342662,27369465,26804,2]
["chr1",27511939,27513898,1960,"ENSBGRG00000000060","ENSBGRT00000000098",7415,"ENSBGRG00000000060","NA","GO:0000276(mitochondrial proton-transporting ATP synthase complex, coupling factor F(o));GO:0015078(proton transmembrane transporter activity);GO:0015986(ATP synthesis coupled proton transport)","00190(Oxidative phosphorylation);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)",{"v":5E-15,"d":"0.00"},3,"127,125,49,","0,730,1911",{"v":-14.3,"d":"-14.30"},{"v":-13.4,"d":"-13.40"},3.76,"3' UTR",1,27511939,27521313,9375,2]
["chr1",27520923,27521163,241,"ENSBGRG00000000060","ENSBGRT00000000098",150,"ENSBGRG00000000060","NA","GO:0000276(mitochondrial proton-transporting ATP synthase complex, coupling factor F(o));GO:0015078(proton transmembrane transporter activity);GO:0015986(ATP synthesis coupled proton transport)","00190(Oxidative phosphorylation);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)",{"v":0.00026,"d":"0.00"},1,"241,",0,-3.59,-2.93,15,"Exon (ENSBGRT00000000098/ENSBGRG00000000060, exon 1 of 5)",1,27511939,27521313,9375,2]
["chr1",27698287,27698526,240,"ENSBGRG00000000062","ENSBGRT00000000103",347352,"APP","amyloid beta precursor protein [Source:HGNC Symbol;Acc:HGNC:620]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001774(microglial cell activation);GO:0001934(positive regulation of protein phosphorylation);GO:0001967(suckling behavior);GO:0002265(astrocyte activation involved in immune response);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005102(signaling receptor binding);GO:0005615(extracellular space);GO:0005641(nuclear envelope lumen);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0005798(Golgi-associated vesicle);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006378(mRNA polyadenylation);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0006878(cellular copper ion homeostasis);GO:0006897(endocytosis);GO:0006979(response to oxidative stress);GO:0007176(regulation of epidermal growth factor-activated receptor activity);GO:0007399(nervous system development);GO:0007409(axonogenesis);GO:0007611(learning or memory);GO:0007612(learning);GO:0007617(mating behavior);GO:0007626(locomotory behavior);GO:0008021(synaptic vesicle);GO:0008088(axo-dendritic transport);GO:0008201(heparin binding);GO:0008203(cholesterol metabolic process);GO:0008285(negative regulation of cell population proliferation);GO:0008344(adult locomotory behavior);GO:0008542(visual learning);GO:0009986(cell surface);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010800(positive regulation of peptidyl-threonine phosphorylation);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0014005(microglia development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016199(axon midline choice point recognition);GO:0016322(neuron remodeling);GO:0016358(dendrite development);GO:0019899(enzyme binding);GO:0030134(COPII-coated ER to Golgi transport vesicle);GO:0030198(extracellular matrix organization);GO:0030424(axon);GO:0030546(signaling receptor activator activity);GO:0030900(forebrain development);GO:0031175(neuron projection development);GO:0031410(cytoplasmic vesicle);GO:0031594(neuromuscular junction);GO:0032092(positive regulation of protein binding);GO:0032640(tumor necrosis factor production);GO:0032731(positive regulation of interleukin-1 beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0035235(ionotropic glutamate receptor signaling pathway);GO:0035253(ciliary rootlet);GO:0040014(regulation of multicellular organism growth);GO:0042327(positive regulation of phosphorylation);GO:0042535(positive regulation of tumor necrosis factor biosynthetic process);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043197(dendritic spine);GO:0043198(dendritic shaft);GO:0043235(receptor complex);GO:0043393(regulation of protein binding);GO:0045080(positive regulation of chemokine biosynthetic process);GO:0045121(membrane raft);GO:0045177(apical part of cell);GO:0045202(synapse);GO:0045665(negative regulation of neuron differentiation);GO:0045821(positive regulation of glycolytic process);GO:0045931(positive regulation of mitotic cell cycle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046330(positive regulation of JNK cascade);GO:0046914(transition metal ion binding);GO:0048143(astrocyte activation);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048669(collateral sprouting in absence of injury);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:0050803(regulation of synapse structure or activity);GO:0050808(synapse organization);GO:0050885(neuromuscular process controlling balance);GO:0050890(cognition);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051124(synaptic growth at neuromuscular junction);GO:0051233(spindle midzone);GO:0051247(positive regulation of protein metabolic process);GO:0051402(neuron apoptotic process);GO:0051425(PTB domain binding);GO:0051563(smooth endoplasmic reticulum calcium ion homeostasis);GO:0055037(recycling endosome);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0090647(modulation of age-related behavioral decline);GO:0098815(modulation of excitatory postsynaptic potential);GO:0150003(regulation of spontaneous synaptic transmission);GO:1900272(negative regulation of long-term synaptic potentiation);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1902004(positive regulation of amyloid-beta formation);GO:1904646(cellular response to amyloid-beta);GO:1905606(regulation of presynapse assembly);GO:1905908(positive regulation of amyloid fibril formation);GO:1990000(amyloid fibril formation);GO:1990535(neuron projection maintenance);GO:2000406(positive regulation of T cell migration)","04726(Serotonergic synapse);05010(Alzheimer disease)",{"v":1e-170,"d":"0.00"},1,"240,",0,-170,-168,3.57,"3' UTR",1,27698287,28045878,347592,2]
["chr1",27857847,27900233,42387,"ENSBGRG00000000064","ENSBGRT00000000111",0,"ENSBGRG00000000064","NA","NA","NA",{"v":1e-122,"d":"0.00"},2,"174,96,","0,42291",-122,-120,1.52,"Exon (ENSBGRT00000000111/ENSBGRG00000000064, exon 1 of 1)",1,27860863,27861963,1101,1]
["chr1",28287124,28287393,270,"ENSBGRG00000000067","ENSBGRT00000000114",159970,"ENSBGRG00000000067","NA","NA","NA",{"v":0.00065,"d":"0.00"},1,"270,",0,-3.19,-2.55,11,"3' UTR",1,28282365,28447363,164999,2]
["chr1",28288991,28289339,349,"ENSBGRG00000000067","ENSBGRT00000000114",158024,"ENSBGRG00000000067","NA","NA","NA",{"v":0.035,"d":"0.04"},2,"152,117,","0,232",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"3' UTR",1,28282365,28447363,164999,2]
["chr1",28754621,28755401,781,"ENSBGRG00000000068","ENSBGRT00000000120",7285,"ADAMTS1","ADAM metallopeptidase with thrombospondin type 1 motif 1 [Source:HGNC Symbol;Acc:HGNC:217]","GO:0001542(ovulation from ovarian follicle);GO:0001822(kidney development);GO:0004222(metalloendopeptidase activity);GO:0005604(basement membrane);GO:0006508(proteolysis);GO:0008201(heparin binding);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016525(negative regulation of angiogenesis);GO:0031012(extracellular matrix);GO:0031410(cytoplasmic vesicle);GO:0060347(heart trabecula formation);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration)","NA",0,1,"781,",0,-1170,"-Inf",4.83,"3' UTR",1,28754201,28762686,8486,2]
["chr1",28761876,28762686,811,"ENSBGRG00000000068","ENSBGRT00000000120",0,"ADAMTS1","ADAM metallopeptidase with thrombospondin type 1 motif 1 [Source:HGNC Symbol;Acc:HGNC:217]","GO:0001542(ovulation from ovarian follicle);GO:0001822(kidney development);GO:0004222(metalloendopeptidase activity);GO:0005604(basement membrane);GO:0006508(proteolysis);GO:0008201(heparin binding);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016525(negative regulation of angiogenesis);GO:0031012(extracellular matrix);GO:0031410(cytoplasmic vesicle);GO:0060347(heart trabecula formation);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration)","NA",{"v":6.3e-81,"d":"0.00"},1,"811,",0,{"v":-80.2,"d":"-80.20"},{"v":-78.5,"d":"-78.50"},2.76,"5' UTR",1,28754201,28762686,8486,2]
["chr1",28867458,28867666,209,"ENSBGRG00000000069","ENSBGRT00000000121",58344,"ADAMTS5","ADAM metallopeptidase with thrombospondin type 1 motif 5 [Source:HGNC Symbol;Acc:HGNC:221]","GO:0004222(metalloendopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008201(heparin binding);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0042742(defense response to bacterium);GO:0050840(extracellular matrix binding);GO:0062023(collagen-containing extracellular matrix);GO:0120163(negative regulation of cold-induced thermogenesis)","NA",{"v":0.004,"d":"0.00"},1,"209,",0,{"v":-2.4,"d":"-2.40"},-1.81,3.15,"3' UTR",1,28866712,28926010,59299,2]
["chr1",28867726,28868561,836,"ENSBGRG00000000069","ENSBGRT00000000121",57449,"ADAMTS5","ADAM metallopeptidase with thrombospondin type 1 motif 5 [Source:HGNC Symbol;Acc:HGNC:221]","GO:0004222(metalloendopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008201(heparin binding);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0042742(defense response to bacterium);GO:0050840(extracellular matrix binding);GO:0062023(collagen-containing extracellular matrix);GO:0120163(negative regulation of cold-induced thermogenesis)","NA",{"v":8.7e-09,"d":"0.00"},1,"836,",0,-8.06,-7.25,8.42,"3' UTR",1,28866712,28926010,59299,2]
["chr1",31363269,31363419,151,"ENSBGRG00000000075","ENSBGRT00000000131",25984,"LTN1","listerin E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:13082]","GO:0004842(ubiquitin-protein transferase activity);GO:0008270(zinc ion binding);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:1990112(RQC complex);GO:1990116(ribosome-associated ubiquitin-dependent protein catabolic process)","00260(Glycine, serine and threonine metabolism);00270(Cysteine and methionine metabolism);00450(Selenocompound metabolism)",{"v":0.0037,"d":"0.00"},1,"151,",0,-2.43,-1.84,2.71,"Exon (ENSBGRT00000000131/ENSBGRG00000000075, exon 10 of 30)",1,31319321,31389403,70083,2]
["chr1",31363479,31363598,120,"ENSBGRG00000000075","ENSBGRT00000000131",25805,"LTN1","listerin E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:13082]","GO:0004842(ubiquitin-protein transferase activity);GO:0008270(zinc ion binding);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:1990112(RQC complex);GO:1990116(ribosome-associated ubiquitin-dependent protein catabolic process)","00260(Glycine, serine and threonine metabolism);00270(Cysteine and methionine metabolism);00450(Selenocompound metabolism)",{"v":3.5E-4,"d":"0.00"},1,"120,",0,-3.46,-2.81,3.01,"Exon (ENSBGRT00000000131/ENSBGRG00000000075, exon 10 of 30)",1,31319321,31389403,70083,2]
["chr1",31403553,31405871,2319,"ENSBGRG00000000076","ENSBGRT00000000133",9243,"RWDD2B","RWD domain containing 2B [Source:HGNC Symbol;Acc:HGNC:1302]","GO:0005515(protein binding)","NA",{"v":4e-26,"d":"0.00"},2,"267,143,","0,2176",{"v":-25.4,"d":"-25.40"},{"v":-24.3,"d":"-24.30"},3.83,"3' UTR",1,31403553,31415114,11562,2]
["chr1",31453238,31456675,3438,"ENSBGRG00000000078","ENSBGRT00000000139",7539,"ENSBGRG00000000078","NA","GO:0005524(ATP binding);GO:0006457(protein folding);GO:0051082(unfolded protein binding)","NA",{"v":1.5E-6,"d":"0.00"},2,"78,103,","0,3335",-5.81,-5.06,1.23,"Exon (ENSBGRT00000000139/ENSBGRG00000000078, exon 12 of 13)",1,31453238,31464214,10977,2]
["chr1",34418102,34418520,419,"ENSBGRG00000000112","ENSBGRT00000000179",54608,"TIAM1","TIAM Rac1 associated GEF 1 [Source:HGNC Symbol;Acc:HGNC:11805]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007160(cell-matrix adhesion);GO:0007165(signal transduction);GO:0008284(positive regulation of cell population proliferation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0016477(cell migration);GO:0016601(Rac protein signal transduction);GO:0019900(kinase binding);GO:0030335(positive regulation of cell migration);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032092(positive regulation of protein binding);GO:0034622(cellular protein-containing complex assembly);GO:0035556(intracellular signal transduction);GO:0044291(cell-cell contact zone);GO:0090630(activation of GTPase activity)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04530(Tight junction);04810(Regulation of actin cytoskeleton);04062(Chemokine signaling pathway);05205(Proteoglycans in cancer)",{"v":8.1e-05,"d":"0.00"},1,"419,",0,-4.09,{"v":-3.4,"d":"-3.40"},3.79,"Exon (ENSBGRT00000000179/ENSBGRG00000000112, exon 13 of 14)",1,34418102,34473128,55027,2]
["chr1",34553696,34553845,150,"ENSBGRG00000000112","ENSBGRT00000000180",66017,"TIAM1","TIAM Rac1 associated GEF 1 [Source:HGNC Symbol;Acc:HGNC:11805]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007160(cell-matrix adhesion);GO:0007165(signal transduction);GO:0008284(positive regulation of cell population proliferation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0016477(cell migration);GO:0016601(Rac protein signal transduction);GO:0019900(kinase binding);GO:0030335(positive regulation of cell migration);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032092(positive regulation of protein binding);GO:0034622(cellular protein-containing complex assembly);GO:0035556(intracellular signal transduction);GO:0044291(cell-cell contact zone);GO:0090630(activation of GTPase activity)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04530(Tight junction);04810(Regulation of actin cytoskeleton);04062(Chemokine signaling pathway);05205(Proteoglycans in cancer)",{"v":0.017,"d":"0.02"},1,"150,",0,-1.76,-1.22,7.02,"Exon (ENSBGRT00000000180/ENSBGRG00000000112, exon 6 of 27)",1,34418116,34619862,201747,2]
["chr1",34579009,34598400,19392,"ENSBGRG00000000113","ENSBGRT00000000182",0,"ENSBGRG00000000113","NA","NA","NA",{"v":0.028,"d":"0.03"},2,"250,20,","0,19372",-1.55,-1.03,3.68,"Exon (ENSBGRT00000000180/ENSBGRG00000000112, exon 3 of 27)",1,34580551,34580627,77,2]
["chr1",34598579,34599087,509,"ENSBGRG00000000112","ENSBGRT00000000180",20775,"TIAM1","TIAM Rac1 associated GEF 1 [Source:HGNC Symbol;Acc:HGNC:11805]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007160(cell-matrix adhesion);GO:0007165(signal transduction);GO:0008284(positive regulation of cell population proliferation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0016477(cell migration);GO:0016601(Rac protein signal transduction);GO:0019900(kinase binding);GO:0030335(positive regulation of cell migration);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032092(positive regulation of protein binding);GO:0034622(cellular protein-containing complex assembly);GO:0035556(intracellular signal transduction);GO:0044291(cell-cell contact zone);GO:0090630(activation of GTPase activity)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04530(Tight junction);04810(Regulation of actin cytoskeleton);04062(Chemokine signaling pathway);05205(Proteoglycans in cancer)",{"v":1.8E-3,"d":"0.00"},1,"509,",0,-2.74,-2.13,4.35,"Exon (ENSBGRT00000000180/ENSBGRG00000000112, exon 3 of 27)",1,34418116,34619862,201747,2]
["chr1",35101017,35101589,573,"ENSBGRG00000000118","ENSBGRT00000000187",65543,"SCAF4","SR-related CTD associated factor 4 [Source:HGNC Symbol;Acc:HGNC:19304]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:1990269(RNA polymerase II C-terminal domain phosphoserine binding);GO:2000805(negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled)","NA",{"v":1e-130,"d":"0.00"},2,"3,567,","0,6",-130,-128,{"v":5.3,"d":"5.30"},"Exon (ENSBGRT00000000187/ENSBGRG00000000118, exon 20 of 21)",1,35101017,35167132,66116,2]
["chr1",35101649,35101739,91,"ENSBGRG00000000118","ENSBGRT00000000187",65393,"SCAF4","SR-related CTD associated factor 4 [Source:HGNC Symbol;Acc:HGNC:19304]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:1990269(RNA polymerase II C-terminal domain phosphoserine binding);GO:2000805(negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled)","NA",{"v":0.00047,"d":"0.00"},1,"91,",0,-3.33,-2.68,1.82,"Exon (ENSBGRT00000000187/ENSBGRG00000000118, exon 20 of 21)",1,35101017,35167132,66116,2]
["chr1",35836490,35838060,1571,"ENSBGRG00000000122","ENSBGRT00000000196",84551,"URB1","URB1 ribosome biogenesis homolog [Source:HGNC Symbol;Acc:HGNC:17344]","GO:0001650(fibrillar center);GO:0005730(nucleolus)","NA",{"v":1.8E-3,"d":"0.00"},2,"182,208,","0,1363",-2.74,-2.13,5.01,"Exon (ENSBGRT00000000196/ENSBGRG00000000122, exon 35 of 36)",1,35836490,35922611,86122,2]
["chr1",36123216,36135409,12194,"ENSBGRG00000000124","ENSBGRT00000000203",235,"ENSBGRG00000000124","cilia and flagella associated protein 298 [Source:HGNC Symbol;Acc:HGNC:1301]","GO:0003352(regulation of cilium movement)","NA",{"v":6.3e-52,"d":"0.00"},9,"161,96,33,33,138,159,68,168,87,","0,450,1994,2029,2064,3509,7897,9663,12107",{"v":-51.2,"d":"-51.20"},{"v":-49.9,"d":"-49.90"},2.29,"3' UTR",1,36123216,36135644,12429,2]
["chr1",36144896,36144956,61,"ENSBGRG00000000125","ENSBGRT00000000209",81790,"SYNJ1","synaptojanin 1 [Source:HGNC Symbol;Acc:HGNC:11503]","GO:0003676(nucleic acid binding);GO:0034595(phosphatidylinositol phosphate 5-phosphatase activity);GO:0042578(phosphoric ester hydrolase activity);GO:0046856(phosphatidylinositol dephosphorylation);GO:0048488(synaptic vesicle endocytosis)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",0.03,1,"61,",0,-1.53,-1.01,2.34,"Exon (ENSBGRT00000000209/ENSBGRG00000000125, exon 27 of 27)",1,36144896,36226746,81851,2]
["chr1",36145015,36145284,270,"ENSBGRG00000000125","ENSBGRT00000000209",81462,"SYNJ1","synaptojanin 1 [Source:HGNC Symbol;Acc:HGNC:11503]","GO:0003676(nucleic acid binding);GO:0034595(phosphatidylinositol phosphate 5-phosphatase activity);GO:0042578(phosphoric ester hydrolase activity);GO:0046856(phosphatidylinositol dephosphorylation);GO:0048488(synaptic vesicle endocytosis)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":0.0026,"d":"0.00"},1,"270,",0,-2.59,-1.99,4.26,"Exon (ENSBGRT00000000209/ENSBGRG00000000125, exon 27 of 27)",1,36144896,36226746,81851,2]
["chr1",36145344,36145553,210,"ENSBGRG00000000125","ENSBGRT00000000209",81193,"SYNJ1","synaptojanin 1 [Source:HGNC Symbol;Acc:HGNC:11503]","GO:0003676(nucleic acid binding);GO:0034595(phosphatidylinositol phosphate 5-phosphatase activity);GO:0042578(phosphoric ester hydrolase activity);GO:0046856(phosphatidylinositol dephosphorylation);GO:0048488(synaptic vesicle endocytosis)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":0.00065,"d":"0.00"},1,"210,",0,-3.19,-2.55,2.27,"Exon (ENSBGRT00000000209/ENSBGRG00000000125, exon 27 of 27)",1,36144896,36226746,81851,2]
["chr1",36258998,36260436,1439,"ENSBGRG00000000127","ENSBGRT00000000213",30162,"PAXBP1","PAX3 and PAX7 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:13579]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0014842(regulation of skeletal muscle satellite cell proliferation);GO:0031062(positive regulation of histone methylation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2000288(positive regulation of myoblast proliferation)","NA",{"v":1e-07,"d":"0.00"},2,"88,91,","0,1348",-6.99,-6.21,{"v":1.5,"d":"1.50"},"Exon (ENSBGRT00000000213/ENSBGRG00000000127, exon 17 of 18)",1,36258968,36290598,31631,2]
["chr1",37145195,37146308,1114,"ENSBGRG00000000137","ENSBGRT00000000227",0,"DNAJC28","DnaJ heat shock protein family (Hsp40) member C28 [Source:HGNC Symbol;Acc:HGNC:1297]","NA","NA",{"v":2.5e-33,"d":"0.00"},1,"1114,",0,{"v":-32.6,"d":"-32.60"},{"v":-31.4,"d":"-31.40"},8.64,"Exon (ENSBGRT00000000227/ENSBGRG00000000137, exon 1 of 1)",1,37145166,37146308,1143,2]
["chr1",37168370,37168489,120,"ENSBGRG00000000138","ENSBGRT00000000228",27536,"GART","phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase [Source:HGNC Symbol;Acc:HGNC:4163]","GO:0004637(phosphoribosylamine-glycine ligase activity);GO:0004641(phosphoribosylformylglycinamidine cyclo-ligase activity);GO:0004644(phosphoribosylglycinamide formyltransferase activity);GO:0005524(ATP binding);GO:0006189('de novo' IMP biosynthetic process);GO:0009058(biosynthetic process);GO:0009113(purine nucleobase biosynthetic process);GO:0016742(hydroxymethyl-, formyl- and related transferase activity);GO:0046872(metal ion binding)","00230(Purine metabolism);00670(One carbon pool by folate);01523(Antifolate resistance)",{"v":0.0068,"d":"0.01"},1,"120,",0,-2.17,{"v":-1.6,"d":"-1.60"},1.45,"Exon (ENSBGRT00000000228/ENSBGRG00000000138, exon 22 of 22)",1,37168340,37196025,27686,2]
["chr1",37184110,37185868,1759,"ENSBGRG00000000138","ENSBGRT00000000228",10157,"GART","phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase [Source:HGNC Symbol;Acc:HGNC:4163]","GO:0004637(phosphoribosylamine-glycine ligase activity);GO:0004641(phosphoribosylformylglycinamidine cyclo-ligase activity);GO:0004644(phosphoribosylglycinamide formyltransferase activity);GO:0005524(ATP binding);GO:0006189('de novo' IMP biosynthetic process);GO:0009058(biosynthetic process);GO:0009113(purine nucleobase biosynthetic process);GO:0016742(hydroxymethyl-, formyl- and related transferase activity);GO:0046872(metal ion binding)","00230(Purine metabolism);00670(One carbon pool by folate);01523(Antifolate resistance)",{"v":2e-05,"d":"0.00"},3,"13,126,40,","0,1089,1719",{"v":-4.7,"d":"-4.70"},-3.99,2.05,"Exon (ENSBGRT00000000228/ENSBGRG00000000138, exon 6 of 22)",1,37168340,37196025,27686,2]
["chr1",37231775,37231954,180,"ENSBGRG00000000141","ENSBGRT00000000234",10920,"DONSON","downstream neighbor of SON [Source:HGNC Symbol;Acc:HGNC:2993]","GO:0000077(DNA damage checkpoint);GO:0005634(nucleus);GO:0005657(replication fork);GO:0006260(DNA replication);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0030894(replisome);GO:0048478(replication fork protection)","NA",{"v":3.2E-13,"d":"0.00"},1,"180,",0,{"v":-12.5,"d":"-12.50"},{"v":-11.6,"d":"-11.60"},2.47,"3' UTR",1,37231178,37242874,11697,2]
["chr1",37241710,37242874,1165,"ENSBGRG00000000141","ENSBGRT00000000234",0,"DONSON","downstream neighbor of SON [Source:HGNC Symbol;Acc:HGNC:2993]","GO:0000077(DNA damage checkpoint);GO:0005634(nucleus);GO:0005657(replication fork);GO:0006260(DNA replication);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0030894(replisome);GO:0048478(replication fork protection)","NA",{"v":1e-126,"d":"0.00"},1,"1165,",0,-126,-124,10,"5' UTR",1,37231178,37242874,11697,2]
["chr1",37567010,37568690,1681,"ENSBGRG00000000144","ENSBGRT00000000247",8688,"ENSBGRG00000000144","NA","GO:0015986(ATP synthesis coupled proton transport);GO:0016020(membrane);GO:0046933(proton-transporting ATP synthase activity, rotational mechanism)","00190(Oxidative phosphorylation);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)",{"v":0.00013,"d":"0.00"},3,"85,87,5,","0,361,1676",{"v":-3.9,"d":"-3.90"},-3.23,1.35,"Exon (ENSBGRT00000000247/ENSBGRG00000000144, exon 6 of 7)",1,37566981,37577378,10398,2]
["chr1",38262094,38262486,393,"ENSBGRG00000000153","ENSBGRT00000000256",0,"ENSBGRG00000000153","NA","GO:0002070(epithelial cell maturation);GO:0005249(voltage-gated potassium channel activity);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0015459(potassium channel regulator activity);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0060047(heart contraction);GO:0086091(regulation of heart rate by cardiac conduction)","04261(Adrenergic signaling in cardiomyocytes)",{"v":3.9e-07,"d":"0.00"},1,"393,",0,-6.41,-5.64,{"v":25.1,"d":"25.10"},"Exon (ENSBGRT00000000256/ENSBGRG00000000153, exon 1 of 1)",1,38262094,38262486,393,2]
["chr1",38315249,38318977,3729,"ENSBGRG00000000154","ENSBGRT00000000259",8224,"RCAN1","regulator of calcineurin 1 [Source:HGNC Symbol;Acc:HGNC:3040]","GO:0002931(response to ischemia);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006979(response to oxidative stress);GO:0007614(short-term memory);GO:0019722(calcium-mediated signaling);GO:0031987(locomotion involved in locomotory behavior);GO:0033173(calcineurin-NFAT signaling cascade);GO:0043666(regulation of phosphoprotein phosphatase activity);GO:0048741(skeletal muscle fiber development)","04921(Oxytocin signaling pathway);04919(Thyroid hormone signaling pathway);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":4e-27,"d":"0.00"},2,"848,38,","0,3691",{"v":-26.4,"d":"-26.40"},{"v":-25.2,"d":"-25.20"},6.69,"3' UTR",1,38314924,38327201,12278,2]
["chr1",38729830,38730248,419,"ENSBGRG00000000164","ENSBGRT00000000269",95739,"CGGBP1","CGG triplet repeat binding protein 1 [Source:HGNC Symbol;Acc:HGNC:1888]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0042802(identical protein binding);GO:0090579(dsDNA loop formation);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":7.9e-93,"d":"0.00"},1,"419,",0,{"v":-92.1,"d":"-92.10"},{"v":-90.4,"d":"-90.40"},3.21,"Exon (ENSBGRT00000000269/ENSBGRG00000000164, exon 4 of 4)",1,38729830,38825987,96158,2]
["chr1",41201960,41202222,263,"ENSBGRG00000000717","ENSBGRT00000001277",0,"ENSBGRG00000000717","NA","GO:0005484(SNAP receptor activity);GO:0006886(intracellular protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport)","04130(SNARE interactions in vesicular transport)",{"v":0.0032,"d":"0.00"},1,"263,",0,{"v":-2.5,"d":"-2.50"},-1.91,11,"Exon (ENSBGRT00000001277/ENSBGRG00000000717, exon 1 of 1)",1,41201785,41202222,438,2]
["chr1",45362625,45365584,2960,"ENSBGRG00000000874","ENSBGRT00000001593",137486,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":3.2e-22,"d":"0.00"},2,"237,271,","0,2689",{"v":-21.5,"d":"-21.50"},{"v":-20.5,"d":"-20.50"},3.18,"3' UTR",1,45225139,45364143,139005,1]
["chr1",45396808,45400991,4184,"ENSBGRG00000000955","ENSBGRT00000001762",0,"RIOX2","ribosomal oxygenase 2 [Source:HGNC Symbol;Acc:HGNC:19441]","GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0042802(identical protein binding)","NA",{"v":1.5E-6,"d":"0.00"},2,"118,2,","0,4182",-5.83,-5.08,2.67,"5' UTR",1,45361838,45400991,39154,2]
["chr1",46063814,46066338,2525,"ENSBGRG00000002153","ENSBGRT00000004080",1636,"CLDND1","claudin domain containing 1 [Source:HGNC Symbol;Acc:HGNC:1322]","GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane)","NA",{"v":0.00026,"d":"0.00"},2,"97,82,","0,2443",-3.59,-2.93,1.56,"Exon (ENSBGRT00000004080/ENSBGRG00000002153, exon 2 of 4)",1,46060763,46067974,7212,2]
["chr1",46143881,46144327,447,"ENSBGRG00000002215","ENSBGRT00000004158",0,"ENSBGRG00000002215","coproporphyrinogen oxidase [Source:HGNC Symbol;Acc:HGNC:2321]","GO:0004109(coproporphyrinogen oxidase activity);GO:0005212(structural constituent of eye lens);GO:0005739(mitochondrion);GO:0006779(porphyrin-containing compound biosynthetic process);GO:0006783(heme biosynthetic process);GO:0016020(membrane);GO:0055114(oxidation-reduction process)","00860(Porphyrin and chlorophyll metabolism)",{"v":2.4e-05,"d":"0.00"},1,"447,",0,-4.62,-3.92,8.02,"Exon (ENSBGRT00000004158/ENSBGRG00000002215, exon 1 of 7)",1,46129945,46144327,14383,2]
["chr1",46381540,46383005,1466,"ENSBGRG00000002387","ENSBGRT00000004632",86243,"DCBLD2","discoidin, CUB and LCCL domain containing 2 [Source:HGNC Symbol;Acc:HGNC:24627]","GO:0005887(integral component of plasma membrane);GO:0009986(cell surface);GO:0030308(negative regulation of cell growth);GO:0042060(wound healing)","NA",{"v":3.2e-32,"d":"0.00"},2,"791,15,","0,1451",{"v":-31.5,"d":"-31.50"},{"v":-30.3,"d":"-30.30"},5.28,"3' UTR",1,46380795,46469248,88454,2]
["chr1",47458319,47469799,11481,"ENSBGRG00000002638","ENSBGRT00000005020",0,"CMSS1","cms1 ribosomal small subunit homolog [Source:HGNC Symbol;Acc:HGNC:28666]","NA","NA",{"v":1.5E-3,"d":"0.00"},2,"43,138,","0,11343",-2.81,-2.19,2.37,"Exon (ENSBGRT00000005020/ENSBGRG00000002638, exon 1 of 10)",1,47458372,47898402,440031,1]
["chr1",47481309,47488669,7361,"ENSBGRG00000002590","ENSBGRT00000004850",104675,"FILIP1L","filamin A interacting protein 1 like [Source:HGNC Symbol;Acc:HGNC:24589]","NA","NA",{"v":2.6E-7,"d":"0.00"},2,"328,453,","0,6908",-6.58,-5.81,1.91,"3' UTR",1,47458229,47593344,135116,2]
["chr1",47489089,47581703,92615,"ENSBGRG00000002590","ENSBGRT00000004850",11641,"FILIP1L","filamin A interacting protein 1 like [Source:HGNC Symbol;Acc:HGNC:24589]","NA","NA",{"v":1E-204,"d":"0.00"},3,"1467,437,16,","0,1925,92599",-204,-202,6.15,"Exon (ENSBGRT00000004850/ENSBGRG00000002590, exon 3 of 7)",1,47458229,47593344,135116,2]
["chr1",48088685,48088924,240,"ENSBGRG00000002944","ENSBGRT00000005529",38139,"TOMM70","translocase of outer mitochondrial membrane 70 [Source:HGNC Symbol;Acc:HGNC:11985]","GO:0005515(protein binding);GO:0005739(mitochondrion)","NA",{"v":1E-35,"d":"0.00"},1,"240,",0,-35,{"v":-33.7,"d":"-33.70"},2.21,"3' UTR",1,48088685,48127063,38379,2]
["chr1",49314756,49314995,240,"ENSBGRG00000003382","ENSBGRT00000006328",66648,"IMPG2","interphotoreceptor matrix proteoglycan 2 [Source:HGNC Symbol;Acc:HGNC:18362]","GO:0005201(extracellular matrix structural constituent);GO:0005540(hyaluronic acid binding);GO:0007601(visual perception);GO:0008201(heparin binding);GO:0033165(interphotoreceptor matrix);GO:0043235(receptor complex)","NA",{"v":0.0022,"d":"0.00"},1,"240,",0,-2.66,-2.06,5.35,"Exon (ENSBGRT00000006328/ENSBGRG00000003382, exon 14 of 20)",1,49292342,49381643,89302,2]
["chr1",49315264,49315357,94,"ENSBGRG00000003382","ENSBGRT00000006328",66286,"IMPG2","interphotoreceptor matrix proteoglycan 2 [Source:HGNC Symbol;Acc:HGNC:18362]","GO:0005201(extracellular matrix structural constituent);GO:0005540(hyaluronic acid binding);GO:0007601(visual perception);GO:0008201(heparin binding);GO:0033165(interphotoreceptor matrix);GO:0043235(receptor complex)","NA",{"v":0.013,"d":"0.01"},2,"35,26,","0,68",-1.88,-1.34,3.21,"Exon (ENSBGRT00000006328/ENSBGRG00000003382, exon 13 of 20)",1,49292342,49381643,89302,2]
["chr1",49433942,49439607,5666,"ENSBGRG00000003455","ENSBGRT00000006822",73324,"SENP7","SUMO specific peptidase 7 [Source:HGNC Symbol;Acc:HGNC:30402]","GO:0005634(nucleus);GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity)","NA",{"v":0.048,"d":"0.05"},2,"114,125,","0,5541",-1.32,{"v":-0.827,"d":"-0.83"},3.51,"Exon (ENSBGRT00000006822/ENSBGRG00000003455, exon 4 of 20)",1,49384551,49512931,128381,2]
["chr1",49518623,49543327,24705,"ENSBGRG00000003455","ENSBGRT00000006748",0,"SENP7","SUMO specific peptidase 7 [Source:HGNC Symbol;Acc:HGNC:30402]","GO:0005634(nucleus);GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity)","NA",0.03,2,"4,86,","0,24619",-1.52,-1,2.23,"5' UTR",1,49384551,49543327,158777,2]
["chr1",49611692,49612844,1153,"ENSBGRG00000003762","ENSBGRT00000006964",29193,"ZBTB11","zinc finger and BTB domain containing 11 [Source:HGNC Symbol;Acc:HGNC:16740]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm)","NA",{"v":6.3e-88,"d":"0.00"},2,"518,49,","0,1104",{"v":-87.2,"d":"-87.20"},{"v":-85.5,"d":"-85.50"},6.63,"Exon (ENSBGRT00000006964/ENSBGRG00000003762, exon 10 of 11)",1,49611692,49642037,30346,2]
["chr1",49621351,49622509,1159,"ENSBGRG00000003762","ENSBGRT00000006964",19528,"ZBTB11","zinc finger and BTB domain containing 11 [Source:HGNC Symbol;Acc:HGNC:16740]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm)","NA",{"v":4e-24,"d":"0.00"},2,"142,813,","0,346",{"v":-23.4,"d":"-23.40"},{"v":-22.3,"d":"-22.30"},6.91,"Exon (ENSBGRT00000006964/ENSBGRG00000003762, exon 4 of 11)",1,49611692,49642037,30346,2]
["chr1",49629836,49630829,994,"ENSBGRG00000003762","ENSBGRT00000006964",11208,"ZBTB11","zinc finger and BTB domain containing 11 [Source:HGNC Symbol;Acc:HGNC:16740]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm)","NA",{"v":0.012,"d":"0.01"},2,"51,129,","0,865",-1.92,-1.37,1.83,"Exon (ENSBGRT00000006964/ENSBGRG00000003762, exon 2 of 11)",1,49611692,49642037,30346,2]
["chr1",49641888,49642007,120,"ENSBGRG00000003762","ENSBGRT00000006964",30,"ZBTB11","zinc finger and BTB domain containing 11 [Source:HGNC Symbol;Acc:HGNC:16740]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm)","NA",{"v":0.0054,"d":"0.01"},1,"120,",0,-2.27,-1.69,2.19,"Exon (ENSBGRT00000006964/ENSBGRG00000003762, exon 1 of 11)",1,49611692,49642037,30346,2]
["chr1",49646404,49647088,685,"ENSBGRG00000003803","ENSBGRT00000007147",7900,"RPL24","ribosomal protein L24 [Source:HGNC Symbol;Acc:HGNC:10325]","GO:0000027(ribosomal large subunit assembly);GO:0002181(cytoplasmic translation);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006412(translation);GO:0007093(mitotic cell cycle checkpoint);GO:0010458(exit from mitosis);GO:0021554(optic nerve development);GO:0022625(cytosolic large ribosomal subunit);GO:0031290(retinal ganglion cell axon guidance);GO:0042788(polysomal ribosome);GO:0060041(retina development in camera-type eye)","03010(Ribosome)",{"v":2E-19,"d":"0.00"},2,"81,8,","0,677",{"v":-18.7,"d":"-18.70"},{"v":-17.7,"d":"-17.70"},2.43,"Exon (ENSBGRT00000007147/ENSBGRG00000003803, exon 6 of 6)",1,49646404,49654988,8585,2]
["chr1",49654226,49654828,603,"ENSBGRG00000003803","ENSBGRT00000007147",160,"RPL24","ribosomal protein L24 [Source:HGNC Symbol;Acc:HGNC:10325]","GO:0000027(ribosomal large subunit assembly);GO:0002181(cytoplasmic translation);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006412(translation);GO:0007093(mitotic cell cycle checkpoint);GO:0010458(exit from mitosis);GO:0021554(optic nerve development);GO:0022625(cytosolic large ribosomal subunit);GO:0031290(retinal ganglion cell axon guidance);GO:0042788(polysomal ribosome);GO:0060041(retina development in camera-type eye)","03010(Ribosome)",{"v":2.5e-44,"d":"0.00"},2,"37,52,","0,551",{"v":-43.6,"d":"-43.60"},{"v":-42.3,"d":"-42.30"},{"v":1.3,"d":"1.30"},"Exon (ENSBGRT00000007147/ENSBGRG00000003803, exon 2 of 6)",1,49646404,49654988,8585,2]
["chr1",54264345,54277194,12850,"ENSBGRG00000004626","ENSBGRT00000008595",228609,"CBLB","Cbl proto-oncogene B [Source:HGNC Symbol;Acc:HGNC:1542]","GO:0001784(phosphotyrosine residue binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005509(calcium ion binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0007166(cell surface receptor signaling pathway);GO:0023051(regulation of signaling)","04120(Ubiquitin mediated proteolysis);04012(ErbB signaling pathway);04144(Endocytosis);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04910(Insulin signaling pathway);05162(Measles)",{"v":5e-41,"d":"0.00"},2,"510,1,","0,12849",{"v":-40.3,"d":"-40.30"},{"v":-39.1,"d":"-39.10"},5.35,"3' UTR",1,54263595,54505803,242209,2]
["chr1",56949662,56949812,151,"ENSBGRG00000005454","ENSBGRT00000010045",75535,"CD47","CD47 molecule [Source:HGNC Symbol;Acc:HGNC:1682]","GO:0005887(integral component of plasma membrane);GO:0008228(opsonization);GO:0008284(positive regulation of cell population proliferation);GO:0009617(response to bacterium);GO:0009986(cell surface);GO:0022409(positive regulation of cell-cell adhesion);GO:0032649(regulation of interferon-gamma production);GO:0032653(regulation of interleukin-10 production);GO:0032655(regulation of interleukin-12 production);GO:0032675(regulation of interleukin-6 production);GO:0032680(regulation of tumor necrosis factor production);GO:0045428(regulation of nitric oxide biosynthetic process);GO:0050729(positive regulation of inflammatory response);GO:0050766(positive regulation of phagocytosis);GO:0050870(positive regulation of T cell activation);GO:0070053(thrombospondin receptor activity);GO:0070062(extracellular exosome);GO:0071349(cellular response to interleukin-12);GO:0098632(cell-cell adhesion mediator activity)","04512(ECM-receptor interaction)",{"v":0.0024,"d":"0.00"},1,"151,",0,-2.62,-2.02,1.54,"3' UTR",1,56949662,57025347,75686,2]
["chr1",57133866,57139564,5699,"ENSBGRG00000005675","ENSBGRT00000010496",71600,"IFT57","intraflagellar transport 57 [Source:HGNC Symbol;Acc:HGNC:17367]","GO:0001843(neural tube closure);GO:0001947(heart looping);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005929(cilium);GO:0005930(axoneme);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0007224(smoothened signaling pathway);GO:0030992(intraciliary transport particle B);GO:0032391(photoreceptor connecting cilium);GO:0036064(ciliary basal body);GO:0042981(regulation of apoptotic process);GO:0044292(dendrite terminus);GO:0044458(motile cilium assembly);GO:0050680(negative regulation of epithelial cell proliferation);GO:0060972(left/right pattern formation);GO:1905515(non-motile cilium assembly)","05016(Huntington disease)",{"v":1.6e-74,"d":"0.00"},4,"388,67,63,50,","0,1435,4272,5649",{"v":-73.8,"d":"-73.80"},{"v":-72.2,"d":"-72.20"},4.23,"3' UTR",1,57133866,57211164,77299,2]
["chr1",57210507,57210657,151,"ENSBGRG00000005675","ENSBGRT00000010496",507,"IFT57","intraflagellar transport 57 [Source:HGNC Symbol;Acc:HGNC:17367]","GO:0001843(neural tube closure);GO:0001947(heart looping);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005929(cilium);GO:0005930(axoneme);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0007224(smoothened signaling pathway);GO:0030992(intraciliary transport particle B);GO:0032391(photoreceptor connecting cilium);GO:0036064(ciliary basal body);GO:0042981(regulation of apoptotic process);GO:0044292(dendrite terminus);GO:0044458(motile cilium assembly);GO:0050680(negative regulation of epithelial cell proliferation);GO:0060972(left/right pattern formation);GO:1905515(non-motile cilium assembly)","05016(Huntington disease)",{"v":0.00021,"d":"0.00"},1,"151,",0,-3.68,-3.01,2.15,"5' UTR",1,57133866,57211164,77299,2]
["chr1",57586883,57589612,2730,"ENSBGRG00000005873","ENSBGRT00000011198",27793,"CIP2A","cell proliferation regulating inhibitor of protein phosphatase 2A [Source:HGNC Symbol;Acc:HGNC:29302]","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007283(spermatogenesis);GO:0042803(protein homodimerization activity);GO:2000179(positive regulation of neural precursor cell proliferation)","NA",{"v":1.5E-9,"d":"0.00"},4,"52,140,83,52,","0,1264,2355,2678",-8.81,-7.98,3.25,"Exon (ENSBGRT00000011198/ENSBGRG00000005873, exon 18 of 21)",1,57586764,57617405,30642,2]
["chr1",61922447,61922626,180,"ENSBGRG00000000674","ENSBGRT00000001264",41875,"ATG3","autophagy related 3 [Source:HGNC Symbol;Acc:HGNC:20962]","GO:0000045(autophagosome assembly);GO:0000153(cytoplasmic ubiquitin ligase complex);GO:0005829(cytosol);GO:0006464(cellular protein modification process);GO:0016236(macroautophagy);GO:0016567(protein ubiquitination);GO:0019776(Atg8 ligase activity);GO:0019777(Atg12 transferase activity);GO:0019787(ubiquitin-like protein transferase activity);GO:0019899(enzyme binding);GO:0043653(mitochondrial fragmentation involved in apoptotic process);GO:0050765(negative regulation of phagocytosis);GO:1902017(regulation of cilium assembly)","04140(Autophagy - animal);04136(Autophagy - other eukaryotes);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":2.5e-06,"d":"0.00"},1,"180,",0,-5.61,-4.87,2.03,"3' UTR",1,61922447,61964501,42055,2]
["chr1",61927801,61953177,25377,"ENSBGRG00000000674","ENSBGRT00000001264",11324,"ATG3","autophagy related 3 [Source:HGNC Symbol;Acc:HGNC:20962]","GO:0000045(autophagosome assembly);GO:0000153(cytoplasmic ubiquitin ligase complex);GO:0005829(cytosol);GO:0006464(cellular protein modification process);GO:0016236(macroautophagy);GO:0016567(protein ubiquitination);GO:0019776(Atg8 ligase activity);GO:0019777(Atg12 transferase activity);GO:0019787(ubiquitin-like protein transferase activity);GO:0019899(enzyme binding);GO:0043653(mitochondrial fragmentation involved in apoptotic process);GO:0050765(negative regulation of phagocytosis);GO:1902017(regulation of cilium assembly)","04140(Autophagy - animal);04136(Autophagy - other eukaryotes);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":1.6E-15,"d":"0.00"},5,"3,82,50,108,26,","0,4005,6160,8896,25351",{"v":-14.8,"d":"-14.80"},{"v":-13.9,"d":"-13.90"},1.96,"Exon (ENSBGRT00000001264/ENSBGRG00000000674, exon 4 of 12)",1,61922447,61964501,42055,2]
["chr1",62036998,62037684,687,"ENSBGRG00000000776","ENSBGRT00000001429",1194,"CCDC80","coiled-coil domain containing 80 [Source:HGNC Symbol;Acc:HGNC:30649]","GO:0001968(fibronectin binding);GO:0005539(glycosaminoglycan binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0008201(heparin binding);GO:0009617(response to bacterium);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)","NA",{"v":9.99999999999998e-283,"d":"0.00"},1,"687,",0,-282,-280,3.34,"Exon (ENSBGRT00000001429/ENSBGRG00000000776, exon 2 of 8)",1,62002733,62038878,36146,2]
["chr1",62037863,62038697,835,"ENSBGRG00000000776","ENSBGRT00000001429",181,"CCDC80","coiled-coil domain containing 80 [Source:HGNC Symbol;Acc:HGNC:30649]","GO:0001968(fibronectin binding);GO:0005539(glycosaminoglycan binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0008201(heparin binding);GO:0009617(response to bacterium);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)","NA",{"v":1.6e-63,"d":"0.00"},1,"835,",0,{"v":-62.8,"d":"-62.80"},{"v":-61.3,"d":"-61.30"},5.67,"Exon (ENSBGRT00000001429/ENSBGRG00000000776, exon 2 of 8)",1,62002733,62038878,36146,2]
["chr1",62038878,62039528,651,"ENSBGRG00000000776","ENSBGRT00000001429",0,"CCDC80","coiled-coil domain containing 80 [Source:HGNC Symbol;Acc:HGNC:30649]","GO:0001968(fibronectin binding);GO:0005539(glycosaminoglycan binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0008201(heparin binding);GO:0009617(response to bacterium);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)","NA",{"v":3.5E-4,"d":"0.00"},2,"1,179,","0,472",-3.45,-2.79,8.52,"Exon (ENSBGRT00000001429/ENSBGRG00000000776, exon 1 of 8)",1,62002733,62038878,36146,2]
["chr1",62039587,62113777,74191,"ENSBGRG00000000776","ENSBGRT00000001411",0,"CCDC80","coiled-coil domain containing 80 [Source:HGNC Symbol;Acc:HGNC:30649]","GO:0001968(fibronectin binding);GO:0005539(glycosaminoglycan binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0008201(heparin binding);GO:0009617(response to bacterium);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)","NA",{"v":7.9e-31,"d":"0.00"},2,"468,40,","0,74151",{"v":-30.1,"d":"-30.10"},-29,{"v":12.5,"d":"12.50"},"Exon (ENSBGRT00000001411/ENSBGRG00000000776, exon 1 of 9)",1,62002733,62113777,111045,2]
["chr1",62372037,62372455,419,"ENSBGRG00000000866","ENSBGRT00000001624",18259,"GTPBP8","GTP binding protein 8 (putative) [Source:HGNC Symbol;Acc:HGNC:25007]","GO:0005525(GTP binding);GO:0005739(mitochondrion)","04146(Peroxisome)",{"v":7.9e-79,"d":"0.00"},1,"419,",0,{"v":-78.1,"d":"-78.10"},{"v":-76.5,"d":"-76.50"},10,"3' UTR",1,62353778,62374443,20666,1]
["chr1",62378261,62378350,90,"ENSBGRG00000000919","ENSBGRT00000001714",8692,"NEPRO","nucleolus and neural progenitor protein [Source:HGNC Symbol;Acc:HGNC:24496]","GO:0005634(nucleus);GO:0005730(nucleolus);GO:0045665(negative regulation of neuron differentiation);GO:0045747(positive regulation of Notch signaling pathway)","NA",{"v":0.014,"d":"0.01"},1,"90,",0,-1.86,-1.31,1.53,"Exon (ENSBGRT00000001714/ENSBGRG00000000919, exon 6 of 9)",1,62371888,62387042,15155,2]
["chr1",62763321,62769640,6320,"ENSBGRG00000001051","ENSBGRT00000001942",68201,"CFAP44","cilia and flagella associated protein 44 [Source:HGNC Symbol;Acc:HGNC:25631]","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0007288(sperm axoneme assembly);GO:0008233(peptidase activity);GO:0030317(flagellated sperm motility)","NA",{"v":1e-05,"d":"0.00"},4,"13,178,175,83,","0,2714,3039,6237",-4.99,-4.27,{"v":20.1,"d":"20.10"},"Exon (ENSBGRT00000001942/ENSBGRG00000001051, exon 22 of 35)",1,62711066,62837841,126776,2]
["chr1",62859482,62859902,421,"ENSBGRG00000001108","ENSBGRT00000002134",47338,"ENSBGRG00000001108","NA","GO:0090307(mitotic spindle assembly)","NA",{"v":6.3E-7,"d":"0.00"},1,"421,",0,{"v":-6.2,"d":"-6.20"},-5.43,4.21,"Exon (ENSBGRT00000002134/ENSBGRG00000001108, exon 14 of 18)",1,62847974,62907240,59267,2]
["chr1",63068151,63068271,121,"ENSBGRG00000001394","ENSBGRT00000002549",19958,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":0.0022,"d":"0.00"},1,"121,",0,-2.65,-2.05,2.41,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 5 of 5)",1,63067523,63088229,20707,2]
["chr1",63069378,63069557,180,"ENSBGRG00000001394","ENSBGRT00000002549",18672,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":0.0026,"d":"0.00"},1,"180,",0,-2.59,-1.99,3.29,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 5 of 5)",1,63067523,63088229,20707,2]
["chr1",63070126,63070455,330,"ENSBGRG00000001394","ENSBGRT00000002549",17774,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":0.0058,"d":"0.01"},1,"330,",0,-2.24,-1.66,4.01,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 5 of 5)",1,63067523,63088229,20707,2]
["chr1",63072288,63072408,121,"ENSBGRG00000001394","ENSBGRT00000002549",15821,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":0.0032,"d":"0.00"},1,"121,",0,{"v":-2.5,"d":"-2.50"},-1.91,11,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 4 of 5)",1,63067523,63088229,20707,2]
["chr1",63072677,63073006,330,"ENSBGRG00000001394","ENSBGRT00000002549",15223,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":2.8e-06,"d":"0.00"},1,"330,",0,-5.56,-4.82,{"v":22.1,"d":"22.10"},"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 4 of 5)",1,63067523,63088229,20707,2]
["chr1",63074786,63074846,61,"ENSBGRG00000001394","ENSBGRT00000002549",13383,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":0.019,"d":"0.02"},1,"61,",0,-1.72,-1.19,5.01,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 3 of 5)",1,63067523,63088229,20707,2]
["chr1",63136585,63137495,911,"ENSBGRG00000001410","ENSBGRT00000002646",30424,"ENSBGRG00000001410","NA","GO:0008080(N-acetyltransferase activity)","NA",{"v":3.2e-12,"d":"0.00"},2,"148,63,","0,848",{"v":-11.5,"d":"-11.50"},{"v":-10.6,"d":"-10.60"},2.66,"Exon (ENSBGRT00000002646/ENSBGRG00000001410, exon 4 of 5)",1,63136555,63167919,31365,2]
["chr1",63392930,63432415,39486,"ENSBGRG00000001705","ENSBGRT00000003162",70636,"CCDC191","coiled-coil domain containing 191 [Source:HGNC Symbol;Acc:HGNC:29272]","NA","NA",{"v":0.032,"d":"0.03"},7,"42,146,146,153,144,144,3,","0,13076,13897,14562,19239,20299,39483",-1.49,{"v":-0.978,"d":"-0.98"},4.51,"Exon (ENSBGRT00000003162/ENSBGRG00000001705, exon 13 of 17)",1,63392571,63503051,110481,2]
["chr1",63448964,63481164,32201,"ENSBGRG00000001705","ENSBGRT00000003162",21887,"CCDC191","coiled-coil domain containing 191 [Source:HGNC Symbol;Acc:HGNC:29272]","NA","NA",{"v":1.5E-3,"d":"0.00"},4,"213,191,151,193,","0,9354,28861,32008",-2.82,{"v":-2.2,"d":"-2.20"},4.51,"Exon (ENSBGRT00000003162/ENSBGRG00000001705, exon 6 of 17)",1,63392571,63503051,110481,2]
["chr1",63774174,63774861,688,"ENSBGRG00000001895","ENSBGRT00000003570",50482,"ZBTB20","zinc finger and BTB domain containing 20 [Source:HGNC Symbol;Acc:HGNC:13503]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010629(negative regulation of gene expression);GO:0032728(positive regulation of interferon-beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0045821(positive regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046889(positive regulation of lipid biosynthetic process);GO:0055088(lipid homeostasis);GO:0071333(cellular response to glucose stimulus)","NA",{"v":7.1e-05,"d":"0.00"},1,"688,",0,-4.15,-3.46,17,"3' UTR",1,63774174,63825343,51170,2]
["chr1",63775099,63775308,210,"ENSBGRG00000001895","ENSBGRT00000003570",50035,"ZBTB20","zinc finger and BTB domain containing 20 [Source:HGNC Symbol;Acc:HGNC:13503]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010629(negative regulation of gene expression);GO:0032728(positive regulation of interferon-beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0045821(positive regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046889(positive regulation of lipid biosynthetic process);GO:0055088(lipid homeostasis);GO:0071333(cellular response to glucose stimulus)","NA",{"v":0.019,"d":"0.02"},1,"210,",0,-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000003570/ENSBGRG00000001895, exon 4 of 4)",1,63774174,63825343,51170,2]
["chr1",63788174,63788741,568,"ENSBGRG00000001895","ENSBGRT00000003570",36602,"ZBTB20","zinc finger and BTB domain containing 20 [Source:HGNC Symbol;Acc:HGNC:13503]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010629(negative regulation of gene expression);GO:0032728(positive regulation of interferon-beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0045821(positive regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046889(positive regulation of lipid biosynthetic process);GO:0055088(lipid homeostasis);GO:0071333(cellular response to glucose stimulus)","NA",{"v":0.0058,"d":"0.01"},1,"568,",0,-2.24,-1.66,10,"Exon (ENSBGRT00000003570/ENSBGRG00000001895, exon 3 of 4)",1,63774174,63825343,51170,2]
["chr1",63789010,63789309,300,"ENSBGRG00000001895","ENSBGRT00000003570",36034,"ZBTB20","zinc finger and BTB domain containing 20 [Source:HGNC Symbol;Acc:HGNC:13503]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010629(negative regulation of gene expression);GO:0032728(positive regulation of interferon-beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0045821(positive regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046889(positive regulation of lipid biosynthetic process);GO:0055088(lipid homeostasis);GO:0071333(cellular response to glucose stimulus)","NA",{"v":2E-3,"d":"0.00"},1,"300,",0,-2.69,-2.08,8.02,"Exon (ENSBGRT00000003570/ENSBGRG00000001895, exon 3 of 4)",1,63774174,63825343,51170,2]
["chr1",65439877,65476765,36889,"ENSBGRG00000001944","ENSBGRT00000003701",735625,"LSAMP","limbic system associated membrane protein [Source:HGNC Symbol;Acc:HGNC:6705]","GO:0005829(cytosol)","NA",{"v":0.0068,"d":"0.01"},4,"98,33,36,10,","0,5665,26212,36879",-2.17,{"v":-1.6,"d":"-1.60"},6.02,"Exon (ENSBGRT00000003701/ENSBGRG00000001944, exon 6 of 9)",1,65439877,66212390,772514,2]
["chr1",69295492,69297396,1905,"ENSBGRG00000002166","ENSBGRT00000004041",31484,"B4GALT4","beta-1,4-galactosyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:927]","GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0016757(transferase activity, transferring glycosyl groups)","00533(Glycosaminoglycan biosynthesis - keratan sulfate);00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":4e-28,"d":"0.00"},2,"133,15,","0,1890",{"v":-27.4,"d":"-27.40"},{"v":-26.3,"d":"-26.30"},2.94,"Exon (ENSBGRT00000004041/ENSBGRG00000002166, exon 7 of 8)",1,69295492,69328880,33389,2]
["chr1",69314564,69328821,14258,"ENSBGRG00000002166","ENSBGRT00000004041",59,"B4GALT4","beta-1,4-galactosyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:927]","GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0016757(transferase activity, transferring glycosyl groups)","00533(Glycosaminoglycan biosynthesis - keratan sulfate);00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":4e-61,"d":"0.00"},3,"265,69,19,","0,11345,14239",{"v":-60.4,"d":"-60.40"},-59,3.15,"5' UTR",1,69295492,69328880,33389,2]
["chr1",69750054,69752045,1992,"ENSBGRG00000002369","ENSBGRT00000004421",0,"COX17","cytochrome c oxidase copper chaperone COX17 [Source:HGNC Symbol;Acc:HGNC:2264]","GO:0005507(copper ion binding);GO:0005737(cytoplasm);GO:0005758(mitochondrial intermembrane space);GO:0006825(copper ion transport);GO:0008284(positive regulation of cell population proliferation);GO:0016531(copper chaperone activity);GO:0033617(mitochondrial respiratory chain complex IV assembly);GO:1903136(cuprous ion binding);GO:1904960(positive regulation of cytochrome-c oxidase activity)","00190(Oxidative phosphorylation);04714(Thermogenesis)",{"v":1e-103,"d":"0.00"},2,"85,107,","0,1885",-103,-101,3.92,"Exon (ENSBGRT00000004421/ENSBGRG00000002369, exon 1 of 2)",1,69750054,69752045,1992,2]
["chr1",70208846,70225940,17095,"ENSBGRG00000002466","ENSBGRT00000004695",0,"GSK3B","glycogen synthase kinase 3 beta [Source:HGNC Symbol;Acc:HGNC:4617]","GO:0001085(RNA polymerase II transcription factor binding);GO:0001837(epithelial to mesenchymal transition);GO:0001954(positive regulation of cell-matrix adhesion);GO:0002020(protease binding);GO:0002039(p53 binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005886(plasma membrane);GO:0005977(glycogen metabolic process);GO:0006468(protein phosphorylation);GO:0006983(ER overload response);GO:0008013(beta-catenin binding);GO:0010822(positive regulation of mitochondrion organization);GO:0016301(kinase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0019901(protein kinase binding);GO:0021766(hippocampus development);GO:0030877(beta-catenin destruction complex);GO:0031175(neuron projection development);GO:0031333(negative regulation of protein-containing complex assembly);GO:0031334(positive regulation of protein-containing complex assembly);GO:0031625(ubiquitin protein ligase binding);GO:0032091(negative regulation of protein binding);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032886(regulation of microtubule-based process);GO:0034236(protein kinase A catalytic subunit binding);GO:0034452(dynactin binding);GO:0035556(intracellular signal transduction);GO:0043066(negative regulation of apoptotic process);GO:0043547(positive regulation of GTPase activity);GO:0046777(protein autophosphorylation);GO:0046827(positive regulation of protein export from nucleus);GO:0050321(tau-protein kinase activity);GO:0051059(NF-kappaB binding);GO:0070885(negative regulation of calcineurin-NFAT signaling cascade);GO:0071109(superior temporal gyrus development);GO:0098978(glutamatergic synapse);GO:0150101(regulation of microtubule anchoring at centrosome);GO:1901215(negative regulation of neuron death);GO:1901216(positive regulation of neuron death);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1904781(positive regulation of protein localization to centrosome);GO:2000300(regulation of synaptic vesicle exocytosis)","04012(ErbB signaling pathway);04310(Wnt signaling pathway);04340(Hedgehog signaling pathway);04390(Hippo signaling pathway);04151(PI3K-Akt signaling pathway);04150(mTOR signaling pathway);04110(Cell cycle);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04660(T cell receptor signaling pathway);04657(IL-17 signaling pathway);04662(B cell receptor signaling pathway);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04917(Prolactin signaling pathway);04919(Thyroid hormone signaling pathway);04916(Melanogenesis);04728(Dopaminergic synapse);04722(Neurotrophin signaling pathway);04360(Axon guidance);05200(Pathways in cancer);05210(Colorectal cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05010(Alzheimer disease);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04934(Cushing syndrome);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);01521(EGFR tyrosine kinase inhibitor resistance)",0.03,2,"62,28,","0,17067",-1.53,-1.02,1.67,"5' UTR",1,69993406,70208907,215502,2]
["chr1",70318805,70332339,13535,"ENSBGRG00000002541","ENSBGRT00000004762",75105,"GPR156","G protein-coupled receptor 156 [Source:HGNC Symbol;Acc:HGNC:20844]","GO:0004930(G protein-coupled receptor activity);GO:0004965(G protein-coupled GABA receptor activity);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","04080(Neuroactive ligand-receptor interaction)",{"v":1.5E-6,"d":"0.00"},2,"693,83,","0,13452",-5.83,-5.08,{"v":19.1,"d":"19.10"},"Exon (ENSBGRT00000004762/ENSBGRG00000002541, exon 8 of 10)",1,70318179,70407444,89266,2]
["chr1",70352604,70407444,54841,"ENSBGRG00000002541","ENSBGRT00000004762",0,"GPR156","G protein-coupled receptor 156 [Source:HGNC Symbol;Acc:HGNC:20844]","GO:0004930(G protein-coupled receptor activity);GO:0004965(G protein-coupled GABA receptor activity);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","04080(Neuroactive ligand-receptor interaction)",{"v":0.019,"d":"0.02"},3,"127,137,452,","0,54043,54389",-1.71,{"v":-0.901,"d":"-0.90"},8.02,"5' UTR",1,70318179,70407444,89266,2]
["chr1",70474763,70474971,209,"ENSBGRG00000002589","ENSBGRT00000004869",17566,"LRRC58","leucine rich repeat containing 58 [Source:HGNC Symbol;Acc:HGNC:26968]","GO:0005515(protein binding)","NA",{"v":0.0058,"d":"0.01"},1,"209,",0,-2.24,-1.66,10,"3' UTR",1,70474763,70492537,17775,2]
["chr1",70538857,70538976,120,"ENSBGRG00000002621","ENSBGRT00000005027",63073,"FSTL1","follistatin like 1 [Source:HGNC Symbol;Acc:HGNC:3972]","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0042594(response to starvation)","04512(ECM-receptor interaction)",{"v":3.5e-06,"d":"0.00"},1,"120,",0,-5.45,-4.71,2.58,"3' UTR",1,70538857,70602049,63193,2]
["chr1",71427952,71428162,211,"ENSBGRG00000002979","ENSBGRT00000005814",114101,"POLQ","DNA polymerase theta [Source:HGNC Symbol;Acc:HGNC:9186]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005524(ATP binding);GO:0006260(DNA replication);GO:0006261(DNA-dependent DNA replication);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006302(double-strand break repair);GO:0006974(cellular response to DNA damage stimulus);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0017116(single-stranded DNA helicase activity);GO:0051260(protein homooligomerization);GO:0051575(5'-deoxyribose-5-phosphate lyase activity);GO:0097681(double-strand break repair via alternative nonhomologous end joining);GO:2000042(negative regulation of double-strand break repair via homologous recombination)","NA",{"v":0.011,"d":"0.01"},1,"211,",0,-1.97,-1.14,9.03,"3' UTR",1,71412021,71542263,130243,2]
["chr1",71429424,71479441,50018,"ENSBGRG00000002979","ENSBGRT00000005814",62822,"POLQ","DNA polymerase theta [Source:HGNC Symbol;Acc:HGNC:9186]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005524(ATP binding);GO:0006260(DNA replication);GO:0006261(DNA-dependent DNA replication);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006302(double-strand break repair);GO:0006974(cellular response to DNA damage stimulus);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0017116(single-stranded DNA helicase activity);GO:0051260(protein homooligomerization);GO:0051575(5'-deoxyribose-5-phosphate lyase activity);GO:0097681(double-strand break repair via alternative nonhomologous end joining);GO:2000042(negative regulation of double-strand break repair via homologous recombination)","NA",{"v":0.019,"d":"0.02"},15,"24,154,125,112,185,185,119,127,175,138,194,241,197,144,190,","0,2361,10932,16652,22016,23236,25879,26635,29575,31067,33480,40295,44121,46924,49828",-1.72,-1.19,8.02,"Exon (ENSBGRT00000005814/ENSBGRG00000002979, exon 16 of 29)",1,71412021,71542263,130243,2]
["chr1",71479561,71480370,810,"ENSBGRG00000002979","ENSBGRT00000005814",61893,"POLQ","DNA polymerase theta [Source:HGNC Symbol;Acc:HGNC:9186]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005524(ATP binding);GO:0006260(DNA replication);GO:0006261(DNA-dependent DNA replication);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006302(double-strand break repair);GO:0006974(cellular response to DNA damage stimulus);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0017116(single-stranded DNA helicase activity);GO:0051260(protein homooligomerization);GO:0051575(5'-deoxyribose-5-phosphate lyase activity);GO:0097681(double-strand break repair via alternative nonhomologous end joining);GO:2000042(negative regulation of double-strand break repair via homologous recombination)","NA",{"v":0.035,"d":"0.04"},1,"810,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000005814/ENSBGRG00000002979, exon 16 of 29)",1,71412021,71542263,130243,2]
["chr1",71618091,71641812,23722,"ENSBGRG00000003280","ENSBGRT00000006163",9702,"HCLS1","hematopoietic cell-specific Lyn substrate 1 [Source:HGNC Symbol;Acc:HGNC:4844]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001085(RNA polymerase II transcription factor binding);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0008284(positive regulation of cell population proliferation);GO:0009725(response to hormone);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0017124(SH3 domain binding);GO:0019901(protein kinase binding);GO:0030041(actin filament polymerization);GO:0030218(erythrocyte differentiation);GO:0030833(regulation of actin filament polymerization);GO:0030854(positive regulation of granulocyte differentiation);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0042307(positive regulation of protein import into nucleus);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0044877(protein-containing complex binding);GO:0045651(positive regulation of macrophage differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051897(positive regulation of protein kinase B signaling);GO:0071345(cellular response to cytokine stimulus);GO:2000107(negative regulation of leukocyte apoptotic process)","04530(Tight junction);05205(Proteoglycans in cancer);05100(Bacterial invasion of epithelial cells)",{"v":1.9E-3,"d":"0.00"},9,"121,105,212,70,56,111,55,111,27,","0,630,1150,1954,2635,3543,16842,18704,23695",-2.73,-2.12,4.51,"Exon (ENSBGRT00000006163/ENSBGRG00000003280, exon 3 of 13)",1,71617464,71651514,34051,2]
["chr1",71681231,71692525,11295,"ENSBGRG00000003446","ENSBGRT00000007938",36994,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":2e-89,"d":"0.00"},3,"10,1912,444,","0,8088,10851",{"v":-88.7,"d":"-88.70"},-87,6.77,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 14 of 23)",1,71662324,71729519,67196,2]
["chr1",71692585,71693812,1228,"ENSBGRG00000003446","ENSBGRT00000007938",35707,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":1.3e-44,"d":"0.00"},1,"1228,",0,{"v":-43.9,"d":"-43.90"},{"v":-42.6,"d":"-42.60"},7.24,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 14 of 23)",1,71662324,71729519,67196,2]
["chr1",71694440,71695548,1109,"ENSBGRG00000003446","ENSBGRT00000007938",33971,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":9.3e-07,"d":"0.00"},1,"1109,",0,-6.03,-5.27,10,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 14 of 23)",1,71662324,71729519,67196,2]
["chr1",71695787,71696416,630,"ENSBGRG00000003446","ENSBGRT00000007938",33103,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":0.035,"d":"0.04"},3,"256,32,312,","0,275,318",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 12 of 23)",1,71662324,71729519,67196,2]
["chr1",71696625,71696775,151,"ENSBGRG00000003446","ENSBGRT00000007938",32744,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":5.9e-05,"d":"0.00"},1,"151,",0,-4.23,-3.54,10,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 12 of 23)",1,71662324,71729519,67196,2]
["chr1",71697014,71697673,660,"ENSBGRG00000003446","ENSBGRT00000007938",31846,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":9.3e-06,"d":"0.00"},1,"660,",0,-5.03,-4.31,11,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 12 of 23)",1,71662324,71729519,67196,2]
["chr1",71698182,71701385,3204,"ENSBGRG00000003446","ENSBGRT00000007938",28134,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":0.0058,"d":"0.01"},2,"162,48,","0,3156",-2.24,-1.66,10,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 11 of 23)",1,71662324,71729519,67196,2]
["chr1",71762461,71762521,61,"ENSBGRG00000004390","ENSBGRT00000008070",47340,"IQCB1","IQ motif containing B1 [Source:HGNC Symbol;Acc:HGNC:28949]","GO:0001750(photoreceptor outer segment);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0015630(microtubule cytoskeleton);GO:0019899(enzyme binding);GO:0032391(photoreceptor connecting cilium);GO:0045171(intercellular bridge);GO:0045494(photoreceptor cell maintenance);GO:0048496(maintenance of animal organ identity);GO:0060271(cilium assembly);GO:0072686(mitotic spindle)","NA",{"v":1.4E-5,"d":"0.00"},2,"2,58,","0,3",-4.86,-4.14,6.52,"Exon (ENSBGRT00000008070/ENSBGRG00000004390, exon 15 of 16)",1,71762461,71809861,47401,2]
["chr1",71776718,71778477,1760,"ENSBGRG00000004390","ENSBGRT00000008070",31384,"IQCB1","IQ motif containing B1 [Source:HGNC Symbol;Acc:HGNC:28949]","GO:0001750(photoreceptor outer segment);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0015630(microtubule cytoskeleton);GO:0019899(enzyme binding);GO:0032391(photoreceptor connecting cilium);GO:0045171(intercellular bridge);GO:0045494(photoreceptor cell maintenance);GO:0048496(maintenance of animal organ identity);GO:0060271(cilium assembly);GO:0072686(mitotic spindle)","NA",{"v":0.0087,"d":"0.01"},2,"10,139,","0,1621",-2.06,{"v":-1.5,"d":"-1.50"},1.42,"Exon (ENSBGRT00000008070/ENSBGRG00000004390, exon 10 of 16)",1,71762461,71809861,47401,2]
["chr1",71804590,71809802,5213,"ENSBGRG00000004390","ENSBGRT00000008070",59,"IQCB1","IQ motif containing B1 [Source:HGNC Symbol;Acc:HGNC:28949]","GO:0001750(photoreceptor outer segment);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0015630(microtubule cytoskeleton);GO:0019899(enzyme binding);GO:0032391(photoreceptor connecting cilium);GO:0045171(intercellular bridge);GO:0045494(photoreceptor cell maintenance);GO:0048496(maintenance of animal organ identity);GO:0060271(cilium assembly);GO:0072686(mitotic spindle)","NA",{"v":0.037,"d":"0.04"},2,"51,40,","0,5173",-1.43,{"v":-0.919,"d":"-0.92"},1.63,"5' UTR",1,71762461,71809861,47401,2]
["chr1",72311283,72313823,2541,"ENSBGRG00000004919","ENSBGRT00000009157",19209,"CCDC58","coiled-coil domain containing 58 [Source:HGNC Symbol;Acc:HGNC:31136]","NA","NA",{"v":8.3e-05,"d":"0.00"},2,"51,215,","0,2326",-4.08,-3.39,3.38,"3' UTR",1,72311283,72333032,21750,2]
["chr1",72384145,72385137,993,"ENSBGRG00000007190","ENSBGRT00000013200",0,"WDR5B","WD repeat domain 5B [Source:HGNC Symbol;Acc:HGNC:17826]","GO:0005515(protein binding)","04934(Cushing syndrome)",{"v":4e-42,"d":"0.00"},1,"993,",0,{"v":-41.4,"d":"-41.40"},{"v":-40.1,"d":"-40.10"},11,"Exon (ENSBGRT00000013200/ENSBGRG00000007190, exon 1 of 1)",1,72384145,72385137,993,2]
["chr1",72440562,72440682,121,"ENSBGRG00000007217","ENSBGRT00000013286",0,"KPNA1","karyopherin subunit alpha 1 [Source:HGNC Symbol;Acc:HGNC:6394]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006606(protein import into nucleus);GO:0042025(host cell nucleus);GO:0061608(nuclear import signal receptor activity);GO:0098978(glutamatergic synapse);GO:0099527(postsynapse to nucleus signaling pathway)","05164(Influenza A)",{"v":0.046,"d":"0.05"},1,"121,",0,-1.34,{"v":-0.841,"d":"-0.84"},2.29,"5' UTR",1,72396619,72440682,44064,2]
["chr1",72485102,72485281,180,"ENSBGRG00000007330","ENSBGRT00000013561",33517,"PARP9","poly(ADP-ribose) polymerase family member 9 [Source:HGNC Symbol;Acc:HGNC:24118]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002230(positive regulation of defense response to virus by host);GO:0003714(transcription corepressor activity);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0004857(enzyme inhibitor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006302(double-strand break repair);GO:0006471(protein ADP-ribosylation);GO:0010608(posttranscriptional regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0032991(protein-containing complex);GO:0035563(positive regulation of chromatin binding);GO:0042393(histone binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0043086(negative regulation of catalytic activity);GO:0044389(ubiquitin-like protein ligase binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060330(regulation of response to interferon-gamma);GO:0060335(positive regulation of interferon-gamma-mediated signaling pathway);GO:0072570(ADP-D-ribose binding);GO:0090734(site of DNA damage);GO:0097677(STAT family protein binding);GO:1900182(positive regulation of protein localization to nucleus);GO:2001034(positive regulation of double-strand break repair via nonhomologous end joining)","NA",{"v":5e-11,"d":"0.00"},1,"180,",0,{"v":-10.3,"d":"-10.30"},-9.42,1.83,"Exon (ENSBGRT00000013561/ENSBGRG00000007330, exon 11 of 11)",1,72485102,72518798,33697,2]
["chr1",72492093,72495891,3799,"ENSBGRG00000007330","ENSBGRT00000013561",22907,"PARP9","poly(ADP-ribose) polymerase family member 9 [Source:HGNC Symbol;Acc:HGNC:24118]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002230(positive regulation of defense response to virus by host);GO:0003714(transcription corepressor activity);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0004857(enzyme inhibitor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006302(double-strand break repair);GO:0006471(protein ADP-ribosylation);GO:0010608(posttranscriptional regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0032991(protein-containing complex);GO:0035563(positive regulation of chromatin binding);GO:0042393(histone binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0043086(negative regulation of catalytic activity);GO:0044389(ubiquitin-like protein ligase binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060330(regulation of response to interferon-gamma);GO:0060335(positive regulation of interferon-gamma-mediated signaling pathway);GO:0072570(ADP-D-ribose binding);GO:0090734(site of DNA damage);GO:0097677(STAT family protein binding);GO:1900182(positive regulation of protein localization to nucleus);GO:2001034(positive regulation of double-strand break repair via nonhomologous end joining)","NA",{"v":2.5e-26,"d":"0.00"},2,"86,333,","0,3466",{"v":-25.6,"d":"-25.60"},{"v":-24.5,"d":"-24.50"},2.55,"Exon (ENSBGRT00000013561/ENSBGRG00000007330, exon 8 of 11)",1,72485102,72518798,33697,2]
["chr1",72505485,72508978,3494,"ENSBGRG00000007330","ENSBGRT00000013561",9820,"PARP9","poly(ADP-ribose) polymerase family member 9 [Source:HGNC Symbol;Acc:HGNC:24118]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002230(positive regulation of defense response to virus by host);GO:0003714(transcription corepressor activity);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0004857(enzyme inhibitor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006302(double-strand break repair);GO:0006471(protein ADP-ribosylation);GO:0010608(posttranscriptional regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0032991(protein-containing complex);GO:0035563(positive regulation of chromatin binding);GO:0042393(histone binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0043086(negative regulation of catalytic activity);GO:0044389(ubiquitin-like protein ligase binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060330(regulation of response to interferon-gamma);GO:0060335(positive regulation of interferon-gamma-mediated signaling pathway);GO:0072570(ADP-D-ribose binding);GO:0090734(site of DNA damage);GO:0097677(STAT family protein binding);GO:1900182(positive regulation of protein localization to nucleus);GO:2001034(positive regulation of double-strand break repair via nonhomologous end joining)","NA",{"v":2.5e-85,"d":"0.00"},2,"5,802,","0,2692",{"v":-84.6,"d":"-84.60"},{"v":-82.9,"d":"-82.90"},6.24,"Exon (ENSBGRT00000013561/ENSBGRG00000007330, exon 4 of 11)",1,72485102,72518798,33697,2]
["chr1",72510875,72518683,7809,"ENSBGRG00000007330","ENSBGRT00000013561",115,"PARP9","poly(ADP-ribose) polymerase family member 9 [Source:HGNC Symbol;Acc:HGNC:24118]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002230(positive regulation of defense response to virus by host);GO:0003714(transcription corepressor activity);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0004857(enzyme inhibitor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006302(double-strand break repair);GO:0006471(protein ADP-ribosylation);GO:0010608(posttranscriptional regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0032991(protein-containing complex);GO:0035563(positive regulation of chromatin binding);GO:0042393(histone binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0043086(negative regulation of catalytic activity);GO:0044389(ubiquitin-like protein ligase binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060330(regulation of response to interferon-gamma);GO:0060335(positive regulation of interferon-gamma-mediated signaling pathway);GO:0072570(ADP-D-ribose binding);GO:0090734(site of DNA damage);GO:0097677(STAT family protein binding);GO:1900182(positive regulation of protein localization to nucleus);GO:2001034(positive regulation of double-strand break repair via nonhomologous end joining)","NA",{"v":9.3e-05,"d":"0.00"},3,"132,80,207,","0,1090,7602",-4.03,-3.35,2.12,"5' UTR",1,72485102,72518798,33697,2]
["chr1",72519136,72519315,180,"ENSBGRG00000007487","ENSBGRT00000013756",0,"ENSBGRG00000007487","NA","GO:0007219(Notch signaling pathway);GO:0016567(protein ubiquitination)","04330(Notch signaling pathway)",{"v":1E-3,"d":"0.00"},1,"180,",0,-2.98,-2.35,2.12,"Exon (ENSBGRT00000013756/ENSBGRG00000007487, exon 1 of 4)",1,72519301,72533190,13890,1]
["chr1",72611836,72612497,662,"ENSBGRG00000007624","ENSBGRT00000013952",63157,"HSPBAP1","HSPB1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16389]","NA","NA",{"v":5e-85,"d":"0.00"},2,"519,16,","0,646",{"v":-84.3,"d":"-84.30"},{"v":-82.6,"d":"-82.60"},9.67,"Exon (ENSBGRT00000013952/ENSBGRG00000007624, exon 7 of 8)",1,72611836,72675654,63819,2]
["chr1",73485641,73485791,151,"ENSBGRG00000008188","ENSBGRT00000015332",2938,"ADCY5","adenylate cyclase 5 [Source:HGNC Symbol;Acc:HGNC:236]","GO:0001973(G protein-coupled adenosine receptor signaling pathway);GO:0004016(adenylate cyclase activity);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0006171(cAMP biosynthetic process);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007191(adenylate cyclase-activating dopamine receptor signaling pathway);GO:0007195(adenylate cyclase-inhibiting dopamine receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007626(locomotory behavior);GO:0008179(adenylate cyclase binding);GO:0009190(cyclic nucleotide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016849(phosphorus-oxygen lyase activity);GO:0035556(intracellular signal transduction);GO:0045111(intermediate filament cytoskeleton);GO:0050885(neuromuscular process controlling balance);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0097110(scaffold protein binding);GO:1904322(cellular response to forskolin)","00230(Purine metabolism);04015(Rap1 signaling pathway);04371(Apelin signaling pathway);04072(Phospholipase D signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04114(Oocyte meiosis);04540(Gap junction);04611(Platelet activation);04062(Chemokine signaling pathway);04911(Insulin secretion);04923(Regulation of lipolysis in adipocyte);04912(GnRH signaling pathway);04913(Ovarian Steroidogenesis);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04918(Thyroid hormone synthesis);04928(Parathyroid hormone synthesis, secretion and action);04916(Melanogenesis);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);04724(Glutamatergic synapse);04727(GABAergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);04750(Inflammatory mediator regulation of TRP channels);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);04713(Circadian entrainment);04714(Thermogenesis);05200(Pathways in cancer);05012(Parkinson disease);05030(Cocaine addiction);05031(Amphetamine addiction);05032(Morphine addiction);05034(Alcoholism);05414(Dilated cardiomyopathy (DCM));04934(Cushing syndrome);05166(HTLV-I infection);05163(Human cytomegalovirus infection);01522(Endocrine resistance)",{"v":0.00015,"d":"0.00"},1,"151,",0,-3.82,-3.15,5.77,"Exon (ENSBGRT00000015332/ENSBGRG00000008188, exon 3 of 24)",1,73298495,73488729,190235,2]
["chr1",73486701,73488729,2029,"ENSBGRG00000008188","ENSBGRT00000015332",0,"ADCY5","adenylate cyclase 5 [Source:HGNC Symbol;Acc:HGNC:236]","GO:0001973(G protein-coupled adenosine receptor signaling pathway);GO:0004016(adenylate cyclase activity);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0006171(cAMP biosynthetic process);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007191(adenylate cyclase-activating dopamine receptor signaling pathway);GO:0007195(adenylate cyclase-inhibiting dopamine receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007626(locomotory behavior);GO:0008179(adenylate cyclase binding);GO:0009190(cyclic nucleotide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016849(phosphorus-oxygen lyase activity);GO:0035556(intracellular signal transduction);GO:0045111(intermediate filament cytoskeleton);GO:0050885(neuromuscular process controlling balance);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0097110(scaffold protein binding);GO:1904322(cellular response to forskolin)","00230(Purine metabolism);04015(Rap1 signaling pathway);04371(Apelin signaling pathway);04072(Phospholipase D signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04114(Oocyte meiosis);04540(Gap junction);04611(Platelet activation);04062(Chemokine signaling pathway);04911(Insulin secretion);04923(Regulation of lipolysis in adipocyte);04912(GnRH signaling pathway);04913(Ovarian Steroidogenesis);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04918(Thyroid hormone synthesis);04928(Parathyroid hormone synthesis, secretion and action);04916(Melanogenesis);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);04724(Glutamatergic synapse);04727(GABAergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);04750(Inflammatory mediator regulation of TRP channels);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);04713(Circadian entrainment);04714(Thermogenesis);05200(Pathways in cancer);05012(Parkinson disease);05030(Cocaine addiction);05031(Amphetamine addiction);05032(Morphine addiction);05034(Alcoholism);05414(Dilated cardiomyopathy (DCM));04934(Cushing syndrome);05166(HTLV-I infection);05163(Human cytomegalovirus infection);01522(Endocrine resistance)",{"v":7.4e-06,"d":"0.00"},2,"440,11,","0,2018",-5.13,-4.41,8.69,"Exon (ENSBGRT00000015332/ENSBGRG00000008188, exon 1 of 24)",1,73298495,73488729,190235,2]
["chr1",73636312,73636670,359,"ENSBGRG00000008479","ENSBGRT00000015416",0,"HACD2","3-hydroxyacyl-CoA dehydratase 2 [Source:HGNC Symbol;Acc:HGNC:9640]","GO:0005783(endoplasmic reticulum);GO:0018812(3-hydroxyacyl-CoA dehydratase activity);GO:0019899(enzyme binding);GO:0030148(sphingolipid biosynthetic process);GO:0030497(fatty acid elongation);GO:0042761(very long-chain fatty acid biosynthetic process)","00062(Fatty acid elongation);01040(Biosynthesis of unsaturated fatty acids)",{"v":2e-07,"d":"0.00"},1,"359,",0,{"v":-6.7,"d":"-6.70"},-5.92,{"v":10.7,"d":"10.70"},"Exon (ENSBGRT00000015416/ENSBGRG00000008479, exon 1 of 7)",1,73542390,73636670,94281,2]
["chr1",73669379,73669619,241,"ENSBGRG00000008571","ENSBGRT00000015698",323130,"MYLK","myosin light chain kinase [Source:HGNC Symbol;Acc:HGNC:7590]","GO:0001725(stress fiber);GO:0004672(protein kinase activity);GO:0004687(myosin light chain kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0015629(actin cytoskeleton);GO:0030027(lamellipodium);GO:0030335(positive regulation of cell migration);GO:0032060(bleb assembly);GO:0032154(cleavage furrow);GO:0051928(positive regulation of calcium ion transport);GO:0060414(aorta smooth muscle tissue morphogenesis);GO:0071476(cellular hypotonic response);GO:0090303(positive regulation of wound healing)","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04921(Oxytocin signaling pathway);04270(Vascular smooth muscle contraction);04971(Gastric acid secretion)",{"v":7.9e-78,"d":"0.00"},1,"241,",0,{"v":-77.1,"d":"-77.10"},{"v":-75.5,"d":"-75.50"},1.41,"Exon (ENSBGRT00000015698/ENSBGRG00000008571, exon 37 of 37)",1,73669379,73992749,323371,2]
["chr1",73768464,73776407,7944,"ENSBGRG00000008571","ENSBGRT00000015698",216342,"MYLK","myosin light chain kinase [Source:HGNC Symbol;Acc:HGNC:7590]","GO:0001725(stress fiber);GO:0004672(protein kinase activity);GO:0004687(myosin light chain kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0015629(actin cytoskeleton);GO:0030027(lamellipodium);GO:0030335(positive regulation of cell migration);GO:0032060(bleb assembly);GO:0032154(cleavage furrow);GO:0051928(positive regulation of calcium ion transport);GO:0060414(aorta smooth muscle tissue morphogenesis);GO:0071476(cellular hypotonic response);GO:0090303(positive regulation of wound healing)","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04921(Oxytocin signaling pathway);04270(Vascular smooth muscle contraction);04971(Gastric acid secretion)",{"v":9.99999999999998e-283,"d":"0.00"},5,"320,374,261,72,84,","0,860,1318,2009,7860",-282,-280,3.59,"Exon (ENSBGRT00000015698/ENSBGRG00000008571, exon 16 of 37)",1,73669379,73992749,323371,2]
["chr1",74023077,74029090,6014,"ENSBGRG00000008926","ENSBGRT00000016521",35876,"CCDC14","coiled-coil domain containing 14 [Source:HGNC Symbol;Acc:HGNC:25766]","GO:0005813(centrosome);GO:0034451(centriolar satellite);GO:0071539(protein localization to centrosome)","NA",{"v":1e-185,"d":"0.00"},4,"603,316,133,80,","0,605,5729,5934",-185,-182,11,"Exon (ENSBGRT00000016521/ENSBGRG00000008926, exon 11 of 14)",1,74023077,74064966,41890,2]
["chr1",74044857,74045154,298,"ENSBGRG00000008926","ENSBGRT00000016521",19812,"CCDC14","coiled-coil domain containing 14 [Source:HGNC Symbol;Acc:HGNC:25766]","GO:0005813(centrosome);GO:0034451(centriolar satellite);GO:0071539(protein localization to centrosome)","NA",{"v":3.2e-29,"d":"0.00"},1,"298,",0,{"v":-28.5,"d":"-28.50"},{"v":-27.3,"d":"-27.30"},5.24,"Exon (ENSBGRT00000016521/ENSBGRG00000008926, exon 8 of 14)",1,74023077,74064966,41890,2]
["chr1",75032033,75040356,8324,"ENSBGRG00000011141","ENSBGRT00000020371",132676,"ITGB5","integrin subunit beta 5 [Source:HGNC Symbol;Acc:HGNC:6160]","GO:0007160(cell-matrix adhesion);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0034684(integrin alphav-beta5 complex);GO:0035987(endodermal cell differentiation);GO:0038023(signaling receptor activity);GO:0043149(stress fiber assembly);GO:0043235(receptor complex);GO:0090136(epithelial cell-cell adhesion)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04145(Phagosome);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);05205(Proteoglycans in cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection)",0,4,"9,508,167,63,","0,5818,6954,8261",-422,"-Inf",5.48,"3' UTR",1,75031197,75173032,141836,2]
["chr1",75040475,75041145,671,"ENSBGRG00000011141","ENSBGRT00000020371",131887,"ITGB5","integrin subunit beta 5 [Source:HGNC Symbol;Acc:HGNC:6160]","GO:0007160(cell-matrix adhesion);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0034684(integrin alphav-beta5 complex);GO:0035987(endodermal cell differentiation);GO:0038023(signaling receptor activity);GO:0043149(stress fiber assembly);GO:0043235(receptor complex);GO:0090136(epithelial cell-cell adhesion)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04145(Phagosome);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);05205(Proteoglycans in cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection)",{"v":1.6E-15,"d":"0.00"},2,"38,172,","0,499",{"v":-14.8,"d":"-14.80"},{"v":-13.9,"d":"-13.90"},4.46,"3' UTR",1,75031197,75173032,141836,2]
["chr1",75072163,75090910,18748,"ENSBGRG00000011141","ENSBGRT00000020371",82122,"ITGB5","integrin subunit beta 5 [Source:HGNC Symbol;Acc:HGNC:6160]","GO:0007160(cell-matrix adhesion);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0034684(integrin alphav-beta5 complex);GO:0035987(endodermal cell differentiation);GO:0038023(signaling receptor activity);GO:0043149(stress fiber assembly);GO:0043235(receptor complex);GO:0090136(epithelial cell-cell adhesion)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04145(Phagosome);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);05205(Proteoglycans in cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection)",{"v":7.9e-36,"d":"0.00"},3,"289,135,25,","0,11936,18723",{"v":-35.1,"d":"-35.10"},{"v":-33.9,"d":"-33.90"},2.24,"Exon (ENSBGRT00000020371/ENSBGRG00000011141, exon 9 of 12)",1,75031197,75173032,141836,2]
["chr1",75172644,75173032,389,"ENSBGRG00000011141","ENSBGRT00000020371",0,"ITGB5","integrin subunit beta 5 [Source:HGNC Symbol;Acc:HGNC:6160]","GO:0007160(cell-matrix adhesion);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0034684(integrin alphav-beta5 complex);GO:0035987(endodermal cell differentiation);GO:0038023(signaling receptor activity);GO:0043149(stress fiber assembly);GO:0043235(receptor complex);GO:0090136(epithelial cell-cell adhesion)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04145(Phagosome);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);05205(Proteoglycans in cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection)",{"v":2.5E-52,"d":"0.00"},1,"389,",0,{"v":-51.6,"d":"-51.60"},{"v":-50.2,"d":"-50.20"},{"v":27.1,"d":"27.10"},"5' UTR",1,75031197,75173032,141836,2]
["chr1",75291837,75296564,4728,"ENSBGRG00000011820","ENSBGRT00000021576",58355,"ENSBGRG00000011820","NA","GO:0005509(calcium ion binding);GO:0007043(cell-cell junction assembly);GO:0007507(heart development)","NA",{"v":2.5e-63,"d":"0.00"},2,"1150,194,","0,4534",{"v":-62.6,"d":"-62.60"},{"v":-61.1,"d":"-61.10"},{"v":14.6,"d":"14.60"},"3' UTR",1,75291837,75354919,63083,2]
["chr1",75335394,75335513,120,"ENSBGRG00000011820","ENSBGRT00000021576",19406,"ENSBGRG00000011820","NA","GO:0005509(calcium ion binding);GO:0007043(cell-cell junction assembly);GO:0007507(heart development)","NA",{"v":3.2e-16,"d":"0.00"},1,"120,",0,{"v":-15.5,"d":"-15.50"},{"v":-14.5,"d":"-14.50"},3.08,"Exon (ENSBGRT00000021576/ENSBGRG00000011820, exon 6 of 16)",1,75291837,75354919,63083,2]
["chr1",75336408,75338342,1935,"ENSBGRG00000011820","ENSBGRT00000021576",16577,"ENSBGRG00000011820","NA","GO:0005509(calcium ion binding);GO:0007043(cell-cell junction assembly);GO:0007507(heart development)","NA",{"v":0.026,"d":"0.03"},2,"19,42,","0,1893",-1.59,-1.07,2.67,"Exon (ENSBGRT00000021576/ENSBGRG00000011820, exon 5 of 16)",1,75291837,75354919,63083,2]
["chr1",75338551,75342652,4102,"ENSBGRG00000011820","ENSBGRT00000021576",12267,"ENSBGRG00000011820","NA","GO:0005509(calcium ion binding);GO:0007043(cell-cell junction assembly);GO:0007507(heart development)","NA",{"v":0.0058,"d":"0.01"},2,"45,16,","0,4086",-2.24,-1.66,4.01,"5' UTR",1,75291837,75354919,63083,2]
["chr1",75343796,75343915,120,"ENSBGRG00000011820","ENSBGRT00000021576",11004,"ENSBGRG00000011820","NA","GO:0005509(calcium ion binding);GO:0007043(cell-cell junction assembly);GO:0007507(heart development)","NA",{"v":1.6e-06,"d":"0.00"},1,"120,",0,{"v":-5.8,"d":"-5.80"},-5.05,2.37,"5' UTR",1,75291837,75354919,63083,2]
["chr1",75582760,75584748,1989,"ENSBGRG00000012130","ENSBGRT00000022245",106540,"ZNF148","zinc finger protein 148 [Source:HGNC Symbol;Acc:HGNC:12933]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0007276(gamete generation);GO:0010629(negative regulation of gene expression);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":6.3e-79,"d":"0.00"},2,"1599,67,","0,1922",{"v":-78.2,"d":"-78.20"},{"v":-76.6,"d":"-76.60"},{"v":12.2,"d":"12.20"},"Exon (ENSBGRT00000022245/ENSBGRG00000012130, exon 7 of 8)",1,75582760,75691288,108529,2]
["chr1",75638653,75666775,28123,"ENSBGRG00000012130","ENSBGRT00000022245",24513,"ZNF148","zinc finger protein 148 [Source:HGNC Symbol;Acc:HGNC:12933]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0007276(gamete generation);GO:0010629(negative regulation of gene expression);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":1.5E-5,"d":"0.00"},2,"30,328,","0,27795",-4.82,-4.11,2.46,"Exon (ENSBGRT00000022245/ENSBGRG00000012130, exon 3 of 8)",1,75582760,75691288,108529,2]
["chr1",75808451,75809642,1192,"ENSBGRG00000012306","ENSBGRT00000022539",52613,"SNX4","sorting nexin 4 [Source:HGNC Symbol;Acc:HGNC:11175]","GO:0005154(epidermal growth factor receptor binding);GO:0005158(insulin receptor binding);GO:0005737(cytoplasm);GO:0005868(cytoplasmic dynein complex);GO:0005886(plasma membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0031201(SNARE complex);GO:0031901(early endosome membrane);GO:0032456(endocytic recycling);GO:0032991(protein-containing complex);GO:0035091(phosphatidylinositol binding);GO:1903595(positive regulation of histamine secretion by mast cell);GO:1990459(transferrin receptor binding);GO:1990460(leptin receptor binding)","04144(Endocytosis)",{"v":0.0027,"d":"0.00"},2,"79,42,","0,1150",-2.57,-1.97,1.35,"Exon (ENSBGRT00000022539/ENSBGRG00000012306, exon 12 of 14)",1,75782493,75862255,79763,2]
["chr1",75882857,75899672,16816,"ENSBGRG00000012716","ENSBGRT00000023302",82997,"OSBPL11","oxysterol binding protein like 11 [Source:HGNC Symbol;Acc:HGNC:16397]","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0010890(positive regulation of sequestering of triglyceride);GO:0045444(fat cell differentiation)","NA",{"v":7.9e-82,"d":"0.00"},3,"691,154,85,","0,9728,16731",{"v":-81.1,"d":"-81.10"},{"v":-79.4,"d":"-79.40"},7.05,"3' UTR",1,75882857,75982669,99813,2]
["chr1",75914752,75914992,241,"ENSBGRG00000012716","ENSBGRT00000023302",67677,"OSBPL11","oxysterol binding protein like 11 [Source:HGNC Symbol;Acc:HGNC:16397]","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0010890(positive regulation of sequestering of triglyceride);GO:0045444(fat cell differentiation)","NA",{"v":0.00069,"d":"0.00"},1,"241,",0,-3.16,-2.52,4.01,"Exon (ENSBGRT00000023302/ENSBGRG00000012716, exon 10 of 14)",1,75882857,75982669,99813,2]
["chr1",76174655,76174715,61,"ENSBGRG00000013795","ENSBGRT00000026551",116269,"LRCH3","leucine rich repeats and calponin homology domain containing 3 [Source:HGNC Symbol;Acc:HGNC:28637]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0032185(septin cytoskeleton organization)","NA",{"v":0.006,"d":"0.01"},1,"61,",0,-2.22,-1.65,1.63,"3' UTR",1,76174565,76290984,116420,2]
["chr1",76177073,76185328,8256,"ENSBGRG00000013795","ENSBGRT00000026551",105656,"LRCH3","leucine rich repeats and calponin homology domain containing 3 [Source:HGNC Symbol;Acc:HGNC:28637]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0032185(septin cytoskeleton organization)","NA",{"v":6.3e-38,"d":"0.00"},2,"326,64,","0,8192",{"v":-37.2,"d":"-37.20"},-36,2.83,"3' UTR",1,76174565,76290984,116420,2]
["chr1",76599655,76602702,3048,"ENSBGRG00000017484","ENSBGRT00000032522",24584,"TNK2","tyrosine kinase non receptor 2 [Source:HGNC Symbol;Acc:HGNC:19297]","GO:0004672(protein kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0016310(phosphorylation)","NA",{"v":1.6e-22,"d":"0.00"},3,"403,92,15,","0,1715,3033",{"v":-21.8,"d":"-21.80"},{"v":-20.7,"d":"-20.70"},2.16,"Exon (ENSBGRT00000032522/ENSBGRG00000017484, exon 12 of 17)",1,76595235,76627286,32052,2]
["chr1",76618450,76627264,8815,"ENSBGRG00000017484","ENSBGRT00000032522",22,"TNK2","tyrosine kinase non receptor 2 [Source:HGNC Symbol;Acc:HGNC:19297]","GO:0004672(protein kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0016310(phosphorylation)","NA",{"v":1.9e-07,"d":"0.00"},3,"4,181,56,","0,2123,8759",-6.72,-5.94,2.51,"5' UTR",1,76595235,76627286,32052,2]
["chr1",76645788,76646117,330,"ENSBGRG00000017484","ENSBGRT00000032392",0,"TNK2","tyrosine kinase non receptor 2 [Source:HGNC Symbol;Acc:HGNC:19297]","GO:0004672(protein kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0016310(phosphorylation)","NA",{"v":7.9e-48,"d":"0.00"},1,"330,",0,{"v":-47.1,"d":"-47.10"},{"v":-45.8,"d":"-45.80"},{"v":10.1,"d":"10.10"},"5' UTR",1,76595235,76646117,50883,2]
["chr1",76646138,76646915,778,"ENSBGRG00000017823","ENSBGRT00000032649",419,"ENSBGRG00000017823","NA","NA","NA",{"v":1.3E-43,"d":"0.00"},1,"778,",0,{"v":-42.9,"d":"-42.90"},{"v":-41.6,"d":"-41.60"},{"v":23.1,"d":"23.10"},"Exon (ENSBGRT00000032649/ENSBGRG00000017823, exon 1 of 1)",1,76646138,76647334,1197,2]
["chr1",76978624,76980912,2289,"ENSBGRG00000018000","ENSBGRT00000033156",55885,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":6.3e-35,"d":"0.00"},3,"395,80,392,","0,1701,1897",{"v":-34.2,"d":"-34.20"},-33,5.54,"3' UTR",1,76787597,77036797,249201,2]
["chr1",76857561,76867048,9488,"ENSBGRG00000018000","ENSBGRT00000033156",169749,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":0.00019,"d":"0.00"},2,"59,1,","0,9487",-3.71,-3.04,14,"Exon (ENSBGRT00000033712/ENSBGRG00000018377, exon 7 of 8)",1,76787597,77036797,249201,2]
["chr1",76943259,76946201,2943,"ENSBGRG00000018000","ENSBGRT00000033156",90596,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":0.0074,"d":"0.01"},2,"110,68,","0,2875",-2.13,-1.56,1.47,"Exon (ENSBGRT00000034129/ENSBGRG00000018600, exon 1 of 5)",1,76787597,77036797,249201,2]
["chr1",76946584,76946673,90,"ENSBGRG00000018000","ENSBGRT00000033156",90124,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":0.035,"d":"0.04"},1,"90,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000034129/ENSBGRG00000018600, exon 1 of 5)",1,76787597,77036797,249201,2]
["chr1",76949962,76950292,331,"ENSBGRG00000018000","ENSBGRT00000033156",86505,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":0.0062,"d":"0.01"},1,"331,",0,-2.21,-1.64,2.67,"3' UTR",1,76787597,77036797,249201,2]
["chr1",76950591,76950951,361,"ENSBGRG00000018000","ENSBGRT00000033156",85846,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",0.01,1,"361,",0,-1.98,-1.42,8.02,"3' UTR",1,76787597,77036797,249201,2]
["chr1",76951431,76951521,91,"ENSBGRG00000018000","ENSBGRT00000033156",85276,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":0.046,"d":"0.05"},1,"91,",0,-1.34,{"v":-0.843,"d":"-0.84"},3.34,"3' UTR",1,76787597,77036797,249201,2]
["chr1",77072182,77095313,23132,"ENSBGRG00000018793","ENSBGRT00000034429",0,"ENSBGRG00000018793","NA","NA","NA",{"v":6.3e-97,"d":"0.00"},6,"1299,82,122,180,77,157,","0,4534,6629,9280,16946,22975",{"v":-96.2,"d":"-96.20"},{"v":-94.5,"d":"-94.50"},{"v":11.7,"d":"11.70"},"Exon (ENSBGRT00000034429/ENSBGRG00000018793, exon 1 of 1)",1,77086383,77087993,1611,1]
["chr1",77146813,77152319,5507,"ENSBGRG00000018865","ENSBGRT00000034606",0,"WDR53","WD repeat domain 53 [Source:HGNC Symbol;Acc:HGNC:28786]","GO:0005515(protein binding)","NA",{"v":6.3e-80,"d":"0.00"},2,"597,496,","0,5011",{"v":-79.2,"d":"-79.20"},{"v":-77.6,"d":"-77.60"},14,"5' UTR",1,77146813,77152319,5507,2]
["chr1",77302430,77303637,1208,"ENSBGRG00000018942","ENSBGRT00000034720",59,"CEP19","centrosomal protein 19 [Source:HGNC Symbol;Acc:HGNC:28209]","GO:0000922(spindle pole);GO:0005813(centrosome);GO:0005814(centriole);GO:0005929(cilium);GO:0034454(microtubule anchoring at centrosome);GO:0036064(ciliary basal body);GO:0060271(cilium assembly);GO:0097712(vesicle targeting, trans-Golgi to periciliary membrane compartment)","NA",{"v":1.3E-73,"d":"0.00"},2,"362,141,","0,1067",{"v":-72.9,"d":"-72.90"},{"v":-71.3,"d":"-71.30"},16,"5' UTR",1,77302430,77303696,1267,2]
["chr1",77512722,77513422,701,"ENSBGRG00000019104","ENSBGRT00000035256",126171,"PAK2","p21 (RAC1) activated kinase 2 [Source:HGNC Symbol;Acc:HGNC:8591]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0014069(postsynaptic density);GO:0016310(phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0030296(protein tyrosine kinase activator activity);GO:0031267(small GTPase binding);GO:0034333(adherens junction assembly);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0048365(Rac GTPase binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051493(regulation of cytoskeleton organization);GO:0051497(negative regulation of stress fiber assembly);GO:0060996(dendritic spine development);GO:0070830(bicellular tight junction assembly);GO:0071407(cellular response to organic cyclic compound);GO:0098978(glutamatergic synapse);GO:0150105(protein localization to cell-cell junction);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04660(T cell receptor signaling pathway);04360(Axon guidance);05211(Renal cell carcinoma)",{"v":1.4E-3,"d":"0.00"},2,"353,34,","0,667",-2.85,-2.23,3.26,"Exon (ENSBGRT00000036186/ENSBGRG00000019688, exon 1 of 2)",1,77386551,77583260,196710,1]
["chr1",77530634,77530693,60,"ENSBGRG00000019688","ENSBGRT00000036163",0,"ENSBGRG00000019688","NA","GO:0016757(transferase activity, transferring glycosyl groups)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":0.032,"d":"0.03"},1,"60,",0,-1.49,{"v":-0.981,"d":"-0.98"},2.01,"5' UTR",1,77511712,77530693,18982,2]
["chr1",77624902,77635110,10209,"ENSBGRG00000020056","ENSBGRT00000041592",277651,"DLG1","discs large MAGUK scaffold protein 1 [Source:HGNC Symbol;Acc:HGNC:2900]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001657(ureteric bud development);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001771(immunological synapse formation);GO:0001772(immunological synapse);GO:0001935(endothelial cell proliferation);GO:0002088(lens development in camera-type eye);GO:0002369(T cell cytokine production);GO:0005515(protein binding);GO:0005604(basement membrane);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005923(bicellular tight junction);GO:0007015(actin filament organization);GO:0008022(protein C-terminus binding);GO:0008104(protein localization);GO:0008284(positive regulation of cell population proliferation);GO:0008360(regulation of cell shape);GO:0009898(cytoplasmic side of plasma membrane);GO:0014069(postsynaptic density);GO:0015459(potassium channel regulator activity);GO:0016323(basolateral plasma membrane);GO:0016328(lateral plasma membrane);GO:0019900(kinase binding);GO:0019901(protein kinase binding);GO:0019902(phosphatase binding);GO:0030054(cell junction);GO:0030432(peristalsis);GO:0030838(positive regulation of actin filament polymerization);GO:0030866(cortical actin cytoskeleton organization);GO:0030953(astral microtubule organization);GO:0031253(cell projection membrane);GO:0031434(mitogen-activated protein kinase kinase binding);GO:0031579(membrane raft organization);GO:0031594(neuromuscular junction);GO:0031641(regulation of myelination);GO:0032147(activation of protein kinase activity);GO:0033268(node of Ranvier);GO:0034629(cellular protein-containing complex localization);GO:0035748(myelin sheath abaxonal region);GO:0042110(T cell activation);GO:0042130(negative regulation of T cell proliferation);GO:0042391(regulation of membrane potential);GO:0042982(amyloid precursor protein metabolic process);GO:0043219(lateral loop);GO:0043268(positive regulation of potassium ion transport);GO:0043622(cortical microtubule organization);GO:0044325(ion channel binding);GO:0045121(membrane raft);GO:0045202(synapse);GO:0045930(negative regulation of mitotic cell cycle);GO:0048471(perinuclear region of cytoplasm);GO:0048608(reproductive structure development);GO:0048704(embryonic skeletal system morphogenesis);GO:0048729(tissue morphogenesis);GO:0048745(smooth muscle tissue development);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051660(establishment of centrosome localization);GO:0051898(negative regulation of protein kinase B signaling);GO:0060022(hard palate development);GO:0060090(molecular adaptor activity);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0070830(bicellular tight junction assembly);GO:0072659(protein localization to plasma membrane);GO:0097016(L27 domain binding);GO:0097025(MPP7-DLG1-LIN7 complex);GO:0097060(synaptic membrane);GO:0098609(cell-cell adhesion);GO:0098911(regulation of ventricular cardiac muscle cell action potential);GO:0098919(structural constituent of postsynaptic density);GO:0098978(glutamatergic synapse);GO:0099645(neurotransmitter receptor localization to postsynaptic specialization membrane);GO:1902473(regulation of protein localization to synapse);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1903286(regulation of potassium ion import);GO:1903753(negative regulation of p38MAPK cascade);GO:1903760(regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization);GO:1903764(regulation of potassium ion export across plasma membrane)","04390(Hippo signaling pathway);04530(Tight junction);04660(T cell receptor signaling pathway);05203(Viral carcinogenesis);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":2.6e-10,"d":"0.00"},3,"107,92,71,","0,2587,10138",-9.58,-8.73,{"v":36.1,"d":"36.10"},"Exon (ENSBGRT00000041592/ENSBGRG00000020056, exon 23 of 25)",1,77624902,77912761,287860,2]
["chr1",77645399,77666436,21038,"ENSBGRG00000020056","ENSBGRT00000041592",246325,"DLG1","discs large MAGUK scaffold protein 1 [Source:HGNC Symbol;Acc:HGNC:2900]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001657(ureteric bud development);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001771(immunological synapse formation);GO:0001772(immunological synapse);GO:0001935(endothelial cell proliferation);GO:0002088(lens development in camera-type eye);GO:0002369(T cell cytokine production);GO:0005515(protein binding);GO:0005604(basement membrane);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005923(bicellular tight junction);GO:0007015(actin filament organization);GO:0008022(protein C-terminus binding);GO:0008104(protein localization);GO:0008284(positive regulation of cell population proliferation);GO:0008360(regulation of cell shape);GO:0009898(cytoplasmic side of plasma membrane);GO:0014069(postsynaptic density);GO:0015459(potassium channel regulator activity);GO:0016323(basolateral plasma membrane);GO:0016328(lateral plasma membrane);GO:0019900(kinase binding);GO:0019901(protein kinase binding);GO:0019902(phosphatase binding);GO:0030054(cell junction);GO:0030432(peristalsis);GO:0030838(positive regulation of actin filament polymerization);GO:0030866(cortical actin cytoskeleton organization);GO:0030953(astral microtubule organization);GO:0031253(cell projection membrane);GO:0031434(mitogen-activated protein kinase kinase binding);GO:0031579(membrane raft organization);GO:0031594(neuromuscular junction);GO:0031641(regulation of myelination);GO:0032147(activation of protein kinase activity);GO:0033268(node of Ranvier);GO:0034629(cellular protein-containing complex localization);GO:0035748(myelin sheath abaxonal region);GO:0042110(T cell activation);GO:0042130(negative regulation of T cell proliferation);GO:0042391(regulation of membrane potential);GO:0042982(amyloid precursor protein metabolic process);GO:0043219(lateral loop);GO:0043268(positive regulation of potassium ion transport);GO:0043622(cortical microtubule organization);GO:0044325(ion channel binding);GO:0045121(membrane raft);GO:0045202(synapse);GO:0045930(negative regulation of mitotic cell cycle);GO:0048471(perinuclear region of cytoplasm);GO:0048608(reproductive structure development);GO:0048704(embryonic skeletal system morphogenesis);GO:0048729(tissue morphogenesis);GO:0048745(smooth muscle tissue development);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051660(establishment of centrosome localization);GO:0051898(negative regulation of protein kinase B signaling);GO:0060022(hard palate development);GO:0060090(molecular adaptor activity);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0070830(bicellular tight junction assembly);GO:0072659(protein localization to plasma membrane);GO:0097016(L27 domain binding);GO:0097025(MPP7-DLG1-LIN7 complex);GO:0097060(synaptic membrane);GO:0098609(cell-cell adhesion);GO:0098911(regulation of ventricular cardiac muscle cell action potential);GO:0098919(structural constituent of postsynaptic density);GO:0098978(glutamatergic synapse);GO:0099645(neurotransmitter receptor localization to postsynaptic specialization membrane);GO:1902473(regulation of protein localization to synapse);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1903286(regulation of potassium ion import);GO:1903753(negative regulation of p38MAPK cascade);GO:1903760(regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization);GO:1903764(regulation of potassium ion export across plasma membrane)","04390(Hippo signaling pathway);04530(Tight junction);04660(T cell receptor signaling pathway);05203(Viral carcinogenesis);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":8.3e-09,"d":"0.00"},6,"68,102,51,42,100,26,","0,5697,6907,9643,17161,21012",-8.08,-7.27,2.53,"Exon (ENSBGRT00000041592/ENSBGRG00000020056, exon 17 of 25)",1,77624902,77912761,287860,2]
["chr1",78122986,78125068,2083,"ENSBGRG00000022869","ENSBGRT00000042238",30863,"BDH1","3-hydroxybutyrate dehydrogenase 1 [Source:HGNC Symbol;Acc:HGNC:1027]","GO:0003858(3-hydroxybutyrate dehydrogenase activity);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0016491(oxidoreductase activity)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies)",{"v":4e-12,"d":"0.00"},2,"699,19,","0,2064",{"v":-11.4,"d":"-11.40"},{"v":-10.5,"d":"-10.50"},5.93,"3' UTR",1,78122628,78155931,33304,2]
["chr1",79155100,79156371,1272,"ENSBGRG00000023485","ENSBGRT00000043328",0,"FAM43A","family with sequence similarity 43 member A [Source:HGNC Symbol;Acc:HGNC:26888]","GO:0005515(protein binding)","NA",{"v":1E-108,"d":"0.00"},1,"1272,",0,-108,-106,{"v":39.1,"d":"39.10"},"Exon (ENSBGRT00000043328/ENSBGRG00000023485, exon 1 of 1)",1,79155100,79156371,1272,2]
["chr1",79729389,79729717,329,"ENSBGRG00000024386","ENSBGRT00000045011",2885,"HES1","hes family bHLH transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:5192]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001085(RNA polymerase II transcription factor binding);GO:0001217(DNA-binding transcription repressor activity);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0001889(liver development);GO:0003143(embryonic heart tube morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0003266(regulation of secondary heart field cardioblast proliferation);GO:0003281(ventricular septum development);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007155(cell adhesion);GO:0007219(Notch signaling pathway);GO:0007224(smoothened signaling pathway);GO:0007389(pattern specification process);GO:0008284(positive regulation of cell population proliferation);GO:0016477(cell migration);GO:0021537(telencephalon development);GO:0021555(midbrain-hindbrain boundary morphogenesis);GO:0021557(oculomotor nerve development);GO:0021558(trochlear nerve development);GO:0021575(hindbrain morphogenesis);GO:0021915(neural tube development);GO:0021983(pituitary gland development);GO:0021984(adenohypophysis development);GO:0030324(lung development);GO:0030513(positive regulation of BMP signaling pathway);GO:0030901(midbrain development);GO:0031016(pancreas development);GO:0032991(protein-containing complex);GO:0035019(somatic stem cell population maintenance);GO:0035909(aorta morphogenesis);GO:0035910(ascending aorta morphogenesis);GO:0042102(positive regulation of T cell proliferation);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0043388(positive regulation of DNA binding);GO:0043398(HLH domain binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045165(cell fate commitment);GO:0045596(negative regulation of cell differentiation);GO:0045598(regulation of fat cell differentiation);GO:0045608(negative regulation of inner ear auditory receptor cell differentiation);GO:0045665(negative regulation of neuron differentiation);GO:0045747(positive regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045977(positive regulation of mitotic cell cycle, embryonic);GO:0046331(lateral inhibition);GO:0046425(regulation of receptor signaling pathway via JAK-STAT);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT);GO:0046983(protein dimerization activity);GO:0048469(cell maturation);GO:0048505(regulation of timing of cell differentiation);GO:0048538(thymus development);GO:0048667(cell morphogenesis involved in neuron differentiation);GO:0048711(positive regulation of astrocyte differentiation);GO:0048715(negative regulation of oligodendrocyte differentiation);GO:0048844(artery morphogenesis);GO:0050678(regulation of epithelial cell proliferation);GO:0050767(regulation of neurogenesis);GO:0051087(chaperone binding);GO:0060122(inner ear receptor cell stereocilium organization);GO:0060164(regulation of timing of neuron differentiation);GO:0060253(negative regulation of glial cell proliferation);GO:0060412(ventricular septum morphogenesis);GO:0060675(ureteric bud morphogenesis);GO:0060716(labyrinthine layer blood vessel development);GO:0061009(common bile duct development);GO:0061106(negative regulation of stomach neuroendocrine cell differentiation);GO:0061309(cardiac neural crest cell development involved in outflow tract morphogenesis);GO:0061626(pharyngeal arch artery morphogenesis);GO:0065003(protein-containing complex assembly);GO:0070888(E-box binding);GO:0071820(N-box binding);GO:0072012(glomerulus vasculature development);GO:0072049(comma-shaped body morphogenesis);GO:0072050(S-shaped body morphogenesis);GO:0072141(renal interstitial fibroblast development);GO:0072282(metanephric nephron tubule morphogenesis);GO:0090102(cochlea development);GO:0090162(establishment of epithelial cell polarity);GO:0097084(vascular smooth muscle cell development);GO:0097150(neuronal stem cell population maintenance);GO:1905934(negative regulation of cell fate determination);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000227(negative regulation of pancreatic A cell differentiation);GO:2000737(negative regulation of stem cell differentiation);GO:2000974(negative regulation of pro-B cell differentiation);GO:2000981(negative regulation of inner ear receptor cell differentiation)","03460(Fanconi anemia pathway);04330(Notch signaling pathway);05200(Pathways in cancer);05224(Breast cancer);04950(Maturity onset diabetes of the young);05165(Human papillomavirus infection)",{"v":3.2e-22,"d":"0.00"},1,"329,",0,{"v":-21.5,"d":"-21.50"},{"v":-20.5,"d":"-20.50"},9.31,"Exon (ENSBGRT00000045011/ENSBGRG00000024386, exon 5 of 5)",1,79729389,79732602,3214,2]
["chr1",79732313,79732602,290,"ENSBGRG00000024386","ENSBGRT00000045011",0,"HES1","hes family bHLH transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:5192]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001085(RNA polymerase II transcription factor binding);GO:0001217(DNA-binding transcription repressor activity);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0001889(liver development);GO:0003143(embryonic heart tube morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0003266(regulation of secondary heart field cardioblast proliferation);GO:0003281(ventricular septum development);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007155(cell adhesion);GO:0007219(Notch signaling pathway);GO:0007224(smoothened signaling pathway);GO:0007389(pattern specification process);GO:0008284(positive regulation of cell population proliferation);GO:0016477(cell migration);GO:0021537(telencephalon development);GO:0021555(midbrain-hindbrain boundary morphogenesis);GO:0021557(oculomotor nerve development);GO:0021558(trochlear nerve development);GO:0021575(hindbrain morphogenesis);GO:0021915(neural tube development);GO:0021983(pituitary gland development);GO:0021984(adenohypophysis development);GO:0030324(lung development);GO:0030513(positive regulation of BMP signaling pathway);GO:0030901(midbrain development);GO:0031016(pancreas development);GO:0032991(protein-containing complex);GO:0035019(somatic stem cell population maintenance);GO:0035909(aorta morphogenesis);GO:0035910(ascending aorta morphogenesis);GO:0042102(positive regulation of T cell proliferation);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0043388(positive regulation of DNA binding);GO:0043398(HLH domain binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045165(cell fate commitment);GO:0045596(negative regulation of cell differentiation);GO:0045598(regulation of fat cell differentiation);GO:0045608(negative regulation of inner ear auditory receptor cell differentiation);GO:0045665(negative regulation of neuron differentiation);GO:0045747(positive regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045977(positive regulation of mitotic cell cycle, embryonic);GO:0046331(lateral inhibition);GO:0046425(regulation of receptor signaling pathway via JAK-STAT);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT);GO:0046983(protein dimerization activity);GO:0048469(cell maturation);GO:0048505(regulation of timing of cell differentiation);GO:0048538(thymus development);GO:0048667(cell morphogenesis involved in neuron differentiation);GO:0048711(positive regulation of astrocyte differentiation);GO:0048715(negative regulation of oligodendrocyte differentiation);GO:0048844(artery morphogenesis);GO:0050678(regulation of epithelial cell proliferation);GO:0050767(regulation of neurogenesis);GO:0051087(chaperone binding);GO:0060122(inner ear receptor cell stereocilium organization);GO:0060164(regulation of timing of neuron differentiation);GO:0060253(negative regulation of glial cell proliferation);GO:0060412(ventricular septum morphogenesis);GO:0060675(ureteric bud morphogenesis);GO:0060716(labyrinthine layer blood vessel development);GO:0061009(common bile duct development);GO:0061106(negative regulation of stomach neuroendocrine cell differentiation);GO:0061309(cardiac neural crest cell development involved in outflow tract morphogenesis);GO:0061626(pharyngeal arch artery morphogenesis);GO:0065003(protein-containing complex assembly);GO:0070888(E-box binding);GO:0071820(N-box binding);GO:0072012(glomerulus vasculature development);GO:0072049(comma-shaped body morphogenesis);GO:0072050(S-shaped body morphogenesis);GO:0072141(renal interstitial fibroblast development);GO:0072282(metanephric nephron tubule morphogenesis);GO:0090102(cochlea development);GO:0090162(establishment of epithelial cell polarity);GO:0097084(vascular smooth muscle cell development);GO:0097150(neuronal stem cell population maintenance);GO:1905934(negative regulation of cell fate determination);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000227(negative regulation of pancreatic A cell differentiation);GO:2000737(negative regulation of stem cell differentiation);GO:2000974(negative regulation of pro-B cell differentiation);GO:2000981(negative regulation of inner ear receptor cell differentiation)","03460(Fanconi anemia pathway);04330(Notch signaling pathway);05200(Pathways in cancer);05224(Breast cancer);04950(Maturity onset diabetes of the young);05165(Human papillomavirus infection)",{"v":5.5e-05,"d":"0.00"},2,"42,108,","0,182",-4.26,-3.57,2.06,"Exon (ENSBGRT00000045011/ENSBGRG00000024386, exon 1 of 5)",1,79729389,79732602,3214,2]
["chr1",80188096,80188156,61,"ENSBGRG00000024652","ENSBGRT00000047806",85880,"ENSBGRG00000024652","NA","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0006915(apoptotic process);GO:0007005(mitochondrion organization)","NA",{"v":0.0013,"d":"0.00"},1,"61,",0,{"v":-2.9,"d":"-2.90"},-2.28,6.02,"Exon (ENSBGRT00000047806/ENSBGRG00000024652, exon 30 of 30)",1,80188096,80274036,85941,2]
["chr1",80240079,80243894,3816,"ENSBGRG00000024652","ENSBGRT00000047806",30142,"ENSBGRG00000024652","NA","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0006915(apoptotic process);GO:0007005(mitochondrion organization)","NA",0.01,4,"23,73,131,73,","0,110,3060,3743",-1.98,-1.43,3.01,"Exon (ENSBGRT00000047806/ENSBGRG00000024652, exon 15 of 30)",1,80188096,80274036,85941,2]
["chr1",82541012,82547893,6882,"ENSBGRG00000000499","ENSBGRT00000000962",79117,"CCDC50","coiled-coil domain containing 50 [Source:HGNC Symbol;Acc:HGNC:18111]","GO:0005829(cytosol);GO:0007605(sensory perception of sound);GO:0031625(ubiquitin protein ligase binding)","NA",{"v":4.8E-8,"d":"0.00"},3,"20,107,80,","0,2520,6802",-7.32,-6.53,6.77,"Exon (ENSBGRT00000000962/ENSBGRG00000000499, exon 10 of 12)",1,82541012,82627010,85999,2]
["chr1",82557238,82566852,9615,"ENSBGRG00000000499","ENSBGRT00000000962",60158,"CCDC50","coiled-coil domain containing 50 [Source:HGNC Symbol;Acc:HGNC:18111]","GO:0005829(cytosol);GO:0007605(sensory perception of sound);GO:0031625(ubiquitin protein ligase binding)","NA",{"v":3.5e-07,"d":"0.00"},2,"60,501,","0,9114",-6.45,-5.68,4.28,"Exon (ENSBGRT00000000962/ENSBGRG00000000499, exon 6 of 12)",1,82541012,82627010,85999,2]
["chr1",85583846,85584145,300,"ENSBGRG00000001121","ENSBGRT00000002076",353764,"LPP","LIM domain containing preferred translocation partner in lipoma [Source:HGNC Symbol;Acc:HGNC:6679]","GO:0005829(cytosol);GO:0005925(focal adhesion)","04621(NOD-like receptor signaling pathway)",{"v":0.00022,"d":"0.00"},1,"300,",0,-3.65,-2.98,3.09,"Exon (ENSBGRT00000002076/ENSBGRG00000001121, exon 6 of 11)",1,85249182,85937909,688728,2]
["chr1",86888664,86917926,29263,"ENSBGRG00000001272","ENSBGRT00000002315",0,"ENSBGRG00000001272","NA","NA","NA",{"v":2e-23,"d":"0.00"},4,"484,193,790,203,","0,3086,14593,29060",{"v":-22.7,"d":"-22.70"},{"v":-21.7,"d":"-21.70"},5.01,"5' UTR",1,86887264,86904046,16783,2]
["chr1",86918134,86918432,299,"ENSBGRG00000001272","ENSBGRT00000002320",0,"ENSBGRG00000001272","NA","NA","NA",{"v":0.0032,"d":"0.00"},1,"299,",0,{"v":-2.5,"d":"-2.50"},-1.91,11,"5' UTR",1,86887524,86918432,30909,2]
["chr1",87073783,87244502,170720,"ENSBGRG00000001521","ENSBGRT00000002838",0,"ST6GAL1","ST6 beta-galactoside alpha-2,6-sialyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10860]","GO:0000139(Golgi membrane);GO:0003835(beta-galactoside alpha-2,6-sialyltransferase activity);GO:0006054(N-acetylneuraminate metabolic process);GO:0006486(protein glycosylation);GO:0008373(sialyltransferase activity);GO:0018279(protein N-linked glycosylation via asparagine);GO:0042803(protein homodimerization activity);GO:0097503(sialylation)","00510(N-Glycan biosynthesis);00514(Other types of O-glycan biosynthesis)",{"v":3.2E-69,"d":"0.00"},3,"520,618,589,","0,2561,170131",{"v":-68.5,"d":"-68.50"},{"v":-66.9,"d":"-66.90"},8.58,"5' UTR",1,87201887,87243002,41116,2]
["chr1",87201887,87201946,60,"ENSBGRG00000001507","ENSBGRT00000002763",42616,"RTP1","receptor transporter protein 1 [Source:HGNC Symbol;Acc:HGNC:28580]","GO:0009986(cell surface);GO:0031849(olfactory receptor binding);GO:0051205(protein insertion into membrane)","00510(N-Glycan biosynthesis);00514(Other types of O-glycan biosynthesis)",{"v":0.0022,"d":"0.00"},1,"60,",0,-2.65,-2.05,2.22,"Exon (ENSBGRT00000002838/ENSBGRG00000001521, exon 5 of 5)",1,87073783,87244562,170780,2]
["chr1",87230127,87244503,14377,"ENSBGRG00000001521","ENSBGRT00000002838",0,"ST6GAL1","ST6 beta-galactoside alpha-2,6-sialyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10860]","GO:0000139(Golgi membrane);GO:0003835(beta-galactoside alpha-2,6-sialyltransferase activity);GO:0006054(N-acetylneuraminate metabolic process);GO:0006486(protein glycosylation);GO:0008373(sialyltransferase activity);GO:0018279(protein N-linked glycosylation via asparagine);GO:0042803(protein homodimerization activity);GO:0097503(sialylation)","00510(N-Glycan biosynthesis);00514(Other types of O-glycan biosynthesis)",{"v":6.3e-70,"d":"0.00"},3,"59,154,590,","0,12722,13787",{"v":-69.2,"d":"-69.20"},{"v":-67.7,"d":"-67.70"},13,"5' UTR",1,87201887,87243002,41116,2]
["chr1",87451350,87464579,13230,"ENSBGRG00000001590","ENSBGRT00000002959",0,"ENSBGRG00000001590","NA","GO:0005515(protein binding)","04152(AMPK signaling pathway);04920(Adipocytokine signaling pathway);03320(PPAR signaling pathway);04211(Longevity regulating pathway - mammal);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":0.00026,"d":"0.00"},3,"164,207,256,","0,1060,12974",-3.59,-2.93,15,"5' UTR",1,87430394,87452616,22223,2]
["chr1",87505785,87506054,270,"ENSBGRG00000001653","ENSBGRT00000003091",5714,"ENSBGRG00000001653","NA","GO:0003676(nucleic acid binding);GO:0005524(ATP binding)","03013(RNA transport)",{"v":1E-156,"d":"0.00"},1,"270,",0,-156,-154,2.03,"3' UTR",1,87505785,87511768,5984,2]
["chr1",87706586,87707278,693,"ENSBGRG00000001887","ENSBGRT00000003524",18245,"ENSBGRG00000001887","NA","GO:0005102(signaling receptor binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006457(protein folding);GO:0016556(mRNA modification);GO:0050768(negative regulation of neurogenesis);GO:0051082(unfolded protein binding)","04141(Protein processing in endoplasmic reticulum)",{"v":1E-25,"d":"0.00"},2,"106,131,","0,562",-25,{"v":-23.9,"d":"-23.90"},3.64,"3' UTR",1,87706586,87725523,18938,2]
["chr1",87725169,87725523,355,"ENSBGRG00000001887","ENSBGRT00000003524",0,"ENSBGRG00000001887","NA","GO:0005102(signaling receptor binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006457(protein folding);GO:0016556(mRNA modification);GO:0050768(negative regulation of neurogenesis);GO:0051082(unfolded protein binding)","04141(Protein processing in endoplasmic reticulum)",{"v":2.5e-11,"d":"0.00"},1,"355,",0,{"v":-10.6,"d":"-10.60"},-9.73,{"v":33.1,"d":"33.10"},"5' UTR",1,87706586,87725523,18938,2]
["chr1",88771718,88774713,2996,"ENSBGRG00000002680","ENSBGRT00000005016",16596,"SENP2","SUMO specific peptidase 2 [Source:HGNC Symbol;Acc:HGNC:23116]","GO:0005643(nuclear pore);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0007507(heart development);GO:0008234(cysteine-type peptidase activity);GO:0016604(nuclear body);GO:0016605(PML body);GO:0016926(protein desumoylation);GO:0031397(negative regulation of protein ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0031648(protein destabilization);GO:0032875(regulation of DNA endoreduplication);GO:0035562(negative regulation of chromatin binding);GO:0045444(fat cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060707(trophoblast giant cell differentiation);GO:0060711(labyrinthine layer development);GO:0060712(spongiotrophoblast layer development);GO:0070139(SUMO-specific endopeptidase activity);GO:0070140(SUMO-specific isopeptidase activity);GO:2000045(regulation of G1/S transition of mitotic cell cycle)","03013(RNA transport);04310(Wnt signaling pathway)",{"v":5.9e-09,"d":"0.00"},3,"147,64,29,","0,2090,2967",-8.23,-7.42,1.51,"Exon (ENSBGRT00000005016/ENSBGRG00000002680, exon 9 of 17)",1,88755640,88791309,35670,2]
["chr1",88775338,88777647,2310,"ENSBGRG00000002680","ENSBGRT00000005016",13662,"SENP2","SUMO specific peptidase 2 [Source:HGNC Symbol;Acc:HGNC:23116]","GO:0005643(nuclear pore);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0007507(heart development);GO:0008234(cysteine-type peptidase activity);GO:0016604(nuclear body);GO:0016605(PML body);GO:0016926(protein desumoylation);GO:0031397(negative regulation of protein ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0031648(protein destabilization);GO:0032875(regulation of DNA endoreduplication);GO:0035562(negative regulation of chromatin binding);GO:0045444(fat cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060707(trophoblast giant cell differentiation);GO:0060711(labyrinthine layer development);GO:0060712(spongiotrophoblast layer development);GO:0070139(SUMO-specific endopeptidase activity);GO:0070140(SUMO-specific isopeptidase activity);GO:2000045(regulation of G1/S transition of mitotic cell cycle)","03013(RNA transport);04310(Wnt signaling pathway)",{"v":0.036,"d":"0.04"},2,"59,62,","0,2248",-1.44,{"v":-0.932,"d":"-0.93"},1.16,"Exon (ENSBGRT00000005016/ENSBGRG00000002680, exon 7 of 17)",1,88755640,88791309,35670,2]
["chr1",88897893,88898431,539,"ENSBGRG00000002802","ENSBGRT00000005394",42803,"MAP3K13","mitogen-activated protein kinase kinase kinase 13 [Source:HGNC Symbol;Acc:HGNC:6852]","GO:0000186(activation of MAPKK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004706(JUN kinase kinase kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007254(JNK cascade);GO:0007256(activation of JNKK activity);GO:0007257(activation of JUN kinase activity);GO:0014042(positive regulation of neuron maturation);GO:0016020(membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0045773(positive regulation of axon extension);GO:0046777(protein autophosphorylation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0106137(IkappaB kinase complex binding);GO:0150012(positive regulation of neuron projection arborization);GO:1905492(positive regulation of branching morphogenesis of a nerve)","04010(MAPK signaling pathway)",{"v":8.3e-06,"d":"0.00"},1,"539,",0,-5.08,-4.36,3.89,"Exon (ENSBGRT00000005394/ENSBGRG00000002802, exon 10 of 13)",1,88889707,88941234,51528,2]
["chr1",88928972,89056230,127259,"ENSBGRG00000002802","ENSBGRT00000005394",0,"MAP3K13","mitogen-activated protein kinase kinase kinase 13 [Source:HGNC Symbol;Acc:HGNC:6852]","GO:0000186(activation of MAPKK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004706(JUN kinase kinase kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007254(JNK cascade);GO:0007256(activation of JNKK activity);GO:0007257(activation of JUN kinase activity);GO:0014042(positive regulation of neuron maturation);GO:0016020(membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0045773(positive regulation of axon extension);GO:0046777(protein autophosphorylation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0106137(IkappaB kinase complex binding);GO:0150012(positive regulation of neuron projection arborization);GO:1905492(positive regulation of branching morphogenesis of a nerve)","04010(MAPK signaling pathway)",{"v":8.7e-05,"d":"0.00"},3,"2,560,38,","0,11703,127221",-4.06,-3.38,13,"5' UTR",1,88889707,88941234,51528,2]
["chr1",89333686,89336762,3077,"ENSBGRG00000002973","ENSBGRT00000005605",310328,"VPS8","VPS8 subunit of CORVET complex [Source:HGNC Symbol;Acc:HGNC:29122]","GO:0005515(protein binding);GO:0005769(early endosome);GO:0033263(CORVET complex);GO:0034058(endosomal vesicle fusion)","NA",{"v":2.5e-11,"d":"0.00"},3,"18,129,64,","0,20,3013",{"v":-10.6,"d":"-10.60"},-9.68,7.52,"Exon (ENSBGRT00000005605/ENSBGRG00000002973, exon 46 of 48)",1,89333686,89647090,313405,2]
["chr1",89646970,89647090,121,"ENSBGRG00000002973","ENSBGRT00000005605",0,"VPS8","VPS8 subunit of CORVET complex [Source:HGNC Symbol;Acc:HGNC:29122]","GO:0005515(protein binding);GO:0005769(early endosome);GO:0033263(CORVET complex);GO:0034058(endosomal vesicle fusion)","NA",{"v":0.022,"d":"0.02"},1,"121,",0,-1.66,-1.14,1.93,"5' UTR",1,89333686,89647090,313405,2]
["chr1",90158231,90159356,1126,"ENSBGRG00000003267","ENSBGRT00000006071",2906,"POLR2H","RNA polymerase II subunit H [Source:HGNC Symbol;Acc:HGNC:9195]","GO:0003697(single-stranded DNA binding);GO:0005634(nucleus);GO:0005665(RNA polymerase II, core complex);GO:0006351(transcription, DNA-templated);GO:0006366(transcription by RNA polymerase II);GO:0032993(protein-DNA complex)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway);05016(Huntington disease);05169(Epstein-Barr virus infection)",{"v":2.3e-09,"d":"0.00"},2,"118,52,","0,1074",-8.64,-7.82,1.84,"Exon (ENSBGRT00000006071/ENSBGRG00000003267, exon 4 of 5)",1,90158231,90162262,4032,2]
["chr1",90183067,90185247,2181,"ENSBGRG00000003599","ENSBGRT00000006707",3897,"FAM131A","family with sequence similarity 131 member A [Source:HGNC Symbol;Acc:HGNC:28308]","NA","03013(RNA transport);05416(Viral myocarditis)",{"v":2e-26,"d":"0.00"},2,"641,45,","0,2136",{"v":-25.7,"d":"-25.70"},{"v":-24.5,"d":"-24.50"},5.18,"3' UTR",1,90182232,90189144,6913,2]
["chr1",90192428,90195624,3197,"ENSBGRG00000003743","ENSBGRT00000009257",20212,"EIF4G1","eukaryotic translation initiation factor 4 gamma 1 [Source:HGNC Symbol;Acc:HGNC:3296]","GO:0001662(behavioral fear response);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005844(polysome);GO:0006412(translation);GO:0006446(regulation of translational initiation);GO:0008135(translation factor activity, RNA binding);GO:0008190(eukaryotic initiation factor 4E binding);GO:0010507(negative regulation of autophagy);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0010942(positive regulation of cell death);GO:0016281(eukaryotic translation initiation factor 4F complex);GO:0030307(positive regulation of cell growth);GO:0031669(cellular response to nutrient levels);GO:0032270(positive regulation of cellular protein metabolic process);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034645(cellular macromolecule biosynthetic process);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042802(identical protein binding);GO:0045666(positive regulation of neuron differentiation);GO:0097009(energy homeostasis);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1905537(positive regulation of eukaryotic translation initiation factor 4F complex assembly);GO:1905606(regulation of presynapse assembly);GO:1905612(positive regulation of mRNA cap binding);GO:1905618(positive regulation of miRNA mediated inhibition of translation);GO:1905696(regulation of polysome binding)","03013(RNA transport);05416(Viral myocarditis)",0,2,"353,66,","0,3131",-337,"-Inf",{"v":16.3,"d":"16.30"},"3' UTR",1,90192428,90215836,23409,2]
["chr1",90206743,90209055,2313,"ENSBGRG00000003743","ENSBGRT00000009257",6781,"EIF4G1","eukaryotic translation initiation factor 4 gamma 1 [Source:HGNC Symbol;Acc:HGNC:3296]","GO:0001662(behavioral fear response);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005844(polysome);GO:0006412(translation);GO:0006446(regulation of translational initiation);GO:0008135(translation factor activity, RNA binding);GO:0008190(eukaryotic initiation factor 4E binding);GO:0010507(negative regulation of autophagy);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0010942(positive regulation of cell death);GO:0016281(eukaryotic translation initiation factor 4F complex);GO:0030307(positive regulation of cell growth);GO:0031669(cellular response to nutrient levels);GO:0032270(positive regulation of cellular protein metabolic process);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034645(cellular macromolecule biosynthetic process);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042802(identical protein binding);GO:0045666(positive regulation of neuron differentiation);GO:0097009(energy homeostasis);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1905537(positive regulation of eukaryotic translation initiation factor 4F complex assembly);GO:1905606(regulation of presynapse assembly);GO:1905612(positive regulation of mRNA cap binding);GO:1905618(positive regulation of miRNA mediated inhibition of translation);GO:1905696(regulation of polysome binding)","03013(RNA transport);05416(Viral myocarditis)",{"v":1e-133,"d":"0.00"},4,"58,89,424,87,","0,150,1758,2226",-133,-131,4.83,"Exon (ENSBGRT00000009257/ENSBGRG00000003743, exon 10 of 36)",1,90192428,90215836,23409,2]
["chr1",90230046,90230690,645,"ENSBGRG00000000173","ENSBGRT00000000288",0,"PSMD2","proteasome 26S subunit, non-ATPase 2 [Source:HGNC Symbol;Acc:HGNC:9559]","GO:0000502(proteasome complex);GO:0005838(proteasome regulatory particle);GO:0022624(proteasome accessory complex);GO:0030234(enzyme regulator activity);GO:0042176(regulation of protein catabolic process)","03050(Proteasome);05169(Epstein-Barr virus infection)",{"v":1.6e-24,"d":"0.00"},2,"46,135,","0,510",{"v":-23.8,"d":"-23.80"},{"v":-22.8,"d":"-22.80"},2.16,"Exon (ENSBGRT00000000288/ENSBGRG00000000173, exon 1 of 21)",1,90221538,90230690,9153,2]
["chr1",90268456,90268603,148,"ENSBGRG00000000248","ENSBGRT00000000391",5903,"EEF1AKMT4","EEF1A lysine methyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:53611]","GO:0008168(methyltransferase activity);GO:0016279(protein-lysine N-methyltransferase activity)","NA",{"v":0.00089,"d":"0.00"},1,"148,",0,-3.05,-2.42,13,"Exon (ENSBGRT00000000391/ENSBGRG00000000248, exon 3 of 3)",1,90268456,90274506,6051,2]
["chr1",90314125,90314679,555,"ENSBGRG00000000581","ENSBGRT00000001191",6984,"ABCF3","ATP binding cassette subfamily F member 3 [Source:HGNC Symbol;Acc:HGNC:72]","GO:0005524(ATP binding);GO:0016887(ATPase activity)","NA",{"v":6.3e-13,"d":"0.00"},3,"159,88,83,","0,247,472",{"v":-12.2,"d":"-12.20"},{"v":-11.3,"d":"-11.30"},3.17,"Exon (ENSBGRT00000001191/ENSBGRG00000000581, exon 20 of 22)",1,90314125,90321663,7539,2]
["chr1",90338565,90338949,385,"ENSBGRG00000000862","ENSBGRT00000001629",8929,"DVL3","dishevelled segment polarity protein 3 [Source:HGNC Symbol;Acc:HGNC:3087]","GO:0000790(nuclear chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0002020(protease binding);GO:0005102(signaling receptor binding);GO:0005109(frizzled binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0008013(beta-catenin binding);GO:0016055(Wnt signaling pathway);GO:0035556(intracellular signal transduction);GO:0035567(non-canonical Wnt signaling pathway);GO:0043507(positive regulation of JUN kinase activity);GO:0043547(positive regulation of GTPase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048365(Rac GTPase binding);GO:0050821(protein stabilization);GO:0060070(canonical Wnt signaling pathway);GO:0060071(Wnt signaling pathway, planar cell polarity pathway);GO:1903827(regulation of cellular protein localization)","04310(Wnt signaling pathway);04330(Notch signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":7.9e-16,"d":"0.00"},2,"264,34,","0,351",{"v":-15.1,"d":"-15.10"},{"v":-14.2,"d":"-14.20"},1.65,"Exon (ENSBGRT00000001629/ENSBGRG00000000862, exon 12 of 14)",1,90337559,90347878,10320,2]
["chr1",90339009,90339068,60,"ENSBGRG00000000862","ENSBGRT00000001629",8810,"DVL3","dishevelled segment polarity protein 3 [Source:HGNC Symbol;Acc:HGNC:3087]","GO:0000790(nuclear chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0002020(protease binding);GO:0005102(signaling receptor binding);GO:0005109(frizzled binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0008013(beta-catenin binding);GO:0016055(Wnt signaling pathway);GO:0035556(intracellular signal transduction);GO:0035567(non-canonical Wnt signaling pathway);GO:0043507(positive regulation of JUN kinase activity);GO:0043547(positive regulation of GTPase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048365(Rac GTPase binding);GO:0050821(protein stabilization);GO:0060070(canonical Wnt signaling pathway);GO:0060071(Wnt signaling pathway, planar cell polarity pathway);GO:1903827(regulation of cellular protein localization)","04310(Wnt signaling pathway);04330(Notch signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":0.0083,"d":"0.01"},1,"60,",0,-2.08,-1.51,{"v":1.3,"d":"1.30"},"Exon (ENSBGRT00000001629/ENSBGRG00000000862, exon 12 of 14)",1,90337559,90347878,10320,2]
["chr1",90363150,90363856,707,"ENSBGRG00000000921","ENSBGRT00000001753",9719,"EIF2B5","eukaryotic translation initiation factor 2B subunit epsilon [Source:HGNC Symbol;Acc:HGNC:3261]","GO:0001541(ovarian follicle development);GO:0003743(translation initiation factor activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005851(eukaryotic translation initiation factor 2B complex);GO:0006413(translational initiation);GO:0009408(response to heat);GO:0014002(astrocyte development);GO:0014003(oligodendrocyte development);GO:0034976(response to endoplasmic reticulum stress);GO:0042552(myelination);GO:0048708(astrocyte differentiation);GO:0050852(T cell receptor signaling pathway)","03013(RNA transport)",{"v":1.3e-98,"d":"0.00"},2,"477,64,","0,643",{"v":-97.9,"d":"-97.90"},{"v":-96.1,"d":"-96.10"},3.01,"3' UTR",1,90362131,90373575,11445,2]
["chr1",90371771,90373575,1805,"ENSBGRG00000000921","ENSBGRT00000001753",0,"EIF2B5","eukaryotic translation initiation factor 2B subunit epsilon [Source:HGNC Symbol;Acc:HGNC:3261]","GO:0001541(ovarian follicle development);GO:0003743(translation initiation factor activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005851(eukaryotic translation initiation factor 2B complex);GO:0006413(translational initiation);GO:0009408(response to heat);GO:0014002(astrocyte development);GO:0014003(oligodendrocyte development);GO:0034976(response to endoplasmic reticulum stress);GO:0042552(myelination);GO:0048708(astrocyte differentiation);GO:0050852(T cell receptor signaling pathway)","03013(RNA transport)",{"v":2.6e-09,"d":"0.00"},3,"109,115,77,","0,1571,1728",-8.58,-7.76,7.82,"Exon (ENSBGRT00000001753/ENSBGRG00000000921, exon 1 of 17)",1,90362131,90373575,11445,2]
["chr1",90704488,90707527,3040,"ENSBGRG00000001414","ENSBGRT00000002587",85943,"YEATS2","YEATS domain containing 2 [Source:HGNC Symbol;Acc:HGNC:25489]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005634(nucleus);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0006355(regulation of transcription, DNA-templated);GO:0017025(TBP-class protein binding);GO:0042393(histone binding);GO:0043966(histone H3 acetylation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0072686(mitotic spindle);GO:0140030(modification-dependent protein binding)","NA",{"v":1.3E-22,"d":"0.00"},4,"109,74,75,12,","0,1377,2097,3028",{"v":-21.9,"d":"-21.90"},{"v":-20.8,"d":"-20.80"},3.25,"Exon (ENSBGRT00000002587/ENSBGRG00000001414, exon 29 of 32)",1,90704488,90793470,88983,2]
["chr1",90850043,90856024,5982,"ENSBGRG00000001442","ENSBGRT00000002647",19067,"KLHL24","kelch like family member 24 [Source:HGNC Symbol;Acc:HGNC:25947]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005912(adherens junction);GO:0016567(protein ubiquitination);GO:0030057(desmosome);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0045109(intermediate filament organization);GO:0051865(protein autoubiquitination);GO:2000312(regulation of kainate selective glutamate receptor activity)","NA",{"v":8.5e-08,"d":"0.00"},2,"201,154,","0,5828",-7.07,-6.28,3.01,"Exon (ENSBGRT00000002647/ENSBGRG00000001442, exon 5 of 6)",1,90850043,90875091,25049,2]
["chr1",90874323,90875091,769,"ENSBGRG00000001442","ENSBGRT00000002647",0,"KLHL24","kelch like family member 24 [Source:HGNC Symbol;Acc:HGNC:25947]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005912(adherens junction);GO:0016567(protein ubiquitination);GO:0030057(desmosome);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0045109(intermediate filament organization);GO:0051865(protein autoubiquitination);GO:2000312(regulation of kainate selective glutamate receptor activity)","NA",{"v":1.3e-09,"d":"0.00"},1,"769,",0,-8.88,-8.05,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000002647/ENSBGRG00000001442, exon 1 of 6)",1,90850043,90875091,25049,2]
["chr1",91244388,91245533,1146,"ENSBGRG00000001683","ENSBGRT00000003117",0,"B3GNT5","UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:15684]","GO:0006486(protein glycosylation);GO:0007417(central nervous system development);GO:0008457(beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity);GO:0016020(membrane)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":6.3e-66,"d":"0.00"},1,"1146,",0,{"v":-65.2,"d":"-65.20"},{"v":-63.7,"d":"-63.70"},{"v":10.4,"d":"10.40"},"Exon (ENSBGRT00000003117/ENSBGRG00000001683, exon 1 of 1)",1,91244388,91245533,1146,2]
["chr1",91572690,91577731,5042,"ENSBGRG00000001781","ENSBGRT00000003296",127920,"ATP11B","ATPase phospholipid transporting 11B (putative) [Source:HGNC Symbol;Acc:HGNC:13553]","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0005524(ATP binding);GO:0005783(endoplasmic reticulum);GO:0015914(phospholipid transport);GO:0016021(integral component of membrane);GO:0055037(recycling endosome);GO:0140326(ATPase-coupled intramembrane lipid transporter activity)","NA",{"v":9.5e-06,"d":"0.00"},2,"229,101,","0,4941",-5.02,{"v":-4.3,"d":"-4.30"},2.04,"3' UTR",1,91572601,91705651,133051,2]
["chr1",93724554,93726222,1669,"ENSBGRG00000001900","ENSBGRT00000003792",81880,"FXR1","FMR1 autosomal homolog 1 [Source:HGNC Symbol;Acc:HGNC:4023]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005844(polysome);GO:0006417(regulation of translation);GO:0007517(muscle organ development);GO:0030424(axon);GO:0030425(dendrite);GO:0033592(RNA strand annealing activity);GO:0035770(ribonucleoprotein granule);GO:0042803(protein homodimerization activity);GO:0043034(costamere);GO:0043197(dendritic spine);GO:0046982(protein heterodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:2000637(positive regulation of gene silencing by miRNA)","03013(RNA transport)",{"v":4e-94,"d":"0.00"},2,"893,36,","0,1633",{"v":-93.4,"d":"-93.40"},{"v":-91.7,"d":"-91.70"},3.02,"3' UTR",1,93724375,93808102,83728,2]
["chr1",93738583,93754763,16181,"ENSBGRG00000001900","ENSBGRT00000003792",53339,"FXR1","FMR1 autosomal homolog 1 [Source:HGNC Symbol;Acc:HGNC:4023]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005844(polysome);GO:0006417(regulation of translation);GO:0007517(muscle organ development);GO:0030424(axon);GO:0030425(dendrite);GO:0033592(RNA strand annealing activity);GO:0035770(ribonucleoprotein granule);GO:0042803(protein homodimerization activity);GO:0043034(costamere);GO:0043197(dendritic spine);GO:0046982(protein heterodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:2000637(positive regulation of gene silencing by miRNA)","03013(RNA transport)",{"v":6.3e-12,"d":"0.00"},5,"8,87,110,79,76,","0,1944,9338,13155,16105",{"v":-11.2,"d":"-11.20"},{"v":-10.3,"d":"-10.30"},1.48,"Exon (ENSBGRT00000003792/ENSBGRG00000001900, exon 8 of 18)",1,93724375,93808102,83728,2]
["chr1",94086763,94087595,833,"ENSBGRG00000002327","ENSBGRT00000004463",8124,"TTC14","tetratricopeptide repeat domain 14 [Source:HGNC Symbol;Acc:HGNC:24697]","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","04140(Autophagy - animal);04136(Autophagy - other eukaryotes)",{"v":9.99999999999998e-229,"d":"0.00"},1,"833,",0,-228,-226,5.33,"3' UTR",1,94086763,94095719,8957,2]
["chr1",95499484,95505233,5750,"ENSBGRG00000003185","ENSBGRT00000005915",0,"ENSBGRG00000003185","NA","NA","NA",{"v":1.3E-33,"d":"0.00"},2,"173,96,","0,5654",{"v":-32.9,"d":"-32.90"},{"v":-31.7,"d":"-31.70"},2.41,"3' UTR",1,95501189,95502547,1359,1]
["chr1",95663651,95671633,7983,"ENSBGRG00000003201","ENSBGRT00000005942",17249,"ENSBGRG00000003201","NA","GO:0006813(potassium ion transport);GO:0015269(calcium-activated potassium channel activity);GO:0016020(membrane)","04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04270(Vascular smooth muscle contraction)",{"v":2.5e-59,"d":"0.00"},3,"22,441,104,","0,6648,7879",{"v":-58.6,"d":"-58.60"},{"v":-57.2,"d":"-57.20"},7.51,"3' UTR",1,95646402,95664125,17724,1]
["chr1",95700351,95716037,15687,"ENSBGRG00000003231","ENSBGRT00000005988",0,"PIK3CA","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [Source:HGNC Symbol;Acc:HGNC:8975]","GO:0001889(liver development);GO:0001932(regulation of protein phosphorylation);GO:0005942(phosphatidylinositol 3-kinase complex);GO:0005943(phosphatidylinositol 3-kinase complex, class IA);GO:0006006(glucose metabolic process);GO:0010468(regulation of gene expression);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0016301(kinase activity);GO:0016303(1-phosphatidylinositol-3-kinase activity);GO:0016310(phosphorylation);GO:0030027(lamellipodium);GO:0030295(protein kinase activator activity);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0035004(phosphatidylinositol 3-kinase activity);GO:0040014(regulation of multicellular organism growth);GO:0043457(regulation of cellular respiration);GO:0043491(protein kinase B signaling);GO:0043524(negative regulation of neuron apoptotic process);GO:0043560(insulin receptor substrate binding);GO:0044029(hypomethylation of CpG island);GO:0046854(phosphatidylinositol phosphorylation);GO:0048015(phosphatidylinositol-mediated signaling);GO:0060612(adipose tissue development);GO:0071333(cellular response to glucose stimulus);GO:0097009(energy homeostasis);GO:2000270(negative regulation of fibroblast apoptotic process);GO:2000653(regulation of genetic imprinting);GO:2000811(negative regulation of anoikis)","00562(Inositol phosphate metabolism);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04630(Jak-STAT signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04218(Cellular senescence);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04670(Leukocyte transendothelial migration);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04919(Thyroid hormone signaling pathway);04973(Carbohydrate digestion and absorption);04960(Aldosterone-regulated sodium reabsorption);04725(Cholinergic synapse);04722(Neurotrophin signaling pathway);04750(Inflammatory mediator regulation of TRP channels);04360(Axon guidance);04380(Osteoclast differentiation);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05205(Proteoglycans in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05100(Bacterial invasion of epithelial cells);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05146(Amoebiasis);05142(Chagas disease (American trypanosomiasis));01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":4.8e-06,"d":"0.00"},2,"403,45,","0,15642",-5.32,-4.59,3.41,"5' UTR",1,95663621,95700753,37133,2]
["chr1",100227019,100542169,315151,"ENSBGRG00000003389","ENSBGRT00000006342",0,"NAALADL2","N-acetylated alpha-linked acidic dipeptidase like 2 [Source:HGNC Symbol;Acc:HGNC:23219]","GO:0005654(nucleoplasm)","NA",{"v":0.026,"d":"0.03"},2,"107,43,","0,315108",-1.59,-1.07,3.01,"5' UTR",1,99324372,100227125,902754,2]
["chr1",101229243,101230921,1679,"ENSBGRG00000003457","ENSBGRT00000006436",811293,"NLGN1","neuroligin 1 [Source:HGNC Symbol;Acc:HGNC:14291]","GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007158(neuron cell-cell adhesion);GO:0007399(nervous system development);GO:0007416(synapse assembly);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010841(positive regulation of circadian sleep/wake cycle, wakefulness);GO:0016020(membrane);GO:0016080(synaptic vesicle targeting);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0030165(PDZ domain binding);GO:0031175(neuron projection development);GO:0035418(protein localization to synapse);GO:0042043(neurexin family protein binding);GO:0043235(receptor complex);GO:0045184(establishment of protein localization);GO:0045202(synapse);GO:0045664(regulation of neuron differentiation);GO:0048789(cytoskeletal matrix organization at active zone);GO:0050804(modulation of chemical synaptic transmission);GO:0050808(synapse organization);GO:0051965(positive regulation of synapse assembly);GO:0060076(excitatory synapse);GO:0060999(positive regulation of dendritic spine development);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0072553(terminal button organization);GO:0097091(synaptic vesicle clustering);GO:0097104(postsynaptic membrane assembly);GO:0097105(presynaptic membrane assembly);GO:0097110(scaffold protein binding);GO:0097113(AMPA glutamate receptor clustering);GO:0097115(neurexin clustering involved in presynaptic membrane assembly);GO:0097119(postsynaptic density protein 95 clustering);GO:0097120(receptor localization to synapse);GO:0099560(synaptic membrane adhesion);GO:1900244(positive regulation of synaptic vesicle endocytosis);GO:1904861(excitatory synapse assembly);GO:2000302(positive regulation of synaptic vesicle exocytosis);GO:2000310(regulation of NMDA receptor activity);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000809(positive regulation of synaptic vesicle clustering)","04514(Cell adhesion molecules (CAMs))",{"v":0.00016,"d":"0.00"},2,"823,41,","0,1638",{"v":-3.8,"d":"-3.80"},-3.13,6.02,"Exon (ENSBGRT00000006436/ENSBGRG00000003457, exon 4 of 5)",1,101229243,102042214,812972,2]
["chr1",101231070,102041767,810698,"ENSBGRG00000003475","ENSBGRT00000006452",0,"ENSBGRG00000003475","NA","NA","04514(Cell adhesion molecules (CAMs))",{"v":0.035,"d":"0.04"},4,"601,213,153,46,","0,4985,563765,810652",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000006460/ENSBGRG00000003486, exon 1 of 1)",1,101231886,101232601,716,2]
["chr1",102041857,102042184,328,"ENSBGRG00000003457","ENSBGRT00000006436",30,"NLGN1","neuroligin 1 [Source:HGNC Symbol;Acc:HGNC:14291]","GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007158(neuron cell-cell adhesion);GO:0007399(nervous system development);GO:0007416(synapse assembly);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010841(positive regulation of circadian sleep/wake cycle, wakefulness);GO:0016020(membrane);GO:0016080(synaptic vesicle targeting);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0030165(PDZ domain binding);GO:0031175(neuron projection development);GO:0035418(protein localization to synapse);GO:0042043(neurexin family protein binding);GO:0043235(receptor complex);GO:0045184(establishment of protein localization);GO:0045202(synapse);GO:0045664(regulation of neuron differentiation);GO:0048789(cytoskeletal matrix organization at active zone);GO:0050804(modulation of chemical synaptic transmission);GO:0050808(synapse organization);GO:0051965(positive regulation of synapse assembly);GO:0060076(excitatory synapse);GO:0060999(positive regulation of dendritic spine development);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0072553(terminal button organization);GO:0097091(synaptic vesicle clustering);GO:0097104(postsynaptic membrane assembly);GO:0097105(presynaptic membrane assembly);GO:0097110(scaffold protein binding);GO:0097113(AMPA glutamate receptor clustering);GO:0097115(neurexin clustering involved in presynaptic membrane assembly);GO:0097119(postsynaptic density protein 95 clustering);GO:0097120(receptor localization to synapse);GO:0099560(synaptic membrane adhesion);GO:1900244(positive regulation of synaptic vesicle endocytosis);GO:1904861(excitatory synapse assembly);GO:2000302(positive regulation of synaptic vesicle exocytosis);GO:2000310(regulation of NMDA receptor activity);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000809(positive regulation of synaptic vesicle clustering)","04514(Cell adhesion molecules (CAMs))",{"v":0.00013,"d":"0.00"},1,"328,",0,-3.87,{"v":-3.2,"d":"-3.20"},16,"Exon (ENSBGRT00000006436/ENSBGRG00000003457, exon 1 of 5)",1,101229243,102042214,812972,2]
["chr1",103391936,103392115,180,"ENSBGRG00000003929","ENSBGRT00000007909",290112,"FNDC3B","fibronectin type III domain containing 3B [Source:HGNC Symbol;Acc:HGNC:24670]","GO:0005515(protein binding)","NA",{"v":3E-10,"d":"0.00"},1,"180,",0,-9.52,-8.67,2.54,"Exon (ENSBGRT00000007909/ENSBGRG00000003929, exon 25 of 25)",1,103391936,103682227,290292,2]
["chr1",103749387,103749624,238,"ENSBGRG00000004384","ENSBGRT00000008058",418,"ENSBGRG00000004384","NA","NA","04146(Peroxisome)",{"v":0.035,"d":"0.04"},1,"238,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000008058/ENSBGRG00000004384, exon 2 of 2)",1,103749387,103750042,656,2]
["chr1",104564131,104565808,1678,"ENSBGRG00000004855","ENSBGRT00000012818",192245,"TNIK","TRAF2 and NCK interacting kinase [Source:HGNC Symbol;Acc:HGNC:30765]","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0007010(cytoskeleton organization);GO:0007256(activation of JNKK activity);GO:0016324(apical plasma membrane);GO:0030033(microvillus assembly);GO:0031532(actin cytoskeleton reorganization);GO:0035556(intracellular signal transduction);GO:0046777(protein autophosphorylation);GO:0048814(regulation of dendrite morphogenesis);GO:0072659(protein localization to plasma membrane)","NA",{"v":0.0058,"d":"0.01"},1,"1678,",0,-2.24,-1.66,10,"Exon (ENSBGRT00000013273/ENSBGRG00000007242, exon 1 of 1)",1,104371886,104828624,456739,1]
["chr1",105493927,105495426,1500,"ENSBGRG00000006204","ENSBGRT00000011461",18263,"SKIL","SKI like proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10897]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001825(blastocyst formation);GO:0002260(lymphocyte homeostasis);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032991(protein-containing complex);GO:0045596(negative regulation of cell differentiation);GO:0046332(SMAD binding);GO:0070306(lens fiber cell differentiation);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902231(positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":6.3e-16,"d":"0.00"},3,"159,225,156,","0,829,1344",{"v":-15.2,"d":"-15.20"},{"v":-14.2,"d":"-14.20"},7.02,"Exon (ENSBGRT00000011461/ENSBGRG00000006204, exon 4 of 6)",1,105493927,105513689,19763,2]
["chr1",105500801,105512641,11841,"ENSBGRG00000006204","ENSBGRT00000011461",1048,"SKIL","SKI like proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10897]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001825(blastocyst formation);GO:0002260(lymphocyte homeostasis);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032991(protein-containing complex);GO:0045596(negative regulation of cell differentiation);GO:0046332(SMAD binding);GO:0070306(lens fiber cell differentiation);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902231(positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":1.4e-06,"d":"0.00"},2,"29,720,","0,11121",-5.84,-5.09,3.29,"Exon (ENSBGRT00000011461/ENSBGRG00000006204, exon 1 of 6)",1,105493927,105513689,19763,2]
["chr1",105512851,105513150,300,"ENSBGRG00000006204","ENSBGRT00000011461",539,"SKIL","SKI like proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10897]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001825(blastocyst formation);GO:0002260(lymphocyte homeostasis);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032991(protein-containing complex);GO:0045596(negative regulation of cell differentiation);GO:0046332(SMAD binding);GO:0070306(lens fiber cell differentiation);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902231(positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":0.0032,"d":"0.00"},1,"300,",0,-2.49,{"v":-1.9,"d":"-1.90"},2.58,"5' UTR",1,105493927,105513689,19763,2]
["chr1",105513210,105513569,360,"ENSBGRG00000006204","ENSBGRT00000011461",120,"SKIL","SKI like proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10897]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001825(blastocyst formation);GO:0002260(lymphocyte homeostasis);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032991(protein-containing complex);GO:0045596(negative regulation of cell differentiation);GO:0046332(SMAD binding);GO:0070306(lens fiber cell differentiation);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902231(positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":7.4e-06,"d":"0.00"},1,"360,",0,-5.13,-4.41,8.69,"5' UTR",1,105493927,105513689,19763,2]
["chr1",105560488,105560727,240,"ENSBGRG00000006256","ENSBGRT00000011845",71088,"PRKCI","protein kinase C iota [Source:HGNC Symbol;Acc:HGNC:9404]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004697(protein kinase C activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005543(phospholipid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007015(actin filament organization);GO:0007163(establishment or maintenance of cell polarity);GO:0010976(positive regulation of neuron projection development);GO:0015630(microtubule cytoskeleton);GO:0016324(apical plasma membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0032869(cellular response to insulin stimulus);GO:0034351(negative regulation of glial cell apoptotic process);GO:0035089(establishment of apical/basal cell polarity);GO:0035556(intracellular signal transduction);GO:0042462(eye photoreceptor cell development);GO:0043220(Schmidt-Lanterman incisure);GO:0043524(negative regulation of neuron apoptotic process);GO:0045171(intercellular bridge);GO:0045177(apical part of cell);GO:0045216(cell-cell junction organization);GO:0046326(positive regulation of glucose import);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0060252(positive regulation of glial cell proliferation);GO:1903078(positive regulation of protein localization to plasma membrane);GO:2000353(positive regulation of endothelial cell apoptotic process)","04015(Rap1 signaling pathway);04390(Hippo signaling pathway);04144(Endocytosis);04530(Tight junction);04611(Platelet activation);04910(Insulin signaling pathway);05165(Human papillomavirus infection)",{"v":3.4E-5,"d":"0.00"},1,"240,",0,-4.47,-3.77,2.39,"3' UTR",1,105560488,105631815,71328,2]
["chr1",105876724,105882390,5667,"ENSBGRG00000006891","ENSBGRT00000012758",19846,"SEC62","SEC62 homolog, preprotein translocation factor [Source:HGNC Symbol;Acc:HGNC:11846]","GO:0006620(posttranslational protein targeting to endoplasmic reticulum membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0031204(posttranslational protein targeting to membrane, translocation)","03060(Protein export);04141(Protein processing in endoplasmic reticulum)",0,2,"578,47,","0,5620",-909,"-Inf",4.63,"3' UTR",1,105876456,105902236,25781,2]
["chr1",105892322,105902102,9781,"ENSBGRG00000006891","ENSBGRT00000012758",134,"SEC62","SEC62 homolog, preprotein translocation factor [Source:HGNC Symbol;Acc:HGNC:11846]","GO:0006620(posttranslational protein targeting to endoplasmic reticulum membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0031204(posttranslational protein targeting to membrane, translocation)","03060(Protein export);04141(Protein processing in endoplasmic reticulum)",{"v":9.99999999999999e-237,"d":"0.00"},5,"80,93,205,106,23,","0,1211,1549,8649,9758",-236,-234,4.23,"Exon (ENSBGRT00000012758/ENSBGRG00000006891, exon 1 of 7)",1,105876456,105902236,25781,2]
["chr1",106110113,106113003,2891,"ENSBGRG00000007490","ENSBGRT00000013746",13307,"MYNN","myoneurin [Source:HGNC Symbol;Acc:HGNC:14955]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:1990830(cellular response to leukemia inhibitory factor)","NA",{"v":4e-24,"d":"0.00"},3,"263,87,8,","0,1920,2883",{"v":-23.4,"d":"-23.40"},{"v":-22.3,"d":"-22.30"},6.27,"Exon (ENSBGRT00000013746/ENSBGRG00000007490, exon 6 of 8)",1,106110113,106126310,16198,2]
["chr1",106119013,106119637,625,"ENSBGRG00000007490","ENSBGRT00000013746",6673,"MYNN","myoneurin [Source:HGNC Symbol;Acc:HGNC:14955]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:1990830(cellular response to leukemia inhibitory factor)","NA",{"v":3.2e-62,"d":"0.00"},1,"625,",0,{"v":-61.5,"d":"-61.50"},-60,7.08,"Exon (ENSBGRT00000013746/ENSBGRG00000007490, exon 3 of 8)",1,106110113,106126310,16198,2]
["chr1",106125753,106126161,409,"ENSBGRG00000007490","ENSBGRT00000013746",149,"MYNN","myoneurin [Source:HGNC Symbol;Acc:HGNC:14955]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:1990830(cellular response to leukemia inhibitory factor)","NA",{"v":2e-07,"d":"0.00"},2,"197,71,","0,338",{"v":-6.7,"d":"-6.70"},-5.92,2.42,"5' UTR",1,106110113,106126310,16198,2]
["chr1",107149563,107149623,61,"ENSBGRG00000008768","ENSBGRT00000016031",270122,"ENSBGRG00000008768","NA","GO:0005509(calcium ion binding)","NA",{"v":2E-3,"d":"0.00"},1,"61,",0,{"v":-2.7,"d":"-2.70"},-2.09,7.02,"3' UTR",1,107149563,107419745,270183,2]
["chr1",107149682,107149861,180,"ENSBGRG00000008768","ENSBGRT00000016031",269884,"ENSBGRG00000008768","NA","GO:0005509(calcium ion binding)","NA",{"v":0.00025,"d":"0.00"},1,"180,",0,{"v":-3.6,"d":"-3.60"},-2.94,2.53,"3' UTR",1,107149563,107419745,270183,2]
["chr1",116150329,116150625,297,"ENSBGRG00000011599","ENSBGRT00000021389",0,"PPM1L","protein phosphatase, Mg2+/Mn2+ dependent 1L [Source:HGNC Symbol;Acc:HGNC:16381]","GO:0000165(MAPK cascade);GO:0003824(catalytic activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0007178(transmembrane receptor protein serine/threonine kinase signaling pathway);GO:0043169(cation binding)","NA",{"v":0.019,"d":"0.02"},1,"297,",0,-1.71,{"v":-0.978,"d":"-0.98"},8.02,"Exon (ENSBGRT00000021389/ENSBGRG00000011599, exon 1 of 5)",1,115791281,116150625,359345,2]
["chr1",116497457,116498106,650,"ENSBGRG00000012219","ENSBGRT00000023058",34471,"SMC4","structural maintenance of chromosomes 4 [Source:HGNC Symbol;Acc:HGNC:14013]","GO:0000775(chromosome, centromeric region);GO:0000796(condensin complex);GO:0000797(condensin core heterodimer);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005694(chromosome);GO:0005829(cytosol);GO:0007076(mitotic chromosome condensation);GO:0010032(meiotic chromosome condensation);GO:0016607(nuclear speck);GO:0045132(meiotic chromosome segregation);GO:0051276(chromosome organization);GO:0051383(kinetochore organization)","NA",{"v":4.1E-5,"d":"0.00"},2,"193,17,","0,633",-4.39,-3.69,2.29,"3' UTR",1,116497307,116532577,35271,2]
["chr1",116514083,116517551,3469,"ENSBGRG00000012219","ENSBGRT00000023058",15026,"SMC4","structural maintenance of chromosomes 4 [Source:HGNC Symbol;Acc:HGNC:14013]","GO:0000775(chromosome, centromeric region);GO:0000796(condensin complex);GO:0000797(condensin core heterodimer);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005694(chromosome);GO:0005829(cytosol);GO:0007076(mitotic chromosome condensation);GO:0010032(meiotic chromosome condensation);GO:0016607(nuclear speck);GO:0045132(meiotic chromosome segregation);GO:0051276(chromosome organization);GO:0051383(kinetochore organization)","NA",{"v":4e-23,"d":"0.00"},3,"225,165,120,","0,1535,3349",{"v":-22.4,"d":"-22.40"},{"v":-21.3,"d":"-21.30"},{"v":11.8,"d":"11.80"},"Exon (ENSBGRT00000023058/ENSBGRG00000012219, exon 9 of 24)",1,116497307,116532577,35271,2]
["chr1",116928247,116928570,324,"ENSBGRG00000013416","ENSBGRT00000024626",7205,"IL12A","interleukin 12A [Source:HGNC Symbol;Acc:HGNC:5969]","GO:0001916(positive regulation of T cell mediated cytotoxicity);GO:0002860(positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target);GO:0005125(cytokine activity);GO:0005143(interleukin-12 receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0006955(immune response);GO:0007050(cell cycle arrest);GO:0008083(growth factor activity);GO:0008283(cell population proliferation);GO:0009615(response to virus);GO:0009986(cell surface);GO:0010224(response to UV-B);GO:0016477(cell migration);GO:0032496(response to lipopolysaccharide);GO:0032700(negative regulation of interleukin-17 production);GO:0032729(positive regulation of interferon-gamma production);GO:0032816(positive regulation of natural killer cell activation);GO:0032946(positive regulation of mononuclear cell proliferation);GO:0034393(positive regulation of smooth muscle cell apoptotic process);GO:0035711(T-helper 1 cell activation);GO:0035744(T-helper 1 cell cytokine production);GO:0042102(positive regulation of T cell proliferation);GO:0042163(interleukin-12 beta subunit binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042832(defense response to protozoan);GO:0043514(interleukin-12 complex);GO:0045513(interleukin-27 binding);GO:0045582(positive regulation of T cell differentiation);GO:0045785(positive regulation of cell adhesion);GO:0045954(positive regulation of natural killer cell mediated cytotoxicity);GO:0046982(protein heterodimerization activity);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0050671(positive regulation of lymphocyte proliferation);GO:0050709(negative regulation of protein secretion);GO:0050830(defense response to Gram-positive bacterium);GO:0051135(positive regulation of NK T cell activation);GO:0071222(cellular response to lipopolysaccharide);GO:0097191(extrinsic apoptotic signaling pathway);GO:0098586(cellular response to virus);GO:1900747(negative regulation of vascular endothelial growth factor signaling pathway);GO:1903588(negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis);GO:2000510(positive regulation of dendritic cell chemotaxis)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04620(Toll-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04658(Th1 and Th2 cell differentiation);05200(Pathways in cancer);05321(Inflammatiory bowel disease (IBD));05330(Allograft rejection);04940(Type I diabetes mellitus);05133(Pertussis);05134(Legionellosis);05152(Tuberculosis);05162(Measles);05164(Influenza A);05168(Herpes simplex infection);05146(Amoebiasis);05144(Malaria);05145(Toxoplasmosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));05143(African trypanosomiasis)",{"v":0.0012,"d":"0.00"},1,"324,",0,-2.91,-2.29,4.21,"3' UTR",1,116928247,116935775,7529,2]
["chr1",117113586,117115367,1782,"ENSBGRG00000013519","ENSBGRT00000025511",0,"ENSBGRG00000013519","NA","NA","03420(Nucleotide excision repair)",{"v":0.00025,"d":"0.00"},2,"30,91,","0,1691",{"v":-3.6,"d":"-3.60"},-2.94,2.06,"5' UTR",1,117065948,117113615,47668,2]
["chr1",117120703,117225494,104792,"ENSBGRG00000013519","ENSBGRT00000024920",0,"ENSBGRG00000013519","NA","NA","03420(Nucleotide excision repair)",{"v":0.00093,"d":"0.00"},2,"76,165,","0,104627",-3.03,{"v":-2.4,"d":"-2.40"},3.34,"Exon (ENSBGRT00000024920/ENSBGRG00000013519, exon 1 of 7)",1,117042715,117120778,78064,2]
["chr1",117225554,117226064,511,"ENSBGRG00000013519","ENSBGRT00000024806",0,"ENSBGRG00000013519","NA","NA","03420(Nucleotide excision repair)",{"v":4e-24,"d":"0.00"},1,"511,",0,{"v":-23.4,"d":"-23.40"},{"v":-22.3,"d":"-22.30"},5.01,"5' UTR",1,117042715,117226010,183296,2]
["chr1",117226124,117793968,567845,"ENSBGRG00000013519","ENSBGRT00000025425",0,"ENSBGRG00000013519","NA","NA","03420(Nucleotide excision repair)",{"v":1E-3,"d":"0.00"},2,"55,66,","0,567779",-3,-2.37,4.01,"3' UTR",1,117065948,117226178,160231,2]
["chr1",118512012,118513232,1221,"ENSBGRG00000014469","ENSBGRT00000027086",56513,"GFM1","G elongation factor mitochondrial 1 [Source:HGNC Symbol;Acc:HGNC:13780]","GO:0003746(translation elongation factor activity);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0006414(translational elongation);GO:0070125(mitochondrial translational elongation)","NA",{"v":7.9e-13,"d":"0.00"},3,"236,54,10,","0,394,1211",{"v":-12.1,"d":"-12.10"},{"v":-11.2,"d":"-11.20"},3.24,"3' UTR",1,118512012,118569745,57734,2]
["chr1",118643466,119094752,451287,"ENSBGRG00000015623","ENSBGRT00000028705",0,"ENSBGRG00000015623","NA","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)",{"v":1.3e-16,"d":"0.00"},8,"10,107,69,107,52,37,174,93,","0,7902,95737,179926,213657,265083,348387,451194",{"v":-15.9,"d":"-15.90"},{"v":-14.9,"d":"-14.90"},3.61,"Exon (ENSBGRT00000028705/ENSBGRG00000015623, exon 1 of 1)",1,118744734,118745597,864,1]
["chr1",119902903,119908560,5658,"ENSBGRG00000016007","ENSBGRT00000029736",95663,"VEPH1","ventricular zone expressed PH domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25735]","GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0060392(negative regulation of SMAD protein signal transduction)","NA",{"v":4E-70,"d":"0.00"},2,"614,123,","0,5535",{"v":-69.4,"d":"-69.40"},{"v":-67.9,"d":"-67.90"},5.73,"Exon (ENSBGRT00000030015/ENSBGRG00000016322, exon 2 of 3)",1,119807240,120097278,290039,1]
["chr1",120364451,120385553,21103,"ENSBGRG00000016645","ENSBGRT00000030590",198332,"ENSBGRG00000016645","NA","NA","NA",{"v":7.2e-06,"d":"0.00"},2,"861,279,","0,20824",-5.14,-4.41,9.53,"3' UTR",1,120363852,120583885,220034,2]
["chr1",120748600,120749995,1396,"ENSBGRG00000016750","ENSBGRT00000030776",26570,"TIPARP","TCDD inducible poly(ADP-ribose) polymerase [Source:HGNC Symbol;Acc:HGNC:23696]","GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001570(vasculogenesis);GO:0001822(kidney development);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005634(nucleus);GO:0006471(protein ADP-ribosylation);GO:0006807(nitrogen compound metabolic process);GO:0008209(androgen metabolic process);GO:0008210(estrogen metabolic process);GO:0008585(female gonad development);GO:0009791(post-embryonic development);GO:0010629(negative regulation of gene expression);GO:0030097(hemopoiesis);GO:0045732(positive regulation of protein catabolic process);GO:0046872(metal ion binding);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048705(skeletal system morphogenesis);GO:0048745(smooth muscle tissue development);GO:0060021(roof of mouth development);GO:0060325(face morphogenesis);GO:0070213(protein auto-ADP-ribosylation);GO:0071407(cellular response to organic cyclic compound);GO:0140289(protein mono-ADP-ribosylation);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":1e-158,"d":"0.00"},2,"448,270,","0,1126",-158,-156,5.71,"Exon (ENSBGRT00000030776/ENSBGRG00000016750, exon 5 of 6)",1,120748600,120776565,27966,2]
["chr1",120755819,120776565,20747,"ENSBGRG00000016750","ENSBGRT00000030776",0,"TIPARP","TCDD inducible poly(ADP-ribose) polymerase [Source:HGNC Symbol;Acc:HGNC:23696]","GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001570(vasculogenesis);GO:0001822(kidney development);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005634(nucleus);GO:0006471(protein ADP-ribosylation);GO:0006807(nitrogen compound metabolic process);GO:0008209(androgen metabolic process);GO:0008210(estrogen metabolic process);GO:0008585(female gonad development);GO:0009791(post-embryonic development);GO:0010629(negative regulation of gene expression);GO:0030097(hemopoiesis);GO:0045732(positive regulation of protein catabolic process);GO:0046872(metal ion binding);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048705(skeletal system morphogenesis);GO:0048745(smooth muscle tissue development);GO:0060021(roof of mouth development);GO:0060325(face morphogenesis);GO:0070213(protein auto-ADP-ribosylation);GO:0071407(cellular response to organic cyclic compound);GO:0140289(protein mono-ADP-ribosylation);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":1e-138,"d":"0.00"},4,"24,169,953,79,","0,1332,17421,20668",-138,-136,4.84,"5' UTR",1,120748600,120776565,27966,2]
["chr1",121285681,121476563,190883,"ENSBGRG00000017121","ENSBGRT00000032358",0,"KCNAB1","potassium voltage-gated channel subfamily A member regulatory beta subunit 1 [Source:HGNC Symbol;Acc:HGNC:6228]","GO:0005249(voltage-gated potassium channel activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006813(potassium ion transport);GO:0007611(learning or memory);GO:0008076(voltage-gated potassium channel complex);GO:0015459(potassium channel regulator activity);GO:0016021(integral component of membrane);GO:0019904(protein domain specific binding);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0034705(potassium channel complex);GO:0055085(transmembrane transport);GO:0070402(NADPH binding);GO:1901016(regulation of potassium ion transmembrane transporter activity);GO:1901379(regulation of potassium ion transmembrane transport);GO:1903817(negative regulation of voltage-gated potassium channel activity)","NA",{"v":0.012,"d":"0.01"},3,"113,242,95,","0,167930,190788",-1.93,-1.38,7.02,"5' UTR",1,120972424,121285793,313370,2]
["chr1",122519715,122520884,1170,"ENSBGRG00000009643","ENSBGRT00000017725",70915,"MME","membrane metalloendopeptidase [Source:HGNC Symbol;Acc:HGNC:7154]","GO:0001786(phosphatidylserine binding);GO:0001822(kidney development);GO:0004175(endopeptidase activity);GO:0004222(metalloendopeptidase activity);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0005903(brush border);GO:0006508(proteolysis);GO:0007568(aging);GO:0007611(learning or memory);GO:0008021(synaptic vesicle);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008238(exopeptidase activity);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0019233(sensory perception of pain);GO:0030424(axon);GO:0030425(dendrite);GO:0031410(cytoplasmic vesicle);GO:0042803(protein homodimerization activity);GO:0043025(neuronal cell body);GO:0044306(neuron projection terminus);GO:0045121(membrane raft);GO:0045202(synapse);GO:0046449(creatinine metabolic process);GO:0050435(amyloid-beta metabolic process);GO:0050769(positive regulation of neurogenesis);GO:0061837(neuropeptide processing);GO:0071345(cellular response to cytokine stimulus);GO:0071492(cellular response to UV-A);GO:0071493(cellular response to UV-B);GO:0090399(replicative senescence);GO:0097242(amyloid-beta clearance);GO:0098793(presynapse);GO:0150094(amyloid-beta clearance by cellular catabolic process);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1901612(cardiolipin binding)","04640(Hematopoietic cell lineage);04614(Renin-angiotensin system);04974(Protein digestion and absorption);05010(Alzheimer disease)",{"v":0.026,"d":"0.03"},3,"11,137,122,","0,120,1048",-1.59,-1.07,3.34,"Exon (ENSBGRT00000017725/ENSBGRG00000009643, exon 12 of 24)",1,122462847,122591799,128953,2]
["chr1",123474453,123475700,1248,"ENSBGRG00000011886","ENSBGRT00000021733",150112,"ARHGEF26","Rho guanine nucleotide exchange factor 26 [Source:HGNC Symbol;Acc:HGNC:24490]","GO:0001886(endothelial cell morphogenesis);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0097178(ruffle assembly)","05100(Bacterial invasion of epithelial cells)",{"v":0.014,"d":"0.01"},2,"49,12,","0,1236",-1.85,{"v":-1.3,"d":"-1.30"},2.72,"Exon (ENSBGRT00000021733/ENSBGRG00000011886, exon 11 of 13)",1,123470614,123625812,155199,2]
["chr1",123624737,123625393,657,"ENSBGRG00000011886","ENSBGRT00000021733",419,"ARHGEF26","Rho guanine nucleotide exchange factor 26 [Source:HGNC Symbol;Acc:HGNC:24490]","GO:0001886(endothelial cell morphogenesis);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0097178(ruffle assembly)","05100(Bacterial invasion of epithelial cells)",{"v":1.7e-07,"d":"0.00"},1,"657,",0,-6.77,-6,8.36,"Exon (ENSBGRT00000021733/ENSBGRG00000011886, exon 1 of 13)",1,123470614,123625812,155199,2]
["chr1",123625601,123625661,61,"ENSBGRG00000011886","ENSBGRT00000021733",151,"ARHGEF26","Rho guanine nucleotide exchange factor 26 [Source:HGNC Symbol;Acc:HGNC:24490]","GO:0001886(endothelial cell morphogenesis);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0097178(ruffle assembly)","05100(Bacterial invasion of epithelial cells)",{"v":0.026,"d":"0.03"},1,"61,",0,-1.59,-1.07,2.38,"Exon (ENSBGRT00000021733/ENSBGRG00000011886, exon 1 of 13)",1,123470614,123625812,155199,2]
["chr1",125149261,125151418,2158,"ENSBGRG00000012398","ENSBGRT00000022700",177,"P2RY1","purinergic receptor P2Y1 [Source:HGNC Symbol;Acc:HGNC:8539]","GO:0001621(G protein-coupled ADP receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005929(cilium);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007200(phospholipase C-activating G protein-coupled receptor signaling pathway);GO:0008360(regulation of cell shape);GO:0016021(integral component of membrane);GO:0030168(platelet activation);GO:0043270(positive regulation of ion transport);GO:0045028(G protein-coupled purinergic nucleotide receptor activity);GO:0071407(cellular response to organic cyclic compound);GO:0071415(cellular response to purine-containing compound);GO:0090075(relaxation of muscle)","04015(Rap1 signaling pathway);04080(Neuroactive ligand-receptor interaction);04611(Platelet activation);04742(Taste transduction)",{"v":7.9e-37,"d":"0.00"},3,"435,261,246,","0,437,1912",{"v":-36.1,"d":"-36.10"},{"v":-34.9,"d":"-34.90"},7.29,"Exon (ENSBGRT00000022700/ENSBGRG00000012398, exon 1 of 3)",1,125149261,125151595,2335,2]
["chr1",125754014,125754522,509,"ENSBGRG00000012526","ENSBGRT00000023959",389,"MBNL1","muscleblind like splicing regulator 1 [Source:HGNC Symbol;Acc:HGNC:6923]","GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008380(RNA splicing);GO:0010494(cytoplasmic stress granule);GO:0043484(regulation of RNA splicing);GO:0046872(metal ion binding)","NA",{"v":1e-17,"d":"0.00"},1,"509,",0,-17,-16,3.31,"5' UTR",1,125576565,125754911,178347,2]
["chr1",126263840,126271599,7760,"ENSBGRG00000013608","ENSBGRT00000024913",0,"SUCNR1","succinate receptor 1 [Source:HGNC Symbol;Acc:HGNC:4542]","GO:0002001(renin secretion into blood stream);GO:0002281(macrophage activation involved in immune response);GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0032611(interleukin-1 beta production);GO:0038023(signaling receptor activity);GO:0042593(glucose homeostasis);GO:0050729(positive regulation of inflammatory response);GO:0050921(positive regulation of chemotaxis);GO:0051592(response to calcium ion);GO:0060177(regulation of angiotensin metabolic process)","04024(cAMP signaling pathway)",{"v":2.8e-08,"d":"0.00"},2,"565,319,","0,7441",-7.56,-6.76,{"v":29.1,"d":"29.10"},"5' UTR",1,126263457,126271599,8143,2]
["chr1",126669129,126670085,957,"ENSBGRG00000013878","ENSBGRT00000025477",0,"C1GALT1C1","C1GALT1 specific chaperone 1 [Source:HGNC Symbol;Acc:HGNC:24338]","GO:0006493(protein O-linked glycosylation)","00512(Mucin type O-glycan biosynthesis)",{"v":1e-17,"d":"0.00"},1,"957,",0,-17,{"v":-16.1,"d":"-16.10"},4.12,"Exon (ENSBGRT00000025477/ENSBGRG00000013878, exon 1 of 1)",1,126669129,126670085,957,2]
["chr1",128009984,128025592,15609,"ENSBGRG00000014873","ENSBGRT00000027440",29246,"EIF2A","eukaryotic translation initiation factor 2A [Source:HGNC Symbol;Acc:HGNC:3254]","GO:0000049(tRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005850(eukaryotic translation initiation factor 2 complex);GO:0006412(translation);GO:0006413(translational initiation);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0009967(positive regulation of signal transduction);GO:0032933(SREBP signaling pathway);GO:0042255(ribosome assembly);GO:0043022(ribosome binding)","NA",{"v":1.6E-44,"d":"0.00"},5,"66,66,129,114,12,","0,3199,3945,10633,15597",{"v":-43.8,"d":"-43.80"},{"v":-42.4,"d":"-42.40"},1.68,"Exon (ENSBGRT00000027440/ENSBGRG00000014873, exon 10 of 14)",1,128009984,128054838,44855,2]
["chr1",128025889,128029233,3345,"ENSBGRG00000014873","ENSBGRT00000027440",25605,"EIF2A","eukaryotic translation initiation factor 2A [Source:HGNC Symbol;Acc:HGNC:3254]","GO:0000049(tRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005850(eukaryotic translation initiation factor 2 complex);GO:0006412(translation);GO:0006413(translational initiation);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0009967(positive regulation of signal transduction);GO:0032933(SREBP signaling pathway);GO:0042255(ribosome assembly);GO:0043022(ribosome binding)","NA",{"v":1E-166,"d":"0.00"},3,"264,117,6,","0,3019,3339",-166,-164,5.37,"Exon (ENSBGRT00000027440/ENSBGRG00000014873, exon 8 of 14)",1,128009984,128054838,44855,2]
["chr1",128054452,128054838,387,"ENSBGRG00000014873","ENSBGRT00000027440",0,"EIF2A","eukaryotic translation initiation factor 2A [Source:HGNC Symbol;Acc:HGNC:3254]","GO:0000049(tRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005850(eukaryotic translation initiation factor 2 complex);GO:0006412(translation);GO:0006413(translational initiation);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0009967(positive regulation of signal transduction);GO:0032933(SREBP signaling pathway);GO:0042255(ribosome assembly);GO:0043022(ribosome binding)","NA",{"v":3.4E-5,"d":"0.00"},1,"387,",0,-4.47,-3.77,3.01,"5' UTR",1,128009984,128054838,44855,2]
["chr1",128139346,128186226,46881,"ENSBGRG00000015241","ENSBGRT00000028693",0,"TSC22D2","TSC22 domain family member 2 [Source:HGNC Symbol;Acc:HGNC:29095]","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006970(response to osmotic stress)","NA",{"v":1e-113,"d":"0.00"},5,"261,52,26,72,95,","0,1202,1923,35583,46786",-113,-111,5.01,"Exon (ENSBGRT00000028693/ENSBGRG00000015241, exon 1 of 3)",1,128139346,128141294,1949,2]
["chr1",128186731,128189852,3122,"ENSBGRG00000015241","ENSBGRT00000028386",0,"TSC22D2","TSC22 domain family member 2 [Source:HGNC Symbol;Acc:HGNC:29095]","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006970(response to osmotic stress)","NA",{"v":1.3E-15,"d":"0.00"},2,"35,1303,","0,1819",{"v":-14.9,"d":"-14.90"},-14,9.03,"Exon (ENSBGRT00000028386/ENSBGRG00000015241, exon 1 of 5)",1,128139346,128189852,50507,2]
["chr1",128740156,128779213,39058,"ENSBGRG00000015971","ENSBGRT00000029509",95733,"RNF13","ring finger protein 13 [Source:HGNC Symbol;Acc:HGNC:10057]","GO:0004842(ubiquitin-protein transferase activity);GO:0005654(nucleoplasm);GO:0005765(lysosomal membrane);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0008432(JUN kinase binding);GO:0031902(late endosome membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0070304(positive regulation of stress-activated protein kinase signaling cascade)","NA",{"v":3.6E-9,"d":"0.00"},3,"332,81,2,","0,574,39056",-8.44,-7.62,1.79,"Exon (ENSBGRT00000029509/ENSBGRG00000015971, exon 8 of 10)",1,128739386,128874946,135561,2]
["chr1",129611916,129616299,4384,"ENSBGRG00000017021","ENSBGRT00000031232",38611,"HPS3","HPS3 biogenesis of lysosomal organelles complex 2 subunit 1 [Source:HGNC Symbol;Acc:HGNC:15597]","GO:0005737(cytoplasm);GO:0006996(organelle organization);GO:0031084(BLOC-2 complex);GO:0043473(pigmentation)","NA",{"v":6.3e-13,"d":"0.00"},2,"613,77,","0,4307",{"v":-12.2,"d":"-12.20"},{"v":-11.3,"d":"-11.30"},2.81,"3' UTR",1,129520908,129654910,134003,2]
["chr1",129644416,129644596,181,"ENSBGRG00000017021","ENSBGRT00000031232",10314,"HPS3","HPS3 biogenesis of lysosomal organelles complex 2 subunit 1 [Source:HGNC Symbol;Acc:HGNC:15597]","GO:0005737(cytoplasm);GO:0006996(organelle organization);GO:0031084(BLOC-2 complex);GO:0043473(pigmentation)","NA",{"v":0.0051,"d":"0.01"},1,"181,",0,-2.29,-1.71,1.83,"Exon (ENSBGRT00000031232/ENSBGRG00000017021, exon 2 of 17)",1,129520908,129654910,134003,2]
["chr1",129769236,129769415,180,"ENSBGRG00000019043","ENSBGRT00000035004",45488,"GYG1","glycogenin 1 [Source:HGNC Symbol;Acc:HGNC:4699]","GO:0005978(glycogen biosynthetic process);GO:0008466(glycogenin glucosyltransferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030145(manganese ion binding);GO:0042803(protein homodimerization activity);GO:0102751(UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity)","00500(Starch and sucrose metabolism)",{"v":0.0072,"d":"0.01"},1,"180,",0,-2.14,-1.57,1.49,"3' UTR",1,129769236,129814903,45668,2]
["chr1",129770403,129770612,210,"ENSBGRG00000019043","ENSBGRT00000035004",44291,"GYG1","glycogenin 1 [Source:HGNC Symbol;Acc:HGNC:4699]","GO:0005978(glycogen biosynthetic process);GO:0008466(glycogenin glucosyltransferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030145(manganese ion binding);GO:0042803(protein homodimerization activity);GO:0102751(UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity)","00500(Starch and sucrose metabolism)",{"v":2.5e-07,"d":"0.00"},1,"210,",0,{"v":-6.6,"d":"-6.60"},-5.83,3.19,"3' UTR",1,129769236,129814903,45668,2]
["chr1",129951919,129972621,20703,"ENSBGRG00000019241","ENSBGRT00000035376",0,"CPA3","carboxypeptidase A3 [Source:HGNC Symbol;Acc:HGNC:2298]","GO:0002002(regulation of angiotensin levels in blood);GO:0004180(carboxypeptidase activity);GO:0004181(metallocarboxypeptidase activity);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008270(zinc ion binding)","04614(Renin-angiotensin system);04972(Pancreatic secretion);04974(Protein digestion and absorption)",{"v":6.3E-3,"d":"0.01"},7,"39,102,102,103,125,76,857,","0,6695,8219,8430,16514,19673,19846",{"v":-2.2,"d":"-2.20"},-1.62,9.03,"5' UTR",1,129935018,129972621,37604,2]
["chr1",130125929,130126286,358,"ENSBGRG00000019592","ENSBGRT00000036014",2017,"AGTR1","angiotensin II receptor type 1 [Source:HGNC Symbol;Acc:HGNC:336]","GO:0004930(G protein-coupled receptor activity);GO:0004945(angiotensin type II receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0019229(regulation of vasoconstriction)","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04072(Phospholipase D signaling pathway);04022(cGMP - PKG signaling pathway);04080(Neuroactive ligand-receptor interaction);04924(Renin secretion);04614(Renin-angiotensin system);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);05200(Pathways in cancer);04933(AGE-RAGE signaling pathway in diabetic complications);04934(Cushing syndrome)",{"v":1.6E-11,"d":"0.00"},1,"358,",0,{"v":-10.8,"d":"-10.80"},-9.89,4.26,"Exon (ENSBGRT00000036014/ENSBGRG00000019592, exon 3 of 3)",1,130125929,130128303,2375,2]
["chr1",130126762,130128303,1542,"ENSBGRG00000019592","ENSBGRT00000036014",0,"AGTR1","angiotensin II receptor type 1 [Source:HGNC Symbol;Acc:HGNC:336]","GO:0004930(G protein-coupled receptor activity);GO:0004945(angiotensin type II receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0019229(regulation of vasoconstriction)","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04072(Phospholipase D signaling pathway);04022(cGMP - PKG signaling pathway);04080(Neuroactive ligand-receptor interaction);04924(Renin secretion);04614(Renin-angiotensin system);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);05200(Pathways in cancer);04933(AGE-RAGE signaling pathway in diabetic complications);04934(Cushing syndrome)",{"v":0.00044,"d":"0.00"},3,"259,29,40,","0,264,1502",-3.36,-2.71,2.41,"Exon (ENSBGRT00000036014/ENSBGRG00000019592, exon 1 of 3)",1,130125929,130128303,2375,2]
["chr1",135940703,135960059,19357,"ENSBGRG00000000180","ENSBGRT00000000286",508,"DIPK2A","divergent protein kinase domain 2A [Source:HGNC Symbol;Acc:HGNC:28490]","GO:0000139(Golgi membrane);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0030126(COPI vesicle coat);GO:0030137(COPI-coated vesicle);GO:0034392(negative regulation of smooth muscle cell apoptotic process);GO:0060038(cardiac muscle cell proliferation);GO:1900020(positive regulation of protein kinase C activity)","NA",{"v":1.6e-29,"d":"0.00"},3,"205,304,149,","0,2907,19208",{"v":-28.8,"d":"-28.80"},{"v":-27.7,"d":"-27.70"},5.48,"Exon (ENSBGRT00000000286/ENSBGRG00000000180, exon 1 of 3)",1,135939807,135960567,20761,2]
["chr1",137060027,137061259,1233,"ENSBGRG00000000218","ENSBGRT00000000347",1517,"CHST2","carbohydrate sulfotransferase 2 [Source:HGNC Symbol;Acc:HGNC:1970]","GO:0000139(Golgi membrane);GO:0001517(N-acetylglucosamine 6-O-sulfotransferase activity);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006044(N-acetylglucosamine metabolic process);GO:0006790(sulfur compound metabolic process);GO:0008146(sulfotransferase activity)","00533(Glycosaminoglycan biosynthesis - keratan sulfate)",{"v":1.6E-27,"d":"0.00"},2,"159,497,","0,736",{"v":-26.8,"d":"-26.80"},{"v":-25.7,"d":"-25.70"},{"v":12.3,"d":"12.30"},"Exon (ENSBGRT00000000347/ENSBGRG00000000218, exon 2 of 3)",1,137060027,137062776,2750,2]
["chr1",137061318,137062597,1280,"ENSBGRG00000000218","ENSBGRT00000000347",179,"CHST2","carbohydrate sulfotransferase 2 [Source:HGNC Symbol;Acc:HGNC:1970]","GO:0000139(Golgi membrane);GO:0001517(N-acetylglucosamine 6-O-sulfotransferase activity);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006044(N-acetylglucosamine metabolic process);GO:0006790(sulfur compound metabolic process);GO:0008146(sulfotransferase activity)","00533(Glycosaminoglycan biosynthesis - keratan sulfate)",{"v":5e-41,"d":"0.00"},2,"610,75,","0,1205",{"v":-40.3,"d":"-40.30"},-39,7.05,"Exon (ENSBGRT00000000347/ENSBGRG00000000218, exon 1 of 3)",1,137060027,137062776,2750,2]
["chr1",137136621,137151574,14954,"ENSBGRG00000000223","ENSBGRT00000000356",40317,"U2SURP","U2 snRNP associated SURP domain containing [Source:HGNC Symbol;Acc:HGNC:30855]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006396(RNA processing)","03040(Spliceosome)",{"v":2.5e-61,"d":"0.00"},6,"139,177,119,111,160,9,","0,2127,3533,6164,10948,14945",{"v":-60.6,"d":"-60.60"},{"v":-59.1,"d":"-59.10"},2.77,"Exon (ENSBGRT00000000356/ENSBGRG00000000223, exon 23 of 28)",1,137136621,137191891,55271,2]
["chr1",137171900,137174942,3043,"ENSBGRG00000000223","ENSBGRT00000000356",16949,"U2SURP","U2 snRNP associated SURP domain containing [Source:HGNC Symbol;Acc:HGNC:30855]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006396(RNA processing)","03040(Spliceosome)",{"v":0.00065,"d":"0.00"},3,"6,115,58,","0,566,2985",-3.19,-2.55,1.68,"Exon (ENSBGRT00000000356/ENSBGRG00000000223, exon 4 of 28)",1,137136621,137191891,55271,2]
["chr1",137481771,137483122,1352,"ENSBGRG00000000286","ENSBGRT00000000536",67339,"TRPC1","transient receptor potential cation channel subfamily C member 1 [Source:HGNC Symbol;Acc:HGNC:12333]","GO:0005102(signaling receptor binding);GO:0005216(ion channel activity);GO:0005262(calcium channel activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042438(melanin biosynthetic process);GO:0043235(receptor complex);GO:0051117(ATPase binding);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0051480(regulation of cytosolic calcium ion concentration);GO:0051592(response to calcium ion);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport);GO:0070679(inositol 1,4,5 trisphosphate binding)","04972(Pancreatic secretion);04724(Glutamatergic synapse);04726(Serotonergic synapse);04360(Axon guidance)",{"v":3.2e-26,"d":"0.00"},2,"228,101,","0,1251",{"v":-25.5,"d":"-25.50"},{"v":-24.4,"d":"-24.40"},9.03,"Exon (ENSBGRT00000000536/ENSBGRG00000000286, exon 12 of 13)",1,137481771,137550461,68691,2]
["chr1",137615168,137621765,6598,"ENSBGRG00000000350","ENSBGRT00000000578",0,"PLS1","plastin 1 [Source:HGNC Symbol;Acc:HGNC:9090]","GO:0001951(intestinal D-glucose absorption);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005903(brush border);GO:0032532(regulation of microvillus length);GO:0040018(positive regulation of multicellular organism growth);GO:0051015(actin filament binding);GO:0051017(actin filament bundle assembly);GO:1902896(terminal web assembly);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1990357(terminal web)","NA",{"v":0.0017,"d":"0.00"},2,"44,106,","0,6492",-2.77,-2.16,12,"5' UTR",1,137555887,137621765,65879,2]
["chr1",138554497,138560974,6478,"ENSBGRG00000001134","ENSBGRT00000002094",0,"RNF7","ring finger protein 7 [Source:HGNC Symbol;Acc:HGNC:10070]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0031466(Cul5-RING ubiquitin ligase complex);GO:0045116(protein neddylation);GO:0061663(NEDD8 ligase activity);GO:0097602(cullin family protein binding)","04120(Ubiquitin mediated proteolysis)",{"v":5.9e-07,"d":"0.00"},3,"119,48,175,","0,2797,6303",-6.23,-5.47,2.26,"Exon (ENSBGRT00000002094/ENSBGRG00000001134, exon 1 of 3)",1,138554497,138560974,6478,2]
["chr1",138696255,138697800,1546,"ENSBGRG00000001166","ENSBGRT00000002256",127538,"RASA2","RAS p21 protein activator 2 [Source:HGNC Symbol;Acc:HGNC:9872]","GO:0005096(GTPase activator activity);GO:0005543(phospholipid binding);GO:0007165(signal transduction);GO:0035556(intracellular signal transduction);GO:0043087(regulation of GTPase activity);GO:0046580(negative regulation of Ras protein signal transduction)","04014(Ras signaling pathway);04010(MAPK signaling pathway);05203(Viral carcinogenesis)",{"v":0.0054,"d":"0.01"},2,"68,83,","0,1463",-2.27,-1.69,2.19,"Exon (ENSBGRT00000002256/ENSBGRG00000001166, exon 22 of 24)",1,138694522,138825338,130817,2]
["chr1",138894957,138899467,4511,"ENSBGRG00000001246","ENSBGRT00000002273",48211,"ZBTB38","zinc finger and BTB domain containing 38 [Source:HGNC Symbol;Acc:HGNC:26636]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006275(regulation of DNA replication);GO:0006974(cellular response to DNA damage stimulus);GO:0008327(methyl-CpG binding);GO:0042803(protein homodimerization activity);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":2.5e-70,"d":"0.00"},2,"44,2442,","0,2069",{"v":-69.6,"d":"-69.60"},{"v":-68.1,"d":"-68.10"},8.42,"Exon (ENSBGRT00000002273/ENSBGRG00000001246, exon 2 of 3)",1,138894957,138947678,52722,2]
["chr1",138899827,138900336,510,"ENSBGRG00000001246","ENSBGRT00000002273",47342,"ZBTB38","zinc finger and BTB domain containing 38 [Source:HGNC Symbol;Acc:HGNC:26636]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006275(regulation of DNA replication);GO:0006974(cellular response to DNA damage stimulus);GO:0008327(methyl-CpG binding);GO:0042803(protein homodimerization activity);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":2.5e-10,"d":"0.00"},1,"510,",0,-9.61,-8.76,3.72,"Exon (ENSBGRT00000002273/ENSBGRG00000001246, exon 2 of 3)",1,138894957,138947678,52722,2]
["chr1",139076837,139093615,16779,"ENSBGRG00000001263","ENSBGRT00000002318",23740,"PXYLP1","2-phosphoxylose phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:26303]","GO:0005794(Golgi apparatus);GO:0006024(glycosaminoglycan biosynthetic process);GO:0010909(positive regulation of heparan sulfate proteoglycan biosynthetic process);GO:0016791(phosphatase activity);GO:0050650(chondroitin sulfate proteoglycan biosynthetic process)","NA",{"v":7.9e-26,"d":"0.00"},3,"790,140,108,","0,5872,16671",{"v":-25.1,"d":"-25.10"},-24,5.85,"Exon (ENSBGRT00000002318/ENSBGRG00000001263, exon 3 of 5)",1,139076689,139117355,40667,2]
["chr1",139446585,139448187,1603,"ENSBGRG00000001317","ENSBGRT00000002419",36161,"SLC25A36","solute carrier family 25 member 36 [Source:HGNC Symbol;Acc:HGNC:25554]","GO:0000002(mitochondrial genome maintenance);GO:0005347(ATP transmembrane transporter activity);GO:0005739(mitochondrion);GO:0006864(pyrimidine nucleotide transport);GO:0007005(mitochondrion organization);GO:0015218(pyrimidine nucleotide transmembrane transporter activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055085(transmembrane transport)","NA",{"v":1e-55,"d":"0.00"},2,"194,193,","0,1410",-55,{"v":-53.6,"d":"-53.60"},12,"Exon (ENSBGRT00000002419/ENSBGRG00000001317, exon 6 of 7)",1,139446585,139484348,37764,2]
["chr1",139859022,139861505,2484,"ENSBGRG00000001375","ENSBGRT00000002548",800901,"CLSTN2","calsyntenin 2 [Source:HGNC Symbol;Acc:HGNC:17448]","GO:0005509(calcium ion binding);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0009986(cell surface);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0045211(postsynaptic membrane);GO:0050806(positive regulation of synaptic transmission);GO:0051965(positive regulation of synapse assembly);GO:0098978(glutamatergic synapse);GO:0099061(integral component of postsynaptic density membrane)","NA",{"v":0.0058,"d":"0.01"},2,"198,12,","0,2472",-2.24,-1.66,10,"Exon (ENSBGRT00000002548/ENSBGRG00000001375, exon 16 of 17)",1,139859022,140662406,803385,2]
["chr1",140044806,140054098,9293,"ENSBGRG00000001375","ENSBGRT00000002548",608308,"CLSTN2","calsyntenin 2 [Source:HGNC Symbol;Acc:HGNC:17448]","GO:0005509(calcium ion binding);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0009986(cell surface);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0045211(postsynaptic membrane);GO:0050806(positive regulation of synaptic transmission);GO:0051965(positive regulation of synapse assembly);GO:0098978(glutamatergic synapse);GO:0099061(integral component of postsynaptic density membrane)","NA",{"v":6.3E-3,"d":"0.01"},2,"52,127,","0,9166",{"v":-2.2,"d":"-2.20"},-1.62,6.02,"Exon (ENSBGRT00000002548/ENSBGRG00000001375, exon 4 of 17)",1,139859022,140662406,803385,2]
["chr1",142184550,142194934,10385,"ENSBGRG00000001673","ENSBGRT00000003109",1425,"FAIM","Fas apoptotic inhibitory molecule [Source:HGNC Symbol;Acc:HGNC:18703]","GO:0043066(negative regulation of apoptotic process)","NA",{"v":2.5e-13,"d":"0.00"},4,"120,50,229,74,","0,4827,9730,10311",{"v":-12.6,"d":"-12.60"},{"v":-11.7,"d":"-11.70"},2.13,"Exon (ENSBGRT00000003109/ENSBGRG00000001673, exon 2 of 6)",1,142184509,142196359,11851,2]
["chr1",142426358,142429370,3013,"ENSBGRG00000001941","ENSBGRT00000003635",82960,"MRAS","muscle RAS oncogene homolog [Source:HGNC Symbol;Acc:HGNC:7227]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0007265(Ras protein signal transduction);GO:0016020(membrane);GO:0030742(GTP-dependent protein binding);GO:1990830(cellular response to leukemia inhibitory factor)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04371(Apelin signaling pathway);04072(Phospholipase D signaling pathway);04140(Autophagy - animal);04137(Mitophagy - animal);04218(Cellular senescence);04810(Regulation of actin cytoskeleton);04625(C-type lectin receptor signaling pathway);05205(Proteoglycans in cancer);05166(HTLV-I infection)",{"v":1.6e-42,"d":"0.00"},2,"725,53,","0,2960",{"v":-41.8,"d":"-41.80"},{"v":-40.5,"d":"-40.50"},5.06,"3' UTR",1,142426358,142512330,85973,2]
["chr1",142511732,142512181,450,"ENSBGRG00000001941","ENSBGRT00000003635",149,"MRAS","muscle RAS oncogene homolog [Source:HGNC Symbol;Acc:HGNC:7227]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0007265(Ras protein signal transduction);GO:0016020(membrane);GO:0030742(GTP-dependent protein binding);GO:1990830(cellular response to leukemia inhibitory factor)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04371(Apelin signaling pathway);04072(Phospholipase D signaling pathway);04140(Autophagy - animal);04137(Mitophagy - animal);04218(Cellular senescence);04810(Regulation of actin cytoskeleton);04625(C-type lectin receptor signaling pathway);05205(Proteoglycans in cancer);05166(HTLV-I infection)",{"v":0.032,"d":"0.03"},1,"450,",0,-1.49,{"v":-0.978,"d":"-0.98"},7.02,"5' UTR",1,142426358,142512330,85973,2]
["chr1",142567061,142583523,16463,"ENSBGRG00000002029","ENSBGRT00000003769",102154,"ARMC8","armadillo repeat containing 8 [Source:HGNC Symbol;Acc:HGNC:24999]","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm)","NA",{"v":7.9e-59,"d":"0.00"},6,"170,94,518,73,96,4,","0,6639,7426,8075,12636,16459",{"v":-58.1,"d":"-58.10"},{"v":-56.7,"d":"-56.70"},16,"3' UTR",1,142567061,142685677,118617,2]
["chr1",144046569,144047462,894,"ENSBGRG00000002412","ENSBGRT00000004515",41989,"NCK1","NCK adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:7664]","GO:0000164(protein phosphatase type 1 complex);GO:0004860(protein kinase inhibitor activity);GO:0005070(SH3/SH2 adaptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005840(ribosome);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006930(substrate-dependent cell migration, cell extension);GO:0007015(actin filament organization);GO:0010976(positive regulation of neuron projection development);GO:0012506(vesicle membrane);GO:0016477(cell migration);GO:0019904(protein domain specific binding);GO:0030032(lamellipodium assembly);GO:0030334(regulation of cell migration);GO:0030674(protein-macromolecule adaptor activity);GO:0030838(positive regulation of actin filament polymerization);GO:0030971(receptor tyrosine kinase binding);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042102(positive regulation of T cell proliferation);GO:0042110(T cell activation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0051707(response to other organism);GO:0060548(negative regulation of cell death);GO:0070262(peptidyl-serine dephosphorylation);GO:0071074(eukaryotic initiation factor eIF2 binding);GO:1902237(positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway);GO:1903676(positive regulation of cap-dependent translational initiation);GO:1903679(positive regulation of cap-independent translational initiation);GO:1903898(negative regulation of PERK-mediated unfolded protein response);GO:1903912(negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation);GO:1990441(negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04012(ErbB signaling pathway);04660(T cell receptor signaling pathway);04360(Axon guidance)",{"v":6.3e-16,"d":"0.00"},1,"894,",0,{"v":-15.2,"d":"-15.20"},{"v":-14.3,"d":"-14.30"},6.27,"3' UTR",1,144046569,144089451,42883,2]
["chr1",144103292,144125538,22247,"ENSBGRG00000002412","ENSBGRT00000004487",0,"NCK1","NCK adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:7664]","GO:0000164(protein phosphatase type 1 complex);GO:0004860(protein kinase inhibitor activity);GO:0005070(SH3/SH2 adaptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005840(ribosome);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006930(substrate-dependent cell migration, cell extension);GO:0007015(actin filament organization);GO:0010976(positive regulation of neuron projection development);GO:0012506(vesicle membrane);GO:0016477(cell migration);GO:0019904(protein domain specific binding);GO:0030032(lamellipodium assembly);GO:0030334(regulation of cell migration);GO:0030674(protein-macromolecule adaptor activity);GO:0030838(positive regulation of actin filament polymerization);GO:0030971(receptor tyrosine kinase binding);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042102(positive regulation of T cell proliferation);GO:0042110(T cell activation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0051707(response to other organism);GO:0060548(negative regulation of cell death);GO:0070262(peptidyl-serine dephosphorylation);GO:0071074(eukaryotic initiation factor eIF2 binding);GO:1902237(positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway);GO:1903676(positive regulation of cap-dependent translational initiation);GO:1903679(positive regulation of cap-independent translational initiation);GO:1903898(negative regulation of PERK-mediated unfolded protein response);GO:1903912(negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation);GO:1990441(negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04012(ErbB signaling pathway);04660(T cell receptor signaling pathway);04360(Axon guidance)",{"v":9.99999999999998e-234,"d":"0.00"},4,"290,713,34,244,","0,2178,15728,22003",-233,-230,5.51,"5' UTR",1,144046569,144125538,78970,2]
["chr1",144970599,144970778,180,"ENSBGRG00000002883","ENSBGRT00000005543",0,"PCCB","propionyl-CoA carboxylase subunit beta [Source:HGNC Symbol;Acc:HGNC:8654]","GO:0004658(propionyl-CoA carboxylase activity);GO:0005759(mitochondrial matrix);GO:0016874(ligase activity)","00630(Glyoxylate and dicarboxylate metabolism);00640(Propanoate metabolism);00280(Valine, leucine and isoleucine degradation)",{"v":2.7e-07,"d":"0.00"},1,"180,",0,-6.57,{"v":-5.8,"d":"-5.80"},2.87,"Exon (ENSBGRT00000005543/ENSBGRG00000002883, exon 1 of 16)",1,144844619,144970778,126160,2]
["chr1",145031457,145032025,569,"ENSBGRG00000003035","ENSBGRT00000005672",2743,"ENSBGRG00000003035","NA","NA","NA",{"v":0.035,"d":"0.04"},1,"569,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000005672/ENSBGRG00000003035, exon 2 of 2)",1,145029635,145034768,5134,2]
["chr1",145033991,145034768,778,"ENSBGRG00000003035","ENSBGRT00000005672",0,"ENSBGRG00000003035","NA","NA","NA",{"v":0.00089,"d":"0.00"},1,"778,",0,-3.05,-2.42,13,"Exon (ENSBGRT00000005672/ENSBGRG00000003035, exon 1 of 2)",1,145029635,145034768,5134,2]
["chr1",145255694,145256052,359,"ENSBGRG00000003074","ENSBGRT00000005767",20183,"PPP2R3A","protein phosphatase 2 regulatory subunit B''alpha [Source:HGNC Symbol;Acc:HGNC:9307]","GO:0000159(protein phosphatase type 2A complex);GO:0005509(calcium ion binding)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);05165(Human papillomavirus infection)",{"v":4.8e-05,"d":"0.00"},1,"359,",0,-4.32,-3.63,3.71,"Exon (ENSBGRT00000005767/ENSBGRG00000003074, exon 2 of 14)",1,145073358,145276235,202878,2]
["chr1",145256827,145257483,657,"ENSBGRG00000003074","ENSBGRT00000005767",18752,"PPP2R3A","protein phosphatase 2 regulatory subunit B''alpha [Source:HGNC Symbol;Acc:HGNC:9307]","GO:0000159(protein phosphatase type 2A complex);GO:0005509(calcium ion binding)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);05165(Human papillomavirus infection)",{"v":1.9e-08,"d":"0.00"},1,"657,",0,-7.72,-6.92,{"v":11.4,"d":"11.40"},"5' UTR",1,145073358,145276235,202878,2]
["chr1",145257573,145276235,18663,"ENSBGRG00000003074","ENSBGRT00000005767",0,"PPP2R3A","protein phosphatase 2 regulatory subunit B''alpha [Source:HGNC Symbol;Acc:HGNC:9307]","GO:0000159(protein phosphatase type 2A complex);GO:0005509(calcium ion binding)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);05165(Human papillomavirus infection)",{"v":0.00045,"d":"0.00"},2,"291,187,","0,18476",-3.35,{"v":-2.7,"d":"-2.70"},9.03,"5' UTR",1,145073358,145276235,202878,2]
["chr1",146134490,146138932,4443,"ENSBGRG00000003150","ENSBGRT00000005871",508070,"ENSBGRG00000003150","EPH receptor B1 [Source:HGNC Symbol;Acc:HGNC:3392]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0016021(integral component of membrane)","04360(Axon guidance)",{"v":1.4e-09,"d":"0.00"},2,"1050,59,","0,4384",-8.85,-8.02,{"v":31.1,"d":"31.10"},"3' UTR",1,146134490,146647002,512513,2]
["chr1",146470347,146471438,1092,"ENSBGRG00000003150","ENSBGRT00000005871",175564,"ENSBGRG00000003150","EPH receptor B1 [Source:HGNC Symbol;Acc:HGNC:3392]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0016021(integral component of membrane)","04360(Axon guidance)",{"v":0.019,"d":"0.02"},2,"137,44,","0,1048",-1.72,-1.19,5.01,"Exon (ENSBGRT00000005871/ENSBGRG00000003150, exon 3 of 17)",1,146134490,146647002,512513,2]
["chr1",146902373,146902774,402,"ENSBGRG00000003279","ENSBGRT00000006099",49168,"CEP63","centrosomal protein 63 [Source:HGNC Symbol;Acc:HGNC:25815]","GO:0005813(centrosome);GO:0007099(centriole replication)","NA",0.04,2,"80,70,","0,332",{"v":-1.4,"d":"-1.40"},{"v":-0.9,"d":"-0.90"},1.41,"Exon (ENSBGRT00000006099/ENSBGRG00000003279, exon 6 of 14)",1,146882524,146951942,69419,2]
["chr1",146932200,146950782,18583,"ENSBGRG00000003279","ENSBGRT00000006099",1160,"CEP63","centrosomal protein 63 [Source:HGNC Symbol;Acc:HGNC:25815]","GO:0005813(centrosome);GO:0007099(centriole replication)","NA",{"v":0.021,"d":"0.02"},3,"75,96,9,","0,1500,18574",-1.68,-1.15,{"v":1.5,"d":"1.50"},"Exon (ENSBGRT00000006099/ENSBGRG00000003279, exon 2 of 14)",1,146882524,146951942,69419,2]
["chr1",146950841,146951942,1102,"ENSBGRG00000003279","ENSBGRT00000006099",0,"CEP63","centrosomal protein 63 [Source:HGNC Symbol;Acc:HGNC:25815]","GO:0005813(centrosome);GO:0007099(centriole replication)","NA",{"v":1.5E-3,"d":"0.00"},2,"111,69,","0,1033",-2.83,-2.21,1.97,"5' UTR",1,146882524,146951942,69419,2]
["chr1",147712998,147713117,120,"ENSBGRG00000003560","ENSBGRT00000006635",42744,"SRPRB","SRP receptor subunit beta [Source:HGNC Symbol;Acc:HGNC:24085]","GO:0005737(cytoplasm);GO:0005881(cytoplasmic microtubule);GO:0016020(membrane)","03060(Protein export)",{"v":0.014,"d":"0.01"},1,"120,",0,-1.84,{"v":-1.3,"d":"-1.30"},1.31,"Exon (ENSBGRT00000006635/ENSBGRG00000003560, exon 7 of 7)",1,147711866,147755861,43996,2]
["chr1",148053661,148065860,12200,"ENSBGRG00000004386","ENSBGRT00000008114",0,"ENSBGRG00000004386","NA","NA","NA",{"v":3.2e-28,"d":"0.00"},5,"151,160,146,77,240,","0,1308,1993,11191,11960",{"v":-27.5,"d":"-27.50"},{"v":-26.4,"d":"-26.40"},{"v":15.7,"d":"15.70"},"Exon (ENSBGRT00000008114/ENSBGRG00000004386, exon 1 of 5)",1,148053661,148065860,12200,2]
["chr1",148233498,148233825,328,"ENSBGRG00000006213","ENSBGRT00000011528",188942,"TMEM108","transmembrane protein 108 [Source:HGNC Symbol;Acc:HGNC:28451]","GO:0005769(early endosome);GO:0006898(receptor-mediated endocytosis);GO:0008090(retrograde axonal transport);GO:0010008(endosome membrane);GO:0014069(postsynaptic density);GO:0021542(dentate gyrus development);GO:0030424(axon);GO:0031175(neuron projection development);GO:0036477(somatodendritic compartment);GO:0051388(positive regulation of neurotrophin TRK receptor signaling pathway);GO:0097106(postsynaptic density organization);GO:0097484(dendrite extension);GO:0098815(modulation of excitatory postsynaptic potential);GO:1990416(cellular response to brain-derived neurotrophic factor stimulus)","NA",{"v":0.0032,"d":"0.00"},1,"328,",0,{"v":-2.5,"d":"-2.50"},-1.91,11,"3' UTR",1,148233498,148422767,189270,2]
["chr1",148248179,148249101,923,"ENSBGRG00000006213","ENSBGRT00000011528",173666,"TMEM108","transmembrane protein 108 [Source:HGNC Symbol;Acc:HGNC:28451]","GO:0005769(early endosome);GO:0006898(receptor-mediated endocytosis);GO:0008090(retrograde axonal transport);GO:0010008(endosome membrane);GO:0014069(postsynaptic density);GO:0021542(dentate gyrus development);GO:0030424(axon);GO:0031175(neuron projection development);GO:0036477(somatodendritic compartment);GO:0051388(positive regulation of neurotrophin TRK receptor signaling pathway);GO:0097106(postsynaptic density organization);GO:0097484(dendrite extension);GO:0098815(modulation of excitatory postsynaptic potential);GO:1990416(cellular response to brain-derived neurotrophic factor stimulus)","NA",{"v":0.00013,"d":"0.00"},1,"923,",0,-3.87,{"v":-3.2,"d":"-3.20"},16,"Exon (ENSBGRT00000011493/ENSBGRG00000006213, exon 4 of 6)",1,148233498,148422767,189270,2]
["chr1",149152963,149154190,1228,"ENSBGRG00000006457","ENSBGRT00000012028",34231,"UBA5","ubiquitin like modifier activating enzyme 5 [Source:HGNC Symbol;Acc:HGNC:23230]","GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0008641(ubiquitin-like modifier activating enzyme activity);GO:0030218(erythrocyte differentiation);GO:0030219(megakaryocyte differentiation);GO:0033146(regulation of intracellular estrogen receptor signaling pathway);GO:0034976(response to endoplasmic reticulum stress);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0050905(neuromuscular process);GO:0061709(reticulophagy);GO:0071566(UFM1 activating enzyme activity);GO:0071569(protein ufmylation);GO:1990592(protein K69-linked ufmylation)","NA",{"v":3.2e-21,"d":"0.00"},4,"3,84,107,44,","0,327,926,1184",{"v":-20.5,"d":"-20.50"},{"v":-19.5,"d":"-19.50"},5.17,"Exon (ENSBGRT00000012028/ENSBGRG00000006457, exon 10 of 12)",1,149152963,149188421,35459,2]
["chr1",149272151,149272998,848,"ENSBGRG00000007089","ENSBGRT00000013019",0,"ACKR4","atypical chemokine receptor 4 [Source:HGNC Symbol;Acc:HGNC:1611]","GO:0004930(G protein-coupled receptor activity);GO:0004950(chemokine receptor activity);GO:0005044(scavenger receptor activity);GO:0006935(chemotaxis);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0019956(chemokine binding)","04060(Cytokine-cytokine receptor interaction)",{"v":5.9e-10,"d":"0.00"},1,"848,",0,-9.23,-8.39,4.68,"Exon (ENSBGRT00000013019/ENSBGRG00000007089, exon 1 of 1)",1,149271946,149272998,1053,2]
["chr1",150673744,150673918,175,"ENSBGRG00000007488","ENSBGRT00000014119",662487,"CPNE4","copine 4 [Source:HGNC Symbol;Acc:HGNC:2317]","NA","NA",{"v":0.0081,"d":"0.01"},1,"175,",0,-2.09,-1.53,3.01,"Exon (ENSBGRT00000014273/ENSBGRG00000007802, exon 1 of 1)",1,150011257,150763344,752088,1]
["chr1",150988836,150989135,300,"ENSBGRG00000008026","ENSBGRT00000014683",2729,"NUDT16","nudix hydrolase 16 [Source:HGNC Symbol;Acc:HGNC:26442]","GO:0000287(magnesium ion binding);GO:0003729(mRNA binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006382(adenosine to inosine editing);GO:0006402(mRNA catabolic process);GO:0008235(metalloexopeptidase activity);GO:0008284(positive regulation of cell population proliferation);GO:0016077(snoRNA catabolic process);GO:0016787(hydrolase activity);GO:0030145(manganese ion binding);GO:0030515(snoRNA binding);GO:0031404(chloride ion binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0046709(IDP catabolic process);GO:0050072(m7G(5')pppN diphosphatase activity);GO:0050897(cobalt ion binding);GO:0090068(positive regulation of cell cycle process);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic);GO:0098519(nucleotide phosphatase activity, acting on free nucleotides);GO:1901639(XDP catabolic process);GO:1901640(XTP binding);GO:1901641(ITP binding);GO:1990174(phosphodiesterase decapping endonuclease activity);GO:2000781(positive regulation of double-strand break repair)","00230(Purine metabolism);03018(RNA degradation)",{"v":5E-15,"d":"0.00"},1,"300,",0,{"v":-14.3,"d":"-14.30"},{"v":-13.4,"d":"-13.40"},{"v":18.1,"d":"18.10"},"3' UTR",1,150988836,150991864,3029,2]
["chr1",150989254,150989464,211,"ENSBGRG00000008026","ENSBGRT00000014683",2400,"NUDT16","nudix hydrolase 16 [Source:HGNC Symbol;Acc:HGNC:26442]","GO:0000287(magnesium ion binding);GO:0003729(mRNA binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006382(adenosine to inosine editing);GO:0006402(mRNA catabolic process);GO:0008235(metalloexopeptidase activity);GO:0008284(positive regulation of cell population proliferation);GO:0016077(snoRNA catabolic process);GO:0016787(hydrolase activity);GO:0030145(manganese ion binding);GO:0030515(snoRNA binding);GO:0031404(chloride ion binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0046709(IDP catabolic process);GO:0050072(m7G(5')pppN diphosphatase activity);GO:0050897(cobalt ion binding);GO:0090068(positive regulation of cell cycle process);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic);GO:0098519(nucleotide phosphatase activity, acting on free nucleotides);GO:1901639(XDP catabolic process);GO:1901640(XTP binding);GO:1901641(ITP binding);GO:1990174(phosphodiesterase decapping endonuclease activity);GO:2000781(positive regulation of double-strand break repair)","00230(Purine metabolism);03018(RNA degradation)",{"v":6.3e-16,"d":"0.00"},1,"211,",0,{"v":-15.2,"d":"-15.20"},{"v":-14.2,"d":"-14.20"},7.84,"3' UTR",1,150988836,150991864,3029,2]
["chr1",150990241,150991864,1624,"ENSBGRG00000008026","ENSBGRT00000014683",0,"NUDT16","nudix hydrolase 16 [Source:HGNC Symbol;Acc:HGNC:26442]","GO:0000287(magnesium ion binding);GO:0003729(mRNA binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006382(adenosine to inosine editing);GO:0006402(mRNA catabolic process);GO:0008235(metalloexopeptidase activity);GO:0008284(positive regulation of cell population proliferation);GO:0016077(snoRNA catabolic process);GO:0016787(hydrolase activity);GO:0030145(manganese ion binding);GO:0030515(snoRNA binding);GO:0031404(chloride ion binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0046709(IDP catabolic process);GO:0050072(m7G(5')pppN diphosphatase activity);GO:0050897(cobalt ion binding);GO:0090068(positive regulation of cell cycle process);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic);GO:0098519(nucleotide phosphatase activity, acting on free nucleotides);GO:1901639(XDP catabolic process);GO:1901640(XTP binding);GO:1901641(ITP binding);GO:1990174(phosphodiesterase decapping endonuclease activity);GO:2000781(positive regulation of double-strand break repair)","00230(Purine metabolism);03018(RNA degradation)",{"v":1e-131,"d":"0.00"},3,"400,270,138,","0,1112,1486",-131,-129,{"v":5.5,"d":"5.50"},"3' UTR",1,150988836,150991864,3029,2]
["chr1",151006871,151102878,96008,"ENSBGRG00000008332","ENSBGRT00000015164",0,"U6","U6 spliceosomal RNA [Source:RFAM;Acc:RF00026]","NA","NA",{"v":0.0017,"d":"0.00"},4,"292,97,61,57,","0,52727,72136,95951",-2.77,-2.16,12,"Exon (ENSBGRT00000015164/ENSBGRG00000008332, exon 1 of 1)",1,151028273,151028379,107,1]
["chr1",151169821,151188851,19031,"ENSBGRG00000008075","ENSBGRT00000014748",109954,"NEK11","NIMA related kinase 11 [Source:HGNC Symbol;Acc:HGNC:18593]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006468(protein phosphorylation);GO:0016572(histone phosphorylation);GO:0031573(intra-S DNA damage checkpoint);GO:0035556(intracellular signal transduction);GO:1901990(regulation of mitotic cell cycle phase transition)","NA",{"v":0.032,"d":"0.03"},3,"79,120,69,","0,3046,18962",-1.49,{"v":-0.978,"d":"-0.98"},5.01,"Exon (ENSBGRT00000014748/ENSBGRG00000008075, exon 10 of 17)",1,151006871,151298805,291935,2]
["chr1",151312711,151337248,24538,"ENSBGRG00000008357","ENSBGRT00000015300",12200,"ASTE1","asteroid homolog 1 [Source:HGNC Symbol;Acc:HGNC:25021]","GO:0004518(nuclease activity);GO:0006281(DNA repair)","NA",{"v":9.99999999999998e-283,"d":"0.00"},2,"36,531,","0,24007",-282,-280,5.87,"3' UTR",1,151300511,151316894,16384,1]
["chr1",151505418,151506044,627,"ENSBGRG00000008500","ENSBGRT00000015560",0,"ATP2C1","ATPase secretory pathway Ca2+ transporting 1 [Source:HGNC Symbol;Acc:HGNC:13211]","GO:0000139(Golgi membrane);GO:0000166(nucleotide binding);GO:0005388(calcium transmembrane transporter activity, phosphorylative mechanism);GO:0005524(ATP binding);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0006816(calcium ion transport);GO:0006874(cellular calcium ion homeostasis);GO:0008544(epidermis development);GO:0016021(integral component of membrane);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0031532(actin cytoskeleton reorganization);GO:0032468(Golgi calcium ion homeostasis);GO:0032472(Golgi calcium ion transport);GO:0070588(calcium ion transmembrane transport)","NA",{"v":9.3e-05,"d":"0.00"},1,"627,",0,-4.03,-3.35,15,"5' UTR",1,151312651,151506044,193394,2]
["chr1",151735579,151750034,14456,"ENSBGRG00000009216","ENSBGRT00000017073",0,"BRWD1","bromodomain and WD repeat domain containing 1 [Source:HGNC Symbol;Acc:HGNC:12760]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0043248(proteasome assembly)","NA",{"v":1e-115,"d":"0.00"},4,"70,134,392,35,","0,1403,4879,14421",-115,-113,9.89,"3' UTR",1,151722680,151737115,14436,2]
["chr1",151750423,151753420,2998,"ENSBGRG00000009216","ENSBGRT00000018882",112158,"BRWD1","bromodomain and WD repeat domain containing 1 [Source:HGNC Symbol;Acc:HGNC:12760]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0043248(proteasome assembly)","NA",{"v":1e-101,"d":"0.00"},2,"1342,699,","0,2299",-101,{"v":-99.4,"d":"-99.40"},8.43,"3' UTR",1,151735566,151865578,130013,2]
["chr1",151761050,151767710,6661,"ENSBGRG00000009216","ENSBGRT00000018882",97868,"BRWD1","bromodomain and WD repeat domain containing 1 [Source:HGNC Symbol;Acc:HGNC:12760]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0043248(proteasome assembly)","NA",{"v":0.014,"d":"0.01"},2,"158,23,","0,6638",-1.85,{"v":-1.3,"d":"-1.30"},2.28,"Exon (ENSBGRT00000018882/ENSBGRG00000009216, exon 36 of 42)",1,151735566,151865578,130013,2]
["chr1",151918280,151921259,2980,"ENSBGRG00000011188","ENSBGRT00000020815",863,"ENSBGRG00000011188","NA","GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)","00310(Lysine degradation);05168(Herpes simplex infection)",{"v":1.8E-7,"d":"0.00"},3,"6,74,10,","0,409,2970",-6.75,-5.97,1.14,"Exon (ENSBGRT00000020815/ENSBGRG00000011188, exon 2 of 4)",1,151916078,151922122,6045,2]
["chr1",151921459,151921667,209,"ENSBGRG00000011188","ENSBGRT00000020815",455,"ENSBGRG00000011188","NA","GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)","00310(Lysine degradation);05168(Herpes simplex infection)",{"v":1.1e-07,"d":"0.00"},1,"209,",0,-6.96,-6.18,{"v":1.5,"d":"1.50"},"Exon (ENSBGRT00000020815/ENSBGRG00000011188, exon 1 of 4)",1,151916078,151922122,6045,2]
["chr1",151921994,151922455,462,"ENSBGRG00000011188","ENSBGRT00000020815",0,"ENSBGRG00000011188","NA","GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)","00310(Lysine degradation);05168(Herpes simplex infection)",{"v":0.019,"d":"0.02"},3,"129,24,26,","0,401,436",-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000020815/ENSBGRG00000011188, exon 1 of 4)",1,151916078,151922122,6045,2]
["chr1",151946279,151946724,446,"ENSBGRG00000011188","ENSBGRT00000020475",0,"ENSBGRG00000011188","NA","GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)","00310(Lysine degradation);05168(Herpes simplex infection)",{"v":0.00065,"d":"0.00"},1,"446,",0,-3.19,-2.55,11,"5' UTR",1,151916078,151946724,30647,2]
["chr1",152727637,152851438,123802,"ENSBGRG00000012032","ENSBGRT00000023435",248958,"DSCAM","DS cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:3039]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007162(negative regulation of cell adhesion);GO:0007399(nervous system development);GO:0007411(axon guidance);GO:0007626(locomotory behavior);GO:0030424(axon);GO:0030425(dendrite);GO:0030426(growth cone);GO:0038007(netrin-activated signaling pathway);GO:0042327(positive regulation of phosphorylation);GO:0043025(neuronal cell body);GO:0048813(dendrite morphogenesis);GO:0048842(positive regulation of axon extension involved in axon guidance);GO:0060060(post-embryonic retina morphogenesis in camera-type eye);GO:0070593(dendrite self-avoidance);GO:1990782(protein tyrosine kinase binding);GO:1990890(netrin receptor binding)","NA",{"v":0.035,"d":"0.04"},19,"626,461,198,150,86,116,31,177,225,115,111,239,131,126,164,118,154,142,139,","0,17281,20128,31676,36468,37677,45630,57869,62479,62738,64491,64735,65006,70665,72443,77580,82074,110648,123663",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"3' UTR",1,152727247,153100396,373150,2]
["chr1",154841379,154843471,2093,"ENSBGRG00000014918","ENSBGRT00000027447",24754,"RIPK4","receptor interacting serine/threonine kinase 4 [Source:HGNC Symbol;Acc:HGNC:496]","GO:0002009(morphogenesis of an epithelium);GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0051092(positive regulation of NF-kappaB transcription factor activity)","NA",{"v":0.032,"d":"0.03"},2,"234,156,","0,1937",-1.49,{"v":-0.978,"d":"-0.98"},6.02,"Exon (ENSBGRT00000027447/ENSBGRG00000014918, exon 7 of 8)",1,154840453,154868225,27773,2]
["chr1",154899558,154899767,210,"ENSBGRG00000014984","ENSBGRT00000028691",57614,"PRDM15","PR/SET domain 15 [Source:HGNC Symbol;Acc:HGNC:13999]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0043409(negative regulation of MAPK cascade);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1990841(promoter-specific chromatin binding);GO:2000035(regulation of stem cell division)","NA",{"v":3.4E-5,"d":"0.00"},1,"210,",0,-4.47,-3.77,4.58,"3' UTR",1,154898543,154957381,58839,2]
["chr1",154899887,154900543,657,"ENSBGRG00000014984","ENSBGRT00000028691",56838,"PRDM15","PR/SET domain 15 [Source:HGNC Symbol;Acc:HGNC:13999]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0043409(negative regulation of MAPK cascade);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1990841(promoter-specific chromatin binding);GO:2000035(regulation of stem cell division)","NA",{"v":1.8E-3,"d":"0.00"},1,"657,",0,-2.74,-2.13,6.52,"3' UTR",1,154898543,154957381,58839,2]
["chr1",154986722,154986781,60,"ENSBGRG00000015751","ENSBGRT00000029333",75134,"C2CD2","C2 calcium dependent domain containing 2 [Source:HGNC Symbol;Acc:HGNC:1266]","NA","NA",{"v":7.1E-8,"d":"0.00"},1,"60,",0,-7.15,-6.36,3.89,"Exon (ENSBGRT00000029333/ENSBGRG00000015751, exon 16 of 16)",1,154986722,155061915,75194,2]
["chr1",154988124,154997220,9097,"ENSBGRG00000015751","ENSBGRT00000029333",64695,"C2CD2","C2 calcium dependent domain containing 2 [Source:HGNC Symbol;Acc:HGNC:1266]","NA","NA",{"v":5e-14,"d":"0.00"},2,"102,225,","0,8872",{"v":-13.3,"d":"-13.30"},{"v":-12.3,"d":"-12.30"},4.54,"Exon (ENSBGRT00000029333/ENSBGRG00000015751, exon 14 of 16)",1,154986722,155061915,75194,2]
["chr1",155098245,155098512,268,"ENSBGRG00000016033","ENSBGRT00000029461",3571,"ZBTB21","zinc finger and BTB domain containing 21 [Source:HGNC Symbol;Acc:HGNC:13083]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008327(methyl-CpG binding);GO:0031208(POZ domain binding)","NA",{"v":3.2e-09,"d":"0.00"},1,"268,",0,-8.49,-7.66,3.39,"Exon (ENSBGRT00000029461/ENSBGRG00000016033, exon 2 of 2)",1,155098245,155102083,3839,2]
["chr1",155098720,155099047,328,"ENSBGRG00000016033","ENSBGRT00000029461",3036,"ZBTB21","zinc finger and BTB domain containing 21 [Source:HGNC Symbol;Acc:HGNC:13083]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008327(methyl-CpG binding);GO:0031208(POZ domain binding)","NA",{"v":0.00036,"d":"0.00"},1,"328,",0,-3.44,-2.79,2.29,"Exon (ENSBGRT00000029461/ENSBGRG00000016033, exon 2 of 2)",1,155098245,155102083,3839,2]
["chr1",155100538,155100924,387,"ENSBGRG00000016033","ENSBGRT00000029461",1159,"ZBTB21","zinc finger and BTB domain containing 21 [Source:HGNC Symbol;Acc:HGNC:13083]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008327(methyl-CpG binding);GO:0031208(POZ domain binding)","NA",{"v":2.3E-6,"d":"0.00"},1,"387,",0,-5.63,-4.89,6.42,"Exon (ENSBGRT00000029461/ENSBGRG00000016033, exon 1 of 2)",1,155098245,155102083,3839,2]
["chr1",155100984,155101994,1011,"ENSBGRG00000016033","ENSBGRT00000029461",89,"ZBTB21","zinc finger and BTB domain containing 21 [Source:HGNC Symbol;Acc:HGNC:13083]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008327(methyl-CpG binding);GO:0031208(POZ domain binding)","NA",{"v":4e-13,"d":"0.00"},1,"1011,",0,{"v":-12.4,"d":"-12.40"},{"v":-11.5,"d":"-11.50"},7.52,"Exon (ENSBGRT00000029461/ENSBGRG00000016033, exon 1 of 2)",1,155098245,155102083,3839,2]
["chr1",156089395,156090235,841,"ENSBGRG00000019836","ENSBGRT00000036514",20073,"WDR4","WD repeat domain 4 [Source:HGNC Symbol;Acc:HGNC:12756]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006400(tRNA modification);GO:0008176(tRNA (guanine-N7-)-methyltransferase activity);GO:0036265(RNA (guanine-N7)-methylation);GO:0043527(tRNA methyltransferase complex)","NA",{"v":0.003,"d":"0.00"},2,"197,39,","0,802",-2.53,-1.94,3.81,"Exon (ENSBGRT00000036514/ENSBGRG00000019836, exon 10 of 11)",1,156089395,156110308,20914,2]
["chr1",156281271,156282860,1590,"ENSBGRG00000020541","ENSBGRT00000037949",11180,"ENSBGRG00000020541","NA","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0016607(nuclear speck);GO:0046872(metal ion binding);GO:0050733(RS domain binding);GO:0089701(U2AF)","03040(Spliceosome);05131(Shigellosis)",{"v":1e-31,"d":"0.00"},3,"139,93,116,","0,1300,1474",-31,{"v":-29.8,"d":"-29.80"},3.72,"Exon (ENSBGRT00000037949/ENSBGRG00000020541, exon 6 of 8)",1,156281271,156294040,12770,2]
["chr1",156565091,156566857,1767,"ENSBGRG00000020700","ENSBGRT00000038146",7857,"ENSBGRG00000020700","NA","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007346(regulation of mitotic cell cycle);GO:0008140(cAMP response element binding protein binding);GO:0010830(regulation of myotube differentiation);GO:0010868(negative regulation of triglyceride biosynthetic process);GO:0019901(protein kinase binding);GO:0032792(negative regulation of CREB transcription factor activity);GO:0035556(intracellular signal transduction);GO:0042826(histone deacetylase binding);GO:0043153(entrainment of circadian clock by photoperiod);GO:0043276(anoikis);GO:0045595(regulation of cell differentiation);GO:0045721(negative regulation of gluconeogenesis);GO:0055007(cardiac muscle cell differentiation)","04922(Glucagon signaling pathway)",{"v":2e-24,"d":"0.00"},3,"367,235,83,","0,769,1684",{"v":-23.7,"d":"-23.70"},{"v":-22.7,"d":"-22.70"},6.73,"Exon (ENSBGRT00000038146/ENSBGRG00000020700, exon 11 of 13)",1,156565091,156574714,9624,2]
["chr1",157379998,157380352,355,"ENSBGRG00000022351","ENSBGRT00000041263",591,"ENSBGRG00000022351","NA","NA","NA",0.02,1,"355,",0,-1.69,-1.16,3.01,"Exon (ENSBGRT00000041263/ENSBGRG00000022351, exon 1 of 1)",1,157379909,157380943,1035,2]
["chr1",157380648,157380825,178,"ENSBGRG00000022351","ENSBGRT00000041263",118,"ENSBGRG00000022351","NA","NA","NA",{"v":3.5E-4,"d":"0.00"},1,"178,",0,-3.45,-2.79,8.52,"Exon (ENSBGRT00000041263/ENSBGRG00000022351, exon 1 of 1)",1,157379909,157380943,1035,2]
["chr1",157393569,157393686,118,"ENSBGRG00000022358","ENSBGRT00000041289",2647,"ENSBGRG00000022358","NA","NA","04514(Cell adhesion molecules (CAMs));04672(Intestinal immune network for IgA production)",{"v":2.4e-06,"d":"0.00"},1,"118,",0,-5.62,-4.87,2.14,"Exon (ENSBGRT00000041289/ENSBGRG00000022358, exon 3 of 7)",1,157386058,157396333,10276,2]
["chr1",157480022,157482651,2630,"ENSBGRG00000022818","ENSBGRT00000042139",0,"ENSBGRG00000022818","NA","NA","04120(Ubiquitin mediated proteolysis);05340(Primary immunodeficiency)",{"v":7.1e-05,"d":"0.00"},4,"43,83,279,213,","0,1145,1584,2417",-4.15,-3.46,17,"Exon (ENSBGRT00000042139/ENSBGRG00000022818, exon 1 of 4)",1,157480022,157482651,2630,2]
["chr1",157881220,157884878,3659,"ENSBGRG00000000181","ENSBGRT00000000292",24551,"UBE2G2","ubiquitin conjugating enzyme E2 G2 [Source:HGNC Symbol;Acc:HGNC:12483]","GO:0004842(ubiquitin-protein transferase activity);GO:0005783(endoplasmic reticulum);GO:0005811(lipid droplet);GO:0005829(cytosol);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0035458(cellular response to interferon-beta);GO:0042802(identical protein binding);GO:0044257(cellular protein catabolic process);GO:0061631(ubiquitin conjugating enzyme activity);GO:0070936(protein K48-linked ubiquitination);GO:1904153(negative regulation of retrograde protein transport, ER to cytosol)","04141(Protein processing in endoplasmic reticulum);04120(Ubiquitin mediated proteolysis);05012(Parkinson disease)",{"v":2.5e-19,"d":"0.00"},2,"496,4,","0,3655",{"v":-18.6,"d":"-18.60"},{"v":-17.6,"d":"-17.60"},3.26,"3' UTR",1,157881015,157909429,28415,2]
["chr1",157913278,157914709,1432,"ENSBGRG00000000186","ENSBGRT00000000302",6845,"ENSBGRG00000000186","NA","GO:0005515(protein binding)","03013(RNA transport);05418(Fluid shear stress and atherosclerosis)",{"v":4.2e-05,"d":"0.00"},3,"21,112,41,","0,23,1391",-4.38,-3.68,1.78,"Exon (ENSBGRT00000000302/ENSBGRG00000000186, exon 3 of 5)",1,157913278,157921554,8277,2]
["chr1",157991075,157991285,211,"ENSBGRG00000000208","ENSBGRT00000000333",18356,"ITGB2","integrin subunit beta 2 [Source:HGNC Symbol;Acc:HGNC:6155]","GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007159(leukocyte cell-cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0019901(protein kinase binding);GO:0030369(ICAM-3 receptor activity);GO:0030593(neutrophil chemotaxis);GO:0031072(heat shock protein binding);GO:0032930(positive regulation of superoxide anion generation);GO:0034113(heterotypic cell-cell adhesion);GO:0034687(integrin alphaL-beta2 complex);GO:0035987(endodermal cell differentiation);GO:0038023(signaling receptor activity);GO:0043113(receptor clustering);GO:0043235(receptor complex);GO:0043315(positive regulation of neutrophil degranulation);GO:0044853(plasma membrane raft);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:0050839(cell adhesion molecule binding);GO:0099568(cytoplasmic region);GO:1990266(neutrophil migration)","04015(Rap1 signaling pathway);04390(Hippo signaling pathway);04514(Cell adhesion molecules (CAMs));04145(Phagosome);04810(Regulation of actin cytoskeleton);04610(Complement and coagulation cascades);04650(Natural killer cell mediated cytotoxicity);04670(Leukocyte transendothelial migration);05323(Rheumatoid arthritis);05416(Viral myocarditis);05133(Pertussis);05134(Legionellosis);05150(Staphylococcus aureus infection);05152(Tuberculosis);05166(HTLV-I infection);05146(Amoebiasis);05144(Malaria);05140(Leishmaniasis)",{"v":4e-47,"d":"0.00"},1,"211,",0,{"v":-46.4,"d":"-46.40"},-45,4.58,"3' UTR",1,157991075,158009641,18567,2]
["chr1",158186208,158186622,415,"ENSBGRG00000000261","ENSBGRT00000000410",620,"ENSBGRG00000000261","NA","NA","NA",{"v":0.021,"d":"0.02"},1,"415,",0,-1.67,-1.14,3.01,"Exon (ENSBGRT00000000410/ENSBGRG00000000261, exon 1 of 1)",1,158186031,158187242,1212,2]
["chr1",158363670,158365809,2140,"ENSBGRG00000000326","ENSBGRT00000000568",13678,"POFUT2","protein O-fucosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:14683]","GO:0001707(mesoderm formation);GO:0005794(Golgi apparatus);GO:0008417(fucosyltransferase activity);GO:0010468(regulation of gene expression);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0036065(fucosylation);GO:0036066(protein O-linked fucosylation);GO:0046922(peptide-O-fucosyltransferase activity);GO:0051046(regulation of secretion);GO:1903334(positive regulation of protein folding)","00514(Other types of O-glycan biosynthesis)",0,3,"1062,124,3,","0,1709,2137",-343,"-Inf",9.03,"3' UTR",1,158363670,158379487,15818,2]
["chr1",158608179,158608746,568,"ENSBGRG00000000631","ENSBGRT00000001126",26660,"SLC19A1","solute carrier family 19 member 1 [Source:HGNC Symbol;Acc:HGNC:10937]","GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0008517(folic acid transmembrane transporter activity);GO:0008518(folate:anion antiporter activity);GO:0015350(methotrexate transmembrane transporter activity);GO:0015884(folic acid transport);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0051180(vitamin transport);GO:0051958(methotrexate transport);GO:0061507(cyclic-GMP-AMP binding);GO:0090482(vitamin transmembrane transporter activity);GO:0098838(folate transmembrane transport);GO:0140360(cyclic-GMP-AMP transmembrane transporter activity);GO:0140361(cyclic-GMP-AMP transmembrane import across plasma membrane);GO:1904447(folate import across plasma membrane)","04977(Vitamin digestion and absorption);01523(Antifolate resistance)",{"v":3.8e-09,"d":"0.00"},1,"568,",0,-8.42,{"v":-7.6,"d":"-7.60"},5.01,"3' UTR",1,158607612,158635406,27795,2]
["chr1",158627194,158627283,90,"ENSBGRG00000000631","ENSBGRT00000001126",8123,"SLC19A1","solute carrier family 19 member 1 [Source:HGNC Symbol;Acc:HGNC:10937]","GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0008517(folic acid transmembrane transporter activity);GO:0008518(folate:anion antiporter activity);GO:0015350(methotrexate transmembrane transporter activity);GO:0015884(folic acid transport);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0051180(vitamin transport);GO:0051958(methotrexate transport);GO:0061507(cyclic-GMP-AMP binding);GO:0090482(vitamin transmembrane transporter activity);GO:0098838(folate transmembrane transport);GO:0140360(cyclic-GMP-AMP transmembrane transporter activity);GO:0140361(cyclic-GMP-AMP transmembrane import across plasma membrane);GO:1904447(folate import across plasma membrane)","04977(Vitamin digestion and absorption);01523(Antifolate resistance)",{"v":0.00023,"d":"0.00"},1,"90,",0,-3.64,-2.98,3.76,"Exon (ENSBGRT00000001126/ENSBGRG00000000631, exon 3 of 6)",1,158607612,158635406,27795,2]
["chr1",159342672,159345869,3198,"ENSBGRG00000001560","ENSBGRT00000002896",39984,"MCM3AP","minichromosome maintenance complex component 3 associated protein [Source:HGNC Symbol;Acc:HGNC:6946]","GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0010484(H3 histone acetyltransferase activity);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0031965(nuclear membrane);GO:0034728(nucleosome organization);GO:0042393(histone binding);GO:0044615(nuclear pore nuclear basket);GO:0070390(transcription export complex 2)","NA",{"v":1e-114,"d":"0.00"},3,"297,151,31,","0,1187,3167",-114,-112,3.68,"3' UTR",1,159342672,159385853,43182,2]
["chr1",159364017,159365302,1286,"ENSBGRG00000001560","ENSBGRT00000002896",20551,"MCM3AP","minichromosome maintenance complex component 3 associated protein [Source:HGNC Symbol;Acc:HGNC:6946]","GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0010484(H3 histone acetyltransferase activity);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0031965(nuclear membrane);GO:0034728(nucleosome organization);GO:0042393(histone binding);GO:0044615(nuclear pore nuclear basket);GO:0070390(transcription export complex 2)","NA",{"v":4.7E-7,"d":"0.00"},2,"110,100,","0,1186",-6.33,-5.56,1.62,"Exon (ENSBGRT00000002896/ENSBGRG00000001560, exon 15 of 28)",1,159342672,159385853,43182,2]
["chr1",159384268,159385823,1556,"ENSBGRG00000001560","ENSBGRT00000002896",30,"MCM3AP","minichromosome maintenance complex component 3 associated protein [Source:HGNC Symbol;Acc:HGNC:6946]","GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0010484(H3 histone acetyltransferase activity);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0031965(nuclear membrane);GO:0034728(nucleosome organization);GO:0042393(histone binding);GO:0044615(nuclear pore nuclear basket);GO:0070390(transcription export complex 2)","NA",{"v":4e-68,"d":"0.00"},2,"25,1290,","0,266",{"v":-67.4,"d":"-67.40"},{"v":-65.9,"d":"-65.90"},4.68,"5' UTR",1,159342672,159385853,43182,2]
["chr1",159725058,159728323,3266,"ENSBGRG00000002365","ENSBGRT00000004417",0,"S100B","S100 calcium binding protein B [Source:HGNC Symbol;Acc:HGNC:10500]","GO:0001726(ruffle);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007611(learning or memory);GO:0007613(memory);GO:0008270(zinc ion binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043025(neuronal cell body);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043231(intracellular membrane-bounded organelle);GO:0044548(S100 protein binding);GO:0046872(metal ion binding);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048306(calcium-dependent protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0050786(RAGE receptor binding)","NA",{"v":1.6E-50,"d":"0.00"},2,"319,138,","0,3128",{"v":-49.8,"d":"-49.80"},{"v":-48.4,"d":"-48.40"},3.33,"3' UTR",1,159725058,159728323,3266,2]
["chr1",160048115,160048265,151,"ENSBGRG00000002585","ENSBGRT00000004839",57648,"ENSBGRG00000002585","NA","GO:0007283(spermatogenesis)","NA",{"v":0.0089,"d":"0.01"},1,"151,",0,-2.05,-1.49,1.67,"3' UTR",1,160047695,160105913,58219,2]
["chr1",160049854,160105913,56060,"ENSBGRG00000002585","ENSBGRT00000004839",0,"ENSBGRG00000002585","NA","GO:0007283(spermatogenesis)","NA",{"v":2.5e-17,"d":"0.00"},3,"385,104,1102,","0,1699,54958",{"v":-16.6,"d":"-16.60"},{"v":-15.6,"d":"-15.60"},5.52,"5' UTR",1,160047695,160105913,58219,2]
["chr1",160571115,160759817,188703,"ENSBGRG00000002635","ENSBGRT00000004955",0,"RUNX1","RUNX family transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:10471]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0030097(hemopoiesis);GO:0030854(positive regulation of granulocyte differentiation);GO:0032743(positive regulation of interleukin-2 production);GO:0043231(intracellular membrane-bounded organelle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","04530(Tight junction);04659(Th17 cell differentiation);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia)",{"v":0.0032,"d":"0.00"},3,"38,117,922,","0,187523,187781",{"v":-2.5,"d":"-2.50"},-1.91,11,"5' UTR",1,160455349,160759817,304469,2]
["chr1",162749131,162751267,2137,"ENSBGRG00000003161","ENSBGRT00000005882",218484,"HLCS","holocarboxylase synthetase [Source:HGNC Symbol;Acc:HGNC:4976]","GO:0004077(biotin-[acetyl-CoA-carboxylase] ligase activity);GO:0006464(cellular protein modification process)","00780(Biotin metabolism)",{"v":5.8e-08,"d":"0.00"},2,"290,10,","0,2127",-7.24,-6.44,3.05,"3' UTR",1,162747427,162969751,222325,2]
["chr1",162950132,162950641,510,"ENSBGRG00000003161","ENSBGRT00000005882",19110,"HLCS","holocarboxylase synthetase [Source:HGNC Symbol;Acc:HGNC:4976]","GO:0004077(biotin-[acetyl-CoA-carboxylase] ligase activity);GO:0006464(cellular protein modification process)","00780(Biotin metabolism)",{"v":6.3E-10,"d":"0.00"},1,"510,",0,{"v":-9.2,"d":"-9.20"},-8.36,7.45,"Exon (ENSBGRT00000005882/ENSBGRG00000003161, exon 3 of 10)",1,162747427,162969751,222325,2]
["chr1",163074841,163075879,1039,"ENSBGRG00000003202","ENSBGRT00000005950",12408,"ENSBGRG00000003202","NA","GO:0006506(GPI anchor biosynthetic process);GO:0017176(phosphatidylinositol N-acetylglucosaminyltransferase activity)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":1.3e-10,"d":"0.00"},3,"18,110,83,","0,21,956",-9.89,-9.03,3.38,"Exon (ENSBGRT00000005950/ENSBGRG00000003202, exon 3 of 5)",1,163074841,163088287,13447,2]
["chr1",163258353,163260504,2152,"ENSBGRG00000003274","ENSBGRT00000006170",37435,"VPS26C","VPS26 endosomal protein sorting factor C [Source:HGNC Symbol;Acc:HGNC:3044]","GO:0006886(intracellular protein transport);GO:0032456(endocytic recycling);GO:1990126(retrograde transport, endosome to plasma membrane)","NA",{"v":0.00024,"d":"0.00"},2,"83,8,","0,2144",-3.62,-2.96,2.65,"Exon (ENSBGRT00000006170/ENSBGRG00000003274, exon 6 of 7)",1,163258353,163297939,39587,2]
["chr1",163378385,163378769,385,"ENSBGRG00000003325","ENSBGRT00000006192",1358,"ENSBGRG00000003325","NA","NA","NA",{"v":0.00081,"d":"0.00"},1,"385,",0,-3.09,-2.46,5.01,"Exon (ENSBGRT00000006192/ENSBGRG00000003325, exon 1 of 1)",1,163378385,163380127,1743,2]
["chr1",164665696,164665875,180,"ENSBGRG00000003442","ENSBGRT00000006832",87584,"ERG","ETS transcription factor ERG [Source:HGNC Symbol;Acc:HGNC:3446]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0006355(regulation of transcription, DNA-templated);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990904(ribonucleoprotein complex)","05202(Transcriptional misregulation in cancers);05215(Prostate cancer)",{"v":9.3e-07,"d":"0.00"},1,"180,",0,-6.03,-5.27,4.19,"3' UTR",1,164665696,164753459,87764,2]
["chr1",164666084,164666948,865,"ENSBGRG00000003442","ENSBGRT00000006832",86511,"ERG","ETS transcription factor ERG [Source:HGNC Symbol;Acc:HGNC:3446]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0006355(regulation of transcription, DNA-templated);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990904(ribonucleoprotein complex)","05202(Transcriptional misregulation in cancers);05215(Prostate cancer)",{"v":0.00023,"d":"0.00"},1,"865,",0,-3.64,-2.98,7.52,"3' UTR",1,164665696,164753459,87764,2]
["chr1",164667157,164668230,1074,"ENSBGRG00000003442","ENSBGRT00000006832",85229,"ERG","ETS transcription factor ERG [Source:HGNC Symbol;Acc:HGNC:3446]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0006355(regulation of transcription, DNA-templated);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990904(ribonucleoprotein complex)","05202(Transcriptional misregulation in cancers);05215(Prostate cancer)",{"v":1E-146,"d":"0.00"},1,"1074,",0,-146,-144,{"v":22.1,"d":"22.10"},"3' UTR",1,164665696,164753459,87764,2]
["chr1",164668409,164668528,120,"ENSBGRG00000003442","ENSBGRT00000006832",84931,"ERG","ETS transcription factor ERG [Source:HGNC Symbol;Acc:HGNC:3446]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0006355(regulation of transcription, DNA-templated);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990904(ribonucleoprotein complex)","05202(Transcriptional misregulation in cancers);05215(Prostate cancer)",{"v":2.3E-3,"d":"0.00"},1,"120,",0,-2.63,-2.03,1.38,"Exon (ENSBGRT00000006832/ENSBGRG00000003442, exon 10 of 10)",1,164665696,164753459,87764,2]
["chr1",164751664,164753400,1737,"ENSBGRG00000003442","ENSBGRT00000006832",59,"ERG","ETS transcription factor ERG [Source:HGNC Symbol;Acc:HGNC:3446]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0006355(regulation of transcription, DNA-templated);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990904(ribonucleoprotein complex)","05202(Transcriptional misregulation in cancers);05215(Prostate cancer)",{"v":1.8E-5,"d":"0.00"},2,"116,124,","0,1613",-4.74,-4.03,1.85,"5' UTR",1,164665696,164753459,87764,2]
["chr1",165737446,165779860,42415,"ENSBGRG00000003893","ENSBGRT00000007197",49116,"COL6A6","collagen type VI alpha 6 chain [Source:HGNC Symbol;Acc:HGNC:27023]","GO:0031012(extracellular matrix)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":9.1E-4,"d":"0.00"},13,"15,36,63,63,36,51,63,63,63,63,36,54,22,","0,132,1334,7923,8687,11710,12598,16818,30553,32223,34368,41116,42393",-3.04,-2.41,4.51,"Exon (ENSBGRT00000007197/ENSBGRG00000003893, exon 18 of 36)",1,165702980,165828976,125997,2]
["chr1",165789839,165791178,1340,"ENSBGRG00000003893","ENSBGRT00000007197",37798,"COL6A6","collagen type VI alpha 6 chain [Source:HGNC Symbol;Acc:HGNC:27023]","GO:0031012(extracellular matrix)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":3.4E-5,"d":"0.00"},4,"48,54,45,3,","0,825,969,1337",-4.47,-3.77,5.01,"Exon (ENSBGRT00000007197/ENSBGRG00000003893, exon 14 of 36)",1,165702980,165828976,125997,2]
["chr1",165822735,165824189,1455,"ENSBGRG00000003893","ENSBGRT00000007197",4787,"COL6A6","collagen type VI alpha 6 chain [Source:HGNC Symbol;Acc:HGNC:27023]","GO:0031012(extracellular matrix)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":5.5e-05,"d":"0.00"},2,"248,112,","0,1343",-4.26,-3.57,14,"Exon (ENSBGRT00000007197/ENSBGRG00000003893, exon 3 of 36)",1,165702980,165828976,125997,2]
["chr1",165979479,165986559,7081,"ENSBGRG00000003956","ENSBGRT00000007296",68518,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":1e-24,"d":"0.00"},3,"362,94,443,","0,905,6638",-24,{"v":-22.9,"d":"-22.90"},{"v":4.8,"d":"4.80"},"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 33 of 41)",1,165937093,166055077,117985,2]
["chr1",166002453,166014720,12268,"ENSBGRG00000003956","ENSBGRT00000007296",40357,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":2E-16,"d":"0.00"},8,"5,63,63,63,36,54,66,10,","0,1811,2881,5882,6407,11080,11559,12258",{"v":-15.7,"d":"-15.70"},{"v":-14.7,"d":"-14.70"},{"v":6.2,"d":"6.20"},"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 17 of 41)",1,165937093,166055077,117985,2]
["chr1",166026390,166032673,6284,"ENSBGRG00000003956","ENSBGRT00000007296",22404,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":2e-11,"d":"0.00"},3,"96,576,347,","0,2757,5937",{"v":-10.7,"d":"-10.70"},-9.87,{"v":40.1,"d":"40.10"},"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 6 of 41)",1,165937093,166055077,117985,2]
["chr1",166036699,166042080,5382,"ENSBGRG00000003956","ENSBGRT00000007296",12997,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":2.7E-8,"d":"0.00"},2,"366,533,","0,4849",-7.57,-6.77,6.18,"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 4 of 41)",1,165937093,166055077,117985,2]
["chr1",166048395,166048575,181,"ENSBGRG00000003956","ENSBGRT00000007296",6502,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":0.0083,"d":"0.01"},1,"181,",0,-2.08,-1.52,4.35,"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 3 of 41)",1,165937093,166055077,117985,2]
["chr1",166482451,166483890,1440,"ENSBGRG00000004132","ENSBGRT00000007669",54384,"SH3BP5","SH3 domain binding protein 5 [Source:HGNC Symbol;Acc:HGNC:10827]","GO:0004860(protein kinase inhibitor activity);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0030659(cytoplasmic vesicle membrane);GO:0035556(intracellular signal transduction)","NA",{"v":6.3e-88,"d":"0.00"},2,"1063,8,","0,1432",{"v":-87.2,"d":"-87.20"},{"v":-85.5,"d":"-85.50"},15,"3' UTR",1,166482451,166538274,55824,2]
["chr1",166489861,166578260,88400,"ENSBGRG00000004132","ENSBGRT00000007669",0,"SH3BP5","SH3 domain binding protein 5 [Source:HGNC Symbol;Acc:HGNC:10827]","GO:0004860(protein kinase inhibitor activity);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0030659(cytoplasmic vesicle membrane);GO:0035556(intracellular signal transduction)","NA",{"v":7.9e-16,"d":"0.00"},5,"77,165,321,186,144,","0,8490,48093,85322,88256",{"v":-15.1,"d":"-15.10"},{"v":-14.2,"d":"-14.20"},6.52,"Exon (ENSBGRT00000007783/ENSBGRG00000004225, exon 1 of 1)",1,166482451,166538274,55824,2]
["chr1",166654621,166659752,5132,"ENSBGRG00000004234","ENSBGRT00000007937",16432,"METTL6","methyltransferase like 6 [Source:HGNC Symbol;Acc:HGNC:28343]","GO:0019899(enzyme binding);GO:0030488(tRNA methylation);GO:0052735(tRNA (cytosine-3-)-methyltransferase activity)","NA",{"v":3.2e-16,"d":"0.00"},3,"167,69,31,","0,3763,5101",{"v":-15.5,"d":"-15.50"},{"v":-14.5,"d":"-14.50"},1.98,"Exon (ENSBGRT00000007937/ENSBGRG00000004234, exon 3 of 4)",1,166654474,166676184,21711,2]
["chr1",166674099,166676340,2242,"ENSBGRG00000004234","ENSBGRT00000007937",0,"METTL6","methyltransferase like 6 [Source:HGNC Symbol;Acc:HGNC:28343]","GO:0019899(enzyme binding);GO:0030488(tRNA methylation);GO:0052735(tRNA (cytosine-3-)-methyltransferase activity)","NA",{"v":1e-112,"d":"0.00"},3,"5,57,381,","0,1250,1861",-112,-110,7.37,"5' UTR",1,166654474,166676184,21711,2]
["chr1",166708334,166708813,480,"ENSBGRG00000004392","ENSBGRT00000008338",45616,"COLQ","collagen like tail subunit of asymmetric acetylcholinesterase [Source:HGNC Symbol;Acc:HGNC:2226]","GO:0005886(plasma membrane);GO:0008582(regulation of synaptic growth at neuromuscular junction);GO:0030054(cell junction);GO:0031594(neuromuscular junction);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090150(establishment of protein localization to membrane)","04146(Peroxisome)",{"v":4e-07,"d":"0.00"},1,"480,",0,{"v":-6.4,"d":"-6.40"},-5.63,4.85,"3' UTR",1,166708334,166754429,46096,2]
["chr1",166708902,166709710,809,"ENSBGRG00000004392","ENSBGRT00000008338",44719,"COLQ","collagen like tail subunit of asymmetric acetylcholinesterase [Source:HGNC Symbol;Acc:HGNC:2226]","GO:0005886(plasma membrane);GO:0008582(regulation of synaptic growth at neuromuscular junction);GO:0030054(cell junction);GO:0031594(neuromuscular junction);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090150(establishment of protein localization to membrane)","04146(Peroxisome)",{"v":3.2e-26,"d":"0.00"},1,"809,",0,{"v":-25.5,"d":"-25.50"},{"v":-24.4,"d":"-24.40"},{"v":7.4,"d":"7.40"},"3' UTR",1,166708334,166754429,46096,2]
["chr1",166725404,166736283,10880,"ENSBGRG00000004392","ENSBGRT00000008338",18146,"COLQ","collagen like tail subunit of asymmetric acetylcholinesterase [Source:HGNC Symbol;Acc:HGNC:2226]","GO:0005886(plasma membrane);GO:0008582(regulation of synaptic growth at neuromuscular junction);GO:0030054(cell junction);GO:0031594(neuromuscular junction);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090150(establishment of protein localization to membrane)","04146(Peroxisome)",{"v":0.0037,"d":"0.00"},5,"96,81,36,45,12,","0,4577,8872,9918,10868",-2.43,-1.84,6.02,"Exon (ENSBGRT00000008338/ENSBGRG00000004392, exon 8 of 17)",1,166708334,166754429,46096,2]
["chr1",166745321,166754326,9006,"ENSBGRG00000004392","ENSBGRT00000008338",103,"COLQ","collagen like tail subunit of asymmetric acetylcholinesterase [Source:HGNC Symbol;Acc:HGNC:2226]","GO:0005886(plasma membrane);GO:0008582(regulation of synaptic growth at neuromuscular junction);GO:0030054(cell junction);GO:0031594(neuromuscular junction);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090150(establishment of protein localization to membrane)","04146(Peroxisome)",{"v":0.032,"d":"0.03"},3,"86,113,72,","0,1146,8934",{"v":-1.5,"d":"-1.50"},{"v":-0.989,"d":"-0.99"},2.81,"Exon (ENSBGRT00000008338/ENSBGRG00000004392, exon 1 of 17)",1,166708334,166754429,46096,2]
["chr1",166836347,166836466,120,"ENSBGRG00000004645","ENSBGRT00000009780",42401,"HACL1","2-hydroxyacyl-CoA lyase 1 [Source:HGNC Symbol;Acc:HGNC:17856]","GO:0000287(magnesium ion binding);GO:0001561(fatty acid alpha-oxidation);GO:0003824(catalytic activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005777(peroxisome);GO:0006625(protein targeting to peroxisome);GO:0006631(fatty acid metabolic process);GO:0016830(carbon-carbon lyase activity);GO:0030976(thiamine pyrophosphate binding);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle);GO:0097089(methyl-branched fatty acid metabolic process);GO:1903512(phytanic acid metabolic process)","04146(Peroxisome)",{"v":5.6e-08,"d":"0.00"},1,"120,",0,-7.25,-6.46,4.87,"3' UTR",1,166836347,166878867,42521,2]
["chr1",166951121,166951719,599,"ENSBGRG00000005474","ENSBGRT00000010449",132725,"ANKRD28","ankyrin repeat domain 28 [Source:HGNC Symbol;Acc:HGNC:29024]","GO:0005515(protein binding)","NA",{"v":1e-115,"d":"0.00"},1,"599,",0,-115,-114,4.78,"3' UTR",1,166951121,167084444,133324,2]
["chr1",167573398,167577845,4448,"ENSBGRG00000005826","ENSBGRT00000010754",89,"DPH3","diphthamide biosynthesis 3 [Source:HGNC Symbol;Acc:HGNC:27717]","NA","NA",{"v":1E-156,"d":"0.00"},3,"940,75,232,","0,3166,4216",-156,-154,5.55,"3' UTR",1,167573309,167577934,4626,2]
["chr1",167658598,167669600,11003,"ENSBGRG00000005969","ENSBGRT00000011001",231135,"ENSBGRG00000005969","raftlin, lipid raft linker 1 [Source:HGNC Symbol;Acc:HGNC:30278]","NA","NA",{"v":2e-39,"d":"0.00"},3,"376,82,82,","0,9898,10921",{"v":-38.7,"d":"-38.70"},{"v":-37.5,"d":"-37.50"},4.35,"3' UTR",1,167657699,167900735,243037,2]
["chr1",168207158,168218554,11397,"ENSBGRG00000000188","ENSBGRT00000000303",10332,"ENSBGRG00000000188","NA","NA","NA",{"v":1.9E-3,"d":"0.00"},2,"147,452,","0,10945",-2.73,-2.12,11,"Exon (ENSBGRT00000000303/ENSBGRG00000000188, exon 2 of 2)",1,168207158,168228886,21729,2]
["chr1",168218793,168219629,837,"ENSBGRG00000000188","ENSBGRT00000000303",9257,"ENSBGRG00000000188","NA","NA","NA",{"v":1.4e-09,"d":"0.00"},1,"837,",0,-8.85,-8.02,14,"Exon (ENSBGRT00000000304/ENSBGRG00000000188, exon 3 of 3)",1,168207158,168228886,21729,2]
["chr1",168227296,168227953,658,"ENSBGRG00000000188","ENSBGRT00000000303",933,"ENSBGRG00000000188","NA","NA","NA",{"v":0.032,"d":"0.03"},1,"658,",0,-1.49,{"v":-0.978,"d":"-0.98"},7.02,"Exon (ENSBGRT00000000307/ENSBGRG00000000188, exon 2 of 2)",1,168207158,168228886,21729,2]
["chr1",168228790,168245760,16971,"ENSBGRG00000000188","ENSBGRT00000000303",0,"ENSBGRG00000000188","NA","NA","NA",{"v":0.011,"d":"0.01"},4,"97,74,69,329,","0,15329,16442,16642",-1.97,-1.14,9.03,"Exon (ENSBGRT00000000303/ENSBGRG00000000188, exon 1 of 2)",1,168207158,168228886,21729,2]
["chr1",168538166,168538429,264,"ENSBGRG00000000231","ENSBGRT00000000372",0,"ENSBGRG00000000231","NA","GO:0000062(fatty-acyl-CoA binding)","03320(PPAR signaling pathway)",{"v":1.3E-33,"d":"0.00"},1,"264,",0,{"v":-32.9,"d":"-32.90"},{"v":-31.8,"d":"-31.80"},{"v":3.5,"d":"3.50"},"Exon (ENSBGRT00000000372/ENSBGRG00000000231, exon 1 of 1)",1,168538166,168538429,264,2]
["chr1",171908518,171908578,61,"ENSBGRG00000001764","ENSBGRT00000003281",7874,"EFHB","EF-hand domain family member B [Source:HGNC Symbol;Acc:HGNC:26330]","GO:0005509(calcium ion binding);GO:0032091(negative regulation of protein binding);GO:0061891(calcium ion sensor activity);GO:0070884(regulation of calcineurin-NFAT signaling cascade);GO:2001256(regulation of store-operated calcium entry)","03440(Homologous recombination)",{"v":0.011,"d":"0.01"},1,"61,",0,-1.97,{"v":-1.4,"d":"-1.40"},9.03,"Exon (ENSBGRT00000003281/ENSBGRG00000001764, exon 4 of 4)",1,171908279,171916452,8174,2]
["chr1",171913764,171915825,2062,"ENSBGRG00000001764","ENSBGRT00000003281",627,"EFHB","EF-hand domain family member B [Source:HGNC Symbol;Acc:HGNC:26330]","GO:0005509(calcium ion binding);GO:0032091(negative regulation of protein binding);GO:0061891(calcium ion sensor activity);GO:0070884(regulation of calcineurin-NFAT signaling cascade);GO:2001256(regulation of store-operated calcium entry)","03440(Homologous recombination)",{"v":0.017,"d":"0.02"},2,"164,136,","0,1926",-1.76,-1.23,3.34,"Exon (ENSBGRT00000003281/ENSBGRG00000001764, exon 2 of 4)",1,171908279,171916452,8174,2]
["chr1",172032010,172032231,222,"ENSBGRG00000001791","ENSBGRT00000003323",35784,"RAB5A","RAB5A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9783]","GO:0001726(ruffle);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0010008(endosome membrane);GO:0015629(actin cytoskeleton);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0030139(endocytic vesicle);GO:0032009(early phagosome);GO:0036465(synaptic vesicle recycling);GO:0036477(somatodendritic compartment);GO:0039694(viral RNA genome replication);GO:0043195(terminal bouton);GO:0045022(early endosome to late endosome transport);GO:0045121(membrane raft);GO:0045335(phagocytic vesicle);GO:0045921(positive regulation of exocytosis);GO:0051036(regulation of endosome size);GO:0051489(regulation of filopodium assembly);GO:0098559(cytoplasmic side of early endosome membrane);GO:0150093(amyloid-beta clearance by transcytosis);GO:2000286(receptor internalization involved in canonical Wnt signaling pathway);GO:2000300(regulation of synaptic vesicle exocytosis)","04014(Ras signaling pathway);04144(Endocytosis);04145(Phagosome);04962(Vasopressin-regulated water reabsorption);05014(Amyotrophic lateral sclerosis (ALS));05152(Tuberculosis);05146(Amoebiasis)",{"v":0.0017,"d":"0.00"},3,"145,8,57,","0,153,165",-2.77,-2.16,12,"Exon (ENSBGRT00000003363/ENSBGRG00000001807, exon 5 of 7)",1,171996226,172032562,36337,1]
["chr1",172049446,172049864,419,"ENSBGRG00000001807","ENSBGRT00000003363",2425,"ENSBGRG00000001807","NA","NA","NA",{"v":0.00076,"d":"0.00"},1,"419,",0,-3.12,-2.49,5.01,"Exon (ENSBGRT00000003363/ENSBGRG00000001807, exon 2 of 7)",1,172032010,172052289,20280,2]
["chr1",172223733,172224073,341,"ENSBGRG00000001982","ENSBGRT00000003698",17860,"SGO1","shugoshin 1 [Source:HGNC Symbol;Acc:HGNC:25088]","GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000779(condensed chromosome, centromeric region);GO:0000922(spindle pole);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0007059(chromosome segregation);GO:0008608(attachment of spindle microtubules to kinetochore);GO:0010457(centriole-centriole cohesion);GO:0016604(nuclear body);GO:0019900(kinase binding);GO:0045132(meiotic chromosome segregation);GO:0071962(mitotic sister chromatid cohesion, centromeric)","04114(Oocyte meiosis)",{"v":0.0032,"d":"0.00"},2,"103,16,","0,325",{"v":-2.5,"d":"-2.50"},-1.91,11,"Exon (ENSBGRT00000003698/ENSBGRG00000001982, exon 7 of 8)",1,172223733,172241933,18201,2]
["chr1",172233072,172233338,267,"ENSBGRG00000001982","ENSBGRT00000003698",8595,"SGO1","shugoshin 1 [Source:HGNC Symbol;Acc:HGNC:25088]","GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000779(condensed chromosome, centromeric region);GO:0000922(spindle pole);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0007059(chromosome segregation);GO:0008608(attachment of spindle microtubules to kinetochore);GO:0010457(centriole-centriole cohesion);GO:0016604(nuclear body);GO:0019900(kinase binding);GO:0045132(meiotic chromosome segregation);GO:0071962(mitotic sister chromatid cohesion, centromeric)","04114(Oocyte meiosis)",{"v":1E-22,"d":"0.00"},1,"267,",0,-22,-21,7.62,"Exon (ENSBGRT00000003698/ENSBGRG00000001982, exon 6 of 8)",1,172223733,172241933,18201,2]
["chr1",172325928,172326315,388,"ENSBGRG00000002023","ENSBGRT00000003804",3386,"ZNF596","zinc finger protein 596 [Source:HGNC Symbol;Acc:HGNC:27268]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":4e-53,"d":"0.00"},1,"388,",0,{"v":-52.4,"d":"-52.40"},-51,6.89,"3' UTR",1,172325928,172329701,3774,2]
["chr1",172326582,172328719,2138,"ENSBGRG00000002023","ENSBGRT00000003804",982,"ZNF596","zinc finger protein 596 [Source:HGNC Symbol;Acc:HGNC:27268]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.6e-56,"d":"0.00"},2,"1639,27,","0,2111",{"v":-55.8,"d":"-55.80"},{"v":-54.3,"d":"-54.30"},{"v":18.3,"d":"18.30"},"3' UTR",1,172325928,172329701,3774,2]
["chr2",102854,104837,1984,"ENSBGRG00000002080","ENSBGRT00000004033",6882,"ENSBGRG00000002080","NA","GO:0005247(voltage-gated chloride channel activity);GO:0006821(chloride transport);GO:0016020(membrane);GO:0055085(transmembrane transport)","04966(Collecting duct acid secretion)",{"v":0.035,"d":"0.04"},5,"37,174,70,111,204,","0,476,1081,1315,1780",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000004033/ENSBGRG00000002080, exon 11 of 18)",2,95972,109372,13401,1]
["chr2",443432,467432,24001,"ENSBGRG00000002351","ENSBGRT00000004398",0,"SZRD1","SUZ RNA binding domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30232]","NA","NA",{"v":2.5e-27,"d":"0.00"},3,"51,50,215,","0,22189,23786",{"v":-26.6,"d":"-26.60"},{"v":-25.4,"d":"-25.40"},2.69,"Exon (ENSBGRT00000004398/ENSBGRG00000002351, exon 1 of 4)",2,443432,468550,25119,1]
["chr2",541899,542197,299,"ENSBGRG00000002425","ENSBGRT00000004547",13332,"NECAP2","NECAP endocytosis associated 2 [Source:HGNC Symbol;Acc:HGNC:25528]","GO:0006897(endocytosis);GO:0016020(membrane);GO:0030125(clathrin vesicle coat)","NA",{"v":6.3e-76,"d":"0.00"},1,"299,",0,{"v":-75.2,"d":"-75.20"},{"v":-73.6,"d":"-73.60"},{"v":2.5,"d":"2.50"},"Exon (ENSBGRT00000004547/ENSBGRG00000002425, exon 6 of 6)",2,528567,541929,13363,1]
["chr2",557356,569731,12376,"ENSBGRG00000002459","ENSBGRT00000004709",30,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":7.4e-06,"d":"0.00"},10,"12,115,2,144,186,84,62,166,107,170,","0,557,1287,1291,6633,6902,7058,7196,7984,12206",-5.13,-4.41,4.64,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 1 of 38)",2,557326,608335,51010,1]
["chr2",571751,572671,921,"ENSBGRG00000002459","ENSBGRT00000004709",14425,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":0.011,"d":"0.01"},2,"169,71,","0,850",-1.96,-1.41,1.87,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 13 of 38)",2,557326,608335,51010,1]
["chr2",575578,582733,7156,"ENSBGRG00000002459","ENSBGRT00000004709",18252,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":2.5e-11,"d":"0.00"},8,"74,145,147,231,194,128,170,19,","0,1142,1887,2731,3659,4041,5110,7137",{"v":-10.6,"d":"-10.60"},-9.74,2.33,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 15 of 38)",2,557326,608335,51010,1]
["chr2",582792,591010,8219,"ENSBGRG00000002459","ENSBGRT00000004709",25466,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":2.5e-37,"d":"0.00"},7,"103,135,144,239,160,168,219,","0,1710,2278,3330,4062,6624,8000",{"v":-36.6,"d":"-36.60"},{"v":-35.4,"d":"-35.40"},8.02,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 22 of 38)",2,557326,608335,51010,1]
["chr2",599130,608335,9206,"ENSBGRG00000002459","ENSBGRT00000004709",41804,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":2E-45,"d":"0.00"},10,"95,121,164,216,225,150,201,132,165,87,","0,309,602,2713,3837,4429,4846,5325,8286,9119",{"v":-44.7,"d":"-44.70"},{"v":-43.4,"d":"-43.40"},3.14,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 29 of 38)",2,557326,608335,51010,1]
["chr2",1016798,1034979,18182,"ENSBGRG00000002860","ENSBGRT00000005395",140039,"PADI1","peptidyl arginine deiminase 1 [Source:HGNC Symbol;Acc:HGNC:18367]","GO:0004668(protein-arginine deiminase activity);GO:0005509(calcium ion binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0018101(protein citrullination)","NA",{"v":0.011,"d":"0.01"},10,"71,104,112,108,155,142,103,71,141,730,","0,187,1193,3412,10516,12852,13249,14178,14721,17452",-1.97,-1.14,9.03,"3' UTR",2,876759,1034979,158221,1]
["chr2",1255264,1264369,9106,"ENSBGRG00000003296","ENSBGRT00000006129",0,"ENSBGRG00000003296","NA","NA","NA",{"v":0.014,"d":"0.01"},2,"1,90,","0,9016",-1.84,{"v":-1.3,"d":"-1.30"},1.62,"Exon (ENSBGRT00000005955/ENSBGRG00000003200, exon 6 of 28)",2,1256605,1257843,1239,2]
["chr2",1360513,1361440,928,"ENSBGRG00000003200","ENSBGRT00000005955",198443,"ARHGEF10L","Rho guanine nucleotide exchange factor 10 like [Source:HGNC Symbol;Acc:HGNC:25540]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0032933(SREBP signaling pathway);GO:0051496(positive regulation of stress fiber assembly)","NA",{"v":4e-42,"d":"0.00"},1,"928,",0,{"v":-41.4,"d":"-41.40"},{"v":-40.1,"d":"-40.10"},3.85,"3' UTR",2,1162070,1361440,199371,1]
["chr2",1430233,1521688,91456,"ENSBGRG00000003302","ENSBGRT00000006148",0,"ACTL8","actin like 8 [Source:HGNC Symbol;Acc:HGNC:24018]","GO:0030855(epithelial cell differentiation)","NA",{"v":0.035,"d":"0.04"},3,"86,400,737,","0,88038,90719",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"5' UTR",2,1430233,1522224,91992,1]
["chr2",2288542,2289017,476,"ENSBGRG00000003326","ENSBGRT00000006207",238,"KLHDC7A","kelch domain containing 7A [Source:HGNC Symbol;Acc:HGNC:26791]","GO:0005515(protein binding)","NA",{"v":0.00048,"d":"0.00"},1,"476,",0,-3.32,-2.67,14,"Exon (ENSBGRT00000006207/ENSBGRG00000003326, exon 1 of 4)",2,2288304,2291102,2799,1]
["chr2",2289404,2291102,1699,"ENSBGRG00000003326","ENSBGRT00000006207",1100,"KLHDC7A","kelch domain containing 7A [Source:HGNC Symbol;Acc:HGNC:26791]","GO:0005515(protein binding)","NA",{"v":0.019,"d":"0.02"},4,"116,206,794,103,","0,152,392,1596",-1.72,-1.19,8.02,"Exon (ENSBGRT00000006207/ENSBGRG00000003326, exon 1 of 4)",2,2288304,2291102,2799,1]
["chr2",3201356,3203992,2637,"ENSBGRG00000003889","ENSBGRT00000007717",0,"EMC1","ER membrane protein complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:28957]","GO:0005783(endoplasmic reticulum);GO:0016021(integral component of membrane);GO:0032991(protein-containing complex);GO:0072546(ER membrane protein complex)","NA",{"v":2.8e-08,"d":"0.00"},3,"473,59,4,","0,2361,2633",-7.55,-6.75,4.14,"5' UTR",2,3171361,3201357,29997,2]
["chr2",3206451,3207104,654,"ENSBGRG00000004243","ENSBGRT00000007876",5095,"MRTO4","MRT4 homolog, ribosome maturation factor [Source:HGNC Symbol;Acc:HGNC:18477]","GO:0000027(ribosomal large subunit assembly);GO:0042254(ribosome biogenesis)","NA",{"v":1E-165,"d":"0.00"},1,"654,",0,-165,-162,4.23,"3' UTR",2,3201356,3207104,5749,1]
["chr2",3599656,3599866,211,"ENSBGRG00000004609","ENSBGRT00000008549",43496,"ENSBGRG00000004609","NA","GO:0005743(mitochondrial inner membrane);GO:0061617(MICOS complex)","NA",{"v":3.2e-20,"d":"0.00"},1,"211,",0,{"v":-19.5,"d":"-19.50"},{"v":-18.5,"d":"-18.50"},{"v":1.6,"d":"1.60"},"3' UTR",2,3556160,3599866,43707,1]
["chr2",3631288,3632537,1250,"ENSBGRG00000004686","ENSBGRT00000008650",686,"NBL1","NBL1, DAN family BMP antagonist [Source:HGNC Symbol;Acc:HGNC:7650]","GO:0005615(extracellular space);GO:0007399(nervous system development);GO:0016015(morphogen activity);GO:0030514(negative regulation of BMP signaling pathway);GO:0035582(sequestering of BMP in extracellular matrix);GO:0036122(BMP binding);GO:0038098(sequestering of BMP from receptor via BMP binding);GO:0042802(identical protein binding);GO:0045666(positive regulation of neuron differentiation);GO:0048263(determination of dorsal identity);GO:0048812(neuron projection morphogenesis);GO:0090027(negative regulation of monocyte chemotaxis)","04350(TGF-beta signaling pathway)",0,2,"82,246,","0,1004",-363,"-Inf",{"v":6.3,"d":"6.30"},"Exon (ENSBGRT00000008650/ENSBGRG00000004686, exon 2 of 3)",2,3630602,3632537,1936,1]
["chr2",3660382,3660591,210,"ENSBGRG00000004712","ENSBGRT00000008718",14065,"ENSBGRG00000004712","NA","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","04020(Calcium signaling pathway);04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04726(Serotonergic synapse)",{"v":0.026,"d":"0.03"},1,"210,",0,-1.58,-1.06,1.79,"Exon (ENSBGRT00000008718/ENSBGRG00000004712, exon 3 of 3)",2,3646317,3660829,14513,1]
["chr2",3912304,3913658,1355,"ENSBGRG00000004823","ENSBGRT00000008922",30685,"OTUD3","OTU deubiquitinase 3 [Source:HGNC Symbol;Acc:HGNC:29038]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005737(cytoplasm);GO:0035871(protein K11-linked deubiquitination);GO:0044313(protein K6-linked deubiquitination);GO:0050821(protein stabilization);GO:0051898(negative regulation of protein kinase B signaling);GO:0071108(protein K48-linked deubiquitination);GO:1990167(protein K27-linked deubiquitination)","NA",{"v":6.8e-09,"d":"0.00"},2,"131,344,","0,1011",-8.17,-7.36,3.34,"3' UTR",2,3881619,3914488,32870,1]
["chr2",4260352,4264158,3807,"ENSBGRG00000005193","ENSBGRT00000009568",0,"UBXN10","UBX domain protein 10 [Source:HGNC Symbol;Acc:HGNC:26354]","GO:0005515(protein binding);GO:0005929(cilium);GO:0030992(intraciliary transport particle B);GO:0060271(cilium assembly)","NA",{"v":0.019,"d":"0.02"},2,"201,96,","0,3711",-1.71,{"v":-0.978,"d":"-0.98"},8.02,"5' UTR",2,4260352,4265594,5243,1]
["chr2",4264306,4264942,637,"ENSBGRG00000005193","ENSBGRT00000009568",3954,"UBXN10","UBX domain protein 10 [Source:HGNC Symbol;Acc:HGNC:26354]","GO:0005515(protein binding);GO:0005929(cilium);GO:0030992(intraciliary transport particle B);GO:0060271(cilium assembly)","NA",{"v":0.015,"d":"0.02"},2,"556,37,","0,600",-1.82,-1.28,7.02,"Exon (ENSBGRT00000009568/ENSBGRG00000005193, exon 2 of 3)",2,4260352,4265594,5243,1]
["chr2",4265091,4265387,297,"ENSBGRG00000005193","ENSBGRT00000009568",4739,"UBXN10","UBX domain protein 10 [Source:HGNC Symbol;Acc:HGNC:26354]","GO:0005515(protein binding);GO:0005929(cilium);GO:0030992(intraciliary transport particle B);GO:0060271(cilium assembly)","NA",{"v":0.019,"d":"0.02"},1,"297,",0,-1.72,-1.19,8.02,"3' UTR",2,4260352,4265594,5243,1]
["chr2",4664177,4664561,385,"ENSBGRG00000005472","ENSBGRT00000010075",147,"ENSBGRG00000005472","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":7.1e-05,"d":"0.00"},1,"385,",0,-4.15,-3.46,17,"Exon (ENSBGRT00000010075/ENSBGRG00000005472, exon 1 of 1)",2,4664030,4665268,1239,1]
["chr2",4664708,4665268,561,"ENSBGRG00000005472","ENSBGRT00000010075",678,"ENSBGRG00000005472","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.035,"d":"0.04"},1,"561,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000010075/ENSBGRG00000005472, exon 1 of 1)",2,4664030,4665268,1239,1]
["chr2",4767840,4768229,390,"ENSBGRG00000000172","ENSBGRT00000000277",23130,"ENSBGRG00000000172","NA","GO:0003824(catalytic activity);GO:0004126(cytidine deaminase activity);GO:0008270(zinc ion binding);GO:0009972(cytidine deamination);GO:0016787(hydrolase activity)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)",{"v":6.3e-12,"d":"0.00"},1,"390,",0,{"v":-11.2,"d":"-11.20"},{"v":-10.3,"d":"-10.30"},6.02,"3' UTR",2,4744710,4768797,24088,1]
["chr2",4806590,4808149,1560,"ENSBGRG00000000185","ENSBGRT00000000301",21427,"PINK1","PTEN induced kinase 1 [Source:HGNC Symbol;Acc:HGNC:14581]","GO:0000287(magnesium ion binding);GO:0000422(autophagy of mitochondrion);GO:0000785(chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0002020(protease binding);GO:0002082(regulation of oxidative phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006979(response to oxidative stress);GO:0007005(mitochondrion organization);GO:0010310(regulation of hydrogen peroxide metabolic process);GO:0010629(negative regulation of gene expression);GO:0010821(regulation of mitochondrion organization);GO:0010857(calcium-dependent protein kinase activity);GO:0016020(membrane);GO:0016239(positive regulation of macroautophagy);GO:0016242(negative regulation of macroautophagy);GO:0016301(kinase activity);GO:0016567(protein ubiquitination);GO:0018105(peptidyl-serine phosphorylation);GO:0022904(respiratory electron transport chain);GO:0030424(axon);GO:0031307(integral component of mitochondrial outer membrane);GO:0031396(regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032226(positive regulation of synaptic transmission, dopaminergic);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033603(positive regulation of dopamine secretion);GO:0033605(positive regulation of catecholamine secretion);GO:0034599(cellular response to oxidative stress);GO:0035307(positive regulation of protein dephosphorylation);GO:0035556(intracellular signal transduction);GO:0036289(peptidyl-serine autophosphorylation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043254(regulation of protein-containing complex assembly);GO:0043422(protein kinase B binding);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0044297(cell body);GO:0044877(protein-containing complex binding);GO:0045727(positive regulation of translation);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055131(C3HC4-type RING finger domain binding);GO:0071456(cellular response to hypoxia);GO:0072655(establishment of protein localization to mitochondrion);GO:0072656(maintenance of protein location in mitochondrion);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0090258(negative regulation of mitochondrial fission);GO:0097237(cellular response to toxic substance);GO:0097449(astrocyte projection);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization);GO:0099074(mitochondrion to lysosome transport);GO:1900407(regulation of cellular response to oxidative stress);GO:1901727(positive regulation of histone deacetylase activity);GO:1902902(negative regulation of autophagosome assembly);GO:1902958(positive regulation of mitochondrial electron transport, NADH to ubiquinone);GO:1903147(negative regulation of autophagy of mitochondrion);GO:1903202(negative regulation of oxidative stress-induced cell death);GO:1903214(regulation of protein targeting to mitochondrion);GO:1903298(negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway);GO:1903384(negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway);GO:1903751(negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:1903852(positive regulation of cristae formation);GO:1904841(TORC2 complex binding);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04137(Mitophagy - animal);05012(Parkinson disease)",{"v":1e-123,"d":"0.00"},2,"150,450,","0,1110",-123,-121,4.15,"3' UTR",2,4785163,4810601,25439,1]
["chr2",4808628,4809197,570,"ENSBGRG00000000185","ENSBGRT00000000301",23465,"PINK1","PTEN induced kinase 1 [Source:HGNC Symbol;Acc:HGNC:14581]","GO:0000287(magnesium ion binding);GO:0000422(autophagy of mitochondrion);GO:0000785(chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0002020(protease binding);GO:0002082(regulation of oxidative phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006979(response to oxidative stress);GO:0007005(mitochondrion organization);GO:0010310(regulation of hydrogen peroxide metabolic process);GO:0010629(negative regulation of gene expression);GO:0010821(regulation of mitochondrion organization);GO:0010857(calcium-dependent protein kinase activity);GO:0016020(membrane);GO:0016239(positive regulation of macroautophagy);GO:0016242(negative regulation of macroautophagy);GO:0016301(kinase activity);GO:0016567(protein ubiquitination);GO:0018105(peptidyl-serine phosphorylation);GO:0022904(respiratory electron transport chain);GO:0030424(axon);GO:0031307(integral component of mitochondrial outer membrane);GO:0031396(regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032226(positive regulation of synaptic transmission, dopaminergic);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033603(positive regulation of dopamine secretion);GO:0033605(positive regulation of catecholamine secretion);GO:0034599(cellular response to oxidative stress);GO:0035307(positive regulation of protein dephosphorylation);GO:0035556(intracellular signal transduction);GO:0036289(peptidyl-serine autophosphorylation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043254(regulation of protein-containing complex assembly);GO:0043422(protein kinase B binding);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0044297(cell body);GO:0044877(protein-containing complex binding);GO:0045727(positive regulation of translation);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055131(C3HC4-type RING finger domain binding);GO:0071456(cellular response to hypoxia);GO:0072655(establishment of protein localization to mitochondrion);GO:0072656(maintenance of protein location in mitochondrion);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0090258(negative regulation of mitochondrial fission);GO:0097237(cellular response to toxic substance);GO:0097449(astrocyte projection);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization);GO:0099074(mitochondrion to lysosome transport);GO:1900407(regulation of cellular response to oxidative stress);GO:1901727(positive regulation of histone deacetylase activity);GO:1902902(negative regulation of autophagosome assembly);GO:1902958(positive regulation of mitochondrial electron transport, NADH to ubiquinone);GO:1903147(negative regulation of autophagy of mitochondrion);GO:1903202(negative regulation of oxidative stress-induced cell death);GO:1903214(regulation of protein targeting to mitochondrion);GO:1903298(negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway);GO:1903384(negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway);GO:1903751(negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:1903852(positive regulation of cristae formation);GO:1904841(TORC2 complex binding);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04137(Mitophagy - animal);05012(Parkinson disease)",{"v":9.99999999999998e-264,"d":"0.00"},1,"570,",0,-263,-261,{"v":4.8,"d":"4.80"},"3' UTR",2,4785163,4810601,25439,1]
["chr2",4809407,4809736,330,"ENSBGRG00000000185","ENSBGRT00000000301",24244,"PINK1","PTEN induced kinase 1 [Source:HGNC Symbol;Acc:HGNC:14581]","GO:0000287(magnesium ion binding);GO:0000422(autophagy of mitochondrion);GO:0000785(chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0002020(protease binding);GO:0002082(regulation of oxidative phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006979(response to oxidative stress);GO:0007005(mitochondrion organization);GO:0010310(regulation of hydrogen peroxide metabolic process);GO:0010629(negative regulation of gene expression);GO:0010821(regulation of mitochondrion organization);GO:0010857(calcium-dependent protein kinase activity);GO:0016020(membrane);GO:0016239(positive regulation of macroautophagy);GO:0016242(negative regulation of macroautophagy);GO:0016301(kinase activity);GO:0016567(protein ubiquitination);GO:0018105(peptidyl-serine phosphorylation);GO:0022904(respiratory electron transport chain);GO:0030424(axon);GO:0031307(integral component of mitochondrial outer membrane);GO:0031396(regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032226(positive regulation of synaptic transmission, dopaminergic);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033603(positive regulation of dopamine secretion);GO:0033605(positive regulation of catecholamine secretion);GO:0034599(cellular response to oxidative stress);GO:0035307(positive regulation of protein dephosphorylation);GO:0035556(intracellular signal transduction);GO:0036289(peptidyl-serine autophosphorylation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043254(regulation of protein-containing complex assembly);GO:0043422(protein kinase B binding);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0044297(cell body);GO:0044877(protein-containing complex binding);GO:0045727(positive regulation of translation);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055131(C3HC4-type RING finger domain binding);GO:0071456(cellular response to hypoxia);GO:0072655(establishment of protein localization to mitochondrion);GO:0072656(maintenance of protein location in mitochondrion);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0090258(negative regulation of mitochondrial fission);GO:0097237(cellular response to toxic substance);GO:0097449(astrocyte projection);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization);GO:0099074(mitochondrion to lysosome transport);GO:1900407(regulation of cellular response to oxidative stress);GO:1901727(positive regulation of histone deacetylase activity);GO:1902902(negative regulation of autophagosome assembly);GO:1902958(positive regulation of mitochondrial electron transport, NADH to ubiquinone);GO:1903147(negative regulation of autophagy of mitochondrion);GO:1903202(negative regulation of oxidative stress-induced cell death);GO:1903214(regulation of protein targeting to mitochondrion);GO:1903298(negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway);GO:1903384(negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway);GO:1903751(negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:1903852(positive regulation of cristae formation);GO:1904841(TORC2 complex binding);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04137(Mitophagy - animal);05012(Parkinson disease)",{"v":1E-221,"d":"0.00"},1,"330,",0,-221,-219,3.23,"3' UTR",2,4785163,4810601,25439,1]
["chr2",6149957,6150500,544,"ENSBGRG00000003260","ENSBGRT00000006046",0,"ENSBGRG00000003260","NA","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":0,"d":"0.00"},2,"389,93,","0,451",-322,-319,2.72,"5' UTR",2,6149957,6150500,544,1]
["chr2",6199645,6200213,569,"ENSBGRG00000003268","ENSBGRT00000006062",299,"ENSBGRG00000003268","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.00048,"d":"0.00"},1,"569,",0,-3.32,-2.67,14,"Exon (ENSBGRT00000006062/ENSBGRG00000003268, exon 1 of 1)",2,6199346,6200452,1107,1]
["chr2",6199645,6200213,569,"ENSBGRG00000003268","ENSBGRT00000006062",299,"ENSBGRG00000003268","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.00048,"d":"0.00"},1,"569,",0,-3.32,-2.67,14,"Exon (ENSBGRT00000006062/ENSBGRG00000003268, exon 1 of 1)",2,6199346,6200452,1107,1]
["chr2",6681771,6682338,568,"ENSBGRG00000003315","ENSBGRT00000006176",11237,"ZBTB40","zinc finger and BTB domain containing 40 [Source:HGNC Symbol;Acc:HGNC:29045]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus)","NA",{"v":5e-31,"d":"0.00"},1,"568,",0,{"v":-30.3,"d":"-30.30"},{"v":-29.1,"d":"-29.10"},{"v":4.6,"d":"4.60"},"5' UTR",2,6670534,6726689,56156,1]
["chr2",6708432,6709245,814,"ENSBGRG00000003315","ENSBGRT00000006176",37898,"ZBTB40","zinc finger and BTB domain containing 40 [Source:HGNC Symbol;Acc:HGNC:29045]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus)","NA",{"v":4e-16,"d":"0.00"},2,"127,382,","0,432",{"v":-15.4,"d":"-15.40"},{"v":-14.4,"d":"-14.40"},2.73,"Exon (ENSBGRT00000006176/ENSBGRG00000003315, exon 10 of 18)",2,6670534,6726689,56156,1]
["chr2",6723505,6726689,3185,"ENSBGRG00000003315","ENSBGRT00000006176",52971,"ZBTB40","zinc finger and BTB domain containing 40 [Source:HGNC Symbol;Acc:HGNC:29045]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus)","NA",{"v":5e-48,"d":"0.00"},2,"58,212,","0,2973",{"v":-47.3,"d":"-47.30"},-46,3.94,"3' UTR",2,6670534,6726689,56156,1]
["chr2",6846912,6850188,3277,"ENSBGRG00000003422","ENSBGRT00000006360",0,"C1QA","complement C1q A chain [Source:HGNC Symbol;Acc:HGNC:1241]","GO:0001774(microglial cell activation);GO:0005515(protein binding);GO:0006958(complement activation, classical pathway);GO:0007568(aging);GO:0016322(neuron remodeling);GO:0045202(synapse);GO:0048143(astrocyte activation);GO:0050808(synapse organization);GO:0098794(postsynapse);GO:0098883(synapse pruning);GO:0150062(complement-mediated synapse pruning);GO:0150064(vertebrate eye-specific patterning);GO:1901216(positive regulation of neuron death)","04610(Complement and coagulation cascades);05322(Systemic lupus erythematosus);05020(Prion diseases);05133(Pertussis);05150(Staphylococcus aureus infection);05142(Chagas disease (American trypanosomiasis))",{"v":3E-10,"d":"0.00"},3,"122,170,6,","0,2076,3271",-9.53,-8.68,6.52,"5' UTR",2,6846912,6850959,4048,1]
["chr2",6850633,6850751,119,"ENSBGRG00000003422","ENSBGRT00000006360",3721,"C1QA","complement C1q A chain [Source:HGNC Symbol;Acc:HGNC:1241]","GO:0001774(microglial cell activation);GO:0005515(protein binding);GO:0006958(complement activation, classical pathway);GO:0007568(aging);GO:0016322(neuron remodeling);GO:0045202(synapse);GO:0048143(astrocyte activation);GO:0050808(synapse organization);GO:0098794(postsynapse);GO:0098883(synapse pruning);GO:0150062(complement-mediated synapse pruning);GO:0150064(vertebrate eye-specific patterning);GO:1901216(positive regulation of neuron death)","04610(Complement and coagulation cascades);05322(Systemic lupus erythematosus);05020(Prion diseases);05133(Pertussis);05150(Staphylococcus aureus infection);05142(Chagas disease (American trypanosomiasis))",{"v":1.9E-6,"d":"0.00"},1,"119,",0,-5.72,-4.97,1.76,"Exon (ENSBGRT00000006360/ENSBGRG00000003422, exon 3 of 3)",2,6846912,6850959,4048,1]
["chr2",6859332,6859540,209,"ENSBGRG00000003430","ENSBGRT00000006373",3857,"C1QC","complement C1q C chain [Source:HGNC Symbol;Acc:HGNC:1245]","GO:0005515(protein binding);GO:0030853(negative regulation of granulocyte differentiation);GO:0045202(synapse);GO:0045650(negative regulation of macrophage differentiation);GO:0098794(postsynapse);GO:0098883(synapse pruning)","04610(Complement and coagulation cascades);05322(Systemic lupus erythematosus);05020(Prion diseases);05133(Pertussis);05150(Staphylococcus aureus infection);05142(Chagas disease (American trypanosomiasis))",{"v":1e-18,"d":"0.00"},1,"209,",0,-18,-17,{"v":3.9,"d":"3.90"},"3' UTR",2,6855475,6860494,5020,1]
["chr2",6860737,6861692,956,"ENSBGRG00000003435","ENSBGRT00000006390",0,"ENSBGRG00000003435","NA","GO:0003676(nucleic acid binding);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus)","NA",{"v":0.035,"d":"0.04"},1,"956,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"5' UTR",2,6860737,6864013,3277,1]
["chr2",6861961,6864013,2053,"ENSBGRG00000003435","ENSBGRT00000006390",1224,"ENSBGRG00000003435","NA","GO:0003676(nucleic acid binding);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus)","NA",{"v":0.035,"d":"0.04"},2,"86,780,","0,1273",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"3' UTR",2,6860737,6864013,3277,1]
["chr2",7016814,7021540,4727,"ENSBGRG00000003473","ENSBGRT00000006575",85295,"EPHB2","EPH receptor B2 [Source:HGNC Symbol;Acc:HGNC:3393]","GO:0000902(cell morphogenesis);GO:0001525(angiogenesis);GO:0001540(amyloid-beta binding);GO:0001655(urogenital system development);GO:0001933(negative regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0007611(learning or memory);GO:0007612(learning);GO:0008046(axon guidance receptor activity);GO:0009887(animal organ morphogenesis);GO:0016021(integral component of membrane);GO:0016310(phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021631(optic nerve morphogenesis);GO:0021952(central nervous system projection neuron axonogenesis);GO:0022038(corpus callosum development);GO:0030193(regulation of blood coagulation);GO:0030424(axon);GO:0030425(dendrite);GO:0031290(retinal ganglion cell axon guidance);GO:0031915(positive regulation of synaptic plasticity);GO:0038023(signaling receptor activity);GO:0042472(inner ear morphogenesis);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0044877(protein-containing complex binding);GO:0046580(negative regulation of Ras protein signal transduction);GO:0048013(ephrin receptor signaling pathway);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048170(positive regulation of long-term neuronal synaptic plasticity);GO:0048593(camera-type eye morphogenesis);GO:0050770(regulation of axonogenesis);GO:0050771(negative regulation of axonogenesis);GO:0050878(regulation of body fluid levels);GO:0051389(inactivation of MAPKK activity);GO:0051965(positive regulation of synapse assembly);GO:0060021(roof of mouth development);GO:0060996(dendritic spine development);GO:0060997(dendritic spine morphogenesis);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0071679(commissural neuron axon guidance);GO:0099557(trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission);GO:0106028(neuron projection retraction);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1904782(negative regulation of NMDA glutamate receptor activity);GO:1904783(positive regulation of NMDA glutamate receptor activity)","04360(Axon guidance)",{"v":1.3E-6,"d":"0.00"},2,"36,293,","0,4434",-5.89,-5.14,2.72,"Exon (ENSBGRT00000006575/ENSBGRG00000003473, exon 2 of 16)",2,6931519,7187286,255768,1]
["chr2",7185405,7186659,1255,"ENSBGRG00000003473","ENSBGRT00000006575",253886,"EPHB2","EPH receptor B2 [Source:HGNC Symbol;Acc:HGNC:3393]","GO:0000902(cell morphogenesis);GO:0001525(angiogenesis);GO:0001540(amyloid-beta binding);GO:0001655(urogenital system development);GO:0001933(negative regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0007611(learning or memory);GO:0007612(learning);GO:0008046(axon guidance receptor activity);GO:0009887(animal organ morphogenesis);GO:0016021(integral component of membrane);GO:0016310(phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021631(optic nerve morphogenesis);GO:0021952(central nervous system projection neuron axonogenesis);GO:0022038(corpus callosum development);GO:0030193(regulation of blood coagulation);GO:0030424(axon);GO:0030425(dendrite);GO:0031290(retinal ganglion cell axon guidance);GO:0031915(positive regulation of synaptic plasticity);GO:0038023(signaling receptor activity);GO:0042472(inner ear morphogenesis);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0044877(protein-containing complex binding);GO:0046580(negative regulation of Ras protein signal transduction);GO:0048013(ephrin receptor signaling pathway);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048170(positive regulation of long-term neuronal synaptic plasticity);GO:0048593(camera-type eye morphogenesis);GO:0050770(regulation of axonogenesis);GO:0050771(negative regulation of axonogenesis);GO:0050878(regulation of body fluid levels);GO:0051389(inactivation of MAPKK activity);GO:0051965(positive regulation of synapse assembly);GO:0060021(roof of mouth development);GO:0060996(dendritic spine development);GO:0060997(dendritic spine morphogenesis);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0071679(commissural neuron axon guidance);GO:0099557(trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission);GO:0106028(neuron projection retraction);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1904782(negative regulation of NMDA glutamate receptor activity);GO:1904783(positive regulation of NMDA glutamate receptor activity)","04360(Axon guidance)",{"v":4e-76,"d":"0.00"},1,"1255,",0,{"v":-75.4,"d":"-75.40"},{"v":-73.8,"d":"-73.80"},9.51,"3' UTR",2,6931519,7187286,255768,1]
["chr2",7259673,7260060,388,"ENSBGRG00000003651","ENSBGRT00000006863",0,"KDM1A","lysine demethylase 1A [Source:HGNC Symbol;Acc:HGNC:29079]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000784(nuclear chromosome, telomeric region);GO:0000790(nuclear chromatin);GO:0002039(p53 binding);GO:0002052(positive regulation of neuroblast proliferation);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006482(protein demethylation);GO:0008134(transcription factor binding);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0016491(oxidoreductase activity);GO:0019899(enzyme binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0032091(negative regulation of protein binding);GO:0032451(demethylase activity);GO:0032452(histone demethylase activity);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0032454(histone demethylase activity (H3-K9 specific));GO:0032991(protein-containing complex);GO:0033169(histone H3-K9 demethylation);GO:0033184(positive regulation of histone ubiquitination);GO:0034644(cellular response to UV);GO:0034648(histone demethylase activity (H3-dimethyl-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0043426(MRF binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050660(flavin adenine dinucleotide binding);GO:0050681(androgen receptor binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0055114(oxidation-reduction process);GO:0061752(telomeric repeat-containing RNA binding);GO:0071480(cellular response to gamma radiation);GO:1902166(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:1903827(regulation of cellular protein localization);GO:1990391(DNA repair complex)","04714(Thermogenesis)",{"v":0.00026,"d":"0.00"},1,"388,",0,-3.59,-2.93,6.52,"5' UTR",2,7259673,7335143,75471,1]
["chr2",7334726,7335143,418,"ENSBGRG00000003651","ENSBGRT00000006863",75053,"KDM1A","lysine demethylase 1A [Source:HGNC Symbol;Acc:HGNC:29079]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000784(nuclear chromosome, telomeric region);GO:0000790(nuclear chromatin);GO:0002039(p53 binding);GO:0002052(positive regulation of neuroblast proliferation);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006482(protein demethylation);GO:0008134(transcription factor binding);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0016491(oxidoreductase activity);GO:0019899(enzyme binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0032091(negative regulation of protein binding);GO:0032451(demethylase activity);GO:0032452(histone demethylase activity);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0032454(histone demethylase activity (H3-K9 specific));GO:0032991(protein-containing complex);GO:0033169(histone H3-K9 demethylation);GO:0033184(positive regulation of histone ubiquitination);GO:0034644(cellular response to UV);GO:0034648(histone demethylase activity (H3-dimethyl-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0043426(MRF binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050660(flavin adenine dinucleotide binding);GO:0050681(androgen receptor binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0055114(oxidation-reduction process);GO:0061752(telomeric repeat-containing RNA binding);GO:0071480(cellular response to gamma radiation);GO:1902166(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:1903827(regulation of cellular protein localization);GO:1990391(DNA repair complex)","04714(Thermogenesis)",0,1,"418,",0,-353,"-Inf",6.47,"3' UTR",2,7259673,7335143,75471,1]
["chr2",8040549,8042982,2434,"ENSBGRG00000004817","ENSBGRT00000008863",0,"ENSBGRG00000004817","NA","NA","NA",{"v":2.5e-75,"d":"0.00"},2,"2017,71,","0,2363",{"v":-74.6,"d":"-74.60"},-73,4.59,"3' UTR",2,8042842,8042932,91,1]
["chr2",8067930,8068017,88,"ENSBGRG00000004830","ENSBGRT00000008925",6720,"PITHD1","PITH domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25022]","GO:0005737(cytoplasm);GO:0007286(spermatid development);GO:0007341(penetration of zona pellucida);GO:0045654(positive regulation of megakaryocyte differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0061136(regulation of proteasomal protein catabolic process);GO:0061956(penetration of cumulus oophorus);GO:0097598(sperm cytoplasmic droplet)","NA",{"v":3.1E-4,"d":"0.00"},1,"88,",0,-3.51,-2.85,1.26,"Exon (ENSBGRT00000008925/ENSBGRG00000004830, exon 6 of 6)",2,8061210,8068017,6808,1]
["chr2",8280282,8281321,1040,"ENSBGRG00000005315","ENSBGRT00000009833",0,"ENSBGRG00000005315","NA","NA","NA",{"v":4e-19,"d":"0.00"},2,"167,4,","0,1036",{"v":-18.4,"d":"-18.40"},{"v":-17.4,"d":"-17.40"},1.79,"Exon (ENSBGRT00000009833/ENSBGRG00000005315, exon 1 of 2)",2,8280282,8281321,1040,1]
["chr2",8281336,8284088,2753,"ENSBGRG00000005344","ENSBGRT00000009878",0,"PNRC2","proline rich nuclear receptor coactivator 2 [Source:HGNC Symbol;Acc:HGNC:23158]","GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0000932(P-body);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus)","NA",{"v":9.99999999999998e-236,"d":"0.00"},2,"299,68,","0,2685",-235,-232,4.26,"Exon (ENSBGRT00000009878/ENSBGRG00000005344, exon 1 of 2)",2,8281336,8284144,2809,1]
["chr2",8854710,8855066,357,"ENSBGRG00000006640","ENSBGRT00000012269",50087,"NIPAL3","NIPA like domain containing 3 [Source:HGNC Symbol;Acc:HGNC:25233]","GO:0015095(magnesium ion transmembrane transporter activity);GO:0015693(magnesium ion transport);GO:0016021(integral component of membrane)","NA",{"v":1.3e-29,"d":"0.00"},1,"357,",0,{"v":-28.9,"d":"-28.90"},{"v":-27.7,"d":"-27.70"},6.15,"3' UTR",2,8804623,8855066,50444,1]
["chr2",8892619,8912930,20312,"ENSBGRG00000006726","ENSBGRT00000012551",0,"RCAN3","RCAN family member 3 [Source:HGNC Symbol;Acc:HGNC:3042]","GO:0003676(nucleic acid binding);GO:0019722(calcium-mediated signaling);GO:0019902(phosphatase binding);GO:0031013(troponin I binding)","NA",{"v":0.00046,"d":"0.00"},2,"255,131,","0,20181",-3.34,-2.69,7.02,"5' UTR",2,8892619,8916870,24252,1]
["chr2",8914134,8918347,4214,"ENSBGRG00000006726","ENSBGRT00000012551",21515,"RCAN3","RCAN family member 3 [Source:HGNC Symbol;Acc:HGNC:3042]","GO:0003676(nucleic acid binding);GO:0019722(calcium-mediated signaling);GO:0019902(phosphatase binding);GO:0031013(troponin I binding)","NA",{"v":7.6e-05,"d":"0.00"},3,"68,591,585,","0,2584,3629",-4.12,-3.44,10,"3' UTR",2,8892619,8916870,24252,1]
["chr2",9033101,9036166,3066,"ENSBGRG00000006897","ENSBGRT00000013165",0,"ENSBGRG00000006897","NA","GO:0006397(mRNA processing)","03013(RNA transport);03015(mRNA surveillance pathway)",{"v":3.3e-07,"d":"0.00"},3,"21,90,69,","0,2597,2997",-6.48,-5.71,{"v":1.8,"d":"1.80"},"Exon (ENSBGRT00000013165/ENSBGRG00000006897, exon 1 of 20)",2,9033101,9064317,31217,1]
["chr2",9060995,9064317,3323,"ENSBGRG00000006897","ENSBGRT00000013165",27894,"ENSBGRG00000006897","NA","GO:0006397(mRNA processing)","03013(RNA transport);03015(mRNA surveillance pathway)",{"v":3.2e-98,"d":"0.00"},3,"44,210,105,","0,2629,3218",{"v":-97.5,"d":"-97.50"},{"v":-95.7,"d":"-95.70"},2.03,"Exon (ENSBGRT00000013165/ENSBGRG00000006897, exon 18 of 20)",2,9033101,9064317,31217,1]
["chr2",9215990,9216287,298,"ENSBGRG00000007301","ENSBGRT00000013449",81074,"CLIC4","chloride intracellular channel 4 [Source:HGNC Symbol;Acc:HGNC:13518]","GO:0001525(angiogenesis);GO:0001886(endothelial cell morphogenesis);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0005911(cell-cell junction);GO:0007035(vacuolar acidification);GO:0009566(fertilization);GO:0009986(cell surface);GO:0015630(microtubule cytoskeleton);GO:0016363(nuclear matrix);GO:0030216(keratinocyte differentiation);GO:0030336(negative regulation of cell migration);GO:0030496(midbody);GO:0035264(multicellular organism growth);GO:0045177(apical part of cell);GO:0048471(perinuclear region of cytoplasm);GO:0048754(branching morphogenesis of an epithelial tube);GO:0061299(retina vasculature morphogenesis in camera-type eye);GO:0071277(cellular response to calcium ion)","NA",{"v":1.6e-76,"d":"0.00"},1,"298,",0,{"v":-75.8,"d":"-75.80"},{"v":-74.2,"d":"-74.20"},1.67,"3' UTR",2,9134916,9217534,82619,1]
["chr2",9815583,9843000,27418,"ENSBGRG00000007916","ENSBGRT00000014465",28755,"MACO1","macoilin 1 [Source:HGNC Symbol;Acc:HGNC:25572]","GO:0005634(nucleus);GO:0007420(brain development);GO:0023041(neuronal signal transduction);GO:0030424(axon);GO:0030867(rough endoplasmic reticulum membrane);GO:0031965(nuclear membrane);GO:0043005(neuron projection);GO:0044306(neuron projection terminus);GO:0045202(synapse)","NA",{"v":1E-107,"d":"0.00"},3,"116,502,101,","0,1320,27317",-107,-105,5.91,"Exon (ENSBGRT00000014465/ENSBGRG00000007916, exon 5 of 11)",2,9786828,9864715,77888,1]
["chr2",9848164,9864715,16552,"ENSBGRG00000007916","ENSBGRT00000014465",61336,"MACO1","macoilin 1 [Source:HGNC Symbol;Acc:HGNC:25572]","GO:0005634(nucleus);GO:0007420(brain development);GO:0023041(neuronal signal transduction);GO:0030424(axon);GO:0030867(rough endoplasmic reticulum membrane);GO:0031965(nuclear membrane);GO:0043005(neuron projection);GO:0044306(neuron projection terminus);GO:0045202(synapse)","NA",{"v":1e-184,"d":"0.00"},4,"183,121,175,718,","0,2354,10645,15834",-184,-181,4.31,"3' UTR",2,9786828,9864715,77888,1]
["chr2",9931617,9932351,735,"ENSBGRG00000008061","ENSBGRT00000014977",27924,"LDLRAP1","low density lipoprotein receptor adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:18640]","GO:0001540(amyloid-beta binding);GO:0001784(phosphotyrosine residue binding);GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005883(neurofilament);GO:0006898(receptor-mediated endocytosis);GO:0009898(cytoplasmic side of plasma membrane);GO:0009925(basal plasma membrane);GO:0030159(receptor signaling complex adaptor activity);GO:0030276(clathrin binding);GO:0031623(receptor internalization);GO:0034383(low-density lipoprotein particle clearance);GO:0035591(signaling adaptor activity);GO:0035612(AP-2 adaptor complex binding);GO:0035650(AP-1 adaptor complex binding);GO:0042632(cholesterol homeostasis);GO:0042982(amyloid precursor protein metabolic process);GO:0043393(regulation of protein binding);GO:0048260(positive regulation of receptor-mediated endocytosis);GO:0050750(low-density lipoprotein particle receptor binding);GO:0055037(recycling endosome);GO:0071345(cellular response to cytokine stimulus);GO:0090118(receptor-mediated endocytosis involved in cholesterol transport);GO:1903076(regulation of protein localization to plasma membrane);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1905581(positive regulation of low-density lipoprotein particle clearance);GO:1905602(positive regulation of receptor-mediated endocytosis involved in cholesterol transport)","04144(Endocytosis);04979(Cholesterol metabolism)",{"v":3.2e-11,"d":"0.00"},2,"62,145,","0,590",{"v":-10.5,"d":"-10.50"},-9.68,4.87,"Exon (ENSBGRT00000014977/ENSBGRG00000008061, exon 10 of 10)",2,9903693,9931678,27986,1]
["chr2",9976093,10053072,76980,"ENSBGRG00000008298","ENSBGRT00000015315",0,"MAN1C1","mannosidase alpha class 1C member 1 [Source:HGNC Symbol;Acc:HGNC:19080]","GO:0003824(catalytic activity);GO:0004571(mannosyl-oligosaccharide 1,2-alpha-mannosidase activity);GO:0005509(calcium ion binding);GO:0016020(membrane)","00510(N-Glycan biosynthesis);04141(Protein processing in endoplasmic reticulum)",{"v":7.9e-26,"d":"0.00"},2,"540,29,","0,76951",{"v":-25.1,"d":"-25.10"},-24,4.86,"Exon (ENSBGRT00000015315/ENSBGRG00000008298, exon 1 of 12)",2,9976093,10160758,184666,1]
["chr2",10159247,10160639,1393,"ENSBGRG00000008298","ENSBGRT00000015315",183154,"MAN1C1","mannosidase alpha class 1C member 1 [Source:HGNC Symbol;Acc:HGNC:19080]","GO:0003824(catalytic activity);GO:0004571(mannosyl-oligosaccharide 1,2-alpha-mannosidase activity);GO:0005509(calcium ion binding);GO:0016020(membrane)","00510(N-Glycan biosynthesis);04141(Protein processing in endoplasmic reticulum)",{"v":1e-18,"d":"0.00"},2,"13,646,","0,747",-18,-17,3.23,"3' UTR",2,9976093,10160758,184666,1]
["chr2",10164430,10165317,888,"ENSBGRG00000008460","ENSBGRT00000015377",1674,"ENSBGRG00000008460","NA","NA","NA",{"v":0.0058,"d":"0.01"},1,"888,",0,-2.24,-1.66,10,"Exon (ENSBGRT00000015377/ENSBGRG00000008460, exon 2 of 2)",2,10162756,10165317,2562,1]
["chr2",10186199,10186585,387,"ENSBGRG00000008512","ENSBGRT00000015467",0,"ENSBGRG00000008512","NA","NA","NA",{"v":5.8e-08,"d":"0.00"},1,"387,",0,-7.24,-6.45,{"v":10.7,"d":"10.70"},"5' UTR",2,10186199,10201579,15381,1]
["chr2",10220227,10227433,7207,"ENSBGRG00000008577","ENSBGRT00000015711",6284,"MTFR1L","mitochondrial fission regulator 1 like [Source:HGNC Symbol;Acc:HGNC:28836]","NA","NA",{"v":1E-146,"d":"0.00"},2,"104,946,","0,6261",-146,-144,5.48,"3' UTR",2,10213943,10226794,12852,1]
["chr2",10445499,10445708,210,"ENSBGRG00000008937","ENSBGRT00000016357",19692,"EXTL1","exostosin like glycosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:3515]","GO:0006486(protein glycosylation);GO:0016021(integral component of membrane);GO:0016757(transferase activity, transferring glycosyl groups)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)",{"v":0.0058,"d":"0.01"},1,"210,",0,-2.24,-1.66,4.01,"3' UTR",2,10425807,10446156,20350,1]
["chr2",10445798,10446156,359,"ENSBGRG00000008937","ENSBGRT00000016357",19991,"EXTL1","exostosin like glycosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:3515]","GO:0006486(protein glycosylation);GO:0016021(integral component of membrane);GO:0016757(transferase activity, transferring glycosyl groups)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)",{"v":5e-05,"d":"0.00"},1,"359,",0,{"v":-4.3,"d":"-4.30"},{"v":-3.6,"d":"-3.60"},14,"3' UTR",2,10425807,10446156,20350,1]
["chr2",10537834,10542590,4757,"ENSBGRG00000005649","ENSBGRT00000010410",179,"PDIK1L","PDLIM1 interacting kinase 1 like [Source:HGNC Symbol;Acc:HGNC:18981]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation)","NA",{"v":5E-36,"d":"0.00"},2,"123,741,","0,4016",{"v":-35.3,"d":"-35.30"},{"v":-34.1,"d":"-34.10"},8.93,"Exon (ENSBGRT00000010410/ENSBGRG00000005649, exon 1 of 2)",2,10537655,10542590,4936,1]
["chr2",10575843,10576655,813,"ENSBGRG00000005660","ENSBGRT00000010438",0,"FAM110D","family with sequence similarity 110 member D [Source:HGNC Symbol;Acc:HGNC:25860]","NA","NA",{"v":5.4E-8,"d":"0.00"},1,"813,",0,-7.27,-6.48,{"v":28.1,"d":"28.10"},"Exon (ENSBGRT00000010438/ENSBGRG00000005660, exon 1 of 1)",2,10575843,10576655,813,1]
["chr2",10583281,10584000,720,"ENSBGRG00000005708","ENSBGRT00000010559",0,"ZNF593","zinc finger protein 593 [Source:HGNC Symbol;Acc:HGNC:30943]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0008270(zinc ion binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1903026(negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding)","NA",{"v":3.2E-77,"d":"0.00"},3,"200,63,142,","0,422,578",{"v":-76.5,"d":"-76.50"},{"v":-74.9,"d":"-74.90"},5.33,"Exon (ENSBGRT00000010559/ENSBGRG00000005708, exon 1 of 3)",2,10583281,10584000,720,1]
["chr2",10605862,10606130,269,"ENSBGRG00000005760","ENSBGRT00000010660",13328,"CNKSR1","connector enhancer of kinase suppressor of Ras 1 [Source:HGNC Symbol;Acc:HGNC:19700]","GO:0005515(protein binding);GO:0005938(cell cortex);GO:0007265(Ras protein signal transduction);GO:0007266(Rho protein signal transduction);GO:0030674(protein-macromolecule adaptor activity)","NA",{"v":5.8e-09,"d":"0.00"},1,"269,",0,-8.24,-7.42,2.81,"5' UTR",2,10592534,10606160,13627,1]
["chr2",10605845,10606145,301,"ENSBGRG00000005760","ENSBGRT00000010660",13311,"CNKSR1","connector enhancer of kinase suppressor of Ras 1 [Source:HGNC Symbol;Acc:HGNC:19700]","GO:0005515(protein binding);GO:0005938(cell cortex);GO:0007265(Ras protein signal transduction);GO:0007266(Rho protein signal transduction);GO:0030674(protein-macromolecule adaptor activity)","NA",{"v":1.3e-08,"d":"0.00"},1,"301,",0,{"v":-7.9,"d":"-7.90"},-7.09,3.23,"5' UTR",2,10592534,10606160,13627,1]
["chr2",10689649,10689918,270,"ENSBGRG00000006005","ENSBGRT00000011174",43116,"CEP85","centrosomal protein 85 [Source:HGNC Symbol;Acc:HGNC:25309]","GO:0000242(pericentriolar material);GO:0000922(spindle pole);GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006469(negative regulation of protein kinase activity);GO:0046602(regulation of mitotic centrosome separation)","NA",{"v":0.0022,"d":"0.00"},1,"270,",0,-2.65,-2.05,2.51,"3' UTR",2,10646533,10689918,43386,1]
["chr2",10730481,10730599,119,"ENSBGRG00000006261","ENSBGRT00000011536",1198,"ENSBGRG00000006261","CD52 molecule [Source:HGNC Symbol;Acc:HGNC:1804]","NA","NA",{"v":0.0056,"d":"0.01"},3,"12,5,90,","0,20,29",-2.25,-1.67,1.26,"Exon (ENSBGRT00000011536/ENSBGRG00000006261, exon 2 of 4)",2,10729283,10730599,1317,1]
["chr2",10882850,10883560,711,"ENSBGRG00000006878","ENSBGRT00000012750",0,"ENSBGRG00000006878","high mobility group nucleosomal binding domain 2 [Source:HGNC Symbol;Acc:HGNC:4986]","GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)","NA",{"v":3.2e-16,"d":"0.00"},2,"15,164,","0,547",{"v":-15.5,"d":"-15.50"},{"v":-14.5,"d":"-14.50"},3.48,"5' UTR",2,10882850,10885225,2376,1]
["chr2",10883708,10885143,1436,"ENSBGRG00000006878","ENSBGRT00000012750",858,"ENSBGRG00000006878","high mobility group nucleosomal binding domain 2 [Source:HGNC Symbol;Acc:HGNC:4986]","GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)","NA",0,5,"39,45,30,51,221,","0,178,417,773,1215",-421,"-Inf",2.49,"5' UTR",2,10882850,10885225,2376,1]
["chr2",10981003,10981750,748,"ENSBGRG00000007015","ENSBGRT00000013869",41453,"RPS6KA1","ribosomal protein S6 kinase A1 [Source:HGNC Symbol;Acc:HGNC:10430]","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0035556(intracellular signal transduction);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2000491(positive regulation of hepatic stellate cell activation)","04010(MAPK signaling pathway);04150(mTOR signaling pathway);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04714(Thermogenesis);04931(Insulin resistance)",{"v":5e-46,"d":"0.00"},1,"748,",0,{"v":-45.3,"d":"-45.30"},-44,4.71,"3' UTR",2,10939550,10981930,42381,1]
["chr2",11087382,11115028,27647,"ENSBGRG00000008144","ENSBGRT00000015489",0,"ARID1A","AT-rich interaction domain 1A [Source:HGNC Symbol;Acc:HGNC:11110]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0001704(formation of primary germ layer);GO:0001843(neural tube closure);GO:0003205(cardiac chamber development);GO:0003408(optic cup formation involved in camera-type eye development);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0007369(gastrulation);GO:0007566(embryo implantation);GO:0016514(SWI/SNF complex);GO:0016922(nuclear receptor binding);GO:0019827(stem cell population maintenance);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030900(forebrain development);GO:0031491(nucleosome binding);GO:0035060(brahma complex);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043044(ATP-dependent chromatin remodeling);GO:0045893(positive regulation of transcription, DNA-templated);GO:0055007(cardiac muscle cell differentiation);GO:0060674(placenta blood vessel development);GO:0070829(heterochromatin maintenance);GO:0071564(npBAF complex);GO:0071565(nBAF complex);GO:1901998(toxin transport)","04714(Thermogenesis);05225(Hepatocellular carcinoma)",{"v":5e-26,"d":"0.00"},2,"1143,25,","0,27622",{"v":-25.3,"d":"-25.30"},{"v":-24.2,"d":"-24.20"},{"v":43.1,"d":"43.10"},"Exon (ENSBGRT00000015489/ENSBGRG00000008144, exon 1 of 20)",2,11087382,11161143,73762,1]
["chr2",11116875,11116994,120,"ENSBGRG00000008144","ENSBGRT00000015489",29493,"ARID1A","AT-rich interaction domain 1A [Source:HGNC Symbol;Acc:HGNC:11110]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0001704(formation of primary germ layer);GO:0001843(neural tube closure);GO:0003205(cardiac chamber development);GO:0003408(optic cup formation involved in camera-type eye development);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0007369(gastrulation);GO:0007566(embryo implantation);GO:0016514(SWI/SNF complex);GO:0016922(nuclear receptor binding);GO:0019827(stem cell population maintenance);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030900(forebrain development);GO:0031491(nucleosome binding);GO:0035060(brahma complex);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043044(ATP-dependent chromatin remodeling);GO:0045893(positive regulation of transcription, DNA-templated);GO:0055007(cardiac muscle cell differentiation);GO:0060674(placenta blood vessel development);GO:0070829(heterochromatin maintenance);GO:0071564(npBAF complex);GO:0071565(nBAF complex);GO:1901998(toxin transport)","04714(Thermogenesis);05225(Hepatocellular carcinoma)",{"v":1.3E-6,"d":"0.00"},1,"120,",0,{"v":-5.9,"d":"-5.90"},-5.15,1.64,"Exon (ENSBGRT00000015489/ENSBGRG00000008144, exon 3 of 20)",2,11087382,11161143,73762,1]
["chr2",11156277,11156666,390,"ENSBGRG00000008144","ENSBGRT00000015489",68895,"ARID1A","AT-rich interaction domain 1A [Source:HGNC Symbol;Acc:HGNC:11110]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0001704(formation of primary germ layer);GO:0001843(neural tube closure);GO:0003205(cardiac chamber development);GO:0003408(optic cup formation involved in camera-type eye development);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0007369(gastrulation);GO:0007566(embryo implantation);GO:0016514(SWI/SNF complex);GO:0016922(nuclear receptor binding);GO:0019827(stem cell population maintenance);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030900(forebrain development);GO:0031491(nucleosome binding);GO:0035060(brahma complex);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043044(ATP-dependent chromatin remodeling);GO:0045893(positive regulation of transcription, DNA-templated);GO:0055007(cardiac muscle cell differentiation);GO:0060674(placenta blood vessel development);GO:0070829(heterochromatin maintenance);GO:0071564(npBAF complex);GO:0071565(nBAF complex);GO:1901998(toxin transport)","04714(Thermogenesis);05225(Hepatocellular carcinoma)",{"v":4.2e-08,"d":"0.00"},1,"390,",0,-7.38,-6.58,1.54,"Exon (ENSBGRT00000015489/ENSBGRG00000008144, exon 18 of 20)",2,11087382,11161143,73762,1]
["chr2",11157221,11161143,3923,"ENSBGRG00000008144","ENSBGRT00000015489",69839,"ARID1A","AT-rich interaction domain 1A [Source:HGNC Symbol;Acc:HGNC:11110]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0001704(formation of primary germ layer);GO:0001843(neural tube closure);GO:0003205(cardiac chamber development);GO:0003408(optic cup formation involved in camera-type eye development);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0007369(gastrulation);GO:0007566(embryo implantation);GO:0016514(SWI/SNF complex);GO:0016922(nuclear receptor binding);GO:0019827(stem cell population maintenance);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030900(forebrain development);GO:0031491(nucleosome binding);GO:0035060(brahma complex);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043044(ATP-dependent chromatin remodeling);GO:0045893(positive regulation of transcription, DNA-templated);GO:0055007(cardiac muscle cell differentiation);GO:0060674(placenta blood vessel development);GO:0070829(heterochromatin maintenance);GO:0071564(npBAF complex);GO:0071565(nBAF complex);GO:1901998(toxin transport)","04714(Thermogenesis);05225(Hepatocellular carcinoma)",{"v":9.99999999999999e-294,"d":"0.00"},2,"98,2088,","0,1835",-293,-291,8.82,"3' UTR",2,11087382,11161143,73762,1]
["chr2",11178918,11179036,119,"ENSBGRG00000008647","ENSBGRT00000015744",6215,"PIGV","phosphatidylinositol glycan anchor biosynthesis class V [Source:HGNC Symbol;Acc:HGNC:26031]","GO:0004584(dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity);GO:0006506(GPI anchor biosynthetic process)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":0.038,"d":"0.04"},1,"119,",0,-1.42,{"v":-0.911,"d":"-0.91"},1.48,"Exon (ENSBGRT00000015744/ENSBGRG00000008647, exon 3 of 4)",2,11172703,11182889,10187,1]
["chr2",11179510,11182889,3380,"ENSBGRG00000008647","ENSBGRT00000015744",6807,"PIGV","phosphatidylinositol glycan anchor biosynthesis class V [Source:HGNC Symbol;Acc:HGNC:26031]","GO:0004584(dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity);GO:0006506(GPI anchor biosynthetic process)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":7.9e-35,"d":"0.00"},2,"459,282,","0,3098",{"v":-34.1,"d":"-34.10"},{"v":-32.9,"d":"-32.90"},{"v":5.3,"d":"5.30"},"Exon (ENSBGRT00000015744/ENSBGRG00000008647, exon 3 of 4)",2,11172703,11182889,10187,1]
["chr2",11228055,11234394,6340,"ENSBGRG00000008689","ENSBGRT00000015860",26342,"ZDHHC18","zinc finger DHHC-type containing 18 [Source:HGNC Symbol;Acc:HGNC:20712]","GO:0005794(Golgi apparatus);GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0034613(cellular protein localization)","NA",{"v":7.9e-20,"d":"0.00"},3,"110,734,51,","0,2133,6289",{"v":-19.1,"d":"-19.10"},{"v":-18.1,"d":"-18.10"},3.68,"3' UTR",2,11201713,11235736,34024,1]
["chr2",11235348,11235736,389,"ENSBGRG00000008689","ENSBGRT00000015860",33635,"ZDHHC18","zinc finger DHHC-type containing 18 [Source:HGNC Symbol;Acc:HGNC:20712]","GO:0005794(Golgi apparatus);GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0034613(cellular protein localization)","NA",{"v":7.1e-05,"d":"0.00"},1,"389,",0,-4.15,-3.46,17,"3' UTR",2,11201713,11235736,34024,1]
["chr2",11301748,11312045,10298,"ENSBGRG00000008953","ENSBGRT00000016406",0,"ENSBGRG00000008953","NA","NA","04976(Bile secretion)",{"v":3.2e-73,"d":"0.00"},3,"81,78,260,","0,2398,10038",{"v":-72.5,"d":"-72.50"},-71,2.26,"5' UTR",2,11281988,11302217,20230,2]
["chr2",11312552,11315311,2760,"ENSBGRG00000008992","ENSBGRT00000016453",10804,"NUDC","nuclear distribution C, dynein complex regulator [Source:HGNC Symbol;Acc:HGNC:8045]","GO:0005737(cytoplasm);GO:0005829(cytosol)","NA",{"v":1e-110,"d":"0.00"},5,"224,66,117,195,26,","0,313,1106,1296,2734",-110,-108,2.46,"Exon (ENSBGRT00000016453/ENSBGRG00000008992, exon 3 of 9)",2,11301748,11318286,16539,1]
["chr2",11316790,11317540,751,"ENSBGRG00000008992","ENSBGRT00000016453",15042,"NUDC","nuclear distribution C, dynein complex regulator [Source:HGNC Symbol;Acc:HGNC:8045]","GO:0005737(cytoplasm);GO:0005829(cytosol)","NA",{"v":3.2e-62,"d":"0.00"},2,"23,306,","0,445",{"v":-61.5,"d":"-61.50"},-60,2.02,"3' UTR",2,11301748,11318286,16539,1]
["chr2",11366720,11367297,578,"ENSBGRG00000009143","ENSBGRT00000016780",0,"ENSBGRG00000009143","NA","NA","NA",{"v":0.019,"d":"0.02"},2,"282,258,","0,320",-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000016780/ENSBGRG00000009143, exon 1 of 2)",2,11366720,11367417,698,1]
["chr2",11668612,11669149,538,"ENSBGRG00000009375","ENSBGRT00000017247",62938,"WDTC1","WD and tetratricopeptide repeats 1 [Source:HGNC Symbol;Acc:HGNC:29175]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001701(in utero embryonic development);GO:0004857(enzyme inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006006(glucose metabolic process);GO:0008361(regulation of cell size);GO:0032869(cellular response to insulin stimulus);GO:0035264(multicellular organism growth);GO:0042393(histone binding);GO:0042826(histone deacetylase binding);GO:0045717(negative regulation of fatty acid biosynthetic process);GO:0055082(cellular chemical homeostasis)","NA",{"v":1E-117,"d":"0.00"},1,"538,",0,-117,-115,3.65,"3' UTR",2,11605674,11669776,64103,1]
["chr2",11697374,11697494,121,"ENSBGRG00000009602","ENSBGRT00000017687",12700,"ENSBGRG00000009602","NA","NA","03040(Spliceosome)",{"v":0.0025,"d":"0.00"},1,"121,",0,{"v":-2.6,"d":"-2.60"},-2,{"v":1.4,"d":"1.40"},"3' UTR",2,11684674,11698866,14193,1]
["chr2",11698150,11698866,717,"ENSBGRG00000009602","ENSBGRT00000017687",13476,"ENSBGRG00000009602","NA","NA","03040(Spliceosome)",0,1,"717,",0,-354,"-Inf",{"v":13.6,"d":"13.60"},"3' UTR",2,11684674,11698866,14193,1]
["chr2",11757988,11758819,832,"ENSBGRG00000011392","ENSBGRT00000020792",0,"GPR3","G protein-coupled receptor 3 [Source:HGNC Symbol;Acc:HGNC:4484]","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0040020(regulation of meiotic nuclear division);GO:0120162(positive regulation of cold-induced thermogenesis)","NA",{"v":0.035,"d":"0.04"},1,"832,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"5' UTR",2,11757988,11768490,10503,1]
["chr2",12059668,12059817,150,"ENSBGRG00000012076","ENSBGRT00000022553",180,"FAM76A","family with sequence similarity 76 member A [Source:HGNC Symbol;Acc:HGNC:28530]","GO:0005654(nucleoplasm)","04150(mTOR signaling pathway);04115(p53 signaling pathway)",{"v":0.022,"d":"0.02"},1,"150,",0,-1.66,-1.14,1.89,"5' UTR",2,12059488,12091300,31813,1]
["chr2",12065160,12065220,61,"ENSBGRG00000012076","ENSBGRT00000022553",5672,"FAM76A","family with sequence similarity 76 member A [Source:HGNC Symbol;Acc:HGNC:28530]","GO:0005654(nucleoplasm)","04150(mTOR signaling pathway);04115(p53 signaling pathway)",0.03,1,"61,",0,-1.52,-1.01,1.59,"Exon (ENSBGRT00000022553/ENSBGRG00000012076, exon 4 of 9)",2,12059488,12091300,31813,1]
["chr2",12176169,12182617,6449,"ENSBGRG00000012519","ENSBGRT00000022916",12599,"PPP1R8","protein phosphatase 1 regulatory subunit 8 [Source:HGNC Symbol;Acc:HGNC:9296]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008283(cell population proliferation);GO:0016607(nuclear speck);GO:0019888(protein phosphatase regulator activity)","NA",{"v":1E-136,"d":"0.00"},3,"51,65,354,","0,4800,6095",-136,-134,4.99,"Exon (ENSBGRT00000022916/ENSBGRG00000012519, exon 5 of 7)",2,12163570,12182617,19048,1]
["chr2",12238335,12239113,779,"ENSBGRG00000012596","ENSBGRT00000023174",11341,"THEMIS2","thymocyte selection associated family member 2 [Source:HGNC Symbol;Acc:HGNC:16839]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0050852(T cell receptor signaling pathway)","NA",{"v":0.0011,"d":"0.00"},1,"779,",0,-2.95,-2.32,9.03,"Exon (ENSBGRT00000023174/ENSBGRG00000012596, exon 5 of 6)",2,12226994,12240040,13047,1]
["chr2",12321476,12321893,418,"ENSBGRG00000012884","ENSBGRT00000023818",35025,"SMPDL3B","sphingomyelin phosphodiesterase acid like 3B [Source:HGNC Symbol;Acc:HGNC:21416]","GO:0004767(sphingomyelin phosphodiesterase activity);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0006685(sphingomyelin catabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0008270(zinc ion binding);GO:0016787(hydrolase activity);GO:0034122(negative regulation of toll-like receptor signaling pathway);GO:0046466(membrane lipid catabolic process);GO:0050728(negative regulation of inflammatory response)","NA",{"v":0.0058,"d":"0.01"},1,"418,",0,-2.24,-1.66,10,"3' UTR",2,12286451,12322071,35621,1]
["chr2",12328239,12328865,627,"ENSBGRG00000013224","ENSBGRT00000024225",5607,"XKR8","XK related 8 [Source:HGNC Symbol;Acc:HGNC:25508]","GO:0005886(plasma membrane);GO:0016021(integral component of membrane);GO:0043652(engulfment of apoptotic cell);GO:0070782(phosphatidylserine exposure on apoptotic cell surface)","NA",{"v":4.8e-05,"d":"0.00"},1,"627,",0,-4.32,-3.62,4.26,"Exon (ENSBGRT00000024225/ENSBGRG00000013224, exon 3 of 3)",2,12322632,12330237,7606,1]
["chr2",12602208,12611995,9788,"ENSBGRG00000013915","ENSBGRT00000025661",0,"ATP5IF1","ATP synthase inhibitory factor subunit 1 [Source:HGNC Symbol;Acc:HGNC:871]","GO:0001937(negative regulation of endothelial cell proliferation);GO:0005739(mitochondrion);GO:0006783(heme biosynthetic process);GO:0009986(cell surface);GO:0019899(enzyme binding);GO:0030218(erythrocyte differentiation);GO:0032780(negative regulation of ATPase activity);GO:0042030(ATPase inhibitor activity);GO:0043532(angiostatin binding);GO:0051117(ATPase binding);GO:0051346(negative regulation of hydrolase activity);GO:0051882(mitochondrial depolarization);GO:0072593(reactive oxygen species metabolic process);GO:0140260(mitochondrial proton-transporting ATP synthase complex binding);GO:1901030(positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway);GO:1903052(positive regulation of proteolysis involved in cellular protein catabolic process);GO:1903214(regulation of protein targeting to mitochondrion);GO:1903578(regulation of ATP metabolic process);GO:1904925(positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization)","NA",{"v":1e-267,"d":"0.00"},6,"87,92,34,151,8,47,","0,189,1901,1974,9719,9741",-267,-264,{"v":2.4,"d":"2.40"},"Exon (ENSBGRT00000025661/ENSBGRG00000013915, exon 1 of 3)",2,12602208,12604142,1935,1]
["chr2",12635808,12636878,1071,"ENSBGRG00000014010","ENSBGRT00000025896",17337,"SESN2","sestrin 2 [Source:HGNC Symbol;Acc:HGNC:20746]","GO:0001932(regulation of protein phosphorylation);GO:0005092(GDP-dissociation inhibitor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006111(regulation of gluconeogenesis);GO:0006635(fatty acid beta-oxidation);GO:0007005(mitochondrion organization);GO:0009749(response to glucose);GO:0016239(positive regulation of macroautophagy);GO:0016684(oxidoreductase activity, acting on peroxide as acceptor);GO:0030308(negative regulation of cell growth);GO:0030330(DNA damage response, signal transduction by p53 class mediator);GO:0031588(nucleotide-activated protein kinase complex);GO:0031932(TORC2 complex);GO:0032042(mitochondrial DNA metabolic process);GO:0032542(sulfiredoxin activity);GO:0032868(response to insulin);GO:0034198(cellular response to amino acid starvation);GO:0034599(cellular response to oxidative stress);GO:0036091(positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress);GO:0042149(cellular response to glucose starvation);GO:0042593(glucose homeostasis);GO:0043491(protein kinase B signaling);GO:0046323(glucose import);GO:0061700(GATOR2 complex);GO:0070328(triglyceride homeostasis);GO:0070728(leucine binding);GO:0071230(cellular response to amino acid stimulus);GO:0071233(cellular response to leucine);GO:0072593(reactive oxygen species metabolic process);GO:0098869(cellular oxidant detoxification);GO:1900182(positive regulation of protein localization to nucleus);GO:1901031(regulation of response to reactive oxygen species);GO:1902010(negative regulation of translation in response to endoplasmic reticulum stress);GO:1904262(negative regulation of TORC1 signaling);GO:1904504(positive regulation of lipophagy);GO:1990253(cellular response to leucine starvation);GO:1990316(Atg1/ULK1 kinase complex);GO:2000479(regulation of cAMP-dependent protein kinase activity)","04150(mTOR signaling pathway);04115(p53 signaling pathway);04211(Longevity regulating pathway - mammal)",{"v":7.9e-30,"d":"0.00"},2,"7,470,","0,601",{"v":-29.1,"d":"-29.10"},{"v":-27.9,"d":"-27.90"},{"v":7.1,"d":"7.10"},"3' UTR",2,12618471,12638249,19779,1]
["chr2",12638160,12638249,90,"ENSBGRG00000014010","ENSBGRT00000025896",19689,"SESN2","sestrin 2 [Source:HGNC Symbol;Acc:HGNC:20746]","GO:0001932(regulation of protein phosphorylation);GO:0005092(GDP-dissociation inhibitor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006111(regulation of gluconeogenesis);GO:0006635(fatty acid beta-oxidation);GO:0007005(mitochondrion organization);GO:0009749(response to glucose);GO:0016239(positive regulation of macroautophagy);GO:0016684(oxidoreductase activity, acting on peroxide as acceptor);GO:0030308(negative regulation of cell growth);GO:0030330(DNA damage response, signal transduction by p53 class mediator);GO:0031588(nucleotide-activated protein kinase complex);GO:0031932(TORC2 complex);GO:0032042(mitochondrial DNA metabolic process);GO:0032542(sulfiredoxin activity);GO:0032868(response to insulin);GO:0034198(cellular response to amino acid starvation);GO:0034599(cellular response to oxidative stress);GO:0036091(positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress);GO:0042149(cellular response to glucose starvation);GO:0042593(glucose homeostasis);GO:0043491(protein kinase B signaling);GO:0046323(glucose import);GO:0061700(GATOR2 complex);GO:0070328(triglyceride homeostasis);GO:0070728(leucine binding);GO:0071230(cellular response to amino acid stimulus);GO:0071233(cellular response to leucine);GO:0072593(reactive oxygen species metabolic process);GO:0098869(cellular oxidant detoxification);GO:1900182(positive regulation of protein localization to nucleus);GO:1901031(regulation of response to reactive oxygen species);GO:1902010(negative regulation of translation in response to endoplasmic reticulum stress);GO:1904262(negative regulation of TORC1 signaling);GO:1904504(positive regulation of lipophagy);GO:1990253(cellular response to leucine starvation);GO:1990316(Atg1/ULK1 kinase complex);GO:2000479(regulation of cAMP-dependent protein kinase activity)","04150(mTOR signaling pathway);04115(p53 signaling pathway);04211(Longevity regulating pathway - mammal)",{"v":3e-08,"d":"0.00"},1,"90,",0,-7.53,-6.73,3.42,"3' UTR",2,12618471,12638249,19779,1]
["chr2",12687384,12691565,4182,"ENSBGRG00000014253","ENSBGRT00000026198",87,"MED18","mediator complex subunit 18 [Source:HGNC Symbol;Acc:HGNC:25944]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016592(mediator complex)","NA",{"v":1.6e-60,"d":"0.00"},2,"57,554,","0,3628",{"v":-59.8,"d":"-59.80"},{"v":-58.3,"d":"-58.30"},7.82,"Exon (ENSBGRT00000026198/ENSBGRG00000014253, exon 1 of 2)",2,12687297,12691565,4269,1]
["chr2",12733938,12760535,26598,"ENSBGRG00000014359","ENSBGRT00000026775",0,"PHACTR4","phosphatase and actin regulator 4 [Source:HGNC Symbol;Acc:HGNC:25793]","GO:0001755(neural crest cell migration);GO:0001843(neural tube closure);GO:0003779(actin binding);GO:0007266(Rho protein signal transduction);GO:0008157(protein phosphatase 1 binding);GO:0019888(protein phosphatase regulator activity);GO:0030027(lamellipodium);GO:0030036(actin cytoskeleton organization);GO:0043085(positive regulation of catalytic activity);GO:0048484(enteric nervous system development);GO:0051726(regulation of cell cycle);GO:0061386(closure of optic fissure);GO:0072542(protein phosphatase activator activity);GO:2001045(negative regulation of integrin-mediated signaling pathway)","NA",0.01,2,"414,5,","0,26593",-1.98,-1.42,5.01,"5' UTR",2,12733938,12850465,116528,1]
["chr2",12832717,12832896,180,"ENSBGRG00000014359","ENSBGRT00000026775",98779,"PHACTR4","phosphatase and actin regulator 4 [Source:HGNC Symbol;Acc:HGNC:25793]","GO:0001755(neural crest cell migration);GO:0001843(neural tube closure);GO:0003779(actin binding);GO:0007266(Rho protein signal transduction);GO:0008157(protein phosphatase 1 binding);GO:0019888(protein phosphatase regulator activity);GO:0030027(lamellipodium);GO:0030036(actin cytoskeleton organization);GO:0043085(positive regulation of catalytic activity);GO:0048484(enteric nervous system development);GO:0051726(regulation of cell cycle);GO:0061386(closure of optic fissure);GO:0072542(protein phosphatase activator activity);GO:2001045(negative regulation of integrin-mediated signaling pathway)","NA",{"v":3.2e-05,"d":"0.00"},1,"180,",0,{"v":-4.5,"d":"-4.50"},{"v":-3.8,"d":"-3.80"},1.43,"Exon (ENSBGRT00000026775/ENSBGRG00000014359, exon 8 of 15)",2,12733938,12850465,116528,1]
["chr2",12837327,12848301,10975,"ENSBGRG00000014359","ENSBGRT00000026775",103389,"PHACTR4","phosphatase and actin regulator 4 [Source:HGNC Symbol;Acc:HGNC:25793]","GO:0001755(neural crest cell migration);GO:0001843(neural tube closure);GO:0003779(actin binding);GO:0007266(Rho protein signal transduction);GO:0008157(protein phosphatase 1 binding);GO:0019888(protein phosphatase regulator activity);GO:0030027(lamellipodium);GO:0030036(actin cytoskeleton organization);GO:0043085(positive regulation of catalytic activity);GO:0048484(enteric nervous system development);GO:0051726(regulation of cell cycle);GO:0061386(closure of optic fissure);GO:0072542(protein phosphatase activator activity);GO:2001045(negative regulation of integrin-mediated signaling pathway)","NA",{"v":1.1e-08,"d":"0.00"},4,"17,154,56,13,","0,796,10466,10962",-7.95,-7.14,2.03,"Exon (ENSBGRT00000026775/ENSBGRG00000014359, exon 10 of 15)",2,12733938,12850465,116528,1]
["chr2",12896698,12901000,4303,"ENSBGRG00000014760","ENSBGRT00000027270",5547,"RCC1","regulator of chromosome condensation 1 [Source:HGNC Symbol;Acc:HGNC:1913]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000785(chromatin);GO:0000790(nuclear chromatin);GO:0000794(condensed nuclear chromosome);GO:0003682(chromatin binding);GO:0005087(Ran guanyl-nucleotide exchange factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0007052(mitotic spindle organization);GO:0007059(chromosome segregation);GO:0007088(regulation of mitotic nuclear division);GO:0008536(Ran GTPase binding);GO:0031491(nucleosome binding);GO:0031492(nucleosomal DNA binding);GO:0031965(nuclear membrane);GO:0032991(protein-containing complex);GO:0042393(histone binding);GO:0043199(sulfate binding);GO:0046982(protein heterodimerization activity);GO:0051225(spindle assembly)","NA",{"v":4e-11,"d":"0.00"},4,"69,153,179,47,","0,414,3048,4256",{"v":-10.4,"d":"-10.40"},{"v":-9.5,"d":"-9.50"},3.58,"3' UTR",2,12891151,12899924,8774,1]
["chr2",12923819,12931126,7308,"ENSBGRG00000014936","ENSBGRT00000027663",18068,"TRNAU1AP","tRNA selenocysteine 1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:30813]","GO:0001514(selenocysteine incorporation);GO:0003676(nucleic acid binding);GO:0005634(nucleus)","NA",{"v":1E-155,"d":"0.00"},3,"68,34,403,","0,270,6905",-155,-153,5.89,"3' UTR",2,12905751,12931126,25376,1]
["chr2",12946291,12946735,445,"ENSBGRG00000015211","ENSBGRT00000027982",3648,"RAB42","RAB42, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:28702]","GO:0003924(GTPase activity);GO:0005525(GTP binding)","NA",{"v":1.4e-06,"d":"0.00"},1,"445,",0,-5.84,-5.09,{"v":23.1,"d":"23.10"},"3' UTR",2,12942643,12947802,5160,1]
["chr2",13045169,13045767,599,"ENSBGRG00000015362","ENSBGRT00000028340",31102,"GMEB1","glucocorticoid modulatory element binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4370]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0042802(identical protein binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051008(Hsp27 protein binding);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1e-120,"d":"0.00"},1,"599,",0,-120,-119,{"v":10.7,"d":"10.70"},"Exon (ENSBGRT00000028340/ENSBGRG00000015362, exon 9 of 9)",2,13014067,13045767,31701,1]
["chr2",13071674,13072181,508,"ENSBGRG00000015573","ENSBGRT00000028695",869,"YTHDF2","YTH N6-methyladenosine RNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:31675]","GO:0000932(P-body);GO:0001556(oocyte maturation);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006402(mRNA catabolic process);GO:0034451(centriolar satellite);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0043488(regulation of mRNA stability);GO:0050767(regulation of neurogenesis);GO:0060339(negative regulation of type I interferon-mediated signaling pathway);GO:0061157(mRNA destabilization);GO:0071425(hematopoietic stem cell proliferation);GO:1902036(regulation of hematopoietic stem cell differentiation);GO:1903538(regulation of meiotic cell cycle process involved in oocyte maturation);GO:1903679(positive regulation of cap-independent translational initiation);GO:1990247(N6-methyladenosine-containing RNA binding)","NA",{"v":0.035,"d":"0.04"},3,"249,15,125,","0,317,383",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000028695/ENSBGRG00000015573, exon 2 of 4)",2,13070805,13073167,2363,1]
["chr2",13072331,13073167,837,"ENSBGRG00000015573","ENSBGRT00000028695",1526,"YTHDF2","YTH N6-methyladenosine RNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:31675]","GO:0000932(P-body);GO:0001556(oocyte maturation);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006402(mRNA catabolic process);GO:0034451(centriolar satellite);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0043488(regulation of mRNA stability);GO:0050767(regulation of neurogenesis);GO:0060339(negative regulation of type I interferon-mediated signaling pathway);GO:0061157(mRNA destabilization);GO:0071425(hematopoietic stem cell proliferation);GO:1902036(regulation of hematopoietic stem cell differentiation);GO:1903538(regulation of meiotic cell cycle process involved in oocyte maturation);GO:1903679(positive regulation of cap-independent translational initiation);GO:1990247(N6-methyladenosine-containing RNA binding)","NA",{"v":1E-204,"d":"0.00"},1,"837,",0,-204,-201,4.85,"Exon (ENSBGRT00000028695/ENSBGRG00000015573, exon 4 of 4)",2,13070805,13073167,2363,1]
["chr2",13308919,13310026,1108,"ENSBGRG00000015780","ENSBGRT00000028946",91682,"ENSBGRG00000015780","NA","NA","NA",{"v":0.019,"d":"0.02"},1,"1108,",0,-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000028946/ENSBGRG00000015780, exon 2 of 2)",2,13217237,13310026,92790,1]
["chr2",13310405,13315174,4770,"ENSBGRG00000016000","ENSBGRT00000039943",358,"EPB41","erythrocyte membrane protein band 4.1 [Source:HGNC Symbol;Acc:HGNC:3377]","GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005545(1-phosphatidylinositol binding);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0008022(protein C-terminus binding);GO:0008092(cytoskeletal protein binding);GO:0008360(regulation of cell shape);GO:0016020(membrane);GO:0016323(basolateral plasma membrane);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030863(cortical cytoskeleton);GO:0030866(cortical actin cytoskeleton organization);GO:0032092(positive regulation of protein binding);GO:0032991(protein-containing complex);GO:0045171(intercellular bridge);GO:0047485(protein N-terminus binding);GO:0051219(phosphoprotein binding);GO:0051924(regulation of calcium ion transport);GO:0072686(mitotic spindle);GO:0099738(cell cortex region);GO:1904478(regulation of intestinal absorption);GO:1904778(positive regulation of protein localization to cell cortex)","NA",{"v":0.0013,"d":"0.00"},2,"113,68,","0,4702",-2.89,-2.27,1.56,"5' UTR",2,13310047,13386697,76651,1]
["chr2",13426453,13426781,329,"ENSBGRG00000016000","ENSBGRT00000038654",116406,"EPB41","erythrocyte membrane protein band 4.1 [Source:HGNC Symbol;Acc:HGNC:3377]","GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005545(1-phosphatidylinositol binding);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0008022(protein C-terminus binding);GO:0008092(cytoskeletal protein binding);GO:0008360(regulation of cell shape);GO:0016020(membrane);GO:0016323(basolateral plasma membrane);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030863(cortical cytoskeleton);GO:0030866(cortical actin cytoskeleton organization);GO:0032092(positive regulation of protein binding);GO:0032991(protein-containing complex);GO:0045171(intercellular bridge);GO:0047485(protein N-terminus binding);GO:0051219(phosphoprotein binding);GO:0051924(regulation of calcium ion transport);GO:0072686(mitotic spindle);GO:0099738(cell cortex region);GO:1904478(regulation of intestinal absorption);GO:1904778(positive regulation of protein localization to cell cortex)","NA",{"v":0.00014,"d":"0.00"},1,"329,",0,-3.85,-3.18,3.01,"3' UTR",2,13310047,13427319,117273,1]
["chr2",15814436,15830518,16083,"ENSBGRG00000007511","ENSBGRT00000014094",29567,"ENSBGRG00000007511","NA","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding)","03040(Spliceosome)",{"v":9.99999999999999e-235,"d":"0.00"},3,"24,146,305,","0,1996,15778",-234,-232,3.91,"3' UTR",2,15784869,15830236,45368,1]
["chr2",15989768,15990095,328,"ENSBGRG00000008317","ENSBGRT00000015230",60,"TINAGL1","tubulointerstitial nephritis antigen like 1 [Source:HGNC Symbol;Acc:HGNC:19168]","GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity);GO:0043236(laminin binding)","04142(Lysosome);04140(Autophagy - animal);04210(Apoptosis);04621(NOD-like receptor signaling pathway)",{"v":0.019,"d":"0.02"},1,"328,",0,-1.72,-1.19,7.02,"5' UTR",2,15989708,16000083,10376,1]
["chr2",16524072,16525645,1574,"ENSBGRG00000010825","ENSBGRT00000019888",23172,"KHDRBS1","KH RNA binding domain containing, signal transduction associated 1 [Source:HGNC Symbol;Acc:HGNC:18116]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","NA",{"v":1e-19,"d":"0.00"},3,"195,68,37,","0,684,1537",-19,-18,1.55,"Exon (ENSBGRT00000019888/ENSBGRG00000010825, exon 6 of 9)",2,16500900,16528007,27108,1]
["chr2",16548587,16551964,3378,"ENSBGRG00000011031","ENSBGRT00000020164",0,"TMEM39B","transmembrane protein 39B [Source:HGNC Symbol;Acc:HGNC:25510]","NA","NA",{"v":0.035,"d":"0.04"},2,"296,64,","0,3314",-1.45,{"v":-0.944,"d":"-0.94"},2.01,"5' UTR",2,16548587,16573300,24714,1]
["chr2",16570401,16570670,270,"ENSBGRG00000011031","ENSBGRT00000020164",21814,"TMEM39B","transmembrane protein 39B [Source:HGNC Symbol;Acc:HGNC:25510]","NA","NA",{"v":5e-63,"d":"0.00"},1,"270,",0,{"v":-62.3,"d":"-62.30"},{"v":-60.8,"d":"-60.80"},5.72,"3' UTR",2,16548587,16573300,24714,1]
["chr2",16574205,16623395,49191,"ENSBGRG00000011110","ENSBGRT00000020631",0,"KPNA6","karyopherin subunit alpha 6 [Source:HGNC Symbol;Acc:HGNC:6399]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006606(protein import into nucleus);GO:0019079(viral genome replication);GO:0030682(mitigation of host defenses by symbiont);GO:0042025(host cell nucleus);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060135(maternal process involved in female pregnancy);GO:0061608(nuclear import signal receptor activity);GO:0075506(entry of viral genome into host nucleus through nuclear pore complex via importin);GO:1900017(positive regulation of cytokine production involved in inflammatory response);GO:1903902(positive regulation of viral life cycle)","NA",{"v":1.6e-16,"d":"0.00"},4,"4,134,93,9,","0,45916,46899,49182",{"v":-15.8,"d":"-15.80"},{"v":-14.9,"d":"-14.90"},6.45,"Exon (ENSBGRT00000020631/ENSBGRG00000011110, exon 1 of 14)",2,16574205,16635700,61496,1]
["chr2",16647395,16647454,60,"ENSBGRG00000011469","ENSBGRT00000020916",59,"TXLNA","taxilin alpha [Source:HGNC Symbol;Acc:HGNC:30685]","GO:0005737(cytoplasm);GO:0019905(syntaxin binding);GO:0042113(B cell activation)","NA",{"v":0.034,"d":"0.03"},1,"60,",0,-1.47,{"v":-0.958,"d":"-0.96"},1.33,"Exon (ENSBGRT00000020916/ENSBGRG00000011469, exon 1 of 11)",2,16647336,16658711,11376,1]
["chr2",16656262,16658711,2450,"ENSBGRG00000011469","ENSBGRT00000020916",8926,"TXLNA","taxilin alpha [Source:HGNC Symbol;Acc:HGNC:30685]","GO:0005737(cytoplasm);GO:0019905(syntaxin binding);GO:0042113(B cell activation)","NA",{"v":1e-158,"d":"0.00"},6,"93,75,93,96,168,126,","0,350,937,1328,2123,2324",-158,-156,4.86,"Exon (ENSBGRT00000020916/ENSBGRG00000011469, exon 6 of 11)",2,16647336,16658711,11376,1]
["chr2",16667949,16670158,2210,"ENSBGRG00000011550","ENSBGRT00000021085",1773,"CCDC28B","coiled-coil domain containing 28B [Source:HGNC Symbol;Acc:HGNC:28163]","GO:0005813(centrosome);GO:0060271(cilium assembly)","03013(RNA transport)",{"v":2e-77,"d":"0.00"},5,"8,167,275,23,55,","0,884,1149,1558,2155",{"v":-76.7,"d":"-76.70"},{"v":-75.1,"d":"-75.10"},3.94,"Exon (ENSBGRT00000021085/ENSBGRG00000011550, exon 3 of 4)",2,16666176,16669372,3197,1]
["chr2",16671218,16673114,1897,"ENSBGRG00000011655","ENSBGRT00000021216",628,"IQCC","IQ motif containing C [Source:HGNC Symbol;Acc:HGNC:25545]","GO:0005515(protein binding)","NA",{"v":1E-125,"d":"0.00"},4,"126,265,119,837,","0,335,821,1060",-125,-123,4.83,"Exon (ENSBGRT00000021216/ENSBGRG00000011655, exon 2 of 5)",2,16670590,16673114,2525,1]
["chr2",16678971,16680131,1161,"ENSBGRG00000011717","ENSBGRT00000021441",5181,"DCDC2B","doublecortin domain containing 2B [Source:HGNC Symbol;Acc:HGNC:32576]","GO:0035556(intracellular signal transduction)","NA",{"v":2.4e-05,"d":"0.00"},2,"6,114,","0,1047",-4.62,-3.91,2.85,"Exon (ENSBGRT00000021441/ENSBGRG00000011717, exon 6 of 7)",2,16673790,16680131,6342,1]
["chr2",16695127,16695186,60,"ENSBGRG00000011926","ENSBGRT00000022021",8704,"EIF3I","eukaryotic translation initiation factor 3 subunit I [Source:HGNC Symbol;Acc:HGNC:3272]","GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005852(eukaryotic translation initiation factor 3 complex);GO:0006413(translational initiation);GO:0071541(eukaryotic translation initiation factor 3 complex, eIF3m)","03013(RNA transport)",{"v":6e-06,"d":"0.00"},1,"60,",0,-5.22,-4.49,1.22,"Exon (ENSBGRT00000022021/ENSBGRG00000011926, exon 10 of 10)",2,16686423,16695186,8764,1]
["chr2",16775154,16775244,91,"ENSBGRG00000012575","ENSBGRT00000023223",33486,"HDAC1","histone deacetylase 1 [Source:HGNC Symbol;Acc:HGNC:4852]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000785(chromatin);GO:0000790(nuclear chromatin);GO:0000792(heterochromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0001046(core promoter sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0002039(p53 binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003714(transcription corepressor activity);GO:0004407(histone deacetylase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005829(cytosol);GO:0006346(methylation-dependent chromatin silencing);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006476(protein deacetylation);GO:0007492(endoderm development);GO:0007623(circadian rhythm);GO:0008134(transcription factor binding);GO:0008284(positive regulation of cell population proliferation);GO:0009913(epidermal cell differentiation);GO:0010629(negative regulation of gene expression);GO:0010870(positive regulation of receptor biosynthetic process);GO:0016575(histone deacetylation);GO:0016580(Sin3 complex);GO:0016581(NuRD complex);GO:0017053(transcriptional repressor complex);GO:0019213(deacetylase activity);GO:0019899(enzyme binding);GO:0021766(hippocampus development);GO:0030182(neuron differentiation);GO:0032922(circadian regulation of gene expression);GO:0032991(protein-containing complex);GO:0033558(protein deacetylase activity);GO:0033613(activating transcription factor binding);GO:0035851(Krueppel-associated box domain binding);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042733(embryonic digit morphogenesis);GO:0042826(histone deacetylase binding);GO:0043025(neuronal cell body);GO:0043066(negative regulation of apoptotic process);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043922(negative regulation by host of viral transcription);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0047485(protein N-terminus binding);GO:0048714(positive regulation of oligodendrocyte differentiation);GO:0051059(NF-kappaB binding);GO:0052548(regulation of endopeptidase activity);GO:0060766(negative regulation of androgen receptor signaling pathway);GO:0060789(hair follicle placode formation);GO:0061029(eyelid development in camera-type eye);GO:0061198(fungiform papilla formation);GO:0070491(repressing transcription factor binding);GO:0070888(E-box binding);GO:0070932(histone H3 deacetylation);GO:0070933(histone H4 deacetylation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:1990841(promoter-specific chromatin binding);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04330(Notch signaling pathway);04110(Cell cycle);04919(Thyroid hormone signaling pathway);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05203(Viral carcinogenesis);05220(Chronic myeloid leukemia);05016(Huntington disease);05034(Alcoholism);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection)",{"v":4e-11,"d":"0.00"},1,"91,",0,{"v":-10.4,"d":"-10.40"},{"v":-9.5,"d":"-9.50"},1.62,"Exon (ENSBGRT00000023223/ENSBGRG00000012575, exon 12 of 12)",2,16741668,16776560,34893,1]
["chr2",16807837,16808076,240,"ENSBGRG00000012978","ENSBGRT00000023708",860,"TSSK3","testis specific serine kinase 3 [Source:HGNC Symbol;Acc:HGNC:15473]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007283(spermatogenesis)","NA",{"v":0.014,"d":"0.01"},1,"240,",0,-1.84,{"v":-1.3,"d":"-1.30"},2.45,"Exon (ENSBGRT00000023708/ENSBGRG00000012978, exon 2 of 2)",2,16806977,16808494,1518,1]
["chr2",17016289,17016616,328,"ENSBGRG00000013499","ENSBGRT00000024773",40947,"ZBTB8A","zinc finger and BTB domain containing 8A [Source:HGNC Symbol;Acc:HGNC:24172]","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","NA",{"v":1.1E-4,"d":"0.00"},1,"328,",0,-3.95,-3.27,3.01,"Exon (ENSBGRT00000024773/ENSBGRG00000013499, exon 4 of 4)",2,16975342,17016616,41275,1]
["chr2",17174620,17175787,1168,"ENSBGRG00000014294","ENSBGRT00000026257",7114,"ENSBGRG00000014294","NA","NA","NA",{"v":4E-73,"d":"0.00"},2,"595,87,","0,1081",{"v":-72.4,"d":"-72.40"},{"v":-70.8,"d":"-70.80"},4.67,"Exon (ENSBGRT00000026257/ENSBGRG00000014294, exon 5 of 6)",2,17167506,17175662,8157,1]
["chr2",17225948,17226687,740,"ENSBGRG00000014680","ENSBGRT00000027077",8507,"S100PBP","S100P binding protein [Source:HGNC Symbol;Acc:HGNC:25768]","GO:0005634(nucleus);GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0048306(calcium-dependent protein binding)","NA",{"v":3.2e-71,"d":"0.00"},1,"740,",0,{"v":-70.5,"d":"-70.50"},-69,4.06,"Exon (ENSBGRT00000027077/ENSBGRG00000014680, exon 3 of 7)",2,17217441,17251495,34055,1]
["chr2",17696129,17696425,297,"ENSBGRG00000016893","ENSBGRT00000031124",27974,"ZNF362","zinc finger protein 362 [Source:HGNC Symbol;Acc:HGNC:18079]","GO:0003676(nucleic acid binding)","NA",{"v":5e-34,"d":"0.00"},1,"297,",0,{"v":-33.3,"d":"-33.30"},{"v":-32.1,"d":"-32.10"},2.46,"3' UTR",2,17668155,17696425,28271,1]
["chr2",18812842,18812962,121,"ENSBGRG00000020792","ENSBGRT00000038420",75985,"PDE6D","phosphodiesterase 6D [Source:HGNC Symbol;Acc:HGNC:8788]","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0005095(GTPase inhibitor activity);GO:0005829(cytosol);GO:0017137(Rab GTPase binding);GO:0031410(cytoplasmic vesicle);GO:0050953(sensory perception of light stimulus)","00230(Purine metabolism)",{"v":0.017,"d":"0.02"},1,"121,",0,-1.76,-1.22,5.01,"3' UTR",2,18736857,18813531,76675,1]
["chr2",18813201,18813531,331,"ENSBGRG00000020792","ENSBGRT00000038420",76344,"PDE6D","phosphodiesterase 6D [Source:HGNC Symbol;Acc:HGNC:8788]","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0005095(GTPase inhibitor activity);GO:0005829(cytosol);GO:0017137(Rab GTPase binding);GO:0031410(cytoplasmic vesicle);GO:0050953(sensory perception of light stimulus)","00230(Purine metabolism)",{"v":4.5e-06,"d":"0.00"},1,"331,",0,-5.35,-4.62,6.69,"3' UTR",2,18736857,18813531,76675,1]
["chr2",19052037,19054202,2166,"ENSBGRG00000021225","ENSBGRT00000039156",0,"SNORD82","Small nucleolar RNA SNORD82 [Source:RFAM;Acc:RF00158]","NA","NA",0,6,"288,101,29,216,87,110,","0,947,1066,1471,1786,2056",-1530,"-Inf",4.41,"Exon (ENSBGRT00000039057/ENSBGRG00000021053, exon 3 of 16)",2,19053950,19054019,70,1]
["chr2",19058223,19059111,889,"ENSBGRG00000021242","ENSBGRT00000039183",0,"SNORA75","Small nucleolar RNA SNORA75 [Source:RFAM;Acc:RF00072]","NA","NA",0,3,"115,224,77,","0,420,812",-589,"-Inf",4.26,"Exon (ENSBGRT00000039057/ENSBGRG00000021053, exon 14 of 16)",2,19058374,19058507,134,1]
["chr2",19435750,19436200,451,"ENSBGRG00000022997","ENSBGRT00000042454",0,"HTR2B","5-hydroxytryptamine receptor 2B [Source:HGNC Symbol;Acc:HGNC:5294]","GO:0001755(neural crest cell migration);GO:0001819(positive regulation of cytokine production);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001965(G-protein alpha-subunit binding);GO:0002031(G protein-coupled receptor internalization);GO:0003007(heart morphogenesis);GO:0003300(cardiac muscle hypertrophy);GO:0004930(G protein-coupled receptor activity);GO:0004993(G protein-coupled serotonin receptor activity);GO:0005096(GTPase activator activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006874(cellular calcium ion homeostasis);GO:0006939(smooth muscle contraction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007202(activation of phospholipase C activity);GO:0007205(protein kinase C-activating G protein-coupled receptor signaling pathway);GO:0007210(serotonin receptor signaling pathway);GO:0007507(heart development);GO:0008144(drug binding);GO:0008284(positive regulation of cell population proliferation);GO:0010507(negative regulation of autophagy);GO:0010513(positive regulation of phosphatidylinositol biosynthetic process);GO:0014033(neural crest cell differentiation);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0014827(intestine smooth muscle contraction);GO:0016021(integral component of membrane);GO:0016310(phosphorylation);GO:0019722(calcium-mediated signaling);GO:0019934(cGMP-mediated signaling);GO:0042310(vasoconstriction);GO:0042493(response to drug);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043406(positive regulation of MAP kinase activity);GO:0048598(embryonic morphogenesis);GO:0050715(positive regulation of cytokine secretion);GO:0050795(regulation of behavior);GO:0051000(positive regulation of nitric-oxide synthase activity);GO:0051209(release of sequestered calcium ion into cytosol);GO:0051378(serotonin binding);GO:0051781(positive regulation of cell division);GO:0060548(negative regulation of cell death);GO:0070371(ERK1 and ERK2 cascade);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070528(protein kinase C signaling);GO:0071502(cellular response to temperature stimulus)","04020(Calcium signaling pathway);04080(Neuroactive ligand-receptor interaction);04540(Gap junction);04726(Serotonergic synapse);04750(Inflammatory mediator regulation of TRP channels)",{"v":0.011,"d":"0.01"},1,"451,",0,-1.97,-1.14,9.03,"5' UTR",2,19435750,19449848,14099,1]
["chr2",19449008,19449188,181,"ENSBGRG00000022636","ENSBGRT00000042287",34266,"PSMD1","proteasome 26S subunit, non-ATPase 1 [Source:HGNC Symbol;Acc:HGNC:9554]","GO:0000502(proteasome complex);GO:0022624(proteasome accessory complex);GO:0030234(enzyme regulator activity);GO:0031625(ubiquitin protein ligase binding);GO:0042176(regulation of protein catabolic process)","03050(Proteasome);05169(Epstein-Barr virus infection)",{"v":0.046,"d":"0.05"},1,"181,",0,-1.34,{"v":-0.841,"d":"-0.84"},3.01,"Exon (ENSBGRT00000042454/ENSBGRG00000022997, exon 3 of 3)",2,19391883,19483454,91572,2]
["chr2",19449398,19449638,241,"ENSBGRG00000022636","ENSBGRT00000042287",33816,"PSMD1","proteasome 26S subunit, non-ATPase 1 [Source:HGNC Symbol;Acc:HGNC:9554]","GO:0000502(proteasome complex);GO:0022624(proteasome accessory complex);GO:0030234(enzyme regulator activity);GO:0031625(ubiquitin protein ligase binding);GO:0042176(regulation of protein catabolic process)","03050(Proteasome);05169(Epstein-Barr virus infection)",{"v":1.2E-5,"d":"0.00"},1,"241,",0,-4.93,-4.21,5.42,"Exon (ENSBGRT00000042454/ENSBGRG00000022997, exon 3 of 3)",2,19391883,19483454,91572,2]
["chr2",19449698,19449848,151,"ENSBGRG00000022636","ENSBGRT00000042287",33606,"PSMD1","proteasome 26S subunit, non-ATPase 1 [Source:HGNC Symbol;Acc:HGNC:9554]","GO:0000502(proteasome complex);GO:0022624(proteasome accessory complex);GO:0030234(enzyme regulator activity);GO:0031625(ubiquitin protein ligase binding);GO:0042176(regulation of protein catabolic process)","03050(Proteasome);05169(Epstein-Barr virus infection)",{"v":0.037,"d":"0.04"},1,"151,",0,-1.43,{"v":-0.923,"d":"-0.92"},2.26,"Exon (ENSBGRT00000042454/ENSBGRG00000022997, exon 3 of 3)",2,19391883,19483454,91572,2]
["chr2",20191127,20202927,11801,"ENSBGRG00000008249","ENSBGRT00000015508",14463,"ENSBGRG00000008249","NA","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus)","05203(Viral carcinogenesis);05168(Herpes simplex infection)",{"v":4e-15,"d":"0.00"},5,"37,84,78,129,121,","0,1880,6156,9276,11680",{"v":-14.4,"d":"-14.40"},{"v":-13.4,"d":"-13.40"},3.55,"Exon (ENSBGRT00000015508/ENSBGRG00000008249, exon 3 of 14)",2,20176664,20223862,47199,1]
["chr2",20223763,20229545,5783,"ENSBGRG00000008249","ENSBGRT00000015508",47099,"ENSBGRG00000008249","NA","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus)","05203(Viral carcinogenesis);05168(Herpes simplex infection)",{"v":0.047,"d":"0.05"},2,"100,51,","0,5732",-1.33,{"v":-0.836,"d":"-0.84"},1.31,"3' UTR",2,20176664,20223862,47199,1]
["chr2",20231833,20233118,1286,"ENSBGRG00000008249","ENSBGRT00000015208",55169,"ENSBGRG00000008249","NA","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus)","05203(Viral carcinogenesis);05168(Herpes simplex infection)",{"v":0.043,"d":"0.04"},2,"6,114,","0,1172",-1.37,{"v":-0.866,"d":"-0.87"},2.12,"Exon (ENSBGRT00000015208/ENSBGRG00000008249, exon 18 of 18)",2,20176664,20231838,55175,1]
["chr2",20340991,20341645,655,"ENSBGRG00000008685","ENSBGRT00000015822",25977,"SLC16A14","solute carrier family 16 member 14 [Source:HGNC Symbol;Acc:HGNC:26417]","GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":4.3e-06,"d":"0.00"},1,"655,",0,-5.37,-4.63,5.16,"Exon (ENSBGRT00000015822/ENSBGRG00000008685, exon 5 of 6)",2,20315014,20353842,38829,1]
["chr2",20341824,20353842,12019,"ENSBGRG00000008685","ENSBGRT00000015822",26810,"SLC16A14","solute carrier family 16 member 14 [Source:HGNC Symbol;Acc:HGNC:26417]","GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":0.0078,"d":"0.01"},2,"27,152,","0,11867",-2.11,-1.54,2.58,"Exon (ENSBGRT00000015822/ENSBGRG00000008685, exon 5 of 6)",2,20315014,20353842,38829,1]
["chr2",20550461,20570137,19677,"ENSBGRG00000008829","ENSBGRT00000016758",42620,"TRIP12","thyroid hormone receptor interactor 12 [Source:HGNC Symbol;Acc:HGNC:12306]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005654(nucleoplasm);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008270(zinc ion binding);GO:0016607(nuclear speck);GO:0045995(regulation of embryonic development);GO:0046966(thyroid hormone receptor binding);GO:0061630(ubiquitin protein ligase activity);GO:1901315(negative regulation of histone H2A K63-linked ubiquitination);GO:2000780(negative regulation of double-strand break repair)","04120(Ubiquitin mediated proteolysis)",{"v":1.6E-49,"d":"0.00"},3,"20,803,17,","0,871,19660",{"v":-48.8,"d":"-48.80"},{"v":-47.4,"d":"-47.40"},5.07,"Exon (ENSBGRT00000016758/ENSBGRG00000008829, exon 3 of 43)",2,20507841,20653726,145886,1]
["chr2",20652197,20653726,1530,"ENSBGRG00000008829","ENSBGRT00000016758",144356,"TRIP12","thyroid hormone receptor interactor 12 [Source:HGNC Symbol;Acc:HGNC:12306]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005654(nucleoplasm);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008270(zinc ion binding);GO:0016607(nuclear speck);GO:0045995(regulation of embryonic development);GO:0046966(thyroid hormone receptor binding);GO:0061630(ubiquitin protein ligase activity);GO:1901315(negative regulation of histone H2A K63-linked ubiquitination);GO:2000780(negative regulation of double-strand break repair)","04120(Ubiquitin mediated proteolysis)",{"v":1E-181,"d":"0.00"},2,"81,549,","0,981",-181,-179,3.36,"3' UTR",2,20507841,20653726,145886,1]
["chr2",21539064,21539472,409,"ENSBGRG00000009672","ENSBGRT00000017766",290683,"PID1","phosphotyrosine interaction domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26084]","GO:0001933(negative regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0010628(positive regulation of gene expression);GO:0042127(regulation of cell population proliferation);GO:0044320(cellular response to leptin stimulus);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046325(negative regulation of glucose import);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0051881(regulation of mitochondrial membrane potential);GO:0070346(positive regulation of fat cell proliferation);GO:0070584(mitochondrion morphogenesis);GO:0071345(cellular response to cytokine stimulus);GO:0071354(cellular response to interleukin-6);GO:0071356(cellular response to tumor necrosis factor);GO:0071398(cellular response to fatty acid);GO:1903077(negative regulation of protein localization to plasma membrane);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000379(positive regulation of reactive oxygen species metabolic process);GO:2001170(negative regulation of ATP biosynthetic process);GO:2001171(positive regulation of ATP biosynthetic process)","NA",{"v":1E-155,"d":"0.00"},1,"409,",0,-155,-153,5.82,"3' UTR",2,21248381,21539472,291092,1]
["chr2",22514255,22514526,272,"ENSBGRG00000009780","ENSBGRT00000018002",166666,"SPHKAP","SPHK1 interactor, AKAP domain containing [Source:HGNC Symbol;Acc:HGNC:30619]","GO:0051018(protein kinase A binding)","NA",{"v":0.015,"d":"0.02"},2,"196,75,","0,197",-1.82,-1.28,3.68,"Exon (ENSBGRT00000018002/ENSBGRG00000009780, exon 7 of 13)",2,22347589,22552581,204993,1]
["chr2",22514825,22515035,211,"ENSBGRG00000009780","ENSBGRT00000018002",167236,"SPHKAP","SPHK1 interactor, AKAP domain containing [Source:HGNC Symbol;Acc:HGNC:30619]","GO:0051018(protein kinase A binding)","NA",{"v":0.0036,"d":"0.00"},1,"211,",0,-2.44,-1.85,9.03,"Exon (ENSBGRT00000018002/ENSBGRG00000009780, exon 8 of 13)",2,22347589,22552581,204993,1]
["chr2",22515125,22515394,270,"ENSBGRG00000009780","ENSBGRT00000018002",167536,"SPHKAP","SPHK1 interactor, AKAP domain containing [Source:HGNC Symbol;Acc:HGNC:30619]","GO:0051018(protein kinase A binding)","NA",{"v":0.0058,"d":"0.01"},1,"270,",0,-2.24,-1.66,10,"Exon (ENSBGRT00000018002/ENSBGRG00000009780, exon 8 of 13)",2,22347589,22552581,204993,1]
["chr2",22516233,22516742,510,"ENSBGRG00000009780","ENSBGRT00000018002",168644,"SPHKAP","SPHK1 interactor, AKAP domain containing [Source:HGNC Symbol;Acc:HGNC:30619]","GO:0051018(protein kinase A binding)","NA",{"v":0.00089,"d":"0.00"},1,"510,",0,-3.05,-2.42,13,"Exon (ENSBGRT00000018002/ENSBGRG00000009780, exon 8 of 13)",2,22347589,22552581,204993,1]
["chr2",22516801,22517161,361,"ENSBGRG00000009780","ENSBGRT00000018002",169212,"SPHKAP","SPHK1 interactor, AKAP domain containing [Source:HGNC Symbol;Acc:HGNC:30619]","GO:0051018(protein kinase A binding)","NA",{"v":2.8e-06,"d":"0.00"},1,"361,",0,-5.56,-4.82,{"v":22.1,"d":"22.10"},"Exon (ENSBGRT00000018002/ENSBGRG00000009780, exon 8 of 13)",2,22347589,22552581,204993,1]
["chr2",22837173,22837323,151,"ENSBGRG00000010183","ENSBGRT00000018690",4425,"ENSBGRG00000010183","solute carrier family 19 member 3 [Source:HGNC Symbol;Acc:HGNC:16266]","GO:0016021(integral component of membrane);GO:0051180(vitamin transport);GO:0090482(vitamin transmembrane transporter activity)","04977(Vitamin digestion and absorption)",{"v":0.00023,"d":"0.00"},1,"151,",0,-3.64,-2.98,3.76,"Exon (ENSBGRT00000018690/ENSBGRG00000010183, exon 2 of 5)",2,22832748,22842587,9840,1]
["chr2",22841718,22842227,510,"ENSBGRG00000010183","ENSBGRT00000018690",8970,"ENSBGRG00000010183","solute carrier family 19 member 3 [Source:HGNC Symbol;Acc:HGNC:16266]","GO:0016021(integral component of membrane);GO:0051180(vitamin transport);GO:0090482(vitamin transmembrane transporter activity)","04977(Vitamin digestion and absorption)",{"v":2.5e-25,"d":"0.00"},1,"510,",0,{"v":-24.6,"d":"-24.60"},{"v":-23.5,"d":"-23.50"},7.21,"3' UTR",2,22832748,22842587,9840,1]
["chr2",23757667,23758505,839,"ENSBGRG00000013185","ENSBGRT00000024094",0,"IRS1","insulin receptor substrate 1 [Source:HGNC Symbol;Acc:HGNC:6125]","GO:0001784(phosphotyrosine residue binding);GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0008286(insulin receptor signaling pathway);GO:0010907(positive regulation of glucose metabolic process);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0030159(receptor signaling complex adaptor activity);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0032868(response to insulin);GO:0032869(cellular response to insulin stimulus);GO:0043548(phosphatidylinositol 3-kinase binding);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0046326(positive regulation of glucose import);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0046676(negative regulation of insulin secretion);GO:0048009(insulin-like growth factor receptor signaling pathway)","04068(FoxO signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04960(Aldosterone-regulated sodium reabsorption);04722(Neurotrophin signaling pathway);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05206(MicroRNAs in cancer);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance)",{"v":1.6E-53,"d":"0.00"},1,"839,",0,{"v":-52.8,"d":"-52.80"},{"v":-51.4,"d":"-51.40"},{"v":17.5,"d":"17.50"},"Exon (ENSBGRT00000024094/ENSBGRG00000013185, exon 1 of 1)",2,23757667,23761380,3714,1]
["chr2",23759374,23761380,2007,"ENSBGRG00000013185","ENSBGRT00000024094",1707,"IRS1","insulin receptor substrate 1 [Source:HGNC Symbol;Acc:HGNC:6125]","GO:0001784(phosphotyrosine residue binding);GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0008286(insulin receptor signaling pathway);GO:0010907(positive regulation of glucose metabolic process);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0030159(receptor signaling complex adaptor activity);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0032868(response to insulin);GO:0032869(cellular response to insulin stimulus);GO:0043548(phosphatidylinositol 3-kinase binding);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0046326(positive regulation of glucose import);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0046676(negative regulation of insulin secretion);GO:0048009(insulin-like growth factor receptor signaling pathway)","04068(FoxO signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04960(Aldosterone-regulated sodium reabsorption);04722(Neurotrophin signaling pathway);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05206(MicroRNAs in cancer);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance)",{"v":4e-66,"d":"0.00"},1,"2007,",0,{"v":-65.4,"d":"-65.40"},{"v":-63.8,"d":"-63.80"},6.52,"Exon (ENSBGRT00000024094/ENSBGRG00000013185, exon 1 of 1)",2,23757667,23761380,3714,1]
["chr2",26352533,26356552,4020,"ENSBGRG00000015353","ENSBGRT00000028229",86615,"CUL3","cullin 3 [Source:HGNC Symbol;Acc:HGNC:2553]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000209(protein polyubiquitination);GO:0000278(mitotic cell cycle);GO:0000902(cell morphogenesis);GO:0000922(spindle pole);GO:0001701(in utero embryonic development);GO:0001831(trophectodermal cellular morphogenesis);GO:0004842(ubiquitin-protein transferase activity);GO:0005112(Notch binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005827(polar microtubule);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006513(protein monoubiquitination);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007080(mitotic metaphase plate congression);GO:0007229(integrin-mediated signaling pathway);GO:0007369(gastrulation);GO:0016055(Wnt signaling pathway);GO:0016477(cell migration);GO:0016567(protein ubiquitination);GO:0017145(stem cell division);GO:0030332(cyclin binding);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0031208(POZ domain binding);GO:0031398(positive regulation of protein ubiquitination);GO:0031461(cullin-RING ubiquitin ligase complex);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0031625(ubiquitin protein ligase binding);GO:0031648(protein destabilization);GO:0032467(positive regulation of cytokinesis);GO:0035024(negative regulation of Rho protein signal transduction);GO:0036126(sperm flagellum);GO:0040016(embryonic cleavage);GO:0043149(stress fiber assembly);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0044346(fibroblast apoptotic process);GO:0045842(positive regulation of mitotic metaphase/anaphase transition);GO:0048208(COPII vesicle coating);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0071630(nuclear protein quality control by the ubiquitin-proteasome system);GO:0072576(liver morphogenesis);GO:0072686(mitotic spindle);GO:1901992(positive regulation of mitotic cell cycle phase transition)","04120(Ubiquitin mediated proteolysis);04340(Hedgehog signaling pathway)",{"v":7.6E-3,"d":"0.01"},2,"64,27,","0,3993",-2.12,-1.56,1.45,"Exon (ENSBGRT00000028229/ENSBGRG00000015353, exon 6 of 15)",2,26265918,26381464,115547,1]
["chr2",26377287,26383647,6361,"ENSBGRG00000015353","ENSBGRT00000028229",111369,"CUL3","cullin 3 [Source:HGNC Symbol;Acc:HGNC:2553]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000209(protein polyubiquitination);GO:0000278(mitotic cell cycle);GO:0000902(cell morphogenesis);GO:0000922(spindle pole);GO:0001701(in utero embryonic development);GO:0001831(trophectodermal cellular morphogenesis);GO:0004842(ubiquitin-protein transferase activity);GO:0005112(Notch binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005827(polar microtubule);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006513(protein monoubiquitination);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007080(mitotic metaphase plate congression);GO:0007229(integrin-mediated signaling pathway);GO:0007369(gastrulation);GO:0016055(Wnt signaling pathway);GO:0016477(cell migration);GO:0016567(protein ubiquitination);GO:0017145(stem cell division);GO:0030332(cyclin binding);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0031208(POZ domain binding);GO:0031398(positive regulation of protein ubiquitination);GO:0031461(cullin-RING ubiquitin ligase complex);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0031625(ubiquitin protein ligase binding);GO:0031648(protein destabilization);GO:0032467(positive regulation of cytokinesis);GO:0035024(negative regulation of Rho protein signal transduction);GO:0036126(sperm flagellum);GO:0040016(embryonic cleavage);GO:0043149(stress fiber assembly);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0044346(fibroblast apoptotic process);GO:0045842(positive regulation of mitotic metaphase/anaphase transition);GO:0048208(COPII vesicle coating);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0071630(nuclear protein quality control by the ubiquitin-proteasome system);GO:0072576(liver morphogenesis);GO:0072686(mitotic spindle);GO:1901992(positive regulation of mitotic cell cycle phase transition)","04120(Ubiquitin mediated proteolysis);04340(Hedgehog signaling pathway)",{"v":1.6e-32,"d":"0.00"},3,"137,299,131,","0,3879,6230",{"v":-31.8,"d":"-31.80"},{"v":-30.7,"d":"-30.70"},5.53,"3' UTR",2,26265918,26381464,115547,1]
["chr2",26463534,26479864,16331,"ENSBGRG00000015631","ENSBGRT00000028720",0,"FAM124B","family with sequence similarity 124 member B [Source:HGNC Symbol;Acc:HGNC:26224]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","NA",{"v":0.00065,"d":"0.00"},4,"17,811,122,127,","0,11481,15995,16204",-3.19,-2.55,8.02,"5' UTR",2,26463534,26490951,27418,1]
["chr2",26479924,26490951,11028,"ENSBGRG00000015631","ENSBGRT00000028720",16390,"FAM124B","family with sequence similarity 124 member B [Source:HGNC Symbol;Acc:HGNC:26224]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","NA",{"v":7.8e-07,"d":"0.00"},2,"602,654,","0,10374",-6.11,-5.35,{"v":19.1,"d":"19.10"},"Exon (ENSBGRT00000028720/ENSBGRG00000015631, exon 3 of 4)",2,26463534,26490951,27418,1]
["chr2",27007996,27009656,1661,"ENSBGRG00000016123","ENSBGRT00000029885",54915,"ENSBGRG00000016123","WD repeat and FYVE domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20451]","GO:0005515(protein binding);GO:0005769(early endosome);GO:0034141(positive regulation of toll-like receptor 3 signaling pathway);GO:0034145(positive regulation of toll-like receptor 4 signaling pathway);GO:0046872(metal ion binding)","04144(Endocytosis);04145(Phagosome)",{"v":1e-102,"d":"0.00"},2,"11,615,","0,1046",-102,-100,4.37,"3' UTR",2,26953081,27010101,57021,1]
["chr2",27009746,27010073,328,"ENSBGRG00000016123","ENSBGRT00000029885",56665,"ENSBGRG00000016123","WD repeat and FYVE domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20451]","GO:0005515(protein binding);GO:0005769(early endosome);GO:0034141(positive regulation of toll-like receptor 3 signaling pathway);GO:0034145(positive regulation of toll-like receptor 4 signaling pathway);GO:0046872(metal ion binding)","04144(Endocytosis);04145(Phagosome)",{"v":4e-23,"d":"0.00"},1,"328,",0,{"v":-22.4,"d":"-22.40"},{"v":-21.3,"d":"-21.30"},2.19,"3' UTR",2,26953081,27010101,57021,1]
["chr2",27061225,27118111,56887,"ENSBGRG00000016365","ENSBGRT00000030199",0,"AP1S3","adaptor related protein complex 1 subunit sigma 3 [Source:HGNC Symbol;Acc:HGNC:18971]","GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0016192(vesicle-mediated transport);GO:0030117(membrane coat)","04142(Lysosome)",{"v":0.019,"d":"0.02"},2,"294,58,","0,56829",-1.71,{"v":-0.901,"d":"-0.90"},8.02,"5' UTR",2,27061225,27129489,68265,1]
["chr2",29608965,29618064,9100,"ENSBGRG00000017734","ENSBGRT00000032509",0,"EPHA4","EPH receptor A4 [Source:HGNC Symbol;Acc:HGNC:3388]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005004(GPI-linked ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007628(adult walking behavior);GO:0008045(motor neuron axon guidance);GO:0010977(negative regulation of neuron projection development);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021957(corticospinal tract morphogenesis);GO:0030424(axon);GO:0030425(dendrite);GO:0031901(early endosome membrane);GO:0034332(adherens junction organization);GO:0042731(PH domain binding);GO:0042802(identical protein binding);GO:0043087(regulation of GTPase activity);GO:0043507(positive regulation of JUN kinase activity);GO:0046777(protein autophosphorylation);GO:0048013(ephrin receptor signaling pathway);GO:0048681(negative regulation of axon regeneration);GO:0048710(regulation of astrocyte differentiation);GO:0050770(regulation of axonogenesis);GO:0050821(protein stabilization);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0072178(nephric duct morphogenesis);GO:0090102(cochlea development);GO:0097155(fasciculation of sensory neuron axon);GO:0097156(fasciculation of motor neuron axon);GO:0097161(DH domain binding);GO:0097485(neuron projection guidance);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099056(integral component of presynaptic membrane);GO:0106030(neuron projection fasciculation);GO:1900272(negative regulation of long-term synaptic potentiation);GO:1902004(positive regulation of amyloid-beta formation);GO:1902961(positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process);GO:1903051(negative regulation of proteolysis involved in cellular protein catabolic process);GO:1904646(cellular response to amyloid-beta);GO:1905244(regulation of modification of synaptic structure);GO:1990782(protein tyrosine kinase binding);GO:2001108(positive regulation of Rho guanyl-nucleotide exchange factor activity)","04360(Axon guidance)",{"v":5.2e-06,"d":"0.00"},4,"398,68,72,511,","0,4391,7969,8589",-5.28,-4.55,14,"5' UTR",2,29608965,29784566,175602,1]
["chr2",29778583,29784566,5984,"ENSBGRG00000017734","ENSBGRT00000032509",169618,"EPHA4","EPH receptor A4 [Source:HGNC Symbol;Acc:HGNC:3388]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005004(GPI-linked ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007628(adult walking behavior);GO:0008045(motor neuron axon guidance);GO:0010977(negative regulation of neuron projection development);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021957(corticospinal tract morphogenesis);GO:0030424(axon);GO:0030425(dendrite);GO:0031901(early endosome membrane);GO:0034332(adherens junction organization);GO:0042731(PH domain binding);GO:0042802(identical protein binding);GO:0043087(regulation of GTPase activity);GO:0043507(positive regulation of JUN kinase activity);GO:0046777(protein autophosphorylation);GO:0048013(ephrin receptor signaling pathway);GO:0048681(negative regulation of axon regeneration);GO:0048710(regulation of astrocyte differentiation);GO:0050770(regulation of axonogenesis);GO:0050821(protein stabilization);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0072178(nephric duct morphogenesis);GO:0090102(cochlea development);GO:0097155(fasciculation of sensory neuron axon);GO:0097156(fasciculation of motor neuron axon);GO:0097161(DH domain binding);GO:0097485(neuron projection guidance);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099056(integral component of presynaptic membrane);GO:0106030(neuron projection fasciculation);GO:1900272(negative regulation of long-term synaptic potentiation);GO:1902004(positive regulation of amyloid-beta formation);GO:1902961(positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process);GO:1903051(negative regulation of proteolysis involved in cellular protein catabolic process);GO:1904646(cellular response to amyloid-beta);GO:1905244(regulation of modification of synaptic structure);GO:1990782(protein tyrosine kinase binding);GO:2001108(positive regulation of Rho guanyl-nucleotide exchange factor activity)","04360(Axon guidance)",{"v":1.4E-5,"d":"0.00"},4,"165,194,156,115,","0,977,5372,5869",-4.84,-4.13,6.02,"Exon (ENSBGRT00000032509/ENSBGRG00000017734, exon 15 of 17)",2,29608965,29784566,175602,1]
["chr2",32030748,32031923,1176,"ENSBGRG00000018601","ENSBGRT00000035228",0,"OBSL1","obscurin like cytoskeletal adaptor 1 [Source:HGNC Symbol;Acc:HGNC:29092]","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0007030(Golgi organization);GO:0007088(regulation of mitotic nuclear division);GO:0034067(protein localization to Golgi apparatus);GO:0048471(perinuclear region of cytoplasm);GO:0050775(positive regulation of dendrite morphogenesis);GO:1990393(3M complex)","NA",{"v":2e-06,"d":"0.00"},2,"369,470,","0,706",-5.69,-4.95,{"v":12.5,"d":"12.50"},"Exon (ENSBGRT00000035228/ENSBGRG00000018601, exon 1 of 24)",2,32030748,32055462,24715,1]
["chr2",32035999,32036149,151,"ENSBGRG00000018601","ENSBGRT00000035228",5251,"OBSL1","obscurin like cytoskeletal adaptor 1 [Source:HGNC Symbol;Acc:HGNC:29092]","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0007030(Golgi organization);GO:0007088(regulation of mitotic nuclear division);GO:0034067(protein localization to Golgi apparatus);GO:0048471(perinuclear region of cytoplasm);GO:0050775(positive regulation of dendrite morphogenesis);GO:1990393(3M complex)","NA",{"v":0.00025,"d":"0.00"},1,"151,",0,{"v":-3.6,"d":"-3.60"},-2.94,1.82,"Exon (ENSBGRT00000035228/ENSBGRG00000018601, exon 5 of 24)",2,32030748,32055462,24715,1]
["chr2",32038558,32038768,211,"ENSBGRG00000018601","ENSBGRT00000035228",7810,"OBSL1","obscurin like cytoskeletal adaptor 1 [Source:HGNC Symbol;Acc:HGNC:29092]","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0007030(Golgi organization);GO:0007088(regulation of mitotic nuclear division);GO:0034067(protein localization to Golgi apparatus);GO:0048471(perinuclear region of cytoplasm);GO:0050775(positive regulation of dendrite morphogenesis);GO:1990393(3M complex)","NA",{"v":3.3E-10,"d":"0.00"},1,"211,",0,-9.48,-8.64,2.62,"Exon (ENSBGRT00000035228/ENSBGRG00000018601, exon 7 of 24)",2,32030748,32055462,24715,1]
["chr2",32042618,32047373,4756,"ENSBGRG00000018601","ENSBGRT00000035228",11870,"OBSL1","obscurin like cytoskeletal adaptor 1 [Source:HGNC Symbol;Acc:HGNC:29092]","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0007030(Golgi organization);GO:0007088(regulation of mitotic nuclear division);GO:0034067(protein localization to Golgi apparatus);GO:0048471(perinuclear region of cytoplasm);GO:0050775(positive regulation of dendrite morphogenesis);GO:1990393(3M complex)","NA",{"v":5.9e-10,"d":"0.00"},2,"16,164,","0,4592",-9.23,-8.39,1.75,"Exon (ENSBGRT00000035228/ENSBGRG00000018601, exon 10 of 24)",2,32030748,32055462,24715,1]
["chr2",32064339,32064518,180,"ENSBGRG00000019378","ENSBGRT00000035619",2055,"CHPF","chondroitin polymerizing factor [Source:HGNC Symbol;Acc:HGNC:24291]","GO:0008376(acetylgalactosaminyltransferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030206(chondroitin sulfate biosynthetic process);GO:0032580(Golgi cisterna membrane);GO:0047238(glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity);GO:0050510(N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)",{"v":2e-06,"d":"0.00"},1,"180,",0,{"v":-5.7,"d":"-5.70"},-4.95,1.67,"Exon (ENSBGRT00000035619/ENSBGRG00000019378, exon 2 of 4)",2,32062284,32066977,4694,1]
["chr2",32064577,32066977,2401,"ENSBGRG00000019378","ENSBGRT00000035619",2293,"CHPF","chondroitin polymerizing factor [Source:HGNC Symbol;Acc:HGNC:24291]","GO:0008376(acetylgalactosaminyltransferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030206(chondroitin sulfate biosynthetic process);GO:0032580(Golgi cisterna membrane);GO:0047238(glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity);GO:0050510(N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)",{"v":9.99999999999999e-271,"d":"0.00"},3,"53,180,1260,","0,550,1141",-270,-267,4.37,"Exon (ENSBGRT00000035619/ENSBGRG00000019378, exon 2 of 4)",2,32062284,32066977,4694,1]
["chr2",32221218,32235400,14183,"ENSBGRG00000020162","ENSBGRT00000037532",0,"DNPEP","aspartyl aminopeptidase [Source:HGNC Symbol;Acc:HGNC:2981]","GO:0004177(aminopeptidase activity);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008270(zinc ion binding)","NA",{"v":0.00072,"d":"0.00"},3,"60,300,29,","0,13253,14154",-3.14,{"v":-2.5,"d":"-2.50"},6.02,"5' UTR",2,32221218,32251594,30377,1]
["chr2",32376868,32384921,8054,"ENSBGRG00000021450","ENSBGRT00000039761",0,"STK16","serine/threonine kinase 16 [Source:HGNC Symbol;Acc:HGNC:11394]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005798(Golgi-associated vesicle);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0046777(protein autophosphorylation)","NA",{"v":7.4e-09,"d":"0.00"},2,"324,95,","0,7959",-8.13,-7.32,3.56,"5' UTR",2,32378812,32382660,3849,2]
["chr2",32392302,32392840,539,"ENSBGRG00000021241","ENSBGRT00000039476",19313,"ENSBGRG00000021241","NA","GO:0003924(GTPase activity);GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0004565(beta-galactosidase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005525(GTP binding);GO:0005874(microtubule);GO:0005975(carbohydrate metabolic process);GO:0007017(microtubule-based process)","04145(Phagosome);04210(Apoptosis);04530(Tight junction);04540(Gap junction);05130(Pathogenic Escherichia coli infection)",{"v":1e-123,"d":"0.00"},1,"539,",0,-123,-121,4.01,"3' UTR",2,32372989,32392537,19549,1]
["chr2",32400044,32400283,240,"ENSBGRG00000021721","ENSBGRT00000040136",602,"ANKZF1","ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1 [Source:HGNC Symbol;Acc:HGNC:25527]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0070301(cellular response to hydrogen peroxide)","NA",0.02,1,"240,",0,-1.69,-1.16,6.02,"5' UTR",2,32392647,32400885,8239,2]
["chr2",32404557,32404736,180,"ENSBGRG00000021811","ENSBGRT00000040355",4723,"ENSBGRG00000021811","autophagy related 9A [Source:HGNC Symbol;Acc:HGNC:22408]","GO:0006914(autophagy)","04140(Autophagy - animal);04136(Autophagy - other eukaryotes);04137(Mitophagy - animal)",{"v":2.7E-6,"d":"0.00"},1,"180,",0,-5.57,-4.83,2.44,"Exon (ENSBGRT00000040355/ENSBGRG00000021811, exon 8 of 16)",2,32399834,32409910,10077,1]
["chr2",32408922,32409162,241,"ENSBGRG00000021811","ENSBGRT00000040355",9088,"ENSBGRG00000021811","autophagy related 9A [Source:HGNC Symbol;Acc:HGNC:22408]","GO:0006914(autophagy)","04140(Autophagy - animal);04136(Autophagy - other eukaryotes);04137(Mitophagy - animal)",{"v":1E-27,"d":"0.00"},1,"241,",0,-27,{"v":-25.9,"d":"-25.90"},1.95,"3' UTR",2,32399834,32409910,10077,1]
["chr2",32409820,32409910,91,"ENSBGRG00000021811","ENSBGRT00000040355",9986,"ENSBGRG00000021811","autophagy related 9A [Source:HGNC Symbol;Acc:HGNC:22408]","GO:0006914(autophagy)","04140(Autophagy - animal);04136(Autophagy - other eukaryotes);04137(Mitophagy - animal)",{"v":2.2e-06,"d":"0.00"},1,"91,",0,-5.65,-4.91,2.95,"3' UTR",2,32399834,32409910,10077,1]
["chr2",32462828,32463008,181,"ENSBGRG00000000191","ENSBGRT00000000311",6109,"CNPPD1","cyclin Pas1/PHO80 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25220]","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0019901(protein kinase binding)","NA",{"v":0.0072,"d":"0.01"},1,"181,",0,-2.14,-1.57,1.27,"3' UTR",2,32456719,32463188,6470,1]
["chr2",32578882,32579212,331,"ENSBGRG00000000275","ENSBGRT00000000562",113748,"ENSBGRG00000000275","NA","GO:0005634(nucleus);GO:0006302(double-strand break repair);GO:0016020(membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","03450(Non-homologous end-joining)",{"v":1E-13,"d":"0.00"},1,"331,",0,-13,-12,2.96,"3' UTR",2,32465134,32579212,114079,1]
["chr2",33034680,33035625,946,"ENSBGRG00000001002","ENSBGRT00000001866",7897,"RNF25","ring finger protein 25 [Source:HGNC Symbol;Acc:HGNC:14662]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0016567(protein ubiquitination);GO:0051059(NF-kappaB binding);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":0,"d":"0.00"},2,"88,655,","0,291",-320,-317,{"v":11.1,"d":"11.10"},"3' UTR",2,33026783,33035625,8843,1]
["chr2",33056474,33057492,1019,"ENSBGRG00000001065","ENSBGRT00000001984",10695,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":1.6E-72,"d":"0.00"},1,"1019,",0,{"v":-71.8,"d":"-71.80"},{"v":-70.2,"d":"-70.20"},8.08,"Exon (ENSBGRT00000001984/ENSBGRG00000001065, exon 6 of 8)",2,33045779,33061179,15401,1]
["chr2",33057641,33058330,690,"ENSBGRG00000001065","ENSBGRT00000001984",11862,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":6.3e-19,"d":"0.00"},1,"690,",0,{"v":-18.2,"d":"-18.20"},{"v":-17.2,"d":"-17.20"},{"v":3.7,"d":"3.70"},"Exon (ENSBGRT00000001984/ENSBGRG00000001065, exon 6 of 8)",2,33045779,33061179,15401,1]
["chr2",33058719,33059048,330,"ENSBGRG00000001065","ENSBGRT00000001984",12940,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":0.0058,"d":"0.01"},1,"330,",0,-2.24,-1.66,10,"Exon (ENSBGRT00000001984/ENSBGRG00000001065, exon 6 of 8)",2,33045779,33061179,15401,1]
["chr2",33059258,33060649,1392,"ENSBGRG00000001065","ENSBGRT00000001984",13479,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":1.6e-92,"d":"0.00"},2,"612,17,","0,1375",{"v":-91.8,"d":"-91.80"},{"v":-90.1,"d":"-90.10"},{"v":10.2,"d":"10.20"},"Exon (ENSBGRT00000001984/ENSBGRG00000001065, exon 6 of 8)",2,33045779,33061179,15401,1]
["chr2",33062365,33062604,240,"ENSBGRG00000001065","ENSBGRT00000001957",16586,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":2.5e-77,"d":"0.00"},1,"240,",0,{"v":-76.6,"d":"-76.60"},-75,5.68,"Exon (ENSBGRT00000001957/ENSBGRG00000001065, exon 8 of 8)",2,33045779,33062604,16826,1]
["chr2",33133098,33133577,480,"ENSBGRG00000001130","ENSBGRT00000002085",0,"CNOT9","CCR4-NOT transcription complex subunit 9 [Source:HGNC Symbol;Acc:HGNC:10445]","GO:0000932(P-body);GO:0005154(epidermal growth factor receptor binding);GO:0006402(mRNA catabolic process);GO:0019221(cytokine-mediated signaling pathway);GO:0019900(kinase binding);GO:0019904(protein domain specific binding);GO:0030014(CCR4-NOT complex);GO:0032991(protein-containing complex);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033147(negative regulation of intracellular estrogen receptor signaling pathway);GO:0042803(protein homodimerization activity);GO:0045742(positive regulation of epidermal growth factor receptor signaling pathway);GO:2000327(positive regulation of nuclear receptor transcription coactivator activity)","03018(RNA degradation)",{"v":3.5E-4,"d":"0.00"},1,"480,",0,-3.45,-2.79,8.52,"5' UTR",2,33100868,33133170,32303,2]
["chr2",33199228,33218193,18966,"ENSBGRG00000001165","ENSBGRT00000002206",66250,"USP37","ubiquitin specific peptidase 37 [Source:HGNC Symbol;Acc:HGNC:20063]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0006275(regulation of DNA replication);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0019901(protein kinase binding);GO:0035871(protein K11-linked deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0071108(protein K48-linked deubiquitination)","NA",{"v":0.00026,"d":"0.00"},4,"74,167,61,89,","0,11736,13868,18877",-3.59,-2.93,15,"Exon (ENSBGRT00000002206/ENSBGRG00000001165, exon 19 of 25)",2,33132978,33222832,89855,1]
["chr2",33221028,33222832,1805,"ENSBGRG00000001165","ENSBGRT00000002206",88050,"USP37","ubiquitin specific peptidase 37 [Source:HGNC Symbol;Acc:HGNC:20063]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0006275(regulation of DNA replication);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0019901(protein kinase binding);GO:0035871(protein K11-linked deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0071108(protein K48-linked deubiquitination)","NA",{"v":0.0037,"d":"0.00"},3,"28,933,88,","0,538,1717",-2.43,-1.84,5.52,"3' UTR",2,33132978,33222832,89855,1]
["chr2",33396967,33397116,150,"ENSBGRG00000001618","ENSBGRT00000003004",6580,"PNKD","PNKD metallo-beta-lactamase domain containing [Source:HGNC Symbol;Acc:HGNC:9153]","GO:0004416(hydroxyacylglutathione hydrolase activity);GO:0005739(mitochondrion);GO:0016020(membrane);GO:0019243(methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione);GO:0032225(regulation of synaptic transmission, dopaminergic);GO:0042053(regulation of dopamine metabolic process);GO:0046929(negative regulation of neurotransmitter secretion);GO:0050884(neuromuscular process controlling posture)","00620(Pyruvate metabolism);04144(Endocytosis);04810(Regulation of actin cytoskeleton);05132(Salmonella infection)",{"v":0.019,"d":"0.02"},1,"150,",0,-1.72,-1.19,8.02,"3' UTR",2,33316633,33403696,87064,2]
["chr2",33403245,33404608,1364,"ENSBGRG00000001618","ENSBGRT00000003004",0,"PNKD","PNKD metallo-beta-lactamase domain containing [Source:HGNC Symbol;Acc:HGNC:9153]","GO:0004416(hydroxyacylglutathione hydrolase activity);GO:0005739(mitochondrion);GO:0016020(membrane);GO:0019243(methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione);GO:0032225(regulation of synaptic transmission, dopaminergic);GO:0042053(regulation of dopamine metabolic process);GO:0046929(negative regulation of neurotransmitter secretion);GO:0050884(neuromuscular process controlling posture)","00620(Pyruvate metabolism);04144(Endocytosis);04810(Regulation of actin cytoskeleton);05132(Salmonella infection)",{"v":1.9e-09,"d":"0.00"},3,"78,153,9,","0,560,1355",-8.73,{"v":-7.9,"d":"-7.90"},1.36,"5' UTR",2,33316633,33403696,87064,2]
["chr2",33788900,33789619,720,"ENSBGRG00000001914","ENSBGRT00000003950",196678,"TNS1","tensin 1 [Source:HGNC Symbol;Acc:HGNC:11973]","GO:0005515(protein binding);GO:0005925(focal adhesion);GO:0007044(cell-substrate junction assembly);GO:0010761(fibroblast migration);GO:0030055(cell-substrate junction);GO:0035556(intracellular signal transduction)","NA",{"v":1E-99,"d":"0.00"},1,"720,",0,-99,{"v":-97.2,"d":"-97.20"},{"v":3.9,"d":"3.90"},"Exon (ENSBGRT00000003950/ENSBGRG00000001914, exon 19 of 35)",2,33592222,33840431,248210,1]
["chr2",33838602,33839412,811,"ENSBGRG00000001914","ENSBGRT00000003950",246380,"TNS1","tensin 1 [Source:HGNC Symbol;Acc:HGNC:11973]","GO:0005515(protein binding);GO:0005925(focal adhesion);GO:0007044(cell-substrate junction assembly);GO:0010761(fibroblast migration);GO:0030055(cell-substrate junction);GO:0035556(intracellular signal transduction)","NA",0,1,"811,",0,-1170,"-Inf",8.93,"3' UTR",2,33592222,33840431,248210,1]
["chr2",35237119,35237478,360,"ENSBGRG00000002228","ENSBGRT00000004148",26119,"IGFBP5","insulin like growth factor binding protein 5 [Source:HGNC Symbol;Acc:HGNC:5474]","GO:0001558(regulation of cell growth);GO:0001649(osteoblast differentiation);GO:0001968(fibronectin binding);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0007565(female pregnancy);GO:0014912(negative regulation of smooth muscle cell migration);GO:0017148(negative regulation of translation);GO:0030336(negative regulation of cell migration);GO:0031069(hair follicle morphogenesis);GO:0031994(insulin-like growth factor I binding);GO:0040008(regulation of growth);GO:0042567(insulin-like growth factor ternary complex);GO:0042593(glucose homeostasis);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0043569(negative regulation of insulin-like growth factor receptor signaling pathway);GO:0044342(type B pancreatic cell proliferation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045926(negative regulation of growth);GO:0048286(lung alveolus development);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0051146(striated muscle cell differentiation);GO:0051897(positive regulation of protein kinase B signaling);GO:0060056(mammary gland involution);GO:0071320(cellular response to cAMP);GO:0071407(cellular response to organic cyclic compound);GO:1901862(negative regulation of muscle tissue development);GO:1904205(negative regulation of skeletal muscle hypertrophy);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration)","04115(p53 signaling pathway);04218(Cellular senescence);05202(Transcriptional misregulation in cancers)",{"v":9.99999999999999e-258,"d":"0.00"},1,"360,",0,-257,-254,2.36,"3' UTR",2,35211000,35238586,27587,1]
["chr2",35238376,35238586,211,"ENSBGRG00000002228","ENSBGRT00000004148",27376,"IGFBP5","insulin like growth factor binding protein 5 [Source:HGNC Symbol;Acc:HGNC:5474]","GO:0001558(regulation of cell growth);GO:0001649(osteoblast differentiation);GO:0001968(fibronectin binding);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0007565(female pregnancy);GO:0014912(negative regulation of smooth muscle cell migration);GO:0017148(negative regulation of translation);GO:0030336(negative regulation of cell migration);GO:0031069(hair follicle morphogenesis);GO:0031994(insulin-like growth factor I binding);GO:0040008(regulation of growth);GO:0042567(insulin-like growth factor ternary complex);GO:0042593(glucose homeostasis);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0043569(negative regulation of insulin-like growth factor receptor signaling pathway);GO:0044342(type B pancreatic cell proliferation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045926(negative regulation of growth);GO:0048286(lung alveolus development);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0051146(striated muscle cell differentiation);GO:0051897(positive regulation of protein kinase B signaling);GO:0060056(mammary gland involution);GO:0071320(cellular response to cAMP);GO:0071407(cellular response to organic cyclic compound);GO:1901862(negative regulation of muscle tissue development);GO:1904205(negative regulation of skeletal muscle hypertrophy);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration)","04115(p53 signaling pathway);04218(Cellular senescence);05202(Transcriptional misregulation in cancers)",{"v":1e-96,"d":"0.00"},1,"211,",0,-96,{"v":-94.2,"d":"-94.20"},{"v":2.3,"d":"2.30"},"3' UTR",2,35211000,35238586,27587,1]
["chr2",35960725,36013342,52618,"ENSBGRG00000002736","ENSBGRT00000005121",110861,"PECR","peroxisomal trans-2-enoyl-CoA reductase [Source:HGNC Symbol;Acc:HGNC:18281]","GO:0005102(signaling receptor binding);GO:0005739(mitochondrion);GO:0005777(peroxisome);GO:0019166(trans-2-enoyl-CoA reductase (NADPH) activity);GO:0032402(melanosome transport);GO:0033306(phytol metabolic process);GO:0042470(melanosome);GO:0055114(oxidation-reduction process)","01040(Biosynthesis of unsaturated fatty acids);04146(Peroxisome)",{"v":0.00065,"d":"0.00"},4,"83,91,164,135,","0,49854,51066,52483",-3.19,-2.55,11,"3' UTR",2,35849864,36010669,160806,1]
["chr2",37262928,37275114,12187,"ENSBGRG00000003261","ENSBGRT00000006470",21364,"BARD1","BRCA1 associated RING domain 1 [Source:HGNC Symbol;Acc:HGNC:952]","GO:0003723(RNA binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016607(nuclear speck);GO:0031436(BRCA1-BARD1 complex);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0042325(regulation of phosphorylation);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046826(negative regulation of protein export from nucleus);GO:0046982(protein heterodimerization activity);GO:0070531(BRCA1-A complex);GO:0085020(protein K6-linked ubiquitination)","03440(Homologous recombination)",{"v":1.4E-3,"d":"0.00"},2,"110,131,","0,12056",-2.85,-2.23,4.68,"Exon (ENSBGRT00000006470/ENSBGRG00000003261, exon 3 of 4)",2,37241564,37290279,48716,1]
["chr2",37275622,37275772,151,"ENSBGRG00000003261","ENSBGRT00000006470",34058,"BARD1","BRCA1 associated RING domain 1 [Source:HGNC Symbol;Acc:HGNC:952]","GO:0003723(RNA binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016607(nuclear speck);GO:0031436(BRCA1-BARD1 complex);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0042325(regulation of phosphorylation);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046826(negative regulation of protein export from nucleus);GO:0046982(protein heterodimerization activity);GO:0070531(BRCA1-A complex);GO:0085020(protein K6-linked ubiquitination)","03440(Homologous recombination)",{"v":9.1E-4,"d":"0.00"},1,"151,",0,-3.04,-2.41,3.38,"Exon (ENSBGRT00000006415/ENSBGRG00000003261, exon 4 of 11)",2,37241564,37290279,48716,1]
["chr2",42265089,42265592,504,"ENSBGRG00000004687","ENSBGRT00000008681",0,"LANCL1","LanC like 1 [Source:HGNC Symbol;Acc:HGNC:6508]","GO:0003824(catalytic activity);GO:0004364(glutathione transferase activity);GO:0008270(zinc ion binding);GO:0017124(SH3 domain binding);GO:0043295(glutathione binding);GO:0043523(regulation of neuron apoptotic process);GO:0050750(low-density lipoprotein particle receptor binding);GO:1903203(regulation of oxidative stress-induced neuron death)","NA",{"v":0.00076,"d":"0.00"},2,"209,87,","0,417",-3.12,-2.49,6.02,"Exon (ENSBGRT00000008681/ENSBGRG00000004687, exon 1 of 9)",2,42265089,42312820,47732,1]
["chr2",42577021,42578100,1080,"ENSBGRG00000004930","ENSBGRT00000009081",929,"KANSL1L","KAT8 regulatory NSL complex subunit 1 like [Source:HGNC Symbol;Acc:HGNC:26310]","GO:0000123(histone acetyltransferase complex)","NA",{"v":3.2e-63,"d":"0.00"},1,"1080,",0,{"v":-62.5,"d":"-62.50"},-61,8.95,"5' UTR",2,42576092,42685209,109118,1]
["chr2",42685089,42685209,121,"ENSBGRG00000004930","ENSBGRT00000009081",108997,"KANSL1L","KAT8 regulatory NSL complex subunit 1 like [Source:HGNC Symbol;Acc:HGNC:26310]","GO:0000123(histone acetyltransferase complex)","NA",{"v":1E-14,"d":"0.00"},1,"121,",0,-14,{"v":-13.1,"d":"-13.10"},1.94,"Exon (ENSBGRT00000009081/ENSBGRG00000004930, exon 14 of 14)",2,42576092,42685209,109118,1]
["chr2",44134303,44135052,750,"ENSBGRG00000006637","ENSBGRT00000012224",0,"IDH1","isocitrate dehydrogenase (NADP(+)) 1 [Source:HGNC Symbol;Acc:HGNC:5382]","GO:0000287(magnesium ion binding);GO:0004448(isocitrate dehydrogenase activity);GO:0004450(isocitrate dehydrogenase (NADP+) activity);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005777(peroxisome);GO:0005829(cytosol);GO:0006102(isocitrate metabolic process);GO:0006103(2-oxoglutarate metabolic process);GO:0006749(glutathione metabolic process);GO:0006979(response to oxidative stress);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0051287(NAD binding);GO:0055114(oxidation-reduction process);GO:0060696(regulation of phospholipid catabolic process);GO:0071071(regulation of phospholipid biosynthetic process)","00020(Citrate cycle (TCA cycle));00480(Glutathione metabolism);04146(Peroxisome)",{"v":2.3E-6,"d":"0.00"},1,"750,",0,-5.64,-4.89,8.02,"5' UTR",2,44134303,44155217,20915,1]
["chr2",44400164,44400820,657,"ENSBGRG00000006928","ENSBGRT00000012867",0,"PLEKHM3","pleckstrin homology domain containing M3 [Source:HGNC Symbol;Acc:HGNC:34006]","GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0045445(myoblast differentiation)","04140(Autophagy - animal)",{"v":1.2E-8,"d":"0.00"},1,"657,",0,-7.93,-7.12,8.42,"5' UTR",2,44400164,44605470,205307,1]
["chr2",44423697,44423995,299,"ENSBGRG00000006928","ENSBGRT00000012867",23533,"PLEKHM3","pleckstrin homology domain containing M3 [Source:HGNC Symbol;Acc:HGNC:34006]","GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0045445(myoblast differentiation)","04140(Autophagy - animal)",{"v":9.5e-05,"d":"0.00"},1,"299,",0,-4.02,-3.34,3.26,"Exon (ENSBGRT00000012867/ENSBGRG00000006928, exon 2 of 7)",2,44400164,44605470,205307,1]
["chr2",44424085,44459411,35327,"ENSBGRG00000006928","ENSBGRT00000012867",23921,"PLEKHM3","pleckstrin homology domain containing M3 [Source:HGNC Symbol;Acc:HGNC:34006]","GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0045445(myoblast differentiation)","04140(Autophagy - animal)",{"v":0.00026,"d":"0.00"},2,"295,34,","0,35293",-3.59,-2.93,4.35,"Exon (ENSBGRT00000012867/ENSBGRG00000006928, exon 2 of 7)",2,44400164,44605470,205307,1]
["chr2",44683959,44684703,745,"ENSBGRG00000007062","ENSBGRT00000012964",1013,"FZD5","frizzled class receptor 5 [Source:HGNC Symbol;Acc:HGNC:4043]","GO:0000578(embryonic axis specification);GO:0001525(angiogenesis);GO:0001540(amyloid-beta binding);GO:0001944(vasculature development);GO:0002726(positive regulation of T cell cytokine production);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005923(bicellular tight junction);GO:0007166(cell surface receptor signaling pathway);GO:0008285(negative regulation of cell population proliferation);GO:0008595(anterior/posterior axis specification, embryo);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0019901(protein kinase binding);GO:0031076(embryonic camera-type eye development);GO:0031077(post-embryonic camera-type eye development);GO:0031625(ubiquitin protein ligase binding);GO:0032729(positive regulation of interferon-gamma production);GO:0032731(positive regulation of interleukin-1 beta production);GO:0033077(T cell differentiation in thymus);GO:0042813(Wnt-activated receptor activity);GO:0043507(positive regulation of JUN kinase activity);GO:0044877(protein-containing complex binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048469(cell maturation);GO:0048471(perinuclear region of cytoplasm);GO:0048596(embryonic camera-type eye morphogenesis);GO:0060061(Spemann organizer formation);GO:0060070(canonical Wnt signaling pathway);GO:0060561(apoptotic process involved in morphogenesis);GO:0060670(branching involved in labyrinthine layer morphogenesis);GO:0060715(syncytiotrophoblast cell differentiation involved in labyrinthine layer development);GO:0060716(labyrinthine layer blood vessel development);GO:0060718(chorionic trophoblast cell differentiation);GO:0071219(cellular response to molecule of bacterial origin);GO:1901382(regulation of chorionic trophoblast cell proliferation);GO:1904469(positive regulation of tumor necrosis factor secretion);GO:2000810(regulation of bicellular tight junction assembly)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":0.00026,"d":"0.00"},1,"745,",0,-3.59,-2.93,15,"Exon (ENSBGRT00000012964/ENSBGRG00000007062, exon 1 of 1)",2,44682946,44684703,1758,1]
["chr2",44828812,44829171,360,"ENSBGRG00000007457","ENSBGRT00000013789",0,"METTL21A","methyltransferase like 21A [Source:HGNC Symbol;Acc:HGNC:30476]","NA","NA",{"v":0.011,"d":"0.01"},1,"360,",0,-1.97,-1.14,9.03,"5' UTR",2,44828812,44839885,11074,1]
["chr2",44830135,44831814,1680,"ENSBGRG00000007457","ENSBGRT00000013789",1323,"METTL21A","methyltransferase like 21A [Source:HGNC Symbol;Acc:HGNC:30476]","NA","NA",{"v":0.0055,"d":"0.01"},2,"166,74,","0,1606",-2.26,-1.68,1.76,"5' UTR",2,44828812,44839885,11074,1]
["chr2",44839509,44857116,17608,"ENSBGRG00000007457","ENSBGRT00000013789",10697,"METTL21A","methyltransferase like 21A [Source:HGNC Symbol;Acc:HGNC:30476]","NA","NA",{"v":2.5e-25,"d":"0.00"},6,"377,21,14,62,26,10,","0,1112,17249,17499,17562,17598",{"v":-24.6,"d":"-24.60"},{"v":-23.5,"d":"-23.50"},5.19,"3' UTR",2,44828812,44839885,11074,1]
["chr2",45327207,45438768,111562,"ENSBGRG00000007842","ENSBGRT00000014355",0,"KLF7","Kruppel like factor 7 [Source:HGNC Symbol;Acc:HGNC:6350]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0007409(axonogenesis);GO:0007411(axon guidance);GO:0042593(glucose homeostasis);GO:0045604(regulation of epidermal cell differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048813(dendrite morphogenesis);GO:0061179(negative regulation of insulin secretion involved in cellular response to glucose stimulus);GO:1904178(negative regulation of adipose tissue development)","NA",{"v":2.5E-46,"d":"0.00"},6,"119,240,51,631,128,656,","0,335,35106,45493,102964,110906",{"v":-45.6,"d":"-45.60"},{"v":-44.2,"d":"-44.20"},6.22,"5' UTR",2,45327207,45430298,103092,1]
["chr2",45779259,45790053,10795,"ENSBGRG00000008051","ENSBGRT00000014677",0,"FASTKD2","FAST kinase domains 2 [Source:HGNC Symbol;Acc:HGNC:29160]","GO:0004672(protein kinase activity);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0019843(rRNA binding);GO:0035770(ribonucleoprotein granule);GO:0042645(mitochondrial nucleoid);GO:0045171(intercellular bridge);GO:0070131(positive regulation of mitochondrial translation);GO:1902775(mitochondrial large ribosomal subunit assembly)","NA",{"v":0.015,"d":"0.02"},3,"98,113,90,","0,7144,10705",-1.82,-1.28,5.01,"5' UTR",2,45753671,45779725,26055,2]
["chr2",45792393,45799120,6728,"ENSBGRG00000008141","ENSBGRT00000015061",13914,"MDH1B","malate dehydrogenase 1B [Source:HGNC Symbol;Acc:HGNC:17836]","GO:0003824(catalytic activity);GO:0005975(carbohydrate metabolic process);GO:0006108(malate metabolic process);GO:0016615(malate dehydrogenase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0055114(oxidation-reduction process)","00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);00630(Glyoxylate and dicarboxylate metabolism);00270(Cysteine and methionine metabolism)",{"v":0.00015,"d":"0.00"},2,"386,5,","0,6723",-3.82,-3.15,6.02,"Exon (ENSBGRT00000015061/ENSBGRG00000008141, exon 6 of 12)",2,45778479,45816282,37804,1]
["chr2",45814783,45815773,991,"ENSBGRG00000008141","ENSBGRT00000015061",36304,"MDH1B","malate dehydrogenase 1B [Source:HGNC Symbol;Acc:HGNC:17836]","GO:0003824(catalytic activity);GO:0005975(carbohydrate metabolic process);GO:0006108(malate metabolic process);GO:0016615(malate dehydrogenase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0055114(oxidation-reduction process)","00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);00630(Glyoxylate and dicarboxylate metabolism);00270(Cysteine and methionine metabolism)",{"v":3.7E-8,"d":"0.00"},1,"991,",0,-7.43,-6.63,14,"3' UTR",2,45778479,45816282,37804,1]
["chr2",45815833,45817812,1980,"ENSBGRG00000008141","ENSBGRT00000015061",37354,"MDH1B","malate dehydrogenase 1B [Source:HGNC Symbol;Acc:HGNC:17836]","GO:0003824(catalytic activity);GO:0005975(carbohydrate metabolic process);GO:0006108(malate metabolic process);GO:0016615(malate dehydrogenase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0055114(oxidation-reduction process)","00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);00630(Glyoxylate and dicarboxylate metabolism);00270(Cysteine and methionine metabolism)",{"v":0.035,"d":"0.04"},2,"450,91,","0,1889",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"3' UTR",2,45778479,45816282,37804,1]
["chr2",46391009,46393614,2606,"ENSBGRG00000009401","ENSBGRT00000017240",51253,"GPR1","G protein-coupled receptor 1 [Source:HGNC Symbol;Acc:HGNC:4463]","GO:0004930(G protein-coupled receptor activity);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":3.3e-05,"d":"0.00"},2,"57,867,","0,1739",-4.48,-3.78,11,"Exon (ENSBGRT00000017240/ENSBGRG00000009401, exon 3 of 4)",2,46339756,46394982,55227,1]
["chr2",46483177,46483895,719,"ENSBGRG00000009960","ENSBGRT00000018260",0,"INO80D","INO80 complex subunit D [Source:HGNC Symbol;Acc:HGNC:25997]","NA","NA",{"v":1E-156,"d":"0.00"},1,"719,",0,-156,-154,8.63,"5' UTR",2,46483177,46550212,67036,1]
["chr2",46511922,46512131,210,"ENSBGRG00000009960","ENSBGRT00000018260",28745,"INO80D","INO80 complex subunit D [Source:HGNC Symbol;Acc:HGNC:25997]","NA","NA",0.02,1,"210,",0,-1.69,-1.16,3.01,"Exon (ENSBGRT00000018260/ENSBGRG00000009960, exon 4 of 11)",2,46483177,46550212,67036,1]
["chr2",46546094,46550212,4119,"ENSBGRG00000009960","ENSBGRT00000018260",62917,"INO80D","INO80 complex subunit D [Source:HGNC Symbol;Acc:HGNC:25997]","NA","NA",{"v":0.0026,"d":"0.00"},3,"78,158,1739,","0,794,2380",-2.59,-1.99,8.02,"3' UTR",2,46483177,46550212,67036,1]
["chr2",49474362,49474571,210,"ENSBGRG00000012733","ENSBGRT00000026863",5329,"ENSBGRG00000012733","NA","GO:0007165(signal transduction)","04015(Rap1 signaling pathway);04611(Platelet activation)",{"v":0.014,"d":"0.01"},1,"210,",0,-1.85,{"v":-1.3,"d":"-1.30"},2.72,"Exon (ENSBGRT00000026863/ENSBGRG00000012733, exon 3 of 15)",2,49469033,49529390,60358,1]
["chr2",50495563,50509322,13760,"ENSBGRG00000017875","ENSBGRT00000032854",0,"ENSBGRG00000017875","NA","GO:0005515(protein binding)","03013(RNA transport);05418(Fluid shear stress and atherosclerosis)",{"v":6.3e-30,"d":"0.00"},2,"746,54,","0,13706",{"v":-29.2,"d":"-29.20"},{"v":-28.1,"d":"-28.10"},4.01,"5' UTR",2,50495563,50523507,27945,1]
["chr2",50523496,50565438,41943,"ENSBGRG00000017875","ENSBGRT00000032854",27933,"ENSBGRG00000017875","NA","GO:0005515(protein binding)","03013(RNA transport);05418(Fluid shear stress and atherosclerosis)",{"v":8.7e-08,"d":"0.00"},3,"12,459,33,","0,41420,41910",-7.06,-6.28,{"v":1.9,"d":"1.90"},"Exon (ENSBGRT00000032854/ENSBGRG00000017875, exon 5 of 5)",2,50495563,50523507,27945,1]
["chr2",51022838,51024220,1383,"ENSBGRG00000018345","ENSBGRT00000033582",0,"ALS2","alsin Rho guanine nucleotide exchange factor ALS2 [Source:HGNC Symbol;Acc:HGNC:443]","GO:0001662(behavioral fear response);GO:0001726(ruffle);GO:0001881(receptor recycling);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006979(response to oxidative stress);GO:0007032(endosome organization);GO:0007041(lysosomal transport);GO:0007528(neuromuscular junction development);GO:0007626(locomotory behavior);GO:0008104(protein localization);GO:0014069(postsynaptic density);GO:0016050(vesicle organization);GO:0016197(endosomal transport);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0030027(lamellipodium);GO:0030425(dendrite);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031982(vesicle);GO:0032991(protein-containing complex);GO:0035249(synaptic transmission, glutamatergic);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043087(regulation of GTPase activity);GO:0043197(dendritic spine);GO:0043539(protein serine/threonine kinase activator activity);GO:0043547(positive regulation of GTPase activity);GO:0045860(positive regulation of protein kinase activity);GO:0048365(Rac GTPase binding);GO:0048812(neuron projection morphogenesis);GO:0051036(regulation of endosome size);GO:0051260(protein homooligomerization)","05014(Amyotrophic lateral sclerosis (ALS))",{"v":0.0052,"d":"0.01"},2,"76,15,","0,1368",-2.28,{"v":-1.7,"d":"-1.70"},5.01,"5' UTR",2,51022838,51085939,63102,1]
["chr2",51024309,51032068,7760,"ENSBGRG00000018345","ENSBGRT00000033582",1471,"ALS2","alsin Rho guanine nucleotide exchange factor ALS2 [Source:HGNC Symbol;Acc:HGNC:443]","GO:0001662(behavioral fear response);GO:0001726(ruffle);GO:0001881(receptor recycling);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006979(response to oxidative stress);GO:0007032(endosome organization);GO:0007041(lysosomal transport);GO:0007528(neuromuscular junction development);GO:0007626(locomotory behavior);GO:0008104(protein localization);GO:0014069(postsynaptic density);GO:0016050(vesicle organization);GO:0016197(endosomal transport);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0030027(lamellipodium);GO:0030425(dendrite);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031982(vesicle);GO:0032991(protein-containing complex);GO:0035249(synaptic transmission, glutamatergic);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043087(regulation of GTPase activity);GO:0043197(dendritic spine);GO:0043539(protein serine/threonine kinase activator activity);GO:0043547(positive regulation of GTPase activity);GO:0045860(positive regulation of protein kinase activity);GO:0048365(Rac GTPase binding);GO:0048812(neuron projection morphogenesis);GO:0051036(regulation of endosome size);GO:0051260(protein homooligomerization)","05014(Amyotrophic lateral sclerosis (ALS))",{"v":6.9E-10,"d":"0.00"},3,"52,935,92,","0,3635,7668",-9.16,-8.32,3.88,"Exon (ENSBGRT00000033582/ENSBGRG00000018345, exon 2 of 33)",2,51022838,51085939,63102,1]
["chr2",51431038,51431487,450,"ENSBGRG00000022201","ENSBGRT00000041007",76402,"TRAK2","trafficking kinesin protein 2 [Source:HGNC Symbol;Acc:HGNC:13206]","NA","04727(GABAergic synapse)",{"v":1.3e-44,"d":"0.00"},1,"450,",0,{"v":-43.9,"d":"-43.90"},{"v":-42.6,"d":"-42.60"},{"v":6.3,"d":"6.30"},"Exon (ENSBGRT00000041007/ENSBGRG00000022201, exon 16 of 16)",2,51354636,51431487,76852,1]
["chr2",51788647,51793334,4688,"ENSBGRG00000022773","ENSBGRT00000042134",53125,"FAM126B","family with sequence similarity 126 member B [Source:HGNC Symbol;Acc:HGNC:28593]","NA","NA",{"v":1e-05,"d":"0.00"},2,"126,531,","0,4157",-4.99,-4.27,{"v":20.1,"d":"20.10"},"Exon (ENSBGRT00000042134/ENSBGRG00000022773, exon 12 of 12)",2,51735522,51793405,57884,1]
["chr2",51821989,51823546,1558,"ENSBGRG00000022926","ENSBGRT00000042326",2672,"ORC2","origin recognition complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:8488]","GO:0000784(nuclear chromosome, telomeric region);GO:0000785(chromatin);GO:0000792(heterochromatin);GO:0000808(origin recognition complex);GO:0000939(condensed chromosome inner kinetochore);GO:0003688(DNA replication origin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005664(nuclear origin of replication recognition complex);GO:0005813(centrosome);GO:0006260(DNA replication)","04110(Cell cycle)",{"v":0.035,"d":"0.04"},2,"58,32,","0,1526",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000042326/ENSBGRG00000022926, exon 3 of 17)",2,51819317,51852155,32839,1]
["chr2",51850052,51852155,2104,"ENSBGRG00000022926","ENSBGRT00000042326",30735,"ORC2","origin recognition complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:8488]","GO:0000784(nuclear chromosome, telomeric region);GO:0000785(chromatin);GO:0000792(heterochromatin);GO:0000808(origin recognition complex);GO:0000939(condensed chromosome inner kinetochore);GO:0003688(DNA replication origin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005664(nuclear origin of replication recognition complex);GO:0005813(centrosome);GO:0006260(DNA replication)","04110(Cell cycle)",{"v":7.1e-05,"d":"0.00"},2,"93,87,","0,2017",-4.15,-3.46,2.05,"Exon (ENSBGRT00000042326/ENSBGRG00000022926, exon 16 of 17)",2,51819317,51852155,32839,1]
["chr2",51888426,51888574,149,"ENSBGRG00000023065","ENSBGRT00000042565",9902,"ENSBGRG00000023065","NA","GO:0000413(protein peptidyl-prolyl isomerization);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0006457(protein folding)","NA",{"v":5.6e-08,"d":"0.00"},1,"149,",0,-7.25,-6.45,2.02,"3' UTR",2,51878524,51889609,11086,1]
["chr2",51898968,51900682,1715,"ENSBGRG00000023102","ENSBGRT00000042767",0,"CLK1","CDC like kinase 1 [Source:HGNC Symbol;Acc:HGNC:2068]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006468(protein phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0043484(regulation of RNA splicing);GO:0046777(protein autophosphorylation)","NA",{"v":7.9e-18,"d":"0.00"},3,"164,229,54,","0,435,1661",{"v":-17.1,"d":"-17.10"},{"v":-16.1,"d":"-16.10"},1.45,"Exon (ENSBGRT00000042767/ENSBGRG00000023102, exon 1 of 12)",2,51898968,51905025,6058,1]
["chr2",52422325,52434285,11961,"ENSBGRG00000026680","ENSBGRT00000049452",7949,"KCTD18","potassium channel tetramerization domain containing 18 [Source:HGNC Symbol;Acc:HGNC:26446]","GO:0051260(protein homooligomerization)","NA",{"v":6.3e-77,"d":"0.00"},4,"17,95,103,505,","0,1106,6847,11456",{"v":-76.2,"d":"-76.20"},{"v":-74.6,"d":"-74.60"},9.17,"Exon (ENSBGRT00000049452/ENSBGRG00000026680, exon 3 of 6)",2,52414376,52434285,19910,1]
["chr2",53004937,53005267,331,"ENSBGRG00000026697","ENSBGRT00000049492",0,"TYW5","tRNA-yW synthesizing protein 5 [Source:HGNC Symbol;Acc:HGNC:26754]","GO:0000049(tRNA binding);GO:0005506(iron ion binding);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0031591(wybutosine biosynthetic process);GO:0042803(protein homodimerization activity)","NA",{"v":2.7E-6,"d":"0.00"},1,"331,",0,-5.57,-4.83,2.69,"5' UTR",2,53004937,53054984,50048,1]
["chr2",53005627,53011124,5498,"ENSBGRG00000026697","ENSBGRT00000049492",690,"TYW5","tRNA-yW synthesizing protein 5 [Source:HGNC Symbol;Acc:HGNC:26754]","GO:0000049(tRNA binding);GO:0005506(iron ion binding);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0031591(wybutosine biosynthetic process);GO:0042803(protein homodimerization activity)","NA",{"v":0.0074,"d":"0.01"},2,"12,49,","0,5449",-2.13,-1.56,1.82,"Exon (ENSBGRT00000049492/ENSBGRG00000026697, exon 1 of 9)",2,53004937,53054984,50048,1]
["chr2",53024156,53026581,2426,"ENSBGRG00000026697","ENSBGRT00000049492",19219,"TYW5","tRNA-yW synthesizing protein 5 [Source:HGNC Symbol;Acc:HGNC:26754]","GO:0000049(tRNA binding);GO:0005506(iron ion binding);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0031591(wybutosine biosynthetic process);GO:0042803(protein homodimerization activity)","NA",{"v":2.5e-34,"d":"0.00"},2,"56,365,","0,2061",{"v":-33.6,"d":"-33.60"},{"v":-32.4,"d":"-32.40"},5.07,"3' UTR",2,53004937,53054984,50048,1]
["chr2",53140227,53140316,90,"ENSBGRG00000026708","ENSBGRT00000049524",41916,"FTCDNL1","formiminotransferase cyclodeaminase N-terminal like [Source:HGNC Symbol;Acc:HGNC:48661]","GO:0005542(folic acid binding);GO:0016740(transferase activity)","00340(Histidine metabolism);00670(One carbon pool by folate);04742(Taste transduction)",{"v":5.5e-05,"d":"0.00"},1,"90,",0,-4.26,-3.57,5.42,"3' UTR",2,53098311,53140460,42150,1]
["chr2",55518725,55521371,2647,"ENSBGRG00000000406","ENSBGRT00000000673",593,"RFTN2","raftlin family member 2 [Source:HGNC Symbol;Acc:HGNC:26402]","GO:0033227(dsRNA transport);GO:0043330(response to exogenous dsRNA)","NA",{"v":0.0025,"d":"0.00"},3,"123,205,29,","0,496,2618",{"v":-2.6,"d":"-2.60"},-2,3.76,"5' UTR",2,55518132,55604374,86243,1]
["chr2",55537097,55543683,6587,"ENSBGRG00000000406","ENSBGRT00000000673",18965,"RFTN2","raftlin family member 2 [Source:HGNC Symbol;Acc:HGNC:26402]","GO:0033227(dsRNA transport);GO:0043330(response to exogenous dsRNA)","NA",{"v":5e-13,"d":"0.00"},3,"12,280,6,","0,3888,6581",{"v":-12.3,"d":"-12.30"},{"v":-11.4,"d":"-11.40"},2.06,"Exon (ENSBGRT00000000673/ENSBGRG00000000406, exon 4 of 9)",2,55518132,55604374,86243,1]
["chr2",55604106,55604374,269,"ENSBGRG00000000406","ENSBGRT00000000673",85974,"RFTN2","raftlin family member 2 [Source:HGNC Symbol;Acc:HGNC:26402]","GO:0033227(dsRNA transport);GO:0043330(response to exogenous dsRNA)","NA",{"v":2E-55,"d":"0.00"},1,"269,",0,{"v":-54.7,"d":"-54.70"},{"v":-53.2,"d":"-53.20"},3.33,"Exon (ENSBGRT00000000673/ENSBGRG00000000406, exon 9 of 9)",2,55518132,55604374,86243,1]
["chr2",55672024,55672382,359,"ENSBGRG00000000539","ENSBGRT00000000953",8471,"HSPD1","heat shock protein family D (Hsp60) member 1 [Source:HGNC Symbol;Acc:HGNC:5261]","GO:0000166(nucleotide binding);GO:0001530(lipopolysaccharide binding);GO:0002039(p53 binding);GO:0002368(B cell cytokine production);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0002842(positive regulation of T cell mediated immune response to tumor cell);GO:0003725(double-stranded RNA binding);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005905(clathrin-coated pit);GO:0006457(protein folding);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006986(response to unfolded protein);GO:0008035(high-density lipoprotein particle binding);GO:0009409(response to cold);GO:0009986(cell surface);GO:0016020(membrane);GO:0016853(isomerase activity);GO:0019899(enzyme binding);GO:0030135(coated vesicle);GO:0030141(secretory granule);GO:0031625(ubiquitin protein ligase binding);GO:0032727(positive regulation of interferon-alpha production);GO:0032729(positive regulation of interferon-gamma production);GO:0032733(positive regulation of interleukin-10 production);GO:0032735(positive regulation of interleukin-12 production);GO:0032755(positive regulation of interleukin-6 production);GO:0032991(protein-containing complex);GO:0034185(apolipoprotein binding);GO:0034186(apolipoprotein A-I binding);GO:0042026(protein refolding);GO:0042100(B cell proliferation);GO:0042110(T cell activation);GO:0042113(B cell activation);GO:0043032(positive regulation of macrophage activation);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0046696(lipopolysaccharide receptor complex);GO:0048291(isotype switching to IgG isotypes);GO:0050821(protein stabilization);GO:0050870(positive regulation of T cell activation);GO:0051087(chaperone binding);GO:0051702(interaction with symbiont);GO:0070062(extracellular exosome);GO:0098761(cellular response to interleukin-7)","03018(RNA degradation);04940(Type I diabetes mellitus);05134(Legionellosis);05152(Tuberculosis)",{"v":1.6E-12,"d":"0.00"},2,"91,147,","0,212",{"v":-11.8,"d":"-11.80"},{"v":-10.9,"d":"-10.90"},1.25,"Exon (ENSBGRT00000000953/ENSBGRG00000000539, exon 9 of 12)",2,55663553,55673581,10029,1]
["chr2",55672719,55673581,863,"ENSBGRG00000000539","ENSBGRT00000000953",9166,"HSPD1","heat shock protein family D (Hsp60) member 1 [Source:HGNC Symbol;Acc:HGNC:5261]","GO:0000166(nucleotide binding);GO:0001530(lipopolysaccharide binding);GO:0002039(p53 binding);GO:0002368(B cell cytokine production);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0002842(positive regulation of T cell mediated immune response to tumor cell);GO:0003725(double-stranded RNA binding);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005905(clathrin-coated pit);GO:0006457(protein folding);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006986(response to unfolded protein);GO:0008035(high-density lipoprotein particle binding);GO:0009409(response to cold);GO:0009986(cell surface);GO:0016020(membrane);GO:0016853(isomerase activity);GO:0019899(enzyme binding);GO:0030135(coated vesicle);GO:0030141(secretory granule);GO:0031625(ubiquitin protein ligase binding);GO:0032727(positive regulation of interferon-alpha production);GO:0032729(positive regulation of interferon-gamma production);GO:0032733(positive regulation of interleukin-10 production);GO:0032735(positive regulation of interleukin-12 production);GO:0032755(positive regulation of interleukin-6 production);GO:0032991(protein-containing complex);GO:0034185(apolipoprotein binding);GO:0034186(apolipoprotein A-I binding);GO:0042026(protein refolding);GO:0042100(B cell proliferation);GO:0042110(T cell activation);GO:0042113(B cell activation);GO:0043032(positive regulation of macrophage activation);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0046696(lipopolysaccharide receptor complex);GO:0048291(isotype switching to IgG isotypes);GO:0050821(protein stabilization);GO:0050870(positive regulation of T cell activation);GO:0051087(chaperone binding);GO:0051702(interaction with symbiont);GO:0070062(extracellular exosome);GO:0098761(cellular response to interleukin-7)","03018(RNA degradation);04940(Type I diabetes mellitus);05134(Legionellosis);05152(Tuberculosis)",{"v":1E-155,"d":"0.00"},2,"149,623,","0,240",-155,-153,2.44,"3' UTR",2,55663553,55673581,10029,1]
["chr2",55725326,55736877,11552,"ENSBGRG00000000604","ENSBGRT00000001240",60,"SF3B1","splicing factor 3b subunit 1 [Source:HGNC Symbol;Acc:HGNC:10768]","GO:0000245(spliceosomal complex assembly);GO:0000398(mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005686(U2 snRNP);GO:0005689(U12-type spliceosomal complex);GO:0016607(nuclear speck);GO:0034693(U11/U12 snRNP);GO:0071005(U2-type precatalytic spliceosome);GO:0071013(catalytic step 2 spliceosome);GO:1990935(splicing factor binding)","03040(Spliceosome)",{"v":6.3e-25,"d":"0.00"},2,"117,62,","0,11490",{"v":-24.2,"d":"-24.20"},{"v":-23.1,"d":"-23.10"},2.01,"5' UTR",2,55725266,55740700,15435,1]
["chr2",55976885,56017846,40962,"ENSBGRG00000000733","ENSBGRT00000001566",138220,"ANKRD44","ankyrin repeat domain 44 [Source:HGNC Symbol;Acc:HGNC:25259]","GO:0005515(protein binding)","NA",{"v":0.015,"d":"0.02"},2,"51,39,","0,40923",-1.82,-1.28,3.51,"Exon (ENSBGRT00000001566/ENSBGRG00000000733, exon 2 of 28)",2,55838665,56173067,334403,1]
["chr2",56166288,56172827,6540,"ENSBGRG00000000733","ENSBGRT00000001566",327623,"ANKRD44","ankyrin repeat domain 44 [Source:HGNC Symbol;Acc:HGNC:25259]","GO:0005515(protein binding)","NA",{"v":0.0046,"d":"0.00"},4,"27,83,92,8,","0,2005,3167,6532",-2.34,-1.76,3.34,"Exon (ENSBGRT00000001566/ENSBGRG00000000733, exon 25 of 28)",2,55838665,56173067,334403,1]
["chr2",56366957,56368909,1953,"ENSBGRG00000001029","ENSBGRT00000001903",7697,"GTF3C3","general transcription factor IIIC subunit 3 [Source:HGNC Symbol;Acc:HGNC:4666]","GO:0000127(transcription factor TFIIIC complex);GO:0001004(obsolete RNA polymerase III transcription regulator recruiting activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006383(transcription by RNA polymerase III);GO:0031965(nuclear membrane)","NA",{"v":2.3E-3,"d":"0.00"},3,"139,124,6,","0,648,1947",-2.63,-2.02,2.31,"Exon (ENSBGRT00000001903/ENSBGRG00000001029, exon 3 of 18)",2,56359260,56393944,34685,1]
["chr2",56393854,56393944,91,"ENSBGRG00000001029","ENSBGRT00000001903",34594,"GTF3C3","general transcription factor IIIC subunit 3 [Source:HGNC Symbol;Acc:HGNC:4666]","GO:0000127(transcription factor TFIIIC complex);GO:0001004(obsolete RNA polymerase III transcription regulator recruiting activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006383(transcription by RNA polymerase III);GO:0031965(nuclear membrane)","NA",{"v":1e-07,"d":"0.00"},1,"91,",0,-7,-6.21,2.35,"Exon (ENSBGRT00000001903/ENSBGRG00000001029, exon 18 of 18)",2,56359260,56393944,34685,1]
["chr2",56923373,56924302,930,"ENSBGRG00000001305","ENSBGRT00000002413",166660,"HECW2","HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:29853]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0030071(regulation of mitotic metaphase/anaphase transition);GO:0072686(mitotic spindle)","NA",{"v":0.00048,"d":"0.00"},1,"930,",0,-3.32,-2.67,14,"Exon (ENSBGRT00000002413/ENSBGRG00000001305, exon 9 of 29)",2,56756713,57057645,300933,1]
["chr2",73664898,73672804,7907,"ENSBGRG00000003157","ENSBGRT00000006179",92552,"CCDC93","coiled-coil domain containing 93 [Source:HGNC Symbol;Acc:HGNC:25611]","GO:0006893(Golgi to plasma membrane transport);GO:0032456(endocytic recycling);GO:0043231(intracellular membrane-bounded organelle);GO:1990126(retrograde transport, endosome to plasma membrane)","NA",{"v":1.9E-3,"d":"0.00"},6,"51,82,72,54,63,98,","0,871,2108,3427,5071,7809",-2.72,-2.11,1.59,"Exon (ENSBGRT00000006179/ENSBGRG00000003157, exon 15 of 25)",2,73572346,73686166,113821,1]
["chr2",81780739,81829533,48795,"ENSBGRG00000000816","ENSBGRT00000001594",0,"RAB3GAP1","RAB3 GTPase activating protein catalytic subunit 1 [Source:HGNC Symbol;Acc:HGNC:17063]","GO:0005096(GTPase activator activity);GO:0005794(Golgi apparatus);GO:0005811(lipid droplet);GO:0007420(brain development);GO:0010628(positive regulation of gene expression);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0021854(hypothalamus development);GO:0032991(protein-containing complex);GO:0034389(lipid droplet organization);GO:0043010(camera-type eye development);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0060079(excitatory postsynaptic potential);GO:0060325(face morphogenesis);GO:0061646(positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization);GO:0071782(endoplasmic reticulum tubular network);GO:0097051(establishment of protein localization to endoplasmic reticulum membrane);GO:1903061(positive regulation of protein lipidation);GO:1903233(regulation of calcium ion-dependent exocytosis of neurotransmitter);GO:1903373(positive regulation of endoplasmic reticulum tubular network organization);GO:2000786(positive regulation of autophagosome assembly)","NA",{"v":1.1e-08,"d":"0.00"},4,"18,56,76,60,","0,119,6889,48735",-7.97,-7.16,3.31,"Exon (ENSBGRT00000001594/ENSBGRG00000000816, exon 1 of 25)",2,81780739,81902507,121769,1]
["chr2",97620223,97647607,27385,"ENSBGRG00000005195","ENSBGRT00000009597",37110,"MBD5","methyl-CpG binding domain protein 5 [Source:HGNC Symbol;Acc:HGNC:20444]","GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0007399(nervous system development);GO:0010369(chromocenter);GO:0030496(midbody);GO:0042025(host cell nucleus);GO:0050795(regulation of behavior)","NA",{"v":2.5E-52,"d":"0.00"},4,"1095,74,76,75,","0,12753,23255,27310",{"v":-51.6,"d":"-51.60"},{"v":-50.2,"d":"-50.20"},{"v":10.1,"d":"10.10"},"3' UTR",2,97583113,97647607,64495,1]
["chr2",116482603,116482782,180,"ENSBGRG00000021834","ENSBGRT00000040359",177929,"CSRNP3","cysteine and serine rich nuclear protein 3 [Source:HGNC Symbol;Acc:HGNC:30729]","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0010923(negative regulation of phosphatase activity);GO:0043065(positive regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":0.00072,"d":"0.00"},1,"180,",0,-3.14,{"v":-2.5,"d":"-2.50"},6.02,"Exon (ENSBGRT00000040359/ENSBGRG00000021834, exon 5 of 5)",2,116304674,116484454,179781,1]
["chr2",120828434,120829344,911,"ENSBGRG00000006620","ENSBGRT00000012225",20777,"PPIG","peptidylprolyl isomerase G [Source:HGNC Symbol;Acc:HGNC:14650]","GO:0000413(protein peptidyl-prolyl isomerization);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005829(cytosol);GO:0006457(protein folding);GO:0016018(cyclosporin A binding);GO:0016607(nuclear speck)","NA",{"v":1.9e-07,"d":"0.00"},2,"147,33,","0,878",-6.71,-5.93,1.69,"Exon (ENSBGRT00000012225/ENSBGRG00000006620, exon 10 of 14)",2,120807657,120833836,26180,1]
["chr2",123095605,123099194,3590,"ENSBGRG00000010265","ENSBGRT00000018820",0,"HAT1","histone acetyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:4821]","GO:0000790(nuclear chromatin);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006335(DNA replication-dependent nucleosome assembly);GO:0006336(DNA replication-independent nucleosome assembly);GO:0006348(chromatin silencing at telomere);GO:0010485(H4 histone acetyltransferase activity);GO:0016573(histone acetylation);GO:0032991(protein-containing complex);GO:0042393(histone binding);GO:0043967(histone H4 acetylation)","05034(Alcoholism)",{"v":0.035,"d":"0.04"},3,"61,154,25,","0,1192,3565",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"5' UTR",2,123095605,123139590,43986,1]
["chr2",129935414,129973752,38339,"ENSBGRG00000000437","ENSBGRT00000000858",163354,"OSBPL6","oxysterol binding protein like 6 [Source:HGNC Symbol;Acc:HGNC:16388]","GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0031901(early endosome membrane);GO:0031965(nuclear membrane);GO:0032374(regulation of cholesterol transport);GO:0097038(perinuclear endoplasmic reticulum)","NA",{"v":1.6E-47,"d":"0.00"},3,"61,109,100,","0,1318,38239",{"v":-46.8,"d":"-46.80"},{"v":-45.4,"d":"-45.40"},3.81,"Exon (ENSBGRT00000000858/ENSBGRG00000000437, exon 26 of 27)",2,129772060,129936840,164781,1]
["chr2",142587777,142588263,487,"ENSBGRG00000003528","ENSBGRT00000006625",43417,"WDR75","WD repeat domain 75 [Source:HGNC Symbol;Acc:HGNC:25725]","GO:0005515(protein binding);GO:0005730(nucleolus);GO:0045943(positive regulation of transcription by RNA polymerase I);GO:2000234(positive regulation of rRNA processing)","03008(Ribosome biogenesis in eukaryotes)",{"v":5E-15,"d":"0.00"},2,"4,205,","0,282",{"v":-14.3,"d":"-14.30"},{"v":-13.3,"d":"-13.30"},{"v":3.1,"d":"3.10"},"Exon (ENSBGRT00000006625/ENSBGRG00000003528, exon 20 of 21)",2,142544360,142588263,43904,1]
["chr2",143744201,143744529,329,"ENSBGRG00000000505","ENSBGRT00000000927",657,"MFSD6","major facilitator superfamily domain containing 6 [Source:HGNC Symbol;Acc:HGNC:24711]","NA","NA",{"v":1.3e-12,"d":"0.00"},1,"329,",0,{"v":-11.9,"d":"-11.90"},-11,4.31,"Exon (ENSBGRT00000000927/ENSBGRG00000000505, exon 1 of 7)",2,143743544,143812349,68806,1]
["chr2",419115,419564,450,"ENSBGRG00000002334","ENSBGRT00000004342",0,"ENSBGRG00000002334","NA","NA","NA",{"v":0.00024,"d":"0.00"},1,"450,",0,-3.62,-2.96,7.02,"Exon (ENSBGRT00000004342/ENSBGRG00000002334, exon 1 of 2)",2,381872,419564,37693,2]
["chr2",4630383,4631052,670,"ENSBGRG00000005394","ENSBGRT00000009932",686,"ENSBGRG00000005394","NA","GO:0004860(protein kinase inhibitor activity)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":1e-05,"d":"0.00"},2,"130,20,","0,650",-4.99,-4.27,{"v":20.1,"d":"20.10"},"Exon (ENSBGRT00000009932/ENSBGRG00000005394, exon 1 of 2)",2,4611237,4631738,20502,2]
["chr2",7474353,7474860,508,"ENSBGRG00000003957","ENSBGRT00000007283",179,"ENSBGRG00000003957","NA","GO:0004930(G protein-coupled receptor activity);GO:0004993(G protein-coupled serotonin receptor activity);GO:0005887(integral component of plasma membrane);GO:0006939(smooth muscle contraction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007268(chemical synaptic transmission);GO:0009636(response to toxic substance);GO:0016021(integral component of membrane);GO:0040012(regulation of locomotion);GO:0042310(vasoconstriction);GO:0050795(regulation of behavior);GO:0051378(serotonin binding)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04726(Serotonergic synapse);04742(Taste transduction)",{"v":0.0032,"d":"0.00"},1,"508,",0,{"v":-2.5,"d":"-2.50"},-1.91,11,"Exon (ENSBGRT00000007283/ENSBGRG00000003957, exon 1 of 1)",2,7473906,7475039,1134,2]
["chr2",7816690,7816898,209,"ENSBGRG00000004509","ENSBGRT00000008355",24190,"E2F2","E2F transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:3114]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0051726(regulation of cell cycle);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0090575(RNA polymerase II transcription factor complex);GO:1903671(negative regulation of sprouting angiogenesis);GO:1990086(lens fiber cell apoptotic process);GO:1990837(sequence-specific double-stranded DNA binding)","04110(Cell cycle);04218(Cellular senescence);05200(Pathways in cancer);05206(MicroRNAs in cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05220(Chronic myeloid leukemia);05218(Melanoma);05219(Bladder cancer);05215(Prostate cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);04934(Cushing syndrome);05166(HTLV-I infection);05161(Hepatitis B);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);01522(Endocrine resistance)",{"v":0.035,"d":"0.04"},1,"209,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000008355/ENSBGRG00000004509, exon 7 of 7)",2,7815825,7841088,25264,2]
["chr2",10465855,10466091,237,"ENSBGRG00000005620","ENSBGRT00000010388",17177,"TRIM63","tripartite motif containing 63 [Source:HGNC Symbol;Acc:HGNC:16007]","GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0031432(titin binding)","NA",{"v":0.0058,"d":"0.01"},1,"237,",0,-2.24,-1.66,10,"3' UTR",2,10465855,10483268,17414,2]
["chr2",13433012,13434172,1161,"ENSBGRG00000021675","ENSBGRT00000040000",0,"TMEM200B","transmembrane protein 200B [Source:HGNC Symbol;Acc:HGNC:33785]","NA","04974(Protein digestion and absorption)",{"v":4E-52,"d":"0.00"},1,"1161,",0,{"v":-51.4,"d":"-51.40"},-50,{"v":17.5,"d":"17.50"},"Exon (ENSBGRT00000040000/ENSBGRG00000021675, exon 1 of 1)",2,13433012,13434172,1161,2]
["chr2",17343358,17345184,1827,"ENSBGRG00000015458","ENSBGRT00000029183",24938,"RNF19B","ring finger protein 19B [Source:HGNC Symbol;Acc:HGNC:26886]","GO:0004842(ubiquitin-protein transferase activity);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0016567(protein ubiquitination);GO:0043130(ubiquitin binding);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":1e-109,"d":"0.00"},3,"774,22,73,","0,802,1754",-109,-107,4.35,"3' UTR",2,17343298,17370122,26825,2]
["chr2",20123365,20147530,24166,"ENSBGRG00000008056","ENSBGRT00000014693",27226,"ENSBGRG00000008056","NA","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016604(nuclear body)","05203(Viral carcinogenesis);05168(Herpes simplex infection)",{"v":3.5e-06,"d":"0.00"},8,"100,90,81,81,84,81,84,57,","0,7709,8191,10449,11620,16889,17946,24109",-5.46,-4.72,1.73,"Exon (ENSBGRT00000014693/ENSBGRG00000008056, exon 8 of 27)",2,20088883,20174756,85874,2]
["chr2",28014492,28020656,6165,"ENSBGRG00000016568","ENSBGRT00000030458",28486,"ACSL3","acyl-CoA synthetase long chain family member 3 [Source:HGNC Symbol;Acc:HGNC:3570]","GO:0001676(long-chain fatty acid metabolic process);GO:0003824(catalytic activity);GO:0004467(long-chain fatty acid-CoA ligase activity);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005811(lipid droplet);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0034379(very-low-density lipoprotein particle assembly);GO:0042998(positive regulation of Golgi to plasma membrane protein transport);GO:0044539(long-chain fatty acid import into cell);GO:0048471(perinuclear region of cytoplasm);GO:0051047(positive regulation of secretion);GO:2001247(positive regulation of phosphatidylcholine biosynthetic process)","00061(Fatty acid biosynthesis);00071(Fatty acid degradation);04146(Peroxisome);04216(Ferroptosis);04920(Adipocytokine signaling pathway);03320(PPAR signaling pathway);04714(Thermogenesis)",{"v":4E-35,"d":"0.00"},3,"10,446,22,","0,357,6143",{"v":-34.4,"d":"-34.40"},{"v":-33.2,"d":"-33.20"},3.38,"3' UTR",2,28014492,28049142,34651,2]
["chr2",33269443,33270635,1193,"ENSBGRG00000001379","ENSBGRT00000002519",7713,"CTDSP1","CTD small phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:21614]","GO:0001933(negative regulation of protein phosphorylation);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006470(protein dephosphorylation);GO:0008420(RNA polymerase II CTD heptapeptide repeat phosphatase activity);GO:0016791(phosphatase activity);GO:0045665(negative regulation of neuron differentiation);GO:0050768(negative regulation of neurogenesis);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","NA",{"v":1e-177,"d":"0.00"},2,"445,36,","0,1157",-177,-175,4.66,"3' UTR",2,33264942,33278348,13407,2]
["chr2",42836651,42841519,4869,"ENSBGRG00000005202","ENSBGRT00000010830",118022,"UNC80","unc-80 homolog, NALCN channel complex subunit [Source:HGNC Symbol;Acc:HGNC:26582]","NA","NA",{"v":0.019,"d":"0.02"},2,"65,86,","0,4783",-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000010830/ENSBGRG00000005202, exon 24 of 66)",2,42713759,42959541,245783,2]
["chr2",45774366,45779069,4704,"ENSBGRG00000008141","ENSBGRT00000015061",0,"MDH1B","malate dehydrogenase 1B [Source:HGNC Symbol;Acc:HGNC:17836]","GO:0003824(catalytic activity);GO:0005975(carbohydrate metabolic process);GO:0006108(malate metabolic process);GO:0016615(malate dehydrogenase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0055114(oxidation-reduction process)","00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);00630(Glyoxylate and dicarboxylate metabolism);00270(Cysteine and methionine metabolism)",{"v":3.2e-45,"d":"0.00"},3,"4,821,101,","0,2972,4603",{"v":-44.5,"d":"-44.50"},{"v":-43.1,"d":"-43.10"},9.03,"5' UTR",2,45778479,45816282,37804,1]
["chr2",51630818,51631799,982,"ENSBGRG00000022578","ENSBGRT00000041790",36069,"CFLAR","CASP8 and FADD like apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:1876]","GO:0002020(protease binding);GO:0004197(cysteine-type endopeptidase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0007519(skeletal muscle tissue development);GO:0008047(enzyme activator activity);GO:0008234(cysteine-type peptidase activity);GO:0009617(response to bacterium);GO:0014732(skeletal muscle atrophy);GO:0014842(regulation of skeletal muscle satellite cell proliferation);GO:0014866(skeletal myofibril assembly);GO:0016504(peptidase activator activity);GO:0031264(death-inducing signaling complex);GO:0042060(wound healing);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043403(skeletal muscle tissue regeneration);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0060544(regulation of necroptotic process);GO:0060546(negative regulation of necroptotic process);GO:0097342(ripoptosome);GO:1901740(negative regulation of myoblast fusion);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04217(Necroptosis);05142(Chagas disease (American trypanosomiasis))",{"v":5e-58,"d":"0.00"},1,"982,",0,{"v":-57.3,"d":"-57.30"},{"v":-55.9,"d":"-55.90"},{"v":4.4,"d":"4.40"},"3' UTR",2,51630818,51667868,37051,2]
["chr2",57503858,57504155,298,"ENSBGRG00000001456","ENSBGRT00000002661",18073,"SLC39A10","solute carrier family 39 member 10 [Source:HGNC Symbol;Acc:HGNC:20861]","GO:0016020(membrane);GO:0030001(metal ion transport);GO:0046873(metal ion transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":8.7e-08,"d":"0.00"},1,"298,",0,-7.06,-6.27,3.12,"Exon (ENSBGRT00000002661/ENSBGRG00000001456, exon 2 of 10)",2,57466305,57522228,55924,2]
["chr2",79012575,79012964,390,"ENSBGRG00000000305","ENSBGRT00000000692",686428,"NCKAP5","NCK associated protein 5 [Source:HGNC Symbol;Acc:HGNC:29847]","NA","NA",{"v":0.0032,"d":"0.00"},1,"390,",0,{"v":-2.5,"d":"-2.50"},-1.91,11,"Exon (ENSBGRT00000000692/ENSBGRG00000000305, exon 11 of 16)",2,78858680,79699392,840713,2]
["chr2",100805909,100807012,1104,"ENSBGRG00000005853","ENSBGRT00000010795",20727,"NMI","N-myc and STAT interactor [Source:HGNC Symbol;Acc:HGNC:7854]","GO:0003712(transcription coregulator activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006366(transcription by RNA polymerase II);GO:0032480(negative regulation of type I interferon production);GO:0032687(negative regulation of interferon-alpha production);GO:0032688(negative regulation of interferon-beta production);GO:0042802(identical protein binding);GO:0045824(negative regulation of innate immune response);GO:0060333(interferon-gamma-mediated signaling pathway);GO:1902524(positive regulation of protein K48-linked ubiquitination)","NA",{"v":1.3e-98,"d":"0.00"},2,"284,75,","0,1029",{"v":-97.9,"d":"-97.90"},{"v":-96.1,"d":"-96.10"},4.54,"3' UTR",2,100805909,100827739,21831,2]
["chr2",102334206,102335496,1291,"ENSBGRG00000015929","ENSBGRT00000029274",0,"PRPF40A","pre-mRNA processing factor 40 homolog A [Source:HGNC Symbol;Acc:HGNC:16463]","GO:0005515(protein binding);GO:0045292(mRNA cis splicing, via spliceosome)","03040(Spliceosome)",{"v":0.0058,"d":"0.01"},2,"966,84,","0,1207",-2.24,-1.66,10,"5' UTR",2,102273201,102335496,62296,2]
["chr2",120742889,120743643,755,"ENSBGRG00000006547","ENSBGRT00000012054",38736,"FASTKD1","FAST kinase domains 1 [Source:HGNC Symbol;Acc:HGNC:26150]","GO:0000959(mitochondrial RNA metabolic process);GO:0004672(protein kinase activity);GO:0005739(mitochondrion);GO:0044528(regulation of mitochondrial mRNA stability)","NA",{"v":0.0071,"d":"0.01"},2,"96,114,","0,641",-2.15,-1.58,1.95,"Exon (ENSBGRT00000012054/ENSBGRG00000006547, exon 13 of 14)",2,120742889,120782379,39491,2]
["chr2",125660075,125660403,329,"ENSBGRG00000014271","ENSBGRT00000026269",65662,"SCRN3","secernin 3 [Source:HGNC Symbol;Acc:HGNC:30382]","GO:0006508(proteolysis);GO:0016805(dipeptidase activity)","NA",{"v":6.2e-09,"d":"0.00"},1,"329,",0,-8.21,-7.39,6.88,"Exon (ENSBGRT00000026406/ENSBGRG00000014360, exon 2 of 15)",2,125594413,125665083,70671,1]
["chr2",128994441,128995006,566,"ENSBGRG00000000256","ENSBGRT00000000402",2573,"ENSBGRG00000000256","NA","GO:0005515(protein binding)","NA",{"v":3.3E-4,"d":"0.00"},1,"566,",0,-3.48,-2.83,3.64,"Exon (ENSBGRT00000000402/ENSBGRG00000000256, exon 2 of 2)",2,128994411,128997579,3169,2]
["chr2",142737243,142738779,1537,"ENSBGRG00000003645","ENSBGRT00000006884",24751,"SLC40A1","solute carrier family 40 member 1 [Source:HGNC Symbol;Acc:HGNC:10909]","GO:0005381(iron ion transmembrane transporter activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006879(cellular iron ion homeostasis);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0017046(peptide hormone binding);GO:0034755(iron ion transmembrane transport)","04216(Ferroptosis);04978(Mineral absorption)",{"v":5e-98,"d":"0.00"},2,"581,138,","0,1399",{"v":-97.3,"d":"-97.30"},{"v":-95.5,"d":"-95.50"},3.06,"Exon (ENSBGRT00000006884/ENSBGRG00000003645, exon 6 of 8)",2,142735016,142763530,28515,2]
["chr2",145165039,145166869,1831,"ENSBGRG00000003536","ENSBGRT00000006580",9684,"AMMECR1L","AMMECR1 like [Source:HGNC Symbol;Acc:HGNC:28658]","NA","NA",{"v":3.2e-88,"d":"0.00"},2,"1112,23,","0,1808",{"v":-87.5,"d":"-87.50"},{"v":-85.8,"d":"-85.80"},{"v":10.7,"d":"10.70"},"3' UTR",2,145165039,145176553,11515,2]
["chr3",738013,745021,7009,"ENSBGRG00000011700","ENSBGRT00000021935",2304,"UBAP2L","ubiquitin associated protein 2 like [Source:HGNC Symbol;Acc:HGNC:29877]","GO:0005515(protein binding);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0007339(binding of sperm to zona pellucida);GO:0031519(PcG protein complex);GO:0034063(stress granule assembly);GO:0061484(hematopoietic stem cell homeostasis)","NA",{"v":1.3E-17,"d":"0.00"},3,"79,202,50,","0,6410,6959",{"v":-16.9,"d":"-16.90"},{"v":-15.9,"d":"-15.90"},1.72,"Exon (ENSBGRT00000021935/ENSBGRG00000011700, exon 3 of 25)",3,735709,776701,40993,1]
["chr3",2414185,2415151,967,"ENSBGRG00000021933","ENSBGRT00000040565",325,"ENSBGRG00000021933","NA","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","04080(Neuroactive ligand-receptor interaction);04926(Relaxin signaling pathway)",{"v":0.0012,"d":"0.00"},2,"120,353,","0,614",-2.91,-2.29,8.02,"Exon (ENSBGRT00000040565/ENSBGRG00000021933, exon 1 of 2)",3,2413860,2415475,1616,1]
["chr3",2692414,2692653,240,"ENSBGRG00000023097","ENSBGRT00000042668",18507,"SLC25A44","solute carrier family 25 member 44 [Source:HGNC Symbol;Acc:HGNC:29036]","GO:0005347(ATP transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":2E-92,"d":"0.00"},1,"240,",0,{"v":-91.7,"d":"-91.70"},-90,3.99,"3' UTR",3,2673907,2692653,18747,1]
["chr3",9662814,9663051,238,"ENSBGRG00000001772","ENSBGRT00000003265",128744,"ENSBGRG00000001772","NA","NA","04145(Phagosome);04662(B cell receptor signaling pathway);04666(Fc gamma R-mediated phagocytosis);04380(Osteoclast differentiation);05150(Staphylococcus aureus infection);05152(Tuberculosis);05162(Measles)",{"v":3.2e-10,"d":"0.00"},1,"238,",0,-9.49,-8.64,4.87,"3' UTR",3,9534070,9662877,128808,1]
["chr3",13640188,13727926,87739,"ENSBGRG00000003094","ENSBGRT00000005913",0,"PBX1","PBX homeobox 1 [Source:HGNC Symbol;Acc:HGNC:8632]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001655(urogenital system development);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008284(positive regulation of cell population proliferation);GO:0009887(animal organ morphogenesis);GO:0009952(anterior/posterior pattern specification);GO:0009954(proximal/distal pattern formation);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0030278(regulation of ossification);GO:0030325(adrenal gland development);GO:0030326(embryonic limb morphogenesis);GO:0035162(embryonic hemopoiesis);GO:0042127(regulation of cell population proliferation);GO:0043565(sequence-specific DNA binding);GO:0045665(negative regulation of neuron differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048536(spleen development);GO:0048538(thymus development);GO:0048568(embryonic organ development);GO:0048706(embryonic skeletal system development);GO:0090575(RNA polymerase II transcription factor complex);GO:1990837(sequence-specific double-stranded DNA binding)","04927(Cortisol synthesis and secretion);05202(Transcriptional misregulation in cancers);04934(Cushing syndrome)",{"v":1.3E-6,"d":"0.00"},3,"277,803,177,","0,77899,87562",-5.87,-5.12,8.02,"5' UTR",3,13718087,13792395,74309,1]
["chr3",16987343,16987433,91,"ENSBGRG00000006721","ENSBGRT00000012409",221390,"POU2F1","POU class 2 homeobox 1 [Source:HGNC Symbol;Acc:HGNC:9212]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0006355(regulation of transcription, DNA-templated);GO:0043231(intracellular membrane-bounded organelle);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0090575(RNA polymerase II transcription factor complex)","NA",{"v":0.0046,"d":"0.00"},1,"91,",0,-2.34,-1.76,3.76,"Exon (ENSBGRT00000012409/ENSBGRG00000006721, exon 17 of 17)",3,16765953,16987433,221481,1]
["chr3",19771524,19771700,177,"ENSBGRG00000013601","ENSBGRT00000024904",0,"NUDT17","nudix hydrolase 17 [Source:HGNC Symbol;Acc:HGNC:26618]","GO:0016787(hydrolase activity)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway)",{"v":0.0056,"d":"0.01"},1,"177,",0,-2.25,-1.67,2.42,"Exon (ENSBGRT00000024904/ENSBGRG00000013601, exon 1 of 8)",3,19771524,19778372,6849,1]
["chr3",20972168,20973004,837,"ENSBGRG00000000897","ENSBGRT00000001653",6353,"ECM1","extracellular matrix protein 1 [Source:HGNC Symbol;Acc:HGNC:3153]","GO:0001938(positive regulation of endothelial cell proliferation);GO:0001960(negative regulation of cytokine-mediated signaling pathway);GO:0002020(protease binding);GO:0002063(chondrocyte development);GO:0002828(regulation of type 2 immune response);GO:0003416(endochondral bone growth);GO:0005134(interleukin-2 receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0008022(protein C-terminus binding);GO:0010466(negative regulation of peptidase activity);GO:0019899(enzyme binding);GO:0030500(regulation of bone mineralization);GO:0030502(negative regulation of bone mineralization);GO:0043236(laminin binding);GO:0045766(positive regulation of angiogenesis);GO:0062023(collagen-containing extracellular matrix);GO:2000404(regulation of T cell migration)","NA",{"v":4e-44,"d":"0.00"},2,"53,367,","0,470",{"v":-43.4,"d":"-43.40"},{"v":-42.1,"d":"-42.10"},8.62,"3' UTR",3,20965815,20974443,8629,1]
["chr3",25956313,25957341,1029,"ENSBGRG00000006069","ENSBGRT00000011176",0,"ENSBGRG00000006069","NA","NA","04144(Endocytosis);04062(Chemokine signaling pathway);05032(Morphine addiction)",{"v":0.0032,"d":"0.00"},1,"1029,",0,{"v":-2.5,"d":"-2.50"},-1.91,11,"Exon (ENSBGRT00000011176/ENSBGRG00000006069, exon 1 of 1)",3,25956313,25957341,1029,1]
["chr3",37641279,37642418,1140,"ENSBGRG00000000439","ENSBGRT00000000734",5906,"ENSBGRG00000000439","NA","NA","03040(Spliceosome)",{"v":1e-112,"d":"0.00"},2,"6,887,","0,253",-112,-110,12,"3' UTR",3,37635373,37642983,7611,1]
["chr3",38214861,38215371,511,"ENSBGRG00000001203","ENSBGRT00000002276",722,"CELSR2","cadherin EGF LAG seven-pass G-type receptor 2 [Source:HGNC Symbol;Acc:HGNC:3231]","GO:0001764(neuron migration);GO:0003341(cilium movement);GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0021591(ventricular system development);GO:0021999(neural plate anterior/posterior regionalization);GO:0032880(regulation of protein localization);GO:0033326(cerebrospinal fluid secretion);GO:0060271(cilium assembly)","NA",{"v":5.2e-06,"d":"0.00"},1,"511,",0,-5.28,-4.55,7.27,"Exon (ENSBGRT00000002276/ENSBGRG00000001203, exon 2 of 36)",3,38214139,38240461,26323,1]
["chr3",39232266,39232446,181,"ENSBGRG00000002816","ENSBGRT00000005258",0,"SLC6A17","solute carrier family 6 member 17 [Source:HGNC Symbol;Acc:HGNC:31399]","GO:0005328(neurotransmitter:sodium symporter activity);GO:0005887(integral component of plasma membrane);GO:0007420(brain development);GO:0016021(integral component of membrane)","NA",{"v":0.0058,"d":"0.01"},1,"181,",0,-2.24,-1.66,4.01,"5' UTR",3,39232266,39279233,46968,1]
["chr3",43520516,43525024,4509,"ENSBGRG00000005851","ENSBGRT00000010915",298,"HIPK1","homeodomain interacting protein kinase 1 [Source:HGNC Symbol;Acc:HGNC:19006]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007224(smoothened signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0009952(anterior/posterior pattern specification);GO:0010803(regulation of tumor necrosis factor-mediated signaling pathway);GO:0010842(retina layer formation);GO:0016605(PML body);GO:0016607(nuclear speck);GO:0030182(neuron differentiation);GO:0034333(adherens junction assembly);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0048596(embryonic camera-type eye morphogenesis);GO:0060059(embryonic retina morphogenesis in camera-type eye);GO:0060235(lens induction in camera-type eye);GO:0061072(iris morphogenesis);GO:0072577(endothelial cell apoptotic process);GO:0097191(extrinsic apoptotic signaling pathway)","04218(Cellular senescence)",{"v":3.2e-29,"d":"0.00"},2,"40,916,","0,3593",{"v":-28.5,"d":"-28.50"},{"v":-27.3,"d":"-27.30"},9.63,"5' UTR",3,43520218,43566398,46181,1]
["chr3",45805891,45923211,117321,"ENSBGRG00000007927","ENSBGRT00000014508",0,"SLC22A15","solute carrier family 22 member 15 [Source:HGNC Symbol;Acc:HGNC:20301]","GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":0.035,"d":"0.04"},12,"602,213,133,165,130,216,141,86,121,73,189,90,","0,23102,64566,65337,76308,83099,88671,95767,112198,113814,116501,117231",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"5' UTR",3,45805891,45923211,117321,1]
["chr3",52857379,52858243,865,"ENSBGRG00000016412","ENSBGRT00000030145",0,"ENSBGRG00000016412","NA","GO:0003779(actin binding);GO:0005515(protein binding);GO:0031032(actomyosin structure organization)","00510(N-Glycan biosynthesis)",{"v":1e-44,"d":"0.00"},1,"865,",0,-44,{"v":-42.7,"d":"-42.70"},9.03,"5' UTR",3,52857379,52889001,31623,1]
["chr3",58722414,58724086,1673,"ENSBGRG00000002523","ENSBGRT00000004723",11001,"ENSBGRG00000002523","NA","NA","NA",{"v":0.0058,"d":"0.01"},2,"244,144,","0,1529",-2.24,-1.66,10,"Exon (ENSBGRT00000004723/ENSBGRG00000002523, exon 7 of 7)",3,58711413,58722657,11245,1]
["chr3",63568574,63570958,2385,"ENSBGRG00000000411","ENSBGRT00000000715",5468,"C1orf52","chromosome 1 open reading frame 52 [Source:HGNC Symbol;Acc:HGNC:24871]","GO:0005654(nucleoplasm)","NA",{"v":3.2e-45,"d":"0.00"},4,"44,44,44,137,","0,506,1697,2248",{"v":-44.5,"d":"-44.50"},{"v":-43.1,"d":"-43.10"},7.43,"3' UTR",3,63563106,63568617,5512,1]
["chr3",83495287,83507999,12713,"ENSBGRG00000008504","ENSBGRT00000015772",110197,"WLS","Wnt ligand secretion mediator [Source:HGNC Symbol;Acc:HGNC:30238]","GO:0005769(early endosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0030177(positive regulation of Wnt signaling pathway);GO:0031410(cytoplasmic vesicle);GO:0061355(Wnt protein secretion);GO:0061357(positive regulation of Wnt protein secretion);GO:0090263(positive regulation of canonical Wnt signaling pathway)","NA",{"v":6.3e-67,"d":"0.00"},3,"43,133,332,","0,4469,12381",{"v":-66.2,"d":"-66.20"},{"v":-64.7,"d":"-64.70"},2.24,"3' UTR",3,83385090,83507999,122910,1]
["chr3",90912639,90912847,209,"ENSBGRG00000022311","ENSBGRT00000042028",63653,"PATJ","PATJ crumbs cell polarity complex component [Source:HGNC Symbol;Acc:HGNC:28881]","GO:0005515(protein binding);GO:0045177(apical part of cell)","04390(Hippo signaling pathway);04530(Tight junction);05165(Human papillomavirus infection)",{"v":1.3E-54,"d":"0.00"},1,"209,",0,{"v":-53.9,"d":"-53.90"},{"v":-52.4,"d":"-52.40"},1.65,"Exon (ENSBGRT00000042351/ENSBGRG00000022922, exon 2 of 2)",3,90573250,90976500,403251,2]
["chr3",99440908,99441176,269,"ENSBGRG00000000886","ENSBGRT00000001695",34590,"DHCR24","24-dehydrocholesterol reductase [Source:HGNC Symbol;Acc:HGNC:2859]","GO:0000246(delta24(24-1) sterol reductase activity);GO:0005634(nucleus);GO:0005783(endoplasmic reticulum);GO:0006695(cholesterol biosynthetic process);GO:0006979(response to oxidative stress);GO:0008104(protein localization);GO:0008203(cholesterol metabolic process);GO:0009888(tissue development);GO:0016125(sterol metabolic process);GO:0016491(oxidoreductase activity);GO:0016628(oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor);GO:0019899(enzyme binding);GO:0030539(male genitalia development);GO:0031639(plasminogen activation);GO:0042605(peptide antigen binding);GO:0042987(amyloid precursor protein catabolic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043588(skin development);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process);GO:0061024(membrane organization);GO:0071949(FAD binding)","00100(Steroid biosynthesis)",{"v":3.2e-30,"d":"0.00"},1,"269,",0,{"v":-29.5,"d":"-29.50"},{"v":-28.3,"d":"-28.30"},2.09,"3' UTR",3,99406318,99441760,35443,1]
["chr3",102838156,102841099,2944,"ENSBGRG00000004115","ENSBGRT00000008792",20582,"NRDC","nardilysin convertase [Source:HGNC Symbol;Acc:HGNC:7995]","GO:0003824(catalytic activity);GO:0004222(metalloendopeptidase activity);GO:0005739(mitochondrion);GO:0006508(proteolysis);GO:0046872(metal ion binding);GO:0051044(positive regulation of membrane protein ectodomain proteolysis);GO:0052548(regulation of endopeptidase activity)","NA",{"v":6.3e-12,"d":"0.00"},3,"70,181,78,","0,94,2866",{"v":-11.2,"d":"-11.20"},{"v":-10.3,"d":"-10.30"},2.16,"Exon (ENSBGRT00000008792/ENSBGRG00000004115, exon 2 of 34)",3,102817574,102918289,100716,1]
["chr3",106161711,106197553,35843,"ENSBGRG00000000244","ENSBGRT00000000392",1339758,"BEND5","BEN domain containing 5 [Source:HGNC Symbol;Acc:HGNC:25668]","GO:0003677(DNA binding);GO:0004181(metallocarboxypeptidase activity);GO:0005794(Golgi apparatus);GO:0006508(proteolysis);GO:0008270(zinc ion binding);GO:0045892(negative regulation of transcription, DNA-templated)","04020(Calcium signaling pathway);04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04728(Dopaminergic synapse);03010(Ribosome);03420(Nucleotide excision repair)",{"v":6.3e-39,"d":"0.00"},5,"98,385,149,214,502,","0,2207,19546,25271,35341",{"v":-38.2,"d":"-38.20"},{"v":-36.9,"d":"-36.90"},{"v":11.5,"d":"11.50"},"3' UTR",3,104821953,106311814,1489862,1]
["chr3",109451312,109451871,560,"ENSBGRG00000002607","ENSBGRT00000004878",903,"CCDC17","coiled-coil domain containing 17 [Source:HGNC Symbol;Acc:HGNC:26574]","NA","NA",{"v":1.3e-12,"d":"0.00"},3,"3,84,212,","0,176,348",{"v":-11.9,"d":"-11.90"},-11,1.87,"Exon (ENSBGRT00000004878/ENSBGRG00000002607, exon 4 of 10)",3,109450409,109454579,4171,1]
["chr3",112076360,112076539,180,"ENSBGRG00000010964","ENSBGRT00000020042",388,"EBNA1BP2","EBNA1 binding protein 2 [Source:HGNC Symbol;Acc:HGNC:15531]","GO:0005730(nucleolus)","NA",{"v":1.1e-08,"d":"0.00"},1,"180,",0,-7.96,-7.15,2.82,"5' UTR",3,112075972,112085060,9089,1]
["chr3",115827251,115827663,413,"ENSBGRG00000000513","ENSBGRT00000000897",3878,"MYCL","MYCL proto-oncogene, bHLH transcription factor [Source:HGNC Symbol;Acc:HGNC:7555]","GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0042025(host cell nucleus);GO:0045607(regulation of inner ear auditory receptor cell differentiation);GO:0046983(protein dimerization activity)","NA",{"v":2E-3,"d":"0.00"},1,"413,",0,-2.69,-2.08,11,"Exon (ENSBGRT00000000897/ENSBGRG00000000513, exon 2 of 2)",3,115823373,115827663,4291,1]
["chr3",117973054,117974007,954,"ENSBGRG00000005914","ENSBGRT00000010928",3770,"YRDC","yrdC N6-threonylcarbamoyltransferase domain containing [Source:HGNC Symbol;Acc:HGNC:28905]","GO:0003725(double-stranded RNA binding);GO:0016020(membrane);GO:0051051(negative regulation of transport)","NA",{"v":2.5e-06,"d":"0.00"},1,"954,",0,{"v":-5.6,"d":"-5.60"},-4.86,10,"3' UTR",3,117969284,117975526,6243,1]
["chr3",119564664,119565032,369,"ENSBGRG00000007878","ENSBGRT00000014380",0,"LSM10","LSM10, U7 small nuclear RNA associated [Source:HGNC Symbol;Acc:HGNC:17562]","GO:0005654(nucleoplasm);GO:0005683(U7 snRNP);GO:0015030(Cajal body);GO:0016604(nuclear body);GO:0071208(histone pre-mRNA DCP binding);GO:0071209(U7 snRNA binding);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle)","NA",{"v":2.5e-20,"d":"0.00"},1,"369,",0,{"v":-19.6,"d":"-19.60"},{"v":-18.5,"d":"-18.50"},5.01,"Exon (ENSBGRT00000014380/ENSBGRG00000007878, exon 1 of 1)",3,119564664,119565032,369,1]
["chr3",120212429,120212846,418,"ENSBGRG00000010482","ENSBGRT00000019261",30334,"CLSPN","claspin [Source:HGNC Symbol;Acc:HGNC:19715]","GO:0000076(DNA replication checkpoint);GO:0000077(DNA damage checkpoint);GO:0000217(DNA secondary structure binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0010997(anaphase-promoting complex binding);GO:0018105(peptidyl-serine phosphorylation);GO:0032147(activation of protein kinase activity);GO:0033314(mitotic DNA replication checkpoint)","NA",{"v":6.3e-30,"d":"0.00"},1,"418,",0,{"v":-29.2,"d":"-29.20"},-28,8.36,"3' UTR",3,120182095,120212906,30812,1]
["chr3",127040651,127040917,267,"ENSBGRG00000017157","ENSBGRT00000031445",14913,"ACKR3","atypical chemokine receptor 3 [Source:HGNC Symbol;Acc:HGNC:23692]","GO:0001525(angiogenesis);GO:0001570(vasculogenesis);GO:0004930(G protein-coupled receptor activity);GO:0005044(scavenger receptor activity);GO:0005768(endosome);GO:0005886(plasma membrane);GO:0005905(clathrin-coated pit);GO:0006935(chemotaxis);GO:0007186(G protein-coupled receptor signaling pathway);GO:0009986(cell surface);GO:0015026(coreceptor activity);GO:0016021(integral component of membrane);GO:0016494(C-X-C chemokine receptor activity);GO:0019956(chemokine binding);GO:0019958(C-X-C chemokine binding);GO:0031623(receptor internalization);GO:0043231(intracellular membrane-bounded organelle);GO:0070098(chemokine-mediated signaling pathway);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:1902230(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","04060(Cytokine-cytokine receptor interaction)",{"v":1.6e-20,"d":"0.00"},1,"267,",0,{"v":-19.8,"d":"-19.80"},{"v":-18.8,"d":"-18.80"},3.95,"3' UTR",3,127025738,127041035,15298,1]
["chr3",127935564,127935624,61,"ENSBGRG00000017362","ENSBGRT00000031802",21605,"ENSBGRG00000017362","NA","NA","NA",{"v":0.011,"d":"0.01"},1,"61,",0,-1.97,-1.28,9.03,"Exon (ENSBGRT00000031802/ENSBGRG00000017362, exon 2 of 2)",3,127913959,127939007,25049,1]
["chr3",131140601,131141166,566,"ENSBGRG00000000315","ENSBGRT00000000629",13210,"CAPN10","calpain 10 [Source:HGNC Symbol;Acc:HGNC:1477]","GO:0004198(calcium-dependent cysteine-type endopeptidase activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0031532(actin cytoskeleton reorganization);GO:0032024(positive regulation of insulin secretion);GO:0032388(positive regulation of intracellular transport);GO:0032869(cellular response to insulin stimulus);GO:0046326(positive regulation of glucose import);GO:0097050(type B pancreatic cell apoptotic process);GO:2000676(positive regulation of type B pancreatic cell apoptotic process)","NA",{"v":4e-42,"d":"0.00"},2,"23,304,","0,262",{"v":-41.4,"d":"-41.40"},{"v":-40.1,"d":"-40.10"},5.36,"3' UTR",3,131127391,131141166,13776,1]
["chr3",129764,130635,872,"ENSBGRG00000006140","ENSBGRT00000011339",0,"S100A6","S100 calcium binding protein A6 [Source:HGNC Symbol;Acc:HGNC:10496]","GO:0001726(ruffle);GO:0005509(calcium ion binding);GO:0005523(tropomyosin binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0042803(protein homodimerization activity);GO:0044548(S100 protein binding);GO:0048306(calcium-dependent protein binding);GO:0048471(perinuclear region of cytoplasm)","04657(IL-17 signaling pathway)",{"v":2.5e-16,"d":"0.00"},4,"110,29,125,27,","0,158,485,845",{"v":-15.6,"d":"-15.60"},{"v":-14.6,"d":"-14.60"},{"v":7.4,"d":"7.40"},"Exon (ENSBGRT00000011339/ENSBGRG00000006140, exon 1 of 4)",3,129764,130635,872,2]
["chr3",1904043,1904133,91,"ENSBGRG00000020526","ENSBGRT00000037795",182476,"ASH1L","ASH1 like histone lysine methyltransferase [Source:HGNC Symbol;Acc:HGNC:19088]","GO:0001501(skeletal system development);GO:0002674(negative regulation of acute inflammatory response);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0007338(single fertilization);GO:0009791(post-embryonic development);GO:0010468(regulation of gene expression);GO:0018024(histone-lysine N-methyltransferase activity);GO:0030317(flagellated sperm motility);GO:0032635(interleukin-6 production);GO:0042800(histone methyltransferase activity (H3-K4 specific));GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043409(negative regulation of MAPK cascade);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046697(decidualization);GO:0046974(histone methyltransferase activity (H3-K9 specific));GO:0046975(histone methyltransferase activity (H3-K36 specific));GO:0048733(sebaceous gland development);GO:0050728(negative regulation of inflammatory response);GO:0051568(histone H3-K4 methylation);GO:0061038(uterus morphogenesis);GO:0097676(histone H3-K36 dimethylation);GO:1903699(tarsal gland development);GO:1903709(uterine gland development)","00310(Lysine degradation)",{"v":0.0055,"d":"0.01"},1,"91,",0,-2.26,-1.69,{"v":1.3,"d":"1.30"},"Exon (ENSBGRT00000037795/ENSBGRG00000020526, exon 26 of 27)",3,1903275,2086609,183335,2]
["chr3",2422803,2422923,121,"ENSBGRG00000022001","ENSBGRT00000041013",23915,"ARHGEF2","Rho/Rac guanine nucleotide exchange factor 2 [Source:HGNC Symbol;Acc:HGNC:682]","GO:0000132(establishment of mitotic spindle orientation);GO:0000902(cell morphogenesis);GO:0002102(podosome);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007015(actin filament organization);GO:0007026(negative regulation of microtubule depolymerization);GO:0008017(microtubule binding);GO:0014069(postsynaptic density);GO:0017048(Rho GTPase binding);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031982(vesicle);GO:0032587(ruffle membrane);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0032991(protein-containing complex);GO:0035023(regulation of Rho protein signal transduction);GO:0035556(intracellular signal transduction);GO:0043025(neuronal cell body);GO:0043198(dendritic shaft);GO:0045666(positive regulation of neuron differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048365(Rac GTPase binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050768(negative regulation of neurogenesis);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0055059(asymmetric neuroblast division);GO:0071225(cellular response to muramyl dipeptide);GO:0071802(negative regulation of podosome assembly);GO:2001224(positive regulation of neuron migration)","04530(Tight junction);05418(Fluid shear stress and atherosclerosis)",{"v":0.0011,"d":"0.00"},1,"121,",0,-2.94,-2.32,1.38,"Exon (ENSBGRT00000041013/ENSBGRG00000022001, exon 20 of 22)",3,2421409,2446838,25430,2]
["chr3",3180923,3185505,4583,"ENSBGRG00000024887","ENSBGRT00000045937",4334,"NES","nestin [Source:HGNC Symbol;Acc:HGNC:7756]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0005737(cytoplasm);GO:0005882(intermediate filament);GO:0007399(nervous system development);GO:0019215(intermediate filament binding);GO:0032091(negative regulation of protein binding);GO:0043086(negative regulation of catalytic activity);GO:0043524(negative regulation of neuron apoptotic process);GO:0045111(intermediate filament cytoskeleton);GO:0048858(cell projection morphogenesis);GO:0072089(stem cell proliferation)","NA",0,2,"1011,3062,","0,1521",-1070,"-Inf",{"v":30.4,"d":"30.40"},"Exon (ENSBGRT00000045937/ENSBGRG00000024887, exon 4 of 5)",3,3180923,3189839,8917,2]
["chr3",9059580,9066456,6877,"ENSBGRG00000000881","ENSBGRT00000001626",0,"ARHGAP30","Rho GTPase activating protein 30 [Source:HGNC Symbol;Acc:HGNC:27414]","GO:0007165(signal transduction);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":0.046,"d":"0.05"},2,"24,97,","0,6780",-1.34,{"v":-0.843,"d":"-0.84"},3.51,"Exon (ENSBGRT00000001626/ENSBGRG00000000881, exon 1 of 13)",3,9047257,9066456,19200,2]
["chr3",12859770,12860095,326,"ENSBGRG00000002940","ENSBGRT00000005515",0,"ENSBGRG00000002940","NA","NA","04514(Cell adhesion molecules (CAMs));04145(Phagosome);04810(Regulation of actin cytoskeleton)",{"v":0.0058,"d":"0.01"},1,"326,",0,-2.24,-1.66,10,"Exon (ENSBGRT00000005515/ENSBGRG00000002940, exon 1 of 3)",3,12761638,12860095,98458,2]
["chr3",19799192,19799401,210,"ENSBGRG00000013826","ENSBGRT00000025532",12477,"ANKRD35","ankyrin repeat domain 35 [Source:HGNC Symbol;Acc:HGNC:26323]","GO:0005515(protein binding)","NA",{"v":1.9e-05,"d":"0.00"},1,"210,",0,-4.73,-4.02,5.82,"Exon (ENSBGRT00000025532/ENSBGRG00000013826, exon 10 of 13)",3,19793975,19811878,17904,2]
["chr3",20277086,20308362,31277,"ENSBGRG00000016034","ENSBGRT00000029506",0,"H2BC18","H2B clustered histone 18 [Source:HGNC Symbol;Acc:HGNC:24700]","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0046982(protein heterodimerization activity)","05203(Viral carcinogenesis);05322(Systemic lupus erythematosus);05034(Alcoholism)",{"v":0.019,"d":"0.02"},2,"19,377,","0,30900",-1.71,{"v":-0.901,"d":"-0.90"},8.02,"3' UTR",3,20277086,20308362,31277,2]
["chr3",21556527,21557215,689,"ENSBGRG00000001699","ENSBGRT00000003148",10393,"SEMA6C","semaphorin 6C [Source:HGNC Symbol;Acc:HGNC:10740]","GO:0005515(protein binding);GO:0030215(semaphorin receptor binding)","04360(Axon guidance)",{"v":2.5e-11,"d":"0.00"},1,"689,",0,{"v":-10.6,"d":"-10.60"},-9.75,{"v":4.1,"d":"4.10"},"Exon (ENSBGRT00000003148/ENSBGRG00000001699, exon 18 of 18)",3,21556347,21567608,11262,2]
["chr3",37986685,37994985,8301,"ENSBGRG00000000773","ENSBGRT00000001687",0,"WDR47","WD repeat domain 47 [Source:HGNC Symbol;Acc:HGNC:29141]","GO:0005515(protein binding)","03013(RNA transport)",{"v":0.046,"d":"0.05"},4,"58,84,104,84,","0,3726,6010,8217",-1.34,{"v":-0.843,"d":"-0.84"},3.34,"5' UTR",3,37951334,37992798,41465,2]
["chr3",40174074,40174312,239,"ENSBGRG00000003232","ENSBGRT00000006001",2096,"LRIF1","ligand dependent nuclear receptor interacting factor 1 [Source:HGNC Symbol;Acc:HGNC:30299]","GO:0000784(nuclear chromosome, telomeric region);GO:0001740(Barr body);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0009048(dosage compensation by inactivation of X chromosome);GO:0034451(centriolar satellite);GO:0042974(retinoic acid receptor binding)","NA",{"v":0.011,"d":"0.01"},1,"239,",0,-1.94,-1.39,1.73,"Exon (ENSBGRT00000006001/ENSBGRG00000003232, exon 2 of 4)",3,40170067,40176408,6342,2]
["chr3",42452546,42453143,598,"ENSBGRG00000004446","ENSBGRT00000008188",25846,"SLC16A1","solute carrier family 16 member 1 [Source:HGNC Symbol;Acc:HGNC:10922]","GO:0005887(integral component of plasma membrane);GO:0008028(monocarboxylic acid transmembrane transporter activity);GO:0015129(lactate transmembrane transporter activity);GO:0015718(monocarboxylic acid transport);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":6.3E-58,"d":"0.00"},1,"598,",0,{"v":-57.2,"d":"-57.20"},{"v":-55.7,"d":"-55.70"},6.48,"Exon (ENSBGRT00000008188/ENSBGRG00000004446, exon 4 of 6)",3,42318443,42478989,160547,2]
["chr3",49821932,49822711,780,"ENSBGRG00000012328","ENSBGRT00000022559",570,"ENSBGRG00000012328","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.035,"d":"0.04"},1,"780,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000022559/ENSBGRG00000012328, exon 1 of 1)",3,49821932,49823281,1350,2]
["chr3",54719963,54730177,10215,"ENSBGRG00000000861","ENSBGRT00000001574",0,"CCDC18","coiled-coil domain containing 18 [Source:HGNC Symbol;Acc:HGNC:30370]","NA","NA",{"v":0.046,"d":"0.05"},3,"80,175,136,","0,9398,10079",-1.34,{"v":-0.843,"d":"-0.84"},4.01,"5' UTR",3,54614437,54730177,115741,2]
["chr3",55754293,55764978,10686,"ENSBGRG00000001711","ENSBGRT00000003268",78289,"BTBD8","BTB domain containing 8 [Source:HGNC Symbol;Acc:HGNC:21019]","GO:0005515(protein binding);GO:0030122(AP-2 adaptor complex);GO:0150007(clathrin-dependent synaptic vesicle endocytosis)","NA",{"v":0.00045,"d":"0.00"},3,"398,62,50,","0,7645,10636",-3.35,{"v":-2.7,"d":"-2.70"},5.26,"Exon (ENSBGRT00000003268/ENSBGRG00000001711, exon 12 of 18)",3,55747768,55843267,95500,2]
["chr3",61840757,61840847,91,"ENSBGRG00000004071","ENSBGRT00000007736",45290,"SH3GLB1","SH3 domain containing GRB2 like, endophilin B1 [Source:HGNC Symbol;Acc:HGNC:10833]","GO:0005504(fatty acid binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006654(phosphatidic acid biosynthetic process);GO:0008654(phospholipid biosynthetic process);GO:0010508(positive regulation of autophagy);GO:0016020(membrane);GO:0032991(protein-containing complex);GO:0042171(lysophosphatidic acid acyltransferase activity);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0048102(autophagic cell death);GO:0051084('de novo' posttranslational protein folding);GO:1900740(positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:1903778(protein localization to vacuolar membrane);GO:2000786(positive regulation of autophagosome assembly)","04144(Endocytosis);04140(Autophagy - animal)",{"v":6.6E-4,"d":"0.00"},1,"91,",0,-3.18,-2.54,1.54,"Exon (ENSBGRT00000007736/ENSBGRG00000004071, exon 10 of 10)",3,61840668,61886137,45470,2]
["chr3",72072699,72081331,8633,"ENSBGRG00000002265","ENSBGRT00000004223",0,"DNAJB4","DnaJ heat shock protein family (Hsp40) member B4 [Source:HGNC Symbol;Acc:HGNC:14886]","GO:0001671(ATPase activator activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006457(protein folding);GO:0051082(unfolded protein binding);GO:0051087(chaperone binding)","NA",0,3,"405,569,242,","0,1794,8391",-334,"-Inf",3.75,"5' UTR",3,72072699,72081331,8633,2]
["chr3",91227544,91248603,21060,"ENSBGRG00000023087","ENSBGRT00000042595",410,"ENSBGRG00000023087","NA","GO:0002138(retinoic acid biosynthetic process);GO:0005829(cytosol);GO:0006776(vitamin A metabolic process);GO:0008289(lipid binding)","00760(Nicotinate and nicotinamide metabolism)",{"v":0.011,"d":"0.01"},2,"226,185,","0,20875",-1.97,-1.19,9.03,"3' UTR",3,91227544,91249013,21470,2]
["chr3",100258642,100260052,1411,"ENSBGRG00000001607","ENSBGRT00000002985",0,"TCEANC2","transcription elongation factor A N-terminal and central domain containing 2 [Source:HGNC Symbol;Acc:HGNC:26494]","GO:0005634(nucleus);GO:0006351(transcription, DNA-templated)","NA",{"v":9.3e-06,"d":"0.00"},2,"80,545,","0,866",-5.03,{"v":-4.3,"d":"-4.30"},{"v":18.1,"d":"18.10"},"5' UTR",3,100213918,100260052,46135,2]
["chr3",102443765,102444484,720,"ENSBGRG00000003793","ENSBGRT00000007025",4877,"ZFYVE9","zinc finger FYVE-type containing 9 [Source:HGNC Symbol;Acc:HGNC:6775]","GO:0005545(1-phosphatidylinositol binding);GO:0005829(cytosol);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0019904(protein domain specific binding);GO:0031901(early endosome membrane);GO:0032991(protein-containing complex);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding)","04350(TGF-beta signaling pathway);04144(Endocytosis)",{"v":3.2e-25,"d":"0.00"},1,"720,",0,{"v":-24.5,"d":"-24.50"},{"v":-23.4,"d":"-23.40"},5.56,"5' UTR",3,102343318,102449361,106044,2]
["chr3",110286551,110286640,90,"ENSBGRG00000003896","ENSBGRT00000007183",957,"RPS8","ribosomal protein S8 [Source:HGNC Symbol;Acc:HGNC:10441]","GO:0003735(structural constituent of ribosome);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005840(ribosome);GO:0006412(translation);GO:0022627(cytosolic small ribosomal subunit);GO:1990904(ribonucleoprotein complex)","03010(Ribosome)",{"v":1e-105,"d":"0.00"},1,"90,",0,-105,-103,2.83,"Exon (ENSBGRT00000007297/ENSBGRG00000003896, exon 2 of 6)",3,110282610,110287597,4988,2]
["chr3",111685676,111693990,8315,"ENSBGRG00000008962","ENSBGRT00000016442",0,"PTPRF","protein tyrosine phosphatase receptor type F [Source:HGNC Symbol;Acc:HGNC:9670]","GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005515(protein binding);GO:0006470(protein dephosphorylation);GO:0010975(regulation of neuron projection development);GO:0016311(dephosphorylation);GO:0016477(cell migration);GO:0016791(phosphatase activity);GO:0031102(neuron projection regeneration);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0035373(chondroitin sulfate proteoglycan binding);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0044877(protein-containing complex binding);GO:0048679(regulation of axon regeneration);GO:0050839(cell adhesion molecule binding);GO:1900121(negative regulation of receptor binding)","04514(Cell adhesion molecules (CAMs));04520(Adherens junction);04910(Insulin signaling pathway);04931(Insulin resistance)",{"v":0.00013,"d":"0.00"},2,"40,290,","0,8025",-3.87,{"v":-3.2,"d":"-3.20"},7.02,"5' UTR",3,111598678,111693990,95313,2]
["chr3",112684697,112684874,178,"ENSBGRG00000011933","ENSBGRT00000021774",2948,"ENSBGRG00000011933","NA","GO:0005515(protein binding)","NA",{"v":0.0083,"d":"0.01"},1,"178,",0,-2.08,-1.52,3.41,"3' UTR",3,112684195,112687822,3628,2]
["chr3",115274767,115275217,451,"ENSBGRG00000017070","ENSBGRT00000031317",0,"ENSBGRG00000017070","NA","NA","NA",{"v":0.019,"d":"0.02"},1,"451,",0,-1.72,-1.19,8.02,"Exon (ENSBGRT00000031317/ENSBGRG00000017070, exon 1 of 1)",3,115274108,115275217,1110,2]
["chr3",116372071,116372580,510,"ENSBGRG00000001404","ENSBGRT00000008991",116622,"MACF1","microtubule actin crosslinking factor 1 [Source:HGNC Symbol;Acc:HGNC:13664]","GO:0003779(actin binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0007010(cytoskeleton organization);GO:0008017(microtubule binding);GO:0008092(cytoskeletal protein binding);GO:0030334(regulation of cell migration);GO:0032587(ruffle membrane);GO:0032886(regulation of microtubule-based process);GO:0043001(Golgi to plasma membrane protein transport);GO:0045104(intermediate filament cytoskeleton organization);GO:0045773(positive regulation of axon extension);GO:0051011(microtubule minus-end binding);GO:0051015(actin filament binding);GO:0051893(regulation of focal adhesion assembly)","NA",{"v":5e-05,"d":"0.00"},1,"510,",0,{"v":-4.3,"d":"-4.30"},{"v":-3.6,"d":"-3.60"},10,"Exon (ENSBGRT00000008845/ENSBGRG00000001404, exon 38 of 103)",3,116231746,116489202,257457,2]
["chr3",121158609,121158728,120,"ENSBGRG00000007563","ENSBGRT00000013827",1303,"GJA4","gap junction protein alpha 4 [Source:HGNC Symbol;Acc:HGNC:4278]","GO:0001568(blood vessel development);GO:0005922(connexin complex);GO:0007154(cell communication)","NA",{"v":1.2E-5,"d":"0.00"},1,"120,",0,-4.91,{"v":-4.2,"d":"-4.20"},2.45,"3' UTR",3,121157648,121160031,2384,2]
["chr3",126840034,126894410,54377,"ENSBGRG00000016792","ENSBGRT00000030907",64504,"IQCA1","IQ motif containing with AAA domain 1 [Source:HGNC Symbol;Acc:HGNC:26195]","GO:0005515(protein binding);GO:0005524(ATP binding)","00061(Fatty acid biosynthesis)",{"v":1.2E-10,"d":"0.00"},4,"26,123,85,5,","0,11103,25982,54372",-9.91,-9.06,2.71,"Exon (ENSBGRT00000030907/ENSBGRG00000016792, exon 6 of 19)",3,126745695,126958914,213220,2]
["chr3",131124168,131124765,598,"ENSBGRG00000000296","ENSBGRT00000000461",1839,"ENSBGRG00000000296","NA","NA","NA",{"v":5.8e-06,"d":"0.00"},1,"598,",0,-5.24,-4.51,13,"Exon (ENSBGRT00000000461/ENSBGRG00000000296, exon 2 of 2)",3,131123481,131126604,3124,2]
["chr4",7164454,7205419,40966,"ENSBGRG00000012528","ENSBGRT00000022900",0,"ENSBGRG00000012528","NA","GO:0006511(ubiquitin-dependent protein catabolic process);GO:0031461(cullin-RING ubiquitin ligase complex);GO:0031625(ubiquitin protein ligase binding)","04141(Protein processing in endoplasmic reticulum);04120(Ubiquitin mediated proteolysis);04310(Wnt signaling pathway);04340(Hedgehog signaling pathway);04350(TGF-beta signaling pathway);04110(Cell cycle);04114(Oocyte meiosis);04710(Circadian rhythm);05200(Pathways in cancer);05168(Herpes simplex infection)",{"v":1e-09,"d":"0.00"},2,"344,226,","0,40740",-9,-8.17,11,"5' UTR",4,7164454,7268379,103926,1]
["chr4",8048562,8050373,1812,"ENSBGRG00000017837","ENSBGRT00000032753",8251,"ZNF862","zinc finger protein 862 [Source:HGNC Symbol;Acc:HGNC:34519]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated);GO:0046983(protein dimerization activity)","NA",{"v":1.3E-13,"d":"0.00"},2,"91,599,","0,1213",{"v":-12.9,"d":"-12.90"},-12,4.96,"Exon (ENSBGRT00000032753/ENSBGRG00000017837, exon 3 of 8)",4,8040311,8075633,35323,1]
["chr4",8156114,8156740,627,"ENSBGRG00000018198","ENSBGRT00000033290",2818,"REPIN1","replication initiator 1 [Source:HGNC Symbol;Acc:HGNC:17922]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005654(nucleoplasm)","NA",{"v":2e-22,"d":"0.00"},1,"627,",0,{"v":-21.7,"d":"-21.70"},{"v":-20.7,"d":"-20.70"},{"v":4.9,"d":"4.90"},"Exon (ENSBGRT00000033290/ENSBGRG00000018198, exon 2 of 4)",4,8153296,8158582,5287,1]
["chr4",8753863,8755372,1510,"ENSBGRG00000004423","ENSBGRT00000008848",0,"NOS3","nitric oxide synthase 3 [Source:HGNC Symbol;Acc:HGNC:7876]","GO:0003100(regulation of systemic arterial blood pressure by endothelin);GO:0003785(actin monomer binding);GO:0004517(nitric-oxide synthase activity);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006527(arginine catabolic process);GO:0006809(nitric oxide biosynthetic process);GO:0010181(FMN binding);GO:0016491(oxidoreductase activity);GO:0019430(removal of superoxide radicals);GO:0020037(heme binding);GO:0031284(positive regulation of guanylate cyclase activity);GO:0034405(response to fluid shear stress);GO:0034617(tetrahydrobiopterin binding);GO:0034618(arginine binding);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0043542(endothelial cell migration);GO:0045766(positive regulation of angiogenesis);GO:0050660(flavin adenine dinucleotide binding);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process)","00220(Arginine biosynthesis);00330(Arginine and proline metabolism);04370(VEGF signaling pathway);04371(Apelin signaling pathway);04066(HIF-1 signaling pathway);04020(Calcium signaling pathway);04071(Sphingolipid signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04611(Platelet activation);04915(Estrogen signaling pathway);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);05418(Fluid shear stress and atherosclerosis);04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications)",{"v":5.1E-5,"d":"0.00"},2,"158,53,","0,1457",-4.29,{"v":-3.6,"d":"-3.60"},{"v":3.9,"d":"3.90"},"Exon (ENSBGRT00000008848/ENSBGRG00000004423, exon 1 of 26)",4,8753863,8772427,18565,1]
["chr4",10577856,10578513,658,"ENSBGRG00000008613","ENSBGRT00000015714",82985,"ENSBGRG00000008613","NA","GO:0005524(ATP binding);GO:0005885(Arp2/3 protein complex);GO:0007015(actin filament organization);GO:0034314(Arp2/3 complex-mediated actin nucleation)","04530(Tight junction)",{"v":3.2e-45,"d":"0.00"},1,"658,",0,{"v":-44.5,"d":"-44.50"},{"v":-43.2,"d":"-43.20"},3.53,"3' UTR",4,10494871,10578513,83643,1]
["chr4",18446405,18446764,360,"ENSBGRG00000001427","ENSBGRT00000002695",223960,"HIPK2","homeodomain interacting protein kinase 2 [Source:HGNC Symbol;Acc:HGNC:14402]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001934(positive regulation of protein phosphorylation);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0006978(DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007224(smoothened signaling pathway);GO:0007628(adult walking behavior);GO:0008284(positive regulation of cell population proliferation);GO:0008344(adult locomotory behavior);GO:0009952(anterior/posterior pattern specification);GO:0010842(retina layer formation);GO:0016604(nuclear body);GO:0016605(PML body);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0030182(neuron differentiation);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0030514(negative regulation of BMP signaling pathway);GO:0032092(positive regulation of protein binding);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0043388(positive regulation of DNA binding);GO:0043524(negative regulation of neuron apoptotic process);GO:0045766(positive regulation of angiogenesis);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046330(positive regulation of JNK cascade);GO:0046332(SMAD binding);GO:0046790(virion binding);GO:0048596(embryonic camera-type eye morphogenesis);GO:0050882(voluntary musculoskeletal movement);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060059(embryonic retina morphogenesis in camera-type eye);GO:0060235(lens induction in camera-type eye);GO:0060395(SMAD protein signal transduction);GO:0061072(iris morphogenesis);GO:0090575(RNA polymerase II transcription factor complex);GO:2000059(negative regulation of ubiquitin-dependent protein catabolic process)","04218(Cellular senescence)",{"v":5.8e-06,"d":"0.00"},1,"360,",0,-5.24,-4.51,14,"3' UTR",4,18222445,18446764,224320,1]
["chr4",22831349,22831737,389,"ENSBGRG00000003642","ENSBGRT00000006782",80323,"ENSBGRG00000003642","NA","GO:0016020(membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":3.2e-88,"d":"0.00"},1,"389,",0,{"v":-87.5,"d":"-87.50"},{"v":-85.8,"d":"-85.80"},4.53,"3' UTR",4,22751026,22831737,80712,1]
["chr4",30339233,30339443,211,"ENSBGRG00000023300","ENSBGRT00000043619",375944,"SND1","staphylococcal nuclease and tudor domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30646]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0004518(nuclease activity);GO:0004519(endonuclease activity);GO:0004521(endoribonuclease activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0010564(regulation of cell cycle process);GO:0010587(miRNA catabolic process);GO:0016442(RISC complex);GO:0031047(gene silencing by RNA);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic);GO:0097433(dense body);GO:1905172(RISC complex binding)","05203(Viral carcinogenesis);05169(Epstein-Barr virus infection)",{"v":0.00026,"d":"0.00"},1,"211,",0,-3.59,-2.93,15,"Exon (ENSBGRT00000043686/ENSBGRG00000023653, exon 2 of 3)",4,30267824,30715387,447564,2]
["chr4",42360357,42364236,3880,"ENSBGRG00000009045","ENSBGRT00000016565",320,"YAE1","YAE1 maturation factor of ABCE1 [Source:HGNC Symbol;Acc:HGNC:24857]","GO:0106035(protein maturation by [4Fe-4S] cluster transfer)","NA",{"v":1.3e-44,"d":"0.00"},5,"34,84,35,428,2,","0,1464,1550,3449,3878",{"v":-43.9,"d":"-43.90"},{"v":-42.6,"d":"-42.60"},3.01,"Exon (ENSBGRT00000016565/ENSBGRG00000009045, exon 1 of 5)",4,42360037,42364236,4200,1]
["chr4",47401502,47401862,361,"ENSBGRG00000017173","ENSBGRT00000031582",10940,"ZMIZ2","zinc finger MIZ-type containing 2 [Source:HGNC Symbol;Acc:HGNC:22229]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008270(zinc ion binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0043596(nuclear replication fork);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":2e-65,"d":"0.00"},1,"361,",0,{"v":-64.7,"d":"-64.70"},{"v":-63.2,"d":"-63.20"},3.04,"3' UTR",4,47390562,47401862,11301,1]
["chr4",52224440,52230047,5608,"ENSBGRG00000020969","ENSBGRT00000038624",22243,"STEAP4","STEAP4 metalloreductase [Source:HGNC Symbol;Acc:HGNC:21923]","GO:0005654(nucleoplasm);GO:0005768(endosome);GO:0005886(plasma membrane);GO:0008823(cupric reductase activity);GO:0009055(electron transfer activity);GO:0015677(copper ion import);GO:0016021(integral component of membrane);GO:0020037(heme binding);GO:0045444(fat cell differentiation);GO:0052851(ferric-chelate reductase (NADPH) activity);GO:0055114(oxidation-reduction process);GO:0070207(protein homotrimerization);GO:0071949(FAD binding);GO:0098706(iron ion import across cell outer membrane)","NA",{"v":0.0032,"d":"0.00"},6,"335,234,84,237,165,111,","0,954,1190,1276,3940,5497",{"v":-2.5,"d":"-2.50"},-1.91,11,"Exon (ENSBGRT00000038624/ENSBGRG00000020969, exon 3 of 6)",4,52202197,52225952,23756,1]
["chr4",59916816,59917114,299,"ENSBGRG00000003692","ENSBGRT00000006858",130522,"MINDY4","MINDY lysine 48 deubiquitinase 4 [Source:HGNC Symbol;Acc:HGNC:21916]","NA","NA",{"v":1.3e-12,"d":"0.00"},1,"299,",0,{"v":-11.9,"d":"-11.90"},-11,3.12,"3' UTR",4,59786294,59918724,132431,1]
["chr4",64590998,64608130,17133,"ENSBGRG00000000345","ENSBGRT00000000550",0,"ENSBGRG00000000345","NA","NA","NA",0,5,"11,126,136,140,111,","0,4608,10205,15872,17022",-415,"-Inf",3.18,"5' UTR",4,64590998,64608421,17424,1]
["chr4",80649190,80659992,10803,"ENSBGRG00000008910","ENSBGRT00000016322",0,"PUS7","pseudouridine synthase 7 [Source:HGNC Symbol;Acc:HGNC:26033]","GO:0001522(pseudouridine synthesis);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0009451(RNA modification);GO:0009982(pseudouridine synthase activity);GO:0017148(negative regulation of translation);GO:0019899(enzyme binding);GO:0031119(tRNA pseudouridine synthesis);GO:1902036(regulation of hematopoietic stem cell differentiation);GO:1990481(mRNA pseudouridine synthesis);GO:2000380(regulation of mesoderm development)","NA",{"v":0.019,"d":"0.02"},2,"127,82,","0,10721",-1.72,-1.19,5.01,"5' UTR",4,80649190,80705932,56743,1]
["chr4",83265619,83290357,24739,"ENSBGRG00000011795","ENSBGRT00000023906",130625,"FBXL13","F-box and leucine rich repeat protein 13 [Source:HGNC Symbol;Acc:HGNC:21658]","GO:0005515(protein binding)","NA",{"v":7.9e-05,"d":"0.00"},3,"56,99,55,","0,24038,24684",{"v":-4.1,"d":"-4.10"},-3.42,3.01,"Exon (ENSBGRT00000023906/ENSBGRG00000011795, exon 12 of 20)",4,83134994,83360516,225523,1]
["chr4",99714560,99715360,801,"ENSBGRG00000001608","ENSBGRT00000002999",10298,"TWISTNB","TWIST neighbor [Source:HGNC Symbol;Acc:HGNC:18027]","GO:0006351(transcription, DNA-templated)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase)",{"v":2.5e-59,"d":"0.00"},1,"801,",0,{"v":-58.6,"d":"-58.60"},{"v":-57.2,"d":"-57.20"},9.03,"3' UTR",4,99704262,99715425,11164,1]
["chr4",116178826,116178975,150,"ENSBGRG00000008346","ENSBGRT00000015470",264664,"SLC25A13","solute carrier family 25 member 13 [Source:HGNC Symbol;Acc:HGNC:10983]","GO:0005313(L-glutamate transmembrane transporter activity);GO:0005347(ATP transmembrane transporter activity);GO:0005509(calcium ion binding);GO:0005739(mitochondrion);GO:0006754(ATP biosynthetic process);GO:0015183(L-aspartate transmembrane transporter activity);GO:0015810(aspartate transmembrane transport);GO:0015813(L-glutamate transmembrane transport);GO:0042802(identical protein binding);GO:0043490(malate-aspartate shuttle);GO:0045333(cellular respiration);GO:0051592(response to calcium ion);GO:0055085(transmembrane transport)","NA",{"v":0.0056,"d":"0.01"},1,"150,",0,-2.25,-1.67,2.42,"Exon (ENSBGRT00000015470/ENSBGRG00000008346, exon 18 of 18)",4,115914162,116178975,264814,1]
["chr4",124991389,124991778,390,"ENSBGRG00000021550","ENSBGRT00000040083",107121,"IKZF1","IKAROS family zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:13176]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0019904(protein domain specific binding);GO:0030098(lymphocyte differentiation);GO:0030218(erythrocyte differentiation);GO:0031618(nuclear pericentric heterochromatin);GO:0032991(protein-containing complex)","NA",{"v":0.011,"d":"0.01"},1,"390,",0,-1.97,-1.14,9.03,"Exon (ENSBGRT00000040083/ENSBGRG00000021550, exon 8 of 8)",4,124884268,124991778,107511,1]
["chr4",1787306,1808696,21391,"ENSBGRG00000010707","ENSBGRT00000019574",0,"ENSBGRG00000010707","NA","NA","04115(p53 signaling pathway)",{"v":2.5e-47,"d":"0.00"},2,"361,597,","0,20794",{"v":-46.6,"d":"-46.60"},{"v":-45.3,"d":"-45.30"},{"v":21.8,"d":"21.80"},"3' UTR",4,1796677,1798591,1915,2]
["chr4",8116805,8117420,616,"ENSBGRG00000017959","ENSBGRT00000032880",1928,"ENSBGRG00000017959","NA","GO:0005102(signaling receptor binding);GO:0006954(inflammatory response);GO:0050994(regulation of lipid catabolic process)","NA",{"v":1e-307,"d":"0.00"},3,"123,129,48,","0,262,568",-307,-304,2.73,"3' UTR",4,8114879,8119348,4470,2]
["chr4",9041111,9076667,35557,"ENSBGRG00000006961","ENSBGRT00000013157",0,"SMARCD3","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 [Source:HGNC Symbol;Acc:HGNC:11108]","GO:0000790(nuclear chromatin);GO:0002052(positive regulation of neuroblast proliferation);GO:0003007(heart morphogenesis);GO:0003139(secondary heart field specification);GO:0003219(cardiac right ventricle formation);GO:0003407(neural retina development);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0006351(transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0016514(SWI/SNF complex);GO:0035257(nuclear hormone receptor binding);GO:0042692(muscle cell differentiation);GO:0043393(regulation of protein binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0071564(npBAF complex);GO:0071565(nBAF complex)","04714(Thermogenesis);05225(Hepatocellular carcinoma)",{"v":6.3e-19,"d":"0.00"},3,"64,78,39,","0,2905,35518",{"v":-18.2,"d":"-18.20"},{"v":-17.2,"d":"-17.20"},3.61,"Exon (ENSBGRT00000013157/ENSBGRG00000006961, exon 1 of 13)",4,9032763,9044093,11331,2]
["chr4",17337021,17341843,4823,"ENSBGRG00000000551","ENSBGRT00000000980",9344,"ADCK2","aarF domain containing kinase 2 [Source:HGNC Symbol;Acc:HGNC:19039]","NA","NA",{"v":2.5e-11,"d":"0.00"},2,"405,42,","0,4781",{"v":-10.6,"d":"-10.60"},-9.71,3.01,"3' UTR",4,17336991,17351187,14197,2]
["chr4",18710172,18713165,2994,"ENSBGRG00000001662","ENSBGRT00000003160",39632,"UBN2","ubinuclein 2 [Source:HGNC Symbol;Acc:HGNC:21931]","GO:0005634(nucleus);GO:0005654(nucleoplasm)","NA",{"v":0.00019,"d":"0.00"},3,"317,104,28,","0,2205,2966",-3.71,-3.04,9.03,"Exon (ENSBGRT00000003160/ENSBGRG00000001662, exon 4 of 15)",4,18661029,18752797,91769,2]
["chr4",29243494,29243937,444,"ENSBGRG00000008318","ENSBGRT00000016568",50812,"AHCYL2","adenosylhomocysteinase like 2 [Source:HGNC Symbol;Acc:HGNC:22204]","GO:0004013(adenosylhomocysteinase activity);GO:0005829(cytosol);GO:0043005(neuron projection);GO:0043231(intracellular membrane-bounded organelle)","00270(Cysteine and methionine metabolism)",{"v":1e-121,"d":"0.00"},1,"444,",0,-121,-119,4.36,"Exon (ENSBGRT00000017507/ENSBGRG00000009523, exon 3 of 3)",4,29087002,29294749,207748,2]
["chr4",37772417,37777519,5103,"ENSBGRG00000026200","ENSBGRT00000048464",0,"ENSBGRG00000026200","NA","NA","NA",{"v":2.5E-80,"d":"0.00"},3,"432,39,97,","0,3958,5006",{"v":-79.6,"d":"-79.60"},-78,6.57,"3' UTR",4,37773405,37774460,1056,1]
["chr4",46981868,46982258,391,"ENSBGRG00000012404","ENSBGRT00000024209",110841,"CAMK2B","calcium/calmodulin dependent protein kinase II beta [Source:HGNC Symbol;Acc:HGNC:1461]","GO:0004672(protein kinase activity);GO:0004683(calmodulin-dependent protein kinase activity);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005954(calcium- and calmodulin-dependent protein kinase complex);GO:0006468(protein phosphorylation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0046777(protein autophosphorylation);GO:2001222(regulation of neuron migration)","04012(ErbB signaling pathway);04310(Wnt signaling pathway);04066(HIF-1 signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04114(Oocyte meiosis);04217(Necroptosis);04911(Insulin secretion);04922(Glucagon signaling pathway);04912(GnRH signaling pathway);04921(Oxytocin signaling pathway);04916(Melanogenesis);04925(Aldosterone synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04971(Gastric acid secretion);04725(Cholinergic synapse);04728(Dopaminergic synapse);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04740(Olfactory transduction);04750(Inflammatory mediator regulation of TRP channels);04360(Axon guidance);04713(Circadian entrainment);05200(Pathways in cancer);05205(Proteoglycans in cancer);05214(Glioma);05031(Amphetamine addiction);04934(Cushing syndrome);05152(Tuberculosis)",{"v":0.0052,"d":"0.01"},1,"391,",0,-2.28,{"v":-1.7,"d":"-1.70"},6.02,"3' UTR",4,46981868,47093099,111232,2]
["chr4",49356511,49358196,1686,"ENSBGRG00000020206","ENSBGRT00000037202",162329,"TNS3","tensin 3 [Source:HGNC Symbol;Acc:HGNC:21616]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0008284(positive regulation of cell population proliferation);GO:0016477(cell migration);GO:0048286(lung alveolus development)","NA",{"v":5e-17,"d":"0.00"},3,"145,27,39,","0,1520,1647",{"v":-16.3,"d":"-16.30"},{"v":-15.3,"d":"-15.30"},2.59,"Exon (ENSBGRT00000037202/ENSBGRG00000020206, exon 27 of 29)",4,49356511,49520525,164015,2]
["chr4",49990945,49994182,3238,"ENSBGRG00000020627","ENSBGRT00000038009",1128,"STEAP2","STEAP2 metalloreductase [Source:HGNC Symbol;Acc:HGNC:17885]","GO:0005768(endosome);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006893(Golgi to plasma membrane transport);GO:0006897(endocytosis);GO:0008823(cupric reductase activity);GO:0009725(response to hormone);GO:0015677(copper ion import);GO:0030140(trans-Golgi network transport vesicle);GO:0030173(integral component of Golgi membrane);GO:0045055(regulated exocytosis);GO:0052851(ferric-chelate reductase (NADPH) activity);GO:0055114(oxidation-reduction process);GO:0098706(iron ion import across cell outer membrane)","04978(Mineral absorption)",{"v":4.2e-06,"d":"0.00"},2,"163,254,","0,2984",-5.38,-4.65,4.01,"Exon (ENSBGRT00000038009/ENSBGRG00000020627, exon 2 of 6)",4,49979742,49995310,15569,2]
["chr4",56058335,56058602,268,"ENSBGRG00000002016","ENSBGRT00000003752",11863,"HOXA4","homeobox A4 [Source:HGNC Symbol;Acc:HGNC:5105]","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0016604(nuclear body);GO:0043565(sequence-specific DNA binding);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":4.6E-6,"d":"0.00"},1,"268,",0,-5.34,-4.61,2.46,"Exon (ENSBGRT00000003752/ENSBGRG00000002016, exon 3 of 3)",4,56058335,56070465,12131,2]
["chr4",61757614,61763191,5578,"ENSBGRG00000005279","ENSBGRT00000009929",7891,"ENSBGRG00000005279","NA","GO:0000287(magnesium ion binding);GO:0005737(cytoplasm);GO:0008253(5'-nucleotidase activity)","00230(Purine metabolism);00240(Pyrimidine metabolism);00760(Nicotinate and nicotinamide metabolism)",{"v":3.5E-4,"d":"0.00"},4,"31,86,47,12,","0,2605,4549,5566",-3.46,{"v":-2.8,"d":"-2.80"},2.19,"Exon (ENSBGRT00000009929/ENSBGRG00000005279, exon 3 of 9)",4,61754761,61771082,16322,2]
["chr4",64970229,64996592,26364,"ENSBGRG00000000402","ENSBGRT00000000803",0,"KIAA0895","KIAA0895 [Source:HGNC Symbol;Acc:HGNC:22206]","NA","NA",{"v":0.017,"d":"0.02"},8,"177,132,133,144,521,116,46,18,","0,738,1894,2724,17924,20676,26194,26346",-1.76,-1.22,7.02,"5' UTR",4,64948467,64973096,24630,2]
["chr4",78574671,78575085,415,"ENSBGRG00000006539","ENSBGRT00000012707",67951,"COG5","component of oligomeric golgi complex 5 [Source:HGNC Symbol;Acc:HGNC:14857]","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0006891(intra-Golgi vesicle-mediated transport);GO:0017119(Golgi transport complex);GO:0048219(inter-Golgi cisterna vesicle-mediated transport)","NA",{"v":0.00065,"d":"0.00"},1,"415,",0,-3.19,-2.55,8.02,"Exon (ENSBGRT00000012785/ENSBGRG00000006931, exon 1 of 1)",4,78506720,78637186,130467,1]
["chr4",84134832,84135233,402,"ENSBGRG00000015510","ENSBGRT00000028484",0,"TMEM60","transmembrane protein 60 [Source:HGNC Symbol;Acc:HGNC:21754]","NA","00515(Mannose type O-glycan biosyntheis)",{"v":1e-148,"d":"0.00"},1,"402,",0,-148,-146,10,"Exon (ENSBGRT00000028484/ENSBGRG00000015510, exon 1 of 1)",4,84134832,84135233,402,2]
["chr4",99034270,99037108,2839,"ENSBGRG00000001411","ENSBGRT00000002582",0,"ITGB8","integrin subunit beta 8 [Source:HGNC Symbol;Acc:HGNC:6163]","GO:0001570(vasculogenesis);GO:0001573(ganglioside metabolic process);GO:0007155(cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0034686(integrin alphav-beta8 complex);GO:0038023(signaling receptor activity);GO:0045766(positive regulation of angiogenesis);GO:0051216(cartilage development);GO:1901388(regulation of transforming growth factor beta activation);GO:1990430(extracellular matrix protein binding)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04514(Cell adhesion molecules (CAMs));04510(Focal adhesion);04810(Regulation of actin cytoskeleton);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection)",{"v":0.00076,"d":"0.00"},2,"232,394,","0,2445",-3.12,-2.49,13,"5' UTR",4,98931122,99037108,105987,2]
["chr4",113755209,113756164,956,"ENSBGRG00000007029","ENSBGRT00000013172",149,"MIOS","meiosis regulator for oocyte development [Source:HGNC Symbol;Acc:HGNC:21905]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0030054(cell junction);GO:0032008(positive regulation of TOR signaling);GO:0034198(cellular response to amino acid starvation);GO:0034629(cellular protein-containing complex localization);GO:0061700(GATOR2 complex)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system);04150(mTOR signaling pathway)",{"v":1E-35,"d":"0.00"},1,"956,",0,-35,{"v":-33.8,"d":"-33.80"},5.57,"Exon (ENSBGRT00000013172/ENSBGRG00000007029, exon 1 of 10)",4,113725390,113756313,30924,2]
["chr4",117735612,117735973,362,"ENSBGRG00000010269","ENSBGRT00000018915",8881,"ENSBGRG00000010269","NA","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding)","NA",{"v":3.2e-11,"d":"0.00"},2,"246,114,","0,248",{"v":-10.5,"d":"-10.50"},-9.64,3.01,"Exon (ENSBGRT00000018915/ENSBGRG00000010269, exon 2 of 3)",4,117734685,117744854,10170,2]
["chr4",122304608,122304906,299,"ENSBGRG00000019992","ENSBGRT00000037308",8246,"CDK14","cyclin dependent kinase 14 [Source:HGNC Symbol;Acc:HGNC:8883]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000308(cytoplasmic cyclin-dependent protein kinase holoenzyme complex);GO:0004672(protein kinase activity);GO:0004693(cyclin-dependent protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0030332(cyclin binding);GO:0060828(regulation of canonical Wnt signaling pathway)","05202(Transcriptional misregulation in cancers)",{"v":0.0058,"d":"0.01"},1,"299,",0,-2.24,-1.66,10,"5' UTR",4,121555236,122313152,757917,2]
["chr5",5478503,5478771,269,"ENSBGRG00000001138","ENSBGRT00000002086",27720,"ENSBGRG00000001138","NA","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":5e-68,"d":"0.00"},1,"269,",0,{"v":-67.3,"d":"-67.30"},{"v":-65.8,"d":"-65.80"},128,"3' UTR",5,5450783,5479693,28911,1]
["chr5",7154362,7154751,390,"ENSBGRG00000001553","ENSBGRT00000002877",0,"H2AJ","H2A.J histone [Source:HGNC Symbol;Acc:HGNC:14456]","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0046982(protein heterodimerization activity)","04217(Necroptosis);05322(Systemic lupus erythematosus);05034(Alcoholism)",{"v":1e-171,"d":"0.00"},1,"390,",0,-171,-169,3.04,"Exon (ENSBGRT00000002877/ENSBGRG00000001553, exon 1 of 1)",5,7154362,7154751,390,1]
["chr5",19650379,19650612,234,"ENSBGRG00000001691","ENSBGRT00000003144",0,"SSPN","sarcospan [Source:HGNC Symbol;Acc:HGNC:11322]","GO:0005887(integral component of plasma membrane);GO:0016010(dystrophin-associated glycoprotein complex);GO:0016021(integral component of membrane);GO:0030133(transport vesicle)","NA",{"v":0.0079,"d":"0.01"},1,"234,",0,{"v":-2.1,"d":"-2.10"},-1.54,3.01,"Exon (ENSBGRT00000003144/ENSBGRG00000001691, exon 1 of 3)",5,19650379,19697487,47109,1]
["chr5",26746569,26750543,3975,"ENSBGRG00000004804","ENSBGRT00000009182",241906,"FGD4","FYVE, RhoGEF and PH domain containing 4 [Source:HGNC Symbol;Acc:HGNC:19125]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0046872(metal ion binding)","NA",{"v":0.00026,"d":"0.00"},2,"98,111,","0,3864",-3.59,-2.93,15,"Exon (ENSBGRT00000009182/ENSBGRG00000004804, exon 15 of 16)",5,26504663,26751513,246851,1]
["chr5",28607344,28608301,958,"ENSBGRG00000006576","ENSBGRT00000012119",43050,"ENSBGRG00000006576","interleukin 2 receptor subunit beta [Source:HGNC Symbol;Acc:HGNC:6009]","GO:0004896(cytokine receptor activity);GO:0005515(protein binding);GO:0016020(membrane)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04144(Endocytosis);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05166(HTLV-I infection);05162(Measles)",{"v":2e-62,"d":"0.00"},1,"958,",0,{"v":-61.7,"d":"-61.70"},{"v":-60.3,"d":"-60.30"},5.76,"3' UTR",5,28564294,28608301,44008,1]
["chr5",39381307,39432066,50760,"ENSBGRG00000000463","ENSBGRT00000000792",26410,"WASHC3","WASH complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:24256]","GO:0071203(WASH complex)","04144(Endocytosis)",{"v":2.5E-15,"d":"0.00"},4,"439,65,82,221,","0,18606,19258,50539",{"v":-14.6,"d":"-14.60"},{"v":-13.6,"d":"-13.60"},6.02,"3' UTR",5,39354897,39432096,77200,1]
["chr5",45238437,45240612,2176,"ENSBGRG00000005998","ENSBGRT00000011320",43274,"CDK17","cyclin dependent kinase 17 [Source:HGNC Symbol;Acc:HGNC:8750]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA",{"v":5E-15,"d":"0.00"},3,"51,78,231,","0,1348,1945",{"v":-14.3,"d":"-14.30"},{"v":-13.3,"d":"-13.30"},2.63,"3' UTR",5,45195163,45241419,46257,1]
["chr5",47647816,47649474,1659,"ENSBGRG00000001206","ENSBGRT00000002201",0,"ZC3H10","zinc finger CCCH-type containing 10 [Source:HGNC Symbol;Acc:HGNC:25893]","GO:0010608(posttranscriptional regulation of gene expression);GO:0035198(miRNA binding);GO:0046872(metal ion binding);GO:1903799(negative regulation of production of miRNAs involved in gene silencing by miRNA)","NA",{"v":2e-62,"d":"0.00"},1,"1659,",0,{"v":-61.7,"d":"-61.70"},{"v":-60.2,"d":"-60.20"},6.02,"Exon (ENSBGRT00000002201/ENSBGRG00000001206, exon 1 of 1)",5,47647816,47649474,1659,1]
["chr5",54497194,54504969,7776,"ENSBGRG00000010558","ENSBGRT00000027820",81733,"MON2","MON2 homolog, regulator of endosome-to-Golgi trafficking [Source:HGNC Symbol;Acc:HGNC:29177]","GO:0015031(protein transport)","04144(Endocytosis)",{"v":6.3e-11,"d":"0.00"},3,"72,204,622,","0,6392,7154",{"v":-10.2,"d":"-10.20"},-9.34,10,"Exon (ENSBGRT00000027820/ENSBGRG00000010558, exon 25 of 33)",5,54415461,54524799,109339,1]
["chr5",56087186,56097035,9850,"ENSBGRG00000015742","ENSBGRT00000028961",312585,"SRGAP1","SLIT-ROBO Rho GTPase activating protein 1 [Source:HGNC Symbol;Acc:HGNC:17382]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0007165(signal transduction)","04360(Axon guidance)",{"v":0.0069,"d":"0.01"},3,"47,80,83,","0,2561,9767",-2.16,-1.59,{"v":1.7,"d":"1.70"},"Exon (ENSBGRT00000028961/ENSBGRG00000015742, exon 17 of 22)",5,55774601,56107629,333029,1]
["chr5",62539534,62547473,7940,"ENSBGRG00000008446","ENSBGRT00000015868",35019,"ENSBGRG00000008446","NA","GO:0005085(guanyl-nucleotide exchange factor activity)","NA",{"v":0.0021,"d":"0.00"},3,"84,78,78,","0,6951,7862",-2.68,-2.07,3.01,"Exon (ENSBGRT00000015868/ENSBGRG00000008446, exon 6 of 11)",5,62504515,62558930,54416,1]
["chr5",74803989,74804287,299,"ENSBGRG00000023644","ENSBGRT00000043713",10356,"SLC48A1","solute carrier family 48 member 1 [Source:HGNC Symbol;Acc:HGNC:26035]","GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0010008(endosome membrane);GO:0015232(heme transporter activity);GO:0015886(heme transport);GO:0020037(heme binding)","NA",{"v":1.4E-5,"d":"0.00"},1,"299,",0,-4.86,-4.14,2.86,"3' UTR",5,74793633,74804287,10655,1]
["chr5",77139794,77156632,16839,"ENSBGRG00000001721","ENSBGRT00000003212",40459,"SPATS2","spermatogenesis associated serine rich 2 [Source:HGNC Symbol;Acc:HGNC:18650]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol)","NA",{"v":0.00056,"d":"0.00"},4,"45,109,50,35,","0,8030,9244,16804",-3.25,-2.61,2.01,"Exon (ENSBGRT00000003212/ENSBGRG00000001721, exon 2 of 12)",5,77099335,77182562,83228,1]
["chr5",80932720,80932990,271,"ENSBGRG00000002918","ENSBGRT00000005513",12500,"PFDN5","prefoldin subunit 5 [Source:HGNC Symbol;Acc:HGNC:8869]","GO:0005829(cytosol);GO:0006457(protein folding);GO:0016272(prefoldin complex);GO:0045111(intermediate filament cytoskeleton);GO:0045892(negative regulation of transcription, DNA-templated);GO:0051082(unfolded protein binding);GO:0060041(retina development in camera-type eye);GO:0090090(negative regulation of canonical Wnt signaling pathway)","03030(DNA replication);03420(Nucleotide excision repair);03430(Mismatch repair)",{"v":1.3e-10,"d":"0.00"},2,"49,71,","0,200",{"v":-9.9,"d":"-9.90"},-9.05,1.86,"3' UTR",5,80920220,80933140,12921,1]
["chr5",81131152,81131271,120,"ENSBGRG00000003386","ENSBGRT00000006357",18945,"PCBP2","poly(rC) binding protein 2 [Source:HGNC Symbol;Acc:HGNC:8648]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0019899(enzyme binding);GO:0031625(ubiquitin protein ligase binding);GO:0039694(viral RNA genome replication);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0050687(negative regulation of defense response to virus);GO:0075522(IRES-dependent viral translational initiation);GO:1990829(C-rich single-stranded DNA binding)","04216(Ferroptosis)",{"v":9.3e-06,"d":"0.00"},1,"120,",0,-5.03,-4.31,2.95,"3' UTR",5,81112207,81131627,19421,1]
["chr5",82014509,82016509,2001,"ENSBGRG00000004153","ENSBGRT00000007652",1732,"ENSBGRG00000004153","NA","NA","NA",{"v":0.035,"d":"0.04"},1,"2001,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000007652/ENSBGRG00000004153, exon 3 of 3)",5,82012777,82016509,3733,1]
["chr5",89249631,89251313,1683,"ENSBGRG00000002711","ENSBGRT00000005093",0,"DUSP6","dual specificity phosphatase 6 [Source:HGNC Symbol;Acc:HGNC:3072]","GO:0000188(inactivation of MAPK activity);GO:0001933(negative regulation of protein phosphorylation);GO:0004721(phosphoprotein phosphatase activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0017017(MAP kinase tyrosine/serine/threonine phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0043065(positive regulation of apoptotic process);GO:0051409(response to nitrosative stress);GO:0060420(regulation of heart growth);GO:0070373(negative regulation of ERK1 and ERK2 cascade)","04010(MAPK signaling pathway);05202(Transcriptional misregulation in cancers);05221(Acute myeloid leukemia)",{"v":2E-41,"d":"0.00"},2,"691,417,","0,1266",{"v":-40.7,"d":"-40.70"},{"v":-39.4,"d":"-39.40"},3.51,"5' UTR",5,89249631,89253198,3568,1]
["chr5",90733156,90742167,9012,"ENSBGRG00000002890","ENSBGRT00000005410",0,"ENSBGRG00000002890","NA","NA","NA",{"v":4e-13,"d":"0.00"},5,"104,173,142,74,17,","0,3504,7217,8384,8995",{"v":-12.4,"d":"-12.40"},{"v":-11.5,"d":"-11.50"},2.88,"Exon (ENSBGRT00000005351/ENSBGRG00000002844, exon 48 of 55)",5,90733728,90734738,1011,2]
["chr5",104749400,104752587,3188,"ENSBGRG00000010440","ENSBGRT00000019302",0,"KRR1","KRR1 small subunit processome component homolog [Source:HGNC Symbol;Acc:HGNC:5176]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0045171(intercellular bridge)","NA",{"v":5.2E-7,"d":"0.00"},2,"178,92,","0,3096",-6.28,-5.52,2.47,"5' UTR",5,104749400,104764551,15152,1]
["chr5",110831219,110831429,211,"ENSBGRG00000000467","ENSBGRT00000000870",11746,"ZNF384","zinc finger protein 384 [Source:HGNC Symbol;Acc:HGNC:11955]","GO:0003676(nucleic acid binding);GO:1990837(sequence-specific double-stranded DNA binding)","04910(Insulin signaling pathway)",{"v":1.3e-19,"d":"0.00"},1,"211,",0,{"v":-18.9,"d":"-18.90"},{"v":-17.9,"d":"-17.90"},2.44,"Exon (ENSBGRT00000000870/ENSBGRG00000000467, exon 9 of 9)",5,110819473,110831429,11957,1]
["chr5",111081585,111081765,181,"ENSBGRG00000001292","ENSBGRT00000002367",330,"ENSBGRG00000001292","NA","GO:0006397(mRNA processing)","03013(RNA transport);03015(mRNA surveillance pathway)",{"v":9.1e-05,"d":"0.00"},1,"181,",0,-4.04,-3.36,1.64,"Exon (ENSBGRT00000002367/ENSBGRG00000001292, exon 1 of 2)",5,111081255,111084014,2760,1]
["chr5",115922557,115922767,211,"ENSBGRG00000019663","ENSBGRT00000036148",20255,"ADIPOR2","adiponectin receptor 2 [Source:HGNC Symbol;Acc:HGNC:24041]","GO:0005886(plasma membrane);GO:0016021(integral component of membrane);GO:0031226(intrinsic component of plasma membrane);GO:0033211(adiponectin-activated signaling pathway);GO:0038023(signaling receptor activity);GO:0042593(glucose homeostasis);GO:0042802(identical protein binding);GO:0055100(adiponectin binding);GO:0061042(vascular wound healing);GO:0097003(adipokinetic hormone receptor activity);GO:0120162(positive regulation of cold-induced thermogenesis)","04152(AMPK signaling pathway);04920(Adipocytokine signaling pathway);04211(Longevity regulating pathway - mammal);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":1.9e-08,"d":"0.00"},1,"211,",0,-7.71,{"v":-6.9,"d":"-6.90"},1.94,"3' UTR",5,115902302,115922767,20466,1]
["chr5",116995845,116996563,719,"ENSBGRG00000000778","ENSBGRT00000001463",46010,"ENSBGRG00000000778","NA","GO:0006915(apoptotic process);GO:0042981(regulation of apoptotic process)","04137(Mitophagy - animal);05134(Legionellosis)",{"v":1e-144,"d":"0.00"},1,"719,",0,-144,-142,{"v":13.6,"d":"13.60"},"3' UTR",5,116949835,116995860,46026,1]
["chr5",117522623,117523991,1369,"ENSBGRG00000001298","ENSBGRT00000002634",50667,"TRIOBP","TRIO and F-actin binding protein [Source:HGNC Symbol;Acc:HGNC:17009]","GO:0007605(sensory perception of sound);GO:0015629(actin cytoskeleton);GO:0031625(ubiquitin protein ligase binding);GO:0051015(actin filament binding);GO:0060088(auditory receptor cell stereocilium organization);GO:0120044(stereocilium base);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading)","NA",{"v":2e-31,"d":"0.00"},4,"33,198,258,21,","0,59,1053,1348",{"v":-30.7,"d":"-30.70"},{"v":-29.6,"d":"-29.60"},4.71,"Exon (ENSBGRT00000002634/ENSBGRG00000001298, exon 16 of 24)",5,117471956,117536766,64811,1]
["chr5",120703535,120703924,390,"ENSBGRG00000006401","ENSBGRT00000012064",67420,"EP300","E1A binding protein p300 [Source:HGNC Symbol;Acc:HGNC:3373]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000123(histone acetyltransferase complex);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001666(response to hypoxia);GO:0001756(somitogenesis);GO:0001966(thigmotaxis);GO:0002039(p53 binding);GO:0002209(behavioral defense response);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003684(damaged DNA binding);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0004468(lysine N-acetyltransferase activity, acting on acetyl phosphate as donor);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005829(cytosol);GO:0006110(regulation of glycolytic process);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006473(protein acetylation);GO:0006475(internal protein amino acid acetylation);GO:0006915(apoptotic process);GO:0006990(positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response);GO:0007507(heart development);GO:0007519(skeletal muscle tissue development);GO:0007611(learning or memory);GO:0007623(circadian rhythm);GO:0008013(beta-catenin binding);GO:0008022(protein C-terminus binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0009887(animal organ morphogenesis);GO:0010628(positive regulation of gene expression);GO:0010742(macrophage derived foam cell differentiation);GO:0010821(regulation of mitochondrion organization);GO:0010976(positive regulation of neuron projection development);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0016746(transferase activity, transferring acyl groups);GO:0018076(N-terminal peptidyl-lysine acetylation);GO:0018393(internal peptidyl-lysine acetylation);GO:0018394(peptidyl-lysine acetylation);GO:0030183(B cell differentiation);GO:0030220(platelet formation);GO:0030324(lung development);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0031333(negative regulation of protein-containing complex assembly);GO:0031490(chromatin DNA binding);GO:0031648(protein destabilization);GO:0032092(positive regulation of protein binding);GO:0032991(protein-containing complex);GO:0033613(activating transcription factor binding);GO:0034644(cellular response to UV);GO:0035257(nuclear hormone receptor binding);GO:0035264(multicellular organism growth);GO:0035855(megakaryocyte development);GO:0036268(swimming);GO:0042025(host cell nucleus);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0043627(response to estrogen);GO:0043923(positive regulation by host of viral transcription);GO:0043967(histone H4 acetylation);GO:0043969(histone H2B acetylation);GO:0045444(fat cell differentiation);GO:0045721(negative regulation of gluconeogenesis);GO:0045815(positive regulation of gene expression, epigenetic);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050681(androgen receptor binding);GO:0050821(protein stabilization);GO:0051059(NF-kappaB binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060325(face morphogenesis);GO:0060765(regulation of androgen receptor signaling pathway);GO:0061733(peptide-lysine-N-acetyltransferase activity);GO:0061920(protein propionyltransferase activity);GO:0061921(peptidyl-lysine propionylation);GO:0090043(regulation of tubulin deacetylation);GO:0097157(pre-mRNA intronic binding);GO:0097677(STAT family protein binding);GO:0140065(peptide butyryltransferase activity);GO:0140066(peptidyl-lysine crotonylation);GO:0140067(peptidyl-lysine butyrylation);GO:0140068(histone crotonyltransferase activity);GO:0140069(histone butyryltransferase activity);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1905636(positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding)","04310(Wnt signaling pathway);04330(Notch signaling pathway);04350(TGF-beta signaling pathway);04630(Jak-STAT signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04024(cAMP signaling pathway);04110(Cell cycle);04520(Adherens junction);04922(Glucagon signaling pathway);04919(Thyroid hormone signaling pathway);04916(Melanogenesis);04720(Long-term potentiation);05200(Pathways in cancer);05206(MicroRNAs in cancer);05203(Viral carcinogenesis);05211(Renal cell carcinoma);05215(Prostate cancer);05016(Huntington disease);05152(Tuberculosis);05166(HTLV-I infection);05164(Influenza A);05161(Hepatitis B);05168(Herpes simplex infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection)",{"v":1.3E-99,"d":"0.00"},1,"390,",0,{"v":-98.9,"d":"-98.90"},{"v":-97.1,"d":"-97.10"},3.88,"Exon (ENSBGRT00000012064/ENSBGRG00000006401, exon 32 of 32)",5,120636115,120703924,67810,1]
["chr5",121264668,121265087,420,"ENSBGRG00000009488","ENSBGRT00000017496",18339,"CCDC134","coiled-coil domain containing 134 [Source:HGNC Symbol;Acc:HGNC:26185]","GO:0001525(angiogenesis);GO:0001890(placenta development);GO:0021591(ventricular system development);GO:0035162(embryonic hemopoiesis);GO:1990402(embryonic liver development)","04146(Peroxisome)",{"v":2E-19,"d":"0.00"},1,"420,",0,{"v":-18.7,"d":"-18.70"},{"v":-17.7,"d":"-17.70"},5.86,"3' UTR",5,121246329,121264772,18444,1]
["chr5",125670495,125676901,6407,"ENSBGRG00000001351","ENSBGRT00000002494",0,"TRMU","tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase [Source:HGNC Symbol;Acc:HGNC:25481]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008033(tRNA processing);GO:0016740(transferase activity);GO:0016783(sulfurtransferase activity)","NA",{"v":1.6e-37,"d":"0.00"},2,"82,334,","0,6073",{"v":-36.8,"d":"-36.80"},{"v":-35.5,"d":"-35.50"},{"v":10.7,"d":"10.70"},"Exon (ENSBGRT00000002494/ENSBGRG00000001351, exon 1 of 10)",5,125670495,125690338,19844,1]
["chr5",129124305,129124574,270,"ENSBGRG00000002485","ENSBGRT00000004638",7044,"PANX2","pannexin 2 [Source:HGNC Symbol;Acc:HGNC:8600]","GO:0002931(response to ischemia);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006812(cation transport);GO:0015267(channel activity);GO:0050716(positive regulation of interleukin-1 secretion);GO:0055085(transmembrane transport)","NA",{"v":0.00042,"d":"0.00"},1,"270,",0,-3.38,-2.73,12,"Exon (ENSBGRT00000004638/ENSBGRG00000002485, exon 2 of 3)",5,129117261,129126254,8994,1]
["chr5",129644880,129645209,330,"ENSBGRG00000005496","ENSBGRT00000011046",42388,"ENSBGRG00000005496","NA","NA","04724(Glutamatergic synapse)",{"v":4.1e-09,"d":"0.00"},1,"330,",0,-8.39,-7.57,2.43,"Exon (ENSBGRT00000011046/ENSBGRG00000005496, exon 24 of 27)",5,129602492,129657291,54800,1]
["chr5",4678588,4683895,5308,"ENSBGRG00000000723","ENSBGRT00000001296",53388,"DUSP16","dual specificity phosphatase 16 [Source:HGNC Symbol;Acc:HGNC:17909]","GO:0000188(inactivation of MAPK activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0017017(MAP kinase tyrosine/serine/threonine phosphatase activity);GO:0043409(negative regulation of MAPK cascade)","04010(MAPK signaling pathway)",{"v":7.9e-42,"d":"0.00"},2,"1503,76,","0,5232",{"v":-41.1,"d":"-41.10"},{"v":-39.8,"d":"-39.80"},8.52,"3' UTR",5,4678141,4737283,59143,2]
["chr5",7222299,7222417,119,"ENSBGRG00000001640","ENSBGRT00000003035",4201,"ENSBGRG00000001640","NA","GO:0003956(NAD(P)+-protein-arginine ADP-ribosyltransferase activity);GO:0006471(protein ADP-ribosylation)","NA",{"v":0.0013,"d":"0.00"},1,"119,",0,{"v":-2.9,"d":"-2.90"},-2.28,4.76,"Exon (ENSBGRT00000003035/ENSBGRG00000001640, exon 2 of 2)",5,7221858,7226618,4761,2]
["chr5",14383575,14386791,3217,"ENSBGRG00000003482","ENSBGRT00000006508",15010,"ENSBGRG00000003482","NA","GO:0003824(catalytic activity);GO:0004459(L-lactate dehydrogenase activity);GO:0005737(cytoplasm);GO:0005975(carbohydrate metabolic process);GO:0016491(oxidoreductase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0019752(carboxylic acid metabolic process);GO:0055114(oxidation-reduction process)","00010(Glycolysis / Gluconeogenesis);00620(Pyruvate metabolism);00640(Propanoate metabolism);00270(Cysteine and methionine metabolism);04922(Glucagon signaling pathway)",{"v":1E-87,"d":"0.00"},3,"197,124,99,","0,1463,3118",-87,{"v":-85.3,"d":"-85.30"},2.35,"3' UTR",5,14383575,14401801,18227,2]
["chr5",29681653,29685599,3947,"ENSBGRG00000009360","ENSBGRT00000017144",8303,"ENSBGRG00000009360","NA","GO:0005576(extracellular region);GO:0006869(lipid transport);GO:0008289(lipid binding);GO:0042157(lipoprotein metabolic process)","NA",{"v":7.9e-24,"d":"0.00"},2,"274,52,","0,3895",{"v":-23.1,"d":"-23.10"},-22,5.93,"Exon (ENSBGRT00000017144/ENSBGRG00000009360, exon 3 of 4)",5,29680915,29693902,12988,2]
["chr5",30797095,30800024,2930,"ENSBGRG00000012577","ENSBGRT00000022992",822,"HMGXB4","HMG-box containing 4 [Source:HGNC Symbol;Acc:HGNC:5003]","GO:0016589(NURF complex);GO:0042802(identical protein binding)","NA",{"v":6.3E-5,"d":"0.00"},3,"565,79,71,","0,2523,2859",{"v":-4.2,"d":"-4.20"},-3.51,2.83,"Exon (ENSBGRT00000022992/ENSBGRG00000012577, exon 2 of 10)",5,30760479,30800846,40368,2]
["chr5",37431066,37432549,1484,"ENSBGRG00000020036","ENSBGRT00000036839",10747,"HSP90B1","heat shock protein 90 beta family member 1 [Source:HGNC Symbol;Acc:HGNC:12028]","GO:0001666(response to hypoxia);GO:0003723(RNA binding);GO:0005524(ATP binding);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0006457(protein folding);GO:0019903(protein phosphatase binding);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0030496(midbody);GO:0030970(retrograde protein transport, ER to cytosol);GO:0031247(actin rod assembly);GO:0032991(protein-containing complex);GO:0043066(negative regulation of apoptotic process);GO:0043666(regulation of phosphoprotein phosphatase activity);GO:0048471(perinuclear region of cytoplasm);GO:0050750(low-density lipoprotein particle receptor binding);GO:0051082(unfolded protein binding);GO:0071318(cellular response to ATP)","04141(Protein processing in endoplasmic reticulum);04151(PI3K-Akt signaling pathway);04657(IL-17 signaling pathway);04915(Estrogen signaling pathway);04918(Thyroid hormone synthesis);05200(Pathways in cancer);05215(Prostate cancer);05418(Fluid shear stress and atherosclerosis)",{"v":1.3E-51,"d":"0.00"},2,"9,111,","0,1373",{"v":-50.9,"d":"-50.90"},{"v":-49.5,"d":"-49.50"},1.52,"Exon (ENSBGRT00000036839/ENSBGRG00000020036, exon 7 of 18)",5,37423027,37443296,20270,2]
["chr5",41271341,41275004,3664,"ENSBGRG00000003369","ENSBGRT00000006400",0,"ENSBGRG00000003369","NA","GO:0005634(nucleus);GO:0006338(chromatin remodeling)","NA",{"v":0.042,"d":"0.04"},2,"23,68,","0,3596",-1.38,-0.88,1.46,"Exon (ENSBGRT00000006400/ENSBGRG00000003369, exon 1 of 11)",5,41254265,41275004,20740,2]
["chr5",47479048,47479227,180,"ENSBGRG00000000563","ENSBGRT00000001151",7902,"PMEL","premelanosome protein [Source:HGNC Symbol;Acc:HGNC:10880]","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0032438(melanosome organization);GO:0032585(multivesicular body membrane);GO:0042470(melanosome);GO:0042802(identical protein binding)","NA",{"v":2e-09,"d":"0.00"},1,"180,",0,-8.69,-7.86,2.01,"3' UTR",5,47479018,47487129,8112,2]
["chr5",49351226,49351686,461,"ENSBGRG00000008348","ENSBGRT00000015835",13517,"AGAP2","ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 [Source:HGNC Symbol;Acc:HGNC:16921]","GO:0003924(GTPase activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0033601(positive regulation of mammary gland epithelial cell proliferation);GO:0043066(negative regulation of apoptotic process);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT);GO:0060749(mammary gland alveolus development);GO:0090543(Flemming body)","04068(FoxO signaling pathway);04144(Endocytosis)",{"v":0.00046,"d":"0.00"},3,"7,91,142,","0,129,319",-3.34,-2.69,3.51,"Exon (ENSBGRT00000015835/ENSBGRG00000008348, exon 16 of 20)",5,49349644,49365203,15560,2]
["chr5",56281580,56286624,5045,"ENSBGRG00000016168","ENSBGRT00000029686",49006,"XPOT","exportin for tRNA [Source:HGNC Symbol;Acc:HGNC:12826]","GO:0000049(tRNA binding);GO:0005643(nuclear pore);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006409(tRNA export from nucleus);GO:0006886(intracellular protein transport);GO:0008536(Ran GTPase binding);GO:0071528(tRNA re-export from nucleus)","03013(RNA transport)",{"v":0.00065,"d":"0.00"},2,"9,202,","0,4843",-3.19,-2.55,9.03,"Exon (ENSBGRT00000030278/ENSBGRG00000016255, exon 4 of 13)",5,56232574,56389976,157403,1]
["chr5",70166595,70167193,599,"ENSBGRG00000019353","ENSBGRT00000035531",0,"ENSBGRG00000019353","NA","GO:0001522(pseudouridine synthesis);GO:0003723(RNA binding);GO:0009451(RNA modification);GO:0009982(pseudouridine synthase activity)","NA",{"v":1.2E-4,"d":"0.00"},1,"599,",0,-3.92,-3.25,7.52,"5' UTR",5,70147311,70167193,19883,2]
["chr5",75436904,75437898,995,"ENSBGRG00000000300","ENSBGRT00000000476",5320,"ZNF641","zinc finger protein 641 [Source:HGNC Symbol;Acc:HGNC:31834]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":0.035,"d":"0.04"},2,"67,83,","0,912",-1.45,{"v":-0.941,"d":"-0.94"},1.82,"Exon (ENSBGRT00000000476/ENSBGRG00000000300, exon 5 of 6)",5,75436216,75443218,7003,2]
["chr5",76487562,76489245,1684,"ENSBGRG00000000933","ENSBGRT00000001720",0,"RND1","Rho family GTPase 1 [Source:HGNC Symbol;Acc:HGNC:18314]","GO:0003924(GTPase activity);GO:0005102(signaling receptor binding);GO:0005525(GTP binding);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0007015(actin filament organization);GO:0007162(negative regulation of cell adhesion);GO:0007264(small GTPase mediated signal transduction);GO:0015629(actin cytoskeleton);GO:0016322(neuron remodeling);GO:0043231(intracellular membrane-bounded organelle)","04360(Axon guidance)",{"v":7.6e-08,"d":"0.00"},2,"5,955,","0,729",-7.12,-6.34,{"v":3.7,"d":"3.70"},"5' UTR",5,76480751,76489245,8495,2]
["chr5",77472510,77478528,6019,"ENSBGRG00000002571","ENSBGRT00000004813",0,"BCDIN3D","BCDIN3 domain containing RNA methyltransferase [Source:HGNC Symbol;Acc:HGNC:27050]","GO:0001510(RNA methylation);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008168(methyltransferase activity);GO:0008171(O-methyltransferase activity);GO:0008173(RNA methyltransferase activity);GO:0008175(tRNA methyltransferase activity);GO:0010586(miRNA metabolic process);GO:0030488(tRNA methylation);GO:0061715(miRNA 2'-O-methylation);GO:2000632(negative regulation of pre-miRNA processing)","NA",{"v":6.3e-52,"d":"0.00"},2,"645,405,","0,5614",{"v":-51.2,"d":"-51.20"},{"v":-49.8,"d":"-49.80"},13,"Exon (ENSBGRT00000004813/ENSBGRG00000002571, exon 1 of 2)",5,77472510,77478528,6019,2]
["chr5",81154859,81155718,860,"ENSBGRG00000003578","ENSBGRT00000006665",178,"NPFF","neuropeptide FF-amide peptide precursor [Source:HGNC Symbol;Acc:HGNC:7901]","GO:0005102(signaling receptor binding);GO:0005184(neuropeptide hormone activity)","04080(Neuroactive ligand-receptor interaction)",{"v":1.4E-8,"d":"0.00"},3,"216,122,50,","0,328,810",-7.84,-7.04,{"v":30.1,"d":"30.10"},"3' UTR",5,81154859,81155896,1038,2]
["chr5",84309906,84555561,245656,"ENSBGRG00000001744","ENSBGRT00000003224",0,"ENSBGRG00000001744","NA","GO:0002020(protease binding);GO:0042981(regulation of apoptotic process);GO:0070513(death domain binding)","04630(Jak-STAT signaling pathway);04910(Insulin signaling pathway);04917(Prolactin signaling pathway);04930(Type II diabetes mellitus)",{"v":1.3E-7,"d":"0.00"},6,"19,17,23,499,208,400,","0,21,40,236983,244278,245256",-6.89,-6.11,4.01,"3' UTR",5,84309906,84555459,245554,2]
["chr5",110543109,110543450,342,"ENSBGRG00000021256","ENSBGRT00000039324",0,"ATN1","atrophin 1 [Source:HGNC Symbol;Acc:HGNC:3033]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016363(nuclear matrix);GO:0019904(protein domain specific binding);GO:0051402(neuron apoptotic process)","NA",{"v":9.1e-10,"d":"0.00"},2,"64,27,","0,315",-9.04,-8.21,1.42,"Exon (ENSBGRT00000039324/ENSBGRG00000021256, exon 1 of 9)",5,110536329,110543450,7122,2]
["chr5",113072663,113073738,1076,"ENSBGRG00000012269","ENSBGRT00000022489",13637,"TIGAR","TP53 induced glycolysis regulatory phosphatase [Source:HGNC Symbol;Acc:HGNC:1185]","GO:0002931(response to ischemia);GO:0003824(catalytic activity);GO:0004083(bisphosphoglycerate 2-phosphatase activity);GO:0004331(fructose-2,6-bisphosphate 2-phosphatase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005829(cytosol);GO:0006003(fructose 2,6-bisphosphate metabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0009410(response to xenobiotic stimulus);GO:0010332(response to gamma radiation);GO:0010666(positive regulation of cardiac muscle cell apoptotic process);GO:0030388(fructose 1,6-bisphosphate metabolic process);GO:0043069(negative regulation of programmed cell death);GO:0043456(regulation of pentose-phosphate shunt);GO:0045739(positive regulation of DNA repair);GO:0045820(negative regulation of glycolytic process);GO:0060576(intestinal epithelial cell development);GO:0071279(cellular response to cobalt ion);GO:0071456(cellular response to hypoxia);GO:1901215(negative regulation of neuron death);GO:1901525(negative regulation of mitophagy);GO:1902153(regulation of response to DNA damage checkpoint signaling);GO:1903301(positive regulation of hexokinase activity);GO:1904024(negative regulation of glucose catabolic process to lactate via pyruvate);GO:2000378(negative regulation of reactive oxygen species metabolic process)","00051(Fructose and mannose metabolism);05230(Central carbon metabolism in cancer)",{"v":2.8E-5,"d":"0.00"},2,"40,20,","0,1056",-4.56,-3.86,3.65,"Exon (ENSBGRT00000022489/ENSBGRG00000012269, exon 5 of 6)",5,113070935,113087375,16441,2]
["chr5",117853029,117853356,328,"ENSBGRG00000002297","ENSBGRT00000004364",39435,"BAIAP2L2","BAR/IMD domain containing adaptor protein 2 like 2 [Source:HGNC Symbol;Acc:HGNC:26203]","GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0007009(plasma membrane organization);GO:0012506(vesicle membrane);GO:0044291(cell-cell contact zone);GO:0061024(membrane organization);GO:0071439(clathrin complex)","NA",{"v":3.2e-12,"d":"0.00"},1,"328,",0,{"v":-11.5,"d":"-11.50"},{"v":-10.6,"d":"-10.60"},4.36,"3' UTR",5,117853029,117892791,39763,2]
["chr5",118821583,118821792,210,"ENSBGRG00000003093","ENSBGRT00000005772",327,"PDGFB","platelet derived growth factor subunit B [Source:HGNC Symbol;Acc:HGNC:8800]","GO:0001938(positive regulation of endothelial cell proliferation);GO:0002548(monocyte chemotaxis);GO:0005161(platelet-derived growth factor receptor binding);GO:0005518(collagen binding);GO:0006468(protein phosphorylation);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0009611(response to wounding);GO:0009986(cell surface);GO:0010512(negative regulation of phosphatidylinositol biosynthetic process);GO:0010544(negative regulation of platelet activation);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0014911(positive regulation of smooth muscle cell migration);GO:0016020(membrane);GO:0016176(superoxide-generating NADPH oxidase activator activity);GO:0018105(peptidyl-serine phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030335(positive regulation of cell migration);GO:0031954(positive regulation of protein autophosphorylation);GO:0032091(negative regulation of protein binding);GO:0032147(activation of protein kinase activity);GO:0032148(activation of protein kinase B activity);GO:0035655(interleukin-18-mediated signaling pathway);GO:0035793(positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway);GO:0042056(chemoattractant activity);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043406(positive regulation of MAP kinase activity);GO:0043410(positive regulation of MAPK cascade);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0045737(positive regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045840(positive regulation of mitotic nuclear division);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046982(protein heterodimerization activity);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048016(inositol phosphate-mediated signaling);GO:0048146(positive regulation of fibroblast proliferation);GO:0048407(platelet-derived growth factor binding);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050921(positive regulation of chemotaxis);GO:0060326(cell chemotaxis);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070528(protein kinase C signaling);GO:0071363(cellular response to growth factor stimulus);GO:0072126(positive regulation of glomerular mesangial cell proliferation);GO:0072593(reactive oxygen species metabolic process);GO:0090280(positive regulation of calcium ion import);GO:1900127(positive regulation of hyaluronan biosynthetic process);GO:1902894(negative regulation of pri-miRNA transcription by RNA polymerase II);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration);GO:1905064(negative regulation of vascular smooth muscle cell differentiation);GO:1905176(positive regulation of vascular smooth muscle cell dedifferentiation);GO:2000379(positive regulation of reactive oxygen species metabolic process);GO:2000573(positive regulation of DNA biosynthetic process);GO:2000591(positive regulation of metanephric mesenchymal cell migration)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04630(Jak-STAT signaling pathway);04072(Phospholipase D signaling pathway);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04540(Gap junction);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer);05231(Choline metabolism in cancer);05206(MicroRNAs in cancer);05214(Glioma);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05418(Fluid shear stress and atherosclerosis);05166(HTLV-I infection);05167(Kaposi sarcoma-associated herpesvirus infection);01521(EGFR tyrosine kinase inhibitor resistance)",{"v":6.6E-3,"d":"0.01"},1,"210,",0,-2.18,-1.61,1.82,"5' UTR",5,118799989,118822119,22131,2]
["chr5",120105380,120182571,77192,"ENSBGRG00000008675","ENSBGRT00000016946",0,"MRTFA","myocardin related transcription factor A [Source:HGNC Symbol;Acc:HGNC:14334]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0001764(neuron migration);GO:0003700(DNA-binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0003779(actin binding);GO:0003785(actin monomer binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0010735(positive regulation of transcription via serum response element binding);GO:0030036(actin cytoskeleton organization);GO:0030900(forebrain development);GO:0031175(neuron projection development);GO:0042025(host cell nucleus);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2001234(negative regulation of apoptotic signaling pathway)","NA",{"v":0.021,"d":"0.02"},3,"34,54,62,","0,50542,77130",-1.68,-1.15,7.02,"5' UTR",5,120034709,120105413,70705,2]
["chr5",122104169,122104821,653,"ENSBGRG00000013056","ENSBGRT00000023839",415,"A4GALT","alpha 1,4-galactosyltransferase (P blood group) [Source:HGNC Symbol;Acc:HGNC:18149]","GO:0001576(globoside biosynthetic process);GO:0007009(plasma membrane organization);GO:0008378(galactosyltransferase activity);GO:0015643(toxic substance binding);GO:0016020(membrane);GO:0050512(lactosylceramide 4-alpha-galactosyltransferase activity)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series);00603(Glycosphingolipid biosynthesis - globo and isoglobo series)",{"v":1E-150,"d":"0.00"},1,"653,",0,-150,-148,6.15,"Exon (ENSBGRT00000023839/ENSBGRG00000013056, exon 1 of 1)",5,122104169,122105236,1068,2]
["chr5",125538669,125538931,263,"ENSBGRG00000001207","ENSBGRT00000002217",3325,"CDPF1","cysteine rich DPF motif domain containing 1 [Source:HGNC Symbol;Acc:HGNC:33710]","NA","NA",{"v":7.9e-14,"d":"0.00"},1,"263,",0,{"v":-13.1,"d":"-13.10"},{"v":-12.2,"d":"-12.20"},3.56,"3' UTR",5,125538669,125542256,3588,2]
["chr5",128801335,128802528,1194,"ENSBGRG00000002122","ENSBGRT00000003971",0,"ENSBGRG00000002122","NA","NA","NA",{"v":5e-13,"d":"0.00"},1,"1194,",0,{"v":-12.3,"d":"-12.30"},{"v":-11.4,"d":"-11.40"},10,"Exon (ENSBGRT00000003956/ENSBGRG00000002067, exon 1 of 7)",5,128801335,128802528,1194,2]
["chr6",500713,506792,6080,"ENSBGRG00000006353","ENSBGRT00000012001",105807,"TBC1D14","TBC1 domain family member 14 [Source:HGNC Symbol;Acc:HGNC:29246]","GO:0005654(nucleoplasm);GO:0005776(autophagosome);GO:0005794(Golgi apparatus);GO:0010507(negative regulation of autophagy);GO:0019901(protein kinase binding);GO:0043231(intracellular membrane-bounded organelle);GO:0055037(recycling endosome);GO:0071955(recycling endosome to Golgi transport);GO:2000785(regulation of autophagosome assembly)","NA",{"v":5e-98,"d":"0.00"},2,"58,1472,","0,4608",{"v":-97.3,"d":"-97.30"},{"v":-95.5,"d":"-95.50"},5.29,"3' UTR",6,394906,506386,111481,1]
["chr6",3892171,3892321,151,"ENSBGRG00000016524","ENSBGRT00000030347",90,"HAUS3","HAUS augmin like complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:28719]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005813(centrosome);GO:0007098(centrosome cycle);GO:0015630(microtubule cytoskeleton);GO:0045171(intercellular bridge);GO:0051225(spindle assembly);GO:0070652(HAUS complex);GO:0072686(mitotic spindle)","NA",{"v":0.0074,"d":"0.01"},1,"151,",0,-2.13,-1.56,1.96,"5' UTR",6,3892081,3907363,15283,1]
["chr6",5415122,5415306,185,"ENSBGRG00000021438","ENSBGRT00000039628",1289,"ENSBGRG00000021438","NA","NA","NA",{"v":0.035,"d":"0.04"},2,"82,99,","0,86",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000039628/ENSBGRG00000021438, exon 5 of 6)",6,5413833,5415546,1714,1]
["chr6",14503422,14506821,3400,"ENSBGRG00000010047","ENSBGRT00000018417",148,"ZBTB49","zinc finger and BTB domain containing 49 [Source:HGNC Symbol;Acc:HGNC:19883]","GO:0001223(transcription coactivator binding);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007050(cell cycle arrest);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0015630(microtubule cytoskeleton);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","04110(Cell cycle);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05222(Small cell lung cancer)",{"v":0.00021,"d":"0.00"},2,"23,68,","0,3332",-3.67,-3,2.46,"Exon (ENSBGRT00000018417/ENSBGRG00000010047, exon 1 of 7)",6,14503274,14525641,22368,1]
["chr6",16053426,16107051,53626,"ENSBGRG00000011517","ENSBGRT00000021141",99587,"EVC","EvC ciliary complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:3497]","GO:0003416(endochondral bone growth);GO:0005929(cilium);GO:0007224(smoothened signaling pathway);GO:0036064(ciliary basal body);GO:0045880(positive regulation of smoothened signaling pathway);GO:0060170(ciliary membrane);GO:0098797(plasma membrane protein complex)","04340(Hedgehog signaling pathway)",{"v":1e-186,"d":"0.00"},7,"120,112,127,94,115,1082,320,","0,3149,11076,12858,13998,14621,53306",-186,-184,6.83,"3' UTR",6,15953839,16069128,115290,1]
["chr6",28796964,28797144,181,"ENSBGRG00000013344","ENSBGRT00000024545",0,"CCNI","cyclin I [Source:HGNC Symbol;Acc:HGNC:1595]","GO:0051726(regulation of cell cycle)","04068(FoxO signaling pathway)",{"v":1.3E-11,"d":"0.00"},1,"181,",0,{"v":-10.9,"d":"-10.90"},{"v":-10.1,"d":"-10.10"},{"v":1.6,"d":"1.60"},"5' UTR",6,28796964,28836150,39187,1]
["chr6",33757150,33757749,600,"ENSBGRG00000026205","ENSBGRT00000048500",298460,"ADAMTS3","ADAM metallopeptidase with thrombospondin type 1 motif 3 [Source:HGNC Symbol;Acc:HGNC:219]","GO:0004175(endopeptidase activity);GO:0004222(metalloendopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0010573(vascular endothelial growth factor production);GO:0016485(protein processing);GO:0032964(collagen biosynthetic process);GO:1900748(positive regulation of vascular endothelial growth factor signaling pathway)","NA",{"v":1e-24,"d":"0.00"},1,"600,",0,-24,{"v":-22.9,"d":"-22.90"},9.36,"3' UTR",6,33458690,33757749,299060,1]
["chr6",40413357,40413477,121,"ENSBGRG00000013918","ENSBGRT00000026329",89258,"EPHA5","EPH receptor A5 [Source:HGNC Symbol;Acc:HGNC:3389]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005004(GPI-linked ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0005912(adherens junction);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0016021(integral component of membrane);GO:0021766(hippocampus development);GO:0032956(regulation of actin cytoskeleton organization);GO:0043087(regulation of GTPase activity);GO:0048013(ephrin receptor signaling pathway);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0071372(cellular response to follicle-stimulating hormone stimulus);GO:0071944(cell periphery);GO:1904322(cellular response to forskolin)","04360(Axon guidance)",{"v":2.1E-7,"d":"0.00"},1,"121,",0,-6.67,{"v":-5.9,"d":"-5.90"},4.81,"Exon (ENSBGRT00000026329/ENSBGRG00000013918, exon 3 of 18)",6,40324099,40764903,440805,1]
["chr6",56000216,56005289,5074,"ENSBGRG00000001037","ENSBGRT00000001922",54661,"TXK","TXK tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:12434]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0010468(regulation of gene expression);GO:0032729(positive regulation of interferon-gamma production);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046777(protein autophosphorylation);GO:0060335(positive regulation of interferon-gamma-mediated signaling pathway)","04670(Leukocyte transendothelial migration)",{"v":4.8E-8,"d":"0.00"},3,"8,158,520,","0,1493,4554",-7.32,-6.53,5.68,"3' UTR",6,55945555,56005289,59735,1]
["chr6",68414629,68434764,20136,"ENSBGRG00000004941","ENSBGRT00000009117",193826,"ARAP2","ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 [Source:HGNC Symbol;Acc:HGNC:16924]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0007165(signal transduction);GO:0043547(positive regulation of GTPase activity)","04144(Endocytosis)",{"v":1.4e-06,"d":"0.00"},6,"44,36,64,135,406,34,","0,1469,3353,9594,18538,20102",-5.84,-5.09,{"v":23.1,"d":"23.10"},"3' UTR",6,68220803,68434764,213962,1]
["chr6",88860327,88860534,208,"ENSBGRG00000020407","ENSBGRT00000037551",8092,"SPP1","secreted phosphoprotein 1 [Source:HGNC Symbol;Acc:HGNC:11255]","GO:0001503(ossification);GO:0005178(integrin binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005794(Golgi apparatus);GO:0006710(androgen catabolic process);GO:0007155(cell adhesion);GO:0033280(response to vitamin D);GO:0045893(positive regulation of transcription, DNA-templated);GO:0071394(cellular response to testosterone stimulus);GO:2000866(positive regulation of estradiol secretion)","04371(Apelin signaling pathway);04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04620(Toll-like receptor signaling pathway);05165(Human papillomavirus infection)",{"v":4e-23,"d":"0.00"},1,"208,",0,{"v":-22.4,"d":"-22.40"},{"v":-21.3,"d":"-21.30"},3.35,"3' UTR",6,88852235,88860770,8536,1]
["chr6",100489187,100489365,179,"ENSBGRG00000001534","ENSBGRT00000002849",996,"ENSBGRG00000001534","NA","GO:0005634(nucleus);GO:0006334(nucleosome assembly)","NA",{"v":3.2E-13,"d":"0.00"},1,"179,",0,{"v":-12.5,"d":"-12.50"},{"v":-11.6,"d":"-11.60"},2.58,"Exon (ENSBGRT00000002849/ENSBGRG00000001534, exon 3 of 3)",6,100488191,100489365,1175,1]
["chr6",101891695,101891905,211,"ENSBGRG00000002511","ENSBGRT00000004679",26730,"ENSBGRG00000002511","NA","GO:0005515(protein binding)","NA",{"v":0.0052,"d":"0.01"},1,"211,",0,-2.28,{"v":-1.7,"d":"-1.70"},2.88,"3' UTR",6,101864965,101892444,27480,1]
["chr6",111831887,111832915,1029,"ENSBGRG00000001872","ENSBGRT00000003489",1712,"GAR1","GAR1 ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:14264]","GO:0000784(nuclear chromosome, telomeric region);GO:0001522(pseudouridine synthesis);GO:0001650(fibrillar center);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0005697(telomerase holoenzyme complex);GO:0007004(telomere maintenance via telomerase);GO:0031429(box H/ACA snoRNP complex);GO:0034513(box H/ACA snoRNA binding);GO:0042254(ribosome biogenesis);GO:0070034(telomerase RNA binding);GO:0090661(box H/ACA telomerase RNP complex)","03008(Ribosome biogenesis in eukaryotes)",{"v":4.2e-08,"d":"0.00"},3,"129,60,168,","0,583,861",-7.38,-6.59,2.47,"Exon (ENSBGRT00000003489/ENSBGRG00000001872, exon 2 of 4)",6,111830175,111833063,2889,1]
["chr6",121966359,121970120,3762,"ENSBGRG00000004790","ENSBGRT00000008842",181213,"SYNPO2","synaptopodin 2 [Source:HGNC Symbol;Acc:HGNC:17732]","GO:0001725(stress fiber);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0015629(actin cytoskeleton);GO:0030018(Z disc);GO:0031005(filamin binding);GO:0043231(intracellular membrane-bounded organelle);GO:0051393(alpha-actinin binding)","04530(Tight junction)",{"v":0,"d":"0.00"},2,"759,554,","0,3208",-314,-311,3.48,"Exon (ENSBGRT00000008842/ENSBGRG00000004790, exon 3 of 5)",6,121785146,121971883,186738,1]
["chr6",128454437,128454795,359,"ENSBGRG00000005629","ENSBGRT00000010394",355,"ENSBGRG00000005629","NA","GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008199(ferric iron binding)","04216(Ferroptosis);04217(Necroptosis);04978(Mineral absorption)",0,2,"180,146,","0,213",-1150,"-Inf",2.62,"3' UTR",6,128454082,128454795,714,1]
["chr6",4320719,4320779,61,"ENSBGRG00000017575","ENSBGRT00000032295",16125,"FGFR3","fibroblast growth factor receptor 3 [Source:HGNC Symbol;Acc:HGNC:3690]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005007(fibroblast growth factor-activated receptor activity);GO:0005524(ATP binding);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0008284(positive regulation of cell population proliferation);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0010518(positive regulation of phospholipase activity);GO:0016021(integral component of membrane);GO:0017134(fibroblast growth factor binding);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030133(transport vesicle);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042802(identical protein binding);GO:0043410(positive regulation of MAPK cascade);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0046777(protein autophosphorylation);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:1902178(fibroblast growth factor receptor apoptotic signaling pathway)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04144(Endocytosis);04550(Signaling pathways regulating pluripotency of stem cells);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05206(MicroRNAs in cancer);05219(Bladder cancer);01521(EGFR tyrosine kinase inhibitor resistance)",{"v":0.019,"d":"0.02"},1,"61,",0,-1.71,{"v":-0.901,"d":"-0.90"},8.02,"3' UTR",6,4320031,4336904,16874,2]
["chr6",15765683,15778990,13308,"ENSBGRG00000010733","ENSBGRT00000020228",170473,"EVC2","EvC ciliary complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:19747]","GO:0005634(nucleus);GO:0005929(cilium);GO:0007224(smoothened signaling pathway);GO:0060170(ciliary membrane);GO:0098797(plasma membrane protein complex)","04340(Hedgehog signaling pathway)",{"v":1E-136,"d":"0.00"},4,"726,102,197,20,","0,3211,6695,13288",-136,-134,{"v":10.6,"d":"10.60"},"3' UTR",6,15765683,15949463,183781,2]
["chr6",22939424,22939809,386,"ENSBGRG00000023470","ENSBGRT00000043540",0,"ENOPH1","enolase-phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:24599]","GO:0000287(magnesium ion binding);GO:0016787(hydrolase activity);GO:0019509(L-methionine salvage from methylthioadenosine);GO:0043874(acireductone synthase activity)","00270(Cysteine and methionine metabolism)",{"v":2e-20,"d":"0.00"},1,"386,",0,{"v":-19.7,"d":"-19.70"},{"v":-18.7,"d":"-18.70"},5.31,"5' UTR",6,22898431,22939809,41379,2]
["chr6",27279763,27283498,3736,"ENSBGRG00000011868","ENSBGRT00000022874",598763,"FRAS1","Fraser extracellular matrix complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:19185]","GO:0002009(morphogenesis of an epithelium);GO:0003338(metanephros morphogenesis);GO:0005515(protein binding);GO:0005604(basement membrane);GO:0007154(cell communication);GO:0015031(protein transport);GO:0016021(integral component of membrane);GO:0030326(embryonic limb morphogenesis);GO:0043588(skin development);GO:0060021(roof of mouth development)","NA",{"v":1.6e-08,"d":"0.00"},2,"594,126,","0,3610",{"v":-7.8,"d":"-7.80"},-6.99,15,"Exon (ENSBGRT00000022874/ENSBGRG00000011868, exon 74 of 75)",6,27279763,27882261,602499,2]
["chr6",29856199,29973121,116923,"ENSBGRG00000014983","ENSBGRT00000027799",0,"ART3","ADP-ribosyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:725]","GO:0003956(NAD(P)+-protein-arginine ADP-ribosyltransferase activity);GO:0006471(protein ADP-ribosylation)","NA",{"v":1.3e-10,"d":"0.00"},4,"574,78,85,31,","0,5075,5543,116892",-9.87,-9.02,3.59,"5' UTR",6,29814189,29861826,47638,2]
["chr6",50570725,50571533,809,"ENSBGRG00000022431","ENSBGRT00000041394",17758,"ENSBGRG00000022431","NA","NA","NA",{"v":1e-24,"d":"0.00"},1,"809,",0,-24,{"v":-22.9,"d":"-22.90"},6.87,"3' UTR",6,50570515,50589291,18777,2]
["chr6",54697753,54698022,270,"ENSBGRG00000000323","ENSBGRT00000000513",2939,"ENSBGRG00000000323","NA","NA","NA",{"v":2E-3,"d":"0.00"},1,"270,",0,-2.69,-2.08,7.02,"Exon (ENSBGRT00000000513/ENSBGRG00000000323, exon 3 of 3)",6,54694744,54700961,6218,2]
["chr6",63739361,63739899,539,"ENSBGRG00000002761","ENSBGRT00000005173",51137,"NSUN7","NOP2/Sun RNA methyltransferase family member 7 [Source:HGNC Symbol;Acc:HGNC:25857]","GO:0008168(methyltransferase activity)","NA",{"v":4.5e-06,"d":"0.00"},2,"6,530,","0,9",-5.35,-4.62,4.76,"Exon (ENSBGRT00000005173/ENSBGRG00000002761, exon 11 of 12)",6,63739361,63791036,51676,2]
["chr6",78138712,78139548,837,"ENSBGRG00000010679","ENSBGRT00000019556",196699,"STIM2","stromal interaction molecule 2 [Source:HGNC Symbol;Acc:HGNC:19205]","GO:0005246(calcium channel regulator activity);GO:0005515(protein binding);GO:0006874(cellular calcium ion homeostasis)","04020(Calcium signaling pathway)",{"v":0.011,"d":"0.01"},2,"120,300,","0,537",-1.97,-1.14,9.03,"Exon (ENSBGRT00000019556/ENSBGRG00000010679, exon 13 of 13)",6,78138354,78336247,197894,2]
["chr6",89610300,89613731,3432,"ENSBGRG00000021778","ENSBGRT00000041837",105377,"FAM13A","family with sequence similarity 13 member A [Source:HGNC Symbol;Acc:HGNC:19367]","GO:0007165(signal transduction)","NA",{"v":7.9e-82,"d":"0.00"},2,"1008,69,","0,3363",{"v":-81.1,"d":"-81.10"},{"v":-79.4,"d":"-79.40"},{"v":9.4,"d":"9.40"},"3' UTR",6,89610181,89719108,108928,2]
["chr6",104350295,104351127,833,"ENSBGRG00000003053","ENSBGRT00000005708",0,"SLC39A8","solute carrier family 39 member 8 [Source:HGNC Symbol;Acc:HGNC:20862]","GO:0005381(iron ion transmembrane transporter activity);GO:0005384(manganese ion transmembrane transporter activity);GO:0005385(zinc ion transmembrane transporter activity);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0006487(protein N-linked glycosylation);GO:0006525(arginine metabolic process);GO:0006829(zinc ion transport);GO:0006876(cellular cadmium ion homeostasis);GO:0006882(cellular zinc ion homeostasis);GO:0015086(cadmium ion transmembrane transporter activity);GO:0015106(bicarbonate transmembrane transporter activity);GO:0015296(anion:cation symporter activity);GO:0015701(bicarbonate transport);GO:0016020(membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0030001(metal ion transport);GO:0030026(cellular manganese ion homeostasis);GO:0030198(extracellular matrix organization);GO:0031090(organelle membrane);GO:0042391(regulation of membrane potential);GO:0046873(metal ion transmembrane transporter activity);GO:0055085(transmembrane transport);GO:0061757(leukocyte adhesion to arterial endothelial cell);GO:0070574(cadmium ion transmembrane transport);GO:0071421(manganese ion transmembrane transport);GO:0071577(zinc ion transmembrane transport);GO:0071578(zinc ion import across plasma membrane);GO:0097079(selenite:proton symporter activity);GO:0097080(plasma membrane selenite transport);GO:0098711(iron ion import across plasma membrane);GO:0140412(zinc:bicarbonate symporter activity);GO:1990079(cartilage homeostasis);GO:1990540(mitochondrial manganese ion transmembrane transport)","04216(Ferroptosis)",{"v":0.00025,"d":"0.00"},2,"122,266,","0,567",-3.61,-2.95,6.02,"5' UTR",6,104251463,104350416,98954,2]
["chr6",107567427,107567606,180,"ENSBGRG00000004759","ENSBGRT00000008775",176127,"ARHGEF38","Rho guanine nucleotide exchange factor 38 [Source:HGNC Symbol;Acc:HGNC:25968]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm)","NA",{"v":8.7e-08,"d":"0.00"},1,"180,",0,-7.06,-6.27,1.72,"Exon (ENSBGRT00000008940/ENSBGRG00000004828, exon 7 of 7)",6,107391300,107606584,215285,1]
["chr6",116172215,116173204,990,"ENSBGRG00000004095","ENSBGRT00000007582",89081,"ARSJ","arylsulfatase family member J [Source:HGNC Symbol;Acc:HGNC:26286]","GO:0003824(catalytic activity);GO:0008484(sulfuric ester hydrolase activity);GO:0015629(actin cytoskeleton)","NA",{"v":2.5E-15,"d":"0.00"},1,"990,",0,{"v":-14.6,"d":"-14.60"},{"v":-13.6,"d":"-13.60"},7.19,"Exon (ENSBGRT00000007582/ENSBGRG00000004095, exon 2 of 2)",6,116172215,116262285,90071,2]
["chr7",4328878,4330925,2048,"ENSBGRG00000009528","ENSBGRT00000017514",1974,"SFTPC","surfactant protein C [Source:HGNC Symbol;Acc:HGNC:10802]","GO:0005576(extracellular region);GO:0007585(respiratory gaseous exchange by respiratory system);GO:0042802(identical protein binding)","NA",{"v":2e-07,"d":"0.00"},4,"5,111,346,1000,","0,243,701,1048",{"v":-6.7,"d":"-6.70"},-5.92,{"v":20.1,"d":"20.10"},"5' UTR",7,4326904,4329924,3021,1]
["chr7",8151269,8151358,90,"ENSBGRG00000016906","ENSBGRT00000031241",44226,"CDCA2","cell division cycle associated 2 [Source:HGNC Symbol;Acc:HGNC:14623]","GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005829(cytosol);GO:0035307(positive regulation of protein dephosphorylation);GO:0051301(cell division)","NA",{"v":1.3e-47,"d":"0.00"},1,"90,",0,{"v":-46.9,"d":"-46.90"},{"v":-45.6,"d":"-45.60"},{"v":9.4,"d":"9.40"},"Exon (ENSBGRT00000031241/ENSBGRG00000016906, exon 14 of 14)",7,8107043,8152072,45030,1]
["chr7",10661956,10664723,2768,"ENSBGRG00000001485","ENSBGRT00000002852",70102,"NFX1","nuclear transcription factor, X-box binding 1 [Source:HGNC Symbol;Acc:HGNC:7803]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0045347(negative regulation of MHC class II biosynthetic process);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity)","05165(Human papillomavirus infection)",{"v":1E-25,"d":"0.00"},3,"101,102,275,","0,1338,2493",-25,{"v":-23.9,"d":"-23.90"},{"v":2.7,"d":"2.70"},"3' UTR",7,10591854,10666783,74930,1]
["chr7",17111123,17111182,60,"ENSBGRG00000006446","ENSBGRT00000011910",0,"CTSL","cathepsin L [Source:HGNC Symbol;Acc:HGNC:2537]","GO:0001968(fibronectin binding);GO:0002250(adaptive immune response);GO:0004197(cysteine-type endopeptidase activity);GO:0005518(collagen binding);GO:0005615(extracellular space);GO:0005764(lysosome);GO:0005771(multivesicular body);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity);GO:0016540(protein autoprocessing);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030574(collagen catabolic process);GO:0031638(zymogen activation);GO:0039654(fusion of virus membrane with host endosome membrane);GO:0042393(histone binding);GO:0043394(proteoglycan binding);GO:0046718(viral entry into host cell);GO:0051603(proteolysis involved in cellular protein catabolic process);GO:0097067(cellular response to thyroid hormone stimulus);GO:0097655(serpin family protein binding)","04145(Phagosome);04142(Lysosome);04140(Autophagy - animal);04210(Apoptosis);04612(Antigen processing and presentation);05205(Proteoglycans in cancer);05323(Rheumatoid arthritis);05418(Fluid shear stress and atherosclerosis)",{"v":0.017,"d":"0.02"},1,"60,",0,-1.77,-1.23,8.02,"Exon (ENSBGRT00000011910/ENSBGRG00000006446, exon 1 of 8)",7,17111123,17116945,5823,1]
["chr7",23363364,23397440,34077,"ENSBGRG00000017467","ENSBGRT00000031970",0,"ENSBGRG00000017467","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":3.9e-09,"d":"0.00"},3,"806,230,100,","0,18437,33977",-8.41,-7.59,7.02,"3' UTR",7,23367384,23368577,1194,2]
["chr7",32766796,32775309,8514,"ENSBGRG00000001636","ENSBGRT00000003270",59516,"FSD1L","fibronectin type III and SPRY domain containing 1 like [Source:HGNC Symbol;Acc:HGNC:13753]","GO:0005515(protein binding)","04120(Ubiquitin mediated proteolysis)",{"v":0.00013,"d":"0.00"},3,"129,89,139,","0,4835,8375",-3.87,{"v":-3.2,"d":"-3.20"},16,"3' UTR",7,32707280,32775309,68030,1]
["chr7",37230420,37397870,167451,"ENSBGRG00000002825","ENSBGRT00000005272",144498,"ENSBGRG00000002825","NA","GO:0008360(regulation of cell shape);GO:0016020(membrane)","NA",{"v":1.5E-3,"d":"0.00"},5,"41,81,131,115,82,","0,105425,113388,166127,167369",-2.81,{"v":-2.2,"d":"-2.20"},3.34,"Exon (ENSBGRT00000005272/ENSBGRG00000002825, exon 2 of 8)",7,37085922,37419275,333354,1]
["chr7",50507546,50508236,691,"ENSBGRG00000014158","ENSBGRT00000026009",128734,"EIPR1","EARP complex and GARP complex interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:12383]","GO:0005515(protein binding)","04150(mTOR signaling pathway)",{"v":2.8e-06,"d":"0.00"},1,"691,",0,-5.56,-4.82,{"v":21.1,"d":"21.10"},"3' UTR",7,50378812,50509795,130984,1]
["chr7",53786006,53786304,299,"ENSBGRG00000000461","ENSBGRT00000000798",7403,"NR4A3","nuclear receptor subfamily 4 group A member 3 [Source:HGNC Symbol;Acc:HGNC:7982]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001223(transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001707(mesoderm formation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0007369(gastrulation);GO:0007411(axon guidance);GO:0008270(zinc ion binding);GO:0009444(pyruvate oxidation);GO:0010828(positive regulation of glucose transmembrane transport);GO:0019901(protein kinase binding);GO:0021766(hippocampus development);GO:0030534(adult behavior);GO:0032765(positive regulation of mast cell cytokine production);GO:0035035(histone acetyltransferase binding);GO:0035497(cAMP response element binding);GO:0035726(common myeloid progenitor cell proliferation);GO:0038097(positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway);GO:0042025(host cell nucleus);GO:0042472(inner ear morphogenesis);GO:0042542(response to hydrogen peroxide);GO:0043066(negative regulation of apoptotic process);GO:0043303(mast cell degranulation);GO:0043524(negative regulation of neuron apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0044320(cellular response to leptin stimulus);GO:0045333(cellular respiration);GO:0045444(fat cell differentiation);GO:0045787(positive regulation of cell cycle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046321(positive regulation of fatty acid oxidation);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048660(regulation of smooth muscle cell proliferation);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0048752(semicircular canal morphogenesis);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050885(neuromuscular process controlling balance);GO:0060005(vestibular reflex);GO:0071376(cellular response to corticotropin-releasing hormone stimulus);GO:0071870(cellular response to catecholamine stimulus);GO:0097009(energy homeostasis);GO:1900625(positive regulation of monocyte aggregation);GO:1903204(negative regulation of oxidative stress-induced neuron death);GO:1903208(negative regulation of hydrogen peroxide-induced neuron death);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration);GO:2000108(positive regulation of leukocyte apoptotic process);GO:2000253(positive regulation of feeding behavior)","05202(Transcriptional misregulation in cancers)",{"v":5e-21,"d":"0.00"},1,"299,",0,{"v":-20.3,"d":"-20.30"},{"v":-19.3,"d":"-19.30"},3.14,"Exon (ENSBGRT00000000798/ENSBGRG00000000461, exon 3 of 8)",7,53778603,53824688,46086,1]
["chr7",55420385,55421039,655,"ENSBGRG00000001316","ENSBGRT00000002421",32515,"TSTD2","thiosulfate sulfurtransferase like domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30087]","NA","NA",{"v":1E-107,"d":"0.00"},1,"655,",0,-107,-106,3.98,"3' UTR",7,55387870,55420489,32620,1]
["chr7",57985575,57988745,3171,"ENSBGRG00000003060","ENSBGRT00000005761",57687,"GNE","glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase [Source:HGNC Symbol;Acc:HGNC:23657]","GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0006047(UDP-N-acetylglucosamine metabolic process)","00520(Amino sugar and nucleotide sugar metabolism)",{"v":4e-60,"d":"0.00"},2,"112,608,","0,2563",{"v":-59.4,"d":"-59.40"},-58,3.67,"3' UTR",7,57927888,57988865,60978,1]
["chr7",71725236,71725654,419,"ENSBGRG00000022945","ENSBGRT00000042513",26149,"CEMIP2","cell migration inducing hyaluronidase 2 [Source:HGNC Symbol;Acc:HGNC:11869]","GO:0004415(hyalurononglucosaminidase activity);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0030214(hyaluronan catabolic process);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":2.6e-08,"d":"0.00"},1,"419,",0,-7.59,-6.79,4.46,"Exon (ENSBGRT00000042513/ENSBGRG00000022945, exon 4 of 24)",7,71699087,71787429,88343,1]
["chr7",80591931,80592347,417,"ENSBGRG00000005214","ENSBGRT00000009729",79524,"SLC1A1","solute carrier family 1 member 1 [Source:HGNC Symbol;Acc:HGNC:10939]","GO:0005313(L-glutamate transmembrane transporter activity);GO:0005314(high-affinity glutamate transmembrane transporter activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0010460(positive regulation of heart rate);GO:0015108(chloride transmembrane transporter activity);GO:0015183(L-aspartate transmembrane transporter activity);GO:0015293(symporter activity);GO:0015501(glutamate:sodium symporter activity);GO:0015813(L-glutamate transmembrane transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0031901(early endosome membrane);GO:0033229(cysteine transmembrane transporter activity);GO:0035633(maintenance of permeability of blood-brain barrier);GO:0036475(neuron death in response to oxidative stress);GO:0042802(identical protein binding);GO:0042883(cysteine transport);GO:0048514(blood vessel morphogenesis);GO:0051938(L-glutamate import);GO:0055038(recycling endosome membrane);GO:0070777(D-aspartate transport);GO:0070778(L-aspartate transmembrane transport);GO:0070779(D-aspartate import across plasma membrane);GO:0098712(L-glutamate import across plasma membrane);GO:0140009(L-aspartate import across plasma membrane);GO:0140010(D-aspartate transmembrane transporter activity);GO:1902476(chloride transmembrane transport);GO:1903712(cysteine transmembrane transport)","04974(Protein digestion and absorption);04724(Glutamatergic synapse)",{"v":0.0017,"d":"0.00"},1,"417,",0,-2.77,-2.16,12,"3' UTR",7,80512407,80592347,79941,1]
["chr7",92831152,92852438,21287,"ENSBGRG00000001014","ENSBGRT00000001860",53986,"CCDC171","coiled-coil domain containing 171 [Source:HGNC Symbol;Acc:HGNC:29828]","NA","NA",{"v":0.019,"d":"0.02"},3,"131,93,46,","0,14427,21241",-1.72,-1.19,5.01,"Exon (ENSBGRT00000001860/ENSBGRG00000001014, exon 6 of 26)",7,92777166,93139866,362701,1]
["chr7",96551191,96551281,91,"ENSBGRG00000001481","ENSBGRT00000003197",534242,"ADAMTSL1","ADAMTS like 1 [Source:HGNC Symbol;Acc:HGNC:14632]","GO:0008233(peptidase activity)","NA",{"v":0.0012,"d":"0.00"},1,"91,",0,-2.91,-2.29,4.21,"Exon (ENSBGRT00000003197/ENSBGRG00000001481, exon 32 of 32)",7,96016949,96551281,534333,1]
["chr7",115948647,115948766,120,"ENSBGRG00000002753","ENSBGRT00000005337",19902,"FDFT1","farnesyl-diphosphate farnesyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:3629]","GO:0003676(nucleic acid binding);GO:0003684(damaged DNA binding);GO:0003906(DNA-(apurinic or apyrimidinic site) endonuclease activity);GO:0004310(farnesyl-diphosphate farnesyltransferase activity);GO:0005783(endoplasmic reticulum);GO:0006284(base-excision repair);GO:0006289(nucleotide-excision repair);GO:0008270(zinc ion binding);GO:0008610(lipid biosynthetic process);GO:0009058(biosynthetic process);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016765(transferase activity, transferring alkyl or aryl (other than methyl) groups);GO:0016799(hydrolase activity, hydrolyzing N-glycosyl compounds);GO:0051996(squalene synthase activity)","03410(Base excision repair);00100(Steroid biosynthesis)",{"v":3.2e-07,"d":"0.00"},1,"120,",0,{"v":-6.5,"d":"-6.50"},-5.73,{"v":2.7,"d":"2.70"},"3' UTR",7,115928745,115949543,20799,1]
["chr7",122704406,122707819,3414,"ENSBGRG00000014664","ENSBGRT00000027027",94315,"NEK1","NIMA related kinase 1 [Source:HGNC Symbol;Acc:HGNC:7744]","GO:0000242(pericentriolar material);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0034451(centriolar satellite);GO:0042769(DNA damage response, detection of DNA damage);GO:0060271(cilium assembly)","NA",{"v":6.6e-08,"d":"0.00"},2,"188,52,","0,3362",-7.18,-6.39,2.16,"Exon (ENSBGRT00000027027/ENSBGRG00000014664, exon 23 of 33)",7,122610091,122748592,138502,1]
["chr7",4393896,4394135,240,"ENSBGRG00000009872","ENSBGRT00000018145",12449,"PHYHIP","phytanoyl-CoA 2-hydroxylase interacting protein [Source:HGNC Symbol;Acc:HGNC:16865]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008104(protein localization);GO:1990782(protein tyrosine kinase binding)","NA",{"v":0.032,"d":"0.03"},1,"240,",0,-1.49,{"v":-0.978,"d":"-0.98"},6.02,"3' UTR",7,4393386,4406584,13199,2]
["chr7",9838683,9838982,300,"ENSBGRG00000000766","ENSBGRT00000001392",15395,"TRIM35","tripartite motif containing 35 [Source:HGNC Symbol;Acc:HGNC:16285]","GO:0005515(protein binding);GO:0008270(zinc ion binding);GO:0043065(positive regulation of apoptotic process);GO:0045087(innate immune response);GO:0045930(negative regulation of mitotic cell cycle);GO:1902187(negative regulation of viral release from host cell)","NA",{"v":1.4E-8,"d":"0.00"},1,"300,",0,-7.84,-7.03,5.89,"Exon (ENSBGRT00000001392/ENSBGRG00000000766, exon 6 of 6)",7,9837517,9854377,16861,2]
["chr7",12832270,12854054,21785,"ENSBGRG00000003572","ENSBGRT00000006723",48130,"KIF27","kinesin family member 27 [Source:HGNC Symbol;Acc:HGNC:18632]","GO:0003351(epithelial cilium movement involved in extracellular fluid movement);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005929(cilium);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0021591(ventricular system development);GO:0060271(cilium assembly)","NA",{"v":3.2e-05,"d":"0.00"},5,"38,216,177,111,179,","0,3202,10012,12928,21606",{"v":-4.5,"d":"-4.50"},-3.79,1.97,"Exon (ENSBGRT00000006723/ENSBGRG00000003572, exon 10 of 18)",7,12814385,12902184,87800,2]
["chr7",19790835,19791423,589,"ENSBGRG00000011910","ENSBGRT00000021844",67569,"ZNF782","zinc finger protein 782 [Source:HGNC Symbol;Acc:HGNC:33110]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.2E-10,"d":"0.00"},2,"480,28,","0,561",-9.93,-9.07,4.88,"Exon (ENSBGRT00000021844/ENSBGRG00000011910, exon 5 of 6)",7,19790835,19858992,68158,2]
["chr7",25796408,25796617,210,"ENSBGRG00000018721","ENSBGRT00000034595",1057,"ENSBGRG00000018721","NA","NA","03010(Ribosome)",{"v":5e-32,"d":"0.00"},2,"159,20,","0,190",{"v":-31.3,"d":"-31.30"},{"v":-30.2,"d":"-30.20"},8.62,"Exon (ENSBGRT00000034595/ENSBGRG00000018721, exon 3 of 4)",7,25796408,25797674,1267,2]
["chr7",28318414,28318683,270,"ENSBGRG00000000588","ENSBGRT00000001034",5711,"ENSBGRG00000000588","NA","NA","NA",{"v":1E-10,"d":"0.00"},1,"270,",0,-10,-9.16,2.34,"Exon (ENSBGRT00000001034/ENSBGRG00000000588, exon 2 of 2)",7,28318295,28324394,6100,2]
["chr7",40924750,40926051,1302,"ENSBGRG00000006210","ENSBGRT00000011483",0,"POLE3","DNA polymerase epsilon 3, accessory subunit [Source:HGNC Symbol;Acc:HGNC:13546]","GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0008622(epsilon DNA polymerase complex);GO:0043966(histone H3 acetylation);GO:0046982(protein heterodimerization activity)","00230(Purine metabolism);00240(Pyrimidine metabolism);03030(DNA replication);03410(Base excision repair);03420(Nucleotide excision repair);05166(HTLV-I infection)",{"v":9.99999999999998e-257,"d":"0.00"},4,"310,119,86,66,","0,594,1050,1236",-256,-253,6.34,"3' UTR",7,40924750,40926051,1302,2]
["chr7",47657618,47658575,958,"ENSBGRG00000010303","ENSBGRT00000018899",222150,"BRINP1","BMP/retinoic acid inducible neural specific 1 [Source:HGNC Symbol;Acc:HGNC:2687]","GO:0001662(behavioral fear response);GO:0005737(cytoplasm);GO:0007614(short-term memory);GO:0008219(cell death);GO:0035176(social behavior);GO:0035640(exploration behavior);GO:0042711(maternal behavior);GO:0045666(positive regulation of neuron differentiation);GO:0045786(negative regulation of cell cycle);GO:0045930(negative regulation of mitotic cell cycle);GO:0050768(negative regulation of neurogenesis);GO:0071300(cellular response to retinoic acid);GO:0071625(vocalization behavior)","NA",{"v":3.2e-05,"d":"0.00"},1,"958,",0,-4.49,-3.79,7.35,"Exon (ENSBGRT00000018899/ENSBGRG00000010303, exon 9 of 9)",7,47657618,47880725,223108,2]
["chr7",50088452,50088570,119,"ENSBGRG00000013017","ENSBGRT00000023785",649,"STOM","stomatin [Source:HGNC Symbol;Acc:HGNC:3383]","GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0016020(membrane);GO:0042802(identical protein binding);GO:0045121(membrane raft);GO:0070063(RNA polymerase binding)","NA",{"v":0.016,"d":"0.02"},1,"119,",0,-1.79,-1.25,1.48,"5' UTR",7,50046637,50089219,42583,2]
["chr7",55706057,55727782,21726,"ENSBGRG00000001397","ENSBGRT00000002554",10065,"ENSBGRG00000001397","NA","NA","00603(Glycosphingolipid biosynthesis - globo and isoglobo series)",{"v":0.011,"d":"0.01"},10,"365,36,127,116,174,123,89,80,120,119,","0,407,2183,3365,4301,6766,9676,13255,19736,21607",-1.97,-1.14,9.03,"Exon (ENSBGRT00000002554/ENSBGRG00000001397, exon 8 of 38)",7,55672941,55737847,64907,2]
["chr7",58762063,58762631,569,"ENSBGRG00000006287","ENSBGRT00000011654",5585,"TESK1","testis associated actin remodelling kinase 1 [Source:HGNC Symbol;Acc:HGNC:11731]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0046872(metal ion binding)","NA",{"v":9.99999999999998e-264,"d":"0.00"},1,"569,",0,-263,-261,4.52,"Exon (ENSBGRT00000011654/ENSBGRG00000006287, exon 12 of 12)",7,58762063,58768216,6154,2]
["chr7",66721060,66721778,719,"ENSBGRG00000019923","ENSBGRT00000036603",568,"GCNT1","glucosaminyl (N-acetyl) transferase 1 [Source:HGNC Symbol;Acc:HGNC:4203]","GO:0005802(trans-Golgi network);GO:0009101(glycoprotein biosynthetic process);GO:0016020(membrane);GO:0031985(Golgi cisterna);GO:0048729(tissue morphogenesis);GO:0050901(leukocyte tethering or rolling);GO:0060352(cell adhesion molecule production);GO:0060993(kidney morphogenesis)","00512(Mucin type O-glycan biosynthesis)",{"v":7.9e-11,"d":"0.00"},1,"719,",0,{"v":-10.1,"d":"-10.10"},-9.26,16,"Exon (ENSBGRT00000036603/ENSBGRG00000019923, exon 1 of 1)",7,66721060,66722346,1287,2]
["chr7",74761552,74764680,3129,"ENSBGRG00000002457","ENSBGRT00000004589",21757,"ENSBGRG00000002457","NA","GO:0004322(ferroxidase activity);GO:0005739(mitochondrion);GO:0008199(ferric iron binding);GO:0016226(iron-sulfur cluster assembly);GO:0055114(oxidation-reduction process)","00860(Porphyrin and chlorophyll metabolism)",{"v":5e-17,"d":"0.00"},2,"169,396,","0,2733",{"v":-16.3,"d":"-16.30"},{"v":-15.4,"d":"-15.40"},8.02,"3' UTR",7,74761552,74786437,24886,2]
["chr7",80117224,80117404,181,"ENSBGRG00000005123","ENSBGRT00000009434",173597,"GLIS3","GLIS family zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:28510]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II)","NA",{"v":0.011,"d":"0.01"},1,"181,",0,-1.95,{"v":-1.4,"d":"-1.40"},5.01,"Exon (ENSBGRT00000009434/ENSBGRG00000005123, exon 4 of 11)",7,79758005,80291001,532997,2]
["chr7",92180139,92183351,3213,"ENSBGRG00000000792","ENSBGRT00000001483",10381,"FREM1","FRAS1 related extracellular matrix 1 [Source:HGNC Symbol;Acc:HGNC:23399]","GO:0005604(basement membrane);GO:0007154(cell communication);GO:0007160(cell-matrix adhesion);GO:0016021(integral component of membrane);GO:0097094(craniofacial suture morphogenesis)","NA",{"v":0.015,"d":"0.02"},2,"207,63,","0,3150",-1.82,-1.28,4.01,"Exon (ENSBGRT00000001483/ENSBGRG00000000792, exon 2 of 36)",7,92026873,92193732,166860,2]
["chr7",99069422,99069510,89,"ENSBGRG00000002367","ENSBGRT00000004415",176,"ENSBGRG00000002367","NA","GO:0005126(cytokine receptor binding);GO:0005576(extracellular region);GO:0006952(defense response)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04622(RIG-I-like receptor signaling pathway)",{"v":0.032,"d":"0.03"},1,"89,",0,-1.49,{"v":-0.978,"d":"-0.98"},4.51,"Exon (ENSBGRT00000004415/ENSBGRG00000002367, exon 1 of 1)",7,99069099,99069686,588,2]
["chr7",100194689,100194984,296,"ENSBGRG00000002626","ENSBGRT00000004922",1100,"ENSBGRG00000002626","NA","GO:0003746(translation elongation factor activity);GO:0005515(protein binding);GO:0006414(translational elongation)","05134(Legionellosis)",0,1,"296,",0,-716,"-Inf",1.89,"3' UTR",7,100194041,100196084,2044,2]
["chr7",111971289,111971379,91,"ENSBGRG00000001455","ENSBGRT00000002660",17484,"ENSBGRG00000001455","NA","NA","04610(Complement and coagulation cascades)",{"v":1.1e-09,"d":"0.00"},1,"91,",0,-8.95,-8.11,8.02,"3' UTR",7,111971289,111988863,17575,2]
["chr7",123120634,123121919,1286,"ENSBGRG00000015322","ENSBGRT00000028168",233285,"ENSBGRG00000015322","palladin, cytoskeletal associated protein [Source:HGNC Symbol;Acc:HGNC:17068]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007411(axon guidance)","NA",{"v":1.6e-29,"d":"0.00"},2,"173,37,","0,1249",{"v":-28.8,"d":"-28.80"},{"v":-27.7,"d":"-27.70"},2.28,"Exon (ENSBGRT00000028168/ENSBGRG00000015322, exon 16 of 17)",7,123120634,123355204,234571,2]
["chr8",4034365,4034817,453,"ENSBGRG00000024426","ENSBGRT00000045175",2555,"ENSBGRG00000024426","NA","NA","04130(SNARE interactions in vesicular transport)",{"v":3.2E-49,"d":"0.00"},2,"26,183,","0,270",{"v":-48.5,"d":"-48.50"},{"v":-47.1,"d":"-47.10"},2.48,"Exon (ENSBGRT00000045175/ENSBGRG00000024426, exon 6 of 6)",8,4031810,4034653,2844,1]
["chr8",4638953,4639042,90,"ENSBGRG00000025987","ENSBGRT00000048075",5374,"B3GNT3","UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:13528]","GO:0006486(protein glycosylation);GO:0008532(N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity);GO:0016020(membrane);GO:0030311(poly-N-acetyllactosamine biosynthetic process)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":0.028,"d":"0.03"},1,"90,",0,-1.56,-1.04,1.53,"Exon (ENSBGRT00000048075/ENSBGRG00000025987, exon 3 of 4)",8,4633579,4639474,5896,1]
["chr8",5523638,5524699,1062,"ENSBGRG00000026408","ENSBGRT00000048872",4162,"ENSBGRG00000026408","NA","NA","03010(Ribosome)",{"v":1e-20,"d":"0.00"},2,"228,73,","0,989",-20,{"v":-18.9,"d":"-18.90"},{"v":6.6,"d":"6.60"},"3' UTR",8,5519476,5523865,4390,1]
["chr8",7397342,7397731,390,"ENSBGRG00000003164","ENSBGRT00000005884",2316,"GJC2","gap junction protein gamma 2 [Source:HGNC Symbol;Acc:HGNC:17494]","GO:0005243(gap junction channel activity);GO:0005921(gap junction);GO:0005922(connexin complex);GO:0007154(cell communication);GO:0007267(cell-cell signaling);GO:0009636(response to toxic substance);GO:0010644(cell communication by electrical coupling);GO:0043209(myelin sheath);GO:1903763(gap junction channel activity involved in cell communication by electrical coupling)","NA",{"v":0.028,"d":"0.03"},1,"390,",0,-1.55,-1.03,4.01,"3' UTR",8,7395026,7398419,3394,1]
["chr8",9054147,9054295,149,"ENSBGRG00000004400","ENSBGRT00000008193",48,"MGAT4B","alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B [Source:HGNC Symbol;Acc:HGNC:7048]","GO:0006487(protein N-linked glycosylation);GO:0008375(acetylglucosaminyltransferase activity);GO:0016757(transferase activity, transferring glycosyl groups)","00510(N-Glycan biosynthesis)",{"v":0.028,"d":"0.03"},1,"149,",0,-1.55,-1.03,6.02,"Exon (ENSBGRT00000008608/ENSBGRG00000004587, exon 1 of 8)",8,9041982,9054343,12362,2]
["chr8",11858022,11858767,746,"ENSBGRG00000008843","ENSBGRT00000016190",0,"NACC1","nucleus accumbens associated 1 [Source:HGNC Symbol;Acc:HGNC:20967]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008284(positive regulation of cell population proliferation);GO:0030054(cell junction);GO:0043231(intracellular membrane-bounded organelle);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":6.3e-14,"d":"0.00"},1,"746,",0,{"v":-13.2,"d":"-13.20"},{"v":-12.3,"d":"-12.30"},3.94,"5' UTR",8,11858022,11861065,3044,1]
["chr8",12522770,12527558,4789,"ENSBGRG00000021611","ENSBGRT00000039899",0,"C19orf53","chromosome 19 open reading frame 53 [Source:HGNC Symbol;Acc:HGNC:24991]","NA","NA",{"v":9.99999999999998e-212,"d":"0.00"},3,"100,56,141,","0,177,4648",-211,-208,3.33,"Exon (ENSBGRT00000039899/ENSBGRG00000021611, exon 1 of 3)",8,12522770,12527558,4789,1]
["chr8",15130804,15131782,979,"ENSBGRG00000002625","ENSBGRT00000004926",31303,"ENSBGRG00000002625","NA","GO:0016020(membrane);GO:0098609(cell-cell adhesion)","04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04514(Cell adhesion molecules (CAMs));04650(Natural killer cell mediated cytotoxicity);04670(Leukocyte transendothelial migration);05323(Rheumatoid arthritis);05418(Fluid shear stress and atherosclerosis);05416(Viral myocarditis);04933(AGE-RAGE signaling pathway in diabetic complications);05150(Staphylococcus aureus infection);05166(HTLV-I infection);05164(Influenza A);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05144(Malaria);05143(African trypanosomiasis)",{"v":9.99999999999999e-235,"d":"0.00"},2,"167,730,","0,249",-234,-231,4.59,"3' UTR",8,15099501,15132440,32940,1]
["chr8",16325379,16326034,656,"ENSBGRG00000013054","ENSBGRT00000024029",14231,"PRKCSH","protein kinase C substrate 80K-H [Source:HGNC Symbol;Acc:HGNC:9411]","GO:0001701(in utero embryonic development);GO:0001889(liver development);GO:0003723(RNA binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0006491(N-glycan processing);GO:0006807(nitrogen compound metabolic process);GO:0010977(negative regulation of neuron projection development);GO:0017177(glucosidase II complex)","04141(Protein processing in endoplasmic reticulum)",{"v":2e-32,"d":"0.00"},2,"171,70,","0,586",{"v":-31.7,"d":"-31.70"},{"v":-30.5,"d":"-30.50"},2.84,"3' UTR",8,16311148,16325549,14402,1]
["chr8",17308190,17308455,266,"ENSBGRG00000020523","ENSBGRT00000037770",4030,"SNAPC2","small nuclear RNA activating complex polypeptide 2 [Source:HGNC Symbol;Acc:HGNC:11135]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016604(nuclear body)","NA",{"v":2.5e-23,"d":"0.00"},1,"266,",0,{"v":-22.6,"d":"-22.60"},{"v":-21.5,"d":"-21.50"},4.16,"3' UTR",8,17304160,17308455,4296,1]
["chr8",18480744,18481279,536,"ENSBGRG00000025958","ENSBGRT00000048026",7838,"GPR108","G protein-coupled receptor 108 [Source:HGNC Symbol;Acc:HGNC:17829]","GO:0016021(integral component of membrane)","NA",{"v":0.011,"d":"0.01"},1,"536,",0,-1.97,-1.14,9.03,"3' UTR",8,18472906,18481279,8374,1]
["chr8",19233268,19255512,22245,"ENSBGRG00000000978","ENSBGRT00000002048",0,"RANBP3","RAN binding protein 3 [Source:HGNC Symbol;Acc:HGNC:9850]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0046907(intracellular transport);GO:0070412(R-SMAD binding)","05166(HTLV-I infection)",{"v":0.00045,"d":"0.00"},3,"22,56,72,","0,21039,22173",-3.35,{"v":-2.7,"d":"-2.70"},5.26,"Exon (ENSBGRT00000002048/ENSBGRG00000000978, exon 1 of 19)",8,19233268,19290876,57609,1]
["chr8",19572875,19578338,5464,"ENSBGRG00000002546","ENSBGRT00000004873",27226,"SAFB2","scaffold attachment factor B2 [Source:HGNC Symbol;Acc:HGNC:21605]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0016604(nuclear body);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle);GO:0050684(regulation of mRNA processing);GO:0060008(Sertoli cell differentiation);GO:0060765(regulation of androgen receptor signaling pathway)","NA",{"v":4.8e-07,"d":"0.00"},3,"20,137,290,","0,3778,5174",-6.32,-5.56,1.45,"Exon (ENSBGRT00000004873/ENSBGRG00000002546, exon 14 of 20)",8,19545649,19581837,36189,1]
["chr8",21465418,21465567,150,"ENSBGRG00000020972","ENSBGRT00000038619",9850,"TBXA2R","thromboxane A2 receptor [Source:HGNC Symbol;Acc:HGNC:11608]","GO:0004930(G protein-coupled receptor activity);GO:0004960(thromboxane receptor activity);GO:0005886(plasma membrane);GO:0006954(inflammatory response);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0016607(nuclear speck);GO:0019229(regulation of vasoconstriction);GO:0019932(second-messenger-mediated signaling);GO:0032496(response to lipopolysaccharide);GO:0045987(positive regulation of smooth muscle contraction);GO:0090051(negative regulation of cell migration involved in sprouting angiogenesis)","04020(Calcium signaling pathway);04080(Neuroactive ligand-receptor interaction);04611(Platelet activation)",{"v":0.011,"d":"0.01"},1,"150,",0,-1.95,{"v":-1.4,"d":"-1.40"},6.02,"3' UTR",8,21455568,21465567,10000,1]
["chr8",21998961,21999051,91,"ENSBGRG00000000857","ENSBGRT00000001678",34219,"TLE2","TLE family member 2, transcriptional corepressor [Source:HGNC Symbol;Acc:HGNC:11838]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005925(focal adhesion);GO:0006355(regulation of transcription, DNA-templated);GO:0016604(nuclear body)","04310(Wnt signaling pathway);04330(Notch signaling pathway);04013(MAPK signaling pathway - fly)",{"v":0.016,"d":"0.02"},1,"91,",0,-1.79,-1.25,1.21,"3' UTR",8,21964742,21999141,34400,1]
["chr8",27439678,27439887,210,"ENSBGRG00000006565","ENSBGRT00000013203",239657,"FBN2","fibrillin 2 [Source:HGNC Symbol;Acc:HGNC:3604]","GO:0001527(microfibril);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0030326(embryonic limb morphogenesis);GO:0030501(positive regulation of bone mineralization);GO:0035108(limb morphogenesis);GO:0035583(sequestering of TGFbeta in extracellular matrix);GO:0043010(camera-type eye development);GO:0045669(positive regulation of osteoblast differentiation);GO:0048048(embryonic eye morphogenesis);GO:0060346(bone trabecula formation)","NA",{"v":3.2e-81,"d":"0.00"},1,"210,",0,{"v":-80.5,"d":"-80.50"},{"v":-78.9,"d":"-78.90"},{"v":8.3,"d":"8.30"},"Exon (ENSBGRT00000013203/ENSBGRG00000006565, exon 67 of 67)",8,27200021,27439887,239867,1]
["chr8",41639372,41639462,91,"ENSBGRG00000016194","ENSBGRT00000029904",26258,"ZNF346","zinc finger protein 346 [Source:HGNC Symbol;Acc:HGNC:16403]","GO:0003676(nucleic acid binding);GO:0003725(double-stranded RNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0008270(zinc ion binding);GO:0019899(enzyme binding);GO:0035198(miRNA binding);GO:0043065(positive regulation of apoptotic process)","NA",{"v":0.041,"d":"0.04"},1,"91,",0,-1.39,{"v":-0.887,"d":"-0.89"},1.22,"3' UTR",8,41613114,41640776,27663,1]
["chr8",46702102,46702191,90,"ENSBGRG00000005465","ENSBGRT00000010056",7942,"ENSBGRG00000005465","NA","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007411(axon guidance)","NA",{"v":2.5e-45,"d":"0.00"},1,"90,",0,{"v":-44.6,"d":"-44.60"},{"v":-43.3,"d":"-43.30"},1.43,"3' UTR",8,46694160,46702191,8032,1]
["chr8",47220273,47229361,9089,"ENSBGRG00000013814","ENSBGRT00000025893",0,"STK11","serine/threonine kinase 11 [Source:HGNC Symbol;Acc:HGNC:11389]","GO:0000287(magnesium ion binding);GO:0001558(regulation of cell growth);GO:0001894(tissue homeostasis);GO:0001944(vasculature development);GO:0002039(p53 binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006470(protein dephosphorylation);GO:0006974(cellular response to DNA damage stimulus);GO:0007050(cell cycle arrest);GO:0007409(axonogenesis);GO:0008285(negative regulation of cell population proliferation);GO:0010212(response to ionizing radiation);GO:0010508(positive regulation of autophagy);GO:0016020(membrane);GO:0030010(establishment of cell polarity);GO:0030111(regulation of Wnt signaling pathway);GO:0030275(LRR domain binding);GO:0030295(protein kinase activator activity);GO:0030308(negative regulation of cell growth);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0032147(activation of protein kinase activity);GO:0042593(glucose homeostasis);GO:0043276(anoikis);GO:0045059(positive thymic T cell selection);GO:0046777(protein autophosphorylation);GO:0048814(regulation of dendrite morphogenesis);GO:0050772(positive regulation of axonogenesis);GO:0050852(T cell receptor signaling pathway);GO:0051645(Golgi localization);GO:0051896(regulation of protein kinase B signaling);GO:0060070(canonical Wnt signaling pathway);GO:0060770(negative regulation of epithelial cell proliferation involved in prostate gland development);GO:0071493(cellular response to UV-B);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0097484(dendrite extension);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900182(positive regulation of protein localization to nucleus);GO:1901610(positive regulation of vesicle transport along microtubule);GO:1904262(negative regulation of TORC1 signaling)","04068(FoxO signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04530(Tight junction);04920(Adipocytokine signaling pathway);04211(Longevity regulating pathway - mammal)",{"v":1E-100,"d":"0.00"},3,"290,84,13,","0,8410,9076",-100,{"v":-98.3,"d":"-98.30"},9.74,"Exon (ENSBGRT00000025893/ENSBGRG00000013814, exon 1 of 10)",8,47220273,47235655,15383,1]
["chr8",47396544,47396694,151,"ENSBGRG00000015207","ENSBGRT00000027929",17739,"PWWP3A","PWWP domain containing 3A, DNA repair factor [Source:HGNC Symbol;Acc:HGNC:29641]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0006325(chromatin organization);GO:0031491(nucleosome binding)","NA",{"v":4.2e-05,"d":"0.00"},1,"151,",0,-4.38,-3.68,1.39,"3' UTR",8,47378805,47397593,18789,1]
["chr8",51613128,51659295,46168,"ENSBGRG00000002538","ENSBGRT00000004752",0,"SMAD5","SMAD family member 5 [Source:HGNC Symbol;Acc:HGNC:6771]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001657(ureteric bud development);GO:0002051(osteoblast fate commitment);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006468(protein phosphorylation);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007281(germ cell development);GO:0017151(DEAD/H-box RNA helicase binding);GO:0030218(erythrocyte differentiation);GO:0030509(BMP signaling pathway);GO:0031625(ubiquitin protein ligase binding);GO:0032991(protein-containing complex);GO:0045669(positive regulation of osteoblast differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051216(cartilage development);GO:0060048(cardiac muscle contraction);GO:0060348(bone development);GO:0060395(SMAD protein signal transduction);GO:0071407(cellular response to organic cyclic compound);GO:0071773(cellular response to BMP stimulus);GO:1901522(positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus);GO:1990837(sequence-specific double-stranded DNA binding)","04350(TGF-beta signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells)",{"v":8.7e-10,"d":"0.00"},2,"301,564,","0,45604",-9.06,-8.23,8.02,"5' UTR",8,51613128,51682087,68960,1]
["chr8",55294083,55295114,1032,"ENSBGRG00000012471","ENSBGRT00000022826",35466,"CXXC5","CXXC finger protein 5 [Source:HGNC Symbol;Acc:HGNC:26943]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008327(methyl-CpG binding);GO:0043565(sequence-specific DNA binding)","04310(Wnt signaling pathway)",{"v":2.5e-32,"d":"0.00"},2,"371,613,","0,419",{"v":-31.6,"d":"-31.60"},{"v":-30.4,"d":"-30.40"},5.99,"5' UTR",8,55258617,55297287,38671,1]
["chr8",56432844,56433893,1050,"ENSBGRG00000021397","ENSBGRT00000040029",14477,"PCDHAC2","protocadherin alpha subfamily C, 2 [Source:HGNC Symbol;Acc:HGNC:8677]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007399(nervous system development);GO:0016020(membrane)","NA",{"v":7.6e-05,"d":"0.00"},1,"1050,",0,-4.12,-3.44,12,"Exon (ENSBGRT00000040123/ENSBGRG00000021397, exon 1 of 4)",8,56418367,56648556,230190,1]
["chr8",56597269,56597628,360,"ENSBGRG00000021397","ENSBGRT00000040029",178902,"PCDHAC2","protocadherin alpha subfamily C, 2 [Source:HGNC Symbol;Acc:HGNC:8677]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007399(nervous system development);GO:0016020(membrane)","NA",{"v":5.6e-05,"d":"0.00"},1,"360,",0,-4.25,-3.56,4.85,"Exon (ENSBGRT00000040611/ENSBGRG00000021397, exon 1 of 4)",8,56418367,56648556,230190,1]
["chr8",56863307,56863574,268,"ENSBGRG00000023202","ENSBGRT00000042897",0,"PCDHB7","protocadherin beta 7 [Source:HGNC Symbol;Acc:HGNC:8692]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane)","NA",{"v":5.4e-05,"d":"0.00"},1,"268,",0,-4.27,-3.57,9.03,"Exon (ENSBGRT00000042897/ENSBGRG00000023202, exon 1 of 4)",8,56863307,56866458,3152,1]
["chr8",57081396,57081786,391,"ENSBGRG00000024033","ENSBGRT00000045398",82015,"PCDHGA4","protocadherin gamma subfamily A, 4 [Source:HGNC Symbol;Acc:HGNC:8702]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane)","NA",{"v":2.5e-17,"d":"0.00"},1,"391,",0,{"v":-16.6,"d":"-16.60"},{"v":-15.6,"d":"-15.60"},3.91,"Exon (ENSBGRT00000045534/ENSBGRG00000024033, exon 2 of 5)",8,56999381,57207978,208598,1]
["chr8",57032264,57032654,391,"ENSBGRG00000024033","ENSBGRT00000045398",32883,"PCDHGA4","protocadherin gamma subfamily A, 4 [Source:HGNC Symbol;Acc:HGNC:8702]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane)","NA",{"v":1.4E-5,"d":"0.00"},1,"391,",0,-4.86,-4.14,3.07,"Exon (ENSBGRT00000045760/ENSBGRG00000024767, exon 1 of 4)",8,56999381,57207978,208598,1]
["chr8",57094175,57096106,1932,"ENSBGRG00000024033","ENSBGRT00000045398",94794,"PCDHGA4","protocadherin gamma subfamily A, 4 [Source:HGNC Symbol;Acc:HGNC:8702]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane)","NA",{"v":2.5e-11,"d":"0.00"},2,"399,614,","0,1318",{"v":-10.6,"d":"-10.60"},{"v":-9.7,"d":"-9.70"},13,"Exon (ENSBGRT00000045936/ENSBGRG00000024880, exon 1 of 7)",8,56999381,57207978,208598,1]
["chr8",67034658,67035737,1080,"ENSBGRG00000020613","ENSBGRT00000037979",62112,"HMGXB3","HMG-box containing 3 [Source:HGNC Symbol;Acc:HGNC:28982]","NA","NA",{"v":1e-102,"d":"0.00"},1,"1080,",0,-102,-100,{"v":8.8,"d":"8.80"},"3' UTR",8,66972546,67035737,63192,1]
["chr8",68085746,68086045,300,"ENSBGRG00000006702","ENSBGRT00000012373",7919,"GPX3","glutathione peroxidase 3 [Source:HGNC Symbol;Acc:HGNC:4555]","GO:0004602(glutathione peroxidase activity);GO:0005615(extracellular space);GO:0006979(response to oxidative stress);GO:0008430(selenium binding);GO:0042802(identical protein binding);GO:0055114(oxidation-reduction process)","00590(Arachidonic acid metabolism);00480(Glutathione metabolism);04918(Thyroid hormone synthesis)",{"v":1E-193,"d":"0.00"},1,"300,",0,-193,-191,5.17,"3' UTR",8,68077827,68087093,9267,1]
["chr8",71475349,71475438,90,"ENSBGRG00000010249","ENSBGRT00000018854",4669,"MFAP3","microfibril associated protein 3 [Source:HGNC Symbol;Acc:HGNC:7034]","NA","NA",{"v":0.0029,"d":"0.00"},1,"90,",0,-2.54,-1.94,{"v":2.1,"d":"2.10"},"Exon (ENSBGRT00000018774/ENSBGRG00000010249, exon 2 of 2)",8,71470680,71475986,5307,1]
["chr8",86403460,86849841,446382,"ENSBGRG00000001510","ENSBGRT00000003188",0,"TENM2","teneurin transmembrane protein 2 [Source:HGNC Symbol;Acc:HGNC:29943]","GO:0005509(calcium ion binding);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0016021(integral component of membrane)","NA",{"v":0.011,"d":"0.01"},2,"67,84,","0,446298",-1.97,-1.19,9.03,"Exon (ENSBGRT00000003153/ENSBGRG00000001510, exon 2 of 29)",8,86849758,87476692,626935,1]
["chr8",88545940,88550659,4720,"ENSBGRG00000002055","ENSBGRT00000003833",299897,"RASGRF2","Ras protein specific guanine nucleotide releasing factor 2 [Source:HGNC Symbol;Acc:HGNC:9876]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005088(Ras guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0007264(small GTPase mediated signal transduction);GO:0034976(response to endoplasmic reticulum stress);GO:0035023(regulation of Rho protein signal transduction);GO:0046578(regulation of Ras protein signal transduction)","04014(Ras signaling pathway);04010(MAPK signaling pathway)",{"v":5.5e-06,"d":"0.00"},3,"109,69,93,","0,678,4627",-5.26,-4.53,2.33,"Exon (ENSBGRT00000003833/ENSBGRG00000002055, exon 25 of 27)",8,88246043,88550659,304617,1]
["chr8",105024085,105028054,3970,"ENSBGRG00000015110","ENSBGRT00000028237",0,"ERAP2","endoplasmic reticulum aminopeptidase 2 [Source:HGNC Symbol;Acc:HGNC:29499]","GO:0004177(aminopeptidase activity);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0019885(antigen processing and presentation of endogenous peptide antigen via MHC class I);GO:0070006(metalloaminopeptidase activity)","NA",{"v":0.00013,"d":"0.00"},2,"163,641,","0,3329",-3.89,-3.21,6.02,"5' UTR",8,105024085,105040723,16639,1]
["chr8",118986995,118987385,391,"ENSBGRG00000021097","ENSBGRT00000038904",243185,"MAN2A1","mannosidase alpha class 2A member 1 [Source:HGNC Symbol;Acc:HGNC:6824]","GO:0000139(Golgi membrane);GO:0001701(in utero embryonic development);GO:0001889(liver development);GO:0003824(catalytic activity);GO:0004559(alpha-mannosidase activity);GO:0005615(extracellular space);GO:0005794(Golgi apparatus);GO:0005797(Golgi medial cisterna);GO:0005801(cis-Golgi network);GO:0005975(carbohydrate metabolic process);GO:0006013(mannose metabolic process);GO:0006491(N-glycan processing);GO:0007005(mitochondrion organization);GO:0007033(vacuole organization);GO:0007585(respiratory gaseous exchange by respiratory system);GO:0015923(mannosidase activity);GO:0016787(hydrolase activity);GO:0016799(hydrolase activity, hydrolyzing N-glycosyl compounds);GO:0030246(carbohydrate binding);GO:0048286(lung alveolus development);GO:0050769(positive regulation of neurogenesis);GO:0060042(retina morphogenesis in camera-type eye)","00510(N-Glycan biosynthesis)",{"v":4E-52,"d":"0.00"},1,"391,",0,{"v":-51.4,"d":"-51.40"},{"v":-50.1,"d":"-50.10"},5.79,"3' UTR",8,118743810,118987945,244136,1]
["chr8",1828886,1829304,419,"ENSBGRG00000022043","ENSBGRT00000040967",32612,"AKAP8L","A-kinase anchoring protein 8 like [Source:HGNC Symbol;Acc:HGNC:29857]","GO:0000785(chromatin);GO:0003677(DNA binding);GO:0005521(lamin binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006397(mRNA processing);GO:0007076(mitotic chromosome condensation);GO:0010793(regulation of mRNA export from nucleus);GO:0016363(nuclear matrix);GO:0016607(nuclear speck);GO:0031065(positive regulation of histone deacetylation);GO:0033127(regulation of histone phosphorylation);GO:0042826(histone deacetylase binding);GO:0044839(cell cycle G2/M phase transition);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051081(nuclear envelope disassembly);GO:1990904(ribonucleoprotein complex)","05169(Epstein-Barr virus infection)",{"v":9.99999999999999e-252,"d":"0.00"},2,"309,20,","0,399",-251,-249,5.39,"Exon (ENSBGRT00000040967/ENSBGRG00000022043, exon 13 of 14)",8,1828886,1861916,33031,2]
["chr8",5023386,5023685,300,"ENSBGRG00000026182","ENSBGRT00000048433",3350,"ENSBGRG00000026182","MPV17 mitochondrial inner membrane protein like 2 [Source:HGNC Symbol;Acc:HGNC:28177]","GO:0016021(integral component of membrane)","04146(Peroxisome)",{"v":1e-15,"d":"0.00"},1,"300,",0,-15,{"v":-14.1,"d":"-14.10"},4.25,"3' UTR",8,5020036,5023936,3901,1]
["chr8",5900461,5900970,510,"ENSBGRG00000001163","ENSBGRT00000002199",10657,"HOMER3","homer scaffold protein 3 [Source:HGNC Symbol;Acc:HGNC:17514]","GO:0005829(cytosol);GO:0008022(protein C-terminus binding);GO:0014069(postsynaptic density);GO:0019904(protein domain specific binding);GO:0032703(negative regulation of interleukin-2 production);GO:0042802(identical protein binding);GO:0045178(basal part of cell);GO:0070885(negative regulation of calcineurin-NFAT signaling cascade)","04068(FoxO signaling pathway);04724(Glutamatergic synapse)",{"v":1.3e-27,"d":"0.00"},1,"510,",0,{"v":-26.9,"d":"-26.90"},{"v":-25.8,"d":"-25.80"},4.21,"3' UTR",8,5900192,5911627,11436,2]
["chr8",6010038,6010218,181,"ENSBGRG00000001227","ENSBGRT00000002251",9197,"SUGP2","SURP and G-patch domain containing 2 [Source:HGNC Symbol;Acc:HGNC:18641]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0006396(RNA processing);GO:0016604(nuclear body)","NA",{"v":8.5e-10,"d":"0.00"},1,"181,",0,-9.07,-8.23,1.35,"Exon (ENSBGRT00000002251/ENSBGRG00000001227, exon 3 of 11)",8,5984736,6019415,34680,2]
["chr8",7781677,7786191,4515,"ENSBGRG00000003387","ENSBGRT00000006301",5669,"TRIM11","tripartite motif containing 11 [Source:HGNC Symbol;Acc:HGNC:16281]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0019904(protein domain specific binding);GO:0032897(negative regulation of viral transcription);GO:0045087(innate immune response);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046597(negative regulation of viral entry into host cell);GO:0046598(positive regulation of viral entry into host cell);GO:0050768(negative regulation of neurogenesis);GO:0061630(ubiquitin protein ligase activity);GO:1902187(negative regulation of viral release from host cell)","NA",{"v":2e-53,"d":"0.00"},5,"548,101,23,231,49,","0,1041,1226,3783,4466",{"v":-52.7,"d":"-52.70"},{"v":-51.3,"d":"-51.30"},8.42,"Exon (ENSBGRT00000006301/ENSBGRG00000003387, exon 2 of 6)",8,7781677,7791860,10184,2]
["chr8",10132432,10132732,301,"ENSBGRG00000006109","ENSBGRT00000011428",24912,"FLT4","fms related tyrosine kinase 4 [Source:HGNC Symbol;Acc:HGNC:3767]","GO:0001934(positive regulation of protein phosphorylation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001946(lymphangiogenesis);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005021(vascular endothelial growth factor-activated receptor activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0010575(positive regulation of vascular endothelial growth factor production);GO:0010595(positive regulation of endothelial cell migration);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019838(growth factor binding);GO:0019903(protein phosphatase binding);GO:0035924(cellular response to vascular endothelial growth factor stimulus);GO:0036328(VEGF-C-activated receptor activity);GO:0038084(vascular endothelial growth factor signaling pathway);GO:0042803(protein homodimerization activity);GO:0043066(negative regulation of apoptotic process);GO:0043235(receptor complex);GO:0043410(positive regulation of MAPK cascade);GO:0046330(positive regulation of JNK cascade);GO:0046777(protein autophosphorylation);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0090037(positive regulation of protein kinase C signaling)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);05200(Pathways in cancer);05224(Breast cancer)",{"v":6.3E-3,"d":"0.01"},1,"301,",0,{"v":-2.2,"d":"-2.20"},-1.62,6.02,"3' UTR",8,10113864,10157644,43781,2]
["chr8",12839635,12839995,361,"ENSBGRG00000023559","ENSBGRT00000043770",13577,"PRKACA","protein kinase cAMP-activated catalytic subunit alpha [Source:HGNC Symbol;Acc:HGNC:9380]","GO:0000287(magnesium ion binding);GO:0001669(acrosomal vesicle);GO:0001707(mesoderm formation);GO:0001843(neural tube closure);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004691(cAMP-dependent protein kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005930(axoneme);GO:0005952(cAMP-dependent protein kinase complex);GO:0006397(mRNA processing);GO:0006468(protein phosphorylation);GO:0010737(protein kinase A signaling);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0030145(manganese ion binding);GO:0031594(neuromuscular junction);GO:0031625(ubiquitin protein ligase binding);GO:0034237(protein kinase A regulatory subunit binding);GO:0034605(cellular response to heat);GO:0036126(sperm flagellum);GO:0043197(dendritic spine);GO:0044853(plasma membrane raft);GO:0045171(intercellular bridge);GO:0045667(regulation of osteoblast differentiation);GO:0046777(protein autophosphorylation);GO:0046827(positive regulation of protein export from nucleus);GO:0048240(sperm capacitation);GO:0048471(perinuclear region of cytoplasm);GO:0050804(modulation of chemical synaptic transmission);GO:0061136(regulation of proteasomal protein catabolic process);GO:0070613(regulation of protein processing);GO:0071158(positive regulation of cell cycle arrest);GO:0071333(cellular response to glucose stimulus);GO:0071374(cellular response to parathyroid hormone stimulus);GO:0097546(ciliary base);GO:1901621(negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning);GO:2000810(regulation of bicellular tight junction assembly)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04310(Wnt signaling pathway);04340(Hedgehog signaling pathway);04371(Apelin signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04140(Autophagy - animal);04114(Oocyte meiosis);04530(Tight junction);04540(Gap junction);04611(Platelet activation);04062(Chemokine signaling pathway);04911(Insulin secretion);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04923(Regulation of lipolysis in adipocyte);04912(GnRH signaling pathway);04913(Ovarian Steroidogenesis);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04918(Thyroid hormone synthesis);04919(Thyroid hormone signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);04916(Melanogenesis);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04976(Bile secretion);04962(Vasopressin-regulated water reabsorption);04961(Endocrine and other factor-regulated calcium reabsorption);04724(Glutamatergic synapse);04727(GABAergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04720(Long-term potentiation);04723(Retrograde endocannabinoid signaling);04740(Olfactory transduction);04742(Taste transduction);04750(Inflammatory mediator regulation of TRP channels);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);04713(Circadian entrainment);04714(Thermogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05203(Viral carcinogenesis);05012(Parkinson disease);05020(Prion diseases);05030(Cocaine addiction);05031(Amphetamine addiction);05032(Morphine addiction);05414(Dilated cardiomyopathy (DCM));04934(Cushing syndrome);05166(HTLV-I infection);05163(Human cytomegalovirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05146(Amoebiasis);01522(Endocrine resistance)",{"v":6.3e-41,"d":"0.00"},1,"361,",0,{"v":-40.2,"d":"-40.20"},-39,2.33,"3' UTR",8,12839066,12853572,14507,2]
["chr8",13233397,13233813,417,"ENSBGRG00000000944","ENSBGRT00000001734",6189,"ENSBGRG00000000944","NA","GO:0006457(protein folding);GO:0051082(unfolded protein binding)","04141(Protein processing in endoplasmic reticulum);05164(Influenza A)",{"v":4e-13,"d":"0.00"},1,"417,",0,{"v":-12.4,"d":"-12.40"},{"v":-11.5,"d":"-11.50"},1.89,"3' UTR",8,13232653,13240002,7350,2]
["chr8",15173901,15174353,453,"ENSBGRG00000002843","ENSBGRT00000005366",457,"ENSBGRG00000002843","NA","GO:0003676(nucleic acid binding)","04514(Cell adhesion molecules (CAMs))",{"v":5e-18,"d":"0.00"},3,"9,188,164,","0,12,289",{"v":-17.3,"d":"-17.30"},{"v":-16.3,"d":"-16.30"},3.39,"5' UTR",8,15159574,15174810,15237,2]
["chr8",16371066,16372278,1213,"ENSBGRG00000013329","ENSBGRT00000024485",0,"ZNF653","zinc finger protein 653 [Source:HGNC Symbol;Acc:HGNC:25196]","GO:0003676(nucleic acid binding);GO:0003714(transcription corepressor activity);GO:0008134(transcription factor binding);GO:0050682(AF-2 domain binding);GO:1900116(extracellular negative regulation of signal transduction);GO:1903507(negative regulation of nucleic acid-templated transcription)","04010(MAPK signaling pathway)",{"v":3.2e-27,"d":"0.00"},3,"355,106,16,","0,931,1197",{"v":-26.5,"d":"-26.50"},{"v":-25.4,"d":"-25.40"},4.04,"5' UTR",8,16352388,16372102,19715,2]
["chr8",18467265,18470280,3016,"ENSBGRG00000025920","ENSBGRT00000047970",0,"TRIP10","thyroid hormone receptor interactor 10 [Source:HGNC Symbol;Acc:HGNC:12304]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006897(endocytosis);GO:0030036(actin cytoskeleton organization);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle)","04910(Insulin signaling pathway)",{"v":2.5e-13,"d":"0.00"},4,"100,57,116,24,","0,978,1119,2992",{"v":-12.6,"d":"-12.60"},{"v":-11.7,"d":"-11.70"},2.45,"Exon (ENSBGRT00000047970/ENSBGRG00000025920, exon 1 of 15)",8,18459025,18470280,11256,2]
["chr8",19354558,19360920,6363,"ENSBGRG00000001261","ENSBGRT00000002299",0,"NRTN","neurturin [Source:HGNC Symbol;Acc:HGNC:8007]","GO:0001755(neural crest cell migration);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0008083(growth factor activity);GO:0021675(nerve development);GO:0031175(neuron projection development)","NA",{"v":6.3E-3,"d":"0.01"},2,"10,169,","0,6194",{"v":-2.2,"d":"-2.20"},-1.63,5.52,"Exon (ENSBGRT00000002299/ENSBGRG00000001261, exon 1 of 2)",8,19354143,19360920,6778,2]
["chr8",20717178,20717478,301,"ENSBGRG00000015141","ENSBGRT00000027945",23396,"CHAF1A","chromatin assembly factor 1 subunit A [Source:HGNC Symbol;Acc:HGNC:1910]","GO:0000790(nuclear chromatin);GO:0006335(DNA replication-dependent nucleosome assembly);GO:0031497(chromatin assembly);GO:0032991(protein-containing complex);GO:0033186(CAF-1 complex);GO:0042802(identical protein binding);GO:0070087(chromo shadow domain binding)","NA",{"v":5e-11,"d":"0.00"},1,"301,",0,{"v":-10.3,"d":"-10.30"},-9.48,4.66,"Exon (ENSBGRT00000027945/ENSBGRG00000015141, exon 14 of 16)",8,20711954,20740874,28921,2]
["chr8",21506742,21506864,123,"ENSBGRG00000021216","ENSBGRT00000039198",7825,"C19orf71","chromosome 19 open reading frame 71 [Source:HGNC Symbol;Acc:HGNC:34496]","NA","NA",{"v":0.011,"d":"0.01"},2,"3,117,","0,6",-1.97,-1.14,9.03,"Exon (ENSBGRT00000039198/ENSBGRG00000021216, exon 4 of 5)",8,21506742,21514689,7948,2]
["chr8",23074229,23074494,266,"ENSBGRG00000002683","ENSBGRT00000005040",1972,"IL13","interleukin 13 [Source:HGNC Symbol;Acc:HGNC:5973]","GO:0005126(cytokine receptor binding);GO:0005576(extracellular region);GO:0006955(immune response);GO:0010628(positive regulation of gene expression);GO:0032733(positive regulation of interleukin-10 production);GO:0042116(macrophage activation);GO:0050728(negative regulation of inflammatory response);GO:1903660(negative regulation of complement-dependent cytotoxicity);GO:2000352(negative regulation of endothelial cell apoptotic process)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04658(Th1 and Th2 cell differentiation);04657(IL-17 signaling pathway);04664(Fc epsilon RI signaling pathway);05200(Pathways in cancer);05310(Asthma);05321(Inflammatiory bowel disease (IBD));05162(Measles)",{"v":2E-3,"d":"0.00"},1,"266,",0,-2.69,-2.08,7.02,"3' UTR",8,23073642,23076466,2825,2]
["chr8",25546465,25547802,1338,"ENSBGRG00000006040","ENSBGRT00000011154",324204,"CHSY3","chondroitin sulfate synthase 3 [Source:HGNC Symbol;Acc:HGNC:24293]","GO:0008376(acetylgalactosaminyltransferase activity);GO:0032580(Golgi cisterna membrane)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)",{"v":2.4E-9,"d":"0.00"},1,"1338,",0,-8.62,-7.79,{"v":23.1,"d":"23.10"},"Exon (ENSBGRT00000011154/ENSBGRG00000006040, exon 4 of 4)",8,25546465,25872006,325542,2]
["chr8",34014383,34015008,626,"ENSBGRG00000011514","ENSBGRT00000020969",31973,"ENSBGRG00000011514","NA","NA","NA",{"v":0.0032,"d":"0.00"},1,"626,",0,{"v":-2.5,"d":"-2.50"},-1.91,11,"5' UTR",8,33980962,34046981,66020,2]
["chr8",42086713,42087515,803,"ENSBGRG00000019280","ENSBGRT00000035923",7444,"DBN1","drebrin 1 [Source:HGNC Symbol;Acc:HGNC:2695]","GO:0003779(actin binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005921(gap junction);GO:0007015(actin filament organization);GO:0010643(cell communication by chemical coupling);GO:0010644(cell communication by electrical coupling);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0030425(dendrite);GO:0030426(growth cone);GO:0031915(positive regulation of synaptic plasticity);GO:0032507(maintenance of protein location in cell);GO:0048699(generation of neurons);GO:0051220(cytoplasmic sequestering of protein);GO:0061003(positive regulation of dendritic spine morphogenesis);GO:0061351(neural precursor cell proliferation);GO:0098978(glutamatergic synapse);GO:0099524(postsynaptic cytosol);GO:1902685(positive regulation of receptor localization to synapse)","NA",{"v":1e-121,"d":"0.00"},2,"350,99,","0,704",-121,-119,2.99,"Exon (ENSBGRT00000035923/ENSBGRG00000019280, exon 9 of 12)",8,42085735,42094959,9225,2]
["chr8",43711323,43711917,595,"ENSBGRG00000013560","ENSBGRT00000024917",0,"ENSBGRG00000013560","NA","GO:0005515(protein binding);GO:0008270(zinc ion binding)","05162(Measles)",{"v":2e-38,"d":"0.00"},1,"595,",0,{"v":-37.7,"d":"-37.70"},{"v":-36.4,"d":"-36.40"},5.89,"Exon (ENSBGRT00000024917/ENSBGRG00000013560, exon 1 of 3)",8,43683366,43711917,28552,2]
["chr8",43854515,43861496,6982,"ENSBGRG00000014412","ENSBGRT00000026482",42587,"ZNF496","zinc finger protein 496 [Source:HGNC Symbol;Acc:HGNC:23713]","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":2e-74,"d":"0.00"},2,"980,69,","0,6913",{"v":-73.7,"d":"-73.70"},{"v":-72.1,"d":"-72.10"},7.13,"3' UTR",8,43853737,43904083,50347,2]
["chr8",47515516,47515696,181,"ENSBGRG00000016801","ENSBGRT00000030831",6352,"ADAMTSL5","ADAMTS like 5 [Source:HGNC Symbol;Acc:HGNC:27912]","GO:0005515(protein binding);GO:0031012(extracellular matrix)","NA",{"v":2e-07,"d":"0.00"},1,"181,",0,{"v":-6.7,"d":"-6.70"},-5.92,{"v":1.4,"d":"1.40"},"3' UTR",8,47513605,47522048,8444,2]
["chr8",48094101,48094660,560,"ENSBGRG00000000396","ENSBGRT00000000661",8406,"SHROOM1","shroom family member 1 [Source:HGNC Symbol;Acc:HGNC:24084]","GO:0000902(cell morphogenesis);GO:0045159(myosin II binding);GO:0051015(actin filament binding);GO:0051017(actin filament bundle assembly)","NA",{"v":0.00016,"d":"0.00"},2,"359,2,","0,558",-3.79,-3.12,2.71,"Exon (ENSBGRT00000000661/ENSBGRG00000000396, exon 5 of 9)",8,48092851,48103066,10216,2]
["chr8",55065358,55066841,1484,"ENSBGRG00000011739","ENSBGRT00000021691",0,"SPATA24","spermatogenesis associated 24 [Source:HGNC Symbol;Acc:HGNC:27322]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0042802(identical protein binding)","NA",{"v":8.9e-08,"d":"0.00"},3,"26,66,117,","0,254,1367",-7.05,-6.27,2.39,"Exon (ENSBGRT00000021691/ENSBGRG00000011739, exon 1 of 7)",8,55059981,55066841,6861,2]
["chr8",56227771,56228162,392,"ENSBGRG00000016751","ENSBGRT00000030811",5385,"SRA1","steroid receptor RNA activator 1 [Source:HGNC Symbol;Acc:HGNC:11281]","GO:0002153(steroid receptor RNA activator RNA binding);GO:0003677(DNA binding);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007346(regulation of mitotic cell cycle);GO:0015630(microtubule cytoskeleton);GO:0030154(cell differentiation);GO:0030374(nuclear receptor transcription coactivator activity);GO:0031209(SCAR complex);GO:0031252(cell leading edge);GO:0042981(regulation of apoptotic process);GO:0045171(intercellular bridge);GO:0045662(negative regulation of myoblast differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0071391(cellular response to estrogen stimulus);GO:1990904(ribonucleoprotein complex)","NA",{"v":4e-22,"d":"0.00"},2,"212,27,","0,365",{"v":-21.4,"d":"-21.40"},{"v":-20.4,"d":"-20.40"},{"v":2.3,"d":"2.30"},"Exon (ENSBGRT00000030811/ENSBGRG00000016751, exon 5 of 6)",8,56227771,56233547,5777,2]
["chr8",57712107,57712826,720,"ENSBGRG00000025686","ENSBGRT00000047492",1976,"PCDH12","protocadherin 12 [Source:HGNC Symbol;Acc:HGNC:8657]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005977(glycogen metabolic process);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0060711(labyrinthine layer development)","NA",{"v":5e-33,"d":"0.00"},1,"720,",0,{"v":-32.3,"d":"-32.30"},{"v":-31.1,"d":"-31.10"},6.25,"Exon (ENSBGRT00000047492/ENSBGRG00000025686, exon 1 of 4)",8,57700659,57714802,14144,2]
["chr8",65951878,65952088,211,"ENSBGRG00000018333","ENSBGRT00000033602",37160,"SH3TC2","SH3 domain and tetratricopeptide repeats 2 [Source:HGNC Symbol;Acc:HGNC:29427]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0022011(myelination in peripheral nervous system);GO:0031410(cytoplasmic vesicle);GO:0032287(peripheral nervous system myelin maintenance);GO:0033157(regulation of intracellular protein transport);GO:1901184(regulation of ERBB signaling pathway)","NA",{"v":0.0021,"d":"0.00"},1,"211,",0,-2.68,-2.07,2.76,"Exon (ENSBGRT00000033602/ENSBGRG00000018333, exon 10 of 17)",8,65862815,65989248,126434,2]
["chr8",68086410,68089269,2860,"ENSBGRG00000006702","ENSBGRT00000012373",8583,"GPX3","glutathione peroxidase 3 [Source:HGNC Symbol;Acc:HGNC:4555]","GO:0004602(glutathione peroxidase activity);GO:0005615(extracellular space);GO:0006979(response to oxidative stress);GO:0008430(selenium binding);GO:0042802(identical protein binding);GO:0055114(oxidation-reduction process)","00590(Arachidonic acid metabolism);00480(Glutathione metabolism);04918(Thyroid hormone synthesis)",{"v":9.99999999999998e-234,"d":"0.00"},3,"645,91,134,","0,1853,2726",-233,-230,11,"3' UTR",8,68077827,68087093,9267,1]
["chr8",68158094,68158393,300,"ENSBGRG00000006833","ENSBGRT00000012702",56472,"ANXA6","annexin A6 [Source:HGNC Symbol;Acc:HGNC:544]","GO:0005509(calcium ion binding);GO:0005525(GTP binding);GO:0005544(calcium-dependent phospholipid binding);GO:0005765(lysosomal membrane);GO:0006816(calcium ion transport);GO:0006937(regulation of muscle contraction);GO:0008289(lipid binding);GO:0015276(ligand-gated ion channel activity);GO:0015485(cholesterol binding);GO:0031902(late endosome membrane);GO:0034220(ion transmembrane transport);GO:0042802(identical protein binding);GO:0048306(calcium-dependent protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0051560(mitochondrial calcium ion homeostasis);GO:0097190(apoptotic signaling pathway)","NA",0,1,"300,",0,-461,"-Inf",{"v":17.8,"d":"17.80"},"3' UTR",8,68158094,68214865,56772,2]
["chr8",78086199,78228681,142483,"ENSBGRG00000017485","ENSBGRT00000032144",0,"PWWP2A","PWWP domain containing 2A [Source:HGNC Symbol;Acc:HGNC:29406]","GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0042025(host cell nucleus);GO:0042393(histone binding)","04068(FoxO signaling pathway)",{"v":0.0025,"d":"0.00"},2,"1318,264,","0,142219",-2.61,-2,5.01,"5' UTR",8,78053226,78087516,34291,2]
["chr8",96310725,96313568,2844,"ENSBGRG00000003562","ENSBGRT00000006694",63432,"MEF2C","myocyte enhancer factor 2C [Source:HGNC Symbol;Acc:HGNC:6996]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000165(MAPK cascade);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001568(blood vessel development);GO:0001649(osteoblast differentiation);GO:0001764(neuron migration);GO:0001782(B cell homeostasis);GO:0001947(heart looping);GO:0001958(endochondral ossification);GO:0001974(blood vessel remodeling);GO:0002062(chondrocyte differentiation);GO:0002467(germinal center formation);GO:0002634(regulation of germinal center formation);GO:0003138(primary heart field specification);GO:0003139(secondary heart field specification);GO:0003151(outflow tract morphogenesis);GO:0003185(sinoatrial valve morphogenesis);GO:0003211(cardiac ventricle formation);GO:0003677(DNA binding);GO:0003680(AT DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006959(humoral immune response);GO:0007507(heart development);GO:0007519(skeletal muscle tissue development);GO:0007521(muscle cell fate determination);GO:0007611(learning or memory);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010694(positive regulation of alkaline phosphatase activity);GO:0014033(neural crest cell differentiation);GO:0014898(cardiac muscle hypertrophy in response to stress);GO:0014902(myotube differentiation);GO:0016607(nuclear speck);GO:0030182(neuron differentiation);GO:0030220(platelet formation);GO:0030224(monocyte differentiation);GO:0030279(negative regulation of ossification);GO:0030318(melanocyte differentiation);GO:0030501(positive regulation of bone mineralization);GO:0030890(positive regulation of B cell proliferation);GO:0032991(protein-containing complex);GO:0033613(activating transcription factor binding);GO:0035690(cellular response to drug);GO:0035914(skeletal muscle cell differentiation);GO:0035984(cellular response to trichostatin A);GO:0042100(B cell proliferation);GO:0042826(histone deacetylase binding);GO:0043231(intracellular membrane-bounded organelle);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0043537(negative regulation of blood vessel endothelial cell migration);GO:0043565(sequence-specific DNA binding);GO:0045165(cell fate commitment);GO:0045652(regulation of megakaryocyte differentiation);GO:0045663(positive regulation of myoblast differentiation);GO:0045666(positive regulation of neuron differentiation);GO:0045669(positive regulation of osteoblast differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046928(regulation of neurotransmitter secretion);GO:0046982(protein heterodimerization activity);GO:0046983(protein dimerization activity);GO:0048167(regulation of synaptic plasticity);GO:0048643(positive regulation of skeletal muscle tissue development);GO:0048666(neuron development);GO:0048667(cell morphogenesis involved in neuron differentiation);GO:0048703(embryonic viscerocranium morphogenesis);GO:0048704(embryonic skeletal system morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0050853(B cell receptor signaling pathway);GO:0051145(smooth muscle cell differentiation);GO:0051963(regulation of synapse assembly);GO:0051966(regulation of synaptic transmission, glutamatergic);GO:0055007(cardiac muscle cell differentiation);GO:0055012(ventricular cardiac muscle cell differentiation);GO:0060021(roof of mouth development);GO:0060025(regulation of synaptic activity);GO:0060045(positive regulation of cardiac muscle cell proliferation);GO:0060079(excitatory postsynaptic potential);GO:0060297(regulation of sarcomere organization);GO:0060536(cartilage morphogenesis);GO:0060998(regulation of dendritic spine development);GO:0061333(renal tubule morphogenesis);GO:0071222(cellular response to lipopolysaccharide);GO:0071277(cellular response to calcium ion);GO:0071374(cellular response to parathyroid hormone stimulus);GO:0071498(cellular response to fluid shear stress);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:0071837(HMG box domain binding);GO:0071864(positive regulation of cell proliferation in bone marrow);GO:0072102(glomerulus morphogenesis);GO:0072160(nephron tubule epithelial cell differentiation);GO:1904706(negative regulation of vascular smooth muscle cell proliferation);GO:1904753(negative regulation of vascular associated smooth muscle cell migration);GO:1905563(negative regulation of vascular endothelial cell proliferation);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000111(positive regulation of macrophage apoptotic process);GO:2000310(regulation of NMDA receptor activity);GO:2000311(regulation of AMPA receptor activity);GO:2000727(positive regulation of cardiac muscle cell differentiation);GO:2000987(positive regulation of behavioral fear response);GO:2001013(epithelial cell proliferation involved in renal tubule morphogenesis);GO:2001016(positive regulation of skeletal muscle cell differentiation)","04010(MAPK signaling pathway);04371(Apelin signaling pathway);04022(cGMP - PKG signaling pathway);04921(Oxytocin signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);05202(Transcriptional misregulation in cancers);05418(Fluid shear stress and atherosclerosis)",{"v":4.2E-7,"d":"0.00"},3,"188,196,36,","0,845,2808",-6.38,-5.61,{"v":21.1,"d":"21.10"},"5' UTR",8,96194136,96377000,182865,2]
["chr8",109125951,109215615,89665,"ENSBGRG00000017706","ENSBGRT00000032453",23832,"ST8SIA4","ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:10871]","GO:0001574(ganglioside biosynthetic process);GO:0003828(alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity);GO:0006486(protein glycosylation);GO:0006491(N-glycan processing);GO:0008373(sialyltransferase activity);GO:0009311(oligosaccharide metabolic process)","NA",{"v":3.2e-22,"d":"0.00"},3,"751,294,153,","0,65026,89512",{"v":-21.5,"d":"-21.50"},{"v":-20.5,"d":"-20.50"},5.62,"3' UTR",8,109125951,109239447,113497,2]
["chr8",119511672,119645968,134297,"ENSBGRG00000010714","ENSBGRT00000019581",0,"ENSBGRG00000010714","NA","NA","NA",{"v":1.3E-6,"d":"0.00"},3,"206,94,30,","0,4069,134267",-5.87,-5.12,6.02,"3' UTR",8,119522748,119531640,8893,2]
["chr9",6173705,6174992,1288,"ENSBGRG00000004090","ENSBGRT00000007575",209,"ZBTB43","zinc finger and BTB domain containing 43 [Source:HGNC Symbol;Acc:HGNC:17908]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":2e-13,"d":"0.00"},1,"1288,",0,{"v":-12.7,"d":"-12.70"},{"v":-11.8,"d":"-11.80"},5.83,"Exon (ENSBGRT00000007575/ENSBGRG00000004090, exon 1 of 1)",9,6173496,6174992,1497,1]
["chr9",7752214,7752514,301,"ENSBGRG00000010359","ENSBGRT00000019155",36554,"CERCAM","cerebral endothelial cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:23723]","GO:0007155(cell adhesion);GO:0042802(identical protein binding)","00310(Lysine degradation);00514(Other types of O-glycan biosynthesis)",{"v":0.00013,"d":"0.00"},1,"301,",0,-3.87,{"v":-3.2,"d":"-3.20"},8.52,"5' UTR",9,7715660,7767805,52146,1]
["chr9",9121473,9124167,2695,"ENSBGRG00000019140","ENSBGRT00000035212",178,"TOR1B","torsin family 1 member B [Source:HGNC Symbol;Acc:HGNC:11995]","GO:0005524(ATP binding);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0007029(endoplasmic reticulum organization);GO:0016887(ATPase activity);GO:0042802(identical protein binding);GO:0051085(chaperone cofactor-dependent protein refolding);GO:0071763(nuclear membrane organization)","NA",{"v":1.3E-6,"d":"0.00"},3,"21,266,41,","0,654,2654",{"v":-5.9,"d":"-5.90"},-5.14,2.21,"Exon (ENSBGRT00000035212/ENSBGRG00000019140, exon 1 of 5)",9,9121295,9128228,6934,1]
["chr9",11496953,11497498,546,"ENSBGRG00000014300","ENSBGRT00000026251",5185,"NTNG2","netrin G2 [Source:HGNC Symbol;Acc:HGNC:14288]","GO:0005886(plasma membrane);GO:0007409(axonogenesis);GO:0010975(regulation of neuron projection development);GO:0030424(axon);GO:0045171(intercellular bridge);GO:0046658(anchored component of plasma membrane);GO:0050804(modulation of chemical synaptic transmission);GO:0090543(Flemming body);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099029(anchored component of presynaptic active zone membrane);GO:0150011(regulation of neuron projection arborization);GO:2001222(regulation of neuron migration)","04514(Cell adhesion molecules (CAMs));04360(Axon guidance)",{"v":6.3e-87,"d":"0.00"},2,"147,212,","0,334",{"v":-86.2,"d":"-86.20"},{"v":-84.5,"d":"-84.50"},{"v":6.8,"d":"6.80"},"5' UTR",9,11491768,11572356,80589,1]
["chr9",13283077,13283795,719,"ENSBGRG00000024972","ENSBGRT00000046261",9426,"GPSM1","G protein signaling modulator 1 [Source:HGNC Symbol;Acc:HGNC:17858]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0030695(GTPase regulator activity)","05030(Cocaine addiction)",{"v":0.032,"d":"0.03"},2,"161,139,","0,580",{"v":-1.5,"d":"-1.50"},{"v":-0.989,"d":"-0.99"},2.81,"5' UTR",9,13273651,13307844,34194,1]
["chr9",14465440,14465694,255,"ENSBGRG00000004918","ENSBGRT00000009048",0,"ENSBGRG00000004918","NA","NA","NA",{"v":7.4e-09,"d":"0.00"},1,"255,",0,-8.13,-7.32,3.56,"Exon (ENSBGRT00000009048/ENSBGRG00000004918, exon 1 of 1)",9,14465440,14465694,255,1]
["chr9",15919276,15919483,208,"ENSBGRG00000008372","ENSBGRT00000015342",1116,"PAXX","PAXX non-homologous end joining factor [Source:HGNC Symbol;Acc:HGNC:27849]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0006974(cellular response to DNA damage stimulus);GO:0035861(site of double-strand break);GO:0042803(protein homodimerization activity);GO:0043564(Ku70:Ku80 complex);GO:0051103(DNA ligation involved in DNA repair);GO:0060090(molecular adaptor activity);GO:0070419(nonhomologous end joining complex)","NA",{"v":5e-12,"d":"0.00"},1,"208,",0,{"v":-11.3,"d":"-11.30"},{"v":-10.4,"d":"-10.40"},1.98,"Exon (ENSBGRT00000015342/ENSBGRG00000008372, exon 6 of 6)",9,15918160,15919446,1287,1]
["chr9",16124172,16124858,687,"ENSBGRG00000010293","ENSBGRT00000018898",0,"ANAPC2","anaphase promoting complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:19989]","GO:0005680(anaphase-promoting complex);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0031625(ubiquitin protein ligase binding);GO:0031915(positive regulation of synaptic plasticity);GO:0070979(protein K11-linked ubiquitination);GO:0090129(positive regulation of synapse maturation)","04120(Ubiquitin mediated proteolysis);04110(Cell cycle);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation);05166(HTLV-I infection)",{"v":2E-19,"d":"0.00"},2,"171,130,","0,557",{"v":-18.7,"d":"-18.70"},{"v":-17.7,"d":"-17.70"},3.46,"5' UTR",9,16111646,16124292,12647,2]
["chr9",19063166,19073222,10057,"ENSBGRG00000026769","ENSBGRT00000049639",63343,"NPHP1","nephrocystin 1 [Source:HGNC Symbol;Acc:HGNC:7905]","GO:0005515(protein binding);GO:0005911(cell-cell junction);GO:0031514(motile cilium);GO:1903348(positive regulation of bicellular tight junction assembly)","NA",{"v":1e-30,"d":"0.00"},4,"13,74,45,735,","0,2163,3360,9322",-30,{"v":-28.9,"d":"-28.90"},4.65,"3' UTR",9,18999823,19073760,73938,1]
["chr9",21985843,21986387,545,"ENSBGRG00000026830","ENSBGRT00000049764",16218,"ENSBGRG00000026830","NA","GO:0003735(structural constituent of ribosome);GO:0006412(translation);GO:0015934(large ribosomal subunit)","03010(Ribosome)",{"v":0.00038,"d":"0.00"},3,"42,74,118,","0,275,427",-3.42,-2.76,1.49,"Exon (ENSBGRT00000049764/ENSBGRG00000026830, exon 4 of 7)",9,21969625,22002052,32428,1]
["chr9",28488425,28488484,60,"ENSBGRG00000006598","ENSBGRT00000012232",14015,"LOXL3","lysyl oxidase like 3 [Source:HGNC Symbol;Acc:HGNC:13869]","GO:0001837(epithelial to mesenchymal transition);GO:0001968(fibronectin binding);GO:0004720(protein-lysine 6-oxidase activity);GO:0005044(scavenger receptor activity);GO:0005507(copper ion binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006954(inflammatory response);GO:0016020(membrane);GO:0016641(oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor);GO:0018057(peptidyl-lysine oxidation);GO:0021510(spinal cord development);GO:0030324(lung development);GO:0045892(negative regulation of transcription, DNA-templated);GO:0055114(oxidation-reduction process);GO:0060021(roof of mouth development);GO:0061053(somite development);GO:1905590(fibronectin fibril organization);GO:2000329(negative regulation of T-helper 17 cell lineage commitment);GO:2001046(positive regulation of integrin-mediated signaling pathway)","NA",{"v":0.049,"d":"0.05"},1,"60,",0,-1.31,{"v":-0.814,"d":"-0.81"},1.47,"Exon (ENSBGRT00000012232/ENSBGRG00000006598, exon 4 of 13)",9,28474410,28492162,17753,1]
["chr9",28837363,28841822,4460,"ENSBGRG00000010120","ENSBGRT00000018538",0,"ENSBGRG00000010120","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":3.2e-05,"d":"0.00"},4,"31,81,4,35,","0,1689,3362,4425",-4.49,-3.79,{"v":10.5,"d":"10.50"},"Exon (ENSBGRT00000018462/ENSBGRG00000009863, exon 24 of 27)",9,28839493,28840509,1017,2]
["chr9",30029338,30041845,12508,"ENSBGRG00000013201","ENSBGRT00000024487",144662,"SFXN5","sideroflexin 5 [Source:HGNC Symbol;Acc:HGNC:16073]","GO:0005739(mitochondrion);GO:0006811(ion transport);GO:0015075(ion transmembrane transporter activity);GO:0016020(membrane);GO:0055085(transmembrane transport)","04120(Ubiquitin mediated proteolysis)",{"v":0.014,"d":"0.01"},2,"748,209,","0,12299",-1.85,{"v":-1.3,"d":"-1.30"},4.01,"3' UTR",9,29884676,30030085,145410,1]
["chr9",34342332,34361724,19393,"ENSBGRG00000008248","ENSBGRT00000015075",162021,"TTC27","tetratricopeptide repeat domain 27 [Source:HGNC Symbol;Acc:HGNC:25986]","GO:0005515(protein binding)","04120(Ubiquitin mediated proteolysis)",{"v":1.3E-20,"d":"0.00"},2,"125,115,","0,19278",{"v":-19.9,"d":"-19.90"},{"v":-18.9,"d":"-18.90"},2.09,"Exon (ENSBGRT00000015075/ENSBGRG00000008248, exon 16 of 20)",9,34180311,34371460,191150,1]
["chr9",49367365,49368975,1611,"ENSBGRG00000007750","ENSBGRT00000014163",0,"SOCS5","suppressor of cytokine signaling 5 [Source:HGNC Symbol;Acc:HGNC:16852]","GO:0005154(epidermal growth factor receptor binding);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007175(negative regulation of epidermal growth factor-activated receptor activity);GO:0007259(receptor signaling pathway via JAK-STAT);GO:0019221(cytokine-mediated signaling pathway);GO:0030971(receptor tyrosine kinase binding);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032715(negative regulation of interleukin-6 production);GO:0035556(intracellular signal transduction);GO:0045627(positive regulation of T-helper 1 cell differentiation);GO:0045629(negative regulation of T-helper 2 cell differentiation);GO:0050728(negative regulation of inflammatory response);GO:0071404(cellular response to low-density lipoprotein particle stimulus);GO:0071638(negative regulation of monocyte chemotactic protein-1 production);GO:0097699(vascular endothelial cell response to fluid shear stress)","04630(Jak-STAT signaling pathway);04917(Prolactin signaling pathway)",{"v":4e-96,"d":"0.00"},1,"1611,",0,{"v":-95.4,"d":"-95.40"},{"v":-93.7,"d":"-93.70"},8.77,"Exon (ENSBGRT00000014163/ENSBGRG00000007750, exon 1 of 1)",9,49367365,49368975,1611,1]
["chr9",51039933,51040529,597,"ENSBGRG00000010377","ENSBGRT00000019188",24407,"FOXN2","forkhead box N2 [Source:HGNC Symbol;Acc:HGNC:5281]","GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0035914(skeletal muscle cell differentiation);GO:0043231(intracellular membrane-bounded organelle);GO:0043565(sequence-specific DNA binding);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":5.2E-7,"d":"0.00"},1,"597,",0,-6.28,-5.52,3.93,"3' UTR",9,51015526,51041304,25779,1]
["chr9",65432241,65464430,32190,"ENSBGRG00000007532","ENSBGRT00000013782",0,"PEX13","peroxisomal biogenesis factor 13 [Source:HGNC Symbol;Acc:HGNC:8855]","GO:0001561(fatty acid alpha-oxidation);GO:0001764(neuron migration);GO:0001967(suckling behavior);GO:0005515(protein binding);GO:0005777(peroxisome);GO:0005778(peroxisomal membrane);GO:0005779(integral component of peroxisomal membrane);GO:0007626(locomotory behavior);GO:0016021(integral component of membrane);GO:0016560(protein import into peroxisome matrix, docking);GO:0021795(cerebral cortex cell migration);GO:0043231(intracellular membrane-bounded organelle);GO:0060152(microtubule-based peroxisome localization)","04146(Peroxisome)",{"v":2.5e-28,"d":"0.00"},3,"92,695,100,","0,27462,32090",{"v":-27.6,"d":"-27.60"},{"v":-26.5,"d":"-26.50"},6.12,"Exon (ENSBGRT00000013782/ENSBGRG00000007532, exon 1 of 4)",9,65432241,65467092,34852,1]
["chr9",70125779,70130537,4759,"ENSBGRG00000018104","ENSBGRT00000033133",25092,"KRCC1","lysine rich coiled-coil 1 [Source:HGNC Symbol;Acc:HGNC:28039]","NA","NA",{"v":1.3e-71,"d":"0.00"},4,"53,113,71,893,","0,852,3468,3866",{"v":-70.9,"d":"-70.90"},{"v":-69.4,"d":"-69.40"},3.51,"5' UTR",9,70100687,70131012,30326,1]
["chr9",71623714,71624256,543,"ENSBGRG00000005435","ENSBGRT00000010052",1592,"C2orf68","chromosome 2 open reading frame 68 [Source:HGNC Symbol;Acc:HGNC:34353]","NA","NA",{"v":1.4E-5,"d":"0.00"},2,"54,123,","0,420",-4.86,-4.14,3.07,"Exon (ENSBGRT00000010052/ENSBGRG00000005435, exon 3 of 4)",9,71622122,71624256,2135,1]
["chr9",92207543,92219510,11968,"ENSBGRG00000004906","ENSBGRT00000009027",53938,"ENSBGRG00000004906","NA","GO:0005515(protein binding);GO:0005635(nuclear envelope);GO:0006355(regulation of transcription, DNA-templated);GO:0016363(nuclear matrix)","NA",{"v":2e-77,"d":"0.00"},2,"10,380,","0,11588",{"v":-76.7,"d":"-76.70"},-75,6.09,"3' UTR",9,92153605,92219510,65906,1]
["chr9",96497999,96499373,1375,"ENSBGRG00000007114","ENSBGRT00000013163",0,"SUPT7L","SPT7 like, STAGA complex gamma subunit [Source:HGNC Symbol;Acc:HGNC:30632]","GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0030914(STAGA complex);GO:0043966(histone H3 acetylation);GO:0046982(protein heterodimerization activity);GO:0051457(maintenance of protein location in nucleus)","NA",{"v":0.0003,"d":"0.00"},2,"101,19,","0,1356",-3.53,-2.88,4.01,"5' UTR",9,96497999,96508315,10317,1]
["chr9",96782212,96783422,1211,"ENSBGRG00000009500","ENSBGRT00000017631",0,"EIF2B4","eukaryotic translation initiation factor 2B subunit delta [Source:HGNC Symbol;Acc:HGNC:3260]","GO:0044237(cellular metabolic process)","03013(RNA transport)",{"v":4e-67,"d":"0.00"},4,"31,138,136,113,","0,318,784,1098",{"v":-66.4,"d":"-66.40"},{"v":-64.8,"d":"-64.80"},4.62,"Exon (ENSBGRT00000017631/ENSBGRG00000009500, exon 1 of 13)",9,96782212,96786671,4460,1]
["chr9",99857723,99857989,267,"ENSBGRG00000019427","ENSBGRT00000035690",0,"WDCP","WD repeat and coiled coil containing [Source:HGNC Symbol;Acc:HGNC:26157]","GO:0019900(kinase binding);GO:0051259(protein complex oligomerization)","NA",{"v":2.8E-5,"d":"0.00"},1,"267,",0,-4.56,-3.86,3.65,"Exon (ENSBGRT00000035690/ENSBGRG00000019427, exon 1 of 2)",9,99857723,99867667,9945,1]
["chr9",100054579,100064336,9758,"ENSBGRG00000019718","ENSBGRT00000036245",112911,"ATAD2B","ATPase family AAA domain containing 2B [Source:HGNC Symbol;Acc:HGNC:29230]","GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0070577(lysine-acetylated histone binding)","04141(Protein processing in endoplasmic reticulum)",{"v":1e-23,"d":"0.00"},4,"18,138,684,119,","0,2780,6404,9639",-23,{"v":-21.9,"d":"-21.90"},6.52,"Exon (ENSBGRT00000036245/ENSBGRG00000019718, exon 23 of 28)",9,99941668,100069128,127461,1]
["chr9",113167618,113168303,686,"ENSBGRG00000024949","ENSBGRT00000046186",104275,"NOL10","nucleolar protein 10 [Source:HGNC Symbol;Acc:HGNC:25862]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus)","NA",{"v":1e-111,"d":"0.00"},1,"686,",0,-111,-110,8.05,"3' UTR",9,113063343,113168363,105021,1]
["chr9",2102074,2103136,1063,"ENSBGRG00000015272","ENSBGRT00000028044",6314,"ENSBGRG00000015272","NA","GO:0003723(RNA binding);GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome);00590(Arachidonic acid metabolism)",{"v":3.2e-83,"d":"0.00"},2,"798,127,","0,936",{"v":-82.5,"d":"-82.50"},{"v":-80.8,"d":"-80.80"},{"v":11.5,"d":"11.50"},"3' UTR",9,2038677,2109450,70774,2]
["chr9",2705453,2705572,120,"ENSBGRG00000017060","ENSBGRT00000031775",599336,"DENND1A","DENN domain containing 1A [Source:HGNC Symbol;Acc:HGNC:29324]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006897(endocytosis);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017124(SH3 domain binding);GO:0017137(Rab GTPase binding);GO:0030136(clathrin-coated vesicle);GO:0030425(dendrite);GO:0030665(clathrin-coated vesicle membrane);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0032456(endocytic recycling);GO:0032483(regulation of Rab protein signal transduction);GO:0043025(neuronal cell body);GO:0043231(intracellular membrane-bounded organelle);GO:0043547(positive regulation of GTPase activity);GO:0045202(synapse);GO:0048488(synaptic vesicle endocytosis);GO:1901981(phosphatidylinositol phosphate binding)","NA",{"v":1.1E-4,"d":"0.00"},1,"120,",0,-3.97,-3.29,12,"Exon (ENSBGRT00000031775/ENSBGRG00000017060, exon 22 of 22)",9,2704408,3304908,600501,2]
["chr9",7291488,7293586,2099,"ENSBGRG00000008048","ENSBGRT00000014730",315,"DPM2","dolichyl-phosphate mannosyltransferase subunit 2, regulatory [Source:HGNC Symbol;Acc:HGNC:3006]","GO:0000506(glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex);GO:0006506(GPI anchor biosynthetic process);GO:0008047(enzyme activator activity);GO:0019348(dolichol metabolic process);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0030234(enzyme regulator activity);GO:0031647(regulation of protein stability);GO:0033185(dolichol-phosphate-mannose synthase complex)","00510(N-Glycan biosynthesis);00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":2.8E-5,"d":"0.00"},3,"3,103,65,","0,1147,2034",-4.56,-3.85,{"v":1.6,"d":"1.60"},"Exon (ENSBGRT00000014730/ENSBGRG00000008048, exon 2 of 4)",9,7291432,7293901,2470,2]
["chr9",7647360,7649137,1778,"ENSBGRG00000010103","ENSBGRT00000018533",11135,"TRUB2","TruB pseudouridine synthase family member 2 [Source:HGNC Symbol;Acc:HGNC:17170]","GO:0001522(pseudouridine synthesis);GO:0003723(RNA binding);GO:0006396(RNA processing);GO:0009451(RNA modification);GO:0009982(pseudouridine synthase activity);GO:0070131(positive regulation of mitochondrial translation)","NA",{"v":1E-134,"d":"0.00"},2,"872,106,","0,1672",-134,-132,17,"3' UTR",9,7647360,7660272,12913,2]
["chr9",8257332,8257601,270,"ENSBGRG00000016243","ENSBGRT00000029879",0,"DOLK","dolichol kinase [Source:HGNC Symbol;Acc:HGNC:23406]","GO:0004168(dolichol kinase activity);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0043048(dolichyl monophosphate biosynthetic process)","00510(N-Glycan biosynthesis)",{"v":5.4e-05,"d":"0.00"},1,"270,",0,-4.27,-3.57,4.51,"Exon (ENSBGRT00000029879/ENSBGRG00000016243, exon 1 of 2)",9,8255573,8257601,2029,2]
["chr9",12959622,12960492,871,"ENSBGRG00000024826","ENSBGRT00000045812",40369,"NACC2","NACC family member 2 [Source:HGNC Symbol;Acc:HGNC:23846]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0008285(negative regulation of cell population proliferation);GO:0034629(cellular protein-containing complex localization);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0044877(protein-containing complex binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0051260(protein homooligomerization);GO:1900477(negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter);GO:1902231(positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","NA",{"v":3e-05,"d":"0.00"},2,"377,101,","0,770",-4.53,-3.82,6.02,"Exon (ENSBGRT00000045812/ENSBGRG00000024826, exon 6 of 7)",9,12959622,13000861,41240,2]
["chr9",13319071,13319427,357,"ENSBGRG00000025118","ENSBGRT00000046472",6360,"CARD9","caspase recruitment domain family member 9 [Source:HGNC Symbol;Acc:HGNC:16391]","GO:0005737(cytoplasm);GO:0009620(response to fungus);GO:0032494(response to peptidoglycan);GO:0032495(response to muramyl dipeptide);GO:0032663(regulation of interleukin-2 production);GO:0032675(regulation of interleukin-6 production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0032991(protein-containing complex);GO:0042493(response to drug);GO:0042534(regulation of tumor necrosis factor biosynthetic process);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043330(response to exogenous dsRNA);GO:0045089(positive regulation of innate immune response);GO:0046330(positive regulation of JNK cascade);GO:0050700(CARD domain binding);GO:0050830(defense response to Gram-positive bacterium);GO:0051607(defense response to virus)","04621(NOD-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);05152(Tuberculosis)",{"v":4.6E-6,"d":"0.00"},1,"357,",0,-5.34,{"v":-4.6,"d":"-4.60"},6.27,"Exon (ENSBGRT00000046513/ENSBGRG00000025118, exon 12 of 12)",9,13317392,13325787,8396,2]
["chr9",13810008,13819509,9502,"ENSBGRG00000025947","ENSBGRT00000047984",30,"SURF6","surfeit 6 [Source:HGNC Symbol;Acc:HGNC:11478]","GO:0001652(granular component);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0042254(ribosome biogenesis)","NA",{"v":1.3e-37,"d":"0.00"},6,"1160,204,89,89,195,64,","0,1267,3331,3858,4500,9438",{"v":-36.9,"d":"-36.90"},{"v":-35.6,"d":"-35.60"},{"v":18.1,"d":"18.10"},"3' UTR",9,13810008,13819539,9532,2]
["chr9",15847160,15847250,91,"ENSBGRG00000007884","ENSBGRT00000014443",3847,"FBXW5","F-box and WD repeat domain containing 5 [Source:HGNC Symbol;Acc:HGNC:13613]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0007088(regulation of mitotic nuclear division);GO:0010824(regulation of centrosome duplication);GO:0016567(protein ubiquitination);GO:0019005(SCF ubiquitin ligase complex);GO:0019901(protein kinase binding);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0080008(Cul4-RING E3 ubiquitin ligase complex)","NA",{"v":0.0055,"d":"0.01"},1,"91,",0,-2.26,-1.68,2.29,"3' UTR",9,15846772,15851097,4326,2]
["chr9",16134778,16135917,1140,"ENSBGRG00000010421","ENSBGRT00000019097",750,"TPRN","taperin [Source:HGNC Symbol;Acc:HGNC:26894]","GO:0007605(sensory perception of sound);GO:0019902(phosphatase binding);GO:0032420(stereocilium);GO:0060088(auditory receptor cell stereocilium organization);GO:0120044(stereocilium base)","NA",{"v":2e-75,"d":"0.00"},1,"1140,",0,{"v":-74.7,"d":"-74.70"},{"v":-73.1,"d":"-73.10"},9.44,"Exon (ENSBGRT00000019097/ENSBGRG00000010421, exon 1 of 2)",9,16127592,16136667,9076,2]
["chr9",20282062,20283956,1895,"ENSBGRG00000026803","ENSBGRT00000049706",9038,"SEMA4C","semaphorin 4C [Source:HGNC Symbol;Acc:HGNC:10731]","GO:0001843(neural tube closure);GO:0005515(protein binding);GO:0014069(postsynaptic density);GO:0021535(cell migration in hindbrain);GO:0021549(cerebellum development);GO:0030215(semaphorin receptor binding);GO:0030672(synaptic vesicle membrane);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0042692(muscle cell differentiation);GO:0071526(semaphorin-plexin signaling pathway)","04360(Axon guidance)",{"v":1e-237,"d":"0.00"},2,"1739,30,","0,1865",-237,-235,106,"3' UTR",9,20282062,20292994,10933,2]
["chr9",21954840,21969604,14765,"ENSBGRG00000026829","ENSBGRT00000049763",0,"MITD1","microtubule interacting and trafficking domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25207]","GO:0000281(mitotic cytokinesis);GO:0019898(extrinsic component of membrane);GO:0019904(protein domain specific binding);GO:0030496(midbody);GO:0032091(negative regulation of protein binding);GO:0035091(phosphatidylinositol binding);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle);GO:0061952(midbody abscission)","03050(Proteasome)",{"v":2e-23,"d":"0.00"},3,"46,102,151,","0,2318,14614",{"v":-22.7,"d":"-22.70"},{"v":-21.6,"d":"-21.60"},3.66,"Exon (ENSBGRT00000049763/ENSBGRG00000026829, exon 1 of 7)",9,21952568,21969604,17037,2]
["chr9",27514320,27514739,420,"ENSBGRG00000005800","ENSBGRT00000010815",31448,"TGFBRAP1","transforming growth factor beta receptor associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16836]","GO:0005160(transforming growth factor beta receptor binding);GO:0005769(early endosome);GO:0006355(regulation of transcription, DNA-templated);GO:0006886(intracellular protein transport);GO:0007165(signal transduction);GO:0008333(endosome to lysosome transport);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0033263(CORVET complex);GO:0034058(endosomal vesicle fusion);GO:0043231(intracellular membrane-bounded organelle);GO:0046332(SMAD binding)","NA",{"v":6.3e-32,"d":"0.00"},1,"420,",0,{"v":-31.2,"d":"-31.20"},-30,3.62,"3' UTR",9,27513333,27546187,32855,2]
["chr9",31898242,31904569,6328,"ENSBGRG00000004990","ENSBGRT00000009199",140025,"ZNF638","zinc finger protein 638 [Source:HGNC Symbol;Acc:HGNC:17894]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008270(zinc ion binding);GO:0008380(RNA splicing);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":7.9e-59,"d":"0.00"},2,"976,11,","0,6317",{"v":-58.1,"d":"-58.10"},{"v":-56.7,"d":"-56.70"},{"v":3.2,"d":"3.20"},"Exon (ENSBGRT00000009199/ENSBGRG00000004990, exon 21 of 28)",9,31887916,32044594,156679,2]
["chr9",33799468,33809759,10292,"ENSBGRG00000007270","ENSBGRT00000013503",4698,"NLRC4","NLR family CARD domain containing 4 [Source:HGNC Symbol;Acc:HGNC:16412]","GO:0002218(activation of innate immune response);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006954(inflammatory response);GO:0010954(positive regulation of protein processing);GO:0016045(detection of bacterium);GO:0032611(interleukin-1 beta production);GO:0032731(positive regulation of interleukin-1 beta production);GO:0042742(defense response to bacterium);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043281(regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051260(protein homooligomerization);GO:0061133(endopeptidase activator activity);GO:0070269(pyroptosis);GO:0072557(IPAF inflammasome complex);GO:0089720(caspase binding);GO:0097202(activation of cysteine-type endopeptidase activity)","04621(NOD-like receptor signaling pathway);05132(Salmonella infection);05134(Legionellosis)",{"v":0.028,"d":"0.03"},2,"10,290,","0,10002",-1.55,-1.03,4.01,"Exon (ENSBGRT00000013503/ENSBGRG00000007270, exon 3 of 8)",9,33778232,33814457,36226,2]
["chr9",40477746,40477804,59,"ENSBGRG00000017055","ENSBGRT00000031327",798,"ENSBGRG00000017055","NA","GO:0000463(maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0003735(structural constituent of ribosome);GO:0022625(cytosolic large ribosomal subunit)","03010(Ribosome)",{"v":2.8E-3,"d":"0.00"},1,"59,",0,-2.55,-1.95,{"v":1.5,"d":"1.50"},"Exon (ENSBGRT00000031327/ENSBGRG00000017055, exon 3 of 3)",9,40477717,40478602,886,2]
["chr9",46645359,46645479,121,"ENSBGRG00000006013","ENSBGRT00000011102",273,"PREPL","prolyl endopeptidase like [Source:HGNC Symbol;Acc:HGNC:30228]","GO:0004252(serine-type endopeptidase activity);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005856(cytoskeleton);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0042147(retrograde transport, endosome to Golgi);GO:0043001(Golgi to plasma membrane protein transport);GO:0070008(serine-type exopeptidase activity);GO:2000300(regulation of synaptic vesicle exocytosis)","04974(Protein digestion and absorption)",{"v":0.023,"d":"0.02"},1,"121,",0,-1.64,-1.11,2.09,"5' UTR",9,46601996,46645752,43757,2]
["chr9",57247898,57248078,181,"ENSBGRG00000014000","ENSBGRT00000025994",93152,"ASB3","ankyrin repeat and SOCS box containing 3 [Source:HGNC Symbol;Acc:HGNC:16013]","GO:0005515(protein binding);GO:0035556(intracellular signal transduction)","NA",{"v":1.6e-35,"d":"0.00"},1,"181,",0,{"v":-34.8,"d":"-34.80"},{"v":-33.6,"d":"-33.60"},5.38,"Exon (ENSBGRT00000025994/ENSBGRG00000014000, exon 9 of 9)",9,57247898,57341230,93333,2]
["chr9",66241952,66242130,179,"ENSBGRG00000008832","ENSBGRT00000016158",0,"SH3RF3","SH3 domain containing ring finger 3 [Source:HGNC Symbol;Acc:HGNC:24699]","GO:0005515(protein binding);GO:0006915(apoptotic process);GO:0046328(regulation of JNK cascade);GO:0046330(positive regulation of JNK cascade);GO:0046872(metal ion binding);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":0.035,"d":"0.04"},1,"179,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000016158/ENSBGRG00000008832, exon 1 of 9)",9,66064175,66242130,177956,2]
["chr9",68393239,68395091,1853,"ENSBGRG00000013844","ENSBGRT00000025700",18126,"ENSBGRG00000013844","NA","NA","00230(Purine metabolism);00240(Pyrimidine metabolism);00760(Nicotinate and nicotinamide metabolism)",{"v":5.5e-10,"d":"0.00"},2,"333,86,","0,1767",-9.26,-8.42,4.51,"3' UTR",9,68375113,68396337,21225,1]
["chr9",70823533,70859250,35718,"ENSBGRG00000003586","ENSBGRT00000006692",13186,"ENSBGRG00000003586","NA","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)",{"v":1.3e-19,"d":"0.00"},3,"25,189,52,","0,31952,35666",{"v":-18.9,"d":"-18.90"},{"v":-17.9,"d":"-17.90"},{"v":21.1,"d":"21.10"},"Exon (ENSBGRT00000035607/ENSBGRG00000019246, exon 6 of 7)",9,70823533,70872436,48904,2]
["chr9",90498819,90498967,149,"ENSBGRG00000003591","ENSBGRT00000006732",28224,"CNRIP1","cannabinoid receptor interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:24546]","GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0008022(protein C-terminus binding);GO:0031718(type 1 cannabinoid receptor binding)","NA",{"v":8.5e-07,"d":"0.00"},1,"149,",0,-6.07,-5.32,1.25,"3' UTR",9,90488103,90527191,39089,2]
["chr9",92700576,92700696,121,"ENSBGRG00000005647","ENSBGRT00000010424",32210,"EHD3","EH domain containing 3 [Source:HGNC Symbol;Acc:HGNC:3244]","GO:0001881(receptor recycling);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0020018(ciliary pocket membrane);GO:0032456(endocytic recycling);GO:0034498(early endosome to Golgi transport);GO:0051260(protein homooligomerization);GO:0055038(recycling endosome membrane);GO:0060271(cilium assembly);GO:0072659(protein localization to plasma membrane);GO:0086036(regulation of cardiac muscle cell membrane potential);GO:0090160(Golgi to lysosome transport);GO:1903358(regulation of Golgi organization)","04144(Endocytosis)",{"v":8.9e-09,"d":"0.00"},1,"121,",0,-8.05,-7.24,2.87,"3' UTR",9,92700126,92732906,32781,2]
["chr9",96511737,96517430,5694,"ENSBGRG00000007243","ENSBGRT00000013563",18278,"GPN1","GPN-loop GTPase 1 [Source:HGNC Symbol;Acc:HGNC:17030]","GO:0003924(GTPase activity);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol)","NA",{"v":2.3E-3,"d":"0.00"},3,"83,108,19,","0,1945,5675",-2.64,-2.03,1.74,"Exon (ENSBGRT00000013563/ENSBGRG00000007243, exon 9 of 11)",9,96511737,96535708,23972,2]
["chr9",97106557,97107404,848,"ENSBGRG00000012181","ENSBGRT00000022293",3354,"AGBL5","ATP/GTP binding protein like 5 [Source:HGNC Symbol;Acc:HGNC:26147]","GO:0004181(metallocarboxypeptidase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008270(zinc ion binding);GO:0015630(microtubule cytoskeleton);GO:0015631(tubulin binding);GO:0030496(midbody);GO:0035608(protein deglutamylation);GO:0035611(protein branching point deglutamylation);GO:0045171(intercellular bridge);GO:0051607(defense response to virus);GO:0072686(mitotic spindle)","04020(Calcium signaling pathway);04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04728(Dopaminergic synapse)",{"v":1.6E-18,"d":"0.00"},2,"6,354,","0,494",{"v":-17.8,"d":"-17.80"},{"v":-16.8,"d":"-16.80"},3.39,"Exon (ENSBGRT00000022293/ENSBGRG00000012181, exon 6 of 14)",9,97093260,97110758,17499,2]
["chr9",106220591,106222066,1476,"ENSBGRG00000022008","ENSBGRT00000040637",0,"KCNS3","potassium voltage-gated channel modifier subfamily S member 3 [Source:HGNC Symbol;Acc:HGNC:6302]","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport)","NA",{"v":1.6E-50,"d":"0.00"},1,"1476,",0,{"v":-49.8,"d":"-49.80"},{"v":-48.4,"d":"-48.40"},7.56,"Exon (ENSBGRT00000040637/ENSBGRG00000022008, exon 1 of 1)",9,106220591,106222066,1476,2]
["chr10",261405,261675,271,"ENSBGRG00000017268","ENSBGRT00000031662",11509,"LATS1","large tumor suppressor kinase 1 [Source:HGNC Symbol;Acc:HGNC:6514]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0000287(magnesium ion binding);GO:0000819(sister chromatid segregation);GO:0000922(spindle pole);GO:0001827(inner cell mass cell fate commitment);GO:0001828(inner cell mass cellular morphogenesis);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0009755(hormone-mediated signaling pathway);GO:0019901(protein kinase binding);GO:0030216(keratinocyte differentiation);GO:0030331(estrogen receptor binding);GO:0030833(regulation of actin filament polymerization);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033146(regulation of intracellular estrogen receptor signaling pathway);GO:0034613(cellular protein localization);GO:0035329(hippo signaling);GO:0043254(regulation of protein-containing complex assembly);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0051220(cytoplasmic sequestering of protein);GO:0060644(mammary gland epithelial cell differentiation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:2000058(regulation of ubiquitin-dependent protein catabolic process)","04390(Hippo signaling pathway);04392(Hippo signaling pathway - multiple species)",{"v":0.00022,"d":"0.00"},1,"271,",0,-3.66,-2.99,3.21,"Exon (ENSBGRT00000031662/ENSBGRG00000017268, exon 3 of 8)",10,249896,273566,23671,1]
["chr10",7528864,7536201,7338,"ENSBGRG00000022707","ENSBGRT00000041956",23777,"HIVEP2","HIVEP zinc finger 2 [Source:HGNC Symbol;Acc:HGNC:4921]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm)","NA",{"v":0.0013,"d":"0.00"},2,"43,78,","0,7260",{"v":-2.9,"d":"-2.90"},-2.28,2.04,"Exon (ENSBGRT00000041956/ENSBGRG00000022707, exon 6 of 7)",10,7505087,7536948,31862,1]
["chr10",19594970,19595479,510,"ENSBGRG00000022788","ENSBGRT00000044010",628,"EPB41L2","erythrocyte membrane protein band 4.1 like 2 [Source:HGNC Symbol;Acc:HGNC:3379]","GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005654(nucleoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0008092(cytoskeletal protein binding);GO:0008180(COP9 signalosome);GO:0030054(cell junction);GO:0030507(spectrin binding);GO:0030866(cortical actin cytoskeleton organization);GO:0042731(PH domain binding);GO:0099738(cell cortex region);GO:1904778(positive regulation of protein localization to cell cortex)","NA",{"v":0.0058,"d":"0.01"},1,"510,",0,-2.24,-1.66,10,"5' UTR",10,19594342,19710155,115814,1]
["chr10",26586648,26586738,91,"ENSBGRG00000021935","ENSBGRT00000040568",98543,"ZNF292","zinc finger protein 292 [Source:HGNC Symbol;Acc:HGNC:18410]","GO:0003676(nucleic acid binding)","NA",{"v":0.026,"d":"0.03"},1,"91,",0,-1.59,-1.06,1.66,"Exon (ENSBGRT00000040568/ENSBGRG00000021935, exon 8 of 8)",10,26488105,26589198,101094,1]
["chr10",26712026,26712174,149,"ENSBGRG00000022115","ENSBGRT00000040830",415,"ENSBGRG00000022115","NA","NA","NA",{"v":0.019,"d":"0.02"},1,"149,",0,-1.72,-1.19,5.01,"Exon (ENSBGRT00000040830/ENSBGRG00000022115, exon 1 of 3)",10,26711611,26723747,12137,1]
["chr10",36876383,36876532,150,"ENSBGRG00000026411","ENSBGRT00000048873",13875,"FHL5","four and a half LIM domains 5 [Source:HGNC Symbol;Acc:HGNC:17371]","GO:0003713(transcription coactivator activity);GO:0045944(positive regulation of transcription by RNA polymerase II)","04380(Osteoclast differentiation)",{"v":1E-14,"d":"0.00"},1,"150,",0,-14,{"v":-13.1,"d":"-13.10"},4.11,"3' UTR",10,36862508,36877486,14979,1]
["chr10",47649615,47649674,60,"ENSBGRG00000006270","ENSBGRT00000011583",19643,"QRSL1","glutaminyl-tRNA amidotransferase subunit QRSL1 [Source:HGNC Symbol;Acc:HGNC:21020]","GO:0004040(amidase activity);GO:0005739(mitochondrion);GO:0030956(glutamyl-tRNA(Gln) amidotransferase complex);GO:0032543(mitochondrial translation);GO:0050567(glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity);GO:0070681(glutaminyl-tRNAGln biosynthesis via transamidation)","00970(Aminoacyl-tRNA biosynthesis)",{"v":0.032,"d":"0.03"},1,"60,",0,{"v":-1.5,"d":"-1.50"},{"v":-0.988,"d":"-0.99"},2.51,"Exon (ENSBGRT00000011583/ENSBGRG00000006270, exon 5 of 8)",10,47629972,47654911,24940,1]
["chr10",51312311,51316509,4199,"ENSBGRG00000010004","ENSBGRT00000018346",25561,"CDC40","cell division cycle 40 [Source:HGNC Symbol;Acc:HGNC:17350]","GO:0000398(mRNA splicing, via spliceosome);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0016607(nuclear speck);GO:0071007(U2-type catalytic step 2 spliceosome);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)",{"v":0.00026,"d":"0.00"},3,"92,97,20,","0,2774,4179",-3.59,-2.93,1.61,"Exon (ENSBGRT00000018346/ENSBGRG00000010004, exon 6 of 16)",10,51286750,51335114,48365,1]
["chr10",64053549,64054951,1403,"ENSBGRG00000010267","ENSBGRT00000018801",0,"SMPDL3A","sphingomyelin phosphodiesterase acid like 3A [Source:HGNC Symbol;Acc:HGNC:17389]","GO:0004767(sphingomyelin phosphodiesterase activity);GO:0005615(extracellular space);GO:0006685(sphingomyelin catabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0008270(zinc ion binding);GO:0009143(nucleoside triphosphate catabolic process);GO:0016787(hydrolase activity)","NA",{"v":4e-34,"d":"0.00"},3,"125,173,2,","0,581,1401",{"v":-33.4,"d":"-33.40"},{"v":-32.2,"d":"-32.20"},2.71,"5' UTR",10,64054130,64082642,28513,1]
["chr10",71724878,71731047,6170,"ENSBGRG00000003767","ENSBGRT00000007010",0,"TENT5A","terminal nucleotidyltransferase 5A [Source:HGNC Symbol;Acc:HGNC:18345]","GO:0009617(response to bacterium);GO:1990817(RNA adenylyltransferase activity)","04371(Apelin signaling pathway);04810(Regulation of actin cytoskeleton);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes)",{"v":6.3E-48,"d":"0.00"},3,"795,884,244,","0,1920,5926",{"v":-47.2,"d":"-47.20"},{"v":-45.9,"d":"-45.90"},6.34,"5' UTR",10,71724878,71727681,2804,1]
["chr10",96396487,96397717,1231,"ENSBGRG00000008738","ENSBGRT00000015916",563,"ENSBGRG00000008738","NA","NA","NA",{"v":0.0048,"d":"0.00"},2,"26,34,","0,1197",-2.32,-1.74,1.37,"Exon (ENSBGRT00000015916/ENSBGRG00000008738, exon 1 of 2)",10,96395924,96398162,2239,1]
["chr10",105577609,105577847,239,"ENSBGRG00000026603","ENSBGRT00000049279",105902,"EZR","ezrin [Source:HGNC Symbol;Acc:HGNC:12691]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001650(fibrillar center);GO:0001726(ruffle);GO:0001772(immunological synapse);GO:0001931(uropod);GO:0001951(intestinal D-glucose absorption);GO:0003376(sphingosine-1-phosphate receptor signaling pathway);GO:0003779(actin binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0005903(brush border);GO:0005925(focal adhesion);GO:0007159(leukocyte cell-cell adhesion);GO:0008017(microtubule binding);GO:0008022(protein C-terminus binding);GO:0008092(cytoskeletal protein binding);GO:0008360(regulation of cell shape);GO:0010628(positive regulation of gene expression);GO:0010737(protein kinase A signaling);GO:0015629(actin cytoskeleton);GO:0016324(apical plasma membrane);GO:0019898(extrinsic component of membrane);GO:0019904(protein domain specific binding);GO:0022614(membrane to membrane docking);GO:0030033(microvillus assembly);GO:0030175(filopodium);GO:0030953(astral microtubule organization);GO:0031532(actin cytoskeleton reorganization);GO:0031623(receptor internalization);GO:0032532(regulation of microvillus length);GO:0032703(negative regulation of interleukin-2 production);GO:0032991(protein-containing complex);GO:0034236(protein kinase A catalytic subunit binding);GO:0034237(protein kinase A regulatory subunit binding);GO:0034629(cellular protein-containing complex localization);GO:0035088(establishment or maintenance of apical/basal cell polarity);GO:0036064(ciliary basal body);GO:0040018(positive regulation of multicellular organism growth);GO:0042802(identical protein binding);GO:0042995(cell projection);GO:0043622(cortical microtubule organization);GO:0044548(S100 protein binding);GO:0044853(plasma membrane raft);GO:0045177(apical part of cell);GO:0046847(filopodium assembly);GO:0048015(phosphatidylinositol-mediated signaling);GO:0048471(perinuclear region of cytoplasm);GO:0050714(positive regulation of protein secretion);GO:0050839(cell adhesion molecule binding);GO:0050860(negative regulation of T cell receptor signaling pathway);GO:0051015(actin filament binding);GO:0051017(actin filament bundle assembly);GO:0051018(protein kinase A binding);GO:0051117(ATPase binding);GO:0051660(establishment of centrosome localization);GO:0061028(establishment of endothelial barrier);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0071320(cellular response to cAMP);GO:0071437(invadopodium);GO:0071944(cell periphery);GO:0072659(protein localization to plasma membrane);GO:0072697(protein localization to cell cortex);GO:0097718(disordered domain specific binding);GO:0098592(cytoplasmic side of apical plasma membrane);GO:1902115(regulation of organelle assembly);GO:1902896(terminal web assembly);GO:1902966(positive regulation of protein localization to early endosome);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1903364(positive regulation of cellular protein catabolic process);GO:1903753(negative regulation of p38MAPK cascade);GO:2000643(positive regulation of early endosome to late endosome transport)","04530(Tight junction);04810(Regulation of actin cytoskeleton);04670(Leukocyte transendothelial migration);04971(Gastric acid secretion);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer)",{"v":1E-204,"d":"0.00"},1,"239,",0,-204,-201,3.73,"3' UTR",10,105471707,105577847,106141,1]
["chr10",107068417,107068656,240,"ENSBGRG00000026710","ENSBGRT00000049525",718,"ENSBGRG00000026710","NA","NA","04742(Taste transduction)",{"v":0.0052,"d":"0.01"},1,"240,",0,-2.28,{"v":-1.7,"d":"-1.70"},3.61,"Exon (ENSBGRT00000049525/ENSBGRG00000026710, exon 1 of 1)",10,107067699,107068925,1227,1]
["chr10",5690983,5692214,1232,"ENSBGRG00000020833","ENSBGRT00000039538",198448,"UTRN","utrophin [Source:HGNC Symbol;Acc:HGNC:12635]","GO:0001954(positive regulation of cell-matrix adhesion);GO:0003779(actin binding);GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0008270(zinc ion binding);GO:0016010(dystrophin-associated glycoprotein complex);GO:0017166(vinculin binding);GO:0019901(protein kinase binding);GO:0030175(filopodium);GO:0031527(filopodium membrane);GO:0031594(neuromuscular junction);GO:0032991(protein-containing complex);GO:0042383(sarcolemma);GO:0045202(synapse);GO:0070938(contractile ring)","NA",{"v":0.013,"d":"0.01"},2,"29,122,","0,1110",-1.88,-1.33,1.95,"Exon (ENSBGRT00000039538/ENSBGRG00000020833, exon 25 of 76)",10,5296910,5890662,593753,2]
["chr10",13298744,13299011,268,"ENSBGRG00000014577","ENSBGRT00000026813",2187,"SLC35D3","solute carrier family 35 member D3 [Source:HGNC Symbol;Acc:HGNC:15621]","GO:0005769(early endosome);GO:0005783(endoplasmic reticulum);GO:0070863(positive regulation of protein exit from endoplasmic reticulum);GO:0097009(energy homeostasis)","NA",{"v":0.019,"d":"0.02"},1,"268,",0,-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000026813/ENSBGRG00000014577, exon 2 of 2)",10,13297762,13301198,3437,2]
["chr10",20489456,20492178,2723,"ENSBGRG00000010620","ENSBGRT00000019608",31677,"L3MBTL3","L3MBTL histone methyl-lysine binding protein 3 [Source:HGNC Symbol;Acc:HGNC:23035]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0030099(myeloid cell differentiation);GO:0030225(macrophage differentiation);GO:0030851(granulocyte differentiation);GO:0042802(identical protein binding);GO:0043249(erythrocyte maturation)","NA",{"v":0.00016,"d":"0.00"},2,"75,105,","0,2618",-3.79,-3.12,1.81,"Exon (ENSBGRT00000019608/ENSBGRG00000010620, exon 5 of 21)",10,20417228,20523855,106628,2]
["chr10",32824629,32829221,4593,"ENSBGRG00000026337","ENSBGRT00000048733",227979,"EPHA7","EPH receptor A7 [Source:HGNC Symbol;Acc:HGNC:3390]","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005004(GPI-linked ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007420(brain development);GO:0008046(axon guidance receptor activity);GO:0016021(integral component of membrane);GO:0022407(regulation of cell-cell adhesion);GO:0031290(retinal ganglion cell axon guidance);GO:0031952(regulation of protein autophosphorylation);GO:0043281(regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043525(positive regulation of neuron apoptotic process);GO:0045499(chemorepellent activity);GO:0048013(ephrin receptor signaling pathway);GO:0048671(negative regulation of collateral sprouting);GO:0048755(branching morphogenesis of a nerve);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:0051964(negative regulation of synapse assembly);GO:0070372(regulation of ERK1 and ERK2 cascade);GO:0072178(nephric duct morphogenesis);GO:0098978(glutamatergic synapse);GO:0099175(regulation of postsynapse organization)","04360(Axon guidance)",{"v":2.5e-08,"d":"0.00"},3,"335,156,16,","0,3191,4577",-7.61,{"v":-6.8,"d":"-6.80"},6.02,"3' UTR",10,32824599,33057200,232602,2]
["chr10",45621043,45652702,31660,"ENSBGRG00000004127","ENSBGRT00000007738",0,"HACE1","HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:21033]","GO:0000139(Golgi membrane);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007030(Golgi organization);GO:0016567(protein ubiquitination);GO:0016604(nuclear body);GO:0017137(Rab GTPase binding);GO:0030334(regulation of cell migration);GO:0048365(Rac GTPase binding);GO:0061025(membrane fusion);GO:0070936(protein K48-linked ubiquitination)","NA",{"v":0.0013,"d":"0.00"},3,"20,631,488,","0,9120,31172",{"v":-2.9,"d":"-2.90"},-2.28,5.68,"5' UTR",10,45500535,45630793,130259,2]
["chr10",51711987,51716745,4759,"ENSBGRG00000010459","ENSBGRT00000019381",174215,"CDK19","cyclin dependent kinase 19 [Source:HGNC Symbol;Acc:HGNC:19338]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA",{"v":1E-22,"d":"0.00"},2,"552,100,","0,4659",-22,-21,6.23,"3' UTR",10,51711987,51890960,178974,2]
["chr10",58828690,58855260,26571,"ENSBGRG00000007399","ENSBGRT00000013660",3634,"ENSBGRG00000007399","golgi associated PDZ and coiled-coil motif containing [Source:HGNC Symbol;Acc:HGNC:17643]","GO:0005109(frizzled binding);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0007289(spermatid nucleus differentiation);GO:0008022(protein C-terminus binding);GO:0030695(GTPase regulator activity);GO:0042803(protein homodimerization activity);GO:0043004(cytoplasmic sequestering of CFTR protein);GO:0045202(synapse)","03010(Ribosome)",{"v":1.6e-16,"d":"0.00"},4,"112,24,165,295,","0,3568,5146,26276",{"v":-15.8,"d":"-15.80"},{"v":-14.8,"d":"-14.80"},3.47,"5' UTR",10,58813385,58858894,45510,2]
["chr10",60085447,60085687,241,"ENSBGRG00000008804","ENSBGRT00000016725",145380,"FAM184A","family with sequence similarity 184 member A [Source:HGNC Symbol;Acc:HGNC:20991]","NA","NA",{"v":1E-4,"d":"0.00"},1,"241,",0,-3.99,-3.31,2.67,"3' UTR",10,60085447,60231067,145621,2]
["chr10",78288012,78288222,211,"ENSBGRG00000004931","ENSBGRT00000009221",168211,"MYO6","myosin VI [Source:HGNC Symbol;Acc:HGNC:7605]","GO:0001726(ruffle);GO:0003774(motor activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006897(endocytosis);GO:0016459(myosin complex);GO:0016591(RNA polymerase II, holoenzyme);GO:0030330(DNA damage response, signal transduction by p53 class mediator);GO:0031410(cytoplasmic vesicle);GO:0031941(filamentous actin);GO:0031965(nuclear membrane);GO:0045334(clathrin-coated endocytic vesicle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048471(perinuclear region of cytoplasm);GO:0051015(actin filament binding);GO:0051046(regulation of secretion)","NA",{"v":8.9e-10,"d":"0.00"},1,"211,",0,-9.05,-8.22,2.05,"3' UTR",10,78288012,78456433,168422,2]
["chr10",84777945,84778363,419,"ENSBGRG00000021710","ENSBGRT00000040775",106443,"FAM135A","family with sequence similarity 135 member A [Source:HGNC Symbol;Acc:HGNC:21084]","NA","NA",{"v":6.9E-6,"d":"0.00"},1,"419,",0,-5.16,-4.44,5.52,"Exon (ENSBGRT00000040444/ENSBGRG00000021710, exon 13 of 20)",10,84741767,84884806,143040,2]
["chr10",95447626,95448697,1072,"ENSBGRG00000023577","ENSBGRT00000043561",18472,"FAM120B","family with sequence similarity 120B [Source:HGNC Symbol;Acc:HGNC:21109]","GO:0005634(nucleus);GO:0035357(peroxisome proliferator activated receptor signaling pathway);GO:0045444(fat cell differentiation)","NA",{"v":2.5e-44,"d":"0.00"},1,"1072,",0,{"v":-43.6,"d":"-43.60"},{"v":-42.2,"d":"-42.20"},6.72,"Exon (ENSBGRT00000043561/ENSBGRG00000023577, exon 2 of 11)",10,95355992,95467169,111178,2]
["chr10",105355229,105355378,150,"ENSBGRG00000026599","ENSBGRT00000049266",1101,"ENSBGRG00000026599","NA","NA","NA",{"v":0.00041,"d":"0.00"},1,"150,",0,-3.39,-2.74,1.56,"Exon (ENSBGRT00000049266/ENSBGRG00000026599, exon 2 of 4)",10,105346529,105356479,9951,2]
["chr10",107551615,107552302,688,"ENSBGRG00000026715","ENSBGRT00000049542",0,"ENSBGRG00000026715","NA","GO:0003677(DNA binding);GO:0006338(chromatin remodeling);GO:0016514(SWI/SNF complex);GO:0035060(brahma complex);GO:0071565(nBAF complex)","04714(Thermogenesis);05225(Hepatocellular carcinoma)",{"v":0.00089,"d":"0.00"},1,"688,",0,-3.05,-2.42,13,"5' UTR",10,107081908,107552302,470395,2]
["chr11",1316646,1317004,359,"ENSBGRG00000004010","ENSBGRT00000007464",12152,"MMP14","matrix metallopeptidase 14 [Source:HGNC Symbol;Acc:HGNC:7160]","GO:0001503(ossification);GO:0001958(endochondral ossification);GO:0004175(endopeptidase activity);GO:0004222(metalloendopeptidase activity);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0010831(positive regulation of myotube differentiation);GO:0016477(cell migration);GO:0030307(positive regulation of cell growth);GO:0030324(lung development);GO:0030335(positive regulation of cell migration);GO:0030574(collagen catabolic process);GO:0031012(extracellular matrix);GO:0031410(cytoplasmic vesicle);GO:0031638(zymogen activation);GO:0035987(endodermal cell differentiation);GO:0035988(chondrocyte proliferation);GO:0044354(macropinosome);GO:0045111(intermediate filament cytoskeleton);GO:0045579(positive regulation of B cell differentiation);GO:0045746(negative regulation of Notch signaling pathway);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0048754(branching morphogenesis of an epithelial tube);GO:0060322(head development);GO:0060348(bone development);GO:0070006(metalloaminopeptidase activity);GO:0097094(craniofacial suture morphogenesis);GO:1903076(regulation of protein localization to plasma membrane);GO:1905523(positive regulation of macrophage migration)","04668(TNF signaling pathway);04912(GnRH signaling pathway);04928(Parathyroid hormone synthesis, secretion and action)",{"v":7.9e-46,"d":"0.00"},1,"359,",0,{"v":-45.1,"d":"-45.10"},{"v":-43.8,"d":"-43.80"},5.62,"3' UTR",11,1304494,1317004,12511,1]
["chr11",2471165,2471939,775,"ENSBGRG00000017845","ENSBGRT00000032815",1173,"TSSK4","testis specific serine kinase 4 [Source:HGNC Symbol;Acc:HGNC:19825]","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007286(spermatid development);GO:0009566(fertilization);GO:0018105(peptidyl-serine phosphorylation);GO:0030317(flagellated sperm motility);GO:0031514(motile cilium);GO:0032793(positive regulation of CREB transcription factor activity);GO:0036126(sperm flagellum);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0044877(protein-containing complex binding);GO:1990443(peptidyl-threonine autophosphorylation)","NA",{"v":0.011,"d":"0.01"},2,"353,5,","0,770",-1.96,{"v":-1.4,"d":"-1.40"},5.52,"Exon (ENSBGRT00000032815/ENSBGRG00000017845, exon 3 of 4)",11,2469992,2472117,2126,1]
["chr11",2582960,2583618,659,"ENSBGRG00000019850","ENSBGRT00000036463",0,"LTB4R","leukotriene B4 receptor [Source:HGNC Symbol;Acc:HGNC:6713]","GO:0004930(G protein-coupled receptor activity);GO:0004974(leukotriene receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","04080(Neuroactive ligand-receptor interaction)",{"v":0.032,"d":"0.03"},1,"659,",0,{"v":-1.5,"d":"-1.50"},{"v":-0.989,"d":"-0.99"},3.01,"Exon (ENSBGRT00000036463/ENSBGRG00000019850, exon 1 of 1)",11,2582960,2584156,1197,1]
["chr11",6010937,6011085,149,"ENSBGRG00000016486","ENSBGRT00000030225",0,"LARP6","La ribonucleoprotein 6, translational regulator [Source:HGNC Symbol;Acc:HGNC:24012]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005844(polysome);GO:0006396(RNA processing);GO:0006417(regulation of translation);GO:0017022(myosin binding);GO:0032967(positive regulation of collagen biosynthetic process);GO:0035613(RNA stem-loop binding);GO:0045727(positive regulation of translation);GO:0048027(mRNA 5'-UTR binding);GO:1902416(positive regulation of mRNA binding);GO:1990825(sequence-specific mRNA binding);GO:1990904(ribonucleoprotein complex)","NA",{"v":0.00026,"d":"0.00"},1,"149,",0,-3.59,-2.93,9.03,"Exon (ENSBGRT00000030225/ENSBGRG00000016486, exon 1 of 4)",11,6010937,6033231,22295,1]
["chr11",11101104,11102709,1606,"ENSBGRG00000024730","ENSBGRT00000045622",15888,"TIPIN","TIMELESS interacting protein [Source:HGNC Symbol;Acc:HGNC:30750]","GO:0000076(DNA replication checkpoint);GO:0000077(DNA damage checkpoint);GO:0000790(nuclear chromatin);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006974(cellular response to DNA damage stimulus);GO:0008284(positive regulation of cell population proliferation);GO:0009411(response to UV);GO:0031573(intra-S DNA damage checkpoint);GO:0044770(cell cycle phase transition);GO:0048478(replication fork protection)","NA",{"v":6.3e-13,"d":"0.00"},2,"16,281,","0,1325",{"v":-12.2,"d":"-12.20"},{"v":-11.3,"d":"-11.30"},2.28,"3' UTR",11,11085216,11102827,17612,1]
["chr11",12424300,12424685,386,"ENSBGRG00000025646","ENSBGRT00000047411",593,"PDCD7","programmed cell death 7 [Source:HGNC Symbol;Acc:HGNC:8767]","GO:0005689(U12-type spliceosomal complex)","NA",{"v":0.0013,"d":"0.00"},1,"386,",0,{"v":-2.9,"d":"-2.90"},-2.28,6.02,"Exon (ENSBGRT00000047411/ENSBGRG00000025646, exon 1 of 5)",11,12423707,12436268,12562,1]
["chr11",17129369,17129637,269,"ENSBGRG00000007931","ENSBGRT00000015453",10791,"IQGAP2","IQ motif containing GTPase activating protein 2 [Source:HGNC Symbol;Acc:HGNC:6111]","GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005737(cytoplasm);GO:0005902(microvillus);GO:0007165(signal transduction);GO:0009986(cell surface);GO:0017048(Rho GTPase binding);GO:0030027(lamellipodium);GO:0030175(filopodium);GO:0034314(Arp2/3 complex-mediated actin nucleation);GO:0043087(regulation of GTPase activity);GO:0048365(Rac GTPase binding);GO:0051015(actin filament binding);GO:0070493(thrombin-activated receptor signaling pathway);GO:0071933(Arp2/3 complex binding);GO:2000249(regulation of actin cytoskeleton reorganization)","04810(Regulation of actin cytoskeleton)",{"v":0.0062,"d":"0.01"},1,"269,",0,-2.21,-1.64,2.31,"Exon (ENSBGRT00000015600/ENSBGRG00000008567, exon 2 of 2)",11,17035941,17140428,104488,2]
["chr11",24060791,24060970,180,"ENSBGRG00000013311","ENSBGRT00000024350",1011,"ENSBGRG00000013311","NA","NA","NA",{"v":0.032,"d":"0.03"},1,"180,",0,-1.49,{"v":-0.978,"d":"-0.98"},7.02,"Exon (ENSBGRT00000024350/ENSBGRG00000013311, exon 1 of 1)",11,24059780,24060970,1191,1]
["chr11",33231609,33231966,358,"ENSBGRG00000026023","ENSBGRT00000048141",80364,"CA12","carbonic anhydrase 12 [Source:HGNC Symbol;Acc:HGNC:1371]","GO:0004089(carbonate dehydratase activity);GO:0008270(zinc ion binding);GO:0016021(integral component of membrane);GO:0055064(chloride ion homeostasis)","00910(Nitrogen metabolism)",{"v":2E-14,"d":"0.00"},1,"358,",0,{"v":-13.7,"d":"-13.70"},{"v":-12.8,"d":"-12.80"},{"v":16.5,"d":"16.50"},"3' UTR",11,33151245,33232592,81348,1]
["chr11",37615711,37616662,952,"ENSBGRG00000008564","ENSBGRT00000015723",6250,"ENSBGRG00000008564","NA","GO:0005672(transcription factor TFIIA complex);GO:0006367(transcription initiation from RNA polymerase II promoter)","00512(Mucin type O-glycan biosynthesis);03022(Basal transcription factors);05203(Viral carcinogenesis)",{"v":5e-43,"d":"0.00"},2,"27,242,","0,710",{"v":-42.3,"d":"-42.30"},-41,2.61,"3' UTR",11,37609461,37615737,6277,1]
["chr11",41202354,41294343,91990,"ENSBGRG00000013787","ENSBGRT00000025245",51004,"MNS1","meiosis specific nuclear structural 1 [Source:HGNC Symbol;Acc:HGNC:29636]","GO:0005635(nuclear envelope);GO:0005882(intermediate filament);GO:0005930(axoneme);GO:0007283(spermatogenesis);GO:0036126(sperm flagellum);GO:0042802(identical protein binding);GO:0044782(cilium organization);GO:0045724(positive regulation of cilium assembly);GO:0070986(left/right axis specification)","NA",{"v":5e-57,"d":"0.00"},9,"11,128,103,230,217,108,258,126,97,","0,26525,46921,60783,61376,61682,82810,90411,91893",{"v":-56.3,"d":"-56.30"},{"v":-54.9,"d":"-54.90"},4.13,"3' UTR",11,41151350,41327163,175814,1]
["chr11",46418881,46419325,445,"ENSBGRG00000008885","ENSBGRT00000016303",14858,"LYSMD2","LysM domain containing 2 [Source:HGNC Symbol;Acc:HGNC:28571]","NA","04742(Taste transduction)",{"v":2.3e-08,"d":"0.00"},1,"445,",0,-7.64,-6.84,{"v":3.3,"d":"3.30"},"3' UTR",11,46404023,46419503,15481,1]
["chr11",49474856,49479776,4921,"ENSBGRG00000015031","ENSBGRT00000027737",59799,"CEP152","centrosomal protein 152 [Source:HGNC Symbol;Acc:HGNC:29298]","GO:0000242(pericentriolar material);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0007099(centriole replication);GO:0019901(protein kinase binding);GO:0051298(centrosome duplication);GO:0098535(de novo centriole assembly involved in multi-ciliated epithelial cell differentiation);GO:0098536(deuterosome)","NA",{"v":0.00065,"d":"0.00"},3,"80,136,115,","0,201,4806",-3.19,-2.55,12,"Exon (ENSBGRT00000027737/ENSBGRG00000015031, exon 15 of 29)",11,49415057,49521216,106160,1]
["chr11",55578940,55579729,790,"ENSBGRG00000023733","ENSBGRT00000043855",30229,"CGRRF1","cell growth regulator with ring finger domain 1 [Source:HGNC Symbol;Acc:HGNC:15528]","GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":3.2e-27,"d":"0.00"},2,"54,513,","0,277",{"v":-26.5,"d":"-26.50"},{"v":-25.4,"d":"-25.40"},4.51,"3' UTR",11,55548711,55580235,31525,1]
["chr11",59562416,59567882,5467,"ENSBGRG00000006268","ENSBGRT00000011564",61703,"ARID4A","AT-rich interaction domain 4A [Source:HGNC Symbol;Acc:HGNC:9885]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006349(regulation of gene expression by genetic imprinting);GO:0007283(spermatogenesis);GO:0017053(transcriptional repressor complex);GO:0034773(histone H4-K20 trimethylation);GO:0036124(histone H3-K9 trimethylation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048821(erythrocyte development);GO:0080182(histone H3-K4 trimethylation);GO:0097368(establishment of Sertoli cell barrier)","NA",{"v":0.00021,"d":"0.00"},3,"19,147,104,","0,639,5363",-3.67,-3,1.28,"Exon (ENSBGRT00000011564/ENSBGRG00000006268, exon 22 of 24)",11,59500713,59567882,67170,1]
["chr11",66177064,66178437,1374,"ENSBGRG00000013924","ENSBGRT00000025648",30,"HSPA2","heat shock protein family A (Hsp70) member 2 [Source:HGNC Symbol;Acc:HGNC:5235]","GO:0000795(synaptonemal complex);GO:0001673(male germ cell nucleus);GO:0001934(positive regulation of protein phosphorylation);GO:0005829(cytosol);GO:0007140(male meiotic nuclear division);GO:0007141(male meiosis I);GO:0007283(spermatogenesis);GO:0007286(spermatid development);GO:0009986(cell surface);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0019899(enzyme binding);GO:0032781(positive regulation of ATPase activity);GO:0036128(CatSper complex);GO:0042026(protein refolding);GO:0051082(unfolded protein binding);GO:0051861(glycolipid binding);GO:0070194(synaptonemal complex disassembly);GO:0072687(meiotic spindle);GO:0090084(negative regulation of inclusion body assembly);GO:0097718(disordered domain specific binding);GO:1901896(positive regulation of ATPase-coupled calcium transmembrane transporter activity)","03040(Spliceosome);04141(Protein processing in endoplasmic reticulum);04010(MAPK signaling pathway);04144(Endocytosis);04612(Antigen processing and presentation);04915(Estrogen signaling pathway);04213(Longevity regulating pathway - multiple species);05134(Legionellosis);05162(Measles);05164(Influenza A);05169(Epstein-Barr virus infection);05145(Toxoplasmosis)",{"v":5e-47,"d":"0.00"},1,"1374,",0,{"v":-46.3,"d":"-46.30"},{"v":-44.9,"d":"-44.90"},4.98,"Exon (ENSBGRT00000025648/ENSBGRG00000013924, exon 1 of 2)",11,66177034,66179695,2662,1]
["chr11",71139985,71144318,4334,"ENSBGRG00000007271","ENSBGRT00000013391",113469,"GALNT16","polypeptide N-acetylgalactosaminyltransferase 16 [Source:HGNC Symbol;Acc:HGNC:23233]","GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity);GO:0018242(protein O-linked glycosylation via serine);GO:0018243(protein O-linked glycosylation via threonine)","00512(Mucin type O-glycan biosynthesis)",{"v":1e-112,"d":"0.00"},2,"9,797,","0,3537",-112,-110,{"v":15.7,"d":"15.70"},"3' UTR",11,71026516,71144616,118101,1]
["chr11",71789537,71808225,18689,"ENSBGRG00000007997","ENSBGRT00000014919",143515,"SMOC1","SPARC related modular calcium binding 1 [Source:HGNC Symbol;Acc:HGNC:20318]","GO:0001654(eye development);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0045667(regulation of osteoblast differentiation);GO:0050840(extracellular matrix binding);GO:0060173(limb development)","NA",{"v":5E-36,"d":"0.00"},4,"7,106,245,330,","0,2207,12612,18359",{"v":-35.3,"d":"-35.30"},-34,2.73,"3' UTR",11,71646022,71811003,164982,1]
["chr11",74865907,74867044,1138,"ENSBGRG00000014589","ENSBGRT00000026817",509,"ENSBGRG00000014589","NA","NA","NA",{"v":1.6E-15,"d":"0.00"},1,"1138,",0,{"v":-14.8,"d":"-14.80"},{"v":-13.9,"d":"-13.90"},{"v":47.1,"d":"47.10"},"Exon (ENSBGRT00000026817/ENSBGRG00000014589, exon 1 of 1)",11,74865398,74867044,1647,1]
["chr11",77420969,77421295,327,"ENSBGRG00000009350","ENSBGRT00000017135",25779,"ENSBGRG00000009350","NA","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0030154(cell differentiation)","NA",{"v":0.032,"d":"0.03"},1,"327,",0,{"v":-1.5,"d":"-1.50"},{"v":-0.989,"d":"-0.99"},3.51,"3' UTR",11,77395190,77421444,26255,1]
["chr11",79514496,79517282,2787,"ENSBGRG00000013505","ENSBGRT00000024785",0,"AHSA1","activator of HSP90 ATPase activity 1 [Source:HGNC Symbol;Acc:HGNC:1189]","GO:0001671(ATPase activator activity);GO:0005829(cytosol);GO:0032781(positive regulation of ATPase activity);GO:0051087(chaperone binding);GO:0051879(Hsp90 protein binding)","04080(Neuroactive ligand-receptor interaction)",{"v":0.00013,"d":"0.00"},3,"175,500,10,","0,903,2777",-3.89,-3.21,11,"5' UTR",11,79514496,79524336,9841,1]
["chr11",95266788,95274564,7777,"ENSBGRG00000007804","ENSBGRT00000014424",88075,"GOLM2","cancer susceptibility 4 [Source:HGNC Symbol;Acc:HGNC:24892]","GO:0005794(Golgi apparatus)","NA",{"v":1.1E-4,"d":"0.00"},2,"169,41,","0,7736",-3.97,-3.29,2.46,"Exon (ENSBGRT00000014424/ENSBGRG00000007804, exon 9 of 9)",11,95178713,95266956,88244,1]
["chr11",1755451,1755747,297,"ENSBGRG00000007218","ENSBGRT00000013504",0,"SLC22A17","solute carrier family 22 member 17 [Source:HGNC Symbol;Acc:HGNC:23095]","GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":1.6E-13,"d":"0.00"},1,"297,",0,{"v":-12.8,"d":"-12.80"},{"v":-11.9,"d":"-11.90"},2.65,"Exon (ENSBGRT00000013504/ENSBGRG00000007218, exon 1 of 10)",11,1748171,1755559,7389,2]
["chr11",2530658,2530836,179,"ENSBGRG00000019282","ENSBGRT00000035478",5869,"RABGGTA","Rab geranylgeranyltransferase subunit alpha [Source:HGNC Symbol;Acc:HGNC:9795]","GO:0004663(Rab geranylgeranyltransferase activity);GO:0005654(nucleoplasm);GO:0005968(Rab-protein geranylgeranyltransferase complex);GO:0008270(zinc ion binding);GO:0008318(protein prenyltransferase activity);GO:0018342(protein prenylation);GO:0018344(protein geranylgeranylation)","NA",{"v":1E-14,"d":"0.00"},1,"179,",0,-14,{"v":-13.1,"d":"-13.10"},5.16,"3' UTR",11,2530658,2536705,6048,2]
["chr11",7825309,7825698,390,"ENSBGRG00000020997","ENSBGRT00000038723",8805,"GLCE","glucuronic acid epimerase [Source:HGNC Symbol;Acc:HGNC:17855]","GO:0005509(calcium ion binding);GO:0005794(Golgi apparatus);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0016857(racemase and epimerase activity, acting on carbohydrates and derivatives);GO:0030210(heparin biosynthetic process);GO:0042803(protein homodimerization activity);GO:0047464(heparosan-N-sulfate-glucuronate 5-epimerase activity)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)",{"v":1e-16,"d":"0.00"},1,"390,",0,-16,-15,4.04,"Exon (ENSBGRT00000038723/ENSBGRG00000020997, exon 2 of 4)",11,7817298,7834503,17206,2]
["chr11",10660853,10661360,508,"ENSBGRG00000024050","ENSBGRT00000044429",83213,"SMAD6","SMAD family member 6 [Source:HGNC Symbol;Acc:HGNC:6772]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001657(ureteric bud development);GO:0003148(outflow tract septum morphogenesis);GO:0003170(heart valve development);GO:0003180(aortic valve morphogenesis);GO:0003183(mitral valve morphogenesis);GO:0003184(pulmonary valve morphogenesis);GO:0003281(ventricular septum development);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006955(immune response);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007352(zygotic specification of dorsal/ventral axis);GO:0008285(negative regulation of cell population proliferation);GO:0010991(negative regulation of SMAD protein complex assembly);GO:0016604(nuclear body);GO:0030279(negative regulation of ossification);GO:0030509(BMP signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030514(negative regulation of BMP signaling pathway);GO:0031589(cell-substrate adhesion);GO:0031625(ubiquitin protein ligase binding);GO:0032496(response to lipopolysaccharide);GO:0032991(protein-containing complex);GO:0034616(response to laminar fluid shear stress);GO:0034713(type I transforming growth factor beta receptor binding);GO:0035904(aorta development);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0045444(fat cell differentiation);GO:0045668(negative regulation of osteoblast differentiation);GO:0060394(negative regulation of pathway-restricted SMAD protein phosphorylation);GO:0060976(coronary vasculature development);GO:0070410(co-SMAD binding);GO:0070411(I-SMAD binding);GO:0070412(R-SMAD binding);GO:0070698(type I activin receptor binding);GO:0140416(DNA-binding transcription factor inhibitor activity);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II)","04350(TGF-beta signaling pathway)",{"v":2e-11,"d":"0.00"},1,"508,",0,{"v":-10.7,"d":"-10.70"},{"v":-9.8,"d":"-9.80"},3.01,"3' UTR",11,10660763,10744573,83811,2]
["chr11",18074131,18075844,1714,"ENSBGRG00000009306","ENSBGRT00000017658",81611,"POLK","DNA polymerase kappa [Source:HGNC Symbol;Acc:HGNC:9183]","GO:0003677(DNA binding);GO:0003684(damaged DNA binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005654(nucleoplasm);GO:0006281(DNA repair);GO:0006297(nucleotide-excision repair, DNA gap filling);GO:0006974(cellular response to DNA damage stimulus);GO:0016604(nuclear body);GO:0034644(cellular response to UV);GO:0042276(error-prone translesion synthesis);GO:0090734(site of DNA damage)","03460(Fanconi anemia pathway);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05216(Thyroid cancer);05220(Chronic myeloid leukemia);05217(Basal cell carcinoma);05218(Melanoma);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer)",{"v":3.2E-54,"d":"0.00"},3,"166,43,720,","0,399,994",{"v":-53.5,"d":"-53.50"},-52,7.26,"3' UTR",11,18073413,18157455,84043,2]
["chr11",22143468,22143617,150,"ENSBGRG00000011476","ENSBGRT00000021016",48852,"KCNN2","potassium calcium-activated channel subfamily N member 2 [Source:HGNC Symbol;Acc:HGNC:6291]","GO:0005516(calmodulin binding);GO:0005886(plasma membrane);GO:0006813(potassium ion transport);GO:0009986(cell surface);GO:0015269(calcium-activated potassium channel activity);GO:0016021(integral component of membrane);GO:0016286(small conductance calcium-activated potassium channel activity);GO:0019904(protein domain specific binding);GO:0042803(protein homodimerization activity);GO:0051393(alpha-actinin binding);GO:0071805(potassium ion transmembrane transport);GO:1901379(regulation of potassium ion transmembrane transport)","04911(Insulin secretion);04976(Bile secretion);04726(Serotonergic synapse)",{"v":3e-05,"d":"0.00"},1,"150,",0,-4.53,-3.82,3.81,"Exon (ENSBGRT00000021016/ENSBGRG00000011476, exon 4 of 9)",11,22013638,22192469,178832,2]
["chr11",28782934,28784283,1350,"ENSBGRG00000015937","ENSBGRT00000029319",0,"DNAAF2","dynein axonemal assembly factor 2 [Source:HGNC Symbol;Acc:HGNC:20188]","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0010033(response to organic substance);GO:0032526(response to retinoic acid);GO:0060285(cilium-dependent cell motility);GO:0070286(axonemal dynein complex assembly)","NA",{"v":5.8E-4,"d":"0.00"},1,"1350,",0,-3.24,{"v":-2.6,"d":"-2.60"},9.03,"Exon (ENSBGRT00000029360/ENSBGRG00000015999, exon 1 of 1)",11,28777534,28784283,6750,2]
["chr11",31758475,31760098,1624,"ENSBGRG00000023364","ENSBGRT00000043165",178756,"ZNF609","zinc finger protein 609 [Source:HGNC Symbol;Acc:HGNC:29003]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990841(promoter-specific chromatin binding);GO:2000291(regulation of myoblast proliferation);GO:2001224(positive regulation of neuron migration)","03420(Nucleotide excision repair)",{"v":1.3E-41,"d":"0.00"},2,"271,478,","0,1146",{"v":-40.9,"d":"-40.90"},{"v":-39.6,"d":"-39.60"},4.53,"Exon (ENSBGRT00000043165/ENSBGRG00000023364, exon 4 of 8)",11,31754526,31938854,184329,2]
["chr11",39816669,39817297,629,"ENSBGRG00000011974","ENSBGRT00000021946",121612,"ENSBGRG00000011974","NA","GO:0030864(cortical actin cytoskeleton);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031674(I band);GO:0035556(intracellular signal transduction)","NA",{"v":0.035,"d":"0.04"},1,"629,",0,-1.46,{"v":-0.949,"d":"-0.95"},3.01,"3' UTR",11,39816579,39938909,122331,2]
["chr11",46221377,46221437,61,"ENSBGRG00000008280","ENSBGRT00000015390",68841,"LEO1","LEO1 homolog, Paf1/RNA polymerase II complex component [Source:HGNC Symbol;Acc:HGNC:30401]","GO:0001650(fibrillar center);GO:0001711(endodermal cell fate commitment);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0006378(mRNA polyadenylation);GO:0010390(histone monoubiquitination);GO:0016570(histone modification);GO:0016593(Cdc73/Paf1 complex);GO:0019827(stem cell population maintenance);GO:0031442(positive regulation of mRNA 3'-end processing);GO:0033523(histone H2B ubiquitination);GO:0045638(negative regulation of myeloid cell differentiation)","NA",{"v":0.013,"d":"0.01"},1,"61,",0,-1.89,-1.34,1.81,"Exon (ENSBGRT00000015861/ENSBGRG00000008702, exon 8 of 10)",11,46152536,46332666,180131,1]
["chr11",53361250,53371548,10299,"ENSBGRG00000019163","ENSBGRT00000035244",0,"SPATA5L1","spermatogenesis associated 5 like 1 [Source:HGNC Symbol;Acc:HGNC:28762]","GO:0005524(ATP binding)","03008(Ribosome biogenesis in eukaryotes)",0.01,2,"68,172,","0,10127",-1.98,-1.42,7.02,"5' UTR",11,53326643,53371548,44906,2]
["chr11",56448602,56463535,14934,"ENSBGRG00000003724","ENSBGRT00000006908",86177,"FBXO34","F-box protein 34 [Source:HGNC Symbol;Acc:HGNC:20201]","GO:0005515(protein binding)","NA",{"v":1.4e-06,"d":"0.00"},4,"914,84,305,47,","0,3281,3843,14887",-5.86,-5.11,3.01,"3' UTR",11,56362425,56455137,92713,1]
["chr11",66616130,66616489,360,"ENSBGRG00000003995","ENSBGRT00000007505",21207,"RAB15","RAB15, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:20150]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005929(cilium);GO:0010008(endosome membrane);GO:0032482(Rab protein signal transduction);GO:0048471(perinuclear region of cytoplasm);GO:1903307(positive regulation of regulated secretory pathway)","NA",{"v":0.022,"d":"0.02"},1,"360,",0,-1.66,-1.14,1.91,"3' UTR",11,66614604,66637696,23093,2]
["chr11",70715098,70716061,964,"ENSBGRG00000006595","ENSBGRT00000012388",0,"ACTN1","actinin alpha 1 [Source:HGNC Symbol;Acc:HGNC:163]","GO:0001725(stress fiber);GO:0001726(ruffle);GO:0003725(double-stranded RNA binding);GO:0005178(integrin binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005884(actin filament);GO:0005903(brush border);GO:0005911(cell-cell junction);GO:0005916(fascia adherens);GO:0005925(focal adhesion);GO:0007015(actin filament organization);GO:0017166(vinculin binding);GO:0030017(sarcomere);GO:0030018(Z disc);GO:0030220(platelet formation);GO:0030374(nuclear receptor transcription coactivator activity);GO:0036344(platelet morphogenesis);GO:0042803(protein homodimerization activity);GO:0042995(cell projection);GO:0044325(ion channel binding);GO:0048041(focal adhesion assembly);GO:0051015(actin filament binding);GO:0051017(actin filament bundle assembly);GO:0051271(negative regulation of cellular component movement);GO:0051639(actin filament network formation);GO:0051764(actin crosslink formation);GO:0098978(glutamatergic synapse);GO:0099186(structural constituent of postsynapse)","04510(Focal adhesion);04520(Adherens junction);04530(Tight junction);04810(Regulation of actin cytoskeleton);04670(Leukocyte transendothelial migration);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus);05146(Amoebiasis)",{"v":1E-10,"d":"0.00"},2,"87,94,","0,870",-9.99,-9.14,3.16,"5' UTR",11,70598259,70715184,116926,2]
["chr11",75154895,75155224,330,"ENSBGRG00000016469","ENSBGRT00000030426",122392,"NUMB","NUMB endocytic adaptor protein [Source:HGNC Symbol;Acc:HGNC:8060]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005905(clathrin-coated pit);GO:0007399(nervous system development);GO:0007405(neuroblast proliferation);GO:0007409(axonogenesis);GO:0008013(beta-catenin binding);GO:0016323(basolateral plasma membrane);GO:0019897(extrinsic component of plasma membrane);GO:0021670(lateral ventricle development);GO:0021849(neuroblast division in subventricular zone);GO:0030136(clathrin-coated vesicle);GO:0030335(positive regulation of cell migration);GO:0030900(forebrain development);GO:0031410(cytoplasmic vesicle);GO:0034332(adherens junction organization);GO:0045177(apical part of cell);GO:0045294(alpha-catenin binding);GO:0045296(cadherin binding);GO:0050769(positive regulation of neurogenesis);GO:0098978(glutamatergic synapse);GO:0099149(regulation of postsynaptic neurotransmitter receptor internalization);GO:1903077(negative regulation of protein localization to plasma membrane)","04330(Notch signaling pathway)",{"v":4E-90,"d":"0.00"},1,"330,",0,{"v":-89.4,"d":"-89.40"},{"v":-87.7,"d":"-87.70"},5.54,"Exon (ENSBGRT00000030426/ENSBGRG00000016469, exon 12 of 12)",11,75154895,75277616,122722,2]
["chr11",76801896,76806452,4557,"ENSBGRG00000008113","ENSBGRT00000014975",10347,"PGF","placental growth factor [Source:HGNC Symbol;Acc:HGNC:8893]","GO:0001658(branching involved in ureteric bud morphogenesis);GO:0005615(extracellular space);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0060688(regulation of morphogenesis of a branching structure)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);05200(Pathways in cancer)",{"v":5e-11,"d":"0.00"},4,"276,63,30,50,","0,3113,3281,4507",{"v":-10.3,"d":"-10.30"},-9.44,2.47,"3' UTR",11,76801896,76816799,14904,2]
["chr11",83913430,83914059,630,"ENSBGRG00000017701","ENSBGRT00000032465",99691,"ENSBGRG00000017701","NA","GO:0006897(endocytosis);GO:0036465(synaptic vesicle recycling)","NA",{"v":0.00021,"d":"0.00"},1,"630,",0,-3.68,-3.02,6.69,"3' UTR",11,83913430,84013750,100321,2]
["chr11",94832901,94837120,4220,"ENSBGRG00000007305","ENSBGRT00000013939",185160,"RPS6KA5","ribosomal protein S6 kinase A5 [Source:HGNC Symbol;Acc:HGNC:10434]","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006468(protein phosphorylation);GO:0016572(histone phosphorylation);GO:0033129(positive regulation of histone phosphorylation);GO:0035066(positive regulation of histone acetylation);GO:0035556(intracellular signal transduction);GO:0043987(histone H3-S10 phosphorylation);GO:0043988(histone H3-S28 phosphorylation);GO:0043990(histone H2A-S1 phosphorylation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0070498(interleukin-1-mediated signaling pathway)","04010(MAPK signaling pathway);04668(TNF signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04722(Neurotrophin signaling pathway);04713(Circadian entrainment);05200(Pathways in cancer);05206(MicroRNAs in cancer);05219(Bladder cancer)",{"v":6.3e-30,"d":"0.00"},2,"867,1,","0,4219",{"v":-29.2,"d":"-29.20"},-28,6.47,"3' UTR",11,94832901,95022280,189380,2]
["chr12",6404560,6405190,631,"ENSBGRG00000010059","ENSBGRT00000019240",103915,"PRKCQ","protein kinase C theta [Source:HGNC Symbol;Acc:HGNC:9410]","GO:0001772(immunological synapse);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004697(protein kinase C activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006468(protein phosphorylation);GO:0006509(membrane protein ectodomain proteolysis);GO:0016235(aggresome);GO:0032212(positive regulation of telomere maintenance via telomerase);GO:0032740(positive regulation of interleukin-17 production);GO:0032743(positive regulation of interleukin-2 production);GO:0032753(positive regulation of interleukin-4 production);GO:0034451(centriolar satellite);GO:0035556(intracellular signal transduction);GO:0042102(positive regulation of T cell proliferation);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0050870(positive regulation of T cell activation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051973(positive regulation of telomerase activity);GO:0060326(cell chemotaxis);GO:0070233(negative regulation of T cell apoptotic process);GO:0090330(regulation of platelet aggregation);GO:1904355(positive regulation of telomere capping);GO:2000318(positive regulation of T-helper 17 type immune response);GO:2000570(positive regulation of T-helper 2 cell activation)","04064(NF-kappa B signaling pathway);04140(Autophagy - animal);04660(T cell receptor signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04920(Adipocytokine signaling pathway);04270(Vascular smooth muscle contraction);04750(Inflammatory mediator regulation of TRP channels);04931(Insulin resistance);05162(Measles)",{"v":1e-05,"d":"0.00"},1,"631,",0,-4.99,-4.27,{"v":20.1,"d":"20.10"},"3' UTR",12,6300645,6404651,104007,1]
["chr12",12719542,12747241,27700,"ENSBGRG00000022038","ENSBGRT00000041499",134412,"ENSBGRG00000022038","NA","NA","04080(Neuroactive ligand-receptor interaction);04727(GABAergic synapse);04723(Retrograde endocannabinoid signaling);04742(Taste transduction);05032(Morphine addiction);05033(Nicotine addiction)",{"v":7.1e-06,"d":"0.00"},7,"28,3,253,38,21,111,26,","0,30,23561,27496,27536,27559,27674",-5.15,-4.43,2.41,"Exon (ENSBGRT00000041499/ENSBGRG00000022038, exon 12 of 43)",12,12585130,12817041,231912,1]
["chr12",25575797,25575915,119,"ENSBGRG00000024778","ENSBGRT00000045709",2301,"ENSBGRG00000024778","NA","NA","NA",{"v":0.00089,"d":"0.00"},1,"119,",0,-3.05,-2.42,13,"Exon (ENSBGRT00000045709/ENSBGRG00000024778, exon 2 of 2)",12,25573496,25575915,2420,1]
["chr12",29842458,29845078,2621,"ENSBGRG00000005416","ENSBGRT00000010102",0,"POLR3F","RNA polymerase III subunit F [Source:HGNC Symbol;Acc:HGNC:15763]","GO:0003690(double-stranded DNA binding);GO:0005666(RNA polymerase III complex);GO:0006383(transcription by RNA polymerase III);GO:0032728(positive regulation of interferon-beta production);GO:0045089(positive regulation of innate immune response)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway);05169(Epstein-Barr virus infection)",{"v":7.6e-08,"d":"0.00"},3,"172,118,40,","0,1487,2581",-7.12,-6.34,6.02,"5' UTR",12,29845039,29859164,14126,1]
["chr12",31012056,31012620,565,"ENSBGRG00000005832","ENSBGRT00000010772",192738,"ENSBGRG00000005832","NA","GO:0007165(signal transduction)","04014(Ras signaling pathway)",{"v":9.99999999999998e-264,"d":"0.00"},1,"565,",0,-263,-261,6.38,"3' UTR",12,30819318,31012620,193303,1]
["chr12",34756026,34756446,421,"ENSBGRG00000009324","ENSBGRT00000017070",0,"ENSBGRG00000009324","NA","GO:0000221(vacuolar proton-transporting V-type ATPase, V1 domain);GO:0046961(proton-transporting ATPase activity, rotational mechanism);GO:1902600(proton transmembrane transport)","00190(Oxidative phosphorylation);04150(mTOR signaling pathway);04145(Phagosome);04142(Lysosome);04721(Synaptic vesicle cycle);05323(Rheumatoid arthritis);05152(Tuberculosis);05165(Human papillomavirus infection)",{"v":3.3e-05,"d":"0.00"},2,"216,114,","0,307",-4.48,-3.78,2.81,"Exon (ENSBGRT00000017070/ENSBGRG00000009324, exon 1 of 2)",12,34756026,34757522,1497,1]
["chr12",45015388,45015477,90,"ENSBGRG00000013110","ENSBGRT00000024036",96,"VPS16","VPS16 core subunit of CORVET and HOPS complexes [Source:HGNC Symbol;Acc:HGNC:14584]","GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005769(early endosome);GO:0005770(late endosome);GO:0006886(intracellular protein transport);GO:0007033(vacuole organization);GO:0008333(endosome to lysosome transport);GO:0030897(HOPS complex);GO:0055037(recycling endosome);GO:0097352(autophagosome maturation)","NA",{"v":0.0027,"d":"0.00"},1,"90,",0,-2.57,-1.97,2.05,"5' UTR",12,44984866,45015573,30708,2]
["chr12",46954405,46954711,307,"ENSBGRG00000015487","ENSBGRT00000028657",7704,"ARFRP1","ADP ribosylation factor related protein 1 [Source:HGNC Symbol;Acc:HGNC:662]","GO:0005525(GTP binding)","NA",{"v":0.00049,"d":"0.00"},2,"96,143,","0,164",-3.31,-2.66,1.95,"3' UTR",12,46946701,46954419,7719,1]
["chr12",47519244,47534919,15676,"ENSBGRG00000020529","ENSBGRT00000037831",2277,"TCFL5","transcription factor like 5 [Source:HGNC Symbol;Acc:HGNC:11646]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001673(male germ cell nucleus);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007283(spermatogenesis);GO:0042127(regulation of cell population proliferation);GO:0045595(regulation of cell differentiation);GO:0046983(protein dimerization activity);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":5e-31,"d":"0.00"},5,"90,140,247,142,610,","0,1382,2567,4661,15066",{"v":-30.3,"d":"-30.30"},{"v":-29.1,"d":"-29.10"},8.27,"3' UTR",12,47516967,47522057,5091,1]
["chr12",52149192,52150387,1196,"ENSBGRG00000009247","ENSBGRT00000017007",10000,"ENSBGRG00000009247","Z-DNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:16176]","GO:0003677(DNA binding);GO:0060340(positive regulation of type I interferon-mediated signaling pathway)","04217(Necroptosis);04623(Cytosolic DNA-sensing pathway)",{"v":0.011,"d":"0.01"},2,"717,152,","0,1044",-1.97,-1.14,9.03,"3' UTR",12,52139192,52149908,10717,1]
["chr12",57571039,57571816,778,"ENSBGRG00000006728","ENSBGRT00000012472",0,"RALY","RALY heterogeneous nuclear ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:15921]","GO:0003676(nucleic acid binding);GO:0003712(transcription coregulator activity);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0042632(cholesterol homeostasis);GO:0071013(catalytic step 2 spliceosome);GO:1903506(regulation of nucleic acid-templated transcription)","NA",{"v":0.00024,"d":"0.00"},1,"778,",0,-3.62,-2.96,8.02,"5' UTR",12,57571039,57671942,100904,1]
["chr12",59064503,59064862,360,"ENSBGRG00000010182","ENSBGRT00000018753",44276,"CEP250","centrosomal protein 250 [Source:HGNC Symbol;Acc:HGNC:1859]","GO:0000278(mitotic cell cycle);GO:0005813(centrosome);GO:0005814(centriole);GO:0008022(protein C-terminus binding);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0030997(regulation of centriole-centriole cohesion);GO:0032991(protein-containing complex);GO:0033365(protein localization to organelle);GO:0060271(cilium assembly);GO:1904781(positive regulation of protein localization to centrosome);GO:1905515(non-motile cilium assembly)","NA",{"v":1E-136,"d":"0.00"},1,"360,",0,-136,-134,9.07,"3' UTR",12,59020227,59064862,44636,1]
["chr12",59759649,59760424,776,"ENSBGRG00000014167","ENSBGRT00000026042",0,"AAR2","AAR2 splicing factor [Source:HGNC Symbol;Acc:HGNC:15886]","NA","NA",{"v":2e-47,"d":"0.00"},1,"776,",0,{"v":-46.7,"d":"-46.70"},{"v":-45.3,"d":"-45.30"},5.59,"5' UTR",12,59759649,59779935,20287,1]
["chr12",61582401,61582844,444,"ENSBGRG00000005933","ENSBGRT00000010991",59085,"RPRD1B","regulation of nuclear pre-mRNA domain containing 1B [Source:HGNC Symbol;Acc:HGNC:16209]","GO:0000993(RNA polymerase II complex binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008284(positive regulation of cell population proliferation);GO:0010564(regulation of cell cycle process);GO:0016591(RNA polymerase II, holoenzyme);GO:0042802(identical protein binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0070940(dephosphorylation of RNA polymerase II C-terminal domain)","NA",{"v":3.4E-5,"d":"0.00"},1,"444,",0,-4.47,-3.77,5.01,"3' UTR",12,61523316,61583465,60150,1]
["chr12",69265419,69273153,7735,"ENSBGRG00000012664","ENSBGRT00000026074",0,"PIGT","phosphatidylinositol glycan anchor biosynthesis class T [Source:HGNC Symbol;Acc:HGNC:14938]","GO:0005737(cytoplasm);GO:0016255(attachment of GPI anchor to protein);GO:0030182(neuron differentiation);GO:0031410(cytoplasmic vesicle);GO:0042765(GPI-anchor transamidase complex);GO:0051402(neuron apoptotic process)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":3.2e-36,"d":"0.00"},3,"82,72,55,","0,4045,7680",{"v":-35.5,"d":"-35.50"},{"v":-34.3,"d":"-34.30"},2.54,"Exon (ENSBGRT00000025922/ENSBGRG00000012664, exon 5 of 18)",12,69269464,69286418,16955,1]
["chr12",74802952,74803430,479,"ENSBGRG00000004126","ENSBGRT00000007646",74155,"PTPN1","protein tyrosine phosphatase non-receptor type 1 [Source:HGNC Symbol;Acc:HGNC:9642]","GO:0004725(protein tyrosine phosphatase activity);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006470(protein dephosphorylation);GO:0007257(activation of JUN kinase activity);GO:0008270(zinc ion binding);GO:0008286(insulin receptor signaling pathway);GO:0009966(regulation of signal transduction);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0030100(regulation of endocytosis);GO:0030948(negative regulation of vascular endothelial growth factor receptor signaling pathway);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0030971(receptor tyrosine kinase binding);GO:0031532(actin cytoskeleton reorganization);GO:0032991(protein-containing complex);GO:0033157(regulation of intracellular protein transport);GO:0034976(response to endoplasmic reticulum stress);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0035791(platelet-derived growth factor receptor-beta signaling pathway);GO:0036498(IRE1-mediated unfolded protein response);GO:0043407(negative regulation of MAP kinase activity);GO:0046875(ephrin receptor binding);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0097443(sorting endosome);GO:0098554(cytoplasmic side of endoplasmic reticulum membrane);GO:1902202(regulation of hepatocyte growth factor receptor signaling pathway);GO:1902236(negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway);GO:1903898(negative regulation of PERK-mediated unfolded protein response);GO:1990264(peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity);GO:2000646(positive regulation of receptor catabolic process)","04520(Adherens junction);04910(Insulin signaling pathway);04931(Insulin resistance)",{"v":1E-27,"d":"0.00"},1,"479,",0,-27,{"v":-25.9,"d":"-25.90"},4.59,"3' UTR",12,74728797,74804034,75238,1]
["chr12",81037598,81095103,57506,"ENSBGRG00000007083","ENSBGRT00000014169",283037,"ENSBGRG00000007083","NA","GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0035091(phosphatidylinositol binding)","NA",{"v":0.011,"d":"0.01"},3,"81,84,15,","0,24390,57491",-1.96,{"v":-1.4,"d":"-1.40"},5.52,"3' UTR",12,80754561,81037678,283118,1]
["chr12",843100,843219,120,"ENSBGRG00000011220","ENSBGRT00000021116",47780,"CDC123","cell division cycle 123 [Source:HGNC Symbol;Acc:HGNC:16827]","GO:0005737(cytoplasm)","NA",{"v":0.0058,"d":"0.01"},1,"120,",0,-2.24,-1.66,2.76,"3' UTR",12,843070,890999,47930,2]
["chr12",16990262,16992130,1869,"ENSBGRG00000010581","ENSBGRT00000019472",0,"FZD8","frizzled class receptor 8 [Source:HGNC Symbol;Acc:HGNC:4046]","GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0007166(cell surface receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030165(PDZ domain binding);GO:0031625(ubiquitin protein ligase binding);GO:0042813(Wnt-activated receptor activity);GO:0060070(canonical Wnt signaling pathway)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":1E-61,"d":"0.00"},5,"15,309,19,484,10,","0,149,542,632,1859",-61,{"v":-59.5,"d":"-59.50"},8.65,"Exon (ENSBGRT00000019472/ENSBGRG00000010581, exon 1 of 6)",12,16988632,16992130,3499,2]
["chr12",27157860,27158274,415,"ENSBGRG00000024890","ENSBGRT00000045977",5648,"ENSBGRG00000024890","NA","NA","04310(Wnt signaling pathway);04350(TGF-beta signaling pathway)",{"v":9.99999999999999e-262,"d":"0.00"},4,"171,126,42,70,","0,173,301,345",-261,-259,{"v":7.1,"d":"7.10"},"Exon (ENSBGRT00000045977/ENSBGRG00000024890, exon 8 of 11)",12,27157860,27163922,6063,2]
["chr12",29152011,29152251,241,"ENSBGRG00000004415","ENSBGRT00000008115",42475,"BFSP1","beaded filament structural protein 1 [Source:HGNC Symbol;Acc:HGNC:1040]","GO:0005212(structural constituent of eye lens)","NA",{"v":7.9e-05,"d":"0.00"},1,"241,",0,{"v":-4.1,"d":"-4.10"},-3.42,2.87,"Exon (ENSBGRT00000008115/ENSBGRG00000004415, exon 8 of 8)",12,29151082,29194726,43645,2]
["chr12",34819623,34820914,1292,"ENSBGRG00000009524","ENSBGRT00000018653",30759,"TASOR2","transcription activation suppressor family member 2 [Source:HGNC Symbol;Acc:HGNC:23484]","GO:0005654(nucleoplasm);GO:0005829(cytosol)","NA",{"v":1e-130,"d":"0.00"},2,"1217,40,","0,1252",-130,-128,4.47,"Exon (ENSBGRT00000018653/ENSBGRG00000009524, exon 11 of 17)",12,34813600,34851673,38074,2]
["chr12",43900141,43901553,1413,"ENSBGRG00000008139","ENSBGRT00000014895",5813,"MAVS","mitochondrial antiviral signaling protein [Source:HGNC Symbol;Acc:HGNC:29233]","GO:0001934(positive regulation of protein phosphorylation);GO:0002218(activation of innate immune response);GO:0002230(positive regulation of defense response to virus by host);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005778(peroxisomal membrane);GO:0007165(signal transduction);GO:0019901(protein kinase binding);GO:0031966(mitochondrial membrane);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0035591(signaling adaptor activity);GO:0042307(positive regulation of protein import into nucleus);GO:0042742(defense response to bacterium);GO:0045071(negative regulation of viral genome replication);GO:0045087(innate immune response);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050700(CARD domain binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051607(defense response to virus);GO:0060340(positive regulation of type I interferon-mediated signaling pathway);GO:0060760(positive regulation of response to cytokine stimulus);GO:0071360(cellular response to exogenous dsRNA);GO:0071651(positive regulation of chemokine (C-C motif) ligand 5 production);GO:0071660(positive regulation of IP-10 production);GO:1900063(regulation of peroxisome organization);GO:1904469(positive regulation of tumor necrosis factor secretion)","04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05168(Herpes simplex infection)",{"v":5.9e-07,"d":"0.00"},3,"435,69,6,","0,1308,1407",-6.23,-5.47,9.03,"Exon (ENSBGRT00000014895/ENSBGRG00000008139, exon 5 of 7)",12,43900141,43907366,7226,2]
["chr12",46928651,46928888,238,"ENSBGRG00000015318","ENSBGRT00000028087",3646,"SLC2A4RG","SLC2A4 regulator [Source:HGNC Symbol;Acc:HGNC:15930]","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0016607(nuclear speck)","NA",{"v":0.0074,"d":"0.01"},1,"238,",0,-2.13,-1.57,1.46,"Exon (ENSBGRT00000028087/ENSBGRG00000015318, exon 6 of 7)",12,46928297,46932534,4238,2]
["chr12",48080632,48080987,356,"ENSBGRG00000022940","ENSBGRT00000042344",5647,"MTG2","mitochondrial ribosome associated GTPase 2 [Source:HGNC Symbol;Acc:HGNC:16239]","GO:0000287(magnesium ion binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005743(mitochondrial inner membrane);GO:0005759(mitochondrial matrix);GO:0005761(mitochondrial ribosome);GO:0044065(regulation of respiratory system process);GO:0070129(regulation of mitochondrial translation)","NA",{"v":1.6E-11,"d":"0.00"},2,"315,40,","0,316",{"v":-10.8,"d":"-10.80"},{"v":-9.9,"d":"-9.90"},12,"Exon (ENSBGRT00000042344/ENSBGRG00000022940, exon 6 of 7)",12,48080632,48086634,6003,2]
["chr12",50006253,50044518,38266,"ENSBGRG00000024502","ENSBGRT00000045362",161203,"ENSBGRG00000024502","NA","GO:0003779(actin binding);GO:0008157(protein phosphatase 1 binding);GO:0019888(protein phosphatase regulator activity)","NA",{"v":0.017,"d":"0.02"},3,"9,56,25,","0,4225,38241",-1.76,-1.23,2.31,"Exon (ENSBGRT00000045362/ENSBGRG00000024502, exon 8 of 13)",12,50001259,50205721,204463,2]
["chr12",55696518,55700900,4383,"ENSBGRG00000017606","ENSBGRT00000032236",0,"PLAGL2","PLAG1 like zinc finger 2 [Source:HGNC Symbol;Acc:HGNC:9047]","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-templated);GO:0006629(lipid metabolic process);GO:0009791(post-embryonic development);GO:0034378(chylomicron assembly);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","NA",{"v":1.1E-5,"d":"0.00"},2,"697,373,","0,4010",-4.94,-4.22,3.74,"5' UTR",12,55695984,55700900,4917,2]
["chr12",58341214,58341513,300,"ENSBGRG00000007972","ENSBGRT00000014615",48161,"NCOA6","nuclear receptor coactivator 6 [Source:HGNC Symbol;Acc:HGNC:15936]","GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006352(DNA-templated transcription, initiation);GO:0006974(cellular response to DNA damage stimulus);GO:0019899(enzyme binding);GO:0030099(myeloid cell differentiation);GO:0030374(nuclear receptor transcription coactivator activity);GO:0035097(histone methyltransferase complex);GO:0043231(intracellular membrane-bounded organelle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046966(thyroid hormone receptor binding)","NA",{"v":1E-10,"d":"0.00"},1,"300,",0,-10,-9.19,2.27,"Exon (ENSBGRT00000014615/ENSBGRG00000007972, exon 7 of 15)",12,58302634,58389674,87041,2]
["chr12",58990243,58996997,6755,"ENSBGRG00000010061","ENSBGRT00000018452",0,"GDF5","growth differentiation factor 5 [Source:HGNC Symbol;Acc:HGNC:4220]","GO:0007178(transmembrane receptor protein serine/threonine kinase signaling pathway);GO:0008083(growth factor activity);GO:0030326(embryonic limb morphogenesis);GO:0030513(positive regulation of BMP signaling pathway);GO:0032331(negative regulation of chondrocyte differentiation);GO:0032332(positive regulation of chondrocyte differentiation);GO:0035136(forelimb morphogenesis);GO:0035137(hindlimb morphogenesis);GO:0036122(BMP binding);GO:0040014(regulation of multicellular organism growth);GO:0042802(identical protein binding);GO:0050680(negative regulation of epithelial cell proliferation);GO:0060390(regulation of SMAD protein signal transduction);GO:0060395(SMAD protein signal transduction);GO:0060591(chondroblast differentiation);GO:2001054(negative regulation of mesenchymal cell apoptotic process)","04350(TGF-beta signaling pathway);04390(Hippo signaling pathway);04060(Cytokine-cytokine receptor interaction)",{"v":0.011,"d":"0.01"},2,"1875,1363,","0,5392",-1.97,-1.14,9.03,"5' UTR",12,58990243,58996997,6755,2]
["chr12",61747549,61748240,692,"ENSBGRG00000006087","ENSBGRT00000011251",19603,"KIAA1755","KIAA1755 [Source:HGNC Symbol;Acc:HGNC:29372]","NA","NA",{"v":9.3e-09,"d":"0.00"},2,"593,97,","0,595",-8.03,-7.22,{"v":19.1,"d":"19.10"},"Exon (ENSBGRT00000011251/ENSBGRG00000006087, exon 3 of 15)",12,61723882,61767843,43962,2]
["chr12",70191352,70191442,91,"ENSBGRG00000018891","ENSBGRT00000034656",0,"ACOT8","acyl-CoA thioesterase 8 [Source:HGNC Symbol;Acc:HGNC:15919]","GO:0005777(peroxisome);GO:0005782(peroxisomal matrix);GO:0006637(acyl-CoA metabolic process);GO:0016290(palmitoyl-CoA hydrolase activity);GO:0016559(peroxisome fission);GO:0043649(dicarboxylic acid catabolic process);GO:0045225(negative regulation of CD4 biosynthetic process);GO:0047617(acyl-CoA hydrolase activity);GO:0052815(medium-chain acyl-CoA hydrolase activity)","00120(Primary bile acid biosynthesis);04146(Peroxisome)",{"v":0.035,"d":"0.04"},1,"91,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"5' UTR",12,70171527,70191442,19916,2]
["chr12",73350217,73350366,150,"ENSBGRG00000025480","ENSBGRT00000047106",18867,"ZNFX1","zinc finger NFX1-type containing 1 [Source:HGNC Symbol;Acc:HGNC:29271]","GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding)","03013(RNA transport);03015(mRNA surveillance pathway)",{"v":2.4e-05,"d":"0.00"},1,"150,",0,-4.62,-3.92,2.05,"Exon (ENSBGRT00000047106/ENSBGRG00000025480, exon 12 of 12)",12,73349232,73369233,20002,2]
["chr12",75111411,75111620,210,"ENSBGRG00000005144","ENSBGRT00000009453",0,"MOCS3","molybdenum cofactor synthesis 3 [Source:HGNC Symbol;Acc:HGNC:15765]","GO:0002098(tRNA wobble uridine modification);GO:0002143(tRNA wobble position uridine thiolation);GO:0004792(thiosulfate sulfurtransferase activity);GO:0005829(cytosol);GO:0006777(Mo-molybdopterin cofactor biosynthetic process);GO:0008641(ubiquitin-like modifier activating enzyme activity);GO:0016779(nucleotidyltransferase activity);GO:0016783(sulfurtransferase activity);GO:0018192(enzyme active site formation via cysteine modification to L-cysteine persulfide);GO:0034227(tRNA thio-modification);GO:0042292(URM1 activating enzyme activity)","04122(Sulfur relay system)",{"v":5.8E-4,"d":"0.00"},1,"210,",0,-3.24,{"v":-2.6,"d":"-2.60"},3.51,"5' UTR",12,75111420,75114026,2607,1]
["chr12",77042198,77064033,21836,"ENSBGRG00000005809","ENSBGRT00000010712",0,"ENSBGRG00000005809","NA","NA","NA",{"v":2.7e-09,"d":"0.00"},3,"205,830,133,","0,1087,21703",-8.57,-7.75,13,"Exon (ENSBGRT00000010744/ENSBGRG00000005830, exon 1 of 2)",12,77023256,77044114,20859,2]
["chr13",2097747,2098296,550,"ENSBGRG00000005774","ENSBGRT00000010796",297,"SERPING1","serpin family G member 1 [Source:HGNC Symbol;Acc:HGNC:1228]","GO:0001869(negative regulation of complement activation, lectin pathway);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005615(extracellular space);GO:0030193(regulation of blood coagulation);GO:0045916(negative regulation of complement activation)","04610(Complement and coagulation cascades);05133(Pertussis)",{"v":9.5e-07,"d":"0.00"},2,"82,38,","0,512",-6.02,-5.26,1.53,"5' UTR",13,2097450,2113110,15661,1]
["chr13",4301792,4302357,566,"ENSBGRG00000012924","ENSBGRT00000024612",55974,"STX3","syntaxin 3 [Source:HGNC Symbol;Acc:HGNC:11438]","GO:0005484(SNAP receptor activity);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006886(intracellular protein transport);GO:0006887(exocytosis);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0016081(synaptic vesicle docking);GO:0016192(vesicle-mediated transport);GO:0016324(apical plasma membrane);GO:0030027(lamellipodium);GO:0030141(secretory granule);GO:0030425(dendrite);GO:0031201(SNARE complex);GO:0042470(melanosome);GO:0042581(specific granule);GO:0042582(azurophil granule);GO:0042589(zymogen granule membrane);GO:0045785(positive regulation of cell adhesion);GO:0050921(positive regulation of chemotaxis);GO:0060291(long-term synaptic potentiation);GO:0098794(postsynapse);GO:0098967(exocytic insertion of neurotransmitter receptor to postsynaptic membrane);GO:0098978(glutamatergic synapse);GO:0099003(vesicle-mediated transport in synapse);GO:1903078(positive regulation of protein localization to plasma membrane);GO:2000010(positive regulation of protein localization to cell surface)","04130(SNARE interactions in vesicular transport);04721(Synaptic vesicle cycle)",{"v":6.3e-100,"d":"0.00"},1,"566,",0,{"v":-99.2,"d":"-99.20"},{"v":-97.4,"d":"-97.40"},4.39,"3' UTR",13,4245818,4301913,56096,1]
["chr13",14970020,14971643,1624,"ENSBGRG00000016588","ENSBGRT00000030690",81518,"QSER1","glutamine and serine rich 1 [Source:HGNC Symbol;Acc:HGNC:26154]","NA","NA",{"v":1e-55,"d":"0.00"},2,"62,359,","0,1265",-55,{"v":-53.6,"d":"-53.60"},7.12,"3' UTR",13,14888502,14971643,83142,1]
["chr13",15285697,15285937,241,"ENSBGRG00000018060","ENSBGRT00000033049",28555,"HIPK3","homeodomain interacting protein kinase 3 [Source:HGNC Symbol;Acc:HGNC:4915]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0009299(mRNA transcription);GO:0016604(nuclear body);GO:0016605(PML body);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0043066(negative regulation of apoptotic process);GO:0043508(negative regulation of JUN kinase activity)","04218(Cellular senescence)",{"v":0.0017,"d":"0.00"},1,"241,",0,-2.77,-2.15,3.21,"Exon (ENSBGRT00000033049/ENSBGRG00000018060, exon 2 of 17)",13,15257142,15340461,83320,1]
["chr13",27669505,27669684,180,"ENSBGRG00000024939","ENSBGRT00000046036",194457,"TSPAN18","tetraspanin 18 [Source:HGNC Symbol;Acc:HGNC:20660]","GO:0016021(integral component of membrane)","NA",{"v":6e-05,"d":"0.00"},1,"180,",0,-4.22,-3.53,2.27,"3' UTR",13,27475048,27670490,195443,1]
["chr13",30421134,30421223,90,"ENSBGRG00000019424","ENSBGRT00000035689",11440,"ENSBGRG00000019424","NA","GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity)","NA",{"v":0.0098,"d":"0.01"},1,"90,",0,-2.01,-1.45,2.37,"Exon (ENSBGRT00000035689/ENSBGRG00000019424, exon 4 of 4)",13,30409694,30421223,11530,1]
["chr13",34341230,34341613,384,"ENSBGRG00000006123","ENSBGRT00000011390",25095,"STARD10","StAR related lipid transfer domain containing 10 [Source:HGNC Symbol;Acc:HGNC:10666]","GO:0005829(cytosol);GO:0005902(microvillus);GO:0008289(lipid binding);GO:0016020(membrane);GO:0032782(bile acid secretion);GO:0035360(positive regulation of peroxisome proliferator activated receptor signaling pathway);GO:0046581(intercellular canaliculus)","NA",{"v":1.3E-20,"d":"0.00"},1,"384,",0,{"v":-19.9,"d":"-19.90"},{"v":-18.9,"d":"-18.90"},7.69,"3' UTR",13,34316135,34341613,25479,1]
["chr13",35000143,35003162,3020,"ENSBGRG00000009230","ENSBGRT00000016957",0,"LRTOMT","leucine rich transmembrane and O-methyltransferase domain containing [Source:HGNC Symbol;Acc:HGNC:25033]","GO:0005515(protein binding)","03040(Spliceosome)",{"v":0.046,"d":"0.05"},3,"28,30,3,","0,2984,3017",-1.34,{"v":-0.843,"d":"-0.84"},6.02,"5' UTR",13,34993017,35000577,7561,2]
["chr13",40125475,40125894,420,"ENSBGRG00000005396","ENSBGRT00000009973",77704,"SYT9","synaptotagmin 9 [Source:HGNC Symbol;Acc:HGNC:19265]","GO:0000149(SNARE binding);GO:0001786(phosphatidylserine binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017158(regulation of calcium ion-dependent exocytosis);GO:0030285(integral component of synaptic vesicle membrane);GO:0031045(dense core granule);GO:0042802(identical protein binding);GO:0050796(regulation of insulin secretion);GO:0098686(hippocampal mossy fiber to CA3 synapse)","NA",{"v":2.5e-45,"d":"0.00"},1,"420,",0,{"v":-44.6,"d":"-44.60"},{"v":-43.3,"d":"-43.30"},6.37,"Exon (ENSBGRT00000009973/ENSBGRG00000005396, exon 3 of 6)",13,40047771,40214520,166750,1]
["chr13",45358293,45362487,4195,"ENSBGRG00000005464","ENSBGRT00000010070",85832,"USP47","ubiquitin specific peptidase 47 [Source:HGNC Symbol;Acc:HGNC:20076]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005737(cytoplasm);GO:0006284(base-excision repair);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0010972(negative regulation of G2/M transition of mitotic cell cycle);GO:0016579(protein deubiquitination);GO:0019005(SCF ubiquitin ligase complex);GO:0030307(positive regulation of cell growth);GO:0034644(cellular response to UV);GO:0035520(monoubiquitinated protein deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042493(response to drug);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0071987(WD40-repeat domain binding);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0101005(ubiquitinyl hydrolase activity);GO:1902230(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","NA",{"v":4E-14,"d":"0.00"},4,"40,113,105,41,","0,2455,3237,4154",{"v":-13.4,"d":"-13.40"},{"v":-12.5,"d":"-12.50"},2.04,"Exon (ENSBGRT00000010070/ENSBGRG00000005464, exon 15 of 29)",13,45272461,45382908,110448,1]
["chr13",51639664,51639904,241,"ENSBGRG00000009664","ENSBGRT00000017721",14836,"ENSBGRG00000009664","NA","NA","NA",{"v":1e-21,"d":"0.00"},1,"241,",0,-21,-20,5.68,"Exon (ENSBGRT00000017721/ENSBGRG00000009664, exon 6 of 6)",13,51624828,51639904,15077,1]
["chr13",57192806,57193015,210,"ENSBGRG00000013920","ENSBGRT00000025552",87358,"NECTIN1","nectin cell adhesion molecule 1 [Source:HGNC Symbol;Acc:HGNC:9706]","GO:0002089(lens morphogenesis in camera-type eye);GO:0002934(desmosome organization);GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0006826(iron ion transport);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0016021(integral component of membrane);GO:0019062(virion attachment to host cell);GO:0038023(signaling receptor activity);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043296(apical junction complex);GO:0044291(cell-cell contact zone);GO:0045202(synapse);GO:0048593(camera-type eye morphogenesis);GO:0050839(cell adhesion molecule binding);GO:0051963(regulation of synapse assembly);GO:0060041(retina development in camera-type eye);GO:0070166(enamel mineralization);GO:0098609(cell-cell adhesion);GO:1902414(protein localization to cell junction)","04514(Cell adhesion molecules (CAMs));04520(Adherens junction);05168(Herpes simplex infection)",{"v":1.6E-15,"d":"0.00"},1,"210,",0,{"v":-14.8,"d":"-14.80"},{"v":-13.9,"d":"-13.90"},7.27,"Exon (ENSBGRT00000025552/ENSBGRG00000013920, exon 7 of 7)",13,57105448,57196867,91420,1]
["chr13",58124646,58128112,3467,"ENSBGRG00000020405","ENSBGRT00000037547",0,"DDX6","DEAD-box helicase 6 [Source:HGNC Symbol;Acc:HGNC:2747]","GO:0000932(P-body);GO:0003676(nucleic acid binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0010494(cytoplasmic stress granule);GO:0016442(RISC complex);GO:0019074(viral RNA genome packaging);GO:0019827(stem cell population maintenance);GO:0019904(protein domain specific binding);GO:0033962(cytoplasmic mRNA processing body assembly);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0045665(negative regulation of neuron differentiation)","03018(RNA degradation)",{"v":6.3e-92,"d":"0.00"},2,"470,6,","0,3461",{"v":-91.2,"d":"-91.20"},{"v":-89.5,"d":"-89.50"},5.49,"5' UTR",13,58124646,58147833,23188,1]
["chr13",65959604,65959810,207,"ENSBGRG00000008627","ENSBGRT00000015747",8692,"IL18","interleukin 18 [Source:HGNC Symbol;Acc:HGNC:5986]","GO:0000165(MAPK cascade);GO:0001525(angiogenesis);GO:0005125(cytokine activity);GO:0005615(extracellular space);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0008283(cell population proliferation);GO:0010628(positive regulation of gene expression);GO:0010744(positive regulation of macrophage derived foam cell differentiation);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0030101(natural killer cell activation);GO:0030155(regulation of cell adhesion);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0032148(activation of protein kinase B activity);GO:0032609(interferon-gamma production);GO:0032635(interleukin-6 production);GO:0032725(positive regulation of granulocyte macrophage colony-stimulating factor production);GO:0032729(positive regulation of interferon-gamma production);GO:0032740(positive regulation of interleukin-17 production);GO:0032819(positive regulation of natural killer cell proliferation);GO:0035655(interleukin-18-mediated signaling pathway);GO:0035744(T-helper 1 cell cytokine production);GO:0042088(T-helper 1 type immune response);GO:0042104(positive regulation of activated T cell proliferation);GO:0042119(neutrophil activation);GO:0042267(natural killer cell mediated cytotoxicity);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042632(cholesterol homeostasis);GO:0045515(interleukin-18 receptor binding);GO:0045630(positive regulation of T-helper 2 cell differentiation);GO:0045662(negative regulation of myoblast differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051142(positive regulation of NK T cell proliferation);GO:0051897(positive regulation of protein kinase B signaling);GO:0070328(triglyceride homeostasis);GO:0071407(cellular response to organic cyclic compound);GO:0120162(positive regulation of cold-induced thermogenesis);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:2000556(positive regulation of T-helper 1 cell cytokine production)","04060(Cytokine-cytokine receptor interaction);04621(NOD-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);05323(Rheumatoid arthritis);05321(Inflammatiory bowel disease (IBD));05132(Salmonella infection);05134(Legionellosis);05152(Tuberculosis);05164(Influenza A);05144(Malaria);05143(African trypanosomiasis)",{"v":5e-11,"d":"0.00"},1,"207,",0,{"v":-10.3,"d":"-10.30"},{"v":-9.4,"d":"-9.40"},3.35,"Exon (ENSBGRT00000015747/ENSBGRG00000008627, exon 5 of 5)",13,65950912,65959810,8899,1]
["chr13",71096720,71096929,210,"ENSBGRG00000014342","ENSBGRT00000027961",32563,"NPAT","nuclear protein, coactivator of histone transcription [Source:HGNC Symbol;Acc:HGNC:7896]","GO:0000083(regulation of transcription involved in G1/S transition of mitotic cell cycle);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0008022(protein C-terminus binding);GO:0010468(regulation of gene expression);GO:0015030(Cajal body);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0097504(Gemini of coiled bodies)","NA",{"v":0.032,"d":"0.03"},1,"210,",0,{"v":-1.5,"d":"-1.50"},{"v":-0.988,"d":"-0.99"},3.01,"Exon (ENSBGRT00000028080/ENSBGRG00000014342, exon 14 of 19)",13,71064157,71107204,43048,1]
["chr13",74786275,74792049,5775,"ENSBGRG00000012542","ENSBGRT00000023936",27094,"CEP57","centrosomal protein 57 [Source:HGNC Symbol;Acc:HGNC:30794]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005874(microtubule);GO:0007286(spermatid development);GO:0008017(microtubule binding);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0017134(fibroblast growth factor binding);GO:0034453(microtubule anchoring);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043015(gamma-tubulin binding);GO:0051260(protein homooligomerization)","NA",{"v":3.2e-15,"d":"0.00"},6,"82,122,117,78,108,3,","0,440,2536,3252,5119,5772",{"v":-14.5,"d":"-14.50"},{"v":-13.6,"d":"-13.60"},3.18,"Exon (ENSBGRT00000023936/ENSBGRG00000012542, exon 3 of 11)",13,74759181,74801470,42290,1]
["chr13",1711803,1712013,211,"ENSBGRG00000004747","ENSBGRT00000008771",269,"TNKS1BP1","tankyrase 1 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:19081]","GO:0005634(nucleus);GO:0005720(nuclear heterochromatin);GO:0005737(cytoplasm);GO:0005912(adherens junction);GO:0006302(double-strand break repair);GO:0010800(positive regulation of peptidyl-threonine phosphorylation);GO:0019899(enzyme binding);GO:0030014(CCR4-NOT complex);GO:0031954(positive regulation of protein autophosphorylation);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0044877(protein-containing complex binding);GO:0071479(cellular response to ionizing radiation);GO:0071532(ankyrin repeat binding)","NA",{"v":0.00013,"d":"0.00"},1,"211,",0,-3.87,{"v":-3.2,"d":"-3.20"},16,"5' UTR",13,1685158,1712282,27125,2]
["chr13",5060528,5060796,269,"ENSBGRG00000016722","ENSBGRT00000030697",16506,"ENSBGRG00000016722","NA","GO:0015018(galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity);GO:0016020(membrane)","00515(Mannose type O-glycan biosyntheis)",{"v":0.021,"d":"0.02"},1,"269,",0,-1.67,-1.14,2.67,"Exon (ENSBGRT00000030697/ENSBGRG00000016722, exon 3 of 5)",13,5058702,5077302,18601,2]
["chr13",15925761,15935446,9686,"ENSBGRG00000019008","ENSBGRT00000034934",4912,"LMO2","LIM domain only 2 [Source:HGNC Symbol;Acc:HGNC:6642]","NA","05202(Transcriptional misregulation in cancers)",{"v":2.5e-89,"d":"0.00"},2,"461,12,","0,9674",{"v":-88.6,"d":"-88.60"},{"v":-86.9,"d":"-86.90"},2.56,"3' UTR",13,15925554,15940358,14805,2]
["chr13",22525749,22525985,237,"ENSBGRG00000023742","ENSBGRT00000043926",237,"LRRC4C","leucine rich repeat containing 4C [Source:HGNC Symbol;Acc:HGNC:29317]","GO:0005515(protein binding);GO:0016020(membrane);GO:0050770(regulation of axonogenesis);GO:0050804(modulation of chemical synaptic transmission);GO:0050839(cell adhesion molecule binding);GO:0098632(cell-cell adhesion mediator activity);GO:0098978(glutamatergic synapse);GO:0099560(synaptic membrane adhesion)","04514(Cell adhesion molecules (CAMs));04360(Axon guidance)",{"v":2E-3,"d":"0.00"},1,"237,",0,{"v":-2.7,"d":"-2.70"},-2.09,6.02,"Exon (ENSBGRT00000043926/ENSBGRG00000023742, exon 1 of 2)",13,22523767,22526222,2456,2]
["chr13",30424130,30425902,1773,"ENSBGRG00000019526","ENSBGRT00000035957",2911,"KBTBD4","kelch repeat and BTB domain containing 4 [Source:HGNC Symbol;Acc:HGNC:23761]","GO:0005515(protein binding)","NA",{"v":3.2e-59,"d":"0.00"},3,"136,399,3,","0,919,1770",{"v":-58.5,"d":"-58.50"},{"v":-57.1,"d":"-57.10"},12,"Exon (ENSBGRT00000035957/ENSBGRG00000019526, exon 3 of 6)",13,30423820,30428813,4994,2]
["chr13",34882981,34883279,299,"ENSBGRG00000008145","ENSBGRT00000014911",0,"INPPL1","inositol polyphosphate phosphatase like 1 [Source:HGNC Symbol;Acc:HGNC:6080]","GO:0001958(endochondral ossification);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006006(glucose metabolic process);GO:0006661(phosphatidylinositol biosynthetic process);GO:0006897(endocytosis);GO:0007015(actin filament organization);GO:0008285(negative regulation of cell population proliferation);GO:0009791(post-embryonic development);GO:0010629(negative regulation of gene expression);GO:0032868(response to insulin);GO:0042169(SH2 domain binding);GO:0044255(cellular lipid metabolic process);GO:0046856(phosphatidylinositol dephosphorylation);GO:0097178(ruffle assembly)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system);04662(B cell receptor signaling pathway);04666(Fc gamma R-mediated phagocytosis);04910(Insulin signaling pathway)",0.01,1,"299,",0,-1.98,-1.42,8.02,"5' UTR",13,34867339,34883279,15941,2]
["chr13",38873729,38882435,8707,"ENSBGRG00000014498","ENSBGRT00000027801",0,"APBB1","amyloid beta precursor protein binding family B member 1 [Source:HGNC Symbol;Acc:HGNC:581]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001540(amyloid-beta binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006974(cellular response to DNA damage stimulus);GO:0030027(lamellipodium);GO:0030426(growth cone);GO:0031625(ubiquitin protein ligase binding);GO:0042393(histone binding);GO:0043065(positive regulation of apoptotic process);GO:0045202(synapse);GO:0045893(positive regulation of transcription, DNA-templated);GO:0070064(proline-rich region binding)","05010(Alzheimer disease)",{"v":1e-101,"d":"0.00"},3,"48,61,728,","0,937,7979",-101,{"v":-99.1,"d":"-99.10"},9.04,"5' UTR",13,38862132,38874726,12595,2]
["chr13",39113441,39114394,954,"ENSBGRG00000004714","ENSBGRT00000009014",14255,"ENSBGRG00000004714","NA","NA","04392(Hippo signaling pathway - multiple species)",{"v":2e-07,"d":"0.00"},2,"641,108,","0,846",{"v":-6.7,"d":"-6.70"},-5.92,{"v":26.1,"d":"26.10"},"Exon (ENSBGRT00000009014/ENSBGRG00000004714, exon 12 of 26)",13,39102063,39128649,26587,2]
["chr13",43933869,44010674,76806,"ENSBGRG00000004494","ENSBGRT00000008920",0,"IRAG1","murine retrovirus integration site 1 homolog [Source:HGNC Symbol;Acc:HGNC:7237]","NA","04022(cGMP - PKG signaling pathway);04270(Vascular smooth muscle contraction)",{"v":2.6e-06,"d":"0.00"},4,"31,101,158,67,","0,1135,17857,76739",-5.58,-4.83,2.14,"Exon (ENSBGRT00000008920/ENSBGRG00000004494, exon 1 of 22)",13,43871582,44010674,139093,2]
["chr13",51393762,51393852,91,"ENSBGRG00000009254","ENSBGRT00000017009",14827,"PIK3C2A","phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha [Source:HGNC Symbol;Acc:HGNC:8971]","GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0010508(positive regulation of autophagy);GO:0016301(kinase activity);GO:0031982(vesicle);GO:0035004(phosphatidylinositol 3-kinase activity);GO:0035091(phosphatidylinositol binding);GO:0046854(phosphatidylinositol phosphorylation);GO:0048015(phosphatidylinositol-mediated signaling);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":0.011,"d":"0.01"},1,"91,",0,-1.97,-1.14,9.03,"Exon (ENSBGRT00000017009/ENSBGRG00000009254, exon 2 of 34)",13,51336420,51408679,72260,2]
["chr13",56484268,56485167,900,"ENSBGRG00000013639","ENSBGRT00000025070",18196,"OAF","out at first homolog [Source:HGNC Symbol;Acc:HGNC:28752]","NA","NA",{"v":3.2E-69,"d":"0.00"},1,"900,",0,{"v":-68.5,"d":"-68.50"},-67,4.48,"3' UTR",13,56484268,56503363,19096,2]
["chr13",57712920,57715430,2511,"ENSBGRG00000016592","ENSBGRT00000030442",707,"NLRX1","NLR family member X1 [Source:HGNC Symbol;Acc:HGNC:29890]","GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0030054(cell junction);GO:0032688(negative regulation of interferon-beta production);GO:0032715(negative regulation of interleukin-6 production);GO:0039536(negative regulation of RIG-I signaling pathway);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045824(negative regulation of innate immune response);GO:0050728(negative regulation of inflammatory response)","04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);05164(Influenza A)",{"v":0.0048,"d":"0.00"},3,"250,89,49,","0,1897,2462",-2.32,-1.74,7.02,"Exon (ENSBGRT00000030442/ENSBGRG00000016592, exon 2 of 9)",13,57698908,57716137,17230,2]
["chr13",58362928,58363048,121,"ENSBGRG00000021523","ENSBGRT00000040709",33384,"ENSBGRG00000021523","NA","NA","00310(Lysine degradation);05202(Transcriptional misregulation in cancers);04934(Cushing syndrome)",{"v":0.0044,"d":"0.00"},1,"121,",0,-2.36,-1.78,{"v":1.7,"d":"1.70"},"Exon (ENSBGRT00000040709/ENSBGRG00000021523, exon 31 of 41)",13,58345665,58396432,50768,2]
["chr13",64343012,64343644,633,"ENSBGRG00000006752","ENSBGRT00000012509",41479,"TTC12","tetratricopeptide repeat domain 12 [Source:HGNC Symbol;Acc:HGNC:23700]","GO:0005515(protein binding)","NA",{"v":0.00098,"d":"0.00"},2,"54,125,","0,508",-3.01,-2.39,1.87,"Exon (ENSBGRT00000012509/ENSBGRG00000006752, exon 15 of 20)",13,64336055,64385123,49069,2]
["chr13",68426143,68426352,210,"ENSBGRG00000013345","ENSBGRT00000024689",37803,"ZC3H12C","zinc finger CCCH-type containing 12C [Source:HGNC Symbol;Acc:HGNC:29362]","GO:0046872(metal ion binding)","NA",{"v":0.0032,"d":"0.00"},1,"210,",0,-2.49,-1.89,2.71,"Exon (ENSBGRT00000024689/ENSBGRG00000013345, exon 7 of 8)",13,68422693,68464155,41463,2]
["chr13",81991154,81991363,210,"ENSBGRG00000015051","ENSBGRT00000027882",0,"PGR","progesterone receptor [Source:HGNC Symbol;Acc:HGNC:8910]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001225(RNA polymerase II transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001542(ovulation from ovarian follicle);GO:0002070(epithelial cell maturation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005496(steroid binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0030879(mammary gland development);GO:0038001(paracrine signaling);GO:0042025(host cell nucleus);GO:0042802(identical protein binding);GO:0043401(steroid hormone mediated signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048286(lung alveolus development);GO:0050678(regulation of epithelial cell proliferation);GO:0050847(progesterone receptor signaling pathway);GO:0051117(ATPase binding);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis)","04114(Oocyte meiosis);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);05224(Breast cancer)",{"v":1e-07,"d":"0.00"},1,"210,",0,-6.98,{"v":-6.2,"d":"-6.20"},{"v":27.1,"d":"27.10"},"Exon (ENSBGRT00000027882/ENSBGRG00000015051, exon 1 of 7)",13,81880670,81991363,110694,2]
["chr14",18965306,18976963,11658,"ENSBGRG00000006991","ENSBGRT00000012912",139001,"MARK1","microtubule affinity regulating kinase 1 [Source:HGNC Symbol;Acc:HGNC:6896]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0010975(regulation of neuron projection development);GO:0050773(regulation of dendrite development);GO:0051654(establishment of mitochondrion localization)","NA",{"v":1E-168,"d":"0.00"},2,"64,355,","0,11303",-168,-166,5.55,"Exon (ENSBGRT00000012912/ENSBGRG00000006991, exon 16 of 17)",14,18826305,18976963,150659,1]
["chr14",22556967,22560652,3686,"ENSBGRG00000009888","ENSBGRT00000018174",7657,"DEGS1","delta 4-desaturase, sphingolipid 1 [Source:HGNC Symbol;Acc:HGNC:13709]","GO:0005739(mitochondrion);GO:0006629(lipid metabolic process);GO:0016021(integral component of membrane);GO:0030148(sphingolipid biosynthetic process);GO:0042284(sphingolipid delta-4 desaturase activity);GO:0043217(myelin maintenance);GO:0050251(retinol isomerase activity)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway)",{"v":9.99999999999998e-282,"d":"0.00"},2,"348,487,","0,3199",-281,-279,4.52,"3' UTR",14,22549310,22560652,11343,1]
["chr14",26356138,26362234,6097,"ENSBGRG00000006812","ENSBGRT00000012714",15343,"TFB2M","transcription factor B2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:18559]","GO:0000154(rRNA modification);GO:0000179(rRNA (adenine-N6,N6-)-dimethyltransferase activity);GO:0003712(transcription coregulator activity);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006355(regulation of transcription, DNA-templated);GO:0006390(mitochondrial transcription);GO:0006391(transcription initiation from mitochondrial promoter);GO:0008649(rRNA methyltransferase activity);GO:0031167(rRNA methylation);GO:0034246(mitochondrial sequence-specific DNA-binding transcription factor activity);GO:0042645(mitochondrial nucleoid)","NA",{"v":4e-11,"d":"0.00"},3,"27,152,122,","0,2667,5975",{"v":-10.4,"d":"-10.40"},-9.53,3.15,"3' UTR",14,26340795,26362846,22052,1]
["chr14",29886714,29886923,210,"ENSBGRG00000010480","ENSBGRT00000019311",64972,"CEP170","centrosomal protein 170 [Source:HGNC Symbol;Acc:HGNC:28920]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0072686(mitotic spindle);GO:0120103(centriolar subdistal appendage)","NA",{"v":2E-12,"d":"0.00"},1,"210,",0,{"v":-11.7,"d":"-11.70"},{"v":-10.8,"d":"-10.80"},3.03,"Exon (ENSBGRT00000019311/ENSBGRG00000010480, exon 12 of 19)",14,29821742,29921777,100036,1]
["chr14",32991342,33045075,53734,"ENSBGRG00000014219","ENSBGRT00000026154",27914,"ATP1B1","ATPase Na+/K+ transporting subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:804]","GO:0001671(ATPase activator activity);GO:0005391(sodium:potassium-exchanging ATPase activity);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005890(sodium:potassium-exchanging ATPase complex);GO:0006813(potassium ion transport);GO:0006814(sodium ion transport);GO:0006874(cellular calcium ion homeostasis);GO:0006883(cellular sodium ion homeostasis);GO:0008022(protein C-terminus binding);GO:0008144(drug binding);GO:0010468(regulation of gene expression);GO:0010882(regulation of cardiac muscle contraction by calcium ion signaling);GO:0014704(intercalated disc);GO:0016020(membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0016328(lateral plasma membrane);GO:0016887(ATPase activity);GO:0019829(ATPase-coupled cation transmembrane transporter activity);GO:0019901(protein kinase binding);GO:0030007(cellular potassium ion homeostasis);GO:0030315(T-tubule);GO:0030955(potassium ion binding);GO:0031090(organelle membrane);GO:0031402(sodium ion binding);GO:0032781(positive regulation of ATPase activity);GO:0035725(sodium ion transmembrane transport);GO:0036126(sperm flagellum);GO:0036376(sodium ion export across plasma membrane);GO:0042383(sarcolemma);GO:0046034(ATP metabolic process);GO:0050821(protein stabilization);GO:0051117(ATPase binding);GO:0055119(relaxation of cardiac muscle);GO:0060048(cardiac muscle contraction);GO:0071805(potassium ion transmembrane transport);GO:0072659(protein localization to plasma membrane);GO:0086009(membrane repolarization);GO:0098655(cation transmembrane transport);GO:1901018(positive regulation of potassium ion transmembrane transporter activity);GO:1903169(regulation of calcium ion transmembrane transport);GO:1903278(positive regulation of sodium ion export across plasma membrane);GO:1903281(positive regulation of calcium:sodium antiporter activity);GO:1903288(positive regulation of potassium ion import across plasma membrane);GO:1990573(potassium ion import across plasma membrane)","04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04918(Thyroid hormone synthesis);04919(Thyroid hormone signaling pathway);04925(Aldosterone synthesis and secretion);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);04973(Carbohydrate digestion and absorption);04974(Protein digestion and absorption);04978(Mineral absorption);04960(Aldosterone-regulated sodium reabsorption);04961(Endocrine and other factor-regulated calcium reabsorption);04964(Proximal tubule bicarbonate reclamation)",{"v":2.5e-17,"d":"0.00"},2,"119,2,","0,53732",{"v":-16.6,"d":"-16.60"},{"v":-15.6,"d":"-15.60"},1.57,"3' UTR",14,32963428,33045075,81648,1]
["chr14",37844552,37848688,4137,"ENSBGRG00000007466","ENSBGRT00000013752",52207,"DHRS3","dehydrogenase/reductase 3 [Source:HGNC Symbol;Acc:HGNC:17693]","GO:0004745(retinol dehydrogenase activity);GO:0042572(retinol metabolic process)","00830(Retinol metabolism)",{"v":7.9e-05,"d":"0.00"},2,"35,85,","0,4052",{"v":-4.1,"d":"-4.10"},-3.42,1.96,"Exon (ENSBGRT00000013752/ENSBGRG00000007466, exon 5 of 6)",14,37792345,37848688,56344,1]
["chr14",38681816,38683225,1410,"ENSBGRG00000009177","ENSBGRT00000016942",12090,"MTHFR","methylenetetrahydrofolate reductase [Source:HGNC Symbol;Acc:HGNC:7436]","GO:0001843(neural tube closure);GO:0004489(methylenetetrahydrofolate reductase (NAD(P)H) activity);GO:0006555(methionine metabolic process);GO:0031060(regulation of histone methylation);GO:0035999(tetrahydrofolate interconversion);GO:0044877(protein-containing complex binding);GO:0050660(flavin adenine dinucleotide binding);GO:0050667(homocysteine metabolic process);GO:0055114(oxidation-reduction process);GO:0070829(heterochromatin maintenance);GO:0072341(modified amino acid binding)","00670(One carbon pool by folate);01523(Antifolate resistance)",{"v":1.3e-26,"d":"0.00"},3,"21,150,99,","0,281,1311",{"v":-25.9,"d":"-25.90"},{"v":-24.8,"d":"-24.80"},3.45,"Exon (ENSBGRT00000016942/ENSBGRG00000009177, exon 11 of 11)",14,38669726,38681836,12111,1]
["chr14",44301958,44302317,360,"ENSBGRG00000014711","ENSBGRT00000027116",0,"KLHL21","kelch like family member 21 [Source:HGNC Symbol;Acc:HGNC:29041]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005827(polar microtubule);GO:0016567(protein ubiquitination);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0032465(regulation of cytokinesis);GO:0035853(chromosome passenger complex localization to spindle midzone);GO:0097602(cullin family protein binding)","NA",{"v":2.7E-6,"d":"0.00"},1,"360,",0,-5.57,-4.83,4.57,"5' UTR",14,44301958,44313900,11943,1]
["chr14",47159601,47159751,151,"ENSBGRG00000020443","ENSBGRT00000037574",359,"LRRC47","leucine rich repeat containing 47 [Source:HGNC Symbol;Acc:HGNC:29207]","GO:0003723(RNA binding);GO:0004826(phenylalanine-tRNA ligase activity);GO:0005515(protein binding)","00970(Aminoacyl-tRNA biosynthesis)",{"v":0.019,"d":"0.02"},1,"151,",0,-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000037574/ENSBGRG00000020443, exon 1 of 7)",14,47159242,47171358,12117,1]
["chr14",49170050,49174798,4749,"ENSBGRG00000010779","ENSBGRT00000019800",369,"TMEM240","transmembrane protein 240 [Source:HGNC Symbol;Acc:HGNC:25186]","GO:0097060(synaptic membrane)","NA",{"v":1E-14,"d":"0.00"},3,"19,209,149,","0,4236,4600",-14,-13,5.01,"Exon (ENSBGRT00000019800/ENSBGRG00000010779, exon 2 of 4)",14,49169681,49174798,5118,1]
["chr14",50231318,50236992,5675,"ENSBGRG00000019581","ENSBGRT00000036344",0,"CASP9","caspase 9 [Source:HGNC Symbol;Acc:HGNC:1511]","GO:0004197(cysteine-type endopeptidase activity);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0009411(response to UV);GO:0017124(SH3 domain binding);GO:0019901(protein kinase binding);GO:0032991(protein-containing complex);GO:0034644(cellular response to UV);GO:0042770(signal transduction in response to DNA damage);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043293(apoptosome);GO:0043525(positive regulation of neuron apoptotic process);GO:0071549(cellular response to dexamethasone stimulus);GO:0097199(cysteine-type endopeptidase activity involved in apoptotic signaling pathway);GO:2001020(regulation of response to DNA damage stimulus)","04370(VEGF signaling pathway);04151(PI3K-Akt signaling pathway);04210(Apoptosis);04215(Apoptosis - multiple species);04115(p53 signaling pathway);04919(Thyroid hormone signaling pathway);05200(Pathways in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05215(Prostate cancer);05213(Endometrial cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05010(Alzheimer disease);05012(Parkinson disease);05014(Amyotrophic lateral sclerosis (ALS));05016(Huntington disease);05416(Viral myocarditis);05134(Legionellosis);05152(Tuberculosis);05164(Influenza A);05161(Hepatitis B);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05145(Toxoplasmosis);01524(Platinum drug resistance)",{"v":1.1e-07,"d":"0.00"},2,"132,316,","0,5359",-6.95,-6.17,2.57,"Exon (ENSBGRT00000036344/ENSBGRG00000019581, exon 1 of 7)",14,50231318,50251490,20173,1]
["chr14",53515679,53515827,149,"ENSBGRG00000021790","ENSBGRT00000040314",1281,"ENSBGRG00000021790","NA","GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0052689(carboxylic ester hydrolase activity)","NA",{"v":2e-15,"d":"0.00"},1,"149,",0,{"v":-14.7,"d":"-14.70"},{"v":-13.8,"d":"-13.80"},3.82,"5' UTR",14,53335833,53517108,181276,2]
["chr14",60565193,60569835,4643,"ENSBGRG00000010338","ENSBGRT00000019413",30477,"CEP350","centrosomal protein 350 [Source:HGNC Symbol;Acc:HGNC:24238]","GO:0005813(centrosome);GO:0005814(centriole);GO:0008017(microtubule binding);GO:0034453(microtubule anchoring);GO:0071539(protein localization to centrosome);GO:1905515(non-motile cilium assembly)","NA",{"v":0.011,"d":"0.01"},3,"303,151,115,","0,2018,4528",-1.97,-1.14,9.03,"Exon (ENSBGRT00000019413/ENSBGRG00000010338, exon 11 of 37)",14,60534716,60669409,134694,1]
["chr14",61664290,61665301,1012,"ENSBGRG00000012291","ENSBGRT00000022494",237,"IER5","immediate early response 5 [Source:HGNC Symbol;Acc:HGNC:5393]","GO:0000159(protein phosphatase type 2A complex);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0034605(cellular response to heat);GO:0042127(regulation of cell population proliferation);GO:0042802(identical protein binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1900036(positive regulation of cellular response to heat)","NA",{"v":1.3E-75,"d":"0.00"},2,"639,312,","0,700",{"v":-74.9,"d":"-74.90"},{"v":-73.3,"d":"-73.30"},7.45,"Exon (ENSBGRT00000022494/ENSBGRG00000012291, exon 1 of 2)",14,61664053,61665301,1249,1]
["chr14",66043299,66043808,510,"ENSBGRG00000015546","ENSBGRT00000028526",52080,"RNF2","ring finger protein 2 [Source:HGNC Symbol;Acc:HGNC:10061]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000151(ubiquitin ligase complex);GO:0000278(mitotic cell cycle);GO:0000791(euchromatin);GO:0000792(heterochromatin);GO:0001702(gastrulation with mouth forming second);GO:0001739(sex chromatin);GO:0003682(chromatin binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0007281(germ cell development);GO:0008270(zinc ion binding);GO:0009948(anterior/posterior axis specification);GO:0010467(gene expression);GO:0016574(histone ubiquitination);GO:0016604(nuclear body);GO:0031519(PcG protein complex);GO:0035102(PRC1 complex);GO:0035518(histone H2A monoubiquitination);GO:0036353(histone H2A-K119 monoubiquitination);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0061630(ubiquitin protein ligase activity);GO:0071339(MLL1 complex);GO:0071535(RING-like zinc finger domain binding)","NA",{"v":4.6e-10,"d":"0.00"},2,"61,178,","0,332",-9.34,{"v":-8.5,"d":"-8.50"},1.54,"3' UTR",14,65991219,66044732,53514,1]
["chr14",72477465,72478001,537,"ENSBGRG00000022277","ENSBGRT00000041110",2886,"SLC30A1","solute carrier family 30 member 1 [Source:HGNC Symbol;Acc:HGNC:11012]","GO:0001701(in utero embryonic development);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006812(cation transport);GO:0006829(zinc ion transport);GO:0006874(cellular calcium ion homeostasis);GO:0006882(cellular zinc ion homeostasis);GO:0008324(cation transmembrane transporter activity);GO:0016021(integral component of membrane);GO:0019855(calcium channel inhibitor activity);GO:0031965(nuclear membrane);GO:0055085(transmembrane transport);GO:0071584(negative regulation of zinc ion transmembrane import);GO:0090281(negative regulation of calcium ion import)","04978(Mineral absorption)",{"v":4e-58,"d":"0.00"},1,"537,",0,{"v":-57.4,"d":"-57.40"},{"v":-55.9,"d":"-55.90"},{"v":12.7,"d":"12.70"},"Exon (ENSBGRT00000041110/ENSBGRG00000022277, exon 2 of 2)",14,72474579,72478001,3423,1]
["chr14",81016385,81021834,5450,"ENSBGRG00000019601","ENSBGRT00000040218",93325,"CAMSAP2","calmodulin regulated spectrin associated protein family member 2 [Source:HGNC Symbol;Acc:HGNC:29188]","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0008017(microtubule binding);GO:0030507(spectrin binding);GO:0031113(regulation of microtubule polymerization);GO:0031175(neuron projection development);GO:0033043(regulation of organelle organization);GO:0036449(microtubule minus-end);GO:0050773(regulation of dendrite development);GO:0051011(microtubule minus-end binding);GO:0061564(axon development);GO:1903358(regulation of Golgi organization);GO:1990752(microtubule end)","NA",{"v":2e-60,"d":"0.00"},3,"1985,137,121,","0,4575,5329",{"v":-59.7,"d":"-59.70"},{"v":-58.3,"d":"-58.30"},{"v":7.5,"d":"7.50"},"Exon (ENSBGRT00000040218/ENSBGRG00000019601, exon 12 of 18)",14,80923060,81027386,104327,1]
["chr14",82133658,82138592,4935,"ENSBGRG00000025844","ENSBGRT00000047771",3041,"PTPN7","protein tyrosine phosphatase non-receptor type 7 [Source:HGNC Symbol;Acc:HGNC:9659]","GO:0004725(protein tyrosine phosphatase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006470(protein dephosphorylation);GO:0009898(cytoplasmic side of plasma membrane);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity)","04010(MAPK signaling pathway)",{"v":0.046,"d":"0.05"},6,"68,138,111,158,114,153,","0,1212,1563,2851,3996,4782",-1.34,{"v":-0.843,"d":"-0.84"},5.01,"3' UTR",14,82130617,82138592,7976,1]
["chr14",83881681,83881978,298,"ENSBGRG00000008085","ENSBGRT00000014759",2645,"ZBED6","zinc finger BED-type containing 6 [Source:HGNC Symbol;Acc:HGNC:33273]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001835(blastocyst hatching);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046983(protein dimerization activity)","NA",{"v":3.7e-05,"d":"0.00"},1,"298,",0,-4.43,-3.73,{"v":18.1,"d":"18.10"},"Exon (ENSBGRT00000014759/ENSBGRG00000008085, exon 1 of 1)",14,83879036,83881978,2943,1]
["chr14",87128695,87129525,831,"ENSBGRG00000015968","ENSBGRT00000029382",7149,"DYRK3","dual specificity tyrosine phosphorylation regulated kinase 3 [Source:HGNC Symbol;Acc:HGNC:3094]","GO:0000242(pericentriolar material);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0010494(cytoplasmic stress granule);GO:0016607(nuclear speck);GO:0030218(erythrocyte differentiation);GO:0035063(nuclear speck organization);GO:0035617(stress granule disassembly);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0080135(regulation of cellular response to stress);GO:1902751(positive regulation of cell cycle G2/M phase transition);GO:1903008(organelle disassembly);GO:1903432(regulation of TORC1 signaling)","NA",{"v":1E-41,"d":"0.00"},1,"831,",0,-41,{"v":-39.7,"d":"-39.70"},5.35,"Exon (ENSBGRT00000029382/ENSBGRG00000015968, exon 3 of 4)",14,87121546,87130996,9451,1]
["chr14",88065493,88065971,479,"ENSBGRG00000019079","ENSBGRT00000035016",14161,"ENSBGRG00000019079","NA","NA","04640(Hematopoietic cell lineage);04610(Complement and coagulation cascades);05416(Viral myocarditis)",{"v":2.5e-20,"d":"0.00"},1,"479,",0,{"v":-19.6,"d":"-19.60"},{"v":-18.6,"d":"-18.60"},{"v":2.5,"d":"2.50"},"Exon (ENSBGRT00000035016/ENSBGRG00000019079, exon 8 of 12)",14,88051332,88079537,28206,1]
["chr14",21072614,21074203,1590,"ENSBGRG00000007778","ENSBGRT00000014209",27252,"TAF1A","TATA-box binding protein associated factor, RNA polymerase I subunit A [Source:HGNC Symbol;Acc:HGNC:11532]","GO:0005654(nucleoplasm);GO:0015630(microtubule cytoskeleton)","NA",{"v":7.6e-06,"d":"0.00"},2,"80,40,","0,1550",-5.12,-4.39,2.11,"Exon (ENSBGRT00000014209/ENSBGRG00000007778, exon 9 of 11)",14,21069426,21101455,32030,2]
["chr14",23842576,23842724,149,"ENSBGRG00000003960","ENSBGRT00000007393",157035,"ENAH","ENAH actin regulator [Source:HGNC Symbol;Acc:HGNC:18271]","GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0030054(cell junction);GO:0050699(WW domain binding)","04810(Regulation of actin cytoskeleton);04360(Axon guidance)",{"v":0.049,"d":"0.05"},1,"149,",0,-1.31,{"v":-0.819,"d":"-0.82"},2.01,"Exon (ENSBGRT00000007393/ENSBGRG00000003960, exon 7 of 15)",14,23817569,23999759,182191,2]
["chr14",28286608,28295537,8930,"ENSBGRG00000009112","ENSBGRT00000016704",35455,"DESI2","desumoylating isopeptidase 2 [Source:HGNC Symbol;Acc:HGNC:24264]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005737(cytoplasm);GO:0061578(Lys63-specific deubiquitinase activity);GO:1990380(Lys48-specific deubiquitinase activity)","NA",{"v":3.2E-13,"d":"0.00"},2,"234,3,","0,8927",{"v":-12.5,"d":"-12.50"},{"v":-11.6,"d":"-11.60"},3.94,"Exon (ENSBGRT00000016704/ENSBGRG00000009112, exon 4 of 5)",14,28286608,28330992,44385,2]
["chr14",37474510,37474712,203,"ENSBGRG00000007264","ENSBGRT00000013468",19799,"TNFSF4","TNF superfamily member 4 [Source:HGNC Symbol;Acc:HGNC:11934]","GO:0005125(cytokine activity);GO:0005164(tumor necrosis factor receptor binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0006955(immune response);GO:0009986(cell surface);GO:0016020(membrane);GO:0032700(negative regulation of interleukin-17 production);GO:0032729(positive regulation of interferon-gamma production);GO:0032753(positive regulation of interleukin-4 production);GO:0032755(positive regulation of interleukin-6 production);GO:0050729(positive regulation of inflammatory response);GO:0071222(cellular response to lipopolysaccharide);GO:0071380(cellular response to prostaglandin E stimulus)","04060(Cytokine-cytokine receptor interaction)",{"v":0.047,"d":"0.05"},1,"203,",0,-1.33,-0.83,2.67,"Exon (ENSBGRT00000013468/ENSBGRG00000007264, exon 3 of 3)",14,37474510,37494511,20002,2]
["chr14",40153546,40153695,150,"ENSBGRG00000012743","ENSBGRT00000023334",59,"CENPS","centromere protein S [Source:HGNC Symbol;Acc:HGNC:23163]","GO:0000712(resolution of meiotic recombination intermediates);GO:0000776(kinetochore);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003690(double-stranded DNA binding);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0031297(replication fork processing);GO:0043240(Fanconi anaemia nuclear complex);GO:0046982(protein heterodimerization activity);GO:0051382(kinetochore assembly);GO:0071821(FANCM-MHF complex)","03460(Fanconi anemia pathway)",{"v":3.2e-05,"d":"0.00"},1,"150,",0,-4.49,-3.79,3.19,"Exon (ENSBGRT00000023334/ENSBGRG00000012743, exon 1 of 5)",14,40139245,40153754,14510,2]
["chr14",41235325,41235594,270,"ENSBGRG00000011224","ENSBGRT00000020484",147325,"H6PD","hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4795]","GO:0004345(glucose-6-phosphate dehydrogenase activity);GO:0005515(protein binding);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0006098(pentose-phosphate shunt);GO:0016614(oxidoreductase activity, acting on CH-OH group of donors);GO:0017057(6-phosphogluconolactonase activity);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process)","00030(Pentose phosphate pathway)",{"v":2.5e-18,"d":"0.00"},1,"270,",0,{"v":-17.6,"d":"-17.60"},{"v":-16.6,"d":"-16.60"},4.27,"3' UTR",14,41234638,41382919,148282,2]
["chr14",49203965,49206348,2384,"ENSBGRG00000011551","ENSBGRT00000021071",1946,"VWA1","von Willebrand factor A domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30910]","GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0005840(ribosome);GO:0006412(translation);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0042802(identical protein binding);GO:0048266(behavioral response to pain)","NA",{"v":1e-48,"d":"0.00"},3,"338,279,9,","0,448,2375",-48,{"v":-46.7,"d":"-46.70"},9.83,"Exon (ENSBGRT00000021071/ENSBGRG00000011551, exon 2 of 4)",14,49203965,49208294,4330,2]
["chr14",49713821,49714031,211,"ENSBGRG00000017044","ENSBGRT00000031277",0,"SAMD11","sterile alpha motif domain containing 11 [Source:HGNC Symbol;Acc:HGNC:28706]","GO:0003677(DNA binding);GO:0005515(protein binding)","NA",{"v":0.035,"d":"0.04"},1,"211,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"5' UTR",14,49692194,49714031,21838,2]
["chr14",50026285,50026641,357,"ENSBGRG00000018908","ENSBGRT00000034676",0,"SLC25A34","solute carrier family 25 member 34 [Source:HGNC Symbol;Acc:HGNC:27653]","GO:0001835(blastocyst hatching)","NA",{"v":8.7e-05,"d":"0.00"},1,"357,",0,-4.06,-3.38,6.02,"5' UTR",14,50022718,50026641,3924,2]
["chr14",52278414,52278743,330,"ENSBGRG00000020945","ENSBGRT00000038672",10577,"PRDM2","PR/SET domain 2 [Source:HGNC Symbol;Acc:HGNC:9347]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0006355(regulation of transcription, DNA-templated);GO:0008340(determination of adult lifespan);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","00310(Lysine degradation)",{"v":1.3E-11,"d":"0.00"},1,"330,",0,{"v":-10.9,"d":"-10.90"},-10,2.81,"Exon (ENSBGRT00000038721/ENSBGRG00000020945, exon 8 of 10)",14,52229391,52289320,59930,2]
["chr14",60375986,60376672,687,"ENSBGRG00000009586","ENSBGRT00000017590",24357,"TOR1AIP2","torsin 1A interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:24055]","GO:0001671(ATPase activator activity);GO:0005783(endoplasmic reticulum);GO:0007029(endoplasmic reticulum organization);GO:0032781(positive regulation of ATPase activity);GO:0051117(ATPase binding);GO:0090435(protein localization to nuclear envelope)","NA",{"v":4e-37,"d":"0.00"},1,"687,",0,{"v":-36.4,"d":"-36.40"},{"v":-35.1,"d":"-35.10"},8.87,"3' UTR",14,60375986,60401029,25044,2]
["chr14",69193894,69194463,570,"ENSBGRG00000019358","ENSBGRT00000035614",37456,"CENPF","centromere protein F [Source:HGNC Symbol;Acc:HGNC:1857]","GO:0000278(mitotic cell cycle);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000922(spindle pole);GO:0000940(condensed chromosome outer kinetochore);GO:0001822(kidney development);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0007059(chromosome segregation);GO:0008022(protein C-terminus binding);GO:0008134(transcription factor binding);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0015031(protein transport);GO:0016363(nuclear matrix);GO:0021591(ventricular system development);GO:0030496(midbody);GO:0042803(protein homodimerization activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0051310(metaphase plate congression);GO:0070840(dynein complex binding);GO:0097539(ciliary transition fiber)","NA",{"v":0.0017,"d":"0.00"},1,"570,",0,-2.77,-2.16,12,"Exon (ENSBGRT00000035614/ENSBGRG00000019358, exon 13 of 19)",14,69165478,69231919,66442,2]
["chr14",74267638,74267847,210,"ENSBGRG00000023209","ENSBGRT00000043012",9446,"UTP25","UTP25 small subunit processor component [Source:HGNC Symbol;Acc:HGNC:28440]","GO:0005634(nucleus);GO:0005730(nucleolus);GO:0030163(protein catabolic process);GO:0031648(protein destabilization)","NA",{"v":0.00026,"d":"0.00"},1,"210,",0,-3.59,-2.93,1.73,"Exon (ENSBGRT00000043012/ENSBGRG00000023209, exon 8 of 14)",14,74240986,74277293,36308,2]
["chr14",77685432,77686239,808,"ENSBGRG00000014882","ENSBGRT00000027386",289998,"DENND1B","DENN domain containing 1B [Source:HGNC Symbol;Acc:HGNC:28404]","GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0032456(endocytic recycling);GO:0035745(T-helper 2 cell cytokine production);GO:0043547(positive regulation of GTPase activity);GO:0050776(regulation of immune response);GO:0050852(T cell receptor signaling pathway)","NA",{"v":0.00048,"d":"0.00"},1,"808,",0,-3.32,-2.67,14,"3' UTR",14,77684065,77976237,292173,2]
["chr14",84372031,84372419,389,"ENSBGRG00000008896","ENSBGRT00000016280",117874,"PLEKHA6","pleckstrin homology domain containing A6 [Source:HGNC Symbol;Acc:HGNC:17053]","NA","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);05200(Pathways in cancer)",{"v":1.3e-29,"d":"0.00"},1,"389,",0,{"v":-28.9,"d":"-28.90"},{"v":-27.7,"d":"-27.70"},5.78,"Exon (ENSBGRT00000016280/ENSBGRG00000008896, exon 8 of 23)",14,84338731,84490293,151563,2]
["chr14",85439578,85456161,16584,"ENSBGRG00000011026","ENSBGRT00000020216",24290,"DSTYK","dual serine/threonine and tyrosine protein kinase [Source:HGNC Symbol;Acc:HGNC:29043]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0033674(positive regulation of kinase activity);GO:0043066(negative regulation of apoptotic process);GO:0044344(cellular response to fibroblast growth factor stimulus);GO:0045743(positive regulation of fibroblast growth factor receptor signaling pathway);GO:0070374(positive regulation of ERK1 and ERK2 cascade)","NA",{"v":2.5e-28,"d":"0.00"},3,"639,75,32,","0,16473,16552",{"v":-27.6,"d":"-27.60"},{"v":-26.5,"d":"-26.50"},5.26,"Exon (ENSBGRT00000020216/ENSBGRG00000011026, exon 3 of 13)",14,85425116,85480451,55336,2]
["chr14",86626927,86627166,240,"ENSBGRG00000014252","ENSBGRT00000026370",0,"ENSBGRG00000014252","NA","NA","NA",{"v":3.7e-05,"d":"0.00"},1,"240,",0,-4.43,-3.73,{"v":18.1,"d":"18.10"},"5' UTR",14,86614606,86627166,12561,2]
["chr15",9156472,9158632,2161,"ENSBGRG00000023354","ENSBGRT00000043128",257380,"CLYBL","citrate lyase beta like [Source:HGNC Symbol;Acc:HGNC:18355]","GO:0000287(magnesium ion binding);GO:0003824(catalytic activity);GO:0004474(malate synthase activity);GO:0047777((S)-citramalyl-CoA lyase activity);GO:0070207(protein homotrimerization);GO:0106064(regulation of cobalamin metabolic process);GO:0106121(positive regulation of cobalamin metabolic process)","NA",{"v":4e-47,"d":"0.00"},2,"67,1637,","0,524",{"v":-46.4,"d":"-46.40"},{"v":-45.1,"d":"-45.10"},5.54,"3' UTR",15,8899092,9156538,257447,1]
["chr15",20331096,20331305,210,"ENSBGRG00000015676","ENSBGRT00000028775",10343,"PROZ","protein Z, vitamin K dependent plasma glycoprotein [Source:HGNC Symbol;Acc:HGNC:9460]","GO:0004252(serine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0006508(proteolysis);GO:0007596(blood coagulation)","NA",{"v":0.00089,"d":"0.00"},1,"210,",0,-3.05,-2.42,13,"Exon (ENSBGRT00000028775/ENSBGRG00000015676, exon 9 of 9)",15,20320753,20331305,10553,1]
["chr15",31703220,31724514,21295,"ENSBGRG00000005748","ENSBGRT00000010613",441103,"KLF12","Kruppel like factor 12 [Source:HGNC Symbol;Acc:HGNC:6346]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":3.5E-4,"d":"0.00"},2,"120,121,","0,21174",-3.46,-2.81,3.01,"Exon (ENSBGRT00000010613/ENSBGRG00000005748, exon 8 of 9)",15,31262117,31725622,463506,1]
["chr15",45584266,45588965,4700,"ENSBGRG00000012512","ENSBGRT00000022951",13670,"IFT88","intraflagellar transport 88 [Source:HGNC Symbol;Acc:HGNC:20606]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0005814(centriole);GO:0005929(cilium);GO:0036064(ciliary basal body)","NA",{"v":1.9E-3,"d":"0.00"},4,"63,70,91,16,","0,720,3282,4684",-2.73,-2.12,1.84,"Exon (ENSBGRT00000022951/ENSBGRG00000012512, exon 5 of 25)",15,45570596,45629357,58762,1]
["chr15",49442830,49446226,3397,"ENSBGRG00000004973","ENSBGRT00000009277",10339,"GTF3A","general transcription factor IIIA [Source:HGNC Symbol;Acc:HGNC:4662]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm)","NA",{"v":4e-31,"d":"0.00"},5,"1129,54,385,138,24,","0,1541,2222,3233,3373",{"v":-30.4,"d":"-30.40"},{"v":-29.3,"d":"-29.30"},7.02,"3' UTR",15,49432491,49443578,11088,1]
["chr15",56448389,56448628,240,"ENSBGRG00000016974","ENSBGRT00000034989",230913,"NBEA","neurobeachin [Source:HGNC Symbol;Acc:HGNC:7648]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0008104(protein localization);GO:0012505(endomembrane system);GO:0019901(protein kinase binding)","04071(Sphingolipid signaling pathway)",{"v":1.8E-3,"d":"0.00"},1,"240,",0,-2.74,-2.13,4.26,"Exon (ENSBGRT00000034989/ENSBGRG00000016974, exon 22 of 58)",15,56217476,56965738,748263,1]
["chr15",61688214,61688304,91,"ENSBGRG00000014141","ENSBGRT00000026090",30696,"CKAP2","cytoskeleton associated protein 2 [Source:HGNC Symbol;Acc:HGNC:1990]","GO:0000281(mitotic cytokinesis);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005881(cytoplasmic microtubule);GO:0015630(microtubule cytoskeleton);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":0.00048,"d":"0.00"},1,"91,",0,-3.32,-2.67,14,"3' UTR",15,61657518,61688752,31235,1]
["chr15",65709287,65711352,2066,"ENSBGRG00000020636","ENSBGRT00000038067",46838,"MED4","mediator complex subunit 4 [Source:HGNC Symbol;Acc:HGNC:17903]","GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006366(transcription by RNA polymerase II);GO:0016592(mediator complex);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046966(thyroid hormone receptor binding);GO:0060261(positive regulation of transcription initiation from RNA polymerase II promoter)","04919(Thyroid hormone signaling pathway)",{"v":3.2e-36,"d":"0.00"},2,"165,131,","0,1935",{"v":-35.5,"d":"-35.50"},{"v":-34.3,"d":"-34.30"},2.93,"3' UTR",15,65662449,65711511,49063,1]
["chr15",69132902,69165509,32608,"ENSBGRG00000004147","ENSBGRT00000007795",2838,"TSC22D1","TSC22 domain family member 1 [Source:HGNC Symbol;Acc:HGNC:16826]","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":2.6e-05,"d":"0.00"},3,"161,147,112,","0,31445,32496",-4.59,-3.89,4.01,"Exon (ENSBGRT00000007795/ENSBGRG00000004147, exon 2 of 4)",15,69130064,69165533,35470,1]
["chr15",8097996,8100124,2129,"ENSBGRG00000022862","ENSBGRT00000042239",238677,"DOCK9","dedicator of cytokinesis 9 [Source:HGNC Symbol;Acc:HGNC:14132]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0007264(small GTPase mediated signal transduction)","NA",{"v":3e-07,"d":"0.00"},3,"126,8,76,","0,1169,2053",-6.53,-5.76,2.01,"Exon (ENSBGRT00000042239/ENSBGRG00000022862, exon 53 of 54)",15,8097996,8338801,240806,2]
["chr15",18835778,18836135,358,"ENSBGRG00000008654","ENSBGRT00000015847",21703,"CARS2","cysteinyl-tRNA synthetase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:25695]","GO:0000166(nucleotide binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004817(cysteine-tRNA ligase activity);GO:0005524(ATP binding);GO:0006418(tRNA aminoacylation for protein translation);GO:0006423(cysteinyl-tRNA aminoacylation)","00970(Aminoacyl-tRNA biosynthesis)",{"v":0.00016,"d":"0.00"},1,"358,",0,{"v":-3.8,"d":"-3.80"},-3.13,4.51,"3' UTR",15,18835540,18857838,22299,2]
["chr15",32877234,32883251,6018,"ENSBGRG00000006206","ENSBGRT00000011658",20142,"BORA","BORA aurora kinase A activator [Source:HGNC Symbol;Acc:HGNC:24724]","GO:0072687(meiotic spindle)","NA",{"v":5e-17,"d":"0.00"},3,"320,132,56,","0,1554,5962",{"v":-16.3,"d":"-16.30"},{"v":-15.4,"d":"-15.40"},5.42,"3' UTR",15,32877234,32903393,26160,2]
["chr15",45672570,45678951,6382,"ENSBGRG00000012982","ENSBGRT00000023791",141,"EEF1AKMT1","EEF1A lysine methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:27351]","GO:0003676(nucleic acid binding);GO:0008168(methyltransferase activity);GO:0016279(protein-lysine N-methyltransferase activity);GO:0018022(peptidyl-lysine methylation);GO:0032259(methylation)","NA",{"v":1e-114,"d":"0.00"},3,"352,83,13,","0,4689,6369",-114,-112,5.25,"Exon (ENSBGRT00000023791/ENSBGRG00000012982, exon 1 of 3)",15,45671081,45679092,8012,2]
["chr15",47428859,47449040,20182,"ENSBGRG00000015382","ENSBGRT00000028798",0,"ENSBGRG00000015382","NA","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0035556(intracellular signal transduction)","04810(Regulation of actin cytoskeleton)",{"v":0.028,"d":"0.03"},2,"24,127,","0,20055",-1.55,-1.03,3.68,"Exon (ENSBGRT00000028798/ENSBGRG00000015382, exon 1 of 11)",15,47399845,47428882,29038,2]
["chr15",50279677,50289690,10014,"ENSBGRG00000006167","ENSBGRT00000011431",83337,"ENSBGRG00000006167","NA","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04066(HIF-1 signaling pathway);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);05202(Transcriptional misregulation in cancers);05323(Rheumatoid arthritis)",{"v":3.2e-30,"d":"0.00"},3,"258,309,30,","0,680,9984",{"v":-29.5,"d":"-29.50"},{"v":-28.4,"d":"-28.40"},4.83,"5' UTR",15,50182486,50373027,190542,2]
["chr15",53691835,53770929,79095,"ENSBGRG00000014613","ENSBGRT00000026861",0,"ENSBGRG00000014613","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":2e-72,"d":"0.00"},2,"150,238,","0,78857",{"v":-71.7,"d":"-71.70"},{"v":-70.2,"d":"-70.20"},{"v":25.6,"d":"25.60"},"3' UTR",15,53696644,53698107,1464,1]
["chr15",58127627,58127954,328,"ENSBGRG00000020902","ENSBGRT00000038496",30,"ENSBGRG00000020902","NA","GO:0001657(ureteric bud development);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006468(protein phosphorylation);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0030509(BMP signaling pathway);GO:0030901(midbrain development);GO:0030902(hindbrain development);GO:0051216(cartilage development);GO:0060348(bone development);GO:0060395(SMAD protein signal transduction);GO:0071407(cellular response to organic cyclic compound)","04350(TGF-beta signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells)",{"v":3.5e-05,"d":"0.00"},1,"328,",0,-4.46,-3.76,2.88,"5' UTR",15,58100925,58127984,27060,2]
["chr15",65612535,65612773,239,"ENSBGRG00000020600","ENSBGRT00000037948",462,"ENSBGRG00000020600","NA","GO:0003676(nucleic acid binding)","03040(Spliceosome)",{"v":2.8E-5,"d":"0.00"},1,"239,",0,-4.56,-3.85,3.23,"Exon (ENSBGRT00000037948/ENSBGRG00000020600, exon 2 of 3)",15,65612160,65613235,1076,2]
["chr15",73480776,73480836,61,"ENSBGRG00000006338","ENSBGRT00000011720",1344,"PCDH8","protocadherin 8 [Source:HGNC Symbol;Acc:HGNC:8660]","GO:0001756(somitogenesis);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016331(morphogenesis of embryonic epithelium)","NA",{"v":0.017,"d":"0.02"},1,"61,",0,-1.76,-1.22,4.01,"Exon (ENSBGRT00000011720/ENSBGRG00000006338, exon 2 of 5)",15,73477489,73482180,4692,2]
["chr16",3943867,3944197,331,"ENSBGRG00000009303","ENSBGRT00000017156",78934,"EDNRA","endothelin receptor type A [Source:HGNC Symbol;Acc:HGNC:3179]","GO:0001569(branching involved in blood vessel morphogenesis);GO:0001666(response to hypoxia);GO:0001701(in utero embryonic development);GO:0004930(G protein-coupled receptor activity);GO:0004962(endothelin receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0007507(heart development);GO:0007585(respiratory gaseous exchange by respiratory system);GO:0008217(regulation of blood pressure);GO:0010827(regulation of glucose transmembrane transport);GO:0014032(neural crest cell development);GO:0014824(artery smooth muscle contraction);GO:0016021(integral component of membrane);GO:0042310(vasoconstriction);GO:0048484(enteric nervous system development);GO:0060322(head development)","04020(Calcium signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04080(Neuroactive ligand-receptor interaction);04924(Renin secretion);04270(Vascular smooth muscle contraction);05200(Pathways in cancer)",{"v":1.1e-09,"d":"0.00"},1,"331,",0,-8.94,-8.11,1.82,"3' UTR",16,3864933,3944197,79265,1]
["chr16",10522938,10523088,151,"ENSBGRG00000016413","ENSBGRT00000030095",38565,"FHDC1","FH2 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29363]","GO:0003779(actin binding);GO:0005794(Golgi apparatus);GO:0005874(microtubule);GO:0005881(cytoplasmic microtubule);GO:0005929(cilium);GO:0008017(microtubule binding);GO:0043149(stress fiber assembly);GO:0060271(cilium assembly);GO:0090161(Golgi ribbon formation)","04310(Wnt signaling pathway)",{"v":0.00016,"d":"0.00"},1,"151,",0,{"v":-3.8,"d":"-3.80"},-3.13,11,"3' UTR",16,10484373,10523088,38716,1]
["chr16",20378324,20387335,9012,"ENSBGRG00000003765","ENSBGRT00000006969",0,"ENSBGRG00000003765","NA","NA","NA",{"v":3.5E-4,"d":"0.00"},3,"924,701,1068,","0,5051,7944",-3.45,-2.79,14,"Exon (ENSBGRT00000006979/ENSBGRG00000003773, exon 1 of 2)",16,20365220,20378324,13105,2]
["chr16",32745650,32745856,207,"ENSBGRG00000006233","ENSBGRT00000013948",38214,"MFSD8","major facilitator superfamily domain containing 8 [Source:HGNC Symbol;Acc:HGNC:28486]","GO:0005654(nucleoplasm);GO:0005764(lysosome);GO:0007040(lysosome organization);GO:0010506(regulation of autophagy);GO:0016020(membrane);GO:0022857(transmembrane transporter activity);GO:0038202(TORC1 signaling);GO:0043231(intracellular membrane-bounded organelle);GO:0048666(neuron development);GO:0055085(transmembrane transport);GO:0097352(autophagosome maturation);GO:1905165(regulation of lysosomal protein catabolic process)","04142(Lysosome)",{"v":2.4E-10,"d":"0.00"},1,"207,",0,-9.62,-8.77,3.05,"Exon (ENSBGRT00000013948/ENSBGRG00000006233, exon 13 of 13)",16,32707436,32745851,38416,1]
["chr16",36393727,36394983,1257,"ENSBGRG00000009949","ENSBGRT00000018242",33036,"ANKRD50","ankyrin repeat domain 50 [Source:HGNC Symbol;Acc:HGNC:29223]","GO:0005515(protein binding);GO:1990126(retrograde transport, endosome to plasma membrane)","NA",{"v":3.2e-36,"d":"0.00"},1,"1257,",0,{"v":-35.5,"d":"-35.50"},{"v":-34.3,"d":"-34.30"},{"v":10.7,"d":"10.70"},"Exon (ENSBGRT00000018242/ENSBGRG00000009949, exon 3 of 3)",16,36360691,36397135,36445,1]
["chr16",48376112,48377494,1383,"ENSBGRG00000005300","ENSBGRT00000009800",14038,"ENSBGRG00000005300","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":0.015,"d":"0.02"},2,"55,64,","0,1319",-1.82,-1.28,3.51,"Exon (ENSBGRT00000009800/ENSBGRG00000005300, exon 2 of 4)",16,48362074,48380851,18778,1]
["chr16",51943603,52619730,676128,"ENSBGRG00000010027","ENSBGRT00000018530",0,"TMEM132D","transmembrane protein 132D [Source:HGNC Symbol;Acc:HGNC:29411]","GO:0010923(negative regulation of phosphatase activity)","NA",{"v":7.4e-06,"d":"0.00"},4,"79,889,147,19,","0,257416,464762,676109",-5.13,-4.41,6.02,"Exon (ENSBGRT00000018530/ENSBGRG00000010027, exon 1 of 9)",16,51943603,52936248,992646,1]
["chr16",57526594,57526713,120,"ENSBGRG00000003817","ENSBGRT00000007052",54424,"RILPL1","Rab interacting lysosomal protein like 1 [Source:HGNC Symbol;Acc:HGNC:26814]","GO:0003382(epithelial cell morphogenesis);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0046983(protein dimerization activity);GO:1901214(regulation of neuron death);GO:1903445(protein transport from ciliary membrane to plasma membrane)","NA",{"v":5e-13,"d":"0.00"},1,"120,",0,{"v":-12.3,"d":"-12.30"},{"v":-11.4,"d":"-11.40"},2.19,"Exon (ENSBGRT00000007052/ENSBGRG00000003817, exon 7 of 7)",16,57472170,57526713,54544,1]
["chr16",58550985,58607201,56217,"ENSBGRG00000006328","ENSBGRT00000011818",37177,"CLIP1","CAP-Gly domain containing linker protein 1 [Source:HGNC Symbol;Acc:HGNC:10461]","GO:0001578(microtubule bundle formation);GO:0005635(nuclear envelope);GO:0005813(centrosome);GO:0005874(microtubule);GO:0005881(cytoplasmic microtubule);GO:0008017(microtubule binding);GO:0008270(zinc ion binding);GO:0015630(microtubule cytoskeleton);GO:0015631(tubulin binding);GO:0031116(positive regulation of microtubule polymerization);GO:0035371(microtubule plus-end);GO:0044354(macropinosome);GO:0044861(protein transport into plasma membrane raft);GO:0051010(microtubule plus-end binding)","04150(mTOR signaling pathway)",{"v":2.5e-21,"d":"0.00"},14,"599,222,117,58,84,157,166,216,117,107,121,53,118,18,","0,2823,5027,7304,8558,9570,11574,11847,18376,20572,25862,47358,56002,56199",{"v":-20.6,"d":"-20.60"},{"v":-19.5,"d":"-19.50"},7.22,"Exon (ENSBGRT00000011818/ENSBGRG00000006328, exon 12 of 28)",16,58513808,58611510,97703,1]
["chr16",59694577,59706143,11567,"ENSBGRG00000010286","ENSBGRT00000018991",6620,"IFT81","intraflagellar transport 81 [Source:HGNC Symbol;Acc:HGNC:14313]","GO:0005813(centrosome);GO:0005929(cilium);GO:0007283(spermatogenesis);GO:0008589(regulation of smoothened signaling pathway);GO:0015631(tubulin binding);GO:0030992(intraciliary transport particle B);GO:0035735(intraciliary transport involved in cilium assembly);GO:0036064(ciliary basal body);GO:0042073(intraciliary transport);GO:0060271(cilium assembly);GO:0097225(sperm midpiece);GO:0097228(sperm principal piece)","NA",{"v":1.9E-6,"d":"0.00"},5,"3,66,111,85,34,","0,2650,3029,4221,11533",-5.72,-4.98,1.95,"Exon (ENSBGRT00000018991/ENSBGRG00000010286, exon 4 of 11)",16,59687957,59727492,39536,1]
["chr16",66496780,66497199,420,"ENSBGRG00000015175","ENSBGRT00000027980",13280,"TBX3","T-box transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:11602]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0001568(blood vessel development);GO:0001701(in utero embryonic development);GO:0001947(heart looping);GO:0003007(heart morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0003167(atrioventricular bundle cell differentiation);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007569(cell aging);GO:0008284(positive regulation of cell population proliferation);GO:0008595(anterior/posterior axis specification, embryo);GO:0009887(animal organ morphogenesis);GO:0010159(specification of animal organ position);GO:0019827(stem cell population maintenance);GO:0021761(limbic system development);GO:0030539(male genitalia development);GO:0030540(female genitalia development);GO:0030857(negative regulation of epithelial cell differentiation);GO:0030879(mammary gland development);GO:0032275(luteinizing hormone secretion);GO:0035050(embryonic heart tube development);GO:0035108(limb morphogenesis);GO:0035115(embryonic forelimb morphogenesis);GO:0035116(embryonic hindlimb morphogenesis);GO:0035136(forelimb morphogenesis);GO:0042127(regulation of cell population proliferation);GO:0042733(embryonic digit morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045662(negative regulation of myoblast differentiation);GO:0045787(positive regulation of cell cycle);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046884(follicle-stimulating hormone secretion);GO:0048332(mesoderm morphogenesis);GO:0051145(smooth muscle cell differentiation);GO:0055007(cardiac muscle cell differentiation);GO:0060021(roof of mouth development);GO:0060412(ventricular septum morphogenesis);GO:0060444(branching involved in mammary gland duct morphogenesis);GO:0060596(mammary placode formation);GO:0060923(cardiac muscle cell fate commitment);GO:0060931(sinoatrial node cell development);GO:0072105(ureteric peristalsis);GO:0090398(cellular senescence);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000648(positive regulation of stem cell proliferation)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":6.3e-24,"d":"0.00"},1,"420,",0,{"v":-23.2,"d":"-23.20"},{"v":-22.1,"d":"-22.10"},3.29,"3' UTR",16,66483500,66497589,14090,1]
["chr16",69765669,69766082,414,"ENSBGRG00000026410","ENSBGRT00000048868",0,"UNC119B","unc-119 lipid binding chaperone B [Source:HGNC Symbol;Acc:HGNC:16488]","GO:0008289(lipid binding);GO:0035869(ciliary transition zone);GO:0042953(lipoprotein transport);GO:0060271(cilium assembly)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":3.2e-14,"d":"0.00"},1,"414,",0,{"v":-13.5,"d":"-13.50"},{"v":-12.6,"d":"-12.60"},5.01,"5' UTR",16,69765669,69774306,8638,1]
["chr16",72346266,72346446,181,"ENSBGRG00000013651","ENSBGRT00000025015",7156,"ENSBGRG00000013651","NA","NA","04514(Cell adhesion molecules (CAMs))",{"v":2E-8,"d":"0.00"},1,"181,",0,-7.69,-6.89,2.74,"Exon (ENSBGRT00000025015/ENSBGRG00000013651, exon 3 of 5)",16,72339110,72477028,137919,1]
["chr16",72486422,72491907,5486,"ENSBGRG00000013693","ENSBGRT00000025382",113391,"ENSBGRG00000013693","NA","NA","NA",{"v":0.00081,"d":"0.00"},3,"39,137,34,","0,784,5452",-3.09,-2.46,4.26,"Exon (ENSBGRT00000025382/ENSBGRG00000013693, exon 6 of 8)",16,72373031,72494925,121895,1]
["chr16",76114484,76128296,13813,"ENSBGRG00000020977","ENSBGRT00000038688",0,"ENSBGRG00000020977","NA","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane)","NA",{"v":1.3e-38,"d":"0.00"},2,"537,180,","0,13633",{"v":-37.9,"d":"-37.90"},{"v":-36.7,"d":"-36.70"},2.89,"5' UTR",16,76116011,76119045,3035,2]
["chr16",78819234,78819794,561,"ENSBGRG00000020789","ENSBGRT00000038285",0,"ENSBGRG00000020789","NA","NA","NA",{"v":1.6E-12,"d":"0.00"},1,"561,",0,{"v":-11.8,"d":"-11.80"},-11,{"v":23.1,"d":"23.10"},"5' UTR",16,78819234,78821113,1880,1]
["chr16",79012365,79016599,4235,"ENSBGRG00000022119","ENSBGRT00000041255",28555,"CABIN1","calcineurin binding protein 1 [Source:HGNC Symbol;Acc:HGNC:24187]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006336(DNA replication-independent nucleosome assembly);GO:0016235(aggresome)","NA",{"v":0.019,"d":"0.02"},2,"80,100,","0,4135",-1.71,{"v":-0.915,"d":"-0.92"},8.02,"Exon (ENSBGRT00000041255/ENSBGRG00000022119, exon 18 of 22)",16,78983810,79023855,40046,1]
["chr16",80106080,80107383,1304,"ENSBGRG00000010834","ENSBGRT00000019841",7713,"SNAP29","synaptosome associated protein 29 [Source:HGNC Symbol;Acc:HGNC:11133]","GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005776(autophagosome);GO:0005813(centrosome);GO:0005829(cytosol);GO:0016240(autophagosome membrane docking);GO:0020018(ciliary pocket membrane);GO:0031201(SNARE complex);GO:0060271(cilium assembly);GO:0097352(autophagosome maturation)","04130(SNARE interactions in vesicular transport);04140(Autophagy - animal)",{"v":1e-16,"d":"0.00"},2,"43,197,","0,1107",-16,-15,2.97,"3' UTR",16,80098367,80107383,9017,1]
["chr16",80942912,80943181,270,"ENSBGRG00000022686","ENSBGRT00000041872",18022,"DGCR8","DGCR8 microprocessor complex subunit [Source:HGNC Symbol;Acc:HGNC:2847]","GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0004525(ribonuclease III activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0020037(heme binding);GO:0031053(primary miRNA processing);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0046907(intracellular transport);GO:0070877(microprocessor complex);GO:0070878(primary miRNA binding)","05203(Viral carcinogenesis);05166(HTLV-I infection)",{"v":1.6e-10,"d":"0.00"},1,"270,",0,-9.79,-8.94,7.52,"3' UTR",16,80924890,80943796,18907,1]
["chr16",8244694,8249034,4341,"ENSBGRG00000013051","ENSBGRT00000025865",48057,"SH3D19","SH3 domain containing 19 [Source:HGNC Symbol;Acc:HGNC:30418]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007010(cytoskeleton organization);GO:0022604(regulation of cell morphogenesis);GO:0051044(positive regulation of membrane protein ectodomain proteolysis)","NA",{"v":2.5e-33,"d":"0.00"},3,"117,102,50,","0,3494,4291",{"v":-32.6,"d":"-32.60"},{"v":-31.4,"d":"-31.40"},2.68,"Exon (ENSBGRT00000025865/ENSBGRG00000013051, exon 12 of 13)",16,8244694,8297091,52398,2]
["chr16",15231285,15231405,121,"ENSBGRG00000019657","ENSBGRT00000036718",389,"KLHL2","kelch like family member 2 [Source:HGNC Symbol;Acc:HGNC:6353]","GO:0003779(actin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0015629(actin cytoskeleton);GO:0016567(protein ubiquitination);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0042802(identical protein binding)","NA",{"v":0.0058,"d":"0.01"},1,"121,",0,-2.24,-1.66,5.01,"5' UTR",16,15056963,15231794,174832,2]
["chr16",15789153,15792445,3293,"ENSBGRG00000020282","ENSBGRT00000037606",30215,"SMARCA5","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 [Source:HGNC Symbol;Acc:HGNC:11101]","GO:0000793(condensed chromosome);GO:0001650(fibrillar center);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006334(nucleosome assembly);GO:0006338(chromatin remodeling);GO:0006352(DNA-templated transcription, initiation);GO:0016584(nucleosome positioning);GO:0016589(NURF complex);GO:0016818(hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides);GO:0016887(ATPase activity);GO:0031213(RSF complex);GO:0031491(nucleosome binding);GO:0042393(histone binding);GO:0043044(ATP-dependent chromatin remodeling);GO:0043596(nuclear replication fork)","NA",{"v":1E-14,"d":"0.00"},3,"5,149,25,","0,196,3268",-14,{"v":-13.1,"d":"-13.10"},1.68,"Exon (ENSBGRT00000037606/ENSBGRG00000020282, exon 14 of 24)",16,15780737,15822660,41924,2]
["chr16",31843726,31860700,16975,"ENSBGRG00000005261","ENSBGRT00000009719",49069,"JADE1","jade family PHD finger 1 [Source:HGNC Symbol;Acc:HGNC:30027]","GO:0000123(histone acetyltransferase complex);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0016607(nuclear speck);GO:0036064(ciliary basal body);GO:0043966(histone H3 acetylation);GO:0043981(histone H4-K5 acetylation);GO:0043982(histone H4-K8 acetylation);GO:0043983(histone H4-K12 acetylation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","NA",{"v":4e-85,"d":"0.00"},5,"911,118,522,117,120,","0,4245,10530,15557,16855",{"v":-84.4,"d":"-84.40"},{"v":-82.8,"d":"-82.80"},5.25,"Exon (ENSBGRT00000009719/ENSBGRG00000005261, exon 7 of 11)",16,31843726,31909769,66044,2]
["chr16",38386462,38386759,298,"ENSBGRG00000010586","ENSBGRT00000019382",1188,"BBS12","Bardet-Biedl syndrome 12 [Source:HGNC Symbol;Acc:HGNC:26648]","GO:0005524(ATP binding);GO:0045599(negative regulation of fat cell differentiation);GO:0051131(chaperone-mediated protein complex assembly)","NA",{"v":0.00036,"d":"0.00"},1,"298,",0,-3.44,-2.79,2.85,"Exon (ENSBGRT00000019382/ENSBGRG00000010586, exon 1 of 1)",16,38385155,38387947,2793,2]
["chr16",48464560,48465069,510,"ENSBGRG00000005358","ENSBGRT00000009890",0,"ZNF891","zinc finger protein 891 [Source:HGNC Symbol;Acc:HGNC:38709]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":0.00016,"d":"0.00"},1,"510,",0,{"v":-3.8,"d":"-3.80"},-3.13,8.02,"Exon (ENSBGRT00000009890/ENSBGRG00000005358, exon 1 of 1)",16,48463423,48465069,1647,2]
["chr16",49634295,49635452,1158,"ENSBGRG00000007587","ENSBGRT00000014464",10018,"ULK1","unc-51 like autophagy activating kinase 1 [Source:HGNC Symbol;Acc:HGNC:12558]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005776(autophagosome);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006914(autophagy);GO:0007165(signal transduction);GO:0007409(axonogenesis);GO:0008104(protein localization);GO:0010508(positive regulation of autophagy);GO:0016236(macroautophagy);GO:0017137(Rab GTPase binding);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0031175(neuron projection development);GO:0031333(negative regulation of protein-containing complex assembly);GO:0032045(guanyl-nucleotide exchange factor complex);GO:0034045(phagophore assembly site membrane);GO:0042802(identical protein binding);GO:0044877(protein-containing complex binding);GO:0046777(protein autophosphorylation);GO:0051020(GTPase binding);GO:0075044(positive regulation by symbiont of host autophagy);GO:0097629(extrinsic component of omegasome membrane);GO:0097632(extrinsic component of phagophore assembly site membrane);GO:0097635(extrinsic component of autophagosome membrane);GO:1990316(Atg1/ULK1 kinase complex)","04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04137(Mitophagy - animal);04211(Longevity regulating pathway - mammal)",{"v":5e-12,"d":"0.00"},3,"56,136,48,","0,136,1110",{"v":-11.3,"d":"-11.30"},{"v":-10.4,"d":"-10.40"},3.82,"Exon (ENSBGRT00000014464/ENSBGRG00000007587, exon 18 of 20)",16,49634295,49645470,11176,2]
["chr16",57720101,57722156,2056,"ENSBGRG00000004182","ENSBGRT00000007733",176,"C12orf65","chromosome 12 open reading frame 65 [Source:HGNC Symbol;Acc:HGNC:26784]","GO:0003747(translation release factor activity);GO:0006415(translational termination)","00760(Nicotinate and nicotinamide metabolism)",{"v":1.3e-77,"d":"0.00"},2,"219,106,","0,1950",{"v":-76.9,"d":"-76.90"},{"v":-75.2,"d":"-75.20"},5.81,"Exon (ENSBGRT00000007733/ENSBGRG00000004182, exon 1 of 2)",16,57720101,57722332,2232,2]
["chr16",59359755,59362336,2582,"ENSBGRG00000008846","ENSBGRT00000016338",18817,"RNF34","ring finger protein 34 [Source:HGNC Symbol;Acc:HGNC:17297]","GO:0002039(p53 binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0035872(nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0061630(ubiquitin protein ligase activity);GO:0070417(cellular response to cold);GO:0070936(protein K48-linked ubiquitination);GO:1901797(negative regulation of signal transduction by p53 class mediator);GO:1901981(phosphatidylinositol phosphate binding);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:2000374(regulation of oxygen metabolic process);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","NA",{"v":1.3E-87,"d":"0.00"},2,"538,202,","0,2380",{"v":-86.9,"d":"-86.90"},{"v":-85.2,"d":"-85.20"},5.63,"3' UTR",16,59359341,59381153,21813,2]
["chr16",63024739,63025152,414,"ENSBGRG00000018498","ENSBGRT00000033902",3849,"ENSBGRG00000018498","NA","GO:0009986(cell surface);GO:0048240(sperm capacitation)","NA",{"v":1E-168,"d":"0.00"},1,"414,",0,-168,-166,1.58,"3' UTR",16,63024739,63029001,4263,2]
["chr16",67768982,67769281,300,"ENSBGRG00000016833","ENSBGRT00000030913",9791,"CFAP73","cilia and flagella associated protein 73 [Source:HGNC Symbol;Acc:HGNC:37100]","NA","NA",{"v":1.6E-46,"d":"0.00"},1,"300,",0,{"v":-45.8,"d":"-45.80"},{"v":-44.4,"d":"-44.40"},6.65,"3' UTR",16,67759191,67769020,9830,1]
["chr16",69591571,69591630,60,"ENSBGRG00000026354","ENSBGRT00000048762",8582,"COQ5","coenzyme Q5, methyltransferase [Source:HGNC Symbol;Acc:HGNC:28722]","GO:0005743(mitochondrial inner membrane);GO:0005759(mitochondrial matrix);GO:0006744(ubiquinone biosynthetic process);GO:0008168(methyltransferase activity);GO:0032259(methylation);GO:0032991(protein-containing complex);GO:0043333(2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity)","00130(Ubiquinone and other terpenoid-quinone biosynthesis)",{"v":0.0079,"d":"0.01"},1,"60,",0,{"v":-2.1,"d":"-2.10"},-1.53,1.56,"Exon (ENSBGRT00000048762/ENSBGRG00000026354, exon 3 of 7)",16,69579810,69600212,20403,2]
["chr16",74842178,74860635,18458,"ENSBGRG00000016197","ENSBGRT00000030489",0,"PITPNB","phosphatidylinositol transfer protein beta [Source:HGNC Symbol;Acc:HGNC:9002]","GO:0005548(phospholipid transporter activity);GO:0008525(phosphatidylcholine transporter activity);GO:0008526(phosphatidylinositol transfer activity);GO:0015914(phospholipid transport);GO:0031210(phosphatidylcholine binding);GO:0035091(phosphatidylinositol binding)","NA",{"v":7.9e-29,"d":"0.00"},5,"18,146,31,26,20,","0,9853,12986,18367,18438",{"v":-28.1,"d":"-28.10"},-27,2.85,"Exon (ENSBGRT00000030489/ENSBGRG00000016197, exon 1 of 11)",16,74792553,74860635,68083,2]
["chr16",76944340,76944607,268,"ENSBGRG00000023579","ENSBGRT00000043560",34736,"ENSBGRG00000023579","NA","NA","NA",{"v":3.2e-33,"d":"0.00"},1,"268,",0,{"v":-32.5,"d":"-32.50"},{"v":-31.3,"d":"-31.30"},3.15,"Exon (ENSBGRT00000043560/ENSBGRG00000023579, exon 8 of 8)",16,76944340,76979343,35004,2]
["chr16",77889600,77890392,793,"ENSBGRG00000008974","ENSBGRT00000016663",8681,"EIF4ENIF1","eukaryotic translation initiation factor 4E nuclear import factor 1 [Source:HGNC Symbol;Acc:HGNC:16687]","GO:0000932(P-body);GO:0003729(mRNA binding);GO:0005049(nuclear export signal receptor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0017148(negative regulation of translation);GO:0019827(stem cell population maintenance);GO:0043231(intracellular membrane-bounded organelle);GO:0045665(negative regulation of neuron differentiation)","NA",{"v":2E-12,"d":"0.00"},2,"242,28,","0,765",{"v":-11.7,"d":"-11.70"},{"v":-10.8,"d":"-10.80"},3.01,"Exon (ENSBGRT00000016663/ENSBGRG00000008974, exon 7 of 8)",16,77889600,77899073,9474,2]
["chr16",79370471,79375976,5506,"ENSBGRG00000023440","ENSBGRT00000043300",3993,"ENSBGRG00000023440","NA","GO:0005515(protein binding)","NA",{"v":1e-18,"d":"0.00"},2,"852,105,","0,5401",-18,-17,{"v":4.2,"d":"4.20"},"Exon (ENSBGRT00000043300/ENSBGRG00000023440, exon 2 of 15)",16,79303976,79379969,75994,2]
["chr16",80432318,80432908,591,"ENSBGRG00000018919","ENSBGRT00000034679",29456,"DGCR2","DiGeorge syndrome critical region gene 2 [Source:HGNC Symbol;Acc:HGNC:2845]","GO:0005515(protein binding);GO:0050890(cognition)","04310(Wnt signaling pathway);04150(mTOR signaling pathway)",{"v":5E-15,"d":"0.00"},2,"248,83,","0,508",{"v":-14.3,"d":"-14.30"},{"v":-13.4,"d":"-13.40"},3.78,"3' UTR",16,80432318,80462364,30047,2]
["chr16",81100490,81100636,147,"ENSBGRG00000023569","ENSBGRT00000043506",4228,"ENSBGRG00000023569","NA","NA","NA",{"v":2.5e-24,"d":"0.00"},1,"147,",0,{"v":-23.6,"d":"-23.60"},{"v":-22.5,"d":"-22.50"},2.23,"3' UTR",16,81100490,81104864,4375,2]
["chr17",4854704,4855393,690,"ENSBGRG00000004716","ENSBGRT00000008710",7586,"LINS1","lines homolog 1 [Source:HGNC Symbol;Acc:HGNC:30922]","GO:0050890(cognition)","NA",{"v":2.5e-62,"d":"0.00"},1,"690,",0,{"v":-61.6,"d":"-61.60"},{"v":-60.1,"d":"-60.10"},6.62,"3' UTR",17,4847118,4855393,8276,1]
["chr17",16540155,16541474,1320,"ENSBGRG00000009001","ENSBGRT00000020029",321721,"AKAP13","A-kinase anchoring protein 13 [Source:HGNC Symbol;Acc:HGNC:371]","GO:0004691(cAMP-dependent protein kinase activity);GO:0005078(MAP-kinase scaffold activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005829(cytosol);GO:0005938(cell cortex);GO:0007186(G protein-coupled receptor signaling pathway);GO:0017048(Rho GTPase binding);GO:0030864(cortical actin cytoskeleton);GO:0035023(regulation of Rho protein signal transduction);GO:0035025(positive regulation of Rho protein signal transduction);GO:0035556(intracellular signal transduction);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0051018(protein kinase A binding);GO:0060090(molecular adaptor activity);GO:0071875(adrenergic receptor signaling pathway)","04928(Parathyroid hormone synthesis, secretion and action);05163(Human cytomegalovirus infection)",{"v":7.4e-05,"d":"0.00"},2,"32,208,","0,1112",-4.13,-3.44,1.62,"Exon (ENSBGRT00000020029/ENSBGRG00000009001, exon 26 of 37)",17,16218434,16560781,342348,1]
["chr17",23209516,23209934,419,"ENSBGRG00000011208","ENSBGRT00000020408",15788,"ZNF592","zinc finger protein 592 [Source:HGNC Symbol;Acc:HGNC:28986]","GO:0003676(nucleic acid binding)","NA",{"v":1.3E-14,"d":"0.00"},1,"419,",0,{"v":-13.9,"d":"-13.90"},-13,3.29,"Exon (ENSBGRT00000020408/ENSBGRG00000011208, exon 4 of 12)",17,23193728,23240930,47203,1]
["chr17",26276304,26290093,13790,"ENSBGRG00000017947","ENSBGRT00000033868",0,"MORF4L1","mortality factor 4 like 1 [Source:HGNC Symbol;Acc:HGNC:16989]","GO:0000724(double-strand break repair via homologous recombination);GO:0005634(nucleus);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-templated);GO:0016575(histone deacetylation);GO:0016580(Sin3 complex);GO:0016607(nuclear speck);GO:0035267(NuA4 histone acetyltransferase complex);GO:0043967(histone H4 acetylation);GO:0043968(histone H2A acetylation);GO:0047485(protein N-terminus binding)","NA",{"v":3.2e-95,"d":"0.00"},9,"40,47,68,117,87,81,26,89,66,","0,4073,5944,8777,10182,10625,12244,12705,13724",{"v":-94.5,"d":"-94.50"},{"v":-92.8,"d":"-92.80"},1.84,"Exon (ENSBGRT00000033868/ENSBGRG00000017947, exon 1 of 9)",17,26276304,26291201,14898,1]
["chr17",29163226,29163375,150,"ENSBGRG00000010998","ENSBGRT00000020100",45778,"KLF13","Kruppel like factor 13 [Source:HGNC Symbol;Acc:HGNC:13672]","GO:0003676(nucleic acid binding);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.044,"d":"0.04"},1,"150,",0,-1.36,{"v":-0.862,"d":"-0.86"},1.88,"3' UTR",17,29117448,29163375,45928,1]
["chr17",34667936,34668233,298,"ENSBGRG00000023187","ENSBGRT00000042860",28513,"HMG20A","high mobility group 20A [Source:HGNC Symbol;Acc:HGNC:5001]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005634(nucleus);GO:0033234(negative regulation of protein sumoylation);GO:0042802(identical protein binding);GO:0045665(negative regulation of neuron differentiation)","NA",{"v":1.3E-14,"d":"0.00"},1,"298,",0,{"v":-13.9,"d":"-13.90"},{"v":-12.9,"d":"-12.90"},2.59,"3' UTR",17,34639423,34668888,29466,1]
["chr17",36398955,36400148,1194,"ENSBGRG00000004203","ENSBGRT00000007792",25243,"SEMA7A","semaphorin 7A (John Milton Hagen blood group) [Source:HGNC Symbol;Acc:HGNC:10741]","GO:0001934(positive regulation of protein phosphorylation);GO:0005178(integrin binding);GO:0005515(protein binding);GO:0007229(integrin-mediated signaling pathway);GO:0009897(external side of plasma membrane);GO:0021988(olfactory lobe development);GO:0030215(semaphorin receptor binding);GO:0031175(neuron projection development);GO:0045773(positive regulation of axon extension);GO:0048675(axon extension);GO:0050727(regulation of inflammatory response);GO:0060907(positive regulation of macrophage cytokine production);GO:0070374(positive regulation of ERK1 and ERK2 cascade)","04360(Axon guidance)",{"v":1e-101,"d":"0.00"},1,"1194,",0,-101,{"v":-98.9,"d":"-98.90"},{"v":25.1,"d":"25.10"},"3' UTR",17,36373712,36400148,26437,1]
["chr17",46133411,46133591,181,"ENSBGRG00000008525","ENSBGRT00000015525",425310,"AKAP6","A-kinase anchoring protein 6 [Source:HGNC Symbol;Acc:HGNC:376]","GO:0005515(protein binding);GO:0005635(nuclear envelope);GO:0016529(sarcoplasmic reticulum);GO:0031965(nuclear membrane);GO:0034704(calcium channel complex);GO:0044325(ion channel binding);GO:0048471(perinuclear region of cytoplasm);GO:0060306(regulation of membrane repolarization);GO:0071320(cellular response to cAMP);GO:1901381(positive regulation of potassium ion transmembrane transport);GO:1902261(positive regulation of delayed rectifier potassium channel activity)","NA",{"v":0.00065,"d":"0.00"},1,"181,",0,-3.19,-2.55,8.02,"Exon (ENSBGRT00000015525/ENSBGRG00000008525, exon 14 of 15)",17,45708101,46136474,428374,1]
["chr17",50744288,50846947,102660,"ENSBGRG00000004103","ENSBGRT00000007794",0,"SLC25A21","solute carrier family 25 member 21 [Source:HGNC Symbol;Acc:HGNC:14411]","GO:0005347(ATP transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":0.00051,"d":"0.00"},4,"3,138,79,20,","0,92320,93029,102640",-3.29,-2.65,5.01,"5' UTR",17,50173613,50746932,573320,2]
["chr17",58783082,58783441,360,"ENSBGRG00000007492","ENSBGRT00000014104",270,"TOGARAM1","TOG array regulator of axonemal microtubules 1 [Source:HGNC Symbol;Acc:HGNC:19959]","GO:0005874(microtubule);GO:0005929(cilium);GO:0031116(positive regulation of microtubule polymerization);GO:0036064(ciliary basal body)","NA",{"v":1e-05,"d":"0.00"},1,"360,",0,-5,-4.28,3.74,"Exon (ENSBGRT00000014104/ENSBGRG00000007492, exon 1 of 21)",17,58782812,58865502,82691,1]
["chr17",61127268,61129119,1852,"ENSBGRG00000019652","ENSBGRT00000036105",29612,"CPSF2","cleavage and polyadenylation specific factor 2 [Source:HGNC Symbol;Acc:HGNC:2325]","GO:0005847(mRNA cleavage and polyadenylation specificity factor complex);GO:0006378(mRNA polyadenylation);GO:0006379(mRNA cleavage);GO:0006398(mRNA 3'-end processing by stem-loop binding and cleavage)","03015(mRNA surveillance pathway)",{"v":1.3E-11,"d":"0.00"},3,"71,135,93,","0,1236,1759",{"v":-10.9,"d":"-10.90"},-9.99,3.43,"Exon (ENSBGRT00000036105/ENSBGRG00000019652, exon 14 of 16)",17,61097656,61129119,31464,1]
["chr17",65033163,65033312,150,"ENSBGRG00000017094","ENSBGRT00000031386",10351,"GLRX5","glutaredoxin 5 [Source:HGNC Symbol;Acc:HGNC:20134]","GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0009055(electron transfer activity);GO:0009249(protein lipoylation);GO:0015035(protein disulfide oxidoreductase activity);GO:0045454(cell redox homeostasis)","NA",{"v":8.1e-07,"d":"0.00"},1,"150,",0,-6.09,-5.33,1.77,"Exon (ENSBGRT00000031386/ENSBGRG00000017094, exon 2 of 2)",17,65022812,65033312,10501,1]
["chr17",69629024,69645256,16233,"ENSBGRG00000019579","ENSBGRT00000036066",179,"ENSBGRG00000019579","NA","GO:0006357(regulation of transcription by RNA polymerase II);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0042025(host cell nucleus)","NA",{"v":7.9e-06,"d":"0.00"},3,"3,72,224,","0,14807,16009",{"v":-5.1,"d":"-5.10"},-4.38,2.44,"5' UTR",17,69628845,69660398,31554,1]
["chr17",72844911,72846010,1100,"ENSBGRG00000016292","ENSBGRT00000031008",93753,"TECPR2","tectonin beta-propeller repeat containing 2 [Source:HGNC Symbol;Acc:HGNC:19957]","GO:0005515(protein binding);GO:0032527(protein exit from endoplasmic reticulum)","NA",{"v":0.00036,"d":"0.00"},3,"80,152,158,","0,109,942",-3.44,-2.79,8.02,"3' UTR",17,72751158,72844990,93833,1]
["chr17",75128201,75129278,1078,"ENSBGRG00000005179","ENSBGRT00000009598",51955,"ENSBGRG00000005179","NA","GO:0003779(actin binding);GO:0016043(cellular component organization);GO:0017048(Rho GTPase binding);GO:0030036(actin cytoskeleton organization)","04810(Regulation of actin cytoskeleton)",{"v":1.6e-23,"d":"0.00"},1,"1078,",0,{"v":-22.8,"d":"-22.80"},{"v":-21.7,"d":"-21.70"},5.38,"3' UTR",17,75076246,75161680,85435,1]
["chr17",4221840,4222530,691,"ENSBGRG00000004461","ENSBGRT00000008226",138202,"LRRK1","leucine rich repeat kinase 1 [Source:HGNC Symbol;Acc:HGNC:18608]","GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0036035(osteoclast development);GO:0042802(identical protein binding);GO:0045453(bone resorption);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050732(negative regulation of peptidyl-tyrosine phosphorylation);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1902533(positive regulation of intracellular signal transduction)","NA",{"v":2e-39,"d":"0.00"},1,"691,",0,{"v":-38.7,"d":"-38.70"},{"v":-37.4,"d":"-37.40"},4.69,"Exon (ENSBGRT00000008226/ENSBGRG00000004461, exon 32 of 34)",17,4217990,4360732,142743,2]
["chr17",9786814,9791150,4337,"ENSBGRG00000006400","ENSBGRT00000011809",0,"NR2F2","nuclear receptor subfamily 2 group F member 2 [Source:HGNC Symbol;Acc:HGNC:7976]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001701(in utero embryonic development);GO:0001764(neuron migration);GO:0001893(maternal placenta development);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001945(lymph vessel development);GO:0001972(retinoic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007519(skeletal muscle tissue development);GO:0008270(zinc ion binding);GO:0009566(fertilization);GO:0009952(anterior/posterior pattern specification);GO:0009956(radial pattern formation);GO:0010596(negative regulation of endothelial cell migration);GO:0030900(forebrain development);GO:0042025(host cell nucleus);GO:0042803(protein homodimerization activity);GO:0043565(sequence-specific DNA binding);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0048514(blood vessel morphogenesis);GO:0060173(limb development);GO:0060674(placenta blood vessel development);GO:0060707(trophoblast giant cell differentiation);GO:0060849(regulation of transcription involved in lymphatic endothelial cell fate commitment)","NA",{"v":6.3e-33,"d":"0.00"},3,"103,281,442,","0,868,3895",{"v":-32.2,"d":"-32.20"},-31,{"v":4.4,"d":"4.40"},"Exon (ENSBGRT00000011809/ENSBGRG00000006400, exon 1 of 4)",17,9783476,9787945,4470,2]
["chr17",16612284,16612973,690,"ENSBGRG00000011800","ENSBGRT00000021542",782,"KLHL25","kelch like family member 25 [Source:HGNC Symbol;Acc:HGNC:25732]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006446(regulation of translational initiation);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0031463(Cul3-RING ubiquitin ligase complex)","NA",{"v":0.00026,"d":"0.00"},1,"690,",0,-3.58,-2.92,5.26,"Exon (ENSBGRT00000021542/ENSBGRG00000011800, exon 2 of 2)",17,16611715,16613755,2041,2]
["chr17",21753433,21753700,268,"ENSBGRG00000005945","ENSBGRT00000010950",0,"MESP1","mesoderm posterior bHLH transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:29658]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001947(heart looping);GO:0003007(heart morphogenesis);GO:0003139(secondary heart field specification);GO:0003143(embryonic heart tube morphogenesis);GO:0003210(cardiac atrium formation);GO:0003211(cardiac ventricle formation);GO:0003236(sinus venosus morphogenesis);GO:0003241(growth involved in heart morphogenesis);GO:0003259(cardioblast anterior-lateral migration);GO:0003260(cardioblast migration);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0007369(gastrulation);GO:0008078(mesodermal cell migration);GO:0010467(gene expression);GO:0022008(neurogenesis);GO:0023019(signal transduction involved in regulation of gene expression);GO:0035481(positive regulation of Notch signaling pathway involved in heart induction);GO:0042662(negative regulation of mesodermal cell fate specification);GO:0042664(negative regulation of endodermal cell fate specification);GO:0045446(endothelial cell differentiation);GO:0045747(positive regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0048368(lateral mesoderm development);GO:0051155(positive regulation of striated muscle cell differentiation);GO:0055007(cardiac muscle cell differentiation);GO:0060913(cardiac cell fate determination);GO:0060921(sinoatrial node cell differentiation);GO:0060947(cardiac vascular smooth muscle cell differentiation);GO:0060975(cardioblast migration to the midline involved in heart field formation);GO:0070368(positive regulation of hepatocyte differentiation);GO:0090082(positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway)","NA",{"v":0.0017,"d":"0.00"},1,"268,",0,-2.77,-2.16,12,"Exon (ENSBGRT00000010950/ENSBGRG00000005945, exon 1 of 2)",17,21752017,21753700,1684,2]
["chr17",22981788,22982108,321,"ENSBGRG00000010283","ENSBGRT00000018829",6461,"ENSBGRG00000010283","NA","NA","04520(Adherens junction);04810(Regulation of actin cytoskeleton);05205(Proteoglycans in cancer)",{"v":7.1e-06,"d":"0.00"},1,"321,",0,-5.15,-4.43,11,"Exon (ENSBGRT00000018904/ENSBGRG00000010300, exon 2 of 2)",17,22981331,22988569,7239,2]
["chr17",25173120,25183776,10657,"ENSBGRG00000015743","ENSBGRT00000030029",303634,"ADAMTSL3","ADAMTS like 3 [Source:HGNC Symbol;Acc:HGNC:14633]","GO:0008233(peptidase activity);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":6.3e-06,"d":"0.00"},2,"29,901,","0,9756",{"v":-5.2,"d":"-5.20"},-4.48,4.01,"Exon (ENSBGRT00000030029/ENSBGRG00000015743, exon 21 of 29)",17,25096097,25487410,391314,2]
["chr17",32882319,32882676,358,"ENSBGRG00000019896","ENSBGRT00000036556",14959,"CHRNB4","cholinergic receptor nicotinic beta 4 subunit [Source:HGNC Symbol;Acc:HGNC:1964]","GO:0001508(action potential);GO:0004888(transmembrane signaling receptor activity);GO:0005216(ion channel activity);GO:0005230(extracellular ligand-gated ion channel activity);GO:0005892(acetylcholine-gated channel complex);GO:0006811(ion transport);GO:0006939(smooth muscle contraction);GO:0006940(regulation of smooth muscle contraction);GO:0007165(signal transduction);GO:0007626(locomotory behavior);GO:0015464(acetylcholine receptor activity);GO:0016021(integral component of membrane);GO:0022848(acetylcholine-gated cation-selective channel activity);GO:0034220(ion transmembrane transport);GO:0035094(response to nicotine);GO:0035095(behavioral response to nicotine);GO:0042391(regulation of membrane potential);GO:0045211(postsynaptic membrane);GO:0051971(positive regulation of transmission of nerve impulse);GO:0060084(synaptic transmission involved in micturition)","04080(Neuroactive ligand-receptor interaction);04725(Cholinergic synapse)",{"v":2E-3,"d":"0.00"},1,"358,",0,{"v":-2.7,"d":"-2.70"},-2.09,7.02,"Exon (ENSBGRT00000036556/ENSBGRG00000019896, exon 5 of 6)",17,32875159,32897635,22477,2]
["chr17",35495924,35496278,355,"ENSBGRG00000024871","ENSBGRT00000046021",220,"ENSBGRG00000024871","NA","NA","NA",{"v":5.1e-07,"d":"0.00"},1,"355,",0,-6.29,-5.53,3.68,"Exon (ENSBGRT00000046021/ENSBGRG00000024871, exon 1 of 7)",17,35493838,35496498,2661,2]
["chr17",36881990,36882049,60,"ENSBGRG00000005233","ENSBGRT00000009649",0,"LOXL1","lysyl oxidase like 1 [Source:HGNC Symbol;Acc:HGNC:6665]","GO:0005507(copper ion binding);GO:0016641(oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor);GO:0055114(oxidation-reduction process)","NA",0.01,1,"60,",0,-2,-1.45,1.91,"Exon (ENSBGRT00000009649/ENSBGRG00000005233, exon 1 of 7)",17,36855873,36882049,26177,2]
["chr17",44534062,44534767,706,"ENSBGRG00000007751","ENSBGRT00000014266",38019,"HECTD1","HECT domain E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:20157]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0016567(protein ubiquitination);GO:0046872(metal ion binding)","NA",{"v":0.014,"d":"0.01"},2,"49,161,","0,545",-1.84,{"v":-1.3,"d":"-1.30"},2.45,"Exon (ENSBGRT00000014266/ENSBGRG00000007751, exon 12 of 43)",17,44490968,44572786,81819,2]
["chr17",52823645,52828104,4460,"ENSBGRG00000007011","ENSBGRT00000012939",19866,"FBXO33","F-box protein 33 [Source:HGNC Symbol;Acc:HGNC:19833]","GO:0005515(protein binding);GO:0019005(SCF ubiquitin ligase complex);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process)","NA",{"v":1.6e-29,"d":"0.00"},3,"327,686,4,","0,2195,4456",{"v":-28.8,"d":"-28.80"},{"v":-27.6,"d":"-27.60"},{"v":12.5,"d":"12.50"},"3' UTR",17,52822927,52847970,25044,2]
["chr17",59298460,59302507,4048,"ENSBGRG00000010090","ENSBGRT00000018725",37990,"TP53BP1","tumor protein p53 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:11999]","GO:0000776(kinetochore);GO:0000781(chromosome, telomeric region);GO:0000784(nuclear chromosome, telomeric region);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0002039(p53 binding);GO:0003684(damaged DNA binding);GO:0003712(transcription coregulator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005657(replication fork);GO:0005737(cytoplasm);GO:0006281(DNA repair);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0006974(cellular response to DNA damage stimulus);GO:0016604(nuclear body);GO:0035064(methylated histone binding);GO:0035861(site of double-strand break);GO:0042162(telomeric DNA binding);GO:0043565(sequence-specific DNA binding);GO:0045830(positive regulation of isotype switching);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051260(protein homooligomerization);GO:0061649(ubiquitin modification-dependent histone binding);GO:1990391(DNA repair complex);GO:2000042(negative regulation of double-strand break repair via homologous recombination)","04621(NOD-like receptor signaling pathway)",{"v":1e-115,"d":"0.00"},2,"130,411,","0,3637",-115,-114,4.19,"Exon (ENSBGRT00000018725/ENSBGRG00000010090, exon 12 of 23)",17,59274343,59340497,66155,2]
["chr17",60258541,60259469,929,"ENSBGRG00000015120","ENSBGRT00000028236",19346,"ENSBGRG00000015120","NA","GO:0016055(Wnt signaling pathway)","NA",{"v":2E-12,"d":"0.00"},1,"929,",0,{"v":-11.7,"d":"-11.70"},{"v":-10.8,"d":"-10.80"},7.47,"3' UTR",17,60257313,60278815,21503,2]
["chr17",61739418,61739746,329,"ENSBGRG00000020111","ENSBGRT00000037081",39705,"LGMN","legumain [Source:HGNC Symbol;Acc:HGNC:9472]","GO:0003014(renal system process);GO:0004197(cysteine-type endopeptidase activity);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005770(late endosome);GO:0006508(proteolysis);GO:0007613(memory);GO:0008233(peptidase activity);GO:0008284(positive regulation of cell population proliferation);GO:0008306(associative learning);GO:0010447(response to acidic pH);GO:0010629(negative regulation of gene expression);GO:0032801(receptor catabolic process);GO:0035729(cellular response to hepatocyte growth factor stimulus);GO:0040015(negative regulation of multicellular organism growth);GO:0043524(negative regulation of neuron apoptotic process);GO:0045177(apical part of cell);GO:0045931(positive regulation of mitotic cell cycle);GO:0048471(perinuclear region of cytoplasm);GO:0051603(proteolysis involved in cellular protein catabolic process);GO:0071277(cellular response to calcium ion);GO:0090026(positive regulation of monocyte chemotaxis);GO:0097061(dendritic spine organization);GO:0097202(activation of cysteine-type endopeptidase activity);GO:0097264(self proteolysis);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1901185(negative regulation of ERBB signaling pathway);GO:1904646(cellular response to amyloid-beta);GO:2001028(positive regulation of endothelial cell chemotaxis)","04142(Lysosome);04612(Antigen processing and presentation)",{"v":1E-181,"d":"0.00"},1,"329,",0,-181,-178,3.61,"3' UTR",17,61739418,61779451,40034,2]
["chr17",64999352,64999592,241,"ENSBGRG00000016809","ENSBGRT00000030890",0,"SYNE3","spectrin repeat containing nuclear envelope family member 3 [Source:HGNC Symbol;Acc:HGNC:19861]","GO:0005635(nuclear envelope);GO:0005640(nuclear outer membrane);GO:0007010(cytoskeleton organization);GO:0008092(cytoskeletal protein binding);GO:0008360(regulation of cell shape);GO:0016021(integral component of membrane);GO:0031965(nuclear membrane);GO:0034993(meiotic nuclear membrane microtubule tethering complex);GO:0051015(actin filament binding);GO:0090150(establishment of protein localization to membrane);GO:0090286(cytoskeletal anchoring at nuclear membrane)","NA",{"v":0.026,"d":"0.03"},1,"241,",0,-1.59,-1.07,4.01,"Exon (ENSBGRT00000030890/ENSBGRG00000016809, exon 1 of 20)",17,64886235,64999592,113358,2]
["chr17",72623810,72625189,1380,"ENSBGRG00000015340","ENSBGRT00000028174",3663,"ENSBGRG00000015340","NA","NA","NA",{"v":7.6e-05,"d":"0.00"},1,"1380,",0,-4.12,-3.43,15,"3' UTR",17,72623331,72628852,5522,2]
["chr17",75460574,75463123,2550,"ENSBGRG00000006002","ENSBGRT00000011697",21956,"JAG2","jagged canonical Notch ligand 2 [Source:HGNC Symbol;Acc:HGNC:6189]","GO:0001501(skeletal system development);GO:0001701(in utero embryonic development);GO:0003016(respiratory system process);GO:0005112(Notch binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0007154(cell communication);GO:0007219(Notch signaling pathway);GO:0007275(multicellular organism development);GO:0007283(spermatogenesis);GO:0008083(growth factor activity);GO:0009912(auditory receptor cell fate commitment);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016331(morphogenesis of embryonic epithelium);GO:0030154(cell differentiation);GO:0030155(regulation of cell adhesion);GO:0030217(T cell differentiation);GO:0042127(regulation of cell population proliferation);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042492(gamma-delta T cell differentiation);GO:0045061(thymic T cell selection);GO:0045747(positive regulation of Notch signaling pathway);GO:1990134(epithelial cell apoptotic process involved in palatal shelf morphogenesis)","04330(Notch signaling pathway);04658(Th1 and Th2 cell differentiation);05200(Pathways in cancer);05224(Breast cancer);01522(Endocrine resistance)",{"v":4e-20,"d":"0.00"},2,"1176,23,","0,2527",{"v":-19.4,"d":"-19.40"},{"v":-18.4,"d":"-18.40"},5.31,"3' UTR",17,75460274,75485079,24806,2]
["chr18",1041804,1041864,61,"ENSBGRG00000009748","ENSBGRT00000017885",21034,"ENSBGRG00000009748","NA","NA","NA",{"v":1.3E-23,"d":"0.00"},1,"61,",0,{"v":-22.9,"d":"-22.90"},{"v":-21.8,"d":"-21.80"},2.46,"Exon (ENSBGRT00000017885/ENSBGRG00000009748, exon 2 of 2)",18,1020770,1043300,22531,1]
["chr18",20081230,20081408,179,"ENSBGRG00000004183","ENSBGRT00000007734",2626,"THEM6","thioesterase superfamily member 6 [Source:HGNC Symbol;Acc:HGNC:29656]","NA","NA",{"v":0.011,"d":"0.01"},1,"179,",0,-1.96,{"v":-1.4,"d":"-1.40"},8.02,"3' UTR",18,20078604,20081585,2982,1]
["chr18",20718677,20719925,1249,"ENSBGRG00000005570","ENSBGRT00000010288",0,"ENSBGRG00000005570","NA","NA","05168(Herpes simplex infection)",{"v":2.5e-49,"d":"0.00"},1,"1249,",0,{"v":-48.6,"d":"-48.60"},{"v":-47.3,"d":"-47.30"},{"v":11.6,"d":"11.60"},"Exon (ENSBGRT00000010307/ENSBGRG00000005583, exon 1 of 1)",18,20708365,20719301,10937,2]
["chr18",21161148,21161419,272,"ENSBGRG00000011912","ENSBGRT00000022412",6049,"ENSBGRG00000011912","NA","NA","NA",{"v":5.6e-10,"d":"0.00"},3,"157,13,11,","0,240,261",-9.25,-8.41,1.73,"Exon (ENSBGRT00000022412/ENSBGRG00000011912, exon 20 of 35)",18,21155099,21163594,8496,1]
["chr18",21697770,21699055,1286,"ENSBGRG00000020366","ENSBGRT00000038772",0,"ENSBGRG00000020366","NA","GO:0003676(nucleic acid binding)","NA",{"v":1.6E-65,"d":"0.00"},2,"209,1075,","0,211",{"v":-64.8,"d":"-64.80"},{"v":-63.2,"d":"-63.20"},8.52,"Exon (ENSBGRT00000037719/ENSBGRG00000020366, exon 3 of 6)",18,21697981,21720714,22734,1]
["chr18",37755512,37842851,87340,"ENSBGRG00000004195","ENSBGRT00000008029",102236,"EIF3H","eukaryotic translation initiation factor 3 subunit H [Source:HGNC Symbol;Acc:HGNC:3273]","GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005852(eukaryotic translation initiation factor 3 complex);GO:0006413(translational initiation);GO:0071541(eukaryotic translation initiation factor 3 complex, eIF3m)","03013(RNA transport);05162(Measles)",0,4,"82,238,5,4,","0,1788,79903,87336",-1010,"-Inf",3.61,"3' UTR",18,37653276,37757537,104262,1]
["chr18",54917688,54921737,4050,"ENSBGRG00000009704","ENSBGRT00000017842",30,"YWHAZ","tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta [Source:HGNC Symbol;Acc:HGNC:12855]","GO:0005634(nucleus);GO:0006468(protein phosphorylation);GO:0006605(protein targeting);GO:0007165(signal transduction);GO:0008039(synaptic target recognition);GO:0008134(transcription factor binding);GO:0010941(regulation of cell death);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0031625(ubiquitin protein ligase binding);GO:0042802(identical protein binding);GO:0044325(ion channel binding);GO:0051683(establishment of Golgi localization);GO:0070372(regulation of ERK1 and ERK2 cascade);GO:0090128(regulation of synapse maturation);GO:0090168(Golgi reassembly);GO:0098686(hippocampal mossy fiber to CA3 synapse);GO:0098978(glutamatergic synapse)","04390(Hippo signaling pathway);04151(PI3K-Akt signaling pathway);04110(Cell cycle);04114(Oocyte meiosis);05203(Viral carcinogenesis);05130(Pathogenic Escherichia coli infection);05161(Hepatitis B);05169(Epstein-Barr virus infection)",{"v":1.3E-39,"d":"0.00"},2,"153,206,","0,3844",{"v":-38.9,"d":"-38.90"},{"v":-37.6,"d":"-37.60"},2.42,"5' UTR",18,54917658,54953575,35918,1]
["chr18",60071046,60075944,4899,"ENSBGRG00000005916","ENSBGRT00000010894",0,"ENSBGRG00000005916","NA","GO:0005750(mitochondrial respiratory chain complex III);GO:0006122(mitochondrial electron transport, ubiquinol to cytochrome c)","00190(Oxidative phosphorylation);04260(Cardiac muscle contraction);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":0.00079,"d":"0.00"},4,"19,72,167,66,","0,2760,3667,4833",{"v":-3.1,"d":"-3.10"},-2.47,3.13,"Exon (ENSBGRT00000010894/ENSBGRG00000005916, exon 1 of 4)",18,60071046,60076921,5876,1]
["chr18",62369119,62371504,2386,"ENSBGRG00000008787","ENSBGRT00000016085",57447,"GEM","GTP binding protein overexpressed in skeletal muscle [Source:HGNC Symbol;Acc:HGNC:4234]","GO:0000278(mitotic cell cycle);GO:0000287(magnesium ion binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0007165(signal transduction);GO:0009898(cytoplasmic side of plasma membrane);GO:0016020(membrane);GO:0019003(GDP binding);GO:0030496(midbody);GO:0051233(spindle midzone);GO:0051276(chromosome organization);GO:0051310(metaphase plate congression);GO:0072686(mitotic spindle);GO:1901842(negative regulation of high voltage-gated calcium channel activity)","NA",0,2,"21,902,","0,1484",-813,"-Inf",4.38,"3' UTR",18,62311672,62371980,60309,1]
["chr18",3462968,3474568,11601,"ENSBGRG00000014056","ENSBGRT00000026553",76856,"FER1L6","fer-1 like family member 6 [Source:HGNC Symbol;Acc:HGNC:28065]","GO:0009617(response to bacterium);GO:0016021(integral component of membrane)","NA",{"v":0.032,"d":"0.03"},4,"133,162,111,43,","0,1444,1871,11558",-1.49,{"v":-0.981,"d":"-0.98"},3.01,"Exon (ENSBGRT00000026553/ENSBGRG00000014056, exon 21 of 40)",18,3409050,3551424,142375,2]
["chr18",17029904,17071082,41179,"ENSBGRG00000024175","ENSBGRT00000044651",0,"U6","U6 spliceosomal RNA [Source:RFAM;Acc:RF00026]","NA","NA",{"v":5e-20,"d":"0.00"},15,"76,45,36,72,54,54,54,45,54,54,54,54,54,54,48,","0,1923,2993,3184,4923,6905,8282,9053,11770,15307,19888,24443,26243,28241,41131",{"v":-19.3,"d":"-19.30"},{"v":-18.3,"d":"-18.30"},5.26,"Exon (ENSBGRT00000044563/ENSBGRG00000024054, exon 47 of 65)",18,17070412,17070518,107,2]
["chr18",18492524,18496392,3869,"ENSBGRG00000024620","ENSBGRT00000046157",151434,"PTK2","protein tyrosine kinase 2 [Source:HGNC Symbol;Acc:HGNC:9611]","GO:0000226(microtubule cytoskeleton organization);GO:0001525(angiogenesis);GO:0001568(blood vessel development);GO:0001570(vasculogenesis);GO:0001725(stress fiber);GO:0001764(neuron migration);GO:0001932(regulation of protein phosphorylation);GO:0001934(positive regulation of protein phosphorylation);GO:0003779(actin binding);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005178(integrin binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006468(protein phosphorylation);GO:0007097(nuclear migration);GO:0007172(signal complex assembly);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0008360(regulation of cell shape);GO:0008432(JUN kinase binding);GO:0010507(negative regulation of autophagy);GO:0010613(positive regulation of cardiac muscle hypertrophy);GO:0010632(regulation of epithelial cell migration);GO:0010759(positive regulation of macrophage chemotaxis);GO:0010763(positive regulation of fibroblast migration);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016324(apical plasma membrane);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019901(protein kinase binding);GO:0019903(protein phosphatase binding);GO:0021955(central nervous system neuron axonogenesis);GO:0022408(negative regulation of cell-cell adhesion);GO:0030027(lamellipodium);GO:0030198(extracellular matrix organization);GO:0030335(positive regulation of cell migration);GO:0033628(regulation of cell adhesion mediated by integrin);GO:0036064(ciliary basal body);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0042127(regulation of cell population proliferation);GO:0042169(SH2 domain binding);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043542(endothelial cell migration);GO:0045667(regulation of osteoblast differentiation);GO:0045860(positive regulation of protein kinase activity);GO:0046621(negative regulation of organ growth);GO:0046777(protein autophosphorylation);GO:0048013(ephrin receptor signaling pathway);GO:0050771(negative regulation of axonogenesis);GO:0051893(regulation of focal adhesion assembly);GO:0051897(positive regulation of protein kinase B signaling);GO:0051964(negative regulation of synapse assembly);GO:0060396(growth hormone receptor signaling pathway);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:0090303(positive regulation of wound healing);GO:0120041(positive regulation of macrophage proliferation);GO:1900024(regulation of substrate adhesion-dependent cell spreading);GO:2000060(positive regulation of ubiquitin-dependent protein catabolic process);GO:2000811(negative regulation of anoikis)","04012(ErbB signaling pathway);04370(VEGF signaling pathway);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04670(Leukocyte transendothelial migration);04062(Chemokine signaling pathway);04360(Axon guidance);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05205(Proteoglycans in cancer);05222(Small cell lung cancer);05418(Fluid shear stress and atherosclerosis);05100(Bacterial invasion of epithelial cells);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05146(Amoebiasis);01522(Endocrine resistance)",{"v":1.3E-15,"d":"0.00"},2,"183,56,","0,3813",{"v":-14.9,"d":"-14.90"},{"v":-13.9,"d":"-13.90"},2.39,"Exon (ENSBGRT00000046157/ENSBGRG00000024620, exon 31 of 32)",18,18492494,18647826,155333,2]
["chr18",20718174,20718263,90,"ENSBGRG00000005570","ENSBGRT00000010288",1038,"ENSBGRG00000005570","NA","NA","05168(Herpes simplex infection)",{"v":0.00072,"d":"0.00"},1,"90,",0,-3.14,{"v":-2.5,"d":"-2.50"},2.61,"Exon (ENSBGRT00000010307/ENSBGRG00000005583, exon 1 of 1)",18,20708365,20719301,10937,2]
["chr18",20982596,20983281,686,"ENSBGRG00000007959","ENSBGRT00000018532",11681,"PLEC","plectin [Source:HGNC Symbol;Acc:HGNC:9069]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005903(brush border);GO:0005925(focal adhesion);GO:0008092(cytoskeletal protein binding);GO:0030056(hemidesmosome);GO:0030506(ankyrin binding);GO:0031581(hemidesmosome assembly);GO:0042383(sarcolemma);GO:0043292(contractile fiber);GO:0045104(intermediate filament cytoskeleton organization);GO:0045111(intermediate filament cytoskeleton)","NA",{"v":1.4E-5,"d":"0.00"},3,"48,357,106,","0,123,580",-4.86,-4.14,3.07,"Exon (ENSBGRT00000018532/ENSBGRG00000007959, exon 26 of 34)",18,20970458,20994962,24505,2]
["chr18",21425553,21425672,120,"ENSBGRG00000017771","ENSBGRT00000032592",0,"TONSL","tonsoku like, DNA repair protein [Source:HGNC Symbol;Acc:HGNC:7801]","GO:0000724(double-strand break repair via homologous recombination);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005662(DNA replication factor A complex);GO:0016604(nuclear body);GO:0031297(replication fork processing);GO:0035101(FACT complex);GO:0042393(histone binding);GO:0042555(MCM complex);GO:0043596(nuclear replication fork)","NA",{"v":0.026,"d":"0.03"},1,"120,",0,-1.59,-1.07,3.01,"Exon (ENSBGRT00000032592/ENSBGRG00000017771, exon 1 of 26)",18,21412753,21425672,12920,2]
["chr18",25669539,25670139,601,"ENSBGRG00000014160","ENSBGRT00000026205",2000,"ENSBGRG00000014160","NA","GO:0000463(maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0003735(structural constituent of ribosome);GO:0022625(cytosolic large ribosomal subunit)","03010(Ribosome)",0,2,"209,61,","0,540",-1480,"-Inf",2.37,"Exon (ENSBGRT00000026205/ENSBGRG00000014160, exon 5 of 6)",18,25669539,25672139,2601,2]
["chr18",33536279,33536369,91,"ENSBGRG00000018852","ENSBGRT00000034802",280160,"ZNF704","zinc finger protein 704 [Source:HGNC Symbol;Acc:HGNC:32291]","GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.048,"d":"0.05"},1,"91,",0,-1.32,{"v":-0.827,"d":"-0.83"},2.67,"Exon (ENSBGRT00000034802/ENSBGRG00000018852, exon 11 of 11)",18,33536279,33816529,280251,2]
["chr18",55649399,55650539,1141,"ENSBGRG00000010255","ENSBGRT00000018792",0,"ENSBGRG00000010255","NA","NA","NA",{"v":0.00013,"d":"0.00"},2,"571,20,","0,1121",-3.88,-3.21,5.01,"Exon (ENSBGRT00000018792/ENSBGRG00000010255, exon 1 of 2)",18,55649822,55653033,3212,1]
["chr18",62683274,62687766,4493,"ENSBGRG00000009030","ENSBGRT00000016822",0,"PDP1","pyruvate dehyrogenase phosphatase catalytic subunit 1 [Source:HGNC Symbol;Acc:HGNC:9279]","GO:0003824(catalytic activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0035970(peptidyl-threonine dephosphorylation);GO:0043169(cation binding)","NA",{"v":4e-30,"d":"0.00"},4,"397,17,46,19,","0,594,855,4474",{"v":-29.4,"d":"-29.40"},{"v":-28.3,"d":"-28.30"},7.79,"Exon (ENSBGRT00000016822/ENSBGRG00000009030, exon 1 of 4)",18,62679759,62683884,4126,2]
["chr18",66608176,66609235,1060,"ENSBGRG00000012340","ENSBGRT00000022775",40435,"RIPK2","receptor interacting serine/threonine kinase 2 [Source:HGNC Symbol;Acc:HGNC:10020]","GO:0001961(positive regulation of cytokine-mediated signaling pathway);GO:0002250(adaptive immune response);GO:0002827(positive regulation of T-helper 1 type immune response);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005102(signaling receptor binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0010800(positive regulation of peptidyl-threonine phosphorylation);GO:0010942(positive regulation of cell death);GO:0030274(LIM domain binding);GO:0031398(positive regulation of protein ubiquitination);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0031982(vesicle);GO:0032092(positive regulation of protein binding);GO:0032722(positive regulation of chemokine production);GO:0032729(positive regulation of interferon-gamma production);GO:0032731(positive regulation of interleukin-1 beta production);GO:0032743(positive regulation of interleukin-2 production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0032991(protein-containing complex);GO:0033091(positive regulation of immature T cell proliferation);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034134(toll-like receptor 2 signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0042098(T cell proliferation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043330(response to exogenous dsRNA);GO:0045087(innate immune response);GO:0045627(positive regulation of T-helper 1 cell differentiation);GO:0046330(positive regulation of JNK cascade);GO:0046641(positive regulation of alpha-beta T cell proliferation);GO:0050700(CARD domain binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050830(defense response to Gram-positive bacterium);GO:0050852(T cell receptor signaling pathway);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070427(nucleotide-binding oligomerization domain containing 1 signaling pathway);GO:0070431(nucleotide-binding oligomerization domain containing 2 signaling pathway);GO:0070555(response to interleukin-1);GO:0070671(response to interleukin-12);GO:0070673(response to interleukin-18);GO:0071222(cellular response to lipopolysaccharide);GO:0071223(cellular response to lipoteichoic acid);GO:0071224(cellular response to peptidoglycan);GO:0071225(cellular response to muramyl dipeptide);GO:0089720(caspase binding);GO:0097202(activation of cysteine-type endopeptidase activity);GO:1904417(positive regulation of xenophagy)","04621(NOD-like receptor signaling pathway);04722(Neurotrophin signaling pathway);05152(Tuberculosis)",{"v":1e-229,"d":"0.00"},2,"381,124,","0,936",-229,-226,{"v":4.8,"d":"4.80"},"3' UTR",18,66608028,66649670,41643,2]
["chr19",1363948,1364278,331,"ENSBGRG00000018479","ENSBGRT00000034032",317225,"CEP112","centrosomal protein 112 [Source:HGNC Symbol;Acc:HGNC:28514]","GO:0005813(centrosome)","NA",{"v":3.5E-4,"d":"0.00"},1,"331,",0,-3.46,-2.81,7.02,"Exon (ENSBGRT00000034032/ENSBGRG00000018479, exon 23 of 26)",19,1046723,1396110,349388,1]
["chr19",7416857,7417096,240,"ENSBGRG00000012539","ENSBGRT00000022919",22351,"GPRC5C","G protein-coupled receptor class C group 5 member C [Source:HGNC Symbol;Acc:HGNC:13309]","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","NA",{"v":7.9e-27,"d":"0.00"},1,"240,",0,{"v":-26.1,"d":"-26.10"},-25,4.55,"3' UTR",19,7394506,7494428,99923,1]
["chr19",8246689,8247402,714,"ENSBGRG00000017681","ENSBGRT00000032431",4936,"MRPS7","mitochondrial ribosomal protein S7 [Source:HGNC Symbol;Acc:HGNC:14499]","GO:0005763(mitochondrial small ribosomal subunit);GO:0006412(translation)","03010(Ribosome)",{"v":7.9E-76,"d":"0.00"},1,"714,",0,{"v":-75.1,"d":"-75.10"},{"v":-73.5,"d":"-73.50"},7.16,"3' UTR",19,8241753,8247877,6125,1]
["chr19",9152125,9152274,150,"ENSBGRG00000024885","ENSBGRT00000045928",5086,"UBALD2","UBA like domain containing 2 [Source:HGNC Symbol;Acc:HGNC:28438]","GO:0005515(protein binding)","NA",{"v":7.9e-11,"d":"0.00"},1,"150,",0,{"v":-10.1,"d":"-10.10"},-9.26,4.46,"Exon (ENSBGRT00000045928/ENSBGRG00000024885, exon 3 of 3)",19,9147039,9152274,5236,1]
["chr19",11043205,11046370,3166,"ENSBGRG00000017127","ENSBGRT00000031517",19945,"PGS1","phosphatidylglycerophosphate synthase 1 [Source:HGNC Symbol;Acc:HGNC:30029]","GO:0003824(catalytic activity);GO:0005783(endoplasmic reticulum);GO:0008444(CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity);GO:0032049(cardiolipin biosynthetic process)","00564(Glycerophospholipid metabolism)",{"v":3.2e-19,"d":"0.00"},2,"4,447,","0,2719",{"v":-18.5,"d":"-18.50"},{"v":-17.5,"d":"-17.50"},3.65,"Exon (ENSBGRT00000031517/ENSBGRG00000017127, exon 7 of 11)",19,11023260,11067959,44700,1]
["chr19",13460146,13460385,240,"ENSBGRG00000024535","ENSBGRT00000045834",77552,"BAIAP2","BAR/IMD domain containing adaptor protein 2 [Source:HGNC Symbol;Acc:HGNC:947]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007009(plasma membrane organization);GO:0008093(cytoskeletal adaptor activity);GO:0008360(regulation of cell shape);GO:0009617(response to bacterium);GO:0015629(actin cytoskeleton);GO:0016358(dendrite development);GO:0032956(regulation of actin cytoskeleton organization);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0048167(regulation of synaptic plasticity);GO:0050804(modulation of chemical synaptic transmission);GO:0051017(actin filament bundle assembly);GO:0051764(actin crosslink formation);GO:0070064(proline-rich region binding);GO:0098685(Schaffer collateral - CA1 synapse)","04520(Adherens junction);04810(Regulation of actin cytoskeleton)",{"v":3.7e-05,"d":"0.00"},1,"240,",0,-4.43,-3.73,{"v":18.1,"d":"18.10"},"3' UTR",19,13382594,13460545,77952,1]
["chr19",14557047,14558253,1207,"ENSBGRG00000005938","ENSBGRT00000010961",7051,"SLC16A3","solute carrier family 16 member 3 [Source:HGNC Symbol;Acc:HGNC:10924]","GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0008028(monocarboxylic acid transmembrane transporter activity);GO:0015129(lactate transmembrane transporter activity);GO:0015293(symporter activity);GO:0015718(monocarboxylic acid transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0016328(lateral plasma membrane);GO:0022857(transmembrane transporter activity);GO:0031965(nuclear membrane);GO:0035873(lactate transmembrane transport);GO:0055085(transmembrane transport)","05230(Central carbon metabolism in cancer)",{"v":3e-05,"d":"0.00"},2,"21,307,","0,900",-4.52,-3.82,2.29,"3' UTR",19,14549996,14558253,8258,1]
["chr19",15079688,15090250,10563,"ENSBGRG00000006665","ENSBGRT00000012295",41679,"FOXK2","forkhead box K2 [Source:HGNC Symbol;Acc:HGNC:6036]","GO:0000287(magnesium ion binding);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001678(cellular glucose homeostasis);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006355(regulation of transcription, DNA-templated);GO:0010507(negative regulation of autophagy);GO:0010906(regulation of glucose metabolic process);GO:0042594(response to starvation);GO:0043231(intracellular membrane-bounded organelle);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061621(canonical glycolysis)","NA",{"v":6.3e-39,"d":"0.00"},2,"130,197,","0,10366",{"v":-38.2,"d":"-38.20"},{"v":-36.9,"d":"-36.90"},6.22,"Exon (ENSBGRT00000012295/ENSBGRG00000006665, exon 8 of 9)",19,15038009,15090250,52242,1]
["chr19",16607056,16613969,6914,"ENSBGRG00000010824","ENSBGRT00000019933",12911,"POLG2","DNA polymerase gamma 2, accessory subunit [Source:HGNC Symbol;Acc:HGNC:9180]","GO:0001701(in utero embryonic development);GO:0003690(double-stranded DNA binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005739(mitochondrion);GO:0005760(gamma DNA polymerase complex);GO:0006260(DNA replication);GO:0006261(DNA-dependent DNA replication);GO:0006281(DNA repair);GO:0022904(respiratory electron transport chain);GO:0030337(DNA polymerase processivity factor activity);GO:0032042(mitochondrial DNA metabolic process);GO:0042645(mitochondrial nucleoid);GO:0042802(identical protein binding);GO:0070182(DNA polymerase binding);GO:0070584(mitochondrion morphogenesis);GO:1900264(positive regulation of DNA-directed DNA polymerase activity)","NA",{"v":2e-23,"d":"0.00"},3,"2,101,166,","0,4881,6748",{"v":-22.7,"d":"-22.70"},{"v":-21.6,"d":"-21.60"},3.52,"Exon (ENSBGRT00000019933/ENSBGRG00000010824, exon 6 of 8)",19,16594145,16613969,19825,1]
["chr19",20403137,20414191,11055,"ENSBGRG00000021695","ENSBGRT00000040435",0,"ENSBGRG00000021695","NA","GO:0005484(SNAP receptor activity);GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016192(vesicle-mediated transport)","04130(SNARE interactions in vesicular transport)",{"v":2.5e-14,"d":"0.00"},4,"158,65,109,58,","0,8199,9905,10997",{"v":-13.6,"d":"-13.60"},{"v":-12.6,"d":"-12.60"},3.29,"5' UTR",19,20403137,20414360,11224,1]
["chr19",21661598,21662033,436,"ENSBGRG00000025212","ENSBGRT00000046831",119592,"ITGA2B","integrin subunit alpha 2b [Source:HGNC Symbol;Acc:HGNC:6138]","GO:0003676(nucleic acid binding);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0007155(cell adhesion);GO:0007160(cell-matrix adhesion);GO:0008305(integrin complex);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0042802(identical protein binding);GO:0050840(extracellular matrix binding);GO:0070062(extracellular exosome)","04015(Rap1 signaling pathway);04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04640(Hematopoietic cell lineage);04611(Platelet activation);05200(Pathways in cancer);05222(Small cell lung cancer);05418(Fluid shear stress and atherosclerosis);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection)",{"v":0.00042,"d":"0.00"},3,"84,98,58,","0,174,378",-3.38,-2.73,{"v":2.2,"d":"2.20"},"Exon (ENSBGRT00000046831/ENSBGRG00000025212, exon 8 of 36)",19,21542006,21673824,131819,1]
["chr19",22480201,22480474,274,"ENSBGRG00000005239","ENSBGRT00000009737",0,"ETV4","ETS variant transcription factor 4 [Source:HGNC Symbol;Acc:HGNC:3493]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding);GO:0045618(positive regulation of keratinocyte differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding)","05202(Transcriptional misregulation in cancers)",{"v":0.0079,"d":"0.01"},2,"136,14,","0,260",{"v":-2.1,"d":"-2.10"},-1.54,3.21,"5' UTR",19,22480201,22498409,18209,1]
["chr19",23148550,23150093,1544,"ENSBGRG00000007335","ENSBGRT00000013741",4126,"ENSBGRG00000007335","beclin 1 [Source:HGNC Symbol;Acc:HGNC:1034]","GO:0006897(endocytosis);GO:0006914(autophagy);GO:0032465(regulation of cytokinesis)","04371(Apelin signaling pathway);04140(Autophagy - animal);04136(Autophagy - other eukaryotes);04137(Mitophagy - animal);04215(Apoptosis - multiple species);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":1.6e-28,"d":"0.00"},3,"77,195,56,","0,237,1488",{"v":-27.8,"d":"-27.80"},{"v":-26.6,"d":"-26.60"},2,"Exon (ENSBGRT00000013741/ENSBGRG00000007335, exon 4 of 8)",19,23144424,23153933,9510,1]
["chr19",25354767,25360112,5346,"ENSBGRG00000016783","ENSBGRT00000030926",0,"KRT24","keratin 24 [Source:HGNC Symbol;Acc:HGNC:18527]","GO:0005198(structural molecule activity)","04915(Estrogen signaling pathway)",{"v":0.00013,"d":"0.00"},10,"175,422,83,157,15,144,126,218,113,306,","0,1255,2476,2931,3576,3593,3834,4304,4735,5040",-3.89,-3.21,5.01,"3' UTR",19,25354767,25360172,5406,1]
["chr19",27373799,27373859,61,"ENSBGRG00000015645","ENSBGRT00000029322",77598,"SRCIN1","SRC kinase signaling inhibitor 1 [Source:HGNC Symbol;Acc:HGNC:29506]","GO:0005737(cytoplasm);GO:0015629(actin cytoskeleton);GO:0019901(protein kinase binding);GO:0030334(regulation of cell migration);GO:0034446(substrate adhesion-dependent cell spreading);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0061099(negative regulation of protein tyrosine kinase activity)","NA",{"v":0.017,"d":"0.02"},1,"61,",0,-1.78,-1.24,2.17,"Exon (ENSBGRT00000029322/ENSBGRG00000015645, exon 20 of 20)",19,27296201,27374488,78288,1]
["chr19",27957269,27957920,652,"ENSBGRG00000019422","ENSBGRT00000035745",0,"MRPL10","mitochondrial ribosomal protein L10 [Source:HGNC Symbol;Acc:HGNC:14055]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit);GO:0042254(ribosome biogenesis)","03010(Ribosome)",{"v":0.00013,"d":"0.00"},1,"652,",0,-3.87,{"v":-3.2,"d":"-3.20"},16,"5' UTR",19,27949400,27957433,8034,2]
["chr19",30531692,30532167,476,"ENSBGRG00000005968","ENSBGRT00000011052",5457,"TMEM92","transmembrane protein 92 [Source:HGNC Symbol;Acc:HGNC:26579]","GO:0005654(nucleoplasm)","NA",{"v":8.3e-07,"d":"0.00"},1,"476,",0,-6.08,-5.32,{"v":3.8,"d":"3.80"},"3' UTR",19,30526235,30532672,6438,1]
["chr19",31428300,31428385,86,"ENSBGRG00000010184","ENSBGRT00000018693",5144,"NME1","NME/NM23 nucleoside diphosphate kinase 1 [Source:HGNC Symbol;Acc:HGNC:7849]","GO:0000287(magnesium ion binding);GO:0004536(deoxyribonuclease activity);GO:0004550(nucleoside diphosphate kinase activity);GO:0005524(ATP binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006165(nucleoside diphosphate phosphorylation);GO:0006183(GTP biosynthetic process);GO:0006228(UTP biosynthetic process);GO:0006241(CTP biosynthetic process);GO:0007595(lactation);GO:0030879(mammary gland development);GO:0032587(ruffle membrane);GO:0042802(identical protein binding);GO:0043024(ribosomal small subunit binding);GO:0043388(positive regulation of DNA binding);GO:0050679(positive regulation of epithelial cell proliferation)","00230(Purine metabolism);00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)",{"v":2.8e-06,"d":"0.00"},1,"86,",0,-5.56,-4.82,1.83,"Exon (ENSBGRT00000018693/ENSBGRG00000010184, exon 4 of 4)",19,31423156,31428385,5230,1]
["chr19",33105411,33107940,2530,"ENSBGRG00000022521","ENSBGRT00000041700",22363,"EPN2","epsin 2 [Source:HGNC Symbol;Acc:HGNC:18639]","GO:0006897(endocytosis);GO:0030128(clathrin coat of endocytic vesicle);GO:0030948(negative regulation of vascular endothelial growth factor receptor signaling pathway);GO:0043231(intracellular membrane-bounded organelle);GO:0045747(positive regulation of Notch signaling pathway);GO:1903671(negative regulation of sprouting angiogenesis)","04144(Endocytosis)",{"v":1.6E-12,"d":"0.00"},3,"26,87,158,","0,267,2372",{"v":-11.8,"d":"-11.80"},{"v":-10.9,"d":"-10.90"},{"v":20.6,"d":"20.60"},"Exon (ENSBGRT00000041700/ENSBGRG00000022521, exon 6 of 9)",19,33083048,33111069,28022,1]
["chr19",34456717,34456836,120,"ENSBGRG00000015356","ENSBGRT00000028162",3827,"CDRT4","CMT1A duplicated region transcript 4 [Source:HGNC Symbol;Acc:HGNC:14383]","NA","NA",{"v":0.048,"d":"0.05"},1,"120,",0,-1.32,{"v":-0.827,"d":"-0.83"},2.61,"3' UTR",19,34452890,34457314,4425,1]
["chr19",38150621,38152337,1717,"ENSBGRG00000020599","ENSBGRT00000038351",13807,"MYH3","myosin heavy chain 3 [Source:HGNC Symbol;Acc:HGNC:7573]","GO:0000146(microfilament motor activity);GO:0003009(skeletal muscle contraction);GO:0003774(motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0016459(myosin complex);GO:0016887(ATPase activity);GO:0043292(contractile fiber);GO:0046034(ATP metabolic process);GO:0051015(actin filament binding)","04530(Tight junction)",{"v":0.0032,"d":"0.00"},4,"126,184,166,64,","0,465,1225,1653",{"v":-2.5,"d":"-2.50"},-1.91,11,"Exon (ENSBGRT00000038351/ENSBGRG00000020599, exon 29 of 40)",19,38136814,38156124,19311,1]
["chr19",40231522,40235212,3691,"ENSBGRG00000026738","ENSBGRT00000049583",0,"HES7","hes family bHLH transcription factor 7 [Source:HGNC Symbol;Acc:HGNC:15977]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001501(skeletal system development);GO:0001756(somitogenesis);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007219(Notch signaling pathway);GO:0036342(post-anal tail morphogenesis);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046983(protein dimerization activity);GO:0048511(rhythmic process);GO:1990837(sequence-specific double-stranded DNA binding)","05165(Human papillomavirus infection)",{"v":2.8e-06,"d":"0.00"},4,"42,96,88,483,","0,951,1618,3208",-5.56,-4.82,{"v":22.1,"d":"22.10"},"3' UTR",19,40231522,40235477,3956,1]
["chr19",41543676,41544752,1077,"ENSBGRG00000025709","ENSBGRT00000047526",0,"GLTPD2","glycolipid transfer protein domain containing 2 [Source:HGNC Symbol;Acc:HGNC:33756]","GO:0005737(cytoplasm);GO:0120009(intermembrane lipid transfer);GO:0120013(lipid transfer activity)","NA",{"v":1.1E-4,"d":"0.00"},4,"82,53,167,310,","0,193,502,767",-3.97,-3.29,14,"Exon (ENSBGRT00000047526/ENSBGRG00000025709, exon 1 of 4)",19,41543676,41544956,1281,1]
["chr19",43207195,43207284,90,"ENSBGRG00000013684","ENSBGRT00000025104",0,"SMTNL2","smoothelin like 2 [Source:HGNC Symbol;Acc:HGNC:24764]","GO:0005515(protein binding)","NA",{"v":0.0072,"d":"0.01"},1,"90,",0,-2.14,-1.58,2.31,"Exon (ENSBGRT00000025104/ENSBGRG00000013684, exon 1 of 8)",19,43207195,43230405,23211,1]
["chr19",43765634,43767071,1438,"ENSBGRG00000015497","ENSBGRT00000034119",88011,"ZZEF1","zinc finger ZZ-type and EF-hand domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29027]","GO:0005509(calcium ion binding);GO:0008270(zinc ion binding)","NA",{"v":0.0016,"d":"0.00"},2,"96,85,","0,1353",-2.79,-2.17,3.44,"Exon (ENSBGRT00000034119/ENSBGRG00000015497, exon 47 of 57)",19,43677623,43781758,104136,1]
["chr19",45330983,45332506,1524,"ENSBGRG00000024485","ENSBGRT00000045361",3760,"SMG6","SMG6 nonsense mediated mRNA decay factor [Source:HGNC Symbol;Acc:HGNC:17809]","GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0003723(RNA binding);GO:0004521(endoribonuclease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0032204(regulation of telomere maintenance);GO:0035145(exon-exon junction complex);GO:0042162(telomeric DNA binding);GO:0043021(ribonucleoprotein complex binding);GO:0070034(telomerase RNA binding);GO:0070182(DNA polymerase binding);GO:1904354(negative regulation of telomere capping)","03015(mRNA surveillance pathway)",{"v":2.5e-45,"d":"0.00"},1,"1524,",0,{"v":-44.6,"d":"-44.60"},{"v":-43.3,"d":"-43.30"},8.87,"Exon (ENSBGRT00000045361/ENSBGRG00000024485, exon 2 of 19)",19,45327223,45544309,217087,1]
["chr19",48055455,48055994,540,"ENSBGRG00000019934","ENSBGRT00000036669",6409,"CORO6","coronin 6 [Source:HGNC Symbol;Acc:HGNC:21356]","GO:0005515(protein binding)","NA",{"v":5e-09,"d":"0.00"},2,"137,314,","0,226",{"v":-8.3,"d":"-8.30"},-7.48,3.32,"3' UTR",19,48049046,48056803,7758,1]
["chr19",48973912,48974629,718,"ENSBGRG00000023394","ENSBGRT00000044665",29787,"ENSBGRG00000023394","NA","NA","NA",{"v":5.9e-10,"d":"0.00"},1,"718,",0,-9.23,-8.39,4.71,"Exon (ENSBGRT00000044665/ENSBGRG00000023394, exon 41 of 41)",19,48944125,48975078,30954,1]
["chr19",50618543,50618633,91,"ENSBGRG00000015199","ENSBGRT00000028074",276089,"NF1","neurofibromin 1 [Source:HGNC Symbol;Acc:HGNC:7765]","GO:0000165(MAPK cascade);GO:0001649(osteoblast differentiation);GO:0001656(metanephros development);GO:0001666(response to hypoxia);GO:0001889(liver development);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001952(regulation of cell-matrix adhesion);GO:0001953(negative regulation of cell-matrix adhesion);GO:0005096(GTPase activator activity);GO:0005737(cytoplasm);GO:0006469(negative regulation of protein kinase activity);GO:0007154(cell communication);GO:0007165(signal transduction);GO:0007265(Ras protein signal transduction);GO:0007406(negative regulation of neuroblast proliferation);GO:0007420(brain development);GO:0007422(peripheral nervous system development);GO:0007507(heart development);GO:0007519(skeletal muscle tissue development);GO:0008285(negative regulation of cell population proliferation);GO:0008429(phosphatidylethanolamine binding);GO:0008542(visual learning);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0010468(regulation of gene expression);GO:0014044(Schwann cell development);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0016525(negative regulation of angiogenesis);GO:0021510(spinal cord development);GO:0021764(amygdala development);GO:0021897(forebrain astrocyte development);GO:0021915(neural tube development);GO:0021987(cerebral cortex development);GO:0022011(myelination in peripheral nervous system);GO:0030036(actin cytoskeleton organization);GO:0030198(extracellular matrix organization);GO:0030199(collagen fibril organization);GO:0030325(adrenal gland development);GO:0030336(negative regulation of cell migration);GO:0030424(axon);GO:0030425(dendrite);GO:0031210(phosphatidylcholine binding);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0034605(cellular response to heat);GO:0035021(negative regulation of Rac protein signal transduction);GO:0042060(wound healing);GO:0042127(regulation of cell population proliferation);GO:0042308(negative regulation of protein import into nucleus);GO:0043065(positive regulation of apoptotic process);GO:0043087(regulation of GTPase activity);GO:0043407(negative regulation of MAP kinase activity);GO:0043408(regulation of MAPK cascade);GO:0043409(negative regulation of MAPK cascade);GO:0043473(pigmentation);GO:0043525(positive regulation of neuron apoptotic process);GO:0043535(regulation of blood vessel endothelial cell migration);GO:0043547(positive regulation of GTPase activity);GO:0045124(regulation of bone resorption);GO:0045671(negative regulation of osteoclast differentiation);GO:0045685(regulation of glial cell differentiation);GO:0045762(positive regulation of adenylate cyclase activity);GO:0045765(regulation of angiogenesis);GO:0046580(negative regulation of Ras protein signal transduction);GO:0046929(negative regulation of neurotransmitter secretion);GO:0048147(negative regulation of fibroblast proliferation);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048485(sympathetic nervous system development);GO:0048593(camera-type eye morphogenesis);GO:0048712(negative regulation of astrocyte differentiation);GO:0048715(negative regulation of oligodendrocyte differentiation);GO:0048745(smooth muscle tissue development);GO:0048820(hair follicle maturation);GO:0048844(artery morphogenesis);GO:0048853(forebrain morphogenesis);GO:0050890(cognition);GO:0061534(gamma-aminobutyric acid secretion, neurotransmission);GO:0061535(glutamate secretion, neurotransmission);GO:0098597(observational learning);GO:1900271(regulation of long-term synaptic potentiation);GO:2001241(positive regulation of extrinsic apoptotic signaling pathway in absence of ligand)","04014(Ras signaling pathway);04010(MAPK signaling pathway);01521(EGFR tyrosine kinase inhibitor resistance)",{"v":2e-18,"d":"0.00"},1,"91,",0,{"v":-17.7,"d":"-17.70"},{"v":-16.7,"d":"-16.70"},2.75,"Exon (ENSBGRT00000028074/ENSBGRG00000015199, exon 58 of 58)",19,50342454,50618633,276180,1]
["chr19",55004162,55009155,4994,"ENSBGRG00000022860","ENSBGRT00000042228",10761,"ENSBGRG00000022860","NA","GO:0005515(protein binding);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0016192(vesicle-mediated transport);GO:0030117(membrane coat);GO:0030131(clathrin adaptor complex);GO:0030276(clathrin binding)","04144(Endocytosis);04961(Endocrine and other factor-regulated calcium reabsorption);04721(Synaptic vesicle cycle);05016(Huntington disease)",{"v":4.6e-09,"d":"0.00"},2,"89,91,","0,4903",-8.34,-7.52,2.47,"Exon (ENSBGRT00000042228/ENSBGRG00000022860, exon 3 of 15)",19,54993401,55069278,75878,1]
["chr19",60935942,60937193,1252,"ENSBGRG00000011191","ENSBGRT00000021357",11383,"ENSBGRG00000011191","NA","GO:0005525(GTP binding);GO:0007286(spermatid development);GO:0007420(brain development);GO:0030382(sperm mitochondrion organization);GO:0031105(septin complex);GO:0031514(motile cilium);GO:0036126(sperm flagellum);GO:0042995(cell projection);GO:0048240(sperm capacitation);GO:0097227(sperm annulus)","04210(Apoptosis);04215(Apoptosis - multiple species)",{"v":1.5E-3,"d":"0.00"},3,"50,97,62,","0,1000,1190",-2.81,-2.19,2.14,"Exon (ENSBGRT00000021357/ENSBGRG00000011191, exon 8 of 12)",19,60924559,60938054,13496,1]
["chr19",64766996,64767400,405,"ENSBGRG00000019828","ENSBGRT00000036460",0,"TMEM100","transmembrane protein 100 [Source:HGNC Symbol;Acc:HGNC:25607]","GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0030509(BMP signaling pathway);GO:0043204(perikaryon);GO:0048471(perinuclear region of cytoplasm);GO:0071773(cellular response to BMP stimulus)","NA",{"v":9.99999999999999e-198,"d":"0.00"},1,"405,",0,-197,-194,3.52,"Exon (ENSBGRT00000036460/ENSBGRG00000019828, exon 1 of 1)",19,64766996,64767400,405,1]
["chr19",2259135,2266553,7419,"ENSBGRG00000020727","ENSBGRT00000039320",50410,"ABCA9","ATP binding cassette subfamily A member 9 [Source:HGNC Symbol;Acc:HGNC:39]","GO:0005524(ATP binding);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0042626(ATPase-coupled transmembrane transporter activity);GO:0055085(transmembrane transport)","02010(ABC transporters)",{"v":8.1e-06,"d":"0.00"},4,"96,56,80,8,","0,433,4895,7411",-5.09,-4.37,2.31,"Exon (ENSBGRT00000039320/ENSBGRG00000020727, exon 36 of 39)",19,2259135,2316963,57829,2]
["chr19",7880130,7880339,210,"ENSBGRG00000014566","ENSBGRT00000027520",0,"FDXR","ferredoxin reductase [Source:HGNC Symbol;Acc:HGNC:3642]","GO:0005739(mitochondrion);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","NA",{"v":0.035,"d":"0.04"},1,"210,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"5' UTR",19,7866577,7880339,13763,2]
["chr19",8914193,8914373,181,"ENSBGRG00000023453","ENSBGRT00000043915",18741,"EVPL","envoplakin [Source:HGNC Symbol;Acc:HGNC:3503]","GO:0001533(cornified envelope);GO:0005198(structural molecule activity);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0008544(epidermis development);GO:0019215(intermediate filament binding);GO:0045104(intermediate filament cytoskeleton organization);GO:0045111(intermediate filament cytoskeleton)","NA",{"v":0.017,"d":"0.02"},1,"181,",0,-1.76,-1.22,4.01,"Exon (ENSBGRT00000043915/ENSBGRG00000023453, exon 25 of 25)",19,8914193,8933114,18922,2]
["chr19",9279438,9279647,210,"ENSBGRG00000025088","ENSBGRT00000046500",48572,"UBE2O","ubiquitin conjugating enzyme E2 O [Source:HGNC Symbol;Acc:HGNC:29554]","GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006513(protein monoubiquitination);GO:0016604(nuclear body);GO:0030513(positive regulation of BMP signaling pathway);GO:0042147(retrograde transport, endosome to Golgi);GO:0061630(ubiquitin protein ligase activity);GO:0061631(ubiquitin conjugating enzyme activity);GO:0070534(protein K63-linked ubiquitination)","04120(Ubiquitin mediated proteolysis)",{"v":3.3E-4,"d":"0.00"},1,"210,",0,-3.48,-2.83,1.86,"Exon (ENSBGRT00000046500/ENSBGRG00000025088, exon 9 of 18)",19,9271623,9328219,56597,2]
["chr19",11068139,11070246,2108,"ENSBGRG00000017127","ENSBGRT00000031433",44879,"PGS1","phosphatidylglycerophosphate synthase 1 [Source:HGNC Symbol;Acc:HGNC:30029]","GO:0003824(catalytic activity);GO:0005783(endoplasmic reticulum);GO:0008444(CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity);GO:0032049(cardiolipin biosynthetic process)","00564(Glycerophospholipid metabolism)",{"v":0.0095,"d":"0.01"},2,"128,172,","0,1936",-2.02,-1.46,2.01,"3' UTR",19,11023260,11069766,46507,1]
["chr19",13549370,13550707,1338,"ENSBGRG00000025011","ENSBGRT00000046491",3559,"CEP131","centrosomal protein 131 [Source:HGNC Symbol;Acc:HGNC:29511]","GO:0005813(centrosome);GO:0008284(positive regulation of cell population proliferation);GO:0010824(regulation of centrosome duplication);GO:0015630(microtubule cytoskeleton);GO:0034451(centriolar satellite);GO:0035735(intraciliary transport involved in cilium assembly);GO:0035869(ciliary transition zone);GO:0036064(ciliary basal body);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0044877(protein-containing complex binding);GO:0045171(intercellular bridge);GO:0071539(protein localization to centrosome);GO:0090316(positive regulation of intracellular protein transport)","NA",{"v":0.041,"d":"0.04"},2,"11,80,","0,1258",-1.39,{"v":-0.886,"d":"-0.89"},1.43,"Exon (ENSBGRT00000046491/ENSBGRG00000025011, exon 6 of 25)",19,13537659,13554266,16608,2]
["chr19",14345911,14346239,329,"ENSBGRG00000005237","ENSBGRT00000009666",7793,"DUS1L","dihydrouridine synthase 1 like [Source:HGNC Symbol;Acc:HGNC:30086]","GO:0003824(catalytic activity);GO:0008033(tRNA processing);GO:0017150(tRNA dihydrouridine synthase activity);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process)","NA",{"v":5e-29,"d":"0.00"},1,"329,",0,{"v":-28.3,"d":"-28.30"},{"v":-27.1,"d":"-27.10"},3.47,"3' UTR",19,14345911,14354032,8122,2]
["chr19",17485498,17486123,626,"ENSBGRG00000014344","ENSBGRT00000026396",3170,"TACO1","translational activator of cytochrome c oxidase I [Source:HGNC Symbol;Acc:HGNC:24316]","GO:0003729(mRNA binding);GO:0005739(mitochondrion);GO:0019843(rRNA binding);GO:0033617(mitochondrial respiratory chain complex IV assembly);GO:0061743(motor learning);GO:0070129(regulation of mitochondrial translation);GO:0097177(mitochondrial ribosome binding);GO:1904959(regulation of cytochrome-c oxidase activity)","NA",{"v":2.5e-07,"d":"0.00"},2,"208,83,","0,543",{"v":-6.6,"d":"-6.60"},-5.83,5.01,"3' UTR",19,17485498,17489293,3796,2]
["chr19",19591182,19591360,179,"ENSBGRG00000020032","ENSBGRT00000038021",53005,"MAPT","microtubule associated protein tau [Source:HGNC Symbol;Acc:HGNC:6893]","GO:0000226(microtubule cytoskeleton organization);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007613(memory);GO:0008017(microtubule binding);GO:0010506(regulation of autophagy);GO:0010629(negative regulation of gene expression);GO:0010917(negative regulation of mitochondrial membrane potential);GO:0015630(microtubule cytoskeleton);GO:0015631(tubulin binding);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0017124(SH3 domain binding);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0030424(axon);GO:0030425(dendrite);GO:0030426(growth cone);GO:0030673(axolemma);GO:0031110(regulation of microtubule polymerization or depolymerization);GO:0031116(positive regulation of microtubule polymerization);GO:0032930(positive regulation of superoxide anion generation);GO:0033673(negative regulation of kinase activity);GO:0034185(apolipoprotein binding);GO:0034399(nuclear periphery);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0036477(somatodendritic compartment);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0044297(cell body);GO:0045298(tubulin complex);GO:0045773(positive regulation of axon extension);GO:0048312(intracellular distribution of mitochondria);GO:0050808(synapse organization);GO:0050848(regulation of calcium-mediated signaling);GO:0051087(chaperone binding);GO:0051258(protein polymerization);GO:0051879(Hsp90 protein binding);GO:0070507(regulation of microtubule cytoskeleton organization);GO:0071813(lipoprotein particle binding);GO:0090258(negative regulation of mitochondrial fission);GO:0097418(neurofibrillary tangle);GO:0097435(supramolecular fiber organization);GO:0099609(microtubule lateral binding);GO:1900034(regulation of cellular response to heat);GO:1901216(positive regulation of neuron death);GO:1902474(positive regulation of protein localization to synapse);GO:1903748(negative regulation of establishment of protein localization to mitochondrion);GO:1903829(positive regulation of cellular protein localization);GO:1904428(negative regulation of tubulin deacetylation);GO:1990000(amyloid fibril formation);GO:2001020(regulation of response to DNA damage stimulus)","04010(MAPK signaling pathway);05010(Alzheimer disease)",{"v":0.011,"d":"0.01"},1,"179,",0,-1.97,{"v":-1.4,"d":"-1.40"},9.03,"3' UTR",19,19591182,19644365,53184,2]
["chr19",21325076,21325136,61,"ENSBGRG00000025059","ENSBGRT00000046300",31454,"ENSBGRG00000025059","NA","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding)","04110(Cell cycle)",{"v":0.048,"d":"0.05"},1,"61,",0,-1.32,{"v":-0.827,"d":"-0.83"},2.61,"Exon (ENSBGRT00000046300/ENSBGRG00000025059, exon 12 of 12)",19,21324061,21356590,32530,2]
["chr19",22932413,22934711,2299,"ENSBGRG00000006232","ENSBGRT00000011506",4712,"RUNDC1","RUN domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25418]","NA","NA",{"v":2e-30,"d":"0.00"},3,"1162,120,173,","0,1560,2126",{"v":-29.7,"d":"-29.70"},{"v":-28.5,"d":"-28.50"},7.02,"3' UTR",19,22932383,22939423,7041,2]
["chr19",23295871,23339720,43850,"ENSBGRG00000009043","ENSBGRT00000016887",0,"TUBG2","tubulin gamma 2 [Source:HGNC Symbol;Acc:HGNC:12419]","GO:0000242(pericentriolar material);GO:0000930(gamma-tubulin complex);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005813(centrosome);GO:0005874(microtubule);GO:0005876(spindle microtubule);GO:0005881(cytoplasmic microtubule);GO:0007017(microtubule-based process);GO:0007020(microtubule nucleation);GO:0031122(cytoplasmic microtubule organization)","05165(Human papillomavirus infection)",{"v":1.6e-19,"d":"0.00"},2,"8,202,","0,43648",{"v":-18.8,"d":"-18.80"},{"v":-17.8,"d":"-17.80"},2.04,"3' UTR",19,23288755,23295878,7124,2]
["chr19",24121095,24121244,150,"ENSBGRG00000010797","ENSBGRT00000019738",9115,"FKBP10","FKBP prolyl isomerase 10 [Source:HGNC Symbol;Acc:HGNC:18169]","GO:0001701(in utero embryonic development);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005509(calcium ion binding);GO:0005528(FK506 binding);GO:0005758(mitochondrial intermembrane space);GO:0005783(endoplasmic reticulum);GO:0016020(membrane);GO:0017185(peptidyl-lysine hydroxylation);GO:0018208(peptidyl-proline modification);GO:0030199(collagen fibril organization);GO:0035909(aorta morphogenesis);GO:0042060(wound healing);GO:0085029(extracellular matrix assembly)","NA",{"v":1.6e-43,"d":"0.00"},1,"150,",0,{"v":-42.8,"d":"-42.80"},{"v":-41.5,"d":"-41.50"},1.81,"3' UTR",19,24120321,24130359,10039,2]
["chr19",27439966,27445269,5304,"ENSBGRG00000017050","ENSBGRT00000031782",31385,"ARHGAP23","Rho GTPase activating protein 23 [Source:HGNC Symbol;Acc:HGNC:29293]","GO:0005515(protein binding);GO:0007165(signal transduction)","NA",{"v":4e-15,"d":"0.00"},3,"864,55,69,","0,3815,5235",{"v":-14.4,"d":"-14.40"},{"v":-13.5,"d":"-13.50"},9.36,"Exon (ENSBGRT00000031782/ENSBGRG00000017050, exon 5 of 25)",19,27404106,27476654,72549,2]
["chr19",28776700,28793185,16486,"ENSBGRG00000021530","ENSBGRT00000039711",0,"MIR10A","microRNA 10a [Source:HGNC Symbol;Acc:HGNC:31497]","NA","NA",{"v":0.013,"d":"0.01"},2,"111,39,","0,16447",-1.87,-1.32,2.58,"Exon (ENSBGRT00000039685/ENSBGRG00000021501, exon 1 of 3)",19,28779534,28779654,121,2]
["chr19",30371808,30372042,235,"ENSBGRG00000005352","ENSBGRT00000009972",18409,"PPP1R9B","protein phosphatase 1 regulatory subunit 9B [Source:HGNC Symbol;Acc:HGNC:9298]","GO:0001932(regulation of protein phosphorylation);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007015(actin filament organization);GO:0008157(protein phosphatase 1 binding);GO:0016358(dendrite development);GO:0016477(cell migration);GO:0019722(calcium-mediated signaling);GO:0030027(lamellipodium);GO:0030175(filopodium);GO:0030308(negative regulation of cell growth);GO:0030864(cortical actin cytoskeleton);GO:0032587(ruffle membrane);GO:0042127(regulation of cell population proliferation);GO:0046847(filopodium assembly);GO:0050804(modulation of chemical synaptic transmission);GO:0071315(cellular response to morphine);GO:2000474(regulation of opioid receptor signaling pathway)","NA",{"v":0.017,"d":"0.02"},2,"54,7,","0,228",-1.76,-1.22,4.01,"Exon (ENSBGRT00000009972/ENSBGRG00000005352, exon 10 of 11)",19,30371808,30390451,18644,2]
["chr19",31248951,31252486,3536,"ENSBGRG00000009172","ENSBGRT00000018435",49323,"SPAG9","sperm associated antigen 9 [Source:HGNC Symbol;Acc:HGNC:14524]","GO:0000187(activation of MAPK activity);GO:0005078(MAP-kinase scaffold activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0008432(JUN kinase binding);GO:0019894(kinesin binding);GO:0030335(positive regulation of cell migration);GO:0032418(lysosome localization);GO:0034451(centriolar satellite);GO:0042147(retrograde transport, endosome to Golgi);GO:0042802(identical protein binding);GO:0043410(positive regulation of MAPK cascade);GO:0045666(positive regulation of neuron differentiation);GO:0051146(striated muscle cell differentiation)","NA",{"v":0.025,"d":"0.03"},3,"44,52,24,","0,3005,3512",-1.61,-1.09,4.51,"Exon (ENSBGRT00000018435/ENSBGRG00000009172, exon 7 of 27)",19,31213646,31301809,88164,2]
["chr19",32789501,32790081,581,"ENSBGRG00000019320","ENSBGRT00000039327",12239,"FLII","FLII actin remodeling protein [Source:HGNC Symbol;Acc:HGNC:3750]","GO:0003779(actin binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005903(brush border);GO:0007275(multicellular organism development);GO:0030036(actin cytoskeleton organization);GO:0034451(centriolar satellite);GO:0051014(actin filament severing);GO:0051015(actin filament binding)","NA",{"v":6.3e-12,"d":"0.00"},3,"96,140,182,","0,182,399",{"v":-11.2,"d":"-11.20"},{"v":-10.3,"d":"-10.30"},2.06,"Exon (ENSBGRT00000039327/ENSBGRG00000019320, exon 21 of 30)",19,32787915,32802320,14406,2]
["chr19",35272612,35272788,177,"ENSBGRG00000015594","ENSBGRT00000028857",112578,"COX10","cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10 [Source:HGNC Symbol;Acc:HGNC:2260]","GO:0000266(mitochondrial fission);GO:0004129(cytochrome-c oxidase activity);GO:0004311(farnesyltranstransferase activity);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006783(heme biosynthetic process);GO:0006784(heme A biosynthetic process);GO:0007005(mitochondrion organization);GO:0008495(protoheme IX farnesyltransferase activity);GO:0008535(respiratory chain complex IV assembly);GO:0009060(aerobic respiration);GO:0016021(integral component of membrane);GO:0016765(transferase activity, transferring alkyl or aryl (other than methyl) groups);GO:0017004(cytochrome complex assembly);GO:0031966(mitochondrial membrane);GO:0045333(cellular respiration);GO:0048034(heme O biosynthetic process);GO:0070069(cytochrome complex)","00190(Oxidative phosphorylation);00860(Porphyrin and chlorophyll metabolism);04714(Thermogenesis)",{"v":3.4e-07,"d":"0.00"},1,"177,",0,-6.47,{"v":-5.7,"d":"-5.70"},3.22,"Exon (ENSBGRT00000028857/ENSBGRG00000015594, exon 8 of 8)",19,35272465,35385366,112902,2]
["chr19",39453065,39453245,181,"ENSBGRG00000026654","ENSBGRT00000049399",20651,"NTN1","netrin 1 [Source:HGNC Symbol;Acc:HGNC:8029]","GO:0001764(neuron migration);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005604(basement membrane);GO:0005737(cytoplasm);GO:0007097(nuclear migration);GO:0007409(axonogenesis);GO:0007411(axon guidance);GO:0008284(positive regulation of cell population proliferation);GO:0030334(regulation of cell migration);GO:0030517(negative regulation of axon extension);GO:0030879(mammary gland development);GO:0033564(anterior/posterior axon guidance);GO:0042472(inner ear morphogenesis);GO:0045773(positive regulation of axon extension);GO:0060603(mammary gland duct morphogenesis);GO:0061643(chemorepulsion of axon);GO:0098609(cell-cell adhesion)","04360(Axon guidance)",{"v":0.0011,"d":"0.00"},1,"181,",0,-2.97,-2.34,6.02,"Exon (ENSBGRT00000049399/ENSBGRG00000026654, exon 2 of 7)",19,39244108,39473896,229789,2]
["chr19",40666741,40668142,1402,"ENSBGRG00000013255","ENSBGRT00000024335",2760,"EFNB3","ephrin B3 [Source:HGNC Symbol;Acc:HGNC:3228]","GO:0005886(plasma membrane);GO:0007411(axon guidance);GO:0007628(adult walking behavior);GO:0016020(membrane);GO:0016198(axon choice point recognition);GO:0031295(T cell costimulation);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0050771(negative regulation of axonogenesis);GO:0098686(hippocampal mossy fiber to CA3 synapse);GO:0098978(glutamatergic synapse);GO:0099056(integral component of presynaptic membrane);GO:0099557(trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission)","04360(Axon guidance)",{"v":0.0046,"d":"0.00"},3,"176,105,70,","0,1117,1332",-2.34,-1.75,3.61,"Exon (ENSBGRT00000024335/ENSBGRG00000013255, exon 3 of 5)",19,40666507,40670902,4396,2]
["chr19",41281854,41282090,237,"ENSBGRG00000024751","ENSBGRT00000045657",634,"ENSBGRG00000024751","NA","GO:0003677(DNA binding);GO:0016589(NURF complex);GO:0071339(MLL1 complex)","NA",{"v":1E-135,"d":"0.00"},1,"237,",0,-135,-133,4.63,"5' UTR",19,41277825,41282724,4900,2]
["chr19",43064438,43065066,629,"ENSBGRG00000012996","ENSBGRT00000024087",0,"ENSBGRG00000012996","NA","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04611(Platelet activation);04926(Relaxin signaling pathway);04974(Protein digestion and absorption);04933(AGE-RAGE signaling pathway in diabetic complications);05165(Human papillomavirus infection);05146(Amoebiasis)",{"v":0.00026,"d":"0.00"},1,"629,",0,-3.59,-2.93,15,"Exon (ENSBGRT00000024087/ENSBGRG00000012996, exon 1 of 16)",19,43061023,43065066,4044,2]
["chr19",45837645,45841515,3871,"ENSBGRG00000011155","ENSBGRT00000021077",3413,"WDR81","WD repeat domain 81 [Source:HGNC Symbol;Acc:HGNC:26600]","GO:0000421(autophagosome membrane);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007005(mitochondrion organization);GO:0010923(negative regulation of phosphatase activity);GO:0031313(extrinsic component of endosome membrane);GO:0031901(early endosome membrane);GO:0031902(late endosome membrane);GO:0035014(phosphatidylinositol 3-kinase regulator activity);GO:0035973(aggrephagy);GO:0043551(regulation of phosphatidylinositol 3-kinase activity);GO:0045022(early endosome to late endosome transport);GO:0050821(protein stabilization);GO:0070530(K63-linked polyubiquitin modification-dependent protein binding)","NA",{"v":2e-49,"d":"0.00"},2,"29,2930,","0,941",{"v":-48.7,"d":"-48.70"},{"v":-47.4,"d":"-47.40"},{"v":12.5,"d":"12.50"},"Exon (ENSBGRT00000021077/ENSBGRG00000011155, exon 2 of 12)",19,45830389,45844928,14540,2]
["chr19",47270016,47293213,23198,"ENSBGRG00000017762","ENSBGRT00000033238",14552,"GOSR1","golgi SNAP receptor complex member 1 [Source:HGNC Symbol;Acc:HGNC:4430]","GO:0000139(Golgi membrane);GO:0005484(SNAP receptor activity);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0016021(integral component of membrane);GO:0042147(retrograde transport, endosome to Golgi)","04130(SNARE interactions in vesicular transport)",{"v":1.3E-54,"d":"0.00"},6,"294,83,30,30,75,24,","0,4079,9985,10587,18204,23174",{"v":-53.9,"d":"-53.90"},{"v":-52.5,"d":"-52.50"},{"v":23.1,"d":"23.10"},"3' UTR",19,47270016,47307765,37750,2]
["chr19",48894762,48895937,1176,"ENSBGRG00000023259","ENSBGRT00000043026",28020,"SUPT6H","SPT6 homolog, histone chaperone and transcription elongation factor [Source:HGNC Symbol;Acc:HGNC:11470]","GO:0001825(blastocyst formation);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0006139(nucleobase-containing compound metabolic process);GO:0010793(regulation of mRNA export from nucleus);GO:0032968(positive regulation of transcription elongation from RNA polymerase II promoter);GO:0042393(histone binding);GO:0045191(regulation of isotype switching);GO:0050684(regulation of mRNA processing);GO:0051147(regulation of muscle cell differentiation);GO:0061086(negative regulation of histone H3-K27 methylation)","NA",{"v":8.99999999999999E-297,"d":"0.00"},2,"782,147,","0,1029",-296,-294,8.37,"3' UTR",19,48894762,48923957,29196,2]
["chr19",54937481,54937720,240,"ENSBGRG00000022760","ENSBGRT00000042007",0,"ENSBGRG00000022760","NA","NA","NA",{"v":0.00036,"d":"0.00"},1,"240,",0,-3.44,-2.79,4.21,"5' UTR",19,54924488,54937720,13233,2]
["chr19",57052428,57052547,120,"ENSBGRG00000016921","ENSBGRT00000031058",20350,"GGNBP2","gametogenetin binding protein 2 [Source:HGNC Symbol;Acc:HGNC:19357]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008285(negative regulation of cell population proliferation);GO:0010629(negative regulation of gene expression);GO:0030154(cell differentiation);GO:0033140(negative regulation of peptidyl-serine phosphorylation of STAT protein);GO:0042532(negative regulation of tyrosine phosphorylation of STAT protein);GO:0060711(labyrinthine layer development);GO:0060716(labyrinthine layer blood vessel development);GO:0061099(negative regulation of protein tyrosine kinase activity)","NA",{"v":9.5e-10,"d":"0.00"},1,"120,",0,-9.02,-8.19,1.32,"Exon (ENSBGRT00000031058/ENSBGRG00000016921, exon 9 of 12)",19,57049920,57072897,22978,2]
["chr19",59594348,59594557,210,"ENSBGRG00000021305","ENSBGRT00000040581",71682,"CLTC","clathrin heavy chain [Source:HGNC Symbol;Acc:HGNC:2092]","GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005764(lysosome);GO:0005768(endosome);GO:0005905(clathrin-coated pit);GO:0006886(intracellular protein transport);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0019901(protein kinase binding);GO:0030117(membrane coat);GO:0030130(clathrin coat of trans-Golgi network vesicle);GO:0030132(clathrin coat of coated pit);GO:0032051(clathrin light chain binding);GO:0071439(clathrin complex);GO:0072686(mitotic spindle)","04144(Endocytosis);04142(Lysosome);04961(Endocrine and other factor-regulated calcium reabsorption);04721(Synaptic vesicle cycle);05016(Huntington disease);05100(Bacterial invasion of epithelial cells)",{"v":6.3e-63,"d":"0.00"},1,"210,",0,{"v":-62.2,"d":"-62.20"},{"v":-60.7,"d":"-60.70"},2.26,"3' UTR",19,59594348,59666239,71892,2]
["chr20",2190603,2198493,7891,"ENSBGRG00000013711","ENSBGRT00000025575",85791,"CEP89","centrosomal protein 89 [Source:HGNC Symbol;Acc:HGNC:25907]","GO:0000922(spindle pole);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007005(mitochondrion organization);GO:0007268(chemical synaptic transmission);GO:0031514(motile cilium);GO:0060271(cilium assembly);GO:0097539(ciliary transition fiber);GO:0097730(non-motile cilium);GO:1905515(non-motile cilium assembly)","NA",{"v":1e-28,"d":"0.00"},3,"128,166,33,","0,7690,7858",-28,{"v":-26.9,"d":"-26.90"},2.86,"Exon (ENSBGRT00000025575/ENSBGRG00000013711, exon 18 of 20)",20,2104812,2198493,93682,1]
["chr20",9842812,9843232,421,"ENSBGRG00000007192","ENSBGRT00000013684",0,"TERF2","telomeric repeat binding factor 2 [Source:HGNC Symbol;Acc:HGNC:11729]","GO:0000723(telomere maintenance);GO:0000781(chromosome, telomeric region);GO:0000783(nuclear telomere cap complex);GO:0000784(nuclear chromosome, telomeric region);GO:0003677(DNA binding);GO:0003691(double-stranded telomeric DNA binding);GO:0003720(telomerase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008022(protein C-terminus binding);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016233(telomere capping);GO:0016604(nuclear body);GO:0019899(enzyme binding);GO:0030870(Mre11 complex);GO:0031627(telomeric loop formation);GO:0031848(protection from non-homologous end joining at telomere);GO:0032204(regulation of telomere maintenance);GO:0032205(negative regulation of telomere maintenance);GO:0032208(negative regulation of telomere maintenance via recombination);GO:0032210(regulation of telomere maintenance via telomerase);GO:0032211(negative regulation of telomere maintenance via telomerase);GO:0042162(telomeric DNA binding);GO:0042803(protein homodimerization activity);GO:0044877(protein-containing complex binding);GO:0051000(positive regulation of nitric-oxide synthase activity);GO:0061820(telomeric D-loop disassembly);GO:0070187(shelterin complex);GO:0070198(protein localization to chromosome, telomeric region);GO:0098505(G-rich strand telomeric DNA binding);GO:1903770(negative regulation of beta-galactosidase activity);GO:1904354(negative regulation of telomere capping);GO:1904357(negative regulation of telomere maintenance via telomere lengthening);GO:1904430(negative regulation of t-circle formation);GO:1905778(negative regulation of exonuclease activity);GO:1905839(negative regulation of telomeric D-loop disassembly);GO:2000773(negative regulation of cellular senescence)","NA",{"v":3.9e-07,"d":"0.00"},1,"421,",0,-6.41,-5.64,{"v":25.1,"d":"25.10"},"Exon (ENSBGRT00000013684/ENSBGRG00000007192, exon 1 of 9)",20,9842812,9870271,27460,1]
["chr20",11092335,11092905,571,"ENSBGRG00000021263","ENSBGRT00000042372",29090,"SLC12A4","solute carrier family 12 member 4 [Source:HGNC Symbol;Acc:HGNC:10913]","GO:0006811(ion transport);GO:0015377(cation:chloride symporter activity);GO:0015379(potassium:chloride symporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019901(protein kinase binding);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",0,1,"571,",0,-344,"-Inf",4.62,"3' UTR",20,11063245,11092905,29661,1]
["chr20",11575577,11575756,180,"ENSBGRG00000026802","ENSBGRT00000049715",0,"TPPP3","tubulin polymerization promoting protein family member 3 [Source:HGNC Symbol;Acc:HGNC:24162]","GO:0001578(microtubule bundle formation);GO:0007566(embryo implantation);GO:0015631(tubulin binding);GO:0046697(decidualization);GO:0046785(microtubule polymerization);GO:0048471(perinuclear region of cytoplasm);GO:0097427(microtubule bundle)","NA",{"v":4.2e-09,"d":"0.00"},1,"180,",0,-8.38,-7.56,2.29,"5' UTR",20,11575577,11576346,770,1]
["chr20",12011164,12011821,658,"ENSBGRG00000026896","ENSBGRT00000049871",2384,"RRAD","RRAD, Ras related glycolysis inhibitor and calcium channel regulator [Source:HGNC Symbol;Acc:HGNC:10446]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane);GO:1901841(regulation of high voltage-gated calcium channel activity)","NA",0,1,"658,",0,-945,"-Inf",5.59,"3' UTR",20,12008780,12011821,3042,1]
["chr20",26174429,26176231,1803,"ENSBGRG00000024918","ENSBGRT00000046013",0,"AKTIP","AKT interacting protein [Source:HGNC Symbol;Acc:HGNC:16710]","GO:0001934(positive regulation of protein phosphorylation);GO:0005886(plasma membrane);GO:0007032(endosome organization);GO:0007040(lysosome organization);GO:0008333(endosome to lysosome transport);GO:0030897(HOPS complex);GO:0032092(positive regulation of protein binding);GO:0045022(early endosome to late endosome transport);GO:0070695(FHF complex)","NA",{"v":2.1e-05,"d":"0.00"},2,"830,123,","0,1680",-4.67,-3.97,3.11,"5' UTR",20,26174429,26185565,11137,1]
["chr20",29271043,29271488,446,"ENSBGRG00000006807","ENSBGRT00000012701",3657,"SNX20","sorting nexin 20 [Source:HGNC Symbol;Acc:HGNC:30390]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0015031(protein transport);GO:0035091(phosphatidylinositol binding)","NA",{"v":0.019,"d":"0.02"},1,"446,",0,-1.71,{"v":-0.901,"d":"-0.90"},8.02,"3' UTR",20,29267386,29272603,5218,1]
["chr20",33723985,33731439,7455,"ENSBGRG00000019153","ENSBGRT00000035657",0,"MYLK3","myosin light chain kinase 3 [Source:HGNC Symbol;Acc:HGNC:29826]","GO:0002528(regulation of vascular permeability involved in acute inflammatory response);GO:0004672(protein kinase activity);GO:0004683(calmodulin-dependent protein kinase activity);GO:0004687(myosin light chain kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0015629(actin cytoskeleton);GO:0045214(sarcomere organization);GO:0071347(cellular response to interleukin-1)","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04921(Oxytocin signaling pathway);04270(Vascular smooth muscle contraction);04971(Gastric acid secretion)",{"v":0.0011,"d":"0.00"},3,"477,91,269,","0,6381,7186",-2.94,-2.31,9.03,"Exon (ENSBGRT00000035657/ENSBGRG00000019153, exon 1 of 13)",20,33723985,33774247,50263,1]
["chr20",35801719,35802199,481,"ENSBGRG00000012190","ENSBGRT00000022352",646,"KLHDC4","kelch domain containing 4 [Source:HGNC Symbol;Acc:HGNC:25272]","GO:0005515(protein binding)","05168(Herpes simplex infection)",{"v":0.00026,"d":"0.00"},1,"481,",0,-3.59,-2.93,15,"5' UTR",20,35801073,35836087,35015,1]
["chr20",39057539,39059047,1509,"ENSBGRG00000016765","ENSBGRT00000030775",3040,"HSDL1","hydroxysteroid dehydrogenase like 1 [Source:HGNC Symbol;Acc:HGNC:16475]","GO:0005739(mitochondrion);GO:0043231(intracellular membrane-bounded organelle);GO:0045111(intermediate filament cytoskeleton)","00062(Fatty acid elongation);01040(Biosynthesis of unsaturated fatty acids)",{"v":4e-59,"d":"0.00"},3,"132,446,51,","0,805,1458",{"v":-58.4,"d":"-58.40"},{"v":-56.9,"d":"-56.90"},6.92,"Exon (ENSBGRT00000030775/ENSBGRG00000016765, exon 2 of 5)",20,39054499,39062046,7548,1]
["chr20",43510899,43510957,59,"ENSBGRG00000023784","ENSBGRT00000043936",525,"ENSBGRG00000023784","NA","NA","NA",{"v":0.0032,"d":"0.00"},1,"59,",0,-2.49,{"v":-1.9,"d":"-1.90"},3.81,"Exon (ENSBGRT00000043936/ENSBGRG00000023784, exon 1 of 3)",20,43510374,43525628,15255,1]
["chr20",48069580,48070327,748,"ENSBGRG00000013722","ENSBGRT00000025614",4795,"LDHD","lactate dehydrogenase D [Source:HGNC Symbol;Acc:HGNC:19708]","GO:0003824(catalytic activity);GO:0005739(mitochondrion);GO:0016491(oxidoreductase activity);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process);GO:0071949(FAD binding);GO:1903457(lactate catabolic process)","00620(Pyruvate metabolism)",{"v":0.032,"d":"0.03"},2,"38,113,","0,635",-1.49,{"v":-0.978,"d":"-0.98"},4.51,"3' UTR",20,48064785,48071120,6336,1]
["chr20",51707856,51710192,2337,"ENSBGRG00000013315","ENSBGRT00000024417",13008,"PPP6R1","protein phosphatase 6 regulatory subunit 1 [Source:HGNC Symbol;Acc:HGNC:29195]","GO:0005829(cytosol);GO:0017048(Rho GTPase binding);GO:0019903(protein phosphatase binding);GO:0043666(regulation of phosphoprotein phosphatase activity)","NA",{"v":0.00018,"d":"0.00"},2,"48,13,","0,2324",-3.75,-3.08,1.26,"Exon (ENSBGRT00000024417/ENSBGRG00000013315, exon 17 of 24)",20,51694848,51713129,18282,1]
["chr20",52681966,52682205,240,"ENSBGRG00000019551","ENSBGRT00000035918",14951,"MBOAT7","membrane bound O-acyltransferase domain containing 7 [Source:HGNC Symbol;Acc:HGNC:15505]","GO:0016020(membrane);GO:0021591(ventricular system development);GO:0021819(layer formation in cerebral cortex);GO:0044233(mitochondria-associated endoplasmic reticulum membrane);GO:0046488(phosphatidylinositol metabolic process);GO:0071617(lysophospholipid acyltransferase activity)","00564(Glycerophospholipid metabolism)",{"v":6.3e-16,"d":"0.00"},1,"240,",0,{"v":-15.2,"d":"-15.20"},{"v":-14.3,"d":"-14.30"},2.73,"5' UTR",20,52667015,52682265,15251,1]
["chr20",52734082,52734201,120,"ENSBGRG00000020367","ENSBGRT00000037421",458,"TFPT","TCF3 fusion partner [Source:HGNC Symbol;Acc:HGNC:13630]","GO:0005654(nucleoplasm);GO:0006915(apoptotic process);GO:0031011(Ino80 complex);GO:0031965(nuclear membrane);GO:0097190(apoptotic signaling pathway)","NA",{"v":1E-3,"d":"0.00"},1,"120,",0,-2.98,-2.35,1.43,"Exon (ENSBGRT00000037421/ENSBGRG00000020367, exon 2 of 5)",20,52733624,52741161,7538,1]
["chr20",53332522,53333300,779,"ENSBGRG00000022177","ENSBGRT00000040928",12360,"ZNF471","zinc finger protein 471 [Source:HGNC Symbol;Acc:HGNC:23226]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1E-4,"d":"0.00"},1,"779,",0,-3.98,{"v":-3.3,"d":"-3.30"},3.01,"Exon (ENSBGRT00000040928/ENSBGRG00000022177, exon 5 of 5)",20,53320162,53335065,14904,1]
["chr20",54595643,54645367,49725,"ENSBGRG00000015710","ENSBGRT00000028929",0,"ENSBGRG00000015710","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.6e-21,"d":"0.00"},2,"242,364,","0,49361",{"v":-20.8,"d":"-20.80"},{"v":-19.7,"d":"-19.70"},{"v":17.7,"d":"17.70"},"5' UTR",20,54594415,54612141,17727,2]
["chr20",55488522,55488879,358,"ENSBGRG00000017986","ENSBGRT00000032917",10249,"ENSBGRG00000017986","NA","NA","NA",{"v":2.8e-09,"d":"0.00"},1,"358,",0,-8.56,-7.74,3.58,"Exon (ENSBGRT00000032917/ENSBGRG00000017986, exon 4 of 4)",20,55478273,55489384,11112,1]
["chr20",57248127,57291938,43812,"ENSBGRG00000018016","ENSBGRT00000033219",0,"ENSBGRG00000018016","NA","NA","NA",{"v":7.1e-06,"d":"0.00"},5,"574,604,316,216,25,","0,634,42602,42996,43787",-5.15,-4.43,15,"5' UTR",20,57257267,57261168,3902,1]
["chr20",57508931,57509287,357,"ENSBGRG00000019132","ENSBGRT00000035119",11144,"ENSBGRG00000019132","NA","NA","NA",{"v":0.0032,"d":"0.00"},1,"357,",0,{"v":-2.5,"d":"-2.50"},-1.91,11,"3' UTR",20,57497787,57509287,11501,1]
["chr20",58689338,58689485,148,"ENSBGRG00000020182","ENSBGRT00000037107",1031,"ENSBGRG00000020182","NA","GO:0003676(nucleic acid binding)","NA",{"v":0.0032,"d":"0.00"},1,"148,",0,{"v":-2.5,"d":"-2.50"},-1.91,2.64,"Exon (ENSBGRT00000037107/ENSBGRG00000020182, exon 1 of 1)",20,58688307,58689485,1179,1]
["chr20",59592915,59593145,231,"ENSBGRG00000017985","ENSBGRT00000032933",402,"NTF4","neurotrophin 4 [Source:HGNC Symbol;Acc:HGNC:8024]","GO:0005102(signaling receptor binding);GO:0005576(extracellular region);GO:0007402(ganglion mother cell fate determination);GO:0007616(long-term memory);GO:0008052(sensory organ boundary specification);GO:0008083(growth factor activity);GO:0008344(adult locomotory behavior);GO:0008544(epidermis development);GO:0042490(mechanoreceptor differentiation);GO:0060384(innervation);GO:0060548(negative regulation of cell death);GO:0061193(taste bud development)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04722(Neurotrophin signaling pathway)",{"v":4e-09,"d":"0.00"},1,"231,",0,{"v":-8.4,"d":"-8.40"},-7.58,4.61,"Exon (ENSBGRT00000032933/ENSBGRG00000017985, exon 1 of 1)",20,59592513,59593145,633,1]
["chr20",59746155,59746452,298,"ENSBGRG00000019543","ENSBGRT00000035937",27574,"PLEKHA4","pleckstrin homology domain containing A4 [Source:HGNC Symbol;Acc:HGNC:14339]","GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0043325(phosphatidylinositol-3,4-bisphosphate binding);GO:0080025(phosphatidylinositol-3,5-bisphosphate binding);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:2000096(positive regulation of Wnt signaling pathway, planar cell polarity pathway)","NA",{"v":1.6E-13,"d":"0.00"},1,"298,",0,{"v":-12.8,"d":"-12.80"},{"v":-11.9,"d":"-11.90"},3.43,"5' UTR",20,59718581,59746387,27807,1]
["chr20",60243458,60254270,10813,"ENSBGRG00000021999","ENSBGRT00000040620",0,"ENSBGRG00000021999","NA","NA","NA",0.01,2,"110,11,","0,10802",-1.98,-1.42,4.35,"Exon (ENSBGRT00000040539/ENSBGRG00000021948, exon 4 of 15)",20,60249437,60250558,1122,2]
["chr20",61815732,61817212,1481,"ENSBGRG00000018221","ENSBGRT00000033316",1186,"ENSBGRG00000018221","NA","NA","NA",{"v":0.019,"d":"0.02"},2,"322,271,","0,1210",-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000033316/ENSBGRG00000018221, exon 2 of 2)",20,61814546,61816053,1508,1]
["chr20",62901835,62903526,1692,"ENSBGRG00000024051","ENSBGRT00000044376",1124,"NKPD1","NTPase KAP family P-loop domain containing 1 [Source:HGNC Symbol;Acc:HGNC:24739]","NA","NA",{"v":1E-10,"d":"0.00"},2,"443,594,","0,1098",-9.99,-9.14,{"v":30.1,"d":"30.10"},"Exon (ENSBGRT00000044376/ENSBGRG00000024051, exon 1 of 2)",20,62900711,62903526,2816,1]
["chr20",64043072,64045549,2478,"ENSBGRG00000011490","ENSBGRT00000020928",3746,"IRGQ","immunity related GTPase Q [Source:HGNC Symbol;Acc:HGNC:24868]","GO:0005525(GTP binding)","NA",{"v":1.3E-43,"d":"0.00"},2,"476,1068,","0,1410",{"v":-42.9,"d":"-42.90"},{"v":-41.6,"d":"-41.60"},8.68,"3' UTR",20,64039326,64045994,6669,1]
["chr20",64206256,64206345,90,"ENSBGRG00000012598","ENSBGRT00000023150",30744,"PHLDB3","pleckstrin homology like domain family B member 3 [Source:HGNC Symbol;Acc:HGNC:30499]","GO:0019899(enzyme binding)","04141(Protein processing in endoplasmic reticulum)",{"v":0.017,"d":"0.02"},1,"90,",0,-1.76,-1.22,7.02,"3' UTR",20,64175512,64206885,31374,1]
["chr20",65447886,65448214,329,"ENSBGRG00000019201","ENSBGRT00000035261",4822,"EXOSC5","exosome component 5 [Source:HGNC Symbol;Acc:HGNC:24662]","GO:0000178(exosome (RNase complex));GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006401(RNA catabolic process);GO:0035327(transcriptionally active chromatin);GO:0043928(exonucleolytic catabolism of deadenylated mRNA);GO:0045006(DNA deamination);GO:0051607(defense response to virus)","03018(RNA degradation)",{"v":3.2e-30,"d":"0.00"},1,"329,",0,{"v":-29.5,"d":"-29.50"},{"v":-28.3,"d":"-28.30"},{"v":5.9,"d":"5.90"},"3' UTR",20,65443064,65448244,5181,1]
["chr20",66364946,66365065,120,"ENSBGRG00000020297","ENSBGRT00000037336",12682,"PRX","periaxin [Source:HGNC Symbol;Acc:HGNC:13797]","GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation)","04218(Cellular senescence)",{"v":0.032,"d":"0.03"},1,"120,",0,-1.49,{"v":-0.978,"d":"-0.98"},4.51,"Exon (ENSBGRT00000037358/ENSBGRG00000020297, exon 3 of 3)",20,66352264,66380206,27943,1]
["chr20",66704251,66704611,361,"ENSBGRG00000021421","ENSBGRT00000041526",2192,"ENSBGRG00000021421","NA","GO:0005515(protein binding)","NA",{"v":5e-05,"d":"0.00"},1,"361,",0,{"v":-4.3,"d":"-4.30"},{"v":-3.6,"d":"-3.60"},15,"5' UTR",20,66702059,66742495,40437,1]
["chr20",67686352,67687748,1397,"ENSBGRG00000025608","ENSBGRT00000047348",0,"HNRNPL","heterogeneous nuclear ribonucleoprotein L [Source:HGNC Symbol;Acc:HGNC:5045]","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0035770(ribonucleoprotein granule);GO:0045120(pronucleus);GO:0097157(pre-mRNA intronic binding);GO:1990904(ribonucleoprotein complex)","NA",{"v":0.0058,"d":"0.01"},2,"291,606,","0,791",-2.24,-1.66,10,"5' UTR",20,67686352,67702124,15773,1]
["chr20",69484189,69509335,25147,"ENSBGRG00000018690","ENSBGRT00000034229",5886,"ZNF382","zinc finger protein 382 [Source:HGNC Symbol;Acc:HGNC:17409]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":5e-13,"d":"0.00"},2,"74,431,","0,24716",{"v":-12.3,"d":"-12.30"},{"v":-11.4,"d":"-11.40"},6.62,"Exon (ENSBGRT00000034229/ENSBGRG00000018690, exon 4 of 5)",20,69478303,69510580,32278,1]
["chr20",70942660,70943185,526,"ENSBGRG00000018925","ENSBGRT00000034684",405,"ENSBGRG00000018925","NA","GO:0005509(calcium ion binding);GO:0019722(calcium-mediated signaling)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04371(Apelin signaling pathway);04020(Calcium signaling pathway);04070(Phosphatidylinositol signaling system);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04114(Oocyte meiosis);04218(Cellular senescence);04625(C-type lectin receptor signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04921(Oxytocin signaling pathway);04916(Melanogenesis);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04728(Dopaminergic synapse);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04744(Phototransduction);04740(Olfactory transduction);04750(Inflammatory mediator regulation of TRP channels);04713(Circadian entrainment);05200(Pathways in cancer);05214(Glioma);05010(Alzheimer disease);05031(Amphetamine addiction);05034(Alcoholism);05418(Fluid shear stress and atherosclerosis);05133(Pertussis);05152(Tuberculosis);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":1.6e-24,"d":"0.00"},2,"16,158,","0,368",{"v":-23.8,"d":"-23.80"},{"v":-22.7,"d":"-22.70"},1.55,"Exon (ENSBGRT00000034684/ENSBGRG00000018925, exon 1 of 2)",20,70942255,70943359,1105,1]
["chr20",1643164,1643583,420,"ENSBGRG00000012352","ENSBGRT00000022611",30,"CEBPG","CCAAT enhancer binding protein gamma [Source:HGNC Symbol;Acc:HGNC:1837]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006955(immune response);GO:0008134(transcription factor binding);GO:0016071(mRNA metabolic process);GO:0030183(B cell differentiation);GO:0032729(positive regulation of interferon-gamma production);GO:0042267(natural killer cell mediated cytotoxicity);GO:0042802(identical protein binding);GO:0043353(enucleate erythrocyte differentiation);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043565(sequence-specific DNA binding);GO:0045739(positive regulation of DNA repair);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding)","05152(Tuberculosis)",{"v":2.5E-93,"d":"0.00"},1,"420,",0,{"v":-92.6,"d":"-92.60"},{"v":-90.9,"d":"-90.90"},8.19,"Exon (ENSBGRT00000022611/ENSBGRG00000012352, exon 1 of 1)",20,1643164,1643613,450,2]
["chr20",2702055,2703637,1583,"ENSBGRG00000017072","ENSBGRT00000031350",11089,"ZNF507","zinc finger protein 507 [Source:HGNC Symbol;Acc:HGNC:23783]","GO:0003676(nucleic acid binding)","NA",0.04,2,"86,64,","0,1519",{"v":-1.4,"d":"-1.40"},{"v":-0.901,"d":"-0.90"},2.01,"Exon (ENSBGRT00000031350/ENSBGRG00000017072, exon 3 of 8)",20,2672099,2714726,42628,2]
["chr20",7775535,7776314,780,"ENSBGRG00000021541","ENSBGRT00000039732",197008,"ZFHX3","zinc finger homeobox 3 [Source:HGNC Symbol;Acc:HGNC:777]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0016604(nuclear body);GO:0019899(enzyme binding);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0071559(response to transforming growth factor beta)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":1E-14,"d":"0.00"},1,"780,",0,-14,{"v":-13.1,"d":"-13.10"},13,"Exon (ENSBGRT00000039732/ENSBGRG00000021541, exon 11 of 11)",20,7774906,7973322,198417,2]
["chr20",9901818,9903721,1904,"ENSBGRG00000008997","ENSBGRT00000016991",98,"ENSBGRG00000008997","NA","GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0036258(multivesicular body assembly);GO:0048471(perinuclear region of cytoplasm);GO:0048524(positive regulation of viral process);GO:0061738(late endosomal microautophagy)","04144(Endocytosis);04217(Necroptosis)",{"v":2e-20,"d":"0.00"},4,"114,62,148,125,","0,230,1531,1779",{"v":-19.7,"d":"-19.70"},{"v":-18.7,"d":"-18.70"},1.95,"Exon (ENSBGRT00000016991/ENSBGRG00000008997, exon 1 of 11)",20,9890095,9903819,13725,2]
["chr20",10050271,10051401,1131,"ENSBGRG00000011661","ENSBGRT00000021503",9500,"HAS3","hyaluronan synthase 3 [Source:HGNC Symbol;Acc:HGNC:4820]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0030213(hyaluronan biosynthetic process);GO:0036117(hyaluranon cable);GO:0042802(identical protein binding);GO:0045226(extracellular polysaccharide biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0050501(hyaluronan synthase activity);GO:0085029(extracellular matrix assembly);GO:1900106(positive regulation of hyaluranon cable assembly)","NA",{"v":1e-200,"d":"0.00"},2,"96,292,","0,839",-200,-198,6.15,"3' UTR",20,10050271,10060901,10631,2]
["chr20",11471782,11471930,149,"ENSBGRG00000026725","ENSBGRT00000049566",59,"ENSBGRG00000026725","NA","NA","NA",{"v":0.039,"d":"0.04"},1,"149,",0,-1.41,{"v":-0.908,"d":"-0.91"},2.51,"Exon (ENSBGRT00000049566/ENSBGRG00000026725, exon 1 of 3)",20,11459727,11471989,12263,2]
["chr20",12054514,12055346,833,"ENSBGRG00000026901","ENSBGRT00000049886",0,"PDP2","pyruvate dehyrogenase phosphatase catalytic subunit 2 [Source:HGNC Symbol;Acc:HGNC:30263]","GO:0003824(catalytic activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0043169(cation binding)","NA",{"v":1.3E-25,"d":"0.00"},1,"833,",0,{"v":-24.9,"d":"-24.90"},{"v":-23.8,"d":"-23.80"},6.52,"Exon (ENSBGRT00000049886/ENSBGRG00000026901, exon 1 of 2)",20,12053041,12055346,2306,2]
["chr20",22577857,22578245,389,"ENSBGRG00000019570","ENSBGRT00000037099",8777,"ENSBGRG00000019570","NA","NA","NA",{"v":0.0044,"d":"0.00"},1,"389,",0,-2.36,-1.77,2.18,"Exon (ENSBGRT00000037099/ENSBGRG00000019570, exon 3 of 40)",20,22519324,22587022,67699,2]
["chr20",29128844,29130800,1957,"ENSBGRG00000005642","ENSBGRT00000010723",63728,"CYLD","CYLD lysine 63 deubiquitinase [Source:HGNC Symbol;Acc:HGNC:2584]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005813(centrosome);GO:0005819(spindle);GO:0005829(cytosol);GO:0005881(cytoplasmic microtubule);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007346(regulation of mitotic cell cycle);GO:0008270(zinc ion binding);GO:0010803(regulation of tumor necrosis factor-mediated signaling pathway);GO:0016579(protein deubiquitination);GO:0019901(protein kinase binding);GO:0030496(midbody);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0036064(ciliary basal body);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0043369(CD4-positive or CD8-positive, alpha-beta T cell lineage commitment);GO:0043393(regulation of protein binding);GO:0045087(innate immune response);GO:0045577(regulation of B cell differentiation);GO:0045582(positive regulation of T cell differentiation);GO:0046329(negative regulation of JNK cascade);GO:0048872(homeostasis of number of cells);GO:0050727(regulation of inflammatory response);GO:0050862(positive regulation of T cell receptor signaling pathway);GO:0060544(regulation of necroptotic process);GO:0061578(Lys63-specific deubiquitinase activity);GO:0070064(proline-rich region binding);GO:0070266(necroptotic process);GO:0070507(regulation of microtubule cytoskeleton organization);GO:0070536(protein K63-linked deubiquitination);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0097542(ciliary tip);GO:1901026(ripoptosome assembly involved in necroptotic process);GO:1901223(negative regulation of NIK/NF-kappaB signaling);GO:1902017(regulation of cilium assembly);GO:1903753(negative regulation of p38MAPK cascade);GO:1903829(positive regulation of cellular protein localization);GO:1990108(protein linear deubiquitination);GO:1990380(Lys48-specific deubiquitinase activity);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001242(regulation of intrinsic apoptotic signaling pathway)","04217(Necroptosis);04622(RIG-I-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04380(Osteoclast differentiation)",{"v":3.4e-09,"d":"0.00"},2,"262,36,","0,1921",-8.47,-7.65,{"v":2.8,"d":"2.80"},"3' UTR",20,29128546,29194528,65983,2]
["chr20",29933440,29933839,400,"ENSBGRG00000011232","ENSBGRT00000020508",0,"HEATR3","HEAT repeat containing 3 [Source:HGNC Symbol;Acc:HGNC:26087]","NA","NA",{"v":0.048,"d":"0.05"},2,"136,135,","0,265",-1.32,{"v":-0.827,"d":"-0.83"},3.01,"Exon (ENSBGRT00000020508/ENSBGRG00000011232, exon 1 of 15)",20,29890871,29933839,42969,2]
["chr20",35018732,35019202,471,"ENSBGRG00000026899","ENSBGRT00000049885",8739,"CTU2","cytosolic thiouridylase subunit 2 [Source:HGNC Symbol;Acc:HGNC:28005]","GO:0000049(tRNA binding);GO:0002098(tRNA wobble uridine modification);GO:0034227(tRNA thio-modification)","04122(Sulfur relay system)",{"v":1E-13,"d":"0.00"},3,"196,59,44,","0,274,427",-13,{"v":-12.1,"d":"-12.10"},2.42,"3' UTR",20,35018732,35027941,9210,2]
["chr20",35653465,35653822,358,"ENSBGRG00000011338","ENSBGRT00000020731",30,"BANP","BTG3 associated nuclear protein [Source:HGNC Symbol;Acc:HGNC:13450]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0045893(positive regulation of transcription, DNA-templated)","NA",{"v":0.0072,"d":"0.01"},1,"358,",0,-2.14,-1.58,5.52,"5' UTR",20,35571344,35653852,82509,2]
["chr20",36791553,36791790,238,"ENSBGRG00000013151","ENSBGRT00000024001",1271,"FOXC2","forkhead box C2 [Source:HGNC Symbol;Acc:HGNC:3801]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001216(DNA-binding transcription activator activity);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0001503(ossification);GO:0001568(blood vessel development);GO:0001569(branching involved in blood vessel morphogenesis);GO:0001656(metanephros development);GO:0001657(ureteric bud development);GO:0001756(somitogenesis);GO:0001822(kidney development);GO:0001945(lymph vessel development);GO:0001946(lymphangiogenesis);GO:0001974(blood vessel remodeling);GO:0003007(heart morphogenesis);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007219(Notch signaling pathway);GO:0007507(heart development);GO:0008283(cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0009725(response to hormone);GO:0010595(positive regulation of endothelial cell migration);GO:0014032(neural crest cell development);GO:0016604(nuclear body);GO:0030199(collagen fibril organization);GO:0031490(chromatin DNA binding);GO:0033630(positive regulation of cell adhesion mediated by integrin);GO:0035050(embryonic heart tube development);GO:0035470(positive regulation of vascular wound healing);GO:0042802(identical protein binding);GO:0043010(camera-type eye development);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046620(regulation of organ growth);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048341(paraxial mesoderm formation);GO:0048343(paraxial mesodermal cell fate commitment);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0048703(embryonic viscerocranium morphogenesis);GO:0048704(embryonic skeletal system morphogenesis);GO:0048844(artery morphogenesis);GO:0055010(ventricular cardiac muscle tissue morphogenesis);GO:0060038(cardiac muscle cell proliferation);GO:0072011(glomerular endothelium development);GO:0072112(glomerular visceral epithelial cell differentiation);GO:0072144(glomerular mesangial cell development);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis);GO:0097746(regulation of blood vessel diameter);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1902257(negative regulation of apoptotic process involved in outflow tract morphogenesis);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990841(promoter-specific chromatin binding)","NA",{"v":0.00089,"d":"0.00"},1,"238,",0,-3.05,-2.42,3.68,"Exon (ENSBGRT00000024001/ENSBGRG00000013151, exon 1 of 1)",20,36791553,36793061,1509,2]
["chr20",41530798,41532875,2078,"ENSBGRG00000020212","ENSBGRT00000041384",58161,"CMIP","c-Maf inducing protein [Source:HGNC Symbol;Acc:HGNC:24319]","GO:0005654(nucleoplasm);GO:0005829(cytosol)","NA",{"v":6.3e-26,"d":"0.00"},2,"488,21,","0,2057",{"v":-25.2,"d":"-25.20"},{"v":-24.1,"d":"-24.10"},{"v":43.1,"d":"43.10"},"3' UTR",20,41530499,41591036,60538,2]
["chr20",48848978,48850579,1602,"ENSBGRG00000017512","ENSBGRT00000032512",20033,"ENSBGRG00000017512","NA","GO:0003676(nucleic acid binding);GO:0005524(ATP binding)","NA",{"v":0.0026,"d":"0.00"},3,"19,200,40,","0,1012,1562",-2.59,-1.99,2.23,"Exon (ENSBGRT00000032512/ENSBGRG00000017512, exon 8 of 12)",20,48828945,48852697,23753,1]
["chr20",51306292,51306620,329,"ENSBGRG00000022243","ENSBGRT00000041122",0,"U2AF2","U2 small nuclear RNA auxiliary factor 2 [Source:HGNC Symbol;Acc:HGNC:23156]","GO:0000398(mRNA splicing, via spliceosome);GO:0000974(Prp19 complex);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005681(spliceosomal complex);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0019899(enzyme binding);GO:0030628(pre-mRNA 3'-splice site binding);GO:0031397(negative regulation of protein ubiquitination);GO:0033120(positive regulation of RNA splicing);GO:0048025(negative regulation of mRNA splicing, via spliceosome);GO:0070742(C2H2 zinc finger domain binding);GO:0071004(U2-type prespliceosome);GO:0089701(U2AF)","03040(Spliceosome)",{"v":1e-239,"d":"0.00"},1,"329,",0,-239,-236,8.03,"5' UTR",20,51292317,51306620,14304,2]
["chr20",51595894,51596905,1012,"ENSBGRG00000012706","ENSBGRT00000023283",6686,"KMT5C","lysine methyltransferase 5C [Source:HGNC Symbol;Acc:HGNC:28405]","GO:0000780(condensed nuclear chromosome, centromeric region);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005720(nuclear heterochromatin);GO:0005721(pericentric heterochromatin);GO:0006281(DNA repair);GO:0016571(histone methylation);GO:0034773(histone H4-K20 trimethylation);GO:0042393(histone binding);GO:0042799(histone methyltransferase activity (H4-K20 specific));GO:0045830(positive regulation of isotype switching);GO:1904047(S-adenosyl-L-methionine binding);GO:2001034(positive regulation of double-strand break repair via nonhomologous end joining)","00310(Lysine degradation)",{"v":2E-35,"d":"0.00"},1,"1012,",0,{"v":-34.7,"d":"-34.70"},{"v":-33.5,"d":"-33.50"},5.12,"3' UTR",20,51595894,51603591,7698,2]
["chr20",53401944,53402244,301,"ENSBGRG00000013301","ENSBGRT00000024400",1724,"ENSBGRG00000013301","NA","GO:0003676(nucleic acid binding)","NA",{"v":1.2e-07,"d":"0.00"},1,"301,",0,-6.93,-6.15,3.51,"Exon (ENSBGRT00000024458/ENSBGRG00000013356, exon 4 of 4)",20,53401636,53403968,2333,2]
["chr20",54359128,54359866,739,"ENSBGRG00000015005","ENSBGRT00000027680",21206,"ENSBGRG00000015005","NA","GO:0003676(nucleic acid binding)","NA",{"v":1.4e-10,"d":"0.00"},1,"739,",0,-9.84,-8.99,{"v":26.1,"d":"26.10"},"Exon (ENSBGRT00000027754/ENSBGRG00000015097, exon 7 of 7)",20,54358673,54381072,22400,2]
["chr20",54562971,54575787,12817,"ENSBGRG00000015633","ENSBGRT00000028749",0,"ENSBGRG00000015633","NA","NA","03010(Ribosome)",{"v":5.5e-05,"d":"0.00"},3,"335,64,51,","0,12662,12766",-4.26,-3.57,5.77,"Exon (ENSBGRT00000028749/ENSBGRG00000015633, exon 1 of 2)",20,54564476,54564858,383,1]
["chr20",55498318,55498674,357,"ENSBGRG00000018097","ENSBGRT00000033103",3010,"ENSBGRG00000018097","NA","NA","NA",{"v":0.0013,"d":"0.00"},1,"357,",0,{"v":-2.9,"d":"-2.90"},-2.28,2.04,"Exon (ENSBGRT00000033103/ENSBGRG00000018097, exon 2 of 2)",20,55497486,55501684,4199,2]
["chr20",55994637,56020482,25846,"ENSBGRG00000015081","ENSBGRT00000027746",419,"ENSBGRG00000015081","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":9.3e-07,"d":"0.00"},3,"14,234,141,","0,19595,25705",-6.03,-5.27,6.62,"5' UTR",20,55957155,56020901,63747,2]
["chr20",57170090,57170480,391,"ENSBGRG00000017669","ENSBGRT00000032341",6683,"ZNF614","zinc finger protein 614 [Source:HGNC Symbol;Acc:HGNC:24722]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":2.7E-10,"d":"0.00"},1,"391,",0,-9.57,-8.73,{"v":11.4,"d":"11.40"},"Exon (ENSBGRT00000032341/ENSBGRG00000017669, exon 5 of 5)",20,57169760,57177163,7404,2]
["chr20",57617582,57620872,3291,"ENSBGRG00000014096","ENSBGRT00000025855",16573,"IGLON5","IgLON family member 5 [Source:HGNC Symbol;Acc:HGNC:34550]","NA","NA",{"v":0.00045,"d":"0.00"},4,"304,155,155,45,","0,1408,2530,3246",-3.35,{"v":-2.7,"d":"-2.70"},11,"3' UTR",20,57616337,57637445,21109,2]
["chr20",58825996,58826620,625,"ENSBGRG00000020970","ENSBGRT00000038821",8194,"TBC1D17","TBC1 domain family member 17 [Source:HGNC Symbol;Acc:HGNC:25699]","GO:0005829(cytosol);GO:0042147(retrograde transport, endosome to Golgi)","04137(Mitophagy - animal)",{"v":2.5e-95,"d":"0.00"},1,"625,",0,{"v":-94.6,"d":"-94.60"},{"v":-92.8,"d":"-92.80"},4.68,"3' UTR",20,58825996,58834814,8819,2]
["chr20",59197957,59198557,601,"ENSBGRG00000014086","ENSBGRT00000026178",240,"ALDH16A1","aldehyde dehydrogenase 16 family member A1 [Source:HGNC Symbol;Acc:HGNC:28114]","GO:0016491(oxidoreductase activity);GO:0016620(oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor);GO:0055114(oxidation-reduction process)","00010(Glycolysis / Gluconeogenesis);00053(Ascorbate and aldarate metabolism);00620(Pyruvate metabolism);00071(Fatty acid degradation);00561(Glycerolipid metabolism);00280(Valine, leucine and isoleucine degradation);00310(Lysine degradation);00330(Arginine and proline metabolism);00340(Histidine metabolism);00380(Tryptophan metabolism);00410(beta-Alanine metabolism)",{"v":0.011,"d":"0.01"},1,"601,",0,-1.97,-1.14,9.03,"5' UTR",20,59181721,59198797,17077,2]
["chr20",60357837,60358047,211,"ENSBGRG00000022110","ENSBGRT00000040821",3615,"ENSBGRG00000022110","NA","GO:0003676(nucleic acid binding)","NA",{"v":0.0013,"d":"0.00"},1,"211,",0,{"v":-2.9,"d":"-2.90"},-2.28,4.76,"Exon (ENSBGRT00000040821/ENSBGRG00000022110, exon 4 of 4)",20,60356368,60361662,5295,2]
["chr20",61507463,61522969,15507,"ENSBGRG00000016330","ENSBGRT00000030164",330,"ARHGAP35","Rho GTPase activating protein 35 [Source:HGNC Symbol;Acc:HGNC:4591]","GO:0001843(neural tube closure);GO:0003924(GTPase activity);GO:0005096(GTPase activator activity);GO:0005525(GTP binding);GO:0005543(phospholipid binding);GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0008064(regulation of actin polymerization or depolymerization);GO:0008360(regulation of cell shape);GO:0010976(positive regulation of neuron projection development);GO:0015629(actin cytoskeleton);GO:0016477(cell migration);GO:0021955(central nervous system neuron axonogenesis);GO:0030879(mammary gland development);GO:0030900(forebrain development);GO:0030950(establishment or maintenance of actin cytoskeleton polarity);GO:0031668(cellular response to extracellular stimulus);GO:0032956(regulation of actin cytoskeleton organization);GO:0035024(negative regulation of Rho protein signal transduction);GO:0036064(ciliary basal body);GO:0043010(camera-type eye development);GO:0043116(negative regulation of vascular permeability);GO:0044319(wound healing, spreading of cells);GO:0045724(positive regulation of cilium assembly);GO:0050770(regulation of axonogenesis);GO:0097485(neuron projection guidance)","04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04670(Leukocyte transendothelial migration)",{"v":2e-68,"d":"0.00"},2,"110,2166,","0,13341",{"v":-67.7,"d":"-67.70"},{"v":-66.2,"d":"-66.20"},5.55,"5' UTR",20,61446195,61523299,77105,2]
["chr20",61667063,61668253,1191,"ENSBGRG00000017133","ENSBGRT00000031407",297,"FKRP","fukutin related protein [Source:HGNC Symbol;Acc:HGNC:17997]","GO:0002162(dystroglycan binding);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005791(rough endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0009101(glycoprotein biosynthetic process);GO:0016485(protein processing);GO:0035269(protein O-linked mannosylation);GO:0042383(sarcolemma)","00515(Mannose type O-glycan biosyntheis)",{"v":1.3E-80,"d":"0.00"},1,"1191,",0,{"v":-79.9,"d":"-79.90"},{"v":-78.3,"d":"-78.30"},{"v":16.4,"d":"16.40"},"Exon (ENSBGRT00000031407/ENSBGRG00000017133, exon 1 of 1)",20,61667063,61668550,1488,2]
["chr20",62909960,62910050,91,"ENSBGRG00000024063","ENSBGRT00000044400",45696,"PPP1R37","protein phosphatase 1 regulatory subunit 37 [Source:HGNC Symbol;Acc:HGNC:27607]","GO:0005515(protein binding);GO:0010923(negative regulation of phosphatase activity)","NA",{"v":0.035,"d":"0.04"},1,"91,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000044400/ENSBGRG00000024063, exon 11 of 14)",20,62908651,62955746,47096,2]
["chr20",63791120,63794366,3247,"ENSBGRG00000010364","ENSBGRT00000019008",625,"ENSBGRG00000010364","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.3E-6,"d":"0.00"},3,"91,88,119,","0,2392,3128",-5.87,-5.11,2.35,"5' UTR",20,63783532,63794991,11460,2]
["chr20",65042155,65042807,653,"ENSBGRG00000018054","ENSBGRT00000033069",2252,"PAFAH1B3","platelet activating factor acetylhydrolase 1b catalytic subunit 3 [Source:HGNC Symbol;Acc:HGNC:8576]","GO:0005737(cytoplasm);GO:0007283(spermatogenesis);GO:0042802(identical protein binding)","00565(Ether lipid metabolism)",{"v":4e-29,"d":"0.00"},1,"653,",0,{"v":-28.4,"d":"-28.40"},{"v":-27.2,"d":"-27.20"},2.24,"3' UTR",20,65041711,65045059,3349,2]
["chr20",66067590,66068518,929,"ENSBGRG00000015946","ENSBGRT00000029402",150,"ITPKC","inositol-trisphosphate 3-kinase C [Source:HGNC Symbol;Acc:HGNC:14897]","GO:0008440(inositol-1,4,5-trisphosphate 3-kinase activity);GO:0016301(kinase activity);GO:0016607(nuclear speck);GO:0032958(inositol phosphate biosynthetic process)","00562(Inositol phosphate metabolism);04020(Calcium signaling pathway);04070(Phosphatidylinositol signaling system)",{"v":5e-61,"d":"0.00"},1,"929,",0,{"v":-60.3,"d":"-60.30"},{"v":-58.9,"d":"-58.90"},6.87,"Exon (ENSBGRT00000029402/ENSBGRG00000015946, exon 1 of 7)",20,66050574,66068668,18095,2]
["chr20",67132369,67132579,211,"ENSBGRG00000024478","ENSBGRT00000045210",60,"SAMD4B","sterile alpha motif domain containing 4B [Source:HGNC Symbol;Acc:HGNC:25492]","GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0017148(negative regulation of translation);GO:0030371(translation repressor activity);GO:0043488(regulation of mRNA stability)","04012(ErbB signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton)",{"v":1.7e-07,"d":"0.00"},1,"211,",0,-6.77,-5.99,2.66,"5' UTR",20,67108636,67132639,24004,2]
["chr20",68390988,68396053,5066,"ENSBGRG00000015384","ENSBGRT00000030524",34383,"SIPA1L3","signal induced proliferation associated 1 like 3 [Source:HGNC Symbol;Acc:HGNC:23801]","GO:0001654(eye development);GO:0001725(stress fiber);GO:0002244(hematopoietic progenitor cell differentiation);GO:0003382(epithelial cell morphogenesis);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0007010(cytoskeleton organization);GO:0045177(apical part of cell);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0061689(tricellular tight junction);GO:0090162(establishment of epithelial cell polarity)","04015(Rap1 signaling pathway)",{"v":1.8E-7,"d":"0.00"},2,"79,550,","0,4516",-6.74,-5.97,3.93,"Exon (ENSBGRT00000030524/ENSBGRG00000015384, exon 11 of 25)",20,68315235,68430436,115202,2]
["chr20",69602819,69603694,876,"ENSBGRG00000018899","ENSBGRT00000034634",0,"ZNF146","zinc finger protein 146 [Source:HGNC Symbol;Acc:HGNC:12931]","GO:0003676(nucleic acid binding);GO:0005730(nucleolus);GO:0005829(cytosol)","NA",{"v":1e-122,"d":"0.00"},1,"876,",0,-122,-120,3.49,"Exon (ENSBGRT00000034634/ENSBGRG00000018899, exon 1 of 1)",20,69602819,69603694,876,2]
["chr20",69722317,69722526,210,"ENSBGRG00000019552","ENSBGRT00000039493",57904,"WDR62","WD repeat domain 62 [Source:HGNC Symbol;Acc:HGNC:24502]","GO:0000922(spindle pole);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0007052(mitotic spindle organization);GO:0007099(centriole replication);GO:0021987(cerebral cortex development);GO:0022008(neurogenesis);GO:0034451(centriolar satellite)","NA",{"v":2E-3,"d":"0.00"},1,"210,",0,-2.69,-2.08,7.02,"Exon (ENSBGRT00000039493/ENSBGRG00000019552, exon 31 of 31)",20,69722317,69780430,58114,2]
["chr20",70552734,70552943,210,"ENSBGRG00000015347","ENSBGRT00000028178",15736,"CD22","CD22 molecule [Source:HGNC Symbol;Acc:HGNC:1643]","GO:0005769(early endosome);GO:0030100(regulation of endocytosis);GO:0042113(B cell activation);GO:0050859(negative regulation of B cell receptor signaling pathway);GO:0055037(recycling endosome)","04514(Cell adhesion molecules (CAMs));04640(Hematopoietic cell lineage);04662(B cell receptor signaling pathway)",{"v":0.00065,"d":"0.00"},1,"210,",0,-3.19,-2.55,13,"3' UTR",20,70552734,70568679,15946,2]
["chr21",9390222,9418268,28047,"ENSBGRG00000022510","ENSBGRT00000041548",0,"ZNF407","zinc finger protein 407 [Source:HGNC Symbol;Acc:HGNC:19904]","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding)","NA",{"v":7.9e-11,"d":"0.00"},2,"353,395,","0,27652",{"v":-10.1,"d":"-10.10"},-9.22,5.93,"5' UTR",21,9390222,9816832,426611,1]
["chr21",13116352,13118518,2167,"ENSBGRG00000024256","ENSBGRT00000044790",15903,"CTDP1","CTD phosphatase subunit 1 [Source:HGNC Symbol;Acc:HGNC:2498]","GO:0000922(spindle pole);GO:0001096(TFIIF-class transcription factor complex binding);GO:0004721(phosphoprotein phosphatase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005819(spindle);GO:0006470(protein dephosphorylation);GO:0008420(RNA polymerase II CTD heptapeptide repeat phosphatase activity);GO:0010458(exit from mitosis);GO:0030496(midbody);GO:0030957(Tat protein binding);GO:0032991(protein-containing complex);GO:0043231(intracellular membrane-bounded organelle);GO:0043923(positive regulation by host of viral transcription);GO:0051233(spindle midzone);GO:0070940(dephosphorylation of RNA polymerase II C-terminal domain)","NA",{"v":1.3E-24,"d":"0.00"},3,"155,978,34,","0,918,2133",{"v":-23.9,"d":"-23.90"},{"v":-22.8,"d":"-22.80"},6.18,"Exon (ENSBGRT00000044790/ENSBGRG00000024256, exon 7 of 13)",21,13100449,13134547,34099,1]
["chr21",15848401,15854872,6472,"ENSBGRG00000019009","ENSBGRT00000035028",72957,"RPRD1A","regulation of nuclear pre-mRNA domain containing 1A [Source:HGNC Symbol;Acc:HGNC:25560]","GO:0016591(RNA polymerase II, holoenzyme);GO:0070940(dephosphorylation of RNA polymerase II C-terminal domain)","NA",{"v":1.1e-07,"d":"0.00"},3,"1,198,71,","0,3700,6401",-6.95,-6.17,2.65,"3' UTR",21,15775444,15854872,79429,1]
["chr21",26480735,26491111,10377,"ENSBGRG00000024680","ENSBGRT00000045596",69389,"SS18","SS18 subunit of BAF chromatin remodeling complex [Source:HGNC Symbol;Acc:HGNC:11340]","GO:0000226(microtubule cytoskeleton organization);GO:0000902(cell morphogenesis);GO:0003713(transcription coactivator activity);GO:0005881(cytoplasmic microtubule);GO:0007010(cytoskeleton organization);GO:0016514(SWI/SNF complex);GO:0030374(nuclear receptor transcription coactivator activity);GO:0035556(intracellular signal transduction);GO:0042493(response to drug);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048013(ephrin receptor signaling pathway);GO:0071564(npBAF complex);GO:0097150(neuronal stem cell population maintenance)","05202(Transcriptional misregulation in cancers)",0,2,"78,580,","0,9797",-374,"-Inf",5.84,"3' UTR",21,26411346,26492305,80960,1]
["chr21",34044044,34044343,300,"ENSBGRG00000022793","ENSBGRT00000042059",31149,"ENSBGRG00000022793","NA","NA","NA",{"v":6.6E-3,"d":"0.01"},1,"300,",0,-2.18,-1.61,3.34,"3' UTR",21,34012895,34170276,157382,1]
["chr21",39191110,39191410,301,"ENSBGRG00000025967","ENSBGRT00000048034",19684,"APCDD1","APC down-regulated 1 [Source:HGNC Symbol;Acc:HGNC:15718]","GO:0001942(hair follicle development);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0017147(Wnt-protein binding);GO:0030178(negative regulation of Wnt signaling pathway);GO:0042487(regulation of odontogenesis of dentin-containing tooth);GO:0042802(identical protein binding);GO:0043615(astrocyte cell migration)","NA",{"v":1.2E-8,"d":"0.00"},1,"301,",0,-7.92,-7.11,2.09,"Exon (ENSBGRT00000048034/ENSBGRG00000025967, exon 3 of 5)",21,39171426,39207747,36322,1]
["chr21",39791488,39792864,1377,"ENSBGRG00000026041","ENSBGRT00000048161",0,"ENSBGRG00000026041","NA","NA","NA",{"v":0.0058,"d":"0.01"},3,"248,132,369,","0,737,1008",-2.24,-1.66,10,"Exon (ENSBGRT00000048161/ENSBGRG00000026041, exon 1 of 3)",21,39791488,39794211,2724,1]
["chr21",41997017,41997976,960,"ENSBGRG00000017294","ENSBGRT00000031807",205987,"SETBP1","SET binding protein 1 [Source:HGNC Symbol;Acc:HGNC:15573]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016604(nuclear body)","00310(Lysine degradation)",{"v":1.2e-07,"d":"0.00"},1,"960,",0,-6.91,-6.13,5.52,"3' UTR",21,41791030,41997523,206494,1]
["chr21",56911402,56912178,777,"ENSBGRG00000014854","ENSBGRT00000027307",62043,"ZNF532","zinc finger protein 532 [Source:HGNC Symbol;Acc:HGNC:30940]","GO:0003676(nucleic acid binding)","NA",{"v":1.3e-52,"d":"0.00"},1,"777,",0,{"v":-51.9,"d":"-51.90"},{"v":-50.5,"d":"-50.50"},4.28,"Exon (ENSBGRT00000027307/ENSBGRG00000014854, exon 3 of 10)",21,56849359,56987021,137663,1]
["chr21",3307020,3310127,3108,"ENSBGRG00000020254","ENSBGRT00000037225",1343,"DSEL","dermatan sulfate epimerase like [Source:HGNC Symbol;Acc:HGNC:18144]","GO:0008146(sulfotransferase activity)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)",{"v":1E-79,"d":"0.00"},2,"1255,1640,","0,1468",-79,{"v":-77.4,"d":"-77.40"},9.38,"3' UTR",21,3307020,3311470,4451,2]
["chr21",11278529,11278918,390,"ENSBGRG00000023225","ENSBGRT00000043199",0,"ENSBGRG00000023225","NA","GO:0019911(structural constituent of myelin sheath)","NA",{"v":2e-22,"d":"0.00"},1,"390,",0,{"v":-21.7,"d":"-21.70"},{"v":-20.6,"d":"-20.60"},4.08,"5' UTR",21,11239565,11278680,39116,2]
["chr21",16565413,16611755,46343,"ENSBGRG00000020002","ENSBGRT00000036853",0,"ZSCAN30","zinc finger and SCAN domain containing 30 [Source:HGNC Symbol;Acc:HGNC:33517]","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":4e-24,"d":"0.00"},3,"233,11,445,","0,34340,45898",{"v":-23.4,"d":"-23.40"},{"v":-22.3,"d":"-22.30"},2.73,"5' UTR",21,16595812,16597138,1327,1]
["chr21",29414120,29415378,1259,"ENSBGRG00000025859","ENSBGRT00000047857",0,"CABLES1","Cdk5 and Abl enzyme substrate 1 [Source:HGNC Symbol;Acc:HGNC:25097]","GO:0005829(cytosol);GO:0051726(regulation of cell cycle)","NA",{"v":0.019,"d":"0.02"},4,"464,5,231,40,","0,466,964,1219",-1.72,-1.19,6.02,"Exon (ENSBGRT00000047857/ENSBGRG00000025859, exon 1 of 13)",21,29300810,29415378,114569,2]
["chr21",34351527,34424461,72935,"ENSBGRG00000022857","ENSBGRT00000043077",0,"DLGAP1","DLG associated protein 1 [Source:HGNC Symbol;Acc:HGNC:2905]","GO:0007268(chemical synaptic transmission);GO:0014069(postsynaptic density);GO:0023052(signaling);GO:0045202(synapse)","04724(Glutamatergic synapse)",{"v":0.022,"d":"0.02"},4,"67,51,221,112,","0,36722,72367,72823",-1.66,-1.14,3.01,"5' UTR",21,34093349,34388299,294951,2]
["chr21",35575418,35576294,877,"ENSBGRG00000023492","ENSBGRT00000043386",84860,"EPB41L3","erythrocyte membrane protein band 4.1 like 3 [Source:HGNC Symbol;Acc:HGNC:3380]","GO:0001558(regulation of cell growth);GO:0002175(protein localization to paranode region of axon);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007010(cytoskeleton organization);GO:0007016(cytoskeletal anchoring at plasma membrane);GO:0008092(cytoskeletal protein binding);GO:0008360(regulation of cell shape);GO:0014069(postsynaptic density);GO:0030054(cell junction);GO:0030673(axolemma);GO:0030866(cortical actin cytoskeleton organization);GO:0030913(paranodal junction assembly);GO:0033270(paranode region of axon);GO:0043217(myelin maintenance);GO:0044224(juxtaparanode region of axon);GO:0048812(neuron projection morphogenesis);GO:0071205(protein localization to juxtaparanode region of axon);GO:0072659(protein localization to plasma membrane)","NA",{"v":0.015,"d":"0.02"},3,"137,66,7,","0,614,870",-1.81,-1.27,2.01,"Exon (ENSBGRT00000043386/ENSBGRG00000023492, exon 14 of 22)",21,35557426,35661154,103729,2]
["chr21",43199613,43258932,59320,"ENSBGRG00000018564","ENSBGRT00000034053",388,"PSTPIP2","proline-serine-threonine phosphatase interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:9581]","GO:0003779(actin binding);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0007010(cytoskeleton organization);GO:0016020(membrane);GO:0016477(cell migration)","NA",{"v":0.048,"d":"0.05"},3,"48,101,90,","0,12959,59230",-1.32,{"v":-0.827,"d":"-0.83"},3.51,"5' UTR",21,43153905,43259320,105416,2]
["chr21",55617954,55618345,392,"ENSBGRG00000011626","ENSBGRT00000021476",3644,"NARS1","asparaginyl-tRNA synthetase 1 [Source:HGNC Symbol;Acc:HGNC:7643]","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004816(asparagine-tRNA ligase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006418(tRNA aminoacylation for protein translation);GO:0006421(asparaginyl-tRNA aminoacylation);GO:0016477(cell migration);GO:0031728(CCR3 chemokine receptor binding);GO:0046983(protein dimerization activity)","00970(Aminoacyl-tRNA biosynthesis)",{"v":6.8e-06,"d":"0.00"},3,"78,93,39,","0,160,353",-5.17,-4.44,1.33,"Exon (ENSBGRT00000021476/ENSBGRG00000011626, exon 3 of 15)",21,55604244,55621989,17746,2]
["chr22",962157,965904,3748,"ENSBGRG00000010580","ENSBGRT00000019431",1328,"MCM2","minichromosome maintenance complex component 2 [Source:HGNC Symbol;Acc:HGNC:6944]","GO:0000785(chromatin);GO:0003677(DNA binding);GO:0003688(DNA replication origin binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005664(nuclear origin of replication recognition complex);GO:0005737(cytoplasm);GO:0006260(DNA replication);GO:0006268(DNA unwinding involved in DNA replication);GO:0006270(DNA replication initiation);GO:0006334(nucleosome assembly);GO:0006915(apoptotic process);GO:0015630(microtubule cytoskeleton);GO:0019899(enzyme binding);GO:0042393(histone binding);GO:0042555(MCM complex);GO:0071353(cellular response to interleukin-4);GO:0090102(cochlea development);GO:1905775(negative regulation of DNA helicase activity)","03030(DNA replication);04110(Cell cycle)",{"v":2.5e-12,"d":"0.00"},2,"29,212,","0,3536",{"v":-11.6,"d":"-11.60"},{"v":-10.7,"d":"-10.70"},2.25,"5' UTR",22,960829,978647,17819,1]
["chr22",1966042,1975668,9627,"ENSBGRG00000014042","ENSBGRT00000025770",7825,"ENSBGRG00000014042","NA","GO:0000350(generation of catalytic spliceosome for second transesterification step)","03040(Spliceosome)",{"v":1e-192,"d":"0.00"},5,"51,118,123,119,246,","0,1847,5895,6811,9381",-192,-189,8.52,"Exon (ENSBGRT00000025770/ENSBGRG00000014042, exon 6 of 10)",22,1958217,1976070,17854,1]
["chr22",5120179,5120389,211,"ENSBGRG00000023333","ENSBGRT00000043349",31611,"CAND2","cullin associated and neddylation dissociated 2 (putative) [Source:HGNC Symbol;Acc:HGNC:30689]","GO:0005634(nucleus);GO:0005829(cytosol);GO:0010265(SCF complex assembly);GO:0017025(TBP-class protein binding)","NA",{"v":1.7e-07,"d":"0.00"},1,"211,",0,-6.78,-6,2.57,"3' UTR",22,5088568,5120389,31822,1]
["chr22",8579930,8581274,1345,"ENSBGRG00000009853","ENSBGRT00000018122",53507,"FYCO1","FYVE and coiled-coil domain containing 1 [Source:HGNC Symbol;Acc:HGNC:14673]","GO:0005764(lysosome);GO:0005770(late endosome);GO:0005776(autophagosome);GO:0005794(Golgi apparatus);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding);GO:0072383(plus-end-directed vesicle transport along microtubule);GO:1901098(positive regulation of autophagosome maturation)","NA",{"v":2e-13,"d":"0.00"},1,"1345,",0,{"v":-12.7,"d":"-12.70"},{"v":-11.8,"d":"-11.80"},9.03,"3' UTR",22,8550124,8634781,84658,2]
["chr22",11228650,11235833,7184,"ENSBGRG00000023980","ENSBGRT00000044374",14293,"P4HTM","prolyl 4-hydroxylase, transmembrane [Source:HGNC Symbol;Acc:HGNC:28858]","GO:0005506(iron ion binding);GO:0005509(calcium ion binding);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0031418(L-ascorbic acid binding);GO:0045646(regulation of erythrocyte differentiation);GO:0055114(oxidation-reduction process)","NA",{"v":1e-199,"d":"0.00"},2,"241,1905,","0,5279",-199,-196,9.51,"3' UTR",22,11214357,11237740,23384,1]
["chr22",11749640,11750061,422,"ENSBGRG00000020998","ENSBGRT00000039348",9647,"APEH","acylaminoacyl-peptide hydrolase [Source:HGNC Symbol;Acc:HGNC:586]","GO:0004252(serine-type endopeptidase activity);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008236(serine-type peptidase activity);GO:0008242(omega peptidase activity);GO:0031965(nuclear membrane);GO:0042802(identical protein binding);GO:0050435(amyloid-beta metabolic process)","NA",{"v":5e-94,"d":"0.00"},2,"59,270,","0,152",{"v":-93.3,"d":"-93.30"},{"v":-91.6,"d":"-91.60"},6.39,"3' UTR",22,11739993,11750061,10069,1]
["chr22",12672295,12673569,1275,"ENSBGRG00000025476","ENSBGRT00000047116",29048,"MAPKAPK3","MAPK activated protein kinase 3 [Source:HGNC Symbol;Acc:HGNC:6888]","GO:0002224(toll-like receptor signaling pathway);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0032496(response to lipopolysaccharide);GO:0034097(response to cytokine);GO:0044351(macropinocytosis)","04010(MAPK signaling pathway);04370(VEGF signaling pathway)",{"v":2.5e-17,"d":"0.00"},2,"44,585,","0,690",{"v":-16.6,"d":"-16.60"},{"v":-15.6,"d":"-15.60"},5.01,"3' UTR",22,12643247,12674435,31189,1]
["chr22",19425488,19425937,450,"ENSBGRG00000024632","ENSBGRT00000045458",630,"PDE12","phosphodiesterase 12 [Source:HGNC Symbol;Acc:HGNC:25386]","GO:0000175(3'-5'-exoribonuclease activity);GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:0000958(mitochondrial mRNA catabolic process);GO:0004527(exonuclease activity);GO:0005759(mitochondrial matrix);GO:0035457(cellular response to interferon-alpha);GO:0044528(regulation of mitochondrial mRNA stability);GO:0045070(positive regulation of viral genome replication);GO:0060548(negative regulation of cell death);GO:0071346(cellular response to interferon-gamma);GO:0071359(cellular response to dsRNA);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0090324(negative regulation of oxidative phosphorylation);GO:0090503(RNA phosphodiester bond hydrolysis, exonucleolytic)","NA",{"v":0.00074,"d":"0.00"},1,"450,",0,-3.13,{"v":-2.5,"d":"-2.50"},6.02,"Exon (ENSBGRT00000045458/ENSBGRG00000024632, exon 1 of 3)",22,19424858,19428212,3355,1]
["chr22",24592725,24594153,1429,"ENSBGRG00000026503","ENSBGRT00000049077",179,"C3orf14","chromosome 3 open reading frame 14 [Source:HGNC Symbol;Acc:HGNC:25024]","NA","NA",{"v":0.013,"d":"0.01"},3,"394,110,65,","0,619,1364",{"v":-1.9,"d":"-1.90"},-1.35,2.07,"5' UTR",22,24592546,24609403,16858,1]
["chr22",35321540,35322559,1020,"ENSBGRG00000021736","ENSBGRT00000040125",0,"ENSBGRG00000021736","NA","NA","NA",{"v":0.0058,"d":"0.01"},1,"1020,",0,-2.24,-1.66,10,"Exon (ENSBGRT00000040125/ENSBGRG00000021736, exon 1 of 1)",22,35321540,35322559,1020,1]
["chr22",48850734,48851330,597,"ENSBGRG00000008315","ENSBGRT00000015222",52328,"SETD5","SET domain containing 5 [Source:HGNC Symbol;Acc:HGNC:25566]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005719(nuclear euchromatin);GO:0016569(covalent chromatin modification);GO:0016593(Cdc73/Paf1 complex);GO:0032784(regulation of DNA-templated transcription, elongation);GO:0035065(regulation of histone acetylation);GO:0046974(histone methyltransferase activity (H3-K9 specific));GO:0046975(histone methyltransferase activity (H3-K36 specific));GO:0050890(cognition);GO:0051963(regulation of synapse assembly);GO:0097198(histone H3-K36 trimethylation);GO:1902275(regulation of chromatin organization)","00310(Lysine degradation)",{"v":1e-239,"d":"0.00"},1,"597,",0,-239,-237,4.84,"Exon (ENSBGRT00000015222/ENSBGRG00000008315, exon 23 of 23)",22,48798406,48851330,52925,1]
["chr22",49762558,49763394,837,"ENSBGRG00000015475","ENSBGRT00000028419",7864,"ZNF445","zinc finger protein 445 [Source:HGNC Symbol;Acc:HGNC:21018]","GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0010216(maintenance of DNA methylation);GO:0010385(double-stranded methylated DNA binding);GO:0071517(maintenance of imprinting at mating-type locus);GO:2000653(regulation of genetic imprinting)","NA",{"v":5E-80,"d":"0.00"},1,"837,",0,{"v":-79.3,"d":"-79.30"},{"v":-77.7,"d":"-77.70"},6.17,"Exon (ENSBGRT00000028419/ENSBGRG00000015475, exon 6 of 6)",22,49754694,49763394,8701,1]
["chr22",59834152,59834246,95,"ENSBGRG00000022675","ENSBGRT00000041952",118749,"GLB1","galactosidase beta 1 [Source:HGNC Symbol;Acc:HGNC:4298]","GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0004565(beta-galactosidase activity);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0016787(hydrolase activity);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0044262(cellular carbohydrate metabolic process)","00052(Galactose metabolism);00600(Sphingolipid metabolism);00531(Glycosaminoglycan degradation);00604(Glycosphingolipid biosynthesis - ganglio series);00511(Other glycan degradation);04142(Lysosome)",{"v":2.6E-7,"d":"0.00"},3,"61,24,6,","0,63,89",-6.59,-5.82,1.86,"Exon (ENSBGRT00000041952/ENSBGRG00000022675, exon 16 of 18)",22,59715403,59834246,118844,1]
["chr22",350074,350252,179,"ENSBGRG00000023918","ENSBGRT00000045440",41930,"TXNRD3","thioredoxin reductase 3 [Source:HGNC Symbol;Acc:HGNC:20667]","GO:0004791(thioredoxin-disulfide reductase activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0009055(electron transfer activity);GO:0015035(protein disulfide oxidoreductase activity);GO:0016491(oxidoreductase activity);GO:0016668(oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor);GO:0045454(cell redox homeostasis);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process)","00450(Selenocompound metabolism);05200(Pathways in cancer);05225(Hepatocellular carcinoma)",{"v":0.0032,"d":"0.00"},1,"179,",0,{"v":-2.5,"d":"-2.50"},-1.91,11,"3' UTR",22,350074,392182,42109,2]
["chr22",1754321,1754681,361,"ENSBGRG00000012986","ENSBGRT00000023712",4662,"ENSBGRG00000012986","NA","NA","NA",{"v":0.017,"d":"0.02"},1,"361,",0,-1.76,-1.22,7.02,"Exon (ENSBGRT00000023712/ENSBGRG00000012986, exon 2 of 2)",22,1752553,1759343,6791,2]
["chr22",5547212,5582521,35310,"ENSBGRG00000024493","ENSBGRT00000045232",0,"TMCC1","transmembrane and coiled-coil domain family 1 [Source:HGNC Symbol;Acc:HGNC:29116]","GO:0005791(rough endoplasmic reticulum);GO:0005829(cytosol);GO:0007029(endoplasmic reticulum organization);GO:0016197(endosomal transport);GO:0042802(identical protein binding);GO:0090148(membrane fission);GO:0097750(endosome membrane tubulation);GO:0140284(endoplasmic reticulum-endosome membrane contact site);GO:0140285(endosome fission)","NA",{"v":0.011,"d":"0.01"},2,"17,133,","0,35177",-1.95,{"v":-1.4,"d":"-1.40"},3.21,"5' UTR",22,5425639,5547228,121590,2]
["chr22",7838477,7839014,538,"ENSBGRG00000006820","ENSBGRT00000012577",1731,"ENSBGRG00000006820","NA","NA","NA",{"v":1E-10,"d":"0.00"},1,"538,",0,-10,-9.14,3.06,"3' UTR",22,7837939,7840745,2807,2]
["chr22",9352879,9352996,118,"ENSBGRG00000012967","ENSBGRT00000023919",3906,"ENSBGRG00000012967","NA","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis)","NA",{"v":0.046,"d":"0.05"},1,"118,",0,-1.34,{"v":-0.843,"d":"-0.84"},3.34,"Exon (ENSBGRT00000023919/ENSBGRG00000012967, exon 5 of 6)",22,9352053,9356902,4850,2]
["chr22",10728082,10729387,1306,"ENSBGRG00000020803","ENSBGRT00000038328",1811,"CCDC51","coiled-coil domain containing 51 [Source:HGNC Symbol;Acc:HGNC:25714]","GO:0031305(integral component of mitochondrial inner membrane);GO:0034705(potassium channel complex);GO:0062156(mitochondrial ATP-gated potassium channel activity);GO:0062157(mitochondrial ATP-gated potassium channel complex);GO:0071805(potassium ion transmembrane transport)","NA",{"v":1.6e-56,"d":"0.00"},2,"753,19,","0,1287",{"v":-55.8,"d":"-55.80"},{"v":-54.3,"d":"-54.30"},{"v":16.4,"d":"16.40"},"Exon (ENSBGRT00000038328/ENSBGRG00000020803, exon 2 of 3)",22,10728082,10731198,3117,2]
["chr22",11355897,11356820,924,"ENSBGRG00000019022","ENSBGRT00000034859",357,"CCDC71","coiled-coil domain containing 71 [Source:HGNC Symbol;Acc:HGNC:25760]","NA","04512(ECM-receptor interaction);04510(Focal adhesion)",{"v":1E-141,"d":"0.00"},1,"924,",0,-141,-139,{"v":12.2,"d":"12.20"},"Exon (ENSBGRT00000034859/ENSBGRG00000019022, exon 1 of 1)",22,11355897,11357177,1281,2]
["chr22",11935493,11936885,1393,"ENSBGRG00000022803","ENSBGRT00000042248",0,"MST1R","macrophage stimulating 1 receptor [Source:HGNC Symbol;Acc:HGNC:7381]","GO:0001725(stress fiber);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005773(vacuole);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0009615(response to virus);GO:0019899(enzyme binding);GO:0043406(positive regulation of MAP kinase activity);GO:0051897(positive regulation of protein kinase B signaling)","NA",{"v":0.0032,"d":"0.00"},4,"402,437,7,52,","0,885,1326,1341",{"v":-2.5,"d":"-2.50"},-1.91,11,"Exon (ENSBGRT00000042248/ENSBGRG00000022803, exon 1 of 21)",22,11921142,11936885,15744,2]
["chr22",12349699,12350218,520,"ENSBGRG00000024550","ENSBGRT00000045410",1038,"NPRL2","NPR2 like, GATOR1 complex subunit [Source:HGNC Symbol;Acc:HGNC:24969]","GO:0004672(protein kinase activity);GO:0005096(GTPase activator activity);GO:0005765(lysosomal membrane);GO:0032007(negative regulation of TOR signaling);GO:0033673(negative regulation of kinase activity);GO:0034198(cellular response to amino acid starvation);GO:1990130(GATOR1 complex)","04150(mTOR signaling pathway)",{"v":0.00045,"d":"0.00"},3,"66,169,31,","0,218,489",-3.35,{"v":-2.7,"d":"-2.70"},2.85,"Exon (ENSBGRT00000045410/ENSBGRG00000024550, exon 2 of 11)",22,12347836,12351256,3421,2]
["chr22",15671492,15677216,5725,"ENSBGRG00000021608","ENSBGRT00000039937",97,"SELENOK","selenoprotein K [Source:HGNC Symbol;Acc:HGNC:30394]","GO:0002230(positive regulation of defense response to virus by host);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006816(calcium ion transport);GO:0006979(response to oxidative stress);GO:0010742(macrophage derived foam cell differentiation);GO:0018345(protein palmitoylation);GO:0030335(positive regulation of cell migration);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0042102(positive regulation of T cell proliferation);GO:0042802(identical protein binding);GO:0045728(respiratory burst after phagocytosis);GO:0050848(regulation of calcium-mediated signaling);GO:0051223(regulation of protein transport);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress);GO:0071639(positive regulation of monocyte chemotactic protein-1 production);GO:0090197(positive regulation of chemokine secretion);GO:2000406(positive regulation of T cell migration)","NA",{"v":1e-24,"d":"0.00"},3,"10,91,132,","0,1465,5593",-24,{"v":-22.9,"d":"-22.90"},2.56,"5' UTR",22,15670108,15677313,7206,2]
["chr22",20391568,20391658,91,"ENSBGRG00000026305","ENSBGRT00000048670",618,"FAM107A","family with sequence similarity 107 member A [Source:HGNC Symbol;Acc:HGNC:30827]","GO:0001558(regulation of cell growth);GO:0001725(stress fiber);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005925(focal adhesion);GO:0015629(actin cytoskeleton);GO:0016607(nuclear speck);GO:0030335(positive regulation of cell migration);GO:0031398(positive regulation of protein ubiquitination);GO:0031647(regulation of protein stability);GO:0032587(ruffle membrane);GO:0032956(regulation of actin cytoskeleton organization);GO:0051895(negative regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","NA",{"v":0.017,"d":"0.02"},1,"91,",0,-1.77,-1.23,2.84,"5' UTR",22,20354854,20392276,37423,2]
["chr22",31742302,31744547,2246,"ENSBGRG00000015776","ENSBGRT00000029944",32429,"TMF1","TATA element modulatory factor 1 [Source:HGNC Symbol;Acc:HGNC:11870]","GO:0001675(acrosome assembly);GO:0001819(positive regulation of cytokine production);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0007286(spermatid development);GO:0007289(spermatid nucleus differentiation);GO:0008584(male gonad development);GO:0010629(negative regulation of gene expression);GO:0030317(flagellated sperm motility);GO:0030374(nuclear receptor transcription coactivator activity);GO:0030521(androgen receptor signaling pathway);GO:0032275(luteinizing hormone secretion);GO:0033327(Leydig cell differentiation);GO:0042742(defense response to bacterium);GO:0043066(negative regulation of apoptotic process);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050681(androgen receptor binding);GO:0061136(regulation of proteasomal protein catabolic process);GO:0071407(cellular response to organic cyclic compound);GO:2000845(positive regulation of testosterone secretion)","NA",{"v":3.5e-08,"d":"0.00"},3,"144,126,90,","0,688,2156",-7.45,-6.65,3.26,"Exon (ENSBGRT00000029944/ENSBGRG00000015776, exon 15 of 17)",22,31742302,31776976,34675,2]
["chr22",48019321,48020457,1137,"ENSBGRG00000007163","ENSBGRT00000013188",22426,"SSUH2","ssu-2 homolog [Source:HGNC Symbol;Acc:HGNC:24809]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0042476(odontogenesis)","NA",{"v":2.2e-07,"d":"0.00"},1,"1137,",0,-6.66,-5.89,8.02,"3' UTR",22,48019321,48042883,23563,2]
["chr22",51335416,51336313,898,"ENSBGRG00000017119","ENSBGRT00000031377",47472,"ACKR2","atypical chemokine receptor 2 [Source:HGNC Symbol;Acc:HGNC:1565]","GO:0004930(G protein-coupled receptor activity);GO:0004950(chemokine receptor activity);GO:0005044(scavenger receptor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006935(chemotaxis);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0016493(C-C chemokine receptor activity);GO:0019957(C-C chemokine binding);GO:0031965(nuclear membrane);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":1.4e-06,"d":"0.00"},1,"898,",0,-5.84,-5.09,{"v":23.1,"d":"23.10"},"Exon (ENSBGRT00000031377/ENSBGRG00000017119, exon 3 of 3)",22,51335416,51383785,48370,2]
["chr22",53794629,53797048,2420,"ENSBGRG00000007397","ENSBGRT00000013531",25093,"ENSBGRG00000007397","ribosomal protein SA [Source:HGNC Symbol;Acc:HGNC:6502]","GO:0003735(structural constituent of ribosome);GO:0005055(laminin receptor activity);GO:0005840(ribosome);GO:0006412(translation);GO:0015935(small ribosomal subunit)","03010(Ribosome)",{"v":1.2E-5,"d":"0.00"},2,"265,89,","0,2331",-4.91,{"v":-4.2,"d":"-4.20"},9.03,"3' UTR",22,53794629,53822141,27513,2]
["chr22",55440879,55456585,15707,"ENSBGRG00000014471","ENSBGRT00000026620",395879,"ITGA9","integrin subunit alpha 9 [Source:HGNC Symbol;Acc:HGNC:6145]","GO:0007155(cell adhesion);GO:0008305(integrin complex);GO:0009925(basal plasma membrane);GO:0030593(neutrophil chemotaxis)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04514(Cell adhesion molecules (CAMs));04510(Focal adhesion);04810(Regulation of actin cytoskeleton);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection)",{"v":1E-194,"d":"0.00"},3,"1061,72,32,","0,15599,15675",-194,-192,8.54,"3' UTR",22,55439476,55852464,412989,2]
["chr22",60568199,60620695,52497,"ENSBGRG00000024032","ENSBGRT00000044442",58050,"ENSBGRG00000024032","glycerol-3-phosphate dehydrogenase 1 like [Source:HGNC Symbol;Acc:HGNC:28956]","GO:0004367(glycerol-3-phosphate dehydrogenase [NAD+] activity);GO:0005975(carbohydrate metabolic process);GO:0006072(glycerol-3-phosphate metabolic process);GO:0009331(glycerol-3-phosphate dehydrogenase complex);GO:0016491(oxidoreductase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0042803(protein homodimerization activity);GO:0046168(glycerol-3-phosphate catabolic process);GO:0051287(NAD binding);GO:0055114(oxidation-reduction process)","00564(Glycerophospholipid metabolism)",{"v":5e-07,"d":"0.00"},4,"34,110,309,891,","0,17253,42630,51606",{"v":-6.3,"d":"-6.30"},-5.54,11,"3' UTR",22,60568199,60678745,110547,2]
["chr23",7568213,7568420,208,"ENSBGRG00000021460","ENSBGRT00000039676",18155,"PDCD6","programmed cell death 6 [Source:HGNC Symbol;Acc:HGNC:8765]","GO:0005509(calcium ion binding)","NA",{"v":4.6E-6,"d":"0.00"},1,"208,",0,-5.34,-4.61,1.55,"3' UTR",23,7550058,7568730,18673,1]
["chr23",8127149,8127986,838,"ENSBGRG00000007004","ENSBGRT00000012876",25179,"NKD2","NKD inhibitor of WNT signaling pathway 2 [Source:HGNC Symbol;Acc:HGNC:17046]","GO:0005886(plasma membrane);GO:0010954(positive regulation of protein processing);GO:0016323(basolateral plasma membrane);GO:0016328(lateral plasma membrane);GO:0019838(growth factor binding);GO:0030178(negative regulation of Wnt signaling pathway);GO:0031410(cytoplasmic vesicle);GO:0031625(ubiquitin protein ligase binding);GO:0032036(myosin heavy chain binding);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0048210(Golgi vesicle fusion to target membrane);GO:0051117(ATPase binding);GO:0070382(exocytic vesicle);GO:0071944(cell periphery);GO:0072659(protein localization to plasma membrane);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:1903078(positive regulation of protein localization to plasma membrane)","04310(Wnt signaling pathway)",{"v":1e-192,"d":"0.00"},1,"838,",0,-192,-190,7.56,"3' UTR",23,8101970,8127986,26017,1]
["chr23",15010845,15015283,4439,"ENSBGRG00000011588","ENSBGRT00000021110",34431,"MTRR","5-methyltetrahydrofolate-homocysteine methyltransferase reductase [Source:HGNC Symbol;Acc:HGNC:7473]","GO:0003958(NADPH-hemoprotein reductase activity);GO:0009086(methionine biosynthetic process);GO:0010181(FMN binding);GO:0016491(oxidoreductase activity);GO:0016723(oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor);GO:0030586([methionine synthase] reductase activity);GO:0043418(homocysteine catabolic process);GO:0046655(folic acid metabolic process);GO:0050444(aquacobalamin reductase (NADPH) activity);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process);GO:0070402(NADPH binding);GO:0071949(FAD binding);GO:1904042(negative regulation of cystathionine beta-synthase activity)","NA",{"v":4e-36,"d":"0.00"},2,"162,437,","0,4002",{"v":-35.4,"d":"-35.40"},{"v":-34.2,"d":"-34.20"},4.58,"3' UTR",23,14976414,15015373,38960,1]
["chr23",40603539,40603927,389,"ENSBGRG00000008076","ENSBGRT00000014751",9437,"C5orf22","chromosome 5 open reading frame 22 [Source:HGNC Symbol;Acc:HGNC:25639]","NA","NA",{"v":1.3E-58,"d":"0.00"},1,"389,",0,{"v":-57.9,"d":"-57.90"},{"v":-56.4,"d":"-56.40"},4.45,"Exon (ENSBGRT00000014751/ENSBGRG00000008076, exon 4 of 9)",23,40594102,40613687,19586,1]
["chr23",45833259,45839116,5858,"ENSBGRG00000018858","ENSBGRT00000037197",18250,"NIPBL","NIPBL cohesin loading factor [Source:HGNC Symbol;Acc:HGNC:28862]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000785(chromatin);GO:0003007(heart morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006974(cellular response to DNA damage stimulus);GO:0007064(mitotic sister chromatid cohesion);GO:0007420(brain development);GO:0007507(heart development);GO:0007605(sensory perception of sound);GO:0008022(protein C-terminus binding);GO:0010468(regulation of gene expression);GO:0019827(stem cell population maintenance);GO:0031065(positive regulation of histone deacetylation);GO:0032039(integrator complex);GO:0032116(SMC loading complex);GO:0034088(maintenance of mitotic sister chromatid cohesion);GO:0034613(cellular protein localization);GO:0035115(embryonic forelimb morphogenesis);GO:0035136(forelimb morphogenesis);GO:0035261(external genitalia morphogenesis);GO:0036033(mediator complex binding);GO:0040018(positive regulation of multicellular organism growth);GO:0042471(ear morphogenesis);GO:0042634(regulation of hair cycle);GO:0042826(histone deacetylase binding);GO:0043231(intracellular membrane-bounded organelle);GO:0045444(fat cell differentiation);GO:0045778(positive regulation of ossification);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045995(regulation of embryonic development);GO:0047485(protein N-terminus binding);GO:0048557(embryonic digestive tract morphogenesis);GO:0048589(developmental growth);GO:0048592(eye morphogenesis);GO:0048638(regulation of developmental growth);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0048703(embryonic viscerocranium morphogenesis);GO:0050890(cognition);GO:0060325(face morphogenesis);GO:0061010(gall bladder development);GO:0061038(uterus morphogenesis);GO:0070087(chromo shadow domain binding);GO:0071481(cellular response to X-ray);GO:0071921(cohesin loading);GO:0090694(Scc2-Scc4 cohesin loading complex);GO:1990841(promoter-specific chromatin binding);GO:2001224(positive regulation of neuron migration)","NA",{"v":7.6e-08,"d":"0.00"},2,"536,35,","0,5823",-7.12,-6.33,6.69,"Exon (ENSBGRT00000037197/ENSBGRG00000018858, exon 8 of 45)",23,45815009,45939080,124072,1]
["chr23",52229032,52259467,30436,"ENSBGRG00000015911","ENSBGRT00000029258",0,"NIM1K","NIM1 serine/threonine protein kinase [Source:HGNC Symbol;Acc:HGNC:28646]","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA",{"v":3.7e-05,"d":"0.00"},2,"1099,34,","0,30402",-4.43,-3.73,{"v":18.1,"d":"18.10"},"5' UTR",23,52229032,52263648,34617,1]
["chr23",60587386,60595442,8057,"ENSBGRG00000022289","ENSBGRT00000041205",598,"MTREX","Mtr4 exosome RNA helicase [Source:HGNC Symbol;Acc:HGNC:18734]","GO:0000176(nuclear exosome (RNase complex));GO:0000178(exosome (RNase complex));GO:0000460(maturation of 5.8S rRNA);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003724(RNA helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006364(rRNA processing);GO:0006401(RNA catabolic process);GO:0031499(TRAMP complex);GO:0071013(catalytic step 2 spliceosome)","03018(RNA degradation)",{"v":0.014,"d":"0.01"},2,"189,82,","0,7975",-1.84,{"v":-1.3,"d":"-1.30"},2.67,"5' UTR",23,60586788,60686566,99779,1]
["chr23",6018097,6024114,6018,"ENSBGRG00000019644","ENSBGRT00000036099",0,"SPDL1","spindle apparatus coiled-coil protein 1 [Source:HGNC Symbol;Acc:HGNC:26010]","GO:0000132(establishment of mitotic spindle orientation);GO:0000922(spindle pole);GO:0000940(condensed chromosome outer kinetochore);GO:0005634(nucleus);GO:0007080(mitotic metaphase plate congression);GO:0007094(mitotic spindle assembly checkpoint);GO:0019899(enzyme binding);GO:0034501(protein localization to kinetochore);GO:0043515(kinetochore binding)","NA",{"v":2.5e-06,"d":"0.00"},3,"34,177,176,","0,4129,5842",{"v":-5.6,"d":"-5.60"},-4.86,3.63,"5' UTR",23,5998073,6024114,26042,2]
["chr23",35444258,35444587,330,"ENSBGRG00000007438","ENSBGRT00000013805",101369,"CDH9","cadherin 9 [Source:HGNC Symbol;Acc:HGNC:1768]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0098609(cell-cell adhesion)","NA",{"v":0.011,"d":"0.01"},1,"330,",0,-1.97,-1.19,9.03,"3' UTR",23,35444258,35545956,101699,2]
["chr23",46523243,46546392,23150,"ENSBGRG00000021590","ENSBGRT00000039894",0,"GDNF","glial cell derived neurotrophic factor [Source:HGNC Symbol;Acc:HGNC:4232]","GO:0001656(metanephros development);GO:0001657(ureteric bud development);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001755(neural crest cell migration);GO:0001759(organ induction);GO:0001941(postsynaptic membrane organization);GO:0003337(mesenchymal to epithelial transition involved in metanephros morphogenesis);GO:0005576(extracellular region);GO:0005794(Golgi apparatus);GO:0007399(nervous system development);GO:0007422(peripheral nervous system development);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0010468(regulation of gene expression);GO:0021516(dorsal spinal cord development);GO:0021784(postganglionic parasympathetic fiber development);GO:0030432(peristalsis);GO:0031175(neuron projection development);GO:0032770(positive regulation of monooxygenase activity);GO:0042803(protein homodimerization activity);GO:0043524(negative regulation of neuron apoptotic process);GO:0045597(positive regulation of cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048255(mRNA stabilization);GO:0048484(enteric nervous system development);GO:0048485(sympathetic nervous system development);GO:0048568(embryonic organ development);GO:0051584(regulation of dopamine uptake involved in synaptic transmission);GO:0060676(ureteric bud formation);GO:0060688(regulation of morphogenesis of a branching structure);GO:0071679(commissural neuron axon guidance);GO:0072107(positive regulation of ureteric bud formation);GO:0072108(positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis);GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis);GO:2001240(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand);GO:2001260(regulation of semaphorin-plexin signaling pathway)","NA",{"v":0.00016,"d":"0.00"},2,"485,151,","0,22999",{"v":-3.8,"d":"-3.80"},-3.13,7.02,"Exon (ENSBGRT00000039894/ENSBGRG00000021590, exon 1 of 2)",23,46523243,46546392,23150,2]
["chr23",48115742,48191655,75914,"ENSBGRG00000023892","ENSBGRT00000044175",0,"FYB1","FYN binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4036]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0008289(lipid binding);GO:0015629(actin cytoskeleton);GO:0032991(protein-containing complex);GO:0072659(protein localization to plasma membrane)","04015(Rap1 signaling pathway)",{"v":0.0058,"d":"0.01"},2,"375,162,","0,75752",-2.24,-1.66,10,"5' UTR",23,48008194,48191655,183462,2]
["chr23",58237087,58237565,479,"ENSBGRG00000020522","ENSBGRT00000037889",10517,"MOCS2","molybdenum cofactor synthesis 2 [Source:HGNC Symbol;Acc:HGNC:7193]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006777(Mo-molybdopterin cofactor biosynthetic process);GO:0016607(nuclear speck);GO:0019008(molybdopterin synthase complex);GO:0030366(molybdopterin synthase activity)","00790(Folate biosynthesis);04122(Sulfur relay system)",{"v":1.2E-5,"d":"0.00"},1,"479,",0,-4.93,-4.21,7.02,"3' UTR",23,58236788,58248082,11295,2]
["chr24",3234741,3236418,1678,"ENSBGRG00000015917","ENSBGRT00000029330",43347,"ENSBGRG00000015917","NA","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0006334(nucleosome assembly);GO:0042025(host cell nucleus)","NA",{"v":2.6e-06,"d":"0.00"},2,"115,288,","0,1390",-5.58,-4.84,6.02,"Exon (ENSBGRT00000029685/ENSBGRG00000016137, exon 1 of 2)",24,3153248,3279765,126518,2]
["chr24",4517996,4518891,896,"ENSBGRG00000015513","ENSBGRT00000028477",0,"ENSBGRG00000015513","NA","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":5.2e-06,"d":"0.00"},2,"451,157,","0,739",-5.28,-4.55,4.01,"5' UTR",24,4518735,4533679,14945,1]
["chr24",6188533,6189802,1270,"ENSBGRG00000019662","ENSBGRT00000036880",0,"MOG","myelin oligodendrocyte glycoprotein [Source:HGNC Symbol;Acc:HGNC:7197]","NA","NA",{"v":1.3e-05,"d":"0.00"},2,"85,64,","0,1206",-4.88,-4.16,10,"Exon (ENSBGRT00000036880/ENSBGRG00000019662, exon 1 of 8)",24,6188533,6198769,10237,1]
["chr24",7230289,7230780,492,"ENSBGRG00000012193","ENSBGRT00000022432",2741,"ENSBGRG00000012193","NA","NA","04650(Natural killer cell mediated cytotoxicity);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":0.0081,"d":"0.01"},3,"3,169,33,","0,44,459",-2.09,-1.53,2.34,"Exon (ENSBGRT00000022432/ENSBGRG00000012193, exon 2 of 8)",24,7227548,7234418,6871,1]
["chr24",14557685,14557985,301,"ENSBGRG00000024761","ENSBGRT00000045690",21325,"TNFRSF21","TNF receptor superfamily member 21 [Source:HGNC Symbol;Acc:HGNC:13469]","GO:0001783(B cell apoptotic process);GO:0002250(adaptive immune response);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0006915(apoptotic process);GO:0006959(humoral immune response);GO:0007165(signal transduction);GO:0030424(axon);GO:0030889(negative regulation of B cell proliferation);GO:0031226(intrinsic component of plasma membrane);GO:0031642(negative regulation of myelination);GO:0032693(negative regulation of interleukin-10 production);GO:0032696(negative regulation of interleukin-13 production);GO:0032714(negative regulation of interleukin-5 production);GO:0042130(negative regulation of T cell proliferation);GO:0042552(myelination);GO:0048713(regulation of oligodendrocyte differentiation);GO:0050852(T cell receptor signaling pathway);GO:0051402(neuron apoptotic process);GO:0071356(cellular response to tumor necrosis factor);GO:0097252(oligodendrocyte apoptotic process)","04060(Cytokine-cytokine receptor interaction)",{"v":6.3e-09,"d":"0.00"},1,"301,",0,{"v":-8.2,"d":"-8.20"},-7.39,3.19,"Exon (ENSBGRT00000045690/ENSBGRG00000024761, exon 3 of 7)",24,14536360,14609175,72816,1]
["chr24",17590886,17592136,1251,"ENSBGRG00000007091","ENSBGRT00000013310",8137,"HSP90AB1","heat shock protein 90 alpha family class B member 1 [Source:HGNC Symbol;Acc:HGNC:5258]","GO:0001890(placenta development);GO:0003725(double-stranded RNA binding);GO:0005524(ATP binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006457(protein folding);GO:0007004(telomere maintenance via telomerase);GO:0008180(COP9 signalosome);GO:0010033(response to organic substance);GO:0019062(virion attachment to host cell);GO:0019887(protein kinase regulator activity);GO:0019900(kinase binding);GO:0019901(protein kinase binding);GO:0021955(central nervous system neuron axonogenesis);GO:0030010(establishment of cell polarity);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0031072(heat shock protein binding);GO:0031396(regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032516(positive regulation of phosphoprotein phosphatase activity);GO:0032991(protein-containing complex);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034605(cellular response to heat);GO:0034751(aryl hydrocarbon receptor complex);GO:0042277(peptide binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0043008(ATP-dependent protein binding);GO:0043025(neuronal cell body);GO:0043066(negative regulation of apoptotic process);GO:0044183(protein folding chaperone);GO:0044294(dendritic growth cone);GO:0044295(axonal growth cone);GO:0045597(positive regulation of cell differentiation);GO:0046983(protein dimerization activity);GO:0048156(tau protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0048675(axon extension);GO:0051082(unfolded protein binding);GO:0051131(chaperone-mediated protein complex assembly);GO:0051897(positive regulation of protein kinase B signaling);GO:0051973(positive regulation of telomerase activity);GO:0060334(regulation of interferon-gamma-mediated signaling pathway);GO:0060338(regulation of type I interferon-mediated signaling pathway);GO:0070182(DNA polymerase binding);GO:0071157(negative regulation of cell cycle arrest);GO:0071353(cellular response to interleukin-4);GO:0097435(supramolecular fiber organization);GO:0097718(disordered domain specific binding);GO:1901389(negative regulation of transforming growth factor beta activation);GO:1901799(negative regulation of proteasomal protein catabolic process);GO:1903827(regulation of cellular protein localization);GO:1904031(positive regulation of cyclin-dependent protein kinase activity);GO:1905323(telomerase holoenzyme complex assembly);GO:1990226(histone methyltransferase binding);GO:1990565(HSP90-CDC37 chaperone complex);GO:2000010(positive regulation of protein localization to cell surface)","04141(Protein processing in endoplasmic reticulum);04151(PI3K-Akt signaling pathway);04217(Necroptosis);04621(NOD-like receptor signaling pathway);04612(Antigen processing and presentation);04659(Th17 cell differentiation);04657(IL-17 signaling pathway);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);05200(Pathways in cancer);05215(Prostate cancer);05418(Fluid shear stress and atherosclerosis)",{"v":5e-63,"d":"0.00"},2,"76,522,","0,729",{"v":-62.3,"d":"-62.30"},{"v":-60.8,"d":"-60.80"},3.77,"Exon (ENSBGRT00000013781/ENSBGRG00000007502, exon 2 of 3)",24,17562530,17600273,37744,2]
["chr24",18308519,18313459,4941,"ENSBGRG00000011005","ENSBGRT00000020418",0,"GTPBP2","GTP binding protein 2 [Source:HGNC Symbol;Acc:HGNC:4670]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle);GO:0070966(nuclear-transcribed mRNA catabolic process, no-go decay);GO:0072344(rescue of stalled ribosome)","03013(RNA transport)",{"v":3.5e-08,"d":"0.00"},6,"42,186,27,185,109,16,","0,1383,3371,3884,4362,4925",-7.46,-6.67,3.26,"Exon (ENSBGRT00000020418/ENSBGRG00000011005, exon 1 of 12)",24,18308519,18317985,9467,1]
["chr24",19679154,19679798,645,"ENSBGRG00000021770","ENSBGRT00000040311",11447,"MRPS10","mitochondrial ribosomal protein S10 [Source:HGNC Symbol;Acc:HGNC:14502]","GO:0005763(mitochondrial small ribosomal subunit)","03010(Ribosome)",{"v":3.2e-15,"d":"0.00"},2,"90,84,","0,561",{"v":-14.5,"d":"-14.50"},{"v":-13.6,"d":"-13.60"},1.82,"Exon (ENSBGRT00000040311/ENSBGRG00000021770, exon 6 of 7)",24,19667707,19679798,12092,1]
["chr24",25525925,25526015,91,"ENSBGRG00000010533","ENSBGRT00000019486",389,"CPNE5","copine 5 [Source:HGNC Symbol;Acc:HGNC:2318]","GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:1903861(positive regulation of dendrite extension)","NA",{"v":0.032,"d":"0.03"},1,"91,",0,{"v":-1.5,"d":"-1.50"},{"v":-0.989,"d":"-0.99"},2.81,"5' UTR",24,25525536,25643728,118193,1]
["chr24",29280231,29280570,340,"ENSBGRG00000017181","ENSBGRT00000031559",2963,"DAXX","death domain associated protein [Source:HGNC Symbol;Acc:HGNC:2681]","GO:0000775(chromosome, centromeric region);GO:0001934(positive regulation of protein phosphorylation);GO:0002039(p53 binding);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006334(nucleosome assembly);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-templated);GO:0016604(nuclear body);GO:0016605(PML body);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0030295(protein kinase activator activity);GO:0030521(androgen receptor signaling pathway);GO:0031396(regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0034605(cellular response to heat);GO:0034620(cellular response to unfolded protein);GO:0042393(histone binding);GO:0045860(positive regulation of protein kinase activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0047485(protein N-terminus binding);GO:0050681(androgen receptor binding);GO:0071276(cellular response to cadmium ion);GO:0071280(cellular response to copper ion);GO:0072738(cellular response to diamide);GO:0140037(sumo-dependent protein binding);GO:0140416(DNA-binding transcription factor inhibitor activity);GO:1901216(positive regulation of neuron death);GO:1903936(cellular response to sodium arsenite)","04010(MAPK signaling pathway);04210(Apoptosis);05014(Amyotrophic lateral sclerosis (ALS));05168(Herpes simplex infection)",{"v":6.8e-06,"d":"0.00"},2,"10,139,","0,201",-5.17,-4.44,1.55,"3' UTR",24,29277268,29280689,3422,1]
["chr24",29423415,29425652,2238,"ENSBGRG00000019137","ENSBGRT00000039336",23420,"COL11A2","collagen type XI alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2187]","GO:0001894(tissue homeostasis);GO:0002062(chondrocyte differentiation);GO:0005201(extracellular matrix structural constituent);GO:0005581(collagen trimer);GO:0007605(sensory perception of sound);GO:0030199(collagen fibril organization);GO:0048705(skeletal system morphogenesis)","04974(Protein digestion and absorption)",{"v":7.4e-06,"d":"0.00"},10,"29,108,54,54,108,54,54,54,54,29,","0,143,381,537,737,1045,1297,1535,1843,2209",-5.13,-4.41,17,"Exon (ENSBGRT00000039336/ENSBGRG00000019137, exon 43 of 67)",24,29399995,29432849,32855,1]
["chr24",39876072,39876611,540,"ENSBGRG00000025891","ENSBGRT00000047874",9607,"ENSBGRG00000025891","NA","NA","NA",{"v":0.0017,"d":"0.00"},1,"540,",0,-2.77,-2.16,12,"Exon (ENSBGRT00000047880/ENSBGRG00000025894, exon 2 of 2)",24,39848276,39886218,37943,2]
["chr24",49603749,49610787,7039,"ENSBGRG00000014298","ENSBGRT00000026883",300,"MAK","male germ cell associated kinase [Source:HGNC Symbol;Acc:HGNC:6816]","GO:0001750(photoreceptor outer segment);GO:0001917(photoreceptor inner segment);GO:0003713(transcription coactivator activity);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005813(centrosome);GO:0005930(axoneme);GO:0006468(protein phosphorylation);GO:0030496(midbody);GO:0031514(motile cilium);GO:0032391(photoreceptor connecting cilium);GO:0045494(photoreceptor cell maintenance);GO:0046777(protein autophosphorylation);GO:0072686(mitotic spindle);GO:1902856(negative regulation of non-motile cilium assembly)","NA",{"v":0.025,"d":"0.03"},3,"33,55,92,","0,5616,6947",-1.61,-1.09,2.21,"Exon (ENSBGRT00000026883/ENSBGRG00000014298, exon 1 of 12)",24,49603449,49641205,37757,1]
["chr24",55136836,55137016,181,"ENSBGRG00000008589","ENSBGRT00000015636",329,"PXDC1","PX domain containing 1 [Source:HGNC Symbol;Acc:HGNC:21361]","GO:0035091(phosphatidylinositol binding)","NA",{"v":0.0052,"d":"0.01"},1,"181,",0,-2.28,{"v":-1.7,"d":"-1.70"},2.88,"Exon (ENSBGRT00000015636/ENSBGRG00000008589, exon 1 of 5)",24,55136507,55160855,24349,1]
["chr24",55482791,55484033,1243,"ENSBGRG00000008862","ENSBGRT00000016208",955,"TUBB2A","tubulin beta 2A class IIa [Source:HGNC Symbol;Acc:HGNC:12412]","GO:0003924(GTPase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005525(GTP binding);GO:0005874(microtubule);GO:0007017(microtubule-based process)","04145(Phagosome);04540(Gap junction);05130(Pathogenic Escherichia coli infection)",{"v":3.2e-08,"d":"0.00"},3,"73,111,446,","0,347,797",{"v":-7.5,"d":"-7.50"},{"v":-6.7,"d":"-6.70"},3.21,"5' UTR",24,55481836,55484633,2798,1]
["chr24",1772689,1772922,234,"ENSBGRG00000023670","ENSBGRT00000043736",90,"TDP2","tyrosyl-DNA phosphodiesterase 2 [Source:HGNC Symbol;Acc:HGNC:17768]","GO:0000287(magnesium ion binding);GO:0003697(single-stranded DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006302(double-strand break repair);GO:0016235(aggresome);GO:0016604(nuclear body);GO:0016605(PML body);GO:0030145(manganese ion binding);GO:0036317(tyrosyl-RNA phosphodiesterase activity);GO:0048666(neuron development);GO:0070260(5'-tyrosyl-DNA phosphodiesterase activity)","NA",{"v":0.00087,"d":"0.00"},2,"44,106,","0,128",-3.06,-2.43,2.23,"Exon (ENSBGRT00000043736/ENSBGRG00000023670, exon 1 of 7)",24,1758809,1773012,14204,2]
["chr24",5011272,5011627,356,"ENSBGRG00000016574","ENSBGRT00000030704",13766,"TRIM27","tripartite motif containing 27 [Source:HGNC Symbol;Acc:HGNC:9975]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001650(fibrillar center);GO:0002820(negative regulation of adaptive immune response);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0006469(negative regulation of protein kinase activity);GO:0008270(zinc ion binding);GO:0030904(retromer complex);GO:0031965(nuclear membrane);GO:0032609(interferon-gamma production);GO:0032703(negative regulation of interleukin-2 production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0032897(negative regulation of viral transcription);GO:0034314(Arp2/3 complex-mediated actin nucleation);GO:0042147(retrograde transport, endosome to Golgi);GO:0042802(identical protein binding);GO:0045087(innate immune response);GO:0045814(negative regulation of gene expression, epigenetic);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0070534(protein K63-linked ubiquitination);GO:0090281(negative regulation of calcium ion import)","NA",{"v":3.2e-80,"d":"0.00"},1,"356,",0,{"v":-79.5,"d":"-79.50"},{"v":-77.9,"d":"-77.90"},{"v":3.4,"d":"3.40"},"Exon (ENSBGRT00000030704/ENSBGRG00000016574, exon 8 of 8)",24,5010887,5025393,14507,2]
["chr24",6775714,6776577,864,"ENSBGRG00000008872","ENSBGRT00000016253",1111,"IER3","immediate early response 3 [Source:HGNC Symbol;Acc:HGNC:5392]","GO:0005634(nucleus);GO:0043066(negative regulation of apoptotic process);GO:2001020(regulation of response to DNA damage stimulus)","NA",{"v":1e-114,"d":"0.00"},1,"864,",0,-114,-112,3.01,"3' UTR",24,6775714,6777688,1975,2]
["chr24",7612796,7612973,178,"ENSBGRG00000017307","ENSBGRT00000031751",326,"HSPA1L","heat shock protein family A (Hsp70) member 1 like [Source:HGNC Symbol;Acc:HGNC:5234]","GO:0002199(zona pellucida receptor complex);GO:0005829(cytosol);GO:0007339(binding of sperm to zona pellucida);GO:0008180(COP9 signalosome);GO:0031072(heat shock protein binding);GO:0031625(ubiquitin protein ligase binding);GO:0042026(protein refolding);GO:0044297(cell body);GO:0051082(unfolded protein binding);GO:1903955(positive regulation of protein targeting to mitochondrion)","03040(Spliceosome);04141(Protein processing in endoplasmic reticulum);04010(MAPK signaling pathway);04144(Endocytosis);04612(Antigen processing and presentation);04915(Estrogen signaling pathway);04213(Longevity regulating pathway - multiple species);05134(Legionellosis);05162(Measles);05164(Influenza A);05169(Epstein-Barr virus infection);05145(Toxoplasmosis)",{"v":0.026,"d":"0.03"},1,"178,",0,-1.59,-1.07,2.81,"Exon (ENSBGRT00000031751/ENSBGRG00000017307, exon 1 of 1)",24,7611374,7613299,1926,2]
["chr24",7899500,7899925,426,"ENSBGRG00000026000","ENSBGRT00000048182",19610,"ENSBGRG00000026000","NA","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);05206(MicroRNAs in cancer);05165(Human papillomavirus infection)",{"v":0.045,"d":"0.05"},2,"53,8,","0,418",-1.35,{"v":-0.847,"d":"-0.85"},1.69,"Exon (ENSBGRT00000048182/ENSBGRG00000026000, exon 10 of 50)",24,7856845,7919535,62691,2]
["chr24",17417693,17432503,14811,"ENSBGRG00000025587","ENSBGRT00000047354",32434,"CDC5L","cell division cycle 5 like [Source:HGNC Symbol;Acc:HGNC:1743]","GO:0000398(mRNA splicing, via spliceosome);GO:0000974(Prp19 complex);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005662(DNA replication factor A complex);GO:0005737(cytoplasm);GO:0016607(nuclear speck);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0071007(U2-type catalytic step 2 spliceosome);GO:0071013(catalytic step 2 spliceosome);GO:0071987(WD40-repeat domain binding);GO:0072422(signal transduction involved in DNA damage checkpoint)","03040(Spliceosome)",{"v":2.5E-96,"d":"0.00"},3,"316,213,190,","0,1058,14621",{"v":-95.6,"d":"-95.60"},{"v":-93.9,"d":"-93.90"},6.08,"3' UTR",24,17417573,17464937,47365,2]
["chr24",18736497,18737005,509,"ENSBGRG00000014571","ENSBGRT00000033170",30,"ENSBGRG00000014571","NA","NA","NA",{"v":7.4e-05,"d":"0.00"},1,"509,",0,-4.13,-3.45,2.27,"Exon (ENSBGRT00000033170/ENSBGRG00000014571, exon 1 of 43)",24,18694957,18737035,42079,2]
["chr24",18774719,18774779,61,"ENSBGRG00000018313","ENSBGRT00000035425",64609,"PTK7","protein tyrosine kinase 7 (inactive) [Source:HGNC Symbol;Acc:HGNC:9618]","GO:0001736(establishment of planar polarity);GO:0001822(kidney development);GO:0001843(neural tube closure);GO:0003281(ventricular septum development);GO:0003401(axis elongation);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0007507(heart development);GO:0010976(positive regulation of neuron projection development);GO:0016020(membrane);GO:0016477(cell migration);GO:0031532(actin cytoskeleton reorganization);GO:0042060(wound healing);GO:0045198(establishment of epithelial cell apical/basal polarity);GO:0060026(convergent extension);GO:0060484(lung-associated mesenchyme development);GO:0060976(coronary vasculature development);GO:0071300(cellular response to retinoic acid);GO:0090103(cochlea morphogenesis);GO:0090179(planar cell polarity pathway involved in neural tube closure);GO:0090263(positive regulation of canonical Wnt signaling pathway)","NA",{"v":1.9E-3,"d":"0.00"},1,"61,",0,-2.73,-2.12,1.84,"Exon (ENSBGRT00000035425/ENSBGRG00000018313, exon 15 of 21)",24,18759540,18839388,79849,2]
["chr24",20200588,20210704,10117,"ENSBGRG00000022743","ENSBGRT00000042025",356,"MDFI","MyoD family inhibitor [Source:HGNC Symbol;Acc:HGNC:6967]","GO:0042802(identical protein binding);GO:0048704(embryonic skeletal system morphogenesis);GO:0060707(trophoblast giant cell differentiation)","NA",{"v":5.9e-10,"d":"0.00"},3,"54,87,127,","0,7238,9990",-9.23,-8.39,2.83,"5' UTR",24,20192827,20211060,18234,2]
["chr24",27054704,27054853,150,"ENSBGRG00000016287","ENSBGRT00000030021",2909,"FANCE","FA complementation group E [Source:HGNC Symbol;Acc:HGNC:3586]","GO:0036297(interstrand cross-link repair);GO:0043240(Fanconi anaemia nuclear complex)","03460(Fanconi anemia pathway)",{"v":0.019,"d":"0.02"},1,"150,",0,-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000030021/ENSBGRG00000016287, exon 2 of 10)",24,27045682,27057762,12081,2]
["chr24",29377755,29380067,2313,"ENSBGRG00000018754","ENSBGRT00000034337",217,"RING1","ring finger protein 1 [Source:HGNC Symbol;Acc:HGNC:10018]","GO:0000151(ubiquitin ligase complex);GO:0001739(sex chromatin);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0009952(anterior/posterior pattern specification);GO:0016574(histone ubiquitination);GO:0016604(nuclear body);GO:0031519(PcG protein complex);GO:0035102(PRC1 complex);GO:0035518(histone H2A monoubiquitination);GO:0045892(negative regulation of transcription, DNA-templated);GO:0048593(camera-type eye morphogenesis);GO:0097027(ubiquitin-protein transferase activator activity)","NA",{"v":1E-173,"d":"0.00"},5,"6,277,390,216,67,","0,239,692,1931,2246",-173,-171,6.48,"Exon (ENSBGRT00000034337/ENSBGRG00000018754, exon 1 of 6)",24,29376502,29380284,3783,2]
["chr24",33413460,33413879,420,"ENSBGRG00000024977","ENSBGRT00000046780",774,"DST","dystonin [Source:HGNC Symbol;Acc:HGNC:1090]","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005856(cytoskeleton);GO:0007010(cytoskeleton organization);GO:0008017(microtubule binding);GO:0008092(cytoskeletal protein binding);GO:0045104(intermediate filament cytoskeleton organization)","NA",{"v":2.5e-45,"d":"0.00"},1,"420,",0,{"v":-44.6,"d":"-44.60"},{"v":-43.3,"d":"-43.30"},4.92,"Exon (ENSBGRT00000046780/ENSBGRG00000024977, exon 1 of 44)",24,33311713,33414653,102941,2]
["chr24",40754157,40761979,7823,"ENSBGRG00000006987","ENSBGRT00000012983",85203,"E2F3","E2F transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:3115]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001216(DNA-binding transcription activator activity);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0006606(protein import into nucleus);GO:0008284(positive regulation of cell population proliferation);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0070345(negative regulation of fat cell proliferation);GO:0090575(RNA polymerase II transcription factor complex);GO:1905461(positive regulation of vascular associated smooth muscle cell apoptotic process);GO:1990837(sequence-specific double-stranded DNA binding)","04110(Cell cycle);04218(Cellular senescence);05200(Pathways in cancer);05206(MicroRNAs in cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05220(Chronic myeloid leukemia);05218(Melanoma);05219(Bladder cancer);05215(Prostate cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);04934(Cushing syndrome);05166(HTLV-I infection);05161(Hepatitis B);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);01522(Endocrine resistance)",{"v":6.3E-3,"d":"0.01"},3,"96,115,88,","0,3183,7735",{"v":-2.2,"d":"-2.20"},-1.62,6.02,"Exon (ENSBGRT00000012983/ENSBGRG00000006987, exon 4 of 7)",24,40751499,40847182,95684,2]
["chr24",48391082,48393955,2874,"ENSBGRG00000012906","ENSBGRT00000023622",108208,"HIVEP1","HIVEP zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:4920]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008270(zinc ion binding);GO:0016604(nuclear body);GO:0030509(BMP signaling pathway);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":6.3e-23,"d":"0.00"},1,"2874,",0,{"v":-22.2,"d":"-22.20"},{"v":-21.2,"d":"-21.20"},{"v":11.7,"d":"11.70"},"5' UTR",24,48351940,48502163,150224,2]
["chr24",52649137,52649766,630,"ENSBGRG00000017936","ENSBGRT00000032883",46455,"RIOK1","RIO kinase 1 [Source:HGNC Symbol;Acc:HGNC:18656]","GO:0003676(nucleic acid binding);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0030490(maturation of SSU-rRNA);GO:0030688(preribosome, small subunit precursor);GO:0034708(methyltransferase complex);GO:0042274(ribosomal small subunit biogenesis);GO:2000234(positive regulation of rRNA processing)","03008(Ribosome biogenesis in eukaryotes)",{"v":1.3E-18,"d":"0.00"},1,"630,",0,{"v":-17.9,"d":"-17.90"},{"v":-16.9,"d":"-16.90"},5.62,"Exon (ENSBGRT00000034168/ENSBGRG00000018653, exon 1 of 5)",24,52513074,52696221,183148,2]
["chr25",244642,244731,90,"ENSBGRG00000012816","ENSBGRT00000023432",714,"ENSBGRG00000012816","NA","NA","NA",{"v":0.00048,"d":"0.00"},1,"90,",0,-3.32,-2.67,14,"Exon (ENSBGRT00000023432/ENSBGRG00000012816, exon 1 of 2)",25,243928,249587,5660,1]
["chr25",11404096,11404545,450,"ENSBGRG00000016961","ENSBGRT00000031286",0,"STAMBPL1","STAM binding protein like 1 [Source:HGNC Symbol;Acc:HGNC:24105]","GO:0005515(protein binding)","NA",{"v":0.00015,"d":"0.00"},1,"450,",0,-3.82,-3.15,4.15,"5' UTR",25,11404096,11465895,61800,1]
["chr25",15715893,15716312,420,"ENSBGRG00000021895","ENSBGRT00000040508",4612,"CYP26A1","cytochrome P450 family 26 subfamily A member 1 [Source:HGNC Symbol;Acc:HGNC:2603]","GO:0001972(retinoic acid binding);GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0006805(xenobiotic metabolic process);GO:0008401(retinoic acid 4-hydroxylase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016709(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen);GO:0020037(heme binding);GO:0034653(retinoic acid catabolic process);GO:0042573(retinoic acid metabolic process);GO:0055114(oxidation-reduction process);GO:0062183(all-trans retinoic acid 18-hydroxylase activity)","00830(Retinol metabolism)",{"v":0.035,"d":"0.04"},1,"420,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"3' UTR",25,15711281,15716312,5032,1]
["chr25",19631143,19631592,450,"ENSBGRG00000026094","ENSBGRT00000048260",132241,"LCOR","ligand dependent nuclear receptor corepressor [Source:HGNC Symbol;Acc:HGNC:29503]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001226(RNA polymerase II transcription corepressor binding);GO:0003677(DNA binding);GO:0003714(transcription corepressor activity);GO:0005654(nucleoplasm);GO:0030331(estrogen receptor binding);GO:0042826(histone deacetylase binding);GO:0071392(cellular response to estradiol stimulus);GO:1990226(histone methyltransferase binding);GO:1990381(ubiquitin-specific protease binding)","04214(Apoptosis - fly)",{"v":6.3e-17,"d":"0.00"},1,"450,",0,{"v":-16.2,"d":"-16.20"},{"v":-15.2,"d":"-15.20"},{"v":10.3,"d":"10.30"},"Exon (ENSBGRT00000048260/ENSBGRG00000026094, exon 7 of 7)",25,19498902,19631592,132691,1]
["chr25",20875920,20887475,11556,"ENSBGRG00000020483","ENSBGRT00000037732",54805,"ENSBGRG00000020483","NA","GO:0003676(nucleic acid binding)","NA",{"v":1e-120,"d":"0.00"},3,"77,141,829,","0,579,10727",-120,-118,15,"3' UTR",25,20821115,20887714,66600,1]
["chr25",23656902,23657786,885,"ENSBGRG00000025268","ENSBGRT00000046753",1625,"TWNK","twinkle mtDNA helicase [Source:HGNC Symbol;Acc:HGNC:1160]","GO:0002020(protease binding);GO:0003678(DNA helicase activity);GO:0003697(single-stranded DNA binding);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0006260(DNA replication);GO:0006264(mitochondrial DNA replication);GO:0006268(DNA unwinding involved in DNA replication);GO:0006390(mitochondrial transcription);GO:0034214(protein hexamerization);GO:0042645(mitochondrial nucleoid);GO:0042802(identical protein binding);GO:0043139(5'-3' DNA helicase activity)","NA",{"v":1e-07,"d":"0.00"},3,"48,108,293,","0,183,592",-7,-6.22,2.79,"3' UTR",25,23655277,23659148,3872,1]
["chr25",25569538,25569836,299,"ENSBGRG00000008807","ENSBGRT00000016361",328,"CNNM2","cyclin and CBS domain divalent metal cation transport mediator 2 [Source:HGNC Symbol;Acc:HGNC:103]","GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0010960(magnesium ion homeostasis);GO:0015095(magnesium ion transmembrane transporter activity);GO:0015693(magnesium ion transport);GO:0016323(basolateral plasma membrane);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":0.00015,"d":"0.00"},1,"299,",0,-3.83,-3.16,3.18,"Exon (ENSBGRT00000016361/ENSBGRG00000008807, exon 1 of 8)",25,25569210,25763427,194218,1]
["chr25",33580962,33591868,10907,"ENSBGRG00000017257","ENSBGRT00000032187",16007,"SMC3","structural maintenance of chromosomes 3 [Source:HGNC Symbol;Acc:HGNC:2468]","GO:0000785(chromatin);GO:0000800(lateral element);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0006275(regulation of DNA replication);GO:0007062(sister chromatid cohesion);GO:0008278(cohesin complex);GO:0016363(nuclear matrix);GO:0019827(stem cell population maintenance);GO:0030893(meiotic cohesin complex);GO:0034991(nuclear meiotic cohesin complex);GO:0036033(mediator complex binding);GO:0046982(protein heterodimerization activity);GO:0048487(beta-tubulin binding);GO:0051276(chromosome organization);GO:0051321(meiotic cell cycle);GO:0070840(dynein complex binding);GO:0090307(mitotic spindle assembly);GO:0097431(mitotic spindle pole)","04110(Cell cycle);04114(Oocyte meiosis)",{"v":1.6e-41,"d":"0.00"},9,"68,176,81,165,122,214,104,100,109,","0,1068,1757,2061,2528,3776,9331,9598,10798",{"v":-40.8,"d":"-40.80"},{"v":-39.5,"d":"-39.50"},4.15,"Exon (ENSBGRT00000032187/ENSBGRG00000017257, exon 8 of 29)",25,33564955,33605120,40166,1]
["chr25",37191084,37198039,6956,"ENSBGRG00000024958","ENSBGRT00000046075",56956,"NHLRC2","NHL repeat containing 2 [Source:HGNC Symbol;Acc:HGNC:24731]","GO:0005515(protein binding);GO:0005829(cytosol)","NA",{"v":1.6E-7,"d":"0.00"},2,"12,257,","0,6699",{"v":-6.8,"d":"-6.80"},-6.02,2.35,"3' UTR",25,37134128,37198039,63912,1]
["chr25",41052480,41053343,864,"ENSBGRG00000019351","ENSBGRT00000035539",6616,"EMX2","empty spiracles homeobox 2 [Source:HGNC Symbol;Acc:HGNC:3341]","GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0007420(brain development);GO:0009952(anterior/posterior pattern specification);GO:0010468(regulation of gene expression);GO:0021542(dentate gyrus development);GO:0021796(cerebral cortex regionalization);GO:0021846(cell proliferation in forebrain);GO:0021885(forebrain cell migration);GO:0021987(cerebral cortex development);GO:0030182(neuron differentiation);GO:0030900(forebrain development);GO:0042493(response to drug);GO:0043565(sequence-specific DNA binding);GO:0072197(ureter morphogenesis);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":4E-78,"d":"0.00"},1,"864,",0,{"v":-77.4,"d":"-77.40"},{"v":-75.8,"d":"-75.80"},{"v":11.8,"d":"11.80"},"3' UTR",25,41045864,41053343,7480,1]
["chr25",45717496,45717825,330,"ENSBGRG00000024000","ENSBGRT00000044297",55723,"ENSBGRG00000024000","NA","GO:0007052(mitotic spindle organization)","NA",{"v":0.00024,"d":"0.00"},1,"330,",0,-3.62,-2.96,15,"Exon (ENSBGRT00000044297/ENSBGRG00000024000, exon 3 of 7)",25,45661773,45863884,202112,1]
["chr25",55950082,55950435,354,"ENSBGRG00000013010","ENSBGRT00000023773",0,"ENSBGRG00000013010","NA","NA","NA",{"v":1e-07,"d":"0.00"},1,"354,",0,-6.98,{"v":-6.2,"d":"-6.20"},{"v":27.1,"d":"27.10"},"Exon (ENSBGRT00000023756/ENSBGRG00000013010, exon 2 of 2)",25,55950210,55967242,17033,1]
["chr25",57052660,57053020,361,"ENSBGRG00000016166","ENSBGRT00000029690",4253,"ENSBGRG00000016166","NA","GO:0003824(catalytic activity)","00640(Propanoate metabolism);00650(Butanoate metabolism);00062(Fatty acid elongation);00071(Fatty acid degradation);00280(Valine, leucine and isoleucine degradation);00310(Lysine degradation);00380(Tryptophan metabolism);00410(beta-Alanine metabolism)",{"v":1.2E-9,"d":"0.00"},1,"361,",0,-8.92,-8.09,2.43,"3' UTR",25,56995027,57057273,62247,2]
["chr25",11495268,11495387,120,"ENSBGRG00000017216","ENSBGRT00000031553",0,"ACTA2","actin alpha 2, smooth muscle [Source:HGNC Symbol;Acc:HGNC:130]","GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0008217(regulation of blood pressure);GO:0009615(response to virus);GO:0014829(vascular smooth muscle contraction);GO:0015629(actin cytoskeleton);GO:0019901(protein kinase binding);GO:0030485(smooth muscle contractile fiber);GO:0032991(protein-containing complex);GO:0072144(glomerular mesangial cell development)","04371(Apelin signaling pathway);04926(Relaxin signaling pathway);04270(Vascular smooth muscle contraction)",0,1,"120,",0,-822,"-Inf",1.92,"5' UTR",25,11479453,11495387,15935,2]
["chr25",19324893,19382011,57119,"ENSBGRG00000026070","ENSBGRT00000048242",13427,"PIK3AP1","phosphoinositide-3-kinase adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:30034]","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0034134(toll-like receptor 2 signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0034154(toll-like receptor 7 signaling pathway);GO:0034162(toll-like receptor 9 signaling pathway);GO:0036312(phosphatidylinositol 3-kinase regulatory subunit binding);GO:0042802(identical protein binding);GO:0050727(regulation of inflammatory response)","04151(PI3K-Akt signaling pathway);04662(B cell receptor signaling pathway)",{"v":0.00065,"d":"0.00"},3,"47,140,54,","0,5276,57065",-3.19,-2.55,13,"5' UTR",25,19253522,19395438,141917,2]
["chr25",22620872,22631864,10993,"ENSBGRG00000023150","ENSBGRT00000043007",120,"DNMBP","dynamin binding protein [Source:HGNC Symbol;Acc:HGNC:30373]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005911(cell-cell junction);GO:0008360(regulation of cell shape);GO:0035556(intracellular signal transduction)","NA",{"v":1.6e-24,"d":"0.00"},3,"713,123,34,","0,8476,10959",{"v":-23.8,"d":"-23.80"},{"v":-22.7,"d":"-22.70"},4.55,"5' UTR",25,22531620,22631984,100365,2]
["chr25",24456420,24456915,496,"ENSBGRG00000025751","ENSBGRT00000047621",1699,"NPM3","nucleophosmin/nucleoplasmin 3 [Source:HGNC Symbol;Acc:HGNC:7931]","GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006364(rRNA processing);GO:0009303(rRNA transcription);GO:0015629(actin cytoskeleton)","NA",{"v":1.3e-10,"d":"0.00"},2,"355,63,","0,433",-9.87,-9.02,3.71,"3' UTR",25,24456420,24458614,2195,2]
["chr25",26004801,26004859,59,"ENSBGRG00000009240","ENSBGRT00000017165",176,"PCGF6","polycomb group ring finger 6 [Source:HGNC Symbol;Acc:HGNC:21156]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0005634(nucleus);GO:0031519(PcG protein complex);GO:0035102(PRC1 complex);GO:0036353(histone H2A-K119 monoubiquitination);GO:0045892(negative regulation of transcription, DNA-templated)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":0.032,"d":"0.03"},1,"59,",0,-1.49,{"v":-0.981,"d":"-0.98"},2.01,"Exon (ENSBGRT00000017165/ENSBGRG00000009240, exon 1 of 10)",25,25968360,26005035,36676,2]
["chr25",35619486,35620209,724,"ENSBGRG00000019335","ENSBGRT00000035521",0,"ZDHHC6","zinc finger DHHC-type containing 6 [Source:HGNC Symbol;Acc:HGNC:19160]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0010636(positive regulation of mitochondrial fusion);GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0043543(protein acylation)","NA",{"v":3.2e-48,"d":"0.00"},2,"416,151,","0,573",{"v":-47.5,"d":"-47.50"},{"v":-46.2,"d":"-46.20"},6.63,"5' UTR",25,35601522,35620209,18688,2]
["chr25",42701259,42701558,300,"ENSBGRG00000020303","ENSBGRT00000037498",16164,"SFXN4","sideroflexin 4 [Source:HGNC Symbol;Acc:HGNC:16088]","GO:0005739(mitochondrion);GO:0006811(ion transport);GO:0015075(ion transmembrane transporter activity);GO:0016020(membrane);GO:0055085(transmembrane transport)","NA",{"v":0.017,"d":"0.02"},1,"300,",0,-1.77,-1.23,2.13,"3' UTR",25,42701259,42717722,16464,2]
["chr25",46642190,46653229,11040,"ENSBGRG00000025418","ENSBGRT00000046997",0,"IKZF5","IKAROS family zinc finger 5 [Source:HGNC Symbol;Acc:HGNC:14283]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding);GO:0019904(protein domain specific binding);GO:0032991(protein-containing complex)","NA",{"v":4.5e-09,"d":"0.00"},3,"171,123,35,","0,9352,11005",-8.35,-7.53,4.58,"5' UTR",25,46621636,46642360,20725,2]
["chr25",49587383,49617801,30419,"ENSBGRG00000008932","ENSBGRT00000016386",0,"DHX32","DEAH-box helicase 32 (putative) [Source:HGNC Symbol;Acc:HGNC:16717]","GO:0004386(helicase activity)","NA",{"v":6.3e-42,"d":"0.00"},3,"88,503,40,","0,10052,30379",{"v":-41.2,"d":"-41.20"},{"v":-39.9,"d":"-39.90"},8.47,"5' UTR",25,49556071,49617801,61731,2]
["chr26",466877,467741,865,"ENSBGRG00000016860","ENSBGRT00000031208",16055,"ZCWPW1","zinc finger CW-type and PWWP domain containing 1 [Source:HGNC Symbol;Acc:HGNC:23486]","GO:0008270(zinc ion binding)","03430(Mismatch repair)",{"v":3.1E-6,"d":"0.00"},2,"50,248,","0,617",-5.51,-4.78,2.51,"Exon (ENSBGRT00000031208/ENSBGRG00000016860, exon 15 of 16)",26,450822,467979,17158,1]
["chr26",1211867,1212163,297,"ENSBGRG00000024040","ENSBGRT00000044357",14961,"ZNF394","zinc finger protein 394 [Source:HGNC Symbol;Acc:HGNC:18832]","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.6e-43,"d":"0.00"},1,"297,",0,{"v":-42.8,"d":"-42.80"},{"v":-41.5,"d":"-41.50"},3.12,"Exon (ENSBGRT00000044357/ENSBGRG00000024040, exon 3 of 3)",26,1196906,1212163,15258,1]
["chr26",2980536,2981594,1059,"ENSBGRG00000025912","ENSBGRT00000047923",9871,"C7orf26","chromosome 7 open reading frame 26 [Source:HGNC Symbol;Acc:HGNC:21702]","GO:0016409(palmitoyltransferase activity)","NA",{"v":6.3e-12,"d":"0.00"},2,"253,197,","0,862",{"v":-11.2,"d":"-11.20"},{"v":-10.3,"d":"-10.30"},2.01,"3' UTR",26,2970665,2980788,10124,1]
["chr26",3237056,3237326,271,"ENSBGRG00000017667","ENSBGRT00000032474",12478,"RNF216","ring finger protein 216 [Source:HGNC Symbol;Acc:HGNC:21698]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0032648(regulation of interferon-beta production);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0050691(regulation of defense response to virus by host);GO:0070936(protein K48-linked ubiquitination)","NA",{"v":0.0095,"d":"0.01"},1,"271,",0,-2.02,-1.47,3.76,"Exon (ENSBGRT00000032474/ENSBGRG00000017667, exon 3 of 15)",26,3224578,3352878,128301,1]
["chr26",5567903,5568230,328,"ENSBGRG00000022907","ENSBGRT00000042268",85187,"GNA12","G protein subunit alpha 12 [Source:HGNC Symbol;Acc:HGNC:4380]","GO:0001664(G protein-coupled receptor binding);GO:0001701(in utero embryonic development);GO:0003924(GTPase activity);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007266(Rho protein signal transduction);GO:0008360(regulation of cell shape);GO:0010762(regulation of fibroblast migration);GO:0019001(guanyl nucleotide binding);GO:0030154(cell differentiation);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0032006(regulation of TOR signaling);GO:0032434(regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0035556(intracellular signal transduction);GO:0042733(embryonic digit morphogenesis)","04010(MAPK signaling pathway);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04022(cGMP - PKG signaling pathway);04810(Regulation of actin cytoskeleton);04928(Parathyroid hormone synthesis, secretion and action);04270(Vascular smooth muscle contraction);04730(Long-term depression);05200(Pathways in cancer);05163(Human cytomegalovirus infection)",{"v":1.3e-61,"d":"0.00"},1,"328,",0,{"v":-60.9,"d":"-60.90"},{"v":-59.4,"d":"-59.40"},3.39,"Exon (ENSBGRT00000042268/ENSBGRG00000022907, exon 6 of 6)",26,5482716,5568230,85515,1]
["chr26",8036437,8036616,180,"ENSBGRG00000025649","ENSBGRT00000047496",185140,"COL26A1","collagen type XXVI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:18038]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0010811(positive regulation of cell-substrate adhesion);GO:0031012(extracellular matrix)","NA",{"v":2.8e-06,"d":"0.00"},1,"180,",0,-5.56,-4.82,{"v":22.1,"d":"22.10"},"3' UTR",26,7851297,8037123,185827,1]
["chr26",9009116,9032595,23480,"ENSBGRG00000008359","ENSBGRT00000015227",0,"YWHAG","tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma [Source:HGNC Symbol;Acc:HGNC:12852]","GO:0005080(protein kinase C binding);GO:0005159(insulin-like growth factor receptor binding);GO:0006605(protein targeting);GO:0019904(protein domain specific binding);GO:0042802(identical protein binding);GO:0045664(regulation of neuron differentiation);GO:0048167(regulation of synaptic plasticity)","04390(Hippo signaling pathway);04151(PI3K-Akt signaling pathway);04110(Cell cycle);04114(Oocyte meiosis);05203(Viral carcinogenesis);05169(Epstein-Barr virus infection)",0,3,"87,666,312,","0,20976,23168",-382,"-Inf",3.66,"3' UTR",26,9009116,9033009,23894,1]
["chr26",10411641,10411881,241,"ENSBGRG00000019878","ENSBGRT00000036539",21651,"LAT2","linker for activation of T cells family member 2 [Source:HGNC Symbol;Acc:HGNC:12749]","GO:0002764(immune response-regulating signaling pathway);GO:0005886(plasma membrane);GO:0019722(calcium-mediated signaling);GO:0035556(intracellular signal transduction);GO:0042113(B cell activation);GO:0042169(SH2 domain binding);GO:0045121(membrane raft);GO:0050853(B cell receptor signaling pathway)","NA",{"v":6.3E-5,"d":"0.00"},1,"241,",0,{"v":-4.2,"d":"-4.20"},-3.52,3.11,"3' UTR",26,10389990,10411911,21922,1]
["chr26",17430672,17459464,28793,"ENSBGRG00000025129","ENSBGRT00000046471",6246,"ENSBGRG00000025129","NA","NA","NA",{"v":6.3e-34,"d":"0.00"},2,"61,88,","0,28705",{"v":-33.2,"d":"-33.20"},-32,2.88,"Exon (ENSBGRT00000046471/ENSBGRG00000025129, exon 6 of 6)",26,17424426,17430732,6307,1]
["chr26",18030257,18031163,907,"ENSBGRG00000026026","ENSBGRT00000048184",0,"MAZ","MYC associated zinc finger protein [Source:HGNC Symbol;Acc:HGNC:6914]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006369(termination of RNA polymerase II transcription);GO:0008284(positive regulation of cell population proliferation);GO:0010628(positive regulation of gene expression);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0030335(positive regulation of cell migration);GO:0045893(positive regulation of transcription, DNA-templated);GO:0051897(positive regulation of protein kinase B signaling);GO:2001234(negative regulation of apoptotic signaling pathway)","03013(RNA transport);00562(Inositol phosphate metabolism);00564(Glycerophospholipid metabolism);04070(Phosphatidylinositol signaling system)",{"v":6.3e-56,"d":"0.00"},3,"36,192,100,","0,532,807",{"v":-55.2,"d":"-55.20"},{"v":-53.8,"d":"-53.80"},9.83,"Exon (ENSBGRT00000048184/ENSBGRG00000026026, exon 1 of 6)",26,18030257,18034322,4066,1]
["chr26",18538250,18538520,271,"ENSBGRG00000009138","ENSBGRT00000016775",179,"ATXN2L","ataxin 2 like [Source:HGNC Symbol;Acc:HGNC:31326]","GO:0005829(cytosol);GO:0010494(cytoplasmic stress granule);GO:0010603(regulation of cytoplasmic mRNA processing body assembly);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0034063(stress granule assembly)","NA",{"v":2e-07,"d":"0.00"},1,"271,",0,{"v":-6.7,"d":"-6.70"},-5.92,3.22,"5' UTR",26,18538071,18553274,15204,1]
["chr26",19913154,19913452,299,"ENSBGRG00000018739","ENSBGRT00000034307",59780,"ENSBGRG00000018739","NA","GO:0006281(DNA repair);GO:0030915(Smc5-Smc6 complex);GO:0035556(intracellular signal transduction)","NA",{"v":0.0058,"d":"0.01"},1,"299,",0,-2.24,-1.66,10,"3' UTR",26,19853374,19914199,60826,1]
["chr26",24124073,24125260,1188,"ENSBGRG00000023114","ENSBGRT00000042929",102379,"COG7","component of oligomeric golgi complex 7 [Source:HGNC Symbol;Acc:HGNC:18622]","GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0006886(intracellular protein transport);GO:0006890(retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum);GO:0017119(Golgi transport complex);GO:0033365(protein localization to organelle);GO:0034067(protein localization to Golgi apparatus);GO:0043231(intracellular membrane-bounded organelle);GO:0050821(protein stabilization)","NA",{"v":3.2e-38,"d":"0.00"},2,"304,354,","0,834",{"v":-37.5,"d":"-37.50"},{"v":-36.2,"d":"-36.20"},5.65,"3' UTR",26,24021694,24124376,102683,1]
["chr26",32693502,32707900,14399,"ENSBGRG00000026089","ENSBGRT00000048572",185460,"PARN","poly(A)-specific ribonuclease [Source:HGNC Symbol;Acc:HGNC:8609]","GO:0000495(box H/ACA snoRNA 3'-end processing);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0004535(poly(A)-specific ribonuclease activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006402(mRNA catabolic process);GO:0010587(miRNA catabolic process);GO:0016607(nuclear speck);GO:0019901(protein kinase binding);GO:0032212(positive regulation of telomere maintenance via telomerase);GO:0043169(cation binding);GO:0046872(metal ion binding);GO:0051973(positive regulation of telomerase activity);GO:0071051(polyadenylation-dependent snoRNA 3'-end processing);GO:0090503(RNA phosphodiester bond hydrolysis, exonucleolytic);GO:0090669(telomerase RNA stabilization);GO:0110008(ncRNA deadenylation);GO:1904872(regulation of telomerase RNA localization to Cajal body)","03018(RNA degradation)",{"v":1.3E-23,"d":"0.00"},2,"170,636,","0,13763",{"v":-22.9,"d":"-22.90"},{"v":-21.9,"d":"-21.90"},2.95,"3' UTR",26,32508042,32708317,200276,1]
["chr26",36001424,36004668,3245,"ENSBGRG00000026441","ENSBGRT00000048938",24686,"ZC3H7A","zinc finger CCCH-type containing 7A [Source:HGNC Symbol;Acc:HGNC:30959]","GO:0005515(protein binding);GO:0010608(posttranscriptional regulation of gene expression);GO:0035196(production of miRNAs involved in gene silencing by miRNA);GO:0035198(miRNA binding);GO:0046872(metal ion binding)","NA",{"v":4e-49,"d":"0.00"},3,"5,164,190,","0,1805,3055",{"v":-48.4,"d":"-48.40"},-47,2.37,"Exon (ENSBGRT00000048938/ENSBGRG00000026441, exon 20 of 22)",26,35976738,36004668,27931,1]
["chr26",43271202,43271650,449,"ENSBGRG00000010556","ENSBGRT00000021236",13323,"ENSBGRG00000010556","NA","NA","00600(Sphingolipid metabolism)",{"v":2.5e-32,"d":"0.00"},1,"449,",0,{"v":-31.6,"d":"-31.60"},{"v":-30.5,"d":"-30.50"},5.62,"3' UTR",26,43257879,43271740,13862,1]
["chr26",44561838,44562853,1016,"ENSBGRG00000022270","ENSBGRT00000041494",4915,"SLX4","SLX4 structure-specific endonuclease subunit [Source:HGNC Symbol;Acc:HGNC:23845]","GO:0000724(double-strand break repair via homologous recombination);GO:0000781(chromosome, telomeric region);GO:0000784(nuclear chromosome, telomeric region);GO:0000790(nuclear chromatin);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006289(nucleotide-excision repair);GO:0008047(enzyme activator activity);GO:0008821(crossover junction endodeoxyribonuclease activity);GO:0010792(DNA double-strand break processing involved in repair via single-strand annealing);GO:0017108(5'-flap endonuclease activity);GO:0030054(cell junction);GO:0033557(Slx1-Slx4 complex);GO:0048257(3'-flap endonuclease activity);GO:0048476(Holliday junction resolvase complex);GO:0061820(telomeric D-loop disassembly);GO:0070522(ERCC4-ERCC1 complex);GO:0072429(response to intra-S DNA damage checkpoint signaling);GO:0090656(t-circle formation);GO:1904357(negative regulation of telomere maintenance via telomere lengthening);GO:1904431(positive regulation of t-circle formation)","03460(Fanconi anemia pathway)",{"v":4e-18,"d":"0.00"},3,"79,209,191,","0,505,825",{"v":-17.4,"d":"-17.40"},{"v":-16.4,"d":"-16.40"},4.76,"Exon (ENSBGRT00000041494/ENSBGRG00000022270, exon 3 of 17)",26,44556923,44574469,17547,1]
["chr26",45383293,45383766,474,"ENSBGRG00000014426","ENSBGRT00000026474",493,"ENSBGRG00000014426","NA","GO:0010923(negative regulation of phosphatase activity)","NA",{"v":0.00013,"d":"0.00"},1,"474,",0,-3.88,-3.21,9.03,"3' UTR",26,45382800,45384269,1470,1]
["chr26",46183185,46184064,880,"ENSBGRG00000025889","ENSBGRT00000047886",11345,"ENSBGRG00000025889","zinc finger protein 598 [Source:HGNC Symbol;Acc:HGNC:28079]","GO:0003676(nucleic acid binding)","NA",{"v":1e-130,"d":"0.00"},4,"91,350,4,270,","0,179,540,610",-130,-128,6.02,"Exon (ENSBGRT00000047886/ENSBGRG00000025889, exon 13 of 15)",26,46171840,46183728,11889,1]
["chr26",46729011,46729589,579,"ENSBGRG00000026455","ENSBGRT00000048979",37677,"ENSBGRG00000026455","NA","GO:0046872(metal ion binding)","NA",{"v":3e-08,"d":"0.00"},2,"79,371,","0,208",-7.52,-6.72,2.27,"Exon (ENSBGRT00000048979/ENSBGRG00000026455, exon 13 of 15)",26,46691334,46731207,39874,1]
["chr26",47568081,47568763,683,"ENSBGRG00000013150","ENSBGRT00000024113",1410,"MRPL28","mitochondrial ribosomal protein L28 [Source:HGNC Symbol;Acc:HGNC:14484]","GO:0003735(structural constituent of ribosome);GO:0005739(mitochondrion);GO:0005761(mitochondrial ribosome);GO:0005762(mitochondrial large ribosomal subunit);GO:0005829(cytosol)","03010(Ribosome)",{"v":1E-25,"d":"0.00"},3,"13,87,108,","0,102,575",-25,{"v":-23.9,"d":"-23.90"},2.11,"Exon (ENSBGRT00000024113/ENSBGRG00000013150, exon 3 of 5)",26,47566671,47568763,2093,1]
["chr26",820242,821199,958,"ENSBGRG00000020033","ENSBGRT00000036947",2170,"AZGP1","alpha-2-glycoprotein 1, zinc-binding [Source:HGNC Symbol;Acc:HGNC:910]","GO:0001580(detection of chemical stimulus involved in sensory perception of bitter taste);GO:0005615(extracellular space);GO:0007155(cell adhesion)","04514(Cell adhesion molecules (CAMs));04144(Endocytosis);04145(Phagosome);04218(Cellular senescence);04650(Natural killer cell mediated cytotoxicity);04612(Antigen processing and presentation);05203(Viral carcinogenesis);05320(Autoimmune thyroid disease);05330(Allograft rejection);05332(Graft-versus-host disease);05416(Viral myocarditis);04940(Type I diabetes mellitus);05166(HTLV-I infection);05168(Herpes simplex infection);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection)",{"v":0.0032,"d":"0.00"},2,"194,42,","0,916",-2.49,{"v":-1.9,"d":"-1.90"},2.47,"Exon (ENSBGRT00000036947/ENSBGRG00000020033, exon 2 of 5)",26,819257,823369,4113,2]
["chr26",1327732,1328058,327,"ENSBGRG00000024499","ENSBGRT00000045218",10999,"ENSBGRG00000024499","NA","GO:0005515(protein binding);GO:0005885(Arp2/3 protein complex);GO:0015629(actin cytoskeleton);GO:0030833(regulation of actin filament polymerization);GO:0034314(Arp2/3 complex-mediated actin nucleation)","04144(Endocytosis);04810(Regulation of actin cytoskeleton);04666(Fc gamma R-mediated phagocytosis);05132(Salmonella infection);05100(Bacterial invasion of epithelial cells)",{"v":1.3e-89,"d":"0.00"},1,"327,",0,{"v":-88.9,"d":"-88.90"},{"v":-87.2,"d":"-87.20"},2.47,"3' UTR",26,1327732,1339057,11326,2]
["chr26",2835517,2836322,806,"ENSBGRG00000025849","ENSBGRT00000047784",27808,"DAGLB","diacylglycerol lipase beta [Source:HGNC Symbol;Acc:HGNC:28923]","GO:0001516(prostaglandin biosynthetic process);GO:0004806(triglyceride lipase activity);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0006690(icosanoid metabolic process);GO:0007405(neuroblast proliferation);GO:0010898(positive regulation of triglyceride catabolic process);GO:0016298(lipase activity);GO:0019369(arachidonic acid metabolic process);GO:0022008(neurogenesis);GO:0042136(neurotransmitter biosynthetic process);GO:0050727(regulation of inflammatory response)","04925(Aldosterone synthesis and secretion);04723(Retrograde endocannabinoid signaling)",{"v":1.3E-31,"d":"0.00"},1,"806,",0,{"v":-30.9,"d":"-30.90"},{"v":-29.7,"d":"-29.70"},10,"3' UTR",26,2830780,2864130,33351,2]
["chr26",5985452,5985600,149,"ENSBGRG00000024138","ENSBGRT00000044570",297,"ENSBGRG00000024138","NA","GO:0006281(DNA repair);GO:0008413(8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity);GO:0016787(hydrolase activity)","NA",{"v":0.039,"d":"0.04"},1,"149,",0,-1.41,{"v":-0.908,"d":"-0.91"},2.51,"Exon (ENSBGRT00000044570/ENSBGRG00000024138, exon 1 of 4)",26,5980763,5985897,5135,2]
["chr26",7819859,7820189,331,"ENSBGRG00000025621","ENSBGRT00000047374",0,"ENSBGRG00000025621","NA","NA","NA",{"v":0.035,"d":"0.04"},1,"331,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"5' UTR",26,7815320,7820189,4870,2]
["chr26",9804881,9813995,9115,"ENSBGRG00000011085","ENSBGRT00000020600",13152,"BAZ1B","bromodomain adjacent to zinc finger domain 1B [Source:HGNC Symbol;Acc:HGNC:961]","GO:0000793(condensed chromosome);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005721(pericentric heterochromatin);GO:0006333(chromatin assembly or disassembly);GO:0006338(chromatin remodeling);GO:0006974(cellular response to DNA damage stimulus);GO:0016572(histone phosphorylation);GO:0016604(nuclear body);GO:0035173(histone kinase activity);GO:0042393(histone binding);GO:0043596(nuclear replication fork)","NA",{"v":5e-11,"d":"0.00"},4,"74,122,202,52,","0,2061,5381,9063",{"v":-10.3,"d":"-10.30"},{"v":-9.4,"d":"-9.40"},1.99,"Exon (ENSBGRT00000020600/ENSBGRG00000011085, exon 3 of 19)",26,9764853,9827147,62295,2]
["chr26",9995542,9995841,300,"ENSBGRG00000012769","ENSBGRT00000023683",2141,"ABHD11","abhydrolase domain containing 11 [Source:HGNC Symbol;Acc:HGNC:16407]","GO:0003824(catalytic activity)","NA",{"v":3.2e-23,"d":"0.00"},1,"300,",0,{"v":-22.5,"d":"-22.50"},{"v":-21.5,"d":"-21.50"},4.66,"3' UTR",26,9995542,9997982,2441,2]
["chr26",17109059,17111583,2525,"ENSBGRG00000022802","ENSBGRT00000042361",9502,"FUS","FUS RNA binding protein [Source:HGNC Symbol;Acc:HGNC:4010]","GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0003713(transcription coactivator activity);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0042802(identical protein binding);GO:0043484(regulation of RNA splicing);GO:0048255(mRNA stabilization);GO:0051260(protein homooligomerization);GO:1905168(positive regulation of double-strand break repair via homologous recombination)","05202(Transcriptional misregulation in cancers)",0,6,"550,101,124,102,130,8,","0,662,1276,1534,1889,2517",-378,"-Inf",{"v":17.8,"d":"17.80"},"3' UTR",26,17107668,17121085,13418,2]
["chr26",17555335,17557584,2250,"ENSBGRG00000025370","ENSBGRT00000047310",30546,"ENSBGRG00000025370","NA","GO:0003677(DNA binding);GO:0005524(ATP binding)","NA",{"v":1e-120,"d":"0.00"},2,"1009,671,","0,1579",-120,-118,{"v":10.6,"d":"10.60"},"Exon (ENSBGRT00000047310/ENSBGRG00000025370, exon 33 of 34)",26,17555065,17588130,33066,2]
["chr26",17634534,17635012,479,"ENSBGRG00000025628","ENSBGRT00000047472",2775,"FBRS","fibrosin [Source:HGNC Symbol;Acc:HGNC:20442]","NA","NA",{"v":3.2e-37,"d":"0.00"},1,"479,",0,{"v":-36.5,"d":"-36.50"},{"v":-35.3,"d":"-35.30"},4.21,"Exon (ENSBGRT00000047472/ENSBGRG00000025628, exon 8 of 8)",26,17634534,17637787,3254,2]
["chr26",18622405,18622966,562,"ENSBGRG00000014809","ENSBGRT00000028010",60,"RABEP2","rabaptin, RAB GTPase binding effector protein 2 [Source:HGNC Symbol;Acc:HGNC:24817]","GO:0005096(GTPase activator activity);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006897(endocytosis);GO:0008083(growth factor activity);GO:0036064(ciliary basal body);GO:0043231(intracellular membrane-bounded organelle);GO:1902017(regulation of cilium assembly)","NA",{"v":0.026,"d":"0.03"},2,"60,1,","0,561",-1.58,-1.06,1.79,"Exon (ENSBGRT00000028010/ENSBGRG00000014809, exon 1 of 13)",26,18610224,18623026,12803,2]
["chr26",25370562,25371221,660,"ENSBGRG00000024381","ENSBGRT00000045017",56936,"EEF2K","eukaryotic elongation factor 2 kinase [Source:HGNC Symbol;Acc:HGNC:24615]","GO:0004674(protein serine/threonine kinase activity);GO:0004686(elongation factor-2 kinase activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0031952(regulation of protein autophosphorylation);GO:0046777(protein autophosphorylation)","04152(AMPK signaling pathway);04921(Oxytocin signaling pathway)",{"v":1e-31,"d":"0.00"},1,"660,",0,-31,{"v":-29.8,"d":"-29.80"},9.03,"3' UTR",26,25369064,25428157,59094,2]
["chr26",32467471,32469649,2179,"ENSBGRG00000026008","ENSBGRT00000048127",16729,"BFAR","bifunctional apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:17613]","GO:0000209(protein polyubiquitination);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016020(membrane);GO:0030674(protein-macromolecule adaptor activity);GO:0043066(negative regulation of apoptotic process);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0070534(protein K63-linked ubiquitination);GO:0070936(protein K48-linked ubiquitination);GO:0089720(caspase binding);GO:1903895(negative regulation of IRE1-mediated unfolded protein response)","NA",{"v":1.6e-30,"d":"0.00"},2,"193,131,","0,2048",{"v":-29.8,"d":"-29.80"},{"v":-28.6,"d":"-28.60"},{"v":3.7,"d":"3.70"},"Exon (ENSBGRT00000048127/ENSBGRG00000026008, exon 6 of 7)",26,32467471,32486378,18908,2]
["chr26",37159895,37160193,299,"ENSBGRG00000026633","ENSBGRT00000049353",20673,"NUBP1","nucleotide binding protein 1 [Source:HGNC Symbol;Acc:HGNC:8041]","GO:0001558(regulation of cell growth);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006879(cellular iron ion homeostasis);GO:0010826(negative regulation of centrosome duplication);GO:0016226(iron-sulfur cluster assembly);GO:0051536(iron-sulfur cluster binding);GO:0051539(4 iron, 4 sulfur cluster binding);GO:0051642(centrosome localization);GO:0072697(protein localization to cell cortex)","NA",{"v":1.3E-59,"d":"0.00"},1,"299,",0,{"v":-58.9,"d":"-58.90"},{"v":-57.4,"d":"-57.40"},9.64,"3' UTR",26,37159895,37180866,20972,2]
["chr26",43437622,43445292,7671,"ENSBGRG00000012919","ENSBGRT00000023783",29014,"UBN1","ubinuclein 1 [Source:HGNC Symbol;Acc:HGNC:12506]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005923(bicellular tight junction);GO:0006325(chromatin organization);GO:0006336(DNA replication-independent nucleosome assembly);GO:0016604(nuclear body)","NA",{"v":6.3e-32,"d":"0.00"},4,"589,43,51,33,","0,1617,1755,7638",{"v":-31.2,"d":"-31.20"},-30,6.91,"Exon (ENSBGRT00000023783/ENSBGRG00000012919, exon 13 of 19)",26,43434635,43474306,39672,2]
["chr26",45031562,45032585,1024,"ENSBGRG00000023966","ENSBGRT00000044347",0,"ZNF205","zinc finger protein 205 [Source:HGNC Symbol;Acc:HGNC:12996]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated);GO:0010729(positive regulation of hydrogen peroxide biosynthetic process);GO:1901030(positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway)","NA",{"v":0.0029,"d":"0.00"},2,"14,167,","0,857",-2.54,-1.94,11,"5' UTR",26,45022503,45031575,9073,2]
["chr26",45687867,45688880,1014,"ENSBGRG00000016154","ENSBGRT00000029708",2535,"NTN3","netrin 3 [Source:HGNC Symbol;Acc:HGNC:8030]","GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005794(Golgi apparatus)","04360(Axon guidance)",{"v":3.7e-05,"d":"0.00"},1,"1014,",0,-4.43,-3.73,{"v":18.1,"d":"18.10"},"3' UTR",26,45687867,45691415,3549,2]
["chr26",45697484,45697782,299,"ENSBGRG00000016254","ENSBGRT00000030135",3968,"TEDC2","tubulin epsilon and delta complex 2 [Source:HGNC Symbol;Acc:HGNC:25849]","GO:0005814(centriole);GO:0005929(cilium);GO:0045880(positive regulation of smoothened signaling pathway)","NA",{"v":6.3e-16,"d":"0.00"},1,"299,",0,{"v":-15.2,"d":"-15.20"},{"v":-14.3,"d":"-14.30"},2.84,"3' UTR",26,45695070,45701750,6681,2]
["chr26",46435816,46440822,5007,"ENSBGRG00000026167","ENSBGRT00000048400",25944,"ENSBGRG00000026167","NA","GO:0005078(MAP-kinase scaffold activity)","04010(MAPK signaling pathway)",{"v":7.8e-08,"d":"0.00"},3,"106,92,41,","0,4694,4966",-7.11,-6.32,2.19,"Exon (ENSBGRT00000048400/ENSBGRG00000026167, exon 3 of 5)",26,46434864,46466766,31903,2]
["chr26",47337490,47338578,1089,"ENSBGRG00000009389","ENSBGRT00000020561",0,"ENSBGRG00000009389","NA","NA","NA",{"v":0.0072,"d":"0.01"},3,"96,213,51,","0,220,1038",-2.14,-1.58,4.01,"Exon (ENSBGRT00000020561/ENSBGRG00000009389, exon 1 of 42)",26,47320331,47338578,18248,2]
["chr27",1807955,1843825,35871,"ENSBGRG00000018864","ENSBGRT00000034608",37572,"TSNAX-DISC1","TSNAX-DISC1 readthrough (NMD candidate) [Source:HGNC Symbol;Acc:HGNC:49177]","GO:0005737(cytoplasm);GO:0043565(sequence-specific DNA binding)","NA",{"v":0.00047,"d":"0.00"},2,"5,56,","0,35815",-3.33,-2.68,1.82,"Exon (ENSBGRT00000034608/ENSBGRG00000018864, exon 6 of 7)",27,1770383,1844961,74579,1]
["chr27",9356845,9357203,359,"ENSBGRG00000023764","ENSBGRT00000043966",0,"ENSBGRG00000023764","NA","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0006915(apoptotic process);GO:0007005(mitochondrion organization)","NA",{"v":0.019,"d":"0.02"},1,"359,",0,-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000043966/ENSBGRG00000023764, exon 1 of 3)",27,9356845,9359891,3047,1]
["chr27",11542189,11554761,12573,"ENSBGRG00000024022","ENSBGRT00000044337",16130,"ZNF248","zinc finger protein 248 [Source:HGNC Symbol;Acc:HGNC:13041]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":5.9e-08,"d":"0.00"},3,"22,96,512,","0,301,12061",-7.23,-6.44,{"v":25.1,"d":"25.10"},"5' UTR",27,11526059,11555748,29690,1]
["chr27",24533023,24533322,300,"ENSBGRG00000009961","ENSBGRT00000018425",84019,"TET1","tet methylcytosine dioxygenase 1 [Source:HGNC Symbol;Acc:HGNC:29484]","GO:0003677(DNA binding);GO:0005506(iron ion binding);GO:0006211(5-methylcytosine catabolic process);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0008327(methyl-CpG binding);GO:0031062(positive regulation of histone methylation);GO:0070579(methylcytosine dioxygenase activity);GO:0080111(DNA demethylation);GO:0090310(negative regulation of methylation-dependent chromatin silencing)","NA",{"v":7.6e-05,"d":"0.00"},1,"300,",0,-4.12,-3.43,7.35,"Exon (ENSBGRT00000018425/ENSBGRG00000009961, exon 4 of 13)",27,24449004,24578706,129703,1]
["chr27",26616378,26649419,33042,"ENSBGRG00000022489","ENSBGRT00000041560",2618,"ADAMTS14","ADAM metallopeptidase with thrombospondin type 1 motif 14 [Source:HGNC Symbol;Acc:HGNC:14899]","GO:0004222(metalloendopeptidase activity);GO:0005576(extracellular region);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0030199(collagen fibril organization)","NA",{"v":6.3E-3,"d":"0.01"},2,"161,49,","0,32993",{"v":-2.2,"d":"-2.20"},-1.62,6.02,"Exon (ENSBGRT00000041560/ENSBGRG00000022489, exon 2 of 22)",27,26613760,26724173,110414,1]
["chr27",27404026,27404435,410,"ENSBGRG00000023045","ENSBGRT00000042516",6514,"ENSBGRG00000023045","NA","NA","NA",{"v":0.0017,"d":"0.00"},1,"410,",0,-2.77,-2.16,12,"Exon (ENSBGRT00000042516/ENSBGRG00000023045, exon 3 of 3)",27,27397512,27404610,7099,1]
["chr27",31532247,31532367,121,"ENSBGRG00000021018","ENSBGRT00000038712",4784,"ENSBGRG00000021018","NA","NA","NA",{"v":0.032,"d":"0.03"},1,"121,",0,-1.49,{"v":-0.978,"d":"-0.98"},4.51,"Exon (ENSBGRT00000038712/ENSBGRG00000021018, exon 2 of 2)",27,31527463,31532957,5495,1]
["chr27",46084758,46087617,2860,"ENSBGRG00000013125","ENSBGRT00000031704",40547,"ENSBGRG00000013125","NA","GO:0071203(WASH complex)","04144(Endocytosis)",{"v":5.1E-10,"d":"0.00"},2,"79,42,","0,2818",-9.29,-8.45,4.21,"Exon (ENSBGRT00000031704/ENSBGRG00000013125, exon 23 of 32)",27,46044211,46099459,55249,1]
["chr27",947139,948271,1133,"ENSBGRG00000016400","ENSBGRT00000030144",0,"C1orf198","chromosome 1 open reading frame 198 [Source:HGNC Symbol;Acc:HGNC:25900]","GO:0005829(cytosol)","NA",{"v":1.5E-6,"d":"0.00"},1,"1133,",0,-5.83,-5.08,{"v":18.1,"d":"18.10"},"5' UTR",27,910187,947639,37453,2]
["chr27",5726725,5732668,5944,"ENSBGRG00000018139","ENSBGRT00000033250",9417,"TOMM20","translocase of outer mitochondrial membrane 20 [Source:HGNC Symbol;Acc:HGNC:20947]","GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005742(mitochondrial outer membrane translocase complex);GO:0006605(protein targeting);GO:0006626(protein targeting to mitochondrion);GO:0006886(intracellular protein transport);GO:0015450(P-P-bond-hydrolysis-driven protein transmembrane transporter activity);GO:0044233(mitochondria-associated endoplasmic reticulum membrane);GO:0051082(unfolded protein binding)","NA",{"v":0.00025,"d":"0.00"},3,"45,143,17,","0,1441,5927",-3.61,-2.95,2.56,"Exon (ENSBGRT00000033250/ENSBGRG00000018139, exon 3 of 5)",27,5726725,5742085,15361,2]
["chr27",12293516,12295335,1820,"ENSBGRG00000024688","ENSBGRT00000045547",4978,"HNRNPF","heterogeneous nuclear ribonucleoprotein F [Source:HGNC Symbol;Acc:HGNC:5039]","GO:0003676(nucleic acid binding);GO:0003727(single-stranded RNA binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0043484(regulation of RNA splicing);GO:0071013(catalytic step 2 spliceosome)","NA",{"v":9.99999999999998e-267,"d":"0.00"},2,"592,1111,","0,709",-266,-263,2.55,"5' UTR",27,12293516,12300313,6798,2]
["chr27",24299046,24302389,3344,"ENSBGRG00000009040","ENSBGRT00000017275",19890,"RUFY2","RUN and FYVE domain containing 2 [Source:HGNC Symbol;Acc:HGNC:19761]","GO:0005737(cytoplasm);GO:0017124(SH3 domain binding);GO:0046872(metal ion binding)","03030(DNA replication)",{"v":0.045,"d":"0.05"},3,"65,109,35,","0,2442,3309",-1.35,{"v":-0.852,"d":"-0.85"},1.56,"Exon (ENSBGRT00000017275/ENSBGRG00000009040, exon 12 of 18)",27,24278546,24322279,43734,2]
["chr27",29826166,29826345,180,"ENSBGRG00000011772","ENSBGRT00000022157",6907,"ENSBGRG00000011772","NA","NA","04530(Tight junction)",{"v":0.035,"d":"0.04"},1,"180,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000022157/ENSBGRG00000011772, exon 5 of 10)",27,29824780,29833252,8473,2]
["chr27",29917107,29917227,121,"ENSBGRG00000014580","ENSBGRT00000032822",64154,"CAMK2G","calcium/calmodulin dependent protein kinase II gamma [Source:HGNC Symbol;Acc:HGNC:1463]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004683(calmodulin-dependent protein kinase activity);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0006816(calcium ion transport);GO:0010975(regulation of neuron projection development);GO:0014069(postsynaptic density);GO:0046777(protein autophosphorylation);GO:1901897(regulation of relaxation of cardiac muscle)","04012(ErbB signaling pathway);04310(Wnt signaling pathway);04066(HIF-1 signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04114(Oocyte meiosis);04217(Necroptosis);04911(Insulin secretion);04922(Glucagon signaling pathway);04912(GnRH signaling pathway);04921(Oxytocin signaling pathway);04916(Melanogenesis);04925(Aldosterone synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04971(Gastric acid secretion);04725(Cholinergic synapse);04728(Dopaminergic synapse);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04740(Olfactory transduction);04750(Inflammatory mediator regulation of TRP channels);04360(Axon guidance);04713(Circadian entrainment);05200(Pathways in cancer);05205(Proteoglycans in cancer);05214(Glioma);05031(Amphetamine addiction);04934(Cushing syndrome);05152(Tuberculosis)",{"v":1.3e-05,"d":"0.00"},1,"121,",0,-4.89,-4.17,{"v":1.6,"d":"1.60"},"3' UTR",27,29916448,29981381,64934,2]
["chr27",45540198,45565618,25421,"ENSBGRG00000011586","ENSBGRT00000021105",10863,"ERCC6","ERCC excision repair 6, chromatin remodeling factor [Source:HGNC Symbol;Acc:HGNC:3438]","GO:0000012(single strand break repair);GO:0000077(DNA damage checkpoint);GO:0000303(response to superoxide);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006281(DNA repair);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0006284(base-excision repair);GO:0006290(pyrimidine dimer repair);GO:0006362(transcription elongation from RNA polymerase I promoter);GO:0006974(cellular response to DNA damage stimulus);GO:0006979(response to oxidative stress);GO:0007256(activation of JNKK activity);GO:0007257(activation of JUN kinase activity);GO:0008022(protein C-terminus binding);GO:0008023(transcription elongation factor complex);GO:0008094(DNA-dependent ATPase activity);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0009411(response to UV);GO:0009636(response to toxic substance);GO:0010165(response to X-ray);GO:0010224(response to UV-B);GO:0010332(response to gamma radiation);GO:0022008(neurogenesis);GO:0030182(neuron differentiation);GO:0030296(protein tyrosine kinase activator activity);GO:0031175(neuron projection development);GO:0032784(regulation of DNA-templated transcription, elongation);GO:0032786(positive regulation of DNA-templated transcription, elongation);GO:0035264(multicellular organism growth);GO:0043044(ATP-dependent chromatin remodeling);GO:0044877(protein-containing complex binding);GO:0045494(photoreceptor cell maintenance);GO:0045739(positive regulation of DNA repair);GO:0047485(protein N-terminus binding);GO:0060261(positive regulation of transcription initiation from RNA polymerase II promoter);GO:0090734(site of DNA damage);GO:0097680(double-strand break repair via classical nonhomologous end joining);GO:1905168(positive regulation of double-strand break repair via homologous recombination);GO:2001033(negative regulation of double-strand break repair via nonhomologous end joining)","03420(Nucleotide excision repair)",{"v":1.6E-11,"d":"0.00"},3,"119,712,67,","0,19599,25354",{"v":-10.8,"d":"-10.80"},-9.91,4.78,"Exon (ENSBGRT00000021105/ENSBGRG00000011586, exon 4 of 21)",27,45498567,45576481,77915,2]
["chr27",49448547,49448876,330,"ENSBGRG00000020548","ENSBGRT00000037824",5374,"URB2","URB2 ribosome biogenesis homolog [Source:HGNC Symbol;Acc:HGNC:28967]","GO:0005730(nucleolus);GO:0016235(aggresome);GO:0030496(midbody)","NA",{"v":0.00089,"d":"0.00"},1,"330,",0,-3.05,-2.42,13,"Exon (ENSBGRT00000037824/ENSBGRG00000020548, exon 3 of 10)",27,49425212,49454250,29039,2]
["chr28",14145233,14145862,630,"ENSBGRG00000012847","ENSBGRT00000023502",150,"LRRC3B","leucine rich repeat containing 3B [Source:HGNC Symbol;Acc:HGNC:28105]","GO:0005515(protein binding)","NA",{"v":7.9e-30,"d":"0.00"},1,"630,",0,{"v":-29.1,"d":"-29.10"},{"v":-27.9,"d":"-27.90"},{"v":5.1,"d":"5.10"},"Exon (ENSBGRT00000023502/ENSBGRG00000012847, exon 1 of 1)",28,14145083,14145862,780,1]
["chr28",16683594,16699353,15760,"ENSBGRG00000008639","ENSBGRT00000015921",659,"PLAT","plasminogen activator, tissue type [Source:HGNC Symbol;Acc:HGNC:9051]","GO:0001666(response to hypoxia);GO:0004252(serine-type endopeptidase activity);GO:0005102(signaling receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0009986(cell surface);GO:0014909(smooth muscle cell migration);GO:0030141(secretory granule);GO:0031639(plasminogen activation);GO:0045177(apical part of cell);GO:0045861(negative regulation of proteolysis);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0051219(phosphoprotein binding);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099183(trans-synaptic signaling by BDNF, modulating synaptic transmission)","04371(Apelin signaling pathway);04610(Complement and coagulation cascades);05202(Transcriptional misregulation in cancers);05215(Prostate cancer);05418(Fluid shear stress and atherosclerosis)",{"v":1e-16,"d":"0.00"},2,"161,20,","0,15740",-16,-15,2.82,"5' UTR",28,16682935,16713213,30279,1]
["chr28",18419311,18419371,61,"ENSBGRG00000011635","ENSBGRT00000021325",417449,"ZMAT4","zinc finger matrin-type 4 [Source:HGNC Symbol;Acc:HGNC:25844]","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding)","04115(p53 signaling pathway);04742(Taste transduction)",{"v":0.011,"d":"0.01"},1,"61,",0,-1.95,{"v":-1.4,"d":"-1.40"},3.01,"3' UTR",28,18001862,18419508,417647,1]
["chr28",25563701,25573006,9306,"ENSBGRG00000023882","ENSBGRT00000044143",80665,"FUT10","fucosyltransferase 10 [Source:HGNC Symbol;Acc:HGNC:19234]","GO:0000139(Golgi membrane);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0008417(fucosyltransferase activity);GO:0016020(membrane);GO:0021799(cerebral cortex radially oriented cell migration);GO:0046920(alpha-(1->3)-fucosyltransferase activity);GO:0097150(neuronal stem cell population maintenance)","NA",{"v":3.2e-55,"d":"0.00"},2,"762,106,","0,9200",{"v":-54.5,"d":"-54.50"},-53,7.95,"Exon (ENSBGRT00000044143/ENSBGRG00000023882, exon 4 of 5)",28,25483036,25573125,90090,1]
["chr28",31957751,32054703,96953,"ENSBGRG00000008770","ENSBGRT00000016020",1103,"ENSBGRG00000008770","NA","NA","04514(Cell adhesion molecules (CAMs))",{"v":1.3E-22,"d":"0.00"},2,"285,610,","0,96343",{"v":-21.9,"d":"-21.90"},{"v":-20.8,"d":"-20.80"},8.36,"3' UTR",28,31956648,32054703,98056,1]
["chr28",35548062,35551885,3824,"ENSBGRG00000009621","ENSBGRT00000017709",79945,"MICU3","mitochondrial calcium uptake family member 3 [Source:HGNC Symbol;Acc:HGNC:27820]","GO:0005509(calcium ion binding);GO:0006851(mitochondrial calcium ion transmembrane transport)","NA",{"v":2.6e-06,"d":"0.00"},3,"73,69,395,","0,1075,3429",-5.59,-4.85,11,"3' UTR",28,35468117,35549205,81089,1]
["chr28",40987512,41009776,22265,"ENSBGRG00000020186","ENSBGRT00000037361",0,"CENPU","centromere protein U [Source:HGNC Symbol;Acc:HGNC:21348]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0034451(centriolar satellite);GO:0043009(chordate embryonic development)","NA",{"v":3.2e-05,"d":"0.00"},5,"213,49,49,118,47,","0,481,1695,4418,22218",{"v":-4.5,"d":"-4.50"},{"v":-3.8,"d":"-3.80"},14,"5' UTR",28,40987512,41040277,52766,1]
["chr28",5805811,5811536,5726,"ENSBGRG00000008855","ENSBGRT00000016201",916,"ENSBGRG00000008855","NA","GO:0001306(age-dependent response to oxidative stress);GO:0005783(endoplasmic reticulum);GO:0006644(phospholipid metabolic process);GO:0007006(mitochondrial membrane organization);GO:0007040(lysosome organization);GO:0007601(visual perception);GO:0007628(adult walking behavior);GO:0008306(associative learning);GO:0008344(adult locomotory behavior);GO:0008361(regulation of cell size);GO:0016021(integral component of membrane);GO:0021522(spinal cord motor neuron differentiation);GO:0021523(somatic motor neuron differentiation);GO:0035176(social behavior);GO:0043066(negative regulation of apoptotic process);GO:0044257(cellular protein catabolic process);GO:0044265(cellular macromolecule catabolic process);GO:0044267(cellular protein metabolic process);GO:0045494(photoreceptor cell maintenance);GO:0050881(musculoskeletal movement);GO:0050884(neuromuscular process controlling posture);GO:0050885(neuromuscular process controlling balance);GO:0051935(glutamate reuptake);GO:0060041(retina development in camera-type eye);GO:0060052(neurofilament cytoskeleton organization)","NA",{"v":1.9e-09,"d":"0.00"},2,"515,21,","0,5705",-8.72,-7.89,3.34,"5' UTR",28,5794924,5812452,17529,2]
["chr28",16566720,16568214,1495,"ENSBGRG00000008023","ENSBGRT00000015189",63314,"IKBKB","inhibitor of nuclear factor kappa B kinase subunit beta [Source:HGNC Symbol;Acc:HGNC:5960]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0008384(IkappaB kinase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0030866(cortical actin cytoskeleton organization);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0035509(negative regulation of myosin-light-chain-phosphatase activity);GO:0042325(regulation of phosphorylation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0070498(interleukin-1-mediated signaling pathway);GO:0071356(cellular response to tumor necrosis factor);GO:0072659(protein localization to plasma membrane);GO:0097110(scaffold protein binding);GO:1903140(regulation of establishment of endothelial barrier);GO:1903347(negative regulation of bicellular tight junction assembly);GO:1990459(transferrin receptor binding)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04068(FoxO signaling pathway);04151(PI3K-Akt signaling pathway);04150(mTOR signaling pathway);04210(Apoptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04657(IL-17 signaling pathway);04662(B cell receptor signaling pathway);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04920(Adipocytokine signaling pathway);04722(Neurotrophin signaling pathway);04380(Osteoclast differentiation);05200(Pathways in cancer);05206(MicroRNAs in cancer);05212(Pancreatic cancer);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05215(Prostate cancer);05222(Small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);05166(HTLV-I infection);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05168(Herpes simplex infection);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05145(Toxoplasmosis);05142(Chagas disease (American trypanosomiasis));01523(Antifolate resistance)",{"v":1.1E-4,"d":"0.00"},2,"133,48,","0,1447",-3.95,-3.27,1.84,"3' UTR",28,16566061,16631528,65468,2]
["chr28",19694258,19705448,11191,"ENSBGRG00000014199","ENSBGRT00000026067",0,"ENSBGRG00000014199","NA","NA","NA",{"v":0.046,"d":"0.05"},2,"412,705,","0,10486",-1.34,{"v":-0.843,"d":"-0.84"},6.02,"Exon (ENSBGRT00000026067/ENSBGRG00000014199, exon 1 of 2)",28,19693964,19705448,11485,2]
["chr28",21138842,21142964,4123,"ENSBGRG00000019012","ENSBGRT00000034903",4526,"BRF2","BRF2 RNA polymerase III transcription initiation factor subunit [Source:HGNC Symbol;Acc:HGNC:17298]","GO:0000126(transcription factor TFIIIB complex);GO:0001006(RNA polymerase III type 3 promoter sequence-specific DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0006359(regulation of transcription by RNA polymerase III);GO:0034599(cellular response to oxidative stress);GO:0070897(transcription preinitiation complex assembly)","NA",0,3,"1387,1369,57,","0,2511,4066",-976,"-Inf",9.47,"3' UTR",28,21134316,21140304,5989,1]
["chr28",21288587,21288797,211,"ENSBGRG00000019985","ENSBGRT00000037135",0,"ZNF703","zinc finger protein 703 [Source:HGNC Symbol;Acc:HGNC:25883]","GO:0003676(nucleic acid binding);GO:0005783(endoplasmic reticulum);GO:0031625(ubiquitin protein ligase binding)","00051(Fructose and mannose metabolism);00520(Amino sugar and nucleotide sugar metabolism)",{"v":2.2e-05,"d":"0.00"},1,"211,",0,-4.65,-3.94,3.39,"Exon (ENSBGRT00000037135/ENSBGRG00000019985, exon 1 of 12)",28,21229854,21288797,58944,2]
["chr28",40630889,40630949,61,"ENSBGRG00000019340","ENSBGRT00000035466",0,"SLC25A4","solute carrier family 25 member 4 [Source:HGNC Symbol;Acc:HGNC:10990]","GO:0005347(ATP transmembrane transporter activity);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0008637(apoptotic mitochondrial changes);GO:0015866(ADP transport);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport);GO:0060546(negative regulation of necroptotic process)","04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04217(Necroptosis);04218(Cellular senescence);05012(Parkinson disease);05016(Huntington disease);05166(HTLV-I infection)",{"v":0.047,"d":"0.05"},1,"61,",0,-1.33,{"v":-0.835,"d":"-0.84"},1.37,"Exon (ENSBGRT00000035466/ENSBGRG00000019340, exon 1 of 4)",28,40627393,40630949,3557,2]
["chr28",41040839,41043700,2862,"ENSBGRG00000020486","ENSBGRT00000037730",45369,"PRIMPOL","primase and DNA directed polymerase [Source:HGNC Symbol;Acc:HGNC:26575]","GO:0003682(chromatin binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0003896(DNA primase activity);GO:0005634(nucleus);GO:0005657(replication fork);GO:0005759(mitochondrial matrix);GO:0006264(mitochondrial DNA replication);GO:0008270(zinc ion binding);GO:0009411(response to UV);GO:0019985(translesion synthesis);GO:0030145(manganese ion binding);GO:0031297(replication fork processing);GO:0042276(error-prone translesion synthesis);GO:0043504(mitochondrial DNA repair);GO:0062176(R-loop disassembly)","NA",{"v":1E-22,"d":"0.00"},2,"246,22,","0,2840",-22,-21,4.53,"Exon (ENSBGRT00000037730/ENSBGRG00000020486, exon 11 of 12)",28,41040839,41089069,48231,2]
["chr29",670681,670977,297,"ENSBGRG00000022819","ENSBGRT00000042150",1687,"ENSBGRG00000022819","NA","GO:0005509(calcium ion binding)","NA",{"v":1.1e-06,"d":"0.00"},2,"96,83,","0,214",-5.96,-5.21,2.73,"3' UTR",29,668994,671625,2632,1]
["chr29",5463538,5466633,3096,"ENSBGRG00000006974","ENSBGRT00000012841",0,"ENSBGRG00000006974","NA","NA","NA",{"v":0.011,"d":"0.01"},1,"3096,",0,-1.97,-1.14,9.03,"Exon (ENSBGRT00000012841/ENSBGRG00000006974, exon 1 of 1)",29,5463538,5466633,3096,1]
["chr29",8170204,8171722,1519,"ENSBGRG00000019629","ENSBGRT00000036348",0,"ENSBGRG00000019629","NA","NA","NA",{"v":1e-138,"d":"0.00"},7,"30,27,21,35,463,228,57,","0,32,61,84,765,1230,1462",-138,-136,{"v":8.4,"d":"8.40"},"Exon (ENSBGRT00000036348/ENSBGRG00000019629, exon 1 of 7)",29,8170204,8171722,1519,1]
["chr29",9297906,9298038,133,"ENSBGRG00000026622","ENSBGRT00000049333",1347,"ENSBGRG00000026622","NA","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","04010(MAPK signaling pathway)",{"v":0.035,"d":"0.04"},2,"52,8,","0,125",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000049333/ENSBGRG00000026622, exon 4 of 6)",29,9296559,9299194,2636,1]
["chr29",13596190,13596874,685,"ENSBGRG00000021642","ENSBGRT00000040063",20184,"ENSBGRG00000021642","NA","GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0062023(collagen-containing extracellular matrix)","NA",{"v":7.8e-07,"d":"0.00"},1,"685,",0,-6.11,-5.35,15,"3' UTR",29,13576006,13596874,20869,1]
["chr29",22295772,22297222,1451,"ENSBGRG00000021032","ENSBGRT00000038931",47058,"FEZ1","fasciculation and elongation protein zeta 1 [Source:HGNC Symbol;Acc:HGNC:3659]","GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0043015(gamma-tubulin binding);GO:1902902(negative regulation of autophagosome assembly)","NA",{"v":5e-14,"d":"0.00"},2,"205,364,","0,1087",{"v":-13.3,"d":"-13.30"},{"v":-12.4,"d":"-12.40"},12,"3' UTR",29,22248714,22295976,47263,1]
["chr29",32246301,32246629,329,"ENSBGRG00000021669","ENSBGRT00000039990",90,"PCF11","PCF11 cleavage and polyadenylation factor subunit [Source:HGNC Symbol;Acc:HGNC:30097]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","03015(mRNA surveillance pathway)",{"v":8.5e-05,"d":"0.00"},1,"329,",0,-4.07,-3.39,1.78,"5' UTR",29,32246211,32275498,29288,1]
["chr29",44503287,44503588,302,"ENSBGRG00000017172","ENSBGRT00000031829",26572,"CEP295","centrosomal protein 295 [Source:HGNC Symbol;Acc:HGNC:29366]","GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0008017(microtubule binding);GO:0010825(positive regulation of centrosome duplication);GO:1901985(positive regulation of protein acetylation);GO:1903724(positive regulation of centriole elongation);GO:1904951(positive regulation of establishment of protein localization);GO:1990498(mitotic spindle microtubule)","NA",{"v":1.2E-5,"d":"0.00"},2,"32,268,","0,34",-4.91,{"v":-4.2,"d":"-4.20"},4.87,"Exon (ENSBGRT00000031829/ENSBGRG00000017172, exon 15 of 34)",29,44476715,44531634,54920,1]
["chr29",128086,128950,865,"ENSBGRG00000014347","ENSBGRT00000026454",0,"ENSBGRG00000014347","NA","NA","NA",{"v":0.0022,"d":"0.00"},6,"29,90,9,57,12,12,","0,677,769,780,839,853",-2.66,-2.05,4.35,"Exon (ENSBGRT00000026454/ENSBGRG00000014347, exon 1 of 8)",29,127905,128950,1046,2]
["chr29",2769556,2770275,720,"ENSBGRG00000014970","ENSBGRT00000027816",728,"ENSBGRG00000014970","NA","NA","04110(Cell cycle)",{"v":0.017,"d":"0.02"},1,"720,",0,-1.77,-1.23,8.02,"Exon (ENSBGRT00000027898/ENSBGRG00000015190, exon 2 of 2)",29,2767535,2771003,3469,2]
["chr29",8131283,8135704,4422,"ENSBGRG00000018735","ENSBGRT00000034946",0,"ENSBGRG00000018735","NA","NA","03040(Spliceosome)",{"v":4e-32,"d":"0.00"},16,"11,104,34,51,9,78,90,13,127,56,58,19,81,96,36,66,","0,13,203,239,291,403,724,816,944,1597,2025,4114,4137,4220,4318,4356",{"v":-31.4,"d":"-31.40"},{"v":-30.2,"d":"-30.20"},3.16,"Exon (ENSBGRT00000034946/ENSBGRG00000018735, exon 1 of 46)",29,8121482,8135704,14223,2]
["chr29",8471615,8472648,1034,"ENSBGRG00000025175","ENSBGRT00000046830",4998,"ENSBGRG00000025175","NA","NA","NA",{"v":0.00078,"d":"0.00"},10,"25,20,33,27,15,18,35,10,53,4,","0,191,212,247,276,292,312,446,460,1030",-3.11,-2.48,4.51,"Exon (ENSBGRT00000046830/ENSBGRG00000025175, exon 6 of 97)",29,8461260,8477646,16387,2]
["chr29",9864475,9864959,485,"ENSBGRG00000008396","ENSBGRT00000015397",0,"ENSBGRG00000008396","NA","NA","NA",{"v":2E-12,"d":"0.00"},10,"31,45,15,15,24,102,101,106,15,12,","0,35,82,99,116,142,246,348,456,473",{"v":-11.7,"d":"-11.70"},{"v":-10.8,"d":"-10.80"},{"v":23.1,"d":"23.10"},"Exon (ENSBGRT00000015397/ENSBGRG00000008396, exon 1 of 13)",29,9864177,9864959,783,2]
["chr29",21521937,21521996,60,"ENSBGRG00000018799","ENSBGRT00000034441",0,"FAM118B","family with sequence similarity 118 member B [Source:HGNC Symbol;Acc:HGNC:26110]","GO:0030576(Cajal body organization);GO:0042802(identical protein binding)","NA",{"v":0.032,"d":"0.03"},1,"60,",0,-1.49,{"v":-0.981,"d":"-0.98"},3.01,"5' UTR",29,21493519,21521996,28478,2]
["chr29",26301422,26318793,17372,"ENSBGRG00000020357","ENSBGRT00000037418",0,"KCTD21","potassium channel tetramerization domain containing 21 [Source:HGNC Symbol;Acc:HGNC:27452]","GO:0005515(protein binding);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0042802(identical protein binding);GO:0042826(histone deacetylase binding);GO:0045879(negative regulation of smoothened signaling pathway);GO:0051260(protein homooligomerization);GO:0097602(cullin family protein binding)","NA",{"v":9.5e-06,"d":"0.00"},2,"403,8,","0,17364",-5.02,{"v":-4.3,"d":"-4.30"},2.65,"Exon (ENSBGRT00000037418/ENSBGRG00000020357, exon 1 of 2)",29,26301011,26318793,17783,2]
["chr29",35181145,35183134,1990,"ENSBGRG00000024253","ENSBGRT00000045223",38655,"SYTL2","synaptotagmin like 2 [Source:HGNC Symbol;Acc:HGNC:15585]","GO:0001786(phosphatidylserine binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006887(exocytosis);GO:0006904(vesicle docking involved in exocytosis);GO:0010923(negative regulation of phosphatase activity);GO:0016020(membrane);GO:0019897(extrinsic component of plasma membrane);GO:0019902(phosphatase binding);GO:0042043(neurexin family protein binding);GO:0042470(melanosome);GO:0070257(positive regulation of mucus secretion);GO:0070382(exocytic vesicle);GO:0072659(protein localization to plasma membrane)","NA",{"v":1e-75,"d":"0.00"},2,"423,28,","0,1962",-75,{"v":-73.4,"d":"-73.40"},9.86,"3' UTR",29,35181145,35221789,40645,2]
["chr29",36610169,36610858,690,"ENSBGRG00000025585","ENSBGRT00000047301",0,"FZD4","frizzled class receptor 4 [Source:HGNC Symbol;Acc:HGNC:4042]","GO:0001540(amyloid-beta binding);GO:0001553(luteinization);GO:0001568(blood vessel development);GO:0001570(vasculogenesis);GO:0004888(transmembrane signaling receptor activity);GO:0004896(cytokine receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007166(cell surface receptor signaling pathway);GO:0007223(Wnt signaling pathway, calcium modulating pathway);GO:0007605(sensory perception of sound);GO:0009986(cell surface);GO:0010812(negative regulation of cell-substrate adhesion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0019955(cytokine binding);GO:0030165(PDZ domain binding);GO:0030425(dendrite);GO:0030947(regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031625(ubiquitin protein ligase binding);GO:0031987(locomotion involved in locomotory behavior);GO:0034446(substrate adhesion-dependent cell spreading);GO:0035426(extracellular matrix-cell signaling);GO:0038023(signaling receptor activity);GO:0042701(progesterone secretion);GO:0042803(protein homodimerization activity);GO:0042813(Wnt-activated receptor activity);GO:0043507(positive regulation of JUN kinase activity);GO:0044877(protein-containing complex binding);GO:0045202(synapse);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046982(protein heterodimerization activity);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060070(canonical Wnt signaling pathway);GO:0061299(retina vasculature morphogenesis in camera-type eye);GO:0061301(cerebellum vasculature morphogenesis);GO:0061304(retinal blood vessel morphogenesis);GO:0098978(glutamatergic synapse);GO:0110135(Norrin signaling pathway);GO:0150012(positive regulation of neuron projection arborization);GO:1990830(cellular response to leukemia inhibitory factor)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":9.3e-09,"d":"0.00"},1,"690,",0,-8.03,-7.22,{"v":25.1,"d":"25.10"},"5' UTR",29,36599990,36610858,10869,2]
["X",499239,500366,1128,"ENSBGRG00000020705","ENSBGRT00000038106",108746,"ENSBGRG00000020705","NA","NA","04120(Ubiquitin mediated proteolysis)",{"v":1e-17,"d":"0.00"},1,"1128,",0,-17,-16,5.19,"Exon (ENSBGRT00000038717/ENSBGRG00000020971, exon 2 of 4)",30,488864,609112,120249,2]
["X",8609748,8610077,330,"ENSBGRG00000025460","ENSBGRT00000047181",19835,"IGSF1","immunoglobulin superfamily member 1 [Source:HGNC Symbol;Acc:HGNC:5948]","GO:0006355(regulation of transcription, DNA-templated);GO:0016020(membrane);GO:0032926(negative regulation of activin receptor signaling pathway);GO:0034711(inhibin binding);GO:0038102(activin receptor antagonist activity)","04380(Osteoclast differentiation)",{"v":0.035,"d":"0.04"},1,"330,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"3' UTR",30,8589913,8610077,20165,1]
["X",38110737,38110913,177,"ENSBGRG00000024735","ENSBGRT00000045627",0,"ENSBGRG00000024735","NA","GO:0005515(protein binding)","NA",{"v":0.035,"d":"0.04"},1,"177,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000045627/ENSBGRG00000024735, exon 1 of 1)",30,38110737,38111939,1203,1]
["X",40079235,40080444,1210,"ENSBGRG00000023696","ENSBGRT00000043864",126354,"GDI1","GDP dissociation inhibitor 1 [Source:HGNC Symbol;Acc:HGNC:4226]","GO:0005092(GDP-dissociation inhibitor activity);GO:0005093(Rab GDP-dissociation inhibitor activity);GO:0005737(cytoplasm);GO:0007264(small GTPase mediated signal transduction);GO:0015031(protein transport);GO:0030496(midbody);GO:0090315(negative regulation of protein targeting to membrane)","NA",{"v":4E-79,"d":"0.00"},2,"45,104,","0,1106",{"v":-78.4,"d":"-78.40"},{"v":-76.8,"d":"-76.80"},2.34,"Exon (ENSBGRT00000043864/ENSBGRG00000023696, exon 2 of 12)",30,39952881,40084960,132080,1]
["X",53993448,53993657,210,"ENSBGRG00000018782","ENSBGRT00000034404",15019,"ENSBGRG00000018782","NA","NA","NA",{"v":6.3e-06,"d":"0.00"},1,"210,",0,{"v":-5.2,"d":"-5.20"},-4.48,4.35,"3' UTR",30,53978429,53993657,15229,1]
["X",58493992,58504359,10368,"ENSBGRG00000022558","ENSBGRT00000041617",565,"SLC25A53","solute carrier family 25 member 53 [Source:HGNC Symbol;Acc:HGNC:31894]","NA","04742(Taste transduction)",{"v":0.0058,"d":"0.01"},2,"200,218,","0,10150",-2.24,-1.66,10,"5' UTR",30,58493427,58505281,11855,1]
["X",60521880,60529855,7976,"ENSBGRG00000019614","ENSBGRT00000036085",0,"DNAAF6","PIH1 domain containing 3 [Source:HGNC Symbol;Acc:HGNC:28570]","GO:0003341(cilium movement);GO:0005737(cytoplasm);GO:0005802(trans-Golgi network);GO:0030317(flagellated sperm motility);GO:0036158(outer dynein arm assembly);GO:0036159(inner dynein arm assembly);GO:0045505(dynein intermediate chain binding);GO:0070286(axonemal dynein complex assembly)","NA",{"v":0.0055,"d":"0.01"},3,"135,64,64,","0,4908,7912",-2.26,-1.68,4.01,"Exon (ENSBGRT00000036085/ENSBGRG00000019614, exon 1 of 6)",30,60521880,60569981,48102,1]
["X",64015273,64017368,2096,"ENSBGRG00000022623","ENSBGRT00000041767",5363,"RTL9","retrotransposon Gag like 9 [Source:HGNC Symbol;Acc:HGNC:29245]","NA","NA",{"v":0.00042,"d":"0.00"},3,"16,52,292,","0,560,1804",-3.38,-2.73,9.03,"3' UTR",30,64009910,64015884,5975,1]
["X",80553972,80554032,61,"ENSBGRG00000014446","ENSBGRT00000026889",50202,"ENSBGRG00000014446","NA","GO:0005515(protein binding)","NA",{"v":0.0052,"d":"0.01"},1,"61,",0,-2.28,{"v":-1.7,"d":"-1.70"},4.01,"Exon (ENSBGRT00000026889/ENSBGRG00000014446, exon 22 of 25)",30,80503770,80569560,65791,1]
["X",84642304,84651645,9342,"ENSBGRG00000024454","ENSBGRT00000046137",0,"PHKA1","phosphorylase kinase regulatory subunit alpha 1 [Source:HGNC Symbol;Acc:HGNC:8925]","GO:0003824(catalytic activity);GO:0005516(calmodulin binding);GO:0005977(glycogen metabolic process)","04020(Calcium signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway)",{"v":2.8E-5,"d":"0.00"},3,"78,159,3,","0,1113,9339",-4.55,-3.84,3.34,"Exon (ENSBGRT00000046137/ENSBGRG00000024454, exon 1 of 34)",30,84642304,84835077,192774,1]
["X",93594730,93594880,151,"ENSBGRG00000015517","ENSBGRT00000028639",10368,"ARAF","A-Raf proto-oncogene, serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:646]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0035556(intracellular signal transduction)","04010(MAPK signaling pathway);04012(ErbB signaling pathway);04068(FoxO signaling pathway);04810(Regulation of actin cytoskeleton);04650(Natural killer cell mediated cytotoxicity);04910(Insulin signaling pathway);04914(Progesterone-mediated oocyte maturation);04928(Parathyroid hormone synthesis, secretion and action);04270(Vascular smooth muscle contraction);04726(Serotonergic synapse);04720(Long-term potentiation);04730(Long-term depression);05200(Pathways in cancer);05205(Proteoglycans in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05219(Bladder cancer);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05223(Non-small cell lung cancer);05034(Alcoholism);05160(Hepatitis C);01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance)",{"v":2E-12,"d":"0.00"},1,"151,",0,{"v":-11.7,"d":"-11.70"},{"v":-10.8,"d":"-10.80"},2.06,"3' UTR",30,93584362,93594880,10519,1]
["X",94593272,94593976,705,"ENSBGRG00000017973","ENSBGRT00000032911",0,"ERAS","ES cell expressed Ras [Source:HGNC Symbol;Acc:HGNC:5174]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane)","NA",{"v":3e-05,"d":"0.00"},1,"705,",0,-4.53,-3.82,5.52,"Exon (ENSBGRT00000032911/ENSBGRG00000017973, exon 1 of 1)",30,94593272,94593976,705,1]
["X",98498034,98499764,1731,"ENSBGRG00000025975","ENSBGRT00000048048",7209,"RIBC1","RIB43A domain with coiled-coils 1 [Source:HGNC Symbol;Acc:HGNC:26537]","NA","NA",{"v":0.011,"d":"0.01"},3,"87,297,1,","0,1432,1730",-1.96,{"v":-1.4,"d":"-1.40"},5.52,"Exon (ENSBGRT00000048048/ENSBGRG00000025975, exon 3 of 6)",30,98490825,98499860,9036,1]
["X",104275250,104275879,630,"ENSBGRG00000009986","ENSBGRT00000018339",1854,"AMER1","APC membrane recruitment protein 1 [Source:HGNC Symbol;Acc:HGNC:26837]","GO:0001822(kidney development);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005886(plasma membrane);GO:0008013(beta-catenin binding);GO:0016604(nuclear body);GO:0031398(positive regulation of protein ubiquitination);GO:0043231(intracellular membrane-bounded organelle);GO:0060348(bone development);GO:0060612(adipose tissue development);GO:0060828(regulation of canonical Wnt signaling pathway);GO:0072161(mesenchymal cell differentiation involved in kidney development);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1903364(positive regulation of cellular protein catabolic process);GO:1904713(beta-catenin destruction complex binding)","NA",{"v":2.5e-12,"d":"0.00"},1,"630,",0,{"v":-11.6,"d":"-11.60"},{"v":-10.7,"d":"-10.70"},5.77,"Exon (ENSBGRT00000018339/ENSBGRG00000009986, exon 2 of 3)",30,104273396,104278310,4915,1]
["X",104276208,104277891,1684,"ENSBGRG00000009986","ENSBGRT00000018339",2812,"AMER1","APC membrane recruitment protein 1 [Source:HGNC Symbol;Acc:HGNC:26837]","GO:0001822(kidney development);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005886(plasma membrane);GO:0008013(beta-catenin binding);GO:0016604(nuclear body);GO:0031398(positive regulation of protein ubiquitination);GO:0043231(intracellular membrane-bounded organelle);GO:0060348(bone development);GO:0060612(adipose tissue development);GO:0060828(regulation of canonical Wnt signaling pathway);GO:0072161(mesenchymal cell differentiation involved in kidney development);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1903364(positive regulation of cellular protein catabolic process);GO:1904713(beta-catenin destruction complex binding)","NA",{"v":7.4e-07,"d":"0.00"},2,"64,626,","0,1058",-6.13,-5.37,2.73,"Exon (ENSBGRT00000018339/ENSBGRG00000009986, exon 2 of 3)",30,104273396,104278310,4915,1]
["X",123164942,123165553,612,"ENSBGRG00000010564","ENSBGRT00000019349",0,"CXorf21","chromosome X open reading frame 21 [Source:HGNC Symbol;Acc:HGNC:25667]","GO:0035751(regulation of lysosomal lumen pH)","NA",{"v":0.035,"d":"0.04"},1,"612,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000019349/ENSBGRG00000010564, exon 1 of 1)",30,123164942,123165844,903,1]
["X",130666154,130667081,928,"ENSBGRG00000007139","ENSBGRT00000013125",35167,"KLHL15","kelch like family member 15 [Source:HGNC Symbol;Acc:HGNC:29347]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0071630(nuclear protein quality control by the ubiquitin-proteasome system);GO:2000042(negative regulation of double-strand break repair via homologous recombination)","NA",{"v":2.5e-33,"d":"0.00"},1,"928,",0,{"v":-32.6,"d":"-32.60"},{"v":-31.4,"d":"-31.40"},7.13,"3' UTR",30,130630987,130668037,37051,1]
["X",1131750,1134186,2437,"ENSBGRG00000021393","ENSBGRT00000039478",12520,"LONRF3","LON peptidase N-terminal domain and ring finger 3 [Source:HGNC Symbol;Acc:HGNC:21152]","GO:0005515(protein binding)","NA",{"v":0.035,"d":"0.04"},2,"150,147,","0,2290",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000039478/ENSBGRG00000021393, exon 4 of 12)",30,1078097,1146706,68610,2]
["X",10001338,10002076,739,"ENSBGRG00000007657","ENSBGRT00000014042",17510,"SASH3","SAM and SH3 domain containing 3 [Source:HGNC Symbol;Acc:HGNC:15975]","GO:0002639(positive regulation of immunoglobulin production);GO:0002726(positive regulation of T cell cytokine production);GO:0002821(positive regulation of adaptive immune response);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0030890(positive regulation of B cell proliferation);GO:0032729(positive regulation of interferon-gamma production);GO:0032733(positive regulation of interleukin-10 production);GO:0032743(positive regulation of interleukin-2 production);GO:0032753(positive regulation of interleukin-4 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0042102(positive regulation of T cell proliferation);GO:0043372(positive regulation of CD4-positive, alpha-beta T cell differentiation);GO:0046622(positive regulation of organ growth);GO:0048873(homeostasis of number of cells within a tissue);GO:0051251(positive regulation of lymphocyte activation)","NA",{"v":0.011,"d":"0.01"},2,"191,45,","0,694",-1.97,-1.19,9.03,"Exon (ENSBGRT00000014042/ENSBGRG00000007657, exon 7 of 8)",30,10001338,10019586,18249,2]
["X",23369462,23369969,508,"ENSBGRG00000012655","ENSBGRT00000023159",1371,"SLITRK2","SLIT and NTRK like family member 2 [Source:HGNC Symbol;Acc:HGNC:13449]","GO:0005515(protein binding);GO:0007409(axonogenesis);GO:0051965(positive regulation of synapse assembly);GO:0099560(synaptic membrane adhesion)","04512(ECM-receptor interaction)",{"v":2.5e-30,"d":"0.00"},1,"508,",0,{"v":-29.6,"d":"-29.60"},{"v":-28.4,"d":"-28.40"},9.81,"Exon (ENSBGRT00000023159/ENSBGRG00000012655, exon 1 of 1)",30,23368806,23371340,2535,2]
["X",39090380,39093754,3375,"ENSBGRG00000018702","ENSBGRT00000034622",17282,"HAUS7","HAUS augmin like complex subunit 7 [Source:HGNC Symbol;Acc:HGNC:32979]","GO:0005813(centrosome);GO:0007098(centrosome cycle);GO:0031996(thioesterase binding);GO:0051225(spindle assembly);GO:0070652(HAUS complex)","NA",{"v":2E-16,"d":"0.00"},2,"206,152,","0,3223",{"v":-15.7,"d":"-15.70"},{"v":-14.8,"d":"-14.80"},2.71,"3' UTR",30,39089515,39111036,21522,2]
["X",40144961,40145377,417,"ENSBGRG00000026237","ENSBGRT00000048524",920,"SLC10A3","solute carrier family 10 member 3 [Source:HGNC Symbol;Acc:HGNC:22979]","GO:0010033(response to organic substance);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032526(response to retinoic acid);GO:0055085(transmembrane transport)","NA",{"v":7.8e-06,"d":"0.00"},1,"417,",0,-5.11,-4.39,3.87,"Exon (ENSBGRT00000048524/ENSBGRG00000026237, exon 1 of 2)",30,40144690,40146297,1608,2]
["X",40161453,40161722,270,"ENSBGRG00000026248","ENSBGRT00000048564",49,"G6PD","glucose-6-phosphate dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4057]","GO:0004345(glucose-6-phosphate dehydrogenase activity);GO:0005536(glucose binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006006(glucose metabolic process);GO:0006098(pentose-phosphate shunt);GO:0006695(cholesterol biosynthetic process);GO:0006739(NADP metabolic process);GO:0006740(NADPH regeneration);GO:0006749(glutathione metabolic process);GO:0009051(pentose-phosphate shunt, oxidative branch);GO:0009898(cytoplasmic side of plasma membrane);GO:0010734(negative regulation of protein glutathionylation);GO:0016614(oxidoreductase activity, acting on CH-OH group of donors);GO:0019322(pentose biosynthetic process);GO:0034451(centriolar satellite);GO:0034599(cellular response to oxidative stress);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0043249(erythrocyte maturation);GO:0045721(negative regulation of gluconeogenesis);GO:0046390(ribose phosphate biosynthetic process);GO:0046890(regulation of lipid biosynthetic process);GO:0050661(NADP binding);GO:0051156(glucose 6-phosphate metabolic process);GO:0055114(oxidation-reduction process)","00030(Pentose phosphate pathway);00480(Glutathione metabolism);05230(Central carbon metabolism in cancer)",{"v":0.0047,"d":"0.00"},1,"270,",0,-2.33,-1.75,2.51,"5' UTR",30,40153094,40161771,8678,2]
["X",56571884,56571944,61,"ENSBGRG00000022212","ENSBGRT00000041097",1212060,"IL1RAPL2","interleukin 1 receptor accessory protein like 2 [Source:HGNC Symbol;Acc:HGNC:5997]","GO:0004910(interleukin-1, type II, blocking receptor activity);GO:0005515(protein binding);GO:0007165(signal transduction)","NA",{"v":0.019,"d":"0.02"},1,"61,",0,-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000041097/ENSBGRG00000022212, exon 10 of 10)",30,56570714,57784004,1213291,2]
["X",60145277,60145843,567,"ENSBGRG00000019066","ENSBGRT00000034985",66720,"MORC4","MORC family CW-type zinc finger 4 [Source:HGNC Symbol;Acc:HGNC:23485]","GO:0005654(nucleoplasm);GO:0008270(zinc ion binding)","NA",{"v":1e-09,"d":"0.00"},2,"109,162,","0,405",-8.99,-8.16,2.29,"Exon (ENSBGRT00000034985/ENSBGRG00000019066, exon 15 of 17)",30,60144642,60212563,67922,2]
["X",73021504,73022397,894,"ENSBGRG00000025225","ENSBGRT00000046618",103978,"APOOL","apolipoprotein O like [Source:HGNC Symbol;Acc:HGNC:24009]","GO:0005739(mitochondrion);GO:0042407(cristae formation);GO:0061617(MICOS complex)","04742(Taste transduction)",{"v":0.035,"d":"0.04"},1,"894,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"3' UTR",30,72892770,73126375,233606,2]
["X",84072472,84072794,323,"ENSBGRG00000024180","ENSBGRT00000044682",3173,"CHIC1","cysteine rich hydrophobic domain 1 [Source:HGNC Symbol;Acc:HGNC:1934]","NA","NA",{"v":5.8E-4,"d":"0.00"},1,"323,",0,-3.24,{"v":-2.6,"d":"-2.60"},4.51,"5' UTR",30,84025553,84075967,50415,2]
["X",86389316,86389584,269,"ENSBGRG00000025879","ENSBGRT00000047843",22619,"NLGN3","neuroligin 3 [Source:HGNC Symbol;Acc:HGNC:14289]","GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007612(learning);GO:0008542(visual learning);GO:0009986(cell surface);GO:0016020(membrane);GO:0030534(adult behavior);GO:0035176(social behavior);GO:0042043(neurexin family protein binding);GO:0045202(synapse);GO:0048709(oligodendrocyte differentiation);GO:0050804(modulation of chemical synaptic transmission);GO:0050808(synapse organization);GO:0051965(positive regulation of synapse assembly);GO:0051966(regulation of synaptic transmission, glutamatergic);GO:0051968(positive regulation of synaptic transmission, glutamatergic);GO:0060076(excitatory synapse);GO:0060079(excitatory postsynaptic potential);GO:0060080(inhibitory postsynaptic potential);GO:0060291(long-term synaptic potentiation);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0071625(vocalization behavior);GO:0090394(negative regulation of excitatory postsynaptic potential);GO:0097104(postsynaptic membrane assembly);GO:0097110(scaffold protein binding);GO:1900271(regulation of long-term synaptic potentiation);GO:2000310(regulation of NMDA receptor activity);GO:2000311(regulation of AMPA receptor activity);GO:2000331(regulation of terminal button organization);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000809(positive regulation of synaptic vesicle clustering);GO:2000969(positive regulation of AMPA receptor activity)","04514(Cell adhesion molecules (CAMs))",{"v":8.7e-07,"d":"0.00"},1,"269,",0,-6.06,-5.31,2.76,"Exon (ENSBGRT00000047843/ENSBGRG00000025879, exon 6 of 7)",30,86389104,86412203,23100,2]
["X",86390968,86395287,4320,"ENSBGRG00000025879","ENSBGRT00000047843",16916,"NLGN3","neuroligin 3 [Source:HGNC Symbol;Acc:HGNC:14289]","GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007612(learning);GO:0008542(visual learning);GO:0009986(cell surface);GO:0016020(membrane);GO:0030534(adult behavior);GO:0035176(social behavior);GO:0042043(neurexin family protein binding);GO:0045202(synapse);GO:0048709(oligodendrocyte differentiation);GO:0050804(modulation of chemical synaptic transmission);GO:0050808(synapse organization);GO:0051965(positive regulation of synapse assembly);GO:0051966(regulation of synaptic transmission, glutamatergic);GO:0051968(positive regulation of synaptic transmission, glutamatergic);GO:0060076(excitatory synapse);GO:0060079(excitatory postsynaptic potential);GO:0060080(inhibitory postsynaptic potential);GO:0060291(long-term synaptic potentiation);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0071625(vocalization behavior);GO:0090394(negative regulation of excitatory postsynaptic potential);GO:0097104(postsynaptic membrane assembly);GO:0097110(scaffold protein binding);GO:1900271(regulation of long-term synaptic potentiation);GO:2000310(regulation of NMDA receptor activity);GO:2000311(regulation of AMPA receptor activity);GO:2000331(regulation of terminal button organization);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000809(positive regulation of synaptic vesicle clustering);GO:2000969(positive regulation of AMPA receptor activity)","04514(Cell adhesion molecules (CAMs))",{"v":2.6E-7,"d":"0.00"},2,"409,69,","0,4251",-6.59,-5.82,10,"Exon (ENSBGRT00000047843/ENSBGRG00000025879, exon 3 of 7)",30,86389104,86412203,23100,2]
["X",86455950,86456127,178,"ENSBGRG00000026112","ENSBGRT00000048304",5899,"FOXO4","forkhead box O4 [Source:HGNC Symbol;Acc:HGNC:7139]","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0007050(cell cycle arrest);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016525(negative regulation of angiogenesis);GO:0016607(nuclear speck);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048863(stem cell differentiation);GO:0051151(negative regulation of smooth muscle cell differentiation);GO:0070317(negative regulation of G0 to G1 transition);GO:0071158(positive regulation of cell cycle arrest);GO:1990837(sequence-specific double-stranded DNA binding)","04014(Ras signaling pathway);04068(FoxO signaling pathway)",{"v":0.0012,"d":"0.00"},1,"178,",0,-2.93,{"v":-2.3,"d":"-2.30"},1.49,"Exon (ENSBGRT00000048304/ENSBGRG00000026112, exon 3 of 4)",30,86455596,86462026,6431,2]
["X",86456983,86462026,5044,"ENSBGRG00000026112","ENSBGRT00000048304",0,"FOXO4","forkhead box O4 [Source:HGNC Symbol;Acc:HGNC:7139]","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0007050(cell cycle arrest);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016525(negative regulation of angiogenesis);GO:0016607(nuclear speck);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048863(stem cell differentiation);GO:0051151(negative regulation of smooth muscle cell differentiation);GO:0070317(negative regulation of G0 to G1 transition);GO:0071158(positive regulation of cell cycle arrest);GO:1990837(sequence-specific double-stranded DNA binding)","04014(Ras signaling pathway);04068(FoxO signaling pathway)",{"v":2.8e-06,"d":"0.00"},3,"11,27,435,","0,4580,4609",-5.55,-4.81,1.69,"Exon (ENSBGRT00000048304/ENSBGRG00000026112, exon 1 of 4)",30,86455596,86462026,6431,2]
["X",86934243,86935692,1450,"ENSBGRG00000007926","ENSBGRT00000014636",52416,"DLG3","discs large MAGUK scaffold protein 3 [Source:HGNC Symbol;Acc:HGNC:2902]","GO:0001736(establishment of planar polarity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005923(bicellular tight junction);GO:0010923(negative regulation of phosphatase activity);GO:0019900(kinase binding);GO:0019902(phosphatase binding);GO:0031625(ubiquitin protein ligase binding);GO:0032281(AMPA glutamate receptor complex);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0098978(glutamatergic synapse);GO:0099072(regulation of postsynaptic membrane neurotransmitter receptor levels)","04390(Hippo signaling pathway);04530(Tight junction);05165(Human papillomavirus infection)",{"v":7.9e-29,"d":"0.00"},2,"332,56,","0,1394",{"v":-28.1,"d":"-28.10"},-27,3.78,"3' UTR",30,86934154,86988108,53955,2]
["X",86985372,86987196,1825,"ENSBGRG00000007926","ENSBGRT00000014636",912,"DLG3","discs large MAGUK scaffold protein 3 [Source:HGNC Symbol;Acc:HGNC:2902]","GO:0001736(establishment of planar polarity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005923(bicellular tight junction);GO:0010923(negative regulation of phosphatase activity);GO:0019900(kinase binding);GO:0019902(phosphatase binding);GO:0031625(ubiquitin protein ligase binding);GO:0032281(AMPA glutamate receptor complex);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0098978(glutamatergic synapse);GO:0099072(regulation of postsynaptic membrane neurotransmitter receptor levels)","04390(Hippo signaling pathway);04530(Tight junction);05165(Human papillomavirus infection)",{"v":0.032,"d":"0.03"},2,"73,106,","0,1719",-1.49,{"v":-0.978,"d":"-0.98"},4.51,"5' UTR",30,86934154,86988108,53955,2]
["X",87024777,87027455,2679,"ENSBGRG00000008356","ENSBGRT00000015266",136017,"KIF4A","kinesin family member 4A [Source:HGNC Symbol;Acc:HGNC:13339]","GO:0000281(mitotic cytokinesis);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0030496(midbody);GO:0051256(mitotic spindle midzone assembly)","NA",{"v":0.0062,"d":"0.01"},2,"87,64,","0,2615",-2.21,-1.64,3.01,"Exon (ENSBGRT00000015266/ENSBGRG00000008356, exon 30 of 32)",30,87024285,87163472,139188,2]
["X",87170628,87171668,1041,"ENSBGRG00000008523","ENSBGRT00000015532",30,"ENSBGRG00000008523","NA","GO:0003924(GTPase activity);GO:0005525(GTP binding)","NA",{"v":1e-11,"d":"0.00"},3,"290,73,21,","0,494,1020",-11,{"v":-10.1,"d":"-10.10"},6.46,"Exon (ENSBGRT00000015532/ENSBGRG00000008523, exon 1 of 3)",30,87170628,87171698,1071,2]
["X",88067946,88068714,769,"ENSBGRG00000009407","ENSBGRT00000017250",0,"FAM155B","family with sequence similarity 155 member B [Source:HGNC Symbol;Acc:HGNC:30701]","NA","NA",{"v":0.019,"d":"0.02"},1,"769,",0,-1.72,-1.19,5.01,"Exon (ENSBGRT00000017250/ENSBGRG00000009407, exon 1 of 3)",30,88036630,88068714,32085,2]
["X",88447921,88448214,294,"ENSBGRG00000009422","ENSBGRT00000017286",2000,"ENSBGRG00000009422","NA","NA","NA",{"v":1E-41,"d":"0.00"},1,"294,",0,-41,{"v":-39.7,"d":"-39.70"},4.41,"Exon (ENSBGRT00000017286/ENSBGRG00000009422, exon 2 of 2)",30,88447833,88450214,2382,2]
["X",88869991,88870704,714,"ENSBGRG00000009492","ENSBGRT00000017469",14370,"EFNB1","ephrin B1 [Source:HGNC Symbol;Acc:HGNC:3226]","GO:0001755(neural crest cell migration);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007411(axon guidance);GO:0009880(embryonic pattern specification);GO:0016020(membrane);GO:0031295(T cell costimulation);GO:0042102(positive regulation of T cell proliferation);GO:0045121(membrane raft);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway)","04360(Axon guidance)",{"v":3.2e-24,"d":"0.00"},1,"714,",0,{"v":-23.5,"d":"-23.50"},{"v":-22.5,"d":"-22.50"},4.26,"3' UTR",30,88857620,88885074,27455,2]
["X",88995859,88996698,840,"ENSBGRG00000009592","ENSBGRT00000017580",40809,"STARD8","StAR related lipid transfer domain containing 8 [Source:HGNC Symbol;Acc:HGNC:19161]","GO:0007165(signal transduction);GO:0008289(lipid binding)","NA",{"v":7.6e-10,"d":"0.00"},1,"840,",0,-9.12,-8.28,{"v":13.7,"d":"13.70"},"Exon (ENSBGRT00000017580/ENSBGRG00000009592, exon 6 of 15)",30,88988942,89037507,48566,2]
["X",88997199,88997409,211,"ENSBGRG00000009592","ENSBGRT00000017580",40098,"STARD8","StAR related lipid transfer domain containing 8 [Source:HGNC Symbol;Acc:HGNC:19161]","GO:0007165(signal transduction);GO:0008289(lipid binding)","NA",{"v":0.017,"d":"0.02"},1,"211,",0,-1.76,-1.22,1.75,"Exon (ENSBGRT00000017580/ENSBGRG00000009592, exon 5 of 15)",30,88988942,89037507,48566,2]
["X",89001528,89037507,35980,"ENSBGRG00000009592","ENSBGRT00000017580",0,"STARD8","StAR related lipid transfer domain containing 8 [Source:HGNC Symbol;Acc:HGNC:19161]","GO:0007165(signal transduction);GO:0008289(lipid binding)","NA",{"v":0.0032,"d":"0.00"},3,"30,72,109,","0,2717,35871",{"v":-2.5,"d":"-2.50"},-1.91,11,"Exon (ENSBGRT00000017580/ENSBGRG00000009592, exon 1 of 15)",30,88988942,89037507,48566,2]
["X",89190680,89193560,2881,"ENSBGRG00000009852","ENSBGRT00000018102",0,"ENSBGRG00000009852","NA","NA","NA",{"v":0.032,"d":"0.03"},3,"1697,603,45,","0,2030,2836",-1.49,{"v":-0.978,"d":"-0.98"},5.01,"Exon (ENSBGRT00000018117/ENSBGRG00000009870, exon 1 of 2)",30,89190561,89193312,2752,2]
["X",90470545,90471324,780,"ENSBGRG00000010012","ENSBGRT00000018343",231892,"AR","androgen receptor [Source:HGNC Symbol;Acc:HGNC:644]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001091(RNA polymerase II general transcription initiation factor binding);GO:0001225(RNA polymerase II transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003073(regulation of systemic arterial blood pressure);GO:0003382(epithelial cell morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0004879(nuclear receptor activity);GO:0005102(signaling receptor binding);GO:0005496(steroid binding);GO:0005497(androgen binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0009566(fertilization);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0016607(nuclear speck);GO:0019102(male somatic sex determination);GO:0019899(enzyme binding);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030522(intracellular receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway);GO:0033327(Leydig cell differentiation);GO:0035264(multicellular organism growth);GO:0042025(host cell nucleus);GO:0042327(positive regulation of phosphorylation);GO:0043410(positive regulation of MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045597(positive regulation of cell differentiation);GO:0045720(negative regulation of integrin biosynthetic process);GO:0045726(positive regulation of integrin biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0048608(reproductive structure development);GO:0048638(regulation of developmental growth);GO:0048645(animal organ formation);GO:0048808(male genitalia morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051117(ATPase binding);GO:0060520(activation of prostate induction by androgen receptor signaling pathway);GO:0060571(morphogenesis of an epithelial fold);GO:0060599(lateral sprouting involved in mammary gland duct morphogenesis);GO:0060685(regulation of prostatic bud formation);GO:0060736(prostate gland growth);GO:0060740(prostate gland epithelium morphogenesis);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis);GO:0060749(mammary gland alveolus development);GO:0060769(positive regulation of epithelial cell proliferation involved in prostate gland development);GO:0061458(reproductive system development);GO:0070974(POU domain binding);GO:0071383(cellular response to steroid hormone stimulus);GO:0071391(cellular response to estrogen stimulus);GO:0071394(cellular response to testosterone stimulus);GO:0072520(seminiferous tubule development);GO:1903076(regulation of protein localization to plasma membrane);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04114(Oocyte meiosis);05200(Pathways in cancer);05215(Prostate cancer)",{"v":2E-45,"d":"0.00"},1,"780,",0,{"v":-44.7,"d":"-44.70"},{"v":-43.4,"d":"-43.40"},7.52,"3' UTR",30,90470545,90703216,232672,2]
["X",90700430,90700939,510,"ENSBGRG00000010012","ENSBGRT00000018343",2277,"AR","androgen receptor [Source:HGNC Symbol;Acc:HGNC:644]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001091(RNA polymerase II general transcription initiation factor binding);GO:0001225(RNA polymerase II transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003073(regulation of systemic arterial blood pressure);GO:0003382(epithelial cell morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0004879(nuclear receptor activity);GO:0005102(signaling receptor binding);GO:0005496(steroid binding);GO:0005497(androgen binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0009566(fertilization);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0016607(nuclear speck);GO:0019102(male somatic sex determination);GO:0019899(enzyme binding);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030522(intracellular receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway);GO:0033327(Leydig cell differentiation);GO:0035264(multicellular organism growth);GO:0042025(host cell nucleus);GO:0042327(positive regulation of phosphorylation);GO:0043410(positive regulation of MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045597(positive regulation of cell differentiation);GO:0045720(negative regulation of integrin biosynthetic process);GO:0045726(positive regulation of integrin biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0048608(reproductive structure development);GO:0048638(regulation of developmental growth);GO:0048645(animal organ formation);GO:0048808(male genitalia morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051117(ATPase binding);GO:0060520(activation of prostate induction by androgen receptor signaling pathway);GO:0060571(morphogenesis of an epithelial fold);GO:0060599(lateral sprouting involved in mammary gland duct morphogenesis);GO:0060685(regulation of prostatic bud formation);GO:0060736(prostate gland growth);GO:0060740(prostate gland epithelium morphogenesis);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis);GO:0060749(mammary gland alveolus development);GO:0060769(positive regulation of epithelial cell proliferation involved in prostate gland development);GO:0061458(reproductive system development);GO:0070974(POU domain binding);GO:0071383(cellular response to steroid hormone stimulus);GO:0071391(cellular response to estrogen stimulus);GO:0071394(cellular response to testosterone stimulus);GO:0072520(seminiferous tubule development);GO:1903076(regulation of protein localization to plasma membrane);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04114(Oocyte meiosis);05200(Pathways in cancer);05215(Prostate cancer)",{"v":2.5e-16,"d":"0.00"},1,"510,",0,{"v":-15.6,"d":"-15.60"},{"v":-14.7,"d":"-14.70"},{"v":14.2,"d":"14.20"},"Exon (ENSBGRT00000018343/ENSBGRG00000010012, exon 1 of 9)",30,90470545,90703216,232672,2]
["X",90701059,90701868,810,"ENSBGRG00000010012","ENSBGRT00000018343",1348,"AR","androgen receptor [Source:HGNC Symbol;Acc:HGNC:644]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001091(RNA polymerase II general transcription initiation factor binding);GO:0001225(RNA polymerase II transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003073(regulation of systemic arterial blood pressure);GO:0003382(epithelial cell morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0004879(nuclear receptor activity);GO:0005102(signaling receptor binding);GO:0005496(steroid binding);GO:0005497(androgen binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0009566(fertilization);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0016607(nuclear speck);GO:0019102(male somatic sex determination);GO:0019899(enzyme binding);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030522(intracellular receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway);GO:0033327(Leydig cell differentiation);GO:0035264(multicellular organism growth);GO:0042025(host cell nucleus);GO:0042327(positive regulation of phosphorylation);GO:0043410(positive regulation of MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045597(positive regulation of cell differentiation);GO:0045720(negative regulation of integrin biosynthetic process);GO:0045726(positive regulation of integrin biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0048608(reproductive structure development);GO:0048638(regulation of developmental growth);GO:0048645(animal organ formation);GO:0048808(male genitalia morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051117(ATPase binding);GO:0060520(activation of prostate induction by androgen receptor signaling pathway);GO:0060571(morphogenesis of an epithelial fold);GO:0060599(lateral sprouting involved in mammary gland duct morphogenesis);GO:0060685(regulation of prostatic bud formation);GO:0060736(prostate gland growth);GO:0060740(prostate gland epithelium morphogenesis);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis);GO:0060749(mammary gland alveolus development);GO:0060769(positive regulation of epithelial cell proliferation involved in prostate gland development);GO:0061458(reproductive system development);GO:0070974(POU domain binding);GO:0071383(cellular response to steroid hormone stimulus);GO:0071391(cellular response to estrogen stimulus);GO:0071394(cellular response to testosterone stimulus);GO:0072520(seminiferous tubule development);GO:1903076(regulation of protein localization to plasma membrane);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04114(Oocyte meiosis);05200(Pathways in cancer);05215(Prostate cancer)",{"v":1.6e-30,"d":"0.00"},1,"810,",0,{"v":-29.8,"d":"-29.80"},{"v":-28.6,"d":"-28.60"},{"v":10.2,"d":"10.20"},"Exon (ENSBGRT00000018343/ENSBGRG00000010012, exon 1 of 9)",30,90470545,90703216,232672,2]
["X",90702317,90703126,810,"ENSBGRG00000010012","ENSBGRT00000018343",90,"AR","androgen receptor [Source:HGNC Symbol;Acc:HGNC:644]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001091(RNA polymerase II general transcription initiation factor binding);GO:0001225(RNA polymerase II transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003073(regulation of systemic arterial blood pressure);GO:0003382(epithelial cell morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0004879(nuclear receptor activity);GO:0005102(signaling receptor binding);GO:0005496(steroid binding);GO:0005497(androgen binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0009566(fertilization);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0016607(nuclear speck);GO:0019102(male somatic sex determination);GO:0019899(enzyme binding);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030522(intracellular receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway);GO:0033327(Leydig cell differentiation);GO:0035264(multicellular organism growth);GO:0042025(host cell nucleus);GO:0042327(positive regulation of phosphorylation);GO:0043410(positive regulation of MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045597(positive regulation of cell differentiation);GO:0045720(negative regulation of integrin biosynthetic process);GO:0045726(positive regulation of integrin biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0048608(reproductive structure development);GO:0048638(regulation of developmental growth);GO:0048645(animal organ formation);GO:0048808(male genitalia morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051117(ATPase binding);GO:0060520(activation of prostate induction by androgen receptor signaling pathway);GO:0060571(morphogenesis of an epithelial fold);GO:0060599(lateral sprouting involved in mammary gland duct morphogenesis);GO:0060685(regulation of prostatic bud formation);GO:0060736(prostate gland growth);GO:0060740(prostate gland epithelium morphogenesis);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis);GO:0060749(mammary gland alveolus development);GO:0060769(positive regulation of epithelial cell proliferation involved in prostate gland development);GO:0061458(reproductive system development);GO:0070974(POU domain binding);GO:0071383(cellular response to steroid hormone stimulus);GO:0071391(cellular response to estrogen stimulus);GO:0071394(cellular response to testosterone stimulus);GO:0072520(seminiferous tubule development);GO:1903076(regulation of protein localization to plasma membrane);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04114(Oocyte meiosis);05200(Pathways in cancer);05215(Prostate cancer)",{"v":1.3e-16,"d":"0.00"},1,"810,",0,{"v":-15.9,"d":"-15.90"},-15,8.11,"5' UTR",30,90470545,90703216,232672,2]
["X",92228030,92229524,1495,"ENSBGRG00000010191","ENSBGRT00000018732",0,"ENSBGRG00000010191","NA","NA","NA",{"v":0.00014,"d":"0.00"},3,"621,295,509,","0,659,986",-3.85,-3.17,11,"Exon (ENSBGRT00000018732/ENSBGRG00000010191, exon 1 of 3)",30,92228030,92229524,1495,2]
["X",92430599,92430719,121,"ENSBGRG00000010277","ENSBGRT00000018911",215882,"SLC9A7","solute carrier family 9 member A7 [Source:HGNC Symbol;Acc:HGNC:17123]","GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0006885(regulation of pH);GO:0015299(solute:proton antiporter activity);GO:0015385(sodium:proton antiporter activity);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport)","NA",{"v":0.00045,"d":"0.00"},1,"121,",0,-3.35,{"v":-2.7,"d":"-2.70"},4.61,"Exon (ENSBGRT00000018911/ENSBGRG00000010277, exon 19 of 19)",30,92430539,92646601,216063,2]
["X",92489679,92496459,6781,"ENSBGRG00000010277","ENSBGRT00000018911",150142,"SLC9A7","solute carrier family 9 member A7 [Source:HGNC Symbol;Acc:HGNC:17123]","GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0006885(regulation of pH);GO:0015299(solute:proton antiporter activity);GO:0015385(sodium:proton antiporter activity);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport)","NA",{"v":0.046,"d":"0.05"},3,"39,106,6,","0,3065,6775",-1.34,{"v":-0.841,"d":"-0.84"},2.29,"Exon (ENSBGRT00000018911/ENSBGRG00000010277, exon 9 of 19)",30,92430539,92646601,216063,2]
["X",93135691,93138642,2952,"ENSBGRG00000010871","ENSBGRT00000019905",90,"NDUFB11","NADH:ubiquinone oxidoreductase subunit B11 [Source:HGNC Symbol;Acc:HGNC:20372]","GO:0005747(mitochondrial respiratory chain complex I);GO:0032981(mitochondrial respiratory chain complex I assembly)","00190(Oxidative phosphorylation);04723(Retrograde endocannabinoid signaling);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":5e-14,"d":"0.00"},2,"63,117,","0,2835",{"v":-13.3,"d":"-13.30"},{"v":-12.4,"d":"-12.40"},1.78,"Exon (ENSBGRT00000019905/ENSBGRG00000010871, exon 1 of 4)",30,93102431,93138732,36302,2]
["X",93412120,93413843,1724,"ENSBGRG00000015259","ENSBGRT00000028421",12812,"ZNF41","zinc finger protein 41 [Source:HGNC Symbol;Acc:HGNC:13107]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":2E-16,"d":"0.00"},2,"566,656,","0,1068",{"v":-15.7,"d":"-15.70"},{"v":-14.8,"d":"-14.80"},8.02,"Exon (ENSBGRT00000028421/ENSBGRG00000015259, exon 6 of 7)",30,93412120,93426655,14536,2]
["X",93414051,93424753,10703,"ENSBGRG00000015259","ENSBGRT00000028421",1902,"ZNF41","zinc finger protein 41 [Source:HGNC Symbol;Acc:HGNC:13107]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":2.5e-11,"d":"0.00"},3,"453,115,88,","0,488,10615",{"v":-10.6,"d":"-10.60"},-9.71,4.89,"Exon (ENSBGRT00000028421/ENSBGRG00000015259, exon 4 of 7)",30,93412120,93426655,14536,2]
["X",93595047,93595196,150,"ENSBGRG00000015712","ENSBGRT00000028844",62180,"SYN1","synapsin I [Source:HGNC Symbol;Acc:HGNC:11494]","GO:0000795(synaptonemal complex);GO:0005524(ATP binding);GO:0005856(cytoskeleton);GO:0007269(neurotransmitter secretion);GO:0008021(synaptic vesicle);GO:0014069(postsynaptic density);GO:0019901(protein kinase binding);GO:0030424(axon);GO:0030672(synaptic vesicle membrane);GO:0042802(identical protein binding);GO:0045202(synapse);GO:0048786(presynaptic active zone);GO:0097091(synaptic vesicle clustering);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098693(regulation of synaptic vesicle cycle);GO:0098793(presynapse);GO:0099504(synaptic vesicle cycle)","NA",{"v":0.032,"d":"0.03"},1,"150,",0,{"v":-1.5,"d":"-1.50"},{"v":-0.989,"d":"-0.99"},2.81,"3' UTR",30,93595017,93657376,62360,2]
["X",93597370,93598211,842,"ENSBGRG00000015712","ENSBGRT00000028844",59165,"SYN1","synapsin I [Source:HGNC Symbol;Acc:HGNC:11494]","GO:0000795(synaptonemal complex);GO:0005524(ATP binding);GO:0005856(cytoskeleton);GO:0007269(neurotransmitter secretion);GO:0008021(synaptic vesicle);GO:0014069(postsynaptic density);GO:0019901(protein kinase binding);GO:0030424(axon);GO:0030672(synaptic vesicle membrane);GO:0042802(identical protein binding);GO:0045202(synapse);GO:0048786(presynaptic active zone);GO:0097091(synaptic vesicle clustering);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098693(regulation of synaptic vesicle cycle);GO:0098793(presynapse);GO:0099504(synaptic vesicle cycle)","NA",{"v":0.0058,"d":"0.01"},3,"252,88,20,","0,351,822",-2.24,-1.66,10,"Exon (ENSBGRT00000028844/ENSBGRG00000015712, exon 10 of 13)",30,93595017,93657376,62360,2]
["X",93664581,93666295,1715,"ENSBGRG00000016091","ENSBGRT00000029558",4710,"CFP","complement factor properdin [Source:HGNC Symbol;Acc:HGNC:8864]","GO:0005615(extracellular space);GO:0006957(complement activation, alternative pathway);GO:0030141(secretory granule)","05168(Herpes simplex infection)",{"v":5e-24,"d":"0.00"},3,"13,240,227,","0,851,1488",{"v":-23.3,"d":"-23.30"},{"v":-22.2,"d":"-22.20"},6.42,"3' UTR",30,93664428,93671005,6578,2]
["X",93800139,93800466,328,"ENSBGRG00000016563","ENSBGRT00000030360",0,"ENSBGRG00000016563","NA","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","04310(Wnt signaling pathway);04340(Hedgehog signaling pathway);05225(Hepatocellular carcinoma);05226(Gastric cancer);05224(Breast cancer);05165(Human papillomavirus infection)",{"v":1e-20,"d":"0.00"},1,"328,",0,-20,-19,2.78,"Exon (ENSBGRT00000030360/ENSBGRG00000016563, exon 1 of 1)",30,93799456,93800466,1011,2]
["X",93934301,93935585,1285,"ENSBGRG00000016643","ENSBGRT00000030538",0,"ENSBGRG00000016643","NA","NA","NA",{"v":0.028,"d":"0.03"},2,"26,202,","0,1083",-1.55,-1.03,5.01,"Exon (ENSBGRT00000030538/ENSBGRG00000016643, exon 1 of 2)",30,93934301,93935585,1285,2]
["X",94005218,94007176,1959,"ENSBGRG00000016702","ENSBGRT00000030966",7220,"ZNF182","zinc finger protein 182 [Source:HGNC Symbol;Acc:HGNC:13001]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":4e-12,"d":"0.00"},3,"640,338,456,","0,1092,1503",{"v":-11.4,"d":"-11.40"},{"v":-10.5,"d":"-10.50"},{"v":4.3,"d":"4.30"},"Exon (ENSBGRT00000030966/ENSBGRG00000016702, exon 5 of 7)",30,94005218,94014396,9179,2]
["X",94026395,94026845,451,"ENSBGRG00000016905","ENSBGRT00000031020",4920,"ENSBGRG00000016905","NA","NA","NA",{"v":0.032,"d":"0.03"},1,"451,",0,-1.49,{"v":-0.978,"d":"-0.98"},7.02,"Exon (ENSBGRT00000031020/ENSBGRG00000016905, exon 2 of 2)",30,94026395,94031765,5371,2]
["X",94027025,94027714,690,"ENSBGRG00000016905","ENSBGRT00000031020",4051,"ENSBGRG00000016905","NA","NA","NA",{"v":6.3E-3,"d":"0.01"},1,"690,",0,{"v":-2.2,"d":"-2.20"},-1.62,7.02,"Exon (ENSBGRT00000031020/ENSBGRG00000016905, exon 2 of 2)",30,94026395,94031765,5371,2]
["X",94028194,94028794,601,"ENSBGRG00000016905","ENSBGRT00000031020",2971,"ENSBGRG00000016905","NA","NA","NA",{"v":0.014,"d":"0.01"},1,"601,",0,-1.85,{"v":-1.3,"d":"-1.30"},6.02,"Exon (ENSBGRT00000031020/ENSBGRG00000016905, exon 2 of 2)",30,94026395,94031765,5371,2]
["X",94029424,94029994,571,"ENSBGRG00000016905","ENSBGRT00000031020",1771,"ENSBGRG00000016905","NA","NA","NA",{"v":0.00015,"d":"0.00"},1,"571,",0,-3.82,-3.15,4.41,"Exon (ENSBGRT00000031020/ENSBGRG00000016905, exon 2 of 2)",30,94026395,94031765,5371,2]
["X",94030054,94030204,151,"ENSBGRG00000016905","ENSBGRT00000031020",1561,"ENSBGRG00000016905","NA","NA","NA",{"v":0.0036,"d":"0.00"},1,"151,",0,-2.44,-1.85,8.02,"Exon (ENSBGRT00000031020/ENSBGRG00000016905, exon 2 of 2)",30,94026395,94031765,5371,2]
["X",94596111,94599484,3374,"ENSBGRG00000017992","ENSBGRT00000032960",271,"PCSK1N","proprotein convertase subtilisin/kexin type 1 inhibitor [Source:HGNC Symbol;Acc:HGNC:17301]","GO:0002021(response to dietary excess);GO:0004866(endopeptidase inhibitor activity);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005615(extracellular space);GO:0005802(trans-Golgi network);GO:0009409(response to cold);GO:0010951(negative regulation of endopeptidase activity);GO:0016486(peptide hormone processing);GO:0030141(secretory granule)","NA",{"v":5e-05,"d":"0.00"},2,"129,21,","0,3353",{"v":-4.3,"d":"-4.30"},{"v":-3.6,"d":"-3.60"},6.27,"Exon (ENSBGRT00000032960/ENSBGRG00000017992, exon 1 of 3)",30,94595262,94599755,4494,2]
["X",94699291,94699530,240,"ENSBGRG00000018196","ENSBGRT00000033528",7042,"SLC35A2","solute carrier family 35 member A2 [Source:HGNC Symbol;Acc:HGNC:11022]","GO:0000139(Golgi membrane);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0015165(pyrimidine nucleotide-sugar transmembrane transporter activity);GO:0016021(integral component of membrane);GO:0090481(pyrimidine nucleotide-sugar transmembrane transport)","NA",{"v":7.4e-05,"d":"0.00"},1,"240,",0,-4.13,-3.45,3.08,"3' UTR",30,94697953,94706572,8620,2]
["X",94710538,94710834,297,"ENSBGRG00000018477","ENSBGRT00000033918",6255,"PIM2","Pim-2 proto-oncogene, serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:8987]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0008285(negative regulation of cell population proliferation);GO:0009615(response to virus);GO:0043066(negative regulation of apoptotic process);GO:0050821(protein stabilization)","05200(Pathways in cancer);05221(Acute myeloid leukemia)",{"v":1.3E-53,"d":"0.00"},1,"297,",0,{"v":-52.9,"d":"-52.90"},{"v":-51.5,"d":"-51.50"},4.76,"3' UTR",30,94710538,94717089,6552,2]
["X",94722745,94723374,630,"ENSBGRG00000018572","ENSBGRT00000034432",33538,"OTUD5","OTU deubiquitinase 5 [Source:HGNC Symbol;Acc:HGNC:25402]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0016579(protein deubiquitination);GO:0032496(response to lipopolysaccharide);GO:0061578(Lys63-specific deubiquitinase activity);GO:0070536(protein K63-linked deubiquitination);GO:0071108(protein K48-linked deubiquitination);GO:0101005(ubiquitinyl hydrolase activity);GO:1990380(Lys48-specific deubiquitinase activity)","04622(RIG-I-like receptor signaling pathway)",{"v":1.3e-48,"d":"0.00"},1,"630,",0,{"v":-47.9,"d":"-47.90"},{"v":-46.6,"d":"-46.60"},8.02,"3' UTR",30,94722745,94756912,34168,2]
["X",94756493,94756912,420,"ENSBGRG00000018572","ENSBGRT00000034432",0,"OTUD5","OTU deubiquitinase 5 [Source:HGNC Symbol;Acc:HGNC:25402]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0016579(protein deubiquitination);GO:0032496(response to lipopolysaccharide);GO:0061578(Lys63-specific deubiquitinase activity);GO:0070536(protein K63-linked deubiquitination);GO:0071108(protein K48-linked deubiquitination);GO:0101005(ubiquitinyl hydrolase activity);GO:1990380(Lys48-specific deubiquitinase activity)","04622(RIG-I-like receptor signaling pathway)",{"v":2e-13,"d":"0.00"},1,"420,",0,{"v":-12.7,"d":"-12.70"},{"v":-11.8,"d":"-11.80"},6.52,"Exon (ENSBGRT00000034432/ENSBGRG00000018572, exon 1 of 9)",30,94722745,94756912,34168,2]
["X",94767373,94768176,804,"ENSBGRG00000018827","ENSBGRT00000034550",4099,"KCND1","potassium voltage-gated channel subfamily D member 1 [Source:HGNC Symbol;Acc:HGNC:6237]","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005515(protein binding);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport)","NA",{"v":3.2e-14,"d":"0.00"},1,"804,",0,{"v":-13.5,"d":"-13.50"},{"v":-12.6,"d":"-12.60"},4.36,"Exon (ENSBGRT00000034550/ENSBGRG00000018827, exon 3 of 8)",30,94762591,94772275,9685,2]
["X",94768265,94773450,5186,"ENSBGRG00000018827","ENSBGRT00000034550",0,"KCND1","potassium voltage-gated channel subfamily D member 1 [Source:HGNC Symbol;Acc:HGNC:6237]","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005515(protein binding);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport)","NA",{"v":2E-3,"d":"0.00"},4,"7,324,481,260,","0,1313,3530,4926",-2.69,-2.08,9.03,"5' UTR",30,94762591,94772275,9685,2]
["X",94776055,94778964,2910,"ENSBGRG00000018956","ENSBGRT00000035769",20096,"GRIPAP1","GRIP1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:18706]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle)","04137(Mitophagy - animal);05202(Transcriptional misregulation in cancers);05211(Renal cell carcinoma)",{"v":1.3E-28,"d":"0.00"},3,"874,155,17,","0,1705,2893",{"v":-27.9,"d":"-27.90"},{"v":-26.8,"d":"-26.80"},{"v":60.2,"d":"60.20"},"3' UTR",30,94776055,94799060,23006,2]
["X",94785530,94785733,204,"ENSBGRG00000018956","ENSBGRT00000035769",13327,"GRIPAP1","GRIP1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:18706]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle)","04137(Mitophagy - animal);05202(Transcriptional misregulation in cancers);05211(Renal cell carcinoma)",{"v":1.1E-4,"d":"0.00"},2,"64,56,","0,148",-3.96,-3.28,1.23,"Exon (ENSBGRT00000035769/ENSBGRG00000018956, exon 17 of 25)",30,94776055,94799060,23006,2]
["X",94797971,94798150,180,"ENSBGRG00000018956","ENSBGRT00000035769",910,"GRIPAP1","GRIP1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:18706]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle)","04137(Mitophagy - animal);05202(Transcriptional misregulation in cancers);05211(Renal cell carcinoma)",{"v":0.0058,"d":"0.01"},1,"180,",0,-2.24,-1.66,10,"5' UTR",30,94776055,94799060,23006,2]
["X",94814200,94814260,61,"ENSBGRG00000019914","ENSBGRT00000036791",11661,"TFE3","transcription factor binding to IGHM enhancer 3 [Source:HGNC Symbol;Acc:HGNC:11752]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006959(humoral immune response);GO:0045670(regulation of osteoclast differentiation);GO:0045785(positive regulation of cell adhesion);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:1990837(sequence-specific double-stranded DNA binding)","04137(Mitophagy - animal);05202(Transcriptional misregulation in cancers);05211(Renal cell carcinoma)",{"v":0.0013,"d":"0.00"},1,"61,",0,-2.87,-2.25,1.72,"3' UTR",30,94814200,94825921,11722,2]
["X",94815454,94816827,1374,"ENSBGRG00000019914","ENSBGRT00000036791",9094,"TFE3","transcription factor binding to IGHM enhancer 3 [Source:HGNC Symbol;Acc:HGNC:11752]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006959(humoral immune response);GO:0045670(regulation of osteoclast differentiation);GO:0045785(positive regulation of cell adhesion);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:1990837(sequence-specific double-stranded DNA binding)","04137(Mitophagy - animal);05202(Transcriptional misregulation in cancers);05211(Renal cell carcinoma)",{"v":1.3E-90,"d":"0.00"},2,"567,91,","0,1283",{"v":-89.9,"d":"-89.90"},{"v":-88.2,"d":"-88.20"},{"v":10.5,"d":"10.50"},"3' UTR",30,94814200,94825921,11722,2]
["X",94865278,94865900,623,"ENSBGRG00000020477","ENSBGRT00000037993",5028,"WDR45","WD repeat domain 45 [Source:HGNC Symbol;Acc:HGNC:28912]","GO:0000045(autophagosome assembly);GO:0000407(phagophore assembly site);GO:0005515(protein binding);GO:0006914(autophagy);GO:0009267(cellular response to starvation);GO:0019901(protein kinase binding);GO:1901981(phosphatidylinositol phosphate binding)","NA",{"v":1.6e-05,"d":"0.00"},2,"178,61,","0,562",{"v":-4.8,"d":"-4.80"},-4.09,1.45,"3' UTR",30,94865248,94870928,5681,2]
["X",94868391,94870302,1912,"ENSBGRG00000020477","ENSBGRT00000037993",626,"WDR45","WD repeat domain 45 [Source:HGNC Symbol;Acc:HGNC:28912]","GO:0000045(autophagosome assembly);GO:0000407(phagophore assembly site);GO:0005515(protein binding);GO:0006914(autophagy);GO:0009267(cellular response to starvation);GO:0019901(protein kinase binding);GO:1901981(phosphatidylinositol phosphate binding)","NA",{"v":1.6e-16,"d":"0.00"},4,"11,75,72,140,","0,100,304,1772",{"v":-15.8,"d":"-15.80"},{"v":-14.9,"d":"-14.90"},2.51,"5' UTR",30,94865248,94870928,5681,2]
["X",94893427,94893546,120,"ENSBGRG00000020742","ENSBGRT00000038185",13641,"GPKOW","G-patch domain and KOW motifs [Source:HGNC Symbol;Acc:HGNC:30677]","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex)","NA",{"v":9.5e-08,"d":"0.00"},1,"120,",0,-7.02,-6.24,5.77,"3' UTR",30,94893427,94907187,13761,2]
["X",94903887,94904066,180,"ENSBGRG00000020742","ENSBGRT00000038185",3121,"GPKOW","G-patch domain and KOW motifs [Source:HGNC Symbol;Acc:HGNC:30677]","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex)","NA",{"v":0.017,"d":"0.02"},1,"180,",0,-1.77,-1.23,3.01,"5' UTR",30,94893427,94907187,13761,2]
["X",94944885,94945424,540,"ENSBGRG00000021159","ENSBGRT00000039076",10818,"PRICKLE3","prickle planar cell polarity protein 3 [Source:HGNC Symbol;Acc:HGNC:6645]","GO:0008270(zinc ion binding)","04310(Wnt signaling pathway)",{"v":6.3e-79,"d":"0.00"},1,"540,",0,{"v":-78.2,"d":"-78.20"},{"v":-76.6,"d":"-76.60"},9.19,"3' UTR",30,94944076,94956242,12167,2]
["X",94958242,94959110,869,"ENSBGRG00000021237","ENSBGRT00000039236",11783,"SYP","synaptophysin [Source:HGNC Symbol;Acc:HGNC:11506]","GO:0008021(synaptic vesicle);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0042169(SH2 domain binding);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043195(terminal bouton);GO:0044306(neuron projection terminus);GO:0045202(synapse);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048488(synaptic vesicle endocytosis);GO:0048786(presynaptic active zone);GO:0060076(excitatory synapse);GO:0071310(cellular response to organic substance)","04122(Sulfur relay system)",{"v":0.0022,"d":"0.00"},1,"869,",0,-2.66,-2.06,9.03,"3' UTR",30,94958242,94970893,12652,2]
["X",94959170,94959678,509,"ENSBGRG00000021237","ENSBGRT00000039236",11215,"SYP","synaptophysin [Source:HGNC Symbol;Acc:HGNC:11506]","GO:0008021(synaptic vesicle);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0042169(SH2 domain binding);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043195(terminal bouton);GO:0044306(neuron projection terminus);GO:0045202(synapse);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048488(synaptic vesicle endocytosis);GO:0048786(presynaptic active zone);GO:0060076(excitatory synapse);GO:0071310(cellular response to organic substance)","04122(Sulfur relay system)",{"v":0.017,"d":"0.02"},1,"509,",0,-1.77,-1.23,4.01,"3' UTR",30,94958242,94970893,12652,2]
["X",94960068,94960487,420,"ENSBGRG00000021237","ENSBGRT00000039236",10406,"SYP","synaptophysin [Source:HGNC Symbol;Acc:HGNC:11506]","GO:0008021(synaptic vesicle);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0042169(SH2 domain binding);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043195(terminal bouton);GO:0044306(neuron projection terminus);GO:0045202(synapse);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048488(synaptic vesicle endocytosis);GO:0048786(presynaptic active zone);GO:0060076(excitatory synapse);GO:0071310(cellular response to organic substance)","04122(Sulfur relay system)",{"v":0.00019,"d":"0.00"},1,"420,",0,-3.73,-3.06,3.81,"3' UTR",30,94958242,94970893,12652,2]
["X",94970105,94970344,240,"ENSBGRG00000021237","ENSBGRT00000039236",549,"SYP","synaptophysin [Source:HGNC Symbol;Acc:HGNC:11506]","GO:0008021(synaptic vesicle);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0042169(SH2 domain binding);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043195(terminal bouton);GO:0044306(neuron projection terminus);GO:0045202(synapse);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048488(synaptic vesicle endocytosis);GO:0048786(presynaptic active zone);GO:0060076(excitatory synapse);GO:0071310(cellular response to organic substance)","04122(Sulfur relay system)",{"v":0.032,"d":"0.03"},1,"240,",0,-1.49,{"v":-0.978,"d":"-0.98"},6.02,"5' UTR",30,94958242,94970893,12652,2]
["X",94978094,94978273,180,"ENSBGRG00000021471","ENSBGRT00000045644",32422,"CACNA1F","calcium voltage-gated channel subunit alpha1 F [Source:HGNC Symbol;Acc:HGNC:1393]","GO:0005216(ion channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0005891(voltage-gated calcium channel complex);GO:0006811(ion transport);GO:0007601(visual perception);GO:0008331(high voltage-gated calcium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043029(T cell homeostasis);GO:0050856(regulation of T cell receptor signaling pathway);GO:0050908(detection of light stimulus involved in visual perception);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport)","04010(MAPK signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04912(GnRH signaling pathway);04921(Oxytocin signaling pathway);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04727(GABAergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);05010(Alzheimer disease);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));04934(Cushing syndrome)",{"v":0.019,"d":"0.02"},1,"180,",0,-1.71,{"v":-0.901,"d":"-0.90"},8.02,"3' UTR",30,94978064,95010695,32632,2]
["X",95349651,95351665,2015,"ENSBGRG00000025443","ENSBGRT00000047038",0,"ENSBGRG00000025443","NA","NA","NA",{"v":3.2e-10,"d":"0.00"},2,"730,13,","0,2002",{"v":-9.5,"d":"-9.50"},-8.65,9.53,"Exon (ENSBGRT00000047038/ENSBGRG00000025443, exon 1 of 2)",30,95349265,95351665,2401,2]
["X",95746508,95748123,1616,"ENSBGRG00000025520","ENSBGRT00000047171",17074,"ENSBGRG00000025520","NA","NA","NA",{"v":1.7E-5,"d":"0.00"},2,"97,734,","0,882",-4.77,-4.05,3.87,"Exon (ENSBGRT00000047171/ENSBGRG00000025520, exon 4 of 5)",30,95746301,95765197,18897,2]
["X",95764248,95764367,120,"ENSBGRG00000025520","ENSBGRT00000047171",830,"ENSBGRG00000025520","NA","NA","NA",{"v":0.0011,"d":"0.00"},1,"120,",0,-2.97,-2.34,3.01,"5' UTR",30,95746301,95765197,18897,2]
["X",96285654,96286923,1270,"ENSBGRG00000025572","ENSBGRT00000047281",0,"ENSBGRG00000025572","NA","GO:0051015(actin filament binding)","NA",{"v":4e-31,"d":"0.00"},2,"246,114,","0,1156",{"v":-30.4,"d":"-30.40"},{"v":-29.2,"d":"-29.20"},3.71,"Exon (ENSBGRT00000047281/ENSBGRG00000025572, exon 1 of 2)",30,96285654,96286923,1270,2]
["X",96991862,96995939,4078,"ENSBGRG00000025627","ENSBGRT00000047379",175,"ENSBGRG00000025627","NA","GO:0016787(hydrolase activity)","NA",{"v":1e-17,"d":"0.00"},2,"1,318,","0,3760",-17,-16,6.02,"Exon (ENSBGRT00000047379/ENSBGRG00000025627, exon 2 of 3)",30,96991862,96996114,4253,2]
["X",97231541,97234145,2605,"ENSBGRG00000025638","ENSBGRT00000047400",0,"GSPT2","G1 to S phase transition 2 [Source:HGNC Symbol;Acc:HGNC:4622]","GO:0003924(GTPase activity);GO:0005525(GTP binding)","03015(mRNA surveillance pathway)",{"v":1.6e-80,"d":"0.00"},3,"895,948,47,","0,932,2558",{"v":-79.8,"d":"-79.80"},{"v":-78.2,"d":"-78.20"},5.66,"Exon (ENSBGRT00000047400/ENSBGRG00000025638, exon 1 of 3)",30,97231541,97234145,2605,2]
["X",98238710,98239953,1244,"ENSBGRG00000025771","ENSBGRT00000047836",30720,"KDM5C","lysine demethylase 5C [Source:HGNC Symbol;Acc:HGNC:11114]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":4e-91,"d":"0.00"},4,"270,200,79,171,","0,378,712,1073",{"v":-90.4,"d":"-90.40"},{"v":-88.7,"d":"-88.70"},4.45,"Exon (ENSBGRT00000047836/ENSBGRG00000025771, exon 25 of 28)",30,98238620,98270673,32054,2]
["X",98240013,98240254,242,"ENSBGRG00000025771","ENSBGRT00000047836",30419,"KDM5C","lysine demethylase 5C [Source:HGNC Symbol;Acc:HGNC:11114]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":7.4e-10,"d":"0.00"},2,"217,23,","0,219",-9.13,-8.29,1.78,"Exon (ENSBGRT00000047836/ENSBGRG00000025771, exon 24 of 28)",30,98238620,98270673,32054,2]
["X",98241599,98242546,948,"ENSBGRG00000025771","ENSBGRT00000047836",28127,"KDM5C","lysine demethylase 5C [Source:HGNC Symbol;Acc:HGNC:11114]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":2e-62,"d":"0.00"},2,"45,315,","0,633",{"v":-61.7,"d":"-61.70"},{"v":-60.2,"d":"-60.20"},2.25,"Exon (ENSBGRT00000047836/ENSBGRG00000025771, exon 20 of 28)",30,98238620,98270673,32054,2]
["X",98262206,98262492,287,"ENSBGRG00000025771","ENSBGRT00000047836",8181,"KDM5C","lysine demethylase 5C [Source:HGNC Symbol;Acc:HGNC:11114]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":6.3e-11,"d":"0.00"},2,"89,92,","0,195",{"v":-10.2,"d":"-10.20"},-9.33,1.59,"Exon (ENSBGRT00000047836/ENSBGRG00000025771, exon 6 of 28)",30,98238620,98270673,32054,2]
["X",98296775,98297104,330,"ENSBGRG00000025892","ENSBGRT00000047945",31841,"IQSEC2","IQ motif and Sec7 domain ArfGEF 2 [Source:HGNC Symbol;Acc:HGNC:29059]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0032012(regulation of ARF protein signal transduction);GO:0050804(modulation of chemical synaptic transmission);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098696(regulation of neurotransmitter receptor localization to postsynaptic specialization membrane)","04144(Endocytosis)",{"v":0.0062,"d":"0.01"},1,"330,",0,-2.21,-1.63,1.69,"Exon (ENSBGRT00000047945/ENSBGRG00000025892, exon 5 of 16)",30,98283184,98328945,45762,2]
["X",98297194,98297344,151,"ENSBGRG00000025892","ENSBGRT00000047945",31601,"IQSEC2","IQ motif and Sec7 domain ArfGEF 2 [Source:HGNC Symbol;Acc:HGNC:29059]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0032012(regulation of ARF protein signal transduction);GO:0050804(modulation of chemical synaptic transmission);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098696(regulation of neurotransmitter receptor localization to postsynaptic specialization membrane)","04144(Endocytosis)",{"v":0.026,"d":"0.03"},1,"151,",0,-1.58,-1.06,1.45,"Exon (ENSBGRT00000047945/ENSBGRG00000025892, exon 5 of 16)",30,98283184,98328945,45762,2]
["X",98300133,98300283,151,"ENSBGRG00000025892","ENSBGRT00000047945",28662,"IQSEC2","IQ motif and Sec7 domain ArfGEF 2 [Source:HGNC Symbol;Acc:HGNC:29059]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0032012(regulation of ARF protein signal transduction);GO:0050804(modulation of chemical synaptic transmission);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098696(regulation of neurotransmitter receptor localization to postsynaptic specialization membrane)","04144(Endocytosis)",0.04,1,"151,",0,{"v":-1.4,"d":"-1.40"},{"v":-0.899,"d":"-0.90"},1.86,"Exon (ENSBGRT00000047945/ENSBGRG00000025892, exon 4 of 16)",30,98283184,98328945,45762,2]
["X",98329075,98374052,44978,"ENSBGRG00000025892","ENSBGRT00000047926",0,"IQSEC2","IQ motif and Sec7 domain ArfGEF 2 [Source:HGNC Symbol;Acc:HGNC:29059]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0032012(regulation of ARF protein signal transduction);GO:0050804(modulation of chemical synaptic transmission);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098696(regulation of neurotransmitter receptor localization to postsynaptic specialization membrane)","04144(Endocytosis)",{"v":1.1E-5,"d":"0.00"},3,"791,30,707,","0,12129,44271",-4.97,-4.25,11,"5' UTR",30,98283184,98374052,90869,2]
["X",98455422,98460799,5378,"ENSBGRG00000025945","ENSBGRT00000048022",22761,"ENSBGRG00000025945","NA","NA","04110(Cell cycle);04114(Oocyte meiosis)",{"v":6.3e-25,"d":"0.00"},3,"95,138,97,","0,1104,5281",{"v":-24.2,"d":"-24.20"},{"v":-23.1,"d":"-23.10"},3.51,"Exon (ENSBGRT00000048022/ENSBGRG00000025945, exon 20 of 29)",30,98441200,98483560,42361,2]
["X",98466405,98466906,502,"ENSBGRG00000025945","ENSBGRT00000048022",16654,"ENSBGRG00000025945","NA","NA","04110(Cell cycle);04114(Oocyte meiosis)",{"v":3e-08,"d":"0.00"},3,"109,143,48,","0,208,454",-7.52,-6.72,3.23,"Exon (ENSBGRT00000048022/ENSBGRG00000025945, exon 15 of 29)",30,98441200,98483560,42361,2]
["X",98468341,98468675,335,"ENSBGRG00000025945","ENSBGRT00000048022",14885,"ENSBGRG00000025945","NA","NA","04110(Cell cycle);04114(Oocyte meiosis)",{"v":4e-17,"d":"0.00"},2,"136,45,","0,290",{"v":-16.4,"d":"-16.40"},{"v":-15.4,"d":"-15.40"},2.66,"Exon (ENSBGRT00000048022/ENSBGRG00000025945, exon 12 of 29)",30,98441200,98483560,42361,2]
["X",98634521,98635614,1094,"ENSBGRG00000026013","ENSBGRT00000048135",154902,"HUWE1","HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:30892]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006284(base-excision repair);GO:0006513(protein monoubiquitination);GO:0010637(negative regulation of mitochondrial fusion);GO:0016574(histone ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0032922(circadian regulation of gene expression);GO:0061630(ubiquitin protein ligase activity);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization)","04120(Ubiquitin mediated proteolysis)",{"v":2.5e-57,"d":"0.00"},2,"388,33,","0,1061",{"v":-56.6,"d":"-56.60"},{"v":-55.1,"d":"-55.10"},2.09,"Exon (ENSBGRT00000048135/ENSBGRG00000026013, exon 66 of 85)",30,98616053,98790516,174464,2]
["X",98642964,98643686,723,"ENSBGRG00000026013","ENSBGRT00000048135",146830,"HUWE1","HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:30892]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006284(base-excision repair);GO:0006513(protein monoubiquitination);GO:0010637(negative regulation of mitochondrial fusion);GO:0016574(histone ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0032922(circadian regulation of gene expression);GO:0061630(ubiquitin protein ligase activity);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization)","04120(Ubiquitin mediated proteolysis)",{"v":1.3e-05,"d":"0.00"},3,"78,90,133,","0,238,590",-4.88,-4.16,{"v":18.1,"d":"18.10"},"Exon (ENSBGRT00000048135/ENSBGRG00000026013, exon 56 of 85)",30,98616053,98790516,174464,2]
["X",98647394,98650229,2836,"ENSBGRG00000026013","ENSBGRT00000048135",140287,"HUWE1","HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:30892]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006284(base-excision repair);GO:0006513(protein monoubiquitination);GO:0010637(negative regulation of mitochondrial fusion);GO:0016574(histone ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0032922(circadian regulation of gene expression);GO:0061630(ubiquitin protein ligase activity);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization)","04120(Ubiquitin mediated proteolysis)",{"v":7.9e-19,"d":"0.00"},5,"85,134,99,76,87,","0,271,993,1920,2749",{"v":-18.1,"d":"-18.10"},{"v":-17.1,"d":"-17.10"},1.69,"Exon (ENSBGRT00000048135/ENSBGRG00000026013, exon 50 of 85)",30,98616053,98790516,174464,2]
["X",99438136,99441266,3131,"ENSBGRG00000026090","ENSBGRT00000048250",133449,"WNK3","WNK lysine deficient protein kinase 3 [Source:HGNC Symbol;Acc:HGNC:14543]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005912(adherens junction);GO:0005923(bicellular tight junction);GO:0006468(protein phosphorylation);GO:0006884(cell volume homeostasis);GO:0007231(osmosensory signaling pathway);GO:0010765(positive regulation of sodium ion transport);GO:0010800(positive regulation of peptidyl-threonine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0019869(chloride channel inhibitor activity);GO:0032414(positive regulation of ion transmembrane transporter activity);GO:0035633(maintenance of permeability of blood-brain barrier);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0050801(ion homeostasis);GO:0051928(positive regulation of calcium ion transport);GO:0072659(protein localization to plasma membrane);GO:0090188(negative regulation of pancreatic juice secretion);GO:0090279(regulation of calcium ion import);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1904062(regulation of cation transmembrane transport);GO:2000651(positive regulation of sodium ion transmembrane transporter activity)","NA",{"v":0.035,"d":"0.04"},4,"434,45,131,228,","0,436,2378,2903",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000048250/ENSBGRG00000026090, exon 17 of 23)",30,99395079,99574715,179637,2]
["X",99445899,99446018,120,"ENSBGRG00000026090","ENSBGRT00000048250",128697,"WNK3","WNK lysine deficient protein kinase 3 [Source:HGNC Symbol;Acc:HGNC:14543]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005912(adherens junction);GO:0005923(bicellular tight junction);GO:0006468(protein phosphorylation);GO:0006884(cell volume homeostasis);GO:0007231(osmosensory signaling pathway);GO:0010765(positive regulation of sodium ion transport);GO:0010800(positive regulation of peptidyl-threonine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0019869(chloride channel inhibitor activity);GO:0032414(positive regulation of ion transmembrane transporter activity);GO:0035633(maintenance of permeability of blood-brain barrier);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0050801(ion homeostasis);GO:0051928(positive regulation of calcium ion transport);GO:0072659(protein localization to plasma membrane);GO:0090188(negative regulation of pancreatic juice secretion);GO:0090279(regulation of calcium ion import);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1904062(regulation of cation transmembrane transport);GO:2000651(positive regulation of sodium ion transmembrane transporter activity)","NA",{"v":0.035,"d":"0.04"},1,"120,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000048250/ENSBGRG00000026090, exon 16 of 23)",30,99395079,99574715,179637,2]
["X",101982349,101983125,777,"ENSBGRG00000008507","ENSBGRT00000015472",0,"ENSBGRG00000008507","NA","GO:0005634(nucleus);GO:0007276(gamete generation);GO:0051726(regulation of cell cycle)","NA",{"v":5e-82,"d":"0.00"},1,"777,",0,{"v":-81.3,"d":"-81.30"},{"v":-79.6,"d":"-79.60"},{"v":12.5,"d":"12.50"},"Exon (ENSBGRT00000015472/ENSBGRG00000008507, exon 1 of 1)",30,101982349,101983125,777,2]
["X",102059514,102060290,777,"ENSBGRG00000008521","ENSBGRT00000015499",0,"ENSBGRG00000008521","NA","GO:0005634(nucleus);GO:0007276(gamete generation);GO:0051726(regulation of cell cycle)","NA",{"v":1E-13,"d":"0.00"},1,"777,",0,-13,-12,9.36,"Exon (ENSBGRT00000015499/ENSBGRG00000008521, exon 1 of 1)",30,102059514,102060290,777,2]
["X",102203240,102208858,5619,"ENSBGRG00000008637","ENSBGRT00000015784",155049,"HEPH","hephaestin [Source:HGNC Symbol;Acc:HGNC:4866]","GO:0004322(ferroxidase activity);GO:0005507(copper ion binding);GO:0005886(plasma membrane);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008198(ferrous iron binding);GO:0016323(basolateral plasma membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00860(Porphyrin and chlorophyll metabolism);04978(Mineral absorption)",{"v":3.2E-54,"d":"0.00"},2,"2031,2,","0,5617",{"v":-53.5,"d":"-53.50"},{"v":-52.1,"d":"-52.10"},6.88,"3' UTR",30,102203240,102363907,160668,2]
["X",102351872,102352743,872,"ENSBGRG00000008637","ENSBGRT00000015784",11164,"HEPH","hephaestin [Source:HGNC Symbol;Acc:HGNC:4866]","GO:0004322(ferroxidase activity);GO:0005507(copper ion binding);GO:0005886(plasma membrane);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008198(ferrous iron binding);GO:0016323(basolateral plasma membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00860(Porphyrin and chlorophyll metabolism);04978(Mineral absorption)",{"v":0.046,"d":"0.05"},2,"167,13,","0,859",-1.34,{"v":-0.843,"d":"-0.84"},3.34,"Exon (ENSBGRT00000015784/ENSBGRG00000008637, exon 5 of 22)",30,102203240,102363907,160668,2]
["X",102363459,102363608,150,"ENSBGRG00000008637","ENSBGRT00000015784",299,"HEPH","hephaestin [Source:HGNC Symbol;Acc:HGNC:4866]","GO:0004322(ferroxidase activity);GO:0005507(copper ion binding);GO:0005886(plasma membrane);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008198(ferrous iron binding);GO:0016323(basolateral plasma membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00860(Porphyrin and chlorophyll metabolism);04978(Mineral absorption)",{"v":0.049,"d":"0.05"},1,"150,",0,-1.31,{"v":-0.819,"d":"-0.82"},1.89,"5' UTR",30,102203240,102363907,160668,2]
["X",102692017,102696788,4772,"ENSBGRG00000009295","ENSBGRT00000017039",76291,"MSN","moesin [Source:HGNC Symbol;Acc:HGNC:7373]","GO:0001771(immunological synapse formation);GO:0001931(uropod);GO:0003725(double-stranded RNA binding);GO:0003779(actin binding);GO:0005102(signaling receptor binding);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0005925(focal adhesion);GO:0007159(leukocyte cell-cell adhesion);GO:0008092(cytoskeletal protein binding);GO:0008360(regulation of cell shape);GO:0008361(regulation of cell size);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0022612(gland morphogenesis);GO:0022614(membrane to membrane docking);GO:0030175(filopodium);GO:0031143(pseudopodium);GO:0042098(T cell proliferation);GO:0045177(apical part of cell);GO:0045198(establishment of epithelial cell apical/basal polarity);GO:0048471(perinuclear region of cytoplasm);GO:0050839(cell adhesion molecule binding);GO:0050900(leukocyte migration);GO:0061028(establishment of endothelial barrier);GO:0070489(T cell aggregation);GO:0071394(cellular response to testosterone stimulus);GO:0071437(invadopodium);GO:0071803(positive regulation of podosome assembly);GO:0071944(cell periphery);GO:0072678(T cell migration);GO:1902115(regulation of organelle assembly);GO:1902966(positive regulation of protein localization to early endosome);GO:1903364(positive regulation of cellular protein catabolic process);GO:2000401(regulation of lymphocyte migration);GO:2000643(positive regulation of early endosome to late endosome transport)","04530(Tight junction);04810(Regulation of actin cytoskeleton);04670(Leukocyte transendothelial migration);05205(Proteoglycans in cancer);05162(Measles)",{"v":1E-117,"d":"0.00"},5,"161,93,161,131,25,","0,506,1780,2201,4747",-117,-115,{"v":2.1,"d":"2.10"},"Exon (ENSBGRT00000017039/ENSBGRG00000009295, exon 10 of 15)",30,102691033,102773079,82047,2]
["X",103004018,103055577,51560,"ENSBGRG00000009366","ENSBGRT00000017339",41764,"LAS1L","LAS1 like ribosome biogenesis factor [Source:HGNC Symbol;Acc:HGNC:25726]","GO:0004519(endonuclease activity);GO:0006364(rRNA processing);GO:0071339(MLL1 complex);GO:0090730(Las1 complex)","NA",{"v":2.2e-06,"d":"0.00"},2,"16,464,","0,51096",-5.65,-4.91,{"v":12.5,"d":"12.50"},"Exon (ENSBGRT00000017339/ENSBGRG00000009366, exon 16 of 16)",30,102962254,103009072,46819,1]
["X",103542879,103543868,990,"ENSBGRG00000009685","ENSBGRT00000017749",60,"ENSBGRG00000009685","NA","NA","NA",{"v":1.1E-4,"d":"0.00"},1,"990,",0,-3.97,-3.29,15,"Exon (ENSBGRT00000017749/ENSBGRG00000009685, exon 1 of 1)",30,103542879,103543928,1050,2]
["X",103542879,103543868,990,"ENSBGRG00000009685","ENSBGRT00000017749",60,"ENSBGRG00000009685","NA","NA","NA",{"v":1.1E-4,"d":"0.00"},1,"990,",0,-3.97,-3.29,15,"Exon (ENSBGRT00000017749/ENSBGRG00000009685, exon 1 of 1)",30,103542879,103543928,1050,2]
["X",105445064,105446207,1144,"ENSBGRG00000010451","ENSBGRT00000019140",0,"ENSBGRG00000010451","NA","NA","NA",{"v":1.3e-19,"d":"0.00"},3,"814,30,166,","0,912,978",{"v":-18.9,"d":"-18.90"},{"v":-17.9,"d":"-17.90"},8.02,"Exon (ENSBGRT00000019140/ENSBGRG00000010451, exon 1 of 2)",30,105445752,105447570,1819,1]
["X",105686605,105716520,29916,"ENSBGRG00000010500","ENSBGRT00000019223",4006,"ENSBGRG00000010500","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.6E-78,"d":"0.00"},3,"1493,99,22,","0,29509,29894",{"v":-77.8,"d":"-77.80"},{"v":-76.2,"d":"-76.20"},8.22,"Exon (ENSBGRT00000019223/ENSBGRG00000010500, exon 3 of 5)",30,105686605,105720526,33922,2]
["X",107003454,107003573,120,"ENSBGRG00000010653","ENSBGRT00000021643",189920,"ENSBGRG00000010653","lysine demethylase 6A [Source:HGNC Symbol;Acc:HGNC:12637]","GO:0005515(protein binding)","05202(Transcriptional misregulation in cancers)",{"v":0.0022,"d":"0.00"},1,"120,",0,-2.66,-2.05,1.42,"Exon (ENSBGRT00000021643/ENSBGRG00000010653, exon 29 of 30)",30,107002280,107193493,191214,2]
["X",107043227,107049285,6059,"ENSBGRG00000010653","ENSBGRT00000021643",144208,"ENSBGRG00000010653","lysine demethylase 6A [Source:HGNC Symbol;Acc:HGNC:12637]","GO:0005515(protein binding)","05202(Transcriptional misregulation in cancers)",{"v":1.3E-51,"d":"0.00"},3,"670,396,10,","0,5014,6049",{"v":-50.9,"d":"-50.90"},{"v":-49.5,"d":"-49.50"},6.77,"Exon (ENSBGRT00000021643/ENSBGRG00000010653, exon 16 of 30)",30,107002280,107193493,191214,2]
["X",108524861,108558238,33378,"ENSBGRG00000013578","ENSBGRT00000024960",0,"ENSBGRG00000013578","NA","GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00260(Glycine, serine and threonine metabolism);00330(Arginine and proline metabolism);00340(Histidine metabolism);00350(Tyrosine metabolism);00360(Phenylalanine metabolism);00380(Tryptophan metabolism);00982(Drug metabolism - cytochrome P450);04728(Dopaminergic synapse);04726(Serotonergic synapse);05030(Cocaine addiction);05031(Amphetamine addiction);05034(Alcoholism)",{"v":2.5e-22,"d":"0.00"},3,"13,95,1327,","0,13305,32051",{"v":-21.6,"d":"-21.60"},{"v":-20.5,"d":"-20.50"},4.01,"Exon (ENSBGRT00000024960/ENSBGRG00000013578, exon 1 of 16)",30,108441376,108558238,116863,2]
["X",110690079,110690465,387,"ENSBGRG00000013967","ENSBGRT00000025878",259415,"CASK","calcium/calmodulin dependent serine protein kinase [Source:HGNC Symbol;Acc:HGNC:1497]","GO:0001953(negative regulation of cell-matrix adhesion);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005604(basement membrane);GO:0005634(nucleus);GO:0005652(nuclear lamina);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0010839(negative regulation of keratinocyte proliferation);GO:0016020(membrane);GO:0016323(basolateral plasma membrane);GO:0016363(nuclear matrix);GO:0031982(vesicle);GO:0042043(neurexin family protein binding);GO:0045202(synapse);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061045(negative regulation of wound healing);GO:0070509(calcium ion import);GO:0090280(positive regulation of calcium ion import);GO:0090288(negative regulation of cellular response to growth factor stimulus);GO:0098685(Schaffer collateral - CA1 synapse);GO:2000300(regulation of synaptic vesicle exocytosis)","NA",{"v":0.0083,"d":"0.01"},1,"387,",0,-2.08,-1.52,3.41,"Exon (ENSBGRT00000027677/ENSBGRG00000015052, exon 1 of 1)",30,110430664,110850880,420217,1]
["X",111020921,111021308,388,"ENSBGRG00000015328","ENSBGRT00000033557",13262,"DDX3X","DEAD-box helicase 3 X-linked [Source:HGNC Symbol;Acc:HGNC:2745]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003678(DNA helicase activity);GO:0003723(RNA binding);GO:0003724(RNA helicase activity);GO:0003729(mRNA binding);GO:0003924(GTPase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005852(eukaryotic translation initiation factor 3 complex);GO:0005886(plasma membrane);GO:0006413(translational initiation);GO:0007059(chromosome segregation);GO:0008134(transcription factor binding);GO:0008143(poly(A) binding);GO:0008190(eukaryotic initiation factor 4E binding);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0009615(response to virus);GO:0010494(cytoplasmic stress granule);GO:0010501(RNA secondary structure unwinding);GO:0010628(positive regulation of gene expression);GO:0016055(Wnt signaling pathway);GO:0016887(ATPase activity);GO:0017111(nucleoside-triphosphatase activity);GO:0017148(negative regulation of translation);GO:0022627(cytosolic small ribosomal subunit);GO:0030307(positive regulation of cell growth);GO:0030308(negative regulation of cell growth);GO:0031252(cell leading edge);GO:0031333(negative regulation of protein-containing complex assembly);GO:0031369(translation initiation factor binding);GO:0031954(positive regulation of protein autophosphorylation);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0033592(RNA strand annealing activity);GO:0034063(stress granule assembly);GO:0034157(positive regulation of toll-like receptor 7 signaling pathway);GO:0034161(positive regulation of toll-like receptor 8 signaling pathway);GO:0035556(intracellular signal transduction);GO:0035613(RNA stem-loop binding);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042256(mature ribosome assembly);GO:0043015(gamma-tubulin binding);GO:0043024(ribosomal small subunit binding);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043273(CTPase activity);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043539(protein serine/threonine kinase activator activity);GO:0045070(positive regulation of viral genome replication);GO:0045087(innate immune response);GO:0045727(positive regulation of translation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045948(positive regulation of translational initiation);GO:0048027(mRNA 5'-UTR binding);GO:0055088(lipid homeostasis);GO:0071243(cellular response to arsenic-containing substance);GO:0071470(cellular response to osmotic stress);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0097193(intrinsic apoptotic signaling pathway);GO:0098586(cellular response to virus);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1901223(negative regulation of NIK/NF-kappaB signaling);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1901985(positive regulation of protein acetylation);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902523(positive regulation of protein K63-linked ubiquitination);GO:1903608(protein localization to cytoplasmic stress granule);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04622(RIG-I-like receptor signaling pathway);05203(Viral carcinogenesis);05161(Hepatitis B)",{"v":6.3e-69,"d":"0.00"},1,"388,",0,{"v":-68.2,"d":"-68.20"},{"v":-66.6,"d":"-66.60"},1.66,"3' UTR",30,111010406,111034570,24165,2]
["X",111027418,111031746,4329,"ENSBGRG00000015328","ENSBGRT00000033557",2824,"DDX3X","DEAD-box helicase 3 X-linked [Source:HGNC Symbol;Acc:HGNC:2745]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003678(DNA helicase activity);GO:0003723(RNA binding);GO:0003724(RNA helicase activity);GO:0003729(mRNA binding);GO:0003924(GTPase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005852(eukaryotic translation initiation factor 3 complex);GO:0005886(plasma membrane);GO:0006413(translational initiation);GO:0007059(chromosome segregation);GO:0008134(transcription factor binding);GO:0008143(poly(A) binding);GO:0008190(eukaryotic initiation factor 4E binding);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0009615(response to virus);GO:0010494(cytoplasmic stress granule);GO:0010501(RNA secondary structure unwinding);GO:0010628(positive regulation of gene expression);GO:0016055(Wnt signaling pathway);GO:0016887(ATPase activity);GO:0017111(nucleoside-triphosphatase activity);GO:0017148(negative regulation of translation);GO:0022627(cytosolic small ribosomal subunit);GO:0030307(positive regulation of cell growth);GO:0030308(negative regulation of cell growth);GO:0031252(cell leading edge);GO:0031333(negative regulation of protein-containing complex assembly);GO:0031369(translation initiation factor binding);GO:0031954(positive regulation of protein autophosphorylation);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0033592(RNA strand annealing activity);GO:0034063(stress granule assembly);GO:0034157(positive regulation of toll-like receptor 7 signaling pathway);GO:0034161(positive regulation of toll-like receptor 8 signaling pathway);GO:0035556(intracellular signal transduction);GO:0035613(RNA stem-loop binding);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042256(mature ribosome assembly);GO:0043015(gamma-tubulin binding);GO:0043024(ribosomal small subunit binding);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043273(CTPase activity);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043539(protein serine/threonine kinase activator activity);GO:0045070(positive regulation of viral genome replication);GO:0045087(innate immune response);GO:0045727(positive regulation of translation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045948(positive regulation of translational initiation);GO:0048027(mRNA 5'-UTR binding);GO:0055088(lipid homeostasis);GO:0071243(cellular response to arsenic-containing substance);GO:0071470(cellular response to osmotic stress);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0097193(intrinsic apoptotic signaling pathway);GO:0098586(cellular response to virus);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1901223(negative regulation of NIK/NF-kappaB signaling);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1901985(positive regulation of protein acetylation);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902523(positive regulation of protein K63-linked ubiquitination);GO:1903608(protein localization to cytoplasmic stress granule);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04622(RIG-I-like receptor signaling pathway);05203(Viral carcinogenesis);05161(Hepatitis B)",{"v":4e-11,"d":"0.00"},3,"88,48,43,","0,2717,4286",{"v":-10.4,"d":"-10.40"},-9.51,1.39,"Exon (ENSBGRT00000033557/ENSBGRG00000015328, exon 2 of 17)",30,111010406,111034570,24165,2]
["X",111152057,111152487,431,"ENSBGRG00000018694","ENSBGRT00000034455",88012,"USP9X","ubiquitin specific peptidase 9 X-linked [Source:HGNC Symbol;Acc:HGNC:12632]","GO:0001764(neuron migration);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0016579(protein deubiquitination);GO:0030426(growth cone);GO:0030509(BMP signaling pathway);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042752(regulation of circadian rhythm);GO:0048675(axon extension);GO:0050821(protein stabilization);GO:0070410(co-SMAD binding);GO:0071947(protein deubiquitination involved in ubiquitin-dependent protein catabolic process);GO:1901537(positive regulation of DNA demethylation);GO:1990380(Lys48-specific deubiquitinase activity)","NA",{"v":2.8e-09,"d":"0.00"},2,"82,9,","0,422",-8.56,-7.73,2.12,"Exon (ENSBGRT00000034455/ENSBGRG00000018694, exon 44 of 47)",30,111149193,111240499,91307,2]
["X",111162575,111165389,2815,"ENSBGRG00000018694","ENSBGRT00000034455",75110,"USP9X","ubiquitin specific peptidase 9 X-linked [Source:HGNC Symbol;Acc:HGNC:12632]","GO:0001764(neuron migration);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0016579(protein deubiquitination);GO:0030426(growth cone);GO:0030509(BMP signaling pathway);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042752(regulation of circadian rhythm);GO:0048675(axon extension);GO:0050821(protein stabilization);GO:0070410(co-SMAD binding);GO:0071947(protein deubiquitination involved in ubiquitin-dependent protein catabolic process);GO:1901537(positive regulation of DNA demethylation);GO:1990380(Lys48-specific deubiquitinase activity)","NA",{"v":1E-150,"d":"0.00"},3,"58,668,23,","0,967,2792",-150,-148,7.81,"Exon (ENSBGRT00000034455/ENSBGRG00000018694, exon 35 of 47)",30,111149193,111240499,91307,2]
["X",111209143,111209412,270,"ENSBGRG00000018694","ENSBGRT00000034455",31087,"USP9X","ubiquitin specific peptidase 9 X-linked [Source:HGNC Symbol;Acc:HGNC:12632]","GO:0001764(neuron migration);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0016579(protein deubiquitination);GO:0030426(growth cone);GO:0030509(BMP signaling pathway);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042752(regulation of circadian rhythm);GO:0048675(axon extension);GO:0050821(protein stabilization);GO:0070410(co-SMAD binding);GO:0071947(protein deubiquitination involved in ubiquitin-dependent protein catabolic process);GO:1901537(positive regulation of DNA demethylation);GO:1990380(Lys48-specific deubiquitinase activity)","NA",{"v":1.2E-4,"d":"0.00"},1,"270,",0,-3.92,-3.25,4.01,"Exon (ENSBGRT00000034455/ENSBGRG00000018694, exon 15 of 47)",30,111149193,111240499,91307,2]
["X",111240409,111240499,91,"ENSBGRG00000018694","ENSBGRT00000034455",0,"USP9X","ubiquitin specific peptidase 9 X-linked [Source:HGNC Symbol;Acc:HGNC:12632]","GO:0001764(neuron migration);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0016579(protein deubiquitination);GO:0030426(growth cone);GO:0030509(BMP signaling pathway);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042752(regulation of circadian rhythm);GO:0048675(axon extension);GO:0050821(protein stabilization);GO:0070410(co-SMAD binding);GO:0071947(protein deubiquitination involved in ubiquitin-dependent protein catabolic process);GO:1901537(positive regulation of DNA demethylation);GO:1990380(Lys48-specific deubiquitinase activity)","NA",{"v":0.011,"d":"0.01"},1,"91,",0,-1.97,-1.14,9.03,"5' UTR",30,111149193,111240499,91307,2]
["X",113671372,113673531,2160,"ENSBGRG00000021050","ENSBGRT00000038802",0,"MID1IP1","MID1 interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:20715]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007026(negative regulation of microtubule depolymerization);GO:0008022(protein C-terminus binding);GO:0015630(microtubule cytoskeleton);GO:0042802(identical protein binding);GO:0045723(positive regulation of fatty acid biosynthetic process);GO:0051258(protein polymerization);GO:0051351(positive regulation of ligase activity)","NA",{"v":1E-182,"d":"0.00"},2,"530,430,","0,1730",-182,-180,5.65,"5' UTR",30,113671372,113673531,2160,2]
["X",114716334,114842245,125912,"ENSBGRG00000021997","ENSBGRT00000040740",0,"SYTL5","synaptotagmin like 5 [Source:HGNC Symbol;Acc:HGNC:15589]","GO:0005543(phospholipid binding);GO:0006886(intracellular protein transport);GO:0017137(Rab GTPase binding)","NA",{"v":0.035,"d":"0.04"},4,"420,94,115,88,","0,115730,116206,125824",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"5' UTR",30,114531827,114832654,300828,2]
["X",121107777,121108361,585,"ENSBGRG00000008820","ENSBGRT00000016136",0,"ENSBGRG00000008820","NA","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","03040(Spliceosome);05168(Herpes simplex infection)",{"v":0.00089,"d":"0.00"},1,"585,",0,-3.05,-2.42,13,"Exon (ENSBGRT00000016136/ENSBGRG00000008820, exon 1 of 1)",30,121107777,121108361,585,2]
["X",129916055,129923436,7382,"ENSBGRG00000011903","ENSBGRT00000022455",538,"POLA1","DNA polymerase alpha 1, catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9173]","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005658(alpha DNA polymerase:primase complex);GO:0005829(cytosol);GO:0006260(DNA replication)","00230(Purine metabolism);00240(Pyrimidine metabolism);03030(DNA replication)",{"v":0.004,"d":"0.00"},3,"18,125,67,","0,2442,7315",{"v":-2.4,"d":"-2.40"},-1.82,2.63,"5' UTR",30,129591579,129923974,332396,2]
["X",130493202,130494192,991,"ENSBGRG00000013130","ENSBGRT00000024173",16003,"ZFX","zinc finger protein X-linked [Source:HGNC Symbol;Acc:HGNC:12869]","GO:0001541(ovarian follicle development);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0009566(fertilization);GO:0009791(post-embryonic development);GO:0035264(multicellular organism growth);GO:0046872(metal ion binding);GO:0048599(oocyte development);GO:0048872(homeostasis of number of cells);GO:0060746(parental behavior)","NA",{"v":6.3e-40,"d":"0.00"},2,"232,248,","0,743",{"v":-39.2,"d":"-39.20"},{"v":-37.9,"d":"-37.90"},6.94,"Exon (ENSBGRT00000024173/ENSBGRG00000013130, exon 7 of 8)",30,130493202,130510195,16994,2]
["X",130494282,130497092,2811,"ENSBGRG00000013130","ENSBGRT00000024173",13103,"ZFX","zinc finger protein X-linked [Source:HGNC Symbol;Acc:HGNC:12869]","GO:0001541(ovarian follicle development);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0009566(fertilization);GO:0009791(post-embryonic development);GO:0035264(multicellular organism growth);GO:0046872(metal ion binding);GO:0048599(oocyte development);GO:0048872(homeostasis of number of cells);GO:0060746(parental behavior)","NA",{"v":7.9e-37,"d":"0.00"},2,"615,75,","0,2736",{"v":-36.1,"d":"-36.10"},{"v":-34.9,"d":"-34.90"},5.19,"Exon (ENSBGRT00000024173/ENSBGRG00000013130, exon 6 of 8)",30,130493202,130510195,16994,2]
["X",130509733,130509883,151,"ENSBGRG00000013130","ENSBGRT00000024173",312,"ZFX","zinc finger protein X-linked [Source:HGNC Symbol;Acc:HGNC:12869]","GO:0001541(ovarian follicle development);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0009566(fertilization);GO:0009791(post-embryonic development);GO:0035264(multicellular organism growth);GO:0046872(metal ion binding);GO:0048599(oocyte development);GO:0048872(homeostasis of number of cells);GO:0060746(parental behavior)","NA",{"v":0.023,"d":"0.02"},1,"151,",0,-1.64,-1.11,3.34,"Exon (ENSBGRT00000024173/ENSBGRG00000013130, exon 2 of 8)",30,130493202,130510195,16994,2]
["X",130509972,130510195,224,"ENSBGRG00000013130","ENSBGRT00000024173",0,"ZFX","zinc finger protein X-linked [Source:HGNC Symbol;Acc:HGNC:12869]","GO:0001541(ovarian follicle development);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0009566(fertilization);GO:0009791(post-embryonic development);GO:0035264(multicellular organism growth);GO:0046872(metal ion binding);GO:0048599(oocyte development);GO:0048872(homeostasis of number of cells);GO:0060746(parental behavior)","NA",{"v":7.6e-05,"d":"0.00"},2,"94,87,","0,137",-4.12,-3.43,7.35,"Exon (ENSBGRT00000024173/ENSBGRG00000013130, exon 1 of 8)",30,130493202,130510195,16994,2]
["X",130718124,130721717,3594,"ENSBGRG00000007185","ENSBGRT00000013212",20005,"CXorf58","chromosome X open reading frame 58 [Source:HGNC Symbol;Acc:HGNC:26356]","NA","NA",{"v":0.038,"d":"0.04"},3,"46,163,28,","0,1010,3566",-1.42,{"v":-0.915,"d":"-0.92"},3.01,"Exon (ENSBGRT00000013212/ENSBGRG00000007185, exon 7 of 9)",30,130717621,130741722,24102,2]
["X",130849473,130849712,240,"ENSBGRG00000007508","ENSBGRT00000014008",2505,"SAT1","spermidine/spermine N1-acetyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10540]","GO:0001525(angiogenesis);GO:0004145(diamine N-acetyltransferase activity);GO:0005515(protein binding);GO:0008080(N-acetyltransferase activity);GO:0042802(identical protein binding)","00330(Arginine and proline metabolism);04216(Ferroptosis)",{"v":2.5e-18,"d":"0.00"},1,"240,",0,{"v":-17.6,"d":"-17.60"},{"v":-16.6,"d":"-16.60"},2.12,"3' UTR",30,130849473,130852217,2745,2]
["X",130939888,130940098,211,"ENSBGRG00000008322","ENSBGRT00000015156",18733,"PRDX4","peroxiredoxin 4 [Source:HGNC Symbol;Acc:HGNC:17169]","GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0007283(spermatogenesis);GO:0008584(male gonad development);GO:0016209(antioxidant activity);GO:0016491(oxidoreductase activity);GO:0018401(peptidyl-proline hydroxylation to 4-hydroxy-L-proline);GO:0022417(protein maturation by protein folding);GO:0030198(extracellular matrix organization);GO:0045454(cell redox homeostasis);GO:0051920(peroxiredoxin activity);GO:0055114(oxidation-reduction process);GO:0072593(reactive oxygen species metabolic process);GO:2000255(negative regulation of male germ cell proliferation)","NA",{"v":0.028,"d":"0.03"},1,"211,",0,-1.55,-1.03,6.02,"3' UTR",30,130939888,130958831,18944,2]
["X",130940488,130940608,121,"ENSBGRG00000008322","ENSBGRT00000015156",18223,"PRDX4","peroxiredoxin 4 [Source:HGNC Symbol;Acc:HGNC:17169]","GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0007283(spermatogenesis);GO:0008584(male gonad development);GO:0016209(antioxidant activity);GO:0016491(oxidoreductase activity);GO:0018401(peptidyl-proline hydroxylation to 4-hydroxy-L-proline);GO:0022417(protein maturation by protein folding);GO:0030198(extracellular matrix organization);GO:0045454(cell redox homeostasis);GO:0051920(peroxiredoxin activity);GO:0055114(oxidation-reduction process);GO:0072593(reactive oxygen species metabolic process);GO:2000255(negative regulation of male germ cell proliferation)","NA",{"v":0.046,"d":"0.05"},1,"121,",0,-1.34,{"v":-0.843,"d":"-0.84"},3.34,"3' UTR",30,130939888,130958831,18944,2]
["X",130944056,130944386,331,"ENSBGRG00000008322","ENSBGRT00000015156",14445,"PRDX4","peroxiredoxin 4 [Source:HGNC Symbol;Acc:HGNC:17169]","GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0007283(spermatogenesis);GO:0008584(male gonad development);GO:0016209(antioxidant activity);GO:0016491(oxidoreductase activity);GO:0018401(peptidyl-proline hydroxylation to 4-hydroxy-L-proline);GO:0022417(protein maturation by protein folding);GO:0030198(extracellular matrix organization);GO:0045454(cell redox homeostasis);GO:0051920(peroxiredoxin activity);GO:0055114(oxidation-reduction process);GO:0072593(reactive oxygen species metabolic process);GO:2000255(negative regulation of male germ cell proliferation)","NA",{"v":6e-07,"d":"0.00"},2,"75,45,","0,286",-6.22,-5.46,1.34,"3' UTR",30,130939888,130958831,18944,2]
["X",131286098,131286847,750,"ENSBGRG00000008455","ENSBGRT00000015371",55406,"PTCHD1","patched domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26392]","GO:0005886(plasma membrane);GO:0007224(smoothened signaling pathway);GO:0007614(short-term memory);GO:0007616(long-term memory);GO:0016021(integral component of membrane);GO:0021794(thalamus development);GO:0035176(social behavior);GO:0045202(synapse);GO:0050890(cognition);GO:0098976(excitatory chemical synaptic transmission);GO:0098977(inhibitory chemical synaptic transmission)","04142(Lysosome)",{"v":0.00089,"d":"0.00"},1,"750,",0,-3.05,-2.42,13,"Exon (ENSBGRT00000015371/ENSBGRG00000008455, exon 3 of 3)",30,131286098,131342253,56156,2]
["X",131287057,131287356,300,"ENSBGRG00000008455","ENSBGRT00000015371",54897,"PTCHD1","patched domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26392]","GO:0005886(plasma membrane);GO:0007224(smoothened signaling pathway);GO:0007614(short-term memory);GO:0007616(long-term memory);GO:0016021(integral component of membrane);GO:0021794(thalamus development);GO:0035176(social behavior);GO:0045202(synapse);GO:0050890(cognition);GO:0098976(excitatory chemical synaptic transmission);GO:0098977(inhibitory chemical synaptic transmission)","04142(Lysosome)",{"v":0.00065,"d":"0.00"},1,"300,",0,-3.19,-2.55,11,"Exon (ENSBGRT00000015371/ENSBGRG00000008455, exon 3 of 3)",30,131286098,131342253,56156,2]
["X",132962871,132964347,1477,"ENSBGRG00000008940","ENSBGRT00000016380",28242,"SMS","spermine synthase [Source:HGNC Symbol;Acc:HGNC:11123]","GO:0006597(spermine biosynthetic process);GO:0008215(spermine metabolic process);GO:0016768(spermine synthase activity)","00270(Cysteine and methionine metabolism);00330(Arginine and proline metabolism);00410(beta-Alanine metabolism);00480(Glutathione metabolism)",{"v":4.5e-07,"d":"0.00"},2,"36,24,","0,1453",-6.35,-5.58,1.81,"Exon (ENSBGRT00000016380/ENSBGRG00000008940, exon 3 of 11)",30,132934992,132992589,57598,2]
["X",133054450,133054748,299,"ENSBGRG00000009064","ENSBGRT00000016882",51588,"MBTPS2","membrane bound transcription factor peptidase, site 2 [Source:HGNC Symbol;Acc:HGNC:15455]","GO:0004222(metalloendopeptidase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0016020(membrane);GO:0031293(membrane protein intracellular domain proteolysis);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0070977(bone maturation);GO:1990440(positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04141(Protein processing in endoplasmic reticulum)",{"v":5e-19,"d":"0.00"},1,"299,",0,{"v":-18.3,"d":"-18.30"},{"v":-17.3,"d":"-17.30"},8.02,"3' UTR",30,133054450,133106336,51887,2]
["X",133079485,133080965,1481,"ENSBGRG00000009064","ENSBGRT00000016882",25371,"MBTPS2","membrane bound transcription factor peptidase, site 2 [Source:HGNC Symbol;Acc:HGNC:15455]","GO:0004222(metalloendopeptidase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0016020(membrane);GO:0031293(membrane protein intracellular domain proteolysis);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0070977(bone maturation);GO:1990440(positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04141(Protein processing in endoplasmic reticulum)",{"v":5e-57,"d":"0.00"},2,"702,181,","0,1300",{"v":-56.3,"d":"-56.30"},{"v":-54.9,"d":"-54.90"},{"v":12.8,"d":"12.80"},"Exon (ENSBGRT00000017019/ENSBGRG00000009234, exon 1 of 2)",30,133054450,133106336,51887,2]
["X",133081024,133081083,60,"ENSBGRG00000009064","ENSBGRT00000016882",25253,"MBTPS2","membrane bound transcription factor peptidase, site 2 [Source:HGNC Symbol;Acc:HGNC:15455]","GO:0004222(metalloendopeptidase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0016020(membrane);GO:0031293(membrane protein intracellular domain proteolysis);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0070977(bone maturation);GO:1990440(positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04141(Protein processing in endoplasmic reticulum)",{"v":0.018,"d":"0.02"},1,"60,",0,-1.75,-1.22,1.81,"Exon (ENSBGRT00000017019/ENSBGRG00000009234, exon 1 of 2)",30,133054450,133106336,51887,2]
["X",133081171,133081318,148,"ENSBGRG00000009234","ENSBGRT00000017019",0,"ENSBGRG00000009234","NA","GO:0003676(nucleic acid binding)","NA",0.02,1,"148,",0,-1.69,-1.16,3.01,"Exon (ENSBGRT00000017019/ENSBGRG00000009234, exon 1 of 2)",30,133079485,133081318,1834,2]
["X",133310495,133361535,51041,"ENSBGRG00000009403","ENSBGRT00000017518",256366,"CNKSR2","connector enhancer of kinase suppressor of Ras 2 [Source:HGNC Symbol;Acc:HGNC:19701]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0009966(regulation of signal transduction);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0019901(protein kinase binding);GO:0035556(intracellular signal transduction)","NA",{"v":7.4e-06,"d":"0.00"},4,"115,5,553,15,","0,7312,48012,51026",-5.13,-4.41,8.69,"Exon (ENSBGRT00000017518/ENSBGRG00000009403, exon 19 of 22)",30,133307182,133617901,310720,2]
["X",135651062,135651597,536,"ENSBGRG00000014128","ENSBGRT00000026657",22403,"PDHA1","pyruvate dehydrogenase E1 alpha 1 subunit [Source:HGNC Symbol;Acc:HGNC:8806]","GO:0004739(pyruvate dehydrogenase (acetyl-transferring) activity);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0006086(acetyl-CoA biosynthetic process from pyruvate);GO:0016624(oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor);GO:0043231(intracellular membrane-bounded organelle);GO:0045254(pyruvate dehydrogenase complex)","00010(Glycolysis / Gluconeogenesis);00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);04066(HIF-1 signaling pathway);04922(Glucagon signaling pathway);05230(Central carbon metabolism in cancer)",{"v":2e-75,"d":"0.00"},1,"536,",0,{"v":-74.7,"d":"-74.70"},{"v":-73.1,"d":"-73.10"},2.55,"3' UTR",30,135651062,135674000,22939,2]
["Y",1626709,1626997,289,"ENSBGRG00000016666","ENSBGRT00000030700",11052,"ENSBGRG00000016666","NA","NA","NA",{"v":0.0058,"d":"0.01"},1,"289,",0,-2.24,-1.66,4.51,"Exon (ENSBGRT00000030765/ENSBGRG00000016770, exon 1 of 1)",31,1612302,1638049,25748,2]
["Y",1946519,1947117,599,"ENSBGRG00000016807","ENSBGRT00000030832",5187,"ENSBGRG00000016807","NA","NA","NA",{"v":0.019,"d":"0.02"},1,"599,",0,-1.71,{"v":-0.901,"d":"-0.90"},8.02,"Exon (ENSBGRT00000030832/ENSBGRG00000016807, exon 3 of 3)",31,1941332,1947834,6503,1]
["Y",2480417,2481014,598,"ENSBGRG00000017134","ENSBGRT00000031412",0,"ENSBGRG00000017134","NA","NA","NA",{"v":0.019,"d":"0.02"},1,"598,",0,-1.71,{"v":-0.978,"d":"-0.98"},8.02,"Exon (ENSBGRT00000031412/ENSBGRG00000017134, exon 1 of 2)",31,2480417,2486697,6281,1]
["Y",2481193,2483593,2401,"ENSBGRG00000017134","ENSBGRT00000031412",776,"ENSBGRG00000017134","NA","NA","NA",{"v":0.0095,"d":"0.01"},2,"261,845,","0,1556",-2.02,-1.47,8.02,"Exon (ENSBGRT00000031412/ENSBGRG00000017134, exon 1 of 2)",31,2480417,2486697,6281,1]
["Y",2484548,2484846,299,"ENSBGRG00000017134","ENSBGRT00000031412",4131,"ENSBGRG00000017134","NA","NA","NA",{"v":0.0012,"d":"0.00"},1,"299,",0,-2.91,-2.29,5.35,"Exon (ENSBGRT00000031412/ENSBGRG00000017134, exon 2 of 2)",31,2480417,2486697,6281,1]
["Y",3931211,3931361,151,"ENSBGRG00000017714","ENSBGRT00000032448",81346,"ENSBGRG00000017714","NA","GO:0016787(hydrolase activity)","NA",{"v":0.0093,"d":"0.01"},1,"151,",0,-2.03,-1.47,{"v":1.5,"d":"1.50"},"3' UTR",31,3849865,3931719,81855,1]
["Y",5088133,5088193,61,"ENSBGRG00000017805","ENSBGRT00000032748",410408,"ENSBGRG00000017805","NA","GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0016020(membrane);GO:0042043(neurexin family protein binding);GO:0045202(synapse);GO:0050808(synapse organization)","04514(Cell adhesion molecules (CAMs))",{"v":0.019,"d":"0.02"},1,"61,",0,-1.72,-1.19,5.01,"Exon (ENSBGRT00000032748/ENSBGRG00000017805, exon 6 of 7)",31,4677725,5102679,424955,1]
["Y",5088253,5101482,13230,"ENSBGRG00000017805","ENSBGRT00000032748",410528,"ENSBGRG00000017805","NA","GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0016020(membrane);GO:0042043(neurexin family protein binding);GO:0045202(synapse);GO:0050808(synapse organization)","04514(Cell adhesion molecules (CAMs))",{"v":0.017,"d":"0.02"},2,"293,97,","0,13133",-1.77,-1.23,3.68,"Exon (ENSBGRT00000032748/ENSBGRG00000017805, exon 6 of 7)",31,4677725,5102679,424955,1]
["Y",5102170,5102290,121,"ENSBGRG00000017805","ENSBGRT00000032748",424445,"ENSBGRG00000017805","NA","GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0016020(membrane);GO:0042043(neurexin family protein binding);GO:0045202(synapse);GO:0050808(synapse organization)","04514(Cell adhesion molecules (CAMs))",{"v":0.017,"d":"0.02"},1,"121,",0,-1.77,-1.23,2.84,"3' UTR",31,4677725,5102679,424955,1]
["Y",6961450,6974585,13136,"ENSBGRG00000018435","ENSBGRT00000033769",60471,"ENSBGRG00000018435","NA","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA",{"v":1E-10,"d":"0.00"},6,"50,96,58,78,149,404,","0,1235,5386,7286,11582,12732",-10,-9.14,10,"3' UTR",31,6900979,6975181,74203,1]
["Y",7141164,7141253,90,"ENSBGRG00000018981","ENSBGRT00000034786",0,"ENSBGRG00000018981","NA","GO:0003824(catalytic activity);GO:0008484(sulfuric ester hydrolase activity)","NA",{"v":3.5E-4,"d":"0.00"},1,"90,",0,-3.45,-2.79,11,"5' UTR",31,7141164,7148026,6863,1]
["Y",7146927,7147076,150,"ENSBGRG00000018584","ENSBGRT00000034448",32987,"ENSBGRG00000018584","NA","GO:0016757(transferase activity, transferring glycosyl groups)","00500(Starch and sucrose metabolism)",{"v":0.0046,"d":"0.00"},1,"150,",0,-2.34,-1.76,2.27,"Exon (ENSBGRT00000034786/ENSBGRG00000018981, exon 3 of 3)",31,7122200,7180063,57864,2]
["Y",7147135,7148026,892,"ENSBGRG00000018584","ENSBGRT00000034448",32037,"ENSBGRG00000018584","NA","GO:0016757(transferase activity, transferring glycosyl groups)","00500(Starch and sucrose metabolism)",{"v":3.2e-33,"d":"0.00"},1,"892,",0,{"v":-32.5,"d":"-32.50"},{"v":-31.3,"d":"-31.30"},{"v":6.6,"d":"6.60"},"3' UTR",31,7122200,7180063,57864,2]
["Y",7519823,7526934,7112,"ENSBGRG00000019175","ENSBGRT00000035211",169718,"ENSBGRG00000019175","dehydrogenase/reductase X-linked [Source:HGNC Symbol;Acc:HGNC:18399]","GO:0016491(oxidoreductase activity)","NA",{"v":1.9e-10,"d":"0.00"},2,"87,661,","0,6451",-9.73,-8.88,5.01,"3' UTR",31,7350105,7527273,177169,1]
["Y",7527113,7566420,39308,"ENSBGRG00000019175","ENSBGRT00000035211",177008,"ENSBGRG00000019175","dehydrogenase/reductase X-linked [Source:HGNC Symbol;Acc:HGNC:18399]","GO:0016491(oxidoreductase activity)","NA",{"v":0.017,"d":"0.02"},2,"161,79,","0,39229",-1.78,-1.24,1.71,"3' UTR",31,7350105,7527273,177169,1]
["Y",7566748,7566987,240,"ENSBGRG00000019175","ENSBGRT00000035334",158949,"ENSBGRG00000019175","dehydrogenase/reductase X-linked [Source:HGNC Symbol;Acc:HGNC:18399]","GO:0016491(oxidoreductase activity)","NA",{"v":0.017,"d":"0.02"},1,"240,",0,-1.76,-1.22,2.01,"3' UTR",31,7407799,7567345,159547,1]
["Y",7369062,7370706,1645,"ENSBGRG00000019175","ENSBGRT00000035289",18957,"ENSBGRG00000019175","dehydrogenase/reductase X-linked [Source:HGNC Symbol;Acc:HGNC:18399]","GO:0016491(oxidoreductase activity)","NA",{"v":2e-47,"d":"0.00"},2,"851,792,","0,853",{"v":-46.7,"d":"-46.70"},{"v":-45.4,"d":"-45.40"},{"v":24.1,"d":"24.10"},"Exon (ENSBGRT00000035505/ENSBGRG00000019303, exon 1 of 2)",31,7350105,7480052,129948,1]
["Y",7921127,7921866,740,"ENSBGRG00000019508","ENSBGRT00000035846",325,"P2RY8","P2Y receptor family member 8 [Source:HGNC Symbol;Acc:HGNC:15524]","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0045028(G protein-coupled purinergic nucleotide receptor activity)","04080(Neuroactive ligand-receptor interaction)",{"v":0.0058,"d":"0.01"},1,"740,",0,-2.24,-1.66,10,"Exon (ENSBGRT00000035846/ENSBGRG00000019508, exon 1 of 1)",31,7920802,7921866,1065,1]
["Y",7947545,7948205,661,"ENSBGRG00000007075","ENSBGRT00000013054",20065,"ASMTL","acetylserotonin O-methyltransferase like [Source:HGNC Symbol;Acc:HGNC:751]","GO:0005829(cytosol);GO:0008171(O-methyltransferase activity);GO:0047429(nucleoside-triphosphate diphosphatase activity)","NA",{"v":4.6e-08,"d":"0.00"},1,"661,",0,-7.34,-6.54,4.08,"3' UTR",31,7927480,7948714,21235,1]
["Y",7948265,7948414,150,"ENSBGRG00000007075","ENSBGRT00000013054",20785,"ASMTL","acetylserotonin O-methyltransferase like [Source:HGNC Symbol;Acc:HGNC:751]","GO:0005829(cytosol);GO:0008171(O-methyltransferase activity);GO:0047429(nucleoside-triphosphate diphosphatase activity)","NA",{"v":0.019,"d":"0.02"},1,"150,",0,-1.71,-1.18,1.94,"3' UTR",31,7927480,7948714,21235,1]
["Y",7957890,7958039,150,"ENSBGRG00000007164","ENSBGRT00000013197",3541,"SLC25A6","solute carrier family 25 member 6 [Source:HGNC Symbol;Acc:HGNC:10992]","GO:0005347(ATP transmembrane transporter activity);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04217(Necroptosis);04218(Cellular senescence);05012(Parkinson disease);05016(Huntington disease);05166(HTLV-I infection);05164(Influenza A)",{"v":6.3E-3,"d":"0.01"},1,"150,",0,{"v":-2.2,"d":"-2.20"},-1.63,8.02,"Exon (ENSBGRT00000013197/ENSBGRG00000007164, exon 3 of 3)",31,7954349,7958089,3741,1]
["Y",8706633,8706872,240,"ENSBGRG00000007677","ENSBGRT00000014083",60,"ENSBGRG00000007677","NA","GO:0005509(calcium ion binding)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);05165(Human papillomavirus infection)",{"v":0.0013,"d":"0.00"},1,"240,",0,{"v":-2.9,"d":"-2.90"},-2.28,4.76,"5' UTR",31,8706573,8755308,48736,1]
["Y",8753729,8755278,1550,"ENSBGRG00000007677","ENSBGRT00000014083",47156,"ENSBGRG00000007677","NA","GO:0005509(calcium ion binding)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);05165(Human papillomavirus infection)",{"v":7.9e-06,"d":"0.00"},3,"40,107,630,","0,142,920",{"v":-5.1,"d":"-5.10"},-4.37,3.72,"3' UTR",31,8706573,8755308,48736,1]
["Y",8761040,8761189,150,"ENSBGRG00000007868","ENSBGRT00000014695",209,"GTPBP6","GTP binding protein 6 (putative) [Source:HGNC Symbol;Acc:HGNC:30189]","GO:0005525(GTP binding)","00250(Alanine, aspartate and glutamate metabolism)",{"v":0.017,"d":"0.02"},1,"150,",0,-1.76,-1.22,1.77,"Exon (ENSBGRT00000014695/ENSBGRG00000007868, exon 1 of 9)",31,8760831,8770231,9401,1]
["Y",8778267,8779813,1547,"ENSBGRG00000007868","ENSBGRT00000014467",17436,"GTPBP6","GTP binding protein 6 (putative) [Source:HGNC Symbol;Acc:HGNC:30189]","GO:0005525(GTP binding)","00250(Alanine, aspartate and glutamate metabolism)",{"v":1e-149,"d":"0.00"},2,"779,148,","0,1399",-149,-147,{"v":11.9,"d":"11.90"},"3' UTR",31,8760831,8779045,18215,1]
["Y",9036027,9037287,1261,"ENSBGRG00000008199","ENSBGRT00000015012",50882,"WWC3","WWC family member 3 [Source:HGNC Symbol;Acc:HGNC:29237]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005829(cytosol);GO:0019900(kinase binding);GO:0035331(negative regulation of hippo signaling);GO:0046621(negative regulation of organ growth);GO:0060090(molecular adaptor activity)","04390(Hippo signaling pathway);04392(Hippo signaling pathway - multiple species)",{"v":6.3E-5,"d":"0.00"},2,"3,475,","0,786",{"v":-4.2,"d":"-4.20"},-3.52,2.79,"Exon (ENSBGRT00000015012/ENSBGRG00000008199, exon 11 of 24)",31,8985145,9064380,79236,1]
["Y",9146015,9164412,18398,"ENSBGRG00000008267","ENSBGRT00000015182",59843,"CLCN4","chloride voltage-gated channel 4 [Source:HGNC Symbol;Acc:HGNC:2022]","GO:0005247(voltage-gated chloride channel activity);GO:0005254(chloride channel activity);GO:0005765(lysosomal membrane);GO:0005789(endoplasmic reticulum membrane);GO:0006821(chloride transport);GO:0010008(endosome membrane);GO:0015297(antiporter activity);GO:0016020(membrane);GO:0055037(recycling endosome);GO:0055085(transmembrane transport)","NA",{"v":0.012,"d":"0.01"},3,"145,217,178,","0,8417,18220",-1.93,-1.38,4.51,"3' UTR",31,9086172,9164412,78241,1]
["Y",10094974,10121366,26393,"ENSBGRG00000008638","ENSBGRT00000015817",12952,"EGFL6","EGF like domain multiple 6 [Source:HGNC Symbol;Acc:HGNC:3235]","GO:0005178(integrin binding);GO:0005509(calcium ion binding);GO:0010811(positive regulation of cell-substrate adhesion);GO:0016020(membrane)","NA",{"v":0.0021,"d":"0.00"},2,"157,21,","0,26372",-2.67,-2.07,5.52,"Exon (ENSBGRT00000015817/ENSBGRG00000008638, exon 3 of 10)",31,10082022,10139772,57751,1]
["Y",10176600,10177425,826,"ENSBGRG00000008725","ENSBGRT00000015941",463,"ENSBGRG00000008725","NA","GO:0005634(nucleus);GO:0006351(transcription, DNA-templated)","NA",{"v":4e-28,"d":"0.00"},3,"503,13,222,","0,538,604",{"v":-27.4,"d":"-27.40"},{"v":-26.3,"d":"-26.30"},6.45,"Exon (ENSBGRT00000015941/ENSBGRG00000008725, exon 2 of 4)",31,10176137,10177425,1289,1]
["Y",10201480,10217895,16416,"ENSBGRG00000008752","ENSBGRT00000015974",0,"ENSBGRG00000008752","NA","NA","NA",{"v":1.3E-14,"d":"0.00"},3,"898,139,160,","0,1106,16256",{"v":-13.9,"d":"-13.90"},{"v":-12.9,"d":"-12.90"},4.76,"Exon (ENSBGRT00000015974/ENSBGRG00000008752, exon 1 of 3)",31,10201480,10218015,16536,1]
["Y",10222965,10223570,606,"ENSBGRG00000008766","ENSBGRT00000016019",0,"RAB9A","RAB9A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9792]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005764(lysosome);GO:0005770(late endosome);GO:0019003(GDP binding);GO:0030659(cytoplasmic vesicle membrane);GO:0032482(Rab protein signal transduction);GO:0032880(regulation of protein localization);GO:0042470(melanosome);GO:0042802(identical protein binding);GO:0045335(phagocytic vesicle);GO:0045921(positive regulation of exocytosis);GO:0052405(negative regulation by host of symbiont molecular function)","05162(Measles)",{"v":1e-32,"d":"0.00"},1,"606,",0,-32,{"v":-30.8,"d":"-30.80"},5.31,"Exon (ENSBGRT00000016019/ENSBGRG00000008766, exon 1 of 1)",31,10222965,10223570,606,1]
["Y",10301499,10301648,150,"ENSBGRG00000008898","ENSBGRT00000017127",55460,"ENSBGRG00000008898","NA","GO:0005515(protein binding)","NA",{"v":0.0032,"d":"0.00"},1,"150,",0,-2.49,-1.89,2.05,"Exon (ENSBGRT00000017127/ENSBGRG00000008898, exon 17 of 25)",31,10246039,10316103,70065,1]
["Y",10314363,10315683,1321,"ENSBGRG00000008898","ENSBGRT00000017127",68324,"ENSBGRG00000008898","NA","GO:0005515(protein binding)","NA",{"v":2.8e-10,"d":"0.00"},3,"74,159,65,","0,559,1256",-9.56,-8.71,3.79,"Exon (ENSBGRT00000017127/ENSBGRG00000008898, exon 22 of 25)",31,10246039,10316103,70065,1]
["Y",12494973,12499844,4872,"ENSBGRG00000012055","ENSBGRT00000022103",7642,"CA5B","carbonic anhydrase 5B [Source:HGNC Symbol;Acc:HGNC:1378]","GO:0004089(carbonate dehydratase activity);GO:0005739(mitochondrion);GO:0008270(zinc ion binding);GO:0009617(response to bacterium)","00910(Nitrogen metabolism)",{"v":2.5e-16,"d":"0.00"},4,"178,198,119,15,","0,849,3690,4857",{"v":-15.6,"d":"-15.60"},{"v":-14.7,"d":"-14.70"},8.02,"3' UTR",31,12487331,12495150,7820,1]
["Y",12512086,12527663,15578,"ENSBGRG00000012125","ENSBGRT00000022170",0,"ENSBGRG00000012125","zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 [Source:HGNC Symbol;Acc:HGNC:23019]","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0046872(metal ion binding);GO:0089701(U2AF)","03040(Spliceosome)",{"v":2.5e-17,"d":"0.00"},7,"384,80,91,109,87,39,68,","0,774,4321,9575,10976,14883,15510",{"v":-16.6,"d":"-16.60"},{"v":-15.6,"d":"-15.60"},{"v":3.1,"d":"3.10"},"5' UTR",31,12512086,12538082,25997,1]
["Y",12534913,12538082,3170,"ENSBGRG00000012125","ENSBGRT00000022170",22827,"ENSBGRG00000012125","zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 [Source:HGNC Symbol;Acc:HGNC:23019]","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0046872(metal ion binding);GO:0089701(U2AF)","03040(Spliceosome)",{"v":1e-148,"d":"0.00"},3,"18,458,27,","0,2682,3143",-148,-146,9.96,"Exon (ENSBGRT00000022170/ENSBGRG00000012125, exon 10 of 12)",31,12512086,12538082,25997,1]
["Y",13565373,13565432,60,"ENSBGRG00000012637","ENSBGRT00000023254",18229,"SYAP1","synapse associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16273]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0030424(axon);GO:0030425(dendrite);GO:0030426(growth cone);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032869(cellular response to insulin stimulus);GO:0036120(cellular response to platelet-derived growth factor stimulus);GO:0038203(TORC2 signaling);GO:0042734(presynaptic membrane);GO:0043204(perikaryon);GO:0045211(postsynaptic membrane);GO:0045600(positive regulation of fat cell differentiation);GO:0048471(perinuclear region of cytoplasm);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:1990314(cellular response to insulin-like growth factor stimulus)","NA",{"v":3.9e-07,"d":"0.00"},1,"60,",0,-6.41,-5.64,{"v":25.1,"d":"25.10"},"Exon (ENSBGRT00000023254/ENSBGRG00000012637, exon 10 of 10)",31,13547144,13565432,18289,1]
["Y",13611694,13635813,24120,"ENSBGRG00000012780","ENSBGRT00000023592",59,"TXLNG","taxilin gamma [Source:HGNC Symbol;Acc:HGNC:18578]","GO:0005829(cytosol);GO:0008134(transcription factor binding);GO:0010564(regulation of cell cycle process);GO:0019905(syntaxin binding);GO:0030500(regulation of bone mineralization);GO:0031965(nuclear membrane);GO:0033613(activating transcription factor binding);GO:0051726(regulation of cell cycle)","NA",{"v":0.0091,"d":"0.01"},3,"43,304,9,","0,21362,24111",-2.04,-1.48,1.87,"Exon (ENSBGRT00000023592/ENSBGRG00000012780, exon 1 of 10)",31,13611635,13655116,43482,1]
["Y",13642738,13654968,12231,"ENSBGRG00000012780","ENSBGRT00000023592",31103,"TXLNG","taxilin gamma [Source:HGNC Symbol;Acc:HGNC:18578]","GO:0005829(cytosol);GO:0008134(transcription factor binding);GO:0010564(regulation of cell cycle process);GO:0019905(syntaxin binding);GO:0030500(regulation of bone mineralization);GO:0031965(nuclear membrane);GO:0033613(activating transcription factor binding);GO:0051726(regulation of cell cycle)","NA",{"v":4e-25,"d":"0.00"},6,"6,120,75,93,96,143,","0,2515,4252,9513,11136,12088",{"v":-24.4,"d":"-24.40"},{"v":-23.3,"d":"-23.30"},4.19,"Exon (ENSBGRT00000023592/ENSBGRG00000012780, exon 5 of 10)",31,13611635,13655116,43482,1]
["Y",14360228,14360708,481,"ENSBGRG00000014125","ENSBGRT00000026136",0,"NHS","NHS actin remodeling regulator [Source:HGNC Symbol;Acc:HGNC:7820]","GO:0002088(lens development in camera-type eye);GO:0005794(Golgi apparatus);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030154(cell differentiation)","NA",{"v":0.011,"d":"0.01"},1,"481,",0,-1.97,-1.14,9.03,"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 1 of 11)",31,14360228,14767640,407413,1]
["Y",14717727,14755699,37973,"ENSBGRG00000014345","ENSBGRT00000026350",0,"ENSBGRG00000014345","NA","NA","NA",0.02,3,"85,63,63,","0,35851,37910",-1.69,-1.16,3.01,"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 3 of 11)",31,14738716,14740161,1446,2]
["Y",14760310,14760430,121,"ENSBGRG00000014125","ENSBGRT00000026136",400082,"NHS","NHS actin remodeling regulator [Source:HGNC Symbol;Acc:HGNC:7820]","GO:0002088(lens development in camera-type eye);GO:0005794(Golgi apparatus);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030154(cell differentiation)","NA",{"v":0.00068,"d":"0.00"},1,"121,",0,-3.17,-2.53,2.78,"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 7 of 11)",31,14360228,14767640,407413,1]
["Y",14760940,14761659,720,"ENSBGRG00000014125","ENSBGRT00000026136",400712,"NHS","NHS actin remodeling regulator [Source:HGNC Symbol;Acc:HGNC:7820]","GO:0002088(lens development in camera-type eye);GO:0005794(Golgi apparatus);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030154(cell differentiation)","NA",{"v":1e-12,"d":"0.00"},1,"720,",0,-12,{"v":-11.1,"d":"-11.10"},6.65,"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 7 of 11)",31,14360228,14767640,407413,1]
["Y",14763417,14763597,181,"ENSBGRG00000014125","ENSBGRT00000026136",403189,"NHS","NHS actin remodeling regulator [Source:HGNC Symbol;Acc:HGNC:7820]","GO:0002088(lens development in camera-type eye);GO:0005794(Golgi apparatus);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030154(cell differentiation)","NA",{"v":0.0093,"d":"0.01"},1,"181,",0,-2.03,-1.47,3.01,"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 9 of 11)",31,14360228,14767640,407413,1]
["Y",14767280,14767640,361,"ENSBGRG00000014125","ENSBGRT00000026136",407052,"NHS","NHS actin remodeling regulator [Source:HGNC Symbol;Acc:HGNC:7820]","GO:0002088(lens development in camera-type eye);GO:0005794(Golgi apparatus);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030154(cell differentiation)","NA",{"v":1e-19,"d":"0.00"},1,"361,",0,-19,-18,7.14,"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 11 of 11)",31,14360228,14767640,407413,1]
["Y",14787534,14788272,739,"ENSBGRG00000014390","ENSBGRT00000026401",111836,"RAI2","retinoic acid induced 2 [Source:HGNC Symbol;Acc:HGNC:9835]","NA","NA",{"v":1.6e-08,"d":"0.00"},2,"58,299,","0,440",{"v":-7.8,"d":"-7.80"},-7,{"v":2.7,"d":"2.70"},"Exon (ENSBGRT00000026503/ENSBGRG00000014444, exon 4 of 7)",31,14751100,14900108,149009,2]
["Y",14790388,14790477,90,"ENSBGRG00000014390","ENSBGRT00000026401",109631,"RAI2","retinoic acid induced 2 [Source:HGNC Symbol;Acc:HGNC:9835]","NA","NA",0.02,1,"90,",0,{"v":-1.7,"d":"-1.70"},-1.17,2.19,"Exon (ENSBGRT00000026503/ENSBGRG00000014444, exon 6 of 7)",31,14751100,14900108,149009,2]
["Y",15761768,15769120,7353,"ENSBGRG00000014796","ENSBGRT00000028536",32682,"CDKL5","cyclin dependent kinase like 5 [Source:HGNC Symbol;Acc:HGNC:11411]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005813(centrosome);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0036064(ciliary basal body);GO:0046777(protein autophosphorylation);GO:0097542(ciliary tip);GO:1902017(regulation of cilium assembly)","NA",{"v":1.1E-4,"d":"0.00"},2,"371,18,","0,7335",-3.97,-3.29,12,"Exon (ENSBGRT00000028536/ENSBGRG00000014796, exon 11 of 17)",31,15729086,15786225,57140,1]
["Y",16414712,16419836,5125,"ENSBGRG00000016871","ENSBGRT00000031010",4417,"HCCS","holocytochrome c synthase [Source:HGNC Symbol;Acc:HGNC:4837]","GO:0004408(holocytochrome-c synthase activity);GO:0005739(mitochondrion)","00860(Porphyrin and chlorophyll metabolism)",{"v":4e-25,"d":"0.00"},3,"38,87,353,","0,3558,4772",{"v":-24.4,"d":"-24.40"},{"v":-23.3,"d":"-23.30"},4.19,"3' UTR",31,16410295,16421237,10943,1]
["Y",17166345,17166980,636,"ENSBGRG00000017670","ENSBGRT00000032689",5187,"MSL3","MSL complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:7370]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-templated);GO:0035064(methylated histone binding);GO:0043984(histone H4-K16 acetylation);GO:0046972(histone acetyltransferase activity (H4-K16 specific));GO:0072487(MSL complex)","NA",{"v":2.8E-3,"d":"0.00"},2,"37,53,","0,583",-2.56,-1.96,1.62,"Exon (ENSBGRT00000032689/ENSBGRG00000017670, exon 5 of 12)",31,17161158,17180899,19742,1]
["Y",17182525,17182674,150,"ENSBGRG00000017670","ENSBGRT00000032454",21367,"MSL3","MSL complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:7370]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-templated);GO:0035064(methylated histone binding);GO:0043984(histone H4-K16 acetylation);GO:0046972(histone acetyltransferase activity (H4-K16 specific));GO:0072487(MSL complex)","NA",{"v":3.9e-05,"d":"0.00"},1,"150,",0,-4.41,-3.72,2.03,"3' UTR",31,17161158,17182674,21517,1]
["Y",18157219,18157609,391,"ENSBGRG00000018169","ENSBGRT00000034323",841964,"FRMPD4","FERM and PDZ domain containing 4 [Source:HGNC Symbol;Acc:HGNC:29007]","GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005856(cytoskeleton);GO:0032991(protein-containing complex);GO:0043197(dendritic spine);GO:0051835(positive regulation of synapse structural plasticity)","NA",{"v":0.0017,"d":"0.00"},1,"391,",0,-2.77,-2.16,12,"Exon (ENSBGRT00000034323/ENSBGRG00000018169, exon 15 of 19)",31,17315255,18162769,847515,1]
["Y",18159070,18159280,211,"ENSBGRG00000018169","ENSBGRT00000034323",843815,"FRMPD4","FERM and PDZ domain containing 4 [Source:HGNC Symbol;Acc:HGNC:29007]","GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005856(cytoskeleton);GO:0032991(protein-containing complex);GO:0043197(dendritic spine);GO:0051835(positive regulation of synapse structural plasticity)","NA",{"v":0.00026,"d":"0.00"},1,"211,",0,-3.59,-2.93,15,"Exon (ENSBGRT00000034323/ENSBGRG00000018169, exon 16 of 19)",31,17315255,18162769,847515,1]
["Y",18159821,18162155,2335,"ENSBGRG00000018169","ENSBGRT00000034323",844566,"FRMPD4","FERM and PDZ domain containing 4 [Source:HGNC Symbol;Acc:HGNC:29007]","GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005856(cytoskeleton);GO:0032991(protein-containing complex);GO:0043197(dendritic spine);GO:0051835(positive regulation of synapse structural plasticity)","NA",{"v":0.0011,"d":"0.00"},2,"20,729,","0,1606",-2.94,-2.31,7.52,"3' UTR",31,17315255,18162769,847515,1]
["Y",18163930,18164020,91,"ENSBGRG00000018169","ENSBGRT00000034165",848675,"FRMPD4","FERM and PDZ domain containing 4 [Source:HGNC Symbol;Acc:HGNC:29007]","GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005856(cytoskeleton);GO:0032991(protein-containing complex);GO:0043197(dendritic spine);GO:0051835(positive regulation of synapse structural plasticity)","NA",{"v":0.0013,"d":"0.00"},1,"91,",0,{"v":-2.9,"d":"-2.90"},-2.28,5.52,"Exon (ENSBGRT00000034165/ENSBGRG00000018169, exon 19 of 19)",31,17315255,18164020,848766,1]
["Y",18300754,18301230,477,"ENSBGRG00000019181","ENSBGRT00000035241",15551,"TLR7","toll like receptor 7 [Source:HGNC Symbol;Acc:HGNC:15631]","GO:0001932(regulation of protein phosphorylation);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007252(I-kappaB phosphorylation);GO:0016021(integral component of membrane);GO:0032009(early phagosome);GO:0032722(positive regulation of chemokine production);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032729(positive regulation of interferon-gamma production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0034154(toll-like receptor 7 signaling pathway);GO:0035197(siRNA binding);GO:0043235(receptor complex);GO:0051607(defense response to virus);GO:0071260(cellular response to mechanical stimulus);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04620(Toll-like receptor signaling pathway);05162(Measles);05164(Influenza A)",{"v":0.00019,"d":"0.00"},1,"477,",0,-3.73,-3.06,3.41,"Exon (ENSBGRT00000035241/ENSBGRG00000019181, exon 2 of 2)",31,18285203,18303404,18202,1]
["Y",18301528,18302094,567,"ENSBGRG00000019181","ENSBGRT00000035241",16325,"TLR7","toll like receptor 7 [Source:HGNC Symbol;Acc:HGNC:15631]","GO:0001932(regulation of protein phosphorylation);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007252(I-kappaB phosphorylation);GO:0016021(integral component of membrane);GO:0032009(early phagosome);GO:0032722(positive regulation of chemokine production);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032729(positive regulation of interferon-gamma production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0034154(toll-like receptor 7 signaling pathway);GO:0035197(siRNA binding);GO:0043235(receptor complex);GO:0051607(defense response to virus);GO:0071260(cellular response to mechanical stimulus);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04620(Toll-like receptor signaling pathway);05162(Measles);05164(Influenza A)",{"v":8.1e-05,"d":"0.00"},1,"567,",0,-4.09,{"v":-3.4,"d":"-3.40"},3.89,"Exon (ENSBGRT00000035241/ENSBGRG00000019181, exon 2 of 2)",31,18285203,18303404,18202,1]
["Y",18302243,18302838,596,"ENSBGRG00000019181","ENSBGRT00000035241",17040,"TLR7","toll like receptor 7 [Source:HGNC Symbol;Acc:HGNC:15631]","GO:0001932(regulation of protein phosphorylation);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007252(I-kappaB phosphorylation);GO:0016021(integral component of membrane);GO:0032009(early phagosome);GO:0032722(positive regulation of chemokine production);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032729(positive regulation of interferon-gamma production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0034154(toll-like receptor 7 signaling pathway);GO:0035197(siRNA binding);GO:0043235(receptor complex);GO:0051607(defense response to virus);GO:0071260(cellular response to mechanical stimulus);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04620(Toll-like receptor signaling pathway);05162(Measles);05164(Influenza A)",{"v":1.5e-08,"d":"0.00"},1,"596,",0,-7.83,-7.02,9.78,"Exon (ENSBGRT00000035241/ENSBGRG00000019181, exon 2 of 2)",31,18285203,18303404,18202,1]
["Y",18302987,18303344,358,"ENSBGRG00000019181","ENSBGRT00000035241",17784,"TLR7","toll like receptor 7 [Source:HGNC Symbol;Acc:HGNC:15631]","GO:0001932(regulation of protein phosphorylation);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007252(I-kappaB phosphorylation);GO:0016021(integral component of membrane);GO:0032009(early phagosome);GO:0032722(positive regulation of chemokine production);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032729(positive regulation of interferon-gamma production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0034154(toll-like receptor 7 signaling pathway);GO:0035197(siRNA binding);GO:0043235(receptor complex);GO:0051607(defense response to virus);GO:0071260(cellular response to mechanical stimulus);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04620(Toll-like receptor signaling pathway);05162(Measles);05164(Influenza A)",{"v":1.6e-06,"d":"0.00"},1,"358,",0,-5.79,-5.05,4.41,"Exon (ENSBGRT00000035241/ENSBGRG00000019181, exon 2 of 2)",31,18285203,18303404,18202,1]
["Y",18343014,18343582,569,"ENSBGRG00000019302","ENSBGRT00000035414",209,"ENSBGRG00000019302","NA","NA","04620(Toll-like receptor signaling pathway)",{"v":0.0032,"d":"0.00"},2,"214,353,","0,216",{"v":-2.5,"d":"-2.50"},-1.91,11,"Exon (ENSBGRT00000035414/ENSBGRG00000019302, exon 1 of 2)",31,18342805,18345905,3101,1]
["Y",18345130,18345667,538,"ENSBGRG00000019302","ENSBGRT00000035414",2325,"ENSBGRG00000019302","NA","NA","04620(Toll-like receptor signaling pathway)",{"v":0.0017,"d":"0.00"},1,"538,",0,-2.77,-2.16,12,"Exon (ENSBGRT00000035414/ENSBGRG00000019302, exon 2 of 2)",31,18342805,18345905,3101,1]
["Y",18381808,18382363,556,"ENSBGRG00000019310","ENSBGRT00000035484",0,"TMSB4Y","thymosin beta 4 X-linked [Source:HGNC Symbol;Acc:HGNC:11881]","GO:0003785(actin monomer binding);GO:0007015(actin filament organization)","04810(Regulation of actin cytoskeleton)",0,2,"100,35,","0,521",-515,"-Inf",1.96,"Exon (ENSBGRT00000035484/ENSBGRG00000019310, exon 1 of 2)",31,18381808,18382363,556,1]
["Y",1612302,1612541,240,"ENSBGRG00000016666","ENSBGRT00000030700",25508,"ENSBGRG00000016666","NA","NA","NA",{"v":9.1e-09,"d":"0.00"},1,"240,",0,-8.04,-7.23,7.52,"Exon (ENSBGRT00000030700/ENSBGRG00000016666, exon 10 of 10)",31,1612302,1638049,25748,2]
["Y",1630697,1633446,2750,"ENSBGRG00000016666","ENSBGRT00000030700",4603,"ENSBGRG00000016666","NA","NA","NA",{"v":0.0048,"d":"0.00"},2,"81,100,","0,2650",-2.32,-1.74,2.06,"Exon (ENSBGRT00000030700/ENSBGRG00000016666, exon 7 of 10)",31,1612302,1638049,25748,2]
["Y",1633535,1633749,215,"ENSBGRG00000016666","ENSBGRT00000030700",4300,"ENSBGRG00000016666","NA","NA","NA",{"v":0.026,"d":"0.03"},4,"51,33,18,109,","0,52,87,106",-1.59,-1.07,3.01,"Exon (ENSBGRT00000030700/ENSBGRG00000016666, exon 4 of 10)",31,1612302,1638049,25748,2]
["Y",2976431,2976491,61,"ENSBGRG00000017179","ENSBGRT00000031473",6909,"ENSBGRG00000017179","NA","NA","NA",{"v":0.011,"d":"0.01"},1,"61,",0,-1.97,-1.14,9.03,"Exon (ENSBGRT00000031473/ENSBGRG00000017179, exon 2 of 2)",31,2974753,2983400,8648,2]
["Y",2978619,2978709,91,"ENSBGRG00000017179","ENSBGRT00000031473",4691,"ENSBGRG00000017179","NA","NA","NA",{"v":0.035,"d":"0.04"},1,"91,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000031473/ENSBGRG00000017179, exon 2 of 2)",31,2974753,2983400,8648,2]
["Y",2978979,2979219,241,"ENSBGRG00000017179","ENSBGRT00000031473",4181,"ENSBGRG00000017179","NA","NA","NA",{"v":0.032,"d":"0.03"},1,"241,",0,-1.49,{"v":-0.978,"d":"-0.98"},7.02,"Exon (ENSBGRT00000031473/ENSBGRG00000017179, exon 2 of 2)",31,2974753,2983400,8648,2]
["Y",3653337,3653575,239,"ENSBGRG00000017387","ENSBGRT00000032306",131615,"STS","steroid sulfatase [Source:HGNC Symbol;Acc:HGNC:11425]","GO:0003824(catalytic activity);GO:0008484(sulfuric ester hydrolase activity)","00140(Steroid hormone biosynthesis)",{"v":0.046,"d":"0.05"},1,"239,",0,-1.34,{"v":-0.841,"d":"-0.84"},2.76,"3' UTR",31,3653337,3785190,131854,2]
["Y",7122200,7155938,33739,"ENSBGRG00000018981","ENSBGRT00000034786",0,"ENSBGRG00000018981","NA","GO:0003824(catalytic activity);GO:0008484(sulfuric ester hydrolase activity)","NA",{"v":2.8e-06,"d":"0.00"},2,"170,10,","0,33729",-5.56,-4.82,{"v":22.1,"d":"22.10"},"5' UTR",31,7141164,7148026,6863,1]
["Y",7190919,7191454,536,"ENSBGRG00000019017","ENSBGRT00000034857",37494,"ENSBGRG00000019017","NA","NA","00500(Starch and sucrose metabolism)",{"v":1E-165,"d":"0.00"},1,"536,",0,-165,-163,{"v":7.5,"d":"7.50"},"3' UTR",31,7190919,7228948,38030,2]
["Y",7191751,7191989,239,"ENSBGRG00000019017","ENSBGRT00000034857",36959,"ENSBGRG00000019017","NA","NA","00500(Starch and sucrose metabolism)",{"v":1e-15,"d":"0.00"},1,"239,",0,-15,-14,{"v":2.4,"d":"2.40"},"3' UTR",31,7190919,7228948,38030,2]
["Y",7192197,7203356,11160,"ENSBGRG00000019017","ENSBGRT00000034857",25592,"ENSBGRG00000019017","NA","NA","00500(Starch and sucrose metabolism)",{"v":1.3e-45,"d":"0.00"},5,"541,111,36,45,11,","0,1690,4122,7311,11149",{"v":-44.9,"d":"-44.90"},{"v":-43.5,"d":"-43.50"},7.69,"3' UTR",31,7190919,7228948,38030,2]
["Y",7236432,7237254,823,"ENSBGRG00000019127","ENSBGRT00000035103",28764,"CD99","CD99 molecule (Xg blood group) [Source:HGNC Symbol;Acc:HGNC:7082]","NA","04514(Cell adhesion molecules (CAMs));04670(Leukocyte transendothelial migration)",0,2,"600,28,","0,795",-1400,"-Inf",5.17,"3' UTR",31,7236432,7266018,29587,2]
["Y",7783831,7784008,178,"ENSBGRG00000019382","ENSBGRT00000035601",32339,"ASMT","acetylserotonin O-methyltransferase [Source:HGNC Symbol;Acc:HGNC:750]","GO:0008168(methyltransferase activity);GO:0008171(O-methyltransferase activity);GO:0016740(transferase activity);GO:0017096(acetylserotonin O-methyltransferase activity);GO:0030187(melatonin biosynthetic process);GO:0032259(methylation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity)","00380(Tryptophan metabolism)",{"v":6.3E-3,"d":"0.01"},1,"178,",0,{"v":-2.2,"d":"-2.20"},-1.62,8.02,"3' UTR",31,7783831,7816347,32517,2]
["Y",7784068,7784600,533,"ENSBGRG00000019382","ENSBGRT00000035601",31747,"ASMT","acetylserotonin O-methyltransferase [Source:HGNC Symbol;Acc:HGNC:750]","GO:0008168(methyltransferase activity);GO:0008171(O-methyltransferase activity);GO:0016740(transferase activity);GO:0017096(acetylserotonin O-methyltransferase activity);GO:0030187(melatonin biosynthetic process);GO:0032259(methylation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity)","00380(Tryptophan metabolism)",{"v":0.0032,"d":"0.00"},1,"533,",0,{"v":-2.5,"d":"-2.50"},-1.91,11,"3' UTR",31,7783831,7816347,32517,2]
["Y",7830647,7842607,11961,"ENSBGRG00000019461","ENSBGRT00000035765",360,"AKAP17A","A-kinase anchoring protein 17A [Source:HGNC Symbol;Acc:HGNC:18783]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0043484(regulation of RNA splicing);GO:0051018(protein kinase A binding)","NA",{"v":1.6E-72,"d":"0.00"},7,"304,206,318,241,149,778,43,","0,869,1135,3608,6929,7786,11918",{"v":-71.8,"d":"-71.80"},{"v":-70.2,"d":"-70.20"},9.03,"5' UTR",31,7830647,7842967,12321,2]
["Y",7962058,7962207,150,"ENSBGRG00000007226","ENSBGRT00000013276",17185,"ENSBGRG00000007226","NA","GO:0005515(protein binding)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04210(Apoptosis);04640(Hematopoietic cell lineage);05200(Pathways in cancer)",0.03,1,"150,",0,-1.52,-1,3.01,"3' UTR",31,7962058,7979392,17335,2]
["Y",7968347,7969208,862,"ENSBGRG00000007226","ENSBGRT00000013276",10184,"ENSBGRG00000007226","NA","GO:0005515(protein binding)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04210(Apoptosis);04640(Hematopoietic cell lineage);05200(Pathways in cancer)",{"v":0.011,"d":"0.01"},2,"94,26,","0,836",-1.97,-1.19,9.03,"Exon (ENSBGRT00000013276/ENSBGRG00000007226, exon 5 of 11)",31,7962058,7979392,17335,2]
["Y",8002299,8002806,508,"ENSBGRG00000007304","ENSBGRT00000013396",17572,"ENSBGRG00000007304","NA","GO:0004896(cytokine receptor activity);GO:0005515(protein binding);GO:0016020(membrane)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage);05200(Pathways in cancer)",{"v":0.017,"d":"0.02"},1,"508,",0,-1.76,-1.22,6.02,"3' UTR",31,8002269,8020378,18110,2]
["Y",8015807,8020378,4572,"ENSBGRG00000007304","ENSBGRT00000013396",0,"ENSBGRG00000007304","NA","GO:0004896(cytokine receptor activity);GO:0005515(protein binding);GO:0016020(membrane)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage);05200(Pathways in cancer)",{"v":5.2e-10,"d":"0.00"},2,"31,328,","0,4244",-9.28,-8.44,4.12,"5' UTR",31,8002269,8020378,18110,2]
["Y",8774749,8775442,694,"ENSBGRG00000007868","ENSBGRT00000014467",13918,"GTPBP6","GTP binding protein 6 (putative) [Source:HGNC Symbol;Acc:HGNC:30189]","GO:0005525(GTP binding)","00250(Alanine, aspartate and glutamate metabolism)",{"v":0.025,"d":"0.03"},2,"89,2,","0,692",{"v":-1.6,"d":"-1.60"},-1.07,1.73,"Exon (ENSBGRT00000014802/ENSBGRG00000008103, exon 7 of 7)",31,8760831,8779045,18215,1]
["Y",8775742,8776749,1008,"ENSBGRG00000007868","ENSBGRT00000014467",14911,"GTPBP6","GTP binding protein 6 (putative) [Source:HGNC Symbol;Acc:HGNC:30189]","GO:0005525(GTP binding)","00250(Alanine, aspartate and glutamate metabolism)",{"v":0.019,"d":"0.02"},2,"182,118,","0,890",-1.72,-1.19,5.01,"Exon (ENSBGRT00000014802/ENSBGRG00000008103, exon 5 of 7)",31,8760831,8779045,18215,1]
["Y",8785208,8789538,4331,"ENSBGRG00000008103","ENSBGRT00000014802",90,"PLCXD1","phosphatidylinositol specific phospholipase C X domain containing 1 [Source:HGNC Symbol;Acc:HGNC:23148]","GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity)","NA",{"v":2.9E-5,"d":"0.00"},2,"244,147,","0,4184",-4.54,-3.84,7.02,"5' UTR",31,8774599,8789628,15030,2]
["Y",8938672,8939504,833,"ENSBGRG00000008177","ENSBGRT00000014938",475,"ENSBGRG00000008177","NA","NA","NA",{"v":0.0011,"d":"0.00"},1,"833,",0,-2.94,-2.31,10,"Exon (ENSBGRT00000014938/ENSBGRG00000008177, exon 1 of 1)",31,8938672,8939979,1308,2]
["Y",9450636,9450815,180,"ENSBGRG00000008397","ENSBGRT00000015543",154358,"MID1","midline 1 [Source:HGNC Symbol;Acc:HGNC:7095]","GO:0005515(protein binding);GO:0005874(microtubule);GO:0005881(cytoplasmic microtubule);GO:0008017(microtubule binding);GO:0008270(zinc ion binding);GO:0019899(enzyme binding);GO:0031625(ubiquitin protein ligase binding);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0035372(protein localization to microtubule);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0051219(phosphoprotein binding)","04120(Ubiquitin mediated proteolysis)",{"v":0.0003,"d":"0.00"},1,"180,",0,-3.53,-2.88,5.01,"Exon (ENSBGRT00000015543/ENSBGRG00000008397, exon 11 of 11)",31,9450636,9605173,154538,2]
["Y",10338837,10503594,164758,"ENSBGRG00000009564","ENSBGRT00000017751",0,"GPM6B","glycoprotein M6B [Source:HGNC Symbol;Acc:HGNC:4461]","GO:0016021(integral component of membrane);GO:0030501(positive regulation of bone mineralization);GO:0032956(regulation of actin cytoskeleton organization);GO:0051893(regulation of focal adhesion assembly);GO:0085029(extracellular matrix assembly)","NA",{"v":7.4e-05,"d":"0.00"},5,"87,120,61,7,265,","0,28625,40736,104699,164493",-4.13,-3.45,8.02,"5' UTR",31,10327526,10379633,52108,2]
["Y",12039375,12039793,419,"ENSBGRG00000010354","ENSBGRT00000019266",31524,"ENSBGRG00000010354","NA","GO:0005515(protein binding);GO:0006506(GPI anchor biosynthetic process);GO:0035556(intracellular signal transduction)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":2.5e-06,"d":"0.00"},1,"419,",0,-5.61,-4.87,3.93,"3' UTR",31,12039315,12071317,32003,2]
["Y",12077825,12078064,240,"ENSBGRG00000010354","ENSBGRT00000019031",4608,"ENSBGRG00000010354","NA","GO:0005515(protein binding);GO:0006506(GPI anchor biosynthetic process);GO:0035556(intracellular signal transduction)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":0.00016,"d":"0.00"},1,"240,",0,{"v":-3.8,"d":"-3.80"},-3.13,5.68,"3' UTR",31,12039315,12082672,43358,2]
["Y",12086790,12089902,3113,"ENSBGRG00000010354","ENSBGRT00000019827",0,"ENSBGRG00000010354","NA","GO:0005515(protein binding);GO:0006506(GPI anchor biosynthetic process);GO:0035556(intracellular signal transduction)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":1.1E-5,"d":"0.00"},2,"610,18,","0,3095",-4.97,-4.25,{"v":19.1,"d":"19.10"},"5' UTR",31,12077205,12087337,10133,2]
["Y",12330244,12330423,180,"ENSBGRG00000011584","ENSBGRT00000021468",52819,"ACE2","angiotensin I converting enzyme 2 [Source:HGNC Symbol;Acc:HGNC:13557]","GO:0001618(virus receptor activity);GO:0003051(angiotensin-mediated drinking behavior);GO:0003081(regulation of systemic arterial blood pressure by renin-angiotensin);GO:0004175(endopeptidase activity);GO:0004180(carboxypeptidase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0008241(peptidyl-dipeptidase activity);GO:0009986(cell surface);GO:0015827(tryptophan transport);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0022898(regulation of transmembrane transporter activity);GO:0031526(brush border membrane);GO:0032800(receptor biosynthetic process);GO:0046718(viral entry into host cell);GO:0046813(receptor-mediated virion attachment to host cell);GO:0051957(positive regulation of amino acid transport);GO:0060452(positive regulation of cardiac muscle contraction);GO:1903598(positive regulation of gap junction assembly);GO:1903779(regulation of cardiac conduction);GO:1905737(positive regulation of L-proline import across plasma membrane)","04614(Renin-angiotensin system);04974(Protein digestion and absorption)",{"v":0.017,"d":"0.02"},1,"180,",0,-1.76,-1.22,4.01,"3' UTR",31,12327679,12383242,55564,2]
["Y",12409728,12410083,356,"ENSBGRG00000012004","ENSBGRT00000021940",50320,"ENSBGRG00000012004","NA","NA","NA",{"v":7.9e-34,"d":"0.00"},1,"356,",0,{"v":-33.1,"d":"-33.10"},{"v":-31.9,"d":"-31.90"},{"v":5.3,"d":"5.30"},"3' UTR",31,12409698,12460403,50706,2]
["Y",12410142,12424072,13931,"ENSBGRG00000012004","ENSBGRT00000021940",36331,"ENSBGRG00000012004","NA","NA","NA",{"v":7.9e-36,"d":"0.00"},2,"366,20,","0,13911",{"v":-35.1,"d":"-35.10"},{"v":-33.9,"d":"-33.90"},{"v":3.3,"d":"3.30"},"3' UTR",31,12409698,12460403,50706,2]
["Y",13407445,13407595,151,"ENSBGRG00000012368","ENSBGRT00000022646",126205,"CTPS2","CTP synthase 2 [Source:HGNC Symbol;Acc:HGNC:2520]","GO:0003883(CTP synthase activity);GO:0006221(pyrimidine nucleotide biosynthetic process);GO:0006241(CTP biosynthetic process);GO:0042802(identical protein binding)","00240(Pyrimidine metabolism)",{"v":6.2e-08,"d":"0.00"},1,"151,",0,-7.21,-6.42,3.39,"3' UTR",31,13407445,13533800,126356,2]
["Y",13680431,13681295,865,"ENSBGRG00000012976","ENSBGRT00000024265",0,"RBBP7","RB binding protein 7, chromatin remodeling factor [Source:HGNC Symbol;Acc:HGNC:9890]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016581(NuRD complex);GO:0030308(negative regulation of cell growth);GO:0035098(ESC/E(Z) complex);GO:0045892(negative regulation of transcription, DNA-templated);GO:0070370(cellular heat acclimation)","NA",{"v":6.3e-11,"d":"0.00"},3,"45,148,16,","0,316,849",{"v":-10.2,"d":"-10.20"},-9.38,1.89,"Exon (ENSBGRT00000024265/ENSBGRG00000012976, exon 1 of 13)",31,13659595,13680894,21300,2]
["Y",14818663,14820148,1486,"ENSBGRG00000014390","ENSBGRT00000026401",79960,"RAI2","retinoic acid induced 2 [Source:HGNC Symbol;Acc:HGNC:9835]","NA","NA",{"v":2.5e-21,"d":"0.00"},2,"59,330,","0,1156",{"v":-20.6,"d":"-20.60"},{"v":-19.5,"d":"-19.50"},3.97,"Exon (ENSBGRT00000026401/ENSBGRG00000014390, exon 2 of 4)",31,14751100,14900108,149009,2]
["Y",14820238,14820566,329,"ENSBGRG00000014390","ENSBGRT00000026401",79542,"RAI2","retinoic acid induced 2 [Source:HGNC Symbol;Acc:HGNC:9835]","NA","NA",{"v":2.5e-17,"d":"0.00"},1,"329,",0,{"v":-16.6,"d":"-16.60"},{"v":-15.6,"d":"-15.60"},1.86,"Exon (ENSBGRT00000026401/ENSBGRG00000014390, exon 2 of 4)",31,14751100,14900108,149009,2]
["Y",16075674,16076123,450,"ENSBGRG00000015880","ENSBGRT00000029238",105949,"PHKA2","phosphorylase kinase regulatory subunit alpha 2 [Source:HGNC Symbol;Acc:HGNC:8926]","GO:0003824(catalytic activity);GO:0005516(calmodulin binding);GO:0005977(glycogen metabolic process)","04020(Calcium signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway)",{"v":1.6e-33,"d":"0.00"},1,"450,",0,{"v":-32.8,"d":"-32.80"},{"v":-31.6,"d":"-31.60"},7.23,"3' UTR",31,16075134,16182072,106939,2]
["Y",16076869,16077408,540,"ENSBGRG00000015880","ENSBGRT00000029238",104664,"PHKA2","phosphorylase kinase regulatory subunit alpha 2 [Source:HGNC Symbol;Acc:HGNC:8926]","GO:0003824(catalytic activity);GO:0005516(calmodulin binding);GO:0005977(glycogen metabolic process)","04020(Calcium signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway)",{"v":0.00089,"d":"0.00"},1,"540,",0,-3.05,-2.42,13,"3' UTR",31,16075134,16182072,106939,2]
["Y",16434313,16440799,6487,"ENSBGRG00000016957","ENSBGRT00000031345",120907,"ARHGAP6","Rho GTPase activating protein 6 [Source:HGNC Symbol;Acc:HGNC:676]","GO:0005096(GTPase activator activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007015(actin filament organization);GO:0007165(signal transduction);GO:0015629(actin cytoskeleton);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0048041(focal adhesion assembly);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly)","NA",{"v":4e-68,"d":"0.00"},3,"1000,81,83,","0,4270,6404",{"v":-67.4,"d":"-67.40"},{"v":-65.9,"d":"-65.90"},{"v":11.2,"d":"11.20"},"3' UTR",31,16434313,16561706,127394,2]
["chr1",61214266,61214506,241,"ENSBGRG00000000255","ENSBGRT00000000490",30494,"PHLDB2","pleckstrin homology like domain family B member 2 [Source:HGNC Symbol;Acc:HGNC:29573]","GO:0000226(microtubule cytoskeleton organization);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0010470(regulation of gastrulation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0031252(cell leading edge);GO:0045111(intermediate filament cytoskeleton);GO:0045180(basal cortex);GO:0045184(establishment of protein localization);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:1903690(negative regulation of wound healing, spreading of epidermal cells);GO:1904261(positive regulation of basement membrane assembly involved in embryonic body morphogenesis)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);04141(Protein processing in endoplasmic reticulum)",{"v":5e-22,"d":"0.00"},1,"241,",0,{"v":-21.3,"d":"-21.30"},{"v":-20.2,"d":"-20.20"},3.29,"5' UTR",1,61183772,61303761,119990,1]
["chr1",61214566,61214776,211,"ENSBGRG00000000255","ENSBGRT00000000490",30794,"PHLDB2","pleckstrin homology like domain family B member 2 [Source:HGNC Symbol;Acc:HGNC:29573]","GO:0000226(microtubule cytoskeleton organization);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0010470(regulation of gastrulation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0031252(cell leading edge);GO:0045111(intermediate filament cytoskeleton);GO:0045180(basal cortex);GO:0045184(establishment of protein localization);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:1903690(negative regulation of wound healing, spreading of epidermal cells);GO:1904261(positive regulation of basement membrane assembly involved in embryonic body morphogenesis)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);04141(Protein processing in endoplasmic reticulum)",{"v":1.7E-6,"d":"0.00"},1,"211,",0,-5.76,-5.01,1.76,"Exon (ENSBGRT00000000490/ENSBGRG00000000255, exon 2 of 19)",1,61183772,61303761,119990,1]
["chr1",61214896,61237880,22985,"ENSBGRG00000000255","ENSBGRT00000000490",31124,"PHLDB2","pleckstrin homology like domain family B member 2 [Source:HGNC Symbol;Acc:HGNC:29573]","GO:0000226(microtubule cytoskeleton organization);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0010470(regulation of gastrulation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0031252(cell leading edge);GO:0045111(intermediate filament cytoskeleton);GO:0045180(basal cortex);GO:0045184(establishment of protein localization);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:1903690(negative regulation of wound healing, spreading of epidermal cells);GO:1904261(positive regulation of basement membrane assembly involved in embryonic body morphogenesis)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);04141(Protein processing in endoplasmic reticulum)",{"v":1.6e-60,"d":"0.00"},2,"714,367,","0,22618",{"v":-59.8,"d":"-59.80"},{"v":-58.4,"d":"-58.40"},6.75,"Exon (ENSBGRT00000000490/ENSBGRG00000000255, exon 2 of 19)",1,61183772,61303761,119990,1]
["chr1",61262720,61269711,6992,"ENSBGRG00000000255","ENSBGRT00000000490",78948,"PHLDB2","pleckstrin homology like domain family B member 2 [Source:HGNC Symbol;Acc:HGNC:29573]","GO:0000226(microtubule cytoskeleton organization);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0010470(regulation of gastrulation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0031252(cell leading edge);GO:0045111(intermediate filament cytoskeleton);GO:0045180(basal cortex);GO:0045184(establishment of protein localization);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:1903690(negative regulation of wound healing, spreading of epidermal cells);GO:1904261(positive regulation of basement membrane assembly involved in embryonic body morphogenesis)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);04141(Protein processing in endoplasmic reticulum)",{"v":1e-15,"d":"0.00"},2,"100,81,","0,6911",-15,-14,2.02,"Exon (ENSBGRT00000000490/ENSBGRG00000000255, exon 6 of 19)",1,61183772,61303761,119990,1]
["chr1",61311034,61311797,764,"ENSBGRG00000000255","ENSBGRT00000000416",127262,"PHLDB2","pleckstrin homology like domain family B member 2 [Source:HGNC Symbol;Acc:HGNC:29573]","GO:0000226(microtubule cytoskeleton organization);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0010470(regulation of gastrulation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0031252(cell leading edge);GO:0045111(intermediate filament cytoskeleton);GO:0045180(basal cortex);GO:0045184(establishment of protein localization);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:1903690(negative regulation of wound healing, spreading of epidermal cells);GO:1904261(positive regulation of basement membrane assembly involved in embryonic body morphogenesis)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);04141(Protein processing in endoplasmic reticulum)",{"v":1E-156,"d":"0.00"},2,"70,141,","0,623",-156,-154,3.28,"Exon (ENSBGRT00000000416/ENSBGRG00000000255, exon 17 of 18)",1,61183772,61311797,128026,1]
["chr1",95557314,95558742,1429,"ENSBGRG00000003142","ENSBGRT00000005846",0,"MFN1","mitofusin 1 [Source:HGNC Symbol;Acc:HGNC:18262]","GO:0003676(nucleic acid binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0008053(mitochondrial fusion);GO:0010918(positive regulation of mitochondrial membrane potential);GO:0016021(integral component of membrane);GO:0031307(integral component of mitochondrial outer membrane);GO:0042802(identical protein binding);GO:0046039(GTP metabolic process);GO:0051646(mitochondrion localization);GO:0098799(outer mitochondrial membrane protein complex);GO:1990613(mitochondrial membrane fusion)","04137(Mitophagy - animal);04621(NOD-like receptor signaling pathway)",{"v":1e-112,"d":"0.00"},2,"1154,126,","0,1303",-112,-110,9.27,"Exon (ENSBGRT00000005846/ENSBGRG00000003142, exon 1 of 18)",1,95499008,95557831,58824,2]
["chr2",135116066,135116875,810,"ENSBGRG00000002427","ENSBGRT00000004510",535,"ENSBGRG00000002427","NA","NA","NA",{"v":0.035,"d":"0.04"},1,"810,",0,-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000004510/ENSBGRG00000002427, exon 1 of 2)",2,135114853,135117410,2558,2]
["chr4",101579906,101643872,63967,"ENSBGRG00000002148","ENSBGRT00000004010",0,"ENSBGRG00000002148","NA","NA","NA",{"v":0.035,"d":"0.04"},3,"3286,456,802,","0,52199,63165",-1.46,{"v":-0.673,"d":"-0.67"},7.02,"Exon (ENSBGRT00000004010/ENSBGRG00000002148, exon 1 of 2)",4,101579906,101632560,52655,2]
["chr5",81708154,81708510,357,"ENSBGRG00000003819","ENSBGRT00000007074",0,"HOXC9","homeobox C9 [Source:HGNC Symbol;Acc:HGNC:5130]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0009952(anterior/posterior pattern specification);GO:0016235(aggresome);GO:0043565(sequence-specific DNA binding);GO:0048704(embryonic skeletal system morphogenesis);GO:0048706(embryonic skeletal system development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.0011,"d":"0.00"},1,"357,",0,-2.95,-2.32,8.02,"Exon (ENSBGRT00000007074/ENSBGRG00000003819, exon 1 of 3)",5,81708154,81720928,12775,1]
["chr5",81718358,81718862,505,"ENSBGRG00000003819","ENSBGRT00000007074",10204,"HOXC9","homeobox C9 [Source:HGNC Symbol;Acc:HGNC:5130]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0009952(anterior/posterior pattern specification);GO:0016235(aggresome);GO:0043565(sequence-specific DNA binding);GO:0048704(embryonic skeletal system morphogenesis);GO:0048706(embryonic skeletal system development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1.6e-14,"d":"0.00"},1,"505,",0,{"v":-13.8,"d":"-13.80"},{"v":-12.8,"d":"-12.80"},4.67,"5' UTR",5,81708154,81720928,12775,1]
["chr5",81720697,81721260,564,"ENSBGRG00000003819","ENSBGRT00000007074",12543,"HOXC9","homeobox C9 [Source:HGNC Symbol;Acc:HGNC:5130]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0009952(anterior/posterior pattern specification);GO:0016235(aggresome);GO:0043565(sequence-specific DNA binding);GO:0048704(embryonic skeletal system morphogenesis);GO:0048706(embryonic skeletal system development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1E-107,"d":"0.00"},1,"564,",0,-107,-106,6.87,"3' UTR",5,81708154,81720928,12775,1]
["chr8",7347199,7347468,270,"ENSBGRG00000003078","ENSBGRT00000005739",867,"ENSBGRG00000003078","NA","NA","NA",{"v":3.7e-10,"d":"0.00"},1,"270,",0,-9.43,-8.59,{"v":22.1,"d":"22.10"},"Exon (ENSBGRT00000005739/ENSBGRG00000003078, exon 2 of 2)",8,7342239,7348335,6097,2]
["chr9",2658348,2659302,955,"ENSBGRG00000016924","ENSBGRT00000031069",0,"ENSBGRG00000016924","NA","NA","NA",{"v":0.0058,"d":"0.01"},1,"955,",0,-2.24,-1.66,10,"Exon (ENSBGRT00000031069/ENSBGRG00000016924, exon 1 of 2)",9,2657453,2658895,1443,2]
["chr11",9068526,9069753,1228,"ENSBGRG00000022370","ENSBGRT00000041311",25,"ENSBGRG00000022370","NA","NA","NA",{"v":1e-09,"d":"0.00"},2,"104,526,","0,702",-9,-8.17,{"v":34.1,"d":"34.10"},"Exon (ENSBGRT00000041311/ENSBGRG00000022370, exon 1 of 2)",11,9066932,9069778,2847,2]
["chr16",20378344,20387993,9650,"ENSBGRG00000003765","ENSBGRT00000006973",0,"ENSBGRG00000003765","NA","NA","NA",{"v":0.011,"d":"0.01"},2,"36,501,","0,9149",-1.96,{"v":-1.4,"d":"-1.40"},8.02,"Exon (ENSBGRT00000006979/ENSBGRG00000003773, exon 1 of 2)",16,20377182,20387993,10812,2]
["chr17",71970776,71971015,240,"ENSBGRG00000011625","ENSBGRT00000021160",12,"ENSBGRG00000011625","NA","NA","NA",{"v":0.014,"d":"0.01"},1,"240,",0,-1.85,{"v":-1.3,"d":"-1.30"},2.72,"Exon (ENSBGRT00000021160/ENSBGRG00000011625, exon 1 of 3)",17,71965931,71971027,5097,2]
["chr20",66493838,66494584,747,"ENSBGRG00000020492","ENSBGRT00000038236",30149,"AKT2","AKT serine/threonine kinase 2 [Source:HGNC Symbol;Acc:HGNC:392]","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006006(glucose metabolic process);GO:0006468(protein phosphorylation);GO:0008284(positive regulation of cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0010748(negative regulation of long-chain fatty acid import across plasma membrane);GO:0010907(positive regulation of glucose metabolic process);GO:0010918(positive regulation of mitochondrial membrane potential);GO:0030335(positive regulation of cell migration);GO:0031340(positive regulation of vesicle fusion);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0032287(peripheral nervous system myelin maintenance);GO:0032587(ruffle membrane);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0046326(positive regulation of glucose import);GO:0065002(intracellular protein transmembrane transport);GO:0071486(cellular response to high light intensity);GO:0072659(protein localization to plasma membrane);GO:0090314(positive regulation of protein targeting to membrane);GO:0090630(activation of GTPase activity);GO:0097473(retinal rod cell apoptotic process);GO:2000147(positive regulation of cell motility)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04371(Apelin signaling pathway);04630(Jak-STAT signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04218(Cellular senescence);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04919(Thyroid hormone signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04973(Carbohydrate digestion and absorption);04725(Cholinergic synapse);04728(Dopaminergic synapse);04722(Neurotrophin signaling pathway);04380(Osteoclast differentiation);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05205(Proteoglycans in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05152(Tuberculosis);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05145(Toxoplasmosis);05142(Chagas disease (American trypanosomiasis));01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":2.5E-53,"d":"0.00"},1,"747,",0,{"v":-52.6,"d":"-52.60"},{"v":-51.2,"d":"-51.20"},2.71,"3' UTR",20,66463689,66494176,30488,1]
["chr20",66494644,66494912,269,"ENSBGRG00000020492","ENSBGRT00000038161",30955,"AKT2","AKT serine/threonine kinase 2 [Source:HGNC Symbol;Acc:HGNC:392]","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006006(glucose metabolic process);GO:0006468(protein phosphorylation);GO:0008284(positive regulation of cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0010748(negative regulation of long-chain fatty acid import across plasma membrane);GO:0010907(positive regulation of glucose metabolic process);GO:0010918(positive regulation of mitochondrial membrane potential);GO:0030335(positive regulation of cell migration);GO:0031340(positive regulation of vesicle fusion);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0032287(peripheral nervous system myelin maintenance);GO:0032587(ruffle membrane);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0046326(positive regulation of glucose import);GO:0065002(intracellular protein transmembrane transport);GO:0071486(cellular response to high light intensity);GO:0072659(protein localization to plasma membrane);GO:0090314(positive regulation of protein targeting to membrane);GO:0090630(activation of GTPase activity);GO:0097473(retinal rod cell apoptotic process);GO:2000147(positive regulation of cell motility)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04371(Apelin signaling pathway);04630(Jak-STAT signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04218(Cellular senescence);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04919(Thyroid hormone signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04973(Carbohydrate digestion and absorption);04725(Cholinergic synapse);04728(Dopaminergic synapse);04722(Neurotrophin signaling pathway);04380(Osteoclast differentiation);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05205(Proteoglycans in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05152(Tuberculosis);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05145(Toxoplasmosis);05142(Chagas disease (American trypanosomiasis));01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":2.3e-07,"d":"0.00"},1,"269,",0,-6.64,-5.86,1.89,"3' UTR",20,66463689,66495330,31642,1]
["chr20",66495211,66495330,120,"ENSBGRG00000020492","ENSBGRT00000038161",31522,"AKT2","AKT serine/threonine kinase 2 [Source:HGNC Symbol;Acc:HGNC:392]","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006006(glucose metabolic process);GO:0006468(protein phosphorylation);GO:0008284(positive regulation of cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0010748(negative regulation of long-chain fatty acid import across plasma membrane);GO:0010907(positive regulation of glucose metabolic process);GO:0010918(positive regulation of mitochondrial membrane potential);GO:0030335(positive regulation of cell migration);GO:0031340(positive regulation of vesicle fusion);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0032287(peripheral nervous system myelin maintenance);GO:0032587(ruffle membrane);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0046326(positive regulation of glucose import);GO:0065002(intracellular protein transmembrane transport);GO:0071486(cellular response to high light intensity);GO:0072659(protein localization to plasma membrane);GO:0090314(positive regulation of protein targeting to membrane);GO:0090630(activation of GTPase activity);GO:0097473(retinal rod cell apoptotic process);GO:2000147(positive regulation of cell motility)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04371(Apelin signaling pathway);04630(Jak-STAT signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04218(Cellular senescence);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04919(Thyroid hormone signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04973(Carbohydrate digestion and absorption);04725(Cholinergic synapse);04728(Dopaminergic synapse);04722(Neurotrophin signaling pathway);04380(Osteoclast differentiation);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05205(Proteoglycans in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05152(Tuberculosis);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05145(Toxoplasmosis);05142(Chagas disease (American trypanosomiasis));01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":2E-14,"d":"0.00"},1,"120,",0,{"v":-13.7,"d":"-13.70"},{"v":-12.8,"d":"-12.80"},3.88,"3' UTR",20,66463689,66495330,31642,1]
["chr20",59646393,59647558,1166,"ENSBGRG00000018680","ENSBGRT00000034477",4456,"BAX","BCL2 associated X, apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:959]","GO:0001541(ovarian follicle development);GO:0001764(neuron migration);GO:0001776(leukocyte homeostasis);GO:0001777(T cell homeostatic proliferation);GO:0001782(B cell homeostasis);GO:0001783(B cell apoptotic process);GO:0001822(kidney development);GO:0001836(release of cytochrome c from mitochondria);GO:0001844(protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:0001974(blood vessel remodeling);GO:0002262(myeloid cell homeostasis);GO:0002352(B cell negative selection);GO:0002358(B cell homeostatic proliferation);GO:0002904(positive regulation of B cell apoptotic process);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005757(mitochondrial permeability transition pore complex);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0006687(glycosphingolipid metabolic process);GO:0006808(regulation of nitrogen utilization);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006974(cellular response to DNA damage stimulus);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0007399(nervous system development);GO:0007548(sex differentiation);GO:0008053(mitochondrial fusion);GO:0008199(ferric iron binding);GO:0008283(cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008289(lipid binding);GO:0008584(male gonad development);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0008635(activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c);GO:0008637(apoptotic mitochondrial changes);GO:0009566(fertilization);GO:0009611(response to wounding);GO:0009636(response to toxic substance);GO:0009651(response to salt stress);GO:0009791(post-embryonic development);GO:0010212(response to ionizing radiation);GO:0010248(establishment or maintenance of transmembrane electrochemical gradient);GO:0010332(response to gamma radiation);GO:0010524(positive regulation of calcium ion transport into cytosol);GO:0010917(negative regulation of mitochondrial membrane potential);GO:0015267(channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021854(hypothalamus development);GO:0021987(cerebral cortex development);GO:0030544(Hsp70 protein binding);GO:0031334(positive regulation of protein-containing complex assembly);GO:0031966(mitochondrial membrane);GO:0032091(negative regulation of protein binding);GO:0032471(negative regulation of endoplasmic reticulum calcium ion concentration);GO:0032976(release of matrix enzymes from mitochondria);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0033599(regulation of mammary gland epithelial cell proliferation);GO:0034644(cellular response to UV);GO:0035108(limb morphogenesis);GO:0035234(ectopic germ cell programmed cell death);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043281(regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0043525(positive regulation of neuron apoptotic process);GO:0043653(mitochondrial fragmentation involved in apoptotic process);GO:0045136(development of secondary sexual characteristics);GO:0046666(retinal cell programmed cell death);GO:0046930(pore complex);GO:0046982(protein heterodimerization activity);GO:0048087(positive regulation of developmental pigmentation);GO:0048147(negative regulation of fibroblast proliferation);GO:0048515(spermatid differentiation);GO:0048597(post-embryonic camera-type eye morphogenesis);GO:0048678(response to axon injury);GO:0048872(homeostasis of number of cells);GO:0048873(homeostasis of number of cells within a tissue);GO:0051087(chaperone binding);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0051402(neuron apoptotic process);GO:0051434(BH3 domain binding);GO:0051726(regulation of cell cycle);GO:0051881(regulation of mitochondrial membrane potential);GO:0060011(Sertoli cell proliferation);GO:0060041(retina development in camera-type eye);GO:0060058(positive regulation of apoptotic process involved in mammary gland involution);GO:0060068(vagina development);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress);GO:0070242(thymocyte apoptotic process);GO:0070584(mitochondrion morphogenesis);GO:0071310(cellular response to organic substance);GO:0071944(cell periphery);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0097136(Bcl-2 family protein complex);GO:0097144(BAX complex);GO:0097145(BAK complex);GO:0097190(apoptotic signaling pathway);GO:0097191(extrinsic apoptotic signaling pathway);GO:0097192(extrinsic apoptotic signaling pathway in absence of ligand);GO:0097193(intrinsic apoptotic signaling pathway);GO:0097296(activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway);GO:1900103(positive regulation of endoplasmic reticulum unfolded protein response);GO:1902108(regulation of mitochondrial membrane permeability involved in apoptotic process);GO:1902110(positive regulation of mitochondrial membrane permeability involved in apoptotic process);GO:1902262(apoptotic process involved in blood vessel morphogenesis);GO:1902263(apoptotic process involved in embryonic digit morphogenesis);GO:1902445(regulation of mitochondrial membrane permeability involved in programmed necrotic cell death);GO:1902512(positive regulation of apoptotic DNA fragmentation);GO:1990117(B cell receptor apoptotic signaling pathway);GO:2001234(negative regulation of apoptotic signaling pathway);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","04216(Ferroptosis);04217(Necroptosis);04978(Mineral absorption);04141(Protein processing in endoplasmic reticulum);04071(Sphingolipid signaling pathway);04210(Apoptosis);04215(Apoptosis - multiple species);04115(p53 signaling pathway);04722(Neurotrophin signaling pathway);04211(Longevity regulating pathway - mammal);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05216(Thyroid cancer);05220(Chronic myeloid leukemia);05217(Basal cell carcinoma);05218(Melanoma);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05014(Amyotrophic lateral sclerosis (ALS));05016(Huntington disease);05020(Prion diseases);04932(Non-alcoholic fatty liver disease (NAFLD));04933(AGE-RAGE signaling pathway in diabetic complications);05152(Tuberculosis);05166(HTLV-I infection);05161(Hepatitis B);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection);01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":0.00089,"d":"0.00"},2,"83,247,","0,919",-3.05,-2.42,13,"3' UTR",20,59641685,59652014,10330,2]
["chr25",55950270,55950450,181,"ENSBGRG00000013010","ENSBGRT00000023756",1402,"ENSBGRG00000013010","NA","NA","NA",{"v":0.0062,"d":"0.01"},1,"181,",0,-2.21,-1.64,4.01,"Exon (ENSBGRT00000023756/ENSBGRG00000013010, exon 2 of 2)",25,55948868,55950671,1804,1]
["chr25",55950570,55963044,12475,"ENSBGRG00000013010","ENSBGRT00000023756",1702,"ENSBGRG00000013010","NA","NA","NA",{"v":1.5E-6,"d":"0.00"},2,"423,88,","0,12387",-5.83,-5.08,14,"Exon (ENSBGRT00000023756/ENSBGRG00000013010, exon 2 of 2)",25,55948868,55950671,1804,1]
["chr25",55963763,55963823,61,"ENSBGRG00000013010","ENSBGRT00000023773",13553,"ENSBGRG00000013010","NA","NA","NA",{"v":0.026,"d":"0.03"},1,"61,",0,-1.59,-1.07,2.67,"Exon (ENSBGRT00000023773/ENSBGRG00000013010, exon 2 of 2)",25,55950210,55967242,17033,1]
["chr25",55965053,55965263,211,"ENSBGRG00000013010","ENSBGRT00000023773",14843,"ENSBGRG00000013010","NA","NA","NA",{"v":0.0065,"d":"0.01"},1,"211,",0,-2.19,-1.62,2.24,"Exon (ENSBGRT00000023773/ENSBGRG00000013010, exon 2 of 2)",25,55950210,55967242,17033,1]
["chr25",55965353,55965563,211,"ENSBGRG00000013010","ENSBGRT00000023773",15143,"ENSBGRG00000013010","NA","NA","NA",{"v":3.2e-07,"d":"0.00"},1,"211,",0,-6.49,-5.72,5.44,"Exon (ENSBGRT00000023773/ENSBGRG00000013010, exon 2 of 2)",25,55950210,55967242,17033,1]
["chr26",47737385,47737664,280,"ENSBGRG00000014632","ENSBGRT00000026993",392,"ENSBGRG00000014632","NA","GO:0005506(iron ion binding);GO:0005833(hemoglobin complex);GO:0015671(oxygen transport);GO:0019825(oxygen binding);GO:0020037(heme binding)","05144(Malaria);05143(African trypanosomiasis)",{"v":0.026,"d":"0.03"},2,"167,9,","0,271",-1.58,-1.06,1.79,"3' UTR",26,47737327,47738056,730,2]
["chr26",47737780,47738056,277,"ENSBGRG00000014632","ENSBGRT00000026993",0,"ENSBGRG00000014632","NA","GO:0005506(iron ion binding);GO:0005833(hemoglobin complex);GO:0015671(oxygen transport);GO:0019825(oxygen binding);GO:0020037(heme binding)","05144(Malaria);05143(African trypanosomiasis)",{"v":0.0055,"d":"0.01"},2,"81,95,","0,182",-2.26,-1.68,2.72,"Exon (ENSBGRT00000026993/ENSBGRG00000014632, exon 1 of 3)",26,47737327,47738056,730,2]

{"sheet":"YO-P","index":2,"n_rows":13524,"n_cols":24,"rows_kept":2250,"cut":true,"bounds":{"rows_first":1000,"rows_last":250,"rows_between":1000,"halvings":1}}
["seqnames","start","end","width","geneId","transcriptId","distanceToTSS","geneName","Description","GO","KEGG","score","blockCount","blockSizes","blockStarts","lg.p","lg.fdr","fold_enrichment","annotation","geneChr","geneStart","geneEnd","geneLength","geneStrand"]
["chr1",956005,982433,26429,"ENSBGRG00000000004","ENSBGRT00000000007",0,"VGLL3","vestigial like family member 3 [Source:HGNC Symbol;Acc:HGNC:24327]","GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.3e-26,"d":"0.00"},4,"609,286,107,70,","0,13644,26250,26359",{"v":-25.9,"d":"-25.90"},{"v":-24.8,"d":"-24.80"},{"v":17.8,"d":"17.80"},"5' UTR",1,956005,1012265,56261,1]
["chr1",982612,1011551,28940,"ENSBGRG00000000004","ENSBGRT00000000007",26607,"VGLL3","vestigial like family member 3 [Source:HGNC Symbol;Acc:HGNC:24327]","GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":3.2e-26,"d":"0.00"},2,"176,123,","0,28817",{"v":-25.5,"d":"-25.50"},{"v":-24.4,"d":"-24.40"},4.15,"3' UTR",1,956005,1012265,56261,1]
["chr1",14212338,14212548,211,"ENSBGRG00000000021","ENSBGRT00000000030",0,"LIPI","lipase I [Source:HGNC Symbol;Acc:HGNC:18821]","GO:0004620(phospholipase activity);GO:0006629(lipid metabolic process);GO:0008201(heparin binding);GO:0016042(lipid catabolic process);GO:0052689(carboxylic ester hydrolase activity)","NA",{"v":0.025,"d":"0.03"},1,"211,",0,-1.61,-1.07,4.86,"Exon (ENSBGRT00000000034/ENSBGRG00000000023, exon 1 of 5)",1,14126671,14212482,85812,2]
["chr1",14389168,14389288,121,"ENSBGRG00000000024","ENSBGRT00000000035",108210,"ENSBGRG00000000024","NA","GO:0005524(ATP binding);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0042626(ATPase-coupled transmembrane transporter activity);GO:0055085(transmembrane transport)","02010(ABC transporters)",{"v":0.043,"d":"0.04"},1,"121,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000000035/ENSBGRG00000000024, exon 28 of 28)",1,14280958,14389288,108331,1]
["chr1",16186650,16187193,544,"ENSBGRG00000000031","ENSBGRT00000000048",170582,"USP25","ubiquitin specific peptidase 25 [Source:HGNC Symbol;Acc:HGNC:12624]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032183(SUMO binding);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0051117(ATPase binding);GO:0070536(protein K63-linked deubiquitination);GO:0071108(protein K48-linked deubiquitination);GO:1904293(negative regulation of ERAD pathway)","04657(IL-17 signaling pathway)",{"v":1e-69,"d":"0.00"},2,"66,173,","0,371",-69,{"v":-67.6,"d":"-67.60"},2.24,"Exon (ENSBGRT00000000048/ENSBGRG00000000031, exon 25 of 26)",1,16016068,16187193,171126,1]
["chr1",16667373,16680127,12755,"ENSBGRG00000000034","ENSBGRT00000000062",0,"ENSBGRG00000000034","NA","NA","NA",{"v":0.025,"d":"0.03"},2,"462,49,","0,12706",-1.61,-1.07,7.56,"Exon (ENSBGRT00000000057/ENSBGRG00000000034, exon 2 of 2)",1,16680079,16751435,71357,1]
["chr1",27555041,27567800,12760,"ENSBGRG00000000061","ENSBGRT00000000101",30009,"GABPA","GA binding protein transcription factor subunit alpha [Source:HGNC Symbol;Acc:HGNC:4071]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0001825(blastocyst formation);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0010628(positive regulation of gene expression);GO:0033613(activating transcription factor binding);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045653(negative regulation of megakaryocyte differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1903351(cellular response to dopamine);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":2e-77,"d":"0.00"},3,"94,193,102,","0,5949,12658",{"v":-76.7,"d":"-76.70"},{"v":-75.2,"d":"-75.20"},3.57,"Exon (ENSBGRT00000000101/ENSBGRG00000000061, exon 8 of 10)",1,27525032,27568278,43247,1]
["chr1",31440744,31447374,6631,"ENSBGRG00000000077","ENSBGRT00000000134",20448,"USP16","ubiquitin specific peptidase 16 [Source:HGNC Symbol;Acc:HGNC:12614]","GO:0000278(mitotic cell cycle);GO:0003713(transcription coactivator activity);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008270(zinc ion binding);GO:0010468(regulation of gene expression);GO:0016578(histone deubiquitination);GO:0016579(protein deubiquitination);GO:0035522(monoubiquitinated histone H2A deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042393(histone binding);GO:0043130(ubiquitin binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045901(positive regulation of translational elongation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051289(protein homotetramerization);GO:0051726(regulation of cell cycle);GO:0070537(histone H2A K63-linked deubiquitination)","NA",{"v":1e-184,"d":"0.00"},4,"10,177,664,16,","0,1866,4900,6615",-184,-182,5.25,"Exon (ENSBGRT00000000134/ENSBGRG00000000077, exon 12 of 18)",1,31420296,31451387,31092,1]
["chr1",31787595,31788100,506,"ENSBGRG00000000080","ENSBGRT00000000142",4132,"BACH1","BTB domain and CNC homolog 1 [Source:HGNC Symbol;Acc:HGNC:935]","GO:0000083(regulation of transcription involved in G1/S transition of mitotic cell cycle);GO:0000117(regulation of transcription involved in G2/M transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0006355(regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061418(regulation of transcription from RNA polymerase II promoter in response to hypoxia)","NA",{"v":1.3e-30,"d":"0.00"},1,"506,",0,{"v":-29.9,"d":"-29.90"},{"v":-28.8,"d":"-28.80"},8.47,"Exon (ENSBGRT00000000142/ENSBGRG00000000080, exon 2 of 4)",1,31783463,31799779,16317,1]
["chr1",36073965,36074262,298,"ENSBGRG00000000123","ENSBGRT00000000199",122312,"EVA1C","eva-1 homolog C [Source:HGNC Symbol;Acc:HGNC:13239]","GO:0005576(extracellular region);GO:0008201(heparin binding);GO:0030246(carbohydrate binding)","03420(Nucleotide excision repair);00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":1e-102,"d":"0.00"},1,"298,",0,-102,-100,7.17,"3' UTR",1,35951653,36074335,122683,1]
["chr1",36825261,36826040,780,"ENSBGRG00000000131","ENSBGRT00000000219",38966,"ENSBGRG00000000131","NA","GO:0005515(protein binding)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04217(Necroptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04380(Osteoclast differentiation);05200(Pathways in cancer);05162(Measles);05164(Influenza A);05160(Hepatitis C);05168(Herpes simplex infection);05167(Kaposi sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection)",{"v":1e-124,"d":"0.00"},1,"780,",0,-124,-122,8.83,"3' UTR",1,36786295,36825265,38971,1]
["chr1",36826159,36826578,420,"ENSBGRG00000000131","ENSBGRT00000000218",39864,"ENSBGRG00000000131","NA","GO:0005515(protein binding)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04217(Necroptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04380(Osteoclast differentiation);05200(Pathways in cancer);05162(Measles);05164(Influenza A);05160(Hepatitis C);05168(Herpes simplex infection);05167(Kaposi sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection)",{"v":6.3e-31,"d":"0.00"},1,"420,",0,{"v":-30.2,"d":"-30.20"},{"v":-29.1,"d":"-29.10"},{"v":2.7,"d":"2.70"},"3' UTR",1,36786295,36826818,40524,1]
["chr1",36967089,36967325,237,"ENSBGRG00000000133","ENSBGRT00000000221",29953,"IFNAR1","interferon alpha and beta receptor subunit 1 [Source:HGNC Symbol;Acc:HGNC:5432]","GO:0004904(interferon receptor activity);GO:0004905(type I interferon receptor activity);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0060337(type I interferon signaling pathway)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04217(Necroptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04380(Osteoclast differentiation);05200(Pathways in cancer);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05168(Herpes simplex infection);05167(Kaposi sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection)",{"v":7.9e-95,"d":"0.00"},1,"237,",0,{"v":-94.1,"d":"-94.10"},{"v":-92.5,"d":"-92.50"},4.14,"Exon (ENSBGRT00000000221/ENSBGRG00000000133, exon 11 of 11)",1,36937136,36967325,30190,1]
["chr1",37065452,37065571,120,"ENSBGRG00000000134","ENSBGRT00000000223",32650,"IFNGR2","interferon gamma receptor 2 [Source:HGNC Symbol;Acc:HGNC:5440]","GO:0005515(protein binding)","04630(Jak-STAT signaling pathway);04066(HIF-1 signaling pathway);04060(Cytokine-cytokine receptor interaction);04217(Necroptosis);04650(Natural killer cell mediated cytotoxicity);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04380(Osteoclast differentiation);05200(Pathways in cancer);05321(Inflammatiory bowel disease (IBD));05132(Salmonella infection);05152(Tuberculosis);05162(Measles);05164(Influenza A);05168(Herpes simplex infection);05145(Toxoplasmosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis))",{"v":1e-106,"d":"0.00"},1,"120,",0,-106,-104,2.96,"Exon (ENSBGRT00000000223/ENSBGRG00000000134, exon 7 of 7)",1,37032802,37065571,32770,1]
["chr1",37202367,37202547,181,"ENSBGRG00000000139","ENSBGRT00000000229",5768,"SON","SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183]","GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0043484(regulation of RNA splicing);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:0050733(RS domain binding);GO:0051726(regulation of cell cycle)","NA",{"v":5e-61,"d":"0.00"},1,"181,",0,{"v":-60.3,"d":"-60.30"},{"v":-58.9,"d":"-58.90"},5.28,"Exon (ENSBGRT00000000232/ENSBGRG00000000139, exon 3 of 8)",1,37196599,37229433,32835,1]
["chr1",37205972,37206332,361,"ENSBGRG00000000139","ENSBGRT00000000229",9373,"SON","SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183]","GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0043484(regulation of RNA splicing);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:0050733(RS domain binding);GO:0051726(regulation of cell cycle)","NA",{"v":1e-252,"d":"0.00"},1,"361,",0,-252,-250,9.93,"Exon (ENSBGRT00000000232/ENSBGRG00000000139, exon 4 of 8)",1,37196599,37229433,32835,1]
["chr1",37206601,37206931,331,"ENSBGRG00000000139","ENSBGRT00000000229",10002,"SON","SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183]","GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0043484(regulation of RNA splicing);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:0050733(RS domain binding);GO:0051726(regulation of cell cycle)","NA",{"v":8.99999999999999E-306,"d":"0.00"},1,"331,",0,-305,-302,{"v":12.3,"d":"12.30"},"Exon (ENSBGRT00000000232/ENSBGRG00000000139, exon 4 of 8)",1,37196599,37229433,32835,1]
["chr1",37206991,37207171,181,"ENSBGRG00000000139","ENSBGRT00000000229",10392,"SON","SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183]","GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0043484(regulation of RNA splicing);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:0050733(RS domain binding);GO:0051726(regulation of cell cycle)","NA",{"v":8.99999999999999E-306,"d":"0.00"},1,"181,",0,-305,-302,{"v":18.1,"d":"18.10"},"Exon (ENSBGRT00000000232/ENSBGRG00000000139, exon 4 of 8)",1,37196599,37229433,32835,1]
["chr1",37207501,37207980,480,"ENSBGRG00000000139","ENSBGRT00000000229",10902,"SON","SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183]","GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0043484(regulation of RNA splicing);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:0050733(RS domain binding);GO:0051726(regulation of cell cycle)","NA",{"v":1e-145,"d":"0.00"},1,"480,",0,-145,-144,2.66,"Exon (ENSBGRT00000000232/ENSBGRG00000000139, exon 4 of 8)",1,37196599,37229433,32835,1]
["chr1",37411726,37450795,39070,"ENSBGRG00000000143","ENSBGRT00000000245",49643,"ITSN1","intersectin 1 [Source:HGNC Symbol;Acc:HGNC:6183]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005905(clathrin-coated pit);GO:0007264(small GTPase mediated signal transduction);GO:0019209(kinase activator activity);GO:0030027(lamellipodium);GO:0030139(endocytic vesicle);GO:0034613(cellular protein localization);GO:0035556(intracellular signal transduction);GO:0043524(negative regulation of neuron apoptotic process);GO:0044305(calyx of Held);GO:0048488(synaptic vesicle endocytosis);GO:0051897(positive regulation of protein kinase B signaling);GO:0060090(molecular adaptor activity);GO:0070064(proline-rich region binding);GO:0098833(presynaptic endocytic zone)","NA",{"v":2e-61,"d":"0.00"},7,"210,150,141,88,140,128,132,","0,2971,3206,11512,11722,34632,38938",{"v":-60.7,"d":"-60.70"},{"v":-59.3,"d":"-59.30"},{"v":3.3,"d":"3.30"},"Exon (ENSBGRT00000000245/ENSBGRG00000000143, exon 11 of 22)",1,37362083,37468747,106665,1]
["chr1",37547675,37551465,3791,"ENSBGRG00000000143","ENSBGRT00000000240",185592,"ITSN1","intersectin 1 [Source:HGNC Symbol;Acc:HGNC:6183]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005905(clathrin-coated pit);GO:0007264(small GTPase mediated signal transduction);GO:0019209(kinase activator activity);GO:0030027(lamellipodium);GO:0030139(endocytic vesicle);GO:0034613(cellular protein localization);GO:0035556(intracellular signal transduction);GO:0043524(negative regulation of neuron apoptotic process);GO:0044305(calyx of Held);GO:0048488(synaptic vesicle endocytosis);GO:0051897(positive regulation of protein kinase B signaling);GO:0060090(molecular adaptor activity);GO:0070064(proline-rich region binding);GO:0098833(presynaptic endocytic zone)","NA",{"v":0.014,"d":"0.01"},2,"9,112,","0,3679",-1.86,{"v":-1.3,"d":"-1.30"},7.56,"Exon (ENSBGRT00000000240/ENSBGRG00000000143, exon 38 of 39)",1,37362083,37551824,189742,1]
["chr1",37857853,37858026,174,"ENSBGRG00000000146","ENSBGRT00000000249",70315,"MRPS6","mitochondrial ribosomal protein S6 [Source:HGNC Symbol;Acc:HGNC:14051]","GO:0003735(structural constituent of ribosome);GO:0005739(mitochondrion);GO:0005763(mitochondrial small ribosomal subunit);GO:0005840(ribosome);GO:0006412(translation);GO:0019843(rRNA binding)","03010(Ribosome)",{"v":7.9e-17,"d":"0.00"},1,"174,",0,{"v":-16.1,"d":"-16.10"},{"v":-15.1,"d":"-15.10"},1.52,"Exon (ENSBGRT00000000249/ENSBGRG00000000146, exon 3 of 3)",1,37787538,37858026,70489,1]
["chr1",38672183,38672599,417,"ENSBGRG00000000161","ENSBGRT00000000266",684,"HTR1F","5-hydroxytryptamine receptor 1F [Source:HGNC Symbol;Acc:HGNC:5292]","GO:0004930(G protein-coupled receptor activity);GO:0004993(G protein-coupled serotonin receptor activity);GO:0005887(integral component of plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0051378(serotonin binding)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04726(Serotonergic synapse);04742(Taste transduction)",{"v":0.00069,"d":"0.00"},1,"417,",0,-3.16,-2.51,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000000266/ENSBGRG00000000161, exon 1 of 1)",1,38671499,38672599,1101,1]
["chr1",38733258,38733526,269,"ENSBGRG00000000164","ENSBGRT00000000269",92461,"CGGBP1","CGG triplet repeat binding protein 1 [Source:HGNC Symbol;Acc:HGNC:1888]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0042802(identical protein binding);GO:0090579(dsDNA loop formation);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.028,"d":"0.03"},1,"269,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",1,38729830,38825987,96158,2]
["chr1",38825429,38825727,299,"ENSBGRG00000000164","ENSBGRT00000000269",260,"CGGBP1","CGG triplet repeat binding protein 1 [Source:HGNC Symbol;Acc:HGNC:1888]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0042802(identical protein binding);GO:0090579(dsDNA loop formation);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":7.9e-50,"d":"0.00"},1,"299,",0,{"v":-49.1,"d":"-49.10"},{"v":-47.8,"d":"-47.80"},5.47,"Exon (ENSBGRT00000000273/ENSBGRG00000000166, exon 8 of 9)",1,38729830,38825987,96158,2]
["chr1",38848592,38849069,478,"ENSBGRG00000000178","ENSBGRT00000000285",12734,"C3orf38","chromosome 3 open reading frame 38 [Source:HGNC Symbol;Acc:HGNC:28384]","GO:0005634(nucleus);GO:0043065(positive regulation of apoptotic process)","NA",{"v":4E-41,"d":"0.00"},1,"478,",0,{"v":-40.4,"d":"-40.40"},{"v":-39.2,"d":"-39.20"},{"v":16.5,"d":"16.50"},"3' UTR",1,38835858,38850353,14496,1]
["chr1",38849159,38849457,299,"ENSBGRG00000000178","ENSBGRT00000000285",13301,"C3orf38","chromosome 3 open reading frame 38 [Source:HGNC Symbol;Acc:HGNC:28384]","GO:0005634(nucleus);GO:0043065(positive regulation of apoptotic process)","NA",{"v":5.6e-05,"d":"0.00"},1,"299,",0,-4.25,-3.56,{"v":10.3,"d":"10.30"},"3' UTR",1,38835858,38850353,14496,1]
["chr1",38849726,38850144,419,"ENSBGRG00000000178","ENSBGRT00000000285",13868,"C3orf38","chromosome 3 open reading frame 38 [Source:HGNC Symbol;Acc:HGNC:28384]","GO:0005634(nucleus);GO:0043065(positive regulation of apoptotic process)","NA",{"v":1e-111,"d":"0.00"},1,"419,",0,-111,-110,{"v":10.7,"d":"10.70"},"3' UTR",1,38835858,38850353,14496,1]
["chr1",39875237,40015131,139895,"ENSBGRG00000000197","ENSBGRT00000000326",0,"EPHA3","EPH receptor A3 [Source:HGNC Symbol;Acc:HGNC:3387]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005004(GPI-linked ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0010976(positive regulation of neuron projection development);GO:0015629(actin cytoskeleton);GO:0016021(integral component of membrane);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0031965(nuclear membrane);GO:0032956(regulation of actin cytoskeleton organization);GO:0043087(regulation of GTPase activity);GO:0045806(negative regulation of endocytosis);GO:0048013(ephrin receptor signaling pathway);GO:0051893(regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:0071300(cellular response to retinoic acid);GO:1903078(positive regulation of protein localization to plasma membrane)","04360(Axon guidance)",{"v":0.028,"d":"0.03"},3,"88,65,475,","0,25381,139420",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000000326/ENSBGRG00000000197, exon 1 of 17)",1,39875237,40333962,458726,1]
["chr1",41217389,41228156,10768,"ENSBGRG00000000594","ENSBGRT00000001136",63594,"ARL13B","ADP ribosylation factor like GTPase 13B [Source:HGNC Symbol;Acc:HGNC:25419]","GO:0001947(heart looping);GO:0005525(GTP binding);GO:0005929(cilium);GO:0005930(axoneme);GO:0007224(smoothened signaling pathway);GO:0007368(determination of left/right symmetry);GO:0009953(dorsal/ventral pattern formation);GO:0021532(neural tube patterning);GO:0021830(interneuron migration from the subpallium to the cortex);GO:0021943(formation of radial glial scaffolds);GO:0031514(motile cilium);GO:0060170(ciliary membrane);GO:0060271(cilium assembly);GO:0070986(left/right axis specification);GO:1905515(non-motile cilium assembly)","NA",{"v":1e-36,"d":"0.00"},6,"41,203,115,70,223,31,","0,925,4554,5460,7836,10737",-36,{"v":-34.9,"d":"-34.90"},2.76,"Exon (ENSBGRT00000001136/ENSBGRG00000000594, exon 4 of 10)",1,41153795,41238379,84585,1]
["chr1",44546092,44818295,272204,"ENSBGRG00000000823","ENSBGRT00000001487",0,"U6","U6 spliceosomal RNA [Source:RFAM;Acc:RF00026]","NA","NA",{"v":0.0013,"d":"0.00"},4,"282,125,163,86,","0,181253,232348,272118",-2.89,-2.26,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000001431/ENSBGRG00000000760, exon 5 of 18)",1,44706179,44706284,106,2]
["chr1",45144214,45144482,269,"ENSBGRG00000000760","ENSBGRT00000001431",1092831,"EPHA6","EPH receptor A6 [Source:HGNC Symbol;Acc:HGNC:19296]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0016021(integral component of membrane)","04360(Axon guidance)",{"v":0.025,"d":"0.03"},1,"269,",0,-1.61,-1.07,7.56,"3' UTR",1,44051383,45144482,1093100,1]
["chr1",45273190,45281401,8212,"ENSBGRG00000000874","ENSBGRT00000001593",48051,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":1.5E-5,"d":"0.00"},2,"83,158,","0,8054",-4.81,{"v":-4.1,"d":"-4.10"},{"v":17.3,"d":"17.30"},"Exon (ENSBGRT00000001593/ENSBGRG00000000874, exon 3 of 23)",1,45225139,45364143,139005,1]
["chr1",45283595,45283864,270,"ENSBGRG00000000874","ENSBGRT00000001593",58456,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":0.0078,"d":"0.01"},1,"270,",0,-2.11,{"v":-1.3,"d":"-1.30"},9.72,"Exon (ENSBGRT00000001593/ENSBGRG00000000874, exon 5 of 23)",1,45225139,45364143,139005,1]
["chr1",45285960,45286050,91,"ENSBGRG00000000874","ENSBGRT00000001593",60821,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":7.9e-17,"d":"0.00"},1,"91,",0,{"v":-16.1,"d":"-16.10"},{"v":-15.2,"d":"-15.20"},5.08,"Exon (ENSBGRT00000001593/ENSBGRG00000000874, exon 5 of 23)",1,45225139,45364143,139005,1]
["chr1",45287068,45287308,241,"ENSBGRG00000000874","ENSBGRT00000001593",61929,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":2e-07,"d":"0.00"},1,"241,",0,{"v":-6.7,"d":"-6.70"},-5.93,3.19,"Exon (ENSBGRT00000001593/ENSBGRG00000000874, exon 5 of 23)",1,45225139,45364143,139005,1]
["chr1",45362694,45363604,911,"ENSBGRG00000000874","ENSBGRT00000001593",137555,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":1.3e-19,"d":"0.00"},2,"80,41,","0,870",{"v":-18.9,"d":"-18.90"},{"v":-17.9,"d":"-17.90"},1.88,"3' UTR",1,45225139,45364143,139005,1]
["chr1",47442845,47442964,120,"ENSBGRG00000002584","ENSBGRT00000004837",64542,"COL8A1","collagen type VIII alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2215]","GO:0005515(protein binding);GO:0010811(positive regulation of cell-substrate adhesion);GO:0035987(endodermal cell differentiation);GO:0048593(camera-type eye morphogenesis);GO:0050673(epithelial cell proliferation)","04974(Protein digestion and absorption)",{"v":4e-37,"d":"0.00"},1,"120,",0,{"v":-36.4,"d":"-36.40"},{"v":-35.2,"d":"-35.20"},3.23,"Exon (ENSBGRT00000004837/ENSBGRG00000002584, exon 3 of 3)",1,47378303,47443264,64962,1]
["chr1",47443084,47443264,181,"ENSBGRG00000002584","ENSBGRT00000004837",64781,"COL8A1","collagen type VIII alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2215]","GO:0005515(protein binding);GO:0010811(positive regulation of cell-substrate adhesion);GO:0035987(endodermal cell differentiation);GO:0048593(camera-type eye morphogenesis);GO:0050673(epithelial cell proliferation)","04974(Protein digestion and absorption)",{"v":2e-64,"d":"0.00"},1,"181,",0,{"v":-63.7,"d":"-63.70"},{"v":-62.3,"d":"-62.30"},3.76,"Exon (ENSBGRT00000004837/ENSBGRG00000002584, exon 3 of 3)",1,47378303,47443264,64962,1]
["chr1",49544595,49549259,4665,"ENSBGRG00000003698","ENSBGRT00000006864",819,"TRMT10C","tRNA methyltransferase 10C, mitochondrial RNase P subunit [Source:HGNC Symbol;Acc:HGNC:26022]","GO:0000049(tRNA binding);GO:0000964(mitochondrial RNA 5'-end processing);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008033(tRNA processing);GO:0009019(tRNA (guanine-N1-)-methyltransferase activity);GO:0016429(tRNA (adenine-N1-)-methyltransferase activity);GO:0042802(identical protein binding);GO:0061953(mRNA (adenine-N1-)-methyltransferase activity);GO:0070131(positive regulation of mitochondrial translation);GO:0080009(mRNA methylation);GO:0090646(mitochondrial tRNA processing);GO:0097745(mitochondrial tRNA 5'-end processing);GO:1990180(mitochondrial tRNA 3'-end processing)","NA",{"v":4.3e-09,"d":"0.00"},2,"35,264,","0,4401",-8.37,-7.56,4.68,"5' UTR",1,49543776,49573670,29895,1]
["chr1",49572598,49573164,567,"ENSBGRG00000003698","ENSBGRT00000006864",28822,"TRMT10C","tRNA methyltransferase 10C, mitochondrial RNase P subunit [Source:HGNC Symbol;Acc:HGNC:26022]","GO:0000049(tRNA binding);GO:0000964(mitochondrial RNA 5'-end processing);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008033(tRNA processing);GO:0009019(tRNA (guanine-N1-)-methyltransferase activity);GO:0016429(tRNA (adenine-N1-)-methyltransferase activity);GO:0042802(identical protein binding);GO:0061953(mRNA (adenine-N1-)-methyltransferase activity);GO:0070131(positive regulation of mitochondrial translation);GO:0080009(mRNA methylation);GO:0090646(mitochondrial tRNA processing);GO:0097745(mitochondrial tRNA 5'-end processing);GO:1990180(mitochondrial tRNA 3'-end processing)","NA",{"v":1e-102,"d":"0.00"},1,"567,",0,-102,-101,5.81,"Exon (ENSBGRT00000006864/ENSBGRG00000003698, exon 3 of 3)",1,49543776,49573670,29895,1]
["chr1",49678260,49678379,120,"ENSBGRG00000003937","ENSBGRT00000007567",11061,"CEP97","centrosomal protein 97 [Source:HGNC Symbol;Acc:HGNC:26244]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0005829(cytosol);GO:0032991(protein-containing complex);GO:0034451(centriolar satellite);GO:1901673(regulation of mitotic spindle assembly);GO:1902018(negative regulation of cilium assembly)","NA",{"v":0.015,"d":"0.02"},1,"120,",0,-1.83,-1.07,8.64,"Exon (ENSBGRT00000007567/ENSBGRG00000003937, exon 7 of 13)",1,49667199,49689989,22791,1]
["chr1",49680427,49680487,61,"ENSBGRG00000003937","ENSBGRT00000007567",13228,"CEP97","centrosomal protein 97 [Source:HGNC Symbol;Acc:HGNC:26244]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0005829(cytosol);GO:0032991(protein-containing complex);GO:0034451(centriolar satellite);GO:1901673(regulation of mitotic spindle assembly);GO:1902018(negative regulation of cilium assembly)","NA",{"v":0.0021,"d":"0.00"},1,"61,",0,-2.67,-2.06,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000007567/ENSBGRG00000003937, exon 9 of 13)",1,49667199,49689989,22791,1]
["chr1",49742383,49742532,150,"ENSBGRG00000004124","ENSBGRT00000007643",32429,"NXPE3","neurexophilin and PC-esterase domain family member 3 [Source:HGNC Symbol;Acc:HGNC:28238]","NA","04068(FoxO signaling pathway)",{"v":1.3e-71,"d":"0.00"},1,"150,",0,{"v":-70.9,"d":"-70.90"},{"v":-69.5,"d":"-69.50"},5.44,"Exon (ENSBGRT00000007643/ENSBGRG00000004124, exon 3 of 6)",1,49709954,49766563,56610,1]
["chr1",49766203,49766563,361,"ENSBGRG00000004124","ENSBGRT00000007643",56249,"NXPE3","neurexophilin and PC-esterase domain family member 3 [Source:HGNC Symbol;Acc:HGNC:28238]","NA","04068(FoxO signaling pathway)",{"v":1E-167,"d":"0.00"},1,"361,",0,-167,-165,4.81,"Exon (ENSBGRT00000007643/ENSBGRG00000004124, exon 6 of 6)",1,49709954,49766563,56610,1]
["chr1",56594589,56594948,360,"ENSBGRG00000005097","ENSBGRT00000009549",281844,"BBX","BBX high mobility group box domain containing [Source:HGNC Symbol;Acc:HGNC:14422]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0060348(bone development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":4e-28,"d":"0.00"},1,"360,",0,{"v":-27.4,"d":"-27.40"},{"v":-26.4,"d":"-26.40"},3.88,"Exon (ENSBGRT00000009549/ENSBGRG00000005097, exon 10 of 16)",1,56312745,56624479,311735,1]
["chr1",57256453,57256572,120,"ENSBGRG00000005718","ENSBGRT00000010553",6798,"ENSBGRG00000005718","NA","NA","NA",{"v":6.6E-10,"d":"0.00"},1,"120,",0,-9.18,-8.35,3.46,"Exon (ENSBGRT00000010553/ENSBGRG00000005718, exon 2 of 2)",1,57249655,57258290,8636,1]
["chr1",57695551,57695670,120,"ENSBGRG00000006159","ENSBGRT00000011460",60126,"DZIP3","DAZ interacting zinc finger protein 3 [Source:HGNC Symbol;Acc:HGNC:30938]","GO:0000209(protein polyubiquitination);GO:0003723(RNA binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005737(cytoplasm);GO:0019902(phosphatase binding);GO:0031593(polyubiquitin modification-dependent protein binding);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":0.0011,"d":"0.00"},1,"120,",0,-2.96,-2.33,13,"Exon (ENSBGRT00000011354/ENSBGRG00000006159, exon 13 of 31)",1,57635425,57753008,117584,1]
["chr1",60480881,60481060,180,"ENSBGRG00000000168","ENSBGRT00000000293",77123,"NECTIN3","nectin cell adhesion molecule 3 [Source:HGNC Symbol;Acc:HGNC:17664]","GO:0002089(lens morphogenesis in camera-type eye);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007286(spermatid development);GO:0009566(fertilization);GO:0042803(protein homodimerization activity);GO:0043296(apical junction complex);GO:0044291(cell-cell contact zone);GO:0050839(cell adhesion molecule binding);GO:0060042(retina morphogenesis in camera-type eye);GO:0061951(establishment of protein localization to plasma membrane);GO:0098609(cell-cell adhesion);GO:0098686(hippocampal mossy fiber to CA3 synapse);GO:0099061(integral component of postsynaptic density membrane);GO:1902414(protein localization to cell junction)","04514(Cell adhesion molecules (CAMs));04520(Adherens junction)",{"v":1E-58,"d":"0.00"},1,"180,",0,-58,{"v":-56.7,"d":"-56.70"},4.09,"Exon (ENSBGRT00000000293/ENSBGRG00000000168, exon 7 of 7)",1,60403758,60481330,77573,1]
["chr1",61366793,61366972,180,"ENSBGRG00000000410","ENSBGRT00000000700",14788,"TAGLN3","transgelin 3 [Source:HGNC Symbol;Acc:HGNC:29868]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005515(protein binding);GO:0005634(nucleus)","NA",{"v":0.0016,"d":"0.00"},1,"180,",0,{"v":-2.8,"d":"-2.80"},-2.18,3.78,"3' UTR",1,61352005,61366972,14968,1]
["chr1",61733661,61733869,209,"ENSBGRG00000000619","ENSBGRT00000001124",7417,"ENSBGRG00000000619","NA","GO:0043031(negative regulation of macrophage activation);GO:0050776(regulation of immune response)","NA",{"v":5e-32,"d":"0.00"},1,"209,",0,{"v":-31.3,"d":"-31.30"},{"v":-30.1,"d":"-30.10"},2.08,"5' UTR",1,61726244,61737301,11058,1]
["chr1",61737002,61737091,90,"ENSBGRG00000000619","ENSBGRT00000001124",10758,"ENSBGRG00000000619","NA","GO:0043031(negative regulation of macrophage activation);GO:0050776(regulation of immune response)","NA",{"v":3.5e-08,"d":"0.00"},1,"90,",0,-7.45,-6.66,1.44,"Exon (ENSBGRT00000001124/ENSBGRG00000000619, exon 4 of 4)",1,61726244,61737301,11058,1]
["chr1",61982796,61982913,118,"ENSBGRG00000000743","ENSBGRT00000001353",16702,"SLC35A5","solute carrier family 35 member A5 [Source:HGNC Symbol;Acc:HGNC:20792]","GO:0000139(Golgi membrane);GO:0015165(pyrimidine nucleotide-sugar transmembrane transporter activity);GO:0016021(integral component of membrane);GO:0090481(pyrimidine nucleotide-sugar transmembrane transport)","NA",{"v":5e-67,"d":"0.00"},1,"118,",0,{"v":-66.3,"d":"-66.30"},{"v":-64.9,"d":"-64.90"},2.54,"Exon (ENSBGRT00000001353/ENSBGRG00000000743, exon 5 of 6)",1,61966094,61983491,17398,1]
["chr1",61983089,61983236,148,"ENSBGRG00000000743","ENSBGRT00000001353",16995,"SLC35A5","solute carrier family 35 member A5 [Source:HGNC Symbol;Acc:HGNC:20792]","GO:0000139(Golgi membrane);GO:0015165(pyrimidine nucleotide-sugar transmembrane transporter activity);GO:0016021(integral component of membrane);GO:0090481(pyrimidine nucleotide-sugar transmembrane transport)","NA",{"v":7.9e-67,"d":"0.00"},1,"148,",0,{"v":-66.1,"d":"-66.10"},{"v":-64.7,"d":"-64.70"},4.24,"Exon (ENSBGRT00000001376/ENSBGRG00000000743, exon 7 of 8)",1,61966094,61983491,17398,1]
["chr1",61986207,61986266,60,"ENSBGRG00000000743","ENSBGRT00000001376",20094,"SLC35A5","solute carrier family 35 member A5 [Source:HGNC Symbol;Acc:HGNC:20792]","GO:0000139(Golgi membrane);GO:0015165(pyrimidine nucleotide-sugar transmembrane transporter activity);GO:0016021(integral component of membrane);GO:0090481(pyrimidine nucleotide-sugar transmembrane transport)","NA",{"v":5e-19,"d":"0.00"},1,"60,",0,{"v":-18.3,"d":"-18.30"},{"v":-17.3,"d":"-17.30"},{"v":2.1,"d":"2.10"},"Exon (ENSBGRT00000001376/ENSBGRG00000000743, exon 8 of 8)",1,61966113,61986266,20154,1]
["chr1",63047743,63048518,776,"ENSBGRG00000001237","ENSBGRT00000002472",112128,"SIDT1","SID1 transmembrane family member 1 [Source:HGNC Symbol;Acc:HGNC:25967]","GO:0015485(cholesterol binding);GO:0016021(integral component of membrane);GO:0033227(dsRNA transport);GO:0051033(RNA transmembrane transporter activity)","NA",{"v":5.9e-07,"d":"0.00"},1,"776,",0,-6.23,-5.47,{"v":17.3,"d":"17.30"},"3' UTR",1,62935615,63048786,113172,1]
["chr1",63263377,63330962,67586,"ENSBGRG00000001529","ENSBGRT00000002923",0,"GRAMD1C","GRAM domain containing 1C [Source:HGNC Symbol;Acc:HGNC:25252]","NA","NA",{"v":0.0078,"d":"0.01"},5,"330,82,39,119,61,","0,26235,54787,66432,67525",-2.11,-1.53,8.64,"5' UTR",1,63263377,63371109,107733,1]
["chr1",63372622,63372772,151,"ENSBGRG00000001676","ENSBGRT00000003112",0,"ZDHHC23","zinc finger DHHC-type containing 23 [Source:HGNC Symbol;Acc:HGNC:28654]","GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0072659(protein localization to plasma membrane)","NA",{"v":0.015,"d":"0.02"},1,"151,",0,-1.83,-1.02,8.64,"5' UTR",1,63372622,63386515,13894,1]
["chr1",63377552,63384311,6760,"ENSBGRG00000001676","ENSBGRT00000003112",4930,"ZDHHC23","zinc finger DHHC-type containing 23 [Source:HGNC Symbol;Acc:HGNC:28654]","GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0072659(protein localization to plasma membrane)","NA",{"v":1.9e-05,"d":"0.00"},4,"606,168,168,78,","0,3221,4491,6682",-4.71,-4,{"v":19.4,"d":"19.40"},"Exon (ENSBGRT00000003112/ENSBGRG00000001676, exon 2 of 4)",1,63372622,63386515,13894,1]
["chr1",63717201,63718556,1356,"ENSBGRG00000001881","ENSBGRT00000003504",0,"TIGIT","T cell immunoreceptor with Ig and ITIM domains [Source:HGNC Symbol;Acc:HGNC:26838]","GO:0005102(signaling receptor binding);GO:0009986(cell surface);GO:0032695(negative regulation of interleukin-12 production);GO:0032733(positive regulation of interleukin-10 production);GO:0042802(identical protein binding);GO:0050868(negative regulation of T cell activation)","04514(Cell adhesion molecules (CAMs))",{"v":0.034,"d":"0.03"},3,"64,135,71,","0,165,1285",-1.47,{"v":-0.937,"d":"-0.94"},4.32,"5' UTR",1,63717201,63735730,18530,1]
["chr1",63718615,63735730,17116,"ENSBGRG00000001881","ENSBGRT00000003504",1414,"TIGIT","T cell immunoreceptor with Ig and ITIM domains [Source:HGNC Symbol;Acc:HGNC:26838]","GO:0005102(signaling receptor binding);GO:0009986(cell surface);GO:0032695(negative regulation of interleukin-12 production);GO:0032733(positive regulation of interleukin-10 production);GO:0042802(identical protein binding);GO:0050868(negative regulation of T cell activation)","04514(Cell adhesion molecules (CAMs))",{"v":0.015,"d":"0.02"},3,"201,107,231,","0,2600,16885",-1.83,-1.02,8.64,"Exon (ENSBGRT00000003504/ENSBGRG00000001881, exon 2 of 4)",1,63717201,63735730,18530,1]
["chr1",64747404,64748233,830,"ENSBGRG00000001918","ENSBGRT00000003578",562,"ENSBGRG00000001918","NA","NA","04144(Endocytosis)",{"v":0.028,"d":"0.03"},1,"830,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000003578/ENSBGRG00000001918, exon 1 of 1)",1,64746842,64748233,1392,1]
["chr1",69494849,69495178,330,"ENSBGRG00000002180","ENSBGRT00000004097",132891,"ARHGAP31","Rho GTPase activating protein 31 [Source:HGNC Symbol;Acc:HGNC:29216]","GO:0005096(GTPase activator activity);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0017124(SH3 domain binding);GO:0030027(lamellipodium)","NA",{"v":9.99999999999999e-220,"d":"0.00"},1,"330,",0,-219,-217,3.56,"Exon (ENSBGRT00000004097/ENSBGRG00000002180, exon 12 of 12)",1,69361958,69496669,134712,1]
["chr1",69495357,69495625,269,"ENSBGRG00000002180","ENSBGRT00000004097",133399,"ARHGAP31","Rho GTPase activating protein 31 [Source:HGNC Symbol;Acc:HGNC:29216]","GO:0005096(GTPase activator activity);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0017124(SH3 domain binding);GO:0030027(lamellipodium)","NA",{"v":1E-179,"d":"0.00"},1,"269,",0,-179,-177,3.12,"Exon (ENSBGRT00000004097/ENSBGRG00000002180, exon 12 of 12)",1,69361958,69496669,134712,1]
["chr1",69495983,69496520,538,"ENSBGRG00000002180","ENSBGRT00000004097",134025,"ARHGAP31","Rho GTPase activating protein 31 [Source:HGNC Symbol;Acc:HGNC:29216]","GO:0005096(GTPase activator activity);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0017124(SH3 domain binding);GO:0030027(lamellipodium)","NA",{"v":0,"d":"0.00"},1,"538,",0,-312,-309,{"v":3.3,"d":"3.30"},"Exon (ENSBGRT00000004097/ENSBGRG00000002180, exon 12 of 12)",1,69361958,69496669,134712,1]
["chr1",69646799,69646888,90,"ENSBGRG00000002318","ENSBGRT00000004323",4242,"ADPRH","ADP-ribosylarginine hydrolase [Source:HGNC Symbol;Acc:HGNC:269]","GO:0000287(magnesium ion binding);GO:0003875(ADP-ribosylarginine hydrolase activity);GO:0006464(cellular protein modification process);GO:0030955(potassium ion binding);GO:0051725(protein de-ADP-ribosylation)","NA",{"v":0.028,"d":"0.03"},1,"90,",0,-1.56,-1.03,1.59,"Exon (ENSBGRT00000004323/ENSBGRG00000002318, exon 2 of 4)",1,69642557,69651492,8936,1]
["chr1",69651106,69651314,209,"ENSBGRG00000002318","ENSBGRT00000004323",8549,"ADPRH","ADP-ribosylarginine hydrolase [Source:HGNC Symbol;Acc:HGNC:269]","GO:0000287(magnesium ion binding);GO:0003875(ADP-ribosylarginine hydrolase activity);GO:0006464(cellular protein modification process);GO:0030955(potassium ion binding);GO:0051725(protein de-ADP-ribosylation)","NA",{"v":0.00041,"d":"0.00"},1,"209,",0,-3.39,-2.74,2.56,"Exon (ENSBGRT00000004323/ENSBGRG00000002318, exon 4 of 4)",1,69642557,69651492,8936,1]
["chr1",70873084,70889185,16102,"ENSBGRG00000002869","ENSBGRT00000005369",0,"SNORA70","Small nucleolar RNA SNORA70 [Source:RFAM;Acc:RF00156]","NA","NA",{"v":4E-35,"d":"0.00"},2,"415,64,","0,16038",{"v":-34.4,"d":"-34.40"},{"v":-33.2,"d":"-33.20"},4.32,"Exon (ENSBGRT00000005332/ENSBGRG00000002850, exon 2 of 5)",1,70878443,70878575,133,2]
["chr1",70895502,70900552,5051,"ENSBGRG00000002850","ENSBGRT00000005332",27532,"GTF2E1","general transcription factor IIE subunit 1 [Source:HGNC Symbol;Acc:HGNC:4650]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005669(transcription factor TFIID complex);GO:0005829(cytosol);GO:0006366(transcription by RNA polymerase II);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0016251(RNA polymerase II general transcription initiation factor activity);GO:0097550(transcriptional preinitiation complex)","03022(Basal transcription factors);05203(Viral carcinogenesis);05169(Epstein-Barr virus infection)",{"v":1.6e-26,"d":"0.00"},2,"53,425,","0,4626",{"v":-25.8,"d":"-25.80"},{"v":-24.7,"d":"-24.70"},4.78,"Exon (ENSBGRT00000005332/ENSBGRG00000002850, exon 4 of 5)",1,70867970,70900552,32583,1]
["chr1",71606442,71606651,210,"ENSBGRG00000003263","ENSBGRT00000006059",13776,"FBXO40","F-box protein 40 [Source:HGNC Symbol;Acc:HGNC:29816]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0042692(muscle cell differentiation);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":0.00056,"d":"0.00"},1,"210,",0,-3.25,{"v":-2.6,"d":"-2.60"},14,"Exon (ENSBGRT00000006059/ENSBGRG00000003263, exon 4 of 5)",1,71592666,71611010,18345,1]
["chr1",71607306,71607425,120,"ENSBGRG00000003263","ENSBGRT00000006059",14640,"FBXO40","F-box protein 40 [Source:HGNC Symbol;Acc:HGNC:29816]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0042692(muscle cell differentiation);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":0.043,"d":"0.04"},1,"120,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000006059/ENSBGRG00000003263, exon 4 of 5)",1,71592666,71611010,18345,1]
["chr1",71607752,71607931,180,"ENSBGRG00000003263","ENSBGRT00000006059",15086,"FBXO40","F-box protein 40 [Source:HGNC Symbol;Acc:HGNC:29816]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0042692(muscle cell differentiation);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":0.025,"d":"0.03"},1,"180,",0,-1.61,-1.07,4.86,"Exon (ENSBGRT00000006059/ENSBGRG00000003263, exon 4 of 5)",1,71592666,71611010,18345,1]
["chr1",71810091,71810807,717,"ENSBGRG00000004433","ENSBGRT00000008164",0,"EAF2","ELL associated factor 2 [Source:HGNC Symbol;Acc:HGNC:23115]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008023(transcription elongation factor complex);GO:0030308(negative regulation of cell growth);GO:0032783(super elongation complex);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060770(negative regulation of epithelial cell proliferation involved in prostate gland development)","NA",{"v":0.043,"d":"0.04"},1,"717,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"5' UTR",1,71810790,71870302,59513,1]
["chr1",72522780,72532212,9433,"ENSBGRG00000007487","ENSBGRT00000013756",3479,"ENSBGRG00000007487","NA","GO:0007219(Notch signaling pathway);GO:0016567(protein ubiquitination)","04330(Notch signaling pathway)",{"v":4.6e-10,"d":"0.00"},2,"156,170,","0,9263",-9.34,{"v":-8.5,"d":"-8.50"},2.64,"Exon (ENSBGRT00000013756/ENSBGRG00000007487, exon 2 of 4)",1,72519301,72533190,13890,1]
["chr1",74863230,74880523,17294,"ENSBGRG00000009282","ENSBGRT00000019256",619012,"KALRN","kalirin RhoGEF kinase [Source:HGNC Symbol;Acc:HGNC:4814]","GO:0004672(protein kinase activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0035023(regulation of Rho protein signal transduction)","NA",{"v":2.3e-10,"d":"0.00"},4,"37,105,96,2,","0,2593,8462,17292",-9.63,-8.79,1.75,"Exon (ENSBGRT00000019256/ENSBGRG00000009282, exon 35 of 60)",1,74244218,74952619,708402,1]
["chr1",74880583,74886594,6012,"ENSBGRG00000009282","ENSBGRT00000019256",636365,"KALRN","kalirin RhoGEF kinase [Source:HGNC Symbol;Acc:HGNC:4814]","GO:0004672(protein kinase activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0035023(regulation of Rho protein signal transduction)","NA",{"v":0.0026,"d":"0.00"},2,"70,21,","0,5991",-2.58,-1.97,3.78,"Exon (ENSBGRT00000019256/ENSBGRG00000009282, exon 38 of 60)",1,74244218,74952619,708402,1]
["chr1",74983337,74993162,9826,"ENSBGRG00000010943","ENSBGRT00000020152",22986,"UMPS","uridine monophosphate synthetase [Source:HGNC Symbol;Acc:HGNC:12563]","GO:0003824(catalytic activity);GO:0004588(orotate phosphoribosyltransferase activity);GO:0004590(orotidine-5'-phosphate decarboxylase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006207('de novo' pyrimidine nucleobase biosynthetic process);GO:0006221(pyrimidine nucleotide biosynthetic process);GO:0006222(UMP biosynthetic process);GO:0009116(nucleoside metabolic process);GO:0044205('de novo' UMP biosynthetic process)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)",{"v":4e-20,"d":"0.00"},3,"20,115,16,","0,1806,9810",{"v":-19.4,"d":"-19.40"},{"v":-18.4,"d":"-18.40"},2.91,"Exon (ENSBGRT00000020152/ENSBGRG00000010943, exon 4 of 6)",1,74960351,74993190,32840,1]
["chr1",75015186,75015575,390,"ENSBGRG00000010943","ENSBGRT00000020093",54835,"UMPS","uridine monophosphate synthetase [Source:HGNC Symbol;Acc:HGNC:12563]","GO:0003824(catalytic activity);GO:0004588(orotate phosphoribosyltransferase activity);GO:0004590(orotidine-5'-phosphate decarboxylase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006207('de novo' pyrimidine nucleobase biosynthetic process);GO:0006221(pyrimidine nucleotide biosynthetic process);GO:0006222(UMP biosynthetic process);GO:0009116(nucleoside metabolic process);GO:0044205('de novo' UMP biosynthetic process)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)",{"v":1E-210,"d":"0.00"},1,"390,",0,-210,-208,7.47,"3' UTR",1,74960351,75016234,55884,1]
["chr1",76158740,76168227,9488,"ENSBGRG00000013579","ENSBGRT00000025031",27807,"IQCG","IQ motif containing G [Source:HGNC Symbol;Acc:HGNC:25251]","GO:0002177(manchette);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007286(spermatid development);GO:0007288(sperm axoneme assembly);GO:0030544(Hsp70 protein binding);GO:0031514(motile cilium);GO:0036126(sperm flagellum)","NA",{"v":0.025,"d":"0.03"},2,"17,74,","0,9414",-1.61,-1.07,2.16,"Exon (ENSBGRT00000025031/ENSBGRG00000013579, exon 7 of 10)",1,76130933,76171918,40986,1]
["chr1",76344864,76344924,61,"ENSBGRG00000015738","ENSBGRT00000029671",0,"RUBCN","rubicon autophagy regulator [Source:HGNC Symbol;Acc:HGNC:28991]","GO:0005654(nucleoplasm);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005829(cytosol);GO:0010507(negative regulation of autophagy);GO:0043231(intracellular membrane-bounded organelle);GO:0043553(negative regulation of phosphatidylinositol 3-kinase activity);GO:0045806(negative regulation of endocytosis);GO:1901097(negative regulation of autophagosome maturation)","04140(Autophagy - animal)",{"v":0.025,"d":"0.03"},1,"61,",0,-1.61,-1.07,4.86,"5' UTR",1,76344864,76398227,53364,1]
["chr1",76372677,76372737,61,"ENSBGRG00000015738","ENSBGRT00000029671",27813,"RUBCN","rubicon autophagy regulator [Source:HGNC Symbol;Acc:HGNC:28991]","GO:0005654(nucleoplasm);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005829(cytosol);GO:0010507(negative regulation of autophagy);GO:0043231(intracellular membrane-bounded organelle);GO:0043553(negative regulation of phosphatidylinositol 3-kinase activity);GO:0045806(negative regulation of endocytosis);GO:1901097(negative regulation of autophagosome maturation)","04140(Autophagy - animal)",{"v":1e-12,"d":"0.00"},1,"61,",0,-12,{"v":-11.1,"d":"-11.10"},2.11,"Exon (ENSBGRT00000029671/ENSBGRG00000015738, exon 7 of 22)",1,76344864,76398227,53364,1]
["chr1",76373094,76374596,1503,"ENSBGRG00000015738","ENSBGRT00000029671",28230,"RUBCN","rubicon autophagy regulator [Source:HGNC Symbol;Acc:HGNC:28991]","GO:0005654(nucleoplasm);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005829(cytosol);GO:0010507(negative regulation of autophagy);GO:0043231(intracellular membrane-bounded organelle);GO:0043553(negative regulation of phosphatidylinositol 3-kinase activity);GO:0045806(negative regulation of endocytosis);GO:1901097(negative regulation of autophagosome maturation)","04140(Autophagy - animal)",{"v":3.2e-06,"d":"0.00"},2,"97,23,","0,1480",{"v":-5.5,"d":"-5.50"},-4.76,2.49,"Exon (ENSBGRT00000029671/ENSBGRG00000015738, exon 7 of 22)",1,76344864,76398227,53364,1]
["chr1",76439244,76439514,271,"ENSBGRG00000016657","ENSBGRT00000030608",8530,"ENSBGRG00000016657","NA","GO:0048012(hepatocyte growth factor receptor signaling pathway)","NA",{"v":1.9E-3,"d":"0.00"},1,"271,",0,-2.73,-2.11,{"v":4.1,"d":"4.10"},"Exon (ENSBGRT00000030608/ENSBGRG00000016657, exon 2 of 3)",1,76430714,76444543,13830,1]
["chr1",77255834,77256553,720,"ENSBGRG00000018922","ENSBGRT00000034677",31472,"NRROS","negative regulator of reactive oxygen species [Source:HGNC Symbol;Acc:HGNC:24613]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0006801(superoxide metabolic process);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0009986(cell surface);GO:0014005(microglia development);GO:0035583(sequestering of TGFbeta in extracellular matrix);GO:0036364(transforming growth factor beta1 activation);GO:0050431(transforming growth factor beta binding)","NA",{"v":0.00069,"d":"0.00"},1,"720,",0,-3.16,-2.51,13,"Exon (ENSBGRT00000034677/ENSBGRG00000018922, exon 3 of 5)",1,77224362,77259784,35423,1]
["chr1",77448331,77462978,14648,"ENSBGRG00000019330","ENSBGRT00000035552",0,"SENP5","SUMO specific peptidase 5 [Source:HGNC Symbol;Acc:HGNC:28407]","GO:0005730(nucleolus);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity);GO:0016926(protein desumoylation);GO:0019783(ubiquitin-like protein-specific protease activity)","NA",{"v":6.9e-05,"d":"0.00"},2,"170,39,","0,14609",-4.16,-3.47,5.94,"5' UTR",1,77448331,77495396,47066,1]
["chr1",77463512,77463572,61,"ENSBGRG00000019104","ENSBGRT00000035256",76961,"PAK2","p21 (RAC1) activated kinase 2 [Source:HGNC Symbol;Acc:HGNC:8591]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0014069(postsynaptic density);GO:0016310(phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0030296(protein tyrosine kinase activator activity);GO:0031267(small GTPase binding);GO:0034333(adherens junction assembly);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0048365(Rac GTPase binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051493(regulation of cytoskeleton organization);GO:0051497(negative regulation of stress fiber assembly);GO:0060996(dendritic spine development);GO:0070830(bicellular tight junction assembly);GO:0071407(cellular response to organic cyclic compound);GO:0098978(glutamatergic synapse);GO:0150105(protein localization to cell-cell junction);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04660(T cell receptor signaling pathway);04360(Axon guidance);05211(Renal cell carcinoma)",{"v":1.8E-10,"d":"0.00"},1,"61,",0,-9.75,-8.91,2.48,"Exon (ENSBGRT00000035552/ENSBGRG00000019330, exon 2 of 10)",1,77386551,77583260,196710,1]
["chr1",78163814,78163904,91,"ENSBGRG00000022910","ENSBGRT00000042265",2562,"ENSBGRG00000022910","NA","NA","NA",{"v":0.043,"d":"0.04"},1,"91,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000042265/ENSBGRG00000022910, exon 3 of 3)",1,78161252,78163904,2653,1]
["chr1",78243928,78244612,685,"ENSBGRG00000022918","ENSBGRT00000042322",89,"APOD","apolipoprotein D [Source:HGNC Symbol;Acc:HGNC:612]","GO:0000302(response to reactive oxygen species);GO:0005615(extracellular space);GO:0006006(glucose metabolic process);GO:0006629(lipid metabolic process);GO:0006869(lipid transport);GO:0007568(aging);GO:0008289(lipid binding);GO:0010642(negative regulation of platelet-derived growth factor receptor signaling pathway);GO:0015485(cholesterol binding);GO:0042308(negative regulation of protein import into nucleus);GO:0048471(perinuclear region of cytoplasm);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0051895(negative regulation of focal adhesion assembly);GO:0060588(negative regulation of lipoprotein lipid oxidation);GO:0071638(negative regulation of monocyte chemotactic protein-1 production);GO:1900016(negative regulation of cytokine production involved in inflammatory response);GO:2000098(negative regulation of smooth muscle cell-matrix adhesion);GO:2000405(negative regulation of T cell migration)","NA",{"v":8.3e-05,"d":"0.00"},1,"685,",0,-4.08,{"v":-3.4,"d":"-3.40"},6.48,"5' UTR",1,78243839,78259182,15344,1]
["chr1",78256675,78259093,2419,"ENSBGRG00000022918","ENSBGRT00000042322",12836,"APOD","apolipoprotein D [Source:HGNC Symbol;Acc:HGNC:612]","GO:0000302(response to reactive oxygen species);GO:0005615(extracellular space);GO:0006006(glucose metabolic process);GO:0006629(lipid metabolic process);GO:0006869(lipid transport);GO:0007568(aging);GO:0008289(lipid binding);GO:0010642(negative regulation of platelet-derived growth factor receptor signaling pathway);GO:0015485(cholesterol binding);GO:0042308(negative regulation of protein import into nucleus);GO:0048471(perinuclear region of cytoplasm);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0051895(negative regulation of focal adhesion assembly);GO:0060588(negative regulation of lipoprotein lipid oxidation);GO:0071638(negative regulation of monocyte chemotactic protein-1 production);GO:1900016(negative regulation of cytokine production involved in inflammatory response);GO:2000098(negative regulation of smooth muscle cell-matrix adhesion);GO:2000405(negative regulation of T cell migration)","NA",0,2,"24,393,","0,2026",-15500,"-Inf",2.69,"3' UTR",1,78243839,78259182,15344,1]
["chr1",78304035,78309129,5095,"ENSBGRG00000022948","ENSBGRT00000042439",13491,"ENSBGRG00000022948","NA","GO:0004864(protein phosphatase inhibitor activity);GO:0009966(regulation of signal transduction);GO:0043666(regulation of phosphoprotein phosphatase activity)","NA",{"v":1.3E-51,"d":"0.00"},3,"38,101,101,","0,584,4994",{"v":-50.9,"d":"-50.90"},{"v":-49.6,"d":"-49.60"},2.97,"Exon (ENSBGRT00000042439/ENSBGRG00000022948, exon 3 of 6)",1,78290544,78311452,20909,1]
["chr1",78737559,78737856,298,"ENSBGRG00000023443","ENSBGRT00000043289",198872,"XXYLT1","xyloside xylosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:26639]","GO:0000287(magnesium ion binding);GO:0016266(O-glycan processing);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030145(manganese ion binding);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0035252(UDP-xylosyltransferase activity)","NA",{"v":1.6e-71,"d":"0.00"},1,"298,",0,{"v":-70.8,"d":"-70.80"},{"v":-69.3,"d":"-69.30"},5.37,"3' UTR",1,78538687,78737916,199230,1]
["chr1",79181865,79187477,5613,"ENSBGRG00000023529","ENSBGRT00000043425",10854,"LSG1","large 60S subunit nuclear export GTPase 1 [Source:HGNC Symbol;Acc:HGNC:25652]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0015030(Cajal body);GO:0016604(nuclear body);GO:0051168(nuclear export)","03008(Ribosome biogenesis in eukaryotes)",{"v":8.99999999999999e-301,"d":"0.00"},2,"129,321,","0,5292",-300,-297,5.13,"Exon (ENSBGRT00000043425/ENSBGRG00000023529, exon 7 of 14)",1,79171011,79197825,26815,1]
["chr1",79194382,79196326,1945,"ENSBGRG00000023529","ENSBGRT00000043425",23371,"LSG1","large 60S subunit nuclear export GTPase 1 [Source:HGNC Symbol;Acc:HGNC:25652]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0015030(Cajal body);GO:0016604(nuclear body);GO:0051168(nuclear export)","03008(Ribosome biogenesis in eukaryotes)",{"v":1e-163,"d":"0.00"},2,"31,390,","0,1555",-163,-161,4.15,"3' UTR",1,79171011,79197825,26815,1]
["chr1",79529182,79529361,180,"ENSBGRG00000024371","ENSBGRT00000044979",1018,"CPN2","carboxypeptidase N subunit 2 [Source:HGNC Symbol;Acc:HGNC:2313]","GO:0005515(protein binding)","NA",{"v":0.0036,"d":"0.00"},1,"180,",0,-2.44,-1.84,4.32,"Exon (ENSBGRT00000044979/ENSBGRG00000024371, exon 1 of 1)",1,79528164,79529810,1647,1]
["chr1",81098442,81098560,119,"ENSBGRG00000000376","ENSBGRT00000000612",122753,"MB21D2","Mab-21 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30438]","GO:0044877(protein-containing complex binding)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer);05226(Gastric cancer);05218(Melanoma);05224(Breast cancer)",{"v":6.3e-40,"d":"0.00"},1,"119,",0,{"v":-39.2,"d":"-39.20"},-38,6.22,"Exon (ENSBGRT00000000612/ENSBGRG00000000376, exon 3 of 3)",1,80975689,81099537,123849,1]
["chr1",81099478,81099537,60,"ENSBGRG00000000376","ENSBGRT00000000612",123789,"MB21D2","Mab-21 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30438]","GO:0044877(protein-containing complex binding)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer);05226(Gastric cancer);05218(Melanoma);05224(Breast cancer)",{"v":1.5E-5,"d":"0.00"},1,"60,",0,-4.81,{"v":-4.1,"d":"-4.10"},{"v":11.3,"d":"11.30"},"Exon (ENSBGRT00000000612/ENSBGRG00000000376, exon 3 of 3)",1,80975689,81099537,123849,1]
["chr1",86544216,86544544,329,"ENSBGRG00000001201","ENSBGRT00000002196",17055,"BCL6","BCL6 transcription repressor [Source:HGNC Symbol;Acc:HGNC:1001]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000902(cell morphogenesis);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001161(intronic transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001953(negative regulation of cell-matrix adhesion);GO:0002467(germinal center formation);GO:0002829(negative regulation of type 2 immune response);GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005657(replication fork);GO:0005794(Golgi apparatus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006974(cellular response to DNA damage stimulus);GO:0007266(Rho protein signal transduction);GO:0007283(spermatogenesis);GO:0008104(protein localization);GO:0008285(negative regulation of cell population proliferation);GO:0030036(actin cytoskeleton organization);GO:0030183(B cell differentiation);GO:0030308(negative regulation of cell growth);GO:0030890(positive regulation of B cell proliferation);GO:0031065(positive regulation of histone deacetylation);GO:0031490(chromatin DNA binding);GO:0032764(negative regulation of mast cell cytokine production);GO:0035024(negative regulation of Rho protein signal transduction);GO:0042092(type 2 immune response);GO:0042127(regulation of cell population proliferation);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043087(regulation of GTPase activity);GO:0043380(regulation of memory T cell differentiation);GO:0043565(sequence-specific DNA binding);GO:0045591(positive regulation of regulatory T cell differentiation);GO:0045596(negative regulation of cell differentiation);GO:0045629(negative regulation of T-helper 2 cell differentiation);GO:0045666(positive regulation of neuron differentiation);GO:0045746(negative regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0048294(negative regulation of isotype switching to IgE isotypes);GO:0048821(erythrocyte development);GO:0050727(regulation of inflammatory response);GO:0051272(positive regulation of cellular component movement);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000773(negative regulation of cellular senescence)","04068(FoxO signaling pathway);05202(Transcriptional misregulation in cancers)",{"v":3.2e-58,"d":"0.00"},1,"329,",0,{"v":-57.5,"d":"-57.50"},{"v":-56.1,"d":"-56.10"},3,"Exon (ENSBGRT00000002196/ENSBGRG00000001201, exon 5 of 10)",1,86527161,86549904,22744,1]
["chr1",86544873,86546076,1204,"ENSBGRG00000001201","ENSBGRT00000002196",17712,"BCL6","BCL6 transcription repressor [Source:HGNC Symbol;Acc:HGNC:1001]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000902(cell morphogenesis);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001161(intronic transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001953(negative regulation of cell-matrix adhesion);GO:0002467(germinal center formation);GO:0002829(negative regulation of type 2 immune response);GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005657(replication fork);GO:0005794(Golgi apparatus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006974(cellular response to DNA damage stimulus);GO:0007266(Rho protein signal transduction);GO:0007283(spermatogenesis);GO:0008104(protein localization);GO:0008285(negative regulation of cell population proliferation);GO:0030036(actin cytoskeleton organization);GO:0030183(B cell differentiation);GO:0030308(negative regulation of cell growth);GO:0030890(positive regulation of B cell proliferation);GO:0031065(positive regulation of histone deacetylation);GO:0031490(chromatin DNA binding);GO:0032764(negative regulation of mast cell cytokine production);GO:0035024(negative regulation of Rho protein signal transduction);GO:0042092(type 2 immune response);GO:0042127(regulation of cell population proliferation);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043087(regulation of GTPase activity);GO:0043380(regulation of memory T cell differentiation);GO:0043565(sequence-specific DNA binding);GO:0045591(positive regulation of regulatory T cell differentiation);GO:0045596(negative regulation of cell differentiation);GO:0045629(negative regulation of T-helper 2 cell differentiation);GO:0045666(positive regulation of neuron differentiation);GO:0045746(negative regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0048294(negative regulation of isotype switching to IgE isotypes);GO:0048821(erythrocyte development);GO:0050727(regulation of inflammatory response);GO:0051272(positive regulation of cellular component movement);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000773(negative regulation of cellular senescence)","04068(FoxO signaling pathway);05202(Transcriptional misregulation in cancers)",{"v":0.00083,"d":"0.00"},2,"3,147,","0,1057",-3.08,-2.45,5.76,"Exon (ENSBGRT00000002196/ENSBGRG00000001201, exon 5 of 10)",1,86527161,86549904,22744,1]
["chr1",87060494,87060554,61,"ENSBGRG00000001306","ENSBGRT00000002546",69872,"MASP1","mannan binding lectin serine peptidase 1 [Source:HGNC Symbol;Acc:HGNC:6901]","GO:0001867(complement activation, lectin pathway);GO:0004252(serine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0042803(protein homodimerization activity);GO:0048306(calcium-dependent protein binding)","04610(Complement and coagulation cascades);05150(Staphylococcus aureus infection)",{"v":0.014,"d":"0.01"},1,"61,",0,-1.86,{"v":-1.3,"d":"-1.30"},{"v":5.4,"d":"5.40"},"3' UTR",1,86990622,87061841,71220,1]
["chr1",87741433,87741982,550,"ENSBGRG00000001905","ENSBGRT00000003558",15553,"TBCCD1","TBCC domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25546]","GO:0000902(cell morphogenesis);GO:0008360(regulation of cell shape);GO:0030334(regulation of cell migration);GO:0031616(spindle pole centrosome);GO:0051661(maintenance of centrosome location);GO:0051684(maintenance of Golgi location)","NA",{"v":1.6E-49,"d":"0.00"},2,"164,253,","0,297",{"v":-48.8,"d":"-48.80"},{"v":-47.5,"d":"-47.50"},2.71,"Exon (ENSBGRT00000003558/ENSBGRG00000001905, exon 5 of 8)",1,87725880,87753459,27580,1]
["chr1",89183766,89319061,135296,"ENSBGRG00000002933","ENSBGRT00000005514",58,"C3orf70","chromosome 3 open reading frame 70 [Source:HGNC Symbol;Acc:HGNC:33731]","NA","NA",{"v":7.6e-05,"d":"0.00"},2,"138,36,","0,135260",-4.12,-3.44,3.02,"Exon (ENSBGRT00000005514/ENSBGRG00000002933, exon 1 of 3)",1,89183708,89319650,135943,1]
["chr1",90153851,90154293,443,"ENSBGRG00000003222","ENSBGRT00000006041",5259,"THPO","thrombopoietin [Source:HGNC Symbol;Acc:HGNC:11795]","GO:0001934(positive regulation of protein phosphorylation);GO:0005125(cytokine activity);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0030099(myeloid cell differentiation);GO:0035855(megakaryocyte development);GO:0038163(thrombopoietin-mediated signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0045654(positive regulation of megakaryocyte differentiation);GO:0051897(positive regulation of protein kinase B signaling);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0097696(receptor signaling pathway via STAT);GO:1902035(positive regulation of hematopoietic stem cell proliferation)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage)",{"v":2e-94,"d":"0.00"},1,"443,",0,{"v":-93.7,"d":"-93.70"},{"v":-92.1,"d":"-92.10"},6.55,"Exon (ENSBGRT00000006041/ENSBGRG00000003222, exon 6 of 6)",1,90148592,90154208,5617,1]
["chr1",90281578,90281817,240,"ENSBGRG00000000258","ENSBGRT00000000412",6263,"ALG3","ALG3 alpha-1,3- mannosyltransferase [Source:HGNC Symbol;Acc:HGNC:23056]","GO:0000030(mannosyltransferase activity);GO:0000033(alpha-1,3-mannosyltransferase activity);GO:0005789(endoplasmic reticulum membrane);GO:0030176(integral component of endoplasmic reticulum membrane)","00510(N-Glycan biosynthesis)",{"v":4e-19,"d":"0.00"},1,"240,",0,{"v":-18.4,"d":"-18.40"},{"v":-17.5,"d":"-17.50"},2.87,"3' UTR",1,90275315,90281817,6503,1]
["chr1",90529794,90535193,5400,"ENSBGRG00000001081","ENSBGRT00000002343",36959,"ABCC5","ATP binding cassette subfamily C member 5 [Source:HGNC Symbol;Acc:HGNC:56]","GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0008514(organic anion transmembrane transporter activity);GO:0015562(efflux transmembrane transporter activity);GO:0015711(organic anion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0016887(ATPase activity);GO:0042626(ATPase-coupled transmembrane transporter activity);GO:0042908(xenobiotic transport);GO:0042910(xenobiotic transmembrane transporter activity);GO:0055085(transmembrane transport);GO:0140115(export across plasma membrane)","02010(ABC transporters);01523(Antifolate resistance)",{"v":1.6E-34,"d":"0.00"},2,"9,262,","0,5138",{"v":-33.8,"d":"-33.80"},{"v":-32.6,"d":"-32.60"},2.28,"Exon (ENSBGRT00000002343/ENSBGRG00000001081, exon 10 of 30)",1,90492835,90584540,91706,1]
["chr1",91009153,91012078,2926,"ENSBGRG00000001459","ENSBGRT00000002678",58499,"KLHL6","kelch like family member 6 [Source:HGNC Symbol;Acc:HGNC:18653]","GO:0002467(germinal center formation);GO:0005515(protein binding);GO:0009617(response to bacterium);GO:0050853(B cell receptor signaling pathway)","NA",{"v":0.015,"d":"0.02"},3,"166,214,302,","0,1166,2624",-1.83,-1.02,8.64,"Exon (ENSBGRT00000002678/ENSBGRG00000001459, exon 5 of 7)",1,90950654,91012078,61425,1]
["chr1",91348341,91348400,60,"ENSBGRG00000001502","ENSBGRT00000003048",275083,"MCF2L2","MCF.2 cell line derived transforming sequence-like 2 [Source:HGNC Symbol;Acc:HGNC:30319]","GO:0005085(guanyl-nucleotide exchange factor activity)","NA",{"v":1.2E-4,"d":"0.00"},1,"60,",0,-3.93,-3.25,4.75,"Exon (ENSBGRT00000003048/ENSBGRG00000001502, exon 30 of 30)",1,91073258,91348460,275203,1]
["chr1",91369010,91369987,978,"ENSBGRG00000001692","ENSBGRT00000003155",7199,"ENSBGRG00000001692","NA","GO:0016020(membrane)","04142(Lysosome)",{"v":2.8E-3,"d":"0.00"},2,"94,25,","0,953",-2.55,-1.94,{"v":3.1,"d":"3.10"},"Exon (ENSBGRT00000003155/ENSBGRG00000001692, exon 2 of 6)",1,91361811,91385624,23814,1]
["chr1",91516165,91517529,1365,"ENSBGRG00000001763","ENSBGRT00000003247",12878,"DCUN1D1","defective in cullin neddylation 1 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:18184]","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:2000436(positive regulation of protein neddylation)","NA",{"v":4e-43,"d":"0.00"},2,"147,31,","0,1334",{"v":-42.4,"d":"-42.40"},{"v":-41.2,"d":"-41.20"},3.14,"Exon (ENSBGRT00000003247/ENSBGRG00000001763, exon 2 of 6)",1,91503287,91535656,32370,1]
["chr1",94040658,94047167,6510,"ENSBGRG00000002146","ENSBGRT00000004291",18664,"CCDC39","coiled-coil domain containing 39 [Source:HGNC Symbol;Acc:HGNC:25244]","GO:0001947(heart looping);GO:0003341(cilium movement);GO:0003356(regulation of cilium beat frequency);GO:0005829(cytosol);GO:0005929(cilium);GO:0005930(axoneme);GO:0007368(determination of left/right symmetry);GO:0007507(heart development);GO:0030317(flagellated sperm motility);GO:0030324(lung development);GO:0035469(determination of pancreatic left/right asymmetry);GO:0036159(inner dynein arm assembly);GO:0044458(motile cilium assembly);GO:0060285(cilium-dependent cell motility);GO:0060287(epithelial cilium movement involved in determination of left/right asymmetry);GO:0070286(axonemal dynein complex assembly);GO:0071907(determination of digestive tract left/right asymmetry);GO:0071910(determination of liver left/right asymmetry)","00514(Other types of O-glycan biosynthesis)",{"v":0.0041,"d":"0.00"},4,"122,104,133,30,","0,3165,3589,6480",-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000004291/ENSBGRG00000002146, exon 7 of 14)",1,94021994,94064542,42549,1]
["chr1",94048175,94048235,61,"ENSBGRG00000002146","ENSBGRT00000004291",26181,"CCDC39","coiled-coil domain containing 39 [Source:HGNC Symbol;Acc:HGNC:25244]","GO:0001947(heart looping);GO:0003341(cilium movement);GO:0003356(regulation of cilium beat frequency);GO:0005829(cytosol);GO:0005929(cilium);GO:0005930(axoneme);GO:0007368(determination of left/right symmetry);GO:0007507(heart development);GO:0030317(flagellated sperm motility);GO:0030324(lung development);GO:0035469(determination of pancreatic left/right asymmetry);GO:0036159(inner dynein arm assembly);GO:0044458(motile cilium assembly);GO:0060285(cilium-dependent cell motility);GO:0060287(epithelial cilium movement involved in determination of left/right asymmetry);GO:0070286(axonemal dynein complex assembly);GO:0071907(determination of digestive tract left/right asymmetry);GO:0071910(determination of liver left/right asymmetry)","00514(Other types of O-glycan biosynthesis)",{"v":0.0078,"d":"0.01"},1,"61,",0,-2.11,-1.53,5.94,"Exon (ENSBGRT00000004291/ENSBGRG00000002146, exon 11 of 14)",1,94021994,94064542,42549,1]
["chr1",94048294,94059994,11701,"ENSBGRG00000002146","ENSBGRT00000004291",26300,"CCDC39","coiled-coil domain containing 39 [Source:HGNC Symbol;Acc:HGNC:25244]","GO:0001947(heart looping);GO:0003341(cilium movement);GO:0003356(regulation of cilium beat frequency);GO:0005829(cytosol);GO:0005929(cilium);GO:0005930(axoneme);GO:0007368(determination of left/right symmetry);GO:0007507(heart development);GO:0030317(flagellated sperm motility);GO:0030324(lung development);GO:0035469(determination of pancreatic left/right asymmetry);GO:0036159(inner dynein arm assembly);GO:0044458(motile cilium assembly);GO:0060285(cilium-dependent cell motility);GO:0060287(epithelial cilium movement involved in determination of left/right asymmetry);GO:0070286(axonemal dynein complex assembly);GO:0071907(determination of digestive tract left/right asymmetry);GO:0071910(determination of liver left/right asymmetry)","00514(Other types of O-glycan biosynthesis)",{"v":0.0013,"d":"0.00"},5,"32,138,57,78,175,","0,5364,6486,6545,11526",-2.89,-2.26,7.56,"Exon (ENSBGRT00000004291/ENSBGRG00000002146, exon 11 of 14)",1,94021994,94064542,42549,1]
["chr1",95071779,95071839,61,"ENSBGRG00000002451","ENSBGRT00000005183",321308,"ENSBGRG00000002451","NA","GO:0005515(protein binding)","04146(Peroxisome)",{"v":0.0041,"d":"0.00"},1,"61,",0,-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000005183/ENSBGRG00000002451, exon 14 of 14)",1,94750471,95071839,321369,1]
["chr1",97983237,97983357,121,"ENSBGRG00000003307","ENSBGRT00000006155",134275,"TBL1XR1","transducin beta like 1 X-linked receptor 1 [Source:HGNC Symbol;Acc:HGNC:29529]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0008013(beta-catenin binding);GO:0017053(transcriptional repressor complex);GO:0042393(histone binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0047485(protein N-terminus binding);GO:0072686(mitotic spindle);GO:0090263(positive regulation of canonical Wnt signaling pathway)","04310(Wnt signaling pathway)",{"v":6.9E-10,"d":"0.00"},1,"121,",0,-9.16,-8.33,2.21,"3' UTR",1,97848962,97985064,136103,1]
["chr1",103105834,103106042,209,"ENSBGRG00000003789","ENSBGRT00000007073",64852,"NCEH1","neutral cholesterol ester hydrolase 1 [Source:HGNC Symbol;Acc:HGNC:29260]","GO:0006470(protein dephosphorylation);GO:0006805(xenobiotic metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0017171(serine hydrolase activity);GO:0042301(phosphate ion binding);GO:0046485(ether lipid metabolic process);GO:0052689(carboxylic ester hydrolase activity);GO:0060395(SMAD protein signal transduction)","04927(Cortisol synthesis and secretion);04976(Bile secretion);04979(Cholesterol metabolism);04934(Cushing syndrome)",{"v":5e-17,"d":"0.00"},1,"209,",0,{"v":-16.3,"d":"-16.30"},{"v":-15.4,"d":"-15.40"},4.22,"Exon (ENSBGRT00000007073/ENSBGRG00000003789, exon 7 of 7)",1,103040982,103107171,66190,1]
["chr1",103252003,103252449,447,"ENSBGRG00000003840","ENSBGRT00000007132",16449,"TNFSF10","TNF superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:11925]","GO:0005164(tumor necrosis factor receptor binding);GO:0005515(protein binding);GO:0006955(immune response);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0032813(tumor necrosis factor receptor superfamily binding);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045569(TRAIL binding);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway)","04068(FoxO signaling pathway);04060(Cytokine-cytokine receptor interaction);04210(Apoptosis);04217(Necroptosis);04650(Natural killer cell mediated cytotoxicity);05162(Measles);05164(Influenza A)",{"v":1e-114,"d":"0.00"},1,"447,",0,-114,-112,8.92,"Exon (ENSBGRT00000007132/ENSBGRG00000003840, exon 5 of 5)",1,103235554,103252449,16896,1]
["chr1",103285520,103286112,593,"ENSBGRG00000003884","ENSBGRT00000007161",1177,"GHSR","growth hormone secretagogue receptor [Source:HGNC Symbol;Acc:HGNC:4267]","GO:0001616(growth hormone secretagogue receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008154(actin polymerization or depolymerization);GO:0008343(adult feeding behavior);GO:0009725(response to hormone);GO:0009755(hormone-mediated signaling pathway);GO:0009986(cell surface);GO:0016021(integral component of membrane);GO:0016520(growth hormone-releasing hormone receptor activity);GO:0030252(growth hormone secretion);GO:0032094(response to food);GO:0032100(positive regulation of appetite);GO:0032691(negative regulation of interleukin-1 beta production);GO:0032715(negative regulation of interleukin-6 production);GO:0032869(cellular response to insulin stimulus);GO:0040018(positive regulation of multicellular organism growth);GO:0042536(negative regulation of tumor necrosis factor biosynthetic process);GO:0043005(neuron projection);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045121(membrane raft);GO:0046697(decidualization);GO:0050728(negative regulation of inflammatory response);GO:0051963(regulation of synapse assembly)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction)",{"v":2.9E-4,"d":"0.00"},1,"593,",0,-3.54,-2.87,{"v":15.1,"d":"15.10"},"Exon (ENSBGRT00000007161/ENSBGRG00000003884, exon 2 of 4)",1,103284343,103288766,4424,1]
["chr1",104243959,104309051,65093,"ENSBGRG00000004430","ENSBGRT00000008272",132802,"PLD1","phospholipase D1 [Source:HGNC Symbol;Acc:HGNC:9067]","GO:0003824(catalytic activity);GO:0004630(phospholipase D activity);GO:0005768(endosome);GO:0005794(Golgi apparatus);GO:0006654(phosphatidic acid biosynthetic process);GO:0016324(apical plasma membrane);GO:0030139(endocytic vesicle);GO:0032534(regulation of microvillus assembly);GO:0035091(phosphatidylinositol binding);GO:0045727(positive regulation of translation);GO:0048017(inositol lipid-mediated signaling);GO:0098693(regulation of synaptic vesicle cycle);GO:0098981(cholinergic synapse)","00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism);04014(Ras signaling pathway);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04144(Endocytosis);04666(Fc gamma R-mediated phagocytosis);04912(GnRH signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);04724(Glutamatergic synapse);05231(Choline metabolism in cancer)",{"v":1E-146,"d":"0.00"},2,"361,30,","0,65063",-146,-144,6.66,"3' UTR",1,104111157,104244319,133163,1]
["chr1",104711288,104719916,8629,"ENSBGRG00000004855","ENSBGRT00000012818",339402,"TNIK","TRAF2 and NCK interacting kinase [Source:HGNC Symbol;Acc:HGNC:30765]","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0007010(cytoskeleton organization);GO:0007256(activation of JNKK activity);GO:0016324(apical plasma membrane);GO:0030033(microvillus assembly);GO:0031532(actin cytoskeleton reorganization);GO:0035556(intracellular signal transduction);GO:0046777(protein autophosphorylation);GO:0048814(regulation of dendrite morphogenesis);GO:0072659(protein localization to plasma membrane)","NA",{"v":2.5e-06,"d":"0.00"},3,"69,67,103,","0,5004,8526",{"v":-5.6,"d":"-5.60"},-4.86,2,"Exon (ENSBGRT00000012818/ENSBGRG00000004855, exon 10 of 34)",1,104371886,104828624,456739,1]
["chr1",104719976,104744973,24998,"ENSBGRG00000004855","ENSBGRT00000012818",348090,"TNIK","TRAF2 and NCK interacting kinase [Source:HGNC Symbol;Acc:HGNC:30765]","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0007010(cytoskeleton organization);GO:0007256(activation of JNKK activity);GO:0016324(apical plasma membrane);GO:0030033(microvillus assembly);GO:0031532(actin cytoskeleton reorganization);GO:0035556(intracellular signal transduction);GO:0046777(protein autophosphorylation);GO:0048814(regulation of dendrite morphogenesis);GO:0072659(protein localization to plasma membrane)","NA",{"v":1.1E-5,"d":"0.00"},3,"43,111,56,","0,23859,24942",-4.95,-4.23,2.81,"Exon (ENSBGRT00000012818/ENSBGRG00000004855, exon 12 of 34)",1,104371886,104828624,456739,1]
["chr1",105743707,105750368,6662,"ENSBGRG00000006509","ENSBGRT00000012422",73291,"PHC3","polyhomeotic homolog 3 [Source:HGNC Symbol;Acc:HGNC:15682]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008270(zinc ion binding);GO:0031519(PcG protein complex);GO:0035102(PRC1 complex)","NA",{"v":0.044,"d":"0.04"},2,"18,103,","0,6559",-1.36,{"v":-0.841,"d":"-0.84"},2.97,"Exon (ENSBGRT00000012422/ENSBGRG00000006509, exon 14 of 15)",1,105670416,105752882,82467,1]
["chr1",106132619,106132799,181,"ENSBGRG00000007581","ENSBGRT00000013870",2003,"ACTRT3","actin related protein T3 [Source:HGNC Symbol;Acc:HGNC:24022]","GO:0001673(male germ cell nucleus)","NA",{"v":0.043,"d":"0.04"},1,"181,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000013870/ENSBGRG00000007581, exon 2 of 2)",1,106130616,106133785,3170,1]
["chr1",106132948,106133785,838,"ENSBGRG00000007581","ENSBGRT00000013870",2332,"ACTRT3","actin related protein T3 [Source:HGNC Symbol;Acc:HGNC:24022]","GO:0001673(male germ cell nucleus)","NA",{"v":1.3e-30,"d":"0.00"},1,"838,",0,{"v":-29.9,"d":"-29.90"},{"v":-28.8,"d":"-28.80"},4.86,"3' UTR",1,106130616,106133785,3170,1]
["chr1",106902006,106902275,270,"ENSBGRG00000007660","ENSBGRT00000015098",675623,"MECOM","MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498]","GO:0000118(histone deacetylase complex);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0043069(negative regulation of programmed cell death);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0051726(regulation of cell cycle)","04010(MAPK signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)",{"v":3E-10,"d":"0.00"},1,"270,",0,-9.53,-8.69,{"v":11.6,"d":"11.60"},"Exon (ENSBGRT00000015098/ENSBGRG00000007660, exon 8 of 19)",1,106226383,106941820,715438,1]
["chr1",106902514,106905100,2587,"ENSBGRG00000007660","ENSBGRT00000015098",676131,"MECOM","MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498]","GO:0000118(histone deacetylase complex);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0043069(negative regulation of programmed cell death);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0051726(regulation of cell cycle)","04010(MAPK signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)",{"v":3.4E-5,"d":"0.00"},3,"135,3,221,","0,2361,2366",-4.47,-3.77,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000015098/ENSBGRG00000007660, exon 8 of 19)",1,106226383,106941820,715438,1]
["chr1",106941701,106941820,120,"ENSBGRG00000007660","ENSBGRT00000015098",715318,"MECOM","MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498]","GO:0000118(histone deacetylase complex);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0043069(negative regulation of programmed cell death);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0051726(regulation of cell cycle)","04010(MAPK signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)",{"v":1e-16,"d":"0.00"},1,"120,",0,-16,-15,4.96,"Exon (ENSBGRT00000015098/ENSBGRG00000007660, exon 19 of 19)",1,106226383,106941820,715438,1]
["chr1",108052038,108096363,44326,"ENSBGRG00000008924","ENSBGRT00000016706",0,"GOLIM4","golgi integral membrane protein 4 [Source:HGNC Symbol;Acc:HGNC:15448]","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0016021(integral component of membrane)","NA",{"v":1.7E-6,"d":"0.00"},2,"94,56,","0,44270",-5.76,-5.01,1.59,"Exon (ENSBGRT00000016330/ENSBGRG00000008924, exon 1 of 16)",1,108096308,108144188,47881,1]
["chr1",108103065,108119720,16656,"ENSBGRG00000008924","ENSBGRT00000016330",51353,"GOLIM4","golgi integral membrane protein 4 [Source:HGNC Symbol;Acc:HGNC:15448]","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0016021(integral component of membrane)","NA",{"v":4e-56,"d":"0.00"},7,"70,50,54,151,83,84,102,","0,1298,3164,5005,11867,12482,16554",{"v":-55.4,"d":"-55.40"},-54,1.78,"Exon (ENSBGRT00000016330/ENSBGRG00000008924, exon 2 of 16)",1,108051712,108144188,92477,1]
["chr1",108124535,108144099,19565,"ENSBGRG00000008924","ENSBGRT00000016330",72823,"GOLIM4","golgi integral membrane protein 4 [Source:HGNC Symbol;Acc:HGNC:15448]","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0016021(integral component of membrane)","NA",0,8,"209,254,83,110,168,69,81,154,","0,2314,4213,6324,9103,10498,19027,19411",-706,"-Inf",4.29,"3' UTR",1,108051712,108144188,92477,1]
["chr1",110439685,110440043,359,"ENSBGRG00000009941","ENSBGRT00000018328",7645,"BCHE","butyrylcholinesterase [Source:HGNC Symbol;Acc:HGNC:983]","GO:0003990(acetylcholinesterase activity);GO:0004104(cholinesterase activity);GO:0005641(nuclear envelope lumen);GO:0005783(endoplasmic reticulum);GO:0042802(identical protein binding)","NA",{"v":3.2e-64,"d":"0.00"},1,"359,",0,{"v":-63.5,"d":"-63.50"},{"v":-62.1,"d":"-62.10"},6.93,"Exon (ENSBGRT00000018328/ENSBGRG00000009941, exon 2 of 3)",1,110432040,110444513,12474,1]
["chr1",114327454,114328383,930,"ENSBGRG00000010725","ENSBGRT00000019611",425,"KNSTRN","kinetochore localized astrin (SPAG5) binding protein [Source:HGNC Symbol;Acc:HGNC:30767]","GO:0000070(mitotic sister chromatid segregation);GO:0000226(microtubule cytoskeleton organization);GO:0000776(kinetochore);GO:0001726(ruffle);GO:0005886(plasma membrane);GO:0007051(spindle organization);GO:0007059(chromosome segregation);GO:0016477(cell migration);GO:0034451(centriolar satellite);GO:0035371(microtubule plus-end);GO:0042803(protein homodimerization activity);GO:0051010(microtubule plus-end binding);GO:0051988(regulation of attachment of spindle microtubules to kinetochore);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0072686(mitotic spindle)","NA",{"v":1e-164,"d":"0.00"},1,"930,",0,-164,-163,5.06,"3' UTR",1,114327029,114328383,1355,1]
["chr1",116430491,116430641,151,"ENSBGRG00000011942","ENSBGRT00000021838",67878,"KPNA4","karyopherin subunit alpha 4 [Source:HGNC Symbol;Acc:HGNC:6397]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006606(protein import into nucleus);GO:0031965(nuclear membrane);GO:0042025(host cell nucleus);GO:0042542(response to hydrogen peroxide);GO:0061608(nuclear import signal receptor activity)","NA",{"v":2.5e-11,"d":"0.00"},1,"151,",0,{"v":-10.6,"d":"-10.60"},-9.72,1.49,"3' UTR",1,116362613,116431299,68687,1]
["chr1",116431060,116431119,60,"ENSBGRG00000011942","ENSBGRT00000021838",68447,"KPNA4","karyopherin subunit alpha 4 [Source:HGNC Symbol;Acc:HGNC:6397]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006606(protein import into nucleus);GO:0031965(nuclear membrane);GO:0042025(host cell nucleus);GO:0042542(response to hydrogen peroxide);GO:0061608(nuclear import signal receptor activity)","NA",{"v":5.2E-7,"d":"0.00"},1,"60,",0,-6.28,-5.52,2.54,"3' UTR",1,116362613,116431299,68687,1]
["chr1",116493418,116493654,237,"ENSBGRG00000012188","ENSBGRT00000022273",324,"TRIM59","tripartite motif containing 59 [Source:HGNC Symbol;Acc:HGNC:30834]","GO:0005783(endoplasmic reticulum);GO:0008270(zinc ion binding);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045087(innate immune response);GO:0046597(negative regulation of viral entry into host cell);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":1e-31,"d":"0.00"},1,"237,",0,-31,{"v":-29.9,"d":"-29.90"},5.25,"Exon (ENSBGRT00000022273/ENSBGRG00000012188, exon 1 of 1)",1,116493094,116494302,1209,1]
["chr1",116493713,116493948,236,"ENSBGRG00000012188","ENSBGRT00000022273",619,"TRIM59","tripartite motif containing 59 [Source:HGNC Symbol;Acc:HGNC:30834]","GO:0005783(endoplasmic reticulum);GO:0008270(zinc ion binding);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045087(innate immune response);GO:0046597(negative regulation of viral entry into host cell);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":2.5e-28,"d":"0.00"},1,"236,",0,{"v":-27.6,"d":"-27.60"},{"v":-26.5,"d":"-26.50"},4.69,"Exon (ENSBGRT00000022273/ENSBGRG00000012188, exon 1 of 1)",1,116493094,116494302,1209,1]
["chr1",119114402,119117273,2872,"ENSBGRG00000015647","ENSBGRT00000028951",0,"SHOX2","short stature homeobox 2 [Source:HGNC Symbol;Acc:HGNC:10854]","GO:0001649(osteoblast differentiation);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002062(chondrocyte differentiation);GO:0002063(chondrocyte development);GO:0003170(heart valve development);GO:0003209(cardiac atrium morphogenesis);GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0030326(embryonic limb morphogenesis);GO:0032330(regulation of chondrocyte differentiation);GO:0035115(embryonic forelimb morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045880(positive regulation of smoothened signaling pathway);GO:0048557(embryonic digestive tract morphogenesis);GO:0048598(embryonic morphogenesis);GO:0048743(positive regulation of skeletal muscle fiber development);GO:0050772(positive regulation of axonogenesis);GO:0060272(embryonic skeletal joint morphogenesis);GO:0060351(cartilage development involved in endochondral bone morphogenesis);GO:0060415(muscle tissue morphogenesis);GO:2000172(regulation of branching morphogenesis of a nerve)","NA",{"v":0.021,"d":"0.02"},2,"721,830,","0,2042",-1.67,-1.12,6.48,"5' UTR",1,119114402,119123330,8929,1]
["chr1",119122737,119125480,2744,"ENSBGRG00000015647","ENSBGRT00000028951",8335,"SHOX2","short stature homeobox 2 [Source:HGNC Symbol;Acc:HGNC:10854]","GO:0001649(osteoblast differentiation);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002062(chondrocyte differentiation);GO:0002063(chondrocyte development);GO:0003170(heart valve development);GO:0003209(cardiac atrium morphogenesis);GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0030326(embryonic limb morphogenesis);GO:0032330(regulation of chondrocyte differentiation);GO:0035115(embryonic forelimb morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045880(positive regulation of smoothened signaling pathway);GO:0048557(embryonic digestive tract morphogenesis);GO:0048598(embryonic morphogenesis);GO:0048743(positive regulation of skeletal muscle fiber development);GO:0050772(positive regulation of axonogenesis);GO:0060272(embryonic skeletal joint morphogenesis);GO:0060351(cartilage development involved in endochondral bone morphogenesis);GO:0060415(muscle tissue morphogenesis);GO:2000172(regulation of branching morphogenesis of a nerve)","NA",{"v":0.0021,"d":"0.00"},2,"594,272,","0,2472",-2.68,-2.06,7.56,"3' UTR",1,119114402,119123330,8929,1]
["chr1",119125539,119125867,329,"ENSBGRG00000015647","ENSBGRT00000029281",9095,"SHOX2","short stature homeobox 2 [Source:HGNC Symbol;Acc:HGNC:10854]","GO:0001649(osteoblast differentiation);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002062(chondrocyte differentiation);GO:0002063(chondrocyte development);GO:0003170(heart valve development);GO:0003209(cardiac atrium morphogenesis);GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0030326(embryonic limb morphogenesis);GO:0032330(regulation of chondrocyte differentiation);GO:0035115(embryonic forelimb morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045880(positive regulation of smoothened signaling pathway);GO:0048557(embryonic digestive tract morphogenesis);GO:0048598(embryonic morphogenesis);GO:0048743(positive regulation of skeletal muscle fiber development);GO:0050772(positive regulation of axonogenesis);GO:0060272(embryonic skeletal joint morphogenesis);GO:0060351(cartilage development involved in endochondral bone morphogenesis);GO:0060415(muscle tissue morphogenesis);GO:2000172(regulation of branching morphogenesis of a nerve)","NA",{"v":5e-16,"d":"0.00"},1,"329,",0,{"v":-15.3,"d":"-15.30"},{"v":-14.3,"d":"-14.30"},{"v":30.2,"d":"30.20"},"3' UTR",1,119116444,119125867,9424,1]
["chr1",120219240,120219330,91,"ENSBGRG00000016437","ENSBGRT00000030425",0,"CCNL1","cyclin L1 [Source:HGNC Symbol;Acc:HGNC:20569]","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006396(RNA processing);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0042025(host cell nucleus)","NA",{"v":0.015,"d":"0.02"},1,"91,",0,-1.83,-1.02,8.64,"5' UTR",1,120219240,120231613,12374,1]
["chr1",120230560,120231744,1185,"ENSBGRG00000016437","ENSBGRT00000030425",11320,"CCNL1","cyclin L1 [Source:HGNC Symbol;Acc:HGNC:20569]","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006396(RNA processing);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0042025(host cell nucleus)","NA",{"v":9.99999999999998e-290,"d":"0.00"},2,"90,480,","0,705",-289,-287,4.14,"3' UTR",1,120219240,120231613,12374,1]
["chr1",121763285,121763433,149,"ENSBGRG00000007545","ENSBGRT00000013909",88,"ENSBGRG00000007545","NA","GO:0008521(acetyl-CoA transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","00604(Glycosphingolipid biosynthesis - ganglio series)",{"v":2e-36,"d":"0.00"},1,"149,",0,{"v":-35.7,"d":"-35.70"},{"v":-34.5,"d":"-34.50"},{"v":6.8,"d":"6.80"},"Exon (ENSBGRT00000013909/ENSBGRG00000007545, exon 1 of 6)",1,121763197,121783645,20449,1]
["chr1",121842163,121842222,60,"ENSBGRG00000007709","ENSBGRT00000014152",30472,"C3orf33","chromosome 3 open reading frame 33 [Source:HGNC Symbol;Acc:HGNC:26434]","GO:0005615(extracellular space);GO:0051090(regulation of DNA-binding transcription factor activity);GO:0070373(negative regulation of ERK1 and ERK2 cascade)","03010(Ribosome)",{"v":2.8e-10,"d":"0.00"},1,"60,",0,-9.56,-8.73,4.38,"Exon (ENSBGRT00000014152/ENSBGRG00000007709, exon 5 of 5)",1,121811691,121842518,30828,1]
["chr1",122120624,122120863,240,"ENSBGRG00000007957","ENSBGRT00000016392",262489,"PLCH1","phospholipase C eta 1 [Source:HGNC Symbol;Acc:HGNC:29185]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0016020(membrane);GO:0035556(intracellular signal transduction);GO:0043231(intracellular membrane-bounded organelle);GO:0048015(phosphatidylinositol-mediated signaling);GO:0050429(calcium-dependent phospholipase C activity)","00562(Inositol phosphate metabolism)",0.01,1,"240,",0,-1.99,-1.42,4.86,"Exon (ENSBGRT00000016392/ENSBGRG00000007957, exon 25 of 25)",1,121858135,122122554,264420,1]
["chr1",122121402,122121521,120,"ENSBGRG00000007957","ENSBGRT00000016392",263267,"PLCH1","phospholipase C eta 1 [Source:HGNC Symbol;Acc:HGNC:29185]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0016020(membrane);GO:0035556(intracellular signal transduction);GO:0043231(intracellular membrane-bounded organelle);GO:0048015(phosphatidylinositol-mediated signaling);GO:0050429(calcium-dependent phospholipase C activity)","00562(Inositol phosphate metabolism)",{"v":0.027,"d":"0.03"},1,"120,",0,-1.57,-1.03,3.24,"Exon (ENSBGRT00000016392/ENSBGRG00000007957, exon 25 of 25)",1,121858135,122122554,264420,1]
["chr1",122121581,122121850,270,"ENSBGRG00000007957","ENSBGRT00000016392",263446,"PLCH1","phospholipase C eta 1 [Source:HGNC Symbol;Acc:HGNC:29185]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0016020(membrane);GO:0035556(intracellular signal transduction);GO:0043231(intracellular membrane-bounded organelle);GO:0048015(phosphatidylinositol-mediated signaling);GO:0050429(calcium-dependent phospholipase C activity)","00562(Inositol phosphate metabolism)",0.01,1,"270,",0,-1.99,-1.42,4.32,"Exon (ENSBGRT00000016392/ENSBGRG00000007957, exon 25 of 25)",1,121858135,122122554,264420,1]
["chr1",122122329,122218138,95810,"ENSBGRG00000009531","ENSBGRT00000017481",0,"ENSBGRG00000009531","NA","NA","NA",{"v":0.043,"d":"0.04"},3,"226,44,60,","0,95703,95750",-1.37,{"v":-0.6,"d":"-0.60"},6.48,"Exon (ENSBGRT00000016392/ENSBGRG00000007957, exon 25 of 25)",1,122191183,122191307,125,2]
["chr1",123451502,123451681,180,"ENSBGRG00000010375","ENSBGRT00000020703",47423,"DHX36","DEAH-box helicase 36 [Source:HGNC Symbol;Acc:HGNC:14410]","GO:0000287(magnesium ion binding);GO:0000781(chromosome, telomeric region);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001503(ossification);GO:0002151(G-quadruplex RNA binding);GO:0002735(positive regulation of myeloid dendritic cell cytokine production);GO:0003676(nucleic acid binding);GO:0003678(DNA helicase activity);GO:0003697(single-stranded DNA binding);GO:0003723(RNA binding);GO:0003724(RNA helicase activity);GO:0003725(double-stranded RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006359(regulation of transcription by RNA polymerase III);GO:0007283(spermatogenesis);GO:0008094(DNA-dependent ATPase activity);GO:0009615(response to virus);GO:0010494(cytoplasmic stress granule);GO:0010501(RNA secondary structure unwinding);GO:0016607(nuclear speck);GO:0017148(negative regulation of translation);GO:0031442(positive regulation of mRNA 3'-end processing);GO:0032206(positive regulation of telomere maintenance);GO:0032727(positive regulation of interferon-alpha production);GO:0034605(cellular response to heat);GO:0034644(cellular response to UV);GO:0035925(mRNA 3'-UTR AU-rich region binding);GO:0042826(histone deacetylase binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043330(response to exogenous dsRNA);GO:0043488(regulation of mRNA stability);GO:0044806(G-quadruplex DNA unwinding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045995(regulation of embryonic development);GO:0048027(mRNA 5'-UTR binding);GO:0051880(G-quadruplex DNA binding);GO:0051891(positive regulation of cardioblast differentiation);GO:0060261(positive regulation of transcription initiation from RNA polymerase II promoter);GO:0061158(3'-UTR-mediated mRNA destabilization);GO:0070034(telomerase RNA binding);GO:0090669(telomerase RNA stabilization);GO:1900153(positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:1901534(positive regulation of hematopoietic progenitor cell differentiation);GO:1902064(regulation of transcription from RNA polymerase II promoter involved in spermatogenesis);GO:1903843(cellular response to arsenite ion);GO:1904358(positive regulation of telomere maintenance via telomere lengthening);GO:2000767(positive regulation of cytoplasmic translation)","03018(RNA degradation)",{"v":2.5e-92,"d":"0.00"},1,"180,",0,{"v":-91.6,"d":"-91.60"},-90,3.64,"3' UTR",1,123404079,123451711,47633,1]
["chr1",127005042,127005132,91,"ENSBGRG00000013927","ENSBGRT00000025582",14989,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":0.0078,"d":"0.01"},1,"91,",0,-2.11,-1.27,9.72,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127005611,127005850,240,"ENSBGRG00000013927","ENSBGRT00000025582",15558,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":6.3e-16,"d":"0.00"},1,"240,",0,{"v":-15.2,"d":"-15.20"},{"v":-14.3,"d":"-14.30"},4.15,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127006808,127006987,180,"ENSBGRG00000013927","ENSBGRT00000025582",16755,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":1.6e-43,"d":"0.00"},1,"180,",0,{"v":-42.8,"d":"-42.80"},{"v":-41.6,"d":"-41.60"},3.47,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127007735,127007944,210,"ENSBGRG00000013927","ENSBGRT00000025582",17682,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":1e-76,"d":"0.00"},1,"210,",0,-76,{"v":-74.5,"d":"-74.50"},{"v":4.9,"d":"4.90"},"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127008962,127009111,150,"ENSBGRG00000013927","ENSBGRT00000025582",18909,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":7.9e-20,"d":"0.00"},1,"150,",0,{"v":-19.1,"d":"-19.10"},{"v":-18.1,"d":"-18.10"},2.64,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 6 of 8)",1,126990053,127017625,27573,1]
["chr1",127010615,127016249,5635,"ENSBGRG00000013927","ENSBGRT00000025582",20562,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":1E-108,"d":"0.00"},2,"97,533,","0,5102",-108,-106,6.98,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 7 of 8)",1,126990053,127017625,27573,1]
["chr1",127016368,127016608,241,"ENSBGRG00000013927","ENSBGRT00000025582",26315,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":5e-93,"d":"0.00"},1,"241,",0,{"v":-92.3,"d":"-92.30"},{"v":-90.7,"d":"-90.70"},5.48,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 8 of 8)",1,126990053,127017625,27573,1]
["chr1",127016847,127017625,779,"ENSBGRG00000013927","ENSBGRT00000025582",26794,"IGSF10","immunoglobulin superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:26384]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:2001222(regulation of neuron migration)","NA",{"v":1E-191,"d":"0.00"},1,"779,",0,-191,-189,5.11,"Exon (ENSBGRT00000025582/ENSBGRG00000013927, exon 8 of 8)",1,126990053,127017625,27573,1]
["chr1",127116344,127116403,60,"ENSBGRG00000014296","ENSBGRT00000026299",0,"P2RY12","purinergic receptor P2Y12 [Source:HGNC Symbol;Acc:HGNC:18124]","GO:0001609(G protein-coupled adenosine receptor activity);GO:0001621(G protein-coupled ADP receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005886(plasma membrane);GO:0006930(substrate-dependent cell migration, cell extension);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G protein-coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0007596(blood coagulation);GO:0016021(integral component of membrane);GO:0030168(platelet activation);GO:0031224(intrinsic component of membrane);GO:0031253(cell projection membrane);GO:0043270(positive regulation of ion transport);GO:0044298(cell body membrane);GO:0045028(G protein-coupled purinergic nucleotide receptor activity);GO:0070527(platelet aggregation);GO:0071318(cellular response to ATP);GO:0071407(cellular response to organic cyclic compound);GO:0150063(visual system development);GO:1904139(regulation of microglial cell migration)","04611(Platelet activation)",{"v":2.3E-3,"d":"0.00"},1,"60,",0,-2.63,-2.01,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000026299/ENSBGRG00000014296, exon 1 of 3)",1,127116344,127117634,1291,1]
["chr1",127116490,127116841,352,"ENSBGRG00000014050","ENSBGRT00000025921",288471,"MED12L","mediator complex subunit 12L [Source:HGNC Symbol;Acc:HGNC:16050]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008013(beta-catenin binding);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)",{"v":0.0012,"d":"0.00"},1,"352,",0,-2.91,-2.28,9.72,"Exon (ENSBGRT00000026299/ENSBGRG00000014296, exon 1 of 3)",1,127021523,127405312,383790,2]
["chr1",127117249,127117634,386,"ENSBGRG00000014050","ENSBGRT00000025921",287678,"MED12L","mediator complex subunit 12L [Source:HGNC Symbol;Acc:HGNC:16050]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008013(beta-catenin binding);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)",{"v":0.025,"d":"0.03"},2,"16,131,","0,255",-1.61,-1.07,7.56,"Exon (ENSBGRT00000026299/ENSBGRG00000014296, exon 2 of 3)",1,127021523,127405312,383790,2]
["chr1",127127896,127128102,207,"ENSBGRG00000014357","ENSBGRT00000026344",0,"P2RY13","purinergic receptor P2Y13 [Source:HGNC Symbol;Acc:HGNC:4537]","GO:0004930(G protein-coupled receptor activity);GO:0005783(endoplasmic reticulum);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007194(negative regulation of adenylate cyclase activity);GO:0016021(integral component of membrane);GO:0045028(G protein-coupled purinergic nucleotide receptor activity);GO:0071407(cellular response to organic cyclic compound)","04080(Neuroactive ligand-receptor interaction)",{"v":0.0041,"d":"0.00"},1,"207,",0,-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000026344/ENSBGRG00000014357, exon 1 of 1)",1,127127896,127128897,1002,1]
["chr1",127128279,127128397,119,"ENSBGRG00000014050","ENSBGRT00000025921",276915,"MED12L","mediator complex subunit 12L [Source:HGNC Symbol;Acc:HGNC:16050]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008013(beta-catenin binding);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)",{"v":0.00069,"d":"0.00"},1,"119,",0,-3.16,-2.51,{"v":8.1,"d":"8.10"},"Exon (ENSBGRT00000026344/ENSBGRG00000014357, exon 1 of 1)",1,127021523,127405312,383790,2]
["chr1",127258914,127259033,120,"ENSBGRG00000014050","ENSBGRT00000025921",146279,"MED12L","mediator complex subunit 12L [Source:HGNC Symbol;Acc:HGNC:16050]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008013(beta-catenin binding);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)",{"v":4.1e-06,"d":"0.00"},1,"120,",0,-5.39,-4.66,3.17,"Exon (ENSBGRT00000026452/ENSBGRG00000014410, exon 1 of 1)",1,127021523,127405312,383790,2]
["chr1",127794543,127814911,20369,"ENSBGRG00000014649","ENSBGRT00000026999",402,"SIAH2","siah E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:10858]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007275(multicellular organism development);GO:0008270(zinc ion binding);GO:0042025(host cell nucleus);GO:0042752(regulation of circadian rhythm);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0044257(cellular protein catabolic process);GO:0061630(ubiquitin protein ligase activity);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","NA",{"v":9.99999999999998e-225,"d":"0.00"},2,"31,558,","0,19811",-224,-222,{"v":10.3,"d":"10.30"},"Exon (ENSBGRT00000026999/ENSBGRG00000014649, exon 3 of 4)",1,127794141,127814911,20771,1]
["chr1",128731873,128734533,2661,"ENSBGRG00000015699","ENSBGRT00000029261",2349,"PFN2","profilin 2 [Source:HGNC Symbol;Acc:HGNC:8882]","GO:0003779(actin binding);GO:0003785(actin monomer binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0010633(negative regulation of epithelial cell migration);GO:0016887(ATPase activity);GO:0030036(actin cytoskeleton organization);GO:0030833(regulation of actin filament polymerization);GO:0030837(negative regulation of actin filament polymerization);GO:0030838(positive regulation of actin filament polymerization);GO:0032233(positive regulation of actin filament bundle assembly);GO:0032781(positive regulation of ATPase activity);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0050821(protein stabilization);GO:0051496(positive regulation of stress fiber assembly);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:1900028(negative regulation of ruffle assembly);GO:2000300(regulation of synaptic vesicle exocytosis)","04015(Rap1 signaling pathway);04810(Regulation of actin cytoskeleton);05132(Salmonella infection)",{"v":4.6e-07,"d":"0.00"},2,"94,22,","0,2639",-6.34,-5.57,1.21,"Exon (ENSBGRT00000029261/ENSBGRG00000015699, exon 2 of 3)",1,128729524,128734609,5086,1]
["chr1",128905875,128918570,12696,"ENSBGRG00000016179","ENSBGRT00000029741",11848,"ANKUB1","ankyrin repeat and ubiquitin domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29642]","GO:0005515(protein binding)","NA",{"v":0.0011,"d":"0.00"},3,"5,115,742,","0,7874,11954",-2.96,-2.33,13,"Exon (ENSBGRT00000029741/ENSBGRG00000016179, exon 3 of 6)",1,128894027,128924733,30707,1]
["chr1",129395375,129395433,59,"ENSBGRG00000016631","ENSBGRT00000030570",59,"TM4SF1","transmembrane 4 L six family member 1 [Source:HGNC Symbol;Acc:HGNC:11853]","GO:0005887(integral component of plasma membrane);GO:0016021(integral component of membrane)","00430(Taurine and hypotaurine metabolism);00480(Glutathione metabolism)",{"v":2e-47,"d":"0.00"},1,"59,",0,{"v":-46.7,"d":"-46.70"},{"v":-45.4,"d":"-45.40"},2.99,"5' UTR",1,129395316,129400764,5449,1]
["chr1",136869788,136869878,91,"ENSBGRG00000000195","ENSBGRT00000000322",739332,"SLC9A9","solute carrier family 9 member A9 [Source:HGNC Symbol;Acc:HGNC:20653]","GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0006885(regulation of pH);GO:0015299(solute:proton antiporter activity);GO:0015385(sodium:proton antiporter activity);GO:0016021(integral component of membrane);GO:0055037(recycling endosome);GO:0055085(transmembrane transport)","NA",{"v":1.3E-41,"d":"0.00"},1,"91,",0,{"v":-40.9,"d":"-40.90"},{"v":-39.7,"d":"-39.70"},5.66,"Exon (ENSBGRT00000000322/ENSBGRG00000000195, exon 18 of 18)",1,136130456,136869878,739423,1]
["chr1",137742026,137745519,3494,"ENSBGRG00000000428","ENSBGRT00000001119",22620,"ATR","ATR serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:882]","GO:0000077(DNA damage checkpoint);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0006974(cellular response to DNA damage stimulus);GO:0008156(negative regulation of DNA replication);GO:0016301(kinase activity);GO:0016605(PML body);GO:0018105(peptidyl-serine phosphorylation);GO:0032405(MutLalpha complex binding);GO:0032407(MutSalpha complex binding);GO:0034644(cellular response to UV);GO:0043517(positive regulation of DNA damage response, signal transduction by p53 class mediator);GO:0046777(protein autophosphorylation);GO:0070198(protein localization to chromosome, telomeric region);GO:0071480(cellular response to gamma radiation);GO:0090399(replicative senescence);GO:0097694(establishment of RNA localization to telomere);GO:1904884(positive regulation of telomerase catalytic core complex assembly)","03460(Fanconi anemia pathway);04110(Cell cycle);04115(p53 signaling pathway);04218(Cellular senescence);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":0.028,"d":"0.03"},4,"431,179,192,187,","0,1293,2081,3307",-1.56,{"v":-0.937,"d":"-0.94"},7.56,"Exon (ENSBGRT00000001119/ENSBGRG00000000428, exon 4 of 47)",1,137719406,137847000,127595,1]
["chr1",141110463,141110763,301,"ENSBGRG00000001428","ENSBGRT00000002725",67394,"NMNAT3","nicotinamide nucleotide adenylyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:20989]","GO:0000309(nicotinamide-nucleotide adenylyltransferase activity);GO:0002138(retinoic acid biosynthetic process);GO:0003824(catalytic activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006776(vitamin A metabolic process);GO:0008289(lipid binding);GO:0009058(biosynthetic process);GO:0009435(NAD biosynthetic process);GO:0009611(response to wounding);GO:0016779(nucleotidyltransferase activity)","00760(Nicotinate and nicotinamide metabolism)",{"v":0.00034,"d":"0.00"},1,"301,",0,-3.47,-2.81,{"v":8.1,"d":"8.10"},"Exon (ENSBGRT00000002725/ENSBGRG00000001428, exon 7 of 7)",1,141043069,141110470,67402,1]
["chr1",141111243,141111603,361,"ENSBGRG00000001428","ENSBGRT00000002698",68174,"NMNAT3","nicotinamide nucleotide adenylyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:20989]","GO:0000309(nicotinamide-nucleotide adenylyltransferase activity);GO:0002138(retinoic acid biosynthetic process);GO:0003824(catalytic activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006776(vitamin A metabolic process);GO:0008289(lipid binding);GO:0009058(biosynthetic process);GO:0009435(NAD biosynthetic process);GO:0009611(response to wounding);GO:0016779(nucleotidyltransferase activity)","00760(Nicotinate and nicotinamide metabolism)",{"v":1.9e-05,"d":"0.00"},1,"361,",0,-4.71,-4,3.55,"3' UTR",1,141043069,141111660,68592,1]
["chr1",141138570,141140123,1554,"ENSBGRG00000001428","ENSBGRT00000002664",95501,"NMNAT3","nicotinamide nucleotide adenylyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:20989]","GO:0000309(nicotinamide-nucleotide adenylyltransferase activity);GO:0002138(retinoic acid biosynthetic process);GO:0003824(catalytic activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006776(vitamin A metabolic process);GO:0008289(lipid binding);GO:0009058(biosynthetic process);GO:0009435(NAD biosynthetic process);GO:0009611(response to wounding);GO:0016779(nucleotidyltransferase activity)","00760(Nicotinate and nicotinamide metabolism)",{"v":9.99999999999999e-258,"d":"0.00"},3,"81,179,130,","0,571,1424",-257,-254,2.16,"5' UTR",1,141043069,141140215,97147,1]
["chr1",141353514,141353901,388,"ENSBGRG00000001520","ENSBGRT00000002817",35598,"ENSBGRG00000001520","NA","GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0006886(intracellular protein transport);GO:0016192(vesicle-mediated transport);GO:0030117(membrane coat)","NA",{"v":1.6E-13,"d":"0.00"},2,"55,96,","0,292",{"v":-12.8,"d":"-12.80"},{"v":-11.9,"d":"-11.90"},1.43,"Exon (ENSBGRT00000002817/ENSBGRG00000001520, exon 21 of 22)",1,141317916,141353901,35986,1]
["chr1",141709874,141710107,234,"ENSBGRG00000001602","ENSBGRT00000002969",1060,"ENSBGRG00000001602","NA","NA","NA",{"v":0.028,"d":"0.03"},1,"234,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000002969/ENSBGRG00000001602, exon 2 of 2)",1,141708814,141710107,1294,1]
["chr1",141846048,141846346,299,"ENSBGRG00000001637","ENSBGRT00000003031",119,"FOXL2","forkhead box L2 [Source:HGNC Symbol;Acc:HGNC:1092]","GO:0001541(ovarian follicle development);GO:0002074(extraocular skeletal muscle development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006309(apoptotic DNA fragmentation);GO:0006355(regulation of transcription, DNA-templated);GO:0031624(ubiquitin conjugating enzyme binding);GO:0043028(cysteine-type endopeptidase regulator activity involved in apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045171(intercellular bridge);GO:0045892(negative regulation of transcription, DNA-templated);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1e-162,"d":"0.00"},1,"299,",0,-162,-160,4.53,"Exon (ENSBGRT00000003031/ENSBGRG00000001637, exon 1 of 1)",1,141845929,141847062,1134,1]
["chr1",142697835,142697984,150,"ENSBGRG00000002171","ENSBGRT00000004059",0,"DBR1","debranching RNA lariats 1 [Source:HGNC Symbol;Acc:HGNC:15594]","GO:0000375(RNA splicing, via transesterification reactions);GO:0000398(mRNA splicing, via spliceosome);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0008419(RNA lariat debranching enzyme activity);GO:0016787(hydrolase activity);GO:0016788(hydrolase activity, acting on ester bonds)","NA",{"v":2.3E-3,"d":"0.00"},1,"150,",0,-2.63,-2.01,9.72,"5' UTR",1,142697835,142711265,13431,1]
["chr1",142709959,142711265,1307,"ENSBGRG00000002171","ENSBGRT00000004059",12124,"DBR1","debranching RNA lariats 1 [Source:HGNC Symbol;Acc:HGNC:15594]","GO:0000375(RNA splicing, via transesterification reactions);GO:0000398(mRNA splicing, via spliceosome);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0008419(RNA lariat debranching enzyme activity);GO:0016787(hydrolase activity);GO:0016788(hydrolase activity, acting on ester bonds)","NA",{"v":1E-108,"d":"0.00"},2,"141,694,","0,613",-108,-106,{"v":11.2,"d":"11.20"},"Exon (ENSBGRT00000004059/ENSBGRG00000002171, exon 7 of 8)",1,142697835,142711265,13431,1]
["chr1",144860534,144862526,1993,"ENSBGRG00000002516","ENSBGRT00000005249",361226,"STAG1","stromal antigen 1 [Source:HGNC Symbol;Acc:HGNC:11354]","GO:0000785(chromatin);GO:0003682(chromatin binding);GO:0005654(nucleoplasm);GO:0008278(cohesin complex);GO:0016363(nuclear matrix);GO:0016604(nuclear body);GO:0090307(mitotic spindle assembly);GO:0097431(mitotic spindle pole)","04110(Cell cycle)",{"v":9.1e-08,"d":"0.00"},2,"46,75,","0,1918",-7.04,-6.26,1.58,"Exon (ENSBGRT00000005249/ENSBGRG00000002516, exon 31 of 33)",1,144499308,144862643,363336,1]
["chr1",145034789,145067508,32720,"ENSBGRG00000003049","ENSBGRT00000005705",0,"MSL2","MSL complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:25544]","GO:0043984(histone H4-K16 acetylation);GO:0061630(ubiquitin protein ligase activity);GO:0072487(MSL complex)","NA",{"v":9.99999999999998e-225,"d":"0.00"},2,"387,1352,","0,31368",-224,-222,5.76,"5' UTR",1,145034789,145067748,32960,1]
["chr1",145218071,145219137,1067,"ENSBGRG00000003074","ENSBGRT00000005794",14144,"PPP2R3A","protein phosphatase 2 regulatory subunit B''alpha [Source:HGNC Symbol;Acc:HGNC:9307]","GO:0000159(protein phosphatase type 2A complex);GO:0005509(calcium ion binding)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);05165(Human papillomavirus infection)",{"v":0.043,"d":"0.04"},1,"1067,",0,-1.37,{"v":-0.6,"d":"-0.60"},6.48,"Exon (ENSBGRT00000005836/ENSBGRG00000003143, exon 1 of 1)",1,145073358,145233281,159924,2]
["chr1",146963551,146968289,4739,"ENSBGRG00000003311","ENSBGRT00000006157",355,"ANAPC13","anaphase promoting complex subunit 13 [Source:HGNC Symbol;Acc:HGNC:24540]","GO:0005680(anaphase-promoting complex);GO:0070979(protein K11-linked ubiquitination)","04120(Ubiquitin mediated proteolysis);04110(Cell cycle);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation)",{"v":1e-60,"d":"0.00"},3,"3,131,74,","0,132,4665",-60,{"v":-58.6,"d":"-58.60"},2.01,"5' UTR",1,146963196,146969444,6249,1]
["chr1",147090559,147090709,151,"ENSBGRG00000003321","ENSBGRT00000006180",180,"AMOTL2","angiomotin like 2 [Source:HGNC Symbol;Acc:HGNC:17812]","GO:0005923(bicellular tight junction);GO:0016324(apical plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0042802(identical protein binding)","04530(Tight junction)",{"v":0.00072,"d":"0.00"},1,"151,",0,-3.14,{"v":-2.5,"d":"-2.50"},6.12,"Exon (ENSBGRT00000006180/ENSBGRG00000003321, exon 1 of 10)",1,147090379,147107653,17275,1]
["chr1",147096131,147096221,91,"ENSBGRG00000003321","ENSBGRT00000006180",5752,"AMOTL2","angiomotin like 2 [Source:HGNC Symbol;Acc:HGNC:17812]","GO:0005923(bicellular tight junction);GO:0016324(apical plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0042802(identical protein binding)","04530(Tight junction)",{"v":2.5e-13,"d":"0.00"},1,"91,",0,{"v":-12.6,"d":"-12.60"},{"v":-11.7,"d":"-11.70"},2.08,"Exon (ENSBGRT00000006180/ENSBGRG00000003321, exon 3 of 10)",1,147090379,147107653,17275,1]
["chr1",147097516,147103583,6068,"ENSBGRG00000003321","ENSBGRT00000006180",7137,"AMOTL2","angiomotin like 2 [Source:HGNC Symbol;Acc:HGNC:17812]","GO:0005923(bicellular tight junction);GO:0016324(apical plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0042802(identical protein binding)","04530(Tight junction)",{"v":7.9e-28,"d":"0.00"},3,"5,93,82,","0,367,5986",{"v":-27.1,"d":"-27.10"},{"v":-26.1,"d":"-26.10"},1.76,"Exon (ENSBGRT00000006180/ENSBGRG00000003321, exon 4 of 10)",1,147090379,147107653,17275,1]
["chr1",147106686,147107653,968,"ENSBGRG00000003321","ENSBGRT00000006180",16307,"AMOTL2","angiomotin like 2 [Source:HGNC Symbol;Acc:HGNC:17812]","GO:0005923(bicellular tight junction);GO:0016324(apical plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0042802(identical protein binding)","04530(Tight junction)",{"v":1e-162,"d":"0.00"},2,"91,150,","0,818",-162,-160,2.98,"3' UTR",1,147090379,147107653,17275,1]
["chr1",147351903,147352113,211,"ENSBGRG00000003356","ENSBGRT00000006334",120265,"RYK","receptor like tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:10481]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004888(transmembrane signaling receptor activity);GO:0005109(frizzled binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007409(axonogenesis);GO:0007411(axon guidance);GO:0016020(membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0022038(corpus callosum development);GO:0030182(neuron differentiation);GO:0031175(neuron projection development);GO:0036518(chemorepulsion of dopaminergic neuron axon);GO:0042813(Wnt-activated receptor activity);GO:0043410(positive regulation of MAPK cascade);GO:0048705(skeletal system morphogenesis);GO:0048843(negative regulation of axon extension involved in axon guidance);GO:0050919(negative chemotaxis);GO:0071679(commissural neuron axon guidance);GO:1904938(planar cell polarity pathway involved in axon guidance);GO:1904948(midbrain dopaminergic neuron differentiation)","04360(Axon guidance)",{"v":1E-210,"d":"0.00"},1,"211,",0,-210,-208,3.73,"3' UTR",1,147231638,147352262,120625,1]
["chr1",150872636,150873313,678,"ENSBGRG00000007836","ENSBGRT00000014532",60944,"MRPL3","mitochondrial ribosomal protein L3 [Source:HGNC Symbol;Acc:HGNC:10379]","GO:0003735(structural constituent of ribosome);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)",{"v":1e-118,"d":"0.00"},2,"80,131,","0,547",-118,-116,1.78,"3' UTR",1,150811692,150872715,61024,1]
["chr1",152075043,152075162,120,"ENSBGRG00000011752","ENSBGRT00000021424",9864,"ENSBGRG00000011752","NA","NA","NA",{"v":2e-21,"d":"0.00"},1,"120,",0,{"v":-20.7,"d":"-20.70"},{"v":-19.7,"d":"-19.70"},1.53,"Exon (ENSBGRT00000021424/ENSBGRG00000011752, exon 2 of 8)",1,152065179,152144752,79574,1]
["chr1",152087758,152138546,50789,"ENSBGRG00000011808","ENSBGRT00000021511",0,"U6","U6 spliceosomal RNA [Source:RFAM;Acc:RF00026]","NA","NA",0,5,"28,75,93,30,132,","0,23189,24116,45701,50657",-527,"-Inf",2.81,"3' UTR",1,152116016,152116122,107,2]
["chr1",152593634,152593898,265,"ENSBGRG00000011953","ENSBGRT00000021867",77792,"PCP4","Purkinje cell protein 4 [Source:HGNC Symbol;Acc:HGNC:8742]","GO:0005509(calcium ion binding);GO:0005516(calmodulin binding);GO:0032991(protein-containing complex);GO:0045666(positive regulation of neuron differentiation);GO:0099004(calmodulin dependent kinase signaling pathway)","NA",{"v":0.025,"d":"0.03"},1,"265,",0,-1.61,-1.07,4.86,"3' UTR",1,152515842,152593898,78057,1]
["chr1",154478904,154483482,4579,"ENSBGRG00000014066","ENSBGRT00000026227",88001,"MX1","MX dynamin like GTPase 1 [Source:HGNC Symbol;Acc:HGNC:7532]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0009615(response to virus);GO:0031965(nuclear membrane);GO:0042802(identical protein binding);GO:0045071(negative regulation of viral genome replication);GO:0048471(perinuclear region of cytoplasm);GO:0051607(defense response to virus)","05162(Measles);05164(Influenza A);05165(Human papillomavirus infection)",{"v":6.3E-21,"d":"0.00"},2,"107,74,","0,4505",{"v":-20.2,"d":"-20.20"},{"v":-19.2,"d":"-19.20"},2.57,"Exon (ENSBGRT00000026227/ENSBGRG00000014066, exon 15 of 16)",1,154390903,154484561,93659,1]
["chr1",154483661,154483961,301,"ENSBGRG00000014066","ENSBGRT00000026227",92758,"MX1","MX dynamin like GTPase 1 [Source:HGNC Symbol;Acc:HGNC:7532]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0009615(response to virus);GO:0031965(nuclear membrane);GO:0042802(identical protein binding);GO:0045071(negative regulation of viral genome replication);GO:0048471(perinuclear region of cytoplasm);GO:0051607(defense response to virus)","05162(Measles);05164(Influenza A);05165(Human papillomavirus infection)",{"v":7.9e-35,"d":"0.00"},1,"301,",0,{"v":-34.1,"d":"-34.10"},{"v":-32.9,"d":"-32.90"},2.24,"3' UTR",1,154390903,154484561,93659,1]
["chr1",154484231,154484561,331,"ENSBGRG00000014066","ENSBGRT00000026227",93328,"MX1","MX dynamin like GTPase 1 [Source:HGNC Symbol;Acc:HGNC:7532]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0009615(response to virus);GO:0031965(nuclear membrane);GO:0042802(identical protein binding);GO:0045071(negative regulation of viral genome replication);GO:0048471(perinuclear region of cytoplasm);GO:0051607(defense response to virus)","05162(Measles);05164(Influenza A);05165(Human papillomavirus infection)",{"v":0.028,"d":"0.03"},1,"331,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"3' UTR",1,154390903,154484561,93659,1]
["chr1",155460255,155460494,240,"ENSBGRG00000017210","ENSBGRT00000032093",71391,"ABCG1","ATP binding cassette subfamily G member 1 [Source:HGNC Symbol;Acc:HGNC:73]","GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0008203(cholesterol metabolic process);GO:0009897(external side of plasma membrane);GO:0010033(response to organic substance);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0019534(toxin transmembrane transporter activity);GO:0032367(intracellular cholesterol transport);GO:0033344(cholesterol efflux);GO:0033700(phospholipid efflux);GO:0033993(response to lipid);GO:0034041(ATPase-coupled sterol transmembrane transporter activity);GO:0034436(glycoprotein transport);GO:0042632(cholesterol homeostasis);GO:0042803(protein homodimerization activity);GO:0042987(amyloid precursor protein catabolic process);GO:0043531(ADP binding);GO:0046982(protein heterodimerization activity);GO:0050714(positive regulation of protein secretion);GO:0055085(transmembrane transport);GO:0055091(phospholipid homeostasis);GO:0090554(phosphatidylcholine floppase activity);GO:0120020(cholesterol transfer activity);GO:0140328(floppase activity);GO:1902004(positive regulation of amyloid-beta formation)","02010(ABC transporters)",{"v":2.9E-4,"d":"0.00"},1,"240,",0,-3.54,-2.87,{"v":15.1,"d":"15.10"},"3' UTR",1,155388864,155460897,72034,1]
["chr1",155460853,155461301,449,"ENSBGRG00000017210","ENSBGRT00000032093",71989,"ABCG1","ATP binding cassette subfamily G member 1 [Source:HGNC Symbol;Acc:HGNC:73]","GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0008203(cholesterol metabolic process);GO:0009897(external side of plasma membrane);GO:0010033(response to organic substance);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0019534(toxin transmembrane transporter activity);GO:0032367(intracellular cholesterol transport);GO:0033344(cholesterol efflux);GO:0033700(phospholipid efflux);GO:0033993(response to lipid);GO:0034041(ATPase-coupled sterol transmembrane transporter activity);GO:0034436(glycoprotein transport);GO:0042632(cholesterol homeostasis);GO:0042803(protein homodimerization activity);GO:0042987(amyloid precursor protein catabolic process);GO:0043531(ADP binding);GO:0046982(protein heterodimerization activity);GO:0050714(positive regulation of protein secretion);GO:0055085(transmembrane transport);GO:0055091(phospholipid homeostasis);GO:0090554(phosphatidylcholine floppase activity);GO:0120020(cholesterol transfer activity);GO:0140328(floppase activity);GO:1902004(positive regulation of amyloid-beta formation)","02010(ABC transporters)",{"v":2.3E-3,"d":"0.00"},3,"45,10,6,","0,431,443",-2.63,-2.01,7.02,"3' UTR",1,155388864,155460897,72034,1]
["chr1",155625554,155625643,90,"ENSBGRG00000018065","ENSBGRT00000033793",0,"UBASH3A","ubiquitin associated and SH3 domain containing A [Source:HGNC Symbol;Acc:HGNC:12462]","GO:0001817(regulation of cytokine production);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0050860(negative regulation of T cell receptor signaling pathway)","NA",{"v":0.015,"d":"0.02"},1,"90,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000033793/ENSBGRG00000018065, exon 1 of 12)",1,155625554,155670641,45088,1]
["chr1",155835456,155835546,91,"ENSBGRG00000018757","ENSBGRT00000034666",86104,"SLC37A1","solute carrier family 37 member 1 [Source:HGNC Symbol;Acc:HGNC:11024]","GO:0015760(glucose-6-phosphate transport);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0035435(phosphate ion transmembrane transport);GO:0055085(transmembrane transport);GO:0061513(glucose 6-phosphate:inorganic phosphate antiporter activity)","NA",{"v":4.3E-3,"d":"0.00"},1,"91,",0,-2.37,-1.77,1.89,"3' UTR",1,155749352,155835546,86195,1]
["chr1",156125627,156127695,2069,"ENSBGRG00000019941","ENSBGRT00000036784",0,"ENSBGRG00000019941","NA","GO:0005739(mitochondrion);GO:0005747(mitochondrial respiratory chain complex I)","00190(Oxidative phosphorylation);04723(Retrograde endocannabinoid signaling);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":7.9e-06,"d":"0.00"},2,"19,102,","0,1967",{"v":-5.1,"d":"-5.10"},-4.38,1.27,"5' UTR",1,156127594,156136106,8513,1]
["chr1",156132775,156133282,508,"ENSBGRG00000019941","ENSBGRT00000036739",9454,"ENSBGRG00000019941","NA","GO:0005739(mitochondrion);GO:0005747(mitochondrial respiratory chain complex I)","00190(Oxidative phosphorylation);04723(Retrograde endocannabinoid signaling);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":2e-56,"d":"0.00"},1,"508,",0,{"v":-55.7,"d":"-55.70"},{"v":-54.3,"d":"-54.30"},2.83,"Exon (ENSBGRT00000036693/ENSBGRG00000019941, exon 3 of 4)",1,156123321,156135753,12433,1]
["chr1",156830418,156831026,609,"ENSBGRG00000021030","ENSBGRT00000038887",17815,"RRP1B","ribosomal RNA processing 1B [Source:HGNC Symbol;Acc:HGNC:23818]","GO:0001652(granular component);GO:0003713(transcription coactivator activity);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0010923(negative regulation of phosphatase activity);GO:0030688(preribosome, small subunit precursor);GO:0043065(positive regulation of apoptotic process);GO:0043923(positive regulation by host of viral transcription);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0098586(cellular response to virus)","NA",{"v":5.8E-5,"d":"0.00"},2,"27,34,","0,575",-4.24,-3.54,1.43,"Exon (ENSBGRT00000038887/ENSBGRG00000021030, exon 9 of 16)",1,156812603,156838207,25605,1]
["chr1",156833037,156833782,746,"ENSBGRG00000021030","ENSBGRT00000038887",20434,"RRP1B","ribosomal RNA processing 1B [Source:HGNC Symbol;Acc:HGNC:23818]","GO:0001652(granular component);GO:0003713(transcription coactivator activity);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0010923(negative regulation of phosphatase activity);GO:0030688(preribosome, small subunit precursor);GO:0043065(positive regulation of apoptotic process);GO:0043923(positive regulation by host of viral transcription);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0098586(cellular response to virus)","NA",{"v":2e-27,"d":"0.00"},2,"68,171,","0,575",{"v":-26.7,"d":"-26.70"},{"v":-25.6,"d":"-25.60"},4.14,"Exon (ENSBGRT00000038887/ENSBGRG00000021030, exon 12 of 16)",1,156812603,156838207,25605,1]
["chr1",156834051,156834666,616,"ENSBGRG00000021030","ENSBGRT00000038887",21448,"RRP1B","ribosomal RNA processing 1B [Source:HGNC Symbol;Acc:HGNC:23818]","GO:0001652(granular component);GO:0003713(transcription coactivator activity);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0010923(negative regulation of phosphatase activity);GO:0030688(preribosome, small subunit precursor);GO:0043065(positive regulation of apoptotic process);GO:0043923(positive regulation by host of viral transcription);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0098586(cellular response to virus)","NA",{"v":4e-66,"d":"0.00"},2,"229,10,","0,606",{"v":-65.4,"d":"-65.40"},-64,6.24,"Exon (ENSBGRT00000038887/ENSBGRG00000021030, exon 13 of 16)",1,156812603,156838207,25605,1]
["chr1",157149561,157150825,1265,"ENSBGRG00000021804","ENSBGRT00000040296",72715,"AGPAT3","1-acylglycerol-3-phosphate O-acyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:326]","GO:0003841(1-acylglycerol-3-phosphate O-acyltransferase activity);GO:0005635(nuclear envelope);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0016746(transferase activity, transferring acyl groups);GO:0042171(lysophosphatidic acid acyltransferase activity)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04072(Phospholipase D signaling pathway)",{"v":1.3e-16,"d":"0.00"},2,"116,153,","0,1112",{"v":-15.9,"d":"-15.90"},-15,2.94,"Exon (ENSBGRT00000040296/ENSBGRG00000021804, exon 8 of 8)",1,157076846,157151135,74290,1]
["chr1",157150885,157151709,825,"ENSBGRG00000021804","ENSBGRT00000040296",74039,"AGPAT3","1-acylglycerol-3-phosphate O-acyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:326]","GO:0003841(1-acylglycerol-3-phosphate O-acyltransferase activity);GO:0005635(nuclear envelope);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0016746(transferase activity, transferring acyl groups);GO:0042171(lysophosphatidic acid acyltransferase activity)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04072(Phospholipase D signaling pathway)",{"v":1E-146,"d":"0.00"},2,"251,258,","0,567",-146,-145,5.54,"3' UTR",1,157076846,157151135,74290,1]
["chr1",157156943,157157093,151,"ENSBGRG00000021874","ENSBGRT00000040382",4805,"ENSBGRG00000021874","NA","NA","NA",{"v":7.9e-47,"d":"0.00"},1,"151,",0,{"v":-46.1,"d":"-46.10"},{"v":-44.8,"d":"-44.80"},4.12,"Exon (ENSBGRT00000040382/ENSBGRG00000021874, exon 2 of 2)",1,157152138,157157182,5045,1]
["chr1",157619695,157619903,209,"ENSBGRG00000023411","ENSBGRT00000043239",565,"LRRC3","leucine rich repeat containing 3 [Source:HGNC Symbol;Acc:HGNC:14965]","GO:0005515(protein binding)","NA",{"v":1.3e-21,"d":"0.00"},1,"209,",0,{"v":-20.9,"d":"-20.90"},{"v":-19.9,"d":"-19.90"},3.01,"Exon (ENSBGRT00000043239/ENSBGRG00000023411, exon 1 of 1)",1,157619130,157619903,774,1]
["chr1",158277294,158277533,240,"ENSBGRG00000000280","ENSBGRT00000000448",39917,"ADARB1","adenosine deaminase RNA specific B1 [Source:HGNC Symbol;Acc:HGNC:226]","GO:0003723(RNA binding);GO:0004000(adenosine deaminase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006382(adenosine to inosine editing);GO:0006396(RNA processing);GO:0007274(neuromuscular synaptic transmission);GO:0008285(negative regulation of cell population proliferation);GO:0021610(facial nerve morphogenesis);GO:0021618(hypoglossal nerve morphogenesis);GO:0021965(spinal cord ventral commissure morphogenesis);GO:0030336(negative regulation of cell migration);GO:0035264(multicellular organism growth);GO:0044387(negative regulation of protein kinase activity by regulation of protein phosphorylation);GO:0045070(positive regulation of viral genome replication);GO:0050884(neuromuscular process controlling posture);GO:0051726(regulation of cell cycle);GO:0060384(innervation);GO:0060415(muscle tissue morphogenesis);GO:0061744(motor behavior);GO:0097049(motor neuron apoptotic process)","NA",{"v":2.5e-21,"d":"0.00"},1,"240,",0,{"v":-20.6,"d":"-20.60"},{"v":-19.6,"d":"-19.60"},{"v":2.9,"d":"2.90"},"Exon (ENSBGRT00000000448/ENSBGRG00000000280, exon 5 of 12)",1,158237377,158319534,82158,1]
["chr1",158586172,158588066,1895,"ENSBGRG00000000404","ENSBGRT00000001044",42566,"ENSBGRG00000000404","NA","NA","04974(Protein digestion and absorption)",{"v":9e-303,"d":"0.00"},5,"6,36,72,36,30,","0,760,1158,1537,1865",-302,-300,2.47,"Exon (ENSBGRT00000001044/ENSBGRG00000000404, exon 24 of 50)",1,158543606,158602983,59378,1]
["chr1",158602864,158602983,120,"ENSBGRG00000000404","ENSBGRT00000001044",59258,"ENSBGRG00000000404","NA","NA","04974(Protein digestion and absorption)",{"v":9.99999999999998e-226,"d":"0.00"},1,"120,",0,-225,-223,2.42,"Exon (ENSBGRT00000001044/ENSBGRG00000000404, exon 50 of 50)",1,158543606,158602983,59378,1]
["chr1",158650218,158650517,300,"ENSBGRG00000000644","ENSBGRT00000001161",1407,"ENSBGRG00000000644","NA","NA","NA",{"v":2.5e-06,"d":"0.00"},1,"300,",0,{"v":-5.6,"d":"-5.60"},-4.86,{"v":22.7,"d":"22.70"},"Exon (ENSBGRT00000001161/ENSBGRG00000000644, exon 1 of 1)",1,158648811,158650517,1707,1]
["chr1",158980654,158987874,7221,"ENSBGRG00000000669","ENSBGRT00000001367",55901,"PCBP3","poly(rC) binding protein 3 [Source:HGNC Symbol;Acc:HGNC:8651]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003690(double-stranded DNA binding);GO:0003723(RNA binding);GO:1990829(C-rich single-stranded DNA binding)","NA",{"v":0.025,"d":"0.03"},3,"27,53,70,","0,6142,7151",-1.61,-1.07,6.48,"Exon (ENSBGRT00000001367/ENSBGRG00000000669, exon 11 of 14)",1,158924753,158989012,64260,1]
["chr1",159063308,159063428,121,"ENSBGRG00000000813","ENSBGRT00000001486",21928,"COL6A1","collagen type VI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2211]","GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0035987(endodermal cell differentiation);GO:0042383(sarcolemma);GO:0048407(platelet-derived growth factor binding);GO:0071230(cellular response to amino acid stimulus)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":9.99999999999999e-223,"d":"0.00"},1,"121,",0,-222,-220,1.51,"Exon (ENSBGRT00000001486/ENSBGRG00000000813, exon 38 of 38)",1,159041380,159063428,22049,1]
["chr1",159214324,159215797,1474,"ENSBGRG00000000863","ENSBGRT00000001699",3200,"COL6A2","collagen type VI alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2212]","GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0042383(sarcolemma)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":9.99999999999998e-260,"d":"0.00"},6,"14,45,27,27,45,53,","0,99,436,692,817,1421",-259,-257,2.13,"Exon (ENSBGRT00000001699/ENSBGRG00000000863, exon 5 of 28)",1,159211124,159225575,14452,1]
["chr1",159229253,159229343,91,"ENSBGRG00000000863","ENSBGRT00000001579",18129,"COL6A2","collagen type VI alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2212]","GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0042383(sarcolemma)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":1E-146,"d":"0.00"},1,"91,",0,-146,-144,1.66,"Exon (ENSBGRT00000001579/ENSBGRG00000000863, exon 27 of 27)",1,159211124,159229552,18429,1]
["chr1",160015957,160017679,1723,"ENSBGRG00000002483","ENSBGRT00000004767",30,"FBXO25","F-box protein 25 [Source:HGNC Symbol;Acc:HGNC:13596]","GO:0005515(protein binding);GO:0005634(nucleus)","04068(FoxO signaling pathway)",{"v":5e-05,"d":"0.00"},2,"111,68,","0,1655",{"v":-4.3,"d":"-4.30"},{"v":-3.6,"d":"-3.60"},1.78,"5' UTR",1,160015927,160032841,16915,1]
["chr1",161996709,161997068,360,"ENSBGRG00000002778","ENSBGRT00000005203",6367,"CBR1","carbonyl reductase 1 [Source:HGNC Symbol;Acc:HGNC:1548]","GO:0004090(carbonyl reductase (NADPH) activity);GO:0016491(oxidoreductase activity);GO:0016655(oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor);GO:0017144(drug metabolic process);GO:0030855(epithelial cell differentiation);GO:0042373(vitamin K metabolic process);GO:0055114(oxidation-reduction process)","00590(Arachidonic acid metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00790(Folate biosynthesis);05204(Chemical carcinogenesis)",{"v":1e-199,"d":"0.00"},1,"360,",0,-199,-197,4.98,"3' UTR",1,161990342,161997190,6849,1]
["chr1",162083797,162083857,61,"ENSBGRG00000002778","ENSBGRT00000005189",93455,"CBR1","carbonyl reductase 1 [Source:HGNC Symbol;Acc:HGNC:1548]","GO:0004090(carbonyl reductase (NADPH) activity);GO:0016491(oxidoreductase activity);GO:0016655(oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor);GO:0017144(drug metabolic process);GO:0030855(epithelial cell differentiation);GO:0042373(vitamin K metabolic process);GO:0055114(oxidation-reduction process)","00590(Arachidonic acid metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00790(Folate biosynthesis);05204(Chemical carcinogenesis)",{"v":1.6e-24,"d":"0.00"},1,"61,",0,{"v":-23.8,"d":"-23.80"},{"v":-22.8,"d":"-22.80"},2.38,"Exon (ENSBGRT00000005189/ENSBGRG00000002778, exon 3 of 3)",1,161990342,162084276,93935,1]
["chr1",162169281,162173502,4222,"ENSBGRG00000002831","ENSBGRT00000005352",67154,"DOP1B","DOP1 leucine zipper like protein B [Source:HGNC Symbol;Acc:HGNC:1291]","GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","04144(Endocytosis)",{"v":0.043,"d":"0.04"},2,"169,12,","0,4210",-1.37,{"v":-0.6,"d":"-0.60"},{"v":5.4,"d":"5.40"},"5' UTR",1,162102127,162248714,146588,1]
["chr1",162190591,162195913,5323,"ENSBGRG00000002831","ENSBGRT00000005352",88464,"DOP1B","DOP1 leucine zipper like protein B [Source:HGNC Symbol;Acc:HGNC:1291]","GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","04144(Endocytosis)",{"v":4.9e-06,"d":"0.00"},3,"105,76,779,","0,1289,4544",-5.31,-4.57,{"v":21.6,"d":"21.60"},"Exon (ENSBGRT00000005352/ENSBGRG00000002831, exon 18 of 38)",1,162102127,162248714,146588,1]
["chr1",162197073,162197133,61,"ENSBGRG00000002831","ENSBGRT00000005352",94946,"DOP1B","DOP1 leucine zipper like protein B [Source:HGNC Symbol;Acc:HGNC:1291]","GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","04144(Endocytosis)",{"v":0.028,"d":"0.03"},1,"61,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000005352/ENSBGRG00000002831, exon 21 of 38)",1,162102127,162248714,146588,1]
["chr1",162246617,162247066,450,"ENSBGRG00000002831","ENSBGRT00000005352",144490,"DOP1B","DOP1 leucine zipper like protein B [Source:HGNC Symbol;Acc:HGNC:1291]","GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","04144(Endocytosis)",{"v":1.6e-06,"d":"0.00"},1,"450,",0,-5.79,-5.04,13,"3' UTR",1,162102127,162248714,146588,1]
["chr1",162300550,162300817,268,"ENSBGRG00000002919","ENSBGRT00000005650",21735,"MORC3","MORC family CW-type zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:23572]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation);GO:0007569(cell aging);GO:0008270(zinc ion binding);GO:0009791(post-embryonic development);GO:0016605(PML body);GO:0018105(peptidyl-serine phosphorylation);GO:0048147(negative regulation of fibroblast proliferation);GO:0050821(protein stabilization);GO:0051457(maintenance of protein location in nucleus)","NA",{"v":2e-63,"d":"0.00"},1,"268,",0,{"v":-62.7,"d":"-62.70"},{"v":-61.3,"d":"-61.30"},{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000005650/ENSBGRG00000002919, exon 13 of 14)",1,162278815,162302351,23537,1]
["chr1",162302069,162302158,90,"ENSBGRG00000002919","ENSBGRT00000005650",23254,"MORC3","MORC family CW-type zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:23572]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation);GO:0007569(cell aging);GO:0008270(zinc ion binding);GO:0009791(post-embryonic development);GO:0016605(PML body);GO:0018105(peptidyl-serine phosphorylation);GO:0048147(negative regulation of fibroblast proliferation);GO:0050821(protein stabilization);GO:0051457(maintenance of protein location in nucleus)","NA",{"v":2E-19,"d":"0.00"},1,"90,",0,{"v":-18.7,"d":"-18.70"},{"v":-17.7,"d":"-17.70"},3.18,"Exon (ENSBGRT00000005650/ENSBGRG00000002919, exon 14 of 14)",1,162278815,162302351,23537,1]
["chr1",163188512,163188869,358,"ENSBGRG00000003250","ENSBGRT00000006023",0,"ENSBGRG00000003250","NA","NA","NA",{"v":2E-91,"d":"0.00"},1,"358,",0,{"v":-90.7,"d":"-90.70"},{"v":-89.1,"d":"-89.10"},5.11,"5' UTR",1,163188512,163228771,40260,1]
["chr1",163188989,163189257,269,"ENSBGRG00000003250","ENSBGRT00000006023",477,"ENSBGRG00000003250","NA","NA","NA",{"v":1e-81,"d":"0.00"},1,"269,",0,-81,{"v":-79.5,"d":"-79.50"},3.32,"5' UTR",1,163188512,163228771,40260,1]
["chr1",163193401,163207243,13843,"ENSBGRG00000003250","ENSBGRT00000006023",4889,"ENSBGRG00000003250","NA","NA","NA",{"v":1e-115,"d":"0.00"},4,"92,140,69,27,","0,10579,13038,13816",-115,-113,{"v":2.2,"d":"2.20"},"5' UTR",1,163188512,163228771,40260,1]
["chr1",163522863,163534734,11872,"ENSBGRG00000003329","ENSBGRT00000006258",89605,"DYRK1A","dual specificity tyrosine phosphorylation regulated kinase 1A [Source:HGNC Symbol;Acc:HGNC:3091]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0007623(circadian rhythm);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030424(axon);GO:0030425(dendrite);GO:0031115(negative regulation of microtubule polymerization);GO:0033120(positive regulation of RNA splicing);GO:0034205(amyloid-beta formation);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0042802(identical protein binding);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0043621(protein self-association);GO:0046777(protein autophosphorylation);GO:0048025(negative regulation of mRNA splicing, via spliceosome);GO:0048156(tau protein binding);GO:0090312(positive regulation of protein deacetylation);GO:1990904(ribonucleoprotein complex)","NA",0,2,"9,561,","0,11311",-552,"-Inf",8.06,"Exon (ENSBGRT00000006258/ENSBGRG00000003329, exon 10 of 10)",1,163433258,163534217,100960,1]
["chr1",165251206,165251266,61,"ENSBGRG00000003739","ENSBGRT00000006960",20450,"ETS2","ETS proto-oncogene 2, transcription factor [Source:HGNC Symbol;Acc:HGNC:3489]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0019904(protein domain specific binding);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:1990837(sequence-specific double-stranded DNA binding)","04014(Ras signaling pathway);05166(HTLV-I infection)",{"v":6.3e-88,"d":"0.00"},1,"61,",0,{"v":-87.2,"d":"-87.20"},{"v":-85.6,"d":"-85.60"},7.08,"3' UTR",1,165230756,165251974,21219,1]
["chr1",165251385,165251564,180,"ENSBGRG00000003739","ENSBGRT00000006960",20629,"ETS2","ETS proto-oncogene 2, transcription factor [Source:HGNC Symbol;Acc:HGNC:3489]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0019904(protein domain specific binding);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:1990837(sequence-specific double-stranded DNA binding)","04014(Ras signaling pathway);05166(HTLV-I infection)",{"v":1.6E-12,"d":"0.00"},1,"180,",0,{"v":-11.8,"d":"-11.80"},{"v":-10.9,"d":"-10.90"},2.68,"3' UTR",1,165230756,165251974,21219,1]
["chr1",165612627,165612985,359,"ENSBGRG00000003866","ENSBGRT00000007146",418,"PIK3R4","phosphoinositide-3-kinase regulatory subunit 4 [Source:HGNC Symbol;Acc:HGNC:8982]","GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005770(late endosome);GO:0006468(protein phosphorylation);GO:0015630(microtubule cytoskeleton);GO:0032465(regulation of cytokinesis);GO:0032801(receptor catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity)","04371(Apelin signaling pathway);04140(Autophagy - animal);04136(Autophagy - other eukaryotes)",{"v":1.3E-99,"d":"0.00"},1,"359,",0,{"v":-98.9,"d":"-98.90"},{"v":-97.3,"d":"-97.30"},5.78,"Exon (ENSBGRT00000007146/ENSBGRG00000003866, exon 1 of 19)",1,165612209,165698664,86456,1]
["chr1",165621244,165623454,2211,"ENSBGRG00000003866","ENSBGRT00000007146",9035,"PIK3R4","phosphoinositide-3-kinase regulatory subunit 4 [Source:HGNC Symbol;Acc:HGNC:8982]","GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005770(late endosome);GO:0006468(protein phosphorylation);GO:0015630(microtubule cytoskeleton);GO:0032465(regulation of cytokinesis);GO:0032801(receptor catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity)","04371(Apelin signaling pathway);04140(Autophagy - animal);04136(Autophagy - other eukaryotes)",{"v":3.2e-41,"d":"0.00"},2,"82,158,","0,2053",{"v":-40.5,"d":"-40.50"},{"v":-39.3,"d":"-39.30"},4.49,"Exon (ENSBGRT00000007146/ENSBGRG00000003866, exon 2 of 19)",1,165612209,165698664,86456,1]
["chr1",166480143,166480561,419,"ENSBGRG00000004003","ENSBGRT00000007541",56648,"CAPN7","calpain 7 [Source:HGNC Symbol;Acc:HGNC:1484]","GO:0004175(endopeptidase activity);GO:0004198(calcium-dependent cysteine-type endopeptidase activity);GO:0006508(proteolysis);GO:0010634(positive regulation of epithelial cell migration);GO:0090541(MIT domain binding);GO:0097264(self proteolysis)","NA",{"v":1e-162,"d":"0.00"},1,"419,",0,-162,-160,4.32,"3' UTR",1,166423495,166480710,57216,1]
["chr1",166681690,166684703,3014,"ENSBGRG00000004328","ENSBGRT00000007994",4188,"EAF1","ELL associated factor 1 [Source:HGNC Symbol;Acc:HGNC:20907]","GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008023(transcription elongation factor complex);GO:0016604(nuclear body);GO:0032783(super elongation complex);GO:0043231(intracellular membrane-bounded organelle);GO:0045171(intercellular bridge)","NA",{"v":1.8E-10,"d":"0.00"},2,"6,115,","0,2899",-9.74,-8.91,1.39,"Exon (ENSBGRT00000007994/ENSBGRG00000004328, exon 3 of 6)",1,166677502,166690138,12637,1]
["chr1",167478731,167478790,60,"ENSBGRG00000005716","ENSBGRT00000010545",0,"GALNT15","polypeptide N-acetylgalactosaminyltransferase 15 [Source:HGNC Symbol;Acc:HGNC:21531]","GO:0030133(transport vesicle)","00512(Mucin type O-glycan biosynthesis)",{"v":0.025,"d":"0.03"},1,"60,",0,-1.61,-1.07,6.48,"Exon (ENSBGRT00000010545/ENSBGRG00000005716, exon 1 of 11)",1,167478731,167528054,49324,1]
["chr1",167636243,167636572,330,"ENSBGRG00000005867","ENSBGRT00000010807",57997,"OXNAD1","oxidoreductase NAD binding domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25128]","GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00520(Amino sugar and nucleotide sugar metabolism)",{"v":1e-121,"d":"0.00"},1,"330,",0,-121,-119,6.48,"3' UTR",1,167578246,167636721,58476,1]
["chr1",168438050,168438260,211,"ENSBGRG00000000215","ENSBGRT00000000343",139482,"PLCL2","phospholipase C like 2 [Source:HGNC Symbol;Acc:HGNC:9064]","GO:0002322(B cell proliferation involved in immune response);GO:0002337(B-1a B cell differentiation);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0050859(negative regulation of B cell receptor signaling pathway);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","NA",{"v":3.2e-67,"d":"0.00"},1,"211,",0,{"v":-66.5,"d":"-66.50"},{"v":-65.1,"d":"-65.10"},4.61,"Exon (ENSBGRT00000000343/ENSBGRG00000000215, exon 3 of 7)",1,168298568,168542235,243668,1]
["chr1",168438530,168439009,480,"ENSBGRG00000000215","ENSBGRT00000000343",139962,"PLCL2","phospholipase C like 2 [Source:HGNC Symbol;Acc:HGNC:9064]","GO:0002322(B cell proliferation involved in immune response);GO:0002337(B-1a B cell differentiation);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0050859(negative regulation of B cell receptor signaling pathway);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","NA",{"v":6.3e-91,"d":"0.00"},1,"480,",0,{"v":-90.2,"d":"-90.20"},{"v":-88.6,"d":"-88.60"},5.57,"Exon (ENSBGRT00000000343/ENSBGRG00000000215, exon 3 of 7)",1,168298568,168542235,243668,1]
["chr1",168439729,168440239,511,"ENSBGRG00000000215","ENSBGRT00000000343",141161,"PLCL2","phospholipase C like 2 [Source:HGNC Symbol;Acc:HGNC:9064]","GO:0002322(B cell proliferation involved in immune response);GO:0002337(B-1a B cell differentiation);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0050859(negative regulation of B cell receptor signaling pathway);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","NA",{"v":1e-144,"d":"0.00"},1,"511,",0,-144,-142,{"v":5.3,"d":"5.30"},"Exon (ENSBGRT00000000343/ENSBGRG00000000215, exon 3 of 7)",1,168298568,168542235,243668,1]
["chr1",168541965,168542235,271,"ENSBGRG00000000215","ENSBGRT00000000343",243397,"PLCL2","phospholipase C like 2 [Source:HGNC Symbol;Acc:HGNC:9064]","GO:0002322(B cell proliferation involved in immune response);GO:0002337(B-1a B cell differentiation);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0050859(negative regulation of B cell receptor signaling pathway);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","NA",{"v":1e-147,"d":"0.00"},1,"271,",0,-147,-145,3.29,"3' UTR",1,168298568,168542235,243668,1]
["chr1",171996226,171999343,3118,"ENSBGRG00000001791","ENSBGRT00000003323",0,"RAB5A","RAB5A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9783]","GO:0001726(ruffle);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0010008(endosome membrane);GO:0015629(actin cytoskeleton);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0030139(endocytic vesicle);GO:0032009(early phagosome);GO:0036465(synaptic vesicle recycling);GO:0036477(somatodendritic compartment);GO:0039694(viral RNA genome replication);GO:0043195(terminal bouton);GO:0045022(early endosome to late endosome transport);GO:0045121(membrane raft);GO:0045335(phagocytic vesicle);GO:0045921(positive regulation of exocytosis);GO:0051036(regulation of endosome size);GO:0051489(regulation of filopodium assembly);GO:0098559(cytoplasmic side of early endosome membrane);GO:0150093(amyloid-beta clearance by transcytosis);GO:2000286(receptor internalization involved in canonical Wnt signaling pathway);GO:2000300(regulation of synaptic vesicle exocytosis)","04014(Ras signaling pathway);04144(Endocytosis);04145(Phagosome);04962(Vasopressin-regulated water reabsorption);05014(Amyotrophic lateral sclerosis (ALS));05152(Tuberculosis);05146(Amoebiasis)",{"v":2.5e-44,"d":"0.00"},2,"84,66,","0,3052",{"v":-43.6,"d":"-43.60"},{"v":-42.4,"d":"-42.40"},3.21,"5' UTR",1,171996226,172032562,36337,1]
["chr1",172194585,172200451,5867,"ENSBGRG00000001845","ENSBGRT00000003653",111873,"KAT2B","lysine acetyltransferase 2B [Source:HGNC Symbol;Acc:HGNC:8638]","GO:0000123(histone acetyltransferase complex);GO:0000776(kinetochore);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003682(chromatin binding);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0004468(lysine N-acetyltransferase activity, acting on acetyl phosphate as donor);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0005813(centrosome);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-templated);GO:0006473(protein acetylation);GO:0008080(N-acetyltransferase activity);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0010835(regulation of protein ADP-ribosylation);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0018076(N-terminal peptidyl-lysine acetylation);GO:0018393(internal peptidyl-lysine acetylation);GO:0018394(peptidyl-lysine acetylation);GO:0019901(protein kinase binding);GO:0031672(A band);GO:0031674(I band);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0042641(actomyosin);GO:0042826(histone deacetylase binding);GO:0043966(histone H3 acetylation);GO:0043970(histone H3-K9 acetylation);GO:0045722(positive regulation of gluconeogenesis);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046600(negative regulation of centriole replication);GO:0061733(peptide-lysine-N-acetyltransferase activity);GO:2000233(negative regulation of rRNA processing)","04330(Notch signaling pathway);04919(Thyroid hormone signaling pathway);05203(Viral carcinogenesis);05166(HTLV-I infection)",{"v":5e-87,"d":"0.00"},4,"50,170,85,176,","0,148,1561,5691",{"v":-86.3,"d":"-86.30"},{"v":-84.7,"d":"-84.70"},{"v":2.8,"d":"2.80"},"3' UTR",1,172082712,172194902,112191,1]
["chr1",11912863,11914856,1994,"ENSBGRG00000000017","ENSBGRT00000000026",203137,"ROBO2","roundabout guidance receptor 2 [Source:HGNC Symbol;Acc:HGNC:10250]","GO:0001657(ureteric bud development);GO:0005515(protein binding);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007420(brain development);GO:0009986(cell surface);GO:0032870(cellular response to hormone stimulus);GO:0042802(identical protein binding);GO:0050772(positive regulation of axonogenesis);GO:0050925(negative regulation of negative chemotaxis);GO:0061364(apoptotic process involved in luteolysis)","04360(Axon guidance)",{"v":1e-101,"d":"0.00"},2,"141,99,","0,1895",-101,{"v":-99.7,"d":"-99.70"},2.63,"3' UTR",1,11912833,12117993,205161,2]
["chr1",14162605,14189068,26464,"ENSBGRG00000000021","ENSBGRT00000000031",14896,"LIPI","lipase I [Source:HGNC Symbol;Acc:HGNC:18821]","GO:0004620(phospholipase activity);GO:0006629(lipid metabolic process);GO:0008201(heparin binding);GO:0016042(lipid catabolic process);GO:0052689(carboxylic ester hydrolase activity)","NA",0.02,6,"43,168,90,102,109,22,","0,1772,3125,15087,24042,26442",-1.69,-1.14,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000000031/ENSBGRG00000000021, exon 2 of 10)",1,14126671,14203964,77294,2]
["chr1",14404460,14406190,1731,"ENSBGRG00000000025","ENSBGRT00000000038",8725,"HSPA13","heat shock protein family A (Hsp70) member 13 [Source:HGNC Symbol;Acc:HGNC:11375]","NA","NA",{"v":1e-223,"d":"0.00"},2,"764,32,","0,1699",-223,-221,11,"3' UTR",1,14404460,14414915,10456,2]
["chr1",14639811,14716965,77155,"ENSBGRG00000000026","ENSBGRT00000000040",0,"SAMSN1","SAM domain, SH3 domain and nuclear localization signals 1 [Source:HGNC Symbol;Acc:HGNC:10528]","GO:0005515(protein binding)","NA",0.01,8,"112,80,57,87,38,38,132,145,","0,22375,28485,31108,37658,40564,69845,77010",-1.99,-1.42,3.78,"5' UTR",1,14535345,14716965,181621,2]
["chr1",15063990,15064288,299,"ENSBGRG00000000027","ENSBGRT00000000044",2980,"NRIP1","nuclear receptor interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:8001]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001543(ovarian follicle rupture);GO:0001650(fibrillar center);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005102(signaling receptor binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0016607(nuclear speck);GO:0019915(lipid storage);GO:0030331(estrogen receptor binding);GO:0030728(ovulation);GO:0032922(circadian regulation of gene expression);GO:0035257(nuclear hormone receptor binding);GO:0035259(glucocorticoid receptor binding);GO:0042826(histone deacetylase binding);GO:0042974(retinoic acid receptor binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046965(retinoid X receptor binding);GO:0071392(cellular response to estradiol stimulus)","NA",{"v":1.3e-78,"d":"0.00"},1,"299,",0,{"v":-77.9,"d":"-77.90"},{"v":-76.4,"d":"-76.40"},5.72,"Exon (ENSBGRT00000000044/ENSBGRG00000000027, exon 1 of 1)",1,15063990,15067268,3279,2]
["chr1",15064973,15065093,121,"ENSBGRG00000000027","ENSBGRT00000000044",2175,"NRIP1","nuclear receptor interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:8001]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001543(ovarian follicle rupture);GO:0001650(fibrillar center);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005102(signaling receptor binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0016607(nuclear speck);GO:0019915(lipid storage);GO:0030331(estrogen receptor binding);GO:0030728(ovulation);GO:0032922(circadian regulation of gene expression);GO:0035257(nuclear hormone receptor binding);GO:0035259(glucocorticoid receptor binding);GO:0042826(histone deacetylase binding);GO:0042974(retinoic acid receptor binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046965(retinoid X receptor binding);GO:0071392(cellular response to estradiol stimulus)","NA",{"v":4e-68,"d":"0.00"},1,"121,",0,{"v":-67.4,"d":"-67.40"},-66,7.56,"Exon (ENSBGRT00000000044/ENSBGRG00000000027, exon 1 of 1)",1,15063990,15067268,3279,2]
["chr1",15066076,15066344,269,"ENSBGRG00000000027","ENSBGRT00000000044",924,"NRIP1","nuclear receptor interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:8001]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001543(ovarian follicle rupture);GO:0001650(fibrillar center);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005102(signaling receptor binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0016607(nuclear speck);GO:0019915(lipid storage);GO:0030331(estrogen receptor binding);GO:0030728(ovulation);GO:0032922(circadian regulation of gene expression);GO:0035257(nuclear hormone receptor binding);GO:0035259(glucocorticoid receptor binding);GO:0042826(histone deacetylase binding);GO:0042974(retinoic acid receptor binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046965(retinoid X receptor binding);GO:0071392(cellular response to estradiol stimulus)","NA",{"v":6.3e-44,"d":"0.00"},1,"269,",0,{"v":-43.2,"d":"-43.20"},-42,4.92,"Exon (ENSBGRT00000000044/ENSBGRG00000000027, exon 1 of 1)",1,15063990,15067268,3279,2]
["chr1",15066404,15066523,120,"ENSBGRG00000000027","ENSBGRT00000000044",745,"NRIP1","nuclear receptor interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:8001]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001543(ovarian follicle rupture);GO:0001650(fibrillar center);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005102(signaling receptor binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0016607(nuclear speck);GO:0019915(lipid storage);GO:0030331(estrogen receptor binding);GO:0030728(ovulation);GO:0032922(circadian regulation of gene expression);GO:0035257(nuclear hormone receptor binding);GO:0035259(glucocorticoid receptor binding);GO:0042826(histone deacetylase binding);GO:0042974(retinoic acid receptor binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046965(retinoid X receptor binding);GO:0071392(cellular response to estradiol stimulus)","NA",{"v":1.6E-44,"d":"0.00"},1,"120,",0,{"v":-43.8,"d":"-43.80"},{"v":-42.5,"d":"-42.50"},6.07,"Exon (ENSBGRT00000000044/ENSBGRG00000000027, exon 1 of 1)",1,15063990,15067268,3279,2]
["chr1",15067059,15067268,210,"ENSBGRG00000000027","ENSBGRT00000000044",0,"NRIP1","nuclear receptor interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:8001]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001543(ovarian follicle rupture);GO:0001650(fibrillar center);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005102(signaling receptor binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0016607(nuclear speck);GO:0019915(lipid storage);GO:0030331(estrogen receptor binding);GO:0030728(ovulation);GO:0032922(circadian regulation of gene expression);GO:0035257(nuclear hormone receptor binding);GO:0035259(glucocorticoid receptor binding);GO:0042826(histone deacetylase binding);GO:0042974(retinoic acid receptor binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046965(retinoid X receptor binding);GO:0071392(cellular response to estradiol stimulus)","NA",{"v":0.0013,"d":"0.00"},1,"210,",0,-2.89,-2.26,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000000044/ENSBGRG00000000027, exon 1 of 1)",1,15063990,15067268,3279,2]
["chr1",18284044,18309270,25227,"ENSBGRG00000000042","ENSBGRT00000000073",2773,"C21orf91","chromosome 21 open reading frame 91 [Source:HGNC Symbol;Acc:HGNC:16459]","GO:0021895(cerebral cortex neuron differentiation);GO:0060999(positive regulation of dendritic spine development)","NA",{"v":4E-52,"d":"0.00"},2,"321,125,","0,25102",{"v":-51.4,"d":"-51.40"},{"v":-50.1,"d":"-50.10"},5.83,"Exon (ENSBGRT00000000073/ENSBGRG00000000042, exon 2 of 5)",1,18279578,18312043,32466,2]
["chr1",26557505,26557806,302,"ENSBGRG00000000055","ENSBGRT00000000088",0,"ENSBGRG00000000055","NA","GO:0042254(ribosome biogenesis)","NA",{"v":4.3E-3,"d":"0.00"},2,"60,123,","0,179",-2.37,-1.77,6.48,"Exon (ENSBGRT00000000088/ENSBGRG00000000055, exon 1 of 2)",1,26557505,26557806,302,2]
["chr1",27857907,27900203,42297,"ENSBGRG00000000064","ENSBGRT00000000111",0,"ENSBGRG00000000064","NA","NA","NA",{"v":1E-97,"d":"0.00"},2,"114,66,","0,42231",-97,{"v":-95.4,"d":"-95.40"},1.35,"Exon (ENSBGRT00000000111/ENSBGRG00000000064, exon 1 of 1)",1,27860863,27861963,1101,1]
["chr1",28286975,28287065,91,"ENSBGRG00000000067","ENSBGRT00000000114",160298,"ENSBGRG00000000067","NA","NA","NA",{"v":0.0005,"d":"0.00"},1,"91,",0,{"v":-3.3,"d":"-3.30"},-2.65,4.59,"3' UTR",1,28282365,28447363,164999,2]
["chr1",28287124,28287214,91,"ENSBGRG00000000067","ENSBGRT00000000114",160149,"ENSBGRG00000000067","NA","NA","NA",{"v":1.9E-3,"d":"0.00"},1,"91,",0,-2.73,-2.11,{"v":4.1,"d":"4.10"},"3' UTR",1,28282365,28447363,164999,2]
["chr1",28287303,28287482,180,"ENSBGRG00000000067","ENSBGRT00000000114",159881,"ENSBGRG00000000067","NA","NA","NA",{"v":0.043,"d":"0.04"},1,"180,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"3' UTR",1,28282365,28447363,164999,2]
["chr1",28288752,28288991,240,"ENSBGRG00000000067","ENSBGRT00000000114",158372,"ENSBGRG00000000067","NA","NA","NA",0.02,1,"240,",0,-1.69,-1.14,{"v":5.4,"d":"5.40"},"3' UTR",1,28282365,28447363,164999,2]
["chr1",28754681,28755281,601,"ENSBGRG00000000068","ENSBGRT00000000120",7405,"ADAMTS1","ADAM metallopeptidase with thrombospondin type 1 motif 1 [Source:HGNC Symbol;Acc:HGNC:217]","GO:0001542(ovulation from ovarian follicle);GO:0001822(kidney development);GO:0004222(metalloendopeptidase activity);GO:0005604(basement membrane);GO:0006508(proteolysis);GO:0008201(heparin binding);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016525(negative regulation of angiogenesis);GO:0031012(extracellular matrix);GO:0031410(cytoplasmic vesicle);GO:0060347(heart trabecula formation);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration)","NA",0,1,"601,",0,-988,"-Inf",4.71,"3' UTR",1,28754201,28762686,8486,2]
["chr1",28762356,28762506,151,"ENSBGRG00000000068","ENSBGRT00000000120",180,"ADAMTS1","ADAM metallopeptidase with thrombospondin type 1 motif 1 [Source:HGNC Symbol;Acc:HGNC:217]","GO:0001542(ovulation from ovarian follicle);GO:0001822(kidney development);GO:0004222(metalloendopeptidase activity);GO:0005604(basement membrane);GO:0006508(proteolysis);GO:0008201(heparin binding);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016525(negative regulation of angiogenesis);GO:0031012(extracellular matrix);GO:0031410(cytoplasmic vesicle);GO:0060347(heart trabecula formation);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration)","NA",{"v":2.5e-84,"d":"0.00"},1,"151,",0,{"v":-83.6,"d":"-83.60"},-82,2.93,"5' UTR",1,28754201,28762686,8486,2]
["chr1",28867994,28868054,61,"ENSBGRG00000000069","ENSBGRT00000000121",57956,"ADAMTS5","ADAM metallopeptidase with thrombospondin type 1 motif 5 [Source:HGNC Symbol;Acc:HGNC:221]","GO:0004222(metalloendopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008201(heparin binding);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0042742(defense response to bacterium);GO:0050840(extracellular matrix binding);GO:0062023(collagen-containing extracellular matrix);GO:0120163(negative regulation of cold-induced thermogenesis)","NA",{"v":1.5e-07,"d":"0.00"},1,"61,",0,-6.82,-6.05,3,"3' UTR",1,28866712,28926010,59299,2]
["chr1",28868501,28868650,150,"ENSBGRG00000000069","ENSBGRT00000000121",57360,"ADAMTS5","ADAM metallopeptidase with thrombospondin type 1 motif 5 [Source:HGNC Symbol;Acc:HGNC:221]","GO:0004222(metalloendopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008201(heparin binding);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0042742(defense response to bacterium);GO:0050840(extracellular matrix binding);GO:0062023(collagen-containing extracellular matrix);GO:0120163(negative regulation of cold-induced thermogenesis)","NA",{"v":0.00026,"d":"0.00"},1,"150,",0,-3.58,-2.92,1.82,"Exon (ENSBGRT00000000121/ENSBGRG00000000069, exon 10 of 10)",1,28866712,28926010,59299,2]
["chr1",31403699,31405784,2086,"ENSBGRG00000000076","ENSBGRT00000000133",9330,"RWDD2B","RWD domain containing 2B [Source:HGNC Symbol;Acc:HGNC:1302]","GO:0005515(protein binding)","NA",{"v":1e-30,"d":"0.00"},2,"121,56,","0,2030",-30,{"v":-28.9,"d":"-28.90"},{"v":2.9,"d":"2.90"},"Exon (ENSBGRT00000000133/ENSBGRG00000000076, exon 5 of 6)",1,31403553,31415114,11562,2]
["chr1",34579218,34598430,19213,"ENSBGRG00000000113","ENSBGRT00000000182",0,"ENSBGRG00000000113","NA","NA","NA",{"v":0.028,"d":"0.03"},2,"41,50,","0,19163",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000000180/ENSBGRG00000000112, exon 3 of 27)",1,34580551,34580627,77,2]
["chr1",34598699,34599087,389,"ENSBGRG00000000112","ENSBGRT00000000180",20775,"TIAM1","TIAM Rac1 associated GEF 1 [Source:HGNC Symbol;Acc:HGNC:11805]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007160(cell-matrix adhesion);GO:0007165(signal transduction);GO:0008284(positive regulation of cell population proliferation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0016477(cell migration);GO:0016601(Rac protein signal transduction);GO:0019900(kinase binding);GO:0030335(positive regulation of cell migration);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032092(positive regulation of protein binding);GO:0034622(cellular protein-containing complex assembly);GO:0035556(intracellular signal transduction);GO:0044291(cell-cell contact zone);GO:0090630(activation of GTPase activity)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04530(Tight junction);04810(Regulation of actin cytoskeleton);04062(Chemokine signaling pathway);05205(Proteoglycans in cancer)",{"v":0.028,"d":"0.03"},1,"389,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000000180/ENSBGRG00000000112, exon 3 of 27)",1,34418116,34619862,201747,2]
["chr1",35101080,35101619,540,"ENSBGRG00000000118","ENSBGRT00000000187",65513,"SCAF4","SR-related CTD associated factor 4 [Source:HGNC Symbol;Acc:HGNC:19304]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:1990269(RNA polymerase II C-terminal domain phosphoserine binding);GO:2000805(negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled)","NA",{"v":1E-173,"d":"0.00"},1,"540,",0,-173,-171,4.26,"Exon (ENSBGRT00000000187/ENSBGRG00000000118, exon 20 of 21)",1,35101017,35167132,66116,2]
["chr1",35781819,35787694,5876,"ENSBGRG00000000120","ENSBGRT00000000190",13497,"MIS18A","MIS18 kinetochore protein A [Source:HGNC Symbol;Acc:HGNC:1286]","GO:0000775(chromosome, centromeric region);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0007059(chromosome segregation);GO:0034080(CENP-A containing nucleosome assembly);GO:0042802(identical protein binding);GO:0044030(regulation of DNA methylation)","NA",{"v":0.012,"d":"0.01"},3,"81,97,56,","0,1738,5820",-1.92,-1.35,4.32,"Exon (ENSBGRT00000000190/ENSBGRG00000000120, exon 3 of 5)",1,35781819,35801191,19373,2]
["chr1",35787753,35794636,6884,"ENSBGRG00000000120","ENSBGRT00000000190",6555,"MIS18A","MIS18 kinetochore protein A [Source:HGNC Symbol;Acc:HGNC:1286]","GO:0000775(chromosome, centromeric region);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0007059(chromosome segregation);GO:0034080(CENP-A containing nucleosome assembly);GO:0042802(identical protein binding);GO:0044030(regulation of DNA methylation)","NA",{"v":0.0029,"d":"0.00"},2,"9,50,","0,6834",-2.54,-1.93,2.81,"Exon (ENSBGRT00000000190/ENSBGRG00000000120, exon 2 of 5)",1,35781819,35801191,19373,2]
["chr1",35836550,35836610,61,"ENSBGRG00000000122","ENSBGRT00000000196",86001,"URB1","URB1 ribosome biogenesis homolog [Source:HGNC Symbol;Acc:HGNC:17344]","GO:0001650(fibrillar center);GO:0005730(nucleolus)","NA",{"v":0.011,"d":"0.01"},1,"61,",0,-1.97,{"v":-1.4,"d":"-1.40"},3.06,"Exon (ENSBGRT00000000196/ENSBGRG00000000122, exon 36 of 36)",1,35836490,35922611,86122,2]
["chr1",35875584,35875913,330,"ENSBGRG00000000122","ENSBGRT00000000196",46698,"URB1","URB1 ribosome biogenesis homolog [Source:HGNC Symbol;Acc:HGNC:17344]","GO:0001650(fibrillar center);GO:0005730(nucleolus)","NA",{"v":0.0041,"d":"0.00"},1,"330,",0,-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000000196/ENSBGRG00000000122, exon 19 of 36)",1,35836490,35922611,86122,2]
["chr1",36123711,36125281,1571,"ENSBGRG00000000124","ENSBGRT00000000203",10363,"ENSBGRG00000000124","cilia and flagella associated protein 298 [Source:HGNC Symbol;Acc:HGNC:1301]","GO:0003352(regulation of cilium movement)","NA",{"v":7.9e-31,"d":"0.00"},4,"51,33,33,2,","0,1499,1534,1569",{"v":-30.1,"d":"-30.10"},-29,1.75,"Exon (ENSBGRT00000000203/ENSBGRG00000000124, exon 6 of 7)",1,36123216,36135644,12429,2]
["chr1",36131170,36135438,4269,"ENSBGRG00000000124","ENSBGRT00000000203",206,"ENSBGRG00000000124","cilia and flagella associated protein 298 [Source:HGNC Symbol;Acc:HGNC:1301]","GO:0003352(regulation of cilium movement)","NA",{"v":3.2e-25,"d":"0.00"},3,"11,168,116,","0,1709,4153",{"v":-24.5,"d":"-24.50"},{"v":-23.5,"d":"-23.50"},1.64,"Exon (ENSBGRT00000000203/ENSBGRG00000000124, exon 1 of 7)",1,36123216,36135644,12429,2]
["chr1",36145404,36145523,120,"ENSBGRG00000000125","ENSBGRT00000000209",81223,"SYNJ1","synaptojanin 1 [Source:HGNC Symbol;Acc:HGNC:11503]","GO:0003676(nucleic acid binding);GO:0034595(phosphatidylinositol phosphate 5-phosphatase activity);GO:0042578(phosphoric ester hydrolase activity);GO:0046856(phosphatidylinositol dephosphorylation);GO:0048488(synaptic vesicle endocytosis)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":1E-4,"d":"0.00"},1,"120,",0,-3.98,-3.29,1.47,"Exon (ENSBGRT00000000209/ENSBGRG00000000125, exon 27 of 27)",1,36144896,36226746,81851,2]
["chr1",36282290,36282379,90,"ENSBGRG00000000127","ENSBGRT00000000213",8219,"PAXBP1","PAX3 and PAX7 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:13579]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0014842(regulation of skeletal muscle satellite cell proliferation);GO:0031062(positive regulation of histone methylation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2000288(positive regulation of myoblast proliferation)","NA",{"v":0.00025,"d":"0.00"},1,"90,",0,-3.61,-2.95,1.42,"Exon (ENSBGRT00000000213/ENSBGRG00000000127, exon 4 of 18)",1,36258968,36290598,31631,2]
["chr1",36290450,36290598,149,"ENSBGRG00000000127","ENSBGRT00000000213",0,"PAXBP1","PAX3 and PAX7 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:13579]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0014842(regulation of skeletal muscle satellite cell proliferation);GO:0031062(positive regulation of histone methylation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2000288(positive regulation of myoblast proliferation)","NA",{"v":0.044,"d":"0.04"},1,"149,",0,-1.36,{"v":-0.841,"d":"-0.84"},2.97,"Exon (ENSBGRT00000000213/ENSBGRG00000000127, exon 1 of 18)",1,36258968,36290598,31631,2]
["chr1",36309469,36309559,91,"ENSBGRG00000000128","ENSBGRT00000000215",477,"C21orf62","chromosome 21 open reading frame 62 [Source:HGNC Symbol;Acc:HGNC:1305]","NA","NA",{"v":0.0002,"d":"0.00"},1,"91,",0,-3.69,-3.02,2.13,"Exon (ENSBGRT00000000215/ENSBGRG00000000128, exon 1 of 1)",1,36309380,36310036,657,2]
["chr1",37145166,37145693,528,"ENSBGRG00000000137","ENSBGRT00000000227",615,"DNAJC28","DnaJ heat shock protein family (Hsp40) member C28 [Source:HGNC Symbol;Acc:HGNC:1297]","NA","NA",{"v":4e-20,"d":"0.00"},1,"528,",0,{"v":-19.4,"d":"-19.40"},{"v":-18.4,"d":"-18.40"},4.47,"Exon (ENSBGRT00000000227/ENSBGRG00000000137, exon 1 of 1)",1,37145166,37146308,1143,2]
["chr1",37145898,37146162,265,"ENSBGRG00000000137","ENSBGRT00000000227",146,"DNAJC28","DnaJ heat shock protein family (Hsp40) member C28 [Source:HGNC Symbol;Acc:HGNC:1297]","NA","NA",{"v":6.3e-24,"d":"0.00"},1,"265,",0,{"v":-23.2,"d":"-23.20"},{"v":-22.1,"d":"-22.10"},{"v":4.2,"d":"4.20"},"Exon (ENSBGRT00000000227/ENSBGRG00000000137, exon 1 of 1)",1,37145166,37146308,1143,2]
["chr1",37242038,37242187,150,"ENSBGRG00000000141","ENSBGRT00000000234",687,"DONSON","downstream neighbor of SON [Source:HGNC Symbol;Acc:HGNC:2993]","GO:0000077(DNA damage checkpoint);GO:0005634(nucleus);GO:0005657(replication fork);GO:0006260(DNA replication);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0030894(replisome);GO:0048478(replication fork protection)","NA",{"v":4.8e-05,"d":"0.00"},1,"150,",0,-4.32,-3.63,2.57,"5' UTR",1,37231178,37242874,11697,2]
["chr1",38315809,38316075,267,"ENSBGRG00000000154","ENSBGRT00000000259",11126,"RCAN1","regulator of calcineurin 1 [Source:HGNC Symbol;Acc:HGNC:3040]","GO:0002931(response to ischemia);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006979(response to oxidative stress);GO:0007614(short-term memory);GO:0019722(calcium-mediated signaling);GO:0031987(locomotion involved in locomotory behavior);GO:0033173(calcineurin-NFAT signaling cascade);GO:0043666(regulation of phosphoprotein phosphatase activity);GO:0048741(skeletal muscle fiber development)","04921(Oxytocin signaling pathway);04919(Thyroid hormone signaling pathway);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":5E-53,"d":"0.00"},1,"267,",0,{"v":-52.3,"d":"-52.30"},-51,4.32,"3' UTR",1,38314924,38327201,12278,2]
["chr1",38729979,38730188,210,"ENSBGRG00000000164","ENSBGRT00000000269",95799,"CGGBP1","CGG triplet repeat binding protein 1 [Source:HGNC Symbol;Acc:HGNC:1888]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0042802(identical protein binding);GO:0090579(dsDNA loop formation);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1.3E-99,"d":"0.00"},1,"210,",0,{"v":-98.9,"d":"-98.90"},{"v":-97.3,"d":"-97.30"},3.29,"Exon (ENSBGRT00000000269/ENSBGRG00000000164, exon 4 of 4)",1,38729830,38825987,96158,2]
["chr1",45362655,45362804,150,"ENSBGRG00000000874","ENSBGRT00000001593",137516,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":1.3E-22,"d":"0.00"},1,"150,",0,{"v":-21.9,"d":"-21.90"},{"v":-20.9,"d":"-20.90"},2.02,"3' UTR",1,45225139,45364143,139005,1]
["chr1",45396510,45396778,269,"ENSBGRG00000000955","ENSBGRT00000001762",4213,"RIOX2","ribosomal oxygenase 2 [Source:HGNC Symbol;Acc:HGNC:19441]","GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0042802(identical protein binding)","NA",{"v":1e-12,"d":"0.00"},1,"269,",0,-12,{"v":-11.1,"d":"-11.10"},2.41,"Exon (ENSBGRT00000001762/ENSBGRG00000000955, exon 2 of 12)",1,45361838,45400991,39154,2]
["chr1",46066802,46068014,1213,"ENSBGRG00000002153","ENSBGRT00000004080",0,"CLDND1","claudin domain containing 1 [Source:HGNC Symbol;Acc:HGNC:1322]","GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane)","NA",{"v":7.2e-08,"d":"0.00"},2,"43,47,","0,1166",-7.14,-6.36,2.63,"Exon (ENSBGRT00000004080/ENSBGRG00000002153, exon 1 of 4)",1,46060763,46067974,7212,2]
["chr1",46068073,46068192,120,"ENSBGRG00000002153","ENSBGRT00000004039",0,"CLDND1","claudin domain containing 1 [Source:HGNC Symbol;Acc:HGNC:1322]","GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane)","NA",{"v":0.015,"d":"0.02"},1,"120,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000004039/ENSBGRG00000002153, exon 1 of 6)",1,46060763,46068192,7430,2]
["chr1",46144238,46144327,90,"ENSBGRG00000002215","ENSBGRT00000004158",0,"ENSBGRG00000002215","coproporphyrinogen oxidase [Source:HGNC Symbol;Acc:HGNC:2321]","GO:0004109(coproporphyrinogen oxidase activity);GO:0005212(structural constituent of eye lens);GO:0005739(mitochondrion);GO:0006779(porphyrin-containing compound biosynthetic process);GO:0006783(heme biosynthetic process);GO:0016020(membrane);GO:0055114(oxidation-reduction process)","00860(Porphyrin and chlorophyll metabolism)",{"v":7.1e-10,"d":"0.00"},1,"90,",0,-9.15,-8.33,{"v":29.2,"d":"29.20"},"Exon (ENSBGRT00000004158/ENSBGRG00000002215, exon 1 of 7)",1,46129945,46144327,14383,2]
["chr1",46382196,46383065,870,"ENSBGRG00000002387","ENSBGRT00000004632",86183,"DCBLD2","discoidin, CUB and LCCL domain containing 2 [Source:HGNC Symbol;Acc:HGNC:24627]","GO:0005887(integral component of plasma membrane);GO:0009986(cell surface);GO:0030308(negative regulation of cell growth);GO:0042060(wound healing)","NA",{"v":5e-24,"d":"0.00"},2,"135,75,","0,795",{"v":-23.3,"d":"-23.30"},{"v":-22.3,"d":"-22.30"},2.03,"Exon (ENSBGRT00000004632/ENSBGRG00000002387, exon 14 of 15)",1,46380795,46469248,88454,2]
["chr1",47489179,47581703,92525,"ENSBGRG00000002590","ENSBGRT00000004850",11641,"FILIP1L","filamin A interacting protein 1 like [Source:HGNC Symbol;Acc:HGNC:24589]","NA","NA",{"v":8.99999999999999E-297,"d":"0.00"},3,"1377,437,16,","0,1835,92509",-296,-294,{"v":4.8,"d":"4.80"},"Exon (ENSBGRT00000004850/ENSBGRG00000002590, exon 3 of 7)",1,47458229,47593344,135116,2]
["chr1",49314488,49314607,120,"ENSBGRG00000003382","ENSBGRT00000006328",67036,"IMPG2","interphotoreceptor matrix proteoglycan 2 [Source:HGNC Symbol;Acc:HGNC:18362]","GO:0005201(extracellular matrix structural constituent);GO:0005540(hyaluronic acid binding);GO:0007601(visual perception);GO:0008201(heparin binding);GO:0033165(interphotoreceptor matrix);GO:0043235(receptor complex)","NA",{"v":1.1e-06,"d":"0.00"},1,"120,",0,-5.95,-5.19,{"v":13.5,"d":"13.50"},"Exon (ENSBGRT00000006328/ENSBGRG00000003382, exon 14 of 20)",1,49292342,49381643,89302,2]
["chr1",49315264,49315476,213,"ENSBGRG00000003382","ENSBGRT00000006328",66167,"IMPG2","interphotoreceptor matrix proteoglycan 2 [Source:HGNC Symbol;Acc:HGNC:18362]","GO:0005201(extracellular matrix structural constituent);GO:0005540(hyaluronic acid binding);GO:0007601(visual perception);GO:0008201(heparin binding);GO:0033165(interphotoreceptor matrix);GO:0043235(receptor complex)","NA",{"v":2.5e-06,"d":"0.00"},2,"35,145,","0,68",{"v":-5.6,"d":"-5.60"},-4.86,{"v":22.7,"d":"22.70"},"Exon (ENSBGRT00000006328/ENSBGRG00000003382, exon 13 of 20)",1,49292342,49381643,89302,2]
["chr1",49611781,49612050,270,"ENSBGRG00000003762","ENSBGRT00000006964",29987,"ZBTB11","zinc finger and BTB domain containing 11 [Source:HGNC Symbol;Acc:HGNC:16740]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm)","NA",{"v":1e-102,"d":"0.00"},1,"270,",0,-102,-101,5.59,"Exon (ENSBGRT00000006964/ENSBGRG00000003762, exon 11 of 11)",1,49611692,49642037,30346,2]
["chr1",49621943,49622092,150,"ENSBGRG00000003762","ENSBGRT00000006964",19945,"ZBTB11","zinc finger and BTB domain containing 11 [Source:HGNC Symbol;Acc:HGNC:16740]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm)","NA",{"v":1.6e-23,"d":"0.00"},1,"150,",0,{"v":-22.8,"d":"-22.80"},{"v":-21.7,"d":"-21.70"},4.23,"Exon (ENSBGRT00000006964/ENSBGRG00000003762, exon 4 of 11)",1,49611692,49642037,30346,2]
["chr1",49622211,49622270,60,"ENSBGRG00000003762","ENSBGRT00000006964",19767,"ZBTB11","zinc finger and BTB domain containing 11 [Source:HGNC Symbol;Acc:HGNC:16740]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm)","NA",{"v":7.9e-40,"d":"0.00"},1,"60,",0,{"v":-39.1,"d":"-39.10"},{"v":-37.9,"d":"-37.90"},6.06,"Exon (ENSBGRT00000006964/ENSBGRG00000003762, exon 4 of 11)",1,49611692,49642037,30346,2]
["chr1",54264345,54264435,91,"ENSBGRG00000004626","ENSBGRT00000008595",241368,"CBLB","Cbl proto-oncogene B [Source:HGNC Symbol;Acc:HGNC:1542]","GO:0001784(phosphotyrosine residue binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005509(calcium ion binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0007166(cell surface receptor signaling pathway);GO:0023051(regulation of signaling)","04120(Ubiquitin mediated proteolysis);04012(ErbB signaling pathway);04144(Endocytosis);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04910(Insulin signaling pathway);05162(Measles)",{"v":4e-23,"d":"0.00"},1,"91,",0,{"v":-22.4,"d":"-22.40"},{"v":-21.4,"d":"-21.40"},4.42,"3' UTR",1,54263595,54505803,242209,2]
["chr1",54264555,54277194,12640,"ENSBGRG00000004626","ENSBGRT00000008595",228609,"CBLB","Cbl proto-oncogene B [Source:HGNC Symbol;Acc:HGNC:1542]","GO:0001784(phosphotyrosine residue binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005509(calcium ion binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0007166(cell surface receptor signaling pathway);GO:0023051(regulation of signaling)","04120(Ubiquitin mediated proteolysis);04012(ErbB signaling pathway);04144(Endocytosis);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04910(Insulin signaling pathway);05162(Measles)",{"v":1.3E-74,"d":"0.00"},2,"300,1,","0,12639",{"v":-73.9,"d":"-73.90"},{"v":-72.4,"d":"-72.40"},7.85,"3' UTR",1,54263595,54505803,242209,2]
["chr1",54505664,54505754,91,"ENSBGRG00000004626","ENSBGRT00000008595",49,"CBLB","Cbl proto-oncogene B [Source:HGNC Symbol;Acc:HGNC:1542]","GO:0001784(phosphotyrosine residue binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005509(calcium ion binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0007166(cell surface receptor signaling pathway);GO:0023051(regulation of signaling)","04120(Ubiquitin mediated proteolysis);04012(ErbB signaling pathway);04144(Endocytosis);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04910(Insulin signaling pathway);05162(Measles)",{"v":0.00048,"d":"0.00"},1,"91,",0,-3.32,-2.67,2.01,"Exon (ENSBGRT00000008595/ENSBGRG00000004626, exon 1 of 18)",1,54263595,54505803,242209,2]
["chr1",60892837,60893493,657,"ENSBGRG00000000207","ENSBGRT00000000332",0,"ZBED2","zinc finger BED-type containing 2 [Source:HGNC Symbol;Acc:HGNC:20710]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0003677(DNA binding);GO:0045618(positive regulation of keratinocyte differentiation)","NA",{"v":0.028,"d":"0.03"},1,"657,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000000332/ENSBGRG00000000207, exon 1 of 1)",1,60892837,60893493,657,2]
["chr1",61508029,61508116,88,"ENSBGRG00000000533","ENSBGRT00000000936",14240,"GCSAM","germinal center associated signaling and motility [Source:HGNC Symbol;Acc:HGNC:20253]","GO:0003779(actin binding);GO:0019901(protein kinase binding);GO:0045159(myosin II binding);GO:0050855(regulation of B cell receptor signaling pathway);GO:2000401(regulation of lymphocyte migration);GO:2000402(negative regulation of lymphocyte migration)","NA",{"v":0.043,"d":"0.04"},1,"88,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000000936/ENSBGRG00000000533, exon 6 of 6)",1,61508029,61522356,14328,2]
["chr1",61931832,61953177,21346,"ENSBGRG00000000674","ENSBGRT00000001264",11324,"ATG3","autophagy related 3 [Source:HGNC Symbol;Acc:HGNC:20962]","GO:0000045(autophagosome assembly);GO:0000153(cytoplasmic ubiquitin ligase complex);GO:0005829(cytosol);GO:0006464(cellular protein modification process);GO:0016236(macroautophagy);GO:0016567(protein ubiquitination);GO:0019776(Atg8 ligase activity);GO:0019777(Atg12 transferase activity);GO:0019787(ubiquitin-like protein transferase activity);GO:0019899(enzyme binding);GO:0043653(mitochondrial fragmentation involved in apoptotic process);GO:0050765(negative regulation of phagocytosis);GO:1902017(regulation of cilium assembly)","04140(Autophagy - animal);04136(Autophagy - other eukaryotes);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":7.9e-18,"d":"0.00"},4,"56,50,108,26,","0,2129,4865,21320",{"v":-17.1,"d":"-17.10"},{"v":-16.2,"d":"-16.20"},1.78,"Exon (ENSBGRT00000001264/ENSBGRG00000000674, exon 4 of 12)",1,61922447,61964501,42055,2]
["chr1",62036998,62037654,657,"ENSBGRG00000000776","ENSBGRT00000001429",1224,"CCDC80","coiled-coil domain containing 80 [Source:HGNC Symbol;Acc:HGNC:30649]","GO:0001968(fibronectin binding);GO:0005539(glycosaminoglycan binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0008201(heparin binding);GO:0009617(response to bacterium);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)","NA",0,1,"657,",0,-484,"-Inf",3.69,"Exon (ENSBGRT00000001429/ENSBGRG00000000776, exon 2 of 8)",1,62002733,62038878,36146,2]
["chr1",62037952,62038012,61,"ENSBGRG00000000776","ENSBGRT00000001429",866,"CCDC80","coiled-coil domain containing 80 [Source:HGNC Symbol;Acc:HGNC:30649]","GO:0001968(fibronectin binding);GO:0005539(glycosaminoglycan binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0008201(heparin binding);GO:0009617(response to bacterium);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)","NA",{"v":1e-110,"d":"0.00"},1,"61,",0,-110,-109,{"v":2.1,"d":"2.10"},"Exon (ENSBGRT00000001429/ENSBGRG00000000776, exon 2 of 8)",1,62002733,62038878,36146,2]
["chr1",62038250,62038697,448,"ENSBGRG00000000776","ENSBGRT00000001429",181,"CCDC80","coiled-coil domain containing 80 [Source:HGNC Symbol;Acc:HGNC:30649]","GO:0001968(fibronectin binding);GO:0005539(glycosaminoglycan binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0008201(heparin binding);GO:0009617(response to bacterium);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)","NA",{"v":7.9e-20,"d":"0.00"},1,"448,",0,{"v":-19.1,"d":"-19.10"},{"v":-18.1,"d":"-18.10"},3.08,"Exon (ENSBGRT00000001429/ENSBGRG00000000776, exon 2 of 8)",1,62002733,62038878,36146,2]
["chr1",62039736,62040034,299,"ENSBGRG00000000776","ENSBGRT00000001411",73743,"CCDC80","coiled-coil domain containing 80 [Source:HGNC Symbol;Acc:HGNC:30649]","GO:0001968(fibronectin binding);GO:0005539(glycosaminoglycan binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0008201(heparin binding);GO:0009617(response to bacterium);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)","NA",{"v":1E-58,"d":"0.00"},1,"299,",0,-58,{"v":-56.7,"d":"-56.70"},5.83,"Exon (ENSBGRT00000001411/ENSBGRG00000000776, exon 2 of 9)",1,62002733,62113777,111045,2]
["chr1",62372067,62372366,300,"ENSBGRG00000000866","ENSBGRT00000001624",18289,"GTPBP8","GTP binding protein 8 (putative) [Source:HGNC Symbol;Acc:HGNC:25007]","GO:0005525(GTP binding);GO:0005739(mitochondrion)","04146(Peroxisome)",{"v":5e-85,"d":"0.00"},1,"300,",0,{"v":-84.3,"d":"-84.30"},{"v":-82.7,"d":"-82.70"},4.51,"Exon (ENSBGRT00000001714/ENSBGRG00000000919, exon 9 of 9)",1,62353778,62374443,20666,1]
["chr1",62762842,62763052,211,"ENSBGRG00000001051","ENSBGRT00000001942",74789,"CFAP44","cilia and flagella associated protein 44 [Source:HGNC Symbol;Acc:HGNC:25631]","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0007288(sperm axoneme assembly);GO:0008233(peptidase activity);GO:0030317(flagellated sperm motility)","NA",{"v":0.0022,"d":"0.00"},1,"211,",0,-2.66,-2.05,3.96,"Exon (ENSBGRT00000001942/ENSBGRG00000001051, exon 25 of 35)",1,62711066,62837841,126776,2]
["chr1",62794802,62794982,181,"ENSBGRG00000001051","ENSBGRT00000001942",42859,"CFAP44","cilia and flagella associated protein 44 [Source:HGNC Symbol;Acc:HGNC:25631]","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0007288(sperm axoneme assembly);GO:0008233(peptidase activity);GO:0030317(flagellated sperm motility)","NA",{"v":0.025,"d":"0.03"},1,"181,",0,-1.61,-1.07,7.56,"Exon (ENSBGRT00000001942/ENSBGRG00000001051, exon 16 of 35)",1,62711066,62837841,126776,2]
["chr1",63068091,63068301,211,"ENSBGRG00000001394","ENSBGRT00000002549",19928,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":1.2E-10,"d":"0.00"},1,"211,",0,-9.91,-9.06,2.96,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 5 of 5)",1,63067523,63088229,20707,2]
["chr1",63069378,63069527,150,"ENSBGRG00000001394","ENSBGRT00000002549",18702,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":1.1e-06,"d":"0.00"},1,"150,",0,-5.96,-5.21,9,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 5 of 5)",1,63067523,63088229,20707,2]
["chr1",63072049,63072348,300,"ENSBGRG00000001394","ENSBGRT00000002549",15881,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":4e-05,"d":"0.00"},1,"300,",0,{"v":-4.4,"d":"-4.40"},{"v":-3.7,"d":"-3.70"},6.48,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 4 of 5)",1,63067523,63088229,20707,2]
["chr1",63072408,63072617,210,"ENSBGRG00000001394","ENSBGRT00000002549",15612,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":6.8e-06,"d":"0.00"},1,"210,",0,-5.17,-4.44,7.29,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 4 of 5)",1,63067523,63088229,20707,2]
["chr1",63073066,63074636,1571,"ENSBGRG00000001394","ENSBGRT00000002549",13593,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":0.0078,"d":"0.01"},2,"255,673,","0,898",-2.11,-1.27,9.72,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 3 of 5)",1,63067523,63088229,20707,2]
["chr1",63074696,63074756,61,"ENSBGRG00000001394","ENSBGRT00000002549",13473,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":0.027,"d":"0.03"},1,"61,",0,-1.57,-1.03,3.24,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 3 of 5)",1,63067523,63088229,20707,2]
["chr1",63074935,63075055,121,"ENSBGRG00000001394","ENSBGRT00000002549",13174,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":0.028,"d":"0.03"},1,"121,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 3 of 5)",1,63067523,63088229,20707,2]
["chr1",63079151,63088229,9079,"ENSBGRG00000001394","ENSBGRT00000002549",0,"USF3","upstream transcription factor family member 3 [Source:HGNC Symbol;Acc:HGNC:30494]","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA",{"v":0.0078,"d":"0.01"},2,"4,117,","0,8962",-2.11,-1.42,9.72,"Exon (ENSBGRT00000002549/ENSBGRG00000001394, exon 1 of 5)",1,63067523,63088229,20707,2]
["chr1",63136585,63137465,881,"ENSBGRG00000001410","ENSBGRT00000002646",30454,"ENSBGRG00000001410","NA","GO:0008080(N-acetyltransferase activity)","NA",{"v":4e-22,"d":"0.00"},2,"148,33,","0,848",{"v":-21.4,"d":"-21.40"},{"v":-20.4,"d":"-20.40"},2.61,"Exon (ENSBGRT00000002646/ENSBGRG00000001410, exon 4 of 5)",1,63136555,63167919,31365,2]
["chr1",63438941,63439031,91,"ENSBGRG00000001705","ENSBGRT00000003162",64020,"CCDC191","coiled-coil domain containing 191 [Source:HGNC Symbol;Acc:HGNC:29272]","NA","NA",{"v":0.032,"d":"0.03"},1,"91,",0,-1.49,{"v":-0.959,"d":"-0.96"},1.93,"Exon (ENSBGRT00000003162/ENSBGRG00000001705, exon 10 of 17)",1,63392571,63503051,110481,2]
["chr1",63481015,63484405,3391,"ENSBGRG00000001705","ENSBGRT00000003162",18646,"CCDC191","coiled-coil domain containing 191 [Source:HGNC Symbol;Acc:HGNC:29272]","NA","NA",{"v":4.2e-05,"d":"0.00"},2,"181,179,","0,3212",-4.38,-3.69,2.65,"Exon (ENSBGRT00000003162/ENSBGRG00000001705, exon 5 of 17)",1,63392571,63503051,110481,2]
["chr1",63774681,63774801,121,"ENSBGRG00000001895","ENSBGRT00000003570",50542,"ZBTB20","zinc finger and BTB domain containing 20 [Source:HGNC Symbol;Acc:HGNC:13503]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010629(negative regulation of gene expression);GO:0032728(positive regulation of interferon-beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0045821(positive regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046889(positive regulation of lipid biosynthetic process);GO:0055088(lipid homeostasis);GO:0071333(cellular response to glucose stimulus)","NA",{"v":0.025,"d":"0.03"},1,"121,",0,-1.61,-1.07,4.86,"3' UTR",1,63774174,63825343,51170,2]
["chr1",63788383,63788891,509,"ENSBGRG00000001895","ENSBGRT00000003570",36452,"ZBTB20","zinc finger and BTB domain containing 20 [Source:HGNC Symbol;Acc:HGNC:13503]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010629(negative regulation of gene expression);GO:0032728(positive regulation of interferon-beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0045821(positive regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046889(positive regulation of lipid biosynthetic process);GO:0055088(lipid homeostasis);GO:0071333(cellular response to glucose stimulus)","NA",{"v":2.3E-3,"d":"0.00"},1,"509,",0,-2.63,-2.01,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000003570/ENSBGRG00000001895, exon 3 of 4)",1,63774174,63825343,51170,2]
["chr1",63789279,63789488,210,"ENSBGRG00000001895","ENSBGRT00000003570",35855,"ZBTB20","zinc finger and BTB domain containing 20 [Source:HGNC Symbol;Acc:HGNC:13503]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010629(negative regulation of gene expression);GO:0032728(positive regulation of interferon-beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0045821(positive regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046889(positive regulation of lipid biosynthetic process);GO:0055088(lipid homeostasis);GO:0071333(cellular response to glucose stimulus)","NA",{"v":0.025,"d":"0.03"},1,"210,",0,-1.61,-1.07,6.48,"Exon (ENSBGRT00000003570/ENSBGRG00000001895, exon 3 of 4)",1,63774174,63825343,51170,2]
["chr1",68571675,68572462,788,"ENSBGRG00000002008","ENSBGRT00000003754",30,"ENSBGRG00000002008","NA","GO:0005787(signal peptidase complex);GO:0006465(signal peptide processing);GO:0008233(peptidase activity);GO:0016021(integral component of membrane)","03060(Protein export)",{"v":0.0021,"d":"0.00"},2,"129,168,","0,620",-2.67,-2.06,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000003754/ENSBGRG00000002008, exon 1 of 2)",1,68571675,68572492,818,2]
["chr1",69295521,69299948,4428,"ENSBGRG00000002166","ENSBGRT00000004041",28932,"B4GALT4","beta-1,4-galactosyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:927]","GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0016757(transferase activity, transferring glycosyl groups)","00533(Glycosaminoglycan biosynthesis - keratan sulfate);00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":7.9e-44,"d":"0.00"},3,"104,105,56,","0,1861,4372",{"v":-43.1,"d":"-43.10"},{"v":-41.9,"d":"-41.90"},3.29,"Exon (ENSBGRT00000004041/ENSBGRG00000002166, exon 6 of 8)",1,69295492,69328880,33389,2]
["chr1",69314506,69314770,265,"ENSBGRG00000002166","ENSBGRT00000004041",14110,"B4GALT4","beta-1,4-galactosyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:927]","GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0016757(transferase activity, transferring glycosyl groups)","00533(Glycosaminoglycan biosynthesis - keratan sulfate);00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":1e-111,"d":"0.00"},1,"265,",0,-111,-110,4.34,"5' UTR",1,69295492,69328880,33389,2]
["chr1",69515876,69515936,61,"ENSBGRG00000002229","ENSBGRT00000004156",24077,"TMEM39A","transmembrane protein 39A [Source:HGNC Symbol;Acc:HGNC:25600]","GO:0005789(endoplasmic reticulum membrane);GO:0045070(positive regulation of viral genome replication);GO:1901097(negative regulation of autophagosome maturation);GO:1902902(negative regulation of autophagosome assembly)","NA",{"v":2.3e-07,"d":"0.00"},1,"61,",0,-6.63,-5.86,{"v":1.4,"d":"1.40"},"Exon (ENSBGRT00000004156/ENSBGRG00000002229, exon 5 of 9)",1,69508987,69540013,31027,2]
["chr1",69621245,69632793,11549,"ENSBGRG00000002311","ENSBGRT00000004303",926,"CD80","CD80 molecule [Source:HGNC Symbol;Acc:HGNC:1700]","GO:0015026(coreceptor activity);GO:0031295(T cell costimulation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0098636(protein complex involved in cell adhesion)","04514(Cell adhesion molecules (CAMs));04620(Toll-like receptor signaling pathway);04672(Intestinal immune network for IgA production);05322(Systemic lupus erythematosus);05323(Rheumatoid arthritis);05320(Autoimmune thyroid disease);05330(Allograft rejection);05332(Graft-versus-host disease);05416(Viral myocarditis);04940(Type I diabetes mellitus)",{"v":0.0078,"d":"0.01"},3,"80,108,22,","0,9928,11527",-2.11,-1.53,5.94,"5' UTR",1,69614777,69633719,18943,2]
["chr1",70318179,70318895,717,"ENSBGRG00000002541","ENSBGRT00000004762",88549,"GPR156","G protein-coupled receptor 156 [Source:HGNC Symbol;Acc:HGNC:20844]","GO:0004930(G protein-coupled receptor activity);GO:0004965(G protein-coupled GABA receptor activity);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","04080(Neuroactive ligand-receptor interaction)",{"v":0.006,"d":"0.01"},2,"336,380,","0,337",-2.22,-1.63,6.48,"3' UTR",1,70318179,70407444,89266,2]
["chr1",70319044,70319401,358,"ENSBGRG00000002541","ENSBGRT00000004762",88043,"GPR156","G protein-coupled receptor 156 [Source:HGNC Symbol;Acc:HGNC:20844]","GO:0004930(G protein-coupled receptor activity);GO:0004965(G protein-coupled GABA receptor activity);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","04080(Neuroactive ligand-receptor interaction)",{"v":1.2E-5,"d":"0.00"},1,"358,",0,-4.91,-4.19,14,"Exon (ENSBGRT00000004762/ENSBGRG00000002541, exon 9 of 10)",1,70318179,70407444,89266,2]
["chr1",70480028,70492389,12362,"ENSBGRG00000002589","ENSBGRT00000004869",148,"LRRC58","leucine rich repeat containing 58 [Source:HGNC Symbol;Acc:HGNC:26968]","GO:0005515(protein binding)","NA",{"v":5.6e-05,"d":"0.00"},2,"35,352,","0,12010",-4.25,-3.56,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000004869/ENSBGRG00000002589, exon 1 of 4)",1,70474763,70492537,17775,2]
["chr1",71479831,71480010,180,"ENSBGRG00000002979","ENSBGRT00000005814",62253,"POLQ","DNA polymerase theta [Source:HGNC Symbol;Acc:HGNC:9186]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005524(ATP binding);GO:0006260(DNA replication);GO:0006261(DNA-dependent DNA replication);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006302(double-strand break repair);GO:0006974(cellular response to DNA damage stimulus);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0017116(single-stranded DNA helicase activity);GO:0051260(protein homooligomerization);GO:0051575(5'-deoxyribose-5-phosphate lyase activity);GO:0097681(double-strand break repair via alternative nonhomologous end joining);GO:2000042(negative regulation of double-strand break repair via homologous recombination)","NA",{"v":0.028,"d":"0.03"},1,"180,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000005814/ENSBGRG00000002979, exon 16 of 29)",1,71412021,71542263,130243,2]
["chr1",71636872,71641812,4941,"ENSBGRG00000003280","ENSBGRT00000006163",9702,"HCLS1","hematopoietic cell-specific Lyn substrate 1 [Source:HGNC Symbol;Acc:HGNC:4844]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001085(RNA polymerase II transcription factor binding);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0008284(positive regulation of cell population proliferation);GO:0009725(response to hormone);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0017124(SH3 domain binding);GO:0019901(protein kinase binding);GO:0030041(actin filament polymerization);GO:0030218(erythrocyte differentiation);GO:0030833(regulation of actin filament polymerization);GO:0030854(positive regulation of granulocyte differentiation);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0042307(positive regulation of protein import into nucleus);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0044877(protein-containing complex binding);GO:0045651(positive regulation of macrophage differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051897(positive regulation of protein kinase B signaling);GO:0071345(cellular response to cytokine stimulus);GO:2000107(negative regulation of leukocyte apoptotic process)","04530(Tight junction);05205(Proteoglycans in cancer);05100(Bacterial invasion of epithelial cells)",{"v":0.006,"d":"0.01"},2,"34,27,","0,4914",-2.22,-1.63,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000006163/ENSBGRG00000003280, exon 3 of 13)",1,71617464,71651514,34051,2]
["chr1",71689639,71690148,510,"ENSBGRG00000003446","ENSBGRT00000007938",39371,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":1e-103,"d":"0.00"},1,"510,",0,-103,-101,3.34,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 15 of 23)",1,71662324,71729519,67196,2]
["chr1",71690327,71690477,151,"ENSBGRG00000003446","ENSBGRT00000007938",39042,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":1E-26,"d":"0.00"},1,"151,",0,-26,-25,2.24,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 15 of 23)",1,71662324,71729519,67196,2]
["chr1",71690656,71690986,331,"ENSBGRG00000003446","ENSBGRT00000007938",38533,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":2e-93,"d":"0.00"},1,"331,",0,{"v":-92.7,"d":"-92.70"},{"v":-91.1,"d":"-91.10"},3.35,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 15 of 23)",1,71662324,71729519,67196,2]
["chr1",71692136,71692495,360,"ENSBGRG00000003446","ENSBGRT00000007938",37024,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":1.3E-54,"d":"0.00"},1,"360,",0,{"v":-53.9,"d":"-53.90"},{"v":-52.6,"d":"-52.60"},3.86,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 14 of 23)",1,71662324,71729519,67196,2]
["chr1",71695727,71695937,211,"ENSBGRG00000003446","ENSBGRT00000007938",33582,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":1.1e-06,"d":"0.00"},1,"211,",0,-5.95,-5.19,{"v":21.6,"d":"21.60"},"Exon (ENSBGRT00000007813/ENSBGRG00000003446, exon 13 of 23)",1,71662324,71729519,67196,2]
["chr1",71696865,71696955,91,"ENSBGRG00000003446","ENSBGRT00000007938",32564,"GOLGB1","golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429]","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:1905793(protein localization to pericentriolar material)","NA",{"v":1.4e-07,"d":"0.00"},1,"91,",0,-6.85,-6.08,4.71,"Exon (ENSBGRT00000007938/ENSBGRG00000003446, exon 12 of 23)",1,71662324,71729519,67196,2]
["chr1",71776688,71782718,6031,"ENSBGRG00000004390","ENSBGRT00000008070",27143,"IQCB1","IQ motif containing B1 [Source:HGNC Symbol;Acc:HGNC:28949]","GO:0001750(photoreceptor outer segment);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0015630(microtubule cytoskeleton);GO:0019899(enzyme binding);GO:0032391(photoreceptor connecting cilium);GO:0045171(intercellular bridge);GO:0045494(photoreceptor cell maintenance);GO:0048496(maintenance of animal organ identity);GO:0060271(cilium assembly);GO:0072686(mitotic spindle)","NA",{"v":3.2e-19,"d":"0.00"},3,"40,143,26,","0,1651,6005",{"v":-18.5,"d":"-18.50"},{"v":-17.5,"d":"-17.50"},{"v":2.8,"d":"2.80"},"Exon (ENSBGRT00000008070/ENSBGRG00000004390, exon 9 of 16)",1,71762461,71809861,47401,2]
["chr1",72485162,72485251,90,"ENSBGRG00000007330","ENSBGRT00000013561",33547,"PARP9","poly(ADP-ribose) polymerase family member 9 [Source:HGNC Symbol;Acc:HGNC:24118]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002230(positive regulation of defense response to virus by host);GO:0003714(transcription corepressor activity);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0004857(enzyme inhibitor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006302(double-strand break repair);GO:0006471(protein ADP-ribosylation);GO:0010608(posttranscriptional regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0032991(protein-containing complex);GO:0035563(positive regulation of chromatin binding);GO:0042393(histone binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0043086(negative regulation of catalytic activity);GO:0044389(ubiquitin-like protein ligase binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060330(regulation of response to interferon-gamma);GO:0060335(positive regulation of interferon-gamma-mediated signaling pathway);GO:0072570(ADP-D-ribose binding);GO:0090734(site of DNA damage);GO:0097677(STAT family protein binding);GO:1900182(positive regulation of protein localization to nucleus);GO:2001034(positive regulation of double-strand break repair via nonhomologous end joining)","NA",{"v":1.2E-5,"d":"0.00"},1,"90,",0,-4.93,-4.21,1.46,"Exon (ENSBGRT00000013561/ENSBGRG00000007330, exon 11 of 11)",1,72485102,72518798,33697,2]
["chr1",72508381,72508590,210,"ENSBGRG00000007330","ENSBGRT00000013561",10208,"PARP9","poly(ADP-ribose) polymerase family member 9 [Source:HGNC Symbol;Acc:HGNC:24118]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002230(positive regulation of defense response to virus by host);GO:0003714(transcription corepressor activity);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0004857(enzyme inhibitor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006302(double-strand break repair);GO:0006471(protein ADP-ribosylation);GO:0010608(posttranscriptional regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0032991(protein-containing complex);GO:0035563(positive regulation of chromatin binding);GO:0042393(histone binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0043086(negative regulation of catalytic activity);GO:0044389(ubiquitin-like protein ligase binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060330(regulation of response to interferon-gamma);GO:0060335(positive regulation of interferon-gamma-mediated signaling pathway);GO:0072570(ADP-D-ribose binding);GO:0090734(site of DNA damage);GO:0097677(STAT family protein binding);GO:1900182(positive regulation of protein localization to nucleus);GO:2001034(positive regulation of double-strand break repair via nonhomologous end joining)","NA",{"v":3.2e-68,"d":"0.00"},1,"210,",0,{"v":-67.5,"d":"-67.50"},{"v":-66.1,"d":"-66.10"},4.28,"Exon (ENSBGRT00000013561/ENSBGRG00000007330, exon 4 of 11)",1,72485102,72518798,33697,2]
["chr1",72611866,72612044,179,"ENSBGRG00000007624","ENSBGRT00000013952",63610,"HSPBAP1","HSPB1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16389]","NA","NA",{"v":1e-120,"d":"0.00"},1,"179,",0,-120,-118,8.94,"Exon (ENSBGRT00000013952/ENSBGRG00000007624, exon 8 of 8)",1,72611836,72675654,63819,2]
["chr1",72612162,72612340,179,"ENSBGRG00000007624","ENSBGRT00000013952",63314,"HSPBAP1","HSPB1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16389]","NA","NA",{"v":4e-57,"d":"0.00"},1,"179,",0,{"v":-56.4,"d":"-56.40"},{"v":-55.1,"d":"-55.10"},3.65,"Exon (ENSBGRT00000013952/ENSBGRG00000007624, exon 8 of 8)",1,72611836,72675654,63819,2]
["chr1",73486642,73486881,240,"ENSBGRG00000008188","ENSBGRT00000015332",1848,"ADCY5","adenylate cyclase 5 [Source:HGNC Symbol;Acc:HGNC:236]","GO:0001973(G protein-coupled adenosine receptor signaling pathway);GO:0004016(adenylate cyclase activity);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0006171(cAMP biosynthetic process);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007191(adenylate cyclase-activating dopamine receptor signaling pathway);GO:0007195(adenylate cyclase-inhibiting dopamine receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007626(locomotory behavior);GO:0008179(adenylate cyclase binding);GO:0009190(cyclic nucleotide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016849(phosphorus-oxygen lyase activity);GO:0035556(intracellular signal transduction);GO:0045111(intermediate filament cytoskeleton);GO:0050885(neuromuscular process controlling balance);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0097110(scaffold protein binding);GO:1904322(cellular response to forskolin)","00230(Purine metabolism);04015(Rap1 signaling pathway);04371(Apelin signaling pathway);04072(Phospholipase D signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04114(Oocyte meiosis);04540(Gap junction);04611(Platelet activation);04062(Chemokine signaling pathway);04911(Insulin secretion);04923(Regulation of lipolysis in adipocyte);04912(GnRH signaling pathway);04913(Ovarian Steroidogenesis);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04918(Thyroid hormone synthesis);04928(Parathyroid hormone synthesis, secretion and action);04916(Melanogenesis);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);04724(Glutamatergic synapse);04727(GABAergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);04750(Inflammatory mediator regulation of TRP channels);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);04713(Circadian entrainment);04714(Thermogenesis);05200(Pathways in cancer);05012(Parkinson disease);05030(Cocaine addiction);05031(Amphetamine addiction);05032(Morphine addiction);05034(Alcoholism);05414(Dilated cardiomyopathy (DCM));04934(Cushing syndrome);05166(HTLV-I infection);05163(Human cytomegalovirus infection);01522(Endocrine resistance)",{"v":2.2e-06,"d":"0.00"},1,"240,",0,-5.66,-4.92,{"v":18.4,"d":"18.40"},"Exon (ENSBGRT00000015332/ENSBGRG00000008188, exon 2 of 24)",1,73298495,73488729,190235,2]
["chr1",73636432,73636670,239,"ENSBGRG00000008479","ENSBGRT00000015416",0,"HACD2","3-hydroxyacyl-CoA dehydratase 2 [Source:HGNC Symbol;Acc:HGNC:9640]","GO:0005783(endoplasmic reticulum);GO:0018812(3-hydroxyacyl-CoA dehydratase activity);GO:0019899(enzyme binding);GO:0030148(sphingolipid biosynthetic process);GO:0030497(fatty acid elongation);GO:0042761(very long-chain fatty acid biosynthetic process)","00062(Fatty acid elongation);01040(Biosynthesis of unsaturated fatty acids)",{"v":0.043,"d":"0.04"},1,"239,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000015416/ENSBGRG00000008479, exon 1 of 7)",1,73542390,73636670,94281,2]
["chr1",73669469,73669559,91,"ENSBGRG00000008571","ENSBGRT00000015698",323190,"MYLK","myosin light chain kinase [Source:HGNC Symbol;Acc:HGNC:7590]","GO:0001725(stress fiber);GO:0004672(protein kinase activity);GO:0004687(myosin light chain kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0015629(actin cytoskeleton);GO:0030027(lamellipodium);GO:0030335(positive regulation of cell migration);GO:0032060(bleb assembly);GO:0032154(cleavage furrow);GO:0051928(positive regulation of calcium ion transport);GO:0060414(aorta smooth muscle tissue morphogenesis);GO:0071476(cellular hypotonic response);GO:0090303(positive regulation of wound healing)","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04921(Oxytocin signaling pathway);04270(Vascular smooth muscle contraction);04971(Gastric acid secretion)",{"v":2e-27,"d":"0.00"},1,"91,",0,{"v":-26.7,"d":"-26.70"},{"v":-25.6,"d":"-25.60"},1.14,"Exon (ENSBGRT00000015698/ENSBGRG00000008571, exon 37 of 37)",1,73669379,73992749,323371,2]
["chr1",73758976,73769958,10983,"ENSBGRG00000008571","ENSBGRT00000015698",222791,"MYLK","myosin light chain kinase [Source:HGNC Symbol;Acc:HGNC:7590]","GO:0001725(stress fiber);GO:0004672(protein kinase activity);GO:0004687(myosin light chain kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0015629(actin cytoskeleton);GO:0030027(lamellipodium);GO:0030335(positive regulation of cell migration);GO:0032060(bleb assembly);GO:0032154(cleavage furrow);GO:0051928(positive regulation of calcium ion transport);GO:0060414(aorta smooth muscle tissue morphogenesis);GO:0071476(cellular hypotonic response);GO:0090303(positive regulation of wound healing)","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04921(Oxytocin signaling pathway);04270(Vascular smooth muscle contraction);04971(Gastric acid secretion)",0,4,"23,357,374,177,","0,9451,10348,10806",-569,"-Inf",3.31,"Exon (ENSBGRT00000015698/ENSBGRG00000008571, exon 18 of 37)",1,73669379,73992749,323371,2]
["chr1",74023285,74028899,5615,"ENSBGRG00000008926","ENSBGRT00000016521",36067,"CCDC14","coiled-coil domain containing 14 [Source:HGNC Symbol;Acc:HGNC:25766]","GO:0005813(centrosome);GO:0034451(centriolar satellite);GO:0071539(protein localization to centrosome)","NA",{"v":9.99999999999998e-217,"d":"0.00"},3,"395,316,94,","0,397,5521",-216,-214,6.34,"Exon (ENSBGRT00000016521/ENSBGRG00000008926, exon 12 of 14)",1,74023077,74064966,41890,2]
["chr1",74044857,74045035,179,"ENSBGRG00000008926","ENSBGRT00000016521",19931,"CCDC14","coiled-coil domain containing 14 [Source:HGNC Symbol;Acc:HGNC:25766]","GO:0005813(centrosome);GO:0034451(centriolar satellite);GO:0071539(protein localization to centrosome)","NA",{"v":4e-29,"d":"0.00"},1,"179,",0,{"v":-28.4,"d":"-28.40"},{"v":-27.3,"d":"-27.30"},4.04,"Exon (ENSBGRT00000016521/ENSBGRG00000008926, exon 8 of 14)",1,74023077,74064966,41890,2]
["chr1",75219673,75222434,2762,"ENSBGRG00000011810","ENSBGRT00000021513",472,"ENSBGRG00000011810","NA","NA","NA",{"v":2.9E-4,"d":"0.00"},2,"842,162,","0,2600",-3.54,-2.87,{"v":15.1,"d":"15.10"},"Exon (ENSBGRT00000021513/ENSBGRG00000011810, exon 1 of 2)",1,75219673,75222906,3234,2]
["chr1",75292106,75296564,4459,"ENSBGRG00000011820","ENSBGRT00000021576",58355,"ENSBGRG00000011820","NA","GO:0005509(calcium ion binding);GO:0007043(cell-cell junction assembly);GO:0007507(heart development)","NA",{"v":1.6e-97,"d":"0.00"},2,"881,194,","0,4265",{"v":-96.8,"d":"-96.80"},{"v":-95.1,"d":"-95.10"},7.92,"3' UTR",1,75291837,75354919,63083,2]
["chr1",75335394,75335543,150,"ENSBGRG00000011820","ENSBGRT00000021576",19376,"ENSBGRG00000011820","NA","GO:0005509(calcium ion binding);GO:0007043(cell-cell junction assembly);GO:0007507(heart development)","NA",{"v":1e-101,"d":"0.00"},1,"150,",0,-101,{"v":-98.9,"d":"-98.90"},{"v":3.8,"d":"3.80"},"Exon (ENSBGRT00000021576/ENSBGRG00000011820, exon 6 of 16)",1,75291837,75354919,63083,2]
["chr1",75342741,75343975,1235,"ENSBGRG00000011820","ENSBGRT00000021576",10944,"ENSBGRG00000011820","NA","GO:0005509(calcium ion binding);GO:0007043(cell-cell junction assembly);GO:0007507(heart development)","NA",{"v":1.3e-21,"d":"0.00"},2,"46,254,","0,981",{"v":-20.9,"d":"-20.90"},{"v":-19.9,"d":"-19.90"},2.77,"5' UTR",1,75291837,75354919,63083,2]
["chr1",75402508,75402746,239,"ENSBGRG00000011908","ENSBGRT00000022020",148726,"SLC12A8","solute carrier family 12 member 8 [Source:HGNC Symbol;Acc:HGNC:15595]","GO:0016020(membrane);GO:0055085(transmembrane transport)","NA",{"v":0.00022,"d":"0.00"},1,"239,",0,-3.65,-2.98,9.72,"3' UTR",1,75402508,75551472,148965,2]
["chr1",75582790,75583474,685,"ENSBGRG00000012130","ENSBGRT00000022245",107814,"ZNF148","zinc finger protein 148 [Source:HGNC Symbol;Acc:HGNC:12933]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0007276(gamete generation);GO:0010629(negative regulation of gene expression);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":1E-136,"d":"0.00"},1,"685,",0,-136,-135,{"v":7.7,"d":"7.70"},"Exon (ENSBGRT00000022245/ENSBGRG00000012130, exon 8 of 8)",1,75582760,75691288,108529,2]
["chr1",75584158,75584247,90,"ENSBGRG00000012130","ENSBGRT00000022245",107041,"ZNF148","zinc finger protein 148 [Source:HGNC Symbol;Acc:HGNC:12933]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0007276(gamete generation);GO:0010629(negative regulation of gene expression);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":1e-39,"d":"0.00"},1,"90,",0,-39,{"v":-37.8,"d":"-37.80"},7.73,"Exon (ENSBGRT00000022245/ENSBGRG00000012130, exon 8 of 8)",1,75582760,75691288,108529,2]
["chr1",75883426,75899672,16247,"ENSBGRG00000012716","ENSBGRT00000023302",82997,"OSBPL11","oxysterol binding protein like 11 [Source:HGNC Symbol;Acc:HGNC:16397]","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0010890(positive regulation of sequestering of triglyceride);GO:0045444(fat cell differentiation)","NA",{"v":3.2e-80,"d":"0.00"},3,"122,154,85,","0,9159,16162",{"v":-79.5,"d":"-79.50"},-78,5.75,"3' UTR",1,75882857,75982669,99813,2]
["chr1",76177312,76185328,8017,"ENSBGRG00000013795","ENSBGRT00000026551",105656,"LRCH3","leucine rich repeats and calponin homology domain containing 3 [Source:HGNC Symbol;Acc:HGNC:28637]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0032185(septin cytoskeleton organization)","NA",{"v":4e-42,"d":"0.00"},2,"87,64,","0,7953",{"v":-41.4,"d":"-41.40"},{"v":-40.2,"d":"-40.20"},2.49,"Exon (ENSBGRT00000026551/ENSBGRG00000013795, exon 19 of 21)",1,76174565,76290984,116420,2]
["chr1",76468741,76473835,5095,"ENSBGRG00000016748","ENSBGRT00000031700",43263,"ENSBGRG00000016748","NA","GO:0005176(ErbB-2 class receptor binding);GO:0005615(extracellular space);GO:0007160(cell-matrix adhesion);GO:0010469(regulation of signaling receptor activity);GO:0030197(extracellular matrix constituent, lubricant activity)","NA",{"v":0.025,"d":"0.03"},4,"11,138,234,96,","0,1662,4130,4999",-1.61,-1.07,4.86,"Exon (ENSBGRT00000031700/ENSBGRG00000016748, exon 14 of 25)",1,76459464,76517098,57635,2]
["chr1",76646138,76646587,450,"ENSBGRG00000017823","ENSBGRT00000032649",747,"ENSBGRG00000017823","NA","NA","NA",{"v":5e-40,"d":"0.00"},1,"450,",0,{"v":-39.3,"d":"-39.30"},{"v":-38.1,"d":"-38.10"},{"v":16.7,"d":"16.70"},"Exon (ENSBGRT00000032649/ENSBGRG00000017823, exon 1 of 1)",1,76646138,76647334,1197,2]
["chr1",76646856,76647334,479,"ENSBGRG00000017823","ENSBGRT00000032649",0,"ENSBGRG00000017823","NA","NA","NA",{"v":6.2e-08,"d":"0.00"},1,"479,",0,-7.21,-6.42,{"v":15.1,"d":"15.10"},"Exon (ENSBGRT00000032649/ENSBGRG00000017823, exon 1 of 1)",1,76646138,76647334,1197,2]
["chr1",76978654,76980378,1725,"ENSBGRG00000018000","ENSBGRT00000033156",56419,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":5e-50,"d":"0.00"},2,"365,54,","0,1671",{"v":-49.3,"d":"-49.30"},-48,3.53,"3' UTR",1,76787597,77036797,249201,2]
["chr1",76980613,76980792,180,"ENSBGRG00000018000","ENSBGRT00000033156",56005,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":7.9e-43,"d":"0.00"},1,"180,",0,{"v":-42.1,"d":"-42.10"},{"v":-40.9,"d":"-40.90"},3.64,"Exon (ENSBGRT00000033156/ENSBGRG00000018000, exon 9 of 12)",1,76787597,77036797,249201,2]
["chr1",76857561,76867223,9663,"ENSBGRG00000018000","ENSBGRT00000033156",169574,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":4E-14,"d":"0.00"},2,"59,176,","0,9487",{"v":-13.4,"d":"-13.40"},{"v":-12.5,"d":"-12.50"},4.77,"Exon (ENSBGRT00000033712/ENSBGRG00000018377, exon 7 of 8)",1,76787597,77036797,249201,2]
["chr1",76949962,76950322,361,"ENSBGRG00000018000","ENSBGRT00000033156",86475,"UBXN7","UBX domain protein 7 [Source:HGNC Symbol;Acc:HGNC:29119]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0043130(ubiquitin binding)","04217(Necroptosis)",{"v":7.9e-16,"d":"0.00"},1,"361,",0,{"v":-15.1,"d":"-15.10"},{"v":-14.1,"d":"-14.10"},3.53,"3' UTR",1,76787597,77036797,249201,2]
["chr1",77072422,77072481,60,"ENSBGRG00000018769","ENSBGRT00000034357",23012,"RNF168","ring finger protein 168 [Source:HGNC Symbol;Acc:HGNC:26661]","GO:0000151(ubiquitin ligase complex);GO:0003682(chromatin binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006302(double-strand break repair);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0010212(response to ionizing radiation);GO:0016567(protein ubiquitination);GO:0031491(nucleosome binding);GO:0032991(protein-containing complex);GO:0034244(negative regulation of transcription elongation from RNA polymerase II promoter);GO:0035518(histone H2A monoubiquitination);GO:0035861(site of double-strand break);GO:0036351(histone H2A-K13 ubiquitination);GO:0036352(histone H2A-K15 ubiquitination);GO:0042393(histone binding);GO:0043130(ubiquitin binding);GO:0045739(positive regulation of DNA repair);GO:0046872(metal ion binding);GO:0070530(K63-linked polyubiquitin modification-dependent protein binding);GO:0070534(protein K63-linked ubiquitination);GO:0070535(histone H2A K63-linked ubiquitination)","NA",{"v":3.2e-99,"d":"0.00"},1,"60,",0,{"v":-98.5,"d":"-98.50"},{"v":-96.8,"d":"-96.80"},4.86,"Exon (ENSBGRT00000034357/ENSBGRG00000018769, exon 6 of 6)",1,77072182,77095493,23312,2]
["chr1",77072901,77073080,180,"ENSBGRG00000018769","ENSBGRT00000034357",22413,"RNF168","ring finger protein 168 [Source:HGNC Symbol;Acc:HGNC:26661]","GO:0000151(ubiquitin ligase complex);GO:0003682(chromatin binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006302(double-strand break repair);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0010212(response to ionizing radiation);GO:0016567(protein ubiquitination);GO:0031491(nucleosome binding);GO:0032991(protein-containing complex);GO:0034244(negative regulation of transcription elongation from RNA polymerase II promoter);GO:0035518(histone H2A monoubiquitination);GO:0035861(site of double-strand break);GO:0036351(histone H2A-K13 ubiquitination);GO:0036352(histone H2A-K15 ubiquitination);GO:0042393(histone binding);GO:0043130(ubiquitin binding);GO:0045739(positive regulation of DNA repair);GO:0046872(metal ion binding);GO:0070530(K63-linked polyubiquitin modification-dependent protein binding);GO:0070534(protein K63-linked ubiquitination);GO:0070535(histone H2A K63-linked ubiquitination)","NA",{"v":2e-13,"d":"0.00"},1,"180,",0,{"v":-12.7,"d":"-12.70"},{"v":-11.8,"d":"-11.80"},{"v":35.6,"d":"35.60"},"Exon (ENSBGRT00000034357/ENSBGRG00000018769, exon 6 of 6)",1,77072182,77095493,23312,2]
["chr1",77081636,77095224,13589,"ENSBGRG00000018793","ENSBGRT00000034429",0,"ENSBGRG00000018793","NA","NA","NA",{"v":6.3e-23,"d":"0.00"},3,"6,77,68,","0,7492,13521",{"v":-22.2,"d":"-22.20"},{"v":-21.2,"d":"-21.20"},3.05,"Exon (ENSBGRT00000034429/ENSBGRG00000018793, exon 1 of 1)",1,77086383,77087993,1611,1]
["chr1",77146990,77147315,326,"ENSBGRG00000018865","ENSBGRT00000034606",5004,"WDR53","WD repeat domain 53 [Source:HGNC Symbol;Acc:HGNC:28786]","GO:0005515(protein binding)","NA",{"v":3.2e-62,"d":"0.00"},1,"326,",0,{"v":-61.5,"d":"-61.50"},{"v":-60.2,"d":"-60.20"},4.51,"Exon (ENSBGRT00000034606/ENSBGRG00000018865, exon 2 of 2)",1,77146813,77152319,5507,2]
["chr1",77302696,77303519,824,"ENSBGRG00000018942","ENSBGRT00000034720",177,"CEP19","centrosomal protein 19 [Source:HGNC Symbol;Acc:HGNC:28209]","GO:0000922(spindle pole);GO:0005813(centrosome);GO:0005814(centriole);GO:0005929(cilium);GO:0034454(microtubule anchoring at centrosome);GO:0036064(ciliary basal body);GO:0060271(cilium assembly);GO:0097712(vesicle targeting, trans-Golgi to periciliary membrane compartment)","NA",{"v":5e-87,"d":"0.00"},2,"96,23,","0,801",{"v":-86.3,"d":"-86.30"},{"v":-84.7,"d":"-84.70"},5.88,"Exon (ENSBGRT00000034720/ENSBGRG00000018942, exon 1 of 2)",1,77302430,77303696,1267,2]
["chr1",78123464,78123554,91,"ENSBGRG00000022869","ENSBGRT00000042238",32377,"BDH1","3-hydroxybutyrate dehydrogenase 1 [Source:HGNC Symbol;Acc:HGNC:1027]","GO:0003858(3-hydroxybutyrate dehydrogenase activity);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0016491(oxidoreductase activity)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies)",{"v":3.7e-05,"d":"0.00"},1,"91,",0,-4.43,-3.72,{"v":15.1,"d":"15.10"},"Exon (ENSBGRT00000042238/ENSBGRG00000022869, exon 7 of 7)",1,78122628,78155931,33304,2]
["chr1",78133263,78148023,14761,"ENSBGRG00000022869","ENSBGRT00000042238",7908,"BDH1","3-hydroxybutyrate dehydrogenase 1 [Source:HGNC Symbol;Acc:HGNC:1027]","GO:0003858(3-hydroxybutyrate dehydrogenase activity);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0016491(oxidoreductase activity)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies)",{"v":0.015,"d":"0.02"},2,"68,52,","0,14709",-1.83,-1.02,8.64,"Exon (ENSBGRT00000042238/ENSBGRG00000022869, exon 4 of 7)",1,78122628,78155931,33304,2]
["chr1",79155396,79155721,326,"ENSBGRG00000023485","ENSBGRT00000043328",650,"FAM43A","family with sequence similarity 43 member A [Source:HGNC Symbol;Acc:HGNC:26888]","GO:0005515(protein binding)","NA",{"v":1e-157,"d":"0.00"},1,"326,",0,-157,-155,5.57,"Exon (ENSBGRT00000043328/ENSBGRG00000023485, exon 1 of 1)",1,79155100,79156371,1272,2]
["chr1",79155809,79156341,533,"ENSBGRG00000023485","ENSBGRT00000043328",30,"FAM43A","family with sequence similarity 43 member A [Source:HGNC Symbol;Acc:HGNC:26888]","GO:0005515(protein binding)","NA",{"v":3.2e-55,"d":"0.00"},1,"533,",0,{"v":-54.5,"d":"-54.50"},{"v":-53.2,"d":"-53.20"},6.87,"Exon (ENSBGRT00000043328/ENSBGRG00000023485, exon 1 of 1)",1,79155100,79156371,1272,2]
["chr1",82566734,82571811,5078,"ENSBGRG00000000499","ENSBGRT00000000962",55199,"CCDC50","coiled-coil domain containing 50 [Source:HGNC Symbol;Acc:HGNC:18111]","GO:0005829(cytosol);GO:0007605(sensory perception of sound);GO:0031625(ubiquitin protein ligase binding)","NA",{"v":9.8e-06,"d":"0.00"},2,"143,6,","0,5072",-5.01,-4.29,2.68,"Exon (ENSBGRT00000000962/ENSBGRG00000000499, exon 5 of 12)",1,82541012,82627010,85999,2]
["chr1",87073783,87243996,170214,"ENSBGRG00000001521","ENSBGRT00000002838",0,"ST6GAL1","ST6 beta-galactoside alpha-2,6-sialyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10860]","GO:0000139(Golgi membrane);GO:0003835(beta-galactoside alpha-2,6-sialyltransferase activity);GO:0006054(N-acetylneuraminate metabolic process);GO:0006486(protein glycosylation);GO:0008373(sialyltransferase activity);GO:0018279(protein N-linked glycosylation via asparagine);GO:0042803(protein homodimerization activity);GO:0097503(sialylation)","00510(N-Glycan biosynthesis);00514(Other types of O-glycan biosynthesis)",{"v":2.2e-05,"d":"0.00"},3,"520,618,83,","0,2561,170131",-4.66,-3.95,4.78,"5' UTR",1,87201887,87243002,41116,2]
["chr1",87244056,87244383,328,"ENSBGRG00000001507","ENSBGRT00000002763",179,"RTP1","receptor transporter protein 1 [Source:HGNC Symbol;Acc:HGNC:28580]","GO:0009986(cell surface);GO:0031849(olfactory receptor binding);GO:0051205(protein insertion into membrane)","00510(N-Glycan biosynthesis);00514(Other types of O-glycan biosynthesis)",{"v":2E-51,"d":"0.00"},1,"328,",0,{"v":-50.7,"d":"-50.70"},{"v":-49.4,"d":"-49.40"},4.57,"5' UTR",1,87073783,87244562,170780,2]
["chr1",87230097,87243968,13872,"ENSBGRG00000001521","ENSBGRT00000002838",0,"ST6GAL1","ST6 beta-galactoside alpha-2,6-sialyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10860]","GO:0000139(Golgi membrane);GO:0003835(beta-galactoside alpha-2,6-sialyltransferase activity);GO:0006054(N-acetylneuraminate metabolic process);GO:0006486(protein glycosylation);GO:0008373(sialyltransferase activity);GO:0018279(protein N-linked glycosylation via asparagine);GO:0042803(protein homodimerization activity);GO:0097503(sialylation)","00510(N-Glycan biosynthesis);00514(Other types of O-glycan biosynthesis)",{"v":0.00065,"d":"0.00"},3,"89,154,55,","0,12752,13817",-3.19,-2.54,7.56,"5' UTR",1,87201887,87243002,41116,2]
["chr1",87244057,87244384,328,"ENSBGRG00000001507","ENSBGRT00000002763",178,"RTP1","receptor transporter protein 1 [Source:HGNC Symbol;Acc:HGNC:28580]","GO:0009986(cell surface);GO:0031849(olfactory receptor binding);GO:0051205(protein insertion into membrane)","00510(N-Glycan biosynthesis);00514(Other types of O-glycan biosynthesis)",{"v":2.5e-50,"d":"0.00"},1,"328,",0,{"v":-49.6,"d":"-49.60"},{"v":-48.3,"d":"-48.30"},{"v":4.6,"d":"4.60"},"5' UTR",1,87073783,87244562,170780,2]
["chr1",87725257,87725316,60,"ENSBGRG00000001887","ENSBGRT00000003524",207,"ENSBGRG00000001887","NA","GO:0005102(signaling receptor binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006457(protein folding);GO:0016556(mRNA modification);GO:0050768(negative regulation of neurogenesis);GO:0051082(unfolded protein binding)","04141(Protein processing in endoplasmic reticulum)",{"v":1.6E-13,"d":"0.00"},1,"60,",0,{"v":-12.8,"d":"-12.80"},{"v":-11.9,"d":"-11.90"},{"v":21.1,"d":"21.10"},"5' UTR",1,87706586,87725523,18938,2]
["chr1",88771838,88775308,3471,"ENSBGRG00000002680","ENSBGRT00000005016",16001,"SENP2","SUMO specific peptidase 2 [Source:HGNC Symbol;Acc:HGNC:23116]","GO:0005643(nuclear pore);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0007507(heart development);GO:0008234(cysteine-type peptidase activity);GO:0016604(nuclear body);GO:0016605(PML body);GO:0016926(protein desumoylation);GO:0031397(negative regulation of protein ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0031648(protein destabilization);GO:0032875(regulation of DNA endoreduplication);GO:0035562(negative regulation of chromatin binding);GO:0045444(fat cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060707(trophoblast giant cell differentiation);GO:0060711(labyrinthine layer development);GO:0060712(spongiotrophoblast layer development);GO:0070139(SUMO-specific endopeptidase activity);GO:0070140(SUMO-specific isopeptidase activity);GO:2000045(regulation of G1/S transition of mitotic cell cycle)","03013(RNA transport);04310(Wnt signaling pathway)",{"v":4e-26,"d":"0.00"},4,"27,64,52,7,","0,1970,2847,3464",{"v":-25.4,"d":"-25.40"},{"v":-24.3,"d":"-24.30"},1.71,"Exon (ENSBGRT00000005016/ENSBGRG00000002680, exon 8 of 17)",1,88755640,88791309,35670,2]
["chr1",88775368,88777677,2310,"ENSBGRG00000002680","ENSBGRT00000005016",13632,"SENP2","SUMO specific peptidase 2 [Source:HGNC Symbol;Acc:HGNC:23116]","GO:0005643(nuclear pore);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0007507(heart development);GO:0008234(cysteine-type peptidase activity);GO:0016604(nuclear body);GO:0016605(PML body);GO:0016926(protein desumoylation);GO:0031397(negative regulation of protein ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0031648(protein destabilization);GO:0032875(regulation of DNA endoreduplication);GO:0035562(negative regulation of chromatin binding);GO:0045444(fat cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060707(trophoblast giant cell differentiation);GO:0060711(labyrinthine layer development);GO:0060712(spongiotrophoblast layer development);GO:0070139(SUMO-specific endopeptidase activity);GO:0070140(SUMO-specific isopeptidase activity);GO:2000045(regulation of G1/S transition of mitotic cell cycle)","03013(RNA transport);04310(Wnt signaling pathway)",{"v":1e-16,"d":"0.00"},2,"29,92,","0,2218",-16,-15,1.62,"Exon (ENSBGRT00000005016/ENSBGRG00000002680, exon 7 of 17)",1,88755640,88791309,35670,2]
["chr1",88889707,88891314,1608,"ENSBGRG00000002802","ENSBGRT00000005394",49920,"MAP3K13","mitogen-activated protein kinase kinase kinase 13 [Source:HGNC Symbol;Acc:HGNC:6852]","GO:0000186(activation of MAPKK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004706(JUN kinase kinase kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007254(JNK cascade);GO:0007256(activation of JNKK activity);GO:0007257(activation of JUN kinase activity);GO:0014042(positive regulation of neuron maturation);GO:0016020(membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0045773(positive regulation of axon extension);GO:0046777(protein autophosphorylation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0106137(IkappaB kinase complex binding);GO:0150012(positive regulation of neuron projection arborization);GO:1905492(positive regulation of branching morphogenesis of a nerve)","04010(MAPK signaling pathway)",{"v":7.4e-06,"d":"0.00"},2,"102,109,","0,1499",-5.13,-4.41,7.56,"Exon (ENSBGRT00000005394/ENSBGRG00000002802, exon 12 of 13)",1,88889707,88941234,51528,2]
["chr1",88897893,88897982,90,"ENSBGRG00000002802","ENSBGRT00000005394",43252,"MAP3K13","mitogen-activated protein kinase kinase kinase 13 [Source:HGNC Symbol;Acc:HGNC:6852]","GO:0000186(activation of MAPKK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004706(JUN kinase kinase kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007254(JNK cascade);GO:0007256(activation of JNKK activity);GO:0007257(activation of JUN kinase activity);GO:0014042(positive regulation of neuron maturation);GO:0016020(membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0045773(positive regulation of axon extension);GO:0046777(protein autophosphorylation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0106137(IkappaB kinase complex binding);GO:0150012(positive regulation of neuron projection arborization);GO:1905492(positive regulation of branching morphogenesis of a nerve)","04010(MAPK signaling pathway)",{"v":0.0049,"d":"0.00"},1,"90,",0,-2.31,-1.72,2.01,"Exon (ENSBGRT00000005394/ENSBGRG00000002802, exon 10 of 13)",1,88889707,88941234,51528,2]
["chr1",88898252,88898431,180,"ENSBGRG00000002802","ENSBGRT00000005394",42803,"MAP3K13","mitogen-activated protein kinase kinase kinase 13 [Source:HGNC Symbol;Acc:HGNC:6852]","GO:0000186(activation of MAPKK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004706(JUN kinase kinase kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007254(JNK cascade);GO:0007256(activation of JNKK activity);GO:0007257(activation of JUN kinase activity);GO:0014042(positive regulation of neuron maturation);GO:0016020(membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0045773(positive regulation of axon extension);GO:0046777(protein autophosphorylation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0106137(IkappaB kinase complex binding);GO:0150012(positive regulation of neuron projection arborization);GO:1905492(positive regulation of branching morphogenesis of a nerve)","04010(MAPK signaling pathway)",{"v":1.6E-15,"d":"0.00"},1,"180,",0,{"v":-14.8,"d":"-14.80"},{"v":-13.9,"d":"-13.90"},4.36,"Exon (ENSBGRT00000005394/ENSBGRG00000002802, exon 10 of 13)",1,88889707,88941234,51528,2]
["chr1",88940793,88940943,151,"ENSBGRG00000002802","ENSBGRT00000005394",291,"MAP3K13","mitogen-activated protein kinase kinase kinase 13 [Source:HGNC Symbol;Acc:HGNC:6852]","GO:0000186(activation of MAPKK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004706(JUN kinase kinase kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007254(JNK cascade);GO:0007256(activation of JNKK activity);GO:0007257(activation of JUN kinase activity);GO:0014042(positive regulation of neuron maturation);GO:0016020(membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0045773(positive regulation of axon extension);GO:0046777(protein autophosphorylation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0106137(IkappaB kinase complex binding);GO:0150012(positive regulation of neuron projection arborization);GO:1905492(positive regulation of branching morphogenesis of a nerve)","04010(MAPK signaling pathway)",{"v":1.3E-6,"d":"0.00"},1,"151,",0,-5.87,-5.12,6.12,"Exon (ENSBGRT00000005394/ENSBGRG00000002802, exon 1 of 13)",1,88889707,88941234,51528,2]
["chr1",88941182,89056230,115049,"ENSBGRG00000002802","ENSBGRT00000005394",0,"MAP3K13","mitogen-activated protein kinase kinase kinase 13 [Source:HGNC Symbol;Acc:HGNC:6852]","GO:0000186(activation of MAPKK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004706(JUN kinase kinase kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007254(JNK cascade);GO:0007256(activation of JNKK activity);GO:0007257(activation of JUN kinase activity);GO:0014042(positive regulation of neuron maturation);GO:0016020(membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0045773(positive regulation of axon extension);GO:0046777(protein autophosphorylation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0106137(IkappaB kinase complex binding);GO:0150012(positive regulation of neuron projection arborization);GO:1905492(positive regulation of branching morphogenesis of a nerve)","04010(MAPK signaling pathway)",{"v":2.2e-06,"d":"0.00"},2,"53,38,","0,115011",-5.66,-4.92,{"v":18.4,"d":"18.40"},"5' UTR",1,88889707,88941234,51528,2]
["chr1",90192458,90195594,3137,"ENSBGRG00000003743","ENSBGRT00000009257",20242,"EIF4G1","eukaryotic translation initiation factor 4 gamma 1 [Source:HGNC Symbol;Acc:HGNC:3296]","GO:0001662(behavioral fear response);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005844(polysome);GO:0006412(translation);GO:0006446(regulation of translational initiation);GO:0008135(translation factor activity, RNA binding);GO:0008190(eukaryotic initiation factor 4E binding);GO:0010507(negative regulation of autophagy);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0010942(positive regulation of cell death);GO:0016281(eukaryotic translation initiation factor 4F complex);GO:0030307(positive regulation of cell growth);GO:0031669(cellular response to nutrient levels);GO:0032270(positive regulation of cellular protein metabolic process);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034645(cellular macromolecule biosynthetic process);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042802(identical protein binding);GO:0045666(positive regulation of neuron differentiation);GO:0097009(energy homeostasis);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1905537(positive regulation of eukaryotic translation initiation factor 4F complex assembly);GO:1905606(regulation of presynapse assembly);GO:1905612(positive regulation of mRNA cap binding);GO:1905618(positive regulation of miRNA mediated inhibition of translation);GO:1905696(regulation of polysome binding)","03013(RNA transport);05416(Viral myocarditis)",{"v":9.99999999999999e-262,"d":"0.00"},2,"323,36,","0,3101",-261,-259,{"v":13.3,"d":"13.30"},"3' UTR",1,90192428,90215836,23409,2]
["chr1",90208682,90209145,464,"ENSBGRG00000003743","ENSBGRT00000009257",6691,"EIF4G1","eukaryotic translation initiation factor 4 gamma 1 [Source:HGNC Symbol;Acc:HGNC:3296]","GO:0001662(behavioral fear response);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005844(polysome);GO:0006412(translation);GO:0006446(regulation of translational initiation);GO:0008135(translation factor activity, RNA binding);GO:0008190(eukaryotic initiation factor 4E binding);GO:0010507(negative regulation of autophagy);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0010942(positive regulation of cell death);GO:0016281(eukaryotic translation initiation factor 4F complex);GO:0030307(positive regulation of cell growth);GO:0031669(cellular response to nutrient levels);GO:0032270(positive regulation of cellular protein metabolic process);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034645(cellular macromolecule biosynthetic process);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042802(identical protein binding);GO:0045666(positive regulation of neuron differentiation);GO:0097009(energy homeostasis);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1905537(positive regulation of eukaryotic translation initiation factor 4F complex assembly);GO:1905606(regulation of presynapse assembly);GO:1905612(positive regulation of mRNA cap binding);GO:1905618(positive regulation of miRNA mediated inhibition of translation);GO:1905696(regulation of polysome binding)","03013(RNA transport);05416(Viral myocarditis)",{"v":9.99999999999998e-239,"d":"0.00"},2,"243,177,","0,287",-238,-235,4.74,"Exon (ENSBGRT00000009257/ENSBGRG00000003743, exon 10 of 36)",1,90192428,90215836,23409,2]
["chr1",90230570,90230660,91,"ENSBGRG00000000173","ENSBGRT00000000288",30,"PSMD2","proteasome 26S subunit, non-ATPase 2 [Source:HGNC Symbol;Acc:HGNC:9559]","GO:0000502(proteasome complex);GO:0005838(proteasome regulatory particle);GO:0022624(proteasome accessory complex);GO:0030234(enzyme regulator activity);GO:0042176(regulation of protein catabolic process)","03050(Proteasome);05169(Epstein-Barr virus infection)",{"v":7.9e-26,"d":"0.00"},1,"91,",0,{"v":-25.1,"d":"-25.10"},-24,2.03,"Exon (ENSBGRT00000000288/ENSBGRG00000000173, exon 1 of 21)",1,90221538,90230690,9153,2]
["chr1",90363390,90363826,437,"ENSBGRG00000000921","ENSBGRT00000001753",9749,"EIF2B5","eukaryotic translation initiation factor 2B subunit epsilon [Source:HGNC Symbol;Acc:HGNC:3261]","GO:0001541(ovarian follicle development);GO:0003743(translation initiation factor activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005851(eukaryotic translation initiation factor 2B complex);GO:0006413(translational initiation);GO:0009408(response to heat);GO:0014002(astrocyte development);GO:0014003(oligodendrocyte development);GO:0034976(response to endoplasmic reticulum stress);GO:0042552(myelination);GO:0048708(astrocyte differentiation);GO:0050852(T cell receptor signaling pathway)","03013(RNA transport)",{"v":9.99999999999999e-198,"d":"0.00"},2,"237,34,","0,403",-197,-195,4.28,"3' UTR",1,90362131,90373575,11445,2]
["chr1",90704518,90706611,2094,"ENSBGRG00000001414","ENSBGRT00000002587",86859,"YEATS2","YEATS domain containing 2 [Source:HGNC Symbol;Acc:HGNC:25489]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005634(nucleus);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0006355(regulation of transcription, DNA-templated);GO:0017025(TBP-class protein binding);GO:0042393(histone binding);GO:0043966(histone H3 acetylation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0072686(mitotic spindle);GO:0140030(modification-dependent protein binding)","NA",{"v":2.5e-17,"d":"0.00"},3,"79,74,27,","0,1347,2067",{"v":-16.6,"d":"-16.60"},{"v":-15.7,"d":"-15.70"},2.26,"Exon (ENSBGRT00000002587/ENSBGRG00000001414, exon 30 of 32)",1,90704488,90793470,88983,2]
["chr1",91133616,91134029,414,"ENSBGRG00000001502","ENSBGRT00000003087",60358,"MCF2L2","MCF.2 cell line derived transforming sequence-like 2 [Source:HGNC Symbol;Acc:HGNC:30319]","GO:0005085(guanyl-nucleotide exchange factor activity)","NA",{"v":0.015,"d":"0.02"},1,"414,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000003104/ENSBGRG00000001679, exon 1 of 1)",1,91073258,91280041,206784,1]
["chr1",91244887,91245533,647,"ENSBGRG00000001683","ENSBGRT00000003117",0,"B3GNT5","UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:15684]","GO:0006486(protein glycosylation);GO:0007417(central nervous system development);GO:0008457(beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity);GO:0016020(membrane)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":1.6E-52,"d":"0.00"},1,"647,",0,{"v":-51.8,"d":"-51.80"},{"v":-50.5,"d":"-50.50"},5.79,"Exon (ENSBGRT00000003117/ENSBGRG00000001683, exon 1 of 1)",1,91244388,91245533,1146,2]
["chr1",91572780,91572840,61,"ENSBGRG00000001781","ENSBGRT00000003296",132811,"ATP11B","ATPase phospholipid transporting 11B (putative) [Source:HGNC Symbol;Acc:HGNC:13553]","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0005524(ATP binding);GO:0005783(endoplasmic reticulum);GO:0015914(phospholipid transport);GO:0016021(integral component of membrane);GO:0055037(recycling endosome);GO:0140326(ATPase-coupled intramembrane lipid transporter activity)","NA",{"v":6.2e-05,"d":"0.00"},1,"61,",0,-4.21,-3.52,1.49,"3' UTR",1,91572601,91705651,133051,2]
["chr1",93747945,93754703,6759,"ENSBGRG00000001900","ENSBGRT00000003792",53399,"FXR1","FMR1 autosomal homolog 1 [Source:HGNC Symbol;Acc:HGNC:4023]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005844(polysome);GO:0006417(regulation of translation);GO:0007517(muscle organ development);GO:0030424(axon);GO:0030425(dendrite);GO:0033592(RNA strand annealing activity);GO:0035770(ribonucleoprotein granule);GO:0042803(protein homodimerization activity);GO:0043034(costamere);GO:0043197(dendritic spine);GO:0046982(protein heterodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:2000637(positive regulation of gene silencing by miRNA)","03013(RNA transport)",{"v":2.5e-18,"d":"0.00"},3,"86,79,16,","0,3793,6743",{"v":-17.6,"d":"-17.60"},{"v":-16.7,"d":"-16.70"},1.48,"Exon (ENSBGRT00000003792/ENSBGRG00000001900, exon 8 of 18)",1,93724375,93808102,83728,2]
["chr1",94086763,94087358,596,"ENSBGRG00000002327","ENSBGRT00000004463",8361,"TTC14","tetratricopeptide repeat domain 14 [Source:HGNC Symbol;Acc:HGNC:24697]","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","04140(Autophagy - animal);04136(Autophagy - other eukaryotes)",{"v":1e-267,"d":"0.00"},1,"596,",0,-267,-264,3.55,"3' UTR",1,94086763,94095719,8957,2]
["chr1",94087417,94087566,150,"ENSBGRG00000002327","ENSBGRT00000004463",8153,"TTC14","tetratricopeptide repeat domain 14 [Source:HGNC Symbol;Acc:HGNC:24697]","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","04140(Autophagy - animal);04136(Autophagy - other eukaryotes)",{"v":2e-81,"d":"0.00"},1,"150,",0,{"v":-80.7,"d":"-80.70"},{"v":-79.1,"d":"-79.10"},2.45,"3' UTR",1,94086763,94095719,8957,2]
["chr1",95670307,95670545,239,"ENSBGRG00000003231","ENSBGRT00000005988",30208,"PIK3CA","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [Source:HGNC Symbol;Acc:HGNC:8975]","GO:0001889(liver development);GO:0001932(regulation of protein phosphorylation);GO:0005942(phosphatidylinositol 3-kinase complex);GO:0005943(phosphatidylinositol 3-kinase complex, class IA);GO:0006006(glucose metabolic process);GO:0010468(regulation of gene expression);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0016301(kinase activity);GO:0016303(1-phosphatidylinositol-3-kinase activity);GO:0016310(phosphorylation);GO:0030027(lamellipodium);GO:0030295(protein kinase activator activity);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0035004(phosphatidylinositol 3-kinase activity);GO:0040014(regulation of multicellular organism growth);GO:0043457(regulation of cellular respiration);GO:0043491(protein kinase B signaling);GO:0043524(negative regulation of neuron apoptotic process);GO:0043560(insulin receptor substrate binding);GO:0044029(hypomethylation of CpG island);GO:0046854(phosphatidylinositol phosphorylation);GO:0048015(phosphatidylinositol-mediated signaling);GO:0060612(adipose tissue development);GO:0071333(cellular response to glucose stimulus);GO:0097009(energy homeostasis);GO:2000270(negative regulation of fibroblast apoptotic process);GO:2000653(regulation of genetic imprinting);GO:2000811(negative regulation of anoikis)","00562(Inositol phosphate metabolism);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04630(Jak-STAT signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04218(Cellular senescence);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04670(Leukocyte transendothelial migration);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04919(Thyroid hormone signaling pathway);04973(Carbohydrate digestion and absorption);04960(Aldosterone-regulated sodium reabsorption);04725(Cholinergic synapse);04722(Neurotrophin signaling pathway);04750(Inflammatory mediator regulation of TRP channels);04360(Axon guidance);04380(Osteoclast differentiation);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05205(Proteoglycans in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05100(Bacterial invasion of epithelial cells);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05146(Amoebiasis);05142(Chagas disease (American trypanosomiasis));01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":3.2e-88,"d":"0.00"},1,"239,",0,{"v":-87.5,"d":"-87.50"},{"v":-85.9,"d":"-85.90"},6.93,"3' UTR",1,95663621,95700753,37133,2]
["chr1",101229243,101229570,328,"ENSBGRG00000003457","ENSBGRT00000006436",812644,"NLGN1","neuroligin 1 [Source:HGNC Symbol;Acc:HGNC:14291]","GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007158(neuron cell-cell adhesion);GO:0007399(nervous system development);GO:0007416(synapse assembly);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010841(positive regulation of circadian sleep/wake cycle, wakefulness);GO:0016020(membrane);GO:0016080(synaptic vesicle targeting);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0030165(PDZ domain binding);GO:0031175(neuron projection development);GO:0035418(protein localization to synapse);GO:0042043(neurexin family protein binding);GO:0043235(receptor complex);GO:0045184(establishment of protein localization);GO:0045202(synapse);GO:0045664(regulation of neuron differentiation);GO:0048789(cytoskeletal matrix organization at active zone);GO:0050804(modulation of chemical synaptic transmission);GO:0050808(synapse organization);GO:0051965(positive regulation of synapse assembly);GO:0060076(excitatory synapse);GO:0060999(positive regulation of dendritic spine development);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0072553(terminal button organization);GO:0097091(synaptic vesicle clustering);GO:0097104(postsynaptic membrane assembly);GO:0097105(presynaptic membrane assembly);GO:0097110(scaffold protein binding);GO:0097113(AMPA glutamate receptor clustering);GO:0097115(neurexin clustering involved in presynaptic membrane assembly);GO:0097119(postsynaptic density protein 95 clustering);GO:0097120(receptor localization to synapse);GO:0099560(synaptic membrane adhesion);GO:1900244(positive regulation of synaptic vesicle endocytosis);GO:1904861(excitatory synapse assembly);GO:2000302(positive regulation of synaptic vesicle exocytosis);GO:2000310(regulation of NMDA receptor activity);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000809(positive regulation of synaptic vesicle clustering)","04514(Cell adhesion molecules (CAMs))",{"v":4E-14,"d":"0.00"},1,"328,",0,{"v":-13.4,"d":"-13.40"},{"v":-12.5,"d":"-12.50"},4.45,"Exon (ENSBGRT00000006436/ENSBGRG00000003457, exon 5 of 5)",1,101229243,102042214,812972,2]
["chr1",102041916,102042125,210,"ENSBGRG00000003457","ENSBGRT00000006436",89,"NLGN1","neuroligin 1 [Source:HGNC Symbol;Acc:HGNC:14291]","GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007158(neuron cell-cell adhesion);GO:0007399(nervous system development);GO:0007416(synapse assembly);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010841(positive regulation of circadian sleep/wake cycle, wakefulness);GO:0016020(membrane);GO:0016080(synaptic vesicle targeting);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0030165(PDZ domain binding);GO:0031175(neuron projection development);GO:0035418(protein localization to synapse);GO:0042043(neurexin family protein binding);GO:0043235(receptor complex);GO:0045184(establishment of protein localization);GO:0045202(synapse);GO:0045664(regulation of neuron differentiation);GO:0048789(cytoskeletal matrix organization at active zone);GO:0050804(modulation of chemical synaptic transmission);GO:0050808(synapse organization);GO:0051965(positive regulation of synapse assembly);GO:0060076(excitatory synapse);GO:0060999(positive regulation of dendritic spine development);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0072553(terminal button organization);GO:0097091(synaptic vesicle clustering);GO:0097104(postsynaptic membrane assembly);GO:0097105(presynaptic membrane assembly);GO:0097110(scaffold protein binding);GO:0097113(AMPA glutamate receptor clustering);GO:0097115(neurexin clustering involved in presynaptic membrane assembly);GO:0097119(postsynaptic density protein 95 clustering);GO:0097120(receptor localization to synapse);GO:0099560(synaptic membrane adhesion);GO:1900244(positive regulation of synaptic vesicle endocytosis);GO:1904861(excitatory synapse assembly);GO:2000302(positive regulation of synaptic vesicle exocytosis);GO:2000310(regulation of NMDA receptor activity);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000809(positive regulation of synaptic vesicle clustering)","04514(Cell adhesion molecules (CAMs))",{"v":1.2E-4,"d":"0.00"},1,"210,",0,-3.93,-3.25,9.18,"Exon (ENSBGRT00000006436/ENSBGRG00000003457, exon 1 of 5)",1,101229243,102042214,812972,2]
["chr1",103391996,103392115,120,"ENSBGRG00000003929","ENSBGRT00000007909",290112,"FNDC3B","fibronectin type III domain containing 3B [Source:HGNC Symbol;Acc:HGNC:24670]","GO:0005515(protein binding)","NA",{"v":1.1e-09,"d":"0.00"},1,"120,",0,-8.95,-8.12,1.53,"Exon (ENSBGRT00000007909/ENSBGRG00000003929, exon 25 of 25)",1,103391936,103682227,290292,2]
["chr1",105493987,105494866,880,"ENSBGRG00000006204","ENSBGRT00000011461",18823,"SKIL","SKI like proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10897]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001825(blastocyst formation);GO:0002260(lymphocyte homeostasis);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032991(protein-containing complex);GO:0045596(negative regulation of cell differentiation);GO:0046332(SMAD binding);GO:0070306(lens fiber cell differentiation);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902231(positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":2e-25,"d":"0.00"},2,"99,111,","0,769",{"v":-24.7,"d":"-24.70"},{"v":-23.6,"d":"-23.60"},3.46,"Exon (ENSBGRT00000011461/ENSBGRG00000006204, exon 5 of 6)",1,105493927,105513689,19763,2]
["chr1",105500801,105512252,11452,"ENSBGRG00000006204","ENSBGRT00000011461",1437,"SKIL","SKI like proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10897]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001825(blastocyst formation);GO:0002260(lymphocyte homeostasis);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032991(protein-containing complex);GO:0045596(negative regulation of cell differentiation);GO:0046332(SMAD binding);GO:0070306(lens fiber cell differentiation);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902231(positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":2e-11,"d":"0.00"},2,"29,331,","0,11121",{"v":-10.7,"d":"-10.70"},{"v":-9.8,"d":"-9.80"},3.76,"Exon (ENSBGRT00000011461/ENSBGRG00000006204, exon 1 of 6)",1,105493927,105513689,19763,2]
["chr1",105876783,105882449,5667,"ENSBGRG00000006891","ENSBGRT00000012758",19787,"SEC62","SEC62 homolog, preprotein translocation factor [Source:HGNC Symbol;Acc:HGNC:11846]","GO:0006620(posttranslational protein targeting to endoplasmic reticulum membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0031204(posttranslational protein targeting to membrane, translocation)","03060(Protein export);04141(Protein processing in endoplasmic reticulum)",0,2,"519,106,","0,5561",-1690,"-Inf",4.65,"3' UTR",1,105876456,105902236,25781,2]
["chr1",105893877,105901039,7163,"ENSBGRG00000006891","ENSBGRT00000012758",1197,"SEC62","SEC62 homolog, preprotein translocation factor [Source:HGNC Symbol;Acc:HGNC:11846]","GO:0006620(posttranslational protein targeting to endoplasmic reticulum membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0031204(posttranslational protein targeting to membrane, translocation)","03060(Protein export);04141(Protein processing in endoplasmic reticulum)",{"v":1E-136,"d":"0.00"},2,"199,69,","0,7094",-136,-134,3.06,"Exon (ENSBGRT00000012758/ENSBGRG00000006891, exon 2 of 7)",1,105876456,105902236,25781,2]
["chr1",106119339,106119696,358,"ENSBGRG00000007490","ENSBGRT00000013746",6614,"MYNN","myoneurin [Source:HGNC Symbol;Acc:HGNC:14955]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:1990830(cellular response to leukemia inhibitory factor)","NA",{"v":1E-100,"d":"0.00"},1,"358,",0,-100,{"v":-98.5,"d":"-98.50"},8.23,"Exon (ENSBGRT00000013746/ENSBGRG00000007490, exon 3 of 8)",1,106110113,106126310,16198,2]
["chr1",106125902,106126132,231,"ENSBGRG00000007490","ENSBGRT00000013746",178,"MYNN","myoneurin [Source:HGNC Symbol;Acc:HGNC:14955]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:1990830(cellular response to leukemia inhibitory factor)","NA",{"v":1E-13,"d":"0.00"},2,"48,42,","0,189",-13,{"v":-12.1,"d":"-12.10"},2.86,"5' UTR",1,106110113,106126310,16198,2]
["chr1",116150536,116150625,90,"ENSBGRG00000011599","ENSBGRT00000021389",0,"PPM1L","protein phosphatase, Mg2+/Mn2+ dependent 1L [Source:HGNC Symbol;Acc:HGNC:16381]","GO:0000165(MAPK cascade);GO:0003824(catalytic activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0007178(transmembrane receptor protein serine/threonine kinase signaling pathway);GO:0043169(cation binding)","NA",{"v":0.043,"d":"0.04"},1,"90,",0,-1.37,{"v":-0.841,"d":"-0.84"},4.32,"Exon (ENSBGRT00000021389/ENSBGRG00000011599, exon 1 of 5)",1,115791281,116150625,359345,2]
["chr1",116500524,116501622,1099,"ENSBGRG00000012219","ENSBGRT00000023058",30955,"SMC4","structural maintenance of chromosomes 4 [Source:HGNC Symbol;Acc:HGNC:14013]","GO:0000775(chromosome, centromeric region);GO:0000796(condensin complex);GO:0000797(condensin core heterodimer);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005694(chromosome);GO:0005829(cytosol);GO:0007076(mitotic chromosome condensation);GO:0010032(meiotic chromosome condensation);GO:0016607(nuclear speck);GO:0045132(meiotic chromosome segregation);GO:0051276(chromosome organization);GO:0051383(kinetochore organization)","NA",{"v":0.018,"d":"0.02"},2,"5,56,","0,1043",-1.75,{"v":-1.2,"d":"-1.20"},1.39,"Exon (ENSBGRT00000023058/ENSBGRG00000012219, exon 18 of 24)",1,116497307,116532577,35271,2]
["chr1",117225374,117225434,61,"ENSBGRG00000013519","ENSBGRT00000024806",576,"ENSBGRG00000013519","NA","NA","03420(Nucleotide excision repair)",{"v":0.0021,"d":"0.00"},1,"61,",0,-2.67,-2.06,2.07,"Exon (ENSBGRT00000024806/ENSBGRG00000013519, exon 1 of 7)",1,117042715,117226010,183296,2]
["chr1",117225734,117226064,331,"ENSBGRG00000013519","ENSBGRT00000024806",0,"ENSBGRG00000013519","NA","NA","03420(Nucleotide excision repair)",{"v":4e-65,"d":"0.00"},1,"331,",0,{"v":-64.4,"d":"-64.40"},-63,5.47,"5' UTR",1,117042715,117226010,183296,2]
["chr1",118651446,119095103,443658,"ENSBGRG00000015623","ENSBGRT00000028705",0,"ENSBGRG00000015623","NA","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)",{"v":2e-29,"d":"0.00"},8,"29,69,107,52,37,174,126,26,","0,87757,171946,205677,257103,340407,443214,443632",{"v":-28.7,"d":"-28.70"},{"v":-27.7,"d":"-27.70"},2.13,"Exon (ENSBGRT00000028705/ENSBGRG00000015623, exon 1 of 1)",1,118744734,118745597,864,1]
["chr1",119903080,119903197,118,"ENSBGRG00000016007","ENSBGRT00000029736",95840,"VEPH1","ventricular zone expressed PH domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25735]","GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0060392(negative regulation of SMAD protein signal transduction)","NA",{"v":1.6e-37,"d":"0.00"},1,"118,",0,{"v":-36.8,"d":"-36.80"},{"v":-35.7,"d":"-35.70"},3,"Exon (ENSBGRT00000030015/ENSBGRG00000016322, exon 3 of 3)",1,119807240,120097278,290039,1]
["chr1",119903374,119903433,60,"ENSBGRG00000016007","ENSBGRT00000029736",96134,"VEPH1","ventricular zone expressed PH domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25735]","GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0060392(negative regulation of SMAD protein signal transduction)","NA",{"v":2.5e-22,"d":"0.00"},1,"60,",0,{"v":-21.6,"d":"-21.60"},{"v":-20.6,"d":"-20.60"},2.87,"Exon (ENSBGRT00000030015/ENSBGRG00000016322, exon 3 of 3)",1,119807240,120097278,290039,1]
["chr1",120363852,120364781,930,"ENSBGRG00000016645","ENSBGRT00000030590",219104,"ENSBGRG00000016645","NA","NA","NA",{"v":1E-8,"d":"0.00"},1,"930,",0,-7.98,-7.17,{"v":25.9,"d":"25.90"},"3' UTR",1,120363852,120583885,220034,2]
["chr1",120364841,120364931,91,"ENSBGRG00000016645","ENSBGRT00000030590",218954,"ENSBGRG00000016645","NA","NA","NA",{"v":6.3e-11,"d":"0.00"},1,"91,",0,{"v":-10.2,"d":"-10.20"},-9.34,7.29,"3' UTR",1,120363852,120583885,220034,2]
["chr1",120748899,120749845,947,"ENSBGRG00000016750","ENSBGRT00000030776",26720,"TIPARP","TCDD inducible poly(ADP-ribose) polymerase [Source:HGNC Symbol;Acc:HGNC:23696]","GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001570(vasculogenesis);GO:0001822(kidney development);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005634(nucleus);GO:0006471(protein ADP-ribosylation);GO:0006807(nitrogen compound metabolic process);GO:0008209(androgen metabolic process);GO:0008210(estrogen metabolic process);GO:0008585(female gonad development);GO:0009791(post-embryonic development);GO:0010629(negative regulation of gene expression);GO:0030097(hemopoiesis);GO:0045732(positive regulation of protein catabolic process);GO:0046872(metal ion binding);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048705(skeletal system morphogenesis);GO:0048745(smooth muscle tissue development);GO:0060021(roof of mouth development);GO:0060325(face morphogenesis);GO:0070213(protein auto-ADP-ribosylation);GO:0071407(cellular response to organic cyclic compound);GO:0140289(protein mono-ADP-ribosylation);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":1E-127,"d":"0.00"},2,"149,120,","0,827",-127,-125,5.62,"Exon (ENSBGRT00000030776/ENSBGRG00000016750, exon 5 of 6)",1,120748600,120776565,27966,2]
["chr1",120757216,120773733,16518,"ENSBGRG00000016750","ENSBGRT00000030776",2832,"TIPARP","TCDD inducible poly(ADP-ribose) polymerase [Source:HGNC Symbol;Acc:HGNC:23696]","GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001570(vasculogenesis);GO:0001822(kidney development);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005634(nucleus);GO:0006471(protein ADP-ribosylation);GO:0006807(nitrogen compound metabolic process);GO:0008209(androgen metabolic process);GO:0008210(estrogen metabolic process);GO:0008585(female gonad development);GO:0009791(post-embryonic development);GO:0010629(negative regulation of gene expression);GO:0030097(hemopoiesis);GO:0045732(positive regulation of protein catabolic process);GO:0046872(metal ion binding);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048705(skeletal system morphogenesis);GO:0048745(smooth muscle tissue development);GO:0060021(roof of mouth development);GO:0060325(face morphogenesis);GO:0070213(protein auto-ADP-ribosylation);GO:0071407(cellular response to organic cyclic compound);GO:0140289(protein mono-ADP-ribosylation);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":1e-114,"d":"0.00"},2,"104,494,","0,16024",-114,-112,6.77,"Exon (ENSBGRT00000030776/ENSBGRG00000016750, exon 2 of 6)",1,120748600,120776565,27966,2]
["chr1",120773823,120776505,2683,"ENSBGRG00000016750","ENSBGRT00000030776",60,"TIPARP","TCDD inducible poly(ADP-ribose) polymerase [Source:HGNC Symbol;Acc:HGNC:23696]","GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001570(vasculogenesis);GO:0001822(kidney development);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005634(nucleus);GO:0006471(protein ADP-ribosylation);GO:0006807(nitrogen compound metabolic process);GO:0008209(androgen metabolic process);GO:0008210(estrogen metabolic process);GO:0008585(female gonad development);GO:0009791(post-embryonic development);GO:0010629(negative regulation of gene expression);GO:0030097(hemopoiesis);GO:0045732(positive regulation of protein catabolic process);GO:0046872(metal ion binding);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048705(skeletal system morphogenesis);GO:0048745(smooth muscle tissue development);GO:0060021(roof of mouth development);GO:0060325(face morphogenesis);GO:0070213(protein auto-ADP-ribosylation);GO:0071407(cellular response to organic cyclic compound);GO:0140289(protein mono-ADP-ribosylation);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":5e-68,"d":"0.00"},2,"370,19,","0,2664",{"v":-67.3,"d":"-67.30"},{"v":-65.9,"d":"-65.90"},5.78,"5' UTR",1,120748600,120776565,27966,2]
["chr1",123625065,123625214,150,"ENSBGRG00000011886","ENSBGRT00000021733",598,"ARHGEF26","Rho guanine nucleotide exchange factor 26 [Source:HGNC Symbol;Acc:HGNC:24490]","GO:0001886(endothelial cell morphogenesis);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0097178(ruffle assembly)","05100(Bacterial invasion of epithelial cells)",{"v":2.5e-17,"d":"0.00"},1,"150,",0,{"v":-16.6,"d":"-16.60"},{"v":-15.7,"d":"-15.70"},5.61,"Exon (ENSBGRT00000021733/ENSBGRG00000011886, exon 1 of 13)",1,123470614,123625812,155199,2]
["chr1",123625273,123625393,121,"ENSBGRG00000011886","ENSBGRT00000021733",419,"ARHGEF26","Rho guanine nucleotide exchange factor 26 [Source:HGNC Symbol;Acc:HGNC:24490]","GO:0001886(endothelial cell morphogenesis);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0097178(ruffle assembly)","05100(Bacterial invasion of epithelial cells)",{"v":2e-26,"d":"0.00"},1,"121,",0,{"v":-25.7,"d":"-25.70"},{"v":-24.6,"d":"-24.60"},7.46,"Exon (ENSBGRT00000021733/ENSBGRG00000011886, exon 1 of 13)",1,123470614,123625812,155199,2]
["chr1",125149643,125149704,62,"ENSBGRG00000012398","ENSBGRT00000022700",1891,"P2RY1","purinergic receptor P2Y1 [Source:HGNC Symbol;Acc:HGNC:8539]","GO:0001621(G protein-coupled ADP receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005929(cilium);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007200(phospholipase C-activating G protein-coupled receptor signaling pathway);GO:0008360(regulation of cell shape);GO:0016021(integral component of membrane);GO:0030168(platelet activation);GO:0043270(positive regulation of ion transport);GO:0045028(G protein-coupled purinergic nucleotide receptor activity);GO:0071407(cellular response to organic cyclic compound);GO:0071415(cellular response to purine-containing compound);GO:0090075(relaxation of muscle)","04015(Rap1 signaling pathway);04080(Neuroactive ligand-receptor interaction);04611(Platelet activation);04742(Taste transduction)",{"v":1.3E-42,"d":"0.00"},2,"53,7,","0,55",{"v":-41.9,"d":"-41.90"},{"v":-40.7,"d":"-40.70"},7.86,"Exon (ENSBGRT00000022700/ENSBGRG00000012398, exon 2 of 3)",1,125149261,125151595,2335,2]
["chr1",125149763,125149910,148,"ENSBGRG00000012398","ENSBGRT00000022700",1685,"P2RY1","purinergic receptor P2Y1 [Source:HGNC Symbol;Acc:HGNC:8539]","GO:0001621(G protein-coupled ADP receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005929(cilium);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007200(phospholipase C-activating G protein-coupled receptor signaling pathway);GO:0008360(regulation of cell shape);GO:0016021(integral component of membrane);GO:0030168(platelet activation);GO:0043270(positive regulation of ion transport);GO:0045028(G protein-coupled purinergic nucleotide receptor activity);GO:0071407(cellular response to organic cyclic compound);GO:0071415(cellular response to purine-containing compound);GO:0090075(relaxation of muscle)","04015(Rap1 signaling pathway);04080(Neuroactive ligand-receptor interaction);04611(Platelet activation);04742(Taste transduction)",{"v":1.3E-20,"d":"0.00"},1,"148,",0,{"v":-19.9,"d":"-19.90"},{"v":-18.9,"d":"-18.90"},{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000022700/ENSBGRG00000012398, exon 2 of 3)",1,125149261,125151595,2335,2]
["chr1",125151183,125151595,413,"ENSBGRG00000012398","ENSBGRT00000022700",0,"P2RY1","purinergic receptor P2Y1 [Source:HGNC Symbol;Acc:HGNC:8539]","GO:0001621(G protein-coupled ADP receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005929(cilium);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007200(phospholipase C-activating G protein-coupled receptor signaling pathway);GO:0008360(regulation of cell shape);GO:0016021(integral component of membrane);GO:0030168(platelet activation);GO:0043270(positive regulation of ion transport);GO:0045028(G protein-coupled purinergic nucleotide receptor activity);GO:0071407(cellular response to organic cyclic compound);GO:0071415(cellular response to purine-containing compound);GO:0090075(relaxation of muscle)","04015(Rap1 signaling pathway);04080(Neuroactive ligand-receptor interaction);04611(Platelet activation);04742(Taste transduction)",{"v":6.9e-05,"d":"0.00"},1,"413,",0,-4.16,-3.47,6.48,"Exon (ENSBGRT00000022700/ENSBGRG00000012398, exon 1 of 3)",1,125149261,125151595,2335,2]
["chr1",126263457,126263516,60,"ENSBGRG00000013608","ENSBGRT00000024913",8083,"SUCNR1","succinate receptor 1 [Source:HGNC Symbol;Acc:HGNC:4542]","GO:0002001(renin secretion into blood stream);GO:0002281(macrophage activation involved in immune response);GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0032611(interleukin-1 beta production);GO:0038023(signaling receptor activity);GO:0042593(glucose homeostasis);GO:0050729(positive regulation of inflammatory response);GO:0050921(positive regulation of chemotaxis);GO:0051592(response to calcium ion);GO:0060177(regulation of angiotensin metabolic process)","04024(cAMP signaling pathway)",{"v":0.0031,"d":"0.00"},1,"60,",0,-2.51,{"v":-1.9,"d":"-1.90"},4.86,"Exon (ENSBGRT00000024913/ENSBGRG00000013608, exon 2 of 2)",1,126263457,126271599,8143,2]
["chr1",126263869,126263928,60,"ENSBGRG00000013608","ENSBGRT00000024913",7671,"SUCNR1","succinate receptor 1 [Source:HGNC Symbol;Acc:HGNC:4542]","GO:0002001(renin secretion into blood stream);GO:0002281(macrophage activation involved in immune response);GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0032611(interleukin-1 beta production);GO:0038023(signaling receptor activity);GO:0042593(glucose homeostasis);GO:0050729(positive regulation of inflammatory response);GO:0050921(positive regulation of chemotaxis);GO:0051592(response to calcium ion);GO:0060177(regulation of angiotensin metabolic process)","04024(cAMP signaling pathway)",{"v":3.9e-06,"d":"0.00"},1,"60,",0,-5.41,-4.68,7.29,"Exon (ENSBGRT00000024913/ENSBGRG00000013608, exon 2 of 2)",1,126263457,126271599,8143,2]
["chr1",126264193,126264252,60,"ENSBGRG00000013608","ENSBGRT00000024913",7347,"SUCNR1","succinate receptor 1 [Source:HGNC Symbol;Acc:HGNC:4542]","GO:0002001(renin secretion into blood stream);GO:0002281(macrophage activation involved in immune response);GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0032611(interleukin-1 beta production);GO:0038023(signaling receptor activity);GO:0042593(glucose homeostasis);GO:0050729(positive regulation of inflammatory response);GO:0050921(positive regulation of chemotaxis);GO:0051592(response to calcium ion);GO:0060177(regulation of angiotensin metabolic process)","04024(cAMP signaling pathway)",{"v":1.5e-07,"d":"0.00"},1,"60,",0,-6.83,-6.05,5.67,"Exon (ENSBGRT00000024913/ENSBGRG00000013608, exon 2 of 2)",1,126263457,126271599,8143,2]
["chr1",126669607,126670085,479,"ENSBGRG00000013878","ENSBGRT00000025477",0,"C1GALT1C1","C1GALT1 specific chaperone 1 [Source:HGNC Symbol;Acc:HGNC:24338]","GO:0006493(protein O-linked glycosylation)","00512(Mucin type O-glycan biosynthesis)",{"v":3.2e-53,"d":"0.00"},1,"479,",0,{"v":-52.5,"d":"-52.50"},{"v":-51.2,"d":"-51.20"},6.71,"Exon (ENSBGRT00000025477/ENSBGRG00000013878, exon 1 of 1)",1,126669129,126670085,957,2]
["chr1",128010043,128020683,10641,"ENSBGRG00000014873","ENSBGRT00000027440",34155,"EIF2A","eukaryotic translation initiation factor 2A [Source:HGNC Symbol;Acc:HGNC:3254]","GO:0000049(tRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005850(eukaryotic translation initiation factor 2 complex);GO:0006412(translation);GO:0006413(translational initiation);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0009967(positive regulation of signal transduction);GO:0032933(SREBP signaling pathway);GO:0042255(ribosome assembly);GO:0043022(ribosome binding)","NA",{"v":1E-194,"d":"0.00"},4,"7,66,129,67,","0,3140,3886,10574",-194,-192,2.14,"Exon (ENSBGRT00000027440/ENSBGRG00000014873, exon 11 of 14)",1,128009984,128054838,44855,2]
["chr1",128025889,128028971,3083,"ENSBGRG00000014873","ENSBGRT00000027440",25867,"EIF2A","eukaryotic translation initiation factor 2A [Source:HGNC Symbol;Acc:HGNC:3254]","GO:0000049(tRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005850(eukaryotic translation initiation factor 2 complex);GO:0006412(translation);GO:0006413(translational initiation);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0009967(positive regulation of signal transduction);GO:0032933(SREBP signaling pathway);GO:0042255(ribosome assembly);GO:0043022(ribosome binding)","NA",{"v":9.99999999999998e-264,"d":"0.00"},2,"264,64,","0,3019",-263,-261,5.84,"Exon (ENSBGRT00000027440/ENSBGRG00000014873, exon 9 of 14)",1,128009984,128054838,44855,2]
["chr1",128139346,128174947,35602,"ENSBGRG00000015241","ENSBGRT00000028693",0,"TSC22D2","TSC22 domain family member 2 [Source:HGNC Symbol;Acc:HGNC:29095]","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006970(response to osmotic stress)","NA",{"v":1E-155,"d":"0.00"},4,"261,52,26,19,","0,1202,1923,35583",-155,-154,4.57,"Exon (ENSBGRT00000028693/ENSBGRG00000015241, exon 1 of 3)",1,128139346,128141294,1949,2]
["chr1",128186167,128186256,90,"ENSBGRG00000015241","ENSBGRT00000028386",3596,"TSC22D2","TSC22 domain family member 2 [Source:HGNC Symbol;Acc:HGNC:29095]","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006970(response to osmotic stress)","NA",{"v":6.9e-05,"d":"0.00"},1,"90,",0,-4.16,-3.47,8.64,"Exon (ENSBGRT00000028386/ENSBGRG00000015241, exon 2 of 5)",1,128139346,128189852,50507,2]
["chr1",128186642,128188990,2349,"ENSBGRG00000015241","ENSBGRT00000028386",862,"TSC22D2","TSC22 domain family member 2 [Source:HGNC Symbol;Acc:HGNC:29095]","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006970(response to osmotic stress)","NA",{"v":1.9E-3,"d":"0.00"},2,"124,441,","0,1908",-2.73,-2.11,{"v":4.1,"d":"4.10"},"Exon (ENSBGRT00000028386/ENSBGRG00000015241, exon 1 of 5)",1,128139346,128189852,50507,2]
["chr1",128189674,128189733,60,"ENSBGRG00000015241","ENSBGRT00000028386",119,"TSC22D2","TSC22 domain family member 2 [Source:HGNC Symbol;Acc:HGNC:29095]","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006970(response to osmotic stress)","NA",{"v":4e-11,"d":"0.00"},1,"60,",0,{"v":-10.4,"d":"-10.40"},{"v":-9.6,"d":"-9.60"},5.85,"Exon (ENSBGRT00000028386/ENSBGRG00000015241, exon 1 of 5)",1,128139346,128189852,50507,2]
["chr1",129644656,129644835,180,"ENSBGRG00000017021","ENSBGRT00000031232",10075,"HPS3","HPS3 biogenesis of lysosomal organelles complex 2 subunit 1 [Source:HGNC Symbol;Acc:HGNC:15597]","GO:0005737(cytoplasm);GO:0006996(organelle organization);GO:0031084(BLOC-2 complex);GO:0043473(pigmentation)","NA",{"v":0.00071,"d":"0.00"},1,"180,",0,-3.15,{"v":-2.5,"d":"-2.50"},1.95,"Exon (ENSBGRT00000031232/ENSBGRG00000017021, exon 2 of 17)",1,129520908,129654910,134003,2]
["chr1",130125959,130126286,328,"ENSBGRG00000019592","ENSBGRT00000036014",2017,"AGTR1","angiotensin II receptor type 1 [Source:HGNC Symbol;Acc:HGNC:336]","GO:0004930(G protein-coupled receptor activity);GO:0004945(angiotensin type II receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0019229(regulation of vasoconstriction)","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04072(Phospholipase D signaling pathway);04022(cGMP - PKG signaling pathway);04080(Neuroactive ligand-receptor interaction);04924(Renin secretion);04614(Renin-angiotensin system);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);05200(Pathways in cancer);04933(AGE-RAGE signaling pathway in diabetic complications);04934(Cushing syndrome)",{"v":3.2E-50,"d":"0.00"},1,"328,",0,{"v":-49.5,"d":"-49.50"},{"v":-48.2,"d":"-48.20"},2.83,"Exon (ENSBGRT00000036014/ENSBGRG00000019592, exon 3 of 3)",1,130125929,130128303,2375,2]
["chr1",135959940,135959999,60,"ENSBGRG00000000180","ENSBGRT00000000286",568,"DIPK2A","divergent protein kinase domain 2A [Source:HGNC Symbol;Acc:HGNC:28490]","GO:0000139(Golgi membrane);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0030126(COPI vesicle coat);GO:0030137(COPI-coated vesicle);GO:0034392(negative regulation of smooth muscle cell apoptotic process);GO:0060038(cardiac muscle cell proliferation);GO:1900020(positive regulation of protein kinase C activity)","NA",{"v":1.5E-6,"d":"0.00"},1,"60,",0,-5.83,-5.08,2.92,"Exon (ENSBGRT00000000286/ENSBGRG00000000180, exon 1 of 3)",1,135939807,135960567,20761,2]
["chr1",137061437,137061675,239,"ENSBGRG00000000218","ENSBGRT00000000347",1101,"CHST2","carbohydrate sulfotransferase 2 [Source:HGNC Symbol;Acc:HGNC:1970]","GO:0000139(Golgi membrane);GO:0001517(N-acetylglucosamine 6-O-sulfotransferase activity);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006044(N-acetylglucosamine metabolic process);GO:0006790(sulfur compound metabolic process);GO:0008146(sulfotransferase activity)","00533(Glycosaminoglycan biosynthesis - keratan sulfate)",{"v":5e-82,"d":"0.00"},1,"239,",0,{"v":-81.3,"d":"-81.30"},{"v":-79.7,"d":"-79.70"},8.82,"Exon (ENSBGRT00000000347/ENSBGRG00000000218, exon 2 of 3)",1,137060027,137062776,2750,2]
["chr1",137062597,137062776,180,"ENSBGRG00000000218","ENSBGRT00000000347",0,"CHST2","carbohydrate sulfotransferase 2 [Source:HGNC Symbol;Acc:HGNC:1970]","GO:0000139(Golgi membrane);GO:0001517(N-acetylglucosamine 6-O-sulfotransferase activity);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006044(N-acetylglucosamine metabolic process);GO:0006790(sulfur compound metabolic process);GO:0008146(sulfotransferase activity)","00533(Glycosaminoglycan biosynthesis - keratan sulfate)",{"v":1.1E-5,"d":"0.00"},1,"180,",0,-4.97,-4.25,8.64,"Exon (ENSBGRT00000000347/ENSBGRG00000000218, exon 1 of 3)",1,137060027,137062776,2750,2]
["chr1",137138877,137151574,12698,"ENSBGRG00000000223","ENSBGRT00000000356",40317,"U2SURP","U2 snRNP associated SURP domain containing [Source:HGNC Symbol;Acc:HGNC:30855]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006396(RNA processing)","03040(Spliceosome)",{"v":2e-89,"d":"0.00"},5,"48,119,111,160,9,","0,1277,3908,8692,12689",{"v":-88.7,"d":"-88.70"},{"v":-87.2,"d":"-87.20"},2.43,"Exon (ENSBGRT00000000356/ENSBGRG00000000223, exon 23 of 28)",1,137136621,137191891,55271,2]
["chr1",138897251,138897551,301,"ENSBGRG00000001246","ENSBGRT00000002273",50127,"ZBTB38","zinc finger and BTB domain containing 38 [Source:HGNC Symbol;Acc:HGNC:26636]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006275(regulation of DNA replication);GO:0006974(cellular response to DNA damage stimulus);GO:0008327(methyl-CpG binding);GO:0042803(protein homodimerization activity);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":7.9e-90,"d":"0.00"},1,"301,",0,{"v":-89.1,"d":"-89.10"},{"v":-87.5,"d":"-87.50"},6.11,"Exon (ENSBGRT00000002273/ENSBGRG00000001246, exon 2 of 3)",1,138894957,138947678,52722,2]
["chr1",138897671,138899318,1648,"ENSBGRG00000001246","ENSBGRT00000002273",48360,"ZBTB38","zinc finger and BTB domain containing 38 [Source:HGNC Symbol;Acc:HGNC:26636]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006275(regulation of DNA replication);GO:0006974(cellular response to DNA damage stimulus);GO:0008327(methyl-CpG binding);GO:0042803(protein homodimerization activity);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":3.2e-92,"d":"0.00"},1,"1648,",0,{"v":-91.5,"d":"-91.50"},{"v":-89.9,"d":"-89.90"},5.96,"Exon (ENSBGRT00000002273/ENSBGRG00000001246, exon 2 of 3)",1,138894957,138947678,52722,2]
["chr1",138899617,138899946,330,"ENSBGRG00000001246","ENSBGRT00000002273",47732,"ZBTB38","zinc finger and BTB domain containing 38 [Source:HGNC Symbol;Acc:HGNC:26636]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006275(regulation of DNA replication);GO:0006974(cellular response to DNA damage stimulus);GO:0008327(methyl-CpG binding);GO:0042803(protein homodimerization activity);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":2.5e-27,"d":"0.00"},1,"330,",0,{"v":-26.6,"d":"-26.60"},{"v":-25.6,"d":"-25.60"},{"v":3.5,"d":"3.50"},"Exon (ENSBGRT00000002273/ENSBGRG00000001246, exon 2 of 3)",1,138894957,138947678,52722,2]
["chr1",139077074,139077193,120,"ENSBGRG00000001263","ENSBGRT00000002318",40162,"PXYLP1","2-phosphoxylose phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:26303]","GO:0005794(Golgi apparatus);GO:0006024(glycosaminoglycan biosynthetic process);GO:0010909(positive regulation of heparan sulfate proteoglycan biosynthetic process);GO:0016791(phosphatase activity);GO:0050650(chondroitin sulfate proteoglycan biosynthetic process)","NA",{"v":7.9e-47,"d":"0.00"},1,"120,",0,{"v":-46.1,"d":"-46.10"},{"v":-44.9,"d":"-44.90"},6.91,"Exon (ENSBGRT00000002318/ENSBGRG00000001263, exon 5 of 5)",1,139076689,139117355,40667,2]
["chr1",139094652,139173686,79035,"ENSBGRG00000001263","ENSBGRT00000002318",0,"PXYLP1","2-phosphoxylose phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:26303]","GO:0005794(Golgi apparatus);GO:0006024(glycosaminoglycan biosynthetic process);GO:0010909(positive regulation of heparan sulfate proteoglycan biosynthetic process);GO:0016791(phosphatase activity);GO:0050650(chondroitin sulfate proteoglycan biosynthetic process)","NA",{"v":0.028,"d":"0.03"},4,"1,31,132,14,","0,22673,25429,79021",-1.56,{"v":-0.937,"d":"-0.94"},7.56,"5' UTR",1,139076689,139117355,40667,2]
["chr1",139446585,139448157,1573,"ENSBGRG00000001317","ENSBGRT00000002419",36191,"SLC25A36","solute carrier family 25 member 36 [Source:HGNC Symbol;Acc:HGNC:25554]","GO:0000002(mitochondrial genome maintenance);GO:0005347(ATP transmembrane transporter activity);GO:0005739(mitochondrion);GO:0006864(pyrimidine nucleotide transport);GO:0007005(mitochondrion organization);GO:0015218(pyrimidine nucleotide transmembrane transporter activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055085(transmembrane transport)","NA",{"v":6.3e-69,"d":"0.00"},2,"194,163,","0,1410",{"v":-68.2,"d":"-68.20"},{"v":-66.8,"d":"-66.80"},5.13,"Exon (ENSBGRT00000002419/ENSBGRG00000001317, exon 6 of 7)",1,139446585,139484348,37764,2]
["chr1",139483903,139484348,446,"ENSBGRG00000001317","ENSBGRT00000002419",0,"SLC25A36","solute carrier family 25 member 36 [Source:HGNC Symbol;Acc:HGNC:25554]","GO:0000002(mitochondrial genome maintenance);GO:0005347(ATP transmembrane transporter activity);GO:0005739(mitochondrion);GO:0006864(pyrimidine nucleotide transport);GO:0007005(mitochondrion organization);GO:0015218(pyrimidine nucleotide transmembrane transporter activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055085(transmembrane transport)","NA",{"v":0.0021,"d":"0.00"},1,"446,",0,-2.67,-2.06,{"v":11.9,"d":"11.90"},"5' UTR",1,139446585,139484348,37764,2]
["chr1",139859022,139859111,90,"ENSBGRG00000001375","ENSBGRT00000002548",803295,"CLSTN2","calsyntenin 2 [Source:HGNC Symbol;Acc:HGNC:17448]","GO:0005509(calcium ion binding);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0009986(cell surface);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0045211(postsynaptic membrane);GO:0050806(positive regulation of synaptic transmission);GO:0051965(positive regulation of synapse assembly);GO:0098978(glutamatergic synapse);GO:0099061(integral component of postsynaptic density membrane)","NA",{"v":0.028,"d":"0.03"},1,"90,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000002548/ENSBGRG00000001375, exon 17 of 17)",1,139859022,140662406,803385,2]
["chr1",142184509,142194875,10367,"ENSBGRG00000001673","ENSBGRT00000003109",1484,"FAIM","Fas apoptotic inhibitory molecule [Source:HGNC Symbol;Acc:HGNC:18703]","GO:0043066(negative regulation of apoptotic process)","NA",{"v":2.5e-33,"d":"0.00"},5,"8,142,50,229,15,","0,19,4868,9771,10352",{"v":-32.6,"d":"-32.60"},{"v":-31.4,"d":"-31.40"},7.56,"Exon (ENSBGRT00000003109/ENSBGRG00000001673, exon 2 of 6)",1,142184509,142196359,11851,2]
["chr1",142427075,142435183,8109,"ENSBGRG00000001941","ENSBGRT00000003635",77147,"MRAS","muscle RAS oncogene homolog [Source:HGNC Symbol;Acc:HGNC:7227]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0007265(Ras protein signal transduction);GO:0016020(membrane);GO:0030742(GTP-dependent protein binding);GO:1990830(cellular response to leukemia inhibitory factor)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04371(Apelin signaling pathway);04072(Phospholipase D signaling pathway);04140(Autophagy - animal);04137(Mitophagy - animal);04218(Cellular senescence);04810(Regulation of actin cytoskeleton);04625(C-type lectin receptor signaling pathway);05205(Proteoglycans in cancer);05166(HTLV-I infection)",{"v":1.6E-13,"d":"0.00"},3,"8,80,3,","0,2243,8106",{"v":-12.8,"d":"-12.80"},{"v":-11.9,"d":"-11.90"},1.98,"3' UTR",1,142426358,142512330,85973,2]
["chr1",142511673,142512061,389,"ENSBGRG00000001941","ENSBGRT00000003635",269,"MRAS","muscle RAS oncogene homolog [Source:HGNC Symbol;Acc:HGNC:7227]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0007265(Ras protein signal transduction);GO:0016020(membrane);GO:0030742(GTP-dependent protein binding);GO:1990830(cellular response to leukemia inhibitory factor)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04371(Apelin signaling pathway);04072(Phospholipase D signaling pathway);04140(Autophagy - animal);04137(Mitophagy - animal);04218(Cellular senescence);04810(Regulation of actin cytoskeleton);04625(C-type lectin receptor signaling pathway);05205(Proteoglycans in cancer);05166(HTLV-I infection)",{"v":0.0078,"d":"0.01"},1,"389,",0,-2.11,-1.53,6.48,"5' UTR",1,142426358,142512330,85973,2]
["chr1",142567061,142574521,7461,"ENSBGRG00000002029","ENSBGRT00000003769",111156,"ARMC8","armadillo repeat containing 8 [Source:HGNC Symbol;Acc:HGNC:24999]","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm)","NA",{"v":1.6e-55,"d":"0.00"},3,"170,94,35,","0,6639,7426",{"v":-54.8,"d":"-54.80"},{"v":-53.5,"d":"-53.50"},8.16,"3' UTR",1,142567061,142685677,118617,2]
["chr1",142574849,142574909,61,"ENSBGRG00000002029","ENSBGRT00000003769",110768,"ARMC8","armadillo repeat containing 8 [Source:HGNC Symbol;Acc:HGNC:24999]","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm)","NA",{"v":1e-19,"d":"0.00"},1,"61,",0,-19,-18,7.64,"3' UTR",1,142567061,142685677,118617,2]
["chr1",144046569,144046926,358,"ENSBGRG00000002412","ENSBGRT00000004515",42525,"NCK1","NCK adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:7664]","GO:0000164(protein phosphatase type 1 complex);GO:0004860(protein kinase inhibitor activity);GO:0005070(SH3/SH2 adaptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005840(ribosome);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006930(substrate-dependent cell migration, cell extension);GO:0007015(actin filament organization);GO:0010976(positive regulation of neuron projection development);GO:0012506(vesicle membrane);GO:0016477(cell migration);GO:0019904(protein domain specific binding);GO:0030032(lamellipodium assembly);GO:0030334(regulation of cell migration);GO:0030674(protein-macromolecule adaptor activity);GO:0030838(positive regulation of actin filament polymerization);GO:0030971(receptor tyrosine kinase binding);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042102(positive regulation of T cell proliferation);GO:0042110(T cell activation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0051707(response to other organism);GO:0060548(negative regulation of cell death);GO:0070262(peptidyl-serine dephosphorylation);GO:0071074(eukaryotic initiation factor eIF2 binding);GO:1902237(positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway);GO:1903676(positive regulation of cap-dependent translational initiation);GO:1903679(positive regulation of cap-independent translational initiation);GO:1903898(negative regulation of PERK-mediated unfolded protein response);GO:1903912(negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation);GO:1990441(negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04012(ErbB signaling pathway);04660(T cell receptor signaling pathway);04360(Axon guidance)",{"v":6.3E-29,"d":"0.00"},1,"358,",0,{"v":-28.2,"d":"-28.20"},{"v":-27.1,"d":"-27.10"},5.64,"3' UTR",1,144046569,144089451,42883,2]
["chr1",144047224,144047283,60,"ENSBGRG00000002412","ENSBGRT00000004515",42168,"NCK1","NCK adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:7664]","GO:0000164(protein phosphatase type 1 complex);GO:0004860(protein kinase inhibitor activity);GO:0005070(SH3/SH2 adaptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005840(ribosome);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006930(substrate-dependent cell migration, cell extension);GO:0007015(actin filament organization);GO:0010976(positive regulation of neuron projection development);GO:0012506(vesicle membrane);GO:0016477(cell migration);GO:0019904(protein domain specific binding);GO:0030032(lamellipodium assembly);GO:0030334(regulation of cell migration);GO:0030674(protein-macromolecule adaptor activity);GO:0030838(positive regulation of actin filament polymerization);GO:0030971(receptor tyrosine kinase binding);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042102(positive regulation of T cell proliferation);GO:0042110(T cell activation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0051707(response to other organism);GO:0060548(negative regulation of cell death);GO:0070262(peptidyl-serine dephosphorylation);GO:0071074(eukaryotic initiation factor eIF2 binding);GO:1902237(positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway);GO:1903676(positive regulation of cap-dependent translational initiation);GO:1903679(positive regulation of cap-independent translational initiation);GO:1903898(negative regulation of PERK-mediated unfolded protein response);GO:1903912(negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation);GO:1990441(negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04012(ErbB signaling pathway);04660(T cell receptor signaling pathway);04360(Axon guidance)",{"v":7.9e-11,"d":"0.00"},1,"60,",0,{"v":-10.1,"d":"-10.10"},-9.25,{"v":3.8,"d":"3.80"},"3' UTR",1,144046569,144089451,42883,2]
["chr1",144103292,144105954,2663,"ENSBGRG00000002412","ENSBGRT00000004487",19584,"NCK1","NCK adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:7664]","GO:0000164(protein phosphatase type 1 complex);GO:0004860(protein kinase inhibitor activity);GO:0005070(SH3/SH2 adaptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005840(ribosome);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006930(substrate-dependent cell migration, cell extension);GO:0007015(actin filament organization);GO:0010976(positive regulation of neuron projection development);GO:0012506(vesicle membrane);GO:0016477(cell migration);GO:0019904(protein domain specific binding);GO:0030032(lamellipodium assembly);GO:0030334(regulation of cell migration);GO:0030674(protein-macromolecule adaptor activity);GO:0030838(positive regulation of actin filament polymerization);GO:0030971(receptor tyrosine kinase binding);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042102(positive regulation of T cell proliferation);GO:0042110(T cell activation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0051707(response to other organism);GO:0060548(negative regulation of cell death);GO:0070262(peptidyl-serine dephosphorylation);GO:0071074(eukaryotic initiation factor eIF2 binding);GO:1902237(positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway);GO:1903676(positive regulation of cap-dependent translational initiation);GO:1903679(positive regulation of cap-independent translational initiation);GO:1903898(negative regulation of PERK-mediated unfolded protein response);GO:1903912(negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation);GO:1990441(negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04012(ErbB signaling pathway);04660(T cell receptor signaling pathway);04360(Axon guidance)",0,2,"290,485,","0,2178",-341,"-Inf",3.64,"3' UTR",1,144046569,144125538,78970,2]
["chr1",144106073,144125538,19466,"ENSBGRG00000002412","ENSBGRT00000004487",0,"NCK1","NCK adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:7664]","GO:0000164(protein phosphatase type 1 complex);GO:0004860(protein kinase inhibitor activity);GO:0005070(SH3/SH2 adaptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005840(ribosome);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006930(substrate-dependent cell migration, cell extension);GO:0007015(actin filament organization);GO:0010976(positive regulation of neuron projection development);GO:0012506(vesicle membrane);GO:0016477(cell migration);GO:0019904(protein domain specific binding);GO:0030032(lamellipodium assembly);GO:0030334(regulation of cell migration);GO:0030674(protein-macromolecule adaptor activity);GO:0030838(positive regulation of actin filament polymerization);GO:0030971(receptor tyrosine kinase binding);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042102(positive regulation of T cell proliferation);GO:0042110(T cell activation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0051707(response to other organism);GO:0060548(negative regulation of cell death);GO:0070262(peptidyl-serine dephosphorylation);GO:0071074(eukaryotic initiation factor eIF2 binding);GO:1902237(positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway);GO:1903676(positive regulation of cap-dependent translational initiation);GO:1903679(positive regulation of cap-independent translational initiation);GO:1903898(negative regulation of PERK-mediated unfolded protein response);GO:1903912(negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation);GO:1990441(negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04012(ErbB signaling pathway);04660(T cell receptor signaling pathway);04360(Axon guidance)",{"v":1.3E-56,"d":"0.00"},3,"110,34,244,","0,12947,19222",{"v":-55.9,"d":"-55.90"},{"v":-54.6,"d":"-54.60"},4.34,"5' UTR",1,144046569,144125538,78970,2]
["chr1",144197094,144197536,443,"ENSBGRG00000002474","ENSBGRT00000004609",470,"SLC35G2","solute carrier family 35 member G2 [Source:HGNC Symbol;Acc:HGNC:28480]","GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":2.2e-05,"d":"0.00"},1,"443,",0,-4.65,-3.94,6.75,"Exon (ENSBGRT00000004609/ENSBGRG00000002474, exon 1 of 1)",1,144196771,144198006,1236,2]
["chr1",145030949,145031188,240,"ENSBGRG00000003035","ENSBGRT00000005672",3580,"ENSBGRG00000003035","NA","NA","NA",{"v":0.015,"d":"0.02"},1,"240,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000005672/ENSBGRG00000003035, exon 2 of 2)",1,145029635,145034768,5134,2]
["chr1",145034081,145034141,61,"ENSBGRG00000003035","ENSBGRT00000005672",627,"ENSBGRG00000003035","NA","NA","NA",{"v":0.0002,"d":"0.00"},1,"61,",0,{"v":-3.7,"d":"-3.70"},-3.03,9.18,"Exon (ENSBGRT00000005672/ENSBGRG00000003035, exon 1 of 2)",1,145029635,145034768,5134,2]
["chr1",146134819,146134879,61,"ENSBGRG00000003150","ENSBGRT00000005871",512123,"ENSBGRG00000003150","EPH receptor B1 [Source:HGNC Symbol;Acc:HGNC:3392]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0016021(integral component of membrane)","04360(Axon guidance)",{"v":0.0002,"d":"0.00"},1,"61,",0,-3.69,-3.02,{"v":4.5,"d":"4.50"},"3' UTR",1,146134490,146647002,512513,2]
["chr1",146135029,146135179,151,"ENSBGRG00000003150","ENSBGRT00000005871",511823,"ENSBGRG00000003150","EPH receptor B1 [Source:HGNC Symbol;Acc:HGNC:3392]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0016021(integral component of membrane)","04360(Axon guidance)",{"v":7.8e-08,"d":"0.00"},1,"151,",0,-7.11,-6.33,4.59,"3' UTR",1,146134490,146647002,512513,2]
["chr1",146135359,146135448,90,"ENSBGRG00000003150","ENSBGRT00000005871",511554,"ENSBGRG00000003150","EPH receptor B1 [Source:HGNC Symbol;Acc:HGNC:3392]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0016021(integral component of membrane)","04360(Axon guidance)",{"v":3.5e-08,"d":"0.00"},1,"90,",0,-7.46,-6.67,{"v":11.9,"d":"11.90"},"3' UTR",1,146134490,146647002,512513,2]
["chr1",146496522,146646822,150301,"ENSBGRG00000003150","ENSBGRT00000005871",180,"ENSBGRG00000003150","EPH receptor B1 [Source:HGNC Symbol;Acc:HGNC:3392]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0016021(integral component of membrane)","04360(Axon guidance)",{"v":6.9e-05,"d":"0.00"},2,"34,266,","0,150035",-4.16,-3.47,8.64,"5' UTR",1,146134490,146647002,512513,2]
["chr1",148053661,148055086,1426,"ENSBGRG00000004386","ENSBGRT00000008114",10774,"ENSBGRG00000004386","NA","NA","NA",{"v":7.9e-25,"d":"0.00"},2,"151,118,","0,1308",{"v":-24.1,"d":"-24.10"},-23,2.65,"Exon (ENSBGRT00000008114/ENSBGRG00000004386, exon 4 of 5)",1,148053661,148065860,12200,2]
["chr1",148065622,148065771,150,"ENSBGRG00000004386","ENSBGRT00000008114",89,"ENSBGRG00000004386","NA","NA","NA",{"v":5e-34,"d":"0.00"},1,"150,",0,{"v":-33.3,"d":"-33.30"},{"v":-32.2,"d":"-32.20"},3.78,"Exon (ENSBGRT00000008114/ENSBGRG00000004386, exon 1 of 5)",1,148053661,148065860,12200,2]
["chr1",151006871,151079064,72194,"ENSBGRG00000008332","ENSBGRT00000015164",0,"U6","U6 spliceosomal RNA [Source:RFAM;Acc:RF00026]","NA","NA",{"v":7.6e-05,"d":"0.00"},3,"292,97,58,","0,52727,72136",-4.12,-3.43,{"v":17.3,"d":"17.30"},"Exon (ENSBGRT00000015164/ENSBGRG00000008332, exon 1 of 1)",1,151028273,151028379,107,1]
["chr1",151337248,151337720,473,"ENSBGRG00000008500","ENSBGRT00000015560",168324,"ATP2C1","ATPase secretory pathway Ca2+ transporting 1 [Source:HGNC Symbol;Acc:HGNC:13211]","GO:0000139(Golgi membrane);GO:0000166(nucleotide binding);GO:0005388(calcium transmembrane transporter activity, phosphorylative mechanism);GO:0005524(ATP binding);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0006816(calcium ion transport);GO:0006874(cellular calcium ion homeostasis);GO:0008544(epidermis development);GO:0016021(integral component of membrane);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0031532(actin cytoskeleton reorganization);GO:0032468(Golgi calcium ion homeostasis);GO:0032472(Golgi calcium ion transport);GO:0070588(calcium ion transmembrane transport)","NA",{"v":1.3E-39,"d":"0.00"},2,"34,87,","0,386",{"v":-38.9,"d":"-38.90"},{"v":-37.7,"d":"-37.70"},1.66,"3' UTR",1,151312651,151506044,193394,2]
["chr1",151750633,151751443,811,"ENSBGRG00000009216","ENSBGRT00000018882",114135,"BRWD1","bromodomain and WD repeat domain containing 1 [Source:HGNC Symbol;Acc:HGNC:12760]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0043248(proteasome assembly)","NA",{"v":1e-131,"d":"0.00"},1,"811,",0,-131,-129,7.18,"Exon (ENSBGRT00000018882/ENSBGRG00000009216, exon 41 of 42)",1,151735566,151865578,130013,2]
["chr1",151751503,151751713,211,"ENSBGRG00000009216","ENSBGRT00000018882",113865,"BRWD1","bromodomain and WD repeat domain containing 1 [Source:HGNC Symbol;Acc:HGNC:12760]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0043248(proteasome assembly)","NA",{"v":2e-47,"d":"0.00"},1,"211,",0,{"v":-46.7,"d":"-46.70"},{"v":-45.4,"d":"-45.40"},5.42,"Exon (ENSBGRT00000018882/ENSBGRG00000009216, exon 41 of 42)",1,151735566,151865578,130013,2]
["chr1",151946427,151946724,298,"ENSBGRG00000011188","ENSBGRT00000020475",0,"ENSBGRG00000011188","NA","GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)","00310(Lysine degradation);05168(Herpes simplex infection)",{"v":0.0011,"d":"0.00"},1,"298,",0,-2.96,-2.33,13,"5' UTR",1,151916078,151946724,30647,2]
["chr1",151994913,151996170,1258,"ENSBGRG00000011685","ENSBGRT00000021279",32958,"LCA5L","lebercilin LCA5 like [Source:HGNC Symbol;Acc:HGNC:1255]","NA","NA",{"v":0.0078,"d":"0.01"},1,"1258,",0,-2.11,-1.53,7.56,"3' UTR",1,151994913,152029128,34216,2]
["chr1",151996260,151996470,211,"ENSBGRG00000011685","ENSBGRT00000021279",32658,"LCA5L","lebercilin LCA5 like [Source:HGNC Symbol;Acc:HGNC:1255]","NA","NA",{"v":4.3E-3,"d":"0.00"},1,"211,",0,-2.37,-1.77,8.64,"Exon (ENSBGRT00000021279/ENSBGRG00000011685, exon 9 of 9)",1,151994913,152029128,34216,2]
["chr1",154900454,154900514,61,"ENSBGRG00000014984","ENSBGRT00000028691",56867,"PRDM15","PR/SET domain 15 [Source:HGNC Symbol;Acc:HGNC:13999]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0043409(negative regulation of MAPK cascade);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1990841(promoter-specific chromatin binding);GO:2000035(regulation of stem cell division)","NA",{"v":0.005,"d":"0.01"},1,"61,",0,{"v":-2.3,"d":"-2.30"},-1.71,2.16,"3' UTR",1,154898543,154957381,58839,2]
["chr1",154933756,154938360,4605,"ENSBGRG00000014984","ENSBGRT00000028691",19021,"PRDM15","PR/SET domain 15 [Source:HGNC Symbol;Acc:HGNC:13999]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0043409(negative regulation of MAPK cascade);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1990841(promoter-specific chromatin binding);GO:2000035(regulation of stem cell division)","NA",0.02,5,"76,179,182,121,40,","0,187,1408,2968,4565",-1.69,-1.14,7.56,"Exon (ENSBGRT00000028691/ENSBGRG00000014984, exon 5 of 22)",1,154898543,154957381,58839,2]
["chr1",155098245,155098750,506,"ENSBGRG00000016033","ENSBGRT00000029461",3333,"ZBTB21","zinc finger and BTB domain containing 21 [Source:HGNC Symbol;Acc:HGNC:13083]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008327(methyl-CpG binding);GO:0031208(POZ domain binding)","NA",{"v":1e-21,"d":"0.00"},1,"506,",0,-21,-20,6.48,"Exon (ENSBGRT00000029461/ENSBGRG00000016033, exon 2 of 2)",1,155098245,155102083,3839,2]
["chr1",155101340,155101400,61,"ENSBGRG00000016033","ENSBGRT00000029461",683,"ZBTB21","zinc finger and BTB domain containing 21 [Source:HGNC Symbol;Acc:HGNC:13083]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008327(methyl-CpG binding);GO:0031208(POZ domain binding)","NA",{"v":4.3E-3,"d":"0.00"},1,"61,",0,-2.37,-1.77,6.48,"Exon (ENSBGRT00000029461/ENSBGRG00000016033, exon 1 of 2)",1,155098245,155102083,3839,2]
["chr1",155696969,155697858,890,"ENSBGRG00000018504","ENSBGRT00000034220",13917,"RSPH1","radial spoke head component 1 [Source:HGNC Symbol;Acc:HGNC:12371]","GO:0000794(condensed nuclear chromosome);GO:0001520(outer dense fiber);GO:0005737(cytoplasm);GO:0007286(spermatid development);GO:0031514(motile cilium);GO:0035082(axoneme assembly);GO:0036126(sperm flagellum);GO:0072687(meiotic spindle)","NA",{"v":0.026,"d":"0.03"},2,"73,17,","0,873",-1.58,-1.04,7.56,"3' UTR",1,155696969,155711775,14807,2]
["chr1",156565091,156565180,90,"ENSBGRG00000020700","ENSBGRT00000038146",9534,"ENSBGRG00000020700","NA","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007346(regulation of mitotic cell cycle);GO:0008140(cAMP response element binding protein binding);GO:0010830(regulation of myotube differentiation);GO:0010868(negative regulation of triglyceride biosynthetic process);GO:0019901(protein kinase binding);GO:0032792(negative regulation of CREB transcription factor activity);GO:0035556(intracellular signal transduction);GO:0042826(histone deacetylase binding);GO:0043153(entrainment of circadian clock by photoperiod);GO:0043276(anoikis);GO:0045595(regulation of cell differentiation);GO:0045721(negative regulation of gluconeogenesis);GO:0055007(cardiac muscle cell differentiation)","04922(Glucagon signaling pathway)",{"v":3.8e-10,"d":"0.00"},1,"90,",0,-9.42,-8.58,{"v":5.2,"d":"5.20"},"Exon (ENSBGRT00000038146/ENSBGRG00000020700, exon 13 of 13)",1,156565091,156574714,9624,2]
["chr1",157991075,157991375,301,"ENSBGRG00000000208","ENSBGRT00000000333",18266,"ITGB2","integrin subunit beta 2 [Source:HGNC Symbol;Acc:HGNC:6155]","GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007159(leukocyte cell-cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0019901(protein kinase binding);GO:0030369(ICAM-3 receptor activity);GO:0030593(neutrophil chemotaxis);GO:0031072(heat shock protein binding);GO:0032930(positive regulation of superoxide anion generation);GO:0034113(heterotypic cell-cell adhesion);GO:0034687(integrin alphaL-beta2 complex);GO:0035987(endodermal cell differentiation);GO:0038023(signaling receptor activity);GO:0043113(receptor clustering);GO:0043235(receptor complex);GO:0043315(positive regulation of neutrophil degranulation);GO:0044853(plasma membrane raft);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:0050839(cell adhesion molecule binding);GO:0099568(cytoplasmic region);GO:1990266(neutrophil migration)","04015(Rap1 signaling pathway);04390(Hippo signaling pathway);04514(Cell adhesion molecules (CAMs));04145(Phagosome);04810(Regulation of actin cytoskeleton);04610(Complement and coagulation cascades);04650(Natural killer cell mediated cytotoxicity);04670(Leukocyte transendothelial migration);05323(Rheumatoid arthritis);05416(Viral myocarditis);05133(Pertussis);05134(Legionellosis);05150(Staphylococcus aureus infection);05152(Tuberculosis);05166(HTLV-I infection);05146(Amoebiasis);05144(Malaria);05140(Leishmaniasis)",{"v":1.3e-55,"d":"0.00"},1,"301,",0,{"v":-54.9,"d":"-54.90"},{"v":-53.6,"d":"-53.60"},4.52,"3' UTR",1,157991075,158009641,18567,2]
["chr1",158363670,158363937,268,"ENSBGRG00000000326","ENSBGRT00000000568",15550,"POFUT2","protein O-fucosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:14683]","GO:0001707(mesoderm formation);GO:0005794(Golgi apparatus);GO:0008417(fucosyltransferase activity);GO:0010468(regulation of gene expression);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0036065(fucosylation);GO:0036066(protein O-linked fucosylation);GO:0046922(peptide-O-fucosyltransferase activity);GO:0051046(regulation of secretion);GO:1903334(positive regulation of protein folding)","00514(Other types of O-glycan biosynthesis)",{"v":9.8e-06,"d":"0.00"},1,"268,",0,-5.01,-4.29,{"v":20.5,"d":"20.50"},"3' UTR",1,158363670,158379487,15818,2]
["chr1",158364531,158365445,915,"ENSBGRG00000000326","ENSBGRT00000000568",14042,"POFUT2","protein O-fucosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:14683]","GO:0001707(mesoderm formation);GO:0005794(Golgi apparatus);GO:0008417(fucosyltransferase activity);GO:0010468(regulation of gene expression);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0036065(fucosylation);GO:0036066(protein O-linked fucosylation);GO:0046922(peptide-O-fucosyltransferase activity);GO:0051046(regulation of secretion);GO:1903334(positive regulation of protein folding)","00514(Other types of O-glycan biosynthesis)",{"v":1e-185,"d":"0.00"},2,"201,67,","0,848",-185,-183,3.41,"3' UTR",1,158363670,158379487,15818,2]
["chr1",158541691,158541751,61,"ENSBGRG00000000371","ENSBGRT00000000602",2732,"ENSBGRG00000000371","NA","NA","NA",{"v":0.043,"d":"0.04"},1,"61,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000000602/ENSBGRG00000000371, exon 2 of 2)",1,158539605,158544483,4879,2]
["chr1",158627074,158627254,181,"ENSBGRG00000000631","ENSBGRT00000001126",8152,"SLC19A1","solute carrier family 19 member 1 [Source:HGNC Symbol;Acc:HGNC:10937]","GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0008517(folic acid transmembrane transporter activity);GO:0008518(folate:anion antiporter activity);GO:0015350(methotrexate transmembrane transporter activity);GO:0015884(folic acid transport);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0051180(vitamin transport);GO:0051958(methotrexate transport);GO:0061507(cyclic-GMP-AMP binding);GO:0090482(vitamin transmembrane transporter activity);GO:0098838(folate transmembrane transport);GO:0140360(cyclic-GMP-AMP transmembrane transporter activity);GO:0140361(cyclic-GMP-AMP transmembrane import across plasma membrane);GO:1904447(folate import across plasma membrane)","04977(Vitamin digestion and absorption);01523(Antifolate resistance)",{"v":1.9E-6,"d":"0.00"},1,"181,",0,-5.72,-4.97,4.22,"Exon (ENSBGRT00000001126/ENSBGRG00000000631, exon 3 of 6)",1,158607612,158635406,27795,2]
["chr1",159385106,159385554,449,"ENSBGRG00000001560","ENSBGRT00000002896",299,"MCM3AP","minichromosome maintenance complex component 3 associated protein [Source:HGNC Symbol;Acc:HGNC:6946]","GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0010484(H3 histone acetyltransferase activity);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0031965(nuclear membrane);GO:0034728(nucleosome organization);GO:0042393(histone binding);GO:0044615(nuclear pore nuclear basket);GO:0070390(transcription export complex 2)","NA",{"v":6.3e-49,"d":"0.00"},1,"449,",0,{"v":-48.2,"d":"-48.20"},{"v":-46.9,"d":"-46.90"},4.18,"Exon (ENSBGRT00000002896/ENSBGRG00000001560, exon 1 of 28)",1,159342672,159385853,43182,2]
["chr1",159725058,159728323,3266,"ENSBGRG00000002365","ENSBGRT00000004417",0,"S100B","S100 calcium binding protein B [Source:HGNC Symbol;Acc:HGNC:10500]","GO:0001726(ruffle);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007611(learning or memory);GO:0007613(memory);GO:0008270(zinc ion binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043025(neuronal cell body);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043231(intracellular membrane-bounded organelle);GO:0044548(S100 protein binding);GO:0046872(metal ion binding);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048306(calcium-dependent protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0050786(RAGE receptor binding)","NA",{"v":7.9e-73,"d":"0.00"},2,"319,138,","0,3128",{"v":-72.1,"d":"-72.10"},{"v":-70.6,"d":"-70.60"},2.32,"3' UTR",1,159725058,159728323,3266,2]
["chr1",160051558,160051618,61,"ENSBGRG00000002585","ENSBGRT00000004839",54295,"ENSBGRG00000002585","NA","GO:0007283(spermatogenesis)","NA",{"v":4e-15,"d":"0.00"},1,"61,",0,{"v":-14.4,"d":"-14.40"},{"v":-13.5,"d":"-13.50"},4.21,"Exon (ENSBGRT00000004839/ENSBGRG00000002585, exon 2 of 3)",1,160047695,160105913,58219,2]
["chr1",160455349,160455439,91,"ENSBGRG00000002635","ENSBGRT00000004955",304378,"RUNX1","RUNX family transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:10471]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0030097(hemopoiesis);GO:0030854(positive regulation of granulocyte differentiation);GO:0032743(positive regulation of interleukin-2 production);GO:0043231(intracellular membrane-bounded organelle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","04530(Tight junction);04659(Th17 cell differentiation);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia)",{"v":1.7E-8,"d":"0.00"},1,"91,",0,-7.76,-6.97,7.56,"Exon (ENSBGRT00000004955/ENSBGRG00000002635, exon 9 of 9)",1,160455349,160759817,304469,2]
["chr1",160455498,160455588,91,"ENSBGRG00000002635","ENSBGRT00000004955",304229,"RUNX1","RUNX family transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:10471]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0030097(hemopoiesis);GO:0030854(positive regulation of granulocyte differentiation);GO:0032743(positive regulation of interleukin-2 production);GO:0043231(intracellular membrane-bounded organelle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","04530(Tight junction);04659(Th17 cell differentiation);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia)",{"v":3e-07,"d":"0.00"},1,"91,",0,-6.53,-5.76,2.68,"Exon (ENSBGRT00000004955/ENSBGRG00000002635, exon 9 of 9)",1,160455349,160759817,304469,2]
["chr1",162749310,162751327,2018,"ENSBGRG00000003161","ENSBGRT00000005882",218424,"HLCS","holocarboxylase synthetase [Source:HGNC Symbol;Acc:HGNC:4976]","GO:0004077(biotin-[acetyl-CoA-carboxylase] ligase activity);GO:0006464(cellular protein modification process)","00780(Biotin metabolism)",{"v":1.9e-09,"d":"0.00"},2,"111,70,","0,1948",-8.72,{"v":-7.9,"d":"-7.90"},2.76,"Exon (ENSBGRT00000005882/ENSBGRG00000003161, exon 9 of 10)",1,162747427,162969751,222325,2]
["chr1",163074841,163075819,979,"ENSBGRG00000003202","ENSBGRT00000005950",12468,"ENSBGRG00000003202","NA","GO:0006506(GPI anchor biosynthetic process);GO:0017176(phosphatidylinositol N-acetylglucosaminyltransferase activity)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":7.9e-09,"d":"0.00"},3,"18,110,23,","0,21,956",{"v":-8.1,"d":"-8.10"},-7.29,1.92,"Exon (ENSBGRT00000005950/ENSBGRG00000003202, exon 3 of 5)",1,163074841,163088287,13447,2]
["chr1",163768776,163769015,240,"ENSBGRG00000003372","ENSBGRT00000006281",210758,"KCNJ6","potassium inwardly rectifying channel subfamily J member 6 [Source:HGNC Symbol;Acc:HGNC:6267]","GO:0005242(inward rectifier potassium channel activity);GO:0006813(potassium ion transport);GO:0015467(G-protein activated inward rectifier potassium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","04915(Estrogen signaling pathway);04921(Oxytocin signaling pathway);04727(GABAergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);04713(Circadian entrainment);05032(Morphine addiction)",{"v":0.028,"d":"0.03"},1,"240,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000006281/ENSBGRG00000003372, exon 3 of 4)",1,163665524,163979773,314250,2]
["chr1",164665905,164665994,90,"ENSBGRG00000003442","ENSBGRT00000006832",87465,"ERG","ETS transcription factor ERG [Source:HGNC Symbol;Acc:HGNC:3446]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0006355(regulation of transcription, DNA-templated);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990904(ribonucleoprotein complex)","05202(Transcriptional misregulation in cancers);05215(Prostate cancer)",{"v":7.6e-05,"d":"0.00"},1,"90,",0,-4.12,-3.43,{"v":17.3,"d":"17.30"},"3' UTR",1,164665696,164753459,87764,2]
["chr1",164666620,164666710,91,"ENSBGRG00000003442","ENSBGRT00000006832",86749,"ERG","ETS transcription factor ERG [Source:HGNC Symbol;Acc:HGNC:3446]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0006355(regulation of transcription, DNA-templated);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990904(ribonucleoprotein complex)","05202(Transcriptional misregulation in cancers);05215(Prostate cancer)",{"v":7.6e-05,"d":"0.00"},1,"91,",0,-4.12,-3.43,{"v":17.3,"d":"17.30"},"3' UTR",1,164665696,164753459,87764,2]
["chr1",164667157,164668260,1104,"ENSBGRG00000003442","ENSBGRT00000006832",85199,"ERG","ETS transcription factor ERG [Source:HGNC Symbol;Acc:HGNC:3446]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0006355(regulation of transcription, DNA-templated);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990904(ribonucleoprotein complex)","05202(Transcriptional misregulation in cancers);05215(Prostate cancer)",{"v":1e-227,"d":"0.00"},1,"1104,",0,-227,-225,{"v":18.2,"d":"18.20"},"3' UTR",1,164665696,164753459,87764,2]
["chr1",165702980,165713204,10225,"ENSBGRG00000003893","ENSBGRT00000007197",115772,"COL6A6","collagen type VI alpha 6 chain [Source:HGNC Symbol;Acc:HGNC:27023]","GO:0031012(extracellular matrix)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":9.5E-4,"d":"0.00"},2,"220,20,","0,10205",-3.02,-2.38,9.72,"Exon (ENSBGRT00000007197/ENSBGRG00000003893, exon 35 of 36)",1,165702980,165828976,125997,2]
["chr1",165778577,165779860,1284,"ENSBGRG00000003893","ENSBGRT00000007197",49116,"COL6A6","collagen type VI alpha 6 chain [Source:HGNC Symbol;Acc:HGNC:27023]","GO:0031012(extracellular matrix)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":0.0045,"d":"0.00"},2,"39,22,","0,1262",-2.35,-1.76,2.97,"Exon (ENSBGRT00000007197/ENSBGRG00000003893, exon 18 of 36)",1,165702980,165828976,125997,2]
["chr1",165813785,165813994,210,"ENSBGRG00000003893","ENSBGRT00000007197",14982,"COL6A6","collagen type VI alpha 6 chain [Source:HGNC Symbol;Acc:HGNC:27023]","GO:0031012(extracellular matrix)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":0.0078,"d":"0.01"},1,"210,",0,-2.11,-1.53,9.72,"Exon (ENSBGRT00000007197/ENSBGRG00000003893, exon 7 of 36)",1,165702980,165828976,125997,2]
["chr1",165822705,165824099,1395,"ENSBGRG00000003893","ENSBGRT00000007197",4877,"COL6A6","collagen type VI alpha 6 chain [Source:HGNC Symbol;Acc:HGNC:27023]","GO:0031012(extracellular matrix)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":2.9E-4,"d":"0.00"},2,"278,22,","0,1373",-3.54,-2.87,{"v":15.1,"d":"15.10"},"Exon (ENSBGRT00000007197/ENSBGRG00000003893, exon 3 of 36)",1,165702980,165828976,125997,2]
["chr1",165824338,165824458,121,"ENSBGRG00000003893","ENSBGRT00000007197",4518,"COL6A6","collagen type VI alpha 6 chain [Source:HGNC Symbol;Acc:HGNC:27023]","GO:0031012(extracellular matrix)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":4.3E-3,"d":"0.00"},1,"121,",0,-2.37,-1.77,6.48,"Exon (ENSBGRT00000007197/ENSBGRG00000003893, exon 3 of 36)",1,165702980,165828976,125997,2]
["chr1",165979449,165979808,360,"ENSBGRG00000003956","ENSBGRT00000007296",75269,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":2.5e-30,"d":"0.00"},1,"360,",0,{"v":-29.6,"d":"-29.60"},{"v":-28.5,"d":"-28.50"},4.72,"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 35 of 41)",1,165937093,166055077,117985,2]
["chr1",166008353,166023207,14855,"ENSBGRG00000003956","ENSBGRT00000007296",31870,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":5e-25,"d":"0.00"},11,"45,36,54,66,63,54,45,27,72,54,25,","0,507,5180,5659,6358,8584,8727,8855,9200,11373,14830",{"v":-24.3,"d":"-24.30"},{"v":-23.3,"d":"-23.30"},4.39,"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 11 of 41)",1,165937093,166055077,117985,2]
["chr1",166041811,166041991,181,"ENSBGRG00000003956","ENSBGRT00000007296",13086,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":5e-16,"d":"0.00"},1,"181,",0,{"v":-15.3,"d":"-15.30"},{"v":-14.4,"d":"-14.40"},6.28,"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 4 of 41)",1,165937093,166055077,117985,2]
["chr1",166048395,166048455,61,"ENSBGRG00000003956","ENSBGRT00000007296",6622,"COL6A5","collagen type VI alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:26674]","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":2.2e-05,"d":"0.00"},1,"61,",0,-4.65,-3.94,6.75,"Exon (ENSBGRT00000007296/ENSBGRG00000003956, exon 3 of 41)",1,165937093,166055077,117985,2]
["chr1",166482481,166482689,209,"ENSBGRG00000004132","ENSBGRT00000007669",55585,"SH3BP5","SH3 domain binding protein 5 [Source:HGNC Symbol;Acc:HGNC:10827]","GO:0004860(protein kinase inhibitor activity);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0030659(cytoplasmic vesicle membrane);GO:0035556(intracellular signal transduction)","NA",{"v":1E-62,"d":"0.00"},1,"209,",0,-62,{"v":-60.6,"d":"-60.60"},6.99,"3' UTR",1,166482451,166538274,55824,2]
["chr1",166538099,166538188,90,"ENSBGRG00000004132","ENSBGRT00000007669",86,"SH3BP5","SH3 domain binding protein 5 [Source:HGNC Symbol;Acc:HGNC:10827]","GO:0004860(protein kinase inhibitor activity);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0030659(cytoplasmic vesicle membrane);GO:0035556(intracellular signal transduction)","NA",{"v":1.3E-24,"d":"0.00"},1,"90,",0,{"v":-23.9,"d":"-23.90"},{"v":-22.9,"d":"-22.90"},2.24,"Exon (ENSBGRT00000007669/ENSBGRG00000004132, exon 1 of 7)",1,166482451,166538274,55824,2]
["chr1",166676104,166676340,237,"ENSBGRG00000004234","ENSBGRT00000007937",0,"METTL6","methyltransferase like 6 [Source:HGNC Symbol;Acc:HGNC:28343]","GO:0019899(enzyme binding);GO:0030488(tRNA methylation);GO:0052735(tRNA (cytosine-3-)-methyltransferase activity)","NA",{"v":2.5E-88,"d":"0.00"},1,"237,",0,{"v":-87.6,"d":"-87.60"},-86,3.65,"5' UTR",1,166654474,166676184,21711,2]
["chr1",166709411,166712228,2818,"ENSBGRG00000004392","ENSBGRT00000008338",42201,"COLQ","collagen like tail subunit of asymmetric acetylcholinesterase [Source:HGNC Symbol;Acc:HGNC:2226]","GO:0005886(plasma membrane);GO:0008582(regulation of synaptic growth at neuromuscular junction);GO:0030054(cell junction);GO:0031594(neuromuscular junction);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090150(establishment of protein localization to membrane)","04146(Peroxisome)",{"v":2e-22,"d":"0.00"},2,"327,3,","0,2815",{"v":-21.7,"d":"-21.70"},{"v":-20.7,"d":"-20.70"},8.21,"3' UTR",1,166708334,166754429,46096,2]
["chr1",166951121,166959008,7888,"ENSBGRG00000005474","ENSBGRT00000010449",125436,"ANKRD28","ankyrin repeat domain 28 [Source:HGNC Symbol;Acc:HGNC:29024]","GO:0005515(protein binding)","NA",{"v":1E-190,"d":"0.00"},2,"662,57,","0,7831",-190,-188,4.57,"3' UTR",1,166951121,167084444,133324,2]
["chr1",167573487,167574021,535,"ENSBGRG00000005826","ENSBGRT00000010754",3913,"DPH3","diphthamide biosynthesis 3 [Source:HGNC Symbol;Acc:HGNC:27717]","NA","NA",{"v":1e-192,"d":"0.00"},1,"535,",0,-192,-190,6.52,"3' UTR",1,167573309,167577934,4626,2]
["chr1",167658837,167669540,10704,"ENSBGRG00000005969","ENSBGRT00000011001",231195,"ENSBGRG00000005969","raftlin, lipid raft linker 1 [Source:HGNC Symbol;Acc:HGNC:30278]","NA","NA",{"v":4e-34,"d":"0.00"},3,"137,82,22,","0,9659,10682",{"v":-33.4,"d":"-33.40"},{"v":-32.3,"d":"-32.30"},2.81,"Exon (ENSBGRT00000011001/ENSBGRG00000005969, exon 7 of 9)",1,167657699,167900735,243037,2]
["chr1",168220555,168227147,6593,"ENSBGRG00000000188","ENSBGRT00000000303",1739,"ENSBGRG00000000188","NA","NA","NA",{"v":5e-28,"d":"0.00"},2,"416,34,","0,6559",{"v":-27.3,"d":"-27.30"},{"v":-26.3,"d":"-26.30"},3.57,"Exon (ENSBGRT00000000304/ENSBGRG00000000188, exon 3 of 3)",1,168207158,168228886,21729,2]
["chr1",168227953,168228013,61,"ENSBGRG00000000188","ENSBGRT00000000303",873,"ENSBGRG00000000188","NA","NA","NA",{"v":0.045,"d":"0.05"},1,"61,",0,-1.35,{"v":-0.833,"d":"-0.83"},1.71,"Exon (ENSBGRT00000000307/ENSBGRG00000000188, exon 2 of 2)",1,168207158,168228886,21729,2]
["chr1",168228252,168228521,270,"ENSBGRG00000000188","ENSBGRT00000000303",365,"ENSBGRG00000000188","NA","NA","NA",{"v":1.3E-6,"d":"0.00"},1,"270,",0,{"v":-5.9,"d":"-5.90"},-5.15,{"v":23.8,"d":"23.80"},"Exon (ENSBGRT00000000307/ENSBGRG00000000188, exon 2 of 2)",1,168207158,168228886,21729,2]
["chr1",168228880,168244171,15292,"ENSBGRG00000000188","ENSBGRT00000000303",0,"ENSBGRG00000000188","NA","NA","NA",{"v":0.025,"d":"0.03"},2,"7,53,","0,15239",-1.61,-1.07,4.86,"Exon (ENSBGRT00000000303/ENSBGRG00000000188, exon 1 of 2)",1,168207158,168228886,21729,2]
["chr1",168245550,168245909,360,"ENSBGRG00000000188","ENSBGRT00000000304",0,"ENSBGRG00000000188","NA","NA","NA",{"v":0.015,"d":"0.02"},1,"360,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000000304/ENSBGRG00000000188, exon 1 of 3)",1,168218103,168245909,27807,2]
["chr1",168545693,168546569,877,"ENSBGRG00000000433","ENSBGRT00000003068",313198,"TBC1D5","TBC1 domain family member 5 [Source:HGNC Symbol;Acc:HGNC:19166]","GO:0002092(positive regulation of receptor internalization);GO:0005776(autophagosome);GO:0005794(Golgi apparatus);GO:0006914(autophagy);GO:0010008(endosome membrane);GO:0016236(macroautophagy);GO:0030122(AP-2 adaptor complex);GO:0030904(retromer complex);GO:0035612(AP-2 adaptor complex binding);GO:0042147(retrograde transport, endosome to Golgi);GO:0042594(response to starvation);GO:0043231(intracellular membrane-bounded organelle);GO:0044877(protein-containing complex binding);GO:1905394(retromer complex binding);GO:1990316(Atg1/ULK1 kinase complex)","NA",{"v":5.5e-06,"d":"0.00"},2,"12,49,","0,828",-5.26,-4.53,2,"Exon (ENSBGRT00000003068/ENSBGRG00000000433, exon 17 of 19)",1,168544388,168859767,315380,2]
["chr1",172033815,172033874,60,"ENSBGRG00000001807","ENSBGRT00000003363",18415,"ENSBGRG00000001807","NA","NA","NA",{"v":0.003,"d":"0.00"},1,"60,",0,-2.53,-1.93,1.99,"Exon (ENSBGRT00000003363/ENSBGRG00000001807, exon 4 of 7)",1,172032010,172052289,20280,2]
["chr1",172049476,172049775,300,"ENSBGRG00000001807","ENSBGRT00000003363",2514,"ENSBGRG00000001807","NA","NA","NA",{"v":1.1e-07,"d":"0.00"},1,"300,",0,-6.94,-6.17,{"v":13.5,"d":"13.50"},"Exon (ENSBGRT00000003363/ENSBGRG00000001807, exon 2 of 7)",1,172032010,172052289,20280,2]
["chr1",172050013,172050073,61,"ENSBGRG00000001807","ENSBGRT00000003363",2216,"ENSBGRG00000001807","NA","NA","NA",{"v":5.8E-4,"d":"0.00"},1,"61,",0,-3.24,-2.59,4.32,"Exon (ENSBGRT00000003363/ENSBGRG00000001807, exon 2 of 7)",1,172032010,172052289,20280,2]
["chr1",172232983,172233309,327,"ENSBGRG00000001982","ENSBGRT00000003698",8624,"SGO1","shugoshin 1 [Source:HGNC Symbol;Acc:HGNC:25088]","GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000779(condensed chromosome, centromeric region);GO:0000922(spindle pole);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0007059(chromosome segregation);GO:0008608(attachment of spindle microtubules to kinetochore);GO:0010457(centriole-centriole cohesion);GO:0016604(nuclear body);GO:0019900(kinase binding);GO:0045132(meiotic chromosome segregation);GO:0071962(mitotic sister chromatid cohesion, centromeric)","04114(Oocyte meiosis)",{"v":1.6E-15,"d":"0.00"},1,"327,",0,{"v":-14.8,"d":"-14.80"},{"v":-13.8,"d":"-13.80"},5.02,"Exon (ENSBGRT00000003698/ENSBGRG00000001982, exon 6 of 8)",1,172223733,172241933,18201,2]
["chr1",172325928,172326344,417,"ENSBGRG00000002023","ENSBGRT00000003804",3357,"ZNF596","zinc finger protein 596 [Source:HGNC Symbol;Acc:HGNC:27268]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1e-65,"d":"0.00"},1,"417,",0,-65,{"v":-63.6,"d":"-63.60"},3.03,"3' UTR",1,172325928,172329701,3774,2]
["chr1",172326998,172327266,269,"ENSBGRG00000002023","ENSBGRT00000003804",2435,"ZNF596","zinc finger protein 596 [Source:HGNC Symbol;Acc:HGNC:27268]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":3.2e-48,"d":"0.00"},1,"269,",0,{"v":-47.5,"d":"-47.50"},{"v":-46.2,"d":"-46.20"},4.54,"Exon (ENSBGRT00000003804/ENSBGRG00000002023, exon 3 of 4)",1,172325928,172329701,3774,2]
["chr2",100220,100591,372,"ENSBGRG00000002080","ENSBGRT00000004033",4248,"ENSBGRG00000002080","NA","GO:0005247(voltage-gated chloride channel activity);GO:0006821(chloride transport);GO:0016020(membrane);GO:0055085(transmembrane transport)","04966(Collecting duct acid secretion)",{"v":0.0013,"d":"0.00"},2,"17,73,","0,299",-2.89,-2.26,7.56,"Exon (ENSBGRT00000004033/ENSBGRG00000002080, exon 5 of 18)",2,95972,109372,13401,1]
["chr2",541989,542197,209,"ENSBGRG00000002425","ENSBGRT00000004516",13422,"NECAP2","NECAP endocytosis associated 2 [Source:HGNC Symbol;Acc:HGNC:25528]","GO:0006897(endocytosis);GO:0016020(membrane);GO:0030125(clathrin vesicle coat)","NA",{"v":1e-131,"d":"0.00"},1,"209,",0,-131,-129,2.56,"Exon (ENSBGRT00000004516/ENSBGRG00000002425, exon 7 of 7)",2,528567,542197,13631,1]
["chr2",579238,579695,458,"ENSBGRG00000002459","ENSBGRT00000004709",21912,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":2.5e-23,"d":"0.00"},2,"193,77,","0,381",{"v":-22.6,"d":"-22.60"},{"v":-21.6,"d":"-21.60"},3.24,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 19 of 38)",2,557326,608335,51010,1]
["chr2",586249,587011,763,"ENSBGRG00000002459","ENSBGRT00000004709",28923,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":1.3E-22,"d":"0.00"},2,"112,158,","0,605",{"v":-21.9,"d":"-21.90"},{"v":-20.9,"d":"-20.90"},2.88,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 25 of 38)",2,557326,608335,51010,1]
["chr2",599785,602969,3185,"ENSBGRG00000002459","ENSBGRT00000004709",42459,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":2E-66,"d":"0.00"},3,"111,216,3,","0,2058,3182",{"v":-65.7,"d":"-65.70"},{"v":-64.3,"d":"-64.30"},3.54,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 31 of 38)",2,557326,608335,51010,1]
["chr2",604569,608305,3737,"ENSBGRG00000002459","ENSBGRT00000004709",47243,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0097729(9+2 motile cilium);GO:0120219(subapical part of cell);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":1.3E-24,"d":"0.00"},3,"18,165,57,","0,2847,3680",{"v":-23.9,"d":"-23.90"},{"v":-22.9,"d":"-22.90"},2.38,"Exon (ENSBGRT00000004709/ENSBGRG00000002459, exon 36 of 38)",2,557326,608335,51010,1]
["chr2",1253455,1255234,1780,"ENSBGRG00000003200","ENSBGRT00000005955",91385,"ARHGEF10L","Rho guanine nucleotide exchange factor 10 like [Source:HGNC Symbol;Acc:HGNC:25540]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0032933(SREBP signaling pathway);GO:0051496(positive regulation of stress fiber assembly)","NA",{"v":0.0062,"d":"0.01"},2,"36,54,","0,1726",-2.21,-1.62,1.64,"Exon (ENSBGRT00000005955/ENSBGRG00000003200, exon 5 of 28)",2,1162070,1361440,199371,1]
["chr2",1361021,1361171,151,"ENSBGRG00000003200","ENSBGRT00000005955",198951,"ARHGEF10L","Rho guanine nucleotide exchange factor 10 like [Source:HGNC Symbol;Acc:HGNC:25540]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0032933(SREBP signaling pathway);GO:0051496(positive regulation of stress fiber assembly)","NA",{"v":4e-18,"d":"0.00"},1,"151,",0,{"v":-17.4,"d":"-17.40"},{"v":-16.5,"d":"-16.50"},2.25,"3' UTR",2,1162070,1361440,199371,1]
["chr2",1361261,1361410,150,"ENSBGRG00000003200","ENSBGRT00000005955",199191,"ARHGEF10L","Rho guanine nucleotide exchange factor 10 like [Source:HGNC Symbol;Acc:HGNC:25540]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0032933(SREBP signaling pathway);GO:0051496(positive regulation of stress fiber assembly)","NA",{"v":7.9e-25,"d":"0.00"},1,"150,",0,{"v":-24.1,"d":"-24.10"},{"v":-23.1,"d":"-23.10"},2.51,"3' UTR",2,1162070,1361440,199371,1]
["chr2",1518632,1521777,3146,"ENSBGRG00000003302","ENSBGRT00000006148",88399,"ACTL8","actin like 8 [Source:HGNC Symbol;Acc:HGNC:24018]","GO:0030855(epithelial cell differentiation)","NA",{"v":0.015,"d":"0.02"},2,"39,826,","0,2320",-1.83,-1.02,8.64,"3' UTR",2,1430233,1522224,91992,1]
["chr2",2288304,2288839,536,"ENSBGRG00000003326","ENSBGRT00000006207",0,"KLHDC7A","kelch domain containing 7A [Source:HGNC Symbol;Acc:HGNC:26791]","GO:0005515(protein binding)","NA",{"v":0.015,"d":"0.02"},1,"536,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000006207/ENSBGRG00000003326, exon 1 of 4)",2,2288304,2291102,2799,1]
["chr2",3206303,3206718,416,"ENSBGRG00000004243","ENSBGRT00000007876",4947,"MRTO4","MRT4 homolog, ribosome maturation factor [Source:HGNC Symbol;Acc:HGNC:18477]","GO:0000027(ribosomal large subunit assembly);GO:0042254(ribosome biogenesis)","NA",{"v":1e-188,"d":"0.00"},2,"5,293,","0,123",-188,-186,4.85,"3' UTR",2,3201356,3207104,5749,1]
["chr2",3206837,3207074,238,"ENSBGRG00000004243","ENSBGRT00000007876",5481,"MRTO4","MRT4 homolog, ribosome maturation factor [Source:HGNC Symbol;Acc:HGNC:18477]","GO:0000027(ribosomal large subunit assembly);GO:0042254(ribosome biogenesis)","NA",{"v":1e-105,"d":"0.00"},1,"238,",0,-105,-103,3.18,"3' UTR",2,3201356,3207104,5749,1]
["chr2",3620095,3620243,149,"ENSBGRG00000004678","ENSBGRT00000008632",1271,"ENSBGRG00000004678","NA","NA","NA",{"v":0.0078,"d":"0.01"},1,"149,",0,-2.11,-1.53,5.94,"Exon (ENSBGRT00000008632/ENSBGRG00000004678, exon 1 of 1)",2,3618824,3620716,1893,1]
["chr2",3632329,3632448,120,"ENSBGRG00000004686","ENSBGRT00000008650",1727,"NBL1","NBL1, DAN family BMP antagonist [Source:HGNC Symbol;Acc:HGNC:7650]","GO:0005615(extracellular space);GO:0007399(nervous system development);GO:0016015(morphogen activity);GO:0030514(negative regulation of BMP signaling pathway);GO:0035582(sequestering of BMP in extracellular matrix);GO:0036122(BMP binding);GO:0038098(sequestering of BMP from receptor via BMP binding);GO:0042802(identical protein binding);GO:0045666(positive regulation of neuron differentiation);GO:0048263(determination of dorsal identity);GO:0048812(neuron projection morphogenesis);GO:0090027(negative regulation of monocyte chemotaxis)","04350(TGF-beta signaling pathway)",0,1,"120,",0,-404,"-Inf",4.67,"Exon (ENSBGRT00000008650/ENSBGRG00000004686, exon 3 of 3)",2,3630602,3632537,1936,1]
["chr2",3913332,3913451,120,"ENSBGRG00000004823","ENSBGRT00000008922",31713,"OTUD3","OTU deubiquitinase 3 [Source:HGNC Symbol;Acc:HGNC:29038]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005737(cytoplasm);GO:0035871(protein K11-linked deubiquitination);GO:0044313(protein K6-linked deubiquitination);GO:0050821(protein stabilization);GO:0051898(negative regulation of protein kinase B signaling);GO:0071108(protein K48-linked deubiquitination);GO:1990167(protein K27-linked deubiquitination)","NA",{"v":1.6E-13,"d":"0.00"},1,"120,",0,{"v":-12.8,"d":"-12.80"},{"v":-11.9,"d":"-11.90"},2.37,"Exon (ENSBGRT00000008922/ENSBGRG00000004823, exon 8 of 8)",2,3881619,3914488,32870,1]
["chr2",4260352,4260530,179,"ENSBGRG00000005193","ENSBGRT00000009568",0,"UBXN10","UBX domain protein 10 [Source:HGNC Symbol;Acc:HGNC:26354]","GO:0005515(protein binding);GO:0005929(cilium);GO:0030992(intraciliary transport particle B);GO:0060271(cilium assembly)","NA",{"v":0.025,"d":"0.03"},1,"179,",0,-1.61,-1.07,4.86,"5' UTR",2,4260352,4265594,5243,1]
["chr2",4265209,4265268,60,"ENSBGRG00000005193","ENSBGRT00000009568",4857,"UBXN10","UBX domain protein 10 [Source:HGNC Symbol;Acc:HGNC:26354]","GO:0005515(protein binding);GO:0005929(cilium);GO:0030992(intraciliary transport particle B);GO:0060271(cilium assembly)","NA",{"v":0.025,"d":"0.03"},1,"60,",0,-1.61,-1.07,4.86,"3' UTR",2,4260352,4265594,5243,1]
["chr2",4664561,4665268,708,"ENSBGRG00000005472","ENSBGRT00000010075",531,"ENSBGRG00000005472","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.0021,"d":"0.00"},1,"708,",0,-2.67,-2.06,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000010075/ENSBGRG00000005472, exon 1 of 1)",2,4664030,4665268,1239,1]
["chr2",4702572,4703952,1381,"ENSBGRG00000005484","ENSBGRT00000010098",0,"ENSBGRG00000005484","NA","NA","03008(Ribosome biogenesis in eukaryotes)",{"v":0.028,"d":"0.03"},2,"530,361,","0,1020",-1.56,{"v":-0.937,"d":"-0.94"},7.56,"3' UTR",2,4700968,4703677,2710,2]
["chr2",4704338,4704902,565,"ENSBGRG00000005498","ENSBGRT00000010126",1944,"FAM43B","family with sequence similarity 43 member B [Source:HGNC Symbol;Acc:HGNC:31791]","GO:0005515(protein binding)","03008(Ribosome biogenesis in eukaryotes)",{"v":1.3E-15,"d":"0.00"},1,"565,",0,{"v":-14.9,"d":"-14.90"},-14,4.15,"3' UTR",2,4702394,4704961,2568,1]
["chr2",4767750,4768139,390,"ENSBGRG00000000172","ENSBGRT00000000277",23040,"ENSBGRG00000000172","NA","GO:0003824(catalytic activity);GO:0004126(cytidine deaminase activity);GO:0008270(zinc ion binding);GO:0009972(cytidine deamination);GO:0016787(hydrolase activity)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)",{"v":1.8E-10,"d":"0.00"},1,"390,",0,-9.74,{"v":-8.9,"d":"-8.90"},5.11,"3' UTR",2,4744710,4768797,24088,1]
["chr2",4808808,4809167,360,"ENSBGRG00000000185","ENSBGRT00000000301",23645,"PINK1","PTEN induced kinase 1 [Source:HGNC Symbol;Acc:HGNC:14581]","GO:0000287(magnesium ion binding);GO:0000422(autophagy of mitochondrion);GO:0000785(chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0002020(protease binding);GO:0002082(regulation of oxidative phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006979(response to oxidative stress);GO:0007005(mitochondrion organization);GO:0010310(regulation of hydrogen peroxide metabolic process);GO:0010629(negative regulation of gene expression);GO:0010821(regulation of mitochondrion organization);GO:0010857(calcium-dependent protein kinase activity);GO:0016020(membrane);GO:0016239(positive regulation of macroautophagy);GO:0016242(negative regulation of macroautophagy);GO:0016301(kinase activity);GO:0016567(protein ubiquitination);GO:0018105(peptidyl-serine phosphorylation);GO:0022904(respiratory electron transport chain);GO:0030424(axon);GO:0031307(integral component of mitochondrial outer membrane);GO:0031396(regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032226(positive regulation of synaptic transmission, dopaminergic);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033603(positive regulation of dopamine secretion);GO:0033605(positive regulation of catecholamine secretion);GO:0034599(cellular response to oxidative stress);GO:0035307(positive regulation of protein dephosphorylation);GO:0035556(intracellular signal transduction);GO:0036289(peptidyl-serine autophosphorylation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043254(regulation of protein-containing complex assembly);GO:0043422(protein kinase B binding);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0044297(cell body);GO:0044877(protein-containing complex binding);GO:0045727(positive regulation of translation);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055131(C3HC4-type RING finger domain binding);GO:0071456(cellular response to hypoxia);GO:0072655(establishment of protein localization to mitochondrion);GO:0072656(maintenance of protein location in mitochondrion);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0090258(negative regulation of mitochondrial fission);GO:0097237(cellular response to toxic substance);GO:0097449(astrocyte projection);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization);GO:0099074(mitochondrion to lysosome transport);GO:1900407(regulation of cellular response to oxidative stress);GO:1901727(positive regulation of histone deacetylase activity);GO:1902902(negative regulation of autophagosome assembly);GO:1902958(positive regulation of mitochondrial electron transport, NADH to ubiquinone);GO:1903147(negative regulation of autophagy of mitochondrion);GO:1903202(negative regulation of oxidative stress-induced cell death);GO:1903214(regulation of protein targeting to mitochondrion);GO:1903298(negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway);GO:1903384(negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway);GO:1903751(negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:1903852(positive regulation of cristae formation);GO:1904841(TORC2 complex binding);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04137(Mitophagy - animal);05012(Parkinson disease)",{"v":8.99999999999999e-301,"d":"0.00"},1,"360,",0,-300,-297,5.01,"3' UTR",2,4785163,4810601,25439,1]
["chr2",4810485,4810544,60,"ENSBGRG00000000185","ENSBGRT00000000301",25322,"PINK1","PTEN induced kinase 1 [Source:HGNC Symbol;Acc:HGNC:14581]","GO:0000287(magnesium ion binding);GO:0000422(autophagy of mitochondrion);GO:0000785(chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0002020(protease binding);GO:0002082(regulation of oxidative phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006979(response to oxidative stress);GO:0007005(mitochondrion organization);GO:0010310(regulation of hydrogen peroxide metabolic process);GO:0010629(negative regulation of gene expression);GO:0010821(regulation of mitochondrion organization);GO:0010857(calcium-dependent protein kinase activity);GO:0016020(membrane);GO:0016239(positive regulation of macroautophagy);GO:0016242(negative regulation of macroautophagy);GO:0016301(kinase activity);GO:0016567(protein ubiquitination);GO:0018105(peptidyl-serine phosphorylation);GO:0022904(respiratory electron transport chain);GO:0030424(axon);GO:0031307(integral component of mitochondrial outer membrane);GO:0031396(regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032226(positive regulation of synaptic transmission, dopaminergic);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033603(positive regulation of dopamine secretion);GO:0033605(positive regulation of catecholamine secretion);GO:0034599(cellular response to oxidative stress);GO:0035307(positive regulation of protein dephosphorylation);GO:0035556(intracellular signal transduction);GO:0036289(peptidyl-serine autophosphorylation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043254(regulation of protein-containing complex assembly);GO:0043422(protein kinase B binding);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0044297(cell body);GO:0044877(protein-containing complex binding);GO:0045727(positive regulation of translation);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055131(C3HC4-type RING finger domain binding);GO:0071456(cellular response to hypoxia);GO:0072655(establishment of protein localization to mitochondrion);GO:0072656(maintenance of protein location in mitochondrion);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0090258(negative regulation of mitochondrial fission);GO:0097237(cellular response to toxic substance);GO:0097449(astrocyte projection);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization);GO:0099074(mitochondrion to lysosome transport);GO:1900407(regulation of cellular response to oxidative stress);GO:1901727(positive regulation of histone deacetylase activity);GO:1902902(negative regulation of autophagosome assembly);GO:1902958(positive regulation of mitochondrial electron transport, NADH to ubiquinone);GO:1903147(negative regulation of autophagy of mitochondrion);GO:1903202(negative regulation of oxidative stress-induced cell death);GO:1903214(regulation of protein targeting to mitochondrion);GO:1903298(negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway);GO:1903384(negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway);GO:1903751(negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:1903852(positive regulation of cristae formation);GO:1904841(TORC2 complex binding);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04137(Mitophagy - animal);05012(Parkinson disease)",{"v":0.0011,"d":"0.00"},1,"60,",0,-2.97,-2.34,2.02,"3' UTR",2,4785163,4810601,25439,1]
["chr2",6131564,6132281,718,"ENSBGRG00000003236","ENSBGRT00000006019",6484,"ENSBGRG00000003236","NA","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis)","04972(Pancreatic secretion);04974(Protein digestion and absorption)",{"v":0.0041,"d":"0.00"},2,"46,193,","0,525",-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000006019/ENSBGRG00000003236, exon 5 of 8)",2,6125080,6134360,9281,1]
["chr2",6199346,6199406,61,"ENSBGRG00000003268","ENSBGRT00000006062",0,"ENSBGRG00000003268","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.0078,"d":"0.01"},1,"61,",0,-2.11,-1.53,5.94,"Exon (ENSBGRT00000006062/ENSBGRG00000003268, exon 1 of 1)",2,6199346,6200452,1107,1]
["chr2",6199495,6199555,61,"ENSBGRG00000003268","ENSBGRT00000006062",149,"ENSBGRG00000003268","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":7.2e-05,"d":"0.00"},1,"61,",0,-4.14,-3.45,6.21,"Exon (ENSBGRT00000006062/ENSBGRG00000003268, exon 1 of 1)",2,6199346,6200452,1107,1]
["chr2",6199615,6199854,240,"ENSBGRG00000003268","ENSBGRT00000006062",269,"ENSBGRG00000003268","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":2.9E-4,"d":"0.00"},1,"240,",0,-3.54,-2.87,{"v":15.1,"d":"15.10"},"Exon (ENSBGRT00000006062/ENSBGRG00000003268, exon 1 of 1)",2,6199346,6200452,1107,1]
["chr2",6200004,6200303,300,"ENSBGRG00000003268","ENSBGRT00000006062",658,"ENSBGRG00000003268","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.00037,"d":"0.00"},1,"300,",0,-3.43,-2.77,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000006062/ENSBGRG00000003268, exon 1 of 1)",2,6199346,6200452,1107,1]
["chr2",6199346,6199406,61,"ENSBGRG00000003268","ENSBGRT00000006062",0,"ENSBGRG00000003268","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.0078,"d":"0.01"},1,"61,",0,-2.11,-1.53,5.94,"Exon (ENSBGRT00000006062/ENSBGRG00000003268, exon 1 of 1)",2,6199346,6200452,1107,1]
["chr2",6199495,6199555,61,"ENSBGRG00000003268","ENSBGRT00000006062",149,"ENSBGRG00000003268","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":7.2e-05,"d":"0.00"},1,"61,",0,-4.14,-3.45,6.21,"Exon (ENSBGRT00000006062/ENSBGRG00000003268, exon 1 of 1)",2,6199346,6200452,1107,1]
["chr2",6199615,6199854,240,"ENSBGRG00000003268","ENSBGRT00000006062",269,"ENSBGRG00000003268","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":2.9E-4,"d":"0.00"},1,"240,",0,-3.54,-2.87,{"v":15.1,"d":"15.10"},"Exon (ENSBGRT00000006062/ENSBGRG00000003268, exon 1 of 1)",2,6199346,6200452,1107,1]
["chr2",6200004,6200303,300,"ENSBGRG00000003268","ENSBGRT00000006062",658,"ENSBGRG00000003268","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":0.00037,"d":"0.00"},1,"300,",0,-3.43,-2.77,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000006062/ENSBGRG00000003268, exon 1 of 1)",2,6199346,6200452,1107,1]
["chr2",6681860,6682159,300,"ENSBGRG00000003315","ENSBGRT00000006176",11326,"ZBTB40","zinc finger and BTB domain containing 40 [Source:HGNC Symbol;Acc:HGNC:29045]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus)","NA",{"v":7.9e-52,"d":"0.00"},1,"300,",0,{"v":-51.1,"d":"-51.10"},{"v":-49.8,"d":"-49.80"},3.91,"Exon (ENSBGRT00000006176/ENSBGRG00000003315, exon 2 of 18)",2,6670534,6726689,56156,1]
["chr2",6709095,6709304,210,"ENSBGRG00000003315","ENSBGRT00000006176",38561,"ZBTB40","zinc finger and BTB domain containing 40 [Source:HGNC Symbol;Acc:HGNC:29045]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus)","NA",{"v":6.3e-15,"d":"0.00"},1,"210,",0,{"v":-14.2,"d":"-14.20"},{"v":-13.3,"d":"-13.30"},2.13,"Exon (ENSBGRT00000006176/ENSBGRG00000003315, exon 11 of 18)",2,6670534,6726689,56156,1]
["chr2",6860737,6861483,747,"ENSBGRG00000003435","ENSBGRT00000006390",0,"ENSBGRG00000003435","NA","GO:0003676(nucleic acid binding);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus)","NA",{"v":0.015,"d":"0.02"},1,"747,",0,-1.83,-1.02,8.64,"5' UTR",2,6860737,6864013,3277,1]
["chr2",6861811,6863267,1457,"ENSBGRG00000003435","ENSBGRT00000006390",1074,"ENSBGRG00000003435","NA","GO:0003676(nucleic acid binding);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus)","NA",{"v":0.0041,"d":"0.00"},2,"236,34,","0,1423",-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000006390/ENSBGRG00000003435, exon 1 of 2)",2,6860737,6864013,3277,1]
["chr2",7185614,7185913,300,"ENSBGRG00000003473","ENSBGRT00000006575",254095,"EPHB2","EPH receptor B2 [Source:HGNC Symbol;Acc:HGNC:3393]","GO:0000902(cell morphogenesis);GO:0001525(angiogenesis);GO:0001540(amyloid-beta binding);GO:0001655(urogenital system development);GO:0001933(negative regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0007611(learning or memory);GO:0007612(learning);GO:0008046(axon guidance receptor activity);GO:0009887(animal organ morphogenesis);GO:0016021(integral component of membrane);GO:0016310(phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021631(optic nerve morphogenesis);GO:0021952(central nervous system projection neuron axonogenesis);GO:0022038(corpus callosum development);GO:0030193(regulation of blood coagulation);GO:0030424(axon);GO:0030425(dendrite);GO:0031290(retinal ganglion cell axon guidance);GO:0031915(positive regulation of synaptic plasticity);GO:0038023(signaling receptor activity);GO:0042472(inner ear morphogenesis);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0044877(protein-containing complex binding);GO:0046580(negative regulation of Ras protein signal transduction);GO:0048013(ephrin receptor signaling pathway);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048170(positive regulation of long-term neuronal synaptic plasticity);GO:0048593(camera-type eye morphogenesis);GO:0050770(regulation of axonogenesis);GO:0050771(negative regulation of axonogenesis);GO:0050878(regulation of body fluid levels);GO:0051389(inactivation of MAPKK activity);GO:0051965(positive regulation of synapse assembly);GO:0060021(roof of mouth development);GO:0060996(dendritic spine development);GO:0060997(dendritic spine morphogenesis);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0071679(commissural neuron axon guidance);GO:0099557(trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission);GO:0106028(neuron projection retraction);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1904782(negative regulation of NMDA glutamate receptor activity);GO:1904783(positive regulation of NMDA glutamate receptor activity)","04360(Axon guidance)",{"v":3.2e-23,"d":"0.00"},1,"300,",0,{"v":-22.5,"d":"-22.50"},{"v":-21.5,"d":"-21.50"},4.95,"3' UTR",2,6931519,7187286,255768,1]
["chr2",7186241,7186719,479,"ENSBGRG00000003473","ENSBGRT00000006575",254722,"EPHB2","EPH receptor B2 [Source:HGNC Symbol;Acc:HGNC:3393]","GO:0000902(cell morphogenesis);GO:0001525(angiogenesis);GO:0001540(amyloid-beta binding);GO:0001655(urogenital system development);GO:0001933(negative regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0007611(learning or memory);GO:0007612(learning);GO:0008046(axon guidance receptor activity);GO:0009887(animal organ morphogenesis);GO:0016021(integral component of membrane);GO:0016310(phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021631(optic nerve morphogenesis);GO:0021952(central nervous system projection neuron axonogenesis);GO:0022038(corpus callosum development);GO:0030193(regulation of blood coagulation);GO:0030424(axon);GO:0030425(dendrite);GO:0031290(retinal ganglion cell axon guidance);GO:0031915(positive regulation of synaptic plasticity);GO:0038023(signaling receptor activity);GO:0042472(inner ear morphogenesis);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0044877(protein-containing complex binding);GO:0046580(negative regulation of Ras protein signal transduction);GO:0048013(ephrin receptor signaling pathway);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048170(positive regulation of long-term neuronal synaptic plasticity);GO:0048593(camera-type eye morphogenesis);GO:0050770(regulation of axonogenesis);GO:0050771(negative regulation of axonogenesis);GO:0050878(regulation of body fluid levels);GO:0051389(inactivation of MAPKK activity);GO:0051965(positive regulation of synapse assembly);GO:0060021(roof of mouth development);GO:0060996(dendritic spine development);GO:0060997(dendritic spine morphogenesis);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0071679(commissural neuron axon guidance);GO:0099557(trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission);GO:0106028(neuron projection retraction);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1904782(negative regulation of NMDA glutamate receptor activity);GO:1904783(positive regulation of NMDA glutamate receptor activity)","04360(Axon guidance)",{"v":1.1e-07,"d":"0.00"},1,"479,",0,-6.96,-6.19,{"v":10.1,"d":"10.10"},"3' UTR",2,6931519,7187286,255768,1]
["chr2",7259673,7259911,239,"ENSBGRG00000003651","ENSBGRT00000006863",0,"KDM1A","lysine demethylase 1A [Source:HGNC Symbol;Acc:HGNC:29079]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000784(nuclear chromosome, telomeric region);GO:0000790(nuclear chromatin);GO:0002039(p53 binding);GO:0002052(positive regulation of neuroblast proliferation);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006482(protein demethylation);GO:0008134(transcription factor binding);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0016491(oxidoreductase activity);GO:0019899(enzyme binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0032091(negative regulation of protein binding);GO:0032451(demethylase activity);GO:0032452(histone demethylase activity);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0032454(histone demethylase activity (H3-K9 specific));GO:0032991(protein-containing complex);GO:0033169(histone H3-K9 demethylation);GO:0033184(positive regulation of histone ubiquitination);GO:0034644(cellular response to UV);GO:0034648(histone demethylase activity (H3-dimethyl-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0043426(MRF binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050660(flavin adenine dinucleotide binding);GO:0050681(androgen receptor binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0055114(oxidation-reduction process);GO:0061752(telomeric repeat-containing RNA binding);GO:0071480(cellular response to gamma radiation);GO:1902166(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:1903827(regulation of cellular protein localization);GO:1990391(DNA repair complex)","04714(Thermogenesis)",{"v":0.0041,"d":"0.00"},1,"239,",0,-2.39,-1.79,{"v":10.8,"d":"10.80"},"5' UTR",2,7259673,7335143,75471,1]
["chr2",7334934,7335054,121,"ENSBGRG00000003651","ENSBGRT00000006863",75261,"KDM1A","lysine demethylase 1A [Source:HGNC Symbol;Acc:HGNC:29079]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000784(nuclear chromosome, telomeric region);GO:0000790(nuclear chromatin);GO:0002039(p53 binding);GO:0002052(positive regulation of neuroblast proliferation);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006482(protein demethylation);GO:0008134(transcription factor binding);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0016491(oxidoreductase activity);GO:0019899(enzyme binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0032091(negative regulation of protein binding);GO:0032451(demethylase activity);GO:0032452(histone demethylase activity);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0032454(histone demethylase activity (H3-K9 specific));GO:0032991(protein-containing complex);GO:0033169(histone H3-K9 demethylation);GO:0033184(positive regulation of histone ubiquitination);GO:0034644(cellular response to UV);GO:0034648(histone demethylase activity (H3-dimethyl-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0043426(MRF binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050660(flavin adenine dinucleotide binding);GO:0050681(androgen receptor binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0055114(oxidation-reduction process);GO:0061752(telomeric repeat-containing RNA binding);GO:0071480(cellular response to gamma radiation);GO:1902166(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:1903827(regulation of cellular protein localization);GO:1990391(DNA repair complex)","04714(Thermogenesis)",{"v":1E-210,"d":"0.00"},1,"121,",0,-210,-208,4.34,"3' UTR",2,7259673,7335143,75471,1]
["chr2",8038723,8040728,2006,"ENSBGRG00000004602","ENSBGRT00000008569",52370,"ENSBGRG00000004602","elongin A [Source:HGNC Symbol;Acc:HGNC:11620]","GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005840(ribosome);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006412(translation);GO:0070449(elongin complex)","03010(Ribosome)",{"v":1.3E-25,"d":"0.00"},3,"53,107,199,","0,1032,1807",{"v":-24.9,"d":"-24.90"},{"v":-23.9,"d":"-23.90"},1.85,"Exon (ENSBGRT00000008569/ENSBGRG00000004602, exon 6 of 8)",2,7986353,8041684,55332,1]
["chr2",8040966,8041294,329,"ENSBGRG00000004602","ENSBGRT00000008569",54613,"ENSBGRG00000004602","elongin A [Source:HGNC Symbol;Acc:HGNC:11620]","GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005840(ribosome);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006412(translation);GO:0070449(elongin complex)","03010(Ribosome)",{"v":2.5e-22,"d":"0.00"},1,"329,",0,{"v":-21.6,"d":"-21.60"},{"v":-20.6,"d":"-20.60"},5.02,"3' UTR",2,7986353,8041684,55332,1]
["chr2",8041682,8042517,836,"ENSBGRG00000004602","ENSBGRT00000008569",55329,"ENSBGRG00000004602","elongin A [Source:HGNC Symbol;Acc:HGNC:11620]","GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005840(ribosome);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006412(translation);GO:0070449(elongin complex)","03010(Ribosome)",{"v":1e-106,"d":"0.00"},1,"836,",0,-106,-105,4.41,"3' UTR",2,7986353,8041684,55332,1]
["chr2",8047670,8048703,1034,"ENSBGRG00000004602","ENSBGRT00000008781",15881,"ENSBGRG00000004602","elongin A [Source:HGNC Symbol;Acc:HGNC:11620]","GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005840(ribosome);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006412(translation);GO:0070449(elongin complex)","03010(Ribosome)",{"v":4.2E-7,"d":"0.00"},2,"58,62,","0,972",-6.38,-5.62,2.29,"Exon (ENSBGRT00000008781/ENSBGRG00000004602, exon 11 of 12)",2,8031789,8048703,16915,1]
["chr2",8280282,8281321,1040,"ENSBGRG00000005315","ENSBGRT00000009833",0,"ENSBGRG00000005315","NA","NA","NA",{"v":6.3e-36,"d":"0.00"},2,"167,4,","0,1036",{"v":-35.2,"d":"-35.20"},-34,1.86,"Exon (ENSBGRT00000009833/ENSBGRG00000005315, exon 1 of 2)",2,8280282,8281321,1040,1]
["chr2",8281336,8281589,254,"ENSBGRG00000005344","ENSBGRT00000009878",0,"PNRC2","proline rich nuclear receptor coactivator 2 [Source:HGNC Symbol;Acc:HGNC:23158]","GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0000932(P-body);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus)","NA",{"v":9.99999999999999e-245,"d":"0.00"},1,"254,",0,-244,-241,3.13,"Exon (ENSBGRT00000009878/ENSBGRG00000005344, exon 1 of 2)",2,8281336,8284144,2809,1]
["chr2",8699911,8720039,20129,"ENSBGRG00000006200","ENSBGRT00000011619",19736,"GRHL3","grainyhead like transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:25839]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001736(establishment of planar polarity);GO:0001843(neural tube closure);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007389(pattern specification process);GO:0007398(ectoderm development);GO:0007417(central nervous system development);GO:0008544(epidermis development);GO:0010628(positive regulation of gene expression);GO:0031490(chromatin DNA binding);GO:0032956(regulation of actin cytoskeleton organization);GO:0042060(wound healing);GO:0043547(positive regulation of GTPase activity);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061029(eyelid development in camera-type eye);GO:0061436(establishment of skin barrier);GO:0090103(cochlea morphogenesis);GO:0090179(planar cell polarity pathway involved in neural tube closure)","NA",{"v":0.028,"d":"0.03"},14,"308,74,154,112,95,159,79,134,35,89,89,86,65,314,","0,560,1106,1485,3318,5825,6507,6694,9679,10874,11974,12852,15459,19815",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"3' UTR",2,8680175,8720666,40492,1]
["chr2",8854621,8854977,357,"ENSBGRG00000006640","ENSBGRT00000012269",49998,"NIPAL3","NIPA like domain containing 3 [Source:HGNC Symbol;Acc:HGNC:25233]","GO:0015095(magnesium ion transmembrane transporter activity);GO:0015693(magnesium ion transport);GO:0016021(integral component of membrane)","NA",{"v":4e-48,"d":"0.00"},1,"357,",0,{"v":-47.4,"d":"-47.40"},{"v":-46.1,"d":"-46.10"},5.13,"3' UTR",2,8804623,8855066,50444,1]
["chr2",8917064,8917933,870,"ENSBGRG00000006726","ENSBGRT00000012523",24445,"RCAN3","RCAN family member 3 [Source:HGNC Symbol;Acc:HGNC:3042]","GO:0003676(nucleic acid binding);GO:0019722(calcium-mediated signaling);GO:0019902(phosphatase binding);GO:0031013(troponin I binding)","NA",{"v":3e-05,"d":"0.00"},2,"245,171,","0,699",-4.53,-3.83,{"v":10.8,"d":"10.80"},"3' UTR",2,8892619,8917308,24690,1]
["chr2",9060995,9063789,2795,"ENSBGRG00000006897","ENSBGRT00000013165",27894,"ENSBGRG00000006897","NA","GO:0006397(mRNA processing)","03013(RNA transport);03015(mRNA surveillance pathway)",{"v":1E-165,"d":"0.00"},2,"44,166,","0,2629",-165,-163,1.92,"Exon (ENSBGRT00000013165/ENSBGRG00000006897, exon 18 of 20)",2,9033101,9064317,31217,1]
["chr2",9216079,9216258,180,"ENSBGRG00000007301","ENSBGRT00000013449",81163,"CLIC4","chloride intracellular channel 4 [Source:HGNC Symbol;Acc:HGNC:13518]","GO:0001525(angiogenesis);GO:0001886(endothelial cell morphogenesis);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0005911(cell-cell junction);GO:0007035(vacuolar acidification);GO:0009566(fertilization);GO:0009986(cell surface);GO:0015630(microtubule cytoskeleton);GO:0016363(nuclear matrix);GO:0030216(keratinocyte differentiation);GO:0030336(negative regulation of cell migration);GO:0030496(midbody);GO:0035264(multicellular organism growth);GO:0045177(apical part of cell);GO:0048471(perinuclear region of cytoplasm);GO:0048754(branching morphogenesis of an epithelial tube);GO:0061299(retina vasculature morphogenesis in camera-type eye);GO:0071277(cellular response to calcium ion)","NA",{"v":1e-198,"d":"0.00"},1,"180,",0,-198,-196,1.92,"3' UTR",2,9134916,9217534,82619,1]
["chr2",9279746,9280196,451,"ENSBGRG00000007375","ENSBGRT00000013497",0,"ENSBGRG00000007375","NA","NA","NA",{"v":0.0036,"d":"0.00"},1,"451,",0,-2.44,-1.84,9.72,"Exon (ENSBGRT00000013497/ENSBGRG00000007375, exon 1 of 2)",2,9279746,9283135,3390,1]
["chr2",9815523,9842970,27448,"ENSBGRG00000007916","ENSBGRT00000014465",28695,"MACO1","macoilin 1 [Source:HGNC Symbol;Acc:HGNC:25572]","GO:0005634(nucleus);GO:0007420(brain development);GO:0023041(neuronal signal transduction);GO:0030424(axon);GO:0030867(rough endoplasmic reticulum membrane);GO:0031965(nuclear membrane);GO:0043005(neuron projection);GO:0044306(neuron projection terminus);GO:0045202(synapse)","NA",{"v":1e-94,"d":"0.00"},3,"176,502,71,","0,1380,27377",-94,{"v":-92.4,"d":"-92.40"},5.42,"Exon (ENSBGRT00000014465/ENSBGRG00000007916, exon 5 of 11)",2,9786828,9864715,77888,1]
["chr2",9843029,9864476,21448,"ENSBGRG00000007916","ENSBGRT00000014465",56201,"MACO1","macoilin 1 [Source:HGNC Symbol;Acc:HGNC:25572]","GO:0005634(nucleus);GO:0007420(brain development);GO:0023041(neuronal signal transduction);GO:0030424(axon);GO:0030867(rough endoplasmic reticulum membrane);GO:0031965(nuclear membrane);GO:0043005(neuron projection);GO:0044306(neuron projection terminus);GO:0045202(synapse)","NA",{"v":1E-196,"d":"0.00"},5,"30,183,121,175,479,","0,5135,7489,15780,20969",-196,-194,5.98,"3' UTR",2,9786828,9864715,77888,1]
["chr2",10160280,10160519,240,"ENSBGRG00000008298","ENSBGRT00000015315",184187,"MAN1C1","mannosidase alpha class 1C member 1 [Source:HGNC Symbol;Acc:HGNC:19080]","GO:0003824(catalytic activity);GO:0004571(mannosyl-oligosaccharide 1,2-alpha-mannosidase activity);GO:0005509(calcium ion binding);GO:0016020(membrane)","00510(N-Glycan biosynthesis);04141(Protein processing in endoplasmic reticulum)",{"v":1.3e-19,"d":"0.00"},1,"240,",0,{"v":-18.9,"d":"-18.90"},{"v":-17.9,"d":"-17.90"},2.68,"3' UTR",2,9976093,10160758,184666,1]
["chr2",10186199,10186407,209,"ENSBGRG00000008512","ENSBGRT00000015467",0,"ENSBGRG00000008512","NA","NA","NA",{"v":2e-06,"d":"0.00"},1,"209,",0,{"v":-5.7,"d":"-5.70"},-4.95,{"v":22.7,"d":"22.70"},"5' UTR",2,10186199,10201579,15381,1]
["chr2",10220197,10226953,6757,"ENSBGRG00000008577","ENSBGRT00000015711",6254,"MTFR1L","mitochondrial fission regulator 1 like [Source:HGNC Symbol;Acc:HGNC:28836]","NA","NA",{"v":1E-176,"d":"0.00"},2,"134,466,","0,6291",-176,-174,4.91,"3' UTR",2,10213943,10226794,12852,1]
["chr2",10227133,10227253,121,"ENSBGRG00000008577","ENSBGRT00000015672",13190,"MTFR1L","mitochondrial fission regulator 1 like [Source:HGNC Symbol;Acc:HGNC:28836]","NA","NA",{"v":2.5e-61,"d":"0.00"},1,"121,",0,{"v":-60.6,"d":"-60.60"},{"v":-59.3,"d":"-59.30"},3.34,"3' UTR",2,10213943,10228033,14091,1]
["chr2",10542382,10542560,179,"ENSBGRG00000005649","ENSBGRT00000010410",4727,"PDIK1L","PDLIM1 interacting kinase 1 like [Source:HGNC Symbol;Acc:HGNC:18981]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation)","NA",{"v":5e-63,"d":"0.00"},1,"179,",0,{"v":-62.3,"d":"-62.30"},{"v":-60.9,"d":"-60.90"},6.58,"Exon (ENSBGRT00000010410/ENSBGRG00000005649, exon 2 of 2)",2,10537655,10542590,4936,1]
["chr2",10575843,10576017,175,"ENSBGRG00000005660","ENSBGRT00000010438",0,"FAM110D","family with sequence similarity 110 member D [Source:HGNC Symbol;Acc:HGNC:25860]","NA","NA",{"v":0.0002,"d":"0.00"},1,"175,",0,{"v":-3.7,"d":"-3.70"},-3.03,9.18,"Exon (ENSBGRT00000010438/ENSBGRG00000005660, exon 1 of 1)",2,10575843,10576655,813,1]
["chr2",10664746,10664895,150,"ENSBGRG00000006005","ENSBGRT00000011174",18213,"CEP85","centrosomal protein 85 [Source:HGNC Symbol;Acc:HGNC:25309]","GO:0000242(pericentriolar material);GO:0000922(spindle pole);GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006469(negative regulation of protein kinase activity);GO:0046602(regulation of mitotic centrosome separation)","NA",{"v":0.0026,"d":"0.00"},1,"150,",0,-2.59,-1.98,3.09,"Exon (ENSBGRT00000011174/ENSBGRG00000006005, exon 4 of 14)",2,10646533,10689918,43386,1]
["chr2",10670014,10670073,60,"ENSBGRG00000006005","ENSBGRT00000011174",23481,"CEP85","centrosomal protein 85 [Source:HGNC Symbol;Acc:HGNC:25309]","GO:0000242(pericentriolar material);GO:0000922(spindle pole);GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006469(negative regulation of protein kinase activity);GO:0046602(regulation of mitotic centrosome separation)","NA",{"v":0.0098,"d":"0.01"},1,"60,",0,-2.01,-1.44,{"v":1.8,"d":"1.80"},"Exon (ENSBGRT00000011174/ENSBGRG00000006005, exon 7 of 14)",2,10646533,10689918,43386,1]
["chr2",10882850,10883530,681,"ENSBGRG00000006878","ENSBGRT00000012750",0,"ENSBGRG00000006878","high mobility group nucleosomal binding domain 2 [Source:HGNC Symbol;Acc:HGNC:4986]","GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)","NA",{"v":1.7e-10,"d":"0.00"},2,"15,134,","0,547",-9.77,-8.94,3.07,"5' UTR",2,10882850,10885225,2376,1]
["chr2",10883708,10885083,1376,"ENSBGRG00000006878","ENSBGRT00000012750",858,"ENSBGRG00000006878","high mobility group nucleosomal binding domain 2 [Source:HGNC Symbol;Acc:HGNC:4986]","GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)","NA",{"v":1e-231,"d":"0.00"},5,"39,45,30,51,161,","0,178,417,773,1215",-231,-229,2.16,"5' UTR",2,10882850,10885225,2376,1]
["chr2",10981062,10981391,330,"ENSBGRG00000007015","ENSBGRT00000013869",41512,"RPS6KA1","ribosomal protein S6 kinase A1 [Source:HGNC Symbol;Acc:HGNC:10430]","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0035556(intracellular signal transduction);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2000491(positive regulation of hepatic stellate cell activation)","04010(MAPK signaling pathway);04150(mTOR signaling pathway);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04714(Thermogenesis);04931(Insulin resistance)",{"v":2E-70,"d":"0.00"},1,"330,",0,{"v":-69.7,"d":"-69.70"},{"v":-68.2,"d":"-68.20"},5.56,"3' UTR",2,10939550,10981930,42381,1]
["chr2",11159078,11160065,988,"ENSBGRG00000008144","ENSBGRT00000015489",71696,"ARID1A","AT-rich interaction domain 1A [Source:HGNC Symbol;Acc:HGNC:11110]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0001704(formation of primary germ layer);GO:0001843(neural tube closure);GO:0003205(cardiac chamber development);GO:0003408(optic cup formation involved in camera-type eye development);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0007369(gastrulation);GO:0007566(embryo implantation);GO:0016514(SWI/SNF complex);GO:0016922(nuclear receptor binding);GO:0019827(stem cell population maintenance);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030900(forebrain development);GO:0031491(nucleosome binding);GO:0035060(brahma complex);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043044(ATP-dependent chromatin remodeling);GO:0045893(positive regulation of transcription, DNA-templated);GO:0055007(cardiac muscle cell differentiation);GO:0060674(placenta blood vessel development);GO:0070829(heterochromatin maintenance);GO:0071564(npBAF complex);GO:0071565(nBAF complex);GO:1901998(toxin transport)","04714(Thermogenesis);05225(Hepatocellular carcinoma)",{"v":9.99999999999998e-242,"d":"0.00"},1,"988,",0,-241,-239,{"v":5.7,"d":"5.70"},"Exon (ENSBGRT00000015489/ENSBGRG00000008144, exon 20 of 20)",2,11087382,11161143,73762,1]
["chr2",11160604,11161083,480,"ENSBGRG00000008144","ENSBGRT00000015489",73222,"ARID1A","AT-rich interaction domain 1A [Source:HGNC Symbol;Acc:HGNC:11110]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0001704(formation of primary germ layer);GO:0001843(neural tube closure);GO:0003205(cardiac chamber development);GO:0003408(optic cup formation involved in camera-type eye development);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0007369(gastrulation);GO:0007566(embryo implantation);GO:0016514(SWI/SNF complex);GO:0016922(nuclear receptor binding);GO:0019827(stem cell population maintenance);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030900(forebrain development);GO:0031491(nucleosome binding);GO:0035060(brahma complex);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043044(ATP-dependent chromatin remodeling);GO:0045893(positive regulation of transcription, DNA-templated);GO:0055007(cardiac muscle cell differentiation);GO:0060674(placenta blood vessel development);GO:0070829(heterochromatin maintenance);GO:0071564(npBAF complex);GO:0071565(nBAF complex);GO:1901998(toxin transport)","04714(Thermogenesis);05225(Hepatocellular carcinoma)",0,1,"480,",0,-781,"-Inf",4.26,"3' UTR",2,11087382,11161143,73762,1]
["chr2",11179392,11179865,474,"ENSBGRG00000008647","ENSBGRT00000015744",6689,"PIGV","phosphatidylinositol glycan anchor biosynthesis class V [Source:HGNC Symbol;Acc:HGNC:26031]","GO:0004584(dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity);GO:0006506(GPI anchor biosynthetic process)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":4e-34,"d":"0.00"},1,"474,",0,{"v":-33.4,"d":"-33.40"},{"v":-32.3,"d":"-32.30"},3.77,"Exon (ENSBGRT00000015744/ENSBGRG00000008647, exon 3 of 4)",2,11172703,11182889,10187,1]
["chr2",11235498,11235736,239,"ENSBGRG00000008689","ENSBGRT00000015860",33785,"ZDHHC18","zinc finger DHHC-type containing 18 [Source:HGNC Symbol;Acc:HGNC:20712]","GO:0005794(Golgi apparatus);GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0034613(cellular protein localization)","NA",{"v":0.017,"d":"0.02"},1,"239,",0,-1.78,-1.22,4.32,"3' UTR",2,11201713,11235736,34024,1]
["chr2",11241274,11241362,89,"ENSBGRG00000008845","ENSBGRT00000016191",0,"SFN","stratifin [Source:HGNC Symbol;Acc:HGNC:10773]","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0001836(release of cytochrome c from mitochondria);GO:0003334(keratinocyte development);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0010482(regulation of epidermal cell division);GO:0010839(negative regulation of keratinocyte proliferation);GO:0019901(protein kinase binding);GO:0030216(keratinocyte differentiation);GO:0030307(positive regulation of cell growth);GO:0031424(keratinization);GO:0042802(identical protein binding);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043588(skin development);GO:0045606(positive regulation of epidermal cell differentiation);GO:0046827(positive regulation of protein export from nucleus);GO:0051219(phosphoprotein binding);GO:0051726(regulation of cell cycle);GO:0061436(establishment of skin barrier)","04110(Cell cycle);04115(p53 signaling pathway);04960(Aldosterone-regulated sodium reabsorption)",{"v":0.043,"d":"0.04"},1,"89,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000016191/ENSBGRG00000008845, exon 1 of 2)",2,11241274,11243163,1890,1]
["chr2",11301748,11311955,10208,"ENSBGRG00000008953","ENSBGRT00000016406",0,"ENSBGRG00000008953","NA","NA","04976(Bile secretion)",{"v":1E-107,"d":"0.00"},3,"81,78,170,","0,2398,10038",-107,-105,2.34,"5' UTR",2,11281988,11302217,20230,2]
["chr2",11312582,11312910,329,"ENSBGRG00000008992","ENSBGRT00000016453",10834,"NUDC","nuclear distribution C, dynein complex regulator [Source:HGNC Symbol;Acc:HGNC:8045]","GO:0005737(cytoplasm);GO:0005829(cytosol)","NA",{"v":4e-100,"d":"0.00"},2,"194,46,","0,283",{"v":-99.4,"d":"-99.40"},{"v":-97.8,"d":"-97.80"},2.41,"Exon (ENSBGRT00000016453/ENSBGRG00000008992, exon 3 of 9)",2,11301748,11318286,16539,1]
["chr2",11366720,11367267,548,"ENSBGRG00000009143","ENSBGRT00000016780",0,"ENSBGRG00000009143","NA","NA","NA",{"v":0.014,"d":"0.01"},2,"282,228,","0,320",-1.86,{"v":-1.3,"d":"-1.30"},7.56,"Exon (ENSBGRT00000016780/ENSBGRG00000009143, exon 1 of 2)",2,11366720,11367417,698,1]
["chr2",11666980,11668582,1603,"ENSBGRG00000009375","ENSBGRT00000017454",61306,"WDTC1","WD and tetratricopeptide repeats 1 [Source:HGNC Symbol;Acc:HGNC:29175]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001701(in utero embryonic development);GO:0004857(enzyme inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006006(glucose metabolic process);GO:0008361(regulation of cell size);GO:0032869(cellular response to insulin stimulus);GO:0035264(multicellular organism growth);GO:0042393(histone binding);GO:0042826(histone deacetylase binding);GO:0045717(negative regulation of fatty acid biosynthetic process);GO:0055082(cellular chemical homeostasis)","NA",{"v":0.0078,"d":"0.01"},2,"266,4,","0,1599",-2.11,-1.27,9.72,"3' UTR",2,11605674,11667245,61572,1]
["chr2",11668910,11669030,121,"ENSBGRG00000009375","ENSBGRT00000017247",63236,"WDTC1","WD and tetratricopeptide repeats 1 [Source:HGNC Symbol;Acc:HGNC:29175]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001701(in utero embryonic development);GO:0004857(enzyme inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006006(glucose metabolic process);GO:0008361(regulation of cell size);GO:0032869(cellular response to insulin stimulus);GO:0035264(multicellular organism growth);GO:0042393(histone binding);GO:0042826(histone deacetylase binding);GO:0045717(negative regulation of fatty acid biosynthetic process);GO:0055082(cellular chemical homeostasis)","NA",{"v":2e-71,"d":"0.00"},1,"121,",0,{"v":-70.7,"d":"-70.70"},{"v":-69.2,"d":"-69.20"},2.33,"3' UTR",2,11605674,11669776,64103,1]
["chr2",12182265,12182617,353,"ENSBGRG00000012519","ENSBGRT00000022916",18695,"PPP1R8","protein phosphatase 1 regulatory subunit 8 [Source:HGNC Symbol;Acc:HGNC:9296]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008283(cell population proliferation);GO:0016607(nuclear speck);GO:0019888(protein phosphatase regulator activity)","NA",{"v":9.99999999999999e-256,"d":"0.00"},1,"353,",0,-255,-252,4.56,"Exon (ENSBGRT00000022916/ENSBGRG00000012519, exon 7 of 7)",2,12163570,12182617,19048,1]
["chr2",12226994,12238335,11342,"ENSBGRG00000012570","ENSBGRT00000022968",0,"ENSBGRG00000012570","NA","NA","NA",{"v":0.00069,"d":"0.00"},5,"94,146,207,187,56,","0,4128,7804,9210,11286",-3.16,-2.51,13,"Exon (ENSBGRT00000023174/ENSBGRG00000012596, exon 1 of 6)",2,12226227,12227279,1053,2]
["chr2",12239233,12239980,748,"ENSBGRG00000012596","ENSBGRT00000023174",12239,"THEMIS2","thymocyte selection associated family member 2 [Source:HGNC Symbol;Acc:HGNC:16839]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0050852(T cell receptor signaling pathway)","NA",{"v":2.1e-06,"d":"0.00"},2,"141,69,","0,679",-5.68,-4.93,6.48,"Exon (ENSBGRT00000023174/ENSBGRG00000012596, exon 5 of 6)",2,12226994,12240040,13047,1]
["chr2",12321744,12321893,150,"ENSBGRG00000012884","ENSBGRT00000023818",35293,"SMPDL3B","sphingomyelin phosphodiesterase acid like 3B [Source:HGNC Symbol;Acc:HGNC:21416]","GO:0004767(sphingomyelin phosphodiesterase activity);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0006685(sphingomyelin catabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0008270(zinc ion binding);GO:0016787(hydrolase activity);GO:0034122(negative regulation of toll-like receptor signaling pathway);GO:0046466(membrane lipid catabolic process);GO:0050728(negative regulation of inflammatory response)","NA",{"v":8.5e-08,"d":"0.00"},1,"150,",0,-7.07,-6.29,5.08,"3' UTR",2,12286451,12322071,35621,1]
["chr2",12602208,12604327,2120,"ENSBGRG00000013915","ENSBGRT00000025661",0,"ATP5IF1","ATP synthase inhibitory factor subunit 1 [Source:HGNC Symbol;Acc:HGNC:871]","GO:0001937(negative regulation of endothelial cell proliferation);GO:0005739(mitochondrion);GO:0006783(heme biosynthetic process);GO:0009986(cell surface);GO:0019899(enzyme binding);GO:0030218(erythrocyte differentiation);GO:0032780(negative regulation of ATPase activity);GO:0042030(ATPase inhibitor activity);GO:0043532(angiostatin binding);GO:0051117(ATPase binding);GO:0051346(negative regulation of hydrolase activity);GO:0051882(mitochondrial depolarization);GO:0072593(reactive oxygen species metabolic process);GO:0140260(mitochondrial proton-transporting ATP synthase complex binding);GO:1901030(positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway);GO:1903052(positive regulation of proteolysis involved in cellular protein catabolic process);GO:1903214(regulation of protein targeting to mitochondrion);GO:1903578(regulation of ATP metabolic process);GO:1904925(positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization)","NA",{"v":0,"d":"0.00"},4,"87,92,34,146,","0,189,1901,1974",-318,-315,2.02,"Exon (ENSBGRT00000025661/ENSBGRG00000013915, exon 1 of 3)",2,12602208,12604142,1935,1]
["chr2",12691071,12691333,263,"ENSBGRG00000014253","ENSBGRT00000026198",3774,"MED18","mediator complex subunit 18 [Source:HGNC Symbol;Acc:HGNC:25944]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016592(mediator complex)","NA",{"v":2E-70,"d":"0.00"},1,"263,",0,{"v":-69.7,"d":"-69.70"},{"v":-68.3,"d":"-68.30"},6.09,"Exon (ENSBGRT00000026198/ENSBGRG00000014253, exon 2 of 2)",2,12687297,12691565,4269,1]
["chr2",12691391,12691565,175,"ENSBGRG00000014253","ENSBGRT00000026198",4094,"MED18","mediator complex subunit 18 [Source:HGNC Symbol;Acc:HGNC:25944]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016592(mediator complex)","NA",{"v":4e-75,"d":"0.00"},1,"175,",0,{"v":-74.4,"d":"-74.40"},{"v":-72.9,"d":"-72.90"},5.14,"Exon (ENSBGRT00000026198/ENSBGRG00000014253, exon 2 of 2)",2,12687297,12691565,4269,1]
["chr2",12828954,12832657,3704,"ENSBGRG00000014359","ENSBGRT00000026775",95016,"PHACTR4","phosphatase and actin regulator 4 [Source:HGNC Symbol;Acc:HGNC:25793]","GO:0001755(neural crest cell migration);GO:0001843(neural tube closure);GO:0003779(actin binding);GO:0007266(Rho protein signal transduction);GO:0008157(protein phosphatase 1 binding);GO:0019888(protein phosphatase regulator activity);GO:0030027(lamellipodium);GO:0030036(actin cytoskeleton organization);GO:0043085(positive regulation of catalytic activity);GO:0048484(enteric nervous system development);GO:0051726(regulation of cell cycle);GO:0061386(closure of optic fissure);GO:0072542(protein phosphatase activator activity);GO:2001045(negative regulation of integrin-mediated signaling pathway)","NA",{"v":9.99999999999998e-218,"d":"0.00"},2,"102,48,","0,3656",-217,-215,4.38,"Exon (ENSBGRT00000026775/ENSBGRG00000014359, exon 7 of 15)",2,12733938,12850465,116528,1]
["chr2",12923878,12931037,7160,"ENSBGRG00000014936","ENSBGRT00000027663",18127,"TRNAU1AP","tRNA selenocysteine 1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:30813]","GO:0001514(selenocysteine incorporation);GO:0003676(nucleic acid binding);GO:0005634(nucleus)","NA",{"v":1e-104,"d":"0.00"},3,"9,34,314,","0,211,6846",-104,-103,3.54,"3' UTR",2,12905751,12931126,25376,1]
["chr2",13045110,13045737,628,"ENSBGRG00000015362","ENSBGRT00000028340",31043,"GMEB1","glucocorticoid modulatory element binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4370]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0042802(identical protein binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051008(Hsp27 protein binding);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1e-111,"d":"0.00"},1,"628,",0,-111,-109,{"v":6.4,"d":"6.40"},"Exon (ENSBGRT00000028340/ENSBGRG00000015362, exon 9 of 9)",2,13014067,13045767,31701,1]
["chr2",13072420,13073167,748,"ENSBGRG00000015573","ENSBGRT00000028695",1615,"YTHDF2","YTH N6-methyladenosine RNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:31675]","GO:0000932(P-body);GO:0001556(oocyte maturation);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006402(mRNA catabolic process);GO:0034451(centriolar satellite);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0043488(regulation of mRNA stability);GO:0050767(regulation of neurogenesis);GO:0060339(negative regulation of type I interferon-mediated signaling pathway);GO:0061157(mRNA destabilization);GO:0071425(hematopoietic stem cell proliferation);GO:1902036(regulation of hematopoietic stem cell differentiation);GO:1903538(regulation of meiotic cell cycle process involved in oocyte maturation);GO:1903679(positive regulation of cap-independent translational initiation);GO:1990247(N6-methyladenosine-containing RNA binding)","NA",{"v":9.99999999999998e-259,"d":"0.00"},1,"748,",0,-258,-256,5.29,"Exon (ENSBGRT00000028695/ENSBGRG00000015573, exon 4 of 4)",2,13070805,13073167,2363,1]
["chr2",13310346,13315233,4888,"ENSBGRG00000016000","ENSBGRT00000039943",299,"EPB41","erythrocyte membrane protein band 4.1 [Source:HGNC Symbol;Acc:HGNC:3377]","GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005545(1-phosphatidylinositol binding);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0008022(protein C-terminus binding);GO:0008092(cytoskeletal protein binding);GO:0008360(regulation of cell shape);GO:0016020(membrane);GO:0016323(basolateral plasma membrane);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030863(cortical cytoskeleton);GO:0030866(cortical actin cytoskeleton organization);GO:0032092(positive regulation of protein binding);GO:0032991(protein-containing complex);GO:0045171(intercellular bridge);GO:0047485(protein N-terminus binding);GO:0051219(phosphoprotein binding);GO:0051924(regulation of calcium ion transport);GO:0072686(mitotic spindle);GO:0099738(cell cortex region);GO:1904478(regulation of intestinal absorption);GO:1904778(positive regulation of protein localization to cell cortex)","NA",{"v":1e-12,"d":"0.00"},2,"172,127,","0,4761",-12,{"v":-11.1,"d":"-11.10"},2.39,"5' UTR",2,13310047,13386697,76651,1]
["chr2",15814377,15830429,16053,"ENSBGRG00000007511","ENSBGRT00000014094",29508,"ENSBGRG00000007511","NA","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding)","03040(Spliceosome)",0,3,"83,146,216,","0,2055,15837",-391,"-Inf",3.86,"3' UTR",2,15784869,15830236,45368,1]
["chr2",16500900,16501319,420,"ENSBGRG00000010825","ENSBGRT00000019888",0,"KHDRBS1","KH RNA binding domain containing, signal transduction associated 1 [Source:HGNC Symbol;Acc:HGNC:18116]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","NA",{"v":0.028,"d":"0.03"},1,"420,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",2,16500900,16528007,27108,1]
["chr2",16524192,16528007,3816,"ENSBGRG00000010825","ENSBGRT00000019888",23292,"KHDRBS1","KH RNA binding domain containing, signal transduction associated 1 [Source:HGNC Symbol;Acc:HGNC:18116]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","NA",{"v":1e-16,"d":"0.00"},4,"75,68,59,98,","0,564,1417,3718",-16,{"v":-15.1,"d":"-15.10"},1.43,"Exon (ENSBGRT00000019888/ENSBGRG00000010825, exon 6 of 9)",2,16500900,16528007,27108,1]
["chr2",16570431,16570670,240,"ENSBGRG00000011031","ENSBGRT00000020164",21844,"TMEM39B","transmembrane protein 39B [Source:HGNC Symbol;Acc:HGNC:25510]","NA","NA",{"v":1.6e-43,"d":"0.00"},1,"240,",0,{"v":-42.8,"d":"-42.80"},{"v":-41.6,"d":"-41.60"},4.33,"3' UTR",2,16548587,16573300,24714,1]
["chr2",16620147,16623395,3249,"ENSBGRG00000011110","ENSBGRT00000020631",45942,"KPNA6","karyopherin subunit alpha 6 [Source:HGNC Symbol;Acc:HGNC:6399]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006606(protein import into nucleus);GO:0019079(viral genome replication);GO:0030682(mitigation of host defenses by symbiont);GO:0042025(host cell nucleus);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060135(maternal process involved in female pregnancy);GO:0061608(nuclear import signal receptor activity);GO:0075506(entry of viral genome into host nucleus through nuclear pore complex via importin);GO:1900017(positive regulation of cytokine production involved in inflammatory response);GO:1903902(positive regulation of viral life cycle)","NA",{"v":6.3e-11,"d":"0.00"},3,"108,93,9,","0,957,3240",{"v":-10.2,"d":"-10.20"},-9.32,3.83,"Exon (ENSBGRT00000020631/ENSBGRG00000011110, exon 2 of 14)",2,16574205,16635700,61496,1]
["chr2",16656262,16656321,60,"ENSBGRG00000011469","ENSBGRT00000020916",8926,"TXLNA","taxilin alpha [Source:HGNC Symbol;Acc:HGNC:30685]","GO:0005737(cytoplasm);GO:0019905(syntaxin binding);GO:0042113(B cell activation)","NA",{"v":0.00044,"d":"0.00"},1,"60,",0,-3.36,-2.71,1.23,"Exon (ENSBGRT00000020916/ENSBGRG00000011469, exon 6 of 11)",2,16647336,16658711,11376,1]
["chr2",16657238,16657654,417,"ENSBGRG00000011469","ENSBGRT00000020916",9902,"TXLNA","taxilin alpha [Source:HGNC Symbol;Acc:HGNC:30685]","GO:0005737(cytoplasm);GO:0019905(syntaxin binding);GO:0042113(B cell activation)","NA",{"v":3.2e-73,"d":"0.00"},2,"54,65,","0,352",{"v":-72.5,"d":"-72.50"},{"v":-71.1,"d":"-71.10"},2.77,"Exon (ENSBGRT00000020916/ENSBGRG00000011469, exon 8 of 11)",2,16647336,16658711,11376,1]
["chr2",16671278,16673114,1837,"ENSBGRG00000011655","ENSBGRT00000021216",688,"IQCC","IQ motif containing C [Source:HGNC Symbol;Acc:HGNC:25545]","GO:0005515(protein binding)","NA",{"v":1.3e-100,"d":"0.00"},4,"66,265,119,837,","0,275,761,1000",{"v":-99.9,"d":"-99.90"},{"v":-98.2,"d":"-98.20"},3.46,"Exon (ENSBGRT00000021216/ENSBGRG00000011655, exon 2 of 5)",2,16670590,16673114,2525,1]
["chr2",16694940,16695186,247,"ENSBGRG00000011926","ENSBGRT00000022021",8517,"EIF3I","eukaryotic translation initiation factor 3 subunit I [Source:HGNC Symbol;Acc:HGNC:3272]","GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005852(eukaryotic translation initiation factor 3 complex);GO:0006413(translational initiation);GO:0071541(eukaryotic translation initiation factor 3 complex, eIF3m)","03013(RNA transport)",{"v":2e-81,"d":"0.00"},2,"38,82,","0,165",{"v":-80.7,"d":"-80.70"},{"v":-79.2,"d":"-79.20"},1.78,"Exon (ENSBGRT00000022021/ENSBGRG00000011926, exon 9 of 10)",2,16686423,16695186,8764,1]
["chr2",16892473,16893367,895,"ENSBGRG00000013452","ENSBGRT00000024686",16360,"ENSBGRG00000013452","NA","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","NA",{"v":0.028,"d":"0.03"},1,"895,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"3' UTR",2,16876113,16893725,17613,1]
["chr2",17007821,17007969,149,"ENSBGRG00000013499","ENSBGRT00000024773",32479,"ZBTB8A","zinc finger and BTB domain containing 8A [Source:HGNC Symbol;Acc:HGNC:24172]","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","NA",{"v":0.00022,"d":"0.00"},1,"149,",0,-3.65,-2.98,2.24,"Exon (ENSBGRT00000024773/ENSBGRG00000013499, exon 2 of 4)",2,16975342,17016616,41275,1]
["chr2",17008029,17008118,90,"ENSBGRG00000013499","ENSBGRT00000024773",32687,"ZBTB8A","zinc finger and BTB domain containing 8A [Source:HGNC Symbol;Acc:HGNC:24172]","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","NA",{"v":2.8E-5,"d":"0.00"},1,"90,",0,-4.56,-3.86,{"v":2.7,"d":"2.70"},"Exon (ENSBGRT00000024773/ENSBGRG00000013499, exon 2 of 4)",2,16975342,17016616,41275,1]
["chr2",17016348,17016497,150,"ENSBGRG00000013499","ENSBGRT00000024773",41006,"ZBTB8A","zinc finger and BTB domain containing 8A [Source:HGNC Symbol;Acc:HGNC:24172]","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","NA",{"v":1.3E-6,"d":"0.00"},1,"150,",0,{"v":-5.9,"d":"-5.90"},-5.15,2.82,"Exon (ENSBGRT00000024773/ENSBGRG00000013499, exon 4 of 4)",2,16975342,17016616,41275,1]
["chr2",17174827,17175153,327,"ENSBGRG00000014294","ENSBGRT00000026257",7321,"ENSBGRG00000014294","NA","NA","NA",{"v":1.6e-85,"d":"0.00"},1,"327,",0,{"v":-84.8,"d":"-84.80"},{"v":-83.2,"d":"-83.20"},{"v":4.2,"d":"4.20"},"Exon (ENSBGRT00000026341/ENSBGRG00000014343, exon 1 of 2)",2,17167506,17175662,8157,1]
["chr2",17226126,17226599,474,"ENSBGRG00000014680","ENSBGRT00000027077",8685,"S100PBP","S100P binding protein [Source:HGNC Symbol;Acc:HGNC:25768]","GO:0005634(nucleus);GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0048306(calcium-dependent protein binding)","NA",{"v":7.9e-97,"d":"0.00"},1,"474,",0,{"v":-96.1,"d":"-96.10"},{"v":-94.5,"d":"-94.50"},3.65,"Exon (ENSBGRT00000027077/ENSBGRG00000014680, exon 3 of 7)",2,17217441,17251495,34055,1]
["chr2",17696188,17696425,238,"ENSBGRG00000016893","ENSBGRT00000031124",28033,"ZNF362","zinc finger protein 362 [Source:HGNC Symbol;Acc:HGNC:18079]","GO:0003676(nucleic acid binding)","NA",{"v":1e-105,"d":"0.00"},1,"238,",0,-105,-103,4.36,"3' UTR",2,17668155,17696425,28271,1]
["chr2",18980890,18983514,2625,"ENSBGRG00000021016","ENSBGRT00000038766",0,"NMUR1","neuromedin U receptor 1 [Source:HGNC Symbol;Acc:HGNC:4518]","GO:0001607(neuromedin U receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0006816(calcium ion transport);GO:0006821(chloride transport);GO:0006939(smooth muscle contraction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007200(phospholipase C-activating G protein-coupled receptor signaling pathway);GO:0007202(activation of phospholipase C activity);GO:0007218(neuropeptide signaling pathway);GO:0008188(neuropeptide receptor activity);GO:0016021(integral component of membrane);GO:0019722(calcium-mediated signaling);GO:0042924(neuromedin U binding);GO:0048016(inositol phosphate-mediated signaling)","04080(Neuroactive ligand-receptor interaction)",{"v":0.015,"d":"0.02"},2,"3,87,","0,2538",-1.83,-1.02,8.64,"Exon (ENSBGRT00000038766/ENSBGRG00000021016, exon 1 of 3)",2,18980890,18990573,9684,1]
["chr2",19052097,19054202,2106,"ENSBGRG00000021225","ENSBGRT00000039156",0,"SNORD82","Small nucleolar RNA SNORD82 [Source:RFAM;Acc:RF00158]","NA","NA",0,6,"228,101,29,216,87,110,","0,887,1006,1411,1726,1996",-2570,"-Inf",3.41,"Exon (ENSBGRT00000039057/ENSBGRG00000021053, exon 3 of 16)",2,19053950,19054019,70,1]
["chr2",19435750,19436020,271,"ENSBGRG00000022997","ENSBGRT00000042454",0,"HTR2B","5-hydroxytryptamine receptor 2B [Source:HGNC Symbol;Acc:HGNC:5294]","GO:0001755(neural crest cell migration);GO:0001819(positive regulation of cytokine production);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001965(G-protein alpha-subunit binding);GO:0002031(G protein-coupled receptor internalization);GO:0003007(heart morphogenesis);GO:0003300(cardiac muscle hypertrophy);GO:0004930(G protein-coupled receptor activity);GO:0004993(G protein-coupled serotonin receptor activity);GO:0005096(GTPase activator activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006874(cellular calcium ion homeostasis);GO:0006939(smooth muscle contraction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007202(activation of phospholipase C activity);GO:0007205(protein kinase C-activating G protein-coupled receptor signaling pathway);GO:0007210(serotonin receptor signaling pathway);GO:0007507(heart development);GO:0008144(drug binding);GO:0008284(positive regulation of cell population proliferation);GO:0010507(negative regulation of autophagy);GO:0010513(positive regulation of phosphatidylinositol biosynthetic process);GO:0014033(neural crest cell differentiation);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0014827(intestine smooth muscle contraction);GO:0016021(integral component of membrane);GO:0016310(phosphorylation);GO:0019722(calcium-mediated signaling);GO:0019934(cGMP-mediated signaling);GO:0042310(vasoconstriction);GO:0042493(response to drug);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043406(positive regulation of MAP kinase activity);GO:0048598(embryonic morphogenesis);GO:0050715(positive regulation of cytokine secretion);GO:0050795(regulation of behavior);GO:0051000(positive regulation of nitric-oxide synthase activity);GO:0051209(release of sequestered calcium ion into cytosol);GO:0051378(serotonin binding);GO:0051781(positive regulation of cell division);GO:0060548(negative regulation of cell death);GO:0070371(ERK1 and ERK2 cascade);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070528(protein kinase C signaling);GO:0071502(cellular response to temperature stimulus)","04020(Calcium signaling pathway);04080(Neuroactive ligand-receptor interaction);04540(Gap junction);04726(Serotonergic synapse);04750(Inflammatory mediator regulation of TRP channels)",{"v":0.015,"d":"0.02"},1,"271,",0,-1.83,-1.02,8.64,"5' UTR",2,19435750,19449848,14099,1]
["chr2",19449698,19449848,151,"ENSBGRG00000022636","ENSBGRT00000042287",33606,"PSMD1","proteasome 26S subunit, non-ATPase 1 [Source:HGNC Symbol;Acc:HGNC:9554]","GO:0000502(proteasome complex);GO:0022624(proteasome accessory complex);GO:0030234(enzyme regulator activity);GO:0031625(ubiquitin protein ligase binding);GO:0042176(regulation of protein catabolic process)","03050(Proteasome);05169(Epstein-Barr virus infection)",{"v":0.0022,"d":"0.00"},1,"151,",0,-2.65,-2.04,2.59,"Exon (ENSBGRT00000042454/ENSBGRG00000022997, exon 3 of 3)",2,19391883,19483454,91572,2]
["chr2",19642686,19643257,572,"ENSBGRG00000007191","ENSBGRT00000013355",474,"ENSBGRG00000007191","NA","NA","NA",{"v":0.015,"d":"0.02"},2,"27,507,","0,65",-1.83,-1.02,8.64,"Exon (ENSBGRT00000013355/ENSBGRG00000007191, exon 1 of 2)",2,19642212,19643257,1046,1]
["chr2",20193090,20206122,13033,"ENSBGRG00000008249","ENSBGRT00000015508",16426,"ENSBGRG00000008249","NA","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus)","05203(Viral carcinogenesis);05168(Herpes simplex infection)",{"v":3.2e-41,"d":"0.00"},6,"1,78,129,150,87,34,","0,4193,7313,9717,11844,12999",{"v":-40.5,"d":"-40.50"},{"v":-39.3,"d":"-39.30"},4.04,"Exon (ENSBGRT00000015508/ENSBGRG00000008249, exon 4 of 14)",2,20176664,20223862,47199,1]
["chr2",20231833,20233118,1286,"ENSBGRG00000008249","ENSBGRT00000015208",55169,"ENSBGRG00000008249","NA","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus)","05203(Viral carcinogenesis);05168(Herpes simplex infection)",{"v":1.9E-3,"d":"0.00"},2,"6,114,","0,1172",-2.73,-2.11,3,"Exon (ENSBGRT00000015208/ENSBGRG00000008249, exon 18 of 18)",2,20176664,20231838,55175,1]
["chr2",20316885,20316945,61,"ENSBGRG00000008685","ENSBGRT00000015822",1871,"SLC16A14","solute carrier family 16 member 14 [Source:HGNC Symbol;Acc:HGNC:26417]","GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",0.02,1,"61,",0,-1.69,-1.14,3.96,"5' UTR",2,20315014,20353842,38829,1]
["chr2",20327476,20340991,13516,"ENSBGRG00000008685","ENSBGRT00000015822",12462,"SLC16A14","solute carrier family 16 member 14 [Source:HGNC Symbol;Acc:HGNC:26417]","GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":3.9e-08,"d":"0.00"},3,"29,144,125,","0,7568,13391",-7.41,-6.62,{"v":29.2,"d":"29.20"},"Exon (ENSBGRT00000015822/ENSBGRG00000008685, exon 3 of 6)",2,20315014,20353842,38829,1]
["chr2",20341289,20341497,209,"ENSBGRG00000008685","ENSBGRT00000015822",26275,"SLC16A14","solute carrier family 16 member 14 [Source:HGNC Symbol;Acc:HGNC:26417]","GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":5e-17,"d":"0.00"},1,"209,",0,{"v":-16.3,"d":"-16.30"},{"v":-15.4,"d":"-15.40"},5.02,"Exon (ENSBGRT00000015822/ENSBGRG00000008685, exon 5 of 6)",2,20315014,20353842,38829,1]
["chr2",20534236,20552031,17796,"ENSBGRG00000008829","ENSBGRT00000016758",26395,"TRIP12","thyroid hormone receptor interactor 12 [Source:HGNC Symbol;Acc:HGNC:12306]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005654(nucleoplasm);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008270(zinc ion binding);GO:0016607(nuclear speck);GO:0045995(regulation of embryonic development);GO:0046966(thyroid hormone receptor binding);GO:0061630(ubiquitin protein ligase activity);GO:1901315(negative regulation of histone H2A K63-linked ubiquitination);GO:2000780(negative regulation of double-strand break repair)","04120(Ubiquitin mediated proteolysis)",{"v":5e-60,"d":"0.00"},3,"44,126,700,","0,16119,17096",{"v":-59.3,"d":"-59.30"},{"v":-57.9,"d":"-57.90"},2.88,"Exon (ENSBGRT00000016758/ENSBGRG00000008829, exon 2 of 43)",2,20507841,20653726,145886,1]
["chr2",21539151,21539472,322,"ENSBGRG00000009672","ENSBGRT00000017766",290770,"PID1","phosphotyrosine interaction domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26084]","GO:0001933(negative regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0010628(positive regulation of gene expression);GO:0042127(regulation of cell population proliferation);GO:0044320(cellular response to leptin stimulus);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046325(negative regulation of glucose import);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0051881(regulation of mitochondrial membrane potential);GO:0070346(positive regulation of fat cell proliferation);GO:0070584(mitochondrion morphogenesis);GO:0071345(cellular response to cytokine stimulus);GO:0071354(cellular response to interleukin-6);GO:0071356(cellular response to tumor necrosis factor);GO:0071398(cellular response to fatty acid);GO:1903077(negative regulation of protein localization to plasma membrane);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000379(positive regulation of reactive oxygen species metabolic process);GO:2001170(negative regulation of ATP biosynthetic process);GO:2001171(positive regulation of ATP biosynthetic process)","NA",{"v":1e-147,"d":"0.00"},1,"322,",0,-147,-145,4.41,"3' UTR",2,21248381,21539472,291092,1]
["chr2",22516412,22516891,480,"ENSBGRG00000009780","ENSBGRT00000018002",168823,"SPHKAP","SPHK1 interactor, AKAP domain containing [Source:HGNC Symbol;Acc:HGNC:30619]","GO:0051018(protein kinase A binding)","NA",{"v":0.0041,"d":"0.00"},1,"480,",0,-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000018002/ENSBGRG00000009780, exon 8 of 13)",2,22347589,22552581,204993,1]
["chr2",22535462,22552581,17120,"ENSBGRG00000009780","ENSBGRT00000018002",187873,"SPHKAP","SPHK1 interactor, AKAP domain containing [Source:HGNC Symbol;Acc:HGNC:30619]","GO:0051018(protein kinase A binding)","NA",{"v":0.028,"d":"0.03"},4,"67,53,185,325,","0,2395,2535,16795",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"3' UTR",2,22347589,22552581,204993,1]
["chr2",22837323,22837383,61,"ENSBGRG00000010183","ENSBGRT00000018690",4575,"ENSBGRG00000010183","solute carrier family 19 member 3 [Source:HGNC Symbol;Acc:HGNC:16266]","GO:0016021(integral component of membrane);GO:0051180(vitamin transport);GO:0090482(vitamin transmembrane transporter activity)","04977(Vitamin digestion and absorption)",{"v":0.019,"d":"0.02"},1,"61,",0,-1.72,-1.17,2.52,"Exon (ENSBGRT00000018690/ENSBGRG00000010183, exon 2 of 5)",2,22832748,22842587,9840,1]
["chr2",22841778,22841987,210,"ENSBGRG00000010183","ENSBGRT00000018690",9030,"ENSBGRG00000010183","solute carrier family 19 member 3 [Source:HGNC Symbol;Acc:HGNC:16266]","GO:0016021(integral component of membrane);GO:0051180(vitamin transport);GO:0090482(vitamin transmembrane transporter activity)","04977(Vitamin digestion and absorption)",{"v":5e-12,"d":"0.00"},1,"210,",0,{"v":-11.3,"d":"-11.30"},{"v":-10.4,"d":"-10.40"},3.42,"3' UTR",2,22832748,22842587,9840,1]
["chr2",23557396,23557605,210,"ENSBGRG00000012460","ENSBGRT00000023562",149775,"COL4A4","collagen type IV alpha 4 chain [Source:HGNC Symbol;Acc:HGNC:2206]","GO:0005201(extracellular matrix structural constituent);GO:0005581(collagen trimer);GO:0005587(collagen type IV trimer);GO:0005604(basement membrane);GO:0032836(glomerular basement membrane development)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04926(Relaxin signaling pathway);04974(Protein digestion and absorption);05200(Pathways in cancer);05222(Small cell lung cancer);04933(AGE-RAGE signaling pathway in diabetic complications);05165(Human papillomavirus infection);05146(Amoebiasis)",{"v":9.99999999999999e-219,"d":"0.00"},1,"210,",0,-218,-216,2.87,"Exon (ENSBGRT00000023562/ENSBGRG00000012460, exon 48 of 48)",2,23407621,23557635,150015,1]
["chr2",23757697,23757877,181,"ENSBGRG00000013185","ENSBGRT00000024094",30,"IRS1","insulin receptor substrate 1 [Source:HGNC Symbol;Acc:HGNC:6125]","GO:0001784(phosphotyrosine residue binding);GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0008286(insulin receptor signaling pathway);GO:0010907(positive regulation of glucose metabolic process);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0030159(receptor signaling complex adaptor activity);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0032868(response to insulin);GO:0032869(cellular response to insulin stimulus);GO:0043548(phosphatidylinositol 3-kinase binding);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0046326(positive regulation of glucose import);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0046676(negative regulation of insulin secretion);GO:0048009(insulin-like growth factor receptor signaling pathway)","04068(FoxO signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04960(Aldosterone-regulated sodium reabsorption);04722(Neurotrophin signaling pathway);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05206(MicroRNAs in cancer);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance)",{"v":7.9e-44,"d":"0.00"},1,"181,",0,{"v":-43.1,"d":"-43.10"},{"v":-41.8,"d":"-41.80"},5.61,"Exon (ENSBGRT00000024094/ENSBGRG00000013185, exon 1 of 1)",2,23757667,23761380,3714,1]
["chr2",23758326,23758416,91,"ENSBGRG00000013185","ENSBGRT00000024094",659,"IRS1","insulin receptor substrate 1 [Source:HGNC Symbol;Acc:HGNC:6125]","GO:0001784(phosphotyrosine residue binding);GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0008286(insulin receptor signaling pathway);GO:0010907(positive regulation of glucose metabolic process);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0030159(receptor signaling complex adaptor activity);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0032868(response to insulin);GO:0032869(cellular response to insulin stimulus);GO:0043548(phosphatidylinositol 3-kinase binding);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0046326(positive regulation of glucose import);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0046676(negative regulation of insulin secretion);GO:0048009(insulin-like growth factor receptor signaling pathway)","04068(FoxO signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04960(Aldosterone-regulated sodium reabsorption);04722(Neurotrophin signaling pathway);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05206(MicroRNAs in cancer);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance)",{"v":1.3e-16,"d":"0.00"},1,"91,",0,{"v":-15.9,"d":"-15.90"},{"v":-14.9,"d":"-14.90"},2.23,"Exon (ENSBGRT00000024094/ENSBGRG00000013185, exon 1 of 1)",2,23757667,23761380,3714,1]
["chr2",23759464,23760003,540,"ENSBGRG00000013185","ENSBGRT00000024094",1797,"IRS1","insulin receptor substrate 1 [Source:HGNC Symbol;Acc:HGNC:6125]","GO:0001784(phosphotyrosine residue binding);GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0008286(insulin receptor signaling pathway);GO:0010907(positive regulation of glucose metabolic process);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0030159(receptor signaling complex adaptor activity);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0032868(response to insulin);GO:0032869(cellular response to insulin stimulus);GO:0043548(phosphatidylinositol 3-kinase binding);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0046326(positive regulation of glucose import);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0046676(negative regulation of insulin secretion);GO:0048009(insulin-like growth factor receptor signaling pathway)","04068(FoxO signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04960(Aldosterone-regulated sodium reabsorption);04722(Neurotrophin signaling pathway);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05206(MicroRNAs in cancer);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance)",{"v":1e-116,"d":"0.00"},1,"540,",0,-116,-114,4.59,"Exon (ENSBGRT00000024094/ENSBGRG00000013185, exon 1 of 1)",2,23757667,23761380,3714,1]
["chr2",26381178,26381267,90,"ENSBGRG00000015353","ENSBGRT00000028229",115260,"CUL3","cullin 3 [Source:HGNC Symbol;Acc:HGNC:2553]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000209(protein polyubiquitination);GO:0000278(mitotic cell cycle);GO:0000902(cell morphogenesis);GO:0000922(spindle pole);GO:0001701(in utero embryonic development);GO:0001831(trophectodermal cellular morphogenesis);GO:0004842(ubiquitin-protein transferase activity);GO:0005112(Notch binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005827(polar microtubule);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006513(protein monoubiquitination);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007080(mitotic metaphase plate congression);GO:0007229(integrin-mediated signaling pathway);GO:0007369(gastrulation);GO:0016055(Wnt signaling pathway);GO:0016477(cell migration);GO:0016567(protein ubiquitination);GO:0017145(stem cell division);GO:0030332(cyclin binding);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0031208(POZ domain binding);GO:0031398(positive regulation of protein ubiquitination);GO:0031461(cullin-RING ubiquitin ligase complex);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0031625(ubiquitin protein ligase binding);GO:0031648(protein destabilization);GO:0032467(positive regulation of cytokinesis);GO:0035024(negative regulation of Rho protein signal transduction);GO:0036126(sperm flagellum);GO:0040016(embryonic cleavage);GO:0043149(stress fiber assembly);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0044346(fibroblast apoptotic process);GO:0045842(positive regulation of mitotic metaphase/anaphase transition);GO:0048208(COPII vesicle coating);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0071630(nuclear protein quality control by the ubiquitin-proteasome system);GO:0072576(liver morphogenesis);GO:0072686(mitotic spindle);GO:1901992(positive regulation of mitotic cell cycle phase transition)","04120(Ubiquitin mediated proteolysis);04340(Hedgehog signaling pathway)",{"v":9.8e-10,"d":"0.00"},1,"90,",0,-9.01,-8.19,1.47,"Exon (ENSBGRT00000028229/ENSBGRG00000015353, exon 15 of 15)",2,26265918,26381464,115547,1]
["chr2",26383558,26383647,90,"ENSBGRG00000015353","ENSBGRT00000028184",117640,"CUL3","cullin 3 [Source:HGNC Symbol;Acc:HGNC:2553]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000209(protein polyubiquitination);GO:0000278(mitotic cell cycle);GO:0000902(cell morphogenesis);GO:0000922(spindle pole);GO:0001701(in utero embryonic development);GO:0001831(trophectodermal cellular morphogenesis);GO:0004842(ubiquitin-protein transferase activity);GO:0005112(Notch binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005827(polar microtubule);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006513(protein monoubiquitination);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007080(mitotic metaphase plate congression);GO:0007229(integrin-mediated signaling pathway);GO:0007369(gastrulation);GO:0016055(Wnt signaling pathway);GO:0016477(cell migration);GO:0016567(protein ubiquitination);GO:0017145(stem cell division);GO:0030332(cyclin binding);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0031208(POZ domain binding);GO:0031398(positive regulation of protein ubiquitination);GO:0031461(cullin-RING ubiquitin ligase complex);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0031625(ubiquitin protein ligase binding);GO:0031648(protein destabilization);GO:0032467(positive regulation of cytokinesis);GO:0035024(negative regulation of Rho protein signal transduction);GO:0036126(sperm flagellum);GO:0040016(embryonic cleavage);GO:0043149(stress fiber assembly);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0044346(fibroblast apoptotic process);GO:0045842(positive regulation of mitotic metaphase/anaphase transition);GO:0048208(COPII vesicle coating);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0071630(nuclear protein quality control by the ubiquitin-proteasome system);GO:0072576(liver morphogenesis);GO:0072686(mitotic spindle);GO:1901992(positive regulation of mitotic cell cycle phase transition)","04120(Ubiquitin mediated proteolysis);04340(Hedgehog signaling pathway)",{"v":6.3e-36,"d":"0.00"},1,"90,",0,{"v":-35.2,"d":"-35.20"},-34,5.13,"3' UTR",2,26265918,26383647,117730,1]
["chr2",26463534,26479774,16241,"ENSBGRG00000015631","ENSBGRT00000028720",0,"FAM124B","family with sequence similarity 124 member B [Source:HGNC Symbol;Acc:HGNC:26224]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","NA",{"v":0.0026,"d":"0.00"},4,"17,811,122,37,","0,11481,15995,16204",-2.58,-1.97,6.48,"5' UTR",2,26463534,26490951,27418,1]
["chr2",26480043,26480163,121,"ENSBGRG00000015631","ENSBGRT00000028720",16509,"FAM124B","family with sequence similarity 124 member B [Source:HGNC Symbol;Acc:HGNC:26224]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","NA",{"v":0.013,"d":"0.01"},1,"121,",0,-1.87,-1.31,3.51,"Exon (ENSBGRT00000028720/ENSBGRG00000015631, exon 3 of 4)",2,26463534,26490951,27418,1]
["chr2",26480372,26490383,10012,"ENSBGRG00000015631","ENSBGRT00000028720",16838,"FAM124B","family with sequence similarity 124 member B [Source:HGNC Symbol;Acc:HGNC:26224]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","NA",{"v":7.2e-05,"d":"0.00"},2,"154,86,","0,9926",-4.14,-3.45,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000028720/ENSBGRG00000015631, exon 3 of 4)",2,26463534,26490951,27418,1]
["chr2",26490592,26490951,360,"ENSBGRG00000015631","ENSBGRT00000028720",27058,"FAM124B","family with sequence similarity 124 member B [Source:HGNC Symbol;Acc:HGNC:26224]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","NA",{"v":2e-09,"d":"0.00"},1,"360,",0,-8.69,-7.87,{"v":32.4,"d":"32.40"},"Exon (ENSBGRT00000028720/ENSBGRG00000015631, exon 4 of 4)",2,26463534,26490951,27418,1]
["chr2",27007966,27009388,1423,"ENSBGRG00000016123","ENSBGRT00000029885",54885,"ENSBGRG00000016123","WD repeat and FYVE domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20451]","GO:0005515(protein binding);GO:0005769(early endosome);GO:0034141(positive regulation of toll-like receptor 3 signaling pathway);GO:0034145(positive regulation of toll-like receptor 4 signaling pathway);GO:0046872(metal ion binding)","04144(Endocytosis);04145(Phagosome)",{"v":1e-124,"d":"0.00"},2,"41,347,","0,1076",-124,-122,4.38,"3' UTR",2,26953081,27010101,57021,1]
["chr2",27009597,27009835,239,"ENSBGRG00000016123","ENSBGRT00000029885",56516,"ENSBGRG00000016123","WD repeat and FYVE domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20451]","GO:0005515(protein binding);GO:0005769(early endosome);GO:0034141(positive regulation of toll-like receptor 3 signaling pathway);GO:0034145(positive regulation of toll-like receptor 4 signaling pathway);GO:0046872(metal ion binding)","04144(Endocytosis);04145(Phagosome)",{"v":4e-44,"d":"0.00"},1,"239,",0,{"v":-43.4,"d":"-43.40"},{"v":-42.2,"d":"-42.20"},2.09,"3' UTR",2,26953081,27010101,57021,1]
["chr2",29608965,29613377,4413,"ENSBGRG00000017734","ENSBGRT00000032509",0,"EPHA4","EPH receptor A4 [Source:HGNC Symbol;Acc:HGNC:3388]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005004(GPI-linked ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007628(adult walking behavior);GO:0008045(motor neuron axon guidance);GO:0010977(negative regulation of neuron projection development);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021957(corticospinal tract morphogenesis);GO:0030424(axon);GO:0030425(dendrite);GO:0031901(early endosome membrane);GO:0034332(adherens junction organization);GO:0042731(PH domain binding);GO:0042802(identical protein binding);GO:0043087(regulation of GTPase activity);GO:0043507(positive regulation of JUN kinase activity);GO:0046777(protein autophosphorylation);GO:0048013(ephrin receptor signaling pathway);GO:0048681(negative regulation of axon regeneration);GO:0048710(regulation of astrocyte differentiation);GO:0050770(regulation of axonogenesis);GO:0050821(protein stabilization);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0072178(nephric duct morphogenesis);GO:0090102(cochlea development);GO:0097155(fasciculation of sensory neuron axon);GO:0097156(fasciculation of motor neuron axon);GO:0097161(DH domain binding);GO:0097485(neuron projection guidance);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099056(integral component of presynaptic membrane);GO:0106030(neuron projection fasciculation);GO:1900272(negative regulation of long-term synaptic potentiation);GO:1902004(positive regulation of amyloid-beta formation);GO:1902961(positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process);GO:1903051(negative regulation of proteolysis involved in cellular protein catabolic process);GO:1904646(cellular response to amyloid-beta);GO:1905244(regulation of modification of synaptic structure);GO:1990782(protein tyrosine kinase binding);GO:2001108(positive regulation of Rho guanyl-nucleotide exchange factor activity)","04360(Axon guidance)",{"v":1.9e-05,"d":"0.00"},2,"398,22,","0,4391",-4.71,-4,{"v":19.4,"d":"19.40"},"5' UTR",2,29608965,29784566,175602,1]
["chr2",29784476,29784566,91,"ENSBGRG00000017734","ENSBGRT00000032509",175511,"EPHA4","EPH receptor A4 [Source:HGNC Symbol;Acc:HGNC:3388]","GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005004(GPI-linked ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007628(adult walking behavior);GO:0008045(motor neuron axon guidance);GO:0010977(negative regulation of neuron projection development);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021957(corticospinal tract morphogenesis);GO:0030424(axon);GO:0030425(dendrite);GO:0031901(early endosome membrane);GO:0034332(adherens junction organization);GO:0042731(PH domain binding);GO:0042802(identical protein binding);GO:0043087(regulation of GTPase activity);GO:0043507(positive regulation of JUN kinase activity);GO:0046777(protein autophosphorylation);GO:0048013(ephrin receptor signaling pathway);GO:0048681(negative regulation of axon regeneration);GO:0048710(regulation of astrocyte differentiation);GO:0050770(regulation of axonogenesis);GO:0050821(protein stabilization);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0072178(nephric duct morphogenesis);GO:0090102(cochlea development);GO:0097155(fasciculation of sensory neuron axon);GO:0097156(fasciculation of motor neuron axon);GO:0097161(DH domain binding);GO:0097485(neuron projection guidance);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099056(integral component of presynaptic membrane);GO:0106030(neuron projection fasciculation);GO:1900272(negative regulation of long-term synaptic potentiation);GO:1902004(positive regulation of amyloid-beta formation);GO:1902961(positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process);GO:1903051(negative regulation of proteolysis involved in cellular protein catabolic process);GO:1904646(cellular response to amyloid-beta);GO:1905244(regulation of modification of synaptic structure);GO:1990782(protein tyrosine kinase binding);GO:2001108(positive regulation of Rho guanyl-nucleotide exchange factor activity)","04360(Axon guidance)",{"v":4.3e-06,"d":"0.00"},1,"91,",0,-5.37,-4.64,5.25,"Exon (ENSBGRT00000032509/ENSBGRG00000017734, exon 17 of 17)",2,29608965,29784566,175602,1]
["chr2",32065873,32066977,1105,"ENSBGRG00000019378","ENSBGRT00000035619",3589,"CHPF","chondroitin polymerizing factor [Source:HGNC Symbol;Acc:HGNC:24291]","GO:0008376(acetylgalactosaminyltransferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030206(chondroitin sulfate biosynthetic process);GO:0032580(Golgi cisterna membrane);GO:0047238(glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity);GO:0050510(N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)",0,1,"1105,",0,-413,"-Inf",7.15,"Exon (ENSBGRT00000035619/ENSBGRG00000019378, exon 4 of 4)",2,32062284,32066977,4694,1]
["chr2",32376719,32377137,419,"ENSBGRG00000021241","ENSBGRT00000039476",3730,"ENSBGRG00000021241","NA","GO:0003924(GTPase activity);GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0004565(beta-galactosidase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005525(GTP binding);GO:0005874(microtubule);GO:0005975(carbohydrate metabolic process);GO:0007017(microtubule-based process)","04145(Phagosome);04210(Apoptosis);04530(Tight junction);04540(Gap junction);05130(Pathogenic Escherichia coli infection)",{"v":6.3e-14,"d":"0.00"},1,"419,",0,{"v":-13.2,"d":"-13.20"},{"v":-12.3,"d":"-12.30"},3.24,"5' UTR",2,32372989,32392537,19549,1]
["chr2",32392482,32392721,240,"ENSBGRG00000021241","ENSBGRT00000039476",19493,"ENSBGRG00000021241","NA","GO:0003924(GTPase activity);GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0004565(beta-galactosidase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005525(GTP binding);GO:0005874(microtubule);GO:0005975(carbohydrate metabolic process);GO:0007017(microtubule-based process)","04145(Phagosome);04210(Apoptosis);04530(Tight junction);04540(Gap junction);05130(Pathogenic Escherichia coli infection)",{"v":2.5e-54,"d":"0.00"},1,"240,",0,{"v":-53.6,"d":"-53.60"},{"v":-52.3,"d":"-52.30"},2.56,"3' UTR",2,32372989,32392537,19549,1]
["chr2",32408982,32409132,151,"ENSBGRG00000021811","ENSBGRT00000040355",9148,"ENSBGRG00000021811","autophagy related 9A [Source:HGNC Symbol;Acc:HGNC:22408]","GO:0006914(autophagy)","04140(Autophagy - animal);04136(Autophagy - other eukaryotes);04137(Mitophagy - animal)",{"v":1.6e-39,"d":"0.00"},1,"151,",0,{"v":-38.8,"d":"-38.80"},{"v":-37.6,"d":"-37.60"},2.06,"3' UTR",2,32399834,32409910,10077,1]
["chr2",32456719,32458488,1770,"ENSBGRG00000000191","ENSBGRT00000000311",0,"CNPPD1","cyclin Pas1/PHO80 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25220]","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0019901(protein kinase binding)","NA",{"v":0.0041,"d":"0.00"},2,"27,813,","0,957",-2.39,-1.79,5.04,"5' UTR",2,32456719,32463188,6470,1]
["chr2",32578882,32579212,331,"ENSBGRG00000000275","ENSBGRT00000000562",113748,"ENSBGRG00000000275","NA","GO:0005634(nucleus);GO:0006302(double-strand break repair);GO:0016020(membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","03450(Non-homologous end-joining)",{"v":6.3e-17,"d":"0.00"},1,"331,",0,{"v":-16.2,"d":"-16.20"},{"v":-15.3,"d":"-15.30"},2.59,"3' UTR",2,32465134,32579212,114079,1]
["chr2",33035001,33035150,150,"ENSBGRG00000001002","ENSBGRT00000001866",8218,"RNF25","ring finger protein 25 [Source:HGNC Symbol;Acc:HGNC:14662]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0016567(protein ubiquitination);GO:0051059(NF-kappaB binding);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":1e-102,"d":"0.00"},1,"150,",0,-102,{"v":-99.9,"d":"-99.90"},3.15,"Exon (ENSBGRT00000001866/ENSBGRG00000001002, exon 10 of 10)",2,33026783,33035625,8843,1]
["chr2",33056504,33057043,540,"ENSBGRG00000001065","ENSBGRT00000001984",10725,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":5e-92,"d":"0.00"},1,"540,",0,{"v":-91.3,"d":"-91.30"},{"v":-89.8,"d":"-89.80"},8.55,"Exon (ENSBGRT00000001984/ENSBGRG00000001065, exon 6 of 8)",2,33045779,33061179,15401,1]
["chr2",33058061,33058150,90,"ENSBGRG00000001065","ENSBGRT00000001984",12282,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":2.5E-42,"d":"0.00"},1,"90,",0,{"v":-41.6,"d":"-41.60"},{"v":-40.4,"d":"-40.40"},6.56,"Exon (ENSBGRT00000001984/ENSBGRG00000001065, exon 6 of 8)",2,33045779,33061179,15401,1]
["chr2",33059647,33060649,1003,"ENSBGRG00000001065","ENSBGRT00000001984",13868,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":4e-75,"d":"0.00"},2,"223,17,","0,986",{"v":-74.4,"d":"-74.40"},{"v":-72.9,"d":"-72.90"},3.47,"Exon (ENSBGRT00000001984/ENSBGRG00000001065, exon 6 of 8)",2,33045779,33061179,15401,1]
["chr2",33062365,33062604,240,"ENSBGRG00000001065","ENSBGRT00000001957",16586,"ENSBGRG00000001065","NA","GO:0003676(nucleic acid binding)","NA",{"v":1e-110,"d":"0.00"},1,"240,",0,-110,-108,4.49,"Exon (ENSBGRT00000001957/ENSBGRG00000001065, exon 8 of 8)",2,33045779,33062604,16826,1]
["chr2",33132978,33133128,151,"ENSBGRG00000001165","ENSBGRT00000002268",0,"USP37","ubiquitin specific peptidase 37 [Source:HGNC Symbol;Acc:HGNC:20063]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0006275(regulation of DNA replication);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0019901(protein kinase binding);GO:0035871(protein K11-linked deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0071108(protein K48-linked deubiquitination)","NA",{"v":0.014,"d":"0.01"},1,"151,",0,-1.86,{"v":-1.3,"d":"-1.30"},{"v":5.4,"d":"5.40"},"5' UTR",2,33132978,33167886,34909,1]
["chr2",33221658,33222436,779,"ENSBGRG00000001165","ENSBGRT00000002206",88680,"USP37","ubiquitin specific peptidase 37 [Source:HGNC Symbol;Acc:HGNC:20063]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0006275(regulation of DNA replication);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0019901(protein kinase binding);GO:0035871(protein K11-linked deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0071108(protein K48-linked deubiquitination)","NA",{"v":0.00037,"d":"0.00"},1,"779,",0,-3.43,-2.77,{"v":11.9,"d":"11.90"},"3' UTR",2,33132978,33222832,89855,1]
["chr2",33788990,33789109,120,"ENSBGRG00000001914","ENSBGRT00000003950",196768,"TNS1","tensin 1 [Source:HGNC Symbol;Acc:HGNC:11973]","GO:0005515(protein binding);GO:0005925(focal adhesion);GO:0007044(cell-substrate junction assembly);GO:0010761(fibroblast migration);GO:0030055(cell-substrate junction);GO:0035556(intracellular signal transduction)","NA",{"v":1.1E-5,"d":"0.00"},1,"120,",0,-4.96,-4.24,4.32,"Exon (ENSBGRT00000003950/ENSBGRG00000001914, exon 19 of 35)",2,33592222,33840431,248210,1]
["chr2",33838632,33839232,601,"ENSBGRG00000001914","ENSBGRT00000003950",246410,"TNS1","tensin 1 [Source:HGNC Symbol;Acc:HGNC:11973]","GO:0005515(protein binding);GO:0005925(focal adhesion);GO:0007044(cell-substrate junction assembly);GO:0010761(fibroblast migration);GO:0030055(cell-substrate junction);GO:0035556(intracellular signal transduction)","NA",0,1,"601,",0,-1800,"-Inf",{"v":8.3,"d":"8.30"},"3' UTR",2,33592222,33840431,248210,1]
["chr2",35237119,35237388,270,"ENSBGRG00000002228","ENSBGRT00000004148",26119,"IGFBP5","insulin like growth factor binding protein 5 [Source:HGNC Symbol;Acc:HGNC:5474]","GO:0001558(regulation of cell growth);GO:0001649(osteoblast differentiation);GO:0001968(fibronectin binding);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0007565(female pregnancy);GO:0014912(negative regulation of smooth muscle cell migration);GO:0017148(negative regulation of translation);GO:0030336(negative regulation of cell migration);GO:0031069(hair follicle morphogenesis);GO:0031994(insulin-like growth factor I binding);GO:0040008(regulation of growth);GO:0042567(insulin-like growth factor ternary complex);GO:0042593(glucose homeostasis);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0043569(negative regulation of insulin-like growth factor receptor signaling pathway);GO:0044342(type B pancreatic cell proliferation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045926(negative regulation of growth);GO:0048286(lung alveolus development);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0051146(striated muscle cell differentiation);GO:0051897(positive regulation of protein kinase B signaling);GO:0060056(mammary gland involution);GO:0071320(cellular response to cAMP);GO:0071407(cellular response to organic cyclic compound);GO:1901862(negative regulation of muscle tissue development);GO:1904205(negative regulation of skeletal muscle hypertrophy);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration)","04115(p53 signaling pathway);04218(Cellular senescence);05202(Transcriptional misregulation in cancers)",{"v":1e-245,"d":"0.00"},1,"270,",0,-245,-243,2.23,"3' UTR",2,35211000,35238586,27587,1]
["chr2",35238376,35238586,211,"ENSBGRG00000002228","ENSBGRT00000004148",27376,"IGFBP5","insulin like growth factor binding protein 5 [Source:HGNC Symbol;Acc:HGNC:5474]","GO:0001558(regulation of cell growth);GO:0001649(osteoblast differentiation);GO:0001968(fibronectin binding);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0007565(female pregnancy);GO:0014912(negative regulation of smooth muscle cell migration);GO:0017148(negative regulation of translation);GO:0030336(negative regulation of cell migration);GO:0031069(hair follicle morphogenesis);GO:0031994(insulin-like growth factor I binding);GO:0040008(regulation of growth);GO:0042567(insulin-like growth factor ternary complex);GO:0042593(glucose homeostasis);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0043569(negative regulation of insulin-like growth factor receptor signaling pathway);GO:0044342(type B pancreatic cell proliferation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045926(negative regulation of growth);GO:0048286(lung alveolus development);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0051146(striated muscle cell differentiation);GO:0051897(positive regulation of protein kinase B signaling);GO:0060056(mammary gland involution);GO:0071320(cellular response to cAMP);GO:0071407(cellular response to organic cyclic compound);GO:1901862(negative regulation of muscle tissue development);GO:1904205(negative regulation of skeletal muscle hypertrophy);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration)","04115(p53 signaling pathway);04218(Cellular senescence);05202(Transcriptional misregulation in cancers)",{"v":2.5e-57,"d":"0.00"},1,"211,",0,{"v":-56.6,"d":"-56.60"},{"v":-55.2,"d":"-55.20"},1.72,"3' UTR",2,35211000,35238586,27587,1]
["chr2",42576931,42577021,91,"ENSBGRG00000004930","ENSBGRT00000009081",839,"KANSL1L","KAT8 regulatory NSL complex subunit 1 like [Source:HGNC Symbol;Acc:HGNC:26310]","GO:0000123(histone acetyltransferase complex)","NA",{"v":0.00038,"d":"0.00"},1,"91,",0,-3.42,-2.77,4.75,"5' UTR",2,42576092,42685209,109118,1]
["chr2",42577111,42577231,121,"ENSBGRG00000004930","ENSBGRT00000009081",1019,"KANSL1L","KAT8 regulatory NSL complex subunit 1 like [Source:HGNC Symbol;Acc:HGNC:26310]","GO:0000123(histone acetyltransferase complex)","NA",{"v":3.2e-25,"d":"0.00"},1,"121,",0,{"v":-24.5,"d":"-24.50"},{"v":-23.5,"d":"-23.50"},{"v":3.6,"d":"3.60"},"Exon (ENSBGRT00000009081/ENSBGRG00000004930, exon 1 of 14)",2,42576092,42685209,109118,1]
["chr2",42577561,42577620,60,"ENSBGRG00000004930","ENSBGRT00000009081",1469,"KANSL1L","KAT8 regulatory NSL complex subunit 1 like [Source:HGNC Symbol;Acc:HGNC:26310]","GO:0000123(histone acetyltransferase complex)","NA",{"v":1e-60,"d":"0.00"},1,"60,",0,-60,{"v":-58.6,"d":"-58.60"},6.52,"Exon (ENSBGRT00000009081/ENSBGRG00000004930, exon 1 of 14)",2,42576092,42685209,109118,1]
["chr2",42577710,42577950,241,"ENSBGRG00000004930","ENSBGRT00000009081",1618,"KANSL1L","KAT8 regulatory NSL complex subunit 1 like [Source:HGNC Symbol;Acc:HGNC:26310]","GO:0000123(histone acetyltransferase complex)","NA",{"v":1e-105,"d":"0.00"},1,"241,",0,-105,-103,8.29,"Exon (ENSBGRT00000009081/ENSBGRG00000004930, exon 1 of 14)",2,42576092,42685209,109118,1]
["chr2",42685029,42685209,181,"ENSBGRG00000004930","ENSBGRT00000009081",108937,"KANSL1L","KAT8 regulatory NSL complex subunit 1 like [Source:HGNC Symbol;Acc:HGNC:26310]","GO:0000123(histone acetyltransferase complex)","NA",{"v":1.3E-36,"d":"0.00"},1,"181,",0,{"v":-35.9,"d":"-35.90"},{"v":-34.8,"d":"-34.80"},2.24,"Exon (ENSBGRT00000009081/ENSBGRG00000004930, exon 14 of 14)",2,42576092,42685209,109118,1]
["chr2",44400761,44400850,90,"ENSBGRG00000006928","ENSBGRT00000012867",597,"PLEKHM3","pleckstrin homology domain containing M3 [Source:HGNC Symbol;Acc:HGNC:34006]","GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0045445(myoblast differentiation)","04140(Autophagy - animal)",{"v":2.5e-06,"d":"0.00"},1,"90,",0,{"v":-5.6,"d":"-5.60"},-4.86,2.72,"Exon (ENSBGRT00000012867/ENSBGRG00000006928, exon 1 of 7)",2,44400164,44605470,205307,1]
["chr2",44683959,44684167,209,"ENSBGRG00000007062","ENSBGRT00000012964",1013,"FZD5","frizzled class receptor 5 [Source:HGNC Symbol;Acc:HGNC:4043]","GO:0000578(embryonic axis specification);GO:0001525(angiogenesis);GO:0001540(amyloid-beta binding);GO:0001944(vasculature development);GO:0002726(positive regulation of T cell cytokine production);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005923(bicellular tight junction);GO:0007166(cell surface receptor signaling pathway);GO:0008285(negative regulation of cell population proliferation);GO:0008595(anterior/posterior axis specification, embryo);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0019901(protein kinase binding);GO:0031076(embryonic camera-type eye development);GO:0031077(post-embryonic camera-type eye development);GO:0031625(ubiquitin protein ligase binding);GO:0032729(positive regulation of interferon-gamma production);GO:0032731(positive regulation of interleukin-1 beta production);GO:0033077(T cell differentiation in thymus);GO:0042813(Wnt-activated receptor activity);GO:0043507(positive regulation of JUN kinase activity);GO:0044877(protein-containing complex binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048469(cell maturation);GO:0048471(perinuclear region of cytoplasm);GO:0048596(embryonic camera-type eye morphogenesis);GO:0060061(Spemann organizer formation);GO:0060070(canonical Wnt signaling pathway);GO:0060561(apoptotic process involved in morphogenesis);GO:0060670(branching involved in labyrinthine layer morphogenesis);GO:0060715(syncytiotrophoblast cell differentiation involved in labyrinthine layer development);GO:0060716(labyrinthine layer blood vessel development);GO:0060718(chorionic trophoblast cell differentiation);GO:0071219(cellular response to molecule of bacterial origin);GO:1901382(regulation of chorionic trophoblast cell proliferation);GO:1904469(positive regulation of tumor necrosis factor secretion);GO:2000810(regulation of bicellular tight junction assembly)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":2.1E-7,"d":"0.00"},1,"209,",0,-6.68,-5.91,7.56,"Exon (ENSBGRT00000012964/ENSBGRG00000007062, exon 1 of 1)",2,44682946,44684703,1758,1]
["chr2",44684227,44684703,477,"ENSBGRG00000007062","ENSBGRT00000012964",1281,"FZD5","frizzled class receptor 5 [Source:HGNC Symbol;Acc:HGNC:4043]","GO:0000578(embryonic axis specification);GO:0001525(angiogenesis);GO:0001540(amyloid-beta binding);GO:0001944(vasculature development);GO:0002726(positive regulation of T cell cytokine production);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005923(bicellular tight junction);GO:0007166(cell surface receptor signaling pathway);GO:0008285(negative regulation of cell population proliferation);GO:0008595(anterior/posterior axis specification, embryo);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0019901(protein kinase binding);GO:0031076(embryonic camera-type eye development);GO:0031077(post-embryonic camera-type eye development);GO:0031625(ubiquitin protein ligase binding);GO:0032729(positive regulation of interferon-gamma production);GO:0032731(positive regulation of interleukin-1 beta production);GO:0033077(T cell differentiation in thymus);GO:0042813(Wnt-activated receptor activity);GO:0043507(positive regulation of JUN kinase activity);GO:0044877(protein-containing complex binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048469(cell maturation);GO:0048471(perinuclear region of cytoplasm);GO:0048596(embryonic camera-type eye morphogenesis);GO:0060061(Spemann organizer formation);GO:0060070(canonical Wnt signaling pathway);GO:0060561(apoptotic process involved in morphogenesis);GO:0060670(branching involved in labyrinthine layer morphogenesis);GO:0060715(syncytiotrophoblast cell differentiation involved in labyrinthine layer development);GO:0060716(labyrinthine layer blood vessel development);GO:0060718(chorionic trophoblast cell differentiation);GO:0071219(cellular response to molecule of bacterial origin);GO:1901382(regulation of chorionic trophoblast cell proliferation);GO:1904469(positive regulation of tumor necrosis factor secretion);GO:2000810(regulation of bicellular tight junction assembly)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":1.5e-07,"d":"0.00"},1,"477,",0,-6.81,-6.03,27,"Exon (ENSBGRT00000012964/ENSBGRG00000007062, exon 1 of 1)",2,44682946,44684703,1758,1]
["chr2",45327207,45438499,111293,"ENSBGRG00000007842","ENSBGRT00000014355",0,"KLF7","Kruppel like factor 7 [Source:HGNC Symbol;Acc:HGNC:6350]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0007409(axonogenesis);GO:0007411(axon guidance);GO:0042593(glucose homeostasis);GO:0045604(regulation of epidermal cell differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048813(dendrite morphogenesis);GO:0061179(negative regulation of insulin secretion involved in cellular response to glucose stimulus);GO:1904178(negative regulation of adipose tissue development)","NA",{"v":1E-182,"d":"0.00"},6,"119,240,51,631,128,387,","0,335,35106,45493,102964,110906",-182,-180,6.09,"5' UTR",2,45327207,45430298,103092,1]
["chr2",45438708,45438917,210,"ENSBGRG00000007842","ENSBGRT00000014419",111166,"KLF7","Kruppel like factor 7 [Source:HGNC Symbol;Acc:HGNC:6350]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0007409(axonogenesis);GO:0007411(axon guidance);GO:0042593(glucose homeostasis);GO:0045604(regulation of epidermal cell differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048813(dendrite morphogenesis);GO:0061179(negative regulation of insulin secretion involved in cellular response to glucose stimulus);GO:1904178(negative regulation of adipose tissue development)","NA",{"v":5.5e-08,"d":"0.00"},1,"210,",0,-7.26,-6.48,1.92,"3' UTR",2,45327542,45439037,111496,1]
["chr2",45811393,45814753,3361,"ENSBGRG00000008141","ENSBGRT00000015061",32914,"MDH1B","malate dehydrogenase 1B [Source:HGNC Symbol;Acc:HGNC:17836]","GO:0003824(catalytic activity);GO:0005975(carbohydrate metabolic process);GO:0006108(malate metabolic process);GO:0016615(malate dehydrogenase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0055114(oxidation-reduction process)","00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);00630(Glyoxylate and dicarboxylate metabolism);00270(Cysteine and methionine metabolism)",{"v":0.00041,"d":"0.00"},2,"6,205,","0,3156",-3.39,-2.74,6.48,"3' UTR",2,45778479,45816282,37804,1]
["chr2",45815653,45815893,241,"ENSBGRG00000008141","ENSBGRT00000015061",37174,"MDH1B","malate dehydrogenase 1B [Source:HGNC Symbol;Acc:HGNC:17836]","GO:0003824(catalytic activity);GO:0005975(carbohydrate metabolic process);GO:0006108(malate metabolic process);GO:0016615(malate dehydrogenase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0055114(oxidation-reduction process)","00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);00630(Glyoxylate and dicarboxylate metabolism);00270(Cysteine and methionine metabolism)",{"v":0.0021,"d":"0.00"},1,"241,",0,-2.68,-2.06,4.59,"3' UTR",2,45778479,45816282,37804,1]
["chr2",46392989,46393703,715,"ENSBGRG00000009401","ENSBGRT00000017240",53233,"GPR1","G protein-coupled receptor 1 [Source:HGNC Symbol;Acc:HGNC:4463]","GO:0004930(G protein-coupled receptor activity);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":1.3E-6,"d":"0.00"},1,"715,",0,-5.87,-5.12,7.56,"Exon (ENSBGRT00000017240/ENSBGRG00000009401, exon 4 of 4)",2,46339756,46394982,55227,1]
["chr2",46483297,46483775,479,"ENSBGRG00000009960","ENSBGRT00000018260",120,"INO80D","INO80 complex subunit D [Source:HGNC Symbol;Acc:HGNC:25997]","NA","NA",{"v":1e-122,"d":"0.00"},1,"479,",0,-122,-120,{"v":4.1,"d":"4.10"},"5' UTR",2,46483177,46550212,67036,1]
["chr2",46506829,46511593,4765,"ENSBGRG00000009960","ENSBGRT00000018260",23652,"INO80D","INO80 complex subunit D [Source:HGNC Symbol;Acc:HGNC:25997]","NA","NA",{"v":0.015,"d":"0.02"},2,"35,26,","0,4739",-1.83,-1.02,8.64,"Exon (ENSBGRT00000018260/ENSBGRG00000009960, exon 3 of 11)",2,46483177,46550212,67036,1]
["chr2",46512101,46531994,19894,"ENSBGRG00000009960","ENSBGRT00000018260",28924,"INO80D","INO80 complex subunit D [Source:HGNC Symbol;Acc:HGNC:25997]","NA","NA",{"v":0.0035,"d":"0.00"},3,"210,109,71,","0,6740,19823",-2.46,-1.86,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000018260/ENSBGRG00000009960, exon 4 of 11)",2,46483177,46550212,67036,1]
["chr2",46546153,46548926,2774,"ENSBGRG00000009960","ENSBGRT00000018260",62976,"INO80D","INO80 complex subunit D [Source:HGNC Symbol;Acc:HGNC:25997]","NA","NA",{"v":1.1e-06,"d":"0.00"},3,"19,158,453,","0,735,2321",-5.95,-5.19,{"v":19.4,"d":"19.40"},"Exon (ENSBGRT00000018260/ENSBGRG00000009960, exon 9 of 11)",2,46483177,46550212,67036,1]
["chr2",46549135,46549255,121,"ENSBGRG00000009960","ENSBGRT00000018260",65958,"INO80D","INO80 complex subunit D [Source:HGNC Symbol;Acc:HGNC:25997]","NA","NA",{"v":0.00041,"d":"0.00"},1,"121,",0,-3.39,-2.74,6.48,"Exon (ENSBGRT00000018260/ENSBGRG00000009960, exon 11 of 11)",2,46483177,46550212,67036,1]
["chr2",49474243,49474302,60,"ENSBGRG00000012733","ENSBGRT00000026863",5210,"ENSBGRG00000012733","NA","GO:0007165(signal transduction)","04015(Rap1 signaling pathway);04611(Platelet activation)",{"v":0.025,"d":"0.03"},1,"60,",0,-1.61,-1.07,2.16,"Exon (ENSBGRT00000026863/ENSBGRG00000012733, exon 3 of 15)",2,49469033,49529390,60358,1]
["chr2",49474422,49474541,120,"ENSBGRG00000012733","ENSBGRT00000026863",5389,"ENSBGRG00000012733","NA","GO:0007165(signal transduction)","04015(Rap1 signaling pathway);04611(Platelet activation)",{"v":0.018,"d":"0.02"},1,"120,",0,-1.75,-1.19,1.78,"Exon (ENSBGRT00000026863/ENSBGRG00000012733, exon 3 of 15)",2,49469033,49529390,60358,1]
["chr2",51028461,51028610,150,"ENSBGRG00000018345","ENSBGRT00000033582",5623,"ALS2","alsin Rho guanine nucleotide exchange factor ALS2 [Source:HGNC Symbol;Acc:HGNC:443]","GO:0001662(behavioral fear response);GO:0001726(ruffle);GO:0001881(receptor recycling);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006979(response to oxidative stress);GO:0007032(endosome organization);GO:0007041(lysosomal transport);GO:0007528(neuromuscular junction development);GO:0007626(locomotory behavior);GO:0008104(protein localization);GO:0014069(postsynaptic density);GO:0016050(vesicle organization);GO:0016197(endosomal transport);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0030027(lamellipodium);GO:0030425(dendrite);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031982(vesicle);GO:0032991(protein-containing complex);GO:0035249(synaptic transmission, glutamatergic);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043087(regulation of GTPase activity);GO:0043197(dendritic spine);GO:0043539(protein serine/threonine kinase activator activity);GO:0043547(positive regulation of GTPase activity);GO:0045860(positive regulation of protein kinase activity);GO:0048365(Rac GTPase binding);GO:0048812(neuron projection morphogenesis);GO:0051036(regulation of endosome size);GO:0051260(protein homooligomerization)","05014(Amyotrophic lateral sclerosis (ALS))",{"v":3.5e-06,"d":"0.00"},1,"150,",0,-5.45,-4.72,2.12,"Exon (ENSBGRT00000033582/ENSBGRG00000018345, exon 3 of 33)",2,51022838,51085939,63102,1]
["chr2",51028820,51031978,3159,"ENSBGRG00000018345","ENSBGRT00000033582",5982,"ALS2","alsin Rho guanine nucleotide exchange factor ALS2 [Source:HGNC Symbol;Acc:HGNC:443]","GO:0001662(behavioral fear response);GO:0001726(ruffle);GO:0001881(receptor recycling);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006979(response to oxidative stress);GO:0007032(endosome organization);GO:0007041(lysosomal transport);GO:0007528(neuromuscular junction development);GO:0007626(locomotory behavior);GO:0008104(protein localization);GO:0014069(postsynaptic density);GO:0016050(vesicle organization);GO:0016197(endosomal transport);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0030027(lamellipodium);GO:0030425(dendrite);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031982(vesicle);GO:0032991(protein-containing complex);GO:0035249(synaptic transmission, glutamatergic);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043087(regulation of GTPase activity);GO:0043197(dendritic spine);GO:0043539(protein serine/threonine kinase activator activity);GO:0043547(positive regulation of GTPase activity);GO:0045860(positive regulation of protein kinase activity);GO:0048365(Rac GTPase binding);GO:0048812(neuron projection morphogenesis);GO:0051036(regulation of endosome size);GO:0051260(protein homooligomerization)","05014(Amyotrophic lateral sclerosis (ALS))",{"v":1.5E-3,"d":"0.00"},2,"59,2,","0,3157",-2.82,-2.19,1.85,"Exon (ENSBGRT00000033582/ENSBGRG00000018345, exon 3 of 33)",2,51022838,51085939,63102,1]
["chr2",51431008,51431307,300,"ENSBGRG00000022201","ENSBGRT00000041007",76372,"TRAK2","trafficking kinesin protein 2 [Source:HGNC Symbol;Acc:HGNC:13206]","NA","04727(GABAergic synapse)",{"v":1.3E-73,"d":"0.00"},1,"300,",0,{"v":-72.9,"d":"-72.90"},{"v":-71.5,"d":"-71.50"},6.47,"Exon (ENSBGRT00000041007/ENSBGRG00000022201, exon 16 of 16)",2,51354636,51431487,76852,1]
["chr2",51793095,51793244,150,"ENSBGRG00000022773","ENSBGRT00000042134",57573,"FAM126B","family with sequence similarity 126 member B [Source:HGNC Symbol;Acc:HGNC:28593]","NA","NA",{"v":4.1E-5,"d":"0.00"},1,"150,",0,-4.39,-3.69,2.26,"Exon (ENSBGRT00000042134/ENSBGRG00000022773, exon 12 of 12)",2,51735522,51793405,57884,1]
["chr2",52434105,52434285,181,"ENSBGRG00000026680","ENSBGRT00000049452",19729,"KCTD18","potassium channel tetramerization domain containing 18 [Source:HGNC Symbol;Acc:HGNC:26446]","GO:0051260(protein homooligomerization)","NA",{"v":5e-75,"d":"0.00"},1,"181,",0,{"v":-74.3,"d":"-74.30"},{"v":-72.8,"d":"-72.80"},6.22,"Exon (ENSBGRT00000049452/ENSBGRG00000026680, exon 6 of 6)",2,52414376,52434285,19910,1]
["chr2",53005327,53005477,151,"ENSBGRG00000026693","ENSBGRT00000049482",63,"MAIP1","matrix AAA peptidase interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:26198]","GO:0005759(mitochondrial matrix);GO:0036444(calcium import into the mitochondrion);GO:0051204(protein insertion into mitochondrial membrane);GO:0051560(mitochondrial calcium ion homeostasis)","NA",{"v":0.044,"d":"0.04"},1,"151,",0,-1.36,{"v":-0.841,"d":"-0.84"},3.24,"5' UTR",2,52961841,53005540,43700,2]
["chr2",53129853,53140168,10316,"ENSBGRG00000026708","ENSBGRT00000049529",31542,"FTCDNL1","formiminotransferase cyclodeaminase N-terminal like [Source:HGNC Symbol;Acc:HGNC:48661]","GO:0005542(folic acid binding);GO:0016740(transferase activity)","00340(Histidine metabolism);00670(One carbon pool by folate);04742(Taste transduction)",{"v":9.5E-4,"d":"0.00"},3,"21,20,19,","0,7302,10297",-3.02,-2.38,3.96,"3' UTR",2,53098311,53129873,31563,1]
["chr2",55604136,55604374,239,"ENSBGRG00000000406","ENSBGRT00000000673",86004,"RFTN2","raftlin family member 2 [Source:HGNC Symbol;Acc:HGNC:26402]","GO:0033227(dsRNA transport);GO:0043330(response to exogenous dsRNA)","NA",{"v":5E-56,"d":"0.00"},1,"239,",0,{"v":-55.3,"d":"-55.30"},{"v":-53.9,"d":"-53.90"},3.09,"Exon (ENSBGRT00000000673/ENSBGRG00000000406, exon 9 of 9)",2,55518132,55604374,86243,1]
["chr2",56247993,56267402,19410,"ENSBGRG00000000882","ENSBGRT00000001688",11337,"PGAP1","post-GPI attachment to proteins inositol deacylase 1 [Source:HGNC Symbol;Acc:HGNC:25712]","GO:0007605(sensory perception of sound);GO:0009880(embryonic pattern specification);GO:0009948(anterior/posterior axis specification);GO:0016788(hydrolase activity, acting on ester bonds);GO:0021871(forebrain regionalization);GO:0060322(head development)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":0.012,"d":"0.01"},3,"79,172,19,","0,11122,19391",-1.92,-1.35,4.32,"Exon (ENSBGRT00000001688/ENSBGRG00000000882, exon 3 of 9)",2,56236656,56276318,39663,1]
["chr2",56916573,56923194,6622,"ENSBGRG00000001305","ENSBGRT00000002413",159860,"HECW2","HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:29853]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0030071(regulation of mitotic metaphase/anaphase transition);GO:0072686(mitotic spindle)","NA",{"v":0.0078,"d":"0.01"},3,"68,101,102,","0,5454,6520",-2.11,-1.27,9.72,"Exon (ENSBGRT00000002413/ENSBGRG00000001305, exon 7 of 29)",2,56756713,57057645,300933,1]
["chr2",56923553,56923613,61,"ENSBGRG00000001305","ENSBGRT00000002413",166840,"HECW2","HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:29853]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0030071(regulation of mitotic metaphase/anaphase transition);GO:0072686(mitotic spindle)","NA",{"v":0.013,"d":"0.01"},1,"61,",0,-1.87,-1.31,3.02,"Exon (ENSBGRT00000002413/ENSBGRG00000001305, exon 9 of 29)",2,56756713,57057645,300933,1]
["chr2",56923883,56924002,120,"ENSBGRG00000001305","ENSBGRT00000002413",167170,"HECW2","HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:29853]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0030071(regulation of mitotic metaphase/anaphase transition);GO:0072686(mitotic spindle)","NA",{"v":0.044,"d":"0.04"},1,"120,",0,-1.36,{"v":-0.841,"d":"-0.84"},2.97,"Exon (ENSBGRT00000002413/ENSBGRG00000001305, exon 9 of 29)",2,56756713,57057645,300933,1]
["chr2",57057465,57057645,181,"ENSBGRG00000001305","ENSBGRT00000002413",300752,"HECW2","HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:29853]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0030071(regulation of mitotic metaphase/anaphase transition);GO:0072686(mitotic spindle)","NA",{"v":2.3E-5,"d":"0.00"},1,"181,",0,-4.63,-3.92,7.02,"3' UTR",2,56756713,57057645,300933,1]
["chr2",57124353,57124472,120,"ENSBGRG00000001329","ENSBGRT00000002440",17539,"STK17B","serine/threonine kinase 17b [Source:HGNC Symbol;Acc:HGNC:11396]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006468(protein phosphorylation);GO:0035556(intracellular signal transduction);GO:2000271(positive regulation of fibroblast apoptotic process)","NA",{"v":7.9e-21,"d":"0.00"},1,"120,",0,{"v":-20.1,"d":"-20.10"},{"v":-19.1,"d":"-19.10"},4.47,"3' UTR",2,57106814,57124712,17899,1]
["chr2",57176557,57367756,191200,"ENSBGRG00000001376","ENSBGRT00000002597",0,"DNAH7","dynein axonemal heavy chain 7 [Source:HGNC Symbol;Acc:HGNC:18661]","GO:0003341(cilium movement);GO:0003777(microtubule motor activity);GO:0005509(calcium ion binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0005929(cilium);GO:0007018(microtubule-based movement);GO:0030286(dynein complex);GO:0036156(inner dynein arm);GO:0036159(inner dynein arm assembly)","05016(Huntington disease)",{"v":0.028,"d":"0.03"},48,"408,63,63,109,148,88,181,76,126,120,184,180,36,87,15,273,128,79,225,147,686,187,194,199,141,213,110,169,103,128,213,99,249,150,183,177,132,225,198,156,169,127,220,1156,230,331,347,176,","0,4734,25278,30435,31279,43769,45924,48285,50134,58865,62042,62830,64276,64314,64404,68773,70064,73450,78919,81534,83336,86702,97541,100129,102546,111819,115943,120911,125170,125393,135451,138867,147608,153808,156059,156602,157270,158933,162218,165265,166156,168609,169951,175100,178207,185516,188267,191024",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",2,57176557,57240975,64419,1]
["chr2",61683540,61684578,1039,"ENSBGRG00000001540","ENSBGRT00000002853",10580,"CAVIN2","caveolae associated protein 2 [Source:HGNC Symbol;Acc:HGNC:10690]","GO:0001786(phosphatidylserine binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0045121(membrane raft);GO:0097320(plasma membrane tubulation)","NA",{"v":1e-213,"d":"0.00"},1,"1039,",0,-213,-211,4.52,"3' UTR",2,61672960,61684861,11902,1]
["chr2",69525414,69525534,121,"ENSBGRG00000002404","ENSBGRT00000004500",269,"CLASP1","cytoplasmic linker associated protein 1 [Source:HGNC Symbol;Acc:HGNC:17088]","GO:0000226(microtubule cytoskeleton organization);GO:0000776(kinetochore);GO:0001578(microtubule bundle formation);GO:0002162(dystroglycan binding);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005828(kinetochore microtubule);GO:0005876(spindle microtubule);GO:0005881(cytoplasmic microtubule);GO:0005925(focal adhesion);GO:0005938(cell cortex);GO:0006903(vesicle targeting);GO:0007020(microtubule nucleation);GO:0007026(negative regulation of microtubule depolymerization);GO:0007030(Golgi organization);GO:0007052(mitotic spindle organization);GO:0008017(microtubule binding);GO:0010458(exit from mitosis);GO:0010470(regulation of gastrulation);GO:0010634(positive regulation of epithelial cell migration);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0030953(astral microtubule organization);GO:0030981(cortical microtubule cytoskeleton);GO:0031023(microtubule organizing center organization);GO:0031111(negative regulation of microtubule polymerization or depolymerization);GO:0031592(centrosomal corona);GO:0034453(microtubule anchoring);GO:0040001(establishment of mitotic spindle localization);GO:0043515(kinetochore binding);GO:0045180(basal cortex);GO:0045921(positive regulation of exocytosis);GO:0051010(microtubule plus-end binding);GO:0051294(establishment of spindle orientation);GO:0051301(cell division);GO:0051497(negative regulation of stress fiber assembly);GO:0051893(regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:0090091(positive regulation of extracellular matrix disassembly);GO:1903690(negative regulation of wound healing, spreading of epidermal cells);GO:1904261(positive regulation of basement membrane assembly involved in embryonic body morphogenesis)","NA",{"v":0.00041,"d":"0.00"},1,"121,",0,-3.39,-2.73,1.89,"5' UTR",2,69525145,69789162,264018,1]
["chr2",69810981,69811040,60,"ENSBGRG00000002469","ENSBGRT00000004605",866,"ENSBGRG00000002469","NA","GO:0006355(regulation of transcription, DNA-templated);GO:0017025(TBP-class protein binding);GO:0070897(transcription preinitiation complex assembly)","03022(Basal transcription factors);05203(Viral carcinogenesis);05169(Epstein-Barr virus infection)",{"v":3.5E-4,"d":"0.00"},1,"60,",0,-3.46,{"v":-2.8,"d":"-2.80"},2.04,"Exon (ENSBGRT00000004605/ENSBGRG00000002469, exon 2 of 2)",2,69810115,69811425,1311,1]
["chr2",71060953,71061245,293,"ENSBGRG00000002677","ENSBGRT00000005010",760,"TMEM185B","transmembrane protein 185B [Source:HGNC Symbol;Acc:HGNC:18896]","NA","NA",{"v":6.3e-70,"d":"0.00"},1,"293,",0,{"v":-69.2,"d":"-69.20"},{"v":-67.8,"d":"-67.80"},2.92,"Exon (ENSBGRT00000005010/ENSBGRG00000002677, exon 1 of 1)",2,71060193,71061245,1053,1]
["chr2",73665778,73668330,2553,"ENSBGRG00000003157","ENSBGRT00000006179",93432,"CCDC93","coiled-coil domain containing 93 [Source:HGNC Symbol;Acc:HGNC:25611]","GO:0006893(Golgi to plasma membrane transport);GO:0032456(endocytic recycling);GO:0043231(intracellular membrane-bounded organelle);GO:1990126(retrograde transport, endosome to plasma membrane)","NA",{"v":4.6e-07,"d":"0.00"},3,"73,72,6,","0,1228,2547",-6.34,-5.58,2.08,"Exon (ENSBGRT00000006179/ENSBGRG00000003157, exon 16 of 25)",2,73572346,73686166,113821,1]
["chr2",73686407,73686557,151,"ENSBGRG00000003157","ENSBGRT00000006130",114061,"CCDC93","coiled-coil domain containing 93 [Source:HGNC Symbol;Acc:HGNC:25611]","GO:0006893(Golgi to plasma membrane transport);GO:0032456(endocytic recycling);GO:0043231(intracellular membrane-bounded organelle);GO:1990126(retrograde transport, endosome to plasma membrane)","NA",{"v":4e-86,"d":"0.00"},1,"151,",0,{"v":-85.4,"d":"-85.40"},{"v":-83.8,"d":"-83.80"},{"v":4.8,"d":"4.80"},"3' UTR",2,73572346,73686707,114362,1]
["chr2",81144174,81144531,358,"ENSBGRG00000000528","ENSBGRT00000000933",423462,"MGAT5","alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase [Source:HGNC Symbol;Acc:HGNC:7049]","GO:0004864(protein phosphatase inhibitor activity);GO:0005794(Golgi apparatus);GO:0006487(protein N-linked glycosylation);GO:0008375(acetylglucosaminyltransferase activity);GO:0016020(membrane);GO:0016757(transferase activity, transferring glycosyl groups);GO:0018279(protein N-linked glycosylation via asparagine);GO:0030144(alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity);GO:0030145(manganese ion binding);GO:0030335(positive regulation of cell migration);GO:1903614(negative regulation of protein tyrosine phosphatase activity);GO:1904894(positive regulation of receptor signaling pathway via STAT)","00510(N-Glycan biosynthesis)",{"v":3.8e-05,"d":"0.00"},1,"358,",0,-4.42,-3.72,{"v":18.4,"d":"18.40"},"3' UTR",2,80720712,81144769,424058,1]
["chr2",81680179,81681431,1253,"ENSBGRG00000000712","ENSBGRT00000001334",29843,"CCNT2","cyclin T2 [Source:HGNC Symbol;Acc:HGNC:1600]","GO:0001223(transcription coactivator binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006351(transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007519(skeletal muscle tissue development);GO:0008024(cyclin/CDK positive transcription elongation factor complex);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0019085(early viral transcription);GO:0019086(late viral transcription);GO:0042025(host cell nucleus);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048471(perinuclear region of cytoplasm);GO:0070063(RNA polymerase binding);GO:0097322(7SK snRNA binding)","05202(Transcriptional misregulation in cancers)",{"v":1e-200,"d":"0.00"},1,"1253,",0,-200,-197,{"v":13.5,"d":"13.50"},"Exon (ENSBGRT00000001334/ENSBGRG00000000712, exon 10 of 11)",2,81650336,81681331,30996,1]
["chr2",81875246,81876421,1176,"ENSBGRG00000000816","ENSBGRT00000001594",94507,"RAB3GAP1","RAB3 GTPase activating protein catalytic subunit 1 [Source:HGNC Symbol;Acc:HGNC:17063]","GO:0005096(GTPase activator activity);GO:0005794(Golgi apparatus);GO:0005811(lipid droplet);GO:0007420(brain development);GO:0010628(positive regulation of gene expression);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0021854(hypothalamus development);GO:0032991(protein-containing complex);GO:0034389(lipid droplet organization);GO:0043010(camera-type eye development);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0060079(excitatory postsynaptic potential);GO:0060325(face morphogenesis);GO:0061646(positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization);GO:0071782(endoplasmic reticulum tubular network);GO:0097051(establishment of protein localization to endoplasmic reticulum membrane);GO:1903061(positive regulation of protein lipidation);GO:1903233(regulation of calcium ion-dependent exocytosis of neurotransmitter);GO:1903373(positive regulation of endoplasmic reticulum tubular network organization);GO:2000786(positive regulation of autophagosome assembly)","NA",{"v":1e-163,"d":"0.00"},2,"3,326,","0,850",-163,-161,{"v":2.8,"d":"2.80"},"Exon (ENSBGRT00000001594/ENSBGRG00000000816, exon 16 of 25)",2,81780739,81902507,121769,1]
["chr2",81896159,81918064,21906,"ENSBGRG00000000816","ENSBGRT00000001594",115420,"RAB3GAP1","RAB3 GTPase activating protein catalytic subunit 1 [Source:HGNC Symbol;Acc:HGNC:17063]","GO:0005096(GTPase activator activity);GO:0005794(Golgi apparatus);GO:0005811(lipid droplet);GO:0007420(brain development);GO:0010628(positive regulation of gene expression);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0021854(hypothalamus development);GO:0032991(protein-containing complex);GO:0034389(lipid droplet organization);GO:0043010(camera-type eye development);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0060079(excitatory postsynaptic potential);GO:0060325(face morphogenesis);GO:0061646(positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization);GO:0071782(endoplasmic reticulum tubular network);GO:0097051(establishment of protein localization to endoplasmic reticulum membrane);GO:1903061(positive regulation of protein lipidation);GO:1903233(regulation of calcium ion-dependent exocytosis of neurotransmitter);GO:1903373(positive regulation of endoplasmic reticulum tubular network organization);GO:2000786(positive regulation of autophagosome assembly)","NA",{"v":4e-88,"d":"0.00"},5,"44,103,21,237,74,","0,2704,5271,6112,21832",{"v":-87.4,"d":"-87.40"},{"v":-85.8,"d":"-85.80"},4.34,"3' UTR",2,81780739,81902507,121769,1]
["chr2",82429413,82429952,540,"ENSBGRG00000000982","ENSBGRT00000001990",102637,"R3HDM1","R3H domain containing 1 [Source:HGNC Symbol;Acc:HGNC:9757]","GO:0003676(nucleic acid binding)","04320(Dorso-ventral axis formation)",{"v":1e-145,"d":"0.00"},1,"540,",0,-145,-143,4.07,"3' UTR",2,82326776,82430252,103477,1]
["chr2",82461197,82469643,8447,"ENSBGRG00000001196","ENSBGRT00000002226",10708,"UBXN4","UBX domain protein 4 [Source:HGNC Symbol;Acc:HGNC:14860]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0030433(ubiquitin-dependent ERAD pathway)","NA",{"v":1E-215,"d":"0.00"},5,"29,94,55,165,47,","0,3526,6737,7535,8400",-215,-213,{"v":2.9,"d":"2.90"},"Exon (ENSBGRT00000002226/ENSBGRG00000001196, exon 5 of 13)",2,82450489,82480833,30345,1]
["chr2",91981130,91982239,1110,"ENSBGRG00000004340","ENSBGRT00000007973",0,"ENSBGRG00000004340","NA","NA","NA",{"v":0.0011,"d":"0.00"},1,"1110,",0,-2.96,-2.33,13,"Exon (ENSBGRT00000007973/ENSBGRG00000004340, exon 1 of 1)",2,91981130,91982239,1110,1]
["chr2",91981130,91982239,1110,"ENSBGRG00000004340","ENSBGRT00000007973",0,"ENSBGRG00000004340","NA","NA","NA",{"v":0.0011,"d":"0.00"},1,"1110,",0,-2.96,-2.33,13,"Exon (ENSBGRT00000007973/ENSBGRG00000004340, exon 1 of 1)",2,91981130,91982239,1110,1]
["chr2",97004527,97004943,417,"ENSBGRG00000004989","ENSBGRT00000009193",101893,"ACVR2A","activin A receptor type 2A [Source:HGNC Symbol;Acc:HGNC:173]","GO:0001702(gastrulation with mouth forming second);GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004675(transmembrane receptor protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007178(transmembrane receptor protein serine/threonine kinase signaling pathway);GO:0007283(spermatogenesis);GO:0007368(determination of left/right symmetry);GO:0007498(mesoderm development);GO:0008584(male gonad development);GO:0009952(anterior/posterior pattern specification);GO:0009966(regulation of signal transduction);GO:0009986(cell surface);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0015026(coreceptor activity);GO:0016020(membrane);GO:0017002(activin-activated receptor activity);GO:0019838(growth factor binding);GO:0030165(PDZ domain binding);GO:0030501(positive regulation of bone mineralization);GO:0030509(BMP signaling pathway);GO:0032924(activin receptor signaling pathway);GO:0032927(positive regulation of activin receptor signaling pathway);GO:0034673(inhibin-betaglycan-ActRII complex);GO:0034711(inhibin binding);GO:0042713(sperm ejaculation);GO:0043084(penile erection);GO:0043235(receptor complex);GO:0043621(protein self-association);GO:0045648(positive regulation of erythrocyte differentiation);GO:0045669(positive regulation of osteoblast differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048185(activin binding);GO:0048706(embryonic skeletal system development);GO:0050999(regulation of nitric-oxide synthase activity);GO:0060011(Sertoli cell proliferation);GO:0071773(cellular response to BMP stimulus);GO:0098821(BMP receptor activity)","04350(TGF-beta signaling pathway);04060(Cytokine-cytokine receptor interaction);04550(Signaling pathways regulating pluripotency of stem cells);05418(Fluid shear stress and atherosclerosis)",{"v":1.6e-64,"d":"0.00"},1,"417,",0,{"v":-63.8,"d":"-63.80"},{"v":-62.4,"d":"-62.40"},{"v":6.5,"d":"6.50"},"3' UTR",2,96902634,97005390,102757,1]
["chr2",97596932,97597142,211,"ENSBGRG00000005195","ENSBGRT00000009597",13819,"MBD5","methyl-CpG binding domain protein 5 [Source:HGNC Symbol;Acc:HGNC:20444]","GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0007399(nervous system development);GO:0010369(chromocenter);GO:0030496(midbody);GO:0042025(host cell nucleus);GO:0050795(regulation of behavior)","NA",{"v":1.3e-16,"d":"0.00"},1,"211,",0,{"v":-15.9,"d":"-15.90"},{"v":-14.9,"d":"-14.90"},3.92,"Exon (ENSBGRT00000009597/ENSBGRG00000005195, exon 5 of 12)",2,97583113,97647607,64495,1]
["chr2",97597262,97597771,510,"ENSBGRG00000005195","ENSBGRT00000009597",14149,"MBD5","methyl-CpG binding domain protein 5 [Source:HGNC Symbol;Acc:HGNC:20444]","GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0007399(nervous system development);GO:0010369(chromocenter);GO:0030496(midbody);GO:0042025(host cell nucleus);GO:0050795(regulation of behavior)","NA",{"v":1E-125,"d":"0.00"},1,"510,",0,-125,-124,6.57,"Exon (ENSBGRT00000009597/ENSBGRG00000005195, exon 5 of 12)",2,97583113,97647607,64495,1]
["chr2",97597861,97598101,241,"ENSBGRG00000005195","ENSBGRT00000009597",14748,"MBD5","methyl-CpG binding domain protein 5 [Source:HGNC Symbol;Acc:HGNC:20444]","GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0007399(nervous system development);GO:0010369(chromocenter);GO:0030496(midbody);GO:0042025(host cell nucleus);GO:0050795(regulation of behavior)","NA",{"v":6.3e-24,"d":"0.00"},1,"241,",0,{"v":-23.2,"d":"-23.20"},{"v":-22.2,"d":"-22.20"},4.02,"Exon (ENSBGRT00000009597/ENSBGRG00000005195, exon 5 of 12)",2,97583113,97647607,64495,1]
["chr2",97598730,97599788,1059,"ENSBGRG00000005195","ENSBGRT00000009597",15617,"MBD5","methyl-CpG binding domain protein 5 [Source:HGNC Symbol;Acc:HGNC:20444]","GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0007399(nervous system development);GO:0010369(chromocenter);GO:0030496(midbody);GO:0042025(host cell nucleus);GO:0050795(regulation of behavior)","NA",{"v":1.3E-43,"d":"0.00"},2,"33,238,","0,821",{"v":-42.9,"d":"-42.90"},{"v":-41.7,"d":"-41.70"},5.01,"Exon (ENSBGRT00000009597/ENSBGRG00000005195, exon 5 of 12)",2,97583113,97647607,64495,1]
["chr2",97620583,97643478,22896,"ENSBGRG00000005195","ENSBGRT00000009597",37470,"MBD5","methyl-CpG binding domain protein 5 [Source:HGNC Symbol;Acc:HGNC:20444]","GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0007399(nervous system development);GO:0010369(chromocenter);GO:0030496(midbody);GO:0042025(host cell nucleus);GO:0050795(regulation of behavior)","NA",{"v":5e-77,"d":"0.00"},3,"735,74,1,","0,12393,22895",{"v":-76.3,"d":"-76.30"},{"v":-74.8,"d":"-74.80"},8.62,"Exon (ENSBGRT00000009597/ENSBGRG00000005195, exon 9 of 12)",2,97583113,97647607,64495,1]
["chr2",97929529,97933633,4105,"ENSBGRG00000005242","ENSBGRT00000009726",114712,"EPC2","enhancer of polycomb homolog 2 [Source:HGNC Symbol;Acc:HGNC:24543]","GO:0006357(regulation of transcription by RNA polymerase II);GO:0032777(Piccolo NuA4 histone acetyltransferase complex);GO:0035267(NuA4 histone acetyltransferase complex)","NA",{"v":3.2E-91,"d":"0.00"},3,"4,146,300,","0,3550,3805",{"v":-90.5,"d":"-90.50"},{"v":-88.9,"d":"-88.90"},3.55,"Exon (ENSBGRT00000009726/ENSBGRG00000005242, exon 8 of 14)",2,97814817,97950112,135296,1]
["chr2",97947899,97950052,2154,"ENSBGRG00000005242","ENSBGRT00000009726",133082,"EPC2","enhancer of polycomb homolog 2 [Source:HGNC Symbol;Acc:HGNC:24543]","GO:0006357(regulation of transcription by RNA polymerase II);GO:0032777(Piccolo NuA4 histone acetyltransferase complex);GO:0035267(NuA4 histone acetyltransferase complex)","NA",{"v":1e-126,"d":"0.00"},2,"257,13,","0,2141",-126,-124,5.28,"Exon (ENSBGRT00000009726/ENSBGRG00000005242, exon 13 of 14)",2,97814817,97950112,135296,1]
["chr2",98164284,98168523,4240,"ENSBGRG00000005336","ENSBGRT00000010179",151939,"KIF5C","kinesin family member 5C [Source:HGNC Symbol;Acc:HGNC:6325]","GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0008045(motor neuron axon guidance);GO:0035253(ciliary rootlet);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0044295(axonal growth cone);GO:0051028(mRNA transport);GO:0150034(distal axon)","04144(Endocytosis);04728(Dopaminergic synapse)",{"v":1.3e-05,"d":"0.00"},3,"596,215,179,","0,2831,4061",-4.89,-4.18,{"v":10.8,"d":"10.80"},"3' UTR",2,98012345,98164879,152535,1]
["chr2",100343759,100344193,435,"ENSBGRG00000005761","ENSBGRT00000010651",1657,"FAM98B","family with sequence similarity 98 member B [Source:HGNC Symbol;Acc:HGNC:26773]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006479(protein methylation);GO:0008276(protein methyltransferase activity);GO:0008284(positive regulation of cell population proliferation);GO:0010628(positive regulation of gene expression);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle);GO:0072669(tRNA-splicing ligase complex)","NA",{"v":3.2e-46,"d":"0.00"},2,"4,387,","0,48",{"v":-45.5,"d":"-45.50"},{"v":-44.2,"d":"-44.20"},103,"Exon (ENSBGRT00000010651/ENSBGRG00000005761, exon 2 of 3)",2,100342102,100344313,2212,1]
["chr2",101000707,101000827,121,"ENSBGRG00000005974","ENSBGRT00000011063",53181,"RIF1","replication timing regulatory factor 1 [Source:HGNC Symbol;Acc:HGNC:23207]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000723(telomere maintenance);GO:0000781(chromosome, telomeric region);GO:0000790(nuclear chromatin);GO:0000793(condensed chromosome);GO:0001939(female pronucleus);GO:0001940(male pronucleus);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006348(chromatin silencing at telomere);GO:0006974(cellular response to DNA damage stimulus);GO:0016604(nuclear body);GO:0019827(stem cell population maintenance);GO:0031965(nuclear membrane);GO:0035861(site of double-strand break);GO:0043247(telomere maintenance in response to DNA damage);GO:0045830(positive regulation of isotype switching);GO:0051233(spindle midzone);GO:0051574(positive regulation of histone H3-K9 methylation);GO:1990830(cellular response to leukemia inhibitory factor);GO:2000042(negative regulation of double-strand break repair via homologous recombination);GO:2001034(positive regulation of double-strand break repair via nonhomologous end joining)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":0.0011,"d":"0.00"},1,"121,",0,-2.96,-2.33,{"v":2.7,"d":"2.70"},"Exon (ENSBGRT00000011063/ENSBGRG00000005974, exon 32 of 39)",2,100947526,101011144,63619,1]
["chr2",101001966,101002116,151,"ENSBGRG00000005974","ENSBGRT00000011063",54440,"RIF1","replication timing regulatory factor 1 [Source:HGNC Symbol;Acc:HGNC:23207]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000723(telomere maintenance);GO:0000781(chromosome, telomeric region);GO:0000790(nuclear chromatin);GO:0000793(condensed chromosome);GO:0001939(female pronucleus);GO:0001940(male pronucleus);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006348(chromatin silencing at telomere);GO:0006974(cellular response to DNA damage stimulus);GO:0016604(nuclear body);GO:0019827(stem cell population maintenance);GO:0031965(nuclear membrane);GO:0035861(site of double-strand break);GO:0043247(telomere maintenance in response to DNA damage);GO:0045830(positive regulation of isotype switching);GO:0051233(spindle midzone);GO:0051574(positive regulation of histone H3-K9 methylation);GO:1990830(cellular response to leukemia inhibitory factor);GO:2000042(negative regulation of double-strand break repair via homologous recombination);GO:2001034(positive regulation of double-strand break repair via nonhomologous end joining)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":7.9e-12,"d":"0.00"},1,"151,",0,{"v":-11.1,"d":"-11.10"},{"v":-10.3,"d":"-10.30"},3.69,"Exon (ENSBGRT00000011063/ENSBGRG00000005974, exon 32 of 39)",2,100947526,101011144,63619,1]
["chr2",101002236,101004380,2145,"ENSBGRG00000005974","ENSBGRT00000011063",54710,"RIF1","replication timing regulatory factor 1 [Source:HGNC Symbol;Acc:HGNC:23207]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000723(telomere maintenance);GO:0000781(chromosome, telomeric region);GO:0000790(nuclear chromatin);GO:0000793(condensed chromosome);GO:0001939(female pronucleus);GO:0001940(male pronucleus);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006348(chromatin silencing at telomere);GO:0006974(cellular response to DNA damage stimulus);GO:0016604(nuclear body);GO:0019827(stem cell population maintenance);GO:0031965(nuclear membrane);GO:0035861(site of double-strand break);GO:0043247(telomere maintenance in response to DNA damage);GO:0045830(positive regulation of isotype switching);GO:0051233(spindle midzone);GO:0051574(positive regulation of histone H3-K9 methylation);GO:1990830(cellular response to leukemia inhibitory factor);GO:2000042(negative regulation of double-strand break repair via homologous recombination);GO:2001034(positive regulation of double-strand break repair via nonhomologous end joining)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":7.9e-12,"d":"0.00"},2,"234,7,","0,2138",{"v":-11.1,"d":"-11.10"},{"v":-10.3,"d":"-10.30"},2.41,"Exon (ENSBGRT00000011063/ENSBGRG00000005974, exon 32 of 39)",2,100947526,101011144,63619,1]
["chr2",101894552,102109675,215124,"ENSBGRG00000015350","ENSBGRT00000028620",0,"FMNL2","formin like 2 [Source:HGNC Symbol;Acc:HGNC:18267]","GO:0003779(actin binding);GO:0007010(cytoskeleton organization);GO:0016043(cellular component organization);GO:0017048(Rho GTPase binding);GO:0022604(regulation of cell morphogenesis);GO:0030036(actin cytoskeleton organization);GO:0030866(cortical actin cytoskeleton organization)","04310(Wnt signaling pathway)",{"v":0.0031,"d":"0.00"},3,"117,12,22,","0,213929,215102",-2.51,{"v":-1.9,"d":"-1.90"},{"v":5.4,"d":"5.40"},"5' UTR",2,101894552,102265090,370539,1]
["chr2",104654599,104862975,208377,"ENSBGRG00000007869","ENSBGRT00000014414",717,"KCNJ3","potassium inwardly rectifying channel subfamily J member 3 [Source:HGNC Symbol;Acc:HGNC:6264]","GO:0005242(inward rectifier potassium channel activity);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0015467(G-protein activated inward rectifier potassium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0098688(parallel fiber to Purkinje cell synapse);GO:0099056(integral component of presynaptic membrane);GO:1990573(potassium ion import across plasma membrane)","04915(Estrogen signaling pathway);04921(Oxytocin signaling pathway);04724(Glutamatergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);04713(Circadian entrainment);05032(Morphine addiction)",{"v":0.0021,"d":"0.00"},4,"40,217,770,587,","0,9897,112209,207790",-2.67,-2.06,{"v":11.9,"d":"11.90"},"3' UTR",2,104653882,104767577,113696,1]
["chr2",108686444,108686563,120,"ENSBGRG00000010064","ENSBGRT00000018475",135855,"PKP4","plakophilin 4 [Source:HGNC Symbol;Acc:HGNC:9026]","GO:0000922(spindle pole);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007043(cell-cell junction assembly);GO:0007155(cell adhesion);GO:0009898(cytoplasmic side of plasma membrane);GO:0014069(postsynaptic density);GO:0030054(cell junction);GO:0030057(desmosome);GO:0030496(midbody);GO:0032467(positive regulation of cytokinesis);GO:0043547(positive regulation of GTPase activity);GO:0044291(cell-cell contact zone);GO:0048471(perinuclear region of cytoplasm);GO:0051233(spindle midzone);GO:0072686(mitotic spindle);GO:0098609(cell-cell adhesion)","04520(Adherens junction)",{"v":4e-48,"d":"0.00"},1,"120,",0,{"v":-47.4,"d":"-47.40"},{"v":-46.2,"d":"-46.20"},4.83,"Exon (ENSBGRT00000018475/ENSBGRG00000010064, exon 7 of 22)",2,108550589,108751797,201209,1]
["chr2",108686623,108695189,8567,"ENSBGRG00000010064","ENSBGRT00000018475",136034,"PKP4","plakophilin 4 [Source:HGNC Symbol;Acc:HGNC:9026]","GO:0000922(spindle pole);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007043(cell-cell junction assembly);GO:0007155(cell adhesion);GO:0009898(cytoplasmic side of plasma membrane);GO:0014069(postsynaptic density);GO:0030054(cell junction);GO:0030057(desmosome);GO:0030496(midbody);GO:0032467(positive regulation of cytokinesis);GO:0043547(positive regulation of GTPase activity);GO:0044291(cell-cell contact zone);GO:0048471(perinuclear region of cytoplasm);GO:0051233(spindle midzone);GO:0072686(mitotic spindle);GO:0098609(cell-cell adhesion)","04520(Adherens junction)",{"v":5e-44,"d":"0.00"},2,"110,40,","0,8527",{"v":-43.3,"d":"-43.30"},-42,4.18,"Exon (ENSBGRT00000018475/ENSBGRG00000010064, exon 7 of 22)",2,108550589,108751797,201209,1]
["chr2",109311425,109311515,91,"ENSBGRG00000010534","ENSBGRT00000019330",206966,"TANC1","tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 [Source:HGNC Symbol;Acc:HGNC:29364]","GO:0005515(protein binding);GO:0007520(myoblast fusion);GO:0008542(visual learning);GO:0030425(dendrite);GO:0043025(neuronal cell body);GO:0043679(axon terminus);GO:0097062(dendritic spine maintenance)","NA",{"v":2e-15,"d":"0.00"},1,"91,",0,{"v":-14.7,"d":"-14.70"},{"v":-13.8,"d":"-13.80"},2.32,"Exon (ENSBGRT00000019330/ENSBGRG00000010534, exon 29 of 29)",2,109104459,109314475,210017,1]
["chr2",109311874,109312143,270,"ENSBGRG00000010534","ENSBGRT00000019330",207415,"TANC1","tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 [Source:HGNC Symbol;Acc:HGNC:29364]","GO:0005515(protein binding);GO:0007520(myoblast fusion);GO:0008542(visual learning);GO:0030425(dendrite);GO:0043025(neuronal cell body);GO:0043679(axon terminus);GO:0097062(dendritic spine maintenance)","NA",{"v":3.2e-73,"d":"0.00"},1,"270,",0,{"v":-72.5,"d":"-72.50"},-71,7.13,"Exon (ENSBGRT00000019330/ENSBGRG00000010534, exon 29 of 29)",2,109104459,109314475,210017,1]
["chr2",109312292,109312801,510,"ENSBGRG00000010534","ENSBGRT00000019330",207833,"TANC1","tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 [Source:HGNC Symbol;Acc:HGNC:29364]","GO:0005515(protein binding);GO:0007520(myoblast fusion);GO:0008542(visual learning);GO:0030425(dendrite);GO:0043025(neuronal cell body);GO:0043679(axon terminus);GO:0097062(dendritic spine maintenance)","NA",{"v":1E-146,"d":"0.00"},1,"510,",0,-146,-144,{"v":5.4,"d":"5.40"},"3' UTR",2,109104459,109314475,210017,1]
["chr2",111517413,111519913,2501,"ENSBGRG00000015484","ENSBGRT00000028517",79156,"TANK","TRAF family member associated NFKB activator [Source:HGNC Symbol;Acc:HGNC:11562]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005829(cytosol);GO:0006974(cellular response to DNA damage stimulus);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0031625(ubiquitin protein ligase binding);GO:0032991(protein-containing complex);GO:0035800(deubiquitinase activator activity);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0071347(cellular response to interleukin-1);GO:0071356(cellular response to tumor necrosis factor);GO:0071479(cellular response to ionizing radiation);GO:1903003(positive regulation of protein deubiquitination);GO:2000158(positive regulation of ubiquitin-specific protease activity)","04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway)",{"v":7.9e-34,"d":"0.00"},2,"428,17,","0,2484",{"v":-33.1,"d":"-33.10"},-32,4.23,"Exon (ENSBGRT00000028517/ENSBGRG00000015484, exon 7 of 9)",2,111438257,111522141,83885,1]
["chr2",115667875,115668742,868,"ENSBGRG00000019248","ENSBGRT00000035340",18084,"ENSBGRG00000019248","NA","NA","NA",{"v":0.028,"d":"0.03"},1,"868,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000035340/ENSBGRG00000019248, exon 2 of 2)",2,115649791,115668891,19101,1]
["chr2",116156480,116167513,11034,"ENSBGRG00000020107","ENSBGRT00000038454",52390,"SCN2A","sodium voltage-gated channel alpha subunit 2 [Source:HGNC Symbol;Acc:HGNC:10588]","GO:0001518(voltage-gated sodium channel complex);GO:0005216(ion channel activity);GO:0005248(voltage-gated sodium channel activity);GO:0005261(cation channel activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0007399(nervous system development);GO:0007613(memory);GO:0008627(intrinsic apoptotic signaling pathway in response to osmotic stress);GO:0014704(intercalated disc);GO:0016020(membrane);GO:0030315(T-tubule);GO:0030424(axon);GO:0033270(paranode region of axon);GO:0035725(sodium ion transmembrane transport);GO:0051402(neuron apoptotic process);GO:0055085(transmembrane transport)","04742(Taste transduction)",{"v":4.3E-3,"d":"0.00"},2,"128,83,","0,10951",-2.37,-1.77,9.72,"Exon (ENSBGRT00000038454/ENSBGRG00000020107, exon 19 of 32)",2,116104090,116190533,86444,1]
["chr2",116189503,116189844,342,"ENSBGRG00000020107","ENSBGRT00000038454",85413,"SCN2A","sodium voltage-gated channel alpha subunit 2 [Source:HGNC Symbol;Acc:HGNC:10588]","GO:0001518(voltage-gated sodium channel complex);GO:0005216(ion channel activity);GO:0005248(voltage-gated sodium channel activity);GO:0005261(cation channel activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0007399(nervous system development);GO:0007613(memory);GO:0008627(intrinsic apoptotic signaling pathway in response to osmotic stress);GO:0014704(intercalated disc);GO:0016020(membrane);GO:0030315(T-tubule);GO:0030424(axon);GO:0033270(paranode region of axon);GO:0035725(sodium ion transmembrane transport);GO:0051402(neuron apoptotic process);GO:0055085(transmembrane transport)","04742(Taste transduction)",{"v":2.1e-08,"d":"0.00"},2,"191,140,","0,202",-7.68,-6.89,{"v":29.2,"d":"29.20"},"Exon (ENSBGRT00000038454/ENSBGRG00000020107, exon 30 of 32)",2,116104090,116190533,86444,1]
["chr2",116190203,116190533,331,"ENSBGRG00000020107","ENSBGRT00000038454",86113,"SCN2A","sodium voltage-gated channel alpha subunit 2 [Source:HGNC Symbol;Acc:HGNC:10588]","GO:0001518(voltage-gated sodium channel complex);GO:0005216(ion channel activity);GO:0005248(voltage-gated sodium channel activity);GO:0005261(cation channel activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0007399(nervous system development);GO:0007613(memory);GO:0008627(intrinsic apoptotic signaling pathway in response to osmotic stress);GO:0014704(intercalated disc);GO:0016020(membrane);GO:0030315(T-tubule);GO:0030424(axon);GO:0033270(paranode region of axon);GO:0035725(sodium ion transmembrane transport);GO:0051402(neuron apoptotic process);GO:0055085(transmembrane transport)","04742(Taste transduction)",{"v":5e-13,"d":"0.00"},1,"331,",0,{"v":-12.3,"d":"-12.30"},{"v":-11.4,"d":"-11.40"},{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000038454/ENSBGRG00000020107, exon 31 of 32)",2,116104090,116190533,86444,1]
["chr2",116482125,116482424,300,"ENSBGRG00000021834","ENSBGRT00000040359",177451,"CSRNP3","cysteine and serine rich nuclear protein 3 [Source:HGNC Symbol;Acc:HGNC:30729]","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0010923(negative regulation of phosphatase activity);GO:0043065(positive regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":0.0011,"d":"0.00"},1,"300,",0,-2.96,-2.33,13,"Exon (ENSBGRT00000040359/ENSBGRG00000021834, exon 5 of 5)",2,116304674,116484454,179781,1]
["chr2",116482842,116483469,628,"ENSBGRG00000021834","ENSBGRT00000040359",178168,"CSRNP3","cysteine and serine rich nuclear protein 3 [Source:HGNC Symbol;Acc:HGNC:30729]","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0010923(negative regulation of phosphatase activity);GO:0043065(positive regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":1.3E-6,"d":"0.00"},1,"628,",0,{"v":-5.9,"d":"-5.90"},-5.15,{"v":23.8,"d":"23.80"},"3' UTR",2,116304674,116484454,179781,1]
["chr2",116483678,116483737,60,"ENSBGRG00000021834","ENSBGRT00000040359",179004,"CSRNP3","cysteine and serine rich nuclear protein 3 [Source:HGNC Symbol;Acc:HGNC:30729]","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0010923(negative regulation of phosphatase activity);GO:0043065(positive regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":0.025,"d":"0.03"},1,"60,",0,-1.61,-1.07,{"v":5.4,"d":"5.40"},"3' UTR",2,116304674,116484454,179781,1]
["chr2",116484245,116484454,210,"ENSBGRG00000021834","ENSBGRT00000040359",179571,"CSRNP3","cysteine and serine rich nuclear protein 3 [Source:HGNC Symbol;Acc:HGNC:30729]","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0010923(negative regulation of phosphatase activity);GO:0043065(positive regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":0.00056,"d":"0.00"},1,"210,",0,-3.25,{"v":-2.6,"d":"-2.60"},14,"3' UTR",2,116304674,116484454,179781,1]
["chr2",118227953,118228043,91,"ENSBGRG00000023219","ENSBGRT00000043320",371199,"XIRP2","xin actin binding repeat containing 2 [Source:HGNC Symbol;Acc:HGNC:14303]","GO:0001725(stress fiber);GO:0003281(ventricular septum development);GO:0003779(actin binding);GO:0005925(focal adhesion);GO:0007507(heart development);GO:0030018(Z disc);GO:0030036(actin cytoskeleton organization);GO:0030054(cell junction);GO:0045216(cell-cell junction organization);GO:0051015(actin filament binding);GO:0051393(alpha-actinin binding);GO:0055008(cardiac muscle tissue morphogenesis)","NA",{"v":0.028,"d":"0.03"},1,"91,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"3' UTR",2,117856754,118229152,372399,1]
["chr2",118228853,118252590,23738,"ENSBGRG00000023219","ENSBGRT00000043320",372099,"XIRP2","xin actin binding repeat containing 2 [Source:HGNC Symbol;Acc:HGNC:14303]","GO:0001725(stress fiber);GO:0003281(ventricular septum development);GO:0003779(actin binding);GO:0005925(focal adhesion);GO:0007507(heart development);GO:0030018(Z disc);GO:0030036(actin cytoskeleton organization);GO:0030054(cell junction);GO:0045216(cell-cell junction organization);GO:0051015(actin filament binding);GO:0051393(alpha-actinin binding);GO:0055008(cardiac muscle tissue morphogenesis)","NA",{"v":0.0041,"d":"0.00"},4,"122,36,138,95,","0,124,162,23643",-2.39,-1.79,{"v":10.8,"d":"10.80"},"3' UTR",2,117856754,118229152,372399,1]
["chr2",118977699,118977789,91,"ENSBGRG00000023512","ENSBGRT00000043389",56860,"ENSBGRG00000023512","NA","NA","NA",{"v":0.00041,"d":"0.00"},1,"91,",0,-3.39,-2.74,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000043389/ENSBGRG00000023512, exon 3 of 3)",2,118920839,118977819,56981,1]
["chr2",118977929,118978464,536,"ENSBGRG00000023526","ENSBGRT00000043417",89,"B3GALT1","beta-1,3-galactosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:916]","GO:0000139(Golgi membrane);GO:0006486(protein glycosylation);GO:0006682(galactosylceramide biosynthetic process);GO:0008499(UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity);GO:0009312(oligosaccharide biosynthetic process);GO:0016020(membrane);GO:0030259(lipid glycosylation)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":3.2e-12,"d":"0.00"},1,"536,",0,{"v":-11.5,"d":"-11.50"},{"v":-10.7,"d":"-10.70"},41,"Exon (ENSBGRT00000043417/ENSBGRG00000023526, exon 1 of 1)",2,118977840,118978820,981,1]
["chr2",118978553,118978820,268,"ENSBGRG00000023526","ENSBGRT00000043417",713,"B3GALT1","beta-1,3-galactosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:916]","GO:0000139(Golgi membrane);GO:0006486(protein glycosylation);GO:0006682(galactosylceramide biosynthetic process);GO:0008499(UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity);GO:0009312(oligosaccharide biosynthetic process);GO:0016020(membrane);GO:0030259(lipid glycosylation)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":1.6e-06,"d":"0.00"},1,"268,",0,-5.79,-5.04,13,"Exon (ENSBGRT00000043417/ENSBGRG00000023526, exon 1 of 1)",2,118977840,118978820,981,1]
["chr2",120719830,120720158,329,"ENSBGRG00000006517","ENSBGRT00000012012",0,"KLHL41","kelch like family member 41 [Source:HGNC Symbol;Acc:HGNC:16905]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016567(protein ubiquitination);GO:0030239(myofibril assembly);GO:0031430(M band);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0033017(sarcoplasmic reticulum membrane);GO:0035914(skeletal muscle cell differentiation);GO:0045214(sarcomere organization);GO:0045661(regulation of myoblast differentiation);GO:0048741(skeletal muscle fiber development);GO:2000291(regulation of myoblast proliferation);GO:2001014(regulation of skeletal muscle cell differentiation)","NA",{"v":0.0002,"d":"0.00"},1,"329,",0,{"v":-3.7,"d":"-3.70"},-3.03,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000012012/ENSBGRG00000006517, exon 1 of 6)",2,120719830,120736976,17147,1]
["chr2",120720307,120720397,91,"ENSBGRG00000006517","ENSBGRT00000012012",477,"KLHL41","kelch like family member 41 [Source:HGNC Symbol;Acc:HGNC:16905]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016567(protein ubiquitination);GO:0030239(myofibril assembly);GO:0031430(M band);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0033017(sarcoplasmic reticulum membrane);GO:0035914(skeletal muscle cell differentiation);GO:0045214(sarcomere organization);GO:0045661(regulation of myoblast differentiation);GO:0048741(skeletal muscle fiber development);GO:2000291(regulation of myoblast proliferation);GO:2001014(regulation of skeletal muscle cell differentiation)","NA",{"v":0.00069,"d":"0.00"},1,"91,",0,-3.16,-2.51,{"v":8.1,"d":"8.10"},"Exon (ENSBGRT00000012012/ENSBGRG00000006517, exon 1 of 6)",2,120719830,120736976,17147,1]
["chr2",120720516,120720636,121,"ENSBGRG00000006517","ENSBGRT00000012012",686,"KLHL41","kelch like family member 41 [Source:HGNC Symbol;Acc:HGNC:16905]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016567(protein ubiquitination);GO:0030239(myofibril assembly);GO:0031430(M band);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0033017(sarcoplasmic reticulum membrane);GO:0035914(skeletal muscle cell differentiation);GO:0045214(sarcomere organization);GO:0045661(regulation of myoblast differentiation);GO:0048741(skeletal muscle fiber development);GO:2000291(regulation of myoblast proliferation);GO:2001014(regulation of skeletal muscle cell differentiation)","NA",{"v":1.2E-4,"d":"0.00"},1,"121,",0,-3.93,-3.25,4.68,"Exon (ENSBGRT00000012012/ENSBGRG00000006517, exon 1 of 6)",2,120719830,120736976,17147,1]
["chr2",120720725,120720785,61,"ENSBGRG00000006517","ENSBGRT00000012012",895,"KLHL41","kelch like family member 41 [Source:HGNC Symbol;Acc:HGNC:16905]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016567(protein ubiquitination);GO:0030239(myofibril assembly);GO:0031430(M band);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0033017(sarcoplasmic reticulum membrane);GO:0035914(skeletal muscle cell differentiation);GO:0045214(sarcomere organization);GO:0045661(regulation of myoblast differentiation);GO:0048741(skeletal muscle fiber development);GO:2000291(regulation of myoblast proliferation);GO:2001014(regulation of skeletal muscle cell differentiation)","NA",0.01,1,"61,",0,-1.99,-1.42,3.78,"Exon (ENSBGRT00000012012/ENSBGRG00000006517, exon 1 of 6)",2,120719830,120736976,17147,1]
["chr2",120828434,120833836,5403,"ENSBGRG00000006620","ENSBGRT00000012225",20777,"PPIG","peptidylprolyl isomerase G [Source:HGNC Symbol;Acc:HGNC:14650]","GO:0000413(protein peptidyl-prolyl isomerization);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005829(cytosol);GO:0006457(protein folding);GO:0016018(cyclosporin A binding);GO:0016607(nuclear speck)","NA",{"v":8.99999999999999e-304,"d":"0.00"},5,"147,168,88,137,1108,","0,878,2429,3995,4295",-303,-301,5.43,"Exon (ENSBGRT00000012225/ENSBGRG00000006620, exon 10 of 14)",2,120807657,120833836,26180,1]
["chr2",120865872,120868478,2607,"ENSBGRG00000006691","ENSBGRT00000012340",288,"PHOSPHO2","phosphatase, orphan 2 [Source:HGNC Symbol;Acc:HGNC:28316]","GO:0016791(phosphatase activity)","00750(Vitamin B6 metabolism)",{"v":9.99999999999998e-283,"d":"0.00"},2,"15,339,","0,2268",-282,-280,{"v":6.2,"d":"6.20"},"5' UTR",2,120865584,120868891,3308,1]
["chr2",120904422,120904602,181,"ENSBGRG00000006712","ENSBGRT00000012377",1601,"KLHL23","kelch like family member 23 [Source:HGNC Symbol;Acc:HGNC:27506]","GO:0005515(protein binding)","NA",{"v":2.5e-06,"d":"0.00"},1,"181,",0,-5.61,-4.87,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000012377/ENSBGRG00000006712, exon 2 of 3)",2,120902821,120920785,17965,1]
["chr2",120944749,120946014,1266,"ENSBGRG00000006739","ENSBGRT00000012435",5148,"SSB","small RNA binding exonuclease protection factor La [Source:HGNC Symbol;Acc:HGNC:11316]","GO:0000049(tRNA binding);GO:0001682(tRNA 5'-leader removal);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006396(RNA processing);GO:0006409(tRNA export from nucleus);GO:0008033(tRNA processing);GO:0008266(poly(U) RNA binding);GO:0042780(tRNA 3'-end processing);GO:0071045(nuclear histone mRNA catabolic process);GO:0075522(IRES-dependent viral translational initiation);GO:1903608(protein localization to cytoplasmic stress granule);GO:1990825(sequence-specific mRNA binding);GO:1990904(ribonucleoprotein complex)","05322(Systemic lupus erythematosus)",{"v":6.3e-14,"d":"0.00"},3,"58,72,19,","0,841,1247",{"v":-13.2,"d":"-13.20"},{"v":-12.3,"d":"-12.30"},1.45,"Exon (ENSBGRT00000012435/ENSBGRG00000006739, exon 5 of 11)",2,120939601,120948632,9032,1]
["chr2",120947307,120948142,836,"ENSBGRG00000006800","ENSBGRT00000012544",0,"U6","U6 spliceosomal RNA [Source:RFAM;Acc:RF00026]","NA","NA",{"v":1E-181,"d":"0.00"},3,"77,187,63,","0,331,773",-181,-179,2.73,"Exon (ENSBGRT00000012435/ENSBGRG00000006739, exon 8 of 11)",2,120947907,120948013,107,1]
["chr2",121095606,121095726,121,"ENSBGRG00000006942","ENSBGRT00000012815",119179,"UBR3","ubiquitin protein ligase E3 component n-recognin 3 [Source:HGNC Symbol;Acc:HGNC:30467]","GO:0001701(in utero embryonic development);GO:0001967(suckling behavior);GO:0004842(ubiquitin-protein transferase activity);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007608(sensory perception of smell);GO:0008270(zinc ion binding);GO:0009792(embryo development ending in birth or egg hatching);GO:0042048(olfactory behavior);GO:0061630(ubiquitin protein ligase activity);GO:0071596(ubiquitin-dependent protein catabolic process via the N-end rule pathway)","NA",{"v":0.00019,"d":"0.00"},1,"121,",0,-3.72,-3.05,1.56,"Exon (ENSBGRT00000012815/ENSBGRG00000006942, exon 23 of 40)",2,120976427,121198019,221593,1]
["chr2",121850147,121851101,955,"ENSBGRG00000007982","ENSBGRT00000014555",939,"SP5","Sp5 transcription factor [Source:HGNC Symbol;Acc:HGNC:14529]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0036342(post-anal tail morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0060349(bone morphogenesis);GO:0071407(cellular response to organic cyclic compound)","NA",{"v":0.0078,"d":"0.01"},1,"955,",0,-2.11,-1.27,9.72,"Exon (ENSBGRT00000014555/ENSBGRG00000007982, exon 2 of 2)",2,121849208,121851101,1894,1]
["chr2",122876719,122882139,5421,"ENSBGRG00000009556","ENSBGRT00000017756",35224,"DYNC1I2","dynein cytoplasmic 1 intermediate chain 2 [Source:HGNC Symbol;Acc:HGNC:2964]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0005868(cytoplasmic dynein complex);GO:0005874(microtubule);GO:0007018(microtubule-based movement);GO:0031982(vesicle)","04145(Phagosome);04962(Vasopressin-regulated water reabsorption);05132(Salmonella infection)",{"v":4.7e-06,"d":"0.00"},2,"10,51,","0,5370",-5.33,-4.59,1.39,"Exon (ENSBGRT00000017756/ENSBGRG00000009556, exon 5 of 18)",2,122841495,122920342,78848,1]
["chr2",123246471,123247429,959,"ENSBGRG00000010401","ENSBGRT00000019080",88717,"METAP1D","methionyl aminopeptidase type 1D, mitochondrial [Source:HGNC Symbol;Acc:HGNC:32583]","GO:0004177(aminopeptidase activity);GO:0005739(mitochondrion);GO:0006508(proteolysis);GO:0008235(metalloexopeptidase activity)","NA",{"v":1e-111,"d":"0.00"},1,"959,",0,-111,-109,14,"3' UTR",2,123157754,123247429,89676,1]
["chr2",123681260,123686344,5085,"ENSBGRG00000010970","ENSBGRT00000020748",90495,"ITGA6","integrin subunit alpha 6 [Source:HGNC Symbol;Acc:HGNC:6142]","GO:0005604(basement membrane);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007160(cell-matrix adhesion);GO:0008305(integrin complex);GO:0009897(external side of plasma membrane);GO:0009925(basal plasma membrane);GO:0009986(cell surface);GO:0010668(ectodermal cell differentiation);GO:0010976(positive regulation of neuron projection development);GO:0016323(basolateral plasma membrane);GO:0022409(positive regulation of cell-cell adhesion);GO:0030056(hemidesmosome);GO:0030335(positive regulation of cell migration);GO:0031589(cell-substrate adhesion);GO:0031668(cellular response to extracellular stimulus);GO:0031994(insulin-like growth factor I binding);GO:0035878(nail development);GO:0038132(neuregulin binding);GO:0042327(positive regulation of phosphorylation);GO:0042475(odontogenesis of dentin-containing tooth);GO:0043065(positive regulation of apoptotic process);GO:0043547(positive regulation of GTPase activity);GO:0043589(skin morphogenesis);GO:0045178(basal part of cell);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046847(filopodium assembly);GO:0050873(brown fat cell differentiation);GO:0050900(leukocyte migration);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04514(Cell adhesion molecules (CAMs));04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04640(Hematopoietic cell lineage);05200(Pathways in cancer);05222(Small cell lung cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection);05145(Toxoplasmosis)",{"v":2e-36,"d":"0.00"},3,"14,130,336,","0,2431,4749",{"v":-35.7,"d":"-35.70"},{"v":-34.5,"d":"-34.50"},{"v":5.4,"d":"5.40"},"3' UTR",2,123590765,123683820,93056,1]
["chr2",123686404,123686614,211,"ENSBGRG00000010970","ENSBGRT00000020286",95639,"ITGA6","integrin subunit alpha 6 [Source:HGNC Symbol;Acc:HGNC:6142]","GO:0005604(basement membrane);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007160(cell-matrix adhesion);GO:0008305(integrin complex);GO:0009897(external side of plasma membrane);GO:0009925(basal plasma membrane);GO:0009986(cell surface);GO:0010668(ectodermal cell differentiation);GO:0010976(positive regulation of neuron projection development);GO:0016323(basolateral plasma membrane);GO:0022409(positive regulation of cell-cell adhesion);GO:0030056(hemidesmosome);GO:0030335(positive regulation of cell migration);GO:0031589(cell-substrate adhesion);GO:0031668(cellular response to extracellular stimulus);GO:0031994(insulin-like growth factor I binding);GO:0035878(nail development);GO:0038132(neuregulin binding);GO:0042327(positive regulation of phosphorylation);GO:0042475(odontogenesis of dentin-containing tooth);GO:0043065(positive regulation of apoptotic process);GO:0043547(positive regulation of GTPase activity);GO:0043589(skin morphogenesis);GO:0045178(basal part of cell);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046847(filopodium assembly);GO:0050873(brown fat cell differentiation);GO:0050900(leukocyte migration);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04514(Cell adhesion molecules (CAMs));04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04640(Hematopoietic cell lineage);05200(Pathways in cancer);05222(Small cell lung cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection);05145(Toxoplasmosis)",{"v":9.99999999999999e-250,"d":"0.00"},1,"211,",0,-249,-247,5.26,"3' UTR",2,123590765,123686614,95850,1]
["chr2",124411905,124415824,3920,"ENSBGRG00000013013","ENSBGRT00000023923",116659,"MAP3K20","mitogen-activated protein kinase kinase kinase 20 [Source:HGNC Symbol;Acc:HGNC:17797]","GO:0000077(DNA damage checkpoint);GO:0000186(activation of MAPKK activity);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007010(cytoskeleton organization);GO:0007050(cell cycle arrest);GO:0007093(mitotic cell cycle checkpoint);GO:0007257(activation of JUN kinase activity);GO:0035556(intracellular signal transduction);GO:0042733(embryonic digit morphogenesis);GO:0043065(positive regulation of apoptotic process);GO:0051403(stress-activated MAPK cascade);GO:0060173(limb development);GO:0071480(cellular response to gamma radiation)","04010(MAPK signaling pathway)",{"v":4e-11,"d":"0.00"},2,"7,84,","0,3836",{"v":-10.4,"d":"-10.40"},{"v":-9.5,"d":"-9.50"},{"v":2.5,"d":"2.50"},"Exon (ENSBGRT00000023923/ENSBGRG00000013013, exon 11 of 12)",2,124295246,124417124,121879,1]
["chr2",124467329,124467509,181,"ENSBGRG00000013013","ENSBGRT00000023811",172083,"MAP3K20","mitogen-activated protein kinase kinase kinase 20 [Source:HGNC Symbol;Acc:HGNC:17797]","GO:0000077(DNA damage checkpoint);GO:0000186(activation of MAPKK activity);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007010(cytoskeleton organization);GO:0007050(cell cycle arrest);GO:0007093(mitotic cell cycle checkpoint);GO:0007257(activation of JUN kinase activity);GO:0035556(intracellular signal transduction);GO:0042733(embryonic digit morphogenesis);GO:0043065(positive regulation of apoptotic process);GO:0051403(stress-activated MAPK cascade);GO:0060173(limb development);GO:0071480(cellular response to gamma radiation)","04010(MAPK signaling pathway)",{"v":2.5e-26,"d":"0.00"},1,"181,",0,{"v":-25.6,"d":"-25.60"},{"v":-24.5,"d":"-24.50"},4.99,"Exon (ENSBGRT00000023811/ENSBGRG00000013013, exon 20 of 20)",2,124295246,124468405,173160,1]
["chr2",125178882,125179031,150,"ENSBGRG00000013676","ENSBGRT00000025060",209,"ENSBGRG00000013676","NA","NA","NA",{"v":0.0071,"d":"0.01"},1,"150,",0,-2.15,-1.57,4.68,"Exon (ENSBGRT00000025060/ENSBGRG00000013676, exon 1 of 1)",2,125178673,125180133,1461,1]
["chr2",125179507,125179746,240,"ENSBGRG00000013676","ENSBGRT00000025060",834,"ENSBGRG00000013676","NA","NA","NA",{"v":0.00022,"d":"0.00"},1,"240,",0,-3.65,-2.98,6.84,"Exon (ENSBGRT00000025060/ENSBGRG00000013676, exon 1 of 1)",2,125178673,125180133,1461,1]
["chr2",125179895,125180133,239,"ENSBGRG00000013676","ENSBGRT00000025060",1222,"ENSBGRG00000013676","NA","NA","NA",{"v":0.0078,"d":"0.01"},1,"239,",0,-2.11,{"v":-1.3,"d":"-1.30"},9.72,"Exon (ENSBGRT00000025060/ENSBGRG00000013676, exon 1 of 1)",2,125178673,125180133,1461,1]
["chr2",127307739,127309205,1467,"ENSBGRG00000016923","ENSBGRT00000031062",4160,"HOXD11","homeobox D11 [Source:HGNC Symbol;Acc:HGNC:5134]","GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":3.6e-05,"d":"0.00"},2,"79,606,","0,861",-4.44,-3.74,{"v":10.3,"d":"10.30"},"3' UTR",2,127303579,127309205,5627,1]
["chr2",127319198,127319346,149,"ENSBGRG00000016979","ENSBGRT00000031186",712,"HOXD10","homeobox D10 [Source:HGNC Symbol;Acc:HGNC:5133]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0007338(single fertilization);GO:0007519(skeletal muscle tissue development);GO:0008344(adult locomotory behavior);GO:0009952(anterior/posterior pattern specification);GO:0009954(proximal/distal pattern formation);GO:0010468(regulation of gene expression);GO:0021520(spinal cord motor neuron cell fate specification);GO:0030326(embryonic limb morphogenesis);GO:0035136(forelimb morphogenesis);GO:0035137(hindlimb morphogenesis);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048704(embryonic skeletal system morphogenesis);GO:0048935(peripheral nervous system neuron development);GO:0050905(neuromuscular process);GO:1990837(sequence-specific double-stranded DNA binding)","05206(MicroRNAs in cancer);05205(Proteoglycans in cancer)",{"v":0.028,"d":"0.03"},1,"149,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000031186/ENSBGRG00000016979, exon 1 of 2)",2,127318486,127322297,3812,1]
["chr2",127321408,127321704,297,"ENSBGRG00000016979","ENSBGRT00000031186",2922,"HOXD10","homeobox D10 [Source:HGNC Symbol;Acc:HGNC:5133]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0007338(single fertilization);GO:0007519(skeletal muscle tissue development);GO:0008344(adult locomotory behavior);GO:0009952(anterior/posterior pattern specification);GO:0009954(proximal/distal pattern formation);GO:0010468(regulation of gene expression);GO:0021520(spinal cord motor neuron cell fate specification);GO:0030326(embryonic limb morphogenesis);GO:0035136(forelimb morphogenesis);GO:0035137(hindlimb morphogenesis);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048704(embryonic skeletal system morphogenesis);GO:0048935(peripheral nervous system neuron development);GO:0050905(neuromuscular process);GO:1990837(sequence-specific double-stranded DNA binding)","05206(MicroRNAs in cancer);05205(Proteoglycans in cancer)",{"v":3.8e-05,"d":"0.00"},1,"297,",0,-4.42,-3.72,{"v":18.4,"d":"18.40"},"3' UTR",2,127318486,127322297,3812,1]
["chr2",127328310,127329145,836,"ENSBGRG00000017014","ENSBGRT00000031211",689,"HOXD9","homeobox D9 [Source:HGNC Symbol;Acc:HGNC:5140]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007338(single fertilization);GO:0007519(skeletal muscle tissue development);GO:0008344(adult locomotory behavior);GO:0009952(anterior/posterior pattern specification);GO:0009954(proximal/distal pattern formation);GO:0010468(regulation of gene expression);GO:0030879(mammary gland development);GO:0035115(embryonic forelimb morphogenesis);GO:0035136(forelimb morphogenesis);GO:0035137(hindlimb morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048704(embryonic skeletal system morphogenesis);GO:0048706(embryonic skeletal system development);GO:0048935(peripheral nervous system neuron development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":9.99999999999999e-223,"d":"0.00"},2,"110,371,","0,465",-222,-219,4.03,"3' UTR",2,127327621,127329744,2124,1]
["chr2",127335661,127336261,601,"ENSBGRG00000017045","ENSBGRT00000031311",0,"HOXD8","homeobox D8 [Source:HGNC Symbol;Acc:HGNC:5139]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0009952(anterior/posterior pattern specification);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048705(skeletal system morphogenesis);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":2e-11,"d":"0.00"},2,"213,52,","0,549",{"v":-10.7,"d":"-10.70"},-9.89,{"v":16.2,"d":"16.20"},"5' UTR",2,127335661,127337650,1990,1]
["chr2",127336731,127337650,920,"ENSBGRG00000017045","ENSBGRT00000031311",1070,"HOXD8","homeobox D8 [Source:HGNC Symbol;Acc:HGNC:5139]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0009952(anterior/posterior pattern specification);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048705(skeletal system morphogenesis);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":9.99999999999998e-264,"d":"0.00"},2,"233,296,","0,624",-263,-261,4.32,"Exon (ENSBGRT00000031311/ENSBGRG00000017045, exon 2 of 3)",2,127335661,127337650,1990,1]
["chr2",127365236,127366137,902,"ENSBGRG00000017167","ENSBGRT00000031452",22218,"ENSBGRG00000017167","NA","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding)","NA",{"v":9.99999999999999e-245,"d":"0.00"},2,"24,334,","0,568",-244,-242,3.35,"Exon (ENSBGRT00000031452/ENSBGRG00000017167, exon 4 of 4)",2,127343018,127366345,23328,1]
["chr2",127386678,127389996,3319,"ENSBGRG00000017255","ENSBGRT00000031652",10650,"HOXD3","homeobox D3 [Source:HGNC Symbol;Acc:HGNC:5137]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007160(cell-matrix adhesion);GO:0007219(Notch signaling pathway);GO:0009952(anterior/posterior pattern specification);GO:0010628(positive regulation of gene expression);GO:0016235(aggresome);GO:0016604(nuclear body);GO:0021615(glossopharyngeal nerve morphogenesis);GO:0030878(thyroid gland development);GO:0043565(sequence-specific DNA binding);GO:0045666(positive regulation of neuron differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048704(embryonic skeletal system morphogenesis);GO:0051216(cartilage development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1E-169,"d":"0.00"},3,"19,630,11,","0,579,3308",-169,-167,3.81,"5' UTR",2,127376028,127391998,15971,1]
["chr2",127391488,127391998,511,"ENSBGRG00000017255","ENSBGRT00000031652",15460,"HOXD3","homeobox D3 [Source:HGNC Symbol;Acc:HGNC:5137]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007160(cell-matrix adhesion);GO:0007219(Notch signaling pathway);GO:0009952(anterior/posterior pattern specification);GO:0010628(positive regulation of gene expression);GO:0016235(aggresome);GO:0016604(nuclear body);GO:0021615(glossopharyngeal nerve morphogenesis);GO:0030878(thyroid gland development);GO:0043565(sequence-specific DNA binding);GO:0045666(positive regulation of neuron differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048704(embryonic skeletal system morphogenesis);GO:0051216(cartilage development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0,"d":"0.00"},1,"511,",0,-321,-319,7.04,"Exon (ENSBGRT00000031652/ENSBGRG00000017255, exon 5 of 5)",2,127376028,127391998,15971,1]
["chr2",127410071,127410737,667,"ENSBGRG00000017303","ENSBGRT00000031743",596,"HOXD1","homeobox D1 [Source:HGNC Symbol;Acc:HGNC:5132]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0019233(sensory perception of pain);GO:0030182(neuron differentiation);GO:0043565(sequence-specific DNA binding);GO:0048706(embryonic skeletal system development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.0041,"d":"0.00"},2,"38,291,","0,376",-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000031743/ENSBGRG00000017303, exon 1 of 2)",2,127409475,127411542,2068,1]
["chr2",128610809,128611539,731,"ENSBGRG00000000202","ENSBGRT00000000325",2559,"ENSBGRG00000000202","heterogeneous nuclear ribonucleoprotein A3 [Source:HGNC Symbol;Acc:HGNC:24941]","GO:0003676(nucleic acid binding)","03040(Spliceosome)",{"v":9.99999999999999e-266,"d":"0.00"},3,"143,90,90,","0,468,641",-265,-262,3.24,"Exon (ENSBGRT00000000325/ENSBGRG00000000202, exon 4 of 10)",2,128608250,128613411,5162,1]
["chr2",128612263,128613411,1149,"ENSBGRG00000000202","ENSBGRT00000000325",4013,"ENSBGRG00000000202","heterogeneous nuclear ribonucleoprotein A3 [Source:HGNC Symbol;Acc:HGNC:24941]","GO:0003676(nucleic acid binding)","03040(Spliceosome)",0,3,"59,123,53,","0,878,1096",-572,"-Inf",3.83,"Exon (ENSBGRT00000000325/ENSBGRG00000000202, exon 8 of 10)",2,128608250,128613411,5162,1]
["chr2",129088576,129089388,813,"ENSBGRG00000000279","ENSBGRT00000000441",238,"ENSBGRG00000000279","NA","NA","NA",{"v":0.0011,"d":"0.00"},2,"49,71,","0,742",-2.96,-2.33,13,"Exon (ENSBGRT00000000441/ENSBGRG00000000279, exon 1 of 2)",2,129088338,129091291,2954,1]
["chr2",129089596,129089685,90,"ENSBGRG00000000279","ENSBGRT00000000441",1258,"ENSBGRG00000000279","NA","NA","NA",{"v":0.0045,"d":"0.00"},1,"90,",0,-2.35,-1.76,3.67,"Exon (ENSBGRT00000000441/ENSBGRG00000000279, exon 2 of 2)",2,129088338,129091291,2954,1]
["chr2",129935474,129973752,38279,"ENSBGRG00000000437","ENSBGRT00000000858",163414,"OSBPL6","oxysterol binding protein like 6 [Source:HGNC Symbol;Acc:HGNC:16388]","GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0031901(early endosome membrane);GO:0031965(nuclear membrane);GO:0032374(regulation of cholesterol transport);GO:0097038(perinuclear endoplasmic reticulum)","NA",{"v":1e-37,"d":"0.00"},3,"1,109,100,","0,1258,38179",-37,{"v":-35.8,"d":"-35.80"},2.49,"Exon (ENSBGRT00000000858/ENSBGRG00000000437, exon 26 of 27)",2,129772060,129936840,164781,1]
["chr2",133509648,133510515,868,"ENSBGRG00000001314","ENSBGRT00000002425",0,"ITGA4","integrin subunit alpha 4 [Source:HGNC Symbol;Acc:HGNC:6140]","GO:0003366(cell-matrix adhesion involved in ameboidal cell migration);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007159(leukocyte cell-cell adhesion);GO:0007160(cell-matrix adhesion);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0019960(C-X3-C chemokine binding);GO:0033631(cell-cell adhesion mediated by integrin);GO:0034113(heterotypic cell-cell adhesion);GO:0034446(substrate adhesion-dependent cell spreading);GO:0034669(integrin alpha4-beta7 complex);GO:0035987(endodermal cell differentiation);GO:0043113(receptor clustering);GO:0050839(cell adhesion molecule binding);GO:0050901(leukocyte tethering or rolling);GO:0090074(negative regulation of protein homodimerization activity);GO:0140039(cell-cell adhesion in response to extracellular stimulus);GO:1904646(cellular response to amyloid-beta);GO:1905564(positive regulation of vascular endothelial cell proliferation);GO:2000353(positive regulation of endothelial cell apoptotic process)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04514(Cell adhesion molecules (CAMs));04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04640(Hematopoietic cell lineage);04670(Leukocyte transendothelial migration);04672(Intestinal immune network for IgA production);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection);05140(Leishmaniasis)",{"v":0.043,"d":"0.04"},1,"868,",0,-1.37,{"v":-0.6,"d":"-0.60"},{"v":5.4,"d":"5.40"},"5' UTR",2,133509648,133612230,102583,1]
["chr2",133610077,133610137,61,"ENSBGRG00000001314","ENSBGRT00000002425",100429,"ITGA4","integrin subunit alpha 4 [Source:HGNC Symbol;Acc:HGNC:6140]","GO:0003366(cell-matrix adhesion involved in ameboidal cell migration);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007159(leukocyte cell-cell adhesion);GO:0007160(cell-matrix adhesion);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0019960(C-X3-C chemokine binding);GO:0033631(cell-cell adhesion mediated by integrin);GO:0034113(heterotypic cell-cell adhesion);GO:0034446(substrate adhesion-dependent cell spreading);GO:0034669(integrin alpha4-beta7 complex);GO:0035987(endodermal cell differentiation);GO:0043113(receptor clustering);GO:0050839(cell adhesion molecule binding);GO:0050901(leukocyte tethering or rolling);GO:0090074(negative regulation of protein homodimerization activity);GO:0140039(cell-cell adhesion in response to extracellular stimulus);GO:1904646(cellular response to amyloid-beta);GO:1905564(positive regulation of vascular endothelial cell proliferation);GO:2000353(positive regulation of endothelial cell apoptotic process)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04514(Cell adhesion molecules (CAMs));04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04640(Hematopoietic cell lineage);04670(Leukocyte transendothelial migration);04672(Intestinal immune network for IgA production);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection);05140(Leishmaniasis)",{"v":5e-43,"d":"0.00"},1,"61,",0,{"v":-42.3,"d":"-42.30"},{"v":-41.1,"d":"-41.10"},4.73,"3' UTR",2,133509648,133612230,102583,1]
["chr2",134046138,134054660,8523,"ENSBGRG00000001467","ENSBGRT00000002984",73461,"ITPRID2","ITPR interacting domain containing 2 [Source:HGNC Symbol;Acc:HGNC:11319]","GO:0003779(actin binding);GO:0005102(signaling receptor binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0051015(actin filament binding)","NA",{"v":1E-136,"d":"0.00"},3,"70,701,7,","0,936,8516",-136,-134,7.12,"Exon (ENSBGRT00000002984/ENSBGRG00000001467, exon 8 of 18)",2,133972677,134077352,104676,1]
["chr2",134060627,134060776,150,"ENSBGRG00000001467","ENSBGRT00000002984",87950,"ITPRID2","ITPR interacting domain containing 2 [Source:HGNC Symbol;Acc:HGNC:11319]","GO:0003779(actin binding);GO:0005102(signaling receptor binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0051015(actin filament binding)","NA",{"v":6.3e-23,"d":"0.00"},1,"150,",0,{"v":-22.2,"d":"-22.20"},{"v":-21.1,"d":"-21.10"},1.93,"Exon (ENSBGRT00000002984/ENSBGRG00000001467, exon 12 of 18)",2,133972677,134077352,104676,1]
["chr2",134061045,134061344,300,"ENSBGRG00000001467","ENSBGRT00000002984",88368,"ITPRID2","ITPR interacting domain containing 2 [Source:HGNC Symbol;Acc:HGNC:11319]","GO:0003779(actin binding);GO:0005102(signaling receptor binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0051015(actin filament binding)","NA",{"v":7.9e-53,"d":"0.00"},1,"300,",0,{"v":-52.1,"d":"-52.10"},{"v":-50.8,"d":"-50.80"},5.03,"Exon (ENSBGRT00000002984/ENSBGRG00000001467, exon 12 of 18)",2,133972677,134077352,104676,1]
["chr2",134067629,134076610,8982,"ENSBGRG00000001467","ENSBGRT00000002984",94952,"ITPRID2","ITPR interacting domain containing 2 [Source:HGNC Symbol;Acc:HGNC:11319]","GO:0003779(actin binding);GO:0005102(signaling receptor binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0051015(actin filament binding)","NA",{"v":2e-43,"d":"0.00"},2,"295,35,","0,8947",{"v":-42.7,"d":"-42.70"},{"v":-41.5,"d":"-41.50"},2.07,"Exon (ENSBGRT00000002984/ENSBGRG00000001467, exon 17 of 18)",2,133972677,134077352,104676,1]
["chr2",134954975,134956702,1728,"ENSBGRG00000002186","ENSBGRT00000004428",508,"DNAJC10","DnaJ heat shock protein family (Hsp40) member C10 [Source:HGNC Symbol;Acc:HGNC:24637]","GO:0001671(ATPase activator activity);GO:0001933(negative regulation of protein phosphorylation);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0015035(protein disulfide oxidoreductase activity);GO:0015036(disulfide oxidoreductase activity);GO:0016671(oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0030544(Hsp70 protein binding);GO:0032781(positive regulation of ATPase activity);GO:0034663(endoplasmic reticulum chaperone complex);GO:0034975(protein folding in endoplasmic reticulum);GO:0034976(response to endoplasmic reticulum stress);GO:0045454(cell redox homeostasis);GO:0051087(chaperone binding);GO:0051117(ATPase binding);GO:0051787(misfolded protein binding);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress)","04141(Protein processing in endoplasmic reticulum)",{"v":1e-57,"d":"0.00"},3,"150,56,35,","0,710,1693",-57,{"v":-55.6,"d":"-55.60"},3.02,"5' UTR",2,134954467,134979191,24725,1]
["chr2",135329692,135336657,6966,"ENSBGRG00000002575","ENSBGRT00000004836",1305,"DUSP19","dual specificity phosphatase 19 [Source:HGNC Symbol;Acc:HGNC:18894]","GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity)","NA",{"v":0.025,"d":"0.03"},2,"150,29,","0,6937",-1.61,-1.07,4.86,"Exon (ENSBGRT00000004836/ENSBGRG00000002575, exon 2 of 4)",2,135328387,135346915,18529,1]
["chr2",137445425,137445543,119,"ENSBGRG00000002708","ENSBGRT00000005068",938,"ENSBGRG00000002708","NA","NA","NA",{"v":4.3e-06,"d":"0.00"},1,"119,",0,-5.37,-4.64,5.25,"Exon (ENSBGRT00000005068/ENSBGRG00000002708, exon 2 of 2)",2,137444487,137446489,2003,1]
["chr2",137445602,137445898,297,"ENSBGRG00000002708","ENSBGRT00000005068",1115,"ENSBGRG00000002708","NA","NA","NA",{"v":1.2E-5,"d":"0.00"},1,"297,",0,-4.91,-4.19,7.02,"Exon (ENSBGRT00000005068/ENSBGRG00000002708, exon 2 of 2)",2,137444487,137446489,2003,1]
["chr2",139323886,139327304,3419,"ENSBGRG00000002787","ENSBGRT00000005229",19524,"ENSBGRG00000002787","zinc finger CCCH-type containing 15 [Source:HGNC Symbol;Acc:HGNC:29528]","GO:0046872(metal ion binding)","00640(Propanoate metabolism);00280(Valine, leucine and isoleucine degradation)",{"v":1.6e-38,"d":"0.00"},3,"45,124,131,","0,832,3288",{"v":-37.8,"d":"-37.80"},{"v":-36.6,"d":"-36.60"},1.91,"Exon (ENSBGRT00000005229/ENSBGRG00000002787, exon 8 of 10)",2,139304362,139327364,23003,1]
["chr2",139627930,139628763,834,"ENSBGRG00000003018","ENSBGRT00000005639",75060,"FAM171B","family with sequence similarity 171 member B [Source:HGNC Symbol;Acc:HGNC:29412]","NA","NA",{"v":1e-116,"d":"0.00"},1,"834,",0,-116,-114,6.94,"Exon (ENSBGRT00000005639/ENSBGRG00000003018, exon 8 of 8)",2,139552870,139629180,76311,1]
["chr2",139628882,139629120,239,"ENSBGRG00000003018","ENSBGRT00000005639",76012,"FAM171B","family with sequence similarity 171 member B [Source:HGNC Symbol;Acc:HGNC:29412]","NA","NA",{"v":1e-123,"d":"0.00"},1,"239,",0,-123,-122,4.99,"Exon (ENSBGRT00000005639/ENSBGRG00000003018, exon 8 of 8)",2,139552870,139629180,76311,1]
["chr2",142877061,142877360,300,"ENSBGRG00000003820","ENSBGRT00000007098",959,"ENSBGRG00000003820","NA","GO:0004066(asparagine synthase (glutamine-hydrolyzing) activity);GO:0006529(asparagine biosynthetic process)","NA",{"v":2E-95,"d":"0.00"},2,"156,143,","0,157",{"v":-94.7,"d":"-94.70"},{"v":-93.1,"d":"-93.10"},4.72,"Exon (ENSBGRT00000007098/ENSBGRG00000003820, exon 2 of 5)",2,142876102,142880839,4738,1]
["chr2",143681452,143681722,271,"ENSBGRG00000000481","ENSBGRT00000000839",41884,"INPP1","inositol polyphosphate-1-phosphatase [Source:HGNC Symbol;Acc:HGNC:6071]","GO:0046854(phosphatidylinositol phosphorylation);GO:0046855(inositol phosphate dephosphorylation)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":1e-121,"d":"0.00"},1,"271,",0,-121,-119,7.81,"Exon (ENSBGRT00000000839/ENSBGRG00000000481, exon 6 of 6)",2,143639568,143681722,42155,1]
["chr2",143743663,143743932,270,"ENSBGRG00000000505","ENSBGRT00000000927",119,"MFSD6","major facilitator superfamily domain containing 6 [Source:HGNC Symbol;Acc:HGNC:24711]","NA","NA",{"v":8.1e-05,"d":"0.00"},1,"270,",0,-4.09,{"v":-3.4,"d":"-3.40"},2.41,"Exon (ENSBGRT00000000927/ENSBGRG00000000505, exon 1 of 7)",2,143743544,143812349,68806,1]
["chr2",143744111,143744409,299,"ENSBGRG00000000505","ENSBGRT00000000927",567,"MFSD6","major facilitator superfamily domain containing 6 [Source:HGNC Symbol;Acc:HGNC:24711]","NA","NA",{"v":1e-20,"d":"0.00"},1,"299,",0,-20,-19,4.96,"Exon (ENSBGRT00000000927/ENSBGRG00000000505, exon 1 of 7)",2,143743544,143812349,68806,1]
["chr2",143744499,143744648,150,"ENSBGRG00000000505","ENSBGRT00000000927",955,"MFSD6","major facilitator superfamily domain containing 6 [Source:HGNC Symbol;Acc:HGNC:24711]","NA","NA",{"v":1.8E-5,"d":"0.00"},1,"150,",0,-4.74,-4.03,2.86,"Exon (ENSBGRT00000000927/ENSBGRG00000000505, exon 1 of 7)",2,143743544,143812349,68806,1]
["chr2",143745006,143745096,91,"ENSBGRG00000000505","ENSBGRT00000000927",1462,"MFSD6","major facilitator superfamily domain containing 6 [Source:HGNC Symbol;Acc:HGNC:24711]","NA","NA",{"v":0.0045,"d":"0.00"},1,"91,",0,-2.35,-1.76,2.97,"Exon (ENSBGRT00000000927/ENSBGRG00000000505, exon 1 of 7)",2,143743544,143812349,68806,1]
["chr2",143812393,143812751,359,"ENSBGRG00000000505","ENSBGRT00000000906",68849,"MFSD6","major facilitator superfamily domain containing 6 [Source:HGNC Symbol;Acc:HGNC:24711]","NA","NA",{"v":7.9e-29,"d":"0.00"},1,"359,",0,{"v":-28.1,"d":"-28.10"},-27,3.84,"3' UTR",2,143743544,143813318,69775,1]
["chr2",143979037,143979275,239,"ENSBGRG00000000603","ENSBGRT00000001072",14589,"NAB1","NGFI-A binding protein 1 [Source:HGNC Symbol;Acc:HGNC:7626]","GO:0001958(endochondral ossification);GO:0003712(transcription coregulator activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0014037(Schwann cell differentiation);GO:0042552(myelination);GO:0045682(regulation of epidermis development);GO:0045892(negative regulation of transcription, DNA-templated)","04146(Peroxisome)",{"v":7.9E-39,"d":"0.00"},1,"239,",0,{"v":-38.1,"d":"-38.10"},{"v":-36.9,"d":"-36.90"},4.33,"Exon (ENSBGRT00000001072/ENSBGRG00000000603, exon 2 of 7)",2,143964448,144013147,48700,1]
["chr2",144013152,144013242,91,"ENSBGRG00000000603","ENSBGRT00000001088",48464,"NAB1","NGFI-A binding protein 1 [Source:HGNC Symbol;Acc:HGNC:7626]","GO:0001958(endochondral ossification);GO:0003712(transcription coregulator activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0014037(Schwann cell differentiation);GO:0042552(myelination);GO:0045682(regulation of epidermis development);GO:0045892(negative regulation of transcription, DNA-templated)","04146(Peroxisome)",{"v":0.00065,"d":"0.00"},1,"91,",0,-3.19,-2.55,2.82,"3' UTR",2,143964688,144013974,49287,1]
["chr2",144015827,144016006,180,"ENSBGRG00000000603","ENSBGRT00000001137",51037,"NAB1","NGFI-A binding protein 1 [Source:HGNC Symbol;Acc:HGNC:7626]","GO:0001958(endochondral ossification);GO:0003712(transcription coregulator activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0014037(Schwann cell differentiation);GO:0042552(myelination);GO:0045682(regulation of epidermis development);GO:0045892(negative regulation of transcription, DNA-templated)","04146(Peroxisome)",{"v":1.1E-4,"d":"0.00"},1,"180,",0,-3.97,-3.29,13,"3' UTR",2,143964790,144016311,51522,1]
["chr2",144743954,144744493,540,"ENSBGRG00000002805","ENSBGRT00000005828",0,"MYO7B","myosin VIIB [Source:HGNC Symbol;Acc:HGNC:7607]","GO:0003774(motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005856(cytoskeleton);GO:0005902(microvillus);GO:0005903(brush border);GO:0016459(myosin complex);GO:0051015(actin filament binding);GO:0090651(apical cytoplasm);GO:1904970(brush border assembly)","NA",{"v":0.043,"d":"0.04"},1,"540,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"5' UTR",2,144743954,144860146,116193,1]
["chr2",145515845,145517762,1918,"ENSBGRG00000003812","ENSBGRT00000007389",117617,"UGGT1","UDP-glucose glycoprotein glucosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:15663]","GO:0003980(UDP-glucose:glycoprotein glucosyltransferase activity);GO:0005783(endoplasmic reticulum);GO:0006486(protein glycosylation);GO:0032991(protein-containing complex);GO:0051082(unfolded protein binding)","04141(Protein processing in endoplasmic reticulum)",{"v":1.6e-37,"d":"0.00"},2,"155,26,","0,1892",{"v":-36.8,"d":"-36.80"},{"v":-35.6,"d":"-35.60"},3.04,"Exon (ENSBGRT00000007389/ENSBGRG00000003812, exon 41 of 42)",2,145398228,145517762,119535,1]
["chr2",149489324,149489923,600,"ENSBGRG00000005631","ENSBGRT00000010383",61003,"ENSBGRG00000005631","NA","GO:0004842(ubiquitin-protein transferase activity)","04120(Ubiquitin mediated proteolysis)",{"v":1e-11,"d":"0.00"},2,"81,40,","0,560",-11,{"v":-10.2,"d":"-10.20"},2.56,"Exon (ENSBGRT00000010383/ENSBGRG00000005631, exon 25 of 26)",2,149428321,149489923,61603,1]
["chr2",186309,195597,9289,"ENSBGRG00000002216","ENSBGRT00000004190",25975,"EPHA2","EPH receptor A2 [Source:HGNC Symbol;Acc:HGNC:3386]","GO:0001501(skeletal system development);GO:0001568(blood vessel development);GO:0001570(vasculogenesis);GO:0001649(osteoblast differentiation);GO:0001818(negative regulation of cytokine production);GO:0002043(blood vessel endothelial cell proliferation involved in sprouting angiogenesis);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005925(focal adhesion);GO:0006468(protein phosphorylation);GO:0006954(inflammatory response);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0009986(cell surface);GO:0010591(regulation of lamellipodium assembly);GO:0014028(notochord formation);GO:0016021(integral component of membrane);GO:0016477(cell migration);GO:0016525(negative regulation of angiogenesis);GO:0021915(neural tube development);GO:0030027(lamellipodium);GO:0030182(neuron differentiation);GO:0030216(keratinocyte differentiation);GO:0030316(osteoclast differentiation);GO:0031256(leading edge membrane);GO:0032682(negative regulation of chemokine production);GO:0033598(mammary gland epithelial cell proliferation);GO:0033628(regulation of cell adhesion mediated by integrin);GO:0036342(post-anal tail morphogenesis);GO:0043491(protein kinase B signaling);GO:0043535(regulation of blood vessel endothelial cell migration);GO:0045765(regulation of angiogenesis);GO:0046058(cAMP metabolic process);GO:0046849(bone remodeling);GO:0048013(ephrin receptor signaling pathway);GO:0048320(axial mesoderm formation);GO:0048514(blood vessel morphogenesis);GO:0048570(notochord morphogenesis);GO:0048870(cell motility);GO:0050830(defense response to Gram-positive bacterium);GO:0051898(negative regulation of protein kinase B signaling);GO:0060035(notochord cell development);GO:0060326(cell chemotaxis);GO:0060444(branching involved in mammary gland duct morphogenesis);GO:0070160(tight junction);GO:0070309(lens fiber cell morphogenesis);GO:0070372(regulation of ERK1 and ERK2 cascade);GO:0070848(response to growth factor);GO:0072659(protein localization to plasma membrane);GO:0090630(activation of GTPase activity);GO:1901491(negative regulation of lymphangiogenesis);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1903348(positive regulation of bicellular tight junction assembly);GO:1904238(pericyte cell differentiation)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04360(Axon guidance)",{"v":1.3E-72,"d":"0.00"},2,"696,20,","0,9269",{"v":-71.9,"d":"-71.90"},{"v":-70.5,"d":"-70.50"},3.88,"3' UTR",2,186011,221572,35562,2]
["chr2",319279,319518,240,"ENSBGRG00000002321","ENSBGRT00000004333",61358,"FBXO42","F-box protein 42 [Source:HGNC Symbol;Acc:HGNC:29249]","GO:0005515(protein binding)","NA",{"v":2.5e-16,"d":"0.00"},1,"240,",0,{"v":-15.6,"d":"-15.60"},{"v":-14.7,"d":"-14.70"},2.82,"3' UTR",2,319279,380876,61598,2]
["chr2",323311,324118,808,"ENSBGRG00000002321","ENSBGRT00000004333",56758,"FBXO42","F-box protein 42 [Source:HGNC Symbol;Acc:HGNC:29249]","GO:0005515(protein binding)","NA",{"v":9.99999999999998e-280,"d":"0.00"},1,"808,",0,-279,-277,{"v":8.5,"d":"8.50"},"3' UTR",2,319279,380876,61598,2]
["chr2",440584,440673,90,"ENSBGRG00000002342","ENSBGRT00000004356",1165,"ENSBGRG00000002342","NA","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding);GO:0016032(viral process);GO:0019068(virion assembly)","00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism)",{"v":2.4e-06,"d":"0.00"},1,"90,",0,-5.62,-4.88,4.99,"Exon (ENSBGRT00000004356/ENSBGRG00000002342, exon 1 of 1)",2,438254,441838,3585,2]
["chr2",1083440,1083679,240,"ENSBGRG00000003136","ENSBGRT00000005857",98,"RCC2","regulator of chromosome condensation 2 [Source:HGNC Symbol;Acc:HGNC:30297]","GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0007229(integrin-mediated signaling pathway);GO:0008017(microtubule binding);GO:0010762(regulation of fibroblast migration);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0016020(membrane);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0030334(regulation of cell migration);GO:0030496(midbody);GO:0031267(small GTPase binding);GO:0031901(early endosome membrane);GO:0034260(negative regulation of GTPase activity);GO:0034506(chromosome, centromeric core domain);GO:0045184(establishment of protein localization);GO:0048041(focal adhesion assembly);GO:0048365(Rac GTPase binding);GO:0051895(negative regulation of focal adhesion assembly);GO:0051987(positive regulation of attachment of spindle microtubules to kinetochore);GO:0072356(chromosome passenger complex localization to kinetochore);GO:0090630(activation of GTPase activity);GO:1900025(negative regulation of substrate adhesion-dependent cell spreading);GO:1900027(regulation of ruffle assembly);GO:1990023(mitotic spindle midzone)","04120(Ubiquitin mediated proteolysis)",{"v":0.0041,"d":"0.00"},1,"240,",0,-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000005857/ENSBGRG00000003136, exon 1 of 10)",2,1063828,1083777,19950,2]
["chr2",2860289,2861094,806,"ENSBGRG00000003470","ENSBGRT00000006479",0,"IFFO2","intermediate filament family orphan 2 [Source:HGNC Symbol;Acc:HGNC:27006]","NA","NA",{"v":0.015,"d":"0.02"},1,"806,",0,-1.83,-1.02,8.64,"5' UTR",2,2806451,2861094,54644,2]
["chr2",2988748,2988928,181,"ENSBGRG00000003531","ENSBGRT00000007006",159112,"UBR4","ubiquitin protein ligase E3 component n-recognin 4 [Source:HGNC Symbol;Acc:HGNC:30313]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008270(zinc ion binding);GO:0061630(ubiquitin protein ligase activity)","05203(Viral carcinogenesis);05165(Human papillomavirus infection)",{"v":1.3E-75,"d":"0.00"},1,"181,",0,{"v":-74.9,"d":"-74.90"},{"v":-73.4,"d":"-73.40"},2.41,"3' UTR",2,2988748,3148040,159293,2]
["chr2",3664993,3676286,11294,"ENSBGRG00000004751","ENSBGRT00000008777",100965,"TMCO4","transmembrane and coiled-coil domains 4 [Source:HGNC Symbol;Acc:HGNC:27393]","NA","NA",{"v":1e-163,"d":"0.00"},2,"259,70,","0,11224",-163,-161,4.66,"Exon (ENSBGRT00000008777/ENSBGRG00000004751, exon 13 of 14)",2,3664844,3777251,112408,2]
["chr2",4629216,4629395,180,"ENSBGRG00000005394","ENSBGRT00000009932",2343,"ENSBGRG00000005394","NA","GO:0004860(protein kinase inhibitor activity)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":1.3E-22,"d":"0.00"},1,"180,",0,{"v":-21.9,"d":"-21.90"},{"v":-20.9,"d":"-20.90"},2.83,"3' UTR",2,4611237,4631738,20502,2]
["chr2",4630413,4630472,60,"ENSBGRG00000005394","ENSBGRT00000009932",1266,"ENSBGRG00000005394","NA","GO:0004860(protein kinase inhibitor activity)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":1.4E-8,"d":"0.00"},1,"60,",0,-7.86,-7.06,9.99,"Exon (ENSBGRT00000009961/ENSBGRG00000005394, exon 2 of 2)",2,4611237,4631738,20502,2]
["chr2",4648187,4648572,386,"ENSBGRG00000005424","ENSBGRT00000010004",7746,"MUL1","mitochondrial E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:25762]","GO:0000266(mitochondrial fission);GO:0004842(ubiquitin-protein transferase activity);GO:0005739(mitochondrion);GO:0005777(peroxisome);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006996(organelle organization);GO:0007257(activation of JUN kinase activity);GO:0010637(negative regulation of mitochondrial fusion);GO:0010821(regulation of mitochondrion organization);GO:0016567(protein ubiquitination);GO:0019789(SUMO transferase activity);GO:0030308(negative regulation of cell growth);GO:0030424(axon);GO:0031307(integral component of mitochondrial outer membrane);GO:0031625(ubiquitin protein ligase binding);GO:0031647(regulation of protein stability);GO:0031648(protein destabilization);GO:0033235(positive regulation of protein sumoylation);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0045824(negative regulation of innate immune response);GO:0050689(negative regulation of defense response to virus by host);GO:0050821(protein stabilization);GO:0051646(mitochondrion localization);GO:0051881(regulation of mitochondrial membrane potential);GO:0051898(negative regulation of protein kinase B signaling);GO:0060339(negative regulation of type I interferon-mediated signaling pathway);GO:0061630(ubiquitin protein ligase activity);GO:0071360(cellular response to exogenous dsRNA);GO:0071650(negative regulation of chemokine (C-C motif) ligand 5 production);GO:0090141(positive regulation of mitochondrial fission);GO:1901028(regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway);GO:1903861(positive regulation of dendrite extension);GO:1904925(positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization)","NA",{"v":6.3e-92,"d":"0.00"},1,"386,",0,{"v":-91.2,"d":"-91.20"},{"v":-89.6,"d":"-89.60"},8.67,"3' UTR",2,4647979,4656318,8340,2]
["chr2",4648750,4648958,209,"ENSBGRG00000005424","ENSBGRT00000010004",7360,"MUL1","mitochondrial E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:25762]","GO:0000266(mitochondrial fission);GO:0004842(ubiquitin-protein transferase activity);GO:0005739(mitochondrion);GO:0005777(peroxisome);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006996(organelle organization);GO:0007257(activation of JUN kinase activity);GO:0010637(negative regulation of mitochondrial fusion);GO:0010821(regulation of mitochondrion organization);GO:0016567(protein ubiquitination);GO:0019789(SUMO transferase activity);GO:0030308(negative regulation of cell growth);GO:0030424(axon);GO:0031307(integral component of mitochondrial outer membrane);GO:0031625(ubiquitin protein ligase binding);GO:0031647(regulation of protein stability);GO:0031648(protein destabilization);GO:0033235(positive regulation of protein sumoylation);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0045824(negative regulation of innate immune response);GO:0050689(negative regulation of defense response to virus by host);GO:0050821(protein stabilization);GO:0051646(mitochondrion localization);GO:0051881(regulation of mitochondrial membrane potential);GO:0051898(negative regulation of protein kinase B signaling);GO:0060339(negative regulation of type I interferon-mediated signaling pathway);GO:0061630(ubiquitin protein ligase activity);GO:0071360(cellular response to exogenous dsRNA);GO:0071650(negative regulation of chemokine (C-C motif) ligand 5 production);GO:0090141(positive regulation of mitochondrial fission);GO:1901028(regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway);GO:1903861(positive regulation of dendrite extension);GO:1904925(positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization)","NA",{"v":5e-58,"d":"0.00"},1,"209,",0,{"v":-57.3,"d":"-57.30"},-56,4.44,"3' UTR",2,4647979,4656318,8340,2]
["chr2",4651208,4652002,795,"ENSBGRG00000005424","ENSBGRT00000010004",4316,"MUL1","mitochondrial E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:25762]","GO:0000266(mitochondrial fission);GO:0004842(ubiquitin-protein transferase activity);GO:0005739(mitochondrion);GO:0005777(peroxisome);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006996(organelle organization);GO:0007257(activation of JUN kinase activity);GO:0010637(negative regulation of mitochondrial fusion);GO:0010821(regulation of mitochondrion organization);GO:0016567(protein ubiquitination);GO:0019789(SUMO transferase activity);GO:0030308(negative regulation of cell growth);GO:0030424(axon);GO:0031307(integral component of mitochondrial outer membrane);GO:0031625(ubiquitin protein ligase binding);GO:0031647(regulation of protein stability);GO:0031648(protein destabilization);GO:0033235(positive regulation of protein sumoylation);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0045824(negative regulation of innate immune response);GO:0050689(negative regulation of defense response to virus by host);GO:0050821(protein stabilization);GO:0051646(mitochondrion localization);GO:0051881(regulation of mitochondrial membrane potential);GO:0051898(negative regulation of protein kinase B signaling);GO:0060339(negative regulation of type I interferon-mediated signaling pathway);GO:0061630(ubiquitin protein ligase activity);GO:0071360(cellular response to exogenous dsRNA);GO:0071650(negative regulation of chemokine (C-C motif) ligand 5 production);GO:0090141(positive regulation of mitochondrial fission);GO:1901028(regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway);GO:1903861(positive regulation of dendrite extension);GO:1904925(positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization)","NA",{"v":5.8e-10,"d":"0.00"},2,"83,66,","0,729",-9.24,-8.41,1.93,"Exon (ENSBGRT00000010004/ENSBGRG00000005424, exon 2 of 5)",2,4647979,4656318,8340,2]
["chr2",4702581,4703677,1097,"ENSBGRG00000005484","ENSBGRT00000010098",0,"ENSBGRG00000005484","NA","NA","03008(Ribosome biogenesis in eukaryotes)",{"v":0.028,"d":"0.03"},2,"495,44,","0,1053",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000010126/ENSBGRG00000005498, exon 1 of 2)",2,4700968,4703677,2710,2]
["chr2",4858450,4874736,16287,"ENSBGRG00000000185","ENSBGRT00000000296",73287,"PINK1","PTEN induced kinase 1 [Source:HGNC Symbol;Acc:HGNC:14581]","GO:0000287(magnesium ion binding);GO:0000422(autophagy of mitochondrion);GO:0000785(chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0002020(protease binding);GO:0002082(regulation of oxidative phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006979(response to oxidative stress);GO:0007005(mitochondrion organization);GO:0010310(regulation of hydrogen peroxide metabolic process);GO:0010629(negative regulation of gene expression);GO:0010821(regulation of mitochondrion organization);GO:0010857(calcium-dependent protein kinase activity);GO:0016020(membrane);GO:0016239(positive regulation of macroautophagy);GO:0016242(negative regulation of macroautophagy);GO:0016301(kinase activity);GO:0016567(protein ubiquitination);GO:0018105(peptidyl-serine phosphorylation);GO:0022904(respiratory electron transport chain);GO:0030424(axon);GO:0031307(integral component of mitochondrial outer membrane);GO:0031396(regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032226(positive regulation of synaptic transmission, dopaminergic);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033603(positive regulation of dopamine secretion);GO:0033605(positive regulation of catecholamine secretion);GO:0034599(cellular response to oxidative stress);GO:0035307(positive regulation of protein dephosphorylation);GO:0035556(intracellular signal transduction);GO:0036289(peptidyl-serine autophosphorylation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043254(regulation of protein-containing complex assembly);GO:0043422(protein kinase B binding);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0044297(cell body);GO:0044877(protein-containing complex binding);GO:0045727(positive regulation of translation);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055131(C3HC4-type RING finger domain binding);GO:0071456(cellular response to hypoxia);GO:0072655(establishment of protein localization to mitochondrion);GO:0072656(maintenance of protein location in mitochondrion);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0090258(negative regulation of mitochondrial fission);GO:0097237(cellular response to toxic substance);GO:0097449(astrocyte projection);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization);GO:0099074(mitochondrion to lysosome transport);GO:1900407(regulation of cellular response to oxidative stress);GO:1901727(positive regulation of histone deacetylase activity);GO:1902902(negative regulation of autophagosome assembly);GO:1902958(positive regulation of mitochondrial electron transport, NADH to ubiquinone);GO:1903147(negative regulation of autophagy of mitochondrion);GO:1903202(negative regulation of oxidative stress-induced cell death);GO:1903214(regulation of protein targeting to mitochondrion);GO:1903298(negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway);GO:1903384(negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway);GO:1903751(negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:1903852(positive regulation of cristae formation);GO:1904841(TORC2 complex binding);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04137(Mitophagy - animal);05012(Parkinson disease)",{"v":0.043,"d":"0.04"},5,"402,148,110,110,36,","0,3381,8087,9265,16251",-1.37,{"v":-0.6,"d":"-0.60"},6.48,"Exon (ENSBGRT00000000363/ENSBGRG00000000228, exon 5 of 16)",2,4785163,4907008,121846,1]
["chr2",4879899,4887029,7131,"ENSBGRG00000000185","ENSBGRT00000000296",94736,"PINK1","PTEN induced kinase 1 [Source:HGNC Symbol;Acc:HGNC:14581]","GO:0000287(magnesium ion binding);GO:0000422(autophagy of mitochondrion);GO:0000785(chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0002020(protease binding);GO:0002082(regulation of oxidative phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006979(response to oxidative stress);GO:0007005(mitochondrion organization);GO:0010310(regulation of hydrogen peroxide metabolic process);GO:0010629(negative regulation of gene expression);GO:0010821(regulation of mitochondrion organization);GO:0010857(calcium-dependent protein kinase activity);GO:0016020(membrane);GO:0016239(positive regulation of macroautophagy);GO:0016242(negative regulation of macroautophagy);GO:0016301(kinase activity);GO:0016567(protein ubiquitination);GO:0018105(peptidyl-serine phosphorylation);GO:0022904(respiratory electron transport chain);GO:0030424(axon);GO:0031307(integral component of mitochondrial outer membrane);GO:0031396(regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032226(positive regulation of synaptic transmission, dopaminergic);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033603(positive regulation of dopamine secretion);GO:0033605(positive regulation of catecholamine secretion);GO:0034599(cellular response to oxidative stress);GO:0035307(positive regulation of protein dephosphorylation);GO:0035556(intracellular signal transduction);GO:0036289(peptidyl-serine autophosphorylation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043254(regulation of protein-containing complex assembly);GO:0043422(protein kinase B binding);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0044297(cell body);GO:0044877(protein-containing complex binding);GO:0045727(positive regulation of translation);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0055131(C3HC4-type RING finger domain binding);GO:0071456(cellular response to hypoxia);GO:0072655(establishment of protein localization to mitochondrion);GO:0072656(maintenance of protein location in mitochondrion);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0090258(negative regulation of mitochondrial fission);GO:0097237(cellular response to toxic substance);GO:0097449(astrocyte projection);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization);GO:0099074(mitochondrion to lysosome transport);GO:1900407(regulation of cellular response to oxidative stress);GO:1901727(positive regulation of histone deacetylase activity);GO:1902902(negative regulation of autophagosome assembly);GO:1902958(positive regulation of mitochondrial electron transport, NADH to ubiquinone);GO:1903147(negative regulation of autophagy of mitochondrion);GO:1903202(negative regulation of oxidative stress-induced cell death);GO:1903214(regulation of protein targeting to mitochondrion);GO:1903298(negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway);GO:1903384(negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway);GO:1903751(negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:1903852(positive regulation of cristae formation);GO:1904841(TORC2 complex binding);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04137(Mitophagy - animal);05012(Parkinson disease)",{"v":0.028,"d":"0.03"},2,"161,48,","0,7083",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000000363/ENSBGRG00000000228, exon 3 of 16)",2,4785163,4907008,121846,1]
["chr2",4895231,4895857,627,"ENSBGRG00000000228","ENSBGRT00000000363",0,"KIF17","kinesin family member 17 [Source:HGNC Symbol;Acc:HGNC:19167]","GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005871(kinesin complex);GO:0005929(cilium);GO:0005930(axoneme);GO:0007017(microtubule-based process);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0015630(microtubule cytoskeleton);GO:0016192(vesicle-mediated transport);GO:0031503(protein-containing complex localization);GO:0032391(photoreceptor connecting cilium);GO:0036064(ciliary basal body);GO:0098971(anterograde dendritic transport of neurotransmitter receptor complex);GO:1990075(periciliary membrane compartment)","NA",{"v":0.028,"d":"0.03"},1,"627,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",2,4828371,4895857,67487,2]
["chr2",4951180,4954610,3431,"ENSBGRG00000000283","ENSBGRT00000000474",119,"HP1BP3","heterochromatin protein 1 binding protein 3 [Source:HGNC Symbol;Acc:HGNC:24973]","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005694(chromosome);GO:0006334(nucleosome assembly);GO:0006355(regulation of transcription, DNA-templated);GO:0042025(host cell nucleus);GO:0070828(heterochromatin organization)","NA",{"v":1e-55,"d":"0.00"},3,"94,100,74,","0,2810,3357",-55,{"v":-53.7,"d":"-53.70"},2.01,"Exon (ENSBGRT00000000474/ENSBGRG00000000283, exon 1 of 15)",2,4920477,4954729,34253,2]
["chr2",4980481,4980750,270,"ENSBGRG00000000420","ENSBGRT00000001139",381495,"EIF4G3","eukaryotic translation initiation factor 4 gamma 3 [Source:HGNC Symbol;Acc:HGNC:3298]","GO:0000339(RNA cap binding);GO:0003723(RNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding)","03013(RNA transport);05416(Viral myocarditis)",{"v":6.3e-68,"d":"0.00"},1,"270,",0,{"v":-67.2,"d":"-67.20"},{"v":-65.8,"d":"-65.80"},2.48,"3' UTR",2,4980451,5362245,381795,2]
["chr2",5028521,5031275,2755,"ENSBGRG00000000420","ENSBGRT00000001139",330970,"EIF4G3","eukaryotic translation initiation factor 4 gamma 3 [Source:HGNC Symbol;Acc:HGNC:3298]","GO:0000339(RNA cap binding);GO:0003723(RNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding)","03013(RNA transport);05416(Viral myocarditis)",{"v":7.9e-17,"d":"0.00"},3,"128,105,97,","0,1522,2658",{"v":-16.1,"d":"-16.10"},{"v":-15.2,"d":"-15.20"},1.63,"Exon (ENSBGRT00000001139/ENSBGRG00000000420, exon 19 of 34)",2,4980451,5362245,381795,2]
["chr2",5117987,5118465,479,"ENSBGRG00000000420","ENSBGRT00000001139",243780,"EIF4G3","eukaryotic translation initiation factor 4 gamma 3 [Source:HGNC Symbol;Acc:HGNC:3298]","GO:0000339(RNA cap binding);GO:0003723(RNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding)","03013(RNA transport);05416(Viral myocarditis)",{"v":1e-47,"d":"0.00"},1,"479,",0,-47,{"v":-45.7,"d":"-45.70"},2.53,"Exon (ENSBGRT00000001139/ENSBGRG00000000420, exon 10 of 34)",2,4980451,5362245,381795,2]
["chr2",5118615,5126815,8201,"ENSBGRG00000000420","ENSBGRT00000001139",235430,"EIF4G3","eukaryotic translation initiation factor 4 gamma 3 [Source:HGNC Symbol;Acc:HGNC:3298]","GO:0000339(RNA cap binding);GO:0003723(RNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding)","03013(RNA transport);05416(Viral myocarditis)",{"v":3.2e-27,"d":"0.00"},2,"33,88,","0,8113",{"v":-26.5,"d":"-26.50"},{"v":-25.4,"d":"-25.40"},3.71,"Exon (ENSBGRT00000001139/ENSBGRG00000000420, exon 9 of 34)",2,4980451,5362245,381795,2]
["chr2",5403088,5403506,419,"ENSBGRG00000000770","ENSBGRT00000001459",72344,"ECE1","endothelin converting enzyme 1 [Source:HGNC Symbol;Acc:HGNC:3146]","GO:0001921(positive regulation of receptor recycling);GO:0004175(endopeptidase activity);GO:0004222(metalloendopeptidase activity);GO:0005768(endosome);GO:0006508(proteolysis);GO:0007507(heart development);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0009897(external side of plasma membrane);GO:0010814(substance P catabolic process);GO:0010815(bradykinin catabolic process);GO:0010816(calcitonin catabolic process);GO:0016021(integral component of membrane);GO:0016485(protein processing);GO:0016486(peptide hormone processing);GO:0033093(Weibel-Palade body);GO:0034959(endothelin maturation);GO:0042447(hormone catabolic process);GO:0042733(embryonic digit morphogenesis);GO:0042803(protein homodimerization activity);GO:0043583(ear development);GO:0048471(perinuclear region of cytoplasm);GO:0060037(pharyngeal system development)","NA",{"v":6.3e-26,"d":"0.00"},1,"419,",0,{"v":-25.2,"d":"-25.20"},{"v":-24.1,"d":"-24.10"},4.97,"3' UTR",2,5401533,5475850,74318,2]
["chr2",5404702,5405469,768,"ENSBGRG00000000770","ENSBGRT00000001459",70381,"ECE1","endothelin converting enzyme 1 [Source:HGNC Symbol;Acc:HGNC:3146]","GO:0001921(positive regulation of receptor recycling);GO:0004175(endopeptidase activity);GO:0004222(metalloendopeptidase activity);GO:0005768(endosome);GO:0006508(proteolysis);GO:0007507(heart development);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0009897(external side of plasma membrane);GO:0010814(substance P catabolic process);GO:0010815(bradykinin catabolic process);GO:0010816(calcitonin catabolic process);GO:0016021(integral component of membrane);GO:0016485(protein processing);GO:0016486(peptide hormone processing);GO:0033093(Weibel-Palade body);GO:0034959(endothelin maturation);GO:0042447(hormone catabolic process);GO:0042733(embryonic digit morphogenesis);GO:0042803(protein homodimerization activity);GO:0043583(ear development);GO:0048471(perinuclear region of cytoplasm);GO:0060037(pharyngeal system development)","NA",{"v":1.6E-99,"d":"0.00"},2,"84,7,","0,761",{"v":-98.8,"d":"-98.80"},{"v":-97.1,"d":"-97.10"},1.78,"Exon (ENSBGRT00000001459/ENSBGRG00000000770, exon 17 of 18)",2,5401533,5475850,74318,2]
["chr2",5475345,5544946,69602,"ENSBGRG00000000770","ENSBGRT00000001459",0,"ECE1","endothelin converting enzyme 1 [Source:HGNC Symbol;Acc:HGNC:3146]","GO:0001921(positive regulation of receptor recycling);GO:0004175(endopeptidase activity);GO:0004222(metalloendopeptidase activity);GO:0005768(endosome);GO:0006508(proteolysis);GO:0007507(heart development);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0009897(external side of plasma membrane);GO:0010814(substance P catabolic process);GO:0010815(bradykinin catabolic process);GO:0010816(calcitonin catabolic process);GO:0016021(integral component of membrane);GO:0016485(protein processing);GO:0016486(peptide hormone processing);GO:0033093(Weibel-Palade body);GO:0034959(endothelin maturation);GO:0042447(hormone catabolic process);GO:0042733(embryonic digit morphogenesis);GO:0042803(protein homodimerization activity);GO:0043583(ear development);GO:0048471(perinuclear region of cytoplasm);GO:0060037(pharyngeal system development)","NA",{"v":0.027,"d":"0.03"},2,"506,3,","0,69599",-1.57,-1.03,4.32,"5' UTR",2,5401533,5475850,74318,2]
["chr2",7341775,7342705,931,"ENSBGRG00000003910","ENSBGRT00000007209",32821,"LUZP1","leucine zipper protein 1 [Source:HGNC Symbol;Acc:HGNC:14985]","GO:0003281(ventricular septum development);GO:0005634(nucleus);GO:0021503(neural fold bending);GO:0060840(artery development)","NA",{"v":6.3e-93,"d":"0.00"},1,"931,",0,{"v":-92.2,"d":"-92.20"},{"v":-90.6,"d":"-90.60"},{"v":11.9,"d":"11.90"},"3' UTR",2,7341775,7375526,33752,2]
["chr2",7342765,7342915,151,"ENSBGRG00000003910","ENSBGRT00000007209",32611,"LUZP1","leucine zipper protein 1 [Source:HGNC Symbol;Acc:HGNC:14985]","GO:0003281(ventricular septum development);GO:0005634(nucleus);GO:0021503(neural fold bending);GO:0060840(artery development)","NA",{"v":2.5e-27,"d":"0.00"},1,"151,",0,{"v":-26.6,"d":"-26.60"},{"v":-25.6,"d":"-25.60"},4.35,"3' UTR",2,7341775,7375526,33752,2]
["chr2",7345964,7346360,397,"ENSBGRG00000003910","ENSBGRT00000007209",29166,"LUZP1","leucine zipper protein 1 [Source:HGNC Symbol;Acc:HGNC:14985]","GO:0003281(ventricular septum development);GO:0005634(nucleus);GO:0021503(neural fold bending);GO:0060840(artery development)","NA",{"v":3.2e-71,"d":"0.00"},2,"10,291,","0,106",{"v":-70.5,"d":"-70.50"},{"v":-69.1,"d":"-69.10"},4.96,"Exon (ENSBGRT00000007209/ENSBGRG00000003910, exon 4 of 6)",2,7341775,7375526,33752,2]
["chr2",7346870,7347050,181,"ENSBGRG00000003910","ENSBGRT00000007209",28476,"LUZP1","leucine zipper protein 1 [Source:HGNC Symbol;Acc:HGNC:14985]","GO:0003281(ventricular septum development);GO:0005634(nucleus);GO:0021503(neural fold bending);GO:0060840(artery development)","NA",{"v":5e-22,"d":"0.00"},1,"181,",0,{"v":-21.3,"d":"-21.30"},{"v":-20.3,"d":"-20.30"},2.53,"Exon (ENSBGRT00000007209/ENSBGRG00000003910, exon 4 of 6)",2,7341775,7375526,33752,2]
["chr2",7347110,7347170,61,"ENSBGRG00000003910","ENSBGRT00000007209",28356,"LUZP1","leucine zipper protein 1 [Source:HGNC Symbol;Acc:HGNC:14985]","GO:0003281(ventricular septum development);GO:0005634(nucleus);GO:0021503(neural fold bending);GO:0060840(artery development)","NA",{"v":3.2e-14,"d":"0.00"},1,"61,",0,{"v":-13.5,"d":"-13.50"},{"v":-12.6,"d":"-12.60"},2.52,"Exon (ENSBGRT00000007209/ENSBGRG00000003910, exon 4 of 6)",2,7341775,7375526,33752,2]
["chr2",7347350,7347890,541,"ENSBGRG00000003910","ENSBGRT00000007209",27636,"LUZP1","leucine zipper protein 1 [Source:HGNC Symbol;Acc:HGNC:14985]","GO:0003281(ventricular septum development);GO:0005634(nucleus);GO:0021503(neural fold bending);GO:0060840(artery development)","NA",{"v":2.5e-68,"d":"0.00"},1,"541,",0,{"v":-67.6,"d":"-67.60"},{"v":-66.2,"d":"-66.20"},2.95,"Exon (ENSBGRT00000007209/ENSBGRG00000003910, exon 4 of 6)",2,7341775,7375526,33752,2]
["chr2",7348010,7349153,1144,"ENSBGRG00000003910","ENSBGRT00000007209",26373,"LUZP1","leucine zipper protein 1 [Source:HGNC Symbol;Acc:HGNC:14985]","GO:0003281(ventricular septum development);GO:0005634(nucleus);GO:0021503(neural fold bending);GO:0060840(artery development)","NA",{"v":2.8e-09,"d":"0.00"},2,"69,171,","0,973",-8.55,-7.73,3.46,"Exon (ENSBGRT00000007209/ENSBGRG00000003910, exon 3 of 6)",2,7341775,7375526,33752,2]
["chr2",7349213,7349933,721,"ENSBGRG00000003910","ENSBGRT00000007209",25593,"LUZP1","leucine zipper protein 1 [Source:HGNC Symbol;Acc:HGNC:14985]","GO:0003281(ventricular septum development);GO:0005634(nucleus);GO:0021503(neural fold bending);GO:0060840(artery development)","NA",{"v":2.5e-40,"d":"0.00"},1,"721,",0,{"v":-39.6,"d":"-39.60"},{"v":-38.4,"d":"-38.40"},4.38,"5' UTR",2,7341775,7375526,33752,2]
["chr2",7372959,7373019,61,"ENSBGRG00000003910","ENSBGRT00000007209",2507,"LUZP1","leucine zipper protein 1 [Source:HGNC Symbol;Acc:HGNC:14985]","GO:0003281(ventricular septum development);GO:0005634(nucleus);GO:0021503(neural fold bending);GO:0060840(artery development)","NA",{"v":2e-05,"d":"0.00"},1,"61,",0,{"v":-4.7,"d":"-4.70"},-3.99,2.32,"5' UTR",2,7341775,7375526,33752,2]
["chr2",7473906,7474115,210,"ENSBGRG00000003957","ENSBGRT00000007283",924,"ENSBGRG00000003957","NA","GO:0004930(G protein-coupled receptor activity);GO:0004993(G protein-coupled serotonin receptor activity);GO:0005887(integral component of plasma membrane);GO:0006939(smooth muscle contraction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007268(chemical synaptic transmission);GO:0009636(response to toxic substance);GO:0016021(integral component of membrane);GO:0040012(regulation of locomotion);GO:0042310(vasoconstriction);GO:0050795(regulation of behavior);GO:0051378(serotonin binding)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04726(Serotonergic synapse);04742(Taste transduction)",{"v":3.1E-7,"d":"0.00"},1,"210,",0,-6.51,-5.74,{"v":25.9,"d":"25.90"},"Exon (ENSBGRT00000007283/ENSBGRG00000003957, exon 1 of 1)",2,7473906,7475039,1134,2]
["chr2",7478659,7478779,121,"ENSBGRG00000003962","ENSBGRT00000007294",22307,"ENSBGRG00000003962","NA","NA","NA",{"v":0.0029,"d":"0.00"},1,"121,",0,-2.54,-1.93,2.81,"Exon (ENSBGRT00000007294/ENSBGRG00000003962, exon 2 of 2)",2,7478060,7501086,23027,2]
["chr2",7480248,7480308,61,"ENSBGRG00000003962","ENSBGRT00000007294",20778,"ENSBGRG00000003962","NA","NA","NA",{"v":0.014,"d":"0.01"},1,"61,",0,-1.86,{"v":-1.3,"d":"-1.30"},8.64,"Exon (ENSBGRT00000007294/ENSBGRG00000003962, exon 2 of 2)",2,7478060,7501086,23027,2]
["chr2",7480457,7480607,151,"ENSBGRG00000003962","ENSBGRT00000007294",20479,"ENSBGRG00000003962","NA","NA","NA",{"v":1.6e-14,"d":"0.00"},1,"151,",0,{"v":-13.8,"d":"-13.80"},{"v":-12.9,"d":"-12.90"},14,"Exon (ENSBGRT00000007294/ENSBGRG00000003962, exon 2 of 2)",2,7478060,7501086,23027,2]
["chr2",7480727,7489596,8870,"ENSBGRG00000003962","ENSBGRT00000007294",11490,"ENSBGRG00000003962","NA","NA","NA",{"v":7.6e-09,"d":"0.00"},2,"297,303,","0,8567",-8.12,-7.31,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000007294/ENSBGRG00000003962, exon 2 of 2)",2,7478060,7501086,23027,2]
["chr2",7492174,7492563,390,"ENSBGRG00000003962","ENSBGRT00000007294",8523,"ENSBGRG00000003962","NA","NA","NA",0.02,1,"390,",0,-1.69,-1.14,4.32,"Exon (ENSBGRT00000007302/ENSBGRG00000003962, exon 2 of 2)",2,7478060,7501086,23027,2]
["chr2",7492773,7492923,151,"ENSBGRG00000003962","ENSBGRT00000007294",8163,"ENSBGRG00000003962","NA","NA","NA",{"v":0.0071,"d":"0.01"},1,"151,",0,-2.15,-1.57,4.86,"Exon (ENSBGRT00000007302/ENSBGRG00000003962, exon 2 of 2)",2,7478060,7501086,23027,2]
["chr2",7607911,7608414,504,"ENSBGRG00000003976","ENSBGRT00000007422",29382,"HNRNPR","heterogeneous nuclear ribonucleoprotein R [Source:HGNC Symbol;Acc:HGNC:5047]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0071013(catalytic step 2 spliceosome);GO:1990904(ribonucleoprotein complex)","NA",0,1,"504,",0,-675,"-Inf",5.63,"Exon (ENSBGRT00000007422/ENSBGRG00000003976, exon 10 of 10)",2,7607911,7637796,29886,2]
["chr2",7658318,7658906,589,"ENSBGRG00000004113","ENSBGRT00000007610",5102,"ZNF436","zinc finger protein 436 [Source:HGNC Symbol;Acc:HGNC:20814]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1e-106,"d":"0.00"},1,"589,",0,-106,-104,5.08,"Exon (ENSBGRT00000007610/ENSBGRG00000004113, exon 3 of 3)",2,7658082,7664008,5927,2]
["chr2",7659054,7663015,3962,"ENSBGRG00000004113","ENSBGRT00000007610",993,"ZNF436","zinc finger protein 436 [Source:HGNC Symbol;Acc:HGNC:20814]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":5e-70,"d":"0.00"},2,"281,14,","0,3948",{"v":-69.3,"d":"-69.30"},{"v":-67.9,"d":"-67.90"},3.15,"Exon (ENSBGRT00000007610/ENSBGRG00000004113, exon 2 of 3)",2,7658082,7664008,5927,2]
["chr2",7826444,7826504,61,"ENSBGRG00000004509","ENSBGRT00000008355",14584,"E2F2","E2F transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:3114]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0051726(regulation of cell cycle);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0090575(RNA polymerase II transcription factor complex);GO:1903671(negative regulation of sprouting angiogenesis);GO:1990086(lens fiber cell apoptotic process);GO:1990837(sequence-specific double-stranded DNA binding)","04110(Cell cycle);04218(Cellular senescence);05200(Pathways in cancer);05206(MicroRNAs in cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05220(Chronic myeloid leukemia);05218(Melanoma);05219(Bladder cancer);05215(Prostate cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);04934(Cushing syndrome);05166(HTLV-I infection);05161(Hepatitis B);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);01522(Endocrine resistance)",{"v":0.027,"d":"0.03"},1,"61,",0,-1.57,-1.03,3.24,"Exon (ENSBGRT00000008355/ENSBGRG00000004509, exon 5 of 7)",2,7815825,7841088,25264,2]
["chr2",7828266,7828927,662,"ENSBGRG00000004509","ENSBGRT00000008355",12161,"E2F2","E2F transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:3114]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0051726(regulation of cell cycle);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0090575(RNA polymerase II transcription factor complex);GO:1903671(negative regulation of sprouting angiogenesis);GO:1990086(lens fiber cell apoptotic process);GO:1990837(sequence-specific double-stranded DNA binding)","04110(Cell cycle);04218(Cellular senescence);05200(Pathways in cancer);05206(MicroRNAs in cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05220(Chronic myeloid leukemia);05218(Melanoma);05219(Bladder cancer);05215(Prostate cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);04934(Cushing syndrome);05166(HTLV-I infection);05161(Hepatitis B);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);01522(Endocrine resistance)",{"v":0.034,"d":"0.03"},2,"49,41,","0,621",-1.47,{"v":-0.937,"d":"-0.94"},{"v":3.6,"d":"3.60"},"Exon (ENSBGRT00000008355/ENSBGRG00000004509, exon 3 of 7)",2,7815825,7841088,25264,2]
["chr2",8076980,8077246,267,"ENSBGRG00000005007","ENSBGRT00000009215",7340,"GALE","UDP-galactose-4-epimerase [Source:HGNC Symbol;Acc:HGNC:4116]","GO:0003978(UDP-glucose 4-epimerase activity);GO:0006012(galactose metabolic process);GO:0019388(galactose catabolic process);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity)","00052(Galactose metabolism);00520(Amino sugar and nucleotide sugar metabolism)",{"v":3.2e-42,"d":"0.00"},1,"267,",0,{"v":-41.5,"d":"-41.50"},{"v":-40.3,"d":"-40.30"},4.78,"3' UTR",2,8076980,8084586,7607,2]
["chr2",8077868,8078243,376,"ENSBGRG00000005007","ENSBGRT00000009215",6343,"GALE","UDP-galactose-4-epimerase [Source:HGNC Symbol;Acc:HGNC:4116]","GO:0003978(UDP-glucose 4-epimerase activity);GO:0006012(galactose metabolic process);GO:0019388(galactose catabolic process);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity)","00052(Galactose metabolism);00520(Amino sugar and nucleotide sugar metabolism)",{"v":4.3E-3,"d":"0.00"},3,"77,86,15,","0,183,361",-2.37,-1.77,7.56,"Exon (ENSBGRT00000009215/ENSBGRG00000005007, exon 7 of 11)",2,8076980,8084586,7607,2]
["chr2",8184424,8185509,1086,"ENSBGRG00000005295","ENSBGRT00000009770",0,"CNR2","cannabinoid receptor 2 [Source:HGNC Symbol;Acc:HGNC:2160]","GO:0004930(G protein-coupled receptor activity);GO:0004949(cannabinoid receptor activity);GO:0005783(endoplasmic reticulum);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0030595(leukocyte chemotaxis)","04080(Neuroactive ligand-receptor interaction)",{"v":0.043,"d":"0.04"},1,"1086,",0,-1.37,{"v":-0.6,"d":"-0.60"},{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000009770/ENSBGRG00000005295, exon 1 of 1)",2,8184424,8185509,1086,2]
["chr2",8289207,8293037,3831,"ENSBGRG00000005382","ENSBGRT00000010170",9120,"ENSBGRG00000005382","NA","GO:0003676(nucleic acid binding);GO:0043484(regulation of RNA splicing)","03040(Spliceosome)",{"v":3.2e-22,"d":"0.00"},4,"2,59,31,56,","0,4,262,3775",{"v":-21.5,"d":"-21.50"},{"v":-20.5,"d":"-20.50"},2,"Exon (ENSBGRT00000010170/ENSBGRG00000005382, exon 6 of 7)",2,8289207,8302157,12951,2]
["chr2",8404612,8404732,121,"ENSBGRG00000005605","ENSBGRT00000011093",8099,"MYOM3","myomesin 3 [Source:HGNC Symbol;Acc:HGNC:26679]","GO:0005515(protein binding);GO:0031430(M band);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity)","NA",{"v":1e-23,"d":"0.00"},1,"121,",0,-23,-22,{"v":2.8,"d":"2.80"},"Exon (ENSBGRT00000011093/ENSBGRG00000005605, exon 11 of 11)",2,8404582,8412831,8250,2]
["chr2",8477431,8477937,507,"ENSBGRG00000006043","ENSBGRT00000011150",28041,"IL22RA1","interleukin 22 receptor subunit alpha 1 [Source:HGNC Symbol;Acc:HGNC:13700]","GO:0005515(protein binding)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction)",{"v":0.043,"d":"0.04"},1,"507,",0,-1.37,{"v":-0.6,"d":"-0.60"},{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000011150/ENSBGRG00000006043, exon 7 of 7)",2,8477431,8505978,28548,2]
["chr2",8519433,8519732,300,"ENSBGRG00000006084","ENSBGRT00000011247",23808,"IFNLR1","interferon lambda receptor 1 [Source:HGNC Symbol;Acc:HGNC:18584]","GO:0002385(mucosal immune response);GO:0005515(protein binding);GO:0032002(interleukin-28 receptor complex);GO:0050691(regulation of defense response to virus by host);GO:0051607(defense response to virus)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction)",{"v":7.6e-05,"d":"0.00"},1,"300,",0,-4.12,-3.43,{"v":17.3,"d":"17.30"},"Exon (ENSBGRT00000011247/ENSBGRG00000006084, exon 7 of 7)",2,8519194,8543540,24347,2]
["chr2",9659153,9664244,5092,"ENSBGRG00000007540","ENSBGRT00000013848",399,"ENSBGRG00000007540","NA","NA","03040(Spliceosome)",{"v":1e-177,"d":"0.00"},7,"166,99,91,118,126,111,95,","0,951,2176,2583,3107,4667,4997",-177,-175,2.76,"5' UTR",2,9659153,9664643,5491,2]
["chr2",10247135,10247254,120,"ENSBGRG00000008672","ENSBGRT00000015801",7146,"ENSBGRG00000008672","NA","GO:0016021(integral component of membrane)","NA",{"v":0.0021,"d":"0.00"},1,"120,",0,-2.67,-2.06,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000015801/ENSBGRG00000008672, exon 3 of 5)",2,10228370,10254400,26031,2]
["chr2",10247492,10248502,1011,"ENSBGRG00000008672","ENSBGRT00000015801",5898,"ENSBGRG00000008672","NA","GO:0016021(integral component of membrane)","NA",{"v":7.9e-31,"d":"0.00"},1,"1011,",0,{"v":-30.1,"d":"-30.10"},-29,7.38,"Exon (ENSBGRT00000015801/ENSBGRG00000008672, exon 3 of 5)",2,10228370,10254400,26031,2]
["chr2",10293463,10295560,2098,"ENSBGRG00000008727","ENSBGRT00000015897",34562,"ENSBGRG00000008727","NA","GO:0031110(regulation of microtubule polymerization or depolymerization)","04010(MAPK signaling pathway);05206(MicroRNAs in cancer)",{"v":2.5e-94,"d":"0.00"},2,"176,1,","0,2097",{"v":-93.6,"d":"-93.60"},-92,1.68,"Exon (ENSBGRT00000015897/ENSBGRG00000008727, exon 3 of 5)",2,10292965,10330122,37158,2]
["chr2",10456151,10456240,90,"ENSBGRG00000009039","ENSBGRT00000016564",0,"SLC30A2","solute carrier family 30 member 2 [Source:HGNC Symbol;Acc:HGNC:11013]","GO:0005737(cytoplasm);GO:0005770(late endosome);GO:0006812(cation transport);GO:0008324(cation transmembrane transporter activity);GO:0016021(integral component of membrane);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport);GO:0061090(positive regulation of sequestering of zinc ion)","NA",{"v":0.0078,"d":"0.01"},1,"90,",0,-2.11,-1.53,7.56,"5' UTR",2,10448973,10456240,7268,2]
["chr2",10465855,10466091,237,"ENSBGRG00000005620","ENSBGRT00000010388",17177,"TRIM63","tripartite motif containing 63 [Source:HGNC Symbol;Acc:HGNC:16007]","GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0031432(titin binding)","NA",{"v":0.00022,"d":"0.00"},1,"237,",0,-3.65,-2.98,13,"3' UTR",2,10465855,10483268,17414,2]
["chr2",10865261,10865409,149,"ENSBGRG00000006684","ENSBGRT00000012397",25642,"DHDDS","dehydrodolichyl diphosphate synthase subunit [Source:HGNC Symbol;Acc:HGNC:20603]","GO:0002094(polyprenyltransferase activity);GO:0006489(dolichyl diphosphate biosynthetic process);GO:0016765(transferase activity, transferring alkyl or aryl (other than methyl) groups);GO:0045547(dehydrodolichyl diphosphate synthase activity);GO:1904423(dehydrodolichyl diphosphate synthase complex)","00900(Terpenoid backbone biosynthesis)",{"v":2.2e-06,"d":"0.00"},1,"149,",0,-5.66,-4.92,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000012644/ENSBGRG00000006850, exon 2 of 2)",2,10839619,10880469,40851,1]
["chr2",11254227,11254287,61,"ENSBGRG00000008777","ENSBGRT00000016051",10043,"GPN2","GPN-loop GTPase 2 [Source:HGNC Symbol;Acc:HGNC:25513]","NA","NA",{"v":7.9e-28,"d":"0.00"},1,"61,",0,{"v":-27.1,"d":"-27.10"},-26,6.56,"3' UTR",2,11239187,11264330,25144,2]
["chr2",11264181,11264330,150,"ENSBGRG00000008777","ENSBGRT00000016051",0,"GPN2","GPN-loop GTPase 2 [Source:HGNC Symbol;Acc:HGNC:25513]","NA","NA",{"v":1e-44,"d":"0.00"},1,"150,",0,-44,{"v":-42.7,"d":"-42.70"},{"v":5.9,"d":"5.90"},"5' UTR",2,11239187,11264330,25144,2]
["chr2",11264177,11264414,238,"ENSBGRG00000008777","ENSBGRT00000016051",0,"GPN2","GPN-loop GTPase 2 [Source:HGNC Symbol;Acc:HGNC:25513]","NA","NA",{"v":1.6E-51,"d":"0.00"},1,"238,",0,{"v":-50.8,"d":"-50.80"},{"v":-49.5,"d":"-49.50"},6.69,"5' UTR",2,11239187,11264330,25144,2]
["chr2",11267621,11269584,1964,"ENSBGRG00000008880","ENSBGRT00000016256",3167,"GPATCH3","G-patch domain containing 3 [Source:HGNC Symbol;Acc:HGNC:25720]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0032480(negative regulation of type I interferon production);GO:0039536(negative regulation of RIG-I signaling pathway);GO:0045893(positive regulation of transcription, DNA-templated)","NA",{"v":1.3E-18,"d":"0.00"},2,"79,218,","0,1746",{"v":-17.9,"d":"-17.90"},-17,3.22,"Exon (ENSBGRT00000016256/ENSBGRG00000008880, exon 2 of 7)",2,11263821,11272751,8931,2]
["chr2",11272336,11272395,60,"ENSBGRG00000008880","ENSBGRT00000016256",356,"GPATCH3","G-patch domain containing 3 [Source:HGNC Symbol;Acc:HGNC:25720]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0032480(negative regulation of type I interferon production);GO:0039536(negative regulation of RIG-I signaling pathway);GO:0045893(positive regulation of transcription, DNA-templated)","NA",{"v":0.00041,"d":"0.00"},1,"60,",0,-3.39,-2.74,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000016256/ENSBGRG00000008880, exon 1 of 7)",2,11263821,11272751,8931,2]
["chr2",11301622,11301979,358,"ENSBGRG00000008992","ENSBGRT00000016453",0,"NUDC","nuclear distribution C, dynein complex regulator [Source:HGNC Symbol;Acc:HGNC:8045]","GO:0005737(cytoplasm);GO:0005829(cytosol)","NA",{"v":1.6e-100,"d":"0.00"},1,"358,",0,{"v":-99.8,"d":"-99.80"},{"v":-98.2,"d":"-98.20"},2.45,"Exon (ENSBGRT00000016453/ENSBGRG00000008992, exon 1 of 9)",2,11301748,11318286,16539,1]
["chr2",11378627,11379302,676,"ENSBGRG00000009168","ENSBGRT00000016812",6805,"TENT5B","terminal nucleotidyltransferase 5B [Source:HGNC Symbol;Acc:HGNC:28273]","GO:1990817(RNA adenylyltransferase activity)","04371(Apelin signaling pathway);04810(Regulation of actin cytoskeleton);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes)",{"v":2e-59,"d":"0.00"},1,"676,",0,{"v":-58.7,"d":"-58.70"},{"v":-57.3,"d":"-57.30"},9.94,"Exon (ENSBGRT00000016812/ENSBGRG00000009168, exon 2 of 2)",2,11378627,11386107,7481,2]
["chr2",11897271,11897451,181,"ENSBGRG00000011636","ENSBGRT00000021174",5216,"AHDC1","AT-hook DNA binding motif containing 1 [Source:HGNC Symbol;Acc:HGNC:25230]","NA","04137(Mitophagy - animal);04621(NOD-like receptor signaling pathway)",{"v":2e-38,"d":"0.00"},1,"181,",0,{"v":-37.7,"d":"-37.70"},{"v":-36.6,"d":"-36.60"},3.89,"Exon (ENSBGRT00000021174/ENSBGRG00000011636, exon 2 of 2)",2,11897062,11902667,5606,2]
["chr2",11897750,11897989,240,"ENSBGRG00000011636","ENSBGRT00000021174",4678,"AHDC1","AT-hook DNA binding motif containing 1 [Source:HGNC Symbol;Acc:HGNC:25230]","NA","04137(Mitophagy - animal);04621(NOD-like receptor signaling pathway)",{"v":5e-86,"d":"0.00"},1,"240,",0,{"v":-85.3,"d":"-85.30"},{"v":-83.8,"d":"-83.80"},4.96,"Exon (ENSBGRT00000021174/ENSBGRG00000011636, exon 2 of 2)",2,11897062,11902667,5606,2]
["chr2",11898318,11899216,899,"ENSBGRG00000011636","ENSBGRT00000021174",3451,"AHDC1","AT-hook DNA binding motif containing 1 [Source:HGNC Symbol;Acc:HGNC:25230]","NA","04137(Mitophagy - animal);04621(NOD-like receptor signaling pathway)",{"v":1e-152,"d":"0.00"},1,"899,",0,-152,-150,{"v":8.8,"d":"8.80"},"Exon (ENSBGRT00000021174/ENSBGRG00000011636, exon 2 of 2)",2,11897062,11902667,5606,2]
["chr2",11899395,11899515,121,"ENSBGRG00000011636","ENSBGRT00000021174",3152,"AHDC1","AT-hook DNA binding motif containing 1 [Source:HGNC Symbol;Acc:HGNC:25230]","NA","04137(Mitophagy - animal);04621(NOD-like receptor signaling pathway)",{"v":7.9e-54,"d":"0.00"},1,"121,",0,{"v":-53.1,"d":"-53.10"},{"v":-51.8,"d":"-51.80"},4.82,"Exon (ENSBGRT00000021174/ENSBGRG00000011636, exon 2 of 2)",2,11897062,11902667,5606,2]
["chr2",11899904,11900113,210,"ENSBGRG00000011636","ENSBGRT00000021174",2554,"AHDC1","AT-hook DNA binding motif containing 1 [Source:HGNC Symbol;Acc:HGNC:25230]","NA","04137(Mitophagy - animal);04621(NOD-like receptor signaling pathway)",{"v":6.3e-34,"d":"0.00"},1,"210,",0,{"v":-33.2,"d":"-33.20"},{"v":-32.1,"d":"-32.10"},7.02,"Exon (ENSBGRT00000021174/ENSBGRG00000011636, exon 2 of 2)",2,11897062,11902667,5606,2]
["chr2",11901041,11901310,270,"ENSBGRG00000011636","ENSBGRT00000021174",1357,"AHDC1","AT-hook DNA binding motif containing 1 [Source:HGNC Symbol;Acc:HGNC:25230]","NA","04137(Mitophagy - animal);04621(NOD-like receptor signaling pathway)",{"v":7.9e-38,"d":"0.00"},1,"270,",0,{"v":-37.1,"d":"-37.10"},{"v":-35.9,"d":"-35.90"},3.95,"Exon (ENSBGRT00000021174/ENSBGRG00000011636, exon 2 of 2)",2,11897062,11902667,5606,2]
["chr2",12024953,12026371,1419,"ENSBGRG00000011996","ENSBGRT00000021966",1679,"IFI6","interferon alpha inducible protein 6 [Source:HGNC Symbol;Acc:HGNC:4054]","GO:0001836(release of cytochrome c from mitochondria);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006915(apoptotic process);GO:0016021(integral component of membrane);GO:0031966(mitochondrial membrane);GO:0042058(regulation of epidermal growth factor receptor signaling pathway);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045087(innate immune response);GO:0051607(defense response to virus);GO:0051902(negative regulation of mitochondrial depolarization);GO:0072593(reactive oxygen species metabolic process);GO:0097193(intrinsic apoptotic signaling pathway);GO:0098586(cellular response to virus);GO:2001240(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand)","NA",{"v":0,"d":"0.00"},2,"246,52,","0,1367",-319,-317,3.27,"3' UTR",2,12024953,12028050,3098,2]
["chr2",12338435,12350941,12507,"ENSBGRG00000013293","ENSBGRT00000025020",40297,"EYA3","EYA transcriptional coactivator and phosphatase 3 [Source:HGNC Symbol;Acc:HGNC:3521]","GO:0004725(protein tyrosine phosphatase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005813(centrosome);GO:0006302(double-strand break repair);GO:0007275(multicellular organism development);GO:0010212(response to ionizing radiation);GO:0016576(histone dephosphorylation);GO:0045739(positive regulation of DNA repair)","NA",{"v":1.3E-11,"d":"0.00"},3,"51,101,58,","0,5710,12449",{"v":-10.9,"d":"-10.90"},{"v":-10.1,"d":"-10.10"},2.83,"Exon (ENSBGRT00000025020/ENSBGRG00000013293, exon 10 of 12)",2,12338405,12391238,52834,2]
["chr2",12515547,12515693,147,"ENSBGRG00000013703","ENSBGRT00000025188",1261,"PTAFR","platelet activating factor receptor [Source:HGNC Symbol;Acc:HGNC:9582]","GO:0001530(lipopolysaccharide binding);GO:0001816(cytokine production);GO:0001875(lipopolysaccharide immune receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0004992(platelet activating factor receptor activity);GO:0005543(phospholipid binding);GO:0005886(plasma membrane);GO:0006935(chemotaxis);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0032496(response to lipopolysaccharide);GO:0032959(inositol trisphosphate biosynthetic process);GO:0048015(phosphatidylinositol-mediated signaling)","04020(Calcium signaling pathway);04080(Neuroactive ligand-receptor interaction);05150(Staphylococcus aureus infection)",{"v":4.6e-07,"d":"0.00"},1,"147,",0,-6.34,-5.58,5.71,"Exon (ENSBGRT00000025188/ENSBGRG00000013703, exon 2 of 2)",2,12515343,12516954,1612,2]
["chr2",12572844,12597091,24248,"ENSBGRG00000013806","ENSBGRT00000025430",0,"DNAJC8","DnaJ heat shock protein family (Hsp40) member C8 [Source:HGNC Symbol;Acc:HGNC:15470]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0030544(Hsp70 protein binding);GO:0045171(intercellular bridge)","NA",{"v":8.99999999999999e-295,"d":"0.00"},9,"370,76,92,72,95,67,57,102,78,","0,1874,4259,7062,8669,9282,12835,20938,24170",-294,-291,3.51,"3' UTR",2,12572400,12597091,24692,2]
["chr2",12972415,12972683,269,"ENSBGRG00000015289","ENSBGRT00000028059",10433,"TAF12","TATA-box binding protein associated factor 12 [Source:HGNC Symbol;Acc:HGNC:11545]","GO:0000124(SAGA complex);GO:0003677(DNA binding);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005669(transcription factor TFIID complex);GO:0006352(DNA-templated transcription, initiation);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0008134(transcription factor binding);GO:0016251(RNA polymerase II general transcription initiation factor activity);GO:0030914(STAGA complex);GO:0033276(transcription factor TFTC complex);GO:0043966(histone H3 acetylation);GO:0046695(SLIK (SAGA-like) complex);GO:0046982(protein heterodimerization activity);GO:0051091(positive regulation of DNA-binding transcription factor activity)","03022(Basal transcription factors)",{"v":4e-05,"d":"0.00"},1,"269,",0,{"v":-4.4,"d":"-4.40"},{"v":-3.7,"d":"-3.70"},6.48,"5' UTR",2,12955904,12983116,27213,2]
["chr2",13433101,13433428,328,"ENSBGRG00000021675","ENSBGRT00000040000",744,"TMEM200B","transmembrane protein 200B [Source:HGNC Symbol;Acc:HGNC:33785]","NA","04974(Protein digestion and absorption)",{"v":5e-88,"d":"0.00"},1,"328,",0,{"v":-87.3,"d":"-87.30"},{"v":-85.8,"d":"-85.80"},{"v":10.6,"d":"10.60"},"Exon (ENSBGRT00000040000/ENSBGRG00000021675, exon 1 of 1)",2,13433012,13434172,1161,2]
["chr2",13433726,13434172,447,"ENSBGRG00000021675","ENSBGRT00000040000",0,"TMEM200B","transmembrane protein 200B [Source:HGNC Symbol;Acc:HGNC:33785]","NA","04974(Protein digestion and absorption)",{"v":0.0021,"d":"0.00"},1,"447,",0,-2.67,-2.06,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000040000/ENSBGRG00000021675, exon 1 of 1)",2,13433012,13434172,1161,2]
["chr2",13464547,13469339,4793,"ENSBGRG00000021699","ENSBGRT00000040164",10774,"SRSF4","serine and arginine rich splicing factor 4 [Source:HGNC Symbol;Acc:HGNC:10786]","GO:0003676(nucleic acid binding);GO:0016607(nuclear speck);GO:0048025(negative regulation of mRNA splicing, via spliceosome)","03040(Spliceosome);05168(Herpes simplex infection)",0,3,"812,90,80,","0,1063,4713",-478,"-Inf",3.49,"Exon (ENSBGRT00000040164/ENSBGRG00000021699, exon 4 of 6)",2,13464488,13480113,15626,2]
["chr2",13480030,13494872,14843,"ENSBGRG00000021699","ENSBGRT00000040164",0,"SRSF4","serine and arginine rich splicing factor 4 [Source:HGNC Symbol;Acc:HGNC:10786]","GO:0003676(nucleic acid binding);GO:0016607(nuclear speck);GO:0048025(negative regulation of mRNA splicing, via spliceosome)","03040(Spliceosome);05168(Herpes simplex infection)",{"v":1.9E-3,"d":"0.00"},3,"84,107,18,","0,13634,14825",-2.73,-2.11,{"v":4.1,"d":"4.10"},"5' UTR",2,13464488,13480113,15626,2]
["chr2",13514396,13514515,120,"ENSBGRG00000021789","ENSBGRT00000040240",29678,"MECR","mitochondrial trans-2-enoyl-CoA reductase [Source:HGNC Symbol;Acc:HGNC:19691]","GO:0005739(mitochondrion);GO:0006631(fatty acid metabolic process);GO:0016491(oxidoreductase activity);GO:0019166(trans-2-enoyl-CoA reductase (NADPH) activity);GO:0055114(oxidation-reduction process)","00062(Fatty acid elongation)",{"v":0.015,"d":"0.02"},1,"120,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000040273/ENSBGRG00000021789, exon 5 of 5)",2,13502733,13544193,41461,2]
["chr2",15380149,15380268,120,"ENSBGRG00000022187","ENSBGRT00000041170",2949,"SDC3","syndecan 3 [Source:HGNC Symbol;Acc:HGNC:10660]","GO:0016020(membrane);GO:0042802(identical protein binding);GO:0044393(microspike)","04514(Cell adhesion molecules (CAMs))",{"v":4E-50,"d":"0.00"},1,"120,",0,{"v":-49.4,"d":"-49.40"},{"v":-48.2,"d":"-48.20"},2.22,"Exon (ENSBGRT00000041170/ENSBGRG00000022187, exon 4 of 5)",2,15378903,15383217,4315,2]
["chr2",15773324,15773382,59,"ENSBGRG00000007293","ENSBGRT00000013474",2967,"SNRNP40","small nuclear ribonucleoprotein U5 subunit 40 [Source:HGNC Symbol;Acc:HGNC:30857]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0071007(U2-type catalytic step 2 spliceosome);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)",{"v":0.028,"d":"0.03"},1,"59,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000013474/ENSBGRG00000007293, exon 2 of 10)",2,15748744,15776349,27606,2]
["chr2",16131896,16134136,2241,"ENSBGRG00000008612","ENSBGRT00000016454",18055,"COL16A1","collagen type XVI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2193]","GO:0005178(integrin binding);GO:0007155(cell adhesion);GO:0033622(integrin activation);GO:0033627(cell adhesion mediated by integrin);GO:0051894(positive regulation of focal adhesion assembly);GO:0071230(cellular response to amino acid stimulus)","04974(Protein digestion and absorption)",{"v":1E-127,"d":"0.00"},6,"4,108,36,132,45,34,","0,320,635,1441,2064,2207",-127,-125,2.76,"Exon (ENSBGRT00000016454/ENSBGRG00000008612, exon 26 of 70)",2,16090111,16152191,62081,2]
["chr2",16137671,16138535,865,"ENSBGRG00000008612","ENSBGRT00000016454",13656,"COL16A1","collagen type XVI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2193]","GO:0005178(integrin binding);GO:0007155(cell adhesion);GO:0033622(integrin activation);GO:0033627(cell adhesion mediated by integrin);GO:0051894(positive regulation of focal adhesion assembly);GO:0071230(cellular response to amino acid stimulus)","04974(Protein digestion and absorption)",{"v":1.2e-07,"d":"0.00"},3,"69,36,15,","0,144,850",-6.91,-6.14,1.31,"Exon (ENSBGRT00000016454/ENSBGRG00000008612, exon 22 of 70)",2,16090111,16152191,62081,2]
["chr2",16141983,16146364,4382,"ENSBGRG00000008612","ENSBGRT00000016454",5827,"COL16A1","collagen type XVI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2193]","GO:0005178(integrin binding);GO:0007155(cell adhesion);GO:0033622(integrin activation);GO:0033627(cell adhesion mediated by integrin);GO:0051894(positive regulation of focal adhesion assembly);GO:0071230(cellular response to amino acid stimulus)","04974(Protein digestion and absorption)",{"v":2.5e-26,"d":"0.00"},6,"9,27,36,27,54,87,","0,1487,2544,3121,3448,4295",{"v":-25.6,"d":"-25.60"},{"v":-24.5,"d":"-24.50"},1.38,"Exon (ENSBGRT00000016454/ENSBGRG00000008612, exon 7 of 70)",2,16090111,16152191,62081,2]
["chr2",16213698,16213758,61,"ENSBGRG00000009144","ENSBGRT00000018692",321,"ADGRB2","adhesion G protein-coupled receptor B2 [Source:HGNC Symbol;Acc:HGNC:944]","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005813(centrosome);GO:0005886(plasma membrane);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007422(peripheral nervous system development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016525(negative regulation of angiogenesis);GO:0033173(calcineurin-NFAT signaling cascade);GO:0051965(positive regulation of synapse assembly)","NA",{"v":0.0078,"d":"0.01"},1,"61,",0,-2.11,{"v":-1.3,"d":"-1.30"},9.72,"Exon (ENSBGRT00000018692/ENSBGRG00000009144, exon 1 of 29)",2,16183203,16214079,30877,2]
["chr2",16214469,16214589,121,"ENSBGRG00000009144","ENSBGRT00000018298",0,"ADGRB2","adhesion G protein-coupled receptor B2 [Source:HGNC Symbol;Acc:HGNC:944]","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005813(centrosome);GO:0005886(plasma membrane);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007422(peripheral nervous system development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016525(negative regulation of angiogenesis);GO:0033173(calcineurin-NFAT signaling cascade);GO:0051965(positive regulation of synapse assembly)","NA",{"v":0.0078,"d":"0.01"},1,"121,",0,-2.11,-1.27,9.72,"5' UTR",2,16183203,16214589,31387,2]
["chr2",16295880,16297243,1364,"ENSBGRG00000010336","ENSBGRT00000019091",507,"SPOCD1","SPOC domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26338]","GO:0006351(transcription, DNA-templated);GO:0010923(negative regulation of phosphatase activity)","NA",{"v":0.025,"d":"0.03"},2,"141,188,","0,1176",-1.61,-1.07,7.56,"Exon (ENSBGRT00000019091/ENSBGRG00000010336, exon 1 of 15)",2,16261842,16297750,35909,2]
["chr2",16777561,16777766,206,"ENSBGRG00000012858","ENSBGRT00000023517",1480,"MARCKSL1","MARCKS like 1 [Source:HGNC Symbol;Acc:HGNC:7142]","GO:0005516(calmodulin binding);GO:0005886(plasma membrane);GO:0008284(positive regulation of cell population proliferation)","04666(Fc gamma R-mediated phagocytosis);05140(Leishmaniasis)",0,1,"206,",0,-491,"-Inf",3.63,"Exon (ENSBGRT00000023517/ENSBGRG00000012858, exon 2 of 2)",2,16777503,16779246,1744,2]
["chr2",16777941,16778866,926,"ENSBGRG00000012858","ENSBGRT00000023517",380,"MARCKSL1","MARCKS like 1 [Source:HGNC Symbol;Acc:HGNC:7142]","GO:0005516(calmodulin binding);GO:0005886(plasma membrane);GO:0008284(positive regulation of cell population proliferation)","04666(Fc gamma R-mediated phagocytosis);05140(Leishmaniasis)",{"v":2.5e-43,"d":"0.00"},2,"72,46,","0,880",{"v":-42.6,"d":"-42.60"},{"v":-41.4,"d":"-41.40"},1.59,"Exon (ENSBGRT00000023517/ENSBGRG00000012858, exon 1 of 2)",2,16777503,16779246,1744,2]
["chr2",16823077,16823341,265,"ENSBGRG00000013022","ENSBGRT00000024442",16995,"BSDC1","BSD domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25501]","NA","NA",{"v":2e-74,"d":"0.00"},1,"265,",0,{"v":-73.7,"d":"-73.70"},{"v":-72.2,"d":"-72.20"},7.19,"Exon (ENSBGRT00000024442/ENSBGRG00000013022, exon 9 of 11)",2,16811737,16840336,28600,2]
["chr2",17038982,17039129,148,"ENSBGRG00000013592","ENSBGRT00000024971",12563,"ZBTB8OS","zinc finger and BTB domain containing 8 opposite strand [Source:HGNC Symbol;Acc:HGNC:24094]","NA","NA",{"v":3.2e-16,"d":"0.00"},1,"148,",0,{"v":-15.5,"d":"-15.50"},{"v":-14.5,"d":"-14.50"},2.29,"3' UTR",2,17016450,17051692,35243,2]
["chr2",17074154,17080670,6517,"ENSBGRG00000014170","ENSBGRT00000026037",12124,"SYNC","syncoilin, intermediate filament protein [Source:HGNC Symbol;Acc:HGNC:28897]","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005882(intermediate filament);GO:0030018(Z disc);GO:0031594(neuromuscular junction);GO:0042383(sarcolemma);GO:0045103(intermediate filament-based process)","NA",{"v":2e-22,"d":"0.00"},2,"109,71,","0,6446",{"v":-21.7,"d":"-21.70"},{"v":-20.7,"d":"-20.70"},2.16,"Exon (ENSBGRT00000026037/ENSBGRG00000014170, exon 2 of 4)",2,17072467,17092794,20328,2]
["chr2",17080908,17081087,180,"ENSBGRG00000014170","ENSBGRT00000026037",11707,"SYNC","syncoilin, intermediate filament protein [Source:HGNC Symbol;Acc:HGNC:28897]","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005882(intermediate filament);GO:0030018(Z disc);GO:0031594(neuromuscular junction);GO:0042383(sarcolemma);GO:0045103(intermediate filament-based process)","NA",{"v":4e-13,"d":"0.00"},1,"180,",0,{"v":-12.4,"d":"-12.40"},{"v":-11.5,"d":"-11.50"},3.33,"Exon (ENSBGRT00000026037/ENSBGRG00000014170, exon 2 of 4)",2,17072467,17092794,20328,2]
["chr2",17081505,17092794,11290,"ENSBGRG00000014170","ENSBGRT00000026037",0,"SYNC","syncoilin, intermediate filament protein [Source:HGNC Symbol;Acc:HGNC:28897]","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005882(intermediate filament);GO:0030018(Z disc);GO:0031594(neuromuscular junction);GO:0042383(sarcolemma);GO:0045103(intermediate filament-based process)","NA",{"v":2.5e-20,"d":"0.00"},2,"269,686,","0,10604",{"v":-19.6,"d":"-19.60"},{"v":-18.6,"d":"-18.60"},4.32,"5' UTR",2,17072467,17092794,20328,2]
["chr2",17179631,17180245,615,"ENSBGRG00000014391","ENSBGRT00000026442",37463,"YARS1","tyrosyl-tRNA synthetase 1 [Source:HGNC Symbol;Acc:HGNC:12840]","GO:0000049(tRNA binding);GO:0000166(nucleotide binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004831(tyrosine-tRNA ligase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006418(tRNA aminoacylation for protein translation);GO:0006437(tyrosyl-tRNA aminoacylation);GO:0016604(nuclear body)","00970(Aminoacyl-tRNA biosynthesis)",{"v":1.3e-05,"d":"0.00"},2,"21,69,","0,546",-4.87,-4.15,3.11,"3' UTR",2,17179541,17217708,38168,2]
["chr2",17298587,17299723,1137,"ENSBGRG00000015118","ENSBGRT00000027920",4520,"TMEM54","transmembrane protein 54 [Source:HGNC Symbol;Acc:HGNC:24143]","NA","NA",{"v":1.6e-06,"d":"0.00"},3,"299,135,15,","0,737,1122",-5.79,-5.04,9.72,"3' UTR",2,17298198,17304243,6046,2]
["chr2",17343597,17347695,4099,"ENSBGRG00000015458","ENSBGRT00000029183",22427,"RNF19B","ring finger protein 19B [Source:HGNC Symbol;Acc:HGNC:26886]","GO:0004842(ubiquitin-protein transferase activity);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0016567(protein ubiquitination);GO:0043130(ubiquitin binding);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":1e-171,"d":"0.00"},4,"535,22,132,1,","0,563,1515,4098",-171,-169,5.73,"3' UTR",2,17343298,17370122,26825,2]
["chr2",17418437,17418646,210,"ENSBGRG00000016106","ENSBGRT00000030183",21937,"AK2","adenylate kinase 2 [Source:HGNC Symbol;Acc:HGNC:362]","GO:0004017(adenylate kinase activity);GO:0005524(ATP binding);GO:0006139(nucleobase-containing compound metabolic process);GO:0006172(ADP biosynthetic process);GO:0016776(phosphotransferase activity, phosphate group as acceptor);GO:0019205(nucleobase-containing compound kinase activity);GO:0036126(sperm flagellum);GO:0097226(sperm mitochondrial sheath)","00230(Purine metabolism);00730(Thiamine metabolism)",{"v":7.9e-81,"d":"0.00"},1,"210,",0,{"v":-80.1,"d":"-80.10"},{"v":-78.6,"d":"-78.60"},3.41,"3' UTR",2,17409578,17440583,31006,2]
["chr2",17543745,17543864,120,"ENSBGRG00000016821","ENSBGRT00000030857",38202,"TRIM62","tripartite motif containing 62 [Source:HGNC Symbol;Acc:HGNC:25574]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0032897(negative regulation of viral transcription);GO:0042802(identical protein binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045087(innate immune response);GO:0046596(regulation of viral entry into host cell);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:1902186(regulation of viral release from host cell)","NA",{"v":6.3e-11,"d":"0.00"},1,"120,",0,{"v":-10.2,"d":"-10.20"},-9.34,2.48,"3' UTR",2,17543237,17582066,38830,2]
["chr2",17543924,17544193,270,"ENSBGRG00000016821","ENSBGRT00000030857",37873,"TRIM62","tripartite motif containing 62 [Source:HGNC Symbol;Acc:HGNC:25574]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0032897(negative regulation of viral transcription);GO:0042802(identical protein binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045087(innate immune response);GO:0046596(regulation of viral entry into host cell);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:1902186(regulation of viral release from host cell)","NA",{"v":4E-35,"d":"0.00"},1,"270,",0,{"v":-34.4,"d":"-34.40"},{"v":-33.2,"d":"-33.20"},6.79,"3' UTR",2,17543237,17582066,38830,2]
["chr2",17544342,17544492,151,"ENSBGRG00000016821","ENSBGRT00000030857",37574,"TRIM62","tripartite motif containing 62 [Source:HGNC Symbol;Acc:HGNC:25574]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0032897(negative regulation of viral transcription);GO:0042802(identical protein binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045087(innate immune response);GO:0046596(regulation of viral entry into host cell);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:1902186(regulation of viral release from host cell)","NA",{"v":1.4e-09,"d":"0.00"},1,"151,",0,-8.86,-8.04,3,"Exon (ENSBGRT00000030857/ENSBGRG00000016821, exon 6 of 6)",2,17543237,17582066,38830,2]
["chr2",17713317,17713466,150,"ENSBGRG00000017093","ENSBGRT00000031347",2500,"ENSBGRG00000017093","NA","NA","NA",{"v":7.8e-08,"d":"0.00"},1,"150,",0,-7.11,-6.33,{"v":28.1,"d":"28.10"},"Exon (ENSBGRT00000031347/ENSBGRG00000017093, exon 2 of 2)",2,17712873,17715966,3094,2]
["chr2",17940330,17949843,9514,"ENSBGRG00000017390","ENSBGRT00000032470",0,"ENSBGRG00000017390","NA","GO:0003723(RNA binding);GO:0003743(translation initiation factor activity);GO:0005737(cytoplasm);GO:0006413(translational initiation)","03013(RNA transport);04150(mTOR signaling pathway);04910(Insulin signaling pathway);04066(HIF-1 signaling pathway);04151(PI3K-Akt signaling pathway);04211(Longevity regulating pathway - mammal);01521(EGFR tyrosine kinase inhibitor resistance)",{"v":4e-45,"d":"0.00"},3,"14,115,20,","0,1041,9494",{"v":-44.4,"d":"-44.40"},{"v":-43.1,"d":"-43.10"},2.42,"Exon (ENSBGRT00000032470/ENSBGRG00000017390, exon 1 of 7)",2,17917891,17949843,31953,2]
["chr2",18726923,18727336,414,"ENSBGRG00000020160","ENSBGRT00000037609",1560,"COPS7B","COP9 signalosome subunit 7B [Source:HGNC Symbol;Acc:HGNC:16760]","GO:0008180(COP9 signalosome);GO:0010387(COP9 signalosome assembly)","NA",{"v":0.013,"d":"0.01"},2,"11,80,","0,334",-1.87,{"v":-1.3,"d":"-1.30"},1.74,"5' UTR",2,18435531,18728896,293366,2]
["chr2",18835754,18840471,4718,"ENSBGRG00000020966","ENSBGRT00000038674",566,"PTMA","prothymosin alpha [Source:HGNC Symbol;Acc:HGNC:9623]","NA","05169(Epstein-Barr virus infection)",0,5,"71,94,72,77,15,","0,596,950,3851,4703",-4000,"-Inf",{"v":3.1,"d":"3.10"},"Exon (ENSBGRT00000038674/ENSBGRG00000020966, exon 1 of 6)",2,18834797,18841037,6241,2]
["chr2",19110303,19110362,60,"ENSBGRG00000021246","ENSBGRT00000039189",3277,"B3GNT7","UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 [Source:HGNC Symbol;Acc:HGNC:18811]","GO:0006486(protein glycosylation);GO:0016020(membrane)","00533(Glycosaminoglycan biosynthesis - keratan sulfate)",{"v":0.025,"d":"0.03"},1,"60,",0,-1.61,-1.07,7.56,"Exon (ENSBGRT00000039189/ENSBGRG00000021246, exon 2 of 2)",2,19110303,19113639,3337,2]
["chr2",19110421,19110509,89,"ENSBGRG00000021246","ENSBGRT00000039189",3130,"B3GNT7","UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 [Source:HGNC Symbol;Acc:HGNC:18811]","GO:0006486(protein glycosylation);GO:0016020(membrane)","00533(Glycosaminoglycan biosynthesis - keratan sulfate)",{"v":0.00072,"d":"0.00"},1,"89,",0,-3.14,{"v":-2.5,"d":"-2.50"},6.12,"Exon (ENSBGRT00000039189/ENSBGRG00000021246, exon 2 of 2)",2,19110303,19113639,3337,2]
["chr2",19110597,19110685,89,"ENSBGRG00000021246","ENSBGRT00000039189",2954,"B3GNT7","UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 [Source:HGNC Symbol;Acc:HGNC:18811]","GO:0006486(protein glycosylation);GO:0016020(membrane)","00533(Glycosaminoglycan biosynthesis - keratan sulfate)",{"v":0.0006,"d":"0.00"},1,"89,",0,-3.22,-2.57,2.54,"Exon (ENSBGRT00000039189/ENSBGRG00000021246, exon 2 of 2)",2,19110303,19113639,3337,2]
["chr2",19110803,19110891,89,"ENSBGRG00000021246","ENSBGRT00000039189",2748,"B3GNT7","UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 [Source:HGNC Symbol;Acc:HGNC:18811]","GO:0006486(protein glycosylation);GO:0016020(membrane)","00533(Glycosaminoglycan biosynthesis - keratan sulfate)",{"v":0.0012,"d":"0.00"},1,"89,",0,-2.92,-2.29,2.33,"Exon (ENSBGRT00000039189/ENSBGRG00000021246, exon 2 of 2)",2,19110303,19113639,3337,2]
["chr2",19111008,19113639,2632,"ENSBGRG00000021246","ENSBGRT00000039189",0,"B3GNT7","UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 [Source:HGNC Symbol;Acc:HGNC:18811]","GO:0006486(protein glycosylation);GO:0016020(membrane)","00533(Glycosaminoglycan biosynthesis - keratan sulfate)",{"v":5.6e-05,"d":"0.00"},2,"490,11,","0,2621",-4.25,-3.56,{"v":10.3,"d":"10.30"},"Exon (ENSBGRT00000039189/ENSBGRG00000021246, exon 1 of 2)",2,19110303,19113639,3337,2]
["chr2",19146346,19147642,1297,"ENSBGRG00000021327","ENSBGRT00000040241",216904,"ARMC9","armadillo repeat containing 9 [Source:HGNC Symbol;Acc:HGNC:20730]","GO:0005515(protein binding);GO:0005814(centriole);GO:0005929(cilium);GO:0036064(ciliary basal body);GO:0045880(positive regulation of smoothened signaling pathway);GO:0060271(cilium assembly);GO:0097542(ciliary tip)","NA",{"v":0.006,"d":"0.01"},2,"32,89,","0,1208",-2.22,-1.63,4.86,"3' UTR",2,19146256,19364546,218291,2]
["chr2",20104073,20122292,18220,"ENSBGRG00000008056","ENSBGRT00000014693",52464,"ENSBGRG00000008056","NA","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016604(nuclear body)","05203(Viral carcinogenesis);05168(Herpes simplex infection)",{"v":7.9e-11,"d":"0.00"},4,"25,87,57,12,","0,3878,5709,18208",{"v":-10.1,"d":"-10.10"},-9.27,{"v":1.6,"d":"1.60"},"Exon (ENSBGRT00000014693/ENSBGRG00000008056, exon 16 of 27)",2,20088883,20174756,85874,2]
["chr2",20135021,20140326,5306,"ENSBGRG00000008056","ENSBGRT00000014693",34430,"ENSBGRG00000008056","NA","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016604(nuclear body)","05203(Viral carcinogenesis);05168(Herpes simplex infection)",{"v":7.9e-28,"d":"0.00"},2,"48,73,","0,5233",{"v":-27.1,"d":"-27.10"},{"v":-26.1,"d":"-26.10"},2.67,"Exon (ENSBGRT00000014693/ENSBGRG00000008056, exon 10 of 27)",2,20088883,20174756,85874,2]
["chr2",20369099,20369189,91,"ENSBGRG00000008723","ENSBGRT00000016005",115128,"FBXO36","F-box protein 36 [Source:HGNC Symbol;Acc:HGNC:27020]","GO:0005515(protein binding)","NA",{"v":0.0071,"d":"0.01"},1,"91,",0,-2.15,-1.56,2.34,"Exon (ENSBGRT00000016005/ENSBGRG00000008723, exon 4 of 4)",2,20369010,20484317,115308,2]
["chr2",26943892,26947321,3430,"ENSBGRG00000015993","ENSBGRT00000029379",0,"MRPL44","mitochondrial ribosomal protein L44 [Source:HGNC Symbol;Acc:HGNC:16650]","GO:0004525(ribonuclease III activity);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit);GO:0005886(plasma membrane);GO:0006396(RNA processing);GO:0070125(mitochondrial translational elongation)","NA",{"v":2e-77,"d":"0.00"},3,"155,179,236,","0,1951,3194",{"v":-76.7,"d":"-76.70"},{"v":-75.2,"d":"-75.20"},{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000029379/ENSBGRG00000015993, exon 1 of 4)",2,26937825,26946021,8197,2]
["chr2",26947381,26947501,121,"ENSBGRG00000015993","ENSBGRT00000029480",0,"MRPL44","mitochondrial ribosomal protein L44 [Source:HGNC Symbol;Acc:HGNC:16650]","GO:0004525(ribonuclease III activity);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit);GO:0005886(plasma membrane);GO:0006396(RNA processing);GO:0070125(mitochondrial translational elongation)","NA",{"v":0.00041,"d":"0.00"},1,"121,",0,-3.39,-2.74,6.48,"Exon (ENSBGRT00000029480/ENSBGRG00000015993, exon 1 of 4)",2,26938416,26947501,9086,2]
["chr2",28014869,28015107,239,"ENSBGRG00000016568","ENSBGRT00000030458",34035,"ACSL3","acyl-CoA synthetase long chain family member 3 [Source:HGNC Symbol;Acc:HGNC:3570]","GO:0001676(long-chain fatty acid metabolic process);GO:0003824(catalytic activity);GO:0004467(long-chain fatty acid-CoA ligase activity);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005811(lipid droplet);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0034379(very-low-density lipoprotein particle assembly);GO:0042998(positive regulation of Golgi to plasma membrane protein transport);GO:0044539(long-chain fatty acid import into cell);GO:0048471(perinuclear region of cytoplasm);GO:0051047(positive regulation of secretion);GO:2001247(positive regulation of phosphatidylcholine biosynthetic process)","00061(Fatty acid biosynthesis);00071(Fatty acid degradation);04146(Peroxisome);04216(Ferroptosis);04920(Adipocytokine signaling pathway);03320(PPAR signaling pathway);04714(Thermogenesis)",{"v":3.2E-34,"d":"0.00"},1,"239,",0,{"v":-33.5,"d":"-33.50"},{"v":-32.3,"d":"-32.30"},3.69,"3' UTR",2,28014492,28049142,34651,2]
["chr2",31959680,31961272,1593,"ENSBGRG00000018255","ENSBGRT00000033404",16827,"SLC4A3","solute carrier family 4 member 3 [Source:HGNC Symbol;Acc:HGNC:11029]","GO:0005452(inorganic anion exchanger activity);GO:0005886(plasma membrane);GO:0006820(anion transport);GO:0008509(anion transmembrane transporter activity);GO:0009897(external side of plasma membrane);GO:0015106(bicarbonate transmembrane transporter activity);GO:0015301(anion:anion antiporter activity);GO:0015701(bicarbonate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0051453(regulation of intracellular pH);GO:0061337(cardiac conduction)","NA",{"v":1e-171,"d":"0.00"},2,"348,102,","0,1491",-171,-169,3.13,"3' UTR",2,31959410,31978099,18690,2]
["chr2",32090925,32091403,479,"ENSBGRG00000019429","ENSBGRT00000035672",299,"ASIC4","acid sensing ion channel subunit family member 4 [Source:HGNC Symbol;Acc:HGNC:21263]","GO:0001662(behavioral fear response);GO:0005272(sodium channel activity);GO:0006814(sodium ion transport);GO:0016020(membrane)","04750(Inflammatory mediator regulation of TRP channels)",{"v":0.028,"d":"0.03"},1,"479,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000035672/ENSBGRG00000019429, exon 1 of 10)",2,32068331,32091702,23372,2]
["chr2",32101660,32101778,119,"ENSBGRG00000019472","ENSBGRT00000035815",6465,"GMPPA","GDP-mannose pyrophosphorylase A [Source:HGNC Symbol;Acc:HGNC:22923]","GO:0009058(biosynthetic process);GO:0016740(transferase activity);GO:0016779(nucleotidyltransferase activity)","00051(Fructose and mannose metabolism);00520(Amino sugar and nucleotide sugar metabolism)",{"v":2E-12,"d":"0.00"},1,"119,",0,{"v":-11.7,"d":"-11.70"},{"v":-10.8,"d":"-10.80"},1.65,"Exon (ENSBGRT00000036134/ENSBGRG00000019643, exon 1 of 3)",2,32101092,32108243,7152,2]
["chr2",32394315,32395286,972,"ENSBGRG00000021721","ENSBGRT00000040136",5599,"ANKZF1","ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1 [Source:HGNC Symbol;Acc:HGNC:25527]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0070301(cellular response to hydrogen peroxide)","NA",{"v":2e-83,"d":"0.00"},2,"164,106,","0,866",{"v":-82.7,"d":"-82.70"},{"v":-81.2,"d":"-81.20"},3.02,"Exon (ENSBGRT00000040136/ENSBGRG00000021721, exon 9 of 14)",2,32392647,32400885,8239,2]
["chr2",32452196,32452550,355,"ENSBGRG00000000177","ENSBGRT00000000282",3760,"RETREG2","reticulophagy regulator family member 2 [Source:HGNC Symbol;Acc:HGNC:28450]","NA","03040(Spliceosome)",0,1,"355,",0,-509,"-Inf",2.37,"Exon (ENSBGRT00000000282/ENSBGRG00000000177, exon 9 of 9)",2,32451989,32456310,4322,2]
["chr2",32722986,32723104,119,"ENSBGRG00000000662","ENSBGRT00000001183",708,"CDK5R2","cyclin dependent kinase 5 regulatory subunit 2 [Source:HGNC Symbol;Acc:HGNC:1776]","GO:0001764(neuron migration);GO:0003779(actin binding);GO:0005737(cytoplasm);GO:0016533(protein kinase 5 complex);GO:0021549(cerebellum development);GO:0021722(superior olivary nucleus maturation);GO:0021766(hippocampus development);GO:0021819(layer formation in cerebral cortex);GO:0045860(positive regulation of protein kinase activity);GO:0045956(positive regulation of calcium ion-dependent exocytosis);GO:0061575(cyclin-dependent protein serine/threonine kinase activator activity)","NA",{"v":1.9E-6,"d":"0.00"},1,"119,",0,-5.72,-4.97,4.56,"Exon (ENSBGRT00000001183/ENSBGRG00000000662, exon 1 of 1)",2,32722691,32723812,1122,2]
["chr2",32796522,32796611,90,"ENSBGRG00000000692","ENSBGRT00000001237",18806,"WNT6","Wnt family member 6 [Source:HGNC Symbol;Acc:HGNC:12785]","GO:0001658(branching involved in ureteric bud morphogenesis);GO:0005102(signaling receptor binding);GO:0005576(extracellular region);GO:0007275(multicellular organism development);GO:0009798(axis specification);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0016055(Wnt signaling pathway);GO:0031012(extracellular matrix);GO:0042475(odontogenesis of dentin-containing tooth);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060684(epithelial-mesenchymal cell signaling);GO:0070172(positive regulation of tooth mineralization);GO:0072079(nephron tubule formation);GO:0072080(nephron tubule development)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":2E-19,"d":"0.00"},1,"90,",0,{"v":-18.7,"d":"-18.70"},{"v":-17.7,"d":"-17.70"},5.88,"3' UTR",2,32796462,32815417,18956,2]
["chr2",32796969,32797028,60,"ENSBGRG00000000692","ENSBGRT00000001237",18389,"WNT6","Wnt family member 6 [Source:HGNC Symbol;Acc:HGNC:12785]","GO:0001658(branching involved in ureteric bud morphogenesis);GO:0005102(signaling receptor binding);GO:0005576(extracellular region);GO:0007275(multicellular organism development);GO:0009798(axis specification);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0016055(Wnt signaling pathway);GO:0031012(extracellular matrix);GO:0042475(odontogenesis of dentin-containing tooth);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060684(epithelial-mesenchymal cell signaling);GO:0070172(positive regulation of tooth mineralization);GO:0072079(nephron tubule formation);GO:0072080(nephron tubule development)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":3.9e-09,"d":"0.00"},1,"60,",0,-8.41,{"v":-7.6,"d":"-7.60"},{"v":10.5,"d":"10.50"},"Exon (ENSBGRT00000001237/ENSBGRG00000000692, exon 4 of 4)",2,32796462,32815417,18956,2]
["chr2",32962166,32962555,390,"ENSBGRG00000000831","ENSBGRT00000001618",1503,"TTLL4","tubulin tyrosine ligase like 4 [Source:HGNC Symbol;Acc:HGNC:28976]","GO:0005524(ATP binding);GO:0006464(cellular protein modification process);GO:0015631(tubulin binding);GO:0018095(protein polyglutamylation);GO:0018200(peptidyl-glutamic acid modification);GO:0070739(protein-glutamic acid ligase activity);GO:0120222(regulation of blastocyst development)","NA",{"v":6.3e-52,"d":"0.00"},1,"390,",0,{"v":-51.2,"d":"-51.20"},{"v":-49.9,"d":"-49.90"},{"v":5.5,"d":"5.50"},"Exon (ENSBGRT00000001618/ENSBGRG00000000831, exon 2 of 20)",2,32944762,32964058,19297,2]
["chr2",32963549,32963759,211,"ENSBGRG00000000831","ENSBGRT00000001618",299,"TTLL4","tubulin tyrosine ligase like 4 [Source:HGNC Symbol;Acc:HGNC:28976]","GO:0005524(ATP binding);GO:0006464(cellular protein modification process);GO:0015631(tubulin binding);GO:0018095(protein polyglutamylation);GO:0018200(peptidyl-glutamic acid modification);GO:0070739(protein-glutamic acid ligase activity);GO:0120222(regulation of blastocyst development)","NA",{"v":4.3e-05,"d":"0.00"},1,"211,",0,-4.37,-3.68,2.16,"Exon (ENSBGRT00000001618/ENSBGRG00000000831, exon 1 of 20)",2,32944762,32964058,19297,2]
["chr2",32998436,32998856,421,"ENSBGRG00000000918","ENSBGRT00000001706",27103,"STK36","serine/threonine kinase 36 [Source:HGNC Symbol;Acc:HGNC:17209]","GO:0003351(epithelial cilium movement involved in extracellular fluid movement);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007228(positive regulation of hh target transcription factor activity);GO:0007420(brain development);GO:0008134(transcription factor binding);GO:0009791(post-embryonic development);GO:0045880(positive regulation of smoothened signaling pathway);GO:0051090(regulation of DNA-binding transcription factor activity);GO:0060271(cilium assembly)","NA",{"v":1.3E-65,"d":"0.00"},1,"421,",0,{"v":-64.9,"d":"-64.90"},{"v":-63.5,"d":"-63.50"},{"v":5.4,"d":"5.40"},"3' UTR",2,32997417,33025959,28543,2]
["chr2",33000936,33001146,211,"ENSBGRG00000000918","ENSBGRT00000001706",24813,"STK36","serine/threonine kinase 36 [Source:HGNC Symbol;Acc:HGNC:17209]","GO:0003351(epithelial cilium movement involved in extracellular fluid movement);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007228(positive regulation of hh target transcription factor activity);GO:0007420(brain development);GO:0008134(transcription factor binding);GO:0009791(post-embryonic development);GO:0045880(positive regulation of smoothened signaling pathway);GO:0051090(regulation of DNA-binding transcription factor activity);GO:0060271(cilium assembly)","NA",{"v":5e-75,"d":"0.00"},1,"211,",0,{"v":-74.3,"d":"-74.30"},{"v":-72.9,"d":"-72.90"},3.75,"Exon (ENSBGRT00000001706/ENSBGRG00000000918, exon 25 of 26)",2,32997417,33025959,28543,2]
["chr2",33063569,33063689,121,"ENSBGRG00000001098","ENSBGRT00000002047",26622,"PLCD4","phospholipase C delta 4 [Source:HGNC Symbol;Acc:HGNC:9062]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0004629(phospholipase C activity);GO:0005509(calcium ion binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007340(acrosome reaction);GO:0008081(phosphoric diester hydrolase activity);GO:0031965(nuclear membrane);GO:0035556(intracellular signal transduction);GO:0046488(phosphatidylinositol metabolic process)","00562(Inositol phosphate metabolism);04020(Calcium signaling pathway);04070(Phosphatidylinositol signaling system);04919(Thyroid hormone signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications)",{"v":0.043,"d":"0.04"},1,"121,",0,-1.37,{"v":-0.741,"d":"-0.74"},4.32,"3' UTR",2,33063359,33090311,26953,2]
["chr2",33064108,33064348,241,"ENSBGRG00000001098","ENSBGRT00000002047",25963,"PLCD4","phospholipase C delta 4 [Source:HGNC Symbol;Acc:HGNC:9062]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0004629(phospholipase C activity);GO:0005509(calcium ion binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007340(acrosome reaction);GO:0008081(phosphoric diester hydrolase activity);GO:0031965(nuclear membrane);GO:0035556(intracellular signal transduction);GO:0046488(phosphatidylinositol metabolic process)","00562(Inositol phosphate metabolism);04020(Calcium signaling pathway);04070(Phosphatidylinositol signaling system);04919(Thyroid hormone signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications)",{"v":6.3e-41,"d":"0.00"},1,"241,",0,{"v":-40.2,"d":"-40.20"},-39,3.84,"3' UTR",2,33063359,33090311,26953,2]
["chr2",33265272,33265541,270,"ENSBGRG00000001379","ENSBGRT00000002519",12807,"CTDSP1","CTD small phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:21614]","GO:0001933(negative regulation of protein phosphorylation);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006470(protein dephosphorylation);GO:0008420(RNA polymerase II CTD heptapeptide repeat phosphatase activity);GO:0016791(phosphatase activity);GO:0045665(negative regulation of neuron differentiation);GO:0050768(negative regulation of neurogenesis);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","NA",{"v":1.6e-96,"d":"0.00"},1,"270,",0,{"v":-95.8,"d":"-95.80"},{"v":-94.2,"d":"-94.20"},6,"3' UTR",2,33264942,33278348,13407,2]
["chr2",33266081,33266350,270,"ENSBGRG00000001379","ENSBGRT00000002519",11998,"CTDSP1","CTD small phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:21614]","GO:0001933(negative regulation of protein phosphorylation);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006470(protein dephosphorylation);GO:0008420(RNA polymerase II CTD heptapeptide repeat phosphatase activity);GO:0016791(phosphatase activity);GO:0045665(negative regulation of neuron differentiation);GO:0050768(negative regulation of neurogenesis);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","NA",{"v":4e-40,"d":"0.00"},1,"270,",0,{"v":-39.4,"d":"-39.40"},{"v":-38.2,"d":"-38.20"},7.37,"3' UTR",2,33264942,33278348,13407,2]
["chr2",33409428,33409518,91,"ENSBGRG00000001769","ENSBGRT00000003261",809,"GPBAR1","G protein-coupled bile acid receptor 1 [Source:HGNC Symbol;Acc:HGNC:19680]","GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0016021(integral component of membrane);GO:0038181(bile acid receptor activity);GO:0038182(G protein-coupled bile acid receptor activity);GO:0038184(cell surface bile acid receptor signaling pathway);GO:0043235(receptor complex);GO:1903413(cellular response to bile acid);GO:2000810(regulation of bicellular tight junction assembly)","NA",{"v":1.9e-05,"d":"0.00"},1,"91,",0,-4.72,-4.01,2.03,"Exon (ENSBGRT00000003261/ENSBGRG00000001769, exon 1 of 1)",2,33409338,33410327,990,2]
["chr2",33418768,33419035,268,"ENSBGRG00000001784","ENSBGRT00000003348",27197,"ARPC2","actin related protein 2/3 complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:705]","GO:0005200(structural constituent of cytoskeleton);GO:0005768(endosome);GO:0005885(Arp2/3 protein complex);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0010592(positive regulation of lamellipodium assembly);GO:0015629(actin cytoskeleton);GO:0030027(lamellipodium);GO:0030041(actin filament polymerization);GO:0030833(regulation of actin filament polymerization);GO:0030838(positive regulation of actin filament polymerization);GO:0031252(cell leading edge);GO:0034314(Arp2/3 complex-mediated actin nucleation);GO:0036195(muscle cell projection membrane);GO:0051015(actin filament binding);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading)","04144(Endocytosis);04810(Regulation of actin cytoskeleton);04666(Fc gamma R-mediated phagocytosis);05132(Salmonella infection);05100(Bacterial invasion of epithelial cells)",0,1,"268,",0,-827,"-Inf",2.64,"3' UTR",2,33418620,33446232,27613,2]
["chr2",33539765,33554871,15107,"ENSBGRG00000001855","ENSBGRT00000003491",5110,"RUFY4","RUN and FYVE domain containing 4 [Source:HGNC Symbol;Acc:HGNC:24804]","GO:0016239(positive regulation of macroautophagy);GO:0071353(cellular response to interleukin-4)","NA",{"v":0.028,"d":"0.03"},5,"357,111,147,107,114,","0,910,6065,14158,14993",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"3' UTR",2,33539019,33559981,20963,2]
["chr2",33555170,33555319,150,"ENSBGRG00000001855","ENSBGRT00000003491",4662,"RUFY4","RUN and FYVE domain containing 4 [Source:HGNC Symbol;Acc:HGNC:24804]","GO:0016239(positive regulation of macroautophagy);GO:0071353(cellular response to interleukin-4)","NA",{"v":0.014,"d":"0.01"},1,"150,",0,-1.86,{"v":-1.3,"d":"-1.30"},{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000003491/ENSBGRG00000001855, exon 7 of 11)",2,33539019,33559981,20963,2]
["chr2",35439388,35443849,4462,"ENSBGRG00000002323","ENSBGRT00000004399",55150,"SMARCAL1","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1 [Source:HGNC Symbol;Acc:HGNC:11102]","GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005662(DNA replication factor A complex);GO:0006259(DNA metabolic process);GO:0006281(DNA repair);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006974(cellular response to DNA damage stimulus);GO:0008094(DNA-dependent ATPase activity);GO:0031297(replication fork processing);GO:0035861(site of double-strand break);GO:0036310(annealing helicase activity)","NA",{"v":6.3e-44,"d":"0.00"},2,"213,58,","0,4404",{"v":-43.2,"d":"-43.20"},-42,5.97,"Exon (ENSBGRT00000004399/ENSBGRG00000002323, exon 17 of 18)",2,35439388,35498999,59612,2]
["chr2",35497940,35498999,1060,"ENSBGRG00000002323","ENSBGRT00000004399",0,"SMARCAL1","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1 [Source:HGNC Symbol;Acc:HGNC:11102]","GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005662(DNA replication factor A complex);GO:0006259(DNA metabolic process);GO:0006281(DNA repair);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006974(cellular response to DNA damage stimulus);GO:0008094(DNA-dependent ATPase activity);GO:0031297(replication fork processing);GO:0035861(site of double-strand break);GO:0036310(annealing helicase activity)","NA",{"v":9.99999999999999e-237,"d":"0.00"},2,"624,36,","0,1024",-236,-234,2.93,"5' UTR",2,35439388,35498999,59612,2]
["chr2",35836361,35836538,178,"ENSBGRG00000002710","ENSBGRT00000005075",13432,"TMEM169","transmembrane protein 169 [Source:HGNC Symbol;Acc:HGNC:25130]","NA","01040(Biosynthesis of unsaturated fatty acids);04146(Peroxisome)",{"v":0.028,"d":"0.03"},1,"178,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000005075/ENSBGRG00000002710, exon 3 of 3)",2,35836361,35849970,13610,2]
["chr2",42715610,42715730,121,"ENSBGRG00000005202","ENSBGRT00000010830",243811,"UNC80","unc-80 homolog, NALCN channel complex subunit [Source:HGNC Symbol;Acc:HGNC:26582]","NA","NA",{"v":1.4E-3,"d":"0.00"},1,"121,",0,-2.86,-2.23,2.35,"Exon (ENSBGRT00000010830/ENSBGRG00000005202, exon 65 of 66)",2,42713759,42959541,245783,2]
["chr2",42908050,42909212,1163,"ENSBGRG00000005202","ENSBGRT00000010830",50329,"UNC80","unc-80 homolog, NALCN channel complex subunit [Source:HGNC Symbol;Acc:HGNC:26582]","NA","NA",{"v":0.025,"d":"0.03"},2,"17,74,","0,1089",-1.61,-1.07,4.86,"Exon (ENSBGRT00000010830/ENSBGRG00000005202, exon 12 of 66)",2,42713759,42959541,245783,2]
["chr2",42909392,42911706,2315,"ENSBGRG00000005202","ENSBGRT00000010830",47835,"UNC80","unc-80 homolog, NALCN channel complex subunit [Source:HGNC Symbol;Acc:HGNC:26582]","NA","NA",{"v":0.0041,"d":"0.00"},3,"16,141,143,","0,1114,2172",-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000010830/ENSBGRG00000005202, exon 10 of 66)",2,42713759,42959541,245783,2]
["chr2",43034246,43035615,1370,"ENSBGRG00000005995","ENSBGRT00000011130",125066,"MAP2","microtubule associated protein 2 [Source:HGNC Symbol;Acc:HGNC:6839]","GO:0000226(microtubule cytoskeleton organization);GO:0001578(microtubule bundle formation);GO:0002162(dystroglycan binding);GO:0005737(cytoplasm);GO:0007409(axonogenesis);GO:0008017(microtubule binding);GO:0014069(postsynaptic density);GO:0015631(tubulin binding);GO:0016358(dendrite development);GO:0021954(central nervous system neuron development);GO:0030010(establishment of cell polarity);GO:0030425(dendrite);GO:0030517(negative regulation of axon extension);GO:0031175(neuron projection development);GO:0034399(nuclear periphery);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0043194(axon initial segment);GO:0043198(dendritic shaft);GO:0043203(axon hillock);GO:0044297(cell body);GO:0048813(dendrite morphogenesis);GO:0071310(cellular response to organic substance);GO:0097442(CA3 pyramidal cell dendrite);GO:1903827(regulation of cellular protein localization);GO:1990769(proximal neuron projection)","NA",{"v":0.0002,"d":"0.00"},2,"53,1116,","0,254",{"v":-3.7,"d":"-3.70"},-3.03,14,"Exon (ENSBGRT00000011130/ENSBGRG00000005995, exon 6 of 14)",2,43000576,43160681,160106,2]
["chr2",43037620,43038099,480,"ENSBGRG00000005995","ENSBGRT00000011130",122582,"MAP2","microtubule associated protein 2 [Source:HGNC Symbol;Acc:HGNC:6839]","GO:0000226(microtubule cytoskeleton organization);GO:0001578(microtubule bundle formation);GO:0002162(dystroglycan binding);GO:0005737(cytoplasm);GO:0007409(axonogenesis);GO:0008017(microtubule binding);GO:0014069(postsynaptic density);GO:0015631(tubulin binding);GO:0016358(dendrite development);GO:0021954(central nervous system neuron development);GO:0030010(establishment of cell polarity);GO:0030425(dendrite);GO:0030517(negative regulation of axon extension);GO:0031175(neuron projection development);GO:0034399(nuclear periphery);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0043194(axon initial segment);GO:0043198(dendritic shaft);GO:0043203(axon hillock);GO:0044297(cell body);GO:0048813(dendrite morphogenesis);GO:0071310(cellular response to organic substance);GO:0097442(CA3 pyramidal cell dendrite);GO:1903827(regulation of cellular protein localization);GO:1990769(proximal neuron projection)","NA",{"v":0.0078,"d":"0.01"},1,"480,",0,-2.11,-1.27,9.72,"Exon (ENSBGRT00000011130/ENSBGRG00000005995, exon 6 of 14)",2,43000576,43160681,160106,2]
["chr2",46807835,46808464,630,"ENSBGRG00000010098","ENSBGRT00000020284",90687,"NRP2","neuropilin 2 [Source:HGNC Symbol;Acc:HGNC:8005]","GO:0001525(angiogenesis);GO:0001755(neural crest cell migration);GO:0001764(neuron migration);GO:0003148(outflow tract septum morphogenesis);GO:0005021(vascular endothelial growth factor-activated receptor activity);GO:0007411(axon guidance);GO:0007507(heart development);GO:0016020(membrane);GO:0017154(semaphorin receptor activity);GO:0021612(facial nerve structural organization);GO:0021649(vestibulocochlear nerve structural organization);GO:0021675(nerve development);GO:0021828(gonadotrophin-releasing hormone neuronal migration to the hypothalamus);GO:0030424(axon);GO:0036486(ventral trunk neural crest cell migration);GO:0038084(vascular endothelial growth factor signaling pathway);GO:0048846(axon extension involved in axon guidance);GO:0050919(negative chemotaxis);GO:0061549(sympathetic ganglion development);GO:0061551(trigeminal ganglion development);GO:0097374(sensory neuron axon guidance);GO:0097490(sympathetic neuron projection extension);GO:0097491(sympathetic neuron projection guidance);GO:0098978(glutamatergic synapse);GO:0099175(regulation of postsynapse organization);GO:1901166(neural crest cell migration involved in autonomic nervous system development);GO:1902285(semaphorin-plexin signaling pathway involved in neuron projection guidance);GO:1903375(facioacoustic ganglion development);GO:1904835(dorsal root ganglion morphogenesis);GO:1990830(cellular response to leukemia inhibitory factor)","NA",{"v":9.99999999999998e-264,"d":"0.00"},1,"630,",0,-263,-261,5.65,"3' UTR",2,46807835,46899151,91317,2]
["chr2",46829913,46830003,91,"ENSBGRG00000010098","ENSBGRT00000020284",69148,"NRP2","neuropilin 2 [Source:HGNC Symbol;Acc:HGNC:8005]","GO:0001525(angiogenesis);GO:0001755(neural crest cell migration);GO:0001764(neuron migration);GO:0003148(outflow tract septum morphogenesis);GO:0005021(vascular endothelial growth factor-activated receptor activity);GO:0007411(axon guidance);GO:0007507(heart development);GO:0016020(membrane);GO:0017154(semaphorin receptor activity);GO:0021612(facial nerve structural organization);GO:0021649(vestibulocochlear nerve structural organization);GO:0021675(nerve development);GO:0021828(gonadotrophin-releasing hormone neuronal migration to the hypothalamus);GO:0030424(axon);GO:0036486(ventral trunk neural crest cell migration);GO:0038084(vascular endothelial growth factor signaling pathway);GO:0048846(axon extension involved in axon guidance);GO:0050919(negative chemotaxis);GO:0061549(sympathetic ganglion development);GO:0061551(trigeminal ganglion development);GO:0097374(sensory neuron axon guidance);GO:0097490(sympathetic neuron projection extension);GO:0097491(sympathetic neuron projection guidance);GO:0098978(glutamatergic synapse);GO:0099175(regulation of postsynapse organization);GO:1901166(neural crest cell migration involved in autonomic nervous system development);GO:1902285(semaphorin-plexin signaling pathway involved in neuron projection guidance);GO:1903375(facioacoustic ganglion development);GO:1904835(dorsal root ganglion morphogenesis);GO:1990830(cellular response to leukemia inhibitory factor)","NA",{"v":2.5e-14,"d":"0.00"},1,"91,",0,{"v":-13.6,"d":"-13.60"},{"v":-12.7,"d":"-12.70"},{"v":1.5,"d":"1.50"},"3' UTR",2,46807835,46899151,91317,2]
["chr2",46830122,46830302,181,"ENSBGRG00000010098","ENSBGRT00000020284",68849,"NRP2","neuropilin 2 [Source:HGNC Symbol;Acc:HGNC:8005]","GO:0001525(angiogenesis);GO:0001755(neural crest cell migration);GO:0001764(neuron migration);GO:0003148(outflow tract septum morphogenesis);GO:0005021(vascular endothelial growth factor-activated receptor activity);GO:0007411(axon guidance);GO:0007507(heart development);GO:0016020(membrane);GO:0017154(semaphorin receptor activity);GO:0021612(facial nerve structural organization);GO:0021649(vestibulocochlear nerve structural organization);GO:0021675(nerve development);GO:0021828(gonadotrophin-releasing hormone neuronal migration to the hypothalamus);GO:0030424(axon);GO:0036486(ventral trunk neural crest cell migration);GO:0038084(vascular endothelial growth factor signaling pathway);GO:0048846(axon extension involved in axon guidance);GO:0050919(negative chemotaxis);GO:0061549(sympathetic ganglion development);GO:0061551(trigeminal ganglion development);GO:0097374(sensory neuron axon guidance);GO:0097490(sympathetic neuron projection extension);GO:0097491(sympathetic neuron projection guidance);GO:0098978(glutamatergic synapse);GO:0099175(regulation of postsynapse organization);GO:1901166(neural crest cell migration involved in autonomic nervous system development);GO:1902285(semaphorin-plexin signaling pathway involved in neuron projection guidance);GO:1903375(facioacoustic ganglion development);GO:1904835(dorsal root ganglion morphogenesis);GO:1990830(cellular response to leukemia inhibitory factor)","NA",{"v":4e-45,"d":"0.00"},1,"181,",0,{"v":-44.4,"d":"-44.40"},{"v":-43.1,"d":"-43.10"},1.73,"3' UTR",2,46807835,46899151,91317,2]
["chr2",47020848,47021147,300,"ENSBGRG00000011721","ENSBGRT00000021352",797270,"PARD3B","par-3 family cell polarity regulator beta [Source:HGNC Symbol;Acc:HGNC:14446]","GO:0005515(protein binding);GO:0030054(cell junction);GO:0032991(protein-containing complex)","04080(Neuroactive ligand-receptor interaction);04144(Endocytosis);04520(Adherens junction);04530(Tight junction)",{"v":6.3e-36,"d":"0.00"},1,"300,",0,{"v":-35.2,"d":"-35.20"},-34,{"v":2.6,"d":"2.60"},"3' UTR",2,47016160,47818417,802258,2]
["chr2",47262153,47386601,124449,"ENSBGRG00000012209","ENSBGRT00000022312",0,"ENSBGRG00000012209","NA","NA","NA",{"v":2e-37,"d":"0.00"},2,"58,123,","0,124326",{"v":-36.7,"d":"-36.70"},{"v":-35.6,"d":"-35.60"},3.17,"Exon (ENSBGRT00000022312/ENSBGRG00000012209, exon 1 of 1)",2,47363259,47364296,1038,1]
["chr2",47387653,47387834,182,"ENSBGRG00000011721","ENSBGRT00000021352",430583,"PARD3B","par-3 family cell polarity regulator beta [Source:HGNC Symbol;Acc:HGNC:14446]","GO:0005515(protein binding);GO:0030054(cell junction);GO:0032991(protein-containing complex)","04080(Neuroactive ligand-receptor interaction);04144(Endocytosis);04520(Adherens junction);04530(Tight junction)",{"v":7.9e-18,"d":"0.00"},2,"50,130,","0,52",{"v":-17.1,"d":"-17.10"},{"v":-16.1,"d":"-16.10"},3.71,"Exon (ENSBGRT00000021620/ENSBGRG00000011721, exon 18 of 23)",2,47016160,47818417,802258,2]
["chr2",48960330,48960658,329,"ENSBGRG00000012246","ENSBGRT00000022449",44411,"ICOS","inducible T cell costimulator [Source:HGNC Symbol;Acc:HGNC:5351]","GO:0005887(integral component of plasma membrane);GO:0009897(external side of plasma membrane);GO:0031295(T cell costimulation)","04514(Cell adhesion molecules (CAMs));04660(T cell receptor signaling pathway);04672(Intestinal immune network for IgA production);05340(Primary immunodeficiency)",{"v":0.015,"d":"0.02"},1,"329,",0,-1.83,-1.02,8.64,"3' UTR",2,48960121,49005069,44949,2]
["chr2",49946142,49948513,2372,"ENSBGRG00000016286","ENSBGRT00000030540",39713,"CARF","calcium responsive transcription factor [Source:HGNC Symbol;Acc:HGNC:14435]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001652(granular component);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0035865(cellular response to potassium ion);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051090(regulation of DNA-binding transcription factor activity);GO:0061400(positive regulation of transcription from RNA polymerase II promoter in response to calcium ion);GO:0071277(cellular response to calcium ion)","NA",{"v":1.6E-47,"d":"0.00"},2,"66,323,","0,2049",{"v":-46.8,"d":"-46.80"},{"v":-45.5,"d":"-45.50"},5.97,"Exon (ENSBGRT00000030540/ENSBGRG00000016286, exon 13 of 14)",2,49945395,49988226,42832,2]
["chr2",50107828,50107978,151,"ENSBGRG00000017110","ENSBGRT00000031543",73419,"FAM117B","family with sequence similarity 117 member B [Source:HGNC Symbol;Acc:HGNC:14440]","NA","NA",{"v":2.5e-16,"d":"0.00"},1,"151,",0,{"v":-15.6,"d":"-15.60"},{"v":-14.6,"d":"-14.60"},2.38,"Exon (ENSBGRT00000031543/ENSBGRG00000017110, exon 8 of 8)",2,50107828,50181397,73570,2]
["chr2",50233472,50235443,1972,"ENSBGRG00000017354","ENSBGRT00000031845",155502,"BMPR2","bone morphogenetic protein receptor type 2 [Source:HGNC Symbol;Acc:HGNC:1078]","GO:0001707(mesoderm formation);GO:0001893(maternal placenta development);GO:0001935(endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001946(lymphangiogenesis);GO:0001974(blood vessel remodeling);GO:0002063(chondrocyte development);GO:0003085(negative regulation of systemic arterial blood pressure);GO:0003148(outflow tract septum morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0003176(aortic valve development);GO:0003177(pulmonary valve development);GO:0003183(mitral valve morphogenesis);GO:0003186(tricuspid valve morphogenesis);GO:0003197(endocardial cushion development);GO:0003252(negative regulation of cell proliferation involved in heart valve morphogenesis);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004675(transmembrane receptor protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0005912(adherens junction);GO:0006468(protein phosphorylation);GO:0007178(transmembrane receptor protein serine/threonine kinase signaling pathway);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0009267(cellular response to starvation);GO:0009952(anterior/posterior pattern specification);GO:0009986(cell surface);GO:0010595(positive regulation of endothelial cell migration);GO:0010634(positive regulation of epithelial cell migration);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0014069(postsynaptic density);GO:0014916(regulation of lung blood pressure);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030308(negative regulation of cell growth);GO:0030501(positive regulation of bone mineralization);GO:0030509(BMP signaling pathway);GO:0030513(positive regulation of BMP signaling pathway);GO:0036122(BMP binding);GO:0038023(signaling receptor activity);GO:0042127(regulation of cell population proliferation);GO:0043235(receptor complex);GO:0045296(cadherin binding);GO:0045669(positive regulation of osteoblast differentiation);GO:0045778(positive regulation of ossification);GO:0045906(negative regulation of vasoconstriction);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048286(lung alveolus development);GO:0048842(positive regulation of axon extension involved in axon guidance);GO:0060173(limb development);GO:0060412(ventricular septum morphogenesis);GO:0060413(atrial septum morphogenesis);GO:0060836(lymphatic endothelial cell differentiation);GO:0060840(artery development);GO:0060841(venous blood vessel development);GO:0061298(retina vasculature development in camera-type eye);GO:0061626(pharyngeal arch artery morphogenesis);GO:0071773(cellular response to BMP stimulus);GO:0072577(endothelial cell apoptotic process);GO:0098821(BMP receptor activity);GO:1902731(negative regulation of chondrocyte proliferation);GO:1905314(semi-lunar valve development);GO:1990782(protein tyrosine kinase binding);GO:2000279(negative regulation of DNA biosynthetic process)","04350(TGF-beta signaling pathway);04390(Hippo signaling pathway);04060(Cytokine-cytokine receptor interaction);04550(Signaling pathways regulating pluripotency of stem cells);04360(Axon guidance);05206(MicroRNAs in cancer);05418(Fluid shear stress and atherosclerosis)",{"v":4e-44,"d":"0.00"},2,"396,322,","0,1650",{"v":-43.4,"d":"-43.40"},{"v":-42.2,"d":"-42.20"},5.16,"3' UTR",2,50232785,50390945,158161,2]
["chr2",50446441,50450930,4490,"ENSBGRG00000017588","ENSBGRT00000032506",21651,"NOP58","NOP58 ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:29926]","GO:0001094(TFIID-class transcription factor complex binding);GO:0001650(fibrillar center);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005732(small nucleolar ribonucleoprotein complex);GO:0005829(cytosol);GO:0015030(Cajal body);GO:0030515(snoRNA binding);GO:0048254(snoRNA localization);GO:0051117(ATPase binding);GO:0070761(pre-snoRNP complex)","03008(Ribosome biogenesis in eukaryotes)",0,5,"21,131,12,134,27,","0,423,578,2505,4463",-466,"-Inf",3.76,"Exon (ENSBGRT00000032506/ENSBGRG00000017588, exon 12 of 16)",2,50446411,50472581,26171,2]
["chr2",50529005,50533245,4241,"ENSBGRG00000017875","ENSBGRT00000032785",33442,"ENSBGRG00000017875","NA","GO:0005515(protein binding)","03013(RNA transport);05418(Fluid shear stress and atherosclerosis)",{"v":0.0041,"d":"0.00"},4,"139,220,173,128,","0,2032,2963,4113",-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000033218/ENSBGRG00000018013, exon 19 of 22)",2,50495563,50565374,69812,1]
["chr2",50720245,50720513,269,"ENSBGRG00000018191","ENSBGRT00000033257",416,"FZD7","frizzled class receptor 7 [Source:HGNC Symbol;Acc:HGNC:4045]","GO:0004888(transmembrane signaling receptor activity);GO:0005109(frizzled binding);GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0007166(cell surface receptor signaling pathway);GO:0010812(negative regulation of cell-substrate adhesion);GO:0014834(skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0019827(stem cell population maintenance);GO:0030165(PDZ domain binding);GO:0033077(T cell differentiation in thymus);GO:0034446(substrate adhesion-dependent cell spreading);GO:0035567(non-canonical Wnt signaling pathway);GO:0038031(non-canonical Wnt signaling pathway via JNK cascade);GO:0042327(positive regulation of phosphorylation);GO:0042666(negative regulation of ectodermal cell fate specification);GO:0042813(Wnt-activated receptor activity);GO:0043231(intracellular membrane-bounded organelle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0048103(somatic stem cell division);GO:0055038(recycling endosome membrane);GO:0060054(positive regulation of epithelial cell proliferation involved in wound healing);GO:0060070(canonical Wnt signaling pathway);GO:0060231(mesenchymal to epithelial transition);GO:0060828(regulation of canonical Wnt signaling pathway);GO:2000726(negative regulation of cardiac muscle cell differentiation)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":7.9e-12,"d":"0.00"},1,"269,",0,{"v":-11.1,"d":"-11.10"},{"v":-10.3,"d":"-10.30"},5.13,"Exon (ENSBGRT00000033257/ENSBGRG00000018191, exon 1 of 1)",2,50719205,50720929,1725,2]
["chr2",51631591,51631799,209,"ENSBGRG00000022578","ENSBGRT00000041790",36069,"CFLAR","CASP8 and FADD like apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:1876]","GO:0002020(protease binding);GO:0004197(cysteine-type endopeptidase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0007519(skeletal muscle tissue development);GO:0008047(enzyme activator activity);GO:0008234(cysteine-type peptidase activity);GO:0009617(response to bacterium);GO:0014732(skeletal muscle atrophy);GO:0014842(regulation of skeletal muscle satellite cell proliferation);GO:0014866(skeletal myofibril assembly);GO:0016504(peptidase activator activity);GO:0031264(death-inducing signaling complex);GO:0042060(wound healing);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043403(skeletal muscle tissue regeneration);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0060544(regulation of necroptotic process);GO:0060546(negative regulation of necroptotic process);GO:0097342(ripoptosome);GO:1901740(negative regulation of myoblast fusion);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04217(Necroptosis);05142(Chagas disease (American trypanosomiasis))",{"v":2e-21,"d":"0.00"},1,"209,",0,{"v":-20.7,"d":"-20.70"},{"v":-19.6,"d":"-19.60"},1.59,"3' UTR",2,51630818,51667868,37051,2]
["chr2",51632067,51634703,2637,"ENSBGRG00000022578","ENSBGRT00000041790",33165,"CFLAR","CASP8 and FADD like apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:1876]","GO:0002020(protease binding);GO:0004197(cysteine-type endopeptidase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0007519(skeletal muscle tissue development);GO:0008047(enzyme activator activity);GO:0008234(cysteine-type peptidase activity);GO:0009617(response to bacterium);GO:0014732(skeletal muscle atrophy);GO:0014842(regulation of skeletal muscle satellite cell proliferation);GO:0014866(skeletal myofibril assembly);GO:0016504(peptidase activator activity);GO:0031264(death-inducing signaling complex);GO:0042060(wound healing);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043403(skeletal muscle tissue regeneration);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0060544(regulation of necroptotic process);GO:0060546(negative regulation of necroptotic process);GO:0097342(ripoptosome);GO:1901740(negative regulation of myoblast fusion);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04217(Necroptosis);05142(Chagas disease (American trypanosomiasis))",{"v":3.2e-86,"d":"0.00"},2,"72,286,","0,2351",{"v":-85.5,"d":"-85.50"},-84,4.24,"Exon (ENSBGRT00000041790/ENSBGRG00000022578, exon 8 of 9)",2,51630818,51667868,37051,2]
["chr2",51667630,51667868,239,"ENSBGRG00000022578","ENSBGRT00000041790",0,"CFLAR","CASP8 and FADD like apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:1876]","GO:0002020(protease binding);GO:0004197(cysteine-type endopeptidase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0007519(skeletal muscle tissue development);GO:0008047(enzyme activator activity);GO:0008234(cysteine-type peptidase activity);GO:0009617(response to bacterium);GO:0014732(skeletal muscle atrophy);GO:0014842(regulation of skeletal muscle satellite cell proliferation);GO:0014866(skeletal myofibril assembly);GO:0016504(peptidase activator activity);GO:0031264(death-inducing signaling complex);GO:0042060(wound healing);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043403(skeletal muscle tissue regeneration);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0060544(regulation of necroptotic process);GO:0060546(negative regulation of necroptotic process);GO:0097342(ripoptosome);GO:1901740(negative regulation of myoblast fusion);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04217(Necroptosis);05142(Chagas disease (American trypanosomiasis))",{"v":1E-161,"d":"0.00"},1,"239,",0,-161,-159,8.12,"5' UTR",2,51630818,51667868,37051,2]
["chr2",51875625,51875924,300,"ENSBGRG00000022968","ENSBGRT00000042476",20,"NIF3L1","NGG1 interacting factor 3 like 1 [Source:HGNC Symbol;Acc:HGNC:13390]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008134(transcription factor binding);GO:0030182(neuron differentiation);GO:0042802(identical protein binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:1903507(negative regulation of nucleic acid-templated transcription)","NA",{"v":5e-33,"d":"0.00"},1,"300,",0,{"v":-32.3,"d":"-32.30"},{"v":-31.2,"d":"-31.20"},4.32,"5' UTR",2,51858070,51875944,17875,2]
["chr2",52377665,52378053,389,"ENSBGRG00000026677","ENSBGRT00000049447",12255,"SGO2","shugoshin 2 [Source:HGNC Symbol;Acc:HGNC:30812]","GO:0000775(chromosome, centromeric region);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0030892(mitotic cohesin complex);GO:0051754(meiotic sister chromatid cohesion, centromeric)","NA",{"v":7.9e-38,"d":"0.00"},1,"389,",0,{"v":-37.1,"d":"-37.10"},{"v":-35.9,"d":"-35.90"},4.16,"Exon (ENSBGRT00000049447/ENSBGRG00000026677, exon 6 of 8)",2,52371655,52390308,18654,2]
["chr2",52378620,52379097,478,"ENSBGRG00000026677","ENSBGRT00000049447",11211,"SGO2","shugoshin 2 [Source:HGNC Symbol;Acc:HGNC:30812]","GO:0000775(chromosome, centromeric region);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0030892(mitotic cohesin complex);GO:0051754(meiotic sister chromatid cohesion, centromeric)","NA",{"v":6.3e-28,"d":"0.00"},1,"478,",0,{"v":-27.2,"d":"-27.20"},{"v":-26.1,"d":"-26.10"},4.38,"Exon (ENSBGRT00000049447/ENSBGRG00000026677, exon 6 of 8)",2,52371655,52390308,18654,2]
["chr2",53005334,53005540,207,"ENSBGRG00000026693","ENSBGRT00000049482",0,"MAIP1","matrix AAA peptidase interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:26198]","GO:0005759(mitochondrial matrix);GO:0036444(calcium import into the mitochondrion);GO:0051204(protein insertion into mitochondrial membrane);GO:0051560(mitochondrial calcium ion homeostasis)","NA",{"v":0.044,"d":"0.04"},1,"207,",0,-1.36,{"v":-0.841,"d":"-0.84"},3.24,"5' UTR",2,52961841,53005540,43700,2]
["chr2",53035844,53035903,60,"ENSBGRG00000026697","ENSBGRT00000049492",30907,"TYW5","tRNA-yW synthesizing protein 5 [Source:HGNC Symbol;Acc:HGNC:26754]","GO:0000049(tRNA binding);GO:0005506(iron ion binding);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0031591(wybutosine biosynthetic process);GO:0042803(protein homodimerization activity)","NA",{"v":6.3E-29,"d":"0.00"},1,"60,",0,{"v":-28.2,"d":"-28.20"},{"v":-27.1,"d":"-27.10"},6.04,"Exon (ENSBGRT00000049506/ENSBGRG00000026703, exon 2 of 4)",2,53004937,53054984,50048,1]
["chr2",54989908,54990027,120,"ENSBGRG00000000210","ENSBGRT00000000342",382680,"PLCL1","phospholipase C like 1 (inactive) [Source:HGNC Symbol;Acc:HGNC:9063]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","04727(GABAergic synapse)",{"v":1.1E-4,"d":"0.00"},1,"120,",0,-3.96,-3.28,2.01,"3' UTR",2,54989848,55372707,382860,2]
["chr2",55065898,55066437,540,"ENSBGRG00000000210","ENSBGRT00000000342",306270,"PLCL1","phospholipase C like 1 (inactive) [Source:HGNC Symbol;Acc:HGNC:9063]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","04727(GABAergic synapse)",{"v":1.3e-16,"d":"0.00"},1,"540,",0,{"v":-15.9,"d":"-15.90"},-15,7.02,"Exon (ENSBGRT00000000342/ENSBGRG00000000210, exon 2 of 6)",2,54989848,55372707,382860,2]
["chr2",55066676,55067364,689,"ENSBGRG00000000210","ENSBGRT00000000342",305343,"PLCL1","phospholipase C like 1 (inactive) [Source:HGNC Symbol;Acc:HGNC:9063]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","04727(GABAergic synapse)",{"v":3.2e-11,"d":"0.00"},1,"689,",0,{"v":-10.5,"d":"-10.50"},-9.64,4.49,"Exon (ENSBGRT00000000342/ENSBGRG00000000210, exon 2 of 6)",2,54989848,55372707,382860,2]
["chr2",55067573,55067633,61,"ENSBGRG00000000210","ENSBGRT00000000342",305074,"PLCL1","phospholipase C like 1 (inactive) [Source:HGNC Symbol;Acc:HGNC:9063]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","04727(GABAergic synapse)",{"v":3.5e-08,"d":"0.00"},1,"61,",0,-7.46,-6.67,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000000342/ENSBGRG00000000210, exon 2 of 6)",2,54989848,55372707,382860,2]
["chr2",55372498,55372707,210,"ENSBGRG00000000210","ENSBGRT00000000342",0,"PLCL1","phospholipase C like 1 (inactive) [Source:HGNC Symbol;Acc:HGNC:9063]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","04727(GABAergic synapse)",{"v":0.028,"d":"0.03"},1,"210,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000000342/ENSBGRG00000000210, exon 1 of 6)",2,54989848,55372707,382860,2]
["chr2",56439348,56440116,769,"ENSBGRG00000001090","ENSBGRT00000002365",18459,"CCDC150","coiled-coil domain containing 150 [Source:HGNC Symbol;Acc:HGNC:26834]","NA","NA",{"v":3.2e-21,"d":"0.00"},3,"6,69,165,","0,96,604",{"v":-20.5,"d":"-20.50"},{"v":-19.5,"d":"-19.50"},2.85,"Exon (ENSBGRT00000002365/ENSBGRG00000001090, exon 7 of 12)",2,56431570,56458575,27006,2]
["chr2",56450246,56458363,8118,"ENSBGRG00000001090","ENSBGRT00000002365",212,"CCDC150","coiled-coil domain containing 150 [Source:HGNC Symbol;Acc:HGNC:26834]","NA","NA",{"v":0.00045,"d":"0.00"},2,"65,115,","0,8003",-3.35,{"v":-2.7,"d":"-2.70"},2.38,"Exon (ENSBGRT00000002365/ENSBGRG00000001090, exon 1 of 12)",2,56431570,56458575,27006,2]
["chr2",57467145,57467293,149,"ENSBGRG00000001456","ENSBGRT00000002661",54935,"SLC39A10","solute carrier family 39 member 10 [Source:HGNC Symbol;Acc:HGNC:20861]","GO:0016020(membrane);GO:0030001(metal ion transport);GO:0046873(metal ion transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":0.025,"d":"0.03"},1,"149,",0,-1.61,-1.07,4.86,"Exon (ENSBGRT00000002686/ENSBGRG00000001456, exon 10 of 10)",2,57466305,57522228,55924,2]
["chr2",57504333,57504571,239,"ENSBGRG00000001456","ENSBGRT00000002661",17657,"SLC39A10","solute carrier family 39 member 10 [Source:HGNC Symbol;Acc:HGNC:20861]","GO:0016020(membrane);GO:0030001(metal ion transport);GO:0046873(metal ion transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":5e-22,"d":"0.00"},1,"239,",0,{"v":-21.3,"d":"-21.30"},{"v":-20.2,"d":"-20.20"},4.37,"Exon (ENSBGRT00000002661/ENSBGRG00000001456, exon 2 of 10)",2,57466305,57522228,55924,2]
["chr2",62865042,62865102,61,"ENSBGRG00000001930","ENSBGRT00000003791",0,"GLS","glutaminase [Source:HGNC Symbol;Acc:HGNC:4331]","GO:0004359(glutaminase activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0006537(glutamate biosynthetic process);GO:0006541(glutamine metabolic process);GO:0006543(glutamine catabolic process);GO:0051289(protein homotetramerization);GO:0090461(glutamate homeostasis)","00250(Alanine, aspartate and glutamate metabolism);00220(Arginine biosynthesis);00471(D-Glutamine and D-glutamate metabolism);04964(Proximal tubule bicarbonate reclamation);04724(Glutamatergic synapse);04727(GABAergic synapse);05230(Central carbon metabolism in cancer);05206(MicroRNAs in cancer)",{"v":6.3E-7,"d":"0.00"},1,"61,",0,{"v":-6.2,"d":"-6.20"},-5.45,{"v":24.8,"d":"24.80"},"Exon (ENSBGRT00000003791/ENSBGRG00000001930, exon 1 of 18)",2,62771656,62865102,93447,2]
["chr2",63415704,63415794,91,"ENSBGRG00000002155","ENSBGRT00000004020",53403,"ENSBGRG00000002155","NA","NA","05144(Malaria)",{"v":5.1E-5,"d":"0.00"},1,"91,",0,-4.29,-3.59,2.16,"Exon (ENSBGRT00000004020/ENSBGRG00000002155, exon 4 of 5)",2,63400227,63469197,68971,2]
["chr2",63415853,63416003,151,"ENSBGRG00000002155","ENSBGRT00000004020",53194,"ENSBGRG00000002155","NA","NA","05144(Malaria)",{"v":1.6E-34,"d":"0.00"},1,"151,",0,{"v":-33.8,"d":"-33.80"},{"v":-32.6,"d":"-32.60"},1.77,"Exon (ENSBGRT00000004020/ENSBGRG00000002155, exon 4 of 5)",2,63400227,63469197,68971,2]
["chr2",65421080,65421578,499,"ENSBGRG00000002176","ENSBGRT00000004090",1285,"ENSBGRG00000002176","NA","GO:0006457(protein folding);GO:0031072(heat shock protein binding);GO:0051082(unfolded protein binding)","04141(Protein processing in endoplasmic reticulum)",{"v":0.015,"d":"0.02"},2,"21,127,","0,372",-1.83,-1.02,8.64,"Exon (ENSBGRT00000004090/ENSBGRG00000002176, exon 4 of 5)",2,65421080,65422863,1784,2]
["chr2",70142720,70143139,420,"ENSBGRG00000002594","ENSBGRT00000004882",229586,"GLI2","GLI family zinc finger 2 [Source:HGNC Symbol;Acc:HGNC:4318]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0001649(osteoblast differentiation);GO:0001701(in utero embryonic development);GO:0001822(kidney development);GO:0002009(morphogenesis of an epithelium);GO:0002062(chondrocyte differentiation);GO:0002076(osteoblast development);GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005929(cilium);GO:0005930(axoneme);GO:0007224(smoothened signaling pathway);GO:0007389(pattern specification process);GO:0007411(axon guidance);GO:0007418(ventral midline development);GO:0007442(hindgut morphogenesis);GO:0007507(heart development);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0009952(anterior/posterior pattern specification);GO:0009953(dorsal/ventral pattern formation);GO:0009954(proximal/distal pattern formation);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0021508(floor plate formation);GO:0021513(spinal cord dorsal/ventral patterning);GO:0021517(ventral spinal cord development);GO:0021522(spinal cord motor neuron differentiation);GO:0021696(cerebellar cortex morphogenesis);GO:0021775(smoothened signaling pathway involved in ventral spinal cord interneuron specification);GO:0021776(smoothened signaling pathway involved in spinal cord motor neuron cell fate specification);GO:0021904(dorsal/ventral neural tube patterning);GO:0021915(neural tube development);GO:0021938(smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation);GO:0021965(spinal cord ventral commissure morphogenesis);GO:0021983(pituitary gland development);GO:0030154(cell differentiation);GO:0030324(lung development);GO:0030879(mammary gland development);GO:0030902(hindbrain development);GO:0031069(hair follicle morphogenesis);GO:0031514(motile cilium);GO:0032331(negative regulation of chondrocyte differentiation);GO:0035295(tube development);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042733(embryonic digit morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045666(positive regulation of neuron differentiation);GO:0045740(positive regulation of DNA replication);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048566(embryonic digestive tract development);GO:0048589(developmental growth);GO:0048646(anatomical structure formation involved in morphogenesis);GO:0048666(neuron development);GO:0048754(branching morphogenesis of an epithelial tube);GO:0048856(anatomical structure development);GO:0060032(notochord regression);GO:0060322(head development);GO:0060513(prostatic bud formation);GO:0060603(mammary gland duct morphogenesis);GO:0060831(smoothened signaling pathway involved in dorsal/ventral neural tube patterning);GO:0071407(cellular response to organic cyclic compound);GO:0090103(cochlea morphogenesis);GO:0097542(ciliary tip);GO:1901620(regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990841(promoter-specific chromatin binding)","04340(Hedgehog signaling pathway);04390(Hippo signaling pathway);05200(Pathways in cancer);05217(Basal cell carcinoma)",{"v":1E-205,"d":"0.00"},1,"420,",0,-205,-203,4.39,"3' UTR",2,70142720,70372725,230006,2]
["chr2",70143768,70144278,511,"ENSBGRG00000002594","ENSBGRT00000004882",228447,"GLI2","GLI family zinc finger 2 [Source:HGNC Symbol;Acc:HGNC:4318]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0001649(osteoblast differentiation);GO:0001701(in utero embryonic development);GO:0001822(kidney development);GO:0002009(morphogenesis of an epithelium);GO:0002062(chondrocyte differentiation);GO:0002076(osteoblast development);GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005929(cilium);GO:0005930(axoneme);GO:0007224(smoothened signaling pathway);GO:0007389(pattern specification process);GO:0007411(axon guidance);GO:0007418(ventral midline development);GO:0007442(hindgut morphogenesis);GO:0007507(heart development);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0009952(anterior/posterior pattern specification);GO:0009953(dorsal/ventral pattern formation);GO:0009954(proximal/distal pattern formation);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0021508(floor plate formation);GO:0021513(spinal cord dorsal/ventral patterning);GO:0021517(ventral spinal cord development);GO:0021522(spinal cord motor neuron differentiation);GO:0021696(cerebellar cortex morphogenesis);GO:0021775(smoothened signaling pathway involved in ventral spinal cord interneuron specification);GO:0021776(smoothened signaling pathway involved in spinal cord motor neuron cell fate specification);GO:0021904(dorsal/ventral neural tube patterning);GO:0021915(neural tube development);GO:0021938(smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation);GO:0021965(spinal cord ventral commissure morphogenesis);GO:0021983(pituitary gland development);GO:0030154(cell differentiation);GO:0030324(lung development);GO:0030879(mammary gland development);GO:0030902(hindbrain development);GO:0031069(hair follicle morphogenesis);GO:0031514(motile cilium);GO:0032331(negative regulation of chondrocyte differentiation);GO:0035295(tube development);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042733(embryonic digit morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045666(positive regulation of neuron differentiation);GO:0045740(positive regulation of DNA replication);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048566(embryonic digestive tract development);GO:0048589(developmental growth);GO:0048646(anatomical structure formation involved in morphogenesis);GO:0048666(neuron development);GO:0048754(branching morphogenesis of an epithelial tube);GO:0048856(anatomical structure development);GO:0060032(notochord regression);GO:0060322(head development);GO:0060513(prostatic bud formation);GO:0060603(mammary gland duct morphogenesis);GO:0060831(smoothened signaling pathway involved in dorsal/ventral neural tube patterning);GO:0071407(cellular response to organic cyclic compound);GO:0090103(cochlea morphogenesis);GO:0097542(ciliary tip);GO:1901620(regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990841(promoter-specific chromatin binding)","04340(Hedgehog signaling pathway);04390(Hippo signaling pathway);05200(Pathways in cancer);05217(Basal cell carcinoma)",{"v":9.99999999999998e-248,"d":"0.00"},1,"511,",0,-247,-245,7.19,"Exon (ENSBGRT00000004882/ENSBGRG00000002594, exon 15 of 15)",2,70142720,70372725,230006,2]
["chr2",70144367,70145386,1020,"ENSBGRG00000002594","ENSBGRT00000004882",227339,"GLI2","GLI family zinc finger 2 [Source:HGNC Symbol;Acc:HGNC:4318]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0001649(osteoblast differentiation);GO:0001701(in utero embryonic development);GO:0001822(kidney development);GO:0002009(morphogenesis of an epithelium);GO:0002062(chondrocyte differentiation);GO:0002076(osteoblast development);GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005929(cilium);GO:0005930(axoneme);GO:0007224(smoothened signaling pathway);GO:0007389(pattern specification process);GO:0007411(axon guidance);GO:0007418(ventral midline development);GO:0007442(hindgut morphogenesis);GO:0007507(heart development);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0009952(anterior/posterior pattern specification);GO:0009953(dorsal/ventral pattern formation);GO:0009954(proximal/distal pattern formation);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0021508(floor plate formation);GO:0021513(spinal cord dorsal/ventral patterning);GO:0021517(ventral spinal cord development);GO:0021522(spinal cord motor neuron differentiation);GO:0021696(cerebellar cortex morphogenesis);GO:0021775(smoothened signaling pathway involved in ventral spinal cord interneuron specification);GO:0021776(smoothened signaling pathway involved in spinal cord motor neuron cell fate specification);GO:0021904(dorsal/ventral neural tube patterning);GO:0021915(neural tube development);GO:0021938(smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation);GO:0021965(spinal cord ventral commissure morphogenesis);GO:0021983(pituitary gland development);GO:0030154(cell differentiation);GO:0030324(lung development);GO:0030879(mammary gland development);GO:0030902(hindbrain development);GO:0031069(hair follicle morphogenesis);GO:0031514(motile cilium);GO:0032331(negative regulation of chondrocyte differentiation);GO:0035295(tube development);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042733(embryonic digit morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045666(positive regulation of neuron differentiation);GO:0045740(positive regulation of DNA replication);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048566(embryonic digestive tract development);GO:0048589(developmental growth);GO:0048646(anatomical structure formation involved in morphogenesis);GO:0048666(neuron development);GO:0048754(branching morphogenesis of an epithelial tube);GO:0048856(anatomical structure development);GO:0060032(notochord regression);GO:0060322(head development);GO:0060513(prostatic bud formation);GO:0060603(mammary gland duct morphogenesis);GO:0060831(smoothened signaling pathway involved in dorsal/ventral neural tube patterning);GO:0071407(cellular response to organic cyclic compound);GO:0090103(cochlea morphogenesis);GO:0097542(ciliary tip);GO:1901620(regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990841(promoter-specific chromatin binding)","04340(Hedgehog signaling pathway);04390(Hippo signaling pathway);05200(Pathways in cancer);05217(Basal cell carcinoma)",{"v":1e-199,"d":"0.00"},1,"1020,",0,-199,-197,7.87,"Exon (ENSBGRT00000004882/ENSBGRG00000002594, exon 15 of 15)",2,70142720,70372725,230006,2]
["chr2",81146045,81146553,509,"ENSBGRG00000000590","ENSBGRT00000001038",6461,"ENSBGRG00000000590","NA","NA","NA",{"v":7.6e-05,"d":"0.00"},1,"509,",0,-4.12,-3.43,{"v":17.3,"d":"17.30"},"Exon (ENSBGRT00000001038/ENSBGRG00000000590, exon 2 of 2)",2,81146045,81153014,6970,2]
["chr2",102334776,102335496,721,"ENSBGRG00000015929","ENSBGRT00000029274",0,"PRPF40A","pre-mRNA processing factor 40 homolog A [Source:HGNC Symbol;Acc:HGNC:16463]","GO:0005515(protein binding);GO:0045292(mRNA cis splicing, via spliceosome)","03040(Spliceosome)",{"v":0.0011,"d":"0.00"},2,"396,84,","0,637",-2.96,-2.33,13,"5' UTR",2,102273201,102335496,62296,2]
["chr2",109530540,109531713,1174,"ENSBGRG00000010962","ENSBGRT00000020067",239111,"BAZ2B","bromodomain adjacent to zinc finger domain 2B [Source:HGNC Symbol;Acc:HGNC:963]","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0042025(host cell nucleus)","NA",{"v":0.014,"d":"0.01"},3,"62,345,133,","0,379,1041",-1.86,{"v":-1.3,"d":"-1.30"},{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000020067/ENSBGRG00000010962, exon 7 of 37)",2,109407784,109770824,363041,2]
["chr2",120846109,120846986,878,"ENSBGRG00000006676","ENSBGRT00000012309",16441,"CCDC173","coiled-coil domain containing 173 [Source:HGNC Symbol;Acc:HGNC:25064]","NA","NA",{"v":1.6E-11,"d":"0.00"},2,"34,175,","0,703",{"v":-10.8,"d":"-10.80"},-9.92,4.32,"Exon (ENSBGRT00000012309/ENSBGRG00000006676, exon 7 of 9)",2,120838971,120863427,24457,2]
["chr2",128995066,128996835,1770,"ENSBGRG00000000256","ENSBGRT00000000402",744,"ENSBGRG00000000256","NA","GO:0005515(protein binding)","NA",{"v":4.8E-8,"d":"0.00"},2,"53,543,","0,1227",-7.32,-6.53,8.64,"Exon (ENSBGRT00000000402/ENSBGRG00000000256, exon 1 of 2)",2,128994411,128997579,3169,2]
["chr2",144216395,144217064,670,"ENSBGRG00000000849","ENSBGRT00000004305",39237,"BIN1","bridging integrator 1 [Source:HGNC Symbol;Acc:HGNC:1052]","GO:0002020(protease binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006997(nucleus organization);GO:0008333(endosome to lysosome transport);GO:0016020(membrane);GO:0019828(aspartic-type endopeptidase inhibitor activity);GO:0030100(regulation of endocytosis);GO:0030424(axon);GO:0033292(T-tubule organization);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0045664(regulation of neuron differentiation);GO:0048156(tau protein binding);GO:0048711(positive regulation of astrocyte differentiation);GO:0051015(actin filament binding);GO:0051087(chaperone binding);GO:0060987(lipid tube);GO:0060988(lipid tube assembly);GO:0070063(RNA polymerase binding);GO:0071156(regulation of cell cycle arrest);GO:1902430(negative regulation of amyloid-beta formation);GO:1902960(negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process)","04144(Endocytosis);04666(Fc gamma R-mediated phagocytosis)",{"v":9.8e-06,"d":"0.00"},2,"42,48,","0,622",-5.01,-4.29,{"v":20.5,"d":"20.50"},"Exon (ENSBGRT00000004305/ENSBGRG00000000849, exon 4 of 21)",2,144195346,144256301,60956,2]
["chr2",145144653,145144861,209,"ENSBGRG00000003509","ENSBGRT00000006534",15869,"POLR2D","RNA polymerase II subunit D [Source:HGNC Symbol;Acc:HGNC:9191]","GO:0000166(nucleotide binding);GO:0003824(catalytic activity);GO:0003899(DNA-directed 5'-3' RNA polymerase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005665(RNA polymerase II, core complex);GO:0005829(cytosol);GO:0006352(DNA-templated transcription, initiation);GO:0006366(transcription by RNA polymerase II);GO:0016607(nuclear speck);GO:0030880(RNA polymerase complex);GO:0044237(cellular metabolic process)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);05016(Huntington disease);05169(Epstein-Barr virus infection)",{"v":1e-80,"d":"0.00"},1,"209,",0,-80,{"v":-78.5,"d":"-78.50"},4.12,"3' UTR",2,145143434,145160730,17297,2]
["chr3",935366,935485,120,"ENSBGRG00000008129","ENSBGRT00000014846",57887,"IL6R","interleukin 6 receptor [Source:HGNC Symbol;Acc:HGNC:6019]","GO:0004896(cytokine receptor activity);GO:0004897(ciliary neurotrophic factor receptor activity);GO:0004915(interleukin-6 receptor activity);GO:0005138(interleukin-6 receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005896(interleukin-6 receptor complex);GO:0008284(positive regulation of cell population proliferation);GO:0010573(vascular endothelial growth factor production);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0019899(enzyme binding);GO:0019981(interleukin-6 binding);GO:0031018(endocrine pancreas development);GO:0032722(positive regulation of chemokine production);GO:0032755(positive regulation of interleukin-6 production);GO:0034097(response to cytokine);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042803(protein homodimerization activity);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0070102(interleukin-6-mediated signaling pathway);GO:0070110(ciliary neurotrophic factor receptor complex);GO:0070119(ciliary neurotrophic factor binding);GO:0070120(ciliary neurotrophic factor-mediated signaling pathway);GO:0072126(positive regulation of glomerular mesangial cell proliferation);GO:0072540(T-helper 17 cell lineage commitment)","04630(Jak-STAT signaling pathway);04066(HIF-1 signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage);04659(Th17 cell differentiation);05200(Pathways in cancer);04932(Non-alcoholic fatty liver disease (NAFLD));05163(Human cytomegalovirus infection);01521(EGFR tyrosine kinase inhibitor resistance)",{"v":1.6e-22,"d":"0.00"},1,"120,",0,{"v":-21.8,"d":"-21.80"},{"v":-20.8,"d":"-20.80"},4.18,"Exon (ENSBGRT00000014846/ENSBGRG00000008129, exon 10 of 10)",3,877479,935485,58007,1]
["chr3",2338543,2338661,119,"ENSBGRG00000021562","ENSBGRT00000039767",6216,"SYT11","synaptotagmin 11 [Source:HGNC Symbol;Acc:HGNC:19239]","GO:0000149(SNARE binding);GO:0001778(plasma membrane repair);GO:0001891(phagocytic cup);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005802(trans-Golgi network);GO:0005887(integral component of plasma membrane);GO:0006914(autophagy);GO:0007612(learning);GO:0007613(memory);GO:0009611(response to wounding);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0030425(dendrite);GO:0031369(translation initiation factor binding);GO:0031625(ubiquitin protein ligase binding);GO:0031982(vesicle);GO:0032009(early phagosome);GO:0032715(negative regulation of interleukin-6 production);GO:0033602(negative regulation of dopamine secretion);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0045335(phagocytic vesicle);GO:0045806(negative regulation of endocytosis);GO:0048487(beta-tubulin binding);GO:0050710(negative regulation of cytokine secretion);GO:0050765(negative regulation of phagocytosis);GO:0051650(establishment of vesicle localization);GO:0055037(recycling endosome);GO:1900424(regulation of defense response to bacterium);GO:1903979(negative regulation of microglial cell activation);GO:1904468(negative regulation of tumor necrosis factor secretion);GO:1905171(positive regulation of protein localization to phagocytic vesicle);GO:1990927(calcium ion regulated lysosome exocytosis)","NA",{"v":4e-13,"d":"0.00"},1,"119,",0,{"v":-12.4,"d":"-12.40"},{"v":-11.5,"d":"-11.50"},2.55,"Exon (ENSBGRT00000039767/ENSBGRG00000021562, exon 2 of 4)",3,2332327,2350927,18601,1]
["chr3",9169658,9170134,477,"ENSBGRG00000001124","ENSBGRT00000002108",2905,"PPOX","protoporphyrinogen oxidase [Source:HGNC Symbol;Acc:HGNC:9280]","GO:0004729(oxygen-dependent protoporphyrinogen oxidase activity);GO:0006779(porphyrin-containing compound biosynthetic process);GO:0006783(heme biosynthetic process);GO:0016491(oxidoreductase activity);GO:0031304(intrinsic component of mitochondrial inner membrane);GO:0031966(mitochondrial membrane);GO:0055114(oxidation-reduction process)","00860(Porphyrin and chlorophyll metabolism)",{"v":1.6e-95,"d":"0.00"},3,"21,43,143,","0,212,334",{"v":-94.8,"d":"-94.80"},{"v":-93.2,"d":"-93.20"},2.76,"Exon (ENSBGRT00000002108/ENSBGRG00000001124, exon 10 of 12)",3,9166753,9170134,3382,1]
["chr3",15105918,15106187,270,"ENSBGRG00000003397","ENSBGRT00000006316",84249,"UCK2","uridine-cytidine kinase 2 [Source:HGNC Symbol;Acc:HGNC:12562]","GO:0005524(ATP binding);GO:0016301(kinase activity);GO:0019206(nucleoside kinase activity);GO:0042802(identical protein binding)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)",{"v":1.6e-43,"d":"0.00"},1,"270,",0,{"v":-42.8,"d":"-42.80"},{"v":-41.6,"d":"-41.60"},5.65,"3' UTR",3,15021669,15106932,85264,1]
["chr3",19219950,19220010,61,"ENSBGRG00000012500","ENSBGRT00000022865",15936,"BCL9","BCL9 transcription coactivator [Source:HGNC Symbol;Acc:HGNC:1008]","GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:0008013(beta-catenin binding);GO:0014908(myotube differentiation involved in skeletal muscle regeneration);GO:0035019(somatic stem cell population maintenance);GO:0035914(skeletal muscle cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060070(canonical Wnt signaling pathway);GO:1990907(beta-catenin-TCF complex)","NA",{"v":1e-17,"d":"0.00"},1,"61,",0,-17,{"v":-16.1,"d":"-16.10"},3.13,"Exon (ENSBGRT00000022865/ENSBGRG00000012500, exon 7 of 10)",3,19204014,19228289,24276,1]
["chr3",20645440,20646069,630,"ENSBGRG00000017135","ENSBGRT00000031424",10119,"PLEKHO1","pleckstrin homology domain containing O1 [Source:HGNC Symbol;Acc:HGNC:24310]","GO:0007520(myoblast fusion);GO:0008360(regulation of cell shape);GO:0032587(ruffle membrane);GO:0036195(muscle cell projection membrane);GO:0051451(myoblast migration);GO:0072673(lamellipodium morphogenesis)","NA",0,1,"630,",0,-581,"-Inf",6.77,"Exon (ENSBGRT00000031424/ENSBGRG00000017135, exon 6 of 6)",3,20635321,20646069,10749,1]
["chr3",21409594,21410719,1126,"ENSBGRG00000001377","ENSBGRT00000002528",21672,"SETDB1","SET domain bifurcated histone lysine methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10761]","GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0007265(Ras protein signal transduction);GO:0008270(zinc ion binding);GO:0018024(histone-lysine N-methyltransferase activity);GO:0034968(histone lysine methylation);GO:0042025(host cell nucleus);GO:0043231(intracellular membrane-bounded organelle);GO:0046974(histone methyltransferase activity (H3-K9 specific));GO:0090309(positive regulation of methylation-dependent chromatin silencing);GO:1990841(promoter-specific chromatin binding)","00310(Lysine degradation);04550(Signaling pathways regulating pluripotency of stem cells)",{"v":4e-43,"d":"0.00"},2,"459,80,","0,1046",{"v":-42.4,"d":"-42.40"},{"v":-41.2,"d":"-41.20"},2.46,"Exon (ENSBGRT00000002528/ENSBGRG00000001377, exon 13 of 22)",3,21387922,21420544,32623,1]
["chr3",22045594,22046194,601,"ENSBGRG00000002259","ENSBGRT00000004261",19393,"ENSBGRG00000002259","NA","GO:0003774(motor activity);GO:0016459(myosin complex)","04530(Tight junction)",{"v":1e-24,"d":"0.00"},2,"165,105,","0,496",-24,-23,3.18,"Exon (ENSBGRT00000004261/ENSBGRG00000002259, exon 11 of 20)",3,22026201,22052913,26713,1]
["chr3",27532116,27532206,91,"ENSBGRG00000006225","ENSBGRT00000011504",11996,"PLPPR4","phospholipid phosphatase related 4 [Source:HGNC Symbol;Acc:HGNC:23496]","GO:0005887(integral component of plasma membrane);GO:0006644(phospholipid metabolic process);GO:0007409(axonogenesis);GO:0008195(phosphatidate phosphatase activity);GO:0042577(lipid phosphatase activity);GO:0046839(phospholipid dephosphorylation);GO:0048839(inner ear development);GO:0098978(glutamatergic synapse);GO:0099061(integral component of postsynaptic density membrane)","NA",{"v":0.0026,"d":"0.00"},1,"91,",0,-2.58,-1.97,3.67,"Exon (ENSBGRT00000011504/ENSBGRG00000006225, exon 5 of 5)",3,27520120,27532386,12267,1]
["chr3",38176101,38187725,11625,"ENSBGRG00000001136","ENSBGRT00000002128",0,"SARS1","seryl-tRNA synthetase 1 [Source:HGNC Symbol;Acc:HGNC:10537]","GO:0000166(nucleotide binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004828(serine-tRNA ligase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006418(tRNA aminoacylation for protein translation);GO:0006434(seryl-tRNA aminoacylation)","00970(Aminoacyl-tRNA biosynthesis)",{"v":2.5e-29,"d":"0.00"},3,"136,71,4,","0,8416,11621",{"v":-28.6,"d":"-28.60"},{"v":-27.5,"d":"-27.50"},1.97,"Exon (ENSBGRT00000002128/ENSBGRG00000001136, exon 1 of 11)",3,38176101,38198260,22160,1]
["chr3",41952902,41955101,2200,"ENSBGRG00000004551","ENSBGRT00000008379",41174,"CTTNBP2NL","CTTNBP2 N-terminal like [Source:HGNC Symbol;Acc:HGNC:25330]","GO:0006470(protein dephosphorylation);GO:0015629(actin cytoskeleton);GO:0032410(negative regulation of transporter activity);GO:0034763(negative regulation of transmembrane transport);GO:0051721(protein phosphatase 2A binding)","NA",0,2,"215,827,","0,1373",-373,"-Inf",5.76,"Exon (ENSBGRT00000008379/ENSBGRG00000004551, exon 5 of 6)",3,41911728,41955101,43374,1]
["chr3",42219302,42219628,327,"ENSBGRG00000004407","ENSBGRT00000008107",6943,"ENSBGRG00000004407","NA","GO:0005615(extracellular space);GO:1903979(negative regulation of microglial cell activation);GO:1903980(positive regulation of microglial cell activation)","NA",{"v":5e-16,"d":"0.00"},1,"327,",0,{"v":-15.3,"d":"-15.30"},{"v":-14.4,"d":"-14.40"},7.56,"3' UTR",3,42212359,42219628,7270,1]
["chr3",47794878,47795113,236,"ENSBGRG00000010319","ENSBGRT00000018901",441,"TENT5C","terminal nucleotidyltransferase 5C [Source:HGNC Symbol;Acc:HGNC:24712]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0048255(mRNA stabilization);GO:1990817(RNA adenylyltransferase activity)","04371(Apelin signaling pathway);04810(Regulation of actin cytoskeleton);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes)",{"v":6.3e-50,"d":"0.00"},1,"236,",0,{"v":-49.2,"d":"-49.20"},{"v":-47.9,"d":"-47.90"},5.02,"Exon (ENSBGRT00000018901/ENSBGRG00000010319, exon 1 of 1)",3,47794437,47795612,1176,1]
["chr3",53302042,53302462,421,"ENSBGRG00000000221","ENSBGRT00000000353",15930,"F3","coagulation factor III, tissue factor [Source:HGNC Symbol;Acc:HGNC:3541]","GO:0001938(positive regulation of endothelial cell proliferation);GO:0002020(protease binding);GO:0002541(activation of plasma proteins involved in acute inflammatory response);GO:0004252(serine-type endopeptidase activity);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0005615(extracellular space);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0007596(blood coagulation);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0010641(positive regulation of platelet-derived growth factor receptor signaling pathway);GO:0016021(integral component of membrane);GO:0016485(protein processing);GO:0032757(positive regulation of interleukin-8 production);GO:0045766(positive regulation of angiogenesis);GO:0051897(positive regulation of protein kinase B signaling);GO:0062023(collagen-containing extracellular matrix);GO:1905286(serine-type peptidase complex)","04610(Complement and coagulation cascades);04933(AGE-RAGE signaling pathway in diabetic complications)",{"v":1.6e-97,"d":"0.00"},1,"421,",0,{"v":-96.8,"d":"-96.80"},{"v":-95.2,"d":"-95.20"},9.65,"3' UTR",3,53286112,53302985,16874,1]
["chr3",56949746,56950171,426,"ENSBGRG00000002204","ENSBGRT00000004141",39907,"ENSBGRG00000002204","NA","NA","NA",{"v":2.5e-19,"d":"0.00"},4,"4,135,9,272,","0,6,143,154",{"v":-18.6,"d":"-18.60"},{"v":-17.6,"d":"-17.60"},3.96,"Exon (ENSBGRT00000004188/ENSBGRG00000002234, exon 1 of 6)",3,56909839,56973915,64077,1]
["chr3",63564035,63564304,270,"ENSBGRG00000000411","ENSBGRT00000000750",929,"C1orf52","chromosome 1 open reading frame 52 [Source:HGNC Symbol;Acc:HGNC:24871]","GO:0005654(nucleoplasm)","NA",{"v":1.3e-30,"d":"0.00"},1,"270,",0,{"v":-29.9,"d":"-29.90"},{"v":-28.8,"d":"-28.80"},3.83,"3' UTR",3,63563106,63566258,3153,1]
["chr3",75924260,75924617,358,"ENSBGRG00000004342","ENSBGRT00000007974",0,"ENSBGRG00000004342","NA","NA","NA",{"v":1e-34,"d":"0.00"},1,"358,",0,-34,{"v":-32.8,"d":"-32.80"},4.54,"Exon (ENSBGRT00000007974/ENSBGRG00000004342, exon 1 of 1)",3,75924260,75926521,2262,1]
["chr3",94811228,94811584,357,"ENSBGRG00000024565","ENSBGRT00000045341",1416,"JUN","Jun proto-oncogene, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:6204]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001525(angiogenesis);GO:0001774(microglial cell activation);GO:0001889(liver development);GO:0001938(positive regulation of endothelial cell proliferation);GO:0003151(outflow tract morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005096(GTPase activator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005719(nuclear euchromatin);GO:0006355(regulation of transcription, DNA-templated);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007265(Ras protein signal transduction);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0009987(cellular process);GO:0010634(positive regulation of epithelial cell migration);GO:0017053(transcriptional repressor complex);GO:0019899(enzyme binding);GO:0030224(monocyte differentiation);GO:0031103(axon regeneration);GO:0031625(ubiquitin protein ligase binding);GO:0031953(negative regulation of protein autophosphorylation);GO:0034614(cellular response to reactive oxygen species);GO:0035026(leading edge cell differentiation);GO:0035497(cAMP response element binding);GO:0035976(transcription factor AP-1 complex);GO:0035994(response to muscle stretch);GO:0042493(response to drug);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043392(negative regulation of DNA binding);GO:0043524(negative regulation of neuron apoptotic process);GO:0043922(negative regulation by host of viral transcription);GO:0043923(positive regulation by host of viral transcription);GO:0044389(ubiquitin-like protein ligase binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048146(positive regulation of fibroblast proliferation);GO:0051726(regulation of cell cycle);GO:0060395(SMAD protein signal transduction);GO:0061029(eyelid development in camera-type eye);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070412(R-SMAD binding);GO:0071276(cellular response to cadmium ion);GO:0071277(cellular response to calcium ion);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1990441(negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000144(positive regulation of DNA-templated transcription, initiation)","04010(MAPK signaling pathway);04012(ErbB signaling pathway);04310(Wnt signaling pathway);04668(TNF signaling pathway);04024(cAMP signaling pathway);04137(Mitophagy - animal);04210(Apoptosis);04510(Focal adhesion);04530(Tight junction);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04657(IL-17 signaling pathway);04662(B cell receptor signaling pathway);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04722(Neurotrophin signaling pathway);04380(Osteoclast differentiation);05200(Pathways in cancer);05231(Choline metabolism in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05211(Renal cell carcinoma);05224(Breast cancer);05323(Rheumatoid arthritis);05321(Inflammatiory bowel disease (IBD));05030(Cocaine addiction);05031(Amphetamine addiction);05418(Fluid shear stress and atherosclerosis);04932(Non-alcoholic fatty liver disease (NAFLD));04933(AGE-RAGE signaling pathway in diabetic complications);05132(Salmonella infection);05133(Pertussis);05166(HTLV-I infection);05164(Influenza A);05161(Hepatitis B);05168(Herpes simplex infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));01522(Endocrine resistance)",0,1,"357,",0,-2790,"-Inf",3.49,"Exon (ENSBGRT00000045341/ENSBGRG00000024565, exon 2 of 2)",3,94809812,94811584,1773,1]
["chr3",99876319,99877719,1401,"ENSBGRG00000001339","ENSBGRT00000002537",415,"SSBP3","single stranded DNA binding protein 3 [Source:HGNC Symbol;Acc:HGNC:15674]","GO:0002244(hematopoietic progenitor cell differentiation);GO:0003697(single-stranded DNA binding);GO:0005515(protein binding);GO:0008284(positive regulation of cell population proliferation);GO:0021501(prechordal plate formation);GO:0021547(midbrain-hindbrain boundary initiation);GO:0032991(protein-containing complex);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060322(head development);GO:0060323(head morphogenesis);GO:0065003(protein-containing complex assembly);GO:2000744(positive regulation of anterior head development)","NA",{"v":1.1E-5,"d":"0.00"},3,"53,73,53,","0,1052,1348",-4.97,-4.25,8.64,"Exon (ENSBGRT00000002537/ENSBGRG00000001339, exon 1 of 15)",3,99875904,100071407,195504,1]
["chr3",109454222,109454579,358,"ENSBGRG00000002607","ENSBGRT00000004878",3813,"CCDC17","coiled-coil domain containing 17 [Source:HGNC Symbol;Acc:HGNC:26574]","NA","NA",{"v":6.3e-75,"d":"0.00"},1,"358,",0,{"v":-74.2,"d":"-74.20"},{"v":-72.7,"d":"-72.70"},{"v":10.5,"d":"10.50"},"3' UTR",3,109450409,109454579,4171,1]
["chr3",112719898,112727106,7209,"ENSBGRG00000011987","ENSBGRT00000021917",0,"SVBP","small vasohibin binding protein [Source:HGNC Symbol;Acc:HGNC:29204]","GO:0006508(proteolysis);GO:0008017(microtubule binding);GO:0009306(protein secretion);GO:0010596(negative regulation of endothelial cell migration);GO:0031397(negative regulation of protein ubiquitination);GO:0045177(apical part of cell);GO:0061564(axon development);GO:1905048(regulation of metallopeptidase activity)","NA",{"v":1E-73,"d":"0.00"},3,"22,175,7,","0,297,7202",-73,{"v":-71.5,"d":"-71.50"},1.86,"5' UTR",3,112719898,112727540,7643,1]
["chr3",115123614,115124787,1174,"ENSBGRG00000016850","ENSBGRT00000030998",15614,"RIMS3","regulating synaptic membrane exocytosis 3 [Source:HGNC Symbol;Acc:HGNC:21292]","GO:0006887(exocytosis);GO:0016020(membrane);GO:0017137(Rab GTPase binding);GO:0042391(regulation of membrane potential);GO:0044325(ion channel binding)","NA",{"v":5.8e-10,"d":"0.00"},2,"27,213,","0,961",-9.24,-8.41,{"v":35.6,"d":"35.60"},"Exon (ENSBGRT00000030998/ENSBGRG00000016850, exon 5 of 6)",3,115108000,115124787,16788,1]
["chr3",117973054,117973262,209,"ENSBGRG00000005914","ENSBGRT00000010928",3770,"YRDC","yrdC N6-threonylcarbamoyltransferase domain containing [Source:HGNC Symbol;Acc:HGNC:28905]","GO:0003725(double-stranded RNA binding);GO:0016020(membrane);GO:0051051(negative regulation of transport)","NA",{"v":2.9E-4,"d":"0.00"},1,"209,",0,-3.54,-2.87,{"v":15.1,"d":"15.10"},"3' UTR",3,117969284,117975526,6243,1]
["chr3",119858057,119858413,357,"ENSBGRG00000009506","ENSBGRT00000017429",0,"ENSBGRG00000009506","NA","NA","NA",{"v":0.0021,"d":"0.00"},1,"357,",0,-2.67,-2.06,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000017429/ENSBGRG00000009506, exon 1 of 1)",3,119858057,119859067,1011,1]
["chr3",120923953,120924132,180,"ENSBGRG00000012230","ENSBGRT00000022380",49941,"ZMYM6","zinc finger MYM-type containing 6 [Source:HGNC Symbol;Acc:HGNC:13050]","GO:0007010(cytoskeleton organization);GO:0008270(zinc ion binding);GO:0022604(regulation of cell morphogenesis)","NA",{"v":4e-48,"d":"0.00"},1,"180,",0,{"v":-47.4,"d":"-47.40"},{"v":-46.1,"d":"-46.10"},{"v":4.9,"d":"4.90"},"Exon (ENSBGRT00000022380/ENSBGRG00000012230, exon 16 of 16)",3,120874012,120925653,51642,1]
["chr3",127646186,127648346,2161,"ENSBGRG00000017207","ENSBGRT00000031644",180,"ENSBGRG00000017207","NA","GO:0000338(protein deneddylation);GO:0008180(COP9 signalosome);GO:0010387(COP9 signalosome assembly)","NA",{"v":1.6E-11,"d":"0.00"},2,"42,19,","0,2142",{"v":-10.8,"d":"-10.80"},-9.93,3.37,"Exon (ENSBGRT00000031644/ENSBGRG00000017207, exon 1 of 9)",3,127646006,127660749,14744,1]
["chr3",129607912,129608928,1017,"ENSBGRG00000022785","ENSBGRT00000042041",0,"ENSBGRG00000022785","NA","NA","NA",{"v":3.7e-06,"d":"0.00"},1,"1017,",0,-5.43,{"v":-4.7,"d":"-4.70"},{"v":17.3,"d":"17.30"},"Exon (ENSBGRT00000042041/ENSBGRG00000022785, exon 1 of 1)",3,129607912,129608928,1017,1]
["chr3",131903342,131904125,784,"ENSBGRG00000001709","ENSBGRT00000003182",8717,"ENSBGRG00000001709","NA","NA","04015(Rap1 signaling pathway);04520(Adherens junction)",{"v":1e-15,"d":"0.00"},3,"30,152,290,","0,133,494",-15,-14,3.24,"3' UTR",3,131894625,131904449,9825,1]
["chr3",1102551,1103480,930,"ENSBGRG00000008643","ENSBGRT00000015734",7691,"ADAR","adenosine deaminase RNA specific [Source:HGNC Symbol;Acc:HGNC:225]","GO:0001649(osteoblast differentiation);GO:0002244(hematopoietic progenitor cell differentiation);GO:0002566(somatic diversification of immune receptors via somatic mutation);GO:0003723(RNA binding);GO:0003726(double-stranded RNA adenosine deaminase activity);GO:0004000(adenosine deaminase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006382(adenosine to inosine editing);GO:0006396(RNA processing);GO:0009615(response to virus);GO:0016553(base conversion or substitution editing);GO:0030218(erythrocyte differentiation);GO:0031054(pre-miRNA processing);GO:0035196(production of miRNAs involved in gene silencing by miRNA);GO:0035280(miRNA loading onto RISC involved in gene silencing by miRNA);GO:0035455(response to interferon-alpha);GO:0043066(negative regulation of apoptotic process);GO:0044387(negative regulation of protein kinase activity by regulation of protein phosphorylation);GO:0044530(supraspliceosomal complex);GO:0045070(positive regulation of viral genome replication);GO:0060216(definitive hemopoiesis);GO:0060339(negative regulation of type I interferon-mediated signaling pathway);GO:0061484(hematopoietic stem cell homeostasis);GO:0098586(cellular response to virus);GO:1900369(negative regulation of RNA interference)","04623(Cytosolic DNA-sensing pathway);05162(Measles);05164(Influenza A)",{"v":9.99999999999999e-223,"d":"0.00"},1,"930,",0,-222,-220,4.85,"5' UTR",3,1079477,1111171,31695,2]
["chr3",2187018,2187231,214,"ENSBGRG00000021040","ENSBGRT00000039464",137868,"ENSBGRG00000021040","NA","GO:0003677(DNA binding);GO:0003714(transcription corepressor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0030183(B cell differentiation);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":7.9e-97,"d":"0.00"},3,"170,3,38,","0,172,176",{"v":-96.1,"d":"-96.10"},{"v":-94.5,"d":"-94.50"},4.41,"Exon (ENSBGRT00000039464/ENSBGRG00000021040, exon 20 of 33)",3,2172934,2325099,152166,2]
["chr3",3181103,3181252,150,"ENSBGRG00000024887","ENSBGRT00000045937",8587,"NES","nestin [Source:HGNC Symbol;Acc:HGNC:7756]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0005737(cytoplasm);GO:0005882(intermediate filament);GO:0007399(nervous system development);GO:0019215(intermediate filament binding);GO:0032091(negative regulation of protein binding);GO:0043086(negative regulation of catalytic activity);GO:0043524(negative regulation of neuron apoptotic process);GO:0045111(intermediate filament cytoskeleton);GO:0048858(cell projection morphogenesis);GO:0072089(stem cell proliferation)","NA",{"v":1e-128,"d":"0.00"},1,"150,",0,-128,-126,5.53,"Exon (ENSBGRT00000045937/ENSBGRG00000024887, exon 5 of 5)",3,3180923,3189839,8917,2]
["chr3",6523667,6527630,3964,"ENSBGRG00000012118","ENSBGRT00000022134",19219,"ENSBGRG00000012118","NA","GO:0002218(activation of innate immune response);GO:0035458(cellular response to interferon-beta)","04621(NOD-like receptor signaling pathway)",{"v":7.9e-19,"d":"0.00"},3,"137,128,180,","0,2750,3784",{"v":-18.1,"d":"-18.10"},{"v":-17.1,"d":"-17.10"},2.14,"Exon (ENSBGRT00000022134/ENSBGRG00000012118, exon 2 of 9)",3,6498993,6546849,47857,2]
["chr3",9050172,9050232,61,"ENSBGRG00000000881","ENSBGRT00000001626",16224,"ARHGAP30","Rho GTPase activating protein 30 [Source:HGNC Symbol;Acc:HGNC:27414]","GO:0007165(signal transduction);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":8.1e-06,"d":"0.00"},1,"61,",0,-5.09,-4.37,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000001626/ENSBGRG00000000881, exon 12 of 13)",3,9047257,9066456,19200,2]
["chr3",16223332,16223391,60,"ENSBGRG00000006378","ENSBGRT00000011732",0,"ENSBGRG00000006378","NA","NA","NA",{"v":0.027,"d":"0.03"},1,"60,",0,-1.57,-1.03,3.24,"5' UTR",3,16223380,16240153,16774,1]
["chr3",20420536,20420654,119,"ENSBGRG00000016698","ENSBGRT00000030707",1660,"ENSBGRG00000016698","NA","GO:0003676(nucleic acid binding)","03040(Spliceosome)",{"v":3.2e-26,"d":"0.00"},1,"119,",0,{"v":-25.5,"d":"-25.50"},{"v":-24.5,"d":"-24.50"},1.61,"Exon (ENSBGRT00000030707/ENSBGRG00000016698, exon 3 of 6)",3,20418216,20422314,4099,2]
["chr3",21454874,21457652,2779,"ENSBGRG00000001466","ENSBGRT00000002697",240,"MINDY1","MINDY lysine 48 deubiquitinase 1 [Source:HGNC Symbol;Acc:HGNC:25648]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0016807(cysteine-type carboxypeptidase activity);GO:0036435(K48-linked polyubiquitin modification-dependent protein binding);GO:1990380(Lys48-specific deubiquitinase activity)","NA",{"v":1e-19,"d":"0.00"},2,"261,159,","0,2620",-19,{"v":-18.1,"d":"-18.10"},1.72,"5' UTR",3,21443339,21457892,14554,2]
["chr3",21929867,21929957,91,"ENSBGRG00000002163","ENSBGRT00000004132",29277,"POGZ","pogo transposable element derived with ZNF domain [Source:HGNC Symbol;Acc:HGNC:18801]","GO:0000790(nuclear chromatin);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007064(mitotic sister chromatid cohesion);GO:0051382(kinetochore assembly)","NA",{"v":1E-173,"d":"0.00"},1,"91,",0,-173,-171,9.72,"Exon (ENSBGRT00000004132/ENSBGRG00000002163, exon 17 of 17)",3,21929837,21959234,29398,2]
["chr3",29345434,29346031,598,"ENSBGRG00000009123","ENSBGRT00000016740",0,"DPH5","diphthamide biosynthesis 5 [Source:HGNC Symbol;Acc:HGNC:24270]","GO:0004164(diphthine synthase activity);GO:0008168(methyltransferase activity);GO:0017183(peptidyl-diphthamide biosynthetic process from peptidyl-histidine)","NA",{"v":3.8e-05,"d":"0.00"},1,"598,",0,-4.42,-3.72,{"v":18.4,"d":"18.40"},"5' UTR",3,29304010,29346031,42022,2]
["chr3",40641961,40642201,241,"ENSBGRG00000003565","ENSBGRT00000006808",105264,"OVGP1","oviductal glycoprotein 1 [Source:HGNC Symbol;Acc:HGNC:8524]","GO:0005975(carbohydrate metabolic process);GO:0008061(chitin binding)","NA",{"v":0.0021,"d":"0.00"},1,"241,",0,-2.67,-2.06,{"v":11.9,"d":"11.90"},"3' UTR",3,40641751,40747465,105715,2]
["chr3",41413054,41413173,120,"ENSBGRG00000004468","ENSBGRT00000008301",507,"KCND3","potassium voltage-gated channel subfamily D member 3 [Source:HGNC Symbol;Acc:HGNC:6239]","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005250(A-type (transient outward) potassium channel activity);GO:0005515(protein binding);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0044325(ion channel binding);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport);GO:0086009(membrane repolarization);GO:0086091(regulation of heart rate by cardiac conduction);GO:0097623(potassium ion export across plasma membrane);GO:0098982(GABA-ergic synapse);GO:0099060(integral component of postsynaptic specialization membrane);GO:0099625(ventricular cardiac muscle cell membrane repolarization);GO:1902282(voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization)","NA",{"v":3.8e-05,"d":"0.00"},1,"120,",0,-4.42,-3.72,{"v":18.4,"d":"18.40"},"Exon (ENSBGRT00000008301/ENSBGRG00000004468, exon 1 of 7)",3,41150765,41413680,262916,2]
["chr3",44323561,44323621,61,"ENSBGRG00000006623","ENSBGRT00000012249",0,"DENND2C","DENN domain containing 2C [Source:HGNC Symbol;Acc:HGNC:24748]","GO:0017112(Rab guanyl-nucleotide exchange factor activity)","NA",{"v":0.0041,"d":"0.00"},1,"61,",0,-2.39,-1.79,{"v":10.8,"d":"10.80"},"5' UTR",3,44279404,44323621,44218,2]
["chr3",46472803,46472922,120,"ENSBGRG00000008748","ENSBGRT00000015961",70807,"ENSBGRG00000008748","NA","NA","04514(Cell adhesion molecules (CAMs));05169(Epstein-Barr virus infection)",{"v":4.3e-06,"d":"0.00"},1,"120,",0,-5.37,-4.63,2.76,"3' UTR",3,46468535,46543729,75195,2]
["chr3",57928532,57934867,6336,"ENSBGRG00000002303","ENSBGRT00000004425",32534,"ZNF326","zinc finger protein 326 [Source:HGNC Symbol;Acc:HGNC:14104]","GO:0000993(RNA polymerase II complex binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0032784(regulation of DNA-templated transcription, elongation);GO:0043231(intracellular membrane-bounded organelle);GO:0043484(regulation of RNA splicing);GO:0044609(DBIRD complex)","NA",{"v":1e-254,"d":"0.00"},3,"339,96,74,","0,5121,6262",-254,-252,{"v":56.2,"d":"56.20"},"Exon (ENSBGRT00000004425/ENSBGRG00000002303, exon 9 of 11)",3,57928532,57967401,38870,2]
["chr3",58722399,58725287,2889,"ENSBGRG00000002540","ENSBGRT00000004743",0,"ENSBGRG00000002540","NA","NA","NA",{"v":3.9e-08,"d":"0.00"},3,"266,1094,344,","0,735,2545",-7.41,-6.62,{"v":29.2,"d":"29.20"},"Exon (ENSBGRT00000004723/ENSBGRG00000002523, exon 7 of 7)",3,58721859,58724227,2369,2]
["chr3",81084495,81094567,10073,"ENSBGRG00000007267","ENSBGRT00000013483",46189,"SRSF11","serine and arginine rich splicing factor 11 [Source:HGNC Symbol;Acc:HGNC:10782]","GO:0003676(nucleic acid binding);GO:0008380(RNA splicing);GO:0016607(nuclear speck)","NA",0,5,"195,139,96,90,18,","0,300,815,6877,10055",-1270,"-Inf",4.39,"Exon (ENSBGRT00000013483/ENSBGRG00000007267, exon 9 of 13)",3,81084495,81140756,56262,2]
["chr3",84792200,84794997,2798,"ENSBGRG00000009812","ENSBGRT00000018431",67279,"MIER1","MIER1 transcriptional regulator [Source:HGNC Symbol;Acc:HGNC:29657]","GO:0003677(DNA binding);GO:0004407(histone deacetylase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0016575(histone deacetylation);GO:0017053(transcriptional repressor complex);GO:0031937(positive regulation of chromatin silencing);GO:0032991(protein-containing complex);GO:0042826(histone deacetylase binding)","NA",{"v":1e-149,"d":"0.00"},2,"239,31,","0,2767",-149,-147,6.75,"Exon (ENSBGRT00000018431/ENSBGRG00000009812, exon 12 of 13)",3,84792110,84862276,70167,2]
["chr3",91227544,91248662,21119,"ENSBGRG00000023087","ENSBGRT00000042595",351,"ENSBGRG00000023087","NA","GO:0002138(retinoic acid biosynthetic process);GO:0005829(cytosol);GO:0006776(vitamin A metabolic process);GO:0008289(lipid binding)","00760(Nicotinate and nicotinamide metabolism)",{"v":1.5e-07,"d":"0.00"},2,"226,244,","0,20875",-6.83,-6.05,7.02,"3' UTR",3,91227544,91249013,21470,2]
["chr3",101860130,101860456,327,"ENSBGRG00000003300","ENSBGRT00000006206",36933,"ZYG11B","zyg-11 family member B, cell cycle regulator [Source:HGNC Symbol;Acc:HGNC:25820]","GO:0005515(protein binding);GO:0006515(protein quality control for misfolded or incompletely synthesized proteins);GO:0031462(Cul2-RING ubiquitin ligase complex);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process)","NA",{"v":3.2e-35,"d":"0.00"},1,"327,",0,{"v":-34.5,"d":"-34.50"},{"v":-33.4,"d":"-33.40"},4.78,"Exon (ENSBGRT00000006206/ENSBGRG00000003300, exon 3 of 15)",3,101814014,101897389,83376,2]
["chr3",109366116,109367593,1478,"ENSBGRG00000002565","ENSBGRT00000004805",120,"TMEM69","transmembrane protein 69 [Source:HGNC Symbol;Acc:HGNC:28035]","NA","NA",{"v":1e-81,"d":"0.00"},2,"310,20,","0,1458",-81,{"v":-79.5,"d":"-79.50"},4.82,"Exon (ENSBGRT00000004805/ENSBGRG00000002565, exon 1 of 3)",3,109364702,109367713,3012,2]
["chr3",111188867,111189876,1010,"ENSBGRG00000007597","ENSBGRT00000013947",8359,"B4GALT2","beta-1,4-galactosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:925]","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0016757(transferase activity, transferring glycosyl groups);GO:0043231(intracellular membrane-bounded organelle)","00052(Galactose metabolism);00510(N-Glycan biosynthesis);00515(Mannose type O-glycan biosyntheis);00514(Other types of O-glycan biosynthesis);00533(Glycosaminoglycan biosynthesis - keratan sulfate);00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":2.9E-4,"d":"0.00"},2,"151,328,","0,682",-3.54,-2.87,{"v":15.1,"d":"15.10"},"3' UTR",3,111188867,111198235,9369,2]
["chr3",114707890,114708728,839,"ENSBGRG00000016063","ENSBGRT00000029593",30292,"CTPS1","CTP synthase 1 [Source:HGNC Symbol;Acc:HGNC:2519]","GO:0003883(CTP synthase activity);GO:0006221(pyrimidine nucleotide biosynthetic process);GO:0006241(CTP biosynthetic process);GO:0042098(T cell proliferation);GO:0042100(B cell proliferation);GO:0042802(identical protein binding);GO:0097268(cytoophidium)","00240(Pyrimidine metabolism)",{"v":1E-150,"d":"0.00"},1,"839,",0,-150,-148,6.24,"3' UTR",3,114707890,114739020,31131,2]
["chr3",115755471,115755619,149,"ENSBGRG00000000405","ENSBGRT00000000818",11783,"MFSD2A","major facilitator superfamily domain containing 2A [Source:HGNC Symbol;Acc:HGNC:25897]","GO:0003406(retinal pigment epithelium development);GO:0005324(long-chain fatty acid transporter activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007420(brain development);GO:0008594(photoreceptor cell morphogenesis);GO:0008643(carbohydrate transport);GO:0009267(cellular response to starvation);GO:0010867(positive regulation of triglyceride biosynthetic process);GO:0015245(fatty acid transmembrane transporter activity);GO:0015293(symporter activity);GO:0015908(fatty acid transport);GO:0016021(integral component of membrane);GO:0021766(hippocampus development);GO:0030307(positive regulation of cell growth);GO:0031999(negative regulation of fatty acid beta-oxidation);GO:0034379(very-low-density lipoprotein particle assembly);GO:0035633(maintenance of permeability of blood-brain barrier);GO:0035845(photoreceptor cell outer segment organization);GO:0040014(regulation of multicellular organism growth);GO:0045056(transcytosis);GO:0045872(positive regulation of rhodopsin gene expression);GO:0050773(regulation of dendrite development);GO:0050890(cognition);GO:0051977(lysophospholipid transport);GO:0051978(lysophospholipid:sodium symporter activity);GO:0060042(retina morphogenesis in camera-type eye);GO:0060856(establishment of blood-brain barrier);GO:0061744(motor behavior);GO:0097009(energy homeostasis);GO:0140329(lysophospholipid translocation);GO:0140348(lysophosphatidylcholine flippase activity);GO:0150011(regulation of neuron projection arborization);GO:0150172(regulation of phosphatidylcholine metabolic process);GO:0150175(regulation of phosphatidylethanolamine metabolic process);GO:0150178(regulation of phosphatidylserine metabolic process);GO:1901480(oleate transmembrane transporter activity);GO:1990379(lipid transport across blood-brain barrier)","NA",{"v":7.9e-21,"d":"0.00"},1,"149,",0,{"v":-20.1,"d":"-20.10"},{"v":-19.2,"d":"-19.20"},4.93,"3' UTR",3,115754101,115767402,13302,2]
["chr3",116307465,116307722,258,"ENSBGRG00000001404","ENSBGRT00000008991",181480,"MACF1","microtubule actin crosslinking factor 1 [Source:HGNC Symbol;Acc:HGNC:13664]","GO:0003779(actin binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0007010(cytoskeleton organization);GO:0008017(microtubule binding);GO:0008092(cytoskeletal protein binding);GO:0030334(regulation of cell migration);GO:0032587(ruffle membrane);GO:0032886(regulation of microtubule-based process);GO:0043001(Golgi to plasma membrane protein transport);GO:0045104(intermediate filament cytoskeleton organization);GO:0045773(positive regulation of axon extension);GO:0051011(microtubule minus-end binding);GO:0051015(actin filament binding);GO:0051893(regulation of focal adhesion assembly)","NA",{"v":1.6e-21,"d":"0.00"},2,"213,27,","0,231",{"v":-20.8,"d":"-20.80"},{"v":-19.8,"d":"-19.80"},{"v":2.9,"d":"2.90"},"Exon (ENSBGRT00000009267/ENSBGRG00000005001, exon 4 of 9)",3,116231746,116489202,257457,2]
["chr3",119660734,119662902,2169,"ENSBGRG00000008220","ENSBGRT00000015081",63274,"THRAP3","thyroid hormone receptor associated protein 3 [Source:HGNC Symbol;Acc:HGNC:22964]","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0000956(nuclear-transcribed mRNA catabolic process);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0007623(circadian rhythm);GO:0008380(RNA splicing);GO:0016592(mediator complex);GO:0016607(nuclear speck);GO:0035145(exon-exon junction complex);GO:0042753(positive regulation of circadian rhythm);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046966(thyroid hormone receptor binding);GO:0048026(positive regulation of mRNA splicing, via spliceosome);GO:0048255(mRNA stabilization);GO:0051219(phosphoprotein binding)","NA",0,2,"451,179,","0,1990",-338,"-Inf",3.61,"Exon (ENSBGRT00000015081/ENSBGRG00000008220, exon 5 of 13)",3,119649463,119726176,76714,2]
["chr3",121173719,121173778,60,"ENSBGRG00000007611","ENSBGRT00000013984",793,"GJB3","gap junction protein beta 3 [Source:HGNC Symbol;Acc:HGNC:4285]","GO:0001890(placenta development);GO:0005737(cytoplasm);GO:0005911(cell-cell junction);GO:0005921(gap junction);GO:0005922(connexin complex);GO:0007154(cell communication);GO:0030054(cell junction);GO:0043231(intracellular membrane-bounded organelle)","NA",0.02,1,"60,",0,-1.69,-1.14,3.96,"Exon (ENSBGRT00000013984/ENSBGRG00000007611, exon 2 of 2)",3,121173250,121174571,1322,2]
["chr3",127964790,127969316,4527,"ENSBGRG00000017439","ENSBGRT00000035744",25155,"ENSBGRG00000017439","NA","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":9.99999999999999e-294,"d":"0.00"},3,"98,224,38,","0,1110,4489",-293,-290,3.93,"Exon (ENSBGRT00000035744/ENSBGRG00000017439, exon 8 of 22)",3,127953157,127994471,41315,2]
["chr3",130768214,130769092,879,"ENSBGRG00000023306","ENSBGRT00000043079",0,"OTOS","otospiralin [Source:HGNC Symbol;Acc:HGNC:22644]","GO:0007605(sensory perception of sound)","NA",{"v":0.0078,"d":"0.01"},1,"879,",0,-2.11,-1.53,9.72,"5' UTR",3,130767312,130769092,1781,2]
["chr4",776239,778783,2545,"ENSBGRG00000002897","ENSBGRT00000005436",2619,"ENSBGRG00000002897","NA","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis)","04080(Neuroactive ligand-receptor interaction);04972(Pancreatic secretion);04974(Protein digestion and absorption);05164(Influenza A)",0,5,"18,254,32,102,153,","0,1390,2020,2054,2392",-346,"-Inf",4.06,"Exon (ENSBGRT00000005436/ENSBGRG00000002897, exon 3 of 7)",4,773620,778783,5164,1]
["chr4",8159353,8159502,150,"ENSBGRG00000018198","ENSBGRT00000033322",5344,"REPIN1","replication initiator 1 [Source:HGNC Symbol;Acc:HGNC:17922]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005654(nucleoplasm)","NA",{"v":2.5E-42,"d":"0.00"},1,"150,",0,{"v":-41.6,"d":"-41.60"},{"v":-40.4,"d":"-40.40"},1.92,"3' UTR",4,8154009,8159681,5673,1]
["chr4",8618482,8618692,211,"ENSBGRG00000004317","ENSBGRT00000007936",12709,"AOC1","amine oxidase copper containing 1 [Source:HGNC Symbol;Acc:HGNC:80]","GO:0005507(copper ion binding);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0008131(primary amine oxidase activity);GO:0008144(drug binding);GO:0008201(heparin binding);GO:0008270(zinc ion binding);GO:0009308(amine metabolic process);GO:0035874(cellular response to copper ion starvation);GO:0042493(response to drug);GO:0042803(protein homodimerization activity);GO:0044877(protein-containing complex binding);GO:0046677(response to antibiotic);GO:0048038(quinone binding);GO:0052597(diamine oxidase activity);GO:0055114(oxidation-reduction process);GO:0070062(extracellular exosome);GO:0071280(cellular response to copper ion);GO:0071420(cellular response to histamine);GO:0097185(cellular response to azide)","00330(Arginine and proline metabolism);00340(Histidine metabolism);00380(Tryptophan metabolism)",{"v":6.3e-16,"d":"0.00"},1,"211,",0,{"v":-15.2,"d":"-15.20"},{"v":-14.3,"d":"-14.30"},7.14,"3' UTR",4,8605773,8618871,13099,1]
["chr4",10576812,10576871,60,"ENSBGRG00000008613","ENSBGRT00000016072",81941,"ENSBGRG00000008613","NA","GO:0005524(ATP binding);GO:0005885(Arp2/3 protein complex);GO:0007015(actin filament organization);GO:0034314(Arp2/3 complex-mediated actin nucleation)","04530(Tight junction)",{"v":7.9e-60,"d":"0.00"},1,"60,",0,{"v":-59.1,"d":"-59.10"},{"v":-57.7,"d":"-57.70"},2.27,"3' UTR",4,10494871,10576831,81961,1]
["chr4",14237477,14237807,331,"ENSBGRG00000012801","ENSBGRT00000023409",1468,"NOM1","nucleolar protein with MIF4G domain 1 [Source:HGNC Symbol;Acc:HGNC:13244]","GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005730(nucleolus);GO:0048820(hair follicle maturation)","NA",{"v":4e-42,"d":"0.00"},1,"331,",0,{"v":-41.4,"d":"-41.40"},{"v":-40.2,"d":"-40.20"},3.08,"Exon (ENSBGRT00000023409/ENSBGRG00000012801, exon 1 of 11)",4,14236009,14252004,15996,1]
["chr4",18446405,18446524,120,"ENSBGRG00000001427","ENSBGRT00000002695",223960,"HIPK2","homeodomain interacting protein kinase 2 [Source:HGNC Symbol;Acc:HGNC:14402]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001934(positive regulation of protein phosphorylation);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0006978(DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007224(smoothened signaling pathway);GO:0007628(adult walking behavior);GO:0008284(positive regulation of cell population proliferation);GO:0008344(adult locomotory behavior);GO:0009952(anterior/posterior pattern specification);GO:0010842(retina layer formation);GO:0016604(nuclear body);GO:0016605(PML body);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0030182(neuron differentiation);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0030514(negative regulation of BMP signaling pathway);GO:0032092(positive regulation of protein binding);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0043388(positive regulation of DNA binding);GO:0043524(negative regulation of neuron apoptotic process);GO:0045766(positive regulation of angiogenesis);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046330(positive regulation of JNK cascade);GO:0046332(SMAD binding);GO:0046790(virion binding);GO:0048596(embryonic camera-type eye morphogenesis);GO:0050882(voluntary musculoskeletal movement);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060059(embryonic retina morphogenesis in camera-type eye);GO:0060235(lens induction in camera-type eye);GO:0060395(SMAD protein signal transduction);GO:0061072(iris morphogenesis);GO:0090575(RNA polymerase II transcription factor complex);GO:2000059(negative regulation of ubiquitin-dependent protein catabolic process)","04218(Cellular senescence)",{"v":5.9e-07,"d":"0.00"},1,"120,",0,-6.23,-5.47,14,"3' UTR",4,18222445,18446764,224320,1]
["chr4",22326739,22326857,119,"ENSBGRG00000003419","ENSBGRT00000006352",14269,"FAM180A","family with sequence similarity 180 member A [Source:HGNC Symbol;Acc:HGNC:33773]","NA","NA",{"v":4e-38,"d":"0.00"},1,"119,",0,{"v":-37.4,"d":"-37.40"},{"v":-36.2,"d":"-36.20"},3.95,"Exon (ENSBGRT00000006352/ENSBGRG00000003419, exon 3 of 3)",4,22312470,22326857,14388,1]
["chr4",29973809,29976862,3054,"ENSBGRG00000023047","ENSBGRT00000042521",0,"PRRT4","proline rich transmembrane protein 4 [Source:HGNC Symbol;Acc:HGNC:37280]","NA","03008(Ribosome biogenesis in eukaryotes)",{"v":0.043,"d":"0.04"},2,"627,689,","0,2365",-1.37,{"v":-0.6,"d":"-0.60"},6.48,"5' UTR",4,29973809,29985778,11970,1]
["chr4",34813217,34813276,60,"ENSBGRG00000024591","ENSBGRT00000045377",1002,"ENSBGRG00000024591","NA","NA","NA",{"v":0.0011,"d":"0.00"},1,"60,",0,-2.96,-2.33,13,"Exon (ENSBGRT00000045377/ENSBGRG00000024591, exon 1 of 1)",4,34812215,34813276,1062,1]
["chr4",46583585,46584034,450,"ENSBGRG00000010569","ENSBGRT00000019456",40014,"STK17A","serine/threonine kinase 17a [Source:HGNC Symbol;Acc:HGNC:11395]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0016607(nuclear speck);GO:0035556(intracellular signal transduction);GO:0043065(positive regulation of apoptotic process);GO:2000271(positive regulation of fibroblast apoptotic process);GO:2000377(regulation of reactive oxygen species metabolic process)","NA",{"v":9.99999999999998e-265,"d":"0.00"},1,"450,",0,-264,-261,6.63,"3' UTR",4,46543571,46584363,40793,1]
["chr4",59252211,59252689,479,"ENSBGRG00000003342","ENSBGRT00000006239",145014,"ENSBGRG00000003342","NA","NA","NA",{"v":0.0068,"d":"0.01"},1,"479,",0,-2.17,-1.58,{"v":5.4,"d":"5.40"},"5' UTR",4,59107197,59306398,199202,1]
["chr4",61741644,61746247,4604,"ENSBGRG00000005217","ENSBGRT00000009663",42652,"FKBP9","FKBP prolyl isomerase 9 [Source:HGNC Symbol;Acc:HGNC:3725]","GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005509(calcium ion binding);GO:0005783(endoplasmic reticulum);GO:0006457(protein folding)","NA",{"v":9.99999999999998e-226,"d":"0.00"},2,"47,342,","0,4262",-225,-223,3.54,"3' UTR",4,61698992,61747082,48091,1]
["chr4",70525606,70533521,7916,"ENSBGRG00000001792","ENSBGRT00000003321",0,"LSMEM1","leucine rich single-pass membrane protein 1 [Source:HGNC Symbol;Acc:HGNC:22036]","GO:0005829(cytosol)","NA",{"v":0.015,"d":"0.02"},3,"127,129,131,","0,1919,7785",-1.83,-1.02,8.64,"Exon (ENSBGRT00000003321/ENSBGRG00000001792, exon 1 of 3)",4,70525606,70533521,7916,1]
["chr4",80409361,80434998,25638,"ENSBGRG00000008420","ENSBGRT00000015500",116751,"ATXN7L1","ataxin 7 like 1 [Source:HGNC Symbol;Acc:HGNC:22210]","NA","NA",{"v":3.2E-49,"d":"0.00"},2,"184,357,","0,25281",{"v":-48.5,"d":"-48.50"},{"v":-47.2,"d":"-47.20"},5.76,"3' UTR",4,80292610,80409544,116935,1]
["chr4",83577505,83603472,25968,"ENSBGRG00000013877","ENSBGRT00000025490",90315,"CCDC146","coiled-coil domain containing 146 [Source:HGNC Symbol;Acc:HGNC:29296]","GO:0005814(centriole)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);05016(Huntington disease);05169(Epstein-Barr virus infection)",{"v":0.0041,"d":"0.00"},9,"70,74,228,187,96,171,89,165,176,","0,2098,3053,3921,18487,19479,24080,24349,25792",-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000025490/ENSBGRG00000013877, exon 5 of 18)",4,83487190,83616121,128932,1]
["chr4",95992842,96004906,12065,"ENSBGRG00000000352","ENSBGRT00000000590",140005,"IGF2BP3","insulin like growth factor 2 mRNA binding protein 3 [Source:HGNC Symbol;Acc:HGNC:28868]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0048027(mRNA 5'-UTR binding)","NA",{"v":1.9e-08,"d":"0.00"},7,"71,75,75,132,132,114,384,","0,3566,7130,9472,10457,11279,11681",-7.72,-6.92,{"v":30.2,"d":"30.20"},"3' UTR",4,95852837,96005322,152486,1]
["chr4",101978221,101978340,120,"ENSBGRG00000002167","ENSBGRT00000004061",160907,"SNX13","sorting nexin 13 [Source:HGNC Symbol;Acc:HGNC:21335]","GO:0005769(early endosome);GO:0006886(intracellular protein transport);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0035091(phosphatidylinositol binding);GO:0043547(positive regulation of GTPase activity)","NA",{"v":2e-05,"d":"0.00"},1,"120,",0,-4.69,-3.98,{"v":3.6,"d":"3.60"},"3' UTR",4,101817314,101978817,161504,1]
["chr4",124322801,124445731,122931,"ENSBGRG00000021289","ENSBGRT00000039275",32418,"VWC2","von Willebrand factor C domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30200]","GO:0005515(protein binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0005615(extracellular space);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030514(negative regulation of BMP signaling pathway);GO:0031012(extracellular matrix);GO:0032281(AMPA glutamate receptor complex);GO:0045666(positive regulation of neuron differentiation)","03008(Ribosome biogenesis in eukaryotes)",{"v":7.4e-06,"d":"0.00"},2,"8,232,","0,122699",-5.13,-4.41,{"v":5.4,"d":"5.40"},"3' UTR",4,124290383,124445731,155349,1]
["chr4",7754812,7757799,2988,"ENSBGRG00000014774","ENSBGRT00000027152",26775,"ZNF777","zinc finger protein 777 [Source:HGNC Symbol;Acc:HGNC:22213]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":2E-16,"d":"0.00"},2,"65,55,","0,2933",{"v":-15.7,"d":"-15.70"},{"v":-14.7,"d":"-14.70"},2.64,"Exon (ENSBGRT00000027152/ENSBGRG00000014774, exon 6 of 7)",4,7752997,7784574,31578,2]
["chr4",8971764,8972536,773,"ENSBGRG00000006572","ENSBGRT00000012154",0,"ASB10","ankyrin repeat and SOCS box containing 10 [Source:HGNC Symbol;Acc:HGNC:17185]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0035556(intracellular signal transduction)","NA",{"v":0.028,"d":"0.03"},2,"56,422,","0,351",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000012154/ENSBGRG00000006572, exon 1 of 7)",4,8958709,8972536,13828,2]
["chr4",15755277,15755457,181,"ENSBGRG00000015840","ENSBGRT00000029145",77615,"VIPR2","vasoactive intestinal peptide receptor 2 [Source:HGNC Symbol;Acc:HGNC:12695]","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0004999(vasoactive intestinal polypeptide receptor activity);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction)",0,1,"181,",0,-437,"-Inf",4.24,"3' UTR",4,15755217,15833072,77856,2]
["chr4",18752469,18752678,210,"ENSBGRG00000001662","ENSBGRT00000003160",119,"UBN2","ubinuclein 2 [Source:HGNC Symbol;Acc:HGNC:21931]","GO:0005634(nucleus);GO:0005654(nucleoplasm)","NA",{"v":8.1e-06,"d":"0.00"},1,"210,",0,-5.09,-4.37,13,"Exon (ENSBGRT00000003160/ENSBGRG00000001662, exon 1 of 15)",4,18661029,18752797,91769,2]
["chr4",29294629,29294749,121,"ENSBGRG00000008318","ENSBGRT00000016568",0,"AHCYL2","adenosylhomocysteinase like 2 [Source:HGNC Symbol;Acc:HGNC:22204]","GO:0004013(adenosylhomocysteinase activity);GO:0005829(cytosol);GO:0043005(neuron projection);GO:0043231(intracellular membrane-bounded organelle)","00270(Cysteine and methionine metabolism)",{"v":4.1E-5,"d":"0.00"},1,"121,",0,-4.39,-3.69,{"v":11.9,"d":"11.90"},"5' UTR",4,29087002,29294749,207748,2]
["chr4",29707791,29712221,4431,"ENSBGRG00000022169","ENSBGRT00000041014",12480,"CCDC136","coiled-coil domain containing 136 [Source:HGNC Symbol;Acc:HGNC:22225]","NA","04010(MAPK signaling pathway);04510(Focal adhesion);05205(Proteoglycans in cancer);05132(Salmonella infection)",{"v":0.015,"d":"0.02"},2,"97,53,","0,4378",-1.83,-1.02,8.64,"Exon (ENSBGRT00000041014/ENSBGRG00000022169, exon 5 of 18)",4,29693941,29724701,30761,2]
["chr4",44820886,44821957,1072,"ENSBGRG00000009720","ENSBGRT00000017863",329290,"GLI3","GLI family zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:4319]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001656(metanephros development);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001701(in utero embryonic development);GO:0001822(kidney development);GO:0002052(positive regulation of neuroblast proliferation);GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005929(cilium);GO:0005930(axoneme);GO:0006355(regulation of transcription, DNA-templated);GO:0007224(smoothened signaling pathway);GO:0007389(pattern specification process);GO:0007411(axon guidance);GO:0007417(central nervous system development);GO:0007420(brain development);GO:0007442(hindgut morphogenesis);GO:0007507(heart development);GO:0008013(beta-catenin binding);GO:0008285(negative regulation of cell population proliferation);GO:0009952(anterior/posterior pattern specification);GO:0009953(dorsal/ventral pattern formation);GO:0009954(proximal/distal pattern formation);GO:0010468(regulation of gene expression);GO:0016485(protein processing);GO:0016607(nuclear speck);GO:0017053(transcriptional repressor complex);GO:0021513(spinal cord dorsal/ventral patterning);GO:0021522(spinal cord motor neuron differentiation);GO:0021537(telencephalon development);GO:0021543(pallium development);GO:0021544(subpallium development);GO:0021631(optic nerve morphogenesis);GO:0021766(hippocampus development);GO:0021775(smoothened signaling pathway involved in ventral spinal cord interneuron specification);GO:0021776(smoothened signaling pathway involved in spinal cord motor neuron cell fate specification);GO:0021798(forebrain dorsal/ventral pattern formation);GO:0021801(cerebral cortex radial glia guided migration);GO:0021819(layer formation in cerebral cortex);GO:0021861(forebrain radial glial cell differentiation);GO:0021915(neural tube development);GO:0022018(lateral ganglionic eminence cell proliferation);GO:0030318(melanocyte differentiation);GO:0030324(lung development);GO:0030326(embryonic limb morphogenesis);GO:0030879(mammary gland development);GO:0030900(forebrain development);GO:0032332(positive regulation of chondrocyte differentiation);GO:0033077(T cell differentiation in thymus);GO:0035035(histone acetyltransferase binding);GO:0035108(limb morphogenesis);GO:0035295(tube development);GO:0036033(mediator complex binding);GO:0042127(regulation of cell population proliferation);GO:0042307(positive regulation of protein import into nucleus);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042733(embryonic digit morphogenesis);GO:0042826(histone deacetylase binding);GO:0042981(regulation of apoptotic process);GO:0043010(camera-type eye development);GO:0043066(negative regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0043586(tongue development);GO:0045060(negative thymic T cell selection);GO:0045595(regulation of cell differentiation);GO:0045596(negative regulation of cell differentiation);GO:0045665(negative regulation of neuron differentiation);GO:0045669(positive regulation of osteoblast differentiation);GO:0045879(negative regulation of smoothened signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046638(positive regulation of alpha-beta T cell differentiation);GO:0046639(negative regulation of alpha-beta T cell differentiation);GO:0048557(embryonic digestive tract morphogenesis);GO:0048566(embryonic digestive tract development);GO:0048568(embryonic organ development);GO:0048589(developmental growth);GO:0048593(camera-type eye morphogenesis);GO:0048598(embryonic morphogenesis);GO:0048646(anatomical structure formation involved in morphogenesis);GO:0048663(neuron fate commitment);GO:0048702(embryonic neurocranium morphogenesis);GO:0048704(embryonic skeletal system morphogenesis);GO:0048709(oligodendrocyte differentiation);GO:0048754(branching morphogenesis of an epithelial tube);GO:0048839(inner ear development);GO:0048856(anatomical structure development);GO:0060021(roof of mouth development);GO:0060173(limb development);GO:0060364(frontal suture morphogenesis);GO:0060366(lambdoid suture morphogenesis);GO:0060367(sagittal suture morphogenesis);GO:0060594(mammary gland specification);GO:0060831(smoothened signaling pathway involved in dorsal/ventral neural tube patterning);GO:0060840(artery development);GO:0060873(anterior semicircular canal development);GO:0060875(lateral semicircular canal development);GO:0061005(cell differentiation involved in kidney development);GO:0070242(thymocyte apoptotic process);GO:0071625(vocalization behavior);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:1901620(regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning);GO:1903010(regulation of bone development);GO:1990837(sequence-specific double-stranded DNA binding)","04340(Hedgehog signaling pathway);04024(cAMP signaling pathway);05200(Pathways in cancer);05217(Basal cell carcinoma)",{"v":4e-33,"d":"0.00"},2,"23,368,","0,704",{"v":-32.4,"d":"-32.40"},{"v":-31.3,"d":"-31.30"},5.86,"Exon (ENSBGRT00000017863/ENSBGRG00000009720, exon 14 of 17)",4,44818966,45151247,332282,2]
["chr4",54029299,54029612,314,"ENSBGRG00000001429","ENSBGRT00000002606",29,"ENSBGRG00000001429","NA","GO:0009055(electron transfer activity);GO:0020037(heme binding)","04210(Apoptosis);04215(Apoptosis - multiple species);04115(p53 signaling pathway);05200(Pathways in cancer);05210(Colorectal cancer);05222(Small cell lung cancer);05010(Alzheimer disease);05012(Parkinson disease);05014(Amyotrophic lateral sclerosis (ALS));05016(Huntington disease);05416(Viral myocarditis);04932(Non-alcoholic fatty liver disease (NAFLD));05134(Legionellosis);05152(Tuberculosis);05164(Influenza A);05161(Hepatitis B);05168(Herpes simplex infection);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05145(Toxoplasmosis);01524(Platinum drug resistance)",{"v":1e-21,"d":"0.00"},2,"57,148,","0,166",-21,-20,1.77,"Exon (ENSBGRT00000002606/ENSBGRG00000001429, exon 1 of 3)",4,53994518,54029641,35124,2]
["chr4",58845228,58846829,1602,"ENSBGRG00000002924","ENSBGRT00000005532",36537,"SCRN1","secernin 1 [Source:HGNC Symbol;Acc:HGNC:22192]","GO:0005634(nucleus);GO:0006508(proteolysis);GO:0016805(dipeptidase activity);GO:0031965(nuclear membrane)","NA",{"v":1.6e-19,"d":"0.00"},2,"385,34,","0,1568",{"v":-18.8,"d":"-18.80"},{"v":-17.8,"d":"-17.80"},2.44,"3' UTR",4,58843287,58883366,40080,2]
["chr4",63650665,63650995,331,"ENSBGRG00000007646","ENSBGRT00000014033",103360,"DPY19L1","dpy-19 like C-mannosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:22205]","GO:0016021(integral component of membrane)","NA",{"v":1E-135,"d":"0.00"},1,"331,",0,-135,-133,3.09,"3' UTR",4,63650665,63754355,103691,2]
["chr4",76346493,76348243,1751,"ENSBGRG00000004719","ENSBGRT00000008705",97013,"CTTNBP2","cortactin binding protein 2 [Source:HGNC Symbol;Acc:HGNC:15679]","GO:0005515(protein binding)","NA",{"v":1.6E-13,"d":"0.00"},2,"111,459,","0,1292",{"v":-12.8,"d":"-12.80"},{"v":-11.9,"d":"-11.90"},3.76,"Exon (ENSBGRT00000008705/ENSBGRG00000004719, exon 5 of 26)",4,76261163,76445256,184094,2]
["chr4",79137894,79137953,60,"ENSBGRG00000007268","ENSBGRT00000013367",3583,"PIK3CG","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [Source:HGNC Symbol;Acc:HGNC:8978]","GO:0001932(regulation of protein phosphorylation);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005944(phosphatidylinositol 3-kinase complex, class IB);GO:0006468(protein phosphorylation);GO:0007186(G protein-coupled receptor signaling pathway);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0042802(identical protein binding);GO:0043085(positive regulation of catalytic activity);GO:0043406(positive regulation of MAP kinase activity);GO:0046854(phosphatidylinositol phosphorylation);GO:0046875(ephrin receptor binding);GO:0048015(phosphatidylinositol-mediated signaling);GO:0051897(positive regulation of protein kinase B signaling);GO:0071320(cellular response to cAMP);GO:1903169(regulation of calcium ion transmembrane transport);GO:2000270(negative regulation of fibroblast apoptotic process)","00562(Inositol phosphate metabolism);04371(Apelin signaling pathway);04072(Phospholipase D signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04611(Platelet activation);04921(Oxytocin signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04725(Cholinergic synapse);05167(Kaposi sarcoma-associated herpesvirus infection);05145(Toxoplasmosis)",{"v":4.6e-07,"d":"0.00"},1,"60,",0,-6.34,-5.58,{"v":10.4,"d":"10.40"},"Exon (ENSBGRT00000013367/ENSBGRG00000007268, exon 2 of 11)",4,79055918,79141536,85619,2]
["chr4",83234131,83244212,10082,"ENSBGRG00000011795","ENSBGRT00000023906",99137,"FBXL13","F-box and leucine rich repeat protein 13 [Source:HGNC Symbol;Acc:HGNC:21658]","GO:0005515(protein binding)","NA",0,2,"77,549,","0,9533",-435,"-Inf",4.55,"Exon (ENSBGRT00000024602/ENSBGRG00000013432, exon 1 of 4)",4,83134994,83360516,225523,1]
["chr4",100512996,100513384,389,"ENSBGRG00000001751","ENSBGRT00000003470",629887,"HDAC9","histone deacetylase 9 [Source:HGNC Symbol;Acc:HGNC:14065]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0004407(histone deacetylase activity);GO:0005080(protein kinase C binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006325(chromatin organization);GO:0008134(transcription factor binding);GO:0016575(histone deacetylation);GO:0032869(cellular response to insulin stimulus);GO:0033558(protein deacetylase activity);GO:0034739(histone deacetylase activity (H4-K16 specific));GO:0034983(peptidyl-lysine deacetylation);GO:0042632(cholesterol homeostasis);GO:0042826(histone deacetylase binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0050710(negative regulation of cytokine secretion);GO:0051005(negative regulation of lipoprotein lipase activity);GO:0070491(repressing transcription factor binding);GO:0070932(histone H3 deacetylation);GO:0070933(histone H4 deacetylation);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis);GO:1990678(histone H4-K16 deacetylation)","05203(Viral carcinogenesis);05034(Alcoholism);05165(Human papillomavirus infection)",{"v":0.0078,"d":"0.01"},1,"389,",0,-2.11,-1.53,9.72,"3' UTR",4,100512996,101143271,630276,2]
["chr4",113162984,113163283,300,"ENSBGRG00000006953","ENSBGRT00000012811",23438,"ENSBGRG00000006953","NA","NA","NA",{"v":0.0021,"d":"0.00"},1,"300,",0,-2.67,-2.06,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000012811/ENSBGRG00000006953, exon 2 of 2)",4,113159457,113186721,27265,2]
["chr4",118669802,118674265,4464,"ENSBGRG00000015452","ENSBGRT00000028390",0,"GNG11","G protein subunit gamma 11 [Source:HGNC Symbol;Acc:HGNC:4403]","GO:0003924(GTPase activity);GO:0005834(heterotrimeric G-protein complex);GO:0007186(G protein-coupled receptor signaling pathway)","04014(Ras signaling pathway);04371(Apelin signaling pathway);04151(PI3K-Akt signaling pathway);04062(Chemokine signaling pathway);04926(Relaxin signaling pathway);04724(Glutamatergic synapse);04727(GABAergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);04713(Circadian entrainment);05200(Pathways in cancer);05032(Morphine addiction);05034(Alcoholism);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection)",0,2,"126,96,","0,4368",-639,"-Inf",{"v":2.3,"d":"2.30"},"Exon (ENSBGRT00000028390/ENSBGRG00000015452, exon 1 of 2)",4,118669802,118674265,4464,2]
["chr5",670914,671150,237,"ENSBGRG00000009725","ENSBGRT00000017834",6040,"GDF3","growth differentiation factor 3 [Source:HGNC Symbol;Acc:HGNC:4218]","GO:0001501(skeletal system development);GO:0001654(eye development);GO:0001701(in utero embryonic development);GO:0002021(response to dietary excess);GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0007492(endoderm development);GO:0007498(mesoderm development);GO:0008083(growth factor activity);GO:0010453(regulation of cell fate commitment);GO:0019901(protein kinase binding);GO:0030514(negative regulation of BMP signaling pathway);GO:0030903(notochord development);GO:0032525(somite rostral/caudal axis specification);GO:0045600(positive regulation of fat cell differentiation);GO:0045605(negative regulation of epidermal cell differentiation);GO:0045662(negative regulation of myoblast differentiation);GO:0048859(formation of anatomical boundary);GO:0090009(primitive streak formation)","04060(Cytokine-cytokine receptor interaction)",{"v":0.0055,"d":"0.01"},1,"237,",0,-2.26,-1.67,4.32,"Exon (ENSBGRT00000017834/ENSBGRG00000009725, exon 2 of 2)",5,664874,671387,6514,1]
["chr5",4994522,4994640,119,"ENSBGRG00000000781","ENSBGRT00000001407",0,"APOLD1","apolipoprotein L domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25268]","GO:0005576(extracellular region);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006869(lipid transport);GO:0008289(lipid binding);GO:0042157(lipoprotein metabolic process)","NA",{"v":3.8e-05,"d":"0.00"},1,"119,",0,-4.42,-3.72,{"v":18.4,"d":"18.40"},"Exon (ENSBGRT00000001407/ENSBGRG00000000781, exon 1 of 1)",5,4994522,4995262,741,1]
["chr5",8406634,8406693,60,"ENSBGRG00000002181","ENSBGRT00000004077",22624,"STRAP","serine/threonine kinase receptor associated protein [Source:HGNC Symbol;Acc:HGNC:30796]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000387(spliceosomal snRNP assembly);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0010633(negative regulation of epithelial cell migration);GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0030277(maintenance of gastrointestinal epithelium);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032797(SMN complex);GO:0034719(SMN-Sm protein complex);GO:0050680(negative regulation of epithelial cell proliferation);GO:0060394(negative regulation of pathway-restricted SMAD protein phosphorylation)","03013(RNA transport)",{"v":1E-26,"d":"0.00"},1,"60,",0,-26,-25,1.52,"Exon (ENSBGRT00000004077/ENSBGRG00000002181, exon 10 of 10)",5,8384010,8406693,22684,1]
["chr5",19484412,19485177,766,"ENSBGRG00000001611","ENSBGRT00000003012",94180,"RASSF8","Ras association domain family member 8 [Source:HGNC Symbol;Acc:HGNC:13232]","GO:0007165(signal transduction);GO:0034334(adherens junction maintenance)","NA",{"v":0.028,"d":"0.03"},2,"113,184,","0,582",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"3' UTR",5,19390232,19484524,94293,1]
["chr5",25994476,25994835,360,"ENSBGRG00000004628","ENSBGRT00000008520",4094,"RESF1","retroelement silencing factor 1 [Source:HGNC Symbol;Acc:HGNC:25559]","NA","NA",{"v":1e-121,"d":"0.00"},1,"360,",0,-121,-119,3.97,"Exon (ENSBGRT00000008520/ENSBGRG00000004628, exon 1 of 1)",5,25990382,25995223,4842,1]
["chr5",28607553,28607733,181,"ENSBGRG00000006576","ENSBGRT00000012119",43259,"ENSBGRG00000006576","interleukin 2 receptor subunit beta [Source:HGNC Symbol;Acc:HGNC:6009]","GO:0004896(cytokine receptor activity);GO:0005515(protein binding);GO:0016020(membrane)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04144(Endocytosis);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05166(HTLV-I infection);05162(Measles)",{"v":1e-101,"d":"0.00"},1,"181,",0,-101,{"v":-99.4,"d":"-99.40"},3.92,"3' UTR",5,28564294,28608301,44008,1]
["chr5",29824611,29824821,211,"ENSBGRG00000009469","ENSBGRT00000017359",5729,"ENSBGRG00000009469","NA","GO:0005576(extracellular region);GO:0006869(lipid transport);GO:0008289(lipid binding);GO:0042157(lipoprotein metabolic process)","NA",{"v":1.6e-14,"d":"0.00"},1,"211,",0,{"v":-13.8,"d":"-13.80"},{"v":-12.9,"d":"-12.90"},4.86,"3' UTR",5,29818882,29824970,6089,1]
["chr5",38988946,38989155,210,"ENSBGRG00000000290","ENSBGRT00000000470",65631,"IGF1","insulin like growth factor 1 [Source:HGNC Symbol;Acc:HGNC:5464]","GO:0000187(activation of MAPK activity);GO:0001775(cell activation);GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005178(integrin binding);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0008083(growth factor activity);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0009408(response to heat);GO:0010468(regulation of gene expression);GO:0010560(positive regulation of glycoprotein biosynthetic process);GO:0010613(positive regulation of cardiac muscle hypertrophy);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0014834(skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration);GO:0014896(muscle hypertrophy);GO:0014904(myotube cell development);GO:0014911(positive regulation of smooth muscle cell migration);GO:0030166(proteoglycan biosynthetic process);GO:0030335(positive regulation of cell migration);GO:0032148(activation of protein kinase B activity);GO:0032691(negative regulation of interleukin-1 beta production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0034392(negative regulation of smooth muscle cell apoptotic process);GO:0035630(bone mineralization involved in bone maturation);GO:0035867(alphav-beta3 integrin-IGF-1-IGF1R complex);GO:0040014(regulation of multicellular organism growth);GO:0042060(wound healing);GO:0042104(positive regulation of activated T cell proliferation);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042567(insulin-like growth factor ternary complex);GO:0043066(negative regulation of apoptotic process);GO:0043388(positive regulation of DNA binding);GO:0043410(positive regulation of MAPK cascade);GO:0043491(protein kinase B signaling);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045445(myoblast differentiation);GO:0045669(positive regulation of osteoblast differentiation);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045821(positive regulation of glycolytic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046326(positive regulation of glucose import);GO:0046579(positive regulation of Ras protein signal transduction);GO:0048009(insulin-like growth factor receptor signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0048146(positive regulation of fibroblast proliferation);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050714(positive regulation of protein secretion);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050821(protein stabilization);GO:0051450(myoblast proliferation);GO:0060283(negative regulation of oocyte development);GO:0061051(positive regulation of cell growth involved in cardiac muscle cell development);GO:0070371(ERK1 and ERK2 cascade);GO:0070886(positive regulation of calcineurin-NFAT signaling cascade);GO:0150079(negative regulation of neuroinflammatory response);GO:1902430(negative regulation of amyloid-beta formation);GO:1904075(positive regulation of trophectodermal cell proliferation);GO:1904646(cellular response to amyloid-beta);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1905460(negative regulation of vascular associated smooth muscle cell apoptotic process);GO:2000679(positive regulation of transcription regulatory region DNA binding);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04114(Oocyte meiosis);04115(p53 signaling pathway);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04913(Ovarian Steroidogenesis);04914(Progesterone-mediated oocyte maturation);04960(Aldosterone-regulated sodium reabsorption);04730(Long-term depression);04750(Inflammatory mediator regulation of TRP channels);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05205(Proteoglycans in cancer);05214(Glioma);05218(Melanoma);05215(Prostate cancer);05224(Breast cancer);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM));01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance)",{"v":7.9e-13,"d":"0.00"},1,"210,",0,{"v":-12.1,"d":"-12.10"},{"v":-11.2,"d":"-11.20"},3.92,"3' UTR",5,38923315,38989200,65886,1]
["chr5",47517511,47517718,208,"ENSBGRG00000000850","ENSBGRT00000001540",2124,"SUOX","sulfite oxidase [Source:HGNC Symbol;Acc:HGNC:11460]","GO:0016491(oxidoreductase activity);GO:0020037(heme binding);GO:0030151(molybdenum ion binding);GO:0055114(oxidation-reduction process)","00920(Sulfur metabolism)",{"v":3.2e-52,"d":"0.00"},1,"208,",0,{"v":-51.5,"d":"-51.50"},{"v":-50.1,"d":"-50.10"},3.66,"Exon (ENSBGRT00000001540/ENSBGRG00000000850, exon 2 of 2)",5,47515387,47518223,2837,1]
["chr5",48639166,48639463,298,"ENSBGRG00000004277","ENSBGRT00000007947",2079,"NAB2","NGFI-A binding protein 2 [Source:HGNC Symbol;Acc:HGNC:7627]","GO:0001958(endochondral ossification);GO:0003712(transcription coregulator activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0014037(Schwann cell differentiation);GO:0016480(negative regulation of transcription by RNA polymerase III);GO:0042552(myelination);GO:0042802(identical protein binding);GO:0045682(regulation of epidermis development);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":9.99999999999998e-267,"d":"0.00"},1,"298,",0,-266,-263,{"v":11.7,"d":"11.70"},"Exon (ENSBGRT00000007947/ENSBGRG00000004277, exon 2 of 7)",5,48637087,48642649,5563,1]
["chr5",57183781,57183990,210,"ENSBGRG00000018023","ENSBGRT00000033175",715,"LEMD3","LEM domain containing 3 [Source:HGNC Symbol;Acc:HGNC:28887]","GO:0003676(nucleic acid binding);GO:0005637(nuclear inner membrane);GO:0006997(nucleus organization);GO:0016021(integral component of membrane);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030514(negative regulation of BMP signaling pathway);GO:0031965(nuclear membrane);GO:0032926(negative regulation of activin receptor signaling pathway);GO:1902531(regulation of intracellular signal transduction)","NA",{"v":1.3E-25,"d":"0.00"},1,"210,",0,{"v":-24.9,"d":"-24.90"},{"v":-23.8,"d":"-23.80"},5.45,"Exon (ENSBGRT00000033175/ENSBGRG00000018023, exon 1 of 13)",5,57183066,57266277,83212,1]
["chr5",59538196,59538405,210,"ENSBGRG00000020115","ENSBGRT00000037570",30166,"CAND1","cullin associated and neddylation dissociated 1 [Source:HGNC Symbol;Acc:HGNC:30688]","GO:0000151(ubiquitin ligase complex);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0010265(SCF complex assembly);GO:0016567(protein ubiquitination);GO:0030154(cell differentiation);GO:0031461(cullin-RING ubiquitin ligase complex);GO:0043086(negative regulation of catalytic activity)","NA",{"v":7.9e-66,"d":"0.00"},1,"210,",0,{"v":-65.1,"d":"-65.10"},{"v":-63.6,"d":"-63.60"},5.83,"Exon (ENSBGRT00000037570/ENSBGRG00000020115, exon 11 of 16)",5,59508030,59545014,36985,1]
["chr5",68556195,68556434,240,"ENSBGRG00000017994","ENSBGRT00000033376",295731,"PPHLN1","periphilin 1 [Source:HGNC Symbol;Acc:HGNC:19369]","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0045814(negative regulation of gene expression, epigenetic);GO:0045892(negative regulation of transcription, DNA-templated);GO:0090309(positive regulation of methylation-dependent chromatin silencing);GO:0097355(protein localization to heterochromatin)","NA",{"v":0.00038,"d":"0.00"},1,"240,",0,-3.42,-2.77,5.13,"3' UTR",5,68260464,68556434,295971,1]
["chr5",74803394,74803543,150,"ENSBGRG00000023644","ENSBGRT00000043713",9761,"SLC48A1","solute carrier family 48 member 1 [Source:HGNC Symbol;Acc:HGNC:26035]","GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0010008(endosome membrane);GO:0015232(heme transporter activity);GO:0015886(heme transport);GO:0020037(heme binding)","NA",{"v":5.2E-7,"d":"0.00"},1,"150,",0,-6.28,-5.52,2.38,"3' UTR",5,74793633,74804287,10655,1]
["chr5",77298198,77298745,548,"ENSBGRG00000001878","ENSBGRT00000003726",20171,"PRPF40B","pre-mRNA processing factor 40 homolog B [Source:HGNC Symbol;Acc:HGNC:25031]","GO:0005515(protein binding);GO:0045292(mRNA cis splicing, via spliceosome)","03040(Spliceosome)",{"v":2E-41,"d":"0.00"},3,"19,62,100,","0,266,448",{"v":-40.7,"d":"-40.70"},{"v":-39.4,"d":"-39.40"},1.75,"Exon (ENSBGRT00000003726/ENSBGRG00000001878, exon 23 of 26)",5,77278027,77299974,21948,1]
["chr5",81050909,81051516,608,"ENSBGRG00000003298","ENSBGRT00000006153",37742,"SP1","Sp1 transcription factor [Source:HGNC Symbol;Acc:HGNC:11205]","GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0004672(protein kinase activity);GO:0004675(transmembrane receptor protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005719(nuclear euchromatin);GO:0006355(regulation of transcription, DNA-templated);GO:0006468(protein phosphorylation);GO:0007178(transmembrane receptor protein serine/threonine kinase signaling pathway);GO:0008022(protein C-terminus binding);GO:0008134(transcription factor binding);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0017053(transcriptional repressor complex);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0043565(sequence-specific DNA binding);GO:0043923(positive regulation by host of viral transcription);GO:0045766(positive regulation of angiogenesis);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0070491(repressing transcription factor binding);GO:0071837(HMG box domain binding);GO:1902004(positive regulation of amyloid-beta formation);GO:1904828(positive regulation of hydrogen sulfide biosynthetic process);GO:1905564(positive regulation of vascular endothelial cell proliferation);GO:1990837(sequence-specific double-stranded DNA binding)","04350(TGF-beta signaling pathway);04060(Cytokine-cytokine receptor interaction);04137(Mitophagy - animal);04915(Estrogen signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);04927(Cortisol synthesis and secretion);05200(Pathways in cancer);05231(Choline metabolism in cancer);05202(Transcriptional misregulation in cancers);05224(Breast cancer);05016(Huntington disease);04934(Cushing syndrome);05163(Human cytomegalovirus infection);01522(Endocrine resistance)",{"v":1.6e-30,"d":"0.00"},2,"64,146,","0,462",{"v":-29.8,"d":"-29.80"},{"v":-28.7,"d":"-28.70"},3.31,"Exon (ENSBGRT00000006153/ENSBGRG00000003298, exon 6 of 7)",5,81013167,81052512,39346,1]
["chr5",83034520,83034669,150,"ENSBGRG00000000973","ENSBGRT00000001926",7282,"FGD6","FYVE, RhoGEF and PH domain containing 6 [Source:HGNC Symbol;Acc:HGNC:21740]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0043087(regulation of GTPase activity);GO:0046872(metal ion binding)","NA",{"v":7.6e-08,"d":"0.00"},1,"150,",0,-7.12,-6.34,3.41,"Exon (ENSBGRT00000001926/ENSBGRG00000000973, exon 2 of 21)",5,83027238,83134906,107669,1]
["chr5",88958400,88968433,10034,"ENSBGRG00000002414","ENSBGRT00000004607",65210,"ATP2B1","ATPase plasma membrane Ca2+ transporting 1 [Source:HGNC Symbol;Acc:HGNC:814]","GO:0000166(nucleotide binding);GO:0001772(immunological synapse);GO:0001818(negative regulation of cytokine production);GO:0003056(regulation of vascular smooth muscle contraction);GO:0005388(calcium transmembrane transporter activity, phosphorylative mechanism);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006874(cellular calcium ion homeostasis);GO:0008217(regulation of blood pressure);GO:0015085(calcium ion transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016887(ATPase activity);GO:0030501(positive regulation of bone mineralization);GO:0051480(regulation of cytosolic calcium ion concentration);GO:0051481(negative regulation of cytosolic calcium ion concentration);GO:0051928(positive regulation of calcium ion transport);GO:0070588(calcium ion transmembrane transport);GO:1900076(regulation of cellular response to insulin stimulus);GO:1990034(calcium ion export across plasma membrane)","04020(Calcium signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04925(Aldosterone synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04970(Salivary secretion);04972(Pancreatic secretion)",0,3,"51,87,668,","0,439,9366",-453,"-Inf",4.86,"3' UTR",5,88893190,88968433,75244,1]
["chr5",90733245,90740455,7211,"ENSBGRG00000002890","ENSBGRT00000005410",0,"ENSBGRG00000002890","NA","NA","NA",{"v":3.2e-19,"d":"0.00"},3,"15,173,83,","0,3415,7128",{"v":-18.5,"d":"-18.50"},{"v":-17.5,"d":"-17.50"},{"v":2.6,"d":"2.60"},"Exon (ENSBGRT00000005351/ENSBGRG00000002844, exon 48 of 55)",5,90733728,90734738,1011,2]
["chr5",110368115,110368203,89,"ENSBGRG00000020276","ENSBGRT00000037314",1947,"ENSBGRG00000020276","NA","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis)","04145(Phagosome);04610(Complement and coagulation cascades);05322(Systemic lupus erythematosus);05133(Pertussis);05150(Staphylococcus aureus infection)",{"v":7.9e-32,"d":"0.00"},1,"89,",0,{"v":-31.1,"d":"-31.10"},-30,1.41,"Exon (ENSBGRT00000037314/ENSBGRG00000020276, exon 4 of 4)",5,110366168,110368203,2036,1]
["chr5",111083714,111083894,181,"ENSBGRG00000001292","ENSBGRT00000002367",2459,"ENSBGRG00000001292","NA","GO:0006397(mRNA processing)","03013(RNA transport);03015(mRNA surveillance pathway)",{"v":6.9E-10,"d":"0.00"},1,"181,",0,-9.16,-8.33,3.51,"Exon (ENSBGRT00000002367/ENSBGRG00000001292, exon 2 of 2)",5,111081255,111084014,2760,1]
["chr5",113619285,113634809,15525,"ENSBGRG00000012734","ENSBGRT00000023373",0,"CRACR2A","calcium release activated channel regulator 2A [Source:HGNC Symbol;Acc:HGNC:28657]","GO:0002115(store-operated calcium entry);GO:0003924(GTPase activity);GO:0005509(calcium ion binding);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0032237(activation of store-operated calcium channel activity);GO:0051928(positive regulation of calcium ion transport)","NA",{"v":0.028,"d":"0.03"},4,"251,112,184,48,","0,9780,11129,15477",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",5,113619285,113697131,77847,1]
["chr5",115190383,115190443,61,"ENSBGRG00000017585","ENSBGRT00000032325",299,"WNK1","WNK lysine deficient protein kinase 1 [Source:HGNC Symbol;Acc:HGNC:14540]","GO:0003084(positive regulation of systemic arterial blood pressure);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0006811(ion transport);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0034260(negative regulation of GTPase activity);GO:0038116(chemokine (C-C motif) ligand 21 signaling pathway);GO:0050794(regulation of cellular process);GO:0050852(T cell receptor signaling pathway);GO:0090188(negative regulation of pancreatic juice secretion);GO:0097022(lymphocyte migration into lymph node);GO:1990869(cellular response to chemokine)","NA",{"v":3.8e-07,"d":"0.00"},1,"61,",0,-6.42,-5.65,8.28,"Exon (ENSBGRT00000032325/ENSBGRG00000017585, exon 1 of 29)",5,115190084,115332364,142281,1]
["chr5",117460657,117461114,458,"ENSBGRG00000001197","ENSBGRT00000002195",6316,"ENSBGRG00000001197","NA","GO:0005730(nucleolus)","NA",{"v":7.9e-51,"d":"0.00"},2,"15,135,","0,323",{"v":-50.1,"d":"-50.10"},{"v":-48.8,"d":"-48.80"},7.08,"Exon (ENSBGRT00000002195/ENSBGRG00000001197, exon 6 of 6)",5,117454341,117461216,6876,1]
["chr5",119129146,119129445,300,"ENSBGRG00000003347","ENSBGRT00000006252",996,"ENSBGRG00000003347","NA","GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II)","04141(Protein processing in endoplasmic reticulum);04010(MAPK signaling pathway);04668(TNF signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04137(Mitophagy - animal);04210(Apoptosis);04911(Insulin secretion);04922(Glucagon signaling pathway);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04926(Relaxin signaling pathway);04918(Thyroid hormone synthesis);04928(Parathyroid hormone synthesis, secretion and action);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04725(Cholinergic synapse);04728(Dopaminergic synapse);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04211(Longevity regulating pathway - mammal);05203(Viral carcinogenesis);05215(Prostate cancer);05030(Cocaine addiction);05031(Amphetamine addiction);05034(Alcoholism);04932(Non-alcoholic fatty liver disease (NAFLD));04934(Cushing syndrome);05166(HTLV-I infection);05161(Hepatitis B);05163(Human cytomegalovirus infection)",0,1,"300,",0,-1690,"-Inf",3.37,"3' UTR",5,119128150,119129475,1326,1]
["chr5",120703655,120703924,270,"ENSBGRG00000006401","ENSBGRT00000012064",67540,"EP300","E1A binding protein p300 [Source:HGNC Symbol;Acc:HGNC:3373]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000123(histone acetyltransferase complex);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001666(response to hypoxia);GO:0001756(somitogenesis);GO:0001966(thigmotaxis);GO:0002039(p53 binding);GO:0002209(behavioral defense response);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003684(damaged DNA binding);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0004468(lysine N-acetyltransferase activity, acting on acetyl phosphate as donor);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005829(cytosol);GO:0006110(regulation of glycolytic process);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006473(protein acetylation);GO:0006475(internal protein amino acid acetylation);GO:0006915(apoptotic process);GO:0006990(positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response);GO:0007507(heart development);GO:0007519(skeletal muscle tissue development);GO:0007611(learning or memory);GO:0007623(circadian rhythm);GO:0008013(beta-catenin binding);GO:0008022(protein C-terminus binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0009887(animal organ morphogenesis);GO:0010628(positive regulation of gene expression);GO:0010742(macrophage derived foam cell differentiation);GO:0010821(regulation of mitochondrion organization);GO:0010976(positive regulation of neuron projection development);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0016746(transferase activity, transferring acyl groups);GO:0018076(N-terminal peptidyl-lysine acetylation);GO:0018393(internal peptidyl-lysine acetylation);GO:0018394(peptidyl-lysine acetylation);GO:0030183(B cell differentiation);GO:0030220(platelet formation);GO:0030324(lung development);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0031333(negative regulation of protein-containing complex assembly);GO:0031490(chromatin DNA binding);GO:0031648(protein destabilization);GO:0032092(positive regulation of protein binding);GO:0032991(protein-containing complex);GO:0033613(activating transcription factor binding);GO:0034644(cellular response to UV);GO:0035257(nuclear hormone receptor binding);GO:0035264(multicellular organism growth);GO:0035855(megakaryocyte development);GO:0036268(swimming);GO:0042025(host cell nucleus);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0043627(response to estrogen);GO:0043923(positive regulation by host of viral transcription);GO:0043967(histone H4 acetylation);GO:0043969(histone H2B acetylation);GO:0045444(fat cell differentiation);GO:0045721(negative regulation of gluconeogenesis);GO:0045815(positive regulation of gene expression, epigenetic);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050681(androgen receptor binding);GO:0050821(protein stabilization);GO:0051059(NF-kappaB binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060325(face morphogenesis);GO:0060765(regulation of androgen receptor signaling pathway);GO:0061733(peptide-lysine-N-acetyltransferase activity);GO:0061920(protein propionyltransferase activity);GO:0061921(peptidyl-lysine propionylation);GO:0090043(regulation of tubulin deacetylation);GO:0097157(pre-mRNA intronic binding);GO:0097677(STAT family protein binding);GO:0140065(peptide butyryltransferase activity);GO:0140066(peptidyl-lysine crotonylation);GO:0140067(peptidyl-lysine butyrylation);GO:0140068(histone crotonyltransferase activity);GO:0140069(histone butyryltransferase activity);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1905636(positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding)","04310(Wnt signaling pathway);04330(Notch signaling pathway);04350(TGF-beta signaling pathway);04630(Jak-STAT signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04024(cAMP signaling pathway);04110(Cell cycle);04520(Adherens junction);04922(Glucagon signaling pathway);04919(Thyroid hormone signaling pathway);04916(Melanogenesis);04720(Long-term potentiation);05200(Pathways in cancer);05206(MicroRNAs in cancer);05203(Viral carcinogenesis);05211(Renal cell carcinoma);05215(Prostate cancer);05016(Huntington disease);05152(Tuberculosis);05166(HTLV-I infection);05164(Influenza A);05161(Hepatitis B);05168(Herpes simplex infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection)",0,1,"270,",0,-367,"-Inf",4.03,"Exon (ENSBGRT00000012064/ENSBGRG00000006401, exon 32 of 32)",5,120636115,120703924,67810,1]
["chr5",124443808,124445612,1805,"ENSBGRG00000018554","ENSBGRT00000034015",11719,"NUP50","nucleoporin 50 [Source:HGNC Symbol;Acc:HGNC:8065]","GO:0005643(nuclear pore);GO:0005654(nucleoplasm);GO:0031965(nuclear membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0046907(intracellular transport)","03013(RNA transport)",{"v":1e-128,"d":"0.00"},2,"38,497,","0,1308",-128,-126,5.58,"Exon (ENSBGRT00000034015/ENSBGRG00000018554, exon 5 of 9)",5,124432089,124450814,18726,1]
["chr5",128801897,128802142,246,"ENSBGRG00000002067","ENSBGRT00000003956",966,"ENSBGRG00000002067","NA","NA","03013(RNA transport)",{"v":5e-11,"d":"0.00"},3,"11,24,204,","0,16,42",{"v":-10.3,"d":"-10.30"},-9.49,{"v":31.3,"d":"31.30"},"Exon (ENSBGRT00000003956/ENSBGRG00000002067, exon 4 of 7)",5,128800931,128804352,3422,1]
["chr5",121010,123891,2882,"ENSBGRG00000008424","ENSBGRT00000016073",4290,"CD163","CD163 molecule [Source:HGNC Symbol;Acc:HGNC:1631]","GO:0005044(scavenger receptor activity);GO:0005886(plasma membrane);GO:0009897(external side of plasma membrane);GO:0016020(membrane)","NA",{"v":7.9e-22,"d":"0.00"},2,"115,96,","0,2786",{"v":-21.1,"d":"-21.10"},{"v":-20.1,"d":"-20.10"},{"v":4.2,"d":"4.20"},"Exon (ENSBGRT00000016073/ENSBGRG00000008424, exon 4 of 17)",5,93316,128181,34866,2]
["chr5",7046883,7047151,269,"ENSBGRG00000001473","ENSBGRT00000002810",73559,"GUCY2C","guanylate cyclase 2C [Source:HGNC Symbol;Acc:HGNC:4688]","GO:0004383(guanylate cyclase activity);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0009190(cyclic nucleotide biosynthetic process);GO:0009636(response to toxic substance);GO:0016849(phosphorus-oxygen lyase activity);GO:0035556(intracellular signal transduction);GO:0042127(regulation of cell population proliferation)","00230(Purine metabolism)",{"v":0.015,"d":"0.02"},1,"269,",0,-1.83,-1.14,8.64,"3' UTR",5,7046794,7120710,73917,2]
["chr5",7152030,7152115,86,"ENSBGRG00000001544","ENSBGRT00000002857",226,"ENSBGRG00000001544","NA","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0006352(DNA-templated transcription, initiation);GO:0042025(host cell nucleus);GO:0046982(protein heterodimerization activity)","NA",{"v":0.043,"d":"0.04"},1,"86,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000002857/ENSBGRG00000001544, exon 1 of 1)",5,7152030,7152341,312,2]
["chr5",19545999,19547886,1888,"ENSBGRG00000001670","ENSBGRT00000003113",0,"BHLHE41","basic helix-loop-helix family member e41 [Source:HGNC Symbol;Acc:HGNC:16617]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0007623(circadian rhythm);GO:0010832(negative regulation of myotube differentiation);GO:0010944(negative regulation of transcription by competitive promoter binding);GO:0032922(circadian regulation of gene expression);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0043425(bHLH transcription factor binding);GO:0043426(MRF binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046982(protein heterodimerization activity);GO:0046983(protein dimerization activity);GO:0070888(E-box binding);GO:1990837(sequence-specific double-stranded DNA binding)","04710(Circadian rhythm)",{"v":1E-41,"d":"0.00"},4,"108,64,62,66,","0,424,625,1822",-41,{"v":-39.8,"d":"-39.80"},5.76,"5' UTR",5,19543977,19546685,2709,2]
["chr5",30513809,30513927,119,"ENSBGRG00000011617","ENSBGRT00000021176",7507,"RASD2","RASD family member 2 [Source:HGNC Symbol;Acc:HGNC:18229]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane);GO:0031681(G-protein beta-subunit binding)","NA",{"v":0.028,"d":"0.03"},1,"119,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"3' UTR",5,30513809,30521434,7626,2]
["chr5",30797155,30797303,149,"ENSBGRG00000012577","ENSBGRT00000022992",3543,"HMGXB4","HMG-box containing 4 [Source:HGNC Symbol;Acc:HGNC:5003]","GO:0016589(NURF complex);GO:0042802(identical protein binding)","NA",{"v":7.9e-17,"d":"0.00"},1,"149,",0,{"v":-16.1,"d":"-16.10"},{"v":-15.1,"d":"-15.10"},3.18,"Exon (ENSBGRT00000022992/ENSBGRG00000012577, exon 4 of 10)",5,30760479,30800846,40368,2]
["chr5",36939485,36939634,150,"ENSBGRG00000019350","ENSBGRT00000035479",0,"CHST11","carbohydrate sulfotransferase 11 [Source:HGNC Symbol;Acc:HGNC:17422]","GO:0001537(N-acetylgalactosamine 4-O-sulfotransferase activity);GO:0002063(chondrocyte development);GO:0007585(respiratory gaseous exchange by respiratory system);GO:0008146(sulfotransferase activity);GO:0009791(post-embryonic development);GO:0016021(integral component of membrane);GO:0016051(carbohydrate biosynthetic process);GO:0030204(chondroitin sulfate metabolic process);GO:0030206(chondroitin sulfate biosynthetic process);GO:0030326(embryonic limb morphogenesis);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0033037(polysaccharide localization);GO:0036342(post-anal tail morphogenesis);GO:0042127(regulation of cell population proliferation);GO:0042733(embryonic digit morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0047756(chondroitin 4-sulfotransferase activity);GO:0048589(developmental growth);GO:0048703(embryonic viscerocranium morphogenesis);GO:0048704(embryonic skeletal system morphogenesis);GO:0050659(N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity);GO:0051216(cartilage development)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)",{"v":0.014,"d":"0.01"},1,"150,",0,-1.86,{"v":-1.3,"d":"-1.30"},{"v":5.4,"d":"5.40"},"5' UTR",5,36626397,36939634,313238,2]
["chr5",40994169,40994289,121,"ENSBGRG00000003123","ENSBGRT00000005820",37907,"NR1H4","nuclear receptor subfamily 1 group H member 4 [Source:HGNC Symbol;Acc:HGNC:7967]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001678(cellular glucose homeostasis);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005719(nuclear euchromatin);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007043(cell-cell junction assembly);GO:0007219(Notch signaling pathway);GO:0008206(bile acid metabolic process);GO:0008270(zinc ion binding);GO:0010804(negative regulation of tumor necrosis factor-mediated signaling pathway);GO:0010903(negative regulation of very-low-density lipoprotein particle remodeling);GO:0010988(regulation of low-density lipoprotein particle clearance);GO:0030522(intracellular receptor signaling pathway);GO:0032052(bile acid binding);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032620(interleukin-17 production);GO:0032689(negative regulation of interferon-gamma production);GO:0032692(negative regulation of interleukin-1 production);GO:0032703(negative regulation of interleukin-2 production);GO:0032715(negative regulation of interleukin-6 production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0034142(toll-like receptor 4 signaling pathway);GO:0034162(toll-like receptor 9 signaling pathway);GO:0034255(regulation of urea metabolic process);GO:0034971(histone H3-R17 methylation);GO:0035356(cellular triglyceride homeostasis);GO:0035774(positive regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0038181(bile acid receptor activity);GO:0038183(bile acid signaling pathway);GO:0038185(intracellular bile acid receptor signaling pathway);GO:0042025(host cell nucleus);GO:0042593(glucose homeostasis);GO:0042632(cholesterol homeostasis);GO:0042742(defense response to bacterium);GO:0043066(negative regulation of apoptotic process);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043235(receptor complex);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0046965(retinoid X receptor binding);GO:0050728(negative regulation of inflammatory response);GO:0055089(fatty acid homeostasis);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0070328(triglyceride homeostasis);GO:0071222(cellular response to lipopolysaccharide);GO:0071398(cellular response to fatty acid);GO:0071417(cellular response to organonitrogen compound);GO:0071638(negative regulation of monocyte chemotactic protein-1 production);GO:1902122(chenodeoxycholic acid binding);GO:1903413(cellular response to bile acid);GO:1904179(positive regulation of adipose tissue development);GO:1904468(negative regulation of tumor necrosis factor secretion);GO:1905695(positive regulation of phosphatidic acid biosynthetic process);GO:2000213(positive regulation of glutamate metabolic process);GO:2001250(positive regulation of ammonia assimilation cycle)","04976(Bile secretion)",{"v":1.3e-26,"d":"0.00"},1,"121,",0,{"v":-25.9,"d":"-25.90"},{"v":-24.8,"d":"-24.80"},4.54,"Exon (ENSBGRT00000005820/ENSBGRG00000003123, exon 4 of 11)",5,40946888,41032196,85309,2]
["chr5",47278201,47278349,149,"ENSBGRG00000009987","ENSBGRT00000018380",3927,"ENSBGRG00000009987","NA","GO:0016021(integral component of membrane)","04142(Lysosome);05205(Proteoglycans in cancer)",{"v":6.3e-11,"d":"0.00"},1,"149,",0,{"v":-10.2,"d":"-10.20"},-9.36,8.18,"3' UTR",5,47278112,47282276,4165,2]
["chr5",47915371,47915715,345,"ENSBGRG00000002908","ENSBGRT00000005466",14597,"TIMELESS","timeless circadian regulator [Source:HGNC Symbol;Acc:HGNC:11813]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0002009(morphogenesis of an epithelium);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006974(cellular response to DNA damage stimulus);GO:0007623(circadian rhythm);GO:0030324(lung development);GO:0035861(site of double-strand break);GO:0042752(regulation of circadian rhythm);GO:0044770(cell cycle phase transition);GO:0045892(negative regulation of transcription, DNA-templated);GO:0048754(branching morphogenesis of an epithelial tube);GO:0072711(cellular response to hydroxyurea);GO:0072719(cellular response to cisplatin);GO:1904976(cellular response to bleomycin);GO:1905168(positive regulation of double-strand break repair via homologous recombination);GO:2000781(positive regulation of double-strand break repair)","NA",{"v":3.2e-16,"d":"0.00"},3,"60,79,41,","0,189,304",{"v":-15.5,"d":"-15.50"},{"v":-14.5,"d":"-14.50"},2.58,"Exon (ENSBGRT00000005466/ENSBGRG00000002908, exon 26 of 29)",5,47915112,47930312,15201,2]
["chr5",49105156,49105404,249,"ENSBGRG00000008064","ENSBGRT00000015621",11031,"DCTN2","dynactin subunit 2 [Source:HGNC Symbol;Acc:HGNC:2712]","GO:0000776(kinetochore);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005869(dynactin complex);GO:0007017(microtubule-based process);GO:0007052(mitotic spindle organization);GO:0007080(mitotic metaphase plate congression);GO:0019901(protein kinase binding);GO:0030426(growth cone);GO:0030507(spectrin binding);GO:0031982(vesicle);GO:0032402(melanosome transport);GO:0042802(identical protein binding);GO:0071539(protein localization to centrosome)","04962(Vasopressin-regulated water reabsorption);05016(Huntington disease)",{"v":1.3E-54,"d":"0.00"},2,"52,38,","0,211",{"v":-53.9,"d":"-53.90"},{"v":-52.6,"d":"-52.60"},{"v":1.4,"d":"1.40"},"Exon (ENSBGRT00000015621/ENSBGRG00000008064, exon 5 of 17)",5,49100694,49116435,15742,2]
["chr5",56186698,56186906,209,"ENSBGRG00000016102","ENSBGRT00000029596",23755,"C12orf66","chromosome 12 open reading frame 66 [Source:HGNC Symbol;Acc:HGNC:26517]","GO:0005764(lysosome);GO:0045171(intercellular bridge)","NA",{"v":5e-07,"d":"0.00"},1,"209,",0,{"v":-6.3,"d":"-6.30"},-5.54,4.23,"Exon (ENSBGRT00000029596/ENSBGRG00000016102, exon 3 of 3)",5,56186104,56210661,24558,2]
["chr5",72850096,72851011,916,"ENSBGRG00000022234","ENSBGRT00000041337",36063,"SCAF11","SR-related CTD associated factor 11 [Source:HGNC Symbol;Acc:HGNC:10784]","GO:0000245(spliceosomal complex assembly);GO:0000375(RNA splicing, via transesterification reactions);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0008380(RNA splicing);GO:0016604(nuclear body);GO:0046872(metal ion binding)","NA",{"v":1.3e-71,"d":"0.00"},3,"138,120,42,","0,406,874",{"v":-70.9,"d":"-70.90"},{"v":-69.4,"d":"-69.40"},2.55,"Exon (ENSBGRT00000041337/ENSBGRG00000022234, exon 9 of 11)",5,72849917,72887074,37158,2]
["chr5",74070386,74070681,296,"ENSBGRG00000022846","ENSBGRT00000042169",30,"AMIGO2","adhesion molecule with Ig like domain 2 [Source:HGNC Symbol;Acc:HGNC:24073]","GO:0005515(protein binding);GO:0043066(negative regulation of apoptotic process);GO:0051965(positive regulation of synapse assembly)","NA",{"v":2e-21,"d":"0.00"},1,"296,",0,{"v":-20.7,"d":"-20.70"},{"v":-19.7,"d":"-19.70"},3.62,"Exon (ENSBGRT00000042169/ENSBGRG00000022846, exon 1 of 1)",5,74069146,74070711,1566,2]
["chr5",76668383,76668473,91,"ENSBGRG00000001247","ENSBGRT00000002298",747,"ENSBGRG00000001247","NA","GO:0035097(histone methyltransferase complex);GO:0042800(histone methyltransferase activity (H3-K4 specific))","00310(Lysine degradation);04934(Cushing syndrome)",{"v":1.3e-21,"d":"0.00"},1,"91,",0,{"v":-20.9,"d":"-20.90"},{"v":-19.9,"d":"-19.90"},3.17,"Exon (ENSBGRT00000002298/ENSBGRG00000001247, exon 2 of 9)",5,76663737,76669220,5484,2]
["chr5",77478198,77478408,211,"ENSBGRG00000002571","ENSBGRT00000004813",120,"BCDIN3D","BCDIN3 domain containing RNA methyltransferase [Source:HGNC Symbol;Acc:HGNC:27050]","GO:0001510(RNA methylation);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008168(methyltransferase activity);GO:0008171(O-methyltransferase activity);GO:0008173(RNA methyltransferase activity);GO:0008175(tRNA methyltransferase activity);GO:0010586(miRNA metabolic process);GO:0030488(tRNA methylation);GO:0061715(miRNA 2'-O-methylation);GO:2000632(negative regulation of pre-miRNA processing)","NA",{"v":4e-19,"d":"0.00"},1,"211,",0,{"v":-18.4,"d":"-18.40"},{"v":-17.5,"d":"-17.50"},4.32,"Exon (ENSBGRT00000004813/ENSBGRG00000002571, exon 1 of 2)",5,77472510,77478528,6019,2]
["chr5",79453580,79453759,180,"ENSBGRG00000000309","ENSBGRT00000000483",30,"FIGNL2","fidgetin like 2 [Source:HGNC Symbol;Acc:HGNC:13287]","GO:0005524(ATP binding)","NA",{"v":5.6e-07,"d":"0.00"},1,"180,",0,-6.25,-5.49,3.18,"Exon (ENSBGRT00000000483/ENSBGRG00000000309, exon 1 of 2)",5,79451385,79453789,2405,2]
["chr5",90588967,90589295,329,"ENSBGRG00000002830","ENSBGRT00000005274",39247,"TMTC3","transmembrane O-mannosyltransferase targeting cadherins 3 [Source:HGNC Symbol;Acc:HGNC:26899]","GO:0000030(mannosyltransferase activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0034976(response to endoplasmic reticulum stress);GO:0035269(protein O-linked mannosylation);GO:1901800(positive regulation of proteasomal protein catabolic process)","NA",{"v":3.2e-58,"d":"0.00"},1,"329,",0,{"v":-57.5,"d":"-57.50"},{"v":-56.1,"d":"-56.10"},5.15,"Exon (ENSBGRT00000005274/ENSBGRG00000002830, exon 13 of 13)",5,90588907,90628542,39636,2]
["chr5",108781414,108786444,5031,"ENSBGRG00000013060","ENSBGRT00000023837",0,"ENSBGRG00000013060","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":1E-134,"d":"0.00"},3,"5,383,26,","0,9,5005",-134,-133,5.58,"Exon (ENSBGRT00000023837/ENSBGRG00000013060, exon 1 of 1)",5,108783922,108784929,1008,1]
["chr5",114374370,114374516,147,"ENSBGRG00000013799","ENSBGRT00000025325",3444,"RHNO1","RAD9-HUS1-RAD1 interacting nuclear orphan 1 [Source:HGNC Symbol;Acc:HGNC:28206]","GO:0000077(DNA damage checkpoint);GO:0000725(recombinational repair);GO:0005634(nucleus);GO:0005694(chromosome);GO:0034644(cellular response to UV);GO:0070318(positive regulation of G0 to G1 transition);GO:0071479(cellular response to ionizing radiation)","NA",{"v":5E-15,"d":"0.00"},1,"147,",0,{"v":-14.3,"d":"-14.30"},{"v":-13.3,"d":"-13.30"},4.72,"3' UTR",5,114374194,114377960,3767,2]
["chr5",118091899,118092018,120,"ENSBGRG00000002435","ENSBGRT00000004535",35831,"ENSBGRG00000002435","NA","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006468(protein phosphorylation);GO:0030177(positive regulation of Wnt signaling pathway);GO:0030178(negative regulation of Wnt signaling pathway);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032922(circadian regulation of gene expression);GO:0034613(cellular protein localization);GO:0042752(regulation of circadian rhythm);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1903827(regulation of cellular protein localization);GO:1990904(ribonucleoprotein complex);GO:2000052(positive regulation of non-canonical Wnt signaling pathway)","04310(Wnt signaling pathway);04340(Hedgehog signaling pathway);04390(Hippo signaling pathway);04392(Hippo signaling pathway - multiple species);04068(FoxO signaling pathway);04710(Circadian rhythm)",{"v":1e-16,"d":"0.00"},1,"120,",0,-16,-15,1.93,"3' UTR",5,118086484,118127849,41366,2]
["chr5",118092974,118093574,601,"ENSBGRG00000002435","ENSBGRT00000004535",34275,"ENSBGRG00000002435","NA","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006468(protein phosphorylation);GO:0030177(positive regulation of Wnt signaling pathway);GO:0030178(negative regulation of Wnt signaling pathway);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032922(circadian regulation of gene expression);GO:0034613(cellular protein localization);GO:0042752(regulation of circadian rhythm);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1903827(regulation of cellular protein localization);GO:1990904(ribonucleoprotein complex);GO:2000052(positive regulation of non-canonical Wnt signaling pathway)","04310(Wnt signaling pathway);04340(Hedgehog signaling pathway);04390(Hippo signaling pathway);04392(Hippo signaling pathway - multiple species);04068(FoxO signaling pathway);04710(Circadian rhythm)",{"v":4.3E-3,"d":"0.00"},2,"106,104,","0,497",-2.37,-1.77,6.48,"3' UTR",5,118086484,118127849,41366,2]
["chr5",121659746,121660315,570,"ENSBGRG00000011570","ENSBGRT00000021212",5097,"TCF20","transcription factor 20 [Source:HGNC Symbol;Acc:HGNC:11631]","GO:0005654(nucleoplasm);GO:0016604(nuclear body)","NA",{"v":1e-98,"d":"0.00"},1,"570,",0,-98,{"v":-96.4,"d":"-96.40"},5.98,"Exon (ENSBGRT00000021212/ENSBGRG00000011570, exon 1 of 3)",5,121609797,121665412,55616,2]
["chr5",121664177,121664626,450,"ENSBGRG00000011570","ENSBGRT00000021212",786,"TCF20","transcription factor 20 [Source:HGNC Symbol;Acc:HGNC:11631]","GO:0005654(nucleoplasm);GO:0016604(nuclear body)","NA",{"v":5e-43,"d":"0.00"},1,"450,",0,{"v":-42.3,"d":"-42.30"},{"v":-41.1,"d":"-41.10"},4.03,"Exon (ENSBGRT00000021212/ENSBGRG00000011570, exon 1 of 3)",5,121609797,121665412,55616,2]
["chr5",125865925,125866135,211,"ENSBGRG00000001407","ENSBGRT00000002941",4712,"CELSR1","cadherin EGF LAG seven-pass G-type receptor 1 [Source:HGNC Symbol;Acc:HGNC:1850]","GO:0001736(establishment of planar polarity);GO:0001764(neuron migration);GO:0001843(neural tube closure);GO:0001942(hair follicle development);GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005509(calcium ion binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007266(Rho protein signal transduction);GO:0007626(locomotory behavior);GO:0009952(anterior/posterior pattern specification);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032956(regulation of actin cytoskeleton organization);GO:0042060(wound healing);GO:0042249(establishment of planar polarity of embryonic epithelium);GO:0042472(inner ear morphogenesis);GO:0045176(apical protein localization);GO:0048105(establishment of body hair planar orientation);GO:0060488(orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis);GO:0060489(planar dichotomous subdivision of terminal units involved in lung branching morphogenesis);GO:0060490(lateral sprouting involved in lung morphogenesis);GO:0090179(planar cell polarity pathway involved in neural tube closure);GO:0090251(protein localization involved in establishment of planar polarity)","NA",{"v":8.7e-07,"d":"0.00"},1,"211,",0,-6.06,-5.31,3.49,"Exon (ENSBGRT00000002941/ENSBGRG00000001407, exon 2 of 35)",5,125698892,125870847,171956,2]
["chr5",129167461,129167628,168,"ENSBGRG00000002564","ENSBGRT00000005022",26635,"ENSBGRG00000002564","NA","NA","NA",{"v":5e-14,"d":"0.00"},2,"32,59,","0,109",{"v":-13.3,"d":"-13.30"},{"v":-12.4,"d":"-12.40"},2.08,"Exon (ENSBGRT00000005022/ENSBGRG00000002564, exon 25 of 26)",5,129167401,129194263,26863,2]
["chr6",336198,336737,540,"ENSBGRG00000006253","ENSBGRT00000011527",39154,"KIAA0232","KIAA0232 [Source:HGNC Symbol;Acc:HGNC:28992]","NA","NA",{"v":1.6E-54,"d":"0.00"},1,"540,",0,{"v":-53.8,"d":"-53.80"},{"v":-52.4,"d":"-52.40"},4.32,"Exon (ENSBGRT00000011527/ENSBGRG00000006253, exon 6 of 9)",6,297044,357761,60718,1]
["chr6",3226866,3228142,1277,"ENSBGRG00000014329","ENSBGRT00000026493",2842,"ENSBGRG00000014329","NA","GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","04080(Neuroactive ligand-receptor interaction)",{"v":0.0021,"d":"0.00"},2,"178,1,","0,1276",-2.67,-2.06,{"v":11.9,"d":"11.90"},"3' UTR",6,3224024,3227043,3020,1]
["chr6",5344475,5344565,91,"ENSBGRG00000020748","ENSBGRT00000038213",7719,"ENSBGRG00000020748","solute carrier family 49 member 3 [Source:HGNC Symbol;Acc:HGNC:26177]","GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":2.5e-13,"d":"0.00"},1,"91,",0,{"v":-12.6,"d":"-12.60"},{"v":-11.8,"d":"-11.80"},{"v":2.2,"d":"2.20"},"Exon (ENSBGRT00000038213/ENSBGRG00000020748, exon 9 of 9)",6,5336756,5345675,8920,1]
["chr6",5344955,5345134,180,"ENSBGRG00000020748","ENSBGRT00000038213",8199,"ENSBGRG00000020748","solute carrier family 49 member 3 [Source:HGNC Symbol;Acc:HGNC:26177]","GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":1E-117,"d":"0.00"},1,"180,",0,-117,-116,6.49,"3' UTR",6,5336756,5345675,8920,1]
["chr6",10104405,10105910,1506,"ENSBGRG00000024140","ENSBGRT00000044565",0,"NKX3-2","NK3 homeobox 2 [Source:HGNC Symbol;Acc:HGNC:951]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0007368(determination of left/right symmetry);GO:0031016(pancreas development);GO:0032331(negative regulation of chondrocyte differentiation);GO:0042474(middle ear morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0048513(animal organ development);GO:0048536(spleen development);GO:0048645(animal organ formation);GO:0048705(skeletal system morphogenesis);GO:0048706(embryonic skeletal system development);GO:0055123(digestive system development);GO:0060576(intestinal epithelial cell development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.0021,"d":"0.00"},2,"321,36,","0,1470",-2.67,-2.06,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000044565/ENSBGRG00000024140, exon 1 of 3)",6,10104405,10110064,5660,1]
["chr6",20393244,20400183,6940,"ENSBGRG00000018444","ENSBGRT00000037739",218452,"WDFY3","WD repeat and FYVE domain containing 3 [Source:HGNC Symbol;Acc:HGNC:20751]","GO:0003831(beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity);GO:0005515(protein binding);GO:0005545(1-phosphatidylinositol binding);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005776(autophagosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0016234(inclusion body);GO:0016605(PML body);GO:0019898(extrinsic component of membrane);GO:0034274(Atg12-Atg5-Atg16 complex);GO:0035973(aggrephagy);GO:0046872(metal ion binding);GO:0097635(extrinsic component of autophagosome membrane)","NA",{"v":1.6E-27,"d":"0.00"},2,"146,124,","0,6816",{"v":-26.8,"d":"-26.80"},{"v":-25.7,"d":"-25.70"},2.45,"Exon (ENSBGRT00000037739/ENSBGRG00000018444, exon 68 of 69)",6,20174792,20400183,225392,1]
["chr6",28956481,29002216,45736,"ENSBGRG00000013500","ENSBGRT00000025132",0,"SEPTIN11","septin 11 [Source:HGNC Symbol;Acc:HGNC:25589]","GO:0001725(stress fiber);GO:0005525(GTP binding);GO:0031105(septin complex)","05100(Bacterial invasion of epithelial cells)",{"v":0.00019,"d":"0.00"},2,"579,16,","0,45720",-3.72,-3.05,5.04,"5' UTR",6,28827875,28957075,129201,2]
["chr6",30416199,30416793,595,"ENSBGRG00000017795","ENSBGRT00000032682",101126,"G3BP2","G3BP stress granule assembly factor 2 [Source:HGNC Symbol;Acc:HGNC:30291]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005829(cytosol);GO:0010494(cytoplasmic stress granule);GO:0034063(stress granule assembly);GO:0051260(protein homooligomerization);GO:0062029(positive regulation of stress granule assembly)","NA",0,1,"595,",0,-341,"-Inf",4.49,"3' UTR",6,30315073,30416793,101721,1]
["chr6",51507491,51507640,150,"ENSBGRG00000023603","ENSBGRT00000043582",92343,"CLOCK","clock circadian regulator [Source:HGNC Symbol;Acc:HGNC:2082]","GO:0000077(DNA damage checkpoint);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006473(protein acetylation);GO:0007283(spermatogenesis);GO:0007623(circadian rhythm);GO:0031490(chromatin DNA binding);GO:0032922(circadian regulation of gene expression);GO:0033391(chromatoid body);GO:0042634(regulation of hair cycle);GO:0042752(regulation of circadian rhythm);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0050729(positive regulation of inflammatory response);GO:0050796(regulation of insulin secretion);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051775(response to redox state);GO:0070888(E-box binding);GO:0071479(cellular response to ionizing radiation);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000074(regulation of type B pancreatic cell development);GO:2000323(negative regulation of glucocorticoid receptor signaling pathway)","04728(Dopaminergic synapse);04710(Circadian rhythm);05168(Herpes simplex infection)",{"v":1.3e-05,"d":"0.00"},1,"150,",0,-4.88,-4.17,6.05,"3' UTR",6,51415148,51508326,93179,1]
["chr6",54811182,54811659,478,"ENSBGRG00000000416","ENSBGRT00000000695",21603,"LRRC66","leucine rich repeat containing 66 [Source:HGNC Symbol;Acc:HGNC:34299]","GO:0005515(protein binding)","NA",{"v":0.0078,"d":"0.01"},1,"478,",0,-2.11,-1.53,8.64,"Exon (ENSBGRT00000000695/ENSBGRG00000000416, exon 4 of 5)",6,54789579,54812052,22474,1]
["chr6",65534345,65534674,330,"ENSBGRG00000004251","ENSBGRT00000007842",1882,"TLR6","toll like receptor 6 [Source:HGNC Symbol;Acc:HGNC:16711]","GO:0001775(cell activation);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0004888(transmembrane signaling receptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0016021(integral component of membrane);GO:0032717(negative regulation of interleukin-8 production);GO:0034136(negative regulation of toll-like receptor 2 signaling pathway);GO:0034150(toll-like receptor 6 signaling pathway);GO:0035663(Toll-like receptor 2 binding);GO:0042496(detection of diacyl bacterial lipopeptide);GO:0042802(identical protein binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043235(receptor complex);GO:0043507(positive regulation of JUN kinase activity);GO:0045121(membrane raft);GO:0046982(protein heterodimerization activity);GO:0050707(regulation of cytokine secretion);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0071726(cellular response to diacyl bacterial lipopeptide);GO:1904646(cellular response to amyloid-beta)","04145(Phagosome);04620(Toll-like receptor signaling pathway);05152(Tuberculosis);05142(Chagas disease (American trypanosomiasis))",{"v":2.5e-34,"d":"0.00"},1,"330,",0,{"v":-33.6,"d":"-33.60"},{"v":-32.5,"d":"-32.50"},6.32,"Exon (ENSBGRT00000007842/ENSBGRG00000004251, exon 1 of 1)",6,65532463,65534853,2391,1]
["chr6",65552358,65552656,299,"ENSBGRG00000004271","ENSBGRT00000007855",595,"TLR1","toll like receptor 1 [Source:HGNC Symbol;Acc:HGNC:11847]","GO:0001775(cell activation);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0006952(defense response);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0016021(integral component of membrane);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0034130(toll-like receptor 1 signaling pathway);GO:0034137(positive regulation of toll-like receptor 2 signaling pathway);GO:0035354(Toll-like receptor 1-Toll-like receptor 2 protein complex);GO:0035663(Toll-like receptor 2 binding);GO:0042116(macrophage activation);GO:0042495(detection of triacyl bacterial lipopeptide);GO:0042535(positive regulation of tumor necrosis factor biosynthetic process);GO:0042802(identical protein binding);GO:0045121(membrane raft);GO:0050707(regulation of cytokine secretion);GO:0071727(cellular response to triacyl bacterial lipopeptide)","04620(Toll-like receptor signaling pathway);05152(Tuberculosis)",{"v":4e-21,"d":"0.00"},1,"299,",0,{"v":-20.4,"d":"-20.40"},{"v":-19.4,"d":"-19.40"},3.54,"Exon (ENSBGRT00000007855/ENSBGRG00000004271, exon 1 of 1)",6,65551763,65553757,1995,1]
["chr6",88071779,88071988,210,"ENSBGRG00000018966","ENSBGRT00000034968",162816,"ENSBGRG00000018966","NA","GO:0003677(DNA binding)","04214(Apoptosis - fly)",{"v":0.0078,"d":"0.01"},1,"210,",0,-2.11,-1.27,9.72,"Exon (ENSBGRT00000034968/ENSBGRG00000018966, exon 7 of 8)",6,87908963,88094751,185789,1]
["chr6",107053949,107054039,91,"ENSBGRG00000004264","ENSBGRT00000007859",59871,"ENSBGRG00000004264","NA","GO:0006211(5-methylcytosine catabolic process);GO:0070579(methylcytosine dioxygenase activity);GO:0080111(DNA demethylation)","NA",{"v":0.027,"d":"0.03"},1,"91,",0,-1.57,-1.03,3.24,"Exon (ENSBGRT00000007859/ENSBGRG00000004264, exon 2 of 3)",6,106994078,107056811,62734,1]
["chr6",109993516,109997095,3580,"ENSBGRG00000006714","ENSBGRT00000012417",14420,"CYP2U1","cytochrome P450 family 2 subfamily U member 1 [Source:HGNC Symbol;Acc:HGNC:20582]","GO:0005506(iron ion binding);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016712(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen);GO:0020037(heme binding);GO:0052869(arachidonic acid omega-hydroxylase activity);GO:0055114(oxidation-reduction process);GO:0097267(omega-hydroxylase P450 pathway)","00590(Arachidonic acid metabolism)",{"v":2.5e-30,"d":"0.00"},3,"499,162,86,","0,2252,3494",{"v":-29.6,"d":"-29.60"},{"v":-28.5,"d":"-28.50"},6.48,"Exon (ENSBGRT00000012417/ENSBGRG00000006714, exon 2 of 5)",6,109979096,110001038,21943,1]
["chr6",114562308,114562428,121,"ENSBGRG00000002371","ENSBGRT00000004580",70434,"ALPK1","alpha kinase 1 [Source:HGNC Symbol;Acc:HGNC:20917]","GO:0002753(cytoplasmic pattern recognition receptor signaling pathway);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045087(innate immune response);GO:0048029(monosaccharide binding)","NA",{"v":2.3e-09,"d":"0.00"},1,"121,",0,-8.63,-7.81,2.72,"Exon (ENSBGRT00000004580/ENSBGRG00000002371, exon 14 of 14)",6,114491874,114562488,70615,1]
["chr6",121971882,122006028,34147,"ENSBGRG00000004790","ENSBGRT00000008842",186736,"SYNPO2","synaptopodin 2 [Source:HGNC Symbol;Acc:HGNC:17732]","GO:0001725(stress fiber);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0015629(actin cytoskeleton);GO:0030018(Z disc);GO:0031005(filamin binding);GO:0043231(intracellular membrane-bounded organelle);GO:0051393(alpha-actinin binding)","04530(Tight junction)",{"v":1.6e-17,"d":"0.00"},2,"2,118,","0,34029",{"v":-16.8,"d":"-16.80"},{"v":-15.8,"d":"-15.80"},3.49,"Exon (ENSBGRT00000008842/ENSBGRG00000004790, exon 5 of 5)",6,121785146,121971883,186738,1]
["chr6",2730451,2730840,390,"ENSBGRG00000008376","ENSBGRT00000015312",29720,"DOK7","docking protein 7 [Source:HGNC Symbol;Acc:HGNC:26594]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0019901(protein kinase binding);GO:0061098(positive regulation of protein tyrosine kinase activity)","NA",{"v":2.9E-4,"d":"0.00"},1,"390,",0,-3.54,-2.87,{"v":15.1,"d":"15.10"},"Exon (ENSBGRT00000015312/ENSBGRG00000008376, exon 7 of 7)",6,2730451,2760560,30110,2]
["chr6",14339258,14340184,927,"ENSBGRG00000009702","ENSBGRT00000017815",708,"DRD5","dopamine receptor D5 [Source:HGNC Symbol;Acc:HGNC:3026]","GO:0001588(dopamine neurotransmitter receptor activity, coupled via Gs);GO:0001975(response to amphetamine);GO:0001992(regulation of systemic arterial blood pressure by vasopressin);GO:0001994(norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure);GO:0004930(G protein-coupled receptor activity);GO:0004952(dopamine neurotransmitter receptor activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005929(cilium);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007191(adenylate cyclase-activating dopamine receptor signaling pathway);GO:0007617(mating behavior);GO:0008306(associative learning);GO:0016021(integral component of membrane);GO:0019226(transmission of nerve impulse);GO:0031526(brush border membrane);GO:0033861(negative regulation of NAD(P)H oxidase activity);GO:0035240(dopamine binding);GO:0042060(wound healing);GO:0042220(response to cocaine);GO:0045776(negative regulation of blood pressure);GO:0045924(regulation of female receptivity);GO:0046960(sensitization);GO:0060170(ciliary membrane);GO:0060292(long-term synaptic depression);GO:0071870(cellular response to catecholamine stimulus);GO:0072593(reactive oxygen species metabolic process);GO:0097730(non-motile cilium)","04020(Calcium signaling pathway);04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04728(Dopaminergic synapse)",{"v":0.0078,"d":"0.01"},2,"666,230,","0,697",-2.11,-1.27,9.72,"Exon (ENSBGRT00000017815/ENSBGRG00000009702, exon 2 of 3)",6,14339258,14340892,1635,2]
["chr6",15949344,15949463,120,"ENSBGRG00000010733","ENSBGRT00000020228",0,"EVC2","EvC ciliary complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:19747]","GO:0005634(nucleus);GO:0005929(cilium);GO:0007224(smoothened signaling pathway);GO:0060170(ciliary membrane);GO:0098797(plasma membrane protein complex)","04340(Hedgehog signaling pathway)",{"v":0.021,"d":"0.02"},1,"120,",0,-1.67,-1.12,4.86,"5' UTR",6,15765683,15949463,183781,2]
["chr6",25482198,25482377,180,"ENSBGRG00000010467","ENSBGRT00000019192",8119,"PRDM8","PR/SET domain 8 [Source:HGNC Symbol;Acc:HGNC:13993]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus)","NA",{"v":1E-51,"d":"0.00"},1,"180,",0,-51,{"v":-49.7,"d":"-49.70"},3.17,"Exon (ENSBGRT00000019192/ENSBGRG00000010467, exon 4 of 4)",6,25481573,25490496,8924,2]
["chr6",29577993,29578757,765,"ENSBGRG00000014491","ENSBGRT00000026605",4423,"STBD1","starch binding domain 1 [Source:HGNC Symbol;Acc:HGNC:24854]","GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005887(integral component of plasma membrane);GO:0005980(glycogen catabolic process);GO:0016020(membrane);GO:0019899(enzyme binding);GO:0030246(carbohydrate binding);GO:0030247(polysaccharide binding);GO:0030315(T-tubule);GO:0046907(intracellular transport);GO:0048471(perinuclear region of cytoplasm);GO:0061723(glycophagy);GO:2001069(glycogen binding);GO:2001070(starch binding)","NA",{"v":1E-100,"d":"0.00"},1,"765,",0,-100,{"v":-98.5,"d":"-98.50"},4.88,"3' UTR",6,29577905,29583180,5276,2]
["chr6",37161593,37163620,2028,"ENSBGRG00000011676","ENSBGRT00000021405",27353,"YTHDC1","YTH domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30626]","GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0010608(posttranscriptional regulation of gene expression)","NA",{"v":1e-162,"d":"0.00"},2,"262,7,","0,2021",-162,-160,3.17,"3' UTR",6,37161504,37190973,29470,2]
["chr6",50393228,50393524,297,"ENSBGRG00000021704","ENSBGRT00000040072",89,"ARL9","ADP ribosylation factor like GTPase 9 [Source:HGNC Symbol;Acc:HGNC:23592]","GO:0005525(GTP binding)","NA",{"v":4e-08,"d":"0.00"},1,"297,",0,{"v":-7.4,"d":"-7.40"},-6.61,9.18,"Exon (ENSBGRT00000040072/ENSBGRG00000021704, exon 1 of 4)",6,50378601,50393613,15013,2]
["chr6",56774414,56774593,180,"ENSBGRG00000001566","ENSBGRT00000002907",490020,"GABRB1","gamma-aminobutyric acid type A receptor beta1 subunit [Source:HGNC Symbol;Acc:HGNC:4081]","GO:0004888(transmembrane signaling receptor activity);GO:0004890(GABA-A receptor activity);GO:0005216(ion channel activity);GO:0005230(extracellular ligand-gated ion channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022851(GABA-gated chloride ion channel activity);GO:0034220(ion transmembrane transport);GO:1902476(chloride transmembrane transport);GO:1902711(GABA-A receptor complex)","04080(Neuroactive ligand-receptor interaction);04727(GABAergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);05032(Morphine addiction);05033(Nicotine addiction)",{"v":1.2E-4,"d":"0.00"},1,"180,",0,-3.93,-3.25,4.97,"Exon (ENSBGRT00000002907/ENSBGRG00000001566, exon 9 of 9)",6,56774414,57264613,490200,2]
["chr6",64716329,64768376,52048,"ENSBGRG00000002976","ENSBGRT00000005668",0,"UBE2K","ubiquitin conjugating enzyme E2 K [Source:HGNC Symbol;Acc:HGNC:4914]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010800(positive regulation of peptidyl-threonine phosphorylation);GO:0010994(free ubiquitin chain polymerization);GO:0031625(ubiquitin protein ligase binding);GO:0032433(filopodium tip);GO:0032434(regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0034450(ubiquitin-ubiquitin ligase activity);GO:0035458(cellular response to interferon-beta);GO:0060340(positive regulation of type I interferon-mediated signaling pathway);GO:0070936(protein K48-linked ubiquitination);GO:1903265(positive regulation of tumor necrosis factor-mediated signaling pathway)","04120(Ubiquitin mediated proteolysis)",{"v":5e-35,"d":"0.00"},3,"16,94,63,","0,4729,51985",{"v":-34.3,"d":"-34.30"},{"v":-33.2,"d":"-33.20"},2.32,"Exon (ENSBGRT00000005668/ENSBGRG00000002976, exon 1 of 7)",6,64691283,64768376,77094,2]
["chr6",85044562,85046925,2364,"ENSBGRG00000016692","ENSBGRT00000034678",9424,"SLIT2","slit guidance ligand 2 [Source:HGNC Symbol;Acc:HGNC:11086]","GO:0001657(ureteric bud development);GO:0001933(negative regulation of protein phosphorylation);GO:0002042(cell migration involved in sprouting angiogenesis);GO:0002689(negative regulation of leukocyte chemotaxis);GO:0005095(GTPase inhibitor activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0007411(axon guidance);GO:0008045(motor neuron axon guidance);GO:0008201(heparin binding);GO:0010593(negative regulation of lamellipodium assembly);GO:0010596(negative regulation of endothelial cell migration);GO:0014912(negative regulation of smooth muscle cell migration);GO:0021836(chemorepulsion involved in postnatal olfactory bulb interneuron migration);GO:0021972(corticospinal neuron axon guidance through spinal cord);GO:0030308(negative regulation of cell growth);GO:0030336(negative regulation of cell migration);GO:0030837(negative regulation of actin filament polymerization);GO:0031290(retinal ganglion cell axon guidance);GO:0032870(cellular response to hormone stimulus);GO:0035385(Roundabout signaling pathway);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0043116(negative regulation of vascular permeability);GO:0043237(laminin-1 binding);GO:0043394(proteoglycan binding);GO:0048495(Roundabout binding);GO:0048754(branching morphogenesis of an epithelial tube);GO:0048846(axon extension involved in axon guidance);GO:0050919(negative chemotaxis);GO:0050929(induction of negative chemotaxis);GO:0051058(negative regulation of small GTPase mediated signal transduction);GO:0051414(response to cortisol);GO:0061364(apoptotic process involved in luteolysis);GO:0070100(negative regulation of chemokine-mediated signaling pathway);GO:0071504(cellular response to heparin);GO:0071672(negative regulation of smooth muscle cell chemotaxis);GO:0071676(negative regulation of mononuclear cell migration);GO:0090024(negative regulation of neutrophil chemotaxis);GO:0090260(negative regulation of retinal ganglion cell axon guidance);GO:0090288(negative regulation of cellular response to growth factor stimulus)","04360(Axon guidance)",{"v":1e-214,"d":"0.00"},2,"734,104,","0,2260",-214,-212,7.23,"3' UTR",6,85044472,85056349,11878,2]
["chr6",90118778,90119104,327,"ENSBGRG00000022791","ENSBGRT00000042053",2016,"GPRIN3","GPRIN family member 3 [Source:HGNC Symbol;Acc:HGNC:27733]","NA","NA",{"v":1.6e-08,"d":"0.00"},1,"327,",0,-7.79,-6.99,5.94,"Exon (ENSBGRT00000042053/ENSBGRG00000022791, exon 1 of 1)",6,90118778,90121120,2343,2]
["chr6",112642892,112660800,17909,"ENSBGRG00000002238","ENSBGRT00000004216",0,"PITX2","paired like homeodomain 2 [Source:HGNC Symbol;Acc:HGNC:9005]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008134(transcription factor binding);GO:0035993(deltoid tuberosity development);GO:0042476(odontogenesis);GO:0043010(camera-type eye development);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061072(iris morphogenesis);GO:1990837(sequence-specific double-stranded DNA binding)","04350(TGF-beta signaling pathway)",{"v":0.0041,"d":"0.00"},5,"1010,206,1187,138,56,","0,3525,4597,17251,17853",-2.39,-1.79,{"v":10.8,"d":"10.80"},"5' UTR",6,112642892,112648675,5784,2]
["chr6",126215950,126216100,151,"ENSBGRG00000005303","ENSBGRT00000009810",9146,"NPY1R","neuropeptide Y receptor Y1 [Source:HGNC Symbol;Acc:HGNC:7956]","GO:0001601(peptide YY receptor activity);GO:0001602(pancreatic polypeptide receptor activity);GO:0003151(outflow tract morphogenesis);GO:0004930(G protein-coupled receptor activity);GO:0004983(neuropeptide Y receptor activity);GO:0006006(glucose metabolic process);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007626(locomotory behavior);GO:0007631(feeding behavior);GO:0008217(regulation of blood pressure);GO:0016021(integral component of membrane);GO:0019233(sensory perception of pain);GO:0040014(regulation of multicellular organism growth)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04923(Regulation of lipolysis in adipocyte)",{"v":1E-179,"d":"0.00"},1,"151,",0,-179,-177,3.94,"3' UTR",6,126215082,126225246,10165,2]
["chr6",126511267,126511715,449,"ENSBGRG00000005351","ENSBGRT00000009874",1166,"TKTL2","transketolase like 2 [Source:HGNC Symbol;Acc:HGNC:25313]","GO:0003824(catalytic activity);GO:0005737(cytoplasm)","00030(Pentose phosphate pathway);01051(Biosynthesis of ansamycins)",{"v":2.3e-10,"d":"0.00"},1,"449,",0,-9.64,{"v":-8.8,"d":"-8.80"},9.94,"Exon (ENSBGRT00000009874/ENSBGRG00000005351, exon 1 of 1)",6,126510998,126512881,1884,2]
["chr7",8913623,8914069,447,"ENSBGRG00000000395","ENSBGRT00000000651",0,"PPP2R2A","protein phosphatase 2 regulatory subunit Balpha [Source:HGNC Symbol;Acc:HGNC:9304]","GO:0000159(protein phosphatase type 2A complex);GO:0005515(protein binding);GO:0006470(protein dephosphorylation);GO:0019888(protein phosphatase regulator activity);GO:0043278(response to morphine);GO:0045202(synapse);GO:0098978(glutamatergic synapse)","03015(mRNA surveillance pathway);04390(Hippo signaling pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04530(Tight junction);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);05160(Hepatitis C);05165(Human papillomavirus infection);05142(Chagas disease (American trypanosomiasis))",{"v":6.2e-10,"d":"0.00"},1,"447,",0,-9.21,-8.38,7.56,"5' UTR",7,8913623,9002385,88763,1]
["chr7",12991553,12991732,180,"ENSBGRG00000004133","ENSBGRT00000007618",1368,"RMI1","RecQ mediated genome instability 1 [Source:HGNC Symbol;Acc:HGNC:25764]","GO:0000166(nucleotide binding);GO:0002021(response to dietary excess);GO:0002023(reduction of food intake in response to dietary excess);GO:0005654(nucleoplasm);GO:0009749(response to glucose);GO:0016604(nuclear body);GO:0035264(multicellular organism growth);GO:0042593(glucose homeostasis)","03460(Fanconi anemia pathway)",{"v":1.4e-10,"d":"0.00"},1,"180,",0,-9.85,-9.01,4.54,"Exon (ENSBGRT00000007618/ENSBGRG00000004133, exon 1 of 1)",7,12990185,12992059,1875,1]
["chr7",18849458,18855132,5675,"ENSBGRG00000009781","ENSBGRT00000018617",0,"ERCC6L2","ERCC excision repair 6 like 2 [Source:HGNC Symbol;Acc:HGNC:26922]","GO:0005524(ATP binding)","NA",{"v":0.00037,"d":"0.00"},2,"46,75,","0,5600",-3.43,-2.77,8.64,"Exon (ENSBGRT00000018617/ENSBGRG00000009781, exon 1 of 20)",7,18849458,19013603,164146,1]
["chr7",23403775,23404581,807,"ENSBGRG00000017164","ENSBGRT00000031454",202263,"ENSBGRG00000017164","AU RNA binding methylglutaconyl-CoA hydratase [Source:HGNC Symbol;Acc:HGNC:890]","GO:0003824(catalytic activity)","00280(Valine, leucine and isoleucine degradation)",{"v":2E-16,"d":"0.00"},1,"807,",0,{"v":-15.7,"d":"-15.70"},{"v":-14.8,"d":"-14.80"},{"v":58.3,"d":"58.30"},"3' UTR",7,23201512,23404581,203070,1]
["chr7",25679892,25680394,503,"ENSBGRG00000018250","ENSBGRT00000033386",41946,"SEMA4D","semaphorin 4D [Source:HGNC Symbol;Acc:HGNC:10732]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001934(positive regulation of protein phosphorylation);GO:0004888(transmembrane signaling receptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005887(integral component of plasma membrane);GO:0007162(negative regulation of cell adhesion);GO:0008360(regulation of cell shape);GO:0010693(negative regulation of alkaline phosphatase activity);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0030215(semaphorin receptor binding);GO:0030335(positive regulation of cell migration);GO:0031344(regulation of cell projection organization);GO:0038023(signaling receptor activity);GO:0043547(positive regulation of GTPase activity);GO:0043931(ossification involved in bone maturation);GO:0045668(negative regulation of osteoblast differentiation);GO:0048672(positive regulation of collateral sprouting);GO:0048814(regulation of dendrite morphogenesis);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050732(negative regulation of peptidyl-tyrosine phosphorylation);GO:0050772(positive regulation of axonogenesis);GO:0070486(leukocyte aggregation);GO:0071526(semaphorin-plexin signaling pathway);GO:1900220(semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis);GO:1905704(positive regulation of inhibitory synapse assembly)","04360(Axon guidance)",{"v":5e-28,"d":"0.00"},2,"180,30,","0,473",{"v":-27.3,"d":"-27.30"},{"v":-26.2,"d":"-26.20"},2.37,"3' UTR",7,25637946,25680071,42126,1]
["chr7",37625275,37625395,121,"ENSBGRG00000002855","ENSBGRT00000005360",327,"PALM2AKAP2","PALM2 and AKAP2 fusion [Source:HGNC Symbol;Acc:HGNC:33529]","NA","NA",{"v":4E-52,"d":"0.00"},1,"121,",0,{"v":-51.4,"d":"-51.40"},{"v":-50.1,"d":"-50.10"},2.24,"Exon (ENSBGRT00000005360/ENSBGRG00000002855, exon 2 of 5)",7,37624948,37649612,24665,1]
["chr7",40952439,40952557,119,"ENSBGRG00000006255","ENSBGRT00000011526",20515,"C9orf43","chromosome 9 open reading frame 43 [Source:HGNC Symbol;Acc:HGNC:23570]","NA","04360(Axon guidance)",{"v":9.5E-4,"d":"0.00"},1,"119,",0,-3.02,-2.38,3.96,"3' UTR",7,40931924,40952587,20664,1]
["chr7",41642875,41643383,509,"ENSBGRG00000006681","ENSBGRT00000012356",223290,"ZNF618","zinc finger protein 618 [Source:HGNC Symbol;Acc:HGNC:29416]","GO:0003676(nucleic acid binding);GO:0042802(identical protein binding)","NA",{"v":1e-131,"d":"0.00"},1,"509,",0,-131,-129,6.44,"3' UTR",7,41419585,41643592,224008,1]
["chr7",49863165,49866912,3748,"ENSBGRG00000012248","ENSBGRT00000022506",70657,"CNTRL","centriolin [Source:HGNC Symbol;Acc:HGNC:1858]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0008092(cytoskeletal protein binding);GO:0051493(regulation of cytoskeleton organization);GO:0120103(centriolar subdistal appendage)","NA",{"v":7.9e-63,"d":"0.00"},2,"176,124,","0,3624",{"v":-62.1,"d":"-62.10"},{"v":-60.7,"d":"-60.70"},3.54,"Exon (ENSBGRT00000022506/ENSBGRG00000012248, exon 32 of 44)",7,49792508,49882184,89677,1]
["chr7",53778603,53778871,269,"ENSBGRG00000000461","ENSBGRT00000000798",0,"NR4A3","nuclear receptor subfamily 4 group A member 3 [Source:HGNC Symbol;Acc:HGNC:7982]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001223(transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001707(mesoderm formation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0007369(gastrulation);GO:0007411(axon guidance);GO:0008270(zinc ion binding);GO:0009444(pyruvate oxidation);GO:0010828(positive regulation of glucose transmembrane transport);GO:0019901(protein kinase binding);GO:0021766(hippocampus development);GO:0030534(adult behavior);GO:0032765(positive regulation of mast cell cytokine production);GO:0035035(histone acetyltransferase binding);GO:0035497(cAMP response element binding);GO:0035726(common myeloid progenitor cell proliferation);GO:0038097(positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway);GO:0042025(host cell nucleus);GO:0042472(inner ear morphogenesis);GO:0042542(response to hydrogen peroxide);GO:0043066(negative regulation of apoptotic process);GO:0043303(mast cell degranulation);GO:0043524(negative regulation of neuron apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0044320(cellular response to leptin stimulus);GO:0045333(cellular respiration);GO:0045444(fat cell differentiation);GO:0045787(positive regulation of cell cycle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046321(positive regulation of fatty acid oxidation);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048660(regulation of smooth muscle cell proliferation);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0048752(semicircular canal morphogenesis);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050885(neuromuscular process controlling balance);GO:0060005(vestibular reflex);GO:0071376(cellular response to corticotropin-releasing hormone stimulus);GO:0071870(cellular response to catecholamine stimulus);GO:0097009(energy homeostasis);GO:1900625(positive regulation of monocyte aggregation);GO:1903204(negative regulation of oxidative stress-induced neuron death);GO:1903208(negative regulation of hydrogen peroxide-induced neuron death);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration);GO:2000108(positive regulation of leukocyte apoptotic process);GO:2000253(positive regulation of feeding behavior)","05202(Transcriptional misregulation in cancers)",{"v":0.0051,"d":"0.01"},1,"269,",0,-2.29,{"v":-1.7,"d":"-1.70"},6.48,"5' UTR",7,53778603,53824688,46086,1]
["chr7",56710481,56710601,121,"ENSBGRG00000001797","ENSBGRT00000003332",19512,"FBXO10","F-box protein 10 [Source:HGNC Symbol;Acc:HGNC:13589]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0042981(regulation of apoptotic process)","NA",{"v":3e-05,"d":"0.00"},1,"121,",0,-4.53,-3.83,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000003332/ENSBGRG00000001797, exon 2 of 11)",7,56690969,56735340,44372,1]
["chr7",57961537,57961597,61,"ENSBGRG00000003060","ENSBGRT00000005761",33649,"GNE","glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase [Source:HGNC Symbol;Acc:HGNC:23657]","GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0006047(UDP-N-acetylglucosamine metabolic process)","00520(Amino sugar and nucleotide sugar metabolism)",{"v":6.3e-24,"d":"0.00"},1,"61,",0,{"v":-23.2,"d":"-23.20"},{"v":-22.2,"d":"-22.20"},5.27,"Exon (ENSBGRT00000005761/ENSBGRG00000003060, exon 3 of 12)",7,57927888,57988865,60978,1]
["chr7",59277685,59277983,299,"ENSBGRG00000012916","ENSBGRT00000023938",7539,"PIGO","phosphatidylinositol glycan anchor biosynthesis class O [Source:HGNC Symbol;Acc:HGNC:23215]","GO:0003824(catalytic activity);GO:0006506(GPI anchor biosynthetic process);GO:0016772(transferase activity, transferring phosphorus-containing groups);GO:0051377(mannose-ethanolamine phosphotransferase activity)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",{"v":5e-99,"d":"0.00"},1,"299,",0,{"v":-98.3,"d":"-98.30"},{"v":-96.6,"d":"-96.60"},2.72,"3' UTR",7,59270146,59278013,7868,1]
["chr7",74300912,74301837,926,"ENSBGRG00000000786","ENSBGRT00000001637",0,"APBA1","amyloid beta precursor protein binding family A member 1 [Source:HGNC Symbol;Acc:HGNC:578]","GO:0001540(amyloid-beta binding);GO:0001701(in utero embryonic development);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0006886(intracellular protein transport);GO:0007268(chemical synaptic transmission);GO:0007626(locomotory behavior);GO:0008021(synaptic vesicle);GO:0010468(regulation of gene expression);GO:0014047(glutamate secretion);GO:0014051(gamma-aminobutyric acid secretion);GO:0016020(membrane);GO:0035264(multicellular organism growth);GO:0065003(protein-containing complex assembly);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:2000300(regulation of synaptic vesicle exocytosis)","NA",{"v":2.1e-08,"d":"0.00"},1,"926,",0,-7.68,-6.89,{"v":16.7,"d":"16.70"},"Exon (ENSBGRT00000001637/ENSBGRG00000000786, exon 1 of 11)",7,74300912,74392606,91695,1]
["chr7",80591812,80592228,417,"ENSBGRG00000005214","ENSBGRT00000009729",79405,"SLC1A1","solute carrier family 1 member 1 [Source:HGNC Symbol;Acc:HGNC:10939]","GO:0005313(L-glutamate transmembrane transporter activity);GO:0005314(high-affinity glutamate transmembrane transporter activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0010460(positive regulation of heart rate);GO:0015108(chloride transmembrane transporter activity);GO:0015183(L-aspartate transmembrane transporter activity);GO:0015293(symporter activity);GO:0015501(glutamate:sodium symporter activity);GO:0015813(L-glutamate transmembrane transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0031901(early endosome membrane);GO:0033229(cysteine transmembrane transporter activity);GO:0035633(maintenance of permeability of blood-brain barrier);GO:0036475(neuron death in response to oxidative stress);GO:0042802(identical protein binding);GO:0042883(cysteine transport);GO:0048514(blood vessel morphogenesis);GO:0051938(L-glutamate import);GO:0055038(recycling endosome membrane);GO:0070777(D-aspartate transport);GO:0070778(L-aspartate transmembrane transport);GO:0070779(D-aspartate import across plasma membrane);GO:0098712(L-glutamate import across plasma membrane);GO:0140009(L-aspartate import across plasma membrane);GO:0140010(D-aspartate transmembrane transporter activity);GO:1902476(chloride transmembrane transport);GO:1903712(cysteine transmembrane transport)","04974(Protein digestion and absorption);04724(Glutamatergic synapse)",{"v":0.0078,"d":"0.01"},1,"417,",0,-2.11,{"v":-1.3,"d":"-1.30"},9.72,"3' UTR",7,80512407,80592347,79941,1]
["chr7",94699212,94700798,1587,"ENSBGRG00000001209","ENSBGRT00000002312",234864,"CNTLN","centlein [Source:HGNC Symbol;Acc:HGNC:23432]","GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0010457(centriole-centriole cohesion);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0030674(protein-macromolecule adaptor activity);GO:0033365(protein localization to organelle)","NA",{"v":0.00022,"d":"0.00"},2,"25,65,","0,1522",-3.66,-2.99,1.69,"Exon (ENSBGRT00000002312/ENSBGRG00000001209, exon 11 of 26)",7,94464348,94845554,381207,1]
["chr7",112040139,112040229,91,"ENSBGRG00000001492","ENSBGRT00000002746",9078,"SCARA3","scavenger receptor class A member 3 [Source:HGNC Symbol;Acc:HGNC:19000]","NA","04145(Phagosome)",{"v":1.3E-13,"d":"0.00"},1,"91,",0,{"v":-12.9,"d":"-12.90"},-12,1.72,"Exon (ENSBGRT00000002746/ENSBGRG00000001492, exon 4 of 6)",7,112031061,112052642,21582,1]
["chr7",117816017,117816106,90,"ENSBGRG00000011973","ENSBGRT00000021880",474,"ENSBGRG00000011973","NA","GO:0046983(protein dimerization activity)","NA",{"v":0.015,"d":"0.02"},1,"90,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000021880/ENSBGRG00000011973, exon 1 of 2)",7,117815543,117818239,2697,1]
["chr7",122668416,122701116,32701,"ENSBGRG00000014664","ENSBGRT00000027027",58325,"NEK1","NIMA related kinase 1 [Source:HGNC Symbol;Acc:HGNC:7744]","GO:0000242(pericentriolar material);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0034451(centriolar satellite);GO:0042769(DNA damage response, detection of DNA damage);GO:0060271(cilium assembly)","NA",{"v":4e-20,"d":"0.00"},6,"44,84,84,78,96,32,","0,27805,28313,28828,29793,32669",{"v":-19.4,"d":"-19.40"},{"v":-18.4,"d":"-18.40"},2.49,"Exon (ENSBGRT00000027027/ENSBGRG00000014664, exon 16 of 33)",7,122610091,122748592,138502,1]
["chr7",4286234,4289064,2831,"ENSBGRG00000008707","ENSBGRT00000016490",239,"HR","HR lysine demethylase and nuclear receptor corepressor [Source:HGNC Symbol;Acc:HGNC:5172]","GO:0003714(transcription corepressor activity);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":0.015,"d":"0.02"},2,"254,912,","0,1919",-1.83,-1.02,8.64,"5' UTR",7,4265982,4289303,23322,2]
["chr7",7421405,7421494,90,"ENSBGRG00000015850","ENSBGRT00000029127",1513,"NEFL","neurofilament light [Source:HGNC Symbol;Acc:HGNC:7739]","GO:0000226(microtubule cytoskeleton organization);GO:0005200(structural constituent of cytoskeleton);GO:0005737(cytoplasm);GO:0005882(intermediate filament);GO:0005883(neurofilament);GO:0008022(protein C-terminus binding);GO:0008089(anterograde axonal transport);GO:0008090(retrograde axonal transport);GO:0014012(peripheral nervous system axon regeneration);GO:0019896(axonal transport of mitochondrion);GO:0030424(axon);GO:0030674(protein-macromolecule adaptor activity);GO:0031133(regulation of axon diameter);GO:0031594(neuromuscular junction);GO:0033693(neurofilament bundle assembly);GO:0040011(locomotion);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043524(negative regulation of neuron apoptotic process);GO:0045109(intermediate filament organization);GO:0045110(intermediate filament bundle assembly);GO:0048812(neuron projection morphogenesis);GO:0050772(positive regulation of axonogenesis);GO:0050885(neuromuscular process controlling balance);GO:0060052(neurofilament cytoskeleton organization);GO:0061564(axon development);GO:0098685(Schaffer collateral - CA1 synapse);GO:0099182(presynaptic intermediate filament cytoskeleton);GO:0099184(structural constituent of postsynaptic intermediate filament cytoskeleton)","05014(Amyotrophic lateral sclerosis (ALS))",{"v":0.0051,"d":"0.01"},1,"90,",0,-2.29,{"v":-1.7,"d":"-1.70"},3.67,"Exon (ENSBGRT00000029222/ENSBGRG00000015920, exon 1 of 2)",7,7418510,7423007,4498,2]
["chr7",11293049,11293228,180,"ENSBGRG00000002133","ENSBGRT00000004134",185,"KIF24","kinesin family member 24 [Source:HGNC Symbol;Acc:HGNC:19916]","GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005814(centriole);GO:0007018(microtubule-based movement);GO:0007019(microtubule depolymerization);GO:0008017(microtubule binding);GO:0032991(protein-containing complex);GO:0042802(identical protein binding);GO:0060271(cilium assembly)","NA",{"v":0.00025,"d":"0.00"},1,"180,",0,-3.61,-2.94,2.47,"Exon (ENSBGRT00000004134/ENSBGRG00000002133, exon 1 of 13)",7,11242598,11293413,50816,2]
["chr7",14861161,14861489,329,"ENSBGRG00000004819","ENSBGRT00000009603",76185,"AGTPBP1","ATP/GTP binding protein 1 [Source:HGNC Symbol;Acc:HGNC:17258]","GO:0001754(eye photoreceptor cell differentiation);GO:0004181(metallocarboxypeptidase activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0007005(mitochondrion organization);GO:0007628(adult walking behavior);GO:0008270(zinc ion binding);GO:0008285(negative regulation of cell population proliferation);GO:0015631(tubulin binding);GO:0021549(cerebellum development);GO:0021680(cerebellar Purkinje cell layer development);GO:0021702(cerebellar Purkinje cell differentiation);GO:0021772(olfactory bulb development);GO:0021954(central nervous system neuron development);GO:0035608(protein deglutamylation);GO:0035609(C-terminal protein deglutamylation);GO:0035610(protein side chain deglutamylation);GO:0042133(neurotransmitter metabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0050905(neuromuscular process);GO:0060041(retina development in camera-type eye);GO:0098930(axonal transport);GO:0098957(anterograde axonal transport of mitochondrion);GO:0098958(retrograde axonal transport of mitochondrion);GO:2000060(positive regulation of ubiquitin-dependent protein catabolic process)","04740(Olfactory transduction)",{"v":1.3E-20,"d":"0.00"},1,"329,",0,{"v":-19.9,"d":"-19.90"},{"v":-18.9,"d":"-18.90"},5.05,"Exon (ENSBGRT00000009603/ENSBGRG00000004819, exon 13 of 25)",7,14773275,14937674,164400,2]
["chr7",19354159,19354219,61,"ENSBGRG00000010244","ENSBGRT00000019408",61638,"ENSBGRG00000010244","NA","GO:0016491(oxidoreductase activity);GO:0030539(male genitalia development);GO:0047045(testosterone 17-beta-dehydrogenase (NADP+) activity);GO:0061370(testosterone biosynthetic process)","00140(Steroid hormone biosynthesis)",{"v":0.0055,"d":"0.01"},1,"61,",0,-2.26,-1.67,1.52,"3' UTR",7,19307304,19415857,108554,2]
["chr7",20711909,20712089,181,"ENSBGRG00000013860","ENSBGRT00000025406",53869,"BICD2","BICD cargo adaptor 2 [Source:HGNC Symbol;Acc:HGNC:17208]","GO:0005635(nuclear envelope);GO:0005642(annulate lamellae);GO:0005643(nuclear pore);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006890(retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum);GO:0007018(microtubule-based movement);GO:0008093(cytoskeletal adaptor activity);GO:0017137(Rab GTPase binding);GO:0031410(cytoplasmic vesicle);GO:0034067(protein localization to Golgi apparatus);GO:0034452(dynactin binding);GO:0051642(centrosome localization);GO:0051959(dynein light intermediate chain binding);GO:0070507(regulation of microtubule cytoskeleton organization);GO:0070840(dynein complex binding);GO:0072385(minus-end-directed organelle transport along microtubule);GO:0072393(microtubule anchoring at microtubule organizing center)","NA",{"v":1e-21,"d":"0.00"},1,"181,",0,-21,-20,3.43,"Exon (ENSBGRT00000025406/ENSBGRG00000013860, exon 5 of 8)",7,20705038,20765958,60921,2]
["chr7",25421814,25421872,59,"ENSBGRG00000018117","ENSBGRT00000033158",0,"GADD45G","growth arrest and DNA damage inducible gamma [Source:HGNC Symbol;Acc:HGNC:4097]","GO:0005634(nucleus);GO:0051726(regulation of cell cycle)","04010(MAPK signaling pathway);04068(FoxO signaling pathway);04110(Cell cycle);04210(Apoptosis);04115(p53 signaling pathway);04218(Cellular senescence);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05216(Thyroid cancer);05220(Chronic myeloid leukemia);05217(Basal cell carcinoma);05218(Melanoma);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer)",{"v":0.028,"d":"0.03"},1,"59,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",7,25419981,25421872,1892,2]
["chr7",37901337,37902355,1019,"ENSBGRG00000002989","ENSBGRT00000005877",182156,"SVEP1","sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 [Source:HGNC Symbol;Acc:HGNC:15985]","GO:0001945(lymph vessel development);GO:0003017(lymph circulation);GO:0003682(chromatin binding);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008544(epidermis development);GO:0010467(gene expression);GO:0036303(lymph vessel morphogenesis);GO:0048014(Tie signaling pathway);GO:0120193(tight junction organization)","NA",{"v":1.6E-72,"d":"0.00"},1,"1019,",0,{"v":-71.8,"d":"-71.80"},{"v":-70.3,"d":"-70.30"},4.88,"Exon (ENSBGRT00000005877/ENSBGRG00000002989, exon 39 of 49)",7,37862199,38084511,222313,2]
["chr7",40895062,40895178,117,"ENSBGRG00000006110","ENSBGRT00000011266",0,"HDHD3","haloacid dehalogenase like hydrolase domain containing 3 [Source:HGNC Symbol;Acc:HGNC:28171]","GO:0005730(nucleolus);GO:0016787(hydrolase activity);GO:0043231(intracellular membrane-bounded organelle)","00860(Porphyrin and chlorophyll metabolism)",{"v":1.3E-14,"d":"0.00"},1,"117,",0,{"v":-13.9,"d":"-13.90"},-13,6.75,"Exon (ENSBGRT00000011266/ENSBGRG00000006110, exon 1 of 1)",7,40894423,40895178,756,2]
["chr7",42792673,42793063,391,"ENSBGRG00000008389","ENSBGRT00000015566",5863,"TNC","tenascin C [Source:HGNC Symbol;Acc:HGNC:5318]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0007155(cell adhesion);GO:0007528(neuromuscular junction development);GO:0008284(positive regulation of cell population proliferation);GO:0009611(response to wounding);GO:0010628(positive regulation of gene expression);GO:0014012(peripheral nervous system axon regeneration);GO:0042127(regulation of cell population proliferation);GO:0045545(syndecan binding);GO:0060739(mesenchymal-epithelial cell signaling involved in prostate gland development);GO:0060740(prostate gland epithelium morphogenesis);GO:0062023(collagen-containing extracellular matrix);GO:0098966(perisynaptic extracellular matrix)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);05206(MicroRNAs in cancer);05165(Human papillomavirus infection)",{"v":3.2e-16,"d":"0.00"},1,"391,",0,{"v":-15.5,"d":"-15.50"},{"v":-14.5,"d":"-14.50"},3.78,"Exon (ENSBGRT00000015566/ENSBGRG00000008389, exon 2 of 28)",7,42711537,42798926,87390,2]
["chr7",55858827,55859006,180,"ENSBGRG00000001522","ENSBGRT00000002809",415,"ALDH1B1","aldehyde dehydrogenase 1 family member B1 [Source:HGNC Symbol;Acc:HGNC:407]","GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0016491(oxidoreductase activity);GO:0016620(oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor);GO:0043231(intracellular membrane-bounded organelle);GO:0055114(oxidation-reduction process)","00010(Glycolysis / Gluconeogenesis);00053(Ascorbate and aldarate metabolism);00620(Pyruvate metabolism);00071(Fatty acid degradation);00561(Glycerolipid metabolism);00280(Valine, leucine and isoleucine degradation);00310(Lysine degradation);00330(Arginine and proline metabolism);00340(Histidine metabolism);00380(Tryptophan metabolism);00410(beta-Alanine metabolism)",{"v":0.043,"d":"0.04"},1,"180,",0,-1.37,{"v":-0.6,"d":"-0.60"},6.48,"Exon (ENSBGRT00000002809/ENSBGRG00000001522, exon 2 of 3)",7,55857618,55859421,1804,2]
["chr7",58796683,58796832,150,"ENSBGRG00000006379","ENSBGRT00000011952",0,"RUSC2","RUN and SH3 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:23625]","GO:0005515(protein binding);GO:0017137(Rab GTPase binding);GO:0031410(cytoplasmic vesicle)","04142(Lysosome)",{"v":1E-25,"d":"0.00"},1,"150,",0,-25,{"v":-23.9,"d":"-23.90"},{"v":2.7,"d":"2.70"},"Exon (ENSBGRT00000011952/ENSBGRG00000006379, exon 1 of 14)",7,58781315,58796832,15518,2]
["chr7",64919552,64919612,61,"ENSBGRG00000015625","ENSBGRT00000033391",38715,"CEP78","centrosomal protein 78 [Source:HGNC Symbol;Acc:HGNC:25740]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0036064(ciliary basal body);GO:0044782(cilium organization)","NA",{"v":3e-05,"d":"0.00"},1,"61,",0,-4.53,-3.83,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000033391/ENSBGRG00000015625, exon 18 of 18)",7,64919552,64958327,38776,2]
["chr7",75005824,75005884,61,"ENSBGRG00000002519","ENSBGRT00000004883",88513,"PIP5K1B","phosphatidylinositol-4-phosphate 5-kinase type 1 beta [Source:HGNC Symbol;Acc:HGNC:8995]","GO:0001931(uropod);GO:0005829(cytosol);GO:0006661(phosphatidylinositol biosynthetic process);GO:0016307(phosphatidylinositol phosphate kinase activity);GO:0016308(1-phosphatidylinositol-4-phosphate 5-kinase activity);GO:0046488(phosphatidylinositol metabolic process)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);04144(Endocytosis);04810(Regulation of actin cytoskeleton);04666(Fc gamma R-mediated phagocytosis);05231(Choline metabolism in cancer)",0.04,1,"61,",0,{"v":-1.4,"d":"-1.40"},{"v":-0.872,"d":"-0.87"},2.52,"Exon (ENSBGRT00000004883/ENSBGRG00000002519, exon 5 of 12)",7,74851413,75094397,242985,2]
["chr7",81242487,81242546,60,"ENSBGRG00000006032","ENSBGRT00000011123",36686,"PLGRKT","plasminogen receptor with a C-terminal lysine [Source:HGNC Symbol;Acc:HGNC:23633]","GO:0005887(integral component of plasma membrane);GO:0010756(positive regulation of plasminogen activation)","NA",{"v":0.0078,"d":"0.01"},1,"60,",0,-2.11,-1.27,9.72,"3' UTR",7,81193499,81279232,85734,2]
["chr7",81951777,81951956,180,"ENSBGRG00000006611","ENSBGRT00000012182",3557,"ENSBGRG00000006611","NA","GO:0006606(protein import into nucleus)","NA",{"v":4e-11,"d":"0.00"},1,"180,",0,{"v":-10.4,"d":"-10.40"},-9.54,1.81,"3' UTR",7,81950316,81955513,5198,2]
["chr7",93712060,93712389,330,"ENSBGRG00000001132","ENSBGRT00000002101",134138,"BNC2","basonuclin 2 [Source:HGNC Symbol;Acc:HGNC:30988]","GO:0003416(endochondral bone growth);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0043586(tongue development);GO:0060021(roof of mouth development);GO:0060485(mesenchyme development)","NA",{"v":7.9e-31,"d":"0.00"},1,"330,",0,{"v":-30.1,"d":"-30.10"},-29,3.12,"Exon (ENSBGRT00000002101/ENSBGRG00000001132, exon 5 of 8)",7,93694331,93846527,152197,2]
["chr7",98852704,98852881,178,"ENSBGRG00000002261","ENSBGRT00000004214",0,"ENSBGRG00000002261","NA","GO:0005125(cytokine activity);GO:0005126(cytokine receptor binding);GO:0005132(type I interferon receptor binding);GO:0005576(extracellular region);GO:0006952(defense response)","04630(Jak-STAT signaling pathway);04668(TNF signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04217(Necroptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);04650(Natural killer cell mediated cytotoxicity);04380(Osteoclast differentiation);05152(Tuberculosis);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05168(Herpes simplex infection);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection);05142(Chagas disease (American trypanosomiasis))",0.04,1,"178,",0,{"v":-1.4,"d":"-1.40"},{"v":-0.872,"d":"-0.87"},2.97,"Exon (ENSBGRT00000004214/ENSBGRG00000002261, exon 1 of 1)",7,98852321,98852881,561,2]
["chr7",105867426,105867545,120,"ENSBGRG00000001111","ENSBGRT00000002056",360,"C9orf72","C9orf72-SMCR8 complex subunit [Source:HGNC Symbol;Acc:HGNC:28337]","GO:0000932(P-body);GO:0001933(negative regulation of protein phosphorylation);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005776(autophagosome);GO:0006897(endocytosis);GO:0006914(autophagy);GO:0010494(cytoplasmic stress granule);GO:0010506(regulation of autophagy);GO:0016239(positive regulation of macroautophagy);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0032045(guanyl-nucleotide exchange factor complex);GO:0034063(stress granule assembly);GO:0044295(axonal growth cone);GO:0044304(main axon);GO:0048675(axon extension);GO:0110053(regulation of actin filament organization);GO:1903432(regulation of TORC1 signaling);GO:1990316(Atg1/ULK1 kinase complex);GO:2000785(regulation of autophagosome assembly)","NA",{"v":6.3e-26,"d":"0.00"},1,"120,",0,{"v":-25.2,"d":"-25.20"},{"v":-24.1,"d":"-24.10"},4.58,"Exon (ENSBGRT00000002056/ENSBGRG00000001111, exon 1 of 11)",7,105828572,105867905,39334,2]
["chr8",2846261,2858319,12059,"ENSBGRG00000010734","ENSBGRT00000019665",8883,"TPM4","tropomyosin 4 [Source:HGNC Symbol;Acc:HGNC:12013]","GO:0001725(stress fiber);GO:0002102(podosome);GO:0005737(cytoplasm);GO:0030863(cortical cytoskeleton);GO:0051015(actin filament binding)","04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))",0,6,"139,134,118,71,76,63,","0,4137,7976,8656,9705,11996",-750,"-Inf",2.49,"5' UTR",8,2837378,2862978,25601,1]
["chr8",2930223,2936275,6053,"ENSBGRG00000011352","ENSBGRT00000020959",0,"FAM32A","family with sequence similarity 32 member A [Source:HGNC Symbol;Acc:HGNC:24563]","NA","NA",0,4,"74,142,373,305,","0,192,4825,5748",-740,"-Inf",4.32,"Exon (ENSBGRT00000020959/ENSBGRG00000011352, exon 1 of 3)",8,2930223,2935392,5170,1]
["chr8",4766928,4774928,8001,"ENSBGRG00000026081","ENSBGRT00000048234",0,"CCDC124","coiled-coil domain containing 124 [Source:HGNC Symbol;Acc:HGNC:25171]","GO:0005829(cytosol);GO:0005886(plasma membrane)","NA",{"v":1.6e-76,"d":"0.00"},5,"83,90,190,115,208,","0,963,6840,7550,7793",{"v":-75.8,"d":"-75.80"},{"v":-74.3,"d":"-74.30"},3.93,"5' UTR",8,4766928,4775166,8239,1]
["chr8",6165222,6165372,151,"ENSBGRG00000001549","ENSBGRT00000002911",4740,"RFXANK","regulatory factor X associated ankyrin containing protein [Source:HGNC Symbol;Acc:HGNC:9987]","GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007265(Ras protein signal transduction);GO:0042826(histone deacetylase binding);GO:0045171(intercellular bridge);GO:0045944(positive regulation of transcription by RNA polymerase II)","04612(Antigen processing and presentation);05340(Primary immunodeficiency);05152(Tuberculosis)",{"v":2.6e-10,"d":"0.00"},1,"151,",0,-9.59,-8.75,1.99,"3' UTR",8,6160482,6165671,5190,1]
["chr8",7687936,7689090,1155,"ENSBGRG00000003221","ENSBGRT00000006224",208415,"ENSBGRG00000003221","NA","NA","NA",{"v":0.015,"d":"0.02"},2,"266,95,","0,1060",-1.83,-1.02,8.64,"Exon (ENSBGRT00000006224/ENSBGRG00000003221, exon 73 of 123)",8,7479521,7742779,263259,1]
["chr8",11516918,11517651,734,"ENSBGRG00000006220","ENSBGRT00000011456",0,"JUNB","JunB proto-oncogene, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:6205]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001570(vasculogenesis);GO:0001649(osteoblast differentiation);GO:0001701(in utero embryonic development);GO:0001829(trophectodermal cell differentiation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0009987(cellular process);GO:0030316(osteoclast differentiation);GO:0033687(osteoblast proliferation);GO:0035976(transcription factor AP-1 complex);GO:0045597(positive regulation of cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046697(decidualization);GO:0051726(regulation of cell cycle);GO:0060136(embryonic process involved in female pregnancy);GO:0060716(labyrinthine layer blood vessel development);GO:0071277(cellular response to calcium ion);GO:1990837(sequence-specific double-stranded DNA binding)","04668(TNF signaling pathway);04380(Osteoclast differentiation)",0,2,"455,236,","0,498",-624,"-Inf",5.71,"Exon (ENSBGRT00000011456/ENSBGRG00000006220, exon 1 of 2)",8,11516918,11518460,1543,1]
["chr8",11648282,11648610,329,"ENSBGRG00000007159","ENSBGRT00000013137",2849,"CALR","calreticulin [Source:HGNC Symbol;Acc:HGNC:1455]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002502(peptide antigen assembly with MHC class I protein complex);GO:0003729(mRNA binding);GO:0005178(integrin binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0005829(cytosol);GO:0005844(polysome);GO:0006457(protein folding);GO:0006611(protein export from nucleus);GO:0008284(positive regulation of cell population proliferation);GO:0009897(external side of plasma membrane);GO:0010595(positive regulation of endothelial cell migration);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0017148(negative regulation of translation);GO:0030246(carbohydrate binding);GO:0030866(cortical actin cytoskeleton organization);GO:0031625(ubiquitin protein ligase binding);GO:0033144(negative regulation of intracellular steroid hormone receptor signaling pathway);GO:0034504(protein localization to nucleus);GO:0040020(regulation of meiotic nuclear division);GO:0042824(MHC class I peptide loading complex);GO:0044322(endoplasmic reticulum quality control compartment);GO:0045665(negative regulation of neuron differentiation);GO:0045787(positive regulation of cell cycle);GO:0045892(negative regulation of transcription, DNA-templated);GO:0048387(negative regulation of retinoic acid receptor signaling pathway);GO:0048471(perinuclear region of cytoplasm);GO:0050681(androgen receptor binding);GO:0050766(positive regulation of phagocytosis);GO:0050821(protein stabilization);GO:0051082(unfolded protein binding);GO:0071157(negative regulation of cell cycle arrest);GO:0090398(cellular senescence);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading);GO:1901164(negative regulation of trophoblast cell migration);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:2000510(positive regulation of dendritic cell chemotaxis)","04141(Protein processing in endoplasmic reticulum);04145(Phagosome);04612(Antigen processing and presentation);05166(HTLV-I infection);05163(Human cytomegalovirus infection);05142(Chagas disease (American trypanosomiasis))",0,2,"39,201,","0,128",-971,"-Inf",3.42,"Exon (ENSBGRT00000013137/ENSBGRG00000007159, exon 8 of 9)",8,11645433,11648610,3178,1]
["chr8",13134605,13134724,120,"ENSBGRG00000000526","ENSBGRT00000001314",17751,"ADGRE5","adhesion G protein-coupled receptor E5 [Source:HGNC Symbol;Acc:HGNC:1711]","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005509(calcium ion binding);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","NA",{"v":1.3E-31,"d":"0.00"},1,"120,",0,{"v":-30.9,"d":"-30.90"},{"v":-29.8,"d":"-29.80"},1.73,"3' UTR",8,13116854,13134750,17897,1]
["chr8",15795685,15795743,59,"ENSBGRG00000005681","ENSBGRT00000010487",781,"TIMM29","translocase of inner mitochondrial membrane 29 [Source:HGNC Symbol;Acc:HGNC:25152]","GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0042721(TIM22 mitochondrial import inner membrane insertion complex);GO:0045039(protein insertion into mitochondrial inner membrane)","NA",{"v":4e-11,"d":"0.00"},1,"59,",0,{"v":-10.4,"d":"-10.40"},-9.53,7.56,"Exon (ENSBGRT00000010487/ENSBGRG00000005681, exon 2 of 2)",8,15794904,15796155,1252,1]
["chr8",16977971,16978060,90,"ENSBGRG00000015732","ENSBGRT00000028948",1760,"ZNF358","zinc finger protein 358 [Source:HGNC Symbol;Acc:HGNC:16838]","GO:0003676(nucleic acid binding)","NA",{"v":2.5e-19,"d":"0.00"},1,"90,",0,{"v":-18.6,"d":"-18.60"},{"v":-17.6,"d":"-17.60"},1.77,"Exon (ENSBGRT00000028948/ENSBGRG00000015732, exon 2 of 2)",8,16976211,16978060,1850,1]
["chr8",17300427,17300576,150,"ENSBGRG00000020311","ENSBGRT00000037478",10314,"MAP2K7","mitogen-activated protein kinase kinase 7 [Source:HGNC Symbol;Acc:HGNC:6847]","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004708(MAP kinase kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0006970(response to osmotic stress);GO:0009408(response to heat);GO:0009411(response to UV);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0032212(positive regulation of telomere maintenance via telomerase);GO:0034612(response to tumor necrosis factor);GO:0045893(positive regulation of transcription, DNA-templated);GO:0051403(stress-activated MAPK cascade);GO:0051973(positive regulation of telomerase activity);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:1904355(positive regulation of telomere capping)","04141(Protein processing in endoplasmic reticulum);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04668(TNF signaling pathway);04530(Tight junction);04620(Toll-like receptor signaling pathway);04660(T cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04912(GnRH signaling pathway);04926(Relaxin signaling pathway);04722(Neurotrophin signaling pathway);04380(Osteoclast differentiation);05418(Fluid shear stress and atherosclerosis);05164(Influenza A);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection)",{"v":1e-112,"d":"0.00"},1,"150,",0,-112,-110,1.98,"3' UTR",8,17290113,17301322,11210,1]
["chr8",17794836,17807919,13084,"ENSBGRG00000025188","ENSBGRT00000046616",25714,"HNRNPM","heterogeneous nuclear ribonucleoprotein M [Source:HGNC Symbol;Acc:HGNC:5046]","GO:0000380(alternative mRNA splicing, via spliceosome);GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0016363(nuclear matrix);GO:0019904(protein domain specific binding);GO:0042382(paraspeckles);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)",{"v":0,"d":"0.00"},6,"6,102,45,78,54,105,","0,2220,3736,4241,10958,12979",-310,-308,4.03,"Exon (ENSBGRT00000046616/ENSBGRG00000025188, exon 8 of 13)",8,17769122,17808869,39748,1]
["chr8",19461593,19461892,300,"ENSBGRG00000001424","ENSBGRT00000002674",18907,"LONP1","lon peptidase 1, mitochondrial [Source:HGNC Symbol;Acc:HGNC:9479]","GO:0001018(mitochondrial promoter sequence-specific DNA binding);GO:0001666(response to hypoxia);GO:0003727(single-stranded RNA binding);GO:0004176(ATP-dependent peptidase activity);GO:0004252(serine-type endopeptidase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006515(protein quality control for misfolded or incompletely synthesized proteins);GO:0007005(mitochondrion organization);GO:0016887(ATPase activity);GO:0030163(protein catabolic process);GO:0034599(cellular response to oxidative stress);GO:0042645(mitochondrial nucleoid);GO:0042802(identical protein binding);GO:0043531(ADP binding);GO:0043565(sequence-specific DNA binding);GO:0051603(proteolysis involved in cellular protein catabolic process);GO:0051880(G-quadruplex DNA binding);GO:0070182(DNA polymerase binding);GO:0070407(oxidation-dependent protein catabolic process)","NA",0,1,"300,",0,-1180,"-Inf",2.08,"3' UTR",8,19442686,19463297,20612,1]
["chr8",20221376,20221585,210,"ENSBGRG00000013632","ENSBGRT00000024999",13138,"ARRDC5","arrestin domain containing 5 [Source:HGNC Symbol;Acc:HGNC:31407]","NA","NA",{"v":2.5e-13,"d":"0.00"},1,"210,",0,{"v":-12.6,"d":"-12.60"},{"v":-11.8,"d":"-11.80"},5.76,"Exon (ENSBGRT00000024999/ENSBGRG00000013632, exon 3 of 3)",8,20208238,20221585,13348,1]
["chr8",20633516,20634026,511,"ENSBGRG00000014527","ENSBGRT00000026771",5893,"PLIN4","perilipin 4 [Source:HGNC Symbol;Acc:HGNC:29393]","GO:0005811(lipid droplet);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0043231(intracellular membrane-bounded organelle)","03320(PPAR signaling pathway)",{"v":8.1e-10,"d":"0.00"},1,"511,",0,-9.09,-8.26,{"v":10.1,"d":"10.10"},"Exon (ENSBGRT00000026771/ENSBGRG00000014527, exon 3 of 7)",8,20627623,20644152,16530,1]
["chr8",21426022,21426141,120,"ENSBGRG00000020521","ENSBGRT00000037758",52507,"PIP5K1C","phosphatidylinositol-4-phosphate 5-kinase type 1 gamma [Source:HGNC Symbol;Acc:HGNC:8996]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0010008(endosome membrane);GO:0016307(phosphatidylinositol phosphate kinase activity);GO:0046488(phosphatidylinositol metabolic process)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);04144(Endocytosis);04810(Regulation of actin cytoskeleton);04666(Fc gamma R-mediated phagocytosis);05231(Choline metabolism in cancer)",{"v":7.6e-09,"d":"0.00"},1,"120,",0,-8.12,-7.31,1.82,"3' UTR",8,21373515,21426141,52627,1]
["chr8",22752253,22753490,1238,"ENSBGRG00000001819","ENSBGRT00000003380",29443,"AP3D1","adaptor related protein complex 3 subunit delta 1 [Source:HGNC Symbol;Acc:HGNC:568]","GO:0006886(intracellular protein transport);GO:0010008(endosome membrane);GO:0015031(protein transport);GO:0016192(vesicle-mediated transport);GO:0030117(membrane coat);GO:0030123(AP-3 adaptor complex);GO:0035646(endosome to melanosome transport);GO:0061088(regulation of sequestering of zinc ion);GO:0072657(protein localization to membrane)","04142(Lysosome)",{"v":0.021,"d":"0.02"},3,"63,48,40,","0,1001,1198",-1.67,-1.12,3.24,"Exon (ENSBGRT00000003380/ENSBGRG00000001819, exon 25 of 32)",8,22722810,22760105,37296,1]
["chr8",31155527,31156095,569,"ENSBGRG00000009381","ENSBGRT00000017222",104376,"ZNF608","zinc finger protein 608 [Source:HGNC Symbol;Acc:HGNC:29238]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003676(nucleic acid binding)","03420(Nucleotide excision repair)",{"v":6.3e-98,"d":"0.00"},1,"569,",0,{"v":-97.2,"d":"-97.20"},{"v":-95.6,"d":"-95.60"},5.95,"Exon (ENSBGRT00000017222/ENSBGRG00000009381, exon 6 of 11)",8,31051151,31164510,113360,1]
["chr8",41881756,41881906,151,"ENSBGRG00000016582","ENSBGRT00000030483",166358,"NSD1","nuclear receptor binding SET domain protein 1 [Source:HGNC Symbol;Acc:HGNC:14234]","GO:0000414(regulation of histone H3-K36 methylation);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0003712(transcription coregulator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0008270(zinc ion binding);GO:0018024(histone-lysine N-methyltransferase activity);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046975(histone methyltransferase activity (H3-K36 specific));GO:0050681(androgen receptor binding);GO:1903025(regulation of RNA polymerase II regulatory region sequence-specific DNA binding)","00310(Lysine degradation)",{"v":1e-163,"d":"0.00"},1,"151,",0,-163,-161,4.18,"Exon (ENSBGRT00000030483/ENSBGRG00000016582, exon 24 of 24)",8,41715398,41882386,166989,1]
["chr8",43680326,43680475,150,"ENSBGRG00000013468","ENSBGRT00000024720",0,"TRIM41","tripartite motif containing 41 [Source:HGNC Symbol;Acc:HGNC:19013]","GO:0005730(nucleolus);GO:0008270(zinc ion binding);GO:0016604(nuclear body);GO:0042802(identical protein binding);GO:0071222(cellular response to lipopolysaccharide);GO:0071225(cellular response to muramyl dipeptide)","NA",{"v":7.9e-20,"d":"0.00"},1,"150,",0,{"v":-19.1,"d":"-19.10"},{"v":-18.2,"d":"-18.20"},{"v":70.2,"d":"70.20"},"5' UTR",8,43680326,43691663,11338,1]
["chr8",46833847,46834056,210,"ENSBGRG00000005972","ENSBGRT00000011078",31150,"PALM","paralemmin [Source:HGNC Symbol;Acc:HGNC:8594]","GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007010(cytoskeleton organization);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0007194(negative regulation of adenylate cyclase activity);GO:0008104(protein localization);GO:0008360(regulation of cell shape);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0030175(filopodium);GO:0031527(filopodium membrane);GO:0031750(D3 dopamine receptor binding);GO:0044309(neuron spine);GO:0051491(positive regulation of filopodium assembly);GO:0060074(synapse maturation);GO:0060160(negative regulation of dopamine receptor signaling pathway);GO:0071257(cellular response to electrical stimulus);GO:0072659(protein localization to plasma membrane)","NA",{"v":1e-132,"d":"0.00"},1,"210,",0,-132,-130,3.42,"Exon (ENSBGRT00000011078/ENSBGRG00000005972, exon 9 of 9)",8,46802697,46835614,32918,1]
["chr8",47238530,47238797,268,"ENSBGRG00000013814","ENSBGRT00000025784",18257,"STK11","serine/threonine kinase 11 [Source:HGNC Symbol;Acc:HGNC:11389]","GO:0000287(magnesium ion binding);GO:0001558(regulation of cell growth);GO:0001894(tissue homeostasis);GO:0001944(vasculature development);GO:0002039(p53 binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006470(protein dephosphorylation);GO:0006974(cellular response to DNA damage stimulus);GO:0007050(cell cycle arrest);GO:0007409(axonogenesis);GO:0008285(negative regulation of cell population proliferation);GO:0010212(response to ionizing radiation);GO:0010508(positive regulation of autophagy);GO:0016020(membrane);GO:0030010(establishment of cell polarity);GO:0030111(regulation of Wnt signaling pathway);GO:0030275(LRR domain binding);GO:0030295(protein kinase activator activity);GO:0030308(negative regulation of cell growth);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0032147(activation of protein kinase activity);GO:0042593(glucose homeostasis);GO:0043276(anoikis);GO:0045059(positive thymic T cell selection);GO:0046777(protein autophosphorylation);GO:0048814(regulation of dendrite morphogenesis);GO:0050772(positive regulation of axonogenesis);GO:0050852(T cell receptor signaling pathway);GO:0051645(Golgi localization);GO:0051896(regulation of protein kinase B signaling);GO:0060070(canonical Wnt signaling pathway);GO:0060770(negative regulation of epithelial cell proliferation involved in prostate gland development);GO:0071493(cellular response to UV-B);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0097484(dendrite extension);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900182(positive regulation of protein localization to nucleus);GO:1901610(positive regulation of vesicle transport along microtubule);GO:1904262(negative regulation of TORC1 signaling)","04068(FoxO signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04530(Tight junction);04920(Adipocytokine signaling pathway);04211(Longevity regulating pathway - mammal)",{"v":1e-36,"d":"0.00"},1,"268,",0,-36,{"v":-34.8,"d":"-34.80"},2.43,"3' UTR",8,47220273,47238975,18703,1]
["chr8",47881521,47881697,177,"ENSBGRG00000018347","ENSBGRT00000033556",0,"ENSBGRG00000018347","NA","NA","NA",{"v":7.8e-08,"d":"0.00"},1,"177,",0,-7.11,-6.33,{"v":28.1,"d":"28.10"},"Exon (ENSBGRT00000033556/ENSBGRG00000018347, exon 1 of 2)",8,47881521,47884724,3204,1]
["chr8",50204074,50204544,471,"ENSBGRG00000001916","ENSBGRT00000003579",587,"C5orf24","chromosome 5 open reading frame 24 [Source:HGNC Symbol;Acc:HGNC:26746]","NA","NA",{"v":1e-152,"d":"0.00"},1,"471,",0,-152,-150,{"v":6.8,"d":"6.80"},"5' UTR",8,50203487,50224245,20759,1]
["chr8",56208668,56209415,748,"ENSBGRG00000015693","ENSBGRT00000030240",104914,"ENSBGRG00000015693","NA","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding)","NA",{"v":1e-160,"d":"0.00"},1,"748,",0,-160,-159,3.24,"Exon (ENSBGRT00000030240/ENSBGRG00000015693, exon 30 of 35)",8,56103754,56217239,113486,1]
["chr8",56426847,56427117,271,"ENSBGRG00000021397","ENSBGRT00000040029",8480,"PCDHAC2","protocadherin alpha subfamily C, 2 [Source:HGNC Symbol;Acc:HGNC:8677]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007399(nervous system development);GO:0016020(membrane)","NA",{"v":0.0078,"d":"0.01"},1,"271,",0,-2.11,{"v":-1.3,"d":"-1.30"},9.72,"Exon (ENSBGRT00000040064/ENSBGRG00000021397, exon 1 of 4)",8,56418367,56648556,230190,1]
["chr8",56790049,56790286,238,"ENSBGRG00000022804","ENSBGRT00000042196",1309,"PCDHB4","protocadherin beta 4 [Source:HGNC Symbol;Acc:HGNC:8689]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane)","NA",{"v":3.2e-19,"d":"0.00"},1,"238,",0,{"v":-18.5,"d":"-18.50"},{"v":-17.5,"d":"-17.50"},3.29,"Exon (ENSBGRT00000042196/ENSBGRG00000022804, exon 2 of 4)",8,56788740,56791567,2828,1]
["chr8",56880990,56881436,447,"ENSBGRG00000023324","ENSBGRT00000043125",898,"ENSBGRG00000023324","NA","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane)","NA",{"v":7.9e-08,"d":"0.00"},1,"447,",0,{"v":-7.1,"d":"-7.10"},-6.32,{"v":15.7,"d":"15.70"},"Exon (ENSBGRT00000043125/ENSBGRG00000023324, exon 2 of 3)",8,56880092,56883773,3682,1]
["chr8",56914604,56915083,480,"ENSBGRG00000023551","ENSBGRT00000043546",2055,"ENSBGRG00000023551","NA","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane)","NA",{"v":0.028,"d":"0.03"},3,"158,126,135,","0,175,345",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000043546/ENSBGRG00000023551, exon 2 of 4)",8,56912549,56915467,2919,1]
["chr8",57028531,57028621,91,"ENSBGRG00000024033","ENSBGRT00000045398",29150,"PCDHGA4","protocadherin gamma subfamily A, 4 [Source:HGNC Symbol;Acc:HGNC:8702]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane)","NA",{"v":1e-06,"d":"0.00"},1,"91,",0,-6,-5.24,2.87,"Exon (ENSBGRT00000045455/ENSBGRG00000024033, exon 2 of 5)",8,56999381,57207978,208598,1]
["chr8",57082235,57082295,61,"ENSBGRG00000024033","ENSBGRT00000045398",82854,"PCDHGA4","protocadherin gamma subfamily A, 4 [Source:HGNC Symbol;Acc:HGNC:8702]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane)","NA",{"v":6.3E-22,"d":"0.00"},1,"61,",0,{"v":-21.2,"d":"-21.20"},{"v":-20.2,"d":"-20.20"},{"v":14.8,"d":"14.80"},"Exon (ENSBGRT00000045534/ENSBGRG00000024033, exon 2 of 5)",8,56999381,57207978,208598,1]
["chr8",57118024,57118084,61,"ENSBGRG00000024033","ENSBGRT00000045398",118643,"PCDHGA4","protocadherin gamma subfamily A, 4 [Source:HGNC Symbol;Acc:HGNC:8702]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane)","NA",{"v":6.9e-05,"d":"0.00"},1,"61,",0,-4.16,-3.47,5.94,"Exon (ENSBGRT00000045574/ENSBGRG00000024033, exon 1 of 4)",8,56999381,57207978,208598,1]
["chr8",57078042,57078191,150,"ENSBGRG00000024033","ENSBGRT00000045398",78661,"PCDHGA4","protocadherin gamma subfamily A, 4 [Source:HGNC Symbol;Acc:HGNC:8702]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane)","NA",{"v":5e-12,"d":"0.00"},1,"150,",0,{"v":-11.3,"d":"-11.30"},{"v":-10.4,"d":"-10.40"},3.15,"Exon (ENSBGRT00000045896/ENSBGRG00000024865, exon 3 of 3)",8,56999381,57207978,208598,1]
["chr8",66350316,66350494,179,"ENSBGRG00000019037","ENSBGRT00000034958",13944,"PCYOX1L","prenylcysteine oxidase 1 like [Source:HGNC Symbol;Acc:HGNC:28477]","GO:0001735(prenylcysteine oxidase activity);GO:0016670(oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor);GO:0030328(prenylcysteine catabolic process);GO:0055114(oxidation-reduction process)","00900(Terpenoid backbone biosynthesis)",{"v":1.3e-21,"d":"0.00"},1,"179,",0,{"v":-20.9,"d":"-20.90"},{"v":-19.8,"d":"-19.80"},2.85,"3' UTR",8,66336372,66350673,14302,1]
["chr8",67588436,67597489,9054,"ENSBGRG00000022569","ENSBGRT00000041955",1685,"NDST1","N-deacetylase and N-sulfotransferase 1 [Source:HGNC Symbol;Acc:HGNC:7680]","GO:0000271(polysaccharide biosynthetic process);GO:0003279(cardiac septum development);GO:0006477(protein sulfation);GO:0007507(heart development);GO:0007585(respiratory gaseous exchange by respiratory system);GO:0008146(sulfotransferase activity);GO:0008283(cell population proliferation);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0009887(animal organ morphogenesis);GO:0015016([heparan sulfate]-glucosamine N-sulfotransferase activity);GO:0016787(hydrolase activity);GO:0019213(deacetylase activity);GO:0030203(glycosaminoglycan metabolic process);GO:0030900(forebrain development);GO:0030901(midbrain development);GO:0035904(aorta development);GO:0043410(positive regulation of MAPK cascade);GO:0045880(positive regulation of smoothened signaling pathway);GO:0048702(embryonic neurocranium morphogenesis);GO:0048703(embryonic viscerocranium morphogenesis);GO:0060976(coronary vasculature development)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)",{"v":2.1e-06,"d":"0.00"},2,"35,56,","0,8998",-5.67,-4.93,2.51,"Exon (ENSBGRT00000041955/ENSBGRG00000022569, exon 2 of 15)",8,67586751,67645854,59104,1]
["chr8",71475823,71476148,326,"ENSBGRG00000010249","ENSBGRT00000018854",5143,"MFAP3","microfibril associated protein 3 [Source:HGNC Symbol;Acc:HGNC:7034]","NA","NA",{"v":1.6e-64,"d":"0.00"},1,"326,",0,{"v":-63.8,"d":"-63.80"},{"v":-62.4,"d":"-62.40"},5.42,"3' UTR",8,71470680,71475986,5307,1]
["chr8",87395949,87398247,2299,"ENSBGRG00000001510","ENSBGRT00000003153",1080198,"TENM2","teneurin transmembrane protein 2 [Source:HGNC Symbol;Acc:HGNC:29943]","GO:0005509(calcium ion binding);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0016021(integral component of membrane)","NA",{"v":3.2e-36,"d":"0.00"},2,"41,379,","0,1920",{"v":-35.5,"d":"-35.50"},{"v":-34.3,"d":"-34.30"},4.46,"Exon (ENSBGRT00000003153/ENSBGRG00000001510, exon 22 of 29)",8,86315751,87476692,1160942,1]
["chr8",88005714,88008503,2790,"ENSBGRG00000001953","ENSBGRT00000003757",10200,"MSH3","mutS homolog 3 [Source:HGNC Symbol;Acc:HGNC:7326]","GO:0003697(single-stranded DNA binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0006298(mismatch repair);GO:0019899(enzyme binding);GO:0030983(mismatched DNA binding);GO:0032139(dinucleotide insertion or deletion binding);GO:0032142(single guanine insertion binding);GO:0032181(dinucleotide repeat insertion binding);GO:0032302(MutSbeta complex);GO:0043570(maintenance of DNA repeat elements);GO:0045910(negative regulation of DNA recombination);GO:0051096(positive regulation of helicase activity)","03430(Mismatch repair);05200(Pathways in cancer);05210(Colorectal cancer);01524(Platinum drug resistance)",{"v":0.028,"d":"0.03"},3,"164,63,101,","0,1476,2689",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000003757/ENSBGRG00000001953, exon 4 of 27)",8,87995514,88192447,196934,1]
["chr8",101440659,101442330,1672,"ENSBGRG00000006526","ENSBGRT00000012137",0,"NR2F1","nuclear receptor subfamily 2 group F member 1 [Source:HGNC Symbol;Acc:HGNC:7975]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1e-133,"d":"0.00"},2,"259,130,","0,1542",-133,-131,2.42,"5' UTR",8,101442201,101451924,9724,1]
["chr8",104811709,104813068,1360,"ENSBGRG00000012119","ENSBGRT00000025567",95846,"CAST","calpastatin [Source:HGNC Symbol;Acc:HGNC:1515]","NA","NA",{"v":1.6E-12,"d":"0.00"},2,"41,49,","0,1311",{"v":-11.8,"d":"-11.80"},{"v":-10.9,"d":"-10.90"},{"v":9.1,"d":"9.10"},"Exon (ENSBGRT00000025567/ENSBGRG00000012119, exon 8 of 32)",8,104715863,104863767,147905,1]
["chr8",1903405,1903465,61,"ENSBGRG00000022665","ENSBGRT00000041835",12099,"RASAL3","RAS protein activator like 3 [Source:HGNC Symbol;Acc:HGNC:26129]","GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0042802(identical protein binding);GO:0043087(regulation of GTPase activity);GO:0046580(negative regulation of Ras protein signal transduction);GO:0051142(positive regulation of NK T cell proliferation);GO:0098562(cytoplasmic side of membrane)","04014(Ras signaling pathway)",{"v":0.0078,"d":"0.01"},1,"61,",0,-2.11,-1.53,5.94,"Exon (ENSBGRT00000041835/ENSBGRG00000022665, exon 14 of 17)",8,1902072,1915564,13493,2]
["chr8",4192231,4192497,267,"ENSBGRG00000025144","ENSBGRT00000046476",2719,"ENSBGRG00000025144","NA","GO:0051607(defense response to virus)","NA",{"v":0.028,"d":"0.03"},1,"267,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"3' UTR",8,4191491,4195216,3726,2]
["chr8",5159918,5159978,61,"ENSBGRG00000026238","ENSBGRT00000048525",0,"JUND","JunD proto-oncogene, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:6206]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0002076(osteoblast development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008134(transcription factor binding);GO:0019899(enzyme binding);GO:0035976(transcription factor AP-1 complex);GO:0045669(positive regulation of osteoblast differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0071277(cellular response to calcium ion);GO:1990837(sequence-specific double-stranded DNA binding)","04010(MAPK signaling pathway);04657(IL-17 signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);04380(Osteoclast differentiation)",{"v":0.025,"d":"0.03"},1,"61,",0,-1.61,-1.07,4.86,"Exon (ENSBGRT00000048525/ENSBGRG00000026238, exon 1 of 4)",8,5153907,5159978,6072,2]
["chr8",6010068,6010218,151,"ENSBGRG00000001227","ENSBGRT00000002251",9197,"SUGP2","SURP and G-patch domain containing 2 [Source:HGNC Symbol;Acc:HGNC:18641]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0006396(RNA processing);GO:0016604(nuclear body)","NA",{"v":2e-38,"d":"0.00"},1,"151,",0,{"v":-37.7,"d":"-37.70"},{"v":-36.5,"d":"-36.50"},1.61,"Exon (ENSBGRT00000002251/ENSBGRG00000001227, exon 3 of 11)",8,5984736,6019415,34680,2]
["chr8",7369249,7370722,1474,"ENSBGRG00000003092","ENSBGRT00000005769",1736,"C1orf35","chromosome 1 open reading frame 35 [Source:HGNC Symbol;Acc:HGNC:19032]","NA","NA",{"v":1E-204,"d":"0.00"},5,"281,123,86,73,6,","0,364,925,1191,1468",-204,-202,3.33,"3' UTR",8,7369219,7372458,3240,2]
["chr8",10113894,10119131,5238,"ENSBGRG00000006109","ENSBGRT00000011428",38513,"FLT4","fms related tyrosine kinase 4 [Source:HGNC Symbol;Acc:HGNC:3767]","GO:0001934(positive regulation of protein phosphorylation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001946(lymphangiogenesis);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005021(vascular endothelial growth factor-activated receptor activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0010575(positive regulation of vascular endothelial growth factor production);GO:0010595(positive regulation of endothelial cell migration);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019838(growth factor binding);GO:0019903(protein phosphatase binding);GO:0035924(cellular response to vascular endothelial growth factor stimulus);GO:0036328(VEGF-C-activated receptor activity);GO:0038084(vascular endothelial growth factor signaling pathway);GO:0042803(protein homodimerization activity);GO:0043066(negative regulation of apoptotic process);GO:0043235(receptor complex);GO:0043410(positive regulation of MAPK cascade);GO:0046330(positive regulation of JNK cascade);GO:0046777(protein autophosphorylation);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0090037(positive regulation of protein kinase C signaling)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);05200(Pathways in cancer);05224(Breast cancer)",{"v":1.6e-14,"d":"0.00"},2,"207,4,","0,5234",{"v":-13.8,"d":"-13.80"},{"v":-12.9,"d":"-12.90"},2.84,"3' UTR",8,10113864,10157644,43781,2]
["chr8",11823372,11823431,60,"ENSBGRG00000008585","ENSBGRT00000015597",2771,"LYL1","LYL1 basic helix-loop-helix family member [Source:HGNC Symbol;Acc:HGNC:6734]","GO:0001955(blood vessel maturation);GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0030183(B cell differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046983(protein dimerization activity);GO:0060216(definitive hemopoiesis)","05202(Transcriptional misregulation in cancers)",{"v":0.043,"d":"0.04"},1,"60,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000015597/ENSBGRG00000008585, exon 3 of 3)",8,11823016,11826202,3187,2]
["chr8",13135250,13135399,150,"ENSBGRG00000000526","ENSBGRT00000001276",18396,"ADGRE5","adhesion G protein-coupled receptor E5 [Source:HGNC Symbol;Acc:HGNC:1711]","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005509(calcium ion binding);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","NA",{"v":1E-22,"d":"0.00"},1,"150,",0,-22,-21,3.21,"3' UTR",8,13116854,13135617,18764,1]
["chr8",15794009,15794883,875,"ENSBGRG00000005541","ENSBGRT00000010440",0,"YIPF2","Yip1 domain family member 2 [Source:HGNC Symbol;Acc:HGNC:28476]","GO:0000138(Golgi trans cisterna);GO:0005794(Golgi apparatus);GO:0005797(Golgi medial cisterna);GO:0005802(trans-Golgi network);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0030133(transport vesicle)","NA",{"v":1e-05,"d":"0.00"},2,"30,31,","0,844",-5,-4.28,1.85,"Exon (ENSBGRT00000010440/ENSBGRG00000005541, exon 1 of 8)",8,15789736,15794038,4303,2]
["chr8",16078595,16090506,11912,"ENSBGRG00000010574","ENSBGRT00000019409",1556,"KANK2","KN motif and ankyrin repeat domains 2 [Source:HGNC Symbol;Acc:HGNC:29300]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0008285(negative regulation of cell population proliferation);GO:0033147(negative regulation of intracellular estrogen receptor signaling pathway);GO:0035023(regulation of Rho protein signal transduction);GO:0043069(negative regulation of programmed cell death);GO:0070563(negative regulation of vitamin D receptor signaling pathway);GO:0072073(kidney epithelium development);GO:0090521(glomerular visceral epithelial cell migration);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","03015(mRNA surveillance pathway);04114(Oocyte meiosis);04218(Cellular senescence);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04910(Insulin signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);05168(Herpes simplex infection)",{"v":1e-137,"d":"0.00"},3,"81,241,8,","0,10600,11904",-137,-135,2.24,"Exon (ENSBGRT00000019409/ENSBGRG00000010574, exon 2 of 12)",8,16063675,16092062,28388,2]
["chr8",19461585,19461882,298,"ENSBGRG00000001424","ENSBGRT00000002674",18899,"LONP1","lon peptidase 1, mitochondrial [Source:HGNC Symbol;Acc:HGNC:9479]","GO:0001018(mitochondrial promoter sequence-specific DNA binding);GO:0001666(response to hypoxia);GO:0003727(single-stranded RNA binding);GO:0004176(ATP-dependent peptidase activity);GO:0004252(serine-type endopeptidase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006515(protein quality control for misfolded or incompletely synthesized proteins);GO:0007005(mitochondrion organization);GO:0016887(ATPase activity);GO:0030163(protein catabolic process);GO:0034599(cellular response to oxidative stress);GO:0042645(mitochondrial nucleoid);GO:0042802(identical protein binding);GO:0043531(ADP binding);GO:0043565(sequence-specific DNA binding);GO:0051603(proteolysis involved in cellular protein catabolic process);GO:0051880(G-quadruplex DNA binding);GO:0070182(DNA polymerase binding);GO:0070407(oxidation-dependent protein catabolic process)","NA",0,1,"298,",0,-1240,"-Inf",1.99,"3' UTR",8,19442686,19463297,20612,1]
["chr8",19521553,19521673,121,"ENSBGRG00000002405","ENSBGRT00000004684",23803,"SAFB","scaffold attachment factor B [Source:HGNC Symbol;Acc:HGNC:10520]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0050684(regulation of mRNA processing)","NA",{"v":1e-23,"d":"0.00"},1,"121,",0,-23,-22,{"v":9.1,"d":"9.10"},"Exon (ENSBGRT00000004684/ENSBGRG00000002405, exon 7 of 22)",8,19487636,19545476,57841,2]
["chr8",20882154,20882362,209,"ENSBGRG00000017470","ENSBGRT00000032433",16149,"ANKRD24","ankyrin repeat domain 24 [Source:HGNC Symbol;Acc:HGNC:29424]","GO:0005515(protein binding)","NA",{"v":0.00049,"d":"0.00"},1,"209,",0,-3.31,-2.66,4.59,"Exon (ENSBGRT00000032433/ENSBGRG00000017470, exon 16 of 21)",8,20874137,20898511,24375,2]
["chr8",21846509,21847340,832,"ENSBGRG00000000735","ENSBGRT00000001321",326,"S1PR4","sphingosine-1-phosphate receptor 4 [Source:HGNC Symbol;Acc:HGNC:3170]","GO:0004930(G protein-coupled receptor activity);GO:0005739(mitochondrion);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0038036(sphingosine-1-phosphate receptor activity)","04068(FoxO signaling pathway);04071(Sphingolipid signaling pathway);04080(Neuroactive ligand-receptor interaction)",{"v":0.0021,"d":"0.00"},1,"832,",0,-2.67,-2.06,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000001321/ENSBGRG00000000735, exon 1 of 1)",8,21846509,21847666,1158,2]
["chr8",23175982,23183692,7711,"ENSBGRG00000002771","ENSBGRT00000005430",58189,"ENSBGRG00000002771","NA","GO:0000723(telomere maintenance);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0016887(ATPase activity);GO:0030870(Mre11 complex)","03440(Homologous recombination);03450(Non-homologous end-joining);04218(Cellular senescence)",{"v":1.7E-6,"d":"0.00"},2,"94,56,","0,7655",-5.77,-5.03,{"v":2.1,"d":"2.10"},"Exon (ENSBGRT00000005430/ENSBGRG00000002771, exon 11 of 25)",8,23121593,23241881,120289,2]
["chr8",26032341,26032520,180,"ENSBGRG00000006107","ENSBGRT00000011477",294644,"ADAMTS19","ADAM metallopeptidase with thrombospondin type 1 motif 19 [Source:HGNC Symbol;Acc:HGNC:17111]","GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity)","NA",{"v":0.043,"d":"0.04"},1,"180,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"3' UTR",8,26032341,26327164,294824,2]
["chr8",33709376,33710154,779,"ENSBGRG00000010838","ENSBGRT00000020509",73898,"SNCAIP","synuclein alpha interacting protein [Source:HGNC Symbol;Acc:HGNC:11139]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0008219(cell death);GO:0031625(ubiquitin protein ligase binding);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0042417(dopamine metabolic process);GO:0042802(identical protein binding);GO:0046928(regulation of neurotransmitter secretion);GO:0090083(regulation of inclusion body assembly)","05012(Parkinson disease)",{"v":1E-210,"d":"0.00"},1,"779,",0,-210,-208,5.46,"Exon (ENSBGRT00000020509/ENSBGRG00000010838, exon 12 of 14)",8,33695127,33784052,88926,2]
["chr8",42237832,42237891,60,"ENSBGRG00000010266","ENSBGRT00000018953",118,"ENSBGRG00000010266","NA","NA","NA",{"v":0.013,"d":"0.01"},1,"60,",0,-1.87,-1.31,{"v":3.6,"d":"3.60"},"Exon (ENSBGRT00000018953/ENSBGRG00000010266, exon 1 of 6)",8,42235504,42238009,2506,2]
["chr8",43269181,43269747,567,"ENSBGRG00000012776","ENSBGRT00000023374",1966,"ZFP62","ZFP62 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:23241]","GO:0003676(nucleic acid binding)","NA",{"v":1.6e-75,"d":"0.00"},1,"567,",0,{"v":-74.8,"d":"-74.80"},{"v":-73.3,"d":"-73.30"},5.16,"Exon (ENSBGRT00000023374/ENSBGRG00000012776, exon 1 of 1)",8,43268675,43271713,3039,2]
["chr8",46495281,46495460,180,"ENSBGRG00000004964","ENSBGRT00000009322",21782,"MIER2","MIER family member 2 [Source:HGNC Symbol;Acc:HGNC:29210]","GO:0003677(DNA binding);GO:0004407(histone deacetylase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016575(histone deacetylation);GO:0032991(protein-containing complex);GO:0042826(histone deacetylase binding)","NA",{"v":5e-30,"d":"0.00"},1,"180,",0,{"v":-29.3,"d":"-29.30"},{"v":-28.2,"d":"-28.20"},2.95,"Exon (ENSBGRT00000009322/ENSBGRG00000004964, exon 13 of 14)",8,46494805,46517242,22438,2]
["chr8",47803744,47804412,669,"ENSBGRG00000018133","ENSBGRT00000033248",10614,"ENSBGRG00000018133","NA","NA","03008(Ribosome biogenesis in eukaryotes)",{"v":2.5e-37,"d":"0.00"},2,"143,37,","0,632",{"v":-36.6,"d":"-36.60"},{"v":-35.4,"d":"-35.40"},4.94,"Exon (ENSBGRT00000033248/ENSBGRG00000018133, exon 2 of 4)",8,47801883,47815026,13144,2]
["chr8",48264924,48279172,14249,"ENSBGRG00000000580","ENSBGRT00000001032",0,"ZCCHC10","zinc finger CCHC-type containing 10 [Source:HGNC Symbol;Acc:HGNC:25954]","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding)","NA",{"v":1e-123,"d":"0.00"},5,"268,42,89,70,41,","0,914,4698,4789,14208",-123,-122,3.88,"Exon (ENSBGRT00000001032/ENSBGRG00000000580, exon 1 of 5)",8,48264924,48279172,14249,2]
["chr8",55055204,55055443,240,"ENSBGRG00000011659","ENSBGRT00000021317",2391,"PROB1","proline rich basic protein 1 [Source:HGNC Symbol;Acc:HGNC:41906]","NA","NA",{"v":4E-55,"d":"0.00"},1,"240,",0,{"v":-54.4,"d":"-54.40"},{"v":-53.1,"d":"-53.10"},8.04,"Exon (ENSBGRT00000021317/ENSBGRG00000011659, exon 2 of 2)",8,55054275,55057834,3560,2]
["chr8",57413642,57414660,1019,"ENSBGRG00000025428","ENSBGRT00000047350",330,"ARAP3","ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 [Source:HGNC Symbol;Acc:HGNC:24097]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0007165(signal transduction);GO:0043325(phosphatidylinositol-3,4-bisphosphate binding);GO:0043547(positive regulation of GTPase activity)","04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04144(Endocytosis)",{"v":0.043,"d":"0.04"},2,"38,203,","0,816",-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000047350/ENSBGRG00000025428, exon 1 of 33)",8,57386490,57414990,28501,2]
["chr8",67036549,67036759,211,"ENSBGRG00000020676","ENSBGRT00000038133",73502,"CSF1R","colony stimulating factor 1 receptor [Source:HGNC Symbol;Acc:HGNC:2433]","GO:0001934(positive regulation of protein phosphorylation);GO:0002931(response to ischemia);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005011(macrophage colony-stimulating factor receptor activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008360(regulation of cell shape);GO:0009986(cell surface);GO:0010759(positive regulation of macrophage chemotaxis);GO:0016020(membrane);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019221(cytokine-mediated signaling pathway);GO:0019903(protein phosphatase binding);GO:0019955(cytokine binding);GO:0021772(olfactory bulb development);GO:0021879(forebrain neuron differentiation);GO:0030097(hemopoiesis);GO:0030316(osteoclast differentiation);GO:0030335(positive regulation of cell migration);GO:0031529(ruffle organization);GO:0036006(cellular response to macrophage colony-stimulating factor stimulus);GO:0038145(macrophage colony-stimulating factor signaling pathway);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042803(protein homodimerization activity);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0044794(positive regulation by host of viral process);GO:0045217(cell-cell junction maintenance);GO:0046488(phosphatidylinositol metabolic process);GO:0046777(protein autophosphorylation);GO:0048015(phosphatidylinositol-mediated signaling);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0061518(microglial cell proliferation);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071345(cellular response to cytokine stimulus);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0090197(positive regulation of chemokine secretion);GO:0120041(positive regulation of macrophage proliferation);GO:1990682(CSF1-CSF1R complex);GO:2000147(positive regulation of cell motility);GO:2000249(regulation of actin cytoskeleton reorganization)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage);04380(Osteoclast differentiation);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05221(Acute myeloid leukemia)",{"v":4e-46,"d":"0.00"},1,"211,",0,{"v":-45.4,"d":"-45.40"},{"v":-44.2,"d":"-44.20"},3.16,"3' UTR",8,67035681,67110261,74581,2]
["chr8",68158094,68158273,180,"ENSBGRG00000006833","ENSBGRT00000012702",56592,"ANXA6","annexin A6 [Source:HGNC Symbol;Acc:HGNC:544]","GO:0005509(calcium ion binding);GO:0005525(GTP binding);GO:0005544(calcium-dependent phospholipid binding);GO:0005765(lysosomal membrane);GO:0006816(calcium ion transport);GO:0006937(regulation of muscle contraction);GO:0008289(lipid binding);GO:0015276(ligand-gated ion channel activity);GO:0015485(cholesterol binding);GO:0031902(late endosome membrane);GO:0034220(ion transmembrane transport);GO:0042802(identical protein binding);GO:0048306(calcium-dependent protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0051560(mitochondrial calcium ion homeostasis);GO:0097190(apoptotic signaling pathway)","NA",0,1,"180,",0,-644,"-Inf",{"v":19.5,"d":"19.50"},"3' UTR",8,68158094,68214865,56772,2]
["chr8",71553165,71553361,197,"ENSBGRG00000010322","ENSBGRT00000018926",0,"ENSBGRG00000010322","NA","NA","NA",{"v":1E-134,"d":"0.00"},1,"197,",0,-134,-133,6.06,"Exon (ENSBGRT00000018926/ENSBGRG00000010322, exon 1 of 1)",8,71553137,71553361,225,2]
["chr8",75561183,75568021,6839,"ENSBGRG00000015659","ENSBGRT00000029044",4181,"CLINT1","clathrin interactor 1 [Source:HGNC Symbol;Acc:HGNC:23186]","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0030276(clathrin binding);GO:0043231(intracellular membrane-bounded organelle)","04144(Endocytosis)",{"v":1E-210,"d":"0.00"},3,"175,178,5,","0,3689,6834",-210,-207,2.32,"Exon (ENSBGRT00000029044/ENSBGRG00000015659, exon 4 of 11)",8,75544652,75572202,27551,2]
["chr8",79500252,79500342,91,"ENSBGRG00000000613","ENSBGRT00000001170",309809,"GABRB2","gamma-aminobutyric acid type A receptor beta2 subunit [Source:HGNC Symbol;Acc:HGNC:4082]","GO:0004888(transmembrane signaling receptor activity);GO:0004890(GABA-A receptor activity);GO:0005216(ion channel activity);GO:0005230(extracellular ligand-gated ion channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0007605(sensory perception of sound);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016917(GABA receptor activity);GO:0022851(GABA-gated chloride ion channel activity);GO:0034220(ion transmembrane transport);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0048666(neuron development);GO:0060119(inner ear receptor cell development);GO:0060384(innervation);GO:0090102(cochlea development);GO:0098982(GABA-ergic synapse);GO:0099060(integral component of postsynaptic specialization membrane);GO:1901215(negative regulation of neuron death);GO:1904315(transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential);GO:1904862(inhibitory synapse assembly)","04080(Neuroactive ligand-receptor interaction);04727(GABAergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);05032(Morphine addiction);05033(Nicotine addiction)",{"v":4.3E-3,"d":"0.00"},1,"91,",0,-2.37,-1.77,7.56,"Exon (ENSBGRT00000001170/ENSBGRG00000000613, exon 8 of 8)",8,79500252,79810151,309900,2]
["chr8",98200552,98200939,388,"ENSBGRG00000005743","ENSBGRT00000010585",6024,"LYSMD3","LysM domain containing 3 [Source:HGNC Symbol;Acc:HGNC:26969]","GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0007030(Golgi organization)","NA",{"v":1.6e-66,"d":"0.00"},1,"388,",0,{"v":-65.8,"d":"-65.80"},{"v":-64.4,"d":"-64.40"},{"v":5.7,"d":"5.70"},"Exon (ENSBGRT00000010585/ENSBGRG00000005743, exon 2 of 2)",8,98198883,98206963,8081,2]
["chr8",118390450,118390509,60,"ENSBGRG00000020960","ENSBGRT00000038614",7531,"PJA2","praja ring finger ubiquitin ligase 2 [Source:HGNC Symbol;Acc:HGNC:17481]","GO:0004842(ubiquitin-protein transferase activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006954(inflammatory response);GO:0010738(regulation of protein kinase A signaling);GO:0016567(protein ubiquitination);GO:0034137(positive regulation of toll-like receptor 2 signaling pathway);GO:0034236(protein kinase A catalytic subunit binding);GO:0034237(protein kinase A regulatory subunit binding);GO:0035329(hippo signaling);GO:0043030(regulation of macrophage activation);GO:0045087(innate immune response);GO:0045111(intermediate filament cytoskeleton);GO:0046330(positive regulation of JNK cascade);GO:1900745(positive regulation of p38MAPK cascade)","NA",{"v":0.00028,"d":"0.00"},1,"60,",0,-3.55,-2.89,{"v":1.3,"d":"1.30"},"Exon (ENSBGRT00000038614/ENSBGRG00000020960, exon 3 of 11)",8,118337320,118398040,60721,2]
["chr8",119511642,119646057,134416,"ENSBGRG00000010714","ENSBGRT00000019581",0,"ENSBGRG00000010714","NA","NA","NA",{"v":4.9e-08,"d":"0.00"},3,"236,94,119,","0,4099,134297",-7.31,-6.52,7.02,"3' UTR",8,119522748,119531640,8893,2]
["chr9",7069884,7070092,209,"ENSBGRG00000006052","ENSBGRT00000011259",16030,"TTC16","tetratricopeptide repeat domain 16 [Source:HGNC Symbol;Acc:HGNC:26536]","GO:0005515(protein binding)","NA",{"v":2.9E-4,"d":"0.00"},1,"209,",0,-3.54,-2.87,{"v":15.1,"d":"15.10"},"Exon (ENSBGRT00000011259/ENSBGRG00000006052, exon 14 of 14)",9,7053854,7070985,17132,1]
["chr9",8223764,8231428,7665,"ENSBGRG00000015966","ENSBGRT00000029317",18456,"LRRC8A","leucine rich repeat containing 8 VRAC subunit A [Source:HGNC Symbol;Acc:HGNC:19027]","GO:0005225(volume-sensitive anion channel activity);GO:0005253(anion channel activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006820(anion transport);GO:0006884(cell volume homeostasis);GO:0006970(response to osmotic stress);GO:0009986(cell surface);GO:0034702(ion channel complex);GO:0042802(identical protein binding);GO:0098656(anion transmembrane transport)","NA",{"v":1e-102,"d":"0.00"},3,"40,270,108,","0,7177,7557",-102,-100,5.17,"Exon (ENSBGRT00000029317/ENSBGRG00000015966, exon 2 of 4)",9,8205308,8231428,26121,1]
["chr9",10037575,10037872,298,"ENSBGRG00000008961","ENSBGRT00000016898",9819,"EXOSC2","exosome component 2 [Source:HGNC Symbol;Acc:HGNC:17097]","GO:0000176(nuclear exosome (RNase complex));GO:0000178(exosome (RNase complex));GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0030307(positive regulation of cell growth)","03018(RNA degradation)",{"v":1e-152,"d":"0.00"},1,"298,",0,-152,-150,3.44,"3' UTR",9,10027756,10038555,10800,1]
["chr9",13678639,13678818,180,"ENSBGRG00000025911","ENSBGRT00000047906",9784,"DIPK1B","divergent protein kinase domain 1B [Source:HGNC Symbol;Acc:HGNC:28290]","NA","NA",{"v":1.3e-27,"d":"0.00"},1,"180,",0,{"v":-26.9,"d":"-26.90"},{"v":-25.8,"d":"-25.80"},2.48,"Exon (ENSBGRT00000047906/ENSBGRG00000025911, exon 5 of 5)",9,13668855,13678818,9964,1]
["chr9",15642577,15643598,1022,"ENSBGRG00000006507","ENSBGRT00000011989",90,"PPP1R26","protein phosphatase 1 regulatory subunit 26 [Source:HGNC Symbol;Acc:HGNC:29089]","GO:0004864(protein phosphatase inhibitor activity);GO:0010923(negative regulation of phosphatase activity)","NA",{"v":6.3e-28,"d":"0.00"},2,"31,179,","0,843",{"v":-27.2,"d":"-27.20"},{"v":-26.1,"d":"-26.10"},4.38,"5' UTR",9,15642487,15648038,5552,1]
["chr9",15853987,15854076,90,"ENSBGRG00000007955","ENSBGRT00000014583",1763,"ENSBGRG00000007955","NA","NA","04610(Complement and coagulation cascades);05322(Systemic lupus erythematosus);05020(Prion diseases);05146(Amoebiasis)",{"v":7.1e-09,"d":"0.00"},1,"90,",0,-8.15,-7.34,1.93,"3' UTR",9,15852224,15854967,2744,1]
["chr9",19317729,19317939,211,"ENSBGRG00000026775","ENSBGRT00000049654",4908,"ZNF2","zinc finger protein 2 [Source:HGNC Symbol;Acc:HGNC:12991]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":7.9e-14,"d":"0.00"},2,"3,206,","0,5",{"v":-13.1,"d":"-13.10"},{"v":-12.2,"d":"-12.20"},2.78,"Exon (ENSBGRT00000049654/ENSBGRG00000026775, exon 4 of 5)",9,19312821,19318561,5741,1]
["chr9",20222448,20247274,24827,"ENSBGRG00000026799","ENSBGRT00000049692",49766,"CNNM4","cyclin and CBS domain divalent metal cation transport mediator 4 [Source:HGNC Symbol;Acc:HGNC:105]","GO:0010960(magnesium ion homeostasis);GO:0015081(sodium ion transmembrane transporter activity);GO:0015095(magnesium ion transmembrane transporter activity);GO:0015693(magnesium ion transport);GO:0016323(basolateral plasma membrane);GO:0032991(protein-containing complex);GO:0055065(metal ion homeostasis);GO:0070166(enamel mineralization)","NA",{"v":1E-183,"d":"0.00"},2,"372,78,","0,24749",-183,-181,6.07,"Exon (ENSBGRT00000049692/ENSBGRG00000026799, exon 2 of 5)",9,20172682,20249806,77125,1]
["chr9",25338424,25338782,359,"ENSBGRG00000005286","ENSBGRT00000009778",66745,"SLC9A4","solute carrier family 9 member A4 [Source:HGNC Symbol;Acc:HGNC:11077]","GO:0001696(gastric acid secretion);GO:0002064(epithelial cell development);GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0006885(regulation of pH);GO:0015299(solute:proton antiporter activity);GO:0015385(sodium:proton antiporter activity);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","04971(Gastric acid secretion)",{"v":0.015,"d":"0.02"},1,"359,",0,-1.83,-1.07,8.64,"3' UTR",9,25271679,25339859,68181,1]
["chr9",28508884,28508974,91,"ENSBGRG00000006864","ENSBGRT00000012668",8030,"DQX1","DEAQ-box RNA dependent ATPase 1 [Source:HGNC Symbol;Acc:HGNC:20410]","GO:0004386(helicase activity)","NA",{"v":1.5E-9,"d":"0.00"},1,"91,",0,-8.81,-7.99,2.36,"3' UTR",9,28500854,28509781,8928,1]
["chr9",29706480,29706658,179,"ENSBGRG00000012675","ENSBGRT00000023269",6516,"PRADC1","protease associated domain containing 1 [Source:HGNC Symbol;Acc:HGNC:16047]","GO:0005576(extracellular region)","NA",{"v":7.9e-15,"d":"0.00"},1,"179,",0,{"v":-14.1,"d":"-14.10"},{"v":-13.1,"d":"-13.10"},{"v":11.6,"d":"11.60"},"3' UTR",9,29699964,29706658,6695,1]
["chr9",33995784,34005109,9326,"ENSBGRG00000007523","ENSBGRT00000014745",60424,"BIRC6","baculoviral IAP repeat containing 6 [Source:HGNC Symbol;Acc:HGNC:13516]","GO:0000922(spindle pole);GO:0001890(placenta development);GO:0004842(ubiquitin-protein transferase activity);GO:0004869(cysteine-type endopeptidase inhibitor activity);GO:0005768(endosome);GO:0005802(trans-Golgi network);GO:0005815(microtubule organizing center);GO:0006915(apoptotic process);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0030496(midbody);GO:0032465(regulation of cytokinesis);GO:0042127(regulation of cell population proliferation);GO:0043066(negative regulation of apoptotic process);GO:0060711(labyrinthine layer development);GO:0060712(spongiotrophoblast layer development);GO:0061631(ubiquitin conjugating enzyme activity);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04120(Ubiquitin mediated proteolysis);04215(Apoptosis - multiple species)",{"v":0.0041,"d":"0.00"},3,"835,150,64,","0,6190,9262",-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000014745/ENSBGRG00000007523, exon 10 of 74)",9,33935360,34162806,227447,1]
["chr9",40596352,40596442,91,"ENSBGRG00000017412","ENSBGRT00000031898",569,"ENSBGRG00000017412","NA","GO:0005515(protein binding)","04120(Ubiquitin mediated proteolysis);04144(Endocytosis)",{"v":1.6e-08,"d":"0.00"},1,"91,",0,-7.79,-6.99,5.67,"Exon (ENSBGRT00000031898/ENSBGRG00000017412, exon 1 of 1)",9,40595783,40597549,1767,1]
["chr9",48704602,48705080,479,"ENSBGRG00000006634","ENSBGRT00000012359",606207,"PRKCE","protein kinase C epsilon [Source:HGNC Symbol;Acc:HGNC:9401]","GO:0002281(macrophage activation involved in immune response);GO:0003785(actin monomer binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004697(protein kinase C activity);GO:0004699(calcium-independent protein kinase C activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0008047(enzyme activator activity);GO:0010634(positive regulation of epithelial cell migration);GO:0010763(positive regulation of fibroblast migration);GO:0010811(positive regulation of cell-substrate adhesion);GO:0016020(membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0019216(regulation of lipid metabolic process);GO:0019899(enzyme binding);GO:0030546(signaling receptor activator activity);GO:0030838(positive regulation of actin filament polymerization);GO:0031397(negative regulation of protein ubiquitination);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0032024(positive regulation of insulin secretion);GO:0032230(positive regulation of synaptic transmission, GABAergic);GO:0032467(positive regulation of cytokinesis);GO:0035276(ethanol binding);GO:0035556(intracellular signal transduction);GO:0035641(locomotory exploration behavior);GO:0035669(TRAM-dependent toll-like receptor 4 signaling pathway);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043278(response to morphine);GO:0043410(positive regulation of MAPK cascade);GO:0048471(perinuclear region of cytoplasm);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:0050996(positive regulation of lipid catabolic process);GO:0051279(regulation of release of sequestered calcium ion into cytosol);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0070257(positive regulation of mucus secretion);GO:0071361(cellular response to ethanol);GO:0071380(cellular response to prostaglandin E stimulus);GO:0071456(cellular response to hypoxia);GO:0071889(14-3-3 protein binding);GO:0071944(cell periphery);GO:0090303(positive regulation of wound healing);GO:2001031(positive regulation of cellular glucuronidation)","04371(Apelin signaling pathway);04071(Sphingolipid signaling pathway);04022(cGMP - PKG signaling pathway);04530(Tight junction);04666(Fc gamma R-mediated phagocytosis);04925(Aldosterone synthesis and secretion);04270(Vascular smooth muscle contraction);04750(Inflammatory mediator regulation of TRP channels);05206(MicroRNAs in cancer);04930(Type II diabetes mellitus);04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications)",{"v":1e-24,"d":"0.00"},1,"479,",0,-24,{"v":-22.9,"d":"-22.90"},4.18,"3' UTR",9,48098395,48705379,606985,1]
["chr9",51224344,51224552,209,"ENSBGRG00000010690","ENSBGRT00000019653",1071,"ENSBGRG00000010690","NA","GO:0005905(clathrin-coated pit);GO:0006897(endocytosis);GO:0006929(substrate-dependent cell migration);GO:0030100(regulation of endocytosis);GO:0031252(cell leading edge);GO:0042995(cell projection);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048041(focal adhesion assembly);GO:0097178(ruffle assembly);GO:0120181(focal adhesion disassembly);GO:0140312(cargo adaptor activity)","NA",{"v":2e-54,"d":"0.00"},1,"209,",0,{"v":-53.7,"d":"-53.70"},{"v":-52.4,"d":"-52.40"},4.99,"Exon (ENSBGRT00000019653/ENSBGRG00000010690, exon 1 of 3)",9,51223273,51237021,13749,1]
["chr9",58347036,58347156,121,"ENSBGRG00000015284","ENSBGRT00000028780",240199,"SPTBN1","spectrin beta, non-erythrocytic 1 [Source:HGNC Symbol;Acc:HGNC:11275]","GO:0000281(mitotic cytokinesis);GO:0003779(actin binding);GO:0005200(structural constituent of cytoskeleton);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007009(plasma membrane organization);GO:0007182(common-partner SMAD protein phosphorylation);GO:0008091(spectrin);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0030506(ankyrin binding);GO:0030673(axolemma);GO:0030863(cortical cytoskeleton);GO:0031430(M band);GO:0032437(cuticular plate);GO:0032743(positive regulation of interleukin-2 production);GO:0043001(Golgi to plasma membrane protein transport);GO:0051020(GTPase binding);GO:0060390(regulation of SMAD protein signal transduction);GO:0071709(membrane assembly);GO:0072659(protein localization to plasma membrane);GO:1903076(regulation of protein localization to plasma membrane);GO:1903078(positive regulation of protein localization to plasma membrane)","NA",{"v":6.3e-50,"d":"0.00"},1,"121,",0,{"v":-49.2,"d":"-49.20"},{"v":-47.9,"d":"-47.90"},1.76,"Exon (ENSBGRT00000028780/ENSBGRG00000015284, exon 38 of 38)",9,58106837,58347156,240320,1]
["chr9",66020824,66038944,18121,"ENSBGRG00000008553","ENSBGRT00000016000",34685,"SEPTIN10","septin 10 [Source:HGNC Symbol;Acc:HGNC:14349]","GO:0005525(GTP binding)","NA",{"v":1.6e-29,"d":"0.00"},3,"17,133,57,","0,8168,18064",{"v":-28.8,"d":"-28.80"},{"v":-27.7,"d":"-27.70"},1.96,"Exon (ENSBGRT00000016000/ENSBGRG00000008553, exon 10 of 13)",9,65986139,66040940,54802,1]
["chr9",86232281,86232401,121,"ENSBGRG00000011374","ENSBGRT00000020787",6179,"ENSBGRG00000011374","NA","GO:0030246(carbohydrate binding)","NA",{"v":1E-53,"d":"0.00"},1,"121,",0,-53,{"v":-51.7,"d":"-51.70"},6.46,"3' UTR",9,86226102,86236029,9928,1]
["chr9",88567571,88626601,59031,"ENSBGRG00000013104","ENSBGRT00000023921",790,"ENSBGRG00000013104","NA","NA","NA",{"v":0.015,"d":"0.02"},2,"175,206,","0,58825",-1.83,-1.02,8.64,"Exon (ENSBGRT00000023921/ENSBGRG00000013104, exon 1 of 2)",9,88566781,88626601,59821,1]
["chr9",96538368,96538722,355,"ENSBGRG00000007462","ENSBGRT00000013650",1620,"ENSBGRG00000007462","NA","NA","NA",{"v":2.5e-14,"d":"0.00"},1,"355,",0,{"v":-13.6,"d":"-13.60"},{"v":-12.7,"d":"-12.70"},6.33,"Exon (ENSBGRT00000013650/ENSBGRG00000007462, exon 2 of 2)",9,96536748,96539047,2300,1]
["chr9",96771994,96772054,61,"ENSBGRG00000009127","ENSBGRT00000016752",360,"ZNF513","zinc finger protein 513 [Source:HGNC Symbol;Acc:HGNC:26498]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0060041(retina development in camera-type eye)","NA",{"v":7.1e-06,"d":"0.00"},1,"61,",0,-5.15,-4.43,1.83,"Exon (ENSBGRT00000016752/ENSBGRG00000009127, exon 2 of 3)",9,96771634,96774571,2938,1]
["chr9",98098085,98098382,298,"ENSBGRG00000013558","ENSBGRT00000025034",119,"KIF3C","kinesin family member 3C [Source:HGNC Symbol;Acc:HGNC:6321]","GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0072384(organelle transport along microtubule)","NA",{"v":2.5e-62,"d":"0.00"},1,"298,",0,{"v":-61.6,"d":"-61.60"},{"v":-60.3,"d":"-60.30"},8.76,"Exon (ENSBGRT00000025034/ENSBGRG00000013558, exon 1 of 9)",9,98097966,98132629,34664,1]
["chr9",99857782,99857930,149,"ENSBGRG00000019427","ENSBGRT00000035690",59,"WDCP","WD repeat and coiled coil containing [Source:HGNC Symbol;Acc:HGNC:26157]","GO:0019900(kinase binding);GO:0051259(protein complex oligomerization)","NA",{"v":1.2e-07,"d":"0.00"},1,"149,",0,-6.92,-6.14,4.32,"Exon (ENSBGRT00000035690/ENSBGRG00000019427, exon 1 of 2)",9,99857723,99867667,9945,1]
["chr9",104789607,104789667,61,"ENSBGRG00000021840","ENSBGRT00000040360",6509,"OSR1","odd-skipped related transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:8111]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001655(urogenital system development);GO:0001656(metanephros development);GO:0001657(ureteric bud development);GO:0001823(mesonephros development);GO:0002062(chondrocyte differentiation);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0007507(heart development);GO:0008406(gonad development);GO:0010628(positive regulation of gene expression);GO:0030154(cell differentiation);GO:0030501(positive regulation of bone mineralization);GO:0030857(negative regulation of epithelial cell differentiation);GO:0035115(embryonic forelimb morphogenesis);GO:0035116(embryonic hindlimb morphogenesis);GO:0036023(embryonic skeletal limb joint morphogenesis);GO:0042474(middle ear morphogenesis);GO:0042476(odontogenesis);GO:0042733(embryonic digit morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048389(intermediate mesoderm development);GO:0048793(pronephros development);GO:0048863(stem cell differentiation);GO:0050679(positive regulation of epithelial cell proliferation);GO:0060021(roof of mouth development);GO:0060272(embryonic skeletal joint morphogenesis);GO:0071300(cellular response to retinoic acid);GO:0072075(metanephric mesenchyme development);GO:0072111(cell proliferation involved in kidney development);GO:0072133(metanephric mesenchyme morphogenesis);GO:0072143(mesangial cell development);GO:0072162(metanephric mesenchymal cell differentiation);GO:0072166(posterior mesonephric tubule development);GO:0072168(specification of anterior mesonephric tubule identity);GO:0072169(specification of posterior mesonephric tubule identity);GO:0072180(mesonephric duct morphogenesis);GO:0072183(negative regulation of nephron tubule epithelial cell differentiation);GO:0072184(renal vesicle progenitor cell differentiation);GO:0072190(ureter urothelium development);GO:0072207(metanephric epithelium development);GO:0072208(metanephric smooth muscle tissue development);GO:0072234(metanephric nephron tubule development);GO:0072239(metanephric glomerulus vasculature development);GO:0072259(metanephric interstitial fibroblast development);GO:0072268(pattern specification involved in metanephros development);GO:0072498(embryonic skeletal joint development);GO:0090094(metanephric cap mesenchymal cell proliferation involved in metanephros development);GO:1905408(negative regulation of creatine transmembrane transporter activity);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000543(positive regulation of gastrulation);GO:2000650(negative regulation of sodium ion transmembrane transporter activity)","NA",{"v":7.9e-19,"d":"0.00"},1,"61,",0,{"v":-18.1,"d":"-18.10"},{"v":-17.1,"d":"-17.10"},3.47,"3' UTR",9,104783098,104790177,7080,1]
["chr9",2213651,2214129,479,"ENSBGRG00000015695","ENSBGRT00000028986",450,"ENSBGRG00000015695","NA","NA","NA",{"v":2e-64,"d":"0.00"},3,"386,10,17,","0,422,462",{"v":-63.7,"d":"-63.70"},{"v":-62.3,"d":"-62.30"},8.09,"Exon (ENSBGRT00000028986/ENSBGRG00000015695, exon 2 of 4)",9,2213152,2214579,1428,2]
["chr9",4231731,4232344,614,"ENSBGRG00000019407","ENSBGRT00000035644",31599,"GOLGA1","golgin A1 [Source:HGNC Symbol;Acc:HGNC:4424]","GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0048471(perinuclear region of cytoplasm)","NA",{"v":1.4E-3,"d":"0.00"},2,"10,51,","0,563",-2.84,-2.22,1.58,"Exon (ENSBGRT00000035644/ENSBGRG00000019407, exon 14 of 23)",9,4215789,4263943,48155,2]
["chr9",7218309,7218671,363,"ENSBGRG00000007407","ENSBGRT00000013758",318,"AK1","adenylate kinase 1 [Source:HGNC Symbol;Acc:HGNC:361]","GO:0001520(outer dense fiber);GO:0004017(adenylate kinase activity);GO:0004550(nucleoside diphosphate kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006139(nucleobase-containing compound metabolic process);GO:0007050(cell cycle arrest);GO:0009142(nucleoside triphosphate biosynthetic process);GO:0019205(nucleobase-containing compound kinase activity);GO:0036126(sperm flagellum);GO:0046034(ATP metabolic process)","00230(Purine metabolism);00730(Thiamine metabolism)",{"v":5e-20,"d":"0.00"},2,"58,123,","0,240",{"v":-19.3,"d":"-19.30"},{"v":-18.3,"d":"-18.30"},2.59,"Exon (ENSBGRT00000013758/ENSBGRG00000007407, exon 2 of 6)",9,7212705,7218989,6285,2]
["chr9",7604586,7608934,4349,"ENSBGRG00000009764","ENSBGRT00000018281",11526,"ENSBGRG00000009764","NA","GO:0005794(Golgi apparatus)","NA",{"v":1E-181,"d":"0.00"},9,"108,338,88,108,87,142,59,107,8,","0,438,1128,1419,1630,2574,3006,4144,4341",-181,-179,3.71,"Exon (ENSBGRT00000018281/ENSBGRG00000009764, exon 11 of 28)",9,7601797,7620460,18664,2]
["chr9",8935793,8935972,180,"ENSBGRG00000018789","ENSBGRT00000034714",4836,"ASB6","ankyrin repeat and SOCS box containing 6 [Source:HGNC Symbol;Acc:HGNC:17181]","GO:0005515(protein binding);GO:0035556(intracellular signal transduction)","NA",{"v":2.5e-23,"d":"0.00"},1,"180,",0,{"v":-22.6,"d":"-22.60"},{"v":-21.6,"d":"-21.60"},3.58,"3' UTR",9,8934601,8940808,6208,2]
["chr9",11590827,11591037,211,"ENSBGRG00000014400","ENSBGRT00000026524",99230,"SETX","senataxin [Source:HGNC Symbol;Acc:HGNC:445]","GO:0000165(MAPK cascade);GO:0000228(nuclear chromosome);GO:0001147(transcription termination site sequence-specific DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006302(double-strand break repair);GO:0006353(DNA-templated transcription, termination);GO:0006369(termination of RNA polymerase II transcription);GO:0006376(mRNA splice site selection);GO:0006974(cellular response to DNA damage stimulus);GO:0007623(circadian rhythm);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0010976(positive regulation of neuron projection development);GO:0016604(nuclear body);GO:0030424(axon);GO:0030426(growth cone);GO:0033120(positive regulation of RNA splicing);GO:0034599(cellular response to oxidative stress);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0043491(protein kinase B signaling);GO:0044344(cellular response to fibroblast growth factor stimulus);GO:0045171(intercellular bridge);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060566(positive regulation of DNA-templated transcription, termination);GO:0070301(cellular response to hydrogen peroxide);GO:0071300(cellular response to retinoic acid);GO:2000144(positive regulation of DNA-templated transcription, initiation);GO:2000806(positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled)","NA",{"v":1e-111,"d":"0.00"},1,"211,",0,-111,-109,3.51,"Exon (ENSBGRT00000026524/ENSBGRG00000014400, exon 29 of 29)",9,11590827,11690267,99441,2]
["chr9",13162595,13162864,270,"ENSBGRG00000024893","ENSBGRT00000045975",23971,"QSOX2","quiescin sulfhydryl oxidase 2 [Source:HGNC Symbol;Acc:HGNC:30249]","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0016971(flavin-linked sulfhydryl oxidase activity);GO:0016972(thiol oxidase activity);GO:0045454(cell redox homeostasis);GO:0055114(oxidation-reduction process)","NA",{"v":4e-86,"d":"0.00"},1,"270,",0,{"v":-85.4,"d":"-85.40"},{"v":-83.8,"d":"-83.80"},5.27,"3' UTR",9,13161251,13186835,25585,2]
["chr9",13785130,13785837,708,"ENSBGRG00000025942","ENSBGRT00000047977",353,"ENSBGRG00000025942","NA","NA","NA",{"v":0.0013,"d":"0.00"},1,"708,",0,-2.89,-2.26,7.56,"Exon (ENSBGRT00000047977/ENSBGRG00000025942, exon 1 of 1)",9,13785042,13786190,1149,2]
["chr9",13811130,13811384,255,"ENSBGRG00000025947","ENSBGRT00000047984",8155,"SURF6","surfeit 6 [Source:HGNC Symbol;Acc:HGNC:11478]","GO:0001652(granular component);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0042254(ribosome biogenesis)","NA",{"v":7.9e-26,"d":"0.00"},2,"38,110,","0,145",{"v":-25.1,"d":"-25.10"},{"v":-24.1,"d":"-24.10"},5.64,"Exon (ENSBGRT00000047984/ENSBGRG00000025947, exon 4 of 5)",9,13810008,13819539,9532,2]
["chr9",17188345,17192269,3925,"ENSBGRG00000026740","ENSBGRT00000049588",74519,"ZC3H6","zinc finger CCCH-type containing 6 [Source:HGNC Symbol;Acc:HGNC:24762]","GO:0046872(metal ion binding)","NA",{"v":2e-28,"d":"0.00"},2,"27,94,","0,3831",{"v":-27.7,"d":"-27.70"},{"v":-26.6,"d":"-26.60"},4.03,"Exon (ENSBGRT00000049588/ENSBGRG00000026740, exon 11 of 13)",9,17185266,17266788,81523,2]
["chr9",19746518,19746905,388,"ENSBGRG00000026785","ENSBGRT00000049669",11756,"TMEM127","transmembrane protein 127 [Source:HGNC Symbol;Acc:HGNC:26038]","GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005886(plasma membrane);GO:0007032(endosome organization);GO:0008285(negative regulation of cell population proliferation);GO:0017137(Rab GTPase binding);GO:0032006(regulation of TOR signaling);GO:0032007(negative regulation of TOR signaling)","NA",{"v":1E-125,"d":"0.00"},1,"388,",0,-125,-123,4.82,"3' UTR",9,19746458,19758661,12204,2]
["chr9",22243305,22243365,61,"ENSBGRG00000026837","ENSBGRT00000049770",18030,"REV1","REV1 DNA directed polymerase [Source:HGNC Symbol;Acc:HGNC:14060]","GO:0003684(damaged DNA binding);GO:0006281(DNA repair);GO:0009411(response to UV);GO:0016779(nucleotidyltransferase activity);GO:0017125(deoxycytidyl transferase activity);GO:0042276(error-prone translesion synthesis)","03460(Fanconi anemia pathway)",{"v":7.1E-8,"d":"0.00"},1,"61,",0,-7.15,-6.36,2.18,"Exon (ENSBGRT00000049770/ENSBGRG00000026837, exon 3 of 22)",9,22185746,22261395,75650,2]
["chr9",28332158,28332307,150,"ENSBGRG00000006275","ENSBGRT00000011932",27500,"SEMA4F","ssemaphorin 4F [Source:HGNC Symbol;Acc:HGNC:10734]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0007411(axon guidance);GO:0016021(integral component of membrane);GO:0030215(semaphorin receptor binding)","04360(Axon guidance)",{"v":1.3e-46,"d":"0.00"},1,"150,",0,{"v":-45.9,"d":"-45.90"},{"v":-44.6,"d":"-44.60"},2.06,"Exon (ENSBGRT00000011932/ENSBGRG00000006275, exon 14 of 14)",9,28331023,28359807,28785,2]
["chr9",29363213,29392004,28792,"ENSBGRG00000011405","ENSBGRT00000021699",157305,"ALMS1","ALMS1 centrosome and basal body associated protein [Source:HGNC Symbol;Acc:HGNC:428]","GO:0005813(centrosome);GO:0005814(centriole);GO:0016197(endosomal transport);GO:0051492(regulation of stress fiber assembly)","NA",{"v":4e-15,"d":"0.00"},2,"18,43,","0,28749",{"v":-14.4,"d":"-14.40"},{"v":-13.4,"d":"-13.40"},1.56,"Exon (ENSBGRT00000021699/ENSBGRG00000011405, exon 12 of 18)",9,29352180,29549309,197130,2]
["chr9",31894572,31895110,539,"ENSBGRG00000004990","ENSBGRT00000009199",149484,"ZNF638","zinc finger protein 638 [Source:HGNC Symbol;Acc:HGNC:17894]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008270(zinc ion binding);GO:0008380(RNA splicing);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":1e-130,"d":"0.00"},1,"539,",0,-130,-128,2.15,"Exon (ENSBGRT00000009199/ENSBGRG00000004990, exon 24 of 28)",9,31887916,32044594,156679,2]
["chr9",38913100,38913599,500,"ENSBGRG00000012523","ENSBGRT00000023489",14405,"EIF2AK2","eukaryotic translation initiation factor 2 alpha kinase 2 [Source:HGNC Symbol;Acc:HGNC:9437]","GO:0000186(activation of MAPKK activity);GO:0001819(positive regulation of cytokine production);GO:0003725(double-stranded RNA binding);GO:0004672(protein kinase activity);GO:0004694(eukaryotic translation initiation factor 2alpha kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006412(translation);GO:0006468(protein phosphorylation);GO:0009615(response to virus);GO:0017148(negative regulation of translation);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0032722(positive regulation of chemokine production);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0033689(negative regulation of osteoblast proliferation);GO:0034198(cellular response to amino acid starvation);GO:0035455(response to interferon-alpha);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0045071(negative regulation of viral genome replication);GO:0046777(protein autophosphorylation);GO:0048471(perinuclear region of cytoplasm);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:1900225(regulation of NLRP3 inflammasome complex assembly);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1901532(regulation of hematopoietic progenitor cell differentiation);GO:1902033(regulation of hematopoietic stem cell proliferation);GO:1902036(regulation of hematopoietic stem cell differentiation)","04141(Protein processing in endoplasmic reticulum);04217(Necroptosis);05203(Viral carcinogenesis);05162(Measles);05164(Influenza A);05160(Hepatitis C);05168(Herpes simplex infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection)",{"v":0.043,"d":"0.04"},2,"32,119,","0,381",-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000023489/ENSBGRG00000012523, exon 5 of 15)",9,38891083,38928004,36922,2]
["chr9",41629309,41629457,149,"ENSBGRG00000019450","ENSBGRT00000035729",42785,"THUMPD2","THUMP domain containing 2 [Source:HGNC Symbol;Acc:HGNC:14890]","GO:0003723(RNA binding)","NA",{"v":2.5e-75,"d":"0.00"},1,"149,",0,{"v":-74.6,"d":"-74.60"},{"v":-73.1,"d":"-73.10"},5.67,"Exon (ENSBGRT00000035729/ENSBGRG00000019450, exon 10 of 10)",9,41629309,41672242,42934,2]
["chr9",50419393,50419453,61,"ENSBGRG00000009485","ENSBGRT00000017900",110995,"FBXO11","F-box protein 11 [Source:HGNC Symbol;Acc:HGNC:13590]","GO:0000151(ubiquitin ligase complex);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006464(cellular protein modification process);GO:0007605(sensory perception of sound);GO:0008270(zinc ion binding);GO:0016274(protein-arginine N-methyltransferase activity);GO:0016567(protein ubiquitination)","NA",{"v":0.015,"d":"0.02"},1,"61,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000018266/ENSBGRG00000009485, exon 17 of 23)",9,50401048,50530448,129401,2]
["chr9",59010738,59010858,121,"ENSBGRG00000017524","ENSBGRT00000032361",16049,"MTIF2","mitochondrial translational initiation factor 2 [Source:HGNC Symbol;Acc:HGNC:7441]","GO:0003743(translation initiation factor activity);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0006413(translational initiation)","NA",{"v":2.8e-10,"d":"0.00"},1,"121,",0,-9.55,-8.72,1.98,"Exon (ENSBGRT00000032361/ENSBGRG00000017524, exon 9 of 13)",9,59003908,59026907,23000,2]
["chr9",66427541,66427660,120,"ENSBGRG00000009160","ENSBGRT00000017946",50272,"RANBP2","RAN binding protein 2 [Source:HGNC Symbol;Acc:HGNC:9848]","GO:0000413(protein peptidyl-prolyl isomerization);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005515(protein binding);GO:0005635(nuclear envelope);GO:0005642(annulate lamellae);GO:0005643(nuclear pore);GO:0005739(mitochondrion);GO:0006111(regulation of gluconeogenesis);GO:0006457(protein folding);GO:0006607(NLS-bearing protein import into nucleus);GO:0008536(Ran GTPase binding);GO:0016925(protein sumoylation);GO:0031965(nuclear membrane);GO:0033133(positive regulation of glucokinase activity);GO:0042405(nuclear inclusion body);GO:0043231(intracellular membrane-bounded organelle);GO:0044614(nuclear pore cytoplasmic filaments);GO:0044615(nuclear pore nuclear basket);GO:0046907(intracellular transport);GO:0051642(centrosome localization)","03013(RNA transport)",{"v":5e-13,"d":"0.00"},1,"120,",0,{"v":-12.3,"d":"-12.30"},{"v":-11.4,"d":"-11.40"},2.49,"Exon (ENSBGRT00000018526/ENSBGRG00000010096, exon 2 of 2)",9,66408214,66477932,69719,2]
["chr9",68393209,68393269,61,"ENSBGRG00000013844","ENSBGRT00000025700",18096,"ENSBGRG00000013844","NA","NA","00230(Purine metabolism);00240(Pyrimidine metabolism);00760(Nicotinate and nicotinamide metabolism)",{"v":1.4E-8,"d":"0.00"},1,"61,",0,-7.86,-7.06,2.59,"3' UTR",9,68375113,68396337,21225,1]
["chr9",82981984,82982134,151,"ENSBGRG00000007924","ENSBGRT00000015592",230789,"USP34","ubiquitin specific peptidase 34 [Source:HGNC Symbol;Acc:HGNC:20066]","GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0071108(protein K48-linked deubiquitination);GO:0090263(positive regulation of canonical Wnt signaling pathway)","NA",{"v":1e-23,"d":"0.00"},1,"151,",0,-23,-22,1.83,"Exon (ENSBGRT00000015592/ENSBGRG00000007924, exon 68 of 80)",9,82959630,83212923,253294,2]
["chr9",85666025,85667600,1576,"ENSBGRG00000010687","ENSBGRT00000019676",79361,"VPS54","VPS54 subunit of GARP complex [Source:HGNC Symbol;Acc:HGNC:18652]","GO:0000938(GARP complex);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0007041(lysosomal transport);GO:0040008(regulation of growth);GO:0042147(retrograde transport, endosome to Golgi);GO:0048471(perinuclear region of cytoplasm);GO:0048873(homeostasis of number of cells within a tissue);GO:0050881(musculoskeletal movement);GO:0060052(neurofilament cytoskeleton organization)","NA",{"v":2e-49,"d":"0.00"},2,"59,121,","0,1455",{"v":-48.7,"d":"-48.70"},{"v":-47.5,"d":"-47.50"},4.48,"3' UTR",9,85665576,85746961,81386,2]
["chr9",92731707,92731947,241,"ENSBGRG00000005647","ENSBGRT00000010424",959,"EHD3","EH domain containing 3 [Source:HGNC Symbol;Acc:HGNC:3244]","GO:0001881(receptor recycling);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0020018(ciliary pocket membrane);GO:0032456(endocytic recycling);GO:0034498(early endosome to Golgi transport);GO:0051260(protein homooligomerization);GO:0055038(recycling endosome membrane);GO:0060271(cilium assembly);GO:0072659(protein localization to plasma membrane);GO:0086036(regulation of cardiac muscle cell membrane potential);GO:0090160(Golgi to lysosome transport);GO:1903358(regulation of Golgi organization)","04144(Endocytosis)",{"v":1.3E-22,"d":"0.00"},1,"241,",0,{"v":-21.9,"d":"-21.90"},{"v":-20.9,"d":"-20.90"},3.51,"5' UTR",9,92700126,92732906,32781,2]
["chr9",97076952,97077431,480,"ENSBGRG00000012069","ENSBGRT00000022064",5347,"EMILIN1","elastin microfibril interfacer 1 [Source:HGNC Symbol;Acc:HGNC:19880]","GO:0003180(aortic valve morphogenesis);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0007160(cell-matrix adhesion);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010811(positive regulation of cell-substrate adhesion);GO:0016477(cell migration);GO:0016525(negative regulation of angiogenesis);GO:0030023(extracellular matrix constituent conferring elasticity);GO:0030198(extracellular matrix organization);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030948(negative regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031012(extracellular matrix);GO:0032966(negative regulation of collagen biosynthetic process);GO:0034668(integrin alpha4-beta1 complex);GO:0042802(identical protein binding);GO:0048251(elastic fiber assembly);GO:0050866(negative regulation of cell activation);GO:0060394(negative regulation of pathway-restricted SMAD protein phosphorylation);GO:0062023(collagen-containing extracellular matrix);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0098640(integrin binding involved in cell-matrix adhesion);GO:1901203(positive regulation of extracellular matrix assembly);GO:1904027(negative regulation of collagen fibril organization);GO:1905522(negative regulation of macrophage migration);GO:1990971(EMILIN complex)","NA",0,1,"480,",0,-2180,"-Inf",{"v":8.1,"d":"8.10"},"Exon (ENSBGRT00000022064/ENSBGRG00000012069, exon 4 of 8)",9,97074875,97082778,7904,2]
["chr9",109377806,109377866,61,"ENSBGRG00000023277","ENSBGRT00000043011",595,"LRATD1","LRAT domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20743]","GO:0000902(cell morphogenesis);GO:0048870(cell motility)","NA",{"v":1.6e-32,"d":"0.00"},1,"61,",0,{"v":-31.8,"d":"-31.80"},{"v":-30.7,"d":"-30.70"},{"v":11.6,"d":"11.60"},"Exon (ENSBGRT00000043011/ENSBGRG00000023277, exon 1 of 1)",9,109377568,109378461,894,2]
["chr10",155038,155336,299,"ENSBGRG00000016135","ENSBGRT00000029774",52009,"LRP11","LDL receptor related protein 11 [Source:HGNC Symbol;Acc:HGNC:16936]","GO:0005515(protein binding);GO:0051219(phosphoprotein binding)","NA",{"v":0.028,"d":"0.03"},1,"299,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000029901/ENSBGRG00000016135, exon 5 of 5)",10,103029,161460,58432,1]
["chr10",7505356,7505416,61,"ENSBGRG00000022707","ENSBGRT00000041956",269,"HIVEP2","HIVEP zinc finger 2 [Source:HGNC Symbol;Acc:HGNC:4921]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm)","NA",{"v":6.8e-05,"d":"0.00"},1,"61,",0,-4.17,-3.48,1.81,"Exon (ENSBGRT00000041956/ENSBGRG00000022707, exon 1 of 7)",10,7505087,7536948,31862,1]
["chr10",7536380,7536888,509,"ENSBGRG00000022707","ENSBGRT00000041956",31293,"HIVEP2","HIVEP zinc finger 2 [Source:HGNC Symbol;Acc:HGNC:4921]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm)","NA",{"v":4e-74,"d":"0.00"},1,"509,",0,{"v":-73.4,"d":"-73.40"},{"v":-71.9,"d":"-71.90"},7.39,"Exon (ENSBGRT00000041956/ENSBGRG00000022707, exon 7 of 7)",10,7505087,7536948,31862,1]
["chr10",11829995,11830055,61,"ENSBGRG00000013172","ENSBGRT00000024062",149247,"NHSL1","NHS like 1 [Source:HGNC Symbol;Acc:HGNC:21021]","NA","NA",{"v":0.00017,"d":"0.00"},1,"61,",0,-3.77,{"v":-3.1,"d":"-3.10"},2.52,"Exon (ENSBGRT00000024062/ENSBGRG00000013172, exon 6 of 8)",10,11680748,11839130,158383,1]
["chr10",20364781,20366450,1670,"ENSBGRG00000024435","ENSBGRT00000045101",0,"ENSBGRG00000024435","NA","GO:0005515(protein binding)","NA",{"v":0.028,"d":"0.03"},3,"532,100,142,","0,773,1528",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",10,20364781,20387051,22271,1]
["chr10",26587458,26587638,181,"ENSBGRG00000021935","ENSBGRT00000040568",99353,"ZNF292","zinc finger protein 292 [Source:HGNC Symbol;Acc:HGNC:18410]","GO:0003676(nucleic acid binding)","NA",{"v":6.9e-09,"d":"0.00"},1,"181,",0,-8.16,-7.35,2.38,"Exon (ENSBGRT00000040568/ENSBGRG00000021935, exon 8 of 8)",10,26488105,26589198,101094,1]
["chr10",29130756,29130935,180,"ENSBGRG00000026235","ENSBGRT00000048514",26255,"CASP8AP2","caspase 8 associated protein 2 [Source:HGNC Symbol;Acc:HGNC:1510]","GO:0003677(DNA binding);GO:0097190(apoptotic signaling pathway)","NA",{"v":4.3e-06,"d":"0.00"},1,"180,",0,-5.37,-4.64,{"v":2.9,"d":"2.90"},"Exon (ENSBGRT00000048514/ENSBGRG00000026235, exon 7 of 9)",10,29104501,29136952,32452,1]
["chr10",48080219,48080487,269,"ENSBGRG00000006478","ENSBGRT00000011937",507,"ENSBGRG00000006478","NA","NA","NA",{"v":0.00069,"d":"0.00"},1,"269,",0,-3.16,-2.51,9.72,"5' UTR",10,48079712,48081561,1850,1]
["chr10",48624258,48624644,387,"ENSBGRG00000006590","ENSBGRT00000012196",160740,"SOBP","sine oculis binding protein homolog [Source:HGNC Symbol;Acc:HGNC:29256]","GO:0005634(nucleus);GO:0007605(sensory perception of sound);GO:0007626(locomotory behavior);GO:0032184(SUMO polymer binding);GO:0042472(inner ear morphogenesis);GO:0050890(cognition);GO:0090102(cochlea development)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)",{"v":5e-32,"d":"0.00"},1,"387,",0,{"v":-31.3,"d":"-31.30"},{"v":-30.2,"d":"-30.20"},{"v":5.1,"d":"5.10"},"Exon (ENSBGRT00000012196/ENSBGRG00000006590, exon 6 of 7)",10,48463518,48646858,183341,1]
["chr10",58012174,58019475,7302,"ENSBGRG00000005878","ENSBGRT00000010949",0,"RSPH4A","radial spoke head component 4A [Source:HGNC Symbol;Acc:HGNC:21558]","GO:0001534(radial spoke);GO:0003341(cilium movement);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005930(axoneme);GO:0035082(axoneme assembly);GO:0060271(cilium assembly);GO:0060294(cilium movement involved in cell motility)","NA",{"v":0.0078,"d":"0.01"},3,"686,235,93,","0,5101,7209",-2.11,{"v":-1.3,"d":"-1.30"},9.72,"Exon (ENSBGRT00000010949/ENSBGRG00000005878, exon 1 of 4)",10,58012174,58022620,10447,1]
["chr10",66634085,66634174,90,"ENSBGRG00000011871","ENSBGRT00000021938",140232,"RNF217","ring finger protein 217 [Source:HGNC Symbol;Acc:HGNC:21487]","GO:0004842(ubiquitin-protein transferase activity);GO:0016567(protein ubiquitination)","NA",{"v":0.00037,"d":"0.00"},1,"90,",0,-3.43,-2.77,14,"3' UTR",10,66493853,66634192,140340,1]
["chr10",71725558,71727600,2043,"ENSBGRG00000003767","ENSBGRT00000007010",680,"TENT5A","terminal nucleotidyltransferase 5A [Source:HGNC Symbol;Acc:HGNC:18345]","GO:0009617(response to bacterium);GO:1990817(RNA adenylyltransferase activity)","04371(Apelin signaling pathway);04810(Regulation of actin cytoskeleton);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes)",{"v":1e-85,"d":"0.00"},2,"115,803,","0,1240",-85,{"v":-83.5,"d":"-83.50"},7.19,"3' UTR",10,71724878,71727681,2804,1]
["chr10",81069315,81069683,369,"ENSBGRG00000009070","ENSBGRT00000016793",1756,"ENSBGRG00000009070","NA","GO:0003746(translation elongation factor activity);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0006414(translational elongation)","03013(RNA transport);05134(Legionellosis)",0,2,"142,125,","0,244",-13000,"-Inf",2.43,"Exon (ENSBGRT00000016793/ENSBGRG00000009070, exon 6 of 7)",10,81067559,81069683,2125,1]
["chr10",105376416,105377855,1440,"ENSBGRG00000026600","ENSBGRT00000049270",16540,"RSPH3","radial spoke head 3 [Source:HGNC Symbol;Acc:HGNC:21054]","GO:0005929(cilium)","NA",{"v":2e-61,"d":"0.00"},3,"24,87,68,","0,730,1372",{"v":-60.7,"d":"-60.70"},{"v":-59.3,"d":"-59.30"},3.51,"Exon (ENSBGRT00000049270/ENSBGRG00000026600, exon 6 of 9)",10,105359876,105406396,46521,1]
["chr10",1399340,1399640,301,"ENSBGRG00000018460","ENSBGRT00000033889",208063,"SASH1","SAM and SH3 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:19182]","GO:0000209(protein polyubiquitination);GO:0001965(G-protein alpha-subunit binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008022(protein C-terminus binding);GO:0010595(positive regulation of endothelial cell migration);GO:0010632(regulation of epithelial cell migration);GO:0019901(protein kinase binding);GO:0031435(mitogen-activated protein kinase kinase kinase binding);GO:0031666(positive regulation of lipopolysaccharide-mediated signaling pathway);GO:0032991(protein-containing complex);GO:0043507(positive regulation of JUN kinase activity);GO:0045766(positive regulation of angiogenesis);GO:0060090(molecular adaptor activity);GO:1900044(regulation of protein K63-linked ubiquitination);GO:1900745(positive regulation of p38MAPK cascade);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1902498(regulation of protein autoubiquitination)","04010(MAPK signaling pathway);04012(ErbB signaling pathway)",{"v":1e-114,"d":"0.00"},1,"301,",0,-114,-112,4.83,"3' UTR",10,1398443,1607703,209261,2]
["chr10",11920451,11921141,691,"ENSBGRG00000013577","ENSBGRT00000024907",184143,"ARFGEF3","ARFGEF family member 3 [Source:HGNC Symbol;Acc:HGNC:21213]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0010923(negative regulation of phosphatase activity);GO:0032012(regulation of ARF protein signal transduction)","NA",{"v":0.0002,"d":"0.00"},1,"691,",0,{"v":-3.7,"d":"-3.70"},-3.03,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000024907/ENSBGRG00000013577, exon 33 of 35)",10,11918062,12105284,187223,2]
["chr10",11974945,12011221,36277,"ENSBGRG00000013577","ENSBGRT00000024907",94063,"ARFGEF3","ARFGEF family member 3 [Source:HGNC Symbol;Acc:HGNC:21213]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0010923(negative regulation of phosphatase activity);GO:0032012(regulation of ARF protein signal transduction)","NA",{"v":0.025,"d":"0.03"},9,"33,167,911,113,334,105,79,43,15,","0,2389,11700,13371,21374,22579,30606,32981,36262",-1.61,-1.07,6.48,"Exon (ENSBGRT00000024907/ENSBGRG00000013577, exon 6 of 35)",10,11918062,12105284,187223,2]
["chr10",27538546,27538863,318,"ENSBGRG00000023046","ENSBGRT00000042567",853,"CNR1","cannabinoid receptor 1 [Source:HGNC Symbol;Acc:HGNC:2159]","GO:0004930(G protein-coupled receptor activity);GO:0004949(cannabinoid receptor activity);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G protein-coupled receptor signaling pathway);GO:0007413(axonal fasciculation);GO:0015629(actin cytoskeleton);GO:0016021(integral component of membrane);GO:0030424(axon);GO:0030426(growth cone);GO:0038171(cannabinoid signaling pathway);GO:0042593(glucose homeostasis);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0099553(trans-synaptic signaling by endocannabinoid, modulating synaptic transmission)","04015(Rap1 signaling pathway);04080(Neuroactive ligand-receptor interaction);04723(Retrograde endocannabinoid signaling);04714(Thermogenesis)",{"v":1.6e-16,"d":"0.00"},2,"38,226,","0,92",{"v":-15.8,"d":"-15.80"},{"v":-14.8,"d":"-14.80"},{"v":34.6,"d":"34.60"},"Exon (ENSBGRT00000042567/ENSBGRG00000023046, exon 2 of 4)",10,27537593,27539716,2124,2]
["chr10",29171663,29172051,389,"ENSBGRG00000026244","ENSBGRT00000048546",325400,"BACH2","BTB domain and CNC homolog 2 [Source:HGNC Symbol;Acc:HGNC:14078]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0051170(import into nucleus);GO:0090721(primary adaptive immune response involving T cells and B cells);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.028,"d":"0.03"},1,"389,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"3' UTR",10,29170649,29497451,326803,2]
["chr10",39427447,39427626,180,"ENSBGRG00000026508","ENSBGRT00000049082",1154,"FBXL4","F-box and leucine rich repeat protein 4 [Source:HGNC Symbol;Acc:HGNC:13601]","GO:0005515(protein binding);GO:0005758(mitochondrial intermembrane space);GO:0016607(nuclear speck)","NA",{"v":2.5e-27,"d":"0.00"},1,"180,",0,{"v":-26.6,"d":"-26.60"},{"v":-25.6,"d":"-25.60"},5.96,"Exon (ENSBGRT00000049082/ENSBGRG00000026508, exon 2 of 8)",10,39367345,39428780,61436,2]
["chr10",45943614,45943673,60,"ENSBGRG00000005006","ENSBGRT00000009203",22059,"POPDC3","popeye domain containing 3 [Source:HGNC Symbol;Acc:HGNC:17649]","GO:0016020(membrane);GO:0030552(cAMP binding);GO:0042391(regulation of membrane potential)","04530(Tight junction)",{"v":0.0078,"d":"0.01"},1,"60,",0,-2.11,-1.53,5.94,"Exon (ENSBGRT00000009203/ENSBGRG00000005006, exon 4 of 4)",10,45943406,45965732,22327,2]
["chr10",51711987,51712046,60,"ENSBGRG00000010459","ENSBGRT00000019381",178914,"CDK19","cyclin dependent kinase 19 [Source:HGNC Symbol;Acc:HGNC:19338]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA",{"v":1.9e-09,"d":"0.00"},1,"60,",0,-8.72,{"v":-7.9,"d":"-7.90"},4.32,"3' UTR",10,51711987,51890960,178974,2]
["chr10",57192901,57194741,1841,"ENSBGRG00000005311","ENSBGRT00000009838",106365,"FRK","fyn related Src family tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:3955]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation)","NA",{"v":0.014,"d":"0.01"},2,"137,42,","0,1799",-1.86,{"v":-1.3,"d":"-1.30"},{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000009838/ENSBGRG00000005311, exon 6 of 8)",10,57192225,57301106,108882,2]
["chr10",64485382,64583255,97874,"ENSBGRG00000010492","ENSBGRT00000020879",318294,"TRDN","triadin [Source:HGNC Symbol;Acc:HGNC:12261]","GO:0005102(signaling receptor binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0009617(response to bacterium);GO:0014808(release of sequestered calcium ion into cytosol by sarcoplasmic reticulum);GO:0016021(integral component of membrane);GO:0016529(sarcoplasmic reticulum);GO:0060047(heart contraction)","NA",{"v":1.7e-09,"d":"0.00"},17,"5,27,21,45,18,48,48,27,30,27,39,51,51,48,48,27,6,","0,908,2449,4750,7776,9167,10982,11751,12942,17675,38170,51948,58452,79679,87773,95374,97868",-8.76,-7.94,{"v":3.1,"d":"3.10"},"Exon (ENSBGRT00000020879/ENSBGRG00000010492, exon 18 of 40)",10,64451120,64901549,450430,2]
["chr10",64747496,64810017,62522,"ENSBGRG00000010492","ENSBGRT00000020879",91532,"TRDN","triadin [Source:HGNC Symbol;Acc:HGNC:12261]","GO:0005102(signaling receptor binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0009617(response to bacterium);GO:0014808(release of sequestered calcium ion into cytosol by sarcoplasmic reticulum);GO:0016021(integral component of membrane);GO:0016529(sarcoplasmic reticulum);GO:0060047(heart contraction)","NA",{"v":7.9e-11,"d":"0.00"},6,"170,60,54,60,33,40,","0,8182,11288,26778,61397,62482",{"v":-10.1,"d":"-10.10"},-9.28,3.08,"Exon (ENSBGRT00000020879/ENSBGRG00000010492, exon 3 of 40)",10,64451120,64901549,450430,2]
["chr10",78620440,78620500,61,"ENSBGRG00000005342","ENSBGRT00000009951",448,"SENP6","SUMO specific peptidase 6 [Source:HGNC Symbol;Acc:HGNC:20944]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity);GO:0016926(protein desumoylation);GO:0070139(SUMO-specific endopeptidase activity);GO:0070646(protein modification by small protein removal);GO:0090169(regulation of spindle assembly);GO:0090234(regulation of kinetochore assembly)","NA",{"v":3.9e-08,"d":"0.00"},1,"61,",0,-7.41,-6.62,{"v":2.7,"d":"2.70"},"5' UTR",10,78474220,78620948,146729,2]
["chr10",94613444,94613952,509,"ENSBGRG00000022995","ENSBGRT00000042537",83174,"PHF3","PHD finger protein 3 [Source:HGNC Symbol;Acc:HGNC:8921]","GO:0006351(transcription, DNA-templated)","NA",{"v":1e-185,"d":"0.00"},1,"509,",0,-185,-183,4.12,"Exon (ENSBGRT00000042537/ENSBGRG00000022995, exon 14 of 14)",10,94611741,94697126,85386,2]
["chr10",97843950,97844135,186,"ENSBGRG00000012482","ENSBGRT00000022908",31630,"CCR6","C-C motif chemokine receptor 6 [Source:HGNC Symbol;Acc:HGNC:1607]","GO:0004930(G protein-coupled receptor activity);GO:0004950(chemokine receptor activity);GO:0006935(chemotaxis);GO:0006955(immune response);GO:0007186(G protein-coupled receptor signaling pathway);GO:0009986(cell surface);GO:0016021(integral component of membrane);GO:0016493(C-C chemokine receptor activity);GO:0019722(calcium-mediated signaling);GO:0019957(C-C chemokine binding);GO:0036126(sperm flagellum);GO:0060326(cell chemotaxis);GO:0060474(positive regulation of flagellated sperm motility involved in capacitation);GO:0097225(sperm midpiece);GO:0097228(sperm principal piece);GO:0097524(sperm plasma membrane)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway)",{"v":0.0036,"d":"0.00"},2,"83,7,","0,179",-2.44,-1.84,5.04,"Exon (ENSBGRT00000022908/ENSBGRG00000012482, exon 2 of 3)",10,97842134,97875765,33632,2]
["chr10",104581839,104583648,1810,"ENSBGRG00000026557","ENSBGRT00000049172",30,"ENSBGRG00000026557","NA","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0005634(nucleus);GO:0080009(mRNA methylation)","NA",{"v":1E-175,"d":"0.00"},2,"302,148,","0,1662",-175,-173,5.72,"Exon (ENSBGRT00000049172/ENSBGRG00000026557, exon 1 of 3)",10,104581565,104583678,2114,2]
["chr10",109758354,109758803,450,"ENSBGRG00000003747","ENSBGRT00000007104",89464,"SCAF8","SR-related CTD associated factor 8 [Source:HGNC Symbol;Acc:HGNC:20959]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm)","NA",{"v":1E-205,"d":"0.00"},1,"450,",0,-205,-203,3.94,"Exon (ENSBGRT00000007104/ENSBGRG00000003747, exon 20 of 21)",10,109689335,109848267,158933,2]
["chr10",112994022,112999213,5192,"ENSBGRG00000006106","ENSBGRT00000011346",36565,"CCDC170","coiled-coil domain containing 170 [Source:HGNC Symbol;Acc:HGNC:21177]","GO:0000226(microtubule cytoskeleton organization);GO:0005794(Golgi apparatus);GO:0008017(microtubule binding);GO:0036064(ciliary basal body)","NA",{"v":6.3e-31,"d":"0.00"},2,"62,207,","0,4985",{"v":-30.2,"d":"-30.20"},{"v":-29.1,"d":"-29.10"},{"v":4.2,"d":"4.20"},"Exon (ENSBGRT00000011346/ENSBGRG00000006106, exon 3 of 11)",10,112931182,113035778,104597,2]
["chr11",2690546,2690816,271,"ENSBGRG00000020512","ENSBGRT00000037741",12108,"NYNRIN","NYN domain and retroviral integrase containing [Source:HGNC Symbol;Acc:HGNC:20165]","GO:0003676(nucleic acid binding);GO:0015074(DNA integration)","NA",{"v":4E-73,"d":"0.00"},1,"271,",0,{"v":-72.4,"d":"-72.40"},{"v":-70.9,"d":"-70.90"},4.74,"5' UTR",11,2678438,2703545,25108,1]
["chr11",2699288,2699528,241,"ENSBGRG00000020512","ENSBGRT00000037741",20850,"NYNRIN","NYN domain and retroviral integrase containing [Source:HGNC Symbol;Acc:HGNC:20165]","GO:0003676(nucleic acid binding);GO:0015074(DNA integration)","NA",{"v":1E-210,"d":"0.00"},1,"241,",0,-210,-208,5.57,"Exon (ENSBGRT00000037741/ENSBGRG00000020512, exon 11 of 11)",11,2678438,2703545,25108,1]
["chr11",6184132,6190502,6371,"ENSBGRG00000016597","ENSBGRT00000032549",86735,"UACA","uveal autoantigen with coiled-coil domains and ankyrin repeats [Source:HGNC Symbol;Acc:HGNC:15947]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0097190(apoptotic signaling pathway);GO:1901222(regulation of NIK/NF-kappaB signaling)","NA",{"v":1e-185,"d":"0.00"},3,"37,2739,30,","0,2011,6341",-185,-183,{"v":5.3,"d":"5.30"},"Exon (ENSBGRT00000032549/ENSBGRG00000016597, exon 15 of 19)",11,6097397,6196707,99311,1]
["chr11",12164159,12164429,271,"ENSBGRG00000025454","ENSBGRT00000047058",43580,"IGDCC4","immunoglobulin superfamily DCC subclass member 4 [Source:HGNC Symbol;Acc:HGNC:13770]","GO:0005515(protein binding)","04514(Cell adhesion molecules (CAMs))",{"v":1e-213,"d":"0.00"},1,"271,",0,-213,-211,{"v":6.5,"d":"6.50"},"Exon (ENSBGRT00000047058/ENSBGRG00000025454, exon 20 of 20)",11,12120579,12164429,43851,1]
["chr11",13013236,13014348,1113,"ENSBGRG00000004169","ENSBGRT00000007687",64794,"GPR137C","G protein-coupled receptor 137C [Source:HGNC Symbol;Acc:HGNC:25445]","GO:0005765(lysosomal membrane)","NA",{"v":1.1e-08,"d":"0.00"},2,"53,155,","0,958",-7.96,-7.16,3.73,"Exon (ENSBGRT00000007687/ENSBGRG00000004169, exon 6 of 7)",11,12948442,13014585,66144,1]
["chr11",17129428,17129637,210,"ENSBGRG00000007931","ENSBGRT00000015453",10791,"IQGAP2","IQ motif containing GTPase activating protein 2 [Source:HGNC Symbol;Acc:HGNC:6111]","GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005737(cytoplasm);GO:0005902(microvillus);GO:0007165(signal transduction);GO:0009986(cell surface);GO:0017048(Rho GTPase binding);GO:0030027(lamellipodium);GO:0030175(filopodium);GO:0034314(Arp2/3 complex-mediated actin nucleation);GO:0043087(regulation of GTPase activity);GO:0048365(Rac GTPase binding);GO:0051015(actin filament binding);GO:0070493(thrombin-activated receptor signaling pathway);GO:0071933(Arp2/3 complex binding);GO:2000249(regulation of actin cytoskeleton reorganization)","04810(Regulation of actin cytoskeleton)",{"v":7.2E-10,"d":"0.00"},1,"210,",0,-9.14,-8.31,3.76,"Exon (ENSBGRT00000015600/ENSBGRG00000008567, exon 2 of 2)",11,17035941,17140428,104488,2]
["chr11",21414913,21415122,210,"ENSBGRG00000011092","ENSBGRT00000020540",44760,"TRIM36","tripartite motif containing 36 [Source:HGNC Symbol;Acc:HGNC:16280]","GO:0000281(mitotic cytokinesis);GO:0001669(acrosomal vesicle);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0007051(spindle organization);GO:0007340(acrosome reaction);GO:0008270(zinc ion binding);GO:0043014(alpha-tubulin binding);GO:0051726(regulation of cell cycle);GO:0070507(regulation of microtubule cytoskeleton organization)","NA",{"v":9.5e-06,"d":"0.00"},1,"210,",0,-5.02,{"v":-4.3,"d":"-4.30"},{"v":2.6,"d":"2.60"},"3' UTR",11,21370153,21415241,45089,1]
["chr11",32701682,32702012,331,"ENSBGRG00000025007","ENSBGRT00000047740",0,"HERC1","HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 [Source:HGNC Symbol;Acc:HGNC:4867]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0010507(negative regulation of autophagy);GO:0021702(cerebellar Purkinje cell differentiation);GO:0031175(neuron projection development);GO:0050885(neuromuscular process controlling balance)","04120(Ubiquitin mediated proteolysis)",{"v":2.8e-09,"d":"0.00"},1,"331,",0,-8.56,-7.75,{"v":30.2,"d":"30.20"},"Exon (ENSBGRT00000047740/ENSBGRG00000025007, exon 1 of 80)",11,32701682,32881578,179897,1]
["chr11",39383331,39383390,60,"ENSBGRG00000011324","ENSBGRT00000021223",59,"ALDH1A2","aldehyde dehydrogenase 1 family member A2 [Source:HGNC Symbol;Acc:HGNC:15472]","GO:0001568(blood vessel development);GO:0001758(retinal dehydrogenase activity);GO:0001936(regulation of endothelial cell proliferation);GO:0002138(retinoic acid biosynthetic process);GO:0003007(heart morphogenesis);GO:0004028(3-chloroallyl aldehyde dehydrogenase activity);GO:0005737(cytoplasm);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0009855(determination of bilateral symmetry);GO:0009952(anterior/posterior pattern specification);GO:0009954(proximal/distal pattern formation);GO:0010628(positive regulation of gene expression);GO:0014032(neural crest cell development);GO:0016331(morphogenesis of embryonic epithelium);GO:0016491(oxidoreductase activity);GO:0016620(oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor);GO:0021915(neural tube development);GO:0030182(neuron differentiation);GO:0030324(lung development);GO:0030326(embryonic limb morphogenesis);GO:0030900(forebrain development);GO:0030902(hindbrain development);GO:0031016(pancreas development);GO:0031076(embryonic camera-type eye development);GO:0034097(response to cytokine);GO:0035115(embryonic forelimb morphogenesis);GO:0035799(ureter maturation);GO:0042573(retinoic acid metabolic process);GO:0042574(retinal metabolic process);GO:0042904(9-cis-retinoic acid biosynthetic process);GO:0043010(camera-type eye development);GO:0043065(positive regulation of apoptotic process);GO:0048384(retinoic acid receptor signaling pathway);GO:0048566(embryonic digestive tract development);GO:0048738(cardiac muscle tissue development);GO:0051289(protein homotetramerization);GO:0055114(oxidation-reduction process);GO:0060324(face development);GO:0071300(cellular response to retinoic acid);GO:0090242(retinoic acid receptor signaling pathway involved in somitogenesis)","00830(Retinol metabolism)",{"v":0.0022,"d":"0.00"},1,"60,",0,-2.66,-2.04,2.07,"5' UTR",11,39383272,39519258,135987,1]
["chr11",42383278,42387946,4669,"ENSBGRG00000016245","ENSBGRT00000030195",13365,"CCPG1","cell cycle progression 1 [Source:HGNC Symbol;Acc:HGNC:24227]","GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0045787(positive regulation of cell cycle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2001106(regulation of Rho guanyl-nucleotide exchange factor activity)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)",0,2,"14,938,","0,3731",-401,"-Inf",4.71,"Exon (ENSBGRT00000030195/ENSBGRG00000016245, exon 7 of 9)",11,42369913,42391752,21840,1]
["chr11",46675049,46675318,270,"ENSBGRG00000009228","ENSBGRT00000017023",143076,"DMXL2","Dmx like 2 [Source:HGNC Symbol;Acc:HGNC:2938]","GO:0005515(protein binding);GO:0008021(synaptic vesicle);GO:0017137(Rab GTPase binding)","04020(Calcium signaling pathway);04080(Neuroactive ligand-receptor interaction)",{"v":0.0078,"d":"0.01"},1,"270,",0,-2.11,-1.27,9.72,"Exon (ENSBGRT00000017023/ENSBGRG00000009228, exon 24 of 44)",11,46531973,46709439,177467,1]
["chr11",49520565,49521216,652,"ENSBGRG00000015031","ENSBGRT00000027737",105508,"CEP152","centrosomal protein 152 [Source:HGNC Symbol;Acc:HGNC:29298]","GO:0000242(pericentriolar material);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0007099(centriole replication);GO:0019901(protein kinase binding);GO:0051298(centrosome duplication);GO:0098535(de novo centriole assembly involved in multi-ciliated epithelial cell differentiation);GO:0098536(deuterosome)","NA",{"v":1.9e-08,"d":"0.00"},2,"420,210,","0,442",-7.72,-6.92,{"v":30.2,"d":"30.20"},"Exon (ENSBGRT00000027737/ENSBGRG00000015031, exon 27 of 29)",11,49415057,49521216,106160,1]
["chr11",56106646,56106705,60,"ENSBGRG00000024612","ENSBGRT00000045415",0,"SOCS4","suppressor of cytokine signaling 4 [Source:HGNC Symbol;Acc:HGNC:19392]","GO:0007175(negative regulation of epidermal growth factor-activated receptor activity);GO:0009968(negative regulation of signal transduction);GO:0016567(protein ubiquitination);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0035556(intracellular signal transduction);GO:0040008(regulation of growth)","04630(Jak-STAT signaling pathway);04910(Insulin signaling pathway);04917(Prolactin signaling pathway);04930(Type II diabetes mellitus)",{"v":0.0083,"d":"0.01"},1,"60,",0,-2.08,{"v":-1.5,"d":"-1.50"},2.97,"Exon (ENSBGRT00000045415/ENSBGRG00000024612, exon 1 of 1)",11,56106646,56107968,1323,1]
["chr11",56452753,56452842,90,"ENSBGRG00000003724","ENSBGRT00000006908",90328,"FBXO34","F-box protein 34 [Source:HGNC Symbol;Acc:HGNC:20201]","GO:0005515(protein binding)","NA",{"v":3.2e-14,"d":"0.00"},1,"90,",0,{"v":-13.5,"d":"-13.50"},{"v":-12.6,"d":"-12.60"},3.88,"Exon (ENSBGRT00000006908/ENSBGRG00000003724, exon 2 of 2)",11,56362425,56455137,92713,1]
["chr11",59555947,59556126,180,"ENSBGRG00000006268","ENSBGRT00000011564",55234,"ARID4A","AT-rich interaction domain 4A [Source:HGNC Symbol;Acc:HGNC:9885]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006349(regulation of gene expression by genetic imprinting);GO:0007283(spermatogenesis);GO:0017053(transcriptional repressor complex);GO:0034773(histone H4-K20 trimethylation);GO:0036124(histone H3-K9 trimethylation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048821(erythrocyte development);GO:0080182(histone H3-K4 trimethylation);GO:0097368(establishment of Sertoli cell barrier)","NA",{"v":3.2e-38,"d":"0.00"},1,"180,",0,{"v":-37.5,"d":"-37.50"},{"v":-36.3,"d":"-36.30"},4.45,"Exon (ENSBGRT00000011564/ENSBGRG00000006268, exon 20 of 24)",11,59500713,59567882,67170,1]
["chr11",61553713,61591282,37570,"ENSBGRG00000008044","ENSBGRT00000014882",0,"PPM1A","protein phosphatase, Mg2+/Mn2+ dependent 1A [Source:HGNC Symbol;Acc:HGNC:9275]","GO:0000287(magnesium ion binding);GO:0003824(catalytic activity);GO:0004721(phosphoprotein phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006470(protein dephosphorylation);GO:0006499(N-terminal protein myristoylation);GO:0010991(negative regulation of SMAD protein complex assembly);GO:0016020(membrane);GO:0016311(dephosphorylation);GO:0030145(manganese ion binding);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030514(negative regulation of BMP signaling pathway);GO:0033192(calmodulin-dependent protein phosphatase activity);GO:0035970(peptidyl-threonine dephosphorylation);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043169(cation binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046827(positive regulation of protein export from nucleus);GO:0070412(R-SMAD binding);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1901223(negative regulation of NIK/NF-kappaB signaling)","04010(MAPK signaling pathway)",{"v":1e-227,"d":"0.00"},3,"16,871,580,","0,5372,36990",-227,-225,8.64,"5' UTR",11,61559085,61600813,41729,1]
["chr11",67449813,67450591,779,"ENSBGRG00000004870","ENSBGRT00000009050",302817,"FUT8","fucosyltransferase 8 [Source:HGNC Symbol;Acc:HGNC:4019]","GO:0005515(protein binding);GO:0008424(glycoprotein 6-alpha-L-fucosyltransferase activity);GO:0016021(integral component of membrane);GO:0018279(protein N-linked glycosylation via asparagine);GO:0032580(Golgi cisterna membrane);GO:0033578(protein glycosylation in Golgi);GO:0046368(GDP-L-fucose metabolic process)","00510(N-Glycan biosynthesis);00533(Glycosaminoglycan biosynthesis - keratan sulfate);05202(Transcriptional misregulation in cancers)",{"v":1e-145,"d":"0.00"},1,"779,",0,-145,-143,{"v":7.2,"d":"7.20"},"3' UTR",11,67146996,67450714,303719,1]
["chr11",68877915,68894754,16840,"ENSBGRG00000005346","ENSBGRT00000009862",12172,"FAM71D","family with sequence similarity 71 member D [Source:HGNC Symbol;Acc:HGNC:20101]","NA","NA",{"v":0.025,"d":"0.03"},3,"1,29,120,","0,9163,16720",-1.61,-1.07,7.56,"3' UTR",11,68865743,68894754,29012,1]
["chr11",74995983,74996073,91,"ENSBGRG00000014814","ENSBGRT00000027274",36786,"RBM25","RNA binding motif protein 25 [Source:HGNC Symbol;Acc:HGNC:23244]","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003729(mRNA binding);GO:0006397(mRNA processing);GO:0016607(nuclear speck);GO:0042981(regulation of apoptotic process)","03040(Spliceosome)",{"v":1.6e-14,"d":"0.00"},1,"91,",0,{"v":-13.8,"d":"-13.80"},{"v":-12.9,"d":"-12.90"},1.51,"Exon (ENSBGRT00000027274/ENSBGRG00000014814, exon 15 of 18)",11,74959197,75000947,41751,1]
["chr11",76646997,76663149,16153,"ENSBGRG00000007101","ENSBGRT00000013672",53849,"YLPM1","YLP motif containing 1 [Source:HGNC Symbol;Acc:HGNC:17798]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016607(nuclear speck)","NA",{"v":5e-49,"d":"0.00"},5,"82,81,52,131,15,","0,2957,6208,11386,16138",{"v":-48.3,"d":"-48.30"},-47,2.28,"Exon (ENSBGRT00000013672/ENSBGRG00000007101, exon 18 of 23)",11,76593148,76663777,70630,1]
["chr11",78052952,78053098,147,"ENSBGRG00000010136","ENSBGRT00000018856",117635,"IFT43","intraflagellar transport 43 [Source:HGNC Symbol;Acc:HGNC:29669]","GO:0005929(cilium);GO:0015630(microtubule cytoskeleton);GO:0030991(intraciliary transport particle A);GO:0034451(centriolar satellite);GO:0035721(intraciliary retrograde transport);GO:0060271(cilium assembly)","NA",{"v":1e-67,"d":"0.00"},1,"147,",0,-67,{"v":-65.6,"d":"-65.60"},2.97,"3' UTR",11,77935317,78053216,117900,1]
["chr11",79523804,79524158,355,"ENSBGRG00000013505","ENSBGRT00000024785",9308,"AHSA1","activator of HSP90 ATPase activity 1 [Source:HGNC Symbol;Acc:HGNC:1189]","GO:0001671(ATPase activator activity);GO:0005829(cytosol);GO:0032781(positive regulation of ATPase activity);GO:0051087(chaperone binding);GO:0051879(Hsp90 protein binding)","04080(Neuroactive ligand-receptor interaction)",{"v":9.99999999999998e-280,"d":"0.00"},2,"23,216,","0,139",-279,-277,{"v":2.9,"d":"2.90"},"3' UTR",11,79514496,79524336,9841,1]
["chr11",92603169,92603348,180,"ENSBGRG00000005119","ENSBGRT00000009691",0,"TTC8","tetratricopeptide repeat domain 8 [Source:HGNC Symbol;Acc:HGNC:20087]","GO:0001736(establishment of planar polarity);GO:0005515(protein binding);GO:0005929(cilium);GO:0007411(axon guidance);GO:0007608(sensory perception of smell);GO:0016020(membrane);GO:0021772(olfactory bulb development);GO:0032391(photoreceptor connecting cilium);GO:0032880(regulation of protein localization);GO:0034260(negative regulation of GTPase activity);GO:0034464(BBSome);GO:0035264(multicellular organism growth);GO:0045198(establishment of epithelial cell apical/basal polarity);GO:0045444(fat cell differentiation);GO:0051492(regulation of stress fiber assembly);GO:0060122(inner ear receptor cell stereocilium organization);GO:0060219(camera-type eye photoreceptor cell differentiation);GO:0060271(cilium assembly);GO:0061326(renal tubule development);GO:0072659(protein localization to plasma membrane);GO:1903251(multi-ciliated epithelial cell differentiation);GO:1905515(non-motile cilium assembly)","NA",{"v":0.0078,"d":"0.01"},1,"180,",0,-2.11,-1.53,8.64,"Exon (ENSBGRT00000009691/ENSBGRG00000005119, exon 1 of 13)",11,92603169,92671905,68737,1]
["chr11",1525263,1544625,19363,"ENSBGRG00000006584","ENSBGRT00000012132",0,"ENSBGRG00000006584","NA","NA","03040(Spliceosome);03013(RNA transport);03015(mRNA surveillance pathway)",{"v":8.99999999999999e-296,"d":"0.00"},6,"382,89,120,112,66,162,","0,1085,15017,15560,17573,19201",-295,-293,3.17,"Exon (ENSBGRT00000012132/ENSBGRG00000006584, exon 1 of 2)",11,1544481,1546908,2428,1]
["chr11",1806757,1807498,742,"ENSBGRG00000007922","ENSBGRT00000014592",13027,"MYH6","myosin heavy chain 6 [Source:HGNC Symbol;Acc:HGNC:7576]","GO:0000146(microfilament motor activity);GO:0001701(in utero embryonic development);GO:0001725(stress fiber);GO:0002026(regulation of the force of heart contraction);GO:0002027(regulation of heart rate);GO:0003774(motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006936(muscle contraction);GO:0006941(striated muscle contraction);GO:0007512(adult heart development);GO:0007522(visceral muscle development);GO:0008016(regulation of heart contraction);GO:0008217(regulation of blood pressure);GO:0014898(cardiac muscle hypertrophy in response to stress);GO:0016459(myosin complex);GO:0016887(ATPase activity);GO:0019901(protein kinase binding);GO:0030016(myofibril);GO:0030018(Z disc);GO:0030048(actin filament-based movement);GO:0030049(muscle filament sliding);GO:0030239(myofibril assembly);GO:0030898(actin-dependent ATPase activity);GO:0043462(regulation of ATPase activity);GO:0045214(sarcomere organization);GO:0046034(ATP metabolic process);GO:0048739(cardiac muscle fiber development);GO:0051015(actin filament binding);GO:0055009(atrial cardiac muscle tissue morphogenesis);GO:0055010(ventricular cardiac muscle tissue morphogenesis);GO:0060048(cardiac muscle contraction);GO:0060420(regulation of heart growth)","04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);05416(Viral myocarditis)",{"v":0.0078,"d":"0.01"},3,"8,243,199,","0,154,543",-2.11,-1.27,9.72,"Exon (ENSBGRT00000014592/ENSBGRG00000007922, exon 19 of 40)",11,1788591,1820525,31935,2]
["chr11",2397821,2398119,299,"ENSBGRG00000015628","ENSBGRT00000028881",1707,"EMC9","ER membrane protein complex subunit 9 [Source:HGNC Symbol;Acc:HGNC:20273]","GO:0005737(cytoplasm);GO:0072546(ER membrane protein complex)","03050(Proteasome);04612(Antigen processing and presentation)",{"v":3.5e-09,"d":"0.00"},2,"92,58,","0,241",-8.46,-7.64,2.44,"Exon (ENSBGRT00000028881/ENSBGRG00000015628, exon 4 of 5)",11,2397732,2399826,2095,2]
["chr11",4605144,4605202,59,"ENSBGRG00000013949","ENSBGRT00000025628",435,"SENP8","SUMO peptidase family member, NEDD8 specific [Source:HGNC Symbol;Acc:HGNC:22992]","GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity)","NA",{"v":7.9e-48,"d":"0.00"},1,"59,",0,{"v":-47.1,"d":"-47.10"},{"v":-45.8,"d":"-45.80"},6.21,"Exon (ENSBGRT00000025628/ENSBGRG00000013949, exon 1 of 1)",11,4604999,4605637,639,2]
["chr11",8206272,8206331,60,"ENSBGRG00000021382","ENSBGRT00000039535",29635,"ENSBGRG00000021382","NA","GO:0001669(acrosomal vesicle);GO:0007340(acrosome reaction);GO:0007342(fusion of sperm to egg plasma membrane involved in single fertilization)","NA",{"v":0.028,"d":"0.03"},1,"60,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000039535/ENSBGRG00000021382, exon 2 of 2)",11,8205349,8235966,30618,2]
["chr11",13940907,13942853,1947,"ENSBGRG00000005128","ENSBGRT00000009561",52932,"CMYA5","cardiomyopathy associated 5 [Source:HGNC Symbol;Acc:HGNC:14305]","GO:0005515(protein binding)","NA",{"v":0.0078,"d":"0.01"},2,"429,799,","0,1148",-2.11,-1.53,9.72,"Exon (ENSBGRT00000009561/ENSBGRG00000005128, exon 4 of 17)",11,13890505,13995785,105281,2]
["chr11",22013906,22014143,238,"ENSBGRG00000011476","ENSBGRT00000021016",178326,"KCNN2","potassium calcium-activated channel subfamily N member 2 [Source:HGNC Symbol;Acc:HGNC:6291]","GO:0005516(calmodulin binding);GO:0005886(plasma membrane);GO:0006813(potassium ion transport);GO:0009986(cell surface);GO:0015269(calcium-activated potassium channel activity);GO:0016021(integral component of membrane);GO:0016286(small conductance calcium-activated potassium channel activity);GO:0019904(protein domain specific binding);GO:0042803(protein homodimerization activity);GO:0051393(alpha-actinin binding);GO:0071805(potassium ion transmembrane transport);GO:1901379(regulation of potassium ion transmembrane transport)","04911(Insulin secretion);04976(Bile secretion);04726(Serotonergic synapse)",{"v":5e-39,"d":"0.00"},1,"238,",0,{"v":-38.3,"d":"-38.30"},{"v":-37.1,"d":"-37.10"},4.42,"3' UTR",11,22013638,22192469,178832,2]
["chr11",29196554,29197001,448,"ENSBGRG00000018125","ENSBGRT00000034056",106688,"SOS2","SOS Ras/Rho guanine nucleotide exchange factor 2 [Source:HGNC Symbol;Acc:HGNC:11188]","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0007264(small GTPase mediated signal transduction);GO:0046982(protein heterodimerization activity)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04630(Jak-STAT signaling pathway);04068(FoxO signaling pathway);04072(Phospholipase D signaling pathway);04151(PI3K-Akt signaling pathway);04150(mTOR signaling pathway);04510(Focal adhesion);04540(Gap junction);04810(Regulation of actin cytoskeleton);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04722(Neurotrophin signaling pathway);04714(Thermogenesis);05200(Pathways in cancer);05231(Choline metabolism in cancer);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05210(Colorectal cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05223(Non-small cell lung cancer);05034(Alcoholism);05160(Hepatitis C);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance)",{"v":9.99999999999998e-212,"d":"0.00"},1,"448,",0,-211,-208,4.87,"Exon (ENSBGRT00000034056/ENSBGRG00000018125, exon 26 of 26)",11,29196554,29303689,107136,2]
["chr11",29811005,29811215,211,"ENSBGRG00000019999","ENSBGRT00000039713",67903,"NIN","ninein [Source:HGNC Symbol;Acc:HGNC:14906]","GO:0000242(pericentriolar material);GO:0000922(spindle pole);GO:0005509(calcium ion binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005813(centrosome);GO:0005814(centriole);GO:0005881(cytoplasmic microtubule);GO:0005886(plasma membrane);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0019900(kinase binding);GO:0021540(corpus callosum morphogenesis);GO:0021957(corticospinal tract morphogenesis);GO:0030424(axon);GO:0030425(dendrite);GO:0031116(positive regulation of microtubule polymerization);GO:0034454(microtubule anchoring at centrosome);GO:0036449(microtubule minus-end);GO:0044295(axonal growth cone);GO:0045177(apical part of cell);GO:0048668(collateral sprouting);GO:0050772(positive regulation of axonogenesis);GO:0051642(centrosome localization);GO:0072686(mitotic spindle);GO:0090222(centrosome-templated microtubule nucleation);GO:0097431(mitotic spindle pole);GO:0097539(ciliary transition fiber);GO:0120103(centriolar subdistal appendage)","NA",{"v":2.3E-6,"d":"0.00"},1,"211,",0,-5.64,{"v":-4.9,"d":"-4.90"},{"v":6.7,"d":"6.70"},"Exon (ENSBGRT00000039713/ENSBGRG00000019999, exon 17 of 31)",11,29777842,29879118,101277,2]
["chr11",33615941,33616329,389,"ENSBGRG00000003979","ENSBGRT00000007640",179,"TPM1","tropomyosin 1 [Source:HGNC Symbol;Acc:HGNC:12010]","GO:0001701(in utero embryonic development);GO:0001725(stress fiber);GO:0003065(positive regulation of heart rate by epinephrine);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008092(cytoskeletal protein binding);GO:0008360(regulation of cell shape);GO:0015629(actin cytoskeleton);GO:0030016(myofibril);GO:0032059(bleb);GO:0032587(ruffle membrane);GO:0034614(cellular response to reactive oxygen species);GO:0045214(sarcomere organization);GO:0051015(actin filament binding);GO:0055010(ventricular cardiac muscle tissue morphogenesis);GO:0060048(cardiac muscle contraction);GO:1904706(negative regulation of vascular smooth muscle cell proliferation);GO:1904753(negative regulation of vascular associated smooth muscle cell migration)","04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);05206(MicroRNAs in cancer);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))",{"v":3e-05,"d":"0.00"},1,"389,",0,-4.53,-3.83,{"v":10.8,"d":"10.80"},"5' UTR",11,33546117,33616508,70392,2]
["chr11",39786947,39793693,6747,"ENSBGRG00000011811","ENSBGRT00000021677",147,"ENSBGRG00000011811","RNA polymerase II subunit M [Source:HGNC Symbol;Acc:HGNC:14862]","GO:0016591(RNA polymerase II, holoenzyme)","NA",0,4,"29,205,648,119,","0,1057,4205,6628",-324,"-Inf",5.66,"5' UTR",11,39786829,39793840,7012,2]
["chr11",46754452,46754661,210,"ENSBGRG00000009477","ENSBGRT00000017410",63505,"GLDN","gliomedin [Source:HGNC Symbol;Acc:HGNC:29514]","GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0009986(cell surface);GO:0032528(microvillus organization);GO:0045162(clustering of voltage-gated sodium channels);GO:0086080(protein binding involved in heterotypic cell-cell adhesion)","NA",{"v":7.4e-06,"d":"0.00"},1,"210,",0,-5.13,-4.41,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000017410/ENSBGRG00000009477, exon 10 of 10)",11,46754213,46818166,63954,2]
["chr11",56480960,56501649,20690,"ENSBGRG00000003787","ENSBGRT00000007033",840,"ATG14","autophagy related 14 [Source:HGNC Symbol;Acc:HGNC:19962]","GO:0000045(autophagosome assembly);GO:0000423(mitophagy);GO:0001932(regulation of protein phosphorylation);GO:0001933(negative regulation of protein phosphorylation);GO:0001934(positive regulation of protein phosphorylation);GO:0005776(autophagosome);GO:0005930(axoneme);GO:0006914(autophagy);GO:0008333(endosome to lysosome transport);GO:0009267(cellular response to starvation);GO:0010608(posttranscriptional regulation of gene expression);GO:0016236(macroautophagy);GO:0016240(autophagosome membrane docking);GO:0034045(phagophore assembly site membrane);GO:0035032(phosphatidylinositol 3-kinase complex, class III);GO:0042149(cellular response to glucose starvation);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0044233(mitochondria-associated endoplasmic reticulum membrane);GO:0045335(phagocytic vesicle);GO:0051020(GTPase binding);GO:0090207(regulation of triglyceride metabolic process);GO:0097629(extrinsic component of omegasome membrane);GO:0097632(extrinsic component of phagophore assembly site membrane);GO:0098780(response to mitochondrial depolarisation)","04140(Autophagy - animal);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":2e-13,"d":"0.00"},5,"47,82,43,63,65,","0,5037,7337,8714,20625",{"v":-12.7,"d":"-12.70"},{"v":-11.9,"d":"-11.90"},2.58,"Exon (ENSBGRT00000007033/ENSBGRG00000003787, exon 1 of 13)",11,56430408,56502489,72082,2]
["chr11",62012946,62017819,4874,"ENSBGRG00000008677","ENSBGRT00000015836",0,"SIX4","SIX homeobox 4 [Source:HGNC Symbol;Acc:HGNC:10890]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007519(skeletal muscle tissue development);GO:0008582(regulation of synaptic growth at neuromuscular junction);GO:0008584(male gonad development);GO:0010468(regulation of gene expression);GO:0030238(male sex determination);GO:0030910(olfactory placode formation);GO:0032880(regulation of protein localization);GO:0034504(protein localization to nucleus);GO:0042472(inner ear morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0043586(tongue development);GO:0045214(sarcomere organization);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046661(male sex differentiation);GO:0048538(thymus development);GO:0048699(generation of neurons);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0048704(embryonic skeletal system morphogenesis);GO:0048856(anatomical structure development);GO:0050678(regulation of epithelial cell proliferation);GO:0051451(myoblast migration);GO:0060037(pharyngeal system development);GO:0061055(myotome development);GO:0061197(fungiform papilla morphogenesis);GO:0061551(trigeminal ganglion development);GO:0072075(metanephric mesenchyme development);GO:0072095(regulation of branch elongation involved in ureteric bud branching);GO:0072107(positive regulation of ureteric bud formation);GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis);GO:0098528(skeletal muscle fiber differentiation);GO:1902725(negative regulation of satellite cell differentiation);GO:1990837(sequence-specific double-stranded DNA binding)","05202(Transcriptional misregulation in cancers)",{"v":3.7e-06,"d":"0.00"},3,"382,293,579,","0,4001,4295",-5.43,{"v":-4.7,"d":"-4.70"},14,"Exon (ENSBGRT00000015836/ENSBGRG00000008677, exon 1 of 4)",11,62007602,62017819,10218,2]
["chr11",66006119,66006179,61,"ENSBGRG00000012917","ENSBGRT00000023849",14507,"ENSBGRG00000012917","NA","NA","NA",{"v":0.027,"d":"0.03"},1,"61,",0,-1.57,-1.03,3.24,"Exon (ENSBGRT00000023849/ENSBGRG00000012917, exon 3 of 9)",11,65987624,66020686,33063,2]
["chr11",74524707,74527746,3040,"ENSBGRG00000013900","ENSBGRT00000026124",125864,"DPF3","double PHD fingers 3 [Source:HGNC Symbol;Acc:HGNC:17427]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0007399(nervous system development);GO:0008270(zinc ion binding);GO:0071565(nBAF complex)","04714(Thermogenesis);05225(Hepatocellular carcinoma)",{"v":6.8e-05,"d":"0.00"},2,"84,95,","0,2945",-4.17,-3.48,7.56,"Exon (ENSBGRT00000026124/ENSBGRG00000013900, exon 8 of 11)",11,74453536,74653610,200075,2]
["chr11",75397238,75397537,300,"ENSBGRG00000017051","ENSBGRT00000031289",6502,"ENSBGRG00000017051","NA","NA","NA",{"v":8.1e-06,"d":"0.00"},1,"300,",0,-5.09,-4.37,{"v":20.5,"d":"20.50"},"Exon (ENSBGRT00000031289/ENSBGRG00000017051, exon 2 of 7)",11,75383563,75404039,20477,2]
["chr11",76910951,76911219,269,"ENSBGRG00000008456","ENSBGRT00000016007",2626,"MLH3","mutL homolog 3 [Source:HGNC Symbol;Acc:HGNC:7128]","GO:0000793(condensed chromosome);GO:0000794(condensed nuclear chromosome);GO:0000795(synaptonemal complex);GO:0001673(male germ cell nucleus);GO:0003682(chromatin binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005712(chiasma);GO:0006298(mismatch repair);GO:0006974(cellular response to DNA damage stimulus);GO:0007130(synaptonemal complex assembly);GO:0007140(male meiotic nuclear division);GO:0007144(female meiosis I);GO:0008104(protein localization);GO:0016887(ATPase activity);GO:0019237(centromeric DNA binding);GO:0030983(mismatched DNA binding);GO:0032300(mismatch repair complex)","03430(Mismatch repair)",{"v":5.9e-07,"d":"0.00"},1,"269,",0,-6.23,-5.47,{"v":17.3,"d":"17.30"},"Exon (ENSBGRT00000016007/ENSBGRG00000008456, exon 1 of 13)",11,76888345,76913845,25501,2]
["chr11",79371987,79372256,270,"ENSBGRG00000012079","ENSBGRT00000022069",0,"POMT2","protein O-mannosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:19743]","GO:0000030(mannosyltransferase activity);GO:0006493(protein O-linked glycosylation);GO:0016020(membrane);GO:0035269(protein O-linked mannosylation)","00515(Mannose type O-glycan biosyntheis);00514(Other types of O-glycan biosynthesis)",{"v":0.043,"d":"0.04"},1,"270,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"5' UTR",11,79320765,79372256,51492,2]
["chr11",95423320,95423530,211,"ENSBGRG00000008668","ENSBGRT00000017072",71445,"SPG11","SPG11 vesicle trafficking associated, spatacsin [Source:HGNC Symbol;Acc:HGNC:11226]","GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007040(lysosome organization);GO:0007268(chemical synaptic transmission);GO:0008088(axo-dendritic transport);GO:0030424(axon);GO:0030425(dendrite);GO:0031410(cytoplasmic vesicle);GO:0045202(synapse);GO:0048489(synaptic vesicle transport);GO:0048675(axon extension);GO:0090389(phagosome-lysosome fusion involved in apoptotic cell clearance);GO:0090659(walking behavior)","NA",{"v":6.3e-67,"d":"0.00"},1,"211,",0,{"v":-66.2,"d":"-66.20"},{"v":-64.8,"d":"-64.80"},8.17,"Exon (ENSBGRT00000017072/ENSBGRG00000008668, exon 31 of 41)",11,95406227,95494975,88749,2]
["chr12",9328339,9328553,215,"ENSBGRG00000016661","ENSBGRT00000034553",154371,"ENSBGRG00000016661","NA","NA","04360(Axon guidance);05166(HTLV-I infection)",{"v":9.99999999999998e-263,"d":"0.00"},3,"70,99,42,","0,72,173",-262,-259,4.66,"Exon (ENSBGRT00000034553/ENSBGRG00000016661, exon 44 of 46)",12,9173968,9328553,154586,1]
["chr12",18103478,18105274,1797,"ENSBGRG00000010711","ENSBGRT00000020562",123,"ENSBGRG00000010711","NA","NA","04137(Mitophagy - animal)",{"v":1.3E-7,"d":"0.00"},2,"41,20,","0,1777",{"v":-6.9,"d":"-6.90"},-6.13,1.62,"Exon (ENSBGRT00000020562/ENSBGRG00000010711, exon 3 of 23)",12,18103355,18135655,32301,1]
["chr12",23980423,23980567,145,"ENSBGRG00000022930","ENSBGRT00000042604",34825,"ENSBGRG00000022930","NA","NA","NA",{"v":0.0041,"d":"0.00"},1,"145,",0,-2.39,-1.79,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000042732/ENSBGRG00000023140, exon 2 of 2)",12,23945598,24054270,108673,1]
["chr12",29573466,29573763,298,"ENSBGRG00000005078","ENSBGRT00000009354",1435,"MGME1","mitochondrial genome maintenance exonuclease 1 [Source:HGNC Symbol;Acc:HGNC:16205]","GO:0000002(mitochondrial genome maintenance);GO:0005739(mitochondrion);GO:0006264(mitochondrial DNA replication);GO:0008297(single-stranded DNA exodeoxyribonuclease activity);GO:0043504(mitochondrial DNA repair)","NA",{"v":3.2E-34,"d":"0.00"},1,"298,",0,{"v":-33.5,"d":"-33.50"},{"v":-32.3,"d":"-32.30"},3.73,"Exon (ENSBGRT00000009354/ENSBGRG00000005078, exon 2 of 4)",12,29572031,29580296,8266,1]
["chr12",29859104,29859164,61,"ENSBGRG00000005416","ENSBGRT00000010000",17577,"POLR3F","RNA polymerase III subunit F [Source:HGNC Symbol;Acc:HGNC:15763]","GO:0003690(double-stranded DNA binding);GO:0005666(RNA polymerase III complex);GO:0006383(transcription by RNA polymerase III);GO:0032728(positive regulation of interferon-beta production);GO:0045089(positive regulation of innate immune response)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway);05169(Epstein-Barr virus infection)",{"v":3.2E-40,"d":"0.00"},1,"61,",0,{"v":-39.5,"d":"-39.50"},{"v":-38.3,"d":"-38.30"},3.22,"3' UTR",12,29841527,29859164,17638,1]
["chr12",34585037,34585186,150,"ENSBGRG00000008602","ENSBGRT00000015652",17533,"ENTPD6","ectonucleoside triphosphate diphosphohydrolase 6 [Source:HGNC Symbol;Acc:HGNC:3368]","GO:0005794(Golgi apparatus);GO:0016787(hydrolase activity)","00230(Purine metabolism);00240(Pyrimidine metabolism)",{"v":7.9e-17,"d":"0.00"},1,"150,",0,{"v":-16.1,"d":"-16.10"},{"v":-15.1,"d":"-15.10"},{"v":2.8,"d":"2.80"},"3' UTR",12,34567504,34586169,18666,1]
["chr12",43459599,43459984,386,"ENSBGRG00000007807","ENSBGRT00000014279",27215,"ADRA1D","adrenoceptor alpha 1D [Source:HGNC Symbol;Acc:HGNC:280]","GO:0004930(G protein-coupled receptor activity);GO:0004935(adrenergic receptor activity);GO:0004937(alpha1-adrenergic receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0042802(identical protein binding)","04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04080(Neuroactive ligand-receptor interaction);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion)",{"v":0.00056,"d":"0.00"},1,"386,",0,-3.25,{"v":-2.6,"d":"-2.60"},14,"3' UTR",12,43432384,43460428,28045,1]
["chr12",45897205,45897770,566,"ENSBGRG00000010593","ENSBGRT00000019437",19717,"PDYN","prodynorphin [Source:HGNC Symbol;Acc:HGNC:8820]","GO:0005886(plasma membrane);GO:0007218(neuropeptide signaling pathway)","05030(Cocaine addiction);05031(Amphetamine addiction);05034(Alcoholism)",{"v":0.0021,"d":"0.00"},1,"566,",0,-2.67,-2.06,{"v":11.9,"d":"11.90"},"3' UTR",12,45877488,45897889,20402,1]
["chr12",47502760,47503090,331,"ENSBGRG00000020262","ENSBGRT00000037302",32196,"DIDO1","death inducer-obliterator 1 [Source:HGNC Symbol;Acc:HGNC:2680]","GO:0005634(nucleus);GO:0006351(transcription, DNA-templated);GO:0097190(apoptotic signaling pathway)","NA",{"v":3.2e-38,"d":"0.00"},1,"331,",0,{"v":-37.5,"d":"-37.50"},{"v":-36.3,"d":"-36.30"},4.03,"Exon (ENSBGRT00000037302/ENSBGRG00000020262, exon 16 of 16)",12,47470564,47506502,35939,1]
["chr12",53445390,53454133,8744,"ENSBGRG00000011719","ENSBGRT00000021684",0,"NSFL1C","NSFL1 cofactor [Source:HGNC Symbol;Acc:HGNC:15912]","GO:0000132(establishment of mitotic spindle orientation);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0045111(intermediate filament cytoskeleton);GO:0046604(positive regulation of mitotic centrosome separation);GO:1904780(negative regulation of protein localization to centrosome)","04141(Protein processing in endoplasmic reticulum)",{"v":1.6e-38,"d":"0.00"},3,"105,98,33,","0,2629,8711",{"v":-37.8,"d":"-37.80"},{"v":-36.6,"d":"-36.60"},2.27,"Exon (ENSBGRT00000021684/ENSBGRG00000011719, exon 1 of 10)",12,53445390,53466845,21456,1]
["chr12",54127623,54127683,61,"ENSBGRG00000013477","ENSBGRT00000024756",16551,"SLC52A3","solute carrier family 52 member 3 [Source:HGNC Symbol;Acc:HGNC:16187]","GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007605(sensory perception of sound);GO:0032217(riboflavin transmembrane transporter activity);GO:0032218(riboflavin transport);GO:0034605(cellular response to heat)","04977(Vitamin digestion and absorption)",{"v":0.021,"d":"0.02"},1,"61,",0,-1.67,-1.12,3.02,"3' UTR",12,54111072,54128340,17269,1]
["chr12",55903047,55904675,1629,"ENSBGRG00000017942","ENSBGRT00000033818",70122,"ASXL1","ASXL transcriptional regulator 1 [Source:HGNC Symbol;Acc:HGNC:18318]","GO:0000902(cell morphogenesis);GO:0003007(heart morphogenesis);GO:0003677(DNA binding);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0009887(animal organ morphogenesis);GO:0030097(hemopoiesis);GO:0032526(response to retinoic acid);GO:0035359(negative regulation of peroxisome proliferator activated receptor signaling pathway);GO:0035517(PR-DUB complex);GO:0035522(monoubiquitinated histone H2A deubiquitination);GO:0035564(regulation of kidney size);GO:0042974(retinoic acid receptor binding);GO:0042975(peroxisome proliferator activated receptor binding);GO:0045599(negative regulation of fat cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048386(positive regulation of retinoic acid receptor signaling pathway);GO:0048534(hematopoietic or lymphoid organ development);GO:0048538(thymus development);GO:0048539(bone marrow development);GO:0048872(homeostasis of number of cells);GO:0060348(bone development);GO:0060430(lung saccule development);GO:0072015(glomerular visceral epithelial cell development)","NA",{"v":9.99999999999998e-226,"d":"0.00"},2,"560,9,","0,1620",-225,-223,6.99,"Exon (ENSBGRT00000033818/ENSBGRG00000017942, exon 14 of 14)",12,55832925,55903606,70682,1]
["chr12",58731820,58732150,331,"ENSBGRG00000009552","ENSBGRT00000017551",539,"PROCR","protein C receptor [Source:HGNC Symbol;Acc:HGNC:9452]","GO:0005813(centrosome);GO:0038023(signaling receptor activity);GO:0050819(negative regulation of coagulation)","04610(Complement and coagulation cascades)",{"v":2.5e-14,"d":"0.00"},1,"331,",0,{"v":-13.6,"d":"-13.60"},{"v":-12.6,"d":"-12.60"},40,"5' UTR",12,58731281,58739980,8700,1]
["chr12",60062913,60063481,569,"ENSBGRG00000014233","ENSBGRT00000026471",98691,"DLGAP4","DLG associated protein 4 [Source:HGNC Symbol;Acc:HGNC:24476]","GO:0023052(signaling);GO:0045202(synapse)","04724(Glutamatergic synapse)",0,1,"569,",0,-550,"-Inf",3.89,"3' UTR",12,59964222,60064678,100457,1]
["chr12",62435003,62439022,4020,"ENSBGRG00000006528","ENSBGRT00000012041",117353,"PPP1R16B","protein phosphatase 1 regulatory subunit 16B [Source:HGNC Symbol;Acc:HGNC:15850]","GO:0001938(positive regulation of endothelial cell proliferation);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0016607(nuclear speck);GO:0019888(protein phosphatase regulator activity);GO:0035304(regulation of protein dephosphorylation);GO:0035307(positive regulation of protein dephosphorylation);GO:0035308(negative regulation of protein dephosphorylation);GO:0042995(cell projection);GO:0048471(perinuclear region of cytoplasm);GO:0061028(establishment of endothelial barrier);GO:1902309(negative regulation of peptidyl-serine dephosphorylation);GO:1903589(positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis)","NA",{"v":2e-11,"d":"0.00"},2,"55,124,","0,3896",{"v":-10.7,"d":"-10.70"},-9.87,2.46,"Exon (ENSBGRT00000012041/ENSBGRG00000006528, exon 11 of 12)",12,62317650,62439408,121759,1]
["chr12",70214663,70214812,150,"ENSBGRG00000019062","ENSBGRT00000034998",208,"ZSWIM1","zinc finger SWIM-type containing 1 [Source:HGNC Symbol;Acc:HGNC:16155]","GO:0005634(nucleus);GO:0008270(zinc ion binding)","NA",{"v":3.4E-5,"d":"0.00"},1,"150,",0,-4.47,-3.77,3.07,"Exon (ENSBGRT00000034998/ENSBGRG00000019062, exon 1 of 2)",12,70214455,70217028,2574,1]
["chr12",83436225,83436884,660,"ENSBGRG00000008288","ENSBGRT00000015175",370288,"MACROD2","mono-ADP ribosylhydrolase 2 [Source:HGNC Symbol;Acc:HGNC:16126]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006974(cellular response to DNA damage stimulus);GO:0007420(brain development);GO:0009617(response to bacterium);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0019213(deacetylase activity);GO:0042278(purine nucleoside metabolic process);GO:0051725(protein de-ADP-ribosylation);GO:0140291(peptidyl-glutamate ADP-deribosylation);GO:0140293(ADP-ribosylglutamate hydrolase activity)","03420(Nucleotide excision repair)",{"v":1.3e-88,"d":"0.00"},1,"660,",0,{"v":-87.9,"d":"-87.90"},{"v":-86.3,"d":"-86.30"},5.63,"Exon (ENSBGRT00000015570/ENSBGRG00000008572, exon 1 of 1)",12,81306626,83807172,2500547,2]
["chr12",87905543,87905932,390,"ENSBGRG00000009959","ENSBGRT00000018640",50307,"JAG1","jagged canonical Notch ligand 1 [Source:HGNC Symbol;Acc:HGNC:6188]","GO:0001953(negative regulation of cell-matrix adhesion);GO:0001974(blood vessel remodeling);GO:0002011(morphogenesis of an epithelial sheet);GO:0002456(T cell mediated immunity);GO:0003184(pulmonary valve morphogenesis);GO:0003215(cardiac right ventricle morphogenesis);GO:0005112(Notch binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0007154(cell communication);GO:0007219(Notch signaling pathway);GO:0007275(multicellular organism development);GO:0009887(animal organ morphogenesis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0022408(negative regulation of cell-cell adhesion);GO:0030336(negative regulation of cell migration);GO:0032495(response to muramyl dipeptide);GO:0035909(aorta morphogenesis);GO:0042127(regulation of cell population proliferation);GO:0042491(inner ear auditory receptor cell differentiation);GO:0043010(camera-type eye development);GO:0045177(apical part of cell);GO:0045596(negative regulation of cell differentiation);GO:0045599(negative regulation of fat cell differentiation);GO:0045602(negative regulation of endothelial cell differentiation);GO:0045639(positive regulation of myeloid cell differentiation);GO:0045665(negative regulation of neuron differentiation);GO:0045669(positive regulation of osteoblast differentiation);GO:0045747(positive regulation of Notch signaling pathway);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048839(inner ear development);GO:0060411(cardiac septum morphogenesis);GO:0061073(ciliary body morphogenesis);GO:0061156(pulmonary artery morphogenesis);GO:0061309(cardiac neural crest cell development involved in outflow tract morphogenesis);GO:0061314(Notch signaling involved in heart development);GO:0061444(endocardial cushion cell development);GO:0072006(nephron development);GO:0072015(glomerular visceral epithelial cell development);GO:0072017(distal tubule development);GO:0072070(loop of Henle development);GO:0097150(neuronal stem cell population maintenance);GO:2000737(negative regulation of stem cell differentiation)","04330(Notch signaling pathway);04371(Apelin signaling pathway);04668(TNF signaling pathway);04658(Th1 and Th2 cell differentiation);05200(Pathways in cancer);05224(Breast cancer);05165(Human papillomavirus infection);01522(Endocrine resistance)",{"v":8.99999999999999e-304,"d":"0.00"},1,"390,",0,-303,-301,4.35,"3' UTR",12,87855236,87906952,51717,1]
["chr12",6672317,6733130,60814,"ENSBGRG00000010811","ENSBGRT00000020291",0,"PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 [Source:HGNC Symbol;Acc:HGNC:8874]","GO:0003824(catalytic activity);GO:0003873(6-phosphofructo-2-kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006000(fructose metabolic process);GO:0006003(fructose 2,6-bisphosphate metabolic process)","00051(Fructose and mannose metabolism);04066(HIF-1 signaling pathway);04152(AMPK signaling pathway)",{"v":0.012,"d":"0.01"},4,"29,123,120,324,","0,42458,59169,60490",-1.92,-1.35,4.32,"5' UTR",12,6636025,6714897,78873,2]
["chr12",15540874,15540935,62,"ENSBGRG00000024752","ENSBGRT00000046851",139423,"ENSBGRG00000024752","NA","NA","NA",{"v":6.2e-10,"d":"0.00"},2,"37,23,","0,39",-9.21,-8.38,2.52,"Exon (ENSBGRT00000046851/ENSBGRG00000024752, exon 70 of 82)",12,15539748,15680358,140611,2]
["chr12",20180116,20180295,180,"ENSBGRG00000015271","ENSBGRT00000028021",2063,"ENSBGRG00000015271","NA","NA","NA",{"v":0.0071,"d":"0.01"},1,"180,",0,-2.15,-1.57,4.68,"Exon (ENSBGRT00000028021/ENSBGRG00000015271, exon 2 of 2)",12,20177193,20182358,5166,2]
["chr12",26290701,26290945,245,"ENSBGRG00000024801","ENSBGRT00000045766",31719,"ENSBGRG00000024801","NA","NA","NA",{"v":4e-25,"d":"0.00"},4,"120,48,24,47,","0,122,172,198",{"v":-24.4,"d":"-24.40"},{"v":-23.4,"d":"-23.40"},5.09,"Exon (ENSBGRT00000045766/ENSBGRG00000024801, exon 20 of 23)",12,26290701,26322664,31964,2]
["chr12",29283050,29284560,1511,"ENSBGRG00000004547","ENSBGRT00000009052",14452,"RRBP1","ribosome binding protein 1 [Source:HGNC Symbol;Acc:HGNC:10448]","GO:0005783(endoplasmic reticulum);GO:0015031(protein transport);GO:0030176(integral component of endoplasmic reticulum membrane)","04141(Protein processing in endoplasmic reticulum)",{"v":2.5e-16,"d":"0.00"},2,"19,72,","0,1439",{"v":-15.6,"d":"-15.60"},{"v":-14.7,"d":"-14.70"},1.38,"Exon (ENSBGRT00000009052/ENSBGRG00000004547, exon 8 of 26)",12,29270703,29299012,28310,2]
["chr12",34821901,34822260,360,"ENSBGRG00000009524","ENSBGRT00000018653",29413,"TASOR2","transcription activation suppressor family member 2 [Source:HGNC Symbol;Acc:HGNC:23484]","GO:0005654(nucleoplasm);GO:0005829(cytosol)","NA",{"v":1e-24,"d":"0.00"},1,"360,",0,-24,-23,{"v":2.7,"d":"2.70"},"Exon (ENSBGRT00000018653/ENSBGRG00000009524, exon 11 of 17)",12,34813600,34851673,38074,2]
["chr12",39605671,39609205,3535,"ENSBGRG00000006155","ENSBGRT00000011333",1473,"ENSBGRG00000006155","NA","NA","NA",{"v":4E-52,"d":"0.00"},2,"112,92,","0,3443",{"v":-51.4,"d":"-51.40"},{"v":-50.1,"d":"-50.10"},2.31,"Exon (ENSBGRT00000011333/ENSBGRG00000006155, exon 2 of 3)",12,39605642,39610678,5037,2]
["chr12",46957831,46957921,91,"ENSBGRG00000015689","ENSBGRT00000028818",1088,"ENSBGRG00000015689","NA","GO:0005515(protein binding)","04060(Cytokine-cytokine receptor interaction)",{"v":0.043,"d":"0.04"},1,"91,",0,-1.37,{"v":-0.6,"d":"-0.60"},{"v":5.4,"d":"5.40"},"5' UTR",12,46955411,46959009,3599,2]
["chr12",48495628,48498654,3027,"ENSBGRG00000024076","ENSBGRT00000044415",0,"ENSBGRG00000024076","NA","NA","NA",{"v":0.0041,"d":"0.00"},2,"1711,50,","0,2977",-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000044415/ENSBGRG00000024076, exon 1 of 2)",12,48495628,48498654,3027,2]
["chr12",53056494,53056584,91,"ENSBGRG00000010689","ENSBGRT00000019679",10464,"TFAP2C","transcription factor AP-2 gamma [Source:HGNC Symbol;Acc:HGNC:11744]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0006355(regulation of transcription, DNA-templated);GO:0008584(male gonad development);GO:0040029(regulation of gene expression, epigenetic);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.043,"d":"0.04"},1,"91,",0,-1.37,{"v":-0.6,"d":"-0.60"},6.48,"3' UTR",12,53056285,53067048,10764,2]
["chr12",55445205,55445504,300,"ENSBGRG00000016804","ENSBGRT00000030915",6607,"PDRG1","p53 and DNA damage regulated 1 [Source:HGNC Symbol;Acc:HGNC:16119]","GO:0006457(protein folding);GO:0016272(prefoldin complex);GO:0051082(unfolded protein binding)","NA",{"v":1e-129,"d":"0.00"},1,"300,",0,-129,-127,9.09,"3' UTR",12,55445205,55452111,6907,2]
["chr12",56178616,56178826,211,"ENSBGRG00000003782","ENSBGRT00000007253",32585,"ENSBGRG00000003782","NA","NA","04146(Peroxisome)",{"v":2.5e-21,"d":"0.00"},1,"211,",0,{"v":-20.6,"d":"-20.60"},{"v":-19.6,"d":"-19.60"},1.83,"3' UTR",12,56139016,56211411,72396,2]
["chr12",58341244,58341692,449,"ENSBGRG00000007972","ENSBGRT00000014615",47982,"NCOA6","nuclear receptor coactivator 6 [Source:HGNC Symbol;Acc:HGNC:15936]","GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006352(DNA-templated transcription, initiation);GO:0006974(cellular response to DNA damage stimulus);GO:0019899(enzyme binding);GO:0030099(myeloid cell differentiation);GO:0030374(nuclear receptor transcription coactivator activity);GO:0035097(histone methyltransferase complex);GO:0043231(intracellular membrane-bounded organelle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046966(thyroid hormone receptor binding)","NA",{"v":6.3e-26,"d":"0.00"},1,"449,",0,{"v":-25.2,"d":"-25.20"},{"v":-24.1,"d":"-24.10"},2.16,"Exon (ENSBGRT00000014615/ENSBGRG00000007972, exon 7 of 15)",12,58302634,58389674,87041,2]
["chr12",64992542,64992780,239,"ENSBGRG00000009220","ENSBGRT00000016995",5315,"EMILIN3","elastin microfibril interfacer 3 [Source:HGNC Symbol;Acc:HGNC:16123]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0042802(identical protein binding)","NA",{"v":4e-13,"d":"0.00"},1,"239,",0,{"v":-12.4,"d":"-12.40"},{"v":-11.5,"d":"-11.50"},{"v":16.6,"d":"16.60"},"Exon (ENSBGRT00000016995/ENSBGRG00000009220, exon 6 of 6)",12,64991618,64998095,6478,2]
["chr12",69230029,69230602,574,"ENSBGRG00000012485","ENSBGRT00000022801",329,"ENSBGRG00000012485","NA","NA","NA",{"v":1E-180,"d":"0.00"},2,"134,257,","0,317",-180,-178,3.07,"Exon (ENSBGRT00000022801/ENSBGRG00000012485, exon 1 of 2)",12,69228292,69230931,2640,2]
["chr12",73221033,73222866,1834,"ENSBGRG00000025224","ENSBGRT00000046766",45541,"STAU1","staufen double-stranded RNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:11370]","GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0030425(dendrite);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0044297(cell body);GO:0045070(positive regulation of viral genome replication);GO:0046726(positive regulation by virus of viral protein levels in host cell)","NA",{"v":5.4E-8,"d":"0.00"},3,"16,86,78,","0,909,1756",-7.27,-6.48,1.55,"Exon (ENSBGRT00000046766/ENSBGRG00000025224, exon 10 of 12)",12,73221033,73268407,47375,2]
["chr12",73617484,73617604,121,"ENSBGRG00000025509","ENSBGRT00000047158",240,"KCNB1","potassium voltage-gated channel subfamily B member 1 [Source:HGNC Symbol;Acc:HGNC:6231]","GO:0001508(action potential);GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005251(delayed rectifier potassium channel activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030425(dendrite);GO:0032809(neuronal cell body membrane);GO:0042593(glucose homeostasis);GO:0044325(ion channel binding);GO:0046676(negative regulation of insulin secretion);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport);GO:0071333(cellular response to glucose stimulus);GO:0071805(potassium ion transmembrane transport);GO:0090314(positive regulation of protein targeting to membrane);GO:0098900(regulation of action potential);GO:1900454(positive regulation of long-term synaptic depression)","NA",{"v":2.3E-3,"d":"0.00"},1,"121,",0,-2.64,-2.02,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000047158/ENSBGRG00000025509, exon 1 of 2)",12,73483316,73617844,134529,2]
["chr12",77064302,77065319,1018,"ENSBGRG00000005809","ENSBGRT00000010700",88,"ENSBGRG00000005809","NA","NA","NA",{"v":1E-108,"d":"0.00"},1,"1018,",0,-108,-106,4.35,"Exon (ENSBGRT00000010744/ENSBGRG00000005830, exon 2 of 2)",12,76998158,77065407,67250,2]
["chr12",83971150,83971908,759,"ENSBGRG00000009078","ENSBGRT00000017008",28096,"NDUFAF5","NADH:ubiquinone oxidoreductase complex assembly factor 5 [Source:HGNC Symbol;Acc:HGNC:15899]","GO:0005739(mitochondrion);GO:0008168(methyltransferase activity);GO:0030961(peptidyl-arginine hydroxylation);GO:0031314(extrinsic component of mitochondrial inner membrane);GO:0032981(mitochondrial respiratory chain complex I assembly)","04714(Thermogenesis)",{"v":6.3e-31,"d":"0.00"},3,"111,83,72,","0,274,687",{"v":-30.2,"d":"-30.20"},{"v":-29.1,"d":"-29.10"},3.28,"3' UTR",12,83971121,84000004,28884,2]
["chr12",88661150,88661298,149,"ENSBGRG00000010960","ENSBGRT00000020021",15869,"ANKEF1","ankyrin repeat and EF-hand domain containing 1 [Source:HGNC Symbol;Acc:HGNC:15803]","GO:0005515(protein binding)","NA",{"v":5.2e-10,"d":"0.00"},1,"149,",0,-9.28,-8.45,6.61,"Exon (ENSBGRT00000020021/ENSBGRG00000010960, exon 5 of 9)",12,88588082,88677167,89086,2]
["chr13",2047146,2047265,120,"ENSBGRG00000005661","ENSBGRT00000010480",537,"SMTNL1","smoothelin like 1 [Source:HGNC Symbol;Acc:HGNC:32394]","GO:0005515(protein binding);GO:0043292(contractile fiber)","NA",{"v":5.2e-08,"d":"0.00"},1,"120,",0,-7.28,-6.49,3.05,"Exon (ENSBGRT00000010480/ENSBGRG00000005661, exon 1 of 7)",13,2046609,2059087,12479,1]
["chr13",6152381,6153039,659,"ENSBGRG00000017662","ENSBGRT00000032330",0,"ENSBGRG00000017662","NA","NA","NA",{"v":4.3E-3,"d":"0.00"},1,"659,",0,-2.37,-1.77,7.56,"Exon (ENSBGRT00000032330/ENSBGRG00000017662, exon 1 of 1)",13,6152381,6153637,1257,1]
["chr13",16227457,16227517,61,"ENSBGRG00000019234","ENSBGRT00000035795",42213,"NAT10","N-acetyltransferase 10 [Source:HGNC Symbol;Acc:HGNC:29830]","GO:0005524(ATP binding);GO:0005697(telomerase holoenzyme complex);GO:0005730(nucleolus);GO:0008080(N-acetyltransferase activity);GO:0016072(rRNA metabolic process);GO:0030496(midbody);GO:0032211(negative regulation of telomere maintenance via telomerase);GO:0034470(ncRNA processing);GO:0045727(positive regulation of translation);GO:0070182(DNA polymerase binding);GO:0106162(mRNA N-acetyltransferase activity)","03008(Ribosome biogenesis in eukaryotes)",{"v":2.3E-3,"d":"0.00"},1,"61,",0,-2.64,-2.02,3,"Exon (ENSBGRT00000035795/ENSBGRG00000019234, exon 8 of 8)",13,16185244,16227564,42321,1]
["chr13",17788345,17788584,240,"ENSBGRG00000022999","ENSBGRT00000042434",1074,"FJX1","four-jointed box kinase 1 [Source:HGNC Symbol;Acc:HGNC:17166]","GO:0005615(extracellular space);GO:0010842(retina layer formation)","04391(Hippo signaling pathway -fly)",{"v":9.3e-09,"d":"0.00"},1,"240,",0,-8.03,-7.23,3.58,"Exon (ENSBGRT00000042434/ENSBGRG00000022999, exon 1 of 1)",13,17787271,17788584,1314,1]
["chr13",27997705,27998004,300,"ENSBGRG00000008834","ENSBGRT00000016242",103689,"PRDM11","PR/SET domain 11 [Source:HGNC Symbol;Acc:HGNC:13996]","GO:0005515(protein binding)","00310(Lysine degradation)",{"v":3e-06,"d":"0.00"},1,"300,",0,-5.53,-4.79,{"v":4.5,"d":"4.50"},"3' UTR",13,27894016,27999114,105099,1]
["chr13",30778152,30778212,61,"ENSBGRG00000021865","ENSBGRT00000040682",0,"PTPRJ","protein tyrosine phosphatase receptor type J [Source:HGNC Symbol;Acc:HGNC:9673]","GO:0001772(immunological synapse);GO:0004725(protein tyrosine phosphatase activity);GO:0005161(platelet-derived growth factor receptor binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006470(protein dephosphorylation);GO:0008013(beta-catenin binding);GO:0008285(negative regulation of cell population proliferation);GO:0009986(cell surface);GO:0010642(negative regulation of platelet-derived growth factor receptor signaling pathway);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0019901(protein kinase binding);GO:0030155(regulation of cell adhesion);GO:0030308(negative regulation of cell growth);GO:0030336(negative regulation of cell migration);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway);GO:0043116(negative regulation of vascular permeability);GO:0043407(negative regulation of MAP kinase activity);GO:0045295(gamma-catenin binding);GO:0045296(cadherin binding);GO:0045785(positive regulation of cell adhesion);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0050860(negative regulation of T cell receptor signaling pathway);GO:0050918(positive chemotaxis);GO:0051019(mitogen-activated protein kinase binding);GO:0051894(positive regulation of focal adhesion assembly);GO:0051897(positive regulation of protein kinase B signaling);GO:0051898(negative regulation of protein kinase B signaling);GO:0070097(delta-catenin binding)","04520(Adherens junction)",{"v":0.044,"d":"0.04"},1,"61,",0,-1.36,{"v":-0.841,"d":"-0.84"},2.97,"Exon (ENSBGRT00000040682/ENSBGRG00000021865, exon 1 of 26)",13,30778152,30975672,197521,1]
["chr13",34414249,34415658,1410,"ENSBGRG00000006242","ENSBGRT00000011819",71544,"ARAP1","ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 [Source:HGNC Symbol;Acc:HGNC:16925]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0008360(regulation of cell shape);GO:0043231(intracellular membrane-bounded organelle);GO:0043547(positive regulation of GTPase activity);GO:0051270(regulation of cellular component movement);GO:0051491(positive regulation of filopodium assembly);GO:0051497(negative regulation of stress fiber assembly)","04144(Endocytosis)",{"v":0.028,"d":"0.03"},1,"1410,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"3' UTR",13,34342705,34415658,72954,1]
["chr13",35078441,35082328,3888,"ENSBGRG00000009339","ENSBGRT00000017443",53529,"NUMA1","nuclear mitotic apparatus protein 1 [Source:HGNC Symbol;Acc:HGNC:8059]","GO:0000132(establishment of mitotic spindle orientation);GO:0000139(Golgi membrane);GO:0000922(spindle pole);GO:0001578(microtubule bundle formation);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005876(spindle microtubule);GO:0005938(cell cortex);GO:0008017(microtubule binding);GO:0008022(protein C-terminus binding);GO:0015631(tubulin binding);GO:0016363(nuclear matrix);GO:0019897(extrinsic component of plasma membrane);GO:0019904(protein domain specific binding);GO:0030513(positive regulation of BMP signaling pathway);GO:0030953(astral microtubule organization);GO:0031116(positive regulation of microtubule polymerization);GO:0031616(spindle pole centrosome);GO:0032388(positive regulation of intracellular transport);GO:0032991(protein-containing complex);GO:0035091(phosphatidylinositol binding);GO:0035371(microtubule plus-end);GO:0036449(microtubule minus-end);GO:0044877(protein-containing complex binding);GO:0045618(positive regulation of keratinocyte differentiation);GO:0051010(microtubule plus-end binding);GO:0051011(microtubule minus-end binding);GO:0051798(positive regulation of hair follicle development);GO:0051984(positive regulation of chromosome segregation);GO:0055028(cortical microtubule);GO:0055048(anastral spindle assembly);GO:0060236(regulation of mitotic spindle organization);GO:0061673(mitotic spindle astral microtubule);GO:0070840(dynein complex binding);GO:0072686(mitotic spindle);GO:0090235(regulation of metaphase plate congression);GO:0097427(microtubule bundle);GO:0097431(mitotic spindle pole);GO:0097575(lateral cell cortex);GO:0097718(disordered domain specific binding);GO:0099738(cell cortex region);GO:1902365(positive regulation of protein localization to spindle pole body);GO:1902846(positive regulation of mitotic spindle elongation);GO:1904778(positive regulation of protein localization to cell cortex);GO:1905720(cytoplasmic microtubule bundle);GO:1905820(positive regulation of chromosome separation);GO:1905832(positive regulation of spindle assembly);GO:1990023(mitotic spindle midzone)","NA",{"v":9.99999999999999e-237,"d":"0.00"},5,"299,42,69,117,103,","0,746,2199,3586,3785",-236,-234,2.35,"Exon (ENSBGRT00000017443/ENSBGRG00000009339, exon 17 of 28)",13,35024912,35090096,65185,1]
["chr13",39802416,39807391,4976,"ENSBGRG00000005292","ENSBGRT00000009802",8047,"NLRP14","NLR family pyrin domain containing 14 [Source:HGNC Symbol;Acc:HGNC:22939]","GO:0005515(protein binding);GO:0007283(spermatogenesis)","NA",{"v":0.0078,"d":"0.01"},4,"16,374,369,111,","0,4118,4494,4865",-2.11,-1.27,9.72,"Exon (ENSBGRT00000009802/ENSBGRG00000005292, exon 4 of 15)",13,39794369,39840637,46269,1]
["chr13",41215327,41216589,1263,"ENSBGRG00000006223","ENSBGRT00000011611",93458,"TUB","TUB bipartite transcription factor [Source:HGNC Symbol;Acc:HGNC:12406]","GO:0001664(G protein-coupled receptor binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005929(cilium);GO:0006910(phagocytosis, recognition);GO:0007605(sensory perception of sound);GO:0008277(regulation of G protein-coupled receptor signaling pathway);GO:0042073(intraciliary transport);GO:0044877(protein-containing complex binding);GO:0045494(photoreceptor cell maintenance);GO:0050766(positive regulation of phagocytosis);GO:0060041(retina development in camera-type eye);GO:0061512(protein localization to cilium);GO:0097500(receptor localization to non-motile cilium);GO:0120160(intraciliary transport particle A binding);GO:1903546(protein localization to photoreceptor outer segment)","NA",{"v":5e-05,"d":"0.00"},2,"28,33,","0,1230",{"v":-4.3,"d":"-4.30"},{"v":-3.6,"d":"-3.60"},2.92,"Exon (ENSBGRT00000011611/ENSBGRG00000006223, exon 5 of 12)",13,41121869,41222495,100627,1]
["chr13",48346930,48347260,331,"ENSBGRG00000007548","ENSBGRT00000014287",839,"PDE3B","phosphodiesterase 3B [Source:HGNC Symbol;Acc:HGNC:8779]","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0007162(negative regulation of cell adhesion);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0016020(membrane);GO:0016525(negative regulation of angiogenesis);GO:0032045(guanyl-nucleotide exchange factor complex);GO:0050995(negative regulation of lipid catabolic process)","00230(Purine metabolism);04371(Apelin signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04923(Regulation of lipolysis in adipocyte);04914(Progesterone-mediated oocyte maturation);04924(Renin secretion);05032(Morphine addiction)",{"v":0.014,"d":"0.01"},1,"331,",0,-1.86,{"v":-1.3,"d":"-1.30"},8.64,"Exon (ENSBGRT00000014287/ENSBGRG00000007548, exon 1 of 16)",13,48346091,48523998,177908,1]
["chr13",53265825,53265914,90,"ENSBGRG00000014719","ENSBGRT00000027258",4440,"HSPA8","heat shock protein family A (Hsp70) member 8 [Source:HGNC Symbol;Acc:HGNC:5241]","GO:0000974(Prp19 complex);GO:0001664(G protein-coupled receptor binding);GO:0001786(phosphatidylserine binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005770(late endosome);GO:0005829(cytosol);GO:0006457(protein folding);GO:0016887(ATPase activity);GO:0019899(enzyme binding);GO:0030674(protein-macromolecule adaptor activity);GO:0031072(heat shock protein binding);GO:0031625(ubiquitin protein ligase binding);GO:0031647(regulation of protein stability);GO:0042026(protein refolding);GO:0044788(modulation by host of viral process);GO:0044829(positive regulation by host of viral genome replication);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046034(ATP metabolic process);GO:0048026(positive regulation of mRNA splicing, via spliceosome);GO:0048471(perinuclear region of cytoplasm);GO:0051082(unfolded protein binding);GO:0051085(chaperone cofactor-dependent protein refolding);GO:0051087(chaperone binding);GO:0051726(regulation of cell cycle);GO:0055131(C3HC4-type RING finger domain binding);GO:0061077(chaperone-mediated protein folding);GO:0061738(late endosomal microautophagy);GO:0061740(protein targeting to lysosome involved in chaperone-mediated autophagy);GO:0070062(extracellular exosome);GO:0072318(clathrin coat disassembly);GO:0098684(photoreceptor ribbon synapse);GO:0098793(presynapse);GO:0098978(glutamatergic synapse);GO:0099175(regulation of postsynapse organization);GO:0101031(chaperone complex);GO:1902904(negative regulation of supramolecular fiber organization);GO:1990904(ribonucleoprotein complex)","03040(Spliceosome);04141(Protein processing in endoplasmic reticulum);04010(MAPK signaling pathway);04144(Endocytosis);04612(Antigen processing and presentation);04915(Estrogen signaling pathway);04213(Longevity regulating pathway - multiple species);05134(Legionellosis);05162(Measles);05164(Influenza A);05169(Epstein-Barr virus infection);05145(Toxoplasmosis)",{"v":1e-138,"d":"0.00"},1,"90,",0,-138,-136,2.44,"3' UTR",13,53261385,53265933,4549,1]
["chr13",57519359,57519509,151,"ENSBGRG00000014287","ENSBGRT00000026788",28166,"USP2","ubiquitin specific peptidase 2 [Source:HGNC Symbol;Acc:HGNC:12618]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005737(cytoplasm);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0030332(cyclin binding);GO:0031625(ubiquitin protein ligase binding);GO:0032922(circadian regulation of gene expression);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042802(identical protein binding);GO:0043153(entrainment of circadian clock by photoperiod);GO:0045475(locomotor rhythm);GO:0045931(positive regulation of mitotic cell cycle);GO:0048512(circadian behavior);GO:0050821(protein stabilization)","NA",{"v":1.1e-06,"d":"0.00"},1,"151,",0,-5.97,-5.21,3.01,"3' UTR",13,57491193,57519509,28317,1]
["chr13",60214294,60214474,181,"ENSBGRG00000025547","ENSBGRT00000047221",271050,"SIK3","SIK family kinase 3 [Source:HGNC Symbol;Acc:HGNC:29165]","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:1904263(positive regulation of TORC1 signaling);GO:1904515(positive regulation of TORC2 signaling)","NA",{"v":1.3e-05,"d":"0.00"},1,"181,",0,-4.89,-4.18,14,"Exon (ENSBGRT00000047221/ENSBGRG00000025547, exon 21 of 21)",13,59943244,60214474,271231,1]
["chr13",66235601,66235840,240,"ENSBGRG00000009743","ENSBGRT00000017874",1829,"FDXACB1","ferredoxin-fold anticodon binding domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25110]","NA","00510(N-Glycan biosynthesis)",{"v":0.019,"d":"0.02"},2,"27,63,","0,177",-1.72,-1.17,2.16,"Exon (ENSBGRT00000017874/ENSBGRG00000009743, exon 3 of 5)",13,66233772,66238332,4561,1]
["chr13",73054700,73054790,91,"ENSBGRG00000010445","ENSBGRT00000019127",0,"FUT4","fucosyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:4015]","GO:0005802(trans-Golgi network);GO:0006486(protein glycosylation);GO:0008417(fucosyltransferase activity);GO:0009311(oligosaccharide metabolic process);GO:0009986(cell surface);GO:0016020(membrane);GO:0017083(4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity);GO:0071944(cell periphery);GO:1903037(regulation of leukocyte cell-cell adhesion);GO:1903238(positive regulation of leukocyte tethering or rolling)","00515(Mannose type O-glycan biosyntheis);00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":0.028,"d":"0.03"},1,"91,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000019127/ENSBGRG00000010445, exon 1 of 1)",13,73054700,73055896,1197,1]
["chr13",74786304,74789565,3262,"ENSBGRG00000012542","ENSBGRT00000023936",27123,"CEP57","centrosomal protein 57 [Source:HGNC Symbol;Acc:HGNC:30794]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005874(microtubule);GO:0007286(spermatid development);GO:0008017(microtubule binding);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0017134(fibroblast growth factor binding);GO:0034453(microtubule anchoring);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043015(gamma-tubulin binding);GO:0051260(protein homooligomerization)","NA",{"v":3.2e-17,"d":"0.00"},4,"53,122,117,39,","0,411,2507,3223",{"v":-16.5,"d":"-16.50"},{"v":-15.5,"d":"-15.50"},2.26,"Exon (ENSBGRT00000023936/ENSBGRG00000012542, exon 3 of 11)",13,74759181,74801470,42290,1]
["chr13",88875202,88875471,270,"ENSBGRG00000021342","ENSBGRT00000040049",77181,"MRE11","MRE11 homolog, double strand break repair nuclease [Source:HGNC Symbol;Acc:HGNC:7230]","GO:0000014(single-stranded DNA endodeoxyribonuclease activity);GO:0000724(double-strand break repair via homologous recombination);GO:0000781(chromosome, telomeric region);GO:0000784(nuclear chromosome, telomeric region);GO:0003677(DNA binding);GO:0003678(DNA helicase activity);GO:0004519(endonuclease activity);GO:0004520(endodeoxyribonuclease activity);GO:0004930(G protein-coupled receptor activity);GO:0004983(neuropeptide Y receptor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005657(replication fork);GO:0005737(cytoplasm);GO:0006302(double-strand break repair);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0006974(cellular response to DNA damage stimulus);GO:0007062(sister chromatid cohesion);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008022(protein C-terminus binding);GO:0008408(3'-5' exonuclease activity);GO:0008409(5'-3' exonuclease activity);GO:0016021(integral component of membrane);GO:0016605(PML body);GO:0016787(hydrolase activity);GO:0030145(manganese ion binding);GO:0030870(Mre11 complex);GO:0031860(telomeric 3' overhang formation);GO:0031954(positive regulation of protein autophosphorylation);GO:0032206(positive regulation of telomere maintenance);GO:0032508(DNA duplex unwinding);GO:0033674(positive regulation of kinase activity);GO:0035861(site of double-strand break);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0110025(DNA strand resection involved in replication fork processing)","03440(Homologous recombination);03450(Non-homologous end-joining);04218(Cellular senescence);04080(Neuroactive ligand-receptor interaction)",{"v":6.3e-33,"d":"0.00"},1,"270,",0,{"v":-32.2,"d":"-32.20"},-31,{"v":8.1,"d":"8.10"},"3' UTR",13,88798021,88876098,78078,1]
["chr13",8874749,8874868,120,"ENSBGRG00000020409","ENSBGRT00000038546",111438,"LGR4","leucine rich repeat containing G protein-coupled receptor 4 [Source:HGNC Symbol;Acc:HGNC:13299]","GO:0001649(osteoblast differentiation);GO:0001942(hair follicle development);GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007283(spermatogenesis);GO:0007623(circadian rhythm);GO:0016021(integral component of membrane);GO:0016500(protein-hormone receptor activity);GO:0030282(bone mineralization);GO:0030539(male genitalia development);GO:0032922(circadian regulation of gene expression);GO:0034122(negative regulation of toll-like receptor signaling pathway);GO:0035239(tube morphogenesis);GO:0036335(intestinal stem cell homeostasis);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046849(bone remodeling);GO:0048565(digestive tract development);GO:0050673(epithelial cell proliferation);GO:0050710(negative regulation of cytokine secretion);GO:0061290(canonical Wnt signaling pathway involved in metanephric kidney development);GO:0072202(cell differentiation involved in metanephros development);GO:0072224(metanephric glomerulus development);GO:0072282(metanephric nephron tubule morphogenesis);GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0120163(negative regulation of cold-induced thermogenesis);GO:2001013(epithelial cell proliferation involved in renal tubule morphogenesis)","NA",{"v":6.3e-14,"d":"0.00"},1,"120,",0,{"v":-13.2,"d":"-13.20"},{"v":-12.3,"d":"-12.30"},3.68,"Exon (ENSBGRT00000038546/ENSBGRG00000020409, exon 18 of 19)",13,8872628,8986306,113679,2]
["chr13",22523767,22523974,208,"ENSBGRG00000023742","ENSBGRT00000043926",2248,"LRRC4C","leucine rich repeat containing 4C [Source:HGNC Symbol;Acc:HGNC:29317]","GO:0005515(protein binding);GO:0016020(membrane);GO:0050770(regulation of axonogenesis);GO:0050804(modulation of chemical synaptic transmission);GO:0050839(cell adhesion molecule binding);GO:0098632(cell-cell adhesion mediator activity);GO:0098978(glutamatergic synapse);GO:0099560(synaptic membrane adhesion)","04514(Cell adhesion molecules (CAMs));04360(Axon guidance)",{"v":1.3e-05,"d":"0.00"},1,"208,",0,-4.87,-4.15,8.64,"Exon (ENSBGRT00000043926/ENSBGRG00000023742, exon 2 of 2)",13,22523767,22526222,2456,2]
["chr13",29438511,29438691,181,"ENSBGRG00000012979","ENSBGRT00000023793",4003,"AMBRA1","autophagy and beclin 1 regulator 1 [Source:HGNC Symbol;Acc:HGNC:25990]","GO:0000045(autophagosome assembly);GO:0000422(autophagy of mitochondrion);GO:0000423(mitophagy);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005930(axoneme);GO:0006914(autophagy);GO:0008285(negative regulation of cell population proliferation);GO:0021915(neural tube development);GO:0031625(ubiquitin protein ligase binding);GO:0043524(negative regulation of neuron apoptotic process);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0045335(phagocytic vesicle);GO:0051020(GTPase binding);GO:0098780(response to mitochondrial depolarisation)","04140(Autophagy - animal);04137(Mitophagy - animal)",{"v":1.6E-12,"d":"0.00"},1,"181,",0,{"v":-11.8,"d":"-11.80"},{"v":-10.9,"d":"-10.90"},2.52,"Exon (ENSBGRT00000023793/ENSBGRG00000012979, exon 6 of 18)",13,29273494,29442694,169201,2]
["chr13",30569567,30569626,60,"ENSBGRG00000020099","ENSBGRT00000037234",8422,"FNBP4","formin binding protein 4 [Source:HGNC Symbol;Acc:HGNC:19752]","GO:0005515(protein binding);GO:0016607(nuclear speck)","NA",{"v":7.9e-32,"d":"0.00"},1,"60,",0,{"v":-31.1,"d":"-31.10"},-30,1.65,"Exon (ENSBGRT00000037234/ENSBGRG00000020099, exon 8 of 17)",13,30545849,30578048,32200,2]
["chr13",33891420,33891748,329,"ENSBGRG00000005652","ENSBGRT00000010411",656,"P2RY2","purinergic receptor P2Y2 [Source:HGNC Symbol;Acc:HGNC:8541]","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007200(phospholipase C-activating G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0045028(G protein-coupled purinergic nucleotide receptor activity);GO:0070257(positive regulation of mucus secretion);GO:0097746(regulation of blood vessel diameter)","04080(Neuroactive ligand-receptor interaction);04750(Inflammatory mediator regulation of TRP channels)",{"v":9.8e-08,"d":"0.00"},1,"329,",0,-7.01,-6.23,3.32,"Exon (ENSBGRT00000010411/ENSBGRG00000005652, exon 1 of 1)",13,33891271,33892404,1134,2]
["chr13",39102452,39102572,121,"ENSBGRG00000004714","ENSBGRT00000009014",26077,"ENSBGRG00000004714","NA","NA","04392(Hippo signaling pathway - multiple species)",{"v":5E-53,"d":"0.00"},1,"121,",0,{"v":-52.3,"d":"-52.30"},-51,2.33,"Exon (ENSBGRT00000009014/ENSBGRG00000004714, exon 26 of 26)",13,39102063,39128649,26587,2]
["chr13",39115975,39116154,180,"ENSBGRG00000004714","ENSBGRT00000009014",12495,"ENSBGRG00000004714","NA","NA","04392(Hippo signaling pathway - multiple species)",{"v":7.9e-52,"d":"0.00"},1,"180,",0,{"v":-51.1,"d":"-51.10"},{"v":-49.8,"d":"-49.80"},9.23,"Exon (ENSBGRT00000009014/ENSBGRG00000004714, exon 9 of 26)",13,39102063,39128649,26587,2]
["chr13",42299660,42300259,600,"ENSBGRG00000008891","ENSBGRT00000016479",0,"SCUBE2","signal peptide, CUB domain and EGF like domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30425]","GO:0005509(calcium ion binding)","NA",{"v":4.3E-3,"d":"0.00"},1,"600,",0,-2.37,-1.77,6.48,"5' UTR",13,42222360,42300259,77900,2]
["chr13",51337565,51337625,61,"ENSBGRG00000009254","ENSBGRT00000017009",71054,"PIK3C2A","phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha [Source:HGNC Symbol;Acc:HGNC:8971]","GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0010508(positive regulation of autophagy);GO:0016301(kinase activity);GO:0031982(vesicle);GO:0035004(phosphatidylinositol 3-kinase activity);GO:0035091(phosphatidylinositol binding);GO:0046854(phosphatidylinositol phosphorylation);GO:0048015(phosphatidylinositol-mediated signaling);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":2e-21,"d":"0.00"},1,"61,",0,{"v":-20.7,"d":"-20.70"},{"v":-19.7,"d":"-19.70"},2.53,"Exon (ENSBGRT00000017009/ENSBGRG00000009254, exon 33 of 34)",13,51336420,51408679,72260,2]
["chr13",58238060,58238210,151,"ENSBGRG00000020717","ENSBGRT00000038144",120,"ENSBGRG00000020717","NA","NA","04141(Protein processing in endoplasmic reticulum)",{"v":4e-13,"d":"0.00"},1,"151,",0,{"v":-12.4,"d":"-12.40"},{"v":-11.5,"d":"-11.50"},1.63,"Exon (ENSBGRT00000038144/ENSBGRG00000020717, exon 1 of 12)",13,58211684,58238330,26647,2]
["chr13",59619231,59634935,15705,"ENSBGRG00000024804","ENSBGRT00000046340",42158,"CEP164","centrosomal protein 164 [Source:HGNC Symbol;Acc:HGNC:29182]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0043231(intracellular membrane-bounded organelle);GO:0060271(cilium assembly);GO:0097539(ciliary transition fiber)","NA",{"v":3.2e-70,"d":"0.00"},10,"54,84,144,123,132,78,217,216,210,61,","0,165,701,1973,2398,2758,4134,4469,8995,15644",{"v":-69.5,"d":"-69.50"},{"v":-68.1,"d":"-68.10"},2.95,"Exon (ENSBGRT00000046340/ENSBGRG00000024804, exon 12 of 30)",13,59610774,59677093,66320,2]
["chr13",63563153,63563422,270,"ENSBGRG00000005665","ENSBGRT00000010472",191,"ZBTB16","zinc finger and BTB domain containing 16 [Source:HGNC Symbol;Acc:HGNC:12930]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0001823(mesonephros development);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007417(central nervous system development);GO:0008168(methyltransferase activity);GO:0008285(negative regulation of cell population proliferation);GO:0009880(embryonic pattern specification);GO:0009952(anterior/posterior pattern specification);GO:0016604(nuclear body);GO:0016605(PML body);GO:0016607(nuclear speck);GO:0017053(transcriptional repressor complex);GO:0030097(hemopoiesis);GO:0032332(positive regulation of chondrocyte differentiation);GO:0032991(protein-containing complex);GO:0035116(embryonic hindlimb morphogenesis);GO:0035136(forelimb morphogenesis);GO:0035137(hindlimb morphogenesis);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0045600(positive regulation of fat cell differentiation);GO:0045638(negative regulation of myeloid cell differentiation);GO:0045778(positive regulation of ossification);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0048133(male germ-line stem cell asymmetric division);GO:0051138(positive regulation of NK T cell differentiation);GO:0051216(cartilage development);GO:0061036(positive regulation of cartilage development)","00760(Nicotinate and nicotinamide metabolism);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05221(Acute myeloid leukemia)",{"v":1.6e-85,"d":"0.00"},1,"270,",0,{"v":-84.8,"d":"-84.80"},{"v":-83.2,"d":"-83.20"},8.15,"Exon (ENSBGRT00000010472/ENSBGRG00000005665, exon 1 of 6)",13,63306238,63563613,257376,2]
["chr13",66435599,66435659,61,"ENSBGRG00000011002","ENSBGRT00000020116",130202,"SIK2","salt inducible kinase 2 [Source:HGNC Symbol;Acc:HGNC:21680]","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0035556(intracellular signal transduction);GO:0046777(protein autophosphorylation)","04922(Glucagon signaling pathway)",{"v":5e-11,"d":"0.00"},1,"61,",0,{"v":-10.3,"d":"-10.30"},-9.45,3.12,"Exon (ENSBGRT00000020116/ENSBGRG00000011002, exon 15 of 15)",13,66434760,66565861,131102,2]
["chr13",70131846,70393472,261627,"ENSBGRG00000013616","ENSBGRT00000024979",76388,"DDX10","DEAD-box helicase 10 [Source:HGNC Symbol;Acc:HGNC:2735]","GO:0003676(nucleic acid binding);GO:0005524(ATP binding);GO:0097065(anterior head development)","NA",{"v":1.3e-40,"d":"0.00"},8,"58,30,156,57,162,120,120,347,","0,31545,31576,137042,151834,159343,261158,261280",{"v":-39.9,"d":"-39.90"},{"v":-38.7,"d":"-38.70"},4.24,"Exon (ENSBGRT00000024979/ENSBGRG00000013616, exon 13 of 19)",13,70131726,70469860,338135,2]
["chr13",82411279,82413848,2570,"ENSBGRG00000015265","ENSBGRT00000028158",171775,"TRPC6","transient receptor potential cation channel subfamily C member 6 [Source:HGNC Symbol;Acc:HGNC:12338]","GO:0005216(ion channel activity);GO:0005261(cation channel activity);GO:0005262(calcium channel activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0015279(store-operated calcium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032414(positive regulation of ion transmembrane transporter activity);GO:0036057(slit diaphragm);GO:0042803(protein homodimerization activity);GO:0051928(positive regulation of calcium ion transport);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport);GO:0070679(inositol 1,4,5 trisphosphate binding)","04022(cGMP - PKG signaling pathway);04360(Axon guidance)",{"v":5E-42,"d":"0.00"},3,"122,76,11,","0,1007,2559",{"v":-41.3,"d":"-41.30"},{"v":-40.1,"d":"-40.10"},3.24,"Exon (ENSBGRT00000028158/ENSBGRG00000015265, exon 11 of 13)",13,82411249,82585623,174375,2]
["chr13",88735129,88735247,119,"ENSBGRG00000021288","ENSBGRT00000039246",1097,"ANKRD49","ankyrin repeat domain 49 [Source:HGNC Symbol;Acc:HGNC:25970]","GO:0005515(protein binding);GO:0045893(positive regulation of transcription, DNA-templated)","NA",{"v":6.3e-12,"d":"0.00"},1,"119,",0,{"v":-11.2,"d":"-11.20"},{"v":-10.4,"d":"-10.40"},2.42,"Exon (ENSBGRT00000039246/ENSBGRG00000021288, exon 2 of 3)",13,88732956,88736344,3389,2]
["chr14",21177695,21178437,743,"ENSBGRG00000008040","ENSBGRT00000014972",6938,"ENSBGRG00000008040","NA","NA","NA",{"v":0.00013,"d":"0.00"},2,"32,29,","0,714",{"v":-3.9,"d":"-3.90"},-3.22,1.39,"Exon (ENSBGRT00000014972/ENSBGRG00000008040, exon 8 of 23)",14,21170757,21194787,24031,1]
["chr14",26097775,26097924,150,"ENSBGRG00000006527","ENSBGRT00000012144",73420,"ENSBGRG00000006527","NA","GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding)","NA",{"v":0.015,"d":"0.02"},1,"150,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000012144/ENSBGRG00000006527, exon 20 of 20)",14,26024355,26097924,73570,1]
["chr14",29887851,29888329,479,"ENSBGRG00000010480","ENSBGRT00000019311",66109,"CEP170","centrosomal protein 170 [Source:HGNC Symbol;Acc:HGNC:28920]","GO:0005515(protein binding);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0072686(mitotic spindle);GO:0120103(centriolar subdistal appendage)","NA",{"v":3.2E-49,"d":"0.00"},1,"479,",0,{"v":-48.5,"d":"-48.50"},{"v":-47.3,"d":"-47.30"},4.47,"Exon (ENSBGRT00000019311/ENSBGRG00000010480, exon 12 of 19)",14,29821742,29921777,100036,1]
["chr14",35532898,35535397,2500,"ENSBGRG00000006273","ENSBGRT00000011603",52679,"PRRC2C","proline rich coiled-coil 2C [Source:HGNC Symbol;Acc:HGNC:24903]","GO:0002244(hematopoietic progenitor cell differentiation);GO:0005829(cytosol);GO:0008022(protein C-terminus binding);GO:0034063(stress granule assembly)","NA",{"v":2.3e-10,"d":"0.00"},2,"67,24,","0,2476",-9.64,-8.81,1.98,"Exon (ENSBGRT00000011603/ENSBGRG00000006273, exon 18 of 36)",14,35480219,35574092,93874,1]
["chr14",36673612,36674061,450,"ENSBGRG00000006780","ENSBGRT00000012556",97041,"SUCO","SUN domain containing ossification factor [Source:HGNC Symbol;Acc:HGNC:1240]","GO:0005791(rough endoplasmic reticulum);GO:0016020(membrane);GO:0032967(positive regulation of collagen biosynthetic process);GO:0045669(positive regulation of osteoblast differentiation);GO:0046850(regulation of bone remodeling)","04144(Endocytosis)",{"v":9.99999999999998e-276,"d":"0.00"},1,"450,",0,-275,-273,3.72,"3' UTR",14,36576571,36674061,97491,1]
["chr14",38856389,38856478,90,"ENSBGRG00000009742","ENSBGRT00000017897",9974,"FBXO2","F-box protein 2 [Source:HGNC Symbol;Acc:HGNC:13581]","GO:0001540(amyloid-beta binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006516(glycoprotein catabolic process);GO:0016567(protein ubiquitination);GO:0019005(SCF ubiquitin ligase complex);GO:0030246(carbohydrate binding);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0031396(regulation of protein ubiquitination);GO:0043197(dendritic spine)","04141(Protein processing in endoplasmic reticulum);04120(Ubiquitin mediated proteolysis)",{"v":0.0044,"d":"0.00"},1,"90,",0,-2.36,-1.76,{"v":2.7,"d":"2.70"},"3' UTR",14,38846415,38856478,10064,1]
["chr14",42660698,42661710,1013,"ENSBGRG00000013160","ENSBGRT00000024086",1891,"ERRFI1","ERBB receptor feedback inhibitor 1 [Source:HGNC Symbol;Acc:HGNC:18185]","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007175(negative regulation of epidermal growth factor-activated receptor activity);GO:0019901(protein kinase binding);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031953(negative regulation of protein autophosphorylation);GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway);GO:0043589(skin morphogenesis);GO:0045616(regulation of keratinocyte differentiation);GO:0048286(lung alveolus development);GO:0060426(lung vasculature development);GO:0060428(lung epithelium development)","NA",0,1,"1013,",0,-708,"-Inf",3.56,"3' UTR",14,42658807,42662156,3350,1]
["chr14",44790081,44790350,270,"ENSBGRG00000018244","ENSBGRT00000034052",73512,"CHD5","chromodomain helicase DNA binding protein 5 [Source:HGNC Symbol;Acc:HGNC:16816]","GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0060850(regulation of transcription involved in cell fate commitment);GO:0061628(H3K27me3 modified histone binding);GO:0098532(histone H3-K27 trimethylation)","NA",{"v":3.2e-11,"d":"0.00"},1,"270,",0,{"v":-10.5,"d":"-10.50"},-9.66,9.72,"3' UTR",14,44716569,44790350,73782,1]
["chr14",49244598,49244806,209,"ENSBGRG00000011847","ENSBGRT00000021640",7327,"CCNL2","cyclin L2 [Source:HGNC Symbol;Acc:HGNC:20570]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0042025(host cell nucleus);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":9.99999999999998e-267,"d":"0.00"},1,"209,",0,-266,-264,3.61,"3' UTR",14,49237271,49245222,7952,1]
["chr14",52630694,52631052,359,"ENSBGRG00000021255","ENSBGRT00000039235",38712,"LRRC38","leucine rich repeat containing 38 [Source:HGNC Symbol;Acc:HGNC:27005]","GO:0005515(protein binding);GO:0008076(voltage-gated potassium channel complex);GO:0044325(ion channel binding);GO:0071805(potassium ion transmembrane transport);GO:0099104(potassium channel activator activity);GO:1903818(positive regulation of voltage-gated potassium channel activity)","NA",{"v":0.015,"d":"0.02"},1,"359,",0,-1.83,-1.02,8.64,"3' UTR",14,52591982,52631321,39340,1]
["chr14",54907245,54916476,9232,"ENSBGRG00000004274","ENSBGRT00000008257",258797,"RABGAP1L","RAB GTPase activating protein 1 like [Source:HGNC Symbol;Acc:HGNC:24663]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0005929(cilium);GO:0017137(Rab GTPase binding);GO:0032880(regulation of protein localization);GO:0090630(activation of GTPase activity)","NA",{"v":0.013,"d":"0.01"},2,"7,54,","0,9178",-1.87,-1.31,1.61,"Exon (ENSBGRT00000008257/ENSBGRG00000004274, exon 6 of 11)",14,54648448,54930043,281596,1]
["chr14",59650329,59650685,357,"ENSBGRG00000008050","ENSBGRT00000014813",33451,"FAM20B","FAM20B glycosaminoglycan xylosylkinase [Source:HGNC Symbol;Acc:HGNC:23017]","GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0016773(phosphotransferase activity, alcohol group as acceptor)","NA",{"v":1e-121,"d":"0.00"},1,"357,",0,-121,-120,8.85,"3' UTR",14,59616878,59650922,34045,1]
["chr14",63221983,63222461,479,"ENSBGRG00000014841","ENSBGRT00000027693",63289,"RGSL1","regulator of G protein signaling like 1 [Source:HGNC Symbol;Acc:HGNC:18636]","NA","NA",{"v":4e-21,"d":"0.00"},1,"479,",0,{"v":-20.4,"d":"-20.40"},{"v":-19.4,"d":"-19.40"},7.78,"3' UTR",14,63158694,63222461,63768,1]
["chr14",64737630,64738257,628,"ENSBGRG00000013827","ENSBGRT00000025376",197076,"RGL1","ral guanine nucleotide dissociation stimulator like 1 [Source:HGNC Symbol;Acc:HGNC:30281]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0008321(Ral guanyl-nucleotide exchange factor activity)","04014(Ras signaling pathway)",{"v":1e-101,"d":"0.00"},1,"628,",0,-101,{"v":-99.7,"d":"-99.70"},4.71,"3' UTR",14,64540554,64738944,198391,1]
["chr14",69476193,69481496,5304,"ENSBGRG00000019676","ENSBGRT00000036164",199543,"PTPN14","protein tyrosine phosphatase non-receptor type 14 [Source:HGNC Symbol;Acc:HGNC:9647]","GO:0001946(lymphangiogenesis);GO:0003712(transcription coregulator activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0006470(protein dephosphorylation);GO:0008285(negative regulation of cell population proliferation);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0030971(receptor tyrosine kinase binding);GO:0046825(regulation of protein export from nucleus)","NA",{"v":1.2E-10,"d":"0.00"},2,"51,129,","0,5175",-9.92,-9.08,1.98,"Exon (ENSBGRT00000036164/ENSBGRG00000019676, exon 18 of 19)",14,69276650,69481496,204847,1]
["chr14",74556527,74557695,1169,"ENSBGRG00000023890","ENSBGRT00000044132",94383,"LAMB3","laminin subunit beta 3 [Source:HGNC Symbol;Acc:HGNC:6490]","GO:0005604(basement membrane);GO:0005610(laminin-5 complex);GO:0035987(endodermal cell differentiation);GO:0050873(brown fat cell differentiation)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);05200(Pathways in cancer);05222(Small cell lung cancer);05165(Human papillomavirus infection);05146(Amoebiasis);05145(Toxoplasmosis)",{"v":0.0041,"d":"0.00"},2,"313,137,","0,1032",-2.39,-1.79,5.04,"3' UTR",14,74462144,74557695,95552,1]
["chr14",82281471,82309800,28330,"ENSBGRG00000025951","ENSBGRT00000047999",208,"LMOD1","leiomodin 1 [Source:HGNC Symbol;Acc:HGNC:6647]","GO:0003779(actin binding);GO:0005523(tropomyosin binding);GO:0005829(cytosol);GO:0006936(muscle contraction);GO:0030016(myofibril);GO:0030838(positive regulation of actin filament polymerization);GO:0045010(actin nucleation);GO:0051694(pointed-end actin filament capping)","NA",0,2,"53,1108,","0,27222",-499,"-Inf",3.01,"Exon (ENSBGRT00000047999/ENSBGRG00000025951, exon 1 of 3)",14,82281263,82311671,30409,1]
["chr14",83801827,83804609,2783,"ENSBGRG00000008055","ENSBGRT00000014699",0,"LAX1","lymphocyte transmembrane adaptor 1 [Source:HGNC Symbol;Acc:HGNC:26005]","GO:0000188(inactivation of MAPK activity);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0016021(integral component of membrane);GO:0019901(protein kinase binding);GO:0035556(intracellular signal transduction);GO:0042113(B cell activation);GO:0042169(SH2 domain binding);GO:0050868(negative regulation of T cell activation);GO:0051249(regulation of lymphocyte activation)","NA",{"v":0.028,"d":"0.03"},2,"199,69,","0,2714",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",14,83801827,83809708,7882,1]
["chr14",84763286,84763555,270,"ENSBGRG00000010201","ENSBGRT00000018682",33530,"ENSBGRG00000010201","NA","NA","NA",{"v":1.6e-20,"d":"0.00"},1,"270,",0,{"v":-19.8,"d":"-19.80"},{"v":-18.8,"d":"-18.80"},{"v":19.4,"d":"19.40"},"Exon (ENSBGRT00000018682/ENSBGRG00000010201, exon 2 of 2)",14,84729756,84763555,33800,1]
["chr14",86981049,87057688,76640,"ENSBGRG00000015132","ENSBGRT00000028412",0,"RASSF5","Ras association domain family member 5 [Source:HGNC Symbol;Acc:HGNC:17609]","GO:0005634(nucleus);GO:0007165(signal transduction);GO:0008285(negative regulation of cell population proliferation);GO:0017016(Ras GTPase binding);GO:0031398(positive regulation of protein ubiquitination);GO:0035556(intracellular signal transduction);GO:0042981(regulation of apoptotic process);GO:1900180(regulation of protein localization to nucleus)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04218(Cellular senescence);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05223(Non-small cell lung cancer)",{"v":0.0078,"d":"0.01"},5,"472,157,122,120,52,","0,13906,31172,46518,76588",-2.11,-1.27,9.72,"Exon (ENSBGRT00000028412/ENSBGRG00000015132, exon 1 of 5)",14,86981049,87062560,81512,1]
["chr14",6370603,6370781,179,"ENSBGRG00000004500","ENSBGRT00000008299",26424,"RGS1","regulator of G protein signaling 1 [Source:HGNC Symbol;Acc:HGNC:9991]","GO:0001965(G-protein alpha-subunit binding);GO:0005096(GTPase activator activity);GO:0005829(cytosol);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008277(regulation of G protein-coupled receptor signaling pathway);GO:0009617(response to bacterium);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0043547(positive regulation of GTPase activity);GO:0061737(leukotriene signaling pathway)","NA",{"v":3.2e-73,"d":"0.00"},1,"179,",0,{"v":-72.5,"d":"-72.50"},{"v":-71.1,"d":"-71.10"},5.77,"3' UTR",14,6370217,6397205,26989,2]
["chr14",21693276,21693514,239,"ENSBGRG00000008930","ENSBGRT00000016343",178,"TLR5","toll like receptor 5 [Source:HGNC Symbol;Acc:HGNC:11851]","GO:0001819(positive regulation of cytokine production);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0007165(signal transduction);GO:0016021(integral component of membrane);GO:0034146(toll-like receptor 5 signaling pathway);GO:0042742(defense response to bacterium);GO:0045087(innate immune response);GO:0050707(regulation of cytokine secretion)","04620(Toll-like receptor signaling pathway);05321(Inflammatiory bowel disease (IBD));05132(Salmonella infection);05134(Legionellosis)",{"v":1.5e-08,"d":"0.00"},1,"239,",0,-7.83,-7.03,4.71,"Exon (ENSBGRT00000016343/ENSBGRG00000008930, exon 1 of 1)",14,21691077,21693692,2616,2]
["chr14",24544328,24544388,61,"ENSBGRG00000004916","ENSBGRT00000009037",30425,"ACBD3","acyl-CoA binding domain containing 3 [Source:HGNC Symbol;Acc:HGNC:15453]","GO:0000062(fatty-acyl-CoA binding);GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0034237(protein kinase A regulatory subunit binding)","NA",{"v":3.2e-11,"d":"0.00"},1,"61,",0,{"v":-10.5,"d":"-10.50"},-9.68,{"v":1.4,"d":"1.40"},"Exon (ENSBGRT00000009037/ENSBGRG00000004916, exon 5 of 8)",14,24533184,24574813,41630,2]
["chr14",27281523,27281613,91,"ENSBGRG00000007186","ENSBGRT00000013687",101976,"KIF26B","kinesin family member 26B [Source:HGNC Symbol;Acc:HGNC:25484]","GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0022409(positive regulation of cell-cell adhesion);GO:0030010(establishment of cell polarity);GO:0072092(ureteric bud invasion)","NA",{"v":7.6e-05,"d":"0.00"},1,"91,",0,-4.12,-3.43,{"v":17.3,"d":"17.30"},"3' UTR",14,27281344,27383589,102246,2]
["chr14",33720952,33721158,207,"ENSBGRG00000004907","ENSBGRT00000009020",590,"METTL18","methyltransferase like 18 [Source:HGNC Symbol;Acc:HGNC:28793]","GO:0031072(heat shock protein binding);GO:0032991(protein-containing complex)","NA",{"v":1e-76,"d":"0.00"},1,"207,",0,-76,{"v":-74.5,"d":"-74.50"},6.31,"Exon (ENSBGRT00000009020/ENSBGRG00000004907, exon 1 of 1)",14,33720627,33721748,1122,2]
["chr14",38316968,38317117,150,"ENSBGRG00000008246","ENSBGRT00000015072",84009,"TNFRSF8","TNF receptor superfamily member 8 [Source:HGNC Symbol;Acc:HGNC:11923]","GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0042535(positive regulation of tumor necrosis factor biosynthetic process);GO:0043065(positive regulation of apoptotic process);GO:0045556(positive regulation of TRAIL biosynthetic process);GO:0071260(cellular response to mechanical stimulus)","04060(Cytokine-cytokine receptor interaction)",{"v":0.0078,"d":"0.01"},1,"150,",0,-2.11,-1.53,5.94,"Exon (ENSBGRT00000015072/ENSBGRG00000008246, exon 15 of 15)",14,38316968,38401126,84159,2]
["chr14",40869889,40869949,61,"ENSBGRG00000014227","ENSBGRT00000026877",15542,"PIK3CD","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [Source:HGNC Symbol;Acc:HGNC:8977]","GO:0010628(positive regulation of gene expression);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0030335(positive regulation of cell migration);GO:0033031(positive regulation of neutrophil apoptotic process);GO:0035004(phosphatidylinositol 3-kinase activity);GO:0046854(phosphatidylinositol phosphorylation);GO:0048015(phosphatidylinositol-mediated signaling)","00562(Inositol phosphate metabolism);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04630(Jak-STAT signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04218(Cellular senescence);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04670(Leukocyte transendothelial migration);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04919(Thyroid hormone signaling pathway);04973(Carbohydrate digestion and absorption);04960(Aldosterone-regulated sodium reabsorption);04725(Cholinergic synapse);04722(Neurotrophin signaling pathway);04750(Inflammatory mediator regulation of TRP channels);04360(Axon guidance);04380(Osteoclast differentiation);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05205(Proteoglycans in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05100(Bacterial invasion of epithelial cells);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05146(Amoebiasis);05142(Chagas disease (American trypanosomiasis));01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":2.2e-08,"d":"0.00"},1,"61,",0,-7.66,-6.86,{"v":11.9,"d":"11.90"},"3' UTR",14,40869889,40885491,15603,2]
["chr14",44318965,44319202,238,"ENSBGRG00000014835","ENSBGRT00000027293",9047,"ZBTB48","zinc finger and BTB domain containing 48 [Source:HGNC Symbol;Acc:HGNC:4930]","GO:0000781(chromosome, telomeric region);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0003691(double-stranded telomeric DNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0010833(telomere maintenance via telomere lengthening);GO:0042802(identical protein binding);GO:0045893(positive regulation of transcription, DNA-templated)","NA",{"v":2.5e-75,"d":"0.00"},1,"238,",0,{"v":-74.6,"d":"-74.60"},{"v":-73.1,"d":"-73.10"},5.21,"3' UTR",14,44318935,44328249,9315,2]
["chr14",47515916,47519074,3159,"ENSBGRG00000022048","ENSBGRT00000040965",391220,"PRDM16","PR/SET domain 16 [Source:HGNC Symbol;Acc:HGNC:14000]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003676(nucleic acid binding);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016235(aggresome);GO:0017053(transcriptional repressor complex);GO:0019827(stem cell population maintenance);GO:0022008(neurogenesis);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0033613(activating transcription factor binding);GO:0035019(somatic stem cell population maintenance);GO:0043457(regulation of cellular respiration);GO:0043565(sequence-specific DNA binding);GO:0043586(tongue development);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046332(SMAD binding);GO:0046974(histone methyltransferase activity (H3-K9 specific));GO:0050872(white fat cell differentiation);GO:0050873(brown fat cell differentiation);GO:0060021(roof of mouth development);GO:0070828(heterochromatin organization);GO:0090336(positive regulation of brown fat cell differentiation);GO:0120162(positive regulation of cold-induced thermogenesis)","NA",{"v":0.034,"d":"0.03"},3,"135,307,36,","0,976,3123",-1.47,{"v":-0.941,"d":"-0.94"},3.78,"3' UTR",14,47515916,47910294,394379,2]
["chr14",49819502,49819771,270,"ENSBGRG00000017603","ENSBGRT00000033855",92127,"SPEN","spen family transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:17575]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001085(RNA polymerase II transcription factor binding);GO:0003676(nucleic acid binding);GO:0003714(transcription corepressor activity);GO:0005654(nucleoplasm);GO:0017053(transcriptional repressor complex);GO:0045892(negative regulation of transcription, DNA-templated);GO:0050769(positive regulation of neurogenesis)","NA",{"v":1.6E-34,"d":"0.00"},1,"270,",0,{"v":-33.8,"d":"-33.80"},{"v":-32.7,"d":"-32.70"},3,"Exon (ENSBGRT00000033855/ENSBGRG00000017603, exon 13 of 17)",14,49814808,49911898,97091,2]
["chr14",49827453,49828173,721,"ENSBGRG00000017603","ENSBGRT00000033855",83725,"SPEN","spen family transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:17575]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001085(RNA polymerase II transcription factor binding);GO:0003676(nucleic acid binding);GO:0003714(transcription corepressor activity);GO:0005654(nucleoplasm);GO:0017053(transcriptional repressor complex);GO:0045892(negative regulation of transcription, DNA-templated);GO:0050769(positive regulation of neurogenesis)","NA",{"v":1.6e-93,"d":"0.00"},1,"721,",0,{"v":-92.8,"d":"-92.80"},{"v":-91.3,"d":"-91.30"},6.67,"Exon (ENSBGRT00000033855/ENSBGRG00000017603, exon 11 of 17)",14,49814808,49911898,97091,2]
["chr14",50361306,50380445,19140,"ENSBGRG00000020058","ENSBGRT00000037578",123476,"FHAD1","forkhead associated phosphopeptide binding domain 1 [Source:HGNC Symbol;Acc:HGNC:29408]","GO:0005515(protein binding)","NA",{"v":9.8e-06,"d":"0.00"},4,"100,108,108,44,","0,7083,13699,19096",-5.01,-4.29,{"v":20.5,"d":"20.50"},"Exon (ENSBGRT00000037578/ENSBGRG00000020058, exon 16 of 30)",14,50325260,50503921,178662,2]
["chr14",59704818,59705088,271,"ENSBGRG00000008350","ENSBGRT00000015752",32621,"ABL2","ABL proto-oncogene 2, non-receptor tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:77]","GO:0000287(magnesium ion binding);GO:0001784(phosphotyrosine residue binding);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0010863(positive regulation of phospholipase C activity);GO:0010976(positive regulation of neuron projection development);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030145(manganese ion binding);GO:0051353(positive regulation of oxidoreductase activity);GO:0071300(cellular response to retinoic acid)","04014(Ras signaling pathway);04012(ErbB signaling pathway);05416(Viral myocarditis)",{"v":5E-15,"d":"0.00"},1,"271,",0,{"v":-14.3,"d":"-14.30"},{"v":-13.4,"d":"-13.40"},5.83,"Exon (ENSBGRT00000015752/ENSBGRG00000008350, exon 12 of 12)",14,59703709,59737709,34001,2]
["chr14",65713601,65714079,479,"ENSBGRG00000015406","ENSBGRT00000028365",199442,"NIBAN1","niban apoptosis regulator 1 [Source:HGNC Symbol;Acc:HGNC:16784]","GO:0001933(negative regulation of protein phosphorylation);GO:0001934(positive regulation of protein phosphorylation);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0034976(response to endoplasmic reticulum stress);GO:0045727(positive regulation of translation)","NA",{"v":1e-253,"d":"0.00"},1,"479,",0,-253,-250,3.89,"Exon (ENSBGRT00000028365/ENSBGRG00000015406, exon 14 of 14)",14,65712884,65913521,200638,2]
["chr14",69189817,69189966,150,"ENSBGRG00000019358","ENSBGRT00000035614",41953,"CENPF","centromere protein F [Source:HGNC Symbol;Acc:HGNC:1857]","GO:0000278(mitotic cell cycle);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000922(spindle pole);GO:0000940(condensed chromosome outer kinetochore);GO:0001822(kidney development);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0007059(chromosome segregation);GO:0008022(protein C-terminus binding);GO:0008134(transcription factor binding);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0015031(protein transport);GO:0016363(nuclear matrix);GO:0021591(ventricular system development);GO:0030496(midbody);GO:0042803(protein homodimerization activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0051310(metaphase plate congression);GO:0070840(dynein complex binding);GO:0097539(ciliary transition fiber)","NA",{"v":8.7e-06,"d":"0.00"},1,"150,",0,-5.06,-4.33,4.32,"Exon (ENSBGRT00000035614/ENSBGRG00000019358, exon 14 of 19)",14,69165478,69231919,66442,2]
["chr14",72687817,72687995,179,"ENSBGRG00000022443","ENSBGRT00000041746",53762,"RCOR3","REST corepressor 3 [Source:HGNC Symbol;Acc:HGNC:25594]","GO:0003677(DNA binding)","05016(Huntington disease)",{"v":1E-50,"d":"0.00"},1,"179,",0,-50,{"v":-48.7,"d":"-48.70"},4.45,"Exon (ENSBGRT00000041746/ENSBGRG00000022443, exon 12 of 12)",14,72687817,72741757,53941,2]
["chr14",77298458,77298908,451,"ENSBGRG00000014539","ENSBGRT00000026711",330,"ZBTB41","zinc finger and BTB domain containing 41 [Source:HGNC Symbol;Acc:HGNC:24819]","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","NA",{"v":0.043,"d":"0.04"},1,"451,",0,-1.37,{"v":-0.6,"d":"-0.60"},6.48,"Exon (ENSBGRT00000026711/ENSBGRG00000014539, exon 1 of 10)",14,77265101,77299238,34138,2]
["chr14",80844590,80848226,3637,"ENSBGRG00000019271","ENSBGRT00000035624",13578,"DDX59","DEAD-box helicase 59 [Source:HGNC Symbol;Acc:HGNC:25360]","GO:0003676(nucleic acid binding);GO:0005524(ATP binding)","NA",{"v":1.3e-85,"d":"0.00"},2,"154,85,","0,3552",{"v":-84.9,"d":"-84.90"},{"v":-83.4,"d":"-83.40"},2.42,"Exon (ENSBGRT00000035624/ENSBGRG00000019271, exon 8 of 9)",14,80844234,80861804,17571,2]
["chr14",83361762,83367883,6122,"ENSBGRG00000026323","ENSBGRT00000048694",929,"FMOD","fibromodulin [Source:HGNC Symbol;Acc:HGNC:3774]","GO:0005515(protein binding);GO:0030199(collagen fibril organization);GO:0062023(collagen-containing extracellular matrix)","NA",{"v":1.3e-38,"d":"0.00"},2,"152,59,","0,6063",{"v":-37.9,"d":"-37.90"},{"v":-36.8,"d":"-36.80"},1.37,"Exon (ENSBGRT00000048694/ENSBGRG00000026323, exon 1 of 2)",14,83361762,83368812,7051,2]
["chr14",84609460,84609968,509,"ENSBGRG00000009666","ENSBGRT00000017764",119,"PIK3C2B","phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta [Source:HGNC Symbol;Acc:HGNC:8972]","GO:0001727(lipid kinase activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0009267(cellular response to starvation);GO:0016236(macroautophagy);GO:0016301(kinase activity);GO:0030139(endocytic vesicle);GO:0035091(phosphatidylinositol binding);GO:0036092(phosphatidylinositol-3-phosphate biosynthetic process);GO:0043491(protein kinase B signaling);GO:0046854(phosphatidylinositol phosphorylation);GO:0048015(phosphatidylinositol-mediated signaling);GO:1905037(autophagosome organization)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":6.3e-66,"d":"0.00"},1,"509,",0,{"v":-65.2,"d":"-65.20"},{"v":-63.8,"d":"-63.80"},3.89,"Exon (ENSBGRT00000017764/ENSBGRG00000009666, exon 1 of 32)",14,84546151,84610087,63937,2]
["chr14",85572980,85573069,90,"ENSBGRG00000011743","ENSBGRT00000021370",20277,"NUAK2","NUAK family kinase 2 [Source:HGNC Symbol;Acc:HGNC:29558]","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0030036(actin cytoskeleton organization);GO:0042149(cellular response to glucose starvation);GO:0043066(negative regulation of apoptotic process)","NA",{"v":0.0011,"d":"0.00"},1,"90,",0,-2.96,-2.33,13,"Exon (ENSBGRT00000021370/ENSBGRG00000011743, exon 7 of 7)",14,85572299,85593346,21048,2]
["chr15",9157078,9157586,509,"ENSBGRG00000023354","ENSBGRT00000043171",255737,"CLYBL","citrate lyase beta like [Source:HGNC Symbol;Acc:HGNC:18355]","GO:0000287(magnesium ion binding);GO:0003824(catalytic activity);GO:0004474(malate synthase activity);GO:0047777((S)-citramalyl-CoA lyase activity);GO:0070207(protein homotrimerization);GO:0106064(regulation of cobalamin metabolic process);GO:0106121(positive regulation of cobalamin metabolic process)","NA",{"v":4e-46,"d":"0.00"},1,"509,",0,{"v":-45.4,"d":"-45.40"},{"v":-44.1,"d":"-44.10"},{"v":5.3,"d":"5.30"},"3' UTR",15,8901341,9158632,257292,1]
["chr15",16965429,16966264,836,"ENSBGRG00000004312","ENSBGRT00000007923",268,"ABHD13","abhydrolase domain containing 13 [Source:HGNC Symbol;Acc:HGNC:20293]","GO:0002084(protein depalmitoylation);GO:0005737(cytoplasm);GO:0008474(palmitoyl-(protein) hydrolase activity);GO:0032839(dendrite cytoplasm)","NA",{"v":7.9e-83,"d":"0.00"},1,"836,",0,{"v":-82.1,"d":"-82.10"},{"v":-80.5,"d":"-80.50"},6.17,"Exon (ENSBGRT00000007923/ENSBGRG00000004312, exon 1 of 1)",15,16965161,16966264,1104,1]
["chr15",20970810,20971555,746,"ENSBGRG00000019502","ENSBGRT00000035833",149,"CHAMP1","chromosome alignment maintaining phosphoprotein 1 [Source:HGNC Symbol;Acc:HGNC:20311]","GO:0000777(condensed chromosome kinetochore);GO:0000793(condensed chromosome);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005819(spindle);GO:0016604(nuclear body);GO:0031134(sister chromatid biorientation);GO:0034501(protein localization to kinetochore);GO:0035372(protein localization to microtubule);GO:0051315(attachment of mitotic spindle microtubules to kinetochore);GO:0090543(Flemming body)","NA",0,1,"746,",0,-350,"-Inf",6.05,"Exon (ENSBGRT00000035833/ENSBGRG00000019502, exon 1 of 1)",15,20970661,20973075,2415,1]
["chr15",29741059,29744882,3824,"ENSBGRG00000005066","ENSBGRT00000010195",222907,"TBC1D4","TBC1 domain family member 4 [Source:HGNC Symbol;Acc:HGNC:19165]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0016192(vesicle-mediated transport);GO:0032869(cellular response to insulin stimulus)","04919(Thyroid hormone signaling pathway);04931(Insulin resistance)",{"v":1E-215,"d":"0.00"},2,"65,234,","0,3590",-215,-212,3.17,"3' UTR",15,29518152,29744882,226731,1]
["chr15",44951242,44951332,91,"ENSBGRG00000009265","ENSBGRT00000017280",20886,"PARP4","poly(ADP-ribose) polymerase family member 4 [Source:HGNC Symbol;Acc:HGNC:271]","GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005876(spindle microtubule);GO:0006464(cellular protein modification process);GO:0006471(protein ADP-ribosylation);GO:0006954(inflammatory response);GO:0008219(cell death);GO:0019899(enzyme binding);GO:0051972(regulation of telomerase activity);GO:0140289(protein mono-ADP-ribosylation);GO:1990404(protein ADP-ribosylase activity)","03410(Base excision repair);04210(Apoptosis);04217(Necroptosis)",{"v":0.0025,"d":"0.00"},1,"91,",0,-2.61,-2,2.03,"Exon (ENSBGRT00000017280/ENSBGRG00000009265, exon 9 of 35)",15,44930356,45022616,92261,1]
["chr15",52054369,52054488,120,"ENSBGRG00000007239","ENSBGRT00000013331",20879,"USPL1","ubiquitin specific peptidase like 1 [Source:HGNC Symbol;Acc:HGNC:20294]","GO:0008283(cell population proliferation);GO:0009301(snRNA transcription);GO:0015030(Cajal body);GO:0016926(protein desumoylation);GO:0030576(Cajal body organization);GO:0032183(SUMO binding);GO:0070140(SUMO-specific isopeptidase activity)","NA",{"v":1.6E-15,"d":"0.00"},1,"120,",0,{"v":-14.8,"d":"-14.80"},{"v":-13.9,"d":"-13.90"},6.97,"Exon (ENSBGRT00000013331/ENSBGRG00000007239, exon 8 of 9)",15,52033490,52056841,23352,1]
["chr15",54436515,54442046,5532,"ENSBGRG00000016337","ENSBGRT00000030031",33105,"KL","klotho [Source:HGNC Symbol;Acc:HGNC:6344]","GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0005104(fibroblast growth factor receptor binding);GO:0005615(extracellular space);GO:0005975(carbohydrate metabolic process);GO:0006112(energy reserve metabolic process);GO:0007568(aging);GO:0008286(insulin receptor signaling pathway);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0016021(integral component of membrane);GO:0017134(fibroblast growth factor binding);GO:0030501(positive regulation of bone mineralization);GO:0055074(calcium ion homeostasis);GO:0090080(positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway)","00040(Pentose and glucuronate interconversions);04928(Parathyroid hormone synthesis, secretion and action);04961(Endocrine and other factor-regulated calcium reabsorption);04211(Longevity regulating pathway - mammal)",{"v":0.034,"d":"0.03"},2,"79,101,","0,5431",-1.47,{"v":-0.941,"d":"-0.94"},4.32,"Exon (ENSBGRT00000030031/ENSBGRG00000016337, exon 4 of 6)",15,54403410,54443921,40512,1]
["chr15",61724279,61724487,209,"ENSBGRG00000014432","ENSBGRT00000026933",23328,"NEK3","NIMA related kinase 3 [Source:HGNC Symbol;Acc:HGNC:7746]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0030010(establishment of cell polarity);GO:0048812(neuron projection morphogenesis);GO:0090043(regulation of tubulin deacetylation)","NA",{"v":0.0011,"d":"0.00"},1,"209,",0,-2.96,-2.33,13,"3' UTR",15,61700951,61724606,23656,1]
["chr15",69130482,69130990,509,"ENSBGRG00000004147","ENSBGRT00000007795",418,"TSC22D1","TSC22 domain family member 1 [Source:HGNC Symbol;Acc:HGNC:16826]","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1e-132,"d":"0.00"},1,"509,",0,-132,-130,5.77,"Exon (ENSBGRT00000007795/ENSBGRG00000004147, exon 1 of 4)",15,69130064,69165533,35470,1]
["chr15",72984123,72984300,178,"ENSBGRG00000006050","ENSBGRT00000011175",1685,"KBTBD6","kelch repeat and BTB domain containing 6 [Source:HGNC Symbol;Acc:HGNC:25340]","GO:0005515(protein binding)","NA",{"v":1.3E-11,"d":"0.00"},1,"178,",0,{"v":-10.9,"d":"-10.90"},-10,5.48,"Exon (ENSBGRT00000011175/ENSBGRG00000006050, exon 2 of 3)",15,72982438,72984771,2334,1]
["chr15",8604256,8604665,410,"ENSBGRG00000023186","ENSBGRT00000042832",0,"GPR183","G protein-coupled receptor 183 [Source:HGNC Symbol;Acc:HGNC:3128]","GO:0002250(adaptive immune response);GO:0002313(mature B cell differentiation involved in immune response);GO:0002407(dendritic cell chemotaxis);GO:0004930(G protein-coupled receptor activity);GO:0005886(plasma membrane);GO:0006959(humoral immune response);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008142(oxysterol binding);GO:0010818(T cell chemotaxis);GO:0016021(integral component of membrane);GO:0030316(osteoclast differentiation);GO:0030595(leukocyte chemotaxis);GO:0030890(positive regulation of B cell proliferation);GO:0036145(dendritic cell homeostasis);GO:0060326(cell chemotaxis);GO:0061470(T follicular helper cell differentiation);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:2000458(regulation of astrocyte chemotaxis)","NA",{"v":7.9e-08,"d":"0.00"},1,"410,",0,{"v":-7.1,"d":"-7.10"},-6.32,6.33,"Exon (ENSBGRT00000042832/ENSBGRG00000023186, exon 1 of 1)",15,8603583,8604665,1083,2]
["chr15",16943107,16943523,417,"ENSBGRG00000004289","ENSBGRT00000007910",1754,"LIG4","DNA ligase 4 [Source:HGNC Symbol;Acc:HGNC:6601]","GO:0000012(single strand break repair);GO:0000793(condensed chromosome);GO:0001701(in utero embryonic development);GO:0002328(pro-B cell differentiation);GO:0003677(DNA binding);GO:0003909(DNA ligase activity);GO:0003910(DNA ligase (ATP) activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005958(DNA-dependent protein kinase-DNA ligase 4 complex);GO:0006266(DNA ligation);GO:0006281(DNA repair);GO:0006297(nucleotide-excision repair, DNA gap filling);GO:0006302(double-strand break repair);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0006310(DNA recombination);GO:0007417(central nervous system development);GO:0008022(protein C-terminus binding);GO:0008283(cell population proliferation);GO:0010165(response to X-ray);GO:0010212(response to ionizing radiation);GO:0010332(response to gamma radiation);GO:0016874(ligase activity);GO:0032807(DNA ligase IV complex);GO:0033077(T cell differentiation in thymus);GO:0033151(V(D)J recombination);GO:0033152(immunoglobulin V(D)J recombination);GO:0033153(T cell receptor V(D)J recombination);GO:0035019(somatic stem cell population maintenance);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0043524(negative regulation of neuron apoptotic process);GO:0045190(isotype switching);GO:0048146(positive regulation of fibroblast proliferation);GO:0050769(positive regulation of neurogenesis);GO:0051102(DNA ligation involved in DNA recombination);GO:0051103(DNA ligation involved in DNA repair);GO:0051276(chromosome organization);GO:0051402(neuron apoptotic process);GO:0070419(nonhomologous end joining complex);GO:0071479(cellular response to ionizing radiation);GO:0071897(DNA biosynthetic process);GO:0097680(double-strand break repair via classical nonhomologous end joining);GO:2001252(positive regulation of chromosome organization)","03450(Non-homologous end-joining)",{"v":1e-18,"d":"0.00"},1,"417,",0,-18,-17,3.77,"Exon (ENSBGRT00000007910/ENSBGRG00000004289, exon 1 of 1)",15,16942542,16945277,2736,2]
["chr15",20647376,20647436,61,"ENSBGRG00000017756","ENSBGRT00000032510",33804,"GAS6","growth arrest specific 6 [Source:HGNC Symbol;Acc:HGNC:4168]","GO:0001764(neuron migration);GO:0001786(phosphatidylserine binding);GO:0001934(positive regulation of protein phosphorylation);GO:0001961(positive regulation of cytokine-mediated signaling pathway);GO:0005102(signaling receptor binding);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0006909(phagocytosis);GO:0007165(signal transduction);GO:0007167(enzyme linked receptor protein signaling pathway);GO:0007596(blood coagulation);GO:0009267(cellular response to starvation);GO:0010628(positive regulation of gene expression);GO:0010804(negative regulation of tumor necrosis factor-mediated signaling pathway);GO:0010934(macrophage cytokine production);GO:0018105(peptidyl-serine phosphorylation);GO:0019064(fusion of virus membrane with host plasma membrane);GO:0019079(viral genome replication);GO:0030296(protein tyrosine kinase activator activity);GO:0030674(protein-macromolecule adaptor activity);GO:0030971(receptor tyrosine kinase binding);GO:0031589(cell-substrate adhesion);GO:0032689(negative regulation of interferon-gamma production);GO:0032692(negative regulation of interleukin-1 production);GO:0032715(negative regulation of interleukin-6 production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0032825(positive regulation of natural killer cell differentiation);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0035457(cellular response to interferon-alpha);GO:0035690(cellular response to drug);GO:0035754(B cell chemotaxis);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043277(apoptotic cell clearance);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043491(protein kinase B signaling);GO:0045860(positive regulation of protein kinase activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046718(viral entry into host cell);GO:0046813(receptor-mediated virion attachment to host cell);GO:0046827(positive regulation of protein export from nucleus);GO:0048018(receptor ligand activity);GO:0048146(positive regulation of fibroblast proliferation);GO:0050766(positive regulation of phagocytosis);GO:0051897(positive regulation of protein kinase B signaling);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0070168(negative regulation of biomineral tissue development);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070588(calcium ion transmembrane transport);GO:0071307(cellular response to vitamin K);GO:0071363(cellular response to growth factor stimulus);GO:0072659(protein localization to plasma membrane);GO:0097028(dendritic cell differentiation);GO:0097241(hematopoietic stem cell migration to bone marrow);GO:1900142(negative regulation of oligodendrocyte apoptotic process);GO:2000270(negative regulation of fibroblast apoptotic process);GO:2000352(negative regulation of endothelial cell apoptotic process);GO:2000510(positive regulation of dendritic cell chemotaxis);GO:2000669(negative regulation of dendritic cell apoptotic process)","01521(EGFR tyrosine kinase inhibitor resistance)",{"v":4e-63,"d":"0.00"},1,"61,",0,{"v":-62.4,"d":"-62.40"},-61,1.78,"3' UTR",15,20647107,20681240,34134,2]
["chr15",29128393,29129229,837,"ENSBGRG00000003974","ENSBGRT00000007425",233770,"LMO7","LIM domain 7 [Source:HGNC Symbol;Acc:HGNC:6646]","GO:0005515(protein binding);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0016324(apical plasma membrane);GO:0023051(regulation of signaling);GO:0030155(regulation of cell adhesion)","04520(Adherens junction)",{"v":6.3E-46,"d":"0.00"},2,"310,20,","0,817",{"v":-45.2,"d":"-45.20"},-44,2.21,"Exon (ENSBGRT00000007425/ENSBGRG00000003974, exon 25 of 32)",15,29116203,29362999,246797,2]
["chr15",45824733,45824943,211,"ENSBGRG00000013606","ENSBGRT00000024945",30882,"LATS2","large tumor suppressor kinase 2 [Source:HGNC Symbol;Acc:HGNC:6515]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000922(spindle pole);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0009755(hormone-mediated signaling pathway);GO:0034451(centriolar satellite);GO:0035329(hippo signaling);GO:0035556(intracellular signal transduction);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0090090(negative regulation of canonical Wnt signaling pathway)","04390(Hippo signaling pathway);04392(Hippo signaling pathway - multiple species)",{"v":7.9e-26,"d":"0.00"},1,"211,",0,{"v":-25.1,"d":"-25.10"},{"v":-24.1,"d":"-24.10"},{"v":10.4,"d":"10.40"},"Exon (ENSBGRT00000024945/ENSBGRG00000013606, exon 6 of 10)",15,45814821,45855825,41005,2]
["chr15",46980556,46980675,120,"ENSBGRG00000014596","ENSBGRT00000026900",1796,"ENSBGRG00000014596","NA","NA","NA",{"v":6.2e-05,"d":"0.00"},1,"120,",0,-4.21,-3.52,2.97,"Exon (ENSBGRT00000026900/ENSBGRG00000014596, exon 1 of 4)",15,46967575,46982471,14897,2]
["chr15",51897541,51899376,1836,"ENSBGRG00000007092","ENSBGRT00000013065",5545,"ENSBGRG00000007092","NA","GO:0003677(DNA binding);GO:0005634(nucleus)","03410(Base excision repair);04140(Autophagy - animal);04217(Necroptosis)",0,3,"182,3,171,","0,329,1665",-683,"-Inf",2.47,"3' UTR",15,51859708,51904921,45214,2]
["chr15",56733938,56735776,1839,"ENSBGRG00000019318","ENSBGRT00000035533",0,"MAB21L1","mab-21 like 1 [Source:HGNC Symbol;Acc:HGNC:6757]","GO:0001654(eye development);GO:0005634(nucleus);GO:0008284(positive regulation of cell population proliferation);GO:0043010(camera-type eye development)","NA",{"v":0.0078,"d":"0.01"},2,"832,722,","0,1117",-2.11,-1.27,9.72,"Exon (ENSBGRT00000035533/ENSBGRG00000019318, exon 1 of 2)",15,56733938,56735776,1839,2]
["chr15",61330530,61330678,149,"ENSBGRG00000012579","ENSBGRT00000023086",270,"FOXO1","forkhead box O1 [Source:HGNC Symbol;Acc:HGNC:3819]","GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006915(apoptotic process);GO:0008013(beta-catenin binding);GO:0009267(cellular response to starvation);GO:0010508(positive regulation of autophagy);GO:0031625(ubiquitin protein ligase binding);GO:0032873(negative regulation of stress-activated MAPK cascade);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045732(positive regulation of protein catabolic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0071455(cellular response to hyperoxia)","04068(FoxO signaling pathway);04152(AMPK signaling pathway);04218(Cellular senescence);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04919(Thyroid hormone signaling pathway);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05215(Prostate cancer);04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05165(Human papillomavirus infection)",{"v":0.043,"d":"0.04"},3,"79,34,8,","0,80,141",-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000023086/ENSBGRG00000012579, exon 1 of 5)",15,61226330,61330948,104619,2]
["chr15",63986394,63986693,300,"ENSBGRG00000017523","ENSBGRT00000032097",478,"TRIM13","tripartite motif containing 13 [Source:HGNC Symbol;Acc:HGNC:9976]","GO:0004842(ubiquitin-protein transferase activity);GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0008270(zinc ion binding);GO:0010332(response to gamma radiation);GO:0010942(positive regulation of cell death);GO:0016239(positive regulation of macroautophagy);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0032897(negative regulation of viral transcription);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0045087(innate immune response);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051865(protein autoubiquitination);GO:0097038(perinuclear endoplasmic reticulum);GO:1902187(negative regulation of viral release from host cell)","NA",{"v":2.5e-89,"d":"0.00"},1,"300,",0,{"v":-88.6,"d":"-88.60"},-87,5.55,"Exon (ENSBGRT00000032097/ENSBGRG00000017523, exon 1 of 1)",15,63985945,63987171,1227,2]
["chr15",71746761,71746851,91,"ENSBGRG00000005093","ENSBGRT00000009837",32304,"AKAP11","A-kinase anchoring protein 11 [Source:HGNC Symbol;Acc:HGNC:369]","GO:0005730(nucleolus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0034237(protein kinase A regulatory subunit binding);GO:0036010(protein localization to endosome)","NA",{"v":1.3E-7,"d":"0.00"},1,"91,",0,{"v":-6.9,"d":"-6.90"},-6.12,1.64,"Exon (ENSBGRT00000009837/ENSBGRG00000005093, exon 12 of 14)",15,71742251,71779155,36905,2]
["chr15",73480836,73482180,1345,"ENSBGRG00000006338","ENSBGRT00000011720",0,"PCDH8","protocadherin 8 [Source:HGNC Symbol;Acc:HGNC:8660]","GO:0001756(somitogenesis);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016331(morphogenesis of embryonic epithelium)","NA",{"v":0.0011,"d":"0.00"},2,"918,393,","0,952",-2.96,-2.33,13,"Exon (ENSBGRT00000011720/ENSBGRG00000006338, exon 1 of 5)",15,73477489,73482180,4692,2]
["chr16",3864933,3869754,4822,"ENSBGRG00000009303","ENSBGRT00000017156",0,"EDNRA","endothelin receptor type A [Source:HGNC Symbol;Acc:HGNC:3179]","GO:0001569(branching involved in blood vessel morphogenesis);GO:0001666(response to hypoxia);GO:0001701(in utero embryonic development);GO:0004930(G protein-coupled receptor activity);GO:0004962(endothelin receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0007507(heart development);GO:0007585(respiratory gaseous exchange by respiratory system);GO:0008217(regulation of blood pressure);GO:0010827(regulation of glucose transmembrane transport);GO:0014032(neural crest cell development);GO:0014824(artery smooth muscle contraction);GO:0016021(integral component of membrane);GO:0042310(vasoconstriction);GO:0048484(enteric nervous system development);GO:0060322(head development)","04020(Calcium signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04080(Neuroactive ligand-receptor interaction);04924(Renin secretion);04270(Vascular smooth muscle contraction);05200(Pathways in cancer)",{"v":9.99999999999999e-305,"d":"0.00"},2,"58,452,","0,4370",-304,-301,6.53,"5' UTR",16,3864933,3944197,79265,1]
["chr16",11251813,11251873,61,"ENSBGRG00000017247","ENSBGRT00000031691",162842,"TMEM131L","transmembrane 131 like [Source:HGNC Symbol;Acc:HGNC:29146]","GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0033088(negative regulation of immature T cell proliferation in thymus);GO:0090090(negative regulation of canonical Wnt signaling pathway)","NA",{"v":0.0011,"d":"0.00"},1,"61,",0,-2.97,-2.34,1.56,"Exon (ENSBGRT00000031691/ENSBGRG00000017247, exon 27 of 37)",16,11088971,11288395,199425,1]
["chr16",22423440,22423968,529,"ENSBGRG00000004464","ENSBGRT00000008250",0,"PCDH18","protocadherin 18 [Source:HGNC Symbol;Acc:HGNC:14268]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007399(nervous system development);GO:0007420(brain development);GO:0016020(membrane)","NA",{"v":2.5e-32,"d":"0.00"},2,"48,310,","0,219",{"v":-31.6,"d":"-31.60"},{"v":-30.5,"d":"-30.50"},3.36,"5' UTR",16,22423440,22437301,13862,1]
["chr16",35705070,35705129,60,"ENSBGRG00000009843","ENSBGRT00000018067",2173,"ENSBGRG00000009843","NA","NA","NA",0.02,1,"60,",0,-1.69,-1.14,3.96,"Exon (ENSBGRT00000018078/ENSBGRG00000009851, exon 1 of 2)",16,35704743,35707302,2560,2]
["chr16",44760834,44760954,121,"ENSBGRG00000004301","ENSBGRT00000007959",1245,"GASK1B","golgi associated kinase 1B [Source:HGNC Symbol;Acc:HGNC:25312]","GO:0005794(Golgi apparatus)","NA",{"v":4e-22,"d":"0.00"},1,"121,",0,{"v":-21.4,"d":"-21.40"},{"v":-20.4,"d":"-20.40"},{"v":2.4,"d":"2.40"},"5' UTR",16,44759589,44778014,18426,1]
["chr16",48487174,48487499,326,"ENSBGRG00000005390","ENSBGRT00000010007",8648,"ENSBGRG00000005390","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.3E-36,"d":"0.00"},1,"326,",0,{"v":-35.9,"d":"-35.90"},{"v":-34.7,"d":"-34.70"},7,"Exon (ENSBGRT00000010007/ENSBGRG00000005390, exon 4 of 5)",16,48478526,48488214,9689,1]
["chr16",48804579,48811438,6860,"ENSBGRG00000005691","ENSBGRT00000010604",27565,"GOLGA3","golgin A3 [Source:HGNC Symbol;Acc:HGNC:4426]","GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0007283(spermatogenesis);GO:0017119(Golgi transport complex);GO:0090498(extrinsic component of Golgi membrane)","NA",{"v":4e-21,"d":"0.00"},9,"8,144,9,9,198,117,140,133,22,","0,1558,1704,1714,2341,3337,5758,6489,6838",{"v":-20.4,"d":"-20.40"},{"v":-19.4,"d":"-19.40"},3,"Exon (ENSBGRT00000010604/ENSBGRG00000005691, exon 14 of 17)",16,48777014,48806301,29288,1]
["chr16",53212922,53213636,715,"ENSBGRG00000010376","ENSBGRT00000019190",36279,"SLC15A4","solute carrier family 15 member 4 [Source:HGNC Symbol;Acc:HGNC:23090]","GO:0006857(oligopeptide transport);GO:0016020(membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",0,1,"715,",0,-355,"-Inf",6.88,"3' UTR",16,53176643,53213636,36994,1]
["chr16",57493677,57514953,21277,"ENSBGRG00000003817","ENSBGRT00000007089",21507,"RILPL1","Rab interacting lysosomal protein like 1 [Source:HGNC Symbol;Acc:HGNC:26814]","GO:0003382(epithelial cell morphogenesis);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0046983(protein dimerization activity);GO:1901214(regulation of neuron death);GO:1903445(protein transport from ciliary membrane to plasma membrane)","NA",{"v":2e-13,"d":"0.00"},3,"96,173,88,","0,16715,21189",{"v":-12.7,"d":"-12.70"},{"v":-11.8,"d":"-11.80"},1.73,"Exon (ENSBGRT00000007089/ENSBGRG00000003817, exon 4 of 8)",16,57472170,57526574,54405,1]
["chr16",58562983,58576917,13935,"ENSBGRG00000006328","ENSBGRT00000011818",49175,"CLIP1","CAP-Gly domain containing linker protein 1 [Source:HGNC Symbol;Acc:HGNC:10461]","GO:0001578(microtubule bundle formation);GO:0005635(nuclear envelope);GO:0005813(centrosome);GO:0005874(microtubule);GO:0005881(cytoplasmic microtubule);GO:0008017(microtubule binding);GO:0008270(zinc ion binding);GO:0015630(microtubule cytoskeleton);GO:0015631(tubulin binding);GO:0031116(positive regulation of microtubule polymerization);GO:0035371(microtubule plus-end);GO:0044354(macropinosome);GO:0044861(protein transport into plasma membrane raft);GO:0051010(microtubule plus-end binding)","04150(mTOR signaling pathway)",{"v":2E-41,"d":"0.00"},4,"65,117,107,71,","0,6378,8574,13864",{"v":-40.7,"d":"-40.70"},{"v":-39.5,"d":"-39.50"},3.92,"Exon (ENSBGRT00000011818/ENSBGRG00000006328, exon 19 of 28)",16,58513808,58611510,97703,1]
["chr16",59881153,59882324,1172,"ENSBGRG00000010412","ENSBGRT00000019891",69184,"ATP2A2","ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [Source:HGNC Symbol;Acc:HGNC:812]","GO:0000166(nucleotide binding);GO:0002026(regulation of the force of heart contraction);GO:0005388(calcium transmembrane transporter activity, phosphorylative mechanism);GO:0005509(calcium ion binding);GO:0005524(ATP binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006816(calcium ion transport);GO:0006874(cellular calcium ion homeostasis);GO:0006984(ER-nucleus signaling pathway);GO:0006996(organelle organization);GO:0014883(transition between fast and slow fiber);GO:0014898(cardiac muscle hypertrophy in response to stress);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016529(sarcoplasmic reticulum);GO:0019899(enzyme binding);GO:0032469(endoplasmic reticulum calcium ion homeostasis);GO:0032470(positive regulation of endoplasmic reticulum calcium ion concentration);GO:0033292(T-tubule organization);GO:0034599(cellular response to oxidative stress);GO:0044325(ion channel binding);GO:0044548(S100 protein binding);GO:0045822(negative regulation of heart contraction);GO:0070296(sarcoplasmic reticulum calcium ion transport);GO:0070588(calcium ion transmembrane transport);GO:0097470(ribbon synapse);GO:1900121(negative regulation of receptor binding);GO:1903233(regulation of calcium ion-dependent exocytosis of neurotransmitter);GO:1903515(calcium ion transport from cytosol to endoplasmic reticulum)","04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04972(Pancreatic secretion);05010(Alzheimer disease)",{"v":4e-49,"d":"0.00"},2,"35,236,","0,936",{"v":-48.4,"d":"-48.40"},{"v":-47.1,"d":"-47.10"},3.19,"Exon (ENSBGRT00000019891/ENSBGRG00000010412, exon 7 of 20)",16,59811969,59902379,90411,1]
["chr16",64381855,64382062,208,"ENSBGRG00000013613","ENSBGRT00000025163",15444,"C12orf49","chromosome 12 open reading frame 49 [Source:HGNC Symbol;Acc:HGNC:26128]","GO:0000139(Golgi membrane);GO:2000640(positive regulation of SREBP signaling pathway)","NA",{"v":5.4e-09,"d":"0.00"},1,"208,",0,-8.27,-7.46,{"v":29.2,"d":"29.20"},"3' UTR",16,64366411,64382543,16133,1]
["chr16",69574803,69576633,1831,"ENSBGRG00000026352","ENSBGRT00000048751",0,"ENSBGRG00000026352","NA","GO:0005875(microtubule associated complex);GO:0007017(microtubule-based process);GO:0030286(dynein complex)","04962(Vasopressin-regulated water reabsorption)",0,2,"132,138,","0,1693",-577,"-Inf",2.83,"Exon (ENSBGRT00000048751/ENSBGRG00000026352, exon 1 of 2)",16,69574803,69576633,1831,1]
["chr16",71198669,71198997,329,"ENSBGRG00000008960","ENSBGRT00000017806",30279,"SSH1","slingshot protein phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:30579]","GO:0000902(cell morphogenesis);GO:0003779(actin binding);GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0030036(actin cytoskeleton organization);GO:0032268(regulation of cellular protein metabolic process);GO:0071318(cellular response to ATP)","04810(Regulation of actin cytoskeleton);04360(Axon guidance)",{"v":7.9e-74,"d":"0.00"},1,"329,",0,{"v":-73.1,"d":"-73.10"},{"v":-71.6,"d":"-71.60"},6.51,"Exon (ENSBGRT00000017806/ENSBGRG00000008960, exon 15 of 15)",16,71168390,71199325,30936,1]
["chr16",73504543,73505715,1173,"ENSBGRG00000015673","ENSBGRT00000028772",24435,"SRRD","SRR1 domain containing [Source:HGNC Symbol;Acc:HGNC:33910]","NA","NA",{"v":4e-60,"d":"0.00"},2,"85,153,","0,1020",{"v":-59.4,"d":"-59.40"},-58,3.09,"Exon (ENSBGRT00000028772/ENSBGRG00000015673, exon 4 of 7)",16,73480108,73506774,26667,1]
["chr16",76233333,76233870,538,"ENSBGRG00000021280","ENSBGRT00000039314",9454,"ENSBGRG00000021280","NA","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005883(neurofilament);GO:0006334(nucleosome assembly);GO:0061564(axon development)","05014(Amyotrophic lateral sclerosis (ALS))",{"v":3.2e-09,"d":"0.00"},1,"538,",0,{"v":-8.5,"d":"-8.50"},-7.69,3.41,"Exon (ENSBGRT00000039314/ENSBGRG00000021280, exon 6 of 6)",16,76223879,76233870,9992,1]
["chr16",77769747,77769897,151,"ENSBGRG00000007932","ENSBGRT00000014803",61648,"LIMK2","LIM domain kinase 2 [Source:HGNC Symbol;Acc:HGNC:6614]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005801(cis-Golgi network);GO:0006468(protein phosphorylation);GO:0007283(spermatogenesis);GO:0030953(astral microtubule organization);GO:0060322(head development);GO:0061303(cornea development in camera-type eye);GO:0072686(mitotic spindle)","04810(Regulation of actin cytoskeleton);04666(Fc gamma R-mediated phagocytosis);04360(Axon guidance)",{"v":1e-101,"d":"0.00"},1,"151,",0,-101,{"v":-99.4,"d":"-99.40"},{"v":8.4,"d":"8.40"},"3' UTR",16,77708099,77770885,62787,1]
["chr16",80470532,80470861,330,"ENSBGRG00000019032","ENSBGRT00000034871",5895,"TSSK1B","testis specific serine kinase 1B [Source:HGNC Symbol;Acc:HGNC:14968]","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007286(spermatid development);GO:0018105(peptidyl-serine phosphorylation);GO:0031514(motile cilium);GO:0044877(protein-containing complex binding)","NA",{"v":0.00056,"d":"0.00"},1,"330,",0,-3.25,{"v":-2.6,"d":"-2.60"},14,"Exon (ENSBGRT00000034871/ENSBGRG00000019032, exon 2 of 2)",16,80464637,80470861,6225,1]
["chr16",80924949,80925036,88,"ENSBGRG00000022929","ENSBGRT00000042315",0,"MIR3618","microRNA 3618 [Source:HGNC Symbol;Acc:HGNC:38937]","NA","NA",{"v":0.00015,"d":"0.00"},1,"88,",0,-3.83,-3.15,{"v":16.2,"d":"16.20"},"5' UTR",16,80924949,80925036,88,1]
["chr16",80970057,80970266,210,"ENSBGRG00000023060","ENSBGRT00000042631",14103,"ZDHHC8","zinc finger DHHC-type containing 8 [Source:HGNC Symbol;Acc:HGNC:18474]","GO:0005739(mitochondrion);GO:0005794(Golgi apparatus);GO:0007626(locomotory behavior);GO:0010875(positive regulation of cholesterol efflux);GO:0016409(palmitoyltransferase activity);GO:0018230(peptidyl-L-cysteine S-palmitoylation);GO:0018345(protein palmitoylation)","NA",{"v":2e-32,"d":"0.00"},1,"210,",0,{"v":-31.7,"d":"-31.70"},{"v":-30.6,"d":"-30.60"},4.03,"3' UTR",16,80955954,80971341,15388,1]
["chr16",10133523,10162902,29380,"ENSBGRG00000015831","ENSBGRT00000029100",28654,"TMEM154","transmembrane protein 154 [Source:HGNC Symbol;Acc:HGNC:26489]","NA","NA",{"v":6.3E-21,"d":"0.00"},6,"99,61,86,28,39,105,","0,13052,15080,16341,29148,29275",{"v":-20.2,"d":"-20.20"},{"v":-19.2,"d":"-19.20"},5.85,"3' UTR",16,10131051,10191556,60506,2]
["chr16",20160745,20160981,237,"ENSBGRG00000022639","ENSBGRT00000041787",148,"ENSBGRG00000022639","NA","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0032482(Rab protein signal transduction)","04140(Autophagy - animal)",{"v":3e-05,"d":"0.00"},1,"237,",0,-4.53,-3.83,{"v":17.3,"d":"17.30"},"Exon (ENSBGRT00000041787/ENSBGRG00000022639, exon 1 of 3)",16,20138140,20161129,22990,2]
["chr16",32768758,32769236,479,"ENSBGRG00000008016","ENSBGRT00000016060",4627,"PLK4","polo like kinase 4 [Source:HGNC Symbol;Acc:HGNC:11397]","GO:0001741(XY body);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005730(nucleolus);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007099(centriole replication);GO:0042802(identical protein binding);GO:0046601(positive regulation of centriole replication);GO:0060707(trophoblast giant cell differentiation);GO:0098535(de novo centriole assembly involved in multi-ciliated epithelial cell differentiation);GO:0098536(deuterosome)","04068(FoxO signaling pathway)",{"v":1.6E-52,"d":"0.00"},1,"479,",0,{"v":-51.8,"d":"-51.80"},{"v":-50.5,"d":"-50.50"},4.55,"Exon (ENSBGRT00000016060/ENSBGRG00000008016, exon 5 of 18)",16,32753743,32773863,20121,2]
["chr16",35702413,35702563,151,"ENSBGRG00000009618","ENSBGRT00000017642",2159,"FAT4","FAT atypical cadherin 4 [Source:HGNC Symbol;Acc:HGNC:23109]","GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001822(kidney development);GO:0003007(heart morphogenesis);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007009(plasma membrane organization);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007219(Notch signaling pathway);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0016020(membrane);GO:0021987(cerebral cortex development);GO:0022008(neurogenesis);GO:0035329(hippo signaling);GO:0043931(ossification involved in bone maturation);GO:0045177(apical part of cell);GO:0048565(digestive tract development);GO:0060122(inner ear receptor cell stereocilium organization);GO:0072006(nephron development);GO:0072137(condensed mesenchymal cell proliferation);GO:0072307(regulation of metanephric nephron tubule epithelial cell differentiation)","04392(Hippo signaling pathway - multiple species)",{"v":0.017,"d":"0.02"},1,"151,",0,-1.78,-1.22,3.51,"Exon (ENSBGRT00000017642/ENSBGRG00000009618, exon 1 of 18)",16,35502823,35704722,201900,2]
["chr16",47862836,47863224,389,"ENSBGRG00000005090","ENSBGRT00000009386",22591,"GUCY1A1","guanylate cyclase 1 soluble subunit alpha 1 [Source:HGNC Symbol;Acc:HGNC:4685]","GO:0004383(guanylate cyclase activity);GO:0006182(cGMP biosynthetic process);GO:0008074(guanylate cyclase complex, soluble);GO:0008217(regulation of blood pressure);GO:0009190(cyclic nucleotide biosynthetic process);GO:0010750(positive regulation of nitric oxide mediated signal transduction);GO:0016849(phosphorus-oxygen lyase activity);GO:0035556(intracellular signal transduction);GO:0060087(relaxation of vascular smooth muscle)","00230(Purine metabolism);04022(cGMP - PKG signaling pathway);04540(Gap junction);04611(Platelet activation);04921(Oxytocin signaling pathway);04924(Renin secretion);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04730(Long-term depression);04713(Circadian entrainment)",{"v":1e-171,"d":"0.00"},1,"389,",0,-171,-169,5.21,"3' UTR",16,47862657,47885815,23159,2]
["chr16",49469007,49469552,546,"ENSBGRG00000006738","ENSBGRT00000012479",445,"ENSBGRG00000006738","NA","NA","NA",{"v":1e-149,"d":"0.00"},4,"33,57,29,297,","0,65,161,249",-149,-147,5.57,"Exon (ENSBGRT00000012479/ENSBGRG00000006738, exon 1 of 4)",16,49469007,49469997,991,2]
["chr16",57720101,57722097,1997,"ENSBGRG00000004182","ENSBGRT00000007733",235,"C12orf65","chromosome 12 open reading frame 65 [Source:HGNC Symbol;Acc:HGNC:26784]","GO:0003747(translation release factor activity);GO:0006415(translational termination)","00760(Nicotinate and nicotinamide metabolism)",{"v":6.3e-52,"d":"0.00"},2,"219,47,","0,1950",{"v":-51.2,"d":"-51.20"},{"v":-49.9,"d":"-49.90"},3.67,"Exon (ENSBGRT00000007733/ENSBGRG00000004182, exon 1 of 2)",16,57720101,57722332,2232,2]
["chr16",58178882,58178941,60,"ENSBGRG00000005267","ENSBGRT00000009808",21837,"CCDC62","coiled-coil domain containing 62 [Source:HGNC Symbol;Acc:HGNC:30723]","GO:0001835(blastocyst hatching);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0030331(estrogen receptor binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0071392(cellular response to estradiol stimulus)","NA",{"v":1e-11,"d":"0.00"},1,"60,",0,-11,{"v":-10.1,"d":"-10.10"},2.69,"Exon (ENSBGRT00000009808/ENSBGRG00000005267, exon 9 of 13)",16,58157920,58200778,42859,2]
["chr16",61575278,61576618,1341,"ENSBGRG00000016630","ENSBGRT00000030705",0,"PRKAB1","protein kinase AMP-activated non-catalytic subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:9378]","GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006468(protein phosphorylation);GO:0010628(positive regulation of gene expression);GO:0035878(nail development);GO:0050790(regulation of catalytic activity);GO:0120162(positive regulation of cold-induced thermogenesis)","04371(Apelin signaling pathway);04068(FoxO signaling pathway);04152(AMPK signaling pathway);04530(Tight junction);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04920(Adipocytokine signaling pathway);04921(Oxytocin signaling pathway);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);04710(Circadian rhythm);04714(Thermogenesis);05410(Hypertrophic cardiomyopathy (HCM));04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance)",{"v":0.015,"d":"0.02"},2,"746,179,","0,1162",-1.83,-1.02,8.64,"5' UTR",16,61563351,61576023,12673,2]
["chr16",68945297,68946725,1429,"ENSBGRG00000026118","ENSBGRT00000048313",388,"ENSBGRG00000026118","NA","GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity)","NA",{"v":0.00037,"d":"0.00"},3,"109,371,805,","0,148,624",-3.43,-2.77,13,"Exon (ENSBGRT00000048313/ENSBGRG00000026118, exon 1 of 4)",16,68944341,68947113,2773,2]
["chr16",71472339,71474292,1954,"ENSBGRG00000011172","ENSBGRT00000020394",685,"FICD","FIC domain containing [Source:HGNC Symbol;Acc:HGNC:18416]","GO:0005515(protein binding);GO:0005524(ATP binding);GO:0018117(protein adenylylation);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0030544(Hsp70 protein binding);GO:0034976(response to endoplasmic reticulum stress);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0051087(chaperone binding);GO:0070733(protein adenylyltransferase activity);GO:1903894(regulation of IRE1-mediated unfolded protein response)","NA",{"v":0.015,"d":"0.02"},2,"124,473,","0,1481",-1.83,-1.02,8.64,"5' UTR",16,71469672,71474977,5306,2]
["chr16",75045831,75045921,91,"ENSBGRG00000016919","ENSBGRT00000031915",527175,"TTC28","tetratricopeptide repeat domain 28 [Source:HGNC Symbol;Acc:HGNC:29179]","GO:0005515(protein binding);GO:0007346(regulation of mitotic cell cycle);GO:0019900(kinase binding);GO:0030496(midbody)","04110(Cell cycle);04115(p53 signaling pathway);04218(Cellular senescence)",{"v":1.1E-4,"d":"0.00"},1,"91,",0,-3.97,-3.29,14,"Exon (ENSBGRT00000031915/ENSBGRG00000016919, exon 8 of 25)",16,74938691,75573096,634406,2]
["chr16",76482668,76482966,299,"ENSBGRG00000022422","ENSBGRT00000041464",40344,"ASCC2","activating signal cointegrator 1 complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:24103]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0099053(activating signal cointegrator 1 complex)","NA",0,1,"299,",0,-409,"-Inf",8.67,"3' UTR",16,76482668,76523310,40643,2]
["chr16",77889600,77889690,91,"ENSBGRG00000008974","ENSBGRT00000016663",9383,"EIF4ENIF1","eukaryotic translation initiation factor 4E nuclear import factor 1 [Source:HGNC Symbol;Acc:HGNC:16687]","GO:0000932(P-body);GO:0003729(mRNA binding);GO:0005049(nuclear export signal receptor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0017148(negative regulation of translation);GO:0019827(stem cell population maintenance);GO:0043231(intracellular membrane-bounded organelle);GO:0045665(negative regulation of neuron differentiation)","NA",{"v":4.5e-08,"d":"0.00"},1,"91,",0,-7.35,-6.56,{"v":1.9,"d":"1.90"},"Exon (ENSBGRT00000016663/ENSBGRG00000008974, exon 8 of 8)",16,77889600,77899073,9474,2]
["chr16",79690187,79693747,3561,"ENSBGRG00000024511","ENSBGRT00000045239",0,"ENSBGRG00000024511","NA","NA","NA",{"v":2.3E-3,"d":"0.00"},2,"1502,827,","0,2734",-2.63,-2.01,7.56,"Exon (ENSBGRT00000045239/ENSBGRG00000024511, exon 1 of 2)",16,79690187,79693747,3561,2]
["chr16",79926242,79926481,240,"ENSBGRG00000025125","ENSBGRT00000046507",19912,"ENSBGRG00000025125","NA","NA","04120(Ubiquitin mediated proteolysis);05012(Parkinson disease)",{"v":1e-103,"d":"0.00"},1,"240,",0,-103,-101,3.08,"3' UTR",16,79925224,79946393,21170,2]
["chr17",5697222,5700141,2920,"ENSBGRG00000005456","ENSBGRT00000010086",177,"LYSMD4","LysM domain containing 4 [Source:HGNC Symbol;Acc:HGNC:26571]","NA","NA",{"v":1e-30,"d":"0.00"},2,"113,213,","0,2707",-30,{"v":-28.9,"d":"-28.90"},6.38,"Exon (ENSBGRT00000010086/ENSBGRG00000005456, exon 1 of 2)",17,5697045,5701027,3983,1]
["chr17",9900687,9900776,90,"ENSBGRG00000006524","ENSBGRT00000012014",738,"ENSBGRG00000006524","NA","NA","NA",{"v":8.9e-10,"d":"0.00"},1,"90,",0,-9.05,-8.22,5.04,"Exon (ENSBGRT00000012014/ENSBGRG00000006524, exon 1 of 1)",17,9899949,9901307,1359,1]
["chr17",20904456,20904696,241,"ENSBGRG00000013726","ENSBGRT00000025195",54834,"ACAN","aggrecan [Source:HGNC Symbol;Acc:HGNC:319]","GO:0001502(cartilage condensation);GO:0002063(chondrocyte development);GO:0005509(calcium ion binding);GO:0005540(hyaluronic acid binding);GO:0005604(basement membrane);GO:0007155(cell adhesion);GO:0007507(heart development);GO:0030166(proteoglycan biosynthetic process);GO:0030199(collagen fibril organization);GO:0031012(extracellular matrix)","NA",{"v":2e-05,"d":"0.00"},1,"241,",0,-4.69,-3.98,4.45,"Exon (ENSBGRT00000025195/ENSBGRG00000013726, exon 12 of 19)",17,20849622,20930448,80827,1]
["chr17",23028489,23029205,717,"ENSBGRG00000010340","ENSBGRT00000019022",0,"ZSCAN2","zinc finger and SCAN domain containing 2 [Source:HGNC Symbol;Acc:HGNC:20994]","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":0.028,"d":"0.03"},1,"717,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",17,23028489,23046467,17979,1]
["chr17",25826565,25826715,151,"ENSBGRG00000016740","ENSBGRT00000030900",24968,"BNC1","basonuclin 1 [Source:HGNC Symbol;Acc:HGNC:1081]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0043231(intracellular membrane-bounded organelle);GO:1900195(positive regulation of oocyte maturation)","NA",{"v":0.0036,"d":"0.00"},1,"151,",0,-2.44,-1.84,4.32,"Exon (ENSBGRT00000030900/ENSBGRG00000016740, exon 4 of 5)",17,25801597,25836066,34470,1]
["chr17",28167450,28167750,301,"ENSBGRG00000007673","ENSBGRT00000014051",30,"TLNRD1","talin rod domain containing 1 [Source:HGNC Symbol;Acc:HGNC:13519]","GO:0001725(stress fiber);GO:0003779(actin binding);GO:0042802(identical protein binding)","NA",{"v":1.6e-38,"d":"0.00"},1,"301,",0,{"v":-37.8,"d":"-37.80"},{"v":-36.7,"d":"-36.70"},{"v":10.3,"d":"10.30"},"Exon (ENSBGRT00000014051/ENSBGRG00000007673, exon 1 of 2)",17,28167420,28168508,1089,1]
["chr17",33121094,33121302,209,"ENSBGRG00000020278","ENSBGRT00000037390",27735,"FBXO22","F-box protein 22 [Source:HGNC Symbol;Acc:HGNC:13593]","GO:0000209(protein polyubiquitination);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006913(nucleocytoplasmic transport);GO:0009267(cellular response to starvation);GO:0010830(regulation of myotube differentiation);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0048742(regulation of skeletal muscle fiber development);GO:2000060(positive regulation of ubiquitin-dependent protein catabolic process)","NA",{"v":4e-71,"d":"0.00"},1,"209,",0,{"v":-70.4,"d":"-70.40"},-69,3.84,"3' UTR",17,33093359,33121391,28033,1]
["chr17",35181227,35181347,121,"ENSBGRG00000023330","ENSBGRT00000043259",23647,"CSPG4","chondroitin sulfate proteoglycan 4 [Source:HGNC Symbol;Acc:HGNC:2466]","GO:0000187(activation of MAPK activity);GO:0001726(ruffle);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006929(substrate-dependent cell migration);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0008283(cell population proliferation);GO:0008347(glial cell migration);GO:0015026(coreceptor activity);GO:0019901(protein kinase binding);GO:0035556(intracellular signal transduction);GO:0042995(cell projection);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0097178(ruffle assembly)","NA",{"v":1.1e-07,"d":"0.00"},1,"121,",0,-6.96,-6.18,2.93,"Exon (ENSBGRT00000043259/ENSBGRG00000023330, exon 3 of 12)",17,35157580,35196316,38737,1]
["chr17",45371242,45371332,91,"ENSBGRG00000008406","ENSBGRT00000015337",13701,"ARHGAP5","Rho GTPase activating protein 5 [Source:HGNC Symbol;Acc:HGNC:675]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0007165(signal transduction);GO:0042169(SH2 domain binding)","04510(Focal adhesion);04670(Leukocyte transendothelial migration)",{"v":2.3E-5,"d":"0.00"},1,"91,",0,-4.63,-3.93,2.41,"Exon (ENSBGRT00000015380/ENSBGRG00000008406, exon 1 of 6)",17,45357541,45437415,79875,1]
["chr17",49226881,49226940,60,"ENSBGRG00000013859","ENSBGRT00000025409",0,"BRMS1L","BRMS1 like transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:20512]","NA","NA",{"v":2.1E-10,"d":"0.00"},1,"60,",0,-9.68,-8.84,4.08,"Exon (ENSBGRT00000025409/ENSBGRG00000013859, exon 1 of 10)",17,49226881,49273370,46490,1]
["chr17",51791217,51791396,180,"ENSBGRG00000004681","ENSBGRT00000008637",3028,"SSTR1","somatostatin receptor 1 [Source:HGNC Symbol;Acc:HGNC:11330]","GO:0004930(G protein-coupled receptor activity);GO:0004994(somatostatin receptor activity);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007215(glutamate receptor signaling pathway);GO:0007218(neuropeptide signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:1990830(cellular response to leukemia inhibitory factor)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction)",{"v":1.5E-5,"d":"0.00"},1,"180,",0,-4.81,{"v":-4.1,"d":"-4.10"},{"v":17.3,"d":"17.30"},"3' UTR",17,51788189,51791396,3208,1]
["chr17",59272777,59272956,180,"ENSBGRG00000009788","ENSBGRT00000018200",44376,"TUBGCP4","tubulin gamma complex associated protein 4 [Source:HGNC Symbol;Acc:HGNC:16691]","GO:0000226(microtubule cytoskeleton organization);GO:0000922(spindle pole);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0007020(microtubule nucleation);GO:0043015(gamma-tubulin binding);GO:0055037(recycling endosome)","NA",{"v":5e-55,"d":"0.00"},1,"180,",0,{"v":-54.3,"d":"-54.30"},{"v":-52.9,"d":"-52.90"},3.44,"3' UTR",17,59228401,59273285,44885,1]
["chr17",59537199,59537799,601,"ENSBGRG00000012583","ENSBGRT00000023237",23678,"PDIA3","protein disulfide isomerase family A member 3 [Source:HGNC Symbol;Acc:HGNC:4606]","GO:0003756(protein disulfide isomerase activity);GO:0005615(extracellular space);GO:0005783(endoplasmic reticulum);GO:0009986(cell surface);GO:0015037(peptide disulfide oxidoreductase activity);GO:0042802(identical protein binding);GO:0042824(MHC class I peptide loading complex);GO:0045454(cell redox homeostasis);GO:0098761(cellular response to interleukin-7);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway)","04141(Protein processing in endoplasmic reticulum);04612(Antigen processing and presentation);05163(Human cytomegalovirus infection)",0,2,"36,351,","0,250",-1100,"-Inf",4.28,"3' UTR",17,59513521,59537799,24279,1]
["chr17",61574298,61574567,270,"ENSBGRG00000019867","ENSBGRT00000036505",0,"RIN3","Ras and Rab interactor 3 [Source:HGNC Symbol;Acc:HGNC:18751]","GO:0005769(early endosome);GO:0007165(signal transduction);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0031410(cytoplasmic vesicle)","04014(Ras signaling pathway)",{"v":0.028,"d":"0.03"},1,"270,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",17,61574298,61728752,154455,1]
["chr17",65459727,65459815,89,"ENSBGRG00000017266","ENSBGRT00000031657",58,"TUNAR","TCL1 upstream neural differentiation-associated RNA [Source:HGNC Symbol;Acc:HGNC:44088]","NA","NA",{"v":1.9E-3,"d":"0.00"},1,"89,",0,-2.73,-2.11,{"v":4.1,"d":"4.10"},"Exon (ENSBGRT00000031657/ENSBGRG00000017266, exon 1 of 1)",17,65459669,65459815,147,1]
["chr17",72612889,72622742,9854,"ENSBGRG00000015019","ENSBGRT00000028014",60511,"WDR20","WD repeat domain 20 [Source:HGNC Symbol;Acc:HGNC:19667]","GO:0005515(protein binding)","03015(mRNA surveillance pathway);04530(Tight junction)",{"v":1e-126,"d":"0.00"},2,"910,9,","0,9845",-126,-124,7.74,"Exon (ENSBGRT00000028014/ENSBGRG00000015019, exon 4 of 5)",17,72552378,72623098,70721,1]
["chr17",75796469,75796587,119,"ENSBGRG00000008089","ENSBGRT00000014767",1030,"TMEM121","transmembrane protein 121 [Source:HGNC Symbol;Acc:HGNC:20511]","NA","05202(Transcriptional misregulation in cancers);05322(Systemic lupus erythematosus);05034(Alcoholism)",{"v":4e-15,"d":"0.00"},1,"119,",0,{"v":-14.4,"d":"-14.40"},{"v":-13.5,"d":"-13.50"},{"v":15.9,"d":"15.90"},"Exon (ENSBGRT00000014767/ENSBGRG00000008089, exon 2 of 2)",17,75795439,75797534,2096,1]
["chr17",677473,678805,1333,"ENSBGRG00000003821","ENSBGRT00000007067",35258,"UBE3A","ubiquitin protein ligase E3A [Source:HGNC Symbol;Acc:HGNC:12496]","GO:0001541(ovarian follicle development);GO:0003713(transcription coactivator activity);GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016567(protein ubiquitination);GO:0030521(androgen receptor signaling pathway);GO:0031398(positive regulation of protein ubiquitination);GO:0032570(response to progesterone);GO:0035037(sperm entry);GO:0042752(regulation of circadian rhythm);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050847(progesterone receptor signaling pathway);GO:0051865(protein autoubiquitination);GO:0060736(prostate gland growth);GO:0061630(ubiquitin protein ligase activity);GO:0070936(protein K48-linked ubiquitination);GO:1905528(positive regulation of Golgi lumen acidification);GO:2000058(regulation of ubiquitin-dependent protein catabolic process)","04120(Ubiquitin mediated proteolysis);05203(Viral carcinogenesis);05165(Human papillomavirus infection)",{"v":1e-138,"d":"0.00"},2,"134,166,","0,1167",-138,-136,6.31,"Exon (ENSBGRT00000007067/ENSBGRG00000003821, exon 4 of 12)",17,654022,714063,60042,2]
["chr17",14677778,14687608,9831,"ENSBGRG00000008626","ENSBGRT00000015793",79434,"SLCO3A1","solute carrier organic anion transporter family member 3A1 [Source:HGNC Symbol;Acc:HGNC:10952]","GO:0001934(positive regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0015732(prostaglandin transport);GO:0016020(membrane);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0055085(transmembrane transport)","NA",{"v":1.6E-13,"d":"0.00"},2,"83,243,","0,9588",{"v":-12.8,"d":"-12.80"},{"v":-11.9,"d":"-11.90"},4.32,"Exon (ENSBGRT00000015793/ENSBGRG00000008626, exon 8 of 9)",17,14677778,14767042,89265,2]
["chr17",20052322,20052501,180,"ENSBGRG00000013025","ENSBGRT00000023769",501,"ENSBGRG00000013025","NA","GO:0016020(membrane)","NA",{"v":2.5e-21,"d":"0.00"},1,"180,",0,{"v":-20.6,"d":"-20.60"},{"v":-19.6,"d":"-19.60"},7.37,"Exon (ENSBGRT00000023769/ENSBGRG00000013025, exon 2 of 2)",17,20052054,20053002,949,2]
["chr17",21682276,21682335,60,"ENSBGRG00000005653","ENSBGRT00000010509",5918,"ENSBGRG00000005653","NA","GO:0005779(integral component of peroxisomal membrane);GO:0016559(peroxisome fission)","04146(Peroxisome)",{"v":7.9E-39,"d":"0.00"},1,"60,",0,{"v":-38.1,"d":"-38.10"},{"v":-36.9,"d":"-36.90"},5.64,"Exon (ENSBGRT00000010548/ENSBGRG00000005653, exon 3 of 3)",17,21680322,21688253,7932,2]
["chr17",24832722,24832901,180,"ENSBGRG00000015184","ENSBGRT00000027887",1600,"MEX3B","mex-3 RNA binding family member B [Source:HGNC Symbol;Acc:HGNC:25297]","GO:0000932(P-body);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0005829(cytosol)","NA",{"v":7.9e-46,"d":"0.00"},1,"180,",0,{"v":-45.1,"d":"-45.10"},{"v":-43.9,"d":"-43.90"},2.49,"Exon (ENSBGRT00000027887/ENSBGRG00000015184, exon 2 of 2)",17,24831918,24834501,2584,2]
["chr17",33841948,33862614,20667,"ENSBGRG00000021400","ENSBGRT00000041087",29207,"SCAPER","S-phase cyclin A associated protein in the ER [Source:HGNC Symbol;Acc:HGNC:13081]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding)","NA",{"v":5E-42,"d":"0.00"},5,"41,82,143,156,116,","0,1446,6914,13215,20551",{"v":-41.3,"d":"-41.30"},{"v":-40.1,"d":"-40.10"},3.25,"Exon (ENSBGRT00000041087/ENSBGRG00000021400, exon 8 of 25)",17,33538734,33891821,353088,2]
["chr17",34272308,34272368,61,"ENSBGRG00000022898","ENSBGRT00000042716",247627,"ENSBGRG00000022898","NA","GO:0016021(integral component of membrane)","NA",{"v":6.3e-11,"d":"0.00"},1,"61,",0,{"v":-10.2,"d":"-10.20"},-9.33,3.34,"5' UTR",17,34174247,34519995,345749,2]
["chr17",35571303,35571632,330,"ENSBGRG00000024963","ENSBGRT00000046083",6396,"C15orf39","chromosome 15 open reading frame 39 [Source:HGNC Symbol;Acc:HGNC:24497]","GO:0005829(cytosol)","NA",{"v":1e-31,"d":"0.00"},1,"330,",0,-31,{"v":-29.9,"d":"-29.90"},{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000046083/ENSBGRG00000024963, exon 2 of 3)",17,35566516,35578028,11513,2]
["chr17",36684598,36685646,1049,"ENSBGRG00000004698","ENSBGRT00000008678",148,"ISLR","immunoglobulin superfamily containing leucine rich repeat [Source:HGNC Symbol;Acc:HGNC:6133]","GO:0005515(protein binding)","NA",0,2,"72,494,","0,555",-391,"-Inf",5.34,"Exon (ENSBGRT00000008678/ENSBGRG00000004698, exon 1 of 2)",17,36684034,36685794,1761,2]
["chr17",48285411,48289217,3807,"ENSBGRG00000009766","ENSBGRT00000017968",50102,"BAZ1A","bromodomain adjacent to zinc finger domain 1A [Source:HGNC Symbol;Acc:HGNC:960]","GO:0005515(protein binding);GO:0006261(DNA-dependent DNA replication);GO:0006338(chromatin remodeling);GO:0008623(CHRAC)","NA",{"v":6.3e-15,"d":"0.00"},4,"60,167,100,4,","0,2135,3049,3803",{"v":-14.2,"d":"-14.20"},{"v":-13.2,"d":"-13.20"},3.98,"Exon (ENSBGRT00000017968/ENSBGRG00000009766, exon 7 of 28)",17,48247298,48339319,92022,2]
["chr17",58747224,58747283,60,"ENSBGRG00000007451","ENSBGRT00000013628",8469,"KLHL28","kelch like family member 28 [Source:HGNC Symbol;Acc:HGNC:19741]","GO:0005515(protein binding)","NA",{"v":0.0002,"d":"0.00"},1,"60,",0,{"v":-3.7,"d":"-3.70"},-3.03,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000013628/ENSBGRG00000007451, exon 4 of 4)",17,58747224,58755752,8529,2]
["chr17",60300300,60300479,180,"ENSBGRG00000015120","ENSBGRT00000027884",8624,"ENSBGRG00000015120","NA","GO:0016055(Wnt signaling pathway)","NA",{"v":5.8e-06,"d":"0.00"},1,"180,",0,-5.24,-4.51,3.55,"5' UTR",17,60257313,60309103,51791,2]
["chr17",60474220,60492319,18100,"ENSBGRG00000015670","ENSBGRT00000029652",119,"PPP4R3A","protein phosphatase 4 regulatory subunit 3A [Source:HGNC Symbol;Acc:HGNC:20219]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016607(nuclear speck)","04922(Glucagon signaling pathway)",{"v":1.6E-86,"d":"0.00"},4,"60,99,56,23,","0,3528,6471,18077",{"v":-85.8,"d":"-85.80"},{"v":-84.3,"d":"-84.30"},6.12,"Exon (ENSBGRT00000029652/ENSBGRG00000015670, exon 1 of 15)",17,60455131,60492438,37308,2]
["chr17",64531904,64532144,241,"ENSBGRG00000016499","ENSBGRT00000030415",45918,"DICER1","dicer 1, ribonuclease III [Source:HGNC Symbol;Acc:HGNC:17098]","GO:0003676(nucleic acid binding);GO:0003725(double-stranded RNA binding);GO:0004521(endoribonuclease activity);GO:0004525(ribonuclease III activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006396(RNA processing);GO:0010629(negative regulation of gene expression);GO:0016442(RISC complex);GO:0016891(endoribonuclease activity, producing 5'-phosphomonoesters);GO:0019904(protein domain specific binding);GO:0030422(production of siRNA involved in RNA interference);GO:0030423(targeting of mRNA for destruction involved in RNA interference);GO:0031054(pre-miRNA processing);GO:0032720(negative regulation of tumor necrosis factor production);GO:0033168(conversion of ds siRNA to ss siRNA involved in RNA interference);GO:0035087(siRNA loading onto RISC involved in RNA interference);GO:0035148(tube formation);GO:0035196(production of miRNAs involved in gene silencing by miRNA);GO:0035197(siRNA binding);GO:0035280(miRNA loading onto RISC involved in gene silencing by miRNA);GO:0036404(conversion of ds siRNA to ss siRNA);GO:0038061(NIK/NF-kappaB signaling);GO:0048471(perinuclear region of cytoplasm);GO:0070062(extracellular exosome);GO:0070578(RISC-loading complex);GO:0070883(pre-miRNA binding);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","05206(MicroRNAs in cancer)",{"v":7.9e-28,"d":"0.00"},1,"241,",0,{"v":-27.1,"d":"-27.10"},-26,5.84,"Exon (ENSBGRT00000030415/ENSBGRG00000016499, exon 25 of 29)",17,64524366,64578062,53697,2]
["chr17",70328322,70328381,60,"ENSBGRG00000021104","ENSBGRT00000038955",18559,"DEGS2","delta 4-desaturase, sphingolipid 2 [Source:HGNC Symbol;Acc:HGNC:20113]","GO:0006629(lipid metabolic process);GO:0006667(sphinganine metabolic process);GO:0016021(integral component of membrane);GO:0030148(sphingolipid biosynthetic process);GO:0042284(sphingolipid delta-4 desaturase activity)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway)",{"v":0.00071,"d":"0.00"},1,"60,",0,-3.15,-2.51,5.13,"Exon (ENSBGRT00000038955/ENSBGRG00000021104, exon 2 of 3)",17,70325113,70346940,21828,2]
["chr17",75523272,75523540,269,"ENSBGRG00000006476","ENSBGRT00000012293",58925,"BRF1","BRF1 RNA polymerase III transcription initiation factor subunit [Source:HGNC Symbol;Acc:HGNC:11551]","GO:0006355(regulation of transcription, DNA-templated);GO:0017025(TBP-class protein binding);GO:0070897(transcription preinitiation complex assembly)","NA",{"v":3.2e-11,"d":"0.00"},1,"269,",0,{"v":-10.5,"d":"-10.50"},-9.61,40,"3' UTR",17,75522825,75582465,59641,2]
["chr18",3805953,3816571,10619,"ENSBGRG00000015765","ENSBGRT00000029003",1191,"KLHL38","kelch like family member 38 [Source:HGNC Symbol;Acc:HGNC:34435]","GO:0005515(protein binding)","NA",{"v":4.3e-07,"d":"0.00"},4,"108,45,106,70,","0,110,9302,10549",-6.37,-5.61,{"v":22.7,"d":"22.70"},"Exon (ENSBGRT00000029003/ENSBGRG00000015765, exon 1 of 4)",18,3804762,3817822,13061,1]
["chr18",4354715,4354954,240,"ENSBGRG00000016813","ENSBGRT00000030879",126703,"DERL1","derlin 1 [Source:HGNC Symbol;Acc:HGNC:28454]","GO:0002020(protease binding);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005783(endoplasmic reticulum);GO:0005785(signal recognition particle receptor complex);GO:0006986(response to unfolded protein);GO:0016021(integral component of membrane);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0030970(retrograde protein transport, ER to cytosol);GO:0031398(positive regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0031648(protein destabilization);GO:0032092(positive regulation of protein binding);GO:0034620(cellular response to unfolded protein);GO:0036502(Derlin-1-VIMP complex);GO:0036503(ERAD pathway);GO:0036513(Derlin-1 retrotranslocation complex);GO:0042288(MHC class I protein binding);GO:0042802(identical protein binding);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0048500(signal recognition particle);GO:0051117(ATPase binding);GO:0071712(ER-associated misfolded protein catabolic process);GO:1990381(ubiquitin-specific protease binding)","04141(Protein processing in endoplasmic reticulum);05014(Amyotrophic lateral sclerosis (ALS))",{"v":2e-27,"d":"0.00"},1,"240,",0,{"v":-26.7,"d":"-26.70"},{"v":-25.6,"d":"-25.60"},1.57,"3' UTR",18,4228012,4355074,127063,1]
["chr18",19881984,19882397,414,"ENSBGRG00000025275","ENSBGRT00000046727",0,"ENSBGRG00000025275","NA","NA","04115(p53 signaling pathway)",{"v":0.043,"d":"0.04"},1,"414,",0,-1.37,{"v":-0.741,"d":"-0.74"},{"v":5.4,"d":"5.40"},"5' UTR",18,19881984,19896575,14592,1]
["chr18",21123636,21123838,203,"ENSBGRG00000010822","ENSBGRT00000019807",1617,"EXOSC4","exosome component 4 [Source:HGNC Symbol;Acc:HGNC:18189]","GO:0000178(exosome (RNase complex));GO:0000460(maturation of 5.8S rRNA);GO:0000956(nuclear-transcribed mRNA catabolic process);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0030307(positive regulation of cell growth);GO:0035327(transcriptionally active chromatin);GO:0035925(mRNA 3'-UTR AU-rich region binding);GO:0045006(DNA deamination);GO:0045111(intermediate filament cytoskeleton);GO:0051607(defense response to virus);GO:0071028(nuclear mRNA surveillance);GO:0071044(histone mRNA catabolic process)","03018(RNA degradation)",{"v":5e-73,"d":"0.00"},1,"203,",0,{"v":-72.3,"d":"-72.30"},{"v":-70.9,"d":"-70.90"},3.39,"3' UTR",18,21122019,21123838,1820,1]
["chr18",25346840,25346899,60,"ENSBGRG00000013790","ENSBGRT00000025289",473946,"KCNB2","potassium voltage-gated channel subfamily B member 2 [Source:HGNC Symbol;Acc:HGNC:6232]","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005515(protein binding);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport)","NA",{"v":0.0083,"d":"0.01"},1,"60,",0,-2.08,{"v":-1.5,"d":"-1.50"},3.51,"Exon (ENSBGRT00000025289/ENSBGRG00000013790, exon 2 of 2)",18,24872894,25348594,475701,1]
["chr18",35524381,35556329,31949,"ENSBGRG00000019880","ENSBGRT00000037055",26266,"ENSBGRG00000019880","NA","GO:0005515(protein binding)","04742(Taste transduction)",{"v":0.025,"d":"0.03"},2,"37,83,","0,31866",-1.61,-1.07,4.86,"Exon (ENSBGRT00000037055/ENSBGRG00000019880, exon 2 of 6)",18,35498115,35774567,276453,1]
["chr18",52357037,52358926,1890,"ENSBGRG00000007419","ENSBGRT00000013696",30101,"ENSBGRG00000007419","NA","GO:0005739(mitochondrion);GO:1904947(folate import into mitochondrion)","NA",{"v":1E-161,"d":"0.00"},2,"34,296,","0,1594",-161,-159,7.88,"3' UTR",18,52326936,52359315,32380,1]
["chr18",62090186,62090479,294,"ENSBGRG00000008337","ENSBGRT00000015244",48391,"VIRMA","vir like m6A methyltransferase associated [Source:HGNC Symbol;Acc:HGNC:24500]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016604(nuclear body);GO:0016607(nuclear speck);GO:0036396(RNA N6-methyladenosine methyltransferase complex);GO:0080009(mRNA methylation);GO:0110104(mRNA alternative polyadenylation)","NA",{"v":7.9e-85,"d":"0.00"},2,"25,125,","0,169",{"v":-84.1,"d":"-84.10"},{"v":-82.5,"d":"-82.50"},3.51,"Exon (ENSBGRT00000015244/ENSBGRG00000008337, exon 12 of 24)",18,62041795,62110602,68808,1]
["chr18",67554549,67554668,120,"ENSBGRG00000012532","ENSBGRT00000023143",425947,"MMP16","matrix metallopeptidase 16 [Source:HGNC Symbol;Acc:HGNC:7162]","GO:0001503(ossification);GO:0001958(endochondral ossification);GO:0004222(metalloendopeptidase activity);GO:0005887(integral component of plasma membrane);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016485(protein processing);GO:0030574(collagen catabolic process);GO:0031012(extracellular matrix);GO:0035988(chondrocyte proliferation);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0060348(bone development);GO:0070006(metalloaminopeptidase activity);GO:0097094(craniofacial suture morphogenesis)","04928(Parathyroid hormone synthesis, secretion and action);05206(MicroRNAs in cancer)",{"v":1.6e-17,"d":"0.00"},1,"120,",0,{"v":-16.8,"d":"-16.80"},{"v":-15.8,"d":"-15.80"},3.45,"Exon (ENSBGRT00000023143/ENSBGRG00000012532, exon 10 of 10)",18,67128602,67555266,426665,1]
["chr18",954498,954616,119,"ENSBGRG00000009732","ENSBGRT00000017852",1153,"ENSBGRG00000009732","NA","NA","NA",{"v":0.025,"d":"0.03"},1,"119,",0,-1.61,-1.07,4.86,"Exon (ENSBGRT00000017852/ENSBGRG00000009732, exon 1 of 1)",18,954498,955769,1272,2]
["chr18",10957534,10957684,151,"ENSBGRG00000019689","ENSBGRT00000036766",480,"ADCY8","adenylate cyclase 8 [Source:HGNC Symbol;Acc:HGNC:239]","GO:0004016(adenylate cyclase activity);GO:0005886(plasma membrane);GO:0006171(cAMP biosynthetic process);GO:0007613(memory);GO:0007616(long-term memory);GO:0007626(locomotory behavior);GO:0008294(calcium- and calmodulin-responsive adenylate cyclase activity);GO:0009190(cyclic nucleotide biosynthetic process);GO:0010255(glucose mediated signaling pathway);GO:0014069(postsynaptic density);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0016849(phosphorus-oxygen lyase activity);GO:0030424(axon);GO:0030425(dendrite);GO:0031915(positive regulation of synaptic plasticity);GO:0032793(positive regulation of CREB transcription factor activity);GO:0032809(neuronal cell body membrane);GO:0035556(intracellular signal transduction);GO:0035774(positive regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0042593(glucose homeostasis);GO:0048786(presynaptic active zone);GO:0050804(modulation of chemical synaptic transmission);GO:0051480(regulation of cytosolic calcium ion concentration);GO:0060076(excitatory synapse);GO:0071315(cellular response to morphine);GO:0080135(regulation of cellular response to stress);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098686(hippocampal mossy fiber to CA3 synapse);GO:0098978(glutamatergic synapse);GO:0099056(integral component of presynaptic membrane);GO:0150076(neuroinflammatory response);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1900454(positive regulation of long-term synaptic depression)","00230(Purine metabolism);04015(Rap1 signaling pathway);04371(Apelin signaling pathway);04020(Calcium signaling pathway);04072(Phospholipase D signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04114(Oocyte meiosis);04540(Gap junction);04611(Platelet activation);04062(Chemokine signaling pathway);04911(Insulin secretion);04923(Regulation of lipolysis in adipocyte);04912(GnRH signaling pathway);04913(Ovarian Steroidogenesis);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04918(Thyroid hormone synthesis);04928(Parathyroid hormone synthesis, secretion and action);04916(Melanogenesis);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);04724(Glutamatergic synapse);04727(GABAergic synapse);04725(Cholinergic synapse);04720(Long-term potentiation);04723(Retrograde endocannabinoid signaling);04742(Taste transduction);04750(Inflammatory mediator regulation of TRP channels);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);04713(Circadian entrainment);04714(Thermogenesis);05200(Pathways in cancer);05032(Morphine addiction);05414(Dilated cardiomyopathy (DCM));04934(Cushing syndrome);05166(HTLV-I infection);05163(Human cytomegalovirus infection);01522(Endocrine resistance)",{"v":0.00098,"d":"0.00"},1,"151,",0,-3.01,-2.38,2.74,"Exon (ENSBGRT00000036766/ENSBGRG00000019689, exon 1 of 19)",18,10702361,10958164,255804,2]
["chr18",18996860,18997276,417,"ENSBGRG00000025134","ENSBGRT00000046457",10654,"GPR20","G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:HGNC:4475]","GO:0004930(G protein-coupled receptor activity);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0043235(receptor complex)","NA",{"v":7.4e-06,"d":"0.00"},1,"417,",0,-5.13,-4.41,9.18,"3' UTR",18,18996086,19007930,11845,2]
["chr18",20775906,20776113,208,"ENSBGRG00000005699","ENSBGRT00000010611",1235,"ENSBGRG00000005699","NA","NA","NA",{"v":0.0041,"d":"0.00"},4,"36,42,65,35,","0,38,81,173",-2.39,-1.79,5.04,"Exon (ENSBGRT00000010611/ENSBGRG00000005699, exon 4 of 7)",18,20775906,20777348,1443,2]
["chr18",20920937,20921326,390,"ENSBGRG00000007617","ENSBGRT00000014045",1138,"ENSBGRG00000007617","NA","NA","NA",{"v":1.3E-6,"d":"0.00"},1,"390,",0,{"v":-5.9,"d":"-5.90"},-5.15,{"v":23.8,"d":"23.80"},"Exon (ENSBGRT00000014045/ENSBGRG00000007617, exon 1 of 7)",18,20909616,20922464,12849,2]
["chr18",21541898,21542166,269,"ENSBGRG00000019822","ENSBGRT00000036443",23311,"ARHGAP39","Rho GTPase activating protein 39 [Source:HGNC Symbol;Acc:HGNC:29351]","GO:0005515(protein binding);GO:0005856(cytoskeleton);GO:0007165(signal transduction);GO:0098978(glutamatergic synapse);GO:0099173(postsynapse organization)","NA",{"v":7.9e-43,"d":"0.00"},1,"269,",0,{"v":-42.1,"d":"-42.10"},{"v":-40.9,"d":"-40.90"},5.66,"Exon (ENSBGRT00000036443/ENSBGRG00000019822, exon 4 of 10)",18,21522424,21565477,43054,2]
["chr18",26313482,26322789,9308,"ENSBGRG00000015189","ENSBGRT00000027953",0,"ENSBGRG00000015189","elongin C [Source:HGNC Symbol;Acc:HGNC:11617]","GO:0006511(ubiquitin-dependent protein catabolic process)","04120(Ubiquitin mediated proteolysis);04066(HIF-1 signaling pathway);05200(Pathways in cancer);05211(Renal cell carcinoma)",{"v":1.6e-20,"d":"0.00"},2,"12,47,","0,9261",{"v":-19.8,"d":"-19.80"},{"v":-18.8,"d":"-18.80"},2.53,"5' UTR",18,26305847,26322789,16943,2]
["chr18",36083340,36084803,1464,"ENSBGRG00000020205","ENSBGRT00000037149",5915,"ENSBGRG00000020205","NA","NA","NA",{"v":0.025,"d":"0.03"},1,"1464,",0,-1.61,-1.07,4.86,"Exon (ENSBGRT00000037184/ENSBGRG00000020234, exon 2 of 2)",18,36077425,36085480,8056,1]
["chr18",45282501,45282858,358,"ENSBGRG00000004673","ENSBGRT00000008625",2762,"ENSBGRG00000004673","NA","GO:0005515(protein binding)","03015(mRNA surveillance pathway)",{"v":0.0078,"d":"0.01"},1,"358,",0,-2.11,-1.27,9.72,"3' UTR",18,45282203,45285620,3418,2]
["chr18",57071946,57072155,210,"ENSBGRG00000004042","ENSBGRT00000007467",4517,"OSR2","odd-skipped related transciption factor 2 [Source:HGNC Symbol;Acc:HGNC:15830]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001656(metanephros development);GO:0001823(mesonephros development);GO:0002062(chondrocyte differentiation);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0008284(positive regulation of cell population proliferation);GO:0009792(embryo development ending in birth or egg hatching);GO:0010628(positive regulation of gene expression);GO:0030154(cell differentiation);GO:0030501(positive regulation of bone mineralization);GO:0033687(osteoblast proliferation);GO:0035115(embryonic forelimb morphogenesis);GO:0035116(embryonic hindlimb morphogenesis);GO:0036023(embryonic skeletal limb joint morphogenesis);GO:0042474(middle ear morphogenesis);GO:0042476(odontogenesis);GO:0042733(embryonic digit morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048704(embryonic skeletal system morphogenesis);GO:0050679(positive regulation of epithelial cell proliferation);GO:0060021(roof of mouth development);GO:0060272(embryonic skeletal joint morphogenesis);GO:0060322(head development);GO:0060349(bone morphogenesis);GO:0061029(eyelid development in camera-type eye);GO:0072498(embryonic skeletal joint development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1e-240,"d":"0.00"},1,"210,",0,-240,-238,2.69,"Exon (ENSBGRT00000007467/ENSBGRG00000004042, exon 2 of 4)",18,57069214,57076672,7459,2]
["chr18",62681807,62683214,1408,"ENSBGRG00000009030","ENSBGRT00000016822",670,"PDP1","pyruvate dehyrogenase phosphatase catalytic subunit 1 [Source:HGNC Symbol;Acc:HGNC:9279]","GO:0003824(catalytic activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0035970(peptidyl-threonine dephosphorylation);GO:0043169(cation binding)","NA",{"v":2.5e-10,"d":"0.00"},2,"168,132,","0,1276",{"v":-9.6,"d":"-9.60"},-8.77,9.07,"Exon (ENSBGRT00000016822/ENSBGRG00000009030, exon 2 of 4)",18,62679759,62683884,4126,2]
["chr18",74061029,74061089,61,"ENSBGRG00000012513","ENSBGRT00000022877",24283,"CHMP4C","charged multivesicular body protein 4C [Source:HGNC Symbol;Acc:HGNC:30599]","GO:0006997(nucleus organization);GO:0007034(vacuolar transport);GO:0007080(mitotic metaphase plate congression);GO:0009838(abscission);GO:0010824(regulation of centrosome duplication);GO:0030496(midbody);GO:0032466(negative regulation of cytokinesis);GO:0042803(protein homodimerization activity);GO:0044878(mitotic cytokinesis checkpoint);GO:0050792(regulation of viral process);GO:0061952(midbody abscission);GO:0090543(Flemming body);GO:0090611(ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway);GO:1901673(regulation of mitotic spindle assembly);GO:1902188(positive regulation of viral release from host cell)","04144(Endocytosis);04217(Necroptosis)",{"v":0.00068,"d":"0.00"},1,"61,",0,-3.17,-2.53,1.56,"Exon (ENSBGRT00000022877/ENSBGRG00000012513, exon 2 of 5)",18,74054407,74085372,30966,2]
["chr19",3324491,3330048,5558,"ENSBGRG00000026468","ENSBGRT00000049009",836,"ENSBGRG00000026468","NA","NA","NA",{"v":4.3e-10,"d":"0.00"},2,"99,200,","0,5358",-9.37,-8.54,9.72,"Exon (ENSBGRT00000049009/ENSBGRG00000026468, exon 1 of 2)",19,3323655,3330048,6394,1]
["chr19",5251628,5251747,120,"ENSBGRG00000026479","ENSBGRT00000049028",5068,"SOX9","SRY-box transcription factor 9 [Source:HGNC Symbol;Acc:HGNC:11204]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0001502(cartilage condensation);GO:0001503(ossification);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001708(cell fate specification);GO:0001837(epithelial to mesenchymal transition);GO:0001894(tissue homeostasis);GO:0001934(positive regulation of protein phosphorylation);GO:0001942(hair follicle development);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002062(chondrocyte differentiation);GO:0002063(chondrocyte development);GO:0002683(negative regulation of immune system process);GO:0003170(heart valve development);GO:0003179(heart valve morphogenesis);GO:0003180(aortic valve morphogenesis);GO:0003188(heart valve formation);GO:0003203(endocardial cushion morphogenesis);GO:0003413(chondrocyte differentiation involved in endochondral bone morphogenesis);GO:0003415(chondrocyte hypertrophy);GO:0003430(growth plate cartilage chondrocyte growth);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0006334(nucleosome assembly);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007219(Notch signaling pathway);GO:0007283(spermatogenesis);GO:0007417(central nervous system development);GO:0007507(heart development);GO:0008013(beta-catenin binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0010468(regulation of gene expression);GO:0010564(regulation of cell cycle process);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010634(positive regulation of epithelial cell migration);GO:0014032(neural crest cell development);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0019100(male germ-line sex determination);GO:0019933(cAMP-mediated signaling);GO:0030154(cell differentiation);GO:0030155(regulation of cell adhesion);GO:0030198(extracellular matrix organization);GO:0030238(male sex determination);GO:0030279(negative regulation of ossification);GO:0030502(negative regulation of bone mineralization);GO:0030850(prostate gland development);GO:0030857(negative regulation of epithelial cell differentiation);GO:0030858(positive regulation of epithelial cell differentiation);GO:0030879(mammary gland development);GO:0030903(notochord development);GO:0030916(otic vesicle formation);GO:0031018(endocrine pancreas development);GO:0032331(negative regulation of chondrocyte differentiation);GO:0032332(positive regulation of chondrocyte differentiation);GO:0032808(lacrimal gland development);GO:0032991(protein-containing complex);GO:0034236(protein kinase A catalytic subunit binding);GO:0034504(protein localization to nucleus);GO:0035019(somatic stem cell population maintenance);GO:0035622(intrahepatic bile duct development);GO:0042127(regulation of cell population proliferation);GO:0043066(negative regulation of apoptotic process);GO:0043491(protein kinase B signaling);GO:0043565(sequence-specific DNA binding);GO:0045165(cell fate commitment);GO:0045595(regulation of cell differentiation);GO:0045662(negative regulation of myoblast differentiation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045732(positive regulation of protein catabolic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046322(negative regulation of fatty acid oxidation);GO:0046533(negative regulation of photoreceptor cell differentiation);GO:0048709(oligodendrocyte differentiation);GO:0048873(homeostasis of number of cells within a tissue);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051216(cartilage development);GO:0060008(Sertoli cell differentiation);GO:0060009(Sertoli cell development);GO:0060018(astrocyte fate commitment);GO:0060041(retina development in camera-type eye);GO:0060174(limb bud formation);GO:0060221(retinal rod cell differentiation);GO:0060350(endochondral bone morphogenesis);GO:0060441(epithelial tube branching involved in lung morphogenesis);GO:0060487(lung epithelial cell differentiation);GO:0060512(prostate gland morphogenesis);GO:0060517(epithelial cell proliferation involved in prostatic bud elongation);GO:0060532(bronchus cartilage development);GO:0060534(trachea cartilage development);GO:0060729(intestinal epithelial structure maintenance);GO:0060784(regulation of cell proliferation involved in tissue homeostasis);GO:0061036(positive regulation of cartilage development);GO:0061046(regulation of branching involved in lung morphogenesis);GO:0061138(morphogenesis of a branching epithelium);GO:0061145(lung smooth muscle development);GO:0065003(protein-containing complex assembly);GO:0070168(negative regulation of biomineral tissue development);GO:0070371(ERK1 and ERK2 cascade);GO:0070384(Harderian gland development);GO:0070542(response to fatty acid);GO:0071260(cellular response to mechanical stimulus);GO:0071300(cellular response to retinoic acid);GO:0071347(cellular response to interleukin-1);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0071504(cellular response to heparin);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:0071599(otic vesicle development);GO:0072034(renal vesicle induction);GO:0072170(metanephric tubule development);GO:0072189(ureter development);GO:0072190(ureter urothelium development);GO:0072193(ureter smooth muscle cell differentiation);GO:0072197(ureter morphogenesis);GO:0072289(metanephric nephron tubule formation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090103(cochlea morphogenesis);GO:0090184(positive regulation of kidney development);GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis);GO:0097065(anterior head development);GO:0097157(pre-mRNA intronic binding);GO:0098609(cell-cell adhesion);GO:1901203(positive regulation of extracellular matrix assembly);GO:1902732(positive regulation of chondrocyte proliferation);GO:1902894(negative regulation of pri-miRNA transcription by RNA polymerase II);GO:1904864(negative regulation of beta-catenin-TCF complex assembly);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000020(positive regulation of male gonad development);GO:2000138(positive regulation of cell proliferation involved in heart morphogenesis);GO:2000741(positive regulation of mesenchymal stem cell differentiation);GO:2000794(regulation of epithelial cell proliferation involved in lung morphogenesis);GO:2001054(negative regulation of mesenchymal cell apoptotic process)","04024(cAMP signaling pathway)",{"v":9.5e-05,"d":"0.00"},1,"120,",0,-4.02,-3.33,4.05,"3' UTR",19,5246560,5253422,6863,1]
["chr19",8117535,8117805,271,"ENSBGRG00000016504","ENSBGRT00000030354",14839,"SLC16A5","solute carrier family 16 member 5 [Source:HGNC Symbol;Acc:HGNC:10926]","GO:0008028(monocarboxylic acid transmembrane transporter activity);GO:0015718(monocarboxylic acid transport);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":1e-19,"d":"0.00"},1,"271,",0,-19,-18,7.13,"3' UTR",19,8102696,8117792,15097,1]
["chr19",10722381,10723209,829,"ENSBGRG00000013779","ENSBGRT00000027215",39248,"TNRC6C","trinucleotide repeat containing adaptor 6C [Source:HGNC Symbol;Acc:HGNC:29318]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0035195(gene silencing by miRNA);GO:0035278(miRNA mediated inhibition of translation);GO:0060213(positive regulation of nuclear-transcribed mRNA poly(A) tail shortening);GO:1900153(positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay)","NA",{"v":2.5e-89,"d":"0.00"},2,"397,413,","0,416",{"v":-88.6,"d":"-88.60"},-87,7.56,"Exon (ENSBGRT00000027215/ENSBGRG00000013779, exon 4 of 22)",19,10683133,10767221,84089,1]
["chr19",12563499,12563559,61,"ENSBGRG00000021204","ENSBGRT00000039578",38380,"CCDC40","coiled-coil domain containing 40 [Source:HGNC Symbol;Acc:HGNC:26090]","GO:0001947(heart looping);GO:0003341(cilium movement);GO:0003351(epithelial cilium movement involved in extracellular fluid movement);GO:0003356(regulation of cilium beat frequency);GO:0005929(cilium);GO:0005930(axoneme);GO:0030317(flagellated sperm motility);GO:0030324(lung development);GO:0035082(axoneme assembly);GO:0035469(determination of pancreatic left/right asymmetry);GO:0036159(inner dynein arm assembly);GO:0044458(motile cilium assembly);GO:0060287(epithelial cilium movement involved in determination of left/right asymmetry);GO:0070286(axonemal dynein complex assembly);GO:0071907(determination of digestive tract left/right asymmetry);GO:0071910(determination of liver left/right asymmetry)","NA",{"v":2.4e-07,"d":"0.00"},1,"61,",0,-6.62,-5.85,3.24,"3' UTR",19,12525119,12564037,38919,1]
["chr19",13778911,13779061,151,"ENSBGRG00000025318","ENSBGRT00000046815",44884,"BAHCC1","BAH domain and coiled-coil containing 1 [Source:HGNC Symbol;Acc:HGNC:29279]","GO:0003682(chromatin binding)","NA",{"v":1.3E-39,"d":"0.00"},1,"151,",0,{"v":-38.9,"d":"-38.90"},{"v":-37.7,"d":"-37.70"},{"v":11.7,"d":"11.70"},"Exon (ENSBGRT00000046815/ENSBGRG00000025318, exon 13 of 30)",19,13734027,13797669,63643,1]
["chr19",15079629,15079777,149,"ENSBGRG00000006665","ENSBGRT00000012295",41620,"FOXK2","forkhead box K2 [Source:HGNC Symbol;Acc:HGNC:6036]","GO:0000287(magnesium ion binding);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001678(cellular glucose homeostasis);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006355(regulation of transcription, DNA-templated);GO:0010507(negative regulation of autophagy);GO:0010906(regulation of glucose metabolic process);GO:0042594(response to starvation);GO:0043231(intracellular membrane-bounded organelle);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061621(canonical glycolysis)","NA",{"v":1.6e-19,"d":"0.00"},1,"149,",0,{"v":-18.8,"d":"-18.80"},{"v":-17.8,"d":"-17.80"},2.03,"Exon (ENSBGRT00000012295/ENSBGRG00000006665, exon 8 of 9)",19,15038009,15090250,52242,1]
["chr19",16415511,16416077,567,"ENSBGRG00000010152","ENSBGRT00000018647",0,"SMURF2","SMAD specific E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:16809]","GO:0000151(ubiquitin ligase complex);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016607(nuclear speck);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030579(ubiquitin-dependent SMAD protein catabolic process);GO:0042802(identical protein binding);GO:0046332(SMAD binding);GO:0061630(ubiquitin protein ligase activity);GO:1901165(positive regulation of trophoblast cell migration)","04120(Ubiquitin mediated proteolysis);04340(Hedgehog signaling pathway);04350(TGF-beta signaling pathway);04144(Endocytosis)",{"v":0.0021,"d":"0.00"},1,"567,",0,-2.67,-2.06,{"v":11.9,"d":"11.90"},"5' UTR",19,16415511,16530679,115169,1]
["chr19",16861845,16888408,26564,"ENSBGRG00000011148","ENSBGRT00000021439",2785,"TEX2","testis expressed 2 [Source:HGNC Symbol;Acc:HGNC:30884]","GO:0008289(lipid binding)","NA",{"v":7.9e-49,"d":"0.00"},4,"307,201,340,46,","0,23161,24888,26518",{"v":-48.1,"d":"-48.10"},{"v":-46.8,"d":"-46.80"},4.94,"Exon (ENSBGRT00000021439/ENSBGRG00000011148, exon 3 of 13)",19,16859060,16932855,73796,1]
["chr19",17303313,17303608,296,"ENSBGRG00000009060","ENSBGRT00000016577",8661,"FTSJ3","FtsJ RNA 2'-O-methyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:17136]","GO:0001510(RNA methylation);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0008168(methyltransferase activity);GO:0008649(rRNA methyltransferase activity);GO:0031167(rRNA methylation);GO:0032259(methylation);GO:0062105(RNA 2'-O-methyltransferase activity)","NA",{"v":0.0039,"d":"0.00"},2,"47,14,","0,282",-2.41,-1.81,1.53,"Exon (ENSBGRT00000016577/ENSBGRG00000009060, exon 15 of 20)",19,17294652,17305000,10349,1]
["chr19",20647100,20647280,181,"ENSBGRG00000022981","ENSBGRT00000042425",58419,"PLEKHM1","pleckstrin homology and RUN domain containing M1 [Source:HGNC Symbol;Acc:HGNC:29017]","GO:0005730(nucleolus);GO:0032418(lysosome localization);GO:0035556(intracellular signal transduction);GO:0043231(intracellular membrane-bounded organelle);GO:0045780(positive regulation of bone resorption);GO:1900029(positive regulation of ruffle assembly)","04140(Autophagy - animal)",{"v":1e-19,"d":"0.00"},1,"181,",0,-19,{"v":-18.1,"d":"-18.10"},3.07,"3' UTR",19,20588681,20650185,61505,1]
["chr19",21858245,21858394,150,"ENSBGRG00000026114","ENSBGRT00000048310",4475,"ATXN7L3","ataxin 7 like 3 [Source:HGNC Symbol;Acc:HGNC:25416]","GO:0000124(SAGA complex);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0010390(histone monoubiquitination);GO:0016578(histone deubiquitination);GO:0030374(nuclear receptor transcription coactivator activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0071819(DUBm complex)","NA",{"v":1e-124,"d":"0.00"},1,"150,",0,-124,-123,5.81,"3' UTR",19,21853770,21860006,6237,1]
["chr19",24086693,24086875,183,"ENSBGRG00000014094","ENSBGRT00000025910",6323,"KLHL11","kelch like family member 11 [Source:HGNC Symbol;Acc:HGNC:19008]","GO:0005515(protein binding)","NA",{"v":1.9e-05,"d":"0.00"},3,"9,150,21,","0,10,162",-4.71,-4,{"v":19.4,"d":"19.40"},"Exon (ENSBGRT00000025910/ENSBGRG00000014094, exon 2 of 4)",19,24080370,24088219,7850,1]
["chr19",26110282,26110580,299,"ENSBGRG00000021074","ENSBGRT00000039000",3089,"ORMDL3","ORMDL sphingolipid biosynthesis regulator 3 [Source:HGNC Symbol;Acc:HGNC:16038]","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006672(ceramide metabolic process);GO:0016021(integral component of membrane);GO:0035339(SPOTS complex);GO:0090156(cellular sphingolipid homeostasis);GO:1900060(negative regulation of ceramide biosynthetic process)","NA",{"v":1e-189,"d":"0.00"},1,"299,",0,-189,-187,4.25,"3' UTR",19,26107193,26111455,4263,1]
["chr19",27363450,27363510,61,"ENSBGRG00000015645","ENSBGRT00000029675",67249,"SRCIN1","SRC kinase signaling inhibitor 1 [Source:HGNC Symbol;Acc:HGNC:29506]","GO:0005737(cytoplasm);GO:0015629(actin cytoskeleton);GO:0019901(protein kinase binding);GO:0030334(regulation of cell migration);GO:0034446(substrate adhesion-dependent cell spreading);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0061099(negative regulation of protein tyrosine kinase activity)","NA",{"v":0.0051,"d":"0.01"},1,"61,",0,-2.29,{"v":-1.7,"d":"-1.70"},4.68,"Exon (ENSBGRT00000029675/ENSBGRG00000015645, exon 14 of 18)",19,27296201,27368513,72313,1]
["chr19",27795530,27795620,91,"ENSBGRG00000018571","ENSBGRT00000034437",23087,"KPNB1","karyopherin subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:6400]","GO:0005515(protein binding);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006606(protein import into nucleus);GO:0006610(ribosomal protein import into nucleus);GO:0006886(intracellular protein transport);GO:0007079(mitotic chromosome movement towards spindle pole);GO:0007080(mitotic metaphase plate congression);GO:0008536(Ran GTPase binding);GO:0010494(cytoplasmic stress granule);GO:0019899(enzyme binding);GO:0019904(protein domain specific binding);GO:0030953(astral microtubule organization);GO:0031291(Ran protein signal transduction);GO:0031965(nuclear membrane);GO:0032991(protein-containing complex);GO:0040001(establishment of mitotic spindle localization);GO:0045184(establishment of protein localization);GO:0051879(Hsp90 protein binding);GO:0061608(nuclear import signal receptor activity);GO:0061676(importin-alpha family protein binding);GO:0071782(endoplasmic reticulum tubular network);GO:0090307(mitotic spindle assembly)","03013(RNA transport)",{"v":7.9e-28,"d":"0.00"},1,"91,",0,{"v":-27.1,"d":"-27.10"},-26,7.99,"3' UTR",19,27772443,27795620,23178,1]
["chr19",29785898,29786046,149,"ENSBGRG00000023572","ENSBGRT00000043537",3030,"NXPH3","neurexophilin 3 [Source:HGNC Symbol;Acc:HGNC:8077]","GO:0005102(signaling receptor binding)","NA",{"v":2e-13,"d":"0.00"},1,"149,",0,{"v":-12.7,"d":"-12.70"},{"v":-11.8,"d":"-11.80"},4.32,"3' UTR",19,29782868,29787081,4214,1]
["chr19",30761334,30761394,61,"ENSBGRG00000007020","ENSBGRT00000012903",3456,"EPN3","epsin 3 [Source:HGNC Symbol;Acc:HGNC:18235]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005905(clathrin-coated pit);GO:0019897(extrinsic component of plasma membrane);GO:0030136(clathrin-coated vesicle);GO:0043231(intracellular membrane-bounded organelle);GO:0048471(perinuclear region of cytoplasm);GO:1990175(EH domain binding)","04144(Endocytosis)",{"v":0.00025,"d":"0.00"},1,"61,",0,{"v":-3.6,"d":"-3.60"},-2.93,3.24,"Exon (ENSBGRT00000012903/ENSBGRG00000007020, exon 2 of 10)",19,30757878,30769314,11437,1]
["chr19",32482656,32482866,211,"ENSBGRG00000013411","ENSBGRT00000024713",64729,"RAI1","retinoic acid induced 1 [Source:HGNC Symbol;Acc:HGNC:9834]","GO:0000987(cis-regulatory region sequence-specific DNA binding);GO:0001501(skeletal system development);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0032922(circadian regulation of gene expression);GO:0040015(negative regulation of multicellular organism growth);GO:0045893(positive regulation of transcription, DNA-templated)","NA",{"v":2e-65,"d":"0.00"},1,"211,",0,{"v":-64.7,"d":"-64.70"},{"v":-63.3,"d":"-63.30"},{"v":13.3,"d":"13.30"},"Exon (ENSBGRT00000024713/ENSBGRG00000013411, exon 2 of 5)",19,32417927,32491302,73376,1]
["chr19",33869227,33869496,270,"ENSBGRG00000010803","ENSBGRT00000019947",31081,"TTC19","tetratricopeptide repeat domain 19 [Source:HGNC Symbol;Acc:HGNC:26006]","GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0034551(mitochondrial respiratory chain complex III assembly)","NA",{"v":7.9e-34,"d":"0.00"},1,"270,",0,{"v":-33.1,"d":"-33.10"},-32,3.16,"3' UTR",19,33838146,33870273,32128,1]
["chr19",38148712,38149335,624,"ENSBGRG00000020599","ENSBGRT00000038351",11898,"MYH3","myosin heavy chain 3 [Source:HGNC Symbol;Acc:HGNC:7573]","GO:0000146(microfilament motor activity);GO:0003009(skeletal muscle contraction);GO:0003774(motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0016459(myosin complex);GO:0016887(ATPase activity);GO:0043292(contractile fiber);GO:0046034(ATP metabolic process);GO:0051015(actin filament binding)","04530(Tight junction)",{"v":0.0021,"d":"0.00"},3,"11,91,79,","0,90,545",-2.68,-2.06,6.48,"Exon (ENSBGRT00000038351/ENSBGRG00000020599, exon 24 of 40)",19,38136814,38156124,19311,1]
["chr19",39873643,39879172,5530,"ENSBGRG00000026685","ENSBGRT00000049463",102217,"MYH10","myosin heavy chain 10 [Source:HGNC Symbol;Acc:HGNC:7568]","GO:0000146(microfilament motor activity);GO:0000281(mitotic cytokinesis);GO:0001701(in utero embryonic development);GO:0001725(stress fiber);GO:0001764(neuron migration);GO:0001778(plasma membrane repair);GO:0003279(cardiac septum development);GO:0003774(motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0005829(cytosol);GO:0005844(polysome);GO:0005886(plasma membrane);GO:0005903(brush border);GO:0005938(cell cortex);GO:0006887(exocytosis);GO:0006930(substrate-dependent cell migration, cell extension);GO:0007097(nuclear migration);GO:0007409(axonogenesis);GO:0007411(axon guidance);GO:0007420(brain development);GO:0007507(heart development);GO:0007512(adult heart development);GO:0008283(cell population proliferation);GO:0008360(regulation of cell shape);GO:0016459(myosin complex);GO:0016460(myosin II complex);GO:0016887(ATPase activity);GO:0021592(fourth ventricle development);GO:0021670(lateral ventricle development);GO:0021678(third ventricle development);GO:0021680(cerebellar Purkinje cell layer development);GO:0030036(actin cytoskeleton organization);GO:0030048(actin filament-based movement);GO:0030239(myofibril assembly);GO:0030424(axon);GO:0030426(growth cone);GO:0030496(midbody);GO:0030898(actin-dependent ATPase activity);GO:0031032(actomyosin structure organization);GO:0031175(neuron projection development);GO:0031594(neuromuscular junction);GO:0032154(cleavage furrow);GO:0035613(RNA stem-loop binding);GO:0035904(aorta development);GO:0042641(actomyosin);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0043197(dendritic spine);GO:0043531(ADP binding);GO:0048027(mRNA 5'-UTR binding);GO:0050714(positive regulation of protein secretion);GO:0050885(neuromuscular process controlling balance);GO:0051015(actin filament binding);GO:0055003(cardiac myofibril assembly);GO:0055015(ventricular cardiac muscle cell development);GO:0060041(retina development in camera-type eye);GO:0060976(coronary vasculature development);GO:0097513(myosin II filament)","04530(Tight junction)",{"v":9.99999999999998e-225,"d":"0.00"},6,"3,132,207,138,124,26,","0,91,1104,3615,4216,5504",-224,-222,2.48,"Exon (ENSBGRT00000049463/ENSBGRG00000026685, exon 21 of 42)",19,39771426,39899516,128091,1]
["chr19",39996836,39999397,2562,"ENSBGRG00000026699","ENSBGRT00000049495",2423,"ENSBGRG00000026699","ribosomal protein L26 [Source:HGNC Symbol;Acc:HGNC:10327]","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0015934(large ribosomal subunit);GO:0071479(cellular response to ionizing radiation);GO:1902167(positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator)","03010(Ribosome)",0,2,"74,135,","0,2427",-5290,"-Inf",2.53,"3' UTR",19,39994413,40003153,8741,1]
["chr19",41805877,41806236,360,"ENSBGRG00000026403","ENSBGRT00000048858",119,"ZFP3","ZFP3 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:12861]","GO:0003676(nucleic acid binding)","NA",{"v":4E-55,"d":"0.00"},1,"360,",0,{"v":-54.4,"d":"-54.40"},{"v":-53.1,"d":"-53.10"},5,"Exon (ENSBGRT00000048858/ENSBGRG00000026403, exon 1 of 1)",19,41805758,41807281,1524,1]
["chr19",42603738,42603978,241,"ENSBGRG00000011809","ENSBGRT00000021583",45006,"WSCD1","WSC domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29060]","GO:0008146(sulfotransferase activity)","NA",{"v":1e-34,"d":"0.00"},1,"241,",0,-34,{"v":-32.9,"d":"-32.90"},4.61,"3' UTR",19,42558732,42604607,45876,1]
["chr19",43957816,43958912,1097,"ENSBGRG00000020896","ENSBGRT00000038489",25895,"NCBP3","nuclear cap binding subunit 3 [Source:HGNC Symbol;Acc:HGNC:24612]","GO:0000339(RNA cap binding);GO:0000340(RNA 7-methylguanosine cap binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016607(nuclear speck);GO:0051607(defense response to virus)","04810(Regulation of actin cytoskeleton)",{"v":6.3e-42,"d":"0.00"},2,"120,147,","0,950",{"v":-41.2,"d":"-41.20"},-40,2.94,"Exon (ENSBGRT00000038489/ENSBGRG00000020896, exon 12 of 13)",19,43931921,43959001,27081,1]
["chr19",45778337,45778397,61,"ENSBGRG00000025102","ENSBGRT00000046381",24940,"SMYD4","SET and MYND domain containing 4 [Source:HGNC Symbol;Acc:HGNC:21067]","GO:0005515(protein binding)","NA",{"v":7.9e-31,"d":"0.00"},1,"61,",0,{"v":-30.1,"d":"-30.10"},-29,6.31,"Exon (ENSBGRT00000046381/ENSBGRG00000025102, exon 5 of 11)",19,45753397,45795136,41740,1]
["chr19",48056533,48056773,241,"ENSBGRG00000019934","ENSBGRT00000036669",7487,"CORO6","coronin 6 [Source:HGNC Symbol;Acc:HGNC:21356]","GO:0005515(protein binding)","NA",{"v":4e-15,"d":"0.00"},1,"241,",0,{"v":-14.4,"d":"-14.40"},{"v":-13.5,"d":"-13.50"},3.42,"3' UTR",19,48049046,48056803,7758,1]
["chr19",48520171,48521128,958,"ENSBGRG00000021707","ENSBGRT00000040138",82012,"MYO18A","myosin XVIIIA [Source:HGNC Symbol;Acc:HGNC:31104]","GO:0003677(DNA binding);GO:0003774(motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005802(trans-Golgi network);GO:0006259(DNA metabolic process);GO:0007030(Golgi organization);GO:0008094(DNA-dependent ATPase activity);GO:0016459(myosin complex);GO:0016477(cell migration);GO:0031032(actomyosin structure organization);GO:0042641(actomyosin);GO:0043030(regulation of macrophage activation);GO:0043066(negative regulation of apoptotic process);GO:0043531(ADP binding);GO:0048194(Golgi vesicle budding);GO:0050714(positive regulation of protein secretion);GO:0051015(actin filament binding);GO:0090161(Golgi ribbon formation);GO:0090164(asymmetric Golgi ribbon formation);GO:1903028(positive regulation of opsonization)","NA",{"v":1e-31,"d":"0.00"},2,"92,88,","0,870",-31,{"v":-29.9,"d":"-29.90"},2.62,"Exon (ENSBGRT00000040138/ENSBGRG00000021707, exon 30 of 41)",19,48438159,48541409,103251,1]
["chr19",49264439,49266069,1631,"ENSBGRG00000012227","ENSBGRT00000022641",3769,"IFT20","intraflagellar transport 20 [Source:HGNC Symbol;Acc:HGNC:30989]","GO:0005801(cis-Golgi network);GO:0005813(centrosome);GO:0017137(Rab GTPase binding);GO:0034067(protein localization to Golgi apparatus);GO:0060271(cilium assembly)","NA",{"v":1e-214,"d":"0.00"},5,"96,104,13,12,225,","0,864,1068,1083,1406",-214,-212,3.15,"3' UTR",19,49260670,49264534,3865,1]
["chr19",50605725,50618633,12909,"ENSBGRG00000015199","ENSBGRT00000028074",263271,"NF1","neurofibromin 1 [Source:HGNC Symbol;Acc:HGNC:7765]","GO:0000165(MAPK cascade);GO:0001649(osteoblast differentiation);GO:0001656(metanephros development);GO:0001666(response to hypoxia);GO:0001889(liver development);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001952(regulation of cell-matrix adhesion);GO:0001953(negative regulation of cell-matrix adhesion);GO:0005096(GTPase activator activity);GO:0005737(cytoplasm);GO:0006469(negative regulation of protein kinase activity);GO:0007154(cell communication);GO:0007165(signal transduction);GO:0007265(Ras protein signal transduction);GO:0007406(negative regulation of neuroblast proliferation);GO:0007420(brain development);GO:0007422(peripheral nervous system development);GO:0007507(heart development);GO:0007519(skeletal muscle tissue development);GO:0008285(negative regulation of cell population proliferation);GO:0008429(phosphatidylethanolamine binding);GO:0008542(visual learning);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0010468(regulation of gene expression);GO:0014044(Schwann cell development);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0016525(negative regulation of angiogenesis);GO:0021510(spinal cord development);GO:0021764(amygdala development);GO:0021897(forebrain astrocyte development);GO:0021915(neural tube development);GO:0021987(cerebral cortex development);GO:0022011(myelination in peripheral nervous system);GO:0030036(actin cytoskeleton organization);GO:0030198(extracellular matrix organization);GO:0030199(collagen fibril organization);GO:0030325(adrenal gland development);GO:0030336(negative regulation of cell migration);GO:0030424(axon);GO:0030425(dendrite);GO:0031210(phosphatidylcholine binding);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0034605(cellular response to heat);GO:0035021(negative regulation of Rac protein signal transduction);GO:0042060(wound healing);GO:0042127(regulation of cell population proliferation);GO:0042308(negative regulation of protein import into nucleus);GO:0043065(positive regulation of apoptotic process);GO:0043087(regulation of GTPase activity);GO:0043407(negative regulation of MAP kinase activity);GO:0043408(regulation of MAPK cascade);GO:0043409(negative regulation of MAPK cascade);GO:0043473(pigmentation);GO:0043525(positive regulation of neuron apoptotic process);GO:0043535(regulation of blood vessel endothelial cell migration);GO:0043547(positive regulation of GTPase activity);GO:0045124(regulation of bone resorption);GO:0045671(negative regulation of osteoclast differentiation);GO:0045685(regulation of glial cell differentiation);GO:0045762(positive regulation of adenylate cyclase activity);GO:0045765(regulation of angiogenesis);GO:0046580(negative regulation of Ras protein signal transduction);GO:0046929(negative regulation of neurotransmitter secretion);GO:0048147(negative regulation of fibroblast proliferation);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048485(sympathetic nervous system development);GO:0048593(camera-type eye morphogenesis);GO:0048712(negative regulation of astrocyte differentiation);GO:0048715(negative regulation of oligodendrocyte differentiation);GO:0048745(smooth muscle tissue development);GO:0048820(hair follicle maturation);GO:0048844(artery morphogenesis);GO:0048853(forebrain morphogenesis);GO:0050890(cognition);GO:0061534(gamma-aminobutyric acid secretion, neurotransmission);GO:0061535(glutamate secretion, neurotransmission);GO:0098597(observational learning);GO:1900271(regulation of long-term synaptic potentiation);GO:2001241(positive regulation of extrinsic apoptotic signaling pathway in absence of ligand)","04014(Ras signaling pathway);04010(MAPK signaling pathway);01521(EGFR tyrosine kinase inhibitor resistance)",{"v":3.2e-30,"d":"0.00"},2,"8,143,","0,12766",{"v":-29.5,"d":"-29.50"},{"v":-28.4,"d":"-28.40"},2.55,"Exon (ENSBGRT00000028074/ENSBGRG00000015199, exon 57 of 58)",19,50342454,50618633,276180,1]
["chr19",54621410,54621678,269,"ENSBGRG00000021180","ENSBGRT00000039245",1449,"LIG3","DNA ligase 3 [Source:HGNC Symbol;Acc:HGNC:6600]","GO:0003677(DNA binding);GO:0003909(DNA ligase activity);GO:0003910(DNA ligase (ATP) activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006281(DNA repair);GO:0006288(base-excision repair, DNA ligation);GO:0006302(double-strand break repair);GO:0006310(DNA recombination);GO:0008270(zinc ion binding);GO:0051103(DNA ligation involved in DNA repair);GO:0071897(DNA biosynthetic process);GO:0090298(negative regulation of mitochondrial DNA replication)","03410(Base excision repair)",{"v":1.6e-31,"d":"0.00"},1,"269,",0,{"v":-30.8,"d":"-30.80"},{"v":-29.7,"d":"-29.70"},{"v":4.1,"d":"4.10"},"Exon (ENSBGRT00000039245/ENSBGRG00000021180, exon 2 of 20)",19,54619961,54642466,22506,1]
["chr19",55988274,55988364,91,"ENSBGRG00000013367","ENSBGRT00000025605",51794,"SYNRG","synergin gamma [Source:HGNC Symbol;Acc:HGNC:557]","GO:0005515(protein binding)","NA",{"v":2e-28,"d":"0.00"},1,"91,",0,{"v":-27.7,"d":"-27.70"},{"v":-26.6,"d":"-26.60"},6.33,"Exon (ENSBGRT00000025605/ENSBGRG00000013367, exon 14 of 22)",19,55936480,56029019,92540,1]
["chr19",61726720,61726929,210,"ENSBGRG00000015169","ENSBGRT00000027870",541,"SRSF1","serine and arginine rich splicing factor 1 [Source:HGNC Symbol;Acc:HGNC:10780]","GO:0000380(alternative mRNA splicing, via spliceosome);GO:0000395(mRNA 5'-splice site recognition);GO:0001701(in utero embryonic development);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0035145(exon-exon junction complex);GO:0044547(DNA topoisomerase binding);GO:0050733(RS domain binding);GO:0060048(cardiac muscle contraction);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome);04657(IL-17 signaling pathway);05168(Herpes simplex infection)",{"v":0.0021,"d":"0.00"},1,"210,",0,-2.67,-2.06,{"v":11.9,"d":"11.90"},"5' UTR",19,61726179,61729572,3394,1]
["chr19",62880208,62892349,12142,"ENSBGRG00000017148","ENSBGRT00000031513",683,"COIL","coilin [Source:HGNC Symbol;Acc:HGNC:2184]","GO:0001650(fibrillar center);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0008022(protein C-terminus binding);GO:0015030(Cajal body);GO:0016604(nuclear body);GO:0042802(identical protein binding)","NA",{"v":3.2e-67,"d":"0.00"},2,"30,239,","0,11903",{"v":-66.5,"d":"-66.50"},{"v":-65.1,"d":"-65.10"},3.08,"Exon (ENSBGRT00000031513/ENSBGRG00000017148, exon 1 of 5)",19,62879525,62897103,17579,1]
["chr19",7960066,7960274,209,"ENSBGRG00000015480","ENSBGRT00000028606",12214,"OTOP3","otopetrin 3 [Source:HGNC Symbol;Acc:HGNC:19658]","NA","NA",{"v":6.9e-08,"d":"0.00"},1,"209,",0,-7.16,-6.38,2.57,"3' UTR",19,7947852,7962636,14785,1]
["chr19",8141308,8141368,61,"ENSBGRG00000016708","ENSBGRT00000030668",119,"NT5C","5', 3'-nucleotidase, cytosolic [Source:HGNC Symbol;Acc:HGNC:17144]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008252(nucleotidase activity);GO:0008253(5'-nucleotidase activity);GO:0009223(pyrimidine deoxyribonucleotide catabolic process);GO:0009264(deoxyribonucleotide catabolic process);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0019103(pyrimidine nucleotide binding);GO:0042802(identical protein binding)","00230(Purine metabolism);00240(Pyrimidine metabolism);00760(Nicotinate and nicotinamide metabolism)",{"v":0.011,"d":"0.01"},1,"61,",0,-1.97,{"v":-1.4,"d":"-1.40"},3.06,"5' UTR",19,8139348,8141487,2140,2]
["chr19",8989770,8990302,533,"ENSBGRG00000024133","ENSBGRT00000044791",18806,"EXOC7","exocyst complex component 7 [Source:HGNC Symbol;Acc:HGNC:23214]","GO:0000145(exocyst);GO:0005815(microtubule organizing center);GO:0006887(exocytosis);GO:0032584(growth cone membrane);GO:0034451(centriolar satellite);GO:2000535(regulation of entry of bacterium into host cell)","04910(Insulin signaling pathway)",{"v":1E-125,"d":"0.00"},3,"31,134,15,","0,278,518",-125,-123,2.75,"Exon (ENSBGRT00000044791/ENSBGRG00000024133, exon 18 of 20)",19,8988698,9009108,20411,2]
["chr19",9354806,9355075,270,"ENSBGRG00000025250","ENSBGRT00000046720",18950,"RHBDF2","rhomboid 5 homolog 2 [Source:HGNC Symbol;Acc:HGNC:20788]","GO:0004252(serine-type endopeptidase activity);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0016021(integral component of membrane);GO:0050709(negative regulation of protein secretion)","NA",{"v":6.3e-81,"d":"0.00"},1,"270,",0,{"v":-80.2,"d":"-80.20"},{"v":-78.7,"d":"-78.70"},5.98,"3' UTR",19,9354507,9374025,19519,2]
["chr19",11487288,11487646,359,"ENSBGRG00000019711","ENSBGRT00000036315",8684,"LGALS3BP","galectin 3 binding protein [Source:HGNC Symbol;Acc:HGNC:6564]","GO:0005044(scavenger receptor activity);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0016020(membrane)","NA",0,1,"359,",0,-578,"-Inf",4.88,"3' UTR",19,11486720,11496330,9611,2]
["chr19",13590848,13591387,540,"ENSBGRG00000025230","ENSBGRT00000046743",41394,"SLC38A10","solute carrier family 38 member 10 [Source:HGNC Symbol;Acc:HGNC:28237]","GO:0005794(Golgi apparatus);GO:0060348(bone development)","NA",{"v":1e-195,"d":"0.00"},2,"268,91,","0,449",-195,-193,5.33,"Exon (ENSBGRT00000046743/ENSBGRG00000025230, exon 10 of 14)",19,13584212,13632781,48570,2]
["chr19",14399285,14399434,150,"ENSBGRG00000005775","ENSBGRT00000010657",34954,"ENSBGRG00000005775","NA","NA","00061(Fatty acid biosynthesis);04152(AMPK signaling pathway);04910(Insulin signaling pathway)",{"v":3.2e-17,"d":"0.00"},1,"150,",0,{"v":-16.5,"d":"-16.50"},{"v":-15.6,"d":"-15.60"},1.92,"3' UTR",19,14398541,14434388,35848,2]
["chr19",17306582,17309778,3197,"ENSBGRG00000009386","ENSBGRT00000017267",21398,"DDX42","DEAD-box helicase 42 [Source:HGNC Symbol;Acc:HGNC:18676]","GO:0003676(nucleic acid binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008104(protein localization);GO:0016607(nuclear speck);GO:0042981(regulation of apoptotic process)","03040(Spliceosome)",{"v":1e-130,"d":"0.00"},4,"163,102,111,12,","0,601,1765,3185",-130,-128,2.55,"Exon (ENSBGRT00000017267/ENSBGRG00000009386, exon 14 of 17)",19,17306016,17331176,25161,2]
["chr19",21898283,21898583,301,"ENSBGRG00000004065","ENSBGRT00000007743",4119,"HROB","homologous recombination factor with OB-fold [Source:HGNC Symbol;Acc:HGNC:28460]","GO:0000731(DNA synthesis involved in DNA repair);GO:0003697(single-stranded DNA binding);GO:0006974(cellular response to DNA damage stimulus);GO:0007292(female gamete generation);GO:0036297(interstrand cross-link repair);GO:0048232(male gamete generation);GO:0090734(site of DNA damage)","NA",{"v":2.5e-08,"d":"0.00"},1,"301,",0,{"v":-7.6,"d":"-7.60"},-6.81,7.56,"Exon (ENSBGRT00000007743/ENSBGRG00000004065, exon 4 of 12)",19,21888755,21902702,13948,2]
["chr19",22152121,22152300,180,"ENSBGRG00000004888","ENSBGRT00000008985",923,"ENSBGRG00000004888","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":1.9e-05,"d":"0.00"},1,"180,",0,-4.71,-4,4.08,"Exon (ENSBGRT00000008985/ENSBGRG00000004888, exon 1 of 1)",19,22151496,22153223,1728,2]
["chr19",23981448,23981566,119,"ENSBGRG00000013438","ENSBGRT00000024655",1764,"CNP","2',3'-cyclic nucleotide 3' phosphodiesterase [Source:HGNC Symbol;Acc:HGNC:2158]","GO:0004113(2',3'-cyclic-nucleotide 3'-phosphodiesterase activity);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007409(axonogenesis);GO:0008344(adult locomotory behavior);GO:0009214(cyclic nucleotide catabolic process);GO:0009636(response to toxic substance);GO:0016020(membrane);GO:0043209(myelin sheath);GO:0048709(oligodendrocyte differentiation)","NA",{"v":1.3E-83,"d":"0.00"},1,"119,",0,{"v":-82.9,"d":"-82.90"},{"v":-81.3,"d":"-81.30"},4,"Exon (ENSBGRT00000024655/ENSBGRG00000013438, exon 2 of 4)",19,23977336,23983330,5995,2]
["chr19",25793816,25796437,2622,"ENSBGRG00000019646","ENSBGRT00000036153",16650,"WIPF2","WAS/WASL interacting protein family member 2 [Source:HGNC Symbol;Acc:HGNC:30923]","GO:0003779(actin binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane)","04144(Endocytosis)",{"v":0.00036,"d":"0.00"},3,"41,102,96,","0,279,2526",-3.44,-2.78,13,"Exon (ENSBGRT00000036153/ENSBGRG00000019646, exon 6 of 7)",19,25793816,25813087,19272,2]
["chr19",27440265,27440325,61,"ENSBGRG00000017050","ENSBGRT00000031782",36329,"ARHGAP23","Rho GTPase activating protein 23 [Source:HGNC Symbol;Acc:HGNC:29293]","GO:0005515(protein binding);GO:0007165(signal transduction)","NA",{"v":2e-29,"d":"0.00"},1,"61,",0,{"v":-28.7,"d":"-28.70"},{"v":-27.6,"d":"-27.60"},6.98,"Exon (ENSBGRT00000031782/ENSBGRG00000017050, exon 7 of 25)",19,27404106,27476654,72549,2]
["chr19",29407969,29408149,181,"ENSBGRG00000022961","ENSBGRT00000042616",14409,"ABI3","ABI family member 3 [Source:HGNC Symbol;Acc:HGNC:29859]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0030027(lamellipodium);GO:0030334(regulation of cell migration);GO:0042802(identical protein binding)","04810(Regulation of actin cytoskeleton)",{"v":2.6e-06,"d":"0.00"},1,"181,",0,-5.58,-4.84,2.28,"3' UTR",19,29393560,29422204,28645,1]
["chr19",30428361,30428630,270,"ENSBGRG00000005548","ENSBGRT00000010265",20131,"ENSBGRG00000005548","NA","GO:0005201(extracellular matrix structural constituent)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04611(Platelet activation);04926(Relaxin signaling pathway);04974(Protein digestion and absorption);04933(AGE-RAGE signaling pathway in diabetic complications);05165(Human papillomavirus infection);05146(Amoebiasis)",0,1,"270,",0,-13600,"-Inf",4.99,"Exon (ENSBGRT00000010265/ENSBGRG00000005548, exon 49 of 49)",19,30428361,30448761,20401,2]
["chr19",32304871,32305363,493,"ENSBGRG00000013295","ENSBGRT00000024420",5914,"ENSBGRG00000013295","NA","GO:0006656(phosphatidylcholine biosynthetic process);GO:0008757(S-adenosylmethionine-dependent methyltransferase activity)","00564(Glycerophospholipid metabolism)",{"v":0.043,"d":"0.04"},2,"88,183,","0,310",-1.37,{"v":-0.6,"d":"-0.60"},{"v":5.4,"d":"5.40"},"3' UTR",19,32300707,32311277,10571,2]
["chr19",33947673,33948208,536,"ENSBGRG00000011022","ENSBGRT00000021875",39436,"NCOR1","nuclear receptor corepressor 1 [Source:HGNC Symbol;Acc:HGNC:7672]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0003677(DNA binding);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016580(Sin3 complex);GO:0017053(transcriptional repressor complex);GO:0035257(nuclear hormone receptor binding);GO:0042826(histone deacetylase binding);GO:0045820(negative regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045922(negative regulation of fatty acid metabolic process);GO:0046329(negative regulation of JNK cascade);GO:0051225(spindle assembly);GO:0060766(negative regulation of androgen receptor signaling pathway);GO:0072686(mitotic spindle);GO:1903799(negative regulation of production of miRNAs involved in gene silencing by miRNA)","04919(Thyroid hormone signaling pathway);05202(Transcriptional misregulation in cancers);01522(Endocrine resistance)",{"v":7.2e-06,"d":"0.00"},2,"7,54,","0,482",-5.14,-4.41,1.64,"Exon (ENSBGRT00000021875/ENSBGRG00000011022, exon 9 of 43)",19,33872241,33987644,115404,2]
["chr19",40407766,40409416,1651,"ENSBGRG00000026747","ENSBGRT00000049604",5132,"CNTROB","centrobin, centriole duplication and spindle assembly protein [Source:HGNC Symbol;Acc:HGNC:29616]","GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0007099(centriole replication);GO:0019904(protein domain specific binding);GO:0051299(centrosome separation);GO:1902017(regulation of cilium assembly);GO:1902410(mitotic cytokinetic process)","NA",{"v":2e-25,"d":"0.00"},3,"12,237,80,","0,307,1571",{"v":-24.7,"d":"-24.70"},{"v":-23.7,"d":"-23.70"},{"v":2.2,"d":"2.20"},"Exon (ENSBGRT00000049604/ENSBGRG00000026747, exon 7 of 19)",19,40399483,40414548,15066,2]
["chr19",40511682,40511741,60,"ENSBGRG00000011083","ENSBGRT00000020740",2487,"KDM6B","lysine demethylase 6B [Source:HGNC Symbol;Acc:HGNC:29012]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0006338(chromatin remodeling);GO:0008013(beta-catenin binding);GO:0010468(regulation of gene expression);GO:0016577(histone demethylation);GO:0043565(sequence-specific DNA binding);GO:0045165(cell fate commitment);GO:0045446(endothelial cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048333(mesodermal cell differentiation);GO:0055007(cardiac muscle cell differentiation);GO:0070301(cellular response to hydrogen peroxide);GO:0071557(histone H3-K27 demethylation);GO:0071558(histone demethylase activity (H3-K27 specific));GO:0120162(positive regulation of cold-induced thermogenesis)","NA",{"v":5e-30,"d":"0.00"},1,"60,",0,{"v":-29.3,"d":"-29.30"},{"v":-28.2,"d":"-28.20"},2.51,"Exon (ENSBGRT00000020740/ENSBGRG00000011083, exon 8 of 22)",19,40505086,40514228,9143,2]
["chr19",40996874,40996993,120,"ENSBGRG00000020229","ENSBGRT00000037447",13490,"ACAP1","ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 [Source:HGNC Symbol;Acc:HGNC:16467]","GO:0005096(GTPase activator activity);GO:0005515(protein binding)","04144(Endocytosis)",{"v":1.6e-30,"d":"0.00"},1,"120,",0,{"v":-29.8,"d":"-29.80"},{"v":-28.7,"d":"-28.70"},{"v":10.7,"d":"10.70"},"3' UTR",19,40995530,41010483,14954,2]
["chr19",42111673,42115313,3641,"ENSBGRG00000011317","ENSBGRT00000020705",6061,"DERL2","derlin 2 [Source:HGNC Symbol;Acc:HGNC:17943]","GO:0001967(suckling behavior);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005783(endoplasmic reticulum);GO:0005785(signal recognition particle receptor complex);GO:0008284(positive regulation of cell population proliferation);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0030307(positive regulation of cell growth);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0030970(retrograde protein transport, ER to cytosol);GO:0048500(signal recognition particle);GO:1904153(negative regulation of retrograde protein transport, ER to cytosol)","04141(Protein processing in endoplasmic reticulum)",{"v":1.6e-33,"d":"0.00"},3,"76,115,47,","0,1720,3594",{"v":-32.8,"d":"-32.80"},{"v":-31.6,"d":"-31.60"},2.63,"3' UTR",19,42111643,42121374,9732,2]
["chr19",43062942,43064318,1377,"ENSBGRG00000012996","ENSBGRT00000024087",748,"ENSBGRG00000012996","NA","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04611(Platelet activation);04926(Relaxin signaling pathway);04974(Protein digestion and absorption);04933(AGE-RAGE signaling pathway in diabetic complications);05165(Human papillomavirus infection);05146(Amoebiasis)",{"v":0.0021,"d":"0.00"},6,"4,12,15,168,3,1145,","0,24,38,55,227,232",-2.67,-2.06,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000024087/ENSBGRG00000012996, exon 1 of 16)",19,43061023,43065066,4044,2]
["chr19",45549399,45549577,179,"ENSBGRG00000024736","ENSBGRT00000045691",1495,"HIC1","HIC ZBTB transcriptional repressor 1 [Source:HGNC Symbol;Acc:HGNC:4909]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0030178(negative regulation of Wnt signaling pathway);GO:0042826(histone deacetylase binding);GO:0043565(sequence-specific DNA binding);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":5e-14,"d":"0.00"},1,"179,",0,{"v":-13.3,"d":"-13.30"},{"v":-12.4,"d":"-12.40"},{"v":42.1,"d":"42.10"},"Exon (ENSBGRT00000045691/ENSBGRG00000024736, exon 3 of 3)",19,45547946,45551072,3127,2]
["chr19",47696123,47702127,6005,"ENSBGRG00000018903","ENSBGRT00000035048",55016,"EFCAB5","EF-hand calcium binding domain 5 [Source:HGNC Symbol;Acc:HGNC:24801]","GO:0005509(calcium ion binding)","NA",{"v":0.025,"d":"0.03"},4,"136,93,78,320,","0,3520,3707,5685",-1.61,-1.07,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000035048/ENSBGRG00000018903, exon 11 of 25)",19,47659447,47757143,97697,2]
["chr19",54607601,54618362,10762,"ENSBGRG00000021151","ENSBGRT00000039030",119,"ENSBGRG00000021151","NA","NA","NA",{"v":0.043,"d":"0.04"},2,"337,139,","0,10623",-1.37,{"v":-0.6,"d":"-0.60"},6.48,"Exon (ENSBGRT00000039030/ENSBGRG00000021151, exon 1 of 2)",19,54605671,54618481,12811,2]
["chr19",57598369,57598726,358,"ENSBGRG00000018430","ENSBGRT00000033741",0,"APPBP2","amyloid beta precursor protein binding protein 2 [Source:HGNC Symbol;Acc:HGNC:622]","GO:0005515(protein binding);GO:0006886(intracellular protein transport);GO:0030659(cytoplasmic vesicle membrane);GO:0046907(intracellular transport)","NA",{"v":7.9e-17,"d":"0.00"},1,"358,",0,{"v":-16.1,"d":"-16.10"},{"v":-15.1,"d":"-15.10"},{"v":31.9,"d":"31.90"},"5' UTR",19,57540282,57598726,58445,2]
["chr19",60760741,60760878,138,"ENSBGRG00000024451","ENSBGRT00000045120",45007,"TEX14","testis expressed 14, intercellular bridge forming factor [Source:HGNC Symbol;Acc:HGNC:11737]","GO:0000776(kinetochore);GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007094(mitotic spindle assembly checkpoint);GO:0007140(male meiotic nuclear division);GO:0008608(attachment of spindle microtubules to kinetochore);GO:0019901(protein kinase binding);GO:0030496(midbody);GO:0032091(negative regulation of protein binding);GO:0032466(negative regulation of cytokinesis);GO:0043063(intercellular bridge organization);GO:0045171(intercellular bridge);GO:0051306(mitotic sister chromatid separation);GO:1990830(cellular response to leukemia inhibitory factor)","NA",{"v":0.017,"d":"0.02"},1,"138,",0,-1.77,-1.22,7.56,"Exon (ENSBGRT00000045302/ENSBGRG00000024545, exon 1 of 1)",19,60715734,60793438,77705,1]
["chr20",6581939,6582414,476,"ENSBGRG00000019121","ENSBGRT00000035163",14307,"MARVELD3","MARVEL domain containing 3 [Source:HGNC Symbol;Acc:HGNC:30525]","GO:0005923(bicellular tight junction);GO:0006970(response to osmotic stress);GO:0010633(negative regulation of epithelial cell migration);GO:0016020(membrane);GO:0031410(cytoplasmic vesicle);GO:0031435(mitogen-activated protein kinase kinase kinase binding);GO:0045216(cell-cell junction organization);GO:0046329(negative regulation of JNK cascade);GO:0050680(negative regulation of epithelial cell proliferation);GO:0070830(bicellular tight junction assembly);GO:1902414(protein localization to cell junction)","04530(Tight junction)",{"v":0.0021,"d":"0.00"},1,"476,",0,-2.67,-2.06,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000035163/ENSBGRG00000019121, exon 3 of 3)",20,6567632,6582414,14783,1]
["chr20",7008196,7008285,90,"ENSBGRG00000020621","ENSBGRT00000038142",6697,"ENSBGRG00000020621","NA","GO:0004252(serine-type endopeptidase activity);GO:0005576(extracellular region);GO:0006508(proteolysis);GO:0007219(Notch signaling pathway);GO:0009617(response to bacterium);GO:0030492(hemoglobin binding)","03040(Spliceosome)",{"v":2.3E-3,"d":"0.00"},1,"90,",0,-2.64,-2.02,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000038142/ENSBGRG00000020621, exon 7 of 7)",20,7001499,7008375,6877,1]
["chr20",9884256,9887637,3382,"ENSBGRG00000008628","ENSBGRT00000015959",2964,"ENSBGRG00000008628","NA","GO:0017119(Golgi transport complex)","NA",{"v":4e-83,"d":"0.00"},2,"420,27,","0,3355",{"v":-82.4,"d":"-82.40"},{"v":-80.9,"d":"-80.90"},5.31,"Exon (ENSBGRT00000015959/ENSBGRG00000008628, exon 3 of 5)",20,9881292,9889369,8078,1]
["chr20",11817626,11817803,178,"ENSBGRG00000026883","ENSBGRT00000049849",8694,"TRADD","TNFRSF1A associated via death domain [Source:HGNC Symbol;Acc:HGNC:12030]","GO:0002947(tumor necrosis factor receptor superfamily complex);GO:0005068(transmembrane receptor protein tyrosine kinase adaptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0019900(kinase binding);GO:0030335(positive regulation of cell migration);GO:0042802(identical protein binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043235(receptor complex);GO:0050729(positive regulation of inflammatory response);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051798(positive regulation of hair follicle development);GO:0060090(molecular adaptor activity);GO:0070513(death domain binding);GO:0071356(cellular response to tumor necrosis factor);GO:0097191(extrinsic apoptotic signaling pathway);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04010(MAPK signaling pathway);04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04071(Sphingolipid signaling pathway);04210(Apoptosis);04217(Necroptosis);04622(RIG-I-like receptor signaling pathway);04657(IL-17 signaling pathway);04920(Adipocytokine signaling pathway);05203(Viral carcinogenesis);05152(Tuberculosis);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection)",{"v":1.3E-13,"d":"0.00"},1,"178,",0,{"v":-12.9,"d":"-12.90"},-12,2.49,"3' UTR",20,11808932,11818188,9257,1]
["chr20",22052677,22057576,4900,"ENSBGRG00000017700","ENSBGRT00000032435",6411,"CCDC102A","coiled-coil domain containing 102A [Source:HGNC Symbol;Acc:HGNC:28097]","GO:0003774(motor activity);GO:0016459(myosin complex)","NA",{"v":5e-19,"d":"0.00"},3,"120,224,107,","0,2901,4793",{"v":-18.3,"d":"-18.30"},{"v":-17.3,"d":"-17.30"},3.33,"Exon (ENSBGRT00000032435/ENSBGRG00000017700, exon 2 of 9)",20,22046266,22066897,20632,1]
["chr20",30344418,30344567,150,"ENSBGRG00000012116","ENSBGRT00000022544",106056,"ZNF423","zinc finger protein 423 [Source:HGNC Symbol;Acc:HGNC:16762]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0007219(Notch signaling pathway);GO:0021930(cerebellar granule cell precursor proliferation);GO:0021938(smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation);GO:0030513(positive regulation of BMP signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060271(cilium assembly);GO:0061512(protein localization to cilium);GO:0120163(negative regulation of cold-induced thermogenesis)","NA",{"v":0.00071,"d":"0.00"},1,"150,",0,-3.15,{"v":-2.5,"d":"-2.50"},1.95,"Exon (ENSBGRT00000022544/ENSBGRG00000012116, exon 4 of 8)",20,30238362,30474149,235788,1]
["chr20",34071884,34072693,810,"ENSBGRG00000021795","ENSBGRT00000040387",8752,"ENSBGRG00000021795","NA","GO:0005737(cytoplasm)","NA",{"v":3.5e-06,"d":"0.00"},2,"100,51,","0,759",-5.46,-4.72,3.04,"Exon (ENSBGRT00000040387/ENSBGRG00000021795, exon 3 of 4)",20,34063132,34073800,10669,1]
["chr20",34561393,34561602,210,"ENSBGRG00000026866","ENSBGRT00000049815",67927,"ANKRD11","ankyrin repeat domain 11 [Source:HGNC Symbol;Acc:HGNC:21316]","GO:0001701(in utero embryonic development);GO:0001894(tissue homeostasis);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0035264(multicellular organism growth);GO:0042475(odontogenesis of dentin-containing tooth);GO:0048705(skeletal system morphogenesis);GO:0060323(head morphogenesis);GO:0060325(face morphogenesis);GO:0060348(bone development)","NA",{"v":2.5e-23,"d":"0.00"},1,"210,",0,{"v":-22.6,"d":"-22.60"},{"v":-21.6,"d":"-21.60"},1.95,"Exon (ENSBGRT00000049815/ENSBGRG00000026866, exon 9 of 13)",20,34493466,34570457,76992,1]
["chr20",35018395,35018608,214,"ENSBGRG00000026892","ENSBGRT00000049878",1941,"PIEZO1","piezo type mechanosensitive ion channel component 1 [Source:HGNC Symbol;Acc:HGNC:28993]","GO:0005783(endoplasmic reticulum);GO:0008381(mechanosensitive ion channel activity);GO:0016021(integral component of membrane);GO:0033625(positive regulation of integrin activation);GO:0033634(positive regulation of cell-cell adhesion mediated by integrin)","NA",{"v":1e-34,"d":"0.00"},2,"61,150,","0,64",-34,{"v":-32.8,"d":"-32.80"},1.86,"Exon (ENSBGRT00000049878/ENSBGRG00000026892, exon 7 of 8)",20,35016454,35018608,2155,1]
["chr20",38788779,38788868,90,"ENSBGRG00000016002","ENSBGRT00000029385",18923,"MEAK7","MTOR associated protein, eak-7 homolog [Source:HGNC Symbol;Acc:HGNC:29325]","GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0016020(membrane);GO:0030334(regulation of cell migration);GO:0031667(response to nutrient levels);GO:0031929(TOR signaling);GO:0032868(response to insulin);GO:0042127(regulation of cell population proliferation);GO:0043200(response to amino acid);GO:0150032(positive regulation of protein localization to lysosome);GO:1903204(negative regulation of oxidative stress-induced neuron death)","NA",{"v":1.2e-06,"d":"0.00"},1,"90,",0,-5.93,-5.18,4.54,"3' UTR",20,38769856,38788988,19133,1]
["chr20",42116794,42125792,8999,"ENSBGRG00000023267","ENSBGRT00000043073",23144,"C16orf46","chromosome 16 open reading frame 46 [Source:HGNC Symbol;Acc:HGNC:26525]","GO:0005654(nucleoplasm);GO:0005829(cytosol)","00630(Glyoxylate and dicarboxylate metabolism);00260(Glycine, serine and threonine metabolism)",{"v":4.1e-09,"d":"0.00"},3,"309,21,24,","0,8931,8975",-8.39,-7.58,3.24,"Exon (ENSBGRT00000043073/ENSBGRG00000023267, exon 4 of 4)",20,42093650,42117102,23453,1]
["chr20",47927294,47928190,897,"ENSBGRG00000013119","ENSBGRT00000023949",20521,"BCAR1","BCAR1 scaffold protein, Cas family member [Source:HGNC Symbol;Acc:HGNC:971]","GO:0001726(ruffle);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0007015(actin filament organization);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0010595(positive regulation of endothelial cell migration);GO:0015629(actin cytoskeleton);GO:0016477(cell migration);GO:0019901(protein kinase binding);GO:0030027(lamellipodium);GO:0030335(positive regulation of cell migration);GO:0035729(cellular response to hepatocyte growth factor stimulus);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048012(hepatocyte growth factor receptor signaling pathway);GO:0050851(antigen receptor-mediated signaling pathway);GO:0050853(B cell receptor signaling pathway);GO:0060326(cell chemotaxis);GO:0086100(endothelin receptor signaling pathway)","04015(Rap1 signaling pathway);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04670(Leukocyte transendothelial migration);04062(Chemokine signaling pathway);05100(Bacterial invasion of epithelial cells);05163(Human cytomegalovirus infection)",{"v":1e-113,"d":"0.00"},2,"147,4,","0,893",-113,-112,5.77,"Exon (ENSBGRT00000023949/ENSBGRG00000013119, exon 7 of 9)",20,47906773,47931465,24693,1]
["chr20",49713951,49714400,450,"ENSBGRG00000020069","ENSBGRT00000036936",0,"UQCRFS1","ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [Source:HGNC Symbol;Acc:HGNC:12587]","GO:0008121(ubiquinol-cytochrome-c reductase activity);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0016679(oxidoreductase activity, acting on diphenols and related substances as donors);GO:0051537(2 iron, 2 sulfur cluster binding);GO:0055114(oxidation-reduction process)","00190(Oxidative phosphorylation);04260(Cardiac muscle contraction);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":0.00056,"d":"0.00"},1,"450,",0,-3.25,{"v":-2.6,"d":"-2.60"},14,"Exon (ENSBGRT00000036936/ENSBGRG00000020069, exon 1 of 2)",20,49713951,49721203,7253,1]
["chr20",52693464,52693524,61,"ENSBGRG00000019600","ENSBGRT00000036259",11824,"TMC4","transmembrane channel like 4 [Source:HGNC Symbol;Acc:HGNC:22998]","GO:0005887(integral component of plasma membrane);GO:0016021(integral component of membrane)","NA",{"v":2.2e-07,"d":"0.00"},1,"61,",0,-6.66,-5.89,1.79,"3' UTR",20,52681640,52702020,20381,1]
["chr20",52901877,52902717,841,"ENSBGRG00000021117","ENSBGRT00000039161",1908,"NLRP8","NLR family pyrin domain containing 8 [Source:HGNC Symbol;Acc:HGNC:22940]","GO:0005515(protein binding)","NA",{"v":0.043,"d":"0.04"},1,"841,",0,-1.37,{"v":-0.6,"d":"-0.60"},6.48,"Exon (ENSBGRT00000039161/ENSBGRG00000021117, exon 3 of 9)",20,52899969,52920274,20306,1]
["chr20",53333988,53334407,420,"ENSBGRG00000022177","ENSBGRT00000040928",13826,"ZNF471","zinc finger protein 471 [Source:HGNC Symbol;Acc:HGNC:23226]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":4e-36,"d":"0.00"},1,"420,",0,{"v":-35.4,"d":"-35.40"},{"v":-34.2,"d":"-34.20"},{"v":3.7,"d":"3.70"},"3' UTR",20,53320162,53335065,14904,1]
["chr20",54546126,54546273,148,"ENSBGRG00000015507","ENSBGRT00000028462",706,"ENSBGRG00000015507","NA","NA","NA",{"v":1.9e-05,"d":"0.00"},1,"148,",0,-4.73,-4.02,{"v":4.2,"d":"4.20"},"Exon (ENSBGRT00000028462/ENSBGRG00000015507, exon 1 of 1)",20,54545420,54546508,1089,1]
["chr20",54747846,54748025,180,"ENSBGRG00000015921","ENSBGRT00000029225",6446,"ENSBGRG00000015921","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1e-28,"d":"0.00"},1,"180,",0,-28,{"v":-26.9,"d":"-26.90"},4.42,"Exon (ENSBGRT00000029225/ENSBGRG00000015921, exon 4 of 4)",20,54741400,54748561,7162,1]
["chr20",55250482,55251136,655,"ENSBGRG00000017010","ENSBGRT00000031245",2984,"ENSBGRG00000017010","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1E-134,"d":"0.00"},1,"655,",0,-134,-132,6.31,"Exon (ENSBGRT00000031245/ENSBGRG00000017010, exon 3 of 4)",20,55247498,55253062,5565,1]
["chr20",55603185,55603365,181,"ENSBGRG00000014568","ENSBGRT00000026776",16902,"ENSBGRG00000014568","NA","GO:0003676(nucleic acid binding);GO:0003677(DNA binding)","NA",{"v":1.6e-28,"d":"0.00"},1,"181,",0,{"v":-27.8,"d":"-27.80"},{"v":-26.7,"d":"-26.70"},3.41,"3' UTR",20,55586283,55603807,17525,1]
["chr20",56491185,56491274,90,"ENSBGRG00000015904","ENSBGRT00000029198",3440,"ENSBGRG00000015904","NA","GO:0003676(nucleic acid binding)","NA",{"v":0.043,"d":"0.04"},1,"90,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000029198/ENSBGRG00000015904, exon 2 of 2)",20,56487745,56491274,3530,1]
["chr20",58810656,58810775,120,"ENSBGRG00000020773","ENSBGRT00000038272",1960,"ATF5","activating transcription factor 5 [Source:HGNC Symbol;Acc:HGNC:790]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0008285(negative regulation of cell population proliferation);GO:0009791(post-embryonic development);GO:0010468(regulation of gene expression);GO:0015631(tubulin binding);GO:0019900(kinase binding);GO:0021889(olfactory bulb interneuron differentiation);GO:0021891(olfactory bulb interneuron development);GO:0021930(cerebellar granule cell precursor proliferation);GO:0021988(olfactory lobe development);GO:0035264(multicellular organism growth);GO:0043066(negative regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045444(fat cell differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046605(regulation of centrosome cycle);GO:1902750(negative regulation of cell cycle G2/M phase transition)","NA",{"v":2.5e-19,"d":"0.00"},1,"120,",0,{"v":-18.6,"d":"-18.60"},{"v":-17.6,"d":"-17.60"},1.82,"Exon (ENSBGRT00000038401/ENSBGRG00000020834, exon 1 of 3)",20,58779797,58812735,32939,2]
["chr20",58825346,58825680,335,"ENSBGRG00000020877","ENSBGRT00000038530",4441,"IL4I1","interleukin 4 induced 1 [Source:HGNC Symbol;Acc:HGNC:19094]","GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00250(Alanine, aspartate and glutamate metabolism);00270(Cysteine and methionine metabolism);00280(Valine, leucine and isoleucine degradation);00350(Tyrosine metabolism);00360(Phenylalanine metabolism);00380(Tryptophan metabolism);00400(Phenylalanine, tyrosine and tryptophan biosynthesis)",{"v":1e-31,"d":"0.00"},3,"247,41,41,","0,251,294",-31,{"v":-29.9,"d":"-29.90"},4,"Exon (ENSBGRT00000038530/ENSBGRG00000020877, exon 7 of 9)",20,58820905,58825710,4806,1]
["chr20",60263501,60263591,91,"ENSBGRG00000021948","ENSBGRT00000040539",22706,"ENSBGRG00000021948","NA","NA","NA",{"v":0.012,"d":"0.01"},1,"91,",0,-1.92,-1.35,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000040539/ENSBGRG00000021948, exon 8 of 15)",20,60240795,60267627,26833,1]
["chr20",61815791,61816975,1185,"ENSBGRG00000018221","ENSBGRT00000033316",1245,"ENSBGRG00000018221","NA","NA","NA",{"v":2.3E-3,"d":"0.00"},2,"263,34,","0,1151",-2.63,-2.01,7.02,"Exon (ENSBGRT00000033316/ENSBGRG00000018221, exon 2 of 2)",20,61814546,61816053,1508,1]
["chr20",62203890,62204039,150,"ENSBGRG00000019522","ENSBGRT00000035868",0,"IRF2BP1","interferon regulatory factor 2 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:21728]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000209(protein polyubiquitination);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008134(transcription factor binding);GO:0046872(metal ion binding);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":5e-67,"d":"0.00"},1,"150,",0,{"v":-66.3,"d":"-66.30"},{"v":-64.9,"d":"-64.90"},8.46,"Exon (ENSBGRT00000035868/ENSBGRG00000019522, exon 1 of 1)",20,62203890,62205644,1755,1]
["chr20",62777438,62777497,60,"ENSBGRG00000023668","ENSBGRT00000043718",4802,"ENSBGRG00000023668","NA","GO:0000145(exocyst);GO:0006887(exocytosis)","NA",{"v":0.00069,"d":"0.00"},1,"60,",0,-3.16,-2.51,{"v":8.1,"d":"8.10"},"5' UTR",20,62772636,62781400,8765,1]
["chr20",64043339,64044748,1410,"ENSBGRG00000011490","ENSBGRT00000020928",4013,"IRGQ","immunity related GTPase Q [Source:HGNC Symbol;Acc:HGNC:24868]","GO:0005525(GTP binding)","NA",{"v":7.9e-72,"d":"0.00"},2,"209,267,","0,1143",{"v":-71.1,"d":"-71.10"},{"v":-69.7,"d":"-69.70"},7.22,"Exon (ENSBGRT00000020928/ENSBGRG00000011490, exon 2 of 3)",20,64039326,64045994,6669,1]
["chr20",64798394,64798633,240,"ENSBGRG00000016709","ENSBGRT00000030643",987,"ENSBGRG00000016709","NA","NA","NA",{"v":0.00025,"d":"0.00"},1,"240,",0,{"v":-3.6,"d":"-3.60"},-2.93,14,"Exon (ENSBGRT00000030643/ENSBGRG00000016709, exon 1 of 1)",20,64797407,64798633,1227,1]
["chr20",65113949,65114333,385,"ENSBGRG00000018363","ENSBGRT00000033588",503,"ENSBGRG00000018363","NA","NA","NA",{"v":1e-101,"d":"0.00"},1,"385,",0,-101,{"v":-99.5,"d":"-99.50"},3.39,"Exon (ENSBGRT00000033588/ENSBGRG00000018363, exon 1 of 1)",20,65113446,65114777,1332,1]
["chr20",67103981,67106518,2538,"ENSBGRG00000024369","ENSBGRT00000045070",2907,"PAF1","PAF1 homolog, Paf1/RNA polymerase II complex component [Source:HGNC Symbol;Acc:HGNC:25459]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000993(RNA polymerase II complex binding);GO:0001711(endodermal cell fate commitment);GO:0003682(chromatin binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0006378(mRNA polyadenylation);GO:0010390(histone monoubiquitination);GO:0016020(membrane);GO:0016570(histone modification);GO:0016584(nucleosome positioning);GO:0016593(Cdc73/Paf1 complex);GO:0019827(stem cell population maintenance);GO:0030054(cell junction);GO:0031062(positive regulation of histone methylation);GO:0031442(positive regulation of mRNA 3'-end processing);GO:0033523(histone H2B ubiquitination);GO:0034504(protein localization to nucleus);GO:0045638(negative regulation of myeloid cell differentiation);GO:0071222(cellular response to lipopolysaccharide);GO:1902808(positive regulation of cell cycle G1/S phase transition)","NA",{"v":8.99999999999999e-296,"d":"0.00"},4,"129,106,91,564,","0,1584,1798,1974",-295,-293,{"v":4.9,"d":"4.90"},"3' UTR",20,67101074,67106518,5445,1]
["chr20",68114146,68114205,60,"ENSBGRG00000026634","ENSBGRT00000049365",0,"GGN","gametogenetin [Source:HGNC Symbol;Acc:HGNC:18869]","GO:0006302(double-strand break repair);GO:0007276(gamete generation)","NA",{"v":0.025,"d":"0.03"},1,"60,",0,-1.61,-1.07,4.86,"Exon (ENSBGRT00000049365/ENSBGRG00000026634, exon 1 of 4)",20,68114146,68117037,2892,1]
["chr20",69257890,69258009,120,"ENSBGRG00000018266","ENSBGRT00000033494",5642,"ENSBGRG00000018266","NA","NA","NA",{"v":0.00065,"d":"0.00"},1,"120,",0,-3.19,-2.54,1.46,"Exon (ENSBGRT00000033494/ENSBGRG00000018266, exon 6 of 6)",20,69252248,69258009,5762,1]
["chr20",70387642,70388444,803,"ENSBGRG00000025300","ENSBGRT00000046772",475,"SBSN","suprabasin [Source:HGNC Symbol;Acc:HGNC:24950]","NA","NA",{"v":0.00056,"d":"0.00"},1,"803,",0,-3.25,{"v":-2.6,"d":"-2.60"},14,"Exon (ENSBGRT00000046772/ENSBGRG00000025300, exon 1 of 2)",20,70387167,70391903,4737,1]
["chr20",71146272,71146541,270,"ENSBGRG00000019082","ENSBGRT00000035108",45476,"ZNF599","zinc finger protein 599 [Source:HGNC Symbol;Acc:HGNC:26408]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":2.8e-09,"d":"0.00"},1,"270,",0,-8.55,-7.73,{"v":12.2,"d":"12.20"},"3' UTR",20,71100796,71148009,47214,1]
["chr20",1947290,1948152,863,"ENSBGRG00000012937","ENSBGRT00000024010",54122,"GPATCH1","G-patch domain containing 1 [Source:HGNC Symbol;Acc:HGNC:24658]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0006397(mRNA processing);GO:0071013(catalytic step 2 spliceosome)","NA",{"v":1e-30,"d":"0.00"},2,"117,94,","0,769",-30,{"v":-28.9,"d":"-28.90"},2.98,"3' UTR",20,1942303,2002274,59972,2]
["chr20",3773944,3774572,629,"ENSBGRG00000017291","ENSBGRT00000031684",4940,"ENSBGRG00000017291","NA","NA","NA",{"v":1.9e-05,"d":"0.00"},1,"629,",0,-4.71,-4,{"v":19.4,"d":"19.40"},"Exon (ENSBGRT00000031684/ENSBGRG00000017291, exon 2 of 2)",20,3772510,3779512,7003,2]
["chr20",7776104,7776254,151,"ENSBGRG00000021541","ENSBGRT00000039732",197068,"ZFHX3","zinc finger homeobox 3 [Source:HGNC Symbol;Acc:HGNC:777]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0016604(nuclear body);GO:0019899(enzyme binding);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0071559(response to transforming growth factor beta)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":0.00026,"d":"0.00"},1,"151,",0,-3.59,-2.93,2.41,"Exon (ENSBGRT00000039732/ENSBGRG00000021541, exon 11 of 11)",20,7774906,7973322,198417,2]
["chr20",10060274,10060901,628,"ENSBGRG00000011661","ENSBGRT00000021503",0,"HAS3","hyaluronan synthase 3 [Source:HGNC Symbol;Acc:HGNC:4820]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0030213(hyaluronan biosynthetic process);GO:0036117(hyaluranon cable);GO:0042802(identical protein binding);GO:0045226(extracellular polysaccharide biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0050501(hyaluronan synthase activity);GO:0085029(extracellular matrix assembly);GO:1900106(positive regulation of hyaluranon cable assembly)","NA",{"v":0.0041,"d":"0.00"},2,"8,618,","0,10",-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000021503/ENSBGRG00000011661, exon 1 of 4)",20,10050271,10060901,10631,2]
["chr20",11179438,11179498,61,"ENSBGRG00000024438","ENSBGRT00000045133",780,"THAP11","THAP domain containing 11 [Source:HGNC Symbol;Acc:HGNC:23194]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0045171(intercellular bridge)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":1e-113,"d":"0.00"},1,"61,",0,-113,-111,3.68,"Exon (ENSBGRT00000045133/ENSBGRG00000024438, exon 1 of 2)",20,11176867,11180278,3412,2]
["chr20",12055108,12055346,239,"ENSBGRG00000026901","ENSBGRT00000049886",0,"PDP2","pyruvate dehyrogenase phosphatase catalytic subunit 2 [Source:HGNC Symbol;Acc:HGNC:30263]","GO:0003824(catalytic activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0043169(cation binding)","NA",{"v":1E-46,"d":"0.00"},1,"239,",0,-46,{"v":-44.7,"d":"-44.70"},5.55,"Exon (ENSBGRT00000049886/ENSBGRG00000026901, exon 1 of 2)",20,12053041,12055346,2306,2]
["chr20",22109955,22110015,61,"ENSBGRG00000017888","ENSBGRT00000032978",7997,"DOK4","docking protein 4 [Source:HGNC Symbol;Acc:HGNC:19868]","GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007399(nervous system development);GO:0043410(positive regulation of MAPK cascade)","05162(Measles)",{"v":2e-28,"d":"0.00"},1,"61,",0,{"v":-27.7,"d":"-27.70"},{"v":-26.6,"d":"-26.60"},1.56,"3' UTR",20,22101958,22120892,18935,1]
["chr20",26339428,26342824,3397,"ENSBGRG00000025060","ENSBGRT00000046893",13604,"CHD9","chromodomain helicase DNA binding protein 9 [Source:HGNC Symbol;Acc:HGNC:25701]","GO:0005515(protein binding);GO:0005524(ATP binding);GO:0016817(hydrolase activity, acting on acid anhydrides)","NA",{"v":0.027,"d":"0.03"},2,"60,1,","0,3396",-1.57,-1.03,3.24,"5' UTR",20,26262564,26356428,93865,2]
["chr20",33275454,33275514,61,"ENSBGRG00000017790","ENSBGRT00000032594",8885,"ENSBGRG00000017790","NA","NA","NA",{"v":0.00059,"d":"0.00"},1,"61,",0,-3.23,-2.59,3.36,"Exon (ENSBGRT00000032594/ENSBGRG00000017790, exon 2 of 2)",20,33275275,33284399,9125,2]
["chr20",35098204,35098705,502,"ENSBGRG00000026911","ENSBGRT00000049908",42547,"ZC3H18","zinc finger CCCH-type containing 18 [Source:HGNC Symbol;Acc:HGNC:25091]","GO:0016607(nuclear speck);GO:0046872(metal ion binding)","NA",{"v":1.1E-4,"d":"0.00"},2,"34,87,","0,415",-3.95,-3.27,{"v":1.5,"d":"1.50"},"Exon (ENSBGRT00000049908/ENSBGRG00000026911, exon 11 of 18)",20,35090968,35141252,50285,2]
["chr20",35295158,35295248,91,"ENSBGRG00000026917","ENSBGRT00000049919",14009,"ENSBGRG00000026917","NA","NA","NA",{"v":2.9e-10,"d":"0.00"},1,"91,",0,-9.54,-8.71,{"v":36.7,"d":"36.70"},"Exon (ENSBGRT00000049924/ENSBGRG00000026919, exon 3 of 34)",20,35281149,35333608,52460,1]
["chr20",42130020,42131513,1494,"ENSBGRG00000023349","ENSBGRT00000043160",11940,"ATMIN","ATM interactor [Source:HGNC Symbol;Acc:HGNC:29034]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0010628(positive regulation of gene expression);GO:0016604(nuclear body);GO:0044458(motile cilium assembly);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0070840(dynein complex binding);GO:1902857(positive regulation of non-motile cilium assembly)","NA",{"v":1E-146,"d":"0.00"},1,"1494,",0,-146,-144,5.64,"3' UTR",20,42129094,42143453,14360,2]
["chr20",48015727,48039894,24168,"ENSBGRG00000013658","ENSBGRT00000025076",183,"ZFP1","ZFP1 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:23328]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1.3E-24,"d":"0.00"},3,"184,127,48,","0,2717,24120",{"v":-23.9,"d":"-23.90"},{"v":-22.9,"d":"-22.90"},4.04,"5' UTR",20,48013873,48040077,26205,2]
["chr20",51432752,51433319,568,"ENSBGRG00000022738","ENSBGRT00000041991",25086,"SSC5D","scavenger receptor cysteine rich family member with 5 domains [Source:HGNC Symbol;Acc:HGNC:26641]","GO:0001968(fibronectin binding);GO:0005044(scavenger receptor activity);GO:0005615(extracellular space);GO:0006952(defense response);GO:0016020(membrane);GO:0032677(regulation of interleukin-8 production);GO:0032717(negative regulation of interleukin-8 production);GO:0042494(detection of bacterial lipoprotein);GO:0043236(laminin binding);GO:0050829(defense response to Gram-negative bacterium);GO:0050830(defense response to Gram-positive bacterium);GO:0050840(extracellular matrix binding);GO:0062023(collagen-containing extracellular matrix)","04970(Salivary secretion)",0,1,"568,",0,-348,"-Inf",5.01,"3' UTR",20,51432722,51458405,25684,2]
["chr20",51810202,51810261,60,"ENSBGRG00000015368","ENSBGRT00000028206",19753,"EPS8L1","EPS8 like 1 [Source:HGNC Symbol;Acc:HGNC:21295]","GO:0003779(actin binding);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0007266(Rho protein signal transduction);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0032587(ruffle membrane);GO:0032991(protein-containing complex);GO:0035023(regulation of Rho protein signal transduction);GO:0042608(T cell receptor binding);GO:1900029(positive regulation of ruffle assembly)","NA",{"v":1e-102,"d":"0.00"},1,"60,",0,-102,-100,4,"3' UTR",20,51809695,51830014,20320,2]
["chr20",53383802,53384219,418,"ENSBGRG00000013184","ENSBGRT00000024272",8323,"ZNF470","zinc finger protein 470 [Source:HGNC Symbol;Acc:HGNC:22220]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0016604(nuclear body)","NA",{"v":2e-71,"d":"0.00"},1,"418,",0,{"v":-70.7,"d":"-70.70"},{"v":-69.3,"d":"-69.30"},3.56,"Exon (ENSBGRT00000024272/ENSBGRG00000013184, exon 6 of 6)",20,53383802,53392542,8741,2]
["chr20",53643796,53644216,421,"ENSBGRG00000013929","ENSBGRT00000025653",11913,"ENSBGRG00000013929","NA","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",0,1,"421,",0,-334,"-Inf",7.82,"3' UTR",20,53643227,53656129,12903,2]
["chr20",54209912,54210121,210,"ENSBGRG00000014537","ENSBGRT00000026690",3239,"ENSBGRG00000014537","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1e-137,"d":"0.00"},1,"210,",0,-137,-135,7.42,"Exon (ENSBGRT00000026758/ENSBGRG00000014537, exon 4 of 4)",20,54189579,54213360,23782,2]
["chr20",54595731,54595790,60,"ENSBGRG00000015710","ENSBGRT00000028929",16351,"ENSBGRG00000015710","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":0.0078,"d":"0.01"},1,"60,",0,-2.11,-1.35,9.72,"Exon (ENSBGRT00000029103/ENSBGRG00000015851, exon 1 of 2)",20,54594415,54612141,17727,2]
["chr20",55531201,55531379,179,"ENSBGRG00000013518","ENSBGRT00000024967",296,"SLC27A5","solute carrier family 27 member 5 [Source:HGNC Symbol;Acc:HGNC:10999]","GO:0000038(very long-chain fatty acid metabolic process);GO:0003824(catalytic activity);GO:0004467(long-chain fatty acid-CoA ligase activity);GO:0005324(long-chain fatty acid transporter activity);GO:0005783(endoplasmic reticulum);GO:0006642(triglyceride mobilization);GO:0006699(bile acid biosynthetic process);GO:0008206(bile acid metabolic process);GO:0009925(basal plasma membrane);GO:0015245(fatty acid transmembrane transporter activity);GO:0015908(fatty acid transport);GO:0015911(long-chain fatty acid import across plasma membrane);GO:0016021(integral component of membrane);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0031957(very long-chain fatty acid-CoA ligase activity);GO:0046951(ketone body biosynthetic process);GO:0047747(cholate-CoA ligase activity)","00120(Primary bile acid biosynthesis);03320(PPAR signaling pathway);04976(Bile secretion);04931(Insulin resistance)",{"v":0.0011,"d":"0.00"},1,"179,",0,-2.96,-2.33,13,"Exon (ENSBGRT00000024967/ENSBGRG00000013518, exon 1 of 11)",20,55520193,55531675,11483,2]
["chr20",55534832,55534921,90,"ENSBGRG00000013752","ENSBGRT00000025211",1073,"ZBTB45","zinc finger and BTB domain containing 45 [Source:HGNC Symbol;Acc:HGNC:23715]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1.1E-4,"d":"0.00"},1,"90,",0,-3.96,-3.28,2.01,"Exon (ENSBGRT00000025211/ENSBGRG00000013752, exon 1 of 2)",20,55533372,55535994,2623,2]
["chr20",56638061,56638120,60,"ENSBGRG00000016048","ENSBGRT00000029441",1290,"ENSBGRG00000016048","NA","NA","NA",{"v":0.011,"d":"0.01"},1,"60,",0,-1.97,{"v":-1.4,"d":"-1.40"},3.02,"Exon (ENSBGRT00000029441/ENSBGRG00000016048, exon 2 of 2)",20,56635876,56639410,3535,2]
["chr20",57171349,57171529,181,"ENSBGRG00000017669","ENSBGRT00000032341",5634,"ZNF614","zinc finger protein 614 [Source:HGNC Symbol;Acc:HGNC:24722]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":2.5e-19,"d":"0.00"},1,"181,",0,{"v":-18.6,"d":"-18.60"},{"v":-17.6,"d":"-17.60"},3.73,"Exon (ENSBGRT00000032341/ENSBGRG00000017669, exon 5 of 5)",20,57169760,57177163,7404,2]
["chr20",57467713,57468103,391,"ENSBGRG00000019031","ENSBGRT00000034999",7612,"ZNF175","zinc finger protein 175 [Source:HGNC Symbol;Acc:HGNC:12964]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0045111(intermediate filament cytoskeleton);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":1e-114,"d":"0.00"},1,"391,",0,-114,-112,{"v":3.5,"d":"3.50"},"Exon (ENSBGRT00000034999/ENSBGRG00000019031, exon 5 of 6)",20,57467680,57475715,8036,2]
["chr20",58782848,58812377,29530,"ENSBGRG00000020773","ENSBGRT00000038321",0,"ATF5","activating transcription factor 5 [Source:HGNC Symbol;Acc:HGNC:790]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0008285(negative regulation of cell population proliferation);GO:0009791(post-embryonic development);GO:0010468(regulation of gene expression);GO:0015631(tubulin binding);GO:0019900(kinase binding);GO:0021889(olfactory bulb interneuron differentiation);GO:0021891(olfactory bulb interneuron development);GO:0021930(cerebellar granule cell precursor proliferation);GO:0021988(olfactory lobe development);GO:0035264(multicellular organism growth);GO:0043066(negative regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045444(fat cell differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046605(regulation of centrosome cycle);GO:1902750(negative regulation of cell cycle G2/M phase transition)","NA",{"v":3.2e-86,"d":"0.00"},3,"104,26,438,","0,1365,29092",{"v":-85.5,"d":"-85.50"},{"v":-83.9,"d":"-83.90"},{"v":12.7,"d":"12.70"},"5' UTR",20,58779797,58784238,4442,2]
["chr20",59230272,59232213,1942,"ENSBGRG00000014846","ENSBGRT00000027325",0,"ENSBGRG00000014846","NA","NA","NA",{"v":0.0078,"d":"0.01"},2,"105,702,","0,1240",-2.11,-1.53,5.94,"5' UTR",20,59229567,59232213,2647,2]
["chr20",60356488,60356638,151,"ENSBGRG00000022110","ENSBGRT00000040821",5024,"ENSBGRG00000022110","NA","GO:0003676(nucleic acid binding)","NA",{"v":5.8E-4,"d":"0.00"},1,"151,",0,-3.24,-2.59,1.81,"3' UTR",20,60356368,60361662,5295,2]
["chr20",61525112,61525382,271,"ENSBGRG00000016330","ENSBGRT00000030060",60,"ARHGAP35","Rho GTPase activating protein 35 [Source:HGNC Symbol;Acc:HGNC:4591]","GO:0001843(neural tube closure);GO:0003924(GTPase activity);GO:0005096(GTPase activator activity);GO:0005525(GTP binding);GO:0005543(phospholipid binding);GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0008064(regulation of actin polymerization or depolymerization);GO:0008360(regulation of cell shape);GO:0010976(positive regulation of neuron projection development);GO:0015629(actin cytoskeleton);GO:0016477(cell migration);GO:0021955(central nervous system neuron axonogenesis);GO:0030879(mammary gland development);GO:0030900(forebrain development);GO:0030950(establishment or maintenance of actin cytoskeleton polarity);GO:0031668(cellular response to extracellular stimulus);GO:0032956(regulation of actin cytoskeleton organization);GO:0035024(negative regulation of Rho protein signal transduction);GO:0036064(ciliary basal body);GO:0043010(camera-type eye development);GO:0043116(negative regulation of vascular permeability);GO:0044319(wound healing, spreading of cells);GO:0045724(positive regulation of cilium assembly);GO:0050770(regulation of axonogenesis);GO:0097485(neuron projection guidance)","04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04670(Leukocyte transendothelial migration)",{"v":3.2e-82,"d":"0.00"},2,"196,44,","0,227",{"v":-81.5,"d":"-81.50"},-80,8.87,"Exon (ENSBGRT00000030060/ENSBGRG00000016330, exon 1 of 7)",20,61446195,61525442,79248,2]
["chr20",62557155,62557425,271,"ENSBGRG00000021919","ENSBGRT00000040548",179,"PPM1N","protein phosphatase, Mg2+/Mn2+ dependent 1N (putative) [Source:HGNC Symbol;Acc:HGNC:26845]","GO:0000287(magnesium ion binding);GO:0003824(catalytic activity);GO:0004721(phosphoprotein phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0030145(manganese ion binding)","NA",{"v":0.0078,"d":"0.01"},1,"271,",0,-2.11,-1.53,7.56,"Exon (ENSBGRT00000040548/ENSBGRG00000021919, exon 1 of 5)",20,62550954,62557604,6651,2]
["chr20",63664627,63664717,91,"ENSBGRG00000009940","ENSBGRT00000018285",3427,"ZNF227","zinc finger protein 227 [Source:HGNC Symbol;Acc:HGNC:13020]","GO:0003676(nucleic acid binding)","NA",{"v":3.5E-4,"d":"0.00"},1,"91,",0,-3.45,-2.79,1.88,"Exon (ENSBGRT00000018285/ENSBGRG00000009940, exon 3 of 6)",20,63657722,63668144,10423,2]
["chr20",63725539,63725925,387,"ENSBGRG00000010046","ENSBGRT00000018598",2501,"ZNF45","zinc finger protein 45 [Source:HGNC Symbol;Acc:HGNC:13111]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm)","NA",{"v":2.5e-77,"d":"0.00"},1,"387,",0,{"v":-76.6,"d":"-76.60"},{"v":-75.1,"d":"-75.10"},{"v":11.5,"d":"11.50"},"Exon (ENSBGRT00000018598/ENSBGRG00000010046, exon 4 of 6)",20,63723310,63728426,5117,2]
["chr20",65042629,65042837,209,"ENSBGRG00000018054","ENSBGRT00000033069",2222,"PAFAH1B3","platelet activating factor acetylhydrolase 1b catalytic subunit 3 [Source:HGNC Symbol;Acc:HGNC:8576]","GO:0005737(cytoplasm);GO:0007283(spermatogenesis);GO:0042802(identical protein binding)","00565(Ether lipid metabolism)",{"v":7.9e-31,"d":"0.00"},1,"209,",0,{"v":-30.1,"d":"-30.10"},-29,2.03,"3' UTR",20,65041711,65045059,3349,2]
["chr20",66621557,66621617,61,"ENSBGRG00000021076","ENSBGRT00000038847",1376,"ENSBGRG00000021076","NA","NA","NA",0.01,1,"61,",0,-1.99,-1.42,3.78,"Exon (ENSBGRT00000038847/ENSBGRG00000021076, exon 1 of 1)",20,66621557,66622993,1437,2]
["chr20",67083000,67083358,359,"ENSBGRG00000024288","ENSBGRT00000044842",775,"ENSBGRG00000024288","NA","NA","NA",{"v":0.028,"d":"0.03"},1,"359,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000044842/ENSBGRG00000024288, exon 1 of 1)",20,67083000,67084133,1134,2]
["chr20",69029893,69030633,741,"ENSBGRG00000017666","ENSBGRT00000032458",4881,"ZNF527","zinc finger protein 527 [Source:HGNC Symbol;Acc:HGNC:29385]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":7.9e-64,"d":"0.00"},1,"741,",0,{"v":-63.1,"d":"-63.10"},{"v":-61.7,"d":"-61.70"},5.64,"Exon (ENSBGRT00000032458/ENSBGRG00000017666, exon 3 of 3)",20,69029302,69035514,6213,2]
["chr20",69875112,69875231,120,"ENSBGRG00000022118","ENSBGRT00000040849",626,"LRFN3","leucine rich repeat and fibronectin type III domain containing 3 [Source:HGNC Symbol;Acc:HGNC:28370]","GO:0005515(protein binding);GO:0009986(cell surface)","NA",{"v":5.8e-06,"d":"0.00"},1,"120,",0,-5.24,-4.51,2.06,"Exon (ENSBGRT00000040849/ENSBGRG00000022118, exon 1 of 2)",20,69869780,69875857,6078,2]
["chr20",69943447,69943596,150,"ENSBGRG00000022530","ENSBGRT00000042505",9882,"APLP1","amyloid beta precursor like protein 1 [Source:HGNC Symbol;Acc:HGNC:597]","GO:0005886(plasma membrane);GO:0008201(heparin binding);GO:0016021(integral component of membrane);GO:0031694(alpha-2A adrenergic receptor binding);GO:0031695(alpha-2B adrenergic receptor binding);GO:0031696(alpha-2C adrenergic receptor binding);GO:0042802(identical protein binding);GO:0046914(transition metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0071874(cellular response to norepinephrine stimulus);GO:0106072(negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway)","NA",0,1,"150,",0,-359,"-Inf",7.75,"3' UTR",20,69943447,69953478,10032,2]
["chr21",1840173,1856542,16370,"ENSBGRG00000020004","ENSBGRT00000036752",149513,"CDH7","cadherin 7 [Source:HGNC Symbol;Acc:HGNC:1766]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0098609(cell-cell adhesion)","NA",{"v":0.015,"d":"0.02"},2,"223,494,","0,15876",-1.83,-1.02,8.64,"Exon (ENSBGRT00000036752/ENSBGRG00000020004, exon 10 of 11)",21,1690660,1856542,165883,1]
["chr21",10006002,10007107,1106,"ENSBGRG00000022648","ENSBGRT00000041829",88484,"TSHZ1","teashirt zinc finger homeobox 1 [Source:HGNC Symbol;Acc:HGNC:10669]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0009952(anterior/posterior pattern specification);GO:0010468(regulation of gene expression);GO:0042474(middle ear morphogenesis);GO:0060023(soft palate development)","NA",{"v":1e-178,"d":"0.00"},1,"1106,",0,-178,-176,6.82,"Exon (ENSBGRT00000041829/ENSBGRG00000022648, exon 3 of 3)",21,9917518,10007136,89619,1]
["chr21",13405388,13405717,330,"ENSBGRG00000024707","ENSBGRT00000045594",34394,"ADNP2","ADNP homeobox 2 [Source:HGNC Symbol;Acc:HGNC:23803]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0030182(neuron differentiation);GO:0030307(positive regulation of cell growth);GO:0034599(cellular response to oxidative stress);GO:0060548(negative regulation of cell death);GO:0071300(cellular response to retinoic acid)","NA",{"v":2.5e-54,"d":"0.00"},1,"330,",0,{"v":-53.6,"d":"-53.60"},{"v":-52.3,"d":"-52.30"},4.65,"Exon (ENSBGRT00000045594/ENSBGRG00000024707, exon 5 of 5)",21,13370994,13406340,35347,1]
["chr21",20034408,20034527,120,"ENSBGRG00000021912","ENSBGRT00000040538",230251,"GAREM1","GRB2 associated regulator of MAPK1 subtype 1 [Source:HGNC Symbol;Acc:HGNC:26136]","GO:0007173(epidermal growth factor receptor signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0070064(proline-rich region binding);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071364(cellular response to epidermal growth factor stimulus)","NA",{"v":1.3e-05,"d":"0.00"},1,"120,",0,{"v":-4.9,"d":"-4.90"},-4.19,3.69,"Exon (ENSBGRT00000040538/ENSBGRG00000021912, exon 4 of 6)",21,19804157,20064386,260230,1]
["chr21",26490663,26490992,330,"ENSBGRG00000024680","ENSBGRT00000045596",79317,"SS18","SS18 subunit of BAF chromatin remodeling complex [Source:HGNC Symbol;Acc:HGNC:11340]","GO:0000226(microtubule cytoskeleton organization);GO:0000902(cell morphogenesis);GO:0003713(transcription coactivator activity);GO:0005881(cytoplasmic microtubule);GO:0007010(cytoskeleton organization);GO:0016514(SWI/SNF complex);GO:0030374(nuclear receptor transcription coactivator activity);GO:0035556(intracellular signal transduction);GO:0042493(response to drug);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048013(ephrin receptor signaling pathway);GO:0071564(npBAF complex);GO:0097150(neuronal stem cell population maintenance)","05202(Transcriptional misregulation in cancers)",0,1,"330,",0,-380,"-Inf",4.87,"3' UTR",21,26411346,26492305,80960,1]
["chr21",33572315,33572643,329,"ENSBGRG00000021481","ENSBGRT00000039634",43562,"EMILIN2","elastin microfibril interfacer 2 [Source:HGNC Symbol;Acc:HGNC:19881]","GO:0005515(protein binding);GO:0005576(extracellular region)","NA",{"v":1E-168,"d":"0.00"},1,"329,",0,-168,-166,6.16,"Exon (ENSBGRT00000039634/ENSBGRG00000021481, exon 4 of 8)",21,33528753,33594477,65725,1]
["chr21",39237670,39237909,240,"ENSBGRG00000025985","ENSBGRT00000048077",10349,"NAPG","NSF attachment protein gamma [Source:HGNC Symbol;Acc:HGNC:7642]","GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0006886(intracellular protein transport)","NA",{"v":2.5e-33,"d":"0.00"},1,"240,",0,{"v":-32.6,"d":"-32.60"},{"v":-31.5,"d":"-31.50"},1.98,"3' UTR",21,39227321,39239610,12290,1]
["chr21",39570896,39573003,2108,"ENSBGRG00000026034","ENSBGRT00000048148",0,"ENSBGRG00000026034","NA","NA","NA",{"v":0.015,"d":"0.02"},2,"86,1207,","0,901",-1.83,-1.02,8.64,"Exon (ENSBGRT00000048151/ENSBGRG00000026035, exon 1 of 2)",21,39570313,39573003,2691,2]
["chr21",43437661,43437840,180,"ENSBGRG00000019304","ENSBGRT00000035462",88796,"C18orf25","chromosome 18 open reading frame 25 [Source:HGNC Symbol;Acc:HGNC:28172]","NA","NA",{"v":1.4e-09,"d":"0.00"},1,"180,",0,-8.85,-8.03,{"v":2.4,"d":"2.40"},"Exon (ENSBGRT00000035462/ENSBGRG00000019304, exon 6 of 6)",21,43348865,43437840,88976,1]
["chr21",56414989,56415289,301,"ENSBGRG00000012253","ENSBGRT00000024628",431117,"NEDD4L","NEDD4 like E3 ubiquitin protein ligase [Source:HGNC Symbol;Acc:HGNC:7728]","GO:0003254(regulation of membrane depolarization);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0010038(response to metal ion);GO:0015459(potassium channel regulator activity);GO:0016567(protein ubiquitination);GO:0017080(sodium channel regulator activity);GO:0019870(potassium channel inhibitor activity);GO:0019871(sodium channel inhibitor activity);GO:0031647(regulation of protein stability);GO:0034765(regulation of ion transmembrane transport);GO:0042391(regulation of membrane potential);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0044325(ion channel binding);GO:0060306(regulation of membrane repolarization);GO:0061630(ubiquitin protein ligase activity);GO:0070936(protein K48-linked ubiquitination);GO:1901016(regulation of potassium ion transmembrane transporter activity);GO:1901017(negative regulation of potassium ion transmembrane transporter activity);GO:1901380(negative regulation of potassium ion transmembrane transport);GO:1902306(negative regulation of sodium ion transmembrane transport);GO:1903861(positive regulation of dendrite extension);GO:2000009(negative regulation of protein localization to cell surface);GO:2000650(negative regulation of sodium ion transmembrane transporter activity)","04120(Ubiquitin mediated proteolysis);04144(Endocytosis);04530(Tight junction);04960(Aldosterone-regulated sodium reabsorption)",{"v":2.5e-18,"d":"0.00"},1,"301,",0,{"v":-17.6,"d":"-17.60"},{"v":-16.7,"d":"-16.70"},3.37,"3' UTR",21,55983872,56415319,431448,1]
["chr21",2496989,2497296,308,"ENSBGRG00000020108","ENSBGRT00000037018",66906,"CDH19","cadherin 19 [Source:HGNC Symbol;Acc:HGNC:1758]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0098609(cell-cell adhesion)","NA",{"v":2.5e-19,"d":"0.00"},2,"262,6,","0,302",{"v":-18.6,"d":"-18.60"},{"v":-17.7,"d":"-17.70"},2.96,"3' UTR",21,2472906,2564202,91297,2]
["chr21",9906766,9906826,61,"ENSBGRG00000022621","ENSBGRT00000041741",8442,"ZADH2","zinc binding alcohol dehydrogenase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:28697]","GO:0005777(peroxisome);GO:0008270(zinc ion binding);GO:0016491(oxidoreductase activity);GO:0036132(13-prostaglandin reductase activity);GO:0045599(negative regulation of fat cell differentiation);GO:0055114(oxidation-reduction process)","NA",{"v":6.3e-23,"d":"0.00"},1,"61,",0,{"v":-22.2,"d":"-22.20"},{"v":-21.2,"d":"-21.20"},{"v":14.8,"d":"14.80"},"Exon (ENSBGRT00000041741/ENSBGRG00000022621, exon 2 of 2)",21,9906587,9915268,8682,2]
["chr21",14398886,14399571,686,"ENSBGRG00000015220","ENSBGRT00000027941",8592,"ENSBGRG00000015220","NA","NA","NA",{"v":0.015,"d":"0.02"},1,"686,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000027941/ENSBGRG00000015220, exon 2 of 2)",21,14398469,14408163,9695,2]
["chr21",16916696,16928247,11552,"ENSBGRG00000020114","ENSBGRT00000037006",0,"MAPRE2","microtubule associated protein RP/EB family member 2 [Source:HGNC Symbol;Acc:HGNC:6891]","GO:0005515(protein binding);GO:0005925(focal adhesion);GO:0008017(microtubule binding);GO:0015630(microtubule cytoskeleton);GO:0019901(protein kinase binding);GO:0032014(positive regulation of ARF protein signal transduction);GO:0035371(microtubule plus-end);GO:0042802(identical protein binding);GO:0043547(positive regulation of GTPase activity);GO:0051549(positive regulation of keratinocyte migration);GO:0120183(positive regulation of focal adhesion disassembly)","NA",{"v":0.017,"d":"0.02"},2,"5,175,","0,11377",-1.77,-1.22,6.48,"5' UTR",21,16728566,16916700,188135,2]
["chr21",31521988,31522794,807,"ENSBGRG00000019242","ENSBGRT00000035431",179385,"COLEC12","collectin subfamily member 12 [Source:HGNC Symbol;Acc:HGNC:16016]","GO:0005044(scavenger receptor activity);GO:0006910(phagocytosis, recognition);GO:0006955(immune response);GO:0030169(low-density lipoprotein particle binding);GO:0034138(toll-like receptor 3 signaling pathway);GO:0038187(pattern recognition receptor activity);GO:0042742(defense response to bacterium);GO:0060355(positive regulation of cell adhesion molecule production);GO:0071360(cellular response to exogenous dsRNA)","04145(Phagosome)",0,1,"807,",0,-388,"-Inf",3.71,"Exon (ENSBGRT00000035431/ENSBGRG00000019242, exon 4 of 9)",21,31491886,31702179,210294,2]
["chr21",34093349,34096653,3305,"ENSBGRG00000022793","ENSBGRT00000042059",80454,"ENSBGRG00000022793","NA","NA","NA",{"v":0.015,"d":"0.02"},2,"210,151,","0,3154",-1.83,-1.02,8.64,"Exon (ENSBGRT00000043077/ENSBGRG00000022857, exon 10 of 11)",21,34012895,34170276,157382,1]
["chr21",45320096,45320484,389,"ENSBGRG00000022372","ENSBGRT00000041397",107295,"ZBTB7C","zinc finger and BTB domain containing 7C [Source:HGNC Symbol;Acc:HGNC:31700]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0008285(negative regulation of cell population proliferation);GO:0045600(positive regulation of fat cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1903025(regulation of RNA polymerase II regulatory region sequence-specific DNA binding)","NA",{"v":1.3e-19,"d":"0.00"},1,"389,",0,{"v":-18.9,"d":"-18.90"},{"v":-17.9,"d":"-17.90"},3.68,"Exon (ENSBGRT00000041397/ENSBGRG00000022372, exon 2 of 3)",21,45304711,45427779,123069,2]
["chr21",51987665,51987787,123,"ENSBGRG00000025200","ENSBGRT00000046630",120,"MBD2","methyl-CpG binding domain protein 2 [Source:HGNC Symbol;Acc:HGNC:6917]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000785(chromatin);GO:0000790(nuclear chromatin);GO:0000792(heterochromatin);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006346(methylation-dependent chromatin silencing);GO:0008327(methyl-CpG binding);GO:0019904(protein domain specific binding);GO:0030177(positive regulation of Wnt signaling pathway);GO:0034622(cellular protein-containing complex assembly);GO:0035197(siRNA binding);GO:0042025(host cell nucleus);GO:0042127(regulation of cell population proliferation);GO:0042711(maternal behavior);GO:0070742(C2H2 zinc finger domain binding)","NA",{"v":0.015,"d":"0.02"},2,"61,60,","0,63",-1.83,-1.02,8.64,"Exon (ENSBGRT00000046630/ENSBGRG00000025200, exon 1 of 8)",21,51908264,51987907,79644,2]
["chr22",1295706,1295976,271,"ENSBGRG00000011463","ENSBGRT00000020996",389,"KBTBD12","kelch repeat and BTB domain containing 12 [Source:HGNC Symbol;Acc:HGNC:25731]","GO:0005515(protein binding)","NA",{"v":1.3e-05,"d":"0.00"},1,"271,",0,{"v":-4.9,"d":"-4.90"},-4.19,3.69,"Exon (ENSBGRT00000020996/ENSBGRG00000011463, exon 1 of 4)",22,1295317,1329935,34619,1]
["chr22",2768771,2768891,121,"ENSBGRG00000017885","ENSBGRT00000032761",25564,"FBLN2","fibulin 2 [Source:HGNC Symbol;Acc:HGNC:3601]","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0050840(extracellular matrix binding);GO:0062023(collagen-containing extracellular matrix)","NA",{"v":1.6e-24,"d":"0.00"},1,"121,",0,{"v":-23.8,"d":"-23.80"},{"v":-22.8,"d":"-22.80"},3.38,"Exon (ENSBGRT00000032761/ENSBGRG00000017885, exon 2 of 19)",22,2743207,2829175,85969,1]
["chr22",5258516,5258845,330,"ENSBGRG00000023990","ENSBGRT00000044669",84529,"IFT122","intraflagellar transport 122 [Source:HGNC Symbol;Acc:HGNC:13556]","GO:0001843(neural tube closure);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005929(cilium);GO:0007227(signal transduction downstream of smoothened);GO:0009953(dorsal/ventral pattern formation);GO:0010172(embryonic body morphogenesis);GO:0021914(negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning);GO:0030991(intraciliary transport particle A);GO:0032391(photoreceptor connecting cilium);GO:0035050(embryonic heart tube development);GO:0035115(embryonic forelimb morphogenesis);GO:0035720(intraciliary anterograde transport);GO:0035721(intraciliary retrograde transport);GO:0036064(ciliary basal body);GO:0042073(intraciliary transport);GO:0042733(embryonic digit morphogenesis);GO:0045879(negative regulation of smoothened signaling pathway);GO:0048593(camera-type eye morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0060173(limb development);GO:0060271(cilium assembly);GO:0060830(ciliary receptor clustering involved in smoothened signaling pathway);GO:0060831(smoothened signaling pathway involved in dorsal/ventral neural tube patterning);GO:0060971(embryonic heart tube left/right pattern formation);GO:0061512(protein localization to cilium);GO:0072594(establishment of protein localization to organelle);GO:0097546(ciliary base);GO:1905515(non-motile cilium assembly)","NA",{"v":1e-110,"d":"0.00"},1,"330,",0,-110,-109,3,"3' UTR",22,5173987,5258845,84859,1]
["chr22",8548061,8548509,449,"ENSBGRG00000009826","ENSBGRT00000018022",16032,"ENSBGRG00000009826","NA","NA","NA",{"v":5e-65,"d":"0.00"},1,"449,",0,{"v":-64.3,"d":"-64.30"},{"v":-62.9,"d":"-62.90"},2.43,"Exon (ENSBGRT00000018022/ENSBGRG00000009826, exon 2 of 2)",22,8532029,8549555,17527,1]
["chr22",11636078,11636197,120,"ENSBGRG00000020861","ENSBGRT00000038408",268,"DAG1","dystroglycan 1 [Source:HGNC Symbol;Acc:HGNC:2666]","GO:0002011(morphogenesis of an epithelial sheet);GO:0002162(dystroglycan binding);GO:0003779(actin binding);GO:0005509(calcium ion binding);GO:0005604(basement membrane);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005925(focal adhesion);GO:0006509(membrane protein ectodomain proteolysis);GO:0007016(cytoskeletal anchoring at plasma membrane);GO:0008307(structural constituent of muscle);GO:0009897(external side of plasma membrane);GO:0010470(regulation of gastrulation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0014044(Schwann cell development);GO:0015631(tubulin binding);GO:0016010(dystrophin-associated glycoprotein complex);GO:0016011(dystroglycan complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017166(vinculin binding);GO:0019048(modulation by virus of host process);GO:0021682(nerve maturation);GO:0022011(myelination in peripheral nervous system);GO:0030027(lamellipodium);GO:0030175(filopodium);GO:0030336(negative regulation of cell migration);GO:0033268(node of Ranvier);GO:0034453(microtubule anchoring);GO:0042169(SH2 domain binding);GO:0042383(sarcolemma);GO:0043409(negative regulation of MAPK cascade);GO:0045121(membrane raft);GO:0051393(alpha-actinin binding);GO:0051898(negative regulation of protein kinase B signaling);GO:0060441(epithelial tube branching involved in lung morphogenesis);GO:0060445(branching involved in salivary gland morphogenesis);GO:0070938(contractile ring);GO:0071679(commissural neuron axon guidance);GO:0071711(basement membrane organization);GO:0098942(retrograde trans-synaptic signaling by trans-synaptic protein complex);GO:0098982(GABA-ergic synapse);GO:1904261(positive regulation of basement membrane assembly involved in embryonic body morphogenesis)","04512(ECM-receptor interaction);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05416(Viral myocarditis)",{"v":1E-127,"d":"0.00"},1,"120,",0,-127,-125,2.11,"Exon (ENSBGRT00000038408/ENSBGRG00000020861, exon 1 of 1)",22,11635810,11637894,2085,1]
["chr22",11749882,11750061,180,"ENSBGRG00000020998","ENSBGRT00000039348",9889,"APEH","acylaminoacyl-peptide hydrolase [Source:HGNC Symbol;Acc:HGNC:586]","GO:0004252(serine-type endopeptidase activity);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008236(serine-type peptidase activity);GO:0008242(omega peptidase activity);GO:0031965(nuclear membrane);GO:0042802(identical protein binding);GO:0050435(amyloid-beta metabolic process)","NA",{"v":1.6E-58,"d":"0.00"},1,"180,",0,{"v":-57.8,"d":"-57.80"},{"v":-56.4,"d":"-56.40"},3.34,"3' UTR",22,11739993,11750061,10069,1]
["chr22",13041187,13041277,91,"ENSBGRG00000025642","ENSBGRT00000047406",690,"RBM15B","RNA binding motif protein 15B [Source:HGNC Symbol;Acc:HGNC:24303]","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0001510(RNA methylation);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0006406(mRNA export from nucleus);GO:0009048(dosage compensation by inactivation of X chromosome);GO:0016607(nuclear speck);GO:0036396(RNA N6-methyladenosine methyltransferase complex)","NA",{"v":0.00015,"d":"0.00"},1,"91,",0,-3.83,-3.15,{"v":16.2,"d":"16.20"},"Exon (ENSBGRT00000047406/ENSBGRG00000025642, exon 1 of 2)",22,13040497,13044196,3700,1]
["chr22",13919007,13919596,590,"ENSBGRG00000007824","ENSBGRT00000014496",1533,"GLYCTK","glycerate kinase [Source:HGNC Symbol;Acc:HGNC:24247]","GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0008887(glycerate kinase activity)","00030(Pentose phosphate pathway);00630(Glyoxylate and dicarboxylate metabolism);00561(Glycerolipid metabolism);00260(Glycine, serine and threonine metabolism)",{"v":7.9e-27,"d":"0.00"},2,"20,309,","0,281",{"v":-26.1,"d":"-26.10"},-25,{"v":6.4,"d":"6.40"},"Exon (ENSBGRT00000014496/ENSBGRG00000007824, exon 3 of 3)",22,13917474,13919463,1990,1]
["chr22",15526522,15526731,210,"ENSBGRG00000018838","ENSBGRT00000037756",563065,"CACNA1D","calcium voltage-gated channel subunit alpha1 D [Source:HGNC Symbol;Acc:HGNC:1391]","GO:0005216(ion channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0005262(calcium channel activity);GO:0005886(plasma membrane);GO:0005891(voltage-gated calcium channel complex);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0007188(adenylate cyclase-modulating G protein-coupled receptor signaling pathway);GO:0007605(sensory perception of sound);GO:0008331(high voltage-gated calcium channel activity);GO:0016020(membrane);GO:0030018(Z disc);GO:0030506(ankyrin binding);GO:0045762(positive regulation of adenylate cyclase activity);GO:0051393(alpha-actinin binding);GO:0051928(positive regulation of calcium ion transport);GO:0055085(transmembrane transport);GO:0060372(regulation of atrial cardiac muscle cell membrane repolarization);GO:0070509(calcium ion import);GO:0070588(calcium ion transmembrane transport);GO:0086002(cardiac muscle cell action potential involved in contraction);GO:0086046(membrane depolarization during SA node cell action potential);GO:0086059(voltage-gated calcium channel activity involved SA node cell action potential);GO:0086091(regulation of heart rate by cardiac conduction);GO:0098683(cochlear hair cell ribbon synapse);GO:0099059(integral component of presynaptic active zone membrane);GO:0099635(voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels);GO:1901016(regulation of potassium ion transmembrane transporter activity);GO:1901379(regulation of potassium ion transmembrane transport);GO:1990454(L-type voltage-gated calcium channel complex)","04010(MAPK signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04218(Cellular senescence);04530(Tight junction);04911(Insulin secretion);04912(GnRH signaling pathway);04921(Oxytocin signaling pathway);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04973(Carbohydrate digestion and absorption);04724(Glutamatergic synapse);04727(GABAergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);04713(Circadian entrainment);05010(Alzheimer disease);05031(Amphetamine addiction);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));04930(Type II diabetes mellitus);04934(Cushing syndrome)",{"v":5.8e-10,"d":"0.00"},1,"210,",0,-9.24,-8.41,{"v":35.6,"d":"35.60"},"Exon (ENSBGRT00000037756/ENSBGRG00000018838, exon 48 of 48)",22,14963457,15526791,563335,1]
["chr22",24552384,24553142,759,"ENSBGRG00000026439","ENSBGRT00000048999",860190,"PTPRG","protein tyrosine phosphatase receptor type G [Source:HGNC Symbol;Acc:HGNC:9671]","GO:0004725(protein tyrosine phosphatase activity);GO:0005515(protein binding);GO:0006470(protein dephosphorylation);GO:0010633(negative regulation of epithelial cell migration);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0042802(identical protein binding)","NA",{"v":1.5E-5,"d":"0.00"},2,"53,128,","0,631",-4.81,{"v":-4.1,"d":"-4.10"},1.87,"Exon (ENSBGRT00000048999/ENSBGRG00000026439, exon 31 of 32)",22,23692194,24553891,861698,1]
["chr22",29636944,29637184,241,"ENSBGRG00000014548","ENSBGRT00000026783",9815,"KBTBD8","kelch repeat and BTB domain containing 8 [Source:HGNC Symbol;Acc:HGNC:30691]","GO:0005515(protein binding);GO:0006513(protein monoubiquitination);GO:0014029(neural crest formation);GO:0014032(neural crest cell development);GO:0031463(Cul3-RING ubiquitin ligase complex)","NA",{"v":1.4E-8,"d":"0.00"},1,"241,",0,-7.86,-7.06,13,"Exon (ENSBGRT00000026783/ENSBGRG00000014548, exon 4 of 4)",22,29627129,29638173,11045,1]
["chr22",44084867,44086752,1886,"ENSBGRG00000026121","ENSBGRT00000048325",1717,"BHLHE40","basic helix-loop-helix family member e40 [Source:HGNC Symbol;Acc:HGNC:1046]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007623(circadian rhythm);GO:0009416(response to light stimulus);GO:0016604(nuclear body);GO:0019904(protein domain specific binding);GO:0032922(circadian regulation of gene expression);GO:0042752(regulation of circadian rhythm);GO:0042803(protein homodimerization activity);GO:0043153(entrainment of circadian clock by photoperiod);GO:0043425(bHLH transcription factor binding);GO:0043426(MRF binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046982(protein heterodimerization activity);GO:0046983(protein dimerization activity);GO:0070888(E-box binding);GO:1990837(sequence-specific double-stranded DNA binding)","04710(Circadian rhythm)",{"v":1E-125,"d":"0.00"},2,"87,503,","0,1383",-125,-123,6.48,"Exon (ENSBGRT00000048325/ENSBGRG00000026121, exon 4 of 5)",22,44083150,44087106,3957,1]
["chr22",49193810,49194199,390,"ENSBGRG00000011707","ENSBGRT00000023907",12144,"IL17RC","interleukin 17 receptor C [Source:HGNC Symbol;Acc:HGNC:18358]","GO:0005102(signaling receptor binding);GO:0005886(plasma membrane);GO:0009986(cell surface);GO:0030368(interleukin-17 receptor activity);GO:0032755(positive regulation of interleukin-6 production);GO:0050832(defense response to fungus);GO:0071621(granulocyte chemotaxis);GO:1900017(positive regulation of cytokine production involved in inflammatory response)","04060(Cytokine-cytokine receptor interaction);04657(IL-17 signaling pathway)",{"v":1.3e-66,"d":"0.00"},1,"390,",0,{"v":-65.9,"d":"-65.90"},{"v":-64.5,"d":"-64.50"},6.56,"5' UTR",22,49181666,49194168,12503,1]
["chr22",49401435,49401674,240,"ENSBGRG00000013697","ENSBGRT00000025297",68851,"IRAK2","interleukin 1 receptor associated kinase 2 [Source:HGNC Symbol;Acc:HGNC:6113]","GO:0001959(regulation of cytokine-mediated signaling pathway);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0042803(protein homodimerization activity);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0046982(protein heterodimerization activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0070498(interleukin-1-mediated signaling pathway);GO:0070555(response to interleukin-1)","04722(Neurotrophin signaling pathway);05152(Tuberculosis)",{"v":0.00022,"d":"0.00"},1,"240,",0,-3.66,-2.99,14,"3' UTR",22,49332584,49401674,69091,1]
["chr22",59475389,59475569,181,"ENSBGRG00000022018","ENSBGRT00000040809",67386,"UBP1","upstream binding protein 1 [Source:HGNC Symbol;Acc:HGNC:12507]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001525(angiogenesis);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0032897(negative regulation of viral transcription);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":2.8e-09,"d":"0.00"},1,"181,",0,-8.56,-7.74,{"v":1.8,"d":"1.80"},"Exon (ENSBGRT00000040809/ENSBGRG00000022018, exon 13 of 13)",22,59408003,59475794,67792,1]
["chr22",942353,942412,60,"ENSBGRG00000026549","ENSBGRT00000049165",2375,"ENSBGRG00000026549","NA","NA","NA",{"v":1.9e-05,"d":"0.00"},1,"60,",0,-4.71,-4,{"v":19.4,"d":"19.40"},"Exon (ENSBGRT00000049165/ENSBGRG00000026549, exon 7 of 9)",22,939836,944787,4952,2]
["chr22",1689287,1689465,179,"ENSBGRG00000012844","ENSBGRT00000023532",15765,"RPN1","ribophorin I [Source:HGNC Symbol;Acc:HGNC:10381]","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005791(rough endoplasmic reticulum);GO:0005829(cytosol);GO:0006486(protein glycosylation);GO:0006487(protein N-linked glycosylation);GO:0008250(oligosaccharyltransferase complex);GO:0016021(integral component of membrane);GO:0018279(protein N-linked glycosylation via asparagine)","00510(N-Glycan biosynthesis);04141(Protein processing in endoplasmic reticulum)",{"v":1.3e-77,"d":"0.00"},1,"179,",0,{"v":-76.9,"d":"-76.90"},{"v":-75.4,"d":"-75.40"},{"v":1.7,"d":"1.70"},"3' UTR",22,1689050,1705230,16181,2]
["chr22",3518699,3518789,91,"ENSBGRG00000020144","ENSBGRT00000038343",49513,"GRIP2","glutamate receptor interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:23841]","GO:0005515(protein binding);GO:0007219(Notch signaling pathway);GO:0014824(artery smooth muscle contraction);GO:0030159(receptor signaling complex adaptor activity);GO:0045777(positive regulation of blood pressure);GO:0098887(neurotransmitter receptor transport, endosome to postsynaptic membrane);GO:0098978(glutamatergic synapse);GO:0099003(vesicle-mediated transport in synapse)","NA",{"v":6.2e-05,"d":"0.00"},1,"91,",0,-4.21,-3.52,3.53,"3' UTR",22,3517145,3568302,51158,2]
["chr22",7556503,7557790,1288,"ENSBGRG00000025573","ENSBGRT00000047287",17153,"ENSBGRG00000025573","NA","GO:0016409(palmitoyltransferase activity)","NA",{"v":4E-52,"d":"0.00"},1,"1288,",0,{"v":-51.4,"d":"-51.40"},{"v":-50.1,"d":"-50.10"},5.69,"3' UTR",22,7539454,7574943,35490,2]
["chr22",9561207,9582622,21416,"ENSBGRG00000015116","ENSBGRT00000027871",112422,"KIF9","kinesin family member 9 [Source:HGNC Symbol;Acc:HGNC:16666]","GO:0002102(podosome);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005874(microtubule);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0022617(extracellular matrix disassembly);GO:0031982(vesicle);GO:0042802(identical protein binding);GO:0071801(regulation of podosome assembly);GO:1903008(organelle disassembly)","NA",{"v":9.99999999999999e-266,"d":"0.00"},6,"24,49,663,120,135,27,","0,1211,11577,13855,15033,21389",-265,-263,{"v":4.3,"d":"4.30"},"Exon (ENSBGRT00000029320/ENSBGRG00000015668, exon 9 of 21)",22,9503278,9695044,191767,2]
["chr22",10985547,10985607,61,"ENSBGRG00000023323","ENSBGRT00000043298",3931,"NCKIPSD","NCK interacting protein with SH3 domain [Source:HGNC Symbol;Acc:HGNC:15486]","GO:0005515(protein binding);GO:0008180(COP9 signalosome);GO:0010976(positive regulation of neuron projection development)","NA",{"v":2.3E-3,"d":"0.00"},1,"61,",0,-2.63,-2.01,7.02,"Exon (ENSBGRT00000043298/ENSBGRG00000023323, exon 7 of 15)",22,10977858,10989538,11681,2]
["chr22",10991727,10991994,268,"ENSBGRG00000023483","ENSBGRT00000043402",8343,"IP6K2","inositol hexakisphosphate kinase 2 [Source:HGNC Symbol;Acc:HGNC:17313]","GO:0000828(inositol hexakisphosphate kinase activity);GO:0000832(inositol hexakisphosphate 5-kinase activity);GO:0001650(fibrillar center);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016301(kinase activity);GO:0030054(cell junction);GO:0030308(negative regulation of cell growth);GO:0032958(inositol phosphate biosynthetic process);GO:0043065(positive regulation of apoptotic process);GO:0043647(inositol phosphate metabolic process);GO:0046854(phosphatidylinositol phosphorylation);GO:0097243(flavonoid binding);GO:1905396(cellular response to flavonoid)","04070(Phosphatidylinositol signaling system)",{"v":1E-155,"d":"0.00"},1,"268,",0,-155,-153,5.76,"Exon (ENSBGRT00000043402/ENSBGRG00000023483, exon 5 of 5)",22,10991727,11000337,8611,2]
["chr22",12314760,12314879,120,"ENSBGRG00000024152","ENSBGRT00000044592",5487,"HYAL1","hyaluronidase 1 [Source:HGNC Symbol;Acc:HGNC:5320]","GO:0000302(response to reactive oxygen species);GO:0003824(catalytic activity);GO:0004415(hyalurononglucosaminidase activity);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005975(carbohydrate metabolic process);GO:0006954(inflammatory response);GO:0008134(transcription factor binding);GO:0009615(response to virus);GO:0010634(positive regulation of epithelial cell migration);GO:0030212(hyaluronan metabolic process);GO:0030213(hyaluronan biosynthetic process);GO:0030214(hyaluronan catabolic process);GO:0030307(positive regulation of cell growth);GO:0030308(negative regulation of cell growth);GO:0031410(cytoplasmic vesicle);GO:0036117(hyaluranon cable);GO:0036120(cellular response to platelet-derived growth factor stimulus);GO:0044344(cellular response to fibroblast growth factor stimulus);GO:0045766(positive regulation of angiogenesis);GO:0045785(positive regulation of cell adhesion);GO:0045927(positive regulation of growth);GO:0046677(response to antibiotic);GO:0050501(hyaluronan synthase activity);GO:0050679(positive regulation of epithelial cell proliferation);GO:0051216(cartilage development);GO:0060272(embryonic skeletal joint morphogenesis);GO:0071347(cellular response to interleukin-1);GO:0071356(cellular response to tumor necrosis factor);GO:0071467(cellular response to pH);GO:0071493(cellular response to UV-B);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1900106(positive regulation of hyaluranon cable assembly)","00531(Glycosaminoglycan degradation)",{"v":1.3e-16,"d":"0.00"},1,"120,",0,{"v":-15.9,"d":"-15.90"},-15,{"v":2.2,"d":"2.20"},"3' UTR",22,12308987,12320366,11380,2]
["chr22",13054391,13067107,12717,"ENSBGRG00000025664","ENSBGRT00000047623",71683,"DCAF1","DDB1 and CUL4 associated factor 1 [Source:HGNC Symbol;Acc:HGNC:30911]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001650(fibrillar center);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008180(COP9 signalosome);GO:0016567(protein ubiquitination);GO:0030183(B cell differentiation);GO:0030331(estrogen receptor binding);GO:0033151(V(D)J recombination);GO:0035212(cell competition in a multicellular organism);GO:0080008(Cul4-RING E3 ubiquitin ligase complex);GO:1990244(histone kinase activity (H2A-T120 specific));GO:1990245(histone H2A-T120 phosphorylation)","NA",{"v":6.3e-28,"d":"0.00"},2,"252,48,","0,12669",{"v":-27.2,"d":"-27.20"},{"v":-26.1,"d":"-26.10"},{"v":2.8,"d":"2.80"},"Exon (ENSBGRT00000047623/ENSBGRG00000025664, exon 22 of 24)",22,13048904,13138790,89887,2]
["chr22",18395115,18395445,331,"ENSBGRG00000021980","ENSBGRT00000040610",0,"ERC2","ELKS/RAB6-interacting/CAST family member 2 [Source:HGNC Symbol;Acc:HGNC:31922]","GO:0045202(synapse);GO:0048786(presynaptic active zone);GO:0098882(structural constituent of presynaptic active zone)","NA",{"v":0.043,"d":"0.04"},1,"331,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"5' UTR",22,17464551,18395445,930895,2]
["chr22",19208541,19208660,120,"ENSBGRG00000023434","ENSBGRT00000043345",6556,"ASB14","ankyrin repeat and SOCS box containing 14 [Source:HGNC Symbol;Acc:HGNC:19766]","GO:0005515(protein binding);GO:0035556(intracellular signal transduction)","NA",{"v":0.014,"d":"0.01"},1,"120,",0,-1.86,{"v":-1.3,"d":"-1.30"},{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000043345/ENSBGRG00000023434, exon 5 of 7)",22,19205141,19215216,10076,2]
["chr22",31805240,31806454,1215,"ENSBGRG00000017411","ENSBGRT00000031893",0,"ENSBGRG00000017411","NA","NA","NA",{"v":0.025,"d":"0.03"},1,"1215,",0,-1.61,-1.07,6.48,"Exon (ENSBGRT00000031893/ENSBGRG00000017411, exon 1 of 1)",22,31805240,31806454,1215,2]
["chr22",36359765,36361168,1404,"ENSBGRG00000022106","ENSBGRT00000040820",55661,"PDZRN3","PDZ domain containing ring finger 3 [Source:HGNC Symbol;Acc:HGNC:17704]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0007528(neuromuscular junction development);GO:0016567(protein ubiquitination);GO:0031594(neuromuscular junction);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":6.3e-68,"d":"0.00"},2,"678,99,","0,1305",{"v":-67.2,"d":"-67.20"},{"v":-65.8,"d":"-65.80"},3.99,"Exon (ENSBGRT00000040820/ENSBGRG00000022106, exon 7 of 9)",22,36356599,36416829,60231,2]
["chr22",50928626,50932242,3617,"ENSBGRG00000016283","ENSBGRT00000030418",236763,"ANO10","anoctamin 10 [Source:HGNC Symbol;Acc:HGNC:25519]","GO:0005227(calcium activated cation channel activity);GO:0005229(intracellular calcium activated chloride channel activity);GO:0005886(plasma membrane);GO:0006812(cation transport);GO:0006821(chloride transport);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":4e-34,"d":"0.00"},2,"72,109,","0,3508",{"v":-33.4,"d":"-33.40"},{"v":-32.3,"d":"-32.30"},2.98,"Exon (ENSBGRT00000031019/ENSBGRG00000016863, exon 6 of 9)",22,50691863,51020182,328320,1]
["chr22",50978040,50978519,480,"ENSBGRG00000016283","ENSBGRT00000030418",286177,"ANO10","anoctamin 10 [Source:HGNC Symbol;Acc:HGNC:25519]","GO:0005227(calcium activated cation channel activity);GO:0005229(intracellular calcium activated chloride channel activity);GO:0005886(plasma membrane);GO:0006812(cation transport);GO:0006821(chloride transport);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":1e-178,"d":"0.00"},1,"480,",0,-178,-176,7.61,"Exon (ENSBGRT00000031019/ENSBGRG00000016863, exon 2 of 9)",22,50691863,51020182,328320,1]
["chr22",53374484,53374544,61,"ENSBGRG00000006898","ENSBGRT00000012949",185429,"MYRIP","myosin VIIA and Rab interacting protein [Source:HGNC Symbol;Acc:HGNC:19156]","GO:0000145(exocyst);GO:0001750(photoreceptor outer segment);GO:0003779(actin binding);GO:0006886(intracellular protein transport);GO:0015629(actin cytoskeleton);GO:0017022(myosin binding);GO:0017137(Rab GTPase binding);GO:0042470(melanosome);GO:0045202(synapse);GO:0051018(protein kinase A binding)","NA",{"v":3.1e-05,"d":"0.00"},1,"61,",0,-4.51,-3.81,4.08,"Exon (ENSBGRT00000012949/ENSBGRG00000006898, exon 10 of 18)",22,53313938,53559973,246036,2]
["chr22",56101019,56101318,300,"ENSBGRG00000014964","ENSBGRT00000027944",76142,"TRANK1","tetratricopeptide repeat and ankyrin repeat containing 1 [Source:HGNC Symbol;Acc:HGNC:29011]","GO:0005515(protein binding)","NA",{"v":7.9e-84,"d":"0.00"},1,"300,",0,{"v":-83.1,"d":"-83.10"},{"v":-81.6,"d":"-81.60"},3.26,"Exon (ENSBGRT00000027944/ENSBGRG00000014964, exon 23 of 25)",22,56095899,56177460,81562,2]
["chr22",56364807,56366070,1264,"ENSBGRG00000016218","ENSBGRT00000029848",87392,"LRRFIP2","LRR binding FLII interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:6703]","GO:0006355(regulation of transcription, DNA-templated);GO:0030275(LRR domain binding)","NA",{"v":2.5E-51,"d":"0.00"},3,"155,135,9,","0,543,1255",{"v":-50.6,"d":"-50.60"},{"v":-49.3,"d":"-49.30"},5.04,"3' UTR",22,56364717,56453462,88746,2]
["chr23",2045316,2045855,540,"ENSBGRG00000013735","ENSBGRT00000025210",16096,"STC2","stanniocalcin 2 [Source:HGNC Symbol;Acc:HGNC:11374]","GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0005783(endoplasmic reticulum);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0020037(heme binding);GO:0042803(protein homodimerization activity);GO:0046885(regulation of hormone biosynthetic process);GO:0048471(perinuclear region of cytoplasm)","NA",{"v":3.5e-08,"d":"0.00"},1,"540,",0,-7.46,-6.67,{"v":21.6,"d":"21.60"},"3' UTR",23,2029220,2046095,16876,1]
["chr23",8101970,8102658,689,"ENSBGRG00000007004","ENSBGRT00000012876",0,"NKD2","NKD inhibitor of WNT signaling pathway 2 [Source:HGNC Symbol;Acc:HGNC:17046]","GO:0005886(plasma membrane);GO:0010954(positive regulation of protein processing);GO:0016323(basolateral plasma membrane);GO:0016328(lateral plasma membrane);GO:0019838(growth factor binding);GO:0030178(negative regulation of Wnt signaling pathway);GO:0031410(cytoplasmic vesicle);GO:0031625(ubiquitin protein ligase binding);GO:0032036(myosin heavy chain binding);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0048210(Golgi vesicle fusion to target membrane);GO:0051117(ATPase binding);GO:0070382(exocytic vesicle);GO:0071944(cell periphery);GO:0072659(protein localization to plasma membrane);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:1903078(positive regulation of protein localization to plasma membrane)","04310(Wnt signaling pathway)",{"v":0.014,"d":"0.01"},1,"689,",0,-1.86,{"v":-1.3,"d":"-1.30"},7.56,"5' UTR",23,8101970,8127986,26017,1]
["chr23",12275298,12275564,267,"ENSBGRG00000009097","ENSBGRT00000016644",8532,"ENSBGRG00000009097","NA","NA","NA",{"v":0.0011,"d":"0.00"},1,"267,",0,-2.96,-2.33,4.32,"Exon (ENSBGRT00000016644/ENSBGRG00000009097, exon 2 of 2)",23,12266766,12275330,8565,1]
["chr23",22616932,22617379,448,"ENSBGRG00000019766","ENSBGRT00000036343",0,"ENSBGRG00000019766","NA","NA","NA",{"v":1E-58,"d":"0.00"},1,"448,",0,-58,{"v":-56.6,"d":"-56.60"},{"v":6.2,"d":"6.20"},"3' UTR",23,22616577,22616986,410,2]
["chr23",40821963,40856263,34301,"ENSBGRG00000008257","ENSBGRT00000015152",0,"PDZD2","PDZ domain containing 2 [Source:HGNC Symbol;Acc:HGNC:18486]","GO:0005515(protein binding);GO:0005737(cytoplasm)","04530(Tight junction)",{"v":9.5e-09,"d":"0.00"},2,"83,547,","0,33754",-8.02,-7.22,{"v":31.3,"d":"31.30"},"5' UTR",23,40821963,41142057,320095,1]
["chr23",50989388,50989655,268,"ENSBGRG00000025120","ENSBGRT00000046453",356,"FBXO4","F-box protein 4 [Source:HGNC Symbol;Acc:HGNC:13583]","GO:0000151(ubiquitin ligase complex);GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0007568(aging);GO:0010608(posttranscriptional regulation of gene expression);GO:0016567(protein ubiquitination);GO:0019005(SCF ubiquitin ligase complex);GO:0019725(cellular homeostasis);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0031398(positive regulation of protein ubiquitination);GO:0031647(regulation of protein stability);GO:0031648(protein destabilization);GO:0032212(positive regulation of telomere maintenance via telomerase);GO:0035726(common myeloid progenitor cell proliferation);GO:0042803(protein homodimerization activity);GO:0048147(negative regulation of fibroblast proliferation);GO:0061630(ubiquitin protein ligase activity);GO:0071479(cellular response to ionizing radiation);GO:1900181(negative regulation of protein localization to nucleus);GO:1902916(positive regulation of protein polyubiquitination);GO:2000001(regulation of DNA damage checkpoint)","04120(Ubiquitin mediated proteolysis)",{"v":0.0021,"d":"0.00"},1,"268,",0,-2.67,-2.06,{"v":11.9,"d":"11.90"},"5' UTR",23,50989032,51003266,14235,1]
["chr23",58152300,58172280,19981,"ENSBGRG00000020432","ENSBGRT00000037596",38518,"ITGA2","integrin subunit alpha 2 [Source:HGNC Symbol;Acc:HGNC:6137]","GO:0001540(amyloid-beta binding);GO:0005518(collagen binding);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006929(substrate-dependent cell migration);GO:0007155(cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0031589(cell-substrate adhesion);GO:0033627(cell adhesion mediated by integrin);GO:0034666(integrin alpha2-beta1 complex);GO:0038064(collagen receptor activity);GO:0038065(collagen-activated signaling pathway);GO:0044877(protein-containing complex binding);GO:0045178(basal part of cell);GO:0048333(mesodermal cell differentiation);GO:0098639(collagen binding involved in cell-matrix adhesion)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04145(Phagosome);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04640(Hematopoietic cell lineage);04611(Platelet activation);05200(Pathways in cancer);05205(Proteoglycans in cancer);05222(Small cell lung cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05165(Human papillomavirus infection)",{"v":0.0078,"d":"0.01"},3,"118,110,43,","0,16124,19938",-2.11,-1.53,5.94,"Exon (ENSBGRT00000037596/ENSBGRG00000020432, exon 2 of 30)",23,58113782,58232130,118349,1]
["chr23",1354669,1354759,91,"ENSBGRG00000012907","ENSBGRT00000024498",0,"CPEB4","cytoplasmic polyadenylation element binding protein 4 [Source:HGNC Symbol;Acc:HGNC:21747]","GO:0002931(response to ischemia);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0006417(regulation of translation);GO:0014069(postsynaptic density);GO:0030425(dendrite);GO:0045182(translation regulator activity);GO:0045202(synapse);GO:0071230(cellular response to amino acid stimulus)","04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation)",{"v":0.034,"d":"0.03"},1,"91,",0,-1.47,{"v":-0.937,"d":"-0.94"},{"v":3.6,"d":"3.60"},"Exon (ENSBGRT00000024498/ENSBGRG00000012907, exon 1 of 13)",23,1281474,1354759,73286,2]
["chr23",2668006,2668153,148,"ENSBGRG00000015084","ENSBGRT00000027802",45474,"NEURL1B","neuralized E3 ubiquitin protein ligase 1B [Source:HGNC Symbol;Acc:HGNC:35422]","NA","NA",{"v":2E-50,"d":"0.00"},1,"148,",0,{"v":-49.7,"d":"-49.70"},{"v":-48.5,"d":"-48.50"},5.04,"3' UTR",23,2667533,2713627,46095,2]
["chr23",22644985,22645402,418,"ENSBGRG00000019829","ENSBGRT00000036618",204084,"ANKH","ANKH inorganic pyrophosphate transport regulator [Source:HGNC Symbol;Acc:HGNC:15492]","GO:0005315(inorganic phosphate transmembrane transporter activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0015114(phosphate ion transmembrane transporter activity);GO:0016021(integral component of membrane);GO:0030500(regulation of bone mineralization);GO:0030504(inorganic diphosphate transmembrane transporter activity);GO:0035435(phosphate ion transmembrane transport)","NA",0,1,"418,",0,-556,"-Inf",7.23,"3' UTR",23,22644033,22849486,205454,2]
["chr23",41158960,41214655,55696,"ENSBGRG00000008466","ENSBGRT00000015392",0,"ENSBGRG00000008466","NA","NA","04390(Hippo signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration);05200(Pathways in cancer);05226(Gastric cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05100(Bacterial invasion of epithelial cells)",{"v":1.3E-49,"d":"0.00"},4,"185,115,132,106,","0,13951,18109,55590",{"v":-48.9,"d":"-48.90"},{"v":-47.6,"d":"-47.60"},2.92,"Exon (ENSBGRT00000015392/ENSBGRG00000008466, exon 1 of 1)",23,41164779,41166047,1269,1]
["chr23",48191566,48191655,90,"ENSBGRG00000023892","ENSBGRT00000044175",0,"FYB1","FYN binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4036]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0008289(lipid binding);GO:0015629(actin cytoskeleton);GO:0032991(protein-containing complex);GO:0072659(protein localization to plasma membrane)","04015(Rap1 signaling pathway)",{"v":0.043,"d":"0.04"},1,"90,",0,-1.37,{"v":-0.6,"d":"-0.60"},4.32,"5' UTR",23,48008194,48191655,183462,2]
["chr24",3284576,3284887,312,"ENSBGRG00000016363","ENSBGRT00000030017",0,"ENSBGRG00000016363","NA","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0006352(DNA-templated transcription, initiation);GO:0042025(host cell nucleus);GO:0046982(protein heterodimerization activity)","NA",{"v":0.014,"d":"0.01"},1,"312,",0,-1.86,{"v":-1.3,"d":"-1.30"},6.48,"Exon (ENSBGRT00000030017/ENSBGRG00000016363, exon 1 of 1)",24,3284576,3284887,312,1]
["chr24",4534424,4534482,59,"ENSBGRG00000015560","ENSBGRT00000028546",412,"ENSBGRG00000015560","NA","GO:0003676(nucleic acid binding)","NA",{"v":2e-05,"d":"0.00"},1,"59,",0,{"v":-4.7,"d":"-4.70"},-3.99,8.28,"Exon (ENSBGRT00000028546/ENSBGRG00000015560, exon 1 of 1)",24,4534012,4535100,1089,1]
["chr24",6574068,6574304,237,"ENSBGRG00000022586","ENSBGRT00000041673",8565,"TRIM39","tripartite motif containing 39 [Source:HGNC Symbol;Acc:HGNC:10065]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0008270(zinc ion binding);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0042802(identical protein binding);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0050821(protein stabilization);GO:1902806(regulation of cell cycle G1/S phase transition);GO:2000059(negative regulation of ubiquitin-dependent protein catabolic process);GO:2001235(positive regulation of apoptotic signaling pathway)","NA",{"v":1.3e-67,"d":"0.00"},1,"237,",0,{"v":-66.9,"d":"-66.90"},{"v":-65.5,"d":"-65.50"},5.18,"Exon (ENSBGRT00000041673/ENSBGRG00000022586, exon 6 of 6)",24,6565503,6574304,8802,1]
["chr24",6957172,6957532,361,"ENSBGRG00000009836","ENSBGRT00000018038",8283,"ENSBGRG00000009836","NA","NA","NA",{"v":0.015,"d":"0.02"},1,"361,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000018038/ENSBGRG00000009836, exon 2 of 2)",24,6948889,6958587,9699,1]
["chr24",7917227,7917585,359,"ENSBGRG00000026000","ENSBGRT00000048182",1950,"ENSBGRG00000026000","NA","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);05206(MicroRNAs in cancer);05165(Human papillomavirus infection)",{"v":0.0078,"d":"0.01"},1,"359,",0,-2.11,-1.53,9.72,"Exon (ENSBGRT00000048200/ENSBGRG00000026062, exon 1 of 1)",24,7856845,7919535,62691,2]
["chr24",14608951,14610227,1277,"ENSBGRG00000024761","ENSBGRT00000045690",72591,"TNFRSF21","TNF receptor superfamily member 21 [Source:HGNC Symbol;Acc:HGNC:13469]","GO:0001783(B cell apoptotic process);GO:0002250(adaptive immune response);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0006915(apoptotic process);GO:0006959(humoral immune response);GO:0007165(signal transduction);GO:0030424(axon);GO:0030889(negative regulation of B cell proliferation);GO:0031226(intrinsic component of plasma membrane);GO:0031642(negative regulation of myelination);GO:0032693(negative regulation of interleukin-10 production);GO:0032696(negative regulation of interleukin-13 production);GO:0032714(negative regulation of interleukin-5 production);GO:0042130(negative regulation of T cell proliferation);GO:0042552(myelination);GO:0048713(regulation of oligodendrocyte differentiation);GO:0050852(T cell receptor signaling pathway);GO:0051402(neuron apoptotic process);GO:0071356(cellular response to tumor necrosis factor);GO:0097252(oligodendrocyte apoptotic process)","04060(Cytokine-cytokine receptor interaction)",{"v":0.00013,"d":"0.00"},2,"225,165,","0,1112",{"v":-3.9,"d":"-3.90"},-3.22,6.48,"3' UTR",24,14536360,14609175,72816,1]
["chr24",18420618,18420798,181,"ENSBGRG00000012257","ENSBGRT00000022776",4995,"YIPF3","Yip1 domain family member 3 [Source:HGNC Symbol;Acc:HGNC:21023]","GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0043231(intracellular membrane-bounded organelle)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway)",{"v":0,"d":"0.00"},1,"181,",0,-313,-311,3.37,"3' UTR",24,18415623,18421667,6045,1]
["chr24",19618695,19618755,61,"ENSBGRG00000021627","ENSBGRT00000040004",187210,"TRERF1","transcriptional regulating factor 1 [Source:HGNC Symbol;Acc:HGNC:18273]","GO:0001650(fibrillar center);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0005829(cytosol)","03015(mRNA surveillance pathway)",{"v":6.5E-8,"d":"0.00"},1,"61,",0,-7.19,{"v":-6.4,"d":"-6.40"},{"v":2.5,"d":"2.50"},"Exon (ENSBGRT00000040004/ENSBGRG00000021627, exon 3 of 16)",24,19431485,19660330,228846,1]
["chr24",20001769,20002691,923,"ENSBGRG00000022427","ENSBGRT00000041410",58045,"MED20","mediator complex subunit 20 [Source:HGNC Symbol;Acc:HGNC:16840]","GO:0003712(transcription coregulator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016592(mediator complex);GO:0035914(skeletal muscle cell differentiation)","NA",{"v":4.3E-3,"d":"0.00"},1,"923,",0,-2.37,-1.77,6.48,"3' UTR",24,19943724,20002691,58968,1]
["chr24",26996001,26996782,782,"ENSBGRG00000015148","ENSBGRT00000028921",964,"TULP1","TUB like protein 1 [Source:HGNC Symbol;Acc:HGNC:12423]","GO:0001750(photoreceptor outer segment);GO:0001895(retina homeostasis);GO:0001917(photoreceptor inner segment);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005576(extracellular region);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006910(phagocytosis, recognition);GO:0016192(vesicle-mediated transport);GO:0016358(dendrite development);GO:0042462(eye photoreceptor cell development);GO:0042995(cell projection);GO:0043679(axon terminus);GO:0045202(synapse);GO:0045494(photoreceptor cell maintenance);GO:0050766(positive regulation of phagocytosis);GO:0050908(detection of light stimulus involved in visual perception);GO:0051015(actin filament binding);GO:0060041(retina development in camera-type eye);GO:1903546(protein localization to photoreceptor outer segment)","NA",{"v":9.3e-05,"d":"0.00"},2,"107,13,","0,769",-4.03,-3.35,2.16,"Exon (ENSBGRT00000028921/ENSBGRG00000015148, exon 4 of 16)",24,26995037,27009803,14767,1]
["chr24",29317169,29317319,151,"ENSBGRG00000017950","ENSBGRT00000033304",9056,"WDR46","WD repeat domain 46 [Source:HGNC Symbol;Acc:HGNC:13923]","GO:0005515(protein binding)","NA",{"v":4.3e-06,"d":"0.00"},1,"151,",0,-5.37,-4.64,1.99,"Exon (ENSBGRT00000033304/ENSBGRG00000017950, exon 12 of 15)",24,29308113,29317891,9779,1]
["chr24",29664686,29667119,2434,"ENSBGRG00000022347","ENSBGRT00000041294",6132,"HLA-DOB","major histocompatibility complex, class II, DO beta [Source:HGNC Symbol;Acc:HGNC:4937]","GO:0002587(negative regulation of antigen processing and presentation of peptide antigen via MHC class II);GO:0005764(lysosome);GO:0006955(immune response);GO:0016020(membrane);GO:0019882(antigen processing and presentation);GO:0023026(MHC class II protein complex binding);GO:0042613(MHC class II protein complex)","04514(Cell adhesion molecules (CAMs));04145(Phagosome);04640(Hematopoietic cell lineage);04612(Antigen processing and presentation);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04672(Intestinal immune network for IgA production);05310(Asthma);05322(Systemic lupus erythematosus);05323(Rheumatoid arthritis);05320(Autoimmune thyroid disease);05321(Inflammatiory bowel disease (IBD));05330(Allograft rejection);05332(Graft-versus-host disease);05416(Viral myocarditis);04940(Type I diabetes mellitus);05150(Staphylococcus aureus infection);05152(Tuberculosis);05166(HTLV-I infection);05164(Influenza A);05168(Herpes simplex infection);05145(Toxoplasmosis);05140(Leishmaniasis)",{"v":0.025,"d":"0.03"},4,"62,282,111,23,","0,507,1432,2411",-1.61,-1.07,7.56,"Exon (ENSBGRT00000041294/ENSBGRG00000022347, exon 2 of 6)",24,29658554,29667903,9350,1]
["chr24",43994205,43994855,651,"ENSBGRG00000009909","ENSBGRT00000018207",0,"ENSBGRG00000009909","NA","NA","NA",{"v":0.0074,"d":"0.01"},1,"651,",0,-2.13,-1.55,4.32,"Exon (ENSBGRT00000018207/ENSBGRG00000009909, exon 1 of 3)",24,43994205,44020626,26422,1]
["chr24",49333598,49333866,269,"ENSBGRG00000013247","ENSBGRT00000024361",136161,"NEDD9","neural precursor cell expressed, developmentally down-regulated 9 [Source:HGNC Symbol;Acc:HGNC:7733]","GO:0000922(spindle pole);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0030335(positive regulation of cell migration);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0090630(activation of GTPase activity);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading);GO:1990782(protein tyrosine kinase binding)","NA",{"v":0.00041,"d":"0.00"},1,"269,",0,-3.39,-2.74,{"v":5.4,"d":"5.40"},"5' UTR",24,49197437,49343687,146251,1]
["chr24",52533954,52534134,181,"ENSBGRG00000018351","ENSBGRT00000033566",0,"CAGE1","cancer antigen 1 [Source:HGNC Symbol;Acc:HGNC:21622]","NA","NA",{"v":0.0011,"d":"0.00"},1,"181,",0,-2.96,-2.33,13,"5' UTR",24,52533954,52572421,38468,1]
["chr24",55630153,55630273,121,"ENSBGRG00000009105","ENSBGRT00000016684",4924,"ENSBGRG00000009105","NA","NA","NA",{"v":9.5e-05,"d":"0.00"},1,"121,",0,-4.02,-3.33,4.05,"Exon (ENSBGRT00000016684/ENSBGRG00000009105, exon 2 of 2)",24,55625229,55631889,6661,1]
["chr24",1788877,1789055,179,"ENSBGRG00000023815","ENSBGRT00000044113",10293,"C6orf62","chromosome 6 open reading frame 62 [Source:HGNC Symbol;Acc:HGNC:20998]","NA","NA",0,1,"179,",0,-525,"-Inf",5.26,"3' UTR",24,1787811,1799348,11538,2]
["chr24",6162639,6162788,150,"ENSBGRG00000018602","ENSBGRT00000035542",2068,"GABBR1","gamma-aminobutyric acid type B receptor subunit 1 [Source:HGNC Symbol;Acc:HGNC:4070]","GO:0004930(G protein-coupled receptor activity);GO:0004965(G protein-coupled GABA receptor activity);GO:0005737(cytoplasm);GO:0005887(integral component of plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0038037(G protein-coupled receptor dimeric complex);GO:0038039(G protein-coupled receptor heterodimeric complex);GO:0042734(presynaptic membrane);GO:0045211(postsynaptic membrane);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098793(presynapse);GO:0098982(GABA-ergic synapse);GO:0099579(G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04915(Estrogen signaling pathway);04727(GABAergic synapse);04742(Taste transduction);05032(Morphine addiction)",{"v":5e-17,"d":"0.00"},1,"150,",0,{"v":-16.3,"d":"-16.30"},{"v":-15.4,"d":"-15.40"},3.38,"Exon (ENSBGRT00000035542/ENSBGRG00000018602, exon 2 of 22)",24,6134269,6164856,30588,2]
["chr24",6336028,6338287,2260,"ENSBGRG00000020507","ENSBGRT00000037804",5451,"TRIM10","tripartite motif containing 10 [Source:HGNC Symbol;Acc:HGNC:10072]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0030218(erythrocyte differentiation);GO:0045087(innate immune response);GO:0046597(negative regulation of viral entry into host cell);GO:0046872(metal ion binding)","NA",{"v":0.00015,"d":"0.00"},2,"518,14,","0,2246",-3.83,-3.15,{"v":16.2,"d":"16.20"},"Exon (ENSBGRT00000037804/ENSBGRG00000020507, exon 6 of 7)",24,6336028,6343738,7711,2]
["chr24",7471115,7471352,238,"ENSBGRG00000014339","ENSBGRT00000026439",178,"ENSBGRG00000014339","NA","NA","NA",{"v":6.3e-82,"d":"0.00"},1,"238,",0,{"v":-81.2,"d":"-81.20"},{"v":-79.7,"d":"-79.70"},8.59,"Exon (ENSBGRT00000026439/ENSBGRG00000014339, exon 1 of 2)",24,7470638,7471530,893,2]
["chr24",7916656,7916896,241,"ENSBGRG00000026000","ENSBGRT00000048182",2639,"ENSBGRG00000026000","NA","NA","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);05206(MicroRNAs in cancer);05165(Human papillomavirus infection)",{"v":7.9e-22,"d":"0.00"},1,"241,",0,{"v":-21.1,"d":"-21.10"},{"v":-20.1,"d":"-20.10"},7.02,"Exon (ENSBGRT00000048200/ENSBGRG00000026062, exon 1 of 1)",24,7856845,7919535,62691,2]
["chr24",15172099,15175172,3074,"ENSBGRG00000025033","ENSBGRT00000046302",5192,"TDRD6","tudor domain containing 6 [Source:HGNC Symbol;Acc:HGNC:21339]","NA","NA",{"v":0.0011,"d":"0.00"},3,"55,125,838,","0,1065,2236",-2.96,-2.33,13,"Exon (ENSBGRT00000046302/ENSBGRG00000025033, exon 3 of 6)",24,15171357,15180364,9008,2]
["chr24",17451896,17458512,6617,"ENSBGRG00000025587","ENSBGRT00000047354",6425,"CDC5L","cell division cycle 5 like [Source:HGNC Symbol;Acc:HGNC:1743]","GO:0000398(mRNA splicing, via spliceosome);GO:0000974(Prp19 complex);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005662(DNA replication factor A complex);GO:0005737(cytoplasm);GO:0016607(nuclear speck);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0071007(U2-type catalytic step 2 spliceosome);GO:0071013(catalytic step 2 spliceosome);GO:0071987(WD40-repeat domain binding);GO:0072422(signal transduction involved in DNA damage checkpoint)","03040(Spliceosome)",{"v":6.9e-07,"d":"0.00"},3,"31,100,19,","0,5126,6598",-6.16,{"v":-5.4,"d":"-5.40"},1.82,"Exon (ENSBGRT00000047354/ENSBGRG00000025587, exon 4 of 16)",24,17417573,17464937,47365,2]
["chr24",19059506,19059626,121,"ENSBGRG00000021301","ENSBGRT00000039412",4019,"BICRAL","BRD4 interacting chromatin remodeling complex associated protein like [Source:HGNC Symbol;Acc:HGNC:21111]","GO:0016514(SWI/SNF complex)","NA",{"v":6.3e-33,"d":"0.00"},1,"121,",0,{"v":-32.2,"d":"-32.20"},{"v":-31.1,"d":"-31.10"},3.06,"Exon (ENSBGRT00000039412/ENSBGRG00000021301, exon 4 of 11)",24,19031295,19063645,32351,2]
["chr24",22105130,22105565,436,"ENSBGRG00000023662","ENSBGRT00000044036",60264,"DAAM2","dishevelled associated activator of morphogenesis 2 [Source:HGNC Symbol;Acc:HGNC:18143]","GO:0003779(actin binding);GO:0007368(determination of left/right symmetry);GO:0016043(cellular component organization);GO:0017048(Rho GTPase binding);GO:0021516(dorsal spinal cord development);GO:0030036(actin cytoskeleton organization);GO:0048715(negative regulation of oligodendrocyte differentiation);GO:0060828(regulation of canonical Wnt signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:2000050(regulation of non-canonical Wnt signaling pathway)","04310(Wnt signaling pathway)",{"v":1E-156,"d":"0.00"},2,"207,32,","0,404",-156,-154,4.63,"Exon (ENSBGRT00000044036/ENSBGRG00000023662, exon 25 of 26)",24,22104115,22165829,61715,2]
["chr24",27055930,27056110,181,"ENSBGRG00000016287","ENSBGRT00000030021",1652,"FANCE","FA complementation group E [Source:HGNC Symbol;Acc:HGNC:3586]","GO:0036297(interstrand cross-link repair);GO:0043240(Fanconi anaemia nuclear complex)","03460(Fanconi anemia pathway)",{"v":2.8e-10,"d":"0.00"},1,"181,",0,-9.56,-8.73,4.55,"Exon (ENSBGRT00000030163/ENSBGRG00000016287, exon 2 of 10)",24,27045682,27057762,12081,2]
["chr24",29498281,29498341,61,"ENSBGRG00000021629","ENSBGRT00000040088",5383,"BRD2","bromodomain containing 2 [Source:HGNC Symbol;Acc:HGNC:1103]","GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006334(nucleosome assembly);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016607(nuclear speck);GO:0070577(lysine-acetylated histone binding)","NA",{"v":5e-11,"d":"0.00"},1,"61,",0,{"v":-10.3,"d":"-10.30"},-9.48,1.45,"Exon (ENSBGRT00000040088/ENSBGRG00000021629, exon 6 of 13)",24,29494173,29503724,9552,2]
["chr24",33414359,33428184,13826,"ENSBGRG00000024977","ENSBGRT00000046780",0,"DST","dystonin [Source:HGNC Symbol;Acc:HGNC:1090]","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005856(cytoskeleton);GO:0007010(cytoskeleton organization);GO:0008017(microtubule binding);GO:0008092(cytoskeletal protein binding);GO:0045104(intermediate filament cytoskeleton organization)","NA",{"v":2.5e-72,"d":"0.00"},2,"295,66,","0,13760",{"v":-71.6,"d":"-71.60"},{"v":-70.1,"d":"-70.10"},5.15,"Exon (ENSBGRT00000046780/ENSBGRG00000024977, exon 1 of 44)",24,33311713,33414653,102941,2]
["chr24",45067787,45068797,1011,"ENSBGRG00000010290","ENSBGRT00000018859",0,"ENSBGRG00000010290","NA","NA","NA",{"v":0.0078,"d":"0.01"},1,"1011,",0,-2.11,-1.27,9.72,"Exon (ENSBGRT00000018859/ENSBGRG00000010290, exon 1 of 1)",24,45067787,45068797,1011,2]
["chr24",49678310,49678427,118,"ENSBGRG00000014807","ENSBGRT00000027385",11616,"PAK1IP1","PAK1 interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:20882]","GO:0005515(protein binding);GO:0005730(nucleolus);GO:0008283(cell population proliferation);GO:0042273(ribosomal large subunit biogenesis);GO:0060021(roof of mouth development);GO:1901796(regulation of signal transduction by p53 class mediator)","NA",{"v":5E-15,"d":"0.00"},1,"118,",0,{"v":-14.3,"d":"-14.30"},{"v":-13.4,"d":"-13.40"},1.52,"Exon (ENSBGRT00000027385/ENSBGRG00000014807, exon 10 of 11)",24,49678248,49690043,11796,2]
["chr24",49820794,49829485,8692,"ENSBGRG00000015016","ENSBGRT00000027641",0,"GCNT2","glucosaminyl (N-acetyl) transferase 2 (I blood group) [Source:HGNC Symbol;Acc:HGNC:4204]","GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0008109(N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity);GO:0010608(posttranscriptional regulation of gene expression);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0010812(negative regulation of cell-substrate adhesion);GO:0016020(membrane);GO:0030335(positive regulation of cell migration);GO:0034116(positive regulation of heterotypic cell-cell adhesion);GO:0036438(maintenance of lens transparency);GO:0051897(positive regulation of protein kinase B signaling);GO:0070374(positive regulation of ERK1 and ERK2 cascade)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)",{"v":0.028,"d":"0.03"},2,"1310,36,","0,8656",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",24,49715068,49822103,107036,2]
["chr24",52629642,52630301,660,"ENSBGRG00000017936","ENSBGRT00000032883",65920,"RIOK1","RIO kinase 1 [Source:HGNC Symbol;Acc:HGNC:18656]","GO:0003676(nucleic acid binding);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0030490(maturation of SSU-rRNA);GO:0030688(preribosome, small subunit precursor);GO:0034708(methyltransferase complex);GO:0042274(ribosomal small subunit biogenesis);GO:2000234(positive regulation of rRNA processing)","03008(Ribosome biogenesis in eukaryotes)",{"v":3.2e-98,"d":"0.00"},1,"660,",0,{"v":-97.5,"d":"-97.50"},{"v":-95.9,"d":"-95.90"},7.89,"3' UTR",24,52513074,52696221,183148,2]
["chr24",54329359,54329625,267,"ENSBGRG00000007585","ENSBGRT00000013876",147,"ENSBGRG00000007585","NA","NA","NA",{"v":2.2e-05,"d":"0.00"},1,"267,",0,-4.66,-3.95,5.76,"Exon (ENSBGRT00000013876/ENSBGRG00000007585, exon 1 of 3)",24,54326637,54329772,3136,2]
["chr25",8044538,8045100,563,"ENSBGRG00000018087","ENSBGRT00000033083",0,"CSTF2T","cleavage stimulation factor subunit 2 tau variant [Source:HGNC Symbol;Acc:HGNC:17086]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0031124(mRNA 3'-end processing);GO:0043231(intracellular membrane-bounded organelle)","03015(mRNA surveillance pathway)",{"v":1E-134,"d":"0.00"},1,"563,",0,-134,-132,4.48,"Exon (ENSBGRT00000033083/ENSBGRG00000018087, exon 1 of 2)",25,8044538,8046878,2341,1]
["chr25",16159780,16161228,1449,"ENSBGRG00000023070","ENSBGRT00000042577",0,"CEP55","centrosomal protein 55 [Source:HGNC Symbol;Acc:HGNC:1161]","GO:0000281(mitotic cytokinesis);GO:0005813(centrosome);GO:0005886(plasma membrane);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0030496(midbody);GO:0034451(centriolar satellite);GO:0042802(identical protein binding);GO:0045171(intercellular bridge);GO:0045184(establishment of protein localization);GO:0061952(midbody abscission);GO:0090543(Flemming body);GO:1904888(cranial skeletal system development)","NA",{"v":0.0041,"d":"0.00"},2,"284,72,","0,1377",-2.39,-1.79,{"v":10.8,"d":"10.80"},"5' UTR",25,16159780,16181675,21896,1]
["chr25",18713894,18725170,11277,"ENSBGRG00000025803","ENSBGRT00000047722",5226,"CCNJ","cyclin J [Source:HGNC Symbol;Acc:HGNC:23434]","GO:0042025(host cell nucleus)","NA",{"v":1.6E-11,"d":"0.00"},4,"73,300,160,412,","0,8523,8910,10865",{"v":-10.8,"d":"-10.80"},-9.92,3.88,"Exon (ENSBGRT00000047722/ENSBGRG00000025803, exon 2 of 5)",25,18708668,18725170,16503,1]
["chr25",20216813,20217228,416,"ENSBGRG00000017993","ENSBGRT00000032955",69204,"UBTD1","ubiquitin domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25683]","GO:0005515(protein binding)","NA",{"v":6.3e-85,"d":"0.00"},1,"416,",0,{"v":-84.2,"d":"-84.20"},{"v":-82.7,"d":"-82.70"},8.77,"3' UTR",25,20147609,20217753,70145,1]
["chr25",23594189,23594369,181,"ENSBGRG00000025048","ENSBGRT00000046464",5275,"SLF2","SMC5-SMC6 complex localization factor 2 [Source:HGNC Symbol;Acc:HGNC:17814]","GO:0000785(chromatin);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006974(cellular response to DNA damage stimulus);GO:0031334(positive regulation of protein-containing complex assembly);GO:0031625(ubiquitin protein ligase binding);GO:0034184(positive regulation of maintenance of mitotic sister chromatid cohesion);GO:0035861(site of double-strand break);GO:0043231(intracellular membrane-bounded organelle);GO:0044877(protein-containing complex binding);GO:1990166(protein localization to site of double-strand break);GO:2000781(positive regulation of double-strand break repair)","NA",{"v":0.0035,"d":"0.00"},1,"181,",0,-2.45,-1.85,2.16,"Exon (ENSBGRT00000046464/ENSBGRG00000025048, exon 3 of 20)",25,23588914,23631196,42283,1]
["chr25",24716396,24719658,3263,"ENSBGRG00000026028","ENSBGRT00000048137",0,"HPS6","HPS6 biogenesis of lysosomal organelles complex 2 subunit 3 [Source:HGNC Symbol;Acc:HGNC:18817]","GO:0005765(lysosomal membrane);GO:0006996(organelle organization);GO:0007596(blood coagulation);GO:0017137(Rab GTPase binding);GO:0030318(melanocyte differentiation);GO:0030742(GTP-dependent protein binding);GO:0031084(BLOC-2 complex);GO:0032418(lysosome localization);GO:0043473(pigmentation);GO:0072657(protein localization to membrane)","NA",{"v":3e-05,"d":"0.00"},2,"291,155,","0,3108",-4.53,-3.83,{"v":17.3,"d":"17.30"},"Exon (ENSBGRT00000048137/ENSBGRG00000026028, exon 1 of 2)",25,24716396,24721618,5223,1]
["chr25",26089849,26092377,2529,"ENSBGRG00000009626","ENSBGRT00000017710",24190,"PDCD11","programmed cell death 11 [Source:HGNC Symbol;Acc:HGNC:13408]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006396(RNA processing);GO:0006397(mRNA processing);GO:0008134(transcription factor binding)","NA",{"v":1e-116,"d":"0.00"},2,"523,47,","0,2482",-116,-114,5.52,"Exon (ENSBGRT00000017710/ENSBGRG00000009626, exon 19 of 35)",25,26065659,26111881,46223,1]
["chr25",33842696,33850090,7395,"ENSBGRG00000017710","ENSBGRT00000032647",195979,"RBM20","RNA binding motif protein 20 [Source:HGNC Symbol;Acc:HGNC:27424]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0007507(heart development);GO:0008270(zinc ion binding);GO:0033120(positive regulation of RNA splicing);GO:0043484(regulation of RNA splicing)","NA",{"v":2.5e-26,"d":"0.00"},3,"222,105,32,","0,5696,7363",{"v":-25.6,"d":"-25.60"},{"v":-24.5,"d":"-24.50"},5.24,"Exon (ENSBGRT00000032647/ENSBGRG00000017710, exon 10 of 15)",25,33646717,33865404,218688,1]
["chr25",35621573,35638166,16594,"ENSBGRG00000019577","ENSBGRT00000036305",0,"VTI1A","vesicle transport through interaction with t-SNAREs 1A [Source:HGNC Symbol;Acc:HGNC:17792]","GO:0005484(SNAP receptor activity);GO:0005776(autophagosome);GO:0005794(Golgi apparatus);GO:0006886(intracellular protein transport);GO:0006914(autophagy);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0042147(retrograde transport, endosome to Golgi);GO:0043231(intracellular membrane-bounded organelle);GO:0050882(voluntary musculoskeletal movement);GO:0090161(Golgi ribbon formation)","04130(SNARE interactions in vesicular transport)",{"v":3E-9,"d":"0.00"},3,"128,59,50,","0,9995,16544",-8.52,-7.71,{"v":2.3,"d":"2.30"},"5' UTR",25,35621573,35871607,250035,1]
["chr25",45720433,45720553,121,"ENSBGRG00000024000","ENSBGRT00000044297",58660,"ENSBGRG00000024000","NA","GO:0007052(mitotic spindle organization)","NA",{"v":1.9E-3,"d":"0.00"},1,"121,",0,-2.73,-2.11,4.59,"Exon (ENSBGRT00000044297/ENSBGRG00000024000, exon 3 of 7)",25,45661773,45863884,202112,1]
["chr25",46611891,46612098,208,"ENSBGRG00000025390","ENSBGRT00000046934",0,"PSTK","phosphoseryl-tRNA kinase [Source:HGNC Symbol;Acc:HGNC:28578]","GO:0000049(tRNA binding);GO:0001514(selenocysteine incorporation);GO:0043915(L-seryl-tRNA(Sec) kinase activity)","00450(Selenocompound metabolism);00970(Aminoacyl-tRNA biosynthesis)",{"v":5e-11,"d":"0.00"},1,"208,",0,{"v":-10.3,"d":"-10.30"},-9.44,2.75,"Exon (ENSBGRT00000046934/ENSBGRG00000025390, exon 1 of 6)",25,46611891,46628228,16338,1]
["chr25",48596062,48621587,25526,"ENSBGRG00000007598","ENSBGRT00000013930",1874,"ZRANB1","zinc finger RANBP2-type containing 1 [Source:HGNC Symbol;Acc:HGNC:18224]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007010(cytoskeleton organization);GO:0016477(cell migration);GO:0022604(regulation of cell morphogenesis);GO:0030177(positive regulation of Wnt signaling pathway);GO:0035523(protein K29-linked deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0043231(intracellular membrane-bounded organelle);GO:0070530(K63-linked polyubiquitin modification-dependent protein binding);GO:0070536(protein K63-linked deubiquitination);GO:0071947(protein deubiquitination involved in ubiquitin-dependent protein catabolic process);GO:1990168(protein K33-linked deubiquitination)","NA",{"v":1e-162,"d":"0.00"},2,"436,68,","0,25458",-162,-160,6.77,"Exon (ENSBGRT00000013930/ENSBGRG00000007598, exon 2 of 10)",25,48594188,48642879,48692,1]
["chr25",7318310,7318368,59,"ENSBGRG00000017698","ENSBGRT00000032429",1845,"DKK1","dickkopf WNT signaling pathway inhibitor 1 [Source:HGNC Symbol;Acc:HGNC:2891]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002090(regulation of receptor internalization);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0007275(multicellular organism development);GO:0010628(positive regulation of gene expression);GO:0030178(negative regulation of Wnt signaling pathway);GO:0032091(negative regulation of protein binding);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0039706(co-receptor binding);GO:0042662(negative regulation of mesodermal cell fate specification);GO:0042663(regulation of endodermal cell fate specification);GO:0043507(positive regulation of JUN kinase activity);GO:0048019(receptor antagonist activity);GO:0050750(low-density lipoprotein particle receptor binding);GO:0060394(negative regulation of pathway-restricted SMAD protein phosphorylation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:1901296(negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment);GO:1904723(negative regulation of Wnt-Frizzled-LRP5/6 complex assembly);GO:2000726(negative regulation of cardiac muscle cell differentiation)","04310(Wnt signaling pathway)",{"v":9.8e-06,"d":"0.00"},1,"59,",0,-5.01,-4.29,{"v":20.5,"d":"20.50"},"Exon (ENSBGRT00000032429/ENSBGRG00000017698, exon 3 of 4)",25,7317873,7320213,2341,2]
["chr25",12220860,12221250,391,"ENSBGRG00000018127","ENSBGRT00000033389",0,"PANK1","pantothenate kinase 1 [Source:HGNC Symbol;Acc:HGNC:8598]","GO:0004594(pantothenate kinase activity);GO:0005524(ATP binding);GO:0015937(coenzyme A biosynthetic process);GO:0042803(protein homodimerization activity);GO:1905502(acetyl-CoA binding)","00770(Pantothenate and CoA biosynthesis)",{"v":0.0041,"d":"0.00"},1,"391,",0,-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000033389/ENSBGRG00000018127, exon 1 of 7)",25,12154802,12221250,66449,2]
["chr25",19382071,19382371,301,"ENSBGRG00000026070","ENSBGRT00000048242",13067,"PIK3AP1","phosphoinositide-3-kinase adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:30034]","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0034134(toll-like receptor 2 signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0034154(toll-like receptor 7 signaling pathway);GO:0034162(toll-like receptor 9 signaling pathway);GO:0036312(phosphatidylinositol 3-kinase regulatory subunit binding);GO:0042802(identical protein binding);GO:0050727(regulation of inflammatory response)","04151(PI3K-Akt signaling pathway);04662(B cell receptor signaling pathway)",{"v":0.014,"d":"0.01"},1,"301,",0,-1.86,{"v":-1.3,"d":"-1.30"},7.56,"5' UTR",25,19253522,19395438,141917,2]
["chr25",20318739,20319059,321,"ENSBGRG00000018935","ENSBGRT00000034723",1472,"AVPI1","arginine vasopressin induced 1 [Source:HGNC Symbol;Acc:HGNC:30898]","GO:0000187(activation of MAPK activity)","NA",{"v":1E-150,"d":"0.00"},1,"321,",0,-150,-148,3.17,"3' UTR",25,20318710,20320531,1822,2]
["chr25",22930134,22930688,555,"ENSBGRG00000024074","ENSBGRT00000044433",0,"BLOC1S2","biogenesis of lysosomal organelles complex 1 subunit 2 [Source:HGNC Symbol;Acc:HGNC:20984]","GO:0000930(gamma-tubulin complex);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0008089(anterograde axonal transport);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0031083(BLOC-1 complex);GO:0032418(lysosome localization);GO:0043015(gamma-tubulin binding);GO:0048490(anterograde synaptic vesicle transport);GO:0097345(mitochondrial outer membrane permeabilization);GO:0099078(BORC complex)","NA",{"v":6.3e-08,"d":"0.00"},2,"110,67,","0,488",{"v":-7.2,"d":"-7.20"},-6.42,2.59,"Exon (ENSBGRT00000044433/ENSBGRG00000024074, exon 1 of 5)",25,22920301,22930688,10388,2]
["chr25",37466694,37473330,6637,"ENSBGRG00000025005","ENSBGRT00000046184",21683,"CCDC186","coiled-coil domain containing 186 [Source:HGNC Symbol;Acc:HGNC:24349]","GO:0005794(Golgi apparatus);GO:0009617(response to bacterium);GO:0035773(insulin secretion involved in cellular response to glucose stimulus);GO:0042593(glucose homeostasis);GO:0099518(vesicle cytoskeletal trafficking)","NA",{"v":2e-11,"d":"0.00"},6,"79,143,143,87,99,47,","0,3552,4759,5762,6013,6590",{"v":-10.7,"d":"-10.70"},-9.87,3.12,"Exon (ENSBGRT00000046184/ENSBGRG00000025005, exon 6 of 13)",25,37456650,37495013,38364,2]
["chr25",39534554,39535061,508,"ENSBGRG00000016210","ENSBGRT00000029863",256451,"GFRA1","GDNF family receptor alpha 1 [Source:HGNC Symbol;Acc:HGNC:4243]","GO:0007399(nervous system development);GO:0038023(signaling receptor activity)","NA",{"v":3.5e-08,"d":"0.00"},1,"508,",0,-7.46,-6.67,{"v":13.5,"d":"13.50"},"3' UTR",25,39534166,39791512,257347,2]
["chr25",41584823,41584972,150,"ENSBGRG00000019403","ENSBGRT00000035638",150,"RAB11FIP2","RAB11 family interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:29152]","GO:0001891(phagocytic cup);GO:0005654(nucleoplasm);GO:0005768(endosome);GO:0006909(phagocytosis);GO:0017137(Rab GTPase binding);GO:0019901(protein kinase binding);GO:0030010(establishment of cell polarity);GO:0035669(TRAM-dependent toll-like receptor 4 signaling pathway);GO:0035773(insulin secretion involved in cellular response to glucose stimulus);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0043547(positive regulation of GTPase activity);GO:0045055(regulated exocytosis)","04144(Endocytosis)",{"v":0.00085,"d":"0.00"},1,"150,",0,-3.07,-2.44,2,"5' UTR",25,41539793,41585122,45330,2]
["chr25",45562256,45562315,60,"ENSBGRG00000023442","ENSBGRT00000043685",8766,"ATE1","arginyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:782]","GO:0004057(arginyltransferase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010498(proteasomal protein catabolic process);GO:0016598(protein arginylation)","NA",{"v":0.00019,"d":"0.00"},1,"60,",0,-3.72,-3.05,1.69,"Exon (ENSBGRT00000043685/ENSBGRG00000023442, exon 3 of 10)",25,45395729,45571081,175353,2]
["chr25",56476498,56478306,1809,"ENSBGRG00000014069","ENSBGRT00000026142",0,"ENSBGRG00000014069","NA","GO:0035082(axoneme assembly);GO:0060294(cilium movement involved in cell motility)","NA",{"v":9.8e-06,"d":"0.00"},3,"112,132,175,","0,199,1634",-5.01,-4.29,{"v":20.5,"d":"20.50"},"5' UTR",25,56451827,56476828,25002,2]
["chr26",882175,882922,748,"ENSBGRG00000020291","ENSBGRT00000037310",0,"ENSBGRG00000020291","NA","NA","04740(Olfactory transduction)",{"v":0.00056,"d":"0.00"},1,"748,",0,-3.25,{"v":-2.6,"d":"-2.60"},14,"Exon (ENSBGRT00000037310/ENSBGRG00000020291, exon 1 of 3)",26,882175,883135,961,1]
["chr26",1159811,1160267,457,"ENSBGRG00000023983","ENSBGRT00000044304",0,"ZNF789","zinc finger protein 789 [Source:HGNC Symbol;Acc:HGNC:27801]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":0.014,"d":"0.01"},2,"64,86,","0,371",-1.86,{"v":-1.3,"d":"-1.30"},{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000044304/ENSBGRG00000023983, exon 1 of 3)",26,1159811,1162350,2540,1]
["chr26",2991573,2991753,181,"ENSBGRG00000025912","ENSBGRT00000047947",9909,"C7orf26","chromosome 7 open reading frame 26 [Source:HGNC Symbol;Acc:HGNC:21702]","GO:0016409(palmitoyltransferase activity)","NA",{"v":3.2e-28,"d":"0.00"},1,"181,",0,{"v":-27.5,"d":"-27.50"},{"v":-26.4,"d":"-26.40"},1.86,"Exon (ENSBGRT00000047947/ENSBGRG00000025912, exon 4 of 6)",26,2981664,2997419,15756,1]
["chr26",3573890,3575495,1606,"ENSBGRG00000018231","ENSBGRT00000035950",43081,"TNRC18","trinucleotide repeat containing 18 [Source:HGNC Symbol;Acc:HGNC:11962]","GO:0003682(chromatin binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0031965(nuclear membrane)","NA",{"v":4.1e-08,"d":"0.00"},2,"83,7,","0,1599",-7.39,-6.61,1.82,"Exon (ENSBGRT00000035950/ENSBGRG00000018231, exon 10 of 29)",26,3530809,3625548,94740,1]
["chr26",8708276,8728204,19929,"ENSBGRG00000025984","ENSBGRT00000048083",8278,"PRKRIP1","PRKR interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:21894]","GO:0003014(renal system process);GO:0003725(double-stranded RNA binding);GO:0004860(protein kinase inhibitor activity);GO:0005730(nucleolus);GO:0006469(negative regulation of protein kinase activity);GO:0019901(protein kinase binding);GO:0042326(negative regulation of phosphorylation)","00230(Purine metabolism);00240(Pyrimidine metabolism);03030(DNA replication);03410(Base excision repair);03420(Nucleotide excision repair);03430(Mismatch repair);03440(Homologous recombination)",{"v":1.3e-19,"d":"0.00"},4,"7,68,127,6,","0,736,9717,19923",{"v":-18.9,"d":"-18.90"},{"v":-17.9,"d":"-17.90"},6.17,"3' UTR",26,8699998,8718119,18122,1]
["chr26",9644491,9644640,150,"ENSBGRG00000010238","ENSBGRT00000018765",17871,"ENSBGRG00000010238","NA","NA","03013(RNA transport)",{"v":2.5e-49,"d":"0.00"},1,"150,",0,{"v":-48.6,"d":"-48.60"},{"v":-47.3,"d":"-47.30"},{"v":3.4,"d":"3.40"},"Exon (ENSBGRT00000018765/ENSBGRG00000010238, exon 11 of 13)",26,9626620,9648173,21554,1]
["chr26",10730659,10730719,61,"ENSBGRG00000020750","ENSBGRT00000038386",90118,"GTF2IRD1","GTF2I repeat domain containing 1 [Source:HGNC Symbol;Acc:HGNC:4661]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006366(transcription by RNA polymerase II);GO:0014886(transition between slow and fast fiber)","03022(Basal transcription factors);04022(cGMP - PKG signaling pathway);05168(Herpes simplex infection)",{"v":0.014,"d":"0.01"},1,"61,",0,-1.86,{"v":-1.3,"d":"-1.30"},{"v":5.4,"d":"5.40"},"3' UTR",26,10640541,10731475,90935,1]
["chr26",17829604,17829842,239,"ENSBGRG00000025886","ENSBGRT00000047866",179,"SEPHS2","selenophosphate synthetase 2 [Source:HGNC Symbol;Acc:HGNC:19686]","GO:0001887(selenium compound metabolic process);GO:0004756(selenide, water dikinase activity);GO:0005524(ATP binding);GO:0016260(selenocysteine biosynthetic process)","00450(Selenocompound metabolism)",{"v":5e-86,"d":"0.00"},1,"239,",0,{"v":-85.3,"d":"-85.30"},{"v":-83.7,"d":"-83.70"},8.06,"Exon (ENSBGRT00000047866/ENSBGRG00000025886, exon 1 of 1)",26,17829425,17830468,1044,1]
["chr26",18031430,18031579,150,"ENSBGRG00000026026","ENSBGRT00000048184",1173,"MAZ","MYC associated zinc finger protein [Source:HGNC Symbol;Acc:HGNC:6914]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006369(termination of RNA polymerase II transcription);GO:0008284(positive regulation of cell population proliferation);GO:0010628(positive regulation of gene expression);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0030335(positive regulation of cell migration);GO:0045893(positive regulation of transcription, DNA-templated);GO:0051897(positive regulation of protein kinase B signaling);GO:2001234(negative regulation of apoptotic signaling pathway)","03013(RNA transport);00562(Inositol phosphate metabolism);00564(Glycerophospholipid metabolism);04070(Phosphatidylinositol signaling system)",{"v":6.3e-67,"d":"0.00"},1,"150,",0,{"v":-66.2,"d":"-66.20"},{"v":-64.8,"d":"-64.80"},1.99,"Exon (ENSBGRT00000048184/ENSBGRG00000026026, exon 3 of 6)",26,18030257,18034322,4066,1]
["chr26",22113631,22115020,1390,"ENSBGRG00000018997","ENSBGRT00000035246",14562,"ZKSCAN2","zinc finger with KRAB and SCAN domains 2 [Source:HGNC Symbol;Acc:HGNC:25677]","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":2e-31,"d":"0.00"},3,"358,45,45,","0,390,1345",{"v":-30.7,"d":"-30.70"},{"v":-29.6,"d":"-29.60"},5.48,"Exon (ENSBGRT00000035246/ENSBGRG00000018997, exon 8 of 9)",26,22099069,22114065,14997,1]
["chr26",26861198,26862007,810,"ENSBGRG00000026538","ENSBGRT00000049146",0,"ENSBGRG00000026538","NA","NA","NA",{"v":0.00056,"d":"0.00"},1,"810,",0,-3.25,{"v":-2.6,"d":"-2.60"},14,"Exon (ENSBGRT00000049146/ENSBGRG00000026538, exon 1 of 1)",26,26861198,26862607,1410,1]
["chr26",35854152,35857652,3501,"ENSBGRG00000026420","ENSBGRT00000048904",17606,"GSPT1","G1 to S phase transition 1 [Source:HGNC Symbol;Acc:HGNC:4621]","GO:0003747(translation release factor activity);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0006449(regulation of translational termination);GO:0006479(protein methylation)","03015(mRNA surveillance pathway)",{"v":3E-10,"d":"0.00"},3,"5,78,37,","0,1592,3464",-9.53,{"v":-8.7,"d":"-8.70"},{"v":1.5,"d":"1.50"},"Exon (ENSBGRT00000048904/ENSBGRG00000026420, exon 5 of 15)",26,35836546,35868759,32214,1]
["chr26",43035038,43035098,61,"ENSBGRG00000010321","ENSBGRT00000019010",107734,"ENSBGRG00000010321","NA","NA","NA",{"v":0.021,"d":"0.02"},1,"61,",0,-1.67,-1.12,3.24,"Exon (ENSBGRT00000019074/ENSBGRG00000010408, exon 2 of 2)",26,42764346,43142832,378487,2]
["chr26",43430095,43430155,61,"ENSBGRG00000012786","ENSBGRT00000023460",50626,"PPL","periplakin [Source:HGNC Symbol;Acc:HGNC:9273]","GO:0005856(cytoskeleton);GO:0009612(response to mechanical stimulus);GO:0045104(intermediate filament cytoskeleton organization)","NA",{"v":0.005,"d":"0.01"},1,"61,",0,{"v":-2.3,"d":"-2.30"},-1.71,1.91,"Exon (ENSBGRT00000023460/ENSBGRG00000012786, exon 22 of 22)",26,43379469,43430723,51255,1]
["chr26",44470244,44470873,630,"ENSBGRG00000016725","ENSBGRT00000038365",108284,"CREBBP","CREB binding protein [Source:HGNC Symbol;Acc:HGNC:2348]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000123(histone acetyltransferase complex);GO:0000790(nuclear chromatin);GO:0001085(RNA polymerase II transcription factor binding);GO:0002039(p53 binding);GO:0003682(chromatin binding);GO:0003684(damaged DNA binding);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0004402(histone acetyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006473(protein acetylation);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0016604(nuclear body);GO:0018076(N-terminal peptidyl-lysine acetylation);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0031648(protein destabilization);GO:0034644(cellular response to UV);GO:0042025(host cell nucleus);GO:0043426(MRF binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061733(peptide-lysine-N-acetyltransferase activity);GO:1990258(histone glutamine methylation)","04310(Wnt signaling pathway);04330(Notch signaling pathway);04350(TGF-beta signaling pathway);04630(Jak-STAT signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04024(cAMP signaling pathway);04110(Cell cycle);04520(Adherens junction);04922(Glucagon signaling pathway);04919(Thyroid hormone signaling pathway);04916(Melanogenesis);04720(Long-term potentiation);05200(Pathways in cancer);05206(MicroRNAs in cancer);05203(Viral carcinogenesis);05211(Renal cell carcinoma);05215(Prostate cancer);05016(Huntington disease);05152(Tuberculosis);05166(HTLV-I infection);05164(Influenza A);05161(Hepatitis B);05168(Herpes simplex infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection)",0,1,"630,",0,-546,"-Inf",4.97,"Exon (ENSBGRT00000038365/ENSBGRG00000016725, exon 33 of 33)",26,44361960,44470903,108944,1]
["chr26",44829059,44831248,2190,"ENSBGRG00000023582","ENSBGRT00000043527",0,"ENSBGRG00000023582","NA","NA","NA",{"v":0.0011,"d":"0.00"},2,"231,249,","0,1941",-2.96,-2.33,13,"Exon (ENSBGRT00000043527/ENSBGRG00000023582, exon 1 of 2)",26,44829059,44834662,5604,1]
["chr26",45320428,45320697,270,"ENSBGRG00000013843","ENSBGRT00000025413",12955,"ENSBGRG00000013843","NA","NA","NA",{"v":1e-163,"d":"0.00"},1,"270,",0,-163,-161,1.76,"Exon (ENSBGRT00000025527/ENSBGRG00000013909, exon 2 of 6)",26,45307473,45324610,17138,1]
["chr26",45992571,45992631,61,"ENSBGRG00000020915","ENSBGRT00000038617",15982,"CASKIN1","CASK interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:20879]","GO:0005515(protein binding);GO:0042802(identical protein binding)","NA",{"v":0.0078,"d":"0.01"},1,"61,",0,-2.11,-1.53,5.94,"Exon (ENSBGRT00000038617/ENSBGRG00000020915, exon 16 of 18)",26,45976589,45995926,19338,1]
["chr26",47292731,47293058,328,"ENSBGRG00000008667","ENSBGRT00000015816",3236,"FBXL16","F-box and leucine rich repeat protein 16 [Source:HGNC Symbol;Acc:HGNC:14150]","GO:0005515(protein binding)","NA",{"v":0.0041,"d":"0.00"},1,"328,",0,-2.39,-1.79,{"v":5.4,"d":"5.40"},"3' UTR",26,47289495,47293740,4246,1]
["chr26",439956,440224,269,"ENSBGRG00000016739","ENSBGRT00000030713",834,"MEPCE","methylphosphate capping enzyme [Source:HGNC Symbol;Acc:HGNC:20247]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001510(RNA methylation);GO:0005634(nucleus);GO:0008168(methyltransferase activity);GO:0008173(RNA methyltransferase activity);GO:0008757(S-adenosylmethionine-dependent methyltransferase activity);GO:0016073(snRNA metabolic process);GO:0035562(negative regulation of chromatin binding);GO:0040031(snRNA modification);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1904871(positive regulation of protein localization to Cajal body);GO:1905382(positive regulation of snRNA transcription by RNA polymerase II);GO:1990276(RNA 5'-methyltransferase activity);GO:1990904(ribonucleoprotein complex)","NA",{"v":1E-142,"d":"0.00"},1,"269,",0,-142,-140,6.29,"Exon (ENSBGRT00000030713/ENSBGRG00000016739, exon 1 of 4)",26,435556,441058,5503,2]
["chr26",2233359,2233447,89,"ENSBGRG00000025237","ENSBGRT00000046643",236,"BHLHA15","basic helix-loop-helix family member a15 [Source:HGNC Symbol;Acc:HGNC:22265]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006851(mitochondrial calcium ion transmembrane transport);GO:0007030(Golgi organization);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007267(cell-cell signaling);GO:0010832(negative regulation of myotube differentiation);GO:0019722(calcium-mediated signaling);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0042149(cellular response to glucose starvation);GO:0042593(glucose homeostasis);GO:0042802(identical protein binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0048312(intracellular distribution of mitochondria);GO:0048469(cell maturation);GO:1990837(sequence-specific double-stranded DNA binding)","04950(Maturity onset diabetes of the young)",{"v":1.9E-3,"d":"0.00"},1,"89,",0,-2.73,-2.11,{"v":4.1,"d":"4.10"},"Exon (ENSBGRT00000046643/ENSBGRG00000025237, exon 1 of 1)",26,2233123,2233683,561,2]
["chr26",2527384,2527682,299,"ENSBGRG00000025699","ENSBGRT00000047517",35960,"EIF2AK1","eukaryotic translation initiation factor 2 alpha kinase 1 [Source:HGNC Symbol;Acc:HGNC:24921]","GO:0002526(acute inflammatory response);GO:0004672(protein kinase activity);GO:0004694(eukaryotic translation initiation factor 2alpha kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0006909(phagocytosis);GO:0008285(negative regulation of cell population proliferation);GO:0010999(regulation of eIF2 alpha phosphorylation by heme);GO:0020037(heme binding);GO:0030225(macrophage differentiation);GO:0042803(protein homodimerization activity);GO:0046501(protoporphyrinogen IX metabolic process);GO:0046777(protein autophosphorylation);GO:0046984(regulation of hemoglobin biosynthetic process);GO:0046986(negative regulation of hemoglobin biosynthetic process);GO:0055072(iron ion homeostasis);GO:1990641(response to iron ion starvation)","04141(Protein processing in endoplasmic reticulum);05162(Measles);05164(Influenza A);05160(Hepatitis C);05168(Herpes simplex infection);05169(Epstein-Barr virus infection)",{"v":0.035,"d":"0.04"},1,"299,",0,-1.45,{"v":-0.919,"d":"-0.92"},4.32,"3' UTR",26,2527384,2563642,36259,2]
["chr26",2836471,2836680,210,"ENSBGRG00000025849","ENSBGRT00000047784",27450,"DAGLB","diacylglycerol lipase beta [Source:HGNC Symbol;Acc:HGNC:28923]","GO:0001516(prostaglandin biosynthetic process);GO:0004806(triglyceride lipase activity);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0006690(icosanoid metabolic process);GO:0007405(neuroblast proliferation);GO:0010898(positive regulation of triglyceride catabolic process);GO:0016298(lipase activity);GO:0019369(arachidonic acid metabolic process);GO:0022008(neurogenesis);GO:0042136(neurotransmitter biosynthetic process);GO:0050727(regulation of inflammatory response)","04925(Aldosterone synthesis and secretion);04723(Retrograde endocannabinoid signaling)",{"v":1E-42,"d":"0.00"},1,"210,",0,-42,{"v":-40.8,"d":"-40.80"},2.61,"3' UTR",26,2830780,2864130,33351,2]
["chr26",5801627,5801776,150,"ENSBGRG00000023939","ENSBGRT00000044233",764,"CHST12","carbohydrate sulfotransferase 12 [Source:HGNC Symbol;Acc:HGNC:17423]","GO:0008146(sulfotransferase activity);GO:0016021(integral component of membrane);GO:0016051(carbohydrate biosynthetic process);GO:0030206(chondroitin sulfate biosynthetic process);GO:0030208(dermatan sulfate biosynthetic process);GO:0047756(chondroitin 4-sulfotransferase activity)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)",{"v":1.3E-7,"d":"0.00"},1,"150,",0,-6.88,{"v":-6.1,"d":"-6.10"},2.81,"Exon (ENSBGRT00000044233/ENSBGRG00000023939, exon 2 of 2)",26,5799478,5802540,3063,2]
["chr26",7648381,7648501,121,"ENSBGRG00000025474","ENSBGRT00000047086",898,"VGF","VGF nerve growth factor inducible [Source:HGNC Symbol;Acc:HGNC:12684]","GO:0001541(ovarian follicle development);GO:0002021(response to dietary excess);GO:0005184(neuropeptide hormone activity);GO:0005615(extracellular space);GO:0005794(Golgi apparatus);GO:0006091(generation of precursor metabolites and energy);GO:0009409(response to cold);GO:0019953(sexual reproduction);GO:0030073(insulin secretion);GO:0031410(cytoplasmic vesicle);GO:0032868(response to insulin);GO:0042593(glucose homeostasis);GO:0043231(intracellular membrane-bounded organelle);GO:0051591(response to cAMP)","NA",{"v":2e-28,"d":"0.00"},1,"121,",0,{"v":-27.7,"d":"-27.70"},{"v":-26.6,"d":"-26.60"},{"v":74.5,"d":"74.50"},"Exon (ENSBGRT00000047086/ENSBGRG00000025474, exon 1 of 1)",26,7647543,7649399,1857,2]
["chr26",9835056,9835652,597,"ENSBGRG00000011398","ENSBGRT00000021061",18896,"BCL7B","BAF chromatin remodeling complex subunit BCL7B [Source:HGNC Symbol;Acc:HGNC:1005]","NA","NA",{"v":1e-101,"d":"0.00"},1,"597,",0,-101,{"v":-99.4,"d":"-99.40"},3.84,"3' UTR",26,9834371,9854548,20178,2]
["chr26",16007471,16045606,38136,"ENSBGRG00000023612","ENSBGRT00000043603",0,"Metazoa_SRP","Metazoan signal recognition particle RNA [Source:RFAM;Acc:RF00017]","NA","NA",{"v":0.044,"d":"0.04"},2,"123,116,","0,38020",-1.36,{"v":-0.841,"d":"-0.84"},3.24,"3' UTR",26,16008987,16009299,313,1]
["chr26",17212306,17212515,210,"ENSBGRG00000024153","ENSBGRT00000044623",1767,"ZNF646","zinc finger protein 646 [Source:HGNC Symbol;Acc:HGNC:29004]","GO:0003676(nucleic acid binding)","NA",{"v":2.5e-14,"d":"0.00"},1,"210,",0,{"v":-13.6,"d":"-13.60"},{"v":-12.7,"d":"-12.70"},2.65,"Exon (ENSBGRT00000044623/ENSBGRG00000024153, exon 1 of 3)",26,17207582,17214282,6701,2]
["chr26",17555695,17556025,331,"ENSBGRG00000025370","ENSBGRT00000047310",32105,"ENSBGRG00000025370","NA","GO:0003677(DNA binding);GO:0005524(ATP binding)","NA",{"v":0,"d":"0.00"},1,"331,",0,-309,-306,3.15,"Exon (ENSBGRT00000047310/ENSBGRG00000025370, exon 34 of 34)",26,17555065,17588130,33066,2]
["chr26",17557194,17557944,751,"ENSBGRG00000025370","ENSBGRT00000047310",30186,"ENSBGRG00000025370","NA","GO:0003677(DNA binding);GO:0005524(ATP binding)","NA",{"v":9.99999999999998e-202,"d":"0.00"},1,"751,",0,-201,-199,5.45,"Exon (ENSBGRT00000047310/ENSBGRG00000025370, exon 33 of 34)",26,17555065,17588130,33066,2]
["chr26",18622286,18622376,91,"ENSBGRG00000014809","ENSBGRT00000028010",650,"RABEP2","rabaptin, RAB GTPase binding effector protein 2 [Source:HGNC Symbol;Acc:HGNC:24817]","GO:0005096(GTPase activator activity);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006897(endocytosis);GO:0008083(growth factor activity);GO:0036064(ciliary basal body);GO:0043231(intracellular membrane-bounded organelle);GO:1902017(regulation of cilium assembly)","NA",{"v":1.5E-3,"d":"0.00"},1,"91,",0,-2.81,-2.19,1.52,"Exon (ENSBGRT00000028010/ENSBGRG00000014809, exon 2 of 13)",26,18610224,18623026,12803,2]
["chr26",25146859,25171088,24230,"ENSBGRG00000023832","ENSBGRT00000044075",0,"IGSF6","immunoglobulin superfamily member 6 [Source:HGNC Symbol;Acc:HGNC:5953]","NA","NA",{"v":2.5e-92,"d":"0.00"},2,"206,33,","0,24197",{"v":-91.6,"d":"-91.60"},-90,3.45,"3' UTR",26,25149517,25161788,12272,1]
["chr26",28454115,28454294,180,"ENSBGRG00000020398","ENSBGRT00000037560",4383,"CCP110","centriolar coiled-coil protein 110 [Source:HGNC Symbol;Acc:HGNC:24342]","GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0007099(centriole replication);GO:0032053(ciliary basal body organization);GO:0032465(regulation of cytokinesis);GO:0032991(protein-containing complex);GO:0045724(positive regulation of cilium assembly);GO:0051298(centrosome duplication);GO:1902018(negative regulation of cilium assembly)","NA",{"v":6.3e-18,"d":"0.00"},1,"180,",0,{"v":-17.2,"d":"-17.20"},{"v":-16.3,"d":"-16.30"},4.35,"Exon (ENSBGRT00000037560/ENSBGRG00000020398, exon 3 of 14)",26,28439519,28458677,19159,2]
["chr26",36090458,36090605,148,"ENSBGRG00000026458","ENSBGRT00000048969",12786,"SNN","stannin [Source:HGNC Symbol;Acc:HGNC:11149]","GO:0005737(cytoplasm);GO:0005741(mitochondrial outer membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding)","NA",{"v":7.9e-47,"d":"0.00"},1,"148,",0,{"v":-46.1,"d":"-46.10"},{"v":-44.8,"d":"-44.80"},3.99,"3' UTR",26,36089511,36103391,13881,2]
["chr26",37010456,37012576,2121,"ENSBGRG00000026606","ENSBGRT00000049330",5769,"CIITA","class II major histocompatibility complex transactivator [Source:HGNC Symbol;Acc:HGNC:7067]","GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0034341(response to interferon-gamma);GO:0045892(negative regulation of transcription, DNA-templated)","04612(Antigen processing and presentation);05340(Primary immunodeficiency);05152(Tuberculosis);05164(Influenza A);05145(Toxoplasmosis)",{"v":0.028,"d":"0.03"},3,"26,63,1,","0,691,2120",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000049330/ENSBGRG00000026606, exon 4 of 18)",26,36986612,37018345,31734,2]
["chr26",44614227,44618409,4183,"ENSBGRG00000022708","ENSBGRT00000042519",25026,"CLUAP1","clusterin associated protein 1 [Source:HGNC Symbol;Acc:HGNC:19009]","GO:0005654(nucleoplasm);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":1e-147,"d":"0.00"},4,"265,57,56,41,","0,2608,2949,4142",-147,-145,4.59,"3' UTR",26,44613601,44643435,29835,2]
["chr26",45345972,45362538,16567,"ENSBGRG00000014276","ENSBGRT00000026314",165,"ENSBGRG00000014276","NA","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis)","NA",{"v":0.0011,"d":"0.00"},3,"803,284,383,","0,15228,16184",-2.96,-2.33,13,"5' UTR",26,45345972,45362703,16732,2]
["chr26",46141283,46141722,440,"ENSBGRG00000025867","ENSBGRT00000047844",7164,"SLC9A3R2","SLC9A3 regulator 2 [Source:HGNC Symbol;Acc:HGNC:11076]","GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0008013(beta-catenin binding);GO:0008022(protein C-terminus binding);GO:0019902(phosphatase binding);GO:0060090(molecular adaptor activity)","04960(Aldosterone-regulated sodium reabsorption)",{"v":5e-20,"d":"0.00"},2,"159,48,","0,392",{"v":-19.3,"d":"-19.30"},{"v":-18.3,"d":"-18.30"},1.54,"Exon (ENSBGRT00000047844/ENSBGRG00000025867, exon 5 of 6)",26,46141283,46148886,7604,2]
["chr26",46861703,46862123,421,"ENSBGRG00000026596","ENSBGRT00000049258",42883,"CACNA1H","calcium voltage-gated channel subunit alpha1 H [Source:HGNC Symbol;Acc:HGNC:1395]","GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0005261(cation channel activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005891(voltage-gated calcium channel complex);GO:0006811(ion transport);GO:0008332(low voltage-gated calcium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032342(aldosterone biosynthetic process);GO:0032870(cellular response to hormone stimulus);GO:0034651(cortisol biosynthetic process);GO:0035865(cellular response to potassium ion);GO:0042391(regulation of membrane potential);GO:0055085(transmembrane transport);GO:0070509(calcium ion import);GO:0070588(calcium ion transmembrane transport);GO:0097110(scaffold protein binding);GO:0098662(inorganic cation transmembrane transport);GO:2000344(positive regulation of acrosome reaction)","04010(MAPK signaling pathway);04020(Calcium signaling pathway);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04713(Circadian entrainment);04934(Cushing syndrome)",{"v":6.3e-94,"d":"0.00"},1,"421,",0,{"v":-93.2,"d":"-93.20"},{"v":-91.6,"d":"-91.60"},3.83,"Exon (ENSBGRT00000049258/ENSBGRG00000026596, exon 8 of 34)",26,46839698,46905006,65309,2]
["chr26",47533807,47534016,210,"ENSBGRG00000012770","ENSBGRT00000023553",11912,"ENSBGRG00000012770","NA","GO:0004550(nucleoside diphosphate kinase activity);GO:0006165(nucleoside diphosphate phosphorylation);GO:0006183(GTP biosynthetic process);GO:0006228(UTP biosynthetic process);GO:0006241(CTP biosynthetic process)","04146(Peroxisome);00230(Purine metabolism);00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)",{"v":3.1e-10,"d":"0.00"},1,"210,",0,-9.51,-8.68,1.46,"3' UTR",26,47533747,47545928,12182,2]
["chr27",8608020,8611869,3850,"ENSBGRG00000022389","ENSBGRT00000042286",838814,"RYR2","ryanodine receptor 2 [Source:HGNC Symbol;Acc:HGNC:10484]","GO:0001666(response to hypoxia);GO:0002027(regulation of heart rate);GO:0003143(embryonic heart tube morphogenesis);GO:0003220(left ventricular cardiac muscle tissue morphogenesis);GO:0003300(cardiac muscle hypertrophy);GO:0005216(ion channel activity);GO:0005219(ryanodine-sensitive calcium-release channel activity);GO:0005262(calcium channel activity);GO:0005509(calcium ion binding);GO:0005513(detection of calcium ion);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005790(smooth endoplasmic reticulum);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0006874(cellular calcium ion homeostasis);GO:0010460(positive regulation of heart rate);GO:0010881(regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion);GO:0010882(regulation of cardiac muscle contraction by calcium ion signaling);GO:0014808(release of sequestered calcium ion into cytosol by sarcoplasmic reticulum);GO:0014850(response to muscle activity);GO:0015278(calcium-release channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016529(sarcoplasmic reticulum);GO:0019722(calcium-mediated signaling);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0030017(sarcomere);GO:0030018(Z disc);GO:0031000(response to caffeine);GO:0032991(protein-containing complex);GO:0033017(sarcoplasmic reticulum membrane);GO:0034236(protein kinase A catalytic subunit binding);GO:0034237(protein kinase A regulatory subunit binding);GO:0034704(calcium channel complex);GO:0035584(calcium-mediated signaling using intracellular calcium source);GO:0035994(response to muscle stretch);GO:0042802(identical protein binding);GO:0043621(protein self-association);GO:0043924(suramin binding);GO:0048763(calcium-induced calcium release activity);GO:0051209(release of sequestered calcium ion into cytosol);GO:0051284(positive regulation of sequestering of calcium ion);GO:0051775(response to redox state);GO:0055085(transmembrane transport);GO:0055117(regulation of cardiac muscle contraction);GO:0060048(cardiac muscle contraction);GO:0060401(cytosolic calcium ion transport);GO:0060402(calcium ion transport into cytosol);GO:0070588(calcium ion transmembrane transport);GO:0071313(cellular response to caffeine);GO:0071872(cellular response to epinephrine stimulus);GO:0072599(establishment of protein localization to endoplasmic reticulum);GO:0086005(ventricular cardiac muscle cell action potential);GO:0086029(Purkinje myocyte to ventricular cardiac muscle cell signaling);GO:0097050(type B pancreatic cell apoptotic process);GO:0097159(organic cyclic compound binding);GO:0098735(positive regulation of the force of heart contraction);GO:0098904(regulation of AV node cell action potential);GO:0098907(regulation of SA node cell action potential);GO:0098910(regulation of atrial cardiac muscle cell action potential);GO:0098911(regulation of ventricular cardiac muscle cell action potential);GO:1901896(positive regulation of ATPase-coupled calcium transmembrane transporter activity)","04371(Apelin signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04911(Insulin secretion);04921(Oxytocin signaling pathway);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04972(Pancreatic secretion);04713(Circadian entrainment);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))",{"v":1.1e-10,"d":"0.00"},3,"186,68,107,","0,985,3743",-9.97,-9.12,6.36,"Exon (ENSBGRT00000042286/ENSBGRG00000022389, exon 90 of 105)",27,7769206,8678585,909380,1]
["chr27",11621590,11625073,3484,"ENSBGRG00000024042","ENSBGRT00000044370",93936,"BMS1","BMS1 ribosome biogenesis factor [Source:HGNC Symbol;Acc:HGNC:23505]","GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0042254(ribosome biogenesis)","03008(Ribosome biogenesis in eukaryotes)",{"v":1E-117,"d":"0.00"},2,"113,427,","0,3057",-117,-115,6.35,"Exon (ENSBGRT00000044370/ENSBGRG00000024042, exon 10 of 24)",27,11527654,11646547,118894,1]
["chr27",17328887,17329156,270,"ENSBGRG00000025826","ENSBGRT00000047739",30,"ENSBGRG00000025826","zinc finger protein 365 [Source:HGNC Symbol;Acc:HGNC:18194]","GO:0000723(telomere maintenance);GO:0021687(cerebellar molecular layer morphogenesis);GO:0048714(positive regulation of oligodendrocyte differentiation);GO:0060997(dendritic spine morphogenesis);GO:0140059(dendrite arborization)","NA",{"v":5e-12,"d":"0.00"},1,"270,",0,{"v":-11.3,"d":"-11.30"},{"v":-10.5,"d":"-10.50"},2.98,"Exon (ENSBGRT00000047739/ENSBGRG00000025826, exon 1 of 5)",27,17328857,17358505,29649,1]
["chr27",24614953,24615282,330,"ENSBGRG00000010118","ENSBGRT00000018806",22190,"CCAR1","cell division cycle and apoptosis regulator 1 [Source:HGNC Symbol;Acc:HGNC:24236]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005641(nuclear envelope lumen);GO:0006355(regulation of transcription, DNA-templated);GO:0008284(positive regulation of cell population proliferation);GO:0030335(positive regulation of cell migration);GO:0030374(nuclear receptor transcription coactivator activity);GO:0043065(positive regulation of apoptotic process)","NA",{"v":5.9e-10,"d":"0.00"},2,"42,18,","0,312",-9.23,{"v":-8.4,"d":"-8.40"},1.94,"Exon (ENSBGRT00000018806/ENSBGRG00000010118, exon 9 of 14)",27,24592763,24622219,29457,1]
["chr27",31152142,31153309,1168,"ENSBGRG00000020126","ENSBGRT00000037123",186443,"KAT6B","lysine acetyltransferase 6B [Source:HGNC Symbol;Acc:HGNC:17582]","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0004402(histone acetyltransferase activity);GO:0006334(nucleosome assembly);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0042025(host cell nucleus);GO:0043966(histone H3 acetylation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0070776(MOZ/MORF histone acetyltransferase complex);GO:1990830(cellular response to leukemia inhibitory factor)","NA",0,1,"1168,",0,-867,"-Inf",5.39,"3' UTR",27,30965699,31154386,188688,1]
["chr27",42814083,42814351,269,"ENSBGRG00000026478","ENSBGRT00000049026",0,"ENSBGRG00000026478","NA","NA","NA",{"v":5.6e-05,"d":"0.00"},1,"269,",0,-4.25,-3.56,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000049026/ENSBGRG00000026478, exon 1 of 1)",27,42814083,42815276,1194,1]
["chr27",47796889,47796978,90,"ENSBGRG00000019074","ENSBGRT00000034994",8414,"ZNF239","zinc finger protein 239 [Source:HGNC Symbol;Acc:HGNC:13031]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding)","NA",{"v":1E-58,"d":"0.00"},1,"90,",0,-58,{"v":-56.7,"d":"-56.70"},4.96,"Exon (ENSBGRT00000034994/ENSBGRG00000019074, exon 3 of 4)",27,47788475,47797706,9232,1]
["chr27",1379784,1382050,2267,"ENSBGRG00000018019","ENSBGRT00000032991",39480,"C1orf131","chromosome 1 open reading frame 131 [Source:HGNC Symbol;Acc:HGNC:25332]","GO:0005694(chromosome)","NA",{"v":2.5E-52,"d":"0.00"},4,"126,53,87,91,","0,1323,1959,2176",{"v":-51.6,"d":"-51.60"},{"v":-50.2,"d":"-50.20"},5.01,"Exon (ENSBGRT00000032991/ENSBGRG00000018019, exon 4 of 8)",27,1361667,1421530,59864,2]
["chr27",5792659,5792868,210,"ENSBGRG00000018433","ENSBGRT00000033772",135332,"ARID4B","AT-rich interaction domain 4B [Source:HGNC Symbol;Acc:HGNC:15550]","GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":5E-42,"d":"0.00"},1,"210,",0,{"v":-41.3,"d":"-41.30"},{"v":-40.1,"d":"-40.10"},{"v":4.2,"d":"4.20"},"Exon (ENSBGRT00000033772/ENSBGRG00000018433, exon 19 of 24)",27,5781417,5928200,146784,2]
["chr27",15358489,15365269,6781,"ENSBGRG00000025733","ENSBGRT00000047574",32692,"RHOBTB1","Rho related BTB domain containing 1 [Source:HGNC Symbol;Acc:HGNC:18738]","GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0007264(small GTPase mediated signal transduction)","04120(Ubiquitin mediated proteolysis)",{"v":1e-130,"d":"0.00"},2,"474,34,","0,6747",-130,-128,4.98,"Exon (ENSBGRT00000047574/ENSBGRG00000025733, exon 4 of 9)",27,15341254,15397961,56708,2]
["chr27",18311823,18311883,61,"ENSBGRG00000025856","ENSBGRT00000047992",259454,"JMJD1C","jumonji domain containing 1C [Source:HGNC Symbol;Acc:HGNC:12313]","NA","05202(Transcriptional misregulation in cancers)",{"v":9.5e-09,"d":"0.00"},1,"61,",0,-8.02,-7.21,2.71,"Exon (ENSBGRT00000047992/ENSBGRG00000025856, exon 10 of 26)",27,18268616,18571337,302722,2]
["chr27",31519982,31522043,2062,"ENSBGRG00000021005","ENSBGRT00000038687",2209,"ZNF503","zinc finger protein 503 [Source:HGNC Symbol;Acc:HGNC:23589]","GO:0003676(nucleic acid binding);GO:0008285(negative regulation of cell population proliferation);GO:0010629(negative regulation of gene expression);GO:0061351(neural precursor cell proliferation);GO:0070315(G1 to G0 transition involved in cell differentiation)","NA",0,2,"680,215,","0,1847",-327,"-Inf",{"v":22.7,"d":"22.70"},"3' UTR",27,31519714,31524252,4539,2]
["chr27",45498567,45498806,240,"ENSBGRG00000011586","ENSBGRT00000021105",77675,"ERCC6","ERCC excision repair 6, chromatin remodeling factor [Source:HGNC Symbol;Acc:HGNC:3438]","GO:0000012(single strand break repair);GO:0000077(DNA damage checkpoint);GO:0000303(response to superoxide);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006281(DNA repair);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0006284(base-excision repair);GO:0006290(pyrimidine dimer repair);GO:0006362(transcription elongation from RNA polymerase I promoter);GO:0006974(cellular response to DNA damage stimulus);GO:0006979(response to oxidative stress);GO:0007256(activation of JNKK activity);GO:0007257(activation of JUN kinase activity);GO:0008022(protein C-terminus binding);GO:0008023(transcription elongation factor complex);GO:0008094(DNA-dependent ATPase activity);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0009411(response to UV);GO:0009636(response to toxic substance);GO:0010165(response to X-ray);GO:0010224(response to UV-B);GO:0010332(response to gamma radiation);GO:0022008(neurogenesis);GO:0030182(neuron differentiation);GO:0030296(protein tyrosine kinase activator activity);GO:0031175(neuron projection development);GO:0032784(regulation of DNA-templated transcription, elongation);GO:0032786(positive regulation of DNA-templated transcription, elongation);GO:0035264(multicellular organism growth);GO:0043044(ATP-dependent chromatin remodeling);GO:0044877(protein-containing complex binding);GO:0045494(photoreceptor cell maintenance);GO:0045739(positive regulation of DNA repair);GO:0047485(protein N-terminus binding);GO:0060261(positive regulation of transcription initiation from RNA polymerase II promoter);GO:0090734(site of DNA damage);GO:0097680(double-strand break repair via classical nonhomologous end joining);GO:1905168(positive regulation of double-strand break repair via homologous recombination);GO:2001033(negative regulation of double-strand break repair via nonhomologous end joining)","03420(Nucleotide excision repair)",{"v":3.2e-30,"d":"0.00"},1,"240,",0,{"v":-29.5,"d":"-29.50"},{"v":-28.4,"d":"-28.40"},{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000021105/ENSBGRG00000011586, exon 21 of 21)",27,45498567,45576481,77915,2]
["chr27",48682144,48682382,239,"ENSBGRG00000020406","ENSBGRT00000037687",215719,"GALNT2","polypeptide N-acetylgalactosaminyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:4124]","GO:0002378(immunoglobulin biosynthetic process);GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity);GO:0005794(Golgi apparatus);GO:0005795(Golgi stack);GO:0006493(protein O-linked glycosylation);GO:0016266(O-glycan processing);GO:0018242(protein O-linked glycosylation via serine);GO:0018243(protein O-linked glycosylation via threonine);GO:0030145(manganese ion binding);GO:0048471(perinuclear region of cytoplasm)","00512(Mucin type O-glycan biosynthesis)",{"v":7.9e-86,"d":"0.00"},1,"239,",0,{"v":-85.1,"d":"-85.10"},{"v":-83.6,"d":"-83.60"},4.31,"3' UTR",27,48681696,48898101,216406,2]
["chr28",577098,577308,211,"ENSBGRG00000007348","ENSBGRT00000013457",17128,"ENSBGRG00000007348","NA","GO:0016021(integral component of membrane)","NA",{"v":2.3e-07,"d":"0.00"},1,"211,",0,-6.64,-5.87,2.24,"3' UTR",28,559970,578085,18116,1]
["chr28",13358566,13359675,1110,"ENSBGRG00000012775","ENSBGRT00000023416",5238,"OXSM","3-oxoacyl-ACP synthase, mitochondrial [Source:HGNC Symbol;Acc:HGNC:26063]","GO:0003824(catalytic activity);GO:0004315(3-oxoacyl-[acyl-carrier-protein] synthase activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006633(fatty acid biosynthetic process);GO:0006637(acyl-CoA metabolic process);GO:0016747(transferase activity, transferring acyl groups other than amino-acyl groups);GO:0051790(short-chain fatty acid biosynthetic process);GO:0051792(medium-chain fatty acid biosynthetic process)","00061(Fatty acid biosynthesis);00780(Biotin metabolism)",{"v":0.025,"d":"0.03"},1,"1110,",0,-1.61,-1.07,4.86,"3' UTR",28,13353328,13359675,6348,1]
["chr28",16147577,16148526,950,"ENSBGRG00000015491","ENSBGRT00000028433",4363,"THAP1","THAP domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20856]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001650(fibrillar center);GO:0001935(endothelial cell proliferation);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007346(regulation of mitotic cell cycle);GO:0008270(zinc ion binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0043565(sequence-specific DNA binding)","NA",{"v":2.5e-16,"d":"0.00"},2,"92,84,","0,866",{"v":-15.6,"d":"-15.60"},{"v":-14.6,"d":"-14.60"},2.19,"Exon (ENSBGRT00000028433/ENSBGRG00000015491, exon 2 of 3)",28,16143214,16148817,5604,1]
["chr28",18419400,18420399,1000,"ENSBGRG00000011635","ENSBGRT00000021325",417538,"ZMAT4","zinc finger matrin-type 4 [Source:HGNC Symbol;Acc:HGNC:25844]","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding)","04115(p53 signaling pathway);04742(Taste transduction)",{"v":5E-15,"d":"0.00"},2,"109,132,","0,868",{"v":-14.3,"d":"-14.30"},{"v":-13.4,"d":"-13.40"},{"v":5.4,"d":"5.40"},"3' UTR",28,18001862,18419508,417647,1]
["chr28",25395199,25395288,90,"ENSBGRG00000023452","ENSBGRT00000043275",5878,"DUSP26","dual specificity phosphatase 26 [Source:HGNC Symbol;Acc:HGNC:28161]","GO:0004725(protein tyrosine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity)","NA",{"v":1e-17,"d":"0.00"},1,"90,",0,-17,{"v":-16.1,"d":"-16.10"},{"v":45.4,"d":"45.40"},"3' UTR",28,25389321,25404039,14719,1]
["chr28",28275270,28275330,61,"ENSBGRG00000025414","ENSBGRT00000046996",88027,"GTF2E2","general transcription factor IIE subunit 2 [Source:HGNC Symbol;Acc:HGNC:4651]","GO:0005654(nucleoplasm);GO:0005669(transcription factor TFIID complex);GO:0005673(transcription factor TFIIE complex);GO:0005829(cytosol);GO:0006366(transcription by RNA polymerase II);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0016251(RNA polymerase II general transcription initiation factor activity);GO:0016607(nuclear speck)","03022(Basal transcription factors);05203(Viral carcinogenesis);05169(Epstein-Barr virus infection)",{"v":1e-48,"d":"0.00"},1,"61,",0,-48,{"v":-46.7,"d":"-46.70"},2.61,"Exon (ENSBGRT00000046996/ENSBGRG00000025414, exon 7 of 7)",28,28187243,28275599,88357,1]
["chr28",39483728,39483848,121,"ENSBGRG00000015602","ENSBGRT00000029230",3494,"FAT1","FAT atypical cadherin 1 [Source:HGNC Symbol;Acc:HGNC:3595]","GO:0002088(lens development in camera-type eye);GO:0003382(epithelial cell morphogenesis);GO:0003412(establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007015(actin filament organization);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007163(establishment or maintenance of cell polarity);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0030027(lamellipodium);GO:0030054(cell junction);GO:0030175(filopodium);GO:0043010(camera-type eye development);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0048471(perinuclear region of cytoplasm);GO:0048593(camera-type eye morphogenesis);GO:0098609(cell-cell adhesion)","NA",{"v":3.5e-06,"d":"0.00"},1,"121,",0,-5.45,-4.71,3.63,"Exon (ENSBGRT00000029230/ENSBGRG00000015602, exon 2 of 28)",28,39480234,39608094,127861,1]
["chr28",39601445,39607794,6350,"ENSBGRG00000015602","ENSBGRT00000029230",121211,"FAT1","FAT atypical cadherin 1 [Source:HGNC Symbol;Acc:HGNC:3595]","GO:0002088(lens development in camera-type eye);GO:0003382(epithelial cell morphogenesis);GO:0003412(establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007015(actin filament organization);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007163(establishment or maintenance of cell polarity);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0030027(lamellipodium);GO:0030054(cell junction);GO:0030175(filopodium);GO:0043010(camera-type eye development);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0048471(perinuclear region of cytoplasm);GO:0048593(camera-type eye morphogenesis);GO:0098609(cell-cell adhesion)","NA",{"v":1E-196,"d":"0.00"},2,"32,329,","0,6021",-196,-194,3.59,"Exon (ENSBGRT00000029230/ENSBGRG00000015602, exon 27 of 28)",28,39480234,39608094,127861,1]
["chr28",1061098,1061188,91,"ENSBGRG00000007575","ENSBGRT00000014539",36295,"MCPH1","microcephalin 1 [Source:HGNC Symbol;Acc:HGNC:6954]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0021987(cerebral cortex development);GO:0042802(identical protein binding);GO:0071850(mitotic cell cycle arrest)","NA",{"v":5e-19,"d":"0.00"},1,"91,",0,{"v":-18.3,"d":"-18.30"},{"v":-17.3,"d":"-17.30"},4.13,"Exon (ENSBGRT00000014539/ENSBGRG00000007575, exon 8 of 15)",28,830971,1097483,266513,2]
["chr28",14902005,14902184,180,"ENSBGRG00000012956","ENSBGRT00000024264",43093,"PSD3","pleckstrin and Sec7 domain containing 3 [Source:HGNC Symbol;Acc:HGNC:19093]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0032012(regulation of ARF protein signal transduction)","04144(Endocytosis)",{"v":1.9e-10,"d":"0.00"},1,"180,",0,-9.71,-8.87,5.09,"5' UTR",28,14539619,14945277,405659,2]
["chr28",16338070,16338159,90,"ENSBGRG00000015834","ENSBGRT00000029147",11759,"ENSBGRG00000015834","NA","NA","NA",{"v":1e-158,"d":"0.00"},1,"90,",0,-158,-156,4.67,"3' UTR",28,16337563,16349918,12356,2]
["chr28",20168007,20175042,7036,"ENSBGRG00000015345","ENSBGRT00000028736",62891,"TACC1","transforming acidic coiled-coil containing protein 1 [Source:HGNC Symbol;Acc:HGNC:11522]","GO:0005829(cytosol);GO:0007052(mitotic spindle organization);GO:0016922(nuclear receptor binding);GO:0030331(estrogen receptor binding);GO:0035259(glucocorticoid receptor binding);GO:0042974(retinoic acid receptor binding);GO:0042975(peroxisome proliferator activated receptor binding);GO:0046965(retinoid X receptor binding);GO:0046966(thyroid hormone receptor binding);GO:2000327(positive regulation of nuclear receptor transcription coactivator activity)","NA",{"v":7.9e-59,"d":"0.00"},4,"78,121,107,23,","0,1301,4898,7013",{"v":-58.1,"d":"-58.10"},{"v":-56.7,"d":"-56.70"},2.79,"3' UTR",28,20168007,20237933,69927,2]
["chr28",21286054,21286234,181,"ENSBGRG00000019985","ENSBGRT00000037135",2563,"ZNF703","zinc finger protein 703 [Source:HGNC Symbol;Acc:HGNC:25883]","GO:0003676(nucleic acid binding);GO:0005783(endoplasmic reticulum);GO:0031625(ubiquitin protein ligase binding)","00051(Fructose and mannose metabolism);00520(Amino sugar and nucleotide sugar metabolism)",{"v":2e-25,"d":"0.00"},1,"181,",0,{"v":-24.7,"d":"-24.70"},{"v":-23.6,"d":"-23.60"},{"v":4.5,"d":"4.50"},"Exon (ENSBGRT00000037135/ENSBGRG00000019985, exon 2 of 12)",28,21229854,21288797,58944,2]
["chr28",31881303,31881393,91,"ENSBGRG00000008226","ENSBGRT00000015623",897,"DLC1","DLC1 Rho GTPase activating protein [Source:HGNC Symbol;Acc:HGNC:2897]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005901(caveola);GO:0005925(focal adhesion);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0007165(signal transduction);GO:0008285(negative regulation of cell population proliferation);GO:0008289(lipid binding);GO:0008360(regulation of cell shape);GO:0030336(negative regulation of cell migration);GO:0030864(cortical actin cytoskeleton);GO:0032587(ruffle membrane);GO:0032956(regulation of actin cytoskeleton organization);GO:0035023(regulation of Rho protein signal transduction);GO:0035024(negative regulation of Rho protein signal transduction);GO:0035307(positive regulation of protein dephosphorylation);GO:0042169(SH2 domain binding);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:1900119(positive regulation of execution phase of apoptosis)","NA",{"v":4.8e-06,"d":"0.00"},1,"91,",0,-5.32,-4.58,{"v":2.5,"d":"2.50"},"Exon (ENSBGRT00000015623/ENSBGRG00000008226, exon 1 of 18)",28,31418688,31882290,463603,2]
["chr28",42007183,42007510,328,"ENSBGRG00000007321","ENSBGRT00000013392",595,"ENSBGRG00000007321","NA","NA","NA",{"v":6.3e-86,"d":"0.00"},1,"328,",0,{"v":-85.2,"d":"-85.20"},{"v":-83.7,"d":"-83.70"},5.74,"Exon (ENSBGRT00000013392/ENSBGRG00000007321, exon 1 of 1)",28,42006975,42008105,1131,2]
["chr29",2220489,2220879,391,"ENSBGRG00000012153","ENSBGRT00000022210",269,"ENSBGRG00000012153","NA","NA","NA",{"v":0.028,"d":"0.03"},1,"391,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000022210/ENSBGRG00000012153, exon 1 of 1)",29,2220220,2222046,1827,1]
["chr29",6141291,6142298,1008,"ENSBGRG00000008821","ENSBGRT00000017437",0,"ENSBGRG00000008821","NA","NA","04310(Wnt signaling pathway);04150(mTOR signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);05200(Pathways in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05224(Breast cancer)",{"v":4.3E-3,"d":"0.00"},1,"1008,",0,-2.37,-1.77,8.64,"Exon (ENSBGRT00000017860/ENSBGRG00000009736, exon 1 of 1)",29,5989112,6141944,152833,2]
["chr29",7748834,7748955,122,"ENSBGRG00000025288","ENSBGRT00000046776",118,"ENSBGRG00000025288","NA","NA","00515(Mannose type O-glycan biosyntheis)",{"v":6.3e-26,"d":"0.00"},2,"32,88,","0,34",{"v":-25.2,"d":"-25.20"},{"v":-24.2,"d":"-24.20"},3.82,"Exon (ENSBGRT00000046776/ENSBGRG00000025288, exon 1 of 12)",29,7748716,7750178,1463,1]
["chr29",8314541,8314601,61,"ENSBGRG00000021381","ENSBGRT00000039769",2152,"ENSBGRG00000021381","NA","NA","NA",{"v":0.00042,"d":"0.00"},1,"61,",0,-3.38,-2.73,2.74,"Exon (ENSBGRT00000039769/ENSBGRG00000021381, exon 17 of 37)",29,8312389,8316179,3791,1]
["chr29",12711271,12712017,747,"ENSBGRG00000020389","ENSBGRT00000037599",78927,"SLC15A3","solute carrier family 15 member 3 [Source:HGNC Symbol;Acc:HGNC:18068]","GO:0006857(oligopeptide transport);GO:0016020(membrane);GO:0022857(transmembrane transporter activity);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport)","NA",{"v":1e-19,"d":"0.00"},2,"44,227,","0,520",-19,-18,2.05,"3' UTR",29,12632344,12712244,79901,1]
["chr29",13701655,13701832,178,"ENSBGRG00000021732","ENSBGRT00000040194",829,"ZBTB44","zinc finger and BTB domain containing 44 [Source:HGNC Symbol;Acc:HGNC:25001]","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","NA",{"v":5e-31,"d":"0.00"},1,"178,",0,{"v":-30.3,"d":"-30.30"},{"v":-29.2,"d":"-29.20"},5.87,"Exon (ENSBGRT00000040194/ENSBGRG00000021732, exon 1 of 6)",29,13700826,13722537,21712,1]
["chr29",18681910,18682030,121,"ENSBGRG00000024553","ENSBGRT00000045311",630,"ENSBGRG00000024553","NA","NA","NA",{"v":1.3e-16,"d":"0.00"},1,"121,",0,{"v":-15.9,"d":"-15.90"},{"v":-14.9,"d":"-14.90"},2.77,"Exon (ENSBGRT00000045311/ENSBGRG00000024553, exon 1 of 3)",29,18681280,18688583,7304,1]
["chr29",23015963,23016142,180,"ENSBGRG00000022338","ENSBGRT00000041379",0,"MSANTD2","Myb/SANT DNA binding domain containing 2 [Source:HGNC Symbol;Acc:HGNC:26266]","NA","NA",{"v":4.3E-3,"d":"0.00"},1,"180,",0,-2.37,-1.77,9.72,"Exon (ENSBGRT00000041379/ENSBGRG00000022338, exon 1 of 3)",29,23015963,23039522,23560,1]
["chr29",31998021,31998201,181,"ENSBGRG00000021411","ENSBGRT00000039528",22547,"DDIAS","DNA damage induced apoptosis suppressor [Source:HGNC Symbol;Acc:HGNC:26351]","GO:0097752(regulation of DNA stability);GO:1902230(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","NA",{"v":4.6e-07,"d":"0.00"},1,"181,",0,-6.34,-5.58,{"v":6.7,"d":"6.70"},"Exon (ENSBGRT00000039528/ENSBGRG00000021411, exon 6 of 6)",29,31975474,31998380,22907,1]
["chr29",44523949,44524279,331,"ENSBGRG00000017172","ENSBGRT00000031829",47234,"CEP295","centrosomal protein 295 [Source:HGNC Symbol;Acc:HGNC:29366]","GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0008017(microtubule binding);GO:0010825(positive regulation of centrosome duplication);GO:1901985(positive regulation of protein acetylation);GO:1903724(positive regulation of centriole elongation);GO:1904951(positive regulation of establishment of protein localization);GO:1990498(mitotic spindle microtubule)","NA",{"v":1e-123,"d":"0.00"},1,"331,",0,-123,-122,8.32,"Exon (ENSBGRT00000031829/ENSBGRG00000017172, exon 28 of 34)",29,44476715,44531634,54920,1]
["chr29",4878525,4878702,178,"ENSBGRG00000024441","ENSBGRT00000045116",0,"CCND1","cyclin D1 [Source:HGNC Symbol;Acc:HGNC:1582]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000307(cyclin-dependent protein kinase holoenzyme complex);GO:0001934(positive regulation of protein phosphorylation);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006974(cellular response to DNA damage stimulus);GO:0008134(transcription factor binding);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0017053(transcriptional repressor complex);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0031571(mitotic G1 DNA damage checkpoint);GO:0042025(host cell nucleus);GO:0042493(response to drug);GO:0042826(histone deacetylase binding);GO:0044321(response to leptin);GO:0045737(positive regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0070064(proline-rich region binding);GO:0070141(response to UV-A);GO:0071157(negative regulation of cell cycle arrest)","04310(Wnt signaling pathway);04340(Hedgehog signaling pathway);04390(Hippo signaling pathway);04371(Apelin signaling pathway);04630(Jak-STAT signaling pathway);04068(FoxO signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04110(Cell cycle);04115(p53 signaling pathway);04218(Cellular senescence);04510(Focal adhesion);04530(Tight junction);04917(Prolactin signaling pathway);04921(Oxytocin signaling pathway);04919(Thyroid hormone signaling pathway);05200(Pathways in cancer);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05216(Thyroid cancer);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05219(Bladder cancer);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05416(Viral myocarditis);04933(AGE-RAGE signaling pathway in diabetic complications);04934(Cushing syndrome);05166(HTLV-I infection);05162(Measles);05161(Hepatitis B);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection);01522(Endocrine resistance)",{"v":0.021,"d":"0.02"},1,"178,",0,-1.67,-1.12,3.02,"5' UTR",29,4868149,4878702,10554,2]
["chr29",7462310,7462395,86,"ENSBGRG00000022563","ENSBGRT00000041748",201,"ENSBGRG00000022563","NA","GO:0003676(nucleic acid binding)","NA",{"v":3.2e-16,"d":"0.00"},1,"86,",0,{"v":-15.5,"d":"-15.50"},{"v":-14.6,"d":"-14.60"},2.35,"Exon (ENSBGRT00000041748/ENSBGRG00000022563, exon 1 of 4)",29,7454420,7462596,8177,2]
["chr29",8470331,8470690,360,"ENSBGRG00000025175","ENSBGRT00000046830",6956,"ENSBGRG00000025175","NA","NA","NA",{"v":1e-17,"d":"0.00"},3,"8,152,140,","0,66,220",-17,-16,2.42,"Exon (ENSBGRT00000046830/ENSBGRG00000025175, exon 32 of 97)",29,8461260,8477646,16387,2]
["chr29",9834801,9836006,1206,"ENSBGRG00000007051","ENSBGRT00000014887",16500,"ENSBGRG00000007051","NA","NA","00562(Inositol phosphate metabolism);04015(Rap1 signaling pathway);04310(Wnt signaling pathway);04371(Apelin signaling pathway);04020(Calcium signaling pathway);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04022(cGMP - PKG signaling pathway);04540(Gap junction);04611(Platelet activation);04621(NOD-like receptor signaling pathway);04062(Chemokine signaling pathway);04911(Insulin secretion);04922(Glucagon signaling pathway);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04918(Thyroid hormone synthesis);04919(Thyroid hormone signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);04916(Melanogenesis);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04961(Endocrine and other factor-regulated calcium reabsorption);04724(Glutamatergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04720(Long-term potentiation);04730(Long-term depression);04723(Retrograde endocannabinoid signaling);04750(Inflammatory mediator regulation of TRP channels);04713(Circadian entrainment);05200(Pathways in cancer);05010(Alzheimer disease);05016(Huntington disease);04933(AGE-RAGE signaling pathway in diabetic complications);04934(Cushing syndrome);05163(Human cytomegalovirus infection);05146(Amoebiasis);05142(Chagas disease (American trypanosomiasis));05143(African trypanosomiasis)",{"v":1.3e-46,"d":"0.00"},7,"77,77,51,69,16,32,8,","0,303,472,525,596,1164,1198",{"v":-45.9,"d":"-45.90"},{"v":-44.6,"d":"-44.60"},2.44,"Exon (ENSBGRT00000014887/ENSBGRG00000007051, exon 72 of 82)",29,9833991,9852506,18516,2]
["chr29",18522898,18524943,2046,"ENSBGRG00000024331","ENSBGRT00000045285",61788,"FLI1","Fli-1 proto-oncogene, ETS transcription factor [Source:HGNC Symbol;Acc:HGNC:3749]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0008015(blood circulation);GO:0009887(animal organ morphogenesis);GO:0016604(nuclear body);GO:0035855(megakaryocyte development);GO:0042025(host cell nucleus);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding)","05202(Transcriptional misregulation in cancers)",0,2,"767,36,","0,2010",-627,"-Inf",7.05,"3' UTR",29,18522541,18586731,64191,2]
["chr29",23142471,23142621,151,"ENSBGRG00000022554","ENSBGRT00000041702",16493,"ENSBGRG00000022554","NA","GO:0005515(protein binding);GO:0007339(binding of sperm to zona pellucida);GO:0016020(membrane)","NA",{"v":2e-17,"d":"0.00"},1,"151,",0,{"v":-16.7,"d":"-16.70"},{"v":-15.7,"d":"-15.70"},2.65,"3' UTR",29,23142321,23159114,16794,2]
["chr29",35150143,35150379,237,"ENSBGRG00000024210","ENSBGRT00000044705",296,"CREBZF","CREB/ATF bZIP transcription factor [Source:HGNC Symbol;Acc:HGNC:24905]","GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0009615(response to virus);GO:0042802(identical protein binding);GO:0045814(negative regulation of gene expression, epigenetic);GO:0045892(negative regulation of transcription, DNA-templated);GO:0051090(regulation of DNA-binding transcription factor activity)","NA",{"v":1E-150,"d":"0.00"},1,"237,",0,-150,-148,{"v":4.5,"d":"4.50"},"Exon (ENSBGRT00000044705/ENSBGRG00000024210, exon 1 of 2)",29,35149308,35150675,1368,2]
["chr29",36609959,36610139,181,"ENSBGRG00000025585","ENSBGRT00000047301",719,"FZD4","frizzled class receptor 4 [Source:HGNC Symbol;Acc:HGNC:4042]","GO:0001540(amyloid-beta binding);GO:0001553(luteinization);GO:0001568(blood vessel development);GO:0001570(vasculogenesis);GO:0004888(transmembrane signaling receptor activity);GO:0004896(cytokine receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007166(cell surface receptor signaling pathway);GO:0007223(Wnt signaling pathway, calcium modulating pathway);GO:0007605(sensory perception of sound);GO:0009986(cell surface);GO:0010812(negative regulation of cell-substrate adhesion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0019955(cytokine binding);GO:0030165(PDZ domain binding);GO:0030425(dendrite);GO:0030947(regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031625(ubiquitin protein ligase binding);GO:0031987(locomotion involved in locomotory behavior);GO:0034446(substrate adhesion-dependent cell spreading);GO:0035426(extracellular matrix-cell signaling);GO:0038023(signaling receptor activity);GO:0042701(progesterone secretion);GO:0042803(protein homodimerization activity);GO:0042813(Wnt-activated receptor activity);GO:0043507(positive regulation of JUN kinase activity);GO:0044877(protein-containing complex binding);GO:0045202(synapse);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046982(protein heterodimerization activity);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060070(canonical Wnt signaling pathway);GO:0061299(retina vasculature morphogenesis in camera-type eye);GO:0061301(cerebellum vasculature morphogenesis);GO:0061304(retinal blood vessel morphogenesis);GO:0098978(glutamatergic synapse);GO:0110135(Norrin signaling pathway);GO:0150012(positive regulation of neuron projection arborization);GO:1990830(cellular response to leukemia inhibitory factor)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);04934(Cushing syndrome);05166(HTLV-I infection);05165(Human papillomavirus infection)",{"v":0.0078,"d":"0.01"},1,"181,",0,-2.11,-1.27,9.72,"5' UTR",29,36599990,36610858,10869,2]
["X",222452,230937,8486,"ENSBGRG00000019641","ENSBGRT00000036639",10393,"UPF3B","UPF3B regulator of nonsense mediated mRNA decay [Source:HGNC Symbol;Acc:HGNC:20439]","GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0003676(nucleic acid binding);GO:0003729(mRNA binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0034451(centriolar satellite);GO:0035145(exon-exon junction complex);GO:0045727(positive regulation of translation)","03013(RNA transport);03015(mRNA surveillance pathway)",0,7,"42,44,183,39,161,295,489,","0,396,922,1490,4271,4769,7997",-326,"-Inf",4.14,"3' UTR",30,212059,222493,10435,1]
["X",9736482,9736601,120,"ENSBGRG00000025869","ENSBGRT00000047825",43117,"ELF4","E74 like ETS transcription factor 4 [Source:HGNC Symbol;Acc:HGNC:3319]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001787(natural killer cell proliferation);GO:0001866(NK T cell proliferation);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0016604(nuclear body);GO:0016605(PML body);GO:0043565(sequence-specific DNA binding);GO:0045087(innate immune response);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":2e-23,"d":"0.00"},1,"120,",0,{"v":-22.7,"d":"-22.70"},{"v":-21.7,"d":"-21.70"},2.53,"Exon (ENSBGRT00000047825/ENSBGRG00000025869, exon 10 of 10)",30,9693365,9737108,43744,1]
["X",16474371,16478252,3882,"ENSBGRG00000010041","ENSBGRT00000019006",117483,"ENSBGRG00000010041","NA","GO:0000347(THO complex);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus)","03040(Spliceosome);03013(RNA transport)",{"v":7.9e-45,"d":"0.00"},5,"129,70,158,77,46,","0,464,616,3280,3836",{"v":-44.1,"d":"-44.10"},{"v":-42.9,"d":"-42.90"},4.28,"3' UTR",30,16356888,16478252,121365,1]
["X",33580260,33580468,209,"ENSBGRG00000020734","ENSBGRT00000038244",9032,"ENSBGRG00000020734","NA","NA","04742(Taste transduction)",{"v":6.3E-21,"d":"0.00"},1,"209,",0,{"v":-20.2,"d":"-20.20"},{"v":-19.2,"d":"-19.20"},3.37,"3' UTR",30,33571228,33580352,9125,1]
["X",38584516,38585085,570,"ENSBGRG00000024985","ENSBGRT00000046158",149221,"F8","coagulation factor VIII [Source:HGNC Symbol;Acc:HGNC:3546]","GO:0005507(copper ion binding);GO:0016491(oxidoreductase activity);GO:0030168(platelet activation);GO:0055114(oxidation-reduction process)","04610(Complement and coagulation cascades)",{"v":1e-164,"d":"0.00"},1,"570,",0,-164,-162,4.75,"3' UTR",30,38435295,38585294,150000,1]
["X",55644216,55644516,301,"ENSBGRG00000021628","ENSBGRT00000040105",98437,"SYTL4","synaptotagmin like 4 [Source:HGNC Symbol;Acc:HGNC:15588]","GO:0001778(plasma membrane repair);GO:0005543(phospholipid binding);GO:0005768(endosome);GO:0006886(intracellular protein transport);GO:0006887(exocytosis);GO:0016020(membrane);GO:0017137(Rab GTPase binding);GO:0032418(lysosome localization);GO:0045921(positive regulation of exocytosis);GO:0050714(positive regulation of protein secretion);GO:0071985(multivesicular body sorting pathway);GO:1905684(regulation of plasma membrane repair)","NA",{"v":0.0078,"d":"0.01"},1,"301,",0,-2.11,-1.27,9.72,"3' UTR",30,55545779,55644666,98888,1]
["X",58493992,58494141,150,"ENSBGRG00000022558","ENSBGRT00000041617",565,"SLC25A53","solute carrier family 25 member 53 [Source:HGNC Symbol;Acc:HGNC:31894]","NA","04742(Taste transduction)",{"v":0.028,"d":"0.03"},1,"150,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",30,58493427,58505281,11855,1]
["X",81110034,81110243,210,"ENSBGRG00000016038","ENSBGRT00000040781",123756,"ATRX","ATRX chromatin remodeler [Source:HGNC Symbol;Acc:HGNC:886]","GO:0000212(meiotic spindle organization);GO:0000228(nuclear chromosome);GO:0000780(condensed nuclear chromosome, centromeric region);GO:0000781(chromosome, telomeric region);GO:0000784(nuclear chromosome, telomeric region);GO:0000792(heterochromatin);GO:0003682(chromatin binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005721(pericentric heterochromatin);GO:0006334(nucleosome assembly);GO:0006336(DNA replication-independent nucleosome assembly);GO:0006338(chromatin remodeling);GO:0007283(spermatogenesis);GO:0010571(positive regulation of nuclear cell cycle DNA replication);GO:0015616(DNA translocase activity);GO:0016604(nuclear body);GO:0016605(PML body);GO:0030330(DNA damage response, signal transduction by p53 class mediator);GO:0030900(forebrain development);GO:0031297(replication fork processing);GO:0031618(nuclear pericentric heterochromatin);GO:0032206(positive regulation of telomere maintenance);GO:0035064(methylated histone binding);GO:0035128(post-embryonic forelimb morphogenesis);GO:0035264(multicellular organism growth);GO:0042393(histone binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060009(Sertoli cell development);GO:0070087(chromo shadow domain binding);GO:0070192(chromosome organization involved in meiotic cell cycle);GO:0070198(protein localization to chromosome, telomeric region);GO:0072520(seminiferous tubule development);GO:0072711(cellular response to hydroxyurea);GO:1900112(regulation of histone H3-K9 trimethylation);GO:1901581(negative regulation of telomeric RNA transcription from RNA pol II promoter);GO:1901582(positive regulation of telomeric RNA transcription from RNA pol II promoter);GO:1904908(negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric);GO:1990707(nuclear subtelomeric heterochromatin)","NA",{"v":4.3E-3,"d":"0.00"},1,"210,",0,-2.37,-1.77,6.48,"Exon (ENSBGRT00000040781/ENSBGRG00000016038, exon 8 of 35)",30,80986278,81308232,321955,1]
["X",85280133,85280312,180,"ENSBGRG00000025136","ENSBGRT00000046525",22277,"PIN4","peptidylprolyl cis/trans isomerase, NIMA-interacting 4 [Source:HGNC Symbol;Acc:HGNC:8992]","GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005654(nucleoplasm);GO:0005730(nucleolus)","NA",{"v":0.0029,"d":"0.00"},1,"180,",0,-2.54,-1.93,2.81,"Exon (ENSBGRT00000046574/ENSBGRG00000025193, exon 2 of 2)",30,85218878,85302589,83712,2]
["X",92802541,92823759,21219,"ENSBGRG00000010488","ENSBGRT00000019206",1822,"RP2","RP2 activator of ARL3 GTPase [Source:HGNC Symbol;Acc:HGNC:10274]","GO:0000287(magnesium ion binding);GO:0000902(cell morphogenesis);GO:0005096(GTPase activator activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005814(centriole);GO:0005886(plasma membrane);GO:0006892(post-Golgi vesicle-mediated transport);GO:0016604(nuclear body);GO:0031410(cytoplasmic vesicle);GO:0036064(ciliary basal body);GO:1990075(periciliary membrane compartment)","NA",{"v":1E-13,"d":"0.00"},2,"96,114,","0,21105",-13,{"v":-12.2,"d":"-12.20"},7.13,"Exon (ENSBGRT00000019206/ENSBGRG00000010488, exon 2 of 5)",30,92800719,92849692,48974,1]
["X",94212112,94212463,352,"ENSBGRG00000017760","ENSBGRT00000032705",4008,"FTSJ1","FtsJ RNA 2'-O-methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:13254]","GO:0001510(RNA methylation);GO:0008033(tRNA processing);GO:0008168(methyltransferase activity);GO:0008175(tRNA methyltransferase activity);GO:0032259(methylation)","NA",{"v":7.9e-11,"d":"0.00"},2,"107,42,","0,310",{"v":-10.1,"d":"-10.10"},-9.22,{"v":2.3,"d":"2.30"},"3' UTR",30,94208104,94212217,4114,1]
["X",94930326,94931424,1099,"ENSBGRG00000020922","ENSBGRT00000038806",0,"ENSBGRG00000020922","NA","GO:0005515(protein binding);GO:0016020(membrane)","04530(Tight junction)",{"v":0.028,"d":"0.03"},2,"404,136,","0,963",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",30,94931289,94943044,11756,1]
["X",99776475,99776562,88,"ENSBGRG00000026149","ENSBGRT00000048369",548,"ENSBGRG00000026149","NA","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane);GO:0032482(Rab protein signal transduction)","NA",{"v":0.012,"d":"0.01"},1,"88,",0,-1.92,-1.35,4.32,"Exon (ENSBGRT00000048369/ENSBGRG00000026149, exon 1 of 1)",30,99775927,99776562,636,1]
["X",104274921,104275101,181,"ENSBGRG00000009986","ENSBGRT00000018339",1525,"AMER1","APC membrane recruitment protein 1 [Source:HGNC Symbol;Acc:HGNC:26837]","GO:0001822(kidney development);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005886(plasma membrane);GO:0008013(beta-catenin binding);GO:0016604(nuclear body);GO:0031398(positive regulation of protein ubiquitination);GO:0043231(intracellular membrane-bounded organelle);GO:0060348(bone development);GO:0060612(adipose tissue development);GO:0060828(regulation of canonical Wnt signaling pathway);GO:0072161(mesenchymal cell differentiation involved in kidney development);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1903364(positive regulation of cellular protein catabolic process);GO:1904713(beta-catenin destruction complex binding)","NA",{"v":3.4E-5,"d":"0.00"},1,"181,",0,-4.47,-3.77,2.19,"Exon (ENSBGRT00000018339/ENSBGRG00000009986, exon 2 of 3)",30,104273396,104278310,4915,1]
["X",104277831,104277891,61,"ENSBGRG00000009986","ENSBGRT00000018339",4435,"AMER1","APC membrane recruitment protein 1 [Source:HGNC Symbol;Acc:HGNC:26837]","GO:0001822(kidney development);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005886(plasma membrane);GO:0008013(beta-catenin binding);GO:0016604(nuclear body);GO:0031398(positive regulation of protein ubiquitination);GO:0043231(intracellular membrane-bounded organelle);GO:0060348(bone development);GO:0060612(adipose tissue development);GO:0060828(regulation of canonical Wnt signaling pathway);GO:0072161(mesenchymal cell differentiation involved in kidney development);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1903364(positive regulation of cellular protein catabolic process);GO:1904713(beta-catenin destruction complex binding)","NA",{"v":7.2e-05,"d":"0.00"},1,"61,",0,-4.14,-3.45,2.06,"Exon (ENSBGRT00000018339/ENSBGRG00000009986, exon 3 of 3)",30,104273396,104278310,4915,1]
["X",129569379,129569765,387,"ENSBGRG00000011822","ENSBGRT00000021634",208,"ARX","aristaless related homeobox [Source:HGNC Symbol;Acc:HGNC:18060]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001764(neuron migration);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0006355(regulation of transcription, DNA-templated);GO:0007411(axon guidance);GO:0010628(positive regulation of gene expression);GO:0021759(globus pallidus development);GO:0021772(olfactory bulb development);GO:0021800(cerebral cortex tangential migration);GO:0021831(embryonic olfactory bulb interneuron precursor migration);GO:0021846(cell proliferation in forebrain);GO:0021853(cerebral cortex GABAergic interneuron migration);GO:0030900(forebrain development);GO:0042127(regulation of cell population proliferation);GO:0043565(sequence-specific DNA binding);GO:0044241(lipid digestion);GO:0046622(positive regulation of organ growth);GO:0072148(epithelial cell fate commitment);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":0.015,"d":"0.02"},1,"387,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000021634/ENSBGRG00000011822, exon 1 of 4)",30,129569171,129582415,13245,1]
["X",292695,293453,759,"ENSBGRG00000020061","ENSBGRT00000036892",0,"SOWAHD","sosondowah ankyrin repeat domain family member D [Source:HGNC Symbol;Acc:HGNC:32960]","GO:0005515(protein binding)","NA",{"v":0.012,"d":"0.01"},1,"759,",0,-1.92,-1.35,4.32,"Exon (ENSBGRT00000036892/ENSBGRG00000020061, exon 1 of 1)",30,292491,293453,963,2]
["X",9641147,9641381,235,"ENSBGRG00000025789","ENSBGRT00000047672",0,"RAB33A","RAB33A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9773]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0019882(antigen processing and presentation);GO:0032482(Rab protein signal transduction)","NA",{"v":0.0078,"d":"0.01"},1,"235,",0,-2.11,-1.27,9.72,"Exon (ENSBGRT00000047672/ENSBGRG00000025789, exon 1 of 2)",30,9630347,9641381,11035,2]
["X",9870900,9874852,3953,"ENSBGRG00000007171","ENSBGRT00000013633",10239,"ENSBGRG00000007171","NA","GO:0006364(rRNA processing);GO:0032040(small-subunit processome)","03008(Ribosome biogenesis in eukaryotes)",0,6,"394,331,57,78,124,64,","0,2170,2503,3020,3180,3889",-730,"-Inf",3.21,"Exon (ENSBGRT00000013633/ENSBGRG00000007171, exon 8 of 17)",30,9867927,9885091,17165,2]
["X",32999240,33001793,2554,"ENSBGRG00000019515","ENSBGRT00000035906",3329,"BRS3","bombesin receptor subtype 3 [Source:HGNC Symbol;Acc:HGNC:1113]","GO:0004930(G protein-coupled receptor activity);GO:0004946(bombesin receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008528(G protein-coupled peptide receptor activity);GO:0016021(integral component of membrane);GO:0031989(bombesin receptor signaling pathway)","04080(Neuroactive ligand-receptor interaction)",{"v":0.012,"d":"0.01"},2,"391,22,","0,2532",-1.92,-1.35,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000035906/ENSBGRG00000019515, exon 2 of 3)",30,32999005,33005122,6118,2]
["X",33304666,33304726,61,"ENSBGRG00000020148","ENSBGRT00000037527",4471,"FHL1","four and a half LIM domains 1 [Source:HGNC Symbol;Acc:HGNC:3702]","GO:0003254(regulation of membrane depolarization);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007517(muscle organ development);GO:0010972(negative regulation of G2/M transition of mitotic cell cycle);GO:0030308(negative regulation of cell growth);GO:0043268(positive regulation of potassium ion transport);GO:0044325(ion channel binding);GO:1901016(regulation of potassium ion transmembrane transporter activity);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","04630(Jak-STAT signaling pathway)",{"v":1e-212,"d":"0.00"},1,"61,",0,-212,-210,2.97,"3' UTR",30,33304666,33309197,4532,2]
["X",34240799,34256282,15484,"ENSBGRG00000021489","ENSBGRT00000042379",0,"ZNF185","zinc finger protein 185 with LIM domain [Source:HGNC Symbol;Acc:HGNC:12976]","GO:0015629(actin cytoskeleton);GO:0051015(actin filament binding)","00100(Steroid biosynthesis)",{"v":0.043,"d":"0.04"},5,"407,124,80,158,68,","0,860,1119,8837,15416",-1.37,{"v":-0.6,"d":"-0.60"},6.48,"5' UTR",30,34186368,34241952,55585,2]
["X",35402909,35403056,148,"ENSBGRG00000023519","ENSBGRT00000043388",1863,"PRRG3","proline rich and Gla domain 3 [Source:HGNC Symbol;Acc:HGNC:30798]","GO:0005509(calcium ion binding);GO:0005576(extracellular region)","04024(cAMP signaling pathway);04740(Olfactory transduction)",{"v":0.015,"d":"0.02"},1,"148,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000043388/ENSBGRG00000023519, exon 3 of 3)",30,35402909,35404919,2011,2]
["X",35610220,35610338,119,"ENSBGRG00000023594","ENSBGRT00000043542",83647,"ENSBGRG00000023594","NA","GO:0070072(vacuolar proton-transporting V-type ATPase complex assembly)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":0.025,"d":"0.03"},1,"119,",0,-1.61,-1.07,4.86,"3' UTR",30,35610220,35693985,83766,2]
["X",36032060,36033286,1227,"ENSBGRG00000023671","ENSBGRT00000043745",4714,"ENSBGRG00000023671","NA","GO:0003677(DNA binding);GO:0005634(nucleus)","NA",{"v":5e-66,"d":"0.00"},3,"118,175,33,","0,531,1194",{"v":-65.3,"d":"-65.30"},{"v":-63.9,"d":"-63.90"},5.79,"Exon (ENSBGRT00000043745/ENSBGRG00000023671, exon 4 of 6)",30,36031171,36038000,6830,2]
["X",37780975,37781154,180,"ENSBGRG00000024611","ENSBGRT00000045417",0,"SPRY3","sprouty RTK signaling antagonist 3 [Source:HGNC Symbol;Acc:HGNC:11271]","GO:0007275(multicellular organism development);GO:0009966(regulation of signal transduction);GO:0016020(membrane);GO:0061564(axon development)","NA",{"v":0.00017,"d":"0.00"},1,"180,",0,-3.76,-3.09,3.07,"Exon (ENSBGRT00000045417/ENSBGRG00000024611, exon 1 of 1)",30,37780288,37781154,867,2]
["X",38280442,38281684,1243,"ENSBGRG00000024843","ENSBGRT00000045927",88783,"BRCC3","BRCA1/BRCA2-containing complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:24185]","GO:0000151(ubiquitin ligase complex);GO:0000152(nuclear ubiquitin ligase complex);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006281(DNA repair);GO:0006302(double-strand break repair);GO:0008237(metallopeptidase activity);GO:0010165(response to X-ray);GO:0010212(response to ionizing radiation);GO:0030234(enzyme regulator activity);GO:0031593(polyubiquitin modification-dependent protein binding);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0045739(positive regulation of DNA repair);GO:0070531(BRCA1-A complex);GO:0070536(protein K63-linked deubiquitination);GO:0070537(histone H2A K63-linked deubiquitination);GO:0070552(BRISC complex);GO:0072425(signal transduction involved in G2 DNA damage checkpoint)","03440(Homologous recombination);04621(NOD-like receptor signaling pathway)",{"v":7.9e-14,"d":"0.00"},2,"45,132,","0,1111",{"v":-13.1,"d":"-13.10"},{"v":-12.2,"d":"-12.20"},2.85,"3' UTR",30,38280442,38370467,90026,2]
["X",38643364,38643573,210,"ENSBGRG00000017777","ENSBGRT00000032887",13248,"DKC1","dyskerin pseudouridine synthase 1 [Source:HGNC Symbol;Acc:HGNC:2890]","GO:0000455(enzyme-directed rRNA pseudouridine synthesis);GO:0001522(pseudouridine synthesis);GO:0001650(fibrillar center);GO:0003720(telomerase activity);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005697(telomerase holoenzyme complex);GO:0006396(RNA processing);GO:0007004(telomere maintenance via telomerase);GO:0009451(RNA modification);GO:0009982(pseudouridine synthase activity);GO:0031429(box H/ACA snoRNP complex);GO:0034513(box H/ACA snoRNA binding);GO:0051973(positive regulation of telomerase activity);GO:0070034(telomerase RNA binding);GO:0090661(box H/ACA telomerase RNP complex);GO:0090666(scaRNA localization to Cajal body);GO:0090669(telomerase RNA stabilization);GO:1904851(positive regulation of establishment of protein localization to telomere);GO:1904872(regulation of telomerase RNA localization to Cajal body);GO:1904874(positive regulation of telomerase RNA localization to Cajal body)","03008(Ribosome biogenesis in eukaryotes)",{"v":7.9e-45,"d":"0.00"},1,"210,",0,{"v":-44.1,"d":"-44.10"},{"v":-42.9,"d":"-42.90"},2.23,"3' UTR",30,38643215,38656821,13607,2]
["X",38643722,38645783,2062,"ENSBGRG00000017777","ENSBGRT00000032887",11038,"DKC1","dyskerin pseudouridine synthase 1 [Source:HGNC Symbol;Acc:HGNC:2890]","GO:0000455(enzyme-directed rRNA pseudouridine synthesis);GO:0001522(pseudouridine synthesis);GO:0001650(fibrillar center);GO:0003720(telomerase activity);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005697(telomerase holoenzyme complex);GO:0006396(RNA processing);GO:0007004(telomere maintenance via telomerase);GO:0009451(RNA modification);GO:0009982(pseudouridine synthase activity);GO:0031429(box H/ACA snoRNP complex);GO:0034513(box H/ACA snoRNA binding);GO:0051973(positive regulation of telomerase activity);GO:0070034(telomerase RNA binding);GO:0090661(box H/ACA telomerase RNP complex);GO:0090666(scaRNA localization to Cajal body);GO:0090669(telomerase RNA stabilization);GO:1904851(positive regulation of establishment of protein localization to telomere);GO:1904872(regulation of telomerase RNA localization to Cajal body);GO:1904874(positive regulation of telomerase RNA localization to Cajal body)","03008(Ribosome biogenesis in eukaryotes)",{"v":1.3E-43,"d":"0.00"},3,"123,82,35,","0,1214,2027",{"v":-42.9,"d":"-42.90"},{"v":-41.7,"d":"-41.70"},2.29,"Exon (ENSBGRT00000032887/ENSBGRG00000017777, exon 12 of 14)",30,38643215,38656821,13607,2]
["X",38810048,38810700,653,"ENSBGRG00000018336","ENSBGRT00000033529",0,"ENSBGRG00000018336","NA","NA","04742(Taste transduction)",{"v":5.4e-09,"d":"0.00"},1,"653,",0,-8.27,-7.46,{"v":29.2,"d":"29.20"},"Exon (ENSBGRT00000033529/ENSBGRG00000018336, exon 1 of 3)",30,38804602,38810700,6099,2]
["X",39036944,39039096,2153,"ENSBGRG00000018463","ENSBGRT00000034093",0,"ENSBGRG00000018463","NA","NA","NA",{"v":0.0041,"d":"0.00"},4,"216,836,30,27,","0,1256,2094,2126",-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000034093/ENSBGRG00000018463, exon 1 of 9)",30,39036006,39039096,3091,2]
["X",39238478,39238687,210,"ENSBGRG00000019445","ENSBGRT00000035717",9938,"CCNQ","cyclin Q [Source:HGNC Symbol;Acc:HGNC:28434]","GO:0006357(regulation of transcription by RNA polymerase II);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0042025(host cell nucleus)","NA",{"v":1e-130,"d":"0.00"},1,"210,",0,-130,-128,{"v":5.6,"d":"5.60"},"3' UTR",30,39238358,39248625,10268,2]
["X",39248475,39248625,151,"ENSBGRG00000019445","ENSBGRT00000035717",0,"CCNQ","cyclin Q [Source:HGNC Symbol;Acc:HGNC:28434]","GO:0006357(regulation of transcription by RNA polymerase II);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0042025(host cell nucleus)","NA",{"v":3.8e-05,"d":"0.00"},1,"151,",0,-4.42,-3.72,{"v":18.4,"d":"18.40"},"Exon (ENSBGRT00000035717/ENSBGRG00000019445, exon 1 of 6)",30,39238358,39248625,10268,2]
["X",39330847,39332232,1386,"ENSBGRG00000019589","ENSBGRT00000035985",4099,"ENSBGRG00000019589","NA","GO:0004672(protein kinase activity);GO:0004683(calmodulin-dependent protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA",{"v":1.9E-3,"d":"0.00"},2,"821,43,","0,1343",-2.73,-2.11,7.56,"3' UTR",30,39330847,39336331,5485,2]
["X",39478320,39478767,448,"ENSBGRG00000020897","ENSBGRT00000038477",38416,"PDZD4","PDZ domain containing 4 [Source:HGNC Symbol;Acc:HGNC:21167]","GO:0005515(protein binding)","NA",{"v":1.1E-5,"d":"0.00"},1,"448,",0,-4.97,-4.25,{"v":17.3,"d":"17.30"},"Exon (ENSBGRT00000038477/ENSBGRG00000020897, exon 8 of 8)",30,39477069,39517183,40115,2]
["X",39549146,39549326,181,"ENSBGRG00000020974","ENSBGRT00000038690",30793,"L1CAM","L1 cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:6470]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007160(cell-matrix adhesion);GO:0007411(axon guidance);GO:0009986(cell surface);GO:0016477(cell migration);GO:0019904(protein domain specific binding);GO:0030424(axon);GO:0031175(neuron projection development);GO:0043025(neuronal cell body);GO:0050808(synapse organization);GO:0061564(axon development)","04514(Cell adhesion molecules (CAMs));04360(Axon guidance)",{"v":1.6e-19,"d":"0.00"},1,"181,",0,{"v":-18.8,"d":"-18.80"},{"v":-17.9,"d":"-17.90"},4.32,"3' UTR",30,39549146,39580119,30974,2]
["X",39658339,39658908,570,"ENSBGRG00000021965","ENSBGRT00000042279",18115,"HCFC1","host cell factor C1 [Source:HGNC Symbol;Acc:HGNC:4839]","GO:0000123(histone acetyltransferase complex);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001835(blastocyst hatching);GO:0003682(chromatin binding);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0010628(positive regulation of gene expression);GO:0019046(release from viral latency);GO:0030674(protein-macromolecule adaptor activity);GO:0032991(protein-containing complex);GO:0033613(activating transcription factor binding);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0043254(regulation of protein-containing complex assembly);GO:0043981(histone H4-K5 acetylation);GO:0043982(histone H4-K8 acetylation);GO:0043984(histone H4-K16 acetylation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048188(Set1C/COMPASS complex);GO:0050821(protein stabilization);GO:0070461(SAGA-type complex);GO:0071339(MLL1 complex)","05168(Herpes simplex infection)",{"v":5e-39,"d":"0.00"},1,"570,",0,{"v":-38.3,"d":"-38.30"},{"v":-37.1,"d":"-37.10"},2.17,"Exon (ENSBGRT00000042279/ENSBGRG00000021965, exon 19 of 27)",30,39652315,39677023,24709,2]
["X",39741946,39742273,328,"ENSBGRG00000023220","ENSBGRT00000042887",28603,"MECP2","methyl-CpG binding protein 2 [Source:HGNC Symbol;Acc:HGNC:6990]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000792(heterochromatin);GO:0001662(behavioral fear response);GO:0001666(response to hypoxia);GO:0001964(startle response);GO:0001976(nervous system process involved in regulation of systemic arterial blood pressure);GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006020(inositol metabolic process);GO:0006122(mitochondrial electron transport, ubiquinol to cytochrome c);GO:0006342(chromatin silencing);GO:0006349(regulation of gene expression by genetic imprinting);GO:0006355(regulation of transcription, DNA-templated);GO:0006541(glutamine metabolic process);GO:0006576(cellular biogenic amine metabolic process);GO:0007052(mitotic spindle organization);GO:0007268(chemical synaptic transmission);GO:0007416(synapse assembly);GO:0007420(brain development);GO:0007585(respiratory gaseous exchange by respiratory system);GO:0007612(learning);GO:0007613(memory);GO:0007616(long-term memory);GO:0008104(protein localization);GO:0008134(transcription factor binding);GO:0008211(glucocorticoid metabolic process);GO:0008284(positive regulation of cell population proliferation);GO:0008327(methyl-CpG binding);GO:0008344(adult locomotory behavior);GO:0008542(visual learning);GO:0009405(pathogenesis);GO:0009791(post-embryonic development);GO:0010385(double-stranded methylated DNA binding);GO:0010468(regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0016358(dendrite development);GO:0016525(negative regulation of angiogenesis);GO:0016571(histone methylation);GO:0016573(histone acetylation);GO:0019230(proprioception);GO:0019233(sensory perception of pain);GO:0019904(protein domain specific binding);GO:0021549(cerebellum development);GO:0021591(ventricular system development);GO:0030182(neuron differentiation);GO:0031175(neuron projection development);GO:0032048(cardiolipin metabolic process);GO:0033555(multicellular organismal response to stress);GO:0035176(social behavior);GO:0035197(siRNA binding);GO:0040029(regulation of gene expression, epigenetic);GO:0042025(host cell nucleus);GO:0042551(neuron maturation);GO:0043524(negative regulation of neuron apoptotic process);GO:0043537(negative regulation of blood vessel endothelial cell migration);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046470(phosphatidylcholine metabolic process);GO:0047485(protein N-terminus binding);GO:0048167(regulation of synaptic plasticity);GO:0050432(catecholamine secretion);GO:0050884(neuromuscular process controlling posture);GO:0050905(neuromuscular process);GO:0051151(negative regulation of smooth muscle cell differentiation);GO:0060079(excitatory postsynaptic potential);GO:0060291(long-term synaptic potentiation);GO:0090063(positive regulation of microtubule nucleation);GO:1900114(positive regulation of histone H3-K9 trimethylation);GO:1905643(positive regulation of DNA methylation);GO:2000820(negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation)","NA",{"v":1E-117,"d":"0.00"},1,"328,",0,-117,-115,{"v":7.4,"d":"7.40"},"3' UTR",30,39741946,39770876,28931,2]
["X",39742333,39742452,120,"ENSBGRG00000023220","ENSBGRT00000042887",28424,"MECP2","methyl-CpG binding protein 2 [Source:HGNC Symbol;Acc:HGNC:6990]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000792(heterochromatin);GO:0001662(behavioral fear response);GO:0001666(response to hypoxia);GO:0001964(startle response);GO:0001976(nervous system process involved in regulation of systemic arterial blood pressure);GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006020(inositol metabolic process);GO:0006122(mitochondrial electron transport, ubiquinol to cytochrome c);GO:0006342(chromatin silencing);GO:0006349(regulation of gene expression by genetic imprinting);GO:0006355(regulation of transcription, DNA-templated);GO:0006541(glutamine metabolic process);GO:0006576(cellular biogenic amine metabolic process);GO:0007052(mitotic spindle organization);GO:0007268(chemical synaptic transmission);GO:0007416(synapse assembly);GO:0007420(brain development);GO:0007585(respiratory gaseous exchange by respiratory system);GO:0007612(learning);GO:0007613(memory);GO:0007616(long-term memory);GO:0008104(protein localization);GO:0008134(transcription factor binding);GO:0008211(glucocorticoid metabolic process);GO:0008284(positive regulation of cell population proliferation);GO:0008327(methyl-CpG binding);GO:0008344(adult locomotory behavior);GO:0008542(visual learning);GO:0009405(pathogenesis);GO:0009791(post-embryonic development);GO:0010385(double-stranded methylated DNA binding);GO:0010468(regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0016358(dendrite development);GO:0016525(negative regulation of angiogenesis);GO:0016571(histone methylation);GO:0016573(histone acetylation);GO:0019230(proprioception);GO:0019233(sensory perception of pain);GO:0019904(protein domain specific binding);GO:0021549(cerebellum development);GO:0021591(ventricular system development);GO:0030182(neuron differentiation);GO:0031175(neuron projection development);GO:0032048(cardiolipin metabolic process);GO:0033555(multicellular organismal response to stress);GO:0035176(social behavior);GO:0035197(siRNA binding);GO:0040029(regulation of gene expression, epigenetic);GO:0042025(host cell nucleus);GO:0042551(neuron maturation);GO:0043524(negative regulation of neuron apoptotic process);GO:0043537(negative regulation of blood vessel endothelial cell migration);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046470(phosphatidylcholine metabolic process);GO:0047485(protein N-terminus binding);GO:0048167(regulation of synaptic plasticity);GO:0050432(catecholamine secretion);GO:0050884(neuromuscular process controlling posture);GO:0050905(neuromuscular process);GO:0051151(negative regulation of smooth muscle cell differentiation);GO:0060079(excitatory postsynaptic potential);GO:0060291(long-term synaptic potentiation);GO:0090063(positive regulation of microtubule nucleation);GO:1900114(positive regulation of histone H3-K9 trimethylation);GO:1905643(positive regulation of DNA methylation);GO:2000820(negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation)","NA",{"v":2.5e-13,"d":"0.00"},1,"120,",0,{"v":-12.6,"d":"-12.60"},{"v":-11.7,"d":"-11.70"},1.63,"3' UTR",30,39741946,39770876,28931,2]
["X",39742571,39742660,90,"ENSBGRG00000023220","ENSBGRT00000042887",28216,"MECP2","methyl-CpG binding protein 2 [Source:HGNC Symbol;Acc:HGNC:6990]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000792(heterochromatin);GO:0001662(behavioral fear response);GO:0001666(response to hypoxia);GO:0001964(startle response);GO:0001976(nervous system process involved in regulation of systemic arterial blood pressure);GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006020(inositol metabolic process);GO:0006122(mitochondrial electron transport, ubiquinol to cytochrome c);GO:0006342(chromatin silencing);GO:0006349(regulation of gene expression by genetic imprinting);GO:0006355(regulation of transcription, DNA-templated);GO:0006541(glutamine metabolic process);GO:0006576(cellular biogenic amine metabolic process);GO:0007052(mitotic spindle organization);GO:0007268(chemical synaptic transmission);GO:0007416(synapse assembly);GO:0007420(brain development);GO:0007585(respiratory gaseous exchange by respiratory system);GO:0007612(learning);GO:0007613(memory);GO:0007616(long-term memory);GO:0008104(protein localization);GO:0008134(transcription factor binding);GO:0008211(glucocorticoid metabolic process);GO:0008284(positive regulation of cell population proliferation);GO:0008327(methyl-CpG binding);GO:0008344(adult locomotory behavior);GO:0008542(visual learning);GO:0009405(pathogenesis);GO:0009791(post-embryonic development);GO:0010385(double-stranded methylated DNA binding);GO:0010468(regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0016358(dendrite development);GO:0016525(negative regulation of angiogenesis);GO:0016571(histone methylation);GO:0016573(histone acetylation);GO:0019230(proprioception);GO:0019233(sensory perception of pain);GO:0019904(protein domain specific binding);GO:0021549(cerebellum development);GO:0021591(ventricular system development);GO:0030182(neuron differentiation);GO:0031175(neuron projection development);GO:0032048(cardiolipin metabolic process);GO:0033555(multicellular organismal response to stress);GO:0035176(social behavior);GO:0035197(siRNA binding);GO:0040029(regulation of gene expression, epigenetic);GO:0042025(host cell nucleus);GO:0042551(neuron maturation);GO:0043524(negative regulation of neuron apoptotic process);GO:0043537(negative regulation of blood vessel endothelial cell migration);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046470(phosphatidylcholine metabolic process);GO:0047485(protein N-terminus binding);GO:0048167(regulation of synaptic plasticity);GO:0050432(catecholamine secretion);GO:0050884(neuromuscular process controlling posture);GO:0050905(neuromuscular process);GO:0051151(negative regulation of smooth muscle cell differentiation);GO:0060079(excitatory postsynaptic potential);GO:0060291(long-term synaptic potentiation);GO:0090063(positive regulation of microtubule nucleation);GO:1900114(positive regulation of histone H3-K9 trimethylation);GO:1905643(positive regulation of DNA methylation);GO:2000820(negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation)","NA",{"v":6.3e-11,"d":"0.00"},1,"90,",0,{"v":-10.2,"d":"-10.20"},-9.31,1.69,"3' UTR",30,39741946,39770876,28931,2]
["X",39742988,39745394,2407,"ENSBGRG00000023220","ENSBGRT00000042887",25482,"MECP2","methyl-CpG binding protein 2 [Source:HGNC Symbol;Acc:HGNC:6990]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000792(heterochromatin);GO:0001662(behavioral fear response);GO:0001666(response to hypoxia);GO:0001964(startle response);GO:0001976(nervous system process involved in regulation of systemic arterial blood pressure);GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006020(inositol metabolic process);GO:0006122(mitochondrial electron transport, ubiquinol to cytochrome c);GO:0006342(chromatin silencing);GO:0006349(regulation of gene expression by genetic imprinting);GO:0006355(regulation of transcription, DNA-templated);GO:0006541(glutamine metabolic process);GO:0006576(cellular biogenic amine metabolic process);GO:0007052(mitotic spindle organization);GO:0007268(chemical synaptic transmission);GO:0007416(synapse assembly);GO:0007420(brain development);GO:0007585(respiratory gaseous exchange by respiratory system);GO:0007612(learning);GO:0007613(memory);GO:0007616(long-term memory);GO:0008104(protein localization);GO:0008134(transcription factor binding);GO:0008211(glucocorticoid metabolic process);GO:0008284(positive regulation of cell population proliferation);GO:0008327(methyl-CpG binding);GO:0008344(adult locomotory behavior);GO:0008542(visual learning);GO:0009405(pathogenesis);GO:0009791(post-embryonic development);GO:0010385(double-stranded methylated DNA binding);GO:0010468(regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0016358(dendrite development);GO:0016525(negative regulation of angiogenesis);GO:0016571(histone methylation);GO:0016573(histone acetylation);GO:0019230(proprioception);GO:0019233(sensory perception of pain);GO:0019904(protein domain specific binding);GO:0021549(cerebellum development);GO:0021591(ventricular system development);GO:0030182(neuron differentiation);GO:0031175(neuron projection development);GO:0032048(cardiolipin metabolic process);GO:0033555(multicellular organismal response to stress);GO:0035176(social behavior);GO:0035197(siRNA binding);GO:0040029(regulation of gene expression, epigenetic);GO:0042025(host cell nucleus);GO:0042551(neuron maturation);GO:0043524(negative regulation of neuron apoptotic process);GO:0043537(negative regulation of blood vessel endothelial cell migration);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046470(phosphatidylcholine metabolic process);GO:0047485(protein N-terminus binding);GO:0048167(regulation of synaptic plasticity);GO:0050432(catecholamine secretion);GO:0050884(neuromuscular process controlling posture);GO:0050905(neuromuscular process);GO:0051151(negative regulation of smooth muscle cell differentiation);GO:0060079(excitatory postsynaptic potential);GO:0060291(long-term synaptic potentiation);GO:0090063(positive regulation of microtubule nucleation);GO:1900114(positive regulation of histone H3-K9 trimethylation);GO:1905643(positive regulation of DNA methylation);GO:2000820(negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation)","NA",{"v":6.3e-15,"d":"0.00"},2,"110,70,","0,2337",{"v":-14.2,"d":"-14.20"},{"v":-13.3,"d":"-13.30"},2.64,"Exon (ENSBGRT00000042887/ENSBGRG00000023220, exon 2 of 3)",30,39741946,39770876,28931,2]
["X",40020170,40020380,211,"ENSBGRG00000023696","ENSBGRT00000043864",67289,"GDI1","GDP dissociation inhibitor 1 [Source:HGNC Symbol;Acc:HGNC:4226]","GO:0005092(GDP-dissociation inhibitor activity);GO:0005093(Rab GDP-dissociation inhibitor activity);GO:0005737(cytoplasm);GO:0007264(small GTPase mediated signal transduction);GO:0015031(protein transport);GO:0030496(midbody);GO:0090315(negative regulation of protein targeting to membrane)","NA",{"v":4.2e-08,"d":"0.00"},1,"211,",0,-7.38,-6.59,1.34,"3' UTR",30,39952881,40084960,132080,1]
["X",40145525,40145941,417,"ENSBGRG00000026237","ENSBGRT00000048524",356,"SLC10A3","solute carrier family 10 member 3 [Source:HGNC Symbol;Acc:HGNC:22979]","GO:0010033(response to organic substance);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032526(response to retinoic acid);GO:0055085(transmembrane transport)","NA",{"v":1.6e-61,"d":"0.00"},1,"417,",0,{"v":-60.8,"d":"-60.80"},{"v":-59.5,"d":"-59.50"},4.32,"Exon (ENSBGRT00000048524/ENSBGRG00000026237, exon 1 of 2)",30,40144690,40146297,1608,2]
["X",40146178,40146297,120,"ENSBGRG00000026237","ENSBGRT00000048524",0,"SLC10A3","solute carrier family 10 member 3 [Source:HGNC Symbol;Acc:HGNC:22979]","GO:0010033(response to organic substance);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032526(response to retinoic acid);GO:0055085(transmembrane transport)","NA",{"v":1.5E-9,"d":"0.00"},1,"120,",0,-8.81,-7.99,2.36,"Exon (ENSBGRT00000048524/ENSBGRG00000026237, exon 1 of 2)",30,40144690,40146297,1608,2]
["X",40169216,40169425,210,"ENSBGRG00000026248","ENSBGRT00000048575",16668,"G6PD","glucose-6-phosphate dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4057]","GO:0004345(glucose-6-phosphate dehydrogenase activity);GO:0005536(glucose binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006006(glucose metabolic process);GO:0006098(pentose-phosphate shunt);GO:0006695(cholesterol biosynthetic process);GO:0006739(NADP metabolic process);GO:0006740(NADPH regeneration);GO:0006749(glutathione metabolic process);GO:0009051(pentose-phosphate shunt, oxidative branch);GO:0009898(cytoplasmic side of plasma membrane);GO:0010734(negative regulation of protein glutathionylation);GO:0016614(oxidoreductase activity, acting on CH-OH group of donors);GO:0019322(pentose biosynthetic process);GO:0034451(centriolar satellite);GO:0034599(cellular response to oxidative stress);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0043249(erythrocyte maturation);GO:0045721(negative regulation of gluconeogenesis);GO:0046390(ribose phosphate biosynthetic process);GO:0046890(regulation of lipid biosynthetic process);GO:0050661(NADP binding);GO:0051156(glucose 6-phosphate metabolic process);GO:0055114(oxidation-reduction process)","00030(Pentose phosphate pathway);00480(Glutathione metabolism);05230(Central carbon metabolism in cancer)",{"v":9.99999999999999e-207,"d":"0.00"},1,"210,",0,-206,-204,{"v":2.5,"d":"2.50"},"Exon (ENSBGRT00000048585/ENSBGRG00000026248, exon 12 of 12)",30,40160993,40186093,25101,2]
["X",40266208,40266591,384,"ENSBGRG00000026304","ENSBGRT00000048661",232,"ENSBGRG00000026304","NA","NA","NA",{"v":4.3E-3,"d":"0.00"},2,"22,37,","0,347",-2.37,-1.77,6.48,"Exon (ENSBGRT00000048661/ENSBGRG00000026304, exon 1 of 3)",30,40238952,40266823,27872,2]
["X",53186276,53187658,1383,"ENSBGRG00000017593","ENSBGRT00000032560",133492,"PCDH19","protocadherin 19 [Source:HGNC Symbol;Acc:HGNC:14270]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007420(brain development);GO:0016020(membrane)","NA",{"v":0.034,"d":"0.03"},2,"90,31,","0,1352",-1.47,{"v":-0.941,"d":"-0.94"},2.97,"Exon (ENSBGRT00000032560/ENSBGRG00000017593, exon 8 of 10)",30,53185886,53321150,135265,2]
["X",53315178,53315238,61,"ENSBGRG00000017593","ENSBGRT00000032560",5912,"PCDH19","protocadherin 19 [Source:HGNC Symbol;Acc:HGNC:14270]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007420(brain development);GO:0016020(membrane)","NA",{"v":4.3E-3,"d":"0.00"},1,"61,",0,-2.37,-1.77,7.56,"Exon (ENSBGRT00000032560/ENSBGRG00000017593, exon 4 of 10)",30,53185886,53321150,135265,2]
["X",53889641,53890691,1051,"ENSBGRG00000018689","ENSBGRT00000034319",3447,"GPRASP1","G protein-coupled receptor associated sorting protein 1 [Source:HGNC Symbol;Acc:HGNC:24834]","GO:0005829(cytosol);GO:0008333(endosome to lysosome transport);GO:1990172(G protein-coupled receptor catabolic process)","NA",{"v":6.3E-29,"d":"0.00"},2,"81,280,","0,771",{"v":-28.2,"d":"-28.20"},{"v":-27.1,"d":"-27.10"},4.08,"Exon (ENSBGRT00000034319/ENSBGRG00000018689, exon 3 of 6)",30,53887658,53894138,6481,2]
["X",54619146,54619294,149,"ENSBGRG00000019276","ENSBGRT00000035385",29,"ARMCX3","armadillo repeat containing X-linked 3 [Source:HGNC Symbol;Acc:HGNC:24065]","GO:0005515(protein binding);GO:0031307(integral component of mitochondrial outer membrane);GO:0034613(cellular protein localization);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA",{"v":4e-93,"d":"0.00"},1,"149,",0,{"v":-92.4,"d":"-92.40"},{"v":-90.8,"d":"-90.80"},5.21,"Exon (ENSBGRT00000035385/ENSBGRG00000019276, exon 1 of 1)",30,54618292,54619323,1032,2]
["X",54677497,54677705,209,"ENSBGRG00000019404","ENSBGRT00000035656",0,"ARMCX1","armadillo repeat containing X-linked 1 [Source:HGNC Symbol;Acc:HGNC:18073]","GO:0005515(protein binding)","NA",{"v":1e-198,"d":"0.00"},1,"209,",0,-198,-196,4.05,"Exon (ENSBGRT00000035656/ENSBGRG00000019404, exon 1 of 2)",30,54676345,54677705,1361,2]
["X",54731770,54731830,61,"ENSBGRG00000019451","ENSBGRT00000035935",90,"ENSBGRG00000019451","NA","NA","NA",{"v":4.7e-10,"d":"0.00"},1,"61,",0,-9.33,{"v":-8.5,"d":"-8.50"},2.89,"Exon (ENSBGRT00000035935/ENSBGRG00000019451, exon 1 of 4)",30,54722449,54731920,9472,2]
["X",54820591,54820681,91,"ENSBGRG00000019747","ENSBGRT00000036277",747,"HNRNPH2","heterogeneous nuclear ribonucleoprotein H2 [Source:HGNC Symbol;Acc:HGNC:5042]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:1990904(ribonucleoprotein complex)","NA",{"v":9.1e-08,"d":"0.00"},1,"91,",0,-7.04,-6.26,{"v":1.5,"d":"1.50"},"Exon (ENSBGRT00000036277/ENSBGRG00000019747, exon 1 of 2)",30,54819151,54821428,2278,2]
["X",54820801,54821428,628,"ENSBGRG00000019747","ENSBGRT00000036277",0,"HNRNPH2","heterogeneous nuclear ribonucleoprotein H2 [Source:HGNC Symbol;Acc:HGNC:5042]","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:1990904(ribonucleoprotein complex)","NA",{"v":1e-115,"d":"0.00"},1,"628,",0,-115,-113,5.13,"5' UTR",30,54819151,54821428,2278,2]
["X",54841675,54844222,2548,"ENSBGRG00000019813","ENSBGRT00000036496",1170,"ENSBGRG00000019813","ribosomal protein L36a [Source:HGNC Symbol;Acc:HGNC:10359]","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)",{"v":1e-138,"d":"0.00"},3,"21,123,32,","0,552,2516",-138,-136,1.48,"Exon (ENSBGRT00000036496/ENSBGRG00000019813, exon 3 of 5)",30,54841675,54845392,3718,2]
["X",55121468,55121763,296,"ENSBGRG00000020650","ENSBGRT00000038024",11631,"TMEM35A","transmembrane protein 35A [Source:HGNC Symbol;Acc:HGNC:25864]","NA","NA",{"v":1.9e-10,"d":"0.00"},1,"296,",0,-9.71,-8.87,3.13,"Exon (ENSBGRT00000038024/ENSBGRG00000020650, exon 2 of 2)",30,55120967,55133394,12428,2]
["X",58393636,58393785,150,"ENSBGRG00000022428","ENSBGRT00000041455",30922,"FAM199X","family with sequence similarity 199, X-linked [Source:HGNC Symbol;Acc:HGNC:25195]","NA","NA",{"v":0.0035,"d":"0.00"},1,"150,",0,-2.46,-1.86,3.24,"Exon (ENSBGRT00000041455/ENSBGRG00000022428, exon 6 of 6)",30,58391393,58424707,33315,2]
["X",58725288,58725467,180,"ENSBGRG00000022644","ENSBGRT00000041963",12607,"PLP1","proteolipid protein 1 [Source:HGNC Symbol;Acc:HGNC:9086]","GO:0005886(plasma membrane);GO:0006954(inflammatory response);GO:0008366(axon ensheathment);GO:0010628(positive regulation of gene expression);GO:0014002(astrocyte development);GO:0016021(integral component of membrane);GO:0022010(central nervous system myelination);GO:0042552(myelination);GO:0042759(long-chain fatty acid biosynthetic process);GO:0043209(myelin sheath);GO:0061564(axon development)","NA",{"v":0.025,"d":"0.03"},1,"180,",0,-1.61,-1.07,7.56,"3' UTR",30,58723549,58738074,14526,2]
["X",58916724,58918382,1659,"ENSBGRG00000022896","ENSBGRT00000042310",660,"TCEAL1","transcription elongation factor A like 1 [Source:HGNC Symbol;Acc:HGNC:11616]","GO:0005634(nucleus);GO:0005654(nucleoplasm)","NA",0,2,"166,214,","0,1445",-407,"-Inf",{"v":13.2,"d":"13.20"},"Exon (ENSBGRT00000042310/ENSBGRG00000022896, exon 2 of 3)",30,58916724,58919042,2319,2]
["X",58918992,58920225,1234,"ENSBGRG00000022896","ENSBGRT00000042310",0,"TCEAL1","transcription elongation factor A like 1 [Source:HGNC Symbol;Acc:HGNC:11616]","GO:0005634(nucleus);GO:0005654(nucleoplasm)","NA",{"v":0.00069,"d":"0.00"},4,"51,98,51,180,","0,349,573,1054",-3.16,-2.51,{"v":8.1,"d":"8.10"},"5' UTR",30,58916724,58919042,2319,2]
["X",58976875,58977939,1065,"ENSBGRG00000022942","ENSBGRT00000042342",148,"ENSBGRG00000022942","NA","NA","NA",0,2,"654,57,","0,1008",-987,"-Inf",3.46,"Exon (ENSBGRT00000042342/ENSBGRG00000022942, exon 1 of 2)",30,58976816,58978087,1272,2]
["X",59213813,59214166,354,"ENSBGRG00000023011","ENSBGRT00000042473",0,"TCEAL8","transcription elongation factor A like 8 [Source:HGNC Symbol;Acc:HGNC:28683]","NA","NA",0,1,"354,",0,-701,"-Inf",4.08,"Exon (ENSBGRT00000042473/ENSBGRG00000023011, exon 1 of 1)",30,59213813,59214166,354,2]
["X",59255935,59256173,239,"ENSBGRG00000023075","ENSBGRT00000042583",0,"ENSBGRG00000023075","NA","NA","NA",{"v":7.9E-75,"d":"0.00"},1,"239,",0,{"v":-74.1,"d":"-74.10"},{"v":-72.7,"d":"-72.70"},{"v":2.8,"d":"2.80"},"Exon (ENSBGRT00000042583/ENSBGRG00000023075, exon 1 of 1)",30,59255787,59256173,387,2]
["X",59348428,59350559,2132,"ENSBGRG00000023145","ENSBGRT00000042725",0,"ENSBGRG00000023145","NA","NA","NA",{"v":1e-126,"d":"0.00"},4,"161,21,262,176,","0,1248,1398,1956",-126,-125,3.24,"Exon (ENSBGRT00000042779/ENSBGRG00000023158, exon 2 of 2)",30,59348075,59350073,1999,2]
["X",60145247,60145337,91,"ENSBGRG00000019066","ENSBGRT00000034985",67226,"MORC4","MORC family CW-type zinc finger 4 [Source:HGNC Symbol;Acc:HGNC:23485]","GO:0005654(nucleoplasm);GO:0008270(zinc ion binding)","NA",{"v":1E-14,"d":"0.00"},1,"91,",0,-14,{"v":-13.1,"d":"-13.10"},2.08,"Exon (ENSBGRT00000034985/ENSBGRG00000019066, exon 16 of 17)",30,60144642,60212563,67922,2]
["X",61187257,61187346,90,"ENSBGRG00000020130","ENSBGRT00000037188",0,"ENSBGRG00000020130","NA","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":0.0071,"d":"0.01"},1,"90,",0,-2.15,-1.57,4.68,"Exon (ENSBGRT00000037188/ENSBGRG00000020130, exon 1 of 6)",30,61115158,61187346,72189,2]
["X",61413530,61415128,1599,"ENSBGRG00000020695","ENSBGRT00000038093",0,"ENSBGRG00000020695","NA","NA","NA",{"v":0.0078,"d":"0.01"},2,"693,491,","0,1108",-2.11,-1.27,9.72,"5' UTR",30,61413530,61415128,1599,2]
["X",61650110,61650470,361,"ENSBGRG00000021026","ENSBGRT00000040255",78076,"COL4A6","collagen type IV alpha 6 chain [Source:HGNC Symbol;Acc:HGNC:2208]","GO:0005201(extracellular matrix structural constituent);GO:0005581(collagen trimer);GO:0005587(collagen type IV trimer);GO:0005604(basement membrane);GO:0030198(extracellular matrix organization);GO:0038063(collagen-activated tyrosine kinase receptor signaling pathway);GO:0071230(cellular response to amino acid stimulus)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04926(Relaxin signaling pathway);04974(Protein digestion and absorption);05200(Pathways in cancer);05222(Small cell lung cancer);04933(AGE-RAGE signaling pathway in diabetic complications);05165(Human papillomavirus infection);05146(Amoebiasis)",{"v":2.5E-96,"d":"0.00"},1,"361,",0,{"v":-95.6,"d":"-95.60"},-94,3.21,"3' UTR",30,61648971,61728546,79576,2]
["X",62348872,62348991,120,"ENSBGRG00000021981","ENSBGRT00000040703",4311,"ENSBGRG00000021981","NA","NA","04068(FoxO signaling pathway);04022(cGMP - PKG signaling pathway);04152(AMPK signaling pathway);04140(Autophagy - animal);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);04930(Type II diabetes mellitus)",{"v":4e-17,"d":"0.00"},1,"120,",0,{"v":-16.4,"d":"-16.40"},{"v":-15.5,"d":"-15.50"},3.69,"Exon (ENSBGRT00000040703/ENSBGRG00000021981, exon 6 of 6)",30,62348425,62353302,4878,2]
["X",62349293,62349382,90,"ENSBGRG00000021981","ENSBGRT00000040703",3920,"ENSBGRG00000021981","NA","NA","04068(FoxO signaling pathway);04022(cGMP - PKG signaling pathway);04152(AMPK signaling pathway);04140(Autophagy - animal);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);04930(Type II diabetes mellitus)",{"v":5E-36,"d":"0.00"},1,"90,",0,{"v":-35.3,"d":"-35.30"},{"v":-34.1,"d":"-34.10"},4.24,"Exon (ENSBGRT00000040703/ENSBGRG00000021981, exon 4 of 6)",30,62348425,62353302,4878,2]
["X",62349739,62350037,299,"ENSBGRG00000021981","ENSBGRT00000040703",3265,"ENSBGRG00000021981","NA","NA","04068(FoxO signaling pathway);04022(cGMP - PKG signaling pathway);04152(AMPK signaling pathway);04140(Autophagy - animal);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);04930(Type II diabetes mellitus)",{"v":1E-70,"d":"0.00"},1,"299,",0,-70,{"v":-68.6,"d":"-68.60"},5.67,"Exon (ENSBGRT00000040703/ENSBGRG00000021981, exon 4 of 6)",30,62348425,62353302,4878,2]
["X",62350846,62350906,61,"ENSBGRG00000021981","ENSBGRT00000040703",2396,"ENSBGRG00000021981","NA","NA","04068(FoxO signaling pathway);04022(cGMP - PKG signaling pathway);04152(AMPK signaling pathway);04140(Autophagy - animal);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);04930(Type II diabetes mellitus)",{"v":1.4E-8,"d":"0.00"},1,"61,",0,-7.85,-7.06,4.57,"Exon (ENSBGRT00000040703/ENSBGRG00000021981, exon 2 of 6)",30,62348425,62353302,4878,2]
["X",63832504,63832768,265,"ENSBGRG00000022551","ENSBGRT00000041645",0,"AMMECR1","AMMECR nuclear protein 1 [Source:HGNC Symbol;Acc:HGNC:467]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","NA",{"v":0.028,"d":"0.03"},1,"265,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",30,63701488,63832768,131281,2]
["X",64192191,64192250,60,"ENSBGRG00000022668","ENSBGRT00000041995",108418,"CHRDL1","chordin like 1 [Source:HGNC Symbol;Acc:HGNC:29861]","GO:0001654(eye development);GO:0005515(protein binding);GO:0030514(negative regulation of BMP signaling pathway)","NA",{"v":1.6e-09,"d":"0.00"},1,"60,",0,-8.79,-7.97,1.59,"Exon (ENSBGRT00000041995/ENSBGRG00000022668, exon 10 of 11)",30,64169098,64300668,131571,2]
["X",64669737,64670006,270,"ENSBGRG00000023382","ENSBGRT00000043215",18871,"CAPN6","calpain 6 [Source:HGNC Symbol;Acc:HGNC:1483]","GO:0001578(microtubule bundle formation);GO:0004198(calcium-dependent cysteine-type endopeptidase activity);GO:0005874(microtubule);GO:0005876(spindle microtubule);GO:0006508(proteolysis);GO:0008017(microtubule binding);GO:0048471(perinuclear region of cytoplasm);GO:0051493(regulation of cytoskeleton organization)","NA",{"v":1.3e-81,"d":"0.00"},1,"270,",0,{"v":-80.9,"d":"-80.90"},{"v":-79.4,"d":"-79.40"},5.59,"3' UTR",30,64669737,64688877,19141,2]
["X",69182775,69182864,90,"ENSBGRG00000024233","ENSBGRT00000044759",0,"LRCH2","leucine rich repeats and calponin homology domain containing 2 [Source:HGNC Symbol;Acc:HGNC:29292]","GO:0005515(protein binding)","NA",{"v":5.6e-05,"d":"0.00"},1,"90,",0,-4.25,-3.56,14,"Exon (ENSBGRT00000044759/ENSBGRG00000024233, exon 1 of 22)",30,69072845,69182864,110020,2]
["X",72819365,72819545,181,"ENSBGRG00000025171","ENSBGRT00000046558",26352,"ZNF711","zinc finger protein 711 [Source:HGNC Symbol;Acc:HGNC:13128]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA",{"v":5.2E-7,"d":"0.00"},1,"181,",0,-6.28,-5.51,3.29,"3' UTR",30,72818916,72845897,26982,2]
["X",72819605,72819995,391,"ENSBGRG00000025171","ENSBGRT00000046558",25902,"ZNF711","zinc finger protein 711 [Source:HGNC Symbol;Acc:HGNC:13128]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA",{"v":0.0078,"d":"0.01"},1,"391,",0,-2.11,-1.27,9.72,"3' UTR",30,72818916,72845897,26982,2]
["X",72820624,72823430,2807,"ENSBGRG00000025171","ENSBGRT00000046558",22467,"ZNF711","zinc finger protein 711 [Source:HGNC Symbol;Acc:HGNC:13128]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA",{"v":2.5e-72,"d":"0.00"},3,"744,144,12,","0,1309,2795",{"v":-71.6,"d":"-71.60"},{"v":-70.2,"d":"-70.20"},{"v":6.5,"d":"6.50"},"Exon (ENSBGRT00000046558/ENSBGRG00000025171, exon 8 of 10)",30,72818916,72845897,26982,2]
["X",72830606,72831684,1079,"ENSBGRG00000025171","ENSBGRT00000046558",14213,"ZNF711","zinc finger protein 711 [Source:HGNC Symbol;Acc:HGNC:13128]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA",{"v":4.5e-07,"d":"0.00"},2,"70,80,","0,999",-6.35,-5.59,2.64,"Exon (ENSBGRT00000046558/ENSBGRG00000025171, exon 5 of 10)",30,72818916,72845897,26982,2]
["X",73329412,73329471,60,"ENSBGRG00000025313","ENSBGRT00000046844",378487,"ENSBGRG00000025313","NA","GO:0003723(RNA binding)","NA",0.01,1,"60,",0,-1.99,-1.42,3.78,"Exon (ENSBGRT00000046844/ENSBGRG00000025313, exon 10 of 12)",30,73321551,73707958,386408,2]
["X",73329681,73329920,240,"ENSBGRG00000025313","ENSBGRT00000046844",378038,"ENSBGRG00000025313","NA","GO:0003723(RNA binding)","NA",{"v":0.014,"d":"0.01"},1,"240,",0,-1.86,{"v":-1.3,"d":"-1.30"},6.48,"Exon (ENSBGRT00000046844/ENSBGRG00000025313, exon 10 of 12)",30,73321551,73707958,386408,2]
["X",77131293,77131382,90,"ENSBGRG00000013400","ENSBGRT00000024542",3870,"ENSBGRG00000013400","NA","GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0006885(regulation of pH);GO:0015299(solute:proton antiporter activity);GO:0015385(sodium:proton antiporter activity);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","NA",{"v":0.028,"d":"0.03"},1,"90,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000024542/ENSBGRG00000013400, exon 2 of 12)",30,77031440,77135252,103813,2]
["X",77131442,77131591,150,"ENSBGRG00000013400","ENSBGRT00000024542",3661,"ENSBGRG00000013400","NA","GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0006885(regulation of pH);GO:0015299(solute:proton antiporter activity);GO:0015385(sodium:proton antiporter activity);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","NA",{"v":0.00065,"d":"0.00"},1,"150,",0,-3.19,-2.54,4.54,"Exon (ENSBGRT00000024542/ENSBGRG00000013400, exon 2 of 12)",30,77031440,77135252,103813,2]
["X",79478977,79479066,90,"ENSBGRG00000014278","ENSBGRT00000026200",883,"GPR174","G protein-coupled receptor 174 [Source:HGNC Symbol;Acc:HGNC:30245]","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0043029(T cell homeostasis);GO:0045125(bioactive lipid receptor activity)","NA",{"v":0.00032,"d":"0.00"},1,"90,",0,-3.49,-2.83,2.58,"Exon (ENSBGRT00000026200/ENSBGRG00000014278, exon 1 of 1)",30,79478948,79479949,1002,2]
["X",79479861,79479949,89,"ENSBGRG00000014278","ENSBGRT00000026200",0,"GPR174","G protein-coupled receptor 174 [Source:HGNC Symbol;Acc:HGNC:30245]","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0043029(T cell homeostasis);GO:0045125(bioactive lipid receptor activity)","NA",{"v":3e-07,"d":"0.00"},1,"89,",0,-6.52,-5.75,{"v":22.7,"d":"22.70"},"Exon (ENSBGRT00000026200/ENSBGRG00000014278, exon 1 of 1)",30,79478948,79479949,1002,2]
["X",79684711,79684830,120,"ENSBGRG00000014291","ENSBGRT00000026255",598,"P2RY10","P2Y receptor family member 10 [Source:HGNC Symbol;Acc:HGNC:19906]","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0045028(G protein-coupled purinergic nucleotide receptor activity)","04080(Neuroactive ligand-receptor interaction)",{"v":3.7e-06,"d":"0.00"},1,"120,",0,-5.43,{"v":-4.7,"d":"-4.70"},7.56,"Exon (ENSBGRT00000026255/ENSBGRG00000014291, exon 1 of 1)",30,79684442,79685428,987,2]
["X",79684950,79685129,180,"ENSBGRG00000014291","ENSBGRT00000026255",299,"P2RY10","P2Y receptor family member 10 [Source:HGNC Symbol;Acc:HGNC:19906]","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0045028(G protein-coupled purinergic nucleotide receptor activity)","04080(Neuroactive ligand-receptor interaction)",{"v":1E-4,"d":"0.00"},1,"180,",0,-4,-3.32,3.44,"Exon (ENSBGRT00000026255/ENSBGRG00000014291, exon 1 of 1)",30,79684442,79685428,987,2]
["X",79955083,79955288,206,"ENSBGRG00000014316","ENSBGRT00000026266",351,"LPAR4","lysophosphatidic acid receptor 4 [Source:HGNC Symbol;Acc:HGNC:4478]","GO:0004930(G protein-coupled receptor activity);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0016604(nuclear body);GO:0035727(lysophosphatidic acid binding);GO:0043231(intracellular membrane-bounded organelle);GO:0070915(lysophosphatidic acid receptor activity)","04015(Rap1 signaling pathway);04072(Phospholipase D signaling pathway);04151(PI3K-Akt signaling pathway);04080(Neuroactive ligand-receptor interaction);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer)",{"v":6.6E-10,"d":"0.00"},1,"206,",0,-9.18,-8.35,3.31,"Exon (ENSBGRT00000026266/ENSBGRG00000014316, exon 1 of 1)",30,79954527,79955639,1113,2]
["X",80785912,80786180,269,"ENSBGRG00000015150","ENSBGRT00000027966",22273,"ATP7A","ATPase copper transporting alpha [Source:HGNC Symbol;Acc:HGNC:869]","GO:0000166(nucleotide binding);GO:0005507(copper ion binding);GO:0005770(late endosome);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0006812(cation transport);GO:0006825(copper ion transport);GO:0006878(cellular copper ion homeostasis);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0019829(ATPase-coupled cation transmembrane transporter activity);GO:0030001(metal ion transport);GO:0030140(trans-Golgi network transport vesicle);GO:0032767(copper-dependent protein binding);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0051353(positive regulation of oxidoreductase activity);GO:1903136(cuprous ion binding)","01524(Platinum drug resistance)",{"v":0.015,"d":"0.02"},1,"269,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000027966/ENSBGRG00000015150, exon 2 of 21)",30,80726682,80808453,81772,2]
["X",82048212,82048845,634,"ENSBGRG00000022890","ENSBGRT00000042288",3996,"PBDC1","polysaccharide biosynthesis domain containing 1 [Source:HGNC Symbol;Acc:HGNC:28790]","NA","NA",{"v":1e-157,"d":"0.00"},2,"251,75,","0,559",-157,-155,4.12,"Exon (ENSBGRT00000042288/ENSBGRG00000022890, exon 5 of 6)",30,82047916,82052841,4926,2]
["X",82049499,82050518,1020,"ENSBGRG00000022890","ENSBGRT00000042288",2323,"PBDC1","polysaccharide biosynthesis domain containing 1 [Source:HGNC Symbol;Acc:HGNC:28790]","NA","NA",{"v":4.7e-05,"d":"0.00"},2,"29,31,","0,989",-4.33,-3.63,{"v":2.3,"d":"2.30"},"Exon (ENSBGRT00000042288/ENSBGRG00000022890, exon 4 of 6)",30,82047916,82052841,4926,2]
["X",83305272,83305482,211,"ENSBGRG00000024018","ENSBGRT00000044344",239,"SLC16A2","solute carrier family 16 member 2 [Source:HGNC Symbol;Acc:HGNC:10923]","GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006520(cellular amino acid metabolic process);GO:0015171(amino acid transmembrane transporter activity);GO:0015349(thyroid hormone transmembrane transporter activity);GO:0016324(apical plasma membrane);GO:0022857(transmembrane transporter activity);GO:0042403(thyroid hormone metabolic process);GO:0055085(transmembrane transport);GO:0070327(thyroid hormone transport);GO:0089718(amino acid import across plasma membrane);GO:0150104(transport across blood-brain barrier);GO:2000178(negative regulation of neural precursor cell proliferation)","04919(Thyroid hormone signaling pathway)",{"v":3.7e-06,"d":"0.00"},1,"211,",0,-5.43,-4.69,2.61,"Exon (ENSBGRT00000044344/ENSBGRG00000024018, exon 1 of 6)",30,83162961,83305721,142761,2]
["X",83689935,83690876,942,"ENSBGRG00000024150","ENSBGRT00000044583",294,"ENSBGRG00000024150","NA","NA","NA",{"v":0.00071,"d":"0.00"},1,"942,",0,-3.15,-2.51,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000044583/ENSBGRG00000024150, exon 1 of 1)",30,83689935,83691170,1236,2]
["X",85218878,85287336,68459,"ENSBGRG00000025193","ENSBGRT00000046574",0,"ERCC6L","ERCC excision repair 6 like, spindle assembly checkpoint helicase [Source:HGNC Symbol;Acc:HGNC:20794]","GO:0005524(ATP binding);GO:0015616(DNA translocase activity)","NA",{"v":0.018,"d":"0.02"},3,"90,144,4,","0,68309,68455",-1.74,-1.19,2.62,"Exon (ENSBGRT00000046574/ENSBGRG00000025193, exon 1 of 2)",30,85251199,85281207,30009,1]
["X",85302553,85302671,119,"ENSBGRG00000025136","ENSBGRT00000046525",0,"PIN4","peptidylprolyl cis/trans isomerase, NIMA-interacting 4 [Source:HGNC Symbol;Acc:HGNC:8992]","GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005654(nucleoplasm);GO:0005730(nucleolus)","NA",{"v":2.8E-3,"d":"0.00"},3,"13,23,54,","0,14,65",-2.55,-1.94,{"v":5.4,"d":"5.40"},"5' UTR",30,85218878,85302589,83712,2]
["X",85352107,85352227,121,"ENSBGRG00000025208","ENSBGRT00000046693",95527,"NHSL2","NHS like 2 [Source:HGNC Symbol;Acc:HGNC:33737]","NA","NA",{"v":5.9e-08,"d":"0.00"},1,"121,",0,-7.23,-6.44,2.67,"Exon (ENSBGRT00000046693/ENSBGRG00000025208, exon 4 of 4)",30,85352017,85447754,95738,2]
["X",85356771,85356831,61,"ENSBGRG00000025208","ENSBGRT00000046693",90923,"NHSL2","NHS like 2 [Source:HGNC Symbol;Acc:HGNC:33737]","NA","NA",{"v":0.0085,"d":"0.01"},1,"61,",0,-2.07,-1.49,{"v":1.6,"d":"1.60"},"Exon (ENSBGRT00000046693/ENSBGRG00000025208, exon 2 of 4)",30,85352017,85447754,95738,2]
["X",85357370,85357430,61,"ENSBGRG00000025208","ENSBGRT00000046693",90324,"NHSL2","NHS like 2 [Source:HGNC Symbol;Acc:HGNC:33737]","NA","NA",{"v":6.6e-06,"d":"0.00"},1,"61,",0,-5.18,-4.45,3.39,"Exon (ENSBGRT00000046693/ENSBGRG00000025208, exon 2 of 4)",30,85352017,85447754,95738,2]
["X",85957736,85965508,7773,"ENSBGRG00000025338","ENSBGRT00000046871",36026,"OGT","O-linked N-acetylglucosamine (GlcNAc) transferase [Source:HGNC Symbol;Acc:HGNC:8127]","GO:0000123(histone acetyltransferase complex);GO:0005515(protein binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006110(regulation of glycolytic process);GO:0006111(regulation of gluconeogenesis);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006493(protein O-linked glycosylation);GO:0006915(apoptotic process);GO:0016262(protein N-acetylglucosaminyltransferase activity);GO:0016485(protein processing);GO:0016757(transferase activity, transferring glycosyl groups);GO:0017122(protein N-acetylglucosaminyltransferase complex);GO:0031397(negative regulation of protein ubiquitination);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032868(response to insulin);GO:0032922(circadian regulation of gene expression);GO:0032991(protein-containing complex);GO:0035020(regulation of Rac protein signal transduction);GO:0043981(histone H4-K5 acetylation);GO:0043982(histone H4-K8 acetylation);GO:0043984(histone H4-K16 acetylation);GO:0043995(histone acetyltransferase activity (H4-K5 specific));GO:0043996(histone acetyltransferase activity (H4-K8 specific));GO:0045862(positive regulation of proteolysis);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046626(regulation of insulin receptor signaling pathway);GO:0046972(histone acetyltransferase activity (H4-K16 specific));GO:0048015(phosphatidylinositol-mediated signaling);GO:0061087(positive regulation of histone H3-K27 methylation);GO:0080182(histone H3-K4 trimethylation);GO:0097363(protein O-GlcNAc transferase activity);GO:0120162(positive regulation of cold-induced thermogenesis)","00514(Other types of O-glycan biosynthesis);04931(Insulin resistance)",0,2,"420,89,","0,7684",-1030,"-Inf",4.55,"3' UTR",30,85956630,86001534,44905,2]
["X",86270831,86272051,1221,"ENSBGRG00000025854","ENSBGRT00000047801",4721,"NONO","non-POU domain containing octamer binding [Source:HGNC Symbol;Acc:HGNC:7871]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001650(fibrillar center);GO:0002218(activation of innate immune response);GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016363(nuclear matrix);GO:0042382(paraspeckles);GO:0042752(regulation of circadian rhythm);GO:0042802(identical protein binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0070888(E-box binding);GO:0090575(RNA polymerase II transcription factor complex);GO:1903377(negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway)","NA",{"v":1E-191,"d":"0.00"},5,"88,85,197,13,4,","0,515,944,1171,1217",-191,-189,1.75,"Exon (ENSBGRT00000047801/ENSBGRG00000025854, exon 4 of 11)",30,86268951,86276772,7822,2]
["X",86389226,86389524,299,"ENSBGRG00000025879","ENSBGRT00000047843",22679,"NLGN3","neuroligin 3 [Source:HGNC Symbol;Acc:HGNC:14289]","GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007612(learning);GO:0008542(visual learning);GO:0009986(cell surface);GO:0016020(membrane);GO:0030534(adult behavior);GO:0035176(social behavior);GO:0042043(neurexin family protein binding);GO:0045202(synapse);GO:0048709(oligodendrocyte differentiation);GO:0050804(modulation of chemical synaptic transmission);GO:0050808(synapse organization);GO:0051965(positive regulation of synapse assembly);GO:0051966(regulation of synaptic transmission, glutamatergic);GO:0051968(positive regulation of synaptic transmission, glutamatergic);GO:0060076(excitatory synapse);GO:0060079(excitatory postsynaptic potential);GO:0060080(inhibitory postsynaptic potential);GO:0060291(long-term synaptic potentiation);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0071625(vocalization behavior);GO:0090394(negative regulation of excitatory postsynaptic potential);GO:0097104(postsynaptic membrane assembly);GO:0097110(scaffold protein binding);GO:1900271(regulation of long-term synaptic potentiation);GO:2000310(regulation of NMDA receptor activity);GO:2000311(regulation of AMPA receptor activity);GO:2000331(regulation of terminal button organization);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000809(positive regulation of synaptic vesicle clustering);GO:2000969(positive regulation of AMPA receptor activity)","04514(Cell adhesion molecules (CAMs))",{"v":4e-19,"d":"0.00"},1,"299,",0,{"v":-18.4,"d":"-18.40"},{"v":-17.4,"d":"-17.40"},2.89,"Exon (ENSBGRT00000047843/ENSBGRG00000025879, exon 6 of 7)",30,86389104,86412203,23100,2]
["X",86390908,86390968,61,"ENSBGRG00000025879","ENSBGRT00000047843",21235,"NLGN3","neuroligin 3 [Source:HGNC Symbol;Acc:HGNC:14289]","GO:0002087(regulation of respiratory gaseous exchange by nervous system process);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007612(learning);GO:0008542(visual learning);GO:0009986(cell surface);GO:0016020(membrane);GO:0030534(adult behavior);GO:0035176(social behavior);GO:0042043(neurexin family protein binding);GO:0045202(synapse);GO:0048709(oligodendrocyte differentiation);GO:0050804(modulation of chemical synaptic transmission);GO:0050808(synapse organization);GO:0051965(positive regulation of synapse assembly);GO:0051966(regulation of synaptic transmission, glutamatergic);GO:0051968(positive regulation of synaptic transmission, glutamatergic);GO:0060076(excitatory synapse);GO:0060079(excitatory postsynaptic potential);GO:0060080(inhibitory postsynaptic potential);GO:0060291(long-term synaptic potentiation);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0071625(vocalization behavior);GO:0090394(negative regulation of excitatory postsynaptic potential);GO:0097104(postsynaptic membrane assembly);GO:0097110(scaffold protein binding);GO:1900271(regulation of long-term synaptic potentiation);GO:2000310(regulation of NMDA receptor activity);GO:2000311(regulation of AMPA receptor activity);GO:2000331(regulation of terminal button organization);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000809(positive regulation of synaptic vesicle clustering);GO:2000969(positive regulation of AMPA receptor activity)","04514(Cell adhesion molecules (CAMs))",{"v":1e-05,"d":"0.00"},1,"61,",0,-4.99,-4.27,2.43,"Exon (ENSBGRT00000047843/ENSBGRG00000025879, exon 4 of 7)",30,86389104,86412203,23100,2]
["X",86461613,86461672,60,"ENSBGRG00000026112","ENSBGRT00000048304",354,"FOXO4","forkhead box O4 [Source:HGNC Symbol;Acc:HGNC:7139]","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0007050(cell cycle arrest);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016525(negative regulation of angiogenesis);GO:0016607(nuclear speck);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048863(stem cell differentiation);GO:0051151(negative regulation of smooth muscle cell differentiation);GO:0070317(negative regulation of G0 to G1 transition);GO:0071158(positive regulation of cell cycle arrest);GO:1990837(sequence-specific double-stranded DNA binding)","04014(Ras signaling pathway);04068(FoxO signaling pathway)",{"v":7.9e-19,"d":"0.00"},1,"60,",0,{"v":-18.1,"d":"-18.10"},{"v":-17.2,"d":"-17.20"},1.85,"Exon (ENSBGRT00000048304/ENSBGRG00000026112, exon 1 of 4)",30,86455596,86462026,6431,2]
["X",86461731,86461790,60,"ENSBGRG00000026112","ENSBGRT00000048304",236,"FOXO4","forkhead box O4 [Source:HGNC Symbol;Acc:HGNC:7139]","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0007050(cell cycle arrest);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016525(negative regulation of angiogenesis);GO:0016607(nuclear speck);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048863(stem cell differentiation);GO:0051151(negative regulation of smooth muscle cell differentiation);GO:0070317(negative regulation of G0 to G1 transition);GO:0071158(positive regulation of cell cycle arrest);GO:1990837(sequence-specific double-stranded DNA binding)","04014(Ras signaling pathway);04068(FoxO signaling pathway)",{"v":4e-16,"d":"0.00"},1,"60,",0,{"v":-15.4,"d":"-15.40"},{"v":-14.5,"d":"-14.50"},1.87,"Exon (ENSBGRT00000048304/ENSBGRG00000026112, exon 1 of 4)",30,86455596,86462026,6431,2]
["X",86934362,86935662,1301,"ENSBGRG00000007926","ENSBGRT00000014636",52446,"DLG3","discs large MAGUK scaffold protein 3 [Source:HGNC Symbol;Acc:HGNC:2902]","GO:0001736(establishment of planar polarity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005923(bicellular tight junction);GO:0010923(negative regulation of phosphatase activity);GO:0019900(kinase binding);GO:0019902(phosphatase binding);GO:0031625(ubiquitin protein ligase binding);GO:0032281(AMPA glutamate receptor complex);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0098978(glutamatergic synapse);GO:0099072(regulation of postsynaptic membrane neurotransmitter receptor levels)","04390(Hippo signaling pathway);04530(Tight junction);05165(Human papillomavirus infection)",{"v":1e-32,"d":"0.00"},2,"213,26,","0,1275",-32,{"v":-30.8,"d":"-30.80"},2.95,"3' UTR",30,86934154,86988108,53955,2]
["X",86987256,86988747,1492,"ENSBGRG00000007926","ENSBGRT00000014636",0,"DLG3","discs large MAGUK scaffold protein 3 [Source:HGNC Symbol;Acc:HGNC:2902]","GO:0001736(establishment of planar polarity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005923(bicellular tight junction);GO:0010923(negative regulation of phosphatase activity);GO:0019900(kinase binding);GO:0019902(phosphatase binding);GO:0031625(ubiquitin protein ligase binding);GO:0032281(AMPA glutamate receptor complex);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0098978(glutamatergic synapse);GO:0099072(regulation of postsynaptic membrane neurotransmitter receptor levels)","04390(Hippo signaling pathway);04530(Tight junction);05165(Human papillomavirus infection)",{"v":0.028,"d":"0.03"},2,"853,189,","0,1303",-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",30,86934154,86988108,53955,2]
["X",87009125,87009214,90,"ENSBGRG00000008136","ENSBGRT00000014886",9924,"GDPD2","glycerophosphodiester phosphodiesterase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:25974]","GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0030027(lamellipodium);GO:0045669(positive regulation of osteoblast differentiation);GO:0090527(actin filament reorganization)","NA",{"v":0.0051,"d":"0.01"},1,"90,",0,-2.29,{"v":-1.7,"d":"-1.70"},3.67,"3' UTR",30,87008915,87019138,10224,2]
["X",87009873,87010083,211,"ENSBGRG00000008136","ENSBGRT00000014886",9055,"GDPD2","glycerophosphodiester phosphodiesterase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:25974]","GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0030027(lamellipodium);GO:0045669(positive regulation of osteoblast differentiation);GO:0090527(actin filament reorganization)","NA",{"v":0.015,"d":"0.02"},1,"211,",0,-1.83,-1.02,8.64,"3' UTR",30,87008915,87019138,10224,2]
["X",87024285,87024465,181,"ENSBGRG00000008356","ENSBGRT00000015266",139007,"KIF4A","kinesin family member 4A [Source:HGNC Symbol;Acc:HGNC:13339]","GO:0000281(mitotic cytokinesis);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0030496(midbody);GO:0051256(mitotic spindle midzone assembly)","NA",{"v":0.013,"d":"0.01"},1,"181,",0,-1.88,-1.32,7.56,"Exon (ENSBGRT00000015266/ENSBGRG00000008356, exon 32 of 32)",30,87024285,87163472,139188,2]
["X",87170628,87170775,148,"ENSBGRG00000008523","ENSBGRT00000015532",923,"ENSBGRG00000008523","NA","GO:0003924(GTPase activity);GO:0005525(GTP binding)","NA",{"v":3.2e-11,"d":"0.00"},1,"148,",0,{"v":-10.5,"d":"-10.50"},-9.62,4.86,"Exon (ENSBGRT00000015532/ENSBGRG00000008523, exon 3 of 3)",30,87170628,87171698,1071,2]
["X",87170835,87171698,864,"ENSBGRG00000008523","ENSBGRT00000015532",0,"ENSBGRG00000008523","NA","GO:0003924(GTPase activity);GO:0005525(GTP binding)","NA",{"v":1.7e-09,"d":"0.00"},3,"83,73,51,","0,287,813",-8.77,-7.95,3.69,"Exon (ENSBGRT00000015532/ENSBGRG00000008523, exon 1 of 3)",30,87170628,87171698,1071,2]
["X",88068389,88068714,326,"ENSBGRG00000009407","ENSBGRT00000017250",0,"FAM155B","family with sequence similarity 155 member B [Source:HGNC Symbol;Acc:HGNC:30701]","NA","NA",{"v":0.015,"d":"0.02"},1,"326,",0,-1.83,-1.02,8.64,"Exon (ENSBGRT00000017250/ENSBGRG00000009407, exon 1 of 3)",30,88036630,88068714,32085,2]
["X",88447950,88448214,265,"ENSBGRG00000009422","ENSBGRT00000017286",2000,"ENSBGRG00000009422","NA","NA","NA",{"v":1.3E-43,"d":"0.00"},1,"265,",0,{"v":-42.9,"d":"-42.90"},{"v":-41.6,"d":"-41.60"},4.05,"Exon (ENSBGRT00000017286/ENSBGRG00000009422, exon 2 of 2)",30,88447833,88450214,2382,2]
["X",88870377,88870823,447,"ENSBGRG00000009492","ENSBGRT00000017469",14251,"EFNB1","ephrin B1 [Source:HGNC Symbol;Acc:HGNC:3226]","GO:0001755(neural crest cell migration);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007411(axon guidance);GO:0009880(embryonic pattern specification);GO:0016020(membrane);GO:0031295(T cell costimulation);GO:0042102(positive regulation of T cell proliferation);GO:0045121(membrane raft);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway)","04360(Axon guidance)",{"v":5e-29,"d":"0.00"},1,"447,",0,{"v":-28.3,"d":"-28.30"},{"v":-27.2,"d":"-27.20"},5.01,"3' UTR",30,88857620,88885074,27455,2]
["X",88996368,88996608,241,"ENSBGRG00000009592","ENSBGRT00000017580",40899,"STARD8","StAR related lipid transfer domain containing 8 [Source:HGNC Symbol;Acc:HGNC:19161]","GO:0007165(signal transduction);GO:0008289(lipid binding)","NA",{"v":9.8e-06,"d":"0.00"},1,"241,",0,-5.01,-4.29,3.39,"Exon (ENSBGRT00000017580/ENSBGRG00000009592, exon 6 of 15)",30,88988942,89037507,48566,2]
["X",90470575,90471264,690,"ENSBGRG00000010012","ENSBGRT00000018343",231952,"AR","androgen receptor [Source:HGNC Symbol;Acc:HGNC:644]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001091(RNA polymerase II general transcription initiation factor binding);GO:0001225(RNA polymerase II transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003073(regulation of systemic arterial blood pressure);GO:0003382(epithelial cell morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0004879(nuclear receptor activity);GO:0005102(signaling receptor binding);GO:0005496(steroid binding);GO:0005497(androgen binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0009566(fertilization);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0016607(nuclear speck);GO:0019102(male somatic sex determination);GO:0019899(enzyme binding);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030522(intracellular receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway);GO:0033327(Leydig cell differentiation);GO:0035264(multicellular organism growth);GO:0042025(host cell nucleus);GO:0042327(positive regulation of phosphorylation);GO:0043410(positive regulation of MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045597(positive regulation of cell differentiation);GO:0045720(negative regulation of integrin biosynthetic process);GO:0045726(positive regulation of integrin biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0048608(reproductive structure development);GO:0048638(regulation of developmental growth);GO:0048645(animal organ formation);GO:0048808(male genitalia morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051117(ATPase binding);GO:0060520(activation of prostate induction by androgen receptor signaling pathway);GO:0060571(morphogenesis of an epithelial fold);GO:0060599(lateral sprouting involved in mammary gland duct morphogenesis);GO:0060685(regulation of prostatic bud formation);GO:0060736(prostate gland growth);GO:0060740(prostate gland epithelium morphogenesis);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis);GO:0060749(mammary gland alveolus development);GO:0060769(positive regulation of epithelial cell proliferation involved in prostate gland development);GO:0061458(reproductive system development);GO:0070974(POU domain binding);GO:0071383(cellular response to steroid hormone stimulus);GO:0071391(cellular response to estrogen stimulus);GO:0071394(cellular response to testosterone stimulus);GO:0072520(seminiferous tubule development);GO:1903076(regulation of protein localization to plasma membrane);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04114(Oocyte meiosis);05200(Pathways in cancer);05215(Prostate cancer)",{"v":1e-143,"d":"0.00"},1,"690,",0,-143,-141,5.47,"3' UTR",30,90470545,90703216,232672,2]
["X",90471384,90471594,211,"ENSBGRG00000010012","ENSBGRT00000018343",231622,"AR","androgen receptor [Source:HGNC Symbol;Acc:HGNC:644]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001091(RNA polymerase II general transcription initiation factor binding);GO:0001225(RNA polymerase II transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003073(regulation of systemic arterial blood pressure);GO:0003382(epithelial cell morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0004879(nuclear receptor activity);GO:0005102(signaling receptor binding);GO:0005496(steroid binding);GO:0005497(androgen binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0009566(fertilization);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0016607(nuclear speck);GO:0019102(male somatic sex determination);GO:0019899(enzyme binding);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030522(intracellular receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway);GO:0033327(Leydig cell differentiation);GO:0035264(multicellular organism growth);GO:0042025(host cell nucleus);GO:0042327(positive regulation of phosphorylation);GO:0043410(positive regulation of MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045597(positive regulation of cell differentiation);GO:0045720(negative regulation of integrin biosynthetic process);GO:0045726(positive regulation of integrin biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0048608(reproductive structure development);GO:0048638(regulation of developmental growth);GO:0048645(animal organ formation);GO:0048808(male genitalia morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051117(ATPase binding);GO:0060520(activation of prostate induction by androgen receptor signaling pathway);GO:0060571(morphogenesis of an epithelial fold);GO:0060599(lateral sprouting involved in mammary gland duct morphogenesis);GO:0060685(regulation of prostatic bud formation);GO:0060736(prostate gland growth);GO:0060740(prostate gland epithelium morphogenesis);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis);GO:0060749(mammary gland alveolus development);GO:0060769(positive regulation of epithelial cell proliferation involved in prostate gland development);GO:0061458(reproductive system development);GO:0070974(POU domain binding);GO:0071383(cellular response to steroid hormone stimulus);GO:0071391(cellular response to estrogen stimulus);GO:0071394(cellular response to testosterone stimulus);GO:0072520(seminiferous tubule development);GO:1903076(regulation of protein localization to plasma membrane);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04114(Oocyte meiosis);05200(Pathways in cancer);05215(Prostate cancer)",{"v":4e-20,"d":"0.00"},1,"211,",0,{"v":-19.4,"d":"-19.40"},{"v":-18.4,"d":"-18.40"},4,"3' UTR",30,90470545,90703216,232672,2]
["X",90700759,90701508,750,"ENSBGRG00000010012","ENSBGRT00000018343",1708,"AR","androgen receptor [Source:HGNC Symbol;Acc:HGNC:644]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001091(RNA polymerase II general transcription initiation factor binding);GO:0001225(RNA polymerase II transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003073(regulation of systemic arterial blood pressure);GO:0003382(epithelial cell morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0004879(nuclear receptor activity);GO:0005102(signaling receptor binding);GO:0005496(steroid binding);GO:0005497(androgen binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0009566(fertilization);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0016607(nuclear speck);GO:0019102(male somatic sex determination);GO:0019899(enzyme binding);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030522(intracellular receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway);GO:0033327(Leydig cell differentiation);GO:0035264(multicellular organism growth);GO:0042025(host cell nucleus);GO:0042327(positive regulation of phosphorylation);GO:0043410(positive regulation of MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045597(positive regulation of cell differentiation);GO:0045720(negative regulation of integrin biosynthetic process);GO:0045726(positive regulation of integrin biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0048608(reproductive structure development);GO:0048638(regulation of developmental growth);GO:0048645(animal organ formation);GO:0048808(male genitalia morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051117(ATPase binding);GO:0060520(activation of prostate induction by androgen receptor signaling pathway);GO:0060571(morphogenesis of an epithelial fold);GO:0060599(lateral sprouting involved in mammary gland duct morphogenesis);GO:0060685(regulation of prostatic bud formation);GO:0060736(prostate gland growth);GO:0060740(prostate gland epithelium morphogenesis);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis);GO:0060749(mammary gland alveolus development);GO:0060769(positive regulation of epithelial cell proliferation involved in prostate gland development);GO:0061458(reproductive system development);GO:0070974(POU domain binding);GO:0071383(cellular response to steroid hormone stimulus);GO:0071391(cellular response to estrogen stimulus);GO:0071394(cellular response to testosterone stimulus);GO:0072520(seminiferous tubule development);GO:1903076(regulation of protein localization to plasma membrane);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04114(Oocyte meiosis);05200(Pathways in cancer);05215(Prostate cancer)",{"v":1e-30,"d":"0.00"},1,"750,",0,-30,{"v":-28.9,"d":"-28.90"},14,"Exon (ENSBGRT00000018343/ENSBGRG00000010012, exon 1 of 9)",30,90470545,90703216,232672,2]
["X",90702737,90702886,150,"ENSBGRG00000010012","ENSBGRT00000018343",330,"AR","androgen receptor [Source:HGNC Symbol;Acc:HGNC:644]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001091(RNA polymerase II general transcription initiation factor binding);GO:0001225(RNA polymerase II transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003073(regulation of systemic arterial blood pressure);GO:0003382(epithelial cell morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0004879(nuclear receptor activity);GO:0005102(signaling receptor binding);GO:0005496(steroid binding);GO:0005497(androgen binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0009566(fertilization);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0016607(nuclear speck);GO:0019102(male somatic sex determination);GO:0019899(enzyme binding);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030522(intracellular receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway);GO:0033327(Leydig cell differentiation);GO:0035264(multicellular organism growth);GO:0042025(host cell nucleus);GO:0042327(positive regulation of phosphorylation);GO:0043410(positive regulation of MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045597(positive regulation of cell differentiation);GO:0045720(negative regulation of integrin biosynthetic process);GO:0045726(positive regulation of integrin biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0048608(reproductive structure development);GO:0048638(regulation of developmental growth);GO:0048645(animal organ formation);GO:0048808(male genitalia morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051117(ATPase binding);GO:0060520(activation of prostate induction by androgen receptor signaling pathway);GO:0060571(morphogenesis of an epithelial fold);GO:0060599(lateral sprouting involved in mammary gland duct morphogenesis);GO:0060685(regulation of prostatic bud formation);GO:0060736(prostate gland growth);GO:0060740(prostate gland epithelium morphogenesis);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis);GO:0060749(mammary gland alveolus development);GO:0060769(positive regulation of epithelial cell proliferation involved in prostate gland development);GO:0061458(reproductive system development);GO:0070974(POU domain binding);GO:0071383(cellular response to steroid hormone stimulus);GO:0071391(cellular response to estrogen stimulus);GO:0071394(cellular response to testosterone stimulus);GO:0072520(seminiferous tubule development);GO:1903076(regulation of protein localization to plasma membrane);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04114(Oocyte meiosis);05200(Pathways in cancer);05215(Prostate cancer)",{"v":1.6e-21,"d":"0.00"},1,"150,",0,{"v":-20.8,"d":"-20.80"},{"v":-19.8,"d":"-19.80"},6.33,"5' UTR",30,90470545,90703216,232672,2]
["X",92228208,92229524,1317,"ENSBGRG00000010191","ENSBGRT00000018732",0,"ENSBGRG00000010191","NA","NA","NA",{"v":2.5e-07,"d":"0.00"},3,"443,295,509,","0,481,808",{"v":-6.6,"d":"-6.60"},-5.83,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000018732/ENSBGRG00000010191, exon 1 of 3)",30,92228030,92229524,1495,2]
["X",92430539,92430629,91,"ENSBGRG00000010277","ENSBGRT00000018911",215972,"SLC9A7","solute carrier family 9 member A7 [Source:HGNC Symbol;Acc:HGNC:17123]","GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0006885(regulation of pH);GO:0015299(solute:proton antiporter activity);GO:0015385(sodium:proton antiporter activity);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport)","NA",{"v":0.0041,"d":"0.00"},1,"91,",0,-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000018911/ENSBGRG00000010277, exon 19 of 19)",30,92430539,92646601,216063,2]
["X",92489498,92492795,3298,"ENSBGRG00000010277","ENSBGRT00000018911",153806,"SLC9A7","solute carrier family 9 member A7 [Source:HGNC Symbol;Acc:HGNC:17123]","GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0006885(regulation of pH);GO:0015299(solute:proton antiporter activity);GO:0015385(sodium:proton antiporter activity);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport)","NA",{"v":5.8E-4,"d":"0.00"},3,"40,89,52,","0,131,3246",-3.24,-2.59,6.48,"Exon (ENSBGRT00000018911/ENSBGRG00000010277, exon 10 of 19)",30,92430539,92646601,216063,2]
["X",92497005,92518472,21468,"ENSBGRG00000010277","ENSBGRT00000018911",128129,"SLC9A7","solute carrier family 9 member A7 [Source:HGNC Symbol;Acc:HGNC:17123]","GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0006885(regulation of pH);GO:0015299(solute:proton antiporter activity);GO:0015385(sodium:proton antiporter activity);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport)","NA",{"v":0.00093,"d":"0.00"},4,"33,25,82,70,","0,15175,15204,21398",-3.03,{"v":-2.4,"d":"-2.40"},4.05,"Exon (ENSBGRT00000018911/ENSBGRG00000010277, exon 5 of 19)",30,92430539,92646601,216063,2]
["X",93412299,93413188,890,"ENSBGRG00000015259","ENSBGRT00000028421",13467,"ZNF41","zinc finger protein 41 [Source:HGNC Symbol;Acc:HGNC:13107]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1.3E-18,"d":"0.00"},2,"387,1,","0,889",{"v":-17.9,"d":"-17.90"},-17,3.06,"Exon (ENSBGRT00000028421/ENSBGRG00000015259, exon 6 of 7)",30,93412120,93426655,14536,2]
["X",93664428,93664551,124,"ENSBGRG00000016091","ENSBGRT00000029558",6454,"CFP","complement factor properdin [Source:HGNC Symbol;Acc:HGNC:8864]","GO:0005615(extracellular space);GO:0006957(complement activation, alternative pathway);GO:0030141(secretory granule)","05168(Herpes simplex infection)",{"v":0.00093,"d":"0.00"},3,"9,11,101,","0,11,23",-3.03,{"v":-2.4,"d":"-2.40"},{"v":3.6,"d":"3.60"},"Exon (ENSBGRT00000029558/ENSBGRG00000016091, exon 9 of 11)",30,93664428,93671005,6578,2]
["X",93665449,93666176,728,"ENSBGRG00000016091","ENSBGRT00000029558",4829,"CFP","complement factor properdin [Source:HGNC Symbol;Acc:HGNC:8864]","GO:0005615(extracellular space);GO:0006957(complement activation, alternative pathway);GO:0030141(secretory granule)","05168(Herpes simplex infection)",{"v":1.6e-32,"d":"0.00"},2,"223,108,","0,620",{"v":-31.8,"d":"-31.80"},{"v":-30.6,"d":"-30.60"},8.13,"3' UTR",30,93664428,93671005,6578,2]
["X",93683391,93683860,470,"ENSBGRG00000016328","ENSBGRT00000029930",0,"ENSBGRG00000016328","NA","NA","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04510(Focal adhesion);04910(Insulin signaling pathway);04912(GnRH signaling pathway);04921(Oxytocin signaling pathway);05200(Pathways in cancer);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05213(Endometrial cancer);05020(Prion diseases);05166(HTLV-I infection);05161(Hepatitis B);05163(Human cytomegalovirus infection);05140(Leishmaniasis)",{"v":0.012,"d":"0.01"},1,"470,",0,-1.92,-1.35,7.56,"5' UTR",30,93681971,93683860,1890,2]
["X",94005427,94005606,180,"ENSBGRG00000016702","ENSBGRT00000030966",8790,"ZNF182","zinc finger protein 182 [Source:HGNC Symbol;Acc:HGNC:13001]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":8.9e-09,"d":"0.00"},1,"180,",0,-8.05,-7.24,2.19,"Exon (ENSBGRT00000030966/ENSBGRG00000016702, exon 7 of 7)",30,94005218,94014396,9179,2]
["X",94005666,94005725,60,"ENSBGRG00000016702","ENSBGRT00000030966",8671,"ZNF182","zinc finger protein 182 [Source:HGNC Symbol;Acc:HGNC:13001]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":3e-05,"d":"0.00"},1,"60,",0,-4.52,-3.82,2.07,"Exon (ENSBGRT00000030966/ENSBGRG00000016702, exon 7 of 7)",30,94005218,94014396,9179,2]
["X",94026665,94026725,61,"ENSBGRG00000016905","ENSBGRT00000031020",5040,"ENSBGRG00000016905","NA","NA","NA",{"v":0.00041,"d":"0.00"},1,"61,",0,-3.39,-2.74,6.48,"Exon (ENSBGRT00000031020/ENSBGRG00000016905, exon 2 of 2)",30,94026395,94031765,5371,2]
["X",94027415,94027625,211,"ENSBGRG00000016905","ENSBGRT00000031020",4140,"ENSBGRG00000016905","NA","NA","NA",{"v":0.00037,"d":"0.00"},1,"211,",0,-3.43,-2.77,8.64,"Exon (ENSBGRT00000031020/ENSBGRG00000016905, exon 2 of 2)",30,94026395,94031765,5371,2]
["X",94027954,94028434,481,"ENSBGRG00000016905","ENSBGRT00000031020",3331,"ENSBGRG00000016905","NA","NA","NA",{"v":7.6e-05,"d":"0.00"},1,"481,",0,-4.12,-3.43,{"v":17.3,"d":"17.30"},"Exon (ENSBGRT00000031020/ENSBGRG00000016905, exon 2 of 2)",30,94026395,94031765,5371,2]
["X",94028764,94029334,571,"ENSBGRG00000016905","ENSBGRT00000031020",2431,"ENSBGRG00000016905","NA","NA","NA",{"v":7.9e-07,"d":"0.00"},1,"571,",0,{"v":-6.1,"d":"-6.10"},-5.34,5.26,"Exon (ENSBGRT00000031020/ENSBGRG00000016905, exon 2 of 2)",30,94026395,94031765,5371,2]
["X",94196696,94198287,1592,"ENSBGRG00000017235","ENSBGRT00000032026",0,"SLC38A5","solute carrier family 38 member 5 [Source:HGNC Symbol;Acc:HGNC:18070]","GO:0005290(L-histidine transmembrane transporter activity);GO:0006868(glutamine transport);GO:0015182(L-asparagine transmembrane transporter activity);GO:0015186(L-glutamine transmembrane transporter activity);GO:0015187(glycine transmembrane transporter activity);GO:0015816(glycine transport);GO:0022858(alanine transmembrane transporter activity);GO:0022889(serine transmembrane transporter activity);GO:0032329(serine transport);GO:0089709(L-histidine transmembrane transport);GO:1903713(asparagine transmembrane transport);GO:1904557(L-alanine transmembrane transport)","04727(GABAergic synapse)",{"v":2.9E-4,"d":"0.00"},2,"484,205,","0,1387",-3.54,-2.87,{"v":15.1,"d":"15.10"},"5' UTR",30,94188969,94197179,8211,2]
["X",94767403,94767581,179,"ENSBGRG00000018827","ENSBGRT00000034550",4694,"KCND1","potassium voltage-gated channel subfamily D member 1 [Source:HGNC Symbol;Acc:HGNC:6237]","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005515(protein binding);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport)","NA",{"v":4e-26,"d":"0.00"},1,"179,",0,{"v":-25.4,"d":"-25.40"},{"v":-24.3,"d":"-24.30"},3.62,"Exon (ENSBGRT00000034550/ENSBGRG00000018827, exon 3 of 8)",30,94762591,94772275,9685,2]
["X",94769869,94773450,3582,"ENSBGRG00000018827","ENSBGRT00000034550",0,"KCND1","potassium voltage-gated channel subfamily D member 1 [Source:HGNC Symbol;Acc:HGNC:6237]","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005515(protein binding);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport)","NA",{"v":4.2e-06,"d":"0.00"},3,"33,481,260,","0,1926,3322",-5.38,-4.64,{"v":15.1,"d":"15.10"},"5' UTR",30,94762591,94772275,9685,2]
["X",94777812,94778994,1183,"ENSBGRG00000018956","ENSBGRT00000035769",20066,"GRIPAP1","GRIP1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:18706]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle)","04137(Mitophagy - animal);05202(Transcriptional misregulation in cancers);05211(Renal cell carcinoma)",{"v":6.2e-08,"d":"0.00"},2,"103,47,","0,1136",-7.21,-6.43,2.03,"3' UTR",30,94776055,94799060,23006,2]
["X",94785560,94785703,144,"ENSBGRG00000018956","ENSBGRT00000035769",13357,"GRIPAP1","GRIP1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:18706]","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle)","04137(Mitophagy - animal);05202(Transcriptional misregulation in cancers);05211(Renal cell carcinoma)",{"v":4e-17,"d":"0.00"},2,"34,26,","0,118",{"v":-16.4,"d":"-16.40"},{"v":-15.4,"d":"-15.40"},1.47,"Exon (ENSBGRT00000035769/ENSBGRG00000018956, exon 17 of 25)",30,94776055,94799060,23006,2]
["X",94815573,94816737,1165,"ENSBGRG00000019914","ENSBGRT00000036791",9184,"TFE3","transcription factor binding to IGHM enhancer 3 [Source:HGNC Symbol;Acc:HGNC:11752]","GO:0000978(RNA polymerase II cis-regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006959(humoral immune response);GO:0045670(regulation of osteoclast differentiation);GO:0045785(positive regulation of cell adhesion);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:1990837(sequence-specific double-stranded DNA binding)","04137(Mitophagy - animal);05202(Transcriptional misregulation in cancers);05211(Renal cell carcinoma)",{"v":1e-106,"d":"0.00"},2,"448,1,","0,1164",-106,-104,{"v":13.4,"d":"13.40"},"3' UTR",30,94814200,94825921,11722,2]
["X",94944885,94945454,570,"ENSBGRG00000021159","ENSBGRT00000039076",10788,"PRICKLE3","prickle planar cell polarity protein 3 [Source:HGNC Symbol;Acc:HGNC:6645]","GO:0008270(zinc ion binding)","04310(Wnt signaling pathway)",{"v":1E-155,"d":"0.00"},1,"570,",0,-155,-153,9.73,"3' UTR",30,94944076,94956242,12167,2]
["X",94958631,94958721,91,"ENSBGRG00000021237","ENSBGRT00000039236",12172,"SYP","synaptophysin [Source:HGNC Symbol;Acc:HGNC:11506]","GO:0008021(synaptic vesicle);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0042169(SH2 domain binding);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043195(terminal bouton);GO:0044306(neuron projection terminus);GO:0045202(synapse);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048488(synaptic vesicle endocytosis);GO:0048786(presynaptic active zone);GO:0060076(excitatory synapse);GO:0071310(cellular response to organic substance)","04122(Sulfur relay system)",{"v":3e-07,"d":"0.00"},1,"91,",0,-6.52,-5.75,{"v":22.7,"d":"22.70"},"3' UTR",30,94958242,94970893,12652,2]
["X",94958990,94959649,660,"ENSBGRG00000021237","ENSBGRT00000039236",11244,"SYP","synaptophysin [Source:HGNC Symbol;Acc:HGNC:11506]","GO:0008021(synaptic vesicle);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0042169(SH2 domain binding);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043195(terminal bouton);GO:0044306(neuron projection terminus);GO:0045202(synapse);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048488(synaptic vesicle endocytosis);GO:0048786(presynaptic active zone);GO:0060076(excitatory synapse);GO:0071310(cellular response to organic substance)","04122(Sulfur relay system)",{"v":1.6e-06,"d":"0.00"},1,"660,",0,-5.79,-5.04,{"v":21.6,"d":"21.60"},"3' UTR",30,94958242,94970893,12652,2]
["X",94970165,94970524,360,"ENSBGRG00000021237","ENSBGRT00000039236",369,"SYP","synaptophysin [Source:HGNC Symbol;Acc:HGNC:11506]","GO:0008021(synaptic vesicle);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0042169(SH2 domain binding);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043195(terminal bouton);GO:0044306(neuron projection terminus);GO:0045202(synapse);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048488(synaptic vesicle endocytosis);GO:0048786(presynaptic active zone);GO:0060076(excitatory synapse);GO:0071310(cellular response to organic substance)","04122(Sulfur relay system)",{"v":0.00056,"d":"0.00"},1,"360,",0,-3.25,{"v":-2.6,"d":"-2.60"},14,"5' UTR",30,94958242,94970893,12652,2]
["X",94978333,94978801,469,"ENSBGRG00000021471","ENSBGRT00000045644",31894,"CACNA1F","calcium voltage-gated channel subunit alpha1 F [Source:HGNC Symbol;Acc:HGNC:1393]","GO:0005216(ion channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0005891(voltage-gated calcium channel complex);GO:0006811(ion transport);GO:0007601(visual perception);GO:0008331(high voltage-gated calcium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043029(T cell homeostasis);GO:0050856(regulation of T cell receptor signaling pathway);GO:0050908(detection of light stimulus involved in visual perception);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport)","04010(MAPK signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04912(GnRH signaling pathway);04921(Oxytocin signaling pathway);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04727(GABAergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04723(Retrograde endocannabinoid signaling);05010(Alzheimer disease);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));04934(Cushing syndrome)",{"v":0.043,"d":"0.04"},2,"33,177,","0,292",-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000045644/ENSBGRG00000021471, exon 39 of 40)",30,94978064,95010695,32632,2]
["X",96285863,96286893,1031,"ENSBGRG00000025572","ENSBGRT00000047281",30,"ENSBGRG00000025572","NA","GO:0051015(actin filament binding)","NA",{"v":1.6E-27,"d":"0.00"},2,"37,84,","0,947",{"v":-26.8,"d":"-26.80"},{"v":-25.8,"d":"-25.80"},3.07,"Exon (ENSBGRT00000047281/ENSBGRG00000025572, exon 1 of 2)",30,96285654,96286923,1270,2]
["X",96995823,96995939,117,"ENSBGRG00000025627","ENSBGRT00000047379",175,"ENSBGRG00000025627","NA","GO:0016787(hydrolase activity)","NA",{"v":2e-13,"d":"0.00"},1,"117,",0,{"v":-12.7,"d":"-12.70"},{"v":-11.8,"d":"-11.80"},2.63,"Exon (ENSBGRT00000047379/ENSBGRG00000025627, exon 2 of 3)",30,96991862,96996114,4253,2]
["X",97231901,97232291,391,"ENSBGRG00000025638","ENSBGRT00000047400",1854,"GSPT2","G1 to S phase transition 2 [Source:HGNC Symbol;Acc:HGNC:4622]","GO:0003924(GTPase activity);GO:0005525(GTP binding)","03015(mRNA surveillance pathway)",{"v":1e-103,"d":"0.00"},1,"391,",0,-103,-101,4.63,"Exon (ENSBGRT00000047400/ENSBGRG00000025638, exon 3 of 3)",30,97231541,97234145,2605,2]
["X",97232567,97233197,631,"ENSBGRG00000025638","ENSBGRT00000047400",948,"GSPT2","G1 to S phase transition 2 [Source:HGNC Symbol;Acc:HGNC:4622]","GO:0003924(GTPase activity);GO:0005525(GTP binding)","03015(mRNA surveillance pathway)",{"v":1e-131,"d":"0.00"},1,"631,",0,-131,-129,6.27,"Exon (ENSBGRT00000047400/ENSBGRG00000025638, exon 2 of 3)",30,97231541,97234145,2605,2]
["X",98262206,98262432,227,"ENSBGRG00000025771","ENSBGRT00000047836",8241,"KDM5C","lysine demethylase 5C [Source:HGNC Symbol;Acc:HGNC:11114]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0045892(negative regulation of transcription, DNA-templated)","NA",{"v":6.3e-08,"d":"0.00"},2,"89,32,","0,195",{"v":-7.2,"d":"-7.20"},-6.42,1.37,"Exon (ENSBGRT00000047836/ENSBGRG00000025771, exon 6 of 28)",30,98238620,98270673,32054,2]
["X",98326524,98326624,101,"ENSBGRG00000025892","ENSBGRT00000047945",2321,"IQSEC2","IQ motif and Sec7 domain ArfGEF 2 [Source:HGNC Symbol;Acc:HGNC:29059]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0032012(regulation of ARF protein signal transduction);GO:0050804(modulation of chemical synaptic transmission);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098696(regulation of neurotransmitter receptor localization to postsynaptic specialization membrane)","04144(Endocytosis)",{"v":0.00018,"d":"0.00"},3,"31,38,22,","0,39,79",-3.75,-3.07,2.88,"Exon (ENSBGRT00000047945/ENSBGRG00000025892, exon 2 of 16)",30,98283184,98328945,45762,2]
["X",98373363,98373543,181,"ENSBGRG00000025892","ENSBGRT00000047926",509,"IQSEC2","IQ motif and Sec7 domain ArfGEF 2 [Source:HGNC Symbol;Acc:HGNC:29059]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0032012(regulation of ARF protein signal transduction);GO:0050804(modulation of chemical synaptic transmission);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098696(regulation of neurotransmitter receptor localization to postsynaptic specialization membrane)","04144(Endocytosis)",{"v":3e-05,"d":"0.00"},1,"181,",0,-4.53,-3.83,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000047926/ENSBGRG00000025892, exon 1 of 16)",30,98283184,98374052,90869,2]
["X",98455481,98465338,9858,"ENSBGRG00000025945","ENSBGRT00000048022",18222,"ENSBGRG00000025945","NA","NA","04110(Cell cycle);04114(Oocyte meiosis)",{"v":1.6E-49,"d":"0.00"},5,"36,138,142,107,57,","0,1045,5222,9596,9801",{"v":-48.8,"d":"-48.80"},{"v":-47.6,"d":"-47.60"},2.62,"Exon (ENSBGRT00000048022/ENSBGRG00000025945, exon 18 of 29)",30,98441200,98483560,42361,2]
["X",98468371,98471702,3332,"ENSBGRG00000025945","ENSBGRT00000048022",11858,"ENSBGRG00000025945","NA","NA","04110(Cell cycle);04114(Oocyte meiosis)",{"v":2.5e-28,"d":"0.00"},6,"106,83,23,17,122,9,","0,260,2945,3042,3149,3323",{"v":-27.6,"d":"-27.60"},{"v":-26.5,"d":"-26.50"},3.22,"Exon (ENSBGRT00000048022/ENSBGRG00000025945, exon 8 of 29)",30,98441200,98483560,42361,2]
["X",98634521,98635704,1184,"ENSBGRG00000026013","ENSBGRT00000048135",154812,"HUWE1","HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:30892]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006284(base-excision repair);GO:0006513(protein monoubiquitination);GO:0010637(negative regulation of mitochondrial fusion);GO:0016574(histone ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0032922(circadian regulation of gene expression);GO:0061630(ubiquitin protein ligase activity);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization)","04120(Ubiquitin mediated proteolysis)",{"v":1e-231,"d":"0.00"},2,"388,123,","0,1061",-231,-229,2.96,"Exon (ENSBGRT00000048135/ENSBGRG00000026013, exon 66 of 85)",30,98616053,98790516,174464,2]
["X",98647670,98650289,2620,"ENSBGRG00000026013","ENSBGRT00000048135",140227,"HUWE1","HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:30892]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006284(base-excision repair);GO:0006513(protein monoubiquitination);GO:0010637(negative regulation of mitochondrial fusion);GO:0016574(histone ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0032922(circadian regulation of gene expression);GO:0061630(ubiquitin protein ligase activity);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization)","04120(Ubiquitin mediated proteolysis)",{"v":4e-69,"d":"0.00"},4,"129,99,76,147,","0,717,1644,2473",{"v":-68.4,"d":"-68.40"},-67,2.21,"Exon (ENSBGRT00000048135/ENSBGRG00000026013, exon 50 of 85)",30,98616053,98790516,174464,2]
["X",99516328,99574715,58388,"ENSBGRG00000026090","ENSBGRT00000048250",0,"WNK3","WNK lysine deficient protein kinase 3 [Source:HGNC Symbol;Acc:HGNC:14543]","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005912(adherens junction);GO:0005923(bicellular tight junction);GO:0006468(protein phosphorylation);GO:0006884(cell volume homeostasis);GO:0007231(osmosensory signaling pathway);GO:0010765(positive regulation of sodium ion transport);GO:0010800(positive regulation of peptidyl-threonine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0019869(chloride channel inhibitor activity);GO:0032414(positive regulation of ion transmembrane transporter activity);GO:0035633(maintenance of permeability of blood-brain barrier);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0050801(ion homeostasis);GO:0051928(positive regulation of calcium ion transport);GO:0072659(protein localization to plasma membrane);GO:0090188(negative regulation of pancreatic juice secretion);GO:0090279(regulation of calcium ion import);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1904062(regulation of cation transmembrane transport);GO:2000651(positive regulation of sodium ion transmembrane transporter activity)","NA",{"v":0.0078,"d":"0.01"},7,"39,220,89,158,221,173,655,","0,11675,15409,26991,28015,28823,57733",-2.11,-1.27,9.72,"5' UTR",30,99395079,99574715,179637,2]
["X",102059514,102059604,91,"ENSBGRG00000008521","ENSBGRT00000015499",686,"ENSBGRG00000008521","NA","GO:0005634(nucleus);GO:0007276(gamete generation);GO:0051726(regulation of cell cycle)","NA",{"v":0.043,"d":"0.04"},1,"91,",0,-1.37,{"v":-0.604,"d":"-0.60"},4.32,"Exon (ENSBGRT00000015499/ENSBGRG00000008521, exon 1 of 1)",30,102059514,102060290,777,2]
["X",102204913,102205093,181,"ENSBGRG00000008637","ENSBGRT00000015784",158814,"HEPH","hephaestin [Source:HGNC Symbol;Acc:HGNC:4866]","GO:0004322(ferroxidase activity);GO:0005507(copper ion binding);GO:0005886(plasma membrane);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008198(ferrous iron binding);GO:0016323(basolateral plasma membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00860(Porphyrin and chlorophyll metabolism);04978(Mineral absorption)",{"v":2e-63,"d":"0.00"},1,"181,",0,{"v":-62.7,"d":"-62.70"},{"v":-61.4,"d":"-61.40"},{"v":5.5,"d":"5.50"},"3' UTR",30,102203240,102363907,160668,2]
["X",102692047,102697783,5737,"ENSBGRG00000009295","ENSBGRT00000017039",75296,"MSN","moesin [Source:HGNC Symbol;Acc:HGNC:7373]","GO:0001771(immunological synapse formation);GO:0001931(uropod);GO:0003725(double-stranded RNA binding);GO:0003779(actin binding);GO:0005102(signaling receptor binding);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0005925(focal adhesion);GO:0007159(leukocyte cell-cell adhesion);GO:0008092(cytoskeletal protein binding);GO:0008360(regulation of cell shape);GO:0008361(regulation of cell size);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0022612(gland morphogenesis);GO:0022614(membrane to membrane docking);GO:0030175(filopodium);GO:0031143(pseudopodium);GO:0042098(T cell proliferation);GO:0045177(apical part of cell);GO:0045198(establishment of epithelial cell apical/basal polarity);GO:0048471(perinuclear region of cytoplasm);GO:0050839(cell adhesion molecule binding);GO:0050900(leukocyte migration);GO:0061028(establishment of endothelial barrier);GO:0070489(T cell aggregation);GO:0071394(cellular response to testosterone stimulus);GO:0071437(invadopodium);GO:0071803(positive regulation of podosome assembly);GO:0071944(cell periphery);GO:0072678(T cell migration);GO:1902115(regulation of organelle assembly);GO:1902966(positive regulation of protein localization to early endosome);GO:1903364(positive regulation of cellular protein catabolic process);GO:2000401(regulation of lymphocyte migration);GO:2000643(positive regulation of early endosome to late endosome transport)","04530(Tight junction);04810(Regulation of actin cytoskeleton);04670(Leukocyte transendothelial migration);05205(Proteoglycans in cancer);05162(Measles)",{"v":0,"d":"0.00"},6,"131,93,161,131,84,1,","0,476,1750,2171,4717,5736",-315,-313,2.79,"Exon (ENSBGRT00000017039/ENSBGRG00000009295, exon 9 of 15)",30,102691033,102773079,82047,2]
["X",102997742,102997922,181,"ENSBGRG00000009366","ENSBGRT00000017339",35488,"LAS1L","LAS1 like ribosome biogenesis factor [Source:HGNC Symbol;Acc:HGNC:25726]","GO:0004519(endonuclease activity);GO:0006364(rRNA processing);GO:0071339(MLL1 complex);GO:0090730(Las1 complex)","NA",{"v":0.014,"d":"0.01"},1,"181,",0,-1.86,{"v":-1.3,"d":"-1.30"},7.56,"Exon (ENSBGRT00000017626/ENSBGRG00000009600, exon 6 of 6)",30,102962254,103009072,46819,1]
["X",102997982,102998341,360,"ENSBGRG00000009366","ENSBGRT00000017339",35728,"LAS1L","LAS1 like ribosome biogenesis factor [Source:HGNC Symbol;Acc:HGNC:25726]","GO:0004519(endonuclease activity);GO:0006364(rRNA processing);GO:0071339(MLL1 complex);GO:0090730(Las1 complex)","NA",{"v":0.015,"d":"0.02"},1,"360,",0,-1.83,-1.14,8.64,"Exon (ENSBGRT00000017626/ENSBGRG00000009600, exon 6 of 6)",30,102962254,103009072,46819,1]
["X",102999175,102999354,180,"ENSBGRG00000009366","ENSBGRT00000017339",36921,"LAS1L","LAS1 like ribosome biogenesis factor [Source:HGNC Symbol;Acc:HGNC:25726]","GO:0004519(endonuclease activity);GO:0006364(rRNA processing);GO:0071339(MLL1 complex);GO:0090730(Las1 complex)","NA",{"v":0.025,"d":"0.03"},1,"180,",0,-1.61,-1.07,6.48,"Exon (ENSBGRT00000017626/ENSBGRG00000009600, exon 5 of 6)",30,102962254,103009072,46819,1]
["X",103055158,103055338,181,"ENSBGRG00000009600","ENSBGRT00000017626",539,"ZC3H12B","zinc finger CCCH-type containing 12B [Source:HGNC Symbol;Acc:HGNC:17407]","GO:0046872(metal ion binding)","NA",{"v":2e-05,"d":"0.00"},1,"181,",0,{"v":-4.7,"d":"-4.70"},-3.99,8.28,"Exon (ENSBGRT00000017626/ENSBGRG00000009600, exon 1 of 6)",30,102997742,103055877,58136,2]
["X",103542879,103543418,540,"ENSBGRG00000009685","ENSBGRT00000017749",510,"ENSBGRG00000009685","NA","NA","NA",{"v":2.3E-3,"d":"0.00"},1,"540,",0,-2.63,-2.01,9.72,"Exon (ENSBGRT00000017749/ENSBGRG00000009685, exon 1 of 1)",30,103542879,103543928,1050,2]
["X",103543538,103543928,391,"ENSBGRG00000009685","ENSBGRT00000017749",0,"ENSBGRG00000009685","NA","NA","NA",{"v":0.00015,"d":"0.00"},1,"391,",0,-3.83,-3.15,{"v":16.2,"d":"16.20"},"Exon (ENSBGRT00000017749/ENSBGRG00000009685, exon 1 of 1)",30,103542879,103543928,1050,2]
["X",103542879,103543418,540,"ENSBGRG00000009685","ENSBGRT00000017749",510,"ENSBGRG00000009685","NA","NA","NA",{"v":2.3E-3,"d":"0.00"},1,"540,",0,-2.63,-2.01,9.72,"Exon (ENSBGRT00000017749/ENSBGRG00000009685, exon 1 of 1)",30,103542879,103543928,1050,2]
["X",103543538,103543928,391,"ENSBGRG00000009685","ENSBGRT00000017749",0,"ENSBGRG00000009685","NA","NA","NA",{"v":0.00015,"d":"0.00"},1,"391,",0,-3.83,-3.15,{"v":16.2,"d":"16.20"},"Exon (ENSBGRT00000017749/ENSBGRG00000009685, exon 1 of 1)",30,103542879,103543928,1050,2]
["X",104155300,104156476,1177,"ENSBGRG00000009820","ENSBGRT00000018051",288441,"MTMR8","myotubularin related protein 8 [Source:HGNC Symbol;Acc:HGNC:16825]","GO:0004438(phosphatidylinositol-3-phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0010506(regulation of autophagy);GO:0016311(dephosphorylation);GO:0046856(phosphatidylinositol dephosphorylation);GO:0052629(phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":0.014,"d":"0.01"},2,"416,49,","0,1128",-1.86,{"v":-1.3,"d":"-1.30"},6.48,"3' UTR",30,103866859,104181355,314497,1]
["X",105444946,105445064,119,"ENSBGRG00000010334","ENSBGRT00000019096",1758,"ENSBGRG00000010334","NA","NA","00340(Histidine metabolism)",{"v":4.9e-08,"d":"0.00"},1,"119,",0,-7.31,-6.52,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000019096/ENSBGRG00000010334, exon 5 of 5)",30,105444382,105446822,2441,2]
["X",105445747,105445806,60,"ENSBGRG00000010451","ENSBGRT00000019140",0,"ENSBGRG00000010451","NA","NA","NA",{"v":3.7e-06,"d":"0.00"},1,"60,",0,-5.43,{"v":-4.7,"d":"-4.70"},7.92,"Exon (ENSBGRT00000019140/ENSBGRG00000010451, exon 1 of 2)",30,105445752,105447570,1819,1]
["X",105445993,105446207,215,"ENSBGRG00000010334","ENSBGRT00000019096",615,"ENSBGRG00000010334","NA","NA","00340(Histidine metabolism)",{"v":0.0078,"d":"0.01"},2,"13,166,","0,49",-2.11,-1.53,8.64,"Exon (ENSBGRT00000019140/ENSBGRG00000010451, exon 1 of 2)",30,105444382,105446822,2441,2]
["X",105686934,105687770,837,"ENSBGRG00000010500","ENSBGRT00000019223",32756,"ENSBGRG00000010500","NA","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":1e-96,"d":"0.00"},1,"837,",0,-96,{"v":-94.4,"d":"-94.40"},5.94,"Exon (ENSBGRT00000019223/ENSBGRG00000010500, exon 5 of 5)",30,105686605,105720526,33922,2]
["X",107043257,107043615,359,"ENSBGRG00000010653","ENSBGRT00000021643",149878,"ENSBGRG00000010653","lysine demethylase 6A [Source:HGNC Symbol;Acc:HGNC:12637]","GO:0005515(protein binding)","05202(Transcriptional misregulation in cancers)",{"v":1e-132,"d":"0.00"},1,"359,",0,-132,-130,4.28,"Exon (ENSBGRT00000021643/ENSBGRG00000010653, exon 18 of 30)",30,107002280,107193493,191214,2]
["X",107043764,107048586,4823,"ENSBGRG00000010653","ENSBGRT00000021643",144907,"ENSBGRG00000010653","lysine demethylase 6A [Source:HGNC Symbol;Acc:HGNC:12637]","GO:0005515(protein binding)","05202(Transcriptional misregulation in cancers)",{"v":2.5E-100,"d":"0.00"},2,"133,346,","0,4477",{"v":-99.6,"d":"-99.60"},{"v":-97.9,"d":"-97.90"},4.71,"Exon (ENSBGRT00000021643/ENSBGRG00000010653, exon 17 of 30)",30,107002280,107193493,191214,2]
["X",111020951,111021279,329,"ENSBGRG00000015328","ENSBGRT00000033557",13291,"DDX3X","DEAD-box helicase 3 X-linked [Source:HGNC Symbol;Acc:HGNC:2745]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003678(DNA helicase activity);GO:0003723(RNA binding);GO:0003724(RNA helicase activity);GO:0003729(mRNA binding);GO:0003924(GTPase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005852(eukaryotic translation initiation factor 3 complex);GO:0005886(plasma membrane);GO:0006413(translational initiation);GO:0007059(chromosome segregation);GO:0008134(transcription factor binding);GO:0008143(poly(A) binding);GO:0008190(eukaryotic initiation factor 4E binding);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0009615(response to virus);GO:0010494(cytoplasmic stress granule);GO:0010501(RNA secondary structure unwinding);GO:0010628(positive regulation of gene expression);GO:0016055(Wnt signaling pathway);GO:0016887(ATPase activity);GO:0017111(nucleoside-triphosphatase activity);GO:0017148(negative regulation of translation);GO:0022627(cytosolic small ribosomal subunit);GO:0030307(positive regulation of cell growth);GO:0030308(negative regulation of cell growth);GO:0031252(cell leading edge);GO:0031333(negative regulation of protein-containing complex assembly);GO:0031369(translation initiation factor binding);GO:0031954(positive regulation of protein autophosphorylation);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0033592(RNA strand annealing activity);GO:0034063(stress granule assembly);GO:0034157(positive regulation of toll-like receptor 7 signaling pathway);GO:0034161(positive regulation of toll-like receptor 8 signaling pathway);GO:0035556(intracellular signal transduction);GO:0035613(RNA stem-loop binding);GO:0036493(positive regulation of translation in response to endoplasmic reticulum stress);GO:0042256(mature ribosome assembly);GO:0043015(gamma-tubulin binding);GO:0043024(ribosomal small subunit binding);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043273(CTPase activity);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043539(protein serine/threonine kinase activator activity);GO:0045070(positive regulation of viral genome replication);GO:0045087(innate immune response);GO:0045727(positive regulation of translation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045948(positive regulation of translational initiation);GO:0048027(mRNA 5'-UTR binding);GO:0055088(lipid homeostasis);GO:0071243(cellular response to arsenic-containing substance);GO:0071470(cellular response to osmotic stress);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0097193(intrinsic apoptotic signaling pathway);GO:0098586(cellular response to virus);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1901223(negative regulation of NIK/NF-kappaB signaling);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1901985(positive regulation of protein acetylation);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902523(positive regulation of protein K63-linked ubiquitination);GO:1903608(protein localization to cytoplasmic stress granule);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04622(RIG-I-like receptor signaling pathway);05203(Viral carcinogenesis);05161(Hepatitis B)",{"v":1e-116,"d":"0.00"},1,"329,",0,-116,-115,1.68,"3' UTR",30,111010406,111034570,24165,2]
["X",111149193,111149555,363,"ENSBGRG00000018694","ENSBGRT00000034455",90944,"USP9X","ubiquitin specific peptidase 9 X-linked [Source:HGNC Symbol;Acc:HGNC:12632]","GO:0001764(neuron migration);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0016579(protein deubiquitination);GO:0030426(growth cone);GO:0030509(BMP signaling pathway);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042752(regulation of circadian rhythm);GO:0048675(axon extension);GO:0050821(protein stabilization);GO:0070410(co-SMAD binding);GO:0071947(protein deubiquitination involved in ubiquitin-dependent protein catabolic process);GO:1901537(positive regulation of DNA demethylation);GO:1990380(Lys48-specific deubiquitinase activity)","NA",{"v":1.3E-18,"d":"0.00"},2,"85,6,","0,357",{"v":-17.9,"d":"-17.90"},{"v":-16.9,"d":"-16.90"},{"v":35.1,"d":"35.10"},"Exon (ENSBGRT00000034455/ENSBGRG00000018694, exon 46 of 47)",30,111149193,111240499,91307,2]
["X",111152057,111152607,551,"ENSBGRG00000018694","ENSBGRT00000034455",87892,"USP9X","ubiquitin specific peptidase 9 X-linked [Source:HGNC Symbol;Acc:HGNC:12632]","GO:0001764(neuron migration);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0016579(protein deubiquitination);GO:0030426(growth cone);GO:0030509(BMP signaling pathway);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042752(regulation of circadian rhythm);GO:0048675(axon extension);GO:0050821(protein stabilization);GO:0070410(co-SMAD binding);GO:0071947(protein deubiquitination involved in ubiquitin-dependent protein catabolic process);GO:1901537(positive regulation of DNA demethylation);GO:1990380(Lys48-specific deubiquitinase activity)","NA",{"v":1E-187,"d":"0.00"},2,"82,129,","0,422",-187,-185,6.07,"Exon (ENSBGRT00000034455/ENSBGRG00000018694, exon 44 of 47)",30,111149193,111240499,91307,2]
["X",111163604,111165389,1786,"ENSBGRG00000018694","ENSBGRT00000034455",75110,"USP9X","ubiquitin specific peptidase 9 X-linked [Source:HGNC Symbol;Acc:HGNC:12632]","GO:0001764(neuron migration);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0016579(protein deubiquitination);GO:0030426(growth cone);GO:0030509(BMP signaling pathway);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042752(regulation of circadian rhythm);GO:0048675(axon extension);GO:0050821(protein stabilization);GO:0070410(co-SMAD binding);GO:0071947(protein deubiquitination involved in ubiquitin-dependent protein catabolic process);GO:1901537(positive regulation of DNA demethylation);GO:1990380(Lys48-specific deubiquitinase activity)","NA",{"v":1e-149,"d":"0.00"},2,"606,23,","0,1763",-149,-147,6.05,"Exon (ENSBGRT00000034455/ENSBGRG00000018694, exon 35 of 47)",30,111149193,111240499,91307,2]
["X",113671432,113671642,211,"ENSBGRG00000021050","ENSBGRT00000038802",1889,"MID1IP1","MID1 interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:20715]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007026(negative regulation of microtubule depolymerization);GO:0008022(protein C-terminus binding);GO:0015630(microtubule cytoskeleton);GO:0042802(identical protein binding);GO:0045723(positive regulation of fatty acid biosynthetic process);GO:0051258(protein polymerization);GO:0051351(positive regulation of ligase activity)","NA",{"v":2e-88,"d":"0.00"},1,"211,",0,{"v":-87.7,"d":"-87.70"},{"v":-86.1,"d":"-86.10"},3.57,"Exon (ENSBGRT00000038802/ENSBGRG00000021050, exon 2 of 2)",30,113671372,113673531,2160,2]
["X",118661888,118663713,1826,"ENSBGRG00000008513","ENSBGRT00000015518",0,"ENSBGRG00000008513","NA","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","03040(Spliceosome);05168(Herpes simplex infection)",{"v":0.025,"d":"0.03"},3,"30,166,14,","0,1183,1812",-1.61,-1.07,7.56,"Exon (ENSBGRT00000015518/ENSBGRG00000008513, exon 1 of 3)",30,118661888,118663713,1826,2]
["X",121108273,121108361,89,"ENSBGRG00000008820","ENSBGRT00000016136",0,"ENSBGRG00000008820","NA","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","03040(Spliceosome);05168(Herpes simplex infection)",{"v":0.0041,"d":"0.00"},1,"89,",0,-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000016136/ENSBGRG00000008820, exon 1 of 1)",30,121107777,121108361,585,2]
["X",122987081,122989007,1927,"ENSBGRG00000010176","ENSBGRT00000019172",75294,"ENSBGRG00000010176","NA","GO:0004370(glycerol kinase activity);GO:0005975(carbohydrate metabolic process);GO:0006072(glycerol-3-phosphate metabolic process);GO:0016773(phosphotransferase activity, alcohol group as acceptor)","00561(Glycerolipid metabolism);03320(PPAR signaling pathway)",{"v":1.5E-3,"d":"0.00"},2,"109,12,","0,1915",-2.83,-2.21,2.66,"3' UTR",30,122986991,123064301,77311,2]
["X",129916025,129923436,7412,"ENSBGRG00000011903","ENSBGRT00000022455",538,"POLA1","DNA polymerase alpha 1, catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9173]","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005658(alpha DNA polymerase:primase complex);GO:0005829(cytosol);GO:0006260(DNA replication)","00230(Purine metabolism);00240(Pyrimidine metabolism);03030(DNA replication)",{"v":0.00022,"d":"0.00"},3,"48,125,67,","0,2472,7345",-3.65,-2.99,2.45,"5' UTR",30,129591579,129923974,332396,2]
["X",130494282,130494402,121,"ENSBGRG00000013130","ENSBGRT00000024173",15793,"ZFX","zinc finger protein X-linked [Source:HGNC Symbol;Acc:HGNC:12869]","GO:0001541(ovarian follicle development);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0009566(fertilization);GO:0009791(post-embryonic development);GO:0035264(multicellular organism growth);GO:0046872(metal ion binding);GO:0048599(oocyte development);GO:0048872(homeostasis of number of cells);GO:0060746(parental behavior)","NA",{"v":4e-46,"d":"0.00"},1,"121,",0,{"v":-45.4,"d":"-45.40"},{"v":-44.1,"d":"-44.10"},5.56,"Exon (ENSBGRT00000024173/ENSBGRG00000013130, exon 7 of 8)",30,130493202,130510195,16994,2]
["X",130494551,130497062,2512,"ENSBGRG00000013130","ENSBGRT00000024173",13133,"ZFX","zinc finger protein X-linked [Source:HGNC Symbol;Acc:HGNC:12869]","GO:0001541(ovarian follicle development);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0009566(fertilization);GO:0009791(post-embryonic development);GO:0035264(multicellular organism growth);GO:0046872(metal ion binding);GO:0048599(oocyte development);GO:0048872(homeostasis of number of cells);GO:0060746(parental behavior)","NA",{"v":6.3e-66,"d":"0.00"},2,"346,45,","0,2467",{"v":-65.2,"d":"-65.20"},{"v":-63.7,"d":"-63.70"},5.97,"Exon (ENSBGRT00000024173/ENSBGRG00000013130, exon 6 of 8)",30,130493202,130510195,16994,2]
["X",133079867,133080818,952,"ENSBGRG00000009064","ENSBGRT00000016882",25518,"MBTPS2","membrane bound transcription factor peptidase, site 2 [Source:HGNC Symbol;Acc:HGNC:15455]","GO:0004222(metalloendopeptidase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0016020(membrane);GO:0031293(membrane protein intracellular domain proteolysis);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0070977(bone maturation);GO:1990440(positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04141(Protein processing in endoplasmic reticulum)",{"v":6.3e-61,"d":"0.00"},2,"320,34,","0,918",{"v":-60.2,"d":"-60.20"},{"v":-58.9,"d":"-58.90"},7.64,"Exon (ENSBGRT00000017019/ENSBGRG00000009234, exon 1 of 2)",30,133054450,133106336,51887,2]
["X",133410980,133411100,121,"ENSBGRG00000009403","ENSBGRT00000017518",206801,"CNKSR2","connector enhancer of kinase suppressor of Ras 2 [Source:HGNC Symbol;Acc:HGNC:19701]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0009966(regulation of signal transduction);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0019901(protein kinase binding);GO:0035556(intracellular signal transduction)","NA",{"v":0.016,"d":"0.02"},1,"121,",0,-1.79,-1.24,1.74,"Exon (ENSBGRT00000017518/ENSBGRG00000009403, exon 13 of 22)",30,133307182,133617901,310720,2]
["X",133617543,133617901,359,"ENSBGRG00000009403","ENSBGRT00000017518",0,"CNKSR2","connector enhancer of kinase suppressor of Ras 2 [Source:HGNC Symbol;Acc:HGNC:19701]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0009966(regulation of signal transduction);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0019901(protein kinase binding);GO:0035556(intracellular signal transduction)","NA",{"v":0.028,"d":"0.03"},1,"359,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"5' UTR",30,133307182,133617901,310720,2]
["X",135651121,135651716,596,"ENSBGRG00000014128","ENSBGRT00000026657",22284,"PDHA1","pyruvate dehydrogenase E1 alpha 1 subunit [Source:HGNC Symbol;Acc:HGNC:8806]","GO:0004739(pyruvate dehydrogenase (acetyl-transferring) activity);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0006086(acetyl-CoA biosynthetic process from pyruvate);GO:0016624(oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor);GO:0043231(intracellular membrane-bounded organelle);GO:0045254(pyruvate dehydrogenase complex)","00010(Glycolysis / Gluconeogenesis);00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);04066(HIF-1 signaling pathway);04922(Glucagon signaling pathway);05230(Central carbon metabolism in cancer)",{"v":9.99999999999998E-281,"d":"0.00"},1,"596,",0,-280,-277,4.43,"3' UTR",30,135651062,135674000,22939,2]
["Y",1946041,1947356,1316,"ENSBGRG00000016807","ENSBGRT00000030832",4709,"ENSBGRG00000016807","NA","NA","NA",{"v":0.028,"d":"0.03"},1,"1316,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000030832/ENSBGRG00000016807, exon 3 of 3)",31,1941332,1947834,6503,1]
["Y",1947595,1947834,240,"ENSBGRG00000016807","ENSBGRT00000030832",6263,"ENSBGRG00000016807","NA","NA","NA",{"v":0.028,"d":"0.03"},1,"240,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"Exon (ENSBGRT00000030832/ENSBGRG00000016807, exon 3 of 3)",31,1941332,1947834,6503,1]
["Y",2481342,2481432,91,"ENSBGRG00000017134","ENSBGRT00000031412",925,"ENSBGRG00000017134","NA","NA","NA",{"v":3.7e-05,"d":"0.00"},1,"91,",0,-4.43,-3.72,5.13,"Exon (ENSBGRT00000031412/ENSBGRG00000017134, exon 1 of 2)",31,2480417,2486697,6281,1]
["Y",2482787,2482846,60,"ENSBGRG00000017134","ENSBGRT00000031412",2370,"ENSBGRG00000017134","NA","NA","NA",0.04,1,"60,",0,{"v":-1.4,"d":"-1.40"},{"v":-0.872,"d":"-0.87"},2.52,"Exon (ENSBGRT00000031412/ENSBGRG00000017134, exon 2 of 2)",31,2480417,2486697,6281,1]
["Y",3095213,3095510,298,"ENSBGRG00000017194","ENSBGRT00000031611",60697,"PNPLA4","patatin like phospholipase domain containing 4 [Source:HGNC Symbol;Acc:HGNC:24887]","GO:0004806(triglyceride lipase activity);GO:0005739(mitochondrion);GO:0006629(lipid metabolic process);GO:0016042(lipid catabolic process);GO:0016787(hydrolase activity);GO:0050253(retinyl-palmitate esterase activity)","00830(Retinol metabolism)",{"v":0.0011,"d":"0.00"},1,"298,",0,-2.96,-2.33,13,"3' UTR",31,3034516,3095510,60995,1]
["Y",3920002,3930286,10285,"ENSBGRG00000017714","ENSBGRT00000032490",70137,"ENSBGRG00000017714","NA","GO:0016787(hydrolase activity)","NA",{"v":2.8e-06,"d":"0.00"},2,"13,48,","0,10237",-5.56,-4.82,2.91,"3' UTR",31,3849865,3920014,70150,1]
["Y",5088193,5088433,241,"ENSBGRG00000017805","ENSBGRT00000032748",410468,"ENSBGRG00000017805","NA","GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0016020(membrane);GO:0042043(neurexin family protein binding);GO:0045202(synapse);GO:0050808(synapse organization)","04514(Cell adhesion molecules (CAMs))",{"v":0.00022,"d":"0.00"},1,"241,",0,-3.66,-2.99,4.97,"Exon (ENSBGRT00000032748/ENSBGRG00000017805, exon 6 of 7)",31,4677725,5102679,424955,1]
["Y",5102410,5102679,270,"ENSBGRG00000017805","ENSBGRT00000032748",424685,"ENSBGRG00000017805","NA","GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0016020(membrane);GO:0042043(neurexin family protein binding);GO:0045202(synapse);GO:0050808(synapse organization)","04514(Cell adhesion molecules (CAMs))",{"v":0.00021,"d":"0.00"},1,"270,",0,-3.68,-3.01,{"v":15.1,"d":"15.10"},"3' UTR",31,4677725,5102679,424955,1]
["Y",7526605,7526755,151,"ENSBGRG00000019175","ENSBGRT00000035211",176500,"ENSBGRG00000019175","dehydrogenase/reductase X-linked [Source:HGNC Symbol;Acc:HGNC:18399]","GO:0016491(oxidoreductase activity)","NA",{"v":7.9e-14,"d":"0.00"},1,"151,",0,{"v":-13.1,"d":"-13.10"},{"v":-12.2,"d":"-12.20"},{"v":3.8,"d":"3.80"},"3' UTR",31,7350105,7527273,177169,1]
["Y",7920802,7921866,1065,"ENSBGRG00000019508","ENSBGRT00000035846",0,"P2RY8","P2Y receptor family member 8 [Source:HGNC Symbol;Acc:HGNC:15524]","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0045028(G protein-coupled purinergic nucleotide receptor activity)","04080(Neuroactive ligand-receptor interaction)",{"v":2.9E-4,"d":"0.00"},1,"1065,",0,-3.54,-2.87,{"v":15.1,"d":"15.10"},"Exon (ENSBGRT00000035846/ENSBGRG00000019508, exon 1 of 1)",31,7920802,7921866,1065,1]
["Y",8778446,8779723,1278,"ENSBGRG00000007868","ENSBGRT00000014467",17615,"GTPBP6","GTP binding protein 6 (putative) [Source:HGNC Symbol;Acc:HGNC:30189]","GO:0005525(GTP binding)","00250(Alanine, aspartate and glutamate metabolism)",{"v":1E-153,"d":"0.00"},2,"600,58,","0,1220",-153,-151,4.69,"3' UTR",31,8760831,8779045,18215,1]
["Y",10176924,10177425,502,"ENSBGRG00000008725","ENSBGRT00000015941",787,"ENSBGRG00000008725","NA","GO:0005634(nucleus);GO:0006351(transcription, DNA-templated)","NA",{"v":1.3e-52,"d":"0.00"},3,"179,13,222,","0,214,280",{"v":-51.9,"d":"-51.90"},{"v":-50.6,"d":"-50.60"},7.25,"Exon (ENSBGRT00000015941/ENSBGRG00000008725, exon 2 of 4)",31,10176137,10177425,1289,1]
["Y",10223080,10223455,376,"ENSBGRG00000008766","ENSBGRT00000016019",115,"RAB9A","RAB9A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9792]","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005764(lysosome);GO:0005770(late endosome);GO:0019003(GDP binding);GO:0030659(cytoplasmic vesicle membrane);GO:0032482(Rab protein signal transduction);GO:0032880(regulation of protein localization);GO:0042470(melanosome);GO:0042802(identical protein binding);GO:0045335(phagocytic vesicle);GO:0045921(positive regulation of exocytosis);GO:0052405(negative regulation by host of symbiont molecular function)","05162(Measles)",{"v":2e-82,"d":"0.00"},1,"376,",0,{"v":-81.7,"d":"-81.70"},{"v":-80.2,"d":"-80.20"},5.85,"Exon (ENSBGRT00000016019/ENSBGRG00000008766, exon 1 of 1)",31,10222965,10223570,606,1]
["Y",10280334,10282218,1885,"ENSBGRG00000008898","ENSBGRT00000017127",34295,"ENSBGRG00000008898","NA","GO:0005515(protein binding)","NA",{"v":0.025,"d":"0.03"},2,"16,74,","0,1811",-1.61,-1.07,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000017127/ENSBGRG00000008898, exon 9 of 25)",31,10246039,10316103,70065,1]
["Y",12494943,12495093,151,"ENSBGRG00000012055","ENSBGRT00000022103",7612,"CA5B","carbonic anhydrase 5B [Source:HGNC Symbol;Acc:HGNC:1378]","GO:0004089(carbonate dehydratase activity);GO:0005739(mitochondrion);GO:0008270(zinc ion binding);GO:0009617(response to bacterium)","00910(Nitrogen metabolism)",{"v":2e-05,"d":"0.00"},1,"151,",0,{"v":-4.7,"d":"-4.70"},-3.99,8.28,"3' UTR",31,12487331,12495150,7820,1]
["Y",12495824,12498766,2943,"ENSBGRG00000012055","ENSBGRT00000022046",8493,"CA5B","carbonic anhydrase 5B [Source:HGNC Symbol;Acc:HGNC:1378]","GO:0004089(carbonate dehydratase activity);GO:0005739(mitochondrion);GO:0008270(zinc ion binding);GO:0009617(response to bacterium)","00910(Nitrogen metabolism)",{"v":1.3E-39,"d":"0.00"},2,"196,104,","0,2839",{"v":-38.9,"d":"-38.90"},{"v":-37.7,"d":"-37.70"},3.67,"Exon (ENSBGRT00000022046/ENSBGRG00000012055, exon 2 of 7)",31,12487331,12505173,17843,1]
["Y",12512086,12527663,15578,"ENSBGRG00000012125","ENSBGRT00000022170",0,"ENSBGRG00000012125","zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 [Source:HGNC Symbol;Acc:HGNC:23019]","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0046872(metal ion binding);GO:0089701(U2AF)","03040(Spliceosome)",{"v":1E-136,"d":"0.00"},7,"384,80,91,109,87,39,68,","0,774,4321,9575,10976,14883,15510",-136,-134,6.09,"5' UTR",31,12512086,12538082,25997,1]
["Y",12537843,12538082,240,"ENSBGRG00000012125","ENSBGRT00000022170",25757,"ENSBGRG00000012125","zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 [Source:HGNC Symbol;Acc:HGNC:23019]","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0046872(metal ion binding);GO:0089701(U2AF)","03040(Spliceosome)",{"v":1e-114,"d":"0.00"},2,"210,27,","0,213",-114,-112,6.54,"Exon (ENSBGRT00000022170/ENSBGRG00000012125, exon 11 of 12)",31,12512086,12538082,25997,1]
["Y",13565373,13565432,60,"ENSBGRG00000012637","ENSBGRT00000023254",18229,"SYAP1","synapse associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16273]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0030424(axon);GO:0030425(dendrite);GO:0030426(growth cone);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032869(cellular response to insulin stimulus);GO:0036120(cellular response to platelet-derived growth factor stimulus);GO:0038203(TORC2 signaling);GO:0042734(presynaptic membrane);GO:0043204(perikaryon);GO:0045211(postsynaptic membrane);GO:0045600(positive regulation of fat cell differentiation);GO:0048471(perinuclear region of cytoplasm);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:1990314(cellular response to insulin-like growth factor stimulus)","NA",{"v":0.00028,"d":"0.00"},1,"60,",0,-3.56,{"v":-2.9,"d":"-2.90"},4.54,"Exon (ENSBGRT00000023254/ENSBGRG00000012637, exon 10 of 10)",31,13547144,13565432,18289,1]
["Y",13642649,13654850,12202,"ENSBGRG00000012780","ENSBGRT00000023592",31014,"TXLNG","taxilin gamma [Source:HGNC Symbol;Acc:HGNC:18578]","GO:0005829(cytosol);GO:0008134(transcription factor binding);GO:0010564(regulation of cell cycle process);GO:0019905(syntaxin binding);GO:0030500(regulation of bone mineralization);GO:0031965(nuclear membrane);GO:0033613(activating transcription factor binding);GO:0051726(regulation of cell cycle)","NA",{"v":1e-21,"d":"0.00"},6,"95,120,75,93,96,25,","0,2604,4341,9602,11225,12177",-21,-20,2.48,"Exon (ENSBGRT00000023592/ENSBGRG00000012780, exon 5 of 10)",31,13611635,13655116,43482,1]
["Y",14760400,14760850,451,"ENSBGRG00000014125","ENSBGRT00000026136",400172,"NHS","NHS actin remodeling regulator [Source:HGNC Symbol;Acc:HGNC:7820]","GO:0002088(lens development in camera-type eye);GO:0005794(Golgi apparatus);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030154(cell differentiation)","NA",{"v":3.2e-17,"d":"0.00"},1,"451,",0,{"v":-16.5,"d":"-16.50"},{"v":-15.5,"d":"-15.50"},4.37,"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 7 of 11)",31,14360228,14767640,407413,1]
["Y",14761060,14761811,752,"ENSBGRG00000014125","ENSBGRT00000026136",400832,"NHS","NHS actin remodeling regulator [Source:HGNC Symbol;Acc:HGNC:7820]","GO:0002088(lens development in camera-type eye);GO:0005794(Golgi apparatus);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030154(cell differentiation)","NA",{"v":1E-35,"d":"0.00"},2,"728,22,","0,730",-35,{"v":-33.8,"d":"-33.80"},4.84,"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 7 of 11)",31,14360228,14767640,407413,1]
["Y",14761901,14763057,1157,"ENSBGRG00000014125","ENSBGRT00000026136",401673,"NHS","NHS actin remodeling regulator [Source:HGNC Symbol;Acc:HGNC:7820]","GO:0002088(lens development in camera-type eye);GO:0005794(Golgi apparatus);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030154(cell differentiation)","NA",{"v":2.5e-39,"d":"0.00"},2,"65,116,","0,1041",{"v":-38.6,"d":"-38.60"},{"v":-37.4,"d":"-37.40"},5.76,"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 8 of 11)",31,14360228,14767640,407413,1]
["Y",14767130,14767340,211,"ENSBGRG00000014125","ENSBGRT00000026136",406902,"NHS","NHS actin remodeling regulator [Source:HGNC Symbol;Acc:HGNC:7820]","GO:0002088(lens development in camera-type eye);GO:0005794(Golgi apparatus);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030154(cell differentiation)","NA",{"v":7.9e-31,"d":"0.00"},1,"211,",0,{"v":-30.1,"d":"-30.10"},{"v":-28.9,"d":"-28.90"},5.01,"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 11 of 11)",31,14360228,14767640,407413,1]
["Y",14767490,14767640,151,"ENSBGRG00000014125","ENSBGRT00000026136",407262,"NHS","NHS actin remodeling regulator [Source:HGNC Symbol;Acc:HGNC:7820]","GO:0002088(lens development in camera-type eye);GO:0005794(Golgi apparatus);GO:0016604(nuclear body);GO:0030054(cell junction);GO:0030154(cell differentiation)","NA",{"v":5e-23,"d":"0.00"},1,"151,",0,{"v":-22.3,"d":"-22.30"},{"v":-21.3,"d":"-21.30"},7.06,"Exon (ENSBGRT00000026136/ENSBGRG00000014125, exon 11 of 11)",31,14360228,14767640,407413,1]
["Y",14787534,14788272,739,"ENSBGRG00000014390","ENSBGRT00000026401",111836,"RAI2","retinoic acid induced 2 [Source:HGNC Symbol;Acc:HGNC:9835]","NA","NA",{"v":7.9e-22,"d":"0.00"},2,"58,299,","0,440",{"v":-21.1,"d":"-21.10"},{"v":-20.1,"d":"-20.10"},2.49,"Exon (ENSBGRT00000026503/ENSBGRG00000014444, exon 4 of 7)",31,14751100,14900108,149009,2]
["Y",15761578,15761738,161,"ENSBGRG00000014796","ENSBGRT00000028536",32492,"CDKL5","cyclin dependent kinase like 5 [Source:HGNC Symbol;Acc:HGNC:11411]","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005813(centrosome);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0036064(ciliary basal body);GO:0046777(protein autophosphorylation);GO:0097542(ciliary tip);GO:1902017(regulation of cilium assembly)","NA",{"v":0.043,"d":"0.04"},2,"105,16,","0,145",-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000028536/ENSBGRG00000014796, exon 10 of 17)",31,15729086,15786225,57140,1]
["Y",18157399,18157758,360,"ENSBGRG00000018169","ENSBGRT00000034323",842144,"FRMPD4","FERM and PDZ domain containing 4 [Source:HGNC Symbol;Acc:HGNC:29007]","GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005856(cytoskeleton);GO:0032991(protein-containing complex);GO:0043197(dendritic spine);GO:0051835(positive regulation of synapse structural plasticity)","NA",{"v":0.0041,"d":"0.00"},1,"360,",0,-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000034323/ENSBGRG00000018169, exon 15 of 19)",31,17315255,18162769,847515,1]
["Y",18157968,18159010,1043,"ENSBGRG00000018169","ENSBGRT00000034323",842713,"FRMPD4","FERM and PDZ domain containing 4 [Source:HGNC Symbol;Acc:HGNC:29007]","GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005856(cytoskeleton);GO:0032991(protein-containing complex);GO:0043197(dendritic spine);GO:0051835(positive regulation of synapse structural plasticity)","NA",{"v":0.0078,"d":"0.01"},2,"227,462,","0,581",-2.11,-1.27,9.72,"Exon (ENSBGRT00000034323/ENSBGRG00000018169, exon 15 of 19)",31,17315255,18162769,847515,1]
["Y",18161976,18162305,330,"ENSBGRG00000018169","ENSBGRT00000034323",846721,"FRMPD4","FERM and PDZ domain containing 4 [Source:HGNC Symbol;Acc:HGNC:29007]","GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005856(cytoskeleton);GO:0032991(protein-containing complex);GO:0043197(dendritic spine);GO:0051835(positive regulation of synapse structural plasticity)","NA",0.04,1,"330,",0,{"v":-1.4,"d":"-1.40"},{"v":-0.872,"d":"-0.87"},4.32,"3' UTR",31,17315255,18162769,847515,1]
["Y",18300665,18300962,298,"ENSBGRG00000019181","ENSBGRT00000035241",15462,"TLR7","toll like receptor 7 [Source:HGNC Symbol;Acc:HGNC:15631]","GO:0001932(regulation of protein phosphorylation);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007252(I-kappaB phosphorylation);GO:0016021(integral component of membrane);GO:0032009(early phagosome);GO:0032722(positive regulation of chemokine production);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032729(positive regulation of interferon-gamma production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0034154(toll-like receptor 7 signaling pathway);GO:0035197(siRNA binding);GO:0043235(receptor complex);GO:0051607(defense response to virus);GO:0071260(cellular response to mechanical stimulus);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04620(Toll-like receptor signaling pathway);05162(Measles);05164(Influenza A)",{"v":9.5E-4,"d":"0.00"},1,"298,",0,-3.02,-2.38,3.96,"Exon (ENSBGRT00000035241/ENSBGRG00000019181, exon 2 of 2)",31,18285203,18303404,18202,1]
["Y",18302153,18302392,240,"ENSBGRG00000019181","ENSBGRT00000035241",16950,"TLR7","toll like receptor 7 [Source:HGNC Symbol;Acc:HGNC:15631]","GO:0001932(regulation of protein phosphorylation);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007252(I-kappaB phosphorylation);GO:0016021(integral component of membrane);GO:0032009(early phagosome);GO:0032722(positive regulation of chemokine production);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032729(positive regulation of interferon-gamma production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0034154(toll-like receptor 7 signaling pathway);GO:0035197(siRNA binding);GO:0043235(receptor complex);GO:0051607(defense response to virus);GO:0071260(cellular response to mechanical stimulus);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04620(Toll-like receptor signaling pathway);05162(Measles);05164(Influenza A)",{"v":9.8e-06,"d":"0.00"},1,"240,",0,-5.01,-4.29,{"v":20.5,"d":"20.50"},"Exon (ENSBGRT00000035241/ENSBGRG00000019181, exon 2 of 2)",31,18285203,18303404,18202,1]
["Y",18343103,18343462,360,"ENSBGRG00000019302","ENSBGRT00000035414",298,"ENSBGRG00000019302","NA","NA","04620(Toll-like receptor signaling pathway)",{"v":0.0041,"d":"0.00"},2,"125,233,","0,127",-2.39,-1.79,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000035414/ENSBGRG00000019302, exon 1 of 2)",31,18342805,18345905,3101,1]
["Y",18343760,18344058,299,"ENSBGRG00000019302","ENSBGRT00000035414",955,"ENSBGRG00000019302","NA","NA","04620(Toll-like receptor signaling pathway)",{"v":0.014,"d":"0.01"},1,"299,",0,-1.86,{"v":-1.3,"d":"-1.30"},7.56,"Exon (ENSBGRT00000035414/ENSBGRG00000019302, exon 2 of 2)",31,18342805,18345905,3101,1]
["Y",18345488,18345667,180,"ENSBGRG00000019302","ENSBGRT00000035414",2683,"ENSBGRG00000019302","NA","NA","04620(Toll-like receptor signaling pathway)",{"v":7.8e-08,"d":"0.00"},1,"180,",0,-7.11,-6.33,{"v":28.1,"d":"28.10"},"Exon (ENSBGRT00000035414/ENSBGRG00000019302, exon 2 of 2)",31,18342805,18345905,3101,1]
["Y",18345786,18345905,120,"ENSBGRG00000019302","ENSBGRT00000035414",2981,"ENSBGRG00000019302","NA","NA","04620(Toll-like receptor signaling pathway)",{"v":1.1E-4,"d":"0.00"},1,"120,",0,-3.97,-3.29,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000035414/ENSBGRG00000019302, exon 2 of 2)",31,18342805,18345905,3101,1]
["Y",7122200,7122260,61,"ENSBGRG00000018584","ENSBGRT00000034448",57803,"ENSBGRG00000018584","NA","GO:0016757(transferase activity, transferring glycosyl groups)","00500(Starch and sucrose metabolism)",{"v":0.00069,"d":"0.00"},1,"61,",0,-3.16,-2.51,13,"Exon (ENSBGRT00000034448/ENSBGRG00000018584, exon 12 of 12)",31,7122200,7180063,57864,2]
["Y",7158854,7163336,4483,"ENSBGRG00000018584","ENSBGRT00000034448",16727,"ENSBGRG00000018584","NA","GO:0016757(transferase activity, transferring glycosyl groups)","00500(Starch and sucrose metabolism)",{"v":0.0055,"d":"0.01"},2,"38,53,","0,4430",-2.26,-1.67,1.63,"Exon (ENSBGRT00000034448/ENSBGRG00000018584, exon 8 of 12)",31,7122200,7180063,57864,2]
["Y",7190919,7191395,477,"ENSBGRG00000019017","ENSBGRT00000034857",37553,"ENSBGRG00000019017","NA","NA","00500(Starch and sucrose metabolism)",{"v":9.99999999999999e-223,"d":"0.00"},1,"477,",0,-222,-220,9.08,"3' UTR",31,7190919,7228948,38030,2]
["Y",7191632,7192108,477,"ENSBGRG00000019017","ENSBGRT00000034857",36840,"ENSBGRG00000019017","NA","NA","00500(Starch and sucrose metabolism)",{"v":5e-14,"d":"0.00"},1,"477,",0,{"v":-13.3,"d":"-13.30"},{"v":-12.4,"d":"-12.40"},1.96,"3' UTR",31,7190919,7228948,38030,2]
["Y",7192405,7192465,61,"ENSBGRG00000019017","ENSBGRT00000034857",36483,"ENSBGRG00000019017","NA","NA","00500(Starch and sucrose metabolism)",{"v":2.5e-27,"d":"0.00"},1,"61,",0,{"v":-26.6,"d":"-26.60"},{"v":-25.6,"d":"-25.60"},3.94,"3' UTR",31,7190919,7228948,38030,2]
["Y",7192643,7196351,3709,"ENSBGRG00000019017","ENSBGRT00000034857",32597,"ENSBGRG00000019017","NA","NA","00500(Starch and sucrose metabolism)",{"v":6.3e-45,"d":"0.00"},3,"95,111,33,","0,1244,3676",{"v":-44.2,"d":"-44.20"},-43,4.31,"3' UTR",31,7190919,7228948,38030,2]
["Y",7236432,7236641,210,"ENSBGRG00000019127","ENSBGRT00000035103",29377,"CD99","CD99 molecule (Xg blood group) [Source:HGNC Symbol;Acc:HGNC:7082]","NA","04514(Cell adhesion molecules (CAMs));04670(Leukocyte transendothelial migration)",0,1,"210,",0,-4070,"-Inf",7.22,"3' UTR",31,7236432,7266018,29587,2]
["Y",7236790,7237029,240,"ENSBGRG00000019127","ENSBGRT00000035103",28989,"CD99","CD99 molecule (Xg blood group) [Source:HGNC Symbol;Acc:HGNC:7082]","NA","04514(Cell adhesion molecules (CAMs));04670(Leukocyte transendothelial migration)",0,1,"240,",0,-949,"-Inf",3.36,"3' UTR",31,7236432,7266018,29587,2]
["Y",7784008,7784245,238,"ENSBGRG00000019382","ENSBGRT00000035601",32102,"ASMT","acetylserotonin O-methyltransferase [Source:HGNC Symbol;Acc:HGNC:750]","GO:0008168(methyltransferase activity);GO:0008171(O-methyltransferase activity);GO:0016740(transferase activity);GO:0017096(acetylserotonin O-methyltransferase activity);GO:0030187(melatonin biosynthetic process);GO:0032259(methylation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity)","00380(Tryptophan metabolism)",{"v":0.028,"d":"0.03"},1,"238,",0,-1.56,{"v":-0.771,"d":"-0.77"},7.56,"3' UTR",31,7783831,7816347,32517,2]
["Y",7830917,7831782,866,"ENSBGRG00000019461","ENSBGRT00000035765",11185,"AKAP17A","A-kinase anchoring protein 17A [Source:HGNC Symbol;Acc:HGNC:18783]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0043484(regulation of RNA splicing);GO:0051018(protein kinase A binding)","NA",{"v":0.0078,"d":"0.01"},3,"34,206,1,","0,599,865",-2.11,-1.27,9.72,"Exon (ENSBGRT00000035765/ENSBGRG00000019461, exon 5 of 7)",31,7830647,7842967,12321,2]
["Y",7834266,7837616,3351,"ENSBGRG00000019461","ENSBGRT00000035765",5351,"AKAP17A","A-kinase anchoring protein 17A [Source:HGNC Symbol;Acc:HGNC:18783]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0043484(regulation of RNA splicing);GO:0051018(protein kinase A binding)","NA",{"v":7.9e-32,"d":"0.00"},2,"230,41,","0,3310",{"v":-31.1,"d":"-31.10"},-30,4.71,"Exon (ENSBGRT00000035765/ENSBGRG00000019461, exon 3 of 7)",31,7830647,7842967,12321,2]
["Y",7838804,7839103,300,"ENSBGRG00000019461","ENSBGRT00000035765",3864,"AKAP17A","A-kinase anchoring protein 17A [Source:HGNC Symbol;Acc:HGNC:18783]","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0043484(regulation of RNA splicing);GO:0051018(protein kinase A binding)","NA",{"v":2.5E-71,"d":"0.00"},1,"300,",0,{"v":-70.6,"d":"-70.60"},{"v":-69.1,"d":"-69.10"},{"v":5.1,"d":"5.10"},"Exon (ENSBGRT00000035765/ENSBGRG00000019461, exon 2 of 7)",31,7830647,7842967,12321,2]
["Y",8072389,8072597,209,"ENSBGRG00000007359","ENSBGRT00000013493",0,"ENSBGRG00000007359","NA","GO:0004896(cytokine receptor activity);GO:0005515(protein binding);GO:0016020(membrane)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage);05200(Pathways in cancer)",{"v":4.9e-06,"d":"0.00"},1,"209,",0,-5.31,-4.57,{"v":21.6,"d":"21.60"},"5' UTR",31,8030794,8072597,41804,2]
["Y",8785358,8789448,4091,"ENSBGRG00000008103","ENSBGRT00000014802",180,"PLCXD1","phosphatidylinositol specific phospholipase C X domain containing 1 [Source:HGNC Symbol;Acc:HGNC:23148]","GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity)","NA",{"v":0.0011,"d":"0.00"},2,"94,57,","0,4034",-2.95,-2.32,{"v":2.5,"d":"2.50"},"5' UTR",31,8774599,8789628,15030,2]
["Y",9450696,9450815,120,"ENSBGRG00000008397","ENSBGRT00000015543",154358,"MID1","midline 1 [Source:HGNC Symbol;Acc:HGNC:7095]","GO:0005515(protein binding);GO:0005874(microtubule);GO:0005881(cytoplasmic microtubule);GO:0008017(microtubule binding);GO:0008270(zinc ion binding);GO:0019899(enzyme binding);GO:0031625(ubiquitin protein ligase binding);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0035372(protein localization to microtubule);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0051219(phosphoprotein binding)","04120(Ubiquitin mediated proteolysis)",{"v":2.1E-7,"d":"0.00"},1,"120,",0,-6.67,-5.89,2.05,"Exon (ENSBGRT00000015543/ENSBGRG00000008397, exon 11 of 11)",31,9450636,9605173,154538,2]
["Y",9604573,9604632,60,"ENSBGRG00000008397","ENSBGRT00000015543",541,"MID1","midline 1 [Source:HGNC Symbol;Acc:HGNC:7095]","GO:0005515(protein binding);GO:0005874(microtubule);GO:0005881(cytoplasmic microtubule);GO:0008017(microtubule binding);GO:0008270(zinc ion binding);GO:0019899(enzyme binding);GO:0031625(ubiquitin protein ligase binding);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0035372(protein localization to microtubule);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0051219(phosphoprotein binding)","04120(Ubiquitin mediated proteolysis)",0.01,1,"60,",0,-1.99,-1.42,{"v":5.4,"d":"5.40"},"Exon (ENSBGRT00000015543/ENSBGRG00000008397, exon 3 of 11)",31,9450636,9605173,154538,2]
["Y",12410261,12410438,178,"ENSBGRG00000012004","ENSBGRT00000021940",49965,"ENSBGRG00000012004","NA","NA","NA",{"v":4e-30,"d":"0.00"},1,"178,",0,{"v":-29.4,"d":"-29.40"},{"v":-28.3,"d":"-28.30"},2.31,"3' UTR",31,12409698,12460403,50706,2]
["Y",13680761,13680821,61,"ENSBGRG00000012976","ENSBGRT00000024265",73,"RBBP7","RB binding protein 7, chromatin remodeling factor [Source:HGNC Symbol;Acc:HGNC:9890]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016581(NuRD complex);GO:0030308(negative regulation of cell growth);GO:0035098(ESC/E(Z) complex);GO:0045892(negative regulation of transcription, DNA-templated);GO:0070370(cellular heat acclimation)","NA",{"v":2E-12,"d":"0.00"},1,"61,",0,{"v":-11.7,"d":"-11.70"},{"v":-10.9,"d":"-10.90"},1.78,"Exon (ENSBGRT00000024265/ENSBGRG00000012976, exon 1 of 13)",31,13659595,13680894,21300,2]
["Y",14819819,14819999,181,"ENSBGRG00000014390","ENSBGRT00000026401",80109,"RAI2","retinoic acid induced 2 [Source:HGNC Symbol;Acc:HGNC:9835]","NA","NA",{"v":1e-66,"d":"0.00"},1,"181,",0,-66,{"v":-64.5,"d":"-64.50"},3.17,"Exon (ENSBGRT00000026401/ENSBGRG00000014390, exon 2 of 4)",31,14751100,14900108,149009,2]
["Y",14820058,14820208,151,"ENSBGRG00000014390","ENSBGRT00000026401",79900,"RAI2","retinoic acid induced 2 [Source:HGNC Symbol;Acc:HGNC:9835]","NA","NA",{"v":1.3e-44,"d":"0.00"},1,"151,",0,{"v":-43.9,"d":"-43.90"},{"v":-42.6,"d":"-42.60"},2.22,"Exon (ENSBGRT00000026401/ENSBGRG00000014390, exon 2 of 4)",31,14751100,14900108,149009,2]
["Y",14820297,14820447,151,"ENSBGRG00000014390","ENSBGRT00000026401",79661,"RAI2","retinoic acid induced 2 [Source:HGNC Symbol;Acc:HGNC:9835]","NA","NA",{"v":1.6E-47,"d":"0.00"},1,"151,",0,{"v":-46.8,"d":"-46.80"},{"v":-45.5,"d":"-45.50"},2.03,"Exon (ENSBGRT00000026401/ENSBGRG00000014390, exon 2 of 4)",31,14751100,14900108,149009,2]
["Y",14821223,14821283,61,"ENSBGRG00000014390","ENSBGRT00000026401",78825,"RAI2","retinoic acid induced 2 [Source:HGNC Symbol;Acc:HGNC:9835]","NA","NA",{"v":2.5e-14,"d":"0.00"},1,"61,",0,{"v":-13.6,"d":"-13.60"},{"v":-12.7,"d":"-12.70"},2.06,"Exon (ENSBGRT00000026401/ENSBGRG00000014390, exon 2 of 4)",31,14751100,14900108,149009,2]
["Y",14899570,14899809,240,"ENSBGRG00000014390","ENSBGRT00000026401",299,"RAI2","retinoic acid induced 2 [Source:HGNC Symbol;Acc:HGNC:9835]","NA","NA",{"v":0.043,"d":"0.04"},1,"240,",0,-1.37,{"v":-0.6,"d":"-0.60"},6.48,"5' UTR",31,14751100,14900108,149009,2]
["Y",16189551,16193953,4403,"ENSBGRG00000016226","ENSBGRT00000030224",134520,"ADGRG2","adhesion G protein-coupled receptor G2 [Source:HGNC Symbol;Acc:HGNC:4516]","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","NA",{"v":6.3E-5,"d":"0.00"},2,"185,56,","0,4347",{"v":-4.2,"d":"-4.20"},-3.51,2.81,"Exon (ENSBGRT00000030224/ENSBGRG00000016226, exon 27 of 28)",31,16189551,16328473,138923,2]
["Y",16434701,16435088,388,"ENSBGRG00000016957","ENSBGRT00000031345",126618,"ARHGAP6","Rho GTPase activating protein 6 [Source:HGNC Symbol;Acc:HGNC:676]","GO:0005096(GTPase activator activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007015(actin filament organization);GO:0007165(signal transduction);GO:0015629(actin cytoskeleton);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0048041(focal adhesion assembly);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly)","NA",{"v":5e-66,"d":"0.00"},1,"388,",0,{"v":-65.3,"d":"-65.30"},{"v":-63.9,"d":"-63.90"},7.02,"3' UTR",31,16434313,16561706,127394,2]
["Y",16435207,16440829,5623,"ENSBGRG00000016957","ENSBGRT00000031345",120877,"ARHGAP6","Rho GTPase activating protein 6 [Source:HGNC Symbol;Acc:HGNC:676]","GO:0005096(GTPase activator activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007015(actin filament organization);GO:0007165(signal transduction);GO:0015629(actin cytoskeleton);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0048041(focal adhesion assembly);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly)","NA",{"v":1.6E-94,"d":"0.00"},3,"106,81,113,","0,3376,5510",{"v":-93.8,"d":"-93.80"},{"v":-92.2,"d":"-92.20"},{"v":2.8,"d":"2.80"},"3' UTR",31,16434313,16561706,127394,2]
["chr1",61183772,61214566,30795,"ENSBGRG00000000255","ENSBGRT00000000490",0,"PHLDB2","pleckstrin homology like domain family B member 2 [Source:HGNC Symbol;Acc:HGNC:29573]","GO:0000226(microtubule cytoskeleton organization);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0010470(regulation of gastrulation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0031252(cell leading edge);GO:0045111(intermediate filament cytoskeleton);GO:0045180(basal cortex);GO:0045184(establishment of protein localization);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:1903690(negative regulation of wound healing, spreading of epidermal cells);GO:1904261(positive regulation of basement membrane assembly involved in embryonic body morphogenesis)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);04141(Protein processing in endoplasmic reticulum)",{"v":5e-55,"d":"0.00"},2,"115,306,","0,30489",{"v":-54.3,"d":"-54.30"},{"v":-52.9,"d":"-52.90"},2.81,"5' UTR",1,61183772,61303761,119990,1]
["chr1",61237880,61248748,10869,"ENSBGRG00000000255","ENSBGRT00000000490",54108,"PHLDB2","pleckstrin homology like domain family B member 2 [Source:HGNC Symbol;Acc:HGNC:29573]","GO:0000226(microtubule cytoskeleton organization);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0010470(regulation of gastrulation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0031252(cell leading edge);GO:0045111(intermediate filament cytoskeleton);GO:0045180(basal cortex);GO:0045184(establishment of protein localization);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:1903690(negative regulation of wound healing, spreading of epidermal cells);GO:1904261(positive regulation of basement membrane assembly involved in embryonic body morphogenesis)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);04141(Protein processing in endoplasmic reticulum)",{"v":6.3e-23,"d":"0.00"},2,"18,133,","0,10736",{"v":-22.2,"d":"-22.20"},{"v":-21.2,"d":"-21.20"},2.01,"Exon (ENSBGRT00000000490/ENSBGRG00000000255, exon 3 of 19)",1,61183772,61303761,119990,1]
["chr1",61311094,61311797,704,"ENSBGRG00000000255","ENSBGRT00000000416",127322,"PHLDB2","pleckstrin homology like domain family B member 2 [Source:HGNC Symbol;Acc:HGNC:29573]","GO:0000226(microtubule cytoskeleton organization);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0010470(regulation of gastrulation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0031252(cell leading edge);GO:0045111(intermediate filament cytoskeleton);GO:0045180(basal cortex);GO:0045184(establishment of protein localization);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:1903690(negative regulation of wound healing, spreading of epidermal cells);GO:1904261(positive regulation of basement membrane assembly involved in embryonic body morphogenesis)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);04141(Protein processing in endoplasmic reticulum)",{"v":1e-212,"d":"0.00"},2,"10,141,","0,563",-212,-210,2.61,"Exon (ENSBGRT00000000416/ENSBGRG00000000255, exon 17 of 18)",1,61183772,61311797,128026,1]
["chr1",95557701,95558742,1042,"ENSBGRG00000003142","ENSBGRT00000005846",0,"MFN1","mitofusin 1 [Source:HGNC Symbol;Acc:HGNC:18262]","GO:0003676(nucleic acid binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0008053(mitochondrial fusion);GO:0010918(positive regulation of mitochondrial membrane potential);GO:0016021(integral component of membrane);GO:0031307(integral component of mitochondrial outer membrane);GO:0042802(identical protein binding);GO:0046039(GTP metabolic process);GO:0051646(mitochondrion localization);GO:0098799(outer mitochondrial membrane protein complex);GO:1990613(mitochondrial membrane fusion)","04137(Mitophagy - animal);04621(NOD-like receptor signaling pathway)",{"v":1e-157,"d":"0.00"},2,"767,126,","0,916",-157,-155,{"v":10.8,"d":"10.80"},"Exon (ENSBGRT00000005846/ENSBGRG00000003142, exon 1 of 18)",1,95499008,95557831,58824,2]
["chr2",135117624,135117954,331,"ENSBGRG00000002427","ENSBGRT00000004514",1957,"ENSBGRG00000002427","NA","NA","NA",{"v":4.3E-3,"d":"0.00"},1,"331,",0,-2.37,-1.77,8.64,"Exon (ENSBGRT00000004514/ENSBGRG00000002427, exon 2 of 2)",2,135115736,135119911,4176,2]
["chr4",101579906,101643872,63967,"ENSBGRG00000002148","ENSBGRT00000004010",0,"ENSBGRG00000002148","NA","NA","NA",{"v":0.0021,"d":"0.00"},3,"3286,456,802,","0,52199,63165",-2.67,-2.06,{"v":11.9,"d":"11.90"},"Exon (ENSBGRT00000004010/ENSBGRG00000002148, exon 1 of 2)",4,101579906,101632560,52655,2]
["chr5",81708154,81708951,798,"ENSBGRG00000003819","ENSBGRT00000007074",0,"HOXC9","homeobox C9 [Source:HGNC Symbol;Acc:HGNC:5130]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0009952(anterior/posterior pattern specification);GO:0016235(aggresome);GO:0043565(sequence-specific DNA binding);GO:0048704(embryonic skeletal system morphogenesis);GO:0048706(embryonic skeletal system development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":3.8e-05,"d":"0.00"},2,"358,147,","0,651",-4.42,-3.72,{"v":18.4,"d":"18.40"},"5' UTR",5,81708154,81720928,12775,1]
["chr5",81720875,81721171,297,"ENSBGRG00000003819","ENSBGRT00000007074",12721,"HOXC9","homeobox C9 [Source:HGNC Symbol;Acc:HGNC:5130]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0009952(anterior/posterior pattern specification);GO:0016235(aggresome);GO:0043565(sequence-specific DNA binding);GO:0048704(embryonic skeletal system morphogenesis);GO:0048706(embryonic skeletal system development);GO:1990837(sequence-specific double-stranded DNA binding)","NA",{"v":1e-120,"d":"0.00"},1,"297,",0,-120,-118,4.56,"3' UTR",5,81708154,81720928,12775,1]
["chr9",2657542,2658497,956,"ENSBGRG00000016924","ENSBGRT00000031069",398,"ENSBGRG00000016924","NA","NA","NA",{"v":0.00072,"d":"0.00"},1,"956,",0,-3.14,{"v":-2.5,"d":"-2.50"},6.12,"Exon (ENSBGRT00000031069/ENSBGRG00000016924, exon 1 of 2)",9,2657453,2658895,1443,2]
["chr9",2658586,2659959,1374,"ENSBGRG00000016924","ENSBGRT00000031069",0,"ENSBGRG00000016924","NA","NA","NA",{"v":2.9E-4,"d":"0.00"},1,"1374,",0,-3.54,-2.87,{"v":15.1,"d":"15.10"},"Exon (ENSBGRT00000031069/ENSBGRG00000016924, exon 1 of 2)",9,2657453,2658895,1443,2]
["chr9",7532436,7533153,718,"ENSBGRG00000009047","ENSBGRT00000017212",4305,"ENSBGRG00000009047","NA","NA","NA",{"v":0.0078,"d":"0.01"},1,"718,",0,-2.11,-1.53,8.64,"Exon (ENSBGRT00000017212/ENSBGRG00000009047, exon 3 of 3)",9,7531809,7537458,5650,2]
["chr11",9069843,9069993,151,"ENSBGRG00000022370","ENSBGRT00000041333",0,"ENSBGRG00000022370","NA","NA","NA",{"v":3.1e-05,"d":"0.00"},1,"151,",0,-4.51,-3.81,4.08,"Exon (ENSBGRT00000041333/ENSBGRG00000022370, exon 1 of 2)",11,9068519,9069993,1475,2]
["chr17",71970478,71970627,150,"ENSBGRG00000011625","ENSBGRT00000021160",400,"ENSBGRG00000011625","NA","NA","NA",{"v":4.3E-3,"d":"0.00"},1,"150,",0,-2.37,-1.77,6.48,"Exon (ENSBGRT00000021160/ENSBGRG00000011625, exon 1 of 3)",17,71965931,71971027,5097,2]
["chr20",66492813,66494167,1355,"ENSBGRG00000020492","ENSBGRT00000038236",29124,"AKT2","AKT serine/threonine kinase 2 [Source:HGNC Symbol;Acc:HGNC:392]","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006006(glucose metabolic process);GO:0006468(protein phosphorylation);GO:0008284(positive regulation of cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0010748(negative regulation of long-chain fatty acid import across plasma membrane);GO:0010907(positive regulation of glucose metabolic process);GO:0010918(positive regulation of mitochondrial membrane potential);GO:0030335(positive regulation of cell migration);GO:0031340(positive regulation of vesicle fusion);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0032287(peripheral nervous system myelin maintenance);GO:0032587(ruffle membrane);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0046326(positive regulation of glucose import);GO:0065002(intracellular protein transmembrane transport);GO:0071486(cellular response to high light intensity);GO:0072659(protein localization to plasma membrane);GO:0090314(positive regulation of protein targeting to membrane);GO:0090630(activation of GTPase activity);GO:0097473(retinal rod cell apoptotic process);GO:2000147(positive regulation of cell motility)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04371(Apelin signaling pathway);04630(Jak-STAT signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04218(Cellular senescence);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04919(Thyroid hormone signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04973(Carbohydrate digestion and absorption);04725(Cholinergic synapse);04728(Dopaminergic synapse);04722(Neurotrophin signaling pathway);04380(Osteoclast differentiation);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05205(Proteoglycans in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05152(Tuberculosis);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05145(Toxoplasmosis);05142(Chagas disease (American trypanosomiasis));01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":1e-220,"d":"0.00"},2,"18,371,","0,984",-220,-218,4.08,"3' UTR",20,66463689,66494176,30488,1]
["chr20",59646393,59647528,1136,"ENSBGRG00000018680","ENSBGRT00000034477",4486,"BAX","BCL2 associated X, apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:959]","GO:0001541(ovarian follicle development);GO:0001764(neuron migration);GO:0001776(leukocyte homeostasis);GO:0001777(T cell homeostatic proliferation);GO:0001782(B cell homeostasis);GO:0001783(B cell apoptotic process);GO:0001822(kidney development);GO:0001836(release of cytochrome c from mitochondria);GO:0001844(protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:0001974(blood vessel remodeling);GO:0002262(myeloid cell homeostasis);GO:0002352(B cell negative selection);GO:0002358(B cell homeostatic proliferation);GO:0002904(positive regulation of B cell apoptotic process);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005757(mitochondrial permeability transition pore complex);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0006687(glycosphingolipid metabolic process);GO:0006808(regulation of nitrogen utilization);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006974(cellular response to DNA damage stimulus);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0007399(nervous system development);GO:0007548(sex differentiation);GO:0008053(mitochondrial fusion);GO:0008199(ferric iron binding);GO:0008283(cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008289(lipid binding);GO:0008584(male gonad development);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0008635(activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c);GO:0008637(apoptotic mitochondrial changes);GO:0009566(fertilization);GO:0009611(response to wounding);GO:0009636(response to toxic substance);GO:0009651(response to salt stress);GO:0009791(post-embryonic development);GO:0010212(response to ionizing radiation);GO:0010248(establishment or maintenance of transmembrane electrochemical gradient);GO:0010332(response to gamma radiation);GO:0010524(positive regulation of calcium ion transport into cytosol);GO:0010917(negative regulation of mitochondrial membrane potential);GO:0015267(channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021854(hypothalamus development);GO:0021987(cerebral cortex development);GO:0030544(Hsp70 protein binding);GO:0031334(positive regulation of protein-containing complex assembly);GO:0031966(mitochondrial membrane);GO:0032091(negative regulation of protein binding);GO:0032471(negative regulation of endoplasmic reticulum calcium ion concentration);GO:0032976(release of matrix enzymes from mitochondria);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0033599(regulation of mammary gland epithelial cell proliferation);GO:0034644(cellular response to UV);GO:0035108(limb morphogenesis);GO:0035234(ectopic germ cell programmed cell death);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043281(regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0043525(positive regulation of neuron apoptotic process);GO:0043653(mitochondrial fragmentation involved in apoptotic process);GO:0045136(development of secondary sexual characteristics);GO:0046666(retinal cell programmed cell death);GO:0046930(pore complex);GO:0046982(protein heterodimerization activity);GO:0048087(positive regulation of developmental pigmentation);GO:0048147(negative regulation of fibroblast proliferation);GO:0048515(spermatid differentiation);GO:0048597(post-embryonic camera-type eye morphogenesis);GO:0048678(response to axon injury);GO:0048872(homeostasis of number of cells);GO:0048873(homeostasis of number of cells within a tissue);GO:0051087(chaperone binding);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0051402(neuron apoptotic process);GO:0051434(BH3 domain binding);GO:0051726(regulation of cell cycle);GO:0051881(regulation of mitochondrial membrane potential);GO:0060011(Sertoli cell proliferation);GO:0060041(retina development in camera-type eye);GO:0060058(positive regulation of apoptotic process involved in mammary gland involution);GO:0060068(vagina development);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress);GO:0070242(thymocyte apoptotic process);GO:0070584(mitochondrion morphogenesis);GO:0071310(cellular response to organic substance);GO:0071944(cell periphery);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0097136(Bcl-2 family protein complex);GO:0097144(BAX complex);GO:0097145(BAK complex);GO:0097190(apoptotic signaling pathway);GO:0097191(extrinsic apoptotic signaling pathway);GO:0097192(extrinsic apoptotic signaling pathway in absence of ligand);GO:0097193(intrinsic apoptotic signaling pathway);GO:0097296(activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway);GO:1900103(positive regulation of endoplasmic reticulum unfolded protein response);GO:1902108(regulation of mitochondrial membrane permeability involved in apoptotic process);GO:1902110(positive regulation of mitochondrial membrane permeability involved in apoptotic process);GO:1902262(apoptotic process involved in blood vessel morphogenesis);GO:1902263(apoptotic process involved in embryonic digit morphogenesis);GO:1902445(regulation of mitochondrial membrane permeability involved in programmed necrotic cell death);GO:1902512(positive regulation of apoptotic DNA fragmentation);GO:1990117(B cell receptor apoptotic signaling pathway);GO:2001234(negative regulation of apoptotic signaling pathway);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","04216(Ferroptosis);04217(Necroptosis);04978(Mineral absorption);04141(Protein processing in endoplasmic reticulum);04071(Sphingolipid signaling pathway);04210(Apoptosis);04215(Apoptosis - multiple species);04115(p53 signaling pathway);04722(Neurotrophin signaling pathway);04211(Longevity regulating pathway - mammal);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05216(Thyroid cancer);05220(Chronic myeloid leukemia);05217(Basal cell carcinoma);05218(Melanoma);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05014(Amyotrophic lateral sclerosis (ALS));05016(Huntington disease);05020(Prion diseases);04932(Non-alcoholic fatty liver disease (NAFLD));04933(AGE-RAGE signaling pathway in diabetic complications);05152(Tuberculosis);05166(HTLV-I infection);05161(Hepatitis B);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection);01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":0.0041,"d":"0.00"},2,"83,217,","0,919",-2.39,-1.79,{"v":10.8,"d":"10.80"},"3' UTR",20,59641685,59652014,10330,2]
["chr20",59651541,59652650,1110,"ENSBGRG00000018680","ENSBGRT00000034477",0,"BAX","BCL2 associated X, apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:959]","GO:0001541(ovarian follicle development);GO:0001764(neuron migration);GO:0001776(leukocyte homeostasis);GO:0001777(T cell homeostatic proliferation);GO:0001782(B cell homeostasis);GO:0001783(B cell apoptotic process);GO:0001822(kidney development);GO:0001836(release of cytochrome c from mitochondria);GO:0001844(protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:0001974(blood vessel remodeling);GO:0002262(myeloid cell homeostasis);GO:0002352(B cell negative selection);GO:0002358(B cell homeostatic proliferation);GO:0002904(positive regulation of B cell apoptotic process);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005757(mitochondrial permeability transition pore complex);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0006687(glycosphingolipid metabolic process);GO:0006808(regulation of nitrogen utilization);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006974(cellular response to DNA damage stimulus);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0007399(nervous system development);GO:0007548(sex differentiation);GO:0008053(mitochondrial fusion);GO:0008199(ferric iron binding);GO:0008283(cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008289(lipid binding);GO:0008584(male gonad development);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0008635(activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c);GO:0008637(apoptotic mitochondrial changes);GO:0009566(fertilization);GO:0009611(response to wounding);GO:0009636(response to toxic substance);GO:0009651(response to salt stress);GO:0009791(post-embryonic development);GO:0010212(response to ionizing radiation);GO:0010248(establishment or maintenance of transmembrane electrochemical gradient);GO:0010332(response to gamma radiation);GO:0010524(positive regulation of calcium ion transport into cytosol);GO:0010917(negative regulation of mitochondrial membrane potential);GO:0015267(channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021854(hypothalamus development);GO:0021987(cerebral cortex development);GO:0030544(Hsp70 protein binding);GO:0031334(positive regulation of protein-containing complex assembly);GO:0031966(mitochondrial membrane);GO:0032091(negative regulation of protein binding);GO:0032471(negative regulation of endoplasmic reticulum calcium ion concentration);GO:0032976(release of matrix enzymes from mitochondria);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0033599(regulation of mammary gland epithelial cell proliferation);GO:0034644(cellular response to UV);GO:0035108(limb morphogenesis);GO:0035234(ectopic germ cell programmed cell death);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043281(regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0043525(positive regulation of neuron apoptotic process);GO:0043653(mitochondrial fragmentation involved in apoptotic process);GO:0045136(development of secondary sexual characteristics);GO:0046666(retinal cell programmed cell death);GO:0046930(pore complex);GO:0046982(protein heterodimerization activity);GO:0048087(positive regulation of developmental pigmentation);GO:0048147(negative regulation of fibroblast proliferation);GO:0048515(spermatid differentiation);GO:0048597(post-embryonic camera-type eye morphogenesis);GO:0048678(response to axon injury);GO:0048872(homeostasis of number of cells);GO:0048873(homeostasis of number of cells within a tissue);GO:0051087(chaperone binding);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0051402(neuron apoptotic process);GO:0051434(BH3 domain binding);GO:0051726(regulation of cell cycle);GO:0051881(regulation of mitochondrial membrane potential);GO:0060011(Sertoli cell proliferation);GO:0060041(retina development in camera-type eye);GO:0060058(positive regulation of apoptotic process involved in mammary gland involution);GO:0060068(vagina development);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress);GO:0070242(thymocyte apoptotic process);GO:0070584(mitochondrion morphogenesis);GO:0071310(cellular response to organic substance);GO:0071944(cell periphery);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0097136(Bcl-2 family protein complex);GO:0097144(BAX complex);GO:0097145(BAK complex);GO:0097190(apoptotic signaling pathway);GO:0097191(extrinsic apoptotic signaling pathway);GO:0097192(extrinsic apoptotic signaling pathway in absence of ligand);GO:0097193(intrinsic apoptotic signaling pathway);GO:0097296(activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway);GO:1900103(positive regulation of endoplasmic reticulum unfolded protein response);GO:1902108(regulation of mitochondrial membrane permeability involved in apoptotic process);GO:1902110(positive regulation of mitochondrial membrane permeability involved in apoptotic process);GO:1902262(apoptotic process involved in blood vessel morphogenesis);GO:1902263(apoptotic process involved in embryonic digit morphogenesis);GO:1902445(regulation of mitochondrial membrane permeability involved in programmed necrotic cell death);GO:1902512(positive regulation of apoptotic DNA fragmentation);GO:1990117(B cell receptor apoptotic signaling pathway);GO:2001234(negative regulation of apoptotic signaling pathway);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","04216(Ferroptosis);04217(Necroptosis);04978(Mineral absorption);04141(Protein processing in endoplasmic reticulum);04071(Sphingolipid signaling pathway);04210(Apoptosis);04215(Apoptosis - multiple species);04115(p53 signaling pathway);04722(Neurotrophin signaling pathway);04211(Longevity regulating pathway - mammal);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05216(Thyroid cancer);05220(Chronic myeloid leukemia);05217(Basal cell carcinoma);05218(Melanoma);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05014(Amyotrophic lateral sclerosis (ALS));05016(Huntington disease);05020(Prion diseases);04932(Non-alcoholic fatty liver disease (NAFLD));04933(AGE-RAGE signaling pathway in diabetic complications);05152(Tuberculosis);05166(HTLV-I infection);05161(Hepatitis B);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection);01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance)",{"v":4.2e-06,"d":"0.00"},2,"474,34,","0,1076",-5.38,-4.64,{"v":12.4,"d":"12.40"},"5' UTR",20,59641685,59652014,10330,2]
["chr25",56557188,56558361,1174,"ENSBGRG00000014069","ENSBGRT00000027055",2213,"ENSBGRG00000014069","NA","GO:0035082(axoneme assembly);GO:0060294(cilium movement involved in cell motility)","NA",{"v":0.043,"d":"0.04"},2,"25,154,","0,1020",-1.37,{"v":-0.6,"d":"-0.60"},4.32,"Exon (ENSBGRT00000027055/ENSBGRG00000014069, exon 3 of 21)",25,56510246,56560574,50329,2]